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Supplementary Table 2. All the peptides identified by LC-MS/MS in the  Guanidine extracts
Search Engine Set: 2 Search Engines
Search Engine: Sequest
Version: SRF v. 5
Samples: All Samples
Fragment Tolerance: 1.00 Da (Monoisotopic)
Parent Tolerance: 1.5 Da (Monoisotopic)
Fixed Modifications: +57 on C (Carbamidomethyl)
Variable Modifications: +16 on M (Oxidation)
Database: the human_Trypsin_C57.fasta.hdr database (UniProtKB/Swiss-Prot Release 14.6, 20333 entries)
Digestion Enzyme: Trypsin
Max Missed Cleavages: 2
Search Engine: X! Tandem
Version: 2007.01.01.2
Samples: All Samples
Fragment Tolerance: 1.00 Da (Monoisotopic)
Parent Tolerance: 1.5 Da (Monoisotopic)
Fixed Modifications: +57 on C (Carbamidomethyl)
Variable Modifications: +16 on M (Oxidation)
Database: a subset of the 14.6human database
Digestion Enzyme: Trypsin
Max Missed Cleavages: 2
Scaffold Version: Scaffold_2_05_00
Peptide Thresholds: X! Tandem: -Log(Expect Scores) scores of greater than 2.0, Sequest: deltaCn scores of greater than 0.10 and XCorr scores of greater than , 2.5, 3.5 and 3.5 for , doubly, triply and quadruply charged peptides
Protein Thresholds: 2 peptides minimum
SAMPLE PROTEIN NAME Protein accession Protein Mw (Da) Protein ID probability Unique peptides, n Unique spectra, n Total spectra, n % coverage Peptide sequence Peptide ID probability SEQUEST XCorr score SEQUEST DCn score X! Tandem -log(e) score Variable modifications Observed m/z Actual peptide mass (AMU) Calculated +1H Peptide Mass (AMU) Spectrum charge Other Proteins
 SAMPLE 1 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1  PLCD1  PLCD1_HUMAN 85,648.70 99.80% 2 2 2 3.31% ALAQGPWWAR 95.00% 2.43 0.431 0 578.3064 1,154.60 1,155.61 2
 SAMPLE 1 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1  PLCD1  PLCD1_HUMAN 85,648.70 99.80% 2 2 2 3.31% EEAAGPALALSLIER 95.00% 3.93 0.521 3.92 770.4205 1,538.83 1,539.84 2
 SAMPLE 3R 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1  PLCD1  PLCD1_HUMAN 85,648.70 100.00% 3 3 4 4.76% ALAQGPWWAR 95.00% 2.36 0.272 2.59 578.3055 1,154.60 1,155.61 2
 SAMPLE 3R 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1  PLCD1  PLCD1_HUMAN 85,648.70 100.00% 3 3 4 4.76% LLQESGNGFVR 95.00% 2.8 0.383 0 610.3281 1,218.64 1,219.64 2
 SAMPLE 3R 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1  PLCD1  PLCD1_HUMAN 85,648.70 100.00% 3 3 4 4.76% EEAAGPALALSLIER 95.00% 2.37 0.355 0 770.4237 1,538.83 1,539.84 2
 SAMPLE 3R 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1  PLCD1  PLCD1_HUMAN 85,648.70 100.00% 3 3 4 4.76% EEAAGPALALSLIER 95.00% 3.92 0.532 4.51 770.9229 1,539.83 1,539.84 2
 SAMPLE 3 14-3-3 protein theta  YWHAQ  1433T_HUMAN 27,747.40 99.80% 2 2 2 10.20% YLAEVAcGDDR 95.00% 2.55 0.39 0 c7: Carbamidomethyl (+57.02) 635.3173 1,268.62 1,268.56 2
 SAMPLE 3 14-3-3 protein theta  YWHAQ  1433T_HUMAN 27,747.40 99.80% 2 2 2 10.20% AVTEQGAELSNEER 95.00% 4.74 0.516 4.96 766.8625 1,531.71 1,532.72 2
 SAMPLE 1 14-3-3 protein zeta/delta  YWHAZ  1433Z_HUMAN 27,727.90 99.80% 2 2 3 17.60% DSTLIMQLLR 95.00% 3.16 0.219 0 595.3436 1,188.67 1,189.66 2 1433T_HUMAN,TITIN_HUMAN
 SAMPLE 1 14-3-3 protein zeta/delta  YWHAZ  1433Z_HUMAN 27,727.90 99.80% 2 2 3 17.60% GIVDQSQQAYQEAFEISKK 95.00% 2.56 0.304 0 724.0321 2,169.07 2,169.08 3
 SAMPLE 1 14-3-3 protein zeta/delta  YWHAZ  1433Z_HUMAN 27,727.90 99.80% 2 2 3 17.60% GIVDQSQQAYQEAFEISKK 95.00% 3.09 0.446 0 724.0373 2,169.09 2,169.08 3
 SAMPLE 1 14-3-3 protein zeta/delta  YWHAZ  1433Z_HUMAN 27,727.90 99.80% 2 2 3 17.60% SVTEQGAELSNEER 95.00% 4.38 0.543 3 775.3644 1,548.71 1,548.71 2
 SAMPLE 1R 14-3-3 protein zeta/delta  YWHAZ  1433Z_HUMAN 27,727.90 100.00% 3 3 3 22.40% DSTLIMQLLR 95.00% 3.16 0.219 0 595.3436 1,188.67 1,189.66 2 1433T_HUMAN,TITIN_HUMAN
 SAMPLE 1R 14-3-3 protein zeta/delta  YWHAZ  1433Z_HUMAN 27,727.90 100.00% 3 3 3 22.40% DSTLIMQLLR 95.00% 2.52 0.209 0 595.3475 1,188.68 1,189.66 2 1433T_HUMAN,TITIN_HUMAN
 SAMPLE 1R 14-3-3 protein zeta/delta  YWHAZ  1433Z_HUMAN 27,727.90 100.00% 3 3 3 22.40% DIcNDVLSLLEK 95.00% 3.01 0.239 3.54 c3: Carbamidomethyl (+57.02) 709.8631 1,417.71 1,418.72 2
 SAMPLE 1R 14-3-3 protein zeta/delta  YWHAZ  1433Z_HUMAN 27,727.90 100.00% 3 3 3 22.40% GIVDQSQQAYQEAFEISKK 95.00% 3.09 0.446 0 724.0373 2,169.09 2,169.08 3
 SAMPLE 1R 14-3-3 protein zeta/delta  YWHAZ  1433Z_HUMAN 27,727.90 100.00% 3 3 3 22.40% SVTEQGAELSNEER 95.00% 4.38 0.543 2.41 775.3644 1,548.71 1,548.71 2
 SAMPLE 2R 14-3-3 protein zeta/delta  YWHAZ  1433Z_HUMAN 27,727.90 99.80% 2 2 3 10.60% DIcNDVLSLLEK 95.00% 3.04 0.208 2.7 c3: Carbamidomethyl (+57.02) 709.863 1,417.71 1,418.72 2
 SAMPLE 2R 14-3-3 protein zeta/delta  YWHAZ  1433Z_HUMAN 27,727.90 99.80% 2 2 3 10.60% SVTEQGAELSNEER 95.00% 5.05 0.537 4.21 774.8587 1,547.70 1,548.71 2
 SAMPLE 2R 14-3-3 protein zeta/delta  YWHAZ  1433Z_HUMAN 27,727.90 99.80% 2 2 3 10.60% SVTEQGAELSNEER 95.00% 5.24 0.514 3.96 775.3615 1,548.71 1,548.71 2
 SAMPLE 3R 3-hydroxyacyl-CoA dehydrogenase type-2  HSD17B10  HCD2_HUMAN 26,905.10 99.80% 2 2 4 12.30% GGIVGMTLPIAR 95.00% 2.83 0.28 0 592.8421 1,183.67 1,184.68 2
 SAMPLE 3R 3-hydroxyacyl-CoA dehydrogenase type-2  HSD17B10  HCD2_HUMAN 26,905.10 99.80% 2 2 4 12.30% GGIVGMTLPIAR 95.00% 2.8 0.332 1.35 592.8427 1,183.67 1,184.68 2
 SAMPLE 3R 3-hydroxyacyl-CoA dehydrogenase type-2  HSD17B10  HCD2_HUMAN 26,905.10 99.80% 2 2 4 12.30% GGIVGMTLPIAR 95.00% 3.13 0.306 1.09 593.3495 1,184.68 1,184.68 2
 SAMPLE 3R 3-hydroxyacyl-CoA dehydrogenase type-2  HSD17B10  HCD2_HUMAN 26,905.10 99.80% 2 2 4 12.30% GLVAVITGGASGLGLATAER 95.00% 2.36 0.441 0 605.0092 1,812.00 1,813.02 3
 SAMPLE 2 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 99.90% 2 2 3 17.90% TPGPGAQSALR 95.00% 1.76 0.318 2 527.7856 1,053.56 1,054.56 2
 SAMPLE 2 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 99.90% 2 2 3 17.90% TPGPGAQSALR 95.00% 2.22 0.411 2 527.7858 1,053.56 1,054.56 2
 SAMPLE 2 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 99.90% 2 2 3 17.90% IGRIEDVTPIPSDSTR 95.00% 2.66 0.253 0 878.3737 1,754.73 1,755.92 2
 SAMPLE 3 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 6 6 8 26.50% cKELGITALHIK 95.00% 3.18 0.412 0 c1: Carbamidomethyl (+57.02) 461.934 1,382.78 1,382.78 3
 SAMPLE 3 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 6 6 8 26.50% TPGPGAQSALR 95.00% 1.99 0.368 0 527.7867 1,053.56 1,054.56 2
 SAMPLE 3 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 6 6 8 26.50% IEDVTPIPSDSTRR 95.00% 2.07 0.258 0 529.2771 1,584.81 1,585.82 3
 SAMPLE 3 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 6 6 8 26.50% ELGITALHIK 95.00% 2.89 0.383 2.96 547.8304 1,093.65 1,094.66 2
 SAMPLE 3 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 6 6 8 26.50% ELGITALHIK 95.00% 2.86 0.374 1.8 547.831 1,093.65 1,094.66 2
 SAMPLE 3 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 6 6 8 26.50% IGRIEDVTPIPSDSTR 95.00% 2.59 0.155 1.29 586.3141 1,755.92 1,755.92 3
 SAMPLE 3 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 6 6 8 26.50% IEDVTPIPSDSTR 95.00% 3.45 0.11 2.92 715.3609 1,428.71 1,429.72 2
 SAMPLE 3 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 6 6 8 26.50% IEDVTPIPSDSTR 95.00% 3.96 0.486 3.74 715.3624 1,428.71 1,429.72 2
 SAMPLE 3R 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 3 3 5 15.20% cKELGITALHIK 95.00% 3.84 0.455 0 c1: Carbamidomethyl (+57.02) 461.6002 1,381.78 1,382.78 3
 SAMPLE 3R 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 3 3 5 15.20% cKELGITALHIK 95.00% 3.18 0.445 0 c1: Carbamidomethyl (+57.02) 461.9337 1,382.78 1,382.78 3
 SAMPLE 3R 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 3 3 5 15.20% TPGPGAQSALR 95.00% 2.01 0.448 0 527.7851 1,053.55 1,054.56 2
 SAMPLE 3R 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 3 3 5 15.20% ELGITALHIK 95.00% 2.98 0.372 2.64 547.8313 1,093.65 1,094.66 2
 SAMPLE 3R 40S ribosomal protein S14  RPS14  RS14_HUMAN 16,254.90 100.00% 3 3 5 15.20% ELGITALHIK 95.00% 2.76 0.357 2.52 547.8323 1,093.65 1,094.66 2
 SAMPLE 3 40S ribosomal protein S15a  RPS15A  RS15A_HUMAN 14,822.00 99.80% 2 2 3 17.70% MNVLADALK 95.00% 2.4 0.166 0 487.7705 973.5254 974.5346 2
 SAMPLE 3 40S ribosomal protein S15a  RPS15A  RS15A_HUMAN 14,822.00 99.80% 2 2 3 17.70% HGYIGEFEIIDDHR 95.00% 3.96 0.476 2.21 567.6049 1,699.79 1,700.80 3
 SAMPLE 3 40S ribosomal protein S15a  RPS15A  RS15A_HUMAN 14,822.00 99.80% 2 2 3 17.70% HGYIGEFEIIDDHR 95.00% 4.09 0.486 1.11 567.6055 1,699.79 1,700.80 3
 SAMPLE 2 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 5 7 29.50% LLEPVLLLGKER 95.00% 2.03 0.328 0 460.6261 1,378.85 1,379.86 3
 SAMPLE 2 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 5 7 29.50% EIKDILIQYDR 95.00% 2.33 0.214 0 469.2608 1,404.76 1,405.77 3
 SAMPLE 2 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 5 7 29.50% EIKDILIQYDR 95.00% 2.95 0.226 0 469.261 1,404.76 1,405.77 3
 SAMPLE 2 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 5 7 29.50% ALVAYYQK 95.00% 2.47 0.191 0 478.2661 954.5165 955.5253 2
 SAMPLE 2 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 5 7 29.50% LLEPVLLLGK 95.00% 2.28 0.342 0 547.8623 1,093.71 1,094.72 2 CADH1_HUMAN
 SAMPLE 2 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 5 7 29.50% LLEPVLLLGK 95.00% 2.23 0.351 0 547.8627 1,093.71 1,094.72 2 CADH1_HUMAN
 SAMPLE 2 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 5 7 29.50% LLEPVLLLGK 95.00% 2.53 0.373 0 547.8635 1,093.71 1,094.72 2 CADH1_HUMAN
 SAMPLE 2 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 5 7 29.50% GGGHVAQIYAIR 95.00% 2.91 0.477 2.34 621.3402 1,240.66 1,241.68 2
 SAMPLE 2 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 5 7 29.50% GGGHVAQIYAIR 95.00% 3.16 0.519 3.25 621.3409 1,240.67 1,241.68 2
 SAMPLE 2 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 5 7 29.50% EIKDILIQYDR 95.00% 2.58 0.456 0 703.3862 1,404.76 1,405.77 2
 SAMPLE 2R 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 99.80% 2 2 2 22.60% EIKDILIQYDR 95.00% 2.24 0.181 0 469.2616 1,404.76 1,405.77 3
 SAMPLE 2R 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 99.80% 2 2 2 22.60% LLEPVLLLGK 95.00% 2.24 0.297 0 547.8622 1,093.71 1,094.72 2 CADH1_HUMAN
 SAMPLE 2R 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 99.80% 2 2 2 22.60% GGGHVAQIYAIR 95.00% 2.5 0.412 1.51 621.3404 1,240.67 1,241.68 2
 SAMPLE 3 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 4 7 36.30% VNGRPLEMIEPR 95.00% 2.93 0.264 1.27 470.9227 1,409.74 1,410.75 3
 SAMPLE 3 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 4 7 36.30% ALVAYYQK 95.00% 2.49 0.228 0 478.2664 954.5172 955.5253 2
 SAMPLE 3 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 4 7 36.30% ALVAYYQK 95.00% 2.24 0.236 0 478.2686 954.5215 955.5253 2
 SAMPLE 3 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 4 7 36.30% LLEPVLLLGK 95.00% 2.36 0.284 0 547.862 1,093.71 1,094.72 2 CADH1_HUMAN
 SAMPLE 3 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 4 7 36.30% LLEPVLLLGK 95.00% 2.32 0.237 0 547.8625 1,093.71 1,094.72 2 CADH1_HUMAN
 SAMPLE 3 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 4 7 36.30% GGGHVAQIYAIR 95.00% 3.31 0.47 2.35 621.3396 1,240.66 1,241.68 2
 SAMPLE 3 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 4 7 36.30% GGGHVAQIYAIR 95.00% 3.34 0.506 2.8 621.3404 1,240.67 1,241.68 2
 SAMPLE 3 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 4 7 36.30% EIKDILIQYDR 95.00% 2.66 0.446 1.77 703.3874 1,404.76 1,405.77 2
 SAMPLE 3 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 4 4 7 36.30% EIKDILIQYDR 95.00% 2.64 0.416 0 703.3878 1,404.76 1,405.77 2
 SAMPLE 3R 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 3 3 5 28.10% ALVAYYQK 95.00% 2.5 0.211 0 478.2662 954.5167 955.5253 2
 SAMPLE 3R 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 3 3 5 28.10% LLEPVLLLGK 95.00% 2.38 0.376 0 547.8623 1,093.71 1,094.72 2 CADH1_HUMAN
 SAMPLE 3R 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 3 3 5 28.10% LLEPVLLLGK 95.00% 2.38 0.373 0 547.8628 1,093.71 1,094.72 2 CADH1_HUMAN
 SAMPLE 3R 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 3 3 5 28.10% GGGHVAQIYAIR 95.00% 3.12 0.447 2.35 621.3404 1,240.67 1,241.68 2
 SAMPLE 3R 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 3 3 5 28.10% GGGHVAQIYAIR 95.00% 3.34 0.527 2.31 621.3413 1,240.67 1,241.68 2
 SAMPLE 3R 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 3 3 5 28.10% EIKDILIQYDR 95.00% 2.84 0.473 1.3 703.3846 1,404.75 1,405.77 2
 SAMPLE 3R 40S ribosomal protein S16  RPS16  RS16_HUMAN 16,427.90 100.00% 3 3 5 28.10% EIKDILIQYDR 95.00% 3.32 0.416 1.24 703.8897 1,405.76 1,405.77 2
 SAMPLE 3 40S ribosomal protein S2  RPS2  RS2_HUMAN 31,307.20 99.80% 2 2 3 7.85% SPYQEFTDHLVK 95.00% 2.82 0.344 0 488.5752 1,462.70 1,463.72 3
 SAMPLE 3 40S ribosomal protein S2  RPS2  RS2_HUMAN 31,307.20 99.80% 2 2 3 7.85% GcTATLGNFAK 95.00% 2.27 0.214 2.6 c2: Carbamidomethyl (+57.02) 570.2779 1,138.54 1,139.55 2
 SAMPLE 3 40S ribosomal protein S2  RPS2  RS2_HUMAN 31,307.20 99.80% 2 2 3 7.85% GcTATLGNFAK 95.00% 2.26 0.28 4.36 c2: Carbamidomethyl (+57.02) 570.279 1,138.54 1,139.55 2
 SAMPLE 3R 40S ribosomal protein S2  RPS2  RS2_HUMAN 31,307.20 99.80% 2 2 3 7.85% SPYQEFTDHLVK 95.00% 3.78 0.477 0 488.575 1,462.70 1,463.72 3
 SAMPLE 3R 40S ribosomal protein S2  RPS2  RS2_HUMAN 31,307.20 99.80% 2 2 3 7.85% SPYQEFTDHLVK 95.00% 3.82 0.439 0 488.9106 1,463.71 1,463.72 3
 SAMPLE 3R 40S ribosomal protein S2  RPS2  RS2_HUMAN 31,307.20 99.80% 2 2 3 7.85% GcTATLGNFAK 95.00% 1.84 0.189 2.96 c2: Carbamidomethyl (+57.02) 570.2794 1,138.54 1,139.55 2
 SAMPLE 2 40S ribosomal protein S20  RPS20  RS20_HUMAN 13,355.00 99.80% 2 2 5 19.30% LIDLHSPSEIVK 95.00% 2.38 0.347 0 450.9265 1,349.76 1,350.76 3
 SAMPLE 2 40S ribosomal protein S20  RPS20  RS20_HUMAN 13,355.00 99.80% 2 2 5 19.30% LIDLHSPSEIVK 95.00% 2.66 0.305 1 450.9269 1,349.76 1,350.76 3
 SAMPLE 2 40S ribosomal protein S20  RPS20  RS20_HUMAN 13,355.00 99.80% 2 2 5 19.30% LIDLHSPSEIVK 95.00% 2.53 0.362 0 450.9279 1,349.76 1,350.76 3
 SAMPLE 2 40S ribosomal protein S20  RPS20  RS20_HUMAN 13,355.00 99.80% 2 2 5 19.30% TPVEPEVAIHR 95.00% 2.55 0.321 2.12 624.3395 1,246.66 1,247.67 2
 SAMPLE 2 40S ribosomal protein S20  RPS20  RS20_HUMAN 13,355.00 99.80% 2 2 5 19.30% TPVEPEVAIHR 95.00% 2.46 0.282 1.66 624.3399 1,246.66 1,247.67 2
 SAMPLE 2R 40S ribosomal protein S20  RPS20  RS20_HUMAN 13,355.00 99.80% 2 2 5 19.30% LIDLHSPSEIVK 95.00% 1.99 0.237 0 450.9255 1,349.75 1,350.76 3
 SAMPLE 2R 40S ribosomal protein S20  RPS20  RS20_HUMAN 13,355.00 99.80% 2 2 5 19.30% LIDLHSPSEIVK 95.00% 1.94 0.334 1 450.9264 1,349.76 1,350.76 3
 SAMPLE 2R 40S ribosomal protein S20  RPS20  RS20_HUMAN 13,355.00 99.80% 2 2 5 19.30% LIDLHSPSEIVK 95.00% 2.41 0.252 2.17 450.9266 1,349.76 1,350.76 3
 SAMPLE 2R 40S ribosomal protein S20  RPS20  RS20_HUMAN 13,355.00 99.80% 2 2 5 19.30% TPVEPEVAIHR 95.00% 2.15 0.316 0 624.3398 1,246.66 1,247.67 2
 SAMPLE 2R 40S ribosomal protein S20  RPS20  RS20_HUMAN 13,355.00 99.80% 2 2 5 19.30% TPVEPEVAIHR 95.00% 2.87 0.415 3.48 624.3415 1,246.67 1,247.67 2
 SAMPLE 2 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 10 24.00% AALQELLSK 95.00% 2.97 0.229 0 486.7894 971.5631 972.5731 2
 SAMPLE 2 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 10 24.00% AALQELLSK 95.00% 2.97 0.29 0 487.2456 972.4755 972.5731 2
 SAMPLE 2 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 10 24.00% LNNLVLFDK 95.00% 2.95 0.323 1.6 538.3094 1,074.60 1,075.62 2
 SAMPLE 2 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 10 24.00% LNNLVLFDK 95.00% 3.04 0.326 1.16 538.3103 1,074.61 1,075.62 2
 SAMPLE 2 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 10 24.00% LITPAVVSER 95.00% 2.19 0.395 1.74 542.8195 1,083.62 1,084.64 2
 SAMPLE 2 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 10 24.00% LITPAVVSER 95.00% 2.21 0.42 0 542.8197 1,083.62 1,084.64 2
 SAMPLE 2 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 10 24.00% LITPAVVSER 95.00% 2.13 0.322 0 542.8205 1,083.63 1,084.64 2
 SAMPLE 2 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 10 24.00% LITPAVVSER 95.00% 2.02 0.382 0 542.821 1,083.63 1,084.64 2
 SAMPLE 2 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 10 24.00% DKLNNLVLFDK 95.00% 3.29 0.377 1.47 659.8697 1,317.72 1,318.74 2
 SAMPLE 2 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 10 24.00% DKLNNLVLFDK 95.00% 3.47 0.374 1.96 660.3726 1,318.73 1,318.74 2
 SAMPLE 2R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 3 3 8 16.80% LNNLVLFDK 95.00% 3.08 0.332 0 538.3092 1,074.60 1,075.62 2
 SAMPLE 2R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 3 3 8 16.80% LNNLVLFDK 95.00% 3.2 0.36 1.15 538.3092 1,074.60 1,075.62 2
 SAMPLE 2R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 3 3 8 16.80% LITPAVVSER 95.00% 2.43 0.383 0 542.8199 1,083.62 1,084.64 2
 SAMPLE 2R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 3 3 8 16.80% LITPAVVSER 95.00% 1.96 0.263 1.12 542.82 1,083.62 1,084.64 2
 SAMPLE 2R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 3 3 8 16.80% LITPAVVSER 95.00% 2.06 0.343 1.68 542.8202 1,083.62 1,084.64 2
 SAMPLE 2R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 3 3 8 16.80% LITPAVVSER 95.00% 2.21 0.42 1.54 542.8203 1,083.62 1,084.64 2
 SAMPLE 2R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 3 3 8 16.80% DKLNNLVLFDK 95.00% 3.33 0.406 3.42 659.8714 1,317.73 1,318.74 2
 SAMPLE 2R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 3 3 8 16.80% DKLNNLVLFDK 95.00% 2.92 0.395 2.85 659.8715 1,317.73 1,318.74 2
 SAMPLE 3 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 8 24.00% AALQELLSK 95.00% 3.16 0.323 1.57 486.7889 971.5622 972.5731 2
 SAMPLE 3 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 8 24.00% AALQELLSK 95.00% 3.19 0.304 1.32 486.7894 971.5632 972.5731 2
 SAMPLE 3 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 8 24.00% LNNLVLFDK 95.00% 2.79 0.346 1.8 538.3101 1,074.60 1,075.62 2
 SAMPLE 3 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 8 24.00% LNNLVLFDK 95.00% 3.43 0.379 0 538.3103 1,074.60 1,075.62 2
 SAMPLE 3 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 8 24.00% LITPAVVSER 95.00% 2.17 0.36 0 542.8192 1,083.62 1,084.64 2
 SAMPLE 3 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 8 24.00% LITPAVVSER 95.00% 1.96 0.402 1.33 542.8198 1,083.62 1,084.64 2
 SAMPLE 3 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 8 24.00% DKLNNLVLFDK 95.00% 3.5 0.413 1.8 659.8702 1,317.72 1,318.74 2
 SAMPLE 3 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 8 24.00% DKLNNLVLFDK 95.00% 3.56 0.469 2.44 659.8709 1,317.73 1,318.74 2
 SAMPLE 3R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 7 24.00% AALQELLSK 95.00% 3.04 0.301 1.92 486.7894 971.5631 972.5731 2
 SAMPLE 3R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 7 24.00% AALQELLSK 95.00% 3.16 0.308 1.31 486.7896 971.5636 972.5731 2
 SAMPLE 3R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 7 24.00% LNNLVLFDK 95.00% 3.24 0.356 0 538.3097 1,074.60 1,075.62 2
 SAMPLE 3R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 7 24.00% LNNLVLFDK 95.00% 3.21 0.355 1.07 538.31 1,074.60 1,075.62 2
 SAMPLE 3R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 7 24.00% LITPAVVSER 95.00% 1.85 0.312 0 542.8211 1,083.63 1,084.64 2
 SAMPLE 3R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 7 24.00% DKLNNLVLFDK 95.00% 3.01 0.342 1.37 659.8711 1,317.73 1,318.74 2
 SAMPLE 3R 40S ribosomal protein S25  RPS25  RS25_HUMAN 13,725.00 100.00% 4 4 7 24.00% DKLNNLVLFDK 95.00% 2.81 0.371 0 659.8724 1,317.73 1,318.74 2
 SAMPLE 3 40S ribosomal protein S27  RPS27  RS27_HUMAN 9,442.90 99.80% 2 2 4 28.60% DLLHPSPEEEK 95.00% 2.26 0.229 0 647.3194 1,292.62 1,293.63 2
 SAMPLE 3 40S ribosomal protein S27  RPS27  RS27_HUMAN 9,442.90 99.80% 2 2 4 28.60% LVQSPNSYFMDVK 95.00% 3.3 0.449 4.85 764.3811 1,526.75 1,527.75 2
 SAMPLE 3 40S ribosomal protein S27  RPS27  RS27_HUMAN 9,442.90 99.80% 2 2 4 28.60% LVQSPNSYFMDVK 95.00% 3.92 0.444 3.72 764.8815 1,527.75 1,527.75 2
 SAMPLE 3 40S ribosomal protein S27  RPS27  RS27_HUMAN 9,442.90 99.80% 2 2 4 28.60% LVQSPNSYFmDVK 95.00% 2.27 0.228 2.74 m10: Oxidation (+15.99) 772.3783 1,542.74 1,543.75 2
 SAMPLE 2 40S ribosomal protein S3  RPS3  RS3_HUMAN 26,670.50 99.80% 2 2 4 8.64% AELNEFLTR 95.00% 2.83 0.432 1.57 546.7858 1,091.56 1,092.57 2
 SAMPLE 2 40S ribosomal protein S3  RPS3  RS3_HUMAN 26,670.50 99.80% 2 2 4 8.64% AELNEFLTR 95.00% 2.85 0.404 0 546.7865 1,091.56 1,092.57 2
 SAMPLE 2 40S ribosomal protein S3  RPS3  RS3_HUMAN 26,670.50 99.80% 2 2 4 8.64% GLcAIAQAESLR 95.00% 3.02 0.409 0 c3: Carbamidomethyl (+57.02) 644.8359 1,287.66 1,288.67 2
 SAMPLE 2 40S ribosomal protein S3  RPS3  RS3_HUMAN 26,670.50 99.80% 2 2 4 8.64% GLcAIAQAESLR 95.00% 2.92 0.4 1.35 c3: Carbamidomethyl (+57.02) 644.8368 1,287.66 1,288.67 2
 SAMPLE 2 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 3 3 5 11.40% APAMFNIR 95.00% 2.09 0.343 0 460.2459 918.4762 919.4824 2
 SAMPLE 2 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 3 3 5 11.40% TTDGYLLR 95.00% 2.31 0.381 0 469.7521 937.4885 938.4949 2 HP1B3_HUMAN
 SAMPLE 2 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 3 3 5 11.40% TTDGYLLR 95.00% 2.35 0.426 0 469.7528 937.4899 938.4949 2 HP1B3_HUMAN
 SAMPLE 2 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 3 3 5 11.40% AcQSIYPLHDVFVR 95.00% 2.96 0.499 0 c2: Carbamidomethyl (+57.02) 569.2883 1,704.84 1,704.85 3
 SAMPLE 2 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 3 3 5 11.40% AcQSIYPLHDVFVR 95.00% 3.15 0.483 0 c2: Carbamidomethyl (+57.02) 569.2888 1,704.84 1,704.85 3
 SAMPLE 2R 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 99.80% 2 2 3 8.33% TTDGYLLR 95.00% 1.99 0.186 1.21 469.7507 937.4858 938.4949 2 HP1B3_HUMAN
 SAMPLE 2R 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 99.80% 2 2 3 8.33% AcQSIYPLHDVFVR 95.00% 3.2 0.476 0 c2: Carbamidomethyl (+57.02) 568.9554 1,703.84 1,704.85 3
 SAMPLE 2R 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 99.80% 2 2 3 8.33% AcQSIYPLHDVFVR 95.00% 3.53 0.464 0 c2: Carbamidomethyl (+57.02) 569.2903 1,704.85 1,704.85 3
 SAMPLE 3 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 4 4 6 15.50% APAMFNIR 95.00% 2.22 0.428 1.38 460.2444 918.4732 919.4824 2
 SAMPLE 3 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 4 4 6 15.50% APAMFNIR 95.00% 2.09 0.445 1.82 460.2445 918.4733 919.4824 2
 SAMPLE 3 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 4 4 6 15.50% LFcVGFTK 95.00% 2.29 0.188 0 c3: Carbamidomethyl (+57.02) 486.2534 970.4912 971.5026 2
 SAMPLE 3 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 4 4 6 15.50% LIPDSIGKDIEK 95.00% 3.12 0.201 0 664.877 1,327.74 1,327.75 2
 SAMPLE 3 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 4 4 6 15.50% LMELHGEGSSSGK 95.00% 3.45 0.42 3.15 666.3165 1,330.62 1,331.63 2
 SAMPLE 3 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 4 4 6 15.50% LMELHGEGSSSGK 95.00% 3.4 0.448 0 666.3198 1,330.62 1,331.63 2
 SAMPLE 3R 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 3 3 4 11.00% APAMFNIR 95.00% 2.34 0.449 1.46 460.2457 918.4757 919.4824 2
 SAMPLE 3R 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 3 3 4 11.00% APAMFNIR 95.00% 2.2 0.453 1.27 460.2461 918.4765 919.4824 2
 SAMPLE 3R 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 3 3 4 11.00% TTDGYLLR 95.00% 2.05 0.32 0 469.7526 937.4896 938.4949 2 HP1B3_HUMAN
 SAMPLE 3R 40S ribosomal protein S3a  RPS3A  RS3A_HUMAN 29,927.30 100.00% 3 3 4 11.00% LMELHGEGSSSGK 95.00% 3.08 0.418 2.22 666.3165 1,330.62 1,331.63 2
 SAMPLE 1 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 5 7.22% LSNIFVIGK 95.00% 3.02 0.435 1.43 495.8014 989.5871 990.5989 2
 SAMPLE 1 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 5 7.22% LSNIFVIGK 95.00% 2.89 0.378 0 495.8029 989.5901 990.5989 2
 SAMPLE 1 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 5 7.22% LSNIFVIGK 95.00% 2.14 0.223 1.17 495.808 989.6004 990.5989 2
 SAMPLE 1 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 5 7.22% LSNIFVIGK 95.00% 3.27 0.397 1.31 495.8098 989.6039 990.5989 2
 SAMPLE 1 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 5 7.22% EcLPLIIFLR 95.00% 2.31 0.312 1.17 c2: Carbamidomethyl (+57.02) 637.3795 1,272.74 1,273.73 2
 SAMPLE 1R 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 5 7.22% LSNIFVIGK 95.00% 2.14 0.223 1.36 495.808 989.6004 990.5989 2
 SAMPLE 1R 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 5 7.22% LSNIFVIGK 95.00% 3.27 0.397 1.74 495.8098 989.6039 990.5989 2
 SAMPLE 1R 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 5 7.22% LSNIFVIGK 95.00% 1.99 0.256 0 495.8109 989.6061 990.5989 2
 SAMPLE 1R 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 5 7.22% EcLPLIIFLR 95.00% 2.31 0.312 1.39 c2: Carbamidomethyl (+57.02) 637.3795 1,272.74 1,273.73 2
 SAMPLE 1R 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 5 7.22% EcLPLIIFLR 95.00% 2.22 0.342 0 c2: Carbamidomethyl (+57.02) 637.8709 1,273.73 1,273.73 2
 SAMPLE 2R 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 4 7.22% LSNIFVIGK 95.00% 2.78 0.359 1.48 495.8016 989.5875 990.5989 2
 SAMPLE 2R 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 4 7.22% LSNIFVIGK 95.00% 3.07 0.431 1.59 495.8022 989.5887 990.5989 2
 SAMPLE 2R 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 4 7.22% EcLPLIIFLR 95.00% 2.03 0.201 1.74 c2: Carbamidomethyl (+57.02) 637.3708 1,272.73 1,273.73 2
 SAMPLE 2R 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 4 7.22% EcLPLIIFLR 95.00% 2.46 0.423 1.82 c2: Carbamidomethyl (+57.02) 637.3711 1,272.73 1,273.73 2
 SAMPLE 3 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 4 7.22% LSNIFVIGK 95.00% 3.08 0.377 1.68 495.8018 989.5879 990.5989 2
 SAMPLE 3 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 4 7.22% LSNIFVIGK 95.00% 2.86 0.357 1.51 495.8022 989.5887 990.5989 2
 SAMPLE 3 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 4 7.22% GNKPWISLPR 95.00% 2.11 0.377 0 584.3344 1,166.65 1,167.66 2
 SAMPLE 3 40S ribosomal protein S4, X isoform  RPS4X  RS4X_HUMAN 29,581.30 99.80% 2 2 4 7.22% GNKPWISLPR 95.00% 2.29 0.367 0 584.3347 1,166.65 1,167.66 2
 SAMPLE 1R 40S ribosomal protein S5  RPS5  RS5_HUMAN 22,859.00 99.80% 2 2 2 13.70% VNQAIWLLcTGAR 95.00% 3.94 0.517 5.36 c9: Carbamidomethyl (+57.02) 751.4147 1,500.81 1,501.80 2
 SAMPLE 1R 40S ribosomal protein S5  RPS5  RS5_HUMAN 22,859.00 99.80% 2 2 2 13.70% TIAEcLADELINAAK 95.00% 5.03 0.582 4.28 c5: Carbamidomethyl (+57.02) 816.4335 1,630.85 1,631.83 2
 SAMPLE 3R 40S ribosomal protein S5  RPS5  RS5_HUMAN 22,859.00 99.80% 2 2 4 13.70% VNQAIWLLcTGAR 95.00% 3.88 0.561 5.18 c9: Carbamidomethyl (+57.02) 751.3996 1,500.78 1,501.80 2
 SAMPLE 3R 40S ribosomal protein S5  RPS5  RS5_HUMAN 22,859.00 99.80% 2 2 4 13.70% VNQAIWLLcTGAR 95.00% 4.43 0.555 5.18 c9: Carbamidomethyl (+57.02) 751.9053 1,501.80 1,501.80 2
 SAMPLE 3R 40S ribosomal protein S5  RPS5  RS5_HUMAN 22,859.00 99.80% 2 2 4 13.70% TIAEcLADELINAAK 95.00% 4.96 0.57 3.72 c5: Carbamidomethyl (+57.02) 816.4177 1,630.82 1,631.83 2
 SAMPLE 3R 40S ribosomal protein S5  RPS5  RS5_HUMAN 22,859.00 99.80% 2 2 4 13.70% TIAEcLADELINAAK 95.00% 5.24 0.562 4.28 c5: Carbamidomethyl (+57.02) 816.9195 1,631.82 1,631.83 2
 SAMPLE 1 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 99.80% 2 2 2 12.00% NcIVLIDSTPYR 95.00% 3.7 0.445 2.44 c2: Carbamidomethyl (+57.02) 726.3718 1,450.73 1,450.74 2
 SAMPLE 1 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 99.80% 2 2 2 12.00% ISSLLEEQFQQGK 95.00% 3.65 0.477 2.38 753.894 1,505.77 1,506.78 2
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% IIDVVYNASNNELVR 95.00% 3.91 0.232 0 573.6397 1,717.90 1,718.91 3
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% IIDVVYNASNNELVR 95.00% 4.12 0.268 1.22 573.6415 1,717.90 1,718.91 3
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% IIDVVYNASNNELVR 95.00% 4.58 0.342 2.02 573.9748 1,718.90 1,718.91 3
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% LTPEEEEILNK 95.00% 2.84 0.276 2.17 657.8418 1,313.67 1,314.68 2
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% LTPEEEEILNK 95.00% 2.95 0.394 0 657.8425 1,313.67 1,314.68 2
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% NcIVLIDSTPYR 95.00% 2.16 0.189 2.34 c2: Carbamidomethyl (+57.02) 725.8728 1,449.73 1,450.74 2
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% NcIVLIDSTPYR 95.00% 3.64 0.446 1.8 c2: Carbamidomethyl (+57.02) 726.373 1,450.73 1,450.74 2
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% ISSLLEEQFQQGK 95.00% 4.24 0.503 2.74 753.8934 1,505.77 1,506.78 2
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% ISSLLEEQFQQGK 95.00% 4.15 0.473 2.36 753.894 1,505.77 1,506.78 2
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% ISSLLEEQFQQGK 95.00% 4.23 0.496 2.43 754.3965 1,506.78 1,506.78 2
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% ISSLLEEQFQQGK 95.00% 0 0 3.82 755.3143 1,508.61 1,506.78 2
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% IIDVVYNASNNELVR 95.00% 4.43 0.343 3.01 859.9577 1,717.90 1,718.91 2
 SAMPLE 2 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 4 5 13 24.50% IIDVVYNASNNELVR 95.00% 4.75 0.336 4.44 860.4554 1,718.90 1,718.91 2
 SAMPLE 2R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 9 18.80% IIDVVYNASNNELVR 95.00% 4.42 0.379 1.4 573.6385 1,717.89 1,718.91 3
 SAMPLE 2R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 9 18.80% IIDVVYNASNNELVR 95.00% 4.05 0.258 1.57 573.6388 1,717.89 1,718.91 3
 SAMPLE 2R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 9 18.80% IIDVVYNASNNELVR 95.00% 5.33 0.315 1.18 573.9721 1,718.89 1,718.91 3
 SAMPLE 2R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 9 18.80% IIDVVYNASNNELVR 95.00% 4.26 0.257 1.46 573.9737 1,718.90 1,718.91 3
 SAMPLE 2R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 9 18.80% LTPEEEEILNK 95.00% 2.89 0.347 1.15 657.8396 1,313.66 1,314.68 2
 SAMPLE 2R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 9 18.80% LTPEEEEILNK 95.00% 2.85 0.388 1.82 657.8416 1,313.67 1,314.68 2
 SAMPLE 2R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 9 18.80% ISSLLEEQFQQGK 95.00% 3.99 0.461 2.06 753.8961 1,505.78 1,506.78 2
 SAMPLE 2R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 9 18.80% ISSLLEEQFQQGK 95.00% 4.16 0.494 2.82 754.3931 1,506.77 1,506.78 2
 SAMPLE 2R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 9 18.80% IIDVVYNASNNELVR 95.00% 4.86 0.389 3.62 860.4571 1,718.90 1,718.91 2
 SAMPLE 3 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 8 19.20% IIDVVYNASNNELVR 95.00% 4.03 0.269 1.34 573.6402 1,717.90 1,718.91 3
 SAMPLE 3 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 8 19.20% IIDVVYNASNNELVR 95.00% 2.78 0.277 0 573.9727 1,718.89 1,718.91 3
 SAMPLE 3 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 8 19.20% NcIVLIDSTPYR 95.00% 3.25 0.237 1.82 c2: Carbamidomethyl (+57.02) 725.8721 1,449.73 1,450.74 2
 SAMPLE 3 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 8 19.20% NcIVLIDSTPYR 95.00% 3.94 0.413 2.25 c2: Carbamidomethyl (+57.02) 726.3726 1,450.73 1,450.74 2
 SAMPLE 3 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 8 19.20% NcIVLIDSTPYR 95.00% 3.72 0.448 2.11 c2: Carbamidomethyl (+57.02) 726.3736 1,450.73 1,450.74 2
 SAMPLE 3 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 8 19.20% ISSLLEEQFQQGK 95.00% 4.58 0.488 2.89 754.3952 1,506.77 1,506.78 2
 SAMPLE 3 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 8 19.20% IIDVVYNASNNELVR 95.00% 4.77 0.385 3.51 859.9568 1,717.90 1,718.91 2
 SAMPLE 3 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 8 19.20% IIDVVYNASNNELVR 95.00% 4.68 0.357 3.33 859.958 1,717.90 1,718.91 2
 SAMPLE 3R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 6 19.20% IIDVVYNASNNELVR 95.00% 4.88 0.326 1.4 573.9744 1,718.90 1,718.91 3
 SAMPLE 3R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 6 19.20% NcIVLIDSTPYR 95.00% 3.2 0.245 1.85 c2: Carbamidomethyl (+57.02) 725.8736 1,449.73 1,450.74 2
 SAMPLE 3R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 6 19.20% ISSLLEEQFQQGK 95.00% 3.82 0.507 3.34 753.8934 1,505.77 1,506.78 2
 SAMPLE 3R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 6 19.20% ISSLLEEQFQQGK 95.00% 3.5 0.428 2 753.8944 1,505.77 1,506.78 2
 SAMPLE 3R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 6 19.20% IIDVVYNASNNELVR 95.00% 4.51 0.388 3.74 859.9567 1,717.90 1,718.91 2
 SAMPLE 3R 40S ribosomal protein S8  RPS8  RS8_HUMAN 24,188.40 100.00% 3 4 6 19.20% IIDVVYNASNNELVR 95.00% 4.6 0.405 3.77 859.9579 1,717.90 1,718.91 2
 SAMPLE 2 40S ribosomal protein S9  RPS9  RS9_HUMAN 22,574.50 99.80% 2 2 2 10.30% LFEGNALLR 95.00% 2.44 0.238 1.23 516.7945 1,031.57 1,032.58 2
 SAMPLE 2 40S ribosomal protein S9  RPS9  RS9_HUMAN 22,574.50 99.80% 2 2 2 10.30% QVVNIPSFIVR 95.00% 2.79 0.369 1.89 636.3755 1,270.74 1,271.75 2
 SAMPLE 3R 40S ribosomal protein S9  RPS9  RS9_HUMAN 22,574.50 99.80% 2 2 4 10.30% LFEGNALLR 95.00% 2.48 0.302 0 516.7942 1,031.57 1,032.58 2
 SAMPLE 3R 40S ribosomal protein S9  RPS9  RS9_HUMAN 22,574.50 99.80% 2 2 4 10.30% LFEGNALLR 95.00% 2.74 0.307 1.36 516.7949 1,031.57 1,032.58 2
 SAMPLE 3R 40S ribosomal protein S9  RPS9  RS9_HUMAN 22,574.50 99.80% 2 2 4 10.30% QVVNIPSFIVR 95.00% 2.83 0.389 2 636.3766 1,270.74 1,271.75 2
 SAMPLE 3R 40S ribosomal protein S9  RPS9  RS9_HUMAN 22,574.50 99.80% 2 2 4 10.30% QVVNIPSFIVR 95.00% 2.74 0.395 1.28 636.3768 1,270.74 1,271.75 2
 SAMPLE 2 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 5 5 6 11.20% VGLQVVAVK 95.00% 2.73 0.211 2.02 457.2434 912.4712 912.5883 2
 SAMPLE 2 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 5 5 6 11.20% VGEVIVTKDDAMLLK 95.00% 3.2 0.354 0 544.64 1,630.90 1,630.91 3
 SAMPLE 2 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 5 5 6 11.20% NAGVEGSLIVEK 95.00% 3.12 0.437 0 608.3322 1,214.65 1,215.66 2
 SAMPLE 2 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 5 5 6 11.20% NAGVEGSLIVEK 95.00% 3.15 0.458 1.4 608.3325 1,214.65 1,215.66 2
 SAMPLE 2 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 5 5 6 11.20% TVIIEQSWGSPK 95.00% 2.1 0.338 1.14 672.8609 1,343.71 1,344.72 2
 SAMPLE 2 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 5 5 6 11.20% cIPALDSLTPANEDQK 95.00% 3.58 0.376 3.62 c1: Carbamidomethyl (+57.02) 886.9127 1,771.81 1,771.85 2
 SAMPLE 2R 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 4 4 7 8.38% VGLQVVAVK 95.00% 2.51 0.18 1.92 456.9924 911.9691 912.5883 2
 SAMPLE 2R 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 4 4 7 8.38% VGLQVVAVK 95.00% 2.56 0.143 1.25 457.2428 912.47 912.5883 2
 SAMPLE 2R 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 4 4 7 8.38% VGEVIVTKDDAMLLK 95.00% 2.85 0.301 0 544.3066 1,629.90 1,630.91 3
 SAMPLE 2R 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 4 4 7 8.38% NAGVEGSLIVEK 95.00% 2.89 0.426 1.64 608.3331 1,214.65 1,215.66 2
 SAMPLE 2R 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 4 4 7 8.38% NAGVEGSLIVEK 95.00% 2.9 0.428 1.24 608.334 1,214.65 1,215.66 2
 SAMPLE 2R 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 4 4 7 8.38% GYISPYFINTSK 95.00% 2.59 0.25 0 695.3562 1,388.70 1,389.71 2
 SAMPLE 2R 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 4 4 7 8.38% GYISPYFINTSK 95.00% 2.44 0.414 3.2 695.8574 1,389.70 1,389.71 2
 SAMPLE 3 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 4 4 4 8.90% LSDGVAVLK 95.00% 1.94 0.392 1.13 451.273 900.5303 901.536 2
 SAMPLE 3 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 4 4 4 8.90% VGLQVVAVK 95.00% 2.47 0.132 1.4 456.9924 911.9692 912.5883 2
 SAMPLE 3 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 4 4 4 8.90% VGEVIVTKDDAMLLK 95.00% 3.48 0.423 1.27 544.3076 1,629.90 1,630.91 3
 SAMPLE 3 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 4 4 4 8.90% ISSIQSIVPALEIANAHR 95.00% 3.53 0.435 1.66 640.6962 1,919.07 1,919.07 3
 SAMPLE 3R 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 2 2 3 5.76% VGEVIVTKDDAMLLK 95.00% 2.77 0.232 0 544.3069 1,629.90 1,630.91 3
 SAMPLE 3R 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 2 2 3 5.76% VGEVIVTKDDAMLLK 95.00% 3.15 0.393 0 544.3074 1,629.90 1,630.91 3
 SAMPLE 3R 60 kDa heat shock protein, mitochondrial  HSPD1  CH60_HUMAN 61,037.70 100.00% 2 2 3 5.76% ISSIQSIVPALEIANAHR 95.00% 3.14 0.432 1.24 640.6984 1,919.07 1,919.07 3
 SAMPLE 2 60S ribosomal protein L11  RPL11  RL11_HUMAN 20,235.20 99.80% 2 2 4 12.90% YDGIILPGK 95.00% 3.01 0.413 1.54 488.2785 974.5414 975.5518 2
 SAMPLE 2 60S ribosomal protein L11  RPL11  RL11_HUMAN 20,235.20 99.80% 2 2 4 12.90% YDGIILPGK 95.00% 2.82 0.434 1.54 488.2791 974.5425 975.5518 2
 SAMPLE 2 60S ribosomal protein L11  RPL11  RL11_HUMAN 20,235.20 99.80% 2 2 4 12.90% VLEQLTGQTPVFSK 95.00% 4.54 0.565 5.35 773.9256 1,545.84 1,546.85 2
 SAMPLE 2 60S ribosomal protein L11  RPL11  RL11_HUMAN 20,235.20 99.80% 2 2 4 12.90% VLEQLTGQTPVFSK 95.00% 4.33 0.539 4.05 773.9264 1,545.84 1,546.85 2
 SAMPLE 2 60S ribosomal protein L13  RPL13  RL13_HUMAN 24,244.20 99.80% 2 2 3 9.00% TIGISVDPR 95.00% 2.04 0.176 1.85 479.2715 956.5273 957.5371 2
 SAMPLE 2 60S ribosomal protein L13  RPL13  RL13_HUMAN 24,244.20 99.80% 2 2 3 9.00% VATWFNQPAR 95.00% 2.95 0.275 0 595.307 1,188.60 1,189.61 2
 SAMPLE 2 60S ribosomal protein L13  RPL13  RL13_HUMAN 24,244.20 99.80% 2 2 3 9.00% VATWFNQPAR 95.00% 3.21 0.368 0 595.3076 1,188.60 1,189.61 2
 SAMPLE 3 60S ribosomal protein L17  RPL17  RL17_HUMAN 21,379.40 100.00% 3 3 4 13.00% YLKDVTLQK 94.70% 1.7 0.199 1.15 554.3243 1,106.63 1,107.64 2
 SAMPLE 3 60S ribosomal protein L17  RPL17  RL17_HUMAN 21,379.40 100.00% 3 3 4 13.00% EQIVPKPEEEVAQKK 95.00% 2.66 0.363 0 584.99 1,751.95 1,751.95 3
 SAMPLE 3 60S ribosomal protein L17  RPL17  RL17_HUMAN 21,379.40 100.00% 3 3 4 13.00% EQIVPKPEEEVAQK 95.00% 3.28 0.406 2.33 812.4333 1,622.85 1,623.86 2
 SAMPLE 3 60S ribosomal protein L17  RPL17  RL17_HUMAN 21,379.40 100.00% 3 3 4 13.00% EQIVPKPEEEVAQK 95.00% 3.53 0.369 3.74 812.9333 1,623.85 1,623.86 2
 SAMPLE 2 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 4 19.70% GcGTVLLSGPR 95.00% 2.83 0.288 0 c2: Carbamidomethyl (+57.02) 558.7908 1,115.57 1,116.58 2
 SAMPLE 2 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 4 19.70% GcGTVLLSGPR 95.00% 2.91 0.366 1.62 c2: Carbamidomethyl (+57.02) 558.7931 1,115.57 1,116.58 2
 SAMPLE 2 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 4 19.70% TAVVVGTITDDVR 95.00% 2.78 0.413 4.08 673.3684 1,344.72 1,345.73 2
 SAMPLE 2 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 4 19.70% TAVVVGTITDDVR 95.00% 2.69 0.368 2.37 673.3698 1,344.72 1,345.73 2
 SAMPLE 2 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 4 19.70% ILTFDQLALDSPK 95.00% 4.64 0.524 3.13 730.9023 1,459.79 1,460.80 2 TITIN_HUMAN
 SAMPLE 2 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 4 19.70% ILTFDQLALDSPK 95.00% 3.92 0.52 3.89 730.9052 1,459.79 1,460.80 2 TITIN_HUMAN
 SAMPLE 2R 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 3 19.70% GcGTVLLSGPR 95.00% 2.66 0.387 2.17 c2: Carbamidomethyl (+57.02) 558.7932 1,115.57 1,116.58 2
 SAMPLE 2R 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 3 19.70% TAVVVGTITDDVR 95.00% 2.92 0.469 3.66 673.3672 1,344.72 1,345.73 2
 SAMPLE 2R 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 3 19.70% TAVVVGTITDDVR 95.00% 2.31 0.338 1.66 673.3686 1,344.72 1,345.73 2
 SAMPLE 2R 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 3 19.70% ILTFDQLALDSPK 95.00% 2.6 0.376 2.52 730.9024 1,459.79 1,460.80 2 TITIN_HUMAN
 SAMPLE 2R 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 3 19.70% ILTFDQLALDSPK 95.00% 3.63 0.556 3.41 731.4027 1,460.79 1,460.80 2 TITIN_HUMAN
 SAMPLE 3 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 4 19.70% GcGTVLLSGPR 95.00% 3.02 0.349 0 c2: Carbamidomethyl (+57.02) 558.7931 1,115.57 1,116.58 2
 SAMPLE 3 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 4 19.70% GcGTVLLSGPR 95.00% 3.31 0.381 0 c2: Carbamidomethyl (+57.02) 558.7934 1,115.57 1,116.58 2
 SAMPLE 3 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 4 19.70% TAVVVGTITDDVR 95.00% 3.58 0.57 3.52 673.3672 1,344.72 1,345.73 2
 SAMPLE 3 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 4 19.70% TAVVVGTITDDVR 95.00% 3.55 0.54 4.54 673.3675 1,344.72 1,345.73 2
 SAMPLE 3 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 4 19.70% ILTFDQLALDSPK 95.00% 5.11 0.53 3.51 730.9029 1,459.79 1,460.80 2 TITIN_HUMAN
 SAMPLE 3 60S ribosomal protein L18  RPL18  RL18_HUMAN 21,617.20 99.80% 2 2 4 19.70% ILTFDQLALDSPK 95.00% 4.88 0.535 3.55 730.903 1,459.79 1,460.80 2 TITIN_HUMAN
 SAMPLE 3R 60S ribosomal protein L18a  RPL18A  RL18A_HUMAN 20,744.60 100.00% 3 3 5 17.60% VKNFGIWLR 95.00% 2.13 0.255 0 566.8332 1,131.65 1,132.66 2
 SAMPLE 3R 60S ribosomal protein L18a  RPL18A  RL18A_HUMAN 20,744.60 100.00% 3 3 5 17.60% FWYFVSQLK 95.00% 2.27 0.298 1.49 609.3195 1,216.62 1,217.64 2
 SAMPLE 3R 60S ribosomal protein L18a  RPL18A  RL18A_HUMAN 20,744.60 100.00% 3 3 5 17.60% FWYFVSQLK 95.00% 2.19 0.309 0 609.32 1,216.62 1,217.64 2
 SAMPLE 3R 60S ribosomal protein L18a  RPL18A  RL18A_HUMAN 20,744.60 100.00% 3 3 5 17.60% DLTTAGAVTQcYR 95.00% 3.18 0.477 2.35 c11: Carbamidomethyl (+57.02) 728.3472 1,454.68 1,455.69 2
 SAMPLE 3R 60S ribosomal protein L18a  RPL18A  RL18A_HUMAN 20,744.60 100.00% 3 3 5 17.60% DLTTAGAVTQcYR 95.00% 2.68 0.147 2.62 c11: Carbamidomethyl (+57.02) 728.3492 1,454.68 1,455.69 2
 SAMPLE 3 60S ribosomal protein L23  RPL23  RL23_HUMAN 14,847.90 99.80% 2 2 4 25.00% LPAAGVGDMVMATVK 95.00% 3.7 0.622 5.7 730.3852 1,458.75 1,459.77 2
 SAMPLE 3 60S ribosomal protein L23  RPL23  RL23_HUMAN 14,847.90 99.80% 2 2 4 25.00% LPAAGVGDMVMATVK 95.00% 4.02 0.578 5.08 730.3859 1,458.76 1,459.77 2
 SAMPLE 3 60S ribosomal protein L23  RPL23  RL23_HUMAN 14,847.90 99.80% 2 2 4 25.00% ISLGLPVGAVINcADNTGAK 95.00% 5.83 0.535 4.59 c13: Carbamidomethyl (+57.02) 986.0229 1,970.03 1,970.04 2
 SAMPLE 3 60S ribosomal protein L23  RPL23  RL23_HUMAN 14,847.90 99.80% 2 2 4 25.00% ISLGLPVGAVINcADNTGAK 95.00% 5.53 0.576 4.96 c13: Carbamidomethyl (+57.02) 986.0237 1,970.03 1,970.04 2
 SAMPLE 3R 60S ribosomal protein L23  RPL23  RL23_HUMAN 14,847.90 99.80% 2 3 5 20.00% EcADLWPR 95.00% 2.18 0.241 0 c2: Carbamidomethyl (+57.02) 523.7401 1,045.46 1,046.47 2
 SAMPLE 3R 60S ribosomal protein L23  RPL23  RL23_HUMAN 14,847.90 99.80% 2 3 5 20.00% EcADLWPR 95.00% 2.11 0.241 0 c2: Carbamidomethyl (+57.02) 523.7403 1,045.46 1,046.47 2
 SAMPLE 3R 60S ribosomal protein L23  RPL23  RL23_HUMAN 14,847.90 99.80% 2 3 5 20.00% ISLGLPVGAVINcADNTGAK 95.00% 3.28 0.391 1.92 c13: Carbamidomethyl (+57.02) 657.6847 1,970.03 1,970.04 3
 SAMPLE 3R 60S ribosomal protein L23  RPL23  RL23_HUMAN 14,847.90 99.80% 2 3 5 20.00% ISLGLPVGAVINcADNTGAK 95.00% 5.5 0.585 7.44 c13: Carbamidomethyl (+57.02) 986.0221 1,970.03 1,970.04 2
 SAMPLE 3R 60S ribosomal protein L23  RPL23  RL23_HUMAN 14,847.90 99.80% 2 3 5 20.00% ISLGLPVGAVINcADNTGAK 95.00% 5.5 0.573 4.82 c13: Carbamidomethyl (+57.02) 986.0246 1,970.03 1,970.04 2
 SAMPLE 2R 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 99.80% 2 2 3 10.80% VFQFLNAK 95.00% 2.56 0.276 0 483.7738 965.5319 966.5413 2
 SAMPLE 2R 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 99.80% 2 2 3 10.80% VFQFLNAK 95.00% 2.79 0.301 1.12 483.774 965.5323 966.5413 2
 SAMPLE 2R 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 99.80% 2 2 3 10.80% QINWTVLYR 95.00% 2.18 0.245 0 596.8267 1,191.64 1,192.65 2
 SAMPLE 3 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 100.00% 2 2 6 21.00% MKVELcSFSGYK 95.00% 2.67 0.36 0 c6: Carbamidomethyl (+57.02) 483.566 1,447.67 1,448.69 3 RSU1_HUMAN
 SAMPLE 3 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 100.00% 2 2 6 21.00% VFQFLNAK 95.00% 2.66 0.322 1.08 483.772 965.5284 966.5413 2
 SAMPLE 3 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 100.00% 2 2 6 21.00% VFQFLNAK 95.00% 2.9 0.395 0 483.7728 965.5299 966.5413 2
 SAMPLE 3 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 100.00% 2 2 6 21.00% VFQFLNAK 95.00% 2.93 0.331 0 483.7731 965.5305 966.5413 2
 SAMPLE 3 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 100.00% 2 2 6 21.00% VFQFLNAK 95.00% 2.79 0.324 0 483.774 965.5324 966.5413 2
 SAMPLE 3 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 100.00% 2 2 6 21.00% AITGASLADImAK 95.00% 2.99 0.456 4.74 m11: Oxidation (+15.99) 639.3405 1,276.67 1,277.68 2
 SAMPLE 3 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 100.00% 2 2 6 21.00% AITGASLADImAK 95.00% 2.59 0.366 3.18 m11: Oxidation (+15.99) 639.8431 1,277.67 1,277.68 2
 SAMPLE 3R 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 99.80% 2 2 5 13.40% VFQFLNAK 95.00% 3.04 0.375 0 483.7719 965.5281 966.5413 2
 SAMPLE 3R 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 99.80% 2 2 5 13.40% VFQFLNAK 95.00% 2.74 0.305 0 483.7745 965.5334 966.5413 2
 SAMPLE 3R 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 99.80% 2 2 5 13.40% VFQFLNAK 95.00% 2.82 0.323 0 483.7746 965.5335 966.5413 2
 SAMPLE 3R 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 99.80% 2 2 5 13.40% AITGASLADIMAK 95.00% 4.28 0.435 4.39 631.3434 1,260.67 1,261.68 2
 SAMPLE 3R 60S ribosomal protein L24  RPL24  RL24_HUMAN 17,761.50 99.80% 2 2 5 13.40% AITGASLADIMAK 95.00% 3.61 0.408 4.16 631.3435 1,260.67 1,261.68 2
 SAMPLE 2R 60S ribosomal protein L26-like 1  RPL26L1  RL26L_HUMAN,RL26_HUMAN 17,238.30 99.80% 2 2 4 11.00% YVIYIER 95.00% 2.28 0.193 0 478.2655 954.5154 955.5253 2
 SAMPLE 2R 60S ribosomal protein L26-like 1  RPL26L1  RL26L_HUMAN,RL26_HUMAN 17,238.30 99.80% 2 2 4 11.00% YVIYIER 95.00% 2.61 0.226 0 478.2655 954.5154 955.5253 2
 SAMPLE 2R 60S ribosomal protein L26-like 1  RPL26L1  RL26L_HUMAN,RL26_HUMAN 17,238.30 99.80% 2 2 4 11.00% FNPFVTSDR 95.00% 2.18 0.27 0 541.7653 1,081.51 1,082.53 2
 SAMPLE 2R 60S ribosomal protein L26-like 1  RPL26L1  RL26L_HUMAN,RL26_HUMAN 17,238.30 99.80% 2 2 4 11.00% FNPFVTSDR 95.00% 2.51 0.376 0 541.7667 1,081.52 1,082.53 2
 SAMPLE 3 60S ribosomal protein L26-like 1  RPL26L1  RL26L_HUMAN,RL26_HUMAN 17,238.30 99.80% 2 2 4 11.00% YVIYIER 95.00% 2.8 0.232 0 478.2651 954.5146 955.5253 2
 SAMPLE 3 60S ribosomal protein L26-like 1  RPL26L1  RL26L_HUMAN,RL26_HUMAN 17,238.30 99.80% 2 2 4 11.00% YVIYIER 95.00% 2.74 0.253 0 478.2659 954.5161 955.5253 2
 SAMPLE 3 60S ribosomal protein L26-like 1  RPL26L1  RL26L_HUMAN,RL26_HUMAN 17,238.30 99.80% 2 2 4 11.00% FNPFVTSDR 95.00% 2.87 0.372 0 541.7657 1,081.52 1,082.53 2
 SAMPLE 3 60S ribosomal protein L26-like 1  RPL26L1  RL26L_HUMAN,RL26_HUMAN 17,238.30 99.80% 2 2 4 11.00% FNPFVTSDR 95.00% 2.73 0.428 1.26 541.7661 1,081.52 1,082.53 2
 SAMPLE 2 60S ribosomal protein L27a  RPL27A  RL27A_HUMAN 16,543.40 99.80% 2 2 3 14.20% TGAAPIIDVVR 95.00% 3.01 0.392 2.64 556.3261 1,110.64 1,111.65 2
 SAMPLE 2 60S ribosomal protein L27a  RPL27A  RL27A_HUMAN 16,543.40 99.80% 2 2 3 14.20% TGAAPIIDVVR 95.00% 2.74 0.365 2.64 556.3264 1,110.64 1,111.65 2
 SAMPLE 2 60S ribosomal protein L27a  RPL27A  RL27A_HUMAN 16,543.40 99.80% 2 2 3 14.20% LWTLVSEQTR 95.00% 2.26 0.271 0 616.8336 1,231.65 1,232.66 2
 SAMPLE 3 60S ribosomal protein L27a  RPL27A  RL27A_HUMAN 16,543.40 99.80% 2 2 3 14.20% TGAAPIIDVVR 95.00% 3.39 0.412 3.38 556.3256 1,110.64 1,111.65 2
 SAMPLE 3 60S ribosomal protein L27a  RPL27A  RL27A_HUMAN 16,543.40 99.80% 2 2 3 14.20% TGAAPIIDVVR 95.00% 3.6 0.439 3.54 556.3263 1,110.64 1,111.65 2
 SAMPLE 3 60S ribosomal protein L27a  RPL27A  RL27A_HUMAN 16,543.40 99.80% 2 2 3 14.20% LWTLVSEQTR 95.00% 2.05 0.303 0 616.8344 1,231.65 1,232.66 2
 SAMPLE 3R 60S ribosomal protein L27a  RPL27A  RL27A_HUMAN 16,543.40 99.80% 2 2 4 14.20% TGAAPIIDVVR 95.00% 2.67 0.338 1.17 556.3272 1,110.64 1,111.65 2
 SAMPLE 3R 60S ribosomal protein L27a  RPL27A  RL27A_HUMAN 16,543.40 99.80% 2 2 4 14.20% TGAAPIIDVVR 95.00% 2.5 0.372 1.4 556.3278 1,110.64 1,111.65 2
 SAMPLE 3R 60S ribosomal protein L27a  RPL27A  RL27A_HUMAN 16,543.40 99.80% 2 2 4 14.20% LWTLVSEQTR 95.00% 2.16 0.278 2.14 616.8341 1,231.65 1,232.66 2
 SAMPLE 3R 60S ribosomal protein L27a  RPL27A  RL27A_HUMAN 16,543.40 99.80% 2 2 4 14.20% LWTLVSEQTR 95.00% 2.2 0.216 1.6 616.8351 1,231.65 1,232.66 2
 SAMPLE 2R 60S ribosomal protein L30  RPL30  RL30_HUMAN 12,766.70 99.80% 2 2 3 24.30% LVILANNcPALR 95.00% 3.5 0.488 3.12 c8: Carbamidomethyl (+57.02) 677.3866 1,352.76 1,353.77 2
 SAMPLE 2R 60S ribosomal protein L30  RPL30  RL30_HUMAN 12,766.70 99.80% 2 2 3 24.30% LVILANNcPALR 95.00% 3.4 0.474 3.44 c8: Carbamidomethyl (+57.02) 677.3867 1,352.76 1,353.77 2
 SAMPLE 2R 60S ribosomal protein L30  RPL30  RL30_HUMAN 12,766.70 99.80% 2 2 3 24.30% VcTLAIIDPGDSDIIR 95.00% 3.94 0.349 1.52 c2: Carbamidomethyl (+57.02) 879.4613 1,756.91 1,757.91 2
 SAMPLE 3 60S ribosomal protein L36  RPL36  RL36_HUMAN 12,236.20 100.00% 3 3 5 28.60% YPMAVGLNK 95.00% 2.43 0.278 2.62 496.7643 991.5129 992.524 2
 SAMPLE 3 60S ribosomal protein L36  RPL36  RL36_HUMAN 12,236.20 100.00% 3 3 5 28.60% EVcGFAPYER 95.00% 2.99 0.361 0 c3: Carbamidomethyl (+57.02) 614.2758 1,226.54 1,227.55 2
 SAMPLE 3 60S ribosomal protein L36  RPL36  RL36_HUMAN 12,236.20 100.00% 3 3 5 28.60% EVcGFAPYER 95.00% 3.26 0.316 0 c3: Carbamidomethyl (+57.02) 614.276 1,226.54 1,227.55 2
 SAMPLE 3 60S ribosomal protein L36  RPL36  RL36_HUMAN 12,236.20 100.00% 3 3 5 28.60% EELSNVLAAMR 95.00% 2.37 0.358 3.08 616.8168 1,231.62 1,232.63 2
 SAMPLE 3 60S ribosomal protein L36  RPL36  RL36_HUMAN 12,236.20 100.00% 3 3 5 28.60% EELSNVLAAMR 95.00% 2.72 0.443 3.77 616.8183 1,231.62 1,232.63 2
 SAMPLE 3R 60S ribosomal protein L4  RPL4  RL4_HUMAN 47,681.10 99.80% 2 2 2 6.32% AAAAAAALQAK 95.00% 2.12 0.26 2.49 478.7795 955.5434 956.5529 2
 SAMPLE 3R 60S ribosomal protein L4  RPL4  RL4_HUMAN 47,681.10 99.80% 2 2 2 6.32% APIRPDIVNFVHTNLR 95.00% 2.97 0.209 1.77 621.6855 1,862.03 1,862.04 3
 SAMPLE 3 60S ribosomal protein L9  RPL9  RL9_HUMAN 21,845.70 100.00% 3 3 5 13.00% DFNHINVELSLLGK 95.00% 3.61 0.328 2.12 533.9559 1,598.84 1,598.85 3
 SAMPLE 3 60S ribosomal protein L9  RPL9  RL9_HUMAN 21,845.70 100.00% 3 3 5 13.00% FLDGIYVSEK 95.00% 3.32 0.377 3.09 585.8045 1,169.59 1,170.60 2
 SAMPLE 3 60S ribosomal protein L9  RPL9  RL9_HUMAN 21,845.70 100.00% 3 3 5 13.00% FLDGIYVSEK 95.00% 3.45 0.404 2.05 585.8047 1,169.59 1,170.60 2
 SAMPLE 3 60S ribosomal protein L9  RPL9  RL9_HUMAN 21,845.70 100.00% 3 3 5 13.00% KFLDGIYVSEK 95.00% 2.64 0.299 1.32 649.8519 1,297.69 1,298.70 2
 SAMPLE 3 60S ribosomal protein L9  RPL9  RL9_HUMAN 21,845.70 100.00% 3 3 5 13.00% KFLDGIYVSEK 95.00% 2.6 0.295 2.21 649.8524 1,297.69 1,298.70 2
 SAMPLE 1 72 kDa type IV collagenase  MMP2  MMP2_HUMAN 73,867.10 100.00% 3 3 5 5.30% VDAAFNWSK 95.00% 2.36 0.384 2.24 519.2546 1,036.49 1,037.51 2
 SAMPLE 1 72 kDa type IV collagenase  MMP2  MMP2_HUMAN 73,867.10 100.00% 3 3 5 5.30% AFQVWSDVTPLR 95.00% 3.53 0.497 1.74 709.8733 1,417.73 1,418.74 2
 SAMPLE 1 72 kDa type IV collagenase  MMP2  MMP2_HUMAN 73,867.10 100.00% 3 3 5 5.30% AFQVWSDVTPLR 95.00% 3.33 0.42 1.77 709.8733 1,417.73 1,418.74 2
 SAMPLE 1 72 kDa type IV collagenase  MMP2  MMP2_HUMAN 73,867.10 100.00% 3 3 5 5.30% FQGTSYDScTTEGR 95.00% 3.39 0.427 2.72 c9: Carbamidomethyl (+57.02) 804.8332 1,607.65 1,608.66 2
 SAMPLE 1 72 kDa type IV collagenase  MMP2  MMP2_HUMAN 73,867.10 100.00% 3 3 5 5.30% FQGTSYDScTTEGR 95.00% 3.75 0.418 2.48 c9: Carbamidomethyl (+57.02) 804.8338 1,607.65 1,608.66 2
 SAMPLE 1R 72 kDa type IV collagenase  MMP2  MMP2_HUMAN 73,867.10 100.00% 4 4 6 7.42% VDAAFNWSK 95.00% 2.58 0.406 1.14 519.2546 1,036.49 1,037.51 2
 SAMPLE 1R 72 kDa type IV collagenase  MMP2  MMP2_HUMAN 73,867.10 100.00% 4 4 6 7.42% VDAAFNWSK 95.00% 2.23 0.392 0 519.2552 1,036.49 1,037.51 2
 SAMPLE 1R 72 kDa type IV collagenase  MMP2  MMP2_HUMAN 73,867.10 100.00% 4 4 6 7.42% AFQVWSDVTPLR 95.00% 2.58 0.354 1.33 709.8734 1,417.73 1,418.74 2
 SAMPLE 1R 72 kDa type IV collagenase  MMP2  MMP2_HUMAN 73,867.10 100.00% 4 4 6 7.42% AFQVWSDVTPLR 95.00% 3.22 0.42 1.96 709.8739 1,417.73 1,418.74 2
 SAMPLE 1R 72 kDa type IV collagenase  MMP2  MMP2_HUMAN 73,867.10 100.00% 4 4 6 7.42% FQGTSYDScTTEGR 95.00% 3.14 0.331 3.89 c9: Carbamidomethyl (+57.02) 804.8313 1,607.65 1,608.66 2
 SAMPLE 1R 72 kDa type IV collagenase  MMP2  MMP2_HUMAN 73,867.10 100.00% 4 4 6 7.42% cGNPDVANYNFFPR 95.00% 4.01 0.526 2.06 c1: Carbamidomethyl (+57.02) 835.873 1,669.73 1,670.74 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% AKFEELNMDLFR 95.00% 4.36 0.489 1.85 504.9213 1,511.74 1,512.75 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% AKFEELNMDLFR 95.00% 3.89 0.444 2.06 504.9218 1,511.74 1,512.75 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% IINEPTAAAIAYGLDK 95.00% 4.55 0.507 2.96 553.9674 1,658.88 1,659.90 3 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% IDTRNELESYAYSLK 95.00% 3.85 0.43 0 601.3019 1,800.88 1,801.90 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% IDTRNELESYAYSLK 95.00% 3.89 0.413 1.14 601.6373 1,801.89 1,801.90 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% IINEPTAAAIAYGLDKR 95.00% 2.13 0.151 1.38 606.3366 1,815.99 1,816.00 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% IINEPTAAAIAYGLDKR 95.00% 2.63 0.276 1.08 606.3381 1,815.99 1,816.00 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% SQIFSTASDNQPTVTIK 95.00% 3.98 0.467 2.11 612.981 1,835.92 1,836.93 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% SQIFSTASDNQPTVTIK 95.00% 4.29 0.394 3 613.3163 1,836.93 1,836.93 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% DAGTIAGLNVmR 95.00% 2.73 0.381 1.49 m11: Oxidation (+15.99) 617.3133 1,232.61 1,233.63 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% MKETAEAYLGK 95.00% 3.03 0.392 2.47 620.8139 1,239.61 1,240.62 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% VTHAVVTVPAYFNDAQR 95.00% 4.45 0.544 3.7 630.3288 1,887.96 1,887.97 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% VTHAVVTVPAYFNDAQR 95.00% 4.53 0.564 4.19 630.3297 1,887.97 1,887.97 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% DNHLLGTFDLTGIPPAPR 95.00% 2.7 0.383 0 645.6755 1,934.00 1,934.01 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% ELEEIVQPIISK 95.00% 3.24 0.451 1.96 699.3957 1,396.78 1,397.79 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% ELEEIVQPIISK 95.00% 2.7 0.445 1.19 699.3965 1,396.78 1,397.79 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% SDIDEIVLVGGSTR 95.00% 2.7 0.124 1.8 730.8827 1,459.75 1,460.76 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% TFAPEEISAMVLTK 95.00% 3.95 0.544 4.68 768.9012 1,535.79 1,536.80 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% ITPSYVAFTPEGER 95.00% 3.82 0.556 4.12 783.8923 1,565.77 1,566.78 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% ITPSYVAFTPEGER 95.00% 3.71 0.562 3.85 783.8927 1,565.77 1,566.78 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% VLEDSDLKKSDIDEIVLVGGSTR 95.00% 6.46 0.397 5.66 830.4438 2,488.31 2,488.32 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% VLEDSDLKKSDIDEIVLVGGSTR 95.00% 6.47 0.463 4.41 830.4463 2,488.32 2,488.32 3
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% NQLTSNPENTVFDAK 95.00% 4.27 0.527 7.36 839.4051 1,676.79 1,677.81 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% IINEPTAAAIAYGLDKR 95.00% 4.81 0.555 5.66 909.0023 1,815.99 1,816.00 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% IINEPTAAAIAYGLDKR 95.00% 4.76 0.499 6.47 909.0039 1,815.99 1,816.00 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% SQIFSTASDNQPTVTIK 95.00% 5.33 0.564 8.46 919.4668 1,836.92 1,836.93 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% SQIFSTASDNQPTVTIK 95.00% 5.36 0.562 5.46 919.4708 1,836.93 1,836.93 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% VTHAVVTVPAYFNDAQR 95.00% 4.58 0.656 7.74 944.4894 1,886.96 1,887.97 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% VTHAVVTVPAYFNDAQR 95.00% 5.22 0.64 6.74 944.9904 1,887.97 1,887.97 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% LYGSAGPPPTGEEDTAEKDEL 95.00% 5.91 0.574 5.82 1,089.00 2,175.98 2,175.99 2
 SAMPLE 1 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 19 31 33.30% LYGSAGPPPTGEEDTAEKDEL 95.00% 5.48 0.6 5.09 1,089.00 2,175.99 2,175.99 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% MKETAEAYLGKK 95.00% 4.5 0.382 0 456.9137 1,367.72 1,368.72 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% TFAPEEISAMVLTK 95.00% 2.03 0.289 0 513.2731 1,536.80 1,536.80 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% MVNDAEKFAEEDKK 95.00% 3.16 0.334 0 551.9303 1,652.77 1,653.78 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% MVNDAEKFAEEDKK 95.00% 3.07 0.403 0 551.9303 1,652.77 1,653.78 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% IDTRNELESYAYSLK 95.00% 3.92 0.396 0 601.303 1,800.89 1,801.90 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% IDTRNELESYAYSLK 95.00% 3.65 0.372 0 601.6368 1,801.89 1,801.90 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% IINEPTAAAIAYGLDKR 95.00% 2.2 0.216 0 606.0033 1,814.99 1,816.00 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% IINEPTAAAIAYGLDKR 95.00% 3.18 0.308 0 606.3365 1,815.99 1,816.00 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% IINEPTAAAIAYGLDKR 95.00% 2.67 0.208 1.37 606.3366 1,815.99 1,816.00 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% DAGTIAGLNVmR 95.00% 2.31 0.338 0 m11: Oxidation (+15.99) 617.3141 1,232.61 1,233.63 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% DAGTIAGLNVmR 95.00% 2.74 0.312 1.44 m11: Oxidation (+15.99) 617.3142 1,232.61 1,233.63 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% VTHAVVTVPAYFNDAQR 95.00% 4.3 0.445 3.82 630.3281 1,887.96 1,887.97 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% VTHAVVTVPAYFNDAQR 95.00% 4.35 0.564 4.66 630.3296 1,887.97 1,887.97 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% DNHLLGTFDLTGIPPAPR 95.00% 3.14 0.359 0 645.6763 1,934.01 1,934.01 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% DNHLLGTFDLTGIPPAPR 95.00% 3 0.354 0 645.6766 1,934.01 1,934.01 3
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% ELEEIVQPIISK 95.00% 2.84 0.424 3.48 699.3949 1,396.77 1,397.79 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% ELEEIVQPIISK 95.00% 2.87 0.437 1.12 699.3972 1,396.78 1,397.79 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% SDIDEIVLVGGSTR 95.00% 2.46 0.102 2.23 730.8832 1,459.75 1,460.76 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% ITPSYVAFTPEGER 95.00% 3.68 0.556 4.59 783.8921 1,565.77 1,566.78 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% ITPSYVAFTPEGER 95.00% 4.27 0.609 4.77 783.8925 1,565.77 1,566.78 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% IINEPTAAAIAYGLDK 95.00% 4.69 0.525 6.62 830.4483 1,658.88 1,659.90 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% IINEPTAAAIAYGLDK 95.00% 4.34 0.564 5.77 830.4503 1,658.88 1,659.90 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% NQLTSNPENTVFDAK 95.00% 4.78 0.527 4.85 839.4065 1,676.80 1,677.81 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% NQLTSNPENTVFDAK 95.00% 4.95 0.479 7.24 839.9083 1,677.80 1,677.81 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% IINEPTAAAIAYGLDKR 95.00% 4.54 0.55 5.8 908.9994 1,815.98 1,816.00 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% IINEPTAAAIAYGLDKR 95.00% 4.91 0.548 7.23 909.0009 1,815.99 1,816.00 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% NQLTSNPENTVFDAKR 95.00% 4.17 0.533 5.33 917.458 1,832.90 1,833.91 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% SQIFSTASDNQPTVTIK 95.00% 5.16 0.614 6.44 918.9699 1,835.92 1,836.93 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% SQIFSTASDNQPTVTIK 95.00% 4.78 0.487 7.3 919.4688 1,836.92 1,836.93 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% VTHAVVTVPAYFNDAQR 95.00% 4.48 0.616 4.62 944.9884 1,887.96 1,887.97 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% VTHAVVTVPAYFNDAQR 95.00% 5.24 0.668 4.89 944.9913 1,887.97 1,887.97 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% LYGSAGPPPTGEEDTAEKDEL 95.00% 5.58 0.569 5.89 1,089.00 2,175.98 2,175.99 2
 SAMPLE 1R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 16 18 33 32.60% LYGSAGPPPTGEEDTAEKDEL 95.00% 5.66 0.537 5.14 1,089.00 2,175.99 2,175.99 2
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% AKFEELNMDLFR 95.00% 3.68 0.425 1.28 504.9214 1,511.74 1,512.75 3
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% AKFEELNMDLFR 95.00% 3.51 0.393 1.51 504.9219 1,511.74 1,512.75 3
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% MVNDAEKFAEEDKK 95.00% 2.72 0.258 0 551.9296 1,652.77 1,653.78 3
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% MVNDAEKFAEEDKK 95.00% 2.9 0.356 0 551.9302 1,652.77 1,653.78 3
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% IINEPTAAAIAYGLDKR 95.00% 3.02 0.248 0 606.0029 1,814.99 1,816.00 3
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% IINEPTAAAIAYGLDKR 95.00% 2.09 0.231 1.21 606.003 1,814.99 1,816.00 3
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% DAGTIAGLNVMR 95.00% 3.73 0.466 1.85 609.3181 1,216.62 1,217.63 2
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% DAGTIAGLNVMR 95.00% 3.73 0.432 3.77 609.3183 1,216.62 1,217.63 2
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% MKETAEAYLGK 95.00% 3.13 0.376 3.24 620.8155 1,239.62 1,240.62 2
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% DNHLLGTFDLTGIPPAPR 95.00% 2.97 0.356 0 645.6734 1,934.00 1,934.01 3
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% DNHLLGTFDLTGIPPAPR 95.00% 3 0.312 1.07 645.6773 1,934.01 1,934.01 3
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% ITPSYVAFTPEGER 95.00% 3.9 0.586 4.22 784.3937 1,566.77 1,566.78 2
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% ITPSYVAFTPEGER 95.00% 4.32 0.55 4 784.3942 1,566.77 1,566.78 2
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% IINEPTAAAIAYGLDK 95.00% 3.68 0.542 3.33 830.4495 1,658.88 1,659.90 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% IINEPTAAAIAYGLDK 95.00% 4.37 0.572 4.74 830.4498 1,658.88 1,659.90 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% NQLTSNPENTVFDAK 95.00% 4.27 0.497 4.52 839.4077 1,676.80 1,677.81 2
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% NQLTSNPENTVFDAK 95.00% 5.12 0.512 5.19 839.9096 1,677.80 1,677.81 2
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% SQIFSTASDNQPTVTIK 95.00% 5.25 0.535 5.17 919.4709 1,836.93 1,836.93 2
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% SQIFSTASDNQPTVTIK 95.00% 4.79 0.515 5.72 919.4724 1,836.93 1,836.93 2
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% VTHAVVTVPAYFNDAQR 95.00% 5.15 0.602 5.39 944.9914 1,887.97 1,887.97 2
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% LYGSAGPPPTGEEDTAEKDEL 95.00% 5.63 0.55 6.8 1,089.00 2,175.98 2,175.99 2
 SAMPLE 2 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 12 12 22 25.70% LYGSAGPPPTGEEDTAEKDEL 95.00% 5.36 0.583 4.52 1,089.00 2,175.99 2,175.99 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% AKFEELNMDLFR 95.00% 2.81 0.241 0 504.9217 1,511.74 1,512.75 3
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% MVNDAEKFAEEDKK 95.00% 2.57 0.357 0 551.9299 1,652.77 1,653.78 3
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% MVNDAEKFAEEDKK 95.00% 3.25 0.428 0 552.2646 1,653.77 1,653.78 3
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% IDTRNELESYAYSLK 95.00% 3.16 0.375 0 600.9674 1,799.88 1,801.90 3
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% IDTRNELESYAYSLK 95.00% 3.41 0.365 0 601.304 1,800.89 1,801.90 3
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% IINEPTAAAIAYGLDKR 95.00% 3.03 0.217 0 606.3362 1,815.99 1,816.00 3
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% IINEPTAAAIAYGLDKR 95.00% 2.3 0.272 0 606.3371 1,815.99 1,816.00 3
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% IINEPTAAAIAYGLDKR 95.00% 2.33 0.307 1.25 606.3383 1,815.99 1,816.00 3
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% DAGTIAGLNVMR 95.00% 3.62 0.45 2.6 609.318 1,216.62 1,217.63 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% DAGTIAGLNVMR 95.00% 3.68 0.448 3.33 609.3182 1,216.62 1,217.63 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% MKETAEAYLGK 95.00% 2.84 0.317 3.36 620.8136 1,239.61 1,240.62 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% VTHAVVTVPAYFNDAQR 95.00% 3.8 0.516 5.12 630.329 1,887.96 1,887.97 3
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% DNHLLGTFDLTGIPPAPR 95.00% 3.17 0.378 0 645.6746 1,934.00 1,934.01 3
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% DNHLLGTFDLTGIPPAPR 95.00% 3.16 0.368 0 645.6777 1,934.01 1,934.01 3
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% AKFEELNMDLFR 95.00% 2.84 0.509 4.08 756.8799 1,511.74 1,512.75 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% ITPSYVAFTPEGER 95.00% 3.85 0.603 3.08 783.8927 1,565.77 1,566.78 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% ITPSYVAFTPEGER 95.00% 3.75 0.573 2.92 784.3938 1,566.77 1,566.78 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% IINEPTAAAIAYGLDK 95.00% 4.2 0.565 4.35 830.4476 1,658.88 1,659.90 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% IINEPTAAAIAYGLDK 95.00% 4.43 0.554 5.89 830.9518 1,659.89 1,659.90 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% NQLTSNPENTVFDAK 95.00% 4.09 0.52 5 839.4055 1,676.80 1,677.81 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% NQLTSNPENTVFDAK 95.00% 4.75 0.519 5.62 839.9068 1,677.80 1,677.81 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% SQIFSTASDNQPTVTIK 95.00% 5.46 0.56 5.2 919.4698 1,836.92 1,836.93 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% SQIFSTASDNQPTVTIK 95.00% 5.16 0.536 5.74 919.4733 1,836.93 1,836.93 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% VTHAVVTVPAYFNDAQR 95.00% 4.47 0.625 4.08 944.9876 1,887.96 1,887.97 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% VTHAVVTVPAYFNDAQR 95.00% 3.94 0.54 4.19 944.9892 1,887.96 1,887.97 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% LYGSAGPPPTGEEDTAEKDEL 95.00% 5.45 0.568 6 1,089.00 2,175.97 2,175.99 2
 SAMPLE 2R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 13 15 27 28.00% LYGSAGPPPTGEEDTAEKDEL 95.00% 5.07 0.547 5.39 1,089.00 2,175.98 2,175.99 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% AKFEELNMDLFR 95.00% 3.49 0.382 1.21 504.9212 1,511.74 1,512.75 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% AKFEELNMDLFR 95.00% 4.22 0.438 2.12 504.9214 1,511.74 1,512.75 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% MVNDAEKFAEEDKK 95.00% 4.19 0.443 0 551.9299 1,652.77 1,653.78 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% MVNDAEKFAEEDKK 95.00% 3.83 0.431 2.36 552.2647 1,653.77 1,653.78 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% IDTRNELESYAYSLK 95.00% 3.93 0.398 0 601.6367 1,801.89 1,801.90 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% IDTRNELESYAYSLK 95.00% 4.02 0.408 0 601.6378 1,801.89 1,801.90 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% IINEPTAAAIAYGLDKR 95.00% 3.02 0.447 0 606.0029 1,814.99 1,816.00 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% IINEPTAAAIAYGLDKR 95.00% 2.23 0.336 0 606.3376 1,815.99 1,816.00 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% IINEPTAAAIAYGLDKR 95.00% 2.42 0.278 0 606.3389 1,815.99 1,816.00 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% IINEPTAAAIAYGLDKR 95.00% 2.87 0.211 1.07 606.3399 1,816.00 1,816.00 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% DAGTIAGLNVMR 95.00% 3.98 0.449 3.85 609.3185 1,216.62 1,217.63 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% DAGTIAGLNVMR 95.00% 4.04 0.426 2.49 609.3191 1,216.62 1,217.63 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% DAGTIAGLNVMR 95.00% 2.74 0.332 1.52 609.3225 1,216.63 1,217.63 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% NQLTSNPENTVFDAKR 95.00% 2.35 0.232 0 612.3085 1,833.90 1,833.91 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% SQIFSTASDNQPTVTIK 95.00% 3.66 0.507 2.46 613.3165 1,836.93 1,836.93 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% SQIFSTASDNQPTVTIK 95.00% 4.14 0.427 1.54 613.3177 1,836.93 1,836.93 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% DAGTIAGLNVmR 95.00% 2.9 0.374 2.06 m11: Oxidation (+15.99) 617.3155 1,232.62 1,233.63 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% MKETAEAYLGK 95.00% 3.34 0.363 4.19 620.8147 1,239.61 1,240.62 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% MKETAEAYLGK 95.00% 3.15 0.372 4.41 620.8149 1,239.61 1,240.62 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% VTHAVVTVPAYFNDAQR 95.00% 3.19 0.415 2.8 630.3291 1,887.96 1,887.97 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% VTHAVVTVPAYFNDAQR 95.00% 3.78 0.421 4.34 630.3295 1,887.97 1,887.97 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% DNHLLGTFDLTGIPPAPR 95.00% 2.81 0.365 0 645.3415 1,933.00 1,934.01 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% DNHLLGTFDLTGIPPAPR 95.00% 3.48 0.381 1.54 645.6774 1,934.01 1,934.01 3
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% ELEEIVQPIISK 95.00% 3.74 0.45 1.42 699.9008 1,397.79 1,397.79 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% AKFEELNMDLFR 95.00% 3.1 0.499 2.1 756.8789 1,511.74 1,512.75 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% ITPSYVAFTPEGER 95.00% 3.71 0.553 3.77 783.8938 1,565.77 1,566.78 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% ITPSYVAFTPEGER 95.00% 3.65 0.562 4.96 783.8944 1,565.77 1,566.78 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% MVNDAEKFAEEDKK 95.00% 4.06 0.493 3.55 827.3921 1,652.77 1,653.78 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% IINEPTAAAIAYGLDK 95.00% 4.86 0.569 4.89 830.4499 1,658.88 1,659.90 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% IINEPTAAAIAYGLDK 95.00% 4.83 0.587 6.51 830.4511 1,658.89 1,659.90 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% IINEPTAAAIAYGLDK 95.00% 4.73 0.599 5.57 830.4518 1,658.89 1,659.90 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% NQLTSNPENTVFDAK 95.00% 4.78 0.53 4.57 839.4063 1,676.80 1,677.81 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% NQLTSNPENTVFDAK 95.00% 4.64 0.554 7.52 839.4067 1,676.80 1,677.81 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% IINEPTAAAIAYGLDKR 95.00% 4.48 0.535 9.01 908.9997 1,815.98 1,816.00 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% IINEPTAAAIAYGLDKR 95.00% 4.87 0.512 9.89 909.0022 1,815.99 1,816.00 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% SQIFSTASDNQPTVTIK 95.00% 5.37 0.595 6.54 918.9686 1,835.92 1,836.93 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% SQIFSTASDNQPTVTIK 95.00% 5.38 0.606 6.8 918.9696 1,835.92 1,836.93 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% LYGSAGPPPTGEEDTAEKDEL 95.00% 5.49 0.6 5.62 1,088.50 2,174.98 2,175.99 2
 SAMPLE 3 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 15 19 39 30.00% LYGSAGPPPTGEEDTAEKDEL 95.00% 5.83 0.588 6.6 1,088.50 2,174.98 2,175.99 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% AKFEELNMDLFR 95.00% 4.11 0.391 1.6 504.9217 1,511.74 1,512.75 3
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% AKFEELNMDLFR 95.00% 4.17 0.464 2.36 504.9218 1,511.74 1,512.75 3
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% MVNDAEKFAEEDKK 95.00% 3.44 0.409 1.13 551.9301 1,652.77 1,653.78 3
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% MVNDAEKFAEEDKK 95.00% 3.91 0.496 1.01 551.9308 1,652.77 1,653.78 3
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% IDTRNELESYAYSLK 95.00% 4.07 0.419 1.02 601.3031 1,800.89 1,801.90 3
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% IDTRNELESYAYSLK 95.00% 4.47 0.403 1.03 601.6381 1,801.89 1,801.90 3
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% DAGTIAGLNVMR 95.00% 3.79 0.423 3.33 609.3185 1,216.62 1,217.63 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% DAGTIAGLNVMR 95.00% 3.56 0.43 2.24 609.3195 1,216.62 1,217.63 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% SQIFSTASDNQPTVTIK 95.00% 3.56 0.458 2.96 613.316 1,836.92 1,836.93 3
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% VEIIANDQGNR 94.50% 0 0 3.11 615.9706 1,229.93 1,228.63 2 HSP7C_HUMAN,HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% DAGTIAGLNVmR 95.00% 2.61 0.276 0 m11: Oxidation (+15.99) 617.3131 1,232.61 1,233.63 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% DAGTIAGLNVmR 95.00% 2.72 0.48 1.57 m11: Oxidation (+15.99) 617.3178 1,232.62 1,233.63 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% MKETAEAYLGK 95.00% 3.35 0.316 2.8 620.8147 1,239.61 1,240.62 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% MKETAEAYLGK 95.00% 3.46 0.375 3.3 620.8152 1,239.61 1,240.62 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% VTHAVVTVPAYFNDAQR 95.00% 3.65 0.382 3 629.9948 1,886.96 1,887.97 3
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% VTHAVVTVPAYFNDAQR 95.00% 3.69 0.34 2.74 630.33 1,887.97 1,887.97 3
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% DNHLLGTFDLTGIPPAPR 95.00% 3.37 0.365 1.72 645.676 1,934.00 1,934.01 3
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% DNHLLGTFDLTGIPPAPR 95.00% 2.91 0.333 1.05 645.677 1,934.01 1,934.01 3
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% ELEEIVQPIISK 95.00% 3.09 0.304 1.47 699.4024 1,396.79 1,397.79 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% AKFEELNMDLFR 95.00% 3.41 0.391 3.62 756.879 1,511.74 1,512.75 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% ITPSYVAFTPEGER 95.00% 3.71 0.591 4.48 783.8932 1,565.77 1,566.78 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% ITPSYVAFTPEGER 95.00% 3.87 0.549 5.27 784.3954 1,566.78 1,566.78 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% MVNDAEKFAEEDKK 95.00% 4.39 0.489 3.08 827.8902 1,653.76 1,653.78 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% IINEPTAAAIAYGLDK 95.00% 5.04 0.603 6.05 830.4508 1,658.89 1,659.90 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% IINEPTAAAIAYGLDK 95.00% 4.8 0.577 6.57 830.4514 1,658.89 1,659.90 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% IINEPTAAAIAYGLDK 95.00% 4.72 0.586 4.31 830.4518 1,658.89 1,659.90 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% NQLTSNPENTVFDAK 95.00% 4.16 0.535 5.07 839.4076 1,676.80 1,677.81 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% NQLTSNPENTVFDAK 95.00% 5.1 0.576 4.17 839.9095 1,677.80 1,677.81 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% IINEPTAAAIAYGLDKR 95.00% 4.78 0.536 7.8 909.0023 1,815.99 1,816.00 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% IINEPTAAAIAYGLDKR 95.00% 4.91 0.531 6.17 909.003 1,815.99 1,816.00 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% SQIFSTASDNQPTVTIK 95.00% 4.98 0.59 5.25 918.9682 1,835.92 1,836.93 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% SQIFSTASDNQPTVTIK 95.00% 4.47 0.56 5.17 918.9706 1,835.93 1,836.93 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% LYGSAGPPPTGEEDTAEKDEL 95.00% 5.57 0.546 5.13 1,089.00 2,175.99 2,175.99 2
 SAMPLE 3R 78 kDa glucose-regulated protein  HSPA5  GRP78_HUMAN 72,316.70 100.00% 14 17 33 31.50% LYGSAGPPPTGEEDTAEKDEL 95.00% 5.66 0.546 5.62 1,089.00 2,175.99 2,175.99 2
 SAMPLE 2 Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 99.80% 2 2 2 7.33% ASHTAPQVLFSHR 95.00% 3.18 0.226 1.36 484.2556 1,449.74 1,450.76 3
 SAMPLE 2 Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 99.80% 2 2 2 7.33% NcFASVFEK 95.00% 2.2 0.245 0 c2: Carbamidomethyl (+57.02) 551.2547 1,100.49 1,101.50 2
 SAMPLE 2R Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 99.80% 2 3 5 7.67% NcFASVFEK 95.00% 2.31 0.309 0 c2: Carbamidomethyl (+57.02) 551.2532 1,100.49 1,101.50 2
 SAMPLE 2R Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 99.80% 2 3 5 7.67% NcFASVFEK 95.00% 2.21 0.248 0 c2: Carbamidomethyl (+57.02) 551.2555 1,100.50 1,101.50 2
 SAMPLE 2R Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 99.80% 2 3 5 7.67% YFQFQEEGKEGENR 95.00% 2.83 0.291 0 587.6 1,759.78 1,760.79 3
 SAMPLE 2R Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 99.80% 2 3 5 7.67% YFQFQEEGKEGENR 95.00% 2.63 0.287 0 587.6003 1,759.78 1,760.79 3
 SAMPLE 2R Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 99.80% 2 3 5 7.67% YFQFQEEGKEGENR 95.00% 4.04 0.479 2.7 881.3976 1,760.78 1,760.79 2
 SAMPLE 3 Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 100.00% 5 5 6 14.00% DSIVHQAGMLKR 95.00% 3.55 0.55 1.34 452.247 1,353.72 1,354.73 3
 SAMPLE 3 Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 100.00% 5 5 6 14.00% DSIVHQAGMLKR 95.00% 3.71 0.413 2.42 452.2475 1,353.72 1,354.73 3
 SAMPLE 3 Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 100.00% 5 5 6 14.00% VFMQEFK 95.00% 2.85 0.265 0 464.7331 927.4505 928.4603 2
 SAMPLE 3 Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 100.00% 5 5 6 14.00% NcFASVFEK 95.00% 2.25 0.293 0 c2: Carbamidomethyl (+57.02) 551.254 1,100.49 1,101.50 2
 SAMPLE 3 Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 100.00% 5 5 6 14.00% YFQFQEEGKEGENR 95.00% 2.56 0.465 0 587.5999 1,759.78 1,760.79 3
 SAMPLE 3 Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 100.00% 5 5 6 14.00% DSIVHQAGMLK 95.00% 2.48 0.331 3.14 599.8185 1,197.62 1,198.63 2
 SAMPLE 3R Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 100.00% 4 4 6 11.00% DSIVHQAGMLKR 95.00% 3.63 0.502 1.1 452.247 1,353.72 1,354.73 3
 SAMPLE 3R Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 100.00% 4 4 6 11.00% DSIVHQAGMLKR 95.00% 3.74 0.45 1 452.2485 1,353.72 1,354.73 3
 SAMPLE 3R Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 100.00% 4 4 6 11.00% VFMQEFK 95.00% 2.34 0.202 0 464.7355 927.4553 928.4603 2
 SAMPLE 3R Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 100.00% 4 4 6 11.00% YFQFQEEGKEGENR 95.00% 2.51 0.298 0 587.5998 1,759.78 1,760.79 3
 SAMPLE 3R Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 100.00% 4 4 6 11.00% DSIVHQAGMLK 95.00% 2.31 0.343 2.26 599.8163 1,197.62 1,198.63 2
 SAMPLE 3R Actin-related protein 2/3 complex subunit 2  ARPC2  ARPC2_HUMAN 34,315.70 100.00% 4 4 6 11.00% DSIVHQAGMLK 95.00% 2.2 0.257 1.72 599.8166 1,197.62 1,198.63 2
 SAMPLE 1R Actin-related protein 2/3 complex subunit 4  ARPC4  ARPC4_HUMAN 19,649.40 99.80% 2 2 2 11.30% AENFFILR 95.00% 2.94 0.315 0 505.2867 1,008.56 1,009.55 2
 SAMPLE 1R Actin-related protein 2/3 complex subunit 4  ARPC4  ARPC4_HUMAN 19,649.40 99.80% 2 2 2 11.30% ELLLQPVTISR 95.00% 3.52 0.361 1.46 634.8929 1,267.77 1,268.76 2
 SAMPLE 2 Actin-related protein 2/3 complex subunit 4  ARPC4  ARPC4_HUMAN 19,649.40 99.80% 2 2 2 13.10% VLIEGSINSVR 95.00% 2.24 0.195 1.37 593.8432 1,185.67 1,186.68 2
 SAMPLE 2 Actin-related protein 2/3 complex subunit 4  ARPC4  ARPC4_HUMAN 19,649.40 99.80% 2 2 2 13.10% ELLLQPVTISR 95.00% 3.03 0.391 1.13 634.8807 1,267.75 1,268.76 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.06 0.413 0 473.28 944.5444 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.09 0.425 0 473.2802 944.5447 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 1.9 0.318 0 473.2802 944.5448 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 1.98 0.362 0 473.2804 944.5451 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.14 0.443 0 473.2804 944.5451 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.04 0.433 0 473.2804 944.5452 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.31 0.486 0 473.2804 944.5452 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.02 0.416 0 473.2806 944.5455 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.31 0.369 0 473.2806 944.5456 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.14 0.433 0 473.2806 944.5456 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.42 0.517 0 473.2806 944.5456 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.15 0.445 0 473.2807 944.5458 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 1.93 0.325 0 473.2808 944.5459 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 1.95 0.261 0 473.2808 944.5459 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.23 0.429 0 473.2808 944.546 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.29 0.46 0 473.2808 944.546 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.08 0.434 0 473.281 944.5463 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.37 0.522 0 473.2811 944.5465 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.13 0.423 0 473.2811 944.5466 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.11 0.31 0 473.2812 944.5467 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.3 0.316 0 473.2812 944.5468 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.1 0.391 0 473.2813 944.5469 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.24 0.334 0 473.2813 944.5469 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.22 0.415 0 473.2815 944.5473 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.19 0.42 0 473.2816 944.5475 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.22 0.43 0 473.2816 944.5476 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.24 0.471 0 473.282 944.5483 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 1.95 0.325 0 473.2822 944.5488 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.13 0.232 0 473.2824 944.5491 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 1.81 0.276 0 473.2826 944.5496 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 2.33 0.385 0 473.2828 944.55 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGR 95.00% 1.91 0.381 0 473.2834 944.5512 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AGFAGDDAPR 95.00% 3.48 0.496 2.72 488.7293 975.4429 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AGFAGDDAPR 95.00% 3.09 0.386 0 488.7298 975.444 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AGFAGDDAPR 95.00% 3.11 0.481 0 488.7301 975.4445 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AGFAGDDAPR 95.00% 3.37 0.486 1.7 488.7301 975.4445 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AGFAGDDAPR 95.00% 2.41 0.282 1.35 488.7301 975.4446 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AGFAGDDAPR 95.00% 3.32 0.432 1.44 488.7301 975.4446 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AGFAGDDAPR 95.00% 3.34 0.493 1.28 488.7302 975.4448 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AGFAGDDAPR 95.00% 3.4 0.458 0 488.7304 975.4452 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.1 0.315 1.48 499.7472 997.4788 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.12 0.29 1.28 499.7474 997.4791 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.03 0.376 0 499.7474 997.4792 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.2 0.367 0 499.7474 997.4792 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.04 0.299 0 499.7475 997.4793 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.15 0.362 1.66 499.7477 997.4797 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.05 0.262 0 499.7477 997.4798 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 1.93 0.26 0 499.7477 997.4798 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.09 0.419 1.68 499.7477 997.4798 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 1.96 0.252 0 499.7478 997.48 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.11 0.424 1.7 499.7479 997.4801 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.1 0.316 0 499.748 997.4803 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.14 0.403 0 499.748 997.4803 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.05 0.322 0 499.7481 997.4805 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.06 0.36 1.44 499.7481 997.4806 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 1.93 0.29 2.77 499.7482 997.4807 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 1.99 0.382 0 499.7483 997.481 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2 0.345 1.46 499.7484 997.4812 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 1.92 0.237 1.28 499.7494 997.4831 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 1.93 0.241 1.36 499.7498 997.484 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLMK 95.00% 2.22 0.243 0 499.7503 997.485 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.36 0.553 0 500.9084 1,499.70 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.33 0.553 0 500.9085 1,499.70 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 2.52 0.459 1.22 500.9086 1,499.70 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 2.91 0.506 0 500.9087 1,499.70 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.83 0.478 1.03 500.9088 1,499.70 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.25 0.471 0 500.9089 1,499.70 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 2.82 0.497 0 500.909 1,499.70 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.02 0.492 0 500.9091 1,499.70 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.15 0.56 1.17 500.9092 1,499.70 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3 0.423 1.38 500.9093 1,499.70 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 2.31 0.506 1 500.9093 1,499.70 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.46 0.5 1.41 500.9095 1,499.71 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 2.82 0.44 0 500.9099 1,499.71 1,500.71 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IWHHTFYNELR 95.00% 3.25 0.466 0 505.9222 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IWHHTFYNELR 95.00% 3.38 0.443 0 505.9245 1,514.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IWHHTFYNELR 95.00% 3.41 0.359 0 505.9249 1,514.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IWHHTFYNELR 95.00% 3.34 0.38 1.16 506.2568 1,515.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLmK 95.00% 1.91 0.272 0 m7: Oxidation (+15.99) 507.7443 1,013.47 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLmK 95.00% 2 0.281 0 m7: Oxidation (+15.99) 507.7448 1,013.47 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLmK 95.00% 2.19 0.311 0 m7: Oxidation (+15.99) 507.7454 1,013.48 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLmK 95.00% 2.28 0.289 0 m7: Oxidation (+15.99) 507.7456 1,013.48 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLTDYLmK 94.60% 1.96 0.231 0 m7: Oxidation (+15.99) 507.7461 1,013.48 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% MQKEITALAPSTMK 95.00% 3.49 0.368 1.34 516.9436 1,547.81 1,548.81 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% MQKEITALAPSTMK 95.00% 3.33 0.339 1.68 516.9439 1,547.81 1,548.81 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% MQKEITALAPSTMK 95.00% 2.61 0.255 0 516.9453 1,547.81 1,548.81 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IKIIAPPER 95.00% 2.23 0.292 0 518.8303 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IKIIAPPER 95.00% 2.17 0.238 0 518.8305 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IKIIAPPER 95.00% 2.54 0.207 0 518.831 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IKIIAPPER 95.00% 2.54 0.23 0 518.8311 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IKIIAPPER 95.00% 2.54 0.229 0 518.8311 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IKIIAPPER 95.00% 2.58 0.221 0 518.8312 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IKIIAPPER 95.00% 2.34 0.21 0 518.8313 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IKIIAPPER 95.00% 2.51 0.225 0 518.8314 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% mQKEITALAPSTmK 95.00% 3.22 0.269 0 m1: Oxidation (+15.99), m13: Oxidation (+15.99) 527.6092 1,579.80 1,580.80 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 2.95 0.383 0 541.9529 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 2.98 0.488 2.39 541.9529 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 2.63 0.426 1.59 541.9531 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 2.53 0.342 0 541.9535 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 2.86 0.452 0 541.9536 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 2.91 0.477 0 541.9536 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 2.74 0.546 2.04 541.9537 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 2.7 0.444 0 541.9537 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 2.23 0.343 0 541.9537 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 2.78 0.418 0 541.9543 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 2.34 0.241 0 541.9551 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 3.19 0.48 0 542.2872 1,623.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAEREIVR 95.00% 2.27 0.498 0 543.287 1,626.84 1,627.84 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAEREIVR 95.00% 2.23 0.512 0 543.2877 1,626.84 1,627.84 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAEREIVR 95.00% 2.36 0.535 0 543.2878 1,626.84 1,627.84 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAEREIVR 95.00% 2.55 0.458 0 543.2882 1,626.84 1,627.84 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 3.13 0.434 1.4 m13: Oxidation (+15.99) 547.2846 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 3.42 0.288 0 m13: Oxidation (+15.99) 547.2851 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 3.58 0.328 0 m13: Oxidation (+15.99) 547.2851 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 3.21 0.388 0 m13: Oxidation (+15.99) 547.2852 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 3.48 0.311 0 m13: Oxidation (+15.99) 547.2856 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 2.25 0.286 0 m13: Oxidation (+15.99) 547.2864 1,638.84 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 3.76 0.276 0 m13: Oxidation (+15.99) 547.6198 1,639.84 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 2.87 0.329 0 m13: Oxidation (+15.99) 547.6202 1,639.84 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.45 0.361 2.11 565.777 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.49 0.562 2.04 565.7771 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.29 0.532 2.13 565.7774 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.49 0.433 2.2 565.7779 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.85 0.455 2.32 565.7782 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.83 0.41 0 565.7782 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.64 0.462 2.57 565.7782 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.13 0.489 2.4 565.7782 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.49 0.55 2.11 565.7785 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.59 0.573 3.27 565.7785 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.25 0.539 2.1 565.7785 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.59 0.516 2.64 565.7785 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.31 0.517 2.08 565.7787 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.53 0.535 2.68 565.7787 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.7 0.547 3.14 565.7788 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.42 0.543 1.82 565.7788 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.87 0.568 1.92 565.7789 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.44 0.55 1.92 565.779 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.19 0.513 2.17 565.779 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.58 0.594 2.41 565.779 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.5 0.557 2 565.7791 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.61 0.559 2.17 565.7792 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.3 0.385 2.34 565.7792 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 1.93 0.328 1.85 565.7792 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.4 0.54 2.24 565.7793 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.51 0.423 2.77 565.7793 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.47 0.424 2 565.7793 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.59 0.564 2.39 565.7793 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.63 0.582 2.34 565.7793 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.7 0.547 2.19 565.7793 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.66 0.545 2.25 565.7794 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3 0.532 4.23 565.7794 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.64 0.59 2.19 565.7796 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.26 0.531 2.7 565.7796 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.17 0.502 2.38 565.7796 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.14 0.529 2.7 565.7797 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.54 0.532 2.96 565.7797 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.99 0.493 4.15 565.7798 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.33 0.526 2.74 565.7798 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.57 0.554 2.2 565.7799 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.71 0.496 2.77 565.78 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.6 0.432 3.26 565.78 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.81 0.494 2.22 565.7801 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.86 0.436 3.19 565.7801 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.83 0.48 2.55 565.7801 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.26 0.539 2.06 565.7801 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.77 0.323 1.85 565.7801 1,129.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.81 0.499 3.3 565.7804 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.36 0.592 3.44 565.7804 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.42 0.202 1.16 565.7804 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.11 0.389 2.29 565.7805 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.61 0.355 0 565.7809 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.51 0.501 2.16 565.781 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.42 0.523 3.92 565.7811 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.49 0.507 2.8 565.7812 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.95 0.542 3.21 565.7812 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.1 0.327 1.17 565.7813 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.62 0.418 1.43 565.7817 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.39 0.548 2.92 565.7819 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.66 0.366 0 565.7819 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.22 0.537 3.1 565.7823 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 3.68 0.522 3.2 565.7824 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.83 0.515 0 565.7829 1,129.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.62 0.263 1.43 565.8009 1,129.59 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.35 0.195 1.38 565.8031 1,129.59 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.39 0.264 1.72 566.2802 1,130.54 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.93 0.251 3.89 566.2823 1,130.55 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.67 0.284 2.43 566.2999 1,130.58 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAER 95.00% 2.91 0.112 3.4 566.3105 1,130.61 1,130.55 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.2 0.252 0 581.3134 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.14 0.392 0 581.3136 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.51 0.286 1.28 581.3144 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 94.60% 2.29 0.203 0 581.3146 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.7 0.404 1.49 581.3147 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.8 0.349 1.3 581.3147 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.59 0.29 0 581.3149 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.75 0.355 0 581.315 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.42 0.305 1.96 581.315 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.53 0.327 1.44 581.3152 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.69 0.339 0 581.3153 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.11 0.329 0 581.3155 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.83 0.383 1.89 581.3155 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.77 0.422 2.21 581.3156 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.45 0.373 0 581.3159 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.23 0.277 0 581.316 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.3 0.41 0 581.3179 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGMGQK 95.00% 2.75 0.462 4.32 586.2896 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGMGQK 95.00% 2.57 0.431 4.34 586.2908 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGMGQK 95.00% 3.01 0.49 4.43 586.2919 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGMGQK 95.00% 1.88 0.258 3.92 586.2928 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGMGQK 95.00% 2.29 0.347 3.18 586.2929 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGMGQK 95.00% 2.81 0.482 3.96 586.2935 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGMGQK 95.00% 2.48 0.341 1.21 586.2936 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTmK 95.00% 3.02 0.354 2.77 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTmK 95.00% 2.63 0.275 1.8 m10: Oxidation (+15.99) 589.3112 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTmK 95.00% 2.04 0.208 1.21 m10: Oxidation (+15.99) 589.3113 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTmK 95.00% 2.82 0.162 1.27 m10: Oxidation (+15.99) 589.3116 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTmK 95.00% 2.62 0.228 1.36 m10: Oxidation (+15.99) 589.3117 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTmK 95.00% 2.92 0.194 1.77 m10: Oxidation (+15.99) 589.3121 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTmK 95.00% 2.92 0.363 2.05 m10: Oxidation (+15.99) 589.3126 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTmK 95.00% 3.1 0.357 1.82 m10: Oxidation (+15.99) 589.3127 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTmK 95.00% 2.15 0.337 0 m10: Oxidation (+15.99) 589.315 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTmK 95.00% 2.91 0.201 0 m10: Oxidation (+15.99) 589.813 1,177.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGmGQK 95.00% 2.06 0.385 5.42 m8: Oxidation (+15.99) 594.2871 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGmGQK 95.00% 2.26 0.414 4.85 m8: Oxidation (+15.99) 594.2893 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGmGQK 95.00% 2.74 0.395 2.96 m8: Oxidation (+15.99) 594.2895 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGmGQK 95.00% 2.63 0.337 4.1 m8: Oxidation (+15.99) 594.2896 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGmGQK 95.00% 2.33 0.256 3.43 m8: Oxidation (+15.99) 594.2919 1,186.57 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.02 0.422 0 597.6349 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 2.15 0.29 0 597.6375 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.04 0.321 0 597.6379 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.57 0.488 4.32 597.638 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.98 0.434 4.31 597.6381 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.03 0.47 3 597.6382 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.03 0.361 0 597.6382 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.54 0.445 3.68 597.9725 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.4 0.234 0 599.3418 1,196.67 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.48 0.241 0 599.3419 1,196.67 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.41 0.274 0 599.3421 1,196.67 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSK 95.00% 2.94 0.502 3.85 599.7675 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSK 95.00% 3.11 0.507 4.64 599.7685 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSK 95.00% 2.53 0.353 1.62 599.7693 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSK 95.00% 2.62 0.152 4.85 599.7694 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSK 95.00% 2.82 0.47 3.38 599.7699 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSK 95.00% 2.29 0.36 3.48 599.7705 1,197.53 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSK 95.00% 3.2 0.47 4.52 599.7707 1,197.53 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.28 0.273 0 599.8578 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.31 0.242 0 599.8579 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.59 0.191 0 599.8579 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.4 0.32 0 599.8582 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.47 0.218 0 599.8582 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.88 0.374 0 599.8583 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.31 0.277 0 599.8583 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.66 0.363 0 599.8584 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.5 0.25 0 599.8586 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.3 0.262 0 599.8586 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.7 0.271 0 599.8587 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.45 0.308 0 599.8588 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.57 0.316 0 599.8588 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.43 0.244 0 599.8589 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.31 0.315 0 599.8609 1,197.71 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AVFPSIVGRPR 95.00% 2.49 0.381 0 599.9893 1,197.96 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVmVGmGQK 95.00% 1.85 0.292 0 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 602.2915 1,202.57 1,203.56 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.26 0.561 1.39 652.6875 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.22 0.476 0 652.6882 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.64 0.571 1.12 652.6882 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.28 0.575 0 652.6883 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.47 0.498 1.68 652.6886 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.78 0.613 0 652.6887 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.49 0.537 1.54 652.6887 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.31 0.54 1.37 652.6889 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.07 0.344 0 652.689 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.12 0.595 2.22 652.6891 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.59 0.49 1.21 652.6898 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.68 0.511 0 652.6907 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.9 0.505 1 652.6907 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.18 0.351 0 652.6909 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 2.93 0.427 0 652.6912 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 2.48 0.335 0 652.692 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.04 0.445 0 652.6927 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.21 0.467 0 653.0215 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.4 0.524 0 653.0217 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.23 0.274 0 653.0222 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.47 0.474 1.21 653.0222 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.69 0.475 1.92 653.0224 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.94 0.436 0 653.0225 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.9 0.492 2.1 653.0225 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.53 0.508 0 653.0226 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.21 0.425 0 653.0227 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.96 0.513 3.51 653.0227 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.8 0.454 0 653.0228 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.77 0.51 0 653.0228 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.98 0.302 0 653.0228 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.25 0.45 0 653.0229 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.89 0.525 0 653.0229 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.99 0.532 1.96 653.0229 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.25 0.402 0 653.0229 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.78 0.465 0 653.023 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.78 0.331 0 653.023 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.43 0.499 1.46 653.023 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.58 0.483 0 653.023 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.54 0.454 0 653.023 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.85 0.467 0 653.0231 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.42 0.433 1.46 653.0233 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.53 0.287 0 653.0234 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.39 0.418 0 653.0238 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.18 0.356 0 653.0242 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.29 0.317 0 653.0244 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 2.36 0.37 0 653.0245 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.25 0.426 0 653.0254 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.57 0.401 0 653.0255 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.35 0.376 0 653.0261 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 2.9 0.382 0 653.0264 1,956.06 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 2.42 0.325 0 653.0264 1,956.06 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 1.87 0.293 0 653.0266 1,956.06 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.32 0.391 0 653.0273 1,956.06 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% YPIEHGIITNWDDMEK 95.00% 3.24 0.184 1.3 654.6451 1,960.91 1,960.91 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSKR 95.00% 2.37 0.409 0 677.3191 1,352.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSKR 95.00% 2.56 0.43 1.19 677.8194 1,353.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSKR 95.00% 2.81 0.5 1.27 677.8209 1,353.63 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSKR 95.00% 2.92 0.5 2.34 677.8216 1,353.63 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSKR 95.00% 2.6 0.436 2.07 678.322 1,354.63 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DSYVGDEAQSKR 95.00% 2.82 0.54 2.72 678.323 1,354.63 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% AGFAGDDAPRAVFPSIVGRPR 95.00% 4.36 0.568 1.62 719.7175 2,156.13 2,156.14 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% qEYDEAGPSIVHR 95.00% 0 0 3.52 n-term: Pyro-cmC (-17.03) 742.3474 1,482.68 1,483.68 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLYANNVLSGGTTMYPGIADR 95.00% 4.54 0.522 4.92 743.3621 2,227.06 2,228.07 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLYANNVLSGGTTMYPGIADR 95.00% 5.91 0.59 5.16 743.6966 2,228.07 2,228.07 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.05 0.571 4.6 750.8593 1,499.70 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 2.92 0.512 3.37 750.8597 1,499.70 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.08 0.621 3.15 750.8603 1,499.70 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 2.89 0.501 2.96 750.8604 1,499.71 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 2.79 0.582 0 750.8604 1,499.71 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3 0.499 1.22 750.8606 1,499.71 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 2.98 0.541 5.34 750.8607 1,499.71 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.01 0.549 2.55 750.8609 1,499.71 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 2.96 0.459 1.66 750.861 1,499.71 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.09 0.618 5.7 750.8613 1,499.71 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 2.53 0.551 3.7 750.8618 1,499.71 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.02 0.554 2.36 750.8621 1,499.71 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHR 95.00% 3.3 0.64 2.89 750.8629 1,499.71 1,500.71 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IWHHTFYNELR 95.00% 2.26 0.352 1.26 758.3791 1,514.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% IWHHTFYNELR 95.00% 2.63 0.395 2.21 758.3845 1,514.75 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% MQKEITALAPSTmK 95.00% 4.06 0.425 2.09 m13: Oxidation (+15.99) 782.9064 1,563.80 1,564.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% MQKEITALAPSTmK 95.00% 3.99 0.419 2.47 m13: Oxidation (+15.99) 782.9106 1,563.81 1,564.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGMGQKDSYVGDEAQSK 95.00% 3.86 0.508 4.12 784.7004 2,351.08 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% KDLYANNVLSGGTTMYPGIADR 95.00% 5.91 0.606 2 786.3949 2,356.16 2,356.16 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% KDLYANNVLSGGTTMYPGIADR 95.00% 6.08 0.547 2.85 786.3965 2,356.17 2,356.16 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.53 0.652 5.22 m8: Oxidation (+15.99) 790.033 2,367.08 2,367.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.23 0.653 4.34 m8: Oxidation (+15.99) 790.0337 2,367.08 2,367.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% KDLYANNVLSGGTTmYPGIADR 95.00% 6.51 0.433 3.68 m15: Oxidation (+15.99) 791.7272 2,372.16 2,372.16 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% KDLYANNVLSGGTTmYPGIADR 95.00% 6.41 0.401 3.21 m15: Oxidation (+15.99) 791.7273 2,372.16 2,372.16 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% KDLYANNVLSGGTTmYPGIADR 95.00% 5.04 0.455 1.57 m15: Oxidation (+15.99) 791.7278 2,372.16 2,372.16 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% KDLYANNVLSGGTTmYPGIADR 95.00% 5.3 0.43 0 m15: Oxidation (+15.99) 791.7287 2,372.16 2,372.16 3
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.57 0.594 2.54 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.0299 2,382.07 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVmVGmGQKDSYVGDEAQSK 95.00% 4.38 0.705 4.22 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3643 2,383.07 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.1 0.588 3.15 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3654 2,383.07 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.48 0.491 4.27 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3655 2,383.07 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.24 0.464 2.03 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.368 2,383.08 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.05 0.399 1.54 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3682 2,383.08 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.55 0.52 2.92 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3685 2,383.08 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.49 0.541 2.19 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3687 2,383.08 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 3.2 0.355 2.54 812.4243 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 3.28 0.359 2.89 812.426 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 3.48 0.384 2.96 812.4265 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 3.18 0.351 1.85 812.4272 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 3.18 0.372 2.82 812.4273 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 3.07 0.374 2.96 812.4275 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 3.12 0.318 2.82 812.4285 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLMK 95.00% 2.96 0.36 2.31 812.429 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% QEYDEAGPSIVHRK 95.00% 2.94 0.191 0 814.3938 1,626.77 1,628.80 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAEREIVR 95.00% 2.78 0.225 0 814.4284 1,626.84 1,627.84 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAEREIVR 95.00% 3.08 0.231 0 814.4291 1,626.84 1,627.84 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAEREIVR 95.00% 3.04 0.248 1.74 814.4293 1,626.84 1,627.84 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAEREIVR 95.00% 3.11 0.188 0 814.43 1,626.84 1,627.84 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAEREIVR 95.00% 2.76 0.291 0 814.4306 1,626.85 1,627.84 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAEREIVR 95.00% 3.13 0.23 0 814.9292 1,627.84 1,627.84 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAEREIVR 95.00% 3 0.245 1.64 814.9303 1,627.85 1,627.84 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% GYSFVTTAEREIVR 95.00% 3.19 0.243 0 814.9315 1,627.85 1,627.84 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 3 0.171 2.33 m13: Oxidation (+15.99) 820.4228 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 3.19 0.187 2.92 m13: Oxidation (+15.99) 820.4231 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 3.31 0.184 1.96 m13: Oxidation (+15.99) 820.4233 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 3.03 0.155 2.52 m13: Oxidation (+15.99) 820.4236 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 2.95 0.148 2.24 m13: Oxidation (+15.99) 820.4241 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 2.92 0.083 2.72 m13: Oxidation (+15.99) 820.4242 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 3.07 0.198 2.06 m13: Oxidation (+15.99) 820.4243 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% LDLAGRDLTDYLmK 95.00% 2.99 0.178 2.7 m13: Oxidation (+15.99) 820.4246 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% ILTERGYSFVTTAER 95.00% 3.68 0.427 3.68 871.9571 1,741.90 1,742.91 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% ILTERGYSFVTTAER 95.00% 3.42 0.465 3.13 871.9586 1,741.90 1,742.91 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% ILTERGYSFVTTAER 95.00% 3.81 0.494 3.17 871.9594 1,741.90 1,742.91 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% ILTERGYSFVTTAER 95.00% 3.91 0.442 4.6 871.9602 1,741.90 1,742.91 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% ILTERGYSFVTTAER 95.00% 3.71 0.454 3.06 871.9619 1,741.91 1,742.91 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% ILTERGYSFVTTAER 95.00% 3.74 0.255 3.3 872.4605 1,742.91 1,742.91 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% ILTERGYSFVTTAER 95.00% 4.22 0.275 3.21 872.461 1,742.91 1,742.91 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% ILTERGYSFVTTAER 95.00% 3.9 0.241 3.72 872.4626 1,742.91 1,742.91 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.62 0.6 5.74 895.9509 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.58 0.611 6.02 895.951 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.74 0.562 6.74 895.9511 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.66 0.645 5.92 895.9513 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.56 0.586 5.55 895.9513 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.67 0.567 5.89 895.9514 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.89 0.579 5.7 895.9516 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.4 0.595 6.82 895.9517 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.49 0.616 7.18 895.9519 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.74 0.615 6.62 895.9519 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.77 0.628 6.21 895.952 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.49 0.596 6.85 895.9523 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.44 0.562 5.89 895.9523 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.82 0.621 6.66 895.9525 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.77 0.596 6.92 895.9527 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.4 0.559 6.24 895.9529 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.26 0.608 5.17 895.9531 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.5 0.486 6.38 895.9535 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.43 0.51 3.3 895.954 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.72 0.482 4.57 895.9543 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.28 0.579 7.96 895.9546 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.31 0.474 4.32 895.9548 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.01 0.565 6.77 895.9555 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.28 0.594 2.35 895.9557 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.36 0.457 3.59 895.956 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.63 0.498 4.64 895.9585 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.08 0.472 3.89 895.9585 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.97 0.56 4.32 895.9594 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.38 0.521 3.09 895.9597 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.69 0.543 5.27 895.9601 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.31 0.514 4.85 895.9612 1,789.91 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.85 0.515 4.8 895.9624 1,789.91 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.97 0.57 4.85 896.4522 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.86 0.579 5 896.4523 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.77 0.589 4.96 896.4523 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 5.02 0.609 7.7 896.4525 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.46 0.559 4.32 896.453 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.89 0.615 5.28 896.4532 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.28 0.604 5.54 896.4539 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.77 0.571 5.85 896.4543 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 4.29 0.561 4.72 896.4558 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 2.93 0.52 4.25 896.4576 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.39 0.466 3.8 896.4585 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.02 0.432 5.05 896.4587 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.29 0.501 3.03 896.4593 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% SYELPDGQVITIGNER 95.00% 3.62 0.55 4.96 896.4618 1,790.91 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.28 0.545 3.59 978.442 1,954.87 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.23 0.503 1.82 978.4429 1,954.87 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.19 0.627 4.24 978.5258 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.17 0.645 3.89 978.5259 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.97 0.625 4.27 978.5268 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.21 0.665 4.47 978.5302 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.79 0.354 2.14 978.5353 1,955.06 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.55 0.474 1.18 978.9489 1,955.88 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.97 0.497 3.57 979.0222 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.35 0.612 4.05 979.025 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.67 0.62 5.06 979.0283 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.46 0.543 3.7 979.0293 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.1 0.604 4.37 979.0294 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.32 0.591 4.82 979.0294 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.01 0.638 3.21 979.0296 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.23 0.626 4.85 979.0296 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.05 0.61 2.89 979.0297 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.16 0.578 3.8 979.0297 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.63 0.558 4.39 979.0298 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.22 0.609 5.13 979.0299 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.04 0.586 4.01 979.0299 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.5 0.529 5.43 979.0303 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.48 0.572 3.4 979.0303 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.44 0.548 4.77 979.0307 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.38 0.568 3.77 979.0307 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.55 0.584 7 979.0311 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 4.44 0.53 4.28 979.0312 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% VAPEEHPTLLTEAPLNPK 95.00% 3.95 0.514 2.04 979.0348 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% YPIEHGIITNWDDMEK 95.00% 4.52 0.447 3.4 981.4616 1,960.91 1,960.91 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% YPIEHGIITNWDDMEK 95.00% 4.68 0.412 3.77 981.4633 1,960.91 1,960.91 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLYANNVLSGGTTMYPGIADR 95.00% 3.99 0.589 3.36 1,115.04 2,228.06 2,228.07 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLYANNVLSGGTTMYPGIADR 95.00% 5.42 0.631 5.6 1,115.04 2,228.06 2,228.07 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLYANNVLSGGTTMYPGIADR 95.00% 5.43 0.662 7.89 1,115.04 2,228.06 2,228.07 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLYANNVLSGGTTMYPGIADR 95.00% 5.61 0.681 8.13 1,115.04 2,228.07 2,228.07 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLYANNVLSGGTTmYPGIADR 95.00% 6.02 0.413 6.6 m14: Oxidation (+15.99) 1,123.04 2,244.06 2,244.06 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLYANNVLSGGTTmYPGIADR 95.00% 6.05 0.533 5.77 m14: Oxidation (+15.99) 1,123.04 2,244.06 2,244.06 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% DLYANNVLSGGTTmYPGIADR 95.00% 6.11 0.44 5.77 m14: Oxidation (+15.99) 1,123.04 2,244.06 2,244.06 2
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% EITALAPSTMK 95.00% 2.77 0.492 1.09 1,162.55 1,161.54 1,161.62 1 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 312 52.30% KDLYANNVLSGGTTMYPGIADR 95.00% 5.73 0.622 9.03 1,178.59 2,355.16 2,356.16 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSKR 95.00% 1.93 0.156 0.959 452.2162 1,353.63 1,354.62 3 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.31 0.49 0 473.2802 944.5447 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.21 0.418 0 473.2802 944.5448 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.03 0.301 0 473.2806 944.5455 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.13 0.393 0 473.2807 944.5458 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.29 0.5 0 473.2807 944.5458 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 1.98 0.365 0 473.2809 944.5461 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.37 0.392 0 473.2809 944.5462 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 1.88 0.372 0 473.281 944.5463 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 1.98 0.362 0 473.281 944.5463 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.05 0.439 0 473.281 944.5464 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.11 0.418 0 473.281 944.5464 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.12 0.395 0 473.281 944.5464 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.33 0.416 0 473.2811 944.5465 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.02 0.431 0 473.2811 944.5465 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.1 0.413 0 473.2811 944.5465 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 1.83 0.322 0 473.2813 944.5469 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.49 0.448 0 473.2813 944.5469 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.11 0.426 0 473.2813 944.5469 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 1.99 0.414 0 473.2813 944.547 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.37 0.502 0 473.2813 944.547 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.06 0.313 0 473.2815 944.5473 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.25 0.342 0 473.2815 944.5473 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 1.96 0.342 0 473.2817 944.5478 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.38 0.335 0 473.2821 944.5485 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 1.92 0.424 0 473.2823 944.549 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.09 0.407 0 473.2824 944.5492 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 1.88 0.326 0 473.2824 944.5492 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.21 0.38 0 473.2828 944.55 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 1.91 0.381 0 473.2834 944.5512 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGR 95.00% 2.03 0.37 0 473.2882 944.5608 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AGFAGDDAPR 95.00% 3.33 0.459 1.64 488.7296 975.4436 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AGFAGDDAPR 95.00% 3.49 0.486 2.02 488.7298 975.4439 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AGFAGDDAPR 95.00% 3.09 0.458 1.41 488.7298 975.4439 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AGFAGDDAPR 95.00% 3.49 0.446 1.82 488.73 975.4444 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AGFAGDDAPR 95.00% 3.06 0.439 1.47 488.7301 975.4445 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AGFAGDDAPR 95.00% 2.78 0.3 0 488.7301 975.4446 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AGFAGDDAPR 95.00% 3.38 0.452 1.28 488.7302 975.4448 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AGFAGDDAPR 95.00% 2.68 0.286 0 488.7303 975.4449 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AGFAGDDAPR 95.00% 2.92 0.39 1.74 488.7306 975.4455 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 1.78 0.343 0 499.7474 997.4791 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 2.09 0.218 0 499.7474 997.4792 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 2.07 0.328 0 499.7475 997.4793 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 2.22 0.344 0 499.7475 997.4794 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 2.08 0.357 0 499.7476 997.4795 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 2.06 0.394 0 499.7478 997.48 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 2.07 0.431 1.36 499.7478 997.48 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 2.14 0.42 0 499.7478 997.48 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 1.91 0.337 0 499.7479 997.4802 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 1.83 0.309 2.01 499.7481 997.4805 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 2.04 0.368 0 499.7481 997.4806 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 1.89 0.267 1.89 499.7483 997.481 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 2.1 0.423 0 499.7487 997.4818 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLMK 95.00% 1.82 0.339 0 499.7563 997.4969 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.28 0.482 1.13 500.9075 1,499.70 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.85 0.502 0 500.9081 1,499.70 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.33 0.538 0 500.9084 1,499.70 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3 0.572 0 500.9089 1,499.70 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.63 0.472 0 500.909 1,499.70 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.35 0.549 0 500.9092 1,499.70 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.71 0.428 0.959 500.9094 1,499.70 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.62 0.583 1.02 500.9095 1,499.70 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.72 0.419 0 500.9095 1,499.71 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.76 0.483 1.62 500.9095 1,499.71 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.91 0.465 1.52 500.9095 1,499.71 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.96 0.497 0 500.9097 1,499.71 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.94 0.425 0 500.91 1,499.71 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.6 0.355 0 500.91 1,499.71 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.15 0.401 1.6 500.9106 1,499.71 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.97 0.48 0 501.2411 1,500.70 1,500.71 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IWHHTFYNELR 95.00% 2.1 0.269 0 505.4907 1,513.45 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IWHHTFYNELR 95.00% 3.12 0.427 0 505.9217 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IWHHTFYNELR 95.00% 2.95 0.371 0 505.9219 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IWHHTFYNELR 95.00% 3.36 0.436 1.19 505.9227 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IWHHTFYNELR 95.00% 2.54 0.224 0 505.923 1,514.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IWHHTFYNELR 95.00% 2.06 0.211 0 505.9237 1,514.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IWHHTFYNELR 95.00% 3.2 0.432 0 505.924 1,514.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IWHHTFYNELR 95.00% 2.26 0.302 0 506.2577 1,515.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLmK 95.00% 2.06 0.392 0 m7: Oxidation (+15.99) 507.7447 1,013.47 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLmK 95.00% 2.16 0.322 0 m7: Oxidation (+15.99) 507.7453 1,013.48 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLmK 95.00% 2.1 0.369 0 m7: Oxidation (+15.99) 507.7454 1,013.48 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLTDYLmK 95.00% 1.92 0.185 1.19 m7: Oxidation (+15.99) 507.746 1,013.48 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% MQKEITALAPSTMK 95.00% 2.83 0.274 1.29 516.944 1,547.81 1,548.81 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% MQKEITALAPSTMK 95.00% 2.91 0.331 1.32 516.9441 1,547.81 1,548.81 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IKIIAPPER 95.00% 2.53 0.223 0 518.83 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IKIIAPPER 95.00% 2.27 0.288 0 518.8301 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IKIIAPPER 95.00% 2.44 0.225 0 518.8307 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IKIIAPPER 95.00% 2.58 0.222 0 518.8307 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IKIIAPPER 95.00% 2.54 0.232 0 518.8309 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IKIIAPPER 95.00% 2.32 0.221 0 518.831 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IKIIAPPER 95.00% 1.93 0.324 0 518.8311 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IKIIAPPER 95.00% 2.47 0.235 0 518.8311 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IKIIAPPER 95.00% 2.56 0.226 0 518.8315 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IKIIAPPER 95.00% 2.45 0.241 0 518.8316 1,035.65 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% mQKEITALAPSTmK 94.70% 2.4 0.161 0 m1: Oxidation (+15.99), m13: Oxidation (+15.99) 527.6073 1,579.80 1,580.80 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% mQKEITALAPSTmK 95.00% 2.62 0.188 0 m1: Oxidation (+15.99), m13: Oxidation (+15.99) 527.6078 1,579.80 1,580.80 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 3.24 0.439 0 541.953 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 2.91 0.361 0 541.9532 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 3.12 0.482 0 541.9533 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 2.13 0.27 0 541.9533 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 3.17 0.509 0 541.9536 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 2.79 0.523 1.12 541.9537 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 2.82 0.449 0 541.9538 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 2.86 0.382 0 541.9539 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 2.86 0.4 0 541.954 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 2.55 0.378 0 542.288 1,623.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAEREIVR 95.00% 2.67 0.547 0 543.2879 1,626.84 1,627.84 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAEREIVR 95.00% 2.47 0.548 0 543.288 1,626.84 1,627.84 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAEREIVR 95.00% 2.94 0.189 0 543.6222 1,627.84 1,627.84 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAEREIVR 95.00% 2.83 0.305 0 543.6224 1,627.84 1,627.84 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 2.14 0.312 0 m13: Oxidation (+15.99) 547.285 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 3.53 0.339 1.28 m13: Oxidation (+15.99) 547.2855 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 3.61 0.352 0 m13: Oxidation (+15.99) 547.2856 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 4.12 0.377 0 m13: Oxidation (+15.99) 547.2858 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 3.41 0.326 1.48 m13: Oxidation (+15.99) 547.286 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 2.53 0.342 0 m13: Oxidation (+15.99) 547.2862 1,638.84 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 4.01 0.231 0 m13: Oxidation (+15.99) 547.2865 1,638.84 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 2.96 0.371 0 m13: Oxidation (+15.99) 547.6191 1,639.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 3.65 0.211 0 m13: Oxidation (+15.99) 547.6191 1,639.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.49 0.501 3.7 565.7771 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.94 0.526 2.39 565.7773 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.24 0.37 1.6 565.7776 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.77 0.475 2.68 565.7777 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.57 0.437 2.74 565.7777 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.48 0.556 2.27 565.7778 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.58 0.555 3.2 565.7782 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.34 0.52 2 565.7782 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.09 0.534 3.01 565.7782 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.54 0.417 1.74 565.7783 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.8 0.446 2.74 565.7784 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.51 0.552 2.64 565.7786 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.56 0.565 2.57 565.7787 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.65 0.573 2.47 565.7787 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.42 0.551 3.35 565.7787 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.47 0.525 2.48 565.7788 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.36 0.545 2.23 565.7788 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.48 0.512 2.16 565.7789 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.19 0.546 4.09 565.779 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.37 0.456 2.77 565.779 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.92 0.33 2.11 565.779 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.61 0.489 2.43 565.7791 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.61 0.478 1.54 565.7791 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.19 0.563 2.29 565.7792 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 1.97 0.281 0 565.7793 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.13 0.486 1.96 565.7793 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.29 0.514 2.62 565.7793 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.56 0.467 2.72 565.7793 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.41 0.554 2.18 565.7794 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.6 0.583 2.64 565.7795 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.79 0.355 2.14 565.7795 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.13 0.517 2.3 565.7796 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.35 0.48 2.42 565.7797 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.41 0.534 2.49 565.7798 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.54 0.592 2.29 565.7799 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.01 0.452 2.42 565.7799 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.31 0.471 2.12 565.7801 1,129.54 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.22 0.543 1.8 565.7804 1,129.55 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.97 0.556 2.66 565.7807 1,129.55 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.3 0.521 1.32 565.7813 1,129.55 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 3.05 0.493 3.92 565.7815 1,129.55 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.77 0.429 2.04 565.7821 1,129.55 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.15 0.2 1.29 565.7823 1,129.55 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.1 0.405 0 565.7823 1,129.55 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.73 0.458 2.37 565.7824 1,129.55 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.1 0.161 1.68 565.7825 1,129.55 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.55 0.376 2.14 565.7826 1,129.55 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 1.77 0.353 0 565.786 1,129.56 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.7 0.253 1.89 566.2804 1,130.55 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.73 0.228 1.68 566.2835 1,130.55 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.97 0.275 1.55 566.2988 1,130.58 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.55 0.273 1.66 566.2995 1,130.58 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.82 0.258 1.51 566.2995 1,130.58 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.67 0.24 0 566.3001 1,130.58 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAER 95.00% 2.92 0.329 1.77 566.3009 1,130.59 1,130.55 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTMK 95.00% 2.6 0.363 0 581.3145 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTMK 95.00% 2.93 0.401 1.72 581.3146 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTMK 95.00% 2.84 0.376 0 581.3148 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTMK 95.00% 2.99 0.395 2.37 581.3152 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTMK 95.00% 2.68 0.317 0 581.3155 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTMK 95.00% 2.6 0.289 0 581.3159 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTMK 95.00% 2.26 0.267 0 581.3161 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTMK 95.00% 2.15 0.286 0 581.815 1,161.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTMK 95.00% 2.17 0.214 1.37 581.8184 1,161.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGMGQK 95.00% 2.35 0.439 3.15 586.2905 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGMGQK 95.00% 2.2 0.407 0 586.2907 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGMGQK 95.00% 2.36 0.429 3.17 586.2909 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGMGQK 95.00% 2.53 0.378 3.2 586.2915 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGMGQK 95.00% 3.04 0.499 4.18 586.2923 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGMGQK 95.00% 2.1 0.466 2.49 586.2924 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGMGQK 95.00% 1.94 0.243 2.82 586.2925 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGMGQK 95.00% 1.99 0.339 2.35 586.2927 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGMGQK 95.00% 2.19 0.375 2.85 586.2941 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGMGQK 95.00% 2.25 0.358 3.23 586.2947 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTmK 95.00% 2.86 0.288 0 m10: Oxidation (+15.99) 589.3115 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTmK 95.00% 3.01 0.36 0 m10: Oxidation (+15.99) 589.3116 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTmK 95.00% 2.85 0.223 0 m10: Oxidation (+15.99) 589.3116 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTmK 94.70% 2.76 0.141 0 m10: Oxidation (+15.99) 589.3117 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTmK 95.00% 2.94 0.263 0 m10: Oxidation (+15.99) 589.3118 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTmK 95.00% 2.28 0.251 0 m10: Oxidation (+15.99) 589.3119 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTmK 95.00% 2.87 0.162 0 m10: Oxidation (+15.99) 589.3119 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTmK 95.00% 2.48 0.356 0 m10: Oxidation (+15.99) 589.3121 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% EITALAPSTmK 95.00% 2.87 0.273 1.59 m10: Oxidation (+15.99) 589.3127 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGmGQK 95.00% 2.78 0.4 4.51 m8: Oxidation (+15.99) 594.2888 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVmVGMGQK 95.00% 2.37 0.32 3.8 m5: Oxidation (+15.99) 594.2892 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGmGQK 95.00% 2.78 0.428 3.66 m8: Oxidation (+15.99) 594.2901 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVmVGMGQK 95.00% 2.74 0.433 4.38 m5: Oxidation (+15.99) 594.2904 1,186.57 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.06 0.472 3.6 597.6371 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.4 0.52 3.49 597.6372 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.57 0.458 3.57 597.6376 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 2.43 0.266 0 597.6381 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 2.37 0.272 0 597.6381 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3.03 0.374 0 597.6381 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3 0.408 1.02 597.6389 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.13 0.514 3.62 597.6399 1,789.90 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 2.3 0.279 0 597.6407 1,789.90 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.68 0.469 3.72 597.9713 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.08 0.442 3.43 597.9716 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3.95 0.397 2.17 597.972 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3.48 0.341 1.41 597.9721 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.82 0.526 3 597.9722 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3.01 0.335 1.05 597.9729 1,790.90 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3.19 0.325 1.4 597.9735 1,790.90 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.17 0.285 0 599.3417 1,196.67 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.24 0.293 0 599.3424 1,196.67 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.39 0.245 0 599.3425 1,196.67 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSK 95.00% 3.18 0.408 4.8 599.7672 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSK 95.00% 2.99 0.42 3.39 599.768 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSK 95.00% 3.15 0.422 4.89 599.7687 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSK 95.00% 2.62 0.386 3.01 599.7688 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSK 95.00% 2.27 0.302 3.72 599.7691 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSK 95.00% 2.79 0.383 4.37 599.7695 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSK 95.00% 2.28 0.264 1.77 599.77 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSK 95.00% 1.99 0.234 2.09 599.7704 1,197.53 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSK 95.00% 2.56 0.385 2.82 599.7713 1,197.53 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.46 0.326 0 599.8572 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.19 0.23 0 599.8579 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.55 0.28 0 599.8585 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.66 0.351 0 599.8585 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.68 0.352 0 599.8586 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.48 0.244 0 599.8587 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.39 0.247 0 599.8588 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.5 0.307 0 599.8589 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.74 0.366 0 599.8589 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.37 0.281 0 599.859 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 94.60% 2.11 0.267 0 599.8591 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.14 0.339 0 599.8622 1,197.71 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.33 0.283 0 599.9885 1,197.96 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSK 95.00% 2.37 0.407 2.47 600.275 1,198.53 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% AVFPSIVGRPR 95.00% 2.51 0.33 0 600.3611 1,198.71 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVmVGmGQK 95.00% 2.01 0.203 1.85 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 602.2876 1,202.56 1,203.56 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.38 0.295 0 652.6866 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.38 0.477 0 652.6885 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.78 0.507 3.09 652.6888 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.92 0.468 0 652.6891 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.07 0.525 1 652.6891 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.99 0.556 1.85 652.6896 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.16 0.414 0 652.6896 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.46 0.298 0 652.6898 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.75 0.523 0 652.6898 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.49 0.51 0 652.6899 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.68 0.495 0 652.6905 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.64 0.427 1.26 652.6905 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.25 0.435 0 652.6905 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.23 0.431 1.89 652.691 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.34 0.329 0 652.6911 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.41 0.211 0 652.6912 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.05 0.545 1.14 652.6913 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.58 0.31 0 652.6927 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.83 0.162 0 652.6929 1,955.06 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.4 0.527 1.77 653.0212 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.34 0.431 0 653.0214 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.49 0.485 0 653.0218 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.62 0.492 0 653.0222 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.65 0.472 0 653.0222 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.23 0.504 1.23 653.0222 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.65 0.27 0 653.0222 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.83 0.503 1.64 653.0223 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.69 0.308 0 653.0224 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.58 0.503 0.959 653.0225 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.65 0.445 2.31 653.0226 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.22 0.443 0 653.0227 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.18 0.438 0 653.0227 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.61 0.513 1.37 653.0228 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.56 0.249 0 653.0228 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.31 0.403 0.959 653.0229 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.58 0.486 1.82 653.0229 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.04 0.504 1.7 653.0229 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.62 0.397 1.38 653.0231 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.74 0.416 1.27 653.0231 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.57 0.502 2.24 653.0232 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.54 0.414 0 653.0232 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.23 0.141 0 653.0233 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.02 0.458 1.37 653.0233 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.41 0.327 0 653.0234 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.36 0.456 1.55 653.0234 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.57 0.196 0 653.024 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.73 0.375 0 653.024 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.18 0.356 0 653.0242 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.02 0.306 0 653.025 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.57 0.401 0 653.0255 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.81 0.38 0 653.0256 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.13 0.338 0 653.0259 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.9 0.382 0 653.0264 1,956.06 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.16 0.24 0 653.0268 1,956.06 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 2.41 0.327 0 653.0282 1,956.06 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% YPIEHGIITNWDDMEK 95.00% 2.97 0.158 0 654.311 1,959.91 1,960.91 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% YPIEHGIITNWDDMEK 95.00% 3.8 0.216 1.01 654.6454 1,960.91 1,960.91 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSKR 95.00% 2.6 0.418 2.49 677.8196 1,353.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSKR 95.00% 2.6 0.53 4.09 677.82 1,353.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSKR 95.00% 3.05 0.509 5.05 677.8207 1,353.63 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSKR 95.00% 2.35 0.502 0 677.8211 1,353.63 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSKR 95.00% 2.22 0.44 1.31 677.8225 1,353.63 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DSYVGDEAQSKR 95.00% 2.36 0.318 0 677.8232 1,353.63 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% qEYDEAGPSIVHR 95.00% 0 0 3.37 n-term: Pyro-cmC (-17.03) 742.3474 1,482.68 1,483.68 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLYANNVLSGGTTMYPGIADR 95.00% 5.3 0.567 3.72 743.6965 2,228.07 2,228.07 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLYANNVLSGGTTMYPGIADR 95.00% 6.3 0.57 4.3 743.6968 2,228.07 2,228.07 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.86 0.525 4.24 750.8585 1,499.70 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.66 0.501 0 750.8592 1,499.70 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.82 0.54 4.47 750.8595 1,499.70 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.06 0.59 2.47 750.8596 1,499.70 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.7 0.517 2.7 750.8602 1,499.70 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.17 0.613 3.82 750.8609 1,499.71 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.03 0.544 4.09 750.8612 1,499.71 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.37 0.593 3.21 750.8615 1,499.71 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.14 0.579 3.08 750.8618 1,499.71 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.09 0.457 2.92 750.8625 1,499.71 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.12 0.613 2.39 750.8639 1,499.71 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 2.83 0.524 2.15 751.3603 1,500.71 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHR 95.00% 3.45 0.616 3.33 751.3614 1,500.71 1,500.71 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% IWHHTFYNELR 95.00% 2.69 0.411 1.92 758.38 1,514.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.14 0.556 4.52 784.6989 2,351.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% KDLYANNVLSGGTTMYPGIADR 95.00% 6 0.571 1.51 786.3964 2,356.17 2,356.16 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% KDLYANNVLSGGTTMYPGIADR 95.00% 5.59 0.615 2.92 786.3964 2,356.17 2,356.16 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.46 0.622 3.35 m8: Oxidation (+15.99) 790.0323 2,367.07 2,367.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.23 0.646 5.29 m8: Oxidation (+15.99) 790.0328 2,367.07 2,367.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% KDLYANNVLSGGTTmYPGIADR 95.00% 6.01 0.431 3.85 m15: Oxidation (+15.99) 791.7271 2,372.16 2,372.16 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% KDLYANNVLSGGTTmYPGIADR 95.00% 5.78 0.358 2.3 m15: Oxidation (+15.99) 791.7278 2,372.16 2,372.16 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.7 0.695 3.07 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3647 2,383.07 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVmVGmGQKDSYVGDEAQSK 95.00% 2.47 0.347 0 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3663 2,383.08 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.46 0.564 3.54 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3664 2,383.08 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.85 0.583 3.12 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3674 2,383.08 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.32 0.591 1.96 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3675 2,383.08 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVmVGmGQKDSYVGDEAQSK 95.00% 2.61 0.396 1.24 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3677 2,383.08 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% HQGVmVGmGQKDSYVGDEAQSK 95.00% 4.33 0.585 1.6 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3685 2,383.08 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 3.01 0.304 2.68 812.4243 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 3.31 0.392 3.47 812.4261 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 3.28 0.385 2.92 812.4264 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 3.19 0.37 2.96 812.4265 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 3.18 0.32 3.49 812.4265 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 3.18 0.31 2.74 812.427 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 3.09 0.379 2.48 812.4273 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLMK 95.00% 3.06 0.373 3.06 812.4283 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHRK 95.00% 2.65 0.206 2.33 814.393 1,626.77 1,628.80 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAEREIVR 95.00% 2.76 0.216 0 814.4258 1,626.84 1,627.84 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAEREIVR 95.00% 3.39 0.205 0 814.4267 1,626.84 1,627.84 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAEREIVR 95.00% 3.26 0.324 1.66 814.4277 1,626.84 1,627.84 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAEREIVR 95.00% 3.07 0.206 0 814.4279 1,626.84 1,627.84 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAEREIVR 95.00% 3.06 0.194 0 814.4281 1,626.84 1,627.84 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAEREIVR 95.00% 3.14 0.289 1.18 814.4289 1,626.84 1,627.84 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% QEYDEAGPSIVHRK 95.00% 2.8 0.179 0 814.8938 1,627.77 1,628.80 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% GYSFVTTAEREIVR 95.00% 2.77 0.24 0 814.9285 1,627.84 1,627.84 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 2.8 0.0843 2.48 m13: Oxidation (+15.99) 820.4238 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 3.13 0.184 3.04 m13: Oxidation (+15.99) 820.4242 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 3.08 0.221 2.66 m13: Oxidation (+15.99) 820.4242 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 3.23 0.216 3.21 m13: Oxidation (+15.99) 820.4243 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 3.25 0.193 3.14 m13: Oxidation (+15.99) 820.4244 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 3.09 0.148 3.03 m13: Oxidation (+15.99) 820.4245 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LDLAGRDLTDYLmK 95.00% 2.71 0.139 1.55 m13: Oxidation (+15.99) 820.4246 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LcYVALDFENEMATAASSSSLEK 95.00% 2.96 0.175 0 c2: Carbamidomethyl (+57.02) 846.395 2,536.16 2,536.16 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LcYVALDFENEMATAASSSSLEK 95.00% 3.86 0.475 0 c2: Carbamidomethyl (+57.02) 846.396 2,536.16 2,536.16 3
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% ILTERGYSFVTTAER 95.00% 4.22 0.477 3.24 871.9601 1,741.90 1,742.91 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% ILTERGYSFVTTAER 95.00% 3.56 0.423 3.7 871.9601 1,741.90 1,742.91 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% ILTERGYSFVTTAER 95.00% 4.06 0.47 4.17 871.9605 1,741.91 1,742.91 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% ILTERGYSFVTTAER 95.00% 3.82 0.407 2.82 871.9609 1,741.91 1,742.91 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% ILTERGYSFVTTAER 95.00% 4.08 0.23 3.34 872.4608 1,742.91 1,742.91 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% ILTERGYSFVTTAER 95.00% 3.93 0.26 3.17 872.4612 1,742.91 1,742.91 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% ILTERGYSFVTTAER 95.00% 4.26 0.274 3.51 872.4616 1,742.91 1,742.91 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% ILTERGYSFVTTAER 95.00% 3.64 0.284 3.06 872.4618 1,742.91 1,742.91 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.86 0.614 6.74 895.951 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.59 0.553 6.35 895.9514 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.73 0.572 5.34 895.9514 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.49 0.625 5.89 895.9514 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.71 0.627 6.17 895.9515 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.64 0.613 7.24 895.9519 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.6 0.554 5.89 895.952 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.68 0.518 5.85 895.952 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.69 0.557 5.41 895.9521 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.36 0.615 4.59 895.9522 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.15 0.597 7.28 895.9522 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.43 0.586 4.68 895.9524 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.66 0.543 6 895.9524 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.76 0.608 4.6 895.9526 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.42 0.589 6.77 895.953 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.95 0.625 5.38 895.9532 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.87 0.586 5.8 895.9534 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.41 0.578 6.17 895.9534 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.75 0.587 5.11 895.9535 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.55 0.599 5.16 895.9541 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.44 0.566 6.19 895.9543 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.83 0.629 5.85 895.9547 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3.99 0.51 7.89 895.9547 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.42 0.603 6 895.9558 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.48 0.552 4.43 895.9564 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 2.96 0.254 4.1 895.9564 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.46 0.565 4.77 895.9568 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.02 0.554 5.4 895.9569 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3.08 0.472 3.46 895.9585 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3.97 0.56 4.72 895.9594 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3.31 0.514 4.92 895.9612 1,789.91 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.94 0.591 5.37 896.4521 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.83 0.613 4.49 896.4527 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.76 0.511 4.82 896.4532 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.84 0.585 5.43 896.4539 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3.68 0.548 6.52 896.4551 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.21 0.501 5.08 896.4552 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.54 0.515 5.74 896.4554 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 4.61 0.593 4.82 896.456 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3.59 0.469 2.28 896.4604 1,790.91 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% SYELPDGQVITIGNER 95.00% 3.79 0.505 5.33 896.4617 1,790.91 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.97 0.618 3.8 978.5276 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.99 0.644 3.08 978.5277 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.79 0.629 2.52 978.5295 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.59 0.576 4.05 978.53 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.56 0.58 2.89 978.5302 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.04 0.563 0 979.0224 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.18 0.549 2.96 979.0263 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.14 0.603 2.41 979.0273 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.29 0.576 4.27 979.0273 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.97 0.631 3.14 979.0277 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.16 0.638 3.14 979.0278 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 3.15 0.569 2.2 979.0288 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.21 0.58 3.37 979.0288 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.29 0.521 6 979.029 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.44 0.54 6.19 979.0292 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.14 0.605 1.92 979.0298 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.02 0.614 3.42 979.0301 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.57 0.616 4.04 979.0301 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.4 0.531 4.17 979.0303 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.31 0.551 2.4 979.0305 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.57 0.544 3.25 979.0307 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.13 0.494 3.52 979.0312 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.3 0.572 4.28 979.0313 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.1 0.562 3.25 979.0313 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.47 0.553 2.82 979.0313 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.29 0.562 2.44 979.032 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% VAPEEHPTLLTEAPLNPK 95.00% 4.4 0.547 3.77 979.0331 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% YPIEHGIITNWDDMEK 95.00% 4.29 0.396 2.64 981.461 1,960.91 1,960.91 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% YPIEHGIITNWDDMEK 95.00% 4.23 0.425 2.96 981.4641 1,960.91 1,960.91 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLYANNVLSGGTTMYPGIADR 95.00% 4.85 0.658 4.54 1,114.54 2,227.06 2,228.07 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLYANNVLSGGTTMYPGIADR 95.00% 5.9 0.679 7.1 1,115.04 2,228.06 2,228.07 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLYANNVLSGGTTMYPGIADR 95.00% 5.81 0.651 3.92 1,115.04 2,228.06 2,228.07 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLYANNVLSGGTTmYPGIADR 95.00% 6.38 0.64 7.03 m14: Oxidation (+15.99) 1,122.53 2,243.05 2,244.06 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLYANNVLSGGTTmYPGIADR 95.00% 4.17 0.607 3.36 m14: Oxidation (+15.99) 1,122.55 2,243.09 2,244.06 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% DLYANNVLSGGTTmYPGIADR 95.00% 6.28 0.459 6.85 m14: Oxidation (+15.99) 1,123.04 2,244.06 2,244.06 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% KDLYANNVLSGGTTMYPGIADR 95.00% 5.6 0.62 4.85 1,179.08 2,356.15 2,356.16 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% KDLYANNVLSGGTTMYPGIADR 95.00% 5.54 0.625 6.05 1,179.09 2,356.16 2,356.16 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LcYVALDFENEMATAASSSSLEK 95.00% 7.05 0.661 8.37 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LcYVALDFENEMATAASSSSLEK 95.00% 7.11 0.664 9.37 c2: Carbamidomethyl (+57.02) 1,269.09 2,536.16 2,536.16 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LcYVALDFENEMATAASSSSLEK 95.00% 7.04 0.658 10.9 c2: Carbamidomethyl (+57.02) 1,269.09 2,536.16 2,536.16 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LcYVALDFENEMATAASSSSLEK 95.00% 7.08 0.647 9.62 c2: Carbamidomethyl (+57.02) 1,269.09 2,536.16 2,536.16 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LcYVALDFENEMATAASSSSLEK 95.00% 7.14 0.68 9.47 c2: Carbamidomethyl (+57.02) 1,269.09 2,536.17 2,536.16 2
 SAMPLE 4R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 18 26 311 58.40% LcYVALDFENEmATAASSSSLEK 95.00% 5.16 0.535 0 c2: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 1,276.60 2,551.19 2,552.15 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.13 0.434 0 473.2781 944.5406 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.1 0.4 0 473.2786 944.5416 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.03 0.415 0 473.2789 944.5421 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.08 0.412 0 473.2789 944.5421 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 1.84 0.324 0 473.2789 944.5422 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.24 0.426 0 473.279 944.5423 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.14 0.433 0 473.2791 944.5425 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.1 0.435 0 473.2791 944.5426 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.22 0.427 0 473.2791 944.5426 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.24 0.419 0 473.2793 944.5429 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.08 0.449 0 473.2794 944.5432 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.29 0.412 0 473.2796 944.5435 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.31 0.459 0 473.2797 944.5438 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.17 0.337 0 473.2798 944.544 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.31 0.388 0 473.2799 944.5441 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.08 0.43 0 473.2804 944.5451 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 2.26 0.402 0 473.2817 944.5478 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGR 95.00% 1.95 0.376 0 473.2844 944.5531 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AGFAGDDAPR 95.00% 2.39 0.406 0 488.7271 975.4386 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2.17 0.425 0 499.7451 997.4746 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 1.97 0.388 1.32 499.7455 997.4753 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2.1 0.422 0 499.7458 997.4759 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2.09 0.413 0 499.7459 997.4761 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2.04 0.286 0 499.746 997.4764 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 1.91 0.385 0 499.746 997.4764 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2.03 0.327 1.33 499.7462 997.4767 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2.19 0.403 0 499.7462 997.4767 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2 0.402 0 499.7462 997.4768 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2.08 0.432 0 499.7468 997.478 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 1.93 0.361 0 499.7474 997.4792 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 1.77 0.248 1.25 499.7474 997.4792 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2.18 0.308 0 499.7509 997.4862 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2.62 0.398 0 499.7529 997.4901 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2.49 0.424 0 499.7536 997.4916 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2.14 0.347 0 499.7548 997.4939 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLMK 95.00% 2.28 0.457 1.51 499.7551 997.4945 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.7 0.407 0 500.9059 1,499.69 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.42 0.534 1.08 500.9062 1,499.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 3.18 0.493 0 500.9062 1,499.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 3.14 0.538 1.05 500.9063 1,499.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.71 0.334 0 500.9064 1,499.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 3.41 0.443 0 500.9066 1,499.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.87 0.423 0 500.9068 1,499.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.91 0.523 0 500.907 1,499.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 3.23 0.46 0 500.907 1,499.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.61 0.5 0 500.9074 1,499.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.69 0.423 0 500.9076 1,499.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.82 0.507 0 500.9076 1,499.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.93 0.376 1.18 500.9082 1,499.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 3.48 0.546 0 501.2406 1,500.70 1,500.71 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% IWHHTFYNELR 95.00% 3.54 0.454 1.74 505.919 1,514.73 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% IWHHTFYNELR 95.00% 3.55 0.385 1.49 505.9216 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% IWHHTFYNELR 95.00% 3.34 0.404 1.29 505.9217 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% IWHHTFYNELR 95.00% 3.48 0.333 0 506.2544 1,515.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLTDYLmK 95.00% 2.19 0.306 0 m7: Oxidation (+15.99) 507.7427 1,013.47 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% IKIIAPPER 95.00% 2.38 0.236 0 518.8272 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% IKIIAPPER 95.00% 2.2 0.228 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% IKIIAPPER 95.00% 2.18 0.247 0 518.8284 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% IKIIAPPER 95.00% 1.98 0.326 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% IKIIAPPER 95.00% 1.99 0.292 0 518.8287 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% IKIIAPPER 95.00% 2.23 0.216 0 518.8298 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLMK 95.00% 2.5 0.367 0 541.9499 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLMK 95.00% 3.12 0.357 0 541.9503 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLMK 95.00% 2.24 0.28 0 541.955 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLMK 95.00% 2.45 0.281 0 542.2871 1,623.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAEREIVR 95.00% 2.21 0.264 0 543.2848 1,626.83 1,627.84 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAEREIVR 95.00% 2.46 0.421 0 543.2859 1,626.83 1,627.84 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLmK 95.00% 3.33 0.35 0 m13: Oxidation (+15.99) 547.2817 1,638.82 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLmK 95.00% 2.98 0.324 0 m13: Oxidation (+15.99) 547.2825 1,638.82 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLmK 95.00% 4.1 0.302 1.12 m13: Oxidation (+15.99) 547.2857 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLmK 95.00% 2.64 0.215 0 m13: Oxidation (+15.99) 547.2888 1,638.84 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLmK 95.00% 3.98 0.258 0 m13: Oxidation (+15.99) 547.6166 1,639.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 2.27 0.244 0 565.7711 1,129.53 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 2.15 0.17 1.77 565.7734 1,129.53 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 2.7 0.513 2.74 565.774 1,129.53 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 2.92 0.467 2.32 565.7742 1,129.53 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 3.17 0.525 2.55 565.7752 1,129.53 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 3.52 0.569 2.31 565.7753 1,129.53 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 2.84 0.496 3.68 565.7753 1,129.53 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 3.39 0.552 2.41 565.7758 1,129.54 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 2.91 0.487 3 565.776 1,129.54 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 3.42 0.53 3.02 565.7765 1,129.54 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 3.42 0.508 2.36 565.7766 1,129.54 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 3.31 0.501 1.96 565.7766 1,129.54 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 3.25 0.47 2.77 565.7767 1,129.54 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 3.55 0.58 1.66 565.7767 1,129.54 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 3.56 0.558 2.92 565.7768 1,129.54 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 3.43 0.514 2.44 565.7769 1,129.54 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAER 95.00% 2.98 0.408 1.51 565.7787 1,129.54 1,130.55 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTMK 95.00% 2.74 0.375 0 581.3109 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTMK 95.00% 2.65 0.385 0 581.3117 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTMK 95.00% 3.2 0.391 2.22 581.3125 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTMK 95.00% 2.94 0.416 2.47 581.3136 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTMK 95.00% 2.43 0.332 0 581.3137 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTMK 95.00% 2.36 0.268 0 581.3161 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTMK 95.00% 2.45 0.343 0 581.3208 1,160.63 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% HQGVMVGMGQK 95.00% 2.03 0.33 1.28 586.2878 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% HQGVMVGMGQK 95.00% 2.4 0.418 3.59 586.288 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% HQGVMVGMGQK 95.00% 2.28 0.428 3.92 586.2881 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% HQGVMVGMGQK 95.00% 2.78 0.32 2.09 586.2883 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% HQGVMVGMGQK 95.00% 2.67 0.475 4.72 586.2891 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% HQGVMVGMGQK 95.00% 2.55 0.464 3.8 586.2893 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTmK 95.00% 2.33 0.257 0 m10: Oxidation (+15.99) 589.3088 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTmK 95.00% 2.65 0.296 0 m10: Oxidation (+15.99) 589.3089 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTmK 95.00% 2.77 0.256 1.89 m10: Oxidation (+15.99) 589.309 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTmK 95.00% 2.99 0.282 1.2 m10: Oxidation (+15.99) 589.3092 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTmK 95.00% 2.66 0.211 0 m10: Oxidation (+15.99) 589.3125 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% EITALAPSTmK 95.00% 2.69 0.247 2.17 m10: Oxidation (+15.99) 589.3132 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 2.97 0.392 0 597.6323 1,789.87 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.25 0.491 2.38 597.6335 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.13 0.49 2.8 597.635 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.42 0.392 4.08 597.6475 1,789.92 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 5.19 0.492 3.08 597.9691 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.73 0.334 1.26 599.8549 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.73 0.372 0 599.855 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.96 0.364 0 599.8554 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.76 0.376 0 599.8555 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.81 0.335 0 599.8557 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.55 0.344 0 599.856 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.69 0.332 0 599.8562 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.47 0.299 0 599.8562 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.56 0.271 0 599.8563 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.43 0.326 0 599.8564 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.16 0.319 0 599.8565 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.57 0.335 0 599.8568 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% AVFPSIVGRPR 95.00% 2.77 0.225 0 599.859 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 2.92 0.462 0 652.6852 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.54 0.543 2.68 652.6852 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.47 0.573 0 652.6852 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.65 0.566 2.24 652.6852 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 2.62 0.286 0 652.6878 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.18 0.358 0 652.6894 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.24 0.53 0 652.6913 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 2.7 0.342 0 652.6929 1,955.06 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.12 0.409 0 653.019 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.3 0.454 0 653.019 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.49 0.464 0 653.0192 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.56 0.545 1.51 653.0196 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.04 0.516 0 653.0196 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.3 0.448 0 653.0197 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.44 0.471 0 653.0197 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.45 0.496 0 653.0198 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.78 0.518 1.55 653.0199 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.42 0.528 1.21 653.0201 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.5 0.464 0.959 653.0201 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 2.95 0.336 0 653.0202 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.91 0.457 2.04 653.0203 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.08 0.486 1.27 653.0204 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 3.63 0.416 0 653.0204 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% YPIEHGIITNWDDMEK 95.00% 3.18 0.163 1.18 654.3077 1,959.90 1,960.91 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% YPIEHGIITNWDDMEK 95.00% 3.84 0.344 1.29 654.308 1,959.90 1,960.91 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% YPIEHGIITNWDDMEK 95.00% 3.03 0.171 0 654.6396 1,960.90 1,960.91 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% YPIEHGIITNWDDMEK 95.00% 3.08 0.156 1.66 654.6418 1,960.90 1,960.91 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% YPIEHGIITNWDDMEK 95.00% 3.56 0.305 0 654.6428 1,960.91 1,960.91 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.94 0.518 1.49 750.8572 1,499.70 1,500.71 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.91 0.441 3.03 750.8582 1,499.70 1,500.71 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 3.05 0.568 1.92 750.8584 1,499.70 1,500.71 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.71 0.491 2.03 750.8592 1,499.70 1,500.71 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.76 0.442 0 750.8608 1,499.71 1,500.71 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% QEYDEAGPSIVHR 95.00% 2.54 0.586 2.08 750.8637 1,499.71 1,500.71 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% KDLYANNVLSGGTTMYPGIADR 95.00% 2.73 0.241 0 786.0547 2,355.14 2,356.16 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% KDLYANNVLSGGTTMYPGIADR 95.00% 5.38 0.603 0 786.3906 2,356.15 2,356.16 3
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLMK 95.00% 3.21 0.368 1.14 812.4218 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLMK 95.00% 2.19 0.247 1.32 812.4256 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLMK 95.00% 2.95 0.305 2.2 812.4337 1,622.85 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLMK 95.00% 3.13 0.358 3.02 812.4381 1,622.86 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLMK 95.00% 3.12 0.385 2.54 812.9229 1,623.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLMK 95.00% 2.94 0.3 1.55 812.9242 1,623.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLMK 95.00% 3.16 0.32 2.06 812.9243 1,623.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% GYSFVTTAEREIVR 95.00% 2.91 0.277 0 814.4243 1,626.83 1,627.84 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLmK 95.00% 2.76 0.256 0 m13: Oxidation (+15.99) 820.4196 1,638.82 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLmK 95.00% 2.84 0.202 1.72 m13: Oxidation (+15.99) 820.4201 1,638.82 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LDLAGRDLTDYLmK 95.00% 3.01 0.212 3.66 m13: Oxidation (+15.99) 820.4252 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.63 0.613 6.14 895.9469 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.84 0.634 5.64 895.9472 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.82 0.63 5.77 895.9478 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.77 0.626 5.39 895.9482 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.74 0.609 6.25 895.9483 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.82 0.632 5.66 895.9484 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.33 0.625 5.43 895.9485 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.68 0.605 5.49 895.9489 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 2.49 0.187 3.77 895.9494 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 3.45 0.422 3.96 895.9494 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.39 0.593 5.64 895.9496 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.47 0.539 6.15 895.9497 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 3.27 0.465 4.54 895.9505 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 2.94 0.363 4.03 895.9544 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 2.82 0.447 3.36 895.956 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.53 0.634 5.8 895.9568 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.36 0.603 6 895.9594 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.43 0.566 6.35 895.9602 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 3.32 0.56 5.38 895.9602 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.81 0.618 5.34 895.9652 1,789.91 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.61 0.62 5.49 895.9666 1,789.92 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.41 0.512 5 895.9666 1,789.92 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.72 0.617 4.96 895.9674 1,789.92 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.63 0.589 5.24 896.4487 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.32 0.573 4.57 896.4491 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.53 0.588 4.42 896.4499 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.76 0.592 4.15 896.4509 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.72 0.599 6 896.4509 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 3.82 0.535 4.05 896.454 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 3.7 0.479 4.85 896.4544 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 4.4 0.515 4.82 896.4593 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% SYELPDGQVITIGNER 95.00% 3.28 0.497 3.19 896.4649 1,790.91 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.61 0.625 5.92 978.5218 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.24 0.572 4.82 978.5237 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.18 0.62 3.52 978.524 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.17 0.602 5.57 978.5247 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.27 0.611 4.85 978.5256 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.34 0.572 4.14 979.0217 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.35 0.612 5.1 979.0231 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.65 0.604 4.55 979.0239 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.42 0.54 5.03 979.0245 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.41 0.564 4.52 979.0246 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.11 0.56 4.33 979.0247 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.81 0.623 5.15 979.0249 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.22 0.628 3.52 979.0255 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.18 0.534 4.13 979.0259 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.39 0.557 3.37 979.026 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.55 0.573 4.7 979.0274 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.4 0.574 4.14 979.0346 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% VAPEEHPTLLTEAPLNPK 95.00% 4.51 0.589 5.15 979.0406 1,956.07 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% YPIEHGIITNWDDMEK 95.00% 4.37 0.443 2.51 981.4581 1,960.90 1,960.91 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% YPIEHGIITNWDDMEK 95.00% 4.61 0.422 2.66 981.4601 1,960.90 1,960.91 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 5.54 0.63 6.51 1,114.53 2,227.05 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 5.87 0.647 6.85 1,115.03 2,228.05 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 6.01 0.663 7.26 1,115.03 2,228.05 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 5.47 0.664 6.66 1,115.04 2,228.05 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 5.29 0.661 6.66 1,115.04 2,228.05 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 5.31 0.659 6.21 1,115.04 2,228.07 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 5.26 0.665 4.19 1,115.04 2,228.07 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 5.47 0.635 6.06 1,115.04 2,228.07 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 5.65 0.655 4.77 1,115.04 2,228.07 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 3.67 0.591 4.1 1,115.04 2,228.07 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 4.44 0.581 4.1 1,115.05 2,228.07 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 4.74 0.633 4.92 1,115.05 2,228.08 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTMYPGIADR 95.00% 5.17 0.667 6.26 1,115.05 2,228.08 2,228.07 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTmYPGIADR 95.00% 6.35 0.45 4.28 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% DLYANNVLSGGTTmYPGIADR 95.00% 6.1 0.454 5.7 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LcYVALDFENEMATAASSSSLEK 95.00% 6.76 0.69 9.89 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 1 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 153 52.80% LcYVALDFENEMATAASSSSLEK 95.00% 2.9 0.46 2.74 c2: Carbamidomethyl (+57.02) 1,269.09 2,536.17 2,536.16 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 94.90% 1.75 0.309 0 473.2781 944.5406 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 1.98 0.397 0 473.2785 944.5414 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 1.98 0.357 0 473.2787 944.5417 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 2.15 0.445 0 473.2788 944.542 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 2.03 0.403 0 473.2788 944.542 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 2.13 0.408 0 473.2789 944.5421 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 1.91 0.363 0 473.279 944.5423 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 1.95 0.343 0 473.2791 944.5426 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 2.2 0.408 0 473.2792 944.5428 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 2.11 0.454 0 473.2793 944.5429 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 2.31 0.459 0 473.2797 944.5438 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 2.1 0.404 0 473.2798 944.5439 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 2.1 0.389 0 473.2802 944.5447 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 2.26 0.402 0 473.2817 944.5478 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGR 95.00% 1.95 0.376 0 473.2844 944.5531 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AGFAGDDAPR 95.00% 2.39 0.406 0 488.7271 975.4386 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AGFAGDDAPR 95.00% 2.36 0.28 2.48 488.729 975.4424 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLTDYLMK 95.00% 2.04 0.366 0 499.7454 997.4751 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLTDYLMK 95.00% 2.2 0.481 0 499.7458 997.4759 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLTDYLMK 95.00% 2 0.41 1.19 499.7459 997.4762 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLTDYLMK 95.00% 1.99 0.335 0 499.7462 997.4767 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLTDYLMK 95.00% 2.18 0.396 0 499.7463 997.4769 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLTDYLMK 95.00% 2.11 0.423 0 499.7479 997.4801 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLTDYLMK 95.00% 2.18 0.308 0 499.7509 997.4862 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLTDYLMK 95.00% 2.49 0.424 0 499.7536 997.4916 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLTDYLMK 95.00% 2.25 0.417 1.15 499.7547 997.4938 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLTDYLMK 95.00% 2.03 0.321 0 499.7553 997.495 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLTDYLMK 95.00% 2.55 0.445 1.12 499.7555 997.4953 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 3.35 0.527 0.959 500.9061 1,499.69 1,500.71 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 2.94 0.513 1.54 500.9062 1,499.70 1,500.71 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 3.36 0.546 0 500.9062 1,499.70 1,500.71 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 2.76 0.518 0 500.9065 1,499.70 1,500.71 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 3.11 0.524 0 500.9066 1,499.70 1,500.71 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 2.91 0.496 0 500.9066 1,499.70 1,500.71 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 3.21 0.515 0 500.9068 1,499.70 1,500.71 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 2.64 0.468 0 500.9075 1,499.70 1,500.71 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 2.93 0.376 1.09 500.9082 1,499.70 1,500.71 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 3.32 0.498 0 501.2398 1,500.70 1,500.71 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 2.46 0.335 0 501.2399 1,500.70 1,500.71 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 3 0.477 0 501.2415 1,500.70 1,500.71 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% IWHHTFYNELR 95.00% 3.32 0.445 1.28 505.9186 1,514.73 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% IWHHTFYNELR 95.00% 2.87 0.349 0 505.9193 1,514.73 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% IWHHTFYNELR 95.00% 2.28 0.211 0 505.9195 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% IWHHTFYNELR 95.00% 3.24 0.278 0 505.9195 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLTDYLmK 95.00% 2 0.312 0 m7: Oxidation (+15.99) 507.7442 1,013.47 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% IKIIAPPER 95.00% 2.12 0.25 0 518.8271 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% IKIIAPPER 95.00% 2.17 0.247 0 518.8282 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% IKIIAPPER 95.00% 2.55 0.205 0 518.8287 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% IKIIAPPER 94.50% 2.11 0.217 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLMK 95.00% 2.6 0.32 0 541.9493 1,622.82 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLMK 95.00% 2.24 0.28 0 541.955 1,622.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLMK 95.00% 2.01 0.287 0 541.9616 1,622.86 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLMK 95.00% 2.44 0.417 0 541.9618 1,622.86 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLmK 95.00% 3.55 0.331 1.28 m13: Oxidation (+15.99) 547.2831 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLmK 95.00% 3.96 0.27 0 m13: Oxidation (+15.99) 547.2831 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLmK 95.00% 2.64 0.215 0 m13: Oxidation (+15.99) 547.2888 1,638.84 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLmK 95.00% 2.08 0.301 0 m13: Oxidation (+15.99) 547.2888 1,638.84 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 2.9 0.35 1.8 565.7744 1,129.53 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 3.08 0.385 3.17 565.7745 1,129.53 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 2.4 0.398 1.77 565.7745 1,129.53 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 3.37 0.507 3.04 565.7751 1,129.53 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 2.32 0.444 1.48 565.7754 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 2.83 0.378 1.57 565.7759 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 3.31 0.46 3.72 565.7759 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 2.88 0.508 3.24 565.7761 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 2.63 0.442 2.89 565.7761 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 3.26 0.499 2.34 565.7764 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 3.42 0.507 3.1 565.7764 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 3.51 0.559 2.52 565.7764 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 3.42 0.509 2.82 565.7765 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 2.51 0.494 2.6 565.7766 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 3.54 0.591 2.25 565.7766 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 2.63 0.404 2.27 565.7768 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 3.38 0.52 3.72 565.7773 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% GYSFVTTAER 95.00% 3.59 0.508 3.14 565.7778 1,129.54 1,130.55 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% EITALAPSTMK 95.00% 2.26 0.238 0 581.3113 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% EITALAPSTMK 95.00% 3.01 0.394 1.92 581.3113 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% EITALAPSTMK 95.00% 2.12 0.345 0 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% EITALAPSTMK 95.00% 2.2 0.333 0 581.3122 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% EITALAPSTMK 95.00% 2.9 0.375 2.21 581.3123 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% EITALAPSTMK 95.00% 2.58 0.382 0 581.3127 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% EITALAPSTMK 95.00% 2.36 0.268 0 581.3161 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% HQGVMVGMGQK 95.00% 2.49 0.318 3.38 586.2877 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% HQGVMVGMGQK 95.00% 2.55 0.443 5.7 586.2878 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% HQGVMVGMGQK 95.00% 2.78 0.32 2.31 586.2883 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% HQGVMVGMGQK 95.00% 2.65 0.467 2.54 586.289 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% HQGVMVGMGQK 95.00% 1.94 0.288 2.07 586.2897 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% HQGVMVGMGQK 95.00% 1.9 0.292 3.25 586.2898 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% HQGVMVGMGQK 95.00% 1.8 0.344 1.15 586.2899 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% EITALAPSTmK 95.00% 2.72 0.28 0 m10: Oxidation (+15.99) 589.3097 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% EITALAPSTmK 95.00% 2.66 0.163 0 m10: Oxidation (+15.99) 589.3106 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% EITALAPSTmK 95.00% 2.67 0.264 1.66 m10: Oxidation (+15.99) 589.3108 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% EITALAPSTmK 95.00% 2.69 0.247 2.11 m10: Oxidation (+15.99) 589.3132 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 2.97 0.392 0 597.6323 1,789.87 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.55 0.499 3.02 597.6347 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 2.88 0.35 0 597.6348 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 3.54 0.35 1.14 597.6353 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.93 0.487 3.02 597.6359 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 3.3 0.359 1.6 597.6362 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.3 0.407 0 597.6467 1,789.92 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 3.87 0.431 2.03 597.9689 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.38 0.461 2.74 597.9805 1,790.92 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.38 0.279 0 599.8539 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.61 0.275 0 599.8549 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.71 0.335 0 599.8551 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.24 0.271 0 599.8551 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.84 0.33 0 599.8556 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.43 0.264 0 599.8557 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.32 0.214 0 599.8557 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.48 0.285 0 599.8559 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.59 0.334 0 599.856 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.3 0.206 1.28 599.8564 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.35 0.299 0 599.8568 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.33 0.265 0 599.8569 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% AVFPSIVGRPR 95.00% 2.77 0.225 0 599.859 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.5 0.53 0 652.685 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.63 0.574 1.59 652.6863 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.34 0.542 0 652.6863 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.47 0.609 1.77 652.6865 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.78 0.543 3.8 652.6868 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.24 0.53 0 652.6913 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.38 0.442 0 653.0186 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.25 0.476 0 653.0188 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.04 0.444 0 653.0191 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.49 0.464 0 653.0192 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.42 0.403 0 653.0194 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.49 0.392 0 653.0195 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.35 0.448 0 653.0197 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.26 0.473 0 653.0197 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 2.45 0.259 0 653.0199 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.56 0.409 0 653.0199 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 2.3 0.409 0 653.02 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.45 0.466 0 653.0201 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.28 0.466 0 653.0207 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.63 0.42 0 653.0223 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 2.53 0.379 0 653.0304 1,956.07 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% YPIEHGIITNWDDMEK 95.00% 3.12 0.199 0 654.3068 1,959.90 1,960.91 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% YPIEHGIITNWDDMEK 95.00% 2.87 0.158 4.27 654.6428 1,960.90 1,960.91 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLYANNVLSGGTTMYPGIADR 95.00% 4.03 0.47 1.24 743.6934 2,228.06 2,228.07 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLYANNVLSGGTTMYPGIADR 95.00% 3.81 0.546 1.44 743.6965 2,228.07 2,228.07 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 2.85 0.55 4.3 750.855 1,499.69 1,500.71 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 2.39 0.357 0 750.8562 1,499.70 1,500.71 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 2.97 0.411 2.07 750.8566 1,499.70 1,500.71 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 2.94 0.297 1.23 750.857 1,499.70 1,500.71 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 2.54 0.224 0 750.8585 1,499.70 1,500.71 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 2.7 0.407 2.34 750.8601 1,499.70 1,500.71 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 3.07 0.289 2.43 750.8607 1,499.71 1,500.71 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% QEYDEAGPSIVHR 95.00% 3.21 0.521 1.38 751.3592 1,500.70 1,500.71 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% MQKEITALAPSTMK 95.00% 3.88 0.348 2.23 774.9079 1,547.80 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% MQKEITALAPSTMK 95.00% 4.08 0.392 2.54 774.9121 1,547.81 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% KDLYANNVLSGGTTMYPGIADR 95.00% 5.49 0.599 0 786.3903 2,356.15 2,356.16 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% KDLYANNVLSGGTTMYPGIADR 95.00% 5.75 0.568 0 786.3926 2,356.15 2,356.16 3
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLMK 95.00% 3.28 0.338 1.38 812.4233 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLMK 95.00% 3.3 0.307 0 812.4245 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLMK 95.00% 2.19 0.247 1.57 812.4256 1,622.84 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLMK 95.00% 2.95 0.305 2.1 812.4337 1,622.85 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LDLAGRDLTDYLMK 95.00% 3.22 0.384 2.62 812.4386 1,622.86 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.99 0.608 5.62 895.946 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.59 0.532 5.55 895.9465 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.68 0.596 6.07 895.9477 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.82 0.62 5.09 895.9482 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 2.94 0.425 2.36 895.9503 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 2.78 0.284 3.62 895.9504 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 3.27 0.465 4.6 895.9505 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.63 0.557 5.08 895.9508 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.6 0.572 4.55 895.9523 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 2.82 0.447 2.89 895.956 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.53 0.634 5.7 895.9568 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.55 0.541 4.23 895.9588 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.36 0.603 5.11 895.9594 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.43 0.566 6.22 895.9602 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 3.32 0.56 5.42 895.9602 1,789.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 2.36 0.203 1.41 895.9648 1,789.91 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.29 0.533 5.38 895.9649 1,789.91 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 3.93 0.553 5.39 895.9657 1,789.92 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.32 0.535 5.89 895.966 1,789.92 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 3.18 0.55 5.55 895.966 1,789.92 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.8 0.551 4.49 895.9662 1,789.92 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 2.1 0.355 0 896.4218 1,790.83 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 3.22 0.461 3.28 896.4442 1,790.87 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.48 0.562 4.55 896.4467 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.73 0.597 4.43 896.4494 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.79 0.572 4.96 896.4495 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.85 0.574 5.55 896.4495 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.8 0.571 5.8 896.4497 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.7 0.546 4.77 896.4505 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.03 0.55 3.52 896.4515 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 2.36 0.177 1.42 896.4537 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 4.4 0.515 4.38 896.4593 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% SYELPDGQVITIGNER 95.00% 3.28 0.497 2.64 896.4649 1,790.91 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 4.13 0.632 3.34 978.5206 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 4.09 0.577 5.28 978.5226 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 4.56 0.622 5.38 978.5238 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 4.13 0.633 3.77 978.5244 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 4.02 0.62 3.21 978.5258 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.84 0.648 2.35 979.0224 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.96 0.546 3.62 979.0237 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.9 0.562 3.15 979.0241 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.87 0.459 3.82 979.0245 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 4.26 0.608 5.96 979.0245 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 4.15 0.628 4.7 979.0247 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 4.19 0.623 4.55 979.0252 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 4.21 0.551 4.08 979.0263 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 3.94 0.618 4.31 979.0277 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 4.39 0.581 4.07 979.0278 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 4.4 0.574 3.59 979.0346 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% VAPEEHPTLLTEAPLNPK 95.00% 4.51 0.589 4.66 979.0406 1,956.07 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% YPIEHGIITNWDDMEK 95.00% 4.37 0.437 2.72 981.4584 1,960.90 1,960.91 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLYANNVLSGGTTMYPGIADR 95.00% 5.93 0.629 6.7 1,115.03 2,228.05 2,228.07 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLYANNVLSGGTTMYPGIADR 95.00% 5.86 0.659 6.29 1,115.03 2,228.05 2,228.07 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLYANNVLSGGTTMYPGIADR 95.00% 5.47 0.635 4.96 1,115.04 2,228.07 2,228.07 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLYANNVLSGGTTMYPGIADR 95.00% 5.65 0.655 5.07 1,115.04 2,228.07 2,228.07 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLYANNVLSGGTTMYPGIADR 95.00% 3.67 0.591 3.92 1,115.04 2,228.07 2,228.07 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLYANNVLSGGTTMYPGIADR 95.00% 4.44 0.581 3.85 1,115.05 2,228.07 2,228.07 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLYANNVLSGGTTMYPGIADR 95.00% 4.74 0.633 4.62 1,115.05 2,228.08 2,228.07 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLYANNVLSGGTTMYPGIADR 95.00% 5.17 0.667 4.19 1,115.05 2,228.08 2,228.07 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLYANNVLSGGTTmYPGIADR 95.00% 6.26 0.438 5.32 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% DLYANNVLSGGTTmYPGIADR 95.00% 5.86 0.45 7 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LcYVALDFENEMATAASSSSLEK 95.00% 6.93 0.632 8.41 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.14 2,536.16 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LcYVALDFENEMATAASSSSLEK 95.00% 6.85 0.658 11 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.14 2,536.16 2
 SAMPLE 1R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 13 18 143 52.50% LcYVALDFENEMATAASSSSLEK 95.00% 2.9 0.46 4 c2: Carbamidomethyl (+57.02) 1,269.09 2,536.17 2,536.16 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DSYVGDEAQSKR 95.00% 2.09 0.195 0 452.2146 1,353.62 1,354.62 3 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DSYVGDEAQSKR 95.00% 2.65 0.366 0 452.2147 1,353.62 1,354.62 3 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DSYVGDEAQSKR 95.00% 2.46 0.345 0 452.2155 1,353.62 1,354.62 3 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% cDIDIRK 95.00% 2.51 0.176 0 c1: Carbamidomethyl (+57.02) 460.2382 918.4607 919.4674 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2 0.41 0 473.278 944.5403 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.12 0.42 0 473.2781 944.5406 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.12 0.427 0 473.2782 944.5407 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.1 0.43 0 473.2785 944.5414 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.12 0.435 0 473.2786 944.5415 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.09 0.434 0 473.2789 944.5421 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.09 0.392 0 473.2789 944.5422 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.09 0.437 0 473.279 944.5424 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.02 0.419 0 473.279 944.5424 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.19 0.379 0 473.2791 944.5425 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.14 0.46 0 473.2791 944.5426 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.27 0.507 0 473.2793 944.5429 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 1.99 0.405 0 473.2793 944.543 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 1.9 0.374 0 473.2794 944.5432 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.2 0.328 0 473.2795 944.5434 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.21 0.387 0 473.2796 944.5435 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.16 0.426 0 473.2796 944.5436 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.23 0.416 0 473.2798 944.5439 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.14 0.398 0 473.2799 944.5442 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.03 0.351 0 473.2801 944.5446 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.12 0.383 0 473.2801 944.5446 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.02 0.34 0 473.2804 944.5452 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.09 0.349 0 473.2807 944.5457 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.32 0.421 0 473.2811 944.5465 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 1.94 0.493 0 473.2811 944.5466 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 1.89 0.343 0 473.2812 944.5468 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 1.91 0.386 0 473.2816 944.5476 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGR 95.00% 2.22 0.494 0 473.2819 944.5482 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AGFAGDDAPR 95.00% 3.37 0.45 1.68 488.7264 975.4372 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AGFAGDDAPR 95.00% 3.45 0.475 1.68 488.727 975.4384 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AGFAGDDAPR 95.00% 3.28 0.455 1.49 488.727 975.4384 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AGFAGDDAPR 95.00% 2.65 0.365 1.41 488.7271 975.4386 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AGFAGDDAPR 95.00% 3.39 0.383 1.52 488.7274 975.4391 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AGFAGDDAPR 95.00% 3.12 0.398 0 488.7274 975.4392 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AGFAGDDAPR 95.00% 2.69 0.31 1.51 488.7286 975.4416 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AGFAGDDAPR 95.00% 2.98 0.387 1.54 488.7293 975.4429 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 1.95 0.396 0 499.7448 997.474 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.19 0.406 0 499.7451 997.4745 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.06 0.367 1.28 499.7455 997.4754 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 1.98 0.351 0 499.7456 997.4756 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.09 0.368 0 499.7457 997.4757 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.03 0.379 1.15 499.7458 997.4759 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.18 0.407 1.48 499.7458 997.476 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 1.97 0.399 1.72 499.7458 997.476 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 1.79 0.287 1.43 499.7459 997.4762 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.09 0.422 0 499.746 997.4763 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.03 0.353 1.52 499.746 997.4763 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.09 0.397 1.19 499.746 997.4763 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 1.92 0.378 0 499.7462 997.4767 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 1.97 0.392 0 499.7462 997.4767 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.2 0.381 0 499.7462 997.4767 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 1.84 0.339 0 499.7465 997.4773 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.23 0.448 1.18 499.7466 997.4776 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.42 0.44 0 499.7467 997.4778 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.16 0.413 0 499.7467 997.4778 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.08 0.376 1.41 499.7468 997.478 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.18 0.428 0 499.7472 997.4787 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.56 0.373 0 499.7477 997.4797 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.27 0.376 0 499.748 997.4804 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.35 0.381 0 499.7482 997.4807 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.38 0.302 0 499.7485 997.4814 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLMK 95.00% 2.31 0.345 0 499.7487 997.4817 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.49 0.589 1.18 500.9056 1,499.69 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.81 0.588 1.22 500.9058 1,499.69 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.88 0.442 0 500.9063 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.42 0.2 0 500.9063 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.41 0.355 0 500.9064 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.63 0.563 1.1 500.9064 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.92 0.52 0 500.9065 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.09 0.533 0 500.9066 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.87 0.536 0 500.9066 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.15 0.558 0 500.9067 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.13 0.578 0 500.9067 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.57 0.566 1.1 500.9068 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.62 0.434 0 500.9068 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.07 0.56 1.48 500.9069 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.27 0.344 0 500.9069 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.53 0.502 0 500.907 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.27 0.228 0 500.907 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.26 0.534 0 500.9072 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.49 0.567 0 500.9074 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.56 0.412 1.19 500.9077 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.48 0.169 0 500.9085 1,499.70 1,500.71 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IWHHTFYNELR 95.00% 2.75 0.38 0 505.9194 1,514.73 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IWHHTFYNELR 95.00% 3.51 0.398 1.54 505.92 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IWHHTFYNELR 95.00% 3.13 0.378 0 505.92 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IWHHTFYNELR 95.00% 3.69 0.481 1.59 505.9208 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IWHHTFYNELR 95.00% 3.32 0.441 0 505.921 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IWHHTFYNELR 95.00% 3.04 0.422 0 506.2542 1,515.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IWHHTFYNELR 95.00% 3.32 0.379 0 506.2546 1,515.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IWHHTFYNELR 95.00% 2.42 0.302 0 506.2556 1,515.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLmK 95.00% 1.96 0.261 0 m7: Oxidation (+15.99) 507.7418 1,013.47 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLTDYLmK 95.00% 2.06 0.278 0 m7: Oxidation (+15.99) 507.7431 1,013.47 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% MQKEITALAPSTMK 95.00% 2.31 0.214 0 516.9419 1,547.80 1,548.81 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% MQKEITALAPSTMK 95.00% 3.24 0.26 0 517.2758 1,548.80 1,548.81 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.51 0.247 0 518.8275 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.13 0.25 0 518.8275 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.4 0.233 0 518.828 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.58 0.218 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.19 0.251 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.6 0.224 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.52 0.229 0 518.8287 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.53 0.222 0 518.8287 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.64 0.229 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.36 0.222 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.5 0.22 0 518.8289 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.28 0.26 0 518.8289 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.03 0.273 0 518.8292 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.12 0.323 0 518.8293 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IKIIAPPER 95.00% 2.3 0.251 0 518.8294 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 2.66 0.477 0 541.9503 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.05 0.445 0 541.9504 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.14 0.531 2.26 541.9508 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 2.89 0.393 0 541.9511 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 2.55 0.406 0 541.9513 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.24 0.53 2.6 541.9514 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 2.99 0.541 2.1 541.9516 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.1 0.492 0 541.9518 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.05 0.449 1.12 542.2846 1,623.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.01 0.493 1.7 542.2853 1,623.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.34 0.526 1.6 542.2855 1,623.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAEREIVR 95.00% 2.51 0.536 0 543.2849 1,626.83 1,627.84 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAEREIVR 95.00% 2.27 0.462 0 543.2856 1,626.83 1,627.84 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHRK 95.00% 2.37 0.282 0 543.6033 1,627.79 1,628.80 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHRK 95.00% 2.15 0.206 0 543.6051 1,627.79 1,628.80 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHRK 95.00% 2.36 0.253 0 543.9399 1,628.80 1,628.80 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLmK 95.00% 2.67 0.308 0 m13: Oxidation (+15.99) 547.282 1,638.82 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLmK 95.00% 3.82 0.231 0.959 m13: Oxidation (+15.99) 547.2831 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLmK 95.00% 3.38 0.306 0 m13: Oxidation (+15.99) 547.2834 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLmK 95.00% 3.41 0.286 0 m13: Oxidation (+15.99) 547.2835 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLmK 95.00% 3.39 0.269 0 m13: Oxidation (+15.99) 547.6171 1,639.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLmK 95.00% 3.28 0.237 0 m13: Oxidation (+15.99) 547.6172 1,639.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLmK 95.00% 3.14 0.409 0 m13: Oxidation (+15.99) 547.618 1,639.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.4 0.435 1.51 565.7699 1,129.52 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.18 0.258 2.09 565.7718 1,129.53 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.24 0.234 0 565.7735 1,129.53 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.23 0.335 0 565.7749 1,129.53 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.44 0.321 2.6 565.7754 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.44 0.551 3.24 565.7755 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.29 0.522 2.54 565.776 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.06 0.477 1.96 565.7762 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.56 0.567 2.74 565.7765 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.25 0.334 1.82 565.7766 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.28 0.467 2.85 565.7767 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.56 0.506 2.62 565.7768 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.53 0.557 2.46 565.7768 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.61 0.503 3.42 565.7769 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.37 0.559 2.46 565.7769 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.41 0.468 2.92 565.777 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.36 0.55 2.54 565.7771 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.57 0.571 2.96 565.7771 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.37 0.526 2.8 565.7771 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.39 0.552 2.82 565.7771 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.5 0.582 2.92 565.7771 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.57 0.519 2.7 565.7771 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.64 0.561 2.54 565.7771 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.19 0.365 2 565.7771 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.46 0.422 1.6 565.7773 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.22 0.495 2.29 565.7774 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.6 0.575 2.85 565.7775 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.9 0.387 1.4 565.7776 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.48 0.579 2.55 565.7776 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.86 0.479 2.57 565.7777 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.65 0.327 0 565.7778 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.5 0.555 2.7 565.7779 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.45 0.535 1.55 565.7782 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.54 0.551 2.96 565.7783 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.7 0.455 2.42 565.7784 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.14 0.482 1.7 565.7787 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.33 0.505 1.59 565.7788 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.57 0.457 3.41 565.779 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.58 0.546 3.32 565.7791 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.92 0.338 3.28 565.7791 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.32 0.449 3.7 565.7791 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 3.02 0.492 3.01 565.7794 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.5 0.438 1.49 565.7799 1,129.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.97 0.541 3.01 565.7803 1,129.55 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.89 0.497 2.09 565.7837 1,129.55 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.88 0.301 2 566.2794 1,130.54 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAER 95.00% 2.5 0.258 2.03 566.2979 1,130.58 1,130.55 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.71 0.357 0 581.3109 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.57 0.332 0 581.3111 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.5 0.345 0 581.3116 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.71 0.291 2.4 581.3118 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.47 0.316 0 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.42 0.325 0 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.1 0.352 0 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.77 0.359 0 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.17 0.309 0 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.95 0.389 0 581.3122 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.68 0.343 0 581.3122 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.85 0.431 0 581.3122 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.56 0.395 2.37 581.3123 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.85 0.359 0 581.3126 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.67 0.428 2.27 581.3128 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.05 0.3 0 581.3129 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.85 0.378 1.54 581.3131 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.02 0.301 0 581.3131 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.64 0.366 1.21 581.3134 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.78 0.392 2.31 581.3134 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.11 0.251 1.48 581.3136 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.24 0.247 0 581.314 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.62 0.388 1.26 581.3144 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.64 0.414 0 581.3146 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.69 0.263 0 581.3148 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.05 0.305 1.54 581.3148 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTMK 95.00% 2.5 0.233 0 581.3155 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.75 0.416 2.89 586.2872 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.6 0.398 3.17 586.2882 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.65 0.46 4.74 586.2883 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.83 0.399 5.72 586.2884 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 3.44 0.459 4.55 586.2885 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.94 0.469 4.96 586.2885 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.89 0.472 5.8 586.2886 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.42 0.415 3.25 586.2887 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.86 0.446 5.44 586.2889 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.73 0.462 4.62 586.289 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.7 0.49 4.82 586.2892 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.1 0.362 1.29 586.2893 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.24 0.287 2 586.2898 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.94 0.486 3.82 586.2903 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.26 0.304 3.74 586.2903 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.62 0.467 4.66 586.2904 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQK 95.00% 2.32 0.356 3.04 586.2909 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.78 0.35 1.59 m10: Oxidation (+15.99) 589.308 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.68 0.193 0 m10: Oxidation (+15.99) 589.3087 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.76 0.236 0 m10: Oxidation (+15.99) 589.3092 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.87 0.349 2.96 m10: Oxidation (+15.99) 589.3093 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.91 0.25 0 m10: Oxidation (+15.99) 589.3094 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.7 0.327 1.21 m10: Oxidation (+15.99) 589.3098 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.85 0.302 1.96 m10: Oxidation (+15.99) 589.31 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.87 0.244 0 m10: Oxidation (+15.99) 589.3103 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.5 0.234 1.2 m10: Oxidation (+15.99) 589.3106 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 94.70% 2.32 0.207 0 m10: Oxidation (+15.99) 589.3106 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.32 0.349 2.14 m10: Oxidation (+15.99) 589.3108 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.85 0.277 2.28 m10: Oxidation (+15.99) 589.3109 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.36 0.227 0 m10: Oxidation (+15.99) 589.3109 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EITALAPSTmK 95.00% 2.17 0.409 0 m10: Oxidation (+15.99) 589.3113 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVmVGMGQK 95.00% 2.67 0.381 5.62 m5: Oxidation (+15.99) 594.2862 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVmVGMGQK 95.00% 2.76 0.379 4.51 m5: Oxidation (+15.99) 594.2864 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGmGQK 95.00% 2.07 0.415 3.47 m8: Oxidation (+15.99) 594.2876 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGmGQK 95.00% 2.48 0.467 3.54 m8: Oxidation (+15.99) 594.2881 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGmGQK 95.00% 2.43 0.456 2.92 m8: Oxidation (+15.99) 594.2884 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGmGQK 95.00% 2.46 0.397 2.06 m8: Oxidation (+15.99) 594.2884 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVmVGMGQK 95.00% 2.29 0.417 5.16 m5: Oxidation (+15.99) 594.289 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 2.88 0.459 1.77 597.569 1,789.68 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.21 0.366 2.77 597.6353 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 3.07 0.411 2.11 597.6357 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 2.36 0.271 0 597.6372 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.98 0.502 2.85 597.9687 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.94 0.495 2.64 597.9692 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 3.66 0.325 2.19 597.9692 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 3.18 0.438 0 597.9699 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 3.38 0.411 3.37 597.9699 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.19 0.478 1.7 597.97 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 3.66 0.433 2.4 597.9704 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.61 0.275 0 599.3396 1,196.66 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.63 0.271 0 599.3398 1,196.66 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DSYVGDEAQSK 95.00% 3.22 0.466 3.89 599.7654 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DSYVGDEAQSK 95.00% 3.3 0.455 4.82 599.7655 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DSYVGDEAQSK 95.00% 2.79 0.429 2.6 599.7663 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.16 0.285 0 599.854 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.52 0.272 0 599.8551 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.52 0.32 0 599.8552 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.51 0.313 1.28 599.8553 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.63 0.277 0 599.8554 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.8 0.314 0 599.8554 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 3.02 0.371 1.38 599.8554 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.5 0.239 0 599.8555 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.68 0.33 0 599.8556 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.88 0.336 0 599.8556 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.44 0.371 0 599.8562 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.43 0.317 0 599.8564 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.02 0.291 0 599.8575 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DSYVGDEAQSK 95.00% 2.54 0.347 3.08 600.2643 1,198.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% AVFPSIVGRPR 95.00% 2.72 0.345 0 600.3555 1,198.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.36 0.507 0 652.6843 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.51 0.597 0 652.6851 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.18 0.571 2.77 652.6855 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.43 0.581 1.96 652.6856 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.35 0.445 2.34 652.6861 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.51 0.547 3.12 652.6862 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.85 0.548 1.31 652.6862 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.51 0.552 0 652.6866 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.9 0.505 0 652.6869 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.34 0.541 0 652.6879 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.01 0.402 0 652.688 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 2.75 0.376 0 652.6884 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 2.42 0.236 0 652.6888 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 2.85 0.452 0 652.689 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.7 0.426 0 652.6895 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.19 0.44 1.29 652.6895 1,955.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.63 0.513 1.39 653.0192 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.04 0.325 0 653.0195 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.7 0.458 0 653.0195 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.82 0.49 1.46 653.0196 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.71 0.449 2.42 653.0198 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.56 0.514 0 653.0198 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.99 0.451 0 653.0199 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.21 0.447 0 653.0199 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.59 0.542 0 653.02 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.55 0.468 1.46 653.02 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 2.8 0.416 0 653.02 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.06 0.529 1.48 653.0201 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.6 0.482 0 653.0203 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.94 0.487 1.19 653.0204 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.57 0.53 1.47 653.0205 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.2 0.235 0 653.0205 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.1 0.516 1.59 653.0206 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.05 0.286 0 653.0206 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.53 0.464 0 653.0208 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 2.99 0.356 0 653.021 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 2.46 0.327 0 653.0212 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.33 0.346 0 653.0217 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.72 0.427 0 653.0217 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.59 0.353 0 653.0218 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 2.21 0.311 0 653.0218 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 2.38 0.296 0 653.022 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.93 0.417 0 653.0221 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.5 0.39 0 653.0224 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.74 0.35 0 653.0225 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 2.76 0.247 0 653.0226 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 2.24 0.334 0 653.0254 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 2.5 0.366 0 653.0256 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% YPIEHGIITNWDDMEK 95.00% 2.53 0.193 0 654.3059 1,959.89 1,960.91 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% YPIEHGIITNWDDMEK 95.00% 2.96 0.139 1.08 654.6417 1,960.90 1,960.91 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% YPIEHGIITNWDDMEK 95.00% 3.67 0.372 0 654.6421 1,960.90 1,960.91 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% YPIEHGIITNWDDMEK 95.00% 3.97 0.349 1.35 654.6422 1,960.90 1,960.91 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% YPIEHGIITNWDDMEK 95.00% 4.08 0.403 0 654.6426 1,960.90 1,960.91 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% YPIEHGIITNWDDMEK 95.00% 3.67 0.299 1.2 654.6428 1,960.90 1,960.91 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DSYVGDEAQSKR 95.00% 2.96 0.538 3.33 677.8178 1,353.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DSYVGDEAQSKR 95.00% 2.21 0.263 1.42 677.8181 1,353.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DSYVGDEAQSKR 95.00% 2.67 0.475 3.23 677.8186 1,353.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DSYVGDEAQSKR 95.00% 2.7 0.52 1.66 677.8187 1,353.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% qEYDEAGPSIVHR 95.00% 0 0 3.44 n-term: Pyro-cmC (-17.03) 742.3441 1,482.67 1,483.68 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% qEYDEAGPSIVHR 95.00% 0 0 3.42 n-term: Pyro-cmC (-17.03) 742.3459 1,482.68 1,483.68 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 6.12 0.571 5.57 743.6929 2,228.06 2,228.07 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 6.25 0.57 5.92 743.6934 2,228.06 2,228.07 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.79 0.555 3.92 743.6937 2,228.06 2,228.07 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTmYPGIADR 95.00% 4.53 0.252 2.48 m14: Oxidation (+15.99) 749.0252 2,244.05 2,244.06 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTmYPGIADR 95.00% 5.86 0.416 6.14 m14: Oxidation (+15.99) 749.027 2,244.06 2,244.06 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.86 0.522 3.21 750.8562 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.55 0.617 4.37 750.8564 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.58 0.521 5.23 750.8568 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.77 0.551 2.74 750.8571 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.58 0.558 4.27 750.8571 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.89 0.502 4.64 750.8572 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.93 0.605 4.74 750.8572 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.23 0.655 5.01 750.8573 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.76 0.566 1.59 750.8576 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.82 0.577 3.32 750.8581 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.65 0.491 4.21 750.8581 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.35 0.578 1.82 750.8582 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.41 0.394 1.24 750.8583 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.26 0.533 1.89 750.8583 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.49 0.388 1.29 750.8596 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.85 0.501 5.12 750.86 1,499.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.35 0.0681 2.25 750.8612 1,499.71 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.28 0.478 2.8 750.8629 1,499.71 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 2.49 0.202 2.17 751.3561 1,500.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.03 0.57 2.41 751.3597 1,500.70 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.02 0.481 2.21 751.361 1,500.71 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHR 95.00% 3.37 0.321 0 751.3617 1,500.71 1,500.71 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IWHHTFYNELR 95.00% 2.26 0.299 0 758.3398 1,514.66 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IWHHTFYNELR 95.00% 3 0.486 1.57 758.3783 1,514.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% IWHHTFYNELR 95.00% 3.13 0.475 2.18 758.8795 1,515.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% MQKEITALAPSTMK 95.00% 4.99 0.42 3.13 774.9083 1,547.80 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% MQKEITALAPSTMK 95.00% 3.96 0.388 1.49 774.9084 1,547.80 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% MQKEITALAPSTMK 95.00% 4.84 0.45 3.14 774.9089 1,547.80 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% MQKEITALAPSTMK 95.00% 5.05 0.414 2.35 774.9095 1,547.80 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% MQKEITALAPSTMK 95.00% 4.55 0.398 2.39 774.912 1,547.81 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% MQKEITALAPSTMK 95.00% 4.37 0.417 1.24 775.4101 1,548.80 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% mQKEITALAPSTMK 95.00% 4.24 0.362 1.96 m1: Oxidation (+15.99) 782.9064 1,563.80 1,564.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% mQKEITALAPSTMK 95.00% 4.04 0.307 3.59 m1: Oxidation (+15.99) 782.9079 1,563.80 1,564.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.98 0.664 5.23 784.6967 2,351.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.67 0.658 5.59 784.6969 2,351.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.43 0.682 4.92 784.699 2,351.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 0 0 6.16 785.0317 2,352.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.99 0.555 1.72 786.3906 2,356.15 2,356.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.09 0.569 0 786.3917 2,356.15 2,356.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.75 0.572 2 786.3918 2,356.15 2,356.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTMYPGIADR 95.00% 4.32 0.553 1.17 786.392 2,356.15 2,356.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTMYPGIADR 95.00% 2.81 0.381 0 786.3922 2,356.15 2,356.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.36 0.568 0 786.3923 2,356.15 2,356.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.54 0.527 0.959 786.3925 2,356.15 2,356.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.22 0.613 1.22 786.3926 2,356.15 2,356.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.44 0.547 0 786.3928 2,356.16 2,356.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.93 0.591 1.82 786.3938 2,356.16 2,356.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.26 0.651 4.77 m8: Oxidation (+15.99) 790.0281 2,367.06 2,367.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.58 0.648 5.52 m8: Oxidation (+15.99) 790.0286 2,367.06 2,367.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTmYPGIADR 95.00% 6.53 0.423 4.96 m15: Oxidation (+15.99) 791.7239 2,372.15 2,372.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.83 0.657 2.82 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.36 2,383.06 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.6 0.663 3.49 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3611 2,383.06 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 4.04 0.532 3.18 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3613 2,383.06 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.55 0.526 1.92 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3638 2,383.07 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 2.93 0.56 3.48 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3644 2,383.07 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.31 0.372 2.7 812.4215 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.15 0.336 1.74 812.4221 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.31 0.355 2.19 812.4223 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.04 0.259 1.72 812.4225 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.29 0.324 2.26 812.4229 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLMK 95.00% 3.32 0.348 2.77 812.4231 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAEREIVR 95.00% 3.08 0.211 0 814.4251 1,626.83 1,627.84 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAEREIVR 95.00% 3.23 0.248 1.64 814.4265 1,626.84 1,627.84 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHRK 95.00% 2.53 0.179 2.29 814.8893 1,627.76 1,628.80 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHRK 95.00% 1.92 0.308 0 814.9045 1,627.79 1,628.80 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHRK 95.00% 3.03 0.41 3.96 814.9057 1,627.80 1,628.80 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHRK 95.00% 2.64 0.371 2.74 814.9062 1,627.80 1,628.80 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% QEYDEAGPSIVHRK 95.00% 2.4 0.333 0 814.9074 1,627.80 1,628.80 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% GYSFVTTAEREIVR 95.00% 3.09 0.213 0 814.9275 1,627.84 1,627.84 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLmK 95.00% 3.12 0.162 2.23 m13: Oxidation (+15.99) 820.4205 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLmK 95.00% 3 0.125 3 m13: Oxidation (+15.99) 820.4206 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LDLAGRDLTDYLmK 95.00% 3.05 0.17 0 m13: Oxidation (+15.99) 820.4206 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQKDSYVGDEAQSKR 95.00% 5.22 0.646 7.85 836.7306 2,507.17 2,507.18 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQKDSYVGDEAQSKR 95.00% 5.56 0.623 7.24 836.7317 2,507.17 2,507.18 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGmGQKDSYVGDEAQSKR 95.00% 5.24 0.584 4.44 m8: Oxidation (+15.99) 842.0611 2,523.16 2,523.17 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGmGQKDSYVGDEAQSKR 95.00% 4.61 0.518 4.62 m8: Oxidation (+15.99) 842.0621 2,523.16 2,523.17 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LcYVALDFENEMATAASSSSLEK 95.00% 6.34 0.552 3.7 c2: Carbamidomethyl (+57.02) 846.3923 2,536.15 2,536.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LcYVALDFENEMATAASSSSLEK 95.00% 6.27 0.582 3.47 c2: Carbamidomethyl (+57.02) 846.3924 2,536.15 2,536.16 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVmVGmGQKDSYVGDEAQSKR 95.00% 4.88 0.585 2.82 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 847.3949 2,539.16 2,539.17 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVmVGmGQKDSYVGDEAQSKR 95.00% 5.19 0.57 2.85 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 847.3951 2,539.16 2,539.17 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LcYVALDFENEmATAASSSSLEK 95.00% 3.22 0.291 1.85 c2: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 851.7239 2,552.15 2,552.15 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% ILTERGYSFVTTAER 95.00% 3.83 0.454 3.3 871.9571 1,741.90 1,742.91 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% ILTERGYSFVTTAER 95.00% 3.83 0.239 4.74 872.4576 1,742.90 1,742.91 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.87 0.604 5.96 895.9469 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.64 0.604 5.74 895.9472 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.76 0.611 5.89 895.9478 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.36 0.605 4.72 895.948 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.83 0.62 6.12 895.9482 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.76 0.608 5.89 895.9482 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.48 0.573 5.92 895.9483 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.6 0.578 6.55 895.9486 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.63 0.601 5.25 895.9488 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.5 0.558 6.43 895.9491 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.65 0.613 6.26 895.9491 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.16 0.517 3.82 895.9495 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.27 0.57 5.29 895.9495 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.36 0.555 6.68 895.9496 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.21 0.59 4.52 895.9497 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 3.94 0.635 3.51 895.9509 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.39 0.593 4.25 895.951 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 3.24 0.401 2.66 895.9512 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.48 0.574 5.31 895.9513 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.43 0.621 5.64 895.952 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 3.92 0.453 4.39 895.9524 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 3.06 0.381 3.68 895.9536 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.6 0.603 5.92 895.9538 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 3.96 0.548 4.01 895.9541 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 3.79 0.538 4.39 895.9546 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 2.51 0.419 2.8 896.4362 1,790.86 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.95 0.552 5.38 896.4479 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.88 0.541 6 896.4487 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.73 0.586 5.77 896.4491 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.78 0.616 5.92 896.4494 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.73 0.536 5.35 896.4497 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.72 0.586 5.49 896.4508 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.39 0.578 5.54 896.4508 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.35 0.541 4.68 896.4512 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.47 0.559 5.34 896.4515 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.82 0.58 6.64 896.453 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.16 0.576 4.7 896.453 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 3.24 0.488 4.54 896.4533 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.88 0.556 5.52 896.4546 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.24 0.535 4.4 896.456 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% SYELPDGQVITIGNER 95.00% 4.47 0.572 4.28 896.4561 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EKLcYVALDFENEMATAASSSSLEK 95.00% 6.55 0.649 2.41 c4: Carbamidomethyl (+57.02) 932.102 2,793.28 2,793.30 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EKLcYVALDFENEMATAASSSSLEK 95.00% 3.83 0.417 1.92 c4: Carbamidomethyl (+57.02) 932.1033 2,793.29 2,793.30 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% EKLcYVALDFENEMATAASSSSLEK 95.00% 5.92 0.581 2.38 c4: Carbamidomethyl (+57.02) 932.1051 2,793.29 2,793.30 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.49 0.573 6.12 978.5219 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.64 0.634 5.46 978.5232 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.1 0.632 3.24 978.5236 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.18 0.584 4.82 978.5236 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.66 0.584 5.43 978.5282 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.24 0.589 4.57 979.0242 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 5.01 0.568 4.89 979.0243 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.55 0.552 4.48 979.0246 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.41 0.594 4.36 979.0246 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.42 0.589 5.29 979.0248 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.74 0.58 2.72 979.0254 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.49 0.604 4.82 979.0256 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.21 0.599 4.31 979.0256 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.39 0.557 4.28 979.0258 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.53 0.613 3.74 979.0258 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.11 0.553 4.3 979.0259 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.51 0.544 4.8 979.026 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.49 0.574 4.85 979.0261 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.26 0.551 3.85 979.0262 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.73 0.583 3.59 979.0263 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.17 0.495 4.96 979.0264 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.35 0.603 5.62 979.0265 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.41 0.564 5.72 979.0271 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.3 0.564 4.11 979.0277 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 4.41 0.567 3.96 979.0282 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.86 0.499 3.31 979.0298 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.61 0.51 1.36 979.0315 1,956.05 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% VAPEEHPTLLTEAPLNPK 95.00% 3.74 0.475 2.72 979.0371 1,956.06 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% YPIEHGIITNWDDMEK 95.00% 4.41 0.467 3.23 980.9568 1,959.90 1,960.91 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% YPIEHGIITNWDDMEK 95.00% 4.32 0.433 4.89 981.4591 1,960.90 1,960.91 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% YPIEHGIITNWDDMEK 95.00% 4.66 0.433 3.34 981.4597 1,960.90 1,960.91 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% YPIEHGIITNWDDMEK 95.00% 4.25 0.413 3.12 981.4612 1,960.91 1,960.91 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% cPETLFQPSFIGMESAGIHETTYNSIMK 95.00% 6.24 0.599 2.46 c1: Carbamidomethyl (+57.02) 1,063.83 3,188.46 3,188.47 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% cPETLFQPSFIGMESAGIHETTYNSIMK 95.00% 5.78 0.634 2.22 c1: Carbamidomethyl (+57.02) 1,063.83 3,188.46 3,188.47 3
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.55 0.67 6.25 1,115.03 2,228.05 2,228.07 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.55 0.664 6.85 1,115.03 2,228.05 2,228.07 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 4.99 0.66 5.66 1,115.04 2,228.05 2,228.07 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.88 0.66 7.47 1,115.04 2,228.05 2,228.07 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.67 0.642 6.8 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.77 0.648 8.27 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 4.56 0.629 6.96 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.95 0.655 8 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.85 0.673 7.92 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.68 0.649 6 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.4 0.62 6.62 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.06 0.582 6.47 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTmYPGIADR 95.00% 5.26 0.616 5.49 m14: Oxidation (+15.99) 1,122.53 2,243.04 2,244.06 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTmYPGIADR 95.00% 5.81 0.471 5.92 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTmYPGIADR 95.00% 6.18 0.458 6.48 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% DLYANNVLSGGTTmYPGIADR 95.00% 6.07 0.46 5.74 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.84 0.655 8.6 1,176.54 2,351.06 2,351.08 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.9 0.64 9.04 1,176.54 2,351.06 2,351.08 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.66 0.635 5.66 1,179.08 2,356.15 2,356.16 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.91 0.627 4.96 1,179.08 2,356.15 2,356.16 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 5.15 0.65 6.48 m8: Oxidation (+15.99) 1,184.04 2,366.06 2,367.07 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 5.36 0.616 4.37 m8: Oxidation (+15.99) 1,184.54 2,367.06 2,367.07 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LcYVALDFENEMATAASSSSLEK 95.00% 7.18 0.651 7.48 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LcYVALDFENEMATAASSSSLEK 95.00% 7.38 0.638 9.25 c2: Carbamidomethyl (+57.02) 1,269.09 2,536.15 2,536.16 2
 SAMPLE 2 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 22 33 352 67.90% LcYVALDFENEmATAASSSSLEK 95.00% 6.5 0.694 10.8 c2: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 1,277.08 2,552.15 2,552.15 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSKR 95.00% 2.3 0.277 0 452.214 1,353.62 1,354.62 3 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSKR 95.00% 2.27 0.213 0 452.2144 1,353.62 1,354.62 3 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% cDIDIRK 95.00% 2.54 0.18 0 c1: Carbamidomethyl (+57.02) 460.238 918.4604 919.4674 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% cDIDIRK 95.00% 2.6 0.172 0 c1: Carbamidomethyl (+57.02) 460.2383 918.4609 919.4674 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.09 0.441 0 473.2783 944.5409 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.33 0.498 0 473.2784 944.5411 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.08 0.43 0 473.2784 944.5412 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.13 0.434 0 473.2785 944.5414 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.44 0.505 0 473.2786 944.5416 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 1.75 0.405 0 473.2787 944.5417 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.16 0.411 0 473.2788 944.542 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.21 0.487 0 473.2789 944.5422 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 1.75 0.342 0 473.279 944.5423 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.28 0.417 0 473.279 944.5423 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.16 0.415 0 473.2791 944.5425 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.15 0.449 0 473.2791 944.5426 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.26 0.438 0 473.2793 944.5429 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 1.8 0.303 0 473.2795 944.5434 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 1.85 0.324 0 473.2795 944.5434 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 1.94 0.403 0 473.2796 944.5435 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.06 0.447 0 473.2796 944.5436 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 1.92 0.361 0 473.2796 944.5436 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 1.86 0.3 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 2.03 0.377 0 473.2797 944.5438 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGR 95.00% 1.92 0.415 0 473.2798 944.5439 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AGFAGDDAPR 95.00% 3.34 0.452 2.28 488.7273 975.439 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AGFAGDDAPR 95.00% 3.28 0.464 2 488.7274 975.4391 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AGFAGDDAPR 95.00% 3.23 0.436 1.72 488.7274 975.4392 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AGFAGDDAPR 95.00% 3.36 0.468 1.8 488.7274 975.4392 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AGFAGDDAPR 95.00% 3.27 0.474 1.8 488.7278 975.44 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AGFAGDDAPR 95.00% 2.23 0.299 0 488.7287 975.4417 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 1.99 0.329 0 499.7449 997.4742 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 1.97 0.322 0 499.7451 997.4745 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 1.91 0.364 0 499.7456 997.4755 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 2.05 0.408 0 499.7456 997.4756 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 2.01 0.364 0 499.7456 997.4756 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 1.94 0.356 0 499.7458 997.4759 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 1.91 0.403 1.6 499.7459 997.4762 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 2.23 0.408 0 499.746 997.4763 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 1.87 0.341 0 499.746 997.4764 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 1.83 0.339 0 499.7461 997.4766 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 2.19 0.391 0 499.7462 997.4767 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 2.02 0.364 0 499.7462 997.4768 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLMK 95.00% 2.13 0.4 1.19 499.7462 997.4768 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.08 0.217 0 500.9047 1,499.69 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.5 0.449 0 500.9055 1,499.69 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.5 0.56 0 500.9059 1,499.69 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.71 0.433 0 500.906 1,499.69 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.18 0.589 0 500.9062 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.48 0.587 1.12 500.9065 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.67 0.541 0 500.9068 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.87 0.494 1.07 500.9068 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.27 0.519 0 500.9069 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.05 0.527 1.43 500.9069 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.47 0.575 0 500.9069 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.81 0.569 0 500.907 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.49 0.435 0 500.9071 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.95 0.558 1.39 500.9071 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.93 0.418 0 500.9072 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.24 0.547 0 500.9073 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.63 0.537 0 500.9074 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.38 0.55 1.57 500.9075 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.97 0.443 0 500.9076 1,499.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.83 0.492 0 501.2403 1,500.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.77 0.44 0 501.2406 1,500.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.97 0.47 1.38 501.2408 1,500.70 1,500.71 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 3.52 0.417 1.55 505.9186 1,514.73 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 3.14 0.339 0 505.9196 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 2.86 0.301 1.2 505.9198 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 3.41 0.506 0 505.9199 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 3.33 0.437 0 505.9203 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 3.39 0.485 1.02 505.9204 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 3.23 0.478 0 505.9207 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 3.56 0.46 0 506.2544 1,515.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLmK 95.00% 1.97 0.302 0 m7: Oxidation (+15.99) 507.7421 1,013.47 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLTDYLmK 95.00% 2.08 0.368 0 m7: Oxidation (+15.99) 507.7427 1,013.47 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% MQKEITALAPSTMK 95.00% 3.73 0.419 1.6 516.942 1,547.80 1,548.81 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% MQKEITALAPSTMK 95.00% 3.4 0.388 1.68 516.9422 1,547.80 1,548.81 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 2.43 0.221 0 518.8266 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 2.51 0.229 0 518.8273 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 2.21 0.23 0 518.8278 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 2.1 0.267 0 518.8282 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 1.99 0.288 0 518.8282 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 2.18 0.255 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 2.08 0.271 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 2.4 0.226 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 2.44 0.22 0 518.8285 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 2.46 0.216 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 2.17 0.269 0 518.8291 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 1.93 0.292 0 518.8292 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IKIIAPPER 95.00% 2.41 0.208 0 518.8299 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.06 0.491 0 541.9504 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 2.56 0.219 0 541.9506 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.21 0.499 1.68 541.9507 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 2.8 0.456 0 541.9508 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 2.5 0.382 0 541.9509 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.16 0.44 0 541.951 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.13 0.387 1 541.9512 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 2.75 0.339 0 541.9512 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 2.67 0.457 0 541.9513 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.2 0.493 0 541.9513 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.23 0.446 0.959 541.9514 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 2.41 0.268 0 541.9515 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 2.37 0.408 0 541.9516 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 2.54 0.437 1.2 541.9518 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.8 0.461 0 542.2842 1,623.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 2.99 0.493 1.41 542.285 1,623.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.17 0.463 0 542.2851 1,623.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 2.91 0.471 2.08 542.2855 1,623.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAEREIVR 95.00% 2 0.523 0 543.2855 1,626.83 1,627.84 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 2.56 0.235 0 543.605 1,627.79 1,628.80 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 2.52 0.389 0 543.6056 1,627.79 1,628.80 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 2.25 0.263 0 543.6058 1,627.79 1,628.80 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 2.31 0.341 0 543.606 1,627.79 1,628.80 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 2.32 0.293 0 543.6061 1,627.79 1,628.80 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 2.3 0.297 0 543.9386 1,628.79 1,628.80 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLmK 95.00% 3.26 0.405 0 m13: Oxidation (+15.99) 547.2823 1,638.82 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLmK 95.00% 2.94 0.395 0 m13: Oxidation (+15.99) 547.2831 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLmK 95.00% 3.01 0.215 0 m13: Oxidation (+15.99) 547.2835 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLmK 95.00% 2.99 0.338 0 m13: Oxidation (+15.99) 547.6166 1,639.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.7 0.427 1.6 565.7739 1,129.53 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.63 0.474 1.8 565.7742 1,129.53 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.34 0.491 3.51 565.7751 1,129.53 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.08 0.458 2.26 565.7754 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.24 0.416 2.8 565.7755 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.04 0.492 4 565.7757 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.12 0.521 2.47 565.7763 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.71 0.494 3.23 565.7763 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.38 0.506 2.57 565.7763 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.17 0.525 2.92 565.7764 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.43 0.557 2.06 565.7765 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.13 0.541 2.03 565.7766 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.22 0.541 2.34 565.7767 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.99 0.433 2.48 565.7767 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.28 0.552 2.48 565.7768 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.63 0.593 2.51 565.7768 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.32 0.538 2.14 565.7769 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.41 0.556 2.1 565.7769 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.56 0.495 2.8 565.7769 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.89 0.43 0 565.7769 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.33 0.539 2.11 565.7769 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.46 0.553 2.51 565.7769 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.43 0.58 3.14 565.7769 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.37 0.365 0 565.7769 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.69 0.554 2.44 565.7771 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.5 0.548 2.72 565.7771 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.48 0.489 2.92 565.7773 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.49 0.494 2.59 565.7774 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.79 0.395 0 565.7778 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.74 0.424 2.85 565.7788 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.25 0.494 2.31 565.7792 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.1 0.482 0 565.7792 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.87 0.458 0 565.7794 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.7 0.444 1.77 565.7798 1,129.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.17 0.245 2.55 566.2768 1,130.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 2.51 0.402 1.48 566.2768 1,130.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAER 95.00% 3.25 0.21 3.59 566.2778 1,130.54 1,130.55 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.47 0.336 0 581.3106 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.79 0.387 0 581.3111 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.51 0.393 1.37 581.3117 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.67 0.437 2.3 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.9 0.392 1.28 581.312 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.39 0.372 0 581.312 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.83 0.403 1.33 581.3123 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.89 0.376 0 581.3124 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.47 0.391 1.48 581.3125 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.9 0.396 1.3 581.3127 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.9 0.372 0 581.3128 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.27 0.337 1.19 581.3128 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.67 0.434 0 581.313 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.78 0.327 0 581.313 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 3.01 0.365 1.96 581.3132 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.9 0.389 2.38 581.3132 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 1.95 0.407 0 581.3133 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.69 0.471 0 581.3134 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.56 0.382 0 581.3136 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTMK 95.00% 2.11 0.262 0 581.3159 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.88 0.439 4.52 586.2874 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.46 0.476 4.09 586.2875 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.86 0.439 4.1 586.2877 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.49 0.386 6.77 586.2879 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.33 0.31 1.96 586.2879 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.9 0.452 4.96 586.2879 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.62 0.477 4.49 586.2889 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 3.16 0.496 4.51 586.2891 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 3.04 0.482 4.85 586.2892 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.75 0.451 5.6 586.2893 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.36 0.409 4.03 586.2893 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.58 0.514 4.07 586.2896 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.47 0.479 4.59 586.2896 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.7 0.474 4.44 586.2902 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.05 0.361 2.96 586.2904 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2 0.336 1.59 586.2909 1,170.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQK 95.00% 2.15 0.377 2.8 586.7903 1,171.57 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTmK 95.00% 2.9 0.301 0 m10: Oxidation (+15.99) 589.3074 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTmK 95.00% 2.82 0.28 0 m10: Oxidation (+15.99) 589.3082 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTmK 95.00% 2.71 0.28 0 m10: Oxidation (+15.99) 589.3086 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTmK 95.00% 2.77 0.224 0 m10: Oxidation (+15.99) 589.3093 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTmK 95.00% 2.69 0.265 1.51 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTmK 95.00% 2.85 0.341 0 m10: Oxidation (+15.99) 589.31 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTmK 95.00% 2.73 0.275 1.24 m10: Oxidation (+15.99) 589.3103 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTmK 95.00% 2.52 0.348 0 m10: Oxidation (+15.99) 589.3105 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTmK 95.00% 2.39 0.302 0 m10: Oxidation (+15.99) 589.3111 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EITALAPSTmK 95.00% 2.69 0.278 0 m10: Oxidation (+15.99) 589.3121 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVmVGMGQK 95.00% 2.44 0.319 4.28 m5: Oxidation (+15.99) 594.286 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVmVGMGQK 95.00% 2.36 0.295 2.54 m5: Oxidation (+15.99) 594.2867 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVmVGMGQK 95.00% 3.13 0.479 5.21 m5: Oxidation (+15.99) 594.2874 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGmGQK 95.00% 2.07 0.415 3.47 m8: Oxidation (+15.99) 594.2876 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVmVGMGQK 95.00% 2.38 0.37 4.03 m5: Oxidation (+15.99) 594.2877 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVmVGMGQK 95.00% 2.31 0.402 3.89 m5: Oxidation (+15.99) 594.2885 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 2.03 0.236 0 597.319 1,788.93 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.05 0.414 4 597.6334 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.02 0.439 2.74 597.6342 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.78 0.369 3.14 597.6344 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.11 0.486 2.25 597.6347 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.69 0.44 3.15 597.635 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.52 0.495 4.7 597.6351 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.45 0.459 2.49 597.6356 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.31 0.451 2.72 597.636 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.59 0.505 2.18 597.9681 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.69 0.482 3.12 597.9689 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 2.63 0.231 0 597.9694 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.31 0.343 0 597.9695 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.63 0.359 1.34 597.9698 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.27 0.465 2.85 597.9699 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.09 0.44 4.62 597.9702 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSK 95.00% 2.42 0.325 4.7 599.7632 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSK 95.00% 2.47 0.371 3.55 599.7641 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSK 95.00% 2.86 0.446 4.28 599.7643 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSK 95.00% 2.91 0.451 3.72 599.7647 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSK 95.00% 2.39 0.331 1.48 599.7664 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSK 95.00% 2.81 0.417 3.74 599.7668 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSK 95.00% 2.85 0.445 3.02 599.767 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGRPR 95.00% 2.91 0.393 0 599.8545 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGRPR 95.00% 2.32 0.246 0 599.8553 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGRPR 95.00% 2.99 0.385 0 599.8556 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGRPR 95.00% 2.89 0.331 0 599.8557 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGRPR 95.00% 2.99 0.422 1.19 599.8558 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGRPR 95.00% 2.77 0.292 0 599.8561 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGRPR 95.00% 2.51 0.334 0 599.8562 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% AVFPSIVGRPR 95.00% 2.26 0.293 0 599.8604 1,197.71 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.72 0.601 1.7 652.6856 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.34 0.379 0 652.6859 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.76 0.564 2 652.6861 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.7 0.519 0 652.6863 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.26 0.469 0 652.688 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3 0.479 0 652.6889 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.52 0.45 0 652.689 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.29 0.316 0 653.0189 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.37 0.518 0 653.0191 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.21 0.387 0 653.0193 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.54 0.519 2.48 653.0194 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.37 0.483 0 653.0196 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.05 0.476 0 653.0197 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.68 0.492 1.26 653.0197 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.87 0.527 1.48 653.0198 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.86 0.5 1.15 653.0199 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.65 0.548 0 653.02 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.99 0.544 2.44 653.02 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.37 0.363 0 653.02 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.89 0.525 0 653.0201 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.73 0.53 0 653.0201 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.44 0.433 0 653.0201 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.79 0.393 0 653.0201 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.57 0.511 0 653.0203 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.44 0.426 0 653.0204 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.58 0.511 0 653.0205 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.4 0.373 0 653.0205 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.83 0.42 0 653.0207 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.02 0.492 0 653.0212 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.59 0.495 0 653.0217 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 2.92 0.251 0 653.0219 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 2.87 0.347 0 653.0229 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% YPIEHGIITNWDDMEK 95.00% 3.08 0.174 0 654.3075 1,959.90 1,960.91 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% YPIEHGIITNWDDMEK 95.00% 3.12 0.222 0 654.3082 1,959.90 1,960.91 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% YPIEHGIITNWDDMEK 95.00% 3.03 0.22 0 654.6396 1,960.90 1,960.91 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% YPIEHGIITNWDDMEK 95.00% 3.19 0.109 1.62 654.6422 1,960.90 1,960.91 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% YPIEHGIITNWDDMEK 95.00% 2.98 0.268 2.06 654.6424 1,960.90 1,960.91 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% YPIEHGIITNWDDMEK 95.00% 3.95 0.323 2.17 654.6428 1,960.91 1,960.91 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% YPIEHGIITNWDDMEK 95.00% 3.23 0.29 0 654.6429 1,960.91 1,960.91 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSKR 95.00% 2.56 0.456 0 677.8144 1,353.61 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSKR 95.00% 2.05 0.271 0 677.8147 1,353.61 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSKR 95.00% 2.96 0.538 3.57 677.8178 1,353.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DSYVGDEAQSKR 95.00% 2.75 0.508 0 678.3169 1,354.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 4.14 0.527 2.66 743.3594 2,227.05 2,228.07 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 3.66 0.355 0 743.6931 2,228.06 2,228.07 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 6.08 0.607 5.23 743.6931 2,228.06 2,228.07 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 4.93 0.565 3.41 743.6932 2,228.06 2,228.07 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.68 0.605 6.36 743.6935 2,228.06 2,228.07 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.88 0.554 4.64 743.6938 2,228.06 2,228.07 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 4.82 0.576 4.04 743.6942 2,228.06 2,228.07 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.34 0.576 3.23 743.6947 2,228.06 2,228.07 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 4.49 0.518 4.33 743.6957 2,228.06 2,228.07 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTmYPGIADR 95.00% 5.16 0.329 5.74 m14: Oxidation (+15.99) 749.0234 2,244.05 2,244.06 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTmYPGIADR 95.00% 5.47 0.311 5.25 m14: Oxidation (+15.99) 749.0259 2,244.05 2,244.06 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.72 0.572 3.6 750.8558 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.82 0.492 1.48 750.8573 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.87 0.599 5.21 750.8573 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.21 0.615 2.01 750.8573 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.79 0.522 4.24 750.8576 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.84 0.529 3.57 750.8578 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.74 0.536 4.34 750.8578 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.36 0.654 3.89 750.8578 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.96 0.596 2.48 750.8582 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.97 0.525 4.43 750.8584 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.33 0.6 3.25 750.8586 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.06 0.449 3.54 750.8587 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.39 0.537 0 750.8592 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.89 0.445 3.46 750.8595 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.68 0.488 0 750.8599 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.49 0.569 3.6 750.8603 1,499.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.47 0.0597 1.85 750.8603 1,499.71 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.21 0.584 2.43 750.8605 1,499.71 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 3.37 0.161 0 750.8618 1,499.71 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.5 0.534 3.17 751.3582 1,500.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.51 0.417 3.82 751.3586 1,500.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHR 95.00% 2.76 0.519 2.41 751.3589 1,500.70 1,500.71 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 3.06 0.459 1.57 758.3695 1,514.72 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 2.96 0.472 1.54 758.3739 1,514.73 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 2.87 0.414 1.43 758.3739 1,514.73 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 2.37 0.475 0 758.3777 1,514.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% IWHHTFYNELR 95.00% 3.35 0.467 1.46 758.8765 1,515.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% MQKEITALAPSTMK 95.00% 4.93 0.434 2.74 774.9093 1,547.80 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% MQKEITALAPSTMK 95.00% 4.72 0.393 2.62 774.9098 1,547.80 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% MQKEITALAPSTMK 95.00% 4.63 0.437 2.74 774.9107 1,547.81 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% MQKEITALAPSTMK 95.00% 4.8 0.414 2.89 775.4101 1,548.80 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.47 0.602 5.7 784.6963 2,351.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.15 0.619 4.42 784.697 2,351.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.57 0.613 5.64 784.6976 2,351.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.47 0.638 4.6 784.6978 2,351.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% KDLYANNVLSGGTTMYPGIADR 95.00% 6.2 0.589 0 786.3921 2,356.15 2,356.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.6 0.603 0 786.3923 2,356.15 2,356.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.95 0.586 0 786.3935 2,356.16 2,356.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.33 0.564 0 786.395 2,356.16 2,356.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.41 0.617 3.82 m8: Oxidation (+15.99) 790.0292 2,367.06 2,367.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.42 0.645 5.82 m8: Oxidation (+15.99) 790.0295 2,367.07 2,367.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% KDLYANNVLSGGTTmYPGIADR 95.00% 5.42 0.504 0 m15: Oxidation (+15.99) 791.7238 2,372.15 2,372.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% KDLYANNVLSGGTTmYPGIADR 95.00% 6.09 0.455 4.42 m15: Oxidation (+15.99) 791.7239 2,372.15 2,372.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 4.33 0.684 3.24 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.0273 2,382.06 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.74 0.613 3.18 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3604 2,383.06 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.86 0.647 3.14 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.361 2,383.06 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.23 0.381 1.85 812.4225 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.15 0.324 2.48 812.4229 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.16 0.286 2.28 812.4234 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.31 0.38 2.55 812.4235 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.29 0.373 2.66 812.4236 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.14 0.318 2.82 812.4237 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 2.44 0.249 0 812.4249 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLMK 95.00% 3.19 0.361 2.48 812.425 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 2.94 0.206 2.96 814.3896 1,626.76 1,628.80 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAEREIVR 95.00% 3.1 0.286 0 814.4239 1,626.83 1,627.84 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAEREIVR 95.00% 2.64 0.235 0 814.424 1,626.83 1,627.84 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAEREIVR 95.00% 3.06 0.226 1.72 814.424 1,626.83 1,627.84 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% GYSFVTTAEREIVR 95.00% 3.06 0.244 0 814.427 1,626.84 1,627.84 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 2.97 0.169 0 814.8918 1,627.77 1,628.80 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 2.33 0.448 0 814.9046 1,627.79 1,628.80 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 2.24 0.25 0 814.905 1,627.79 1,628.80 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 3.12 0.489 2.09 814.9061 1,627.80 1,628.80 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 1.76 0.349 0 814.9065 1,627.80 1,628.80 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% QEYDEAGPSIVHRK 95.00% 2.52 0.31 0 814.9071 1,627.80 1,628.80 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLmK 95.00% 3.44 0.281 2.13 m13: Oxidation (+15.99) 820.4193 1,638.82 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLmK 95.00% 3.18 0.203 2.68 m13: Oxidation (+15.99) 820.4214 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLmK 95.00% 3.26 0.299 3.6 m13: Oxidation (+15.99) 820.4218 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLmK 95.00% 2.61 0.165 1.74 m13: Oxidation (+15.99) 820.4255 1,638.84 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LDLAGRDLTDYLmK 95.00% 2.89 0.0839 2.01 m13: Oxidation (+15.99) 820.9232 1,639.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQKDSYVGDEAQSKR 95.00% 5.6 0.649 6.62 836.7296 2,507.17 2,507.18 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQKDSYVGDEAQSKR 95.00% 4.96 0.624 7.74 836.7313 2,507.17 2,507.18 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGmGQKDSYVGDEAQSKR 95.00% 5 0.575 4.92 m8: Oxidation (+15.99) 842.0636 2,523.17 2,523.17 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 6.11 0.537 3.41 c2: Carbamidomethyl (+57.02) 846.3897 2,536.15 2,536.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 5.14 0.595 2.38 c2: Carbamidomethyl (+57.02) 846.3898 2,536.15 2,536.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 4.05 0.489 0 c2: Carbamidomethyl (+57.02) 846.3905 2,536.15 2,536.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 5.51 0.558 3.23 c2: Carbamidomethyl (+57.02) 846.3906 2,536.15 2,536.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 5.51 0.594 3.51 c2: Carbamidomethyl (+57.02) 846.3907 2,536.15 2,536.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 6.05 0.579 2.66 c2: Carbamidomethyl (+57.02) 846.3919 2,536.15 2,536.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 5.25 0.578 3.49 c2: Carbamidomethyl (+57.02) 846.3923 2,536.15 2,536.16 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVmVGmGQKDSYVGDEAQSKR 95.00% 5.23 0.553 4.24 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 847.3955 2,539.16 2,539.17 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVmVGmGQKDSYVGDEAQSKR 95.00% 5.35 0.492 2.18 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 847.3964 2,539.17 2,539.17 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEmATAASSSSLEK 95.00% 5.26 0 3.32 c2: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 851.0635 2,550.17 2,552.15 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEmATAASSSSLEK 95.00% 5.44 0.487 3.77 c2: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 851.397 2,551.17 2,552.15 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEmATAASSSSLEK 95.00% 5.98 0.574 3.41 c2: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 851.7257 2,552.15 2,552.15 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% ILTERGYSFVTTAER 95.00% 3.9 0.437 2.96 871.9586 1,741.90 1,742.91 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% ILTERGYSFVTTAER 95.00% 4.03 0.267 2.89 872.4581 1,742.90 1,742.91 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.81 0.495 4.51 895.9455 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.23 0.575 5.21 895.946 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.86 0.61 6.07 895.947 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.87 0.544 6.8 895.9471 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.84 0.591 5.4 895.9475 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.77 0.611 6.55 895.9476 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.89 0.612 5.64 895.9477 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.67 0.602 5.28 895.9477 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.59 0.609 6.23 895.9477 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.61 0.557 5.12 895.9479 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.64 0.591 6 895.9482 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.8 0.608 7.18 895.9483 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.85 0.516 5.51 895.9483 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.42 0.598 6.38 895.9485 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.77 0.564 5.11 895.9489 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.26 0.603 5.7 895.9489 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.74 0.614 3.8 895.9492 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.83 0.611 6.21 895.9497 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 2.24 0.295 1.38 895.9497 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.14 0.572 4.77 895.9497 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.18 0.468 4.55 895.9497 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 2.8 0.287 0 895.95 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.78 0.577 5.14 895.9501 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.33 0.577 5.52 895.9503 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.65 0.577 6.2 895.9507 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.11 0.589 4.85 895.9513 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.81 0.575 4.68 895.9534 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.6 0.603 5.36 895.9538 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 2.19 0.447 2.4 896.3631 1,790.71 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 1.82 0.443 1.7 896.4201 1,790.82 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.1 0.521 5.14 896.4477 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.77 0.517 4.36 896.4487 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.91 0.53 5.12 896.449 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.53 0.59 5.09 896.4495 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.25 0.503 4.17 896.4496 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 5.18 0.589 4.72 896.45 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.59 0.595 4.8 896.4507 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.94 0.486 4.68 896.4516 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.18 0.572 3.33 896.4522 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.62 0.487 4.27 896.4532 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.05 0.556 5.15 896.4538 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.88 0.556 4.89 896.4546 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 4.4 0.517 4.89 896.4573 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% SYELPDGQVITIGNER 95.00% 3.56 0.563 4.24 896.4586 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% EKLcYVALDFENEMATAASSSSLEK 95.00% 4.55 0.471 1.72 c4: Carbamidomethyl (+57.02) 932.1016 2,793.28 2,793.30 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.14 0.566 5.68 978.5229 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.01 0.649 5.1 978.5235 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.95 0.573 2.85 978.524 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.13 0.654 4.08 978.5243 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.37 0.525 5.13 978.5245 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.34 0.608 5.51 978.5251 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.11 0.62 3.82 978.5263 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.55 0.632 3.46 978.5268 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.56 0.621 2.82 978.5271 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.74 0.579 4.68 978.5294 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.18 0.655 4.59 978.5296 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.17 0.605 3.25 979.023 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4 0.525 3.96 979.0238 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.48 0.569 4.77 979.0251 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.27 0.575 4.92 979.0251 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.2 0.612 3.3 979.0251 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.38 0.608 3.04 979.0251 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.14 0.614 4.62 979.0255 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.83 0.594 4.19 979.0258 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.29 0.548 4.36 979.0258 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.28 0.559 4.72 979.026 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.43 0.573 4.03 979.026 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.52 0.594 4.11 979.0261 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.41 0.546 4.46 979.0262 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.16 0.569 3.72 979.0263 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 4.35 0.542 2.48 979.0277 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% VAPEEHPTLLTEAPLNPK 95.00% 3.86 0.499 4.32 979.0298 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% YPIEHGIITNWDDMEK 95.00% 4.16 0.506 2.66 980.9582 1,959.90 1,960.91 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% YPIEHGIITNWDDMEK 95.00% 4.22 0.441 3.72 980.9594 1,959.90 1,960.91 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% YPIEHGIITNWDDMEK 95.00% 4.48 0.427 2.57 981.4585 1,960.90 1,960.91 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% YPIEHGIITNWDDMEK 95.00% 4.21 0.415 2.8 981.4622 1,960.91 1,960.91 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% cPETLFQPSFIGMESAGIHETTYNSIMK 95.00% 5.75 0.618 2.28 c1: Carbamidomethyl (+57.02) 1,063.83 3,188.46 3,188.47 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% cPETLFQPSFIGMESAGIHETTYNSIMK 95.00% 5.96 0.57 1.92 c1: Carbamidomethyl (+57.02) 1,063.83 3,188.46 3,188.47 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% TTGIVLDSGDGVTHNVPIYEGYALPHAIMR 95.00% 7.11 0.684 4.82 1,066.54 3,196.60 3,196.61 3
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.22 0.679 6.72 1,114.53 2,227.05 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.36 0.641 7.54 1,115.03 2,228.05 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.73 0.65 6.57 1,115.03 2,228.05 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 4.7 0.633 7.72 1,115.03 2,228.05 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.56 0.641 7.31 1,115.03 2,228.05 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 4.65 0.661 5.72 1,115.03 2,228.05 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.77 0.651 9.04 1,115.03 2,228.05 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.8 0.646 8.27 1,115.04 2,228.05 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.41 0.646 6.47 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.79 0.652 7.43 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.58 0.667 8.27 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.38 0.617 8.08 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.62 0.667 8.22 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.23 0.627 6.06 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTMYPGIADR 95.00% 4.68 0.637 4.74 1,115.04 2,228.06 2,228.07 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTmYPGIADR 95.00% 6.24 0.433 6.55 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTmYPGIADR 95.00% 6.1 0.464 6.38 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% DLYANNVLSGGTTmYPGIADR 95.00% 5.77 0.559 6.25 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.78 0.639 9.12 1,176.54 2,351.07 2,351.08 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.77 0.638 8.15 1,176.54 2,351.07 2,351.08 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.5 0.635 4.68 1,179.08 2,356.14 2,356.16 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.61 0.614 7.34 1,179.08 2,356.15 2,356.16 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.66 0.589 5.17 1,179.08 2,356.15 2,356.16 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 5.14 0.65 4.66 m8: Oxidation (+15.99) 1,184.54 2,367.07 2,367.07 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 6.91 0.665 9.49 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.14 2,536.16 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 7.22 0.64 9.8 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 7.23 0.639 10.2 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 7.18 0.691 8.89 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 6.96 0.671 8.68 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 6.97 0.648 11.6 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 7.15 0.674 10.8 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 7.29 0.634 12.3 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEMATAASSSSLEK 95.00% 7.28 0.66 9.66 c2: Carbamidomethyl (+57.02) 1,269.09 2,536.16 2,536.16 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEmATAASSSSLEK 95.00% 6.96 0.714 10.1 c2: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 1,277.08 2,552.14 2,552.15 2
 SAMPLE 2R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 23 34 365 75.90% LcYVALDFENEmATAASSSSLEK 95.00% 6.94 0.699 11.3 c2: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 1,277.08 2,552.14 2,552.15 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSKR 95.00% 2.82 0.388 0 452.2146 1,353.62 1,354.62 3 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSKR 95.00% 2.52 0.489 0 452.2148 1,353.62 1,354.62 3 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.02 0.39 0 473.2781 944.5406 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.14 0.424 0 473.2784 944.5411 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.08 0.433 0 473.2787 944.5417 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.1 0.434 0 473.2787 944.5417 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.14 0.44 0 473.2787 944.5418 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2 0.343 0 473.2788 944.542 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 1.94 0.312 0 473.2789 944.5421 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.04 0.407 0 473.279 944.5424 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 1.89 0.338 0 473.2791 944.5425 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.17 0.425 0 473.2792 944.5427 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.13 0.462 0 473.2792 944.5428 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.33 0.502 0 473.2794 944.5431 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.17 0.402 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.14 0.378 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 1.87 0.338 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 1.99 0.411 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.14 0.408 0 473.2798 944.5439 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.16 0.323 0 473.2798 944.5439 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.01 0.245 0 473.2798 944.544 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.12 0.369 0 473.2801 944.5445 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2.2 0.435 0 473.2801 944.5445 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 1.82 0.316 0 473.2803 944.545 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 1.72 0.43 0 473.2807 944.5457 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 2 0.361 0 473.281 944.5463 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 1.86 0.308 0 473.2811 944.5466 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGR 95.00% 1.72 0.361 0 473.2812 944.5468 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AGFAGDDAPR 95.00% 3.3 0.482 1.8 488.7267 975.4377 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AGFAGDDAPR 95.00% 3.49 0.479 1.82 488.7269 975.4382 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AGFAGDDAPR 95.00% 2.9 0.426 1.8 488.7274 975.4391 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AGFAGDDAPR 95.00% 2.92 0.424 1.54 488.7278 975.44 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AGFAGDDAPR 95.00% 2.59 0.308 1.7 488.7279 975.4401 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 1.93 0.357 0 499.745 997.4744 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.01 0.393 0 499.7451 997.4745 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 1.9 0.375 0 499.7451 997.4746 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.15 0.414 0 499.7452 997.4748 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.3 0.453 0 499.7455 997.4754 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 1.91 0.354 0 499.7457 997.4757 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.13 0.409 0 499.7457 997.4757 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.2 0.409 1.42 499.7458 997.476 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.17 0.426 1.18 499.7458 997.476 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.19 0.363 0 499.7459 997.4762 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.15 0.394 1.09 499.7459 997.4762 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.13 0.388 0 499.746 997.4764 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.12 0.42 0 499.7463 997.4769 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.04 0.369 0 499.7463 997.477 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.29 0.303 0 499.7465 997.4773 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.12 0.388 0 499.7465 997.4774 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.11 0.407 0 499.7468 997.4779 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 1.8 0.341 0 499.7468 997.4779 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 1.96 0.359 0 499.7474 997.4792 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 1.97 0.29 0 499.7475 997.4793 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 1.99 0.323 0 499.7479 997.4801 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 1.96 0.211 1.28 499.7483 997.4809 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLMK 95.00% 2.23 0.342 0 499.7494 997.4831 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.79 0.495 0 500.9054 1,499.69 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.43 0.41 0 500.9059 1,499.69 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 3.23 0.493 0 500.906 1,499.69 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.77 0.492 0 500.906 1,499.69 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 3.55 0.589 1.01 500.9064 1,499.70 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 3.69 0.595 1.17 500.9065 1,499.70 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 3.32 0.561 0 500.9066 1,499.70 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 3.36 0.457 0 500.9066 1,499.70 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.99 0.498 0 500.9066 1,499.70 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.8 0.493 0 500.9067 1,499.70 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.83 0.542 0.959 500.9068 1,499.70 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.56 0.4 0 500.9069 1,499.70 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 3.28 0.506 0 500.9071 1,499.70 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 3.07 0.517 1.49 500.9071 1,499.70 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.31 0.262 0 500.9072 1,499.70 1,500.71 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IWHHTFYNELR 95.00% 2.87 0.316 0 505.9202 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IWHHTFYNELR 95.00% 1.85 0.22 0 505.9204 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IWHHTFYNELR 95.00% 2.02 0.255 0 505.9218 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLmK 95.00% 1.93 0.332 0 m7: Oxidation (+15.99) 507.7431 1,013.47 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLTDYLmK 95.00% 2.1 0.364 0 m7: Oxidation (+15.99) 507.7436 1,013.47 1,014.48 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPER 95.00% 2.26 0.243 0 518.8277 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPER 95.00% 2.44 0.242 0 518.8279 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPER 95.00% 2.36 0.231 0 518.8281 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPER 95.00% 2.51 0.232 0 518.8282 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPER 95.00% 2.52 0.26 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPER 95.00% 2.05 0.26 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPER 95.00% 2.5 0.2 0 518.8285 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPER 95.00% 2.51 0.22 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPER 95.00% 2.59 0.219 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPER 95.00% 2.18 0.231 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPER 95.00% 2.44 0.212 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPER 95.00% 2.45 0.222 0 518.829 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 2.94 0.446 0 541.9503 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 2.36 0.326 0 541.9505 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 3.36 0.473 0 541.9511 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 2.95 0.483 0 541.9512 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 3.18 0.488 1 541.9516 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 2.86 0.471 1.57 541.9519 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 2.22 0.242 0 541.952 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 2.18 0.292 0 541.9521 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 3.1 0.489 0 542.285 1,623.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 2.97 0.454 1.55 542.2856 1,623.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 3.16 0.463 1.16 542.2863 1,623.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 2.22 0.296 0 542.2882 1,623.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAEREIVR 95.00% 2.02 0.541 1.49 543.2841 1,626.83 1,627.84 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHRK 95.00% 2.28 0.185 0 543.605 1,627.79 1,628.80 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHRK 95.00% 2.04 0.274 0 543.6053 1,627.79 1,628.80 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAEREIVR 95.00% 2.23 0.28 0 543.6191 1,627.83 1,627.84 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLmK 95.00% 3.41 0.25 0 m13: Oxidation (+15.99) 547.2824 1,638.82 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLmK 95.00% 3.11 0.298 0 m13: Oxidation (+15.99) 547.2825 1,638.82 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLmK 95.00% 2.66 0.323 0 m13: Oxidation (+15.99) 547.2831 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.41 0.446 2.07 565.7751 1,129.53 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.22 0.509 2.48 565.7752 1,129.53 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 2.85 0.48 3.24 565.7762 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.02 0.434 2.8 565.7762 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 2.96 0.517 4.66 565.7763 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.45 0.527 3 565.7764 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.66 0.522 4.23 565.7764 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.29 0.529 3.7 565.7764 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.42 0.559 2.68 565.7764 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 2.71 0.399 1.77 565.7765 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.29 0.576 2.28 565.7765 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.51 0.488 4.11 565.7766 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.48 0.518 3.96 565.7766 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.16 0.531 3.82 565.7766 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 2.98 0.505 2.82 565.7768 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 2.6 0.441 0 565.7768 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.37 0.545 3.36 565.7769 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.54 0.482 2.35 565.7769 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.47 0.515 3.57 565.777 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.45 0.529 3.1 565.777 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 2.88 0.444 2.38 565.7772 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.27 0.555 2.96 565.7773 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.47 0.559 2.42 565.7774 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.07 0.51 3.26 565.7777 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.04 0.52 5.52 565.778 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 2.37 0.362 1.33 565.7781 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 2.17 0.366 0 565.7782 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.32 0.531 2.7 565.7782 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.29 0.494 3.52 565.7783 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.29 0.53 2.89 565.7784 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 2.78 0.513 1.8 565.7788 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 3.05 0.521 3.42 565.779 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 2.62 0.448 3.38 565.7792 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% GYSFVTTAER 95.00% 2.94 0.426 0 565.7793 1,129.54 1,130.55 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.43 0.334 0 581.3109 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.74 0.38 0 581.3111 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.46 0.358 0 581.3114 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.83 0.374 0 581.3117 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.06 0.225 1.16 581.312 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.98 0.502 1.6 581.3122 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.85 0.365 1.24 581.3123 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.86 0.387 1.7 581.3125 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.71 0.426 1.96 581.3126 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.43 0.38 0 581.3127 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.86 0.406 1.85 581.3127 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.47 0.356 0 581.3128 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.38 0.289 0 581.3134 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.03 0.355 0 581.3138 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.94 0.343 0 581.3141 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.27 0.357 1.17 581.3142 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.11 0.286 0 581.3144 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.47 0.353 1.43 581.3147 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.04 0.344 0 581.3149 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.32 0.217 1.34 581.3152 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.48 0.431 1.31 581.3155 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.22 0.435 0 581.3167 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTMK 95.00% 2.14 0.312 0 581.3217 1,160.63 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% IKIIAPPERK 95.00% 2.17 0.246 0 582.8756 1,163.74 1,164.75 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.19 0.446 3.59 586.2862 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.51 0.48 3.7 586.2868 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.88 0.488 3.62 586.2871 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.63 0.448 5.19 586.2881 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.94 0.495 4.18 586.2883 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.92 0.395 3.77 586.2885 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.8 0.458 4.54 586.2885 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 3.08 0.451 4 586.2885 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.8 0.496 4.03 586.2885 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.85 0.461 4.72 586.2888 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.76 0.489 4.54 586.2889 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.49 0.437 5.06 586.2891 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.38 0.306 4.01 586.2891 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.84 0.447 3.85 586.2892 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQK 95.00% 2.53 0.396 3.33 586.2892 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.7 0.278 0 m10: Oxidation (+15.99) 589.3086 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.76 0.142 0 m10: Oxidation (+15.99) 589.3087 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.61 0.272 2.09 m10: Oxidation (+15.99) 589.3091 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.84 0.249 0 m10: Oxidation (+15.99) 589.3092 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.84 0.237 0 m10: Oxidation (+15.99) 589.3092 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.5 0.197 0 m10: Oxidation (+15.99) 589.3094 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.72 0.325 1.21 m10: Oxidation (+15.99) 589.3094 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.66 0.289 0 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.77 0.269 2.89 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.66 0.255 1.77 m10: Oxidation (+15.99) 589.3096 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.83 0.316 0 m10: Oxidation (+15.99) 589.3101 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.11 0.263 0 m10: Oxidation (+15.99) 589.3101 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.67 0.235 1.62 m10: Oxidation (+15.99) 589.3103 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% EITALAPSTmK 95.00% 2.04 0.266 0 m10: Oxidation (+15.99) 589.3116 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVmVGMGQK 95.00% 2.43 0.3 2.24 m5: Oxidation (+15.99) 594.2857 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVmVGMGQK 95.00% 2.24 0.373 2.34 m5: Oxidation (+15.99) 594.2862 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVmVGMGQK 95.00% 1.88 0.251 2.13 m5: Oxidation (+15.99) 594.2869 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGmGQK 95.00% 2.42 0.444 3.92 m8: Oxidation (+15.99) 594.2871 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVmVGMGQK 95.00% 2.16 0.333 2.62 m5: Oxidation (+15.99) 594.2873 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGmGQK 95.00% 2.53 0.473 2.7 m8: Oxidation (+15.99) 594.288 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.5 0.472 4 597.6349 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 3.94 0.45 3.39 597.6355 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 2.82 0.179 0 597.9683 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 3.82 0.374 2.33 597.9684 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.12 0.434 4.11 597.9694 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.78 0.504 2.36 597.9695 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSK 95.00% 2.41 0.374 4.18 599.7646 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSK 95.00% 3.23 0.417 5.08 599.7647 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSK 95.00% 2.96 0.471 3.09 599.7648 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSK 95.00% 3.07 0.474 3.89 599.7652 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSK 95.00% 2.49 0.327 2.57 599.7657 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSK 95.00% 2.67 0.238 2.82 599.7664 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSK 95.00% 2.12 0.347 0 599.7671 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.33 0.216 0 599.8549 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.58 0.355 0 599.8551 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.41 0.279 0 599.8553 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.48 0.228 1.34 599.8553 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.64 0.271 0 599.8556 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.27 0.297 0 599.8561 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.49 0.254 0 599.8562 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.78 0.333 0 599.8562 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 94.70% 2.27 0.205 0 599.8563 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.79 0.342 0 599.8563 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.46 0.277 0 599.8565 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.28 0.283 0 599.8565 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.62 0.353 0 599.8571 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSK 95.00% 3 0.467 3.43 600.2675 1,198.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSK 95.00% 2.2 0.235 2.85 600.2683 1,198.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.62 0.306 0 600.3551 1,198.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AVFPSIVGRPR 95.00% 2.52 0.246 0 600.3582 1,198.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 2.79 0.448 1 652.6859 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.41 0.566 1.7 652.686 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.46 0.593 1.31 652.686 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.04 0.501 0 652.6863 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.11 0.597 3.01 652.6864 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 2.8 0.369 0 652.6867 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.53 0.464 0 652.6868 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.91 0.475 0 652.687 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.63 0.48 0 652.6883 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 2.88 0.462 0 652.6885 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.78 0.486 1.43 653.0181 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.58 0.43 0 653.0193 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.85 0.45 1.39 653.0193 1,956.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.14 0.531 1.02 653.0195 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.04 0.553 2 653.0197 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.24 0.423 1.4 653.0197 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 2.04 0.265 0 653.0197 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.42 0.546 1.96 653.0199 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.78 0.472 3.15 653.0199 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.89 0.49 1.68 653.02 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.44 0.493 1.09 653.0201 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.58 0.561 2.62 653.0201 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.08 0.411 1.59 653.0201 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.45 0.55 1.17 653.0202 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.51 0.484 0 653.0202 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.87 0.526 2.2 653.0202 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.58 0.458 1.52 653.0203 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 2.74 0.392 0 653.0203 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.26 0.448 0 653.0205 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.82 0.537 0 653.0206 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.54 0.345 0 653.0207 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.54 0.389 0 653.0208 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.64 0.406 0 653.022 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.5 0.403 0 653.0225 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.06 0.433 0 653.0233 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 2.28 0.244 0 653.0233 1,956.05 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% YPIEHGIITNWDDMEK 95.00% 3.1 0.24 0 654.3058 1,959.89 1,960.91 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% YPIEHGIITNWDDMEK 95.00% 2.96 0.174 0 654.6417 1,960.90 1,960.91 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% YPIEHGIITNWDDMEK 95.00% 3.54 0.194 0 654.642 1,960.90 1,960.91 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% YPIEHGIITNWDDMEK 95.00% 4.24 0.283 0 654.6424 1,960.90 1,960.91 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSKR 95.00% 2.73 0.456 2.8 677.8163 1,353.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DSYVGDEAQSKR 95.00% 2.95 0.48 3 677.8174 1,353.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AGFAGDDAPRAVFPSIVGRPR 95.00% 5.1 0.534 1.82 719.7163 2,156.13 2,156.14 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% AGFAGDDAPRAVFPSIVGRPR 95.00% 5.17 0.501 3.77 719.7175 2,156.13 2,156.14 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% qEYDEAGPSIVHR 95.00% 0 0 3.47 n-term: Pyro-cmC (-17.03) 742.3437 1,482.67 1,483.68 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLYANNVLSGGTTMYPGIADR 95.00% 6.28 0.567 6.8 743.6938 2,228.06 2,228.07 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.93 0.597 5.08 743.694 2,228.06 2,228.07 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLYANNVLSGGTTmYPGIADR 95.00% 5.64 0.352 5.25 m14: Oxidation (+15.99) 749.0255 2,244.05 2,244.06 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLYANNVLSGGTTmYPGIADR 95.00% 5.61 0.343 5.85 m14: Oxidation (+15.99) 749.0256 2,244.05 2,244.06 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 3.02 0.56 3.51 750.8557 1,499.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.71 0.532 3.28 750.8557 1,499.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.82 0.55 5.82 750.8566 1,499.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.82 0.563 4.6 750.8568 1,499.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 1.9 0.285 0 750.857 1,499.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 3.18 0.56 3.64 750.8573 1,499.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.91 0.461 3.51 750.8576 1,499.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.89 0.486 2.44 750.8577 1,499.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.42 0.432 0 750.8582 1,499.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 3.4 0.609 3.44 750.8582 1,499.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.88 0.544 4.14 750.8586 1,499.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 3.2 0.413 2.2 750.8599 1,499.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.72 0.563 3.77 751.358 1,500.70 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHR 95.00% 2.57 0.638 3.96 751.3606 1,500.71 1,500.71 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% MQKEITALAPSTMK 95.00% 4.76 0.406 1.62 774.9094 1,547.80 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% MQKEITALAPSTMK 95.00% 4.82 0.437 1.92 774.9104 1,547.81 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.93 0.654 5.77 784.3633 2,350.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.74 0.677 4.7 784.6978 2,351.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.51 0.576 5.77 784.6981 2,351.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.95 0.587 1.89 786.3917 2,356.15 2,356.16 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% KDLYANNVLSGGTTMYPGIADR 95.00% 6.27 0.597 1.89 786.3922 2,356.15 2,356.16 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% KDLYANNVLSGGTTMYPGIADR 95.00% 4.53 0.537 0 786.3925 2,356.15 2,356.16 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% KDLYANNVLSGGTTMYPGIADR 95.00% 4.69 0.597 0 786.3928 2,356.16 2,356.16 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.59 0.626 5.48 m8: Oxidation (+15.99) 790.0278 2,367.06 2,367.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.84 0.676 4.89 m8: Oxidation (+15.99) 790.0281 2,367.06 2,367.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% KDLYANNVLSGGTTmYPGIADR 95.00% 6.08 0.516 2.92 m15: Oxidation (+15.99) 791.7233 2,372.15 2,372.16 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% KDLYANNVLSGGTTmYPGIADR 95.00% 5.18 0.583 2.89 m15: Oxidation (+15.99) 791.7241 2,372.15 2,372.16 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.8 0.62 2.96 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3603 2,383.06 2,383.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 2.85 0.274 0 812.4223 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 3.27 0.34 3.3 812.4224 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 3.04 0.324 2.82 812.4231 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 3.07 0.344 2.82 812.4234 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLMK 95.00% 2.96 0.31 2.59 812.9249 1,623.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHRK 95.00% 2.88 0.434 3.31 814.9049 1,627.79 1,628.80 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% QEYDEAGPSIVHRK 95.00% 2.75 0.437 2.29 814.9049 1,627.79 1,628.80 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% LDLAGRDLTDYLmK 95.00% 3.06 0.156 1.96 m13: Oxidation (+15.99) 820.4215 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQKDSYVGDEAQSKR 95.00% 5.32 0.647 5.05 836.7299 2,507.17 2,507.18 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQKDSYVGDEAQSKR 95.00% 5.5 0.623 4.62 836.7305 2,507.17 2,507.18 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVmVGmGQKDSYVGDEAQSKR 95.00% 4.49 0.51 2.18 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 847.3937 2,539.16 2,539.17 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% ILTERGYSFVTTAER 95.00% 3.46 0.288 2.44 872.46 1,742.90 1,742.91 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% ILTERGYSFVTTAER 95.00% 3.39 0.295 2.25 872.4634 1,742.91 1,742.91 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 3.63 0.48 5.02 895.9472 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 2.71 0.303 3 895.9479 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.8 0.599 5.44 895.9482 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 3.16 0.308 0 895.9482 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.72 0.6 5.31 895.9483 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.8 0.591 6.54 895.9483 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 3.13 0.41 0 895.9485 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.69 0.615 5.85 895.9488 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 3.81 0.564 4.82 895.9496 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.71 0.61 6.03 895.9501 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 2.97 0.511 2.66 895.9502 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.71 0.577 5.22 895.9503 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 2.95 0.518 2.41 895.9505 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 3.96 0.507 4.92 895.9517 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.11 0.504 4.32 895.9521 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 3.63 0.517 2.82 895.9528 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 3.95 0.483 6.17 895.9532 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.32 0.498 3.14 895.9535 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 3.67 0.484 4.19 896.4471 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.74 0.553 5.21 896.4489 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.59 0.564 5.38 896.4492 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 3.19 0.551 5.66 896.4499 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.67 0.61 6.37 896.4501 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.95 0.592 5.92 896.4501 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.68 0.557 4.77 896.4503 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.52 0.57 5.4 896.4507 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.59 0.506 5.62 896.4513 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.35 0.491 5.28 896.4541 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.24 0.513 5.35 896.4547 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.09 0.571 4.41 896.4549 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 3.73 0.544 3.46 896.4555 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% SYELPDGQVITIGNER 95.00% 4.18 0.456 3.89 896.4557 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.27 0.635 4.06 978.521 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.01 0.628 4.96 978.5213 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.18 0.658 6.11 978.523 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.9 0.658 4.34 978.5232 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.08 0.601 3.77 978.5239 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4 0.66 5.31 978.5241 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.1 0.619 4.66 978.5279 1,955.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.66 0.568 5.68 979.021 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.41 0.62 6.08 979.023 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.64 0.574 4.35 979.0244 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.7 0.599 5.04 979.0244 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.18 0.557 5.57 979.0246 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.7 0.606 4.33 979.0249 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.52 0.558 4.04 979.0249 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.35 0.522 4.85 979.0254 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.24 0.519 4.68 979.0254 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.44 0.579 4.54 979.0255 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 3.91 0.553 4.32 979.0256 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.49 0.6 4.6 979.0257 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.44 0.528 5.04 979.0259 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.3 0.576 4.8 979.0265 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.35 0.589 4.44 979.0265 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.06 0.61 4.92 979.0268 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% VAPEEHPTLLTEAPLNPK 95.00% 4.2 0.584 6.04 979.0271 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% YPIEHGIITNWDDMEK 95.00% 4.52 0.46 3.96 980.955 1,959.89 1,960.91 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% YPIEHGIITNWDDMEK 95.00% 4.52 0.411 2.55 981.4565 1,960.90 1,960.91 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% cPETLFQPSFIGMESAGIHETTYNSIMK 95.00% 5.8 0.597 2.7 c1: Carbamidomethyl (+57.02) 1,063.83 3,188.46 3,188.47 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% cPETLFQPSFIGMESAGIHETTYNSIMK 95.00% 6 0.582 3.03 c1: Carbamidomethyl (+57.02) 1,063.83 3,188.46 3,188.47 3
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.83 0.654 8.28 1,115.03 2,228.05 2,228.07 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.75 0.653 6.8 1,115.04 2,228.06 2,228.07 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLYANNVLSGGTTMYPGIADR 95.00% 5.57 0.662 7.64 1,115.04 2,228.06 2,228.07 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLYANNVLSGGTTMYPGIADR 95.00% 4.82 0.647 7.28 1,115.04 2,228.06 2,228.07 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% DLYANNVLSGGTTmYPGIADR 95.00% 5.93 0.447 5.34 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.87 0.665 9.74 1,176.54 2,351.07 2,351.08 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 6.09 0.65 9 1,176.54 2,351.07 2,351.08 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.64 0.597 7.8 1,179.08 2,356.15 2,356.16 2
 SAMPLE 3 Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 21 29 245 59.90% KDLYANNVLSGGTTMYPGIADR 95.00% 5.57 0.617 5.64 1,179.08 2,356.15 2,356.16 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DSYVGDEAQSKR 95.00% 2.13 0.3 0 452.2142 1,353.62 1,354.62 3 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 2.19 0.434 0 473.2779 944.5401 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 2.23 0.424 0 473.2782 944.5407 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 2.13 0.462 0 473.2789 944.5421 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 2.19 0.368 0 473.2792 944.5427 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 2.04 0.338 0 473.2792 944.5428 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 2.03 0.443 0 473.2793 944.5429 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 1.7 0.296 0 473.2794 944.5431 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 2.06 0.36 0 473.2794 944.5432 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 1.96 0.364 0 473.2795 944.5434 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 1.94 0.365 0 473.2795 944.5434 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 1.79 0.347 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 2.12 0.499 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 2.01 0.363 0 473.2798 944.544 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 1.88 0.367 0 473.2799 944.5442 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 1.9 0.322 0 473.2802 944.5447 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGR 95.00% 2.27 0.415 0 473.2802 944.5448 945.5522 2 CPXM2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,KTN1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AGFAGDDAPR 95.00% 2.72 0.361 1.39 488.7266 975.4375 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AGFAGDDAPR 95.00% 3.38 0.49 1.66 488.727 975.4384 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AGFAGDDAPR 95.00% 3.42 0.468 1.21 488.727 975.4384 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AGFAGDDAPR 95.00% 2.88 0.277 1.14 488.7275 975.4394 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AGFAGDDAPR 95.00% 2.76 0.315 1.17 488.7277 975.4398 976.449 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLTDYLMK 95.00% 2.21 0.351 0 499.7459 997.4761 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLTDYLMK 95.00% 1.75 0.324 0 499.7459 997.4762 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLTDYLMK 95.00% 2.1 0.351 0 499.746 997.4764 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLTDYLMK 95.00% 1.94 0.344 0 499.746 997.4764 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLTDYLMK 95.00% 2.17 0.402 0 499.7461 997.4765 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLTDYLMK 95.00% 1.82 0.335 0 499.7461 997.4765 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLTDYLMK 95.00% 1.98 0.35 1.19 499.7462 997.4767 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLTDYLMK 95.00% 2.05 0.403 0 499.7463 997.4769 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLTDYLMK 95.00% 1.82 0.38 0 499.7464 997.4772 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLTDYLMK 95.00% 1.74 0.343 0 499.7465 997.4773 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLTDYLMK 95.00% 2.28 0.394 0 499.7465 997.4774 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLTDYLMK 95.00% 2.1 0.426 0 499.7469 997.4782 998.4871 2 ACTB_HUMAN,TITIN_HUMAN,MYH10_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3.31 0.544 1.1 500.9059 1,499.69 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3.16 0.509 0 500.9061 1,499.69 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 1.86 0.23 0 500.9061 1,499.69 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3.57 0.592 1.13 500.9062 1,499.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3.5 0.504 1.68 500.9062 1,499.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3.22 0.533 0 500.9065 1,499.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3.68 0.58 0 500.9065 1,499.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3.31 0.559 0 500.9068 1,499.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.78 0.53 0 500.9068 1,499.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.49 0.417 0 500.9069 1,499.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3.22 0.51 0 500.9073 1,499.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.65 0.53 1.27 500.9073 1,499.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.28 0.383 0 500.9074 1,499.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.52 0.465 0 501.2392 1,500.69 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.66 0.43 0 501.2407 1,500.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.24 0.435 0 501.2408 1,500.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.11 0.243 1.41 501.2416 1,500.70 1,500.71 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IWHHTFYNELR 95.00% 2.48 0.368 0 505.9207 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IWHHTFYNELR 95.00% 1.92 0.308 0 505.9215 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2 0.234 0 518.8281 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2.28 0.21 0 518.8282 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2.34 0.26 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2.56 0.227 0 518.8285 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2.54 0.219 0 518.8285 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2.26 0.249 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2.49 0.227 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2.01 0.264 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2.38 0.216 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2.3 0.22 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2.2 0.297 0 518.8289 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2.19 0.249 0 518.8289 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 2.05 0.282 0 518.8289 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPER 95.00% 1.97 0.264 0 518.829 1,035.64 1,036.65 2 K22E_HUMAN,ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 3.08 0.498 0 541.9503 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 2.98 0.483 1.14 541.9504 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 2.21 0.213 0 541.9509 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 3.11 0.473 0 541.9509 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 3.08 0.463 0 541.951 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 2.85 0.511 0 541.951 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 2.39 0.344 0 541.951 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 2.36 0.199 0 541.951 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 2.35 0.307 0 541.9512 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 3.17 0.443 0 541.9514 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 3.06 0.411 0 541.9515 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 2.36 0.285 0 541.9519 1,622.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 2.78 0.421 0 542.2848 1,623.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 3.04 0.415 0 542.2852 1,623.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 2.45 0.263 0 542.2858 1,623.83 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 2.43 0.236 0 542.2864 1,623.84 1,623.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAEREIVR 95.00% 2.14 0.489 0 543.285 1,626.83 1,627.84 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHRK 95.00% 2.28 0.222 0 543.6047 1,627.79 1,628.80 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHRK 95.00% 2.44 0.225 0 543.6049 1,627.79 1,628.80 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHRK 95.00% 1.98 0.221 0 543.6051 1,627.79 1,628.80 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHRK 95.00% 2.26 0.347 0 543.9389 1,628.79 1,628.80 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLmK 95.00% 3.16 0.418 0 m13: Oxidation (+15.99) 547.2824 1,638.82 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLmK 95.00% 2.58 0.329 0 m13: Oxidation (+15.99) 547.2824 1,638.82 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLmK 95.00% 2.66 0.264 0 m13: Oxidation (+15.99) 547.2827 1,638.82 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLmK 95.00% 3.78 0.252 1.37 m13: Oxidation (+15.99) 547.283 1,638.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLmK 95.00% 3.43 0.36 0 m13: Oxidation (+15.99) 547.6164 1,639.83 1,639.84 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 2.78 0.45 2.48 565.7723 1,129.53 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 2.51 0.455 3.52 565.7753 1,129.53 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 2.3 0.166 1.77 565.7755 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.5 0.535 2.92 565.7758 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.36 0.538 3.19 565.7759 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.14 0.504 3.17 565.776 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.32 0.581 3.07 565.7761 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 2.13 0.303 1.55 565.7762 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.27 0.509 3.06 565.7762 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.2 0.47 3.66 565.7765 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.4 0.532 3.43 565.7765 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.26 0.542 3.12 565.7766 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.35 0.467 2.85 565.7771 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.27 0.444 2.52 565.7771 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.57 0.593 2.77 565.7772 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.38 0.539 4.38 565.7773 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 2.83 0.467 2.82 565.7774 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.6 0.601 3.66 565.7774 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.03 0.435 1.89 565.7781 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 3.05 0.439 3.05 565.7787 1,129.54 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAER 95.00% 2.82 0.197 1.41 566.3397 1,130.66 1,130.55 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTMK 95.00% 2.71 0.323 0 581.31 1,160.60 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTMK 95.00% 2.6 0.292 0 581.3111 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTMK 95.00% 2.76 0.398 1.55 581.3118 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTMK 95.00% 2.58 0.342 0 581.312 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTMK 95.00% 2.78 0.401 0 581.312 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTMK 95.00% 2.82 0.359 1.33 581.3121 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTMK 95.00% 2.92 0.379 1.28 581.3123 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTMK 95.00% 2.64 0.369 0 581.3125 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTMK 95.00% 2.57 0.325 0 581.3125 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTMK 95.00% 2.69 0.265 0 581.313 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTMK 94.70% 2.04 0.242 0 581.3134 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTMK 95.00% 2.72 0.407 2.96 581.3135 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPERK 95.00% 2.16 0.235 0 582.8768 1,163.74 1,164.75 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IKIIAPPERK 95.00% 2.44 0.222 0 583.3763 1,164.74 1,164.75 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.13 0.403 3.33 586.2876 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.74 0.423 4.59 586.2878 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.76 0.453 3.85 586.2879 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.68 0.449 4.57 586.2879 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.71 0.469 4.02 586.288 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.46 0.452 3.8 586.2884 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.61 0.406 5.06 586.2884 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.59 0.457 3.89 586.2884 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.43 0.387 2.7 586.2884 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.65 0.442 4.66 586.2887 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.92 0.522 2.82 586.2888 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 3.17 0.508 4.46 586.2888 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 3.01 0.481 3.64 586.2889 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 3.12 0.461 4.35 586.2892 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.38 0.384 3.38 586.2895 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.3 0.37 3.09 586.2897 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.04 0.316 2.09 586.2899 1,170.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQK 95.00% 2.24 0.238 2.64 586.7887 1,171.56 1,171.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTmK 95.00% 2.68 0.219 0 m10: Oxidation (+15.99) 589.3081 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTmK 95.00% 2.76 0.169 0 m10: Oxidation (+15.99) 589.3089 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTmK 95.00% 2.88 0.313 2 m10: Oxidation (+15.99) 589.3093 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTmK 95.00% 2.65 0.205 0 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTmK 95.00% 2.54 0.301 1.09 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTmK 95.00% 2.81 0.361 1.12 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTmK 95.00% 2.48 0.164 1.09 m10: Oxidation (+15.99) 589.3097 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTmK 95.00% 2.67 0.304 0 m10: Oxidation (+15.99) 589.3097 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EITALAPSTmK 95.00% 2.72 0.159 0 m10: Oxidation (+15.99) 589.3114 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTB_HUMAN,CO1A1_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVmVGMGQK 95.00% 2.08 0.258 2.77 m5: Oxidation (+15.99) 594.2863 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVmVGMGQK 95.00% 2.28 0.356 4.49 m5: Oxidation (+15.99) 594.2865 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVmVGMGQK 95.00% 2.29 0.186 1.62 m5: Oxidation (+15.99) 594.2867 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVmVGMGQK 95.00% 1.97 0.23 3.82 m5: Oxidation (+15.99) 594.2867 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVmVGMGQK 95.00% 2.81 0.425 4.48 m5: Oxidation (+15.99) 594.2868 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVmVGMGQK 95.00% 3.19 0.432 4.66 m5: Oxidation (+15.99) 594.287 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGmGQK 95.00% 2.42 0.444 4.02 m8: Oxidation (+15.99) 594.2871 1,186.56 1,187.57 2 ACTB_HUMAN,K2C1_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 5.02 0.507 2.42 597.6349 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 3.59 0.396 2.64 597.6352 1,789.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 3.51 0.394 1.66 597.6371 1,789.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.14 0.456 4.24 597.9685 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.22 0.404 3.8 597.969 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 3.74 0.454 2.17 597.9692 1,790.88 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.16 0.476 4.72 597.9698 1,790.89 1,790.89 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DSYVGDEAQSK 95.00% 2.68 0.295 4.52 599.7628 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DSYVGDEAQSK 95.00% 2.44 0.337 3.89 599.7632 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DSYVGDEAQSK 95.00% 2.73 0.351 4.54 599.7638 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DSYVGDEAQSK 95.00% 1.97 0.28 1.4 599.7644 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DSYVGDEAQSK 95.00% 2.13 0.273 1.24 599.7646 1,197.51 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DSYVGDEAQSK 95.00% 2.13 0.356 1.54 599.7655 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DSYVGDEAQSK 95.00% 2.92 0.428 4.37 599.7656 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DSYVGDEAQSK 95.00% 2.4 0.329 2.02 599.7669 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DSYVGDEAQSK 95.00% 2.76 0.291 4.92 599.7669 1,197.52 1,198.52 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGRPR 95.00% 2.11 0.26 0 599.8549 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGRPR 95.00% 2.43 0.239 0 599.8551 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGRPR 95.00% 2.62 0.337 0 599.8552 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGRPR 95.00% 2.33 0.272 0 599.8554 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGRPR 95.00% 2.5 0.29 0 599.8554 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGRPR 95.00% 2.24 0.253 0 599.8556 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGRPR 95.00% 2.77 0.366 0 599.8559 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGRPR 95.00% 2.74 0.337 0 599.856 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AVFPSIVGRPR 95.00% 2.81 0.356 0 599.8567 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTB_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.22 0.402 0 652.6855 1,955.03 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3 0.509 1.36 652.6862 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.49 0.498 0 652.6865 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.24 0.559 1.25 652.6867 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.15 0.508 0 652.6869 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 2.81 0.318 0 652.6872 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.42 0.462 0 652.6881 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.59 0.479 0 652.6884 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.09 0.535 0 652.6885 1,955.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.65 0.528 1.82 653.0198 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.57 0.502 1.72 653.0198 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.43 0.458 0 653.0198 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.45 0.453 3 653.02 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.64 0.509 1.74 653.02 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.29 0.329 0 653.0201 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.84 0.473 1.66 653.0202 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.77 0.477 2.89 653.0203 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.41 0.524 1.92 653.0203 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.69 0.452 1.74 653.0204 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.96 0.52 0 653.0205 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.4 0.48 0 653.0206 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.62 0.448 1.25 653.0206 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 2.92 0.492 0 653.0208 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.05 0.207 0 653.0217 1,956.04 1,956.04 3 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% YPIEHGIITNWDDMEK 95.00% 3.47 0.11 0 654.3071 1,959.90 1,960.91 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% YPIEHGIITNWDDMEK 95.00% 3.28 0.214 1 654.6422 1,960.90 1,960.91 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DSYVGDEAQSKR 95.00% 2.96 0.564 4.96 677.8169 1,353.62 1,354.62 2 ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AGFAGDDAPRAVFPSIVGRPR 95.00% 4.56 0.434 2.48 719.3828 2,155.13 2,156.14 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% AGFAGDDAPRAVFPSIVGRPR 95.00% 4.65 0.536 3.55 719.7165 2,156.13 2,156.14 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% qEYDEAGPSIVHR 95.00% 0 0 3.2 n-term: Pyro-cmC (-17.03) 742.343 1,482.67 1,483.68 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLYANNVLSGGTTMYPGIADR 95.00% 5.87 0.58 5.43 743.6937 2,228.06 2,228.07 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLYANNVLSGGTTMYPGIADR 95.00% 5.5 0.58 3.55 743.6942 2,228.06 2,228.07 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLYANNVLSGGTTMYPGIADR 95.00% 3.91 0.338 0 743.6955 2,228.06 2,228.07 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3 0.5 2.59 750.8542 1,499.69 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.98 0.498 1.85 750.856 1,499.70 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3.06 0.568 1.52 750.8572 1,499.70 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.7 0.548 2 750.8573 1,499.70 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.82 0.592 3.06 750.8575 1,499.70 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.96 0.63 3.54 750.8578 1,499.70 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.98 0.511 2.92 750.8578 1,499.70 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.72 0.492 2.72 750.8579 1,499.70 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.88 0.551 2.89 750.8579 1,499.70 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.65 0.519 2.28 750.8584 1,499.70 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.74 0.464 4.42 750.8586 1,499.70 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.96 0.495 2.82 750.8589 1,499.70 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.93 0.597 2.28 750.8603 1,499.71 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3.1 0.588 2.16 751.3596 1,500.70 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3.4 0.519 3.06 751.3609 1,500.71 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 2.07 0.314 0 751.3612 1,500.71 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHR 95.00% 3.59 0.54 2.12 751.3617 1,500.71 1,500.71 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IWHHTFYNELR 95.00% 2.59 0.463 1.23 758.3758 1,514.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% IWHHTFYNELR 95.00% 2.61 0.351 0 758.3797 1,514.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTB_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% MQKEITALAPSTMK 95.00% 4.85 0.416 1.89 774.9106 1,547.81 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% MQKEITALAPSTMK 95.00% 4.79 0.456 3.21 775.4118 1,548.81 1,548.81 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.2 0.679 4.85 784.6971 2,351.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.85 0.636 4.62 784.6972 2,351.07 2,351.08 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% KDLYANNVLSGGTTMYPGIADR 95.00% 6.03 0.59 0 786.3917 2,356.15 2,356.16 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% KDLYANNVLSGGTTMYPGIADR 95.00% 5.03 0.562 0 786.3944 2,356.16 2,356.16 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% KDLYANNVLSGGTTMYPGIADR 95.00% 4.64 0.572 0 786.3944 2,356.16 2,356.16 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% KDLYANNVLSGGTTMYPGIADR 95.00% 5.42 0.608 0 786.3957 2,356.16 2,356.16 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.07 0.612 4.89 m8: Oxidation (+15.99) 790.0291 2,367.06 2,367.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.4 0.68 4.44 m8: Oxidation (+15.99) 790.0303 2,367.07 2,367.07 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 3.18 0.352 1.62 812.4231 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 2.89 0.297 1.54 812.4232 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 3.02 0.344 3.2 812.424 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLMK 95.00% 3.02 0.314 2.57 812.4248 1,622.83 1,623.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAEREIVR 95.00% 3.12 0.306 0 814.4239 1,626.83 1,627.84 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% GYSFVTTAEREIVR 95.00% 2.96 0.258 0 814.4294 1,626.84 1,627.84 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHRK 95.00% 2.59 0.42 3.1 814.9046 1,627.79 1,628.80 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% QEYDEAGPSIVHRK 95.00% 2.48 0.399 3.49 815.406 1,628.80 1,628.80 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLmK 95.00% 2.8 0.209 1.82 m13: Oxidation (+15.99) 820.4195 1,638.82 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LDLAGRDLTDYLmK 95.00% 2.8 0.16 2.42 m13: Oxidation (+15.99) 820.4208 1,638.83 1,639.84 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 4.6 0.489 2.64 c2: Carbamidomethyl (+57.02) 846.3894 2,536.14 2,536.16 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 5.93 0.595 3.18 c2: Carbamidomethyl (+57.02) 846.3902 2,536.15 2,536.16 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 6.51 0.615 3.82 c2: Carbamidomethyl (+57.02) 846.3905 2,536.15 2,536.16 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 4.63 0.444 2.27 c2: Carbamidomethyl (+57.02) 846.3909 2,536.15 2,536.16 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 5.76 0.566 5.23 c2: Carbamidomethyl (+57.02) 846.3911 2,536.15 2,536.16 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 4.87 0.457 2.34 c2: Carbamidomethyl (+57.02) 846.3918 2,536.15 2,536.16 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 5.78 0.571 3.57 c2: Carbamidomethyl (+57.02) 846.392 2,536.15 2,536.16 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 4.98 0.48 2.57 c2: Carbamidomethyl (+57.02) 846.3928 2,536.16 2,536.16 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVmVGmGQKDSYVGDEAQSKR 95.00% 4.79 0.519 2.77 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 847.3947 2,539.16 2,539.17 3 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEmATAASSSSLEK 95.00% 5.42 0 3.24 c2: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 851.0623 2,550.16 2,552.15 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEmATAASSSSLEK 95.00% 5.06 0.465 1.77 c2: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 851.3945 2,551.16 2,552.15 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEmATAASSSSLEK 95.00% 5.05 0.474 1.82 c2: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 851.3974 2,551.17 2,552.15 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% ILTERGYSFVTTAER 95.00% 3.29 0.453 2.52 871.9557 1,741.90 1,742.91 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% ILTERGYSFVTTAER 95.00% 3.43 0.386 2.11 871.9573 1,741.90 1,742.91 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.66 0.633 5.15 895.9481 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.89 0.604 5.72 895.9485 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.76 0.557 4.89 895.9485 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 3.69 0.428 2.85 895.9487 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.81 0.593 6.72 895.949 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.28 0.557 5.68 895.9492 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.56 0.582 5.85 895.9496 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.62 0.611 5.4 895.9496 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.6 0.583 5.2 895.9498 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.05 0.566 6.31 895.9499 1,789.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.32 0.555 4.51 895.9513 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.21 0.562 5.68 895.9519 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 3.56 0.577 4.34 895.9528 1,789.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.87 0.582 4.92 896.4477 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.63 0.557 4.64 896.448 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.02 0.471 2.96 896.4484 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.68 0.578 5.4 896.4499 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.73 0.575 6.2 896.45 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.73 0.565 5.02 896.45 1,790.88 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.62 0.546 5.24 896.4506 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 3.3 0.326 2.3 896.4507 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.38 0.495 4.16 896.4512 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.53 0.551 4.11 896.4514 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.05 0.491 5.6 896.4524 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 3.42 0.397 3.37 896.4524 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.95 0.594 4.2 896.4524 1,790.89 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% SYELPDGQVITIGNER 95.00% 4.03 0.481 4.8 896.4568 1,790.90 1,790.89 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EKLcYVALDFENEMATAASSSSLEK 95.00% 6.46 0.632 3.42 c4: Carbamidomethyl (+57.02) 932.1013 2,793.28 2,793.30 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EKLcYVALDFENEMATAASSSSLEK 95.00% 5.88 0.6 4.12 c4: Carbamidomethyl (+57.02) 932.1019 2,793.28 2,793.30 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EKLcYVALDFENEMATAASSSSLEK 95.00% 4.55 0.493 3.21 c4: Carbamidomethyl (+57.02) 932.1025 2,793.28 2,793.30 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% EKLcYVALDFENEMATAASSSSLEK 95.00% 6.8 0.657 2.6 c4: Carbamidomethyl (+57.02) 932.1025 2,793.28 2,793.30 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.14 0.588 5.57 978.5223 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.25 0.643 3.77 978.5233 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.23 0.661 2.8 978.5238 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.02 0.635 3.36 978.524 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.84 0.605 3.02 978.5244 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.43 0.552 3.55 978.5249 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.86 0.616 2.82 978.5252 1,955.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.05 0.587 5.18 979.0245 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.4 0.582 4.07 979.0246 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.28 0.614 4.48 979.0246 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.17 0.587 3.17 979.0251 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.43 0.578 3.39 979.0253 1,956.03 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.35 0.507 3.37 979.0255 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.51 0.571 4.12 979.0255 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.44 0.549 2.92 979.0257 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.67 0.606 3.41 979.0258 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.27 0.577 3.55 979.0263 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.39 0.588 4.2 979.0268 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.14 0.601 2.89 979.0269 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 3.98 0.648 3.66 979.027 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.08 0.566 3.68 979.0271 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.33 0.571 4.96 979.0274 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.41 0.491 2.85 979.0276 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% VAPEEHPTLLTEAPLNPK 95.00% 4.11 0.603 3.36 979.0281 1,956.04 1,956.04 2 LMCD1_HUMAN,SFPQ_HUMAN,ANK3_HUMAN,CO4A2_HUMAN,CBR1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% YPIEHGIITNWDDMEK 95.00% 4.59 0.428 2.85 980.9549 1,959.89 1,960.91 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% YPIEHGIITNWDDMEK 95.00% 4.66 0.415 2.72 981.4573 1,960.90 1,960.91 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% cPETLFQPSFIGMESAGIHETTYNSIMK 95.00% 5.91 0.555 2.54 c1: Carbamidomethyl (+57.02) 1,063.83 3,188.46 3,188.47 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% cPETLFQPSFIGMESAGIHETTYNSIMK 95.00% 6.04 0.555 2.92 c1: Carbamidomethyl (+57.02) 1,063.83 3,188.46 3,188.47 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% cPETLFQPSFIGMESAGIHETTYNSIMK 95.00% 6.26 0.608 2.51 c1: Carbamidomethyl (+57.02) 1,063.83 3,188.46 3,188.47 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% TTGIVLDSGDGVTHNVPIYEGYALPHAIMR 95.00% 6.89 0.615 6.39 1,066.54 3,196.59 3,196.61 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% TTGIVLDSGDGVTHNVPIYEGYALPHAIMR 95.00% 6.86 0.612 5.96 1,066.54 3,196.60 3,196.61 3
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLYANNVLSGGTTMYPGIADR 95.00% 3.95 0.621 4.31 1,114.53 2,227.05 2,228.07 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLYANNVLSGGTTMYPGIADR 95.00% 5.59 0.626 6.92 1,115.03 2,228.05 2,228.07 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLYANNVLSGGTTMYPGIADR 95.00% 5.45 0.667 5.92 1,115.04 2,228.05 2,228.07 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLYANNVLSGGTTMYPGIADR 95.00% 3.97 0.631 6.31 1,115.04 2,228.06 2,228.07 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLYANNVLSGGTTMYPGIADR 95.00% 5.85 0.641 6.82 1,115.04 2,228.06 2,228.07 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLYANNVLSGGTTMYPGIADR 95.00% 5.75 0.653 7.1 1,115.04 2,228.06 2,228.07 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLYANNVLSGGTTMYPGIADR 95.00% 5.52 0.653 5.72 1,115.04 2,228.06 2,228.07 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLYANNVLSGGTTmYPGIADR 95.00% 5.72 0.44 5.55 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% DLYANNVLSGGTTmYPGIADR 95.00% 5.79 0.469 5.15 m14: Oxidation (+15.99) 1,123.03 2,244.05 2,244.06 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.77 0.636 8.41 1,176.54 2,351.07 2,351.08 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.93 0.623 9.32 1,176.54 2,351.07 2,351.08 2 ACTB_HUMAN,ACTG_HUMAN
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% KDLYANNVLSGGTTMYPGIADR 95.00% 5.65 0.61 6.92 1,179.08 2,356.15 2,356.16 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% KDLYANNVLSGGTTMYPGIADR 95.00% 5.56 0.593 6.24 1,179.09 2,356.15 2,356.16 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 7.52 0.644 9.27 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 7.31 0.673 9.52 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 7.11 0.651 9.77 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 7.13 0.652 8.85 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 7.21 0.634 8.51 c2: Carbamidomethyl (+57.02) 1,269.08 2,536.15 2,536.16 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 7.1 0.656 8.64 c2: Carbamidomethyl (+57.02) 1,269.09 2,536.16 2,536.16 2
 SAMPLE 3R Actin, alpha cardiac muscle 1  ACTC1  ACTC_HUMAN 42,002.10 100.00% 24 34 259 74.50% LcYVALDFENEMATAASSSSLEK 95.00% 0 0 7.28 c2: Carbamidomethyl (+57.02) 1,269.58 2,537.15 2,536.16 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.06 0.413 0 473.28 944.5444 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.09 0.425 0 473.2802 944.5447 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 1.9 0.318 0 473.2802 944.5448 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 1.98 0.362 0 473.2804 944.5451 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.14 0.443 0 473.2804 944.5451 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.04 0.433 0 473.2804 944.5452 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.31 0.486 0 473.2804 944.5452 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.02 0.416 0 473.2806 944.5455 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.31 0.369 0 473.2806 944.5456 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.14 0.433 0 473.2806 944.5456 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.42 0.517 0 473.2806 944.5456 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.15 0.445 0 473.2807 944.5458 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 1.93 0.325 0 473.2808 944.5459 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 1.95 0.261 0 473.2808 944.5459 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.23 0.429 0 473.2808 944.546 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.29 0.46 0 473.2808 944.546 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.08 0.434 0 473.281 944.5463 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.37 0.522 0 473.2811 944.5465 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.13 0.423 0 473.2811 944.5466 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.11 0.31 0 473.2812 944.5467 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.3 0.316 0 473.2812 944.5468 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.1 0.391 0 473.2813 944.5469 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.24 0.334 0 473.2813 944.5469 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.22 0.415 0 473.2815 944.5473 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.19 0.42 0 473.2816 944.5475 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.22 0.43 0 473.2816 944.5476 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.24 0.471 0 473.282 944.5483 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 1.95 0.325 0 473.2822 944.5488 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.13 0.232 0 473.2824 944.5491 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 1.81 0.276 0 473.2826 944.5496 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 2.33 0.385 0 473.2828 944.55 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGR 95.00% 1.91 0.381 0 473.2834 944.5512 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AGFAGDDAPR 95.00% 3.48 0.496 2.72 488.7293 975.4429 976.449 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AGFAGDDAPR 95.00% 3.09 0.386 0 488.7298 975.444 976.449 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AGFAGDDAPR 95.00% 3.11 0.481 0 488.7301 975.4445 976.449 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AGFAGDDAPR 95.00% 3.37 0.486 1.7 488.7301 975.4445 976.449 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AGFAGDDAPR 95.00% 2.41 0.282 1.35 488.7301 975.4446 976.449 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AGFAGDDAPR 95.00% 3.32 0.432 1.44 488.7301 975.4446 976.449 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AGFAGDDAPR 95.00% 3.34 0.493 1.28 488.7302 975.4448 976.449 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AGFAGDDAPR 95.00% 3.4 0.458 0 488.7304 975.4452 976.449 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.1 0.315 1.48 499.7472 997.4788 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.12 0.29 1.28 499.7474 997.4791 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.03 0.376 0 499.7474 997.4792 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.2 0.367 0 499.7474 997.4792 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.04 0.299 0 499.7475 997.4793 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.15 0.362 1.66 499.7477 997.4797 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.05 0.262 0 499.7477 997.4798 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 1.93 0.26 0 499.7477 997.4798 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.09 0.419 1.68 499.7477 997.4798 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 1.96 0.252 0 499.7478 997.48 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.11 0.424 1.7 499.7479 997.4801 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.1 0.316 0 499.748 997.4803 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.14 0.403 0 499.748 997.4803 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.05 0.322 0 499.7481 997.4805 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.06 0.36 1.44 499.7481 997.4806 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 1.93 0.29 2.77 499.7482 997.4807 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 1.99 0.382 0 499.7483 997.481 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2 0.345 1.46 499.7484 997.4812 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 1.92 0.237 1.28 499.7494 997.4831 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 1.93 0.241 1.36 499.7498 997.484 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLMK 95.00% 2.22 0.243 0 499.7503 997.485 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IWHHTFYNELR 95.00% 3.25 0.466 0 505.9222 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IWHHTFYNELR 95.00% 3.38 0.443 0 505.9245 1,514.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IWHHTFYNELR 95.00% 3.41 0.359 0 505.9249 1,514.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 2.39 0.404 0 506.2394 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 3.15 0.519 0 506.2399 1,515.70 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 3.06 0.473 0 506.2401 1,515.70 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 2.72 0.396 0 506.2401 1,515.70 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 2.03 0.291 0 506.2407 1,515.70 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 2.06 0.316 0 506.2409 1,515.70 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 2.22 0.33 0 506.242 1,515.70 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IWHHTFYNELR 95.00% 3.34 0.38 1.16 506.2568 1,515.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLmK 95.00% 1.91 0.272 0 m7: Oxidation (+15.99) 507.7443 1,013.47 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLmK 95.00% 2 0.281 0 m7: Oxidation (+15.99) 507.7448 1,013.47 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLmK 95.00% 2.19 0.311 0 m7: Oxidation (+15.99) 507.7454 1,013.48 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLmK 95.00% 2.28 0.289 0 m7: Oxidation (+15.99) 507.7456 1,013.48 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLTDYLmK 94.60% 1.96 0.231 0 m7: Oxidation (+15.99) 507.7461 1,013.48 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% MQKEITALAPSTMK 95.00% 3.49 0.368 1.34 516.9436 1,547.81 1,548.81 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% MQKEITALAPSTMK 95.00% 3.33 0.339 1.68 516.9439 1,547.81 1,548.81 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% MQKEITALAPSTMK 95.00% 2.61 0.255 0 516.9453 1,547.81 1,548.81 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IKIIAPPER 95.00% 2.23 0.292 0 518.8303 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IKIIAPPER 95.00% 2.17 0.238 0 518.8305 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IKIIAPPER 95.00% 2.54 0.207 0 518.831 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IKIIAPPER 95.00% 2.54 0.23 0 518.8311 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IKIIAPPER 95.00% 2.54 0.229 0 518.8311 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IKIIAPPER 95.00% 2.58 0.221 0 518.8312 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IKIIAPPER 95.00% 2.34 0.21 0 518.8313 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IKIIAPPER 95.00% 2.51 0.225 0 518.8314 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% mQKEITALAPSTmK 95.00% 3.22 0.269 0 m1: Oxidation (+15.99), m13: Oxidation (+15.99) 527.6092 1,579.80 1,580.80 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 2.95 0.383 0 541.9529 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 2.98 0.488 2.39 541.9529 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 2.63 0.426 1.59 541.9531 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 2.53 0.342 0 541.9535 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 2.86 0.452 0 541.9536 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 2.91 0.477 0 541.9536 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 2.74 0.546 2.04 541.9537 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 2.7 0.444 0 541.9537 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 2.23 0.343 0 541.9537 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 2.78 0.418 0 541.9543 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 2.34 0.241 0 541.9551 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 3.19 0.48 0 542.2872 1,623.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAEREIVR 95.00% 1.82 0.365 0 543.9479 1,628.82 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAEREIVR 95.00% 1.92 0.495 0 544.2829 1,629.83 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 3.13 0.434 1.4 m13: Oxidation (+15.99) 547.2846 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 3.42 0.288 0 m13: Oxidation (+15.99) 547.2851 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 3.58 0.328 0 m13: Oxidation (+15.99) 547.2851 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 3.21 0.388 0 m13: Oxidation (+15.99) 547.2852 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 3.48 0.311 0 m13: Oxidation (+15.99) 547.2856 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 2.25 0.286 0 m13: Oxidation (+15.99) 547.2864 1,638.84 1,639.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 3.76 0.276 0 m13: Oxidation (+15.99) 547.6198 1,639.84 1,639.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 2.87 0.329 0 m13: Oxidation (+15.99) 547.6202 1,639.84 1,639.84 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 2.61 0.567 3.4 566.7683 1,131.52 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 2.75 0.536 2.64 566.7686 1,131.52 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 3.35 0.553 3 566.7687 1,131.52 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 3.19 0.513 2.74 566.7688 1,131.52 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 3.07 0.573 2.7 566.7693 1,131.52 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 2.76 0.556 3.42 566.7697 1,131.52 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 2.52 0.503 2.12 566.7697 1,131.52 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 2.15 0.401 0 566.7704 1,131.53 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 2.77 0.524 2.74 566.7705 1,131.53 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 1.98 0.276 0 566.799 1,131.58 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 2.42 0.312 0 566.7994 1,131.58 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 2.31 0.329 0 567.2928 1,132.57 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 2.37 0.383 0 567.2929 1,132.57 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAER 95.00% 1.92 0.332 0 567.2934 1,132.57 1,132.53 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.2 0.252 0 581.3134 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.14 0.392 0 581.3136 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.51 0.286 1.28 581.3144 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 94.60% 2.29 0.203 0 581.3146 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.7 0.404 1.49 581.3147 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.8 0.349 1.3 581.3147 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.59 0.29 0 581.3149 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.75 0.355 0 581.315 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.42 0.305 1.96 581.315 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.53 0.327 1.44 581.3152 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.69 0.339 0 581.3153 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.11 0.329 0 581.3155 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.83 0.383 1.89 581.3155 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.77 0.422 2.21 581.3156 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.45 0.373 0 581.3159 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.23 0.277 0 581.316 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.3 0.41 0 581.3179 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% ILTERGYSFTTTAER 95.00% 3.58 0.442 0 582.3021 1,743.88 1,744.89 3
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% ILTERGYSFTTTAER 95.00% 3.36 0.418 0 582.6351 1,744.88 1,744.89 3
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGMGQK 95.00% 2.75 0.462 4.32 586.2896 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGMGQK 95.00% 2.57 0.431 4.34 586.2908 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGMGQK 95.00% 3.01 0.49 4.43 586.2919 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGMGQK 95.00% 1.88 0.258 3.92 586.2928 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGMGQK 95.00% 2.29 0.347 3.18 586.2929 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGMGQK 95.00% 2.81 0.482 3.96 586.2935 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGMGQK 95.00% 2.48 0.341 1.21 586.2936 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTmK 95.00% 3.02 0.354 2.77 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTmK 95.00% 2.63 0.275 1.8 m10: Oxidation (+15.99) 589.3112 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTmK 95.00% 2.04 0.208 1.21 m10: Oxidation (+15.99) 589.3113 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTmK 95.00% 2.82 0.162 1.27 m10: Oxidation (+15.99) 589.3116 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTmK 95.00% 2.62 0.228 1.36 m10: Oxidation (+15.99) 589.3117 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTmK 95.00% 2.92 0.194 1.77 m10: Oxidation (+15.99) 589.3121 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTmK 95.00% 2.92 0.363 2.05 m10: Oxidation (+15.99) 589.3126 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTmK 95.00% 3.1 0.357 1.82 m10: Oxidation (+15.99) 589.3127 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTmK 95.00% 2.15 0.337 0 m10: Oxidation (+15.99) 589.315 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTmK 95.00% 2.91 0.201 0 m10: Oxidation (+15.99) 589.813 1,177.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGmGQK 95.00% 2.06 0.385 5.42 m8: Oxidation (+15.99) 594.2871 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGmGQK 95.00% 2.26 0.414 4.85 m8: Oxidation (+15.99) 594.2893 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGmGQK 95.00% 2.74 0.395 2.96 m8: Oxidation (+15.99) 594.2895 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGmGQK 95.00% 2.63 0.337 4.1 m8: Oxidation (+15.99) 594.2896 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGmGQK 95.00% 2.33 0.256 3.43 m8: Oxidation (+15.99) 594.2919 1,186.57 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.02 0.422 0 597.6349 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 2.15 0.29 0 597.6375 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.04 0.321 0 597.6379 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.57 0.488 4.32 597.638 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.98 0.434 4.31 597.6381 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.03 0.47 3 597.6382 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.03 0.361 0 597.6382 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.54 0.445 3.68 597.9725 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.4 0.234 0 599.3418 1,196.67 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.48 0.241 0 599.3419 1,196.67 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.41 0.274 0 599.3421 1,196.67 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSK 95.00% 2.94 0.502 3.85 599.7675 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSK 95.00% 3.11 0.507 4.64 599.7685 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSK 95.00% 2.53 0.353 1.62 599.7693 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSK 95.00% 2.62 0.152 4.85 599.7694 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSK 95.00% 2.82 0.47 3.38 599.7699 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSK 95.00% 2.29 0.36 3.48 599.7705 1,197.53 1,198.52 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSK 95.00% 3.2 0.47 4.52 599.7707 1,197.53 1,198.52 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.28 0.273 0 599.8578 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.31 0.242 0 599.8579 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.59 0.191 0 599.8579 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.4 0.32 0 599.8582 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.47 0.218 0 599.8582 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.88 0.374 0 599.8583 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.31 0.277 0 599.8583 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.66 0.363 0 599.8584 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.5 0.25 0 599.8586 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.3 0.262 0 599.8586 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.7 0.271 0 599.8587 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.45 0.308 0 599.8588 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.57 0.316 0 599.8588 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.43 0.244 0 599.8589 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.31 0.315 0 599.8609 1,197.71 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AVFPSIVGRPR 95.00% 2.49 0.381 0 599.9893 1,197.96 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVmVGmGQK 95.00% 1.85 0.292 0 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 602.2915 1,202.57 1,203.56 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 3.93 0.0829 1.15 652.0289 1,953.06 1,954.07 3
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.1 0.0518 1.54 652.3629 1,954.07 1,954.07 3
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.35 0.0625 1.92 652.3631 1,954.07 1,954.07 3
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.25 0.0511 1.64 652.3633 1,954.07 1,954.07 3
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.2 0.0326 1.77 652.3633 1,954.07 1,954.07 3
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.2 0.0271 1.89 652.3633 1,954.07 1,954.07 3
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 3.98 0.0545 1.55 652.3636 1,954.07 1,954.07 3
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.35 0.0784 2.21 652.3641 1,954.07 1,954.07 3
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSKR 95.00% 2.37 0.409 0 677.3191 1,352.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSKR 95.00% 2.56 0.43 1.19 677.8194 1,353.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSKR 95.00% 2.81 0.5 1.27 677.8209 1,353.63 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSKR 95.00% 2.92 0.5 2.34 677.8216 1,353.63 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSKR 95.00% 2.6 0.436 2.07 678.322 1,354.63 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DSYVGDEAQSKR 95.00% 2.82 0.54 2.72 678.323 1,354.63 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% AGFAGDDAPRAVFPSIVGRPR 95.00% 4.36 0.568 1.62 719.7175 2,156.13 2,156.14 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% qEYDESGPSIVHR 95.00% 0 0 3.82 n-term: Pyro-cmC (-17.03) 750.3445 1,498.67 1,499.68 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IWHHTFYNELR 95.00% 2.26 0.352 1.26 758.3791 1,514.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% IWHHTFYNELR 95.00% 2.63 0.395 2.21 758.3845 1,514.75 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 2.67 0.38 3.74 758.8573 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 2.72 0.456 4.05 758.8575 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 2.83 0.492 4.22 758.8584 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 2.57 0.455 3.89 758.8587 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 2.68 0.483 3.8 758.8588 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 2.54 0.457 4.89 758.86 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% QEYDESGPSIVHR 95.00% 2.61 0.438 3.64 759.3609 1,516.71 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% MQKEITALAPSTmK 95.00% 4.06 0.425 2.09 m13: Oxidation (+15.99) 782.9064 1,563.80 1,564.81 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% MQKEITALAPSTmK 95.00% 3.99 0.419 2.47 m13: Oxidation (+15.99) 782.9106 1,563.81 1,564.81 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGMGQKDSYVGDEAQSK 95.00% 3.86 0.508 4.12 784.7004 2,351.08 2,351.08 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.53 0.652 5.22 m8: Oxidation (+15.99) 790.033 2,367.08 2,367.07 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.23 0.653 4.34 m8: Oxidation (+15.99) 790.0337 2,367.08 2,367.07 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.57 0.594 2.54 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.0299 2,382.07 2,383.07 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVmVGmGQKDSYVGDEAQSK 95.00% 4.38 0.705 4.22 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3643 2,383.07 2,383.07 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.1 0.588 3.15 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3654 2,383.07 2,383.07 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.48 0.491 4.27 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3655 2,383.07 2,383.07 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.24 0.464 2.03 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.368 2,383.08 2,383.07 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.05 0.399 1.54 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3682 2,383.08 2,383.07 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.55 0.52 2.92 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3685 2,383.08 2,383.07 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.49 0.541 2.19 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3687 2,383.08 2,383.07 3 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 3.2 0.355 2.54 812.4243 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 3.28 0.359 2.89 812.426 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 3.48 0.384 2.96 812.4265 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 3.18 0.351 1.85 812.4272 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 3.18 0.372 2.82 812.4273 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 3.07 0.374 2.96 812.4275 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 3.12 0.318 2.82 812.4285 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLMK 95.00% 2.96 0.36 2.31 812.429 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAEREIVR 95.00% 2.93 0.25 0 815.4192 1,628.82 1,629.82 2 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% GYSFTTTAEREIVR 95.00% 3 0.302 0 815.9195 1,629.82 1,629.82 2 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 3 0.171 2.33 m13: Oxidation (+15.99) 820.4228 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 3.19 0.187 2.92 m13: Oxidation (+15.99) 820.4231 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 3.31 0.184 1.96 m13: Oxidation (+15.99) 820.4233 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 3.03 0.155 2.52 m13: Oxidation (+15.99) 820.4236 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 2.95 0.148 2.24 m13: Oxidation (+15.99) 820.4241 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 2.92 0.083 2.72 m13: Oxidation (+15.99) 820.4242 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 3.07 0.198 2.06 m13: Oxidation (+15.99) 820.4243 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% LDLAGRDLTDYLmK 95.00% 2.99 0.178 2.7 m13: Oxidation (+15.99) 820.4246 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.62 0.6 5.74 895.9509 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.58 0.611 6.02 895.951 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.74 0.562 6.74 895.9511 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.66 0.645 5.92 895.9513 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.56 0.586 5.55 895.9513 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.67 0.567 5.89 895.9514 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.89 0.579 5.7 895.9516 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.4 0.595 6.82 895.9517 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.49 0.616 7.18 895.9519 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.74 0.615 6.62 895.9519 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.77 0.628 6.21 895.952 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.49 0.596 6.85 895.9523 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.44 0.562 5.89 895.9523 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.82 0.621 6.66 895.9525 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.77 0.596 6.92 895.9527 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.4 0.559 6.24 895.9529 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.26 0.608 5.17 895.9531 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.5 0.486 6.38 895.9535 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.43 0.51 3.3 895.954 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.72 0.482 4.57 895.9543 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.28 0.579 7.96 895.9546 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.31 0.474 4.32 895.9548 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.01 0.565 6.77 895.9555 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.28 0.594 2.35 895.9557 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.36 0.457 3.59 895.956 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.63 0.498 4.64 895.9585 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.08 0.472 3.89 895.9585 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.97 0.56 4.32 895.9594 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.38 0.521 3.09 895.9597 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.69 0.543 5.27 895.9601 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.31 0.514 4.85 895.9612 1,789.91 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.85 0.515 4.8 895.9624 1,789.91 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.97 0.57 4.85 896.4522 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.86 0.579 5 896.4523 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.77 0.589 4.96 896.4523 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 5.02 0.609 7.7 896.4525 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.46 0.559 4.32 896.453 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.89 0.615 5.28 896.4532 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.28 0.604 5.54 896.4539 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.77 0.571 5.85 896.4543 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 4.29 0.561 4.72 896.4558 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 2.93 0.52 4.25 896.4576 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.39 0.466 3.8 896.4585 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.02 0.432 5.05 896.4587 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.29 0.501 3.03 896.4593 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% SYELPDGQVITIGNER 95.00% 3.62 0.55 4.96 896.4618 1,790.91 1,790.89 2 ACTC_HUMAN
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.55 0.152 7.09 978.0385 1,954.06 1,954.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.49 0.19 5.85 978.0388 1,954.06 1,954.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.46 0.153 6.26 978.0391 1,954.06 1,954.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.5 0.135 6.77 978.0392 1,954.06 1,954.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.4 0.162 6.31 978.0392 1,954.06 1,954.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.45 0.15 6.05 978.0393 1,954.06 1,954.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.44 0.135 6.42 978.0395 1,954.06 1,954.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.48 0.103 6.15 978.04 1,954.06 1,954.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.5 0.193 5 978.0406 1,954.07 1,954.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% VAPEEHPVLLTEAPLNPK 95.00% 4.51 0.129 5.96 978.0413 1,954.07 1,954.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLYANTVLSGGTTMYPGIADR 95.00% 5.97 0.735 5.3 1,108.04 2,214.07 2,215.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLYANTVLSGGTTMYPGIADR 95.00% 6.55 0.431 7.41 1,108.54 2,215.07 2,215.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% DLYANTVLSGGTTmYPGIADR 95.00% 6.09 0.677 5.12 m14: Oxidation (+15.99) 1,116.54 2,231.06 2,231.07 2
 SAMPLE 4 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 52 47.70% EITALAPSTMK 95.00% 2.77 0.492 1.09 1,162.55 1,161.54 1,161.62 1 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSKR 95.00% 1.93 0.156 0.959 452.2162 1,353.63 1,354.62 3 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.31 0.49 0 473.2802 944.5447 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.21 0.418 0 473.2802 944.5448 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.03 0.301 0 473.2806 944.5455 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.13 0.393 0 473.2807 944.5458 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.29 0.5 0 473.2807 944.5458 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 1.98 0.365 0 473.2809 944.5461 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.37 0.392 0 473.2809 944.5462 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 1.88 0.372 0 473.281 944.5463 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 1.98 0.362 0 473.281 944.5463 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.05 0.439 0 473.281 944.5464 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.11 0.418 0 473.281 944.5464 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.12 0.395 0 473.281 944.5464 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.33 0.416 0 473.2811 944.5465 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.02 0.431 0 473.2811 944.5465 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.1 0.413 0 473.2811 944.5465 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 1.83 0.322 0 473.2813 944.5469 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.49 0.448 0 473.2813 944.5469 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.11 0.426 0 473.2813 944.5469 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 1.99 0.414 0 473.2813 944.547 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.37 0.502 0 473.2813 944.547 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.06 0.313 0 473.2815 944.5473 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.25 0.342 0 473.2815 944.5473 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 1.96 0.342 0 473.2817 944.5478 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.38 0.335 0 473.2821 944.5485 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 1.92 0.424 0 473.2823 944.549 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.09 0.407 0 473.2824 944.5492 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 1.88 0.326 0 473.2824 944.5492 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.21 0.38 0 473.2828 944.55 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 1.91 0.381 0 473.2834 944.5512 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGR 95.00% 2.03 0.37 0 473.2882 944.5608 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AGFAGDDAPR 95.00% 3.33 0.459 1.64 488.7296 975.4436 976.449 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AGFAGDDAPR 95.00% 3.49 0.486 2.02 488.7298 975.4439 976.449 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AGFAGDDAPR 95.00% 3.09 0.458 1.41 488.7298 975.4439 976.449 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AGFAGDDAPR 95.00% 3.49 0.446 1.82 488.73 975.4444 976.449 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AGFAGDDAPR 95.00% 3.06 0.439 1.47 488.7301 975.4445 976.449 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AGFAGDDAPR 95.00% 2.78 0.3 0 488.7301 975.4446 976.449 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AGFAGDDAPR 95.00% 3.38 0.452 1.28 488.7302 975.4448 976.449 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AGFAGDDAPR 95.00% 2.68 0.286 0 488.7303 975.4449 976.449 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AGFAGDDAPR 95.00% 2.92 0.39 1.74 488.7306 975.4455 976.449 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 1.78 0.343 0 499.7474 997.4791 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 2.09 0.218 0 499.7474 997.4792 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 2.07 0.328 0 499.7475 997.4793 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 2.22 0.344 0 499.7475 997.4794 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 2.08 0.357 0 499.7476 997.4795 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 2.06 0.394 0 499.7478 997.48 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 2.07 0.431 1.36 499.7478 997.48 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 2.14 0.42 0 499.7478 997.48 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 1.91 0.337 0 499.7479 997.4802 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 1.83 0.309 2.01 499.7481 997.4805 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 2.04 0.368 0 499.7481 997.4806 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 1.89 0.267 1.89 499.7483 997.481 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 2.1 0.423 0 499.7487 997.4818 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLMK 95.00% 1.82 0.339 0 499.7563 997.4969 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IWHHTFYNELR 95.00% 2.1 0.269 0 505.4907 1,513.45 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IWHHTFYNELR 95.00% 3.12 0.427 0 505.9217 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IWHHTFYNELR 95.00% 2.95 0.371 0 505.9219 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IWHHTFYNELR 95.00% 3.36 0.436 1.19 505.9227 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IWHHTFYNELR 95.00% 2.54 0.224 0 505.923 1,514.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IWHHTFYNELR 95.00% 2.06 0.211 0 505.9237 1,514.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IWHHTFYNELR 95.00% 3.2 0.432 0 505.924 1,514.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% QEYDESGPSIVHR 95.00% 2.89 0.418 0 506.2395 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% QEYDESGPSIVHR 95.00% 3.28 0.466 0 506.2401 1,515.70 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% QEYDESGPSIVHR 95.00% 3.15 0.447 0 506.2406 1,515.70 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% QEYDESGPSIVHR 95.00% 3.28 0.506 0 506.241 1,515.70 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% QEYDESGPSIVHR 95.00% 3.4 0.545 0 506.2413 1,515.70 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IWHHTFYNELR 95.00% 2.26 0.302 0 506.2577 1,515.75 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLmK 95.00% 2.06 0.392 0 m7: Oxidation (+15.99) 507.7447 1,013.47 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLmK 95.00% 2.16 0.322 0 m7: Oxidation (+15.99) 507.7453 1,013.48 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLmK 95.00% 2.1 0.369 0 m7: Oxidation (+15.99) 507.7454 1,013.48 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLTDYLmK 95.00% 1.92 0.185 1.19 m7: Oxidation (+15.99) 507.746 1,013.48 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% MQKEITALAPSTMK 95.00% 2.83 0.274 1.29 516.944 1,547.81 1,548.81 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% MQKEITALAPSTMK 95.00% 2.91 0.331 1.32 516.9441 1,547.81 1,548.81 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IKIIAPPER 95.00% 2.53 0.223 0 518.83 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IKIIAPPER 95.00% 2.27 0.288 0 518.8301 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IKIIAPPER 95.00% 2.44 0.225 0 518.8307 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IKIIAPPER 95.00% 2.58 0.222 0 518.8307 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IKIIAPPER 95.00% 2.54 0.232 0 518.8309 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IKIIAPPER 95.00% 2.32 0.221 0 518.831 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IKIIAPPER 95.00% 1.93 0.324 0 518.8311 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IKIIAPPER 95.00% 2.47 0.235 0 518.8311 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IKIIAPPER 95.00% 2.56 0.226 0 518.8315 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IKIIAPPER 95.00% 2.45 0.241 0 518.8316 1,035.65 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% mQKEITALAPSTmK 94.70% 2.4 0.161 0 m1: Oxidation (+15.99), m13: Oxidation (+15.99) 527.6073 1,579.80 1,580.80 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% mQKEITALAPSTmK 95.00% 2.62 0.188 0 m1: Oxidation (+15.99), m13: Oxidation (+15.99) 527.6078 1,579.80 1,580.80 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 3.24 0.439 0 541.953 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 2.91 0.361 0 541.9532 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 3.12 0.482 0 541.9533 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 2.13 0.27 0 541.9533 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 3.17 0.509 0 541.9536 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 2.79 0.523 1.12 541.9537 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 2.82 0.449 0 541.9538 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 2.86 0.382 0 541.9539 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 2.86 0.4 0 541.954 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 2.55 0.378 0 542.288 1,623.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAEREIVR 95.00% 1.85 0.308 0 543.9469 1,628.82 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAEREIVR 95.00% 1.83 0.502 0 543.9474 1,628.82 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAEREIVR 95.00% 2.11 0.316 0 544.2815 1,629.82 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 2.14 0.312 0 m13: Oxidation (+15.99) 547.285 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 3.53 0.339 1.28 m13: Oxidation (+15.99) 547.2855 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 3.61 0.352 0 m13: Oxidation (+15.99) 547.2856 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 4.12 0.377 0 m13: Oxidation (+15.99) 547.2858 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 3.41 0.326 1.48 m13: Oxidation (+15.99) 547.286 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 2.53 0.342 0 m13: Oxidation (+15.99) 547.2862 1,638.84 1,639.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 4.01 0.231 0 m13: Oxidation (+15.99) 547.2865 1,638.84 1,639.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 2.96 0.371 0 m13: Oxidation (+15.99) 547.6191 1,639.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 3.65 0.211 0 m13: Oxidation (+15.99) 547.6191 1,639.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAER 95.00% 2.44 0.332 0 566.6323 1,131.25 1,132.53 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAER 95.00% 3.13 0.511 2.39 566.7686 1,131.52 1,132.53 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAER 95.00% 2.35 0.435 2.92 566.7686 1,131.52 1,132.53 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAER 95.00% 3.46 0.555 2.68 566.7686 1,131.52 1,132.53 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAER 95.00% 2.46 0.462 1.41 566.7687 1,131.52 1,132.53 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAER 95.00% 2.91 0.542 1.7 566.7691 1,131.52 1,132.53 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAER 95.00% 2.64 0.55 3.64 566.7692 1,131.52 1,132.53 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAER 95.00% 2.99 0.549 1.7 566.7694 1,131.52 1,132.53 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAER 95.00% 2.71 0.552 2.19 566.77 1,131.52 1,132.53 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAER 95.00% 2.07 0.277 0 566.7713 1,131.53 1,132.53 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAER 95.00% 2.17 0.358 0 567.2936 1,132.57 1,132.53 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTMK 95.00% 2.6 0.363 0 581.3145 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTMK 95.00% 2.93 0.401 1.72 581.3146 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTMK 95.00% 2.84 0.376 0 581.3148 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTMK 95.00% 2.99 0.395 2.37 581.3152 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTMK 95.00% 2.68 0.317 0 581.3155 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTMK 95.00% 2.6 0.289 0 581.3159 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTMK 95.00% 2.26 0.267 0 581.3161 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTMK 95.00% 2.15 0.286 0 581.815 1,161.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTMK 95.00% 2.17 0.214 1.37 581.8184 1,161.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% ILTERGYSFTTTAER 95.00% 3.42 0.382 0 582.3016 1,743.88 1,744.89 3
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGMGQK 95.00% 2.35 0.439 3.15 586.2905 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGMGQK 95.00% 2.2 0.407 0 586.2907 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGMGQK 95.00% 2.36 0.429 3.17 586.2909 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGMGQK 95.00% 2.53 0.378 3.2 586.2915 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGMGQK 95.00% 3.04 0.499 4.18 586.2923 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGMGQK 95.00% 2.1 0.466 2.49 586.2924 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGMGQK 95.00% 1.94 0.243 2.82 586.2925 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGMGQK 95.00% 1.99 0.339 2.35 586.2927 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGMGQK 95.00% 2.19 0.375 2.85 586.2941 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGMGQK 95.00% 2.25 0.358 3.23 586.2947 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTmK 95.00% 2.86 0.288 0 m10: Oxidation (+15.99) 589.3115 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTmK 95.00% 3.01 0.36 0 m10: Oxidation (+15.99) 589.3116 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTmK 95.00% 2.85 0.223 0 m10: Oxidation (+15.99) 589.3116 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTmK 94.70% 2.76 0.141 0 m10: Oxidation (+15.99) 589.3117 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTmK 95.00% 2.94 0.263 0 m10: Oxidation (+15.99) 589.3118 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTmK 95.00% 2.28 0.251 0 m10: Oxidation (+15.99) 589.3119 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTmK 95.00% 2.87 0.162 0 m10: Oxidation (+15.99) 589.3119 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTmK 95.00% 2.48 0.356 0 m10: Oxidation (+15.99) 589.3121 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% EITALAPSTmK 95.00% 2.87 0.273 1.59 m10: Oxidation (+15.99) 589.3127 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGmGQK 95.00% 2.78 0.4 4.51 m8: Oxidation (+15.99) 594.2888 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVmVGMGQK 95.00% 2.37 0.32 3.8 m5: Oxidation (+15.99) 594.2892 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGmGQK 95.00% 2.78 0.428 3.66 m8: Oxidation (+15.99) 594.2901 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVmVGMGQK 95.00% 2.74 0.433 4.38 m5: Oxidation (+15.99) 594.2904 1,186.57 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.06 0.472 3.6 597.6371 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.4 0.52 3.49 597.6372 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.57 0.458 3.57 597.6376 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 2.43 0.266 0 597.6381 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 2.37 0.272 0 597.6381 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3.03 0.374 0 597.6381 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3 0.408 1.02 597.6389 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.13 0.514 3.62 597.6399 1,789.90 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 2.3 0.279 0 597.6407 1,789.90 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.68 0.469 3.72 597.9713 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.08 0.442 3.43 597.9716 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3.95 0.397 2.17 597.972 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3.48 0.341 1.41 597.9721 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.82 0.526 3 597.9722 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3.01 0.335 1.05 597.9729 1,790.90 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3.19 0.325 1.4 597.9735 1,790.90 1,790.89 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.17 0.285 0 599.3417 1,196.67 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.24 0.293 0 599.3424 1,196.67 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.39 0.245 0 599.3425 1,196.67 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSK 95.00% 3.18 0.408 4.8 599.7672 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSK 95.00% 2.99 0.42 3.39 599.768 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSK 95.00% 3.15 0.422 4.89 599.7687 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSK 95.00% 2.62 0.386 3.01 599.7688 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSK 95.00% 2.27 0.302 3.72 599.7691 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSK 95.00% 2.79 0.383 4.37 599.7695 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSK 95.00% 2.28 0.264 1.77 599.77 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSK 95.00% 1.99 0.234 2.09 599.7704 1,197.53 1,198.52 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSK 95.00% 2.56 0.385 2.82 599.7713 1,197.53 1,198.52 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.46 0.326 0 599.8572 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.19 0.23 0 599.8579 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.55 0.28 0 599.8585 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.66 0.351 0 599.8585 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.68 0.352 0 599.8586 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.48 0.244 0 599.8587 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.39 0.247 0 599.8588 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.5 0.307 0 599.8589 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.74 0.366 0 599.8589 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.37 0.281 0 599.859 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 94.60% 2.11 0.267 0 599.8591 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.14 0.339 0 599.8622 1,197.71 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.33 0.283 0 599.9885 1,197.96 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSK 95.00% 2.37 0.407 2.47 600.275 1,198.53 1,198.52 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% AVFPSIVGRPR 95.00% 2.51 0.33 0 600.3611 1,198.71 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVmVGmGQK 95.00% 2.01 0.203 1.85 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 602.2876 1,202.56 1,203.56 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 4.01 0.0452 1.55 652.0285 1,953.06 1,954.07 3
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 3.72 0.0586 1.42 652.0286 1,953.06 1,954.07 3
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 4.01 0.0807 1.96 652.0288 1,953.06 1,954.07 3
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 3.69 0.0571 1.92 652.0289 1,953.06 1,954.07 3
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 3.83 0.0843 0 652.029 1,953.06 1,954.07 3
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 3.71 0.173 1.08 652.0292 1,953.06 1,954.07 3
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 3.83 0.0819 0 652.0293 1,953.06 1,954.07 3
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSKR 95.00% 2.6 0.418 2.49 677.8196 1,353.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSKR 95.00% 2.6 0.53 4.09 677.82 1,353.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSKR 95.00% 3.05 0.509 5.05 677.8207 1,353.63 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSKR 95.00% 2.35 0.502 0 677.8211 1,353.63 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSKR 95.00% 2.22 0.44 1.31 677.8225 1,353.63 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DSYVGDEAQSKR 95.00% 2.36 0.318 0 677.8232 1,353.63 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% qEYDESGPSIVHR 95.00% 0 0 4.28 n-term: Pyro-cmC (-17.03) 750.3451 1,498.67 1,499.68 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% qEYDESGPSIVHR 95.00% 0 0 3.57 n-term: Pyro-cmC (-17.03) 750.3451 1,498.67 1,499.68 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% qEYDESGPSIVHR 95.00% 0 0 3.52 n-term: Pyro-cmC (-17.03) 750.8463 1,499.68 1,499.68 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% IWHHTFYNELR 95.00% 2.69 0.411 1.92 758.38 1,514.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% QEYDESGPSIVHR 95.00% 2.75 0.414 4.55 758.857 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% QEYDESGPSIVHR 95.00% 2.85 0.445 4.49 758.8579 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% QEYDESGPSIVHR 95.00% 2.59 0.446 3.92 758.8581 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% QEYDESGPSIVHR 95.00% 2.6 0.463 4.77 758.859 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% QEYDESGPSIVHR 95.00% 2.47 0.442 5.89 758.8591 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.14 0.556 4.52 784.6989 2,351.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.46 0.622 3.35 m8: Oxidation (+15.99) 790.0323 2,367.07 2,367.07 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.23 0.646 5.29 m8: Oxidation (+15.99) 790.0328 2,367.07 2,367.07 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.7 0.695 3.07 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3647 2,383.07 2,383.07 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 2.47 0.347 0 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3663 2,383.08 2,383.07 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.46 0.564 3.54 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3664 2,383.08 2,383.07 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.85 0.583 3.12 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3674 2,383.08 2,383.07 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.32 0.591 1.96 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3675 2,383.08 2,383.07 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 2.61 0.396 1.24 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3677 2,383.08 2,383.07 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 4.33 0.585 1.6 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3685 2,383.08 2,383.07 3 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 3.01 0.304 2.68 812.4243 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 3.31 0.392 3.47 812.4261 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 3.28 0.385 2.92 812.4264 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 3.19 0.37 2.96 812.4265 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 3.18 0.32 3.49 812.4265 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 3.18 0.31 2.74 812.427 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 3.09 0.379 2.48 812.4273 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLMK 95.00% 3.06 0.373 3.06 812.4283 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAEREIVR 95.00% 2.83 0.329 0 815.4198 1,628.82 1,629.82 2 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% GYSFTTTAEREIVR 95.00% 2.85 0.245 0 815.9203 1,629.82 1,629.82 2 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 2.8 0.0843 2.48 m13: Oxidation (+15.99) 820.4238 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 3.13 0.184 3.04 m13: Oxidation (+15.99) 820.4242 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 3.08 0.221 2.66 m13: Oxidation (+15.99) 820.4242 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 3.23 0.216 3.21 m13: Oxidation (+15.99) 820.4243 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 3.25 0.193 3.14 m13: Oxidation (+15.99) 820.4244 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 3.09 0.148 3.03 m13: Oxidation (+15.99) 820.4245 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LDLAGRDLTDYLmK 95.00% 2.71 0.139 1.55 m13: Oxidation (+15.99) 820.4246 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.86 0.614 6.74 895.951 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.59 0.553 6.35 895.9514 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.73 0.572 5.34 895.9514 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.49 0.625 5.89 895.9514 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.71 0.627 6.17 895.9515 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.64 0.613 7.24 895.9519 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.6 0.554 5.89 895.952 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.68 0.518 5.85 895.952 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.69 0.557 5.41 895.9521 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.36 0.615 4.59 895.9522 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.15 0.597 7.28 895.9522 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.43 0.586 4.68 895.9524 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.66 0.543 6 895.9524 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.76 0.608 4.6 895.9526 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.42 0.589 6.77 895.953 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.95 0.625 5.38 895.9532 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.87 0.586 5.8 895.9534 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.41 0.578 6.17 895.9534 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.75 0.587 5.11 895.9535 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.55 0.599 5.16 895.9541 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.44 0.566 6.19 895.9543 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.83 0.629 5.85 895.9547 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3.99 0.51 7.89 895.9547 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.42 0.603 6 895.9558 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.48 0.552 4.43 895.9564 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 2.96 0.254 4.1 895.9564 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.46 0.565 4.77 895.9568 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.02 0.554 5.4 895.9569 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3.08 0.472 3.46 895.9585 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3.97 0.56 4.72 895.9594 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3.31 0.514 4.92 895.9612 1,789.91 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.94 0.591 5.37 896.4521 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.83 0.613 4.49 896.4527 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.76 0.511 4.82 896.4532 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.84 0.585 5.43 896.4539 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3.68 0.548 6.52 896.4551 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.21 0.501 5.08 896.4552 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.54 0.515 5.74 896.4554 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 4.61 0.593 4.82 896.456 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3.59 0.469 2.28 896.4604 1,790.91 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% SYELPDGQVITIGNER 95.00% 3.79 0.505 5.33 896.4617 1,790.91 1,790.89 2 ACTC_HUMAN
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 4.59 0.359 6.55 977.5373 1,953.06 1,954.07 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 4.6 0.353 4.57 977.5376 1,953.06 1,954.07 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 4.42 0.369 5.59 977.5395 1,953.06 1,954.07 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 4.45 0.101 5.09 978.0392 1,954.06 1,954.07 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 4.5 0.101 6.04 978.0393 1,954.06 1,954.07 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% VAPEEHPVLLTEAPLNPK 95.00% 4.36 0.117 4.96 978.0415 1,954.07 1,954.07 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLYANTVLSGGTTMYPGIADR 95.00% 6.76 0.436 5.26 1,108.54 2,215.07 2,215.07 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% DLYANTVLSGGTTMYPGIADR 95.00% 6.62 0.421 4.39 1,108.54 2,215.07 2,215.07 2
 SAMPLE 4R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 41 53.90% LcYVALDFEQEMATAASSSSLEK 95.00% 6.94 0.33 8.62 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.17 2,550.17 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.13 0.434 0 473.2781 944.5406 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.1 0.4 0 473.2786 944.5416 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.03 0.415 0 473.2789 944.5421 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.08 0.412 0 473.2789 944.5421 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 1.84 0.324 0 473.2789 944.5422 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.24 0.426 0 473.279 944.5423 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.14 0.433 0 473.2791 944.5425 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.1 0.435 0 473.2791 944.5426 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.22 0.427 0 473.2791 944.5426 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.24 0.419 0 473.2793 944.5429 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.08 0.449 0 473.2794 944.5432 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.29 0.412 0 473.2796 944.5435 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.31 0.459 0 473.2797 944.5438 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.17 0.337 0 473.2798 944.544 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.31 0.388 0 473.2799 944.5441 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.08 0.43 0 473.2804 944.5451 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 2.26 0.402 0 473.2817 944.5478 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGR 95.00% 1.95 0.376 0 473.2844 944.5531 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AGFAGDDAPR 95.00% 2.39 0.406 0 488.7271 975.4386 976.449 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2.17 0.425 0 499.7451 997.4746 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 1.97 0.388 1.32 499.7455 997.4753 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2.1 0.422 0 499.7458 997.4759 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2.09 0.413 0 499.7459 997.4761 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2.04 0.286 0 499.746 997.4764 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 1.91 0.385 0 499.746 997.4764 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2.03 0.327 1.33 499.7462 997.4767 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2.19 0.403 0 499.7462 997.4767 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2 0.402 0 499.7462 997.4768 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2.08 0.432 0 499.7468 997.478 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 1.93 0.361 0 499.7474 997.4792 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 1.77 0.248 1.25 499.7474 997.4792 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2.18 0.308 0 499.7509 997.4862 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2.62 0.398 0 499.7529 997.4901 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2.49 0.424 0 499.7536 997.4916 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2.14 0.347 0 499.7548 997.4939 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLMK 95.00% 2.28 0.457 1.51 499.7551 997.4945 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% IWHHTFYNELR 95.00% 3.54 0.454 1.74 505.919 1,514.73 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% IWHHTFYNELR 95.00% 3.55 0.385 1.49 505.9216 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% IWHHTFYNELR 95.00% 3.34 0.404 1.29 505.9217 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 2.83 0.51 0 506.237 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 1.69 0.449 0 506.237 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 3.12 0.495 0 506.2372 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 2.41 0.454 0 506.2375 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 2.93 0.468 0 506.2376 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 2.65 0.456 0 506.2379 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 3.18 0.452 0 506.238 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 3.2 0.531 0 506.238 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 3.2 0.448 1.36 506.2385 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 3.36 0.535 0 506.2386 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 2.06 0.285 0 506.239 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 2.73 0.37 0 506.2393 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% IWHHTFYNELR 95.00% 3.48 0.333 0 506.2544 1,515.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLTDYLmK 95.00% 2.19 0.306 0 m7: Oxidation (+15.99) 507.7427 1,013.47 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% IKIIAPPER 95.00% 2.38 0.236 0 518.8272 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% IKIIAPPER 95.00% 2.2 0.228 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% IKIIAPPER 95.00% 2.18 0.247 0 518.8284 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% IKIIAPPER 95.00% 1.98 0.326 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% IKIIAPPER 95.00% 1.99 0.292 0 518.8287 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% IKIIAPPER 95.00% 2.23 0.216 0 518.8298 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLMK 95.00% 2.5 0.367 0 541.9499 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLMK 95.00% 3.12 0.357 0 541.9503 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLMK 95.00% 2.24 0.28 0 541.955 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLMK 95.00% 2.45 0.281 0 542.2871 1,623.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% GYSFTTTAEREIVR 95.00% 2.03 0.212 0 543.9448 1,628.81 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% GYSFTTTAEREIVR 95.00% 2.33 0.426 0 544.278 1,629.81 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLmK 95.00% 3.33 0.35 0 m13: Oxidation (+15.99) 547.2817 1,638.82 1,639.84 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLmK 95.00% 2.98 0.324 0 m13: Oxidation (+15.99) 547.2825 1,638.82 1,639.84 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLmK 95.00% 4.1 0.302 1.12 m13: Oxidation (+15.99) 547.2857 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLmK 95.00% 2.64 0.215 0 m13: Oxidation (+15.99) 547.2888 1,638.84 1,639.84 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLmK 95.00% 3.98 0.258 0 m13: Oxidation (+15.99) 547.6166 1,639.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% GYSFTTTAER 95.00% 3.28 0.572 3.06 566.7661 1,131.52 1,132.53 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% GYSFTTTAER 95.00% 2.69 0.495 2 566.7663 1,131.52 1,132.53 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% GYSFTTTAER 95.00% 2.81 0.529 1.28 566.7665 1,131.52 1,132.53 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% GYSFTTTAER 95.00% 2.98 0.538 1.7 566.7669 1,131.52 1,132.53 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% GYSFTTTAER 95.00% 3.2 0.564 2.89 566.7674 1,131.52 1,132.53 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTMK 95.00% 2.74 0.375 0 581.3109 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTMK 95.00% 2.65 0.385 0 581.3117 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTMK 95.00% 3.2 0.391 2.22 581.3125 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTMK 95.00% 2.94 0.416 2.47 581.3136 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTMK 95.00% 2.43 0.332 0 581.3137 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTMK 95.00% 2.36 0.268 0 581.3161 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTMK 95.00% 2.45 0.343 0 581.3208 1,160.63 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% HQGVMVGMGQK 95.00% 2.03 0.33 1.28 586.2878 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% HQGVMVGMGQK 95.00% 2.4 0.418 3.59 586.288 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% HQGVMVGMGQK 95.00% 2.28 0.428 3.92 586.2881 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% HQGVMVGMGQK 95.00% 2.78 0.32 2.09 586.2883 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% HQGVMVGMGQK 95.00% 2.67 0.475 4.72 586.2891 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% HQGVMVGMGQK 95.00% 2.55 0.464 3.8 586.2893 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTmK 95.00% 2.33 0.257 0 m10: Oxidation (+15.99) 589.3088 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTmK 95.00% 2.65 0.296 0 m10: Oxidation (+15.99) 589.3089 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTmK 95.00% 2.77 0.256 1.89 m10: Oxidation (+15.99) 589.309 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTmK 95.00% 2.99 0.282 1.2 m10: Oxidation (+15.99) 589.3092 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTmK 95.00% 2.66 0.211 0 m10: Oxidation (+15.99) 589.3125 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% EITALAPSTmK 95.00% 2.69 0.247 2.17 m10: Oxidation (+15.99) 589.3132 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 2.97 0.392 0 597.6323 1,789.87 1,790.89 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.25 0.491 2.38 597.6335 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.13 0.49 2.8 597.635 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.42 0.392 4.08 597.6475 1,789.92 1,790.89 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 5.19 0.492 3.08 597.9691 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.73 0.334 1.26 599.8549 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.73 0.372 0 599.855 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.96 0.364 0 599.8554 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.76 0.376 0 599.8555 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.81 0.335 0 599.8557 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.55 0.344 0 599.856 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.69 0.332 0 599.8562 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.47 0.299 0 599.8562 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.56 0.271 0 599.8563 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.43 0.326 0 599.8564 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.16 0.319 0 599.8565 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.57 0.335 0 599.8568 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% AVFPSIVGRPR 95.00% 2.77 0.225 0 599.859 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 3.99 0.0398 2 652.3599 1,954.06 1,954.07 3
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.14 0.0805 1.43 652.3602 1,954.06 1,954.07 3
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 3.9 0.0573 1.03 652.361 1,954.06 1,954.07 3
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% qEYDESGPSIVHR 95.00% 0 0 3.62 n-term: Pyro-cmC (-17.03) 750.3451 1,498.67 1,499.68 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 2.51 0.453 2.68 758.8537 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 2.37 0.406 3.68 758.8546 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 2.64 0.372 2.85 758.8549 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 2.52 0.373 1.37 758.8556 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% QEYDESGPSIVHR 95.00% 1.89 0.303 1.92 758.8592 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLMK 95.00% 3.21 0.368 1.14 812.4218 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLMK 95.00% 2.19 0.247 1.32 812.4256 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLMK 95.00% 2.95 0.305 2.2 812.4337 1,622.85 1,623.84 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLMK 95.00% 3.13 0.358 3.02 812.4381 1,622.86 1,623.84 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLMK 95.00% 3.12 0.385 2.54 812.9229 1,623.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLMK 95.00% 2.94 0.3 1.55 812.9242 1,623.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLMK 95.00% 3.16 0.32 2.06 812.9243 1,623.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLmK 95.00% 2.76 0.256 0 m13: Oxidation (+15.99) 820.4196 1,638.82 1,639.84 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLmK 95.00% 2.84 0.202 1.72 m13: Oxidation (+15.99) 820.4201 1,638.82 1,639.84 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LDLAGRDLTDYLmK 95.00% 3.01 0.212 3.66 m13: Oxidation (+15.99) 820.4252 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.63 0.613 6.14 895.9469 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.84 0.634 5.64 895.9472 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.82 0.63 5.77 895.9478 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.77 0.626 5.39 895.9482 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.74 0.609 6.25 895.9483 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.82 0.632 5.66 895.9484 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.33 0.625 5.43 895.9485 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.68 0.605 5.49 895.9489 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 2.49 0.187 3.77 895.9494 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 3.45 0.422 3.96 895.9494 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.39 0.593 5.64 895.9496 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.47 0.539 6.15 895.9497 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 3.27 0.465 4.54 895.9505 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 2.94 0.363 4.03 895.9544 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 2.82 0.447 3.36 895.956 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.53 0.634 5.8 895.9568 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.36 0.603 6 895.9594 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.43 0.566 6.35 895.9602 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 3.32 0.56 5.38 895.9602 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.81 0.618 5.34 895.9652 1,789.91 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.61 0.62 5.49 895.9666 1,789.92 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.41 0.512 5 895.9666 1,789.92 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.72 0.617 4.96 895.9674 1,789.92 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.63 0.589 5.24 896.4487 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.32 0.573 4.57 896.4491 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.53 0.588 4.42 896.4499 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.76 0.592 4.15 896.4509 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.72 0.599 6 896.4509 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 3.82 0.535 4.05 896.454 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 3.7 0.479 4.85 896.4544 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 4.4 0.515 4.82 896.4593 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% SYELPDGQVITIGNER 95.00% 3.28 0.497 3.19 896.4649 1,790.91 1,790.89 2 ACTC_HUMAN
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.26 0.318 3.74 977.5324 1,953.05 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.01 0.342 3.82 977.5334 1,953.05 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.45 0.375 5.33 977.5354 1,953.06 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.02 0.333 4.92 977.537 1,953.06 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.55 0.228 6.59 978.0327 1,954.05 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.37 0.261 4.92 978.0345 1,954.05 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.64 0.256 5.42 978.035 1,954.05 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.28 0.292 4.72 978.0353 1,954.06 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 3.89 0.292 4.01 978.0354 1,954.06 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.71 0.231 5.42 978.0354 1,954.06 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.45 0.255 4.82 978.0363 1,954.06 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.54 0.238 4.13 978.037 1,954.06 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.22 0.314 5.47 978.037 1,954.06 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.38 0.208 4.49 978.0372 1,954.06 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.41 0.198 4.16 978.0458 1,954.08 1,954.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLYANTVLSGGTTMYPGIADR 95.00% 4.35 0.593 3.17 1,108.05 2,214.08 2,215.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLYANTVLSGGTTMYPGIADR 95.00% 3.97 0.436 2.72 1,108.54 2,215.06 2,215.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLYANTVLSGGTTMYPGIADR 95.00% 5.65 0.412 7.7 1,108.54 2,215.06 2,215.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLYANTVLSGGTTMYPGIADR 95.00% 5.5 0.409 7.33 1,108.54 2,215.06 2,215.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLYANTVLSGGTTMYPGIADR 95.00% 5.76 0.403 6.66 1,108.54 2,215.06 2,215.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLYANTVLSGGTTMYPGIADR 95.00% 4.73 0.314 4.37 1,108.55 2,215.09 2,215.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLYANTVLSGGTTMYPGIADR 95.00% 4.82 0.374 4.85 1,108.55 2,215.09 2,215.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% DLYANTVLSGGTTMYPGIADR 95.00% 4.88 0.353 6.26 1,108.55 2,215.09 2,215.07 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LcYVALDFEQEMATAASSSSLEK 95.00% 5.91 0.311 4.68 c2: Carbamidomethyl (+57.02) 1,276.11 2,550.20 2,550.17 2
 SAMPLE 1 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 51 48.50% LcYVALDFEQEMATAASSSSLEK 95.00% 5.65 0.294 6.85 c2: Carbamidomethyl (+57.02) 1,276.11 2,550.21 2,550.17 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 94.90% 1.75 0.309 0 473.2781 944.5406 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 1.98 0.397 0 473.2785 944.5414 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 1.98 0.357 0 473.2787 944.5417 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 2.15 0.445 0 473.2788 944.542 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 2.03 0.403 0 473.2788 944.542 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 2.13 0.408 0 473.2789 944.5421 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 1.91 0.363 0 473.279 944.5423 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 1.95 0.343 0 473.2791 944.5426 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 2.2 0.408 0 473.2792 944.5428 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 2.11 0.454 0 473.2793 944.5429 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 2.31 0.459 0 473.2797 944.5438 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 2.1 0.404 0 473.2798 944.5439 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 2.1 0.389 0 473.2802 944.5447 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 2.26 0.402 0 473.2817 944.5478 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGR 95.00% 1.95 0.376 0 473.2844 944.5531 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AGFAGDDAPR 95.00% 2.39 0.406 0 488.7271 975.4386 976.449 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AGFAGDDAPR 95.00% 2.36 0.28 2.48 488.729 975.4424 976.449 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLTDYLMK 95.00% 2.04 0.366 0 499.7454 997.4751 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLTDYLMK 95.00% 2.2 0.481 0 499.7458 997.4759 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLTDYLMK 95.00% 2 0.41 1.19 499.7459 997.4762 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLTDYLMK 95.00% 1.99 0.335 0 499.7462 997.4767 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLTDYLMK 95.00% 2.18 0.396 0 499.7463 997.4769 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLTDYLMK 95.00% 2.11 0.423 0 499.7479 997.4801 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLTDYLMK 95.00% 2.18 0.308 0 499.7509 997.4862 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLTDYLMK 95.00% 2.49 0.424 0 499.7536 997.4916 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLTDYLMK 95.00% 2.25 0.417 1.15 499.7547 997.4938 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLTDYLMK 95.00% 2.03 0.321 0 499.7553 997.495 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLTDYLMK 95.00% 2.55 0.445 1.12 499.7555 997.4953 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% IWHHTFYNELR 95.00% 3.32 0.445 1.28 505.9186 1,514.73 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% IWHHTFYNELR 95.00% 2.87 0.349 0 505.9193 1,514.73 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% IWHHTFYNELR 95.00% 2.28 0.211 0 505.9195 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% IWHHTFYNELR 95.00% 3.24 0.278 0 505.9195 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 2.44 0.413 0 506.2376 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 3.11 0.488 0 506.2376 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 3.01 0.456 0 506.2379 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 2.47 0.447 0 506.2379 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 2.96 0.487 0 506.2381 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 2.5 0.359 0 506.2382 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 3.28 0.508 0 506.2384 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 2.18 0.237 0 506.2385 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 3.22 0.503 0 506.2385 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 3.02 0.464 0 506.2385 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 2.98 0.491 0 506.2388 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 3.16 0.548 0 506.2399 1,515.70 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLTDYLmK 95.00% 2 0.312 0 m7: Oxidation (+15.99) 507.7442 1,013.47 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% IKIIAPPER 95.00% 2.12 0.25 0 518.8271 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% IKIIAPPER 95.00% 2.17 0.247 0 518.8282 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% IKIIAPPER 95.00% 2.55 0.205 0 518.8287 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% IKIIAPPER 94.50% 2.11 0.217 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLMK 95.00% 2.6 0.32 0 541.9493 1,622.82 1,623.84 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLMK 95.00% 2.24 0.28 0 541.955 1,622.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLMK 95.00% 2.01 0.287 0 541.9616 1,622.86 1,623.84 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLMK 95.00% 2.44 0.417 0 541.9618 1,622.86 1,623.84 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLmK 95.00% 3.55 0.331 1.28 m13: Oxidation (+15.99) 547.2831 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLmK 95.00% 3.96 0.27 0 m13: Oxidation (+15.99) 547.2831 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLmK 95.00% 2.64 0.215 0 m13: Oxidation (+15.99) 547.2888 1,638.84 1,639.84 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLmK 95.00% 2.08 0.301 0 m13: Oxidation (+15.99) 547.2888 1,638.84 1,639.84 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% GYSFTTTAER 95.00% 3.14 0.567 2.24 566.7648 1,131.51 1,132.53 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% GYSFTTTAER 95.00% 3.09 0.564 2.82 566.7649 1,131.51 1,132.53 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% GYSFTTTAER 95.00% 3.1 0.505 2.64 566.7652 1,131.51 1,132.53 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% GYSFTTTAER 95.00% 3 0.518 1.62 566.7656 1,131.52 1,132.53 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% GYSFTTTAER 95.00% 2.87 0.505 2.29 566.7659 1,131.52 1,132.53 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% GYSFTTTAER 95.00% 2.84 0.495 2.92 566.7661 1,131.52 1,132.53 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% GYSFTTTAER 95.00% 2.94 0.492 2.12 566.7662 1,131.52 1,132.53 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% GYSFTTTAER 95.00% 2.75 0.494 3.39 566.7664 1,131.52 1,132.53 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% GYSFTTTAER 95.00% 2.81 0.529 1.29 566.7665 1,131.52 1,132.53 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% GYSFTTTAER 95.00% 1.83 0.339 0 566.9759 1,131.94 1,132.53 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% GYSFTTTAER 95.00% 2.72 0.229 0 567.3258 1,132.64 1,132.53 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% EITALAPSTMK 95.00% 2.26 0.238 0 581.3113 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% EITALAPSTMK 95.00% 3.01 0.394 1.92 581.3113 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% EITALAPSTMK 95.00% 2.12 0.345 0 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% EITALAPSTMK 95.00% 2.2 0.333 0 581.3122 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% EITALAPSTMK 95.00% 2.9 0.375 2.21 581.3123 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% EITALAPSTMK 95.00% 2.58 0.382 0 581.3127 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% EITALAPSTMK 95.00% 2.36 0.268 0 581.3161 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% HQGVMVGMGQK 95.00% 2.49 0.318 3.38 586.2877 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% HQGVMVGMGQK 95.00% 2.55 0.443 5.7 586.2878 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% HQGVMVGMGQK 95.00% 2.78 0.32 2.31 586.2883 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% HQGVMVGMGQK 95.00% 2.65 0.467 2.54 586.289 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% HQGVMVGMGQK 95.00% 1.94 0.288 2.07 586.2897 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% HQGVMVGMGQK 95.00% 1.9 0.292 3.25 586.2898 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% HQGVMVGMGQK 95.00% 1.8 0.344 1.15 586.2899 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% EITALAPSTmK 95.00% 2.72 0.28 0 m10: Oxidation (+15.99) 589.3097 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% EITALAPSTmK 95.00% 2.66 0.163 0 m10: Oxidation (+15.99) 589.3106 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% EITALAPSTmK 95.00% 2.67 0.264 1.66 m10: Oxidation (+15.99) 589.3108 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% EITALAPSTmK 95.00% 2.69 0.247 2.11 m10: Oxidation (+15.99) 589.3132 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 2.97 0.392 0 597.6323 1,789.87 1,790.89 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.55 0.499 3.02 597.6347 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 2.88 0.35 0 597.6348 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 3.54 0.35 1.14 597.6353 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.93 0.487 3.02 597.6359 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 3.3 0.359 1.6 597.6362 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.3 0.407 0 597.6467 1,789.92 1,790.89 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 3.87 0.431 2.03 597.9689 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.38 0.461 2.74 597.9805 1,790.92 1,790.89 3 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.38 0.279 0 599.8539 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.61 0.275 0 599.8549 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.71 0.335 0 599.8551 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.24 0.271 0 599.8551 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.84 0.33 0 599.8556 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.43 0.264 0 599.8557 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.32 0.214 0 599.8557 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.48 0.285 0 599.8559 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.59 0.334 0 599.856 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.3 0.206 1.28 599.8564 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.35 0.299 0 599.8568 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.33 0.265 0 599.8569 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% AVFPSIVGRPR 95.00% 2.77 0.225 0 599.859 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 3.66 0.0444 1.14 652.0255 1,953.05 1,954.07 3
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 3.91 0.108 0 652.3599 1,954.06 1,954.07 3
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.17 0.108 0 652.36 1,954.06 1,954.07 3
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 3.89 0.0844 1.01 652.3607 1,954.06 1,954.07 3
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 2.59 0.442 3.54 758.8535 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 2.75 0.472 2.92 758.8546 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 2.47 0.453 4.52 758.8551 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% QEYDESGPSIVHR 95.00% 1.89 0.303 1.8 758.8592 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% MQKEITALAPSTMK 95.00% 3.88 0.348 2.23 774.9079 1,547.80 1,548.81 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% MQKEITALAPSTMK 95.00% 4.08 0.392 2.54 774.9121 1,547.81 1,548.81 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% KDLYANTVLSGGTTMYPGIADR 95.00% 4.78 0.409 0 782.062 2,343.16 2,343.17 3
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLMK 95.00% 3.28 0.338 1.38 812.4233 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLMK 95.00% 3.3 0.307 0 812.4245 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLMK 95.00% 2.19 0.247 1.57 812.4256 1,622.84 1,623.84 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLMK 95.00% 2.95 0.305 2.1 812.4337 1,622.85 1,623.84 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LDLAGRDLTDYLMK 95.00% 3.22 0.384 2.62 812.4386 1,622.86 1,623.84 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.99 0.608 5.62 895.946 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.59 0.532 5.55 895.9465 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.68 0.596 6.07 895.9477 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.82 0.62 5.09 895.9482 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 2.94 0.425 2.36 895.9503 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 2.78 0.284 3.62 895.9504 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 3.27 0.465 4.6 895.9505 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.63 0.557 5.08 895.9508 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.6 0.572 4.55 895.9523 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 2.82 0.447 2.89 895.956 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.53 0.634 5.7 895.9568 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.55 0.541 4.23 895.9588 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.36 0.603 5.11 895.9594 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.43 0.566 6.22 895.9602 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 3.32 0.56 5.42 895.9602 1,789.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 2.36 0.203 1.41 895.9648 1,789.91 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.29 0.533 5.38 895.9649 1,789.91 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 3.93 0.553 5.39 895.9657 1,789.92 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.32 0.535 5.89 895.966 1,789.92 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 3.18 0.55 5.55 895.966 1,789.92 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.8 0.551 4.49 895.9662 1,789.92 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 2.1 0.355 0 896.4218 1,790.83 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 3.22 0.461 3.28 896.4442 1,790.87 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.48 0.562 4.55 896.4467 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.73 0.597 4.43 896.4494 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.79 0.572 4.96 896.4495 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.85 0.574 5.55 896.4495 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.8 0.571 5.8 896.4497 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.7 0.546 4.77 896.4505 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.03 0.55 3.52 896.4515 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 2.36 0.177 1.42 896.4537 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 4.4 0.515 4.38 896.4593 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% SYELPDGQVITIGNER 95.00% 3.28 0.497 2.64 896.4649 1,790.91 1,790.89 2 ACTC_HUMAN
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.06 0.319 4.57 977.5332 1,953.05 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 3.59 0.338 4.43 977.536 1,953.06 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.2 0.331 5.85 977.5365 1,953.06 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.27 0.286 4.92 978.0316 1,954.05 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.36 0.163 4.92 978.0345 1,954.05 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.28 0.16 7.17 978.0347 1,954.05 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.51 0.156 6.02 978.0347 1,954.05 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.29 0.231 4.54 978.0349 1,954.05 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 3.98 0.319 3.34 978.0351 1,954.05 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.6 0.173 5.12 978.0352 1,954.05 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.12 0.313 5.14 978.0358 1,954.06 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.13 0.326 4.68 978.0374 1,954.06 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.41 0.198 5.17 978.0458 1,954.08 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% VAPEEHPVLLTEAPLNPK 95.00% 4.42 0.32 5.52 978.0559 1,954.10 1,954.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLYANTVLSGGTTMYPGIADR 95.00% 6.43 0.402 6.92 1,108.54 2,215.06 2,215.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLYANTVLSGGTTMYPGIADR 95.00% 5.67 0.407 6.3 1,108.54 2,215.06 2,215.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLYANTVLSGGTTMYPGIADR 95.00% 4.82 0.374 5 1,108.55 2,215.09 2,215.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLYANTVLSGGTTMYPGIADR 95.00% 4.88 0.353 7 1,108.55 2,215.09 2,215.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% DLYANTVLSGGTTmYPGIADR 95.00% 5.88 0.676 5.59 m14: Oxidation (+15.99) 1,116.53 2,231.05 2,231.07 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LcYVALDFEQEMATAASSSSLEK 95.00% 5.11 0.322 6.43 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.16 2,550.17 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LcYVALDFEQEMATAASSSSLEK 95.00% 5.91 0.311 4.24 c2: Carbamidomethyl (+57.02) 1,276.11 2,550.20 2,550.17 2
 SAMPLE 1R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 8 54 48.50% LcYVALDFEQEMATAASSSSLEK 95.00% 5.65 0.294 6.42 c2: Carbamidomethyl (+57.02) 1,276.11 2,550.21 2,550.17 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DSYVGDEAQSKR 95.00% 2.09 0.195 0 452.2146 1,353.62 1,354.62 3 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DSYVGDEAQSKR 95.00% 2.65 0.366 0 452.2147 1,353.62 1,354.62 3 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DSYVGDEAQSKR 95.00% 2.46 0.345 0 452.2155 1,353.62 1,354.62 3 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2 0.41 0 473.278 944.5403 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.12 0.42 0 473.2781 944.5406 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.12 0.427 0 473.2782 944.5407 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.1 0.43 0 473.2785 944.5414 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.12 0.435 0 473.2786 944.5415 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.09 0.434 0 473.2789 944.5421 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.09 0.392 0 473.2789 944.5422 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.09 0.437 0 473.279 944.5424 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.02 0.419 0 473.279 944.5424 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.19 0.379 0 473.2791 944.5425 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.14 0.46 0 473.2791 944.5426 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.27 0.507 0 473.2793 944.5429 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 1.99 0.405 0 473.2793 944.543 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 1.9 0.374 0 473.2794 944.5432 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.2 0.328 0 473.2795 944.5434 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.21 0.387 0 473.2796 944.5435 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.16 0.426 0 473.2796 944.5436 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.23 0.416 0 473.2798 944.5439 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.14 0.398 0 473.2799 944.5442 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.03 0.351 0 473.2801 944.5446 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.12 0.383 0 473.2801 944.5446 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.02 0.34 0 473.2804 944.5452 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.09 0.349 0 473.2807 944.5457 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.32 0.421 0 473.2811 944.5465 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 1.94 0.493 0 473.2811 944.5466 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 1.89 0.343 0 473.2812 944.5468 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 1.91 0.386 0 473.2816 944.5476 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGR 95.00% 2.22 0.494 0 473.2819 944.5482 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AGFAGDDAPR 95.00% 3.37 0.45 1.68 488.7264 975.4372 976.449 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AGFAGDDAPR 95.00% 3.45 0.475 1.68 488.727 975.4384 976.449 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AGFAGDDAPR 95.00% 3.28 0.455 1.49 488.727 975.4384 976.449 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AGFAGDDAPR 95.00% 2.65 0.365 1.41 488.7271 975.4386 976.449 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AGFAGDDAPR 95.00% 3.39 0.383 1.52 488.7274 975.4391 976.449 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AGFAGDDAPR 95.00% 3.12 0.398 0 488.7274 975.4392 976.449 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AGFAGDDAPR 95.00% 2.69 0.31 1.51 488.7286 975.4416 976.449 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AGFAGDDAPR 95.00% 2.98 0.387 1.54 488.7293 975.4429 976.449 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 1.95 0.396 0 499.7448 997.474 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.19 0.406 0 499.7451 997.4745 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.06 0.367 1.28 499.7455 997.4754 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 1.98 0.351 0 499.7456 997.4756 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.09 0.368 0 499.7457 997.4757 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.03 0.379 1.15 499.7458 997.4759 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.18 0.407 1.48 499.7458 997.476 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 1.97 0.399 1.72 499.7458 997.476 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 1.79 0.287 1.43 499.7459 997.4762 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.09 0.422 0 499.746 997.4763 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.03 0.353 1.52 499.746 997.4763 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.09 0.397 1.19 499.746 997.4763 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 1.92 0.378 0 499.7462 997.4767 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 1.97 0.392 0 499.7462 997.4767 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.2 0.381 0 499.7462 997.4767 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 1.84 0.339 0 499.7465 997.4773 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.23 0.448 1.18 499.7466 997.4776 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.42 0.44 0 499.7467 997.4778 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.16 0.413 0 499.7467 997.4778 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.08 0.376 1.41 499.7468 997.478 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.18 0.428 0 499.7472 997.4787 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.56 0.373 0 499.7477 997.4797 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.27 0.376 0 499.748 997.4804 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.35 0.381 0 499.7482 997.4807 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.38 0.302 0 499.7485 997.4814 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLMK 95.00% 2.31 0.345 0 499.7487 997.4817 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IWHHTFYNELR 95.00% 2.75 0.38 0 505.9194 1,514.73 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IWHHTFYNELR 95.00% 3.51 0.398 1.54 505.92 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IWHHTFYNELR 95.00% 3.13 0.378 0 505.92 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IWHHTFYNELR 95.00% 3.69 0.481 1.59 505.9208 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IWHHTFYNELR 95.00% 3.32 0.441 0 505.921 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.24 0.311 0 506.237 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.89 0.47 0 506.2372 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 3.51 0.541 0 506.2377 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 3.04 0.399 0 506.2378 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 3.38 0.535 0 506.2379 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 3.08 0.483 0 506.2381 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.73 0.453 0 506.2381 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.38 0.326 0 506.2381 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 3.01 0.476 0 506.2382 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.62 0.425 0 506.2383 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.84 0.479 0 506.2383 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.98 0.461 0 506.2383 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 3.23 0.507 0 506.2383 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.96 0.512 0 506.2386 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.86 0.437 0 506.2386 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 3.38 0.495 0 506.2387 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 3 0.438 0 506.2389 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 3.17 0.495 0 506.239 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 3.2 0.497 0 506.2391 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 3.07 0.425 0 506.2393 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IWHHTFYNELR 95.00% 3.04 0.422 0 506.2542 1,515.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IWHHTFYNELR 95.00% 3.32 0.379 0 506.2546 1,515.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IWHHTFYNELR 95.00% 2.42 0.302 0 506.2556 1,515.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLmK 95.00% 1.96 0.261 0 m7: Oxidation (+15.99) 507.7418 1,013.47 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLTDYLmK 95.00% 2.06 0.278 0 m7: Oxidation (+15.99) 507.7431 1,013.47 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% MQKEITALAPSTMK 95.00% 2.31 0.214 0 516.9419 1,547.80 1,548.81 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% MQKEITALAPSTMK 95.00% 3.24 0.26 0 517.2758 1,548.80 1,548.81 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.51 0.247 0 518.8275 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.13 0.25 0 518.8275 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.4 0.233 0 518.828 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.58 0.218 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.19 0.251 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.6 0.224 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.52 0.229 0 518.8287 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.53 0.222 0 518.8287 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.64 0.229 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.36 0.222 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.5 0.22 0 518.8289 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.28 0.26 0 518.8289 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.03 0.273 0 518.8292 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.12 0.323 0 518.8293 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IKIIAPPER 95.00% 2.3 0.251 0 518.8294 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 2.66 0.477 0 541.9503 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.05 0.445 0 541.9504 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.14 0.531 2.26 541.9508 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 2.89 0.393 0 541.9511 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 2.55 0.406 0 541.9513 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.24 0.53 2.6 541.9514 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 2.99 0.541 2.1 541.9516 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.1 0.492 0 541.9518 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.05 0.449 1.12 542.2846 1,623.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.01 0.493 1.7 542.2853 1,623.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.34 0.526 1.6 542.2855 1,623.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAEREIVR 95.00% 2.24 0.389 0 543.9438 1,628.81 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAEREIVR 95.00% 1.42 0.422 0 543.9453 1,628.81 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAEREIVR 95.00% 2.28 0.335 0 544.2788 1,629.81 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAEREIVR 95.00% 1.81 0.317 0 544.2803 1,629.82 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLmK 95.00% 2.67 0.308 0 m13: Oxidation (+15.99) 547.282 1,638.82 1,639.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLmK 95.00% 3.82 0.231 0.959 m13: Oxidation (+15.99) 547.2831 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLmK 95.00% 3.38 0.306 0 m13: Oxidation (+15.99) 547.2834 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLmK 95.00% 3.41 0.286 0 m13: Oxidation (+15.99) 547.2835 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLmK 95.00% 3.39 0.269 0 m13: Oxidation (+15.99) 547.6171 1,639.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLmK 95.00% 3.28 0.237 0 m13: Oxidation (+15.99) 547.6172 1,639.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLmK 95.00% 3.14 0.409 0 m13: Oxidation (+15.99) 547.618 1,639.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHRK 95.00% 2.32 0.313 0 548.9369 1,643.79 1,644.80 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAER 95.00% 3.25 0.518 2.16 566.7662 1,131.52 1,132.53 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAER 95.00% 3.02 0.504 1.82 566.7664 1,131.52 1,132.53 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAER 95.00% 2.89 0.392 2.31 566.7679 1,131.52 1,132.53 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAER 95.00% 2.37 0.424 0 566.7697 1,131.52 1,132.53 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAER 95.00% 2.81 0.495 1.8 566.7705 1,131.53 1,132.53 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAER 95.00% 2.24 0.327 1.66 566.9762 1,131.94 1,132.53 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAER 95.00% 2.52 0.353 1.25 566.9774 1,131.94 1,132.53 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAER 95.00% 2.38 0.438 0 567.3031 1,132.59 1,132.53 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAER 95.00% 1.81 0.392 0 567.3108 1,132.61 1,132.53 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.71 0.357 0 581.3109 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.57 0.332 0 581.3111 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.5 0.345 0 581.3116 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.71 0.291 2.4 581.3118 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.47 0.316 0 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.42 0.325 0 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.1 0.352 0 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.77 0.359 0 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.17 0.309 0 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.95 0.389 0 581.3122 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.68 0.343 0 581.3122 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.85 0.431 0 581.3122 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.56 0.395 2.37 581.3123 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.85 0.359 0 581.3126 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.67 0.428 2.27 581.3128 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.05 0.3 0 581.3129 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.85 0.378 1.54 581.3131 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.02 0.301 0 581.3131 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.64 0.366 1.21 581.3134 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.78 0.392 2.31 581.3134 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.11 0.251 1.48 581.3136 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.24 0.247 0 581.314 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.62 0.388 1.26 581.3144 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.64 0.414 0 581.3146 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.69 0.263 0 581.3148 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.05 0.305 1.54 581.3148 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTMK 95.00% 2.5 0.233 0 581.3155 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.75 0.416 2.89 586.2872 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.6 0.398 3.17 586.2882 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.65 0.46 4.74 586.2883 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.83 0.399 5.72 586.2884 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 3.44 0.459 4.55 586.2885 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.94 0.469 4.96 586.2885 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.89 0.472 5.8 586.2886 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.42 0.415 3.25 586.2887 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.86 0.446 5.44 586.2889 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.73 0.462 4.62 586.289 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.7 0.49 4.82 586.2892 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.1 0.362 1.29 586.2893 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.24 0.287 2 586.2898 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.94 0.486 3.82 586.2903 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.26 0.304 3.74 586.2903 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.62 0.467 4.66 586.2904 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQK 95.00% 2.32 0.356 3.04 586.2909 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.78 0.35 1.59 m10: Oxidation (+15.99) 589.308 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.68 0.193 0 m10: Oxidation (+15.99) 589.3087 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.76 0.236 0 m10: Oxidation (+15.99) 589.3092 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.87 0.349 2.96 m10: Oxidation (+15.99) 589.3093 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.91 0.25 0 m10: Oxidation (+15.99) 589.3094 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.7 0.327 1.21 m10: Oxidation (+15.99) 589.3098 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.85 0.302 1.96 m10: Oxidation (+15.99) 589.31 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.87 0.244 0 m10: Oxidation (+15.99) 589.3103 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.5 0.234 1.2 m10: Oxidation (+15.99) 589.3106 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 94.70% 2.32 0.207 0 m10: Oxidation (+15.99) 589.3106 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.32 0.349 2.14 m10: Oxidation (+15.99) 589.3108 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.85 0.277 2.28 m10: Oxidation (+15.99) 589.3109 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.36 0.227 0 m10: Oxidation (+15.99) 589.3109 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% EITALAPSTmK 95.00% 2.17 0.409 0 m10: Oxidation (+15.99) 589.3113 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVmVGMGQK 95.00% 2.67 0.381 5.62 m5: Oxidation (+15.99) 594.2862 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVmVGMGQK 95.00% 2.76 0.379 4.51 m5: Oxidation (+15.99) 594.2864 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGmGQK 95.00% 2.07 0.415 3.47 m8: Oxidation (+15.99) 594.2876 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGmGQK 95.00% 2.48 0.467 3.54 m8: Oxidation (+15.99) 594.2881 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGmGQK 95.00% 2.43 0.456 2.92 m8: Oxidation (+15.99) 594.2884 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGmGQK 95.00% 2.46 0.397 2.06 m8: Oxidation (+15.99) 594.2884 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVmVGMGQK 95.00% 2.29 0.417 5.16 m5: Oxidation (+15.99) 594.289 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 2.88 0.459 1.77 597.569 1,789.68 1,790.89 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.21 0.366 2.77 597.6353 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 3.07 0.411 2.11 597.6357 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 2.36 0.271 0 597.6372 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.98 0.502 2.85 597.9687 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.94 0.495 2.64 597.9692 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 3.66 0.325 2.19 597.9692 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 3.18 0.438 0 597.9699 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 3.38 0.411 3.37 597.9699 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.19 0.478 1.7 597.97 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 3.66 0.433 2.4 597.9704 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.61 0.275 0 599.3396 1,196.66 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.63 0.271 0 599.3398 1,196.66 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DSYVGDEAQSK 95.00% 3.22 0.466 3.89 599.7654 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DSYVGDEAQSK 95.00% 3.3 0.455 4.82 599.7655 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DSYVGDEAQSK 95.00% 2.79 0.429 2.6 599.7663 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.16 0.285 0 599.854 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.52 0.272 0 599.8551 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.52 0.32 0 599.8552 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.51 0.313 1.28 599.8553 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.63 0.277 0 599.8554 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.8 0.314 0 599.8554 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 3.02 0.371 1.38 599.8554 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.5 0.239 0 599.8555 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.68 0.33 0 599.8556 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.88 0.336 0 599.8556 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.44 0.371 0 599.8562 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.43 0.317 0 599.8564 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.02 0.291 0 599.8575 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DSYVGDEAQSK 95.00% 2.54 0.347 3.08 600.2643 1,198.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% AVFPSIVGRPR 95.00% 2.72 0.345 0 600.3555 1,198.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 3.91 0.0367 1.74 652.0251 1,953.05 1,954.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 3.96 0.0532 1.2 652.0253 1,953.05 1,954.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 3.7 0.11 0 652.0258 1,953.05 1,954.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4 0.0239 0.959 652.3599 1,954.06 1,954.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 3.99 0.0302 1.29 652.3599 1,954.06 1,954.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 3.94 0.0723 2.29 652.36 1,954.06 1,954.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.19 0.0543 1.55 652.3603 1,954.06 1,954.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.05 0.0827 0.921 652.3604 1,954.06 1,954.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 3.92 0.0309 1.1 652.3604 1,954.06 1,954.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.05 0.0506 1.7 652.3606 1,954.06 1,954.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 3.74 0.0332 1.22 652.3608 1,954.06 1,954.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DSYVGDEAQSKR 95.00% 2.96 0.538 3.33 677.8178 1,353.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DSYVGDEAQSKR 95.00% 2.21 0.263 1.42 677.8181 1,353.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DSYVGDEAQSKR 95.00% 2.67 0.475 3.23 677.8186 1,353.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DSYVGDEAQSKR 95.00% 2.7 0.52 1.66 677.8187 1,353.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTMYPGIADR 95.00% 6.09 0.377 4.23 739.361 2,215.06 2,215.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTMYPGIADR 95.00% 5.85 0.349 4.66 739.362 2,215.06 2,215.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTMYPGIADR 95.00% 4.66 0.469 0 739.3621 2,215.06 2,215.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTMYPGIADR 95.00% 4.21 0.279 0 739.3648 2,215.07 2,215.07 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IWHHTFYNELR 95.00% 2.26 0.299 0 758.3398 1,514.66 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IWHHTFYNELR 95.00% 3 0.486 1.57 758.3783 1,514.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.43 0.451 2.85 758.8539 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.23 0.352 2.24 758.854 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.72 0.418 3.01 758.854 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.52 0.395 3 758.854 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.46 0.428 1.66 758.8541 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.53 0.418 4.66 758.8543 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.57 0.431 3.39 758.8546 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.65 0.418 3.55 758.8546 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.56 0.374 3.89 758.8548 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.42 0.464 4.15 758.8548 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.13 0.363 0 758.8556 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.59 0.375 3.34 758.8556 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% IWHHTFYNELR 95.00% 3.13 0.475 2.18 758.8795 1,515.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.24 0.365 3.55 759.3549 1,516.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.47 0.326 1.32 759.355 1,516.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% QEYDESGPSIVHR 95.00% 2.53 0.379 2.66 759.3571 1,516.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% MQKEITALAPSTMK 95.00% 4.99 0.42 3.13 774.9083 1,547.80 1,548.81 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% MQKEITALAPSTMK 95.00% 3.96 0.388 1.49 774.9084 1,547.80 1,548.81 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% MQKEITALAPSTMK 95.00% 4.84 0.45 3.14 774.9089 1,547.80 1,548.81 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% MQKEITALAPSTMK 95.00% 5.05 0.414 2.35 774.9095 1,547.80 1,548.81 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% MQKEITALAPSTMK 95.00% 4.55 0.398 2.39 774.912 1,547.81 1,548.81 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% MQKEITALAPSTMK 95.00% 4.37 0.417 1.24 775.4101 1,548.80 1,548.81 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% mQKEITALAPSTMK 95.00% 4.24 0.362 1.96 m1: Oxidation (+15.99) 782.9064 1,563.80 1,564.81 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% mQKEITALAPSTMK 95.00% 4.04 0.307 3.59 m1: Oxidation (+15.99) 782.9079 1,563.80 1,564.81 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.98 0.664 5.23 784.6967 2,351.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.67 0.658 5.59 784.6969 2,351.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.43 0.682 4.92 784.699 2,351.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 0 0 6.16 785.0317 2,352.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.26 0.651 4.77 m8: Oxidation (+15.99) 790.0281 2,367.06 2,367.07 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.58 0.648 5.52 m8: Oxidation (+15.99) 790.0286 2,367.06 2,367.07 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.83 0.657 2.82 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.36 2,383.06 2,383.07 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.6 0.663 3.49 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3611 2,383.06 2,383.07 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 4.04 0.532 3.18 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3613 2,383.06 2,383.07 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.55 0.526 1.92 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3638 2,383.07 2,383.07 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVmVGmGQKDSYVGDEAQSK 95.00% 2.93 0.56 3.48 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3644 2,383.07 2,383.07 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.31 0.372 2.7 812.4215 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.15 0.336 1.74 812.4221 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.31 0.355 2.19 812.4223 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.04 0.259 1.72 812.4225 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.29 0.324 2.26 812.4229 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLMK 95.00% 3.32 0.348 2.77 812.4231 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAEREIVR 95.00% 3.02 0.352 0 815.4158 1,628.82 1,629.82 2 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% GYSFTTTAEREIVR 95.00% 2.88 0.354 0 815.4181 1,628.82 1,629.82 2 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLmK 95.00% 3.12 0.162 2.23 m13: Oxidation (+15.99) 820.4205 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLmK 95.00% 3 0.125 3 m13: Oxidation (+15.99) 820.4206 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% LDLAGRDLTDYLmK 95.00% 3.05 0.17 0 m13: Oxidation (+15.99) 820.4206 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQKDSYVGDEAQSKR 95.00% 5.22 0.646 7.85 836.7306 2,507.17 2,507.18 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQKDSYVGDEAQSKR 95.00% 5.56 0.623 7.24 836.7317 2,507.17 2,507.18 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGmGQKDSYVGDEAQSKR 95.00% 5.24 0.584 4.44 m8: Oxidation (+15.99) 842.0611 2,523.16 2,523.17 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGmGQKDSYVGDEAQSKR 95.00% 4.61 0.518 4.62 m8: Oxidation (+15.99) 842.0621 2,523.16 2,523.17 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVmVGmGQKDSYVGDEAQSKR 95.00% 4.88 0.585 2.82 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 847.3949 2,539.16 2,539.17 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVmVGmGQKDSYVGDEAQSKR 95.00% 5.19 0.57 2.85 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 847.3951 2,539.16 2,539.17 3 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.87 0.604 5.96 895.9469 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.64 0.604 5.74 895.9472 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.76 0.611 5.89 895.9478 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.36 0.605 4.72 895.948 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.83 0.62 6.12 895.9482 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.76 0.608 5.89 895.9482 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.48 0.573 5.92 895.9483 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.6 0.578 6.55 895.9486 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.63 0.601 5.25 895.9488 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.5 0.558 6.43 895.9491 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.65 0.613 6.26 895.9491 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.16 0.517 3.82 895.9495 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.27 0.57 5.29 895.9495 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.36 0.555 6.68 895.9496 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.21 0.59 4.52 895.9497 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 3.94 0.635 3.51 895.9509 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.39 0.593 4.25 895.951 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 3.24 0.401 2.66 895.9512 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.48 0.574 5.31 895.9513 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.43 0.621 5.64 895.952 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 3.92 0.453 4.39 895.9524 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 3.06 0.381 3.68 895.9536 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.6 0.603 5.92 895.9538 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 3.96 0.548 4.01 895.9541 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 3.79 0.538 4.39 895.9546 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 2.51 0.419 2.8 896.4362 1,790.86 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.95 0.552 5.38 896.4479 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.88 0.541 6 896.4487 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.73 0.586 5.77 896.4491 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.78 0.616 5.92 896.4494 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.73 0.536 5.35 896.4497 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.72 0.586 5.49 896.4508 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.39 0.578 5.54 896.4508 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.35 0.541 4.68 896.4512 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.47 0.559 5.34 896.4515 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.82 0.58 6.64 896.453 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.16 0.576 4.7 896.453 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 3.24 0.488 4.54 896.4533 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.88 0.556 5.52 896.4546 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.24 0.535 4.4 896.456 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% SYELPDGQVITIGNER 95.00% 4.47 0.572 4.28 896.4561 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.22 0.325 5.96 977.5327 1,953.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.52 0.373 6.52 977.5332 1,953.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 3.95 0.332 4.6 977.5335 1,953.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.35 0.316 6.19 977.5337 1,953.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.23 0.321 6.34 977.5338 1,953.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.55 0.383 4.68 977.5341 1,953.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.42 0.391 5.92 977.5342 1,953.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 3.4 0.34 4.24 977.5343 1,953.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.36 0.312 6.1 977.5343 1,953.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.36 0.388 4.44 977.5344 1,953.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.49 0.362 6.17 977.5348 1,953.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.01 0.375 5.11 977.5354 1,953.06 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.47 0.215 6.51 978.0343 1,954.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.48 0.232 5.89 978.0346 1,954.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.45 0.256 5.54 978.0352 1,954.05 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.35 0.202 6.77 978.0356 1,954.06 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.15 0.169 5.09 978.0357 1,954.06 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.31 0.168 5.72 978.0357 1,954.06 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.39 0.182 5.89 978.036 1,954.06 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.3 0.0404 6 978.036 1,954.06 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.24 0.267 4.18 978.0367 1,954.06 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% VAPEEHPVLLTEAPLNPK 95.00% 4.01 0.212 4.15 978.0373 1,954.06 1,954.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% TTGIVMDSGDGVTHTVPIYEGYALPHAILR 95.00% 6.66 0.584 5.55 1,062.21 3,183.60 3,183.62 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% TTGIVMDSGDGVTHTVPIYEGYALPHAILR 95.00% 0 0 7.42 1,062.54 3,184.61 3,183.62 3
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTMYPGIADR 95.00% 5.54 0.4 5.48 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTMYPGIADR 95.00% 5.48 0.404 5.14 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTMYPGIADR 95.00% 6.71 0.445 6.21 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTMYPGIADR 95.00% 6.16 0.485 6.48 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTMYPGIADR 95.00% 6.35 0.42 4.4 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTMYPGIADR 95.00% 6.46 0.47 5.06 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTMYPGIADR 95.00% 6.22 0.395 5.08 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTmYPGIADR 95.00% 5.33 0.676 4.15 m14: Oxidation (+15.99) 1,116.54 2,231.06 2,231.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% DLYANTVLSGGTTmYPGIADR 95.00% 6.02 0.662 6.1 m14: Oxidation (+15.99) 1,116.54 2,231.06 2,231.07 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% KDLYANTVLSGGTTMYPGIADR 95.00% 6.89 0.221 8.48 1,172.58 2,343.15 2,343.17 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% KDLYANTVLSGGTTMYPGIADR 95.00% 6.33 0.257 8.92 1,172.58 2,343.15 2,343.17 2
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.84 0.655 8.6 1,176.54 2,351.06 2,351.08 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.9 0.64 9.04 1,176.54 2,351.06 2,351.08 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 5.15 0.65 6.48 m8: Oxidation (+15.99) 1,184.04 2,366.06 2,367.07 2 ACTC_HUMAN
 SAMPLE 2 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 7 10 95 54.90% HQGVMVGmGQKDSYVGDEAQSK 95.00% 5.36 0.616 4.37 m8: Oxidation (+15.99) 1,184.54 2,367.06 2,367.07 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSKR 95.00% 2.3 0.277 0 452.214 1,353.62 1,354.62 3 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSKR 95.00% 2.27 0.213 0 452.2144 1,353.62 1,354.62 3 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.09 0.441 0 473.2783 944.5409 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.33 0.498 0 473.2784 944.5411 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.08 0.43 0 473.2784 944.5412 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.13 0.434 0 473.2785 944.5414 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.44 0.505 0 473.2786 944.5416 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 1.75 0.405 0 473.2787 944.5417 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.16 0.411 0 473.2788 944.542 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.21 0.487 0 473.2789 944.5422 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 1.75 0.342 0 473.279 944.5423 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.28 0.417 0 473.279 944.5423 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.16 0.415 0 473.2791 944.5425 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.15 0.449 0 473.2791 944.5426 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.26 0.438 0 473.2793 944.5429 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 1.8 0.303 0 473.2795 944.5434 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 1.85 0.324 0 473.2795 944.5434 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 1.94 0.403 0 473.2796 944.5435 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.06 0.447 0 473.2796 944.5436 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 1.92 0.361 0 473.2796 944.5436 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 1.86 0.3 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 2.03 0.377 0 473.2797 944.5438 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGR 95.00% 1.92 0.415 0 473.2798 944.5439 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AGFAGDDAPR 95.00% 3.34 0.452 2.28 488.7273 975.439 976.449 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AGFAGDDAPR 95.00% 3.28 0.464 2 488.7274 975.4391 976.449 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AGFAGDDAPR 95.00% 3.23 0.436 1.72 488.7274 975.4392 976.449 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AGFAGDDAPR 95.00% 3.36 0.468 1.8 488.7274 975.4392 976.449 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AGFAGDDAPR 95.00% 3.27 0.474 1.8 488.7278 975.44 976.449 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AGFAGDDAPR 95.00% 2.23 0.299 0 488.7287 975.4417 976.449 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 1.99 0.329 0 499.7449 997.4742 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 1.97 0.322 0 499.7451 997.4745 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 1.91 0.364 0 499.7456 997.4755 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 2.05 0.408 0 499.7456 997.4756 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 2.01 0.364 0 499.7456 997.4756 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 1.94 0.356 0 499.7458 997.4759 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 1.91 0.403 1.6 499.7459 997.4762 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 2.23 0.408 0 499.746 997.4763 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 1.87 0.341 0 499.746 997.4764 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 1.83 0.339 0 499.7461 997.4766 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 2.19 0.391 0 499.7462 997.4767 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 2.02 0.364 0 499.7462 997.4768 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLMK 95.00% 2.13 0.4 1.19 499.7462 997.4768 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 3.52 0.417 1.55 505.9186 1,514.73 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 3.14 0.339 0 505.9196 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 2.86 0.301 1.2 505.9198 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 3.41 0.506 0 505.9199 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 3.33 0.437 0 505.9203 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 3.39 0.485 1.02 505.9204 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 3.23 0.478 0 505.9207 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.32 0.244 0 506.237 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.62 0.411 0 506.2376 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.95 0.54 0 506.2377 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.82 0.432 0 506.2378 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.09 0.221 0 506.2378 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.78 0.469 0 506.2379 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 3.28 0.495 0 506.238 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.64 0.481 0 506.238 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.86 0.483 0 506.2382 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.88 0.426 0 506.2383 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.85 0.454 0 506.2384 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.65 0.449 0 506.2384 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.84 0.474 0 506.2384 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 3.2 0.514 0 506.2385 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.81 0.446 0 506.2385 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.68 0.323 0 506.2386 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.73 0.447 0 506.2386 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 3.41 0.545 0 506.2387 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 3.28 0.479 0 506.239 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 3.56 0.46 0 506.2544 1,515.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLmK 95.00% 1.97 0.302 0 m7: Oxidation (+15.99) 507.7421 1,013.47 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLTDYLmK 95.00% 2.08 0.368 0 m7: Oxidation (+15.99) 507.7427 1,013.47 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% MQKEITALAPSTMK 95.00% 3.73 0.419 1.6 516.942 1,547.80 1,548.81 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% MQKEITALAPSTMK 95.00% 3.4 0.388 1.68 516.9422 1,547.80 1,548.81 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 2.43 0.221 0 518.8266 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 2.51 0.229 0 518.8273 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 2.21 0.23 0 518.8278 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 2.1 0.267 0 518.8282 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 1.99 0.288 0 518.8282 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 2.18 0.255 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 2.08 0.271 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 2.4 0.226 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 2.44 0.22 0 518.8285 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 2.46 0.216 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 2.17 0.269 0 518.8291 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 1.93 0.292 0 518.8292 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IKIIAPPER 95.00% 2.41 0.208 0 518.8299 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.06 0.491 0 541.9504 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 2.56 0.219 0 541.9506 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.21 0.499 1.68 541.9507 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 2.8 0.456 0 541.9508 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 2.5 0.382 0 541.9509 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.16 0.44 0 541.951 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.13 0.387 1 541.9512 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 2.75 0.339 0 541.9512 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 2.67 0.457 0 541.9513 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.2 0.493 0 541.9513 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.23 0.446 0.959 541.9514 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 2.41 0.268 0 541.9515 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 2.37 0.408 0 541.9516 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 2.54 0.437 1.2 541.9518 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.8 0.461 0 542.2842 1,623.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 2.99 0.493 1.41 542.285 1,623.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.17 0.463 0 542.2851 1,623.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 2.91 0.471 2.08 542.2855 1,623.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAEREIVR 95.00% 1.2 0.336 0 543.9445 1,628.81 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAEREIVR 95.00% 1.32 0.329 0 543.9453 1,628.81 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAEREIVR 95.00% 2.12 0.383 0 543.9454 1,628.81 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAEREIVR 95.00% 2.19 0.414 0 544.2796 1,629.82 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLmK 95.00% 3.26 0.405 0 m13: Oxidation (+15.99) 547.2823 1,638.82 1,639.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLmK 95.00% 2.94 0.395 0 m13: Oxidation (+15.99) 547.2831 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLmK 95.00% 3.01 0.215 0 m13: Oxidation (+15.99) 547.2835 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLmK 95.00% 2.99 0.338 0 m13: Oxidation (+15.99) 547.6166 1,639.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHRK 95.00% 1.98 0.281 0 548.9365 1,643.79 1,644.80 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHRK 95.00% 2.41 0.233 0 548.9382 1,643.79 1,644.80 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 3.17 0.526 2.21 566.7655 1,131.52 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 3.08 0.539 3.28 566.766 1,131.52 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 2.83 0.457 2.05 566.7661 1,131.52 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 2.74 0.478 2.38 566.7664 1,131.52 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 3.15 0.491 3.23 566.7665 1,131.52 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 2.88 0.545 1.96 566.7665 1,131.52 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 3.25 0.551 2.37 566.7666 1,131.52 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 3.26 0.562 3.09 566.7666 1,131.52 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 3.33 0.531 3.22 566.7666 1,131.52 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 3.33 0.517 3.55 566.7669 1,131.52 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 2.98 0.443 2.42 566.7671 1,131.52 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 3.49 0.512 4.05 566.7672 1,131.52 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 2.25 0.314 0 566.8036 1,131.59 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 2.64 0.474 2.48 566.976 1,131.94 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 2.07 0.291 0 566.9767 1,131.94 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 2.01 0.364 1.49 567.3098 1,132.60 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 2.84 0.441 2.7 567.3103 1,132.61 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 2.09 0.404 1.23 567.3106 1,132.61 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 1.93 0.391 1.21 567.3112 1,132.61 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAER 95.00% 2.09 0.328 0 567.5142 1,133.01 1,132.53 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.47 0.336 0 581.3106 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.79 0.387 0 581.3111 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.51 0.393 1.37 581.3117 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.67 0.437 2.3 581.3119 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.9 0.392 1.28 581.312 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.39 0.372 0 581.312 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.83 0.403 1.33 581.3123 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.89 0.376 0 581.3124 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.47 0.391 1.48 581.3125 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.9 0.396 1.3 581.3127 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.9 0.372 0 581.3128 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.27 0.337 1.19 581.3128 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.67 0.434 0 581.313 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.78 0.327 0 581.313 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 3.01 0.365 1.96 581.3132 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.9 0.389 2.38 581.3132 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 1.95 0.407 0 581.3133 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.69 0.471 0 581.3134 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.56 0.382 0 581.3136 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTMK 95.00% 2.11 0.262 0 581.3159 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.88 0.439 4.52 586.2874 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.46 0.476 4.09 586.2875 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.86 0.439 4.1 586.2877 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.49 0.386 6.77 586.2879 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.33 0.31 1.96 586.2879 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.9 0.452 4.96 586.2879 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.62 0.477 4.49 586.2889 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 3.16 0.496 4.51 586.2891 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 3.04 0.482 4.85 586.2892 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.75 0.451 5.6 586.2893 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.36 0.409 4.03 586.2893 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.58 0.514 4.07 586.2896 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.47 0.479 4.59 586.2896 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.7 0.474 4.44 586.2902 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.05 0.361 2.96 586.2904 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2 0.336 1.59 586.2909 1,170.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQK 95.00% 2.15 0.377 2.8 586.7903 1,171.57 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTmK 95.00% 2.9 0.301 0 m10: Oxidation (+15.99) 589.3074 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTmK 95.00% 2.82 0.28 0 m10: Oxidation (+15.99) 589.3082 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTmK 95.00% 2.71 0.28 0 m10: Oxidation (+15.99) 589.3086 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTmK 95.00% 2.77 0.224 0 m10: Oxidation (+15.99) 589.3093 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTmK 95.00% 2.69 0.265 1.51 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTmK 95.00% 2.85 0.341 0 m10: Oxidation (+15.99) 589.31 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTmK 95.00% 2.73 0.275 1.24 m10: Oxidation (+15.99) 589.3103 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTmK 95.00% 2.52 0.348 0 m10: Oxidation (+15.99) 589.3105 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTmK 95.00% 2.39 0.302 0 m10: Oxidation (+15.99) 589.3111 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% EITALAPSTmK 95.00% 2.69 0.278 0 m10: Oxidation (+15.99) 589.3121 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVmVGMGQK 95.00% 2.44 0.319 4.28 m5: Oxidation (+15.99) 594.286 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVmVGMGQK 95.00% 2.36 0.295 2.54 m5: Oxidation (+15.99) 594.2867 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVmVGMGQK 95.00% 3.13 0.479 5.21 m5: Oxidation (+15.99) 594.2874 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGmGQK 95.00% 2.07 0.415 3.47 m8: Oxidation (+15.99) 594.2876 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVmVGMGQK 95.00% 2.38 0.37 4.03 m5: Oxidation (+15.99) 594.2877 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVmVGMGQK 95.00% 2.31 0.402 3.89 m5: Oxidation (+15.99) 594.2885 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 2.03 0.236 0 597.319 1,788.93 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.05 0.414 4 597.6334 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.02 0.439 2.74 597.6342 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.78 0.369 3.14 597.6344 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.11 0.486 2.25 597.6347 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.69 0.44 3.15 597.635 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.52 0.495 4.7 597.6351 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.45 0.459 2.49 597.6356 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.31 0.451 2.72 597.636 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.59 0.505 2.18 597.9681 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.69 0.482 3.12 597.9689 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 2.63 0.231 0 597.9694 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.31 0.343 0 597.9695 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.63 0.359 1.34 597.9698 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.27 0.465 2.85 597.9699 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.09 0.44 4.62 597.9702 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSK 95.00% 2.42 0.325 4.7 599.7632 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSK 95.00% 2.47 0.371 3.55 599.7641 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSK 95.00% 2.86 0.446 4.28 599.7643 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSK 95.00% 2.91 0.451 3.72 599.7647 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSK 95.00% 2.39 0.331 1.48 599.7664 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSK 95.00% 2.81 0.417 3.74 599.7668 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSK 95.00% 2.85 0.445 3.02 599.767 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGRPR 95.00% 2.91 0.393 0 599.8545 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGRPR 95.00% 2.32 0.246 0 599.8553 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGRPR 95.00% 2.99 0.385 0 599.8556 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGRPR 95.00% 2.89 0.331 0 599.8557 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGRPR 95.00% 2.99 0.422 1.19 599.8558 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGRPR 95.00% 2.77 0.292 0 599.8561 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGRPR 95.00% 2.51 0.334 0 599.8562 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% AVFPSIVGRPR 95.00% 2.26 0.293 0 599.8604 1,197.71 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.06 0.0726 2.43 652.024 1,953.05 1,954.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 3.61 0.00442 1.24 652.0259 1,953.05 1,954.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.07 0.07 0 652.0265 1,953.06 1,954.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.13 0.0211 1.66 652.3595 1,954.06 1,954.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 3.9 0.0532 1.92 652.3598 1,954.06 1,954.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 3.99 0.0606 1.54 652.3599 1,954.06 1,954.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 3.88 0.0356 2.28 652.36 1,954.06 1,954.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.09 0.0565 1.66 652.3601 1,954.06 1,954.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.38 0.0585 1.92 652.3601 1,954.06 1,954.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 3.67 0.0619 1.1 652.3603 1,954.06 1,954.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.07 0.0447 3 652.3604 1,954.06 1,954.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.04 0.0448 1.31 652.3607 1,954.06 1,954.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSKR 95.00% 2.56 0.456 0 677.8144 1,353.61 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSKR 95.00% 2.05 0.271 0 677.8147 1,353.61 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSKR 95.00% 2.96 0.538 3.57 677.8178 1,353.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DSYVGDEAQSKR 95.00% 2.75 0.508 0 678.3169 1,354.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLYANTVLSGGTTMYPGIADR 95.00% 4.81 0.558 2.17 739.0281 2,214.06 2,215.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLYANTVLSGGTTMYPGIADR 95.00% 5.63 0.32 3.89 739.3614 2,215.06 2,215.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLYANTVLSGGTTMYPGIADR 95.00% 4.59 0.385 1.26 739.3627 2,215.06 2,215.07 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 3.06 0.459 1.57 758.3695 1,514.72 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 2.96 0.472 1.54 758.3739 1,514.73 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 2.87 0.414 1.43 758.3739 1,514.73 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 2.37 0.475 0 758.3777 1,514.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.51 0.402 3 758.8531 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.4 0.427 2.1 758.8533 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.31 0.421 1.6 758.8534 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.54 0.362 3.09 758.8544 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.79 0.468 2.8 758.8544 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.67 0.434 2.96 758.8545 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.09 0.359 1.74 758.8547 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.12 0.388 2.25 758.8548 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.18 0.463 2.38 758.8553 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.22 0.44 3.8 758.8553 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.51 0.425 1.21 758.8557 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.41 0.439 3.09 758.856 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.49 0.466 0 758.8563 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.13 0.3 0 758.8577 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% QEYDESGPSIVHR 95.00% 2.38 0.415 1.41 758.8579 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% IWHHTFYNELR 95.00% 3.35 0.467 1.46 758.8765 1,515.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% MQKEITALAPSTMK 95.00% 4.93 0.434 2.74 774.9093 1,547.80 1,548.81 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% MQKEITALAPSTMK 95.00% 4.72 0.393 2.62 774.9098 1,547.80 1,548.81 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% MQKEITALAPSTMK 95.00% 4.63 0.437 2.74 774.9107 1,547.81 1,548.81 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% MQKEITALAPSTMK 95.00% 4.8 0.414 2.89 775.4101 1,548.80 1,548.81 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.47 0.602 5.7 784.6963 2,351.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.15 0.619 4.42 784.697 2,351.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.57 0.613 5.64 784.6976 2,351.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.47 0.638 4.6 784.6978 2,351.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.41 0.617 3.82 m8: Oxidation (+15.99) 790.0292 2,367.06 2,367.07 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.42 0.645 5.82 m8: Oxidation (+15.99) 790.0295 2,367.07 2,367.07 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVmVGmGQKDSYVGDEAQSK 95.00% 4.33 0.684 3.24 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.0273 2,382.06 2,383.07 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.74 0.613 3.18 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3604 2,383.06 2,383.07 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.86 0.647 3.14 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.361 2,383.06 2,383.07 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.23 0.381 1.85 812.4225 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.15 0.324 2.48 812.4229 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.16 0.286 2.28 812.4234 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.31 0.38 2.55 812.4235 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.29 0.373 2.66 812.4236 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.14 0.318 2.82 812.4237 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 2.44 0.249 0 812.4249 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLMK 95.00% 3.19 0.361 2.48 812.425 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAEREIVR 95.00% 3.15 0.389 0 815.4155 1,628.82 1,629.82 2 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% GYSFTTTAEREIVR 95.00% 3.14 0.309 0 815.4157 1,628.82 1,629.82 2 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLmK 95.00% 3.44 0.281 2.13 m13: Oxidation (+15.99) 820.4193 1,638.82 1,639.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLmK 95.00% 3.18 0.203 2.68 m13: Oxidation (+15.99) 820.4214 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLmK 95.00% 3.26 0.299 3.6 m13: Oxidation (+15.99) 820.4218 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLmK 95.00% 2.61 0.165 1.74 m13: Oxidation (+15.99) 820.4255 1,638.84 1,639.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LDLAGRDLTDYLmK 95.00% 2.89 0.0839 2.01 m13: Oxidation (+15.99) 820.9232 1,639.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQKDSYVGDEAQSKR 95.00% 5.6 0.649 6.62 836.7296 2,507.17 2,507.18 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQKDSYVGDEAQSKR 95.00% 4.96 0.624 7.74 836.7313 2,507.17 2,507.18 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGmGQKDSYVGDEAQSKR 95.00% 5 0.575 4.92 m8: Oxidation (+15.99) 842.0636 2,523.17 2,523.17 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVmVGmGQKDSYVGDEAQSKR 95.00% 5.23 0.553 4.24 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 847.3955 2,539.16 2,539.17 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVmVGmGQKDSYVGDEAQSKR 95.00% 5.35 0.492 2.18 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 847.3964 2,539.17 2,539.17 3 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 6.34 0.244 5.16 c2: Carbamidomethyl (+57.02) 851.0619 2,550.16 2,550.17 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 5.93 0.218 0 c2: Carbamidomethyl (+57.02) 851.0623 2,550.16 2,550.17 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 5.98 0.264 3.41 c2: Carbamidomethyl (+57.02) 851.0624 2,550.16 2,550.17 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 6.08 0.214 3.59 c2: Carbamidomethyl (+57.02) 851.0625 2,550.16 2,550.17 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 4.79 0.243 1.49 c2: Carbamidomethyl (+57.02) 851.0638 2,550.17 2,550.17 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 5.42 0.306 3.8 c2: Carbamidomethyl (+57.02) 851.0649 2,550.17 2,550.17 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.81 0.495 4.51 895.9455 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.23 0.575 5.21 895.946 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.86 0.61 6.07 895.947 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.87 0.544 6.8 895.9471 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.84 0.591 5.4 895.9475 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.77 0.611 6.55 895.9476 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.89 0.612 5.64 895.9477 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.67 0.602 5.28 895.9477 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.59 0.609 6.23 895.9477 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.61 0.557 5.12 895.9479 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.64 0.591 6 895.9482 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.8 0.608 7.18 895.9483 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.85 0.516 5.51 895.9483 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.42 0.598 6.38 895.9485 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.77 0.564 5.11 895.9489 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.26 0.603 5.7 895.9489 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.74 0.614 3.8 895.9492 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.83 0.611 6.21 895.9497 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 2.24 0.295 1.38 895.9497 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.14 0.572 4.77 895.9497 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.18 0.468 4.55 895.9497 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 2.8 0.287 0 895.95 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.78 0.577 5.14 895.9501 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.33 0.577 5.52 895.9503 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.65 0.577 6.2 895.9507 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.11 0.589 4.85 895.9513 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.81 0.575 4.68 895.9534 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.6 0.603 5.36 895.9538 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 2.19 0.447 2.4 896.3631 1,790.71 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 1.82 0.443 1.7 896.4201 1,790.82 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.1 0.521 5.14 896.4477 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.77 0.517 4.36 896.4487 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.91 0.53 5.12 896.449 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.53 0.59 5.09 896.4495 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.25 0.503 4.17 896.4496 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 5.18 0.589 4.72 896.45 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.59 0.595 4.8 896.4507 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.94 0.486 4.68 896.4516 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.18 0.572 3.33 896.4522 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.62 0.487 4.27 896.4532 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.05 0.556 5.15 896.4538 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.88 0.556 4.89 896.4546 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 4.4 0.517 4.89 896.4573 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% SYELPDGQVITIGNER 95.00% 3.56 0.563 4.24 896.4586 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.09 0.317 5.7 977.5293 1,953.04 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.32 0.364 4.85 977.5316 1,953.05 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 3.79 0.376 5.52 977.532 1,953.05 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.05 0.371 4.6 977.5324 1,953.05 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 3.62 0.303 3.48 977.5331 1,953.05 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.58 0.332 4.6 977.5335 1,953.05 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.52 0.399 4.82 977.5338 1,953.05 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.35 0.38 6.15 977.5341 1,953.05 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.07 0.312 5.44 977.5348 1,953.05 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.53 0.178 5.68 978.0341 1,954.05 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.26 0.19 5.85 978.0351 1,954.05 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.61 0.142 5.74 978.0352 1,954.05 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.27 0.0988 6 978.0355 1,954.06 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.6 0.183 6.54 978.0356 1,954.06 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.26 0.121 4.74 978.036 1,954.06 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.32 0.134 5.31 978.0362 1,954.06 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.31 0.0978 5.62 978.0363 1,954.06 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 3.98 0.0148 4.11 978.0367 1,954.06 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 3.96 0.315 4.11 978.0369 1,954.06 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% VAPEEHPVLLTEAPLNPK 95.00% 4.23 0.165 5.96 978.0376 1,954.06 1,954.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% TTGIVMDSGDGVTHTVPIYEGYALPHAILR 95.00% 6.87 0.657 5.14 1,062.21 3,183.60 3,183.62 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% TTGIVMDSGDGVTHTVPIYEGYALPHAILR 95.00% 0 0 7.68 1,062.54 3,184.60 3,183.62 3
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLYANTVLSGGTTMYPGIADR 95.00% 6.15 0.733 6.96 1,108.04 2,214.06 2,215.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLYANTVLSGGTTMYPGIADR 95.00% 5.75 0.392 6.05 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLYANTVLSGGTTMYPGIADR 95.00% 5.72 0.388 5.28 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLYANTVLSGGTTMYPGIADR 95.00% 6.79 0.451 4.66 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLYANTVLSGGTTMYPGIADR 95.00% 6.56 0.461 6 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLYANTVLSGGTTMYPGIADR 95.00% 5.4 0.408 5.74 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLYANTVLSGGTTMYPGIADR 95.00% 6.07 0.481 5.77 1,108.54 2,215.06 2,215.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLYANTVLSGGTTMYPGIADR 95.00% 6.39 0.387 6.06 1,108.54 2,215.07 2,215.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% DLYANTVLSGGTTmYPGIADR 95.00% 5.97 0.688 5.31 m14: Oxidation (+15.99) 1,116.53 2,231.05 2,231.07 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% KDLYANTVLSGGTTMYPGIADR 95.00% 6.68 0.242 8.04 1,172.59 2,343.15 2,343.17 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% KDLYANTVLSGGTTMYPGIADR 95.00% 6.5 0.265 8.54 1,172.59 2,343.16 2,343.17 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.78 0.639 9.12 1,176.54 2,351.07 2,351.08 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.77 0.638 8.15 1,176.54 2,351.07 2,351.08 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% HQGVMVGmGQKDSYVGDEAQSK 95.00% 5.14 0.65 4.66 m8: Oxidation (+15.99) 1,184.54 2,367.07 2,367.07 2 ACTC_HUMAN
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 7.36 0.324 9.47 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.16 2,550.17 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 7.39 0.32 8.32 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.16 2,550.17 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 7.24 0.308 8.03 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.16 2,550.17 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 7.17 0.297 8.89 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.16 2,550.17 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 7.47 0.313 8.04 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.17 2,550.17 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 6.99 0.293 9.25 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.17 2,550.17 2
 SAMPLE 2R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 8 12 117 61.10% LcYVALDFEQEMATAASSSSLEK 95.00% 6.68 0.278 8.77 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.17 2,550.17 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSKR 95.00% 2.82 0.388 0 452.2146 1,353.62 1,354.62 3 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSKR 95.00% 2.52 0.489 0 452.2148 1,353.62 1,354.62 3 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.02 0.39 0 473.2781 944.5406 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.14 0.424 0 473.2784 944.5411 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.08 0.433 0 473.2787 944.5417 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.1 0.434 0 473.2787 944.5417 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.14 0.44 0 473.2787 944.5418 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2 0.343 0 473.2788 944.542 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 1.94 0.312 0 473.2789 944.5421 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.04 0.407 0 473.279 944.5424 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 1.89 0.338 0 473.2791 944.5425 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.17 0.425 0 473.2792 944.5427 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.13 0.462 0 473.2792 944.5428 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.33 0.502 0 473.2794 944.5431 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.17 0.402 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.14 0.378 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 1.87 0.338 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 1.99 0.411 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.14 0.408 0 473.2798 944.5439 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.16 0.323 0 473.2798 944.5439 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.01 0.245 0 473.2798 944.544 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.12 0.369 0 473.2801 944.5445 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2.2 0.435 0 473.2801 944.5445 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 1.82 0.316 0 473.2803 944.545 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 1.72 0.43 0 473.2807 944.5457 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 2 0.361 0 473.281 944.5463 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 1.86 0.308 0 473.2811 944.5466 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGR 95.00% 1.72 0.361 0 473.2812 944.5468 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AGFAGDDAPR 95.00% 3.3 0.482 1.8 488.7267 975.4377 976.449 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AGFAGDDAPR 95.00% 3.49 0.479 1.82 488.7269 975.4382 976.449 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AGFAGDDAPR 95.00% 2.9 0.426 1.8 488.7274 975.4391 976.449 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AGFAGDDAPR 95.00% 2.92 0.424 1.54 488.7278 975.44 976.449 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AGFAGDDAPR 95.00% 2.59 0.308 1.7 488.7279 975.4401 976.449 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 1.93 0.357 0 499.745 997.4744 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.01 0.393 0 499.7451 997.4745 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 1.9 0.375 0 499.7451 997.4746 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.15 0.414 0 499.7452 997.4748 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.3 0.453 0 499.7455 997.4754 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 1.91 0.354 0 499.7457 997.4757 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.13 0.409 0 499.7457 997.4757 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.2 0.409 1.42 499.7458 997.476 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.17 0.426 1.18 499.7458 997.476 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.19 0.363 0 499.7459 997.4762 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.15 0.394 1.09 499.7459 997.4762 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.13 0.388 0 499.746 997.4764 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.12 0.42 0 499.7463 997.4769 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.04 0.369 0 499.7463 997.477 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.29 0.303 0 499.7465 997.4773 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.12 0.388 0 499.7465 997.4774 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.11 0.407 0 499.7468 997.4779 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 1.8 0.341 0 499.7468 997.4779 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 1.96 0.359 0 499.7474 997.4792 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 1.97 0.29 0 499.7475 997.4793 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 1.99 0.323 0 499.7479 997.4801 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 1.96 0.211 1.28 499.7483 997.4809 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLMK 95.00% 2.23 0.342 0 499.7494 997.4831 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IWHHTFYNELR 95.00% 2.87 0.316 0 505.9202 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IWHHTFYNELR 95.00% 1.85 0.22 0 505.9204 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IWHHTFYNELR 95.00% 2.02 0.255 0 505.9218 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 1.9 0.249 0 506.2364 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 2.46 0.406 0 506.2366 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 3.19 0.469 0 506.2372 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 3.26 0.496 0 506.2374 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 2.37 0.293 0 506.238 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 2.51 0.459 0 506.238 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 2.86 0.456 0 506.2381 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 3.19 0.487 0 506.2382 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 2.89 0.429 0 506.2383 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 2.6 0.439 0 506.2383 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 2.84 0.415 0 506.2386 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLmK 95.00% 1.93 0.332 0 m7: Oxidation (+15.99) 507.7431 1,013.47 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLTDYLmK 95.00% 2.1 0.364 0 m7: Oxidation (+15.99) 507.7436 1,013.47 1,014.48 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPER 95.00% 2.26 0.243 0 518.8277 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPER 95.00% 2.44 0.242 0 518.8279 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPER 95.00% 2.36 0.231 0 518.8281 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPER 95.00% 2.51 0.232 0 518.8282 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPER 95.00% 2.52 0.26 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPER 95.00% 2.05 0.26 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPER 95.00% 2.5 0.2 0 518.8285 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPER 95.00% 2.51 0.22 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPER 95.00% 2.59 0.219 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPER 95.00% 2.18 0.231 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPER 95.00% 2.44 0.212 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPER 95.00% 2.45 0.222 0 518.829 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 2.94 0.446 0 541.9503 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 2.36 0.326 0 541.9505 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 3.36 0.473 0 541.9511 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 2.95 0.483 0 541.9512 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 3.18 0.488 1 541.9516 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 2.86 0.471 1.57 541.9519 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 2.22 0.242 0 541.952 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 2.18 0.292 0 541.9521 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 3.1 0.489 0 542.285 1,623.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 2.97 0.454 1.55 542.2856 1,623.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 3.16 0.463 1.16 542.2863 1,623.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 2.22 0.296 0 542.2882 1,623.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAEREIVR 95.00% 2.17 0.222 0 543.9456 1,628.81 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAEREIVR 95.00% 2.1 0.446 0 543.9456 1,628.81 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLmK 95.00% 3.41 0.25 0 m13: Oxidation (+15.99) 547.2824 1,638.82 1,639.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLmK 95.00% 3.11 0.298 0 m13: Oxidation (+15.99) 547.2825 1,638.82 1,639.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLmK 95.00% 2.66 0.323 0 m13: Oxidation (+15.99) 547.2831 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.92 0.416 3.47 566.7655 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.87 0.42 2.89 566.7657 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 3.09 0.528 3.41 566.7658 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.92 0.562 2.92 566.7661 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.97 0.486 2.74 566.7661 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.92 0.478 2.66 566.7663 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 3.26 0.592 2.28 566.7664 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 3.08 0.52 3.14 566.7666 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.84 0.518 4.72 566.7666 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.92 0.503 2.82 566.7668 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.99 0.536 3.92 566.7669 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.94 0.512 2.59 566.7671 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 3.04 0.542 2.51 566.7688 1,131.52 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.93 0.452 2.1 566.7707 1,131.53 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.14 0.336 0 566.9771 1,131.94 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.02 0.396 0 566.9772 1,131.94 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAER 95.00% 2.07 0.361 2.21 567.3111 1,132.61 1,132.53 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.43 0.334 0 581.3109 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.74 0.38 0 581.3111 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.46 0.358 0 581.3114 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.83 0.374 0 581.3117 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.06 0.225 1.16 581.312 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.98 0.502 1.6 581.3122 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.85 0.365 1.24 581.3123 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.86 0.387 1.7 581.3125 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.71 0.426 1.96 581.3126 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.43 0.38 0 581.3127 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.86 0.406 1.85 581.3127 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.47 0.356 0 581.3128 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.38 0.289 0 581.3134 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.03 0.355 0 581.3138 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.94 0.343 0 581.3141 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.27 0.357 1.17 581.3142 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.11 0.286 0 581.3144 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.47 0.353 1.43 581.3147 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.04 0.344 0 581.3149 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.32 0.217 1.34 581.3152 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.48 0.431 1.31 581.3155 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.22 0.435 0 581.3167 1,160.62 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTMK 95.00% 2.14 0.312 0 581.3217 1,160.63 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% IKIIAPPERK 95.00% 2.17 0.246 0 582.8756 1,163.74 1,164.75 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.19 0.446 3.59 586.2862 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.51 0.48 3.7 586.2868 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.88 0.488 3.62 586.2871 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.63 0.448 5.19 586.2881 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.94 0.495 4.18 586.2883 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.92 0.395 3.77 586.2885 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.8 0.458 4.54 586.2885 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 3.08 0.451 4 586.2885 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.8 0.496 4.03 586.2885 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.85 0.461 4.72 586.2888 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.76 0.489 4.54 586.2889 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.49 0.437 5.06 586.2891 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.38 0.306 4.01 586.2891 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.84 0.447 3.85 586.2892 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQK 95.00% 2.53 0.396 3.33 586.2892 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.7 0.278 0 m10: Oxidation (+15.99) 589.3086 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.76 0.142 0 m10: Oxidation (+15.99) 589.3087 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.61 0.272 2.09 m10: Oxidation (+15.99) 589.3091 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.84 0.249 0 m10: Oxidation (+15.99) 589.3092 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.84 0.237 0 m10: Oxidation (+15.99) 589.3092 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.5 0.197 0 m10: Oxidation (+15.99) 589.3094 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.72 0.325 1.21 m10: Oxidation (+15.99) 589.3094 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.66 0.289 0 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.77 0.269 2.89 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.66 0.255 1.77 m10: Oxidation (+15.99) 589.3096 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.83 0.316 0 m10: Oxidation (+15.99) 589.3101 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.11 0.263 0 m10: Oxidation (+15.99) 589.3101 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.67 0.235 1.62 m10: Oxidation (+15.99) 589.3103 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% EITALAPSTmK 95.00% 2.04 0.266 0 m10: Oxidation (+15.99) 589.3116 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVmVGMGQK 95.00% 2.43 0.3 2.24 m5: Oxidation (+15.99) 594.2857 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVmVGMGQK 95.00% 2.24 0.373 2.34 m5: Oxidation (+15.99) 594.2862 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVmVGMGQK 95.00% 1.88 0.251 2.13 m5: Oxidation (+15.99) 594.2869 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGmGQK 95.00% 2.42 0.444 3.92 m8: Oxidation (+15.99) 594.2871 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVmVGMGQK 95.00% 2.16 0.333 2.62 m5: Oxidation (+15.99) 594.2873 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGmGQK 95.00% 2.53 0.473 2.7 m8: Oxidation (+15.99) 594.288 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.5 0.472 4 597.6349 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 3.94 0.45 3.39 597.6355 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 2.82 0.179 0 597.9683 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 3.82 0.374 2.33 597.9684 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.12 0.434 4.11 597.9694 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.78 0.504 2.36 597.9695 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSK 95.00% 2.41 0.374 4.18 599.7646 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSK 95.00% 3.23 0.417 5.08 599.7647 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSK 95.00% 2.96 0.471 3.09 599.7648 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSK 95.00% 3.07 0.474 3.89 599.7652 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSK 95.00% 2.49 0.327 2.57 599.7657 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSK 95.00% 2.67 0.238 2.82 599.7664 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSK 95.00% 2.12 0.347 0 599.7671 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.33 0.216 0 599.8549 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.58 0.355 0 599.8551 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.41 0.279 0 599.8553 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.48 0.228 1.34 599.8553 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.64 0.271 0 599.8556 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.27 0.297 0 599.8561 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.49 0.254 0 599.8562 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.78 0.333 0 599.8562 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 94.70% 2.27 0.205 0 599.8563 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.79 0.342 0 599.8563 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.46 0.277 0 599.8565 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.28 0.283 0 599.8565 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.62 0.353 0 599.8571 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSK 95.00% 3 0.467 3.43 600.2675 1,198.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSK 95.00% 2.2 0.235 2.85 600.2683 1,198.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.62 0.306 0 600.3551 1,198.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AVFPSIVGRPR 95.00% 2.52 0.246 0 600.3582 1,198.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.26 0.00963 1.33 652.3599 1,954.06 1,954.07 3
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.2 0.059 1 652.3602 1,954.06 1,954.07 3
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.08 0.0526 1.21 652.3603 1,954.06 1,954.07 3
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 3.71 0.0423 1.21 652.3604 1,954.06 1,954.07 3
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.02 0.0307 1.44 652.3608 1,954.06 1,954.07 3
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSKR 95.00% 2.73 0.456 2.8 677.8163 1,353.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DSYVGDEAQSKR 95.00% 2.95 0.48 3 677.8174 1,353.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AGFAGDDAPRAVFPSIVGRPR 95.00% 5.1 0.534 1.82 719.7163 2,156.13 2,156.14 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% AGFAGDDAPRAVFPSIVGRPR 95.00% 5.17 0.501 3.77 719.7175 2,156.13 2,156.14 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% qEYDESGPSIVHR 95.00% 0 0 4.19 n-term: Pyro-cmC (-17.03) 750.3399 1,498.66 1,499.68 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% qEYDESGPSIVHR 95.00% 0 0 4 n-term: Pyro-cmC (-17.03) 750.3406 1,498.67 1,499.68 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% qEYDESGPSIVHR 95.00% 0 0 4.74 n-term: Pyro-cmC (-17.03) 750.3442 1,498.67 1,499.68 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 2.54 0.456 2.92 758.854 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 2.13 0.395 4.96 758.8545 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 2.73 0.36 1.47 758.855 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 2.76 0.445 3.25 758.855 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% QEYDESGPSIVHR 95.00% 2.58 0.443 5.07 758.8559 1,515.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% MQKEITALAPSTMK 95.00% 4.76 0.406 1.62 774.9094 1,547.80 1,548.81 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% MQKEITALAPSTMK 95.00% 4.82 0.437 1.92 774.9104 1,547.81 1,548.81 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.93 0.654 5.77 784.3633 2,350.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.74 0.677 4.7 784.6978 2,351.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.51 0.576 5.77 784.6981 2,351.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.59 0.626 5.48 m8: Oxidation (+15.99) 790.0278 2,367.06 2,367.07 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.84 0.676 4.89 m8: Oxidation (+15.99) 790.0281 2,367.06 2,367.07 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVmVGmGQKDSYVGDEAQSK 95.00% 3.8 0.62 2.96 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 795.3603 2,383.06 2,383.07 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 2.85 0.274 0 812.4223 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 3.27 0.34 3.3 812.4224 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 3.04 0.324 2.82 812.4231 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 3.07 0.344 2.82 812.4234 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLMK 95.00% 2.96 0.31 2.59 812.9249 1,623.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% GYSFTTTAEREIVR 95.00% 3.21 0.276 0 815.4166 1,628.82 1,629.82 2 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% LDLAGRDLTDYLmK 95.00% 3.06 0.156 1.96 m13: Oxidation (+15.99) 820.4215 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQKDSYVGDEAQSKR 95.00% 5.32 0.647 5.05 836.7299 2,507.17 2,507.18 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQKDSYVGDEAQSKR 95.00% 5.5 0.623 4.62 836.7305 2,507.17 2,507.18 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVmVGmGQKDSYVGDEAQSKR 95.00% 4.49 0.51 2.18 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 847.3937 2,539.16 2,539.17 3 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 3.63 0.48 5.02 895.9472 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 2.71 0.303 3 895.9479 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.8 0.599 5.44 895.9482 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 3.16 0.308 0 895.9482 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.72 0.6 5.31 895.9483 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.8 0.591 6.54 895.9483 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 3.13 0.41 0 895.9485 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.69 0.615 5.85 895.9488 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 3.81 0.564 4.82 895.9496 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.71 0.61 6.03 895.9501 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 2.97 0.511 2.66 895.9502 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.71 0.577 5.22 895.9503 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 2.95 0.518 2.41 895.9505 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 3.96 0.507 4.92 895.9517 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.11 0.504 4.32 895.9521 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 3.63 0.517 2.82 895.9528 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 3.95 0.483 6.17 895.9532 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.32 0.498 3.14 895.9535 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 3.67 0.484 4.19 896.4471 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.74 0.553 5.21 896.4489 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.59 0.564 5.38 896.4492 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 3.19 0.551 5.66 896.4499 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.67 0.61 6.37 896.4501 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.95 0.592 5.92 896.4501 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.68 0.557 4.77 896.4503 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.52 0.57 5.4 896.4507 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.59 0.506 5.62 896.4513 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.35 0.491 5.28 896.4541 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.24 0.513 5.35 896.4547 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.09 0.571 4.41 896.4549 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 3.73 0.544 3.46 896.4555 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% SYELPDGQVITIGNER 95.00% 4.18 0.456 3.89 896.4557 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 3.51 0.343 2.96 977.5312 1,953.05 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.46 0.351 4.66 977.5335 1,953.05 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.27 0.341 5.54 977.5336 1,953.05 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 3.28 0.36 3.24 977.5337 1,953.05 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.16 0.386 5 977.5337 1,953.05 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.53 0.382 6.29 977.5338 1,953.05 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.23 0.349 4.68 977.5349 1,953.05 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.31 0.307 5.57 978.0318 1,954.05 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 3.47 0.27 1.96 978.0322 1,954.05 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 3.88 0.237 3.03 978.0341 1,954.05 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.34 0.215 4.4 978.0351 1,954.05 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 3.78 0.354 4.48 978.0353 1,954.06 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.35 0.219 4.33 978.0357 1,954.06 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.46 0.286 4.41 978.0361 1,954.06 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.65 0.261 4.96 978.0368 1,954.06 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.43 0.235 4.49 978.0368 1,954.06 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.5 0.308 5.21 978.0369 1,954.06 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.38 0.234 5.66 978.037 1,954.06 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.2 0.243 5.05 978.0371 1,954.06 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 3.88 0.336 5.46 978.0371 1,954.06 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% VAPEEHPVLLTEAPLNPK 95.00% 4.13 0.352 5.89 978.0377 1,954.06 1,954.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% TTGIVMDSGDGVTHTVPIYEGYALPHAILR 95.00% 7.11 0.602 6.07 1,062.21 3,183.60 3,183.62 3
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLYANTVLSGGTTMYPGIADR 95.00% 6.12 0.704 6.2 1,108.04 2,214.06 2,215.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLYANTVLSGGTTMYPGIADR 95.00% 5.4 0.397 5.8 1,108.54 2,215.06 2,215.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLYANTVLSGGTTMYPGIADR 95.00% 6.31 0.451 5.17 1,108.54 2,215.06 2,215.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% DLYANTVLSGGTTmYPGIADR 95.00% 4.61 0.654 4.59 m14: Oxidation (+15.99) 1,116.54 2,231.06 2,231.07 2
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.87 0.665 9.74 1,176.54 2,351.07 2,351.08 2 ACTC_HUMAN
 SAMPLE 3 Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 5 7 67 54.70% HQGVMVGMGQKDSYVGDEAQSK 95.00% 6.09 0.65 9 1,176.54 2,351.07 2,351.08 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DSYVGDEAQSKR 95.00% 2.13 0.3 0 452.2142 1,353.62 1,354.62 3 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 2.19 0.434 0 473.2779 944.5401 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 2.23 0.424 0 473.2782 944.5407 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 2.13 0.462 0 473.2789 944.5421 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 2.19 0.368 0 473.2792 944.5427 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 2.04 0.338 0 473.2792 944.5428 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 2.03 0.443 0 473.2793 944.5429 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 1.7 0.296 0 473.2794 944.5431 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 2.06 0.36 0 473.2794 944.5432 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 1.96 0.364 0 473.2795 944.5434 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 1.94 0.365 0 473.2795 944.5434 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 1.79 0.347 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 2.12 0.499 0 473.2797 944.5437 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 2.01 0.363 0 473.2798 944.544 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 1.88 0.367 0 473.2799 944.5442 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 1.9 0.322 0 473.2802 944.5447 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGR 95.00% 2.27 0.415 0 473.2802 944.5448 945.5522 2 CPXM2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,KTN1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AGFAGDDAPR 95.00% 2.72 0.361 1.39 488.7266 975.4375 976.449 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AGFAGDDAPR 95.00% 3.38 0.49 1.66 488.727 975.4384 976.449 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AGFAGDDAPR 95.00% 3.42 0.468 1.21 488.727 975.4384 976.449 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AGFAGDDAPR 95.00% 2.88 0.277 1.14 488.7275 975.4394 976.449 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AGFAGDDAPR 95.00% 2.76 0.315 1.17 488.7277 975.4398 976.449 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLTDYLMK 95.00% 2.21 0.351 0 499.7459 997.4761 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLTDYLMK 95.00% 1.75 0.324 0 499.7459 997.4762 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLTDYLMK 95.00% 2.1 0.351 0 499.746 997.4764 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLTDYLMK 95.00% 1.94 0.344 0 499.746 997.4764 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLTDYLMK 95.00% 2.17 0.402 0 499.7461 997.4765 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLTDYLMK 95.00% 1.82 0.335 0 499.7461 997.4765 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLTDYLMK 95.00% 1.98 0.35 1.19 499.7462 997.4767 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLTDYLMK 95.00% 2.05 0.403 0 499.7463 997.4769 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLTDYLMK 95.00% 1.82 0.38 0 499.7464 997.4772 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLTDYLMK 95.00% 1.74 0.343 0 499.7465 997.4773 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLTDYLMK 95.00% 2.28 0.394 0 499.7465 997.4774 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLTDYLMK 95.00% 2.1 0.426 0 499.7469 997.4782 998.4871 2 ACTC_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IWHHTFYNELR 95.00% 2.48 0.368 0 505.9207 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IWHHTFYNELR 95.00% 1.92 0.308 0 505.9215 1,514.74 1,515.75 3 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% QEYDESGPSIVHR 95.00% 2.64 0.456 0 506.2378 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% QEYDESGPSIVHR 95.00% 2.38 0.322 0 506.2379 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% QEYDESGPSIVHR 95.00% 2.83 0.437 0 506.2382 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% QEYDESGPSIVHR 95.00% 2.72 0.437 0 506.2385 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% QEYDESGPSIVHR 95.00% 2.99 0.417 0 506.2386 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% QEYDESGPSIVHR 95.00% 3.2 0.495 0 506.2387 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% QEYDESGPSIVHR 95.00% 2.72 0.425 0 506.2388 1,515.69 1,516.70 3 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2 0.234 0 518.8281 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2.28 0.21 0 518.8282 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2.34 0.26 0 518.8283 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2.56 0.227 0 518.8285 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2.54 0.219 0 518.8285 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2.26 0.249 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2.49 0.227 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2.01 0.264 0 518.8286 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2.38 0.216 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2.3 0.22 0 518.8288 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2.2 0.297 0 518.8289 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2.19 0.249 0 518.8289 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 2.05 0.282 0 518.8289 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPER 95.00% 1.97 0.264 0 518.829 1,035.64 1,036.65 2 K22E_HUMAN,ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 3.08 0.498 0 541.9503 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 2.98 0.483 1.14 541.9504 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 2.21 0.213 0 541.9509 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 3.11 0.473 0 541.9509 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 3.08 0.463 0 541.951 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 2.85 0.511 0 541.951 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 2.39 0.344 0 541.951 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 2.36 0.199 0 541.951 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 2.35 0.307 0 541.9512 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 3.17 0.443 0 541.9514 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 3.06 0.411 0 541.9515 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 2.36 0.285 0 541.9519 1,622.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 2.78 0.421 0 542.2848 1,623.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 3.04 0.415 0 542.2852 1,623.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 2.45 0.263 0 542.2858 1,623.83 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 2.43 0.236 0 542.2864 1,623.84 1,623.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAEREIVR 95.00% 2 0.367 0 543.946 1,628.81 1,629.82 3 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLmK 95.00% 3.16 0.418 0 m13: Oxidation (+15.99) 547.2824 1,638.82 1,639.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLmK 95.00% 2.58 0.329 0 m13: Oxidation (+15.99) 547.2824 1,638.82 1,639.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLmK 95.00% 2.66 0.264 0 m13: Oxidation (+15.99) 547.2827 1,638.82 1,639.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLmK 95.00% 3.78 0.252 1.37 m13: Oxidation (+15.99) 547.283 1,638.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLmK 95.00% 3.43 0.36 0 m13: Oxidation (+15.99) 547.6164 1,639.83 1,639.84 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 3.03 0.489 2.8 566.7651 1,131.51 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 2.68 0.457 2.15 566.7652 1,131.51 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 2.8 0.538 2.96 566.7653 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 2.8 0.451 2.68 566.7655 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 2.96 0.566 2.89 566.7657 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 2.77 0.472 2.66 566.7659 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 2.46 0.428 1.62 566.766 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 2.47 0.379 2.59 566.7661 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 3.01 0.532 2.17 566.7663 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 3.1 0.535 2.49 566.7665 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 3.07 0.519 2.57 566.7665 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 3.18 0.566 2.64 566.7666 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 3.09 0.528 2.2 566.7667 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 2.99 0.545 2.62 566.7667 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 3.1 0.587 2.62 566.7674 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 2.88 0.543 2 566.7676 1,131.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 2.86 0.442 4.35 567.2666 1,132.52 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAER 95.00% 2.3 0.429 2.24 567.3114 1,132.61 1,132.53 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTMK 95.00% 2.71 0.323 0 581.31 1,160.60 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTMK 95.00% 2.6 0.292 0 581.3111 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTMK 95.00% 2.76 0.398 1.55 581.3118 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTMK 95.00% 2.58 0.342 0 581.312 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTMK 95.00% 2.78 0.401 0 581.312 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTMK 95.00% 2.82 0.359 1.33 581.3121 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTMK 95.00% 2.92 0.379 1.28 581.3123 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTMK 95.00% 2.64 0.369 0 581.3125 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTMK 95.00% 2.57 0.325 0 581.3125 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTMK 95.00% 2.69 0.265 0 581.313 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTMK 94.70% 2.04 0.242 0 581.3134 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTMK 95.00% 2.72 0.407 2.96 581.3135 1,160.61 1,161.62 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPERK 95.00% 2.16 0.235 0 582.8768 1,163.74 1,164.75 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IKIIAPPERK 95.00% 2.44 0.222 0 583.3763 1,164.74 1,164.75 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.13 0.403 3.33 586.2876 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.74 0.423 4.59 586.2878 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.76 0.453 3.85 586.2879 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.68 0.449 4.57 586.2879 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.71 0.469 4.02 586.288 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.46 0.452 3.8 586.2884 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.61 0.406 5.06 586.2884 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.59 0.457 3.89 586.2884 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.43 0.387 2.7 586.2884 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.65 0.442 4.66 586.2887 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.92 0.522 2.82 586.2888 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 3.17 0.508 4.46 586.2888 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 3.01 0.481 3.64 586.2889 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 3.12 0.461 4.35 586.2892 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.38 0.384 3.38 586.2895 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.3 0.37 3.09 586.2897 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.04 0.316 2.09 586.2899 1,170.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQK 95.00% 2.24 0.238 2.64 586.7887 1,171.56 1,171.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTmK 95.00% 2.68 0.219 0 m10: Oxidation (+15.99) 589.3081 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTmK 95.00% 2.76 0.169 0 m10: Oxidation (+15.99) 589.3089 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTmK 95.00% 2.88 0.313 2 m10: Oxidation (+15.99) 589.3093 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTmK 95.00% 2.65 0.205 0 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTmK 95.00% 2.54 0.301 1.09 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTmK 95.00% 2.81 0.361 1.12 m10: Oxidation (+15.99) 589.3095 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTmK 95.00% 2.48 0.164 1.09 m10: Oxidation (+15.99) 589.3097 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTmK 95.00% 2.67 0.304 0 m10: Oxidation (+15.99) 589.3097 1,176.60 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% EITALAPSTmK 95.00% 2.72 0.159 0 m10: Oxidation (+15.99) 589.3114 1,176.61 1,177.61 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,CO1A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVmVGMGQK 95.00% 2.08 0.258 2.77 m5: Oxidation (+15.99) 594.2863 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVmVGMGQK 95.00% 2.28 0.356 4.49 m5: Oxidation (+15.99) 594.2865 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVmVGMGQK 95.00% 2.29 0.186 1.62 m5: Oxidation (+15.99) 594.2867 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVmVGMGQK 95.00% 1.97 0.23 3.82 m5: Oxidation (+15.99) 594.2867 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVmVGMGQK 95.00% 2.81 0.425 4.48 m5: Oxidation (+15.99) 594.2868 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVmVGMGQK 95.00% 3.19 0.432 4.66 m5: Oxidation (+15.99) 594.287 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGmGQK 95.00% 2.42 0.444 4.02 m8: Oxidation (+15.99) 594.2871 1,186.56 1,187.57 2 ACTC_HUMAN,K2C1_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 5.02 0.507 2.42 597.6349 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 3.59 0.396 2.64 597.6352 1,789.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 3.51 0.394 1.66 597.6371 1,789.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.14 0.456 4.24 597.9685 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.22 0.404 3.8 597.969 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 3.74 0.454 2.17 597.9692 1,790.88 1,790.89 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.16 0.476 4.72 597.9698 1,790.89 1,790.89 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DSYVGDEAQSK 95.00% 2.68 0.295 4.52 599.7628 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DSYVGDEAQSK 95.00% 2.44 0.337 3.89 599.7632 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DSYVGDEAQSK 95.00% 2.73 0.351 4.54 599.7638 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DSYVGDEAQSK 95.00% 1.97 0.28 1.4 599.7644 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DSYVGDEAQSK 95.00% 2.13 0.273 1.24 599.7646 1,197.51 1,198.52 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DSYVGDEAQSK 95.00% 2.13 0.356 1.54 599.7655 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DSYVGDEAQSK 95.00% 2.92 0.428 4.37 599.7656 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DSYVGDEAQSK 95.00% 2.4 0.329 2.02 599.7669 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DSYVGDEAQSK 95.00% 2.76 0.291 4.92 599.7669 1,197.52 1,198.52 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGRPR 95.00% 2.11 0.26 0 599.8549 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGRPR 95.00% 2.43 0.239 0 599.8551 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGRPR 95.00% 2.62 0.337 0 599.8552 1,197.69 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGRPR 95.00% 2.33 0.272 0 599.8554 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGRPR 95.00% 2.5 0.29 0 599.8554 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGRPR 95.00% 2.24 0.253 0 599.8556 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGRPR 95.00% 2.77 0.366 0 599.8559 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGRPR 95.00% 2.74 0.337 0 599.856 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AVFPSIVGRPR 95.00% 2.81 0.356 0 599.8567 1,197.70 1,198.71 2 HSP7C_HUMAN,ACTC_HUMAN,CO4A1_HUMAN,LAMA5_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 3.83 0.0533 1.68 652.0259 1,953.05 1,954.07 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.21 0.0369 1.64 652.3598 1,954.06 1,954.07 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.15 0.0955 0 652.36 1,954.06 1,954.07 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.11 0.0654 2.48 652.3601 1,954.06 1,954.07 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 94.80% 3.87 0.0243 1.16 652.3602 1,954.06 1,954.07 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.09 0.0529 2.32 652.3605 1,954.06 1,954.07 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.26 0.062 1.59 652.3605 1,954.06 1,954.07 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 3.97 0.0479 1.42 652.3611 1,954.06 1,954.07 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DSYVGDEAQSKR 95.00% 2.96 0.564 4.96 677.8169 1,353.62 1,354.62 2 ACTC_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AGFAGDDAPRAVFPSIVGRPR 95.00% 4.56 0.434 2.48 719.3828 2,155.13 2,156.14 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% AGFAGDDAPRAVFPSIVGRPR 95.00% 4.65 0.536 3.55 719.7165 2,156.13 2,156.14 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLYANTVLSGGTTMYPGIADR 95.00% 3.8 0.386 2.64 739.3619 2,215.06 2,215.07 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLYANTVLSGGTTMYPGIADR 95.00% 2.65 0.353 0 739.3634 2,215.07 2,215.07 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% qEYDESGPSIVHR 95.00% 0 0 4.01 n-term: Pyro-cmC (-17.03) 750.3407 1,498.67 1,499.68 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% qEYDESGPSIVHR 95.00% 0 0 4.04 n-term: Pyro-cmC (-17.03) 750.3409 1,498.67 1,499.68 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% qEYDESGPSIVHR 95.00% 0 0 3.82 n-term: Pyro-cmC (-17.03) 750.3409 1,498.67 1,499.68 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% qEYDESGPSIVHR 95.00% 0 0 3.19 n-term: Pyro-cmC (-17.03) 750.3425 1,498.67 1,499.68 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IWHHTFYNELR 95.00% 2.59 0.463 1.23 758.3758 1,514.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% IWHHTFYNELR 95.00% 2.61 0.351 0 758.3797 1,514.74 1,515.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,SEPT2_HUMAN,DHSB_HUMAN,TITIN_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% QEYDESGPSIVHR 95.00% 2.11 0.427 1.62 758.8543 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% QEYDESGPSIVHR 95.00% 2.57 0.374 3.68 758.8545 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% QEYDESGPSIVHR 95.00% 2.48 0.462 1.82 758.8546 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% QEYDESGPSIVHR 95.00% 2.54 0.53 3 758.855 1,515.69 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% QEYDESGPSIVHR 95.00% 2.62 0.37 4.48 759.3559 1,516.70 1,516.70 2 RL9_HUMAN,H2A2A_HUMAN,H2A2C_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% MQKEITALAPSTMK 95.00% 4.85 0.416 1.89 774.9106 1,547.81 1,548.81 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% MQKEITALAPSTMK 95.00% 4.79 0.456 3.21 775.4118 1,548.81 1,548.81 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.2 0.679 4.85 784.6971 2,351.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQKDSYVGDEAQSK 95.00% 4.85 0.636 4.62 784.6972 2,351.07 2,351.08 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.07 0.612 4.89 m8: Oxidation (+15.99) 790.0291 2,367.06 2,367.07 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGmGQKDSYVGDEAQSK 95.00% 4.4 0.68 4.44 m8: Oxidation (+15.99) 790.0303 2,367.07 2,367.07 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 3.18 0.352 1.62 812.4231 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 2.89 0.297 1.54 812.4232 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 3.02 0.344 3.2 812.424 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLMK 95.00% 3.02 0.314 2.57 812.4248 1,622.83 1,623.84 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% GYSFTTTAEREIVR 95.00% 3.05 0.381 0 815.4236 1,628.83 1,629.82 2 MYH9_HUMAN,COEA1_HUMAN,AHNK_HUMAN,RL27A_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLmK 95.00% 2.8 0.209 1.82 m13: Oxidation (+15.99) 820.4195 1,638.82 1,639.84 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LDLAGRDLTDYLmK 95.00% 2.8 0.16 2.42 m13: Oxidation (+15.99) 820.4208 1,638.83 1,639.84 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVmVGmGQKDSYVGDEAQSKR 95.00% 4.79 0.519 2.77 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 847.3947 2,539.16 2,539.17 3 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 5.68 0.105 0 c2: Carbamidomethyl (+57.02) 851.0623 2,550.16 2,550.17 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 5.95 0.228 2.89 c2: Carbamidomethyl (+57.02) 851.0626 2,550.16 2,550.17 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 6.23 0.151 0 c2: Carbamidomethyl (+57.02) 851.0626 2,550.16 2,550.17 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 6.11 0.225 3.52 c2: Carbamidomethyl (+57.02) 851.0632 2,550.17 2,550.17 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 5.78 0.267 4.13 c2: Carbamidomethyl (+57.02) 851.0638 2,550.17 2,550.17 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 5.87 0.146 0 c2: Carbamidomethyl (+57.02) 851.0652 2,550.17 2,550.17 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.66 0.633 5.15 895.9481 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.89 0.604 5.72 895.9485 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.76 0.557 4.89 895.9485 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 3.69 0.428 2.85 895.9487 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.81 0.593 6.72 895.949 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.28 0.557 5.68 895.9492 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.56 0.582 5.85 895.9496 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.62 0.611 5.4 895.9496 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.6 0.583 5.2 895.9498 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.05 0.566 6.31 895.9499 1,789.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.32 0.555 4.51 895.9513 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.21 0.562 5.68 895.9519 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 3.56 0.577 4.34 895.9528 1,789.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.87 0.582 4.92 896.4477 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.63 0.557 4.64 896.448 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.02 0.471 2.96 896.4484 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.68 0.578 5.4 896.4499 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.73 0.575 6.2 896.45 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.73 0.565 5.02 896.45 1,790.88 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.62 0.546 5.24 896.4506 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 3.3 0.326 2.3 896.4507 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.38 0.495 4.16 896.4512 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.53 0.551 4.11 896.4514 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.05 0.491 5.6 896.4524 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 3.42 0.397 3.37 896.4524 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.95 0.594 4.2 896.4524 1,790.89 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% SYELPDGQVITIGNER 95.00% 4.03 0.481 4.8 896.4568 1,790.90 1,790.89 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.23 0.333 4.77 977.5342 1,953.05 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 2.81 0.395 0 977.5351 1,953.05 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.11 0.358 6 977.5352 1,953.05 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.02 0.338 4.74 977.5358 1,953.06 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 3.91 0.394 4.41 978.0297 1,954.04 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.35 0.149 3.7 978.0335 1,954.05 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.37 0.109 7.21 978.0349 1,954.05 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.24 0.281 4.2 978.0351 1,954.05 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.38 0.143 6.24 978.0352 1,954.05 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.47 0.162 4.55 978.0354 1,954.06 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.57 0.245 5.14 978.0359 1,954.06 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 4.3 0.167 4.66 978.0361 1,954.06 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 3.69 0.39 3.85 978.0377 1,954.06 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% VAPEEHPVLLTEAPLNPK 95.00% 3.97 0.266 4.37 978.0379 1,954.06 1,954.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% TTGIVMDSGDGVTHTVPIYEGYALPHAILR 95.00% 6.3 0.555 7.02 1,062.21 3,183.60 3,183.62 3
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLYANTVLSGGTTMYPGIADR 95.00% 6.41 0.45 5.8 1,108.54 2,215.06 2,215.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLYANTVLSGGTTMYPGIADR 95.00% 6.2 0.491 3.96 1,108.54 2,215.06 2,215.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLYANTVLSGGTTMYPGIADR 95.00% 6.61 0.439 4.77 1,108.54 2,215.06 2,215.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% DLYANTVLSGGTTMYPGIADR 95.00% 5.71 0.401 5.35 1,108.54 2,215.06 2,215.07 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.77 0.636 8.41 1,176.54 2,351.07 2,351.08 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% HQGVMVGMGQKDSYVGDEAQSK 95.00% 5.93 0.623 9.32 1,176.54 2,351.07 2,351.08 2 ACTC_HUMAN
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 7.22 0.362 8.17 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.16 2,550.17 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 7.03 0.359 8.74 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.16 2,550.17 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 6.82 0.34 8.77 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.16 2,550.17 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 7.5 0.34 8.2 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.17 2,550.17 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 7.62 0.33 7.85 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.17 2,550.17 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 7.36 0.34 10.1 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.17 2,550.17 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 7.25 0.308 7.64 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.17 2,550.17 2
 SAMPLE 3R Actin, cytoplasmic 1  ACTB  ACTB_HUMAN,ACTG_HUMAN 41,719.80 100.00% 6 10 77 60.80% LcYVALDFEQEMATAASSSSLEK 95.00% 7.23 0.341 8.18 c2: Carbamidomethyl (+57.02) 1,276.09 2,550.17 2,550.17 2
 SAMPLE 3 Adenylate kinase isoenzyme 1  AK1  KAD1_HUMAN 21,617.10 99.80% 2 2 3 11.30% YGYTHLSTGDLLR 95.00% 4.19 0.501 2.92 499.2546 1,494.74 1,495.75 3
 SAMPLE 3 Adenylate kinase isoenzyme 1  AK1  KAD1_HUMAN 21,617.10 99.80% 2 2 3 11.30% YGYTHLSTGDLLR 95.00% 2.97 0.437 1.39 499.2552 1,494.74 1,495.75 3
 SAMPLE 3 Adenylate kinase isoenzyme 1  AK1  KAD1_HUMAN 21,617.10 99.80% 2 2 3 11.30% GFLIDGYPR 95.00% 2.69 0.467 1.77 519.2729 1,036.53 1,037.54 2
 SAMPLE 3R Adenylate kinase isoenzyme 1  AK1  KAD1_HUMAN 21,617.10 99.80% 2 2 2 11.30% YGYTHLSTGDLLR 95.00% 3.31 0.497 0.959 499.255 1,494.74 1,495.75 3
 SAMPLE 3R Adenylate kinase isoenzyme 1  AK1  KAD1_HUMAN 21,617.10 99.80% 2 2 2 11.30% GFLIDGYPR 95.00% 2.19 0.282 0 519.274 1,036.53 1,037.54 2
 SAMPLE 1 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 10 20.00% cVNTTLQIK 95.00% 2.76 0.178 0 c1: Carbamidomethyl (+57.02) 538.7912 1,075.57 1,076.58 2
 SAMPLE 1 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 10 20.00% EPAVLELEGK 95.00% 1.85 0.345 0 542.7971 1,083.58 1,084.59 2
 SAMPLE 1 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 10 20.00% EPAVLELEGK 95.00% 1.89 0.339 1.16 542.7975 1,083.58 1,084.59 2
 SAMPLE 1 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 10 20.00% EFHTTGLAWSK 95.00% 2.58 0.433 0 638.8176 1,275.62 1,276.63 2
 SAMPLE 1 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 10 20.00% LSDLLAPISEQIK 95.00% 3.34 0.416 1.66 713.9105 1,425.81 1,426.82 2
 SAMPLE 1 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 10 20.00% LSDLLAPISEQIK 95.00% 3.64 0.502 2.39 713.9109 1,425.81 1,426.82 2
 SAMPLE 1 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 10 20.00% ALLVTASQcQQPAENK 95.00% 4.89 0.588 5.28 c9: Carbamidomethyl (+57.02) 879.4459 1,756.88 1,757.89 2
 SAMPLE 1 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 10 20.00% ALLVTASQcQQPAENK 95.00% 5.1 0.59 3.74 c9: Carbamidomethyl (+57.02) 879.9461 1,757.88 1,757.89 2
 SAMPLE 1 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 10 20.00% SGPKPFSAPKPQTSPSPK 95.00% 4.04 0.371 0 919.9927 1,837.97 1,837.98 2 GELS_HUMAN
 SAMPLE 1 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 10 20.00% VENQENVSNLVIEDTELK 95.00% 6.28 0.6 4.16 1,037.52 2,073.02 2,073.04 2
 SAMPLE 1 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 10 20.00% VENQENVSNLVIEDTELK 95.00% 6.51 0.625 4.66 1,037.52 2,073.02 2,073.04 2
 SAMPLE 1R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 4 4 8 15.60% cVNTTLQIK 95.00% 2.59 0.149 0 c1: Carbamidomethyl (+57.02) 538.7906 1,075.57 1,076.58 2
 SAMPLE 1R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 4 4 8 15.60% cVNTTLQIK 94.90% 2.55 0.145 0 c1: Carbamidomethyl (+57.02) 538.791 1,075.57 1,076.58 2
 SAMPLE 1R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 4 4 8 15.60% SGPKPFSAPKPQTSPSPK 95.00% 2.53 0.234 0 613.3291 1,836.96 1,837.98 3 GELS_HUMAN
 SAMPLE 1R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 4 4 8 15.60% SGPKPFSAPKPQTSPSPK 95.00% 2.74 0.355 0 613.6655 1,837.97 1,837.98 3 GELS_HUMAN
 SAMPLE 1R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 4 4 8 15.60% LSDLLAPISEQIK 95.00% 3.45 0.468 3.28 713.9102 1,425.80 1,426.82 2
 SAMPLE 1R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 4 4 8 15.60% LSDLLAPISEQIK 95.00% 3.27 0.472 2.4 713.9107 1,425.81 1,426.82 2
 SAMPLE 1R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 4 4 8 15.60% ALLVTASQcQQPAENK 95.00% 5 0.518 4.77 c9: Carbamidomethyl (+57.02) 879.4449 1,756.87 1,757.89 2
 SAMPLE 1R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 4 4 8 15.60% ALLVTASQcQQPAENK 95.00% 4.71 0.582 5.21 c9: Carbamidomethyl (+57.02) 879.4455 1,756.88 1,757.89 2
 SAMPLE 1R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 4 4 8 15.60% SGPKPFSAPKPQTSPSPK 95.00% 3.85 0.308 1.77 919.4944 1,836.97 1,837.98 2 GELS_HUMAN
 SAMPLE 1R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 4 4 8 15.60% SGPKPFSAPKPQTSPSPK 95.00% 3.82 0.425 1.77 919.4967 1,836.98 1,837.98 2 GELS_HUMAN
 SAMPLE 1R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 4 4 8 15.60% VENQENVSNLVIEDTELK 95.00% 6 0.57 7.64 1,037.52 2,073.02 2,073.04 2
 SAMPLE 1R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 4 4 8 15.60% VENQENVSNLVIEDTELK 95.00% 6.25 0.61 5.02 1,037.52 2,073.03 2,073.04 2
 SAMPLE 3 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 7 7 12 16.20% cVNTTLQIK 95.00% 2.29 0.193 0 c1: Carbamidomethyl (+57.02) 538.7912 1,075.57 1,076.58 2
 SAMPLE 3 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 7 7 12 16.20% EPAVLELEGK 95.00% 1.77 0.22 1.08 542.7964 1,083.58 1,084.59 2
 SAMPLE 3 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 7 7 12 16.20% KEPAVLELEGK 95.00% 2.47 0.319 2.89 606.8435 1,211.67 1,212.68 2
 SAMPLE 3 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 7 7 12 16.20% KEPAVLELEGK 95.00% 2.34 0.329 2.6 606.8444 1,211.67 1,212.68 2
 SAMPLE 3 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 7 7 12 16.20% NSLDcEIVSAK 95.00% 2.26 0.367 2.2 c5: Carbamidomethyl (+57.02) 618.2982 1,234.58 1,235.59 2
 SAMPLE 3 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 7 7 12 16.20% NSLDcEIVSAK 95.00% 3.66 0.541 2.77 c5: Carbamidomethyl (+57.02) 618.2997 1,234.58 1,235.59 2
 SAMPLE 3 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 7 7 12 16.20% NSLDcEIVSAK 95.00% 3.59 0.484 2.52 c5: Carbamidomethyl (+57.02) 618.3002 1,234.58 1,235.59 2
 SAMPLE 3 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 7 7 12 16.20% EMNDAAMFYTNR 95.00% 2.67 0.367 1.64 731.8071 1,461.60 1,462.61 2
 SAMPLE 3 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 7 7 12 16.20% EMNDAAMFYTNR 95.00% 2.9 0.407 1.36 731.8075 1,461.60 1,462.61 2
 SAMPLE 3 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 7 7 12 16.20% ALLVTASQcQQPAENK 95.00% 4.67 0.574 2.89 c9: Carbamidomethyl (+57.02) 879.4456 1,756.88 1,757.89 2
 SAMPLE 3 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 7 7 12 16.20% ALLVTASQcQQPAENK 95.00% 4.35 0.543 3.43 c9: Carbamidomethyl (+57.02) 879.4469 1,756.88 1,757.89 2
 SAMPLE 3 Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 7 7 12 16.20% VENQENVSNLVIEDTELK 95.00% 5.68 0.592 6 1,037.52 2,073.02 2,073.04 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% PFSAPKPQTSPSPK 95.00% 2.23 0.273 0 490.2642 1,467.77 1,468.78 3
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% KEPAVLELEGK 95.00% 2.4 0.285 3.77 606.8441 1,211.67 1,212.68 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% KEPAVLELEGK 95.00% 2.24 0.226 1.89 606.8447 1,211.67 1,212.68 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% KEPAVLELEGK 95.00% 2.26 0.247 2.96 606.8449 1,211.67 1,212.68 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% SGPKPFSAPKPQTSPSPK 95.00% 2.14 0.254 0 613.3295 1,836.96 1,837.98 3 GELS_HUMAN
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% SGPKPFSAPKPQTSPSPK 95.00% 2.41 0.252 0 613.6642 1,837.97 1,837.98 3 GELS_HUMAN
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% NSLDcEIVSAK 95.00% 3.36 0.506 1.8 c5: Carbamidomethyl (+57.02) 618.2994 1,234.58 1,235.59 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% NSLDcEIVSAK 95.00% 2.79 0.459 3 c5: Carbamidomethyl (+57.02) 618.3003 1,234.59 1,235.59 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% EMNDAAMFYTNR 95.00% 2.71 0.404 1.82 731.8064 1,461.60 1,462.61 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% EMNDAAMFYTNR 95.00% 2.09 0.254 0 731.809 1,461.60 1,462.61 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% ALLVTASQcQQPAENK 95.00% 5.03 0.555 3.82 c9: Carbamidomethyl (+57.02) 879.9428 1,757.87 1,757.89 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% ALLVTASQcQQPAENK 95.00% 4.86 0.548 4.3 c9: Carbamidomethyl (+57.02) 879.9449 1,757.87 1,757.89 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% ALLVTASQcQQPAENK 95.00% 4.84 0.549 5.28 c9: Carbamidomethyl (+57.02) 879.9458 1,757.88 1,757.89 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% VENQENVSNLVIEDTELK 95.00% 4.96 0.535 5.04 1,037.01 2,072.01 2,073.04 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% VENQENVSNLVIEDTELK 95.00% 4.37 0.52 3.15 1,037.02 2,072.02 2,073.04 2
 SAMPLE 3R Adenylyl cyclase-associated protein 1  CAP1  CAP1_HUMAN 51,837.50 100.00% 6 6 14 18.10% VENQENVSNLVIEDTELK 95.00% 6.17 0.568 4.57 1,037.52 2,073.03 2,073.04 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% ILNPGEYR 95.00% 2.39 0.36 0 481.2579 960.5001 961.5108 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% ILNPGEYR 95.00% 2.32 0.323 0 481.2584 960.5011 961.5108 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% ILNPGEYR 95.00% 2.24 0.24 0 481.2587 960.5017 961.5108 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% FTGVITQGR 95.00% 3.24 0.45 1.62 489.771 977.5263 978.5374 2 CPXM2_HUMAN
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% FTGVITQGR 95.00% 3.14 0.462 2.06 489.7718 977.5279 978.5374 2 CPXM2_HUMAN
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% TPTQEQLLAAAMAAAR 95.00% 4.09 0.51 2.09 548.2885 1,641.84 1,642.86 3
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% TPTQEQLLAAAMAAAR 95.00% 4.41 0.522 2.4 548.2905 1,641.85 1,642.86 3
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% TPTQEQLLAAAMAAAR 95.00% 3.7 0.502 2.12 548.2906 1,641.85 1,642.86 3
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% TPTQEQLLAAAMAAAR 95.00% 2.44 0.304 0.959 548.2908 1,641.85 1,642.86 3
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% TPTQEQLLAAAMAAAR 95.00% 4.26 0.525 2.7 548.2908 1,641.85 1,642.86 3
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% TPTQEQLLAAAMAAAR 95.00% 3.19 0.446 1.15 548.2914 1,641.85 1,642.86 3
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% KGEELEEEWTPTEK 95.00% 3.53 0.35 0 568.9354 1,703.78 1,704.80 3
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% KGEELEEEWTPTEK 95.00% 3.73 0.409 0 568.9357 1,703.78 1,704.80 3
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% KGEELEEEWTPTEK 95.00% 2.78 0.235 0 568.9358 1,703.78 1,704.80 3
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% KGEELEEEWTPTEK 95.00% 3.43 0.295 0 569.2723 1,704.79 1,704.80 3
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% VPNNNLPIPER 95.00% 2.46 0.321 1.7 631.8445 1,261.67 1,262.69 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% VVNEEcPTITR 95.00% 2.64 0.447 0 c6: Carbamidomethyl (+57.02) 659.3245 1,316.63 1,317.65 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% VVNEEcPTITR 95.00% 3.56 0.549 2.82 c6: Carbamidomethyl (+57.02) 659.3255 1,316.64 1,317.65 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% VVNEEcPTITR 95.00% 3.14 0.485 2.82 c6: Carbamidomethyl (+57.02) 659.3259 1,316.64 1,317.65 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% VVNEEcPTITR 95.00% 2.68 0.374 1.19 c6: Carbamidomethyl (+57.02) 659.3264 1,316.64 1,317.65 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% VVNEEcPTITR 95.00% 3.75 0.523 2.92 c6: Carbamidomethyl (+57.02) 659.3265 1,316.64 1,317.65 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% VVNEEcPTITR 95.00% 2.85 0.473 1.55 c6: Carbamidomethyl (+57.02) 659.3268 1,316.64 1,317.65 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% YLSPDATVSTEVR 95.00% 3.37 0.564 4.92 719.3634 1,436.71 1,437.72 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% YLSPDATVSTEVR 95.00% 3.65 0.444 6.14 719.3636 1,436.71 1,437.72 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% NPFVLGANLNGGER 95.00% 4.92 0.481 3.08 729.3766 1,456.74 1,457.75 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% NPFVLGANLNGGER 95.00% 4 0.371 3.72 729.3779 1,456.74 1,457.75 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% NPFVLGANLNGGER 95.00% 4.79 0.423 3.35 729.3787 1,456.74 1,457.75 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% NPFVLGANLNGGER 95.00% 4.15 0.505 3.47 729.8788 1,457.74 1,457.75 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% TPTQEQLLAAAMAAAR 95.00% 4.82 0.683 8.09 821.9312 1,641.85 1,642.86 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% TPTQEQLLAAAMAAAR 95.00% 4.4 0.656 6.49 821.9325 1,641.85 1,642.86 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% KGEELEEEWTPTEK 95.00% 4.88 0.434 2.64 852.9011 1,703.79 1,704.80 2
 SAMPLE 1 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 8 10 32 8.29% KGEELEEEWTPTEK 95.00% 5.23 0.407 4.35 852.9021 1,703.79 1,704.80 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% ILNPGEYR 95.00% 2.16 0.202 0 481.2577 960.4997 961.5108 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% ILNPGEYR 95.00% 2.12 0.262 0 481.2579 960.5002 961.5108 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% ILNPGEYR 95.00% 2.32 0.211 0 481.2581 960.5005 961.5108 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% FTGVITQGR 95.00% 2.81 0.35 1.44 489.7695 977.5233 978.5374 2 CPXM2_HUMAN
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% FTGVITQGR 95.00% 2.53 0.353 1.64 489.7711 977.5266 978.5374 2 CPXM2_HUMAN
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% FTGVITQGR 95.00% 2.56 0.381 1.6 489.7714 977.5271 978.5374 2 CPXM2_HUMAN
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% TPTQEQLLAAAMAAAR 95.00% 4.16 0.561 3.09 548.2889 1,641.84 1,642.86 3
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% TPTQEQLLAAAMAAAR 95.00% 4.29 0.563 2.27 548.2892 1,641.84 1,642.86 3
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% TPTQEQLLAAAMAAAR 95.00% 4.5 0.506 2.66 548.2898 1,641.85 1,642.86 3
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% TPTQEQLLAAAMAAAR 95.00% 4.29 0.553 3.46 548.2903 1,641.85 1,642.86 3
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% TPTQEQLLAAAMAAAR 95.00% 3.56 0.328 2.6 548.6233 1,642.85 1,642.86 3
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% TPTQEQLLAAAMAAAR 95.00% 3.54 0.437 1.02 548.6246 1,642.85 1,642.86 3
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% KGEELEEEWTPTEK 95.00% 3.97 0.346 0 568.936 1,703.78 1,704.80 3
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% KGEELEEEWTPTEK 95.00% 3.81 0.336 0 569.2713 1,704.79 1,704.80 3
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% KGEELEEEWTPTEK 95.00% 2.64 0.198 0 569.2731 1,704.80 1,704.80 3
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% VPNNNLPIPER 95.00% 2.09 0.298 0 631.844 1,261.67 1,262.69 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% VPNNNLPIPER 95.00% 3.04 0.302 1.34 631.8446 1,261.67 1,262.69 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% VPNNNLPIPER 95.00% 2.72 0.265 0 631.8451 1,261.67 1,262.69 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% VPNNNLPIPER 95.00% 2.7 0.272 0 631.8455 1,261.68 1,262.69 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% VVNEEcPTITR 95.00% 2.53 0.405 0 c6: Carbamidomethyl (+57.02) 659.324 1,316.63 1,317.65 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% VVNEEcPTITR 95.00% 2.86 0.392 1.55 c6: Carbamidomethyl (+57.02) 659.3258 1,316.64 1,317.65 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% VVNEEcPTITR 95.00% 2.64 0.502 2.54 c6: Carbamidomethyl (+57.02) 659.3259 1,316.64 1,317.65 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% VVNEEcPTITR 95.00% 2.81 0.517 1.37 c6: Carbamidomethyl (+57.02) 659.8271 1,317.64 1,317.65 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% YLSPDATVSTEVR 95.00% 3.23 0.523 4.85 719.3637 1,436.71 1,437.72 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% YLSPDATVSTEVR 95.00% 3.13 0.49 5.54 719.3647 1,436.71 1,437.72 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% NPFVLGANLNGGER 95.00% 4.74 0.459 3.15 729.3771 1,456.74 1,457.75 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% NPFVLGANLNGGER 95.00% 4.47 0.445 4.21 729.3778 1,456.74 1,457.75 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% GEDEDEVSEAQETPDHAIFR 95.00% 2.41 0.268 0 758.8848 2,273.63 2,273.98 3
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% GEDEDEVSEAQETPDHAIFR 95.00% 4.3 0.571 1.08 758.9988 2,273.97 2,273.98 3
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% DTPVLSELPEPVVAR 95.00% 3.6 0.482 3.11 811.9433 1,621.87 1,621.88 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% TPTQEQLLAAAMAAAR 95.00% 5.3 0.703 8.17 821.932 1,641.85 1,642.86 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% TPTQEQLLAAAMAAAR 95.00% 5.35 0.669 8.26 821.9325 1,641.85 1,642.86 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% TPTQEQLLAAAMAAAR 95.00% 5.4 0.677 5.92 821.9331 1,641.85 1,642.86 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% KGEELEEEWTPTEK 95.00% 4.39 0.447 2.82 852.9018 1,703.79 1,704.80 2
 SAMPLE 1R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 11 13 35 13.00% TcNVDYDIGATQcNFILAR 95.00% 6.74 0.586 9.12 c2: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,116.51 2,231.01 2,231.02 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% ILNPGEYR 95.00% 2.4 0.222 0 481.2582 960.5007 961.5108 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% ILNPGEYR 95.00% 1.99 0.291 0 481.2585 960.5014 961.5108 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% ILNPGEYR 95.00% 2.26 0.283 0 481.2592 960.5027 961.5108 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% FTGVITQGR 95.00% 2.56 0.292 1.32 489.7708 977.526 978.5374 2 CPXM2_HUMAN
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% TPTQEQLLAAAMAAAR 95.00% 3.78 0.452 1.85 548.29 1,641.85 1,642.86 3
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% TPTQEQLLAAAMAAAR 95.00% 4.04 0.519 1.77 548.2908 1,641.85 1,642.86 3
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% KGEELEEEWTPTEK 95.00% 3.55 0.303 0 568.9366 1,703.79 1,704.80 3
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% VVNEEcPTITR 95.00% 2.53 0.353 2 c6: Carbamidomethyl (+57.02) 659.3259 1,316.64 1,317.65 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% VVNEEcPTITR 95.00% 2.98 0.507 1.7 c6: Carbamidomethyl (+57.02) 659.3261 1,316.64 1,317.65 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% VVNEEcPTITR 95.00% 3.1 0.538 1.6 c6: Carbamidomethyl (+57.02) 659.3263 1,316.64 1,317.65 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% VVNEEcPTITR 95.00% 3.08 0.531 1.66 c6: Carbamidomethyl (+57.02) 659.3266 1,316.64 1,317.65 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% YLSPDATVSTEVR 95.00% 3.27 0.528 4.62 719.364 1,436.71 1,437.72 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% YLSPDATVSTEVR 95.00% 3.28 0.523 4.04 719.3653 1,436.71 1,437.72 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% NPFVLGANLNGGER 95.00% 4.2 0.456 2.85 729.3766 1,456.74 1,457.75 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% NPFVLGANLNGGER 95.00% 4.23 0.398 3.27 729.3769 1,456.74 1,457.75 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% NPFVLGANLNGGER 95.00% 3.37 0.321 2.47 729.378 1,456.74 1,457.75 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% NPFVLGANLNGGER 95.00% 4.39 0.461 2.66 729.3806 1,456.75 1,457.75 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% KGEELEEEWTPTEK 95.00% 4.47 0.445 2.66 852.8958 1,703.78 1,704.80 2
 SAMPLE 2 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 8 18 8.98% GGcQAQDYTGGMGIVNGAK 95.00% 5.2 0.589 7.16 c3: Carbamidomethyl (+57.02) 942.9218 1,883.83 1,883.84 2 TITIN_HUMAN
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% ILNPGEYR 95.00% 2.29 0.2 0 481.2581 960.5005 961.5108 2
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% ILNPGEYR 95.00% 2.18 0.208 0 481.2586 960.5016 961.5108 2
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% FTGVITQGR 95.00% 2.25 0.231 0 489.7722 977.5287 978.5374 2 CPXM2_HUMAN
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% TPTQEQLLAAAMAAAR 95.00% 3.8 0.478 2.64 548.2899 1,641.85 1,642.86 3
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% TPTQEQLLAAAMAAAR 95.00% 3.25 0.435 2.59 548.2899 1,641.85 1,642.86 3
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% TPTQEQLLAAAMAAAR 95.00% 4.16 0.529 2.54 548.2909 1,641.85 1,642.86 3
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% TPTQEQLLAAAMAAAR 95.00% 4.16 0.526 2.47 548.2911 1,641.85 1,642.86 3
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% TPTQEQLLAAAMAAAR 95.00% 3.72 0.435 1.82 548.6243 1,642.85 1,642.86 3
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% TPTQEQLLAAAMAAAR 95.00% 4.38 0.518 2.68 548.6248 1,642.85 1,642.86 3
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% KGEELEEEWTPTEK 95.00% 3.6 0.367 0 568.9348 1,703.78 1,704.80 3
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% KGEELEEEWTPTEK 95.00% 3.27 0.194 0 568.9366 1,703.79 1,704.80 3
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% VVNEEcPTITR 95.00% 2.72 0.357 1.47 c6: Carbamidomethyl (+57.02) 659.3236 1,316.63 1,317.65 2
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% VVNEEcPTITR 95.00% 2.38 0.355 0 c6: Carbamidomethyl (+57.02) 659.325 1,316.63 1,317.65 2
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% VVNEEcPTITR 95.00% 2.76 0.485 2.46 c6: Carbamidomethyl (+57.02) 659.3264 1,316.64 1,317.65 2
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% YLSPDATVSTEVR 95.00% 2.58 0.305 3.92 719.3626 1,436.71 1,437.72 2
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% YLSPDATVSTEVR 95.00% 2.4 0.453 2.33 719.3649 1,436.71 1,437.72 2
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% YLSPDATVSTEVR 95.00% 3.28 0.552 4.38 719.3656 1,436.72 1,437.72 2
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% NPFVLGANLNGGER 95.00% 4.17 0.344 1.77 729.3767 1,456.74 1,457.75 2
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% NPFVLGANLNGGER 95.00% 3.93 0.444 1.43 729.378 1,456.74 1,457.75 2
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% NPFVLGANLNGGER 95.00% 3.81 0.424 2.92 729.3788 1,456.74 1,457.75 2
 SAMPLE 2R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 7 21 7.34% NPFVLGANLNGGER 95.00% 4.22 0.393 2.34 729.3795 1,456.74 1,457.75 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% ILNPGEYR 95.00% 2.42 0.357 0 481.2577 960.4997 961.5108 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% ILNPGEYR 95.00% 2.05 0.285 0 481.2581 960.5006 961.5108 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% ILNPGEYR 95.00% 2.19 0.217 0 481.2584 960.5012 961.5108 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% ILNPGEYR 95.00% 1.91 0.287 0 481.2585 960.5013 961.5108 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% AIIAWMEK 95.00% 1.84 0.313 1.09 481.2621 960.5086 961.5182 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% FTGVITQGR 95.00% 2.69 0.321 1.28 489.7723 977.529 978.5374 2 CPXM2_HUMAN
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% TPTQEQLLAAAMAAAR 95.00% 3.68 0.46 1.96 548.2892 1,641.84 1,642.86 3
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% TPTQEQLLAAAMAAAR 95.00% 4.1 0.529 3.11 548.2906 1,641.85 1,642.86 3
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% TPTQEQLLAAAMAAAR 95.00% 4.14 0.474 2.54 548.2909 1,641.85 1,642.86 3
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% TPTQEQLLAAAMAAAR 95.00% 4.29 0.538 3.54 548.2911 1,641.85 1,642.86 3
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% KGEELEEEWTPTEK 95.00% 3.32 0.336 0 568.9371 1,703.79 1,704.80 3
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% KGEELEEEWTPTEK 95.00% 3.91 0.235 0 569.2695 1,704.78 1,704.80 3
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% VPNNNLPIPER 95.00% 2.1 0.246 0 631.8457 1,261.68 1,262.69 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% VVNEEcPTITR 95.00% 3.01 0.495 1.44 c6: Carbamidomethyl (+57.02) 659.3257 1,316.64 1,317.65 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% VVNEEcPTITR 95.00% 2.9 0.469 1.33 c6: Carbamidomethyl (+57.02) 659.3264 1,316.64 1,317.65 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% VVNEEcPTITR 95.00% 2.4 0.359 1.34 c6: Carbamidomethyl (+57.02) 659.3269 1,316.64 1,317.65 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% YLSPDATVSTEVR 95.00% 2.93 0.481 6.02 719.3646 1,436.71 1,437.72 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% YLSPDATVSTEVR 95.00% 3.28 0.573 3.66 719.3647 1,436.71 1,437.72 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% NPFVLGANLNGGER 95.00% 3.88 0.384 1.82 729.3764 1,456.74 1,457.75 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% NPFVLGANLNGGER 95.00% 4.22 0.455 4.36 729.3789 1,456.74 1,457.75 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% NPFVLGANLNGGER 95.00% 4.61 0.424 2.92 729.8795 1,457.74 1,457.75 2
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% GEDEDEVSEAQETPDHAIFR 95.00% 2.58 0.383 0 758.8916 2,273.65 2,273.98 3
 SAMPLE 3 Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 10 10 23 10.70% GEDEDEVSEAQETPDHAIFR 95.00% 3.78 0.498 1.42 759.0001 2,273.98 2,273.98 3
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% ILNPGEYR 95.00% 2.07 0.248 0 481.2589 960.5021 961.5108 2
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% ILNPGEYR 95.00% 2 0.31 0 481.2589 960.5022 961.5108 2
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% ILNPGEYR 95.00% 2.19 0.257 0 481.2592 960.5027 961.5108 2
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% FTGVITQGR 95.00% 2.7 0.36 1.09 489.7713 977.5269 978.5374 2 CPXM2_HUMAN
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% FTGVITQGR 95.00% 2.81 0.296 1.46 489.7721 977.5285 978.5374 2 CPXM2_HUMAN
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% TPTQEQLLAAAMAAAR 95.00% 3.23 0.43 0 548.2898 1,641.85 1,642.86 3
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% TPTQEQLLAAAMAAAR 95.00% 4.32 0.555 3.19 548.2901 1,641.85 1,642.86 3
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% TPTQEQLLAAAMAAAR 95.00% 3.97 0.458 1.64 548.2906 1,641.85 1,642.86 3
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% TPTQEQLLAAAMAAAR 95.00% 4.02 0.472 2.04 548.6252 1,642.85 1,642.86 3
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% KGEELEEEWTPTEK 95.00% 3.54 0.33 0 568.9363 1,703.79 1,704.80 3
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% KGEELEEEWTPTEK 95.00% 3.19 0.25 0 569.2703 1,704.79 1,704.80 3
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% VPNNNLPIPER 95.00% 2.29 0.229 0 631.8435 1,261.67 1,262.69 2
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% VVNEEcPTITR 95.00% 2.61 0.472 1.38 c6: Carbamidomethyl (+57.02) 659.3261 1,316.64 1,317.65 2
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% VVNEEcPTITR 95.00% 2.08 0.339 0 c6: Carbamidomethyl (+57.02) 659.3279 1,316.64 1,317.65 2
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% VVNEEcPTITR 95.00% 2.62 0.426 0 c6: Carbamidomethyl (+57.02) 659.328 1,316.64 1,317.65 2
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% NPFVLGANLNGGER 95.00% 3.88 0.379 2.11 729.3789 1,456.74 1,457.75 2
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% TPTQEQLLAAAMAAAR 95.00% 3.26 0.534 1.13 821.933 1,641.85 1,642.86 2
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% TPTQEQLLAAAMAAAR 95.00% 5.02 0.648 6.55 822.4351 1,642.85 1,642.86 2
 SAMPLE 3R Adipocyte enhancer-binding protein 1  AEBP1  AEBP1_HUMAN 130,912.90 100.00% 7 9 19 7.17% KGEELEEEWTPTEK 95.00% 4.42 0.452 2.24 853.4009 1,704.79 1,704.80 2
 SAMPLE 2 ADP/ATP translocase 3  SLC25A6  ADT3_HUMAN 32,849.10 100.00% 3 3 4 10.70% EQGVLSFWR 95.00% 1.8 0.344 0 561.2867 1,120.56 1,121.57 2
 SAMPLE 2 ADP/ATP translocase 3  SLC25A6  ADT3_HUMAN 32,849.10 100.00% 3 3 4 10.70% AAYFGVYDTAK 95.00% 2.19 0.424 1.28 603.2936 1,204.57 1,205.58 2
 SAMPLE 2 ADP/ATP translocase 3  SLC25A6  ADT3_HUMAN 32,849.10 100.00% 3 3 4 10.70% AAYFGVYDTAK 95.00% 2.03 0.377 0 603.2939 1,204.57 1,205.58 2
 SAMPLE 2 ADP/ATP translocase 3  SLC25A6  ADT3_HUMAN 32,849.10 100.00% 3 3 4 10.70% YFPTQALNFAFK 95.00% 2.89 0.399 2.72 724.3771 1,446.74 1,446.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 2.04 0.295 0 c10: Carbamidomethyl (+57.02) 458.2373 1,371.69 1,372.60 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 4.25 0.363 2.96 c5: Carbamidomethyl (+57.02) 461.9138 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 4.7 0.351 2.8 c5: Carbamidomethyl (+57.02) 461.9138 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 2.45 0.226 0 c5: Carbamidomethyl (+57.02) 461.914 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 4.64 0.369 2.4 c5: Carbamidomethyl (+57.02) 461.9141 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 4.49 0.395 2.74 c5: Carbamidomethyl (+57.02) 461.9142 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 4.79 0.368 2.29 c5: Carbamidomethyl (+57.02) 461.9143 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.99 0.399 2.19 c5: Carbamidomethyl (+57.02) 461.9144 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 4.64 0.372 2.44 c5: Carbamidomethyl (+57.02) 461.9147 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 4.62 0.374 2 c5: Carbamidomethyl (+57.02) 461.9147 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 4.47 0.438 3.08 c5: Carbamidomethyl (+57.02) 461.9149 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 4.19 0.357 2.37 c5: Carbamidomethyl (+57.02) 461.9149 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.77 0.384 2.05 c5: Carbamidomethyl (+57.02) 461.9149 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 4.79 0.349 1.96 c5: Carbamidomethyl (+57.02) 461.9153 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 4.29 0.411 2.15 c5: Carbamidomethyl (+57.02) 461.9158 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 4.11 0.435 1.44 c5: Carbamidomethyl (+57.02) 461.9163 1,382.73 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.68 0.333 1.77 c5: Carbamidomethyl (+57.02) 461.9164 1,382.73 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 2.81 0.387 2.62 c5: Carbamidomethyl (+57.02) 461.9181 1,382.73 1,383.73 3 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YTLDFDR 95.00% 2.24 0.305 0 465.2214 928.4272 929.437 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YTLDFDR 95.00% 2.35 0.363 1.3 465.2217 928.4278 929.437 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YTLDFDR 95.00% 2.33 0.353 1.77 465.2218 928.428 929.437 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YTLDFDR 95.00% 2.26 0.374 1.52 465.2218 928.428 929.437 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YTLDFDR 95.00% 2.32 0.371 1.92 465.2221 928.4286 929.437 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YTLDFDR 95.00% 2.28 0.342 1.77 465.2223 928.4289 929.437 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YTLDFDR 95.00% 2.36 0.315 0 465.2224 928.4291 929.437 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YTLDFDR 95.00% 2.33 0.396 1.59 465.2224 928.4292 929.437 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YTLDFDR 95.00% 2.38 0.371 1.4 465.2227 928.4297 929.437 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YTLDFDR 95.00% 2.32 0.351 2.24 465.2227 928.4297 929.437 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YTLDFDR 95.00% 2.25 0.311 1.42 465.2228 928.4299 929.437 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YTLDFDR 95.00% 2.46 0.411 1.38 465.2231 928.4305 929.437 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 2.39 0.0914 1.01 481.6108 1,441.81 1,442.82 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 2.5 0.177 0 481.6123 1,441.81 1,442.82 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 2.99 0.305 1.14 481.6132 1,441.82 1,442.82 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.75 0.377 1.8 486.5832 1,456.73 1,457.74 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.85 0.284 1.14 486.5833 1,456.73 1,457.74 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.62 0.328 1.05 486.5835 1,456.73 1,457.74 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.7 0.424 1.57 486.5835 1,456.73 1,457.74 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.75 0.407 2.01 486.5835 1,456.73 1,457.74 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 3 0.421 1.2 486.5836 1,456.73 1,457.74 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.78 0.419 1.3 486.5837 1,456.73 1,457.74 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.71 0.171 0 486.5837 1,456.73 1,457.74 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 3.24 0.377 0 486.5839 1,456.73 1,457.74 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.79 0.42 1.92 486.5841 1,456.73 1,457.74 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.74 0.219 0 486.5842 1,456.73 1,457.74 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.54 0.336 1.85 486.5844 1,456.73 1,457.74 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% TPcVGDKDSSPGVR 95.00% 2.57 0.312 0 c3: Carbamidomethyl (+57.02) 492.2383 1,473.69 1,474.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% TPcVGDKDSSPGVR 95.00% 3.48 0.4 1.17 c3: Carbamidomethyl (+57.02) 492.2386 1,473.69 1,474.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% TPcVGDKDSSPGVR 95.00% 3.06 0.437 1.19 c3: Carbamidomethyl (+57.02) 492.5716 1,474.69 1,474.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YEINSLVR 95.00% 2.15 0.126 1.49 497.2707 992.5257 993.5369 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcRR 95.00% 1.59 0.362 0 c10: Carbamidomethyl (+57.02) 510.236 1,527.68 1,528.70 3 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% GTVAcGEPPVVEHAR 95.00% 2.68 0.395 0 c5: Carbamidomethyl (+57.02) 526.9274 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% GTVAcGEPPVVEHAR 95.00% 2.58 0.432 0 c5: Carbamidomethyl (+57.02) 526.9277 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.52 0.455 0.959 c3: Carbamidomethyl (+57.02) 543.5704 1,627.69 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.33 0.43 0 c3: Carbamidomethyl (+57.02) 543.5707 1,627.69 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.03 0.327 0 c3: Carbamidomethyl (+57.02) 543.5708 1,627.69 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.19 0.388 0 c3: Carbamidomethyl (+57.02) 543.571 1,627.69 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.15 0.438 0 c3: Carbamidomethyl (+57.02) 543.5712 1,627.69 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.37 0.269 0 c3: Carbamidomethyl (+57.02) 543.5715 1,627.69 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.6 0.432 0 c3: Carbamidomethyl (+57.02) 543.5715 1,627.69 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.26 0.401 0 c3: Carbamidomethyl (+57.02) 543.5715 1,627.69 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.02 0.336 0 c3: Carbamidomethyl (+57.02) 543.5715 1,627.69 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 2.3 0.174 0 c3: Carbamidomethyl (+57.02) 543.5718 1,627.69 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.22 0.426 0 c3: Carbamidomethyl (+57.02) 543.5731 1,627.70 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 2.83 0.335 1.06 c3: Carbamidomethyl (+57.02) 543.575 1,627.70 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.24 0.407 0 c3: Carbamidomethyl (+57.02) 543.9059 1,628.69 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 2.55 0.211 0 c3: Carbamidomethyl (+57.02) 543.9061 1,628.69 1,628.70 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% PNcGGNLLGVR 95.00% 3.04 0.446 0 c3: Carbamidomethyl (+57.02) 578.7962 1,155.58 1,156.59 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% PNcGGNLLGVR 95.00% 2.71 0.461 0 c3: Carbamidomethyl (+57.02) 578.7995 1,155.58 1,156.59 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSKEKEVVLLVATEGR 95.00% 3.5 0.468 0 586.3433 1,756.01 1,757.02 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSKEKEVVLLVATEGR 95.00% 3.46 0.359 0 586.3441 1,756.01 1,757.02 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSKEKEVVLLVATEGR 95.00% 3.31 0.382 0 586.6777 1,757.01 1,757.02 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 4.33 0.53 4.96 593.3439 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 3.22 0.496 2.54 593.3439 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 4.01 0.512 6.1 593.3443 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 4.03 0.507 5.17 593.3444 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 3.96 0.513 5.24 593.3445 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 4.28 0.529 6.46 593.3445 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 4.17 0.506 5.51 593.3446 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 4.3 0.534 5.02 593.3446 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 4.05 0.503 4.62 593.3447 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 4 0.512 4.74 593.3448 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 4.4 0.518 5.03 593.3449 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 4.28 0.549 4.19 593.3451 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 3.03 0.467 2.36 593.3451 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EVVLLVATEGR 95.00% 4.14 0.523 4.34 593.3451 1,184.67 1,185.68 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YQcTEGFVQR 95.00% 2.71 0.491 1.68 c3: Carbamidomethyl (+57.02) 644.2915 1,286.57 1,287.58 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YQcTEGFVQR 95.00% 3.29 0.543 2.07 c3: Carbamidomethyl (+57.02) 644.2924 1,286.57 1,287.58 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% YQcTEGFVQR 95.00% 3.25 0.529 2.8 c3: Carbamidomethyl (+57.02) 644.2934 1,286.57 1,287.58 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cYAGWLADGSLR 95.00% 2.93 0.438 3.74 c1: Carbamidomethyl (+57.02) 684.8192 1,367.62 1,368.64 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cYAGWLADGSLR 95.00% 3.91 0.61 3.85 c1: Carbamidomethyl (+57.02) 684.8195 1,367.62 1,368.64 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cYAGWLADGSLR 95.00% 3.51 0.576 3.89 c1: Carbamidomethyl (+57.02) 684.8195 1,367.62 1,368.64 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cYAGWLADGSLR 95.00% 3.11 0.461 1.77 c1: Carbamidomethyl (+57.02) 684.8197 1,367.62 1,368.64 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cYAGWLADGSLR 95.00% 3.72 0.609 3.82 c1: Carbamidomethyl (+57.02) 684.8199 1,367.62 1,368.64 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cYAGWLADGSLR 95.00% 2.17 0.268 1.41 c1: Carbamidomethyl (+57.02) 684.8203 1,367.62 1,368.64 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cYAGWLADGSLR 95.00% 3.59 0.541 2.68 c1: Carbamidomethyl (+57.02) 684.8206 1,367.63 1,368.64 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cYAGWLADGSLR 95.00% 3.21 0.524 3.7 c1: Carbamidomethyl (+57.02) 684.8208 1,367.63 1,368.64 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cYAGWLADGSLR 95.00% 4.44 0.616 4.23 c1: Carbamidomethyl (+57.02) 684.8212 1,367.63 1,368.64 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cYAGWLADGSLR 95.00% 2.92 0.509 3.47 c1: Carbamidomethyl (+57.02) 684.822 1,367.63 1,368.64 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cYAGWLADGSLR 95.00% 2.92 0.382 2.72 c1: Carbamidomethyl (+57.02) 684.8228 1,367.63 1,368.64 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 3.66 0.6 3.66 c10: Carbamidomethyl (+57.02) 686.7995 1,371.58 1,372.60 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 3.42 0.597 4.14 c10: Carbamidomethyl (+57.02) 686.7998 1,371.58 1,372.60 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 3.9 0.608 3.48 c10: Carbamidomethyl (+57.02) 686.7998 1,371.58 1,372.60 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 3.95 0.596 4.29 c10: Carbamidomethyl (+57.02) 686.7999 1,371.58 1,372.60 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 4.16 0.575 3.42 c10: Carbamidomethyl (+57.02) 686.8001 1,371.58 1,372.60 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 3.92 0.592 3.62 c10: Carbamidomethyl (+57.02) 686.8002 1,371.58 1,372.60 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 4.18 0.588 3.28 c10: Carbamidomethyl (+57.02) 686.8003 1,371.59 1,372.60 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 3.93 0.582 3.62 c10: Carbamidomethyl (+57.02) 686.8005 1,371.59 1,372.60 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 3.81 0.58 3.89 c10: Carbamidomethyl (+57.02) 686.8007 1,371.59 1,372.60 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 3.24 0.543 4 c10: Carbamidomethyl (+57.02) 686.8011 1,371.59 1,372.60 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 3.76 0.588 3.36 c10: Carbamidomethyl (+57.02) 686.8021 1,371.59 1,372.60 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% FTFQEAANEcR 95.00% 3.87 0.606 3.23 c10: Carbamidomethyl (+57.02) 686.8026 1,371.59 1,372.60 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.36 0.371 1.66 c5: Carbamidomethyl (+57.02) 692.3652 1,382.71 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.62 0.433 2.1 c5: Carbamidomethyl (+57.02) 692.3654 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.68 0.436 1.7 c5: Carbamidomethyl (+57.02) 692.3656 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.41 0.397 1.6 c5: Carbamidomethyl (+57.02) 692.3663 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.32 0.388 2.72 c5: Carbamidomethyl (+57.02) 692.3664 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.62 0.396 1.72 c5: Carbamidomethyl (+57.02) 692.3664 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.35 0.391 1.33 c5: Carbamidomethyl (+57.02) 692.3665 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.65 0.408 2.18 c5: Carbamidomethyl (+57.02) 692.3665 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.47 0.424 1.82 c5: Carbamidomethyl (+57.02) 692.3668 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.24 0.394 2.07 c5: Carbamidomethyl (+57.02) 692.3669 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.74 0.379 1.59 c5: Carbamidomethyl (+57.02) 692.3669 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.4 0.393 0 c5: Carbamidomethyl (+57.02) 692.3675 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.57 0.419 2.04 c5: Carbamidomethyl (+57.02) 692.3677 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% ARPNcGGNLLGVR 95.00% 3.41 0.433 1.4 c5: Carbamidomethyl (+57.02) 692.3679 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 5.02 0.484 1.52 c1: Carbamidomethyl (+57.02) 716.0102 2,145.01 2,145.02 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 5.05 0.509 1.2 c1: Carbamidomethyl (+57.02) 716.0107 2,145.01 2,145.02 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 4.85 0.472 3.6 c1: Carbamidomethyl (+57.02) 716.0109 2,145.01 2,145.02 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 3.26 0.406 0 c1: Carbamidomethyl (+57.02) 716.0109 2,145.01 2,145.02 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 5.29 0.546 2.74 c1: Carbamidomethyl (+57.02) 716.0124 2,145.01 2,145.02 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 4.22 0.517 1.04 c1: Carbamidomethyl (+57.02) 716.0128 2,145.01 2,145.02 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 2.3 0.36 1.54 721.3802 1,440.74 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 2.1 0.404 0 721.3805 1,440.75 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 4.61 0.585 4.15 721.9126 1,441.81 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 2.9 0.472 3.42 721.913 1,441.81 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 2.89 0.355 1.44 721.9135 1,441.81 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 3.76 0.57 4.57 721.9138 1,441.81 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 2.14 0.44 0 721.9142 1,441.81 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 4.15 0.497 3.64 721.9144 1,441.81 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 3.77 0.417 1.54 721.9145 1,441.81 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 3.05 0.431 2.4 721.9148 1,441.81 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 4.5 0.55 5.54 721.9148 1,441.81 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 2.86 0.459 0 721.915 1,441.81 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 4.28 0.569 4.92 721.915 1,441.81 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EKEVVLLVATEGR 95.00% 4.07 0.589 4.35 721.9152 1,441.81 1,442.82 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.44 0.328 2.21 729.3714 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.76 0.416 1.7 729.3714 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.73 0.425 1.66 729.3715 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.87 0.384 1.12 729.3716 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 3.18 0.411 2.54 729.3717 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.66 0.126 1.34 729.3719 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.79 0.38 0 729.372 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.92 0.395 1.41 729.372 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.36 0.331 1.62 729.3722 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.58 0.297 1.19 729.3723 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.44 0.356 1.57 729.3726 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.97 0.438 1.29 729.3729 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.9 0.307 1.66 729.373 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.61 0.387 1.89 729.3733 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.65 0.354 1.29 729.3733 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% AISTRYTLDFDR 95.00% 2.91 0.329 0 729.3736 1,456.73 1,457.74 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EDLVGSASGDLDLGK 95.00% 3.28 0.505 2.14 738.8635 1,475.71 1,475.72 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 5.24 0.566 2.52 757.7386 2,270.19 2,270.20 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 5.1 0.537 1.66 757.739 2,270.19 2,270.20 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 5.57 0.563 2.18 757.7396 2,270.20 2,270.20 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 3.26 0.452 0 757.7397 2,270.20 2,270.20 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 4.63 0.588 1.46 757.74 2,270.20 2,270.20 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 5.12 0.574 2.47 757.7401 2,270.20 2,270.20 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 5.14 0.568 2.85 757.7402 2,270.20 2,270.20 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% TYGVRPSTETYDVYcFVDR 95.00% 4.5 0.528 5.46 c15: Carbamidomethyl (+57.02) 776.6913 2,327.05 2,328.06 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% TYGVRPSTETYDVYcFVDR 95.00% 4.82 0.605 3.24 c15: Carbamidomethyl (+57.02) 776.6919 2,327.05 2,328.06 3
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.51 0.468 2.82 c3: Carbamidomethyl (+57.02) 814.8523 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.26 0.425 2.25 c3: Carbamidomethyl (+57.02) 814.8523 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.74 0.564 1.89 c3: Carbamidomethyl (+57.02) 814.8527 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.65 0.522 2.12 c3: Carbamidomethyl (+57.02) 814.8528 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.51 0.516 2.74 c3: Carbamidomethyl (+57.02) 814.8532 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.89 0.542 2.47 c3: Carbamidomethyl (+57.02) 814.8532 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.52 0.526 2.66 c3: Carbamidomethyl (+57.02) 814.8534 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.32 0.472 3.21 c3: Carbamidomethyl (+57.02) 814.8535 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.5 0.516 1.64 c3: Carbamidomethyl (+57.02) 814.8536 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.7 0.557 2.74 c3: Carbamidomethyl (+57.02) 814.8536 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.78 0.539 3.43 c3: Carbamidomethyl (+57.02) 814.8537 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.65 0.525 2.77 c3: Carbamidomethyl (+57.02) 814.8544 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.51 0.541 1.66 c3: Carbamidomethyl (+57.02) 814.8548 1,627.69 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.88 0.536 3.41 c3: Carbamidomethyl (+57.02) 814.8554 1,627.70 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% EGcYGDKDEFPGVR 95.00% 3.34 0.444 1.35 c3: Carbamidomethyl (+57.02) 815.3556 1,628.70 1,628.70 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 0 0 6.41 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,065.00 2,127.98 2,127.99 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 0 0 4.09 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,065.00 2,127.98 2,127.99 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 0 0 5.22 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,065.00 2,127.98 2,127.99 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 0 0 6.92 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,065.00 2,127.99 2,127.99 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 0 0 4.01 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,065.00 2,127.99 2,127.99 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 4.75 0.58 3.74 c1: Carbamidomethyl (+57.02) 1,073.02 2,144.02 2,145.02 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% cEVMHGIEDSEATLEVVVK 95.00% 4.92 0.604 5.6 c1: Carbamidomethyl (+57.02) 1,073.51 2,145.01 2,145.02 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 4.42 0.516 5.13 1,136.10 2,270.19 2,270.20 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 4.14 0.491 7.09 1,136.10 2,270.19 2,270.20 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 4.43 0.556 5.66 1,136.10 2,270.19 2,270.20 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 4.18 0.516 6 1,136.10 2,270.19 2,270.20 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 4.3 0.556 5.96 1,136.10 2,270.19 2,270.20 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 4.27 0.51 5.37 1,136.11 2,270.19 2,270.20 2
 SAMPLE 1 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 16 21 155 8.28% VSLPNYPAIPSDATLEVQSLR 95.00% 4.14 0.495 5.4 1,136.11 2,270.20 2,270.20 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.44 0.419 1.54 c5: Carbamidomethyl (+57.02) 461.9131 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.15 0.436 1.77 c5: Carbamidomethyl (+57.02) 461.9134 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 5.1 0.387 1.54 c5: Carbamidomethyl (+57.02) 461.9137 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.23 0.394 1.66 c5: Carbamidomethyl (+57.02) 461.9138 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.67 0.416 1.28 c5: Carbamidomethyl (+57.02) 461.9141 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.61 0.383 2.6 c5: Carbamidomethyl (+57.02) 461.9142 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4 0.435 2.4 c5: Carbamidomethyl (+57.02) 461.9143 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.54 0.365 2.64 c5: Carbamidomethyl (+57.02) 461.9143 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.34 0.398 1.92 c5: Carbamidomethyl (+57.02) 461.9145 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.26 0.438 2.08 c5: Carbamidomethyl (+57.02) 461.9145 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.63 0.412 1.39 c5: Carbamidomethyl (+57.02) 461.9148 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.56 0.367 2.02 c5: Carbamidomethyl (+57.02) 461.9149 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.58 0.366 0 c5: Carbamidomethyl (+57.02) 461.9151 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.11 0.435 1.28 c5: Carbamidomethyl (+57.02) 461.9163 1,382.73 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 4.69 0.375 1.35 c5: Carbamidomethyl (+57.02) 461.917 1,382.73 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 2.81 0.387 1.21 c5: Carbamidomethyl (+57.02) 461.9181 1,382.73 1,383.73 3 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% YTLDFDR 95.00% 2.36 0.356 1.13 465.2213 928.4269 929.437 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% YTLDFDR 95.00% 2.18 0.308 1.29 465.2214 928.4272 929.437 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% YTLDFDR 95.00% 2.28 0.347 1.19 465.2214 928.4272 929.437 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% YTLDFDR 95.00% 2.4 0.37 1.24 465.2216 928.4276 929.437 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% YTLDFDR 95.00% 2.06 0.269 0 465.2218 928.428 929.437 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% YTLDFDR 95.00% 2.38 0.342 1.49 465.2222 928.4287 929.437 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% YTLDFDR 95.00% 2.1 0.304 1.52 465.2234 928.4311 929.437 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% YTLDFDR 95.00% 2.21 0.367 0 465.2235 928.4314 929.437 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 2.55 0.191 0 481.6126 1,441.81 1,442.82 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 2.59 0.188 0 481.9455 1,442.81 1,442.82 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.7 0.43 1.82 486.583 1,456.73 1,457.74 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.87 0.399 1.8 486.583 1,456.73 1,457.74 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.85 0.403 1.12 486.5832 1,456.73 1,457.74 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 3.12 0.406 1.36 486.5832 1,456.73 1,457.74 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.63 0.348 0 486.5835 1,456.73 1,457.74 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.88 0.434 2 486.5836 1,456.73 1,457.74 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 1.84 0.241 0 486.5836 1,456.73 1,457.74 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.74 0.285 0 486.5836 1,456.73 1,457.74 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.64 0.322 0 486.5837 1,456.73 1,457.74 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 3.14 0.244 1.06 486.5844 1,456.73 1,457.74 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% TPcVGDKDSSPGVR 95.00% 3.27 0.333 2.33 c3: Carbamidomethyl (+57.02) 492.2365 1,473.69 1,474.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% TPcVGDKDSSPGVR 95.00% 3.15 0.342 1.24 c3: Carbamidomethyl (+57.02) 492.2365 1,473.69 1,474.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% TPcVGDKDSSPGVR 95.00% 2.62 0.237 1.64 c3: Carbamidomethyl (+57.02) 492.2369 1,473.69 1,474.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% TPcVGDKDSSPGVR 95.00% 3.57 0.391 2.41 c3: Carbamidomethyl (+57.02) 492.2372 1,473.69 1,474.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% GTVAcGEPPVVEHAR 95.00% 2.63 0.301 0 c5: Carbamidomethyl (+57.02) 526.9268 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% GTVAcGEPPVVEHAR 95.00% 2.57 0.375 0 c5: Carbamidomethyl (+57.02) 526.9269 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.01 0.342 0 c3: Carbamidomethyl (+57.02) 543.5706 1,627.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 2.43 0.202 0 c3: Carbamidomethyl (+57.02) 543.5708 1,627.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.29 0.453 0 c3: Carbamidomethyl (+57.02) 543.5709 1,627.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.31 0.436 1.13 c3: Carbamidomethyl (+57.02) 543.5712 1,627.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.65 0.42 0 c3: Carbamidomethyl (+57.02) 543.5712 1,627.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.04 0.314 0 c3: Carbamidomethyl (+57.02) 543.5713 1,627.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.72 0.461 0 c3: Carbamidomethyl (+57.02) 543.5713 1,627.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.22 0.441 0 c3: Carbamidomethyl (+57.02) 543.5715 1,627.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 2.99 0.356 0 c3: Carbamidomethyl (+57.02) 543.5717 1,627.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.19 0.293 0 c3: Carbamidomethyl (+57.02) 543.5718 1,627.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.11 0.3 0 c3: Carbamidomethyl (+57.02) 543.5718 1,627.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 2.83 0.335 1.39 c3: Carbamidomethyl (+57.02) 543.575 1,627.70 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.37 0.348 0 c3: Carbamidomethyl (+57.02) 543.9053 1,628.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.48 0.448 0 c3: Carbamidomethyl (+57.02) 543.9058 1,628.69 1,628.70 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% PNcGGNLLGVR 95.00% 2.66 0.419 0 c3: Carbamidomethyl (+57.02) 578.7976 1,155.58 1,156.59 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% PNcGGNLLGVR 95.00% 3.04 0.463 0 c3: Carbamidomethyl (+57.02) 578.7977 1,155.58 1,156.59 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% LEGEVFFATR 95.00% 3.46 0.348 2.82 584.8016 1,167.59 1,168.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% LEGEVFFATR 95.00% 3.24 0.389 1.68 584.8027 1,167.59 1,168.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% LEGEVFFATR 95.00% 3.53 0.34 2.52 584.8028 1,167.59 1,168.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% LEGEVFFATR 95.00% 3.38 0.353 2.96 584.8028 1,167.59 1,168.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% LEGEVFFATR 95.00% 3.57 0.348 2.49 584.8029 1,167.59 1,168.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSKEKEVVLLVATEGR 95.00% 2.76 0.223 1.06 586.3019 1,755.88 1,757.02 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 3.43 0.504 2.34 593.3433 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 4.23 0.499 3.64 593.3437 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 2.79 0.365 1.7 593.3438 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 3.82 0.492 3.72 593.344 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 4.15 0.529 3.39 593.3441 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 4.12 0.534 4.1 593.3444 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 3.55 0.469 4.44 593.3444 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 4.05 0.557 5.09 593.3445 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 4.11 0.499 4.07 593.3445 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 4.05 0.518 3.46 593.3446 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 4.25 0.56 4.6 593.3446 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 3.49 0.493 1.96 593.3448 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 2.83 0.43 1.44 593.3451 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 4.13 0.55 3.14 593.3451 1,184.67 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 2.8 0.466 2.55 593.3464 1,184.68 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 2.81 0.36 0 593.3493 1,184.68 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 2.99 0.401 0 593.35 1,184.68 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 2.82 0.327 0 593.3512 1,184.69 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EVVLLVATEGR 95.00% 2.49 0.309 1.72 593.353 1,184.69 1,185.68 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% YQcTEGFVQR 95.00% 2.36 0.408 1.21 c3: Carbamidomethyl (+57.02) 644.2892 1,286.56 1,287.58 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% YQcTEGFVQR 95.00% 2.91 0.533 2.37 c3: Carbamidomethyl (+57.02) 644.2909 1,286.57 1,287.58 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% YQcTEGFVQR 95.00% 2.62 0.466 0 c3: Carbamidomethyl (+57.02) 644.2917 1,286.57 1,287.58 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% YQcTEGFVQR 95.00% 3.18 0.55 2.39 c3: Carbamidomethyl (+57.02) 644.2923 1,286.57 1,287.58 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cYAGWLADGSLR 95.00% 3.85 0.551 6.09 c1: Carbamidomethyl (+57.02) 684.8197 1,367.62 1,368.64 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cYAGWLADGSLR 95.00% 2.55 0.258 2.51 c1: Carbamidomethyl (+57.02) 684.8206 1,367.63 1,368.64 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cYAGWLADGSLR 95.00% 3.47 0.605 4.85 c1: Carbamidomethyl (+57.02) 684.8206 1,367.63 1,368.64 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cYAGWLADGSLR 95.00% 1.93 0.33 2.64 c1: Carbamidomethyl (+57.02) 684.8207 1,367.63 1,368.64 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cYAGWLADGSLR 95.00% 3.8 0.595 4.96 c1: Carbamidomethyl (+57.02) 684.8208 1,367.63 1,368.64 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cYAGWLADGSLR 95.00% 2.22 0.406 1.64 c1: Carbamidomethyl (+57.02) 684.821 1,367.63 1,368.64 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cYAGWLADGSLR 95.00% 4.01 0.593 4.74 c1: Carbamidomethyl (+57.02) 684.8212 1,367.63 1,368.64 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cYAGWLADGSLR 95.00% 2.57 0.453 0 c1: Carbamidomethyl (+57.02) 684.8213 1,367.63 1,368.64 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cYAGWLADGSLR 95.00% 2.54 0.319 3.4 c1: Carbamidomethyl (+57.02) 684.8215 1,367.63 1,368.64 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% FTFQEAANEcR 95.00% 3.73 0.557 3.05 c10: Carbamidomethyl (+57.02) 686.7984 1,371.58 1,372.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% FTFQEAANEcR 95.00% 3.75 0.579 3.14 c10: Carbamidomethyl (+57.02) 686.7993 1,371.58 1,372.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% FTFQEAANEcR 95.00% 3.72 0.598 2.51 c10: Carbamidomethyl (+57.02) 686.7994 1,371.58 1,372.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% FTFQEAANEcR 95.00% 3.99 0.576 2.82 c10: Carbamidomethyl (+57.02) 686.7996 1,371.58 1,372.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% FTFQEAANEcR 95.00% 4.07 0.567 2.77 c10: Carbamidomethyl (+57.02) 686.7998 1,371.58 1,372.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% FTFQEAANEcR 95.00% 4.12 0.587 2.43 c10: Carbamidomethyl (+57.02) 686.8001 1,371.58 1,372.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% FTFQEAANEcR 95.00% 3.71 0.558 2.85 c10: Carbamidomethyl (+57.02) 686.8004 1,371.59 1,372.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% FTFQEAANEcR 95.00% 3.93 0.548 2.4 c10: Carbamidomethyl (+57.02) 686.8011 1,371.59 1,372.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% FTFQEAANEcR 95.00% 3.65 0.561 2.85 c10: Carbamidomethyl (+57.02) 686.8015 1,371.59 1,372.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% FTFQEAANEcR 95.00% 3.61 0.565 1.82 c10: Carbamidomethyl (+57.02) 686.8028 1,371.59 1,372.60 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.08 0.388 1.17 c5: Carbamidomethyl (+57.02) 692.3654 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.62 0.445 2.24 c5: Carbamidomethyl (+57.02) 692.3655 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.46 0.442 1.55 c5: Carbamidomethyl (+57.02) 692.3656 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.56 0.459 1.59 c5: Carbamidomethyl (+57.02) 692.3658 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.34 0.445 1.7 c5: Carbamidomethyl (+57.02) 692.3659 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.61 0.38 1.74 c5: Carbamidomethyl (+57.02) 692.3659 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.49 0.434 1.85 c5: Carbamidomethyl (+57.02) 692.3659 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.68 0.437 2.02 c5: Carbamidomethyl (+57.02) 692.3661 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.52 0.411 1.47 c5: Carbamidomethyl (+57.02) 692.3661 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.56 0.424 2.46 c5: Carbamidomethyl (+57.02) 692.3662 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.5 0.413 1.66 c5: Carbamidomethyl (+57.02) 692.3663 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.58 0.444 1.64 c5: Carbamidomethyl (+57.02) 692.3669 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% ARPNcGGNLLGVR 95.00% 3.07 0.337 2.24 c5: Carbamidomethyl (+57.02) 692.3686 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 4.1 0.561 0 c1: Carbamidomethyl (+57.02) 715.676 2,144.00 2,145.02 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 4.34 0.466 1.72 c1: Carbamidomethyl (+57.02) 715.6761 2,144.01 2,145.02 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 4.42 0.518 2.08 c1: Carbamidomethyl (+57.02) 715.6766 2,144.01 2,145.02 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 5.36 0.553 0 c1: Carbamidomethyl (+57.02) 716.0088 2,145.00 2,145.02 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 4.62 0.524 1.6 c1: Carbamidomethyl (+57.02) 716.0103 2,145.01 2,145.02 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 4.87 0.582 2.49 c1: Carbamidomethyl (+57.02) 716.0108 2,145.01 2,145.02 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 4.65 0.484 1.85 c1: Carbamidomethyl (+57.02) 716.0111 2,145.01 2,145.02 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 4.27 0.432 2.47 c1: Carbamidomethyl (+57.02) 716.0116 2,145.01 2,145.02 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 3.67 0.418 1.17 c1: Carbamidomethyl (+57.02) 716.012 2,145.01 2,145.02 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 3.99 0.44 0 c1: Carbamidomethyl (+57.02) 716.0127 2,145.01 2,145.02 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 2.11 0.25 1.11 721.381 1,440.75 1,442.82 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 3.09 0.418 2.13 721.9135 1,441.81 1,442.82 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 3.18 0.483 2.06 721.9135 1,441.81 1,442.82 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 3.05 0.518 2.12 721.9138 1,441.81 1,442.82 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 4.62 0.559 4.77 721.9139 1,441.81 1,442.82 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 4.32 0.484 5.47 721.9141 1,441.81 1,442.82 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 2.88 0.465 1.85 721.9143 1,441.81 1,442.82 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 4.24 0.564 4.36 721.9149 1,441.81 1,442.82 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 3.19 0.512 3.52 721.9149 1,441.81 1,442.82 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 4.06 0.569 4.15 721.9153 1,441.81 1,442.82 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EKEVVLLVATEGR 95.00% 3.95 0.522 4.66 722.413 1,442.81 1,442.82 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.55 0.325 0 729.3705 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.33 0.295 1.72 729.3709 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.53 0.247 1.44 729.3711 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.45 0.328 3.01 729.3719 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.89 0.356 2.14 729.372 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 3.13 0.366 2.03 729.3721 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.48 0.343 1.55 729.3725 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.8 0.35 2.26 729.3725 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.82 0.396 1.77 729.3725 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.16 0.278 2.13 729.3725 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 3.03 0.313 1.39 729.3727 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.97 0.404 2.57 729.3727 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.77 0.353 0 729.3733 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% AISTRYTLDFDR 95.00% 2.46 0.365 2.48 729.3733 1,456.73 1,457.74 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSLPNYPAIPSDATLEVQSLR 95.00% 5.14 0.578 2.68 757.7385 2,270.19 2,270.20 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSLPNYPAIPSDATLEVQSLR 95.00% 5.02 0.53 3.18 757.7397 2,270.20 2,270.20 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSLPNYPAIPSDATLEVQSLR 95.00% 5.16 0.526 1.55 757.7401 2,270.20 2,270.20 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSLPNYPAIPSDATLEVQSLR 95.00% 4.54 0.534 0 757.7408 2,270.20 2,270.20 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.27 0.494 2.2 c3: Carbamidomethyl (+57.02) 814.8517 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.38 0.492 3 c3: Carbamidomethyl (+57.02) 814.8523 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.04 0.512 1.68 c3: Carbamidomethyl (+57.02) 814.8526 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.36 0.479 3.13 c3: Carbamidomethyl (+57.02) 814.8526 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.6 0.443 3.49 c3: Carbamidomethyl (+57.02) 814.8529 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.43 0.475 3.06 c3: Carbamidomethyl (+57.02) 814.853 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.29 0.461 2.34 c3: Carbamidomethyl (+57.02) 814.8531 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.83 0.475 2.47 c3: Carbamidomethyl (+57.02) 814.8539 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.58 0.502 3.4 c3: Carbamidomethyl (+57.02) 814.8539 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.62 0.5 3.08 c3: Carbamidomethyl (+57.02) 814.8539 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.56 0.518 2.4 c3: Carbamidomethyl (+57.02) 814.854 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.64 0.539 3 c3: Carbamidomethyl (+57.02) 814.8547 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.47 0.523 2.52 c3: Carbamidomethyl (+57.02) 814.8548 1,627.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.5 0.505 2.74 c3: Carbamidomethyl (+57.02) 815.3542 1,628.69 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% EGcYGDKDEFPGVR 95.00% 3.22 0.38 1.55 c3: Carbamidomethyl (+57.02) 815.356 1,628.70 1,628.70 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VNSAYQDKVSLPNYPAIPSDATLEVQSLR 95.00% 5.88 0.573 3.64 1,059.55 3,175.61 3,175.63 3
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 0 0 4.64 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,064.50 2,126.98 2,127.99 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 0 0 6.08 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,065.00 2,127.99 2,127.99 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 3.62 0.519 1.77 c1: Carbamidomethyl (+57.02) 1,073.01 2,144.01 2,145.02 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 4.66 0.637 5.52 c1: Carbamidomethyl (+57.02) 1,073.01 2,144.01 2,145.02 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% cEVMHGIEDSEATLEVVVK 95.00% 4.31 0.577 3.7 c1: Carbamidomethyl (+57.02) 1,073.51 2,145.01 2,145.02 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSLPNYPAIPSDATLEVQSLR 95.00% 4.32 0.536 5.49 1,136.10 2,270.19 2,270.20 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSLPNYPAIPSDATLEVQSLR 95.00% 4.31 0.556 5.36 1,136.10 2,270.19 2,270.20 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSLPNYPAIPSDATLEVQSLR 95.00% 4.2 0.508 5.92 1,136.10 2,270.19 2,270.20 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSLPNYPAIPSDATLEVQSLR 95.00% 4.25 0.529 5.89 1,136.10 2,270.19 2,270.20 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSLPNYPAIPSDATLEVQSLR 95.00% 4.27 0.572 5.57 1,136.10 2,270.19 2,270.20 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSLPNYPAIPSDATLEVQSLR 95.00% 4.34 0.544 7.09 1,136.10 2,270.19 2,270.20 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSLPNYPAIPSDATLEVQSLR 95.00% 4.15 0.478 5.72 1,136.11 2,270.20 2,270.20 2
 SAMPLE 1R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 19 143 7.25% VSLPNYPAIPSDATLEVQSLR 95.00% 4.42 0.521 5.96 1,136.11 2,270.20 2,270.20 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 4.19 0.364 2.21 c5: Carbamidomethyl (+57.02) 461.9138 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.94 0.328 1.77 c5: Carbamidomethyl (+57.02) 461.9141 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 4.54 0.396 1.59 c5: Carbamidomethyl (+57.02) 461.9143 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.96 0.377 1.39 c5: Carbamidomethyl (+57.02) 461.9144 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 2.95 0.389 0 c5: Carbamidomethyl (+57.02) 461.9145 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.42 0.242 1 c5: Carbamidomethyl (+57.02) 461.9146 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 4.55 0.286 1.32 c5: Carbamidomethyl (+57.02) 461.9146 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 4.02 0.365 1.44 c5: Carbamidomethyl (+57.02) 461.9146 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 4.18 0.392 1.85 c5: Carbamidomethyl (+57.02) 461.9147 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.93 0.264 1.06 c5: Carbamidomethyl (+57.02) 461.9149 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 4.13 0.465 2.34 c5: Carbamidomethyl (+57.02) 461.9149 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 4.07 0.374 1.31 c5: Carbamidomethyl (+57.02) 461.9154 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.65 0.261 0 c5: Carbamidomethyl (+57.02) 461.9154 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 4.41 0.451 1.74 c5: Carbamidomethyl (+57.02) 461.9157 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% YTLDFDR 95.00% 2.33 0.273 0 465.2216 928.4276 929.437 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% YTLDFDR 95.00% 2.28 0.354 0 465.2218 928.4279 929.437 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% YTLDFDR 95.00% 2.39 0.302 0 465.2221 928.4286 929.437 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% YTLDFDR 95.00% 2.11 0.288 0 465.2223 928.429 929.437 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% YTLDFDR 95.00% 2.03 0.364 0 465.2227 928.4297 929.437 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% YTLDFDR 95.00% 2.06 0.294 0 465.2229 928.4302 929.437 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% YTLDFDR 95.00% 2.16 0.32 0 465.223 928.4303 929.437 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EKEVVLLVATEGR 95.00% 2.28 0.13 1 481.612 1,441.81 1,442.82 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EKEVVLLVATEGR 95.00% 2.61 0.193 0 481.6133 1,441.82 1,442.82 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% AISTRYTLDFDR 95.00% 2.81 0.304 1.22 486.5829 1,456.73 1,457.74 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% AISTRYTLDFDR 95.00% 2.64 0.316 2 486.5834 1,456.73 1,457.74 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% AISTRYTLDFDR 95.00% 3.43 0.236 1.64 486.5837 1,456.73 1,457.74 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% AISTRYTLDFDR 95.00% 2.19 0.294 1.32 486.5837 1,456.73 1,457.74 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% AISTRYTLDFDR 95.00% 2.02 0.313 0 486.5843 1,456.73 1,457.74 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% TPcVGDKDSSPGVR 95.00% 2.95 0.33 1.3 c3: Carbamidomethyl (+57.02) 492.2354 1,473.68 1,474.70 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% TPcVGDKDSSPGVR 95.00% 4.15 0.452 1.04 c3: Carbamidomethyl (+57.02) 492.2361 1,473.69 1,474.70 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% TPcVGDKDSSPGVR 95.00% 3.78 0.382 2.27 c3: Carbamidomethyl (+57.02) 492.2372 1,473.69 1,474.70 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% YEINSLVR 95.00% 2.58 0.234 1.44 497.272 992.5283 993.5369 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% GTVAcGEPPVVEHAR 95.00% 2.81 0.491 1.22 c5: Carbamidomethyl (+57.02) 526.9265 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% GTVAcGEPPVVEHAR 95.00% 2.86 0.477 0 c5: Carbamidomethyl (+57.02) 526.9268 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.04 0.317 0 c3: Carbamidomethyl (+57.02) 543.5712 1,627.69 1,628.70 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 2.46 0.222 0 c3: Carbamidomethyl (+57.02) 543.5712 1,627.69 1,628.70 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.07 0.337 0 c3: Carbamidomethyl (+57.02) 543.5712 1,627.69 1,628.70 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.24 0.359 0 c3: Carbamidomethyl (+57.02) 543.5715 1,627.69 1,628.70 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.18 0.435 0 c3: Carbamidomethyl (+57.02) 543.5718 1,627.69 1,628.70 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.67 0.445 0 c3: Carbamidomethyl (+57.02) 543.572 1,627.69 1,628.70 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 2.59 0.336 0 c3: Carbamidomethyl (+57.02) 543.5725 1,627.69 1,628.70 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% KGTVAcGEPPVVEHAR 95.00% 3.86 0.495 2.62 c6: Carbamidomethyl (+57.02) 569.6253 1,705.85 1,706.87 3
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% PNcGGNLLGVR 95.00% 2.36 0.345 0 c3: Carbamidomethyl (+57.02) 579.302 1,156.59 1,156.59 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% LEGEVFFATR 95.00% 3.34 0.361 2.51 584.803 1,167.59 1,168.60 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EVVLLVATEGR 95.00% 3.56 0.499 3.11 593.3448 1,184.67 1,185.68 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EVVLLVATEGR 95.00% 3.53 0.449 2.36 593.3449 1,184.67 1,185.68 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EVVLLVATEGR 95.00% 3.61 0.469 3.57 593.345 1,184.67 1,185.68 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EVVLLVATEGR 95.00% 3.36 0.393 2.24 593.3457 1,184.68 1,185.68 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% DRYEINSLVR 95.00% 2.99 0.359 1.77 632.8355 1,263.66 1,264.67 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% DRYEINSLVR 95.00% 3.04 0.357 0 632.8364 1,263.66 1,264.67 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% YQcTEGFVQR 95.00% 3.28 0.51 2.49 c3: Carbamidomethyl (+57.02) 644.2924 1,286.57 1,287.58 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% YQcTEGFVQR 95.00% 3.27 0.495 2.59 c3: Carbamidomethyl (+57.02) 644.2926 1,286.57 1,287.58 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% YQcTEGFVQR 95.00% 2.58 0.484 1.62 c3: Carbamidomethyl (+57.02) 644.2928 1,286.57 1,287.58 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% YQcTEGFVQR 95.00% 2.64 0.43 2.3 c3: Carbamidomethyl (+57.02) 644.7915 1,287.57 1,287.58 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% cYAGWLADGSLR 95.00% 4.09 0.62 4.17 c1: Carbamidomethyl (+57.02) 684.8191 1,367.62 1,368.64 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% cYAGWLADGSLR 95.00% 4.26 0.585 3.72 c1: Carbamidomethyl (+57.02) 684.8205 1,367.63 1,368.64 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% cYAGWLADGSLR 95.00% 4.24 0.63 4.96 c1: Carbamidomethyl (+57.02) 684.8208 1,367.63 1,368.64 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% cYAGWLADGSLR 95.00% 3.58 0.615 4.44 c1: Carbamidomethyl (+57.02) 684.8212 1,367.63 1,368.64 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% cYAGWLADGSLR 95.00% 2.94 0.506 2.32 c1: Carbamidomethyl (+57.02) 684.8214 1,367.63 1,368.64 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% cYAGWLADGSLR 95.00% 2.49 0.487 3.46 c1: Carbamidomethyl (+57.02) 684.8214 1,367.63 1,368.64 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% cYAGWLADGSLR 95.00% 3.83 0.611 5.36 c1: Carbamidomethyl (+57.02) 684.822 1,367.63 1,368.64 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% FTFQEAANEcR 95.00% 3.94 0.583 3.85 c10: Carbamidomethyl (+57.02) 686.8009 1,371.59 1,372.60 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% FTFQEAANEcR 95.00% 3.83 0.58 3.72 c10: Carbamidomethyl (+57.02) 686.8014 1,371.59 1,372.60 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% FTFQEAANEcR 95.00% 3.22 0.505 3.68 c10: Carbamidomethyl (+57.02) 686.8014 1,371.59 1,372.60 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% FTFQEAANEcR 95.00% 3.34 0.499 3.21 c10: Carbamidomethyl (+57.02) 686.8023 1,371.59 1,372.60 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.2 0.364 0 c5: Carbamidomethyl (+57.02) 692.365 1,382.71 1,383.73 2 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.51 0.417 2.27 c5: Carbamidomethyl (+57.02) 692.3659 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.22 0.405 2 c5: Carbamidomethyl (+57.02) 692.3661 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.56 0.391 2.31 c5: Carbamidomethyl (+57.02) 692.3665 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.56 0.416 2.08 c5: Carbamidomethyl (+57.02) 692.3669 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.25 0.35 2.09 c5: Carbamidomethyl (+57.02) 692.3671 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.29 0.385 1.48 c5: Carbamidomethyl (+57.02) 692.3672 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.37 0.429 2.12 c5: Carbamidomethyl (+57.02) 692.3672 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.5 0.464 2.25 c5: Carbamidomethyl (+57.02) 692.3672 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 3.51 0.46 2.32 c5: Carbamidomethyl (+57.02) 692.3673 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% ARPNcGGNLLGVR 95.00% 2.62 0.258 0 c5: Carbamidomethyl (+57.02) 692.3674 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EKEVVLLVATEGR 95.00% 4.11 0.544 4.8 721.913 1,441.81 1,442.82 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EKEVVLLVATEGR 95.00% 3.18 0.465 3.42 721.9136 1,441.81 1,442.82 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EKEVVLLVATEGR 95.00% 3.98 0.539 4.41 721.9148 1,441.81 1,442.82 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% AISTRYTLDFDR 95.00% 2.41 0.257 1.7 729.372 1,456.73 1,457.74 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% AISTRYTLDFDR 95.00% 2.57 0.294 0 729.3726 1,456.73 1,457.74 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% AISTRYTLDFDR 95.00% 2.46 0.198 2.49 729.3726 1,456.73 1,457.74 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% AISTRYTLDFDR 95.00% 2.52 0.357 0 729.3734 1,456.73 1,457.74 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% AISTRYTLDFDR 95.00% 2.36 0.276 1.62 729.3739 1,456.73 1,457.74 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.28 0.509 3 c3: Carbamidomethyl (+57.02) 814.8531 1,627.69 1,628.70 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.41 0.495 3.18 c3: Carbamidomethyl (+57.02) 814.8532 1,627.69 1,628.70 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.33 0.493 3.03 c3: Carbamidomethyl (+57.02) 814.8539 1,627.69 1,628.70 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.53 0.525 1.82 c3: Carbamidomethyl (+57.02) 814.854 1,627.69 1,628.70 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.54 0.524 3.85 c3: Carbamidomethyl (+57.02) 814.8543 1,627.69 1,628.70 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.38 0.541 2.96 c3: Carbamidomethyl (+57.02) 814.8544 1,627.69 1,628.70 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.26 0.506 1.64 c3: Carbamidomethyl (+57.02) 814.855 1,627.69 1,628.70 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.44 0.51 2.85 c3: Carbamidomethyl (+57.02) 814.855 1,627.69 1,628.70 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.46 0.483 1.39 c3: Carbamidomethyl (+57.02) 815.354 1,628.69 1,628.70 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGcYGDKDEFPGVR 95.00% 3.45 0.501 2.02 c3: Carbamidomethyl (+57.02) 815.3551 1,628.69 1,628.70 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% EGLETSASGAEDLSGLPSGK 95.00% 4.76 0.592 5.82 952.9561 1,903.90 1,904.91 2
 SAMPLE 2 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 17 20 71 7.29% VSLPNYPAIPSDATLEVQSLR 95.00% 4.07 0.526 4.46 1,136.11 2,270.19 2,270.20 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.66 0.33 0 c5: Carbamidomethyl (+57.02) 461.9136 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 4.37 0.401 0 c5: Carbamidomethyl (+57.02) 461.9138 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.39 0.412 0 c5: Carbamidomethyl (+57.02) 461.914 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 4.31 0.34 2.08 c5: Carbamidomethyl (+57.02) 461.9142 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 4.23 0.419 1.47 c5: Carbamidomethyl (+57.02) 461.9143 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 4.14 0.382 1.66 c5: Carbamidomethyl (+57.02) 461.9146 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 4.28 0.45 2 c5: Carbamidomethyl (+57.02) 461.9149 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 4.27 0.38 1.59 c5: Carbamidomethyl (+57.02) 461.9149 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 5.02 0.433 3.42 c5: Carbamidomethyl (+57.02) 461.9155 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.88 0.322 1.31 c5: Carbamidomethyl (+57.02) 461.9157 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.66 0.382 1.44 c5: Carbamidomethyl (+57.02) 461.9158 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.9 0.349 1.33 c5: Carbamidomethyl (+57.02) 461.9165 1,382.73 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 4.06 0.374 0 c5: Carbamidomethyl (+57.02) 462.249 1,383.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.55 0.308 0 c5: Carbamidomethyl (+57.02) 462.2493 1,383.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% AISTRYTLDFDR 95.00% 3.14 0.316 0 486.583 1,456.73 1,457.74 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% AISTRYTLDFDR 95.00% 3 0.348 0 486.5836 1,456.73 1,457.74 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% AISTRYTLDFDR 95.00% 3.26 0.369 1.21 486.584 1,456.73 1,457.74 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% AISTRYTLDFDR 95.00% 2.52 0.203 0 486.584 1,456.73 1,457.74 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% TPcVGDKDSSPGVR 95.00% 3.34 0.302 1.96 c3: Carbamidomethyl (+57.02) 492.2358 1,473.68 1,474.70 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% TPcVGDKDSSPGVR 95.00% 3.9 0.472 1.4 c3: Carbamidomethyl (+57.02) 492.2363 1,473.69 1,474.70 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% TPcVGDKDSSPGVR 95.00% 3.61 0.364 2.1 c3: Carbamidomethyl (+57.02) 492.5717 1,474.69 1,474.70 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% YEINSLVR 95.00% 2.34 0.225 1.51 497.2703 992.5249 993.5369 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% YEINSLVR 95.00% 2.26 0.172 1.47 497.2716 992.5276 993.5369 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% FTFQEAANEcRR 94.70% 1.79 0.26 0 c10: Carbamidomethyl (+57.02) 510.2364 1,527.69 1,528.70 3 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% GTVAcGEPPVVEHAR 95.00% 2.4 0.459 1.11 c5: Carbamidomethyl (+57.02) 526.9273 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% GTVAcGEPPVVEHAR 95.00% 2.69 0.463 0.959 c5: Carbamidomethyl (+57.02) 526.9277 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 2.82 0.275 0 c3: Carbamidomethyl (+57.02) 543.5708 1,627.69 1,628.70 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 2.62 0.259 0 c3: Carbamidomethyl (+57.02) 543.5709 1,627.69 1,628.70 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 2.73 0.325 0 c3: Carbamidomethyl (+57.02) 543.571 1,627.69 1,628.70 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.3 0.46 0 c3: Carbamidomethyl (+57.02) 543.5713 1,627.69 1,628.70 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 2.45 0.306 0 c3: Carbamidomethyl (+57.02) 543.5713 1,627.69 1,628.70 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.4 0.47 0 c3: Carbamidomethyl (+57.02) 543.5714 1,627.69 1,628.70 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.32 0.461 0 c3: Carbamidomethyl (+57.02) 543.5715 1,627.69 1,628.70 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 2.97 0.435 0 c3: Carbamidomethyl (+57.02) 543.5717 1,627.69 1,628.70 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 2.92 0.387 0 c3: Carbamidomethyl (+57.02) 543.5717 1,627.69 1,628.70 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% KGTVAcGEPPVVEHAR 95.00% 3.99 0.52 2.38 c6: Carbamidomethyl (+57.02) 569.6248 1,705.85 1,706.87 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% LEGEVFFATR 95.00% 3.84 0.474 2.7 584.8015 1,167.59 1,168.60 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% LEGEVFFATR 95.00% 3.06 0.391 1.64 584.8021 1,167.59 1,168.60 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% LEGEVFFATR 95.00% 3.62 0.336 2.3 584.8026 1,167.59 1,168.60 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% LEGEVFFATR 95.00% 3.02 0.362 1.55 584.8027 1,167.59 1,168.60 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% LEGEVFFATR 95.00% 3.03 0.366 2.04 584.8029 1,167.59 1,168.60 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% LEGEVFFATR 95.00% 3.07 0.377 1.48 584.8036 1,167.59 1,168.60 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EVVLLVATEGR 95.00% 2.94 0.416 3.33 593.3441 1,184.67 1,185.68 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EVVLLVATEGR 95.00% 3.33 0.518 1.74 593.3446 1,184.67 1,185.68 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EVVLLVATEGR 95.00% 3.96 0.54 3.74 593.3448 1,184.67 1,185.68 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% DRYEINSLVR 95.00% 2.58 0.32 0 632.8349 1,263.65 1,264.67 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% DRYEINSLVR 95.00% 2.56 0.267 0 632.8355 1,263.66 1,264.67 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% YQcTEGFVQR 95.00% 3.4 0.535 2.17 c3: Carbamidomethyl (+57.02) 644.2908 1,286.57 1,287.58 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% YQcTEGFVQR 95.00% 2.61 0.502 2.11 c3: Carbamidomethyl (+57.02) 644.291 1,286.57 1,287.58 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% YQcTEGFVQR 95.00% 3.24 0.513 2.3 c3: Carbamidomethyl (+57.02) 644.2914 1,286.57 1,287.58 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% YQcTEGFVQR 95.00% 2.49 0.416 1.85 c3: Carbamidomethyl (+57.02) 644.7931 1,287.57 1,287.58 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% cYAGWLADGSLR 95.00% 3.07 0.491 2.49 c1: Carbamidomethyl (+57.02) 684.8198 1,367.62 1,368.64 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% cYAGWLADGSLR 95.00% 3.25 0.568 3.68 c1: Carbamidomethyl (+57.02) 684.821 1,367.63 1,368.64 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% cYAGWLADGSLR 95.00% 3.51 0.552 3.14 c1: Carbamidomethyl (+57.02) 684.8211 1,367.63 1,368.64 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% cYAGWLADGSLR 95.00% 4.28 0.596 3.82 c1: Carbamidomethyl (+57.02) 684.8211 1,367.63 1,368.64 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% cYAGWLADGSLR 95.00% 3.01 0.541 3.11 c1: Carbamidomethyl (+57.02) 684.8212 1,367.63 1,368.64 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% cYAGWLADGSLR 95.00% 3.75 0.59 3.72 c1: Carbamidomethyl (+57.02) 684.8212 1,367.63 1,368.64 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% FTFQEAANEcR 95.00% 3.36 0.571 3.52 c10: Carbamidomethyl (+57.02) 686.7993 1,371.58 1,372.60 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% FTFQEAANEcR 95.00% 3.47 0.51 3.37 c10: Carbamidomethyl (+57.02) 686.7994 1,371.58 1,372.60 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% FTFQEAANEcR 95.00% 3.87 0.55 2.38 c10: Carbamidomethyl (+57.02) 686.8 1,371.58 1,372.60 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% FTFQEAANEcR 95.00% 3.5 0.543 3.6 c10: Carbamidomethyl (+57.02) 686.8006 1,371.59 1,372.60 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.2 0.401 1.18 c5: Carbamidomethyl (+57.02) 692.3658 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.34 0.39 2.01 c5: Carbamidomethyl (+57.02) 692.3661 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.39 0.385 3.1 c5: Carbamidomethyl (+57.02) 692.3664 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.5 0.38 2.06 c5: Carbamidomethyl (+57.02) 692.3665 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.27 0.425 0 c5: Carbamidomethyl (+57.02) 692.3665 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.48 0.389 1.68 c5: Carbamidomethyl (+57.02) 692.3666 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.32 0.482 1.72 c5: Carbamidomethyl (+57.02) 692.3666 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.5 0.425 2.92 c5: Carbamidomethyl (+57.02) 692.3667 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.31 0.381 1.43 c5: Carbamidomethyl (+57.02) 692.3667 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.07 0.403 1.55 c5: Carbamidomethyl (+57.02) 692.3668 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 3.3 0.421 1.62 c5: Carbamidomethyl (+57.02) 692.3675 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% ARPNcGGNLLGVR 95.00% 2.74 0.317 0 c5: Carbamidomethyl (+57.02) 692.3679 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EKEVVLLVATEGR 95.00% 3.68 0.581 3.42 721.9137 1,441.81 1,442.82 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% AISTRYTLDFDR 95.00% 2.55 0.237 1.8 729.3726 1,456.73 1,457.74 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% AISTRYTLDFDR 95.00% 2.68 0.312 1.28 729.3732 1,456.73 1,457.74 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% AISTRYTLDFDR 95.00% 2.3 0.361 1.89 729.3732 1,456.73 1,457.74 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% AISTRYTLDFDR 95.00% 2.37 0.317 0 729.3733 1,456.73 1,457.74 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% AISTRYTLDFDR 95.00% 2.34 0.312 2.82 729.3735 1,456.73 1,457.74 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% AISTRYTLDFDR 95.00% 2.45 0.32 2.06 729.8747 1,457.73 1,457.74 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.29 0.517 2.62 c3: Carbamidomethyl (+57.02) 814.8531 1,627.69 1,628.70 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.71 0.534 2.48 c3: Carbamidomethyl (+57.02) 814.8531 1,627.69 1,628.70 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.48 0.513 1.89 c3: Carbamidomethyl (+57.02) 814.8535 1,627.69 1,628.70 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.25 0.518 3.14 c3: Carbamidomethyl (+57.02) 814.8537 1,627.69 1,628.70 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.26 0.465 3.22 c3: Carbamidomethyl (+57.02) 814.854 1,627.69 1,628.70 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.16 0.496 1.6 c3: Carbamidomethyl (+57.02) 814.8542 1,627.69 1,628.70 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.64 0.544 2.25 c3: Carbamidomethyl (+57.02) 814.8546 1,627.69 1,628.70 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.41 0.535 2.17 c3: Carbamidomethyl (+57.02) 814.8572 1,627.70 1,628.70 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.3 0.452 1.77 c3: Carbamidomethyl (+57.02) 815.3555 1,628.70 1,628.70 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% EGcYGDKDEFPGVR 95.00% 3.24 0.493 2.46 c3: Carbamidomethyl (+57.02) 815.3563 1,628.70 1,628.70 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% VNSAYQDKVSLPNYPAIPSDATLEVQSLR 95.00% 2.87 0.395 0 1,059.54 3,175.59 3,175.63 3
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% VSLPNYPAIPSDATLEVQSLR 95.00% 4.07 0.514 5.16 1,135.60 2,269.19 2,270.20 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% VSLPNYPAIPSDATLEVQSLR 95.00% 4.18 0.518 4.82 1,136.10 2,270.19 2,270.20 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% VSLPNYPAIPSDATLEVQSLR 95.00% 3.99 0.472 5.19 1,136.11 2,270.20 2,270.20 2
 SAMPLE 2R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 15 17 68 6.83% VSLPNYPAIPSDATLEVQSLR 95.00% 4.3 0.541 4.89 1,136.11 2,270.20 2,270.20 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 4.01 0.298 1.64 c5: Carbamidomethyl (+57.02) 461.9127 1,382.71 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.72 0.388 1.11 c5: Carbamidomethyl (+57.02) 461.9136 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 4.62 0.384 1.8 c5: Carbamidomethyl (+57.02) 461.9136 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.51 0.332 0 c5: Carbamidomethyl (+57.02) 461.914 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 4.28 0.378 2.48 c5: Carbamidomethyl (+57.02) 461.9141 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 4.59 0.476 2.3 c5: Carbamidomethyl (+57.02) 461.9143 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 4.15 0.377 2.32 c5: Carbamidomethyl (+57.02) 461.9143 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.68 0.41 1.54 c5: Carbamidomethyl (+57.02) 461.9144 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.67 0.333 3.12 c5: Carbamidomethyl (+57.02) 461.9144 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 4.12 0.422 1.77 c5: Carbamidomethyl (+57.02) 461.9145 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 4.83 0.388 2.02 c5: Carbamidomethyl (+57.02) 461.9145 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 4.4 0.417 1.39 c5: Carbamidomethyl (+57.02) 461.9146 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.97 0.36 1.08 c5: Carbamidomethyl (+57.02) 461.915 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.93 0.32 1.85 c5: Carbamidomethyl (+57.02) 461.915 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 5.07 0.381 1.62 c5: Carbamidomethyl (+57.02) 461.9151 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 4.87 0.432 2.15 c5: Carbamidomethyl (+57.02) 461.9153 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.39 0.422 1.92 c5: Carbamidomethyl (+57.02) 461.9155 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 4.39 0.378 3.01 c5: Carbamidomethyl (+57.02) 461.9157 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.89 0.375 1.1 c5: Carbamidomethyl (+57.02) 461.9164 1,382.73 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 4.72 0.388 1.96 c5: Carbamidomethyl (+57.02) 461.9176 1,382.73 1,383.73 3 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.49 0.324 1.66 465.2212 928.4267 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.12 0.272 1.8 465.2213 928.4269 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.36 0.376 0 465.2214 928.4272 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.36 0.346 1.21 465.2217 928.4278 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.4 0.407 1.42 465.2219 928.4281 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.4 0.311 0 465.222 928.4284 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.24 0.363 0 465.2221 928.4285 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.51 0.376 1.17 465.2223 928.429 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.28 0.389 1.1 465.2224 928.4292 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.35 0.322 1.08 465.2225 928.4294 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.42 0.301 1.41 465.2226 928.4295 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.34 0.367 1.17 465.2227 928.4297 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.19 0.367 0 465.2227 928.4298 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.31 0.339 0 465.2229 928.4301 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YTLDFDR 95.00% 2.32 0.355 0 465.2236 928.4315 929.437 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 2.53 0.204 0 481.6106 1,441.81 1,442.82 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 2.29 0.299 0 481.6111 1,441.81 1,442.82 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 2.68 0.255 0 481.6113 1,441.81 1,442.82 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 2.68 0.291 0 481.6114 1,441.81 1,442.82 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 2.79 0.273 0 481.6114 1,441.81 1,442.82 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 2.74 0.236 1.02 481.612 1,441.81 1,442.82 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 2.91 0.279 0 481.6122 1,441.81 1,442.82 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 2.65 0.26 0 481.9466 1,442.82 1,442.82 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.31 0.31 0 486.5828 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.31 0.285 0 486.583 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.96 0.317 1.15 486.5833 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.6 0.266 1.06 486.5834 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.52 0.253 0 486.5834 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.85 0.251 1.23 486.5835 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.44 0.265 1.23 486.5836 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.89 0.396 1.66 486.5836 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.61 0.26 0 486.5836 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 3.27 0.443 0 486.5837 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.87 0.403 1.25 486.5839 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.93 0.273 1.35 486.584 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 3 0.402 0 486.5841 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.94 0.359 0 486.5843 1,456.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.33 0.231 0 486.9178 1,457.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.38 0.188 0 486.9188 1,457.73 1,457.74 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 3.96 0.431 2.34 c3: Carbamidomethyl (+57.02) 492.2354 1,473.68 1,474.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 4.4 0.449 2.28 c3: Carbamidomethyl (+57.02) 492.236 1,473.68 1,474.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 4.24 0.402 2.15 c3: Carbamidomethyl (+57.02) 492.2361 1,473.68 1,474.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 3.97 0.381 2.46 c3: Carbamidomethyl (+57.02) 492.2364 1,473.69 1,474.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 3.7 0.23 1.35 c3: Carbamidomethyl (+57.02) 492.2367 1,473.69 1,474.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 3.59 0.369 1.74 c3: Carbamidomethyl (+57.02) 492.2374 1,473.69 1,474.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 3.35 0.332 1.32 c3: Carbamidomethyl (+57.02) 492.2384 1,473.69 1,474.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 4.47 0.39 3.1 c3: Carbamidomethyl (+57.02) 492.5708 1,474.69 1,474.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 2.95 0.254 0 c3: Carbamidomethyl (+57.02) 492.5727 1,474.69 1,474.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YEINSLVR 95.00% 2.76 0.284 1.11 497.2711 992.5266 993.5369 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YEINSLVR 95.00% 2.86 0.231 1.85 497.2711 992.5266 993.5369 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YEINSLVR 95.00% 1.91 0.194 1.74 497.2721 992.5285 993.5369 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTVAcGEPPVVEHAR 95.00% 2.04 0.397 0 c5: Carbamidomethyl (+57.02) 526.9257 1,577.75 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTVAcGEPPVVEHAR 95.00% 2.65 0.431 0 c5: Carbamidomethyl (+57.02) 526.926 1,577.75 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTVAcGEPPVVEHAR 95.00% 2.73 0.477 0 c5: Carbamidomethyl (+57.02) 526.9265 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTVAcGEPPVVEHAR 95.00% 3 0.552 0 c5: Carbamidomethyl (+57.02) 526.9269 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTVAcGEPPVVEHAR 95.00% 1.9 0.417 0 c5: Carbamidomethyl (+57.02) 526.927 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTVAcGEPPVVEHAR 95.00% 2.53 0.562 0 c5: Carbamidomethyl (+57.02) 526.9271 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTVAcGEPPVVEHAR 95.00% 3.07 0.452 0 c5: Carbamidomethyl (+57.02) 526.9271 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTVAcGEPPVVEHAR 95.00% 2.04 0.353 0 c5: Carbamidomethyl (+57.02) 526.9276 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTVAcGEPPVVEHAR 95.00% 2.99 0.539 1.74 c5: Carbamidomethyl (+57.02) 526.9277 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTVAcGEPPVVEHAR 95.00% 2.69 0.501 0 c5: Carbamidomethyl (+57.02) 527.2606 1,578.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.4 0.444 1.09 c3: Carbamidomethyl (+57.02) 543.571 1,627.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 2.68 0.351 0 c3: Carbamidomethyl (+57.02) 543.571 1,627.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 2.16 0.232 0 c3: Carbamidomethyl (+57.02) 543.5713 1,627.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.55 0.465 0 c3: Carbamidomethyl (+57.02) 543.5714 1,627.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.54 0.486 0 c3: Carbamidomethyl (+57.02) 543.5715 1,627.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.69 0.479 0 c3: Carbamidomethyl (+57.02) 543.5715 1,627.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.15 0.396 0 c3: Carbamidomethyl (+57.02) 543.5716 1,627.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.62 0.406 0 c3: Carbamidomethyl (+57.02) 543.5717 1,627.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.27 0.386 0 c3: Carbamidomethyl (+57.02) 543.5717 1,627.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 2.61 0.421 0 c3: Carbamidomethyl (+57.02) 543.5718 1,627.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.32 0.414 0 c3: Carbamidomethyl (+57.02) 543.5719 1,627.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.7 0.426 0 c3: Carbamidomethyl (+57.02) 543.5719 1,627.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.23 0.433 0 c3: Carbamidomethyl (+57.02) 543.9056 1,628.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.76 0.471 0 c3: Carbamidomethyl (+57.02) 543.9061 1,628.69 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 2.76 0.228 0 c3: Carbamidomethyl (+57.02) 543.9396 1,628.80 1,628.70 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% KGTVAcGEPPVVEHAR 95.00% 2.53 0.288 0 c6: Carbamidomethyl (+57.02) 569.6269 1,705.86 1,706.87 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% KGTVAcGEPPVVEHAR 95.00% 3.76 0.497 2.64 c6: Carbamidomethyl (+57.02) 569.9607 1,706.86 1,706.87 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% PNcGGNLLGVR 95.00% 2.47 0.36 0 c3: Carbamidomethyl (+57.02) 578.7952 1,155.57 1,156.59 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% PNcGGNLLGVR 95.00% 2.71 0.461 0 c3: Carbamidomethyl (+57.02) 578.7976 1,155.58 1,156.59 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% PNcGGNLLGVR 95.00% 2.76 0.477 0 c3: Carbamidomethyl (+57.02) 578.7978 1,155.58 1,156.59 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% PNcGGNLLGVR 95.00% 2.82 0.493 0 c3: Carbamidomethyl (+57.02) 579.2993 1,156.58 1,156.59 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% LEGEVFFATR 95.00% 3.53 0.366 2.24 584.8025 1,167.59 1,168.60 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% LEGEVFFATR 95.00% 3.5 0.35 2.41 584.8027 1,167.59 1,168.60 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% LEGEVFFATR 95.00% 3.63 0.363 2.4 584.8028 1,167.59 1,168.60 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% LEGEVFFATR 95.00% 3.64 0.37 2.38 584.8029 1,167.59 1,168.60 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% LEGEVFFATR 95.00% 3.64 0.365 2.6 584.803 1,167.59 1,168.60 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSKEKEVVLLVATEGR 95.00% 3.02 0.288 0 586.3445 1,756.01 1,757.02 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 4.23 0.546 4 593.344 1,184.67 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 3.87 0.484 4.11 593.3443 1,184.67 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 4.25 0.532 3.7 593.3444 1,184.67 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 3.98 0.484 4.12 593.3448 1,184.67 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 4.03 0.508 3.21 593.3449 1,184.67 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 4.17 0.548 2.54 593.3449 1,184.67 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 3.85 0.53 3.89 593.3449 1,184.67 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 4.03 0.543 4.96 593.3449 1,184.67 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 4.27 0.552 4.34 593.3451 1,184.67 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 4.11 0.52 3.37 593.3451 1,184.67 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 3.99 0.48 4.01 593.3451 1,184.67 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 3.79 0.592 3.55 593.3454 1,184.68 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 3.61 0.47 4.09 593.3456 1,184.68 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 4.21 0.575 2.92 593.3457 1,184.68 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EVVLLVATEGR 95.00% 3.34 0.398 4.11 593.3459 1,184.68 1,185.68 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% DRYEINSLVR 95.00% 2.52 0.311 0 632.8344 1,263.65 1,264.67 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% DRYEINSLVR 95.00% 3.14 0.386 0 632.8345 1,263.65 1,264.67 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% DRYEINSLVR 95.00% 2.77 0.343 0 632.8348 1,263.65 1,264.67 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% DRYEINSLVR 95.00% 3.15 0.344 0 632.8349 1,263.65 1,264.67 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% DRYEINSLVR 95.00% 3.29 0.381 0 632.8351 1,263.65 1,264.67 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% DRYEINSLVR 95.00% 3.01 0.264 0 632.8355 1,263.66 1,264.67 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% DRYEINSLVR 95.00% 2.53 0.194 0 632.8361 1,263.66 1,264.67 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% DRYEINSLVR 95.00% 2.78 0.228 0 632.8363 1,263.66 1,264.67 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 2.73 0.41 2.57 c3: Carbamidomethyl (+57.02) 644.2907 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 2.66 0.457 2.09 c3: Carbamidomethyl (+57.02) 644.2914 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 2.82 0.476 1.92 c3: Carbamidomethyl (+57.02) 644.2914 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 2.99 0.447 3.11 c3: Carbamidomethyl (+57.02) 644.2915 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 2.92 0.508 2.32 c3: Carbamidomethyl (+57.02) 644.2918 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 2.8 0.463 2.02 c3: Carbamidomethyl (+57.02) 644.2919 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 3.04 0.446 2.96 c3: Carbamidomethyl (+57.02) 644.2923 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 2.91 0.462 2.04 c3: Carbamidomethyl (+57.02) 644.2925 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 3.43 0.502 2.6 c3: Carbamidomethyl (+57.02) 644.2926 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 2.97 0.524 2.13 c3: Carbamidomethyl (+57.02) 644.2926 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 2.61 0.472 1.96 c3: Carbamidomethyl (+57.02) 644.2927 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 3.3 0.477 2.1 c3: Carbamidomethyl (+57.02) 644.2928 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 3.06 0.525 1.96 c3: Carbamidomethyl (+57.02) 644.293 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% YQcTEGFVQR 95.00% 2.79 0.502 2.39 c3: Carbamidomethyl (+57.02) 644.293 1,286.57 1,287.58 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cYAGWLADGSLR 95.00% 2.51 0.352 2 c1: Carbamidomethyl (+57.02) 684.8201 1,367.62 1,368.64 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cYAGWLADGSLR 95.00% 3.78 0.563 3.49 c1: Carbamidomethyl (+57.02) 684.8204 1,367.63 1,368.64 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cYAGWLADGSLR 95.00% 3.84 0.562 5.05 c1: Carbamidomethyl (+57.02) 684.8205 1,367.63 1,368.64 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cYAGWLADGSLR 95.00% 4.16 0.622 4.85 c1: Carbamidomethyl (+57.02) 684.8206 1,367.63 1,368.64 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cYAGWLADGSLR 95.00% 3.88 0.588 4.21 c1: Carbamidomethyl (+57.02) 684.8206 1,367.63 1,368.64 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cYAGWLADGSLR 95.00% 3.72 0.574 3.89 c1: Carbamidomethyl (+57.02) 684.8207 1,367.63 1,368.64 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cYAGWLADGSLR 95.00% 4.42 0.592 4.38 c1: Carbamidomethyl (+57.02) 684.8211 1,367.63 1,368.64 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cYAGWLADGSLR 95.00% 4.14 0.622 4.26 c1: Carbamidomethyl (+57.02) 684.8216 1,367.63 1,368.64 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cYAGWLADGSLR 95.00% 4.68 0.649 4.2 c1: Carbamidomethyl (+57.02) 684.8218 1,367.63 1,368.64 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% FTFQEAANEcR 95.00% 3.82 0.611 3.57 c10: Carbamidomethyl (+57.02) 686.7997 1,371.58 1,372.60 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% FTFQEAANEcR 95.00% 3.58 0.529 3.74 c10: Carbamidomethyl (+57.02) 686.8003 1,371.59 1,372.60 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% FTFQEAANEcR 95.00% 3.99 0.593 3 c10: Carbamidomethyl (+57.02) 686.8003 1,371.59 1,372.60 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% FTFQEAANEcR 95.00% 4.09 0.605 3.49 c10: Carbamidomethyl (+57.02) 686.8006 1,371.59 1,372.60 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.33 0.414 1.85 c5: Carbamidomethyl (+57.02) 692.3656 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.53 0.41 2.03 c5: Carbamidomethyl (+57.02) 692.3656 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.27 0.39 1.64 c5: Carbamidomethyl (+57.02) 692.3657 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.42 0.399 1.74 c5: Carbamidomethyl (+57.02) 692.3662 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.35 0.404 1.24 c5: Carbamidomethyl (+57.02) 692.3662 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.44 0.417 2.49 c5: Carbamidomethyl (+57.02) 692.3664 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.6 0.424 1.96 c5: Carbamidomethyl (+57.02) 692.3664 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 2.83 0.369 1.96 c5: Carbamidomethyl (+57.02) 692.3664 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.22 0.386 0 c5: Carbamidomethyl (+57.02) 692.3664 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.38 0.396 1.11 c5: Carbamidomethyl (+57.02) 692.3665 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.53 0.438 1.96 c5: Carbamidomethyl (+57.02) 692.3665 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.23 0.384 3.09 c5: Carbamidomethyl (+57.02) 692.3666 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.66 0.42 2.33 c5: Carbamidomethyl (+57.02) 692.3667 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.14 0.421 1.62 c5: Carbamidomethyl (+57.02) 692.3668 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.09 0.415 2.46 c5: Carbamidomethyl (+57.02) 692.3668 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.25 0.363 1.92 c5: Carbamidomethyl (+57.02) 692.3673 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% ARPNcGGNLLGVR 95.00% 3.36 0.379 2.6 c5: Carbamidomethyl (+57.02) 692.3676 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GEWNDVPcNYHLPFTcK 95.00% 3.61 0.343 0 c8: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 712.98 2,135.92 2,136.93 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cEVMHGIEDSEATLEVVVK 95.00% 5.47 0.5 1.17 c1: Carbamidomethyl (+57.02) 715.678 2,144.01 2,145.02 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cEVMHGIEDSEATLEVVVK 95.00% 2.74 0.256 1 c1: Carbamidomethyl (+57.02) 716.0114 2,145.01 2,145.02 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cEVMHGIEDSEATLEVVVK 95.00% 6.16 0.565 1.04 c1: Carbamidomethyl (+57.02) 716.0117 2,145.01 2,145.02 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cEVMHGIEDSEATLEVVVK 95.00% 5.74 0.52 1.7 c1: Carbamidomethyl (+57.02) 716.012 2,145.01 2,145.02 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cEVMHGIEDSEATLEVVVK 95.00% 5.5 0.464 2.3 c1: Carbamidomethyl (+57.02) 716.0125 2,145.01 2,145.02 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cEVmHGIEDSEATLEVVVK 95.00% 3.27 0.24 2.47 c1: Carbamidomethyl (+57.02), m4: Oxidation (+15.99) 720.6837 2,159.03 2,161.02 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 3.27 0.522 1.68 721.9117 1,441.81 1,442.82 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 3.57 0.478 2.92 721.9129 1,441.81 1,442.82 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 2.81 0.543 1.12 721.913 1,441.81 1,442.82 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 4.23 0.527 4.27 721.914 1,441.81 1,442.82 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 3.9 0.487 3.4 721.9143 1,441.81 1,442.82 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 4.38 0.5 2.07 721.9146 1,441.81 1,442.82 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 3.23 0.525 3.31 721.9146 1,441.81 1,442.82 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 3.69 0.502 3.59 721.9147 1,441.81 1,442.82 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EKEVVLLVATEGR 95.00% 2.92 0.557 2.27 721.9153 1,441.81 1,442.82 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.24 0.24 2.42 728.8564 1,455.70 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 3.04 0.318 1.54 729.3717 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.75 0.348 2.01 729.3722 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.48 0.363 2 729.3723 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.72 0.413 1.52 729.3723 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.64 0.415 3.07 729.3725 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.44 0.362 2.19 729.3726 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.98 0.347 1.68 729.3726 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 3.03 0.414 1.37 729.3727 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.79 0.324 1.25 729.3727 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.32 0.387 2.89 729.3728 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.86 0.391 1.49 729.3728 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.7 0.297 0 729.3733 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.61 0.377 1.43 729.3734 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.77 0.394 1.7 729.3734 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% AISTRYTLDFDR 95.00% 2.49 0.296 2.74 729.3735 1,456.73 1,457.74 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 3.73 0.504 2.68 c3: Carbamidomethyl (+57.02) 737.8476 1,473.68 1,474.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 3.87 0.491 3.68 c3: Carbamidomethyl (+57.02) 737.8515 1,473.69 1,474.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 3.31 0.395 4.24 c3: Carbamidomethyl (+57.02) 737.8522 1,473.69 1,474.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 3.53 0.422 3.15 c3: Carbamidomethyl (+57.02) 737.8527 1,473.69 1,474.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TPcVGDKDSSPGVR 95.00% 3.53 0.439 3 c3: Carbamidomethyl (+57.02) 737.8545 1,473.69 1,474.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EDLVGSASGDLDLGK 95.00% 2.2 0.344 0 738.3658 1,474.72 1,475.72 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 5.31 0.564 1.6 757.7388 2,270.19 2,270.20 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 5.41 0.545 2.14 757.74 2,270.20 2,270.20 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 5.52 0.585 2.51 757.7402 2,270.20 2,270.20 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 4.96 0.557 2.08 757.7404 2,270.20 2,270.20 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TYGVRPSTETYDVYcFVDR 95.00% 2.92 0.314 0 c15: Carbamidomethyl (+57.02) 776.692 2,327.05 2,328.06 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TYGVRPSTETYDVYcFVDR 95.00% 5.2 0.551 3.89 c15: Carbamidomethyl (+57.02) 777.0244 2,328.05 2,328.06 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TYGVRPSTETYDVYcFVDR 95.00% 4.47 0.407 0 c15: Carbamidomethyl (+57.02) 777.0254 2,328.05 2,328.06 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TYGVRPSTETYDVYcFVDR 95.00% 5.14 0.512 2.85 c15: Carbamidomethyl (+57.02) 777.0258 2,328.05 2,328.06 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% TYGVRPSTETYDVYcFVDR 95.00% 5.25 0.496 5.23 c15: Carbamidomethyl (+57.02) 777.0262 2,328.06 2,328.06 3
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTVAcGEPPVVEHAR 95.00% 4.05 0.489 5.4 c5: Carbamidomethyl (+57.02) 789.8877 1,577.76 1,578.77 2 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTVAcGEPPVVEHAR 95.00% 4.49 0.543 5.89 c5: Carbamidomethyl (+57.02) 789.8889 1,577.76 1,578.77 2 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.47 0.497 2.34 c3: Carbamidomethyl (+57.02) 814.8518 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.41 0.515 2.64 c3: Carbamidomethyl (+57.02) 814.8527 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.99 0.523 2.96 c3: Carbamidomethyl (+57.02) 814.8528 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.42 0.496 2.34 c3: Carbamidomethyl (+57.02) 814.8533 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.41 0.497 2.96 c3: Carbamidomethyl (+57.02) 814.8535 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.45 0.565 3.38 c3: Carbamidomethyl (+57.02) 814.8539 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.45 0.498 2.62 c3: Carbamidomethyl (+57.02) 814.8539 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.8 0.542 2.62 c3: Carbamidomethyl (+57.02) 814.854 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.49 0.522 2.25 c3: Carbamidomethyl (+57.02) 814.854 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.39 0.5 2.7 c3: Carbamidomethyl (+57.02) 814.8543 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.52 0.506 2.64 c3: Carbamidomethyl (+57.02) 814.8543 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.32 0.494 3.27 c3: Carbamidomethyl (+57.02) 814.8544 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.7 0.503 2.4 c3: Carbamidomethyl (+57.02) 814.8548 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.16 0.51 2.05 c3: Carbamidomethyl (+57.02) 814.8549 1,627.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.41 0.519 1.96 c3: Carbamidomethyl (+57.02) 814.8559 1,627.70 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.57 0.55 2.54 c3: Carbamidomethyl (+57.02) 815.354 1,628.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.56 0.5 2.85 c3: Carbamidomethyl (+57.02) 815.3545 1,628.69 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGcYGDKDEFPGVR 95.00% 3.27 0.466 1.72 c3: Carbamidomethyl (+57.02) 815.3564 1,628.70 1,628.70 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGLETSASGAEDLSGLPSGK 95.00% 4.96 0.541 7.31 953.4602 1,904.90 1,904.91 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% EGLETSASGAEDLSGLPSGK 95.00% 4.59 0.529 5.09 953.4612 1,904.91 1,904.91 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cEVMHGIEDSEATLEVVVK 95.00% 4.98 0.569 6.43 c1: Carbamidomethyl (+57.02) 1,073.51 2,145.01 2,145.02 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cEVMHGIEDSEATLEVVVK 95.00% 5.23 0.579 4.42 c1: Carbamidomethyl (+57.02) 1,073.51 2,145.01 2,145.02 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cEVMHGIEDSEATLEVVVK 95.00% 5.1 0.587 5.66 c1: Carbamidomethyl (+57.02) 1,073.51 2,145.01 2,145.02 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cEVMHGIEDSEATLEVVVK 95.00% 5.3 0.585 4.6 c1: Carbamidomethyl (+57.02) 1,073.51 2,145.01 2,145.02 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% cEVMHGIEDSEATLEVVVK 95.00% 4.96 0.593 3.57 c1: Carbamidomethyl (+57.02) 1,073.52 2,145.01 2,145.02 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 4.06 0.528 5.68 1,136.10 2,270.18 2,270.20 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 4.34 0.549 5.11 1,136.10 2,270.19 2,270.20 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 4.31 0.532 5.19 1,136.10 2,270.19 2,270.20 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 4.17 0.526 5.19 1,136.10 2,270.19 2,270.20 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 4.17 0.533 4.96 1,136.10 2,270.19 2,270.20 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 4.41 0.512 5.17 1,136.10 2,270.19 2,270.20 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 4.02 0.499 7.28 1,136.11 2,270.19 2,270.20 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 4.21 0.515 4.72 1,136.11 2,270.20 2,270.20 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% VSLPNYPAIPSDATLEVQSLR 95.00% 4.41 0.545 5.06 1,136.11 2,270.20 2,270.20 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTIGISGAGEISGLPSSELDISGR 95.00% 6.74 0.674 8.55 1,137.58 2,273.15 2,273.16 2
 SAMPLE 3 Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 212 11.30% GTIGISGAGEISGLPSSELDISGR 95.00% 6.72 0.658 8.57 1,137.58 2,273.15 2,273.16 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.31 0.402 1.39 c5: Carbamidomethyl (+57.02) 461.9135 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.92 0.398 1.15 c5: Carbamidomethyl (+57.02) 461.9135 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.42 0.397 1.96 c5: Carbamidomethyl (+57.02) 461.9137 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.34 0.477 1.07 c5: Carbamidomethyl (+57.02) 461.9139 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.21 0.349 0 c5: Carbamidomethyl (+57.02) 461.914 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.14 0.365 0 c5: Carbamidomethyl (+57.02) 461.9141 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.58 0.401 0 c5: Carbamidomethyl (+57.02) 461.9143 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.93 0.411 1.57 c5: Carbamidomethyl (+57.02) 461.9143 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.58 0.422 0.959 c5: Carbamidomethyl (+57.02) 461.9144 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.02 0.397 0 c5: Carbamidomethyl (+57.02) 461.9146 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.17 0.446 0 c5: Carbamidomethyl (+57.02) 461.9149 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.89 0.365 0.959 c5: Carbamidomethyl (+57.02) 461.915 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.26 0.44 1.36 c5: Carbamidomethyl (+57.02) 461.9152 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.51 0.378 2.21 c5: Carbamidomethyl (+57.02) 461.9153 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.75 0.407 1.72 c5: Carbamidomethyl (+57.02) 461.9154 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.88 0.416 2.02 c5: Carbamidomethyl (+57.02) 461.9156 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.98 0.328 0 c5: Carbamidomethyl (+57.02) 461.9158 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 4.36 0.445 0 c5: Carbamidomethyl (+57.02) 461.9159 1,382.72 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.64 0.356 0.959 c5: Carbamidomethyl (+57.02) 461.9163 1,382.73 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.84 0.361 1.42 c5: Carbamidomethyl (+57.02) 461.9164 1,382.73 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.82 0.382 1.12 c5: Carbamidomethyl (+57.02) 461.9167 1,382.73 1,383.73 3 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 1.95 0.173 1.17 465.2207 928.4258 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 2.11 0.319 1.16 465.2214 928.4272 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 2.34 0.317 1.12 465.2216 928.4276 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 2.35 0.323 1.59 465.2217 928.4278 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 1.86 0.374 1.25 465.2218 928.428 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 2.42 0.311 1.23 465.2219 928.4281 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 2.07 0.319 1.08 465.2221 928.4285 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 1.92 0.148 1.82 465.2223 928.429 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 2.28 0.299 0 465.2223 928.429 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 2.16 0.35 1.51 465.2226 928.4295 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 2.23 0.337 0 465.2229 928.4301 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 2.24 0.319 0 465.223 928.4303 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 2.27 0.359 1.39 465.2236 928.4315 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YTLDFDR 95.00% 2.3 0.381 1.3 465.2237 928.4318 929.437 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 2.97 0.213 0 481.6115 1,441.81 1,442.82 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 3.11 0.313 0 481.6132 1,441.82 1,442.82 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 3.21 0.233 0 481.9457 1,442.81 1,442.82 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 2.54 0.251 0 481.9466 1,442.82 1,442.82 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.88 0.392 0 486.5824 1,456.72 1,457.74 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.92 0.299 0 486.583 1,456.73 1,457.74 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.97 0.336 0 486.5831 1,456.73 1,457.74 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.87 0.313 0 486.5831 1,456.73 1,457.74 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 3.08 0.326 0 486.5834 1,456.73 1,457.74 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.95 0.413 0 486.5839 1,456.73 1,457.74 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.8 0.417 0 486.5839 1,456.73 1,457.74 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 3.13 0.32 0 486.5841 1,456.73 1,457.74 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.45 0.199 0 486.5843 1,456.73 1,457.74 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.56 0.159 0 486.5844 1,456.73 1,457.74 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.89 0.279 0 486.9183 1,457.73 1,457.74 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% TPcVGDKDSSPGVR 95.00% 4.04 0.297 2.66 c3: Carbamidomethyl (+57.02) 492.2354 1,473.68 1,474.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% TPcVGDKDSSPGVR 95.00% 4.13 0.403 1.85 c3: Carbamidomethyl (+57.02) 492.2358 1,473.68 1,474.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% TPcVGDKDSSPGVR 95.00% 4.13 0.392 2.24 c3: Carbamidomethyl (+57.02) 492.2358 1,473.68 1,474.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% TPcVGDKDSSPGVR 95.00% 3.91 0.309 2.11 c3: Carbamidomethyl (+57.02) 492.2364 1,473.69 1,474.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% TPcVGDKDSSPGVR 95.00% 4.67 0.428 2.19 c3: Carbamidomethyl (+57.02) 492.2371 1,473.69 1,474.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% TPcVGDKDSSPGVR 95.00% 4.48 0.488 2.62 c3: Carbamidomethyl (+57.02) 492.2372 1,473.69 1,474.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YEINSLVR 95.00% 2.85 0.286 1.7 497.2708 992.526 993.5369 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YEINSLVR 95.00% 2.97 0.266 1.31 497.2709 992.5262 993.5369 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTVAcGEPPVVEHAR 95.00% 2.54 0.454 0 c5: Carbamidomethyl (+57.02) 526.926 1,577.75 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTVAcGEPPVVEHAR 95.00% 2.33 0.502 0 c5: Carbamidomethyl (+57.02) 526.9268 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTVAcGEPPVVEHAR 95.00% 3.19 0.515 0 c5: Carbamidomethyl (+57.02) 526.9269 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTVAcGEPPVVEHAR 95.00% 2.46 0.474 1.15 c5: Carbamidomethyl (+57.02) 526.9271 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTVAcGEPPVVEHAR 95.00% 2.79 0.471 0 c5: Carbamidomethyl (+57.02) 526.9272 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTVAcGEPPVVEHAR 95.00% 2.69 0.467 0 c5: Carbamidomethyl (+57.02) 526.9274 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTVAcGEPPVVEHAR 95.00% 2.16 0.388 0 c5: Carbamidomethyl (+57.02) 526.9275 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTVAcGEPPVVEHAR 95.00% 2.6 0.452 1.12 c5: Carbamidomethyl (+57.02) 526.9277 1,577.76 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTVAcGEPPVVEHAR 95.00% 2.7 0.552 0 c5: Carbamidomethyl (+57.02) 527.2633 1,578.77 1,578.77 3 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.14 0.42 1.7 c3: Carbamidomethyl (+57.02) 543.5707 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.65 0.482 0 c3: Carbamidomethyl (+57.02) 543.5708 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 2.65 0.343 0 c3: Carbamidomethyl (+57.02) 543.5708 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.36 0.449 0 c3: Carbamidomethyl (+57.02) 543.571 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 2.53 0.195 0 c3: Carbamidomethyl (+57.02) 543.5713 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.45 0.404 0 c3: Carbamidomethyl (+57.02) 543.5713 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 2.71 0.313 0 c3: Carbamidomethyl (+57.02) 543.5713 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 2.7 0.355 0 c3: Carbamidomethyl (+57.02) 543.5714 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 2.74 0.262 0 c3: Carbamidomethyl (+57.02) 543.5715 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.85 0.486 0 c3: Carbamidomethyl (+57.02) 543.5717 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.24 0.415 0 c3: Carbamidomethyl (+57.02) 543.5717 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 2.69 0.309 0 c3: Carbamidomethyl (+57.02) 543.5721 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.44 0.411 0 c3: Carbamidomethyl (+57.02) 543.5723 1,627.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.61 0.405 0 c3: Carbamidomethyl (+57.02) 543.9058 1,628.69 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 2.76 0.267 0 c3: Carbamidomethyl (+57.02) 543.9072 1,628.70 1,628.70 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% HFPDRETWVDAER 95.00% 1.81 0.241 0 553.2614 1,656.76 1,657.77 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% KGTVAcGEPPVVEHAR 95.00% 2.93 0.438 1.28 c6: Carbamidomethyl (+57.02) 569.6286 1,705.86 1,706.87 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% PNcGGNLLGVR 95.00% 2.51 0.332 0 c3: Carbamidomethyl (+57.02) 578.795 1,155.57 1,156.59 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% PNcGGNLLGVR 95.00% 2.48 0.419 0 c3: Carbamidomethyl (+57.02) 578.7952 1,155.57 1,156.59 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% PNcGGNLLGVR 95.00% 2.77 0.467 0 c3: Carbamidomethyl (+57.02) 578.7956 1,155.58 1,156.59 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% PNcGGNLLGVR 95.00% 2.68 0.459 0 c3: Carbamidomethyl (+57.02) 578.7963 1,155.58 1,156.59 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% PNcGGNLLGVR 95.00% 2.81 0.48 0 c3: Carbamidomethyl (+57.02) 578.7978 1,155.58 1,156.59 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% LEGEVFFATR 95.00% 3.53 0.357 1.82 584.8021 1,167.59 1,168.60 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% LEGEVFFATR 95.00% 3.52 0.399 1.72 584.8028 1,167.59 1,168.60 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% LEGEVFFATR 95.00% 3.59 0.359 2.06 584.803 1,167.59 1,168.60 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% LEGEVFFATR 95.00% 3.48 0.371 2.54 584.8033 1,167.59 1,168.60 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% LEGEVFFATR 95.00% 3.46 0.373 1.7 584.8036 1,167.59 1,168.60 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% LEGEVFFATR 95.00% 3.46 0.376 1.82 584.8038 1,167.59 1,168.60 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% LEGEVFFATR 95.00% 3.28 0.362 1.72 584.8044 1,167.59 1,168.60 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% LEGEVFFATR 95.00% 2.48 0.34 1.89 584.8073 1,167.60 1,168.60 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 2.78 0.356 3.51 593.3415 1,184.67 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 3.15 0.495 3.92 593.343 1,184.67 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 3.21 0.497 3.04 593.3443 1,184.67 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 4.01 0.531 4.55 593.3447 1,184.67 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 4.22 0.522 5.46 593.3448 1,184.67 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 4.09 0.536 4.36 593.345 1,184.67 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 3.94 0.44 4.49 593.345 1,184.67 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 3.77 0.509 4.15 593.3451 1,184.67 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 4.09 0.525 3.82 593.3452 1,184.67 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 4.05 0.517 3.55 593.3454 1,184.68 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 3.88 0.506 4.8 593.3456 1,184.68 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 3.98 0.5 3.62 593.3462 1,184.68 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 3.5 0.455 3.85 593.3463 1,184.68 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 3.31 0.442 3.6 593.3471 1,184.68 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EVVLLVATEGR 95.00% 3.3 0.415 2.82 593.8243 1,185.63 1,185.68 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% DRYEINSLVR 95.00% 2.5 0.309 0 632.8333 1,263.65 1,264.67 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% DRYEINSLVR 95.00% 2.68 0.356 0 632.8347 1,263.65 1,264.67 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% DRYEINSLVR 95.00% 2.95 0.247 0 632.8352 1,263.65 1,264.67 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% DRYEINSLVR 95.00% 2.86 0.31 0 632.8354 1,263.66 1,264.67 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% DRYEINSLVR 95.00% 3.13 0.361 0 632.8357 1,263.66 1,264.67 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% DRYEINSLVR 95.00% 3.33 0.367 1.25 632.8357 1,263.66 1,264.67 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% DRYEINSLVR 95.00% 3.09 0.381 0 633.3402 1,264.66 1,264.67 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 2.72 0.416 1.44 c3: Carbamidomethyl (+57.02) 644.29 1,286.56 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 3.09 0.479 3.1 c3: Carbamidomethyl (+57.02) 644.2915 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 2.83 0.438 1.39 c3: Carbamidomethyl (+57.02) 644.2917 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 3.23 0.51 1.82 c3: Carbamidomethyl (+57.02) 644.2919 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 2.81 0.526 2.72 c3: Carbamidomethyl (+57.02) 644.2919 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 2.86 0.471 1.85 c3: Carbamidomethyl (+57.02) 644.2923 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 2.37 0.444 1.74 c3: Carbamidomethyl (+57.02) 644.2924 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 3.3 0.483 1.96 c3: Carbamidomethyl (+57.02) 644.2925 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 2.98 0.501 3.22 c3: Carbamidomethyl (+57.02) 644.2925 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 3.08 0.532 2.47 c3: Carbamidomethyl (+57.02) 644.2926 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 3.12 0.507 2.14 c3: Carbamidomethyl (+57.02) 644.2929 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 3.05 0.53 3 c3: Carbamidomethyl (+57.02) 644.293 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 2.53 0.457 2.72 c3: Carbamidomethyl (+57.02) 644.2931 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 2.27 0.432 1.8 c3: Carbamidomethyl (+57.02) 644.2932 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% YQcTEGFVQR 95.00% 2.35 0.494 3.14 c3: Carbamidomethyl (+57.02) 644.2953 1,286.57 1,287.58 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cYAGWLADGSLR 95.00% 3.06 0.457 3.49 c1: Carbamidomethyl (+57.02) 684.8206 1,367.63 1,368.64 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cYAGWLADGSLR 95.00% 4.11 0.618 4.25 c1: Carbamidomethyl (+57.02) 684.8207 1,367.63 1,368.64 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cYAGWLADGSLR 95.00% 2.99 0.511 3.55 c1: Carbamidomethyl (+57.02) 684.8211 1,367.63 1,368.64 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cYAGWLADGSLR 95.00% 4.44 0.631 4.82 c1: Carbamidomethyl (+57.02) 684.8212 1,367.63 1,368.64 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cYAGWLADGSLR 95.00% 4.11 0.576 4.41 c1: Carbamidomethyl (+57.02) 684.8213 1,367.63 1,368.64 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cYAGWLADGSLR 95.00% 3.65 0.565 3.68 c1: Carbamidomethyl (+57.02) 684.8213 1,367.63 1,368.64 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cYAGWLADGSLR 95.00% 2.15 0.255 2.68 c1: Carbamidomethyl (+57.02) 684.8214 1,367.63 1,368.64 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cYAGWLADGSLR 95.00% 2.91 0.545 2.7 c1: Carbamidomethyl (+57.02) 684.8216 1,367.63 1,368.64 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cYAGWLADGSLR 95.00% 3.67 0.498 4.19 c1: Carbamidomethyl (+57.02) 684.8217 1,367.63 1,368.64 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cYAGWLADGSLR 95.00% 2.79 0.513 4.19 c1: Carbamidomethyl (+57.02) 684.8227 1,367.63 1,368.64 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cYAGWLADGSLR 95.00% 2.82 0.544 4 c1: Carbamidomethyl (+57.02) 684.8235 1,367.63 1,368.64 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cYAGWLADGSLR 95.00% 3.12 0.53 3.35 c1: Carbamidomethyl (+57.02) 685.3217 1,368.63 1,368.64 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% FTFQEAANEcR 95.00% 3.57 0.546 3.28 c10: Carbamidomethyl (+57.02) 686.8 1,371.58 1,372.60 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% FTFQEAANEcR 95.00% 3.84 0.547 3.08 c10: Carbamidomethyl (+57.02) 686.8 1,371.58 1,372.60 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% FTFQEAANEcR 95.00% 3.89 0.578 3.14 c10: Carbamidomethyl (+57.02) 686.8001 1,371.58 1,372.60 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% FTFQEAANEcR 95.00% 3.99 0.538 3.47 c10: Carbamidomethyl (+57.02) 686.8006 1,371.59 1,372.60 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.07 0.373 1.74 c5: Carbamidomethyl (+57.02) 692.3657 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.39 0.374 2.7 c5: Carbamidomethyl (+57.02) 692.3661 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.19 0.365 0 c5: Carbamidomethyl (+57.02) 692.3662 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.52 0.415 1.89 c5: Carbamidomethyl (+57.02) 692.3663 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.52 0.413 1.85 c5: Carbamidomethyl (+57.02) 692.3664 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 2.7 0.403 0 c5: Carbamidomethyl (+57.02) 692.3667 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.28 0.385 1.43 c5: Carbamidomethyl (+57.02) 692.3667 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.24 0.405 1.52 c5: Carbamidomethyl (+57.02) 692.3667 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.15 0.378 1.82 c5: Carbamidomethyl (+57.02) 692.3668 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 2.98 0.409 2.22 c5: Carbamidomethyl (+57.02) 692.3669 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.42 0.405 1.7 c5: Carbamidomethyl (+57.02) 692.3669 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.25 0.457 2.19 c5: Carbamidomethyl (+57.02) 692.367 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.23 0.34 3.48 c5: Carbamidomethyl (+57.02) 692.3671 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.52 0.421 2.48 c5: Carbamidomethyl (+57.02) 692.3673 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3.29 0.37 1.82 c5: Carbamidomethyl (+57.02) 692.3675 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 3 0.429 1.62 c5: Carbamidomethyl (+57.02) 692.3676 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% ARPNcGGNLLGVR 95.00% 2.76 0.346 1.82 c5: Carbamidomethyl (+57.02) 692.3676 1,382.72 1,383.73 2 TITIN_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GEWNDVPcNYHLPFTcK 95.00% 3.32 0.227 0 c8: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 713.3143 2,136.92 2,136.93 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GEWNDVPcNYHLPFTcK 95.00% 3.06 0.267 0 c8: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 713.3156 2,136.92 2,136.93 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 5.76 0.544 2.68 c1: Carbamidomethyl (+57.02) 715.6779 2,144.01 2,145.02 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 5.29 0.504 2.02 c1: Carbamidomethyl (+57.02) 715.6793 2,144.01 2,145.02 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 5.58 0.492 2.15 c1: Carbamidomethyl (+57.02) 716.0111 2,145.01 2,145.02 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 5.61 0.416 1.74 c1: Carbamidomethyl (+57.02) 716.0112 2,145.01 2,145.02 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 5.65 0.524 2.09 c1: Carbamidomethyl (+57.02) 716.0117 2,145.01 2,145.02 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 5.37 0.529 1.85 c1: Carbamidomethyl (+57.02) 716.0123 2,145.01 2,145.02 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 2.19 0.256 0 721.9113 1,441.81 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 2.95 0.426 2.21 721.9125 1,441.81 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 3.79 0.508 3.7 721.9128 1,441.81 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 2.54 0.317 0 721.913 1,441.81 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 3.97 0.552 3.29 721.9133 1,441.81 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 3.48 0.448 2.68 721.9135 1,441.81 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 3.25 0.55 1.92 721.9138 1,441.81 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 3.76 0.491 4.15 721.915 1,441.81 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 3.93 0.519 3.32 721.9151 1,441.81 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 3.09 0.509 1.21 721.9153 1,441.81 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 3.16 0.415 3.57 722.4126 1,442.81 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 4.11 0.474 6.4 722.4153 1,442.81 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EKEVVLLVATEGR 95.00% 4.72 0.512 4.6 722.4156 1,442.82 1,442.82 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.34 0.289 1.22 728.8579 1,455.70 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.38 0.377 1.64 729.3717 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 3.01 0.318 0 729.3717 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.44 0.327 1.54 729.372 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.67 0.371 1.7 729.372 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.64 0.27 0 729.3721 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 3 0.385 2 729.3723 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.92 0.339 0 729.3726 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.82 0.422 1.72 729.3728 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 3.22 0.302 1.7 729.3729 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.38 0.308 1.62 729.373 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.45 0.327 2.07 729.373 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 3 0.358 1.66 729.3731 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.62 0.329 2.57 729.3734 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.16 0.181 1.96 729.3742 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.25 0.306 0 729.3753 1,456.73 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% AISTRYTLDFDR 95.00% 2.37 0.32 1.59 729.8756 1,457.74 1,457.74 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% TPcVGDKDSSPGVR 95.00% 3.53 0.43 3.52 c3: Carbamidomethyl (+57.02) 737.851 1,473.69 1,474.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% TPcVGDKDSSPGVR 95.00% 3.13 0.345 3.96 c3: Carbamidomethyl (+57.02) 737.8528 1,473.69 1,474.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% TPcVGDKDSSPGVR 95.00% 3.41 0.343 3.33 c3: Carbamidomethyl (+57.02) 737.8534 1,473.69 1,474.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 4.05 0.544 0 757.7393 2,270.19 2,270.20 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 5 0.544 2.32 757.7404 2,270.20 2,270.20 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 4.64 0.559 2.77 757.7408 2,270.20 2,270.20 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 5.25 0.534 3.48 757.7424 2,270.20 2,270.20 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% TYGVRPSTETYDVYcFVDR 95.00% 4.53 0.389 2.43 c15: Carbamidomethyl (+57.02) 777.0251 2,328.05 2,328.06 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTVAcGEPPVVEHAR 95.00% 4.52 0.598 4.24 c5: Carbamidomethyl (+57.02) 789.8883 1,577.76 1,578.77 2 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTVAcGEPPVVEHAR 95.00% 3.6 0.00916 2.89 c5: Carbamidomethyl (+57.02) 789.8924 1,577.77 1,578.77 2 MOES_HUMAN,MY18B_HUMAN
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.18 0.383 0 c3: Carbamidomethyl (+57.02) 814.8401 1,627.66 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.43 0.568 2.33 c3: Carbamidomethyl (+57.02) 814.8523 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.69 0.498 2.89 c3: Carbamidomethyl (+57.02) 814.8524 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.63 0.553 2.74 c3: Carbamidomethyl (+57.02) 814.8528 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.16 0.414 1.85 c3: Carbamidomethyl (+57.02) 814.853 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.38 0.388 2.23 c3: Carbamidomethyl (+57.02) 814.8531 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.75 0.497 2.09 c3: Carbamidomethyl (+57.02) 814.8532 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.24 0.501 2.24 c3: Carbamidomethyl (+57.02) 814.8535 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.48 0.496 2.72 c3: Carbamidomethyl (+57.02) 814.8537 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.54 0.53 2.77 c3: Carbamidomethyl (+57.02) 814.8538 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.65 0.527 2.32 c3: Carbamidomethyl (+57.02) 814.8538 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.46 0.508 3.43 c3: Carbamidomethyl (+57.02) 814.854 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.38 0.513 2.85 c3: Carbamidomethyl (+57.02) 814.8541 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.28 0.449 3.07 c3: Carbamidomethyl (+57.02) 814.8545 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.5 0.5 3.42 c3: Carbamidomethyl (+57.02) 814.8553 1,627.69 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.25 0.518 1.47 c3: Carbamidomethyl (+57.02) 814.8557 1,627.70 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% EGcYGDKDEFPGVR 95.00% 3.28 0.553 1.54 c3: Carbamidomethyl (+57.02) 814.8575 1,627.70 1,628.70 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% PSTETYDVYcFVDR 95.00% 5.38 0.54 0 c10: Carbamidomethyl (+57.02) 876.8818 1,751.75 1,751.76 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% PSTETYDVYcFVDR 95.00% 5.18 0.561 0 c10: Carbamidomethyl (+57.02) 876.8864 1,751.76 1,751.76 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VNSAYQDKVSLPNYPAIPSDATLEVQSLR 95.00% 3.52 0.369 0 1,059.54 3,175.59 3,175.63 3
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 0 0 6.36 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,064.50 2,126.98 2,127.99 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 0 0 6.2 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,064.50 2,126.98 2,127.99 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 0 0 3.41 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,064.50 2,126.99 2,127.99 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 0 0 6 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,065.00 2,127.98 2,127.99 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 0 0 5.2 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,065.00 2,127.98 2,127.99 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 0 0 6 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,065.00 2,127.98 2,127.99 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 0 0 7.7 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,065.00 2,127.99 2,127.99 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 5.08 0.606 3.68 c1: Carbamidomethyl (+57.02) 1,073.01 2,144.01 2,145.02 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 4.03 0.464 3.85 c1: Carbamidomethyl (+57.02) 1,073.01 2,144.01 2,145.02 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 4.71 0.584 3.52 c1: Carbamidomethyl (+57.02) 1,073.51 2,145.01 2,145.02 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 4.98 0.574 5.15 c1: Carbamidomethyl (+57.02) 1,073.51 2,145.01 2,145.02 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 4.9 0.59 3.89 c1: Carbamidomethyl (+57.02) 1,073.51 2,145.01 2,145.02 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% cEVMHGIEDSEATLEVVVK 95.00% 5 0.606 4.74 c1: Carbamidomethyl (+57.02) 1,073.51 2,145.01 2,145.02 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 4.35 0.558 6.03 1,136.10 2,270.19 2,270.20 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 4.44 0.57 5.82 1,136.10 2,270.19 2,270.20 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 4.4 0.503 5.6 1,136.10 2,270.19 2,270.20 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 4.14 0.545 5.77 1,136.10 2,270.19 2,270.20 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 4.3 0.564 6.15 1,136.10 2,270.19 2,270.20 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 4.31 0.526 5.72 1,136.11 2,270.19 2,270.20 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 4.39 0.539 4.92 1,136.11 2,270.19 2,270.20 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 4.21 0.547 6.29 1,136.11 2,270.20 2,270.20 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 4.16 0.527 5.68 1,136.11 2,270.20 2,270.20 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% VSLPNYPAIPSDATLEVQSLR 95.00% 4.34 0.516 5.7 1,136.11 2,270.20 2,270.20 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTIGISGAGEISGLPSSELDISGR 95.00% 6.75 0.671 8.96 1,137.58 2,273.15 2,273.16 2
 SAMPLE 3R Aggrecan core protein  ACAN  PGCA_HUMAN 250,168.00 100.00% 22 28 203 10.60% GTIGISGAGEISGLPSSELDISGR 95.00% 6.77 0.671 7.47 1,137.58 2,273.15 2,273.16 2
 SAMPLE 1 Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 3 3 5 2.35% SFLAFPTLR 95.00% 2.03 0.194 1.32 526.2997 1,050.58 1,051.59 2
 SAMPLE 1 Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 3 3 5 2.35% SFLAFPTLR 95.00% 2.56 0.314 1.24 526.3002 1,050.58 1,051.59 2
 SAMPLE 1 Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 3 3 5 2.35% VLGAPVPAFEGR 95.00% 2.83 0.517 0 606.8397 1,211.66 1,212.67 2
 SAMPLE 1 Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 3 3 5 2.35% VLGAPVPAFEGR 95.00% 3.06 0.454 2.32 606.8401 1,211.66 1,212.67 2
 SAMPLE 1 Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 3 3 5 2.35% TEATQGLVLWSGK 95.00% 3.25 0.515 3.68 695.3741 1,388.73 1,389.74 2
 SAMPLE 1 Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 3 3 5 2.35% EAAcLQQTQIEEAR 95.00% 2.96 0.217 0 c4: Carbamidomethyl (+57.02) 823.8971 1,645.78 1,646.78 2
 SAMPLE 1 Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 3 3 5 2.35% EAAcLQQTQIEEAR 95.00% 3.13 0.231 0 c4: Carbamidomethyl (+57.02) 823.8976 1,645.78 1,646.78 2
 SAMPLE 1R Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 4 4 9 2.93% SFLAFPTLR 95.00% 2.12 0.195 1.25 526.2995 1,050.58 1,051.59 2
 SAMPLE 1R Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 4 4 9 2.93% SFLAFPTLR 95.00% 2.61 0.246 0 526.3 1,050.58 1,051.59 2
 SAMPLE 1R Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 4 4 9 2.93% SFLAFPTLR 95.00% 2.86 0.279 1.37 526.3006 1,050.59 1,051.59 2
 SAMPLE 1R Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 4 4 9 2.93% SFLAFPTLR 95.00% 2.25 0.22 0 526.3012 1,050.59 1,051.59 2
 SAMPLE 1R Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 4 4 9 2.93% VLGAPVPAFEGR 95.00% 2.2 0.272 0 606.8362 1,211.66 1,212.67 2
 SAMPLE 1R Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 4 4 9 2.93% VLGAPVPAFEGR 95.00% 2.8 0.47 0 606.8385 1,211.66 1,212.67 2
 SAMPLE 1R Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 4 4 9 2.93% VLGAPVPAFEGR 95.00% 2.69 0.491 2.27 606.8396 1,211.66 1,212.67 2
 SAMPLE 1R Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 4 4 9 2.93% SIESTLDDLFR 95.00% 3.25 0.45 3.52 648.3283 1,294.64 1,295.65 2
 SAMPLE 1R Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 4 4 9 2.93% SIESTLDDLFR 95.00% 2.93 0.439 4.44 648.3306 1,294.65 1,295.65 2
 SAMPLE 1R Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 4 4 9 2.93% TFVEYLNAVTESEK 95.00% 5 0.603 4.44 815.4037 1,628.79 1,629.80 2
 SAMPLE 1R Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 4 4 9 2.93% EAAcLQQTQIEEAR 95.00% 2.7 0.304 0 c4: Carbamidomethyl (+57.02) 823.8961 1,645.78 1,646.78 2
 SAMPLE 1R Agrin  AGRN  AGRIN_HUMAN 214,820.00 100.00% 4 4 9 2.93% EAAcLQQTQIEEAR 95.00% 3.11 0.254 0 c4: Carbamidomethyl (+57.02) 824.3968 1,646.78 1,646.78 2
 SAMPLE 2 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 5 5 8 16.80% KPFSIEDVEVAPPK 95.00% 2.32 0.381 1.74 519.6184 1,555.83 1,555.84 3 TENX_HUMAN,AHNK_HUMAN,FHL1_HUMAN,K2C1_HUMAN
 SAMPLE 2 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 5 5 8 16.80% IIAVDINKDK 95.00% 2.57 0.127 1.24 564.8337 1,127.65 1,128.66 2
 SAMPLE 2 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 5 5 8 16.80% AKELGATEcINPQDYK 95.00% 2.51 0.349 1.11 c9: Carbamidomethyl (+57.02) 613.2964 1,836.87 1,836.88 3
 SAMPLE 2 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 5 5 8 16.80% VIPLFTPQcGK 95.00% 2.29 0.481 2.04 c9: Carbamidomethyl (+57.02) 630.3434 1,258.67 1,259.68 2
 SAMPLE 2 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 5 5 8 16.80% INEGFDLLHSGK 95.00% 3.47 0.458 0 665.3387 1,328.66 1,329.68 2
 SAMPLE 2 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 5 5 8 16.80% INEGFDLLHSGK 95.00% 3.56 0.432 0 665.3394 1,328.66 1,329.68 2
 SAMPLE 2 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 5 5 8 16.80% INEGFDLLHSGK 95.00% 2.21 0.29 0 665.6697 1,329.32 1,329.68 2
 SAMPLE 2 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 5 5 8 16.80% KPFSIEDVEVAPPK 95.00% 3.26 0.477 4.31 778.4213 1,554.83 1,555.84 2 TENX_HUMAN,AHNK_HUMAN,FHL1_HUMAN,K2C1_HUMAN
 SAMPLE 2 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 5 5 8 16.80% KPFSIEDVEVAPPK 95.00% 2.75 0.313 0 778.8501 1,555.68 1,555.84 2 TENX_HUMAN,AHNK_HUMAN,FHL1_HUMAN,K2C1_HUMAN
 SAMPLE 2 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 5 5 8 16.80% KPFSIEDVEVAPPK 95.00% 3.17 0.489 5 778.924 1,555.83 1,555.84 2 TENX_HUMAN,AHNK_HUMAN,FHL1_HUMAN,K2C1_HUMAN
 SAMPLE 2 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 5 5 8 16.80% ELGATEcINPQDYK 95.00% 3.29 0.511 2.19 c7: Carbamidomethyl (+57.02) 819.375 1,636.73 1,637.75 2
 SAMPLE 2 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 5 5 8 16.80% ELGATEcINPQDYK 95.00% 2.92 0.467 2.96 c7: Carbamidomethyl (+57.02) 819.3752 1,636.73 1,637.75 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% AAVLWEVK 95.00% 2.7 0.399 0 458.269 914.5224 915.5304 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% AAVLWEVK 95.00% 2.55 0.324 0 458.2698 914.524 915.5304 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% AAVLWEVK 95.00% 2.63 0.379 0 458.2701 914.5245 915.5304 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% AAVLWEVK 95.00% 2.09 0.273 0 458.2704 914.5252 915.5304 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% AAVLWEVK 95.00% 2.68 0.437 0 458.2711 914.5265 915.5304 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% KPFSIEDVEVAPPK 95.00% 2.19 0.283 0 519.2831 1,554.83 1,555.84 3 TENX_HUMAN,AHNK_HUMAN,FHL1_HUMAN,K2C1_HUMAN
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% KPFSIEDVEVAPPK 95.00% 3.02 0.442 0 519.2841 1,554.83 1,555.84 3 TENX_HUMAN,AHNK_HUMAN,FHL1_HUMAN,K2C1_HUMAN
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% FSLDALITHVLPFEK 95.00% 3.29 0.394 0 577.3231 1,728.95 1,729.95 3
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% FSLDALITHVLPFEK 95.00% 3.22 0.481 0 577.6553 1,729.94 1,729.95 3
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% AKELGATEcINPQDYK 95.00% 2.94 0.339 0 c9: Carbamidomethyl (+57.02) 613.295 1,836.86 1,836.88 3
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% AKELGATEcINPQDYK 95.00% 3.03 0.367 0 c9: Carbamidomethyl (+57.02) 613.2993 1,836.87 1,836.88 3
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% VIPLFTPQcGK 95.00% 2.27 0.296 1.31 c9: Carbamidomethyl (+57.02) 630.343 1,258.67 1,259.68 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% VIPLFTPQcGK 95.00% 2.26 0.478 2.72 c9: Carbamidomethyl (+57.02) 630.3434 1,258.67 1,259.68 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% VIPLFTPQcGK 95.00% 2.33 0.429 1.28 c9: Carbamidomethyl (+57.02) 630.3443 1,258.67 1,259.68 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% VIPLFTPQcGK 95.00% 1.97 0.451 1.7 c9: Carbamidomethyl (+57.02) 630.3456 1,258.68 1,259.68 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% VIPLFTPQcGK 95.00% 1.76 0.413 0 c9: Carbamidomethyl (+57.02) 630.3466 1,258.68 1,259.68 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% INEGFDLLHSGK 95.00% 3.44 0.415 0 665.3419 1,328.67 1,329.68 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% INEGFDLLHSGK 95.00% 3.5 0.385 0 665.3423 1,328.67 1,329.68 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% VTPGSTcAVFGLGGVGLSAVMGcK 95.00% 4.21 0.554 3.07 c7: Carbamidomethyl (+57.02), c23: Carbamidomethyl (+57.02) 776.053 2,325.14 2,325.14 3
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% VTPGSTcAVFGLGGVGLSAVMGcK 95.00% 3.98 0.528 2.64 c7: Carbamidomethyl (+57.02), c23: Carbamidomethyl (+57.02) 776.0543 2,325.14 2,325.14 3
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% ELGATEcINPQDYK 95.00% 4.22 0.549 3.01 c7: Carbamidomethyl (+57.02) 819.8785 1,637.74 1,637.75 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% ELGATEcINPQDYK 95.00% 4.14 0.523 3.12 c7: Carbamidomethyl (+57.02) 819.8792 1,637.74 1,637.75 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% AKELGATEcINPQDYK 95.00% 4.82 0.657 6.12 c9: Carbamidomethyl (+57.02) 918.9423 1,835.87 1,836.88 2
 SAMPLE 2R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 7 9 22 26.70% VTPGSTcAVFGLGGVGLSAVMGcK 95.00% 5.22 0.696 8.92 c7: Carbamidomethyl (+57.02), c23: Carbamidomethyl (+57.02) 1,163.57 2,325.13 2,325.14 2
 SAMPLE 3 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 2 2 4 8.80% AAVLWEVK 95.00% 2.62 0.387 0 458.2689 914.5221 915.5304 2
 SAMPLE 3 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 2 2 4 8.80% AAVLWEVK 95.00% 2.26 0.373 0 458.2701 914.5246 915.5304 2
 SAMPLE 3 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 2 2 4 8.80% KPFSIEDVEVAPPK 95.00% 2.16 0.346 0 519.6174 1,555.83 1,555.84 3 TENX_HUMAN,AHNK_HUMAN,FHL1_HUMAN,K2C1_HUMAN
 SAMPLE 3 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 2 2 4 8.80% VIPLFTPQcGK 95.00% 1.93 0.377 2.74 c9: Carbamidomethyl (+57.02) 630.3425 1,258.67 1,259.68 2
 SAMPLE 3 Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 100.00% 2 2 4 8.80% VIPLFTPQcGK 95.00% 1.94 0.381 3.38 c9: Carbamidomethyl (+57.02) 630.3434 1,258.67 1,259.68 2
 SAMPLE 3R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 99.80% 2 2 4 5.07% AAVLWEVK 95.00% 2.6 0.403 0 458.2683 914.521 915.5304 2
 SAMPLE 3R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 99.80% 2 2 4 5.07% AAVLWEVK 95.00% 2.32 0.32 0 458.269 914.5223 915.5304 2
 SAMPLE 3R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 99.80% 2 2 4 5.07% AAVLWEVK 95.00% 2.67 0.382 0 458.2705 914.5254 915.5304 2
 SAMPLE 3R Alcohol dehydrogenase 1B  ADH1B  ADH1B_HUMAN 39,836.30 99.80% 2 2 4 5.07% VIPLFTPQcGK 95.00% 1.84 0.466 0 c9: Carbamidomethyl (+57.02) 630.3433 1,258.67 1,259.68 2
 SAMPLE 4 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 12 10.40% YGLAAAVFTR 95.00% 2.94 0.472 3.96 534.7956 1,067.58 1,068.58 2
 SAMPLE 4 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 12 10.40% YGLAAAVFTR 95.00% 3.87 0.465 3.46 534.7964 1,067.58 1,068.58 2
 SAMPLE 4 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 12 10.40% YGLAAAVFTR 95.00% 3.96 0.502 2.85 534.7964 1,067.58 1,068.58 2
 SAMPLE 4 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 12 10.40% YGLAAAVFTR 95.00% 3.9 0.454 2.74 534.7968 1,067.58 1,068.58 2
 SAMPLE 4 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 12 10.40% YGLAAAVFTR 95.00% 3.27 0.449 3.25 534.7969 1,067.58 1,068.58 2
 SAMPLE 4 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 12 10.40% YGLAAAVFTR 95.00% 2.22 0.0961 1.89 534.7978 1,067.58 1,068.58 2
 SAMPLE 4 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 12 10.40% YGLAAAVFTR 95.00% 3.73 0.492 2.64 534.7982 1,067.58 1,068.58 2
 SAMPLE 4 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 12 10.40% IAKEEIFGPVQPLFK 95.00% 3.63 0.294 0 572.9978 1,715.97 1,715.97 3
 SAMPLE 4 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 12 10.40% LAPALATGNTVVMK 95.00% 2.65 0.461 1.38 693.3958 1,384.78 1,385.78 2
 SAMPLE 4 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 12 10.40% LAPALATGNTVVMK 95.00% 2.24 0.321 2.89 693.3971 1,384.78 1,385.78 2
 SAMPLE 4 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 12 10.40% VAFTGSTEVGHLIQK 95.00% 3.93 0.478 3.74 793.9324 1,585.85 1,586.85 2
 SAMPLE 4 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 12 10.40% VAFTGSTEVGHLIQK 95.00% 4.12 0.475 2.46 794.4364 1,586.86 1,586.85 2
 SAMPLE 4R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 4 11 8.12% VAFTGSTEVGHLIQK 95.00% 1.77 0.247 1.38 529.959 1,586.85 1,586.85 3
 SAMPLE 4R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 4 11 8.12% YGLAAAVFTR 95.00% 3.88 0.464 2.8 534.7962 1,067.58 1,068.58 2
 SAMPLE 4R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 4 11 8.12% YGLAAAVFTR 95.00% 2.88 0.416 2.02 534.7963 1,067.58 1,068.58 2
 SAMPLE 4R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 4 11 8.12% YGLAAAVFTR 95.00% 3.56 0.485 3.15 534.7966 1,067.58 1,068.58 2
 SAMPLE 4R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 4 11 8.12% YGLAAAVFTR 95.00% 3.6 0.514 3.33 534.7967 1,067.58 1,068.58 2
 SAMPLE 4R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 4 11 8.12% YGLAAAVFTR 95.00% 3.97 0.508 3.03 534.7968 1,067.58 1,068.58 2
 SAMPLE 4R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 4 11 8.12% YGLAAAVFTR 95.00% 3.64 0.469 2.74 534.7969 1,067.58 1,068.58 2
 SAMPLE 4R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 4 11 8.12% YGLAAAVFTR 95.00% 3.61 0.502 3.68 534.797 1,067.58 1,068.58 2
 SAMPLE 4R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 4 11 8.12% YGLAAAVFTR 95.00% 2.57 0.395 2.59 534.7971 1,067.58 1,068.58 2
 SAMPLE 4R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 4 11 8.12% VAFTGSTEVGHLIQK 95.00% 3.67 0.435 2.85 793.9336 1,585.85 1,586.85 2
 SAMPLE 4R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 4 11 8.12% VAEQTPLSALYLASLIK 95.00% 4.42 0.566 2.32 909.5303 1,817.05 1,817.04 2
 SAMPLE 1 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 5 12.80% VAFTGSTEVGHLIQK 95.00% 2.18 0.303 0 529.6218 1,585.84 1,586.85 3
 SAMPLE 1 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 5 12.80% IAKEEIFGPVQPLFK 95.00% 4.49 0.371 0 572.6616 1,714.96 1,715.97 3
 SAMPLE 1 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 5 12.80% IAKEEIFGPVQPLFK 95.00% 4.3 0.342 0 572.9964 1,715.97 1,715.97 3
 SAMPLE 1 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 5 12.80% VGNPFELDTQQGPQVDKEQFER 95.00% 2.91 0.38 0 854.7466 2,561.22 2,561.23 3
 SAMPLE 1 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 4 4 5 12.80% TFVEESIYNEFLER 95.00% 4.64 0.468 5.64 888.4254 1,774.84 1,775.85 2
 SAMPLE 1R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 14.30% YGLAAAVFTR 95.00% 3.24 0.512 3.55 534.7942 1,067.57 1,068.58 2
 SAMPLE 1R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 14.30% LLNLLADLVER 95.00% 3.87 0.463 1.74 634.8816 1,267.75 1,268.76 2
 SAMPLE 1R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 14.30% LLNLLADLVER 95.00% 3.23 0.417 3.05 634.8828 1,267.75 1,268.76 2
 SAMPLE 1R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 14.30% VGNPFELDTQQGPQVDKEQFER 95.00% 3.49 0.348 1.64 854.7466 2,561.22 2,561.23 3
 SAMPLE 1R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 14.30% TFVEESIYNEFLER 95.00% 5.16 0.463 4 888.9264 1,775.84 1,775.85 2
 SAMPLE 1R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 14.30% TFVEESIYNEFLER 95.00% 5.1 0.478 5.52 888.9267 1,775.84 1,775.85 2
 SAMPLE 1R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 14.30% VAEQTPLSALYLASLIK 95.00% 4.94 0.644 3.92 909.0246 1,816.03 1,817.04 2
 SAMPLE 1R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 14.30% VAEQTPLSALYLASLIK 95.00% 5.26 0.612 4.13 909.525 1,817.03 1,817.04 2
 SAMPLE 2R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 3 4 7.35% YGLAAAVFTR 95.00% 2.92 0.461 1.68 534.7951 1,067.57 1,068.58 2
 SAMPLE 2R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 3 4 7.35% LLNLLADLVER 95.00% 2.36 0.283 0 634.8831 1,267.75 1,268.76 2
 SAMPLE 2R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 3 4 7.35% VAEQTPLSALYLASLIK 95.00% 4.18 0.494 3.09 909.0229 1,816.03 1,817.04 2
 SAMPLE 2R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 3 3 4 7.35% VAEQTPLSALYLASLIK 95.00% 4.22 0.524 2.89 909.5252 1,817.03 1,817.04 2
 SAMPLE 3 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 13.50% YGLAAAVFTR 95.00% 3.57 0.48 3.24 534.7943 1,067.57 1,068.58 2
 SAMPLE 3 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 13.50% YGLAAAVFTR 95.00% 3.81 0.471 2.89 534.795 1,067.57 1,068.58 2
 SAMPLE 3 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 13.50% VLGYIQLGQK 95.00% 3.14 0.507 2.06 559.8311 1,117.65 1,118.66 2
 SAMPLE 3 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 13.50% LAPALATGNTVVMK 95.00% 3.92 0.603 7.51 693.3937 1,384.77 1,385.78 2
 SAMPLE 3 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 13.50% LAPALATGNTVVMK 95.00% 3.19 0.413 5.66 693.3941 1,384.77 1,385.78 2
 SAMPLE 3 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 13.50% ELGEDGLKAYTEVK 95.00% 2.83 0.351 0 776.3979 1,550.78 1,551.79 2
 SAMPLE 3 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 13.50% VGNPFELDTQQGPQVDKEQFER 95.00% 3.66 0.471 2.74 854.7475 2,561.22 2,561.23 3
 SAMPLE 3 Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 5 5 8 13.50% VGNPFELDTQQGPQVDKEQFER 95.00% 3.58 0.508 1.92 854.7485 2,561.22 2,561.23 3
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% YGLAAAVFTR 95.00% 3.17 0.558 2.89 534.7935 1,067.57 1,068.58 2
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% YGLAAAVFTR 95.00% 3.54 0.454 2.68 534.7943 1,067.57 1,068.58 2
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% VAEQTPLSALYLASLIK 95.00% 4.47 0.406 2.05 606.6855 1,817.03 1,817.04 3
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% VAEQTPLSALYLASLIK 95.00% 4.22 0.501 2.68 606.6859 1,817.03 1,817.04 3
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% EEIFGPVQPLFK 95.00% 2.83 0.164 0 702.3827 1,402.75 1,403.76 2
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% VAFTGSTEVGHLIQK 95.00% 3.11 0.429 2 793.9308 1,585.85 1,586.85 2
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% VAFTGSTEVGHLIQK 95.00% 3.68 0.426 1.89 793.9313 1,585.85 1,586.85 2
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% VGNPFELDTQQGPQVDKEQFER 95.00% 3.94 0.493 2.37 854.7457 2,561.21 2,561.23 3
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% VGNPFELDTQQGPQVDKEQFER 95.00% 3.58 0.521 3.8 854.7476 2,561.22 2,561.23 3
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% TFVEESIYNEFLER 95.00% 4.66 0.504 4.64 888.4274 1,774.84 1,775.85 2
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% TFVEESIYNEFLER 95.00% 5.06 0.483 4.48 888.9292 1,775.84 1,775.85 2
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% VAEQTPLSALYLASLIK 95.00% 4.85 0.661 5.01 909.0243 1,816.03 1,817.04 2
 SAMPLE 3R Aldehyde dehydrogenase X, mitochondrial  ALDH1B1  AL1B1_HUMAN 57,220.80 100.00% 6 7 13 17.40% VAEQTPLSALYLASLIK 95.00% 5.56 0.593 4.28 909.5249 1,817.03 1,817.04 2
 SAMPLE 3R Aldehyde dehydrogenase, mitochondrial  ALDH2  ALDH2_HUMAN 56,363.40 99.80% 2 2 2 5.61% VIQVAAGSSNLK 95.00% 2.75 0.325 2.37 593.8413 1,185.67 1,186.68 2
 SAMPLE 3R Aldehyde dehydrogenase, mitochondrial  ALDH2  ALDH2_HUMAN 56,363.40 99.80% 2 2 2 5.61% VAEQTPLTALYVANLIK 95.00% 4.63 0.567 5.96 922.5261 1,843.04 1,844.05 2
 SAMPLE 1R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 99.80% 2 2 3 8.75% LYGSEAFATDFQDSAAAK 95.00% 4.97 0.577 4.62 946.4346 1,890.85 1,891.87 2
 SAMPLE 1R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 99.80% 2 2 3 8.75% AVLDVFEEGTEASAATAVK 95.00% 5.02 0.628 7.6 954.9846 1,907.95 1,907.96 2
 SAMPLE 1R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 99.80% 2 2 3 8.75% AVLDVFEEGTEASAATAVK 95.00% 5.86 0.625 6.44 954.9855 1,907.96 1,907.96 2
 SAMPLE 2 Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 8 12.50% ADLSGITGAR 95.00% 3.18 0.395 2.41 480.7575 959.4994 960.5116 2
 SAMPLE 2 Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 8 12.50% ADLSGITGAR 95.00% 3.39 0.413 2.24 480.758 959.5004 960.5116 2
 SAMPLE 2 Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 8 12.50% NLAVSQVVHK 95.00% 2.59 0.188 2.32 547.8184 1,093.62 1,094.63 2
 SAMPLE 2 Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 8 12.50% NLAVSQVVHK 95.00% 2.64 0.185 1.52 547.8194 1,093.62 1,094.63 2
 SAMPLE 2 Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 8 12.50% EQLSLLDRFTEDAKR 95.00% 2.79 0.332 0 607.9891 1,820.94 1,820.95 3
 SAMPLE 2 Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 8 12.50% LYGSEAFATDFQDSAAAK 95.00% 5.76 0.639 4.08 946.4333 1,890.85 1,891.87 2
 SAMPLE 2 Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 8 12.50% LYGSEAFATDFQDSAAAK 95.00% 4.86 0.616 3.15 946.4368 1,890.86 1,891.87 2
 SAMPLE 2 Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 8 12.50% LYGSEAFATDFQDSAAAK 95.00% 3.45 0.571 3.92 946.4398 1,890.86 1,891.87 2
 SAMPLE 2R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 12 13.50% ADLSGITGAR 95.00% 3.51 0.342 1.8 480.7566 959.4976 960.5116 2
 SAMPLE 2R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 12 13.50% ADLSGITGAR 95.00% 2.97 0.382 1.57 480.7573 959.4989 960.5116 2
 SAMPLE 2R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 12 13.50% ADLSGITGAR 95.00% 2.97 0.45 2.16 480.7575 959.4994 960.5116 2
 SAMPLE 2R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 12 13.50% ADLSGITGAR 95.00% 3.24 0.457 1.85 480.7594 959.5031 960.5116 2
 SAMPLE 2R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 12 13.50% NLAVSQVVHK 95.00% 2.39 0.135 2.57 547.8187 1,093.62 1,094.63 2
 SAMPLE 2R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 12 13.50% LYGSEAFATDFQDSAAAK 95.00% 5.5 0.595 4.37 946.4371 1,890.86 1,891.87 2
 SAMPLE 2R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 12 13.50% LYGSEAFATDFQDSAAAK 95.00% 4.75 0.642 4.89 946.9373 1,891.86 1,891.87 2
 SAMPLE 2R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 12 13.50% LYGSEAFATDFQDSAAAK 95.00% 5.87 0.631 5.1 946.9404 1,891.87 1,891.87 2
 SAMPLE 2R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 12 13.50% AVLDVFEEGTEASAATAVK 95.00% 4.09 0.552 3.82 954.4829 1,906.95 1,907.96 2
 SAMPLE 2R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 12 13.50% AVLDVFEEGTEASAATAVK 95.00% 3.74 0.513 5.24 954.4834 1,906.95 1,907.96 2
 SAMPLE 2R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 12 13.50% AVLDVFEEGTEASAATAVK 95.00% 4.09 0.596 3.21 954.4837 1,906.95 1,907.96 2
 SAMPLE 2R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 100.00% 4 4 12 13.50% AVLDVFEEGTEASAATAVK 95.00% 5.8 0.625 7.47 954.9826 1,907.95 1,907.96 2
 SAMPLE 3R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 99.80% 2 2 2 6.62% ADLSGITGAR 95.00% 2.22 0.34 0 480.7583 959.501 960.5116 2
 SAMPLE 3R Alpha-1-antichymotrypsin  SERPINA3  AACT_HUMAN 47,634.90 99.80% 2 2 2 6.62% LYGSEAFATDFQDSAAAK 95.00% 5.17 0.681 5.55 946.9378 1,891.86 1,891.87 2
 SAMPLE 4 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.80% 2 2 3 6.46% LSSWVLLMK 95.00% 2.23 0.262 0 538.8147 1,075.61 1,076.62 2
 SAMPLE 4 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.80% 2 2 3 6.46% VFSNGADLSGVTEEAPLK 95.00% 2.7 0.337 0 917.4643 1,832.91 1,833.92 2
 SAMPLE 4 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.80% 2 2 3 6.46% VFSNGADLSGVTEEAPLK 95.00% 4.92 0.604 7.11 917.4674 1,832.92 1,833.92 2
 SAMPLE 1 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.80% 2 2 4 6.70% SVLGQLGITK 95.00% 2.45 0.468 1.2 508.3097 1,014.60 1,015.62 2
 SAMPLE 1 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.80% 2 2 4 6.70% SVLGQLGITK 95.00% 2.63 0.462 1.6 508.3099 1,014.60 1,015.62 2
 SAMPLE 1 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.80% 2 2 4 6.70% VFSNGADLSGVTEEAPLK 95.00% 5.65 0.6 6.51 917.463 1,832.91 1,833.92 2
 SAMPLE 1 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.80% 2 2 4 6.70% VFSNGADLSGVTEEAPLK 95.00% 5.62 0.572 6.7 917.464 1,832.91 1,833.92 2
 SAMPLE 1R Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 100.00% 3 3 5 10.00% SVLGQLGITK 95.00% 2.78 0.526 1.52 508.3098 1,014.60 1,015.62 2
 SAMPLE 1R Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 100.00% 3 3 5 10.00% SVLGQLGITK 95.00% 2.54 0.495 2.12 508.3101 1,014.60 1,015.62 2
 SAMPLE 1R Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 100.00% 3 3 5 10.00% ITPNLAEFAFSLYR 95.00% 3.99 0.556 5.92 821.4361 1,640.86 1,641.86 2
 SAMPLE 1R Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 100.00% 3 3 5 10.00% VFSNGADLSGVTEEAPLK 95.00% 5.58 0.576 7.39 917.4637 1,832.91 1,833.92 2
 SAMPLE 1R Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 100.00% 3 3 5 10.00% VFSNGADLSGVTEEAPLK 95.00% 5.44 0.563 5.44 917.4639 1,832.91 1,833.92 2
 SAMPLE 2 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.80% 2 2 4 5.02% VFSNGADLSGVTEEAPLKLSK 95.00% 3.64 0.5 1.28 721.7165 2,162.13 2,162.13 3
 SAMPLE 2 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.80% 2 2 4 5.02% VFSNGADLSGVTEEAPLK 95.00% 4.99 0.504 4.6 917.4612 1,832.91 1,833.92 2
 SAMPLE 2 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.80% 2 2 4 5.02% VFSNGADLSGVTEEAPLK 95.00% 4.7 0.499 4.27 917.4646 1,832.91 1,833.92 2
 SAMPLE 2 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.80% 2 2 4 5.02% VFSNGADLSGVTEEAPLK 95.00% 5.65 0.53 5.7 917.9652 1,833.91 1,833.92 2
 SAMPLE 3 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 100.00% 4 4 7 12.40% SVLGQLGITK 95.00% 2.97 0.482 1.21 508.3096 1,014.60 1,015.62 2
 SAMPLE 3 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 100.00% 4 4 7 12.40% SVLGQLGITK 95.00% 2.64 0.501 1.27 508.3096 1,014.60 1,015.62 2
 SAMPLE 3 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 100.00% 4 4 7 12.40% LSSWVLLMK 95.00% 1.72 0.319 0 538.9398 1,075.86 1,076.62 2
 SAMPLE 3 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 100.00% 4 4 7 12.40% LQHLENELTHDIITK 95.00% 2.62 0.215 0 601.9919 1,802.95 1,803.96 3
 SAMPLE 3 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 100.00% 4 4 7 12.40% VFSNGADLSGVTEEAPLK 95.00% 5.2 0.483 4.68 917.4646 1,832.91 1,833.92 2
 SAMPLE 3 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 100.00% 4 4 7 12.40% VFSNGADLSGVTEEAPLK 95.00% 4.09 0.231 4.62 917.4659 1,832.92 1,833.92 2
 SAMPLE 3 Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 100.00% 4 4 7 12.40% VFSNGADLSGVTEEAPLK 95.00% 4.64 0.466 3.96 917.9639 1,833.91 1,833.92 2
 SAMPLE 3R Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.90% 2 2 3 7.66% ITPNLAEFAFSLYR 95.00% 2.56 0.304 4.07 821.4367 1,640.86 1,641.86 2
 SAMPLE 3R Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.90% 2 2 3 7.66% VFSNGADLSGVTEEAPLK 95.00% 4.68 0.503 5 917.4648 1,832.91 1,833.92 2
 SAMPLE 3R Alpha-1-antitrypsin  SERPINA1  A1AT_HUMAN 46,719.90 99.90% 2 2 3 7.66% VFSNGADLSGVTEEAPLK 95.00% 5.54 0.493 4.14 917.9669 1,833.92 1,833.92 2
 SAMPLE 1 Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 99.90% 2 2 2 5.66% ATWSGAVLAGR 95.00% 3.09 0.311 2.74 544.7948 1,087.57 1,088.59 2
 SAMPLE 1 Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 99.90% 2 2 2 5.66% VTLTcVAPLSGVDFQLR 95.00% 3.73 0.447 2.82 c5: Carbamidomethyl (+57.02) 939.0041 1,875.99 1,876.00 2
 SAMPLE 1R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 99.80% 2 2 4 4.85% LETPDFQLFK 95.00% 2.46 0.474 0 619.3246 1,236.63 1,237.65 2
 SAMPLE 1R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 99.80% 2 2 4 4.85% LETPDFQLFK 95.00% 2.24 0.395 1.26 619.3254 1,236.64 1,237.65 2
 SAMPLE 1R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 99.80% 2 2 4 4.85% cEGPIPDVTFELLR 95.00% 2.64 0.346 0 c1: Carbamidomethyl (+57.02) 823.4145 1,644.81 1,645.83 2
 SAMPLE 1R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 99.80% 2 2 4 4.85% cEGPIPDVTFELLR 95.00% 3.54 0.55 4.35 c1: Carbamidomethyl (+57.02) 823.4168 1,644.82 1,645.83 2
 SAMPLE 2 Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 3 3 4 6.06% cLAPLEGAR 95.00% 2.55 0.234 1.54 c1: Carbamidomethyl (+57.02) 493.7572 985.4987 986.5095 2
 SAMPLE 2 Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 3 3 4 6.06% ATWSGAVLAGR 95.00% 3.51 0.382 1.66 544.794 1,087.57 1,088.59 2
 SAMPLE 2 Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 3 3 4 6.06% ATWSGAVLAGR 95.00% 3.42 0.389 1.62 544.7941 1,087.57 1,088.59 2
 SAMPLE 2 Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 3 3 4 6.06% LETPDFQLFK 95.00% 2.18 0.414 1.57 619.326 1,236.64 1,237.65 2
 SAMPLE 2R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 6 6 10 13.70% cLAPLEGAR 95.00% 2.29 0.23 0 c1: Carbamidomethyl (+57.02) 493.7572 985.4988 986.5095 2
 SAMPLE 2R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 6 6 10 13.70% ATWSGAVLAGR 95.00% 2.9 0.289 1.85 544.7943 1,087.57 1,088.59 2
 SAMPLE 2R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 6 6 10 13.70% ATWSGAVLAGR 95.00% 2.96 0.286 1.41 544.7946 1,087.57 1,088.59 2
 SAMPLE 2R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 6 6 10 13.70% LETPDFQLFK 95.00% 2.25 0.409 1.62 619.3254 1,236.64 1,237.65 2
 SAMPLE 2R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 6 6 10 13.70% LETPDFQLFK 95.00% 2.76 0.446 0 619.3261 1,236.64 1,237.65 2
 SAMPLE 2R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 6 6 10 13.70% SGLSTGWTQLSK 95.00% 2.61 0.278 2.24 632.83 1,263.64 1,264.65 2
 SAMPLE 2R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 6 6 10 13.70% SGLSTGWTQLSK 95.00% 2.8 0.398 1.89 632.8303 1,263.64 1,264.65 2
 SAMPLE 2R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 6 6 10 13.70% HQFLLTGDTQGR 95.00% 2.38 0.349 4.12 686.8482 1,371.68 1,372.70 2
 SAMPLE 2R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 6 6 10 13.70% cEGPIPDVTFELLR 95.00% 3.73 0.495 5.24 c1: Carbamidomethyl (+57.02) 823.4132 1,644.81 1,645.83 2
 SAMPLE 2R Alpha-1B-glycoprotein  A1BG  A1BG_HUMAN 54,254.40 100.00% 6 6 10 13.70% cEGPIPDVTFELLR 95.00% 4.06 0.553 4.12 c1: Carbamidomethyl (+57.02) 823.4153 1,644.82 1,645.83 2
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% LASDLLEWIRR 95.00% 1.49 0.307 0 457.9335 1,370.78 1,371.78 3 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% MLDAEDIVGTARPDEK 95.00% 2.37 0.193 0 587.291 1,758.85 1,759.85 3
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% EGLLLWcQR 95.00% 2.97 0.298 0 c7: Carbamidomethyl (+57.02) 587.807 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% EGLLLWcQR 95.00% 2.35 0.297 0 c7: Carbamidomethyl (+57.02) 587.8075 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% EGLLLWcQR 95.00% 3.23 0.303 0 c7: Carbamidomethyl (+57.02) 587.8078 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% EGLLLWcQR 95.00% 3.07 0.275 0 c7: Carbamidomethyl (+57.02) 587.808 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% GYEEWLLNEIR 95.00% 2.98 0.363 0 711.3576 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% GYEEWLLNEIR 95.00% 3.18 0.459 1.41 711.3578 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% GYEEWLLNEIR 95.00% 3.16 0.396 1.38 711.3578 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% GYEEWLLNEIR 95.00% 3.08 0.406 1.8 711.3584 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% GYEEWLLNEIR 95.00% 2.97 0.383 1.43 711.3592 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% TINEVENQILTR 95.00% 3.6 0.434 3.21 715.3857 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% TINEVENQILTR 95.00% 3.69 0.435 2.27 715.3867 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% TINEVENQILTR 95.00% 3.5 0.453 3.18 715.3875 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% TINEVENQILTR 95.00% 3.58 0.44 2.44 715.3882 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% TINEVENQILTR 95.00% 3.87 0.468 2.07 715.3889 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% TINEVENQILTR 95.00% 3.87 0.473 2.13 715.3894 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% FAIQDISVEETSAK 95.00% 2.93 0.358 0 770.0313 1,538.05 1,537.78 2 ACTN4_HUMAN
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% IcDQWDNLGALTQK 95.00% 4.57 0.297 3.66 c2: Carbamidomethyl (+57.02) 831.4023 1,660.79 1,661.80 2
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% IcDQWDNLGALTQK 95.00% 4.7 0.306 4.8 c2: Carbamidomethyl (+57.02) 831.4024 1,660.79 1,661.80 2
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% IcDQWDNLGALTQK 95.00% 4.73 0.277 4.6 c2: Carbamidomethyl (+57.02) 831.4044 1,660.79 1,661.80 2
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% IcDQWDNLGALTQK 95.00% 4.83 0.272 4.64 c2: Carbamidomethyl (+57.02) 831.9023 1,661.79 1,661.80 2
 SAMPLE 4 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 99.90% 2 2 6 9.75% IcDQWDNLGALTQK 95.00% 4.72 0.294 4.89 c2: Carbamidomethyl (+57.02) 831.9068 1,661.80 1,661.80 2
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% LSNRPAFmPSEGR 95.00% 3.15 0.245 1.72 m8: Oxidation (+15.99) 493.2484 1,476.72 1,477.72 3
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% EGLLLWcQR 95.00% 3.12 0.274 0 c7: Carbamidomethyl (+57.02) 587.8074 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% EGLLLWcQR 95.00% 2.98 0.258 0 c7: Carbamidomethyl (+57.02) 587.8075 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% EGLLLWcQR 95.00% 3.01 0.254 0 c7: Carbamidomethyl (+57.02) 587.8078 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% EGLLLWcQR 95.00% 2.9 0.228 0 c7: Carbamidomethyl (+57.02) 587.8086 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% VGWEQLLTTIAR 95.00% 3.9 0.458 2.89 693.8918 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% VGWEQLLTTIAR 95.00% 4.6 0.466 1.92 693.8924 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% VGWEQLLTTIAR 95.00% 3.29 0.464 3.28 693.8938 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% VGWEQLLTTIAR 95.00% 4.28 0.492 2.54 693.8938 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% VGWEQLLTTIAR 95.00% 4.14 0.479 2.46 693.8944 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% GYEEWLLNEIR 95.00% 2.51 0.327 0 711.3571 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% GYEEWLLNEIR 95.00% 2.6 0.349 1.29 711.3585 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% GYEEWLLNEIR 95.00% 2.31 0.279 1.48 711.3594 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% TINEVENQILTR 95.00% 3.37 0.386 2.29 715.3868 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% TINEVENQILTR 95.00% 3.7 0.424 2.44 715.3879 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% TINEVENQILTR 95.00% 3.88 0.432 2.22 715.388 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% TINEVENQILTR 95.00% 3.58 0.364 1.8 715.3882 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% TINEVENQILTR 95.00% 2.85 0.286 0 715.3885 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% TINEVENQILTR 95.00% 3.13 0.436 2.12 715.3887 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% IcDQWDNLGALTQK 95.00% 4.3 0.251 2.89 c2: Carbamidomethyl (+57.02) 831.4037 1,660.79 1,661.80 2
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% IcDQWDNLGALTQK 95.00% 4.62 0.295 3.96 c2: Carbamidomethyl (+57.02) 831.4045 1,660.79 1,661.80 2
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% IcDQWDNLGALTQK 95.00% 4.89 0.331 4.89 c2: Carbamidomethyl (+57.02) 831.4063 1,660.80 1,661.80 2
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% IcDQWDNLGALTQK 95.00% 4.81 0.243 4.62 c2: Carbamidomethyl (+57.02) 831.9031 1,661.79 1,661.80 2
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% IcDQWDNLGALTQK 95.00% 4.55 0.261 3.96 c2: Carbamidomethyl (+57.02) 831.9056 1,661.80 1,661.80 2
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% IcDQWDNLGALTQK 95.00% 4.72 0.214 4.07 c2: Carbamidomethyl (+57.02) 831.906 1,661.80 1,661.80 2
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% IcDQWDNLGALTQK 95.00% 5.08 0.293 4.37 c2: Carbamidomethyl (+57.02) 831.9106 1,661.81 1,661.80 2
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% QFGAQANVIGPWIQTK 95.00% 4.22 0.516 2.46 879.4725 1,756.93 1,757.93 2
 SAMPLE 4R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 3 3 10 9.75% QFGAQANVIGPWIQTK 95.00% 5.02 0.421 2.36 879.9751 1,757.93 1,757.93 2
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% TFTAWcNSHLR 95.00% 1.88 0.362 0 c6: Carbamidomethyl (+57.02) 464.8878 1,391.64 1,392.65 3 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% TFTAWcNSHLR 95.00% 1.76 0.257 0 c6: Carbamidomethyl (+57.02) 464.8883 1,391.64 1,392.65 3 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% EGLLLWcQR 95.00% 2.42 0.244 0 c7: Carbamidomethyl (+57.02) 587.8046 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% EGLLLWcQR 95.00% 2.59 0.278 0 c7: Carbamidomethyl (+57.02) 587.8052 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% LAILGIHNEVSK 95.00% 3.35 0.516 3.34 647.3814 1,292.75 1,293.75 2
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% GISQEQMNEFR 95.00% 2.78 0.419 2.19 669.807 1,337.60 1,338.61 2 CO6A3_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% GISQEQMNEFR 95.00% 2.94 0.461 1.8 669.8076 1,337.60 1,338.61 2 CO6A3_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% TFTAWcNSHLR 95.00% 2.41 0.232 0 c6: Carbamidomethyl (+57.02) 696.8249 1,391.63 1,392.65 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% GYEEWLLNEIR 95.00% 3.09 0.397 2.66 711.3547 1,420.69 1,421.71 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% GYEEWLLNEIR 95.00% 3.01 0.42 2.36 711.3556 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% GYEEWLLNEIR 95.00% 2.65 0.282 1.48 711.3564 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% GYEEWLLNEIR 95.00% 2.79 0.201 1.57 711.3567 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% TINEVENQILTR 95.00% 3.74 0.451 2.09 715.3842 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% TINEVENQILTR 95.00% 2.82 0.304 3.82 715.3843 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% TINEVENQILTR 95.00% 2.71 0.281 1.68 715.385 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% TINEVENQILTR 95.00% 3.73 0.456 2.1 715.3852 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% TINEVENQILTR 95.00% 3.02 0.375 2.43 715.3853 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% TINEVENQILTR 95.00% 3.73 0.394 1.77 715.386 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% LSNRPAFMPSEGR 95.00% 2.73 0.354 2.24 731.3651 1,460.71 1,461.73 2
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% FAIQDISVEETSAK 95.00% 2.92 0.366 0 769.3888 1,536.76 1,537.78 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% FAIQDISVEETSAK 95.00% 4.18 0.504 5.14 769.3903 1,536.76 1,537.78 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% FAIQDISVEETSAK 95.00% 4.3 0.497 3.72 769.3919 1,536.77 1,537.78 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% LVSIGAEEIVDGNVK 95.00% 4.42 0.502 3.14 772.4224 1,542.83 1,542.84 2
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% ELPPDQAEYcIAR 95.00% 2.63 0.615 1.7 c10: Carbamidomethyl (+57.02) 781.3669 1,560.72 1,561.73 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% ELPPDQAEYcIAR 95.00% 2.45 0.477 2.21 c10: Carbamidomethyl (+57.02) 781.3671 1,560.72 1,561.73 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% cQLEINFNTLQTK 95.00% 4.07 0.453 4.89 c1: Carbamidomethyl (+57.02) 804.9036 1,607.79 1,608.81 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% cQLEINFNTLQTK 95.00% 4.32 0.488 4.38 c1: Carbamidomethyl (+57.02) 804.9048 1,607.79 1,608.81 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% cQLEINFNTLQTK 95.00% 4.16 0.453 4.77 c1: Carbamidomethyl (+57.02) 804.9072 1,607.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% cQLEINFNTLQTK 95.00% 4.77 0.541 5.22 c1: Carbamidomethyl (+57.02) 805.4061 1,608.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% PPKVQEKcQLEINFNTLQTK 95.00% 2.42 0.352 0 c8: Carbamidomethyl (+57.02) 805.4062 2,413.20 2,415.27 3 ACTN4_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% IcDQWDNLGALTQK 95.00% 4.76 0.31 4.31 c2: Carbamidomethyl (+57.02) 831.4 1,660.78 1,661.80 2
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% IcDQWDNLGALTQK 95.00% 5.14 0.307 4.44 c2: Carbamidomethyl (+57.02) 831.9065 1,661.80 1,661.80 2
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% ETADTDTADQVMASFK 95.00% 2.93 0.35 0 865.9492 1,729.88 1,729.76 2
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% DDPLTNLNTAFDVAEK 95.00% 4.63 0.524 3.82 882.4308 1,762.85 1,762.85 2 HNRPU_HUMAN
 SAMPLE 1 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 7 7 8 22.90% VLAVNQENEQLMEDYEK 95.00% 5.02 0.602 4.8 1,026.98 2,051.95 2,051.96 2
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% TFTAWcNSHLR 95.00% 2.25 0.389 0 c6: Carbamidomethyl (+57.02) 464.8889 1,391.64 1,392.65 3 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% EGLLLWcQR 95.00% 2.66 0.303 0 c7: Carbamidomethyl (+57.02) 587.8026 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% EGLLLWcQR 95.00% 2.5 0.232 0 c7: Carbamidomethyl (+57.02) 587.8037 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% EGLLLWcQR 95.00% 2.15 0.241 0 c7: Carbamidomethyl (+57.02) 587.8039 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% EGLLLWcQR 95.00% 2.87 0.228 0 c7: Carbamidomethyl (+57.02) 587.8044 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% EGLLLWcQR 95.00% 2.88 0.271 0 c7: Carbamidomethyl (+57.02) 587.8045 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% LASDLLEWIR 95.00% 2.99 0.339 0 608.338 1,214.66 1,215.67 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% LASDLLEWIR 95.00% 2.85 0.322 0 608.3383 1,214.66 1,215.67 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% LASDLLEWIR 95.00% 2.78 0.25 0 608.3403 1,214.67 1,215.67 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% LAILGIHNEVSK 95.00% 2.98 0.465 3.13 647.3788 1,292.74 1,293.75 2
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% LAILGIHNEVSK 95.00% 3.27 0.489 2.23 647.3795 1,292.74 1,293.75 2
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% HTNYTMEHIR 95.00% 1.86 0.325 0 651.3056 1,300.60 1,301.61 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% GISQEQMNEFR 95.00% 2.87 0.438 1.85 669.8093 1,337.60 1,338.61 2 CO6A3_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% GISQEQMNEFR 95.00% 2.86 0.406 1.68 669.8094 1,337.60 1,338.61 2 CO6A3_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% VGWEQLLTTIAR 95.00% 4.63 0.487 1.49 693.8896 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% VGWEQLLTTIAR 95.00% 4.7 0.471 1.82 693.8897 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% VGWEQLLTTIAR 95.00% 4.39 0.486 2.28 693.8899 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% VGWEQLLTTIAR 95.00% 4.52 0.425 2.24 693.8899 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% VGWEQLLTTIAR 95.00% 4.22 0.439 1.8 693.8904 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% VGWEQLLTTIAR 95.00% 3.22 0.454 2.68 693.8904 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% VGWEQLLTTIAR 95.00% 3.43 0.524 2.21 693.8908 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% VGWEQLLTTIAR 95.00% 4.2 0.376 2.8 693.891 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% VGWEQLLTTIAR 95.00% 3.55 0.445 2.21 693.8927 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% VGWEQLLTTIAR 95.00% 3.11 0.357 1.96 694.4048 1,386.79 1,386.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% GYEEWLLNEIR 95.00% 2.36 0.327 0 711.354 1,420.69 1,421.71 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% GYEEWLLNEIR 95.00% 2.47 0.264 0 711.3548 1,420.69 1,421.71 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% GYEEWLLNEIR 95.00% 2.49 0.36 1.62 711.3551 1,420.69 1,421.71 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% GYEEWLLNEIR 95.00% 2.61 0.439 1.19 711.3564 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% TINEVENQILTR 95.00% 3.74 0.442 2.37 715.3834 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% TINEVENQILTR 95.00% 2.86 0.353 1.14 715.384 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% TINEVENQILTR 95.00% 3.54 0.441 2.64 715.3849 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% TINEVENQILTR 95.00% 3.57 0.454 2.35 715.386 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% TINEVENQILTR 95.00% 3.45 0.518 2.31 715.3863 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% FAIQDISVEETSAK 95.00% 4.44 0.477 3.49 769.3897 1,536.76 1,537.78 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% FAIQDISVEETSAK 95.00% 4.14 0.411 3.8 769.391 1,536.77 1,537.78 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% FAIQDISVEETSAK 95.00% 4.08 0.48 4.14 769.3911 1,536.77 1,537.78 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% FAIQDISVEETSAK 95.00% 4.31 0.504 3.85 769.3916 1,536.77 1,537.78 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% ELPPDQAEYcIAR 95.00% 2.45 0.51 1.36 c10: Carbamidomethyl (+57.02) 781.3684 1,560.72 1,561.73 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% ELPPDQAEYcIAR 95.00% 3.26 0.62 3.8 c10: Carbamidomethyl (+57.02) 781.869 1,561.72 1,561.73 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% cQLEINFNTLQTK 95.00% 4.1 0.496 4.42 c1: Carbamidomethyl (+57.02) 804.9043 1,607.79 1,608.81 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% cQLEINFNTLQTK 95.00% 3.1 0.393 1.62 c1: Carbamidomethyl (+57.02) 804.9048 1,607.79 1,608.81 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% cQLEINFNTLQTK 95.00% 4 0.463 3.72 c1: Carbamidomethyl (+57.02) 805.4082 1,608.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% cQLEINFNTLQTK 95.00% 4.46 0.515 4.47 c1: Carbamidomethyl (+57.02) 805.4082 1,608.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% PPKVQEKcQLEINFNTLQTK 95.00% 2.07 0.243 0 c8: Carbamidomethyl (+57.02) 805.4083 2,413.20 2,415.27 3 ACTN4_HUMAN
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% IcDQWDNLGALTQK 95.00% 4.29 0.274 4.07 c2: Carbamidomethyl (+57.02) 831.4 1,660.78 1,661.80 2
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% IcDQWDNLGALTQK 95.00% 4.51 0.29 4.64 c2: Carbamidomethyl (+57.02) 831.4001 1,660.78 1,661.80 2
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% IcDQWDNLGALTQK 95.00% 3.95 0.264 2.96 c2: Carbamidomethyl (+57.02) 831.4041 1,660.79 1,661.80 2
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% LLETIDQLYLEYAK 95.00% 4.21 0.538 4 856.9597 1,711.90 1,711.92 2
 SAMPLE 1R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 4 4 7 21.20% DDPLTNLNTAFDVAEK 95.00% 4.89 0.524 5.36 882.4272 1,762.84 1,762.85 2 HNRPU_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% LASDLLEWIRR 95.00% 1.42 0.349 0 457.93 1,370.77 1,371.78 3 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% TFTAWcNSHLR 95.00% 2 0.475 2.04 c6: Carbamidomethyl (+57.02) 464.8874 1,391.64 1,392.65 3 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% TFTAWcNSHLR 95.00% 2.1 0.411 0.921 c6: Carbamidomethyl (+57.02) 464.8878 1,391.64 1,392.65 3 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% LSNRPAFMPSEGR 95.00% 2.62 0.214 0 487.9131 1,460.72 1,461.73 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% LSNRPAFMPSEGR 95.00% 2.5 0.172 0 487.9133 1,460.72 1,461.73 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% LSNRPAFMPSEGR 95.00% 2.77 0.266 0 487.9135 1,460.72 1,461.73 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% LSNRPAFmPSEGR 95.00% 2.22 0.162 1.42 m8: Oxidation (+15.99) 493.5785 1,477.71 1,477.72 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% QKDYETATLSEIK 95.00% 3.1 0.429 0 509.2619 1,524.76 1,525.78 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% QKDYETATLSEIK 95.00% 3.1 0.396 0 509.5965 1,525.77 1,525.78 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% IMSIVDPNR 95.00% 2.5 0.279 0 522.7778 1,043.54 1,044.55 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% IMSIVDPNR 95.00% 2.43 0.253 0 522.7786 1,043.54 1,044.55 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% HEAFESDLAAHQDR 95.00% 3.73 0.416 2.55 542.5801 1,624.72 1,625.73 3 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% HEAFESDLAAHQDR 95.00% 4.17 0.501 1.54 542.5814 1,624.72 1,625.73 3 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% ILAGDKNYITMDELR 95.00% 4.16 0.411 2.77 584.6377 1,750.89 1,751.90 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% ILAGDKNYITMDELR 95.00% 4 0.377 2.03 584.9715 1,751.89 1,751.90 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% KHEAFESDLAAHQDR 95.00% 2.79 0.4 0 585.6138 1,753.82 1,753.83 3 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% MLDAEDIVGTARPDEK 95.00% 3.77 0.323 1.89 587.2889 1,758.84 1,759.85 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% MLDAEDIVGTARPDEK 95.00% 3.02 0.306 2.21 587.6228 1,759.84 1,759.85 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% EGLLLWcQR 95.00% 2.67 0.289 0 c7: Carbamidomethyl (+57.02) 587.8045 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% EGLLLWcQR 95.00% 2.68 0.237 0 c7: Carbamidomethyl (+57.02) 587.8045 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% EGLLLWcQR 95.00% 2.73 0.286 0 c7: Carbamidomethyl (+57.02) 587.805 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% EGLLLWcQR 95.00% 2.52 0.289 0 c7: Carbamidomethyl (+57.02) 587.8054 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% EGLLLWcQR 95.00% 2.59 0.253 0 c7: Carbamidomethyl (+57.02) 587.8058 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% DLLLDPAWEK 95.00% 2.77 0.0776 1.57 600.3179 1,198.62 1,199.63 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% ASIHEAWTDGKEAMLR 95.00% 3.52 0.403 1.66 605.6328 1,813.88 1,814.89 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% ASIHEAWTDGKEAMLR 95.00% 3.65 0.387 2.11 605.968 1,814.88 1,814.89 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% LLETIDQLYLEYAKR 95.00% 3.39 0.319 0 623.3436 1,867.01 1,868.02 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% LLETIDQLYLEYAKR 95.00% 2.97 0.405 0 623.6775 1,868.01 1,868.02 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% DGLGFcALIHR 95.00% 2.44 0.331 1.85 c6: Carbamidomethyl (+57.02) 629.8194 1,257.62 1,258.64 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% DGLGFcALIHR 95.00% 2.79 0.366 1.85 c6: Carbamidomethyl (+57.02) 629.8204 1,257.63 1,258.64 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% HTNYTMEHIR 95.00% 1.94 0.473 0 651.306 1,300.60 1,301.61 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% ISIEMHGTLEDQLSHLR 95.00% 4.81 0.611 3.05 660.3365 1,977.99 1,979.00 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% ISIEMHGTLEDQLSHLR 95.00% 5.17 0.508 0 660.6724 1,978.99 1,979.00 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% GISQEQMNEFR 95.00% 3.35 0.462 2.37 669.8078 1,337.60 1,338.61 2 CO6A3_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% GISQEQMNEFR 95.00% 3.68 0.418 3.09 669.808 1,337.60 1,338.61 2 CO6A3_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% AIMTYVSSFYHAFSGAQK 95.00% 2.7 0.492 1.72 669.9924 2,006.95 2,007.96 3 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% AIMTYVSSFYHAFSGAQK 95.00% 2.96 0.435 1.28 670.3277 2,007.96 2,007.96 3 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% VLAVNQENEQLMEDYEK 95.00% 3.86 0.421 2.1 684.9897 2,051.95 2,051.96 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% VLAVNQENEQLMEDYEK 95.00% 3.82 0.454 0.921 684.9926 2,051.95 2,051.96 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% TFTAWcNSHLR 95.00% 3.07 0.377 1.41 c6: Carbamidomethyl (+57.02) 696.8253 1,391.63 1,392.65 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% TFTAWcNSHLR 95.00% 3.19 0.419 2.12 c6: Carbamidomethyl (+57.02) 696.8263 1,391.64 1,392.65 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% TINEVENQILTR 95.00% 3.64 0.421 1.8 715.3849 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% TINEVENQILTR 95.00% 3.89 0.463 2.74 715.3852 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% TINEVENQILTR 95.00% 3.85 0.462 1.8 715.3853 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% TINEVENQILTR 95.00% 3.72 0.517 2.08 715.3867 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% LRKDDPLTNLNTAFDVAEK 95.00% 4.88 0.543 2.52 720.7145 2,159.12 2,160.13 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% LSNRPAFMPSEGR 95.00% 3.3 0.41 1.41 731.3667 1,460.72 1,461.73 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% LSNRPAFMPSEGR 95.00% 3.34 0.465 1.89 731.3667 1,460.72 1,461.73 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% FAIQDISVEETSAK 95.00% 4.51 0.466 4.36 769.3894 1,536.76 1,537.78 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% FAIQDISVEETSAK 95.00% 4.53 0.461 4.48 769.3902 1,536.76 1,537.78 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% LVSIGAEEIVDGNVK 95.00% 4.27 0.619 5.51 771.9235 1,541.83 1,542.84 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% LVSIGAEEIVDGNVK 95.00% 4.79 0.582 6.28 772.4214 1,542.83 1,542.84 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% IDQLEGDHQLIQEALIFDNK 95.00% 5.59 0.454 3 780.7341 2,339.18 2,339.19 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% IDQLEGDHQLIQEALIFDNK 95.00% 5.12 0.473 2.96 780.7344 2,339.18 2,339.19 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% ELPPDQAEYcIAR 95.00% 3.05 0.59 4.6 c10: Carbamidomethyl (+57.02) 781.3653 1,560.71 1,561.73 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% ELPPDQAEYcIAR 95.00% 2.68 0.625 3.64 c10: Carbamidomethyl (+57.02) 781.3672 1,560.72 1,561.73 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% cQLEINFNTLQTK 95.00% 4.21 0.524 3.89 c1: Carbamidomethyl (+57.02) 804.9046 1,607.79 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% cQLEINFNTLQTK 95.00% 4.72 0.513 3.8 c1: Carbamidomethyl (+57.02) 804.9049 1,607.79 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% cQLEINFNTLQTK 95.00% 4.64 0.517 4.12 c1: Carbamidomethyl (+57.02) 804.9052 1,607.79 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% cQLEINFNTLQTK 95.00% 3.66 0.483 4.23 c1: Carbamidomethyl (+57.02) 804.9054 1,607.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% cQLEINFNTLQTK 95.00% 4.27 0.528 4 c1: Carbamidomethyl (+57.02) 804.9074 1,607.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% cQLEINFNTLQTK 95.00% 3.81 0.464 5.14 c1: Carbamidomethyl (+57.02) 804.9081 1,607.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% IcDQWDNLGALTQK 95.00% 5.28 0.331 3.8 c2: Carbamidomethyl (+57.02) 831.3999 1,660.78 1,661.80 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% IcDQWDNLGALTQK 95.00% 5.25 0.302 4.49 c2: Carbamidomethyl (+57.02) 831.3999 1,660.78 1,661.80 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% IcDQWDNLGALTQK 95.00% 4.83 0.311 4.06 c2: Carbamidomethyl (+57.02) 831.4009 1,660.79 1,661.80 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% IcDQWDNLGALTQK 95.00% 4.58 0.283 3.77 c2: Carbamidomethyl (+57.02) 831.4019 1,660.79 1,661.80 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% IcDQWDNLGALTQK 95.00% 4.56 0.229 3.46 c2: Carbamidomethyl (+57.02) 831.9005 1,661.79 1,661.80 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% ETADTDTADQVMASFK 95.00% 5.54 0.647 8.15 865.3814 1,728.75 1,729.76 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% ETADTDTADQVMASFK 95.00% 5.26 0.61 8.54 865.382 1,728.75 1,729.76 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% ILAGDKNYITMDELR 95.00% 4.62 0.566 4 876.453 1,750.89 1,751.90 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% MLDAEDIVGTARPDEK 95.00% 4.06 0.347 2.6 880.9302 1,759.84 1,759.85 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% MLDAEDIVGTARPDEK 95.00% 4.01 0.398 2.92 880.9303 1,759.85 1,759.85 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% DDPLTNLNTAFDVAEK 95.00% 5.37 0.549 3.92 881.9262 1,761.84 1,762.85 2 HNRPU_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% DDPLTNLNTAFDVAEK 95.00% 5.26 0.571 6.05 881.9275 1,761.84 1,762.85 2 HNRPU_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% KDDPLTNLNTAFDVAEK 95.00% 5.88 0.603 6.46 945.9738 1,889.93 1,890.95 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% KDDPLTNLNTAFDVAEK 95.00% 5.66 0.602 6.46 945.974 1,889.93 1,890.95 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% IVQTYHVNMAGTNPYTTITPQEINGK 95.00% 5.16 0.581 1.39 964.4843 2,890.43 2,890.44 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% IVQTYHVNMAGTNPYTTITPQEINGK 95.00% 5.26 0.593 1.39 964.4847 2,890.43 2,890.44 3
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% MVSDINNAWGcLEQVEK 95.00% 5.17 0.494 4.59 c11: Carbamidomethyl (+57.02) 997.4625 1,992.91 1,992.92 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% AIMTYVSSFYHAFSGAQK 95.00% 4.8 0.608 3.92 1,004.49 2,006.96 2,007.96 2 ACTN4_HUMAN
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% VLAVNQENEQLMEDYEK 95.00% 5.93 0.543 4.2 1,026.98 2,051.95 2,051.96 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% VLAVNQENEQLMEDYEK 95.00% 6.01 0.559 5.22 1,026.98 2,051.95 2,051.96 2
 SAMPLE 2 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 19 23 49 46.60% VLAVNQENEQLmEDYEK 95.00% 4.13 0.55 1.72 m12: Oxidation (+15.99) 1,034.98 2,067.95 2,067.95 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TFTAWcNSHLR 95.00% 1.9 0.296 0 c6: Carbamidomethyl (+57.02) 464.8884 1,391.64 1,392.65 3 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TFTAWcNSHLR 95.00% 1.88 0.448 1.6 c6: Carbamidomethyl (+57.02) 464.8885 1,391.64 1,392.65 3 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% GYEEWLLNEIR 95.00% 3.49 0.237 0 474.573 1,420.70 1,421.71 3 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% GYEEWLLNEIR 95.00% 3.92 0.296 1.04 474.9079 1,421.70 1,421.71 3 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LSNRPAFMPSEGR 95.00% 2.65 0.253 0 487.9127 1,460.71 1,461.73 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LSNRPAFMPSEGR 95.00% 2.93 0.268 1 487.9131 1,460.72 1,461.73 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LSNRPAFmPSEGR 95.00% 2.42 0.195 0 m8: Oxidation (+15.99) 493.2448 1,476.71 1,477.72 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% QKDYETATLSEIK 95.00% 3.1 0.413 1.03 509.2627 1,524.76 1,525.78 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% QKDYETATLSEIK 95.00% 3.04 0.431 0 509.2629 1,524.77 1,525.78 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LLETIDQLYLEYAK 95.00% 4.77 0.559 2.72 571.6429 1,711.91 1,711.92 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LLETIDQLYLEYAK 95.00% 4.29 0.538 1.37 571.6445 1,711.91 1,711.92 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% ILAGDKNYITMDELR 95.00% 3.84 0.366 2.49 584.6373 1,750.89 1,751.90 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% ILAGDKNYITMDELR 95.00% 3.99 0.332 2.33 584.9712 1,751.89 1,751.90 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% KHEAFESDLAAHQDR 95.00% 3.72 0.456 0 585.614 1,753.82 1,753.83 3 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% MLDAEDIVGTARPDEK 95.00% 2.57 0.334 2.06 587.2887 1,758.84 1,759.85 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% MLDAEDIVGTARPDEK 95.00% 3.48 0.299 2.64 587.2888 1,758.84 1,759.85 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% EGLLLWcQR 95.00% 3.33 0.32 1.17 c7: Carbamidomethyl (+57.02) 587.8045 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% EGLLLWcQR 95.00% 2.57 0.238 0 c7: Carbamidomethyl (+57.02) 587.8047 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% EGLLLWcQR 95.00% 2.81 0.284 0 c7: Carbamidomethyl (+57.02) 587.8048 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% EGLLLWcQR 95.00% 3.32 0.276 1.32 c7: Carbamidomethyl (+57.02) 587.8048 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% EGLLLWcQR 95.00% 2.54 0.283 0 c7: Carbamidomethyl (+57.02) 587.8053 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% EGLLLWcQR 95.00% 2.27 0.261 0 c7: Carbamidomethyl (+57.02) 587.8053 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% EGLLLWcQR 95.00% 2.32 0.252 0 c7: Carbamidomethyl (+57.02) 587.8054 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% EGLLLWcQR 95.00% 2.44 0.215 0 c7: Carbamidomethyl (+57.02) 587.8061 1,173.60 1,174.60 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% mLDAEDIVGTARPDEK 95.00% 2.45 0.253 1.06 m1: Oxidation (+15.99) 592.6197 1,774.84 1,775.85 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% mLDAEDIVGTARPDEK 95.00% 3.2 0.423 2.92 m1: Oxidation (+15.99) 592.9533 1,775.84 1,775.85 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LASDLLEWIR 95.00% 3.06 0.311 0 608.3394 1,214.66 1,215.67 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LASDLLEWIR 95.00% 3.29 0.368 0 608.3398 1,214.66 1,215.67 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LASDLLEWIR 95.00% 2.51 0.236 0 608.8379 1,215.66 1,215.67 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LASDLLEWIR 95.00% 3.2 0.3 0 608.84 1,215.66 1,215.67 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% HRPELIDYGK 95.00% 2.46 0.405 1.72 614.3242 1,226.63 1,227.65 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% HRPELIDYGK 95.00% 2.56 0.468 1.54 614.3265 1,226.64 1,227.65 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LLETIDQLYLEYAKR 95.00% 3.51 0.303 0 623.3431 1,867.01 1,868.02 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LLETIDQLYLEYAKR 95.00% 3.35 0.479 0 623.6781 1,868.01 1,868.02 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% DGLGFcALIHR 95.00% 2.37 0.331 1.43 c6: Carbamidomethyl (+57.02) 629.8197 1,257.62 1,258.64 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% DGLGFcALIHR 95.00% 2.47 0.327 2.21 c6: Carbamidomethyl (+57.02) 629.8205 1,257.63 1,258.64 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% HTNYTMEHIR 95.00% 2.74 0.537 1.18 651.3064 1,300.60 1,301.61 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% HTNYTMEHIR 95.00% 2.7 0.485 2.42 651.3072 1,300.60 1,301.61 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% ISIEMHGTLEDQLSHLR 95.00% 4.26 0.466 1.09 660.3374 1,977.99 1,979.00 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% GISQEQMNEFR 95.00% 3.52 0.49 1.52 669.8083 1,337.60 1,338.61 2 CO6A3_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% GISQEQMNEFR 95.00% 3.39 0.496 1.48 669.8089 1,337.60 1,338.61 2 CO6A3_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% AIMTYVSSFYHAFSGAQK 95.00% 3.08 0.533 1.62 670.3271 2,007.96 2,007.96 3 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VLAVNQENEQLMEDYEK 95.00% 5.12 0.386 3.74 684.9916 2,051.95 2,051.96 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 4.29 0.551 1.12 693.8896 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 4.26 0.454 1.24 693.8897 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 4.19 0.49 2.03 693.8897 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 4.35 0.471 1.89 693.8903 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 4.36 0.539 1.64 693.8903 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 4.38 0.523 1.38 693.8903 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 4.28 0.496 1.96 693.8903 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 4.22 0.505 1.42 693.8906 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 4.47 0.414 1.7 693.8908 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 4.27 0.483 1.33 693.891 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 4.23 0.442 2.08 693.8911 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 4.15 0.495 1.46 693.8916 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 3.96 0.451 1.89 694.3914 1,386.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VGWEQLLTTIAR 95.00% 1.84 0.294 1.19 694.3916 1,386.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TFTAWcNSHLR 95.00% 2.6 0.295 0 c6: Carbamidomethyl (+57.02) 696.8252 1,391.63 1,392.65 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TFTAWcNSHLR 95.00% 3.13 0.432 2.51 c6: Carbamidomethyl (+57.02) 696.8272 1,391.64 1,392.65 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VPENTMHAMQQK 95.00% 3.55 0.501 2.66 707.3354 1,412.66 1,413.66 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VPENTMHAMQQK 95.00% 1.97 0.334 0 707.3358 1,412.66 1,413.66 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% GYEEWLLNEIR 95.00% 2.67 0.334 1.39 711.3548 1,420.69 1,421.71 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% GYEEWLLNEIR 95.00% 2.56 0.21 0 711.3557 1,420.70 1,421.71 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TINEVENQILTR 95.00% 3.89 0.473 3.15 715.3844 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TINEVENQILTR 95.00% 2.53 0.213 0 715.385 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TINEVENQILTR 95.00% 3.76 0.438 1.6 715.3852 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TINEVENQILTR 95.00% 3.61 0.404 2.96 715.3855 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TINEVENQILTR 95.00% 3.33 0.403 1.54 715.3857 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TINEVENQILTR 95.00% 3.59 0.423 2.72 715.3858 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TINEVENQILTR 95.00% 3.76 0.376 1.74 715.386 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TINEVENQILTR 95.00% 3.27 0.365 1.59 715.3869 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% TINEVENQILTR 95.00% 2.88 0.29 1.55 715.8457 1,429.68 1,429.77 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LRKDDPLTNLNTAFDVAEK 95.00% 5.12 0.399 2.44 721.0485 2,160.12 2,160.13 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LRKDDPLTNLNTAFDVAEK 95.00% 5.46 0.499 3.2 721.0502 2,160.13 2,160.13 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LSNRPAFMPSEGR 95.00% 2.9 0.416 1.17 731.3656 1,460.72 1,461.73 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LSNRPAFMPSEGR 95.00% 2.94 0.394 0 731.3683 1,460.72 1,461.73 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% FAIQDISVEETSAK 95.00% 2.74 0.373 1.24 769.3908 1,536.77 1,537.78 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% FAIQDISVEETSAK 95.00% 4.69 0.498 3.31 769.3911 1,536.77 1,537.78 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% FAIQDISVEETSAK 95.00% 5.14 0.509 4.96 769.3911 1,536.77 1,537.78 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% FAIQDISVEETSAK 95.00% 2.85 0.322 2.44 769.3929 1,536.77 1,537.78 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LVSIGAEEIVDGNVK 95.00% 4.77 0.605 5.34 771.9231 1,541.83 1,542.84 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LVSIGAEEIVDGNVK 95.00% 4.38 0.58 4.09 771.9232 1,541.83 1,542.84 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IDQLEGDHQLIQEALIFDNK 95.00% 5.35 0.546 3.54 780.7342 2,339.18 2,339.19 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IDQLEGDHQLIQEALIFDNK 95.00% 5.33 0.461 2.66 780.735 2,339.18 2,339.19 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% ELPPDQAEYcIAR 95.00% 2.72 0.644 3.15 c10: Carbamidomethyl (+57.02) 781.3672 1,560.72 1,561.73 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% ELPPDQAEYcIAR 95.00% 2.5 0.583 2.27 c10: Carbamidomethyl (+57.02) 781.3675 1,560.72 1,561.73 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% cQLEINFNTLQTK 95.00% 4.84 0.53 5.09 c1: Carbamidomethyl (+57.02) 804.9049 1,607.79 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% cQLEINFNTLQTK 95.00% 4.2 0.485 4.19 c1: Carbamidomethyl (+57.02) 804.9055 1,607.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% cQLEINFNTLQTK 95.00% 4.07 0.491 2.89 c1: Carbamidomethyl (+57.02) 804.9057 1,607.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% cQLEINFNTLQTK 95.00% 2.9 0.444 0 c1: Carbamidomethyl (+57.02) 804.9061 1,607.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% cQLEINFNTLQTK 95.00% 4.81 0.507 4.6 c1: Carbamidomethyl (+57.02) 804.9062 1,607.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% cQLEINFNTLQTK 95.00% 3.88 0.493 4.68 c1: Carbamidomethyl (+57.02) 804.9077 1,607.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% cQLEINFNTLQTK 95.00% 3.98 0.524 3.92 c1: Carbamidomethyl (+57.02) 805.405 1,608.79 1,608.81 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IcDQWDNLGALTQK 95.00% 4.46 0.312 4.1 c2: Carbamidomethyl (+57.02) 831.3993 1,660.78 1,661.80 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IcDQWDNLGALTQK 95.00% 5.21 0.342 4.39 c2: Carbamidomethyl (+57.02) 831.3999 1,660.78 1,661.80 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IcDQWDNLGALTQK 95.00% 5.31 0.307 4.3 c2: Carbamidomethyl (+57.02) 831.3999 1,660.78 1,661.80 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IcDQWDNLGALTQK 95.00% 4.02 0.353 2.14 c2: Carbamidomethyl (+57.02) 831.4005 1,660.79 1,661.80 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IcDQWDNLGALTQK 95.00% 4.24 0.293 4.14 c2: Carbamidomethyl (+57.02) 831.4045 1,660.79 1,661.80 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IcDQWDNLGALTQK 95.00% 4.69 0.225 2.89 c2: Carbamidomethyl (+57.02) 831.9011 1,661.79 1,661.80 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IcDQWDNLGALTQK 95.00% 4.57 0.285 3.92 c2: Carbamidomethyl (+57.02) 831.9042 1,661.79 1,661.80 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LLETIDQLYLEYAK 95.00% 5.16 0.595 4.42 856.4604 1,710.91 1,711.92 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LLETIDQLYLEYAK 95.00% 5.06 0.55 4.24 856.9604 1,711.91 1,711.92 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% ETADTDTADQVMASFK 95.00% 4.79 0.599 7.21 865.3842 1,728.75 1,729.76 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% ILAGDKNYITMDELR 95.00% 4.66 0.528 4.64 876.4513 1,750.89 1,751.90 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% ILAGDKNYITMDELR 95.00% 4.76 0.541 3.34 876.9519 1,751.89 1,751.90 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% QFGAQANVIGPWIQTK 95.00% 4.56 0.5 2.06 879.4663 1,756.92 1,757.93 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% QFGAQANVIGPWIQTK 95.00% 4.58 0.473 1.96 879.4701 1,756.92 1,757.93 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% QFGAQANVIGPWIQTK 95.00% 3.69 0.438 1.72 879.9718 1,757.93 1,757.93 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% MLDAEDIVGTARPDEK 95.00% 3.84 0.358 1.28 880.932 1,759.85 1,759.85 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% MLDAEDIVGTARPDEK 95.00% 3.86 0.358 1.85 880.9328 1,759.85 1,759.85 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% DDPLTNLNTAFDVAEK 95.00% 5.4 0.578 4.72 881.9275 1,761.84 1,762.85 2 HNRPU_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% DDPLTNLNTAFDVAEK 95.00% 4.84 0.594 7.22 881.9279 1,761.84 1,762.85 2 HNRPU_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% LLETIDQLYLEYAKR 95.00% 4.46 0.541 4.12 935.011 1,868.01 1,868.02 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% KDDPLTNLNTAFDVAEK 95.00% 5.93 0.619 5.51 946.4719 1,890.93 1,890.95 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% KDDPLTNLNTAFDVAEK 95.00% 5.83 0.616 6 946.4754 1,890.94 1,890.95 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IVQTYHVNMAGTNPYTTITPQEINGK 95.00% 4.77 0.593 1.7 964.4837 2,890.43 2,890.44 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IVQTYHVNMAGTNPYTTITPQEINGK 95.00% 4.62 0.563 1.85 964.4842 2,890.43 2,890.44 3
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% AIMTYVSSFYHAFSGAQK 95.00% 4.96 0.589 8.89 1,004.99 2,007.96 2,007.96 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% AIMTYVSSFYHAFSGAQK 95.00% 4.98 0.561 6.96 1,004.99 2,007.96 2,007.96 2 ACTN4_HUMAN
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VLAVNQENEQLMEDYEK 95.00% 5.6 0.539 4.54 1,026.98 2,051.95 2,051.96 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VLAVNQENEQLMEDYEK 95.00% 5.62 0.539 4.4 1,026.98 2,051.95 2,051.96 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% VLAVNQENEQLMEDYEK 95.00% 5.21 0.57 5.7 1,026.98 2,051.95 2,051.96 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IDQLEGDHQLIQEALIFDNK 95.00% 5.82 0.602 8.41 1,170.60 2,339.18 2,339.19 2
 SAMPLE 2R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 20 27 60 47.50% IDQLEGDHQLIQEALIFDNK 95.00% 5.66 0.602 7.8 1,170.60 2,339.18 2,339.19 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% LASDLLEWIRR 95.00% 1.57 0.303 0 457.9306 1,370.77 1,371.78 3 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% TFTAWcNSHLR 95.00% 2.25 0.386 0 c6: Carbamidomethyl (+57.02) 464.8873 1,391.64 1,392.65 3 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% KTFTAWcNSHLR 95.00% 2.99 0.388 0 c7: Carbamidomethyl (+57.02) 507.5846 1,519.73 1,520.74 3 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% QKDYETATLSEIK 95.00% 3.25 0.432 0 509.2618 1,524.76 1,525.78 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% QKDYETATLSEIK 95.00% 2.72 0.38 0 509.2625 1,524.76 1,525.78 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% ILAGDKNYITMDELR 95.00% 3.93 0.356 1.96 584.6369 1,750.89 1,751.90 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% ILAGDKNYITMDELR 95.00% 3.98 0.381 2.36 584.9721 1,751.89 1,751.90 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% MLDAEDIVGTARPDEK 95.00% 3.61 0.409 0.959 587.2883 1,758.84 1,759.85 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% MLDAEDIVGTARPDEK 95.00% 2.9 0.362 2.24 587.2883 1,758.84 1,759.85 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% MLDAEDIVGTARPDEK 95.00% 3.65 0.449 2.7 587.2888 1,758.84 1,759.85 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% MLDAEDIVGTARPDEK 95.00% 3.37 0.345 1.12 587.2892 1,758.84 1,759.85 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% EGLLLWcQR 95.00% 3.07 0.32 0 c7: Carbamidomethyl (+57.02) 587.8052 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% EGLLLWcQR 95.00% 3.02 0.233 0 c7: Carbamidomethyl (+57.02) 587.8053 1,173.59 1,174.60 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% ASIHEAWTDGKEAMLR 95.00% 3.05 0.405 0 605.9668 1,814.88 1,814.89 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% ASIHEAWTDGKEAMLR 95.00% 3.14 0.516 1.06 605.9677 1,814.88 1,814.89 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% DGLGFcALIHR 95.00% 2.67 0.455 0 c6: Carbamidomethyl (+57.02) 629.8196 1,257.62 1,258.64 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% KDDPLTNLNTAFDVAEK 95.00% 3.63 0.426 0 630.9866 1,889.94 1,890.95 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% DYETATLSEIK 95.00% 2.85 0.459 3.43 635.3136 1,268.61 1,269.62 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% AGTQIENIEEDFRDGLK 95.00% 2.34 0.222 2.11 645.9868 1,934.94 1,934.95 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% HTNYTMEHIR 95.00% 3.09 0.463 2.42 651.305 1,300.59 1,301.61 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% HTNYTMEHIR 95.00% 2.98 0.435 2.32 651.3053 1,300.60 1,301.61 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% GISQEQMNEFR 95.00% 3.6 0.467 2.74 669.8086 1,337.60 1,338.61 2 CO6A3_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% GISQEQMNEFR 95.00% 3.48 0.473 3.38 669.8086 1,337.60 1,338.61 2 CO6A3_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% TFTAWcNSHLR 95.00% 3.15 0.493 2.8 c6: Carbamidomethyl (+57.02) 696.8263 1,391.64 1,392.65 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% TFTAWcNSHLR 95.00% 3.11 0.536 2.44 c6: Carbamidomethyl (+57.02) 696.8269 1,391.64 1,392.65 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% VPENTMHAMQQK 95.00% 3.55 0.341 2.54 707.3318 1,412.65 1,413.66 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% VPENTMHAMQQK 95.00% 3.76 0.401 1.09 707.3333 1,412.65 1,413.66 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% TINEVENQILTR 95.00% 3.94 0.484 1.77 715.3841 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% TINEVENQILTR 95.00% 3.9 0.47 1.7 715.3842 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% TINEVENQILTR 95.00% 2.46 0.292 0 715.3849 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% TINEVENQILTR 95.00% 3.72 0.455 1.44 715.385 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% TINEVENQILTR 95.00% 2.41 0.317 0 715.3867 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% TINEVENQILTR 95.00% 2.8 0.305 0 715.3884 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% TINEVENQILTR 95.00% 3.07 0.48 1.64 715.8874 1,429.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% LRKDDPLTNLNTAFDVAEK 95.00% 4.86 0.567 3.17 720.7138 2,159.12 2,160.13 3
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% LSNRPAFMPSEGR 95.00% 3.47 0.491 0 731.3666 1,460.72 1,461.73 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% LSNRPAFMPSEGR 95.00% 3.13 0.414 0 731.3679 1,460.72 1,461.73 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% FAIQDISVEETSAK 95.00% 4.24 0.495 3.12 769.39 1,536.76 1,537.78 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% FAIQDISVEETSAK 95.00% 4.67 0.514 5.2 769.39 1,536.76 1,537.78 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% ELPPDQAEYcIAR 95.00% 2.67 0.574 4.66 c10: Carbamidomethyl (+57.02) 781.3667 1,560.72 1,561.73 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% ELPPDQAEYcIAR 95.00% 2.35 0.567 4.54 c10: Carbamidomethyl (+57.02) 781.3676 1,560.72 1,561.73 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% cQLEINFNTLQTK 95.00% 4.99 0.526 3.57 c1: Carbamidomethyl (+57.02) 804.905 1,607.79 1,608.81 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% cQLEINFNTLQTK 95.00% 4.69 0.506 4.04 c1: Carbamidomethyl (+57.02) 804.9062 1,607.80 1,608.81 2 ACTN4_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% IcDQWDNLGALTQK 95.00% 5.37 0.301 4.42 c2: Carbamidomethyl (+57.02) 831.3995 1,660.78 1,661.80 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% IcDQWDNLGALTQK 95.00% 3.51 0.274 2.8 c2: Carbamidomethyl (+57.02) 831.4004 1,660.79 1,661.80 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% IcDQWDNLGALTQK 95.00% 5.38 0.296 4.57 c2: Carbamidomethyl (+57.02) 831.9028 1,661.79 1,661.80 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% ETADTDTADQVMASFK 95.00% 5.41 0.6 5.43 865.381 1,728.75 1,729.76 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% ETADTDTADQVMASFK 95.00% 5.28 0.632 8.19 865.3821 1,728.75 1,729.76 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% ILAGDKNYITMDELR 95.00% 4.55 0.492 4.54 876.4523 1,750.89 1,751.90 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% ILAGDKNYITMDELR 95.00% 4.31 0.566 5.03 876.4544 1,750.89 1,751.90 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% MLDAEDIVGTARPDEK 95.00% 4.26 0.422 4.14 880.4282 1,758.84 1,759.85 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% MLDAEDIVGTARPDEK 95.00% 4.01 0.413 2.59 880.4304 1,758.85 1,759.85 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% DDPLTNLNTAFDVAEK 95.00% 5.26 0.545 5 881.9278 1,761.84 1,762.85 2 HNRPU_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% DDPLTNLNTAFDVAEK 95.00% 5.58 0.514 6.55 882.4274 1,762.84 1,762.85 2 HNRPU_HUMAN
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% KDDPLTNLNTAFDVAEK 95.00% 4.53 0.599 6.02 945.973 1,889.93 1,890.95 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% KDDPLTNLNTAFDVAEK 95.00% 6.37 0.597 7.96 946.4771 1,890.94 1,890.95 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% VLAVNQENEQLMEDYEK 95.00% 5.68 0.567 3.46 1,026.98 2,051.95 2,051.96 2
 SAMPLE 3 Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 18 34 31.80% VLAVNQENEQLMEDYEK 95.00% 6.07 0.562 3.82 1,026.98 2,051.95 2,051.96 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% LASDLLEWIRR 95.00% 1.32 0.314 0 457.9301 1,370.77 1,371.78 3 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% LASDLLEWIRR 95.00% 1.74 0.325 0 457.9305 1,370.77 1,371.78 3 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% TFTAWcNSHLR 95.00% 1.8 0.386 0 c6: Carbamidomethyl (+57.02) 464.8877 1,391.64 1,392.65 3 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% TFTAWcNSHLR 95.00% 1.84 0.295 0 c6: Carbamidomethyl (+57.02) 464.8891 1,391.64 1,392.65 3 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% LSNRPAFMPSEGR 95.00% 2.8 0.195 0 487.914 1,460.72 1,461.73 3
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% NVNIQNFHISWK 95.00% 2 0.25 0 500.5964 1,498.77 1,499.78 3
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% QKDYETATLSEIK 95.00% 3.38 0.422 0 509.2621 1,524.76 1,525.78 3
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% QKDYETATLSEIK 95.00% 2.85 0.404 0 509.2625 1,524.76 1,525.78 3
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% IMSIVDPNR 95.00% 2.23 0.261 0 522.779 1,043.54 1,044.55 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% ILAGDKNYITMDELR 95.00% 3.91 0.367 2.85 584.6365 1,750.89 1,751.90 3
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% ILAGDKNYITMDELR 95.00% 3.77 0.346 2.52 584.6384 1,750.89 1,751.90 3
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% MLDAEDIVGTARPDEK 95.00% 3.33 0.279 1.85 587.2885 1,758.84 1,759.85 3
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% MLDAEDIVGTARPDEK 95.00% 3.13 0.215 3.01 587.6217 1,759.84 1,759.85 3
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% MLDAEDIVGTARPDEK 95.00% 2.68 0.239 1.39 587.6227 1,759.84 1,759.85 3
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% ASIHEAWTDGKEAMLR 95.00% 2.96 0.395 1.09 605.9658 1,814.87 1,814.89 3
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% LASDLLEWIR 95.00% 3.02 0.333 0 608.3394 1,214.66 1,215.67 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% LASDLLEWIR 95.00% 2.8 0.221 0 608.3398 1,214.66 1,215.67 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% DGLGFcALIHR 95.00% 2.19 0.228 0 c6: Carbamidomethyl (+57.02) 629.8167 1,257.62 1,258.64 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% DGLGFcALIHR 95.00% 2.63 0.365 1.54 c6: Carbamidomethyl (+57.02) 629.821 1,257.63 1,258.64 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% HTNYTMEHIR 95.00% 2.67 0.467 1.74 651.3077 1,300.60 1,301.61 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% HTNYTMEHIR 95.00% 2.32 0.315 0 651.3095 1,300.60 1,301.61 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% ISIEMHGTLEDQLSHLR 95.00% 3.92 0.415 0 660.6721 1,978.99 1,979.00 3
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% GISQEQMNEFR 95.00% 3.83 0.466 2.72 669.8083 1,337.60 1,338.61 2 CO6A3_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% GISQEQMNEFR 95.00% 3.57 0.476 2.48 669.8095 1,337.60 1,338.61 2 CO6A3_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 4.28 0.545 1.33 693.8896 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 4.16 0.476 2.19 693.8898 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 4.1 0.435 1.66 693.8899 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 4.43 0.441 2.07 693.89 1,385.76 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 4.28 0.503 1.6 693.8903 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 3.91 0.435 1.68 693.8905 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 4.04 0.492 1.85 693.8905 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 3.59 0.371 0 693.8907 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 2.36 0.228 0 693.8908 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 4.32 0.475 2.36 693.8919 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 3.49 0.478 2.68 693.8925 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 3.85 0.527 2.16 693.8931 1,385.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VGWEQLLTTIAR 95.00% 4.53 0.411 2.02 694.3905 1,386.77 1,386.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% TFTAWcNSHLR 95.00% 3.23 0.55 2.85 c6: Carbamidomethyl (+57.02) 696.8261 1,391.64 1,392.65 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% TFTAWcNSHLR 95.00% 3.06 0.462 1.92 c6: Carbamidomethyl (+57.02) 696.8264 1,391.64 1,392.65 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VPENTMHAMQQK 95.00% 3.64 0.423 3.13 707.3343 1,412.65 1,413.66 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VPENTMHAMQQK 95.00% 3.35 0.415 1.72 707.3351 1,412.65 1,413.66 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% TINEVENQILTR 95.00% 2.93 0.316 0 715.3839 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% TINEVENQILTR 95.00% 3.53 0.461 1.82 715.3839 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% TINEVENQILTR 95.00% 3.57 0.448 1.92 715.3844 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% TINEVENQILTR 95.00% 3.83 0.466 2.21 715.3846 1,428.75 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% TINEVENQILTR 95.00% 3.34 0.374 1.25 715.3855 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% TINEVENQILTR 95.00% 3.75 0.475 2.31 715.3857 1,428.76 1,429.77 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% LSNRPAFMPSEGR 95.00% 3.18 0.384 1.85 731.3668 1,460.72 1,461.73 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% LSNRPAFMPSEGR 95.00% 2.95 0.447 1.33 731.8677 1,461.72 1,461.73 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% NVNIQNFHISWK 95.00% 3.85 0.514 2.34 750.3907 1,498.77 1,499.78 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% NVNIQNFHISWK 95.00% 4.23 0.502 1.22 750.391 1,498.77 1,499.78 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% FAIQDISVEETSAK 95.00% 4.82 0.492 5.35 769.3889 1,536.76 1,537.78 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% FAIQDISVEETSAK 95.00% 4.36 0.479 3.33 769.3905 1,536.77 1,537.78 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% ELPPDQAEYcIAR 95.00% 2.81 0.657 2.32 c10: Carbamidomethyl (+57.02) 781.3661 1,560.72 1,561.73 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% ELPPDQAEYcIAR 95.00% 2.47 0.577 4.32 c10: Carbamidomethyl (+57.02) 781.3684 1,560.72 1,561.73 2 ACTN4_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% IcDQWDNLGALTQK 95.00% 5.26 0.3 4.49 c2: Carbamidomethyl (+57.02) 831.4002 1,660.78 1,661.80 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% IcDQWDNLGALTQK 95.00% 5.05 0.27 4.72 c2: Carbamidomethyl (+57.02) 831.9021 1,661.79 1,661.80 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% ETADTDTADQVMASFK 95.00% 4.8 0.616 5.85 865.3818 1,728.75 1,729.76 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% ETADTDTADQVMASFK 95.00% 5.46 0.614 7.68 865.3822 1,728.75 1,729.76 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% ILAGDKNYITMDELR 95.00% 4.5 0.488 4.32 876.4538 1,750.89 1,751.90 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% MLDAEDIVGTARPDEK 95.00% 3.83 0.336 2.92 880.4291 1,758.84 1,759.85 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% MLDAEDIVGTARPDEK 95.00% 3.99 0.343 1.8 880.9301 1,759.84 1,759.85 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% DDPLTNLNTAFDVAEK 95.00% 5.02 0.567 4.7 881.9265 1,761.84 1,762.85 2 HNRPU_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% DDPLTNLNTAFDVAEK 95.00% 5.19 0.529 4.85 882.4289 1,762.84 1,762.85 2 HNRPU_HUMAN
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% KDDPLTNLNTAFDVAEK 95.00% 5.79 0.625 6.54 945.9743 1,889.93 1,890.95 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VLAVNQENEQLMEDYEK 95.00% 5.76 0.535 3.92 1,026.98 2,051.95 2,051.96 2
 SAMPLE 3R Alpha-actinin-1  ACTN1  ACTN1_HUMAN 103,043.00 100.00% 15 19 32 32.70% VLAVNQENEQLMEDYEK 95.00% 5.8 0.524 3.82 1,026.98 2,051.95 2,051.96 2
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% LASDLLEWIRR 95.00% 1.49 0.307 0 457.9335 1,370.78 1,371.78 3 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% EGLLLWcQR 95.00% 2.97 0.298 0 c7: Carbamidomethyl (+57.02) 587.807 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% EGLLLWcQR 95.00% 2.35 0.297 0 c7: Carbamidomethyl (+57.02) 587.8075 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% EGLLLWcQR 95.00% 3.23 0.303 0 c7: Carbamidomethyl (+57.02) 587.8078 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% EGLLLWcQR 95.00% 3.07 0.275 0 c7: Carbamidomethyl (+57.02) 587.808 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% GYEEWLLNEIR 95.00% 2.98 0.363 0 711.3576 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% GYEEWLLNEIR 95.00% 3.18 0.459 1.41 711.3578 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% GYEEWLLNEIR 95.00% 3.16 0.396 1.38 711.3578 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% GYEEWLLNEIR 95.00% 3.08 0.406 1.8 711.3584 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% GYEEWLLNEIR 95.00% 2.97 0.383 1.43 711.3592 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% TINEVENQILTR 95.00% 3.6 0.434 3.21 715.3857 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% TINEVENQILTR 95.00% 3.69 0.435 2.27 715.3867 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% TINEVENQILTR 95.00% 3.5 0.453 3.18 715.3875 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% TINEVENQILTR 95.00% 3.58 0.44 2.44 715.3882 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% TINEVENQILTR 95.00% 3.87 0.468 2.07 715.3889 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% TINEVENQILTR 95.00% 3.87 0.473 2.13 715.3894 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 4 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 5 5 17 6.26% FAIQDISVEETSAK 95.00% 2.93 0.358 0 770.0313 1,538.05 1,537.78 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% EGLLLWcQR 95.00% 3.12 0.274 0 c7: Carbamidomethyl (+57.02) 587.8074 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% EGLLLWcQR 95.00% 2.98 0.258 0 c7: Carbamidomethyl (+57.02) 587.8075 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% EGLLLWcQR 95.00% 3.01 0.254 0 c7: Carbamidomethyl (+57.02) 587.8078 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% EGLLLWcQR 95.00% 2.9 0.228 0 c7: Carbamidomethyl (+57.02) 587.8086 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% VGWEQLLTTIAR 95.00% 3.9 0.458 2.89 693.8918 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% VGWEQLLTTIAR 95.00% 4.6 0.466 1.92 693.8924 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% VGWEQLLTTIAR 95.00% 3.29 0.464 3.28 693.8938 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% VGWEQLLTTIAR 95.00% 4.28 0.492 2.54 693.8938 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% VGWEQLLTTIAR 95.00% 4.14 0.479 2.46 693.8944 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% GYEEWLLNEIR 95.00% 2.51 0.327 0 711.3571 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% GYEEWLLNEIR 95.00% 2.6 0.349 1.29 711.3585 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% GYEEWLLNEIR 95.00% 2.31 0.279 1.48 711.3594 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% TINEVENQILTR 95.00% 3.37 0.386 2.29 715.3868 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% TINEVENQILTR 95.00% 3.7 0.424 2.44 715.3879 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% TINEVENQILTR 95.00% 3.88 0.432 2.22 715.388 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% TINEVENQILTR 95.00% 3.58 0.364 1.8 715.3882 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% TINEVENQILTR 95.00% 2.85 0.286 0 715.3885 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 4R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 4 4 18 4.83% TINEVENQILTR 95.00% 3.13 0.436 2.12 715.3887 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% TFTAWcNSHLR 95.00% 1.88 0.362 0 c6: Carbamidomethyl (+57.02) 464.8878 1,391.64 1,392.65 3 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% TFTAWcNSHLR 95.00% 1.76 0.257 0 c6: Carbamidomethyl (+57.02) 464.8883 1,391.64 1,392.65 3 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% LSNRPAFMPSEGK 95.00% 3.25 0.397 0 478.5771 1,432.71 1,433.72 3
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% LSNRPAFMPSEGK 95.00% 2.73 0.291 1.14 478.9125 1,433.71 1,433.72 3
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% HRDYETATLSDIK 95.00% 3.43 0.289 1.92 516.9255 1,547.75 1,548.77 3
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% HRDYETATLSDIK 95.00% 3.06 0.294 1.74 517.2598 1,548.76 1,548.77 3
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% QLEAIDQLHLEYAK 95.00% 2.21 0.306 0 557.629 1,669.86 1,670.88 3
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% EGLLLWcQR 95.00% 2.42 0.244 0 c7: Carbamidomethyl (+57.02) 587.8046 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% EGLLLWcQR 95.00% 2.59 0.278 0 c7: Carbamidomethyl (+57.02) 587.8052 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% MLDAEDIVNTARPDEK 95.00% 2.25 0.254 0 606.6304 1,816.87 1,816.88 3
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% MLDAEDIVNTARPDEK 95.00% 2.73 0.28 0 606.6306 1,816.87 1,816.88 3
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% TFTAWcNSHLR 95.00% 2.41 0.232 0 c6: Carbamidomethyl (+57.02) 696.8249 1,391.63 1,392.65 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% GYEEWLLNEIR 95.00% 3.09 0.397 2.66 711.3547 1,420.69 1,421.71 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% GYEEWLLNEIR 95.00% 3.01 0.42 2.36 711.3556 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% GYEEWLLNEIR 95.00% 2.65 0.282 1.48 711.3564 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% GYEEWLLNEIR 95.00% 2.79 0.201 1.57 711.3567 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% TINEVENQILTR 95.00% 3.74 0.451 2.09 715.3842 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% TINEVENQILTR 95.00% 2.82 0.304 3.82 715.3843 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% TINEVENQILTR 95.00% 2.71 0.281 1.68 715.385 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% TINEVENQILTR 95.00% 3.73 0.456 2.1 715.3852 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% TINEVENQILTR 95.00% 3.02 0.375 2.43 715.3853 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% TINEVENQILTR 95.00% 3.73 0.394 1.77 715.386 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% FAIQDISVEETSAK 95.00% 2.92 0.366 0 769.3888 1,536.76 1,537.78 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% FAIQDISVEETSAK 95.00% 4.18 0.504 5.14 769.3903 1,536.76 1,537.78 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% FAIQDISVEETSAK 95.00% 4.3 0.497 3.72 769.3919 1,536.77 1,537.78 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% ELPPDQAEYcIAR 95.00% 2.63 0.615 1.7 c10: Carbamidomethyl (+57.02) 781.3669 1,560.72 1,561.73 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% ELPPDQAEYcIAR 95.00% 2.45 0.477 2.21 c10: Carbamidomethyl (+57.02) 781.3671 1,560.72 1,561.73 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% cQLEINFNTLQTK 95.00% 4.07 0.453 4.89 c1: Carbamidomethyl (+57.02) 804.9036 1,607.79 1,608.81 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% cQLEINFNTLQTK 95.00% 4.32 0.488 4.38 c1: Carbamidomethyl (+57.02) 804.9048 1,607.79 1,608.81 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% cQLEINFNTLQTK 95.00% 4.16 0.453 4.77 c1: Carbamidomethyl (+57.02) 804.9072 1,607.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% cQLEINFNTLQTK 95.00% 4.77 0.541 5.22 c1: Carbamidomethyl (+57.02) 805.4061 1,608.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% PPKVQEKcQLEINFNTLQTK 95.00% 2.42 0.352 0 c8: Carbamidomethyl (+57.02) 805.4062 2,413.20 2,415.27 3 ACTN1_HUMAN
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% ETTDTDTADQVIASFK 95.00% 5.05 0.589 8.47 871.4067 1,740.80 1,741.81 2
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% ETTDTDTADQVIASFK 95.00% 5.26 0.629 10.9 871.4091 1,740.80 1,741.81 2
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% ETTDTDTADQVIASFK 95.00% 5.07 0.594 8.2 871.9095 1,741.80 1,741.81 2
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% QFASQANVVGPWIQTK 95.00% 3.71 0.522 3.82 887.4687 1,772.92 1,773.93 2
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% QFASQANVVGPWIQTK 95.00% 4.05 0.411 2.57 887.9681 1,773.92 1,773.93 2
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% QFASQANVVGPWIQTK 95.00% 4.15 0.464 3 887.9687 1,773.92 1,773.93 2
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% QFASQANVVGPWIQTK 95.00% 4.62 0.514 3 887.9693 1,773.92 1,773.93 2
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% KDDPVTNLNNAFEVAEK 95.00% 4.71 0.63 6.89 952.4685 1,902.92 1,903.94 2
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% LSGSNPYTTVTPQIINSK 95.00% 5.25 0.398 6.01 961.0071 1,920.00 1,920.01 2
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% LSGSNPYTTVTPQIINSK 95.00% 5.56 0.478 8 961.0081 1,920.00 1,920.01 2
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% LSGSNPYTTVTPQIINSK 95.00% 5.3 0.455 6.46 961.0083 1,920.00 1,920.01 2
 SAMPLE 1 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 16 17 44 23.40% LSGSNPYTTVTPQIINSK 95.00% 5.45 0.479 4.57 961.0088 1,920.00 1,920.01 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% TFTAWcNSHLR 95.00% 2.25 0.389 0 c6: Carbamidomethyl (+57.02) 464.8889 1,391.64 1,392.65 3 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% LSNRPAFMPSEGK 95.00% 3.12 0.393 0 478.9123 1,433.71 1,433.72 3
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% HRDYETATLSDIK 95.00% 3.48 0.387 0 516.9252 1,547.75 1,548.77 3
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% QLEAIDQLHLEYAK 95.00% 2.55 0.312 0 557.6265 1,669.86 1,670.88 3
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% QLEAIDQLHLEYAK 95.00% 2.17 0.327 0 557.6294 1,669.86 1,670.88 3
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% EGLLLWcQR 95.00% 2.66 0.303 0 c7: Carbamidomethyl (+57.02) 587.8026 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% EGLLLWcQR 95.00% 2.5 0.232 0 c7: Carbamidomethyl (+57.02) 587.8037 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% EGLLLWcQR 95.00% 2.15 0.241 0 c7: Carbamidomethyl (+57.02) 587.8039 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% EGLLLWcQR 95.00% 2.87 0.228 0 c7: Carbamidomethyl (+57.02) 587.8044 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% EGLLLWcQR 95.00% 2.88 0.271 0 c7: Carbamidomethyl (+57.02) 587.8045 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% LASDLLEWIR 95.00% 2.99 0.339 0 608.338 1,214.66 1,215.67 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% LASDLLEWIR 95.00% 2.85 0.322 0 608.3383 1,214.66 1,215.67 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% LASDLLEWIR 95.00% 2.78 0.25 0 608.3403 1,214.67 1,215.67 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% DGLAFNALIHR 95.00% 2.46 0.327 2.14 613.8351 1,225.65 1,226.66 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% DGLAFNALIHR 95.00% 2.31 0.279 0 613.8351 1,225.65 1,226.66 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% HTNYTMEHIR 95.00% 1.86 0.325 0 651.3056 1,300.60 1,301.61 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% GISQEQMQEFR 95.00% 2.44 0.369 2.18 676.8162 1,351.62 1,352.63 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% GISQEQMQEFR 95.00% 2.21 0.364 0 676.8187 1,351.62 1,352.63 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% VGWEQLLTTIAR 95.00% 4.63 0.487 1.49 693.8896 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% VGWEQLLTTIAR 95.00% 4.7 0.471 1.82 693.8897 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% VGWEQLLTTIAR 95.00% 4.39 0.486 2.28 693.8899 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% VGWEQLLTTIAR 95.00% 4.52 0.425 2.24 693.8899 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% VGWEQLLTTIAR 95.00% 4.22 0.439 1.8 693.8904 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% VGWEQLLTTIAR 95.00% 3.22 0.454 2.68 693.8904 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% VGWEQLLTTIAR 95.00% 3.43 0.524 2.21 693.8908 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% VGWEQLLTTIAR 95.00% 4.2 0.376 2.8 693.891 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% VGWEQLLTTIAR 95.00% 3.55 0.445 2.21 693.8927 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% VGWEQLLTTIAR 95.00% 3.11 0.357 1.96 694.4048 1,386.79 1,386.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% GYEEWLLNEIR 95.00% 2.36 0.327 0 711.354 1,420.69 1,421.71 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% GYEEWLLNEIR 95.00% 2.47 0.264 0 711.3548 1,420.69 1,421.71 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% GYEEWLLNEIR 95.00% 2.49 0.36 1.62 711.3551 1,420.69 1,421.71 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% GYEEWLLNEIR 95.00% 2.61 0.439 1.19 711.3564 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% TINEVENQILTR 95.00% 3.74 0.442 2.37 715.3834 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% TINEVENQILTR 95.00% 2.86 0.353 1.14 715.384 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% TINEVENQILTR 95.00% 3.54 0.441 2.64 715.3849 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% TINEVENQILTR 95.00% 3.57 0.454 2.35 715.386 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% TINEVENQILTR 95.00% 3.45 0.518 2.31 715.3863 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% FAIQDISVEETSAK 95.00% 4.44 0.477 3.49 769.3897 1,536.76 1,537.78 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% FAIQDISVEETSAK 95.00% 4.14 0.411 3.8 769.391 1,536.77 1,537.78 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% FAIQDISVEETSAK 95.00% 4.08 0.48 4.14 769.3911 1,536.77 1,537.78 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% FAIQDISVEETSAK 95.00% 4.31 0.504 3.85 769.3916 1,536.77 1,537.78 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% ELPPDQAEYcIAR 95.00% 2.45 0.51 1.36 c10: Carbamidomethyl (+57.02) 781.3684 1,560.72 1,561.73 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% ELPPDQAEYcIAR 95.00% 3.26 0.62 3.8 c10: Carbamidomethyl (+57.02) 781.869 1,561.72 1,561.73 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% cQLEINFNTLQTK 95.00% 4.1 0.496 4.42 c1: Carbamidomethyl (+57.02) 804.9043 1,607.79 1,608.81 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% cQLEINFNTLQTK 95.00% 3.1 0.393 1.62 c1: Carbamidomethyl (+57.02) 804.9048 1,607.79 1,608.81 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% cQLEINFNTLQTK 95.00% 4 0.463 3.72 c1: Carbamidomethyl (+57.02) 805.4082 1,608.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% cQLEINFNTLQTK 95.00% 4.46 0.515 4.47 c1: Carbamidomethyl (+57.02) 805.4082 1,608.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% PPKVQEKcQLEINFNTLQTK 95.00% 2.07 0.243 0 c8: Carbamidomethyl (+57.02) 805.4083 2,413.20 2,415.27 3 ACTN1_HUMAN
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% ETTDTDTADQVIASFK 95.00% 5.18 0.589 8.54 871.4065 1,740.80 1,741.81 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% ETTDTDTADQVIASFK 95.00% 5.07 0.612 7.62 871.9084 1,741.80 1,741.81 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% ETTDTDTADQVIASFK 95.00% 5.32 0.638 7.44 871.9136 1,741.81 1,741.81 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% QFASQANVVGPWIQTK 95.00% 3.97 0.457 2.96 887.4701 1,772.92 1,773.93 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% QFASQANVVGPWIQTK 95.00% 3.76 0.467 2.23 887.9687 1,773.92 1,773.93 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% LSGSNPYTTVTPQIINSK 95.00% 5.05 0.513 6.96 960.5066 1,919.00 1,920.01 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% LSGSNPYTTVTPQIINSK 95.00% 5.13 0.537 4.35 961.005 1,919.99 1,920.01 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% LSGSNPYTTVTPQIINSK 95.00% 5.18 0.511 5.17 961.0065 1,920.00 1,920.01 2
 SAMPLE 1R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 19 19 57 25.70% LSGSNPYTTVTPQIINSK 95.00% 5.14 0.481 4.8 961.008 1,920.00 1,920.01 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% LASDLLEWIRR 95.00% 1.42 0.349 0 457.93 1,370.77 1,371.78 3 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% TFTAWcNSHLR 95.00% 2 0.475 2.04 c6: Carbamidomethyl (+57.02) 464.8874 1,391.64 1,392.65 3 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% TFTAWcNSHLR 95.00% 2.1 0.411 0.921 c6: Carbamidomethyl (+57.02) 464.8878 1,391.64 1,392.65 3 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% LSNRPAFMPSEGK 95.00% 2.12 0.275 0 478.5776 1,432.71 1,433.72 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% LSNRPAFMPSEGK 95.00% 3.32 0.374 0 478.5785 1,432.71 1,433.72 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% LSNRPAFMPSEGK 95.00% 2.64 0.308 0 478.5795 1,432.72 1,433.72 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% HRDYETATLSDIK 95.00% 3.51 0.284 0 516.9255 1,547.75 1,548.77 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% HRDYETATLSDIK 95.00% 3.71 0.242 2.32 516.9264 1,547.76 1,548.77 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% HEAFESDLAAHQDR 95.00% 3.73 0.416 2.55 542.5801 1,624.72 1,625.73 3 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% HEAFESDLAAHQDR 95.00% 4.17 0.501 1.54 542.5814 1,624.72 1,625.73 3 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% VLAGDKNFITAEELR 95.00% 3.83 0.339 0 559.3038 1,674.89 1,675.90 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% ETTDTDTADQVIASFK 95.00% 4.27 0.581 5.48 581.2756 1,740.80 1,741.81 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% KHEAFESDLAAHQDR 95.00% 2.79 0.4 0 585.6138 1,753.82 1,753.83 3 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% IcDQWDALGSLTHSR 95.00% 5.12 0.479 2.85 c2: Carbamidomethyl (+57.02) 587.2797 1,758.82 1,758.82 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% EGLLLWcQR 95.00% 2.67 0.289 0 c7: Carbamidomethyl (+57.02) 587.8045 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% EGLLLWcQR 95.00% 2.68 0.237 0 c7: Carbamidomethyl (+57.02) 587.8045 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% EGLLLWcQR 95.00% 2.73 0.286 0 c7: Carbamidomethyl (+57.02) 587.805 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% EGLLLWcQR 95.00% 2.52 0.289 0 c7: Carbamidomethyl (+57.02) 587.8054 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% EGLLLWcQR 95.00% 2.59 0.253 0 c7: Carbamidomethyl (+57.02) 587.8058 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% ASIHEAWTDGKEAMLK 95.00% 3.34 0.369 1.12 596.6323 1,786.87 1,786.88 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% DLLLDPAWEK 95.00% 2.77 0.0776 1.57 600.3179 1,198.62 1,199.63 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% MLDAEDIVNTARPDEK 95.00% 3.87 0.445 1.96 606.2959 1,815.86 1,816.88 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% MLDAEDIVNTARPDEK 95.00% 2.2 0.269 2.51 606.6304 1,816.87 1,816.88 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% DGLAFNALIHR 95.00% 2.74 0.377 1.4 613.8349 1,225.65 1,226.66 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% DGLAFNALIHR 95.00% 3.1 0.408 1.49 613.8351 1,225.65 1,226.66 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% KDDPVTNLNNAFEVAEK 95.00% 5.42 0.404 4.11 635.3171 1,902.93 1,903.94 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% KDDPVTNLNNAFEVAEK 95.00% 5.49 0.489 3.49 635.3171 1,902.93 1,903.94 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% AGTQIENIDEDFRDGLK 95.00% 2.81 0.454 1.54 640.9808 1,919.92 1,920.93 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% LSGSNPYTTVTPQIINSK 95.00% 2.67 0.177 1.39 641.0086 1,920.00 1,920.01 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% AGTQIENIDEDFRDGLK 95.00% 3.1 0.429 1.92 641.3151 1,920.92 1,920.93 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% HRPELIEYDK 95.00% 2.53 0.207 0 650.3366 1,298.66 1,299.67 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% HTNYTMEHIR 95.00% 1.94 0.473 0 651.306 1,300.60 1,301.61 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% MVSDINNGWQHLEQAEK 95.00% 2.07 0.233 1.06 667.3163 1,998.93 1,998.93 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% MVSDINNGWQHLEQAEK 95.00% 2.31 0.39 0 667.3165 1,998.93 1,998.93 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% AIMTYVSSFYHAFSGAQK 95.00% 2.7 0.492 1.72 669.9924 2,006.95 2,007.96 3 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% AIMTYVSSFYHAFSGAQK 95.00% 2.96 0.435 1.28 670.3277 2,007.96 2,007.96 3 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% GISQEQMQEFR 95.00% 2.96 0.522 2.14 676.8148 1,351.61 1,352.63 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% GISQEQMQEFR 95.00% 2.84 0.459 1.92 677.3169 1,352.62 1,352.63 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% VLAVNQENEHLMEDYEK 95.00% 2.24 0.355 1.44 687.9915 2,060.95 2,060.96 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% VLAVNQENEHLMEDYEK 95.00% 2.15 0.318 0 687.9918 2,060.95 2,060.96 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% TFTAWcNSHLR 95.00% 3.07 0.377 1.41 c6: Carbamidomethyl (+57.02) 696.8253 1,391.63 1,392.65 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% TFTAWcNSHLR 95.00% 3.19 0.419 2.12 c6: Carbamidomethyl (+57.02) 696.8263 1,391.64 1,392.65 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% TINEVENQILTR 95.00% 3.64 0.421 1.8 715.3849 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% TINEVENQILTR 95.00% 3.89 0.463 2.74 715.3852 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% TINEVENQILTR 95.00% 3.85 0.462 1.8 715.3853 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% TINEVENQILTR 95.00% 3.72 0.517 2.08 715.3867 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% LSNRPAFMPSEGK 95.00% 3.98 0.461 3.29 717.3619 1,432.71 1,433.72 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% LSNRPAFMPSEGK 95.00% 3.95 0.434 3.42 717.3628 1,432.71 1,433.72 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% ASFNHFDKDHGGALGPEEFK 95.00% 4.33 0.512 3.49 735.3466 2,203.02 2,203.02 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% TIPWLEDRVPQK 95.00% 3.1 0.188 0 741.4074 1,480.80 1,481.81 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% TIPWLEDRVPQK 95.00% 2.79 0.234 0 741.4091 1,480.80 1,481.81 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% FAIQDISVEETSAK 95.00% 4.51 0.466 4.36 769.3894 1,536.76 1,537.78 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% FAIQDISVEETSAK 95.00% 4.53 0.461 4.48 769.3902 1,536.76 1,537.78 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% ELPPDQAEYcIAR 95.00% 3.05 0.59 4.6 c10: Carbamidomethyl (+57.02) 781.3653 1,560.71 1,561.73 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% ELPPDQAEYcIAR 95.00% 2.68 0.625 3.64 c10: Carbamidomethyl (+57.02) 781.3672 1,560.72 1,561.73 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% cQLEINFNTLQTK 95.00% 4.21 0.524 3.89 c1: Carbamidomethyl (+57.02) 804.9046 1,607.79 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% cQLEINFNTLQTK 95.00% 4.72 0.513 3.8 c1: Carbamidomethyl (+57.02) 804.9049 1,607.79 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% cQLEINFNTLQTK 95.00% 4.64 0.517 4.12 c1: Carbamidomethyl (+57.02) 804.9052 1,607.79 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% cQLEINFNTLQTK 95.00% 3.66 0.483 4.23 c1: Carbamidomethyl (+57.02) 804.9054 1,607.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% cQLEINFNTLQTK 95.00% 4.27 0.528 4 c1: Carbamidomethyl (+57.02) 804.9074 1,607.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% cQLEINFNTLQTK 95.00% 3.81 0.464 5.14 c1: Carbamidomethyl (+57.02) 804.9081 1,607.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% AcLISLGYDVENDR 95.00% 4.63 0.47 5.96 c2: Carbamidomethyl (+57.02) 812.8861 1,623.76 1,624.76 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% AcLISLGYDVENDR 95.00% 5.18 0.477 6.14 c2: Carbamidomethyl (+57.02) 813.3854 1,624.76 1,624.76 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% QLEAIDQLHLEYAK 95.00% 4.18 0.402 3.33 835.9416 1,669.87 1,670.88 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% AcLISLGYDVENDRQGEAEFNR 95.00% 3.44 0.525 2.89 c2: Carbamidomethyl (+57.02) 853.063 2,556.17 2,556.18 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% AcLISLGYDVENDRQGEAEFNR 95.00% 3.67 0.54 2.7 c2: Carbamidomethyl (+57.02) 853.0654 2,556.17 2,556.18 3
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% ETTDTDTADQVIASFK 95.00% 5.35 0.559 8.19 871.4087 1,740.80 1,741.81 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% ETTDTDTADQVIASFK 95.00% 5.55 0.583 8.52 871.4088 1,740.80 1,741.81 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% IcDQWDALGSLTHSR 95.00% 4.86 0.471 3.38 c2: Carbamidomethyl (+57.02) 879.9144 1,757.81 1,758.82 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% IcDQWDALGSLTHSR 95.00% 4.66 0.529 2.43 c2: Carbamidomethyl (+57.02) 879.9149 1,757.81 1,758.82 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% QFASQANVVGPWIQTK 95.00% 2.84 0.395 0 887.4654 1,772.92 1,773.93 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% QFASQANVVGPWIQTK 95.00% 5.48 0.578 5.44 887.4665 1,772.92 1,773.93 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% QFASQANVVGPWIQTK 95.00% 5.09 0.565 6 887.4691 1,772.92 1,773.93 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% MAPYQGPDAVPGALDYK 95.00% 5.02 0.533 5.51 897.4309 1,792.85 1,792.86 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% MLDAEDIVNTARPDEK 95.00% 4.83 0.45 1.85 908.9391 1,815.86 1,816.88 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% MLDAEDIVNTARPDEK 95.00% 4.68 0.444 2.04 909.4394 1,816.86 1,816.88 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% KDDPVTNLNNAFEVAEK 95.00% 5.45 0.608 6.41 952.9722 1,903.93 1,903.94 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% KDDPVTNLNNAFEVAEK 95.00% 5.27 0.612 6.68 952.974 1,903.93 1,903.94 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% LSGSNPYTTVTPQIINSK 95.00% 5.48 0.495 6 960.5049 1,918.99 1,920.01 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% LSGSNPYTTVTPQIINSK 95.00% 5.48 0.482 7.15 960.5063 1,919.00 1,920.01 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% MVSDINNGWQHLEQAEK 95.00% 5.34 0.525 2.08 1,000.47 1,998.93 1,998.93 2
 SAMPLE 2 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 43 82 50.40% AIMTYVSSFYHAFSGAQK 95.00% 4.8 0.608 3.92 1,004.49 2,006.96 2,007.96 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TFTAWcNSHLR 95.00% 1.9 0.296 0 c6: Carbamidomethyl (+57.02) 464.8884 1,391.64 1,392.65 3 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TFTAWcNSHLR 95.00% 1.88 0.448 1.6 c6: Carbamidomethyl (+57.02) 464.8885 1,391.64 1,392.65 3 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% GYEEWLLNEIR 95.00% 3.49 0.237 0 474.573 1,420.70 1,421.71 3 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% GYEEWLLNEIR 95.00% 3.92 0.296 1.04 474.9079 1,421.70 1,421.71 3 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LSNRPAFMPSEGK 95.00% 3.23 0.358 0 478.5775 1,432.71 1,433.72 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LSNRPAFMPSEGK 95.00% 3.24 0.362 1.32 478.5776 1,432.71 1,433.72 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LSNRPAFMPSEGK 95.00% 2.55 0.321 0 478.5782 1,432.71 1,433.72 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% HRDYETATLSDIK 95.00% 3.44 0.242 1.37 516.9257 1,547.75 1,548.77 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% HRDYETATLSDIK 95.00% 3.53 0.317 1.49 516.9267 1,547.76 1,548.77 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% QLEAIDQLHLEYAK 95.00% 3.36 0.406 0 557.6293 1,669.86 1,670.88 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% QLEAIDQLHLEYAK 95.00% 3.38 0.423 0 557.6295 1,669.87 1,670.88 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VLAGDKNFITAEELR 95.00% 3.93 0.294 0 559.3051 1,674.89 1,675.90 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VLAGDKNFITAEELR 95.00% 4.39 0.326 0 559.6393 1,675.89 1,675.90 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% ETTDTDTADQVIASFK 95.00% 2.89 0.259 0 581.2756 1,740.80 1,741.81 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% KHEAFESDLAAHQDR 95.00% 3.72 0.456 0 585.614 1,753.82 1,753.83 3 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% IcDQWDALGSLTHSR 95.00% 3.55 0.451 1.74 c2: Carbamidomethyl (+57.02) 586.9452 1,757.81 1,758.82 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% IcDQWDALGSLTHSR 95.00% 3.83 0.465 2.25 c2: Carbamidomethyl (+57.02) 586.9454 1,757.81 1,758.82 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% EGLLLWcQR 95.00% 3.33 0.32 1.17 c7: Carbamidomethyl (+57.02) 587.8045 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% EGLLLWcQR 95.00% 2.57 0.238 0 c7: Carbamidomethyl (+57.02) 587.8047 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% EGLLLWcQR 95.00% 2.81 0.284 0 c7: Carbamidomethyl (+57.02) 587.8048 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% EGLLLWcQR 95.00% 3.32 0.276 1.32 c7: Carbamidomethyl (+57.02) 587.8048 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% EGLLLWcQR 95.00% 2.54 0.283 0 c7: Carbamidomethyl (+57.02) 587.8053 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% EGLLLWcQR 95.00% 2.27 0.261 0 c7: Carbamidomethyl (+57.02) 587.8053 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% EGLLLWcQR 95.00% 2.32 0.252 0 c7: Carbamidomethyl (+57.02) 587.8054 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% EGLLLWcQR 95.00% 2.44 0.215 0 c7: Carbamidomethyl (+57.02) 587.8061 1,173.60 1,174.60 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% MLDAEDIVNTARPDEK 95.00% 2.26 0.252 0 606.2955 1,815.86 1,816.88 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% MLDAEDIVNTARPDEK 95.00% 2.8 0.418 1.96 606.2961 1,815.87 1,816.88 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% MLDAEDIVNTARPDEK 95.00% 2.79 0.372 1.3 606.2965 1,815.87 1,816.88 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% MLDAEDIVNTARPDEK 95.00% 2.92 0.423 0 606.6328 1,816.87 1,816.88 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LASDLLEWIR 95.00% 3.06 0.311 0 608.3394 1,214.66 1,215.67 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LASDLLEWIR 95.00% 3.29 0.368 0 608.3398 1,214.66 1,215.67 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LASDLLEWIR 95.00% 2.51 0.236 0 608.8379 1,215.66 1,215.67 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LASDLLEWIR 95.00% 3.2 0.3 0 608.84 1,215.66 1,215.67 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VLAGDKNFITAEELRR 95.00% 2.54 0.216 0 611.3376 1,830.99 1,832.00 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% DGLAFNALIHR 95.00% 2.31 0.274 1.46 613.8343 1,225.65 1,226.66 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% DGLAFNALIHR 95.00% 2.66 0.26 0 613.8343 1,225.65 1,226.66 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% KDDPVTNLNNAFEVAEK 95.00% 5.27 0.436 3.43 635.3181 1,902.93 1,903.94 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% KDDPVTNLNNAFEVAEK 95.00% 5.19 0.368 3.2 635.6518 1,903.93 1,903.94 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% AGTQIENIDEDFRDGLK 95.00% 2.28 0.364 1.42 640.9811 1,919.92 1,920.93 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LSGSNPYTTVTPQIINSK 95.00% 3.2 0.189 2.09 641.0113 1,920.01 1,920.01 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% AGTQIENIDEDFRDGLK 95.00% 2.66 0.389 1.64 641.3143 1,920.92 1,920.93 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% HRPELIEYDK 95.00% 2.46 0.371 0 650.3362 1,298.66 1,299.67 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% HTNYTMEHIR 95.00% 2.74 0.537 1.18 651.3064 1,300.60 1,301.61 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% HTNYTMEHIR 95.00% 2.7 0.485 2.42 651.3072 1,300.60 1,301.61 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% MVSDINNGWQHLEQAEK 95.00% 1.81 0.366 0 667.3147 1,998.92 1,998.93 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% MVSDINNGWQHLEQAEK 95.00% 2.28 0.303 0 667.3162 1,998.93 1,998.93 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% AIMTYVSSFYHAFSGAQK 95.00% 3.08 0.533 1.62 670.3271 2,007.96 2,007.96 3 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% GISQEQMQEFR 95.00% 3.44 0.551 2.7 676.815 1,351.61 1,352.63 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% GISQEQMQEFR 95.00% 2.43 0.154 1.8 676.8158 1,351.62 1,352.63 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% KAGTQIENIDEDFRDGLK 95.00% 3.37 0.508 1.44 684.0112 2,049.01 2,049.03 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VLAVNQENEHLMEDYEK 95.00% 2.32 0.252 1.04 687.9918 2,060.95 2,060.96 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VLAVNQENEHLMEDYEK 95.00% 2.19 0.254 0.959 687.9918 2,060.95 2,060.96 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 4.29 0.551 1.12 693.8896 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 4.26 0.454 1.24 693.8897 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 4.19 0.49 2.03 693.8897 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 4.35 0.471 1.89 693.8903 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 4.36 0.539 1.64 693.8903 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 4.38 0.523 1.38 693.8903 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 4.28 0.496 1.96 693.8903 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 4.22 0.505 1.42 693.8906 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 4.47 0.414 1.7 693.8908 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 4.27 0.483 1.33 693.891 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 4.23 0.442 2.08 693.8911 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 4.15 0.495 1.46 693.8916 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 3.96 0.451 1.89 694.3914 1,386.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VGWEQLLTTIAR 95.00% 1.84 0.294 1.19 694.3916 1,386.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TFTAWcNSHLR 95.00% 2.6 0.295 0 c6: Carbamidomethyl (+57.02) 696.8252 1,391.63 1,392.65 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TFTAWcNSHLR 95.00% 3.13 0.432 2.51 c6: Carbamidomethyl (+57.02) 696.8272 1,391.64 1,392.65 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% GYEEWLLNEIR 95.00% 2.67 0.334 1.39 711.3548 1,420.69 1,421.71 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% GYEEWLLNEIR 95.00% 2.56 0.21 0 711.3557 1,420.70 1,421.71 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TINEVENQILTR 95.00% 3.89 0.473 3.15 715.3844 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TINEVENQILTR 95.00% 2.53 0.213 0 715.385 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TINEVENQILTR 95.00% 3.76 0.438 1.6 715.3852 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TINEVENQILTR 95.00% 3.61 0.404 2.96 715.3855 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TINEVENQILTR 95.00% 3.33 0.403 1.54 715.3857 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TINEVENQILTR 95.00% 3.59 0.423 2.72 715.3858 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TINEVENQILTR 95.00% 3.76 0.376 1.74 715.386 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TINEVENQILTR 95.00% 3.27 0.365 1.59 715.3869 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TINEVENQILTR 95.00% 2.88 0.29 1.55 715.8457 1,429.68 1,429.77 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LSNRPAFMPSEGK 95.00% 3.39 0.423 1.68 717.3619 1,432.71 1,433.72 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LSNRPAFMPSEGK 95.00% 3.78 0.399 2.1 717.3634 1,432.71 1,433.72 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TIPWLEDRVPQK 95.00% 3.09 0.367 0 741.4097 1,480.80 1,481.81 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% TIPWLEDRVPQK 95.00% 2.97 0.272 0 741.4098 1,480.80 1,481.81 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LVSIGAEEIVDGNAK 95.00% 2.88 0.341 0 758.3693 1,514.72 1,514.81 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LVSIGAEEIVDGNAK 95.00% 3.05 0.575 1.23 758.3709 1,514.73 1,514.81 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% FAIQDISVEETSAK 95.00% 2.74 0.373 1.24 769.3908 1,536.77 1,537.78 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% FAIQDISVEETSAK 95.00% 4.69 0.498 3.31 769.3911 1,536.77 1,537.78 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% FAIQDISVEETSAK 95.00% 5.14 0.509 4.96 769.3911 1,536.77 1,537.78 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% FAIQDISVEETSAK 95.00% 2.85 0.322 2.44 769.3929 1,536.77 1,537.78 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% ELPPDQAEYcIAR 95.00% 2.72 0.644 3.15 c10: Carbamidomethyl (+57.02) 781.3672 1,560.72 1,561.73 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% ELPPDQAEYcIAR 95.00% 2.5 0.583 2.27 c10: Carbamidomethyl (+57.02) 781.3675 1,560.72 1,561.73 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% cQLEINFNTLQTK 95.00% 4.84 0.53 5.09 c1: Carbamidomethyl (+57.02) 804.9049 1,607.79 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% cQLEINFNTLQTK 95.00% 4.2 0.485 4.19 c1: Carbamidomethyl (+57.02) 804.9055 1,607.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% cQLEINFNTLQTK 95.00% 4.07 0.491 2.89 c1: Carbamidomethyl (+57.02) 804.9057 1,607.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% cQLEINFNTLQTK 95.00% 2.9 0.444 0 c1: Carbamidomethyl (+57.02) 804.9061 1,607.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% cQLEINFNTLQTK 95.00% 4.81 0.507 4.6 c1: Carbamidomethyl (+57.02) 804.9062 1,607.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% cQLEINFNTLQTK 95.00% 3.88 0.493 4.68 c1: Carbamidomethyl (+57.02) 804.9077 1,607.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% cQLEINFNTLQTK 95.00% 3.98 0.524 3.92 c1: Carbamidomethyl (+57.02) 805.405 1,608.79 1,608.81 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% AcLISLGYDVENDR 95.00% 4.94 0.519 4.8 c2: Carbamidomethyl (+57.02) 812.8828 1,623.75 1,624.76 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% AcLISLGYDVENDR 95.00% 4.82 0.46 6.31 c2: Carbamidomethyl (+57.02) 812.8844 1,623.75 1,624.76 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% qLEAIDQLHLEYAK 95.00% 0 0 4.92 n-term: Pyro-cmC (-17.03) 827.4295 1,652.84 1,653.85 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% QLEAIDQLHLEYAK 95.00% 3.62 0.459 2.03 835.9463 1,669.88 1,670.88 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% QLEAIDQLHLEYAK 95.00% 3.98 0.455 3.74 836.4401 1,670.86 1,670.88 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VLAGDKNFITAEELR 95.00% 4.14 0.478 4.48 838.454 1,674.89 1,675.90 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VLAGDKNFITAEELR 95.00% 4.6 0.501 4.15 838.956 1,675.90 1,675.90 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% AcLISLGYDVENDRQGEAEFNR 95.00% 4.17 0.495 3.36 c2: Carbamidomethyl (+57.02) 853.0649 2,556.17 2,556.18 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% AcLISLGYDVENDRQGEAEFNR 95.00% 3.86 0.467 3.62 c2: Carbamidomethyl (+57.02) 853.0658 2,556.17 2,556.18 3
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% ETTDTDTADQVIASFK 95.00% 5.37 0.586 7.68 871.4082 1,740.80 1,741.81 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% ETTDTDTADQVIASFK 95.00% 5.36 0.587 7.74 871.9093 1,741.80 1,741.81 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% qFASQANVVGPWIQTK 94.80% 0 0 3.28 n-term: Pyro-cmC (-17.03) 878.9535 1,755.89 1,756.90 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% qFASQANVVGPWIQTK 95.00% 0 0 3.36 n-term: Pyro-cmC (-17.03) 878.9543 1,755.89 1,756.90 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% QFASQANVVGPWIQTK 95.00% 5.3 0.544 3.96 887.4666 1,772.92 1,773.93 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% QFASQANVVGPWIQTK 95.00% 5.2 0.593 6.77 887.4668 1,772.92 1,773.93 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% MLDAEDIVNTARPDEK 95.00% 4.46 0.472 2.64 908.9398 1,815.86 1,816.88 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% MLDAEDIVNTARPDEK 95.00% 4.3 0.46 2.82 908.9411 1,815.87 1,816.88 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% KDDPVTNLNNAFEVAEK 95.00% 5.4 0.61 6.92 952.4718 1,902.93 1,903.94 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% KDDPVTNLNNAFEVAEK 95.00% 5.18 0.598 5.82 952.9732 1,903.93 1,903.94 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LSGSNPYTTVTPQIINSK 95.00% 5.48 0.455 5.96 961.007 1,920.00 1,920.01 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% LSGSNPYTTVTPQIINSK 95.00% 5.26 0.477 7.14 961.007 1,920.00 1,920.01 2
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% AIMTYVSSFYHAFSGAQK 95.00% 4.96 0.589 8.89 1,004.99 2,007.96 2,007.96 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% AIMTYVSSFYHAFSGAQK 95.00% 4.98 0.561 6.96 1,004.99 2,007.96 2,007.96 2 ACTN1_HUMAN
 SAMPLE 2R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 34 45 122 47.70% VLAVNQENEHLMEDYEK 95.00% 0 0 4.96 1,032.50 2,062.98 2,060.96 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% LASDLLEWIRR 95.00% 1.57 0.303 0 457.9306 1,370.77 1,371.78 3 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% TFTAWcNSHLR 95.00% 2.25 0.386 0 c6: Carbamidomethyl (+57.02) 464.8873 1,391.64 1,392.65 3 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% LSNRPAFMPSEGK 95.00% 3.25 0.388 1.57 478.5779 1,432.71 1,433.72 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% LSNRPAFMPSEGK 95.00% 2.65 0.194 0 478.5779 1,432.71 1,433.72 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% LSNRPAFMPSEGK 95.00% 3.45 0.391 0 478.5781 1,432.71 1,433.72 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% KTFTAWcNSHLR 95.00% 2.99 0.388 0 c7: Carbamidomethyl (+57.02) 507.5846 1,519.73 1,520.74 3 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% HRDYETATLSDIK 95.00% 3.37 0.252 2.1 516.9254 1,547.75 1,548.77 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% HRDYETATLSDIK 95.00% 3.66 0.244 2.62 516.9259 1,547.75 1,548.77 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% QLEAIDQLHLEYAK 95.00% 2.77 0.291 0 557.6295 1,669.86 1,670.88 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% QLEAIDQLHLEYAK 95.00% 2.03 0.291 0 557.6296 1,669.87 1,670.88 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% QLEAIDQLHLEYAK 95.00% 2.92 0.339 0 557.9632 1,670.87 1,670.88 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% VLAGDKNFITAEELR 95.00% 4.06 0.314 0 559.3044 1,674.89 1,675.90 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% VLAGDKNFITAEELR 95.00% 3.99 0.297 0 559.3044 1,674.89 1,675.90 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% EGLLLWcQR 95.00% 3.07 0.32 0 c7: Carbamidomethyl (+57.02) 587.8052 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% EGLLLWcQR 95.00% 3.02 0.233 0 c7: Carbamidomethyl (+57.02) 587.8053 1,173.59 1,174.60 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% ASIHEAWTDGKEAMLK 95.00% 4.42 0.444 0.959 596.6315 1,786.87 1,786.88 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% ASIHEAWTDGKEAMLK 95.00% 4.75 0.476 2.14 596.6315 1,786.87 1,786.88 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% MLDAEDIVNTARPDEK 95.00% 3.74 0.425 1.18 606.295 1,815.86 1,816.88 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% MLDAEDIVNTARPDEK 95.00% 3.58 0.426 2.18 606.2959 1,815.86 1,816.88 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% QLEAIDQLHLEYAKR 95.00% 3.03 0.415 0 609.6619 1,825.96 1,826.98 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% QLEAIDQLHLEYAKR 95.00% 2.42 0.245 0 609.662 1,825.96 1,826.98 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% DGLAFNALIHR 95.00% 2.7 0.395 1.15 613.8339 1,225.65 1,226.66 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% DGLAFNALIHR 95.00% 2.67 0.327 1.77 613.8343 1,225.65 1,226.66 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% KDDPVTNLNNAFEVAEK 95.00% 5.44 0.444 3.1 635.3174 1,902.93 1,903.94 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% KDDPVTNLNNAFEVAEK 95.00% 5.23 0.434 3.18 635.3186 1,902.93 1,903.94 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% AGTQIENIDEDFRDGLK 95.00% 3.06 0.44 0.959 641.3146 1,920.92 1,920.93 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% AGTQIENIDEDFRDGLK 95.00% 2.48 0.432 1.39 641.3151 1,920.92 1,920.93 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% HRPELIEYDK 95.00% 2.4 0.353 0 650.3371 1,298.66 1,299.67 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% HTNYTMEHIR 95.00% 3.09 0.463 2.42 651.305 1,300.59 1,301.61 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% HTNYTMEHIR 95.00% 2.98 0.435 2.32 651.3053 1,300.60 1,301.61 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% GISQEQMQEFR 95.00% 2 0.258 1.52 676.8154 1,351.62 1,352.63 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% GISQEQMQEFR 95.00% 3.7 0.528 2.46 676.8156 1,351.62 1,352.63 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% GISQEQMQEFR 95.00% 3.7 0.551 2.42 676.8159 1,351.62 1,352.63 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% VLAVNQENEHLMEDYEK 95.00% 3.1 0.436 1.46 687.6571 2,059.95 2,060.96 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% VLAVNQENEHLMEDYEK 95.00% 2.9 0.324 1.47 687.6577 2,059.95 2,060.96 3
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% TFTAWcNSHLR 95.00% 3.15 0.493 2.8 c6: Carbamidomethyl (+57.02) 696.8263 1,391.64 1,392.65 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% TFTAWcNSHLR 95.00% 3.11 0.536 2.44 c6: Carbamidomethyl (+57.02) 696.8269 1,391.64 1,392.65 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% TINEVENQILTR 95.00% 3.94 0.484 1.77 715.3841 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% TINEVENQILTR 95.00% 3.9 0.47 1.7 715.3842 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% TINEVENQILTR 95.00% 2.46 0.292 0 715.3849 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% TINEVENQILTR 95.00% 3.72 0.455 1.44 715.385 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% TINEVENQILTR 95.00% 2.41 0.317 0 715.3867 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% TINEVENQILTR 95.00% 2.8 0.305 0 715.3884 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% TINEVENQILTR 95.00% 3.07 0.48 1.64 715.8874 1,429.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% LSNRPAFMPSEGK 95.00% 3.79 0.391 3.11 717.3624 1,432.71 1,433.72 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% LSNRPAFMPSEGK 95.00% 4.08 0.455 2.37 717.3643 1,432.71 1,433.72 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% TIPWLEDRVPQK 95.00% 3 0.335 1.48 741.4088 1,480.80 1,481.81 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% TIPWLEDRVPQK 95.00% 2.66 0.225 1.19 741.4092 1,480.80 1,481.81 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% LVSIGAEEIVDGNAK 95.00% 4.68 0.533 5 757.9064 1,513.80 1,514.81 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% LVSIGAEEIVDGNAK 95.00% 4.69 0.504 5.55 757.9068 1,513.80 1,514.81 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% FAIQDISVEETSAK 95.00% 4.24 0.495 3.12 769.39 1,536.76 1,537.78 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% FAIQDISVEETSAK 95.00% 4.67 0.514 5.2 769.39 1,536.76 1,537.78 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% HRDYETATLSDIK 95.00% 4.14 0.444 3.15 774.8846 1,547.75 1,548.77 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% HRDYETATLSDIK 95.00% 3.86 0.453 2.36 774.8871 1,547.76 1,548.77 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% ELPPDQAEYcIAR 95.00% 2.67 0.574 4.66 c10: Carbamidomethyl (+57.02) 781.3667 1,560.72 1,561.73 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% ELPPDQAEYcIAR 95.00% 2.35 0.567 4.54 c10: Carbamidomethyl (+57.02) 781.3676 1,560.72 1,561.73 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% cQLEINFNTLQTK 95.00% 4.99 0.526 3.57 c1: Carbamidomethyl (+57.02) 804.905 1,607.79 1,608.81 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% cQLEINFNTLQTK 95.00% 4.69 0.506 4.04 c1: Carbamidomethyl (+57.02) 804.9062 1,607.80 1,608.81 2 ACTN1_HUMAN
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% AcLISLGYDVENDR 95.00% 5.15 0.5 5.74 c2: Carbamidomethyl (+57.02) 812.8844 1,623.75 1,624.76 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% QLEAIDQLHLEYAK 95.00% 4.47 0.386 4.77 835.9402 1,669.86 1,670.88 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% QLEAIDQLHLEYAK 95.00% 4.01 0.459 6.28 835.9419 1,669.87 1,670.88 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% ETTDTDTADQVIASFK 95.00% 5.45 0.609 8.33 871.4076 1,740.80 1,741.81 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% ETTDTDTADQVIASFK 95.00% 5.44 0.588 9.12 871.4085 1,740.80 1,741.81 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% IcDQWDALGSLTHSR 95.00% 5.31 0.497 4.44 c2: Carbamidomethyl (+57.02) 879.9127 1,757.81 1,758.82 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% IcDQWDALGSLTHSR 95.00% 4.95 0.424 4.4 c2: Carbamidomethyl (+57.02) 880.4127 1,758.81 1,758.82 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% QFASQANVVGPWIQTK 95.00% 5.21 0.579 5.4 887.466 1,772.92 1,773.93 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% QFASQANVVGPWIQTK 95.00% 5.31 0.516 4.38 887.9683 1,773.92 1,773.93 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% MAPYQGPDAVPGALDYK 95.00% 4.59 0.21 5.02 896.9318 1,791.85 1,792.86 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% MAPYQGPDAVPGALDYK 95.00% 4.88 0.54 4.92 897.4323 1,792.85 1,792.86 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% MLDAEDIVNTARPDEK 95.00% 4.41 0.467 2.41 908.9397 1,815.86 1,816.88 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% MLDAEDIVNTARPDEK 95.00% 4.7 0.458 2.27 908.9403 1,815.87 1,816.88 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% KDDPVTNLNNAFEVAEK 95.00% 5.83 0.599 8 952.9728 1,903.93 1,903.94 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% KDDPVTNLNNAFEVAEK 95.00% 5.75 0.612 8 952.9734 1,903.93 1,903.94 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% LSGSNPYTTVTPQIINSK 95.00% 5.63 0.486 3.8 961.0071 1,920.00 1,920.01 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% LSGSNPYTTVTPQIINSK 95.00% 5.63 0.492 6.1 961.0072 1,920.00 1,920.01 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% VLAVNQENEHLMEDYEK 95.00% 5.05 0.595 5.89 1,031.48 2,060.95 2,060.96 2
 SAMPLE 3 Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 30 37 77 42.60% VLAVNQENEHLMEDYEK 95.00% 5.12 0.579 5.7 1,031.49 2,060.96 2,060.96 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% LASDLLEWIRR 95.00% 1.32 0.314 0 457.9301 1,370.77 1,371.78 3 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% LASDLLEWIRR 95.00% 1.74 0.325 0 457.9305 1,370.77 1,371.78 3 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% TFTAWcNSHLR 95.00% 1.8 0.386 0 c6: Carbamidomethyl (+57.02) 464.8877 1,391.64 1,392.65 3 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% TFTAWcNSHLR 95.00% 1.84 0.295 0 c6: Carbamidomethyl (+57.02) 464.8891 1,391.64 1,392.65 3 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% LSNRPAFMPSEGK 95.00% 2.93 0.262 1.32 478.5781 1,432.71 1,433.72 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% LSNRPAFMPSEGK 95.00% 3.41 0.333 0 478.5781 1,432.71 1,433.72 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% HRDYETATLSDIK 95.00% 3.3 0.301 1.19 516.926 1,547.75 1,548.77 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% HRDYETATLSDIK 95.00% 3.8 0.226 1.96 516.926 1,547.75 1,548.77 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% NFITAEELR 95.00% 2.26 0.186 0 546.7875 1,091.56 1,092.57 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% QLEAIDQLHLEYAK 95.00% 2.44 0.387 0 557.6294 1,669.86 1,670.88 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% QLEAIDQLHLEYAK 95.00% 3.11 0.345 0 557.9634 1,670.87 1,670.88 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VLAGDKNFITAEELR 95.00% 4.15 0.342 0 559.3043 1,674.89 1,675.90 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VLAGDKNFITAEELR 95.00% 4.02 0.371 1.72 559.305 1,674.89 1,675.90 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% ETTDTDTADQVIASFK 95.00% 4.27 0.533 3.74 581.2757 1,740.80 1,741.81 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% ETTDTDTADQVIASFK 95.00% 3.97 0.548 5 581.2762 1,740.81 1,741.81 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% IcDQWDALGSLTHSR 95.00% 3.85 0.47 1.36 c2: Carbamidomethyl (+57.02) 586.9446 1,757.81 1,758.82 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% IcDQWDALGSLTHSR 95.00% 4.44 0.525 3 c2: Carbamidomethyl (+57.02) 586.9446 1,757.81 1,758.82 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% MLDAEDIVNTARPDEK 95.00% 3.22 0.433 1.74 606.2954 1,815.86 1,816.88 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% MLDAEDIVNTARPDEK 95.00% 2.8 0.277 1.62 606.6299 1,816.87 1,816.88 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% MLDAEDIVNTARPDEK 95.00% 3.09 0.366 0 606.6307 1,816.87 1,816.88 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% LASDLLEWIR 95.00% 3.02 0.333 0 608.3394 1,214.66 1,215.67 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% LASDLLEWIR 95.00% 2.8 0.221 0 608.3398 1,214.66 1,215.67 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VLAGDKNFITAEELRR 95.00% 2.31 0.197 0 611.3387 1,830.99 1,832.00 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VLAGDKNFITAEELRR 95.00% 2.55 0.254 0 611.6738 1,832.00 1,832.00 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% DGLAFNALIHR 95.00% 2.68 0.348 0 613.8341 1,225.65 1,226.66 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% DGLAFNALIHR 95.00% 2.52 0.341 1.48 613.8352 1,225.65 1,226.66 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% KDDPVTNLNNAFEVAEK 95.00% 5.2 0.415 2.89 635.6514 1,903.93 1,903.94 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% KDDPVTNLNNAFEVAEK 95.00% 4.89 0.347 3.7 635.6519 1,903.93 1,903.94 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% SFSTALYGESDL 95.00% 2.37 0.413 3.39 645.2982 1,288.58 1,289.59 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% SFSTALYGESDL 95.00% 1.9 0.304 1.07 645.2984 1,288.58 1,289.59 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% HTNYTMEHIR 95.00% 2.67 0.467 1.74 651.3077 1,300.60 1,301.61 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% HTNYTMEHIR 95.00% 2.32 0.315 0 651.3095 1,300.60 1,301.61 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% GISQEQMQEFR 95.00% 3.56 0.549 2.42 676.8162 1,351.62 1,352.63 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% GISQEQMQEFR 95.00% 3.31 0.539 2.05 676.8172 1,351.62 1,352.63 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VLAVNQENEHLMEDYEK 95.00% 2.87 0.47 0 687.658 2,059.95 2,060.96 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VLAVNQENEHLMEDYEK 95.00% 2.39 0.376 0 687.9927 2,060.95 2,060.96 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 4.28 0.545 1.33 693.8896 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 4.16 0.476 2.19 693.8898 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 4.1 0.435 1.66 693.8899 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 4.43 0.441 2.07 693.89 1,385.76 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 4.28 0.503 1.6 693.8903 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 3.91 0.435 1.68 693.8905 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 4.04 0.492 1.85 693.8905 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 3.59 0.371 0 693.8907 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 2.36 0.228 0 693.8908 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 4.32 0.475 2.36 693.8919 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 3.49 0.478 2.68 693.8925 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 3.85 0.527 2.16 693.8931 1,385.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VGWEQLLTTIAR 95.00% 4.53 0.411 2.02 694.3905 1,386.77 1,386.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% TFTAWcNSHLR 95.00% 3.23 0.55 2.85 c6: Carbamidomethyl (+57.02) 696.8261 1,391.64 1,392.65 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% TFTAWcNSHLR 95.00% 3.06 0.462 1.92 c6: Carbamidomethyl (+57.02) 696.8264 1,391.64 1,392.65 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% TINEVENQILTR 95.00% 2.93 0.316 0 715.3839 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% TINEVENQILTR 95.00% 3.53 0.461 1.82 715.3839 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% TINEVENQILTR 95.00% 3.57 0.448 1.92 715.3844 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% TINEVENQILTR 95.00% 3.83 0.466 2.21 715.3846 1,428.75 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% TINEVENQILTR 95.00% 3.34 0.374 1.25 715.3855 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% TINEVENQILTR 95.00% 3.75 0.475 2.31 715.3857 1,428.76 1,429.77 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% LSNRPAFMPSEGK 95.00% 3.86 0.43 1.92 717.3625 1,432.71 1,433.72 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% LSNRPAFMPSEGK 95.00% 4.14 0.435 1.72 717.364 1,432.71 1,433.72 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% ASFNHFDKDHGGALGPEEFK 95.00% 4.69 0.581 3.41 735.345 2,203.01 2,203.02 3
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% LVSIGAEEIVDGNAK 95.00% 4.67 0.514 5.51 757.9065 1,513.80 1,514.81 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% LVSIGAEEIVDGNAK 95.00% 4.57 0.505 4.68 757.9075 1,513.80 1,514.81 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% FAIQDISVEETSAK 95.00% 4.82 0.492 5.35 769.3889 1,536.76 1,537.78 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% FAIQDISVEETSAK 95.00% 4.36 0.479 3.33 769.3905 1,536.77 1,537.78 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% HRDYETATLSDIK 95.00% 2.94 0.147 1.29 774.8877 1,547.76 1,548.77 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% ELPPDQAEYcIAR 95.00% 2.81 0.657 2.32 c10: Carbamidomethyl (+57.02) 781.3661 1,560.72 1,561.73 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% ELPPDQAEYcIAR 95.00% 2.47 0.577 4.32 c10: Carbamidomethyl (+57.02) 781.3684 1,560.72 1,561.73 2 ACTN1_HUMAN
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% AcLISLGYDVENDR 95.00% 4.96 0.474 5.54 c2: Carbamidomethyl (+57.02) 812.8839 1,623.75 1,624.76 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% AcLISLGYDVENDR 95.00% 5.03 0.489 6 c2: Carbamidomethyl (+57.02) 812.8848 1,623.75 1,624.76 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% QLEAIDQLHLEYAK 95.00% 3.66 0.437 6.06 835.9407 1,669.87 1,670.88 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% QLEAIDQLHLEYAK 95.00% 4.05 0.471 3.89 836.4427 1,670.87 1,670.88 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VLAGDKNFITAEELR 95.00% 4.38 0.457 3.55 838.4537 1,674.89 1,675.90 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VLAGDKNFITAEELR 95.00% 4.04 0.423 4.2 838.4581 1,674.90 1,675.90 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% ETTDTDTADQVIASFK 95.00% 5.65 0.572 9.92 871.4085 1,740.80 1,741.81 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% ETTDTDTADQVIASFK 95.00% 5.44 0.621 7.8 871.4087 1,740.80 1,741.81 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% IcDQWDALGSLTHSR 95.00% 4.88 0.487 4.17 c2: Carbamidomethyl (+57.02) 879.913 1,757.81 1,758.82 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% IcDQWDALGSLTHSR 95.00% 4.83 0.46 4.42 c2: Carbamidomethyl (+57.02) 879.9135 1,757.81 1,758.82 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% QFASQANVVGPWIQTK 95.00% 5.04 0.558 4.36 887.467 1,772.92 1,773.93 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% QFASQANVVGPWIQTK 95.00% 5.53 0.488 3.62 887.9666 1,773.92 1,773.93 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% MLDAEDIVNTARPDEK 95.00% 4.6 0.451 2.48 909.4398 1,816.86 1,816.88 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% MLDAEDIVNTARPDEK 95.00% 4.87 0.442 3.49 909.4406 1,816.87 1,816.88 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% KDDPVTNLNNAFEVAEK 95.00% 5.72 0.632 6.96 952.4746 1,902.93 1,903.94 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% KDDPVTNLNNAFEVAEK 95.00% 5.9 0.577 7.55 952.9721 1,903.93 1,903.94 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% LSGSNPYTTVTPQIINSK 95.00% 5.8 0.495 7.17 960.504 1,918.99 1,920.01 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% LSGSNPYTTVTPQIINSK 95.00% 5.83 0.471 7.11 960.5052 1,918.99 1,920.01 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VLAVNQENEHLMEDYEK 95.00% 5.23 0.612 6.29 1,031.48 2,060.95 2,060.96 2
 SAMPLE 3R Alpha-actinin-4  ACTN4  ACTN4_HUMAN 104,839.20 100.00% 27 37 87 37.00% VLAVNQENEHLMEDYEK 95.00% 5.25 0.59 4.74 1,031.48 2,060.95 2,060.96 2
 SAMPLE 3 Alpha-crystallin B chain  CRYAB  CRYAB_HUMAN 20,141.40 100.00% 3 3 6 16.60% FSVNLDVK 95.00% 2.74 0.297 0 461.2552 920.4947 921.5046 2
 SAMPLE 3 Alpha-crystallin B chain  CRYAB  CRYAB_HUMAN 20,141.40 100.00% 3 3 6 16.60% FSVNLDVK 95.00% 2.7 0.232 0 461.2568 920.498 921.5046 2
 SAMPLE 3 Alpha-crystallin B chain  CRYAB  CRYAB_HUMAN 20,141.40 100.00% 3 3 6 16.60% HFSPEELK 95.00% 2.46 0.24 0 493.75 985.4843 986.4948 2
 SAMPLE 3 Alpha-crystallin B chain  CRYAB  CRYAB_HUMAN 20,141.40 100.00% 3 3 6 16.60% APSWFDTGLSEMR 95.00% 3.75 0.58 4.08 748.8455 1,495.68 1,496.68 2
 SAMPLE 3 Alpha-crystallin B chain  CRYAB  CRYAB_HUMAN 20,141.40 100.00% 3 3 6 16.60% APSWFDTGLSEMR 95.00% 3.97 0.628 4.74 748.8455 1,495.68 1,496.68 2
 SAMPLE 3 Alpha-crystallin B chain  CRYAB  CRYAB_HUMAN 20,141.40 100.00% 3 3 6 16.60% APSWFDTGLSEmR 95.00% 3.42 0.661 4.4 m12: Oxidation (+15.99) 756.8433 1,511.67 1,512.68 2
 SAMPLE 3R Alpha-crystallin B chain  CRYAB  CRYAB_HUMAN 20,141.40 100.00% 3 3 6 18.30% RPFFPFHSPSR 95.00% 3.23 0.302 0 459.2453 1,374.71 1,374.71 3
 SAMPLE 3R Alpha-crystallin B chain  CRYAB  CRYAB_HUMAN 20,141.40 100.00% 3 3 6 18.30% FSVNLDVK 95.00% 2.75 0.281 0 461.2556 920.4956 921.5046 2
 SAMPLE 3R Alpha-crystallin B chain  CRYAB  CRYAB_HUMAN 20,141.40 100.00% 3 3 6 18.30% APSWFDTGLSEMR 95.00% 4.05 0.623 3.68 748.8456 1,495.68 1,496.68 2
 SAMPLE 3R Alpha-crystallin B chain  CRYAB  CRYAB_HUMAN 20,141.40 100.00% 3 3 6 18.30% APSWFDTGLSEMR 95.00% 3.86 0.617 3.43 749.3466 1,496.68 1,496.68 2
 SAMPLE 3R Alpha-crystallin B chain  CRYAB  CRYAB_HUMAN 20,141.40 100.00% 3 3 6 18.30% APSWFDTGLSEmR 95.00% 3.22 0.613 4 m12: Oxidation (+15.99) 756.8438 1,511.67 1,512.68 2
 SAMPLE 3R Alpha-crystallin B chain  CRYAB  CRYAB_HUMAN 20,141.40 100.00% 3 3 6 18.30% APSWFDTGLSEmR 95.00% 3.29 0.632 4.68 m12: Oxidation (+15.99) 756.8442 1,511.67 1,512.68 2
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% IGAEVYHNLK 95.00% 2.24 0.267 0 572.3106 1,142.61 1,143.62 2 TITIN_HUMAN
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% IGAEVYHNLK 95.00% 2.43 0.286 0 572.313 1,142.61 1,143.62 2 TITIN_HUMAN
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% GNPTVEVDLFTSK 95.00% 2.74 0.293 1.96 703.8622 1,405.71 1,406.72 2
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% YISPDQLADLYK 95.00% 2.82 0.419 3.59 713.365 1,424.71 1,425.73 2
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% YISPDQLADLYK 95.00% 3.88 0.477 4.28 713.3656 1,424.72 1,425.73 2
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% YISPDQLADLYK 95.00% 1.94 0.343 2.55 713.3658 1,424.72 1,425.73 2
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% VVIGMDVAASEFFR 95.00% 4.24 0.582 3.74 770.8946 1,539.77 1,540.78 2 LAMA5_HUMAN
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% VNQIGSVTESLQAcK 95.00% 5.4 0.531 7.4 c14: Carbamidomethyl (+57.02) 817.4125 1,632.81 1,633.82 2
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% VNQIGSVTESLQAcK 95.00% 5.27 0.544 6.77 c14: Carbamidomethyl (+57.02) 817.4131 1,632.81 1,633.82 2
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% AAVPSGASTGIYEALELR 95.00% 4.88 0.577 7.31 902.9737 1,803.93 1,804.94 2
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% AAVPSGASTGIYEALELR 95.00% 5.23 0.637 6.38 902.9743 1,803.93 1,804.94 2
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% SGKYDLDFKSPDDPSR 95.00% 3.84 0.522 3.96 914.4341 1,826.85 1,826.86 2
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% SGKYDLDFKSPDDPSR 95.00% 3.86 0.484 3.85 914.4398 1,826.86 1,826.86 2
 SAMPLE 1 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 11 27.20% FTASAGIQVVGDDLTVTNPK 95.00% 6.02 0.528 7.68 1,017.53 2,033.04 2,033.06 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% AVEHINKTIAPALVSK 95.00% 2.37 0.31 0 564.3324 1,689.97 1,690.99 3
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% IGAEVYHNLK 95.00% 3.74 0.33 0 572.3098 1,142.60 1,143.62 2 TITIN_HUMAN
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% IGAEVYHNLK 95.00% 3.35 0.275 1.6 572.3101 1,142.60 1,143.62 2 TITIN_HUMAN
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% AAVPSGASTGIYEALELR 95.00% 4.24 0.454 1.14 602.6537 1,804.94 1,804.94 3
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% SGKYDLDFKSPDDPSR 95.00% 3.28 0.481 1.41 609.6212 1,825.84 1,826.86 3
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% SGKYDLDFKSPDDPSR 95.00% 3.14 0.414 1.62 609.9575 1,826.85 1,826.86 3
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% GNPTVEVDLFTSK 95.00% 2.62 0.274 1.82 703.8594 1,405.70 1,406.72 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% GNPTVEVDLFTSK 95.00% 3.67 0.29 2.52 703.8597 1,405.70 1,406.72 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% YISPDQLADLYK 95.00% 2.38 0.395 1.13 713.3638 1,424.71 1,425.73 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% YISPDQLADLYK 95.00% 3.2 0.463 3.7 713.3654 1,424.72 1,425.73 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% YISPDQLADLYK 95.00% 2.42 0.469 1.68 713.3802 1,424.74 1,425.73 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% VNQIGSVTESLQAcK 95.00% 5.27 0.538 8.04 c14: Carbamidomethyl (+57.02) 817.4127 1,632.81 1,633.82 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% VNQIGSVTESLQAcK 95.00% 5.4 0.551 5.8 c14: Carbamidomethyl (+57.02) 817.9154 1,633.82 1,633.82 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% AAVPSGASTGIYEALELR 95.00% 4.76 0.596 6.89 902.9718 1,803.93 1,804.94 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% AAVPSGASTGIYEALELR 95.00% 4.94 0.599 7.23 902.9736 1,803.93 1,804.94 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% AAVPSGASTGIYEALELR 95.00% 0 0 3.32 904.4517 1,806.89 1,804.94 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% SGKYDLDFKSPDDPSR 95.00% 4.3 0.543 5.42 914.4306 1,826.85 1,826.86 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% DATNVGDEGGFAPNILENKEGLELLK 95.00% 4.81 0.0813 4.59 915.4643 2,743.37 2,743.38 3
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% DATNVGDEGGFAPNILENK 95.00% 5.02 0.557 5.24 980.9641 1,959.91 1,960.93 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% DATNVGDEGGFAPNILENK 95.00% 5.27 0.517 5.7 981.4674 1,960.92 1,960.93 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% FTASAGIQVVGDDLTVTNPK 95.00% 5.61 0.561 6.28 1,017.53 2,033.04 2,033.06 2
 SAMPLE 1R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 9 11 20 33.60% FTASAGIQVVGDDLTVTNPK 95.00% 5.48 0.539 6 1,017.53 2,033.05 2,033.06 2
 SAMPLE 2 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 99.80% 2 2 3 8.53% IGAEVYHNLK 95.00% 3.43 0.288 1.29 572.3098 1,142.60 1,143.62 2 TITIN_HUMAN
 SAMPLE 2 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 99.80% 2 2 3 8.53% IGAEVYHNLK 95.00% 2.53 0.269 1.26 572.3098 1,142.60 1,143.62 2 TITIN_HUMAN
 SAMPLE 2 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 99.80% 2 2 3 8.53% IGAEVYHNLK 95.00% 3.37 0.313 1.62 572.31 1,142.60 1,143.62 2 TITIN_HUMAN
 SAMPLE 2 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 99.80% 2 2 3 8.53% YISPDQLADLYK 95.00% 2.07 0.382 3.62 713.3662 1,424.72 1,425.73 2
 SAMPLE 2 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 99.80% 2 2 3 8.53% VNQIGSVTESLQAcK 95.00% 5.41 0.59 7.31 c14: Carbamidomethyl (+57.02) 817.413 1,632.81 1,633.82 2
 SAMPLE 2 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 99.80% 2 2 3 8.53% VNQIGSVTESLQAcK 95.00% 5.1 0.589 7.27 c14: Carbamidomethyl (+57.02) 817.4137 1,632.81 1,633.82 2
 SAMPLE 2R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 5 5 8 18.40% KLNVTEQEKIDK 95.00% 2.83 0.226 0 482.626 1,444.85 1,444.80 3
 SAMPLE 2R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 5 5 8 18.40% IGAEVYHNLK 95.00% 3.2 0.282 0 572.3101 1,142.60 1,143.62 2 TITIN_HUMAN
 SAMPLE 2R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 5 5 8 18.40% IGAEVYHNLK 95.00% 3.35 0.304 1.19 572.3105 1,142.61 1,143.62 2 TITIN_HUMAN
 SAMPLE 2R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 5 5 8 18.40% IGAEVYHNLK 94.70% 2.21 0.263 0 572.3128 1,142.61 1,143.62 2 TITIN_HUMAN
 SAMPLE 2R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 5 5 8 18.40% GNPTVEVDLFTSK 95.00% 2.35 0.244 1.37 703.8612 1,405.71 1,406.72 2
 SAMPLE 2R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 5 5 8 18.40% YISPDQLADLYK 95.00% 2 0.348 2.8 713.3649 1,424.71 1,425.73 2
 SAMPLE 2R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 5 5 8 18.40% YISPDQLADLYK 95.00% 2.42 0.425 2.96 713.3665 1,424.72 1,425.73 2
 SAMPLE 2R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 5 5 8 18.40% VNQIGSVTESLQAcK 95.00% 5.1 0.58 6.85 c14: Carbamidomethyl (+57.02) 817.4148 1,632.81 1,633.82 2
 SAMPLE 2R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 5 5 8 18.40% VNQIGSVTESLQAcK 95.00% 5.29 0.541 6.28 c14: Carbamidomethyl (+57.02) 817.9157 1,633.82 1,633.82 2
 SAMPLE 2R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 5 5 8 18.40% AAVPSGASTGIYEALELR 95.00% 3.45 0.471 0 902.9774 1,803.94 1,804.94 2
 SAMPLE 2R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 5 5 8 18.40% AAVPSGASTGIYEALELR 95.00% 4.37 0.611 4.01 903.4773 1,804.94 1,804.94 2
 SAMPLE 3 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 9 20.30% KLNVTEQEKIDK 95.00% 4.11 0.302 1.49 482.2715 1,443.79 1,444.80 3
 SAMPLE 3 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 9 20.30% KLNVTEQEKIDK 95.00% 3.65 0.161 1.08 482.272 1,443.79 1,444.80 3
 SAMPLE 3 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 9 20.30% ScNcLLLK 95.00% 2.16 0.232 0 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 504.2519 1,006.49 1,007.50 2
 SAMPLE 3 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 9 20.30% ScNcLLLK 95.00% 2.24 0.23 0 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 504.2535 1,006.49 1,007.50 2
 SAMPLE 3 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 9 20.30% IGAEVYHNLK 95.00% 3.45 0.274 1.49 572.3107 1,142.61 1,143.62 2 TITIN_HUMAN
 SAMPLE 3 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 9 20.30% IGAEVYHNLK 95.00% 3.58 0.286 2.03 572.3111 1,142.61 1,143.62 2 TITIN_HUMAN
 SAMPLE 3 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 9 20.30% LMIEMDGTENK 95.00% 3.1 0.366 1.51 641.2984 1,280.58 1,280.59 2
 SAMPLE 3 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 9 20.30% GNPTVEVDLFTSK 95.00% 2.32 0.264 0 703.8612 1,405.71 1,406.72 2
 SAMPLE 3 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 9 20.30% VNQIGSVTESLQAcK 95.00% 5.07 0.621 8.37 c14: Carbamidomethyl (+57.02) 817.4138 1,632.81 1,633.82 2
 SAMPLE 3 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 9 20.30% VNQIGSVTESLQAcK 95.00% 5.28 0.554 6.68 c14: Carbamidomethyl (+57.02) 817.9146 1,633.81 1,633.82 2
 SAMPLE 3 Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 6 6 9 20.30% DATNVGDEGGFAPNILENK 95.00% 4.65 0.481 3.37 981.4687 1,960.92 1,960.93 2
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% KLNVTEQEKIDK 95.00% 3.71 0.0972 0 482.2717 1,443.79 1,444.80 3
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% KLNVTEQEKIDK 95.00% 3.48 0.213 1.19 482.2726 1,443.79 1,444.80 3
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% ScNcLLLK 95.00% 2.36 0.281 0 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 504.253 1,006.49 1,007.50 2
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% ScNcLLLK 95.00% 2.37 0.233 0 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 504.2543 1,006.49 1,007.50 2
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% IGAEVYHNLK 95.00% 3.52 0.305 1.74 572.3109 1,142.61 1,143.62 2 TITIN_HUMAN
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% IGAEVYHNLK 95.00% 3.43 0.287 1.15 572.3112 1,142.61 1,143.62 2 TITIN_HUMAN
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% GNPTVEVDLFTSK 95.00% 1.92 0.329 0 703.862 1,405.71 1,406.72 2
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% VNQIGSVTESLQAcK 95.00% 5 0.609 7.74 c14: Carbamidomethyl (+57.02) 817.4147 1,632.81 1,633.82 2
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% VNQIGSVTESLQAcK 95.00% 2.24 0.286 0 c14: Carbamidomethyl (+57.02) 817.8685 1,633.72 1,633.82 2
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% VNQIGSVTESLQAcK 95.00% 5.21 0.591 8.8 c14: Carbamidomethyl (+57.02) 817.9162 1,633.82 1,633.82 2
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% AAVPSGASTGIYEALELR 95.00% 4.31 0.556 8.19 902.9735 1,803.93 1,804.94 2
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% AAVPSGASTGIYEALELR 95.00% 4.62 0.66 8.17 902.9741 1,803.93 1,804.94 2
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% DATNVGDEGGFAPNILENKEGLELLK 95.00% 2.65 0.132 2 915.4663 2,743.38 2,743.38 3
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% LAMQEFMILPVGAANFR 95.00% 3.85 0.496 2.39 954.9975 1,907.98 1,907.99 2
 SAMPLE 3R Alpha-enolase  ENO1  ENOA_HUMAN 47,152.20 100.00% 8 8 13 27.40% DATNVGDEGGFAPNILENK 95.00% 4.87 0.427 3.8 981.463 1,960.91 1,960.93 2
 SAMPLE 3 Ankyrin-3  ANK3  ANK3_HUMAN 480,382.30 99.80% 2 2 2 1.10% SIITSAAPLISSPLKSVVSPVKSR 95.00% 2.47 0.27 0 813.4159 2,437.22 2,437.44 3
 SAMPLE 3 Ankyrin-3  ANK3  ANK3_HUMAN 480,382.30 99.80% 2 2 2 1.10% FVVFAKmNDPVESSLRcFcMTDDK 95.00% 2.15 0.262 0 m7: Oxidation (+15.99), c17: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 971.9293 2,912.76 2,912.31 3
 SAMPLE 1R Annexin A11  ANXA11  ANX11_HUMAN 54,373.70 99.80% 2 2 3 3.96% SETDLLDIR 95.00% 2.26 0.258 0 531.2719 1,060.53 1,061.55 2
 SAMPLE 1R Annexin A11  ANXA11  ANX11_HUMAN 54,373.70 99.80% 2 2 3 3.96% TPVLFDIYEIK 95.00% 2.18 0.19 1.64 669.3706 1,336.73 1,337.74 2
 SAMPLE 1R Annexin A11  ANXA11  ANX11_HUMAN 54,373.70 99.80% 2 2 3 3.96% TPVLFDIYEIK 95.00% 2.59 0.326 1.55 669.371 1,336.73 1,337.74 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% GVDEVTIVNILTNR 95.00% 4.04 0.471 1.06 514.9518 1,541.83 1,542.85 3
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% GVDEVTIVNILTNR 95.00% 3.19 0.418 0 514.9569 1,541.85 1,542.85 3
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% WISIMTER 95.00% 2.15 0.22 0 518.2713 1,034.53 1,035.53 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% SALSGHLETVILGLLK 95.00% 3.63 0.406 2.36 551.0061 1,649.99 1,650.98 3
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% QDIAFAYQR 95.00% 2.91 0.32 1.41 556.2807 1,110.55 1,111.55 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% QDIAFAYQR 95.00% 3.14 0.294 1.21 556.2827 1,110.55 1,111.55 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% QDIAFAYQR 95.00% 2.82 0.286 1.38 556.284 1,110.55 1,111.55 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% QDIAFAYQR 95.00% 2.87 0.312 0 556.7795 1,111.54 1,111.55 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% TPAQYDASELK 95.00% 2.49 0.436 1.28 611.7977 1,221.58 1,222.60 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% TPAQYDASELK 95.00% 3.37 0.441 2.19 611.8001 1,221.58 1,222.60 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% TPAQYDASELK 95.00% 1.8 0.245 2.43 611.8028 1,221.59 1,222.60 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% TDLEKDIISDTSGDFRK 95.00% 5.19 0.587 3.66 647.3239 1,938.95 1,939.96 3
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% TDLEKDIISDTSGDFRK 95.00% 5.73 0.615 3.77 647.6575 1,939.95 1,939.96 3
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% TDLEKDIISDTSGDFRK 95.00% 5.05 0.488 2.8 647.6674 1,939.98 1,939.96 3
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% TDLEKDIISDTSGDFRK 95.00% 5.22 0.523 3.15 647.6677 1,939.98 1,939.96 3
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% RAEDGSVIDYELIDQDAR 95.00% 4.55 0.31 1.96 689.3413 2,065.00 2,064.98 3
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% GVDEVTIVNILTNR 95.00% 4.76 0.524 2.43 771.9272 1,541.84 1,542.85 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% GVDEVTIVNILTNR 95.00% 4.65 0.547 2.7 771.9297 1,541.84 1,542.85 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% GVDEVTIVNILTNR 95.00% 4.38 0.524 2 771.9347 1,541.85 1,542.85 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% GVDEVTIVNILTNR 95.00% 2.29 0.367 0 771.9353 1,541.85 1,542.85 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% GVDEVTIVNILTNR 95.00% 4.53 0.549 2.46 771.9429 1,541.87 1,542.85 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% GVDEVTIVNILTNR 95.00% 4.46 0.555 1.8 771.9431 1,541.87 1,542.85 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% SALSGHLETVILGLLK 95.00% 3.47 0.293 2.96 826.0002 1,649.98 1,650.98 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% GLGTDEDSLIEIIcSR 95.00% 5.23 0.597 4.17 c14: Carbamidomethyl (+57.02) 889.4336 1,776.85 1,777.86 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% GLGTDEDSLIEIIcSR 95.00% 3.95 0.562 4.49 c14: Carbamidomethyl (+57.02) 889.4404 1,776.87 1,777.86 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% GLGTDEDSLIEIIcSR 95.00% 4.97 0.538 4.21 c14: Carbamidomethyl (+57.02) 889.4557 1,776.90 1,777.86 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% GLGTDEDSLIEIIcSR 95.00% 4.93 0.591 3.66 c14: Carbamidomethyl (+57.02) 889.937 1,777.86 1,777.86 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% LSLEGDHSTPPSAYGSVK 95.00% 1.95 0.496 0 922.9579 1,843.90 1,844.90 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% LSLEGDHSTPPSAYGSVK 95.00% 2.42 0.473 1.14 923.4535 1,844.89 1,844.90 2
 SAMPLE 1 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 10 12 30 37.50% AEDGSVIDYELIDQDAR 95.00% 4.76 0.503 3.06 955.4462 1,908.88 1,908.88 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GVDEVTIVNILTNR 95.00% 4.04 0.471 1.22 514.9518 1,541.83 1,542.85 3
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GVDEVTIVNILTNR 95.00% 3.19 0.418 0 514.9569 1,541.85 1,542.85 3
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GVDEVTIVNILTNR 95.00% 4.16 0.448 1.12 514.9638 1,541.87 1,542.85 3
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GVDEVTIVNILTNR 95.00% 4.07 0.445 0 514.9639 1,541.87 1,542.85 3
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% WISIMTER 95.00% 2.15 0.22 0 518.2713 1,034.53 1,035.53 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% SALSGHLETVILGLLK 95.00% 3.63 0.406 2.34 551.0061 1,649.99 1,650.98 3
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% SALSGHLETVILGLLK 95.00% 3.86 0.433 0 551.0084 1,650.00 1,650.98 3
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% SALSGHLETVILGLLK 95.00% 4.68 0.441 2.04 551.0084 1,650.00 1,650.98 3
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% QDIAFAYQR 95.00% 2.82 0.286 0 556.284 1,110.55 1,111.55 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% QDIAFAYQR 95.00% 2.87 0.312 0 556.7795 1,111.54 1,111.55 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% TPAQYDASELK 95.00% 3.37 0.441 1.8 611.8001 1,221.58 1,222.60 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% TPAQYDASELK 95.00% 1.8 0.245 2.89 611.8028 1,221.59 1,222.60 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% TDLEKDIISDTSGDFRK 95.00% 5.05 0.488 3.04 647.6674 1,939.98 1,939.96 3
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% TDLEKDIISDTSGDFRK 95.00% 5.22 0.523 2.72 647.6677 1,939.98 1,939.96 3
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% RAEDGSVIDYELIDQDAR 95.00% 4.55 0.31 2.12 689.3413 2,065.00 2,064.98 3
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GVDEVTIVNILTNR 95.00% 4.39 0.528 3.15 771.9299 1,541.84 1,542.85 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GVDEVTIVNILTNR 95.00% 3.9 0.497 2.44 771.934 1,541.85 1,542.85 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GVDEVTIVNILTNR 95.00% 4.38 0.524 2.62 771.9347 1,541.85 1,542.85 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GVDEVTIVNILTNR 95.00% 4.03 0.486 1.82 771.9409 1,541.87 1,542.85 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GVDEVTIVNILTNR 95.00% 3.96 0.529 2.41 771.9425 1,541.87 1,542.85 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% SALSGHLETVILGLLK 95.00% 3.47 0.293 3.43 826.0002 1,649.98 1,650.98 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% SALSGHLETVILGLLK 95.00% 4.87 0.378 3.82 826.5094 1,651.00 1,650.98 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GLGTDEDSLIEIIcSR 95.00% 3.95 0.562 3.41 c14: Carbamidomethyl (+57.02) 889.4404 1,776.87 1,777.86 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GLGTDEDSLIEIIcSR 95.00% 4.13 0.56 3.55 c14: Carbamidomethyl (+57.02) 889.4535 1,776.89 1,777.86 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GLGTDEDSLIEIIcSR 95.00% 4.93 0.598 3.77 c14: Carbamidomethyl (+57.02) 889.4535 1,776.89 1,777.86 2
 SAMPLE 1R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 8 10 26 32.20% GLGTDEDSLIEIIcSR 95.00% 4.93 0.591 3.96 c14: Carbamidomethyl (+57.02) 889.937 1,777.86 1,777.86 2
 SAMPLE 2 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 4 5 9 13.60% WISIMTER 95.00% 2.39 0.366 0 518.2668 1,034.52 1,035.53 2
 SAMPLE 2 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 4 5 9 13.60% WISIMTER 95.00% 2.36 0.309 0 518.2671 1,034.52 1,035.53 2
 SAMPLE 2 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 4 5 9 13.60% QDIAFAYQR 95.00% 2.06 0.349 0 556.28 1,110.54 1,111.55 2
 SAMPLE 2 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 4 5 9 13.60% TPAQYDASELK 95.00% 3.17 0.429 3.55 611.7969 1,221.58 1,222.60 2
 SAMPLE 2 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 4 5 9 13.60% TPAQYDASELK 95.00% 3.61 0.486 4.42 611.7982 1,221.58 1,222.60 2
 SAMPLE 2 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 4 5 9 13.60% TPAQYDASELK 95.00% 3.04 0.524 3.39 611.7992 1,221.58 1,222.60 2
 SAMPLE 2 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 4 5 9 13.60% LSLEGDHSTPPSAYGSVK 95.00% 2.41 0.3 1 615.6381 1,843.89 1,844.90 3
 SAMPLE 2 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 4 5 9 13.60% LSLEGDHSTPPSAYGSVK 95.00% 5.29 0.636 2.33 923.4544 1,844.89 1,844.90 2
 SAMPLE 2 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 4 5 9 13.60% LSLEGDHSTPPSAYGSVK 95.00% 4.53 0.598 2.43 923.4554 1,844.90 1,844.90 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% GVDEVTIVNILTNR 95.00% 4.21 0.308 0 514.9532 1,541.84 1,542.85 3
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% GVDEVTIVNILTNR 95.00% 4.66 0.386 0 515.2874 1,542.84 1,542.85 3
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% WISIMTER 95.00% 2.42 0.353 0 518.2676 1,034.52 1,035.53 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% SALSGHLETVILGLLK 95.00% 3.95 0.456 2.57 550.9969 1,649.97 1,650.98 3
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% SALSGHLETVILGLLK 95.00% 2.92 0.311 2.02 550.9985 1,649.97 1,650.98 3
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% SALSGHLETVILGLLK 95.00% 3.08 0.436 1.48 550.9986 1,649.97 1,650.98 3
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% SALSGHLETVILGLLK 95.00% 4.14 0.435 2 550.9996 1,649.98 1,650.98 3
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% SALSGHLETVILGLLK 95.00% 2.91 0.222 0 551.3301 1,650.97 1,650.98 3
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% SALSGHLETVILGLLK 95.00% 4.97 0.444 2.23 551.3313 1,650.97 1,650.98 3
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% TPAQYDASELK 95.00% 2.91 0.424 3.77 611.797 1,221.58 1,222.60 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% TPAQYDASELK 95.00% 3.52 0.485 3.57 611.7998 1,221.58 1,222.60 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% TPAQYDASELK 95.00% 3.61 0.431 3.59 611.8001 1,221.58 1,222.60 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% TPAQYDASELK 95.00% 2.45 0.422 3.12 611.8004 1,221.59 1,222.60 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% TDLEKDIISDTSGDFRK 95.00% 4.31 0.433 3.05 647.6591 1,939.95 1,939.96 3
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% TDLEKDIISDTSGDFRK 95.00% 4.14 0.523 3 647.6598 1,939.96 1,939.96 3
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% GVDEVTIVNILTNR 95.00% 2.98 0.461 0 771.9301 1,541.84 1,542.85 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% GVDEVTIVNILTNR 95.00% 2.55 0.352 0 771.9305 1,541.85 1,542.85 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% GVDEVTIVNILTNR 95.00% 3.52 0.534 1.41 772.4284 1,542.84 1,542.85 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% GVDEVTIVNILTNR 95.00% 3.12 0.421 0 772.4301 1,542.84 1,542.85 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% SALSGHLETVILGLLK 95.00% 4.32 0.364 5.18 825.9911 1,649.97 1,650.98 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% GLGTDEDSLIEIIcSR 95.00% 4.07 0.563 2.23 c14: Carbamidomethyl (+57.02) 889.435 1,776.85 1,777.86 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% GLGTDEDSLIEIIcSR 95.00% 4.5 0.512 3.34 c14: Carbamidomethyl (+57.02) 889.4372 1,776.86 1,777.86 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% LSLEGDHSTPPSAYGSVK 95.00% 5.53 0.652 3.24 922.9551 1,843.89 1,844.90 2
 SAMPLE 2R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 9 24 29.50% LSLEGDHSTPPSAYGSVK 95.00% 5.52 0.626 3.17 923.4577 1,844.90 1,844.90 2
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% DALNIETAIK 95.00% 2.62 0.275 0 544.3027 1,086.59 1,087.60 2
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% DALNIETAIK 95.00% 2.56 0.232 0 544.3045 1,086.59 1,087.60 2
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% QDIAFAYQR 95.00% 2.84 0.293 0 556.2808 1,110.55 1,111.55 2
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% QDIAFAYQR 95.00% 2.35 0.19 0 556.2808 1,110.55 1,111.55 2
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% TPAQYDASELK 95.00% 3.93 0.536 3.66 611.7999 1,221.58 1,222.60 2
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% TPAQYDASELK 95.00% 3.44 0.493 3.85 611.8 1,221.58 1,222.60 2
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% TPAQYDASELK 95.00% 4.1 0.53 2.8 611.8001 1,221.58 1,222.60 2
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% TPAQYDASELK 95.00% 2.74 0.479 3.1 611.8006 1,221.59 1,222.60 2
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% TPAQYDASELK 95.00% 3.33 0.469 2.16 611.8014 1,221.59 1,222.60 2
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% LSLEGDHSTPPSAYGSVK 95.00% 2.3 0.294 1.96 615.6385 1,843.89 1,844.90 3
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% TDLEKDIISDTSGDFRK 95.00% 2.69 0.403 0 647.6569 1,939.95 1,939.96 3
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% TDLEKDIISDTSGDFRK 95.00% 5.53 0.623 2.89 647.658 1,939.95 1,939.96 3
 SAMPLE 3 Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 5 5 13 19.20% TDLEKDIISDTSGDFRK 95.00% 5.43 0.584 4.72 647.6584 1,939.95 1,939.96 3
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% DALNIETAIK 95.00% 2.64 0.299 0 544.3028 1,086.59 1,087.60 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% DALNIETAIK 95.00% 2.77 0.305 0 544.3032 1,086.59 1,087.60 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% SALSGHLETVILGLLK 95.00% 3.1 0.419 0 550.9967 1,649.97 1,650.98 3
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% SALSGHLETVILGLLK 95.00% 4.12 0.458 3.3 550.9978 1,649.97 1,650.98 3
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% QDIAFAYQR 95.00% 2.38 0.304 1.14 556.2792 1,110.54 1,111.55 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% TPAQYDASELK 95.00% 3.81 0.477 3.57 611.7998 1,221.58 1,222.60 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% TPAQYDASELK 95.00% 2.66 0.377 2.03 611.8001 1,221.58 1,222.60 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% TPAQYDASELK 95.00% 3.88 0.493 2.72 611.8004 1,221.59 1,222.60 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% TPAQYDASELK 95.00% 2.77 0.488 1.57 611.8021 1,221.59 1,222.60 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% TDLEKDIISDTSGDFRK 95.00% 4.69 0.596 1.96 647.6587 1,939.95 1,939.96 3
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% GVDEVTIVNILTNR 95.00% 1.57 0.416 0 771.6644 1,541.31 1,542.85 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% GVDEVTIVNILTNR 95.00% 2.98 0.437 0 771.9256 1,541.84 1,542.85 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% GVDEVTIVNILTNR 95.00% 3.61 0.403 1.36 771.9268 1,541.84 1,542.85 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% GVDEVTIVNILTNR 95.00% 3.36 0.5 1.54 771.9273 1,541.84 1,542.85 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% GVDEVTIVNILTNR 95.00% 3.35 0.572 2.08 771.9275 1,541.84 1,542.85 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% GVDEVTIVNILTNR 95.00% 2.93 0.535 1.57 771.9289 1,541.84 1,542.85 2
 SAMPLE 3R Annexin A2  ANXA2  ANXA2_HUMAN 38,588.10 100.00% 7 7 17 28.00% LSLEGDHSTPPSAYGSVK 95.00% 5.22 0.6 3.03 922.9543 1,843.89 1,844.90 2
 SAMPLE 1 Annexin A5  ANXA5  ANXA5_HUMAN 35,920.60 99.80% 2 2 2 8.44% NFATSLYSMIK 95.00% 2.64 0.323 1.17 637.831 1,273.65 1,274.65 2
 SAMPLE 1 Annexin A5  ANXA5  ANXA5_HUMAN 35,920.60 99.80% 2 2 2 8.44% GLGTDEESILTLLTSR 95.00% 4.77 0.404 0 852.9638 1,703.91 1,704.90 2
 SAMPLE 1R Annexin A5  ANXA5  ANXA5_HUMAN 35,920.60 99.90% 2 2 3 8.44% NFATSLYSMIK 95.00% 2.64 0.323 0 637.831 1,273.65 1,274.65 2
 SAMPLE 1R Annexin A5  ANXA5  ANXA5_HUMAN 35,920.60 99.90% 2 2 3 8.44% GLGTDEESILTLLTSR 95.00% 4.87 0.531 3.62 852.9562 1,703.90 1,704.90 2
 SAMPLE 1R Annexin A5  ANXA5  ANXA5_HUMAN 35,920.60 99.90% 2 2 3 8.44% GLGTDEESILTLLTSR 95.00% 4.77 0.404 0 852.9638 1,703.91 1,704.90 2
 SAMPLE 3 Annexin A5  ANXA5  ANXA5_HUMAN 35,920.60 99.90% 2 2 3 5.94% VLTEIIASR 95.00% 1.98 0.144 1.57 501.3007 1,000.59 1,001.60 2
 SAMPLE 3 Annexin A5  ANXA5  ANXA5_HUMAN 35,920.60 99.90% 2 2 3 5.94% SEIDLFNIRK 95.00% 2.66 0.281 1.1 617.8418 1,233.67 1,234.68 2
 SAMPLE 3 Annexin A5  ANXA5  ANXA5_HUMAN 35,920.60 99.90% 2 2 3 5.94% SEIDLFNIRK 95.00% 2.5 0.205 0 617.8456 1,233.68 1,234.68 2
 SAMPLE 3R Annexin A5  ANXA5  ANXA5_HUMAN 35,920.60 99.90% 2 3 4 8.12% GLGTDEESILTLLTSR 95.00% 2.74 0.242 0 569.3059 1,704.89 1,704.90 3
 SAMPLE 3R Annexin A5  ANXA5  ANXA5_HUMAN 35,920.60 99.90% 2 3 4 8.12% SEIDLFNIRK 95.00% 2.37 0.218 0 617.8364 1,233.66 1,234.68 2
 SAMPLE 3R Annexin A5  ANXA5  ANXA5_HUMAN 35,920.60 99.90% 2 3 4 8.12% SEIDLFNIRK 95.00% 2.44 0.247 0 617.8447 1,233.67 1,234.68 2
 SAMPLE 3R Annexin A5  ANXA5  ANXA5_HUMAN 35,920.60 99.90% 2 3 4 8.12% GLGTDEESILTLLTSR 95.00% 4.73 0.493 2.68 852.9502 1,703.88 1,704.90 2
 SAMPLE 4R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 99.80% 2 2 4 3.71% ALIEILATR 95.00% 2.53 0.231 0 500.3155 998.6154 999.6204 2
 SAMPLE 4R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 99.80% 2 2 4 3.71% ALIEILATR 95.00% 2.5 0.321 0 500.3163 998.6169 999.6204 2
 SAMPLE 4R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 99.80% 2 2 4 3.71% GLGTDEDTIIDIITHR 95.00% 2.49 0.349 0 590.3085 1,767.90 1,768.91 3
 SAMPLE 4R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 99.80% 2 2 4 3.71% GLGTDEDTIIDIITHR 95.00% 2.55 0.225 0 590.6428 1,768.90 1,768.91 3
 SAMPLE 1 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 10 10.80% ALIEILATR 95.00% 2.1 0.246 0 500.3123 998.609 999.6204 2
 SAMPLE 1 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 10 10.80% ALIEILATR 95.00% 2.87 0.243 1.47 500.7682 999.5208 999.6204 2
 SAMPLE 1 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 10 10.80% GFGSDKEAILDIITSR 95.00% 3.84 0.413 1.68 574.639 1,720.89 1,721.91 3
 SAMPLE 1 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 10 10.80% GFGSDKEAILDIITSR 95.00% 3.07 0.38 0 574.9736 1,721.90 1,721.91 3
 SAMPLE 1 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 10 10.80% DLEADIIGDTSGHFQK 95.00% 2.73 0.424 1 582.6155 1,744.82 1,745.84 3
 SAMPLE 1 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 10 10.80% DLEADIIGDTSGHFQK 95.00% 2.85 0.321 0 582.9491 1,745.82 1,745.84 3
 SAMPLE 1 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 10 10.80% GLGTDEDTIIDIITHR 95.00% 3.63 0.56 0 590.3065 1,767.90 1,768.91 3
 SAMPLE 1 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 10 10.80% GLGTDEDTIIDIITHR 95.00% 2.31 0.432 0 590.6418 1,768.90 1,768.91 3
 SAMPLE 1 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 10 10.80% GTVRPANDFNPDADAK 95.00% 3.35 0.389 2.64 844.4034 1,686.79 1,687.80 2
 SAMPLE 1 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 10 10.80% GLGTDEDTIIDIITHR 95.00% 4.94 0.582 3.59 884.9558 1,767.90 1,768.91 2
 SAMPLE 1R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 9 11.10% GFGSDKEAILDIITSR 95.00% 3.95 0.422 1.48 574.9743 1,721.90 1,721.91 3
 SAMPLE 1R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 9 11.10% DLEADIIGDTSGHFQK 95.00% 2.35 0.233 0 582.6143 1,744.82 1,745.84 3
 SAMPLE 1R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 9 11.10% DLEADIIGDTSGHFQK 95.00% 2.49 0.341 0 582.9485 1,745.82 1,745.84 3
 SAMPLE 1R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 9 11.10% DAFVAIVQSVK 95.00% 2.94 0.346 3 588.8326 1,175.65 1,176.66 2
 SAMPLE 1R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 9 11.10% GLGTDEDTIIDIITHR 95.00% 2.74 0.469 0 590.3055 1,767.89 1,768.91 3
 SAMPLE 1R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 9 11.10% GTVRPANDFNPDADAK 95.00% 3.28 0.455 2.96 844.404 1,686.79 1,687.80 2
 SAMPLE 1R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 9 11.10% GTVRPANDFNPDADAK 95.00% 3.44 0.437 2.29 844.406 1,686.80 1,687.80 2
 SAMPLE 1R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 9 11.10% GLGTDEDTIIDIITHR 95.00% 4.63 0.597 3.64 884.9549 1,767.89 1,768.91 2
 SAMPLE 1R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 5 6 9 11.10% GLGTDEDTIIDIITHR 95.00% 4.99 0.671 4.26 885.4565 1,768.90 1,768.91 2
 SAMPLE 2 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 8 8 11 17.40% MTNYDVEHTIKK 95.00% 2.88 0.307 0 493.5803 1,477.72 1,478.73 3
 SAMPLE 2 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 8 8 11 17.40% SELDMLDIR 95.00% 2.48 0.368 1.15 546.2727 1,090.53 1,091.54 2
 SAMPLE 2 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 8 8 11 17.40% DLEADIIGDTSGHFQK 95.00% 2.54 0.375 1.36 582.616 1,744.82 1,745.84 3
 SAMPLE 2 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 8 8 11 17.40% DLEADIIGDTSGHFQK 95.00% 2.91 0.386 0 582.9504 1,745.83 1,745.84 3
 SAMPLE 2 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 8 8 11 17.40% DAFVAIVQSVK 95.00% 3.73 0.396 2.31 588.834 1,175.65 1,176.66 2
 SAMPLE 2 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 8 8 11 17.40% DAFVAIVQSVK 95.00% 3.47 0.431 1.31 588.8345 1,175.65 1,176.66 2
 SAMPLE 2 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 8 8 11 17.40% SLEDALSSDTSGHFRR 95.00% 1.93 0.239 0 593.2869 1,776.84 1,777.85 3
 SAMPLE 2 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 8 8 11 17.40% ILISLATGHREEGGENLDQAR 95.00% 4 0.481 2.62 760.7311 2,279.17 2,279.17 3
 SAMPLE 2 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 8 8 11 17.40% GTVRPANDFNPDADAK 95.00% 3.78 0.445 4.05 844.4041 1,686.79 1,687.80 2
 SAMPLE 2 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 8 8 11 17.40% GTVRPANDFNPDADAK 95.00% 3.48 0.425 3.15 844.9076 1,687.80 1,687.80 2
 SAMPLE 2 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 8 8 11 17.40% SLHQAIEGDTSGDFLK 95.00% 3.98 0.478 1.82 859.427 1,716.84 1,717.84 2
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% MTNYDVEHTIKK 95.00% 2.85 0.262 0 493.5804 1,477.72 1,478.73 3
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% MTNYDVEHTIKK 95.00% 2.86 0.281 0 493.5805 1,477.72 1,478.73 3
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% SEIDLLNIR 95.00% 2.5 0.252 0 536.8023 1,071.59 1,072.60 2
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% SEIDLLNIR 95.00% 2.58 0.223 0 536.8026 1,071.59 1,072.60 2
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% LILGLMMPPAHYDAK 95.00% 2.42 0.316 0 557.2977 1,668.87 1,669.88 3
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% LILGLMMPPAHYDAK 95.00% 2.8 0.408 2.18 557.6326 1,669.87 1,669.88 3
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% GFGSDKEAILDIITSR 95.00% 3.67 0.329 1.29 574.6394 1,720.89 1,721.91 3
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% GFGSDKEAILDIITSR 95.00% 3.3 0.327 0 574.6395 1,720.90 1,721.91 3
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% DLEADIIGDTSGHFQK 95.00% 3.09 0.409 2.18 582.6152 1,744.82 1,745.84 3
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% DLEADIIGDTSGHFQK 95.00% 2.72 0.273 0 582.9493 1,745.82 1,745.84 3
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% SLEDALSSDTSGHFRR 94.80% 2.15 0.218 0 593.6204 1,777.84 1,777.85 3
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% DLIADLKYELTGK 95.00% 4.02 0.584 3.96 740.4095 1,478.80 1,478.81 2
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% GTVRPANDFNPDADAK 95.00% 3.61 0.469 2.54 844.404 1,686.79 1,687.80 2
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% GTVRPANDFNPDADAK 95.00% 3.5 0.441 2.35 844.906 1,687.80 1,687.80 2
 SAMPLE 2R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 15 19.20% GLGTDEDTIIDIITHR 95.00% 5.23 0.631 3 885.4561 1,768.90 1,768.91 2
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% FMTILcTR 95.00% 1.97 0.364 0 c6: Carbamidomethyl (+57.02) 521.2638 1,040.51 1,041.52 2
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% cLIEILASR 95.00% 3.57 0.36 0 c1: Carbamidomethyl (+57.02) 537.8017 1,073.59 1,074.60 2
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% SLEDALSSDTSGHFR 95.00% 2.42 0.29 0 541.2525 1,620.73 1,621.75 3
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% SLEDALSSDTSGHFR 95.00% 2.33 0.219 0 541.2535 1,620.74 1,621.75 3
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% SELDMLDIR 95.00% 3.12 0.389 0 546.2732 1,090.53 1,091.54 2
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% SELDMLDIR 95.00% 2.81 0.415 0 546.2733 1,090.53 1,091.54 2
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% LILGLMMPPAHYDAK 95.00% 2.81 0.4 1.96 557.2981 1,668.87 1,669.88 3
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% LILGLMMPPAHYDAK 95.00% 3.1 0.357 1.62 557.6324 1,669.87 1,669.88 3
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% GFGSDKEAILDIITSR 95.00% 2.37 0.247 0 574.8189 1,721.43 1,721.91 3
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% GFGSDKEAILDIITSR 95.00% 2.12 0.235 0 574.8196 1,721.44 1,721.91 3
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% DLEADIIGDTSGHFQK 95.00% 2.59 0.268 0 582.6158 1,744.82 1,745.84 3
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% DLEADIIGDTSGHFQK 95.00% 2.58 0.284 1 582.616 1,744.82 1,745.84 3
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% DAFVAIVQSVK 95.00% 3.77 0.422 3.24 588.834 1,175.65 1,176.66 2
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% DAFVAIVQSVK 95.00% 3.86 0.425 2.29 588.8343 1,175.65 1,176.66 2
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% GTVRPANDFNPDADAK 95.00% 3.9 0.474 2.57 844.4026 1,686.79 1,687.80 2
 SAMPLE 3 Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 9 9 16 17.10% GTVRPANDFNPDADAK 95.00% 3.72 0.474 2.8 844.405 1,686.79 1,687.80 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% FMTILcTR 95.00% 2.13 0.429 0 c6: Carbamidomethyl (+57.02) 521.2642 1,040.51 1,041.52 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% FMTILcTR 95.00% 1.82 0.291 0 c6: Carbamidomethyl (+57.02) 521.2648 1,040.51 1,041.52 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% SEIDLLNIR 95.00% 2.42 0.228 0 536.8034 1,071.59 1,072.60 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% cLIEILASR 95.00% 3.45 0.375 0 c1: Carbamidomethyl (+57.02) 537.8018 1,073.59 1,074.60 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% cLIEILASR 95.00% 3.47 0.361 0 c1: Carbamidomethyl (+57.02) 537.8019 1,073.59 1,074.60 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% SELDMLDIR 95.00% 3.12 0.413 0 546.2729 1,090.53 1,091.54 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% SELDMLDIR 95.00% 3.07 0.378 1.25 546.273 1,090.53 1,091.54 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% LILGLMMPPAHYDAK 95.00% 3.54 0.427 0 557.2974 1,668.87 1,669.88 3
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% LILGLMMPPAHYDAK 95.00% 3.21 0.352 0 557.6316 1,669.87 1,669.88 3
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% MLVVLLQGTR 95.00% 3.61 0.375 2.04 565.3413 1,128.67 1,129.68 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% EAILDIITSR 95.00% 2.73 0.363 1.92 565.8222 1,129.63 1,130.64 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% EAILDIITSR 95.00% 2.23 0.308 0 565.8244 1,129.63 1,130.64 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% GFGSDKEAILDIITSR 95.00% 3.3 0.333 0 574.6399 1,720.90 1,721.91 3
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% GFGSDKEAILDIITSR 95.00% 3.54 0.411 0 574.6401 1,720.90 1,721.91 3
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% DLEADIIGDTSGHFQK 95.00% 2.73 0.307 0 582.616 1,744.82 1,745.84 3
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% DLEADIIGDTSGHFQK 95.00% 2.88 0.327 0.959 582.6161 1,744.82 1,745.84 3
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% DAFVAIVQSVK 95.00% 3.78 0.41 1.89 588.8338 1,175.65 1,176.66 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% DAFVAIVQSVK 95.00% 2.8 0.335 1.48 588.8343 1,175.65 1,176.66 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% DAFVAIVQSVK 95.00% 3.95 0.401 2.77 588.8345 1,175.65 1,176.66 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% DLIADLKYELTGK 95.00% 3.49 0.565 4.64 739.9068 1,477.80 1,478.81 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% DLIADLKYELTGK 95.00% 3.81 0.546 3.82 739.9105 1,477.81 1,478.81 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% TNEQMHQLVAAYK 95.00% 3.09 0.41 4.34 766.8819 1,531.75 1,532.75 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% GTVRPANDFNPDADAK 95.00% 3.91 0.554 3.43 844.4028 1,686.79 1,687.80 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% GTVRPANDFNPDADAK 95.00% 3.72 0.409 2.51 844.4029 1,686.79 1,687.80 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% SLHQAIEGDTSGDFLK 95.00% 3.53 0.209 0 859.4266 1,716.84 1,717.84 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% SLHQAIEGDTSGDFLK 95.00% 3.68 0.194 1.68 859.4266 1,716.84 1,717.84 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% DLMTDLKSEISGDLAR 95.00% 3.9 0.305 2.72 882.4453 1,762.87 1,763.89 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% GLGTDEDTIIDIITHR 95.00% 4.5 0.569 3.89 884.9577 1,767.90 1,768.91 2
 SAMPLE 3R Annexin A6  ANXA6  ANXA6_HUMAN 75,859.50 100.00% 16 16 29 28.70% GLGTDEDTIIDIITHR 95.00% 4.87 0.633 4.68 885.4575 1,768.90 1,768.91 2
 SAMPLE 2 Antileukoproteinase  SLPI  SLPI_HUMAN 14,308.00 99.80% 2 2 3 20.50% YKKPEcQSDWQcPGK 95.00% 3.38 0.37 0 c6: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 637.6258 1,909.85 1,910.85 3
 SAMPLE 2 Antileukoproteinase  SLPI  SLPI_HUMAN 14,308.00 99.80% 2 2 3 20.50% YKKPEcQSDWQcPGK 95.00% 2.92 0.385 0 c6: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 637.9588 1,910.85 1,910.85 3
 SAMPLE 2 Antileukoproteinase  SLPI  SLPI_HUMAN 14,308.00 99.80% 2 2 3 20.50% cLDPVDTPNPTR 95.00% 2.65 0.322 0 c1: Carbamidomethyl (+57.02) 692.8307 1,383.65 1,384.65 2
 SAMPLE 2R Antileukoproteinase  SLPI  SLPI_HUMAN 14,308.00 99.80% 2 2 3 20.50% YKKPEcQSDWQcPGK 95.00% 2.68 0.433 0 c6: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 637.9591 1,910.85 1,910.85 3
 SAMPLE 2R Antileukoproteinase  SLPI  SLPI_HUMAN 14,308.00 99.80% 2 2 3 20.50% cLDPVDTPNPTR 95.00% 2.76 0.397 1.96 c1: Carbamidomethyl (+57.02) 692.8293 1,383.64 1,384.65 2
 SAMPLE 2R Antileukoproteinase  SLPI  SLPI_HUMAN 14,308.00 99.80% 2 2 3 20.50% cLDPVDTPNPTR 95.00% 2.76 0.388 1.77 c1: Carbamidomethyl (+57.02) 692.8293 1,383.64 1,384.65 2
 SAMPLE 1 Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 4 13.90% IPSGLPELK 95.00% 2.52 0.297 0 477.2857 952.5558 953.5674 2
 SAMPLE 1 Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 4 13.90% IPSGLPELK 95.00% 2.36 0.278 0 477.2871 952.5586 953.5674 2
 SAMPLE 1 Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 4 13.90% VGVNDFcPTVPK 95.00% 2.78 0.306 0 c7: Carbamidomethyl (+57.02) 666.8313 1,331.65 1,332.66 2
 SAMPLE 1 Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 4 13.90% ISTVELEDFKR 95.00% 2.34 0.352 1.38 668.8583 1,335.70 1,336.71 2
 SAMPLE 1 Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 4 13.90% VVHcSDLGLTSVPTNIPFDTR 95.00% 3.31 0.402 0 c4: Carbamidomethyl (+57.02) 777.0585 2,328.15 2,328.17 3
 SAMPLE 1R Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 3 14.70% IPSGLPELK 95.00% 2.41 0.205 0 477.2873 952.5589 953.5674 2
 SAMPLE 1R Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 3 14.70% VGVNDFcPTVPK 95.00% 3 0.32 1.57 c7: Carbamidomethyl (+57.02) 666.8303 1,331.64 1,332.66 2
 SAMPLE 1R Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 3 14.70% VVHcSDLGLTSVPTNIPFDTR 95.00% 2.85 0.344 0 c4: Carbamidomethyl (+57.02) 777.0583 2,328.15 2,328.17 3
 SAMPLE 1R Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 3 14.70% VVHcSDLGLTSVPTNIPFDTR 95.00% 2.89 0.339 1.28 c4: Carbamidomethyl (+57.02) 777.0591 2,328.15 2,328.17 3
 SAMPLE 1R Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 3 14.70% SLYSAISLFNNPVK 95.00% 4.34 0.507 4.72 777.4233 1,552.83 1,552.84 2
 SAMPLE 2 Asporin  ASPN  ASPN_HUMAN 43,401.70 99.80% 2 2 3 6.84% VGVNDFcPTVPK 95.00% 2.87 0.203 0 c7: Carbamidomethyl (+57.02) 666.8302 1,331.64 1,332.66 2
 SAMPLE 2 Asporin  ASPN  ASPN_HUMAN 43,401.70 99.80% 2 2 3 6.84% VGVNDFcPTVPK 95.00% 3.08 0.352 1.49 c7: Carbamidomethyl (+57.02) 666.8321 1,331.65 1,332.66 2
 SAMPLE 2 Asporin  ASPN  ASPN_HUMAN 43,401.70 99.80% 2 2 3 6.84% SLYSAISLFNNPVK 95.00% 4.68 0.614 2.89 776.9225 1,551.83 1,552.84 2
 SAMPLE 2R Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 5 10.50% VGVNDFcPTVPK 95.00% 3.09 0.411 0 c7: Carbamidomethyl (+57.02) 666.8317 1,331.65 1,332.66 2
 SAMPLE 2R Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 5 10.50% GLTSLYGLILNNNK 95.00% 2.58 0.362 0 760.425 1,518.83 1,519.85 2
 SAMPLE 2R Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 5 10.50% GLTSLYGLILNNNK 95.00% 3.64 0.376 1.54 760.4279 1,518.84 1,519.85 2
 SAMPLE 2R Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 5 10.50% SLYSAISLFNNPVK 95.00% 2.68 0.366 3.89 776.9223 1,551.83 1,552.84 2
 SAMPLE 2R Asporin  ASPN  ASPN_HUMAN 43,401.70 100.00% 3 3 5 10.50% SLYSAISLFNNPVK 95.00% 3.83 0.59 3.14 777.4226 1,552.83 1,552.84 2
 SAMPLE 4 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 99.80% 2 2 4 4.70% AVDSLVPIGR 95.00% 2.3 0.301 0 513.8018 1,025.59 1,026.59 2
 SAMPLE 4 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 99.80% 2 2 4 4.70% AVDSLVPIGR 95.00% 2.11 0.297 0 513.8033 1,025.59 1,026.59 2
 SAMPLE 4 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 99.80% 2 2 4 4.70% TGAIVDVPVGEELLGR 95.00% 4.08 0.495 4.35 813.4544 1,624.89 1,624.89 2
 SAMPLE 4 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 99.80% 2 2 4 4.70% TGAIVDVPVGEELLGR 95.00% 4.39 0.447 2.64 813.455 1,624.89 1,624.89 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% VLSIGDGIAR 95.00% 2.05 0.292 3 500.7913 999.567 1,000.58 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% AVDSLVPIGR 95.00% 2.3 0.376 0 513.799 1,025.58 1,026.59 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% AVDSLVPIGR 95.00% 2.09 0.269 0 513.8012 1,025.59 1,026.59 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% GYLDKLEPSK 95.00% 2.25 0.356 2.52 575.3086 1,148.60 1,149.62 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% GYLDKLEPSK 95.00% 2.41 0.387 2.2 575.3105 1,148.61 1,149.62 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% VVDALGNAIDGK 95.00% 3.89 0.576 3.82 586.3191 1,170.62 1,171.63 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% VVDALGNAIDGK 95.00% 3.91 0.5 3.82 586.3192 1,170.62 1,171.63 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% HALIIYDDLSK 95.00% 3.07 0.466 3.74 644.3496 1,286.68 1,287.70 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% HALIIYDDLSK 95.00% 2.6 0.494 2.35 644.3501 1,286.68 1,287.70 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% TSIAIDTIINQK 95.00% 2.82 0.186 0 658.8733 1,315.73 1,316.74 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% EAYPGDVFYLHSR 95.00% 2.58 0.473 4.35 777.3713 1,552.73 1,553.74 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% EAYPGDVFYLHSR 95.00% 3.21 0.507 4.4 777.3725 1,552.73 1,553.74 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% ILGADTSVDLEETGR 95.00% 4.38 0.584 6.59 788.399 1,574.78 1,575.79 2
 SAMPLE 1 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 17.90% VVDALGNAIDGKGPIGSK 95.00% 4.08 0.643 4.77 855.9714 1,709.93 1,710.94 2
 SAMPLE 1R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 7 7 12 15.70% VLSIGDGIAR 95.00% 2.41 0.387 2.92 500.7921 999.5686 1,000.58 2
 SAMPLE 1R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 7 7 12 15.70% VVDALGNAIDGK 95.00% 3.51 0.488 4.08 586.318 1,170.62 1,171.63 2
 SAMPLE 1R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 7 7 12 15.70% VVDALGNAIDGK 95.00% 3.68 0.533 3.54 586.3184 1,170.62 1,171.63 2
 SAMPLE 1R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 7 7 12 15.70% HALIIYDDLSK 95.00% 2.45 0.485 4.57 644.3488 1,286.68 1,287.70 2
 SAMPLE 1R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 7 7 12 15.70% HALIIYDDLSK 95.00% 2.97 0.442 5 644.3503 1,286.69 1,287.70 2
 SAMPLE 1R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 7 7 12 15.70% TSIAIDTIINQK 95.00% 2.41 0.243 0 658.8733 1,315.73 1,316.74 2
 SAMPLE 1R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 7 7 12 15.70% TSIAIDTIINQK 95.00% 3.11 0.346 1.89 658.8739 1,315.73 1,316.74 2
 SAMPLE 1R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 7 7 12 15.70% LKEIVTNFLAGFEA 95.00% 2.59 0.37 0 776.425 1,550.83 1,551.84 2
 SAMPLE 1R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 7 7 12 15.70% LKEIVTNFLAGFEA 95.00% 2.79 0.334 2.08 776.4254 1,550.84 1,551.84 2
 SAMPLE 1R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 7 7 12 15.70% EAYPGDVFYLHSR 95.00% 2.55 0.304 2.23 777.372 1,552.73 1,553.74 2
 SAMPLE 1R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 7 7 12 15.70% ILGADTSVDLEETGR 95.00% 4.2 0.581 8.07 788.3957 1,574.78 1,575.79 2
 SAMPLE 1R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 7 7 12 15.70% ILGADTSVDLEETGR 95.00% 4.7 0.5 8.77 788.8985 1,575.78 1,575.79 2
 SAMPLE 2 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 4 4 6 8.86% VLSIGDGIAR 95.00% 2.76 0.372 1.59 500.7908 999.566 1,000.58 2
 SAMPLE 2 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 4 4 6 8.86% AVDSLVPIGR 95.00% 2.09 0.241 0 513.8002 1,025.58 1,026.59 2
 SAMPLE 2 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 4 4 6 8.86% VVDALGNAIDGKGPIGSK 95.00% 2.44 0.262 0 570.9843 1,709.93 1,710.94 3
 SAMPLE 2 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 4 4 6 8.86% VVDALGNAIDGKGPIGSK 95.00% 2.68 0.406 0 571.3187 1,710.93 1,710.94 3
 SAMPLE 2 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 4 4 6 8.86% HALIIYDDLSK 95.00% 1.72 0.343 0 644.3484 1,286.68 1,287.70 2
 SAMPLE 2 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 4 4 6 8.86% HALIIYDDLSK 95.00% 2.01 0.332 1.23 644.3517 1,286.69 1,287.70 2
 SAMPLE 2R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 3 3 5 5.79% VVDALGNAIDGKGPIGSK 95.00% 2.1 0.267 0 570.9846 1,709.93 1,710.94 3
 SAMPLE 2R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 3 3 5 5.79% VVDALGNAIDGKGPIGSK 95.00% 2.56 0.26 1.74 571.3185 1,710.93 1,710.94 3
 SAMPLE 2R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 3 3 5 5.79% VVDALGNAIDGK 95.00% 2.22 0.302 4.11 586.317 1,170.62 1,171.63 2
 SAMPLE 2R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 3 3 5 5.79% VVDALGNAIDGK 95.00% 2.33 0.382 2.37 586.3184 1,170.62 1,171.63 2
 SAMPLE 2R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 3 3 5 5.79% LKEIVTNFLAGFEA 95.00% 2.13 0.337 1.68 776.4291 1,550.84 1,551.84 2
 SAMPLE 3 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 6 6 10 12.80% ISVREPMQTGIK 95.00% 3.04 0.48 0 453.5886 1,357.74 1,358.75 3
 SAMPLE 3 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 6 6 10 12.80% ISVREPMQTGIK 95.00% 3.52 0.432 1.03 453.589 1,357.74 1,358.75 3
 SAMPLE 3 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 6 6 10 12.80% VLSIGDGIAR 95.00% 1.98 0.306 1.64 500.7917 999.5677 1,000.58 2
 SAMPLE 3 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 6 6 10 12.80% VLSIGDGIAR 95.00% 2.19 0.337 3.02 500.7924 999.5691 1,000.58 2
 SAMPLE 3 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 6 6 10 12.80% AVDSLVPIGR 95.00% 2.39 0.249 0 513.7995 1,025.58 1,026.59 2
 SAMPLE 3 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 6 6 10 12.80% VVDALGNAIDGKGPIGSK 95.00% 2.8 0.47 1 570.9839 1,709.93 1,710.94 3
 SAMPLE 3 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 6 6 10 12.80% VVDALGNAIDGKGPIGSK 95.00% 2.52 0.434 1.89 571.3185 1,710.93 1,710.94 3
 SAMPLE 3 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 6 6 10 12.80% GYLDKLEPSK 95.00% 2.09 0.276 0 575.3094 1,148.60 1,149.62 2
 SAMPLE 3 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 6 6 10 12.80% HALIIYDDLSK 95.00% 2.36 0.35 0 644.3473 1,286.68 1,287.70 2
 SAMPLE 3 ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 6 6 10 12.80% HALIIYDDLSK 95.00% 2.27 0.473 2.36 644.3532 1,286.69 1,287.70 2
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% ISVREPMQTGIK 95.00% 2.61 0.343 0 453.5887 1,357.74 1,358.75 3
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% ISVREPMQTGIK 95.00% 3.26 0.466 0 453.5891 1,357.74 1,358.75 3
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% VLSIGDGIAR 95.00% 1.87 0.319 2.6 500.7918 999.5679 1,000.58 2
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% VVDALGNAIDGKGPIGSK 95.00% 2.68 0.308 1.41 570.9825 1,709.92 1,710.94 3
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% VVDALGNAIDGKGPIGSK 95.00% 2.62 0.417 0 570.9833 1,709.93 1,710.94 3
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% VVDALGNAIDGK 95.00% 3.69 0.514 4.59 586.3191 1,170.62 1,171.63 2
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% VVDALGNAIDGK 95.00% 3.6 0.417 2.82 586.3203 1,170.62 1,171.63 2
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% HALIIYDDLSK 95.00% 2.26 0.469 2.15 644.3506 1,286.69 1,287.70 2
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% HALIIYDDLSK 95.00% 2.18 0.482 0 644.3545 1,286.69 1,287.70 2
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% HALIIYDDLSK 95.00% 2.92 0.601 3.7 644.8507 1,287.69 1,287.70 2
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% LKEIVTNFLAGFEA 95.00% 3.09 0.541 2.57 776.4248 1,550.83 1,551.84 2
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% EAYPGDVFYLHSR 95.00% 2.24 0.186 1.89 777.8717 1,553.73 1,553.74 2
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% ILGADTSVDLEETGR 95.00% 2.96 0.545 2.68 788.4002 1,574.78 1,575.79 2
 SAMPLE 3R ATP synthase subunit alpha, mitochondrial  ATP5A1  ATPA_HUMAN 59,734.10 100.00% 9 9 14 19.70% TGAIVDVPVGEELLGR 95.00% 3.61 0.436 1.49 812.9488 1,623.88 1,624.89 2
 SAMPLE 4R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 99.80% 2 2 3 4.54% VVDLLAPYAK 95.00% 2.28 0.328 0 544.8219 1,087.63 1,088.64 2
 SAMPLE 4R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 99.80% 2 2 3 4.54% FTQAGSEVSALLGR 95.00% 3.92 0.562 3.96 718.3848 1,434.75 1,435.75 2
 SAMPLE 4R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 99.80% 2 2 3 4.54% FTQAGSEVSALLGR 95.00% 3.33 0.504 5.89 718.3866 1,434.76 1,435.75 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% IGLFGGAGVGK 95.00% 2.83 0.442 2.26 488.2833 974.5509 975.563 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% IGLFGGAGVGK 95.00% 2.75 0.417 2.82 488.2841 974.5526 975.563 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% IGLFGGAGVGK 95.00% 2.71 0.421 2.31 488.2845 974.5534 975.563 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% VVDLLAPYAK 95.00% 2.63 0.385 0 544.8193 1,087.62 1,088.64 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% VVDLLAPYAK 95.00% 2.35 0.328 0 544.8194 1,087.62 1,088.64 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% VVDLLAPYAK 95.00% 2.55 0.377 1.21 544.82 1,087.62 1,088.64 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% VVDLLAPYAK 95.00% 2.43 0.381 0 544.82 1,087.62 1,088.64 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% IMDPNIVGSEHYDVAR 95.00% 2.94 0.33 0 605.9597 1,814.86 1,815.87 3 IMMT_HUMAN,HNRPU_HUMAN,CFAH_HUMAN
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% IMDPNIVGSEHYDVAR 95.00% 3.08 0.335 0 606.2938 1,815.86 1,815.87 3 IMMT_HUMAN,HNRPU_HUMAN,CFAH_HUMAN
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% TIAMDGTEGLVR 95.00% 2.17 0.281 1.44 631.8232 1,261.63 1,262.64 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% TIAMDGTEGLVR 95.00% 2.29 0.39 0 631.8238 1,261.63 1,262.64 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% VLDSGAPIKIPVGPETLGR 95.00% 4.75 0.543 4.6 640.3692 1,918.08 1,919.10 3
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% VLDSGAPIKIPVGPETLGR 95.00% 4.13 0.522 4.08 640.3702 1,918.09 1,919.10 3
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% VLDSGAPIKIPVGPETLGR 95.00% 3.88 0.465 5.43 640.3705 1,918.09 1,919.10 3
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% VLDSGAPIKIPVGPETLGR 95.00% 4.09 0.462 3.96 640.7047 1,919.09 1,919.10 3
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% FTQAGSEVSALLGR 95.00% 3.04 0.486 4.54 718.3771 1,434.74 1,435.75 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% FTQAGSEVSALLGR 95.00% 3.79 0.557 4.02 718.38 1,434.74 1,435.75 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% FTQAGSEVSALLGR 95.00% 4.3 0.518 5.28 718.3803 1,434.74 1,435.75 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% FTQAGSEVSALLGR 95.00% 4.11 0.518 5.6 718.3806 1,434.75 1,435.75 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% TVLIMELINNVAK 95.00% 3.57 0.313 1.28 729.4295 1,456.84 1,457.84 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% TVLIMELINNVAK 95.00% 2.77 0.36 0 729.4335 1,456.85 1,457.84 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% LVLEVAQHLGESTVR 95.00% 4.59 0.474 4.92 825.9629 1,649.91 1,650.92 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% LVLEVAQHLGESTVR 95.00% 4.58 0.436 2.85 825.9647 1,649.91 1,650.92 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% VLDSGAPIKIPVGPETLGR 95.00% 4 0.548 3.47 960.05 1,918.08 1,919.10 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% VLDSGAPIKIPVGPETLGR 95.00% 4.83 0.504 3.28 960.5533 1,919.09 1,919.10 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% AIAELGIYPAVDPLDSTSR 95.00% 4.81 0.623 4.11 994.5166 1,987.02 1,988.03 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% AIAELGIYPAVDPLDSTSR 95.00% 3.4 0.574 2.38 994.5171 1,987.02 1,988.03 2
 SAMPLE 1 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 26 24.40% AIAELGIYPAVDPLDSTSR 95.00% 4.62 0.622 5.74 994.5172 1,987.02 1,988.03 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% IGLFGGAGVGK 95.00% 2.44 0.467 3.02 488.2825 974.5494 975.563 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% IGLFGGAGVGK 95.00% 2.66 0.454 2.59 488.2831 974.5506 975.563 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% IGLFGGAGVGK 95.00% 2.79 0.475 3.32 488.2836 974.5515 975.563 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% IGLFGGAGVGK 95.00% 3 0.457 3.22 488.2837 974.5517 975.563 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% VVDLLAPYAK 95.00% 2.63 0.413 0 544.8189 1,087.62 1,088.64 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% VVDLLAPYAK 95.00% 2.38 0.345 0 544.8191 1,087.62 1,088.64 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% VVDLLAPYAK 95.00% 2.3 0.326 0 544.8197 1,087.62 1,088.64 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% VVDLLAPYAK 95.00% 2.37 0.3 1.41 544.8199 1,087.62 1,088.64 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% IMDPNIVGSEHYDVAR 95.00% 3.35 0.34 0 605.9606 1,814.86 1,815.87 3 IMMT_HUMAN,HNRPU_HUMAN,CFAH_HUMAN
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% IMDPNIVGSEHYDVAR 95.00% 3.11 0.318 1.28 606.2949 1,815.86 1,815.87 3 IMMT_HUMAN,HNRPU_HUMAN,CFAH_HUMAN
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% TIAMDGTEGLVR 95.00% 2.44 0.368 1.92 631.8239 1,261.63 1,262.64 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% TIAMDGTEGLVR 95.00% 2.14 0.321 0 631.824 1,261.63 1,262.64 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% VLDSGAPIKIPVGPETLGR 95.00% 4.48 0.449 6.13 640.3691 1,918.08 1,919.10 3
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% VLDSGAPIKIPVGPETLGR 95.00% 4.17 0.516 4.34 640.7036 1,919.09 1,919.10 3
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% VLDSGAPIKIPVGPETLGR 95.00% 3.96 0.478 4.03 640.7037 1,919.09 1,919.10 3
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% VLDSGAPIKIPVGPETLGR 95.00% 4.06 0.363 5.42 640.7043 1,919.09 1,919.10 3
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% FLSQPFQVAEVFTGHMGK 95.00% 2.17 0.247 0 675.3406 2,023.00 2,023.01 3
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% FLSQPFQVAEVFTGHMGK 95.00% 2.4 0.315 0 675.3411 2,023.00 2,023.01 3
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% FTQAGSEVSALLGR 95.00% 4.35 0.521 5.24 718.3785 1,434.74 1,435.75 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% FTQAGSEVSALLGR 95.00% 4.27 0.553 4.15 718.379 1,434.74 1,435.75 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% FTQAGSEVSALLGR 95.00% 3.22 0.507 3.34 718.3793 1,434.74 1,435.75 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% FTQAGSEVSALLGR 95.00% 3.3 0.498 4.74 718.3805 1,434.75 1,435.75 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% VALTGLTVAEYFR 95.00% 3.73 0.466 2.62 720.398 1,438.78 1,439.79 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% VALTGLTVAEYFR 95.00% 3.12 0.385 3.49 720.3996 1,438.78 1,439.79 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% VALTGLTVAEYFR 95.00% 4.48 0.643 3.05 720.8988 1,439.78 1,439.79 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% TVLIMELINNVAK 95.00% 3.76 0.376 2.59 729.4215 1,456.83 1,457.84 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% TVLIMELINNVAK 95.00% 4.28 0.324 3.62 729.4221 1,456.83 1,457.84 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% TVLIMELINNVAK 95.00% 4.94 0.35 3 729.4225 1,456.83 1,457.84 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% TVLIMELINNVAK 95.00% 3.57 0.313 1.17 729.4295 1,456.84 1,457.84 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% TVLIMELINNVAK 95.00% 2.77 0.36 0 729.4335 1,456.85 1,457.84 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% VALVYGQMNEPPGAR 95.00% 1.7 0.474 2.05 801.0691 1,600.12 1,601.81 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% AIAELGIYPAVDPLDSTSR 95.00% 4.85 0.627 3.05 994.5179 1,987.02 1,988.03 2
 SAMPLE 1R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 10 10 31 30.20% AIAELGIYPAVDPLDSTSR 95.00% 5.3 0.621 2.74 995.0208 1,988.03 1,988.03 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% IGLFGGAGVGK 95.00% 3.21 0.44 2.25 488.2837 974.5517 975.563 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% IGLFGGAGVGK 95.00% 2.92 0.411 2.4 488.2841 974.5525 975.563 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% IGLFGGAGVGK 95.00% 2.82 0.418 2.07 488.2841 974.5526 975.563 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% IGLFGGAGVGK 95.00% 3.03 0.435 2.92 488.2845 974.5534 975.563 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% VVDLLAPYAK 95.00% 2.53 0.327 1.37 544.8196 1,087.62 1,088.64 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% VVDLLAPYAK 95.00% 2.62 0.316 0 544.8197 1,087.62 1,088.64 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% VVDLLAPYAK 95.00% 2.69 0.294 0 544.8199 1,087.62 1,088.64 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% VVDLLAPYAK 95.00% 2.74 0.368 1.92 544.8203 1,087.62 1,088.64 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% IMDPNIVGSEHYDVAR 95.00% 3.49 0.349 0 605.9598 1,814.86 1,815.87 3 IMMT_HUMAN,HNRPU_HUMAN,CFAH_HUMAN
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% IMDPNIVGSEHYDVAR 95.00% 2.75 0.271 0 606.2946 1,815.86 1,815.87 3 IMMT_HUMAN,HNRPU_HUMAN,CFAH_HUMAN
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% TIAMDGTEGLVR 95.00% 2.92 0.488 2.85 631.8232 1,261.63 1,262.64 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% TIAMDGTEGLVR 95.00% 2.49 0.462 2.07 631.8247 1,261.63 1,262.64 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% VLDSGAPIKIPVGPETLGR 95.00% 4.18 0.499 4.47 640.3687 1,918.08 1,919.10 3
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% VLDSGAPIKIPVGPETLGR 95.00% 3.74 0.44 4.29 640.3693 1,918.08 1,919.10 3
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% VLDSGAPIKIPVGPETLGR 95.00% 4.33 0.454 4.82 640.7037 1,919.09 1,919.10 3
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% VLDSGAPIKIPVGPETLGR 95.00% 4.4 0.463 4.66 640.7038 1,919.09 1,919.10 3
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% AHGGYSVFAGVGER 95.00% 2.89 0.472 3.38 703.8452 1,405.67 1,406.68 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% FTQAGSEVSALLGR 95.00% 4.06 0.594 4.1 718.3776 1,434.74 1,435.75 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% FTQAGSEVSALLGR 95.00% 4.49 0.585 4 718.3788 1,434.74 1,435.75 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% LVLEVAQHLGESTVR 95.00% 4.3 0.505 3.55 826.4637 1,650.91 1,650.92 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% LVLEVAQHLGESTVR 95.00% 2.55 0.471 1.55 826.635 1,651.25 1,650.92 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% VLDSGAPIKIPVGPETLGR 95.00% 3.7 0.491 1.7 960.5519 1,919.09 1,919.10 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% VLDSGAPIKIPVGPETLGR 95.00% 3.91 0.556 2.8 960.5527 1,919.09 1,919.10 2
 SAMPLE 2 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 9 22 24.60% AIAELGIYPAVDPLDSTSR 95.00% 4.58 0.579 3.35 995.0212 1,988.03 1,988.03 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% IGLFGGAGVGK 95.00% 2.44 0.413 2.92 488.2835 974.5513 975.563 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% IGLFGGAGVGK 95.00% 3.02 0.396 3.35 488.284 974.5523 975.563 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% IGLFGGAGVGK 95.00% 2.62 0.359 2.47 488.284 974.5523 975.563 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% IGLFGGAGVGK 95.00% 2.3 0.374 1.82 488.2845 974.5534 975.563 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% VVDLLAPYAK 95.00% 2.6 0.333 1.27 544.82 1,087.62 1,088.64 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% VVDLLAPYAK 95.00% 2.41 0.307 0 544.8202 1,087.62 1,088.64 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% IMDPNIVGSEHYDVAR 95.00% 2.78 0.296 0 606.2961 1,815.87 1,815.87 3 IMMT_HUMAN,HNRPU_HUMAN,CFAH_HUMAN
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% TIAMDGTEGLVR 95.00% 2.46 0.39 1.72 631.8218 1,261.63 1,262.64 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% VLDSGAPIKIPVGPETLGR 95.00% 4.07 0.454 4.46 640.7032 1,919.09 1,919.10 3
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% VLDSGAPIKIPVGPETLGR 95.00% 4.18 0.433 5.77 640.7037 1,919.09 1,919.10 3
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% VLDSGAPIKIPVGPETLGR 95.00% 3.92 0.534 3.51 640.7038 1,919.09 1,919.10 3
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% FTQAGSEVSALLGR 95.00% 3.92 0.566 3.66 718.3788 1,434.74 1,435.75 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% FTQAGSEVSALLGR 95.00% 3.28 0.466 5.72 718.3813 1,434.75 1,435.75 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% FTQAGSEVSALLGR 95.00% 3.5 0.533 3.85 718.3829 1,434.75 1,435.75 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% VALTGLTVAEYFR 95.00% 2.83 0.125 3.74 720.398 1,438.78 1,439.79 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% TVLIMELINNVAK 95.00% 4.05 0.316 1.28 729.4228 1,456.83 1,457.84 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% TVLIMELINNVAK 95.00% 3.74 0.314 2.92 729.4245 1,456.83 1,457.84 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% VALVYGQMNEPPGAR 95.00% 4.13 0.424 4.25 801.9082 1,601.80 1,601.81 2
 SAMPLE 2R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 8 8 18 23.30% VALVYGQMNEPPGAR 95.00% 4.07 0.441 3.1 801.9104 1,601.81 1,601.81 2
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% AHGGYSVFAGVGER 95.00% 2.81 0.242 0 469.566 1,405.67 1,406.68 3
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% IGLFGGAGVGK 95.00% 3.21 0.481 1.89 488.2838 974.5519 975.563 2
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% IGLFGGAGVGK 95.00% 2.99 0.452 2.77 488.2842 974.5527 975.563 2
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% VVDLLAPYAK 95.00% 2.74 0.395 1.6 544.8209 1,087.63 1,088.64 2
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% VVDLLAPYAK 95.00% 2.44 0.319 1.54 544.821 1,087.63 1,088.64 2
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% IMDPNIVGSEHYDVAR 95.00% 2.29 0.335 0 606.2928 1,815.85 1,815.87 3 IMMT_HUMAN,HNRPU_HUMAN,CFAH_HUMAN
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% IMDPNIVGSEHYDVAR 95.00% 2.43 0.355 1.09 606.2946 1,815.86 1,815.87 3 IMMT_HUMAN,HNRPU_HUMAN,CFAH_HUMAN
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% TIAMDGTEGLVR 95.00% 2.95 0.374 2.28 631.8235 1,261.63 1,262.64 2
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% VLDSGAPIKIPVGPETLGR 95.00% 3.78 0.45 6 640.3699 1,918.09 1,919.10 3
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% AHGGYSVFAGVGER 95.00% 3.59 0.616 7.09 703.8424 1,405.67 1,406.68 2
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% AHGGYSVFAGVGER 95.00% 3.48 0.655 5.46 703.8436 1,405.67 1,406.68 2
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% FTQAGSEVSALLGR 95.00% 4.39 0.574 3.82 718.3804 1,434.75 1,435.75 2
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% FTQAGSEVSALLGR 95.00% 4.62 0.508 3.92 718.8819 1,435.75 1,435.75 2
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% VLDSGAPIKIPVGPETLGR 95.00% 4.43 0.526 2.29 960.0484 1,918.08 1,919.10 2
 SAMPLE 3 ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 7 9 13 22.10% IPSAVGYQPTLATDMGTMQER 95.00% 5.73 0.651 6.92 1,134.05 2,266.08 2,266.09 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% IGLFGGAGVGK 95.00% 2.06 0.346 1.7 488.284 974.5523 975.563 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% IGLFGGAGVGK 95.00% 2.09 0.34 2.1 488.2844 974.5531 975.563 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% VVDLLAPYAK 95.00% 2.52 0.311 2.12 544.82 1,087.62 1,088.64 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% IMDPNIVGSEHYDVAR 95.00% 2.64 0.3 2.02 605.9611 1,814.86 1,815.87 3 IMMT_HUMAN,HNRPU_HUMAN,CFAH_HUMAN
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% IMDPNIVGSEHYDVAR 95.00% 2.39 0.38 1.08 606.2952 1,815.86 1,815.87 3 IMMT_HUMAN,HNRPU_HUMAN,CFAH_HUMAN
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% TIAMDGTEGLVR 95.00% 3.29 0.494 4.28 631.8233 1,261.63 1,262.64 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% TIAMDGTEGLVR 95.00% 2.89 0.411 3.4 631.8238 1,261.63 1,262.64 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% FLSQPFQVAEVFTGHMGK 95.00% 3.81 0.419 1.12 675.3418 2,023.00 2,023.01 3
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% FLSQPFQVAEVFTGHMGK 95.00% 3.26 0.343 1.11 675.3427 2,023.00 2,023.01 3
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% IMNVIGEPIDER 95.00% 3.05 0.364 0 693.8582 1,385.70 1,385.71 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% AHGGYSVFAGVGER 95.00% 2.68 0.456 2.66 703.843 1,405.67 1,406.68 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% FTQAGSEVSALLGR 95.00% 3.97 0.572 3.8 718.3788 1,434.74 1,435.75 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% FTQAGSEVSALLGR 95.00% 4 0.511 4.11 718.38 1,434.74 1,435.75 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% VALTGLTVAEYFR 95.00% 4.63 0.617 4.06 720.398 1,438.78 1,439.79 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% VALTGLTVAEYFR 95.00% 3.89 0.594 4.26 720.3994 1,438.78 1,439.79 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% VALVYGQMNEPPGAR 95.00% 4.79 0.521 5.77 801.407 1,600.80 1,601.81 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% VALVYGQMNEPPGAR 95.00% 4.64 0.523 6.34 801.411 1,600.81 1,601.81 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% VLDSGAPIKIPVGPETLGR 95.00% 4.26 0.503 2.51 960.5541 1,919.09 1,919.10 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% AIAELGIYPAVDPLDSTSR 95.00% 4.39 0.563 4.17 995.0184 1,988.02 1,988.03 2
 SAMPLE 3R ATP synthase subunit beta, mitochondrial  ATP5B  ATPB_HUMAN 56,542.50 100.00% 12 12 18 36.70% IPSAVGYQPTLATDMGTMQER 95.00% 0 0 6.92 1,134.55 2,267.08 2,266.09 2
 SAMPLE 2 ATP synthase subunit gamma, mitochondrial  ATP5C1  ATPG_HUMAN 32,980.00 100.00% 3 3 3 11.70% GLcGAIHSSIAK 95.00% 2.74 0.289 2.7 c3: Carbamidomethyl (+57.02) 607.3183 1,212.62 1,213.64 2
 SAMPLE 2 ATP synthase subunit gamma, mitochondrial  ATP5C1  ATPG_HUMAN 32,980.00 100.00% 3 3 3 11.70% THSDQFLVAFK 95.00% 2.02 0.349 2.34 646.8333 1,291.65 1,292.66 2
 SAMPLE 2 ATP synthase subunit gamma, mitochondrial  ATP5C1  ATPG_HUMAN 32,980.00 100.00% 3 3 3 11.70% IYGLGSLALYEK 95.00% 3.94 0.511 4.74 664.3617 1,326.71 1,326.73 2
 SAMPLE 2 ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 100.00% 3 3 5 16.00% YATALYSAASK 95.00% 2.7 0.378 3.49 573.2936 1,144.57 1,145.58 2
 SAMPLE 2 ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 100.00% 3 3 5 16.00% YATALYSAASK 95.00% 2.61 0.376 2.25 573.2954 1,144.58 1,145.58 2
 SAMPLE 2 ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 100.00% 3 3 5 16.00% VAASVLNPYVK 95.00% 3.79 0.565 2.44 580.8363 1,159.66 1,160.67 2
 SAMPLE 2 ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 100.00% 3 3 5 16.00% VAASVLNPYVK 95.00% 3.73 0.55 3.11 580.8374 1,159.66 1,160.67 2
 SAMPLE 2 ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 100.00% 3 3 5 16.00% TDPSILGGMIVR 95.00% 2.53 0.312 2.27 629.844 1,257.67 1,258.68 2
 SAMPLE 2R ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 99.80% 2 2 3 10.30% YATALYSAASK 95.00% 2.43 0.25 1.55 573.2932 1,144.57 1,145.58 2
 SAMPLE 2R ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 99.80% 2 2 3 10.30% VAASVLNPYVK 95.00% 2.81 0.425 0 580.8364 1,159.66 1,160.67 2
 SAMPLE 2R ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 99.80% 2 2 3 10.30% VAASVLNPYVK 95.00% 2.41 0.299 1.37 580.8373 1,159.66 1,160.67 2
 SAMPLE 3 ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 99.80% 2 2 4 10.30% YATALYSAASK 95.00% 3 0.394 3.6 573.2931 1,144.57 1,145.58 2
 SAMPLE 3 ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 99.80% 2 2 4 10.30% YATALYSAASK 95.00% 2.26 0.294 2.64 573.294 1,144.57 1,145.58 2
 SAMPLE 3 ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 99.80% 2 2 4 10.30% VAASVLNPYVK 95.00% 3.3 0.466 1.14 580.836 1,159.66 1,160.67 2
 SAMPLE 3 ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 99.80% 2 2 4 10.30% VAASVLNPYVK 95.00% 3.49 0.514 1.15 580.8365 1,159.66 1,160.67 2
 SAMPLE 3R ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 99.80% 2 2 4 10.30% YATALYSAASK 95.00% 2.64 0.34 1.66 573.2935 1,144.57 1,145.58 2
 SAMPLE 3R ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 99.80% 2 2 4 10.30% YATALYSAASK 95.00% 2.51 0.318 3.07 573.2952 1,144.57 1,145.58 2
 SAMPLE 3R ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 99.80% 2 2 4 10.30% VAASVLNPYVK 95.00% 2.32 0.321 0 580.8359 1,159.66 1,160.67 2
 SAMPLE 3R ATP synthase subunit O, mitochondrial  ATP5O  ATPO_HUMAN 23,259.40 99.80% 2 2 4 10.30% VAASVLNPYVK 95.00% 2.69 0.341 0 580.8382 1,159.66 1,160.67 2
 SAMPLE 1 ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 100.00% 4 4 5 6.35% ELLIIGGVAAR 95.00% 2.84 0.458 3.92 556.3429 1,110.67 1,111.68 2
 SAMPLE 1 ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 100.00% 4 4 5 6.35% FLIcTDVAAR 95.00% 2.33 0.422 1.77 c4: Carbamidomethyl (+57.02) 583.3046 1,164.59 1,165.60 2
 SAMPLE 1 ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 100.00% 4 4 5 6.35% FLIcTDVAAR 95.00% 2.47 0.354 1.59 c4: Carbamidomethyl (+57.02) 583.305 1,164.59 1,165.60 2
 SAMPLE 1 ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 100.00% 4 4 5 6.35% HYYEVScHDQGLcR 95.00% 3.28 0.504 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 608.9233 1,823.75 1,823.76 3
 SAMPLE 1 ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 100.00% 4 4 5 6.35% MGLAISLVATEK 95.00% 1.81 0.396 0 616.3347 1,230.65 1,232.69 2
 SAMPLE 1R ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 100.00% 4 5 6 7.16% FLIcTDVAAR 95.00% 2.36 0.378 2.68 c4: Carbamidomethyl (+57.02) 583.3044 1,164.59 1,165.60 2
 SAMPLE 1R ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 100.00% 4 5 6 7.16% HYYEVScHDQGLcR 95.00% 3.38 0.499 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 608.9235 1,823.75 1,823.76 3
 SAMPLE 1R ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 100.00% 4 5 6 7.16% GHVDILAPTVQELAALEK 95.00% 3.47 0.426 1.38 635.686 1,904.03 1,904.05 3
 SAMPLE 1R ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 100.00% 4 5 6 7.16% GHVDILAPTVQELAALEK 95.00% 3.29 0.433 0 635.6872 1,904.04 1,904.05 3
 SAMPLE 1R ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 100.00% 4 5 6 7.16% ELAEQTLNNIK 95.00% 2.69 0.333 1.2 636.8438 1,271.67 1,272.68 2
 SAMPLE 1R ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 100.00% 4 5 6 7.16% GHVDILAPTVQELAALEK 95.00% 4.78 0.491 4.07 953.025 1,904.03 1,904.05 2
 SAMPLE 2 ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 99.80% 2 2 3 3.24% FLIcTDVAAR 95.00% 2.49 0.253 0 c4: Carbamidomethyl (+57.02) 583.304 1,164.59 1,165.60 2
 SAMPLE 2 ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 99.80% 2 2 3 3.24% FLIcTDVAAR 95.00% 2.37 0.285 1.66 c4: Carbamidomethyl (+57.02) 583.3058 1,164.60 1,165.60 2
 SAMPLE 2 ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 99.80% 2 2 3 3.24% HYYEVScHDQGLcR 95.00% 2.87 0.496 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 608.592 1,822.75 1,823.76 3
 SAMPLE 2R ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 99.80% 2 2 3 2.84% ELLIIGGVAAR 95.00% 2.5 0.337 2.37 556.3454 1,110.68 1,111.68 2
 SAMPLE 2R ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 99.80% 2 2 3 2.84% FLIcTDVAAR 95.00% 2.41 0.356 1.68 c4: Carbamidomethyl (+57.02) 583.3054 1,164.60 1,165.60 2
 SAMPLE 2R ATP-dependent RNA helicase DDX1  DDX1  DDX1_HUMAN 82,415.10 99.80% 2 2 3 2.84% FLIcTDVAAR 95.00% 2.51 0.333 1.27 c4: Carbamidomethyl (+57.02) 583.3054 1,164.60 1,165.60 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 4.15 0.402 1.48 481.5857 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 3.18 0.362 0 481.5858 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 4.48 0.433 1.89 481.586 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 3.45 0.481 0 481.586 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 4.26 0.391 2.17 481.5861 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 4.14 0.414 1.8 481.5861 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 3.23 0.409 0 481.5862 1,441.74 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 4.46 0.489 1.51 481.5862 1,441.74 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 3.55 0.486 1.19 481.5869 1,441.74 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 2.21 0.305 0 481.5869 1,441.74 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 4.19 0.456 1.66 481.5872 1,441.74 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 4 0.397 1.4 481.5872 1,441.74 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 3.16 0.242 0 481.7579 1,442.25 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 3.81 0.43 1.64 481.9205 1,442.74 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% RPEEVcGPTQFR 95.00% 2.48 0.329 0 c6: Carbamidomethyl (+57.02) 492.9094 1,475.70 1,475.71 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LGTVPQFPR 95.00% 2.29 0.319 1.7 507.795 1,013.57 1,014.57 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LGTVPQFPR 95.00% 2.71 0.301 2.01 507.7951 1,013.57 1,014.57 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% FLGDKVTSYGGELR 95.00% 2.72 0.237 1.03 514.6033 1,540.79 1,541.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% FLGDKVTSYGGELR 95.00% 2.59 0.365 0 514.6033 1,540.79 1,541.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% FLGDKVTSYGGELR 95.00% 2.86 0.379 1.8 514.6041 1,540.79 1,541.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% FLGDKVTSYGGELR 95.00% 3.02 0.305 0 514.6041 1,540.79 1,541.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% FLGDKVTSYGGELR 95.00% 3.55 0.419 3.25 514.6055 1,540.79 1,541.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% FLGDKVTSYGGELR 95.00% 2.72 0.264 0 514.6082 1,540.80 1,541.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LDGSLPPDSR 95.00% 2.35 0.286 1.85 528.7697 1,055.52 1,056.53 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% NELLHFER 95.00% 2.55 0.165 0 529.274 1,056.53 1,057.54 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VAEGQTLDLK 95.00% 2.51 0.434 1.96 537.2958 1,072.58 1,073.58 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VAEGQTLDLK 95.00% 2.53 0.458 1.35 537.2975 1,072.58 1,073.58 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 3.22 0.424 0 562.937 1,685.79 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 3.92 0.501 2.8 563.3279 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 4.33 0.573 2.29 563.3295 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 4.95 0.552 3.4 563.3295 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 3.81 0.466 4.07 563.3296 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 5.09 0.567 2.85 563.33 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 5.21 0.555 3.96 563.33 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 4.88 0.505 2.74 563.3301 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 3.88 0.459 2.46 563.3301 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 4.53 0.513 2.28 563.3303 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 3.51 0.447 3.52 563.3304 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 4.46 0.504 2.42 563.3311 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 3.54 0.447 1.85 563.3314 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 4.75 0.564 4.06 563.3318 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 5.11 0.54 2.8 563.663 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 4.63 0.508 2.82 563.6638 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 4.01 0.531 3.05 563.6641 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 4.56 0.534 3.06 563.6646 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 4.04 0.427 1.17 563.6647 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 4.5 0.468 2.57 563.6653 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 3.86 0.49 2.08 563.6655 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 3.47 0.438 0 563.6656 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 4.16 0.47 5.32 c14: Carbamidomethyl (+57.02) 568.28 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 4.06 0.499 3.01 c14: Carbamidomethyl (+57.02) 568.2805 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 3.89 0.442 2.09 c14: Carbamidomethyl (+57.02) 568.2806 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 3.88 0.383 4.11 c14: Carbamidomethyl (+57.02) 568.2808 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 4.24 0.524 3.77 c14: Carbamidomethyl (+57.02) 568.2808 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 2.84 0.404 0 c14: Carbamidomethyl (+57.02) 568.2811 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 4.1 0.476 2.96 c14: Carbamidomethyl (+57.02) 568.2811 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 4.06 0.393 3.47 c14: Carbamidomethyl (+57.02) 568.2812 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 4.25 0.5 5.47 c14: Carbamidomethyl (+57.02) 568.2813 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 3.67 0.407 3.42 c14: Carbamidomethyl (+57.02) 568.2824 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 4.39 0.555 2.24 c14: Carbamidomethyl (+57.02) 568.614 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 4.8 0.559 3.41 c14: Carbamidomethyl (+57.02) 568.6142 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 4.91 0.54 4.96 c14: Carbamidomethyl (+57.02) 568.6153 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 4.45 0.573 4.02 c14: Carbamidomethyl (+57.02) 568.6153 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LLQVTPADSGEYVcR 95.00% 3.76 0.307 0 c14: Carbamidomethyl (+57.02) 569.9777 1,706.91 1,707.84 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLIHDGAAPISLEWK 95.00% 2.81 0.396 0 c1: Carbamidomethyl (+57.02) 570.963 1,709.87 1,709.87 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLIHDGAAPISLEWK 95.00% 2.68 0.253 0 c1: Carbamidomethyl (+57.02) 570.9632 1,709.87 1,709.87 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 4.99 0.412 4.4 c14: Carbamidomethyl (+57.02) 576.2698 1,725.79 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 5.44 0.397 2.66 c14: Carbamidomethyl (+57.02) 576.2719 1,725.79 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 4.97 0.426 3.04 c14: Carbamidomethyl (+57.02) 576.272 1,725.79 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 5.37 0.451 2.66 c14: Carbamidomethyl (+57.02) 576.2723 1,725.79 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 4.66 0.399 3.7 c14: Carbamidomethyl (+57.02) 576.2724 1,725.79 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 3.72 0.364 2.52 c14: Carbamidomethyl (+57.02) 576.2727 1,725.79 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 4.7 0.35 2.57 c14: Carbamidomethyl (+57.02) 576.2731 1,725.80 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 5.06 0.398 2.82 c14: Carbamidomethyl (+57.02) 576.274 1,725.80 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 4.72 0.423 3.54 c14: Carbamidomethyl (+57.02) 576.2747 1,725.80 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 2.86 0.399 0 c14: Carbamidomethyl (+57.02) 576.6055 1,726.79 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 4.93 0.401 2.4 c14: Carbamidomethyl (+57.02) 576.606 1,726.79 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 5.09 0.46 3.07 c14: Carbamidomethyl (+57.02) 576.6061 1,726.79 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 5.49 0.416 3.21 c14: Carbamidomethyl (+57.02) 576.6063 1,726.80 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 4.85 0.394 2.82 c14: Carbamidomethyl (+57.02) 576.6065 1,726.80 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 4.46 0.349 3.72 c14: Carbamidomethyl (+57.02) 576.6065 1,726.80 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 4.8 0.342 2.59 c14: Carbamidomethyl (+57.02) 576.6069 1,726.80 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 4.78 0.348 3.62 c14: Carbamidomethyl (+57.02) 576.6071 1,726.80 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 4.99 0.337 2 c14: Carbamidomethyl (+57.02) 576.6076 1,726.80 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 3.62 0.399 1.72 c14: Carbamidomethyl (+57.02) 576.6085 1,726.80 1,726.80 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SIGASVEFHcAVPSDR 95.00% 2.79 0.166 0 c10: Carbamidomethyl (+57.02) 577.9434 1,730.81 1,731.81 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SIGASVEFHcAVPSDR 95.00% 2.26 0.313 0 c10: Carbamidomethyl (+57.02) 577.9446 1,730.81 1,731.81 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SIGASVEFHcAVPSDR 95.00% 2.14 0.241 0 c10: Carbamidomethyl (+57.02) 578.2762 1,731.81 1,731.81 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SIGASVEFHcAVPSDR 95.00% 3.33 0.346 1.05 c10: Carbamidomethyl (+57.02) 578.277 1,731.81 1,731.81 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SIGASVEFHcAVPSDR 95.00% 2.82 0.306 2.03 c10: Carbamidomethyl (+57.02) 578.2772 1,731.81 1,731.81 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AFAHLQVPER 95.00% 3.31 0.335 1.77 584.3167 1,166.62 1,167.63 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AFAHLQVPER 95.00% 3.22 0.402 0 584.318 1,166.62 1,167.63 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AFAHLQVPER 95.00% 3.34 0.381 2.66 584.3183 1,166.62 1,167.63 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AFAHLQVPER 95.00% 3.1 0.38 2.49 584.3187 1,166.62 1,167.63 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AFAHLQVPER 95.00% 3.4 0.34 1.54 584.3189 1,166.62 1,167.63 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AFAHLQVPER 95.00% 3.31 0.365 0 584.3189 1,166.62 1,167.63 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AFAHLQVPER 95.00% 3.03 0.402 1.28 584.3199 1,166.62 1,167.63 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AFAHLQVPER 95.00% 3.34 0.371 0 584.3205 1,166.63 1,167.63 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHQMSVADSGEYVcR 95.00% 4.33 0.448 1.03 c14: Carbamidomethyl (+57.02) 584.6013 1,750.78 1,751.78 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AFAHLQVPER 95.00% 2.35 0.281 1.52 584.961 1,167.91 1,167.63 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AFAHLQVPER 94.60% 2.07 0.207 1.39 584.9614 1,167.91 1,167.63 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GDLcEHEENPcQLR 95.00% 2.83 0.19 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.2521 1,755.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GDLcEHEENPcQLR 95.00% 2.72 0.192 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.5871 1,756.74 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% YELGSGLAVLR 95.00% 3.49 0.486 4.05 589.3331 1,176.65 1,177.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% YELGSGLAVLR 95.00% 3.62 0.536 5.7 589.3336 1,176.65 1,177.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% YELGSGLAVLR 95.00% 3.65 0.52 4.92 589.3339 1,176.65 1,177.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% YELGSGLAVLR 95.00% 3.49 0.496 4.57 589.3339 1,176.65 1,177.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% YELGSGLAVLR 95.00% 3.48 0.492 4.85 589.334 1,176.65 1,177.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% YELGSGLAVLR 95.00% 3.54 0.504 4.39 589.3341 1,176.65 1,177.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% YELGSGLAVLR 95.00% 3.24 0.458 5.85 589.3341 1,176.65 1,177.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% YELGSGLAVLR 95.00% 3.12 0.456 3.12 589.3343 1,176.65 1,177.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% YELGSGLAVLR 95.00% 3.64 0.505 3.47 589.3343 1,176.65 1,177.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% YELGSGLAVLR 95.00% 3.52 0.503 4.51 589.3347 1,176.65 1,177.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% YELGSGLAVLR 95.00% 3.37 0.488 4.66 589.3349 1,176.65 1,177.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% YELGSGLAVLR 95.00% 3.05 0.435 3.18 589.3349 1,176.65 1,177.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LcNEcADGSFHLSTR 95.00% 4.39 0.363 2.12 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5925 1,765.75 1,766.76 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LcNEcADGSFHLSTR 95.00% 3.89 0.36 2.85 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5927 1,765.75 1,766.76 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.56 0.584 3.44 597.3188 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.52 0.606 3.05 597.319 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.56 0.577 3.07 597.3192 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 2.71 0.508 1.49 597.3197 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.98 0.617 3.02 597.3197 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.77 0.609 2.2 597.3202 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.77 0.588 3.12 597.3203 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.7 0.592 3.38 597.3203 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.9 0.597 2.04 597.3205 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.82 0.593 3.11 597.3206 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.56 0.606 2.48 597.3206 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.87 0.601 2.8 597.3207 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.67 0.583 2.66 597.3207 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.64 0.576 3.51 597.3208 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.95 0.525 2.85 597.321 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.42 0.592 2.28 597.3214 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 3.78 0.617 3.4 597.3218 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPAYTLVWTR 95.00% 2.68 0.473 0 597.643 1,193.27 1,193.63 2 LU_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 3.87 0.453 4.46 c10: Carbamidomethyl (+57.02) 612.315 1,222.61 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 4.11 0.475 3.28 c10: Carbamidomethyl (+57.02) 612.3152 1,222.61 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 3.94 0.471 4.11 c10: Carbamidomethyl (+57.02) 612.3152 1,222.61 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 4.26 0.515 3.39 c10: Carbamidomethyl (+57.02) 612.3152 1,222.61 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 4 0.448 3.96 c10: Carbamidomethyl (+57.02) 612.3153 1,222.62 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 3.95 0.48 4.1 c10: Carbamidomethyl (+57.02) 612.3154 1,222.62 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 4.16 0.505 4.25 c10: Carbamidomethyl (+57.02) 612.3156 1,222.62 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 4.13 0.51 3.96 c10: Carbamidomethyl (+57.02) 612.3156 1,222.62 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 3.04 0.465 4.06 c10: Carbamidomethyl (+57.02) 612.3158 1,222.62 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 3.95 0.475 3.89 c10: Carbamidomethyl (+57.02) 612.3159 1,222.62 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 4.07 0.494 4.05 c10: Carbamidomethyl (+57.02) 612.3159 1,222.62 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 3.68 0.478 4.24 c10: Carbamidomethyl (+57.02) 612.3161 1,222.62 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 3.7 0.473 3.15 c10: Carbamidomethyl (+57.02) 612.3167 1,222.62 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AGLSSGFIGcVR 95.00% 3.72 0.423 1.46 c10: Carbamidomethyl (+57.02) 612.318 1,222.62 1,223.62 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.37 0.463 3.42 c14: Carbamidomethyl (+57.02) 612.9811 1,835.92 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 3.09 0.376 0 c14: Carbamidomethyl (+57.02) 612.9831 1,835.93 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.48 0.495 0 c14: Carbamidomethyl (+57.02) 613.3157 1,836.92 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.58 0.576 2.74 c14: Carbamidomethyl (+57.02) 613.3166 1,836.93 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.8 0.491 2.17 c14: Carbamidomethyl (+57.02) 613.3166 1,836.93 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.68 0.571 3.26 c14: Carbamidomethyl (+57.02) 613.3168 1,836.93 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.08 0.535 2.85 c14: Carbamidomethyl (+57.02) 613.317 1,836.93 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 3.37 0.431 2.82 c14: Carbamidomethyl (+57.02) 613.317 1,836.93 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.62 0.51 3.92 c14: Carbamidomethyl (+57.02) 613.3176 1,836.93 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 3.98 0.533 2.04 c14: Carbamidomethyl (+57.02) 613.3176 1,836.93 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.24 0.483 1.89 c14: Carbamidomethyl (+57.02) 613.3179 1,836.93 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 3.52 0.468 1.4 c14: Carbamidomethyl (+57.02) 613.3185 1,836.93 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 3.44 0.454 3.2 c14: Carbamidomethyl (+57.02) 613.3186 1,836.93 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.47 0.526 3.28 c14: Carbamidomethyl (+57.02) 613.3191 1,836.93 1,836.93 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AAGVPSATITWR 95.00% 1.91 0.345 1.89 615.3365 1,228.66 1,229.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AAGVPSATITWR 95.00% 2.11 0.434 2.85 615.3372 1,228.66 1,229.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AAGVPSATITWR 95.00% 2.21 0.436 4.15 615.3374 1,228.66 1,229.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AAGVPSATITWR 95.00% 2.65 0.477 3.77 615.3376 1,228.66 1,229.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AAGVPSATITWR 95.00% 2.06 0.294 0 615.3378 1,228.66 1,229.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AAGVPSATITWR 95.00% 1.9 0.337 2.26 615.3379 1,228.66 1,229.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AAGVPSATITWR 95.00% 2.53 0.397 2.24 615.3379 1,228.66 1,229.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AAGVPSATITWR 95.00% 1.86 0.306 1.54 615.3382 1,228.66 1,229.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AAGVPSATITWR 95.00% 2.52 0.401 1.8 615.3398 1,228.66 1,229.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cQVSGSPPHYFYWSR 95.00% 2.44 0.31 0 c1: Carbamidomethyl (+57.02) 624.2852 1,869.83 1,870.83 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% QPQAIITWYK 95.00% 1.82 0.334 0 624.344 1,246.67 1,247.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% QPQAIITWYK 95.00% 1.82 0.341 0 624.3441 1,246.67 1,247.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% QPQAIITWYK 95.00% 1.77 0.342 0 624.3447 1,246.67 1,247.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% QPQAIITWYK 95.00% 1.77 0.336 0 624.3448 1,246.67 1,247.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% QPQAIITWYK 95.00% 1.81 0.345 0 624.3449 1,246.67 1,247.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% QPQAIITWYK 95.00% 1.78 0.308 0 624.3449 1,246.67 1,247.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% QPQAIITWYK 95.00% 1.79 0.28 1.34 624.3468 1,246.68 1,247.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cQVSGSPPHYFYWSR 95.00% 2.04 0.262 0 c1: Carbamidomethyl (+57.02) 624.6193 1,870.83 1,870.83 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AMDFNGILTIR 95.00% 2.57 0.447 0 625.8325 1,249.65 1,250.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AMDFNGILTIR 95.00% 3.68 0.538 2.43 625.8335 1,249.65 1,250.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AMDFNGILTIR 95.00% 3.29 0.557 1.8 625.8337 1,249.65 1,250.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AMDFNGILTIR 95.00% 3.64 0.523 2.68 625.834 1,249.65 1,250.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AMDFNGILTIR 95.00% 3.55 0.553 2.32 625.8341 1,249.65 1,250.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AMDFNGILTIR 95.00% 3.84 0.457 2.68 625.8343 1,249.65 1,250.66 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLcLPGFSGPR 95.00% 2.78 0.391 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3032 1,262.59 1,263.60 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLcLPGFSGPR 95.00% 2.47 0.323 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3039 1,262.59 1,263.60 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLcLPGFSGPR 95.00% 2.67 0.323 2.55 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3045 1,262.59 1,263.60 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLcLPGFSGPR 95.00% 2.56 0.325 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3053 1,262.60 1,263.60 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLcLPGFSGPR 95.00% 2.79 0.403 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3055 1,262.60 1,263.60 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLcLPGFSGPR 95.00% 2.71 0.412 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3056 1,262.60 1,263.60 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLcLPGFSGPR 95.00% 2.5 0.176 1.24 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3056 1,262.60 1,263.60 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLcLPGFSGPR 95.00% 2.35 0.241 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.8056 1,263.60 1,263.60 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 3.37 0.48 1.85 m2: Oxidation (+15.99) 633.8294 1,265.64 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 3.07 0.331 1.15 m2: Oxidation (+15.99) 633.8294 1,265.64 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 2.82 0.478 2.4 m2: Oxidation (+15.99) 633.8296 1,265.64 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 3.5 0.499 2.96 m2: Oxidation (+15.99) 633.8296 1,265.64 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 3.26 0.6 2 m2: Oxidation (+15.99) 633.8305 1,265.65 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 3.23 0.473 2.29 m2: Oxidation (+15.99) 633.8307 1,265.65 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 3.64 0.548 3.96 m2: Oxidation (+15.99) 633.8308 1,265.65 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 3.84 0.576 1.82 m2: Oxidation (+15.99) 633.8309 1,265.65 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 3.99 0.54 2.82 m2: Oxidation (+15.99) 633.8311 1,265.65 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 3.57 0.589 1.92 m2: Oxidation (+15.99) 633.8315 1,265.65 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 3.73 0.538 3.35 m2: Oxidation (+15.99) 634.332 1,266.65 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 3.16 0.459 0 m2: Oxidation (+15.99) 634.3432 1,266.67 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AmDFNGILTIR 95.00% 3.85 0.472 0 m2: Oxidation (+15.99) 634.3473 1,266.68 1,266.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% PGADVTFIcTAK 95.00% 2.89 0.55 0 c9: Carbamidomethyl (+57.02) 640.3239 1,278.63 1,279.64 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% PGADVTFIcTAK 95.00% 3.13 0.617 0 c9: Carbamidomethyl (+57.02) 640.3249 1,278.63 1,279.64 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% QPDFISFGLVGGRPEFR 95.00% 2.02 0.31 0 641.3357 1,920.98 1,921.99 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% QPDFISFGLVGGRPEFR 95.00% 2.32 0.484 1.11 641.6711 1,921.99 1,921.99 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% QPDFISFGLVGGRPEFR 95.00% 2.19 0.331 0 641.6733 1,922.00 1,921.99 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% QPDFISFGLVGGRPEFR 95.00% 2.1 0.383 0 641.6733 1,922.00 1,921.99 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LRLPQVSPADSGEYVcR 95.00% 4.02 0.521 3.24 c16: Carbamidomethyl (+57.02) 649.6659 1,945.97 1,946.98 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LRLPQVSPADSGEYVcR 95.00% 4.6 0.564 5.48 c16: Carbamidomethyl (+57.02) 649.9981 1,946.97 1,946.98 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LRLPQVSPADSGEYVcR 95.00% 5.65 0.553 5.2 c16: Carbamidomethyl (+57.02) 650.0001 1,946.98 1,946.98 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LRLPQVSPADSGEYVcR 95.00% 4.25 0.549 2.77 c16: Carbamidomethyl (+57.02) 650.0002 1,946.98 1,946.98 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LRLPQVSPADSGEYVcR 95.00% 5.63 0.505 6.08 c16: Carbamidomethyl (+57.02) 650.0002 1,946.98 1,946.98 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LRLPQVSPADSGEYVcR 95.00% 4.62 0.624 4.28 c16: Carbamidomethyl (+57.02) 650.0003 1,946.98 1,946.98 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LRLPQVSPADSGEYVcR 95.00% 4.95 0.606 7.43 c16: Carbamidomethyl (+57.02) 650.0005 1,946.98 1,946.98 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 3.99 0.394 0 653.6904 1,958.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 4.37 0.422 0 653.6909 1,958.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 3.09 0.386 0 653.6909 1,958.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 3.57 0.347 0 653.6909 1,958.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 3.68 0.407 0 653.6909 1,958.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYIFQASPADAGQYVcR 95.00% 3.5 0.494 0 c16: Carbamidomethyl (+57.02) 653.9886 1,958.94 1,958.94 3 DOCK9_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYIFQASPADAGQYVcR 95.00% 2.48 0.276 0 c16: Carbamidomethyl (+57.02) 653.989 1,958.94 1,958.94 3 DOCK9_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 2.86 0.196 0 654.0236 1,959.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 3.95 0.43 0 654.0239 1,959.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 4.24 0.335 1.14 654.0242 1,959.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 3.33 0.231 0 654.0246 1,959.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 4.36 0.378 0 654.0246 1,959.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 4.45 0.395 0 654.025 1,959.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 4.42 0.373 0 654.0251 1,959.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 3.8 0.365 0 654.0255 1,959.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 4.52 0.385 0 654.0261 1,959.05 1,959.05 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% TPSGLYLGTcER 95.00% 3.79 0.453 4.33 c10: Carbamidomethyl (+57.02) 677.3277 1,352.64 1,353.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% TPSGLYLGTcER 95.00% 3.91 0.456 3.7 c10: Carbamidomethyl (+57.02) 677.3283 1,352.64 1,353.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% TPSGLYLGTcER 95.00% 3.2 0.408 2 c10: Carbamidomethyl (+57.02) 677.3284 1,352.64 1,353.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% TPSGLYLGTcER 95.00% 3.96 0.421 4.2 c10: Carbamidomethyl (+57.02) 677.3287 1,352.64 1,353.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% TPSGLYLGTcER 95.00% 3.97 0.443 4.1 c10: Carbamidomethyl (+57.02) 677.3288 1,352.64 1,353.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% TPSGLYLGTcER 95.00% 4.09 0.429 3.92 c10: Carbamidomethyl (+57.02) 677.3289 1,352.64 1,353.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% TPSGLYLGTcER 95.00% 3.98 0.422 3.33 c10: Carbamidomethyl (+57.02) 677.3289 1,352.64 1,353.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% TPSGLYLGTcER 95.00% 3.9 0.411 3.96 c10: Carbamidomethyl (+57.02) 677.3293 1,352.64 1,353.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% TPSGLYLGTcER 95.00% 3.44 0.418 1.59 c10: Carbamidomethyl (+57.02) 677.3338 1,352.65 1,353.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% TPSGLYLGTcER 95.00% 3.97 0.425 1.19 c10: Carbamidomethyl (+57.02) 677.3365 1,352.66 1,353.65 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GmLEPVQRPDVVLVGAGYR 95.00% 1.53 0.258 2.35 m2: Oxidation (+15.99) 691.3696 2,071.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GmLEPVQRPDVVLVGAGYR 95.00% 2.1 0.272 1.96 m2: Oxidation (+15.99) 691.3716 2,071.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GmLEPVQRPDVVLVGAGYR 95.00% 2.4 0.258 2.1 m2: Oxidation (+15.99) 691.7047 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GmLEPVQRPDVVLVGAGYR 95.00% 2.89 0.41 2.08 m2: Oxidation (+15.99) 691.7053 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GmLEPVQRPDVVLVGAGYR 95.00% 3.62 0.523 3.62 m2: Oxidation (+15.99) 691.7054 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GmLEPVQRPDVVLVGAGYR 95.00% 2.17 0.422 2.27 m2: Oxidation (+15.99) 691.7059 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GmLEPVQRPDVVLVGAGYR 95.00% 2.14 0.319 1.24 m2: Oxidation (+15.99) 691.7075 2,072.10 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GmLEPVQRPDVVLVGAGYR 95.00% 3.78 0.55 3.85 m2: Oxidation (+15.99) 691.7078 2,072.10 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% RcEScAPGYEGNPIQPGGK 95.00% 2.3 0.36 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3156 2,076.92 2,076.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AVTLEcVSAGEPR 95.00% 2.2 0.433 2.34 c6: Carbamidomethyl (+57.02) 694.8457 1,387.68 1,388.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AVTLEcVSAGEPR 95.00% 3.2 0.466 3.17 c6: Carbamidomethyl (+57.02) 694.8469 1,387.68 1,388.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AVTLEcVSAGEPR 95.00% 2.33 0.373 3.23 c6: Carbamidomethyl (+57.02) 694.847 1,387.68 1,388.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AVTLEcVSAGEPR 95.00% 2 0.237 2.32 c6: Carbamidomethyl (+57.02) 694.8471 1,387.68 1,388.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AVTLEcVSAGEPR 95.00% 2.02 0.301 2.72 c6: Carbamidomethyl (+57.02) 694.8481 1,387.68 1,388.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 3.18 0.551 2.21 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.978 2,081.91 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 4.11 0.475 3.89 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.9788 2,081.91 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 3.05 0.55 1.89 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.9791 2,081.91 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 2.23 0.263 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.9792 2,081.91 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 2.44 0.298 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3096 2,082.91 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 3.58 0.474 2.46 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3112 2,082.91 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 3.3 0.422 1.39 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3114 2,082.91 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 3.12 0.468 1.15 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3118 2,082.91 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 2.78 0.475 0.959 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.312 2,082.91 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 3.61 0.455 3 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.312 2,082.91 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 3.73 0.484 2.21 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3137 2,082.92 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 3.61 0.421 2.35 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3138 2,082.92 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 3.59 0.469 3.33 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3143 2,082.92 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 2.6 0.316 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3145 2,082.92 2,082.92 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AVTLEcVSAGEPR 95.00% 3.51 0.477 3.08 c6: Carbamidomethyl (+57.02) 695.3495 1,388.68 1,388.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AVTLEcVSAGEPR 95.00% 3.09 0.46 3.05 c6: Carbamidomethyl (+57.02) 695.3506 1,388.69 1,388.68 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IPGDQVVSVVFIK 95.00% 4.33 0.538 2.42 700.912 1,399.81 1,400.82 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IPGDQVVSVVFIK 95.00% 4.26 0.483 3.59 700.9131 1,399.81 1,400.82 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IPGDQVVSVVFIK 95.00% 3.47 0.509 4.09 700.9131 1,399.81 1,400.82 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IPGDQVVSVVFIK 95.00% 3.82 0.528 2.62 701.4155 1,400.82 1,400.82 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 3.6 0.486 3.2 721.8736 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 3.77 0.486 4.6 721.8736 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 3.73 0.529 4.38 721.875 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 4.17 0.518 5.77 721.8759 1,441.74 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 4.24 0.506 3.28 721.8764 1,441.74 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IAHVELADAGQYR 95.00% 4.07 0.468 4.77 721.8772 1,441.74 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPVISIDPPSSTVQQGQDASFK 95.00% 3.59 0.518 0 763.7212 2,288.14 2,288.14 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.8 0.616 1.6 771.092 2,310.25 2,310.26 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.46 0.656 3.06 771.0922 2,310.25 2,310.26 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AELLVTEAPSKPITVTVEEQR 95.00% 7.02 0.633 2.74 771.0923 2,310.25 2,310.26 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.09 0.642 3.59 771.0925 2,310.25 2,310.26 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.09 0.614 3.1 771.0931 2,310.26 2,310.26 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AELLVTEAPSKPITVTVEEQR 95.00% 4.34 0.54 2.44 771.0932 2,310.26 2,310.26 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.25 0.633 3.17 771.0936 2,310.26 2,310.26 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.87 0.61 2.68 771.0941 2,310.26 2,310.26 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SIEYSPQLEDAGSR 95.00% 3.77 0.535 3.41 776.3698 1,550.72 1,551.73 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SIEYSPQLEDAGSR 95.00% 4.33 0.599 5.02 776.3711 1,550.73 1,551.73 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SIEYSPQLEDAGSR 95.00% 4.17 0.535 3.08 776.3712 1,550.73 1,551.73 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SIEYSPQLEDAGSR 95.00% 2.57 0.513 0 776.8705 1,551.73 1,551.73 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SIEYSPQLEDAGSR 95.00% 3.41 0.576 3.96 776.8716 1,551.73 1,551.73 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SIEYSPQLEDAGSR 95.00% 4.09 0.563 3.72 776.8734 1,551.73 1,551.73 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 6.05 0.612 3.35 c18: Carbamidomethyl (+57.02) 792.4061 2,374.19 2,374.19 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.21 0.611 2.32 c18: Carbamidomethyl (+57.02) 792.4067 2,374.20 2,374.19 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 4.16 0.446 3.46 817.1149 2,448.32 2,448.31 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPQVSPADSGEYVcR 95.00% 4.17 0.591 4.14 c14: Carbamidomethyl (+57.02) 839.4009 1,676.79 1,677.79 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPQVSPADSGEYVcR 95.00% 4.65 0.554 6.74 c14: Carbamidomethyl (+57.02) 839.401 1,676.79 1,677.79 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPQVSPADSGEYVcR 95.00% 3.62 0.596 5.68 c14: Carbamidomethyl (+57.02) 839.4017 1,676.79 1,677.79 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPQVSPADSGEYVcR 95.00% 4.3 0.562 5.29 c14: Carbamidomethyl (+57.02) 839.403 1,676.79 1,677.79 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPQVSPADSGEYVcR 95.00% 4.48 0.557 5.96 c14: Carbamidomethyl (+57.02) 839.9012 1,677.79 1,677.79 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPQVSPADSGEYVcR 95.00% 3.94 0.557 5.21 c14: Carbamidomethyl (+57.02) 839.9039 1,677.79 1,677.79 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPQVSPADSGEYVcR 95.00% 2.99 0.417 1.8 c14: Carbamidomethyl (+57.02) 839.904 1,677.79 1,677.79 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 3.96 0.603 3.42 844.0775 1,686.14 1,687.97 2 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VGGHLRPGIVQSGGVVR 95.00% 3.64 0.578 5.02 844.08 1,686.14 1,687.97 2 ATPA_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GSVYIGGAPDVATLTGGR 95.00% 4.29 0.557 3.6 845.9447 1,689.87 1,690.88 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GSVYIGGAPDVATLTGGR 95.00% 4.3 0.494 5.29 845.9457 1,689.88 1,690.88 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GSVYIGGAPDVATLTGGR 95.00% 4.82 0.568 4.17 845.9474 1,689.88 1,690.88 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% GSVYIGGAPDVATLTGGR 95.00% 4.29 0.521 3.92 846.446 1,690.88 1,690.88 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLIHDGAAPISLEWK 95.00% 0 0 5.77 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 846.9265 1,691.84 1,692.84 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLIHDGAAPISLEWK 95.00% 0 0 3.54 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 848.0233 1,694.03 1,692.84 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHLVSPADSGEYVcR 95.00% 2.72 0.304 0 c14: Carbamidomethyl (+57.02) 851.9162 1,701.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.74 0.665 5.16 853.4492 2,557.32 2,557.33 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.67 0.629 6.16 853.4496 2,557.33 2,557.33 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IQVVVLSASDASPPPVK 95.00% 3.42 0.43 7.57 853.9897 1,705.96 1,706.97 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IQVVVLSASDASPPPVK 95.00% 4.17 0.526 5.48 853.9897 1,705.96 1,706.97 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IQVVVLSASDASPPPVK 95.00% 3.13 0.444 7.66 853.9901 1,705.96 1,706.97 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IQVVVLSASDASPPPVK 95.00% 4.24 0.543 5.17 853.9903 1,705.96 1,706.97 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IQVVVLSASDASPPPVK 95.00% 3.45 0.471 7.24 853.991 1,705.97 1,706.97 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IQVVVLSASDASPPPVK 95.00% 3.02 0.34 5.3 853.991 1,705.97 1,706.97 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IQVVVLSASDASPPPVK 95.00% 3.22 0.473 7.89 853.9917 1,705.97 1,706.97 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IQVVVLSASDASPPPVK 95.00% 3.26 0.447 4.24 853.9957 1,705.98 1,706.97 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IQVVVLSASDASPPPVK 95.00% 4.55 0.52 10.1 854.4925 1,706.97 1,706.97 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IQVVVLSASDASPPPVK 95.00% 3.96 0.499 5.6 854.4937 1,706.97 1,706.97 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.33 0.503 1.43 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7306 2,561.17 2,561.17 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IQNLDQScQGTYIcQAHGPWGK 95.00% 3.77 0.468 0 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7313 2,561.17 2,561.17 3
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLIHDGAAPISLEWK 95.00% 4.49 0.567 5.8 c1: Carbamidomethyl (+57.02) 855.44 1,708.86 1,709.87 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cLIHDGAAPISLEWK 95.00% 4.44 0.601 5.04 c1: Carbamidomethyl (+57.02) 855.4412 1,708.87 1,709.87 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYQASPADSGEYVcR 95.00% 4.93 0.572 5.09 c14: Carbamidomethyl (+57.02) 858.3874 1,714.76 1,715.77 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYQASPADSGEYVcR 95.00% 4.54 0.573 6.17 c14: Carbamidomethyl (+57.02) 858.3886 1,714.76 1,715.77 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYQASPADSGEYVcR 95.00% 4.96 0.617 6.48 c14: Carbamidomethyl (+57.02) 858.3897 1,714.76 1,715.77 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYQASPADSGEYVcR 95.00% 4.83 0.575 5.35 c14: Carbamidomethyl (+57.02) 858.3906 1,714.77 1,715.77 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYQASPADSGEYVcR 95.00% 4.84 0.593 5.57 c14: Carbamidomethyl (+57.02) 858.3908 1,714.77 1,715.77 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYQASPADSGEYVcR 95.00% 4.6 0.639 5.62 c14: Carbamidomethyl (+57.02) 858.3911 1,714.77 1,715.77 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYQASPADSGEYVcR 95.00% 4.54 0.606 5.59 c14: Carbamidomethyl (+57.02) 858.3921 1,714.77 1,715.77 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYQASPADSGEYVcR 95.00% 4.78 0.559 5.36 c14: Carbamidomethyl (+57.02) 858.3923 1,714.77 1,715.77 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYQASPADSGEYVcR 95.00% 4.85 0.634 5.8 c14: Carbamidomethyl (+57.02) 858.3924 1,714.77 1,715.77 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYQASPADSGEYVcR 95.00% 4.54 0.512 6.24 c14: Carbamidomethyl (+57.02) 858.8922 1,715.77 1,715.77 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYQASPADSGEYVcR 95.00% 4.6 0.606 6.19 c14: Carbamidomethyl (+57.02) 858.8937 1,715.77 1,715.77 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYQASPADSGEYVcR 95.00% 3.15 0.336 1.7 c14: Carbamidomethyl (+57.02) 858.943 1,715.87 1,715.77 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LHHVSPADSGEYVcR 95.00% 3.04 0.405 0 c14: Carbamidomethyl (+57.02) 864.4083 1,726.80 1,726.80 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5.13 0.549 4.85 c14: Carbamidomethyl (+57.02) 880.9361 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5 0.551 5.19 c14: Carbamidomethyl (+57.02) 880.9362 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5.32 0.547 5.82 c14: Carbamidomethyl (+57.02) 880.9368 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 4.96 0.586 4.64 c14: Carbamidomethyl (+57.02) 880.9374 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5.1 0.573 5.74 c14: Carbamidomethyl (+57.02) 880.9374 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5.12 0.56 6.66 c14: Carbamidomethyl (+57.02) 880.9374 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5.14 0.591 5.7 c14: Carbamidomethyl (+57.02) 880.9377 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5.14 0.608 6.15 c14: Carbamidomethyl (+57.02) 880.9377 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5.06 0.567 5.8 c14: Carbamidomethyl (+57.02) 880.9378 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 4.93 0.601 4.96 c14: Carbamidomethyl (+57.02) 880.9379 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5.07 0.601 7.35 c14: Carbamidomethyl (+57.02) 880.9382 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5.44 0.6 4.72 c14: Carbamidomethyl (+57.02) 880.9383 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 4.97 0.581 5.48 c14: Carbamidomethyl (+57.02) 880.9384 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5.08 0.573 5.64 c14: Carbamidomethyl (+57.02) 880.94 1,759.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 4.76 0.605 3.41 c14: Carbamidomethyl (+57.02) 880.9408 1,759.87 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 4.94 0.531 5.18 c14: Carbamidomethyl (+57.02) 881.4384 1,760.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5.06 0.568 4.64 c14: Carbamidomethyl (+57.02) 881.4395 1,760.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 5.11 0.564 6.25 c14: Carbamidomethyl (+57.02) 881.44 1,760.86 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 4.41 0.496 3.66 c14: Carbamidomethyl (+57.02) 881.4407 1,760.87 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 4.81 0.547 4.74 c14: Carbamidomethyl (+57.02) 881.4413 1,760.87 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LPAVEPTDQAQYLcR 95.00% 3.83 0.408 3.62 c14: Carbamidomethyl (+57.02) 881.4431 1,760.87 1,760.86 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LcNEcADGSFHLSTR 95.00% 5.07 0.557 4.4 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8861 1,765.76 1,766.76 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LcNEcADGSFHLSTR 95.00% 4.64 0.573 5.51 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.3831 1,766.75 1,766.76 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LcNEcADGSFHLSTR 95.00% 4.79 0.525 4.26 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.386 1,766.76 1,766.76 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% EVSEAVVDTLESEYLK 95.00% 4.56 0.595 5.28 905.9514 1,809.89 1,810.90 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% EVSEAVVDTLESEYLK 95.00% 6.11 0.533 5.37 905.9529 1,809.89 1,810.90 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% EVSEAVVDTLESEYLK 95.00% 5.55 0.548 5.08 905.9541 1,809.89 1,810.90 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% EVSEAVVDTLESEYLK 95.00% 4.73 0.528 4.89 905.9556 1,809.90 1,810.90 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% EVSEAVVDTLESEYLK 95.00% 4.99 0.57 3.44 905.9582 1,809.90 1,810.90 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% EVSEAVVDTLESEYLK 95.00% 4.09 0.505 3.02 905.9585 1,809.90 1,810.90 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% EVSEAVVDTLESEYLK 95.00% 5.62 0.537 4.77 906.4543 1,810.89 1,810.90 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% EVSEAVVDTLESEYLK 95.00% 5.66 0.536 6.37 906.4549 1,810.89 1,810.90 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% EVSEAVVDTLESEYLK 95.00% 5.19 0.524 5.12 906.4572 1,810.90 1,810.90 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% EVSEAVVDTLESEYLK 95.00% 5.11 0.503 5.52 906.4573 1,810.90 1,810.90 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.47 0.449 3.57 c14: Carbamidomethyl (+57.02) 918.9689 1,835.92 1,836.93 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.53 0.437 4.85 c14: Carbamidomethyl (+57.02) 918.9701 1,835.92 1,836.93 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.48 0.419 3.64 c14: Carbamidomethyl (+57.02) 918.9711 1,835.93 1,836.93 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.48 0.395 4.14 c14: Carbamidomethyl (+57.02) 919.4695 1,836.92 1,836.93 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.49 0.424 3.72 c14: Carbamidomethyl (+57.02) 919.4701 1,836.92 1,836.93 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SQSVRPGADVTFIcTAK 95.00% 4.29 0.469 3.44 c14: Carbamidomethyl (+57.02) 919.4702 1,836.92 1,836.93 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cAPGYYGNPSQGQPcQR 95.00% 4.15 0.659 5.77 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4134 1,938.81 1,939.82 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cAPGYYGNPSQGQPcQR 95.00% 4.24 0.65 6.51 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4147 1,938.81 1,939.82 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cAPGYYGNPSQGQPcQR 95.00% 4.15 0.611 5.47 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4158 1,938.82 1,939.82 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cAPGYYGNPSQGQPcQR 95.00% 3.95 0.665 5.51 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4165 1,938.82 1,939.82 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cAPGYYGNPSQGQPcQR 95.00% 4.24 0.627 6.37 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9154 1,939.82 1,939.82 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cAPGYYGNPSQGQPcQR 95.00% 4.6 0.616 4.89 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9164 1,939.82 1,939.82 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% cAPGYYGNPSQGQPcQR 95.00% 4.28 0.602 4.7 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9165 1,939.82 1,939.82 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LRLPQVSPADSGEYVcR 95.00% 4.24 0.592 5.44 c16: Carbamidomethyl (+57.02) 973.9948 1,945.97 1,946.98 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LRLPQVSPADSGEYVcR 95.00% 4.06 0.469 0 c16: Carbamidomethyl (+57.02) 974.4987 1,946.98 1,946.98 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYIFQASPADAGQYVcR 95.00% 4.07 0.572 4.19 c16: Carbamidomethyl (+57.02) 979.9802 1,957.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 5.24 0.54 3.72 980.0304 1,958.05 1,959.05 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 5.08 0.557 4.14 980.0313 1,958.05 1,959.05 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 4.86 0.533 4 980.032 1,958.05 1,959.05 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 3.48 0.416 5.17 980.034 1,958.05 1,959.05 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYIFQASPADAGQYVcR 95.00% 5.91 0.532 4.85 c16: Carbamidomethyl (+57.02) 980.4763 1,958.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYIFQASPADAGQYVcR 95.00% 5.48 0.55 6.77 c16: Carbamidomethyl (+57.02) 980.4771 1,958.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYIFQASPADAGQYVcR 95.00% 5.64 0.548 5.68 c16: Carbamidomethyl (+57.02) 980.4771 1,958.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYIFQASPADAGQYVcR 95.00% 5.58 0.571 5.96 c16: Carbamidomethyl (+57.02) 980.4778 1,958.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% LYIFQASPADAGQYVcR 95.00% 5.71 0.569 6.6 c16: Carbamidomethyl (+57.02) 980.4779 1,958.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 5.37 0.507 4.85 980.5306 1,959.05 1,959.05 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% VVGSSGTQEASVLVTIQQR 95.00% 4.02 0.5 2.17 980.5363 1,959.06 1,959.05 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% ATATScRPcPcPYIDASR 95.00% 4 0.418 2.54 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.92 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPVISIDPPSSTVQQGQDASFK 95.00% 4.38 0.593 6.89 1,144.58 2,287.14 2,288.14 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPVISIDPPSSTVQQGQDASFK 95.00% 5.39 0.527 12.6 1,145.08 2,288.14 2,288.14 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPVISIDPPSSTVQQGQDASFK 95.00% 5.64 0.542 12.5 1,145.08 2,288.14 2,288.14 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPVISIDPPSSTVQQGQDASFK 95.00% 5.01 0.557 8.62 1,145.08 2,288.14 2,288.14 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPVISIDPPSSTVQQGQDASFK 95.00% 4.55 0.582 6.96 1,145.08 2,288.14 2,288.14 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% SPVISIDPPSSTVQQGQDASFK 95.00% 3.45 0.424 3.24 1,145.08 2,288.15 2,288.14 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.2 0.62 5.24 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.42 0.691 4.49 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.21 0.674 5.13 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.28 0.657 4.39 c18: Carbamidomethyl (+57.02) 1,188.11 2,374.19 2,374.19 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.28 0.624 5.41 c18: Carbamidomethyl (+57.02) 1,188.11 2,374.20 2,374.19 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.37 0.658 6.04 c18: Carbamidomethyl (+57.02) 1,188.11 2,374.20 2,374.19 2
 SAMPLE 4 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 64 425 16.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 3.85 0.635 3.92 c18: Carbamidomethyl (+57.02) 1,188.11 2,374.20 2,374.19 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 3.91 0.486 1.47 481.5846 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 4.48 0.414 2.3 481.585 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 3.85 0.392 0 481.5854 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 3.97 0.489 2.6 481.5857 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 3.65 0.436 1 481.5858 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 2.43 0.225 0 481.5861 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 3.52 0.482 0 481.5862 1,441.74 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 4 0.471 1.44 481.5864 1,441.74 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 4.37 0.43 2.11 481.5864 1,441.74 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 3.36 0.386 0 481.587 1,441.74 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 2.63 0.312 0 481.5884 1,441.74 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% FLGDKVTSYGGELR 95.00% 3.34 0.314 2.04 514.6041 1,540.79 1,541.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% FLGDKVTSYGGELR 95.00% 3.16 0.405 2.3 514.6057 1,540.79 1,541.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% FLGDKVTSYGGELR 95.00% 2.54 0.245 1.49 514.9388 1,541.79 1,541.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% NELLHFER 95.00% 2.28 0.257 0 529.2793 1,056.54 1,057.54 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VAEGQTLDLK 95.00% 2.46 0.377 2.92 537.2973 1,072.58 1,073.58 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 4.83 0.523 3.18 563.3292 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 4.08 0.506 3.04 563.3295 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 3.79 0.45 2 563.3298 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 4.57 0.497 3.72 563.33 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 4.81 0.556 4.55 563.33 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 4.6 0.495 3.18 563.3301 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 2.86 0.363 3.02 563.3302 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 4.24 0.534 3.21 563.3304 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 4.66 0.516 3.47 563.3304 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 4.06 0.539 1.92 563.3304 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 4.6 0.497 3.54 563.3309 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 4.81 0.531 2.4 563.3313 1,686.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 3.97 0.525 3 563.6636 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 4.29 0.519 2.36 563.6642 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 5.08 0.528 3.59 563.6644 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VGGHLRPGIVQSGGVVR 95.00% 3.86 0.512 1.24 563.6656 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LEGDTLIIPR 95.00% 3.22 0.364 1.68 563.8271 1,125.64 1,126.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LEGDTLIIPR 95.00% 2.88 0.326 1.82 563.828 1,125.64 1,126.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LEGDTLIIPR 95.00% 2.28 0.295 1.33 563.83 1,125.64 1,126.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LEGDTLIIPR 95.00% 2.65 0.31 0 563.8304 1,125.65 1,126.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHLVSPADSGEYVcR 95.00% 4.15 0.56 2.6 c14: Carbamidomethyl (+57.02) 568.2797 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHLVSPADSGEYVcR 95.00% 5.21 0.436 3.77 c14: Carbamidomethyl (+57.02) 568.2799 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHLVSPADSGEYVcR 95.00% 3.39 0.411 3.57 c14: Carbamidomethyl (+57.02) 568.2803 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHLVSPADSGEYVcR 95.00% 3.34 0.468 1.77 c14: Carbamidomethyl (+57.02) 568.281 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHLVSPADSGEYVcR 95.00% 3.14 0.506 1.47 c14: Carbamidomethyl (+57.02) 568.2819 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHLVSPADSGEYVcR 95.00% 3.94 0.494 4.46 c14: Carbamidomethyl (+57.02) 568.2823 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHLVSPADSGEYVcR 95.00% 3.75 0.44 3.49 c14: Carbamidomethyl (+57.02) 568.2827 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHLVSPADSGEYVcR 95.00% 4.69 0.548 6 c14: Carbamidomethyl (+57.02) 568.6144 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHLVSPADSGEYVcR 95.00% 1.84 0.281 1.51 c14: Carbamidomethyl (+57.02) 568.6169 1,702.83 1,702.82 3 TITIN_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cLIHDGAAPISLEWK 95.00% 2.29 0.235 0 c1: Carbamidomethyl (+57.02) 570.9626 1,709.86 1,709.87 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 4.89 0.46 3.17 c14: Carbamidomethyl (+57.02) 576.2716 1,725.79 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 5.67 0.427 1.82 c14: Carbamidomethyl (+57.02) 576.2718 1,725.79 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 4.74 0.437 2.35 c14: Carbamidomethyl (+57.02) 576.2719 1,725.79 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 4.28 0.272 1.92 c14: Carbamidomethyl (+57.02) 576.272 1,725.79 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 4.94 0.442 2.89 c14: Carbamidomethyl (+57.02) 576.2724 1,725.79 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 4.54 0.351 3.15 c14: Carbamidomethyl (+57.02) 576.2725 1,725.79 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 5.15 0.403 2.89 c14: Carbamidomethyl (+57.02) 576.2726 1,725.79 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 4.57 0.411 1.92 c14: Carbamidomethyl (+57.02) 576.2726 1,725.79 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 4.85 0.37 2.74 c14: Carbamidomethyl (+57.02) 576.2727 1,725.79 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 4.88 0.451 1.82 c14: Carbamidomethyl (+57.02) 576.2731 1,725.80 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 3.52 0.295 2.2 c14: Carbamidomethyl (+57.02) 576.2758 1,725.80 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 5.52 0.426 4.92 c14: Carbamidomethyl (+57.02) 576.6056 1,726.79 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 5.08 0.363 4.36 c14: Carbamidomethyl (+57.02) 576.606 1,726.79 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 5.09 0.407 4.74 c14: Carbamidomethyl (+57.02) 576.6063 1,726.80 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 4.95 0.427 3.55 c14: Carbamidomethyl (+57.02) 576.6067 1,726.80 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 4.69 0.382 5.33 c14: Carbamidomethyl (+57.02) 576.6071 1,726.80 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHHVSPADSGEYVcR 95.00% 4.57 0.444 2.24 c14: Carbamidomethyl (+57.02) 576.6088 1,726.80 1,726.80 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SIGASVEFHcAVPSDR 94.60% 2.1 0.215 0 c10: Carbamidomethyl (+57.02) 577.9425 1,730.80 1,731.81 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SIGASVEFHcAVPSDR 95.00% 2.77 0.376 1.23 c10: Carbamidomethyl (+57.02) 577.9432 1,730.81 1,731.81 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SIGASVEFHcAVPSDR 95.00% 2.82 0.329 0 c10: Carbamidomethyl (+57.02) 577.9455 1,730.81 1,731.81 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SIGASVEFHcAVPSDR 95.00% 2.84 0.321 0 c10: Carbamidomethyl (+57.02) 578.2773 1,731.81 1,731.81 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AFAHLQVPER 95.00% 3.19 0.393 0 584.3177 1,166.62 1,167.63 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AFAHLQVPER 95.00% 3.14 0.374 2.43 584.318 1,166.62 1,167.63 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AFAHLQVPER 95.00% 2.76 0.345 1.64 584.3184 1,166.62 1,167.63 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AFAHLQVPER 95.00% 3.15 0.403 1.38 584.3185 1,166.62 1,167.63 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AFAHLQVPER 95.00% 2.98 0.374 0 584.3186 1,166.62 1,167.63 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AFAHLQVPER 95.00% 2.83 0.403 2.77 584.3196 1,166.62 1,167.63 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHQMSVADSGEYVcR 95.00% 3.81 0.429 0 c14: Carbamidomethyl (+57.02) 584.6014 1,750.78 1,751.78 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHQMSVADSGEYVcR 95.00% 2.8 0.284 0 c14: Carbamidomethyl (+57.02) 584.9366 1,751.79 1,751.78 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 2.78 0.316 0 c14: Carbamidomethyl (+57.02) 587.9449 1,760.81 1,760.86 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 3.13 0.454 3.55 589.3323 1,176.65 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 3.04 0.432 3.04 589.3327 1,176.65 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 3.29 0.488 3.23 589.3332 1,176.65 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 3.1 0.423 4.05 589.334 1,176.65 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 3 0.461 3.52 589.3342 1,176.65 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 3.31 0.472 4.68 589.3343 1,176.65 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 3.24 0.449 3.24 589.3343 1,176.65 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 3.3 0.486 4.12 589.3344 1,176.65 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 3.32 0.488 3.28 589.3349 1,176.65 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 3.39 0.476 4.18 589.3354 1,176.66 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 3.31 0.471 4.35 589.3354 1,176.66 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 2.62 0.433 2.96 589.3355 1,176.66 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% YELGSGLAVLR 95.00% 2.98 0.441 2.34 589.3368 1,176.66 1,177.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LcNEcADGSFHLSTR 95.00% 3.75 0.336 1.92 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.592 1,765.75 1,766.76 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LcNEcADGSFHLSTR 95.00% 3.5 0.37 1.28 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5927 1,765.75 1,766.76 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LcNEcADGSFHLSTR 95.00% 3.6 0.402 1.89 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5931 1,765.76 1,766.76 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LcNEcADGSFHLSTR 95.00% 4.17 0.424 2.01 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5934 1,765.76 1,766.76 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LcNEcADGSFHLSTR 95.00% 3.06 0.295 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.925 1,766.75 1,766.76 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LcNEcADGSFHLSTR 95.00% 3.95 0.367 3.05 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.9265 1,766.76 1,766.76 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3 0.562 3.07 597.3191 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.76 0.588 3.42 597.3193 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.28 0.586 2.51 597.3197 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.52 0.583 2.7 597.3199 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.14 0.575 2.64 597.3201 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.36 0.575 3.74 597.3202 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.27 0.563 2.72 597.3203 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.57 0.56 3.36 597.3203 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.98 0.588 3.35 597.3205 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 4.12 0.618 2.02 597.3206 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.77 0.62 3.06 597.3206 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.85 0.579 3.8 597.3209 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 4.02 0.588 3.77 597.3209 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.69 0.568 4.06 597.3214 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.07 0.551 4.28 597.3215 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 3.51 0.599 2.89 597.3218 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 4.04 0.614 2.92 597.3328 1,192.65 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPAYTLVWTR 95.00% 2.5 0.486 3.68 597.638 1,193.26 1,193.63 2 LU_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% EVSEAVVDTLESEYLK 95.00% 3.07 0.397 0 604.3051 1,809.89 1,810.90 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% EVSEAVVDTLESEYLK 95.00% 4.35 0.415 0 604.6392 1,810.89 1,810.90 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% EVSEAVVDTLESEYLK 95.00% 4.06 0.368 0 604.6395 1,810.89 1,810.90 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AGLSSGFIGcVR 95.00% 4.08 0.489 4.92 c10: Carbamidomethyl (+57.02) 612.3144 1,222.61 1,223.62 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AGLSSGFIGcVR 95.00% 3.84 0.444 3.22 c10: Carbamidomethyl (+57.02) 612.3153 1,222.61 1,223.62 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AGLSSGFIGcVR 95.00% 3.96 0.51 3.85 c10: Carbamidomethyl (+57.02) 612.3155 1,222.62 1,223.62 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AGLSSGFIGcVR 95.00% 3.79 0.448 3.55 c10: Carbamidomethyl (+57.02) 612.3155 1,222.62 1,223.62 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AGLSSGFIGcVR 95.00% 3.8 0.5 3.64 c10: Carbamidomethyl (+57.02) 612.3157 1,222.62 1,223.62 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AGLSSGFIGcVR 95.00% 3.74 0.506 4.28 c10: Carbamidomethyl (+57.02) 612.316 1,222.62 1,223.62 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 3.55 0.52 3.1 c14: Carbamidomethyl (+57.02) 612.9816 1,835.92 1,836.93 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 3.7 0.473 1.49 c14: Carbamidomethyl (+57.02) 612.9818 1,835.92 1,836.93 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 3.77 0.503 2.37 c14: Carbamidomethyl (+57.02) 612.982 1,835.92 1,836.93 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 3.58 0.463 1.37 c14: Carbamidomethyl (+57.02) 612.9828 1,835.92 1,836.93 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 4.74 0.502 3.04 c14: Carbamidomethyl (+57.02) 612.983 1,835.93 1,836.93 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 3.75 0.43 2.36 c14: Carbamidomethyl (+57.02) 612.9834 1,835.93 1,836.93 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 3.48 0.46 1.66 c14: Carbamidomethyl (+57.02) 612.9846 1,835.93 1,836.93 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AAGVPSATITWR 95.00% 1.78 0.321 2.19 615.3333 1,228.65 1,229.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AAGVPSATITWR 95.00% 1.97 0.403 3.02 615.3356 1,228.66 1,229.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AAGVPSATITWR 95.00% 2.05 0.423 3.29 615.3366 1,228.66 1,229.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AAGVPSATITWR 95.00% 2.19 0.302 2.15 615.3371 1,228.66 1,229.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AAGVPSATITWR 95.00% 2.42 0.462 2.02 615.3377 1,228.66 1,229.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AAGVPSATITWR 95.00% 1.9 0.276 1.74 615.3381 1,228.66 1,229.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AAGVPSATITWR 95.00% 2.54 0.474 2.39 615.3382 1,228.66 1,229.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% QPQAIITWYK 95.00% 1.71 0.35 0 624.3443 1,246.67 1,247.68 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% QPQAIITWYK 95.00% 1.88 0.371 0 624.3455 1,246.68 1,247.68 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% QPQAIITWYK 95.00% 1.65 0.367 0 624.3456 1,246.68 1,247.68 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cQVSGSPPHYFYWSR 95.00% 2.47 0.325 0 c1: Carbamidomethyl (+57.02) 624.6193 1,870.83 1,870.83 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AMDFNGILTIR 95.00% 2.94 0.524 2.59 625.8325 1,249.65 1,250.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AMDFNGILTIR 95.00% 3.36 0.587 2.24 625.8337 1,249.65 1,250.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AMDFNGILTIR 95.00% 2.58 0.432 1.59 625.8338 1,249.65 1,250.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AMDFNGILTIR 95.00% 2.82 0.503 2.23 625.8342 1,249.65 1,250.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AMDFNGILTIR 95.00% 2.75 0.43 2.4 625.8347 1,249.65 1,250.66 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cLcLPGFSGPR 95.00% 2.73 0.224 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3031 1,262.59 1,263.60 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cLcLPGFSGPR 95.00% 2.73 0.341 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3039 1,262.59 1,263.60 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cLcLPGFSGPR 95.00% 2.79 0.312 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3042 1,262.59 1,263.60 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cLcLPGFSGPR 95.00% 2.55 0.361 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3044 1,262.59 1,263.60 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cLcLPGFSGPR 95.00% 2.69 0.369 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3045 1,262.59 1,263.60 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cLcLPGFSGPR 95.00% 3.05 0.254 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3046 1,262.59 1,263.60 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cLcLPGFSGPR 95.00% 2.77 0.325 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3062 1,262.60 1,263.60 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cLcLPGFSGPR 95.00% 2.54 0.381 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3067 1,262.60 1,263.60 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cLcLPGFSGPR 95.00% 2.66 0.244 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3075 1,262.60 1,263.60 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cLcLPGFSGPR 95.00% 2.53 0.267 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3081 1,262.60 1,263.60 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 2.68 0.47 2.09 m2: Oxidation (+15.99) 633.8298 1,265.64 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 2.88 0.341 2.6 m2: Oxidation (+15.99) 633.83 1,265.64 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 2.02 0.255 1.64 m2: Oxidation (+15.99) 633.8302 1,265.64 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 2.32 0.335 2.09 m2: Oxidation (+15.99) 633.8308 1,265.65 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 3.31 0.474 2.38 m2: Oxidation (+15.99) 633.8308 1,265.65 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 3.5 0.542 2.21 m2: Oxidation (+15.99) 633.831 1,265.65 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 3.68 0.519 2.54 m2: Oxidation (+15.99) 633.8311 1,265.65 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 3.34 0.443 2.89 m2: Oxidation (+15.99) 633.8312 1,265.65 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 3.67 0.535 2.85 m2: Oxidation (+15.99) 633.8315 1,265.65 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 3.14 0.517 3.66 m2: Oxidation (+15.99) 633.8322 1,265.65 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 3.59 0.505 2.27 m2: Oxidation (+15.99) 633.8331 1,265.65 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 2.52 0.391 2.36 m2: Oxidation (+15.99) 633.8344 1,265.65 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AmDFNGILTIR 95.00% 2.83 0.245 2.36 m2: Oxidation (+15.99) 633.8345 1,265.65 1,266.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% PGADVTFIcTAK 95.00% 2.9 0.544 0 c9: Carbamidomethyl (+57.02) 640.3258 1,278.64 1,279.64 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% QPDFISFGLVGGRPEFR 95.00% 2.11 0.234 0 641.6724 1,921.99 1,921.99 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% QPDFISFGLVGGRPEFR 95.00% 2.45 0.36 0 641.6724 1,921.99 1,921.99 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LRLPQVSPADSGEYVcR 95.00% 3.34 0.407 2.47 c16: Carbamidomethyl (+57.02) 649.6647 1,945.97 1,946.98 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LRLPQVSPADSGEYVcR 95.00% 5.07 0.556 3.46 c16: Carbamidomethyl (+57.02) 649.6658 1,945.97 1,946.98 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LRLPQVSPADSGEYVcR 95.00% 2.18 0.306 2.96 c16: Carbamidomethyl (+57.02) 649.8903 1,946.65 1,946.98 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LRLPQVSPADSGEYVcR 95.00% 2.1 0.366 4.1 c16: Carbamidomethyl (+57.02) 649.8912 1,946.65 1,946.98 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LRLPQVSPADSGEYVcR 95.00% 5.21 0.491 6.02 c16: Carbamidomethyl (+57.02) 649.9991 1,946.97 1,946.98 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LRLPQVSPADSGEYVcR 95.00% 5.21 0.537 4.6 c16: Carbamidomethyl (+57.02) 649.9999 1,946.98 1,946.98 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LRLPQVSPADSGEYVcR 95.00% 5.29 0.541 5.4 c16: Carbamidomethyl (+57.02) 650.0001 1,946.98 1,946.98 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VVGSSGTQEASVLVTIQQR 95.00% 3.51 0.395 0 653.6899 1,958.05 1,959.05 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VVGSSGTQEASVLVTIQQR 95.00% 4.14 0.444 0 653.6914 1,958.05 1,959.05 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VVGSSGTQEASVLVTIQQR 95.00% 2.71 0.239 0 653.6915 1,958.05 1,959.05 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYIFQASPADAGQYVcR 95.00% 3.79 0.539 1.14 c16: Carbamidomethyl (+57.02) 653.9886 1,958.94 1,958.94 3 DOCK9_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VVGSSGTQEASVLVTIQQR 95.00% 4.39 0.345 0 654.0247 1,959.05 1,959.05 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VVGSSGTQEASVLVTIQQR 95.00% 2.87 0.215 0 654.0248 1,959.05 1,959.05 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VVGSSGTQEASVLVTIQQR 95.00% 4.02 0.331 0 654.0259 1,959.05 1,959.05 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VVGSSGTQEASVLVTIQQR 95.00% 3.73 0.333 0 654.0263 1,959.06 1,959.05 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% TPSGLYLGTcER 95.00% 2.99 0.361 2.05 c10: Carbamidomethyl (+57.02) 677.3272 1,352.64 1,353.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% TPSGLYLGTcER 95.00% 3.97 0.409 3.51 c10: Carbamidomethyl (+57.02) 677.328 1,352.64 1,353.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% TPSGLYLGTcER 95.00% 3.68 0.411 3.8 c10: Carbamidomethyl (+57.02) 677.3282 1,352.64 1,353.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% TPSGLYLGTcER 95.00% 3.58 0.449 3.7 c10: Carbamidomethyl (+57.02) 677.3285 1,352.64 1,353.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% TPSGLYLGTcER 95.00% 3 0.443 2.46 c10: Carbamidomethyl (+57.02) 677.3286 1,352.64 1,353.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% TPSGLYLGTcER 95.00% 3.4 0.463 3.51 c10: Carbamidomethyl (+57.02) 677.3287 1,352.64 1,353.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% TPSGLYLGTcER 95.00% 2.25 0.276 0 c10: Carbamidomethyl (+57.02) 677.3288 1,352.64 1,353.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% TPSGLYLGTcER 95.00% 4.22 0.423 3.16 c10: Carbamidomethyl (+57.02) 677.3294 1,352.64 1,353.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% TPSGLYLGTcER 95.00% 3.3 0.457 2.27 c10: Carbamidomethyl (+57.02) 677.3299 1,352.64 1,353.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% TPSGLYLGTcER 95.00% 4.18 0.415 4.23 c10: Carbamidomethyl (+57.02) 677.3304 1,352.65 1,353.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% TPSGLYLGTcER 95.00% 3.01 0.388 2.74 c10: Carbamidomethyl (+57.02) 677.3307 1,352.65 1,353.65 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% PSDAGTYVcLAQNALGTAQK 95.00% 3.82 0.4 0 c9: Carbamidomethyl (+57.02) 689.3405 2,065.00 2,065.00 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% PSDAGTYVcLAQNALGTAQK 95.00% 4.3 0.418 0 c9: Carbamidomethyl (+57.02) 689.3405 2,065.00 2,065.00 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% PSDAGTYVcLAQNALGTAQK 95.00% 4.2 0.329 0 c9: Carbamidomethyl (+57.02) 689.3409 2,065.00 2,065.00 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% PSDAGTYVcLAQNALGTAQK 95.00% 3.77 0.477 0 c9: Carbamidomethyl (+57.02) 689.3439 2,065.01 2,065.00 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% GmLEPVQRPDVVLVGAGYR 95.00% 1.91 0.314 2.09 m2: Oxidation (+15.99) 691.7036 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% GmLEPVQRPDVVLVGAGYR 95.00% 2.09 0.285 2.06 m2: Oxidation (+15.99) 691.7048 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% GmLEPVQRPDVVLVGAGYR 95.00% 1.9 0.333 2.32 m2: Oxidation (+15.99) 691.7053 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% RcEScAPGYEGNPIQPGGK 95.00% 3.42 0.395 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3164 2,076.93 2,076.92 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AVTLEcVSAGEPR 95.00% 2.51 0.316 2.24 c6: Carbamidomethyl (+57.02) 694.8451 1,387.67 1,388.68 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AVTLEcVSAGEPR 95.00% 2.51 0.38 3.07 c6: Carbamidomethyl (+57.02) 694.8465 1,387.68 1,388.68 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AVTLEcVSAGEPR 95.00% 2.12 0.317 3.96 c6: Carbamidomethyl (+57.02) 694.8468 1,387.68 1,388.68 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AVTLEcVSAGEPR 95.00% 1.77 0.18 3.6 c6: Carbamidomethyl (+57.02) 694.8469 1,387.68 1,388.68 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AVTLEcVSAGEPR 95.00% 1.86 0.231 3.72 c6: Carbamidomethyl (+57.02) 694.8478 1,387.68 1,388.68 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AVTLEcVSAGEPR 95.00% 3.99 0.424 3.54 c6: Carbamidomethyl (+57.02) 694.8502 1,387.68 1,388.68 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% ATATScRPcPcPYIDASR 95.00% 3.05 0.468 2.74 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.9774 2,081.91 2,082.92 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% ATATScRPcPcPYIDASR 95.00% 3.18 0.517 1.82 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.9788 2,081.91 2,082.92 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% ATATScRPcPcPYIDASR 95.00% 3.74 0.443 3.08 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3112 2,082.91 2,082.92 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% ATATScRPcPcPYIDASR 95.00% 3.35 0.481 1.8 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3116 2,082.91 2,082.92 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% ATATScRPcPcPYIDASR 95.00% 3.62 0.505 2.89 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3122 2,082.91 2,082.92 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% ATATScRPcPcPYIDASR 95.00% 3.57 0.431 2.48 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3128 2,082.91 2,082.92 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% ATATScRPcPcPYIDASR 95.00% 3.65 0.39 2.54 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.313 2,082.92 2,082.92 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% ATATScRPcPcPYIDASR 95.00% 3.84 0.473 2.82 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3132 2,082.92 2,082.92 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% ATATScRPcPcPYIDASR 95.00% 3.86 0.533 2.74 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3145 2,082.92 2,082.92 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IPGDQVVSVVFIK 95.00% 4.26 0.521 4.52 700.9128 1,399.81 1,400.82 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IPGDQVVSVVFIK 95.00% 3.67 0.533 3.74 700.9128 1,399.81 1,400.82 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IPGDQVVSVVFIK 95.00% 4.29 0.534 3.62 700.9129 1,399.81 1,400.82 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IPGDQVVSVVFIK 95.00% 4.15 0.501 3.72 700.9129 1,399.81 1,400.82 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IPGDQVVSVVFIK 95.00% 3.07 0.543 4.38 700.9132 1,399.81 1,400.82 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IPGDQVVSVVFIK 95.00% 4.4 0.525 3.11 700.9135 1,399.81 1,400.82 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VISSGSVASYVTSPQGFQFR 95.00% 3.16 0.363 1.96 706.6953 2,117.06 2,117.07 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 3.89 0.533 4.12 721.8749 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 3.54 0.43 3.74 721.8756 1,441.74 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 3.49 0.405 5.59 721.8758 1,441.74 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IAHVELADAGQYR 95.00% 3.65 0.514 4.31 722.0106 1,442.01 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LLSGPYFWSLPSR 95.00% 3.73 0.379 2.19 761.9042 1,521.79 1,522.81 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LLSGPYFWSLPSR 95.00% 3.98 0.433 2.85 761.907 1,521.80 1,522.81 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LLSGPYFWSLPSR 95.00% 4.19 0.426 1.7 761.9079 1,521.80 1,522.81 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LLSGPYFWSLPSR 95.00% 4.24 0.46 2.38 761.9084 1,521.80 1,522.81 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LLSGPYFWSLPSR 95.00% 4.36 0.479 3.72 761.9088 1,521.80 1,522.81 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LLSGPYFWSLPSR 95.00% 4.1 0.441 1.92 761.9093 1,521.80 1,522.81 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LLSGPYFWSLPSR 95.00% 3.8 0.468 2.28 761.91 1,521.80 1,522.81 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LLSGPYFWSLPSR 95.00% 3.63 0.388 0 761.9118 1,521.81 1,522.81 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LLSGPYFWSLPSR 95.00% 3.89 0.447 1.74 762.4102 1,522.80 1,522.81 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LLSGPYFWSLPSR 95.00% 3.17 0.365 0 762.4104 1,522.81 1,522.81 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.71 0.632 2.09 771.0934 2,310.26 2,310.26 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.58 0.607 3.21 771.0939 2,310.26 2,310.26 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.69 0.626 1.54 771.0941 2,310.26 2,310.26 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.5 0.65 3.7 771.0944 2,310.26 2,310.26 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.61 0.602 3.36 771.0947 2,310.26 2,310.26 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.65 0.567 3.42 771.095 2,310.26 2,310.26 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.08 0.618 3 771.0956 2,310.26 2,310.26 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.37 0.623 3.11 771.096 2,310.26 2,310.26 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.37 0.655 3 771.0974 2,310.27 2,310.26 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SIEYSPQLEDAGSR 95.00% 3.89 0.472 3.28 776.3683 1,550.72 1,551.73 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SIEYSPQLEDAGSR 95.00% 3.51 0.52 3.12 776.3687 1,550.72 1,551.73 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SIEYSPQLEDAGSR 95.00% 4.49 0.577 3.12 776.3723 1,550.73 1,551.73 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SIEYSPQLEDAGSR 95.00% 4.63 0.598 6.48 776.8734 1,551.73 1,551.73 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.8 0.494 2.17 c18: Carbamidomethyl (+57.02) 792.0684 2,373.18 2,374.19 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.96 0.573 0 c18: Carbamidomethyl (+57.02) 792.4029 2,374.19 2,374.19 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 3.5 0.451 0 c18: Carbamidomethyl (+57.02) 792.4052 2,374.19 2,374.19 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 3.01 0.356 0 c18: Carbamidomethyl (+57.02) 792.4059 2,374.19 2,374.19 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.07 0.475 1.14 c18: Carbamidomethyl (+57.02) 792.407 2,374.20 2,374.19 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SLPEVPETIELEVR 95.00% 3.31 0.425 3.2 806.438 1,610.86 1,610.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 4.58 0.475 4.05 817.1127 2,448.31 2,448.31 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPQVSPADSGEYVcR 95.00% 3.47 0.577 3.66 c14: Carbamidomethyl (+57.02) 839.3999 1,676.78 1,677.79 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPQVSPADSGEYVcR 95.00% 3.73 0.583 5.96 c14: Carbamidomethyl (+57.02) 839.4009 1,676.79 1,677.79 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPQVSPADSGEYVcR 95.00% 4.02 0.635 4.54 c14: Carbamidomethyl (+57.02) 839.4015 1,676.79 1,677.79 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPQVSPADSGEYVcR 95.00% 4.59 0.5 4.6 c14: Carbamidomethyl (+57.02) 839.4025 1,676.79 1,677.79 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPQVSPADSGEYVcR 95.00% 3.9 0.574 4.23 c14: Carbamidomethyl (+57.02) 839.4042 1,676.79 1,677.79 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPQVSPADSGEYVcR 95.00% 3.88 0.521 3.68 c14: Carbamidomethyl (+57.02) 839.9024 1,677.79 1,677.79 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% GSVYIGGAPDVATLTGGR 95.00% 4.69 0.548 6.24 845.9426 1,689.87 1,690.88 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% GSVYIGGAPDVATLTGGR 95.00% 4.04 0.549 6.32 845.9441 1,689.87 1,690.88 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cLIHDGAAPISLEWK 95.00% 0 0 5.14 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 846.9268 1,691.84 1,692.84 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHLVSPADSGEYVcR 95.00% 3.5 0.315 3.41 c14: Carbamidomethyl (+57.02) 851.9143 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LHLVSPADSGEYVcR 95.00% 3.55 0.215 3.74 c14: Carbamidomethyl (+57.02) 852.417 1,702.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IQVVVLSASDASPPPVK 95.00% 2.57 0.371 8.34 853.9901 1,705.96 1,706.97 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IQVVVLSASDASPPPVK 95.00% 3.82 0.5 7 853.9903 1,705.97 1,706.97 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IQVVVLSASDASPPPVK 95.00% 2.8 0.387 3.01 853.9911 1,705.97 1,706.97 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IQVVVLSASDASPPPVK 95.00% 3.73 0.506 7.51 853.9916 1,705.97 1,706.97 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IQVVVLSASDASPPPVK 95.00% 3.52 0.448 5.08 853.9921 1,705.97 1,706.97 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IQVVVLSASDASPPPVK 95.00% 3.32 0.13 8.03 854.4961 1,706.98 1,706.97 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IQVVVLSASDASPPPVK 95.00% 3.91 0.388 9.8 854.4967 1,706.98 1,706.97 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IQNLDQScQGTYIcQAHGPWGK 95.00% 3.5 0.455 2.02 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7283 2,561.16 2,561.17 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.81 0.391 0 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7316 2,561.17 2,561.17 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.4 0.527 0 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7316 2,561.17 2,561.17 3
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYQASPADSGEYVcR 95.00% 4 0.529 5.46 c14: Carbamidomethyl (+57.02) 858.3902 1,714.76 1,715.77 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYQASPADSGEYVcR 95.00% 4.47 0.588 4.02 c14: Carbamidomethyl (+57.02) 858.3908 1,714.77 1,715.77 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYQASPADSGEYVcR 95.00% 4.78 0.608 5.22 c14: Carbamidomethyl (+57.02) 858.3913 1,714.77 1,715.77 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYQASPADSGEYVcR 95.00% 4.46 0.602 5 c14: Carbamidomethyl (+57.02) 858.3914 1,714.77 1,715.77 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYQASPADSGEYVcR 95.00% 4.74 0.557 4.11 c14: Carbamidomethyl (+57.02) 858.392 1,714.77 1,715.77 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYQASPADSGEYVcR 95.00% 4.18 0.555 3.6 c14: Carbamidomethyl (+57.02) 858.3923 1,714.77 1,715.77 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYQASPADSGEYVcR 95.00% 4.46 0.554 3.59 c14: Carbamidomethyl (+57.02) 858.8871 1,715.76 1,715.77 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYQASPADSGEYVcR 95.00% 4.72 0.557 4.35 c14: Carbamidomethyl (+57.02) 858.8915 1,715.77 1,715.77 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYQASPADSGEYVcR 95.00% 4.67 0.545 4.92 c14: Carbamidomethyl (+57.02) 858.8933 1,715.77 1,715.77 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYQASPADSGEYVcR 95.00% 4.35 0.584 3.59 c14: Carbamidomethyl (+57.02) 858.8951 1,715.77 1,715.77 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 5.14 0.597 5.41 c14: Carbamidomethyl (+57.02) 880.9355 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 4.93 0.552 6.4 c14: Carbamidomethyl (+57.02) 880.937 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 5.38 0.593 5.8 c14: Carbamidomethyl (+57.02) 880.9374 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 5.03 0.58 6.18 c14: Carbamidomethyl (+57.02) 880.9375 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 5.22 0.599 5.37 c14: Carbamidomethyl (+57.02) 880.9376 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 4.88 0.547 4.96 c14: Carbamidomethyl (+57.02) 880.9377 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 4.62 0.555 6.43 c14: Carbamidomethyl (+57.02) 880.9377 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 5.24 0.568 5.92 c14: Carbamidomethyl (+57.02) 880.9377 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 4.62 0.602 5.48 c14: Carbamidomethyl (+57.02) 880.9378 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 5.15 0.602 4.66 c14: Carbamidomethyl (+57.02) 880.9378 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 5.31 0.614 6.59 c14: Carbamidomethyl (+57.02) 880.9378 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 5.08 0.569 5.89 c14: Carbamidomethyl (+57.02) 880.9386 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 4.67 0.551 6.17 c14: Carbamidomethyl (+57.02) 880.9386 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 4.53 0.59 5.64 c14: Carbamidomethyl (+57.02) 880.9389 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 4.98 0.537 5.16 c14: Carbamidomethyl (+57.02) 880.9393 1,759.86 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 5 0.602 5.96 c14: Carbamidomethyl (+57.02) 880.9405 1,759.87 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 4.75 0.554 4.59 c14: Carbamidomethyl (+57.02) 881.4406 1,760.87 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 4.75 0.494 4.49 c14: Carbamidomethyl (+57.02) 881.4414 1,760.87 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LPAVEPTDQAQYLcR 95.00% 4.95 0.532 6.47 c14: Carbamidomethyl (+57.02) 881.4431 1,760.87 1,760.86 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LcNEcADGSFHLSTR 95.00% 4.78 0.558 3.85 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8863 1,765.76 1,766.76 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LcNEcADGSFHLSTR 95.00% 5.05 0.593 4.72 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.3832 1,766.75 1,766.76 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% EVSEAVVDTLESEYLK 95.00% 5.5 0.571 7.06 905.9502 1,809.88 1,810.90 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% EVSEAVVDTLESEYLK 95.00% 4.79 0.587 7.21 905.9532 1,809.89 1,810.90 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% EVSEAVVDTLESEYLK 95.00% 2.69 0.284 0 905.9542 1,809.89 1,810.90 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% EVSEAVVDTLESEYLK 95.00% 5.99 0.483 6.39 906.4548 1,810.89 1,810.90 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% EVSEAVVDTLESEYLK 95.00% 0 0 5 906.9561 1,811.90 1,810.90 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 4.51 0.455 4.7 c14: Carbamidomethyl (+57.02) 918.9708 1,835.93 1,836.93 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 4.33 0.392 3.89 c14: Carbamidomethyl (+57.02) 919.4699 1,836.92 1,836.93 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 3.76 0.426 6.59 c14: Carbamidomethyl (+57.02) 919.47 1,836.92 1,836.93 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 4.39 0.448 4.44 c14: Carbamidomethyl (+57.02) 919.4718 1,836.93 1,836.93 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 4.35 0.443 3.96 c14: Carbamidomethyl (+57.02) 919.4724 1,836.93 1,836.93 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SQSVRPGADVTFIcTAK 95.00% 4.21 0.487 3.59 c14: Carbamidomethyl (+57.02) 919.4734 1,836.93 1,836.93 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cAPGYYGNPSQGQPcQR 95.00% 4.21 0.59 5.92 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9138 1,939.81 1,939.82 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cAPGYYGNPSQGQPcQR 95.00% 4.53 0.574 4.24 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9166 1,939.82 1,939.82 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cAPGYYGNPSQGQPcQR 95.00% 4.14 0.584 4.28 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9175 1,939.82 1,939.82 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% cAPGYYGNPSQGQPcQR 95.00% 4.58 0.644 6.82 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9184 1,939.82 1,939.82 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYIFQASPADAGQYVcR 95.00% 5.36 0.672 6.55 c16: Carbamidomethyl (+57.02) 979.9762 1,957.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYIFQASPADAGQYVcR 95.00% 5.64 0.676 8.59 c16: Carbamidomethyl (+57.02) 979.9777 1,957.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYIFQASPADAGQYVcR 95.00% 5.46 0.661 8.52 c16: Carbamidomethyl (+57.02) 979.9792 1,957.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYIFQASPADAGQYVcR 95.00% 5.72 0.656 6.82 c16: Carbamidomethyl (+57.02) 979.9796 1,957.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VVGSSGTQEASVLVTIQQR 95.00% 4.96 0.548 4.28 980.0299 1,958.04 1,959.05 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYIFQASPADAGQYVcR 95.00% 5.71 0.547 6.82 c16: Carbamidomethyl (+57.02) 980.4768 1,958.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYIFQASPADAGQYVcR 95.00% 5.43 0.558 6.66 c16: Carbamidomethyl (+57.02) 980.4778 1,958.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYIFQASPADAGQYVcR 95.00% 5.6 0.565 7.48 c16: Carbamidomethyl (+57.02) 980.4782 1,958.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% LYIFQASPADAGQYVcR 95.00% 5.47 0.598 7.66 c16: Carbamidomethyl (+57.02) 980.4806 1,958.95 1,958.94 2 DOCK9_HUMAN
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% VVGSSGTQEASVLVTIQQR 95.00% 5.2 0.495 3.16 980.5331 1,959.05 1,959.05 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% ATATScRPcPcPYIDASR 95.00% 3.61 0.431 2.48 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.92 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% ATATScRPcPcPYIDASR 95.00% 4.09 0.448 3.85 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.47 2,082.92 2,082.92 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPVISIDPPSSTVQQGQDASFK 95.00% 5.53 0.527 13.6 1,145.08 2,288.14 2,288.14 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% SPVISIDPPSSTVQQGQDASFK 95.00% 5.21 0.528 10.4 1,145.08 2,288.14 2,288.14 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.36 0.654 4.54 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.39 0.706 5.7 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.21 0.616 7.46 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.44 0.648 5.02 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.23 0.63 5.11 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.25 0.675 5.1 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 4R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 51 62 349 17.40% AASGPGPEQEASFTVTVPPSEGSSYR 95.00% 3.53 0.571 3.68 1,305.12 2,608.22 2,608.22 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SAEPLALGR 95.00% 2.31 0.351 0 457.2582 912.5008 913.5108 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SAEPLALGR 95.00% 2.55 0.376 0 457.2593 912.503 913.5108 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SAEPLALGR 95.00% 2.1 0.262 1.59 457.2594 912.5031 913.5108 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SAEPLALGR 95.00% 2.27 0.41 2.02 457.2597 912.5038 913.5108 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SAEPLALGR 95.00% 2.29 0.428 0 457.26 912.5044 913.5108 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SAEPLALGR 95.00% 2.43 0.346 0 457.26 912.5044 913.5108 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SAEPLALGR 95.00% 2.47 0.346 0 457.2603 912.5049 913.5108 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GHTPTQPGALNQR 95.00% 2.72 0.189 1.21 459.5738 1,375.70 1,376.70 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VKAFAHLQVPER 95.00% 3.47 0.526 1.62 465.6024 1,393.78 1,394.79 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VKAFAHLQVPER 95.00% 3.29 0.497 0 465.6053 1,393.79 1,394.79 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IPGDQVVSVVFIK 95.00% 3.31 0.306 2.31 467.6111 1,399.81 1,400.82 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IPGDQVVSVVFIK 95.00% 3.62 0.47 1.82 467.6113 1,399.81 1,400.82 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IPGDQVVSVVFIK 95.00% 3.93 0.448 1.57 467.6119 1,399.81 1,400.82 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AGFFGDAMK 95.00% 3 0.323 0 472.2202 942.4248 943.4349 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AGFFGDAMK 95.00% 2.34 0.247 0 472.2219 942.4281 943.4349 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AGFFGDAMK 95.00% 2.69 0.274 0 472.222 942.4283 943.4349 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VDSYGGSLR 95.00% 2.14 0.432 0 477.2398 952.4639 953.4693 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AGFFGDAmK 95.00% 2.58 0.298 0 m8: Oxidation (+15.99) 480.2173 958.4189 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AGFFGDAmK 95.00% 3.1 0.259 0 m8: Oxidation (+15.99) 480.2179 958.4201 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AGFFGDAmK 95.00% 2.77 0.177 0 m8: Oxidation (+15.99) 480.2179 958.4202 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LSGSHSQGVAYPVR 95.00% 3.8 0.332 1.48 486.5875 1,456.74 1,457.75 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LSGSHSQGVAYPVR 95.00% 4.37 0.471 1.09 486.588 1,456.74 1,457.75 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LSGSHSQGVAYPVR 95.00% 3.33 0.373 0 486.5894 1,456.74 1,457.75 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LSGSHSQGVAYPVR 95.00% 4.02 0.432 0 486.5907 1,456.75 1,457.75 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RPEEVcGPTQFR 95.00% 3.58 0.414 1.48 c6: Carbamidomethyl (+57.02) 492.5723 1,474.69 1,475.71 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RPEEVcGPTQFR 95.00% 3.72 0.387 1.41 c6: Carbamidomethyl (+57.02) 492.5728 1,474.69 1,475.71 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RPEEVcGPTQFR 95.00% 4.34 0.38 3.07 c6: Carbamidomethyl (+57.02) 492.573 1,474.70 1,475.71 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RPEEVcGPTQFR 95.00% 4.08 0.342 2.26 c6: Carbamidomethyl (+57.02) 492.5733 1,474.70 1,475.71 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RPEEVcGPTQFR 95.00% 4.24 0.37 1.57 c6: Carbamidomethyl (+57.02) 492.5736 1,474.70 1,475.71 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RPEEVcGPTQFR 95.00% 3.72 0.361 2.13 c6: Carbamidomethyl (+57.02) 492.5748 1,474.70 1,475.71 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FDQPDDFK 95.00% 2.76 0.395 0 506.2245 1,010.43 1,011.44 2 LAMA4_HUMAN,SPRL1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FDQPDDFK 95.00% 2.5 0.391 0 506.2247 1,010.43 1,011.44 2 LAMA4_HUMAN,SPRL1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LGTVPQFPR 95.00% 2.46 0.298 2.11 507.7888 1,013.56 1,014.57 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LGTVPQFPR 95.00% 2.72 0.327 1.66 507.7888 1,013.56 1,014.57 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LGTVPQFPR 95.00% 2.19 0.264 1.89 507.7894 1,013.56 1,014.57 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LGTVPQFPR 95.00% 2.27 0.24 1.82 507.7895 1,013.56 1,014.57 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LGTVPQFPR 95.00% 2.48 0.333 1.64 507.7896 1,013.56 1,014.57 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LGTVPQFPR 95.00% 2.2 0.222 1.96 507.7898 1,013.56 1,014.57 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cFcMGVSR 95.00% 2.54 0.407 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 508.7076 1,015.40 1,016.41 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FLGDKVTSYGGELR 95.00% 2.66 0.376 1.7 514.6017 1,540.78 1,541.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FLGDKVTSYGGELR 95.00% 4.35 0.509 2.85 514.6019 1,540.78 1,541.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FLGDKVTSYGGELR 95.00% 4.06 0.462 2.96 514.6022 1,540.78 1,541.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FLGDKVTSYGGELR 95.00% 3.83 0.423 2.74 514.6022 1,540.78 1,541.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FLGDKVTSYGGELR 95.00% 3.79 0.459 2.89 514.6025 1,540.78 1,541.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FLGDKVTSYGGELR 95.00% 3.48 0.381 3.03 514.6028 1,540.78 1,541.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FLGDKVTSYGGELR 95.00% 3.64 0.424 3.27 514.6035 1,540.79 1,541.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FLGDKVTSYGGELR 95.00% 3.71 0.441 2.68 514.9372 1,541.79 1,541.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cFcmGVSR 95.00% 2.25 0.251 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), m4: Oxidation (+15.99) 516.7061 1,031.40 1,032.41 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cFcmGVSR 95.00% 2.52 0.384 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), m4: Oxidation (+15.99) 516.7069 1,031.40 1,032.41 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIEYSPQLEDAGSR 95.00% 3.98 0.517 1.33 517.9136 1,550.72 1,551.73 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LDGSLPPDSR 95.00% 2.68 0.44 1.14 528.7677 1,055.52 1,056.53 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LDGSLPPDSR 95.00% 2.7 0.451 1.34 528.7679 1,055.52 1,056.53 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LDGSLPPDSR 95.00% 2.84 0.401 1.3 528.7679 1,055.52 1,056.53 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LDGSLPPDSR 95.00% 2.59 0.372 0 528.7686 1,055.52 1,056.53 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LDGSLPPDSR 95.00% 2.61 0.464 1.74 528.7688 1,055.52 1,056.53 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LDGSLPPDSR 95.00% 2.51 0.488 1.17 528.769 1,055.52 1,056.53 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% NELLHFER 95.00% 2.68 0.177 0 529.2741 1,056.53 1,057.54 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPAPTIHWSK 95.00% 3.97 0.552 1.96 c1: Carbamidomethyl (+57.02) 533.9248 1,598.75 1,599.76 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPAPTIHWSK 95.00% 4.03 0.553 1.77 c1: Carbamidomethyl (+57.02) 533.9249 1,598.75 1,599.76 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% PGIVQSGGVVR 95.00% 3.11 0.337 0 534.601 1,067.19 1,068.62 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% PGIVQSGGVVR 95.00% 3.5 0.328 0 534.8111 1,067.61 1,068.62 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VAEGQTLDLK 95.00% 3.41 0.494 1.89 537.2928 1,072.57 1,073.58 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VAEGQTLDLK 95.00% 3.08 0.443 2.14 537.2932 1,072.57 1,073.58 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VAEGQTLDLK 95.00% 3.13 0.456 2.74 537.2937 1,072.57 1,073.58 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VAEGQTLDLK 95.00% 3.33 0.492 2.01 537.2941 1,072.57 1,073.58 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VAEGQTLDLK 95.00% 3.68 0.51 2.55 537.2942 1,072.57 1,073.58 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VAEGQTLDLK 95.00% 3.6 0.521 1.33 537.2948 1,072.57 1,073.58 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VAEGQTLDLK 95.00% 3.13 0.49 1.64 537.2949 1,072.57 1,073.58 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VAEGQTLDLK 95.00% 3.09 0.55 1.96 537.2959 1,072.58 1,073.58 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EQAWQRPDGQPATR 95.00% 2.8 0.3 0 547.2675 1,638.78 1,639.79 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EQAWQRPDGQPATR 95.00% 2.43 0.364 0 547.2684 1,638.78 1,639.79 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EQAWQRPDGQPATR 95.00% 2.48 0.37 0 547.2687 1,638.78 1,639.79 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EQAWQRPDGQPATR 95.00% 2.84 0.288 0 547.6035 1,639.79 1,639.79 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RSYEIMFR 95.00% 2.61 0.218 0 551.2763 1,100.54 1,101.55 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RSYEIMFR 95.00% 2.6 0.181 0 551.2769 1,100.54 1,101.55 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LVSEDPINDGEWHR 95.00% 1.99 0.225 0 556.2631 1,665.77 1,666.78 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPQVSPADSGEYVcR 95.00% 4.02 0.403 1.77 c14: Carbamidomethyl (+57.02) 559.9326 1,676.77 1,677.79 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPQVSPADSGEYVcR 95.00% 3.16 0.306 1.77 c14: Carbamidomethyl (+57.02) 559.9327 1,676.77 1,677.79 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LEGDTLIIPR 95.00% 2.08 0.353 0 563.2689 1,124.52 1,126.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LEGDTLIIPR 95.00% 2.25 0.374 1.39 563.269 1,124.52 1,126.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FDAGSGMATIR 95.00% 3.6 0.441 4.8 563.2699 1,124.52 1,125.54 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FDAGSGMATIR 95.00% 3.79 0.412 4.39 563.2705 1,124.53 1,125.54 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FDAGSGMATIR 95.00% 3.49 0.403 4.34 563.2705 1,124.53 1,125.54 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FDAGSGMATIR 95.00% 3.49 0.42 5.52 563.2713 1,124.53 1,125.54 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VPGSPTNLANR 95.00% 3.18 0.495 4.38 563.3021 1,124.59 1,125.60 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VPGSPTNLANR 95.00% 3.11 0.57 3.92 563.3023 1,124.59 1,125.60 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VPGSPTNLANR 95.00% 3.19 0.514 3.48 563.3024 1,124.59 1,125.60 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VPGSPTNLANR 95.00% 3.23 0.574 4.27 563.3026 1,124.59 1,125.60 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VPGSPTNLANR 95.00% 3.31 0.55 3.72 563.3033 1,124.59 1,125.60 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VPGSPTNLANR 95.00% 3.37 0.54 2.77 563.3041 1,124.59 1,125.60 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VGGHLRPGIVQSGGVVR 95.00% 4.3 0.523 2.41 563.3273 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VGGHLRPGIVQSGGVVR 95.00% 4.66 0.572 2 563.3278 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VGGHLRPGIVQSGGVVR 95.00% 4.09 0.462 2.49 563.3282 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VGGHLRPGIVQSGGVVR 95.00% 2.9 0.515 0 563.5824 1,687.72 1,687.97 3 ATPA_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VGGHLRPGIVQSGGVVR 95.00% 4.96 0.54 2.74 563.6613 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VGGHLRPGIVQSGGVVR 95.00% 4.55 0.463 3.31 563.6617 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VGGHLRPGIVQSGGVVR 95.00% 2.9 0.262 1.42 563.6624 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LEGDTLIIPR 95.00% 3.33 0.383 1.33 563.8233 1,125.63 1,126.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LEGDTLIIPR 95.00% 3.05 0.349 2 563.8248 1,125.63 1,126.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LEGDTLIIPR 95.00% 3.37 0.401 1.96 563.8259 1,125.64 1,126.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LEGDTLIIPR 95.00% 3.27 0.422 2.13 563.826 1,125.64 1,126.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LEGDTLIIPR 95.00% 3.6 0.401 1.7 563.8261 1,125.64 1,126.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LEGDTLIIPR 95.00% 3.54 0.396 1.47 563.8263 1,125.64 1,126.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LEGDTLIIPR 95.00% 3.25 0.42 1.82 563.8264 1,125.64 1,126.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LEGDTLIIPR 95.00% 3.48 0.416 2.77 563.8265 1,125.64 1,126.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LEGDTLIIPR 95.00% 3.58 0.405 2.06 563.8265 1,125.64 1,126.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 1.86 0.312 1.72 c14: Carbamidomethyl (+57.02) 568.0812 1,701.22 1,702.82 3 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ESDQGAYTcEAMNAR 95.00% 3.99 0.509 0 c9: Carbamidomethyl (+57.02) 568.23 1,701.67 1,702.68 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ESDQGAYTcEAMNAR 95.00% 3.95 0.457 1.49 c9: Carbamidomethyl (+57.02) 568.2305 1,701.67 1,702.68 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 3.14 0.479 1.44 c14: Carbamidomethyl (+57.02) 568.2782 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 3.28 0.518 1.41 c14: Carbamidomethyl (+57.02) 568.2782 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 4.48 0.415 4.82 c14: Carbamidomethyl (+57.02) 568.2783 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 5.08 0.444 4.42 c14: Carbamidomethyl (+57.02) 568.2783 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 4.68 0.412 5.85 c14: Carbamidomethyl (+57.02) 568.2791 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 4.2 0.466 4.18 c14: Carbamidomethyl (+57.02) 568.2794 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 4.07 0.514 3.85 c14: Carbamidomethyl (+57.02) 568.6132 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 4.63 0.581 2.85 c14: Carbamidomethyl (+57.02) 568.6132 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQVVVLSASDASPPPVK 95.00% 4.26 0.401 4.92 569.66 1,705.96 1,706.97 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQVVVLSASDASPPPVK 95.00% 4.19 0.438 5.07 569.66 1,705.96 1,706.97 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQVVVLSASDASPPPVK 95.00% 3.79 0.457 4.52 569.661 1,705.96 1,706.97 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQVVVLSASDASPPPVK 95.00% 3.72 0.374 2.8 569.6613 1,705.96 1,706.97 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LLQVTPADSGEYVcR 95.00% 4.52 0.486 1.89 c14: Carbamidomethyl (+57.02) 569.9489 1,706.82 1,707.84 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LLQVTPADSGEYVcR 95.00% 5.36 0.534 2.68 c14: Carbamidomethyl (+57.02) 569.9502 1,706.83 1,707.84 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQVVVLSASDASPPPVK 95.00% 4.27 0.464 4.47 569.9943 1,706.96 1,706.97 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQVVVLSASDASPPPVK 95.00% 3.69 0.375 2.52 569.9943 1,706.96 1,706.97 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQVVVLSASDASPPPVK 95.00% 4.73 0.388 3.6 569.9947 1,706.96 1,706.97 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLIHDGAAPISLEWK 95.00% 2.74 0.294 1.19 c1: Carbamidomethyl (+57.02) 570.6265 1,708.86 1,709.87 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLIHDGAAPISLEWK 95.00% 2.37 0.135 1.8 c1: Carbamidomethyl (+57.02) 570.6269 1,708.86 1,709.87 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLIHDGAAPISLEWK 95.00% 2.77 0.0985 2.03 c1: Carbamidomethyl (+57.02) 570.6271 1,708.86 1,709.87 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLIHDGAAPISLEWK 95.00% 2.72 0.307 2 c1: Carbamidomethyl (+57.02) 570.9611 1,709.86 1,709.87 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FDAGSGmATIR 95.00% 3.08 0.404 4.66 m7: Oxidation (+15.99) 571.2668 1,140.52 1,141.53 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FDAGSGmATIR 95.00% 2.89 0.394 4.42 m7: Oxidation (+15.99) 571.2689 1,140.52 1,141.53 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FDAGSGmATIR 95.00% 2.74 0.42 3.55 m7: Oxidation (+15.99) 571.2691 1,140.52 1,141.53 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FDAGSGmATIR 95.00% 2.99 0.448 3.28 m7: Oxidation (+15.99) 571.2694 1,140.52 1,141.53 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FDAGSGmATIR 95.00% 2.37 0.456 3.74 m7: Oxidation (+15.99) 571.2698 1,140.52 1,141.53 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FDAGSGmATIR 95.00% 3.04 0.414 3.09 m7: Oxidation (+15.99) 571.27 1,140.52 1,141.53 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYQASPADSGEYVcR 95.00% 4.5 0.513 3.72 c14: Carbamidomethyl (+57.02) 572.5938 1,714.76 1,715.77 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYQASPADSGEYVcR 95.00% 5.52 0.512 5.09 c14: Carbamidomethyl (+57.02) 572.5944 1,714.76 1,715.77 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHHVSPADSGEYVcR 95.00% 4.83 0.401 3.57 c14: Carbamidomethyl (+57.02) 576.269 1,725.78 1,726.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHHVSPADSGEYVcR 95.00% 4.84 0.402 1.36 c14: Carbamidomethyl (+57.02) 576.2694 1,725.78 1,726.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHHVSPADSGEYVcR 95.00% 5.29 0.436 3.16 c14: Carbamidomethyl (+57.02) 576.2696 1,725.79 1,726.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHHVSPADSGEYVcR 95.00% 5.15 0.465 4.48 c14: Carbamidomethyl (+57.02) 576.2698 1,725.79 1,726.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHHVSPADSGEYVcR 95.00% 2.9 0.367 0 c14: Carbamidomethyl (+57.02) 576.2701 1,725.79 1,726.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHHVSPADSGEYVcR 95.00% 4.9 0.39 2.8 c14: Carbamidomethyl (+57.02) 576.2704 1,725.79 1,726.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHHVSPADSGEYVcR 95.00% 5.09 0.428 1 c14: Carbamidomethyl (+57.02) 576.2705 1,725.79 1,726.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHHVSPADSGEYVcR 95.00% 4.78 0.432 1.85 c14: Carbamidomethyl (+57.02) 576.6031 1,726.79 1,726.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHHVSPADSGEYVcR 95.00% 4.85 0.359 5.46 c14: Carbamidomethyl (+57.02) 576.6037 1,726.79 1,726.80 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIGASVEFHcAVPSDR 95.00% 3.27 0.266 1.2 c10: Carbamidomethyl (+57.02) 577.941 1,730.80 1,731.81 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIGASVEFHcAVPSDR 95.00% 2.44 0.346 1.89 c10: Carbamidomethyl (+57.02) 577.9412 1,730.80 1,731.81 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EGGQLPPGHSVQDGVLR 95.00% 2.23 0.234 0.959 582.6352 1,744.88 1,745.89 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EGGQLPPGHSVQDGVLR 95.00% 2.31 0.23 0 582.9692 1,745.88 1,745.89 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EGGQLPPGHSVQDGVLR 95.00% 2.38 0.229 0 582.9707 1,745.89 1,745.89 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AFAHLQVPER 95.00% 2.62 0.109 1.52 583.7997 1,165.58 1,167.63 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AFAHLQVPER 95.00% 2.78 0.145 1.44 583.8006 1,165.59 1,167.63 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AFAHLQVPER 95.00% 3.29 0.374 2.35 584.3165 1,166.62 1,167.63 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AFAHLQVPER 95.00% 3.06 0.339 3.03 584.3171 1,166.62 1,167.63 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AFAHLQVPER 95.00% 2.9 0.37 2.82 584.3174 1,166.62 1,167.63 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AFAHLQVPER 95.00% 3.17 0.379 3.17 584.318 1,166.62 1,167.63 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AFAHLQVPER 95.00% 3.04 0.375 2.23 584.3189 1,166.62 1,167.63 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AFAHLQVPER 95.00% 2.86 0.371 2.62 584.3195 1,166.62 1,167.63 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHQMSVADSGEYVcR 95.00% 4.38 0.497 0 c14: Carbamidomethyl (+57.02) 584.5981 1,750.77 1,751.78 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% TcESLGAGGYR 95.00% 3 0.49 2.28 c2: Carbamidomethyl (+57.02) 585.7637 1,169.51 1,170.52 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RLGTVPQFPR 95.00% 2.54 0.26 0 585.8401 1,169.66 1,170.67 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RLGTVPQFPR 95.00% 2.45 0.33 0 585.8402 1,169.66 1,170.67 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GDLcEHEENPcQLR 95.00% 3.41 0.314 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.2489 1,755.72 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GDLcEHEENPcQLR 95.00% 3.58 0.306 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.2497 1,755.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GDLcEHEENPcQLR 95.00% 3.75 0.394 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.2499 1,755.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GDLcEHEENPcQLR 95.00% 3.53 0.363 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.2499 1,755.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GDLcEHEENPcQLR 95.00% 3.7 0.332 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.251 1,755.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GDLcEHEENPcQLR 95.00% 3.6 0.253 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.5836 1,756.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 4.84 0.505 1.62 c14: Carbamidomethyl (+57.02) 587.625 1,759.85 1,760.86 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 4.74 0.489 2.28 c14: Carbamidomethyl (+57.02) 587.6254 1,759.85 1,760.86 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% YELGSGLAVLR 95.00% 3.2 0.49 3.18 589.3308 1,176.65 1,177.66 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% YELGSGLAVLR 95.00% 3.68 0.504 4.16 589.3317 1,176.65 1,177.66 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% YELGSGLAVLR 95.00% 3.43 0.503 3.51 589.3318 1,176.65 1,177.66 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% YELGSGLAVLR 95.00% 3.2 0.45 4.55 589.3325 1,176.65 1,177.66 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% YELGSGLAVLR 95.00% 3.33 0.489 3.03 589.3325 1,176.65 1,177.66 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LcNEcADGSFHLSTR 95.00% 3.96 0.441 2.05 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5896 1,765.75 1,766.76 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LcNEcADGSFHLSTR 95.00% 4.21 0.442 2.33 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5906 1,765.75 1,766.76 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LcNEcADGSFHLSTR 95.00% 3.82 0.427 2.21 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5909 1,765.75 1,766.76 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LcNEcADGSFHLSTR 95.00% 4.06 0.381 1.55 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.9242 1,766.75 1,766.76 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LcNEcADGSFHLSTR 95.00% 3.3 0.359 1.57 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.9253 1,766.75 1,766.76 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LcNEcADGSFHLSTR 95.00% 4.22 0.487 3.24 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.9258 1,766.75 1,766.76 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.05 0.555 1.74 597.3148 1,192.61 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.56 0.549 2.17 597.3152 1,192.61 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.63 0.557 2.38 597.3161 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.7 0.566 2.51 597.3164 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.44 0.574 2.01 597.3168 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.44 0.577 2.68 597.3172 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.57 0.549 3.28 597.3177 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.44 0.586 2.92 597.318 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.62 0.596 2.6 597.318 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.4 0.599 2.14 597.318 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.3 0.545 2.22 597.3181 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.8 0.599 2.21 597.3185 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.64 0.557 2.74 597.3186 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.94 0.617 2.7 597.3189 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPAYTLVWTR 95.00% 3.89 0.578 2.1 597.82 1,193.62 1,193.63 2 LU_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EVSEAVVDTLESEYLK 95.00% 4.49 0.483 0 604.3032 1,809.89 1,810.90 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EVSEAVVDTLESEYLK 95.00% 3.95 0.419 1.14 604.6378 1,810.89 1,810.90 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AGLSSGFIGcVR 95.00% 3.87 0.478 3.17 c10: Carbamidomethyl (+57.02) 612.3124 1,222.61 1,223.62 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AGLSSGFIGcVR 95.00% 4.25 0.462 4.38 c10: Carbamidomethyl (+57.02) 612.3134 1,222.61 1,223.62 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AGLSSGFIGcVR 95.00% 4 0.493 4.01 c10: Carbamidomethyl (+57.02) 612.3135 1,222.61 1,223.62 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.49 0.573 3.05 c14: Carbamidomethyl (+57.02) 612.9796 1,835.92 1,836.93 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.49 0.562 2.47 c14: Carbamidomethyl (+57.02) 612.9799 1,835.92 1,836.93 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 5.34 0.589 3.19 c14: Carbamidomethyl (+57.02) 612.9802 1,835.92 1,836.93 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 3.43 0.477 2.74 c14: Carbamidomethyl (+57.02) 612.9803 1,835.92 1,836.93 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 3.19 0.507 2.21 c14: Carbamidomethyl (+57.02) 613.3118 1,836.91 1,836.93 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 3.18 0.47 1.92 c14: Carbamidomethyl (+57.02) 613.3134 1,836.92 1,836.93 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.65 0.525 1.46 c14: Carbamidomethyl (+57.02) 613.3137 1,836.92 1,836.93 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.85 0.557 2.49 c14: Carbamidomethyl (+57.02) 613.314 1,836.92 1,836.93 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.45 0.568 2.18 c14: Carbamidomethyl (+57.02) 613.3148 1,836.92 1,836.93 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 3.54 0.462 0 c14: Carbamidomethyl (+57.02) 613.315 1,836.92 1,836.93 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AAGVPSATITWR 95.00% 1.95 0.368 2.19 615.3337 1,228.65 1,229.66 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AAGVPSATITWR 95.00% 2.48 0.43 3.96 615.3346 1,228.65 1,229.66 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AAGVPSATITWR 95.00% 2.48 0.506 3 615.3347 1,228.65 1,229.66 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AAGVPSATITWR 95.00% 2.67 0.451 3.27 615.3348 1,228.65 1,229.66 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AAGVPSATITWR 95.00% 2.37 0.444 3.14 615.3349 1,228.65 1,229.66 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIVPQGGSHSLR 95.00% 2.34 0.374 2.43 619.3354 1,236.66 1,237.67 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIVPQGGSHSLR 95.00% 2.3 0.37 2.89 619.3356 1,236.66 1,237.67 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIVPQGGSHSLR 95.00% 2.01 0.326 2.02 619.8363 1,237.66 1,237.67 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cQVSGSPPHYFYWSR 95.00% 2.79 0.5 0 c1: Carbamidomethyl (+57.02) 624.2817 1,869.82 1,870.83 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% QPQAIITWYK 95.00% 1.84 0.346 0 624.3414 1,246.67 1,247.68 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% QPQAIITWYK 95.00% 1.81 0.327 0 624.3415 1,246.67 1,247.68 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% QPQAIITWYK 95.00% 1.54 0.401 0 624.3419 1,246.67 1,247.68 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cQVSGSPPHYFYWSR 95.00% 2.59 0.42 0 c1: Carbamidomethyl (+57.02) 624.6151 1,870.82 1,870.83 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cQVSGSPPHYFYWSR 95.00% 3.09 0.466 0 c1: Carbamidomethyl (+57.02) 624.6158 1,870.82 1,870.83 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cQVSGSPPHYFYWSR 95.00% 2.28 0.353 0 c1: Carbamidomethyl (+57.02) 624.6166 1,870.83 1,870.83 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cQVSGSPPHYFYWSR 95.00% 2.72 0.42 0 c1: Carbamidomethyl (+57.02) 624.6173 1,870.83 1,870.83 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLcLPGFSGPR 95.00% 2.67 0.326 1.77 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3013 1,262.59 1,263.60 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLcLPGFSGPR 95.00% 2.84 0.325 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3019 1,262.59 1,263.60 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLcLPGFSGPR 95.00% 2.61 0.338 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3023 1,262.59 1,263.60 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLcLPGFSGPR 95.00% 2.56 0.343 1.21 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3023 1,262.59 1,263.60 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLcLPGFSGPR 95.00% 2.66 0.307 1.35 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3024 1,262.59 1,263.60 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AmDFNGILTIR 95.00% 2.47 0.258 1.92 m2: Oxidation (+15.99) 633.8259 1,265.64 1,266.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AmDFNGILTIR 95.00% 3.54 0.543 2.39 m2: Oxidation (+15.99) 633.8275 1,265.64 1,266.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AmDFNGILTIR 95.00% 3.67 0.556 2.43 m2: Oxidation (+15.99) 633.8281 1,265.64 1,266.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AmDFNGILTIR 95.00% 3.6 0.501 2.38 m2: Oxidation (+15.99) 633.8284 1,265.64 1,266.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AmDFNGILTIR 95.00% 3.68 0.439 2.74 m2: Oxidation (+15.99) 633.8285 1,265.64 1,266.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AmDFNGILTIR 95.00% 3.38 0.488 1.92 m2: Oxidation (+15.99) 633.8286 1,265.64 1,266.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AmDFNGILTIR 95.00% 3.84 0.555 2.22 m2: Oxidation (+15.99) 633.8291 1,265.64 1,266.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AmDFNGILTIR 95.00% 3.91 0.563 1.96 m2: Oxidation (+15.99) 633.8291 1,265.64 1,266.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AmDFNGILTIR 95.00% 3.64 0.503 2.11 m2: Oxidation (+15.99) 633.8294 1,265.64 1,266.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRFDQPDDFK 95.00% 2.76 0.379 1.92 640.8151 1,279.61 1,280.63 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRFDQPDDFK 95.00% 2.78 0.339 1.57 640.8161 1,279.62 1,280.63 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% QPDFISFGLVGGRPEFR 95.00% 2.42 0.456 1.62 641.3333 1,920.98 1,921.99 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% QPDFISFGLVGGRPEFR 95.00% 2.21 0.3 1.15 641.6701 1,921.99 1,921.99 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% QPDFISFGLVGGRPEFR 95.00% 2.66 0.414 2.62 641.6702 1,921.99 1,921.99 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cAPGYYGNPSQGQPcQR 95.00% 4.76 0.429 4.08 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.2767 1,938.81 1,939.82 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cAPGYYGNPSQGQPcQR 95.00% 3.27 0.177 0 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.6107 1,939.81 1,939.82 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cAPGYYGNPSQGQPcQR 95.00% 5.54 0.404 4.96 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.611 1,939.81 1,939.82 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 5.38 0.589 4.74 c16: Carbamidomethyl (+57.02) 649.6624 1,945.96 1,946.98 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 5.84 0.626 5.16 c16: Carbamidomethyl (+57.02) 649.6633 1,945.97 1,946.98 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 5.48 0.572 4.74 c16: Carbamidomethyl (+57.02) 649.6636 1,945.97 1,946.98 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 3.15 0.475 3.42 c16: Carbamidomethyl (+57.02) 649.9942 1,946.96 1,946.98 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 4.93 0.579 4.42 c16: Carbamidomethyl (+57.02) 649.9955 1,946.96 1,946.98 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 4.88 0.581 5 c16: Carbamidomethyl (+57.02) 649.9964 1,946.97 1,946.98 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 6.07 0.579 5.42 c16: Carbamidomethyl (+57.02) 649.997 1,946.97 1,946.98 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 5.7 0.583 6.74 c16: Carbamidomethyl (+57.02) 649.997 1,946.97 1,946.98 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 5.57 0.589 5.14 c16: Carbamidomethyl (+57.02) 649.997 1,946.97 1,946.98 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 5.5 0.59 5.72 c16: Carbamidomethyl (+57.02) 649.9978 1,946.97 1,946.98 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 5.78 0.599 5.55 c16: Carbamidomethyl (+57.02) 649.9982 1,946.97 1,946.98 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 4.69 0.436 1.19 653.6874 1,958.04 1,959.05 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 4.98 0.438 1.72 653.688 1,958.04 1,959.05 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 4.85 0.439 0 653.6883 1,958.04 1,959.05 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 3.6 0.355 0 653.6889 1,958.04 1,959.05 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYIFQASPADAGQYVcR 95.00% 4.94 0.431 3.07 c16: Carbamidomethyl (+57.02) 653.987 1,958.94 1,958.94 3 DOCK9_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYIFQASPADAGQYVcR 95.00% 5.23 0.464 2.28 c16: Carbamidomethyl (+57.02) 653.9871 1,958.94 1,958.94 3 DOCK9_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 3.63 0.357 0 654.0218 1,959.04 1,959.05 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 4.28 0.403 0 654.0227 1,959.04 1,959.05 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 4.57 0.421 0 654.0234 1,959.05 1,959.05 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIEYSPQLEDAGSREFR 95.00% 2.12 0.252 0 662.3158 1,983.92 1,983.94 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIEYSPQLEDAGSREFR 95.00% 2.05 0.273 0 662.3201 1,983.94 1,983.94 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% PcPcPYIDASR 95.00% 2.09 0.288 0 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 668.2907 1,334.57 1,335.58 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ITFRPDSADGMLLYNGQK 95.00% 4.35 0.507 0 676.3402 2,026.00 2,026.01 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% TPSGLYLGTcER 95.00% 3.2 0.347 2.21 c10: Carbamidomethyl (+57.02) 677.325 1,352.63 1,353.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% TPSGLYLGTcER 95.00% 3.38 0.397 2.77 c10: Carbamidomethyl (+57.02) 677.325 1,352.63 1,353.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% TPSGLYLGTcER 95.00% 3.78 0.452 4.43 c10: Carbamidomethyl (+57.02) 677.3252 1,352.63 1,353.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% TPSGLYLGTcER 95.00% 3.28 0.339 1.48 c10: Carbamidomethyl (+57.02) 677.3256 1,352.64 1,353.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% TPSGLYLGTcER 95.00% 3.98 0.412 4.15 c10: Carbamidomethyl (+57.02) 677.3258 1,352.64 1,353.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% TPSGLYLGTcER 95.00% 4.1 0.422 4.28 c10: Carbamidomethyl (+57.02) 677.3261 1,352.64 1,353.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% TPSGLYLGTcER 95.00% 3.4 0.44 3.43 c10: Carbamidomethyl (+57.02) 677.3266 1,352.64 1,353.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% TPSGLYLGTcER 95.00% 1.9 0.289 1.47 c10: Carbamidomethyl (+57.02) 677.3271 1,352.64 1,353.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% TPSGLYLGTcER 95.00% 2.73 0.31 1.85 c10: Carbamidomethyl (+57.02) 677.3271 1,352.64 1,353.65 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% DVKESDQGAYTcEAMNAR 95.00% 4.93 0.428 2.82 c12: Carbamidomethyl (+57.02) 682.2939 2,043.86 2,044.87 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% DVKESDQGAYTcEAMNAR 95.00% 4.69 0.448 2.89 c12: Carbamidomethyl (+57.02) 682.2946 2,043.86 2,044.87 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% DVKESDQGAYTcEAMNAR 95.00% 3.95 0.331 1.92 c12: Carbamidomethyl (+57.02) 682.6287 2,044.86 2,044.87 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GMLEPVQRPDVVLVGAGYR 95.00% 2.79 0.417 2.64 686.3703 2,056.09 2,056.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% PSDAGTYVcLAQNALGTAQK 95.00% 4.79 0.431 0 c9: Carbamidomethyl (+57.02) 689.005 2,063.99 2,065.00 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% PSDAGTYVcLAQNALGTAQK 95.00% 4.89 0.461 0 c9: Carbamidomethyl (+57.02) 689.006 2,063.99 2,065.00 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% PSDAGTYVcLAQNALGTAQK 95.00% 5.61 0.439 0 c9: Carbamidomethyl (+57.02) 689.3386 2,064.99 2,065.00 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% PSDAGTYVcLAQNALGTAQK 95.00% 5.99 0.462 0 c9: Carbamidomethyl (+57.02) 689.3391 2,064.99 2,065.00 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GmLEPVQRPDVVLVGAGYR 95.00% 2.61 0.362 3.33 m2: Oxidation (+15.99) 691.7024 2,072.08 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GmLEPVQRPDVVLVGAGYR 95.00% 3.03 0.435 2.96 m2: Oxidation (+15.99) 691.7031 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GmLEPVQRPDVVLVGAGYR 95.00% 4.37 0.582 4.57 m2: Oxidation (+15.99) 691.7032 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GmLEPVQRPDVVLVGAGYR 95.00% 4.42 0.61 3.47 m2: Oxidation (+15.99) 691.7036 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RcEScAPGYEGNPIQPGGK 95.00% 3.59 0.494 1.55 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3129 2,076.92 2,076.92 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RcEScAPGYEGNPIQPGGK 95.00% 4.3 0.508 3.26 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3129 2,076.92 2,076.92 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RcEScAPGYEGNPIQPGGK 95.00% 4.09 0.412 1.85 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3131 2,076.92 2,076.92 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RcEScAPGYEGNPIQPGGK 95.00% 3.01 0.39 1.35 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3147 2,076.92 2,076.92 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AVTLEcVSAGEPR 95.00% 2.8 0.192 1.39 c6: Carbamidomethyl (+57.02) 694.8423 1,387.67 1,388.68 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AVTLEcVSAGEPR 95.00% 2.68 0.176 1.16 c6: Carbamidomethyl (+57.02) 694.8427 1,387.67 1,388.68 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ATATScRPcPcPYIDASR 95.00% 3.06 0.337 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.9736 2,081.90 2,082.92 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ATATScRPcPcPYIDASR 95.00% 4.22 0.511 2.01 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.976 2,081.90 2,082.92 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ATATScRPcPcPYIDASR 95.00% 3.4 0.534 1.48 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.9768 2,081.91 2,082.92 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ATATScRPcPcPYIDASR 95.00% 2.61 0.382 1.28 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.31 2,082.91 2,082.92 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ATATScRPcPcPYIDASR 95.00% 3.09 0.368 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3104 2,082.91 2,082.92 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ATATScRPcPcPYIDASR 95.00% 3.72 0.429 2.8 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3105 2,082.91 2,082.92 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ATATScRPcPcPYIDASR 95.00% 3.95 0.499 2.51 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3106 2,082.91 2,082.92 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AVTLEcVSAGEPR 95.00% 2.51 0.367 1.66 c6: Carbamidomethyl (+57.02) 695.3481 1,388.68 1,388.68 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IPGDQVVSVVFIK 95.00% 3.96 0.509 3.8 700.909 1,399.80 1,400.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IPGDQVVSVVFIK 95.00% 4.12 0.517 3.66 700.9098 1,399.80 1,400.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IPGDQVVSVVFIK 95.00% 4.44 0.522 2.66 700.91 1,399.80 1,400.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IPGDQVVSVVFIK 95.00% 4.41 0.53 3.08 700.9103 1,399.81 1,400.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IPGDQVVSVVFIK 95.00% 4.46 0.543 2.08 700.9108 1,399.81 1,400.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SKSPAYTLVWTR 95.00% 1.92 0.324 0 704.8813 1,407.75 1,408.76 2 TENA_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IAHVELADAGQYR 95.00% 4.31 0.515 4.1 721.8717 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IAHVELADAGQYR 95.00% 4.57 0.545 4.24 721.8722 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IAHVELADAGQYR 95.00% 4.65 0.558 3.15 721.8725 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IAHVELADAGQYR 95.00% 4.45 0.503 3.7 721.8733 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IAHVELADAGQYR 95.00% 4.38 0.504 3.66 721.8734 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IAHVELADAGQYR 95.00% 4.43 0.545 2.74 721.8743 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GSIQVDGEELVSGR 95.00% 3.25 0.503 5.96 723.3632 1,444.71 1,445.72 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GSIQVDGEELVSGR 95.00% 3.57 0.552 5.38 723.3633 1,444.71 1,445.72 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LSGSHSQGVAYPVR 95.00% 3.33 0.499 3.14 728.8618 1,455.71 1,457.75 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LSGSHSQGVAYPVR 95.00% 3.66 0.489 3.46 728.8647 1,455.71 1,457.75 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% DGFKGDLcEHEENPcQLR 95.00% 3.89 0.476 1.12 c8: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 735.6569 2,203.95 2,203.95 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RPEEVcGPTQFR 95.00% 2.94 0.414 4.24 c6: Carbamidomethyl (+57.02) 738.3553 1,474.70 1,475.71 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RPEEVcGPTQFR 95.00% 3.51 0.449 5.03 c6: Carbamidomethyl (+57.02) 738.3554 1,474.70 1,475.71 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RPEEVcGPTQFR 95.00% 3.78 0.428 4.2 c6: Carbamidomethyl (+57.02) 738.3558 1,474.70 1,475.71 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RPEEVcGPTQFR 95.00% 3.8 0.389 5 c6: Carbamidomethyl (+57.02) 738.3568 1,474.70 1,475.71 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RPEEVcGPTQFR 95.00% 3.42 0.4 4.74 c6: Carbamidomethyl (+57.02) 738.3578 1,474.70 1,475.71 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPVISIDPPSSTVQQGQDASFK 95.00% 3.97 0.539 1.09 763.7176 2,288.13 2,288.14 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPVISIDPPSSTVQQGQDASFK 95.00% 4.92 0.448 2.01 763.7178 2,288.13 2,288.14 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPVISIDPPSSTVQQGQDASFK 95.00% 4.46 0.461 0 763.7183 2,288.13 2,288.14 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPVISIDPPSSTVQQGQDASFK 95.00% 4.23 0.516 1.8 763.7184 2,288.13 2,288.14 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cDGDFDcEDRTDEANcPTK 95.00% 4.13 0.549 1.7 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 769.2878 2,304.84 2,304.84 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cDGDFDcEDRTDEANcPTK 95.00% 4.09 0.528 1.55 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 769.2885 2,304.84 2,304.84 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cDGDFDcEDRTDEANcPTK 95.00% 3.46 0.408 0 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 769.2888 2,304.84 2,304.84 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.6 0.657 1.89 771.0899 2,310.25 2,310.26 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.62 0.624 2.89 771.0901 2,310.25 2,310.26 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.66 0.653 3.06 771.0902 2,310.25 2,310.26 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.95 0.622 2.3 771.0908 2,310.25 2,310.26 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.67 0.649 3.04 771.0908 2,310.25 2,310.26 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.92 0.651 2.37 771.0909 2,310.25 2,310.26 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.53 0.65 2.39 771.0911 2,310.25 2,310.26 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FLGDKVTSYGGELR 95.00% 4.59 0.534 4.17 771.4004 1,540.79 1,541.80 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FLGDKVTSYGGELR 95.00% 4.87 0.508 3.6 771.4012 1,540.79 1,541.80 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FLGDKVTSYGGELR 95.00% 4.62 0.547 4.39 771.4024 1,540.79 1,541.80 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% FLGDKVTSYGGELR 95.00% 4.5 0.511 4.12 771.4026 1,540.79 1,541.80 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIEYSPQLEDAGSR 95.00% 4.44 0.561 6.21 776.3663 1,550.72 1,551.73 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIEYSPQLEDAGSR 95.00% 4.86 0.578 4.42 776.3669 1,550.72 1,551.73 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIEYSPQLEDAGSR 95.00% 4.45 0.619 5.24 776.3673 1,550.72 1,551.73 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIEYSPQLEDAGSR 95.00% 4.28 0.584 5.08 776.3678 1,550.72 1,551.73 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIEYSPQLEDAGSR 95.00% 4.69 0.584 3.59 776.368 1,550.72 1,551.73 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIEYSPQLEDAGSR 95.00% 4.57 0.617 3.36 776.3686 1,550.72 1,551.73 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 3.81 0.497 1.24 c1: Carbamidomethyl (+57.02) 791.0511 2,370.13 2,370.14 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5.11 0.624 4.54 c1: Carbamidomethyl (+57.02) 791.0532 2,370.14 2,370.14 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 3.55 0.497 0 c1: Carbamidomethyl (+57.02) 791.0534 2,370.14 2,370.14 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5.88 0.604 5.04 c1: Carbamidomethyl (+57.02) 791.0535 2,370.14 2,370.14 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 6.06 0.59 4.14 c1: Carbamidomethyl (+57.02) 791.0541 2,370.14 2,370.14 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 6.32 0.585 3.96 c18: Carbamidomethyl (+57.02) 792.4009 2,374.18 2,374.19 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.45 0.535 3.55 c18: Carbamidomethyl (+57.02) 792.4019 2,374.18 2,374.19 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.2 0.547 3.43 c18: Carbamidomethyl (+57.02) 792.4022 2,374.18 2,374.19 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 6.43 0.588 4.62 c18: Carbamidomethyl (+57.02) 792.4022 2,374.18 2,374.19 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.03 0.488 2.48 c18: Carbamidomethyl (+57.02) 792.4039 2,374.19 2,374.19 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPAPTIHWSK 95.00% 3.78 0.57 5.85 c1: Carbamidomethyl (+57.02) 800.3807 1,598.75 1,599.76 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPAPTIHWSK 95.00% 3.79 0.58 4.29 c1: Carbamidomethyl (+57.02) 800.3828 1,598.75 1,599.76 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SLPEVPETIELEVR 95.00% 3.7 0.616 5 805.935 1,609.85 1,610.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SLPEVPETIELEVR 95.00% 3.61 0.602 6.1 806.4362 1,610.86 1,610.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 3.94 0.519 2.23 817.1099 2,448.31 2,448.31 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 4.84 0.49 3.68 817.11 2,448.31 2,448.31 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EQAWQRPDGQPATR 95.00% 2.74 0.201 0 820.3984 1,638.78 1,639.79 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EQAWQRPDGQPATR 95.00% 2.81 0.235 0 820.4037 1,638.79 1,639.79 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LVSEDPINDGEWHR 95.00% 3.63 0.577 3.12 833.8946 1,665.77 1,666.78 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPQVSPADSGEYVcR 95.00% 4.23 0.578 4.8 c14: Carbamidomethyl (+57.02) 839.3972 1,676.78 1,677.79 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPQVSPADSGEYVcR 95.00% 4.92 0.581 5.42 c14: Carbamidomethyl (+57.02) 839.3979 1,676.78 1,677.79 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPQVSPADSGEYVcR 95.00% 5.04 0.585 6.46 c14: Carbamidomethyl (+57.02) 839.3981 1,676.78 1,677.79 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPQVSPADSGEYVcR 95.00% 4.44 0.563 6 c14: Carbamidomethyl (+57.02) 839.3982 1,676.78 1,677.79 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPQVSPADSGEYVcR 95.00% 3.79 0.585 5.46 c14: Carbamidomethyl (+57.02) 839.3989 1,676.78 1,677.79 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPQVSPADSGEYVcR 95.00% 4.29 0.578 4.21 c14: Carbamidomethyl (+57.02) 839.399 1,676.78 1,677.79 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPQVSPADSGEYVcR 95.00% 5.25 0.562 4.6 c14: Carbamidomethyl (+57.02) 839.8983 1,677.78 1,677.79 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VGGHLRPGIVQSGGVVR 95.00% 3.5 0.393 2.92 844.4873 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VGGHLRPGIVQSGGVVR 95.00% 3.92 0.534 2.28 844.4875 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VGGHLRPGIVQSGGVVR 95.00% 4.04 0.522 2.72 844.4889 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VGGHLRPGIVQSGGVVR 95.00% 3.62 0.433 2.12 844.4898 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GSVYIGGAPDVATLTGGR 95.00% 4.36 0.53 2.85 845.9402 1,689.86 1,690.88 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GSVYIGGAPDVATLTGGR 95.00% 4.69 0.546 3.4 845.9414 1,689.87 1,690.88 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GSVYIGGAPDVATLTGGR 95.00% 5.21 0.561 4.07 845.9415 1,689.87 1,690.88 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GSVYIGGAPDVATLTGGR 95.00% 4.77 0.562 3.96 845.943 1,689.87 1,690.88 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GSVYIGGAPDVATLTGGR 95.00% 4.84 0.513 3.57 845.945 1,689.87 1,690.88 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLIHDGAAPISLEWK 95.00% 0 0 4.96 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 846.9225 1,691.83 1,692.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLIHDGAAPISLEWK 95.00% 0 0 4.92 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 846.923 1,691.83 1,692.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLIHDGAAPISLEWK 95.00% 0 0 5.77 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 847.4245 1,692.83 1,692.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ESDQGAYTcEAMNAR 95.00% 4.36 0.548 5.36 c9: Carbamidomethyl (+57.02) 851.8423 1,701.67 1,702.68 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ESDQGAYTcEAMNAR 95.00% 4.32 0.56 3.19 c9: Carbamidomethyl (+57.02) 851.8426 1,701.67 1,702.68 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ESDQGAYTcEAMNAR 95.00% 4.15 0.554 3.06 c9: Carbamidomethyl (+57.02) 851.8442 1,701.67 1,702.68 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ESDQGAYTcEAMNAR 95.00% 3.9 0.416 3.35 c9: Carbamidomethyl (+57.02) 851.8452 1,701.67 1,702.68 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 4.16 0.405 6.28 c14: Carbamidomethyl (+57.02) 851.9127 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 4.2 0.428 7 c14: Carbamidomethyl (+57.02) 851.9128 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 3.77 0.374 4.09 c14: Carbamidomethyl (+57.02) 851.9134 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 4.56 0.345 6.39 c14: Carbamidomethyl (+57.02) 852.4142 1,702.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 3.87 0.339 5.6 c14: Carbamidomethyl (+57.02) 852.4174 1,702.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHLVSPADSGEYVcR 95.00% 4.32 0.38 6.64 c14: Carbamidomethyl (+57.02) 852.4185 1,702.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRSPVISIDPPSSTVQQGQDASFK 95.00% 7.11 0.647 6.42 853.4463 2,557.32 2,557.33 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRSPVISIDPPSSTVQQGQDASFK 95.00% 5.48 0.536 5.47 853.4463 2,557.32 2,557.33 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRSPVISIDPPSSTVQQGQDASFK 95.00% 7.16 0.636 7.34 853.4468 2,557.32 2,557.33 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.03 0.629 4.38 853.4476 2,557.32 2,557.33 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQVVVLSASDASPPPVK 95.00% 4.29 0.472 6.02 853.9882 1,705.96 1,706.97 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LLQVTPADSGEYVcR 95.00% 4.68 0.413 3.96 c14: Carbamidomethyl (+57.02) 854.4112 1,706.81 1,707.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LLQVTPADSGEYVcR 95.00% 4.25 0.206 4.6 c14: Carbamidomethyl (+57.02) 854.4138 1,706.81 1,707.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LLQVTPADSGEYVcR 95.00% 4.44 0.323 3.85 c14: Carbamidomethyl (+57.02) 854.415 1,706.81 1,707.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LLQVTPADSGEYVcR 95.00% 4.24 0.473 3.85 c14: Carbamidomethyl (+57.02) 854.4181 1,706.82 1,707.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LLQVTPADSGEYVcR 95.00% 4.87 0.628 4.89 c14: Carbamidomethyl (+57.02) 854.4187 1,706.82 1,707.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LLQVTPADSGEYVcR 95.00% 4.45 0.67 5.17 c14: Carbamidomethyl (+57.02) 854.4215 1,706.83 1,707.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQVVVLSASDASPPPVK 95.00% 3.58 0.113 4.42 854.4857 1,706.96 1,706.97 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQVVVLSASDASPPPVK 95.00% 3.57 0.441 6.01 854.4879 1,706.96 1,706.97 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQVVVLSASDASPPPVK 95.00% 3.42 0.441 5.13 854.4886 1,706.96 1,706.97 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQVVVLSASDASPPPVK 95.00% 3.83 0.425 5.35 854.489 1,706.96 1,706.97 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.19 0.498 1.72 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7265 2,561.16 2,561.17 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.99 0.558 2.59 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7281 2,561.16 2,561.17 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LLQVTPADSGEYVcR 95.00% 4.33 0.346 3.74 c14: Carbamidomethyl (+57.02) 854.9129 1,707.81 1,707.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LLQVTPADSGEYVcR 95.00% 4.53 0.519 4.29 c14: Carbamidomethyl (+57.02) 854.9193 1,707.82 1,707.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LLQVTPADSGEYVcR 95.00% 4.74 0.566 4.51 c14: Carbamidomethyl (+57.02) 854.9212 1,707.83 1,707.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LLQVTPADSGEYVcR 95.00% 4.59 0.603 3.66 c14: Carbamidomethyl (+57.02) 854.9219 1,707.83 1,707.84 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLIHDGAAPISLEWK 95.00% 4.86 0.613 6.23 c1: Carbamidomethyl (+57.02) 855.4364 1,708.86 1,709.87 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLIHDGAAPISLEWK 95.00% 4.91 0.59 6.38 c1: Carbamidomethyl (+57.02) 855.4375 1,708.86 1,709.87 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLIHDGAAPISLEWK 95.00% 3.71 0.498 0 c1: Carbamidomethyl (+57.02) 855.4382 1,708.86 1,709.87 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cLIHDGAAPISLEWK 95.00% 3.64 0.447 1.8 c1: Carbamidomethyl (+57.02) 855.9372 1,709.86 1,709.87 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYQASPADSGEYVcR 95.00% 4.61 0.601 4.96 c14: Carbamidomethyl (+57.02) 858.3864 1,714.76 1,715.77 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYQASPADSGEYVcR 95.00% 5.32 0.583 6.25 c14: Carbamidomethyl (+57.02) 858.387 1,714.76 1,715.77 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYQASPADSGEYVcR 95.00% 5.23 0.609 6.26 c14: Carbamidomethyl (+57.02) 858.3875 1,714.76 1,715.77 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYQASPADSGEYVcR 95.00% 4.14 0.567 3.92 c14: Carbamidomethyl (+57.02) 858.3878 1,714.76 1,715.77 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYQASPADSGEYVcR 95.00% 5.31 0.642 4.8 c14: Carbamidomethyl (+57.02) 858.3893 1,714.76 1,715.77 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYQASPADSGEYVcR 95.00% 3.81 0.523 4.28 c14: Carbamidomethyl (+57.02) 858.3961 1,714.78 1,715.77 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYQASPADSGEYVcR 95.00% 5.14 0.608 6.22 c14: Carbamidomethyl (+57.02) 858.8869 1,715.76 1,715.77 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYQASPADSGEYVcR 95.00% 4.96 0.576 5.41 c14: Carbamidomethyl (+57.02) 858.8888 1,715.76 1,715.77 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYQASPADSGEYVcR 95.00% 4.87 0.585 4.7 c14: Carbamidomethyl (+57.02) 858.8889 1,715.76 1,715.77 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYQASPADSGEYVcR 95.00% 5.14 0.578 6.66 c14: Carbamidomethyl (+57.02) 858.889 1,715.76 1,715.77 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LHHVSPADSGEYVcR 95.00% 3.16 0.375 0 c14: Carbamidomethyl (+57.02) 863.9011 1,725.79 1,726.80 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIGASVEFHcAVPSDR 95.00% 4.22 0.441 2.92 c10: Carbamidomethyl (+57.02) 866.4065 1,730.80 1,731.81 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIGASVEFHcAVPSDR 95.00% 4.57 0.387 3.51 c10: Carbamidomethyl (+57.02) 866.4085 1,730.80 1,731.81 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIGASVEFHcAVPSDR 95.00% 3.96 0.392 3.05 c10: Carbamidomethyl (+57.02) 866.9087 1,731.80 1,731.81 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIGASVEFHcAVPSDR 95.00% 4.44 0.387 2.26 c10: Carbamidomethyl (+57.02) 866.9108 1,731.81 1,731.81 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIGASVEFHcAVPSDR 95.00% 4.28 0.394 2.14 c10: Carbamidomethyl (+57.02) 866.9108 1,731.81 1,731.81 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EGGQLPPGHSVQDGVLR 95.00% 3.65 0.529 3.14 873.4478 1,744.88 1,745.89 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EGGQLPPGHSVQDGVLR 95.00% 3.88 0.527 3.66 873.4491 1,744.88 1,745.89 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EGGQLPPGHSVQDGVLR 95.00% 3.18 0.487 3.62 873.4499 1,744.88 1,745.89 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EGGQLPPGHSVQDGVLR 95.00% 3.56 0.511 2.68 873.4503 1,744.88 1,745.89 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EGGQLPPGHSVQDGVLR 95.00% 3.25 0.497 3.59 873.4505 1,744.89 1,745.89 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EGGQLPPGHSVQDGVLR 95.00% 3.47 0.514 4.1 873.951 1,745.89 1,745.89 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% GDLcEHEENPcQLR 95.00% 4.42 0.514 2.44 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 878.8717 1,755.73 1,756.74 2 NID1_HUMAN,DESP_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EASITVSVLHGTHSGPSYTPVPGSTR 95.00% 5.66 0.602 0 880.1149 2,637.32 2,637.33 3
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 5.22 0.55 5.04 c14: Carbamidomethyl (+57.02) 880.9315 1,759.85 1,760.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 5.14 0.557 5.37 c14: Carbamidomethyl (+57.02) 880.9322 1,759.85 1,760.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 5.02 0.557 5.03 c14: Carbamidomethyl (+57.02) 880.9328 1,759.85 1,760.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 3.75 0.502 3.82 c14: Carbamidomethyl (+57.02) 880.9336 1,759.85 1,760.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 5.2 0.616 5.12 c14: Carbamidomethyl (+57.02) 880.9337 1,759.85 1,760.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 4.32 0.529 5.82 c14: Carbamidomethyl (+57.02) 880.9338 1,759.85 1,760.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 5.11 0.591 5.59 c14: Carbamidomethyl (+57.02) 880.9343 1,759.85 1,760.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 4.12 0.556 3.96 c14: Carbamidomethyl (+57.02) 880.9343 1,759.85 1,760.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 4.49 0.612 3.82 c14: Carbamidomethyl (+57.02) 880.9363 1,759.86 1,760.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 4.02 0.518 4.48 c14: Carbamidomethyl (+57.02) 881.433 1,760.85 1,760.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LPAVEPTDQAQYLcR 95.00% 4.33 0.529 4.46 c14: Carbamidomethyl (+57.02) 881.4369 1,760.86 1,760.86 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LcNEcADGSFHLSTR 95.00% 5.48 0.597 4 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8813 1,765.75 1,766.76 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LcNEcADGSFHLSTR 95.00% 4.81 0.604 4.66 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8813 1,765.75 1,766.76 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LcNEcADGSFHLSTR 95.00% 5.63 0.591 5.41 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8823 1,765.75 1,766.76 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LcNEcADGSFHLSTR 95.00% 5.38 0.598 4.42 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.3841 1,766.75 1,766.76 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LcNEcADGSFHLSTR 95.00% 5.35 0.601 4.31 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.3841 1,766.75 1,766.76 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EVSEAVVDTLESEYLK 95.00% 5.79 0.531 4.16 905.9478 1,809.88 1,810.90 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EVSEAVVDTLESEYLK 95.00% 5.86 0.518 5.12 905.9488 1,809.88 1,810.90 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EVSEAVVDTLESEYLK 95.00% 5.65 0.528 4.8 905.9502 1,809.88 1,810.90 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EVSEAVVDTLESEYLK 95.00% 4.78 0.476 3.77 906.4528 1,810.89 1,810.90 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% EVSEAVVDTLESEYLK 95.00% 5.85 0.486 5.07 906.4543 1,810.89 1,810.90 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SDEFGcMPPQVVTPPR 95.00% 3.61 0.541 2.66 c6: Carbamidomethyl (+57.02) 908.9208 1,815.83 1,816.84 2 ANXA5_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SDEFGcMPPQVVTPPR 95.00% 3.97 0.469 3.16 c6: Carbamidomethyl (+57.02) 909.4223 1,816.83 1,816.84 2 ANXA5_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SDEFGcmPPQVVTPPR 95.00% 4 0.535 3.52 c6: Carbamidomethyl (+57.02), m7: Oxidation (+15.99) 916.9162 1,831.82 1,832.83 2 ANXA5_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SDEFGcmPPQVVTPPR 95.00% 3.8 0.548 2.85 c6: Carbamidomethyl (+57.02), m7: Oxidation (+15.99) 917.4167 1,832.82 1,832.83 2 ANXA5_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.49 0.477 3.92 c14: Carbamidomethyl (+57.02) 918.9649 1,835.91 1,836.93 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.03 0.526 4.05 c14: Carbamidomethyl (+57.02) 918.9657 1,835.92 1,836.93 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.49 0.494 3.48 c14: Carbamidomethyl (+57.02) 918.967 1,835.92 1,836.93 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.49 0.484 4.21 c14: Carbamidomethyl (+57.02) 918.9683 1,835.92 1,836.93 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.45 0.41 4.52 c14: Carbamidomethyl (+57.02) 919.4672 1,836.92 1,836.93 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.4 0.407 4 c14: Carbamidomethyl (+57.02) 919.4687 1,836.92 1,836.93 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.22 0.407 4.24 c14: Carbamidomethyl (+57.02) 919.4688 1,836.92 1,836.93 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SQSVRPGADVTFIcTAK 95.00% 4.46 0.425 2.92 c14: Carbamidomethyl (+57.02) 919.469 1,836.92 1,836.93 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cQVSGSPPHYFYWSR 95.00% 5.14 0.593 3.92 c1: Carbamidomethyl (+57.02) 936.4184 1,870.82 1,870.83 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cQVSGSPPHYFYWSR 95.00% 4.98 0.572 3.23 c1: Carbamidomethyl (+57.02) 936.4201 1,870.82 1,870.83 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cQVSGSPPHYFYWSR 95.00% 4.23 0.573 2.85 c1: Carbamidomethyl (+57.02) 936.4206 1,870.83 1,870.83 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cEScAPGYEGNPIQPGGK 95.00% 5.2 0.516 7.44 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 960.9127 1,919.81 1,920.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cEScAPGYEGNPIQPGGK 95.00% 4.84 0.498 6.04 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 960.9145 1,919.81 1,920.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cEScAPGYEGNPIQPGGK 95.00% 3.97 0.446 2.38 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 961.413 1,920.81 1,920.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cEScAPGYEGNPIQPGGK 95.00% 4.75 0.469 5.62 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 961.4134 1,920.81 1,920.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cEScAPGYEGNPIQPGGK 95.00% 4.66 0.436 3.77 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 961.414 1,920.81 1,920.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cAPGYYGNPSQGQPcQR 95.00% 4.81 0.66 6.82 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4087 1,938.80 1,939.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cAPGYYGNPSQGQPcQR 95.00% 4.23 0.708 8.51 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4099 1,938.80 1,939.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cAPGYYGNPSQGQPcQR 95.00% 4.16 0.658 5.44 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4118 1,938.81 1,939.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cAPGYYGNPSQGQPcQR 95.00% 4.65 0.601 5.49 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9106 1,939.81 1,939.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cAPGYYGNPSQGQPcQR 95.00% 4.26 0.632 5.62 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9113 1,939.81 1,939.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cAPGYYGNPSQGQPcQR 95.00% 4.27 0.607 5 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9117 1,939.81 1,939.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cAPGYYGNPSQGQPcQR 95.00% 4.95 0.639 6.47 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9121 1,939.81 1,939.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cAPGYYGNPSQGQPcQR 95.00% 4.35 0.59 5.43 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9131 1,939.81 1,939.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cAPGYYGNPSQGQPcQR 95.00% 4.19 0.631 6.3 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9132 1,939.81 1,939.82 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 4.69 0.531 6.66 c16: Carbamidomethyl (+57.02) 973.9888 1,945.96 1,946.98 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 5.01 0.588 7 c16: Carbamidomethyl (+57.02) 973.9915 1,945.97 1,946.98 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 4.59 0.58 5.6 c16: Carbamidomethyl (+57.02) 974.4883 1,946.96 1,946.98 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 4.78 0.539 6.77 c16: Carbamidomethyl (+57.02) 974.4898 1,946.96 1,946.98 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 4.68 0.541 7.04 c16: Carbamidomethyl (+57.02) 974.4916 1,946.97 1,946.98 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LRLPQVSPADSGEYVcR 95.00% 4.55 0.504 3.68 c16: Carbamidomethyl (+57.02) 974.4932 1,946.97 1,946.98 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYIFQASPADAGQYVcR 95.00% 5.68 0.632 4.92 c16: Carbamidomethyl (+57.02) 979.9718 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 2.75 0.268 1.66 980.0272 1,958.04 1,959.05 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 5.52 0.508 4.17 980.0285 1,958.04 1,959.05 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYIFQASPADAGQYVcR 95.00% 4.77 0.621 4.36 c16: Carbamidomethyl (+57.02) 980.4729 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYIFQASPADAGQYVcR 95.00% 5.77 0.53 7.06 c16: Carbamidomethyl (+57.02) 980.4732 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYIFQASPADAGQYVcR 95.00% 5.27 0.591 5.1 c16: Carbamidomethyl (+57.02) 980.4733 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYIFQASPADAGQYVcR 95.00% 4.86 0.621 5.74 c16: Carbamidomethyl (+57.02) 980.4739 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYIFQASPADAGQYVcR 95.00% 5.8 0.549 5.14 c16: Carbamidomethyl (+57.02) 980.4742 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYIFQASPADAGQYVcR 95.00% 5.82 0.549 6.31 c16: Carbamidomethyl (+57.02) 980.4747 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYIFQASPADAGQYVcR 95.00% 5.69 0.54 5.08 c16: Carbamidomethyl (+57.02) 980.4748 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYIFQASPADAGQYVcR 95.00% 6.28 0.608 3.96 c16: Carbamidomethyl (+57.02) 980.4748 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% LYIFQASPADAGQYVcR 95.00% 5.9 0.597 6 c16: Carbamidomethyl (+57.02) 980.4749 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 5.6 0.5 3.41 980.528 1,959.04 1,959.05 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 5.22 0.503 2.18 980.528 1,959.04 1,959.05 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 5.3 0.481 3.52 980.5285 1,959.04 1,959.05 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 5.63 0.454 2.92 980.5294 1,959.04 1,959.05 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% VVGSSGTQEASVLVTIQQR 95.00% 5.49 0.492 2.7 980.5297 1,959.04 1,959.05 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIEYSPQLEDAGSREFR 95.00% 3.48 0.428 2.03 992.4729 1,982.93 1,983.94 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SIEYSPQLEDAGSREFR 95.00% 3.45 0.361 1.68 992.9738 1,983.93 1,983.94 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ITFRPDSADGMLLYNGQK 95.00% 4.41 0.448 3.41 1,014.00 2,025.99 2,026.01 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% DVKESDQGAYTcEAMNAR 95.00% 5.73 0.505 6.85 c12: Carbamidomethyl (+57.02) 1,022.94 2,043.86 2,044.87 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% DVKESDQGAYTcEAMNAR 95.00% 5.66 0.513 8.07 c12: Carbamidomethyl (+57.02) 1,022.94 2,043.86 2,044.87 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% PSDAGTYVcLAQNALGTAQK 95.00% 6.95 0.616 0 c9: Carbamidomethyl (+57.02) 1,033.00 2,063.99 2,065.00 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% PSDAGTYVcLAQNALGTAQK 95.00% 7.03 0.615 0 c9: Carbamidomethyl (+57.02) 1,033.00 2,063.99 2,065.00 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% PSDAGTYVcLAQNALGTAQK 95.00% 6.83 0.576 0 c9: Carbamidomethyl (+57.02) 1,033.50 2,064.99 2,065.00 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% PSDAGTYVcLAQNALGTAQK 95.00% 6.85 0.592 0 c9: Carbamidomethyl (+57.02) 1,033.51 2,064.99 2,065.00 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RcEScAPGYEGNPIQPGGK 95.00% 5.65 0.61 5.7 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 1,038.96 2,075.91 2,076.92 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% RcEScAPGYEGNPIQPGGK 95.00% 5.44 0.583 4.74 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 1,039.47 2,076.91 2,076.92 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ATATScRPcPcPYIDASR 95.00% 4.33 0.435 3.35 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,041.96 2,081.90 2,082.92 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ATATScRPcPcPYIDASR 95.00% 4.06 0.402 3.24 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.92 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ATATScRPcPcPYIDASR 95.00% 3.61 0.355 3.4 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.92 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% ATATScRPcPcPYIDASR 95.00% 4.12 0.453 3.18 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.92 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cPPGYIGLScQDcAPGYTR 95.00% 4.84 0.599 10.5 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.47 2,170.92 2,171.93 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cPPGYIGLScQDcAPGYTR 95.00% 4.66 0.56 9.19 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.97 2,171.92 2,171.93 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cPPGYIGLScQDcAPGYTR 95.00% 4.75 0.562 8.57 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.97 2,171.93 2,171.93 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPVISIDPPSSTVQQGQDASFK 95.00% 5.86 0.551 11.7 1,145.07 2,288.13 2,288.14 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPVISIDPPSSTVQQGQDASFK 95.00% 5.95 0.54 13.6 1,145.07 2,288.13 2,288.14 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPVISIDPPSSTVQQGQDASFK 95.00% 6.28 0.508 13.5 1,145.07 2,288.13 2,288.14 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPVISIDPPSSTVQQGQDASFK 95.00% 6.19 0.538 13.2 1,145.07 2,288.13 2,288.14 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPVISIDPPSSTVQQGQDASFK 95.00% 5.47 0.57 11.9 1,145.08 2,288.13 2,288.14 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% SPVISIDPPSSTVQQGQDASFK 95.00% 0 0 10.3 1,145.58 2,289.14 2,288.14 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.57 0.521 4.44 1,156.13 2,310.24 2,310.26 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.47 0.5 4.92 1,156.13 2,310.24 2,310.26 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5.04 0.719 4.24 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.83 0.662 3.02 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.75 0.694 5.13 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.68 0.688 4.28 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.87 0.701 4.35 c1: Carbamidomethyl (+57.02) 1,186.08 2,370.14 2,370.14 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.19 0.651 6.18 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.64 0.677 5.92 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.51 0.664 5.15 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.44 0.689 5.6 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.4 0.659 6.24 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.4 0.67 6.28 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 1 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 87 126 564 25.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.13 0.666 5.08 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SAEPLALGR 95.00% 2.16 0.34 0 457.2593 912.503 913.5108 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SAEPLALGR 95.00% 2.5 0.332 0 457.2596 912.5035 913.5108 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SAEPLALGR 95.00% 2.14 0.334 0 457.2597 912.5038 913.5108 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SAEPLALGR 95.00% 2.3 0.376 0 457.2602 912.5048 913.5108 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SAEPLALGR 95.00% 2.22 0.367 0 457.2605 912.5053 913.5108 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SAEPLALGR 95.00% 2.39 0.34 0 457.2608 912.506 913.5108 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SAEPLALGR 95.00% 1.85 0.246 1.35 457.2615 912.5074 913.5108 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SAEPLALGR 95.00% 1.96 0.313 0 457.2631 912.5105 913.5108 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SAEPLALGR 95.00% 2 0.225 1.28 457.265 912.5143 913.5108 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IPGDQVVSVVFIK 95.00% 4.1 0.403 1.77 467.6103 1,399.81 1,400.82 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IPGDQVVSVVFIK 95.00% 3.48 0.362 2.22 467.6103 1,399.81 1,400.82 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IPGDQVVSVVFIK 95.00% 3.9 0.394 1.92 467.6105 1,399.81 1,400.82 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IPGDQVVSVVFIK 95.00% 3.59 0.424 2.07 467.6121 1,399.81 1,400.82 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AGFFGDAMK 95.00% 2.18 0.228 0 472.2211 942.4265 943.4349 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AGFFGDAMK 95.00% 2.37 0.223 0 472.2226 942.4295 943.4349 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AGFFGDAmK 95.00% 2.51 0.248 0 m8: Oxidation (+15.99) 480.2186 958.4215 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AGFFGDAmK 95.00% 2.66 0.298 0 m8: Oxidation (+15.99) 480.2188 958.422 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AGFFGDAmK 95.00% 3 0.326 0 m8: Oxidation (+15.99) 480.219 958.4223 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IAHVELADAGQYR 95.00% 4.09 0.429 0 481.5836 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IAHVELADAGQYR 95.00% 4.59 0.442 1.01 481.5847 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LSGSHSQGVAYPVR 95.00% 3.85 0.42 0 486.5883 1,456.74 1,457.75 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LSGSHSQGVAYPVR 95.00% 3.97 0.374 1.22 486.5889 1,456.74 1,457.75 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LSGSHSQGVAYPVR 95.00% 4.22 0.406 1.04 486.589 1,456.74 1,457.75 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LSGSHSQGVAYPVR 95.00% 3.55 0.355 0 486.5893 1,456.74 1,457.75 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RPEEVcGPTQFR 95.00% 2.77 0.39 1 c6: Carbamidomethyl (+57.02) 492.5717 1,474.69 1,475.71 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RPEEVcGPTQFR 95.00% 2.55 0.296 0 c6: Carbamidomethyl (+57.02) 492.5723 1,474.69 1,475.71 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RPEEVcGPTQFR 95.00% 3.9 0.325 2.22 c6: Carbamidomethyl (+57.02) 492.5723 1,474.69 1,475.71 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RPEEVcGPTQFR 95.00% 4.17 0.397 3.92 c6: Carbamidomethyl (+57.02) 492.5728 1,474.70 1,475.71 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RPEEVcGPTQFR 95.00% 4.17 0.399 2.21 c6: Carbamidomethyl (+57.02) 492.5729 1,474.70 1,475.71 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RPEEVcGPTQFR 95.00% 2.32 0.297 0 c6: Carbamidomethyl (+57.02) 492.9099 1,475.71 1,475.71 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FDQPDDFK 95.00% 2.89 0.364 0 506.2234 1,010.43 1,011.44 2 LAMA4_HUMAN,SPRL1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FDQPDDFK 95.00% 2.42 0.23 0 506.2235 1,010.43 1,011.44 2 LAMA4_HUMAN,SPRL1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LGTVPQFPR 95.00% 2.78 0.327 2.16 507.7889 1,013.56 1,014.57 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LGTVPQFPR 95.00% 2.33 0.299 1.8 507.7889 1,013.56 1,014.57 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LGTVPQFPR 95.00% 2.24 0.321 2.2 507.7893 1,013.56 1,014.57 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LGTVPQFPR 95.00% 2.06 0.326 1.92 507.7895 1,013.56 1,014.57 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LGTVPQFPR 95.00% 2.35 0.255 2.09 507.7898 1,013.56 1,014.57 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LGTVPQFPR 95.00% 2.27 0.243 0 507.7903 1,013.56 1,014.57 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LGTVPQFPR 95.00% 2.06 0.234 0 507.7906 1,013.57 1,014.57 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cFcMGVSR 95.00% 2.11 0.147 1.49 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 508.7088 1,015.40 1,016.41 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cFcMGVSR 95.00% 2.4 0.379 2.24 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 508.7089 1,015.40 1,016.41 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FLGDKVTSYGGELR 95.00% 3.94 0.45 2.28 514.6017 1,540.78 1,541.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FLGDKVTSYGGELR 95.00% 4.03 0.454 4.06 514.6017 1,540.78 1,541.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FLGDKVTSYGGELR 95.00% 2.41 0.251 0 514.6017 1,540.78 1,541.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FLGDKVTSYGGELR 95.00% 4.43 0.425 3.22 514.6021 1,540.78 1,541.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FLGDKVTSYGGELR 95.00% 3.6 0.433 2.96 514.603 1,540.79 1,541.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FLGDKVTSYGGELR 95.00% 3.84 0.436 3.48 514.6031 1,540.79 1,541.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FLGDKVTSYGGELR 95.00% 3.29 0.3 2.89 514.9372 1,541.79 1,541.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FLGDKVTSYGGELR 95.00% 3.39 0.428 3.03 514.9377 1,541.79 1,541.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cFcmGVSR 95.00% 2.3 0.241 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), m4: Oxidation (+15.99) 516.7062 1,031.40 1,032.41 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cFcmGVSR 95.00% 2.2 0.347 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), m4: Oxidation (+15.99) 516.7085 1,031.40 1,032.41 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIEYSPQLEDAGSR 95.00% 4.27 0.435 2.07 518.2483 1,551.72 1,551.73 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LDGSLPPDSR 95.00% 2.91 0.436 2.4 528.7681 1,055.52 1,056.53 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LDGSLPPDSR 95.00% 2.53 0.387 0 528.7683 1,055.52 1,056.53 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LDGSLPPDSR 95.00% 2.73 0.392 1.92 528.7683 1,055.52 1,056.53 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LDGSLPPDSR 95.00% 2.82 0.424 0 528.7685 1,055.52 1,056.53 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LDGSLPPDSR 95.00% 2.63 0.389 0 528.7686 1,055.52 1,056.53 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LDGSLPPDSR 95.00% 2.89 0.404 0 528.7688 1,055.52 1,056.53 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% NELLHFER 95.00% 2.47 0.142 0 529.2735 1,056.53 1,057.54 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% NELLHFER 95.00% 2.64 0.152 0 529.2736 1,056.53 1,057.54 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cSATGSPAPTIHWSK 95.00% 3.55 0.453 1.37 c1: Carbamidomethyl (+57.02) 533.9238 1,598.75 1,599.76 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cSATGSPAPTIHWSK 95.00% 3.62 0.446 2.07 c1: Carbamidomethyl (+57.02) 533.924 1,598.75 1,599.76 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RGSIQVDGEELVSGR 95.00% 2.61 0.329 0 534.6115 1,600.81 1,601.82 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PGIVQSGGVVR 95.00% 3.39 0.318 0 534.8103 1,067.61 1,068.62 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PGIVQSGGVVR 95.00% 3.3 0.303 0 534.811 1,067.61 1,068.62 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VAEGQTLDLK 95.00% 3.5 0.521 2.68 537.2939 1,072.57 1,073.58 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VAEGQTLDLK 95.00% 3.08 0.483 3.19 537.2945 1,072.57 1,073.58 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VAEGQTLDLK 95.00% 3.52 0.503 0 537.295 1,072.57 1,073.58 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VAEGQTLDLK 95.00% 3.14 0.516 1.7 537.2954 1,072.58 1,073.58 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EQAWQRPDGQPATR 95.00% 2.63 0.201 0 547.2681 1,638.78 1,639.79 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EQAWQRPDGQPATR 95.00% 2.61 0.229 1.28 547.2687 1,638.78 1,639.79 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EQAWQRPDGQPATR 95.00% 2.26 0.265 0 547.2695 1,638.79 1,639.79 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EQAWQRPDGQPATR 95.00% 2.59 0.284 0 547.2709 1,638.79 1,639.79 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RSYEIMFR 95.00% 2.29 0.191 0 551.2746 1,100.53 1,101.55 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPQVSPADSGEYVcR 95.00% 3.53 0.414 3.96 c14: Carbamidomethyl (+57.02) 559.9347 1,676.78 1,677.79 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPQVSPADSGEYVcR 95.00% 3.44 0.464 4.13 c14: Carbamidomethyl (+57.02) 559.9352 1,676.78 1,677.79 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FDAGSGMATIR 95.00% 3.41 0.433 4.62 563.2704 1,124.53 1,125.54 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FDAGSGMATIR 95.00% 3.45 0.423 4.59 563.2705 1,124.53 1,125.54 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FDAGSGMATIR 95.00% 3.38 0.376 3.06 563.2709 1,124.53 1,125.54 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VPGSPTNLANR 95.00% 3.24 0.541 3.25 563.3026 1,124.59 1,125.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VPGSPTNLANR 95.00% 2.99 0.537 3.15 563.3029 1,124.59 1,125.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VPGSPTNLANR 95.00% 3.11 0.498 2.42 563.3031 1,124.59 1,125.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VPGSPTNLANR 95.00% 3.05 0.582 2.92 563.3033 1,124.59 1,125.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VPGSPTNLANR 95.00% 3.34 0.571 3.02 563.3035 1,124.59 1,125.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VPGSPTNLANR 95.00% 3.05 0.562 2.82 563.3036 1,124.59 1,125.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VGGHLRPGIVQSGGVVR 95.00% 4.45 0.519 3.32 563.3268 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VGGHLRPGIVQSGGVVR 95.00% 4.18 0.475 2.19 563.3275 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VGGHLRPGIVQSGGVVR 95.00% 3.48 0.406 2.23 563.328 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VGGHLRPGIVQSGGVVR 95.00% 3.58 0.504 4.12 563.328 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VGGHLRPGIVQSGGVVR 95.00% 3.95 0.478 2.4 563.3292 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VGGHLRPGIVQSGGVVR 95.00% 2.74 0.408 2.08 563.582 1,687.72 1,687.97 3 ATPA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VGGHLRPGIVQSGGVVR 95.00% 3.28 0.333 1.6 563.6597 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VGGHLRPGIVQSGGVVR 95.00% 2.96 0.232 1.49 563.6633 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LEGDTLIIPR 95.00% 3.08 0.348 0 563.8247 1,125.63 1,126.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LEGDTLIIPR 95.00% 2.79 0.278 1.72 563.8249 1,125.63 1,126.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LEGDTLIIPR 95.00% 3.02 0.377 2.02 563.8249 1,125.63 1,126.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LEGDTLIIPR 95.00% 3.36 0.409 2.21 563.8253 1,125.63 1,126.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LEGDTLIIPR 95.00% 3.46 0.398 1.96 563.8257 1,125.64 1,126.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LEGDTLIIPR 95.00% 3.15 0.358 0 563.826 1,125.64 1,126.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LEGDTLIIPR 95.00% 3.56 0.391 2.47 563.8263 1,125.64 1,126.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LEGDTLIIPR 95.00% 3.53 0.401 1.77 563.8264 1,125.64 1,126.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LEGDTLIIPR 95.00% 2.9 0.379 1.57 563.8268 1,125.64 1,126.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LEGDTLIIPR 95.00% 3.17 0.352 0 563.8269 1,125.64 1,126.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ESDQGAYTcEAMNAR 95.00% 3.61 0.506 0 c9: Carbamidomethyl (+57.02) 568.2304 1,701.67 1,702.68 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 4.75 0.466 3.01 c14: Carbamidomethyl (+57.02) 568.2781 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 3.56 0.488 2.47 c14: Carbamidomethyl (+57.02) 568.2784 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 4.4 0.445 5.44 c14: Carbamidomethyl (+57.02) 568.2784 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 4.65 0.423 6.07 c14: Carbamidomethyl (+57.02) 568.2787 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 3.88 0.403 3.49 c14: Carbamidomethyl (+57.02) 568.2788 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 3.79 0.512 2.8 c14: Carbamidomethyl (+57.02) 568.2789 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 4.76 0.555 2.85 c14: Carbamidomethyl (+57.02) 568.6119 1,702.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 4.38 0.548 2.82 c14: Carbamidomethyl (+57.02) 568.6125 1,702.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 4.49 0.551 3.38 c14: Carbamidomethyl (+57.02) 568.6134 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 4.58 0.544 3.96 c14: Carbamidomethyl (+57.02) 568.6136 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 3.9 0.431 4.62 569.6602 1,705.96 1,706.97 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 2.99 0.241 3.19 569.6603 1,705.96 1,706.97 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 4.02 0.389 4.33 569.6605 1,705.96 1,706.97 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 4.01 0.36 5.8 569.6614 1,705.96 1,706.97 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 4.24 0.457 1.68 c14: Carbamidomethyl (+57.02) 569.9489 1,706.82 1,707.84 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 4.18 0.487 2.32 c14: Carbamidomethyl (+57.02) 569.9497 1,706.83 1,707.84 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 6.04 0.586 4.96 c14: Carbamidomethyl (+57.02) 569.95 1,706.83 1,707.84 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 5.41 0.526 4.23 c14: Carbamidomethyl (+57.02) 569.9504 1,706.83 1,707.84 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 4.62 0.431 6.36 569.9946 1,706.96 1,706.97 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 3.76 0.358 3.12 569.9946 1,706.96 1,706.97 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 4.25 0.446 4.09 569.9951 1,706.96 1,706.97 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 4.4 0.466 4.74 569.9954 1,706.96 1,706.97 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FDAGSGmATIR 95.00% 2.82 0.367 4.34 m7: Oxidation (+15.99) 571.2668 1,140.52 1,141.53 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FDAGSGmATIR 95.00% 2.78 0.346 2.96 m7: Oxidation (+15.99) 571.2669 1,140.52 1,141.53 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FDAGSGmATIR 95.00% 2.73 0.401 3.19 m7: Oxidation (+15.99) 571.2679 1,140.52 1,141.53 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FDAGSGmATIR 95.00% 2.89 0.419 4.46 m7: Oxidation (+15.99) 571.2683 1,140.52 1,141.53 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FDAGSGmATIR 95.00% 2.72 0.32 2.85 m7: Oxidation (+15.99) 571.7691 1,141.52 1,141.53 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 4.27 0.513 1.89 c14: Carbamidomethyl (+57.02) 572.5932 1,714.76 1,715.77 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 5.24 0.528 4.47 c14: Carbamidomethyl (+57.02) 572.9284 1,715.76 1,715.77 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 2.91 0.247 0 c14: Carbamidomethyl (+57.02) 572.9291 1,715.76 1,715.77 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHHVSPADSGEYVcR 95.00% 4.67 0.45 3.92 c14: Carbamidomethyl (+57.02) 576.2695 1,725.79 1,726.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHHVSPADSGEYVcR 95.00% 3.66 0.338 1.82 c14: Carbamidomethyl (+57.02) 576.2695 1,725.79 1,726.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHHVSPADSGEYVcR 95.00% 5.49 0.365 2.26 c14: Carbamidomethyl (+57.02) 576.2697 1,725.79 1,726.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHHVSPADSGEYVcR 95.00% 4.48 0.397 1 c14: Carbamidomethyl (+57.02) 576.27 1,725.79 1,726.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHHVSPADSGEYVcR 95.00% 5 0.404 3.28 c14: Carbamidomethyl (+57.02) 576.2701 1,725.79 1,726.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHHVSPADSGEYVcR 95.00% 4.53 0.42 2.62 c14: Carbamidomethyl (+57.02) 576.2703 1,725.79 1,726.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHHVSPADSGEYVcR 95.00% 4.61 0.403 1.37 c14: Carbamidomethyl (+57.02) 576.2704 1,725.79 1,726.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHHVSPADSGEYVcR 95.00% 1.93 0.327 0 c14: Carbamidomethyl (+57.02) 576.2704 1,725.79 1,726.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHHVSPADSGEYVcR 95.00% 3.43 0.321 1.14 c14: Carbamidomethyl (+57.02) 576.6025 1,726.78 1,726.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHHVSPADSGEYVcR 95.00% 3.85 0.357 1.68 c14: Carbamidomethyl (+57.02) 576.6038 1,726.79 1,726.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHHVSPADSGEYVcR 95.00% 4.7 0.386 3.82 c14: Carbamidomethyl (+57.02) 576.6043 1,726.79 1,726.80 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIGASVEFHcAVPSDR 95.00% 3.14 0.213 0 c10: Carbamidomethyl (+57.02) 577.9413 1,730.80 1,731.81 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIGASVEFHcAVPSDR 95.00% 2.62 0.241 1.57 c10: Carbamidomethyl (+57.02) 577.9416 1,730.80 1,731.81 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EGGQLPPGHSVQDGVLR 95.00% 2.07 0.213 1.44 582.6354 1,744.88 1,745.89 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EGGQLPPGHSVQDGVLR 95.00% 1.99 0.256 1.12 582.6357 1,744.88 1,745.89 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EGGQLPPGHSVQDGVLR 95.00% 2.4 0.261 1.43 582.6365 1,744.89 1,745.89 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EGGQLPPGHSVQDGVLR 95.00% 2.64 0.287 0 582.9695 1,745.89 1,745.89 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EGGQLPPGHSVQDGVLR 95.00% 2.02 0.264 0 582.9708 1,745.89 1,745.89 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AFAHLQVPER 95.00% 2.62 0.229 1.42 583.7997 1,165.58 1,167.63 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AFAHLQVPER 95.00% 3.2 0.381 1.85 584.3169 1,166.62 1,167.63 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AFAHLQVPER 95.00% 3.04 0.353 2.44 584.3169 1,166.62 1,167.63 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AFAHLQVPER 95.00% 3.12 0.363 1.59 584.3171 1,166.62 1,167.63 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AFAHLQVPER 95.00% 3.26 0.353 2.72 584.3173 1,166.62 1,167.63 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AFAHLQVPER 95.00% 2.94 0.39 1.42 584.3174 1,166.62 1,167.63 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AFAHLQVPER 95.00% 3.09 0.368 1.77 584.3177 1,166.62 1,167.63 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHQMSVADSGEYVcR 95.00% 3.01 0.396 0 c14: Carbamidomethyl (+57.02) 584.6 1,750.78 1,751.78 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AFAHLQVPER 95.00% 2.34 0.24 1.48 584.9581 1,167.90 1,167.63 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% TcESLGAGGYR 95.00% 2.73 0.478 0 c2: Carbamidomethyl (+57.02) 585.763 1,169.51 1,170.52 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% TcESLGAGGYR 95.00% 2.71 0.476 2.48 c2: Carbamidomethyl (+57.02) 585.764 1,169.51 1,170.52 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RLGTVPQFPR 95.00% 2.37 0.293 0 585.8404 1,169.67 1,170.67 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GDLcEHEENPcQLR 95.00% 3.88 0.385 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.2504 1,755.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GDLcEHEENPcQLR 95.00% 3.53 0.239 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.5848 1,756.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.81 0.534 1.44 c14: Carbamidomethyl (+57.02) 587.6245 1,759.85 1,760.86 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.97 0.517 2.89 c14: Carbamidomethyl (+57.02) 587.625 1,759.85 1,760.86 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.3 0.427 1.85 c14: Carbamidomethyl (+57.02) 587.6254 1,759.85 1,760.86 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.17 0.486 2 c14: Carbamidomethyl (+57.02) 587.9601 1,760.86 1,760.86 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% YELGSGLAVLR 95.00% 3.27 0.464 1.96 589.3307 1,176.65 1,177.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% YELGSGLAVLR 95.00% 3.64 0.511 4.8 589.3313 1,176.65 1,177.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% YELGSGLAVLR 95.00% 3.37 0.5 4.37 589.3314 1,176.65 1,177.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% YELGSGLAVLR 95.00% 3.17 0.492 3.1 589.3318 1,176.65 1,177.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% YELGSGLAVLR 95.00% 3.32 0.471 3.77 589.3323 1,176.65 1,177.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% YELGSGLAVLR 95.00% 2.91 0.454 3.8 589.3327 1,176.65 1,177.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% YELGSGLAVLR 95.00% 3.58 0.51 4.68 589.3328 1,176.65 1,177.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% YELGSGLAVLR 95.00% 2.92 0.463 1.96 589.333 1,176.65 1,177.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% YELGSGLAVLR 95.00% 2.48 0.32 2.04 589.3343 1,176.65 1,177.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LcNEcADGSFHLSTR 95.00% 3.46 0.286 1.62 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5899 1,765.75 1,766.76 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LcNEcADGSFHLSTR 95.00% 3.72 0.373 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5904 1,765.75 1,766.76 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LcNEcADGSFHLSTR 95.00% 4.04 0.454 2.46 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5905 1,765.75 1,766.76 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LcNEcADGSFHLSTR 95.00% 3.44 0.335 1.8 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5908 1,765.75 1,766.76 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% YELGSGLAVLR 95.00% 2.79 0.377 5.57 589.835 1,177.65 1,177.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.59 0.51 2.96 597.3147 1,192.61 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.61 0.58 3.55 597.3168 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.5 0.564 2.2 597.3169 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.52 0.561 2.59 597.3175 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.98 0.581 2.82 597.3178 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 4 0.621 2.82 597.3178 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.95 0.583 3.09 597.318 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.71 0.566 3.51 597.318 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.97 0.617 2.59 597.3181 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.7 0.582 2.12 597.3181 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.84 0.552 2.59 597.3181 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 2.93 0.541 2.09 597.3182 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.38 0.554 2.21 597.3183 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.33 0.57 2.72 597.3191 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.21 0.536 2.85 597.32 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 3.29 0.564 2.6 597.3224 1,192.63 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 1.74 0.362 0 597.6347 1,193.25 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 1.58 0.368 0 597.6352 1,193.25 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 1.76 0.322 1.21 597.8517 1,193.69 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPAYTLVWTR 95.00% 2.05 0.351 0 597.8553 1,193.69 1,193.63 2 LU_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EVSEAVVDTLESEYLK 95.00% 3.97 0.429 0 604.3019 1,809.88 1,810.90 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EVSEAVVDTLESEYLK 95.00% 4 0.47 1.19 604.3035 1,809.89 1,810.90 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EVSEAVVDTLESEYLK 95.00% 3.86 0.445 0 604.6375 1,810.89 1,810.90 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AGLSSGFIGcVR 95.00% 3.92 0.458 2.89 c10: Carbamidomethyl (+57.02) 612.3124 1,222.61 1,223.62 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AGLSSGFIGcVR 95.00% 4.07 0.486 4.85 c10: Carbamidomethyl (+57.02) 612.3125 1,222.61 1,223.62 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AGLSSGFIGcVR 95.00% 4.16 0.451 2.8 c10: Carbamidomethyl (+57.02) 612.3128 1,222.61 1,223.62 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AGLSSGFIGcVR 95.00% 4.08 0.46 4.68 c10: Carbamidomethyl (+57.02) 612.313 1,222.61 1,223.62 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AGLSSGFIGcVR 95.00% 2.51 0.248 0 c10: Carbamidomethyl (+57.02) 612.3145 1,222.61 1,223.62 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 3.53 0.284 1.59 c14: Carbamidomethyl (+57.02) 612.9796 1,835.92 1,836.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.8 0.557 3.59 c14: Carbamidomethyl (+57.02) 612.98 1,835.92 1,836.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.16 0.511 2.92 c14: Carbamidomethyl (+57.02) 612.9803 1,835.92 1,836.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.85 0.589 2.33 c14: Carbamidomethyl (+57.02) 612.9805 1,835.92 1,836.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.23 0.487 3.42 c14: Carbamidomethyl (+57.02) 612.981 1,835.92 1,836.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 3.55 0.462 0 c14: Carbamidomethyl (+57.02) 613.3123 1,836.91 1,836.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 3.6 0.458 0 c14: Carbamidomethyl (+57.02) 613.3129 1,836.92 1,836.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.13 0.538 2.17 c14: Carbamidomethyl (+57.02) 613.3134 1,836.92 1,836.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.07 0.511 2.85 c14: Carbamidomethyl (+57.02) 613.3136 1,836.92 1,836.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 2.85 0.39 1.19 c14: Carbamidomethyl (+57.02) 613.3137 1,836.92 1,836.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.11 0.539 2.74 c14: Carbamidomethyl (+57.02) 613.3144 1,836.92 1,836.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.28 0.5 3.29 c14: Carbamidomethyl (+57.02) 613.3148 1,836.92 1,836.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AAGVPSATITWR 95.00% 2.12 0.353 1.85 615.3331 1,228.65 1,229.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AAGVPSATITWR 95.00% 1.87 0.215 1.28 615.334 1,228.65 1,229.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AAGVPSATITWR 95.00% 2.49 0.467 2.82 615.3346 1,228.65 1,229.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AAGVPSATITWR 95.00% 2.12 0.331 2.8 615.3347 1,228.65 1,229.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AAGVPSATITWR 95.00% 2.18 0.512 1.52 615.3348 1,228.65 1,229.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AAGVPSATITWR 95.00% 2.47 0.456 4.07 615.3348 1,228.65 1,229.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AAGVPSATITWR 95.00% 1.85 0.306 1.21 615.3351 1,228.65 1,229.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AAGVPSATITWR 95.00% 2.21 0.319 2.44 615.3362 1,228.66 1,229.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AAGVPSATITWR 95.00% 2.39 0.394 1.82 615.8345 1,229.65 1,229.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIVPQGGSHSLR 95.00% 2.24 0.332 2.51 619.3352 1,236.65 1,237.67 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIVPQGGSHSLR 95.00% 2.34 0.45 2.8 619.3357 1,236.66 1,237.67 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% QPQAIITWYK 95.00% 1.78 0.346 0 624.3413 1,246.67 1,247.68 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% QPQAIITWYK 95.00% 1.71 0.354 0 624.3428 1,246.67 1,247.68 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cQVSGSPPHYFYWSR 95.00% 1.86 0.279 0 c1: Carbamidomethyl (+57.02) 624.6154 1,870.82 1,870.83 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AMDFNGILTIR 95.00% 2 0.331 0 625.8311 1,249.65 1,250.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AMDFNGILTIR 95.00% 3.93 0.502 2.85 625.8311 1,249.65 1,250.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AMDFNGILTIR 95.00% 3.73 0.476 1.8 625.8319 1,249.65 1,250.66 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cLcLPGFSGPR 95.00% 2.85 0.365 2.1 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3003 1,262.59 1,263.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cLcLPGFSGPR 95.00% 2.63 0.315 1.72 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3005 1,262.59 1,263.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cLcLPGFSGPR 95.00% 2.54 0.309 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3018 1,262.59 1,263.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cLcLPGFSGPR 95.00% 2.88 0.401 3 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3019 1,262.59 1,263.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cLcLPGFSGPR 95.00% 2.21 0.281 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.302 1,262.59 1,263.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cLcLPGFSGPR 95.00% 2.88 0.377 2.02 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3021 1,262.59 1,263.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cLcLPGFSGPR 95.00% 2.75 0.284 1.82 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3023 1,262.59 1,263.60 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AmDFNGILTIR 95.00% 2.89 0.386 2.57 m2: Oxidation (+15.99) 633.8283 1,265.64 1,266.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AmDFNGILTIR 95.00% 3.29 0.367 2.2 m2: Oxidation (+15.99) 633.8284 1,265.64 1,266.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AmDFNGILTIR 95.00% 3.28 0.494 2.59 m2: Oxidation (+15.99) 633.8284 1,265.64 1,266.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AmDFNGILTIR 95.00% 3.69 0.494 2.09 m2: Oxidation (+15.99) 633.8288 1,265.64 1,266.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AmDFNGILTIR 95.00% 3.26 0.223 2.09 m2: Oxidation (+15.99) 633.8291 1,265.64 1,266.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AmDFNGILTIR 95.00% 3.48 0.406 2.17 m2: Oxidation (+15.99) 633.8305 1,265.65 1,266.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AmDFNGILTIR 95.00% 2.67 0.394 1.25 m2: Oxidation (+15.99) 633.8308 1,265.65 1,266.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AmDFNGILTIR 95.00% 3.53 0.438 2.47 m2: Oxidation (+15.99) 634.3297 1,266.64 1,266.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cRPVNQEIVR 95.00% 2.21 0.272 0 c1: Carbamidomethyl (+57.02) 635.8418 1,269.67 1,270.67 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cRPVNQEIVR 95.00% 2.41 0.3 0 c1: Carbamidomethyl (+57.02) 636.3416 1,270.67 1,270.67 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PGADVTFIcTAK 95.00% 2.67 0.465 0 c9: Carbamidomethyl (+57.02) 640.3206 1,278.63 1,279.64 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRFDQPDDFK 95.00% 2.6 0.37 0 640.8155 1,279.62 1,280.63 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PGADVTFIcTAK 95.00% 3.6 0.547 0 c9: Carbamidomethyl (+57.02) 640.8166 1,279.62 1,279.64 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRFDQPDDFK 95.00% 2.72 0.347 0 640.8169 1,279.62 1,280.63 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PGADVTFIcTAK 95.00% 3.19 0.585 0 c9: Carbamidomethyl (+57.02) 640.823 1,279.63 1,279.64 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% QPDFISFGLVGGRPEFR 95.00% 2.85 0.334 1.85 641.6691 1,921.98 1,921.99 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% QPDFISFGLVGGRPEFR 95.00% 2.52 0.353 1.96 641.6691 1,921.98 1,921.99 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% QPDFISFGLVGGRPEFR 95.00% 2.2 0.288 0 641.6698 1,921.99 1,921.99 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cAPGYYGNPSQGQPcQR 95.00% 5.28 0.463 4.39 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.2758 1,938.80 1,939.82 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cAPGYYGNPSQGQPcQR 95.00% 5.2 0.38 3.51 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.6104 1,939.81 1,939.82 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 6.08 0.644 4.85 c16: Carbamidomethyl (+57.02) 649.6634 1,945.97 1,946.98 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 4.19 0.51 3 c16: Carbamidomethyl (+57.02) 649.6639 1,945.97 1,946.98 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 1.9 0.192 1.47 c16: Carbamidomethyl (+57.02) 649.8879 1,946.64 1,946.98 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 5.46 0.602 4.52 c16: Carbamidomethyl (+57.02) 649.9953 1,946.96 1,946.98 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 3.68 0.553 3.49 c16: Carbamidomethyl (+57.02) 649.9956 1,946.96 1,946.98 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 5.8 0.614 3.77 c16: Carbamidomethyl (+57.02) 649.9958 1,946.96 1,946.98 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 4.86 0.637 3.22 c16: Carbamidomethyl (+57.02) 649.9967 1,946.97 1,946.98 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 5.13 0.595 5.3 c16: Carbamidomethyl (+57.02) 649.9968 1,946.97 1,946.98 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 5.98 0.607 6.51 c16: Carbamidomethyl (+57.02) 649.9968 1,946.97 1,946.98 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 2.74 0.342 0 653.6876 1,958.04 1,959.05 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 4.63 0.392 0 653.6878 1,958.04 1,959.05 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 3.89 0.361 0 653.6883 1,958.04 1,959.05 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 4.49 0.322 0 653.6885 1,958.04 1,959.05 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYIFQASPADAGQYVcR 95.00% 4.93 0.507 2.92 c16: Carbamidomethyl (+57.02) 653.9864 1,958.94 1,958.94 3 DOCK9_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYIFQASPADAGQYVcR 95.00% 4.83 0.465 1.96 c16: Carbamidomethyl (+57.02) 653.9878 1,958.94 1,958.94 3 DOCK9_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 4.92 0.374 0 654.0209 1,959.04 1,959.05 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 5.17 0.391 2.72 654.0214 1,959.04 1,959.05 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 3.96 0.366 0 654.0214 1,959.04 1,959.05 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 3.71 0.333 0 654.0214 1,959.04 1,959.05 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PcPcPYIDASR 95.00% 2.32 0.33 0 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 668.2929 1,334.57 1,335.58 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ITFRPDSADGMLLYNGQK 95.00% 2.6 0.266 0 676.3394 2,025.99 2,026.01 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ITFRPDSADGMLLYNGQK 95.00% 2.65 0.214 0 676.3402 2,026.00 2,026.01 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ITFRPDSADGMLLYNGQK 95.00% 3.17 0.454 0 676.3405 2,026.00 2,026.01 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% TPSGLYLGTcER 95.00% 3.21 0.384 2.44 c10: Carbamidomethyl (+57.02) 677.3246 1,352.63 1,353.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% TPSGLYLGTcER 95.00% 3.05 0.293 2.04 c10: Carbamidomethyl (+57.02) 677.3258 1,352.64 1,353.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% TPSGLYLGTcER 95.00% 4.02 0.473 2.7 c10: Carbamidomethyl (+57.02) 677.3259 1,352.64 1,353.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% TPSGLYLGTcER 95.00% 3.85 0.436 4.22 c10: Carbamidomethyl (+57.02) 677.3267 1,352.64 1,353.65 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PLPcGPQEAAcR 95.00% 2.29 0.412 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 678.3109 1,354.61 1,355.62 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PLPcGPQEAAcR 95.00% 2.8 0.597 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 678.8153 1,355.61 1,355.62 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% DVKESDQGAYTcEAMNAR 95.00% 3.9 0.363 2.74 c12: Carbamidomethyl (+57.02) 682.2938 2,043.86 2,044.87 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% DVKESDQGAYTcEAMNAR 95.00% 3.83 0.343 1.64 c12: Carbamidomethyl (+57.02) 682.6275 2,044.86 2,044.87 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% DVKESDQGAYTcEAMNAR 95.00% 4.5 0.37 3.92 c12: Carbamidomethyl (+57.02) 682.6281 2,044.86 2,044.87 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PSDAGTYVcLAQNALGTAQK 95.00% 4.74 0.452 0 c9: Carbamidomethyl (+57.02) 689.0044 2,063.99 2,065.00 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PSDAGTYVcLAQNALGTAQK 95.00% 2.81 0.286 0 c9: Carbamidomethyl (+57.02) 689.3381 2,064.99 2,065.00 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PSDAGTYVcLAQNALGTAQK 95.00% 5.09 0.465 0 c9: Carbamidomethyl (+57.02) 689.3383 2,064.99 2,065.00 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PSDAGTYVcLAQNALGTAQK 95.00% 5.36 0.494 0 c9: Carbamidomethyl (+57.02) 689.3392 2,064.99 2,065.00 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PSDAGTYVcLAQNALGTAQK 95.00% 5.79 0.468 0 c9: Carbamidomethyl (+57.02) 689.3392 2,064.99 2,065.00 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GmLEPVQRPDVVLVGAGYR 95.00% 2.15 0.261 0 m2: Oxidation (+15.99) 691.3671 2,071.08 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GmLEPVQRPDVVLVGAGYR 95.00% 3.72 0.621 3.15 m2: Oxidation (+15.99) 691.3687 2,071.08 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GmLEPVQRPDVVLVGAGYR 95.00% 2.03 0.246 0.959 m2: Oxidation (+15.99) 691.7011 2,072.08 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GmLEPVQRPDVVLVGAGYR 95.00% 4.69 0.678 2.82 m2: Oxidation (+15.99) 691.7028 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GmLEPVQRPDVVLVGAGYR 95.00% 2.88 0.517 3.89 m2: Oxidation (+15.99) 691.7038 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RcEScAPGYEGNPIQPGGK 95.00% 4.61 0.431 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3123 2,076.91 2,076.92 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RcEScAPGYEGNPIQPGGK 95.00% 4.1 0.495 2.85 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3126 2,076.91 2,076.92 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RcEScAPGYEGNPIQPGGK 95.00% 3.84 0.456 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.314 2,076.92 2,076.92 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AVTLEcVSAGEPR 95.00% 3.11 0.338 0 c6: Carbamidomethyl (+57.02) 694.84 1,387.66 1,388.68 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AVTLEcVSAGEPR 95.00% 3.02 0.286 0 c6: Carbamidomethyl (+57.02) 694.8424 1,387.67 1,388.68 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ATATScRPcPcPYIDASR 95.00% 3.21 0.32 1.41 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.9759 2,081.90 2,082.92 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ATATScRPcPcPYIDASR 95.00% 2.55 0.379 1.28 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3093 2,082.90 2,082.92 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ATATScRPcPcPYIDASR 95.00% 3.21 0.485 2.15 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3096 2,082.91 2,082.92 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ATATScRPcPcPYIDASR 95.00% 3.41 0.426 1.77 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3105 2,082.91 2,082.92 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ATATScRPcPcPYIDASR 95.00% 3.89 0.44 2.19 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3107 2,082.91 2,082.92 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IPGDQVVSVVFIK 95.00% 3.88 0.486 3 700.9096 1,399.80 1,400.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IPGDQVVSVVFIK 95.00% 4.46 0.509 3.52 700.9101 1,399.80 1,400.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IPGDQVVSVVFIK 95.00% 4.17 0.54 3.01 700.9102 1,399.80 1,400.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IPGDQVVSVVFIK 95.00% 4.53 0.498 3.3 700.9112 1,399.81 1,400.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IPGDQVVSVVFIK 95.00% 3.62 0.485 3.32 700.9112 1,399.81 1,400.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IPGDQVVSVVFIK 95.00% 4.15 0.518 3.06 700.9116 1,399.81 1,400.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SKSPAYTLVWTR 95.00% 2.71 0.427 1.39 705.3841 1,408.75 1,408.76 2 TENA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VISSGSVASYVTSPQGFQFR 95.00% 4.4 0.589 3.15 706.6926 2,117.05 2,117.07 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VISSGSVASYVTSPQGFQFR 95.00% 5.26 0.606 3.89 706.6934 2,117.06 2,117.07 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VISSGSVASYVTSPQGFQFR 95.00% 4.89 0.619 5 706.6937 2,117.06 2,117.07 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VISSGSVASYVTSPQGFQFR 95.00% 3.02 0.322 2.47 706.6941 2,117.06 2,117.07 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IAHVELADAGQYR 95.00% 4.21 0.509 5.24 721.8723 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IAHVELADAGQYR 95.00% 4.65 0.526 3.48 721.8723 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IAHVELADAGQYR 95.00% 4.5 0.503 2.92 721.8724 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IAHVELADAGQYR 95.00% 4.15 0.492 3.96 721.8733 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IAHVELADAGQYR 95.00% 4.3 0.494 4.05 721.8734 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IAHVELADAGQYR 95.00% 4.36 0.521 2.96 721.8734 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cPPGYIGLScQDcAPGYTR 95.00% 3.37 0.388 0 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 724.9815 2,171.92 2,171.93 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LSGSHSQGVAYPVR 95.00% 3.74 0.473 3.43 728.862 1,455.71 1,457.75 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LSGSHSQGVAYPVR 95.00% 3.21 0.459 3.21 728.8626 1,455.71 1,457.75 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LSGSHSQGVAYPVR 95.00% 4.13 0.593 3.62 729.3781 1,456.74 1,457.75 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LSGSHSQGVAYPVR 95.00% 3.77 0.555 2.96 729.3784 1,456.74 1,457.75 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% DGFKGDLcEHEENPcQLR 95.00% 4.5 0.463 1.49 c8: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 735.657 2,203.95 2,203.95 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RPEEVcGPTQFR 95.00% 3.4 0.385 5.1 c6: Carbamidomethyl (+57.02) 738.3549 1,474.69 1,475.71 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RPEEVcGPTQFR 95.00% 2.84 0.376 3 c6: Carbamidomethyl (+57.02) 738.3549 1,474.69 1,475.71 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RPEEVcGPTQFR 95.00% 3.51 0.431 4.62 c6: Carbamidomethyl (+57.02) 738.355 1,474.69 1,475.71 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RPEEVcGPTQFR 95.00% 3.24 0.407 4.74 c6: Carbamidomethyl (+57.02) 738.3557 1,474.70 1,475.71 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RPEEVcGPTQFR 95.00% 3.78 0.488 5.19 c6: Carbamidomethyl (+57.02) 738.356 1,474.70 1,475.71 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RPEEVcGPTQFR 95.00% 2.65 0.394 2.74 c6: Carbamidomethyl (+57.02) 738.3581 1,474.70 1,475.71 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLSGPYFWSLPSR 95.00% 3.44 0.246 0 761.8992 1,521.78 1,522.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLSGPYFWSLPSR 95.00% 4.01 0.356 2.22 761.9019 1,521.79 1,522.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLSGPYFWSLPSR 95.00% 3.94 0.463 2.11 761.9021 1,521.79 1,522.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLSGPYFWSLPSR 95.00% 3.84 0.423 1.72 761.9035 1,521.79 1,522.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLSGPYFWSLPSR 95.00% 4.19 0.435 1.82 761.9041 1,521.79 1,522.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLSGPYFWSLPSR 95.00% 3.59 0.489 2.44 761.906 1,521.80 1,522.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLSGPYFWSLPSR 95.00% 3.64 0.347 2.22 762.4047 1,522.79 1,522.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLSGPYFWSLPSR 95.00% 3.46 0.386 2.57 762.4068 1,522.80 1,522.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLSGPYFWSLPSR 95.00% 4.09 0.377 2.6 762.4076 1,522.80 1,522.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLSGPYFWSLPSR 95.00% 4.11 0.453 2.39 762.4078 1,522.80 1,522.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLSGPYFWSLPSR 95.00% 3.29 0.269 0 762.4081 1,522.80 1,522.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPVISIDPPSSTVQQGQDASFK 95.00% 4.46 0.489 2.28 763.7175 2,288.13 2,288.14 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPVISIDPPSSTVQQGQDASFK 95.00% 4.04 0.432 0 763.7177 2,288.13 2,288.14 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPVISIDPPSSTVQQGQDASFK 95.00% 2.59 0.368 0 763.7202 2,288.14 2,288.14 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cDGDFDcEDRTDEANcPTK 95.00% 3.66 0.501 2.27 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 768.9542 2,303.84 2,304.84 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cDGDFDcEDRTDEANcPTK 95.00% 3.8 0.494 2.21 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 769.2894 2,304.84 2,304.84 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AELLVTEAPSKPITVTVEEQR 95.00% 5.15 0.633 2.68 770.7562 2,309.25 2,310.26 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AELLVTEAPSKPITVTVEEQR 95.00% 2.97 0.319 0 770.9069 2,309.70 2,310.26 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AELLVTEAPSKPITVTVEEQR 95.00% 6.03 0.605 2.89 771.0889 2,310.24 2,310.26 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AELLVTEAPSKPITVTVEEQR 95.00% 6.71 0.633 1.72 771.0897 2,310.25 2,310.26 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AELLVTEAPSKPITVTVEEQR 95.00% 6.36 0.646 3.74 771.0897 2,310.25 2,310.26 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AELLVTEAPSKPITVTVEEQR 95.00% 4.44 0.561 1.82 771.0898 2,310.25 2,310.26 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AELLVTEAPSKPITVTVEEQR 95.00% 6.46 0.603 3.48 771.09 2,310.25 2,310.26 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AELLVTEAPSKPITVTVEEQR 95.00% 7.08 0.636 3.19 771.09 2,310.25 2,310.26 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AELLVTEAPSKPITVTVEEQR 95.00% 5.03 0.604 2.74 771.0906 2,310.25 2,310.26 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AELLVTEAPSKPITVTVEEQR 95.00% 6.39 0.648 3.77 771.0917 2,310.25 2,310.26 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FLGDKVTSYGGELR 95.00% 4.4 0.494 3.8 771.4004 1,540.79 1,541.80 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FLGDKVTSYGGELR 95.00% 4.56 0.524 3.85 771.4011 1,540.79 1,541.80 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FLGDKVTSYGGELR 95.00% 4.8 0.526 4.6 771.4012 1,540.79 1,541.80 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% FLGDKVTSYGGELR 95.00% 4.48 0.527 4.29 771.4027 1,540.79 1,541.80 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIEYSPQLEDAGSR 95.00% 4.63 0.575 3.46 776.3666 1,550.72 1,551.73 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIEYSPQLEDAGSR 95.00% 4.56 0.628 3.52 776.3673 1,550.72 1,551.73 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIEYSPQLEDAGSR 95.00% 4.08 0.561 3.85 776.3675 1,550.72 1,551.73 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIEYSPQLEDAGSR 95.00% 4.84 0.561 5 776.3684 1,550.72 1,551.73 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIEYSPQLEDAGSR 95.00% 4.29 0.594 4.46 776.3684 1,550.72 1,551.73 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% MASVGLSDIAMDTTVTHATSHGR 95.00% 2.56 0.29 1.4 787.0453 2,358.11 2,358.12 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.74 0.535 0 c1: Carbamidomethyl (+57.02) 791.0497 2,370.13 2,370.14 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5.48 0.62 5.59 c1: Carbamidomethyl (+57.02) 791.0499 2,370.13 2,370.14 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.76 0.635 1.77 c1: Carbamidomethyl (+57.02) 791.0511 2,370.13 2,370.14 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.64 0.568 3.82 c18: Carbamidomethyl (+57.02) 792.4001 2,374.18 2,374.19 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.49 0.583 1.12 c18: Carbamidomethyl (+57.02) 792.4012 2,374.18 2,374.19 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.11 0.445 0 c18: Carbamidomethyl (+57.02) 792.4014 2,374.18 2,374.19 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.49 0.491 2.62 c18: Carbamidomethyl (+57.02) 792.4019 2,374.18 2,374.19 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.7 0.586 3 c18: Carbamidomethyl (+57.02) 792.4024 2,374.18 2,374.19 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.19 0.582 3.31 c18: Carbamidomethyl (+57.02) 792.4033 2,374.19 2,374.19 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cSATGSPAPTIHWSK 95.00% 4.03 0.526 4.6 c1: Carbamidomethyl (+57.02) 800.883 1,599.75 1,599.76 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cSATGSPAPTIHWSK 95.00% 3.75 0.577 3.7 c1: Carbamidomethyl (+57.02) 800.8849 1,599.75 1,599.76 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SLPEVPETIELEVR 95.00% 3.65 0.619 4.92 805.9338 1,609.85 1,610.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SLPEVPETIELEVR 95.00% 3.58 0.564 4.7 805.9341 1,609.85 1,610.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SLPEVPETIELEVR 95.00% 3.37 0.563 4.24 805.9376 1,609.86 1,610.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SLPEVPETIELEVR 95.00% 3.56 0.555 4.6 806.4364 1,610.86 1,610.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 3.52 0.489 3.77 817.1094 2,448.30 2,448.31 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 3.72 0.592 3.82 817.1097 2,448.31 2,448.31 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 4.73 0.44 1.72 817.1098 2,448.31 2,448.31 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 3.43 0.415 2.89 817.1111 2,448.31 2,448.31 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 4.75 0.386 3.38 817.1116 2,448.31 2,448.31 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EQAWQRPDGQPATR 95.00% 3.16 0.305 0 820.3994 1,638.78 1,639.79 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EQAWQRPDGQPATR 95.00% 2.98 0.226 0 820.4019 1,638.79 1,639.79 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LVSEDPINDGEWHR 95.00% 3.64 0.52 3.17 833.8954 1,665.78 1,666.78 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPQVSPADSGEYVcR 95.00% 4.35 0.57 7.77 c14: Carbamidomethyl (+57.02) 839.3981 1,676.78 1,677.79 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPQVSPADSGEYVcR 95.00% 4.89 0.545 5.96 c14: Carbamidomethyl (+57.02) 839.3982 1,676.78 1,677.79 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPQVSPADSGEYVcR 95.00% 5.06 0.544 5.52 c14: Carbamidomethyl (+57.02) 839.3983 1,676.78 1,677.79 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPQVSPADSGEYVcR 95.00% 4.49 0.499 6.54 c14: Carbamidomethyl (+57.02) 839.3991 1,676.78 1,677.79 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPQVSPADSGEYVcR 95.00% 3.54 0.59 5.17 c14: Carbamidomethyl (+57.02) 839.4021 1,676.79 1,677.79 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPQVSPADSGEYVcR 95.00% 4.81 0.552 4.15 c14: Carbamidomethyl (+57.02) 839.8999 1,677.78 1,677.79 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPQVSPADSGEYVcR 95.00% 4.61 0.563 5.1 c14: Carbamidomethyl (+57.02) 839.9002 1,677.78 1,677.79 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VGGHLRPGIVQSGGVVR 95.00% 3.57 0.437 2.82 844.4876 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VGGHLRPGIVQSGGVVR 95.00% 3.45 0.389 3.26 844.4902 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VGGHLRPGIVQSGGVVR 95.00% 3.35 0.423 2.89 844.9912 1,687.97 1,687.97 2 ATPA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VGGHLRPGIVQSGGVVR 95.00% 2.98 0.362 2.31 844.9912 1,687.97 1,687.97 2 ATPA_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GSVYIGGAPDVATLTGGR 95.00% 5 0.531 4.72 845.9397 1,689.86 1,690.88 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GSVYIGGAPDVATLTGGR 95.00% 4.6 0.532 4.43 845.9417 1,689.87 1,690.88 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GSVYIGGAPDVATLTGGR 95.00% 4.99 0.544 4.74 845.9421 1,689.87 1,690.88 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GSVYIGGAPDVATLTGGR 95.00% 4.74 0.519 5.07 845.9452 1,689.87 1,690.88 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ESDQGAYTcEAMNAR 95.00% 3.15 0.383 2.08 c9: Carbamidomethyl (+57.02) 851.8404 1,701.67 1,702.68 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ESDQGAYTcEAMNAR 95.00% 3.9 0.497 1.92 c9: Carbamidomethyl (+57.02) 851.8415 1,701.67 1,702.68 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ESDQGAYTcEAMNAR 95.00% 4.27 0.579 2.16 c9: Carbamidomethyl (+57.02) 851.8427 1,701.67 1,702.68 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ESDQGAYTcEAMNAR 95.00% 4.33 0.567 2.32 c9: Carbamidomethyl (+57.02) 851.8438 1,701.67 1,702.68 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 3.66 0.456 4.8 c14: Carbamidomethyl (+57.02) 851.9143 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 3.86 0.369 6.52 c14: Carbamidomethyl (+57.02) 851.9148 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 3.55 0.392 3.21 c14: Carbamidomethyl (+57.02) 851.9148 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 3.92 0.414 5.34 c14: Carbamidomethyl (+57.02) 851.9149 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LHLVSPADSGEYVcR 95.00% 3.22 0.351 1.29 c14: Carbamidomethyl (+57.02) 851.9161 1,701.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ESDQGAYTcEAMNAR 95.00% 4.01 0.554 1.82 c9: Carbamidomethyl (+57.02) 852.3416 1,702.67 1,702.68 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ESDQGAYTcEAMNAR 95.00% 3.87 0.482 1.47 c9: Carbamidomethyl (+57.02) 852.3467 1,702.68 1,702.68 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.42 0.632 6.41 853.4463 2,557.32 2,557.33 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRSPVISIDPPSSTVQQGQDASFK 95.00% 7.44 0.6 5.85 853.4463 2,557.32 2,557.33 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 4.11 0.504 5.2 853.9867 1,705.96 1,706.97 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 4.17 0.47 7.82 853.9872 1,705.96 1,706.97 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 3.57 0.469 5.54 853.9874 1,705.96 1,706.97 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 4.09 0.423 6.08 853.9883 1,705.96 1,706.97 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 3.33 0.469 4.64 853.9894 1,705.96 1,706.97 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 4.22 0.121 4.64 c14: Carbamidomethyl (+57.02) 854.4142 1,706.81 1,707.84 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 4.45 0.386 4.6 c14: Carbamidomethyl (+57.02) 854.4167 1,706.82 1,707.84 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 4.51 0.493 3.26 c14: Carbamidomethyl (+57.02) 854.4177 1,706.82 1,707.84 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 4.29 0.632 5.7 c14: Carbamidomethyl (+57.02) 854.4225 1,706.83 1,707.84 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 3.6 0.314 5.55 854.4862 1,706.96 1,706.97 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 3.83 0.454 5.24 854.4892 1,706.96 1,706.97 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQVVVLSASDASPPPVK 95.00% 3.93 0.481 5.85 854.4899 1,706.96 1,706.97 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.71 0.579 1.62 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7286 2,561.16 2,561.17 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 4.38 0.329 4.17 c14: Carbamidomethyl (+57.02) 854.9198 1,707.82 1,707.84 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 4.74 0.596 3 c14: Carbamidomethyl (+57.02) 854.9205 1,707.83 1,707.84 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 5.03 0.638 4.8 c14: Carbamidomethyl (+57.02) 854.9208 1,707.83 1,707.84 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 4.93 0.633 5.85 c14: Carbamidomethyl (+57.02) 854.9212 1,707.83 1,707.84 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LLQVTPADSGEYVcR 95.00% 4.76 0.617 3.89 c14: Carbamidomethyl (+57.02) 854.9225 1,707.83 1,707.84 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cLIHDGAAPISLEWK 95.00% 4.48 0.627 5.8 c1: Carbamidomethyl (+57.02) 855.4366 1,708.86 1,709.87 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cLIHDGAAPISLEWK 95.00% 4.45 0.588 6.64 c1: Carbamidomethyl (+57.02) 855.4372 1,708.86 1,709.87 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 5.28 0.625 5.55 c14: Carbamidomethyl (+57.02) 858.3858 1,714.76 1,715.77 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 5.47 0.621 5.6 c14: Carbamidomethyl (+57.02) 858.3863 1,714.76 1,715.77 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 5.44 0.605 5.54 c14: Carbamidomethyl (+57.02) 858.3872 1,714.76 1,715.77 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 5.07 0.614 4.33 c14: Carbamidomethyl (+57.02) 858.3874 1,714.76 1,715.77 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 5.1 0.636 6.06 c14: Carbamidomethyl (+57.02) 858.3874 1,714.76 1,715.77 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 5.14 0.578 5.24 c14: Carbamidomethyl (+57.02) 858.3875 1,714.76 1,715.77 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 4.95 0.645 6.24 c14: Carbamidomethyl (+57.02) 858.3877 1,714.76 1,715.77 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 4.98 0.583 5.8 c14: Carbamidomethyl (+57.02) 858.3882 1,714.76 1,715.77 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 4.93 0.569 4.46 c14: Carbamidomethyl (+57.02) 858.3889 1,714.76 1,715.77 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYQASPADSGEYVcR 95.00% 4.31 0.636 4.18 c14: Carbamidomethyl (+57.02) 858.3905 1,714.77 1,715.77 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIGASVEFHcAVPSDR 95.00% 4.42 0.379 4.12 c10: Carbamidomethyl (+57.02) 866.4087 1,730.80 1,731.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIGASVEFHcAVPSDR 95.00% 4.38 0.421 2.8 c10: Carbamidomethyl (+57.02) 866.4091 1,730.80 1,731.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIGASVEFHcAVPSDR 95.00% 4.65 0.431 2.7 c10: Carbamidomethyl (+57.02) 866.4103 1,730.81 1,731.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIGASVEFHcAVPSDR 95.00% 4.29 0.453 2.55 c10: Carbamidomethyl (+57.02) 866.9109 1,731.81 1,731.81 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EGGQLPPGHSVQDGVLR 95.00% 3.28 0.452 3.11 873.4483 1,744.88 1,745.89 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EGGQLPPGHSVQDGVLR 95.00% 3.18 0.431 4.33 873.4488 1,744.88 1,745.89 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EGGQLPPGHSVQDGVLR 95.00% 3.89 0.534 2.28 873.4491 1,744.88 1,745.89 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EGGQLPPGHSVQDGVLR 95.00% 3.26 0.477 3.48 873.4504 1,744.89 1,745.89 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EGGQLPPGHSVQDGVLR 95.00% 3.83 0.509 3.15 873.4504 1,744.89 1,745.89 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EGGQLPPGHSVQDGVLR 95.00% 3.42 0.48 3.44 873.9521 1,745.89 1,745.89 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GDLcEHEENPcQLR 95.00% 4.34 0.505 3.12 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 878.8718 1,755.73 1,756.74 2 NID1_HUMAN,DESP_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 5.22 0.536 5.37 c14: Carbamidomethyl (+57.02) 880.932 1,759.85 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.97 0.572 6.11 c14: Carbamidomethyl (+57.02) 880.9324 1,759.85 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.36 0.574 4.85 c14: Carbamidomethyl (+57.02) 880.933 1,759.85 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.82 0.522 6.38 c14: Carbamidomethyl (+57.02) 880.9334 1,759.85 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.74 0.567 6.32 c14: Carbamidomethyl (+57.02) 880.9337 1,759.85 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.52 0.606 3.85 c14: Carbamidomethyl (+57.02) 880.9339 1,759.85 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.05 0.511 4.4 c14: Carbamidomethyl (+57.02) 880.9345 1,759.85 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.27 0.533 4.1 c14: Carbamidomethyl (+57.02) 880.9349 1,759.85 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.95 0.59 5.72 c14: Carbamidomethyl (+57.02) 880.9353 1,759.86 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.63 0.57 4 c14: Carbamidomethyl (+57.02) 880.9354 1,759.86 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.62 0.603 4.96 c14: Carbamidomethyl (+57.02) 880.937 1,759.86 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.42 0.536 4.41 c14: Carbamidomethyl (+57.02) 881.4353 1,760.85 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 5.27 0.525 5.47 c14: Carbamidomethyl (+57.02) 881.4358 1,760.86 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.77 0.527 4.85 c14: Carbamidomethyl (+57.02) 881.4361 1,760.86 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LPAVEPTDQAQYLcR 95.00% 4.76 0.572 4.96 c14: Carbamidomethyl (+57.02) 881.4372 1,760.86 1,760.86 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LcNEcADGSFHLSTR 95.00% 5.12 0.582 3.04 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8809 1,765.75 1,766.76 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LcNEcADGSFHLSTR 95.00% 4.31 0.607 4.48 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8819 1,765.75 1,766.76 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LcNEcADGSFHLSTR 95.00% 5.4 0.623 4.24 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8827 1,765.75 1,766.76 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LcNEcADGSFHLSTR 95.00% 5.1 0.602 4.7 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.3802 1,766.74 1,766.76 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LcNEcADGSFHLSTR 95.00% 5.42 0.58 5.8 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.3822 1,766.75 1,766.76 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EVSEAVVDTLESEYLK 95.00% 2.86 0.358 0 905.9478 1,809.88 1,810.90 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EVSEAVVDTLESEYLK 95.00% 5.56 0.529 4.66 905.9487 1,809.88 1,810.90 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EVSEAVVDTLESEYLK 95.00% 5.81 0.539 4.48 905.9521 1,809.89 1,810.90 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EVSEAVVDTLESEYLK 95.00% 4.95 0.605 5.11 905.9542 1,809.89 1,810.90 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% EVSEAVVDTLESEYLK 95.00% 5.99 0.495 5.05 906.451 1,810.89 1,810.90 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SDEFGcMPPQVVTPPR 95.00% 3.76 0.546 3.8 c6: Carbamidomethyl (+57.02) 908.9204 1,815.83 1,816.84 2 ANXA5_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SDEFGcMPPQVVTPPR 95.00% 4.04 0.512 0 c6: Carbamidomethyl (+57.02) 909.4223 1,816.83 1,816.84 2 ANXA5_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SDEFGcmPPQVVTPPR 95.00% 3.89 0.594 3.19 c6: Carbamidomethyl (+57.02), m7: Oxidation (+15.99) 917.4212 1,832.83 1,832.83 2 ANXA5_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.47 0.474 3.31 c14: Carbamidomethyl (+57.02) 918.9641 1,835.91 1,836.93 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.63 0.428 3.82 c14: Carbamidomethyl (+57.02) 918.9658 1,835.92 1,836.93 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.41 0.458 4 c14: Carbamidomethyl (+57.02) 918.9659 1,835.92 1,836.93 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.41 0.381 3.17 c14: Carbamidomethyl (+57.02) 919.4674 1,836.92 1,836.93 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.07 0.491 4.02 c14: Carbamidomethyl (+57.02) 919.4676 1,836.92 1,836.93 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.35 0.36 4.92 c14: Carbamidomethyl (+57.02) 919.4677 1,836.92 1,836.93 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SQSVRPGADVTFIcTAK 95.00% 4.43 0.377 2.68 c14: Carbamidomethyl (+57.02) 919.4682 1,836.92 1,836.93 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% GmVFGIPDGVLELVPQR 95.00% 3.74 0.397 4.72 m2: Oxidation (+15.99) 922.4931 1,842.97 1,842.98 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cEScAPGYEGNPIQPGGK 95.00% 0 0 3.89 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 952.4012 1,902.79 1,903.80 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cEScAPGYEGNPIQPGGK 95.00% 2.32 0.388 0 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 960.9101 1,919.80 1,920.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cEScAPGYEGNPIQPGGK 95.00% 4.15 0.479 6.27 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 960.9146 1,919.81 1,920.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cEScAPGYEGNPIQPGGK 95.00% 4.67 0.453 5.02 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 960.915 1,919.81 1,920.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cEScAPGYEGNPIQPGGK 95.00% 2.73 0.296 2.89 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 961.4132 1,920.81 1,920.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cEScAPGYEGNPIQPGGK 95.00% 4.31 0.392 2.85 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 961.4146 1,920.81 1,920.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cAPGYYGNPSQGQPcQR 95.00% 4.38 0.687 4.92 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4098 1,938.80 1,939.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cAPGYYGNPSQGQPcQR 95.00% 4.09 0.632 6.59 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4124 1,938.81 1,939.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cAPGYYGNPSQGQPcQR 95.00% 4.44 0.628 4.43 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9096 1,939.80 1,939.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cAPGYYGNPSQGQPcQR 95.00% 4.65 0.586 4.4 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.911 1,939.81 1,939.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cAPGYYGNPSQGQPcQR 95.00% 4.5 0.636 4.89 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9112 1,939.81 1,939.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cAPGYYGNPSQGQPcQR 95.00% 4.4 0.599 5.34 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9119 1,939.81 1,939.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cAPGYYGNPSQGQPcQR 95.00% 4.67 0.636 4.47 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.912 1,939.81 1,939.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cAPGYYGNPSQGQPcQR 95.00% 4.58 0.588 5 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.913 1,939.81 1,939.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cAPGYYGNPSQGQPcQR 95.00% 4.38 0.603 4.09 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9138 1,939.81 1,939.82 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 5.05 0.582 6.15 c16: Carbamidomethyl (+57.02) 973.9886 1,945.96 1,946.98 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 4.85 0.609 6.4 c16: Carbamidomethyl (+57.02) 973.9908 1,945.97 1,946.98 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 4.71 0.55 6.08 c16: Carbamidomethyl (+57.02) 974.4897 1,946.96 1,946.98 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 5.08 0.583 6.8 c16: Carbamidomethyl (+57.02) 974.4904 1,946.97 1,946.98 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 4.87 0.547 5.09 c16: Carbamidomethyl (+57.02) 974.4909 1,946.97 1,946.98 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 4.8 0.542 3.74 c16: Carbamidomethyl (+57.02) 974.4942 1,946.97 1,946.98 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LRLPQVSPADSGEYVcR 95.00% 4.37 0.565 4.36 c16: Carbamidomethyl (+57.02) 974.4943 1,946.97 1,946.98 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYIFQASPADAGQYVcR 95.00% 6.14 0.692 11.3 c16: Carbamidomethyl (+57.02) 979.9727 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYIFQASPADAGQYVcR 95.00% 4.6 0.629 4.08 c16: Carbamidomethyl (+57.02) 979.973 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYIFQASPADAGQYVcR 95.00% 5.64 0.647 7.8 c16: Carbamidomethyl (+57.02) 979.9738 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 5.51 0.545 3.27 980.027 1,958.04 1,959.05 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYIFQASPADAGQYVcR 95.00% 6.16 0.612 7.04 c16: Carbamidomethyl (+57.02) 980.473 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYIFQASPADAGQYVcR 95.00% 5.72 0.583 6.51 c16: Carbamidomethyl (+57.02) 980.4743 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYIFQASPADAGQYVcR 95.00% 5.63 0.553 7.49 c16: Carbamidomethyl (+57.02) 980.4744 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYIFQASPADAGQYVcR 95.00% 5.61 0.566 6.62 c16: Carbamidomethyl (+57.02) 980.4745 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYIFQASPADAGQYVcR 95.00% 5.99 0.607 8.27 c16: Carbamidomethyl (+57.02) 980.4746 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% LYIFQASPADAGQYVcR 95.00% 5.26 0.555 7.22 c16: Carbamidomethyl (+57.02) 980.4747 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 5.5 0.439 3.12 980.5276 1,959.04 1,959.05 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 5.2 0.477 2.96 980.5277 1,959.04 1,959.05 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 5.56 0.506 3.3 980.5279 1,959.04 1,959.05 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 4.3 0.478 2.96 980.5285 1,959.04 1,959.05 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 4.93 0.491 3 980.5288 1,959.04 1,959.05 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VVGSSGTQEASVLVTIQQR 95.00% 5.52 0.535 2.82 980.5307 1,959.05 1,959.05 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SIEYSPQLEDAGSREFR 95.00% 3.43 0.39 2.06 992.9739 1,983.93 1,983.94 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PSDAGTYVcLAQNALGTAQK 95.00% 6.66 0.601 0 c9: Carbamidomethyl (+57.02) 1,033.00 2,063.99 2,065.00 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PSDAGTYVcLAQNALGTAQK 95.00% 6.62 0.619 0 c9: Carbamidomethyl (+57.02) 1,033.00 2,063.99 2,065.00 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PSDAGTYVcLAQNALGTAQK 95.00% 6.99 0.573 0 c9: Carbamidomethyl (+57.02) 1,033.50 2,064.99 2,065.00 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% PSDAGTYVcLAQNALGTAQK 95.00% 6.52 0.559 0 c9: Carbamidomethyl (+57.02) 1,033.51 2,065.00 2,065.00 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RcEScAPGYEGNPIQPGGK 95.00% 5.31 0.593 4.28 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 1,038.96 2,075.91 2,076.92 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RcEScAPGYEGNPIQPGGK 95.00% 3.32 0.503 1.4 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 1,039.46 2,076.91 2,076.92 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% RcEScAPGYEGNPIQPGGK 95.00% 5.15 0.621 4.29 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 1,039.47 2,076.91 2,076.92 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ATATScRPcPcPYIDASR 95.00% 4.07 0.492 1.8 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,041.96 2,081.90 2,082.92 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ATATScRPcPcPYIDASR 95.00% 3.9 0.397 1.92 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,041.96 2,081.90 2,082.92 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ATATScRPcPcPYIDASR 95.00% 4.25 0.482 2.24 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.90 2,082.92 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ATATScRPcPcPYIDASR 95.00% 3.86 0.413 2.1 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.92 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% ALEVEEcRcPPGYIGLScQDcAPGYTR 95.00% 5.4 0.555 3.26c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02), c21: Carbamidomethyl (+57.02)1,053.80 3,158.37 3,158.38 3
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VISSGSVASYVTSPQGFQFR 95.00% 3.81 0.282 0 1,059.53 2,117.05 2,117.07 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VISSGSVASYVTSPQGFQFR 95.00% 5.35 0.557 6.05 1,059.54 2,117.06 2,117.07 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VISSGSVASYVTSPQGFQFR 95.00% 5.44 0.602 2.62 1,059.54 2,117.06 2,117.07 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VISSGSVASYVTSPQGFQFR 95.00% 5.49 0.61 4.62 1,059.54 2,117.06 2,117.07 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VISSGSVASYVTSPQGFQFR 95.00% 5.81 0.603 6.25 1,059.54 2,117.06 2,117.07 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VISSGSVASYVTSPQGFQFR 95.00% 5.64 0.604 6.17 1,059.54 2,117.06 2,117.07 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% VISSGSVASYVTSPQGFQFR 95.00% 5.65 0.589 4.74 1,059.54 2,117.06 2,117.07 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPVISIDPPSSTVQQGQDASFK 95.00% 5.45 0.558 12.8 1,144.57 2,287.13 2,288.14 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPVISIDPPSSTVQQGQDASFK 95.00% 5.61 0.524 12.2 1,145.07 2,288.13 2,288.14 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPVISIDPPSSTVQQGQDASFK 95.00% 6.17 0.561 10.2 1,145.07 2,288.13 2,288.14 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPVISIDPPSSTVQQGQDASFK 95.00% 5.7 0.561 12.9 1,145.08 2,288.14 2,288.14 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPVISIDPPSSTVQQGQDASFK 95.00% 5.97 0.511 12.3 1,145.08 2,288.14 2,288.14 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% SPVISIDPPSSTVQQGQDASFK 95.00% 5.42 0.558 11 1,145.08 2,288.14 2,288.14 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AELLVTEAPSKPITVTVEEQR 95.00% 5.5 0.526 6.01 1,156.13 2,310.24 2,310.26 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% AELLVTEAPSKPITVTVEEQR 95.00% 5.13 0.502 6.05 1,156.13 2,310.24 2,310.26 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.64 0.731 4.44 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.12 2,370.14 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.77 0.669 4.55 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.73 0.677 4.41 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.66 0.711 3.18 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.9 0.711 4.72 c1: Carbamidomethyl (+57.02) 1,186.08 2,370.14 2,370.14 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.43 0.674 8.18 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.27 0.632 4.92 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.79 0.664 6.96 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.43 0.622 5.7 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.12 0.655 5.24 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.45 0.705 5.62 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.42 0.65 5.12 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.06 0.682 5.02 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 1R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 91 125 593 26.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.78 0.666 4.12 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SAEPLALGR 95.00% 2.38 0.252 0 457.2087 912.4018 913.5108 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SAEPLALGR 95.00% 2.25 0.356 1.46 457.2587 912.5018 913.5108 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SAEPLALGR 95.00% 2.18 0.299 1.46 457.2588 912.502 913.5108 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SAEPLALGR 95.00% 2.4 0.332 0 457.2592 912.5027 913.5108 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SAEPLALGR 95.00% 2.11 0.297 1.17 457.2592 912.5027 913.5108 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SAEPLALGR 95.00% 2.15 0.323 0 457.2597 912.5037 913.5108 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SAEPLALGR 95.00% 2.28 0.343 0 457.2601 912.5046 913.5108 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% GHTPTQPGALNQR 95.00% 2.95 0.305 0 459.5742 1,375.70 1,376.70 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IPGDQVVSVVFIK 95.00% 3.83 0.373 1.92 467.6104 1,399.81 1,400.82 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IPGDQVVSVVFIK 95.00% 3.29 0.345 1.52 467.6122 1,399.81 1,400.82 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SYEIMFR 95.00% 2.22 0.189 0 473.2277 944.4398 945.4504 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SYEIMFR 95.00% 2.23 0.22 0 473.2282 944.4407 945.4504 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SYEIMFR 95.00% 2.06 0.217 0 473.2287 944.4418 945.4504 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AGFFGDAmK 95.00% 2.79 0.25 0 m8: Oxidation (+15.99) 480.2178 958.42 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AGFFGDAmK 95.00% 2.77 0.25 0 m8: Oxidation (+15.99) 480.2182 958.4208 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AGFFGDAmK 95.00% 2.46 0.269 0 m8: Oxidation (+15.99) 480.2189 958.4221 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IAHVELADAGQYR 95.00% 4.34 0.468 1.74 481.5839 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IAHVELADAGQYR 95.00% 4.34 0.466 1.41 481.5839 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IAHVELADAGQYR 95.00% 3.84 0.342 1.04 481.584 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IAHVELADAGQYR 95.00% 2.58 0.303 0 481.584 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IAHVELADAGQYR 95.00% 4.19 0.44 1.24 481.5841 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LSGSHSQGVAYPVR 95.00% 4.51 0.473 1.77 486.5874 1,456.74 1,457.75 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LSGSHSQGVAYPVR 95.00% 4.31 0.45 0.959 486.5878 1,456.74 1,457.75 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LSGSHSQGVAYPVR 95.00% 4.07 0.445 0 486.5888 1,456.74 1,457.75 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LSGSHSQGVAYPVR 95.00% 3.55 0.31 0.921 486.9215 1,457.74 1,457.75 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LSGSHSQGVAYPVR 95.00% 3.1 0.213 0 486.9221 1,457.74 1,457.75 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RPEEVcGPTQFR 95.00% 2.98 0.379 1.82 c6: Carbamidomethyl (+57.02) 492.5723 1,474.69 1,475.71 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RPEEVcGPTQFR 95.00% 3.82 0.382 1.92 c6: Carbamidomethyl (+57.02) 492.5728 1,474.70 1,475.71 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RPEEVcGPTQFR 95.00% 3.82 0.446 1.51 c6: Carbamidomethyl (+57.02) 492.5733 1,474.70 1,475.71 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RPEEVcGPTQFR 95.00% 3.53 0.345 1.33 c6: Carbamidomethyl (+57.02) 492.5738 1,474.70 1,475.71 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RPEEVcGPTQFR 95.00% 3.39 0.366 1.24 c6: Carbamidomethyl (+57.02) 492.9078 1,475.70 1,475.71 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LGTVPQFPR 95.00% 2.37 0.323 2.55 507.7888 1,013.56 1,014.57 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LGTVPQFPR 95.00% 2.51 0.372 3.01 507.7896 1,013.56 1,014.57 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LGTVPQFPR 95.00% 2.32 0.289 1.19 507.7898 1,013.56 1,014.57 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LGTVPQFPR 95.00% 2.28 0.31 2.42 507.7899 1,013.56 1,014.57 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LGTVPQFPR 95.00% 2.7 0.313 1.52 507.79 1,013.56 1,014.57 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% PGAPPPQPLDLQHR 95.00% 3.07 0.531 0 508.61 1,522.81 1,522.81 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cFcMGVSR 95.00% 2.7 0.314 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 508.7086 1,015.40 1,016.41 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cFcMGVSR 95.00% 2.65 0.372 1.62 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 508.7089 1,015.40 1,016.41 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FLGDKVTSYGGELR 95.00% 2.93 0.363 1.13 514.6024 1,540.78 1,541.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FLGDKVTSYGGELR 95.00% 3.72 0.351 1.57 514.6025 1,540.78 1,541.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FLGDKVTSYGGELR 95.00% 3.66 0.46 2.82 514.603 1,540.79 1,541.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FLGDKVTSYGGELR 95.00% 3.87 0.436 2.92 514.6031 1,540.79 1,541.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FLGDKVTSYGGELR 95.00% 4.07 0.408 3.17 514.6031 1,540.79 1,541.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FLGDKVTSYGGELR 95.00% 3.83 0.431 2.85 514.6032 1,540.79 1,541.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIEYSPQLEDAGSR 95.00% 3.04 0.249 1.06 517.9132 1,550.72 1,551.73 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LDGSLPPDSR 95.00% 3.04 0.449 1.38 528.7678 1,055.52 1,056.53 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LDGSLPPDSR 95.00% 2.72 0.484 0 528.7685 1,055.52 1,056.53 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LDGSLPPDSR 95.00% 2.9 0.439 0 528.7688 1,055.52 1,056.53 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LDGSLPPDSR 95.00% 2.52 0.422 1.37 528.7693 1,055.52 1,056.53 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LDGSLPPDSR 95.00% 2.95 0.427 1.15 528.7695 1,055.52 1,056.53 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% HQVHGPLLR 95.00% 2.21 0.0957 1.96 528.8048 1,055.59 1,056.61 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% NELLHFER 95.00% 2.63 0.138 0 529.2734 1,056.53 1,057.54 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% NELLHFER 95.00% 2.41 0.168 0 529.2738 1,056.53 1,057.54 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% NELLHFER 94.80% 2.4 0.159 0 529.2738 1,056.53 1,057.54 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% NELLHFER 95.00% 2.72 0.186 0 529.2742 1,056.53 1,057.54 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPAPTIHWSK 95.00% 3.72 0.491 0 c1: Carbamidomethyl (+57.02) 533.924 1,598.75 1,599.76 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VAEGQTLDLK 95.00% 3.62 0.523 1.33 537.2946 1,072.57 1,073.58 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VAEGQTLDLK 95.00% 3.58 0.497 0 537.295 1,072.57 1,073.58 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VAEGQTLDLK 95.00% 3.63 0.472 1.14 537.295 1,072.57 1,073.58 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VAEGQTLDLK 95.00% 3.47 0.469 1.96 537.2953 1,072.57 1,073.58 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EQAWQRPDGQPATR 95.00% 2.81 0.368 0 547.2682 1,638.78 1,639.79 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EQAWQRPDGQPATR 95.00% 2.51 0.275 0 547.2683 1,638.78 1,639.79 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EQAWQRPDGQPATR 95.00% 2.8 0.326 0 547.2688 1,638.78 1,639.79 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EQAWQRPDGQPATR 95.00% 2.6 0.296 0 547.2698 1,638.79 1,639.79 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EQAWQRPDGQPATR 95.00% 2.85 0.341 0 547.2704 1,638.79 1,639.79 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EQAWQRPDGQPATR 95.00% 2.78 0.233 0 547.603 1,639.79 1,639.79 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EQAWQRPDGQPATR 95.00% 2.86 0.366 0 547.6035 1,639.79 1,639.79 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LVSEDPINDGEWHR 95.00% 2.65 0.439 1.51 556.2645 1,665.77 1,666.78 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LVSEDPINDGEWHR 95.00% 2.54 0.322 1.11 556.5993 1,666.77 1,666.78 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LEGDTLIIPR 95.00% 2.14 0.321 1.28 563.2686 1,124.52 1,126.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FDAGSGMATIR 95.00% 2.6 0.395 1.82 563.2686 1,124.52 1,125.54 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FDAGSGMATIR 95.00% 2.79 0.381 1.66 563.2691 1,124.52 1,125.54 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FDAGSGMATIR 95.00% 2.71 0.377 2.62 563.2699 1,124.52 1,125.54 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FDAGSGMATIR 95.00% 2.92 0.41 4.14 563.2702 1,124.52 1,125.54 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FDAGSGMATIR 95.00% 3.25 0.375 3.51 563.2705 1,124.53 1,125.54 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FDAGSGMATIR 95.00% 2.53 0.309 2.52 563.2705 1,124.53 1,125.54 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FDAGSGMATIR 95.00% 3.33 0.405 3.09 563.2705 1,124.53 1,125.54 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VPGSPTNLANR 95.00% 2.71 0.502 2.11 563.3016 1,124.59 1,125.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VPGSPTNLANR 95.00% 2.76 0.415 1.55 563.3017 1,124.59 1,125.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VPGSPTNLANR 95.00% 3.1 0.532 3.6 563.3018 1,124.59 1,125.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VPGSPTNLANR 95.00% 3.39 0.548 3.46 563.3032 1,124.59 1,125.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VPGSPTNLANR 95.00% 3.21 0.582 2.48 563.3034 1,124.59 1,125.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VPGSPTNLANR 95.00% 2.67 0.43 0 563.3037 1,124.59 1,125.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VPGSPTNLANR 95.00% 2.96 0.511 3.92 563.3038 1,124.59 1,125.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VPGSPTNLANR 95.00% 2.59 0.412 1.72 563.3043 1,124.59 1,125.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VPGSPTNLANR 95.00% 2.51 0.412 1.48 563.3047 1,124.59 1,125.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VGGHLRPGIVQSGGVVR 95.00% 3.54 0.437 2.42 563.3277 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VGGHLRPGIVQSGGVVR 95.00% 4.96 0.499 2.6 563.3282 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VGGHLRPGIVQSGGVVR 95.00% 4.8 0.564 3.34 563.3284 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VGGHLRPGIVQSGGVVR 95.00% 5.12 0.474 2.82 563.3284 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VGGHLRPGIVQSGGVVR 95.00% 4.92 0.574 4.36 563.3284 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VGGHLRPGIVQSGGVVR 95.00% 3.96 0.425 2.6 563.6622 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LEGDTLIIPR 95.00% 3.59 0.416 2 563.8263 1,125.64 1,126.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LEGDTLIIPR 95.00% 3.54 0.407 2.55 563.8264 1,125.64 1,126.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LEGDTLIIPR 95.00% 3.62 0.386 1.54 563.8264 1,125.64 1,126.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LEGDTLIIPR 95.00% 3.76 0.408 1.66 563.8265 1,125.64 1,126.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 3.33 0.516 0 c14: Carbamidomethyl (+57.02) 568.2766 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 3.85 0.41 4.14 c14: Carbamidomethyl (+57.02) 568.2775 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 4.18 0.442 3.32 c14: Carbamidomethyl (+57.02) 568.2776 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 4.81 0.451 3.66 c14: Carbamidomethyl (+57.02) 568.2787 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 3.96 0.434 3.07 c14: Carbamidomethyl (+57.02) 568.2792 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 3.71 0.467 1.42 c14: Carbamidomethyl (+57.02) 568.612 1,702.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 5.05 0.548 5.17 c14: Carbamidomethyl (+57.02) 568.6124 1,702.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 3.93 0.583 1.77 c14: Carbamidomethyl (+57.02) 568.6129 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 4.6 0.56 5.07 c14: Carbamidomethyl (+57.02) 568.613 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQVVVLSASDASPPPVK 95.00% 4.04 0.461 6 569.6602 1,705.96 1,706.97 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQVVVLSASDASPPPVK 95.00% 4.39 0.501 8.18 569.6607 1,705.96 1,706.97 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQVVVLSASDASPPPVK 95.00% 2.36 0.235 0 569.6608 1,705.96 1,706.97 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LLQVTPADSGEYVcR 95.00% 4.1 0.441 2.51 c14: Carbamidomethyl (+57.02) 569.9491 1,706.82 1,707.84 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LLQVTPADSGEYVcR 95.00% 4.88 0.562 5.08 c14: Carbamidomethyl (+57.02) 569.9498 1,706.83 1,707.84 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQVVVLSASDASPPPVK 95.00% 3.53 0.463 4.57 569.9948 1,706.96 1,706.97 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQVVVLSASDASPPPVK 95.00% 4.85 0.492 5.77 569.9952 1,706.96 1,706.97 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LLQVTPADSGEYVcR 95.00% 3.62 0.462 0 c14: Carbamidomethyl (+57.02) 570.2814 1,707.82 1,707.84 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLIHDGAAPISLEWK 95.00% 2.65 0.265 1.27 c1: Carbamidomethyl (+57.02) 570.6265 1,708.86 1,709.87 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLIHDGAAPISLEWK 95.00% 2.67 0.363 1.62 c1: Carbamidomethyl (+57.02) 570.9618 1,709.86 1,709.87 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FDAGSGmATIR 95.00% 3.08 0.448 3.48 m7: Oxidation (+15.99) 571.2658 1,140.52 1,141.53 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FDAGSGmATIR 95.00% 3.06 0.421 5.82 m7: Oxidation (+15.99) 571.2674 1,140.52 1,141.53 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYQASPADSGEYVcR 95.00% 5.41 0.533 2.77 c14: Carbamidomethyl (+57.02) 572.9283 1,715.76 1,715.77 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYQASPADSGEYVcR 95.00% 4.24 0.5 1.28 c14: Carbamidomethyl (+57.02) 572.9294 1,715.76 1,715.77 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cVVPGQAHAQVTWHK 95.00% 2.21 0.247 0 c1: Carbamidomethyl (+57.02) 573.2897 1,716.85 1,717.86 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHHVSPADSGEYVcR 95.00% 5.59 0.405 3.22 c14: Carbamidomethyl (+57.02) 576.2697 1,725.79 1,726.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHHVSPADSGEYVcR 95.00% 4.79 0.339 3.21 c14: Carbamidomethyl (+57.02) 576.27 1,725.79 1,726.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHHVSPADSGEYVcR 95.00% 5.48 0.406 2 c14: Carbamidomethyl (+57.02) 576.27 1,725.79 1,726.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHHVSPADSGEYVcR 95.00% 5.12 0.396 2 c14: Carbamidomethyl (+57.02) 576.2701 1,725.79 1,726.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHHVSPADSGEYVcR 95.00% 5.01 0.381 2.44 c14: Carbamidomethyl (+57.02) 576.2703 1,725.79 1,726.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHHVSPADSGEYVcR 95.00% 5.5 0.393 2.89 c14: Carbamidomethyl (+57.02) 576.6041 1,726.79 1,726.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHHVSPADSGEYVcR 95.00% 4.95 0.45 2.72 c14: Carbamidomethyl (+57.02) 576.6043 1,726.79 1,726.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHHVSPADSGEYVcR 95.00% 4.9 0.309 2.6 c14: Carbamidomethyl (+57.02) 576.6044 1,726.79 1,726.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHHVSPADSGEYVcR 95.00% 5.11 0.417 3.12 c14: Carbamidomethyl (+57.02) 576.6046 1,726.79 1,726.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHHVSPADSGEYVcR 95.00% 4.18 0.326 2.57 c14: Carbamidomethyl (+57.02) 576.605 1,726.79 1,726.80 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIGASVEFHcAVPSDR 95.00% 2.49 0.257 1.09 c10: Carbamidomethyl (+57.02) 577.942 1,730.80 1,731.81 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIGASVEFHcAVPSDR 95.00% 3.13 0.25 2.51 c10: Carbamidomethyl (+57.02) 578.2758 1,731.80 1,731.81 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIGASVEFHcAVPSDR 95.00% 3.14 0.184 1.28 c10: Carbamidomethyl (+57.02) 578.2766 1,731.81 1,731.81 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AVLHVHGGGGPR 95.00% 2.14 0.321 0 578.8186 1,155.62 1,156.63 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EGGQLPPGHSVQDGVLR 95.00% 2.9 0.261 0.921 582.6353 1,744.88 1,745.89 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EGGQLPPGHSVQDGVLR 95.00% 2.74 0.363 0 582.6368 1,744.89 1,745.89 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EGGQLPPGHSVQDGVLR 95.00% 2.21 0.314 0 582.9694 1,745.88 1,745.89 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AFAHLQVPER 95.00% 3.46 0.371 2.48 584.3174 1,166.62 1,167.63 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AFAHLQVPER 95.00% 3.5 0.384 2.35 584.3174 1,166.62 1,167.63 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHQMSVADSGEYVcR 95.00% 3.02 0.351 0 c14: Carbamidomethyl (+57.02) 584.5978 1,750.77 1,751.78 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHQMSVADSGEYVcR 95.00% 4.32 0.454 1.48 c14: Carbamidomethyl (+57.02) 584.9332 1,751.78 1,751.78 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHQMSVADSGEYVcR 95.00% 4.62 0.457 1.06 c14: Carbamidomethyl (+57.02) 584.9333 1,751.78 1,751.78 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% TcESLGAGGYR 95.00% 2.74 0.45 2.17 c2: Carbamidomethyl (+57.02) 585.7621 1,169.51 1,170.52 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% GDLcEHEENPcQLR 95.00% 3.9 0.421 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.2493 1,755.72 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% GDLcEHEENPcQLR 95.00% 3.67 0.291 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.25 1,755.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 4.42 0.484 1.52 c14: Carbamidomethyl (+57.02) 587.6245 1,759.85 1,760.86 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 4.93 0.473 2.62 c14: Carbamidomethyl (+57.02) 587.6249 1,759.85 1,760.86 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 4.88 0.498 2.24 c14: Carbamidomethyl (+57.02) 587.6258 1,759.85 1,760.86 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 4.61 0.436 1.77 c14: Carbamidomethyl (+57.02) 587.626 1,759.85 1,760.86 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 5.14 0.468 2.68 c14: Carbamidomethyl (+57.02) 587.9592 1,760.85 1,760.86 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 4.4 0.524 2.2 c14: Carbamidomethyl (+57.02) 587.9603 1,760.86 1,760.86 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% YELGSGLAVLR 95.00% 3.68 0.507 4.09 589.3316 1,176.65 1,177.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% YELGSGLAVLR 95.00% 3.05 0.44 3.21 589.3316 1,176.65 1,177.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% YELGSGLAVLR 95.00% 3.49 0.504 3.66 589.3319 1,176.65 1,177.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% YELGSGLAVLR 95.00% 3.72 0.541 4.6 589.332 1,176.65 1,177.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% YELGSGLAVLR 95.00% 3.68 0.521 4.04 589.3321 1,176.65 1,177.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% YELGSGLAVLR 95.00% 3.24 0.457 4.48 589.3322 1,176.65 1,177.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% YELGSGLAVLR 95.00% 3.65 0.512 3.85 589.3322 1,176.65 1,177.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% YELGSGLAVLR 95.00% 3.68 0.517 4.21 589.3324 1,176.65 1,177.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% YELGSGLAVLR 95.00% 3.63 0.528 3.82 589.3325 1,176.65 1,177.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LcNEcADGSFHLSTR 95.00% 3.91 0.332 2.46 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5899 1,765.75 1,766.76 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LcNEcADGSFHLSTR 95.00% 3.82 0.469 2.62 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5902 1,765.75 1,766.76 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LcNEcADGSFHLSTR 95.00% 4.03 0.402 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5904 1,765.75 1,766.76 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LcNEcADGSFHLSTR 95.00% 3.73 0.387 2.37 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.9247 1,766.75 1,766.76 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPAYTLVWTR 95.00% 3.53 0.619 2.77 597.3149 1,192.61 1,193.63 2 LU_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPAYTLVWTR 95.00% 3.01 0.465 2.64 597.3159 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPAYTLVWTR 95.00% 3.54 0.583 2.28 597.3175 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPAYTLVWTR 95.00% 3.33 0.547 1.77 597.3176 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPAYTLVWTR 95.00% 3.93 0.595 2.03 597.3177 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPAYTLVWTR 95.00% 3.55 0.596 2.05 597.3183 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPAYTLVWTR 95.00% 3.81 0.576 2.49 597.3184 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPAYTLVWTR 95.00% 3.96 0.608 2.1 597.3186 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPAYTLVWTR 95.00% 3.94 0.576 2.51 597.3186 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPAYTLVWTR 95.00% 3.9 0.598 2.51 597.3188 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPAYTLVWTR 95.00% 3.97 0.602 2.59 597.3188 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPAYTLVWTR 95.00% 3.73 0.591 2.05 597.3196 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ASYAQQPAESR 95.00% 2.66 0.207 1.37 604.2914 1,206.57 1,207.57 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% TYGLMDSHAVLQISSAK 95.00% 3.21 0.469 0 607.9791 1,820.91 1,820.92 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AGLSSGFIGcVR 95.00% 3.91 0.496 3.57 c10: Carbamidomethyl (+57.02) 612.3128 1,222.61 1,223.62 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AGLSSGFIGcVR 95.00% 3.68 0.447 4.72 c10: Carbamidomethyl (+57.02) 612.3129 1,222.61 1,223.62 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AGLSSGFIGcVR 95.00% 4.17 0.43 3.37 c10: Carbamidomethyl (+57.02) 612.3132 1,222.61 1,223.62 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AGLSSGFIGcVR 95.00% 3.95 0.453 3.89 c10: Carbamidomethyl (+57.02) 612.3132 1,222.61 1,223.62 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AGLSSGFIGcVR 95.00% 4.34 0.501 4.51 c10: Carbamidomethyl (+57.02) 612.3134 1,222.61 1,223.62 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AGLSSGFIGcVR 95.00% 3.89 0.46 4.3 c10: Carbamidomethyl (+57.02) 612.3134 1,222.61 1,223.62 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AGLSSGFIGcVR 95.00% 4.36 0.491 3.62 c10: Carbamidomethyl (+57.02) 612.3136 1,222.61 1,223.62 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AGLSSGFIGcVR 95.00% 3.98 0.454 4.96 c10: Carbamidomethyl (+57.02) 612.3138 1,222.61 1,223.62 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 3.6 0.493 1.05 c14: Carbamidomethyl (+57.02) 612.9799 1,835.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.82 0.608 3.68 c14: Carbamidomethyl (+57.02) 612.9801 1,835.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.92 0.549 3.09 c14: Carbamidomethyl (+57.02) 612.9802 1,835.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 3.57 0.54 2.51 c14: Carbamidomethyl (+57.02) 612.9802 1,835.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.11 0.533 2.64 c14: Carbamidomethyl (+57.02) 612.9805 1,835.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.05 0.53 1.92 c14: Carbamidomethyl (+57.02) 612.9812 1,835.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 3.9 0.479 2.21 c14: Carbamidomethyl (+57.02) 612.9813 1,835.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 3.42 0.461 0 c14: Carbamidomethyl (+57.02) 613.3138 1,836.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 3.88 0.478 1.17 c14: Carbamidomethyl (+57.02) 613.314 1,836.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.22 0.576 2.85 c14: Carbamidomethyl (+57.02) 613.3141 1,836.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.64 0.6 1.77 c14: Carbamidomethyl (+57.02) 613.3142 1,836.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.56 0.587 2.55 c14: Carbamidomethyl (+57.02) 613.3143 1,836.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.48 0.501 1.15 c14: Carbamidomethyl (+57.02) 613.3146 1,836.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 2.65 0.443 0.959 c14: Carbamidomethyl (+57.02) 613.3151 1,836.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 2.27 0.388 0 c14: Carbamidomethyl (+57.02) 613.3152 1,836.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.59 0.562 1.68 c14: Carbamidomethyl (+57.02) 613.3153 1,836.92 1,836.93 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AAGVPSATITWR 95.00% 1.94 0.31 2.62 615.3347 1,228.65 1,229.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AAGVPSATITWR 95.00% 1.64 0.134 3.74 615.3347 1,228.65 1,229.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AAGVPSATITWR 95.00% 2.32 0.422 2.19 615.3354 1,228.66 1,229.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AAGVPSATITWR 95.00% 2.24 0.419 3.19 615.3357 1,228.66 1,229.66 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIVPQGGSHSLR 95.00% 2.03 0.325 1.26 619.3326 1,236.65 1,237.67 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIVPQGGSHSLR 95.00% 2.21 0.397 1.72 619.3338 1,236.65 1,237.67 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIVPQGGSHSLR 95.00% 2.23 0.444 1.77 619.334 1,236.65 1,237.67 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIVPQGGSHSLR 95.00% 1.87 0.351 1.36 619.3346 1,236.65 1,237.67 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cQVSGSPPHYFYWSR 95.00% 2.57 0.405 0 c1: Carbamidomethyl (+57.02) 624.281 1,869.82 1,870.83 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cQVSGSPPHYFYWSR 95.00% 2.49 0.244 0 c1: Carbamidomethyl (+57.02) 624.2819 1,869.82 1,870.83 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QPQAIITWYK 95.00% 1.63 0.319 1.16 624.3419 1,246.67 1,247.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QPQAIITWYK 95.00% 1.67 0.345 0 624.3423 1,246.67 1,247.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QPQAIITWYK 95.00% 1.77 0.338 0 624.3427 1,246.67 1,247.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cQVSGSPPHYFYWSR 95.00% 3.22 0.523 0 c1: Carbamidomethyl (+57.02) 624.6141 1,870.82 1,870.83 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cQVSGSPPHYFYWSR 95.00% 2.56 0.504 0 c1: Carbamidomethyl (+57.02) 624.6157 1,870.82 1,870.83 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cQVSGSPPHYFYWSR 95.00% 2.78 0.439 0 c1: Carbamidomethyl (+57.02) 624.6161 1,870.82 1,870.83 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cQVSGSPPHYFYWSR 95.00% 2.65 0.421 0 c1: Carbamidomethyl (+57.02) 624.6168 1,870.83 1,870.83 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cQVSGSPPHYFYWSR 95.00% 2.62 0.401 0 c1: Carbamidomethyl (+57.02) 624.6174 1,870.83 1,870.83 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cQVSGSPPHYFYWSR 95.00% 2.41 0.426 0 c1: Carbamidomethyl (+57.02) 624.6177 1,870.83 1,870.83 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QPQAIITWYK 95.00% 1.82 0.278 1.23 624.8423 1,247.67 1,247.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLcLPGFSGPR 95.00% 2.15 0.335 1.28 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.0657 1,262.12 1,263.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLcLPGFSGPR 95.00% 2.93 0.399 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3003 1,262.59 1,263.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLcLPGFSGPR 95.00% 2.9 0.396 2.03 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3016 1,262.59 1,263.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLcLPGFSGPR 95.00% 3.06 0.389 2.15 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.302 1,262.59 1,263.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLcLPGFSGPR 95.00% 2.85 0.376 2.22 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3021 1,262.59 1,263.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLcLPGFSGPR 95.00% 2.52 0.404 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3022 1,262.59 1,263.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLcLPGFSGPR 95.00% 2.86 0.4 1.85 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3024 1,262.59 1,263.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLcLPGFSGPR 95.00% 2.63 0.158 1.28 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3031 1,262.59 1,263.60 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AmDFNGILTIR 95.00% 3.44 0.301 2.46 m2: Oxidation (+15.99) 633.8238 1,265.63 1,266.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AmDFNGILTIR 95.00% 3.76 0.488 2.4 m2: Oxidation (+15.99) 633.8278 1,265.64 1,266.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AmDFNGILTIR 95.00% 3.69 0.552 2.7 m2: Oxidation (+15.99) 633.8287 1,265.64 1,266.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AmDFNGILTIR 95.00% 3.78 0.499 2.74 m2: Oxidation (+15.99) 633.8291 1,265.64 1,266.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AmDFNGILTIR 95.00% 3.71 0.487 2.52 m2: Oxidation (+15.99) 633.8292 1,265.64 1,266.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AmDFNGILTIR 95.00% 2.54 0.435 2.72 m2: Oxidation (+15.99) 633.8293 1,265.64 1,266.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AmDFNGILTIR 95.00% 3.61 0.482 2.62 m2: Oxidation (+15.99) 633.8294 1,265.64 1,266.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cRPVNQEIVR 95.00% 2.02 0.313 0 c1: Carbamidomethyl (+57.02) 635.838 1,269.66 1,270.67 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRFDQPDDFK 95.00% 2.58 0.304 1.72 640.8163 1,279.62 1,280.63 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRFDQPDDFK 95.00% 2.36 0.328 1.92 640.8168 1,279.62 1,280.63 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QPDFISFGLVGGRPEFR 95.00% 1.98 0.24 0 641.3352 1,920.98 1,921.99 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QPDFISFGLVGGRPEFR 95.00% 2.66 0.392 0.959 641.6682 1,921.98 1,921.99 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QPDFISFGLVGGRPEFR 95.00% 2.65 0.384 0.921 641.6694 1,921.98 1,921.99 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QPDFISFGLVGGRPEFR 95.00% 2.57 0.464 2.02 641.6697 1,921.99 1,921.99 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QPDFISFGLVGGRPEFR 95.00% 2.17 0.343 0 641.67 1,921.99 1,921.99 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QPDFISFGLVGGRPEFR 95.00% 2.65 0.414 1.47 641.6702 1,921.99 1,921.99 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cAPGYYGNPSQGQPcQR 95.00% 4.84 0.487 3.12 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.2757 1,938.80 1,939.82 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cAPGYYGNPSQGQPcQR 95.00% 4.17 0.235 1.85 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.2765 1,938.81 1,939.82 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cAPGYYGNPSQGQPcQR 95.00% 2.5 0.265 0 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.2779 1,938.81 1,939.82 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 3.06 0.417 1.17 c16: Carbamidomethyl (+57.02) 649.6617 1,945.96 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 5.39 0.577 5.54 c16: Carbamidomethyl (+57.02) 649.6634 1,945.97 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 5.73 0.617 5.36 c16: Carbamidomethyl (+57.02) 649.6635 1,945.97 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 5.48 0.59 5.05 c16: Carbamidomethyl (+57.02) 649.6638 1,945.97 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 2.4 0.219 0 c16: Carbamidomethyl (+57.02) 649.6663 1,945.98 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 1.95 0.232 2.96 c16: Carbamidomethyl (+57.02) 649.887 1,946.64 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 5.69 0.52 5.62 c16: Carbamidomethyl (+57.02) 649.9965 1,946.97 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 5.35 0.568 4.24 c16: Carbamidomethyl (+57.02) 649.9968 1,946.97 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 3.64 0.53 2.72 c16: Carbamidomethyl (+57.02) 649.997 1,946.97 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 3.04 0.443 2.15 c16: Carbamidomethyl (+57.02) 649.9972 1,946.97 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 6.3 0.648 5.21 c16: Carbamidomethyl (+57.02) 649.9973 1,946.97 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 6.02 0.634 6.24 c16: Carbamidomethyl (+57.02) 649.9974 1,946.97 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 5.49 0.567 6.14 c16: Carbamidomethyl (+57.02) 649.9979 1,946.97 1,946.98 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VVGSSGTQEASVLVTIQQR 95.00% 4.39 0.395 0 653.6879 1,958.04 1,959.05 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VVGSSGTQEASVLVTIQQR 95.00% 4.61 0.323 0 654.0224 1,959.04 1,959.05 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VVGSSGTQEASVLVTIQQR 95.00% 5.24 0.394 1.51 654.0225 1,959.04 1,959.05 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VVGSSGTQEASVLVTIQQR 95.00% 4.63 0.39 0 654.0228 1,959.04 1,959.05 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ITFRPDSADGMLLYNGQK 95.00% 4.08 0.426 1.14 676.0062 2,025.00 2,026.01 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ITFRPDSADGMLLYNGQK 95.00% 3.74 0.417 1.49 676.34 2,026.00 2,026.01 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ITFRPDSADGMLLYNGQK 95.00% 3.67 0.456 1.49 676.341 2,026.00 2,026.01 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ITFRPDSADGMLLYNGQK 95.00% 3.49 0.281 0 676.3411 2,026.00 2,026.01 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ITFRPDSADGMLLYNGQK 95.00% 3.89 0.505 2.24 676.3421 2,026.00 2,026.01 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ITFRPDSADGMLLYNGQK 95.00% 2.53 0.354 0 676.3426 2,026.00 2,026.01 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% TPSGLYLGTcER 95.00% 3.25 0.372 1.8 c10: Carbamidomethyl (+57.02) 677.3251 1,352.63 1,353.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% TPSGLYLGTcER 95.00% 3.78 0.385 2.47 c10: Carbamidomethyl (+57.02) 677.3255 1,352.64 1,353.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% TPSGLYLGTcER 95.00% 2.91 0.258 1.68 c10: Carbamidomethyl (+57.02) 677.3258 1,352.64 1,353.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% TPSGLYLGTcER 95.00% 4.03 0.431 3.44 c10: Carbamidomethyl (+57.02) 677.326 1,352.64 1,353.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% TPSGLYLGTcER 95.00% 4.09 0.466 3.85 c10: Carbamidomethyl (+57.02) 677.3261 1,352.64 1,353.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% TPSGLYLGTcER 95.00% 3.92 0.5 3.04 c10: Carbamidomethyl (+57.02) 677.3266 1,352.64 1,353.65 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% DVKESDQGAYTcEAMNAR 95.00% 3.5 0.393 0 c12: Carbamidomethyl (+57.02) 682.6285 2,044.86 2,044.87 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% DVKESDQGAYTcEAMNAR 95.00% 4.07 0.327 4.04 c12: Carbamidomethyl (+57.02) 682.6292 2,044.86 2,044.87 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% GMLEPVQRPDVVLVGAGYR 95.00% 2.53 0.389 1.89 686.0376 2,055.09 2,056.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% GMLEPVQRPDVVLVGAGYR 95.00% 3.47 0.554 2.77 686.371 2,056.09 2,056.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% GMLEPVQRPDVVLVGAGYR 95.00% 4.8 0.657 4.07 686.3714 2,056.09 2,056.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% GMLEPVQRPDVVLVGAGYR 95.00% 4.59 0.601 3.8 686.3724 2,056.09 2,056.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% PSDAGTYVcLAQNALGTAQK 95.00% 5.55 0.415 0 c9: Carbamidomethyl (+57.02) 689.3386 2,064.99 2,065.00 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% PSDAGTYVcLAQNALGTAQK 95.00% 5.61 0.412 0 c9: Carbamidomethyl (+57.02) 689.3394 2,064.99 2,065.00 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% GmLEPVQRPDVVLVGAGYR 95.00% 4.37 0.655 4.15 m2: Oxidation (+15.99) 691.7021 2,072.08 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% GmLEPVQRPDVVLVGAGYR 95.00% 4.36 0.636 4.03 m2: Oxidation (+15.99) 691.7036 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RcEScAPGYEGNPIQPGGK 95.00% 4.37 0.512 3.03 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3115 2,076.91 2,076.92 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RcEScAPGYEGNPIQPGGK 95.00% 4.35 0.446 2.09 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3123 2,076.91 2,076.92 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RcEScAPGYEGNPIQPGGK 95.00% 4.17 0.497 1.8 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3132 2,076.92 2,076.92 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RcEScAPGYEGNPIQPGGK 95.00% 4.06 0.385 3.1 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3137 2,076.92 2,076.92 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ATATScRPcPcPYIDASR 95.00% 3.73 0.523 1.3 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.976 2,081.90 2,082.92 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ATATScRPcPcPYIDASR 95.00% 3.33 0.552 1.19 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3091 2,082.90 2,082.92 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ATATScRPcPcPYIDASR 95.00% 2.89 0.475 2.41 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3096 2,082.91 2,082.92 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ATATScRPcPcPYIDASR 95.00% 3.94 0.433 1.92 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.31 2,082.91 2,082.92 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ATATScRPcPcPYIDASR 95.00% 3.62 0.407 1.77 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.31 2,082.91 2,082.92 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ATATScRPcPcPYIDASR 95.00% 3.8 0.463 2.68 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.311 2,082.91 2,082.92 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ATATScRPcPcPYIDASR 95.00% 4.04 0.467 1.46 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3118 2,082.91 2,082.92 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AVTLEcVSAGEPR 95.00% 2.78 0.297 1.37 c6: Carbamidomethyl (+57.02) 695.3479 1,388.68 1,388.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AVTLEcVSAGEPR 95.00% 2.42 0.268 1.92 c6: Carbamidomethyl (+57.02) 695.3479 1,388.68 1,388.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AVTLEcVSAGEPR 95.00% 2.48 0.386 1.57 c6: Carbamidomethyl (+57.02) 695.3485 1,388.68 1,388.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IPGDQVVSVVFIK 95.00% 4.5 0.518 3.16 700.9099 1,399.80 1,400.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IPGDQVVSVVFIK 95.00% 4.13 0.519 3.74 700.9111 1,399.81 1,400.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IPGDQVVSVVFIK 95.00% 3.73 0.464 3.49 701.4122 1,400.81 1,400.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SKSPAYTLVWTR 95.00% 2.38 0.411 2 704.883 1,407.75 1,408.76 2 TENA_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IAHVELADAGQYR 95.00% 4.17 0.517 3.57 721.8715 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IAHVELADAGQYR 95.00% 4.54 0.573 3.25 721.8722 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IAHVELADAGQYR 95.00% 4.68 0.559 4.09 721.8726 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IAHVELADAGQYR 95.00% 4.7 0.57 3.42 721.8728 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IAHVELADAGQYR 95.00% 4.54 0.551 3.55 721.8731 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IAHVELADAGQYR 95.00% 4.5 0.517 3.03 721.8741 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LSGSHSQGVAYPVR 95.00% 3.8 0.575 3.89 729.3773 1,456.74 1,457.75 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LSGSHSQGVAYPVR 95.00% 3.55 0.57 4.8 729.3786 1,456.74 1,457.75 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LSGSHSQGVAYPVR 95.00% 3.74 0.483 3.4 729.3793 1,456.74 1,457.75 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% DGFKGDLcEHEENPcQLR 95.00% 3.66 0.369 1.77 c8: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 735.3209 2,202.94 2,203.95 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RPEEVcGPTQFR 95.00% 3.61 0.432 5.54 c6: Carbamidomethyl (+57.02) 738.3554 1,474.70 1,475.71 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RPEEVcGPTQFR 95.00% 3.9 0.51 4.96 c6: Carbamidomethyl (+57.02) 738.3556 1,474.70 1,475.71 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RPEEVcGPTQFR 95.00% 3.49 0.415 4.82 c6: Carbamidomethyl (+57.02) 738.3564 1,474.70 1,475.71 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RPEEVcGPTQFR 95.00% 3.65 0.473 5.62 c6: Carbamidomethyl (+57.02) 738.357 1,474.70 1,475.71 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPVISIDPPSSTVQQGQDASFK 95.00% 4.91 0.445 4.82 763.7184 2,288.13 2,288.14 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPVISIDPPSSTVQQGQDASFK 95.00% 3.63 0.461 0 763.7187 2,288.13 2,288.14 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPVISIDPPSSTVQQGQDASFK 95.00% 4.82 0.408 3.44 763.7192 2,288.13 2,288.14 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPVISIDPPSSTVQQGQDASFK 95.00% 4.52 0.428 3.4 763.7195 2,288.14 2,288.14 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cDGDFDcEDRTDEANcPTK 95.00% 3.72 0.516 2.4 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 769.2875 2,304.84 2,304.84 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cDGDFDcEDRTDEANcPTK 95.00% 3.95 0.548 3.28 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 769.2875 2,304.84 2,304.84 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 6.35 0.65 2.43 770.7568 2,309.25 2,310.26 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 6.43 0.645 3.02 771.0899 2,310.25 2,310.26 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 6.86 0.648 2.89 771.0901 2,310.25 2,310.26 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 6.47 0.667 2.33 771.0904 2,310.25 2,310.26 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 6.77 0.625 3.51 771.0906 2,310.25 2,310.26 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 6.62 0.62 2.23 771.0908 2,310.25 2,310.26 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 6.29 0.619 2.14 771.0908 2,310.25 2,310.26 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 6.85 0.653 3.92 771.0909 2,310.25 2,310.26 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 4.8 0.499 3.6 771.0916 2,310.25 2,310.26 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FLGDKVTSYGGELR 95.00% 4.26 0.562 4.59 771.4001 1,540.78 1,541.80 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% FLGDKVTSYGGELR 95.00% 4.36 0.549 3.82 771.404 1,540.79 1,541.80 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIEYSPQLEDAGSR 95.00% 4.48 0.618 4.21 776.367 1,550.72 1,551.73 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIEYSPQLEDAGSR 95.00% 4.48 0.582 6.29 776.3681 1,550.72 1,551.73 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIEYSPQLEDAGSR 95.00% 4.69 0.608 4.03 776.3683 1,550.72 1,551.73 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIEYSPQLEDAGSR 95.00% 4.87 0.593 4.47 776.3694 1,550.72 1,551.73 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QVQFSEEHWVHESGRPVQR 95.00% 3.01 0.375 0 779.051 2,334.13 2,335.13 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QVQFSEEHWVHESGRPVQR 95.00% 3.15 0.343 1.14 779.3815 2,335.12 2,335.13 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QVQFSEEHWVHESGRPVQR 95.00% 2.87 0.38 0 779.3832 2,335.13 2,335.13 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% QVQFSEEHWVHESGRPVQR 95.00% 3.16 0.392 2.24 779.3834 2,335.13 2,335.13 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% MASVGLSDIAMDTTVTHATSHGR 95.00% 3.38 0.358 3.7 787.0446 2,358.11 2,358.12 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% MASVGLSDIAMDTTVTHATSHGR 95.00% 3.46 0.501 2.64 787.0447 2,358.11 2,358.12 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPAPTIHWSK 95.00% 0 0 4.02 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 791.8685 1,581.72 1,582.73 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPAPTIHWSK 95.00% 0 0 3.38 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 791.8688 1,581.72 1,582.73 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPAPTIHWSK 95.00% 0 0 3.48 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 791.8692 1,581.72 1,582.73 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPAPTIHWSK 95.00% 0 0 3.85 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 792.3682 1,582.72 1,582.73 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IESSSPTVVEGQTLDLNcVVAR 95.00% 6.43 0.533 2.51 c18: Carbamidomethyl (+57.02) 792.4008 2,374.18 2,374.19 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IESSSPTVVEGQTLDLNcVVAR 95.00% 6.16 0.592 3.18 c18: Carbamidomethyl (+57.02) 792.401 2,374.18 2,374.19 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IESSSPTVVEGQTLDLNcVVAR 95.00% 6.45 0.56 3.89 c18: Carbamidomethyl (+57.02) 792.4019 2,374.18 2,374.19 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.69 0.57 5.85 c18: Carbamidomethyl (+57.02) 792.4023 2,374.18 2,374.19 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPAPTIHWSK 95.00% 3.78 0.516 5.3 c1: Carbamidomethyl (+57.02) 800.3834 1,598.75 1,599.76 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SLPEVPETIELEVR 95.00% 4.05 0.646 3.57 805.9342 1,609.85 1,610.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SLPEVPETIELEVR 95.00% 2.75 0.268 1.85 806.4324 1,610.85 1,610.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SLPEVPETIELEVR 95.00% 3.25 0.463 4.34 806.4355 1,610.86 1,610.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SLPEVPETIELEVR 95.00% 3.71 0.629 6.25 806.4364 1,610.86 1,610.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 4.36 0.502 3.25 817.1108 2,448.31 2,448.31 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EQAWQRPDGQPATR 95.00% 3.16 0.277 0 820.4004 1,638.79 1,639.79 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EQAWQRPDGQPATR 95.00% 2.78 0.29 0 820.4008 1,638.79 1,639.79 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LVSEDPINDGEWHR 95.00% 4.31 0.556 3.96 833.8925 1,665.77 1,666.78 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPQVSPADSGEYVcR 95.00% 4.85 0.58 6.21 c14: Carbamidomethyl (+57.02) 839.3976 1,676.78 1,677.79 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPQVSPADSGEYVcR 95.00% 4.29 0.579 7.44 c14: Carbamidomethyl (+57.02) 839.398 1,676.78 1,677.79 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPQVSPADSGEYVcR 95.00% 4.77 0.56 4.7 c14: Carbamidomethyl (+57.02) 839.3982 1,676.78 1,677.79 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPQVSPADSGEYVcR 95.00% 4.06 0.579 6.44 c14: Carbamidomethyl (+57.02) 839.896 1,677.78 1,677.79 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPQVSPADSGEYVcR 95.00% 4.14 0.547 4.77 c14: Carbamidomethyl (+57.02) 839.899 1,677.78 1,677.79 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPQVSPADSGEYVcR 95.00% 4.8 0.595 5.09 c14: Carbamidomethyl (+57.02) 839.9004 1,677.79 1,677.79 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPQVSPADSGEYVcR 95.00% 4.92 0.603 5.6 c14: Carbamidomethyl (+57.02) 839.9004 1,677.79 1,677.79 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPQVSPADSGEYVcR 95.00% 4.35 0.535 5.8 c14: Carbamidomethyl (+57.02) 839.9005 1,677.79 1,677.79 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPQVSPADSGEYVcR 95.00% 4.42 0.586 4.92 c14: Carbamidomethyl (+57.02) 839.901 1,677.79 1,677.79 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VGGHLRPGIVQSGGVVR 95.00% 3.69 0.444 3.43 844.4886 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VGGHLRPGIVQSGGVVR 95.00% 4.08 0.492 3.21 844.4891 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VGGHLRPGIVQSGGVVR 95.00% 3.76 0.401 4.68 844.4903 1,686.97 1,687.97 2 ATPA_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VGGHLRPGIVQSGGVVR 95.00% 3.85 0.476 2.62 844.9901 1,687.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VGGHLRPGIVQSGGVVR 95.00% 3.36 0.28 2.85 844.9906 1,687.97 1,687.97 2 ATPA_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ESDQGAYTcEAMNAR 95.00% 4.08 0.517 3.96 c9: Carbamidomethyl (+57.02) 851.8426 1,701.67 1,702.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ESDQGAYTcEAMNAR 95.00% 3.23 0.483 2.14 c9: Carbamidomethyl (+57.02) 851.8427 1,701.67 1,702.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 3.71 0.424 5.27 c14: Carbamidomethyl (+57.02) 851.9134 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 4.13 0.405 6.3 c14: Carbamidomethyl (+57.02) 851.9159 1,701.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ESDQGAYTcEAMNAR 95.00% 4.45 0.533 2.74 c9: Carbamidomethyl (+57.02) 852.3427 1,702.67 1,702.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ESDQGAYTcEAMNAR 95.00% 3.92 0.521 2.04 c9: Carbamidomethyl (+57.02) 852.3438 1,702.67 1,702.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ESDQGAYTcEAMNAR 95.00% 3.9 0.501 2.7 c9: Carbamidomethyl (+57.02) 852.3438 1,702.67 1,702.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ESDQGAYTcEAMNAR 95.00% 3.8 0.489 1.6 c9: Carbamidomethyl (+57.02) 852.3459 1,702.68 1,702.68 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 4.57 0.463 7.66 c14: Carbamidomethyl (+57.02) 852.4148 1,702.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 4.97 0.442 7.18 c14: Carbamidomethyl (+57.02) 852.4158 1,702.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHLVSPADSGEYVcR 95.00% 4.31 0.38 5.82 c14: Carbamidomethyl (+57.02) 852.4165 1,702.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.82 0.668 8.11 853.446 2,557.31 2,557.33 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRSPVISIDPPSSTVQQGQDASFK 95.00% 7.21 0.628 6.52 853.4467 2,557.32 2,557.33 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.54 0.637 5.52 853.4475 2,557.32 2,557.33 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRSPVISIDPPSSTVQQGQDASFK 95.00% 7.01 0.642 4.48 853.4476 2,557.32 2,557.33 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQVVVLSASDASPPPVK 95.00% 3.92 0.537 7.48 853.9873 1,705.96 1,706.97 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQVVVLSASDASPPPVK 95.00% 3.35 0.454 7.19 853.9883 1,705.96 1,706.97 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQVVVLSASDASPPPVK 95.00% 3.14 0.436 5 853.9884 1,705.96 1,706.97 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQVVVLSASDASPPPVK 95.00% 2.96 0.483 4.02 853.9897 1,705.96 1,706.97 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LLQVTPADSGEYVcR 95.00% 3.8 0.076 1.6 c14: Carbamidomethyl (+57.02) 854.4139 1,706.81 1,707.84 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LLQVTPADSGEYVcR 95.00% 4.37 0.388 4.55 c14: Carbamidomethyl (+57.02) 854.4174 1,706.82 1,707.84 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LLQVTPADSGEYVcR 95.00% 4.28 0.486 2.8 c14: Carbamidomethyl (+57.02) 854.4186 1,706.82 1,707.84 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LLQVTPADSGEYVcR 95.00% 4.55 0.662 5.2 c14: Carbamidomethyl (+57.02) 854.4191 1,706.82 1,707.84 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LLQVTPADSGEYVcR 95.00% 4.65 0.662 5.52 c14: Carbamidomethyl (+57.02) 854.4211 1,706.83 1,707.84 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQVVVLSASDASPPPVK 95.00% 3.7 0.462 7.47 854.4874 1,706.96 1,706.97 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQVVVLSASDASPPPVK 95.00% 3.54 0.402 4.51 854.4881 1,706.96 1,706.97 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQVVVLSASDASPPPVK 95.00% 3.77 0.393 6.31 854.4888 1,706.96 1,706.97 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.55 0.55 2.77 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7264 2,561.16 2,561.17 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.69 0.58 1.77 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7271 2,561.16 2,561.17 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLIHDGAAPISLEWK 95.00% 4.16 0.579 3.49 c1: Carbamidomethyl (+57.02) 855.434 1,708.85 1,709.87 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLIHDGAAPISLEWK 95.00% 4.55 0.591 7.68 c1: Carbamidomethyl (+57.02) 855.435 1,708.85 1,709.87 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLIHDGAAPISLEWK 95.00% 4.64 0.592 7.51 c1: Carbamidomethyl (+57.02) 855.4356 1,708.86 1,709.87 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLIHDGAAPISLEWK 95.00% 4.95 0.583 7.47 c1: Carbamidomethyl (+57.02) 855.4373 1,708.86 1,709.87 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLIHDGAAPISLEWK 95.00% 4.61 0.6 6.8 c1: Carbamidomethyl (+57.02) 855.441 1,708.87 1,709.87 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cLIHDGAAPISLEWK 95.00% 4.52 0.561 6.11 c1: Carbamidomethyl (+57.02) 855.9389 1,709.86 1,709.87 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYQASPADSGEYVcR 95.00% 5.32 0.624 5.77 c14: Carbamidomethyl (+57.02) 858.3869 1,714.76 1,715.77 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYQASPADSGEYVcR 95.00% 5.46 0.619 5.72 c14: Carbamidomethyl (+57.02) 858.3872 1,714.76 1,715.77 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYQASPADSGEYVcR 95.00% 5.11 0.633 6.19 c14: Carbamidomethyl (+57.02) 858.3876 1,714.76 1,715.77 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYQASPADSGEYVcR 95.00% 5.25 0.628 6.03 c14: Carbamidomethyl (+57.02) 858.3885 1,714.76 1,715.77 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYQASPADSGEYVcR 95.00% 5.32 0.627 5.51 c14: Carbamidomethyl (+57.02) 858.8889 1,715.76 1,715.77 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYQASPADSGEYVcR 95.00% 5.46 0.618 5.85 c14: Carbamidomethyl (+57.02) 858.8892 1,715.76 1,715.77 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cVVPGQAHAQVTWHK 95.00% 4.25 0.456 1.62 c1: Carbamidomethyl (+57.02) 859.9337 1,717.85 1,717.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cVVPGQAHAQVTWHK 95.00% 4.31 0.571 3.29 c1: Carbamidomethyl (+57.02) 859.9341 1,717.85 1,717.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIGASVEFHcAVPSDR 95.00% 4.55 0.394 2.7 c10: Carbamidomethyl (+57.02) 866.4101 1,730.80 1,731.81 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIGASVEFHcAVPSDR 95.00% 4.03 0.36 2.18 c10: Carbamidomethyl (+57.02) 866.4103 1,730.81 1,731.81 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIGASVEFHcAVPSDR 95.00% 4.29 0.428 2.4 c10: Carbamidomethyl (+57.02) 866.9101 1,731.80 1,731.81 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SIGASVEFHcAVPSDR 95.00% 4.41 0.46 2.32 c10: Carbamidomethyl (+57.02) 866.9117 1,731.81 1,731.81 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EGGQLPPGHSVQDGVLR 95.00% 3.4 0.514 4.14 873.4485 1,744.88 1,745.89 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EGGQLPPGHSVQDGVLR 95.00% 3.15 0.526 1.7 873.4507 1,744.89 1,745.89 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EGGQLPPGHSVQDGVLR 95.00% 3.57 0.517 2.68 873.451 1,744.89 1,745.89 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EGGQLPPGHSVQDGVLR 95.00% 3.57 0.492 4.41 873.9468 1,745.88 1,745.89 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EGGQLPPGHSVQDGVLR 95.00% 3.7 0.525 3.24 873.9511 1,745.89 1,745.89 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LHQMSVADSGEYVcR 95.00% 4.54 0.581 7.17 c14: Carbamidomethyl (+57.02) 876.3926 1,750.77 1,751.78 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 2.94 0.345 1.54 c14: Carbamidomethyl (+57.02) 880.4428 1,758.87 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 4.22 0.588 4 c14: Carbamidomethyl (+57.02) 880.932 1,759.85 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 4.4 0.568 4.6 c14: Carbamidomethyl (+57.02) 880.9323 1,759.85 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 5.05 0.52 5.55 c14: Carbamidomethyl (+57.02) 880.9328 1,759.85 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 5.42 0.572 6.29 c14: Carbamidomethyl (+57.02) 880.9336 1,759.85 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 4.78 0.547 5.89 c14: Carbamidomethyl (+57.02) 880.9339 1,759.85 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 5.06 0.541 5.17 c14: Carbamidomethyl (+57.02) 880.9341 1,759.85 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 5.1 0.59 5.85 c14: Carbamidomethyl (+57.02) 880.9342 1,759.85 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 5.31 0.566 5.46 c14: Carbamidomethyl (+57.02) 880.9343 1,759.85 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 5.11 0.579 7.1 c14: Carbamidomethyl (+57.02) 880.9344 1,759.85 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 4.09 0.503 4.12 c14: Carbamidomethyl (+57.02) 880.9347 1,759.85 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 5.08 0.578 5.7 c14: Carbamidomethyl (+57.02) 880.9348 1,759.85 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 4.2 0.52 6.4 c14: Carbamidomethyl (+57.02) 880.9361 1,759.86 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 4.7 0.516 4.62 c14: Carbamidomethyl (+57.02) 881.4359 1,760.86 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LPAVEPTDQAQYLcR 95.00% 4.55 0.552 4.52 c14: Carbamidomethyl (+57.02) 881.4367 1,760.86 1,760.86 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LcNEcADGSFHLSTR 95.00% 5.29 0.601 3.33 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8828 1,765.75 1,766.76 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LcNEcADGSFHLSTR 95.00% 5.47 0.604 4.82 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8832 1,765.75 1,766.76 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LcNEcADGSFHLSTR 95.00% 5.23 0.619 5.06 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.3816 1,766.75 1,766.76 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LcNEcADGSFHLSTR 95.00% 5.38 0.607 5.09 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.382 1,766.75 1,766.76 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LcNEcADGSFHLSTR 95.00% 4.91 0.583 5.28 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.382 1,766.75 1,766.76 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LcNEcADGSFHLSTR 95.00% 4.65 0.565 4.35 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.3829 1,766.75 1,766.76 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRIPQVTPADSGEYVcHVSNGAGSR 95.00% 0 0 3.62 c16: Carbamidomethyl (+57.02) 891.4338 2,671.28 2,670.31 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRIPQVTPADSGEYVcHVSNGAGSR 95.00% 0 0 5.92 c16: Carbamidomethyl (+57.02) 891.4347 2,671.28 2,670.31 3
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EVSEAVVDTLESEYLK 95.00% 5.47 0.559 5.08 905.9476 1,809.88 1,810.90 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EVSEAVVDTLESEYLK 95.00% 5.42 0.538 6.07 905.9483 1,809.88 1,810.90 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EVSEAVVDTLESEYLK 95.00% 5.45 0.561 5.02 905.9491 1,809.88 1,810.90 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EVSEAVVDTLESEYLK 95.00% 5.63 0.522 4.96 905.9492 1,809.88 1,810.90 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EVSEAVVDTLESEYLK 95.00% 3.7 0.49 3.6 905.9524 1,809.89 1,810.90 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% EVSEAVVDTLESEYLK 95.00% 5.79 0.514 6.68 906.4521 1,810.89 1,810.90 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SDEFGcMPPQVVTPPR 95.00% 3.98 0.553 2.35 c6: Carbamidomethyl (+57.02) 909.4211 1,816.83 1,816.84 2 ANXA5_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SDEFGcMPPQVVTPPR 95.00% 3.89 0.563 2.32 c6: Carbamidomethyl (+57.02) 909.4211 1,816.83 1,816.84 2 ANXA5_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.26 0.429 3.8 c14: Carbamidomethyl (+57.02) 918.9663 1,835.92 1,836.93 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.43 0.422 3.92 c14: Carbamidomethyl (+57.02) 918.9664 1,835.92 1,836.93 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.5 0.424 3.68 c14: Carbamidomethyl (+57.02) 919.4662 1,836.92 1,836.93 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.71 0.454 3.85 c14: Carbamidomethyl (+57.02) 919.4664 1,836.92 1,836.93 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 3.92 0.354 4.33 c14: Carbamidomethyl (+57.02) 919.4665 1,836.92 1,836.93 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 3.94 0.356 3.85 c14: Carbamidomethyl (+57.02) 919.4676 1,836.92 1,836.93 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SQSVRPGADVTFIcTAK 95.00% 4.6 0.424 4.82 c14: Carbamidomethyl (+57.02) 919.4683 1,836.92 1,836.93 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cQVSGSPPHYFYWSR 95.00% 4.38 0.597 4.46 c1: Carbamidomethyl (+57.02) 935.917 1,869.82 1,870.83 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cQVSGSPPHYFYWSR 95.00% 4.76 0.54 2.48 c1: Carbamidomethyl (+57.02) 936.4177 1,870.82 1,870.83 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cQVSGSPPHYFYWSR 95.00% 4.41 0.54 3.03 c1: Carbamidomethyl (+57.02) 936.4178 1,870.82 1,870.83 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cQVSGSPPHYFYWSR 95.00% 4.9 0.58 3.72 c1: Carbamidomethyl (+57.02) 936.4187 1,870.82 1,870.83 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cEScAPGYEGNPIQPGGK 95.00% 4.86 0.469 5.37 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 960.9126 1,919.81 1,920.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cEScAPGYEGNPIQPGGK 95.00% 4.59 0.467 6.04 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 960.9131 1,919.81 1,920.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cEScAPGYEGNPIQPGGK 95.00% 4.92 0.432 6.52 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 960.9134 1,919.81 1,920.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cEScAPGYEGNPIQPGGK 95.00% 5.18 0.494 3.85 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 961.414 1,920.81 1,920.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cAPGYYGNPSQGQPcQR 95.00% 4.7 0.669 5 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4095 1,938.80 1,939.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cAPGYYGNPSQGQPcQR 95.00% 4.15 0.645 5.72 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4096 1,938.80 1,939.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cAPGYYGNPSQGQPcQR 95.00% 5.01 0.626 6.06 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4101 1,938.80 1,939.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cAPGYYGNPSQGQPcQR 95.00% 4.51 0.611 3.89 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4113 1,938.81 1,939.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cAPGYYGNPSQGQPcQR 95.00% 4.15 0.651 5.19 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4116 1,938.81 1,939.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cAPGYYGNPSQGQPcQR 95.00% 4.66 0.612 4.3 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9095 1,939.80 1,939.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cAPGYYGNPSQGQPcQR 95.00% 4.45 0.611 5.52 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9134 1,939.81 1,939.82 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 4.93 0.541 6.96 c16: Carbamidomethyl (+57.02) 973.989 1,945.96 1,946.98 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 4.96 0.556 5.38 c16: Carbamidomethyl (+57.02) 974.4862 1,946.96 1,946.98 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 4.86 0.562 4.6 c16: Carbamidomethyl (+57.02) 974.4903 1,946.96 1,946.98 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 4.61 0.588 4.64 c16: Carbamidomethyl (+57.02) 974.4916 1,946.97 1,946.98 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 4.7 0.55 5.01 c16: Carbamidomethyl (+57.02) 974.4917 1,946.97 1,946.98 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 4.88 0.542 5.34 c16: Carbamidomethyl (+57.02) 974.4929 1,946.97 1,946.98 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 4.99 0.579 4.31 c16: Carbamidomethyl (+57.02) 974.4933 1,946.97 1,946.98 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 4.5 0.556 6.89 c16: Carbamidomethyl (+57.02) 974.4934 1,946.97 1,946.98 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LRLPQVSPADSGEYVcR 95.00% 4.84 0.527 5.4 c16: Carbamidomethyl (+57.02) 974.4948 1,946.97 1,946.98 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VVGSSGTQEASVLVTIQQR 95.00% 3.33 0.373 2.17 980.0259 1,958.04 1,959.05 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VVGSSGTQEASVLVTIQQR 95.00% 5.28 0.512 3.46 980.0273 1,958.04 1,959.05 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYIFQASPADAGQYVcR 95.00% 6.02 0.577 7.2 c16: Carbamidomethyl (+57.02) 980.4737 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYIFQASPADAGQYVcR 95.00% 6.15 0.575 8.77 c16: Carbamidomethyl (+57.02) 980.4742 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYIFQASPADAGQYVcR 95.00% 5.5 0.534 6.62 c16: Carbamidomethyl (+57.02) 980.4742 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYIFQASPADAGQYVcR 95.00% 5.89 0.57 8 c16: Carbamidomethyl (+57.02) 980.475 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% LYIFQASPADAGQYVcR 95.00% 6.06 0.601 6.8 c16: Carbamidomethyl (+57.02) 980.4751 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VVGSSGTQEASVLVTIQQR 95.00% 3.81 0.437 3.37 980.528 1,959.04 1,959.05 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VVGSSGTQEASVLVTIQQR 95.00% 5.33 0.442 3.46 980.5296 1,959.04 1,959.05 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VVGSSGTQEASVLVTIQQR 95.00% 5.44 0.514 4 980.5299 1,959.04 1,959.05 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% VVGSSGTQEASVLVTIQQR 95.00% 5.2 0.475 4.14 980.5309 1,959.05 1,959.05 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ITFRPDSADGMLLYNGQK 95.00% 4.06 0.464 4.82 1,014.01 2,026.00 2,026.01 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% DVKESDQGAYTcEAMNAR 95.00% 5.65 0.519 6.64 c12: Carbamidomethyl (+57.02) 1,023.44 2,044.86 2,044.87 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% DVKESDQGAYTcEAMNAR 95.00% 5.56 0.479 6.43 c12: Carbamidomethyl (+57.02) 1,023.44 2,044.86 2,044.87 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% GMLEPVQRPDVVLVGAGYR 95.00% 4.16 0.56 3 1,028.55 2,055.09 2,056.10 2 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% PSDAGTYVcLAQNALGTAQK 95.00% 6.73 0.586 0 c9: Carbamidomethyl (+57.02) 1,033.50 2,064.99 2,065.00 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% PSDAGTYVcLAQNALGTAQK 95.00% 5.27 0.668 0 c9: Carbamidomethyl (+57.02) 1,033.51 2,065.00 2,065.00 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RcEScAPGYEGNPIQPGGK 95.00% 5.3 0.631 4.59 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 1,039.47 2,076.92 2,076.92 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% RcEScAPGYEGNPIQPGGK 95.00% 5.33 0.618 3.82 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 1,039.47 2,076.92 2,076.92 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ATATScRPcPcPYIDASR 95.00% 3.76 0.415 2.92 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.90 2,082.92 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ATATScRPcPcPYIDASR 95.00% 3.98 0.432 3.35 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.90 2,082.92 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ATATScRPcPcPYIDASR 95.00% 4.09 0.46 2.13 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.92 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% ATATScRPcPcPYIDASR 95.00% 3.76 0.406 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.92 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cPPGYIGLScQDcAPGYTR 95.00% 4.45 0.517 4.29 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.47 2,170.92 2,171.93 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cPPGYIGLScQDcAPGYTR 95.00% 4.79 0.627 8.51 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.96 2,171.91 2,171.93 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cPPGYIGLScQDcAPGYTR 95.00% 5.07 0.629 7.35 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.97 2,171.92 2,171.93 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cPPGYIGLScQDcAPGYTR 95.00% 4.86 0.611 8.21 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.97 2,171.92 2,171.93 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cPPGYIGLScQDcAPGYTR 95.00% 4.47 0.493 3.44 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.97 2,171.92 2,171.93 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cPIGYSGLScEScDAHFTR 95.00% 5.02 0.605 6.57 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,109.46 2,216.90 2,216.92 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPVISIDPPSSTVQQGQDASFK 95.00% 5.92 0.51 8.92 1,145.07 2,288.13 2,288.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPVISIDPPSSTVQQGQDASFK 95.00% 5.78 0.525 11.5 1,145.07 2,288.13 2,288.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPVISIDPPSSTVQQGQDASFK 95.00% 6.18 0.513 10.1 1,145.07 2,288.13 2,288.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPVISIDPPSSTVQQGQDASFK 95.00% 6.25 0.519 11.9 1,145.07 2,288.13 2,288.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPVISIDPPSSTVQQGQDASFK 95.00% 6.23 0.509 11.9 1,145.07 2,288.13 2,288.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% SPVISIDPPSSTVQQGQDASFK 95.00% 5.7 0.52 11.7 1,145.08 2,288.14 2,288.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 5.33 0.562 5.19 1,156.13 2,310.25 2,310.26 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 5.36 0.518 4.59 1,156.13 2,310.25 2,310.26 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 5.42 0.532 4.96 1,156.13 2,310.25 2,310.26 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AELLVTEAPSKPITVTVEEQR 95.00% 5.34 0.521 5.31 1,156.13 2,310.25 2,310.26 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.97 0.673 7.96 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5 0.732 6.96 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5.05 0.653 7.62 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.91 0.714 6.85 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.84 0.679 5.66 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.72 0.691 6.09 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5.16 0.711 8.26 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.75 0.678 5.6 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.29 0.632 4.64 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.52 0.667 3.64 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.17 0.655 6.15 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.42 0.633 4.47 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.35 0.623 4.92 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 2 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 89 124 547 28.30% AASGPGPEQEASFTVTVPPSEGSSYR 95.00% 3.52 0.454 4.55 1,305.12 2,608.22 2,608.22 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VTVTSEGGR 95.00% 1.99 0.357 0 453.2402 904.4648 905.4693 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SAEPLALGR 95.00% 2.28 0.319 0 457.2593 912.503 913.5108 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SAEPLALGR 95.00% 2.26 0.349 0 457.2595 912.5033 913.5108 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SAEPLALGR 95.00% 1.99 0.372 1.74 457.2595 912.5034 913.5108 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SAEPLALGR 95.00% 2.36 0.323 0 457.2597 912.5038 913.5108 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SAEPLALGR 95.00% 2.05 0.317 0 457.2605 912.5053 913.5108 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SAEPLALGR 95.00% 2.12 0.34 0 457.2607 912.5057 913.5108 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% GHTPTQPGALNQR 95.00% 3.06 0.375 1.06 459.5739 1,375.70 1,376.70 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VKAFAHLQVPER 95.00% 2.17 0.195 0 465.7474 1,394.22 1,394.79 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IPGDQVVSVVFIK 95.00% 3.93 0.351 2 467.6107 1,399.81 1,400.82 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IPGDQVVSVVFIK 95.00% 3.84 0.394 2.59 467.6111 1,399.81 1,400.82 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SYEIMFR 95.00% 2.19 0.251 0 473.2298 944.4439 945.4504 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AGFFGDAmK 95.00% 3.01 0.311 0 m8: Oxidation (+15.99) 480.2177 958.4197 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AGFFGDAmK 95.00% 2.87 0.3 0 m8: Oxidation (+15.99) 480.218 958.4204 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IAHVELADAGQYR 95.00% 4.33 0.44 1.66 481.5838 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IAHVELADAGQYR 95.00% 4.28 0.417 1.39 481.5842 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LSGSHSQGVAYPVR 95.00% 3.67 0.436 0 486.5874 1,456.74 1,457.75 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LSGSHSQGVAYPVR 95.00% 4.3 0.406 0 486.5878 1,456.74 1,457.75 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LSGSHSQGVAYPVR 95.00% 4.43 0.44 1.15 486.5885 1,456.74 1,457.75 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LSGSHSQGVAYPVR 95.00% 3.48 0.413 0 486.9219 1,457.74 1,457.75 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RPEEVcGPTQFR 95.00% 4.02 0.357 2.36 c6: Carbamidomethyl (+57.02) 492.5729 1,474.70 1,475.71 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RPEEVcGPTQFR 95.00% 3.06 0.305 1.66 c6: Carbamidomethyl (+57.02) 492.5738 1,474.70 1,475.71 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RPEEVcGPTQFR 95.00% 3.44 0.28 1.82 c6: Carbamidomethyl (+57.02) 492.5747 1,474.70 1,475.71 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RPEEVcGPTQFR 95.00% 2.97 0.368 1.46 c6: Carbamidomethyl (+57.02) 492.908 1,475.70 1,475.71 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RPEEVcGPTQFR 95.00% 3.91 0.312 1.62 c6: Carbamidomethyl (+57.02) 492.9081 1,475.70 1,475.71 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LGTVPQFPR 95.00% 2.43 0.341 2.55 507.7886 1,013.56 1,014.57 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LGTVPQFPR 95.00% 2.25 0.366 3.17 507.7894 1,013.56 1,014.57 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LGTVPQFPR 95.00% 2.37 0.297 1.64 507.7897 1,013.56 1,014.57 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LGTVPQFPR 95.00% 2.34 0.372 2.1 507.7897 1,013.56 1,014.57 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LGTVPQFPR 95.00% 1.91 0.259 1.13 507.7899 1,013.56 1,014.57 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% FLGDKVTSYGGELR 95.00% 3.01 0.385 2.01 514.6009 1,540.78 1,541.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% FLGDKVTSYGGELR 95.00% 2.62 0.331 1.1 514.6025 1,540.78 1,541.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% FLGDKVTSYGGELR 95.00% 3.71 0.437 2.7 514.6026 1,540.78 1,541.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% FLGDKVTSYGGELR 95.00% 3.66 0.377 3.25 514.6028 1,540.78 1,541.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% FLGDKVTSYGGELR 95.00% 4.14 0.387 3.36 514.6028 1,540.78 1,541.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% FLGDKVTSYGGELR 95.00% 4.01 0.413 3.34 514.6031 1,540.79 1,541.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% FLGDKVTSYGGELR 95.00% 3.69 0.379 3.09 514.6032 1,540.79 1,541.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIEYSPQLEDAGSR 95.00% 3.29 0.442 2.11 517.9138 1,550.72 1,551.73 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LDGSLPPDSR 95.00% 2.83 0.364 0 528.7678 1,055.52 1,056.53 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LDGSLPPDSR 95.00% 2.98 0.362 0 528.7679 1,055.52 1,056.53 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LDGSLPPDSR 95.00% 2.68 0.279 0 528.7684 1,055.52 1,056.53 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LDGSLPPDSR 95.00% 3.1 0.326 1.57 528.77 1,055.52 1,056.53 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% NELLHFER 95.00% 2.51 0.157 0 529.2743 1,056.53 1,057.54 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% NELLHFER 95.00% 2.64 0.172 0 529.2744 1,056.53 1,057.54 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VAEGQTLDLK 95.00% 2.94 0.457 1.18 537.2947 1,072.57 1,073.58 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VAEGQTLDLK 95.00% 3.5 0.501 2.12 537.295 1,072.57 1,073.58 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VAEGQTLDLK 95.00% 3.18 0.515 0 537.2951 1,072.57 1,073.58 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VAEGQTLDLK 95.00% 3.54 0.527 1.92 537.2954 1,072.58 1,073.58 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VAEGQTLDLK 95.00% 3.38 0.508 1.85 537.2956 1,072.58 1,073.58 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VAEGQTLDLK 95.00% 3.03 0.449 2.15 537.2965 1,072.58 1,073.58 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EQAWQRPDGQPATR 95.00% 2.95 0.343 0 547.268 1,638.78 1,639.79 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EQAWQRPDGQPATR 95.00% 2.75 0.252 0 547.2695 1,638.78 1,639.79 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EQAWQRPDGQPATR 95.00% 3.24 0.368 0 547.6035 1,639.79 1,639.79 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EQAWQRPDGQPATR 95.00% 2.79 0.262 0 547.6044 1,639.79 1,639.79 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EQAWQRPDGQPATR 95.00% 2.8 0.318 0 547.6044 1,639.79 1,639.79 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LVSEDPINDGEWHR 95.00% 2.99 0.43 1.25 556.2628 1,665.76 1,666.78 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LVSEDPINDGEWHR 95.00% 2.44 0.235 1.05 556.6001 1,666.78 1,666.78 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% FDAGSGMATIR 95.00% 2.59 0.377 1.15 563.2683 1,124.52 1,125.54 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VPGSPTNLANR 95.00% 2.61 0.366 3.18 563.3012 1,124.59 1,125.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VPGSPTNLANR 95.00% 2.76 0.407 1.4 563.3012 1,124.59 1,125.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VPGSPTNLANR 95.00% 3.43 0.56 4.22 563.3029 1,124.59 1,125.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VPGSPTNLANR 95.00% 3.6 0.558 4.6 563.3031 1,124.59 1,125.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VPGSPTNLANR 95.00% 3.08 0.587 4.19 563.3033 1,124.59 1,125.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VPGSPTNLANR 95.00% 2.94 0.525 4 563.3035 1,124.59 1,125.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VPGSPTNLANR 95.00% 2.75 0.499 2.44 563.3037 1,124.59 1,125.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VPGSPTNLANR 95.00% 2.53 0.393 1.74 563.3047 1,124.59 1,125.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VPGSPTNLANR 95.00% 2.96 0.398 2.09 563.3047 1,124.59 1,125.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VGGHLRPGIVQSGGVVR 95.00% 3.79 0.367 3.02 563.3265 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VGGHLRPGIVQSGGVVR 95.00% 4.47 0.473 1.25 563.3284 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VGGHLRPGIVQSGGVVR 95.00% 4.22 0.484 2.57 563.6611 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VGGHLRPGIVQSGGVVR 95.00% 3.43 0.382 1.85 563.6631 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LEGDTLIIPR 95.00% 3.51 0.366 1.77 563.8255 1,125.64 1,126.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LEGDTLIIPR 95.00% 3.31 0.407 3.2 563.8259 1,125.64 1,126.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LEGDTLIIPR 95.00% 3.45 0.379 3.31 563.826 1,125.64 1,126.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LEGDTLIIPR 95.00% 3.53 0.385 1.82 563.8263 1,125.64 1,126.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LEGDTLIIPR 95.00% 3.55 0.395 1.55 563.8263 1,125.64 1,126.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LEGDTLIIPR 95.00% 3.51 0.396 1.74 563.8265 1,125.64 1,126.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 5.06 0.404 4.21 c14: Carbamidomethyl (+57.02) 568.2784 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 3.78 0.488 3.96 c14: Carbamidomethyl (+57.02) 568.2784 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 5.07 0.368 3.74 c14: Carbamidomethyl (+57.02) 568.2786 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 4.68 0.449 3.96 c14: Carbamidomethyl (+57.02) 568.2787 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 4.24 0.392 3.48 c14: Carbamidomethyl (+57.02) 568.2791 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 3.25 0.448 0 c14: Carbamidomethyl (+57.02) 568.2794 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 3.3 0.421 0 c14: Carbamidomethyl (+57.02) 568.2794 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 2.98 0.413 1.17 c14: Carbamidomethyl (+57.02) 568.2795 1,701.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 4.06 0.544 3.89 c14: Carbamidomethyl (+57.02) 568.6131 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 3.99 0.355 1.96 c14: Carbamidomethyl (+57.02) 568.6133 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 3.84 0.532 1.37 c14: Carbamidomethyl (+57.02) 568.6138 1,702.82 1,702.82 3 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQVVVLSASDASPPPVK 95.00% 3.46 0.498 2.8 569.6607 1,705.96 1,706.97 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQVVVLSASDASPPPVK 95.00% 4.03 0.474 6.28 569.6615 1,705.96 1,706.97 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLQVTPADSGEYVcR 95.00% 2.63 0.35 0 c14: Carbamidomethyl (+57.02) 569.9451 1,706.81 1,707.84 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLQVTPADSGEYVcR 95.00% 4.61 0.503 2.43 c14: Carbamidomethyl (+57.02) 569.9482 1,706.82 1,707.84 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLQVTPADSGEYVcR 95.00% 3.25 0.504 1.26 c14: Carbamidomethyl (+57.02) 569.9495 1,706.83 1,707.84 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQVVVLSASDASPPPVK 95.00% 4.42 0.455 5.6 569.9942 1,706.96 1,706.97 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQVVVLSASDASPPPVK 95.00% 4.28 0.453 7.04 569.9942 1,706.96 1,706.97 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQVVVLSASDASPPPVK 95.00% 3.79 0.43 4.33 569.9951 1,706.96 1,706.97 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQVVVLSASDASPPPVK 95.00% 4.26 0.423 3.96 569.9957 1,706.96 1,706.97 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLQVTPADSGEYVcR 95.00% 4.6 0.502 2.85 c14: Carbamidomethyl (+57.02) 570.2827 1,707.82 1,707.84 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLQVTPADSGEYVcR 95.00% 4.89 0.507 2.48 c14: Carbamidomethyl (+57.02) 570.2833 1,707.83 1,707.84 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLIHDGAAPISLEWK 95.00% 2.52 0.2 1.22 c1: Carbamidomethyl (+57.02) 570.6266 1,708.86 1,709.87 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLIHDGAAPISLEWK 95.00% 2.56 0.295 1.19 c1: Carbamidomethyl (+57.02) 570.6272 1,708.86 1,709.87 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLIHDGAAPISLEWK 95.00% 2.98 0.369 0 c1: Carbamidomethyl (+57.02) 570.6272 1,708.86 1,709.87 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLIHDGAAPISLEWK 95.00% 2.64 0.289 1.57 c1: Carbamidomethyl (+57.02) 570.6276 1,708.86 1,709.87 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLIHDGAAPISLEWK 95.00% 2.49 0.208 1.47 c1: Carbamidomethyl (+57.02) 570.9603 1,709.86 1,709.87 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% FDAGSGmATIR 95.00% 2.95 0.415 3.59 m7: Oxidation (+15.99) 571.2677 1,140.52 1,141.53 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% FDAGSGmATIR 95.00% 3.07 0.434 3.62 m7: Oxidation (+15.99) 571.2693 1,140.52 1,141.53 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYQASPADSGEYVcR 95.00% 4.65 0.536 0 c14: Carbamidomethyl (+57.02) 572.5937 1,714.76 1,715.77 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYQASPADSGEYVcR 95.00% 5.01 0.573 1.66 c14: Carbamidomethyl (+57.02) 572.5944 1,714.76 1,715.77 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYQASPADSGEYVcR 95.00% 5.05 0.497 3.03 c14: Carbamidomethyl (+57.02) 572.9293 1,715.76 1,715.77 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHHVSPADSGEYVcR 95.00% 5.16 0.396 2.66 c14: Carbamidomethyl (+57.02) 576.2698 1,725.79 1,726.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHHVSPADSGEYVcR 95.00% 4.61 0.404 3 c14: Carbamidomethyl (+57.02) 576.2698 1,725.79 1,726.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHHVSPADSGEYVcR 95.00% 5.55 0.495 3.26 c14: Carbamidomethyl (+57.02) 576.27 1,725.79 1,726.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHHVSPADSGEYVcR 95.00% 4.83 0.384 4.06 c14: Carbamidomethyl (+57.02) 576.2701 1,725.79 1,726.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHHVSPADSGEYVcR 95.00% 4.86 0.39 3.64 c14: Carbamidomethyl (+57.02) 576.2702 1,725.79 1,726.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHHVSPADSGEYVcR 95.00% 4.68 0.38 3.1 c14: Carbamidomethyl (+57.02) 576.2706 1,725.79 1,726.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHHVSPADSGEYVcR 95.00% 4.25 0.385 3.01 c14: Carbamidomethyl (+57.02) 576.2715 1,725.79 1,726.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHHVSPADSGEYVcR 95.00% 5.07 0.372 2.89 c14: Carbamidomethyl (+57.02) 576.6035 1,726.79 1,726.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHHVSPADSGEYVcR 95.00% 5.11 0.326 4.3 c14: Carbamidomethyl (+57.02) 576.6041 1,726.79 1,726.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHHVSPADSGEYVcR 95.00% 4.5 0.304 2.21 c14: Carbamidomethyl (+57.02) 576.6046 1,726.79 1,726.80 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIGASVEFHcAVPSDR 95.00% 3.05 0.388 1.55 c10: Carbamidomethyl (+57.02) 577.9415 1,730.80 1,731.81 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIGASVEFHcAVPSDR 95.00% 2.59 0.331 2.36 c10: Carbamidomethyl (+57.02) 578.2763 1,731.81 1,731.81 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AVLHVHGGGGPR 95.00% 2.14 0.321 0 578.8186 1,155.62 1,156.63 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EGGQLPPGHSVQDGVLR 95.00% 2.13 0.251 0 582.6361 1,744.88 1,745.89 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EGGQLPPGHSVQDGVLR 95.00% 2.14 0.242 0 582.9701 1,745.89 1,745.89 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EGGQLPPGHSVQDGVLR 95.00% 2.52 0.336 0 582.9703 1,745.89 1,745.89 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AFAHLQVPER 95.00% 3.35 0.37 2.11 584.3172 1,166.62 1,167.63 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AFAHLQVPER 95.00% 3.05 0.377 1.64 584.3181 1,166.62 1,167.63 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHQMSVADSGEYVcR 95.00% 3.89 0.436 1.03 c14: Carbamidomethyl (+57.02) 584.5991 1,750.77 1,751.78 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHQMSVADSGEYVcR 95.00% 3.95 0.435 1.82 c14: Carbamidomethyl (+57.02) 584.9327 1,751.77 1,751.78 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% TcESLGAGGYR 95.00% 2.13 0.399 2.6 c2: Carbamidomethyl (+57.02) 585.7613 1,169.51 1,170.52 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% TcESLGAGGYR 95.00% 2.29 0.439 0 c2: Carbamidomethyl (+57.02) 585.7636 1,169.51 1,170.52 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% GDLcEHEENPcQLR 95.00% 3.65 0.377 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.2507 1,755.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% GDLcEHEENPcQLR 95.00% 3.61 0.308 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.5837 1,756.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 4.43 0.495 2.41 c14: Carbamidomethyl (+57.02) 587.6248 1,759.85 1,760.86 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 3.46 0.482 2.52 c14: Carbamidomethyl (+57.02) 587.6254 1,759.85 1,760.86 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 4.27 0.472 2.51 c14: Carbamidomethyl (+57.02) 587.6255 1,759.85 1,760.86 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 4.96 0.532 1.96 c14: Carbamidomethyl (+57.02) 587.6257 1,759.85 1,760.86 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 4.62 0.436 2.29 c14: Carbamidomethyl (+57.02) 587.959 1,760.85 1,760.86 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 3.95 0.52 1 c14: Carbamidomethyl (+57.02) 587.9593 1,760.85 1,760.86 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% YELGSGLAVLR 95.00% 3.08 0.477 3.54 589.3302 1,176.64 1,177.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% YELGSGLAVLR 95.00% 3.48 0.479 4.03 589.3315 1,176.65 1,177.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% YELGSGLAVLR 95.00% 3.34 0.449 3.77 589.3316 1,176.65 1,177.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% YELGSGLAVLR 95.00% 3.67 0.494 4.47 589.3316 1,176.65 1,177.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% YELGSGLAVLR 95.00% 3.27 0.465 3.82 589.3316 1,176.65 1,177.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% YELGSGLAVLR 95.00% 3.65 0.497 3.59 589.3317 1,176.65 1,177.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% YELGSGLAVLR 95.00% 3.47 0.496 4.06 589.3321 1,176.65 1,177.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% YELGSGLAVLR 95.00% 3.17 0.454 3.47 589.3321 1,176.65 1,177.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% YELGSGLAVLR 95.00% 3.59 0.519 4.16 589.3322 1,176.65 1,177.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% YELGSGLAVLR 95.00% 3.34 0.472 4.7 589.3322 1,176.65 1,177.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% YELGSGLAVLR 95.00% 2.06 0.369 1.66 589.3331 1,176.65 1,177.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LcNEcADGSFHLSTR 95.00% 3.35 0.348 1.27 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5889 1,765.74 1,766.76 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LcNEcADGSFHLSTR 95.00% 3.98 0.458 1.72 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5906 1,765.75 1,766.76 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LcNEcADGSFHLSTR 95.00% 4.02 0.409 1.66 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.9244 1,766.75 1,766.76 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LcNEcADGSFHLSTR 95.00% 3.62 0.411 2.11 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.9246 1,766.75 1,766.76 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EHLLMALAGIDTLLIR 95.00% 4.18 0.305 1.2 594.013 1,779.02 1,779.02 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EHLLMALAGIDTLLIR 95.00% 4.29 0.29 1.24 594.0131 1,779.02 1,779.02 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 3.49 0.541 2.8 597.3158 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 3.16 0.535 2.15 597.3159 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 4.02 0.564 2.6 597.3166 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 3.57 0.522 2.74 597.3166 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 3.48 0.591 2.2 597.317 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 3.52 0.554 3.96 597.3172 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 3.54 0.563 1.68 597.3178 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 4.01 0.593 1.57 597.3181 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 3.92 0.606 2.02 597.3185 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 3.81 0.571 2.05 597.3186 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 4.14 0.503 2.43 597.3188 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 2.67 0.552 0 597.3189 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 3.66 0.605 2.07 597.3191 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 2.7 0.451 1.77 597.3194 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 2.45 0.484 1.34 597.8537 1,193.69 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPAYTLVWTR 95.00% 2.65 0.499 1.37 597.8545 1,193.69 1,193.63 2 LU_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EVSEAVVDTLESEYLK 95.00% 3.49 0.446 0 604.303 1,809.89 1,810.90 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EVSEAVVDTLESEYLK 95.00% 3.61 0.413 0 604.6363 1,810.89 1,810.90 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EVSEAVVDTLESEYLK 95.00% 4.3 0.538 1.82 604.637 1,810.89 1,810.90 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EVSEAVVDTLESEYLK 95.00% 5.04 0.49 2.85 604.637 1,810.89 1,810.90 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SDEFGcMPPQVVTPPR 95.00% 2.92 0.486 0 c6: Carbamidomethyl (+57.02) 606.2825 1,815.82 1,816.84 3 ANXA5_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AGLSSGFIGcVR 95.00% 4.02 0.49 3.74 c10: Carbamidomethyl (+57.02) 612.3128 1,222.61 1,223.62 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AGLSSGFIGcVR 95.00% 3.96 0.465 3.59 c10: Carbamidomethyl (+57.02) 612.3129 1,222.61 1,223.62 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AGLSSGFIGcVR 95.00% 3.81 0.427 3.32 c10: Carbamidomethyl (+57.02) 612.313 1,222.61 1,223.62 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AGLSSGFIGcVR 95.00% 4.03 0.485 5.06 c10: Carbamidomethyl (+57.02) 612.3131 1,222.61 1,223.62 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AGLSSGFIGcVR 95.00% 4.08 0.449 5.07 c10: Carbamidomethyl (+57.02) 612.3132 1,222.61 1,223.62 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AGLSSGFIGcVR 95.00% 3.85 0.477 4.29 c10: Carbamidomethyl (+57.02) 612.3135 1,222.61 1,223.62 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 3.05 0.422 2.59 c14: Carbamidomethyl (+57.02) 612.9793 1,835.91 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.07 0.469 1.96 c14: Carbamidomethyl (+57.02) 612.9795 1,835.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 3.44 0.365 1.19 c14: Carbamidomethyl (+57.02) 612.9803 1,835.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.32 0.585 2.26 c14: Carbamidomethyl (+57.02) 612.9803 1,835.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 3.45 0.475 1.22 c14: Carbamidomethyl (+57.02) 612.9805 1,835.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 3.59 0.478 2.89 c14: Carbamidomethyl (+57.02) 612.9807 1,835.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.3 0.556 2.04 c14: Carbamidomethyl (+57.02) 612.9811 1,835.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 2.53 0.39 0 c14: Carbamidomethyl (+57.02) 612.9821 1,835.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.5 0.55 1.64 c14: Carbamidomethyl (+57.02) 613.314 1,836.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.1 0.471 1.47 c14: Carbamidomethyl (+57.02) 613.3144 1,836.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.43 0.566 4.89 c14: Carbamidomethyl (+57.02) 613.3145 1,836.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 3.92 0.608 3.14 c14: Carbamidomethyl (+57.02) 613.3149 1,836.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 2.09 0.258 0 c14: Carbamidomethyl (+57.02) 613.3151 1,836.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.04 0.465 0 c14: Carbamidomethyl (+57.02) 613.3153 1,836.92 1,836.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AAGVPSATITWR 95.00% 2.18 0.395 1.12 615.3347 1,228.65 1,229.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AAGVPSATITWR 95.00% 1.91 0.347 4.02 615.3351 1,228.65 1,229.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AAGVPSATITWR 95.00% 2.11 0.419 2.34 615.3352 1,228.65 1,229.66 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIVPQGGSHSLR 95.00% 1.69 0.259 3 619.3315 1,236.65 1,237.67 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIVPQGGSHSLR 95.00% 2.24 0.334 2.17 619.3324 1,236.65 1,237.67 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIVPQGGSHSLR 95.00% 1.83 0.291 2.6 619.3326 1,236.65 1,237.67 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cQVSGSPPHYFYWSR 95.00% 2.97 0.461 0 c1: Carbamidomethyl (+57.02) 624.2811 1,869.82 1,870.83 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% QPQAIITWYK 95.00% 1.67 0.302 1.28 624.3411 1,246.67 1,247.68 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% QPQAIITWYK 95.00% 1.77 0.352 0 624.3435 1,246.67 1,247.68 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cQVSGSPPHYFYWSR 95.00% 2.41 0.331 0 c1: Carbamidomethyl (+57.02) 624.6158 1,870.82 1,870.83 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cQVSGSPPHYFYWSR 95.00% 3.11 0.471 0 c1: Carbamidomethyl (+57.02) 624.6163 1,870.83 1,870.83 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cQVSGSPPHYFYWSR 95.00% 2.73 0.458 0 c1: Carbamidomethyl (+57.02) 624.6165 1,870.83 1,870.83 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cQVSGSPPHYFYWSR 95.00% 2.99 0.518 0 c1: Carbamidomethyl (+57.02) 624.6166 1,870.83 1,870.83 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cQVSGSPPHYFYWSR 95.00% 2.39 0.403 0 c1: Carbamidomethyl (+57.02) 624.6168 1,870.83 1,870.83 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cQVSGSPPHYFYWSR 95.00% 2.77 0.454 0 c1: Carbamidomethyl (+57.02) 624.6168 1,870.83 1,870.83 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cQVSGSPPHYFYWSR 95.00% 2.26 0.422 0 c1: Carbamidomethyl (+57.02) 624.6182 1,870.83 1,870.83 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLcLPGFSGPR 95.00% 2.68 0.382 1.49 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.2989 1,262.58 1,263.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLcLPGFSGPR 95.00% 2.47 0.302 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3014 1,262.59 1,263.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLcLPGFSGPR 95.00% 2.79 0.318 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3018 1,262.59 1,263.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLcLPGFSGPR 95.00% 2.31 0.291 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3026 1,262.59 1,263.60 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AmDFNGILTIR 95.00% 3.51 0.282 2.92 m2: Oxidation (+15.99) 633.8257 1,265.64 1,266.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AmDFNGILTIR 95.00% 3.5 0.402 2.85 m2: Oxidation (+15.99) 633.8271 1,265.64 1,266.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AmDFNGILTIR 95.00% 3.6 0.488 2.96 m2: Oxidation (+15.99) 633.8282 1,265.64 1,266.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AmDFNGILTIR 95.00% 3.39 0.463 3.03 m2: Oxidation (+15.99) 633.8286 1,265.64 1,266.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AmDFNGILTIR 95.00% 3.03 0.447 2.47 m2: Oxidation (+15.99) 633.8293 1,265.64 1,266.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AmDFNGILTIR 95.00% 3.48 0.478 3.46 m2: Oxidation (+15.99) 633.8296 1,265.64 1,266.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cRPVNQEIVR 95.00% 1.96 0.322 0 c1: Carbamidomethyl (+57.02) 635.8368 1,269.66 1,270.67 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% PGADVTFIcTAK 95.00% 3.73 0.602 0 c9: Carbamidomethyl (+57.02) 640.3194 1,278.62 1,279.64 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% PGADVTFIcTAK 95.00% 3.81 0.603 0 c9: Carbamidomethyl (+57.02) 640.3197 1,278.62 1,279.64 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% QPDFISFGLVGGRPEFR 95.00% 2.74 0.469 0 641.335 1,920.98 1,921.99 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% QPDFISFGLVGGRPEFR 95.00% 2.34 0.531 1.35 641.3361 1,920.98 1,921.99 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% QPDFISFGLVGGRPEFR 95.00% 2.18 0.415 0 641.3369 1,920.99 1,921.99 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% QPDFISFGLVGGRPEFR 95.00% 2.44 0.414 0 641.6689 1,921.98 1,921.99 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cAPGYYGNPSQGQPcQR 95.00% 4.31 0.434 2.77 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.2772 1,938.81 1,939.82 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cAPGYYGNPSQGQPcQR 95.00% 4.77 0.453 3.59 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.6101 1,939.81 1,939.82 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cAPGYYGNPSQGQPcQR 95.00% 3.37 0.261 4.06 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.6114 1,939.81 1,939.82 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 5.08 0.605 4.27 c16: Carbamidomethyl (+57.02) 649.6633 1,945.97 1,946.98 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 5.34 0.626 5.55 c16: Carbamidomethyl (+57.02) 649.6633 1,945.97 1,946.98 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 5.64 0.506 4.06 c16: Carbamidomethyl (+57.02) 649.6636 1,945.97 1,946.98 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 5.59 0.607 5.18 c16: Carbamidomethyl (+57.02) 649.9965 1,946.97 1,946.98 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 5.38 0.594 6.02 c16: Carbamidomethyl (+57.02) 649.9966 1,946.97 1,946.98 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 5.16 0.587 5.92 c16: Carbamidomethyl (+57.02) 649.9966 1,946.97 1,946.98 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 6.49 0.631 5.68 c16: Carbamidomethyl (+57.02) 649.9974 1,946.97 1,946.98 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 5.26 0.562 5.66 c16: Carbamidomethyl (+57.02) 649.9977 1,946.97 1,946.98 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 4.17 0.525 3.1 c16: Carbamidomethyl (+57.02) 649.9977 1,946.97 1,946.98 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VVGSSGTQEASVLVTIQQR 95.00% 4.56 0.379 0 653.6873 1,958.04 1,959.05 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VVGSSGTQEASVLVTIQQR 95.00% 4.75 0.441 0 653.688 1,958.04 1,959.05 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VVGSSGTQEASVLVTIQQR 95.00% 4.49 0.371 0 653.688 1,958.04 1,959.05 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VVGSSGTQEASVLVTIQQR 95.00% 4.91 0.375 0 654.0211 1,959.04 1,959.05 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VVGSSGTQEASVLVTIQQR 95.00% 3.75 0.341 0 654.0218 1,959.04 1,959.05 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VVGSSGTQEASVLVTIQQR 95.00% 2.91 0.205 0 654.0247 1,959.05 1,959.05 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ITFRPDSADGMLLYNGQK 95.00% 2.68 0.312 0 676.0062 2,025.00 2,026.01 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ITFRPDSADGMLLYNGQK 95.00% 3.71 0.423 1.92 676.0066 2,025.00 2,026.01 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ITFRPDSADGMLLYNGQK 95.00% 4.03 0.522 1.47 676.34 2,026.00 2,026.01 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ITFRPDSADGMLLYNGQK 95.00% 3.35 0.294 0 676.3403 2,026.00 2,026.01 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% TPSGLYLGTcER 95.00% 2.34 0.269 2.4 c10: Carbamidomethyl (+57.02) 677.325 1,352.63 1,353.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% TPSGLYLGTcER 95.00% 2.81 0.337 2.14 c10: Carbamidomethyl (+57.02) 677.3253 1,352.63 1,353.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% TPSGLYLGTcER 95.00% 4.34 0.404 3.82 c10: Carbamidomethyl (+57.02) 677.3257 1,352.64 1,353.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% TPSGLYLGTcER 95.00% 3.81 0.462 4.89 c10: Carbamidomethyl (+57.02) 677.3263 1,352.64 1,353.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% TPSGLYLGTcER 95.00% 2.91 0.392 0 c10: Carbamidomethyl (+57.02) 677.3264 1,352.64 1,353.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% TPSGLYLGTcER 95.00% 2.79 0.313 0 c10: Carbamidomethyl (+57.02) 677.3266 1,352.64 1,353.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% TPSGLYLGTcER 95.00% 3.35 0.291 2.96 c10: Carbamidomethyl (+57.02) 677.8282 1,353.64 1,353.65 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% DVKESDQGAYTcEAMNAR 95.00% 4.21 0.377 2.64 c12: Carbamidomethyl (+57.02) 682.6283 2,044.86 2,044.87 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% DVKESDQGAYTcEAMNAR 95.00% 4.92 0.406 3.34 c12: Carbamidomethyl (+57.02) 682.6294 2,044.86 2,044.87 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% GMLEPVQRPDVVLVGAGYR 95.00% 2.18 0.347 2.46 686.3703 2,056.09 2,056.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% GMLEPVQRPDVVLVGAGYR 95.00% 3.87 0.598 4.04 686.3721 2,056.09 2,056.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% PSDAGTYVcLAQNALGTAQK 95.00% 4.99 0.457 0 c9: Carbamidomethyl (+57.02) 689.0048 2,063.99 2,065.00 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% PSDAGTYVcLAQNALGTAQK 95.00% 4.81 0.432 0 c9: Carbamidomethyl (+57.02) 689.3373 2,064.99 2,065.00 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% PSDAGTYVcLAQNALGTAQK 95.00% 5.11 0.526 0 c9: Carbamidomethyl (+57.02) 689.3378 2,064.99 2,065.00 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% PSDAGTYVcLAQNALGTAQK 95.00% 5.15 0.514 0 c9: Carbamidomethyl (+57.02) 689.3395 2,065.00 2,065.00 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% GmLEPVQRPDVVLVGAGYR 95.00% 2.47 0.462 0 m2: Oxidation (+15.99) 691.7034 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% GmLEPVQRPDVVLVGAGYR 95.00% 4.3 0.572 4.74 m2: Oxidation (+15.99) 691.7045 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% GmLEPVQRPDVVLVGAGYR 95.00% 4.25 0.556 4.85 m2: Oxidation (+15.99) 691.7049 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RcEScAPGYEGNPIQPGGK 95.00% 4.38 0.522 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 692.9785 2,075.91 2,076.92 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RcEScAPGYEGNPIQPGGK 95.00% 4.24 0.47 3.54 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3112 2,076.91 2,076.92 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RcEScAPGYEGNPIQPGGK 95.00% 3.74 0.497 2.92 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3124 2,076.91 2,076.92 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AVTLEcVSAGEPR 95.00% 2.3 0.181 1.32 c6: Carbamidomethyl (+57.02) 695.0139 1,388.01 1,388.68 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ATATScRPcPcPYIDASR 95.00% 2.83 0.463 1.32 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3091 2,082.90 2,082.92 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ATATScRPcPcPYIDASR 95.00% 4.09 0.448 2.74 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3102 2,082.91 2,082.92 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ATATScRPcPcPYIDASR 95.00% 3.98 0.455 2.68 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3102 2,082.91 2,082.92 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ATATScRPcPcPYIDASR 95.00% 3.92 0.469 2.32 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3103 2,082.91 2,082.92 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ATATScRPcPcPYIDASR 95.00% 3.6 0.424 2.17 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3105 2,082.91 2,082.92 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AVTLEcVSAGEPR 95.00% 3.11 0.299 1.16 c6: Carbamidomethyl (+57.02) 695.3473 1,388.68 1,388.68 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AVTLEcVSAGEPR 95.00% 2.76 0.265 2.16 c6: Carbamidomethyl (+57.02) 695.3474 1,388.68 1,388.68 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IPGDQVVSVVFIK 95.00% 4.05 0.503 3.05 700.9097 1,399.80 1,400.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IPGDQVVSVVFIK 95.00% 4.5 0.504 2.92 700.9102 1,399.80 1,400.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IPGDQVVSVVFIK 95.00% 2.41 0.419 0 700.9106 1,399.81 1,400.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IPGDQVVSVVFIK 95.00% 4.09 0.54 2.47 700.9107 1,399.81 1,400.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IPGDQVVSVVFIK 95.00% 4.29 0.539 2.02 700.9115 1,399.81 1,400.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IPGDQVVSVVFIK 95.00% 2.51 0.386 1.51 700.9121 1,399.81 1,400.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IPGDQVVSVVFIK 95.00% 3.6 0.472 1.66 701.414 1,400.81 1,400.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VISSGSVASYVTSPQGFQFR 95.00% 3.54 0.518 1.38 706.3596 2,116.06 2,117.07 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VISSGSVASYVTSPQGFQFR 95.00% 4.14 0.437 2.68 706.6931 2,117.06 2,117.07 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VISSGSVASYVTSPQGFQFR 95.00% 3.86 0.587 2.59 706.6932 2,117.06 2,117.07 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IAHVELADAGQYR 95.00% 4.42 0.523 4.24 721.8722 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IAHVELADAGQYR 95.00% 4.55 0.547 3.59 721.8725 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IAHVELADAGQYR 95.00% 4.35 0.493 4.41 721.8727 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IAHVELADAGQYR 95.00% 4.41 0.509 3.89 721.8728 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IAHVELADAGQYR 95.00% 4.47 0.525 4.32 721.8729 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IAHVELADAGQYR 95.00% 4.25 0.513 5.11 721.8745 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cPPGYIGLScQDcAPGYTR 95.00% 4.38 0.517 2.23 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 724.6486 2,170.92 2,171.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cPPGYIGLScQDcAPGYTR 95.00% 3.7 0.485 0 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 724.9828 2,171.93 2,171.93 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LSGSHSQGVAYPVR 95.00% 3.69 0.528 3.74 729.3777 1,456.74 1,457.75 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LSGSHSQGVAYPVR 95.00% 3.47 0.534 3.59 729.3782 1,456.74 1,457.75 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LSGSHSQGVAYPVR 95.00% 3.26 0.536 4.33 729.3788 1,456.74 1,457.75 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% DGFKGDLcEHEENPcQLR 95.00% 4.74 0.509 1.96 c8: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 735.6547 2,203.94 2,203.95 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% DGFKGDLcEHEENPcQLR 95.00% 3.99 0.439 0 c8: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 735.6556 2,203.94 2,203.95 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RPEEVcGPTQFR 95.00% 3.78 0.541 5.19 c6: Carbamidomethyl (+57.02) 738.3543 1,474.69 1,475.71 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RPEEVcGPTQFR 95.00% 3.53 0.416 5.35 c6: Carbamidomethyl (+57.02) 738.3559 1,474.70 1,475.71 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RPEEVcGPTQFR 95.00% 3.22 0.443 5 c6: Carbamidomethyl (+57.02) 738.3574 1,474.70 1,475.71 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RPEEVcGPTQFR 95.00% 4.04 0.477 4.92 c6: Carbamidomethyl (+57.02) 738.3576 1,474.70 1,475.71 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLSGPYFWSLPSR 95.00% 3.89 0.378 1.96 761.9021 1,521.79 1,522.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLSGPYFWSLPSR 95.00% 2.9 0.385 1.29 761.9024 1,521.79 1,522.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLSGPYFWSLPSR 95.00% 4.09 0.453 4.2 761.904 1,521.79 1,522.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLSGPYFWSLPSR 95.00% 4.11 0.441 2.21 761.9041 1,521.79 1,522.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLSGPYFWSLPSR 95.00% 4.06 0.43 2.26 761.9042 1,521.79 1,522.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLSGPYFWSLPSR 95.00% 3.17 0.428 0 761.905 1,521.79 1,522.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLSGPYFWSLPSR 95.00% 4.04 0.505 2.38 761.9054 1,521.80 1,522.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLSGPYFWSLPSR 95.00% 4.17 0.428 1.68 761.9055 1,521.80 1,522.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLSGPYFWSLPSR 95.00% 4.16 0.406 2.47 762.4064 1,522.80 1,522.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPVISIDPPSSTVQQGQDASFK 95.00% 3.28 0.477 1.1 763.7192 2,288.13 2,288.14 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPVISIDPPSSTVQQGQDASFK 95.00% 4.41 0.451 1.8 763.7204 2,288.14 2,288.14 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cDGDFDcEDRTDEANcPTK 95.00% 3.5 0.384 2.6 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 769.2873 2,304.84 2,304.84 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 7.09 0.649 1.85 771.0892 2,310.24 2,310.26 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 6.91 0.656 3.31 771.0897 2,310.25 2,310.26 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 6.52 0.627 3.43 771.0902 2,310.25 2,310.26 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 6.72 0.646 2.42 771.0905 2,310.25 2,310.26 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 7.31 0.657 1.72 771.0906 2,310.25 2,310.26 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 6.31 0.62 4.14 771.0906 2,310.25 2,310.26 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 5.32 0.558 1.8 771.0917 2,310.25 2,310.26 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 6.22 0.651 3 771.0919 2,310.25 2,310.26 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 5.88 0.625 2.21 771.0922 2,310.25 2,310.26 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIEYSPQLEDAGSR 95.00% 4.93 0.592 3.44 776.3672 1,550.72 1,551.73 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIEYSPQLEDAGSR 95.00% 4.9 0.573 3.8 776.3673 1,550.72 1,551.73 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIEYSPQLEDAGSR 95.00% 4.59 0.589 3.07 776.3674 1,550.72 1,551.73 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% QVQFSEEHWVHESGRPVQR 95.00% 2.89 0.408 0 779.3836 2,335.13 2,335.13 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% QVQFSEEHWVHESGRPVQR 95.00% 3 0.393 1.96 779.384 2,335.13 2,335.13 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% MASVGLSDIAMDTTVTHATSHGR 95.00% 3.7 0.466 2.92 787.0446 2,358.11 2,358.12 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% MASVGLSDIAMDTTVTHATSHGR 95.00% 4.16 0.502 3.14 787.0455 2,358.11 2,358.12 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5.78 0.644 4.29 c1: Carbamidomethyl (+57.02) 790.7186 2,369.13 2,370.14 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5.01 0.59 2.96 c1: Carbamidomethyl (+57.02) 791.0514 2,370.13 2,370.14 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 6.1 0.627 4.48 c1: Carbamidomethyl (+57.02) 791.0519 2,370.13 2,370.14 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5.47 0.578 2.7 c1: Carbamidomethyl (+57.02) 791.0533 2,370.14 2,370.14 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IESSSPTVVEGQTLDLNcVVAR 95.00% 2.34 0.341 0 c18: Carbamidomethyl (+57.02) 792.4001 2,374.18 2,374.19 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IESSSPTVVEGQTLDLNcVVAR 95.00% 3.78 0.403 1.23 c18: Carbamidomethyl (+57.02) 792.4017 2,374.18 2,374.19 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.27 0.476 2.25 c18: Carbamidomethyl (+57.02) 792.402 2,374.18 2,374.19 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cSATGSPAPTIHWSK 95.00% 3.21 0.479 5.7 c1: Carbamidomethyl (+57.02) 800.8862 1,599.76 1,599.76 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cSATGSPAPTIHWSK 95.00% 0 0 5.11 c1: Carbamidomethyl (+57.02) 801.8875 1,601.76 1,599.76 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SLPEVPETIELEVR 95.00% 3.04 0.423 4.48 805.9348 1,609.85 1,610.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SLPEVPETIELEVR 95.00% 3.06 0.273 3.77 806.4335 1,610.85 1,610.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 4.21 0.482 2.8 817.1106 2,448.31 2,448.31 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 4.75 0.533 4.05 817.1108 2,448.31 2,448.31 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EQAWQRPDGQPATR 95.00% 2.92 0.236 0 820.3999 1,638.78 1,639.79 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EQAWQRPDGQPATR 95.00% 2.68 0.312 0 820.4002 1,638.78 1,639.79 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EQAWQRPDGQPATR 95.00% 2.95 0.25 0 820.4009 1,638.79 1,639.79 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EQAWQRPDGQPATR 95.00% 2.71 0.281 0 820.4028 1,638.79 1,639.79 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LVSEDPINDGEWHR 95.00% 4.11 0.535 4.7 834.3974 1,666.78 1,666.78 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPQVSPADSGEYVcR 95.00% 4.56 0.553 7.49 c14: Carbamidomethyl (+57.02) 839.3976 1,676.78 1,677.79 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPQVSPADSGEYVcR 95.00% 4.89 0.574 5.34 c14: Carbamidomethyl (+57.02) 839.3983 1,676.78 1,677.79 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPQVSPADSGEYVcR 95.00% 4.9 0.514 6.36 c14: Carbamidomethyl (+57.02) 839.3991 1,676.78 1,677.79 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPQVSPADSGEYVcR 95.00% 4.46 0.565 6.17 c14: Carbamidomethyl (+57.02) 839.3998 1,676.78 1,677.79 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPQVSPADSGEYVcR 95.00% 4.92 0.58 5.51 c14: Carbamidomethyl (+57.02) 839.9011 1,677.79 1,677.79 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPQVSPADSGEYVcR 95.00% 4.24 0.538 5.34 c14: Carbamidomethyl (+57.02) 839.9013 1,677.79 1,677.79 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VGGHLRPGIVQSGGVVR 95.00% 3.49 0.36 2.64 844.4875 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VGGHLRPGIVQSGGVVR 95.00% 3.44 0.319 3.77 844.4897 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VGGHLRPGIVQSGGVVR 95.00% 3.54 0.351 3.77 844.9882 1,687.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VGGHLRPGIVQSGGVVR 95.00% 3.11 0.366 2.08 844.9904 1,687.97 1,687.97 2 ATPA_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VGGHLRPGIVQSGGVVR 95.00% 3.75 0.501 1.72 844.9907 1,687.97 1,687.97 2 ATPA_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLIHDGAAPISLEWK 95.00% 0 0 7.1 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 846.9225 1,691.83 1,692.84 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLIHDGAAPISLEWK 95.00% 0 0 5.59 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 847.4255 1,692.84 1,692.84 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLIHDGAAPISLEWK 95.00% 0 0 4.38 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 847.4267 1,692.84 1,692.84 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ESDQGAYTcEAMNAR 95.00% 3.71 0.477 2.59 c9: Carbamidomethyl (+57.02) 851.8418 1,701.67 1,702.68 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ESDQGAYTcEAMNAR 95.00% 4.14 0.581 3.04 c9: Carbamidomethyl (+57.02) 851.8423 1,701.67 1,702.68 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ESDQGAYTcEAMNAR 95.00% 4.03 0.524 2.7 c9: Carbamidomethyl (+57.02) 851.8449 1,701.67 1,702.68 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 3.98 0.397 5.85 c14: Carbamidomethyl (+57.02) 851.9135 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 4.02 0.395 6.44 c14: Carbamidomethyl (+57.02) 851.9154 1,701.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 3.85 0.44 5.92 c14: Carbamidomethyl (+57.02) 851.916 1,701.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 3.39 0.37 4.55 c14: Carbamidomethyl (+57.02) 851.9164 1,701.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 4.11 0.351 6.42 c14: Carbamidomethyl (+57.02) 851.9165 1,701.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LHLVSPADSGEYVcR 95.00% 4.46 0.423 6.14 c14: Carbamidomethyl (+57.02) 852.4151 1,702.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.81 0.639 5.96 853.4457 2,557.31 2,557.33 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRSPVISIDPPSSTVQQGQDASFK 95.00% 7.06 0.566 4.85 853.4462 2,557.32 2,557.33 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.97 0.62 5.48 853.4473 2,557.32 2,557.33 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.78 0.662 5.37 853.4482 2,557.32 2,557.33 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.56 0.639 4.06 853.4498 2,557.33 2,557.33 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.93 0.609 5.82 853.4502 2,557.33 2,557.33 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQVVVLSASDASPPPVK 95.00% 3.91 0.397 7.05 853.9857 1,705.96 1,706.97 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQVVVLSASDASPPPVK 95.00% 3.52 0.435 9.09 853.9883 1,705.96 1,706.97 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLQVTPADSGEYVcR 95.00% 4.15 0.278 4.39 c14: Carbamidomethyl (+57.02) 854.4152 1,706.81 1,707.84 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LLQVTPADSGEYVcR 95.00% 4.45 0.451 2.96 c14: Carbamidomethyl (+57.02) 854.4184 1,706.82 1,707.84 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQVVVLSASDASPPPVK 95.00% 3.55 0.4 5.52 854.4828 1,706.95 1,706.97 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.29 0.564 2.14 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7258 2,561.15 2,561.17 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.27 0.538 1.44 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7264 2,561.16 2,561.17 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.5 0.554 1.74 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7284 2,561.16 2,561.17 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.43 0.571 2.8 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7288 2,561.16 2,561.17 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLIHDGAAPISLEWK 95.00% 4.5 0.573 5.74 c1: Carbamidomethyl (+57.02) 855.4356 1,708.86 1,709.87 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLIHDGAAPISLEWK 95.00% 4.43 0.608 6.52 c1: Carbamidomethyl (+57.02) 855.437 1,708.86 1,709.87 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cLIHDGAAPISLEWK 95.00% 4.56 0.581 7.33 c1: Carbamidomethyl (+57.02) 855.4373 1,708.86 1,709.87 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYQASPADSGEYVcR 95.00% 5.13 0.591 6.46 c14: Carbamidomethyl (+57.02) 858.3868 1,714.76 1,715.77 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYQASPADSGEYVcR 95.00% 5.52 0.608 5.59 c14: Carbamidomethyl (+57.02) 858.3869 1,714.76 1,715.77 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYQASPADSGEYVcR 95.00% 4.96 0.636 5.29 c14: Carbamidomethyl (+57.02) 858.3878 1,714.76 1,715.77 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYQASPADSGEYVcR 95.00% 5.4 0.592 6.48 c14: Carbamidomethyl (+57.02) 858.3884 1,714.76 1,715.77 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYQASPADSGEYVcR 95.00% 5.14 0.622 5.06 c14: Carbamidomethyl (+57.02) 858.3884 1,714.76 1,715.77 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYQASPADSGEYVcR 95.00% 4.47 0.634 6.06 c14: Carbamidomethyl (+57.02) 858.3885 1,714.76 1,715.77 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYQASPADSGEYVcR 95.00% 5.29 0.6 6.57 c14: Carbamidomethyl (+57.02) 858.3889 1,714.76 1,715.77 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYQASPADSGEYVcR 95.00% 4.99 0.604 5.64 c14: Carbamidomethyl (+57.02) 858.8888 1,715.76 1,715.77 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cVVPGQAHAQVTWHK 95.00% 3.37 0.51 3.8 c1: Carbamidomethyl (+57.02) 859.9343 1,717.85 1,717.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIGASVEFHcAVPSDR 95.00% 4.22 0.346 3.62 c10: Carbamidomethyl (+57.02) 866.4083 1,730.80 1,731.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIGASVEFHcAVPSDR 95.00% 4.5 0.412 3.34 c10: Carbamidomethyl (+57.02) 866.4091 1,730.80 1,731.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIGASVEFHcAVPSDR 95.00% 4.21 0.39 2.64 c10: Carbamidomethyl (+57.02) 866.4104 1,730.81 1,731.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SIGASVEFHcAVPSDR 95.00% 4.4 0.4 2.85 c10: Carbamidomethyl (+57.02) 866.9094 1,731.80 1,731.81 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EGGQLPPGHSVQDGVLR 95.00% 3.49 0.517 4.48 873.4483 1,744.88 1,745.89 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EGGQLPPGHSVQDGVLR 95.00% 3.57 0.547 4.37 873.4496 1,744.88 1,745.89 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EGGQLPPGHSVQDGVLR 95.00% 3.58 0.521 3.72 873.4507 1,744.89 1,745.89 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EGGQLPPGHSVQDGVLR 95.00% 3.86 0.51 4.7 873.9517 1,745.89 1,745.89 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 4.96 0.526 7.21 c14: Carbamidomethyl (+57.02) 880.9325 1,759.85 1,760.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 4.74 0.586 5.54 c14: Carbamidomethyl (+57.02) 880.9326 1,759.85 1,760.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 5.24 0.543 5.96 c14: Carbamidomethyl (+57.02) 880.9332 1,759.85 1,760.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 5.1 0.613 7.04 c14: Carbamidomethyl (+57.02) 880.9337 1,759.85 1,760.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 4.32 0.605 3.96 c14: Carbamidomethyl (+57.02) 880.9337 1,759.85 1,760.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 3.44 0.571 4.28 c14: Carbamidomethyl (+57.02) 880.9342 1,759.85 1,760.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 5.11 0.625 5.49 c14: Carbamidomethyl (+57.02) 880.9344 1,759.85 1,760.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 5.21 0.62 6.27 c14: Carbamidomethyl (+57.02) 880.9356 1,759.86 1,760.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 4.17 0.511 4 c14: Carbamidomethyl (+57.02) 880.9356 1,759.86 1,760.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 4.98 0.516 6.82 c14: Carbamidomethyl (+57.02) 881.4348 1,760.85 1,760.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 4.93 0.524 6.12 c14: Carbamidomethyl (+57.02) 881.4356 1,760.86 1,760.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LPAVEPTDQAQYLcR 95.00% 4.64 0.516 6.43 c14: Carbamidomethyl (+57.02) 881.4359 1,760.86 1,760.86 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LcNEcADGSFHLSTR 95.00% 5.17 0.625 5.08 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8815 1,765.75 1,766.76 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LcNEcADGSFHLSTR 95.00% 5.29 0.58 3.48 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8823 1,765.75 1,766.76 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LcNEcADGSFHLSTR 95.00% 5.24 0.577 3.62 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8825 1,765.75 1,766.76 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRIPQVTPADSGEYVcHVSNGAGSR 95.00% 0 0 3.85 c16: Carbamidomethyl (+57.02) 891.4357 2,671.28 2,670.31 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EVSEAVVDTLESEYLK 95.00% 6.09 0.529 6.12 905.9478 1,809.88 1,810.90 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EVSEAVVDTLESEYLK 95.00% 5.56 0.533 6.11 905.949 1,809.88 1,810.90 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EVSEAVVDTLESEYLK 95.00% 2.95 0.257 0 906.4513 1,810.89 1,810.90 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% EVSEAVVDTLESEYLK 95.00% 5.86 0.499 5.85 906.4513 1,810.89 1,810.90 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SDEFGcMPPQVVTPPR 95.00% 3.81 0.518 1.37 c6: Carbamidomethyl (+57.02) 909.42 1,816.82 1,816.84 2 ANXA5_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SDEFGcMPPQVVTPPR 95.00% 4.14 0.596 3.42 c6: Carbamidomethyl (+57.02) 909.4225 1,816.83 1,816.84 2 ANXA5_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% GMVFGIPDGVLELVPQR 95.00% 3.82 0.505 4.18 913.9948 1,825.97 1,826.98 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% GMVFGIPDGVLELVPQR 95.00% 3.26 0.47 3.77 913.9975 1,825.98 1,826.98 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% GMVFGIPDGVLELVPQR 95.00% 3.66 0.522 4.49 914.495 1,826.97 1,826.98 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.2 0.438 3.54 c14: Carbamidomethyl (+57.02) 918.9639 1,835.91 1,836.93 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.49 0.472 3.46 c14: Carbamidomethyl (+57.02) 918.9669 1,835.92 1,836.93 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.25 0.435 4.36 c14: Carbamidomethyl (+57.02) 918.9671 1,835.92 1,836.93 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.83 0.489 2.74 c14: Carbamidomethyl (+57.02) 918.9672 1,835.92 1,836.93 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 3.98 0.48 4 c14: Carbamidomethyl (+57.02) 918.968 1,835.92 1,836.93 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.53 0.386 3.42 c14: Carbamidomethyl (+57.02) 919.4669 1,836.92 1,836.93 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SQSVRPGADVTFIcTAK 95.00% 4.23 0.406 3.52 c14: Carbamidomethyl (+57.02) 919.4674 1,836.92 1,836.93 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cQVSGSPPHYFYWSR 95.00% 4.46 0.606 4.49 c1: Carbamidomethyl (+57.02) 935.9188 1,869.82 1,870.83 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cQVSGSPPHYFYWSR 95.00% 4.15 0.576 3.44 c1: Carbamidomethyl (+57.02) 935.9212 1,869.83 1,870.83 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cQVSGSPPHYFYWSR 95.00% 4.16 0.538 2.31 c1: Carbamidomethyl (+57.02) 935.922 1,869.83 1,870.83 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cQVSGSPPHYFYWSR 95.00% 4.92 0.6 3.57 c1: Carbamidomethyl (+57.02) 936.4189 1,870.82 1,870.83 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cEScAPGYEGNPIQPGGK 95.00% 4.53 0.477 3.23 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 960.9116 1,919.81 1,920.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cEScAPGYEGNPIQPGGK 95.00% 4.83 0.439 4.18 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 961.4134 1,920.81 1,920.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cEScAPGYEGNPIQPGGK 95.00% 5.05 0.433 5.06 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 961.4141 1,920.81 1,920.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cAPGYYGNPSQGQPcQR 95.00% 4.19 0.625 6.64 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4084 1,938.80 1,939.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cAPGYYGNPSQGQPcQR 95.00% 4.53 0.644 7.41 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4093 1,938.80 1,939.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cAPGYYGNPSQGQPcQR 95.00% 4.19 0.633 5.11 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4093 1,938.80 1,939.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cAPGYYGNPSQGQPcQR 95.00% 4.17 0.682 5.2 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4106 1,938.81 1,939.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cAPGYYGNPSQGQPcQR 95.00% 4.94 0.658 6.96 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.4113 1,938.81 1,939.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ATFSSVPLAASISAVSLEVAQPGPSNRPR 95.00% 2.22 0.331 2.64 970.8524 2,909.53 2,909.55 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ATFSSVPLAASISAVSLEVAQPGPSNRPR 95.00% 2.41 0.429 4.51 970.8524 2,909.53 2,909.55 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ATFSSVPLAASISAVSLEVAQPGPSNRPR 95.00% 2.23 0.194 1.85 970.8552 2,909.54 2,909.55 3
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cAPGYYGNPSQGQPcQR 95.00% 4.37 0.619 5.57 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9123 1,939.81 1,939.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cAPGYYGNPSQGQPcQR 95.00% 4.2 0.617 6.27 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9129 1,939.81 1,939.82 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 4.79 0.577 5.77 c16: Carbamidomethyl (+57.02) 973.9897 1,945.96 1,946.98 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 4.78 0.573 6.55 c16: Carbamidomethyl (+57.02) 973.9898 1,945.96 1,946.98 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 4.89 0.59 6.36 c16: Carbamidomethyl (+57.02) 973.9945 1,945.97 1,946.98 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LRLPQVSPADSGEYVcR 95.00% 4.98 0.594 4.44 c16: Carbamidomethyl (+57.02) 974.4947 1,946.97 1,946.98 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYIFQASPADAGQYVcR 95.00% 4.92 0.634 6.68 c16: Carbamidomethyl (+57.02) 979.9718 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYIFQASPADAGQYVcR 95.00% 5.77 0.687 8.21 c16: Carbamidomethyl (+57.02) 979.9718 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYIFQASPADAGQYVcR 95.00% 5.49 0.672 6.2 c16: Carbamidomethyl (+57.02) 979.9724 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYIFQASPADAGQYVcR 95.00% 5.85 0.675 8.8 c16: Carbamidomethyl (+57.02) 979.9735 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VVGSSGTQEASVLVTIQQR 95.00% 5.11 0.523 4.17 980.0278 1,958.04 1,959.05 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VVGSSGTQEASVLVTIQQR 95.00% 5.09 0.486 4.29 980.0278 1,958.04 1,959.05 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYIFQASPADAGQYVcR 95.00% 5.37 0.509 5.77 c16: Carbamidomethyl (+57.02) 980.4732 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYIFQASPADAGQYVcR 95.00% 6.06 0.56 6.89 c16: Carbamidomethyl (+57.02) 980.4733 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYIFQASPADAGQYVcR 95.00% 5.88 0.62 6.62 c16: Carbamidomethyl (+57.02) 980.4746 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYIFQASPADAGQYVcR 95.00% 5.68 0.569 6 c16: Carbamidomethyl (+57.02) 980.4747 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% LYIFQASPADAGQYVcR 95.00% 5.48 0.578 8.41 c16: Carbamidomethyl (+57.02) 980.4758 1,958.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VVGSSGTQEASVLVTIQQR 95.00% 4.47 0.529 3.54 980.5278 1,959.04 1,959.05 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VVGSSGTQEASVLVTIQQR 95.00% 5.61 0.463 4.21 980.5299 1,959.04 1,959.05 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VVGSSGTQEASVLVTIQQR 95.00% 5.41 0.481 5.19 980.5319 1,959.05 1,959.05 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ITFRPDSADGmLLYNGQK 95.00% 2.16 0.367 0 m11: Oxidation (+15.99) 1,021.93 2,041.85 2,042.00 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% DVKESDQGAYTcEAMNAR 95.00% 5.71 0.508 6.8 c12: Carbamidomethyl (+57.02) 1,023.44 2,044.86 2,044.87 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% GMLEPVQRPDVVLVGAGYR 95.00% 4.59 0.573 4.52 1,029.05 2,056.09 2,056.10 2 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% PSDAGTYVcLAQNALGTAQK 95.00% 6.85 0.605 0 c9: Carbamidomethyl (+57.02) 1,033.00 2,063.99 2,065.00 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% PSDAGTYVcLAQNALGTAQK 95.00% 6.77 0.611 0 c9: Carbamidomethyl (+57.02) 1,033.00 2,063.99 2,065.00 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% PSDAGTYVcLAQNALGTAQK 95.00% 6.07 0.63 0 c9: Carbamidomethyl (+57.02) 1,033.50 2,064.99 2,065.00 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% PSDAGTYVcLAQNALGTAQK 95.00% 6.36 0.583 0 c9: Carbamidomethyl (+57.02) 1,033.50 2,064.99 2,065.00 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RcEScAPGYEGNPIQPGGK 95.00% 5.41 0.621 5.05 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 1,038.97 2,075.92 2,076.92 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% RcEScAPGYEGNPIQPGGK 95.00% 5.04 0.599 4.6 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 1,039.46 2,076.91 2,076.92 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ATATScRPcPcPYIDASR 95.00% 3.94 0.464 2.46 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,041.96 2,081.90 2,082.92 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ATATScRPcPcPYIDASR 95.00% 4.19 0.476 3.11 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,041.96 2,081.91 2,082.92 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ATATScRPcPcPYIDASR 95.00% 4.05 0.48 2.74 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.90 2,082.92 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% ATATScRPcPcPYIDASR 95.00% 4.12 0.457 2.27 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.92 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VISSGSVASYVTSPQGFQFR 95.00% 5.2 0.604 2.49 1,059.54 2,117.05 2,117.07 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VISSGSVASYVTSPQGFQFR 95.00% 5.58 0.581 6.49 1,059.54 2,117.06 2,117.07 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VISSGSVASYVTSPQGFQFR 95.00% 4.92 0.63 5.09 1,059.54 2,117.06 2,117.07 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VISSGSVASYVTSPQGFQFR 95.00% 5.26 0.594 4.04 1,059.54 2,117.06 2,117.07 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% VISSGSVASYVTSPQGFQFR 95.00% 4.56 0.605 5.29 1,059.54 2,117.06 2,117.07 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cPPGYIGLScQDcAPGYTR 95.00% 5.11 0.632 6.51 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.97 2,171.92 2,171.93 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cPPGYIGLScQDcAPGYTR 95.00% 4.84 0.594 6.57 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.97 2,171.92 2,171.93 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cPPGYIGLScQDcAPGYTR 95.00% 4.82 0.565 6.59 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.97 2,171.93 2,171.93 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cPIGYSGLScEScDAHFTR 95.00% 4.89 0.618 5.8 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,108.96 2,215.90 2,216.92 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cPIGYSGLScEScDAHFTR 95.00% 4.93 0.584 5.62 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,109.46 2,216.90 2,216.92 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPVISIDPPSSTVQQGQDASFK 95.00% 6.2 0.508 11.4 1,145.07 2,288.13 2,288.14 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPVISIDPPSSTVQQGQDASFK 95.00% 5.54 0.527 13.2 1,145.07 2,288.13 2,288.14 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPVISIDPPSSTVQQGQDASFK 95.00% 6 0.52 10.9 1,145.07 2,288.13 2,288.14 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPVISIDPPSSTVQQGQDASFK 95.00% 5.63 0.501 14.3 1,145.07 2,288.13 2,288.14 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% SPVISIDPPSSTVQQGQDASFK 95.00% 5.44 0.542 10.9 1,145.08 2,288.14 2,288.14 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 5.35 0.493 6.85 1,156.13 2,310.24 2,310.26 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 5.42 0.516 6.77 1,156.13 2,310.24 2,310.26 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 5.35 0.502 7.62 1,156.13 2,310.25 2,310.26 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AELLVTEAPSKPITVTVEEQR 95.00% 5.29 0.568 5.17 1,156.14 2,310.25 2,310.26 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.85 0.681 6.01 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.12 2,370.14 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.81 0.72 6.42 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.12 2,370.14 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.77 0.694 4.48 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.77 0.63 5.82 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.87 0.692 7.19 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5.11 0.731 5.24 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.84 0.642 4.02 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.44 0.676 5.85 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.5 0.651 5.31 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.09 0.645 5.37 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.94 0.66 6.1 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.19 0.657 5.15 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 2R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 126 524 29.10% AASGPGPEQEASFTVTVPPSEGSSYR 95.00% 3.99 0.561 3.68 1,305.11 2,608.20 2,608.22 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VTVTSEGGR 95.00% 1.79 0.349 0 453.2404 904.4652 905.4693 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VTVTSEGGR 95.00% 1.81 0.431 1.08 453.2427 904.4697 905.4693 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SAEPLALGR 95.00% 2.23 0.324 0 457.2586 912.5016 913.5108 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SAEPLALGR 95.00% 2.37 0.292 0 457.2587 912.5018 913.5108 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SAEPLALGR 95.00% 2.6 0.326 1.46 457.2588 912.5019 913.5108 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SAEPLALGR 95.00% 2.32 0.354 0 457.2591 912.5025 913.5108 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SAEPLALGR 95.00% 2.2 0.334 1.15 457.2594 912.5031 913.5108 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SAEPLALGR 95.00% 2.54 0.343 1.15 457.2597 912.5038 913.5108 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SAEPLALGR 95.00% 2.51 0.334 0 457.2599 912.5041 913.5108 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SAEPLALGR 95.00% 2.26 0.352 0 457.2602 912.5047 913.5108 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SAEPLALGR 95.00% 2.43 0.329 0 457.2603 912.5049 913.5108 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SAEPLALGR 95.00% 2.25 0.334 0 457.2604 912.5052 913.5108 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GHTPTQPGALNQR 95.00% 2.74 0.298 0 459.5733 1,375.70 1,376.70 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GHTPTQPGALNQR 95.00% 2.42 0.163 1.06 459.5741 1,375.70 1,376.70 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GHTPTQPGALNQR 95.00% 3.25 0.32 1.22 459.5745 1,375.70 1,376.70 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GHTPTQPGALNQR 95.00% 3.51 0.321 1.57 459.9085 1,376.70 1,376.70 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IPGDQVVSVVFIK 95.00% 3.68 0.399 2.49 467.6106 1,399.81 1,400.82 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IPGDQVVSVVFIK 95.00% 4.62 0.472 2.42 467.6109 1,399.81 1,400.82 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SYEIMFR 95.00% 2.45 0.255 0 473.2282 944.4407 945.4504 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SYEIMFR 95.00% 2.3 0.159 0 473.2284 944.4411 945.4504 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AGFFGDAmK 95.00% 2.53 0.198 0 m8: Oxidation (+15.99) 480.218 958.4203 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IAHVELADAGQYR 95.00% 4.61 0.446 3.03 481.5841 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IAHVELADAGQYR 95.00% 3.47 0.419 0 481.5842 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IAHVELADAGQYR 95.00% 4.16 0.433 2.25 481.5845 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IAHVELADAGQYR 95.00% 4.49 0.399 1.38 481.5848 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IAHVELADAGQYR 95.00% 4.33 0.491 1.68 481.5854 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LSGSHSQGVAYPVR 95.00% 3.86 0.435 1.68 486.5876 1,456.74 1,457.75 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LSGSHSQGVAYPVR 95.00% 2.84 0.439 0 486.5882 1,456.74 1,457.75 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LSGSHSQGVAYPVR 95.00% 3.5 0.408 1.46 486.9218 1,457.74 1,457.75 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RPEEVcGPTQFR 95.00% 3 0.327 1.41 c6: Carbamidomethyl (+57.02) 492.5738 1,474.70 1,475.71 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RPEEVcGPTQFR 95.00% 3.92 0.466 2.7 c6: Carbamidomethyl (+57.02) 492.9065 1,475.70 1,475.71 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RPEEVcGPTQFR 95.00% 3.88 0.316 1.77 c6: Carbamidomethyl (+57.02) 492.9069 1,475.70 1,475.71 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RPEEVcGPTQFR 95.00% 4.24 0.374 1.11 c6: Carbamidomethyl (+57.02) 492.9072 1,475.70 1,475.71 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RPEEVcGPTQFR 95.00% 2.4 0.253 0 c6: Carbamidomethyl (+57.02) 492.909 1,475.70 1,475.71 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RPEEVcGPTQFR 95.00% 2.94 0.332 1.04 c6: Carbamidomethyl (+57.02) 492.9095 1,475.71 1,475.71 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EGGSLPPQAR 95.00% 2.14 0.374 0 506.2634 1,010.51 1,011.52 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LGTVPQFPR 95.00% 1.93 0.144 1.44 507.7889 1,013.56 1,014.57 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LGTVPQFPR 95.00% 2.47 0.339 2.39 507.7891 1,013.56 1,014.57 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LGTVPQFPR 95.00% 2.36 0.211 1.39 507.7893 1,013.56 1,014.57 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LGTVPQFPR 95.00% 2.41 0.281 2.15 507.7894 1,013.56 1,014.57 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LGTVPQFPR 95.00% 2.5 0.282 2.62 507.7894 1,013.56 1,014.57 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LGTVPQFPR 95.00% 2.26 0.191 1.68 507.7894 1,013.56 1,014.57 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LGTVPQFPR 95.00% 2.48 0.314 1.54 507.7896 1,013.56 1,014.57 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LGTVPQFPR 95.00% 2.56 0.427 1.77 507.79 1,013.56 1,014.57 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FLGDKVTSYGGELR 95.00% 3.88 0.445 3.42 514.602 1,540.78 1,541.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FLGDKVTSYGGELR 95.00% 3.81 0.389 4.34 514.6024 1,540.78 1,541.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FLGDKVTSYGGELR 95.00% 3 0.41 2.92 514.6025 1,540.78 1,541.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FLGDKVTSYGGELR 95.00% 3.94 0.395 3.34 514.6027 1,540.78 1,541.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FLGDKVTSYGGELR 95.00% 2.79 0.256 1.54 514.6039 1,540.79 1,541.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FLGDKVTSYGGELR 95.00% 4.07 0.378 2.74 514.937 1,541.79 1,541.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% HQTHGSLLR 95.00% 2.07 0.323 0 524.7868 1,047.56 1,048.57 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LDGSLPPDSR 95.00% 2.84 0.439 0 528.7688 1,055.52 1,056.53 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LDGSLPPDSR 95.00% 2.83 0.407 0 528.7698 1,055.52 1,056.53 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% NELLHFER 95.00% 2.69 0.182 0 529.273 1,056.53 1,057.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% NELLHFER 95.00% 2.66 0.16 0 529.2737 1,056.53 1,057.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% NELLHFER 95.00% 2.5 0.146 0 529.274 1,056.53 1,057.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% NELLHFER 95.00% 2.65 0.157 0 529.2741 1,056.53 1,057.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% NELLHFER 95.00% 2.63 0.141 0 529.2746 1,056.53 1,057.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% NELLHFER 95.00% 2.57 0.158 0 529.2746 1,056.53 1,057.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPAPTIHWSK 95.00% 4.66 0.569 1.52 c1: Carbamidomethyl (+57.02) 533.9236 1,598.75 1,599.76 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPAPTIHWSK 95.00% 4.15 0.571 1.59 c1: Carbamidomethyl (+57.02) 533.9236 1,598.75 1,599.76 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPAPTIHWSK 95.00% 4.03 0.498 1.17 c1: Carbamidomethyl (+57.02) 533.9245 1,598.75 1,599.76 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPAPTIHWSK 95.00% 3.95 0.529 1.96 c1: Carbamidomethyl (+57.02) 533.9247 1,598.75 1,599.76 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RGSIQVDGEELVSGR 95.00% 2.54 0.362 0 534.6119 1,600.81 1,601.82 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RGSIQVDGEELVSGR 95.00% 2.63 0.414 0 534.6138 1,600.82 1,601.82 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VAEGQTLDLK 95.00% 3.43 0.511 0 537.2949 1,072.57 1,073.58 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VAEGQTLDLK 95.00% 3.21 0.456 2.01 537.295 1,072.57 1,073.58 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VAEGQTLDLK 95.00% 3 0.446 1.35 537.2951 1,072.57 1,073.58 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VAEGQTLDLK 95.00% 3.47 0.456 2.28 537.2951 1,072.57 1,073.58 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VAEGQTLDLK 95.00% 3.62 0.485 2.35 537.2953 1,072.58 1,073.58 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VAEGQTLDLK 95.00% 3.56 0.518 1.25 537.2957 1,072.58 1,073.58 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EQAWQRPDGQPATR 95.00% 2.33 0.296 0 547.2677 1,638.78 1,639.79 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EQAWQRPDGQPATR 95.00% 2.56 0.272 0 547.2687 1,638.78 1,639.79 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EQAWQRPDGQPATR 95.00% 2.7 0.328 0 547.2687 1,638.78 1,639.79 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EQAWQRPDGQPATR 95.00% 2.23 0.265 0 547.2689 1,638.78 1,639.79 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EQAWQRPDGQPATR 95.00% 2.06 0.212 0 547.2697 1,638.79 1,639.79 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EQAWQRPDGQPATR 95.00% 2.55 0.285 1.02 547.6022 1,639.78 1,639.79 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EQAWQRPDGQPATR 95.00% 2.53 0.388 0 547.603 1,639.79 1,639.79 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EQAWQRPDGQPATR 95.00% 2.53 0.355 1.08 547.6033 1,639.79 1,639.79 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RSYEIMFR 95.00% 2.62 0.176 0 551.278 1,100.54 1,101.55 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RSYEIMFR 95.00% 2.61 0.161 0 551.2796 1,100.54 1,101.55 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LVSEDPINDGEWHR 95.00% 1.99 0.412 1.12 556.2645 1,665.77 1,666.78 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LVSEDPINDGEWHR 95.00% 2.91 0.489 0 556.2646 1,665.77 1,666.78 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPQVSPADSGEYVcR 95.00% 3.8 0.377 1.57 c14: Carbamidomethyl (+57.02) 560.2704 1,677.79 1,677.79 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FDAGSGMATIR 95.00% 3.33 0.415 4.48 563.2688 1,124.52 1,125.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FDAGSGMATIR 95.00% 3.52 0.431 3.8 563.2692 1,124.52 1,125.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FDAGSGMATIR 95.00% 3.5 0.397 4.08 563.2702 1,124.52 1,125.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FDAGSGMATIR 95.00% 3.42 0.443 4.96 563.2702 1,124.52 1,125.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FDAGSGMATIR 95.00% 3.05 0.374 2.37 563.2702 1,124.52 1,125.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FDAGSGMATIR 95.00% 2.98 0.372 2.11 563.2702 1,124.52 1,125.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FDAGSGMATIR 95.00% 3.14 0.426 3.57 563.2708 1,124.53 1,125.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LEGDTLIIPR 95.00% 1.99 0.25 1.64 563.2708 1,124.53 1,126.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FDAGSGMATIR 95.00% 2.52 0.339 1.8 563.2711 1,124.53 1,125.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FDAGSGMATIR 95.00% 3.42 0.451 4.82 563.2714 1,124.53 1,125.54 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VPGSPTNLANR 95.00% 2.63 0.54 1.96 563.3023 1,124.59 1,125.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VPGSPTNLANR 95.00% 3.02 0.575 3.92 563.3025 1,124.59 1,125.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VPGSPTNLANR 95.00% 2.79 0.446 2.38 563.3028 1,124.59 1,125.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VPGSPTNLANR 95.00% 2.97 0.498 3.12 563.3036 1,124.59 1,125.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VPGSPTNLANR 95.00% 3.25 0.567 3.43 563.3038 1,124.59 1,125.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VPGSPTNLANR 95.00% 2.6 0.44 4.33 563.3038 1,124.59 1,125.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VPGSPTNLANR 95.00% 3.38 0.569 3.43 563.3039 1,124.59 1,125.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VPGSPTNLANR 95.00% 3.07 0.545 3.43 563.304 1,124.59 1,125.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VPGSPTNLANR 95.00% 3.21 0.549 4.66 563.3041 1,124.59 1,125.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VPGSPTNLANR 95.00% 2.16 0.429 0 563.3049 1,124.59 1,125.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 4.38 0.518 2.92 563.3278 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 4.89 0.517 3.06 563.328 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 5.25 0.533 3.02 563.328 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 4.68 0.516 3.68 563.3281 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 4.37 0.503 2.12 563.3284 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 5.26 0.463 3.89 563.3286 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 3.53 0.438 1.48 563.6623 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 4.71 0.525 2.77 563.6625 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 4.83 0.499 2.6 563.6625 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 4.77 0.525 1.8 563.6629 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LEGDTLIIPR 95.00% 3.64 0.403 2.26 563.8253 1,125.63 1,126.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LEGDTLIIPR 95.00% 3.49 0.397 2.44 563.8258 1,125.64 1,126.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LEGDTLIIPR 95.00% 3.57 0.419 2.64 563.8261 1,125.64 1,126.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHLVSPADSGEYVcR 95.00% 3.77 0.433 3.64 c14: Carbamidomethyl (+57.02) 568.278 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHLVSPADSGEYVcR 95.00% 4.01 0.428 3.89 c14: Carbamidomethyl (+57.02) 568.2792 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHLVSPADSGEYVcR 95.00% 4.04 0.51 3.03 c14: Carbamidomethyl (+57.02) 568.6116 1,702.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHLVSPADSGEYVcR 95.00% 4.64 0.557 4.54 c14: Carbamidomethyl (+57.02) 568.6119 1,702.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHLVSPADSGEYVcR 95.00% 5.13 0.537 4 c14: Carbamidomethyl (+57.02) 568.6124 1,702.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHLVSPADSGEYVcR 95.00% 4.23 0.481 2.96 c14: Carbamidomethyl (+57.02) 568.6124 1,702.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHLVSPADSGEYVcR 95.00% 2.47 0.301 0 c14: Carbamidomethyl (+57.02) 568.6126 1,702.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IQVVVLSASDASPPPVK 95.00% 4.03 0.426 5.35 569.6609 1,705.96 1,706.97 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IQVVVLSASDASPPPVK 95.00% 3.89 0.47 4.24 569.6619 1,705.96 1,706.97 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LLQVTPADSGEYVcR 95.00% 4.22 0.474 3.09 c14: Carbamidomethyl (+57.02) 569.9505 1,706.83 1,707.84 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IQVVVLSASDASPPPVK 95.00% 3.97 0.483 3.54 569.9942 1,706.96 1,706.97 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IQVVVLSASDASPPPVK 95.00% 4.65 0.446 4.03 569.9943 1,706.96 1,706.97 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IQVVVLSASDASPPPVK 95.00% 4.44 0.425 5.03 569.995 1,706.96 1,706.97 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LLQVTPADSGEYVcR 95.00% 4.81 0.536 3.62 c14: Carbamidomethyl (+57.02) 570.2839 1,707.83 1,707.84 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLIHDGAAPISLEWK 95.00% 3.07 0.39 1.4 c1: Carbamidomethyl (+57.02) 570.6249 1,708.85 1,709.87 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FDAGSGmATIR 95.00% 2.08 0.385 1.54 m7: Oxidation (+15.99) 571.2669 1,140.52 1,141.53 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FDAGSGmATIR 95.00% 2.86 0.399 3.28 m7: Oxidation (+15.99) 571.2675 1,140.52 1,141.53 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% FDAGSGmATIR 95.00% 2.78 0.408 3.13 m7: Oxidation (+15.99) 571.2697 1,140.52 1,141.53 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LYQASPADSGEYVcR 95.00% 3.47 0.431 0 c14: Carbamidomethyl (+57.02) 572.5942 1,714.76 1,715.77 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHHVSPADSGEYVcR 95.00% 4.76 0.443 2.72 c14: Carbamidomethyl (+57.02) 576.2682 1,725.78 1,726.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHHVSPADSGEYVcR 95.00% 4.91 0.408 1.51 c14: Carbamidomethyl (+57.02) 576.269 1,725.78 1,726.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHHVSPADSGEYVcR 95.00% 5.01 0.434 1.64 c14: Carbamidomethyl (+57.02) 576.2693 1,725.78 1,726.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHHVSPADSGEYVcR 95.00% 5.07 0.37 1.48 c14: Carbamidomethyl (+57.02) 576.2696 1,725.79 1,726.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHHVSPADSGEYVcR 95.00% 4.74 0.409 2.8 c14: Carbamidomethyl (+57.02) 576.2703 1,725.79 1,726.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHHVSPADSGEYVcR 95.00% 4.82 0.378 2.01 c14: Carbamidomethyl (+57.02) 576.6036 1,726.79 1,726.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHHVSPADSGEYVcR 95.00% 5.04 0.356 3.1 c14: Carbamidomethyl (+57.02) 576.6044 1,726.79 1,726.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHHVSPADSGEYVcR 95.00% 4.9 0.386 1.23 c14: Carbamidomethyl (+57.02) 576.6045 1,726.79 1,726.80 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIGASVEFHcAVPSDR 95.00% 2.39 0.299 0 c10: Carbamidomethyl (+57.02) 577.9408 1,730.80 1,731.81 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIGASVEFHcAVPSDR 95.00% 2.73 0.367 0 c10: Carbamidomethyl (+57.02) 577.9413 1,730.80 1,731.81 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIGASVEFHcAVPSDR 95.00% 3.52 0.26 1.15 c10: Carbamidomethyl (+57.02) 577.9415 1,730.80 1,731.81 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIGASVEFHcAVPSDR 95.00% 2.78 0.312 0 c10: Carbamidomethyl (+57.02) 578.2764 1,731.81 1,731.81 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AVLHVHGGGGPR 95.00% 2.21 0.394 0 578.8213 1,155.63 1,156.63 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EGGQLPPGHSVQDGVLR 95.00% 2.09 0.23 0 582.6368 1,744.89 1,745.89 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EGGQLPPGHSVQDGVLR 95.00% 2.4 0.21 0 582.9706 1,745.89 1,745.89 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AFAHLQVPER 95.00% 2.76 0.353 1.4 584.3149 1,166.61 1,167.63 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AFAHLQVPER 95.00% 3.31 0.374 1.74 584.3167 1,166.62 1,167.63 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AFAHLQVPER 95.00% 3.09 0.358 2.09 584.317 1,166.62 1,167.63 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AFAHLQVPER 95.00% 3.18 0.355 1.96 584.3171 1,166.62 1,167.63 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AFAHLQVPER 95.00% 3.3 0.358 1.92 584.3175 1,166.62 1,167.63 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHQMSVADSGEYVcR 95.00% 3.1 0.259 0 c14: Carbamidomethyl (+57.02) 584.9324 1,751.77 1,751.78 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RLGTVPQFPR 95.00% 1.96 0.282 0 585.8388 1,169.66 1,170.67 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GDLcEHEENPcQLR 95.00% 3.56 0.369 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.2491 1,755.72 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GDLcEHEENPcQLR 95.00% 3.87 0.372 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.2499 1,755.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GDLcEHEENPcQLR 95.00% 3.63 0.314 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.585 1,756.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.55 0.444 1.24 c14: Carbamidomethyl (+57.02) 587.6246 1,759.85 1,760.86 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.81 0.484 3.59 c14: Carbamidomethyl (+57.02) 587.6246 1,759.85 1,760.86 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.94 0.519 3 c14: Carbamidomethyl (+57.02) 587.6254 1,759.85 1,760.86 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.6 0.521 3.14 c14: Carbamidomethyl (+57.02) 587.9594 1,760.85 1,760.86 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% YELGSGLAVLR 95.00% 3.38 0.477 3.57 589.3312 1,176.65 1,177.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% YELGSGLAVLR 95.00% 3.64 0.526 3 589.3314 1,176.65 1,177.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% YELGSGLAVLR 95.00% 3.68 0.5 3.7 589.3319 1,176.65 1,177.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% YELGSGLAVLR 95.00% 3.33 0.472 4.62 589.3319 1,176.65 1,177.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% YELGSGLAVLR 95.00% 3.34 0.479 4.05 589.3319 1,176.65 1,177.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% YELGSGLAVLR 95.00% 3.54 0.524 3.31 589.3322 1,176.65 1,177.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% YELGSGLAVLR 95.00% 3.79 0.521 4.24 589.3326 1,176.65 1,177.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% YELGSGLAVLR 95.00% 3.62 0.514 3.31 589.3328 1,176.65 1,177.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LcNEcADGSFHLSTR 95.00% 3.92 0.385 1.14 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5894 1,765.74 1,766.76 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LcNEcADGSFHLSTR 95.00% 3.52 0.475 2.7 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5897 1,765.75 1,766.76 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LcNEcADGSFHLSTR 95.00% 3.6 0.413 1 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5898 1,765.75 1,766.76 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LcNEcADGSFHLSTR 95.00% 4.04 0.429 2.85 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5906 1,765.75 1,766.76 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LcNEcADGSFHLSTR 95.00% 3.37 0.337 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.592 1,765.75 1,766.76 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LcNEcADGSFHLSTR 95.00% 4.09 0.33 2.11 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.9243 1,766.75 1,766.76 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LcNEcADGSFHLSTR 95.00% 4.17 0.39 2.17 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.9252 1,766.75 1,766.76 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPAYTLVWTR 95.00% 3.78 0.574 3.12 597.3178 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPAYTLVWTR 95.00% 3.74 0.569 2.7 597.3184 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPAYTLVWTR 95.00% 3.6 0.553 3.08 597.3185 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPAYTLVWTR 95.00% 4.05 0.602 2.8 597.3188 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPAYTLVWTR 95.00% 3.82 0.583 2.08 597.3189 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPAYTLVWTR 95.00% 3.8 0.527 3.19 597.3189 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPAYTLVWTR 95.00% 4.01 0.595 2.37 597.3191 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPAYTLVWTR 95.00% 3.89 0.575 2.44 597.3197 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EVSEAVVDTLESEYLK 95.00% 4.05 0.491 0 604.3032 1,809.89 1,810.90 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EVSEAVVDTLESEYLK 95.00% 3.71 0.404 1.28 604.3034 1,809.89 1,810.90 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SDEFGcMPPQVVTPPR 95.00% 3.25 0.497 1.46 c6: Carbamidomethyl (+57.02) 606.2832 1,815.83 1,816.84 3 ANXA5_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SDEFGcMPPQVVTPPR 95.00% 3.26 0.484 0 c6: Carbamidomethyl (+57.02) 606.6177 1,816.83 1,816.84 3 ANXA5_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AGLSSGFIGcVR 95.00% 3 0.443 3.22 c10: Carbamidomethyl (+57.02) 612.3114 1,222.61 1,223.62 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AGLSSGFIGcVR 95.00% 2.76 0.397 2.92 c10: Carbamidomethyl (+57.02) 612.3127 1,222.61 1,223.62 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AGLSSGFIGcVR 95.00% 3.95 0.451 3.44 c10: Carbamidomethyl (+57.02) 612.313 1,222.61 1,223.62 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AGLSSGFIGcVR 95.00% 3.97 0.465 3.18 c10: Carbamidomethyl (+57.02) 612.3133 1,222.61 1,223.62 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AGLSSGFIGcVR 95.00% 4.34 0.512 3.27 c10: Carbamidomethyl (+57.02) 612.3138 1,222.61 1,223.62 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AGLSSGFIGcVR 95.00% 4.15 0.462 4.1 c10: Carbamidomethyl (+57.02) 612.3142 1,222.61 1,223.62 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AGLSSGFIGcVR 95.00% 2.45 0.394 2.09 c10: Carbamidomethyl (+57.02) 612.3144 1,222.61 1,223.62 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AGLSSGFIGcVR 95.00% 2.45 0.338 1.22 c10: Carbamidomethyl (+57.02) 612.8127 1,223.61 1,223.62 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 4.18 0.54 2.49 c14: Carbamidomethyl (+57.02) 612.9784 1,835.91 1,836.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 4.35 0.53 2.14 c14: Carbamidomethyl (+57.02) 612.9791 1,835.91 1,836.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 3.98 0.557 2.33 c14: Carbamidomethyl (+57.02) 612.98 1,835.92 1,836.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 4.83 0.591 2.06 c14: Carbamidomethyl (+57.02) 612.9803 1,835.92 1,836.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 4.17 0.526 1.05 c14: Carbamidomethyl (+57.02) 612.9804 1,835.92 1,836.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 3.98 0.488 2.48 c14: Carbamidomethyl (+57.02) 612.9808 1,835.92 1,836.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 4.15 0.537 2.7 c14: Carbamidomethyl (+57.02) 612.981 1,835.92 1,836.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 4.25 0.479 1.52 c14: Carbamidomethyl (+57.02) 612.9824 1,835.92 1,836.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 4.15 0.522 1.11 c14: Carbamidomethyl (+57.02) 613.3143 1,836.92 1,836.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 3.97 0.525 1.8 c14: Carbamidomethyl (+57.02) 613.3145 1,836.92 1,836.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 4.31 0.448 0 c14: Carbamidomethyl (+57.02) 613.3148 1,836.92 1,836.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 4.4 0.494 2.64 c14: Carbamidomethyl (+57.02) 613.3149 1,836.92 1,836.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AAGVPSATITWR 95.00% 2.43 0.431 1.89 615.334 1,228.65 1,229.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AAGVPSATITWR 95.00% 2.42 0.461 1.43 615.3349 1,228.65 1,229.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AAGVPSATITWR 95.00% 1.79 0.196 1.6 615.3351 1,228.65 1,229.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AAGVPSATITWR 95.00% 2.39 0.356 1.08 615.3365 1,228.66 1,229.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIVPQGGSHSLR 95.00% 1.9 0.329 1.92 619.3333 1,236.65 1,237.67 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIVPQGGSHSLR 95.00% 2.32 0.366 2.85 619.335 1,236.65 1,237.67 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIVPQGGSHSLR 95.00% 2.46 0.381 2.06 619.3355 1,236.66 1,237.67 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIVPQGGSHSLR 95.00% 2.22 0.41 0 619.3383 1,236.66 1,237.67 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% QPQAIITWYK 95.00% 1.69 0.34 0 624.3412 1,246.67 1,247.68 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% QPQAIITWYK 95.00% 1.82 0.356 0 624.3424 1,246.67 1,247.68 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% QPQAIITWYK 95.00% 1.81 0.31 0 624.3426 1,246.67 1,247.68 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cQVSGSPPHYFYWSR 95.00% 2.81 0.476 0 c1: Carbamidomethyl (+57.02) 624.6155 1,870.82 1,870.83 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cQVSGSPPHYFYWSR 95.00% 2.06 0.293 0 c1: Carbamidomethyl (+57.02) 624.616 1,870.82 1,870.83 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cQVSGSPPHYFYWSR 95.00% 3.02 0.509 0 c1: Carbamidomethyl (+57.02) 624.6163 1,870.83 1,870.83 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cQVSGSPPHYFYWSR 95.00% 2.8 0.444 0 c1: Carbamidomethyl (+57.02) 624.6164 1,870.83 1,870.83 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cQVSGSPPHYFYWSR 95.00% 2.17 0.384 0 c1: Carbamidomethyl (+57.02) 624.6165 1,870.83 1,870.83 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cQVSGSPPHYFYWSR 95.00% 3.05 0.507 0 c1: Carbamidomethyl (+57.02) 624.618 1,870.83 1,870.83 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AMDFNGILTIR 95.00% 2.43 0.393 0 625.8321 1,249.65 1,250.66 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLcLPGFSGPR 95.00% 2.71 0.379 1.11 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3004 1,262.59 1,263.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLcLPGFSGPR 95.00% 2.86 0.404 2 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3011 1,262.59 1,263.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLcLPGFSGPR 95.00% 2.92 0.344 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3017 1,262.59 1,263.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLcLPGFSGPR 95.00% 2.89 0.331 1.19 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3017 1,262.59 1,263.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLcLPGFSGPR 95.00% 2.86 0.367 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3022 1,262.59 1,263.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLcLPGFSGPR 95.00% 2.93 0.433 1.8 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3022 1,262.59 1,263.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLcLPGFSGPR 95.00% 2.73 0.362 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3025 1,262.59 1,263.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLcLPGFSGPR 95.00% 2.59 0.362 2.62 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3031 1,262.59 1,263.60 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AmDFNGILTIR 95.00% 3.16 0.12 0 m2: Oxidation (+15.99) 633.8266 1,265.64 1,266.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AmDFNGILTIR 95.00% 2.64 0.397 1.14 m2: Oxidation (+15.99) 633.8275 1,265.64 1,266.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AmDFNGILTIR 95.00% 3 0.461 1.74 m2: Oxidation (+15.99) 633.8283 1,265.64 1,266.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AmDFNGILTIR 95.00% 3.37 0.482 3.37 m2: Oxidation (+15.99) 633.8285 1,265.64 1,266.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AmDFNGILTIR 95.00% 3.93 0.492 3.17 m2: Oxidation (+15.99) 633.8291 1,265.64 1,266.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AmDFNGILTIR 95.00% 3.34 0.372 2.49 m2: Oxidation (+15.99) 633.8294 1,265.64 1,266.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRFDQPDDFK 95.00% 2.58 0.47 1.38 640.8155 1,279.62 1,280.63 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRFDQPDDFK 95.00% 2.5 0.343 0 640.8157 1,279.62 1,280.63 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRFDQPDDFK 95.00% 2.62 0.361 0 640.817 1,279.62 1,280.63 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRFDQPDDFK 95.00% 2.65 0.439 0 640.8175 1,279.62 1,280.63 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% QPDFISFGLVGGRPEFR 95.00% 2.44 0.471 1.28 641.3361 1,920.98 1,921.99 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% QPDFISFGLVGGRPEFR 95.00% 2.66 0.392 0 641.669 1,921.98 1,921.99 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% QPDFISFGLVGGRPEFR 95.00% 2.54 0.451 1.72 641.6698 1,921.99 1,921.99 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% QPDFISFGLVGGRPEFR 95.00% 2.66 0.429 1.66 641.6706 1,921.99 1,921.99 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRLPQVSPADSGEYVcR 95.00% 5.45 0.634 5.54 c16: Carbamidomethyl (+57.02) 649.6622 1,945.96 1,946.98 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRLPQVSPADSGEYVcR 95.00% 5.35 0.627 5.85 c16: Carbamidomethyl (+57.02) 649.6626 1,945.96 1,946.98 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRLPQVSPADSGEYVcR 95.00% 5.51 0.594 6.74 c16: Carbamidomethyl (+57.02) 649.6635 1,945.97 1,946.98 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRLPQVSPADSGEYVcR 95.00% 4.79 0.573 5.05 c16: Carbamidomethyl (+57.02) 649.9941 1,946.96 1,946.98 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRLPQVSPADSGEYVcR 95.00% 5.09 0.563 4.44 c16: Carbamidomethyl (+57.02) 649.9955 1,946.96 1,946.98 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRLPQVSPADSGEYVcR 95.00% 5.74 0.635 3.74 c16: Carbamidomethyl (+57.02) 649.996 1,946.96 1,946.98 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRLPQVSPADSGEYVcR 95.00% 5.55 0.617 5.24 c16: Carbamidomethyl (+57.02) 649.997 1,946.97 1,946.98 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRLPQVSPADSGEYVcR 95.00% 5.79 0.577 4.96 c16: Carbamidomethyl (+57.02) 649.9972 1,946.97 1,946.98 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VVGSSGTQEASVLVTIQQR 95.00% 4.78 0.378 0 653.688 1,958.04 1,959.05 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VVGSSGTQEASVLVTIQQR 95.00% 4.89 0.439 0 653.6884 1,958.04 1,959.05 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VVGSSGTQEASVLVTIQQR 95.00% 4.9 0.331 0 654.0225 1,959.04 1,959.05 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VVGSSGTQEASVLVTIQQR 95.00% 4.53 0.402 0 654.0229 1,959.05 1,959.05 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LNWGHIPSHPR 95.00% 2.49 0.364 2.55 657.3462 1,312.68 1,313.69 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LNWGHIPSHPR 95.00% 3.11 0.42 2.28 657.347 1,312.68 1,313.69 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIEYSPQLEDAGSREFR 95.00% 1.82 0.312 0 662.319 1,983.93 1,983.94 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ITFRPDSADGMLLYNGQK 95.00% 4.46 0.426 0 676.3402 2,026.00 2,026.01 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ITFRPDSADGMLLYNGQK 95.00% 4.07 0.39 0 676.3411 2,026.00 2,026.01 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ITFRPDSADGMLLYNGQK 95.00% 3.71 0.402 0 676.3411 2,026.00 2,026.01 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ITFRPDSADGMLLYNGQK 95.00% 3.98 0.432 0 676.3412 2,026.00 2,026.01 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ITFRPDSADGMLLYNGQK 95.00% 2.59 0.275 0 676.3414 2,026.00 2,026.01 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% TPSGLYLGTcER 95.00% 3.05 0.511 2.8 c10: Carbamidomethyl (+57.02) 677.325 1,352.63 1,353.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% TPSGLYLGTcER 95.00% 4.01 0.392 2.68 c10: Carbamidomethyl (+57.02) 677.3253 1,352.63 1,353.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% TPSGLYLGTcER 95.00% 4.3 0.387 4.51 c10: Carbamidomethyl (+57.02) 677.3263 1,352.64 1,353.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% TPSGLYLGTcER 95.00% 3.05 0.47 3.46 c10: Carbamidomethyl (+57.02) 677.3268 1,352.64 1,353.65 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% DVKESDQGAYTcEAMNAR 95.00% 4.89 0.401 3.55 c12: Carbamidomethyl (+57.02) 682.2947 2,043.86 2,044.87 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% DVKESDQGAYTcEAMNAR 95.00% 4.05 0.432 0 c12: Carbamidomethyl (+57.02) 682.6278 2,044.86 2,044.87 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% DVKESDQGAYTcEAMNAR 95.00% 4.93 0.461 4.14 c12: Carbamidomethyl (+57.02) 682.6287 2,044.86 2,044.87 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GMLEPVQRPDVVLVGAGYR 95.00% 2.1 0.317 0 686.371 2,056.09 2,056.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GMLEPVQRPDVVLVGAGYR 95.00% 2.95 0.473 1 686.3733 2,056.10 2,056.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% PSDAGTYVcLAQNALGTAQK 95.00% 4.28 0.497 0 c9: Carbamidomethyl (+57.02) 689.0034 2,063.99 2,065.00 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% PSDAGTYVcLAQNALGTAQK 95.00% 5.5 0.446 0 c9: Carbamidomethyl (+57.02) 689.3386 2,064.99 2,065.00 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% PSDAGTYVcLAQNALGTAQK 95.00% 5.05 0.404 0 c9: Carbamidomethyl (+57.02) 689.3386 2,064.99 2,065.00 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GmLEPVQRPDVVLVGAGYR 95.00% 2.23 0.307 1.43 m2: Oxidation (+15.99) 691.7009 2,072.08 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GmLEPVQRPDVVLVGAGYR 95.00% 3.6 0.419 3.13 m2: Oxidation (+15.99) 691.7021 2,072.08 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GmLEPVQRPDVVLVGAGYR 95.00% 4.16 0.559 2.35 m2: Oxidation (+15.99) 691.7039 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GmLEPVQRPDVVLVGAGYR 95.00% 4.56 0.574 3.38 m2: Oxidation (+15.99) 691.7042 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GmLEPVQRPDVVLVGAGYR 95.00% 4.4 0.599 3.92 m2: Oxidation (+15.99) 691.7043 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RcEScAPGYEGNPIQPGGK 95.00% 4.29 0.535 3.3 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 692.9783 2,075.91 2,076.92 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RcEScAPGYEGNPIQPGGK 95.00% 3.99 0.389 2.57 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.313 2,076.92 2,076.92 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ATATScRPcPcPYIDASR 95.00% 3.31 0.464 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.9767 2,081.91 2,082.92 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ATATScRPcPcPYIDASR 95.00% 3.56 0.451 1.22 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.9768 2,081.91 2,082.92 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ATATScRPcPcPYIDASR 95.00% 3.49 0.386 2.47 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3077 2,082.90 2,082.92 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ATATScRPcPcPYIDASR 95.00% 2.53 0.319 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3093 2,082.90 2,082.92 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ATATScRPcPcPYIDASR 95.00% 4.04 0.473 2.48 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3101 2,082.91 2,082.92 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ATATScRPcPcPYIDASR 95.00% 4.31 0.41 2.74 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3102 2,082.91 2,082.92 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ATATScRPcPcPYIDASR 95.00% 2.32 0.169 1.07 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3109 2,082.91 2,082.92 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AVTLEcVSAGEPR 95.00% 2.45 0.25 2.51 c6: Carbamidomethyl (+57.02) 695.347 1,388.68 1,388.68 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AVTLEcVSAGEPR 95.00% 2.3 0.215 2.72 c6: Carbamidomethyl (+57.02) 695.3486 1,388.68 1,388.68 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IPGDQVVSVVFIK 95.00% 3.27 0.503 2.54 700.9095 1,399.80 1,400.82 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IPGDQVVSVVFIK 95.00% 4.44 0.556 2.92 700.9099 1,399.80 1,400.82 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IPGDQVVSVVFIK 95.00% 4.13 0.551 3.41 700.9104 1,399.81 1,400.82 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IPGDQVVSVVFIK 95.00% 4.49 0.494 3.47 700.9107 1,399.81 1,400.82 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IPGDQVVSVVFIK 95.00% 4.53 0.538 2.37 700.9107 1,399.81 1,400.82 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SKSPAYTLVWTR 95.00% 2.23 0.387 1.4 705.3869 1,408.76 1,408.76 2 TENA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IAHVELADAGQYR 95.00% 4.53 0.522 4.1 721.8722 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IAHVELADAGQYR 95.00% 4.43 0.522 3.4 721.8725 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IAHVELADAGQYR 95.00% 4.18 0.512 4.85 721.8731 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IAHVELADAGQYR 95.00% 4.45 0.515 4.72 721.8739 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IAHVELADAGQYR 95.00% 3.43 0.474 4.07 721.8741 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IAHVELADAGQYR 95.00% 4.47 0.495 3.4 721.8741 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cPPGYIGLScQDcAPGYTR 95.00% 4.64 0.503 2.24 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 724.649 2,170.92 2,171.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cPPGYIGLScQDcAPGYTR 95.00% 2.52 0.33 0 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 724.9825 2,171.92 2,171.93 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LSGSHSQGVAYPVR 95.00% 3.46 0.489 3.51 729.3646 1,456.71 1,457.75 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LSGSHSQGVAYPVR 95.00% 3.8 0.484 3.54 729.3658 1,456.72 1,457.75 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LSGSHSQGVAYPVR 95.00% 4.33 0.609 3.74 729.3783 1,456.74 1,457.75 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LSGSHSQGVAYPVR 95.00% 3.86 0.53 4.8 729.8802 1,457.74 1,457.75 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% DGFKGDLcEHEENPcQLR 95.00% 4.15 0.298 0 c8: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 735.6542 2,203.94 2,203.95 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% DGFKGDLcEHEENPcQLR 95.00% 3.71 0.372 1.14 c8: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 735.6554 2,203.94 2,203.95 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RPEEVcGPTQFR 95.00% 3.66 0.446 6.1 c6: Carbamidomethyl (+57.02) 738.3548 1,474.69 1,475.71 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RPEEVcGPTQFR 95.00% 3.51 0.373 4.96 c6: Carbamidomethyl (+57.02) 738.8584 1,475.70 1,475.71 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cPIGYSGLScEScDAHFTR 95.00% 4.38 0.526 3.03 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 739.9791 2,216.91 2,216.92 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPVISIDPPSSTVQQGQDASFK 95.00% 4.39 0.514 2.7 763.7185 2,288.13 2,288.14 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPVISIDPPSSTVQQGQDASFK 95.00% 4.63 0.444 1.51 763.719 2,288.13 2,288.14 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPVISIDPPSSTVQQGQDASFK 95.00% 4.28 0.501 1.66 763.7202 2,288.14 2,288.14 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPVISIDPPSSTVQQGQDASFK 95.00% 3.02 0.331 0 763.7212 2,288.14 2,288.14 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cDGDFDcEDRTDEANcPTK 95.00% 3.78 0.494 1.2 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 769.2867 2,304.84 2,304.84 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cDGDFDcEDRTDEANcPTK 95.00% 3.81 0.392 1.11 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 769.2877 2,304.84 2,304.84 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AELLVTEAPSKPITVTVEEQR 95.00% 2.43 0.283 0 770.9049 2,309.69 2,310.26 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AELLVTEAPSKPITVTVEEQR 95.00% 6.87 0.627 2.96 771.0889 2,310.24 2,310.26 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AELLVTEAPSKPITVTVEEQR 95.00% 6.68 0.641 2.55 771.0898 2,310.25 2,310.26 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AELLVTEAPSKPITVTVEEQR 95.00% 7.1 0.653 3.21 771.09 2,310.25 2,310.26 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AELLVTEAPSKPITVTVEEQR 95.00% 6.18 0.589 3.02 771.0903 2,310.25 2,310.26 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AELLVTEAPSKPITVTVEEQR 95.00% 6.29 0.633 2.64 771.0912 2,310.25 2,310.26 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AELLVTEAPSKPITVTVEEQR 95.00% 6.2 0.613 2.51 771.0917 2,310.25 2,310.26 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIEYSPQLEDAGSR 95.00% 4.31 0.62 5.4 776.3672 1,550.72 1,551.73 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIEYSPQLEDAGSR 95.00% 4.36 0.62 4.32 776.3675 1,550.72 1,551.73 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIEYSPQLEDAGSR 95.00% 4.61 0.586 3.66 776.369 1,550.72 1,551.73 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIEYSPQLEDAGSR 95.00% 4.48 0.574 3.66 776.8692 1,551.72 1,551.73 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% QVQFSEEHWVHESGRPVQR 95.00% 2.89 0.483 1.35 779.3853 2,335.13 2,335.13 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% MASVGLSDIAMDTTVTHATSHGR 95.00% 3.54 0.53 3.96 787.0442 2,358.11 2,358.12 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% MASVGLSDIAMDTTVTHATSHGR 95.00% 3.4 0.449 1.8 787.0448 2,358.11 2,358.12 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% MASVGLSDIAMDTTVTHATSHGR 95.00% 3.13 0.419 1.27 787.0466 2,358.12 2,358.12 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPAPTIHWSK 95.00% 0 0 4.15 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 791.8691 1,581.72 1,582.73 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.09 0.496 4.54 c18: Carbamidomethyl (+57.02) 792.0679 2,373.18 2,374.19 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.84 0.579 3.92 c18: Carbamidomethyl (+57.02) 792.4025 2,374.18 2,374.19 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 6.34 0.531 3.38 c18: Carbamidomethyl (+57.02) 792.4037 2,374.19 2,374.19 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPAPTIHWSK 95.00% 3.74 0.565 5.09 c1: Carbamidomethyl (+57.02) 800.382 1,598.75 1,599.76 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPAPTIHWSK 95.00% 3.45 0.528 4.52 c1: Carbamidomethyl (+57.02) 800.3828 1,598.75 1,599.76 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPAPTIHWSK 95.00% 2.14 0.277 1.57 c1: Carbamidomethyl (+57.02) 800.3852 1,598.75 1,599.76 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IPQVTPADSGEYVcHVSNGAGSR 95.00% 3.11 0.328 2.29 c14: Carbamidomethyl (+57.02) 801.3738 2,401.10 2,401.12 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SLPEVPETIELEVR 95.00% 2.83 0.34 6.44 805.9341 1,609.85 1,610.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SLPEVPETIELEVR 95.00% 3.48 0.613 5.35 805.9351 1,609.85 1,610.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SLPEVPETIELEVR 95.00% 3.61 0.665 5.14 805.9357 1,609.86 1,610.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SLPEVPETIELEVR 95.00% 3.04 0.211 5.09 806.4349 1,610.85 1,610.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EQAWQRPDGQPATR 95.00% 2.8 0.252 0 820.3999 1,638.78 1,639.79 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LVSEDPINDGEWHR 95.00% 3.77 0.545 2.8 833.8999 1,665.78 1,666.78 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LVSEDPINDGEWHR 95.00% 3.58 0.47 2.72 834.3991 1,666.78 1,666.78 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPQVSPADSGEYVcR 95.00% 4.23 0.532 5.54 c14: Carbamidomethyl (+57.02) 839.3988 1,676.78 1,677.79 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPQVSPADSGEYVcR 95.00% 4.97 0.578 6.14 c14: Carbamidomethyl (+57.02) 839.399 1,676.78 1,677.79 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPQVSPADSGEYVcR 95.00% 4.9 0.54 5.85 c14: Carbamidomethyl (+57.02) 839.3994 1,676.78 1,677.79 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPQVSPADSGEYVcR 95.00% 5.05 0.578 6.4 c14: Carbamidomethyl (+57.02) 839.9005 1,677.79 1,677.79 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 3.52 0.435 2.19 844.4885 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 3.17 0.417 1.8 844.4898 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VGGHLRPGIVQSGGVVR 95.00% 3.59 0.445 1.25 844.9911 1,687.97 1,687.97 2 ATPA_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GSVYIGGAPDVATLTGGR 95.00% 4.81 0.508 5.33 845.9388 1,689.86 1,690.88 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GSVYIGGAPDVATLTGGR 95.00% 4.59 0.581 5.62 845.9414 1,689.87 1,690.88 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GSVYIGGAPDVATLTGGR 95.00% 4.84 0.544 6.26 845.9417 1,689.87 1,690.88 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% GSVYIGGAPDVATLTGGR 95.00% 4.95 0.516 4.89 845.9421 1,689.87 1,690.88 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ESDQGAYTcEAMNAR 95.00% 4.25 0.533 2.92 c9: Carbamidomethyl (+57.02) 851.8385 1,701.66 1,702.68 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ESDQGAYTcEAMNAR 95.00% 4.4 0.585 2.92 c9: Carbamidomethyl (+57.02) 851.8413 1,701.67 1,702.68 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ESDQGAYTcEAMNAR 95.00% 4.3 0.54 2.49 c9: Carbamidomethyl (+57.02) 851.8427 1,701.67 1,702.68 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ESDQGAYTcEAMNAR 95.00% 4.09 0.546 2.6 c9: Carbamidomethyl (+57.02) 851.8435 1,701.67 1,702.68 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHLVSPADSGEYVcR 95.00% 3.75 0.39 3.92 c14: Carbamidomethyl (+57.02) 851.9129 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LHLVSPADSGEYVcR 95.00% 3.75 0.424 5.19 c14: Carbamidomethyl (+57.02) 851.9134 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ESDQGAYTcEAMNAR 95.00% 4.28 0.548 3.55 c9: Carbamidomethyl (+57.02) 852.3463 1,702.68 1,702.68 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ESDQGAYTcEAMNAR 95.00% 4.26 0.48 2.96 c9: Carbamidomethyl (+57.02) 852.3465 1,702.68 1,702.68 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.23 0.646 5.39 853.4451 2,557.31 2,557.33 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRSPVISIDPPSSTVQQGQDASFK 95.00% 7.01 0.661 4.16 853.446 2,557.31 2,557.33 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6.71 0.617 5.26 853.4463 2,557.32 2,557.33 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRSPVISIDPPSSTVQQGQDASFK 95.00% 5.64 0.604 4.09 853.4468 2,557.32 2,557.33 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRSPVISIDPPSSTVQQGQDASFK 95.00% 7.07 0.626 5.26 853.4469 2,557.32 2,557.33 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRSPVISIDPPSSTVQQGQDASFK 95.00% 7.03 0.658 4.43 853.4487 2,557.32 2,557.33 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IQVVVLSASDASPPPVK 95.00% 3.74 0.398 3.77 853.9869 1,705.96 1,706.97 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LLQVTPADSGEYVcR 95.00% 4.36 0.338 4.04 c14: Carbamidomethyl (+57.02) 854.4117 1,706.81 1,707.84 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LLQVTPADSGEYVcR 95.00% 4.24 0.305 3.48 c14: Carbamidomethyl (+57.02) 854.4153 1,706.82 1,707.84 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LLQVTPADSGEYVcR 95.00% 4.09 0.384 4.6 c14: Carbamidomethyl (+57.02) 854.4178 1,706.82 1,707.84 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LLQVTPADSGEYVcR 95.00% 4.37 0.632 6.06 c14: Carbamidomethyl (+57.02) 854.4195 1,706.82 1,707.84 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LLQVTPADSGEYVcR 95.00% 4.35 0.649 5.7 c14: Carbamidomethyl (+57.02) 854.4204 1,706.83 1,707.84 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IQVVVLSASDASPPPVK 95.00% 4.27 0.497 5.44 854.485 1,706.95 1,706.97 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IQVVVLSASDASPPPVK 95.00% 3.76 0.296 5.72 854.4908 1,706.97 1,706.97 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.4 0.51 1.92 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7269 2,561.16 2,561.17 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.14 0.519 1.48 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7281 2,561.16 2,561.17 3
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LLQVTPADSGEYVcR 95.00% 4.32 0.289 4.41 c14: Carbamidomethyl (+57.02) 854.9137 1,707.81 1,707.84 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LLQVTPADSGEYVcR 95.00% 4.3 0.544 4.46 c14: Carbamidomethyl (+57.02) 854.919 1,707.82 1,707.84 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLIHDGAAPISLEWK 95.00% 4.67 0.588 6.16 c1: Carbamidomethyl (+57.02) 855.4361 1,708.86 1,709.87 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLIHDGAAPISLEWK 95.00% 4.65 0.618 4.96 c1: Carbamidomethyl (+57.02) 855.437 1,708.86 1,709.87 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLIHDGAAPISLEWK 95.00% 3.69 0.0721 1.89 c1: Carbamidomethyl (+57.02) 855.4372 1,708.86 1,709.87 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cLIHDGAAPISLEWK 95.00% 4.09 0.0572 3.51 c1: Carbamidomethyl (+57.02) 855.9377 1,709.86 1,709.87 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LYQASPADSGEYVcR 95.00% 4.82 0.597 3.47 c14: Carbamidomethyl (+57.02) 858.3866 1,714.76 1,715.77 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LYQASPADSGEYVcR 95.00% 4.38 0.558 3.14 c14: Carbamidomethyl (+57.02) 858.3868 1,714.76 1,715.77 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cVVPGQAHAQVTWHK 95.00% 2.73 0.399 0 c1: Carbamidomethyl (+57.02) 858.8486 1,715.68 1,717.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIGASVEFHcAVPSDR 95.00% 3.62 0.394 2.96 c10: Carbamidomethyl (+57.02) 866.4034 1,730.79 1,731.81 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIGASVEFHcAVPSDR 95.00% 3.9 0.352 2.85 c10: Carbamidomethyl (+57.02) 866.409 1,730.80 1,731.81 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIGASVEFHcAVPSDR 95.00% 4.39 0.389 3.11 c10: Carbamidomethyl (+57.02) 866.4105 1,730.81 1,731.81 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SIGASVEFHcAVPSDR 95.00% 4.6 0.446 2.19 c10: Carbamidomethyl (+57.02) 866.9129 1,731.81 1,731.81 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EGGQLPPGHSVQDGVLR 95.00% 3.41 0.502 4.49 873.4488 1,744.88 1,745.89 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EGGQLPPGHSVQDGVLR 95.00% 3.52 0.475 6.01 873.4521 1,744.89 1,745.89 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EGGQLPPGHSVQDGVLR 95.00% 3.8 0.452 2.39 873.9531 1,745.89 1,745.89 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.92 0.56 6.11 c14: Carbamidomethyl (+57.02) 880.9328 1,759.85 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.29 0.518 4.57 c14: Carbamidomethyl (+57.02) 880.9329 1,759.85 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 5.26 0.606 5.17 c14: Carbamidomethyl (+57.02) 880.9335 1,759.85 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.92 0.609 5.89 c14: Carbamidomethyl (+57.02) 880.9337 1,759.85 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 5.04 0.555 6.6 c14: Carbamidomethyl (+57.02) 880.9339 1,759.85 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.91 0.55 4.68 c14: Carbamidomethyl (+57.02) 880.934 1,759.85 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.91 0.528 3.89 c14: Carbamidomethyl (+57.02) 880.9341 1,759.85 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.85 0.538 7.72 c14: Carbamidomethyl (+57.02) 880.9342 1,759.85 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.9 0.577 4.48 c14: Carbamidomethyl (+57.02) 880.9343 1,759.85 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 3.93 0.488 2.66 c14: Carbamidomethyl (+57.02) 881.4339 1,760.85 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.69 0.534 3.77 c14: Carbamidomethyl (+57.02) 881.4347 1,760.85 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.42 0.509 3.77 c14: Carbamidomethyl (+57.02) 881.4353 1,760.85 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LPAVEPTDQAQYLcR 95.00% 4.55 0.466 3.62 c14: Carbamidomethyl (+57.02) 881.4367 1,760.86 1,760.86 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LcNEcADGSFHLSTR 95.00% 5.07 0.62 4.23 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8816 1,765.75 1,766.76 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LcNEcADGSFHLSTR 95.00% 5.22 0.607 4.66 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8823 1,765.75 1,766.76 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LcNEcADGSFHLSTR 95.00% 2.98 0.251 1.54 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.9 1,765.78 1,766.76 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LcNEcADGSFHLSTR 95.00% 5.16 0.606 4.7 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.3828 1,766.75 1,766.76 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LcNEcADGSFHLSTR 95.00% 5.12 0.628 3.74 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.3836 1,766.75 1,766.76 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EVSEAVVDTLESEYLK 95.00% 5.85 0.515 4.85 905.9491 1,809.88 1,810.90 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EVSEAVVDTLESEYLK 95.00% 5.63 0.55 6.41 905.9494 1,809.88 1,810.90 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EVSEAVVDTLESEYLK 95.00% 5.57 0.525 6.09 905.95 1,809.88 1,810.90 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% EVSEAVVDTLESEYLK 95.00% 6.23 0.51 6.26 906.4531 1,810.89 1,810.90 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SDEFGcMPPQVVTPPR 95.00% 3.88 0.548 2.3 c6: Carbamidomethyl (+57.02) 908.9203 1,815.83 1,816.84 2 ANXA5_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SDEFGcMPPQVVTPPR 95.00% 4.23 0.499 3.37 c6: Carbamidomethyl (+57.02) 908.9205 1,815.83 1,816.84 2 ANXA5_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 3.98 0.347 4.68 c14: Carbamidomethyl (+57.02) 918.966 1,835.92 1,836.93 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 3.21 0.357 2.89 c14: Carbamidomethyl (+57.02) 918.9674 1,835.92 1,836.93 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 3.89 0.341 3.16 c14: Carbamidomethyl (+57.02) 918.9674 1,835.92 1,836.93 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 2.96 0.282 2.96 c14: Carbamidomethyl (+57.02) 918.9679 1,835.92 1,836.93 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 4.33 0.341 5 c14: Carbamidomethyl (+57.02) 919.4672 1,836.92 1,836.93 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SQSVRPGADVTFIcTAK 95.00% 4.19 0.385 5.01 c14: Carbamidomethyl (+57.02) 919.4709 1,836.93 1,836.93 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cQVSGSPPHYFYWSR 95.00% 4.22 0.548 2.23 c1: Carbamidomethyl (+57.02) 935.914 1,869.81 1,870.83 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cQVSGSPPHYFYWSR 95.00% 4.04 0.566 3.51 c1: Carbamidomethyl (+57.02) 935.9199 1,869.82 1,870.83 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cQVSGSPPHYFYWSR 95.00% 4.54 0.591 3.43 c1: Carbamidomethyl (+57.02) 935.9207 1,869.83 1,870.83 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cQVSGSPPHYFYWSR 95.00% 4.52 0.567 3.77 c1: Carbamidomethyl (+57.02) 936.4211 1,870.83 1,870.83 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cEScAPGYEGNPIQPGGK 95.00% 4.78 0.485 6.15 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 960.9132 1,919.81 1,920.82 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cEScAPGYEGNPIQPGGK 95.00% 4.44 0.427 4.05 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 961.4144 1,920.81 1,920.82 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cAPGYYGNPSQGQPcQR 95.00% 4.01 0.581 4.36 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9101 1,939.80 1,939.82 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cAPGYYGNPSQGQPcQR 95.00% 4.86 0.635 5.36 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9135 1,939.81 1,939.82 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cAPGYYGNPSQGQPcQR 95.00% 4.75 0.589 5.51 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9137 1,939.81 1,939.82 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cAPGYYGNPSQGQPcQR 95.00% 4.85 0.643 5.48 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9142 1,939.81 1,939.82 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cAPGYYGNPSQGQPcQR 95.00% 4.83 0.619 5.92 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9143 1,939.81 1,939.82 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRLPQVSPADSGEYVcR 95.00% 4.95 0.574 5.96 c16: Carbamidomethyl (+57.02) 973.9889 1,945.96 1,946.98 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRLPQVSPADSGEYVcR 95.00% 4.71 0.509 5.15 c16: Carbamidomethyl (+57.02) 973.9904 1,945.97 1,946.98 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRLPQVSPADSGEYVcR 95.00% 4.93 0.587 4.72 c16: Carbamidomethyl (+57.02) 974.4923 1,946.97 1,946.98 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LRLPQVSPADSGEYVcR 95.00% 4.93 0.584 5.82 c16: Carbamidomethyl (+57.02) 974.4926 1,946.97 1,946.98 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LYIFQASPADAGQYVcR 95.00% 4.35 0.58 5.96 c16: Carbamidomethyl (+57.02) 979.9728 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LYIFQASPADAGQYVcR 95.00% 5.69 0.655 6.96 c16: Carbamidomethyl (+57.02) 979.9745 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LYIFQASPADAGQYVcR 95.00% 5.3 0.639 7.11 c16: Carbamidomethyl (+57.02) 979.9751 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LYIFQASPADAGQYVcR 95.00% 6.04 0.583 5.92 c16: Carbamidomethyl (+57.02) 980.4737 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LYIFQASPADAGQYVcR 95.00% 5.86 0.564 6.66 c16: Carbamidomethyl (+57.02) 980.4741 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LYIFQASPADAGQYVcR 95.00% 6.17 0.588 6.22 c16: Carbamidomethyl (+57.02) 980.4743 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LYIFQASPADAGQYVcR 95.00% 5.81 0.552 5.82 c16: Carbamidomethyl (+57.02) 980.4743 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% LYIFQASPADAGQYVcR 95.00% 5.61 0.543 7.89 c16: Carbamidomethyl (+57.02) 980.4758 1,958.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VVGSSGTQEASVLVTIQQR 95.00% 5.52 0.474 3.44 980.5265 1,959.04 1,959.05 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VVGSSGTQEASVLVTIQQR 95.00% 5.48 0.508 3.55 980.5279 1,959.04 1,959.05 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VVGSSGTQEASVLVTIQQR 95.00% 5.25 0.481 3.39 980.5285 1,959.04 1,959.05 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VVGSSGTQEASVLVTIQQR 95.00% 4.36 0.465 1.59 980.5286 1,959.04 1,959.05 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VVGSSGTQEASVLVTIQQR 95.00% 5.11 0.489 3.35 980.5299 1,959.04 1,959.05 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% VVGSSGTQEASVLVTIQQR 95.00% 5.18 0.459 3.21 980.5306 1,959.05 1,959.05 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% DVKESDQGAYTcEAMNAR 95.00% 5.32 0.482 5.44 c12: Carbamidomethyl (+57.02) 1,023.44 2,044.86 2,044.87 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% DVKESDQGAYTcEAMNAR 95.00% 5.69 0.505 6.36 c12: Carbamidomethyl (+57.02) 1,023.44 2,044.86 2,044.87 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% PSDAGTYVcLAQNALGTAQK 95.00% 6.68 0.662 0 c9: Carbamidomethyl (+57.02) 1,033.00 2,063.99 2,065.00 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% PSDAGTYVcLAQNALGTAQK 95.00% 6.68 0.65 0 c9: Carbamidomethyl (+57.02) 1,033.00 2,063.99 2,065.00 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% PSDAGTYVcLAQNALGTAQK 95.00% 6.57 0.584 0 c9: Carbamidomethyl (+57.02) 1,033.50 2,064.99 2,065.00 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RcEScAPGYEGNPIQPGGK 95.00% 5.63 0.625 4.72 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 1,038.96 2,075.91 2,076.92 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% RcEScAPGYEGNPIQPGGK 95.00% 5.14 0.598 3.82 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 1,038.96 2,075.91 2,076.92 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ATATScRPcPcPYIDASR 95.00% 3.88 0.413 2.82 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.90 2,082.92 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ATATScRPcPcPYIDASR 95.00% 3.95 0.421 1.77 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.92 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% ATATScRPcPcPYIDASR 95.00% 3.97 0.445 1.7 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.92 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cPPGYIGLScQDcAPGYTR 95.00% 5.03 0.633 8.46 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.97 2,171.92 2,171.93 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cPPGYIGLScQDcAPGYTR 95.00% 4.86 0.615 8.1 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.97 2,171.92 2,171.93 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cPIGYSGLScEScDAHFTR 95.00% 5.24 0.616 6.12 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,109.46 2,216.91 2,216.92 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cPIGYSGLScEScDAHFTR 95.00% 5.07 0.631 5.85 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,109.46 2,216.91 2,216.92 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPVISIDPPSSTVQQGQDASFK 95.00% 5.96 0.536 12.9 1,145.07 2,288.12 2,288.14 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPVISIDPPSSTVQQGQDASFK 95.00% 6.16 0.531 11.7 1,145.07 2,288.13 2,288.14 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPVISIDPPSSTVQQGQDASFK 95.00% 6.02 0.553 11.3 1,145.08 2,288.13 2,288.14 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPVISIDPPSSTVQQGQDASFK 95.00% 5.96 0.523 11.2 1,145.08 2,288.14 2,288.14 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% SPVISIDPPSSTVQQGQDASFK 95.00% 5.92 0.55 10.9 1,145.08 2,288.14 2,288.14 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AELLVTEAPSKPITVTVEEQR 95.00% 5.64 0.517 5.44 1,156.13 2,310.25 2,310.26 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AELLVTEAPSKPITVTVEEQR 95.00% 5.27 0.514 6.64 1,156.13 2,310.25 2,310.26 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AELLVTEAPSKPITVTVEEQR 95.00% 5.43 0.484 4.2 1,156.13 2,310.25 2,310.26 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.91 0.695 6.66 c1: Carbamidomethyl (+57.02) 1,185.57 2,369.13 2,370.14 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.95 0.716 5.14 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.12 2,370.14 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5.08 0.69 6.64 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 5.22 0.711 6.32 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.68 0.689 6.26 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.8 0.737 5.42 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.67 0.734 7.68 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.25 0.662 4.2 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.61 0.66 4.92 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.41 0.663 4.39 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.14 0.671 4.55 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.39 0.638 4.57 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 3 Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 90 123 504 27.60% AASGPGPEQEASFTVTVPPSEGSSYR 95.00% 3.47 0.466 4.66 1,305.11 2,608.21 2,608.22 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SAEPLALGR 95.00% 2.06 0.331 0 457.2587 912.5018 913.5108 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SAEPLALGR 95.00% 2.39 0.33 1.7 457.259 912.5024 913.5108 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SAEPLALGR 95.00% 2.19 0.312 0 457.2597 912.5038 913.5108 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SAEPLALGR 95.00% 2.34 0.373 0 457.26 912.5043 913.5108 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SAEPLALGR 95.00% 2.27 0.337 0 457.26 912.5044 913.5108 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SAEPLALGR 95.00% 2.17 0.335 0 457.2604 912.5051 913.5108 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GHTPTQPGALNQR 95.00% 2.64 0.247 0 459.572 1,375.69 1,376.70 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GHTPTQPGALNQR 95.00% 2.74 0.298 0.959 459.5742 1,375.70 1,376.70 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IPGDQVVSVVFIK 95.00% 3.46 0.347 1.21 467.6102 1,399.81 1,400.82 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IPGDQVVSVVFIK 95.00% 3.17 0.456 2.01 467.6107 1,399.81 1,400.82 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IPGDQVVSVVFIK 95.00% 4.14 0.418 1.41 467.6113 1,399.81 1,400.82 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AGFFGDAmK 95.00% 2.72 0.283 0 m8: Oxidation (+15.99) 480.2184 958.4212 959.4298 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IAHVELADAGQYR 95.00% 3.58 0.524 1.59 481.5846 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IAHVELADAGQYR 95.00% 3.96 0.47 0 481.5851 1,441.73 1,442.74 3 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LSGSHSQGVAYPVR 95.00% 3.68 0.399 0 486.5877 1,456.74 1,457.75 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LSGSHSQGVAYPVR 95.00% 3.97 0.413 1.36 486.5877 1,456.74 1,457.75 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RPEEVcGPTQFR 95.00% 2.7 0.435 1 c6: Carbamidomethyl (+57.02) 492.5719 1,474.69 1,475.71 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RPEEVcGPTQFR 95.00% 3.82 0.35 3.02 c6: Carbamidomethyl (+57.02) 492.5723 1,474.69 1,475.71 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RPEEVcGPTQFR 95.00% 3.32 0.383 1.89 c6: Carbamidomethyl (+57.02) 492.5734 1,474.70 1,475.71 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RPEEVcGPTQFR 95.00% 3.84 0.492 1.89 c6: Carbamidomethyl (+57.02) 492.5735 1,474.70 1,475.71 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RPEEVcGPTQFR 95.00% 2.7 0.362 1.42 c6: Carbamidomethyl (+57.02) 492.5742 1,474.70 1,475.71 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDQPDDFK 95.00% 2.51 0.347 0 506.2247 1,010.43 1,011.44 2 LAMA4_HUMAN,SPRL1_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LGTVPQFPR 95.00% 2.2 0.221 2.08 507.7889 1,013.56 1,014.57 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LGTVPQFPR 95.00% 2.32 0.263 2.2 507.7892 1,013.56 1,014.57 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LGTVPQFPR 95.00% 2.43 0.392 1.85 507.7892 1,013.56 1,014.57 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LGTVPQFPR 95.00% 2.18 0.326 2.12 507.7896 1,013.56 1,014.57 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LGTVPQFPR 95.00% 2.03 0.19 1.66 507.7898 1,013.56 1,014.57 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cFcMGVSR 95.00% 2.08 0.308 1.3 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 509.2606 1,016.51 1,016.41 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FLGDKVTSYGGELR 95.00% 3.62 0.484 2.74 514.6022 1,540.78 1,541.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FLGDKVTSYGGELR 95.00% 2.1 0.314 0 514.6025 1,540.78 1,541.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FLGDKVTSYGGELR 95.00% 3.79 0.385 3.1 514.6027 1,540.78 1,541.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FLGDKVTSYGGELR 95.00% 3.64 0.387 3.8 514.6028 1,540.79 1,541.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FLGDKVTSYGGELR 95.00% 4.14 0.411 3.51 514.6029 1,540.79 1,541.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FLGDKVTSYGGELR 95.00% 3.35 0.413 2.31 514.6034 1,540.79 1,541.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIEYSPQLEDAGSR 95.00% 4.22 0.535 0 517.9135 1,550.72 1,551.73 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIEYSPQLEDAGSR 95.00% 3.78 0.396 1.68 517.9145 1,550.72 1,551.73 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FSSGITGcVK 95.00% 2.27 0.306 1.21 c8: Carbamidomethyl (+57.02) 528.2628 1,054.51 1,055.52 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LDGSLPPDSR 95.00% 1.96 0.421 0 528.7682 1,055.52 1,056.53 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LDGSLPPDSR 95.00% 2.34 0.421 1.62 528.7687 1,055.52 1,056.53 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LDGSLPPDSR 95.00% 2.92 0.383 0 528.769 1,055.52 1,056.53 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LDGSLPPDSR 95.00% 2.8 0.448 0 528.7695 1,055.52 1,056.53 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% NELLHFER 95.00% 2.58 0.127 0 529.2743 1,056.53 1,057.54 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPAPTIHWSK 95.00% 3.87 0.551 1.6 c1: Carbamidomethyl (+57.02) 533.9226 1,598.74 1,599.76 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPAPTIHWSK 95.00% 3.79 0.552 1.55 c1: Carbamidomethyl (+57.02) 533.9235 1,598.75 1,599.76 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPAPTIHWSK 95.00% 4.1 0.542 0 c1: Carbamidomethyl (+57.02) 533.9241 1,598.75 1,599.76 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPAPTIHWSK 95.00% 3.97 0.573 1.46 c1: Carbamidomethyl (+57.02) 533.9241 1,598.75 1,599.76 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPAPTIHWSK 95.00% 3.74 0.513 0.959 c1: Carbamidomethyl (+57.02) 533.9244 1,598.75 1,599.76 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RGSIQVDGEELVSGR 95.00% 2.54 0.417 0 534.6131 1,600.82 1,601.82 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VAEGQTLDLK 95.00% 3.39 0.474 3 537.2945 1,072.57 1,073.58 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VAEGQTLDLK 95.00% 3.34 0.499 2.26 537.2949 1,072.57 1,073.58 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VAEGQTLDLK 95.00% 3.46 0.48 2.55 537.2956 1,072.58 1,073.58 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VAEGQTLDLK 95.00% 3.3 0.474 1.4 537.2956 1,072.58 1,073.58 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EQAWQRPDGQPATR 95.00% 2.34 0.26 1.27 547.2681 1,638.78 1,639.79 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EQAWQRPDGQPATR 95.00% 2.41 0.283 0 547.2695 1,638.79 1,639.79 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EQAWQRPDGQPATR 95.00% 2.64 0.27 0 547.2695 1,638.79 1,639.79 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RSYEIMFR 95.00% 2.33 0.162 0 551.2802 1,100.54 1,101.55 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LVSEDPINDGEWHR 95.00% 2.09 0.331 0 556.2645 1,665.77 1,666.78 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LVSEDPINDGEWHR 95.00% 2.14 0.251 0 556.5974 1,666.77 1,666.78 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LVSEDPINDGEWHR 95.00% 3.12 0.499 0 556.5983 1,666.77 1,666.78 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPQVSPADSGEYVcR 95.00% 2.12 0.233 0 c14: Carbamidomethyl (+57.02) 559.9326 1,676.77 1,677.79 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGMATIR 95.00% 2.45 0.377 1.96 563.266 1,124.52 1,125.54 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGMATIR 95.00% 2.48 0.373 2.24 563.2674 1,124.52 1,125.54 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGMATIR 95.00% 3.1 0.397 4.55 563.2688 1,124.52 1,125.54 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGMATIR 95.00% 3.11 0.4 3.25 563.2702 1,124.52 1,125.54 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGMATIR 95.00% 3.15 0.453 4 563.2704 1,124.53 1,125.54 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGMATIR 95.00% 3.16 0.414 4.57 563.2707 1,124.53 1,125.54 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGMATIR 95.00% 2.96 0.459 4.32 563.2708 1,124.53 1,125.54 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGMATIR 95.00% 3.44 0.417 4.24 563.2715 1,124.53 1,125.54 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VPGSPTNLANR 95.00% 2.65 0.379 0 563.3017 1,124.59 1,125.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VPGSPTNLANR 95.00% 3.11 0.578 3.52 563.3026 1,124.59 1,125.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VPGSPTNLANR 95.00% 3.03 0.572 2.54 563.3028 1,124.59 1,125.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VPGSPTNLANR 95.00% 2.85 0.538 2.47 563.3033 1,124.59 1,125.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VPGSPTNLANR 95.00% 3.1 0.56 3.77 563.3033 1,124.59 1,125.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VPGSPTNLANR 95.00% 3.36 0.548 2.82 563.3035 1,124.59 1,125.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VPGSPTNLANR 95.00% 2.71 0.494 3.22 563.3035 1,124.59 1,125.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VPGSPTNLANR 95.00% 2.21 0.5 1.09 563.3038 1,124.59 1,125.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 4.84 0.488 2.46 563.3279 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 4.02 0.381 2.59 563.3281 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 5.39 0.55 2.96 563.3282 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 4.74 0.517 3.51 563.3284 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 4.46 0.491 2.19 563.3284 1,686.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGMATIR 95.00% 1.91 0.25 1.09 563.6292 1,125.24 1,125.54 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 4.05 0.366 2.92 563.6622 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 4.01 0.423 2.46 563.6625 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 4.66 0.435 2.17 563.6627 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 5.31 0.561 3.49 563.6627 1,687.96 1,687.97 3 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 4.39 0.426 3 563.6637 1,687.97 1,687.97 3 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VPGSPTNLANR 95.00% 2.81 0.532 2.21 563.8042 1,125.59 1,125.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LEGDTLIIPR 95.00% 3.66 0.412 1.89 563.8257 1,125.64 1,126.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LEGDTLIIPR 95.00% 3.64 0.389 2.92 563.8262 1,125.64 1,126.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LEGDTLIIPR 95.00% 2.21 0.329 2.55 563.8264 1,125.64 1,126.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ESDQGAYTcEAMNAR 95.00% 2.46 0.255 0 c9: Carbamidomethyl (+57.02) 568.2303 1,701.67 1,702.68 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 4.97 0.487 3.7 c14: Carbamidomethyl (+57.02) 568.2767 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 3.3 0.504 2.09 c14: Carbamidomethyl (+57.02) 568.2783 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 2.45 0.328 0 c14: Carbamidomethyl (+57.02) 568.2786 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 4.51 0.398 4.89 c14: Carbamidomethyl (+57.02) 568.2787 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 4.34 0.442 3.06 c14: Carbamidomethyl (+57.02) 568.2792 1,701.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 3.4 0.514 2.07 c14: Carbamidomethyl (+57.02) 568.6122 1,702.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 4.83 0.551 4.12 c14: Carbamidomethyl (+57.02) 568.6124 1,702.81 1,702.82 3 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IQVVVLSASDASPPPVK 95.00% 3.92 0.453 4.31 569.6607 1,705.96 1,706.97 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IQVVVLSASDASPPPVK 95.00% 3.71 0.417 5.96 569.6617 1,705.96 1,706.97 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IQVVVLSASDASPPPVK 95.00% 4.16 0.452 5.89 569.6617 1,705.96 1,706.97 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IQVVVLSASDASPPPVK 95.00% 4.05 0.434 4.74 569.6619 1,705.96 1,706.97 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LLQVTPADSGEYVcR 95.00% 4.28 0.53 1.82 c14: Carbamidomethyl (+57.02) 569.9495 1,706.82 1,707.84 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LLQVTPADSGEYVcR 95.00% 5.1 0.563 2.05 c14: Carbamidomethyl (+57.02) 569.9503 1,706.83 1,707.84 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IQVVVLSASDASPPPVK 95.00% 4.63 0.453 5.43 569.994 1,706.96 1,706.97 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLIHDGAAPISLEWK 95.00% 3.16 0.334 1.14 c1: Carbamidomethyl (+57.02) 570.627 1,708.86 1,709.87 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLIHDGAAPISLEWK 95.00% 3.02 0.273 0 c1: Carbamidomethyl (+57.02) 570.9609 1,709.86 1,709.87 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLIHDGAAPISLEWK 95.00% 2.79 0.164 0 c1: Carbamidomethyl (+57.02) 570.9611 1,709.86 1,709.87 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLIHDGAAPISLEWK 95.00% 2.48 0.211 0 c1: Carbamidomethyl (+57.02) 570.9612 1,709.86 1,709.87 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGmATIR 95.00% 2.57 0.373 2.8 m7: Oxidation (+15.99) 571.2678 1,140.52 1,141.53 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGmATIR 95.00% 2.52 0.342 2.57 m7: Oxidation (+15.99) 571.2683 1,140.52 1,141.53 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGmATIR 95.00% 2.42 0.368 2.92 m7: Oxidation (+15.99) 571.2686 1,140.52 1,141.53 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% FDAGSGmATIR 95.00% 2.85 0.396 2.8 m7: Oxidation (+15.99) 571.2699 1,140.52 1,141.53 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LYQASPADSGEYVcR 95.00% 4.51 0.52 3.1 c14: Carbamidomethyl (+57.02) 572.9287 1,715.76 1,715.77 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LYQASPADSGEYVcR 95.00% 3.59 0.312 0 c14: Carbamidomethyl (+57.02) 572.929 1,715.76 1,715.77 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHHVSPADSGEYVcR 95.00% 5.49 0.479 1.57 c14: Carbamidomethyl (+57.02) 576.2673 1,725.78 1,726.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHHVSPADSGEYVcR 95.00% 3.96 0.361 0.959 c14: Carbamidomethyl (+57.02) 576.2693 1,725.78 1,726.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHHVSPADSGEYVcR 95.00% 5.29 0.385 1.72 c14: Carbamidomethyl (+57.02) 576.2701 1,725.79 1,726.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHHVSPADSGEYVcR 95.00% 4.77 0.397 1.8 c14: Carbamidomethyl (+57.02) 576.2707 1,725.79 1,726.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHHVSPADSGEYVcR 95.00% 5.41 0.488 1.77 c14: Carbamidomethyl (+57.02) 576.2717 1,725.79 1,726.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHHVSPADSGEYVcR 95.00% 4.5 0.353 1.19 c14: Carbamidomethyl (+57.02) 576.6041 1,726.79 1,726.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHHVSPADSGEYVcR 95.00% 4.78 0.418 2.33 c14: Carbamidomethyl (+57.02) 576.6042 1,726.79 1,726.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHHVSPADSGEYVcR 95.00% 4.45 0.409 3.96 c14: Carbamidomethyl (+57.02) 576.6049 1,726.79 1,726.80 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIGASVEFHcAVPSDR 95.00% 2.64 0.336 0 c10: Carbamidomethyl (+57.02) 577.9413 1,730.80 1,731.81 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIGASVEFHcAVPSDR 95.00% 2.48 0.101 1.2 c10: Carbamidomethyl (+57.02) 577.9417 1,730.80 1,731.81 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIGASVEFHcAVPSDR 95.00% 2.47 0.292 0 c10: Carbamidomethyl (+57.02) 577.9419 1,730.80 1,731.81 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EGGQLPPGHSVQDGVLR 95.00% 2.12 0.179 1.49 582.6364 1,744.89 1,745.89 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EGGQLPPGHSVQDGVLR 95.00% 2.24 0.125 2.77 582.6365 1,744.89 1,745.89 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EGGQLPPGHSVQDGVLR 95.00% 2.27 0.288 0 582.6373 1,744.89 1,745.89 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EGGQLPPGHSVQDGVLR 95.00% 2.38 0.14 1.37 582.9701 1,745.89 1,745.89 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AFAHLQVPER 95.00% 2.59 0.106 1.55 583.7995 1,165.58 1,167.63 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AFAHLQVPER 95.00% 3.19 0.368 2.33 584.3164 1,166.62 1,167.63 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AFAHLQVPER 95.00% 3.2 0.384 2 584.317 1,166.62 1,167.63 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AFAHLQVPER 95.00% 3.17 0.386 2.49 584.317 1,166.62 1,167.63 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AFAHLQVPER 95.00% 3.16 0.368 2.17 584.3175 1,166.62 1,167.63 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHQMSVADSGEYVcR 95.00% 4.11 0.493 0 c14: Carbamidomethyl (+57.02) 584.5997 1,750.78 1,751.78 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHQMSVADSGEYVcR 95.00% 3.99 0.392 0 c14: Carbamidomethyl (+57.02) 584.9328 1,751.77 1,751.78 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GDLcEHEENPcQLR 95.00% 3.6 0.263 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.5843 1,756.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GDLcEHEENPcQLR 95.00% 3.68 0.273 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.5845 1,756.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GDLcEHEENPcQLR 95.00% 3.59 0.241 0 c4: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 586.5847 1,756.73 1,756.74 3 NID1_HUMAN,DESP_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 2.97 0.149 0 c14: Carbamidomethyl (+57.02) 587.6249 1,759.85 1,760.86 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.38 0.512 1.96 c14: Carbamidomethyl (+57.02) 587.6253 1,759.85 1,760.86 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.76 0.519 2.34 c14: Carbamidomethyl (+57.02) 587.6254 1,759.85 1,760.86 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.95 0.405 2.19 c14: Carbamidomethyl (+57.02) 587.6259 1,759.85 1,760.86 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% YELGSGLAVLR 95.00% 2.98 0.497 2.96 589.3308 1,176.65 1,177.66 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% YELGSGLAVLR 95.00% 3.64 0.506 3.6 589.3313 1,176.65 1,177.66 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% YELGSGLAVLR 95.00% 3.11 0.449 3.03 589.3316 1,176.65 1,177.66 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% YELGSGLAVLR 95.00% 3.37 0.498 4.21 589.3316 1,176.65 1,177.66 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% YELGSGLAVLR 95.00% 3.49 0.482 2.12 589.3319 1,176.65 1,177.66 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% YELGSGLAVLR 95.00% 3.51 0.494 3.55 589.3325 1,176.65 1,177.66 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% YELGSGLAVLR 95.00% 3.26 0.475 3.36 589.3325 1,176.65 1,177.66 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LcNEcADGSFHLSTR 95.00% 3.56 0.386 1.77 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5905 1,765.75 1,766.76 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LcNEcADGSFHLSTR 95.00% 3.52 0.311 1.15 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5905 1,765.75 1,766.76 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LcNEcADGSFHLSTR 95.00% 3.8 0.385 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5906 1,765.75 1,766.76 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LcNEcADGSFHLSTR 95.00% 4.01 0.276 2.17 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5909 1,765.75 1,766.76 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LcNEcADGSFHLSTR 95.00% 3.95 0.36 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.5912 1,765.75 1,766.76 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LcNEcADGSFHLSTR 95.00% 3.71 0.391 1.14 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.9241 1,766.75 1,766.76 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LcNEcADGSFHLSTR 95.00% 3.91 0.366 2 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 589.9251 1,766.75 1,766.76 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EHLLMALAGIDTLLIR 95.00% 3.2 0.412 0 593.6765 1,778.01 1,779.02 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EHLLMALAGIDTLLIR 95.00% 3 0.241 0 593.6783 1,778.01 1,779.02 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 3.77 0.589 2.24 597.318 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 3.51 0.605 2.32 597.3184 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 3.82 0.593 2.24 597.3188 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 4.11 0.587 2.38 597.3188 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 3.65 0.614 2.23 597.3188 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 3.78 0.605 2.28 597.3189 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 3.74 0.606 3.01 597.3191 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 3.31 0.581 2.46 597.3194 1,192.62 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 3.89 0.572 3.85 597.8197 1,193.62 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 2.41 0.346 0 597.8534 1,193.69 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 2.4 0.339 1.2 597.8536 1,193.69 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 3.03 0.44 2.32 597.8549 1,193.69 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPAYTLVWTR 95.00% 3.23 0.589 2.11 597.8552 1,193.69 1,193.63 2 LU_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EVSEAVVDTLESEYLK 95.00% 3.43 0.462 0 604.3023 1,809.88 1,810.90 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EVSEAVVDTLESEYLK 95.00% 2.36 0.312 0 604.6346 1,810.88 1,810.90 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EVSEAVVDTLESEYLK 95.00% 2.47 0.314 0 604.6354 1,810.88 1,810.90 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EVSEAVVDTLESEYLK 95.00% 3.67 0.378 0 604.6373 1,810.89 1,810.90 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SDEFGcMPPQVVTPPR 95.00% 2.54 0.328 0 c6: Carbamidomethyl (+57.02) 606.6165 1,816.83 1,816.84 3 ANXA5_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SDEFGcMPPQVVTPPR 95.00% 3.31 0.502 0 c6: Carbamidomethyl (+57.02) 606.6173 1,816.83 1,816.84 3 ANXA5_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AGLSSGFIGcVR 95.00% 2.29 0.407 0 c10: Carbamidomethyl (+57.02) 612.3121 1,222.61 1,223.62 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AGLSSGFIGcVR 95.00% 3.85 0.474 3 c10: Carbamidomethyl (+57.02) 612.3134 1,222.61 1,223.62 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AGLSSGFIGcVR 95.00% 3.87 0.514 3.17 c10: Carbamidomethyl (+57.02) 612.3138 1,222.61 1,223.62 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AGLSSGFIGcVR 95.00% 3.74 0.449 3.28 c10: Carbamidomethyl (+57.02) 612.3139 1,222.61 1,223.62 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AGLSSGFIGcVR 95.00% 3.76 0.481 3.37 c10: Carbamidomethyl (+57.02) 612.3141 1,222.61 1,223.62 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AGLSSGFIGcVR 95.00% 2.82 0.479 1.82 c10: Carbamidomethyl (+57.02) 612.3148 1,222.61 1,223.62 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AGLSSGFIGcVR 95.00% 2.75 0.393 3.32 c10: Carbamidomethyl (+57.02) 612.315 1,222.61 1,223.62 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 3.49 0.462 1.21 c14: Carbamidomethyl (+57.02) 612.9791 1,835.91 1,836.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 3.82 0.439 1.66 c14: Carbamidomethyl (+57.02) 612.9798 1,835.92 1,836.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 4.73 0.562 1.68 c14: Carbamidomethyl (+57.02) 612.9801 1,835.92 1,836.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 3.73 0.441 2 c14: Carbamidomethyl (+57.02) 612.9804 1,835.92 1,836.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 3.96 0.481 2.89 c14: Carbamidomethyl (+57.02) 612.9804 1,835.92 1,836.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 4.37 0.54 2.03 c14: Carbamidomethyl (+57.02) 612.9808 1,835.92 1,836.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 4.03 0.459 2.85 c14: Carbamidomethyl (+57.02) 612.9817 1,835.92 1,836.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 3.52 0.51 1.92 c14: Carbamidomethyl (+57.02) 612.9822 1,835.92 1,836.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 3.82 0.555 3.06 c14: Carbamidomethyl (+57.02) 613.3139 1,836.92 1,836.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 4.61 0.583 2.44 c14: Carbamidomethyl (+57.02) 613.3143 1,836.92 1,836.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 4.31 0.591 3.03 c14: Carbamidomethyl (+57.02) 613.3151 1,836.92 1,836.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 3.55 0.457 2.35 c14: Carbamidomethyl (+57.02) 613.3151 1,836.92 1,836.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AAGVPSATITWR 95.00% 1.87 0.251 1.96 615.3338 1,228.65 1,229.66 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AAGVPSATITWR 95.00% 2.04 0.331 0 615.3353 1,228.65 1,229.66 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AAGVPSATITWR 95.00% 2.16 0.419 2.35 615.3357 1,228.66 1,229.66 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIVPQGGSHSLR 95.00% 2.24 0.328 3 619.3357 1,236.66 1,237.67 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIVPQGGSHSLR 95.00% 2.04 0.282 1.6 619.336 1,236.66 1,237.67 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% QPQAIITWYK 95.00% 1.83 0.34 0 624.3413 1,246.67 1,247.68 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% QPQAIITWYK 95.00% 1.78 0.359 0 624.3423 1,246.67 1,247.68 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cQVSGSPPHYFYWSR 95.00% 2.93 0.458 0 c1: Carbamidomethyl (+57.02) 624.6165 1,870.83 1,870.83 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cQVSGSPPHYFYWSR 95.00% 2.98 0.455 0 c1: Carbamidomethyl (+57.02) 624.6168 1,870.83 1,870.83 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cQVSGSPPHYFYWSR 95.00% 2.23 0.388 0 c1: Carbamidomethyl (+57.02) 624.6175 1,870.83 1,870.83 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AMDFNGILTIR 95.00% 2.31 0.317 0 625.8322 1,249.65 1,250.66 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLcLPGFSGPR 95.00% 1.75 0.251 1.72 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3002 1,262.58 1,263.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLcLPGFSGPR 95.00% 2.47 0.339 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3011 1,262.59 1,263.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLcLPGFSGPR 95.00% 2.46 0.326 1.51 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3015 1,262.59 1,263.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLcLPGFSGPR 95.00% 3.12 0.392 1.82 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.302 1,262.59 1,263.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLcLPGFSGPR 95.00% 3.07 0.433 2.4 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3028 1,262.59 1,263.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLcLPGFSGPR 95.00% 2.45 0.398 1.08 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 632.3032 1,262.59 1,263.60 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AmDFNGILTIR 95.00% 3.22 0.411 2.89 m2: Oxidation (+15.99) 633.8286 1,265.64 1,266.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AmDFNGILTIR 95.00% 3 0.425 2.3 m2: Oxidation (+15.99) 633.8286 1,265.64 1,266.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AmDFNGILTIR 95.00% 3.34 0.445 2.02 m2: Oxidation (+15.99) 633.8294 1,265.64 1,266.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AmDFNGILTIR 95.00% 3 0.392 2.6 m2: Oxidation (+15.99) 633.8297 1,265.64 1,266.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AmDFNGILTIR 95.00% 3.06 0.37 2.89 m2: Oxidation (+15.99) 633.8297 1,265.64 1,266.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AmDFNGILTIR 95.00% 2.92 0.28 2.82 m2: Oxidation (+15.99) 633.8305 1,265.65 1,266.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AmDFNGILTIR 95.00% 3.22 0.0964 2.44 m2: Oxidation (+15.99) 634.3206 1,266.63 1,266.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRFDQPDDFK 95.00% 2.81 0.497 0 640.8159 1,279.62 1,280.63 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRFDQPDDFK 95.00% 2.61 0.404 1.43 640.8187 1,279.62 1,280.63 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% QPDFISFGLVGGRPEFR 95.00% 2.11 0.403 0 641.335 1,920.98 1,921.99 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% QPDFISFGLVGGRPEFR 95.00% 2.43 0.513 1.31 641.335 1,920.98 1,921.99 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% QPDFISFGLVGGRPEFR 95.00% 2 0.274 0 641.3371 1,920.99 1,921.99 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% QPDFISFGLVGGRPEFR 95.00% 2.32 0.225 1.39 641.6694 1,921.98 1,921.99 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cAPGYYGNPSQGQPcQR 95.00% 2.89 0.384 2.08 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.2764 1,938.81 1,939.82 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cAPGYYGNPSQGQPcQR 95.00% 2.82 0.22 0 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 647.6108 1,939.81 1,939.82 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 5.73 0.623 5.31 c16: Carbamidomethyl (+57.02) 649.6625 1,945.96 1,946.98 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 5.64 0.617 4.59 c16: Carbamidomethyl (+57.02) 649.6631 1,945.97 1,946.98 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 2.87 0.289 2.47 c16: Carbamidomethyl (+57.02) 649.6631 1,945.97 1,946.98 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 5.34 0.615 4.21 c16: Carbamidomethyl (+57.02) 649.6632 1,945.97 1,946.98 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 5.59 0.615 3.82 c16: Carbamidomethyl (+57.02) 649.6636 1,945.97 1,946.98 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 5.87 0.633 3.36 c16: Carbamidomethyl (+57.02) 649.6639 1,945.97 1,946.98 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 4.32 0.594 4.52 c16: Carbamidomethyl (+57.02) 649.9965 1,946.97 1,946.98 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 3.47 0.499 3.35 c16: Carbamidomethyl (+57.02) 649.9965 1,946.97 1,946.98 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 5.02 0.552 4.59 c16: Carbamidomethyl (+57.02) 649.9977 1,946.97 1,946.98 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 6.19 0.597 6.19 c16: Carbamidomethyl (+57.02) 649.9977 1,946.97 1,946.98 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 3.19 0.44 2.8 c16: Carbamidomethyl (+57.02) 649.998 1,946.97 1,946.98 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VVGSSGTQEASVLVTIQQR 95.00% 4.4 0.403 1.01 653.6878 1,958.04 1,959.05 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VVGSSGTQEASVLVTIQQR 95.00% 4.25 0.366 1.04 654.0228 1,959.05 1,959.05 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LNWGHIPSHPR 95.00% 2.6 0.208 1.8 657.3475 1,312.68 1,313.69 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LNWGHIPSHPR 95.00% 2.25 0.138 1.85 657.3494 1,312.68 1,313.69 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIEYSPQLEDAGSREFR 95.00% 1.69 0.373 0 662.3172 1,983.93 1,983.94 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ITFRPDSADGMLLYNGQK 95.00% 3.3 0.417 0 676.3411 2,026.00 2,026.01 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ITFRPDSADGMLLYNGQK 95.00% 3.03 0.364 0 676.3417 2,026.00 2,026.01 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ITFRPDSADGMLLYNGQK 95.00% 3.25 0.391 0 676.3417 2,026.00 2,026.01 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ITFRPDSADGMLLYNGQK 95.00% 3.71 0.417 0 676.342 2,026.00 2,026.01 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% TPSGLYLGTcER 95.00% 2.78 0.364 2.89 c10: Carbamidomethyl (+57.02) 677.3248 1,352.63 1,353.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% TPSGLYLGTcER 95.00% 4.02 0.445 3.4 c10: Carbamidomethyl (+57.02) 677.3261 1,352.64 1,353.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% TPSGLYLGTcER 95.00% 3.88 0.463 3.08 c10: Carbamidomethyl (+57.02) 677.3263 1,352.64 1,353.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% TPSGLYLGTcER 95.00% 2.96 0.301 1.57 c10: Carbamidomethyl (+57.02) 677.3274 1,352.64 1,353.65 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% DVKESDQGAYTcEAMNAR 95.00% 4.22 0.436 3.29 c12: Carbamidomethyl (+57.02) 682.2937 2,043.86 2,044.87 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% DVKESDQGAYTcEAMNAR 95.00% 3.55 0.384 2.37 c12: Carbamidomethyl (+57.02) 682.2942 2,043.86 2,044.87 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% PSDAGTYVcLAQNALGTAQK 95.00% 4.78 0.465 0 c9: Carbamidomethyl (+57.02) 689.3386 2,064.99 2,065.00 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% PSDAGTYVcLAQNALGTAQK 95.00% 4.42 0.474 0 c9: Carbamidomethyl (+57.02) 689.3386 2,064.99 2,065.00 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% PSDAGTYVcLAQNALGTAQK 95.00% 3.81 0.446 0 c9: Carbamidomethyl (+57.02) 689.3392 2,064.99 2,065.00 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% PSDAGTYVcLAQNALGTAQK 95.00% 5.24 0.446 0 c9: Carbamidomethyl (+57.02) 689.34 2,065.00 2,065.00 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GmLEPVQRPDVVLVGAGYR 95.00% 3.53 0.499 2.74 m2: Oxidation (+15.99) 691.3698 2,071.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GmLEPVQRPDVVLVGAGYR 95.00% 4.39 0.648 3.96 m2: Oxidation (+15.99) 691.7037 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GmLEPVQRPDVVLVGAGYR 95.00% 4.85 0.559 3.13 m2: Oxidation (+15.99) 691.7038 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GmLEPVQRPDVVLVGAGYR 95.00% 4.71 0.59 4.57 m2: Oxidation (+15.99) 691.7039 2,072.09 2,072.10 3 FBN1_HUMAN,CO1A1_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RcEScAPGYEGNPIQPGGK 95.00% 4.2 0.473 2.23 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 692.9786 2,075.91 2,076.92 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RcEScAPGYEGNPIQPGGK 95.00% 2.77 0.258 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.3134 2,076.92 2,076.92 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RcEScAPGYEGNPIQPGGK 95.00% 4.28 0.51 1.72 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 693.314 2,076.92 2,076.92 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AVTLEcVSAGEPR 95.00% 3.05 0.502 2.01 c6: Carbamidomethyl (+57.02) 694.8454 1,387.68 1,388.68 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AVTLEcVSAGEPR 95.00% 3.44 0.438 2.85 c6: Carbamidomethyl (+57.02) 694.8458 1,387.68 1,388.68 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ATATScRPcPcPYIDASR 95.00% 3.68 0.469 2.02 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 694.976 2,081.90 2,082.92 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ATATScRPcPcPYIDASR 95.00% 2.77 0.386 0.959 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3085 2,082.90 2,082.92 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ATATScRPcPcPYIDASR 95.00% 3.34 0.438 2.36 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 695.3115 2,082.91 2,082.92 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AVTLEcVSAGEPR 95.00% 0 0 3.59 c6: Carbamidomethyl (+57.02) 695.8631 1,389.71 1,388.68 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IPGDQVVSVVFIK 95.00% 4.03 0.504 3.15 700.9105 1,399.81 1,400.82 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IPGDQVVSVVFIK 95.00% 4.11 0.543 2.66 700.911 1,399.81 1,400.82 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IPGDQVVSVVFIK 95.00% 4.12 0.513 2.19 700.9115 1,399.81 1,400.82 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IPGDQVVSVVFIK 95.00% 4.02 0.545 3.41 700.9117 1,399.81 1,400.82 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IPGDQVVSVVFIK 95.00% 3.63 0.541 3.11 700.9152 1,399.81 1,400.82 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IAHVELADAGQYR 95.00% 4.23 0.495 3.26 721.8716 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IAHVELADAGQYR 95.00% 3.47 0.462 5.06 721.8721 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IAHVELADAGQYR 95.00% 4.32 0.484 3.31 721.8744 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IAHVELADAGQYR 95.00% 3.01 0.334 4 721.8748 1,441.73 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IAHVELADAGQYR 95.00% 4.3 0.486 3.28 722.376 1,442.74 1,442.74 2 LU_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cPPGYIGLScQDcAPGYTR 95.00% 3.6 0.452 0 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 724.9807 2,171.92 2,171.93 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LSGSHSQGVAYPVR 95.00% 2.63 0.411 2.68 728.8667 1,455.72 1,457.75 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LSGSHSQGVAYPVR 95.00% 3.48 0.586 3.85 729.3765 1,456.74 1,457.75 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LSGSHSQGVAYPVR 95.00% 3.71 0.58 3.59 729.378 1,456.74 1,457.75 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RPEEVcGPTQFR 95.00% 3.58 0.443 3.82 c6: Carbamidomethyl (+57.02) 738.3554 1,474.70 1,475.71 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RPEEVcGPTQFR 95.00% 3.41 0.493 4.82 c6: Carbamidomethyl (+57.02) 738.3573 1,474.70 1,475.71 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cPIGYSGLScEScDAHFTR 95.00% 4.8 0.506 2.13 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 739.9757 2,216.90 2,216.92 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cPIGYSGLScEScDAHFTR 95.00% 4.55 0.477 2.41 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 739.9794 2,216.91 2,216.92 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPVISIDPPSSTVQQGQDASFK 95.00% 3.66 0.459 1.01 763.718 2,288.13 2,288.14 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPVISIDPPSSTVQQGQDASFK 95.00% 3.61 0.49 0.959 763.7195 2,288.14 2,288.14 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPVISIDPPSSTVQQGQDASFK 95.00% 4.88 0.512 1.06 763.7202 2,288.14 2,288.14 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPVISIDPPSSTVQQGQDASFK 95.00% 4.58 0.447 0 763.7215 2,288.14 2,288.14 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cDGDFDcEDRTDEANcPTK 95.00% 3.36 0.285 0 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 769.2878 2,304.84 2,304.84 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.54 0.647 3.24 770.7567 2,309.25 2,310.26 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.09 0.628 2.37 771.0903 2,310.25 2,310.26 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.29 0.631 2.27 771.0906 2,310.25 2,310.26 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.44 0.619 2.23 771.0906 2,310.25 2,310.26 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AELLVTEAPSKPITVTVEEQR 95.00% 4.4 0.532 1.7 771.0916 2,310.25 2,310.26 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AELLVTEAPSKPITVTVEEQR 95.00% 6.22 0.64 2.44 771.0919 2,310.25 2,310.26 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.79 0.597 2.1 771.0926 2,310.25 2,310.26 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AELLVTEAPSKPITVTVEEQR 95.00% 3.79 0.534 0 771.0927 2,310.25 2,310.26 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIEYSPQLEDAGSR 95.00% 4.18 0.492 2.62 776.3664 1,550.72 1,551.73 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIEYSPQLEDAGSR 95.00% 4.45 0.589 5.66 776.3676 1,550.72 1,551.73 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIEYSPQLEDAGSR 95.00% 4.38 0.588 6.82 776.3681 1,550.72 1,551.73 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIEYSPQLEDAGSR 95.00% 4.17 0.559 6.37 776.8679 1,551.72 1,551.73 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIEYSPQLEDAGSR 95.00% 4.17 0.598 5.07 776.868 1,551.72 1,551.73 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIEYSPQLEDAGSR 95.00% 5.02 0.589 4.08 776.8689 1,551.72 1,551.73 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% MASVGLSDIAMDTTVTHATSHGR 95.00% 3.92 0.57 1.47 787.0446 2,358.11 2,358.12 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% MASVGLSDIAMDTTVTHATSHGR 95.00% 3.68 0.55 1.82 787.0453 2,358.11 2,358.12 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.87 0.511 1.47 c1: Carbamidomethyl (+57.02) 791.0526 2,370.13 2,370.14 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.39 0.554 2.49 c1: Carbamidomethyl (+57.02) 791.056 2,370.14 2,370.14 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.71 0.559 3.77 c18: Carbamidomethyl (+57.02) 792.4023 2,374.18 2,374.19 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.96 0.591 4.42 c18: Carbamidomethyl (+57.02) 792.4028 2,374.19 2,374.19 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPAPTIHWSK 95.00% 3.44 0.522 3.85 c1: Carbamidomethyl (+57.02) 800.3827 1,598.75 1,599.76 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPAPTIHWSK 95.00% 3.35 0.533 4.92 c1: Carbamidomethyl (+57.02) 800.383 1,598.75 1,599.76 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPAPTIHWSK 95.00% 3.37 0.501 3.64 c1: Carbamidomethyl (+57.02) 800.383 1,598.75 1,599.76 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPAPTIHWSK 95.00% 3.68 0.479 5.96 c1: Carbamidomethyl (+57.02) 800.8863 1,599.76 1,599.76 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SLPEVPETIELEVR 95.00% 3.86 0.612 4.96 805.9351 1,609.85 1,610.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SLPEVPETIELEVR 95.00% 2.72 0.199 3.05 805.9362 1,609.86 1,610.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SLPEVPETIELEVR 95.00% 3.44 0.634 5.7 805.937 1,609.86 1,610.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 4.43 0.639 3.2 816.7745 2,447.30 2,448.31 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 5.05 0.597 4.02 817.1104 2,448.31 2,448.31 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ETSLIVTIQGSGSSHVPSVSPPIR 95.00% 3.77 0.44 1.14 817.1109 2,448.31 2,448.31 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EQAWQRPDGQPATR 95.00% 3.24 0.271 0 820.3996 1,638.78 1,639.79 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPQVSPADSGEYVcR 95.00% 4.12 0.562 5.05 c14: Carbamidomethyl (+57.02) 839.3977 1,676.78 1,677.79 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPQVSPADSGEYVcR 95.00% 4.22 0.544 4.06 c14: Carbamidomethyl (+57.02) 839.3979 1,676.78 1,677.79 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPQVSPADSGEYVcR 95.00% 4.22 0.553 5.06 c14: Carbamidomethyl (+57.02) 839.898 1,677.78 1,677.79 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPQVSPADSGEYVcR 95.00% 4.87 0.531 5.09 c14: Carbamidomethyl (+57.02) 839.8993 1,677.78 1,677.79 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 2.95 0.316 1.42 844.4889 1,686.96 1,687.97 2 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 3.32 0.391 3.2 844.9912 1,687.97 1,687.97 2 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VGGHLRPGIVQSGGVVR 95.00% 3.73 0.458 2.44 844.9937 1,687.97 1,687.97 2 ATPA_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GSVYIGGAPDVATLTGGR 95.00% 4.86 0.546 4.43 845.9409 1,689.87 1,690.88 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GSVYIGGAPDVATLTGGR 95.00% 3.3 0.339 3.51 845.9417 1,689.87 1,690.88 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GSVYIGGAPDVATLTGGR 95.00% 4.93 0.515 4.85 845.943 1,689.87 1,690.88 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% GSVYIGGAPDVATLTGGR 95.00% 4.86 0.549 5 846.4431 1,690.87 1,690.88 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLIHDGAAPISLEWK 95.00% 0 0 3.49 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 846.9211 1,691.83 1,692.84 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLIHDGAAPISLEWK 95.00% 0 0 3.64 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 846.922 1,691.83 1,692.84 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ESDQGAYTcEAMNAR 95.00% 3.83 0.474 3.02 c9: Carbamidomethyl (+57.02) 851.8438 1,701.67 1,702.68 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ESDQGAYTcEAMNAR 95.00% 3.89 0.522 3.05 c9: Carbamidomethyl (+57.02) 851.8441 1,701.67 1,702.68 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ESDQGAYTcEAMNAR 95.00% 4.08 0.541 2.68 c9: Carbamidomethyl (+57.02) 851.8451 1,701.67 1,702.68 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 4 0.452 4.09 c14: Carbamidomethyl (+57.02) 851.9137 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 3.46 0.403 3.46 c14: Carbamidomethyl (+57.02) 851.9138 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 3.01 0.279 2.27 c14: Carbamidomethyl (+57.02) 851.9149 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 3.62 0.428 4.42 c14: Carbamidomethyl (+57.02) 851.9151 1,701.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 3.78 0.317 4.55 c14: Carbamidomethyl (+57.02) 851.916 1,701.82 1,702.82 2 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ESDQGAYTcEAMNAR 95.00% 4.13 0.51 2.96 c9: Carbamidomethyl (+57.02) 852.3465 1,702.68 1,702.68 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LHLVSPADSGEYVcR 95.00% 3.87 0.337 6.29 c14: Carbamidomethyl (+57.02) 852.4107 1,702.81 1,702.82 2 TITIN_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRSPVISIDPPSSTVQQGQDASFK 95.00% 7 0.611 4.59 853.4461 2,557.31 2,557.33 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRSPVISIDPPSSTVQQGQDASFK 95.00% 7.18 0.596 5.32 853.4466 2,557.32 2,557.33 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRSPVISIDPPSSTVQQGQDASFK 95.00% 5.7 0.538 3.08 853.4474 2,557.32 2,557.33 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRSPVISIDPPSSTVQQGQDASFK 95.00% 6 0.589 3.26 853.4476 2,557.32 2,557.33 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRSPVISIDPPSSTVQQGQDASFK 95.00% 0 0 5.55 853.7831 2,558.33 2,557.33 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRSPVISIDPPSSTVQQGQDASFK 95.00% 0 0 4.7 853.7836 2,558.33 2,557.33 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IQVVVLSASDASPPPVK 95.00% 3.35 0.439 5.36 853.9859 1,705.96 1,706.97 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IQVVVLSASDASPPPVK 95.00% 2.98 0.413 3.54 853.9882 1,705.96 1,706.97 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LLQVTPADSGEYVcR 95.00% 4.41 0.437 4.82 c14: Carbamidomethyl (+57.02) 854.4184 1,706.82 1,707.84 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LLQVTPADSGEYVcR 95.00% 4.56 0.642 4.51 c14: Carbamidomethyl (+57.02) 854.4221 1,706.83 1,707.84 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LLQVTPADSGEYVcR 95.00% 4.19 0.514 4.72 c14: Carbamidomethyl (+57.02) 854.4221 1,706.83 1,707.84 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LLQVTPADSGEYVcR 95.00% 4.27 0.626 5.96 c14: Carbamidomethyl (+57.02) 854.424 1,706.83 1,707.84 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IQVVVLSASDASPPPVK 95.00% 3.84 0.455 5.44 854.4885 1,706.96 1,706.97 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IQVVVLSASDASPPPVK 95.00% 3.53 0.46 3.36 854.4904 1,706.97 1,706.97 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IQVVVLSASDASPPPVK 95.00% 3.21 0.422 5.51 854.4909 1,706.97 1,706.97 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IQNLDQScQGTYIcQAHGPWGK 95.00% 4.09 0.527 1.59 c8: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 854.7286 2,561.16 2,561.17 3
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LLQVTPADSGEYVcR 95.00% 4.23 0.0976 2.59 c14: Carbamidomethyl (+57.02) 854.9138 1,707.81 1,707.84 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LLQVTPADSGEYVcR 95.00% 4.26 0.377 6.72 c14: Carbamidomethyl (+57.02) 854.9187 1,707.82 1,707.84 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLIHDGAAPISLEWK 95.00% 4.36 0.434 3.57 c1: Carbamidomethyl (+57.02) 855.4344 1,708.85 1,709.87 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLIHDGAAPISLEWK 95.00% 3.97 0.163 2.46 c1: Carbamidomethyl (+57.02) 855.4356 1,708.86 1,709.87 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cLIHDGAAPISLEWK 95.00% 4.31 0.554 5.49 c1: Carbamidomethyl (+57.02) 855.4374 1,708.86 1,709.87 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LYQASPADSGEYVcR 95.00% 3.84 0.563 2.89 c14: Carbamidomethyl (+57.02) 858.3888 1,714.76 1,715.77 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cEQcQPGYYGDAQR 95.00% 2.44 0.424 0 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 866.4057 1,730.80 1,731.69 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIGASVEFHcAVPSDR 95.00% 4.23 0.373 2.25 c10: Carbamidomethyl (+57.02) 866.4101 1,730.80 1,731.81 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIGASVEFHcAVPSDR 95.00% 4.26 0.417 2.32 c10: Carbamidomethyl (+57.02) 866.4102 1,730.80 1,731.81 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIGASVEFHcAVPSDR 95.00% 3.68 0.365 2.41 c10: Carbamidomethyl (+57.02) 866.4103 1,730.81 1,731.81 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SIGASVEFHcAVPSDR 95.00% 4.36 0.369 2.92 c10: Carbamidomethyl (+57.02) 866.9132 1,731.81 1,731.81 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EGGQLPPGHSVQDGVLR 95.00% 3.18 0.494 3 873.4503 1,744.88 1,745.89 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EGGQLPPGHSVQDGVLR 95.00% 3.79 0.454 4.49 873.4505 1,744.89 1,745.89 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EGGQLPPGHSVQDGVLR 95.00% 3.63 0.472 2.62 873.9511 1,745.89 1,745.89 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EGGQLPPGHSVQDGVLR 95.00% 3.29 0.429 4.24 873.9516 1,745.89 1,745.89 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.86 0.581 5.82 c14: Carbamidomethyl (+57.02) 880.9332 1,759.85 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.76 0.536 7.42 c14: Carbamidomethyl (+57.02) 880.9336 1,759.85 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.9 0.582 5.27 c14: Carbamidomethyl (+57.02) 880.9337 1,759.85 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.54 0.508 6.48 c14: Carbamidomethyl (+57.02) 880.9339 1,759.85 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 5.02 0.536 5.55 c14: Carbamidomethyl (+57.02) 880.934 1,759.85 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.88 0.504 7.44 c14: Carbamidomethyl (+57.02) 880.9347 1,759.85 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.98 0.557 7.32 c14: Carbamidomethyl (+57.02) 880.935 1,759.85 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.5 0.5 6.28 c14: Carbamidomethyl (+57.02) 880.9357 1,759.86 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.53 0.534 4.72 c14: Carbamidomethyl (+57.02) 880.936 1,759.86 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.34 0.578 5.62 c14: Carbamidomethyl (+57.02) 880.9362 1,759.86 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 3.94 0.517 4.51 c14: Carbamidomethyl (+57.02) 880.9388 1,759.86 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 3.86 0.52 4.54 c14: Carbamidomethyl (+57.02) 881.4355 1,760.86 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.49 0.493 6.96 c14: Carbamidomethyl (+57.02) 881.4359 1,760.86 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 4.69 0.539 7.12 c14: Carbamidomethyl (+57.02) 881.4362 1,760.86 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LPAVEPTDQAQYLcR 95.00% 3.66 0.515 2.68 c14: Carbamidomethyl (+57.02) 881.4391 1,760.86 1,760.86 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LcNEcADGSFHLSTR 95.00% 4.43 0.591 3.31 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8799 1,765.74 1,766.76 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LcNEcADGSFHLSTR 95.00% 5.06 0.535 3.64 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8819 1,765.75 1,766.76 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LcNEcADGSFHLSTR 95.00% 2.86 0.305 1.82 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 883.8971 1,765.78 1,766.76 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LcNEcADGSFHLSTR 95.00% 4.83 0.624 3.16 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.3818 1,766.75 1,766.76 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LcNEcADGSFHLSTR 95.00% 5.14 0.591 4.27 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 884.3828 1,766.75 1,766.76 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EVSEAVVDTLESEYLK 95.00% 5.68 0.548 5.21 905.9495 1,809.88 1,810.90 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EVSEAVVDTLESEYLK 95.00% 6.03 0.532 5.35 905.9499 1,809.88 1,810.90 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EVSEAVVDTLESEYLK 95.00% 5.41 0.534 3.89 905.95 1,809.88 1,810.90 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EVSEAVVDTLESEYLK 95.00% 5.39 0.554 4.42 905.9505 1,809.89 1,810.90 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EVSEAVVDTLESEYLK 95.00% 5.35 0.54 5.21 905.9544 1,809.89 1,810.90 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EVSEAVVDTLESEYLK 95.00% 5.31 0.537 4.64 906.452 1,810.89 1,810.90 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% EVSEAVVDTLESEYLK 95.00% 5.97 0.543 4.54 906.4535 1,810.89 1,810.90 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SDEFGcMPPQVVTPPR 95.00% 3.26 0.485 2.15 c6: Carbamidomethyl (+57.02) 908.9206 1,815.83 1,816.84 2 ANXA5_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SDEFGcMPPQVVTPPR 95.00% 3.86 0.571 2 c6: Carbamidomethyl (+57.02) 908.9228 1,815.83 1,816.84 2 ANXA5_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 3.47 0.346 3.04 c14: Carbamidomethyl (+57.02) 918.9639 1,835.91 1,836.93 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 3.42 0.302 3.52 c14: Carbamidomethyl (+57.02) 918.9676 1,835.92 1,836.93 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 2.7 0.342 2.15 c14: Carbamidomethyl (+57.02) 918.9676 1,835.92 1,836.93 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 3.48 0.371 3.3 c14: Carbamidomethyl (+57.02) 919.4698 1,836.92 1,836.93 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SQSVRPGADVTFIcTAK 95.00% 3.71 0.328 2.96 c14: Carbamidomethyl (+57.02) 919.4703 1,836.93 1,836.93 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cQVSGSPPHYFYWSR 95.00% 5.03 0.58 2.68 c1: Carbamidomethyl (+57.02) 936.4195 1,870.82 1,870.83 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cQVSGSPPHYFYWSR 95.00% 4.62 0.556 3.08 c1: Carbamidomethyl (+57.02) 936.4228 1,870.83 1,870.83 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cAPGYYGNPSQGQPcQR 95.00% 4.28 0.622 6.18 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9091 1,939.80 1,939.82 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cAPGYYGNPSQGQPcQR 95.00% 4.66 0.669 4.96 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9121 1,939.81 1,939.82 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cAPGYYGNPSQGQPcQR 95.00% 4.43 0.611 6.1 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9123 1,939.81 1,939.82 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cAPGYYGNPSQGQPcQR 95.00% 4.42 0.6 6.44 c1: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 970.9141 1,939.81 1,939.82 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 4.98 0.568 5.24 c16: Carbamidomethyl (+57.02) 973.9899 1,945.96 1,946.98 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 4.75 0.502 5.24 c16: Carbamidomethyl (+57.02) 973.992 1,945.97 1,946.98 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 4.92 0.56 4.11 c16: Carbamidomethyl (+57.02) 974.4898 1,946.96 1,946.98 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LRLPQVSPADSGEYVcR 95.00% 4.74 0.499 3.96 c16: Carbamidomethyl (+57.02) 974.4934 1,946.97 1,946.98 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LYIFQASPADAGQYVcR 95.00% 5.74 0.68 7.48 c16: Carbamidomethyl (+57.02) 979.9721 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LYIFQASPADAGQYVcR 95.00% 5.8 0.696 7.89 c16: Carbamidomethyl (+57.02) 979.9737 1,957.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VVGSSGTQEASVLVTIQQR 95.00% 5.17 0.532 3.57 980.0287 1,958.04 1,959.05 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LYIFQASPADAGQYVcR 95.00% 5.64 0.535 4.92 c16: Carbamidomethyl (+57.02) 980.4745 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LYIFQASPADAGQYVcR 95.00% 5.69 0.562 6.18 c16: Carbamidomethyl (+57.02) 980.4747 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LYIFQASPADAGQYVcR 95.00% 5.86 0.576 5.96 c16: Carbamidomethyl (+57.02) 980.4749 1,958.93 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% LYIFQASPADAGQYVcR 95.00% 5.91 0.556 5.39 c16: Carbamidomethyl (+57.02) 980.4755 1,958.94 1,958.94 2 DOCK9_HUMAN
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VVGSSGTQEASVLVTIQQR 95.00% 5.63 0.494 4 980.5284 1,959.04 1,959.05 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VVGSSGTQEASVLVTIQQR 95.00% 4.96 0.473 3.6 980.5285 1,959.04 1,959.05 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VVGSSGTQEASVLVTIQQR 95.00% 5.51 0.514 4.02 980.5305 1,959.05 1,959.05 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VVGSSGTQEASVLVTIQQR 95.00% 5.41 0.51 4.25 980.5315 1,959.05 1,959.05 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% PSDAGTYVcLAQNALGTAQK 95.00% 6.19 0.615 0 c9: Carbamidomethyl (+57.02) 1,033.50 2,064.99 2,065.00 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% PSDAGTYVcLAQNALGTAQK 95.00% 6.82 0.598 0 c9: Carbamidomethyl (+57.02) 1,033.50 2,064.99 2,065.00 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% PSDAGTYVcLAQNALGTAQK 95.00% 6.54 0.607 0 c9: Carbamidomethyl (+57.02) 1,033.50 2,064.99 2,065.00 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% PSDAGTYVcLAQNALGTAQK 95.00% 6.51 0.56 0 c9: Carbamidomethyl (+57.02) 1,033.50 2,064.99 2,065.00 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% RcEScAPGYEGNPIQPGGK 95.00% 5.04 0.609 3.41 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 1,039.46 2,076.91 2,076.92 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ATATScRPcPcPYIDASR 95.00% 3.94 0.424 1.8 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,041.96 2,081.90 2,082.92 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ATATScRPcPcPYIDASR 95.00% 4.22 0.462 2.44 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.90 2,082.92 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ATATScRPcPcPYIDASR 95.00% 4.3 0.47 1.8 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.90 2,082.92 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% ATATScRPcPcPYIDASR 95.00% 3.74 0.406 2.36 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.92 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% VISSGSVASYVTSPQGFQFR 95.00% 4.37 0.422 1.89 1,059.54 2,117.06 2,117.07 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cPPGYIGLScQDcAPGYTR 95.00% 4.41 0.516 6.92 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.47 2,170.92 2,171.93 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cPPGYIGLScQDcAPGYTR 95.00% 4.65 0.581 8.68 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.97 2,171.93 2,171.93 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cPPGYIGLScQDcAPGYTR 95.00% 4.9 0.612 7.32 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,086.97 2,171.93 2,171.93 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cPIGYSGLScEScDAHFTR 95.00% 5.02 0.592 6.7 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,109.46 2,216.90 2,216.92 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cPIGYSGLScEScDAHFTR 95.00% 5.04 0.59 6.36 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,109.46 2,216.91 2,216.92 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPVISIDPPSSTVQQGQDASFK 95.00% 5.46 0.529 12 1,145.07 2,288.13 2,288.14 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPVISIDPPSSTVQQGQDASFK 95.00% 5.83 0.534 11.9 1,145.07 2,288.13 2,288.14 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPVISIDPPSSTVQQGQDASFK 95.00% 5.44 0.543 10.9 1,145.07 2,288.13 2,288.14 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% SPVISIDPPSSTVQQGQDASFK 95.00% 5.97 0.538 11.2 1,145.08 2,288.14 2,288.14 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.36 0.511 5.06 1,156.13 2,310.25 2,310.26 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AELLVTEAPSKPITVTVEEQR 95.00% 5.71 0.565 6.6 1,156.13 2,310.25 2,310.26 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.85 0.727 4.72 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.76 0.652 6.01 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.13 0.705 4.55 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.75 0.667 5.51 c1: Carbamidomethyl (+57.02) 1,186.07 2,370.13 2,370.14 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% cSATGSPTPTLEWTGGPGGQLPAK 95.00% 4.66 0.706 6.12 c1: Carbamidomethyl (+57.02) 1,186.08 2,370.13 2,370.14 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 4.94 0.666 4.57 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.17 0.672 4.57 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.43 0.657 4.96 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.44 0.674 4.4 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.18 2,374.19 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5 0.659 4.37 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% IESSSPTVVEGQTLDLNcVVAR 95.00% 5.39 0.683 5.15 c18: Carbamidomethyl (+57.02) 1,188.10 2,374.19 2,374.19 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AASGPGPEQEASFTVTVPPSEGSSYR 95.00% 4.09 0.573 4.17 1,305.11 2,608.21 2,608.22 2
 SAMPLE 3R Basement membrane-specific heparan sulfate proteoglycan core protein  HSPG2  PGBM_HUMAN 468,760.50 100.00% 85 120 471 27.40% AASGPGPEQEASFTVTVPPSEGSSYR 95.00% 3.88 0.487 3.08 1,305.11 2,608.21 2,608.22 2
 SAMPLE 1 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 4 8 20.00% VcPFAGILENGAVR 95.00% 4.22 0.333 0 c2: Carbamidomethyl (+57.02) 501.5965 1,501.77 1,502.78 3
 SAMPLE 1 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 4 8 20.00% VcPFAGILENGAVR 95.00% 4.12 0.287 1 c2: Carbamidomethyl (+57.02) 501.5968 1,501.77 1,502.78 3
 SAMPLE 1 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 4 8 20.00% TcPKPDDLPFSTVVPLK 95.00% 3.51 0.362 1.62 c2: Carbamidomethyl (+57.02) 638.6723 1,912.99 1,914.01 3
 SAMPLE 1 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 4 8 20.00% VcPFAGILENGAVR 95.00% 4.76 0.425 3.85 c2: Carbamidomethyl (+57.02) 751.8912 1,501.77 1,502.78 2
 SAMPLE 1 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 4 8 20.00% VcPFAGILENGAVR 95.00% 4.34 0.405 3.66 c2: Carbamidomethyl (+57.02) 751.8919 1,501.77 1,502.78 2
 SAMPLE 1 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 4 8 20.00% VcPFAGILENGAVR 95.00% 4.25 0.405 4.16 c2: Carbamidomethyl (+57.02) 751.8929 1,501.77 1,502.78 2
 SAMPLE 1 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 4 8 20.00% VcPFAGILENGAVR 95.00% 4.2 0.39 2.96 c2: Carbamidomethyl (+57.02) 751.8933 1,501.77 1,502.78 2
 SAMPLE 1 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 4 8 20.00% TcPKPDDLPFSTVVPLK 95.00% 4 0.591 2.47 c2: Carbamidomethyl (+57.02) 958.0069 1,914.00 1,914.01 2
 SAMPLE 1 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 4 8 20.00% cSYTEDAQcIDGTIEVPK 95.00% 5.94 0.599 7.09 c1: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,043.96 2,085.90 2,085.91 2 TITIN_HUMAN
 SAMPLE 1 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 4 8 20.00% TFYEPGEEITYScKPGYVSR 95.00% 5.29 0.614 4.62 c13: Carbamidomethyl (+57.02) 1,192.55 2,383.09 2,383.09 2 ZYX_HUMAN,TENX_HUMAN,CPXM2_HUMAN,AEBP1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 4 8 20.00% TFYEPGEEITYScKPGYVSR 95.00% 5.39 0.638 5.68 c13: Carbamidomethyl (+57.02) 1,192.55 2,383.09 2,383.09 2 ZYX_HUMAN,TENX_HUMAN,CPXM2_HUMAN,AEBP1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% VcPFAGILENGAVR 95.00% 4.01 0.22 1.2 c2: Carbamidomethyl (+57.02) 501.9311 1,502.77 1,502.78 3
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% TcPKPDDLPFSTVVPLK 95.00% 4.16 0.439 1.24 c2: Carbamidomethyl (+57.02) 639.0066 1,914.00 1,914.01 3
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% TcPKPDDLPFSTVVPLK 95.00% 4.1 0.406 1.54 c2: Carbamidomethyl (+57.02) 639.0067 1,914.00 1,914.01 3
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% cPFPSRPDNGFVNYPAK 95.00% 2.63 0.382 0 c1: Carbamidomethyl (+57.02) 656.3135 1,965.92 1,965.93 3
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% cPFPSRPDNGFVNYPAK 95.00% 3.03 0.346 0 c1: Carbamidomethyl (+57.02) 656.3157 1,965.92 1,965.93 3
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% VcPFAGILENGAVR 95.00% 4.17 0.415 3.7 c2: Carbamidomethyl (+57.02) 751.8903 1,501.77 1,502.78 2
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% VcPFAGILENGAVR 95.00% 4.32 0.397 4.3 c2: Carbamidomethyl (+57.02) 751.8916 1,501.77 1,502.78 2
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% VcPFAGILENGAVR 95.00% 4.57 0.436 5.11 c2: Carbamidomethyl (+57.02) 751.892 1,501.77 1,502.78 2
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% VcPFAGILENGAVR 95.00% 4.22 0.433 3.34 c2: Carbamidomethyl (+57.02) 751.8925 1,501.77 1,502.78 2
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% ATFGcHDGYSLDGPEEIEcTK 95.00% 4.86 0.442 3.7 c5: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 796.3364 2,385.99 2,386.00 3
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% ATFGcHDGYSLDGPEEIEcTK 95.00% 4.56 0.425 3.41 c5: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 796.3367 2,385.99 2,386.00 3
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% FIcPLTGLWPINTLK 95.00% 4.4 0.545 5.1 c3: Carbamidomethyl (+57.02) 886.9899 1,771.96 1,772.98 2
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% FIcPLTGLWPINTLK 95.00% 4.22 0.528 4.28 c3: Carbamidomethyl (+57.02) 886.9904 1,771.97 1,772.98 2
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% FIcPLTGLWPINTLK 95.00% 4.68 0.527 4.77 c3: Carbamidomethyl (+57.02) 886.9919 1,771.97 1,772.98 2
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% FIcPLTGLWPINTLK 95.00% 4.43 0.499 3.64 c3: Carbamidomethyl (+57.02) 887.4942 1,772.97 1,772.98 2
 SAMPLE 1R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 5 6 15 30.10% TFYEPGEEITYScKPGYVSR 95.00% 5.07 0.619 5.54 c13: Carbamidomethyl (+57.02) 1,192.55 2,383.08 2,383.09 2 ZYX_HUMAN,TENX_HUMAN,CPXM2_HUMAN,AEBP1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 2 5 14.80% TcPKPDDLPFSTVVPLK 95.00% 3.8 0.447 2.27 c2: Carbamidomethyl (+57.02) 638.6725 1,912.99 1,914.01 3
 SAMPLE 2 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 2 5 14.80% TcPKPDDLPFSTVVPLK 95.00% 3.58 0.362 1.35 c2: Carbamidomethyl (+57.02) 638.6731 1,913.00 1,914.01 3
 SAMPLE 2 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 2 5 14.80% VcPFAGILENGAVR 95.00% 3.88 0.451 2.03 c2: Carbamidomethyl (+57.02) 751.8922 1,501.77 1,502.78 2
 SAMPLE 2 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 2 5 14.80% VcPFAGILENGAVR 95.00% 3.95 0.388 1.25 c2: Carbamidomethyl (+57.02) 751.8922 1,501.77 1,502.78 2
 SAMPLE 2 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 2 5 14.80% VcPFAGILENGAVR 95.00% 4.5 0.45 2.66 c2: Carbamidomethyl (+57.02) 751.8923 1,501.77 1,502.78 2
 SAMPLE 2 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 99.80% 2 2 5 14.80% TFYEPGEEITYScKPGYVSR 95.00% 4.97 0.632 4.62 c13: Carbamidomethyl (+57.02) 1,192.55 2,383.08 2,383.09 2 ZYX_HUMAN,TENX_HUMAN,CPXM2_HUMAN,AEBP1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 7 13.30% TcPKPDDLPFSTVVPLK 95.00% 3.15 0.39 1.89 c2: Carbamidomethyl (+57.02) 639.0061 1,913.99 1,914.01 3
 SAMPLE 2R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 7 13.30% TcPKPDDLPFSTVVPLK 95.00% 4.11 0.483 1.68 c2: Carbamidomethyl (+57.02) 639.0073 1,914.00 1,914.01 3
 SAMPLE 2R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 7 13.30% VcPFAGILENGAVR 95.00% 4.24 0.417 4.06 c2: Carbamidomethyl (+57.02) 751.8921 1,501.77 1,502.78 2
 SAMPLE 2R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 7 13.30% VcPFAGILENGAVR 95.00% 4.47 0.402 3.74 c2: Carbamidomethyl (+57.02) 751.8931 1,501.77 1,502.78 2
 SAMPLE 2R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 7 13.30% VcPFAGILENGAVR 95.00% 3.19 0.408 2.3 c2: Carbamidomethyl (+57.02) 751.8943 1,501.77 1,502.78 2
 SAMPLE 2R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 7 13.30% FIcPLTGLWPINTLK 95.00% 3.42 0.477 1.49 c3: Carbamidomethyl (+57.02) 886.9883 1,771.96 1,772.98 2
 SAMPLE 2R Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 7 13.30% FIcPLTGLWPINTLK 95.00% 3.87 0.478 4.24 c3: Carbamidomethyl (+57.02) 886.9911 1,771.97 1,772.98 2
 SAMPLE 3 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 6 18.00% ATVVYQGER 95.00% 2.16 0.274 0 512.2583 1,022.50 1,022.53 2
 SAMPLE 3 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 6 18.00% VcPFAGILENGAVR 95.00% 3.77 0.337 2 c2: Carbamidomethyl (+57.02) 751.8916 1,501.77 1,502.78 2
 SAMPLE 3 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 6 18.00% VcPFAGILENGAVR 95.00% 4.36 0.396 4.06 c2: Carbamidomethyl (+57.02) 751.8926 1,501.77 1,502.78 2
 SAMPLE 3 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 6 18.00% VcPFAGILENGAVR 95.00% 4.36 0.422 4.32 c2: Carbamidomethyl (+57.02) 751.8927 1,501.77 1,502.78 2
 SAMPLE 3 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 6 18.00% VcPFAGILENGAVR 95.00% 3.58 0.272 2 c2: Carbamidomethyl (+57.02) 752.3938 1,502.77 1,502.78 2
 SAMPLE 3 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 6 18.00% ATFGcHDGYSLDGPEEIEcTK 95.00% 4.35 0.437 4.19 c5: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 796.3377 2,385.99 2,386.00 3
 SAMPLE 3 Beta-2-glycoprotein 1  APOH  APOH_HUMAN 38,280.50 100.00% 3 3 6 18.00% cSYTEDAQcIDGTIEVPK 95.00% 5.38 0.552 6.21 c1: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,043.96 2,085.90 2,085.91 2 TITIN_HUMAN
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VPSGLPDLK 95.00% 2.83 0.366 0 463.272 924.5284 925.5361 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VPSGLPDLK 95.00% 2.55 0.254 0 463.2737 924.5318 925.5361 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VPSGLPDLK 95.00% 2.72 0.246 0 463.2737 924.5318 925.5361 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VPSGLPDLK 95.00% 2.8 0.311 0 463.2741 924.5325 925.5361 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VPSGLPDLK 95.00% 2.77 0.319 0 463.2741 924.5326 925.5361 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VPSGLPDLK 95.00% 2.93 0.333 0 463.2742 924.5327 925.5361 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VPSGLPDLK 95.00% 2.95 0.291 0 463.2743 924.5329 925.5361 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VPSGLPDLK 95.00% 2.77 0.316 0 463.2749 924.5341 925.5361 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VPSGLPDLK 95.00% 2.78 0.283 0 463.2751 924.5345 925.5361 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% GLQHLYALVLVNNK 95.00% 3.11 0.336 0 527.9753 1,580.90 1,581.91 3
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% GLQHLYALVLVNNK 95.00% 2.76 0.232 0 527.9779 1,580.91 1,581.91 3
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% GLQHLYALVLVNNK 95.00% 3.4 0.282 0 528.3116 1,581.91 1,581.91 3
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VVQcSDLGLK 95.00% 2.91 0.423 1.31 c4: Carbamidomethyl (+57.02) 559.7987 1,117.58 1,118.59 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VVQcSDLGLK 95.00% 3.02 0.475 1.57 c4: Carbamidomethyl (+57.02) 559.7989 1,117.58 1,118.59 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VVQcSDLGLK 95.00% 2.63 0.364 0 c4: Carbamidomethyl (+57.02) 559.7989 1,117.58 1,118.59 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VVQcSDLGLK 95.00% 2.63 0.413 1.37 c4: Carbamidomethyl (+57.02) 559.799 1,117.58 1,118.59 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VVQcSDLGLK 95.00% 3.18 0.471 3.14 c4: Carbamidomethyl (+57.02) 559.7991 1,117.58 1,118.59 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VVQcSDLGLK 95.00% 2.58 0.358 2.89 c4: Carbamidomethyl (+57.02) 559.7992 1,117.58 1,118.59 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VVQcSDLGLK 95.00% 3.17 0.522 2.35 c4: Carbamidomethyl (+57.02) 559.7995 1,117.58 1,118.59 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VVQcSDLGLK 95.00% 3.1 0.465 1.82 c4: Carbamidomethyl (+57.02) 559.7997 1,117.58 1,118.59 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VVQcSDLGLK 95.00% 3.04 0.467 1.85 c4: Carbamidomethyl (+57.02) 559.7997 1,117.58 1,118.59 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VVQcSDLGLK 95.00% 3.01 0.467 2.27 c4: Carbamidomethyl (+57.02) 559.8 1,117.58 1,118.59 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VVQcSDLGLK 95.00% 3.01 0.477 2.08 c4: Carbamidomethyl (+57.02) 559.8001 1,117.58 1,118.59 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VVQcSDLGLK 95.00% 2.6 0.433 1.46 c4: Carbamidomethyl (+57.02) 559.8013 1,117.59 1,118.59 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 3.7 0.304 2.96 656.8786 1,311.74 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 3.84 0.302 2.1 656.879 1,311.74 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 3.95 0.305 2.92 656.8793 1,311.74 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 4.01 0.327 2.74 656.8797 1,311.74 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 3.98 0.335 1.85 656.8799 1,311.74 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 3.09 0.237 2.01 656.88 1,311.74 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 4.13 0.315 2.49 656.88 1,311.74 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 4.18 0.314 2.01 656.88 1,311.74 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 3.86 0.319 2.15 656.8802 1,311.74 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 4.22 0.305 1.82 656.8804 1,311.75 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 3.55 0.221 2.68 656.8805 1,311.75 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 4.06 0.324 2.24 656.8806 1,311.75 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% IQAIELEDLLR 95.00% 3.14 0.271 2.41 656.8811 1,311.75 1,312.75 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VGVNDFcPmGFGVK 95.00% 3.32 0.458 0 c7: Carbamidomethyl (+57.02), m9: Oxidation (+15.99) 771.8623 1,541.71 1,542.71 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% VGVNDFcPmGFGVK 95.00% 3.65 0.493 2.24 c7: Carbamidomethyl (+57.02), m9: Oxidation (+15.99) 772.3628 1,542.71 1,542.71 2
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% EISPDTTLLDLQNNDISELRK 95.00% 2.28 0.347 3.55 805.7544 2,414.24 2,414.24 3
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% EISPDTTLLDLQNNDISELRK 95.00% 2.46 0.429 2.89 805.7557 2,414.24 2,414.24 3
 SAMPLE 4 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 7 7 42 26.40% NHLVEIPPNLPSSLVELR 95.00% 4.22 0.507 4.64 1,014.57 2,027.13 2,027.13 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VPSGLPDLK 95.00% 2.47 0.271 0 463.2735 924.5313 925.5361 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VPSGLPDLK 95.00% 2.51 0.2 0 463.2735 924.5314 925.5361 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VPSGLPDLK 95.00% 2.72 0.295 0 463.274 924.5323 925.5361 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VPSGLPDLK 95.00% 2.93 0.302 0 463.2744 924.5331 925.5361 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VPSGLPDLK 95.00% 2.37 0.288 0 463.2745 924.5333 925.5361 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VPSGLPDLK 95.00% 2.4 0.251 0 463.2745 924.5334 925.5361 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VPSGLPDLK 95.00% 2.78 0.335 0 463.2748 924.534 925.5361 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VPSGLPDLK 95.00% 2.58 0.233 0 463.2749 924.5342 925.5361 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% GLQHLYALVLVNNK 95.00% 3.18 0.408 0 527.9756 1,580.90 1,581.91 3
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% GLQHLYALVLVNNK 95.00% 3.05 0.322 0 527.9766 1,580.91 1,581.91 3
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% GLQHLYALVLVNNK 95.00% 3.13 0.274 0 527.9777 1,580.91 1,581.91 3
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% GLQHLYALVLVNNK 95.00% 3.3 0.403 0 527.9783 1,580.91 1,581.91 3
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% GLQHLYALVLVNNK 95.00% 3.18 0.309 0 528.3111 1,581.91 1,581.91 3
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VVQcSDLGLK 95.00% 3.01 0.486 2.42 c4: Carbamidomethyl (+57.02) 559.7992 1,117.58 1,118.59 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VVQcSDLGLK 95.00% 3.03 0.493 1.7 c4: Carbamidomethyl (+57.02) 559.7993 1,117.58 1,118.59 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VVQcSDLGLK 95.00% 2.55 0.378 2.21 c4: Carbamidomethyl (+57.02) 559.7995 1,117.58 1,118.59 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VVQcSDLGLK 95.00% 2.71 0.398 1.44 c4: Carbamidomethyl (+57.02) 559.7995 1,117.58 1,118.59 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VVQcSDLGLK 95.00% 3.15 0.479 2.92 c4: Carbamidomethyl (+57.02) 559.7995 1,117.58 1,118.59 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VVQcSDLGLK 95.00% 3.06 0.467 2.57 c4: Carbamidomethyl (+57.02) 559.7996 1,117.58 1,118.59 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VVQcSDLGLK 95.00% 3 0.497 1.66 c4: Carbamidomethyl (+57.02) 559.7996 1,117.58 1,118.59 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VVQcSDLGLK 95.00% 2.95 0.398 1.54 c4: Carbamidomethyl (+57.02) 559.7998 1,117.58 1,118.59 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VVQcSDLGLK 95.00% 2.93 0.475 2.05 c4: Carbamidomethyl (+57.02) 559.8002 1,117.58 1,118.59 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% VVQcSDLGLK 95.00% 2.77 0.36 0 c4: Carbamidomethyl (+57.02) 559.8004 1,117.59 1,118.59 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 2.46 0.214 0 656.8779 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 2.75 0.362 1.57 656.8789 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 2.9 0.309 2.31 656.8791 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 2.64 0.209 0 656.8791 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 3.72 0.304 2.7 656.8791 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 2.38 0.248 0 656.8792 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 3.89 0.313 2.77 656.8794 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 3.63 0.317 2.59 656.8797 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 3.86 0.318 1.7 656.8797 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 3.66 0.286 2.77 656.8799 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 3.92 0.32 2.51 656.8799 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 3.95 0.328 2.64 656.88 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 3.56 0.276 2.48 656.88 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 2.66 0.324 0 656.88 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 4.3 0.312 2.18 656.8802 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 3.9 0.337 2.96 656.8802 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% IQAIELEDLLR 95.00% 2.63 0.297 2.49 656.8803 1,311.74 1,312.75 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% NHLVEIPPNLPSSLVELR 95.00% 2.61 0.216 5 676.3843 2,026.13 2,027.13 3
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% NHLVEIPPNLPSSLVELR 95.00% 3.84 0.338 7.38 676.7186 2,027.13 2,027.13 3
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% GLQHLYALVLVNNK 95.00% 3.98 0.497 3.89 791.9637 1,581.91 1,581.91 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% EISPDTTLLDLQNNDISELRK 95.00% 3 0.54 1.72 805.7556 2,414.24 2,414.24 3
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% EISPDTTLLDLQNNDISELRK 95.00% 2.94 0.391 2.62 805.7562 2,414.25 2,414.24 3
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% NHLVEIPPNLPSSLVELR 95.00% 4.5 0.506 5.35 1,014.57 2,027.13 2,027.13 2
 SAMPLE 4R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 6 8 47 22.60% NHLVEIPPNLPSSLVELR 95.00% 4.27 0.562 5.3 1,014.58 2,027.13 2,027.13 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.33 0.214 0 463.2683 924.521 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.88 0.304 0 463.2707 924.5258 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.61 0.25 0 463.2711 924.5266 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.77 0.259 0 463.2712 924.5268 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.74 0.336 0 463.2715 924.5274 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.87 0.24 0 463.2716 924.5275 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.51 0.266 0 463.2718 924.528 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.31 0.243 0 463.2721 924.5285 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.79 0.305 0 463.2722 924.5288 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.65 0.226 0 463.2723 924.529 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.48 0.236 0 463.273 924.5304 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.68 0.196 0 463.2732 924.5307 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.67 0.296 0 463.2732 924.5307 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.57 0.252 0 463.2733 924.5309 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VPSGLPDLK 95.00% 2.42 0.268 0 463.274 924.5324 925.5361 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% LAIQFGNYK 95.00% 2.7 0.402 2.96 527.2885 1,052.56 1,053.57 2 AHNK_HUMAN
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% LAIQFGNYK 95.00% 2.55 0.408 3.43 527.2892 1,052.56 1,053.57 2 AHNK_HUMAN
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 3.19 0.249 0 527.9735 1,580.90 1,581.91 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 3.77 0.321 0 527.9742 1,580.90 1,581.91 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 3 0.219 0 527.9743 1,580.90 1,581.91 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 3.33 0.28 0 527.9744 1,580.90 1,581.91 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 4.11 0.33 0 527.9746 1,580.90 1,581.91 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 3.99 0.307 0 527.9761 1,580.90 1,581.91 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 3.93 0.214 0 527.9791 1,580.91 1,581.91 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 3.49 0.291 0 527.9849 1,580.93 1,581.91 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 3.64 0.334 0 527.9852 1,580.93 1,581.91 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 2.99 0.236 0 528.3154 1,581.92 1,581.91 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.25 0.407 0 c4: Carbamidomethyl (+57.02) 559.7937 1,117.57 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.96 0.432 0 c4: Carbamidomethyl (+57.02) 559.7945 1,117.57 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 3.2 0.529 2.34 c4: Carbamidomethyl (+57.02) 559.7957 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.93 0.479 1.46 c4: Carbamidomethyl (+57.02) 559.7961 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.87 0.448 0 c4: Carbamidomethyl (+57.02) 559.7962 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.9 0.402 0 c4: Carbamidomethyl (+57.02) 559.7968 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.45 0.324 0 c4: Carbamidomethyl (+57.02) 559.7969 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.94 0.496 0 c4: Carbamidomethyl (+57.02) 559.797 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.86 0.477 1.42 c4: Carbamidomethyl (+57.02) 559.797 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.93 0.421 0 c4: Carbamidomethyl (+57.02) 559.7971 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.87 0.43 2.52 c4: Carbamidomethyl (+57.02) 559.7971 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 3.01 0.445 2.28 c4: Carbamidomethyl (+57.02) 559.7977 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 3 0.404 2.08 c4: Carbamidomethyl (+57.02) 559.7979 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.94 0.49 2.07 c4: Carbamidomethyl (+57.02) 559.7979 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 3.34 0.497 2.49 c4: Carbamidomethyl (+57.02) 559.7979 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.86 0.506 2.38 c4: Carbamidomethyl (+57.02) 559.7989 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 2.12 0.284 0 c4: Carbamidomethyl (+57.02) 559.7996 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VVQcSDLGLK 95.00% 3 0.435 1.52 c4: Carbamidomethyl (+57.02) 559.8003 1,117.58 1,118.59 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VGVNDFcPMGFGVKR 95.00% 3.22 0.359 1.09 c7: Carbamidomethyl (+57.02) 561.6062 1,681.80 1,682.81 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VGVNDFcPMGFGVKR 95.00% 2.6 0.253 0 c7: Carbamidomethyl (+57.02) 561.6063 1,681.80 1,682.81 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNKISK 95.00% 5.02 0.559 3.03 637.7128 1,910.12 1,910.12 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.16 0.266 1.92 656.8754 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.06 0.328 2.11 656.8758 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.18 0.306 1.31 656.8759 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.15 0.32 1.64 656.8761 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 3.6 0.322 3.06 656.8766 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.1 0.338 1.34 656.8766 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.2 0.3 1.29 656.8766 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.17 0.316 1.52 656.8767 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.06 0.32 1.85 656.8767 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.03 0.311 1.35 656.8767 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.33 0.327 2.22 656.8767 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.04 0.3 2.03 656.8769 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.16 0.362 1.7 656.8769 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.03 0.306 1.77 656.8769 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.21 0.298 1.62 656.877 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.12 0.343 1.51 656.8771 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 3.85 0.286 1.66 656.8778 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.05 0.348 2.04 656.8779 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 2.94 0.15 0 656.8779 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 3.36 0.241 1.92 656.8789 1,311.74 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 3.59 0.275 2 656.882 1,311.75 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 3.44 0.248 0 656.8858 1,311.76 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 3.84 0.275 2.17 656.8896 1,311.76 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.08 0.362 1.44 656.8896 1,311.76 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% IQAIELEDLLR 95.00% 4.22 0.315 1.4 656.8905 1,311.77 1,312.75 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 3.39 0.354 6.34 676.3798 2,026.12 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 3.33 0.357 4.02 676.3806 2,026.12 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 3.47 0.437 4.52 676.7137 2,027.12 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 4.01 0.392 5.24 676.714 2,027.12 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 3.79 0.353 6.13 676.7143 2,027.12 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 3.58 0.326 4.74 676.7143 2,027.12 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 4.02 0.382 4.7 676.7145 2,027.12 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 3.68 0.332 5.57 676.7146 2,027.12 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 4.78 0.498 6.85 676.7146 2,027.12 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 4.3 0.345 5.74 676.7151 2,027.12 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 3.8 0.362 5.55 676.7154 2,027.12 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 4.72 0.407 5.92 676.7164 2,027.13 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 4.28 0.383 5.28 676.7172 2,027.13 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 4.47 0.436 5.07 676.7173 2,027.13 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 3.18 0.335 2 676.7173 2,027.13 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 4.35 0.298 6.51 676.7202 2,027.14 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 4.55 0.431 4.54 676.7204 2,027.14 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 3.37 0.368 6.17 676.7215 2,027.14 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 3.31 0.397 6.64 676.7269 2,027.16 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 3.45 0.376 6.6 676.7271 2,027.16 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 2.42 0.388 3.03 676.7277 2,027.16 2,027.13 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% DDFKGLQHLYALVLVNNK 95.00% 3.5 0.312 0 696.7179 2,087.13 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% DDFKGLQHLYALVLVNNK 95.00% 4.5 0.533 0 696.7235 2,087.15 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% DDFKGLQHLYALVLVNNK 95.00% 3.34 0.383 0 696.7266 2,087.16 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELR 95.00% 6.51 0.57 3.48 763.0532 2,286.14 2,286.15 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELR 95.00% 6.65 0.582 3.43 763.0535 2,286.14 2,286.15 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VGVNDFcPMGFGVK 95.00% 4.48 0.58 5.01 c7: Carbamidomethyl (+57.02) 763.8579 1,525.70 1,526.71 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VGVNDFcPMGFGVK 95.00% 3.94 0.581 4.02 c7: Carbamidomethyl (+57.02) 763.8585 1,525.70 1,526.71 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VGVNDFcPMGFGVK 95.00% 4.39 0.591 4.27 c7: Carbamidomethyl (+57.02) 763.8586 1,525.70 1,526.71 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VGVNDFcPMGFGVK 95.00% 4.2 0.577 5.05 c7: Carbamidomethyl (+57.02) 763.8587 1,525.70 1,526.71 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VGVNDFcPMGFGVK 95.00% 3.91 0.531 3.77 c7: Carbamidomethyl (+57.02) 763.8589 1,525.70 1,526.71 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VGVNDFcPMGFGVK 95.00% 4.05 0.54 4.38 c7: Carbamidomethyl (+57.02) 763.8592 1,525.70 1,526.71 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VGVNDFcPMGFGVK 95.00% 3.39 0.494 1.82 c7: Carbamidomethyl (+57.02) 763.8596 1,525.70 1,526.71 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VGVNDFcPMGFGVK 95.00% 3.45 0.532 2.4 c7: Carbamidomethyl (+57.02) 763.8662 1,525.72 1,526.71 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VGVNDFcPMGFGVK 95.00% 2.44 0.476 0 c7: Carbamidomethyl (+57.02) 763.8673 1,525.72 1,526.71 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% VGVNDFcPMGFGVK 95.00% 4 0.533 3.85 c7: Carbamidomethyl (+57.02) 764.3607 1,526.71 1,526.71 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% MIENGSLSFLPTLR 95.00% 2.74 0.179 1.8 789.9119 1,577.81 1,577.84 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% MIENGSLSFLPTLR 95.00% 3.05 0.19 2.22 789.9137 1,577.81 1,577.84 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 4.66 0.608 3.12 791.457 1,580.90 1,581.91 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 5.3 0.571 2.57 791.4581 1,580.90 1,581.91 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 4.15 0.562 3.28 791.4588 1,580.90 1,581.91 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 4.78 0.57 2.37 791.4597 1,580.90 1,581.91 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 4.71 0.543 3 791.4679 1,580.92 1,581.91 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 4.72 0.478 2.82 791.4728 1,580.93 1,581.91 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 5.29 0.553 3.2 791.9587 1,581.90 1,581.91 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% GLQHLYALVLVNNK 95.00% 5.14 0.536 2.15 791.9591 1,581.90 1,581.91 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 2.5 0.455 3.47 805.7496 2,414.23 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 2.55 0.338 1.54 805.7503 2,414.23 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 2.33 0.348 1.04 805.751 2,414.23 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 2.93 0.474 2.82 805.751 2,414.23 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 2.55 0.55 1.51 805.7512 2,414.23 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 3.01 0.422 0 805.7516 2,414.23 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 2.46 0.471 2.29 805.7522 2,414.23 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 2.1 0.292 0 805.7524 2,414.23 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 2.4 0.331 1.89 805.7535 2,414.24 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 2.3 0.312 1.24 805.7588 2,414.25 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 2.61 0.288 1.24 805.7598 2,414.26 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 2.58 0.503 1.77 805.7628 2,414.27 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 1.85 0.283 0 805.7632 2,414.27 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 2.79 0.419 1.39 805.7647 2,414.27 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 3.08 0.416 3.89 805.7648 2,414.27 2,414.24 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% DLPETLNELHLDHNK 95.00% 4.57 0.395 2.12 894.447 1,786.88 1,787.89 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% DLPETLNELHLDHNK 95.00% 4.53 0.503 3.49 894.4471 1,786.88 1,787.89 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% DLPETLNELHLDHNK 95.00% 4.81 0.47 3.52 894.4475 1,786.88 1,787.89 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% DLPETLNELHLDHNK 95.00% 4.29 0.488 1.89 894.4488 1,786.88 1,787.89 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% DLPETLNELHLDHNK 95.00% 4.63 0.553 4.41 894.4491 1,786.88 1,787.89 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% DLPETLNELHLDHNK 95.00% 4.1 0.363 4.04 894.9476 1,787.88 1,787.89 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% DLPETLNELHLDHNK 95.00% 3.79 0.39 1.68 894.9486 1,787.88 1,787.89 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% SVPKEISPDTTLLDLQNNDISELRK 95.00% 4.28 0.405 0 942.8339 2,825.48 2,825.49 3
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 4.65 0.499 7 1,014.56 2,027.11 2,027.13 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 4.49 0.528 8.12 1,014.57 2,027.12 2,027.13 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 3.9 0.513 5.28 1,014.58 2,027.15 2,027.13 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% NHLVEIPPNLPSSLVELR 95.00% 4.32 0.547 4.77 1,014.59 2,027.16 2,027.13 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% DDFKGLQHLYALVLVNNK 95.00% 4.78 0.538 4.74 1,044.57 2,087.12 2,087.13 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELR 95.00% 5.55 0.621 7.06 1,144.07 2,286.13 2,286.15 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELR 95.00% 5.82 0.639 6.24 1,144.07 2,286.13 2,286.15 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELR 95.00% 5.51 0.606 6.24 1,144.08 2,286.13 2,286.15 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELR 95.00% 5.79 0.615 4.82 1,144.08 2,286.14 2,286.15 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELR 95.00% 4.86 0.618 5.51 1,144.08 2,286.14 2,286.15 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELR 95.00% 5.02 0.576 4.24 1,144.08 2,286.14 2,286.15 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 4.53 0.518 1.8 1,208.12 2,414.23 2,414.24 2
 SAMPLE 1 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 149 39.90% EISPDTTLLDLQNNDISELRK 95.00% 4.74 0.517 2.07 1,208.13 2,414.23 2,414.24 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VPSGLPDLK 95.00% 2.59 0.259 0 463.27 924.5243 925.5361 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VPSGLPDLK 95.00% 2.8 0.323 0 463.2704 924.5252 925.5361 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VPSGLPDLK 95.00% 2.7 0.332 0 463.2704 924.5252 925.5361 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VPSGLPDLK 95.00% 2.55 0.266 0 463.2709 924.5262 925.5361 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VPSGLPDLK 95.00% 2.77 0.278 0 463.2711 924.5266 925.5361 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VPSGLPDLK 95.00% 2.78 0.289 0 463.2713 924.527 925.5361 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VPSGLPDLK 95.00% 2.71 0.286 0 463.2715 924.5273 925.5361 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VPSGLPDLK 95.00% 2.55 0.257 0 463.2716 924.5275 925.5361 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VPSGLPDLK 95.00% 2.79 0.256 0 463.2718 924.5279 925.5361 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VPSGLPDLK 95.00% 2.54 0.228 0 463.2722 924.5288 925.5361 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VPSGLPDLK 95.00% 2.77 0.327 0 463.2723 924.529 925.5361 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VPSGLPDLK 95.00% 2.61 0.177 0 463.2742 924.5327 925.5361 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% LGLGHNQIR 95.00% 2.25 0.285 0 504.2906 1,006.57 1,007.58 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 3.78 0.384 0 527.9739 1,580.90 1,581.91 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 2.49 0.331 0 527.9744 1,580.90 1,581.91 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 3.36 0.23 0 527.9745 1,580.90 1,581.91 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 4.01 0.311 0 527.9747 1,580.90 1,581.91 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 3.28 0.323 0 527.9755 1,580.90 1,581.91 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 3.99 0.307 0 527.9761 1,580.90 1,581.91 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 3.93 0.214 0 527.9791 1,580.91 1,581.91 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 3.66 0.261 0 527.9847 1,580.93 1,581.91 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 3.16 0.164 0 527.9849 1,580.93 1,581.91 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 3.08 0.196 0 528.3104 1,581.91 1,581.91 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 2.99 0.236 0 528.3154 1,581.92 1,581.91 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 3.19 0.518 1.96 c4: Carbamidomethyl (+57.02) 559.7954 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.8 0.434 2.18 c4: Carbamidomethyl (+57.02) 559.7956 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 3.18 0.511 1.48 c4: Carbamidomethyl (+57.02) 559.7957 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.76 0.399 1.8 c4: Carbamidomethyl (+57.02) 559.7959 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.42 0.34 0 c4: Carbamidomethyl (+57.02) 559.7959 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 3.21 0.52 2.44 c4: Carbamidomethyl (+57.02) 559.7961 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.77 0.43 1.16 c4: Carbamidomethyl (+57.02) 559.7962 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.78 0.49 1.66 c4: Carbamidomethyl (+57.02) 559.7963 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.85 0.448 2.66 c4: Carbamidomethyl (+57.02) 559.7965 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 3.2 0.495 2.25 c4: Carbamidomethyl (+57.02) 559.7965 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.94 0.43 2.08 c4: Carbamidomethyl (+57.02) 559.7966 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.69 0.459 0 c4: Carbamidomethyl (+57.02) 559.7966 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.96 0.393 1.36 c4: Carbamidomethyl (+57.02) 559.7967 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.44 0.435 1.89 c4: Carbamidomethyl (+57.02) 559.7968 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.83 0.441 0 c4: Carbamidomethyl (+57.02) 559.7968 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.86 0.457 2 c4: Carbamidomethyl (+57.02) 559.7975 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.65 0.492 1.21 c4: Carbamidomethyl (+57.02) 559.7978 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 2.24 0.313 0 c4: Carbamidomethyl (+57.02) 559.7997 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VVQcSDLGLK 95.00% 3 0.435 1.8 c4: Carbamidomethyl (+57.02) 559.8003 1,117.58 1,118.59 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% ISEAKLTGIPK 95.00% 2.61 0.284 0 578.8485 1,155.68 1,156.69 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% ISEAKLTGIPK 95.00% 2.69 0.296 1.24 578.8542 1,155.69 1,156.69 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNKISK 95.00% 3.06 0.435 1.03 637.3785 1,909.11 1,910.12 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.25 0.303 2 656.8747 1,311.73 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.47 0.327 1.96 656.8751 1,311.73 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.33 0.288 1.54 656.8756 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 4 0.315 2.66 656.8761 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 4.11 0.323 2.22 656.8761 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 2.98 0.31 2.01 656.8761 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.95 0.345 2.28 656.8762 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.85 0.336 1.77 656.8763 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.87 0.331 1.55 656.8765 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.85 0.338 2.28 656.8766 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 4.09 0.324 2.01 656.8768 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 2.4 0.218 0 656.8769 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.42 0.307 2.24 656.877 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.92 0.271 2.92 656.8773 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.38 0.309 1.31 656.8773 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.53 0.296 1.85 656.8779 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 2.94 0.15 1.43 656.8779 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 2.84 0.207 2.21 656.878 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.36 0.241 2.11 656.8789 1,311.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.59 0.275 1.17 656.882 1,311.75 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.44 0.248 1.13 656.8858 1,311.76 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.76 0.305 1.47 656.89 1,311.76 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 4.02 0.364 3.09 656.8901 1,311.76 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 3.1 0.349 2 656.8908 1,311.77 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% IQAIELEDLLR 95.00% 2.88 0.176 1.7 657.3796 1,312.74 1,312.75 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 3.28 0.377 4.92 676.3807 2,026.12 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 2.65 0.4 5.89 676.3931 2,026.16 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 3.67 0.316 4.85 676.714 2,027.12 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.11 0.317 5.36 676.7143 2,027.12 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.11 0.38 6.74 676.7144 2,027.12 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.19 0.387 6.21 676.7145 2,027.12 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 3.03 0.446 6.3 676.7147 2,027.12 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.43 0.364 5 676.7148 2,027.12 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 3.79 0.371 6.51 676.7151 2,027.12 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.66 0.426 6.8 676.7152 2,027.12 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 3.42 0.326 6.39 676.7154 2,027.12 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 3.71 0.356 6.82 676.7154 2,027.12 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.72 0.407 5.59 676.7164 2,027.13 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 3.18 0.335 2.36 676.7173 2,027.13 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.35 0.298 6.23 676.7202 2,027.14 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.55 0.431 5.38 676.7204 2,027.14 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 3.37 0.368 5.92 676.7215 2,027.14 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.07 0.23 3.7 676.7278 2,027.16 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.62 0.373 5.92 676.7283 2,027.16 2,027.13 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% DDFKGLQHLYALVLVNNK 95.00% 4.73 0.438 0 696.7148 2,087.12 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% DDFKGLQHLYALVLVNNK 95.00% 4.5 0.533 0 696.7235 2,087.15 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% DDFKGLQHLYALVLVNNK 95.00% 3.34 0.383 0 696.7266 2,087.16 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELR 95.00% 6.83 0.569 3.24 763.0524 2,286.13 2,286.15 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELR 95.00% 7.42 0.587 2.68 763.0541 2,286.14 2,286.15 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VGVNDFcPMGFGVK 95.00% 4.09 0.533 4.21 c7: Carbamidomethyl (+57.02) 763.8586 1,525.70 1,526.71 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VGVNDFcPMGFGVK 95.00% 4.12 0.563 3.96 c7: Carbamidomethyl (+57.02) 763.8586 1,525.70 1,526.71 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VGVNDFcPMGFGVK 95.00% 4.14 0.554 4.89 c7: Carbamidomethyl (+57.02) 763.8588 1,525.70 1,526.71 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VGVNDFcPMGFGVK 95.00% 3.69 0.507 3.59 c7: Carbamidomethyl (+57.02) 763.8594 1,525.70 1,526.71 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VGVNDFcPMGFGVK 95.00% 2.44 0.476 0 c7: Carbamidomethyl (+57.02) 763.8673 1,525.72 1,526.71 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VGVNDFcPMGFGVK 95.00% 3.97 0.471 4.3 c7: Carbamidomethyl (+57.02) 764.3608 1,526.71 1,526.71 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% VGVNDFcPMGFGVK 95.00% 3.62 0.499 3.01 c7: Carbamidomethyl (+57.02) 764.3621 1,526.71 1,526.71 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% MIENGSLSFLPTLR 95.00% 2.88 0.224 1.49 789.9273 1,577.84 1,577.84 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 5.14 0.557 2.15 791.4572 1,580.90 1,581.91 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 4.66 0.596 3.64 791.4582 1,580.90 1,581.91 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 4.92 0.575 2 791.4583 1,580.90 1,581.91 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 4.24 0.532 4.48 791.4595 1,580.90 1,581.91 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 4.67 0.548 1.96 791.4596 1,580.90 1,581.91 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 2.71 0.276 0 791.4654 1,580.92 1,581.91 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 4.71 0.543 2.85 791.4679 1,580.92 1,581.91 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 3.78 0.54 3.04 791.4732 1,580.93 1,581.91 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 4.14 0.548 3.96 791.4743 1,580.93 1,581.91 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% GLQHLYALVLVNNK 95.00% 4.68 0.582 3 791.9604 1,581.91 1,581.91 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 2.42 0.253 1.72 805.4182 2,413.23 2,414.24 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 2.73 0.461 2 805.7495 2,414.22 2,414.24 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 2.62 0.405 2.64 805.7507 2,414.23 2,414.24 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 2.27 0.414 1.33 805.7518 2,414.23 2,414.24 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 2.64 0.367 1.64 805.752 2,414.23 2,414.24 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 2.2 0.137 1.8 805.7524 2,414.23 2,414.24 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 2.7 0.349 0 805.7537 2,414.24 2,414.24 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 2.61 0.288 1.82 805.7598 2,414.26 2,414.24 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 2.58 0.503 2.24 805.7628 2,414.27 2,414.24 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 1.85 0.283 1.02 805.7632 2,414.27 2,414.24 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 2.79 0.419 2.34 805.7647 2,414.27 2,414.24 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 3.08 0.416 4 805.7648 2,414.27 2,414.24 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% DLPETLNELHLDHNK 95.00% 4.77 0.443 3.82 894.4487 1,786.88 1,787.89 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% DLPETLNELHLDHNK 95.00% 4.62 0.365 2.77 894.9452 1,787.87 1,787.89 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% DLPETLNELHLDHNK 95.00% 3.79 0.39 1.49 894.9486 1,787.88 1,787.89 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% DLPETLNELHLDHNK 95.00% 4.52 0.49 2.85 894.9491 1,787.88 1,787.89 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% SVPKEISPDTTLLDLQNNDISELR 95.00% 4.28 0.413 0 900.134 2,697.38 2,697.40 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% SVPKEISPDTTLLDLQNNDISELR 95.00% 6.15 0.541 4.16 900.1359 2,697.38 2,697.40 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% SVPKEISPDTTLLDLQNNDISELRK 95.00% 3.82 0.411 0 942.836 2,825.48 2,825.49 3
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 3.91 0.394 5.46 1,014.07 2,026.12 2,027.13 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.14 0.485 5.23 1,014.07 2,026.13 2,027.13 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.51 0.54 5.66 1,014.57 2,027.12 2,027.13 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.7 0.492 6.29 1,014.57 2,027.12 2,027.13 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 3.9 0.513 5.18 1,014.58 2,027.15 2,027.13 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.38 0.52 6.66 1,014.59 2,027.16 2,027.13 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 4.14 0.507 5.96 1,014.59 2,027.17 2,027.13 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% NHLVEIPPNLPSSLVELR 95.00% 3.48 0.445 1.89 1,014.59 2,027.17 2,027.13 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% DDFKGLQHLYALVLVNNK 95.00% 4.86 0.499 4.62 1,044.57 2,087.12 2,087.13 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% DDFKGLQHLYALVLVNNK 95.00% 4.5 0.487 2.96 1,044.57 2,087.13 2,087.13 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELR 95.00% 5.7 0.607 5.64 1,144.07 2,286.13 2,286.15 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELR 95.00% 4.86 0.618 6.2 1,144.08 2,286.14 2,286.15 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELR 95.00% 5.9 0.595 7.48 1,144.08 2,286.14 2,286.15 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELR 95.00% 5.8 0.631 5.05 1,144.08 2,286.14 2,286.15 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 4.22 0.498 2.47 1,208.12 2,414.23 2,414.24 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 4.48 0.526 2.77 1,208.12 2,414.23 2,414.24 2
 SAMPLE 1R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 15 19 144 42.70% EISPDTTLLDLQNNDISELRK 95.00% 4.61 0.474 2.74 1,208.12 2,414.23 2,414.24 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 94.80% 2.34 0.212 0 463.2703 924.525 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.52 0.285 0 463.271 924.5263 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.59 0.301 0 463.2711 924.5266 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.45 0.305 0 463.2712 924.5267 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.7 0.326 0 463.2712 924.5267 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.81 0.32 0 463.2712 924.5268 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.77 0.335 0 463.2713 924.5269 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.48 0.252 0 463.2716 924.5276 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.45 0.261 0 463.2719 924.5282 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.84 0.319 0 463.2719 924.5282 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.57 0.301 0 463.272 924.5284 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.54 0.279 0 463.272 924.5284 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.78 0.279 0 463.2725 924.5293 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.59 0.277 0 463.2733 924.531 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.33 0.238 0 463.2735 924.5313 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VPSGLPDLK 95.00% 2.32 0.221 0 463.2735 924.5313 925.5361 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% LGLGHNQIR 95.00% 2.61 0.298 0 504.2889 1,006.56 1,007.58 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% LGLGHNQIR 95.00% 2.5 0.319 0 504.2897 1,006.56 1,007.58 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% LGLGHNQIR 95.00% 2.22 0.282 0 504.2899 1,006.56 1,007.58 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% LGLGHNQIR 95.00% 2.32 0.339 0 504.2927 1,006.57 1,007.58 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% LAIQFGNYK 95.00% 2.74 0.357 2.96 527.2888 1,052.56 1,053.57 2 AHNK_HUMAN
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% LAIQFGNYK 95.00% 2.8 0.411 2.54 527.2894 1,052.56 1,053.57 2 AHNK_HUMAN
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 3.31 0.309 0 527.9737 1,580.90 1,581.91 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 2.95 0.19 0 527.9738 1,580.90 1,581.91 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 3.71 0.291 0 527.9744 1,580.90 1,581.91 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 3.26 0.218 0 527.9745 1,580.90 1,581.91 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 3.72 0.388 0.921 527.9745 1,580.90 1,581.91 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 3.45 0.283 0 527.9746 1,580.90 1,581.91 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 4.19 0.298 0 527.9746 1,580.90 1,581.91 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 3.36 0.266 0 527.9747 1,580.90 1,581.91 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 3.7 0.311 0 528.3081 1,581.90 1,581.91 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 3.52 0.289 0 528.3085 1,581.90 1,581.91 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 2.24 0.371 0 c4: Carbamidomethyl (+57.02) 559.7948 1,117.57 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 2.23 0.354 0 c4: Carbamidomethyl (+57.02) 559.795 1,117.57 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 3.08 0.457 1.25 c4: Carbamidomethyl (+57.02) 559.7956 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 2.44 0.377 0 c4: Carbamidomethyl (+57.02) 559.796 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 3.03 0.479 1.19 c4: Carbamidomethyl (+57.02) 559.7961 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 2.83 0.426 0 c4: Carbamidomethyl (+57.02) 559.7965 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 3.13 0.507 1.49 c4: Carbamidomethyl (+57.02) 559.7965 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 3.35 0.483 1.96 c4: Carbamidomethyl (+57.02) 559.7965 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 2.91 0.394 1.34 c4: Carbamidomethyl (+57.02) 559.7967 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 2.47 0.326 0 c4: Carbamidomethyl (+57.02) 559.7967 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 3.14 0.455 1.85 c4: Carbamidomethyl (+57.02) 559.7968 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 2.34 0.379 0 c4: Carbamidomethyl (+57.02) 559.7968 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 3.06 0.427 0 c4: Carbamidomethyl (+57.02) 559.797 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 2.78 0.435 1.55 c4: Carbamidomethyl (+57.02) 559.7971 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 3.22 0.509 1.55 c4: Carbamidomethyl (+57.02) 559.7971 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 3.18 0.505 1.49 c4: Carbamidomethyl (+57.02) 559.7973 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 3.17 0.514 1.17 c4: Carbamidomethyl (+57.02) 559.7973 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 3.13 0.537 1.82 c4: Carbamidomethyl (+57.02) 559.7973 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 3.23 0.481 1.43 c4: Carbamidomethyl (+57.02) 559.7975 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 3.23 0.519 1.72 c4: Carbamidomethyl (+57.02) 559.7975 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 2.69 0.375 1.19 c4: Carbamidomethyl (+57.02) 559.7976 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 2.56 0.333 0 c4: Carbamidomethyl (+57.02) 559.7977 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VVQcSDLGLK 95.00% 2.44 0.355 0 c4: Carbamidomethyl (+57.02) 559.7997 1,117.58 1,118.59 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% ISEAKLTGIPK 95.00% 2.63 0.391 1.23 578.8534 1,155.69 1,156.69 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% IQAIELEDLLR 95.00% 3.85 0.328 1.29 656.876 1,311.74 1,312.75 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% IQAIELEDLLR 95.00% 4.13 0.33 1.51 656.8762 1,311.74 1,312.75 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% IQAIELEDLLR 95.00% 3.59 0.325 2.12 656.8763 1,311.74 1,312.75 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% IQAIELEDLLR 95.00% 4.02 0.345 2.26 656.8768 1,311.74 1,312.75 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% IQAIELEDLLR 95.00% 3.17 0.278 1.28 656.879 1,311.74 1,312.75 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% IQAIELEDLLR 95.00% 2.46 0.21 0 656.8791 1,311.74 1,312.75 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% ELHLDNNKLAR 95.00% 2.61 0.479 0 661.861 1,321.71 1,322.72 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% ELHLDNNKLAR 95.00% 2.75 0.414 1.38 661.8627 1,321.71 1,322.72 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 2.99 0.268 4.74 676.3811 2,026.12 2,027.13 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 4.15 0.353 6.96 676.7138 2,027.12 2,027.13 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 4.59 0.452 6.09 676.7145 2,027.12 2,027.13 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 3.66 0.331 6.2 676.7146 2,027.12 2,027.13 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 4.48 0.355 5.35 676.7148 2,027.12 2,027.13 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 3.63 0.414 6.04 676.715 2,027.12 2,027.13 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 3.58 0.341 1.54 676.7153 2,027.12 2,027.13 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 3.14 0.346 2.24 676.7158 2,027.12 2,027.13 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 2.98 0.191 1.85 676.7166 2,027.13 2,027.13 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 3.57 0.335 5.14 676.7176 2,027.13 2,027.13 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 3.95 0.382 4.21 676.7185 2,027.13 2,027.13 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% DDFKGLQHLYALVLVNNK 95.00% 5.5 0.523 0 696.3801 2,086.12 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% DDFKGLQHLYALVLVNNK 95.00% 5.72 0.484 1.72 696.7174 2,087.13 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% EISPDTTLLDLQNNDISELR 95.00% 6.37 0.573 3.92 763.0533 2,286.14 2,286.15 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% EISPDTTLLDLQNNDISELR 95.00% 6.34 0.59 3.57 763.0543 2,286.14 2,286.15 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VGVNDFcPMGFGVK 95.00% 4.42 0.592 5.68 c7: Carbamidomethyl (+57.02) 763.8578 1,525.70 1,526.71 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VGVNDFcPMGFGVK 95.00% 3.82 0.47 4.41 c7: Carbamidomethyl (+57.02) 763.8594 1,525.70 1,526.71 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VGVNDFcPMGFGVK 95.00% 3.83 0.468 1.8 c7: Carbamidomethyl (+57.02) 763.8596 1,525.70 1,526.71 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VGVNDFcPMGFGVK 95.00% 4.06 0.571 4.77 c7: Carbamidomethyl (+57.02) 763.8597 1,525.70 1,526.71 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VGVNDFcPMGFGVK 95.00% 3.61 0.529 2.77 c7: Carbamidomethyl (+57.02) 764.3609 1,526.71 1,526.71 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VGVNDFcPMGFGVK 95.00% 3.82 0.511 2.96 c7: Carbamidomethyl (+57.02) 764.3614 1,526.71 1,526.71 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VGVNDFcPMGFGVK 95.00% 3.24 0.395 2.11 c7: Carbamidomethyl (+57.02) 764.3615 1,526.71 1,526.71 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VGVNDFcPMGFGVK 95.00% 4.15 0.523 2.41 c7: Carbamidomethyl (+57.02) 764.3622 1,526.71 1,526.71 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% VGVNDFcPmGFGVK 95.00% 2.95 0.401 1.64 c7: Carbamidomethyl (+57.02), m9: Oxidation (+15.99) 771.86 1,541.70 1,542.71 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 5.19 0.538 2.72 791.4582 1,580.90 1,581.91 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 4.58 0.531 3.4 791.4586 1,580.90 1,581.91 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 5.2 0.565 2.42 791.9597 1,581.90 1,581.91 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 5.19 0.54 2.55 791.9601 1,581.90 1,581.91 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% GLQHLYALVLVNNK 95.00% 4.76 0.582 2.32 791.9607 1,581.91 1,581.91 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% EISPDTTLLDLQNNDISELRK 95.00% 2.82 0.518 2.48 805.7492 2,414.22 2,414.24 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% EISPDTTLLDLQNNDISELRK 95.00% 2.12 0.387 3.08 805.7513 2,414.23 2,414.24 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% EISPDTTLLDLQNNDISELRK 95.00% 2.88 0.51 2.7 805.7515 2,414.23 2,414.24 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% EISPDTTLLDLQNNDISELRK 95.00% 2.95 0.507 2.4 805.7516 2,414.23 2,414.24 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% EISPDTTLLDLQNNDISELRK 95.00% 2.67 0.551 2.42 805.7522 2,414.23 2,414.24 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% EISPDTTLLDLQNNDISELRK 95.00% 3.42 0.358 1.46 805.7526 2,414.23 2,414.24 3
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% DLPETLNELHLDHNK 95.00% 4.03 0.348 2.19 894.4452 1,786.87 1,787.89 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% DLPETLNELHLDHNK 95.00% 4.72 0.498 4.3 894.4488 1,786.88 1,787.89 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% DLPETLNELHLDHNK 95.00% 4.55 0.459 2.89 894.4496 1,786.88 1,787.89 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% DLPETLNELHLDHNK 95.00% 4.7 0.499 3.06 894.4513 1,786.89 1,787.89 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% DLPETLNELHLDHNK 95.00% 4.81 0.513 3.03 894.9478 1,787.88 1,787.89 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% DLPETLNELHLDHNK 95.00% 4.51 0.396 1.74 894.9484 1,787.88 1,787.89 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 2.97 0.254 1.57 1,013.93 2,025.83 2,027.13 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 2.97 0.288 2.14 1,013.93 2,025.84 2,027.13 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 4.75 0.531 5.55 1,014.57 2,027.12 2,027.13 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 4.63 0.492 5.96 1,014.57 2,027.12 2,027.13 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 3.27 0.236 2.31 1,014.57 2,027.13 2,027.13 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% NHLVEIPPNLPSSLVELR 95.00% 3.37 0.426 4.72 1,014.57 2,027.13 2,027.13 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% DDFKGLQHLYALVLVNNK 95.00% 5.02 0.515 5.89 1,044.57 2,087.12 2,087.13 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% DDFKGLQHLYALVLVNNK 95.00% 4.84 0.505 6.26 1,044.57 2,087.12 2,087.13 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% EISPDTTLLDLQNNDISELR 95.00% 5.83 0.611 3.72 1,144.08 2,286.14 2,286.15 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% EISPDTTLLDLQNNDISELR 95.00% 5.89 0.639 5.1 1,144.08 2,286.14 2,286.15 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% EISPDTTLLDLQNNDISELRK 95.00% 4.5 0.543 2.59 1,208.12 2,414.23 2,414.24 2
 SAMPLE 2 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 111 42.40% EISPDTTLLDLQNNDISELRK 95.00% 4.52 0.513 2.34 1,208.12 2,414.23 2,414.24 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.64 0.204 0 463.269 924.5223 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.66 0.297 0 463.2706 924.5255 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.83 0.301 0 463.2711 924.5266 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.43 0.28 0 463.2714 924.5271 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.37 0.297 0 463.2714 924.5271 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.41 0.27 0 463.2714 924.5272 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.68 0.301 0 463.2716 924.5276 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.65 0.317 0 463.2716 924.5276 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.65 0.27 0 463.2717 924.5277 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.28 0.272 0 463.2718 924.5279 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.43 0.286 1.54 463.2718 924.5279 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.43 0.315 0 463.2719 924.5281 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.14 0.256 0 463.2719 924.5282 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.74 0.268 0 463.2719 924.5282 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.48 0.26 0 463.2722 924.5287 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VPSGLPDLK 95.00% 2.28 0.282 0 463.2725 924.5293 925.5361 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% ELHLDNNK 95.00% 2.1 0.369 0 491.7514 981.4872 982.4959 2 PGS2_HUMAN
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% LGLGHNQIR 95.00% 2.45 0.336 0 504.2896 1,006.56 1,007.58 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% LGLGHNQIR 95.00% 2.15 0.282 1.51 504.29 1,006.56 1,007.58 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% LGLGHNQIR 95.00% 2.1 0.356 0 504.2901 1,006.56 1,007.58 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 3.08 0.18 0 527.9741 1,580.90 1,581.91 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 2.86 0.148 0 527.9749 1,580.90 1,581.91 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 3.06 0.278 0 527.975 1,580.90 1,581.91 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 2.69 0.292 0 528.2731 1,581.80 1,581.91 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 3.51 0.362 0 528.307 1,581.90 1,581.91 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 3.29 0.271 0 528.3071 1,581.90 1,581.91 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 3.97 0.267 1.11 528.3088 1,581.90 1,581.91 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 3.44 0.217 0 528.3089 1,581.90 1,581.91 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 3.56 0.256 0 528.309 1,581.90 1,581.91 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 4.07 0.295 0 528.3092 1,581.90 1,581.91 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.82 0.38 1.29 c4: Carbamidomethyl (+57.02) 559.7953 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.76 0.422 0 c4: Carbamidomethyl (+57.02) 559.7954 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.55 0.374 0 c4: Carbamidomethyl (+57.02) 559.7962 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 3.07 0.462 0 c4: Carbamidomethyl (+57.02) 559.7963 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.7 0.398 0 c4: Carbamidomethyl (+57.02) 559.7964 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.61 0.42 0 c4: Carbamidomethyl (+57.02) 559.7965 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.72 0.437 0 c4: Carbamidomethyl (+57.02) 559.7965 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 3.13 0.47 1.47 c4: Carbamidomethyl (+57.02) 559.7967 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 3.1 0.459 0 c4: Carbamidomethyl (+57.02) 559.7969 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.68 0.476 1.8 c4: Carbamidomethyl (+57.02) 559.797 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 3.02 0.451 0 c4: Carbamidomethyl (+57.02) 559.797 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 3.26 0.53 2.62 c4: Carbamidomethyl (+57.02) 559.797 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.77 0.342 0 c4: Carbamidomethyl (+57.02) 559.7971 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 3.16 0.499 2.11 c4: Carbamidomethyl (+57.02) 559.7971 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.71 0.374 1.48 c4: Carbamidomethyl (+57.02) 559.7972 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.39 0.307 0 c4: Carbamidomethyl (+57.02) 559.7985 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.7 0.304 1.51 c4: Carbamidomethyl (+57.02) 559.7986 1,117.58 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.2 0.328 0 c4: Carbamidomethyl (+57.02) 560.294 1,118.57 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 95.00% 2.41 0.35 0 c4: Carbamidomethyl (+57.02) 560.3013 1,118.59 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VVQcSDLGLK 94.80% 1.97 0.307 0 c4: Carbamidomethyl (+57.02) 560.3085 1,118.60 1,118.59 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% ISEAKLTGIPK 95.00% 2.46 0.279 0 578.8486 1,155.68 1,156.69 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% ISEAKLTGIPK 95.00% 2.61 0.304 0 578.8509 1,155.69 1,156.69 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNKISK 95.00% 2.58 0.268 0 637.7311 1,910.17 1,910.12 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 2.62 0.299 1.57 656.8725 1,311.73 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 4.09 0.312 1.29 656.8746 1,311.73 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 4.08 0.325 2.59 656.8752 1,311.73 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 3.23 0.334 2.28 656.876 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 2.83 0.201 1.22 656.8761 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 3.97 0.321 1.85 656.8763 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 3.97 0.301 0 656.8763 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 4.18 0.322 2.05 656.8763 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 4.2 0.312 2.6 656.8767 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 3.95 0.346 1.85 656.8769 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 4.17 0.333 2.09 656.8769 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 3.58 0.319 2.09 656.8769 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 3.81 0.33 2 656.8769 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 4.25 0.316 2.14 656.877 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 3.85 0.31 1.85 656.877 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 4.24 0.271 2.16 656.877 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 4.07 0.324 1.77 656.8771 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 4.08 0.37 2.57 656.8772 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 3.71 0.301 2.05 656.8772 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 3.89 0.287 1.92 656.8773 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 3.26 0.318 1.6 656.8774 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% IQAIELEDLLR 95.00% 3.71 0.297 2.15 656.8774 1,311.74 1,312.75 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% ELHLDNNKLAR 95.00% 3.05 0.503 2.41 661.8597 1,321.70 1,322.72 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% ELHLDNNKLAR 95.00% 2.39 0.429 1.66 661.8607 1,321.71 1,322.72 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 3.79 0.413 7.07 676.3799 2,026.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 3.6 0.393 4.25 676.3801 2,026.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 2.49 0.111 2.89 676.3809 2,026.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 4.24 0.341 5.1 676.7129 2,027.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 3.06 0.184 1.96 676.7131 2,027.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 3.89 0.37 4.54 676.7133 2,027.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 2.94 0.199 3.25 676.7133 2,027.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 2.9 0.316 5.09 676.7134 2,027.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 4.08 0.319 6.12 676.7142 2,027.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 3.05 0.196 2.85 676.7142 2,027.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 3.24 0.271 3.82 676.7145 2,027.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 3.58 0.294 5.68 676.7147 2,027.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 3.63 0.34 4.36 676.7148 2,027.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 3.79 0.369 4.51 676.7156 2,027.12 2,027.13 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DDFKGLQHLYALVLVNNK 95.00% 5.94 0.483 0 696.3804 2,086.12 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DDFKGLQHLYALVLVNNK 95.00% 5 0.512 1.24 696.382 2,086.12 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DDFKGLQHLYALVLVNNK 95.00% 4.68 0.445 0 696.7141 2,087.12 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DDFKGLQHLYALVLVNNK 95.00% 5.6 0.478 1.19 696.7158 2,087.12 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELR 95.00% 6.78 0.581 2.96 763.0545 2,286.14 2,286.15 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELR 95.00% 6.41 0.576 2.92 763.0548 2,286.14 2,286.15 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELR 95.00% 5.06 0.445 1.4 763.0553 2,286.14 2,286.15 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELR 95.00% 6.13 0.554 2.26 763.0554 2,286.14 2,286.15 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VGVNDFcPMGFGVK 95.00% 4.08 0.563 2.96 c7: Carbamidomethyl (+57.02) 763.8587 1,525.70 1,526.71 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VGVNDFcPMGFGVK 95.00% 3.97 0.549 3.32 c7: Carbamidomethyl (+57.02) 763.8588 1,525.70 1,526.71 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VGVNDFcPMGFGVK 95.00% 3.4 0.459 1.13 c7: Carbamidomethyl (+57.02) 764.3605 1,526.71 1,526.71 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VGVNDFcPMGFGVK 95.00% 3.03 0.482 2.03 c7: Carbamidomethyl (+57.02) 764.3612 1,526.71 1,526.71 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VGVNDFcPmGFGVK 95.00% 2.46 0.303 0 c7: Carbamidomethyl (+57.02), m9: Oxidation (+15.99) 771.856 1,541.70 1,542.71 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% VGVNDFcPmGFGVK 95.00% 2.52 0.254 0 c7: Carbamidomethyl (+57.02), m9: Oxidation (+15.99) 771.8576 1,541.70 1,542.71 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% MIENGSLSFLPTLR 95.00% 3.13 0.23 1.92 789.9154 1,577.82 1,577.84 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 4.96 0.553 2.8 791.4574 1,580.90 1,581.91 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 5.26 0.524 2.07 791.4583 1,580.90 1,581.91 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 4.53 0.565 3 791.4587 1,580.90 1,581.91 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 4.38 0.551 2.8 791.4587 1,580.90 1,581.91 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% GLQHLYALVLVNNK 95.00% 4.3 0.488 2.49 791.4601 1,580.90 1,581.91 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELRK 95.00% 2.52 0.457 2 805.7512 2,414.23 2,414.24 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELRK 95.00% 2.78 0.457 2 805.752 2,414.23 2,414.24 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELRK 95.00% 3.06 0.478 2.1 805.7521 2,414.23 2,414.24 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELRK 95.00% 2.43 0.439 2.17 805.7529 2,414.24 2,414.24 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELRK 95.00% 2.67 0.425 0 805.7559 2,414.24 2,414.24 3
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DLPETLNELHLDHNK 95.00% 4.23 0.562 2.29 894.4476 1,786.88 1,787.89 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DLPETLNELHLDHNK 95.00% 4.89 0.502 2.8 894.4482 1,786.88 1,787.89 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DLPETLNELHLDHNK 95.00% 4.73 0.48 3.12 894.9485 1,787.88 1,787.89 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DLPETLNELHLDHNK 95.00% 4.4 0.452 2.07 894.951 1,787.89 1,787.89 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DLPETLNELHLDHNK 95.00% 3.78 0.3 1.92 894.9559 1,787.90 1,787.89 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 4.77 0.517 5.89 1,014.57 2,027.12 2,027.13 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 4.61 0.505 8.17 1,014.57 2,027.12 2,027.13 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 4.56 0.49 6.36 1,014.57 2,027.12 2,027.13 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 4.56 0.526 6.43 1,014.57 2,027.12 2,027.13 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% NHLVEIPPNLPSSLVELR 95.00% 4.52 0.557 5.19 1,014.57 2,027.12 2,027.13 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DDFKGLQHLYALVLVNNK 95.00% 4.78 0.504 4.27 1,044.57 2,087.12 2,087.13 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DDFKGLQHLYALVLVNNK 95.00% 5.02 0.522 3.96 1,044.57 2,087.12 2,087.13 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DDFKGLQHLYALVLVNNK 95.00% 0 0 4.54 1,045.51 2,089.01 2,087.13 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% DDFKGLQHLYALVLVNNK 95.00% 0 0 4.96 1,045.51 2,089.01 2,087.13 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELR 95.00% 5.79 0.626 6.82 1,144.07 2,286.13 2,286.15 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELR 95.00% 5.58 0.621 6.34 1,144.08 2,286.14 2,286.15 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELRK 95.00% 4.32 0.5 2.27 1,208.12 2,414.23 2,414.24 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELRK 95.00% 4.51 0.575 4.34 1,208.12 2,414.23 2,414.24 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELRK 95.00% 4.54 0.526 2.48 1,208.12 2,414.23 2,414.24 2
 SAMPLE 2R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 14 18 127 44.60% EISPDTTLLDLQNNDISELRK 95.00% 4.4 0.534 2.92 1,208.13 2,414.24 2,414.24 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VPSGLPDLK 95.00% 2.06 0.253 0 463.2693 924.5229 925.5361 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VPSGLPDLK 95.00% 2.56 0.254 0 463.27 924.5244 925.5361 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VPSGLPDLK 95.00% 2.49 0.297 0 463.2705 924.5253 925.5361 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VPSGLPDLK 95.00% 2.61 0.203 0 463.2707 924.5257 925.5361 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VPSGLPDLK 95.00% 2.74 0.267 0 463.2711 924.5265 925.5361 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VPSGLPDLK 95.00% 2.45 0.293 0 463.2712 924.5267 925.5361 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VPSGLPDLK 95.00% 2.56 0.301 0 463.2712 924.5268 925.5361 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VPSGLPDLK 95.00% 2.6 0.301 0 463.2715 924.5274 925.5361 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VPSGLPDLK 95.00% 2.1 0.333 0 463.2735 924.5313 925.5361 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% LGLGHNQIR 95.00% 2.51 0.307 1.15 504.2901 1,006.56 1,007.58 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% LGLGHNQIR 95.00% 2.39 0.292 1.7 504.2902 1,006.56 1,007.58 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% LAIQFGNYK 95.00% 1.55 0.27 2.16 527.2892 1,052.56 1,053.57 2 AHNK_HUMAN
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% GLQHLYALVLVNNK 95.00% 3.27 0.249 0 527.9744 1,580.90 1,581.91 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% GLQHLYALVLVNNK 95.00% 3.42 0.359 0 527.9745 1,580.90 1,581.91 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% GLQHLYALVLVNNK 95.00% 3.81 0.339 0 527.9746 1,580.90 1,581.91 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% GLQHLYALVLVNNK 95.00% 3.55 0.303 0 527.9748 1,580.90 1,581.91 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% GLQHLYALVLVNNK 95.00% 3.31 0.274 0 527.9749 1,580.90 1,581.91 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% GLQHLYALVLVNNK 95.00% 3.98 0.302 0 527.9755 1,580.90 1,581.91 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% GLQHLYALVLVNNK 95.00% 3.43 0.36 0 527.9756 1,580.90 1,581.91 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% GLQHLYALVLVNNK 95.00% 3.38 0.268 0 528.3085 1,581.90 1,581.91 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% GLQHLYALVLVNNK 95.00% 3.03 0.209 0 528.309 1,581.90 1,581.91 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 2.38 0.319 1.11 c4: Carbamidomethyl (+57.02) 559.7949 1,117.57 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 3.01 0.485 1.85 c4: Carbamidomethyl (+57.02) 559.7962 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 2.58 0.42 1.39 c4: Carbamidomethyl (+57.02) 559.7963 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 3.23 0.479 1.15 c4: Carbamidomethyl (+57.02) 559.7964 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 3.13 0.474 2.85 c4: Carbamidomethyl (+57.02) 559.7965 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 3.31 0.513 2.03 c4: Carbamidomethyl (+57.02) 559.7967 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 3.03 0.452 0 c4: Carbamidomethyl (+57.02) 559.7967 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 3.27 0.531 1.52 c4: Carbamidomethyl (+57.02) 559.7967 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 3.04 0.42 0 c4: Carbamidomethyl (+57.02) 559.7967 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 2.82 0.404 1.32 c4: Carbamidomethyl (+57.02) 559.7967 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 3.33 0.524 2 c4: Carbamidomethyl (+57.02) 559.7968 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 2.87 0.423 0 c4: Carbamidomethyl (+57.02) 559.7968 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 3.32 0.526 1.96 c4: Carbamidomethyl (+57.02) 559.7968 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 3.16 0.533 1.89 c4: Carbamidomethyl (+57.02) 559.7968 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 3.07 0.463 1.39 c4: Carbamidomethyl (+57.02) 559.7969 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 2.24 0.407 1.82 c4: Carbamidomethyl (+57.02) 559.7971 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 1.96 0.408 1.19 c4: Carbamidomethyl (+57.02) 559.7972 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 2.61 0.36 1.47 c4: Carbamidomethyl (+57.02) 559.7974 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 2.29 0.336 0 c4: Carbamidomethyl (+57.02) 559.7974 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 2.01 0.308 0 c4: Carbamidomethyl (+57.02) 559.7978 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 2.35 0.291 0 c4: Carbamidomethyl (+57.02) 559.7983 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 2.22 0.263 0 c4: Carbamidomethyl (+57.02) 559.8001 1,117.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VVQcSDLGLK 95.00% 2.52 0.243 0 c4: Carbamidomethyl (+57.02) 560.2971 1,118.58 1,118.59 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VGVNDFcPMGFGVKR 95.00% 3.78 0.371 2.51 c7: Carbamidomethyl (+57.02) 561.6082 1,681.80 1,682.81 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VGVNDFcPMGFGVKR 95.00% 3.11 0.36 1.85 c7: Carbamidomethyl (+57.02) 561.6085 1,681.80 1,682.81 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% IQAIELEDLLR 95.00% 4.09 0.334 1.72 656.8766 1,311.74 1,312.75 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% IQAIELEDLLR 95.00% 4.06 0.325 2.03 656.8776 1,311.74 1,312.75 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% ELHLDNNKLAR 95.00% 2.95 0.456 2.26 661.8616 1,321.71 1,322.72 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% ELHLDNNKLAR 95.00% 2.83 0.419 2.38 662.3633 1,322.71 1,322.72 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 2.94 0.321 3.51 676.3802 2,026.12 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 3.45 0.394 5.3 676.3805 2,026.12 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 3.4 0.37 6.52 676.3813 2,026.12 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 3.53 0.364 4.31 676.3817 2,026.12 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 2.7 0.199 1.51 676.7137 2,027.12 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 3.73 0.352 5.66 676.7142 2,027.12 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 4.16 0.477 4.68 676.7143 2,027.12 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 4.51 0.422 6.42 676.7144 2,027.12 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 4.01 0.357 6.01 676.7151 2,027.12 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 2.93 0.359 5.74 676.7155 2,027.12 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 3.31 0.339 2.04 676.7161 2,027.12 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 3.77 0.355 4.6 676.7164 2,027.13 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 3.82 0.32 5.72 676.7166 2,027.13 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 2.83 0.224 1.16 676.717 2,027.13 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 3.41 0.372 3.4 676.7182 2,027.13 2,027.13 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% DDFKGLQHLYALVLVNNK 95.00% 3.03 0.339 0 696.7155 2,087.12 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% DDFKGLQHLYALVLVNNK 95.00% 4.9 0.482 0.959 696.7173 2,087.13 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELR 95.00% 5.91 0.608 3.36 763.0536 2,286.14 2,286.15 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELR 95.00% 5.89 0.549 2.89 763.0547 2,286.14 2,286.15 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VGVNDFcPMGFGVK 95.00% 4.02 0.536 3 c7: Carbamidomethyl (+57.02) 763.8594 1,525.70 1,526.71 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VGVNDFcPMGFGVK 95.00% 4.39 0.574 4.07 c7: Carbamidomethyl (+57.02) 763.8595 1,525.70 1,526.71 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VGVNDFcPMGFGVK 95.00% 4.1 0.573 3.06 c7: Carbamidomethyl (+57.02) 763.8596 1,525.70 1,526.71 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VGVNDFcPMGFGVK 95.00% 4.15 0.541 3.89 c7: Carbamidomethyl (+57.02) 763.8603 1,525.71 1,526.71 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VGVNDFcPMGFGVK 95.00% 4.13 0.571 3.57 c7: Carbamidomethyl (+57.02) 764.3613 1,526.71 1,526.71 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% VGVNDFcPmGFGVK 95.00% 3.25 0.322 0 c7: Carbamidomethyl (+57.02), m9: Oxidation (+15.99) 771.856 1,541.70 1,542.71 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% GLQHLYALVLVNNK 95.00% 5.35 0.564 2.89 791.4592 1,580.90 1,581.91 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% GLQHLYALVLVNNK 95.00% 5.18 0.571 2.04 791.4594 1,580.90 1,581.91 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELRK 95.00% 2.63 0.529 2.55 805.7505 2,414.23 2,414.24 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELRK 95.00% 2.42 0.38 2.7 805.7509 2,414.23 2,414.24 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELRK 95.00% 2.35 0.427 1.41 805.752 2,414.23 2,414.24 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELRK 95.00% 3.46 0.515 1.68 805.7527 2,414.23 2,414.24 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELRK 95.00% 2.74 0.525 1.05 805.7534 2,414.24 2,414.24 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELRK 95.00% 2.22 0.348 2.77 805.7545 2,414.24 2,414.24 3
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% DLPETLNELHLDHNK 95.00% 4.4 0.419 2.66 894.4467 1,786.88 1,787.89 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% DLPETLNELHLDHNK 95.00% 4.75 0.49 3.55 894.4497 1,786.88 1,787.89 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 3.44 0.418 5.25 1,014.57 2,027.12 2,027.13 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 4.5 0.517 6.96 1,014.57 2,027.12 2,027.13 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% NHLVEIPPNLPSSLVELR 95.00% 4.45 0.505 5.03 1,014.57 2,027.13 2,027.13 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELR 95.00% 6.05 0.639 5.6 1,144.08 2,286.14 2,286.15 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELR 95.00% 5.61 0.614 6.42 1,144.08 2,286.14 2,286.15 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELR 95.00% 5.87 0.587 6.05 1,144.08 2,286.14 2,286.15 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELR 95.00% 5.84 0.636 5.85 1,144.08 2,286.14 2,286.15 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELRK 95.00% 4.24 0.562 2.68 1,208.12 2,414.22 2,414.24 2
 SAMPLE 3 Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 12 16 91 39.70% EISPDTTLLDLQNNDISELRK 95.00% 4.47 0.546 2.11 1,208.12 2,414.23 2,414.24 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VPSGLPDLK 95.00% 2.64 0.203 0 463.2704 924.5251 925.5361 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VPSGLPDLK 95.00% 2.7 0.306 0 463.2705 924.5253 925.5361 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VPSGLPDLK 95.00% 2.73 0.301 0 463.2719 924.5281 925.5361 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VPSGLPDLK 95.00% 2.37 0.251 0 463.2722 924.5288 925.5361 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VPSGLPDLK 95.00% 2.48 0.278 0 463.2722 924.5288 925.5361 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VPSGLPDLK 95.00% 2.65 0.287 0 463.2723 924.529 925.5361 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VPSGLPDLK 95.00% 2.39 0.245 0 463.2727 924.5298 925.5361 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.23 0.255 0 527.9733 1,580.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.01 0.201 0 527.9734 1,580.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.28 0.321 0 527.9745 1,580.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.26 0.337 0 527.9745 1,580.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.72 0.282 0 527.9754 1,580.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.35 0.275 0 527.9755 1,580.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.24 0.359 0 527.9756 1,580.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.63 0.246 0 527.9759 1,580.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.36 0.209 0 527.9762 1,580.91 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.28 0.284 0 528.3069 1,581.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.66 0.365 0 528.3079 1,581.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.68 0.31 0 528.3082 1,581.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.21 0.292 0 528.3087 1,581.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.24 0.317 0 528.3091 1,581.90 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.95 0.198 0 528.3096 1,581.91 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 3.73 0.338 0 528.3098 1,581.91 1,581.91 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 3.18 0.48 2.3 c4: Carbamidomethyl (+57.02) 559.7959 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 3.12 0.385 2.37 c4: Carbamidomethyl (+57.02) 559.7962 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 2.1 0.267 0 c4: Carbamidomethyl (+57.02) 559.7962 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 2.78 0.4 0 c4: Carbamidomethyl (+57.02) 559.7963 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 3.11 0.502 2.09 c4: Carbamidomethyl (+57.02) 559.7963 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 3.01 0.452 1.72 c4: Carbamidomethyl (+57.02) 559.7965 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 3.26 0.507 2.89 c4: Carbamidomethyl (+57.02) 559.7966 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 3.11 0.508 1.28 c4: Carbamidomethyl (+57.02) 559.7967 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 2.98 0.481 2.1 c4: Carbamidomethyl (+57.02) 559.7968 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 3.24 0.506 1.48 c4: Carbamidomethyl (+57.02) 559.7968 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 2.57 0.435 2.13 c4: Carbamidomethyl (+57.02) 559.7968 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 2.96 0.459 1.82 c4: Carbamidomethyl (+57.02) 559.797 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 3.08 0.483 1.96 c4: Carbamidomethyl (+57.02) 559.797 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 2.44 0.306 1.4 c4: Carbamidomethyl (+57.02) 559.797 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 2.7 0.448 1.51 c4: Carbamidomethyl (+57.02) 559.7971 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 2.81 0.379 1.72 c4: Carbamidomethyl (+57.02) 559.7974 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 3.34 0.507 1.8 c4: Carbamidomethyl (+57.02) 559.7974 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 2.54 0.365 2.57 c4: Carbamidomethyl (+57.02) 559.7979 1,117.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VVQcSDLGLK 95.00% 2.49 0.332 0 c4: Carbamidomethyl (+57.02) 560.2971 1,118.58 1,118.59 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VGVNDFcPMGFGVKR 95.00% 2.35 0.236 0 c7: Carbamidomethyl (+57.02) 561.6075 1,681.80 1,682.81 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VGVNDFcPMGFGVKR 95.00% 2.73 0.274 1.57 c7: Carbamidomethyl (+57.02) 561.6078 1,681.80 1,682.81 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 2.33 0.293 0 656.6579 1,311.30 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 2.68 0.318 1.89 656.8756 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 3.11 0.284 0 656.876 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 4.02 0.305 1.37 656.8761 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 4.02 0.302 2.03 656.8763 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 4.02 0.323 3.09 656.8764 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 4.14 0.314 1.62 656.8764 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 3.59 0.277 2.14 656.8764 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 2.82 0.297 0 656.8764 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 3.59 0.299 1.92 656.8765 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 3.93 0.303 1.74 656.8766 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 3.98 0.307 1.41 656.8768 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 2.84 0.282 1.18 656.8771 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 3.97 0.349 1.33 656.8772 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 3 0.307 1.8 656.8784 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 3.07 0.325 0 656.8787 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 3.12 0.25 1.7 656.8794 1,311.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% IQAIELEDLLR 95.00% 3.44 0.334 1.62 657.3785 1,312.74 1,312.75 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% ELHLDNNKLAR 95.00% 2.6 0.441 0 661.8592 1,321.70 1,322.72 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% ELHLDNNKLAR 95.00% 2.75 0.351 1.51 661.8606 1,321.71 1,322.72 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 2.82 0.3 2.62 676.3808 2,026.12 2,027.13 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 2.21 0.255 1.57 676.3815 2,026.12 2,027.13 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 1.92 0.223 2.92 676.7139 2,027.12 2,027.13 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 4.1 0.327 6.27 676.7144 2,027.12 2,027.13 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 4.05 0.38 5.72 676.7144 2,027.12 2,027.13 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 2.25 0.255 4.01 676.7147 2,027.12 2,027.13 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 3.39 0.345 4.89 676.7147 2,027.12 2,027.13 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 2.45 0.264 0 676.715 2,027.12 2,027.13 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 3.61 0.41 4.09 676.7155 2,027.12 2,027.13 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 3.16 0.354 6.06 676.7156 2,027.12 2,027.13 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 3.24 0.225 4.74 676.7157 2,027.12 2,027.13 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% DDFKGLQHLYALVLVNNK 95.00% 4.65 0.381 1.06 696.7162 2,087.13 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% DDFKGLQHLYALVLVNNK 95.00% 3.71 0.489 1.28 696.7173 2,087.13 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% DDFKGLQHLYALVLVNNK 95.00% 4.76 0.485 0 696.7176 2,087.13 2,087.13 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELR 95.00% 5.07 0.41 1.52 763.0538 2,286.14 2,286.15 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELR 95.00% 5.8 0.573 2.96 763.0538 2,286.14 2,286.15 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VGVNDFcPMGFGVK 95.00% 4.5 0.523 2.77 c7: Carbamidomethyl (+57.02) 763.8593 1,525.70 1,526.71 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VGVNDFcPMGFGVK 95.00% 3.82 0.465 3.12 c7: Carbamidomethyl (+57.02) 763.8595 1,525.70 1,526.71 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VGVNDFcPMGFGVK 95.00% 4.15 0.576 3.13 c7: Carbamidomethyl (+57.02) 763.8598 1,525.70 1,526.71 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VGVNDFcPMGFGVK 95.00% 4.2 0.531 3.42 c7: Carbamidomethyl (+57.02) 763.86 1,525.70 1,526.71 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VGVNDFcPMGFGVK 95.00% 3.56 0.48 2.85 c7: Carbamidomethyl (+57.02) 764.3605 1,526.71 1,526.71 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VGVNDFcPMGFGVK 95.00% 4.17 0.569 3.55 c7: Carbamidomethyl (+57.02) 764.3615 1,526.71 1,526.71 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% VGVNDFcPMGFGVK 95.00% 4.23 0.563 3.19 c7: Carbamidomethyl (+57.02) 764.3622 1,526.71 1,526.71 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% MIENGSLSFLPTLR 95.00% 2.44 0.183 1.49 789.9128 1,577.81 1,577.84 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 4.41 0.521 3.08 791.4579 1,580.90 1,581.91 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 4.03 0.471 3.62 791.4591 1,580.90 1,581.91 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 5.13 0.539 2.96 791.4593 1,580.90 1,581.91 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 4.16 0.596 2.72 791.4594 1,580.90 1,581.91 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 5.09 0.543 2.82 791.4605 1,580.91 1,581.91 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% GLQHLYALVLVNNK 95.00% 4.41 0.605 2.32 791.4608 1,580.91 1,581.91 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELRK 95.00% 2.88 0.459 3.7 805.4182 2,413.23 2,414.24 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELRK 95.00% 3.51 0.562 3.35 805.7511 2,414.23 2,414.24 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELRK 95.00% 2.84 0.507 2.11 805.7513 2,414.23 2,414.24 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELRK 95.00% 2.77 0.483 4.11 805.752 2,414.23 2,414.24 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELRK 95.00% 2.14 0.375 2.42 805.7521 2,414.23 2,414.24 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELRK 95.00% 2.31 0.375 3.74 805.7524 2,414.23 2,414.24 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELRK 95.00% 2.47 0.306 2 805.7529 2,414.24 2,414.24 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELRK 95.00% 2.48 0.332 1.82 805.7532 2,414.24 2,414.24 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELRK 95.00% 2.69 0.418 1.47 805.7534 2,414.24 2,414.24 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% DDFKGLQHLYALVLVNNKISK 95.00% 2.79 0.279 0 805.9478 2,414.82 2,415.34 3
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% DLPETLNELHLDHNK 95.00% 4.54 0.511 2.46 894.4485 1,786.88 1,787.89 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% DLPETLNELHLDHNK 95.00% 4.91 0.453 3.02 894.9494 1,787.88 1,787.89 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 4.55 0.508 6.72 1,014.57 2,027.12 2,027.13 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 4.42 0.559 5.32 1,014.57 2,027.12 2,027.13 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 4.64 0.467 8.22 1,014.57 2,027.12 2,027.13 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 4.11 0.489 5.92 1,014.57 2,027.13 2,027.13 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% NHLVEIPPNLPSSLVELR 95.00% 3.54 0.516 4.34 1,014.57 2,027.13 2,027.13 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELR 95.00% 5.55 0.595 5.82 1,144.07 2,286.13 2,286.15 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELR 95.00% 5.69 0.604 5.11 1,144.08 2,286.14 2,286.15 2
 SAMPLE 3R Biglycan  BGN  PGS1_HUMAN 41,637.90 100.00% 13 17 111 39.40% EISPDTTLLDLQNNDISELRK 95.00% 4.49 0.509 2.82 1,208.13 2,414.24 2,414.24 2
 SAMPLE 1R Bone morphogenetic protein 4  BMP4  BMP4_HUMAN 46,536.50 99.80% 2 2 2 10.80% EKQPNYGLAIEVTHLHQTR 95.00% 2.08 0.273 0 745.3739 2,233.10 2,234.17 3
 SAMPLE 1R Bone morphogenetic protein 4  BMP4  BMP4_HUMAN 46,536.50 99.80% 2 2 2 10.80% AccVPTELSAISmLYLDEYDKVVLK 95.00% 2.32 0.202 0 c2: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), m13: Oxidation (+15.99) 978.5204 2,932.54 2,933.44 3
 SAMPLE 1 C-type lectin domain family 11 member A  CLEC11A  CLC11_HUMAN 35,676.40 99.80% 2 2 2 6.19% VVELTQGLR 95.00% 2.59 0.244 1.92 507.8005 1,013.59 1,014.59 2
 SAMPLE 1 C-type lectin domain family 11 member A  CLEC11A  CLC11_HUMAN 35,676.40 99.80% 2 2 2 6.19% DFEAQAAAQAR 95.00% 2.06 0.425 1.47 589.2828 1,176.55 1,177.56 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QQEAALELEELKK 95.00% 2.61 0.406 0 510.2812 1,527.82 1,528.82 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% RGETESEEFEKLK 95.00% 2.22 0.311 0 527.9285 1,580.76 1,581.78 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% RGETESEEFEKLK 95.00% 3.67 0.316 0 527.9321 1,580.77 1,581.78 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% RGETESEEFEKLK 95.00% 3.36 0.378 0 527.9323 1,580.77 1,581.78 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% MPEDGLSDDKKPFK 95.00% 2.56 0.308 0 536.2661 1,605.77 1,606.78 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% mPEDGLSDDKKPFK 95.00% 2.72 0.263 0 m1: Oxidation (+15.99) 541.5983 1,621.77 1,622.77 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SPAPKPSDLRPGDVSSK 95.00% 2.39 0.324 0 579.9777 1,736.91 1,737.91 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SPAPKPSDLRPGDVSSK 95.00% 2.54 0.453 0 579.9782 1,736.91 1,737.91 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SPAPKPSDLRPGDVSSK 95.00% 2.34 0.233 0 579.979 1,736.91 1,737.91 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SPAPKPSDLRPGDVSSK 95.00% 2.55 0.352 0 579.9803 1,736.92 1,737.91 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SPAPKPSDLRPGDVSSK 95.00% 2.24 0.272 0 580.3107 1,737.91 1,737.91 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SPAPKPSDLRPGDVSSK 94.90% 2.17 0.24 0 580.3122 1,737.91 1,737.91 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SPAPKPSDLRPGDVSSK 95.00% 2.49 0.367 0 580.313 1,737.92 1,737.91 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SPAPKPSDLRPGDVSSK 95.00% 2.74 0.396 0 580.3135 1,737.92 1,737.91 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QERYEIEETETVTK 95.00% 3.2 0.393 0 585.6214 1,753.84 1,754.85 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QKQQEAALELEELKK 95.00% 3.07 0.194 0 595.6645 1,783.97 1,784.98 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QKQQEAALELEELKK 95.00% 3.79 0.332 0 595.665 1,783.97 1,784.98 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QKQQEAALELEELKK 95.00% 3.46 0.333 0 595.6652 1,783.97 1,784.98 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QKQQEAALELEELKK 95.00% 2.97 0.258 0 595.6655 1,783.97 1,784.98 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QKQQEAALELEELKK 95.00% 3.43 0.247 0 595.6656 1,783.97 1,784.98 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% ASVDTKEAEGAPQVEAGK 95.00% 2.46 0.331 0 595.9553 1,784.84 1,786.88 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QKQQEAALELEELKK 95.00% 3.79 0.332 0 595.9987 1,784.97 1,784.98 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QKQQEAALELEELKK 94.90% 2.73 0.177 0 595.9991 1,784.97 1,784.98 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% ASVDTKEAEGAPQVEAGK 95.00% 3.15 0.415 2.66 596.3014 1,785.88 1,786.88 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% ASVDTKEAEGAPQVEAGK 95.00% 3.6 0.276 2.02 596.6348 1,786.88 1,786.88 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% RGSIGENQVEVmVEEK 95.00% 3.05 0.182 2.15 m12: Oxidation (+15.99) 607.6363 1,819.89 1,819.89 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% ASVDTKEAEGAPQVEAGKR 95.00% 3.15 0.386 1.54 648.3392 1,941.99 1,942.98 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% ASVDTKEAEGAPQVEAGKR 95.00% 3.67 0.453 0 648.6707 1,942.99 1,942.98 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SAKPTKPAASDLPVPAEGVR 95.00% 3.44 0.281 2.89 664.3704 1,990.09 1,991.09 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SAKPTKPAASDLPVPAEGVR 95.00% 2.91 0.381 1.72 664.371 1,990.09 1,991.09 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SAKPTKPAASDLPVPAEGVR 95.00% 4.12 0.363 2.57 664.3718 1,990.09 1,991.09 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SAKPTKPAASDLPVPAEGVR 95.00% 3.28 0.313 1.43 664.3718 1,990.09 1,991.09 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SAKPTKPAASDLPVPAEGVR 95.00% 3.86 0.362 2.96 664.7042 1,991.09 1,991.09 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SAKPTKPAASDLPVPAEGVR 95.00% 3.42 0.347 2.6 664.7047 1,991.09 1,991.09 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SAKPTKPAASDLPVPAEGVR 95.00% 4.34 0.444 3.22 664.7049 1,991.09 1,991.09 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SAKPTKPAASDLPVPAEGVR 95.00% 3.27 0.337 1.68 664.705 1,991.09 1,991.09 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SAKPTKPAASDLPVPAEGVR 95.00% 3.55 0.236 1.24 664.7054 1,991.09 1,991.09 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SAKPTKPAASDLPVPAEGVR 95.00% 3.68 0.39 0 664.7055 1,991.09 1,991.09 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SAKPTKPAASDLPVPAEGVR 95.00% 4.07 0.396 3.39 664.7056 1,991.09 1,991.09 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QKEFDPTITDASLSLPSR 95.00% 2.94 0.266 1.16 669.3473 2,005.02 2,005.02 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QKEFDPTITDASLSLPSR 95.00% 3.3 0.395 2.51 669.3479 2,005.02 2,005.02 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QKEFDPTITDASLSLPSR 95.00% 3.1 0.371 1.92 669.3489 2,005.02 2,005.02 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QKEFDPTITDASLSLPSR 95.00% 3.87 0.335 2.96 669.3493 2,005.02 2,005.02 3
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% LEQYTSAIEGTK 95.00% 2.4 0.337 0 670.3419 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% LEQYTSAIEGTK 95.00% 3.77 0.499 3.14 670.3419 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% LEQYTSAIEGTK 95.00% 3.54 0.476 4.21 670.3425 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% LEQYTSAIEGTK 95.00% 3.38 0.446 2.62 670.3428 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% LEQYTSAIEGTK 95.00% 3.7 0.474 3.23 670.3428 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% LEQYTSAIEGTK 95.00% 3.78 0.449 3.13 670.3431 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% LEQYTSAIEGTK 95.00% 3.82 0.473 4.15 670.3434 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% YEIEETETVTK 95.00% 2.64 0.392 0 671.3255 1,340.64 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% YEIEETETVTK 95.00% 2.99 0.433 3.21 671.3255 1,340.64 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% YEIEETETVTK 95.00% 3.36 0.422 2.74 671.3257 1,340.64 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% YEIEETETVTK 95.00% 3.38 0.447 2.21 671.3263 1,340.64 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% YEIEETETVTK 95.00% 3.13 0.473 3.08 671.3264 1,340.64 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% YEIEETETVTK 95.00% 2.66 0.417 1.8 671.3278 1,340.64 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% AQEDKLQTAVLK 95.00% 3.07 0.435 0 672.382 1,342.75 1,343.75 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QKEFDPTITDASLSLPSRR 95.00% 2.19 0.294 0 721.3842 2,161.13 2,161.13 3 ANX11_HUMAN,MAP1B_HUMAN,RS5_HUMAN
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% QQEAALELEELKK 95.00% 3.19 0.368 0 764.9185 1,527.82 1,528.82 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% TTESQEETVVMSLK 95.00% 3.62 0.462 3.02 791.3948 1,580.77 1,581.77 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% TTESQEETVVmSLK 95.00% 3.1 0.256 3.38 m11: Oxidation (+15.99) 799.3882 1,596.76 1,597.76 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% TTESQEETVVmSLK 95.00% 4.1 0.561 2.74 m11: Oxidation (+15.99) 799.8889 1,597.76 1,597.76 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SPAPKPSDLRPGDVSSK 95.00% 2.06 0.293 0 869.466 1,736.92 1,737.91 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% ASVDTKEAEGAPQVEAGK 95.00% 4.31 0.495 3.6 893.9497 1,785.88 1,786.88 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% ASVDTKEAEGAPQVEAGK 95.00% 5.45 0.501 3.92 893.9511 1,785.89 1,786.88 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% ASVDTKEAEGAPQVEAGK 95.00% 5.45 0.561 3.54 893.9532 1,785.89 1,786.88 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% SAKPTKPAASDLPVPAEGVR 95.00% 3.99 0.452 4.06 996.5576 1,991.10 1,991.09 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% TTTTNTQVEGDDEAAFLER 95.00% 6.32 0.612 7.32 1,049.48 2,096.95 2,097.96 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% TTTTNTQVEGDDEAAFLER 95.00% 6.06 0.595 7.11 1,049.48 2,096.95 2,097.96 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% TTTTNTQVEGDDEAAFLER 95.00% 6.09 0.629 6.8 1,049.48 2,096.95 2,097.96 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% TTTTNTQVEGDDEAAFLER 95.00% 6.25 0.616 8.23 1,049.49 2,096.96 2,097.96 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% TTTTNTQVEGDDEAAFLER 95.00% 6.22 0.61 6.38 1,049.99 2,097.96 2,097.96 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% TTTTNTQVEGDDEAAFLER 95.00% 5.79 0.623 6.05 1,049.99 2,097.96 2,097.96 2
 SAMPLE 4 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 16 20 68 25.70% TTTTNTQVEGDDEAAFLER 95.00% 6.34 0.592 5.74 1,049.99 2,097.96 2,097.96 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% QQEAALELEELKK 95.00% 2.67 0.37 0 510.2809 1,527.82 1,528.82 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ARIEAEEKAAAQER 95.00% 3.35 0.398 0 524.6118 1,570.81 1,571.81 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ARIEAEEKAAAQER 95.00% 3 0.362 0 524.6125 1,570.81 1,571.81 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% RGETESEEFEKLK 95.00% 2.66 0.339 0 527.5945 1,579.76 1,581.78 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% RGETESEEFEKLK 95.00% 3.87 0.431 0 527.9324 1,580.77 1,581.78 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% RGETESEEFEKLK 95.00% 3.8 0.347 0 528.2674 1,581.78 1,581.78 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% SPAPKPSDLRPGDVSSK 95.00% 2.66 0.384 0 579.9767 1,736.91 1,737.91 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% SPAPKPSDLRPGDVSSK 95.00% 2.63 0.386 0 579.9788 1,736.91 1,737.91 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% SPAPKPSDLRPGDVSSK 95.00% 2.06 0.338 0 580.3126 1,737.91 1,737.91 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% SPAPKPSDLRPGDVSSK 95.00% 2.54 0.436 0 580.313 1,737.92 1,737.91 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% QKQQEAALELEELKK 95.00% 3 0.219 0 595.6656 1,783.97 1,784.98 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% QKQQEAALELEELKK 95.00% 2.94 0.285 0 595.6661 1,783.97 1,784.98 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% QKQQEAALELEELKK 95.00% 3.46 0.166 0 595.6665 1,783.98 1,784.98 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% QKQQEAALELEELKK 95.00% 3.25 0.17 0 595.9991 1,784.97 1,784.98 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% QKQQEAALELEELKK 95.00% 3.55 0.299 0 595.9998 1,784.98 1,784.98 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 3.05 0.412 2.03 596.3 1,785.88 1,786.88 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 2.73 0.322 1.96 596.3018 1,785.88 1,786.88 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 4.04 0.492 2.02 596.3021 1,785.88 1,786.88 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 3.61 0.4 1.62 596.3033 1,785.89 1,786.88 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 2.87 0.162 2.47 596.6351 1,786.88 1,786.88 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 2.84 0.287 3.85 596.6351 1,786.88 1,786.88 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 3.36 0.325 2.21 596.6371 1,786.89 1,786.88 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGKR 95.00% 3.68 0.495 1.82 648.3383 1,941.99 1,942.98 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGKR 95.00% 3.73 0.43 1.68 648.6733 1,943.00 1,942.98 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% SAKPTKPAASDLPVPAEGVR 95.00% 3.9 0.289 2.74 664.7029 1,991.09 1,991.09 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% SAKPTKPAASDLPVPAEGVR 95.00% 4.35 0.432 4.06 664.7046 1,991.09 1,991.09 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% SAKPTKPAASDLPVPAEGVR 95.00% 4.2 0.376 2.57 664.7049 1,991.09 1,991.09 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% SAKPTKPAASDLPVPAEGVR 95.00% 4.01 0.324 2.8 664.7053 1,991.09 1,991.09 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% SAKPTKPAASDLPVPAEGVR 95.00% 3.68 0.26 1.55 664.7056 1,991.09 1,991.09 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% SAKPTKPAASDLPVPAEGVR 95.00% 4.61 0.447 2.68 664.7056 1,991.09 1,991.09 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% SAKPTKPAASDLPVPAEGVR 95.00% 3.29 0.289 0 664.7057 1,991.09 1,991.09 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% SAKPTKPAASDLPVPAEGVR 95.00% 3.9 0.436 1.92 664.7067 1,991.10 1,991.09 3
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% LEQYTSAIEGTK 95.00% 3.68 0.464 3.74 670.3415 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% LEQYTSAIEGTK 95.00% 3.44 0.48 3.31 670.3422 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% LEQYTSAIEGTK 95.00% 3.57 0.441 3.31 670.3424 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% LEQYTSAIEGTK 95.00% 3.18 0.393 3.3 670.3437 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% LEQYTSAIEGTK 95.00% 3 0.397 3.06 670.8446 1,339.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% YEIEETETVTK 95.00% 2.23 0.325 0 671.3248 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% YEIEETETVTK 95.00% 2.58 0.402 2.92 671.326 1,340.64 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% YEIEETETVTK 95.00% 2.65 0.387 3.25 671.3271 1,340.64 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% YEIEETETVTK 95.00% 2.03 0.289 0 671.3272 1,340.64 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% AQEDKLQTAVLK 95.00% 2.87 0.201 0 672.383 1,342.75 1,343.75 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% GNVFSSPTAAGTPNK 95.00% 3.68 0.485 4.62 724.3683 1,446.72 1,447.72 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% GNVFSSPTAAGTPNK 95.00% 0 0 3.25 725.3594 1,448.70 1,447.72 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% EFDPTITDASLSLPSR 95.00% 4.17 0.529 3.7 874.9397 1,747.86 1,748.87 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 5.08 0.482 3.31 893.9491 1,785.88 1,786.88 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 5.58 0.528 4.31 893.9491 1,785.88 1,786.88 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 4.65 0.526 3.39 893.9492 1,785.88 1,786.88 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 4.83 0.455 4 893.9502 1,785.88 1,786.88 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 4.97 0.474 3.68 894.4444 1,786.87 1,786.88 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% ASVDTKEAEGAPQVEAGK 95.00% 5 0.444 1.92 894.4522 1,786.89 1,786.88 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% TTTTNTQVEGDDEAAFLER 95.00% 6.38 0.577 6.59 1,049.99 2,097.96 2,097.96 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% TTTTNTQVEGDDEAAFLER 95.00% 5.96 0.58 6.62 1,049.99 2,097.96 2,097.96 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% TTTTNTQVEGDDEAAFLER 95.00% 6.21 0.627 6.24 1,049.99 2,097.96 2,097.96 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% TTTTNTQVEGDDEAAFLER 95.00% 5.95 0.548 4.08 1,049.99 2,097.96 2,097.96 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% TTTTNTQVEGDDEAAFLER 95.00% 5.69 0.622 6.8 1,049.99 2,097.96 2,097.96 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% TTTTNTQVEGDDEAAFLER 95.00% 6.5 0.594 6.07 1,049.99 2,097.96 2,097.96 2
 SAMPLE 4R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 13 14 54 23.10% TTTTNTQVEGDDEAAFLER 95.00% 6.13 0.61 6.12 1,049.99 2,097.96 2,097.96 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% INEWLTK 95.00% 2.27 0.239 0 452.2501 902.4845 903.4941 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% INEWLTK 95.00% 2.18 0.219 0 452.2513 902.4869 903.4941 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% INEWLTK 95.00% 2.35 0.223 0 452.2519 902.4882 903.4941 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% INEWLTK 95.00% 2.2 0.214 0 452.2536 902.4916 903.4941 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% INEWLTK 95.00% 2.44 0.229 0 452.2549 902.4942 903.4941 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GETESEEFEKLK 95.00% 2.19 0.244 0 475.8959 1,424.66 1,425.68 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% KAQEDKLQTAVLK 95.00% 3.86 0.268 0 491.2857 1,470.83 1,471.85 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% KAQEDKLQTAVLK 95.00% 2.66 0.193 0 491.2864 1,470.84 1,471.85 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% KAQEDKLQTAVLK 95.00% 2.62 0.163 0 491.2877 1,470.84 1,471.85 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% KAQEDKLQTAVLK 95.00% 3.96 0.296 0 491.6219 1,471.84 1,471.85 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QQEAALELEELKK 95.00% 2.84 0.334 0 510.283 1,527.83 1,528.82 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QQEAALELEELKK 95.00% 2.21 0.3 0 510.6122 1,528.81 1,528.82 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% RGETESEEFEKLK 95.00% 3.96 0.415 1.25 527.9298 1,580.77 1,581.78 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% RGETESEEFEKLK 95.00% 4.29 0.382 0 527.9302 1,580.77 1,581.78 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% RGETESEEFEKLK 95.00% 3.77 0.374 1.08 528.2643 1,581.77 1,581.78 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% MPEDGLSDDKKPFK 95.00% 2.41 0.195 0 536.2629 1,605.77 1,606.78 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% MPEDGLSDDKKPFK 95.00% 2.36 0.239 0 536.2635 1,605.77 1,606.78 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% MPEDGLSDDKKPFK 95.00% 2.3 0.396 0 536.5968 1,606.77 1,606.78 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 2.86 0.444 0 579.975 1,736.90 1,737.91 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 2.5 0.406 0 579.9752 1,736.90 1,737.91 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 2.26 0.326 0 579.9753 1,736.90 1,737.91 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 2.26 0.422 0 579.9753 1,736.90 1,737.91 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 2.56 0.43 0 579.9755 1,736.90 1,737.91 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 2.72 0.386 0 579.9756 1,736.90 1,737.91 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 2.59 0.355 0 579.9762 1,736.91 1,737.91 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 1.57 0.317 0 579.9774 1,736.91 1,737.91 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 2.41 0.337 0 580.3094 1,737.90 1,737.91 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QERYEIEETETVTK 95.00% 3.76 0.351 0 585.6175 1,753.83 1,754.85 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QERYEIEETETVTK 95.00% 3.64 0.279 0 585.6193 1,753.83 1,754.85 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QERYEIEETETVTK 95.00% 3.57 0.347 0 585.6193 1,753.83 1,754.85 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QERYEIEETETVTK 95.00% 3.79 0.405 0 585.9529 1,754.84 1,754.85 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKQQEAALELEELKK 95.00% 3.9 0.366 0 595.6614 1,783.96 1,784.98 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKQQEAALELEELKK 95.00% 3.64 0.335 0 595.6622 1,783.96 1,784.98 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKQQEAALELEELKK 95.00% 3.8 0.333 0 595.6624 1,783.96 1,784.98 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKQQEAALELEELKK 95.00% 3.62 0.34 0 595.997 1,784.97 1,784.98 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 2.49 0.188 0 596.2969 1,785.87 1,786.88 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 3.74 0.476 3.19 596.2971 1,785.87 1,786.88 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 3.65 0.452 3.77 596.2976 1,785.87 1,786.88 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 3.56 0.449 3.92 596.2979 1,785.87 1,786.88 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 3.09 0.363 3 596.2983 1,785.87 1,786.88 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 2.74 0.374 1.62 596.2984 1,785.87 1,786.88 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 2.09 0.302 2.59 596.2989 1,785.87 1,786.88 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 2.5 0.328 2.25 596.632 1,786.87 1,786.88 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 3.44 0.395 3.02 596.6321 1,786.87 1,786.88 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 3.62 0.324 2.44 596.6324 1,786.87 1,786.88 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% IDSRLEQYTSAIEGTK 95.00% 4.92 0.45 2.8 604.3093 1,809.90 1,810.92 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% IDSRLEQYTSAIEGTK 95.00% 4.79 0.521 2.4 604.3107 1,809.91 1,810.92 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% IDSRLEQYTSAIEGTK 95.00% 4.97 0.546 1.32 604.3113 1,809.91 1,810.92 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% IDSRLEQYTSAIEGTK 95.00% 4.04 0.323 1.85 604.6434 1,810.91 1,810.92 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGKR 95.00% 4.15 0.564 2.51 648.3333 1,941.98 1,942.98 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGKR 95.00% 4.26 0.544 2.28 648.3337 1,941.98 1,942.98 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGKR 95.00% 4.71 0.586 2.59 648.6663 1,942.98 1,942.98 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGKR 95.00% 4.93 0.58 3.25 648.6667 1,942.98 1,942.98 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGKR 95.00% 4.89 0.57 2.49 648.6671 1,942.98 1,942.98 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGKR 95.00% 5.04 0.545 1.96 648.6673 1,942.98 1,942.98 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGKR 95.00% 4.37 0.464 1.41 648.6678 1,942.98 1,942.98 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGKR 95.00% 3.97 0.506 2.07 648.6696 1,942.99 1,942.98 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 3.8 0.304 2.21 664.3682 1,990.08 1,991.09 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 2.68 0.25 1.17 664.3691 1,990.08 1,991.09 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 3.73 0.362 0 664.7023 1,991.08 1,991.09 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 4.65 0.417 2.96 664.7024 1,991.08 1,991.09 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 4.96 0.433 3.64 664.7027 1,991.08 1,991.09 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 4.74 0.34 2.48 664.7028 1,991.08 1,991.09 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 3.97 0.324 2.66 664.7037 1,991.09 1,991.09 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 4.61 0.39 2.96 664.7057 1,991.09 1,991.09 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKEFDPTITDASLSLPSR 95.00% 3.08 0.324 1.02 669.3448 2,005.01 2,005.02 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKEFDPTITDASLSLPSR 95.00% 3.13 0.371 0 669.3451 2,005.01 2,005.02 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKEFDPTITDASLSLPSR 95.00% 3.56 0.385 1.41 669.3461 2,005.01 2,005.02 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKEFDPTITDASLSLPSR 95.00% 3.42 0.313 1.77 669.3467 2,005.02 2,005.02 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 4.18 0.447 4.27 670.339 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 3.58 0.485 3.46 670.3393 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 3.81 0.434 3.06 670.3394 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 3.7 0.475 3.11 670.3396 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 4.07 0.451 3.52 670.3397 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 4 0.463 3.29 670.3398 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 4.03 0.478 3.6 670.3398 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 4.09 0.467 4.15 670.3399 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 3.8 0.473 4.72 670.3399 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 3.83 0.489 3.64 670.3401 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 3.61 0.492 4.28 670.3401 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 3.78 0.501 2.46 670.3402 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% LEQYTSAIEGTK 95.00% 3.85 0.452 2.96 670.3412 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% YEIEETETVTK 95.00% 3.86 0.423 3.1 671.3233 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% YEIEETETVTK 95.00% 2.85 0.441 3.13 671.3236 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% YEIEETETVTK 95.00% 3.79 0.408 3.11 671.3237 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% YEIEETETVTK 95.00% 3.59 0.358 2.82 671.324 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% YEIEETETVTK 95.00% 1.96 0.388 0 671.3257 1,340.64 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% YEIEETETVTK 95.00% 0 0 3.47 672.3432 1,342.67 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% AQEDKLQTAVLK 95.00% 2.96 0.388 0 672.3788 1,342.74 1,343.75 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNKETAGLK 95.00% 2.23 0.407 0 683.0197 2,046.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNKETAGLK 95.00% 2.2 0.376 0 683.3553 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTTTNTQVEGDDEAAFLER 95.00% 2.19 0.221 0 699.9011 2,096.68 2,097.96 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GETESEEFEKLK 95.00% 3.36 0.388 1.32 713.3387 1,424.66 1,425.68 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNK 95.00% 4.34 0.569 5.96 724.3594 1,446.70 1,447.72 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNK 95.00% 4.08 0.557 5.35 724.3603 1,446.70 1,447.72 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNK 95.00% 4.52 0.604 4.85 724.3613 1,446.71 1,447.72 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNK 95.00% 4.56 0.596 5.7 724.3616 1,446.71 1,447.72 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNK 95.00% 3.97 0.544 4.19 724.3617 1,446.71 1,447.72 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNK 95.00% 3.83 0.576 5.24 724.3619 1,446.71 1,447.72 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNK 95.00% 4.66 0.594 5.33 724.3623 1,446.71 1,447.72 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNK 95.00% 2.77 0.314 0 724.8701 1,447.72 1,447.72 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNK 95.00% 2.05 0.396 0 724.8712 1,447.73 1,447.72 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SESRQERYEIEETETVTK 95.00% 2.39 0.363 0 739.0221 2,214.04 2,214.05 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QQEAALELEELKK 95.00% 2.99 0.385 1.17 764.9141 1,527.81 1,528.82 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QQEAALELEELKK 95.00% 2.9 0.361 1.19 764.9144 1,527.81 1,528.82 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QQEAALELEELKK 95.00% 3.27 0.284 0 764.9148 1,527.81 1,528.82 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QQEAALELEELKK 95.00% 2.83 0.317 0 764.915 1,527.81 1,528.82 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QQEAALELEELKK 95.00% 3.21 0.29 1.66 764.915 1,527.81 1,528.82 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TPDGNKSPAPKPSDLRPGDVSSK 95.00% 0 0 4.13 784.4044 2,350.19 2,350.20 3
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTESQEETVVMSLK 95.00% 3.98 0.492 4.27 791.3848 1,580.75 1,581.77 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTESQEETVVMSLK 95.00% 3.9 0.45 3.12 791.3862 1,580.76 1,581.77 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTESQEETVVMSLK 95.00% 3.25 0.475 4.34 791.3877 1,580.76 1,581.77 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTESQEETVVMSLK 95.00% 4.12 0.463 4.7 791.8871 1,581.76 1,581.77 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% MPEDGLSDDKKPFK 95.00% 3.66 0.453 0 803.8902 1,605.76 1,606.78 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% MPEDGLSDDKKPFK 95.00% 4.31 0.442 2.06 803.891 1,605.77 1,606.78 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% MPEDGLSDDKKPFK 95.00% 4.39 0.477 2.09 803.892 1,605.77 1,606.78 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% MPEDGLSDDKKPFK 95.00% 3.99 0.435 2.26 803.895 1,605.77 1,606.78 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% MPEDGLSDDKKPFK 95.00% 4.69 0.501 3.03 804.3945 1,606.77 1,606.78 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% MPEDGLSDDKKPFK 95.00% 4.41 0.528 2.29 804.3954 1,606.78 1,606.78 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 2.28 0.393 0 869.4585 1,736.90 1,737.91 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 3.27 0.566 0 869.4601 1,736.90 1,737.91 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 3.21 0.599 0 869.4607 1,736.91 1,737.91 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 3.35 0.504 0 869.9598 1,737.90 1,737.91 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 3.4 0.5 0 869.9607 1,737.91 1,737.91 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SPAPKPSDLRPGDVSSK 95.00% 2.47 0.354 0 869.964 1,737.91 1,737.91 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% EFDPTITDASLSLPSR 95.00% 4.57 0.561 3.55 874.9367 1,747.86 1,748.87 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% EFDPTITDASLSLPSR 95.00% 5.13 0.581 2.82 874.9395 1,747.86 1,748.87 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QERYEIEETETVTK 95.00% 4.28 0.394 2.96 877.9204 1,753.83 1,754.85 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QERYEIEETETVTK 95.00% 3.91 0.339 3.21 877.9217 1,753.83 1,754.85 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QERYEIEETETVTK 95.00% 4.47 0.419 5.15 877.923 1,753.83 1,754.85 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QERYEIEETETVTK 95.00% 4.35 0.448 5.14 877.9237 1,753.83 1,754.85 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QERYEIEETETVTK 95.00% 4.44 0.404 2.85 878.4246 1,754.83 1,754.85 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QERYEIEETETVTK 95.00% 4.47 0.406 2.18 878.4249 1,754.83 1,754.85 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKQQEAALELEELKK 95.00% 2.86 0.398 0 892.9903 1,783.96 1,784.98 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKQQEAALELEELKK 95.00% 2.63 0.416 1.47 892.9926 1,783.97 1,784.98 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 4.9 0.5 4.55 893.942 1,785.87 1,786.88 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 5.61 0.521 4.21 893.9429 1,785.87 1,786.88 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 5.5 0.479 3.85 893.9441 1,785.87 1,786.88 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 5.4 0.471 3.85 893.9449 1,785.87 1,786.88 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 5.64 0.542 5.19 893.9458 1,785.88 1,786.88 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% ASVDTKEAEGAPQVEAGK 95.00% 5.64 0.506 3.24 894.4436 1,786.87 1,786.88 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% IDSRLEQYTSAIEGTK 95.00% 4.64 0.518 4.96 905.961 1,809.91 1,810.92 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% IDSRLEQYTSAIEGTK 95.00% 4.03 0.408 5.43 905.9611 1,809.91 1,810.92 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% IDSRLEQYTSAIEGTK 95.00% 3.89 0.405 5.2 905.9636 1,809.91 1,810.92 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% IDSRLEQYTSAIEGTK 95.00% 4.69 0.467 4.1 906.4619 1,810.91 1,810.92 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 5.16 0.557 6.33 996.047 1,990.08 1,991.09 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 5.08 0.537 6 996.0481 1,990.08 1,991.09 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 4.94 0.539 5.4 996.049 1,990.08 1,991.09 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 5.34 0.559 6.72 996.5488 1,991.08 1,991.09 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 5.16 0.518 6.62 996.55 1,991.08 1,991.09 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% SAKPTKPAASDLPVPAEGVR 95.00% 5.68 0.533 5.92 996.5504 1,991.09 1,991.09 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKEFDPTITDASLSLPSR 95.00% 4.61 0.568 4.07 1,003.01 2,004.01 2,005.02 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKEFDPTITDASLSLPSR 95.00% 4.24 0.58 4.48 1,003.51 2,005.01 2,005.02 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKEFDPTITDASLSLPSR 95.00% 4.23 0.527 4.26 1,003.51 2,005.01 2,005.02 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNKETAGLK 95.00% 4.77 0.527 2.35 1,024.52 2,047.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNKETAGLK 95.00% 4.32 0.568 3.74 1,024.52 2,047.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNKETAGLK 95.00% 4.59 0.547 3.31 1,024.52 2,047.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNKETAGLK 95.00% 4.55 0.562 6.14 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNKETAGLK 95.00% 4.89 0.632 3.96 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% GNVFSSPTAAGTPNKETAGLK 95.00% 4.62 0.628 4.15 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTTTNTQVEGDDEAAFLER 95.00% 5.19 0.565 7.19 1,049.49 2,096.97 2,097.96 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTTTNTQVEGDDEAAFLER 95.00% 6.19 0.584 5.74 1,049.98 2,097.94 2,097.96 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTTTNTQVEGDDEAAFLER 95.00% 6.31 0.572 8.41 1,049.98 2,097.95 2,097.96 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTTTNTQVEGDDEAAFLER 95.00% 6.43 0.626 6.8 1,049.98 2,097.95 2,097.96 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTTTNTQVEGDDEAAFLER 95.00% 6.21 0.594 7.43 1,049.98 2,097.95 2,097.96 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTTTNTQVEGDDEAAFLER 95.00% 6.22 0.574 6.92 1,049.98 2,097.95 2,097.96 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTTTNTQVEGDDEAAFLER 95.00% 6.17 0.601 7.42 1,049.98 2,097.95 2,097.96 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTTTNTQVEGDDEAAFLER 95.00% 6.34 0.61 6.85 1,049.98 2,097.95 2,097.96 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTTTNTQVEGDDEAAFLER 95.00% 6.04 0.585 6.25 1,049.98 2,097.95 2,097.96 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTTTNTQVEGDDEAAFLER 95.00% 6.35 0.587 8.21 1,049.98 2,097.95 2,097.96 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% TTTTNTQVEGDDEAAFLER 95.00% 6.18 0.619 7.07 1,049.99 2,097.97 2,097.96 2
 SAMPLE 1 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 34 158 32.70% QKQEEESLGQVTDQVEVNAQNSVPDEEAK 95.00% 5.9 0.545 3.29 1,077.17 3,228.50 3,228.51 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% INEWLTK 95.00% 2.27 0.256 0 452.2503 902.485 903.4941 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% INEWLTK 95.00% 2.19 0.224 0 452.2504 902.4851 903.4941 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% INEWLTK 95.00% 2.31 0.214 0 452.2504 902.4851 903.4941 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% INEWLTK 95.00% 2.39 0.266 0 452.2508 902.4859 903.4941 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% INEWLTK 94.60% 2.21 0.221 0 452.2541 902.4926 903.4941 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% INEWLTK 95.00% 2.44 0.229 0 452.2549 902.4942 903.4941 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% KAQEDKLQTAVLK 95.00% 3.82 0.34 0 491.2865 1,470.84 1,471.85 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% KAQEDKLQTAVLK 95.00% 3.84 0.316 0 491.2873 1,470.84 1,471.85 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QQEAALELEELKK 95.00% 3.05 0.339 0 510.2775 1,527.81 1,528.82 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QQEAALELEELKK 95.00% 2.75 0.36 0 510.2778 1,527.81 1,528.82 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QQEAALELEELKK 95.00% 2.83 0.321 0 510.278 1,527.81 1,528.82 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QQEAALELEELKK 95.00% 2.48 0.292 0 510.2783 1,527.81 1,528.82 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QQEAALELEELKK 95.00% 3.18 0.348 0 510.2786 1,527.81 1,528.82 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QQEAALELEELKK 95.00% 2.91 0.441 0 510.2786 1,527.81 1,528.82 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ARIEAEEKAAAQER 95.00% 3.27 0.382 0 524.6089 1,570.80 1,571.81 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ARIEAEEKAAAQER 95.00% 2.46 0.254 0 524.9456 1,571.81 1,571.81 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% RGETESEEFEKLK 95.00% 4.49 0.419 1.1 527.9292 1,580.76 1,581.78 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% RGETESEEFEKLK 95.00% 4.19 0.408 0 527.9295 1,580.77 1,581.78 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% RGETESEEFEKLK 95.00% 3.7 0.36 0 527.9295 1,580.77 1,581.78 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% RGETESEEFEKLK 95.00% 3.89 0.367 1.11 527.9297 1,580.77 1,581.78 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% RGETESEEFEKLK 95.00% 3.88 0.403 1.17 527.93 1,580.77 1,581.78 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% RGETESEEFEKLK 95.00% 4.16 0.4 1.74 527.9301 1,580.77 1,581.78 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% MPEDGLSDDKKPFK 95.00% 2.48 0.257 0 536.2629 1,605.77 1,606.78 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% MPEDGLSDDKKPFK 95.00% 2.96 0.333 0 536.2634 1,605.77 1,606.78 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% MPEDGLSDDKKPFK 95.00% 2.61 0.299 0 536.2635 1,605.77 1,606.78 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% MPEDGLSDDKKPFK 95.00% 2.61 0.338 0 536.2639 1,605.77 1,606.78 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% PTKPAASDLPVPAEGVR 95.00% 2.53 0.286 0 568.9808 1,703.92 1,704.93 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 2.25 0.35 0 579.9753 1,736.90 1,737.91 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 2.68 0.464 0 579.9756 1,736.90 1,737.91 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 2.23 0.375 0 579.9757 1,736.90 1,737.91 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 2.17 0.342 0 579.9764 1,736.91 1,737.91 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 2.63 0.407 0 579.9765 1,736.91 1,737.91 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 1.57 0.317 0 579.9774 1,736.91 1,737.91 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 1.6 0.307 0 579.978 1,736.91 1,737.91 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 2.71 0.386 0 580.3094 1,737.90 1,737.91 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 2.29 0.342 0 580.3104 1,737.91 1,737.91 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 2.56 0.377 0 580.311 1,737.91 1,737.91 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QERYEIEETETVTK 95.00% 3.81 0.35 0 585.6182 1,753.83 1,754.85 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QERYEIEETETVTK 95.00% 3.72 0.397 0 585.9526 1,754.83 1,754.85 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKQQEAALELEELKK 95.00% 3.37 0.25 0 595.6622 1,783.96 1,784.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKQQEAALELEELKK 95.00% 3.57 0.379 0 595.6624 1,783.96 1,784.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKQQEAALELEELKK 95.00% 3.11 0.236 0 595.6625 1,783.96 1,784.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKQQEAALELEELKK 95.00% 2.76 0.245 0 595.9966 1,784.97 1,784.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKQQEAALELEELKK 95.00% 3.54 0.326 0 595.9971 1,784.97 1,784.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKQQEAALELEELKK 95.00% 3.8 0.372 1.08 595.9972 1,784.97 1,784.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 3.96 0.417 4.24 596.2982 1,785.87 1,786.88 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 3.29 0.468 4.64 596.2983 1,785.87 1,786.88 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 4.24 0.462 3.7 596.2986 1,785.87 1,786.88 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 3.57 0.487 5 596.2986 1,785.87 1,786.88 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 2.52 0.302 0 596.2986 1,785.87 1,786.88 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 2.09 0.302 2.82 596.2989 1,785.87 1,786.88 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 3.17 0.414 3.66 596.299 1,785.87 1,786.88 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 2.99 0.266 4.38 596.6324 1,786.87 1,786.88 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 3.47 0.28 2.24 596.6329 1,786.88 1,786.88 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 2.8 0.209 4 596.633 1,786.88 1,786.88 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% IDSRLEQYTSAIEGTK 95.00% 4.65 0.534 3.08 604.3098 1,809.91 1,810.92 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% IDSRLEQYTSAIEGTK 95.00% 4.09 0.518 1.68 604.3105 1,809.91 1,810.92 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% IDSRLEQYTSAIEGTK 95.00% 4.29 0.464 1.89 604.3109 1,809.91 1,810.92 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% IDSRLEQYTSAIEGTK 95.00% 5.14 0.51 2.49 604.6439 1,810.91 1,810.92 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGKR 95.00% 4.67 0.583 2.36 648.3316 1,941.97 1,942.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGKR 95.00% 4.09 0.529 3.36 648.3339 1,941.98 1,942.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGKR 95.00% 4.12 0.503 2.66 648.6657 1,942.97 1,942.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGKR 95.00% 4.22 0.488 2.59 648.667 1,942.98 1,942.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGKR 95.00% 3.61 0.506 3.03 648.6671 1,942.98 1,942.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGKR 95.00% 4.71 0.541 3.28 648.6672 1,942.98 1,942.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGKR 95.00% 3.83 0.479 2.28 648.6676 1,942.98 1,942.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGKR 95.00% 3.59 0.446 1.52 648.6678 1,942.98 1,942.98 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 4.55 0.416 2.32 664.3683 1,990.08 1,991.09 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 3.89 0.367 3.01 664.7015 1,991.08 1,991.09 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 4.74 0.411 1.44 664.7022 1,991.08 1,991.09 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 4.2 0.393 1.96 664.7023 1,991.08 1,991.09 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 4.51 0.354 2.74 664.7025 1,991.08 1,991.09 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 4.64 0.362 2.96 664.7028 1,991.08 1,991.09 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 4.27 0.413 3.26 664.7033 1,991.09 1,991.09 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 4.15 0.398 1.14 664.7042 1,991.09 1,991.09 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 4.61 0.39 3.27 664.7057 1,991.09 1,991.09 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 3.75 0.17 0 664.7076 1,991.10 1,991.09 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKEFDPTITDASLSLPSR 95.00% 4.09 0.479 1.32 669.3445 2,005.01 2,005.02 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKEFDPTITDASLSLPSR 95.00% 2.59 0.333 0 669.3455 2,005.01 2,005.02 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKEFDPTITDASLSLPSR 95.00% 3.98 0.433 1.77 669.3461 2,005.01 2,005.02 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKEFDPTITDASLSLPSR 95.00% 3.67 0.248 1.26 669.3463 2,005.02 2,005.02 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKEFDPTITDASLSLPSR 95.00% 3.49 0.272 1.13 669.3467 2,005.02 2,005.02 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% LEQYTSAIEGTK 95.00% 3.63 0.489 2.77 670.3391 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% LEQYTSAIEGTK 95.00% 3.63 0.449 3.02 670.3391 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% LEQYTSAIEGTK 95.00% 4.07 0.496 3.03 670.3391 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% LEQYTSAIEGTK 95.00% 4.11 0.456 3.03 670.3394 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% LEQYTSAIEGTK 95.00% 4.01 0.468 3.55 670.3396 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% LEQYTSAIEGTK 95.00% 3.27 0.481 3.24 670.3396 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% LEQYTSAIEGTK 95.00% 3.63 0.481 2.72 670.3398 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% LEQYTSAIEGTK 95.00% 3.97 0.45 3.14 670.3398 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% LEQYTSAIEGTK 95.00% 4.04 0.441 2.7 670.3399 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% LEQYTSAIEGTK 95.00% 4.33 0.486 3.34 670.3399 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% LEQYTSAIEGTK 95.00% 3.83 0.489 3.06 670.3401 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% YEIEETETVTK 95.00% 2.4 0.391 2.54 671.323 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% YEIEETETVTK 95.00% 3.75 0.396 2.77 671.3232 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% YEIEETETVTK 95.00% 3.11 0.443 3.16 671.3232 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% YEIEETETVTK 95.00% 3.68 0.407 2.85 671.3238 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% YEIEETETVTK 95.00% 3.74 0.451 2.89 671.3239 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% YEIEETETVTK 95.00% 3.85 0.408 2.66 671.3243 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% YEIEETETVTK 95.00% 1.96 0.388 0 671.3257 1,340.64 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNKETAGLK 95.00% 1.65 0.295 1.09 683.019 2,046.03 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNKETAGLK 95.00% 2.01 0.396 0 683.3536 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNKETAGLK 95.00% 2.2 0.376 0 683.3553 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTTTNTQVEGDDEAAFLER 95.00% 2.82 0.234 1.4 699.9001 2,096.68 2,097.96 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTTTNTQVEGDDEAAFLER 95.00% 2.67 0.308 0 699.9003 2,096.68 2,097.96 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKEFDPTITDASLSLPSRR 95.00% 2.13 0.259 0 721.3811 2,161.12 2,161.13 3 ANX11_HUMAN,MAP1B_HUMAN,RS5_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNK 95.00% 4.36 0.615 4.7 724.3581 1,446.70 1,447.72 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNK 95.00% 3.89 0.578 4.89 724.3603 1,446.71 1,447.72 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNK 95.00% 4.25 0.579 5.23 724.3619 1,446.71 1,447.72 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNK 95.00% 4.25 0.566 5.46 724.3622 1,446.71 1,447.72 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNK 95.00% 4.23 0.581 4.8 724.3623 1,446.71 1,447.72 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNK 95.00% 4.38 0.568 5.25 724.3626 1,446.71 1,447.72 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNK 95.00% 2.83 0.271 1.23 724.8691 1,447.72 1,447.72 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SESRQERYEIEETETVTK 95.00% 2.23 0.221 0 739.0223 2,214.04 2,214.05 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QQEAALELEELKK 95.00% 3.08 0.348 1.12 764.9118 1,527.81 1,528.82 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QQEAALELEELKK 95.00% 2.92 0.338 0 764.913 1,527.81 1,528.82 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QQEAALELEELKK 95.00% 3.3 0.396 0 764.9148 1,527.81 1,528.82 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QQEAALELEELKK 95.00% 3.55 0.36 0 764.9149 1,527.81 1,528.82 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QQEAALELEELKK 95.00% 2.99 0.351 1.43 764.9149 1,527.81 1,528.82 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QQEAALELEELKK 95.00% 2.88 0.255 0 765.4163 1,528.82 1,528.82 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TPDGNKSPAPKPSDLRPGDVSSK 95.00% 0 0 3.48 784.4053 2,350.19 2,350.20 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TPDGNKSPAPKPSDLRPGDVSSK 95.00% 0 0 3.49 784.4054 2,350.19 2,350.20 3
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTESQEETVVMSLK 95.00% 4.19 0.431 4.24 791.3869 1,580.76 1,581.77 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTESQEETVVMSLK 95.00% 3.98 0.442 3.72 791.3871 1,580.76 1,581.77 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTESQEETVVMSLK 95.00% 3.64 0.219 2.54 791.8774 1,581.74 1,581.77 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% MPEDGLSDDKKPFK 95.00% 4.3 0.467 2.31 803.8916 1,605.77 1,606.78 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% MPEDGLSDDKKPFK 95.00% 3.94 0.496 2.4 803.8923 1,605.77 1,606.78 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% MPEDGLSDDKKPFK 95.00% 4.34 0.516 2.82 803.8936 1,605.77 1,606.78 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% MPEDGLSDDKKPFK 95.00% 4.41 0.431 1.92 804.3941 1,606.77 1,606.78 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 3.25 0.55 0 869.4586 1,736.90 1,737.91 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 3.28 0.614 0 869.4602 1,736.90 1,737.91 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 3.23 0.546 0 869.4607 1,736.91 1,737.91 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SPAPKPSDLRPGDVSSK 95.00% 3.19 0.483 0 869.9629 1,737.91 1,737.91 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% EFDPTITDASLSLPSR 95.00% 4.24 0.541 3.96 874.9414 1,747.87 1,748.87 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% EFDPTITDASLSLPSR 95.00% 4.47 0.505 2.6 875.4373 1,748.86 1,748.87 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QERYEIEETETVTK 95.00% 4.44 0.424 3.09 877.9237 1,753.83 1,754.85 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QERYEIEETETVTK 95.00% 4.24 0.381 3.35 877.9256 1,753.84 1,754.85 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QERYEIEETETVTK 95.00% 4.06 0.397 3.28 877.926 1,753.84 1,754.85 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QERYEIEETETVTK 95.00% 4.18 0.34 2.17 877.9275 1,753.84 1,754.85 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QERYEIEETETVTK 95.00% 3.77 0.359 2.41 878.4244 1,754.83 1,754.85 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QERYEIEETETVTK 95.00% 4.2 0.354 1.8 878.4269 1,754.84 1,754.85 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 5.52 0.513 5.77 893.943 1,785.87 1,786.88 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 5.33 0.442 3.85 893.9433 1,785.87 1,786.88 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 5.29 0.478 4.29 893.9435 1,785.87 1,786.88 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 5.18 0.503 5 893.9436 1,785.87 1,786.88 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 4.87 0.463 3.96 893.9439 1,785.87 1,786.88 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 5.63 0.504 3.27 893.9442 1,785.87 1,786.88 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 2.43 0.51 3.37 894.4447 1,786.87 1,786.88 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 5.52 0.468 3.54 894.445 1,786.87 1,786.88 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% ASVDTKEAEGAPQVEAGK 95.00% 4.89 0.411 5.03 894.4469 1,786.88 1,786.88 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% IDSRLEQYTSAIEGTK 95.00% 3.56 0.422 4.15 905.9594 1,809.90 1,810.92 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% IDSRLEQYTSAIEGTK 95.00% 4.13 0.375 4.39 905.9607 1,809.91 1,810.92 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% IDSRLEQYTSAIEGTK 95.00% 4.77 0.48 3.06 906.4618 1,810.91 1,810.92 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% IDSRLEQYTSAIEGTK 95.00% 4.83 0.435 3.92 906.4649 1,810.91 1,810.92 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 5.73 0.57 5.04 996.0469 1,990.08 1,991.09 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 4.93 0.569 6.44 996.0521 1,990.09 1,991.09 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 4.77 0.517 6.22 996.5492 1,991.08 1,991.09 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 5.46 0.54 5.8 996.5494 1,991.08 1,991.09 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% SAKPTKPAASDLPVPAEGVR 95.00% 4.88 0.467 6.05 996.5525 1,991.09 1,991.09 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKEFDPTITDASLSLPSR 95.00% 4.14 0.522 5.51 1,003.51 2,005.01 2,005.02 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKEFDPTITDASLSLPSR 95.00% 4.18 0.559 6.38 1,003.51 2,005.01 2,005.02 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKEFDPTITDASLSLPSR 95.00% 4.29 0.598 4.52 1,003.51 2,005.01 2,005.02 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKEFDPTITDASLSLPSR 95.00% 4.27 0.581 5.54 1,003.52 2,005.01 2,005.02 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNKETAGLK 95.00% 4.65 0.58 5.39 1,024.02 2,046.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNKETAGLK 95.00% 4.91 0.586 4.29 1,024.52 2,047.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNKETAGLK 95.00% 4.76 0.628 4.09 1,024.52 2,047.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNKETAGLK 95.00% 4.7 0.57 3.25 1,024.52 2,047.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% GNVFSSPTAAGTPNKETAGLK 95.00% 4.65 0.614 3.68 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTTTNTQVEGDDEAAFLER 95.00% 5.65 0.589 7.36 1,049.48 2,096.94 2,097.96 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTTTNTQVEGDDEAAFLER 95.00% 6.44 0.6 6.49 1,049.48 2,096.94 2,097.96 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTTTNTQVEGDDEAAFLER 95.00% 5.19 0.565 7.52 1,049.49 2,096.97 2,097.96 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTTTNTQVEGDDEAAFLER 95.00% 6 0.6 8.31 1,049.50 2,096.98 2,097.96 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTTTNTQVEGDDEAAFLER 95.00% 5.98 0.605 8.24 1,049.50 2,096.98 2,097.96 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTTTNTQVEGDDEAAFLER 95.00% 6.53 0.595 6.8 1,049.98 2,097.95 2,097.96 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTTTNTQVEGDDEAAFLER 95.00% 6.53 0.609 7 1,049.98 2,097.95 2,097.96 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTTTNTQVEGDDEAAFLER 95.00% 6.23 0.579 7.09 1,049.98 2,097.95 2,097.96 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTTTNTQVEGDDEAAFLER 95.00% 6.05 0.611 6.15 1,049.98 2,097.95 2,097.96 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% TTTTNTQVEGDDEAAFLER 95.00% 6.18 0.619 7.04 1,049.99 2,097.97 2,097.96 2
 SAMPLE 1R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 24 33 164 34.60% QKQEEESLGQVTDQVEVNAQNSVPDEEAK 95.00% 6.69 0.613 2.72 1,077.18 3,228.51 3,228.51 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% INEWLTK 95.00% 2.51 0.251 0 452.2506 902.4855 903.4941 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% INEWLTK 95.00% 2.51 0.281 0 452.2513 902.4869 903.4941 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% INEWLTK 95.00% 2.57 0.262 0 452.2513 902.4869 903.4941 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% INEWLTK 95.00% 2.46 0.197 0 452.2514 902.4872 903.4941 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% INEWLTK 95.00% 2.22 0.218 0 452.2525 902.4893 903.4941 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% KAQEDKLQTAVLK 95.00% 3.98 0.337 0 491.2861 1,470.83 1,471.85 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% KAQEDKLQTAVLK 95.00% 2.57 0.164 0 491.2863 1,470.84 1,471.85 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% KAQEDKLQTAVLK 95.00% 3.99 0.388 0 491.2866 1,470.84 1,471.85 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% KAQEDKLQTAVLK 95.00% 3.29 0.256 0 491.2874 1,470.84 1,471.85 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 2.98 0.387 0 510.2781 1,527.81 1,528.82 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 2.74 0.37 0 510.2783 1,527.81 1,528.82 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 2.96 0.355 0 510.2784 1,527.81 1,528.82 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 2.17 0.342 0 510.2785 1,527.81 1,528.82 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 2.96 0.347 0 510.2787 1,527.81 1,528.82 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 3.05 0.393 0 510.2788 1,527.81 1,528.82 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 2.06 0.295 0 510.6125 1,528.81 1,528.82 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTESQEETVVMSLK 95.00% 3.33 0.428 2.54 527.9278 1,580.76 1,581.77 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% RGETESEEFEKLK 95.00% 4.46 0.42 1.16 527.9278 1,580.76 1,581.78 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTESQEETVVMSLK 95.00% 3.49 0.386 1.05 527.9282 1,580.76 1,581.77 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% RGETESEEFEKLK 95.00% 4.05 0.386 1.3 527.9295 1,580.77 1,581.78 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% MPEDGLSDDKKPFK 95.00% 2.47 0.212 0 536.262 1,605.76 1,606.78 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% MPEDGLSDDKKPFK 95.00% 2.32 0.196 0 536.2638 1,605.77 1,606.78 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% MPEDGLSDDKKPFK 95.00% 3.13 0.355 0 536.2638 1,605.77 1,606.78 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% MPEDGLSDDKKPFK 95.00% 2.99 0.363 0 536.5989 1,606.77 1,606.78 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% MPEDGLSDDKKPFK 95.00% 2.76 0.302 0 536.5991 1,606.77 1,606.78 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% PTKPAASDLPVPAEGVR 95.00% 2.47 0.221 0 569.3152 1,704.92 1,704.93 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.36 0.244 0 579.9738 1,736.90 1,737.91 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.54 0.412 0 579.9753 1,736.90 1,737.91 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.32 0.343 0 579.9755 1,736.90 1,737.91 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.27 0.385 0 579.9756 1,736.90 1,737.91 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.59 0.452 0 579.9762 1,736.91 1,737.91 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.6 0.392 0 579.9764 1,736.91 1,737.91 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.64 0.452 0 579.9773 1,736.91 1,737.91 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.81 0.355 0 580.3087 1,737.90 1,737.91 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.61 0.331 0 580.3096 1,737.91 1,737.91 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.42 0.35 0 580.3102 1,737.91 1,737.91 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.26 0.279 0 580.3104 1,737.91 1,737.91 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.36 0.353 0 580.3106 1,737.91 1,737.91 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QKQQEAALELEELKK 95.00% 3.47 0.321 0 595.6629 1,783.97 1,784.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QKQQEAALELEELKK 95.00% 3.6 0.249 0 595.6631 1,783.97 1,784.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 3.04 0.364 4.37 596.298 1,785.87 1,786.88 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 3.23 0.402 3.3 596.298 1,785.87 1,786.88 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 3.95 0.483 4.51 596.2986 1,785.87 1,786.88 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 3.06 0.506 1.66 596.2994 1,785.87 1,786.88 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 2.68 0.266 1.96 596.2994 1,785.87 1,786.88 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 3.51 0.435 3.62 596.2996 1,785.88 1,786.88 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 3.17 0.329 1.85 596.3 1,785.88 1,786.88 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 3.44 0.287 2.68 596.6324 1,786.87 1,786.88 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 3.38 0.319 1.92 596.6329 1,786.88 1,786.88 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 3.15 0.322 3.36 596.6332 1,786.88 1,786.88 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 2.81 0.228 2.89 596.634 1,786.88 1,786.88 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 3.04 0.256 1.02 596.6357 1,786.88 1,786.88 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% RGSIGENQVEVMVEEK 95.00% 3.89 0.4 2.27 602.3012 1,803.88 1,803.89 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% RGSIGENQVEVMVEEK 95.00% 3.92 0.319 0 602.3027 1,803.88 1,803.89 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% IDSRLEQYTSAIEGTK 95.00% 4.2 0.501 2.15 604.3105 1,809.91 1,810.92 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% IDSRLEQYTSAIEGTK 95.00% 4.62 0.528 1.82 604.6429 1,810.91 1,810.92 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% IDSRLEQYTSAIEGTK 95.00% 4.42 0.529 1.96 604.6445 1,810.91 1,810.92 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% IDSRLEQYTSAIEGTK 95.00% 3.95 0.451 2.21 604.6447 1,810.91 1,810.92 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QSVDKVTSPTKV 95.00% 2.13 0.352 0 644.8595 1,287.70 1,288.71 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.59 0.543 2.16 648.3324 1,941.97 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 5.03 0.519 2.54 648.3326 1,941.97 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 5.37 0.547 2.38 648.3326 1,941.97 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 3.9 0.469 2.38 648.3338 1,941.98 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.3 0.528 1.96 648.3339 1,941.98 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.76 0.558 2.49 648.666 1,942.97 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.9 0.55 3.43 648.666 1,942.97 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 2.84 0.339 1.66 648.6661 1,942.97 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.17 0.474 2.52 648.6662 1,942.98 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.76 0.544 3.62 648.6663 1,942.98 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.11 0.536 1.85 648.6664 1,942.98 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 3.47 0.47 1.39 648.6678 1,942.98 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.44 0.531 1.66 648.6679 1,942.98 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGKR 95.00% 3.81 0.398 1.43 648.6688 1,942.98 1,942.98 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 3.52 0.338 1.17 664.3681 1,990.08 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.55 0.394 2.41 664.3686 1,990.08 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.53 0.381 2.85 664.3691 1,990.08 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 3.68 0.442 2.02 664.3691 1,990.08 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.66 0.408 1.49 664.7022 1,991.08 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.77 0.327 2.7 664.7022 1,991.08 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.49 0.296 1.3 664.7024 1,991.08 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.93 0.38 2.12 664.7025 1,991.08 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.4 0.366 2.28 664.7028 1,991.08 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 3.93 0.301 0.959 664.7029 1,991.09 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.25 0.345 2.8 664.7031 1,991.09 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.37 0.429 2.12 664.7032 1,991.09 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.47 0.366 2.46 664.7034 1,991.09 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.43 0.377 1.92 664.7041 1,991.09 1,991.09 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QKEFDPTITDASLSLPSR 95.00% 3.92 0.365 0 669.012 2,004.01 2,005.02 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QKEFDPTITDASLSLPSR 95.00% 3.91 0.377 1.52 669.0125 2,004.01 2,005.02 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QKEFDPTITDASLSLPSR 95.00% 2.91 0.295 0 669.0126 2,004.01 2,005.02 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QKEFDPTITDASLSLPSR 95.00% 3.08 0.367 1.77 669.346 2,005.01 2,005.02 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% LEQYTSAIEGTK 95.00% 2.75 0.401 2.77 670.339 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% LEQYTSAIEGTK 95.00% 4.27 0.469 2.77 670.3391 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% LEQYTSAIEGTK 95.00% 4.14 0.498 3.31 670.3395 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% LEQYTSAIEGTK 95.00% 4.43 0.49 3.11 670.3396 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% LEQYTSAIEGTK 95.00% 4.14 0.478 3.15 670.3397 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% LEQYTSAIEGTK 95.00% 4.19 0.472 3.64 670.3399 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% LEQYTSAIEGTK 95.00% 4.07 0.477 3.12 670.34 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% LEQYTSAIEGTK 95.00% 3.52 0.494 2.74 670.3402 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% LEQYTSAIEGTK 95.00% 3.3 0.465 3.31 670.3405 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% LEQYTSAIEGTK 95.00% 2.7 0.46 4.24 670.3419 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNKETAGLK 95.00% 2.03 0.346 0 683.3532 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNKETAGLK 95.00% 2.35 0.384 0 683.3535 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 2.6 0.215 0 699.9 2,096.68 2,097.96 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 4.03 0.478 0 700.3239 2,097.95 2,097.96 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 3.41 0.357 0 700.3255 2,097.95 2,097.96 3
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GETESEEFEKLK 95.00% 3.26 0.427 1.48 713.3384 1,424.66 1,425.68 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNK 95.00% 2.44 0.197 1.92 724.3577 1,446.70 1,447.72 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNK 95.00% 4.38 0.573 5.12 724.3615 1,446.71 1,447.72 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNK 95.00% 4.33 0.58 5.96 724.3616 1,446.71 1,447.72 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNK 95.00% 4.19 0.573 5.96 724.3616 1,446.71 1,447.72 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNK 95.00% 4.01 0.581 3.96 724.3625 1,446.71 1,447.72 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNK 95.00% 3.96 0.533 4.23 724.3631 1,446.71 1,447.72 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNK 95.00% 3.59 0.562 5.52 724.3635 1,446.71 1,447.72 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNK 95.00% 3.14 0.453 2.72 724.3651 1,446.71 1,447.72 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 2.81 0.395 1.24 764.9137 1,527.81 1,528.82 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 3.54 0.379 0 764.9142 1,527.81 1,528.82 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 3.09 0.276 1.62 764.9142 1,527.81 1,528.82 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 3.04 0.4 0 764.9143 1,527.81 1,528.82 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 3.06 0.338 1.54 764.9145 1,527.81 1,528.82 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QQEAALELEELKK 95.00% 3.47 0.324 0 764.9154 1,527.82 1,528.82 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTESQEETVVMSLK 95.00% 3.87 0.479 2.89 791.3862 1,580.76 1,581.77 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTESQEETVVMSLK 95.00% 4.2 0.444 4.36 791.3877 1,580.76 1,581.77 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTESQEETVVMSLK 95.00% 4.17 0.516 4.96 791.388 1,580.76 1,581.77 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTESQEETVVMSLK 95.00% 4.26 0.473 3.34 791.388 1,580.76 1,581.77 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% MPEDGLSDDKKPFK 95.00% 4.28 0.49 1.77 803.8911 1,605.77 1,606.78 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% MPEDGLSDDKKPFK 95.00% 4.46 0.474 2.46 803.8916 1,605.77 1,606.78 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% MPEDGLSDDKKPFK 95.00% 2.97 0.312 1.17 803.8926 1,605.77 1,606.78 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% MPEDGLSDDKKPFK 95.00% 4.42 0.474 2.8 803.8936 1,605.77 1,606.78 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% MPEDGLSDDKKPFK 95.00% 4.1 0.457 2.02 804.3919 1,606.77 1,606.78 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GSIGENQVEVMVEEK 95.00% 5.02 0.479 3.85 824.9016 1,647.79 1,647.79 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 3.42 0.667 2.31 869.459 1,736.90 1,737.91 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.99 0.459 0 869.4592 1,736.90 1,737.91 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.76 0.485 0 869.4595 1,736.90 1,737.91 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 2.74 0.467 0 869.4606 1,736.91 1,737.91 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 3.45 0.532 0 869.9598 1,737.90 1,737.91 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SPAPKPSDLRPGDVSSK 95.00% 3.12 0.507 0 869.9616 1,737.91 1,737.91 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QERYEIEETETVTK 95.00% 4.23 0.409 2.52 877.9225 1,753.83 1,754.85 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QERYEIEETETVTK 95.00% 4.52 0.459 2.96 877.9249 1,753.83 1,754.85 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QERYEIEETETVTK 95.00% 4.2 0.364 2.47 877.925 1,753.83 1,754.85 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QERYEIEETETVTK 95.00% 4.28 0.418 2.33 877.9256 1,753.84 1,754.85 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QERYEIEETETVTK 95.00% 3.99 0.315 4 878.4254 1,754.84 1,754.85 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 5.31 0.48 5.13 893.9433 1,785.87 1,786.88 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 4.95 0.53 4.96 893.9443 1,785.87 1,786.88 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 4.61 0.554 3.08 893.9445 1,785.87 1,786.88 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 5.5 0.506 5.03 893.9445 1,785.87 1,786.88 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 5.22 0.432 4.1 893.9449 1,785.87 1,786.88 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 4.62 0.479 4.15 893.945 1,785.87 1,786.88 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 5.49 0.512 3.17 893.9458 1,785.88 1,786.88 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 5.63 0.509 6.05 894.4435 1,786.87 1,786.88 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% ASVDTKEAEGAPQVEAGK 95.00% 5.73 0.502 6.49 894.4472 1,786.88 1,786.88 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% IDSRLEQYTSAIEGTK 95.00% 3.68 0.38 4.6 905.9618 1,809.91 1,810.92 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% IDSRLEQYTSAIEGTK 95.00% 4.29 0.432 3.51 905.9634 1,809.91 1,810.92 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% IDSRLEQYTSAIEGTK 95.00% 3.95 0.38 3.36 906.462 1,810.91 1,810.92 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 5.63 0.568 6.18 996.0484 1,990.08 1,991.09 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 5.56 0.559 5.68 996.0489 1,990.08 1,991.09 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 5.29 0.547 6.89 996.0491 1,990.08 1,991.09 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 5.57 0.549 5.8 996.0493 1,990.08 1,991.09 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 5.31 0.533 4.18 996.5475 1,991.08 1,991.09 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.97 0.522 5.4 996.5502 1,991.08 1,991.09 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QKEFDPTITDASLSLPSR 95.00% 4.44 0.575 3.74 1,003.01 2,004.01 2,005.02 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QKEFDPTITDASLSLPSR 95.00% 4.18 0.537 4.14 1,003.51 2,005.01 2,005.02 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QKEFDPTITDASLSLPSR 95.00% 3.95 0.572 5.35 1,003.52 2,005.02 2,005.02 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QKEFDPTITDASLSLPSR 95.00% 4.64 0.492 4.49 1,003.52 2,005.02 2,005.02 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNKETAGLK 95.00% 4.84 0.621 4.04 1,024.02 2,046.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNKETAGLK 95.00% 4.49 0.556 2.21 1,024.02 2,046.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNKETAGLK 95.00% 4.58 0.602 6.62 1,024.02 2,046.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNKETAGLK 95.00% 4.7 0.59 4.8 1,024.52 2,047.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNKETAGLK 95.00% 4.62 0.618 4.11 1,024.53 2,047.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% GNVFSSPTAAGTPNKETAGLK 95.00% 4.97 0.566 4.89 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 6.31 0.609 5.44 1,049.48 2,096.94 2,097.96 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 6.16 0.599 6.74 1,049.48 2,096.94 2,097.96 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 6.38 0.581 6.23 1,049.48 2,096.94 2,097.96 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 6.58 0.591 6.37 1,049.48 2,096.95 2,097.96 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 6.53 0.581 6.28 1,049.98 2,097.95 2,097.96 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 6.47 0.624 4.89 1,049.98 2,097.95 2,097.96 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 6.29 0.604 5.54 1,049.98 2,097.95 2,097.96 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 6.19 0.615 6.43 1,049.98 2,097.95 2,097.96 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 6.83 0.577 6.14 1,049.98 2,097.95 2,097.96 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% TTTTNTQVEGDDEAAFLER 95.00% 6.11 0.591 3.8 1,049.98 2,097.95 2,097.96 2
 SAMPLE 2 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 32 173 34.90% QKQEEESLGQVTDQVEVNAQNSVPDEEAK 95.00% 6.08 0.556 3.02 1,077.17 3,228.50 3,228.51 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% INEWLTK 95.00% 2.21 0.221 0 452.2507 902.4858 903.4941 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% INEWLTK 95.00% 2.2 0.201 0 452.251 902.4864 903.4941 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% INEWLTK 95.00% 2.23 0.217 0 452.2511 902.4866 903.4941 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% KAQEDKLQTAVLK 95.00% 3.38 0.296 0 491.288 1,470.84 1,471.85 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QQEAALELEELKK 95.00% 3.03 0.39 0 510.2773 1,527.81 1,528.82 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QQEAALELEELKK 95.00% 2.82 0.343 0 510.2777 1,527.81 1,528.82 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ARIEAEEKAAAQER 95.00% 2.59 0.346 0 524.6071 1,570.80 1,571.81 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ARIEAEEKAAAQER 95.00% 2.51 0.289 0 524.6084 1,570.80 1,571.81 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ARIEAEEKAAAQER 95.00% 2.85 0.379 0 524.9418 1,571.80 1,571.81 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% RGETESEEFEKLK 95.00% 4.32 0.424 0 527.9292 1,580.76 1,581.78 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% RGETESEEFEKLK 95.00% 4.31 0.393 1.17 527.9295 1,580.77 1,581.78 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% RGETESEEFEKLK 95.00% 4.61 0.421 1.57 527.9296 1,580.77 1,581.78 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% MPEDGLSDDKKPFK 95.00% 2.49 0.208 0 536.2625 1,605.76 1,606.78 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% MPEDGLSDDKKPFK 95.00% 2.81 0.256 0 536.2634 1,605.77 1,606.78 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% MPEDGLSDDKKPFK 95.00% 2.66 0.196 0 536.5976 1,606.77 1,606.78 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% PTKPAASDLPVPAEGVR 95.00% 2.38 0.204 0 568.9805 1,703.92 1,704.93 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 95.00% 2.38 0.388 0 579.9757 1,736.90 1,737.91 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 95.00% 2.06 0.292 0 579.976 1,736.90 1,737.91 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 95.00% 2.51 0.438 0 579.9762 1,736.91 1,737.91 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 95.00% 2.21 0.281 0 579.9763 1,736.91 1,737.91 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 95.00% 2.63 0.372 0 579.9764 1,736.91 1,737.91 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 95.00% 2.62 0.409 0 579.9779 1,736.91 1,737.91 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 95.00% 2.39 0.446 0 580.3088 1,737.90 1,737.91 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 95.00% 2.57 0.307 0 580.3093 1,737.90 1,737.91 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 94.60% 2.01 0.273 0 580.3099 1,737.91 1,737.91 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 95.00% 2.35 0.296 0 580.3106 1,737.91 1,737.91 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QERYEIEETETVTK 95.00% 3.82 0.374 0 585.9545 1,754.84 1,754.85 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKQQEAALELEELKK 95.00% 3.07 0.299 0 595.6619 1,783.96 1,784.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKQQEAALELEELKK 95.00% 2.6 0.253 0 595.663 1,783.97 1,784.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKQQEAALELEELKK 95.00% 3.11 0.284 0 595.6631 1,783.97 1,784.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKQQEAALELEELKK 95.00% 3.85 0.299 0 595.9971 1,784.97 1,784.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 3.43 0.462 4 596.2981 1,785.87 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 3.6 0.442 4.64 596.2983 1,785.87 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 3.92 0.434 3.74 596.2984 1,785.87 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 3.61 0.492 4.47 596.2987 1,785.87 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 3.21 0.508 3.21 596.2989 1,785.87 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 4.12 0.502 3.46 596.2991 1,785.87 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 2.66 0.284 1.36 596.2992 1,785.87 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 2.96 0.314 2.24 596.3005 1,785.88 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 2.67 0.296 1.32 596.6321 1,786.87 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 2.92 0.244 2.48 596.6321 1,786.87 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 2.7 0.26 1.01 596.6326 1,786.87 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 3.37 0.357 3.44 596.6331 1,786.88 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 2.88 0.272 3.62 596.6333 1,786.88 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 2.79 0.256 0 596.6347 1,786.88 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 3.11 0.274 2.96 596.6348 1,786.88 1,786.88 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% RGSIGENQVEVMVEEK 95.00% 4.02 0.314 1.54 601.9676 1,802.88 1,803.89 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% RGSIGENQVEVMVEEK 95.00% 2.62 0.41 0 601.9677 1,802.88 1,803.89 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% RGSIGENQVEVMVEEK 95.00% 3.32 0.33 1.54 602.301 1,803.88 1,803.89 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% IDSRLEQYTSAIEGTK 95.00% 4 0.534 1.54 604.3091 1,809.90 1,810.92 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% IDSRLEQYTSAIEGTK 95.00% 4.28 0.519 2.62 604.6435 1,810.91 1,810.92 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% IDSRLEQYTSAIEGTK 95.00% 4.94 0.56 3.16 604.6442 1,810.91 1,810.92 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% IDSRLEQYTSAIEGTK 95.00% 4.61 0.549 2.59 604.6453 1,810.91 1,810.92 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 5.25 0.566 2.77 648.3325 1,941.97 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.55 0.568 2.54 648.3331 1,941.98 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 3.29 0.492 0.959 648.3331 1,941.98 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.35 0.582 3.44 648.6658 1,942.97 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 5.03 0.555 2.85 648.6659 1,942.97 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.57 0.549 3.68 648.6661 1,942.97 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.45 0.575 2.36 648.6667 1,942.98 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.77 0.578 2.35 648.6669 1,942.98 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 3.28 0.503 3 648.6671 1,942.98 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.24 0.52 2.33 648.6672 1,942.98 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 4.64 0.407 1.54 648.6674 1,942.98 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 3.47 0.456 0.959 648.6679 1,942.98 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 2.46 0.293 0 648.67 1,942.99 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 2.46 0.214 0 648.67 1,942.99 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGKR 95.00% 3.91 0.416 2.16 648.6705 1,942.99 1,942.98 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.38 0.321 1.29 664.7012 1,991.08 1,991.09 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.65 0.39 2.96 664.7025 1,991.08 1,991.09 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 2.59 0.376 0 664.7025 1,991.08 1,991.09 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.94 0.371 2.72 664.7026 1,991.08 1,991.09 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.51 0.341 4.44 664.7028 1,991.08 1,991.09 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.04 0.4 1.68 664.7028 1,991.08 1,991.09 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.21 0.384 3.96 664.7028 1,991.09 1,991.09 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.56 0.382 3.2 664.7029 1,991.09 1,991.09 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.48 0.412 2.96 664.7032 1,991.09 1,991.09 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 3.58 0.332 1.01 664.7036 1,991.09 1,991.09 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 3.5 0.304 0 664.7054 1,991.09 1,991.09 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKEFDPTITDASLSLPSR 95.00% 3.14 0.201 1.12 669.0112 2,004.01 2,005.02 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKEFDPTITDASLSLPSR 95.00% 3.4 0.295 0 669.0131 2,004.02 2,005.02 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKEFDPTITDASLSLPSR 95.00% 2.61 0.261 2.29 669.3464 2,005.02 2,005.02 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKEFDPTITDASLSLPSR 95.00% 2.71 0.316 0 669.3475 2,005.02 2,005.02 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% LEQYTSAIEGTK 95.00% 4.06 0.47 3.19 670.3391 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% LEQYTSAIEGTK 95.00% 3.47 0.463 3.23 670.3393 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% LEQYTSAIEGTK 95.00% 4.17 0.473 2.85 670.3396 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% LEQYTSAIEGTK 95.00% 4.06 0.492 2.89 670.3397 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% LEQYTSAIEGTK 95.00% 4.16 0.475 2.92 670.3397 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% LEQYTSAIEGTK 95.00% 2.81 0.412 2 670.34 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% LEQYTSAIEGTK 95.00% 4.04 0.493 3.11 670.3401 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% LEQYTSAIEGTK 95.00% 3.45 0.454 2.74 670.3402 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% LEQYTSAIEGTK 95.00% 4.12 0.441 2.7 670.3403 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% YEIEETETVTK 95.00% 2.15 0.267 0 671.3236 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% YEIEETETVTK 95.00% 3.92 0.402 2.96 671.3238 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% YEIEETETVTK 95.00% 3.46 0.411 3.09 671.3239 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNKETAGLK 95.00% 2.06 0.458 1.06 683.3535 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNKETAGLK 95.00% 2.2 0.367 0 683.3535 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNKETAGLK 95.00% 2.1 0.293 0 683.3555 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTTTNTQVEGDDEAAFLER 95.00% 2.7 0.279 0 699.9003 2,096.68 2,097.96 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNK 95.00% 4.46 0.618 4.37 724.3614 1,446.71 1,447.72 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNK 95.00% 4.26 0.582 4.11 724.3614 1,446.71 1,447.72 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNK 95.00% 4.53 0.608 5.1 724.3622 1,446.71 1,447.72 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNK 95.00% 4.51 0.567 3.47 724.3623 1,446.71 1,447.72 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNK 95.00% 4.26 0.568 4.05 724.3648 1,446.71 1,447.72 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNK 95.00% 3.29 0.56 3.1 724.3648 1,446.71 1,447.72 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNK 95.00% 4.45 0.598 4.34 724.3652 1,446.71 1,447.72 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNK 95.00% 3.23 0.453 5.27 724.8714 1,447.73 1,447.72 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QQEAALELEELKK 95.00% 3.11 0.393 0 764.9133 1,527.81 1,528.82 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QQEAALELEELKK 95.00% 3.53 0.334 1.17 764.9143 1,527.81 1,528.82 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QQEAALELEELKK 95.00% 3.08 0.337 0 764.9146 1,527.81 1,528.82 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TPDGNKSPAPKPSDLRPGDVSSK 95.00% 0 0 3.57 784.4042 2,350.19 2,350.20 3
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTESQEETVVMSLK 95.00% 4.17 0.498 4.19 791.3864 1,580.76 1,581.77 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTESQEETVVMSLK 95.00% 4 0.431 3.96 791.3867 1,580.76 1,581.77 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTESQEETVVMSLK 95.00% 4.04 0.447 3.7 791.3872 1,580.76 1,581.77 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTESQEETVVMSLK 95.00% 4.37 0.488 3.92 791.8887 1,581.76 1,581.77 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% MPEDGLSDDKKPFK 95.00% 4.3 0.371 2.29 803.8927 1,605.77 1,606.78 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% MPEDGLSDDKKPFK 95.00% 4.49 0.516 1.82 803.8932 1,605.77 1,606.78 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% MPEDGLSDDKKPFK 95.00% 3.7 0.494 2.47 803.8945 1,605.77 1,606.78 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% MPEDGLSDDKKPFK 95.00% 4.02 0.475 3.19 804.3923 1,606.77 1,606.78 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GSIGENQVEVMVEEK 95.00% 3.28 0.419 2.03 824.4004 1,646.79 1,647.79 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GSIGENQVEVMVEEK 95.00% 3.96 0.468 3.03 824.4014 1,646.79 1,647.79 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 95.00% 2.71 0.517 0 869.4626 1,736.91 1,737.91 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 95.00% 3.28 0.514 0 869.9595 1,737.90 1,737.91 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SPAPKPSDLRPGDVSSK 95.00% 3.32 0.466 0 869.9603 1,737.90 1,737.91 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QERYEIEETETVTK 95.00% 4.26 0.438 2.49 877.9225 1,753.83 1,754.85 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QERYEIEETETVTK 95.00% 4.03 0.353 2.89 877.9237 1,753.83 1,754.85 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QERYEIEETETVTK 95.00% 4.41 0.436 3.55 877.9248 1,753.83 1,754.85 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QERYEIEETETVTK 95.00% 4.56 0.452 3.62 877.9263 1,753.84 1,754.85 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QERYEIEETETVTK 95.00% 4.3 0.419 3.29 878.4255 1,754.84 1,754.85 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QERYEIEETETVTK 95.00% 4.24 0.398 4.57 878.4268 1,754.84 1,754.85 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKQQEAALELEELKK 95.00% 2.78 0.344 1.22 892.9916 1,783.97 1,784.98 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 5.42 0.478 4.02 893.942 1,785.87 1,786.88 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 5.12 0.428 3.74 893.9443 1,785.87 1,786.88 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 4.85 0.53 4.12 893.9449 1,785.87 1,786.88 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 5.44 0.466 3.92 893.9454 1,785.88 1,786.88 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 5.27 0.45 3.43 894.4435 1,786.87 1,786.88 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 4.87 0.513 4.41 894.4449 1,786.87 1,786.88 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 5.55 0.505 2.8 894.4456 1,786.88 1,786.88 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% ASVDTKEAEGAPQVEAGK 95.00% 5.04 0.473 2.7 894.446 1,786.88 1,786.88 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% IDSRLEQYTSAIEGTK 95.00% 4.42 0.552 4.12 905.9619 1,809.91 1,810.92 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% IDSRLEQYTSAIEGTK 95.00% 4.74 0.503 3.44 906.4574 1,810.90 1,810.92 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 5.51 0.562 6.34 996.049 1,990.08 1,991.09 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 5.16 0.572 5.92 996.0496 1,990.08 1,991.09 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 5.29 0.547 5.35 996.5467 1,991.08 1,991.09 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 4.66 0.494 6 996.547 1,991.08 1,991.09 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 5.17 0.524 6.89 996.5481 1,991.08 1,991.09 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% SAKPTKPAASDLPVPAEGVR 95.00% 5.29 0.524 4.68 996.55 1,991.08 1,991.09 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKEFDPTITDASLSLPSR 95.00% 4.21 0.526 4.08 1,003.51 2,005.01 2,005.02 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKEFDPTITDASLSLPSR 95.00% 4.03 0.591 4.89 1,003.52 2,005.02 2,005.02 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKEFDPTITDASLSLPSR 95.00% 4.61 0.532 3.77 1,003.52 2,005.02 2,005.02 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKEFDPTITDASLSLPSR 95.00% 4.26 0.538 3.59 1,003.52 2,005.02 2,005.02 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNKETAGLK 95.00% 4.59 0.648 4.48 1,024.02 2,046.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNKETAGLK 95.00% 4.63 0.593 4.28 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNKETAGLK 95.00% 4.78 0.585 4.15 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNKETAGLK 95.00% 4.54 0.542 3.46 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% GNVFSSPTAAGTPNKETAGLK 95.00% 4.51 0.549 2.89 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTTTNTQVEGDDEAAFLER 95.00% 6.24 0.592 5.3 1,049.48 2,096.95 2,097.96 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTTTNTQVEGDDEAAFLER 95.00% 2.87 0.298 0 1,049.59 2,097.16 2,097.96 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTTTNTQVEGDDEAAFLER 95.00% 6.13 0.606 4.96 1,049.98 2,097.94 2,097.96 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTTTNTQVEGDDEAAFLER 95.00% 6.17 0.595 8.55 1,049.98 2,097.95 2,097.96 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTTTNTQVEGDDEAAFLER 95.00% 6.19 0.593 5.66 1,049.98 2,097.95 2,097.96 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTTTNTQVEGDDEAAFLER 95.00% 6.06 0.598 4.7 1,049.98 2,097.95 2,097.96 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTTTNTQVEGDDEAAFLER 95.00% 6.66 0.608 4.51 1,049.98 2,097.95 2,097.96 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTTTNTQVEGDDEAAFLER 95.00% 5.79 0.615 5.11 1,049.98 2,097.95 2,097.96 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% TTTTNTQVEGDDEAAFLER 95.00% 6.27 0.597 7.01 1,049.98 2,097.95 2,097.96 2
 SAMPLE 2R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 23 33 155 35.90% QKQEEESLGQVTDQVEVNAQNSVPDEEAK 95.00% 0 0 3.39 1,077.51 3,229.50 3,228.51 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% INEWLTK 95.00% 2.35 0.204 0 452.2504 902.4852 903.4941 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% INEWLTK 95.00% 2.33 0.246 0 452.2506 902.4856 903.4941 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% INEWLTK 95.00% 2.12 0.242 0 452.2512 902.4867 903.4941 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% INEWLTK 95.00% 2.36 0.281 0 452.2512 902.4868 903.4941 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% INEWLTK 95.00% 2.16 0.223 0 452.2514 902.4871 903.4941 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% INEWLTK 95.00% 2.19 0.176 0 452.2515 902.4873 903.4941 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% INEWLTK 95.00% 2.33 0.243 0 452.2517 902.4878 903.4941 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% INEWLTK 95.00% 2.28 0.22 0 452.2517 902.4878 903.4941 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% INEWLTK 95.00% 2.53 0.21 0 452.2519 902.4881 903.4941 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% INEWLTK 95.00% 2.54 0.202 0 452.2523 902.4889 903.4941 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% INEWLTK 95.00% 2.44 0.218 0 452.2526 902.4895 903.4941 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GETESEEFEKLK 95.00% 1.99 0.241 0 476.2309 1,425.67 1,425.68 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% KAQEDKLQTAVLK 95.00% 2.68 0.26 0 491.2868 1,470.84 1,471.85 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% AQEDKLQTAVLKK 95.00% 3.54 0.344 0 491.2874 1,470.84 1,471.85 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% KAQEDKLQTAVLK 95.00% 2.81 0.313 0 491.2874 1,470.84 1,471.85 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% AQEDKLQTAVLKK 95.00% 2.97 0.438 0 491.2879 1,470.84 1,471.85 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% AQEDKLQTAVLKK 95.00% 2.79 0.265 0 491.2888 1,470.84 1,471.85 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% KAQEDKLQTAVLK 95.00% 3.52 0.339 0 491.2888 1,470.84 1,471.85 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELKK 95.00% 2.79 0.301 0 510.278 1,527.81 1,528.82 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELKK 95.00% 2.52 0.402 0 510.2782 1,527.81 1,528.82 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELKK 95.00% 2.91 0.382 0 510.2783 1,527.81 1,528.82 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELKK 95.00% 2.54 0.394 0 510.2784 1,527.81 1,528.82 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELKK 95.00% 3.05 0.356 0 510.2786 1,527.81 1,528.82 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELKK 95.00% 2.79 0.396 0 510.2791 1,527.81 1,528.82 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELKK 95.00% 2.07 0.401 0 510.2794 1,527.81 1,528.82 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ARIEAEEKAAAQER 95.00% 2.59 0.269 0 524.6097 1,570.81 1,571.81 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ARIEAEEKAAAQER 95.00% 2.46 0.252 0 524.6098 1,570.81 1,571.81 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ARIEAEEKAAAQER 95.00% 3.61 0.318 0 524.6108 1,570.81 1,571.81 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTESQEETVVMSLK 95.00% 3.61 0.483 1.8 527.9283 1,580.76 1,581.77 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% RGETESEEFEKLK 95.00% 3.59 0.417 1.08 527.929 1,580.76 1,581.78 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% RGETESEEFEKLK 95.00% 3.89 0.39 1 527.9304 1,580.77 1,581.78 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTESQEETVVMSLK 95.00% 3.53 0.462 2.2 528.2614 1,581.76 1,581.77 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% MPEDGLSDDKKPFK 95.00% 2.83 0.204 0 536.2634 1,605.77 1,606.78 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% MPEDGLSDDKKPFK 95.00% 2.53 0.221 0 536.2635 1,605.77 1,606.78 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% MPEDGLSDDKKPFK 95.00% 3.07 0.248 0 536.2638 1,605.77 1,606.78 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% PTKPAASDLPVPAEGVR 95.00% 3.1 0.252 0 569.3149 1,704.92 1,704.93 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% PTKPAASDLPVPAEGVR 95.00% 3.1 0.316 0 569.3161 1,704.92 1,704.93 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 2.78 0.44 0 579.9738 1,736.90 1,737.91 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 2.04 0.283 0 579.9746 1,736.90 1,737.91 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 2.81 0.453 0 579.976 1,736.90 1,737.91 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 2.41 0.4 0 579.976 1,736.90 1,737.91 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 2.44 0.349 0 579.976 1,736.90 1,737.91 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 2.41 0.281 0 580.3084 1,737.90 1,737.91 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 2.17 0.337 0 580.309 1,737.90 1,737.91 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 2.48 0.388 0 580.3096 1,737.91 1,737.91 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 2.45 0.24 0 580.3098 1,737.91 1,737.91 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QERYEIEETETVTK 95.00% 3.24 0.236 0 585.6183 1,753.83 1,754.85 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QERYEIEETETVTK 95.00% 3.6 0.282 0 585.6189 1,753.83 1,754.85 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 3 0.319 0 596.2974 1,785.87 1,786.88 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 3.47 0.438 2.8 596.2984 1,785.87 1,786.88 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 3.05 0.385 2.74 596.2985 1,785.87 1,786.88 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 3.19 0.393 3.18 596.2986 1,785.87 1,786.88 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 3.24 0.426 3.19 596.2993 1,785.87 1,786.88 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 3.23 0.383 3.29 596.6332 1,786.88 1,786.88 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 3.34 0.2 2.19 596.6334 1,786.88 1,786.88 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 3.42 0.397 3.89 596.6334 1,786.88 1,786.88 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% RGSIGENQVEVMVEEK 95.00% 3.65 0.447 0 601.9662 1,802.88 1,803.89 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% RGSIGENQVEVMVEEK 95.00% 3.5 0.238 1.49 601.9683 1,802.88 1,803.89 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% RGSIGENQVEVMVEEK 95.00% 3.02 0.359 1.41 601.9686 1,802.88 1,803.89 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% RGSIGENQVEVMVEEK 95.00% 4.14 0.37 2.25 602.301 1,803.88 1,803.89 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% IDSRLEQYTSAIEGTK 95.00% 3.57 0.376 2.18 604.3083 1,809.90 1,810.92 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% IDSRLEQYTSAIEGTK 95.00% 3.43 0.341 1.32 604.309 1,809.90 1,810.92 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% IDSRLEQYTSAIEGTK 95.00% 4.52 0.519 1.62 604.3102 1,809.91 1,810.92 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% IDSRLEQYTSAIEGTK 95.00% 5.07 0.478 2.14 604.6442 1,810.91 1,810.92 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.58 0.574 3.89 648.3309 1,941.97 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.8 0.598 2.82 648.3315 1,941.97 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.63 0.54 1.85 648.3318 1,941.97 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.69 0.547 3.04 648.3319 1,941.97 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 3.99 0.45 1.96 648.3323 1,941.97 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.65 0.574 3.47 648.3326 1,941.97 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.71 0.558 3.18 648.3326 1,941.97 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 3.38 0.472 1.82 648.3329 1,941.98 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.79 0.541 2.96 648.3333 1,941.98 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.49 0.537 0 648.6658 1,942.97 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.38 0.548 2.92 648.6666 1,942.98 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.95 0.523 2.14 648.6668 1,942.98 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.57 0.546 2.13 648.6668 1,942.98 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.75 0.561 2.64 648.6669 1,942.98 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 3.99 0.551 2.17 648.6669 1,942.98 1,942.98 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 4.61 0.397 1.96 664.3682 1,990.08 1,991.09 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 4.62 0.407 3.14 664.7024 1,991.08 1,991.09 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 3.9 0.245 1.82 664.7026 1,991.08 1,991.09 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 4.7 0.431 2.44 664.7028 1,991.09 1,991.09 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 4.45 0.397 2.66 664.7029 1,991.09 1,991.09 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 4.59 0.426 1.49 664.7029 1,991.09 1,991.09 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 4.55 0.404 1.51 664.7029 1,991.09 1,991.09 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 4.1 0.312 1.06 664.7031 1,991.09 1,991.09 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 4.41 0.389 1.36 664.7034 1,991.09 1,991.09 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 3.87 0.405 3.51 664.7037 1,991.09 1,991.09 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSR 95.00% 3.19 0.374 1.92 669.0125 2,004.01 2,005.02 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSR 95.00% 3.5 0.344 0 669.0127 2,004.01 2,005.02 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSR 95.00% 3.17 0.344 1.09 669.0128 2,004.01 2,005.02 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSR 95.00% 3.77 0.42 0 669.3449 2,005.01 2,005.02 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSR 95.00% 3.39 0.313 1.89 669.345 2,005.01 2,005.02 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSR 95.00% 2.67 0.199 1.09 669.3453 2,005.01 2,005.02 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSR 95.00% 2.71 0.248 1.1 669.3478 2,005.02 2,005.02 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 3.19 0.505 3.52 670.3394 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 3.73 0.487 3.22 670.3396 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 3.42 0.533 3.16 670.3396 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 3.99 0.482 3.77 670.3398 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 2.6 0.406 3.29 670.3398 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 3.47 0.497 2.8 670.3398 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 4.11 0.464 3.57 670.3399 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 4.18 0.48 3.33 670.3399 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 4.13 0.502 3.89 670.3399 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 4.11 0.47 2.92 670.34 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 4.3 0.485 3.32 670.3402 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 3.54 0.503 2.47 670.3402 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 3.79 0.456 2.25 670.3402 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 3.18 0.492 2.92 670.341 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 3.24 0.462 2.47 670.3415 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% LEQYTSAIEGTK 95.00% 3.81 0.514 3.96 670.3415 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% YEIEETETVTK 95.00% 2.22 0.349 1.89 671.3228 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% YEIEETETVTK 95.00% 3.67 0.416 3.89 671.3233 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% YEIEETETVTK 95.00% 3.7 0.407 3.47 671.3239 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% YEIEETETVTK 95.00% 3.92 0.418 3 671.3239 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% YEIEETETVTK 95.00% 3.31 0.428 2.89 671.3242 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% AQEDKLQTAVLK 95.00% 3.55 0.47 1.42 672.3774 1,342.74 1,343.75 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% AQEDKLQTAVLK 95.00% 3.7 0.482 1.7 672.379 1,342.74 1,343.75 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNKETAGLK 95.00% 2.2 0.44 0 683.3532 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNKETAGLK 95.00% 2.08 0.351 0 683.3533 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNKETAGLK 95.00% 2.07 0.323 0 683.3533 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNKETAGLK 95.00% 2.08 0.289 0 683.3545 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNKETAGLK 95.00% 2.26 0.249 1.03 683.355 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 2.28 0.201 0 699.8997 2,096.68 2,097.96 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 2.66 0.38 0 699.9003 2,096.68 2,097.96 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELK 95.00% 2.91 0.488 0 700.8675 1,399.72 1,400.73 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GETESEEFEKLK 95.00% 2.9 0.358 1.92 713.3396 1,424.66 1,425.68 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GETESEEFEKLK 95.00% 3.33 0.422 2.23 713.3416 1,424.67 1,425.68 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GETESEEFEKLK 95.00% 2.98 0.333 0 713.3424 1,424.67 1,425.68 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSRR 95.00% 2.08 0.289 0 721.0461 2,160.12 2,161.13 3 ANX11_HUMAN,MAP1B_HUMAN,RS5_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSRR 95.00% 2.15 0.275 0 721.3783 2,161.11 2,161.13 3 ANX11_HUMAN,MAP1B_HUMAN,RS5_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNK 95.00% 4.2 0.552 3.8 724.3612 1,446.71 1,447.72 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNK 95.00% 3.9 0.546 4.13 724.3617 1,446.71 1,447.72 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNK 95.00% 4.49 0.578 3.41 724.3618 1,446.71 1,447.72 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNK 95.00% 4.18 0.555 5.82 724.362 1,446.71 1,447.72 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNK 95.00% 4.35 0.585 4.92 724.3624 1,446.71 1,447.72 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNK 95.00% 3.67 0.443 3.24 724.3625 1,446.71 1,447.72 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNK 95.00% 3.63 0.419 2.74 724.363 1,446.71 1,447.72 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNK 95.00% 4.11 0.541 4.26 724.863 1,447.71 1,447.72 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNK 95.00% 2.38 0.247 2.32 724.8694 1,447.72 1,447.72 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% KAQEDKLQTAVLK 95.00% 4.28 0.368 2.66 736.4267 1,470.84 1,471.85 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% KAQEDKLQTAVLK 95.00% 3.81 0.351 2.82 736.4283 1,470.84 1,471.85 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELKK 95.00% 3.14 0.282 0 764.914 1,527.81 1,528.82 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELKK 95.00% 3.15 0.361 0 764.9141 1,527.81 1,528.82 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELKK 95.00% 3.2 0.299 0 764.9148 1,527.81 1,528.82 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELKK 95.00% 2.98 0.343 0 764.9161 1,527.82 1,528.82 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QQEAALELEELKK 95.00% 2.76 0.359 0 764.9166 1,527.82 1,528.82 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTESQEETVVMSLK 95.00% 4.09 0.472 3.68 791.385 1,580.75 1,581.77 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTESQEETVVMSLK 95.00% 4.39 0.473 4.24 791.3863 1,580.76 1,581.77 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTESQEETVVMSLK 95.00% 4.47 0.484 5.19 791.3872 1,580.76 1,581.77 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTESQEETVVMSLK 95.00% 4.31 0.482 3.89 791.3876 1,580.76 1,581.77 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTESQEETVVMSLK 95.00% 3.83 0.484 4.09 791.3885 1,580.76 1,581.77 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTESQEETVVMSLK 95.00% 4.3 0.493 3.52 791.3885 1,580.76 1,581.77 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% MPEDGLSDDKKPFK 95.00% 4.38 0.445 1.51 803.8912 1,605.77 1,606.78 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% MPEDGLSDDKKPFK 95.00% 4.68 0.504 2.09 803.8925 1,605.77 1,606.78 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% MPEDGLSDDKKPFK 95.00% 4.06 0.476 1.89 803.8933 1,605.77 1,606.78 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% MPEDGLSDDKKPFK 95.00% 4.56 0.502 1.46 803.8934 1,605.77 1,606.78 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% MPEDGLSDDKKPFK 95.00% 3.81 0.448 2.52 803.894 1,605.77 1,606.78 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% MPEDGLSDDKKPFK 95.00% 4.31 0.521 1.85 804.394 1,606.77 1,606.78 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 2.8 0.397 0 869.4591 1,736.90 1,737.91 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 3.43 0.636 0 869.4599 1,736.90 1,737.91 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 3.48 0.459 0 869.4602 1,736.90 1,737.91 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 3.31 0.625 0 869.4605 1,736.91 1,737.91 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 3 0.474 0 869.9596 1,737.90 1,737.91 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SPAPKPSDLRPGDVSSK 95.00% 2.83 0.49 0 869.9606 1,737.91 1,737.91 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% EFDPTITDASLSLPSR 95.00% 5.1 0.558 4 874.9364 1,747.86 1,748.87 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% EFDPTITDASLSLPSR 95.00% 3.9 0.5 3.42 874.9367 1,747.86 1,748.87 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% EFDPTITDASLSLPSR 95.00% 4.85 0.572 4.19 875.4406 1,748.87 1,748.87 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QERYEIEETETVTK 95.00% 3.99 0.406 3.39 877.924 1,753.83 1,754.85 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QERYEIEETETVTK 95.00% 4.24 0.423 2.92 877.9242 1,753.83 1,754.85 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QERYEIEETETVTK 95.00% 3.9 0.371 2.92 877.9251 1,753.83 1,754.85 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QERYEIEETETVTK 95.00% 3.47 0.367 2.92 877.9262 1,753.84 1,754.85 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QERYEIEETETVTK 95.00% 4.32 0.427 3.52 877.9274 1,753.84 1,754.85 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QERYEIEETETVTK 95.00% 4.03 0.399 3.11 878.424 1,754.83 1,754.85 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QERYEIEETETVTK 95.00% 3.99 0.333 2.57 878.4292 1,754.84 1,754.85 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 4.48 0.539 4.17 893.943 1,785.87 1,786.88 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 5.5 0.506 5.27 893.9433 1,785.87 1,786.88 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 5.25 0.543 4.49 893.944 1,785.87 1,786.88 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 5.55 0.51 5.77 893.9442 1,785.87 1,786.88 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 4.97 0.5 5.48 893.9446 1,785.87 1,786.88 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 5.52 0.536 6.05 893.945 1,785.87 1,786.88 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 5.44 0.493 4.74 893.9452 1,785.87 1,786.88 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 5.59 0.481 4.11 893.9456 1,785.88 1,786.88 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 5.7 0.458 4.7 894.4453 1,786.87 1,786.88 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 5.11 0.484 3.77 894.4461 1,786.88 1,786.88 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 5.46 0.445 5.82 894.4463 1,786.88 1,786.88 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGK 95.00% 4.95 0.444 2.54 894.4497 1,786.88 1,786.88 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% IDSRLEQYTSAIEGTK 95.00% 4.17 0.569 3.57 905.9611 1,809.91 1,810.92 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% IDSRLEQYTSAIEGTK 95.00% 4.84 0.486 5.24 906.4639 1,810.91 1,810.92 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% IDSRLEQYTSAIEGTK 95.00% 3.96 0.419 4.42 906.4642 1,810.91 1,810.92 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% ASVDTKEAEGAPQVEAGKR 95.00% 4.63 0.435 1.51 972.4962 1,942.98 1,942.98 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 5.12 0.544 5.74 996.0473 1,990.08 1,991.09 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 5.52 0.543 4.18 996.5497 1,991.08 1,991.09 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 5.84 0.528 8.82 996.5501 1,991.08 1,991.09 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 5.21 0.53 5.09 996.5504 1,991.09 1,991.09 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 5.08 0.507 5.38 996.5506 1,991.09 1,991.09 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% SAKPTKPAASDLPVPAEGVR 95.00% 5.46 0.555 4.92 996.5512 1,991.09 1,991.09 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSR 95.00% 4.77 0.512 5.02 1,003.51 2,005.01 2,005.02 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSR 95.00% 4.13 0.561 4.3 1,003.51 2,005.01 2,005.02 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSR 95.00% 4.11 0.53 4.89 1,003.52 2,005.01 2,005.02 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSR 95.00% 4.25 0.578 4.31 1,003.52 2,005.02 2,005.02 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKEFDPTITDASLSLPSR 95.00% 4.58 0.576 3.8 1,003.52 2,005.02 2,005.02 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNKETAGLK 95.00% 4.68 0.61 4.05 1,024.02 2,046.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNKETAGLK 95.00% 4.76 0.62 5.46 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNKETAGLK 95.00% 4.88 0.601 4.32 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNKETAGLK 95.00% 4.86 0.591 4.77 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% GNVFSSPTAAGTPNKETAGLK 95.00% 4.52 0.552 3.04 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 5.82 0.569 7.04 1,049.48 2,096.94 2,097.96 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 6.42 0.584 5.57 1,049.98 2,097.94 2,097.96 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 6.35 0.563 5.74 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 6.5 0.591 5.48 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 6.17 0.611 6.34 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 6.48 0.604 6.28 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 6.29 0.614 5.01 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 6.4 0.598 5 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 6.38 0.595 5.39 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 6.17 0.595 7.11 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% TTTTNTQVEGDDEAAFLER 95.00% 5.93 0.603 5.19 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKQEEESLGQVTDQVEVNAQNSVPDEEAK 95.00% 6.88 0.618 2.29 1,077.17 3,228.50 3,228.51 3
 SAMPLE 3 Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 26 39 206 35.20% QKQEEESLGQVTDQVEVNAQNSVPDEEAK 95.00% 6.83 0.625 3.74 1,077.17 3,228.50 3,228.51 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% INEWLTK 95.00% 2.36 0.245 0 452.2502 902.4848 903.4941 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% INEWLTK 95.00% 2.03 0.226 0 452.2513 902.4869 903.4941 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% INEWLTK 95.00% 2.19 0.214 0 452.2513 902.4869 903.4941 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% INEWLTK 95.00% 2.85 0.197 0 452.2515 902.4874 903.4941 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% INEWLTK 95.00% 2.31 0.243 0 452.2518 902.488 903.4941 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% INEWLTK 95.00% 2.01 0.28 0 452.252 902.4884 903.4941 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% INEWLTK 95.00% 2.34 0.193 0 452.2522 902.4888 903.4941 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% INEWLTK 95.00% 2.04 0.241 0 452.2524 902.4892 903.4941 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% AQEDKLQTAVLKK 95.00% 3.74 0.302 1.12 491.2864 1,470.84 1,471.85 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% KAQEDKLQTAVLK 95.00% 3 0.146 0 491.2867 1,470.84 1,471.85 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% KAQEDKLQTAVLK 95.00% 2.84 0.207 0 491.2867 1,470.84 1,471.85 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% AQEDKLQTAVLKK 95.00% 3.42 0.365 0 491.287 1,470.84 1,471.85 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 2.72 0.375 0 510.2778 1,527.81 1,528.82 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 2.96 0.417 0 510.2779 1,527.81 1,528.82 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 2.24 0.305 0 510.2783 1,527.81 1,528.82 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 2.31 0.346 0 510.2783 1,527.81 1,528.82 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 2.4 0.298 0 510.2785 1,527.81 1,528.82 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 2.78 0.327 0 510.6111 1,528.81 1,528.82 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 2.35 0.255 0 510.6142 1,528.82 1,528.82 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% VLEEEEQR 95.00% 2.4 0.307 0 516.2524 1,030.49 1,031.50 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% VLEEEEQR 95.00% 2.41 0.253 0 516.2533 1,030.49 1,031.50 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% VLEEEEQR 95.00% 2.25 0.211 0 516.2551 1,030.49 1,031.50 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ARIEAEEKAAAQER 95.00% 2.74 0.39 0 524.608 1,570.80 1,571.81 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ARIEAEEKAAAQER 95.00% 2.62 0.327 0 524.6089 1,570.80 1,571.81 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ARIEAEEKAAAQER 95.00% 2.86 0.259 0 524.6099 1,570.81 1,571.81 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ARIEAEEKAAAQER 95.00% 2.58 0.241 0 524.6112 1,570.81 1,571.81 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ARIEAEEKAAAQER 95.00% 3.64 0.421 0 524.9445 1,571.81 1,571.81 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ARIEAEEKAAAQER 95.00% 3.33 0.372 0 524.9451 1,571.81 1,571.81 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ARIEAEEKAAAQER 95.00% 2.61 0.304 0 524.9454 1,571.81 1,571.81 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTESQEETVVMSLK 95.00% 3.92 0.479 2.72 527.9263 1,580.76 1,581.77 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% RGETESEEFEKLK 95.00% 3.71 0.41 0 527.9299 1,580.77 1,581.78 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% RGETESEEFEKLK 95.00% 3.02 0.315 0 527.9316 1,580.77 1,581.78 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTESQEETVVMSLK 95.00% 2.69 0.247 0 528.2615 1,581.76 1,581.77 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% MPEDGLSDDKKPFK 95.00% 2.68 0.39 0 536.2632 1,605.77 1,606.78 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% MPEDGLSDDKKPFK 95.00% 2.6 0.319 0 536.2636 1,605.77 1,606.78 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% MPEDGLSDDKKPFK 95.00% 2.21 0.217 0 536.2641 1,605.77 1,606.78 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKQQEAALELEELK 95.00% 2.73 0.334 0 552.9661 1,655.87 1,656.88 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% PTKPAASDLPVPAEGVR 95.00% 2.91 0.29 0 568.98 1,703.92 1,704.93 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% PTKPAASDLPVPAEGVR 95.00% 2.87 0.246 0 568.9802 1,703.92 1,704.93 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2.59 0.371 0 579.9744 1,736.90 1,737.91 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2.68 0.467 0 579.9753 1,736.90 1,737.91 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2.04 0.263 0 579.9754 1,736.90 1,737.91 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2.52 0.389 0 579.9756 1,736.90 1,737.91 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2.33 0.32 0 579.9766 1,736.91 1,737.91 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2.49 0.339 0 580.3082 1,737.90 1,737.91 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2.03 0.328 0 580.3088 1,737.90 1,737.91 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2 0.324 0 580.3091 1,737.90 1,737.91 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2.37 0.335 0 580.3093 1,737.90 1,737.91 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2.2 0.361 0 580.3098 1,737.91 1,737.91 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2.61 0.351 0 580.3115 1,737.91 1,737.91 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QERYEIEETETVTK 95.00% 3.81 0.244 0 585.6179 1,753.83 1,754.85 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QERYEIEETETVTK 95.00% 3.71 0.404 0 585.6192 1,753.83 1,754.85 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QERYEIEETETVTK 95.00% 3.72 0.38 0 585.6194 1,753.83 1,754.85 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QERYEIEETETVTK 95.00% 3.55 0.349 0 585.954 1,754.84 1,754.85 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% EAEGAPQVEAGK 95.00% 2.43 0.42 1.8 593.2898 1,184.56 1,185.58 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% EAEGAPQVEAGK 95.00% 2.44 0.368 1.19 593.2908 1,184.57 1,185.58 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% EAEGAPQVEAGK 95.00% 2.06 0.363 0 593.2933 1,184.57 1,185.58 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKQQEAALELEELKK 95.00% 2.7 0.148 0 595.6624 1,783.96 1,784.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKQQEAALELEELKK 95.00% 3.75 0.289 0 595.9968 1,784.97 1,784.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKQQEAALELEELKK 95.00% 3.69 0.35 0 595.9971 1,784.97 1,784.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 3.35 0.459 3.25 596.2976 1,785.87 1,786.88 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 3.74 0.382 3.15 596.2981 1,785.87 1,786.88 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 3.14 0.432 3.49 596.2981 1,785.87 1,786.88 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 3.98 0.436 5.19 596.2986 1,785.87 1,786.88 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 3.09 0.489 2.72 596.2986 1,785.87 1,786.88 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 3.38 0.45 1.8 596.2992 1,785.87 1,786.88 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 3.45 0.426 3.15 596.3002 1,785.88 1,786.88 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 3.43 0.265 2.28 596.632 1,786.87 1,786.88 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 3.52 0.342 3.4 596.6332 1,786.88 1,786.88 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% RGSIGENQVEVMVEEK 95.00% 2.81 0.226 0 601.9682 1,802.88 1,803.89 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% RGSIGENQVEVMVEEK 95.00% 3.5 0.419 1.32 601.9697 1,802.89 1,803.89 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% RGSIGENQVEVMVEEK 95.00% 4.04 0.292 0 602.2996 1,803.88 1,803.89 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% RGSIGENQVEVMVEEK 95.00% 2.84 0.187 0 602.3 1,803.88 1,803.89 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% IDSRLEQYTSAIEGTK 95.00% 3.92 0.495 2.12 604.3113 1,809.91 1,810.92 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% IDSRLEQYTSAIEGTK 95.00% 4.26 0.566 1.46 604.6439 1,810.91 1,810.92 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 3.84 0.547 3.1 648.3309 1,941.97 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 3.71 0.595 2.6 648.3318 1,941.97 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 4.79 0.593 2.85 648.3324 1,941.97 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 4.56 0.559 3.02 648.3331 1,941.98 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 4.18 0.539 1.89 648.3331 1,941.98 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 4.78 0.499 3.62 648.3334 1,941.98 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 3.94 0.467 0 648.3337 1,941.98 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 3.81 0.405 1.03 648.665 1,942.97 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 4.42 0.532 2.57 648.6655 1,942.97 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 3.66 0.516 1.96 648.6661 1,942.97 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 4.82 0.541 2.46 648.6663 1,942.98 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 5.06 0.599 3.07 648.6664 1,942.98 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 4.23 0.519 2.46 648.6673 1,942.98 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 4.23 0.533 3.82 648.6675 1,942.98 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 4.55 0.57 2.26 648.6677 1,942.98 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 4.28 0.479 1.89 648.6683 1,942.98 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGKR 95.00% 2.54 0.245 0 648.8171 1,943.43 1,942.98 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 3.96 0.401 1.4 664.3682 1,990.08 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 4.27 0.354 2.41 664.3683 1,990.08 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 4.12 0.4 2.85 664.3688 1,990.08 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 4.52 0.378 2.41 664.369 1,990.08 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 4.51 0.385 2.96 664.3693 1,990.08 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 3.88 0.335 0 664.7004 1,991.08 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 4.22 0.279 2.24 664.7019 1,991.08 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 4.41 0.394 0 664.7022 1,991.08 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 4.05 0.296 3.35 664.7025 1,991.08 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 3.98 0.398 3.07 664.703 1,991.09 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 4.49 0.348 1.82 664.703 1,991.09 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 3.31 0.305 1.02 664.7037 1,991.09 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 4.9 0.373 3.7 664.7037 1,991.09 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 3.7 0.314 0 664.7039 1,991.09 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 3.63 0.304 1.64 664.7043 1,991.09 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 4.61 0.355 1.77 664.7059 1,991.09 1,991.09 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKEFDPTITDASLSLPSR 95.00% 3.42 0.303 0 669.0125 2,004.01 2,005.02 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKEFDPTITDASLSLPSR 95.00% 3.4 0.28 1.42 669.0127 2,004.01 2,005.02 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKEFDPTITDASLSLPSR 95.00% 2.99 0.238 1.27 669.3458 2,005.01 2,005.02 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKEFDPTITDASLSLPSR 95.00% 3.55 0.428 1.66 669.3463 2,005.02 2,005.02 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKEFDPTITDASLSLPSR 95.00% 3.25 0.32 2.34 669.3469 2,005.02 2,005.02 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKEFDPTITDASLSLPSR 95.00% 2.71 0.328 0 669.3474 2,005.02 2,005.02 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% LEQYTSAIEGTK 95.00% 4.09 0.461 3.54 670.3394 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% LEQYTSAIEGTK 95.00% 2.7 0.489 2.02 670.3394 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% LEQYTSAIEGTK 95.00% 3.21 0.546 2.92 670.3394 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% LEQYTSAIEGTK 95.00% 4.07 0.483 3.51 670.3395 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% LEQYTSAIEGTK 95.00% 4.04 0.474 3.08 670.3396 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% LEQYTSAIEGTK 95.00% 3.94 0.465 2.68 670.3396 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% LEQYTSAIEGTK 95.00% 4.07 0.473 3.51 670.3397 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% LEQYTSAIEGTK 95.00% 2.32 0.27 1.54 670.3397 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% LEQYTSAIEGTK 95.00% 3.01 0.49 2.68 670.3402 1,338.66 1,339.67 2 CFAH_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% LEQYTSAIEGTK 95.00% 4.03 0.492 3.72 670.3407 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% LEQYTSAIEGTK 95.00% 3.39 0.485 3.13 670.3406 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% LEQYTSAIEGTK 95.00% 3.25 0.519 2.85 670.3418 1,338.67 1,339.67 2 CFAH_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% YEIEETETVTK 95.00% 3.8 0.444 2.77 671.3238 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% YEIEETETVTK 95.00% 3.44 0.406 3.23 671.3241 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% YEIEETETVTK 95.00% 2.94 0.422 4.14 671.3246 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% YEIEETETVTK 95.00% 3.51 0.417 3.96 671.3248 1,340.63 1,341.64 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% AQEDKLQTAVLK 95.00% 3.2 0.392 1.55 672.3792 1,342.74 1,343.75 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% AQEDKLQTAVLK 95.00% 3.19 0.415 1.49 672.3799 1,342.74 1,343.75 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNKETAGLK 95.00% 2.09 0.281 0 683.3518 2,047.03 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNKETAGLK 95.00% 2.16 0.447 0 683.3533 2,047.04 2,047.05 3 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTTTNTQVEGDDEAAFLER 95.00% 3.68 0.357 0 700.324 2,097.95 2,097.96 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTTTNTQVEGDDEAAFLER 95.00% 4.34 0.449 0 700.3249 2,097.95 2,097.96 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKEFDPTITDASLSLPSRR 95.00% 2.51 0.215 0 721.3789 2,161.11 2,161.13 3 ANX11_HUMAN,MAP1B_HUMAN,RS5_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKEFDPTITDASLSLPSRR 95.00% 2.47 0.221 0 721.3796 2,161.12 2,161.13 3 ANX11_HUMAN,MAP1B_HUMAN,RS5_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNK 95.00% 4.31 0.557 4.77 724.3614 1,446.71 1,447.72 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNK 95.00% 4.12 0.566 4.24 724.3619 1,446.71 1,447.72 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNK 95.00% 3.7 0.53 4.13 724.3626 1,446.71 1,447.72 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNK 95.00% 4.07 0.597 5.82 724.3631 1,446.71 1,447.72 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNK 95.00% 4.26 0.593 5.3 724.3632 1,446.71 1,447.72 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNK 95.00% 4.19 0.583 6 724.3637 1,446.71 1,447.72 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNK 95.00% 2.5 0.301 1.72 724.8692 1,447.72 1,447.72 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNK 95.00% 2.57 0.194 1.46 724.8712 1,447.73 1,447.72 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% KAQEDKLQTAVLK 95.00% 3.66 0.31 1.74 736.4279 1,470.84 1,471.85 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% KAQEDKLQTAVLK 95.00% 3.95 0.4 2 736.4285 1,470.84 1,471.85 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 3.16 0.44 0 764.914 1,527.81 1,528.82 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 3.14 0.37 0 764.9142 1,527.81 1,528.82 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 2.27 0.297 0 764.9146 1,527.81 1,528.82 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 3.4 0.302 0 764.9148 1,527.81 1,528.82 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 3.46 0.404 0 764.9153 1,527.81 1,528.82 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QQEAALELEELKK 95.00% 3.13 0.3 0 764.9159 1,527.82 1,528.82 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTESQEETVVMSLK 95.00% 4.02 0.458 3.54 791.3852 1,580.75 1,581.77 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTESQEETVVMSLK 95.00% 4.03 0.452 3.82 791.3882 1,580.76 1,581.77 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTESQEETVVMSLK 95.00% 3.35 0.391 4.04 791.3894 1,580.76 1,581.77 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTESQEETVVMSLK 95.00% 4.48 0.503 4.72 791.8885 1,581.76 1,581.77 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTESQEETVVMSLK 95.00% 4.14 0.486 4.05 791.8894 1,581.76 1,581.77 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTESQEETVVMSLK 95.00% 4.03 0.48 5 791.891 1,581.77 1,581.77 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% MPEDGLSDDKKPFK 95.00% 4.13 0.522 1.62 803.8913 1,605.77 1,606.78 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% MPEDGLSDDKKPFK 95.00% 4.57 0.483 2.19 803.8916 1,605.77 1,606.78 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% MPEDGLSDDKKPFK 95.00% 4.19 0.536 1.68 803.8932 1,605.77 1,606.78 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% MPEDGLSDDKKPFK 95.00% 4.59 0.478 2.15 803.894 1,605.77 1,606.78 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% MPEDGLSDDKKPFK 95.00% 4.24 0.419 2.21 803.8952 1,605.77 1,606.78 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% MPEDGLSDDKKPFK 95.00% 4.52 0.544 2.04 804.3927 1,606.77 1,606.78 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 3.41 0.585 0 869.4576 1,736.90 1,737.91 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2.74 0.507 0 869.4582 1,736.90 1,737.91 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 3.16 0.566 0 869.4595 1,736.90 1,737.91 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 2.77 0.398 0 869.4604 1,736.91 1,737.91 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 3.41 0.518 0 869.9599 1,737.90 1,737.91 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SPAPKPSDLRPGDVSSK 95.00% 3.17 0.478 0 869.9614 1,737.91 1,737.91 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% EFDPTITDASLSLPSR 95.00% 4.54 0.499 3.77 874.938 1,747.86 1,748.87 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% EFDPTITDASLSLPSR 95.00% 4.36 0.522 4.82 874.9381 1,747.86 1,748.87 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% EFDPTITDASLSLPSR 95.00% 4.68 0.577 4.43 874.9386 1,747.86 1,748.87 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% EFDPTITDASLSLPSR 95.00% 4.62 0.544 3.77 875.4398 1,748.86 1,748.87 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QERYEIEETETVTK 95.00% 3.83 0.393 3.41 877.924 1,753.83 1,754.85 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QERYEIEETETVTK 95.00% 4.1 0.366 3.55 877.9251 1,753.83 1,754.85 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QERYEIEETETVTK 95.00% 4.32 0.451 2.54 877.926 1,753.84 1,754.85 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QERYEIEETETVTK 95.00% 4.13 0.363 3.82 877.9262 1,753.84 1,754.85 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QERYEIEETETVTK 95.00% 4.14 0.416 3.08 877.9271 1,753.84 1,754.85 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QERYEIEETETVTK 95.00% 3.98 0.371 2.12 878.4254 1,754.84 1,754.85 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QERYEIEETETVTK 95.00% 4.46 0.391 3.21 878.4261 1,754.84 1,754.85 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKQQEAALELEELKK 95.00% 2.39 0.325 0 892.9898 1,783.96 1,784.98 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 4.63 0.454 5.62 893.9429 1,785.87 1,786.88 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 5.08 0.497 4.39 893.9442 1,785.87 1,786.88 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 4.81 0.519 2.52 893.9444 1,785.87 1,786.88 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 5.52 0.464 3.8 894.4458 1,786.88 1,786.88 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 5.2 0.491 4.74 894.4458 1,786.88 1,786.88 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 5.51 0.512 3.48 894.4471 1,786.88 1,786.88 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 5.23 0.457 4.51 894.4474 1,786.88 1,786.88 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% ASVDTKEAEGAPQVEAGK 95.00% 4.55 0.414 2.68 894.448 1,786.88 1,786.88 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% IDSRLEQYTSAIEGTK 95.00% 3.8 0.498 6.26 906.4619 1,810.91 1,810.92 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% IDSRLEQYTSAIEGTK 95.00% 4.4 0.514 4.64 906.4641 1,810.91 1,810.92 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 5.11 0.526 5.6 996.0478 1,990.08 1,991.09 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 4.84 0.538 3.57 996.5487 1,991.08 1,991.09 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 5.25 0.534 4.54 996.5489 1,991.08 1,991.09 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 5.42 0.491 3.92 996.5492 1,991.08 1,991.09 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 4.84 0.489 5.24 996.5509 1,991.09 1,991.09 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% SAKPTKPAASDLPVPAEGVR 95.00% 5.4 0.512 4.42 996.5522 1,991.09 1,991.09 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKEFDPTITDASLSLPSR 95.00% 4.25 0.521 5.19 1,003.02 2,004.02 2,005.02 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKEFDPTITDASLSLPSR 95.00% 3.97 0.529 4.85 1,003.51 2,005.01 2,005.02 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKEFDPTITDASLSLPSR 95.00% 4.03 0.517 5.96 1,003.51 2,005.01 2,005.02 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKEFDPTITDASLSLPSR 95.00% 3.86 0.437 5.4 1,003.52 2,005.02 2,005.02 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNKETAGLK 95.00% 4.46 0.646 3.35 1,024.03 2,046.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNKETAGLK 95.00% 4.71 0.603 4.92 1,024.52 2,047.03 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNKETAGLK 95.00% 4.54 0.512 2.21 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNKETAGLK 95.00% 4.34 0.482 2.19 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNKETAGLK 95.00% 5.07 0.582 3.41 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNKETAGLK 95.00% 4.65 0.587 6.6 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNKETAGLK 95.00% 4.59 0.619 4.89 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% GNVFSSPTAAGTPNKETAGLK 95.00% 4.4 0.571 4.44 1,024.53 2,047.04 2,047.05 2 ,LRP1_HUMAN,MAP4_HUMAN,CO4A2_HUMAN,TITIN_HUMAN
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTTTNTQVEGDDEAAFLER 95.00% 6.35 0.609 5.48 1,049.48 2,096.95 2,097.96 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTTTNTQVEGDDEAAFLER 95.00% 5.82 0.575 5 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTTTNTQVEGDDEAAFLER 95.00% 6.16 0.589 6.51 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTTTNTQVEGDDEAAFLER 95.00% 6.57 0.621 7.04 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTTTNTQVEGDDEAAFLER 95.00% 6.11 0.589 4.96 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTTTNTQVEGDDEAAFLER 95.00% 6.32 0.595 5.57 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTTTNTQVEGDDEAAFLER 95.00% 6.28 0.633 6.82 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTTTNTQVEGDDEAAFLER 95.00% 5.52 0.582 4.82 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTTTNTQVEGDDEAAFLER 95.00% 5.69 0.611 5.31 1,049.98 2,097.95 2,097.96 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% TTTTNTQVEGDDEAAFLER 95.00% 6.25 0.628 7.17 1,049.99 2,097.96 2,097.96 2
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKQEEESLGQVTDQVEVNAQNSVPDEEAK 95.00% 7.18 0.611 2.8 1,077.17 3,228.50 3,228.51 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKQEEESLGQVTDQVEVNAQNSVPDEEAK 95.00% 7.18 0.59 2.28 1,077.18 3,228.50 3,228.51 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKQEEESLGQVTDQVEVNAQNSVPDEEAK 95.00% 6.72 0.605 3.08 1,077.18 3,228.50 3,228.51 3
 SAMPLE 3R Caldesmon  CALD1  CALD1_HUMAN 93,232.80 100.00% 28 40 212 36.40% QKQEEESLGQVTDQVEVNAQNSVPDEEAK 95.00% 6.7 0.627 1.62 1,077.18 3,228.50 3,228.51 3
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% GmTVYGLPR 95.00% 2.88 0.42 2.48 m2: Oxidation (+15.99) 505.261 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% GmTVYGLPR 95.00% 3.01 0.432 2.11 m2: Oxidation (+15.99) 505.2615 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% GmTVYGLPR 95.00% 2.65 0.323 1.6 m2: Oxidation (+15.99) 505.2617 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% GmTVYGLPR 95.00% 2.4 0.27 1.52 m2: Oxidation (+15.99) 505.2624 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% EWIEGVTGR 95.00% 1.83 0.339 1.3 523.7688 1,045.52 1,046.53 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% GPAYGLSAEVK 95.00% 3.23 0.518 2.15 546.2918 1,090.57 1,091.57 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% GPAYGLSAEVK 95.00% 3.28 0.477 2.01 546.2919 1,090.57 1,091.57 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% GPAYGLSAEVK 95.00% 3.23 0.471 1.59 546.2921 1,090.57 1,091.57 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% GPAYGLSAEVK 95.00% 3.18 0.494 1.24 546.2921 1,090.57 1,091.57 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% GPAYGLSAEVK 95.00% 3.15 0.505 1.92 546.2922 1,090.57 1,091.57 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% GPAYGLSAEVK 95.00% 3.08 0.506 1.74 546.2922 1,090.57 1,091.57 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% GPAYGLSAEVK 95.00% 3.21 0.48 1.59 546.2923 1,090.57 1,091.57 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% EQELREWIEGVTGR 95.00% 2.49 0.237 0 567.9586 1,700.85 1,701.86 3
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% EQELREWIEGVTGR 95.00% 2.64 0.231 0 567.959 1,700.85 1,701.86 3
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% EQELREWIEGVTGR 95.00% 2.54 0.35 0 568.2917 1,701.85 1,701.86 3
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% EQELREWIEGVTGR 95.00% 2.6 0.408 0 568.2924 1,701.85 1,701.86 3
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% EQELREWIEGVTGR 95.00% 2.85 0.397 0 568.2928 1,701.86 1,701.86 3
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% NIIGLQMGTNK 95.00% 2.99 0.437 2.7 594.8249 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% NIIGLQMGTNK 95.00% 3.37 0.558 2.64 594.825 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% NIIGLQMGTNK 95.00% 3.39 0.516 2.89 594.8258 1,187.64 1,188.64 2 DESP_HUMAN
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% NIIGLQMGTNK 95.00% 2.97 0.493 2.89 594.826 1,187.64 1,188.64 2 DESP_HUMAN
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% NIIGLQmGTNK 95.00% 3.02 0.361 4.51 m7: Oxidation (+15.99) 602.8228 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% NIIGLQmGTNK 95.00% 3 0.402 3.92 m7: Oxidation (+15.99) 602.8228 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% EQELREWIEGVTGRR 95.00% 3.13 0.276 0 620.3267 1,857.96 1,857.96 3 TITIN_HUMAN
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% EQELREWIEGVTGRR 95.00% 2.96 0.27 0 620.3275 1,857.96 1,857.96 3 TITIN_HUMAN
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% FASQQGMTAYGTR 95.00% 3.15 0.509 2.85 709.3312 1,416.65 1,417.65 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% FASQQGMTAYGTR 95.00% 3.04 0.385 2.62 709.3322 1,416.65 1,417.65 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% FASQQGMTAYGTR 95.00% 4.16 0.546 3 709.3325 1,416.65 1,417.65 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% FASQQGMTAYGTR 95.00% 4.06 0.529 4.1 709.3329 1,416.65 1,417.65 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% LGTDQPLDQATISLQmGTNK 95.00% 3.21 0.321 0 m16: Oxidation (+15.99) 716.6959 2,147.06 2,147.07 3
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% FASQQGmTAYGTR 95.00% 3.29 0.486 2.8 m7: Oxidation (+15.99) 717.3318 1,432.65 1,433.65 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% FASQQGmTAYGTR 95.00% 3.37 0.523 2.17 m7: Oxidation (+15.99) 717.3325 1,432.65 1,433.65 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% FASQQGmTAYGTR 95.00% 3.39 0.483 3.37 m7: Oxidation (+15.99) 717.829 1,433.64 1,433.65 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% FASQQGmTAYGTR 95.00% 3.8 0.545 4.33 m7: Oxidation (+15.99) 717.8319 1,433.65 1,433.65 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% LGTDQPLDQATISLQMGTNK 95.00% 6.05 0.576 4.28 1,066.54 2,131.06 2,131.07 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% LGTDQPLDQATISLQmGTNK 95.00% 5.56 0.642 4.25 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% LGTDQPLDQATISLQmGTNK 95.00% 5.71 0.626 3.66 m16: Oxidation (+15.99) 1,074.54 2,147.07 2,147.07 2
 SAMPLE 4 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 32 26.60% LGTDQPLDQATISLQmGTNK 95.00% 5.01 0.623 3.92 m16: Oxidation (+15.99) 1,074.54 2,147.07 2,147.07 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% GmTVYGLPR 95.00% 2.95 0.422 1.28 m2: Oxidation (+15.99) 505.2632 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% GmTVYGLPR 95.00% 2.49 0.254 0 m2: Oxidation (+15.99) 505.9218 1,009.83 1,009.51 2 TITIN_HUMAN
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% GPAYGLSAEVK 95.00% 3.03 0.468 1.66 546.2917 1,090.57 1,091.57 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% GPAYGLSAEVK 95.00% 2.62 0.378 1.32 546.2917 1,090.57 1,091.57 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% GPAYGLSAEVK 95.00% 3.4 0.484 2.24 546.2917 1,090.57 1,091.57 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% GPAYGLSAEVK 95.00% 3.18 0.502 2 546.2918 1,090.57 1,091.57 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% GPAYGLSAEVK 95.00% 3.02 0.533 2 546.2921 1,090.57 1,091.57 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% GPAYGLSAEVK 95.00% 3.33 0.496 1.96 546.2921 1,090.57 1,091.57 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% GPAYGLSAEVK 95.00% 2.78 0.453 2.05 546.2923 1,090.57 1,091.57 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% GPAYGLSAEVK 95.00% 2.9 0.405 1.82 546.2929 1,090.57 1,091.57 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% EQELREWIEGVTGR 95.00% 2.46 0.215 0 567.9598 1,700.86 1,701.86 3
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% NIIGLQMGTNK 95.00% 2.74 0.382 3.38 594.8237 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% NIIGLQMGTNK 95.00% 3.03 0.453 3.55 594.8253 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% NIIGLQMGTNK 95.00% 3.1 0.487 3.6 594.8255 1,187.64 1,188.64 2 DESP_HUMAN
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% NIIGLQMGTNK 95.00% 3.27 0.545 3.89 594.826 1,187.64 1,188.64 2 DESP_HUMAN
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% NIIGLQMGTNK 95.00% 2.11 0.289 1.54 594.8282 1,187.64 1,188.64 2 DESP_HUMAN
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% NIIGLQmGTNK 95.00% 3.08 0.423 3.39 m7: Oxidation (+15.99) 602.8228 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% NIIGLQmGTNK 95.00% 3.07 0.421 3.17 m7: Oxidation (+15.99) 602.8238 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% DGIILcEFINK 95.00% 3.15 0.319 0 c6: Carbamidomethyl (+57.02) 661.3447 1,320.67 1,321.68 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% DGIILcEFINK 95.00% 3.76 0.484 0 c6: Carbamidomethyl (+57.02) 661.3457 1,320.68 1,321.68 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% FASQQGMTAYGTR 95.00% 3.62 0.504 3.92 709.3331 1,416.65 1,417.65 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% FASQQGMTAYGTR 95.00% 3.97 0.559 4.15 709.3333 1,416.65 1,417.65 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% FASQQGmTAYGTR 95.00% 3.56 0.539 1.74 m7: Oxidation (+15.99) 717.331 1,432.65 1,433.65 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% FASQQGmTAYGTR 95.00% 3.08 0.468 3 m7: Oxidation (+15.99) 717.331 1,432.65 1,433.65 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% FASQQGmTAYGTR 95.00% 3.37 0.603 3.23 m7: Oxidation (+15.99) 717.3318 1,432.65 1,433.65 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% FASQQGmTAYGTR 95.00% 3.46 0.473 1.42 m7: Oxidation (+15.99) 717.3318 1,432.65 1,433.65 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% FASQQGmTAYGTR 95.00% 3.83 0.482 2.6 m7: Oxidation (+15.99) 717.332 1,432.65 1,433.65 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% FASQQGmTAYGTR 95.00% 3.22 0.445 2.14 m7: Oxidation (+15.99) 717.3335 1,432.65 1,433.65 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% EQELREWIEGVTGR 95.00% 3.24 0.355 3.36 851.9304 1,701.85 1,701.86 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% LGTDQPLDQATISLQMGTNK 95.00% 5.63 0.651 5.09 1,066.04 2,130.07 2,131.07 2
 SAMPLE 4R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 6 7 29 30.00% LGTDQPLDQATISLQmGTNK 95.00% 5.59 0.651 3.7 m16: Oxidation (+15.99) 1,074.54 2,147.07 2,147.07 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GMTVYGLPR 95.00% 2.97 0.342 0 497.2625 992.5093 993.5193 2 TITIN_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GMTVYGLPR 95.00% 3.14 0.364 1.66 497.2635 992.5113 993.5193 2 TITIN_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GMTVYGLPR 95.00% 2.98 0.319 1.14 497.2636 992.5115 993.5193 2 TITIN_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GMTVYGLPR 95.00% 3.06 0.325 0 497.2645 992.5134 993.5193 2 TITIN_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GmTVYGLPR 95.00% 2.84 0.458 2.62 m2: Oxidation (+15.99) 505.258 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GmTVYGLPR 95.00% 2.97 0.44 2 m2: Oxidation (+15.99) 505.2588 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GmTVYGLPR 95.00% 2.78 0.437 2.52 m2: Oxidation (+15.99) 505.2619 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GmTVYGLPR 95.00% 2.75 0.451 1.66 m2: Oxidation (+15.99) 505.264 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EWIEGVTGR 95.00% 1.59 0.432 0 523.7662 1,045.52 1,046.53 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EWIEGVTGR 95.00% 2.12 0.463 1.96 523.7672 1,045.52 1,046.53 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GPAYGLSAEVK 95.00% 3.1 0.494 1.7 546.2891 1,090.56 1,091.57 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GPAYGLSAEVK 95.00% 2.93 0.482 2.12 546.2894 1,090.56 1,091.57 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GPAYGLSAEVK 95.00% 2.56 0.42 2.25 546.2902 1,090.56 1,091.57 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GPAYGLSAEVK 95.00% 3.6 0.469 2.11 546.2903 1,090.57 1,091.57 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GPAYGLSAEVK 95.00% 3.39 0.488 1.8 546.2904 1,090.57 1,091.57 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GPAYGLSAEVK 95.00% 2.36 0.426 2.33 546.2905 1,090.57 1,091.57 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GPAYGLSAEVK 95.00% 3.12 0.402 1.42 546.2905 1,090.57 1,091.57 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GPAYGLSAEVK 95.00% 2.41 0.405 1.52 546.2911 1,090.57 1,091.57 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GPAYGLSAEVK 95.00% 2.45 0.418 1.72 546.2918 1,090.57 1,091.57 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% GPAYGLSAEVK 95.00% 2.44 0.435 2.11 546.2924 1,090.57 1,091.57 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% IGNNFMDGLK 95.00% 2.34 0.215 1.64 554.6595 1,107.30 1,108.55 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGR 95.00% 3.24 0.431 0 567.9547 1,700.84 1,701.86 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGR 95.00% 2.63 0.404 0 567.9559 1,700.84 1,701.86 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGR 95.00% 3.34 0.392 0 567.9657 1,700.87 1,701.86 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGR 95.00% 3.41 0.445 0 567.966 1,700.87 1,701.86 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGR 95.00% 3.05 0.375 0 568.2901 1,701.85 1,701.86 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGR 95.00% 2.44 0.25 0 568.2954 1,701.86 1,701.86 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% NIIGLQMGTNK 95.00% 3.12 0.502 3.17 594.8226 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% NIIGLQMGTNK 95.00% 3.32 0.539 3.16 594.8232 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% NIIGLQMGTNK 95.00% 3.27 0.562 2.77 594.83 1,187.64 1,188.64 2 DESP_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGRR 95.00% 3.88 0.359 0 619.9886 1,856.94 1,857.96 3 TITIN_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGRR 95.00% 3.67 0.36 0 620.3232 1,857.95 1,857.96 3 TITIN_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGRR 95.00% 3.63 0.244 0 620.3293 1,857.96 1,857.96 3 TITIN_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGRR 95.00% 2.85 0.17 0 620.3306 1,857.97 1,857.96 3 TITIN_HUMAN
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% DGIILcEFINK 95.00% 3.17 0.35 0 c6: Carbamidomethyl (+57.02) 661.3432 1,320.67 1,321.68 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% DGIILcEFINK 95.00% 3.28 0.432 1.15 c6: Carbamidomethyl (+57.02) 661.3462 1,320.68 1,321.68 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% DGIILcEFINK 95.00% 3.14 0.431 1.29 c6: Carbamidomethyl (+57.02) 661.3473 1,320.68 1,321.68 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% DGIILcEFINK 95.00% 2.98 0.451 0 c6: Carbamidomethyl (+57.02) 661.352 1,320.69 1,321.68 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% DGIILcEFINK 95.00% 3.81 0.509 0 c6: Carbamidomethyl (+57.02) 661.3559 1,320.70 1,321.68 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% DGIILcEFINK 95.00% 3.5 0.527 0 c6: Carbamidomethyl (+57.02) 661.3585 1,320.70 1,321.68 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% DGIILcEFINK 95.00% 3.9 0.502 1.21 c6: Carbamidomethyl (+57.02) 661.3585 1,320.70 1,321.68 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% DGIILcEFINK 95.00% 3.78 0.506 1.55 c6: Carbamidomethyl (+57.02) 661.3586 1,320.70 1,321.68 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% DGIILcEFINK 95.00% 3.41 0.414 1.16 c6: Carbamidomethyl (+57.02) 661.3587 1,320.70 1,321.68 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% FASQQGMTAYGTR 95.00% 3.76 0.468 4.89 709.3284 1,416.64 1,417.65 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% FASQQGMTAYGTR 95.00% 3.78 0.485 4.1 709.3294 1,416.64 1,417.65 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% FASQQGMTAYGTR 95.00% 3.43 0.516 3.55 709.3295 1,416.64 1,417.65 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% FASQQGMTAYGTR 95.00% 2 0.485 1.82 709.3304 1,416.65 1,417.65 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% FASQQGMTAYGTR 95.00% 4.17 0.528 6.66 709.3311 1,416.65 1,417.65 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% FASQQGMTAYGTR 95.00% 4.43 0.539 4.3 709.3315 1,416.65 1,417.65 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% FASQQGMTAYGTR 95.00% 3.94 0.56 5.66 709.8294 1,417.64 1,417.65 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQMGTNK 95.00% 5.24 0.573 2.24 711.3594 2,131.05 2,131.07 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQMGTNK 95.00% 5.75 0.61 2.21 711.3598 2,131.06 2,131.07 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQMGTNK 95.00% 5.09 0.516 3.26 711.3618 2,131.06 2,131.07 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQMGTNK 95.00% 4.52 0.464 1.89 711.3733 2,131.10 2,131.07 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% FASQQGmTAYGTR 95.00% 2.73 0.408 1.33 m7: Oxidation (+15.99) 717.3268 1,432.64 1,433.65 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% INESTQNWHQLENIGNFIK 95.00% 3.83 0.488 0 762.7134 2,285.12 2,285.13 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% INESTQNWHQLENIGNFIK 95.00% 5.62 0.559 1.96 762.7137 2,285.12 2,285.13 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% INESTQNWHQLENIGNFIK 95.00% 5.18 0.524 1.03 762.714 2,285.12 2,285.13 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% INESTQNWHQLENIGNFIK 95.00% 4.1 0.428 1.33 762.7144 2,285.12 2,285.13 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% INESTQNWHQLENIGNFIK 95.00% 3.75 0.406 0 762.7204 2,285.14 2,285.13 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% INESTQNWHQLENIGNFIK 95.00% 4.33 0.521 0 762.7253 2,285.15 2,285.13 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% INESTQNWHQLENIGNFIK 95.00% 3.91 0.43 0 762.7262 2,285.16 2,285.13 3
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGR 95.00% 3.36 0.33 0 851.4424 1,700.87 1,701.86 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGR 95.00% 3.27 0.356 1.38 851.4438 1,700.87 1,701.86 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGR 95.00% 2.98 0.3 1.42 851.4439 1,700.87 1,701.86 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGR 95.00% 3.39 0.309 0 851.4445 1,700.87 1,701.86 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGR 95.00% 3.09 0.463 0 851.446 1,700.88 1,701.86 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% EQELREWIEGVTGR 95.00% 3.09 0.361 0 851.9306 1,701.85 1,701.86 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQMGTNK 95.00% 5.76 0.655 5.05 1,066.04 2,130.06 2,131.07 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQMGTNK 95.00% 6.16 0.595 4.85 1,066.54 2,131.06 2,131.07 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQMGTNK 95.00% 6 0.628 4.32 1,066.54 2,131.06 2,131.07 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQMGTNK 95.00% 6.07 0.648 5 1,066.54 2,131.06 2,131.07 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQMGTNK 95.00% 4.74 0.551 4.64 1,066.56 2,131.10 2,131.07 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQMGTNK 95.00% 6.37 0.654 5.19 1,066.56 2,131.10 2,131.07 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQmGTNK 95.00% 5.37 0.626 5.49 m16: Oxidation (+15.99) 1,074.04 2,146.06 2,147.07 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQmGTNK 95.00% 5.54 0.639 4.52 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQmGTNK 95.00% 5.39 0.596 5.01 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% LGTDQPLDQATISLQmGTNK 95.00% 2.76 0.414 0 m16: Oxidation (+15.99) 1,074.55 2,147.08 2,147.07 2
 SAMPLE 1 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 9 12 67 40.10% INESTQNWHQLENIGNFIK 95.00% 4.67 0.48 5 1,143.56 2,285.11 2,285.13 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GMTVYGLPR 95.00% 2.88 0.38 0 497.2643 992.5129 993.5193 2 TITIN_HUMAN
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GMTVYGLPR 95.00% 2.7 0.26 0 497.2645 992.5133 993.5193 2 TITIN_HUMAN
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GMTVYGLPR 95.00% 2.9 0.374 0 497.2646 992.5135 993.5193 2 TITIN_HUMAN
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GmTVYGLPR 95.00% 2.78 0.437 2.55 m2: Oxidation (+15.99) 505.2619 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GmTVYGLPR 95.00% 2.75 0.451 1.72 m2: Oxidation (+15.99) 505.264 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EWIEGVTGR 95.00% 1.59 0.432 0 523.7662 1,045.52 1,046.53 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EWIEGVTGR 95.00% 2.12 0.463 1.43 523.7672 1,045.52 1,046.53 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GPAYGLSAEVK 95.00% 2.88 0.409 2.6 546.288 1,090.56 1,091.57 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GPAYGLSAEVK 95.00% 2.26 0.402 1.54 546.2881 1,090.56 1,091.57 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GPAYGLSAEVK 95.00% 2.58 0.516 2.04 546.2885 1,090.56 1,091.57 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GPAYGLSAEVK 95.00% 2.24 0.405 0 546.2888 1,090.56 1,091.57 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GPAYGLSAEVK 95.00% 2.62 0.386 1.51 546.2904 1,090.57 1,091.57 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GPAYGLSAEVK 95.00% 3.39 0.488 2.09 546.2904 1,090.57 1,091.57 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GPAYGLSAEVK 95.00% 2.76 0.481 1.18 546.2908 1,090.57 1,091.57 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GPAYGLSAEVK 95.00% 2.44 0.435 2.32 546.2924 1,090.57 1,091.57 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% GPAYGLSAEVK 95.00% 2.43 0.346 1.68 546.7919 1,091.57 1,091.57 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% IGNNFMDGLK 95.00% 2.34 0.215 1.22 554.6595 1,107.30 1,108.55 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGR 95.00% 3.34 0.392 0 567.9657 1,700.87 1,701.86 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGR 95.00% 3.41 0.445 0 567.966 1,700.87 1,701.86 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGR 95.00% 3.24 0.428 0 567.9667 1,700.88 1,701.86 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGR 95.00% 2.91 0.408 0 567.9667 1,700.88 1,701.86 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGR 95.00% 2.47 0.359 0 567.9668 1,700.88 1,701.86 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGR 95.00% 2.94 0.448 0 567.967 1,700.88 1,701.86 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGR 95.00% 2.44 0.25 0 568.2954 1,701.86 1,701.86 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% NIIGLQMGTNK 95.00% 3.27 0.562 2.96 594.83 1,187.64 1,188.64 2 DESP_HUMAN
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% NIIGLQMGTNK 95.00% 2.17 0.407 1.55 594.8335 1,187.65 1,188.64 2 DESP_HUMAN
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGRR 95.00% 3.12 0.341 0 620.0014 1,856.98 1,857.96 3 TITIN_HUMAN
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGRR 95.00% 3.63 0.244 0 620.3293 1,857.96 1,857.96 3 TITIN_HUMAN
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGRR 95.00% 2.85 0.17 0 620.3306 1,857.97 1,857.96 3 TITIN_HUMAN
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGRR 95.00% 3.36 0.354 0 620.3339 1,857.98 1,857.96 3 TITIN_HUMAN
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% DGIILcEFINK 95.00% 2.73 0.257 0 c6: Carbamidomethyl (+57.02) 661.3526 1,320.69 1,321.68 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% DGIILcEFINK 95.00% 3.81 0.509 0 c6: Carbamidomethyl (+57.02) 661.3559 1,320.70 1,321.68 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% DGIILcEFINK 95.00% 2.88 0.475 1.46 c6: Carbamidomethyl (+57.02) 661.3567 1,320.70 1,321.68 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% DGIILcEFINK 95.00% 3.92 0.495 0 c6: Carbamidomethyl (+57.02) 661.3568 1,320.70 1,321.68 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% DGIILcEFINK 95.00% 3.34 0.489 0 c6: Carbamidomethyl (+57.02) 661.3576 1,320.70 1,321.68 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% DGIILcEFINK 95.00% 3.92 0.502 0 c6: Carbamidomethyl (+57.02) 661.3577 1,320.70 1,321.68 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% FASQQGMTAYGTR 95.00% 3.34 0.507 2.66 709.3281 1,416.64 1,417.65 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% FASQQGMTAYGTR 95.00% 4.17 0.528 6.29 709.3311 1,416.65 1,417.65 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% FASQQGMTAYGTR 95.00% 4.43 0.539 4.46 709.3315 1,416.65 1,417.65 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% FASQQGMTAYGTR 95.00% 3.43 0.446 5.42 709.8309 1,417.65 1,417.65 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% LGTDQPLDQATISLQMGTNK 95.00% 5.09 0.516 3.22 711.3618 2,131.06 2,131.07 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% LGTDQPLDQATISLQMGTNK 95.00% 5.18 0.562 1.92 711.3713 2,131.09 2,131.07 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% LGTDQPLDQATISLQMGTNK 95.00% 4.52 0.464 1.96 711.3733 2,131.10 2,131.07 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% LGTDQPLDQATISLQMGTNK 95.00% 5.17 0.56 1.92 711.3749 2,131.10 2,131.07 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% FASQQGmTAYGTR 95.00% 2.73 0.408 2 m7: Oxidation (+15.99) 717.3268 1,432.64 1,433.65 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% INESTQNWHQLENIGNFIK 95.00% 4.33 0.521 0 762.7253 2,285.15 2,285.13 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% INESTQNWHQLENIGNFIK 95.00% 3.91 0.43 0 762.7262 2,285.16 2,285.13 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% KINESTQNWHQLENIGNFIK 95.00% 4.07 0.304 2.13 805.4295 2,413.27 2,413.23 3
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGR 95.00% 3.36 0.33 0 851.4424 1,700.87 1,701.86 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGR 95.00% 2.98 0.3 1.54 851.4439 1,700.87 1,701.86 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGR 95.00% 3.38 0.424 1.64 851.4451 1,700.87 1,701.86 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGR 95.00% 3.05 0.417 1.96 851.4455 1,700.88 1,701.86 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% EQELREWIEGVTGR 95.00% 3.07 0.268 0 851.4469 1,700.88 1,701.86 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% LGTDQPLDQATISLQMGTNK 95.00% 5.76 0.655 5.43 1,066.04 2,130.06 2,131.07 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% LGTDQPLDQATISLQMGTNK 95.00% 4.74 0.551 4.96 1,066.56 2,131.10 2,131.07 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% LGTDQPLDQATISLQMGTNK 95.00% 5.97 0.659 4.6 1,066.56 2,131.10 2,131.07 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% LGTDQPLDQATISLQMGTNK 95.00% 4.29 0.595 2.74 1,066.56 2,131.10 2,131.07 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% LGTDQPLDQATISLQmGTNK 95.00% 5.39 0.596 5.49 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% LGTDQPLDQATISLQmGTNK 95.00% 2.76 0.414 0 m16: Oxidation (+15.99) 1,074.55 2,147.08 2,147.07 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% INESTQNWHQLENIGNFIK 95.00% 4.46 0.494 2.51 1,143.59 2,285.17 2,285.13 2
 SAMPLE 1R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 10 13 52 40.40% INESTQNWHQLENIGNFIK 95.00% 4.46 0.481 3.03 1,143.59 2,285.17 2,285.13 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GMTVYGLPR 95.00% 2.46 0.401 1.37 497.2615 992.5074 993.5193 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GMTVYGLPR 95.00% 3.08 0.532 1.89 497.2623 992.5089 993.5193 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GMTVYGLPR 95.00% 3.39 0.458 1.6 497.2626 992.5095 993.5193 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GMTVYGLPR 95.00% 2.29 0.404 2.1 497.2626 992.5096 993.5193 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GMTVYGLPR 95.00% 3.41 0.469 1.27 497.2628 992.51 993.5193 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GMTVYGLPR 95.00% 2.33 0.363 0 497.2636 992.5115 993.5193 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GMTVYGLPR 95.00% 3.19 0.225 0 497.2647 992.5138 993.5193 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GmTVYGLPR 95.00% 2.79 0.409 0 m2: Oxidation (+15.99) 505.2592 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GmTVYGLPR 95.00% 2.81 0.403 1.64 m2: Oxidation (+15.99) 505.2596 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GmTVYGLPR 95.00% 1.91 0.33 1.59 m2: Oxidation (+15.99) 505.2597 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GmTVYGLPR 95.00% 2.16 0.275 1.33 m2: Oxidation (+15.99) 505.2597 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GmTVYGLPR 95.00% 2.69 0.456 1.48 m2: Oxidation (+15.99) 505.2599 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GmTVYGLPR 95.00% 2.12 0.301 1.31 m2: Oxidation (+15.99) 505.2603 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EWIEGVTGR 95.00% 2.24 0.318 0 523.7641 1,045.51 1,046.53 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EWIEGVTGR 95.00% 2.22 0.489 1.96 523.7657 1,045.52 1,046.53 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EWIEGVTGR 95.00% 2.35 0.374 1.28 523.7657 1,045.52 1,046.53 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EWIEGVTGR 95.00% 2.45 0.473 2.04 523.7665 1,045.52 1,046.53 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 3.44 0.488 2.06 546.2887 1,090.56 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 2.91 0.459 2.07 546.2889 1,090.56 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 3.16 0.502 1.89 546.2893 1,090.56 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 3.11 0.485 1.7 546.2895 1,090.56 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 3.13 0.472 1.92 546.2896 1,090.56 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 3.09 0.488 1.43 546.2896 1,090.56 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 2.98 0.45 0 546.2896 1,090.56 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 3.42 0.479 1.32 546.2896 1,090.56 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 3.38 0.481 1.74 546.2898 1,090.56 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 2.88 0.454 1.36 546.29 1,090.56 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 3.29 0.487 1.82 546.2901 1,090.56 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 3.31 0.499 1.57 546.2904 1,090.57 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 2.67 0.394 0 546.291 1,090.57 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 2.3 0.325 2.14 546.291 1,090.57 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 2.51 0.366 1.77 546.2912 1,090.57 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 2.27 0.317 1.17 546.2914 1,090.57 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GPAYGLSAEVK 95.00% 3.59 0.448 1.34 546.7925 1,091.57 1,091.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% IGNNFMDGLK 95.00% 2.35 0.459 1.62 554.772 1,107.53 1,108.55 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% IGNNFMDGLK 95.00% 3.18 0.521 2.21 554.7754 1,107.54 1,108.55 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% IGNNFMDGLK 95.00% 3.16 0.495 1.51 554.7755 1,107.54 1,108.55 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% IGNNFMDGLK 95.00% 3.38 0.524 2.27 554.7755 1,107.54 1,108.55 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% IGNNFMDGLK 95.00% 3.27 0.544 2.48 554.7757 1,107.54 1,108.55 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% IGNNFMDGLK 95.00% 3.11 0.476 0 554.7766 1,107.54 1,108.55 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% IGNNFMDGLK 95.00% 2.7 0.44 0 554.7773 1,107.54 1,108.55 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% IGNNFmDGLK 95.00% 2.34 0.406 0 m6: Oxidation (+15.99) 562.7715 1,123.53 1,124.54 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% IGNNFmDGLK 95.00% 2.13 0.301 0 m6: Oxidation (+15.99) 562.7718 1,123.53 1,124.54 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% IGNNFmDGLK 95.00% 2.44 0.378 0 m6: Oxidation (+15.99) 562.7719 1,123.53 1,124.54 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% IGNNFmDGLK 95.00% 2.28 0.368 0 m6: Oxidation (+15.99) 562.7735 1,123.53 1,124.54 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% IGNNFmDGLK 95.00% 2.26 0.295 0 m6: Oxidation (+15.99) 563.3054 1,124.60 1,124.54 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EQELREWIEGVTGR 95.00% 2.67 0.343 0 567.9559 1,700.84 1,701.86 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EQELREWIEGVTGR 95.00% 3.13 0.285 0 568.29 1,701.85 1,701.86 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EQELREWIEGVTGR 95.00% 3.02 0.373 0 568.29 1,701.85 1,701.86 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EQELREWIEGVTGR 95.00% 2.43 0.292 0 568.2912 1,701.85 1,701.86 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GASQAGMTAPGTK 95.00% 2.47 0.337 0 588.7896 1,175.56 1,176.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% GASQAGMTAPGTK 95.00% 2.76 0.373 1.25 588.7898 1,175.56 1,176.57 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% NIIGLQMGTNK 95.00% 2.99 0.544 1.62 594.8213 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% NIIGLQMGTNK 95.00% 3.05 0.403 2.17 594.8218 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% NIIGLQMGTNK 95.00% 2.56 0.468 3.06 594.8225 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% NIIGLQMGTNK 95.00% 3.24 0.477 2.82 594.8225 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% NIIGLQMGTNK 95.00% 3.8 0.563 2.74 594.8226 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% NIIGLQMGTNK 95.00% 3.17 0.491 3.03 594.8227 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% NIIGLQMGTNK 95.00% 2.97 0.546 3.24 594.8228 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% NIIGLQMGTNK 95.00% 3.85 0.5 3.68 594.8232 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% NIIGLQMGTNK 95.00% 2.88 0.407 2.85 594.8235 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% NIIGLQMGTNK 95.00% 3.3 0.544 4.1 594.8241 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% NIIGLQmGTNK 95.00% 2.59 0.201 2.51 m7: Oxidation (+15.99) 602.8204 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% NIIGLQmGTNK 95.00% 2.57 0.368 1.74 m7: Oxidation (+15.99) 602.8207 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EQELREWIEGVTGRR 95.00% 3.5 0.282 0 619.9896 1,856.95 1,857.96 3 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EQELREWIEGVTGRR 95.00% 3.32 0.361 0 619.9922 1,856.95 1,857.96 3 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EQELREWIEGVTGRR 95.00% 3.26 0.365 0 620.3246 1,857.95 1,857.96 3 TITIN_HUMAN
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% DGIILcEFINK 95.00% 2.78 0.388 0 c6: Carbamidomethyl (+57.02) 661.3436 1,320.67 1,321.68 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% DGIILcEFINK 95.00% 4.11 0.52 0 c6: Carbamidomethyl (+57.02) 661.3438 1,320.67 1,321.68 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% DGIILcEFINK 95.00% 3.64 0.499 0 c6: Carbamidomethyl (+57.02) 661.3438 1,320.67 1,321.68 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% DGIILcEFINK 95.00% 3.92 0.567 0 c6: Carbamidomethyl (+57.02) 661.3438 1,320.67 1,321.68 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% DGIILcEFINK 95.00% 3.92 0.512 0 c6: Carbamidomethyl (+57.02) 661.3441 1,320.67 1,321.68 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% DGIILcEFINK 95.00% 3.94 0.525 1.4 c6: Carbamidomethyl (+57.02) 661.3442 1,320.67 1,321.68 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% DGIILcEFINK 95.00% 3.99 0.528 0 c6: Carbamidomethyl (+57.02) 661.3443 1,320.67 1,321.68 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGMTAYGTR 95.00% 4.11 0.539 4.66 709.328 1,416.64 1,417.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGMTAYGTR 95.00% 4.14 0.558 5.34 709.3283 1,416.64 1,417.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGMTAYGTR 95.00% 4.31 0.553 5.44 709.3286 1,416.64 1,417.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGMTAYGTR 95.00% 4.23 0.562 5 709.3287 1,416.64 1,417.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGMTAYGTR 95.00% 4.16 0.555 4.6 709.3289 1,416.64 1,417.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGMTAYGTR 95.00% 3.87 0.581 4.52 709.329 1,416.64 1,417.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGMTAYGTR 95.00% 4.35 0.553 4.74 709.3293 1,416.64 1,417.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGMTAYGTR 95.00% 3.93 0.546 4.77 709.3296 1,416.64 1,417.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGMTAYGTR 95.00% 4.43 0.526 4.82 709.3303 1,416.64 1,417.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.02 0.595 3.02 711.0272 2,130.06 2,131.07 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQMGTNK 95.00% 4.85 0.569 2.17 711.3611 2,131.06 2,131.07 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.76 0.578 3.48 711.3613 2,131.06 2,131.07 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.92 0.54 1.7 711.3613 2,131.06 2,131.07 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQMGTNK 95.00% 4.37 0.564 1.24 711.3619 2,131.06 2,131.07 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQMGTNK 95.00% 4.4 0.505 2.44 711.3646 2,131.07 2,131.07 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGmTAYGTR 95.00% 3.77 0.59 3.62 m7: Oxidation (+15.99) 717.3261 1,432.64 1,433.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGmTAYGTR 95.00% 4.02 0.543 4.59 m7: Oxidation (+15.99) 717.3273 1,432.64 1,433.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGmTAYGTR 95.00% 3.75 0.584 5.06 m7: Oxidation (+15.99) 717.3275 1,432.64 1,433.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% FASQQGmTAYGTR 95.00% 3.48 0.502 2.82 m7: Oxidation (+15.99) 717.3298 1,432.64 1,433.65 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% INESTQNWHQLENIGNFIK 95.00% 4.62 0.542 0 762.7142 2,285.12 2,285.13 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% INESTQNWHQLENIGNFIK 95.00% 5.15 0.475 0 762.7151 2,285.12 2,285.13 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% KINESTQNWHQLENIGNFIK 95.00% 4.6 0.251 1.59 805.412 2,413.21 2,413.23 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% KINESTQNWHQLENIGNFIK 95.00% 4.72 0.199 2.12 805.4136 2,413.22 2,413.23 3
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EQELREWIEGVTGR 95.00% 3.13 0.372 0 851.4315 1,700.85 1,701.86 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% EQELREWIEGVTGR 95.00% 2.97 0.355 0 851.9311 1,701.85 1,701.86 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.64 0.62 5.92 1,066.54 2,131.06 2,131.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.05 0.637 6.32 1,066.54 2,131.06 2,131.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.07 0.637 7.68 1,066.54 2,131.06 2,131.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.88 0.616 5.72 1,066.54 2,131.06 2,131.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.98 0.648 3.85 1,066.54 2,131.06 2,131.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.18 0.582 5.04 1,066.54 2,131.06 2,131.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.64 0.656 4.54 m16: Oxidation (+15.99) 1,074.04 2,146.06 2,147.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.74 0.628 4.42 m16: Oxidation (+15.99) 1,074.53 2,147.05 2,147.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.54 0.653 4.6 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.63 0.635 4.89 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.35 0.633 4.38 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.82 0.649 6.15 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.4 0.647 4.66 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% INESTQNWHQLENIGNFIK 95.00% 4.16 0.563 2.85 1,142.59 2,283.17 2,285.13 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% INESTQNWHQLENIGNFIK 95.00% 4.69 0.496 3.43 1,143.57 2,285.12 2,285.13 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% INESTQNWHQLENIGNFIK 95.00% 4.93 0.5 4.55 1,143.57 2,285.12 2,285.13 2
 SAMPLE 2 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 100 44.80% INESTQNWHQLENIGNFIK 95.00% 5.27 0.541 3.64 1,143.57 2,285.12 2,285.13 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 3.12 0.537 2.03 497.2621 992.5085 993.5193 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 2.59 0.478 2.06 497.2623 992.5089 993.5193 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 3.18 0.482 1.29 497.2625 992.5093 993.5193 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 2.6 0.503 2.06 497.2628 992.5099 993.5193 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 2.39 0.198 1.15 497.2629 992.5102 993.5193 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 3.27 0.492 1.77 497.2631 992.5105 993.5193 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 3.25 0.447 1.36 497.2631 992.5106 993.5193 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 3 0.224 0 497.2649 992.5141 993.5193 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 3.2 0.446 1.89 497.2653 992.5149 993.5193 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GmTVYGLPR 95.00% 2.38 0.412 2.62 m2: Oxidation (+15.99) 505.2589 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GmTVYGLPR 95.00% 2.68 0.465 1.6 m2: Oxidation (+15.99) 505.2596 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GmTVYGLPR 95.00% 2.39 0.35 1.62 m2: Oxidation (+15.99) 505.2597 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GmTVYGLPR 95.00% 2.58 0.468 2.77 m2: Oxidation (+15.99) 505.2597 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GmTVYGLPR 95.00% 1.99 0.247 1.29 m2: Oxidation (+15.99) 505.2602 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GmTVYGLPR 95.00% 2.53 0.433 2.55 m2: Oxidation (+15.99) 505.2606 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EWIEGVTGR 95.00% 2.49 0.433 1.33 523.7653 1,045.52 1,046.53 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EWIEGVTGR 95.00% 2.33 0.392 1.51 523.7655 1,045.52 1,046.53 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EWIEGVTGR 95.00% 2.41 0.449 1.24 523.7656 1,045.52 1,046.53 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EWIEGVTGR 95.00% 1.92 0.331 0 523.7658 1,045.52 1,046.53 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EWIEGVTGR 95.00% 2.2 0.482 1.57 523.7661 1,045.52 1,046.53 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.6 0.396 0 546.2874 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.17 0.461 1.77 546.2884 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.07 0.504 1.82 546.2886 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.15 0.514 1.85 546.2888 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.61 0.44 2.24 546.289 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.3 0.505 1.92 546.2894 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.46 0.463 1.72 546.2895 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.05 0.482 0 546.2895 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.41 0.485 1.37 546.2896 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.24 0.503 1.96 546.2896 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3 0.449 1.3 546.2897 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.39 0.462 1.82 546.2897 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.15 0.465 2.02 546.2898 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.38 0.341 1.3 546.2899 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.1 0.499 2.35 546.29 1,090.56 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.16 0.32 1.57 546.2903 1,090.57 1,091.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 2.98 0.507 0 554.7752 1,107.53 1,108.55 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 3.11 0.537 2.7 554.7752 1,107.53 1,108.55 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 3.33 0.555 2.89 554.7758 1,107.54 1,108.55 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 2.55 0.397 0 554.7758 1,107.54 1,108.55 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 2.72 0.412 1.12 554.776 1,107.54 1,108.55 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 2.65 0.479 0 554.776 1,107.54 1,108.55 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 3.01 0.506 2 554.776 1,107.54 1,108.55 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 3.09 0.534 2.1 554.7763 1,107.54 1,108.55 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFmDGLK 95.00% 2.21 0.324 0 m6: Oxidation (+15.99) 562.7737 1,123.53 1,124.54 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 2.42 0.304 0 567.954 1,700.84 1,701.86 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 2.68 0.361 0 567.9555 1,700.84 1,701.86 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 2.83 0.33 0 567.9559 1,700.84 1,701.86 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 3.25 0.419 0 567.9568 1,700.85 1,701.86 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 3.09 0.378 0 567.9568 1,700.85 1,701.86 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 2.58 0.373 0 567.9569 1,700.85 1,701.86 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 2.46 0.312 0 567.9573 1,700.85 1,701.86 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 2.74 0.326 0 567.9573 1,700.85 1,701.86 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GASQAGMTAPGTK 95.00% 2.98 0.502 1.15 588.7885 1,175.56 1,176.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GASQAGMTAPGTK 95.00% 3.02 0.509 1.8 588.7889 1,175.56 1,176.57 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 3.49 0.534 3 594.8225 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.75 0.515 1.46 594.8228 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2 0.207 1.7 594.8228 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 3.79 0.571 2.77 594.8231 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 3.24 0.487 2.64 594.8232 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.86 0.462 2.48 594.8233 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 3.36 0.561 2.74 594.8234 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 3.9 0.562 2.26 594.8235 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.03 0.239 2.14 595.2838 1,188.55 1,188.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.81 0.505 3.1 595.3246 1,188.63 1,188.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.78 0.287 2 595.328 1,188.64 1,188.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQmGTNK 95.00% 2.54 0.113 1.96 m7: Oxidation (+15.99) 602.8205 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQmGTNK 95.00% 2.25 0.271 0 m7: Oxidation (+15.99) 602.8209 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQmGTNK 95.00% 2.4 0.305 0 m7: Oxidation (+15.99) 602.8224 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGRR 95.00% 3.07 0.396 0 619.9883 1,856.94 1,857.96 3 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGRR 95.00% 3.34 0.338 0 619.9897 1,856.95 1,857.96 3 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGRR 95.00% 3.14 0.281 0 619.9914 1,856.95 1,857.96 3 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGRR 95.00% 2.65 0.203 0 620.3237 1,857.95 1,857.96 3 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGRR 95.00% 3.06 0.31 0 620.324 1,857.95 1,857.96 3 TITIN_HUMAN
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 3.61 0.486 0 c6: Carbamidomethyl (+57.02) 661.343 1,320.67 1,321.68 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 3.57 0.46 1.18 c6: Carbamidomethyl (+57.02) 661.3435 1,320.67 1,321.68 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 3.63 0.483 1.21 c6: Carbamidomethyl (+57.02) 661.3435 1,320.67 1,321.68 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 3.73 0.477 0 c6: Carbamidomethyl (+57.02) 661.3437 1,320.67 1,321.68 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 3.78 0.495 1.17 c6: Carbamidomethyl (+57.02) 661.3437 1,320.67 1,321.68 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 2.99 0.408 0 c6: Carbamidomethyl (+57.02) 661.3438 1,320.67 1,321.68 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 3.93 0.538 0 c6: Carbamidomethyl (+57.02) 661.344 1,320.67 1,321.68 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 3.11 0.474 0 c6: Carbamidomethyl (+57.02) 661.3446 1,320.67 1,321.68 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.01 0.374 1.89 709.3274 1,416.64 1,417.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 4.2 0.545 4.82 709.3285 1,416.64 1,417.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.98 0.489 3.64 709.3289 1,416.64 1,417.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 4.67 0.559 4.82 709.3293 1,416.64 1,417.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.87 0.485 4.18 709.3294 1,416.64 1,417.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.12 0.533 4.92 709.3297 1,416.64 1,417.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 4.11 0.54 5.1 709.3299 1,416.64 1,417.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.56 0.49 4.41 709.3301 1,416.64 1,417.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 4.45 0.537 5 709.3302 1,416.64 1,417.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 1.97 0.322 0 709.3307 1,416.65 1,417.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.35 0.583 2.21 711.3602 2,131.06 2,131.07 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 4.8 0.519 1.85 711.3606 2,131.06 2,131.07 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 4.66 0.572 1.74 711.3613 2,131.06 2,131.07 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.62 0.551 2.48 711.3614 2,131.06 2,131.07 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.36 0.537 2.16 711.362 2,131.06 2,131.07 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 3.35 0.466 3.66 711.3621 2,131.06 2,131.07 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQmGTNK 95.00% 3.75 0.39 1.8 m16: Oxidation (+15.99) 716.6942 2,147.06 2,147.07 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGmTAYGTR 95.00% 3.76 0.515 4.74 m7: Oxidation (+15.99) 717.3266 1,432.64 1,433.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGmTAYGTR 95.00% 3.37 0.542 3.28 m7: Oxidation (+15.99) 717.328 1,432.64 1,433.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGmTAYGTR 95.00% 3.06 0.42 0 m7: Oxidation (+15.99) 717.3295 1,432.64 1,433.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGmTAYGTR 95.00% 3.55 0.499 3.48 m7: Oxidation (+15.99) 717.8293 1,433.64 1,433.65 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% INESTQNWHQLENIGNFIK 95.00% 4.25 0.553 0 762.7148 2,285.12 2,285.13 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% INESTQNWHQLENIGNFIK 95.00% 4.57 0.46 0 762.7149 2,285.12 2,285.13 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% KINESTQNWHQLENIGNFIK 95.00% 5.34 0.237 2.43 805.4134 2,413.22 2,413.23 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% KINESTQNWHQLENIGNFIK 95.00% 5.02 0.162 1.68 805.4139 2,413.22 2,413.23 3
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 3.1 0.395 0 851.4324 1,700.85 1,701.86 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 3.02 0.37 1.19 851.9323 1,701.85 1,701.86 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 3.27 0.333 2.72 851.9344 1,701.85 1,701.86 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.14 0.612 4.64 1,066.04 2,130.06 2,131.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 4.86 0.684 4.17 1,066.04 2,130.06 2,131.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.98 0.634 5.7 1,066.54 2,131.06 2,131.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.9 0.635 4.42 1,066.54 2,131.06 2,131.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.12 0.626 4.49 1,066.54 2,131.06 2,131.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.01 0.61 5.35 1,066.54 2,131.06 2,131.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.83 0.642 5.21 1,066.54 2,131.06 2,131.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.38 0.614 5.54 1,066.54 2,131.07 2,131.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.07 0.644 4.74 m16: Oxidation (+15.99) 1,074.53 2,147.05 2,147.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.18 0.639 4.44 m16: Oxidation (+15.99) 1,074.53 2,147.05 2,147.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.66 0.629 4.37 m16: Oxidation (+15.99) 1,074.53 2,147.05 2,147.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.48 0.606 4.74 m16: Oxidation (+15.99) 1,074.53 2,147.05 2,147.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.39 0.629 3.96 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.04 0.593 4.82 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQmGTNK 95.00% 0 0 4.62 m16: Oxidation (+15.99) 1,075.04 2,148.06 2,147.07 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% INESTQNWHQLENIGNFIK 95.00% 4.57 0.512 2.62 1,143.57 2,285.12 2,285.13 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% INESTQNWHQLENIGNFIK 95.00% 4.9 0.493 3.33 1,143.57 2,285.12 2,285.13 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% INESTQNWHQLENIGNFIK 95.00% 4.92 0.514 4.52 1,143.57 2,285.12 2,285.13 2
 SAMPLE 2R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% INESTQNWHQLENIGNFIK 95.00% 4.37 0.482 3.05 1,143.57 2,285.12 2,285.13 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GMTVYGLPR 95.00% 2.96 0.519 1.32 497.262 992.5083 993.5193 2 TITIN_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GMTVYGLPR 95.00% 3.19 0.57 2.42 497.262 992.5083 993.5193 2 TITIN_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GMTVYGLPR 95.00% 3.02 0.514 1.35 497.263 992.5104 993.5193 2 TITIN_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GmTVYGLPR 95.00% 2.63 0.435 2 m2: Oxidation (+15.99) 505.2592 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GmTVYGLPR 95.00% 2.74 0.424 1.46 m2: Oxidation (+15.99) 505.2594 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GmTVYGLPR 95.00% 2.95 0.395 1.92 m2: Oxidation (+15.99) 505.2594 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GmTVYGLPR 95.00% 2.79 0.394 1.92 m2: Oxidation (+15.99) 505.2597 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GmTVYGLPR 95.00% 2.67 0.489 1.37 m2: Oxidation (+15.99) 505.2597 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GmTVYGLPR 95.00% 2.76 0.402 2.3 m2: Oxidation (+15.99) 505.2597 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EWIEGVTGR 95.00% 2.35 0.435 1.25 523.7653 1,045.52 1,046.53 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EWIEGVTGR 95.00% 2.35 0.446 1.74 523.7661 1,045.52 1,046.53 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EWIEGVTGR 95.00% 2.18 0.301 1.32 523.7661 1,045.52 1,046.53 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EWIEGVTGR 95.00% 2.09 0.227 1.22 523.7664 1,045.52 1,046.53 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EWIEGVTGR 95.00% 2.26 0.427 1.29 523.7671 1,045.52 1,046.53 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.63 0.459 2.48 546.2888 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 2.6 0.446 2.11 546.2892 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.07 0.503 2.43 546.2892 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 2.71 0.331 1.6 546.2893 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.22 0.461 2.15 546.2893 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.06 0.438 1.82 546.2893 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.2 0.476 1.37 546.2893 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.33 0.486 2.1 546.2895 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.06 0.475 1.18 546.2895 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 2.67 0.406 2.05 546.2896 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 2.91 0.511 2.42 546.2896 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.05 0.518 1.77 546.2896 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.12 0.453 2.07 546.2896 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.06 0.465 2.12 546.2896 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.12 0.455 2.33 546.2899 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.05 0.482 1.62 546.2899 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 3.07 0.529 2.17 546.2901 1,090.56 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 2.49 0.3 1.29 546.2906 1,090.57 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GPAYGLSAEVK 95.00% 2.33 0.447 0 546.7962 1,091.58 1,091.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% IGNNFMDGLK 95.00% 2.7 0.366 0 554.775 1,107.53 1,108.55 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% IGNNFMDGLK 95.00% 2.8 0.418 0 554.7753 1,107.53 1,108.55 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGR 95.00% 2.82 0.401 0 567.9556 1,700.84 1,701.86 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGR 95.00% 3.52 0.467 0 567.9558 1,700.84 1,701.86 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGR 95.00% 2.92 0.309 0 567.956 1,700.84 1,701.86 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGR 95.00% 2.71 0.347 0 567.9561 1,700.84 1,701.86 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGR 95.00% 2.89 0.387 0 568.2905 1,701.85 1,701.86 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGR 95.00% 2.98 0.372 0 568.2906 1,701.85 1,701.86 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GASQAGMTAPGTK 95.00% 2.84 0.481 1.64 588.7874 1,175.56 1,176.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GASQAGMTAPGTK 95.00% 3.04 0.487 0 588.7882 1,175.56 1,176.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GASQAGMTAPGTK 95.00% 2.72 0.392 0 588.7882 1,175.56 1,176.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% GASQAGMTAPGTK 95.00% 2.06 0.41 0 588.7887 1,175.56 1,176.57 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 2.63 0.449 1.89 594.8221 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 3.3 0.576 3.02 594.8226 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 3.06 0.559 2.6 594.8226 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 3.4 0.554 3.05 594.8227 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 3.28 0.548 3.52 594.8227 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 3.31 0.581 2.85 594.8229 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 3.18 0.565 3.29 594.823 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 3.32 0.549 3.18 594.8232 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 3.42 0.549 3.4 594.8235 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 3.14 0.462 2.89 594.8236 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 2.7 0.474 2.96 594.8236 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 2.78 0.462 2.21 594.8238 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQMGTNK 95.00% 2.84 0.514 2.68 594.824 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQmGTNK 95.00% 2.78 0.305 2.1 m7: Oxidation (+15.99) 602.8211 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQmGTNK 95.00% 2.74 0.344 2.44 m7: Oxidation (+15.99) 602.822 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQmGTNK 95.00% 2.6 0.322 1.48 m7: Oxidation (+15.99) 602.8232 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% NIIGLQmGTNK 95.00% 2.61 0.247 0 m7: Oxidation (+15.99) 602.8241 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGRR 95.00% 3.28 0.359 0 619.9893 1,856.94 1,857.96 3 TITIN_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGRR 95.00% 3.07 0.379 0 619.9893 1,856.94 1,857.96 3 TITIN_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGRR 95.00% 2.58 0.247 0 620.3229 1,857.95 1,857.96 3 TITIN_HUMAN
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% DGIILcEFINK 95.00% 3.63 0.514 0 c6: Carbamidomethyl (+57.02) 661.3432 1,320.67 1,321.68 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% DGIILcEFINK 95.00% 3.86 0.494 1.11 c6: Carbamidomethyl (+57.02) 661.3436 1,320.67 1,321.68 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% DGIILcEFINK 95.00% 3.87 0.514 1.18 c6: Carbamidomethyl (+57.02) 661.3439 1,320.67 1,321.68 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% DGIILcEFINK 95.00% 3.8 0.509 0 c6: Carbamidomethyl (+57.02) 661.3439 1,320.67 1,321.68 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% DGIILcEFINK 95.00% 3.56 0.513 0 c6: Carbamidomethyl (+57.02) 661.3443 1,320.67 1,321.68 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% DGIILcEFINK 95.00% 3.62 0.521 0 c6: Carbamidomethyl (+57.02) 661.3445 1,320.67 1,321.68 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 4.53 0.543 5.89 709.328 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 4.05 0.542 4.41 709.3284 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 4.26 0.535 4.3 709.3286 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 4.6 0.54 5.72 709.3286 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 4.16 0.538 5 709.3288 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 4.48 0.571 4.96 709.3289 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 3.92 0.576 4.31 709.329 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 4.41 0.543 5.29 709.3293 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 3.61 0.481 4.74 709.3296 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 4.1 0.55 6.24 709.3296 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 4.05 0.561 4.89 709.3297 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 3.9 0.527 4.44 709.3299 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 4 0.521 4.05 709.33 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGMTAYGTR 95.00% 4.1 0.562 3.92 709.3303 1,416.64 1,417.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQMGTNK 95.00% 4.28 0.514 3.18 711.0284 2,130.06 2,131.07 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.43 0.534 2.47 711.3611 2,131.06 2,131.07 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.07 0.62 2.04 711.3616 2,131.06 2,131.07 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQMGTNK 95.00% 4.85 0.477 1.38 711.3619 2,131.06 2,131.07 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGmTAYGTR 95.00% 3.79 0.574 5.89 m7: Oxidation (+15.99) 717.3262 1,432.64 1,433.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGmTAYGTR 95.00% 3.73 0.566 3.54 m7: Oxidation (+15.99) 717.3263 1,432.64 1,433.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGmTAYGTR 95.00% 3.87 0.555 5.07 m7: Oxidation (+15.99) 717.3274 1,432.64 1,433.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% FASQQGmTAYGTR 95.00% 3.34 0.547 4.07 m7: Oxidation (+15.99) 717.3277 1,432.64 1,433.65 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% INESTQNWHQLENIGNFIK 95.00% 5.61 0.586 0 762.7146 2,285.12 2,285.13 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% INESTQNWHQLENIGNFIK 95.00% 4.69 0.558 0 762.7155 2,285.12 2,285.13 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% INESTQNWHQLENIGNFIK 95.00% 4.74 0.534 0 762.7158 2,285.12 2,285.13 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% KINESTQNWHQLENIGNFIK 95.00% 4.88 0.321 2.26 805.4134 2,413.22 2,413.23 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% KINESTQNWHQLENIGNFIK 95.00% 4.77 0.266 1.24 805.4142 2,413.22 2,413.23 3
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGR 95.00% 2.84 0.311 0 851.4301 1,700.84 1,701.86 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGR 95.00% 2.99 0.35 0 851.4309 1,700.85 1,701.86 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGR 95.00% 3.45 0.382 0 851.4325 1,700.85 1,701.86 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGR 95.00% 2.89 0.25 1.11 851.9302 1,701.84 1,701.86 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGR 95.00% 3.54 0.346 0 851.9308 1,701.85 1,701.86 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% EQELREWIEGVTGR 95.00% 3.11 0.345 0 851.9314 1,701.85 1,701.86 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.84 0.608 8.8 1,066.04 2,130.06 2,131.07 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.08 0.596 4.89 1,066.04 2,130.06 2,131.07 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.17 0.626 4.37 1,066.53 2,131.05 2,131.07 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.19 0.664 4.2 1,066.54 2,131.06 2,131.07 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.9 0.631 5.44 1,066.54 2,131.06 2,131.07 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.68 0.654 4.8 1,066.54 2,131.06 2,131.07 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.1 0.628 5.46 1,066.54 2,131.06 2,131.07 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.95 0.645 5 1,066.54 2,131.06 2,131.07 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.46 0.651 4.11 m16: Oxidation (+15.99) 1,074.03 2,146.05 2,147.07 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQmGTNK 95.00% 4.34 0.644 4.32 m16: Oxidation (+15.99) 1,074.04 2,146.06 2,147.07 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.28 0.653 4.28 m16: Oxidation (+15.99) 1,074.53 2,147.05 2,147.07 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.43 0.64 4.24 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% INESTQNWHQLENIGNFIK 95.00% 4.96 0.523 2.89 1,143.57 2,285.12 2,285.13 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% INESTQNWHQLENIGNFIK 95.00% 4.67 0.516 2.8 1,143.57 2,285.12 2,285.13 2
 SAMPLE 3 Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 107 44.80% INESTQNWHQLENIGNFIK 95.00% 5.16 0.524 2.6 1,143.57 2,285.12 2,285.13 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 2.74 0.448 0 497.2622 992.5088 993.5193 2 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 3.32 0.489 0 497.2623 992.5089 993.5193 2 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 2.94 0.507 1.14 497.2624 992.5091 993.5193 2 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 3.01 0.545 1.32 497.2625 992.5093 993.5193 2 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 2.96 0.489 0 497.263 992.5104 993.5193 2 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 2.78 0.357 0 497.2635 992.5114 993.5193 2 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 2.58 0.291 0 497.2639 992.5122 993.5193 2 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GMTVYGLPR 95.00% 2.85 0.436 1.07 497.2645 992.5133 993.5193 2 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GmTVYGLPR 95.00% 2.84 0.394 2.49 m2: Oxidation (+15.99) 505.2599 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GmTVYGLPR 95.00% 2.51 0.442 0 m2: Oxidation (+15.99) 505.2599 1,008.50 1,009.51 2 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GmTVYGLPR 95.00% 2.34 0.397 1.72 m2: Oxidation (+15.99) 505.2603 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GmTVYGLPR 95.00% 2.96 0.383 0 m2: Oxidation (+15.99) 505.2609 1,008.51 1,009.51 2 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.88 0.422 1.92 546.2878 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.95 0.465 2.12 546.2884 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.32 0.443 1.96 546.2888 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.14 0.474 2.02 546.2891 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 1.87 0.274 1.07 546.2894 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.9 0.492 2.1 546.2896 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.35 0.509 1.74 546.2898 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.56 0.456 1.82 546.2899 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.01 0.507 1.92 546.2899 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.12 0.475 1.52 546.29 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.21 0.498 2.11 546.29 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 3.02 0.523 2.24 546.2901 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.82 0.447 2.18 546.2901 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.77 0.447 2.17 546.2901 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.97 0.504 1.66 546.2901 1,090.56 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.4 0.397 1.6 546.2918 1,090.57 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 1.89 0.276 1.17 546.2927 1,090.57 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GPAYGLSAEVK 95.00% 2.69 0.191 2.07 546.7648 1,091.51 1,091.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 3.02 0.548 1.82 554.7754 1,107.54 1,108.55 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 2.62 0.352 1.37 554.7758 1,107.54 1,108.55 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 2.69 0.488 2.05 554.7759 1,107.54 1,108.55 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 2.94 0.525 1.48 554.776 1,107.54 1,108.55 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 2.96 0.574 3.47 554.7762 1,107.54 1,108.55 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 2.59 0.361 0 554.7762 1,107.54 1,108.55 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLK 95.00% 2.55 0.391 1.1 554.7766 1,107.54 1,108.55 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 3.39 0.417 0 567.9551 1,700.84 1,701.86 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 2.48 0.356 0 567.9554 1,700.84 1,701.86 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 3.19 0.345 0 567.9562 1,700.85 1,701.86 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 3.12 0.42 0 567.9562 1,700.85 1,701.86 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 2.73 0.385 0 568.2906 1,701.85 1,701.86 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 2.74 0.436 0 568.291 1,701.85 1,701.86 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GASQAGMTAPGTK 95.00% 2.4 0.408 0 588.7871 1,175.56 1,176.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GASQAGMTAPGTK 95.00% 3.09 0.486 0 588.7878 1,175.56 1,176.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% GASQAGMTAPGTK 95.00% 2.84 0.489 1.3 588.788 1,175.56 1,176.57 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.81 0.532 1.85 594.8218 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.4 0.264 0 594.8219 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 3.26 0.533 2.54 594.8221 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 3.17 0.521 2.4 594.8221 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 3.63 0.573 2.64 594.8223 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 3.52 0.552 2.74 594.8225 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.89 0.536 2.92 594.8226 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.91 0.386 2.28 594.8228 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 3.17 0.552 2.85 594.8228 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.85 0.497 2.03 594.8235 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.78 0.504 1.85 594.8236 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.58 0.439 2.02 594.8246 1,187.63 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.49 0.431 1.64 594.8275 1,187.64 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQMGTNK 95.00% 2.41 0.398 1.74 595.3258 1,188.64 1,188.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQmGTNK 95.00% 3.14 0.4 1.82 m7: Oxidation (+15.99) 602.8203 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQmGTNK 95.00% 2.66 0.364 1.41 m7: Oxidation (+15.99) 602.8213 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% NIIGLQmGTNK 95.00% 2.31 0.255 1.31 m7: Oxidation (+15.99) 602.8234 1,203.63 1,204.64 2 DESP_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGRR 95.00% 3.35 0.306 0 619.99 1,856.95 1,857.96 3 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGRR 95.00% 3.79 0.399 0 620.3235 1,857.95 1,857.96 3 TITIN_HUMAN
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 3.91 0.511 0 c6: Carbamidomethyl (+57.02) 661.3425 1,320.67 1,321.68 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 3.71 0.512 0 c6: Carbamidomethyl (+57.02) 661.3432 1,320.67 1,321.68 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 2.8 0.406 0 c6: Carbamidomethyl (+57.02) 661.3435 1,320.67 1,321.68 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 3.73 0.476 1.41 c6: Carbamidomethyl (+57.02) 661.3436 1,320.67 1,321.68 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 3.55 0.494 1.14 c6: Carbamidomethyl (+57.02) 661.3437 1,320.67 1,321.68 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 2.78 0.422 0 c6: Carbamidomethyl (+57.02) 661.3441 1,320.67 1,321.68 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 2.78 0.502 0 c6: Carbamidomethyl (+57.02) 661.3443 1,320.67 1,321.68 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% DGIILcEFINK 95.00% 3.49 0.543 0 c6: Carbamidomethyl (+57.02) 661.3448 1,320.67 1,321.68 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 2.99 0.369 0 709.3273 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.79 0.516 3.96 709.3275 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.52 0.493 3.44 709.3283 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.96 0.56 4.19 709.3283 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.56 0.557 3.57 709.3287 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.98 0.579 4.28 709.3288 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 4.15 0.56 4.77 709.3292 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 4.04 0.558 3.92 709.3294 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 4.02 0.547 4.7 709.3295 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.86 0.567 5.32 709.3299 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 4.24 0.526 3.44 709.3299 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 4 0.514 3.43 709.3302 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.74 0.554 3.49 709.3302 1,416.64 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 3.95 0.552 4.59 709.331 1,416.65 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGMTAYGTR 95.00% 2.89 0.452 2.62 709.3337 1,416.65 1,417.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 4.44 0.515 1.33 711.028 2,130.06 2,131.07 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 4.95 0.553 1.16 711.3592 2,131.05 2,131.07 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 4.99 0.571 2 711.3607 2,131.06 2,131.07 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 4.86 0.529 3.08 711.361 2,131.06 2,131.07 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 2.88 0.393 0 711.3638 2,131.07 2,131.07 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGmTAYGTR 95.00% 3.75 0.511 3.48 m7: Oxidation (+15.99) 717.3266 1,432.64 1,433.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGmTAYGTR 95.00% 3.7 0.56 3.55 m7: Oxidation (+15.99) 717.3267 1,432.64 1,433.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGmTAYGTR 95.00% 3.73 0.538 5.85 m7: Oxidation (+15.99) 717.3279 1,432.64 1,433.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% FASQQGmTAYGTR 95.00% 3.2 0.521 2.52 m7: Oxidation (+15.99) 717.3291 1,432.64 1,433.65 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% INESTQNWHQLENIGNFIK 95.00% 3.79 0.498 0 762.7147 2,285.12 2,285.13 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% INESTQNWHQLENIGNFIK 95.00% 4.49 0.528 0 762.7158 2,285.12 2,285.13 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% IGNNFMDGLKDGIILcEFINK 95.00% 3.05 0.195 0 c16: Carbamidomethyl (+57.02) 804.4353 2,410.28 2,411.21 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% KINESTQNWHQLENIGNFIK 95.00% 5 0.273 1.89 805.415 2,413.22 2,413.23 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% KINESTQNWHQLENIGNFIK 95.00% 4.8 0.316 2.15 805.4167 2,413.23 2,413.23 3
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 3.16 0.288 0 851.4293 1,700.84 1,701.86 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 3.04 0.345 0 851.4306 1,700.85 1,701.86 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 3.07 0.35 0 851.4309 1,700.85 1,701.86 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 2.95 0.283 0 851.4312 1,700.85 1,701.86 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 3.09 0.336 0 851.9316 1,701.85 1,701.86 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% EQELREWIEGVTGR 95.00% 2.94 0.338 0 851.9334 1,701.85 1,701.86 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.15 0.596 4.54 1,066.53 2,131.05 2,131.07 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.46 0.669 3.1 1,066.54 2,131.06 2,131.07 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.52 0.654 4.02 1,066.54 2,131.06 2,131.07 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.96 0.634 3.6 1,066.54 2,131.06 2,131.07 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.07 0.613 3.62 1,066.54 2,131.06 2,131.07 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 6.06 0.577 5.24 1,066.54 2,131.06 2,131.07 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQMGTNK 95.00% 5.59 0.588 3.82 1,066.54 2,131.06 2,131.07 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.29 0.632 5.7 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQmGTNK 95.00% 4.55 0.569 3.44 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.6 0.643 5.62 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% LGTDQPLDQATISLQmGTNK 95.00% 5.56 0.636 5.57 m16: Oxidation (+15.99) 1,074.54 2,147.06 2,147.07 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% INESTQNWHQLENIGNFIK 95.00% 4.78 0.524 3.62 1,143.57 2,285.12 2,285.13 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% INESTQNWHQLENIGNFIK 95.00% 4.89 0.475 3.39 1,143.57 2,285.12 2,285.13 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% INESTQNWHQLENIGNFIK 95.00% 4.54 0.493 3.03 1,143.57 2,285.12 2,285.13 2
 SAMPLE 3R Calponin-1  CNN1  CNN1_HUMAN 33,153.00 100.00% 11 14 109 44.80% INESTQNWHQLENIGNFIK 95.00% 4.71 0.509 4.29 1,143.57 2,285.13 2,285.13 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% GMSVYGLGR 95.00% 2.55 0.422 1.92 470.2393 938.4629 939.4723 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% GMSVYGLGR 95.00% 2.79 0.45 2.54 470.2408 938.466 939.4723 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% DGIILcELINK 95.00% 3.21 0.294 0 c6: Carbamidomethyl (+57.02) 644.3509 1,286.69 1,287.70 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% DGIILcELINK 95.00% 3.36 0.311 0 c6: Carbamidomethyl (+57.02) 644.3512 1,286.69 1,287.70 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% DGIILcELINK 95.00% 2.7 0.253 0 c6: Carbamidomethyl (+57.02) 644.3621 1,286.71 1,287.70 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% DGIILcELINK 95.00% 3.03 0.373 0 c6: Carbamidomethyl (+57.02) 644.3661 1,286.72 1,287.70 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% DGIILcELINK 95.00% 3.3 0.25 0 c6: Carbamidomethyl (+57.02) 644.3662 1,286.72 1,287.70 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% AGQSVIGLQMGTNK 95.00% 4.47 0.602 3.19 702.3684 1,402.72 1,403.73 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% AGQSVIGLQMGTNK 95.00% 4.54 0.668 4.82 702.3707 1,402.73 1,403.73 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% LTLQPVDNSTISLQMGTNK 95.00% 4.26 0.486 3.72 1,030.53 2,059.05 2,060.07 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% LTLQPVDNSTISLQMGTNK 95.00% 6.23 0.611 5.52 1,031.04 2,060.05 2,060.07 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% LTLQPVDNSTISLQMGTNK 95.00% 6.35 0.59 5.62 1,031.04 2,060.06 2,060.07 2
 SAMPLE 1 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 4 4 13 16.10% LTLQPVDNSTISLQMGTNK 95.00% 4.76 0.499 3.89 1,031.05 2,060.09 2,060.07 2
 SAMPLE 1R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 99.80% 2 2 6 9.12% DGIILcELINK 95.00% 2.7 0.253 0 c6: Carbamidomethyl (+57.02) 644.3621 1,286.71 1,287.70 2
 SAMPLE 1R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 99.80% 2 2 6 9.12% DGIILcELINK 95.00% 2.58 0.169 1.27 c6: Carbamidomethyl (+57.02) 644.3665 1,286.72 1,287.70 2
 SAMPLE 1R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 99.80% 2 2 6 9.12% LTLQPVDNSTISLQMGTNK 95.00% 4.26 0.486 3.37 1,030.53 2,059.05 2,060.07 2
 SAMPLE 1R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 99.80% 2 2 6 9.12% LTLQPVDNSTISLQMGTNK 95.00% 4.76 0.499 3.85 1,031.05 2,060.09 2,060.07 2
 SAMPLE 1R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 99.80% 2 2 6 9.12% LTLQPVDNSTISLQMGTNK 95.00% 4.95 0.581 4.74 1,031.06 2,060.10 2,060.07 2
 SAMPLE 1R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 99.80% 2 2 6 9.12% LTLQPVDNSTISLQMGTNK 95.00% 5.01 0.498 5.31 1,031.06 2,060.10 2,060.07 2
 SAMPLE 2 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 8 17.30% GASQAGmLAPGTR 95.00% 2.49 0.326 0 m7: Oxidation (+15.99) 616.8085 1,231.60 1,232.61 2
 SAMPLE 2 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 8 17.30% DGIILcELINK 95.00% 2.5 0.31 0 c6: Carbamidomethyl (+57.02) 644.3513 1,286.69 1,287.70 2
 SAMPLE 2 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 8 17.30% DGIILcELINK 95.00% 3.81 0.338 1.42 c6: Carbamidomethyl (+57.02) 644.3524 1,286.69 1,287.70 2
 SAMPLE 2 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 8 17.30% AGQSVIGLQMGTNK 95.00% 3.59 0.588 3.57 702.3671 1,402.72 1,403.73 2
 SAMPLE 2 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 8 17.30% AGQSVIGLQMGTNK 95.00% 3.18 0.445 1.2 702.3673 1,402.72 1,403.73 2
 SAMPLE 2 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 8 17.30% AGQSVIGLQMGTNK 95.00% 2.99 0.413 0 702.3687 1,402.72 1,403.73 2
 SAMPLE 2 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 8 17.30% AGQSVIGLQMGTNK 95.00% 3.42 0.559 3.32 702.3697 1,402.72 1,403.73 2
 SAMPLE 2 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 8 17.30% LTLQPVDNSTISLQMGTNK 95.00% 5.23 0.348 4.92 1,031.04 2,060.06 2,060.07 2
 SAMPLE 2 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 8 17.30% LTLQPVDNSTISLQMGTNK 95.00% 5.82 0.58 4.59 1,031.04 2,060.07 2,060.07 2
 SAMPLE 2R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 5 13.40% DGIILcELINK 95.00% 2.71 0.302 2.28 c6: Carbamidomethyl (+57.02) 644.3522 1,286.69 1,287.70 2
 SAMPLE 2R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 5 13.40% AGQSVIGLQMGTNK 95.00% 4.18 0.595 3.96 702.8681 1,403.72 1,403.73 2
 SAMPLE 2R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 5 13.40% AGQSVIGLQMGTNK 95.00% 3.36 0.624 2.68 702.8686 1,403.72 1,403.73 2
 SAMPLE 2R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 5 13.40% AGQSVIGLQMGTNK 95.00% 4.07 0.56 4.02 702.8713 1,403.73 1,403.73 2
 SAMPLE 2R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 5 13.40% LTLQPVDNSTISLQMGTNK 95.00% 5.74 0.642 5.23 1,031.04 2,060.06 2,060.07 2
 SAMPLE 3 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 4 13.40% GPSYGLSAEVK 95.00% 2.43 0.371 2.54 554.2877 1,106.56 1,107.57 2
 SAMPLE 3 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 4 13.40% AGQSVIGLQMGTNK 95.00% 2.78 0.492 0 702.3672 1,402.72 1,403.73 2
 SAMPLE 3 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 4 13.40% AGQSVIGLQMGTNK 95.00% 3.1 0.546 2.46 702.3672 1,402.72 1,403.73 2
 SAMPLE 3 Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 4 13.40% LTLQPVDNSTISLQMGTNK 95.00% 4.11 0.585 5.07 1,031.04 2,060.07 2,060.07 2
 SAMPLE 3R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 7 11.90% GMSVYGLGR 95.00% 2.42 0.315 2.92 470.2396 938.4635 939.4723 2
 SAMPLE 3R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 7 11.90% GPSYGLSAEVK 95.00% 2.53 0.261 1.12 554.2866 1,106.56 1,107.57 2
 SAMPLE 3R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 7 11.90% GPSYGLSAEVK 95.00% 2.49 0.295 2.54 554.2868 1,106.56 1,107.57 2
 SAMPLE 3R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 7 11.90% GPSYGLSAEVK 95.00% 2.16 0.279 1.77 554.289 1,106.56 1,107.57 2
 SAMPLE 3R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 7 11.90% LTLQPVDNSTISLQMGTNK 95.00% 3.61 0.459 3.77 1,030.54 2,059.07 2,060.07 2
 SAMPLE 3R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 7 11.90% LTLQPVDNSTISLQMGTNK 95.00% 4.85 0.616 3.77 1,031.04 2,060.06 2,060.07 2
 SAMPLE 3R Calponin-3  CNN3  CNN3_HUMAN 36,396.60 100.00% 3 3 7 11.90% LTLQPVDNSTISLQMGTNK 95.00% 4.6 0.584 3.89 1,031.04 2,060.06 2,060.07 2
 SAMPLE 1 Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 3 10.80% IKDPDASKPEDWDER 95.00% 2.75 0.156 0 600.9509 1,799.83 1,800.84 3
 SAMPLE 1 Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 3 10.80% IKDPDASKPEDWDER 95.00% 2.77 0.321 1.37 601.285 1,800.83 1,800.84 3
 SAMPLE 1 Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 3 10.80% FYGDEEKDKGLQTSQDAR 95.00% 4.37 0.57 2.32 696.3265 2,085.96 2,086.97 3 GRP75_HUMAN
 SAMPLE 1 Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 3 10.80% FYGDEEKDKGLQTSQDAR 95.00% 4.49 0.486 1.24 696.6608 2,086.96 2,086.97 3 GRP75_HUMAN
 SAMPLE 1 Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 3 10.80% EQFLDGDGWTSR 95.00% 2.29 0.392 1.43 705.8177 1,409.62 1,410.63 2
 SAMPLE 1 Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 3 10.80% FYGDEEKDKGLQTSQDAR 95.00% 5.83 0.659 4.11 1,044.49 2,086.96 2,086.97 2 GRP75_HUMAN
 SAMPLE 1R Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 6 13.20% IKDPDASKPEDWDER 95.00% 2.28 0.232 0 600.9504 1,799.83 1,800.84 3
 SAMPLE 1R Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 6 13.20% IKDPDASKPEDWDER 95.00% 2.68 0.274 1.12 600.9506 1,799.83 1,800.84 3
 SAMPLE 1R Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 6 13.20% IKDPDASKPEDWDER 95.00% 2.36 0.122 1 600.9506 1,799.83 1,800.84 3
 SAMPLE 1R Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 6 13.20% IKDPDASKPEDWDER 95.00% 2.51 0.307 0 601.2855 1,800.83 1,800.84 3
 SAMPLE 1R Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 6 13.20% FYGDEEKDKGLQTSQDAR 95.00% 4.67 0.524 1.42 696.6611 2,086.96 2,086.97 3 GRP75_HUMAN
 SAMPLE 1R Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 6 13.20% FYGDEEKDKGLQTSQDAR 95.00% 4.41 0.443 2.15 696.6622 2,086.96 2,086.97 3 GRP75_HUMAN
 SAMPLE 1R Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 6 13.20% IDNSQVESGSLEDDWDFLPPKK 95.00% 4.2 0.46 1.8 840.7356 2,519.18 2,519.19 3
 SAMPLE 1R Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 6 13.20% IDNSQVESGSLEDDWDFLPPKK 95.00% 4.2 0.537 1.92 840.7358 2,519.18 2,519.19 3
 SAMPLE 3R Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 2 13.20% IKDPDASKPEDWDER 95.00% 2.28 0.19 1.03 601.2848 1,800.83 1,800.84 3
 SAMPLE 3R Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 2 13.20% FYGDEEKDKGLQTSQDAR 95.00% 4.04 0.509 3.49 696.6609 2,086.96 2,086.97 3 GRP75_HUMAN
 SAMPLE 3R Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 2 13.20% FYGDEEKDKGLQTSQDAR 95.00% 4.52 0.456 1.66 696.6622 2,086.96 2,086.97 3 GRP75_HUMAN
 SAMPLE 3R Calreticulin  CALR  CALR_HUMAN 48,124.90 99.80% 2 2 2 13.20% IDNSQVESGSLEDDWDFLPPKK 95.00% 4.05 0.457 1.2 840.7338 2,519.18 2,519.19 3
 SAMPLE 1 Carbonyl reductase [NADPH] 1  CBR1  CBR1_HUMAN 30,356.80 99.80% 2 2 3 8.66% FHQLDIDDLQSIR 95.00% 3.46 0.307 0 533.9418 1,598.80 1,599.81 3
 SAMPLE 1 Carbonyl reductase [NADPH] 1  CBR1  CBR1_HUMAN 30,356.80 99.80% 2 2 3 8.66% LFSGDVVLTAR 95.00% 2.94 0.293 1.85 589.3305 1,176.65 1,177.66 2
 SAMPLE 1 Carbonyl reductase [NADPH] 1  CBR1  CBR1_HUMAN 30,356.80 99.80% 2 2 3 8.66% LFSGDVVLTAR 95.00% 3.41 0.388 1.72 589.3311 1,176.65 1,177.66 2
 SAMPLE 3 Carbonyl reductase [NADPH] 1  CBR1  CBR1_HUMAN 30,356.80 99.80% 2 2 3 7.94% LFSGDVVLTAR 95.00% 2.79 0.352 2.04 589.3294 1,176.64 1,177.66 2
 SAMPLE 3 Carbonyl reductase [NADPH] 1  CBR1  CBR1_HUMAN 30,356.80 99.80% 2 2 3 7.94% LFSGDVVLTAR 95.00% 3.06 0.446 2.7 589.3311 1,176.65 1,177.66 2
 SAMPLE 3 Carbonyl reductase [NADPH] 1  CBR1  CBR1_HUMAN 30,356.80 99.80% 2 2 3 7.94% VVNVSSIMSVR 95.00% 2.63 0.432 1.19 595.8294 1,189.64 1,190.66 2
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% WLAYSYASTHR 95.00% 2.38 0.279 0 452.2258 1,353.65 1,354.65 3
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% ITDFQLHASTVK 95.00% 2.09 0.397 0 453.9141 1,358.72 1,359.73 3
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% ITDFQLHASTVK 95.00% 2.67 0.441 0 453.9149 1,358.72 1,359.73 3
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% FTGVITQGR 95.00% 3.24 0.45 1.62 489.771 977.5263 978.5374 2 AEBP1_HUMAN
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% FTGVITQGR 95.00% 3.14 0.462 2.06 489.7718 977.5279 978.5374 2 AEBP1_HUMAN
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% ESLIVFMEQVHR 95.00% 2.34 0.233 0 496.5931 1,486.76 1,487.77 3
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% TQEHTPTPDDHVFR 95.00% 4.05 0.603 1.39 560.5965 1,678.77 1,679.78 3
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% TQEHTPTPDDHVFR 95.00% 3.71 0.62 2.7 560.5967 1,678.77 1,679.78 3
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% EScPPLGLETLK 95.00% 2.79 0.436 0 c3: Carbamidomethyl (+57.02) 672.3469 1,342.68 1,343.69 2
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% EScPPLGLETLK 95.00% 2.44 0.421 0 c3: Carbamidomethyl (+57.02) 672.3477 1,342.68 1,343.69 2
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% NDLQQWIEVDAR 95.00% 2.9 0.365 0 743.8662 1,485.72 1,486.73 2
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% NDLQQWIEVDAR 95.00% 4.43 0.512 2.44 743.8679 1,485.72 1,486.73 2
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% TQEHTPTPDDHVFR 95.00% 3.54 0.559 2.09 840.3907 1,678.77 1,679.78 2
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% TQEHTPTPDDHVFR 95.00% 3.54 0.523 2.03 840.3912 1,678.77 1,679.78 2
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% GIPNAIISVEGINHDIR 95.00% 4.58 0.535 5.47 909.4972 1,816.98 1,817.99 2
 SAMPLE 1 Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 7 8 14 13.10% GIPNAIISVEGINHDIR 95.00% 5.26 0.532 5.77 909.9961 1,817.98 1,817.99 2
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% ITDFQLHASTVK 95.00% 2.37 0.407 0 453.9149 1,358.72 1,359.73 3
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% ITDFQLHASTVK 95.00% 2.33 0.465 0 454.2487 1,359.72 1,359.73 3
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% FTGVITQGR 95.00% 2.81 0.35 1.44 489.7695 977.5233 978.5374 2 AEBP1_HUMAN
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% FTGVITQGR 95.00% 2.53 0.353 1.64 489.7711 977.5266 978.5374 2 AEBP1_HUMAN
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% FTGVITQGR 95.00% 2.56 0.381 1.6 489.7714 977.5271 978.5374 2 AEBP1_HUMAN
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% NDLQQWIEVDARR 95.00% 2.42 0.436 0 548.2798 1,641.82 1,642.83 3
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% EIPVLNELPVPMVAR 95.00% 2.45 0.412 0 559.9847 1,676.93 1,676.94 3
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% TQEHTPTPDDHVFR 95.00% 4.02 0.625 1.38 560.5958 1,678.76 1,679.78 3
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% TQEHTPTPDDHVFR 95.00% 4.04 0.6 2.41 560.5965 1,678.77 1,679.78 3
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% EScPPLGLETLK 95.00% 2.21 0.244 0 c3: Carbamidomethyl (+57.02) 672.3459 1,342.68 1,343.69 2
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% NDLQQWIEVDAR 95.00% 4.16 0.475 2.82 743.8675 1,485.72 1,486.73 2
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% NDLQQWIEVDAR 95.00% 4.05 0.509 3.89 743.8681 1,485.72 1,486.73 2
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% NSLWLSDWVTSYK 95.00% 2.29 0.349 1.31 799.8946 1,597.77 1,598.79 2
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% EIPVLNELPVPMVAR 95.00% 4.53 0.531 3.82 838.9732 1,675.93 1,676.94 2
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% EIPVLNELPVPMVAR 95.00% 4.47 0.529 4.22 839.4757 1,676.94 1,676.94 2
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% TQEHTPTPDDHVFR 95.00% 3.46 0.523 0 840.3926 1,678.77 1,679.78 2
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% TQEHTPTPDDHVFR 95.00% 3.9 0.549 2.51 840.896 1,679.78 1,679.78 2
 SAMPLE 1R Carboxypeptidase-like protein X2  CPXM2  CPXM2_HUMAN 85,880.80 100.00% 8 10 15 13.90% GIPNAIISVEGINHDIR 95.00% 4.66 0.517 4.55 910 1,817.98 1,817.99 2
 SAMPLE 1 Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 4 5 7 8.06% AVAEPGIQLK 95.00% 2.24 0.316 1.64 513.3021 1,024.59 1,025.60 2
 SAMPLE 1 Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 4 5 7 8.06% NALWHTGDTESQVR 95.00% 2.24 0.336 0 538.593 1,612.76 1,613.77 3
 SAMPLE 1 Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 4 5 7 8.06% ELQETNAALQDVR 95.00% 4.24 0.481 2.82 743.8783 1,485.74 1,486.75 2
 SAMPLE 1 Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 4 5 7 8.06% NALWHTGDTESQVR 95.00% 3.37 0.592 5.05 807.386 1,612.76 1,613.77 2
 SAMPLE 1 Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 4 5 7 8.06% NALWHTGDTESQVR 95.00% 3.93 0.576 4.03 807.8876 1,613.76 1,613.77 2
 SAMPLE 1 Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 4 5 7 8.06% VPNSDQKDSDGDGIGDAcDNcPQK 95.00% 7.49 0.66 3.7 c18: Carbamidomethyl (+57.02), c21: Carbamidomethyl (+57.02) 865.0254 2,592.05 2,592.06 3
 SAMPLE 1 Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 4 5 7 8.06% VPNSDQKDSDGDGIGDAcDNcPQK 95.00% 6.71 0.601 5.25 c18: Carbamidomethyl (+57.02), c21: Carbamidomethyl (+57.02) 865.0265 2,592.06 2,592.06 3
 SAMPLE 1R Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 3 4 6 6.74% NALWHTGDTESQVR 95.00% 2.16 0.327 0 538.5933 1,612.76 1,613.77 3
 SAMPLE 1R Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 3 4 6 6.74% ELQETNAALQDVR 95.00% 3.87 0.461 2.82 743.878 1,485.74 1,486.75 2
 SAMPLE 1R Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 3 4 6 6.74% NALWHTGDTESQVR 95.00% 2.91 0.575 3.89 807.3864 1,612.76 1,613.77 2
 SAMPLE 1R Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 3 4 6 6.74% VPNSDQKDSDGDGIGDAcDNcPQK 95.00% 6.63 0.635 4.43 c18: Carbamidomethyl (+57.02), c21: Carbamidomethyl (+57.02) 865.0247 2,592.05 2,592.06 3
 SAMPLE 1R Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 3 4 6 6.74% VPNSDQKDSDGDGIGDAcDNcPQK 95.00% 7.28 0.644 3.1 c18: Carbamidomethyl (+57.02), c21: Carbamidomethyl (+57.02) 865.0256 2,592.05 2,592.06 3
 SAMPLE 1R Cartilage oligomeric matrix protein  COMP  COMP_HUMAN 82,840.00 100.00% 3 4 6 6.74% VPNSDQKDSDGDGIGDAcDNcPQK 95.00% 5.94 0.588 2.85 c18: Carbamidomethyl (+57.02), c21: Carbamidomethyl (+57.02) 865.0256 2,592.05 2,592.06 3
 SAMPLE 1 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 3 3 11 8.98% LSPEDYTLK 95.00% 1.66 0.417 0 533.2792 1,064.54 1,065.55 2
 SAMPLE 1 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 3 3 11 8.98% FDGILGMAYPR 95.00% 3.79 0.51 3.44 620.3116 1,238.61 1,239.62 2
 SAMPLE 1 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 3 3 11 8.98% FDGILGMAYPR 95.00% 3.47 0.44 2.92 620.3119 1,238.61 1,239.62 2
 SAMPLE 1 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 3 3 11 8.98% FDGILGMAYPR 95.00% 3.47 0.482 3.02 620.3173 1,238.62 1,239.62 2
 SAMPLE 1 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 3 3 11 8.98% FDGILGMAYPR 95.00% 3.51 0.495 2.55 620.3235 1,238.63 1,239.62 2
 SAMPLE 1 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 3 3 11 8.98% FDGILGMAYPR 95.00% 2.64 0.372 2.92 620.3237 1,238.63 1,239.62 2
 SAMPLE 1 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 3 3 11 8.98% ISVNNVLPVFDNLmQQK 95.00% 4.04 0.547 4.21 m14: Oxidation (+15.99) 988.041 1,974.07 1,975.03 2
 SAMPLE 1 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 3 3 11 8.98% ISVNNVLPVFDNLmQQK 95.00% 4 0.519 3.14 m14: Oxidation (+15.99) 988.5181 1,975.02 1,975.03 2
 SAMPLE 1 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 3 3 11 8.98% ISVNNVLPVFDNLmQQK 95.00% 3.75 0.504 3.85 m14: Oxidation (+15.99) 988.5182 1,975.02 1,975.03 2
 SAMPLE 1 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 3 3 11 8.98% ISVNNVLPVFDNLmQQK 95.00% 4.68 0.487 4.54 m14: Oxidation (+15.99) 988.5188 1,975.02 1,975.03 2
 SAMPLE 1 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 3 3 11 8.98% ISVNNVLPVFDNLmQQK 95.00% 2.88 0.263 1.34 m14: Oxidation (+15.99) 988.542 1,975.07 1,975.03 2
 SAMPLE 1R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 9 14.30% FDGILGMAYPR 95.00% 3.47 0.482 3.02 620.3173 1,238.62 1,239.62 2
 SAMPLE 1R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 9 14.30% FDGILGMAYPR 95.00% 3.54 0.448 3.96 620.325 1,238.63 1,239.62 2
 SAMPLE 1R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 9 14.30% LVDQNIFSFYLSR 95.00% 3.96 0.436 2.96 801.4322 1,600.85 1,601.83 2
 SAMPLE 1R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 9 14.30% LVDQNIFSFYLSR 95.00% 4.27 0.491 2.43 801.9169 1,601.82 1,601.83 2
 SAMPLE 1R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 9 14.30% ISVNNVLPVFDNLMQQK 95.00% 2.59 0.192 2.57 980.5431 1,959.07 1,959.04 2
 SAMPLE 1R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 9 14.30% ISVNNVLPVFDNLmQQK 95.00% 4 0.519 3.24 m14: Oxidation (+15.99) 988.5181 1,975.02 1,975.03 2
 SAMPLE 1R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 9 14.30% ISVNNVLPVFDNLmQQK 95.00% 4.69 0.548 4.13 m14: Oxidation (+15.99) 988.5412 1,975.07 1,975.03 2
 SAMPLE 1R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 9 14.30% ISVNNVLPVFDNLmQQK 95.00% 3.71 0.552 4.1 m14: Oxidation (+15.99) 988.5418 1,975.07 1,975.03 2
 SAMPLE 1R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 9 14.30% AIGAVPLIQGEYmIPcEK 95.00% 3.91 0.6 4.74 m13: Oxidation (+15.99), c16: Carbamidomethyl (+57.02) 1,003.53 2,005.05 2,005.01 2
 SAMPLE 2 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 6 14.10% FDGILGMAYPR 95.00% 3.89 0.494 3.37 620.312 1,238.61 1,239.62 2
 SAMPLE 2 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 6 14.10% QVFGEATKQPGITFIAAK 95.00% 2.82 0.418 0 636.3525 1,906.03 1,906.04 3
 SAMPLE 2 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 6 14.10% YYTVFDRDNNR 95.00% 2.36 0.229 0 731.8366 1,461.66 1,462.67 2
 SAMPLE 2 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 6 14.10% YYTVFDRDNNR 95.00% 2.38 0.265 0 731.8366 1,461.66 1,462.67 2
 SAMPLE 2 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 6 14.10% DPDAQPGGELMLGGTDSK 95.00% 3.03 0.466 2.19 894.9095 1,787.80 1,787.81 2
 SAMPLE 2 Cathepsin D  CTSD  CATD_HUMAN 44,535.00 100.00% 4 4 6 14.10% DPDAQPGGELMLGGTDSK 95.00% 4.27 0.589 4.47 894.9096 1,787.80 1,787.81 2
 SAMPLE 2R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 99.80% 2 2 4 7.04% FDGILGMAYPR 95.00% 3.69 0.508 3.82 620.3123 1,238.61 1,239.62 2
 SAMPLE 2R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 99.80% 2 2 4 7.04% FDGILGMAYPR 95.00% 3.63 0.483 3.34 620.3128 1,238.61 1,239.62 2
 SAMPLE 2R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 99.80% 2 2 4 7.04% QVFGEATKQPGITFIAAK 95.00% 2.43 0.332 1.16 636.3525 1,906.03 1,906.04 3
 SAMPLE 2R Cathepsin D  CTSD  CATD_HUMAN 44,535.00 99.80% 2 2 4 7.04% QVFGEATKQPGITFIAAK 95.00% 2.45 0.257 0 636.3529 1,906.04 1,906.04 3
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% IFGSYDPR 95.00% 1.9 0.306 1.7 477.7387 953.4618 954.4686 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% IFGSYDPR 95.00% 2.37 0.45 1.89 477.7394 953.4631 954.4686 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% IFGSYDPR 95.00% 2.03 0.345 1.15 477.7401 953.4646 954.4686 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% NVNPVALPR 95.00% 2.17 0.417 1.49 490.2871 978.5586 979.5689 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% NVNPVALPR 95.00% 1.59 0.32 1.54 490.2895 978.5633 979.5689 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% VSSFLPWIR 95.00% 2.85 0.339 0 552.8141 1,103.61 1,104.62 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% VSSFLPWIR 95.00% 3.09 0.402 0 552.8153 1,103.61 1,104.62 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% VSSFLPWIR 95.00% 2.38 0.393 1.27 552.8154 1,103.62 1,104.62 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% VSSFLPWIR 95.00% 2.01 0.337 0 552.8155 1,103.62 1,104.62 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% VSSFLPWIR 95.00% 3.19 0.398 1.38 552.8155 1,103.62 1,104.62 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% VSSFLPWIR 95.00% 2.73 0.335 0 552.8155 1,103.62 1,104.62 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% VSSFLPWIR 95.00% 2.97 0.415 1.55 552.8156 1,103.62 1,104.62 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% VSSFLPWIR 95.00% 2.93 0.393 1.27 552.8164 1,103.62 1,104.62 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% VSSFLPWIR 95.00% 2.64 0.334 0 552.8171 1,103.62 1,104.62 2
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% AQEGLRPGTLcTVAGWGR 95.00% 3.62 0.482 0 c11: Carbamidomethyl (+57.02) 643.6659 1,927.97 1,928.98 3
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% AQEGLRPGTLcTVAGWGR 95.00% 3.75 0.613 2.47 c11: Carbamidomethyl (+57.02) 643.6664 1,927.98 1,928.98 3
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% AQEGLRPGTLcTVAGWGR 95.00% 3.7 0.48 1.72 c11: Carbamidomethyl (+57.02) 643.9994 1,928.97 1,928.98 3
 SAMPLE 4 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 18 17.30% AQEGLRPGTLcTVAGWGR 95.00% 3.02 0.442 1.28 c11: Carbamidomethyl (+57.02) 643.9998 1,928.98 1,928.98 3
 SAMPLE 4R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 3 3 7 14.90% IFGSYDPR 95.00% 1.91 0.299 1.32 477.7389 953.4622 954.4686 2
 SAMPLE 4R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 3 3 7 14.90% IFGSYDPR 95.00% 2.19 0.353 0 477.7396 953.4636 954.4686 2
 SAMPLE 4R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 3 3 7 14.90% VSSFLPWIR 95.00% 2.52 0.355 0 552.816 1,103.62 1,104.62 2
 SAMPLE 4R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 3 3 7 14.90% VSSFLPWIR 95.00% 2.51 0.324 0 552.8164 1,103.62 1,104.62 2
 SAMPLE 4R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 3 3 7 14.90% VSSFLPWIR 95.00% 2.33 0.304 1.37 552.817 1,103.62 1,104.62 2
 SAMPLE 4R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 3 3 7 14.90% VSSFLPWIR 95.00% 2.34 0.323 0 553.3186 1,104.62 1,104.62 2
 SAMPLE 4R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 3 3 7 14.90% GDSGGPLLcNNVAHGIVSYGK 95.00% 2.38 0.291 0 c9: Carbamidomethyl (+57.02) 706.017 2,115.03 2,115.03 3
 SAMPLE 1 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 99.80% 2 2 6 12.20% AQEGLRPGTLcTVAGWGR 95.00% 3.57 0.541 1.34 c11: Carbamidomethyl (+57.02) 643.996 1,928.96 1,928.98 3
 SAMPLE 1 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 99.80% 2 2 6 12.20% AQEGLRPGTLcTVAGWGR 95.00% 3.25 0.394 1.29 c11: Carbamidomethyl (+57.02) 643.9971 1,928.97 1,928.98 3
 SAMPLE 1 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 99.80% 2 2 6 12.20% TIQNDIMLLQLSR 95.00% 3.65 0.479 2.52 772.9226 1,543.83 1,544.85 2
 SAMPLE 1 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 99.80% 2 2 6 12.20% TIQNDIMLLQLSR 95.00% 3.29 0.486 2.64 772.9289 1,543.84 1,544.85 2
 SAMPLE 1 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 99.80% 2 2 6 12.20% TIQNDIMLLQLSR 95.00% 4.22 0.463 3.25 772.9383 1,543.86 1,544.85 2
 SAMPLE 1 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 99.80% 2 2 6 12.20% TIQNDIMLLQLSR 95.00% 4.18 0.338 1.72 773.425 1,544.83 1,544.85 2
 SAMPLE 1R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 99.80% 2 2 4 8.63% VSSFLPWIR 95.00% 2.53 0.385 0 552.813 1,103.61 1,104.62 2
 SAMPLE 1R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 99.80% 2 2 4 8.63% VSSFLPWIR 95.00% 2.79 0.35 0 552.8252 1,103.63 1,104.62 2
 SAMPLE 1R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 99.80% 2 2 4 8.63% TIQNDIMLLQLSR 95.00% 4.22 0.463 2.89 772.9383 1,543.86 1,544.85 2
 SAMPLE 1R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 99.80% 2 2 4 8.63% TIQNDIMLLQLSR 95.00% 4.18 0.338 2.47 773.425 1,544.83 1,544.85 2
 SAMPLE 2 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 5 5 12 22.40% IFGSYDPR 95.00% 2.5 0.321 1.25 477.7368 953.458 954.4686 2
 SAMPLE 2 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 5 5 12 22.40% IFGSYDPR 95.00% 2.53 0.438 1.17 477.7372 953.4588 954.4686 2
 SAMPLE 2 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 5 5 12 22.40% NVNPVALPR 95.00% 1.98 0.213 2.31 490.2872 978.5588 979.5689 2
 SAMPLE 2 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 5 5 12 22.40% NVNPVALPR 95.00% 1.73 0.311 0 490.2876 978.5595 979.5689 2
 SAMPLE 2 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 5 5 12 22.40% NVNPVALPR 95.00% 1.9 0.292 1.64 490.2876 978.5595 979.5689 2
 SAMPLE 2 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 5 5 12 22.40% NVNPVALPR 95.00% 1.67 0.3 1.15 490.2882 978.5607 979.5689 2
 SAMPLE 2 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 5 5 12 22.40% NVNPVALPR 95.00% 1.55 0.27 1.2 490.2891 978.5625 979.5689 2
 SAMPLE 2 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 5 5 12 22.40% VSSFLPWIR 95.00% 2.32 0.273 0 552.8135 1,103.61 1,104.62 2
 SAMPLE 2 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 5 5 12 22.40% VSSFLPWIR 95.00% 2.68 0.332 1.39 552.8141 1,103.61 1,104.62 2
 SAMPLE 2 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 5 5 12 22.40% AQEGLRPGTLcTVAGWGR 95.00% 4.17 0.565 1.72 c11: Carbamidomethyl (+57.02) 643.9964 1,928.97 1,928.98 3
 SAMPLE 2 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 5 5 12 22.40% AQEGLRPGTLcTVAGWGR 95.00% 4.71 0.615 2.13 c11: Carbamidomethyl (+57.02) 643.9973 1,928.97 1,928.98 3
 SAMPLE 2 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 5 5 12 22.40% TIQNDIMLLQLSR 95.00% 3.64 0.428 3.48 772.9272 1,543.84 1,544.85 2
 SAMPLE 2R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 6 17.30% IFGSYDPR 95.00% 1.93 0.361 2.06 477.7375 953.4593 954.4686 2
 SAMPLE 2R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 6 17.30% NVNPVALPR 95.00% 1.86 0.321 1.59 490.2863 978.557 979.5689 2
 SAMPLE 2R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 6 17.30% NVNPVALPR 95.00% 1.74 0.338 0 490.287 978.5583 979.5689 2
 SAMPLE 2R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 6 17.30% VSSFLPWIR 95.00% 2.18 0.285 0 552.8127 1,103.61 1,104.62 2
 SAMPLE 2R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 6 17.30% VSSFLPWIR 95.00% 2.3 0.243 0 552.8133 1,103.61 1,104.62 2
 SAMPLE 2R Cathepsin G  CTSG  CATG_HUMAN 28,819.50 100.00% 4 4 6 17.30% AQEGLRPGTLcTVAGWGR 95.00% 3.51 0.254 2.64 c11: Carbamidomethyl (+57.02) 965.4881 1,928.96 1,928.98 2
 SAMPLE 3 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 99.80% 2 2 2 11.80% NVNPVALPR 95.00% 1.65 0.365 0 490.2863 978.557 979.5689 2
 SAMPLE 3 Cathepsin G  CTSG  CATG_HUMAN 28,819.50 99.80% 2 2 2 11.80% GDSGGPLLcNNVAHGIVSYGK 95.00% 1.69 0.0917 3.32 c9: Carbamidomethyl (+57.02) 1,058.45 2,114.88 2,115.03 2
 SAMPLE 3R Caveolin-1  CAV1  CAV1_HUMAN 20,454.20 99.80% 2 2 2 15.20% IFSNVRINLQKEI 95.00% 1.82 0.275 0 525.7657 1,574.27 1,573.91 3
 SAMPLE 3R Caveolin-1  CAV1  CAV1_HUMAN 20,454.20 99.80% 2 2 2 15.20% YVDSEGHLYTVPIR 95.00% 1.76 0.286 0 550.2803 1,647.82 1,648.83 3
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% RNFVLTAAHcAGR 95.00% 3.21 0.408 0 c10: Carbamidomethyl (+57.02) 491.5907 1,471.75 1,472.75 3
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% RNFVLTAAHcAGR 95.00% 2.85 0.288 1.13 c10: Carbamidomethyl (+57.02) 491.5919 1,471.75 1,472.75 3
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% TGVLKPGSDTLQEVK 95.00% 3.17 0.488 0 524.6275 1,570.86 1,571.86 3
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% TGVLKPGSDTLQEVK 95.00% 3.59 0.424 0 524.6276 1,570.86 1,571.86 3
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% TGVLKPGSDTLQEVK 95.00% 4.16 0.468 0 524.6282 1,570.86 1,571.86 3
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% TGVLKPGSDTLQEVK 95.00% 2.98 0.383 1.54 524.6286 1,570.86 1,571.86 3
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% NFVLTAAHcAGR 95.00% 3.22 0.395 1.55 c9: Carbamidomethyl (+57.02) 658.8313 1,315.65 1,316.65 2
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% NFVLTAAHcAGR 95.00% 3.19 0.35 2.66 c9: Carbamidomethyl (+57.02) 658.8317 1,315.65 1,316.65 2
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% NFVLTAAHcAGR 95.00% 3.14 0.354 2.92 c9: Carbamidomethyl (+57.02) 658.8325 1,315.65 1,316.65 2
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% NFVLTAAHcAGR 95.00% 3.14 0.373 2.74 c9: Carbamidomethyl (+57.02) 658.833 1,315.65 1,316.65 2
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% TGVLKPGSDTLQEVK 95.00% 3.63 0.362 2.16 786.4359 1,570.86 1,571.86 2
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% TGVLKPGSDTLQEVK 95.00% 3.61 0.324 1.92 786.4375 1,570.86 1,571.86 2
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% TGVLKPGSDTLQEVK 95.00% 3.49 0.347 1.68 786.4377 1,570.86 1,571.86 2
 SAMPLE 4 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 14 11.30% TGVLKPGSDTLQEVK 95.00% 3.48 0.327 0 786.4384 1,570.86 1,571.86 2
 SAMPLE 4R Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 11 10.90% TGVLKPGSDTLQEVK 95.00% 2.83 0.313 0 524.6271 1,570.86 1,571.86 3
 SAMPLE 4R Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 11 10.90% TGVLKPGSDTLQEVK 95.00% 3.69 0.475 1.15 524.6276 1,570.86 1,571.86 3
 SAMPLE 4R Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 11 10.90% TGVLKPGSDTLQEVK 95.00% 3.8 0.448 1.92 524.6277 1,570.86 1,571.86 3
 SAMPLE 4R Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 11 10.90% TGVLKPGSDTLQEVK 95.00% 2.58 0.33 0 524.6282 1,570.86 1,571.86 3
 SAMPLE 4R Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 11 10.90% NFVLTAAHcAGR 95.00% 2.99 0.381 1.48 c9: Carbamidomethyl (+57.02) 658.8321 1,315.65 1,316.65 2
 SAMPLE 4R Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 11 10.90% NFVLTAAHcAGR 95.00% 2.91 0.358 1.68 c9: Carbamidomethyl (+57.02) 658.8324 1,315.65 1,316.65 2
 SAMPLE 4R Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 11 10.90% NFVLTAAHcAGR 95.00% 3.04 0.345 0 c9: Carbamidomethyl (+57.02) 658.8325 1,315.65 1,316.65 2
 SAMPLE 4R Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 11 10.90% NFVLTAAHcAGR 95.00% 3.17 0.36 3.21 c9: Carbamidomethyl (+57.02) 658.8329 1,315.65 1,316.65 2
 SAMPLE 4R Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 11 10.90% TGVLKPGSDTLQEVK 95.00% 3.64 0.402 1.59 786.4361 1,570.86 1,571.86 2
 SAMPLE 4R Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 11 10.90% TGVLKPGSDTLQEVK 95.00% 3.32 0.324 1.72 786.4375 1,570.86 1,571.86 2
 SAMPLE 4R Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 11 10.90% TGVLKPGSDTLQEVK 95.00% 3.49 0.349 1.8 786.4386 1,570.86 1,571.86 2
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% FcGGFLIR 95.00% 2.48 0.446 1.49 c2: Carbamidomethyl (+57.02) 485.2512 968.4867 969.4982 2 RS8_HUMAN,TITIN_HUMAN
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% FcGGFLIR 95.00% 2.23 0.387 1.11 c2: Carbamidomethyl (+57.02) 485.2528 968.49 969.4982 2 RS8_HUMAN,TITIN_HUMAN
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% FcGGFLIR 95.00% 2.24 0.459 2.02 c2: Carbamidomethyl (+57.02) 485.2573 968.4989 969.4982 2 RS8_HUMAN,TITIN_HUMAN
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% FcGGFLIR 95.00% 2.58 0.486 2.48 c2: Carbamidomethyl (+57.02) 485.2582 968.5008 969.4982 2 RS8_HUMAN,TITIN_HUMAN
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% TGVLKPGSDTLQEVK 95.00% 2.1 0.345 0 524.6254 1,570.85 1,571.86 3
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% TGVLKPGSDTLQEVK 95.00% 3.74 0.466 1.39 524.6291 1,570.86 1,571.86 3
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% TGVLKPGSDTLQEVK 95.00% 2.36 0.355 0 524.9597 1,571.86 1,571.86 3
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% ISHYRPWINQILQAN 95.00% 2.49 0.206 0 618.3307 1,851.97 1,852.98 3
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% NFVLTAAHcAGR 95.00% 3.77 0.399 2.85 c9: Carbamidomethyl (+57.02) 658.8293 1,315.64 1,316.65 2
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% NFVLTAAHcAGR 95.00% 3.55 0.385 2.46 c9: Carbamidomethyl (+57.02) 658.8305 1,315.65 1,316.65 2
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% NFVLTAAHcAGR 95.00% 3.58 0.378 1.8 c9: Carbamidomethyl (+57.02) 658.8319 1,315.65 1,316.65 2
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% GDSGGPLLcAGVAQGIVSYGR 95.00% 5.71 0.709 8.42 c9: Carbamidomethyl (+57.02) 1,018.00 2,033.99 2,034.01 2
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% GDSGGPLLcAGVAQGIVSYGR 95.00% 4.78 0.612 7.92 c9: Carbamidomethyl (+57.02) 1,018.01 2,034.00 2,034.01 2
 SAMPLE 1 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 4 4 10 28.70% GDSGGPLLcAGVAQGIVSYGR 95.00% 5.27 0.67 7.74 c9: Carbamidomethyl (+57.02) 1,018.02 2,034.02 2,034.01 2
 SAMPLE 1R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 3 5 22.70% FcGGFLIR 95.00% 2.24 0.459 2 c2: Carbamidomethyl (+57.02) 485.2573 968.4989 969.4982 2 RS8_HUMAN,TITIN_HUMAN
 SAMPLE 1R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 3 5 22.70% FcGGFLIR 95.00% 2.58 0.486 2.24 c2: Carbamidomethyl (+57.02) 485.2582 968.5008 969.4982 2 RS8_HUMAN,TITIN_HUMAN
 SAMPLE 1R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 3 5 22.70% TGVLKPGSDTLQEVK 95.00% 3.74 0.466 2.52 524.6291 1,570.86 1,571.86 3
 SAMPLE 1R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 3 5 22.70% NFVLTAAHcAGR 95.00% 3.58 0.378 1.51 c9: Carbamidomethyl (+57.02) 658.8319 1,315.65 1,316.65 2
 SAMPLE 1R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 3 5 22.70% GDSGGPLLcAGVAQGIVSYGR 95.00% 4.78 0.612 7.77 c9: Carbamidomethyl (+57.02) 1,018.01 2,034.00 2,034.01 2
 SAMPLE 1R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 3 5 22.70% GDSGGPLLcAGVAQGIVSYGR 95.00% 5.27 0.67 4.68 c9: Carbamidomethyl (+57.02) 1,018.02 2,034.02 2,034.01 2
 SAMPLE 1R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 3 5 22.70% GDSGGPLLcAGVAQGIVSYGR 95.00% 5.49 0.619 7.92 c9: Carbamidomethyl (+57.02) 1,018.03 2,034.04 2,034.01 2
 SAMPLE 2 Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 8 14.20% FcGGFLIR 95.00% 1.67 0.279 1.57 c2: Carbamidomethyl (+57.02) 485.89 969.7644 969.4982 2 RS8_HUMAN,TITIN_HUMAN
 SAMPLE 2 Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 8 14.20% TGVLKPGSDTLQEVK 95.00% 2.38 0.216 0 524.6252 1,570.85 1,571.86 3
 SAMPLE 2 Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 8 14.20% TGVLKPGSDTLQEVK 95.00% 2.09 0.245 0 524.6253 1,570.85 1,571.86 3
 SAMPLE 2 Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 8 14.20% TGVLKPGSDTLQEVK 95.00% 3.96 0.438 1.17 524.6255 1,570.85 1,571.86 3
 SAMPLE 2 Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 8 14.20% TGVLKPGSDTLQEVK 95.00% 4.37 0.405 1.51 524.9605 1,571.86 1,571.86 3
 SAMPLE 2 Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 8 14.20% NFVLTAAHcAGR 95.00% 3.5 0.397 4.03 c9: Carbamidomethyl (+57.02) 658.8294 1,315.64 1,316.65 2
 SAMPLE 2 Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 8 14.20% NFVLTAAHcAGR 95.00% 3.53 0.37 2.92 c9: Carbamidomethyl (+57.02) 659.3297 1,316.64 1,316.65 2
 SAMPLE 2 Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 8 14.20% TGVLKPGSDTLQEVK 95.00% 3.95 0.341 2.24 786.4336 1,570.85 1,571.86 2
 SAMPLE 2 Chymase  CMA1  CMA1_HUMAN 27,307.50 99.80% 2 3 8 14.20% TGVLKPGSDTLQEVK 95.00% 4.08 0.414 2.96 786.435 1,570.85 1,571.86 2
 SAMPLE 2R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 8 15.40% TGVLKPGSDTLQEVK 95.00% 2.29 0.212 0 524.6237 1,570.85 1,571.86 3
 SAMPLE 2R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 8 15.40% TGVLKPGSDTLQEVK 95.00% 4.24 0.444 2.3 524.6257 1,570.85 1,571.86 3
 SAMPLE 2R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 8 15.40% TGVLKPGSDTLQEVK 95.00% 3.98 0.39 1.74 524.9614 1,571.86 1,571.86 3
 SAMPLE 2R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 8 15.40% SDAKPPAVFTR 95.00% 2.19 0.344 0 594.8215 1,187.63 1,188.64 2
 SAMPLE 2R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 8 15.40% NFVLTAAHcAGR 95.00% 3.55 0.416 2.55 c9: Carbamidomethyl (+57.02) 658.8291 1,315.64 1,316.65 2
 SAMPLE 2R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 8 15.40% NFVLTAAHcAGR 95.00% 3.38 0.423 2.36 c9: Carbamidomethyl (+57.02) 658.8293 1,315.64 1,316.65 2
 SAMPLE 2R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 8 15.40% TGVLKPGSDTLQEVK 95.00% 3.76 0.289 2.49 786.9364 1,571.86 1,571.86 2
 SAMPLE 2R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 3 4 8 15.40% TGVLKPGSDTLQEVK 95.00% 3.9 0.316 2.19 786.9372 1,571.86 1,571.86 2
 SAMPLE 3 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 2 3 6 10.90% TGVLKPGSDTLQEVK 95.00% 4.3 0.456 1.09 524.624 1,570.85 1,571.86 3
 SAMPLE 3 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 2 3 6 10.90% TGVLKPGSDTLQEVK 95.00% 4.05 0.435 0 524.6255 1,570.85 1,571.86 3
 SAMPLE 3 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 2 3 6 10.90% TGVLKPGSDTLQEVK 95.00% 2.61 0.261 0 524.6256 1,570.85 1,571.86 3
 SAMPLE 3 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 2 3 6 10.90% NFVLTAAHcAGR 95.00% 3.63 0.374 3.39 c9: Carbamidomethyl (+57.02) 658.8291 1,315.64 1,316.65 2
 SAMPLE 3 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 2 3 6 10.90% TGVLKPGSDTLQEVK 95.00% 4.02 0.37 2.34 786.4324 1,570.85 1,571.86 2
 SAMPLE 3 Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 2 3 6 10.90% TGVLKPGSDTLQEVK 95.00% 3.83 0.37 1.8 786.4356 1,570.86 1,571.86 2
 SAMPLE 3R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 5 6 9 33.20% FcGGFLIR 95.00% 2.46 0.393 1.85 c2: Carbamidomethyl (+57.02) 485.2516 968.4876 969.4982 2 RS8_HUMAN,TITIN_HUMAN
 SAMPLE 3R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 5 6 9 33.20% FcGGFLIR 95.00% 1.85 0.346 2.15 c2: Carbamidomethyl (+57.02) 485.2526 968.4896 969.4982 2 RS8_HUMAN,TITIN_HUMAN
 SAMPLE 3R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 5 6 9 33.20% TGVLKPGSDTLQEVK 95.00% 3.79 0.494 1 524.6257 1,570.85 1,571.86 3
 SAMPLE 3R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 5 6 9 33.20% TGVLKPGSDTLQEVK 95.00% 3.69 0.503 1.09 524.6263 1,570.86 1,571.86 3
 SAMPLE 3R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 5 6 9 33.20% SDAKPPAVFTR 95.00% 1.96 0.246 1.24 594.8204 1,187.63 1,188.64 2
 SAMPLE 3R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 5 6 9 33.20% ISHYRPWINQILQAN 95.00% 2.39 0.178 0 618.3316 1,851.97 1,852.98 3
 SAMPLE 3R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 5 6 9 33.20% NFVLTAAHcAGR 95.00% 2.9 0.417 1.96 c9: Carbamidomethyl (+57.02) 658.8288 1,315.64 1,316.65 2
 SAMPLE 3R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 5 6 9 33.20% NFVLTAAHcAGR 95.00% 2.42 0.372 1.1 c9: Carbamidomethyl (+57.02) 658.8305 1,315.65 1,316.65 2
 SAMPLE 3R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 5 6 9 33.20% TGVLKPGSDTLQEVK 95.00% 3.87 0.314 1.24 786.4345 1,570.85 1,571.86 2
 SAMPLE 3R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 5 6 9 33.20% TGVLKPGSDTLQEVK 95.00% 3.73 0.389 1.8 786.437 1,570.86 1,571.86 2
 SAMPLE 3R Chymase  CMA1  CMA1_HUMAN 27,307.50 100.00% 5 6 9 33.20% GDSGGPLLcAGVAQGIVSYGR 95.00% 5.56 0.654 9.06 c9: Carbamidomethyl (+57.02) 1,018.00 2,033.99 2,034.01 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% KTLLSNLEEAKK 95.00% 3.18 0.172 0 458.6071 1,372.80 1,373.80 3
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% KTLLSNLEEAKK 95.00% 3.5 0.346 0 458.6089 1,372.80 1,373.80 3
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% YVNKEIQNAVNGVK 95.00% 2.39 0.232 0 525.9592 1,574.85 1,575.85 3
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% IDSLLENDR 95.00% 2.63 0.364 0 537.7764 1,073.54 1,074.54 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% IDSLLENDR 95.00% 2.39 0.229 0 537.7771 1,073.54 1,074.54 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% TLLSNLEEAK 95.00% 3.36 0.397 1.8 559.3069 1,116.60 1,117.61 2 MYH9_HUMAN,HP1B3_HUMAN,TITIN_HUMAN,MYH11_HUMAN,DESP_HUMAN
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% TLLSNLEEAK 95.00% 2.92 0.414 1.96 559.3072 1,116.60 1,117.61 2 MYH9_HUMAN,HP1B3_HUMAN,TITIN_HUMAN,MYH11_HUMAN,DESP_HUMAN
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% TLLSNLEEAKK 95.00% 3.17 0.337 0 623.3553 1,244.69 1,245.71 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% KTLLSNLEEAK 95.00% 3.49 0.334 2.96 623.356 1,244.70 1,245.71 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% TLLSNLEEAKK 95.00% 3.24 0.38 1.85 623.3561 1,244.70 1,245.71 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% KTLLSNLEEAK 95.00% 3.05 0.327 2.48 623.3572 1,244.70 1,245.71 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ELDESLQVAER 95.00% 2.35 0.313 0 644.8195 1,287.62 1,288.64 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ELDESLQVAER 95.00% 2.72 0.307 0 644.8203 1,287.62 1,288.64 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ELDESLQVAER 95.00% 3.07 0.343 1.15 644.8209 1,287.63 1,288.64 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ELDESLQVAER 95.00% 3.12 0.31 2.27 644.8223 1,287.63 1,288.64 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ELDESLQVAER 95.00% 3.09 0.326 0 644.8224 1,287.63 1,288.64 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ELDESLQVAER 95.00% 2.47 0.277 0 644.8246 1,287.63 1,288.64 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% EPQDTYHYLPFSLPHR 95.00% 2.8 0.418 0 667.3266 1,998.96 1,999.97 3
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% EPQDTYHYLPFSLPHR 95.00% 3.06 0.457 0 667.3321 1,998.97 1,999.97 3
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% EPQDTYHYLPFSLPHR 95.00% 2.6 0.359 0 667.6592 1,999.95 1,999.97 3
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% EPQDTYHYLPFSLPHR 95.00% 3.33 0.396 0 667.6604 1,999.96 1,999.97 3
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 2.94 0.395 1.82 696.7265 1,391.44 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 2.35 0.36 0 697.3492 1,392.68 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 3.26 0.46 1.8 697.3506 1,392.69 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 3.35 0.434 1.52 697.3509 1,392.69 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 3.38 0.387 1.25 697.351 1,392.69 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 3.82 0.459 1.89 697.3513 1,392.69 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 3.02 0.423 2.34 697.3518 1,392.69 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 3.15 0.371 1.51 697.3526 1,392.69 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 4.26 0.47 1.46 697.3564 1,392.70 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 3.33 0.474 2.26 697.3575 1,392.70 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 3.41 0.442 1.82 697.3648 1,392.71 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 3.1 0.432 1.7 697.3648 1,392.71 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 3.69 0.502 1.74 697.3654 1,392.72 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 3.78 0.431 1.8 697.3665 1,392.72 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% ASSIIDELFQDR 95.00% 2.21 0.338 0 697.8407 1,393.67 1,393.70 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.21 0.269 2.1 772.3975 2,314.17 2,314.18 3
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.76 0.343 2.66 772.3988 2,314.17 2,314.18 3
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.35 0.35 2.41 772.4015 2,314.18 2,314.18 3
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.11 0.251 1.82 772.4017 2,314.18 2,314.18 3
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.84 0.408 3.1 772.4093 2,314.20 2,314.18 3
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% YVNKEIQNAVNGVK 95.00% 3.4 0.472 1.72 788.4275 1,574.84 1,575.85 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% YVNKEIQNAVNGVK 95.00% 2.46 0.369 0 788.4277 1,574.84 1,575.85 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% YVNKEIQNAVNGVK 95.00% 4.72 0.585 3.48 788.4314 1,574.85 1,575.85 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% YVNKEIQNAVNGVK 95.00% 4.85 0.538 3.89 788.4322 1,574.85 1,575.85 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% YVNKEIQNAVNGVK 95.00% 3.52 0.465 0 788.4345 1,574.85 1,575.85 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% EILSVDcSTNNPSQAK 95.00% 3.46 0.634 2.89 c7: Carbamidomethyl (+57.02) 881.9145 1,761.81 1,762.83 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% EILSVDcSTNNPSQAK 95.00% 4.43 0.598 4.32 c7: Carbamidomethyl (+57.02) 881.9162 1,761.82 1,762.83 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% EILSVDcSTNNPSQAK 95.00% 4.41 0.541 2.49 c7: Carbamidomethyl (+57.02) 881.9175 1,761.82 1,762.83 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% EILSVDcSTNNPSQAK 95.00% 4.06 0.607 4.19 c7: Carbamidomethyl (+57.02) 881.9189 1,761.82 1,762.83 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% EILSVDcSTNNPSQAK 95.00% 4.6 0.619 5.54 c7: Carbamidomethyl (+57.02) 881.9201 1,761.82 1,762.83 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% EILSVDcSTNNPSQAK 95.00% 2.55 0.529 2.8 c7: Carbamidomethyl (+57.02) 881.922 1,761.83 1,762.83 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% EILSVDcSTNNPSQAK 95.00% 3.59 0.583 3.39 c7: Carbamidomethyl (+57.02) 882.4165 1,762.82 1,762.83 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% EILSVDcSTNNPSQAK 95.00% 2.62 0.341 0 c7: Carbamidomethyl (+57.02) 882.4237 1,762.83 1,762.83 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% LFDSDPITVTVPVEVSR 95.00% 4.89 0.545 5.2 937.5001 1,872.98 1,873.99 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% LFDSDPITVTVPVEVSR 95.00% 5.17 0.515 5.01 937.5185 1,873.02 1,873.99 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% LFDSDPITVTVPVEVSR 95.00% 4.06 0.48 4 937.5207 1,873.03 1,873.99 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% LFDSDPITVTVPVEVSR 95.00% 5.46 0.571 5.85 937.9967 1,873.98 1,873.99 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% LFDSDPITVTVPVEVSR 95.00% 5.36 0.54 5.96 938.0116 1,874.01 1,873.99 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% LFDSDPITVTVPVEVSR 95.00% 4.59 0.603 6.12 938.0124 1,874.01 1,873.99 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% VTTVASHTSDSDVPSGVTEVVVK 95.00% 6.65 0.611 4.85 1,158.09 2,314.16 2,314.18 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% VTTVASHTSDSDVPSGVTEVVVK 95.00% 5.95 0.596 5.54 1,158.10 2,314.18 2,314.18 2
 SAMPLE 1 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 13 61 29.00% VTTVASHTSDSDVPSGVTEVVVK 95.00% 6.43 0.632 5.19 1,158.10 2,314.18 2,314.18 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% KTLLSNLEEAKK 95.00% 4.38 0.32 0 458.6049 1,372.79 1,373.80 3
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% KTLLSNLEEAKK 95.00% 4.98 0.347 0 458.6051 1,372.79 1,373.80 3
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% KTLLSNLEEAKK 95.00% 4.42 0.286 1.03 458.6073 1,372.80 1,373.80 3
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% IDSLLENDR 95.00% 2.39 0.229 0 537.7771 1,073.54 1,074.54 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% KTLLSNLEEAK 95.00% 3.05 0.327 2.43 623.3572 1,244.70 1,245.71 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ELDESLQVAER 95.00% 2.87 0.328 0 644.8214 1,287.63 1,288.64 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ELDESLQVAER 95.00% 3.08 0.295 0 644.8214 1,287.63 1,288.64 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% EPQDTYHYLPFSLPHR 95.00% 2.8 0.418 0 667.3266 1,998.96 1,999.97 3
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% EPQDTYHYLPFSLPHR 95.00% 3.06 0.457 0 667.3321 1,998.97 1,999.97 3
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% EPQDTYHYLPFSLPHR 95.00% 1.78 0.331 0 667.6589 1,999.95 1,999.97 3
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% EPQDTYHYLPFSLPHR 95.00% 2.53 0.27 0 667.6592 1,999.95 1,999.97 3
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% EPQDTYHYLPFSLPHR 95.00% 2.29 0.413 0 667.6609 1,999.96 1,999.97 3
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 2.94 0.395 2.08 696.7265 1,391.44 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 3.11 0.438 2.24 697.3502 1,392.68 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 3.77 0.491 1.66 697.3502 1,392.68 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 3.66 0.437 2.54 697.3505 1,392.69 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 3.38 0.44 2.22 697.3507 1,392.69 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 3.29 0.48 2.32 697.3507 1,392.69 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 3.56 0.444 1.77 697.3509 1,392.69 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 3.23 0.392 0 697.3514 1,392.69 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 3.57 0.403 1.33 697.3516 1,392.69 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 3.37 0.381 1.77 697.3525 1,392.69 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 2.9 0.373 1.52 697.3543 1,392.69 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 4.26 0.47 1.52 697.3564 1,392.70 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 3.46 0.368 0 697.3647 1,392.71 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 3.47 0.325 0 697.3654 1,392.72 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 3.92 0.478 2.14 697.3655 1,392.72 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 2.73 0.419 0 697.8382 1,393.66 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% ASSIIDELFQDR 95.00% 2.28 0.378 1.29 697.8393 1,393.66 1,393.70 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.11 0.251 2.52 772.4017 2,314.18 2,314.18 3
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% VTTVASHTSDSDVPSGVTEVVVK 95.00% 2.77 0.249 1.12 772.4026 2,314.18 2,314.18 3
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.84 0.408 3.55 772.4093 2,314.20 2,314.18 3
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% YVNKEIQNAVNGVK 95.00% 4.85 0.538 3.8 788.4322 1,574.85 1,575.85 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% EILSVDcSTNNPSQAK 95.00% 3.11 0.278 1.62 c7: Carbamidomethyl (+57.02) 881.9149 1,761.81 1,762.83 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% EILSVDcSTNNPSQAK 95.00% 4.33 0.622 4.59 c7: Carbamidomethyl (+57.02) 881.9184 1,761.82 1,762.83 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% EILSVDcSTNNPSQAK 95.00% 4.6 0.619 4.41 c7: Carbamidomethyl (+57.02) 881.9201 1,761.82 1,762.83 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% EILSVDcSTNNPSQAK 95.00% 2.55 0.529 2.82 c7: Carbamidomethyl (+57.02) 881.922 1,761.83 1,762.83 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% EILSVDcSTNNPSQAK 95.00% 3.57 0.622 3.92 c7: Carbamidomethyl (+57.02) 882.4193 1,762.82 1,762.83 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% EILSVDcSTNNPSQAK 95.00% 3.29 0.446 0 c7: Carbamidomethyl (+57.02) 882.4207 1,762.83 1,762.83 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% EILSVDcSTNNPSQAK 95.00% 3.83 0.597 3.37 c7: Carbamidomethyl (+57.02) 882.4209 1,762.83 1,762.83 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% LFDSDPITVTVPVEVSR 95.00% 4.31 0.485 3.77 937.5231 1,873.03 1,873.99 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% LFDSDPITVTVPVEVSR 95.00% 5.24 0.511 4.49 938.0016 1,873.99 1,873.99 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% LFDSDPITVTVPVEVSR 95.00% 4.66 0.546 4.07 938.0042 1,873.99 1,873.99 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% LFDSDPITVTVPVEVSR 95.00% 5.36 0.54 5.33 938.0116 1,874.01 1,873.99 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% LFDSDPITVTVPVEVSR 95.00% 4.59 0.603 5.48 938.0124 1,874.01 1,873.99 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% LFDSDPITVTVPVEVSR 95.00% 5.3 0.583 6.01 938.0193 1,874.02 1,873.99 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% LFDSDPITVTVPVEVSR 95.00% 5.2 0.621 6.05 938.0207 1,874.03 1,873.99 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% LFDSDPITVTVPVEVSR 95.00% 5.02 0.573 4.54 938.0213 1,874.03 1,873.99 2
 SAMPLE 1R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 11 49 29.00% VTTVASHTSDSDVPSGVTEVVVK 95.00% 5.95 0.596 6.08 1,158.10 2,314.18 2,314.18 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% KTLLSNLEEAKK 95.00% 3.15 0.257 0 458.6043 1,372.79 1,373.80 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% KTLLSNLEEAKK 95.00% 3.57 0.269 0 458.6053 1,372.79 1,373.80 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% KTLLSNLEEAKK 95.00% 4.54 0.321 1.38 458.6054 1,372.79 1,373.80 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% KTLLSNLEEAKK 95.00% 4.56 0.306 1 458.6059 1,372.79 1,373.80 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% KTLLSNLEEAKK 95.00% 4.42 0.264 0 458.6072 1,372.80 1,373.80 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% KTLLSNLEEAKK 95.00% 4.48 0.323 1.01 458.6078 1,372.80 1,373.80 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% TLLSNLEEAK 95.00% 2.29 0.267 1.35 559.3066 1,116.60 1,117.61 2 MYH9_HUMAN,HP1B3_HUMAN,TITIN_HUMAN,MYH11_HUMAN,DESP_HUMAN
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% TLLSNLEEAK 95.00% 2.03 0.288 0 559.3072 1,116.60 1,117.61 2 MYH9_HUMAN,HP1B3_HUMAN,TITIN_HUMAN,MYH11_HUMAN,DESP_HUMAN
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% TLLSNLEEAK 95.00% 2.07 0.31 1.16 559.3076 1,116.60 1,117.61 2 MYH9_HUMAN,HP1B3_HUMAN,TITIN_HUMAN,MYH11_HUMAN,DESP_HUMAN
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% KTLLSNLEEAK 95.00% 3.26 0.356 3.09 623.3521 1,244.69 1,245.71 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% KTLLSNLEEAK 95.00% 3 0.297 1.16 623.3546 1,244.69 1,245.71 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% TLLSNLEEAKK 95.00% 2.75 0.382 0 623.3547 1,244.69 1,245.71 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% TLLSNLEEAKK 95.00% 2.86 0.36 0 623.3557 1,244.70 1,245.71 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% ELDESLQVAER 95.00% 3.25 0.375 1.18 644.8202 1,287.62 1,288.64 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% ELDESLQVAER 95.00% 2.57 0.321 0 644.8209 1,287.63 1,288.64 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% ELDESLQVAER 95.00% 3.01 0.373 1.96 644.8214 1,287.63 1,288.64 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% ELDESLQVAER 95.00% 3.14 0.325 1.21 644.8216 1,287.63 1,288.64 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% ELDESLQVAER 95.00% 3.01 0.309 0 644.8222 1,287.63 1,288.64 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% EPQDTYHYLPFSLPHR 95.00% 2.64 0.432 0 667.6603 1,999.96 1,999.97 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% KTLLSNLEEAKK 95.00% 3 0.445 2.38 687.4007 1,372.79 1,373.80 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% KTLLSNLEEAKK 95.00% 3.64 0.398 2.24 687.4023 1,372.79 1,373.80 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% KTLLSNLEEAKK 95.00% 3.06 0.306 0 687.4026 1,372.79 1,373.80 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% KTLLSNLEEAKK 95.00% 3.57 0.398 2.62 687.403 1,372.79 1,373.80 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% ASSIIDELFQDR 95.00% 4.22 0.435 2.03 697.3506 1,392.69 1,393.70 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% ASSIIDELFQDR 95.00% 4.09 0.434 2.62 697.351 1,392.69 1,393.70 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% ASSIIDELFQDR 95.00% 3.46 0.517 2.32 697.3522 1,392.69 1,393.70 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% ASSIIDELFQDR 95.00% 3.6 0.466 2.03 697.3527 1,392.69 1,393.70 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% VTTVASHTSDSDVPSGVTEVVVK 95.00% 2.78 0.241 2.52 772.0644 2,313.17 2,314.18 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% VTTVASHTSDSDVPSGVTEVVVK 95.00% 2.27 0.224 0 772.0654 2,313.17 2,314.18 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.66 0.394 2.82 772.397 2,314.17 2,314.18 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.73 0.323 2.51 772.3975 2,314.17 2,314.18 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.45 0.369 1.92 772.3983 2,314.17 2,314.18 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.05 0.307 1.89 772.3995 2,314.17 2,314.18 3
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% YVNKEIQNAVNGVK 95.00% 4.79 0.576 5.06 788.4264 1,574.84 1,575.85 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% YVNKEIQNAVNGVK 95.00% 4.99 0.567 4.15 788.4288 1,574.84 1,575.85 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% EILSVDcSTNNPSQAK 95.00% 4.53 0.621 3.12 c7: Carbamidomethyl (+57.02) 881.9159 1,761.82 1,762.83 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% EILSVDcSTNNPSQAK 95.00% 3.21 0.481 0 c7: Carbamidomethyl (+57.02) 881.9164 1,761.82 1,762.83 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% EILSVDcSTNNPSQAK 95.00% 4.17 0.637 1.55 c7: Carbamidomethyl (+57.02) 881.9168 1,761.82 1,762.83 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% EILSVDcSTNNPSQAK 95.00% 3.72 0.556 2.96 c7: Carbamidomethyl (+57.02) 881.917 1,761.82 1,762.83 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% EILSVDcSTNNPSQAK 95.00% 3.86 0.605 3.02 c7: Carbamidomethyl (+57.02) 881.9185 1,761.82 1,762.83 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% EILSVDcSTNNPSQAK 95.00% 4.32 0.564 3 c7: Carbamidomethyl (+57.02) 882.4161 1,762.82 1,762.83 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% EILSVDcSTNNPSQAK 95.00% 4.53 0.623 3.03 c7: Carbamidomethyl (+57.02) 882.4179 1,762.82 1,762.83 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% EILSVDcSTNNPSQAK 95.00% 4.14 0.557 4.19 c7: Carbamidomethyl (+57.02) 882.4211 1,762.83 1,762.83 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% EILSVDcSTNNPSQAK 95.00% 2.45 0.361 2.47 c7: Carbamidomethyl (+57.02) 882.4225 1,762.83 1,762.83 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% LFDSDPITVTVPVEVSR 95.00% 4.91 0.578 5.29 937.4984 1,872.98 1,873.99 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% LFDSDPITVTVPVEVSR 95.00% 4.83 0.522 5.26 938.0031 1,873.99 1,873.99 2
 SAMPLE 2 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.90% VTTVASHTSDSDVPSGVTEVVVK 95.00% 6.16 0.625 4.6 1,158.10 2,314.18 2,314.18 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% KTLLSNLEEAKK 95.00% 4.31 0.27 0 458.6041 1,372.79 1,373.80 3
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% KTLLSNLEEAKK 95.00% 4.41 0.274 0 458.6046 1,372.79 1,373.80 3
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% KTLLSNLEEAKK 95.00% 4.03 0.354 0 458.6051 1,372.79 1,373.80 3
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% KTLLSNLEEAKK 95.00% 4.28 0.254 0 458.6056 1,372.79 1,373.80 3
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% KTLLSNLEEAKK 95.00% 4.49 0.306 0 458.6058 1,372.79 1,373.80 3
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% KTLLSNLEEAKK 95.00% 3.91 0.253 0 458.6064 1,372.80 1,373.80 3
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% KTLLSNLEEAK 95.00% 3.1 0.179 0 623.3543 1,244.69 1,245.71 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% KTLLSNLEEAK 95.00% 2.78 0.347 1.23 623.3545 1,244.69 1,245.71 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ELDESLQVAER 95.00% 2.78 0.349 1.26 644.8204 1,287.63 1,288.64 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ELDESLQVAER 95.00% 2.44 0.282 0 644.8213 1,287.63 1,288.64 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ELDESLQVAER 95.00% 3.3 0.392 1.57 644.8214 1,287.63 1,288.64 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ELDESLQVAER 95.00% 3.05 0.347 0 644.8217 1,287.63 1,288.64 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ELDESLQVAER 95.00% 2.33 0.34 0 644.8217 1,287.63 1,288.64 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ELDESLQVAER 95.00% 2.93 0.375 1.66 644.8219 1,287.63 1,288.64 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ELDESLQVAER 95.00% 2.87 0.345 0 644.8219 1,287.63 1,288.64 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ELDESLQVAER 95.00% 2.73 0.404 0 644.8219 1,287.63 1,288.64 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% EPQDTYHYLPFSLPHR 95.00% 3.09 0.431 0 667.6611 1,999.96 1,999.97 3
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% KTLLSNLEEAKK 95.00% 3.63 0.401 1.92 687.4047 1,372.79 1,373.80 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% KTLLSNLEEAKK 95.00% 3.36 0.401 2.57 687.9032 1,373.79 1,373.80 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 3.1 0.434 0 697.3476 1,392.68 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 3.03 0.438 1.6 697.349 1,392.68 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 2.97 0.396 0 697.3491 1,392.68 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 3.39 0.442 1.55 697.3496 1,392.68 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 2.46 0.356 1.59 697.3501 1,392.68 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 3.4 0.435 0 697.3501 1,392.68 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 2.58 0.303 0 697.3504 1,392.69 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 3.46 0.414 2.68 697.3504 1,392.69 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 2.53 0.373 1.24 697.3506 1,392.69 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 3.59 0.463 2.11 697.3506 1,392.69 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 3.55 0.452 2.52 697.3508 1,392.69 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 3.48 0.419 1.96 697.352 1,392.69 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% ASSIIDELFQDR 95.00% 2.4 0.381 1.39 697.8522 1,393.69 1,393.70 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.64 0.381 1.43 772.3964 2,314.17 2,314.18 3
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% VTTVASHTSDSDVPSGVTEVVVK 95.00% 2.83 0.265 0 772.3973 2,314.17 2,314.18 3
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.22 0.352 2.4 772.3975 2,314.17 2,314.18 3
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.3 0.345 1.7 772.3979 2,314.17 2,314.18 3
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% VTTVASHTSDSDVPSGVTEVVVK 95.00% 2.96 0.224 2.33 772.399 2,314.17 2,314.18 3
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% YVNKEIQNAVNGVK 95.00% 4.82 0.537 4.8 788.4263 1,574.84 1,575.85 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% YVNKEIQNAVNGVK 95.00% 5.04 0.565 5.08 788.4286 1,574.84 1,575.85 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% YVNKEIQNAVNGVK 95.00% 2.62 0.0702 5.8 788.9193 1,575.82 1,575.85 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% EILSVDcSTNNPSQAK 95.00% 2.77 0.408 1.14 c7: Carbamidomethyl (+57.02) 881.9142 1,761.81 1,762.83 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% EILSVDcSTNNPSQAK 95.00% 4.43 0.615 2.74 c7: Carbamidomethyl (+57.02) 881.9164 1,761.82 1,762.83 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% EILSVDcSTNNPSQAK 95.00% 4.36 0.61 2.6 c7: Carbamidomethyl (+57.02) 881.9172 1,761.82 1,762.83 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% EILSVDcSTNNPSQAK 95.00% 4.15 0.618 3.38 c7: Carbamidomethyl (+57.02) 881.9182 1,761.82 1,762.83 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% EILSVDcSTNNPSQAK 95.00% 4.36 0.649 2.4 c7: Carbamidomethyl (+57.02) 881.9189 1,761.82 1,762.83 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% EILSVDcSTNNPSQAK 95.00% 4.07 0.617 3.19 c7: Carbamidomethyl (+57.02) 881.9189 1,761.82 1,762.83 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% EILSVDcSTNNPSQAK 95.00% 4.07 0.541 4.32 c7: Carbamidomethyl (+57.02) 882.416 1,762.82 1,762.83 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% EILSVDcSTNNPSQAK 95.00% 3.93 0.607 3.55 c7: Carbamidomethyl (+57.02) 882.4177 1,762.82 1,762.83 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% EILSVDcSTNNPSQAK 95.00% 4.24 0.528 2.6 c7: Carbamidomethyl (+57.02) 882.4214 1,762.83 1,762.83 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% EILSVDcSTNNPSQAK 95.00% 3.08 0.431 1.82 c7: Carbamidomethyl (+57.02) 882.4256 1,762.84 1,762.83 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% LFDSDPITVTVPVEVSR 95.00% 4.99 0.566 5.07 938.0008 1,873.99 1,873.99 2
 SAMPLE 2R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 9 10 52 26.90% LFDSDPITVTVPVEVSR 95.00% 5.1 0.559 5.72 938.0019 1,873.99 1,873.99 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% KTLLSNLEEAKK 95.00% 3.64 0.19 0 458.4427 1,372.30 1,373.80 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% KTLLSNLEEAKK 95.00% 4.44 0.341 0 458.6054 1,372.79 1,373.80 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% KTLLSNLEEAKK 95.00% 4.37 0.308 0 458.6054 1,372.79 1,373.80 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% KTLLSNLEEAKK 95.00% 4.56 0.202 0 458.6061 1,372.79 1,373.80 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% KTLLSNLEEAKK 95.00% 4.63 0.318 0 458.6063 1,372.80 1,373.80 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% FMETVAEK 95.00% 1.83 0.233 1.11 477.7331 953.4505 954.4607 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% ELDESLQVAERLTR 95.00% 2.02 0.321 0 553.6276 1,657.86 1,658.87 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% ELDESLQVAERLTR 95.00% 2.63 0.317 0 553.9625 1,658.86 1,658.87 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% TLLSNLEEAK 95.00% 2.16 0.301 2.4 559.3072 1,116.60 1,117.61 2 MYH9_HUMAN,HP1B3_HUMAN,TITIN_HUMAN,MYH11_HUMAN,DESP_HUMAN
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% TLLSNLEEAK 95.00% 3.29 0.372 1.24 559.3072 1,116.60 1,117.61 2 MYH9_HUMAN,HP1B3_HUMAN,TITIN_HUMAN,MYH11_HUMAN,DESP_HUMAN
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% TLLSNLEEAK 95.00% 2.8 0.381 1.8 559.3073 1,116.60 1,117.61 2 MYH9_HUMAN,HP1B3_HUMAN,TITIN_HUMAN,MYH11_HUMAN,DESP_HUMAN
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% TLLSNLEEAK 95.00% 2.3 0.249 2.09 559.3078 1,116.60 1,117.61 2 MYH9_HUMAN,HP1B3_HUMAN,TITIN_HUMAN,MYH11_HUMAN,DESP_HUMAN
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% TLLSNLEEAK 95.00% 2.22 0.286 2.18 559.3078 1,116.60 1,117.61 2 MYH9_HUMAN,HP1B3_HUMAN,TITIN_HUMAN,MYH11_HUMAN,DESP_HUMAN
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% TLLSNLEEAK 95.00% 2.78 0.308 2.17 559.308 1,116.60 1,117.61 2 MYH9_HUMAN,HP1B3_HUMAN,TITIN_HUMAN,MYH11_HUMAN,DESP_HUMAN
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% KTLLSNLEEAK 95.00% 2.42 0.353 1.64 623.3539 1,244.69 1,245.71 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% KTLLSNLEEAK 95.00% 3.11 0.337 1.96 623.3556 1,244.70 1,245.71 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% ELDESLQVAER 95.00% 2.5 0.26 0 644.8205 1,287.63 1,288.64 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% ELDESLQVAER 95.00% 2.41 0.288 0 644.8211 1,287.63 1,288.64 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% ELDESLQVAER 95.00% 3.09 0.341 1.72 644.8213 1,287.63 1,288.64 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% ELDESLQVAER 95.00% 2.42 0.273 0 644.8214 1,287.63 1,288.64 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% ELDESLQVAER 95.00% 2.67 0.273 0 644.8215 1,287.63 1,288.64 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% ELDESLQVAER 95.00% 2.67 0.355 1.47 644.8215 1,287.63 1,288.64 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% ELDESLQVAER 95.00% 2.38 0.336 0 645.33 1,288.64 1,288.64 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% EPQDTYHYLPFSLPHR 95.00% 2.28 0.238 0 667.3275 1,998.96 1,999.97 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% EPQDTYHYLPFSLPHR 95.00% 3.13 0.439 0 667.6592 1,999.95 1,999.97 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% EPQDTYHYLPFSLPHR 95.00% 2.43 0.352 0 667.6605 1,999.96 1,999.97 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% EPQDTYHYLPFSLPHR 95.00% 2.54 0.392 0 667.6613 1,999.96 1,999.97 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% KTLLSNLEEAKK 95.00% 4.27 0.38 3.72 687.403 1,372.79 1,373.80 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.33 0.293 1.27 772.0641 2,313.17 2,314.18 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.4 0.363 1.96 772.3975 2,314.17 2,314.18 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% VTTVASHTSDSDVPSGVTEVVVK 95.00% 4.34 0.366 2.06 772.3978 2,314.17 2,314.18 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.2 0.299 2.02 772.398 2,314.17 2,314.18 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.08 0.335 2.11 772.3983 2,314.17 2,314.18 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.34 0.369 2.77 772.3988 2,314.17 2,314.18 3
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% YVNKEIQNAVNGVK 95.00% 4.95 0.552 5.38 788.4286 1,574.84 1,575.85 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% YVNKEIQNAVNGVK 95.00% 5.08 0.565 5.08 788.4297 1,574.84 1,575.85 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% YVNKEIQNAVNGVK 95.00% 2.59 0.0845 3.92 788.9178 1,575.82 1,575.85 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% EILSVDcSTNNPSQAK 95.00% 4.32 0.632 2.54 c7: Carbamidomethyl (+57.02) 881.9139 1,761.81 1,762.83 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% EILSVDcSTNNPSQAK 95.00% 4.51 0.641 3.62 c7: Carbamidomethyl (+57.02) 881.9165 1,761.82 1,762.83 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% EILSVDcSTNNPSQAK 95.00% 4.38 0.618 3.77 c7: Carbamidomethyl (+57.02) 881.917 1,761.82 1,762.83 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% EILSVDcSTNNPSQAK 95.00% 4.5 0.637 4.12 c7: Carbamidomethyl (+57.02) 881.9171 1,761.82 1,762.83 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% EILSVDcSTNNPSQAK 95.00% 4.38 0.611 3.33 c7: Carbamidomethyl (+57.02) 881.9172 1,761.82 1,762.83 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% EILSVDcSTNNPSQAK 95.00% 4.6 0.621 4.4 c7: Carbamidomethyl (+57.02) 881.9176 1,761.82 1,762.83 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% EILSVDcSTNNPSQAK 95.00% 4.71 0.603 2.92 c7: Carbamidomethyl (+57.02) 882.4161 1,762.82 1,762.83 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% EILSVDcSTNNPSQAK 95.00% 4.38 0.539 2.57 c7: Carbamidomethyl (+57.02) 882.4162 1,762.82 1,762.83 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% LFDSDPITVTVPVEVSR 95.00% 3.66 0.46 2.8 937.4967 1,872.98 1,873.99 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% LFDSDPITVTVPVEVSR 95.00% 5.54 0.574 4.13 937.9993 1,873.98 1,873.99 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% LFDSDPITVTVPVEVSR 95.00% 5.65 0.561 4.54 938.001 1,873.99 1,873.99 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% VTTVASHTSDSDVPSGVTEVVVK 95.00% 6.48 0.636 6.24 1,158.09 2,314.17 2,314.18 2
 SAMPLE 3 Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 10 12 44 26.70% VTTVASHTSDSDVPSGVTEVVVK 95.00% 6.29 0.638 5.89 1,158.09 2,314.17 2,314.18 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% KTLLSNLEEAKK 95.00% 4.17 0.24 0 458.6053 1,372.79 1,373.80 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% KTLLSNLEEAKK 95.00% 4.22 0.216 0 458.6059 1,372.79 1,373.80 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% KTLLSNLEEAKK 95.00% 3.81 0.209 0 458.6062 1,372.80 1,373.80 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% KTLLSNLEEAKK 95.00% 3 0.153 0 458.6437 1,372.91 1,373.80 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% FMETVAEK 95.00% 1.91 0.193 1.6 477.7334 953.4511 954.4607 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% YVNKEIQNAVNGVK 95.00% 2.75 0.48 0 525.9537 1,574.84 1,575.85 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% KTLLSNLEEAK 95.00% 2.34 0.304 0 623.3539 1,244.69 1,245.71 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% KTLLSNLEEAK 95.00% 2.4 0.343 1.74 623.355 1,244.69 1,245.71 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ELDESLQVAER 95.00% 2.33 0.21 1.55 644.8191 1,287.62 1,288.64 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ELDESLQVAER 95.00% 3.06 0.296 1.09 644.8209 1,287.63 1,288.64 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ELDESLQVAER 95.00% 2.32 0.278 0 644.8213 1,287.63 1,288.64 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ELDESLQVAER 95.00% 2.8 0.358 1.6 644.8219 1,287.63 1,288.64 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDRFFTR 95.00% 2.69 0.437 0 649.3322 1,944.97 1,944.98 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDRFFTR 95.00% 2.31 0.35 0 649.334 1,944.98 1,944.98 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% EPQDTYHYLPFSLPHR 95.00% 2.58 0.365 0 667.6591 1,999.95 1,999.97 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% EPQDTYHYLPFSLPHR 95.00% 2.64 0.382 0 667.6595 1,999.96 1,999.97 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% EPQDTYHYLPFSLPHR 95.00% 2.53 0.355 0 667.66 1,999.96 1,999.97 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% KTLLSNLEEAKK 95.00% 3.45 0.41 3.72 687.4018 1,372.79 1,373.80 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDR 95.00% 2.76 0.314 1.44 697.349 1,392.68 1,393.70 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDR 95.00% 3.74 0.456 1.6 697.3496 1,392.68 1,393.70 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDR 95.00% 3.25 0.409 2.52 697.3501 1,392.68 1,393.70 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDR 95.00% 3.43 0.37 2.7 697.3502 1,392.68 1,393.70 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDR 95.00% 2.81 0.308 2.62 697.3503 1,392.69 1,393.70 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDR 95.00% 3.45 0.357 1.89 697.3509 1,392.69 1,393.70 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDR 95.00% 3.46 0.449 2.68 697.351 1,392.69 1,393.70 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDR 95.00% 3.29 0.431 2.14 697.351 1,392.69 1,393.70 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDR 95.00% 3.87 0.366 1.47 697.3512 1,392.69 1,393.70 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDR 95.00% 3.62 0.362 1.6 697.3512 1,392.69 1,393.70 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDR 95.00% 2.55 0.24 2.28 697.352 1,392.69 1,393.70 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% ASSIIDELFQDR 95.00% 3.49 0.468 2.89 697.3528 1,392.69 1,393.70 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.28 0.419 0 772.3965 2,314.17 2,314.18 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.3 0.414 2.47 772.3981 2,314.17 2,314.18 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.67 0.354 1.92 772.3981 2,314.17 2,314.18 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.22 0.3 1.89 772.3982 2,314.17 2,314.18 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% VTTVASHTSDSDVPSGVTEVVVK 95.00% 3.67 0.323 1.92 772.3986 2,314.17 2,314.18 3
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% YVNKEIQNAVNGVK 95.00% 4.73 0.505 3.96 788.4296 1,574.84 1,575.85 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% YVNKEIQNAVNGVK 95.00% 2.61 0.0718 5.04 788.9195 1,575.82 1,575.85 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% EILSVDcSTNNPSQAK 95.00% 4.28 0.593 2 c7: Carbamidomethyl (+57.02) 881.911 1,761.81 1,762.83 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% EILSVDcSTNNPSQAK 95.00% 4.29 0.624 3.36 c7: Carbamidomethyl (+57.02) 881.9149 1,761.81 1,762.83 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% EILSVDcSTNNPSQAK 95.00% 4.13 0.597 3.85 c7: Carbamidomethyl (+57.02) 881.9153 1,761.82 1,762.83 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% EILSVDcSTNNPSQAK 95.00% 3.87 0.607 3.96 c7: Carbamidomethyl (+57.02) 881.9158 1,761.82 1,762.83 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% EILSVDcSTNNPSQAK 95.00% 4.43 0.663 3.36 c7: Carbamidomethyl (+57.02) 881.9161 1,761.82 1,762.83 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% EILSVDcSTNNPSQAK 95.00% 3.37 0.493 0 c7: Carbamidomethyl (+57.02) 881.9168 1,761.82 1,762.83 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% EILSVDcSTNNPSQAK 95.00% 4.1 0.634 2.49 c7: Carbamidomethyl (+57.02) 881.9176 1,761.82 1,762.83 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% EILSVDcSTNNPSQAK 95.00% 4.39 0.613 2.96 c7: Carbamidomethyl (+57.02) 881.9179 1,761.82 1,762.83 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% EILSVDcSTNNPSQAK 95.00% 4.18 0.637 3.6 c7: Carbamidomethyl (+57.02) 881.9182 1,761.82 1,762.83 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% LFDSDPITVTVPVEVSR 95.00% 4.74 0.513 3.27 937.4993 1,872.98 1,873.99 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% LFDSDPITVTVPVEVSR 95.00% 4.34 0.483 3.39 937.5003 1,872.98 1,873.99 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% LFDSDPITVTVPVEVSR 95.00% 5.23 0.523 5.27 937.998 1,873.98 1,873.99 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% LFDSDPITVTVPVEVSR 95.00% 4.81 0.479 4.02 938.0034 1,873.99 1,873.99 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% VTTVASHTSDSDVPSGVTEVVVK 95.00% 6.35 0.645 5.04 1,158.09 2,314.17 2,314.18 2
 SAMPLE 3R Clusterin  CLU  CLUS_HUMAN 52,476.90 100.00% 11 14 52 29.60% VTTVASHTSDSDVPSGVTEVVVK 95.00% 6.27 0.642 5.16 1,158.10 2,314.17 2,314.18 2
 SAMPLE 3R Cofilin-1  CFL1  COF1_HUMAN 18,485.10 99.90% 2 2 4 15.10% HELQANcYEEVKDR 95.00% 2.78 0.306 0 c7: Carbamidomethyl (+57.02) 597.9591 1,790.85 1,790.81 3
 SAMPLE 3R Cofilin-1  CFL1  COF1_HUMAN 18,485.10 99.90% 2 2 4 15.10% HELQANcYEEVKDR 95.00% 2.54 0.268 0 c7: Carbamidomethyl (+57.02) 597.9598 1,790.86 1,790.81 3
 SAMPLE 3R Cofilin-1  CFL1  COF1_HUMAN 18,485.10 99.90% 2 2 4 15.10% YALYDATYETK 95.00% 2.27 0.437 0 669.3155 1,336.62 1,337.63 2
 SAMPLE 3R Cofilin-1  CFL1  COF1_HUMAN 18,485.10 99.90% 2 2 4 15.10% YALYDATYETK 95.00% 2.43 0.394 1.74 669.9806 1,337.95 1,337.63 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GFSGLDGAKGDAGPAGPK 95.00% 3.17 0.514 2.62 534.6024 1,600.78 1,601.79 3
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GFSGLDGAKGDAGPAGPK 95.00% 3.25 0.539 2.74 534.6036 1,600.79 1,601.79 3
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GVPGPPGAVGPAGK 95.00% 1.67 0.34 0 580.8254 1,159.64 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GVPGPPGAVGPAGK 95.00% 1.68 0.544 0 580.8268 1,159.64 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GVPGPPGAVGPAGK 95.00% 1.65 0.461 0 580.8268 1,159.64 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 2.84 0.361 1.39 m6: Oxidation (+15.99) 581.2884 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 3.14 0.401 1.74 m6: Oxidation (+15.99) 581.289 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 3.13 0.421 1.17 m6: Oxidation (+15.99) 581.2895 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 3.06 0.355 3.48 m6: Oxidation (+15.99) 581.2903 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 3.04 0.338 1.85 m6: Oxidation (+15.99) 581.2907 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 3.04 0.394 2.82 m6: Oxidation (+15.99) 581.2907 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 2.59 0.347 2.89 m6: Oxidation (+15.99) 581.2909 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 3.03 0.358 1.47 m6: Oxidation (+15.99) 581.2909 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 3.06 0.333 2.21 m6: Oxidation (+15.99) 581.291 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 2.88 0.369 1.64 m6: Oxidation (+15.99) 581.2911 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 2.55 0.215 1.17 m6: Oxidation (+15.99) 581.2913 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 3.03 0.362 2.92 m6: Oxidation (+15.99) 581.2914 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 3.09 0.443 1.96 m6: Oxidation (+15.99) 581.2915 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 2.86 0.324 1.89 m6: Oxidation (+15.99) 581.2915 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 3.05 0.286 1.59 m6: Oxidation (+15.99) 581.2917 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 2.51 0.239 0 m6: Oxidation (+15.99) 581.2918 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 2.75 0.392 0 m6: Oxidation (+15.99) 581.2921 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GQAGVmGFPGPK 95.00% 2.33 0.22 0 m6: Oxidation (+15.99) 581.2943 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GESGPSGPAGPTGAR 95.00% 2.73 0.481 0 649.3123 1,296.61 1,297.61 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GESGPSGPAGPTGAR 95.00% 2.9 0.452 1.85 649.3131 1,296.61 1,297.61 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.98 0.561 4.82 654.6651 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.28 0.581 3.54 654.6656 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.18 0.499 3.49 654.6656 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.27 0.534 5.64 654.6657 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.59 0.559 3.08 654.6661 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.13 0.509 3.48 654.6664 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.93 0.448 4.62 654.6664 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.11 0.542 6.72 654.6666 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.09 0.58 4.4 654.6669 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.9 0.487 4.89 654.6672 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.95 0.506 5.04 654.6672 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.13 0.547 3.74 654.6674 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.52 0.481 3.09 654.6682 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.6 0.213 1.4 654.6688 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.28 0.43 2.72 654.9979 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.86 0.488 2.59 654.999 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.02 0.465 2.51 654.9994 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.07 0.493 4.31 654.9996 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.17 0.445 4.44 654.9996 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.56 0.445 2.96 654.9997 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.52 0.56 2.41 654.9998 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.67 0.483 4.62 654.9999 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.8 0.52 4.42 655.0001 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.5 0.424 4.04 655.0002 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.22 0.468 3.92 655.0003 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.08 0.494 3.72 655.0003 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.96 0.544 1.59 655.0004 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.92 0.516 3.8 655.0004 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.58 0.512 2.3 655.0005 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.01 0.384 2.35 655.0005 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.59 0.465 3.02 655.0005 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.21 0.512 4.3 655.0007 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.2 0.495 3.15 655.0007 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.05 0.473 4.72 655.0008 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.93 0.474 3.7 655.0009 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.39 0.443 5.14 655.001 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.97 0.452 4.82 655.001 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.13 0.318 1.05 655.001 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.04 0.514 3.28 655.001 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.56 0.569 4.33 655.0011 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.39 0.218 1.13 655.0012 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.13 0.265 3.12 655.0012 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.1 0.496 3.72 655.0012 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.16 0.481 3.66 655.0013 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.84 0.394 3.05 655.002 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.67 0.489 4.85 655.0026 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4 0.505 3 655.0026 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.24 0.487 3.21 655.0029 1,961.99 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.61 0.46 0 655.003 1,961.99 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.04 0.484 3.13 655.0036 1,961.99 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.86 0.494 3.14 655.0038 1,961.99 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.27 0.437 4.55 655.0043 1,961.99 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.89 0.247 1.19 655.0044 1,961.99 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.88 0.427 3 655.0044 1,961.99 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GETGPAGPAGPVGPVGAR 95.00% 3.98 0.517 3.47 773.9044 1,545.79 1,546.80 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GETGPAGPAGPVGPVGAR 95.00% 4.15 0.515 2.96 773.9054 1,545.80 1,546.80 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GETGPAGPAGPVGPVGAR 95.00% 3.7 0.531 4.68 773.9063 1,545.80 1,546.80 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GETGPAGPAGPVGPVGAR 95.00% 3.91 0.573 3.89 773.9063 1,545.80 1,546.80 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GETGPAGPAGPVGPVGAR 95.00% 4.15 0.455 3.64 774.407 1,546.80 1,546.80 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% STGGISVPGPMGPSGPR 95.00% 2.02 0.351 3.47 777.393 1,552.77 1,553.77 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% STGGISVPGPMGPSGPR 95.00% 2.39 0.371 4.34 777.3934 1,552.77 1,553.77 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% STGGISVPGPMGPSGPR 95.00% 2.27 0.346 4.33 777.3935 1,552.77 1,553.77 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% STGGISVPGPMGPSGPR 95.00% 2.09 0.343 2.89 777.394 1,552.77 1,553.77 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% STGGISVPGPMGPSGPR 95.00% 2.02 0.384 2.57 777.3968 1,552.78 1,553.77 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% STGGISVPGPMGPSGPR 95.00% 2.62 0.366 4.14 777.8944 1,553.77 1,553.77 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GFSGLDGAKGDAGPAGPK 95.00% 4.58 0.446 7.31 801.4018 1,600.79 1,601.79 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GFSGLDGAKGDAGPAGPK 95.00% 4.42 0.51 6.68 801.4035 1,600.79 1,601.79 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GFSGLDGAKGDAGPAGPK 95.00% 4.46 0.439 5.85 801.4041 1,600.79 1,601.79 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% GFSGLDGAKGDAGPAGPK 95.00% 4.19 0.393 6.62 801.4054 1,600.80 1,601.79 2
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.96 0.604 6.52 981.4938 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.92 0.584 8.08 981.4942 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.43 0.579 6.8 981.4946 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.97 0.583 7.44 981.4947 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.97 0.565 7.39 981.4949 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.63 0.573 7.64 981.9934 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.23 0.59 7.89 981.9953 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.13 0.584 8.92 981.9957 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.74 0.553 7.42 981.9962 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.01 0.582 6.49 981.9963 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.99 0.599 7.33 981.9964 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.97 0.577 6.89 981.9966 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.69 0.592 5.43 981.9967 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.08 0.586 6.19 981.9976 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.44 0.563 6.77 981.9983 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.7 0.578 6.85 981.9987 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.12 0.579 7.4 981.9991 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 19 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.18 0.607 6.77 981.9997 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GFSGLDGAKGDAGPAGPK 95.00% 1.65 0.456 0 534.6039 1,600.79 1,601.79 3
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GVPGPPGAVGPAGK 95.00% 1.49 0.38 0 580.8255 1,159.64 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GVPGPPGAVGPAGK 95.00% 1.59 0.572 0 580.8263 1,159.64 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GVPGPPGAVGPAGK 95.00% 1.7 0.492 0 580.8268 1,159.64 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 2.79 0.388 0 m6: Oxidation (+15.99) 581.2901 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 2.84 0.402 0 m6: Oxidation (+15.99) 581.2902 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 3.07 0.417 2.96 m6: Oxidation (+15.99) 581.2903 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 3.03 0.371 3.62 m6: Oxidation (+15.99) 581.2903 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 2.76 0.35 0 m6: Oxidation (+15.99) 581.2906 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 3.03 0.437 0 m6: Oxidation (+15.99) 581.2906 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 3.3 0.366 2.62 m6: Oxidation (+15.99) 581.2907 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 2.68 0.276 2.02 m6: Oxidation (+15.99) 581.2909 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 2.64 0.239 2 m6: Oxidation (+15.99) 581.2911 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 3.07 0.354 2.74 m6: Oxidation (+15.99) 581.2912 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 3.31 0.408 3.23 m6: Oxidation (+15.99) 581.2912 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 2.89 0.388 2.77 m6: Oxidation (+15.99) 581.2914 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 2.73 0.333 2.8 m6: Oxidation (+15.99) 581.2916 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 3.14 0.429 2.57 m6: Oxidation (+15.99) 581.2917 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 2.97 0.381 0 m6: Oxidation (+15.99) 581.2917 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 2.43 0.256 0 m6: Oxidation (+15.99) 581.2919 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GQAGVmGFPGPK 95.00% 2.78 0.346 1.62 m6: Oxidation (+15.99) 581.2931 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GESGPSGPAGPTGAR 95.00% 2.96 0.472 0 649.3139 1,296.61 1,297.61 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GESGPSGPAGPTGAR 95.00% 3.24 0.496 2.47 649.3147 1,296.61 1,297.61 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GESGPSGPAGPTGAR 95.00% 2.44 0.374 1.96 649.3153 1,296.61 1,297.61 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GESGPSGPAGPTGAR 95.00% 2.43 0.357 0 649.3159 1,296.62 1,297.61 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GESGPSGPAGPTGAR 95.00% 2.55 0.42 1.28 649.8167 1,297.62 1,297.61 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.41 0.446 4.07 654.6649 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.23 0.549 4.33 654.6652 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.92 0.496 4.96 654.666 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.88 0.536 2.82 654.666 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.08 0.519 5 654.666 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.05 0.537 2.51 654.6661 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.78 0.545 3.96 654.6661 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.86 0.586 4.13 654.6663 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.77 0.538 4.2 654.6665 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.99 0.461 5.19 654.6671 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.92 0.516 3.12 654.6679 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.71 0.435 2.15 654.6679 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.1 0.549 2.89 654.6685 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.76 0.477 3.52 654.6788 1,961.01 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.51 0.542 3.42 655 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.62 0.479 3.72 655.0001 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.42 0.483 2.82 655.0002 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.72 0.45 5.92 655.0003 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.01 0.481 3.77 655.0004 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3 0.435 4.07 655.0005 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.12 0.511 4.32 655.0005 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.99 0.476 3.92 655.0006 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.48 0.515 4.55 655.0007 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.22 0.47 2.37 655.0007 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.51 0.549 3.55 655.001 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.94 0.5 1.28 655.001 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.65 0.523 5.36 655.001 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.47 0.54 4.09 655.0011 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.03 0.467 3.47 655.0012 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.23 0.444 3.92 655.0012 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.12 0.47 4.46 655.0013 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.21 0.484 5.43 655.0013 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.45 0.54 5.13 655.0015 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.18 0.488 6.62 655.0015 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.33 0.533 3.52 655.0016 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.64 0.3 0 655.0022 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.07 0.373 3.51 655.0023 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.66 0.496 5.85 655.0023 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.16 0.33 1 655.0026 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.53 0.529 4.34 655.0029 1,961.99 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.98 0.495 4.09 655.0039 1,961.99 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.01 0.464 4.52 655.0134 1,962.02 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4 0.416 3 655.0146 1,962.02 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GETGPAGPAGPVGPVGAR 95.00% 3.87 0.554 4.47 773.9043 1,545.79 1,546.80 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GETGPAGPAGPVGPVGAR 95.00% 3.65 0.547 4.08 773.9047 1,545.79 1,546.80 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GETGPAGPAGPVGPVGAR 95.00% 3.99 0.554 4.82 773.9052 1,545.79 1,546.80 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GETGPAGPAGPVGPVGAR 95.00% 3.97 0.529 4.43 773.9054 1,545.80 1,546.80 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GETGPAGPAGPVGPVGAR 95.00% 3.88 0.164 3.13 773.9058 1,545.80 1,546.80 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GETGPAGPAGPVGPVGAR 95.00% 3.84 0.499 4.09 773.9059 1,545.80 1,546.80 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GETGPAGPAGPVGPVGAR 95.00% 4.41 0.559 3.54 773.9069 1,545.80 1,546.80 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GETGPAGPAGPVGPVGAR 95.00% 4.04 0.43 3.6 774.4047 1,546.79 1,546.80 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GETGPAGPAGPVGPVGAR 95.00% 3.78 0.503 3.04 774.4055 1,546.80 1,546.80 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% STGGISVPGPMGPSGPR 95.00% 1.94 0.341 4.43 777.3928 1,552.77 1,553.77 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% STGGISVPGPMGPSGPR 95.00% 2.3 0.298 2.68 777.8943 1,553.77 1,553.77 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% STGGISVPGPMGPSGPR 95.00% 2.06 0.269 2.54 777.8951 1,553.77 1,553.77 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% STGGISVPGPMGPSGPR 95.00% 2.35 0.345 3.6 777.8952 1,553.77 1,553.77 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% STGGISVPGPMGPSGPR 95.00% 2.51 0.366 1.82 777.8956 1,553.78 1,553.77 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% STGGISVPGPmGPSGPR 95.00% 2.48 0.339 2.7 m11: Oxidation (+15.99) 785.8907 1,569.77 1,569.77 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GFSGLDGAKGDAGPAGPK 95.00% 4.28 0.505 6.82 801.4035 1,600.79 1,601.79 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% GFSGLDGAKGDAGPAGPK 95.00% 4.49 0.409 5.74 801.9033 1,601.79 1,601.79 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% DGEAGAQGPPGPAGPAGER 95.00% 4.3 0.627 5.55 845.8937 1,689.77 1,690.78 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% DGEAGAQGPPGPAGPAGER 95.00% 3.45 0.55 3.66 845.8969 1,689.78 1,690.78 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% DGEAGAQGPPGPAGPAGER 95.00% 4.28 0.591 5.48 846.3988 1,690.78 1,690.78 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% DGEAGAQGPPGPAGPAGER 95.00% 4.13 0.613 5.8 846.4141 1,690.81 1,690.78 2
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.55 0.425 0 980.9341 1,959.85 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.06 0.587 6.51 981.4904 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.13 0.595 8.04 981.4937 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.88 0.578 7.96 981.4937 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.8 0.568 6.4 981.4944 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.33 0.54 6.48 981.495 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.91 0.608 6.85 981.4961 1,960.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.03 0.582 8.26 981.4969 1,960.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.79 0.582 5.7 981.4976 1,960.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.98 0.576 6.89 981.4981 1,960.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.93 0.548 5.92 981.5151 1,961.01 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.31 0.559 5.03 981.9946 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.95 0.59 8 981.9951 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.16 0.565 6.55 981.9957 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.54 0.567 5.85 981.9967 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.96 0.579 7.89 981.9971 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.1 0.57 8.43 981.9973 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.9 0.574 7.68 981.9983 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.17 0.597 6.77 981.9986 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 4R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 27 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.07 0.586 6.64 981.9989 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GETGPAGPAGPVGPVGAR 95.00% 2.4 0.277 0 516.6043 1,546.79 1,546.80 3
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GETGPAGPAGPVGPVGAR 95.00% 3.27 0.43 1.82 516.6047 1,546.79 1,546.80 3
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GFSGLDGAKGDAGPAGPK 95.00% 1.78 0.384 0 534.6011 1,600.78 1,601.79 3
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GVPGPPGAVGPAGK 95.00% 1.66 0.428 0 580.8235 1,159.63 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GQAGVmGFPGPK 95.00% 2.47 0.249 1.55 m6: Oxidation (+15.99) 581.2856 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GQAGVmGFPGPK 95.00% 2.79 0.271 2.11 m6: Oxidation (+15.99) 581.2857 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GQAGVmGFPGPK 95.00% 2.2 0.276 0 m6: Oxidation (+15.99) 581.2879 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GQAGVmGFPGPK 95.00% 3.02 0.404 2.17 m6: Oxidation (+15.99) 581.2882 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GQAGVmGFPGPK 95.00% 2.63 0.193 1.29 m6: Oxidation (+15.99) 581.2885 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GQAGVmGFPGPK 95.00% 2.74 0.327 0 m6: Oxidation (+15.99) 581.2887 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GQAGVmGFPGPK 95.00% 2.74 0.349 0 m6: Oxidation (+15.99) 581.289 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GQAGVmGFPGPK 95.00% 2.58 0.342 1.54 m6: Oxidation (+15.99) 581.2892 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GQAGVmGFPGPK 95.00% 2.94 0.42 2 m6: Oxidation (+15.99) 581.2894 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GQAGVmGFPGPK 95.00% 2.88 0.376 1.96 m6: Oxidation (+15.99) 581.2898 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GQAGVmGFPGPK 95.00% 2.89 0.334 0 m6: Oxidation (+15.99) 581.2905 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GQAGVmGFPGPK 95.00% 2.76 0.404 0 m6: Oxidation (+15.99) 581.7907 1,161.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GESGPSGPAGPTGAR 95.00% 2.27 0.453 1.27 649.3155 1,296.62 1,297.61 2
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GESGPSGPAGPTGAR 95.00% 2.37 0.475 0 649.3165 1,296.62 1,297.61 2
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.4 0.488 5.35 654.6624 1,960.96 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 4 0.523 5.32 654.6625 1,960.96 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.8 0.522 5.89 654.6636 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.4 0.421 5.3 654.6656 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.02 0.478 5.24 654.9973 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.75 0.504 6.2 654.9977 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.83 0.371 1.96 654.9978 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.32 0.486 5.18 654.9982 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.41 0.491 5.19 654.9982 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.18 0.508 5.7 654.9986 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.96 0.48 5.12 654.9988 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.65 0.537 5.62 654.999 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GETGPAGPAGPVGPVGAR 95.00% 4.53 0.539 3.33 774.4026 1,546.79 1,546.80 2
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% STGGISVPGPMGPSGPR 95.00% 2.61 0.461 2.59 777.3892 1,552.76 1,553.77 2
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% STGGISVPGPMGPSGPR 95.00% 2.29 0.301 3.1 777.3894 1,552.76 1,553.77 2
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% STGGISVPGPMGPSGPR 95.00% 2.57 0.414 3.04 777.3897 1,552.76 1,553.77 2
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% STGGISVPGPMGPSGPR 95.00% 2.83 0.445 5.11 777.39 1,552.76 1,553.77 2
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% STGGISVPGPMGPSGPR 95.00% 2.4 0.474 3.8 777.39 1,552.76 1,553.77 2
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% STGGISVPGPMGPSGPR 95.00% 2.92 0.443 2.96 777.3903 1,552.76 1,553.77 2
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% STGGISVPGPMGPSGPR 95.00% 2.32 0.411 1.89 777.8913 1,553.77 1,553.77 2
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GFSGLDGAKGDAGPAGPK 95.00% 3.8 0.485 6.6 801.9039 1,601.79 1,601.79 2
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% GDRGETGPAGPPGAPGAPGAPGPVGPAGK 95.00% 2.3 0.337 0 816.722 2,447.14 2,449.22 3
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.24 0.558 6.82 981.4882 1,960.96 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.86 0.574 7.34 981.4922 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.78 0.59 8.08 981.4934 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.53 0.584 7.85 981.494 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.45 0.581 6.72 981.9903 1,961.96 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.93 0.589 6.28 981.9916 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.15 0.582 8.72 981.9923 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.31 0.592 6.46 981.9928 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.57 0.58 6.92 981.9932 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 7 15 8.67% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.23 0.579 5.42 981.9944 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GETGPAGPAGPVGPVGAR 95.00% 3.44 0.435 2.62 516.2693 1,545.78 1,546.80 3
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GETGPAGPAGPVGPVGAR 95.00% 2.96 0.212 3.06 516.6051 1,546.79 1,546.80 3
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GQAGVmGFPGPK 95.00% 2.38 0.338 1.68 m6: Oxidation (+15.99) 581.2859 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GQAGVmGFPGPK 95.00% 2.32 0.333 1.46 m6: Oxidation (+15.99) 581.2874 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GQAGVmGFPGPK 95.00% 2.35 0.36 1.12 m6: Oxidation (+15.99) 581.2882 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GQAGVmGFPGPK 95.00% 2.99 0.414 1.92 m6: Oxidation (+15.99) 581.2882 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GQAGVmGFPGPK 95.00% 3.1 0.407 1.8 m6: Oxidation (+15.99) 581.2888 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GQAGVmGFPGPK 95.00% 2.64 0.345 1.34 m6: Oxidation (+15.99) 581.2889 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GQAGVmGFPGPK 95.00% 2.68 0.388 2.92 m6: Oxidation (+15.99) 581.2892 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GQAGVmGFPGPK 95.00% 2.82 0.365 1.74 m6: Oxidation (+15.99) 581.2892 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GQAGVmGFPGPK 95.00% 2.52 0.394 1.51 m6: Oxidation (+15.99) 581.2893 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GQAGVmGFPGPK 95.00% 2.35 0.264 0 m6: Oxidation (+15.99) 581.2895 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GQAGVmGFPGPK 95.00% 3.1 0.397 2.48 m6: Oxidation (+15.99) 581.7896 1,161.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GESGPSGPAGPTGAR 95.00% 2.27 0.453 1.2 649.3155 1,296.62 1,297.61 2
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.15 0.553 4.19 654.6625 1,960.96 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.19 0.511 4.52 654.6629 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.08 0.515 4.52 654.6635 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.94 0.462 5 654.6638 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.4 0.421 5.34 654.6656 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.26 0.543 4.47 654.9966 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.98 0.506 4.54 654.9971 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.32 0.504 4.47 654.9976 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.83 0.537 3.68 654.9977 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.23 0.225 2.14 654.9978 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.04 0.408 3.8 654.998 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.03 0.472 5.06 654.9981 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.13 0.531 4.82 654.9981 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.41 0.504 4.17 654.9983 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.83 0.499 5.11 655.0005 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GETGPAGPAGPVGPVGAR 95.00% 2.58 0.346 0 773.9013 1,545.79 1,546.80 2
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% GETGPAGPAGPVGPVGAR 95.00% 2.86 0.332 2.33 774.4027 1,546.79 1,546.80 2
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% STGGISVPGPMGPSGPR 95.00% 2.28 0.343 0 777.388 1,552.76 1,553.77 2
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% STGGISVPGPMGPSGPR 95.00% 2.69 0.488 4.17 777.3899 1,552.76 1,553.77 2
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% STGGISVPGPMGPSGPR 95.00% 2.67 0.381 1.39 777.3913 1,552.77 1,553.77 2
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% STGGISVPGPMGPSGPR 95.00% 2.96 0.506 3.28 777.3913 1,552.77 1,553.77 2
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% STGGISVPGPMGPSGPR 95.00% 2.74 0.412 2.72 777.8917 1,553.77 1,553.77 2
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% STGGISVPGPMGPSGPR 95.00% 2.76 0.418 2.3 777.8918 1,553.77 1,553.77 2
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% STGGISVPGPmGPSGPR 95.00% 2.13 0.344 2.51 m11: Oxidation (+15.99) 785.8897 1,569.76 1,569.77 2
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% DGEAGAQGPPGPAGPAGER 95.00% 3.67 0.533 4.6 845.8923 1,689.77 1,690.78 2
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% DGEAGAQGPPGPAGPAGER 95.00% 3.9 0.553 4.55 846.3952 1,690.77 1,690.78 2
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.83 0.601 7.92 981.496 1,960.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.78 0.548 6 981.9912 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.33 0.576 5.36 981.992 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.01 0.592 7.09 981.9922 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.41 0.596 7.59 981.9925 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.13 0.595 6.55 981.9929 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.65 0.589 7.52 981.9933 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.03 0.609 7.51 981.9936 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.02 0.611 7.72 981.9939 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 1R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 14 5.81% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.6 0.608 6.77 981.9942 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GFSGLDGAKGDAGPAGPK 95.00% 2.74 0.484 1.09 534.6021 1,600.78 1,601.79 3
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GQAGVmGFPGPK 95.00% 2.57 0.281 0 m6: Oxidation (+15.99) 581.2884 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GQAGVmGFPGPK 95.00% 3.52 0.446 2.82 m6: Oxidation (+15.99) 581.2887 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GQAGVmGFPGPK 95.00% 2.87 0.416 3.18 m6: Oxidation (+15.99) 581.2888 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GQAGVmGFPGPK 95.00% 3.02 0.417 2.42 m6: Oxidation (+15.99) 581.2888 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GQAGVmGFPGPK 95.00% 2.97 0.403 2.96 m6: Oxidation (+15.99) 581.289 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GQAGVmGFPGPK 95.00% 2.97 0.403 3.09 m6: Oxidation (+15.99) 581.289 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GQAGVmGFPGPK 95.00% 2.57 0.252 1.31 m6: Oxidation (+15.99) 581.2891 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GQAGVmGFPGPK 95.00% 2.95 0.392 2.51 m6: Oxidation (+15.99) 581.2892 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GQAGVmGFPGPK 95.00% 3.01 0.435 2.44 m6: Oxidation (+15.99) 581.2893 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GQAGVmGFPGPK 95.00% 2.76 0.294 2.19 m6: Oxidation (+15.99) 581.2895 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GQAGVmGFPGPK 95.00% 2.87 0.4 1.44 m6: Oxidation (+15.99) 581.2895 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GQAGVmGFPGPK 95.00% 2.09 0.312 0 m6: Oxidation (+15.99) 581.2917 1,160.57 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SLSQQIENIR 95.00% 2.39 0.219 0 594.3204 1,186.63 1,187.64 2
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.76 0.531 3.82 654.6624 1,960.96 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.48 0.494 4.66 654.6637 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.88 0.566 4.52 654.6642 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.34 0.553 3.55 654.6642 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.81 0.447 4.27 654.9965 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.03 0.308 3.07 654.9972 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.04 0.515 3.44 654.998 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 4 0.536 4.24 654.9983 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.71 0.527 4.52 654.9984 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.43 0.5 4.66 654.9984 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.93 0.457 3.62 654.9984 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.23 0.493 3.35 654.9986 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.2 0.494 4.46 654.9988 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GETGPAGPAGPVGPVGAR 95.00% 3.94 0.451 3.15 773.9023 1,545.79 1,546.80 2
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% GETGPAGPAGPVGPVGAR 95.00% 3.06 0.344 0 774.4034 1,546.79 1,546.80 2
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% STGGISVPGPMGPSGPR 95.00% 2.19 0.456 4.24 777.3893 1,552.76 1,553.77 2
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% STGGISVPGPMGPSGPR 95.00% 2.57 0.45 4.36 777.3898 1,552.76 1,553.77 2
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% STGGISVPGPMGPSGPR 95.00% 2.75 0.453 4.28 777.3901 1,552.76 1,553.77 2
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% STGGISVPGPMGPSGPR 95.00% 2.46 0.439 3.22 777.3905 1,552.77 1,553.77 2
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% STGGISVPGPMGPSGPR 95.00% 2.51 0.436 3.23 777.3905 1,552.77 1,553.77 2
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% STGGISVPGPMGPSGPR 95.00% 2.61 0.433 4.52 777.3906 1,552.77 1,553.77 2
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% STGGISVPGPMGPSGPR 95.00% 2.2 0.391 2 777.3918 1,552.77 1,553.77 2
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% STGGISVPGPMGPSGPR 95.00% 2.37 0.384 1.8 777.8911 1,553.77 1,553.77 2
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.95 0.588 6.44 981.4914 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.31 0.569 5.36 981.4919 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.12 0.597 7.24 981.492 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.49 0.565 6.6 981.4923 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.03 0.616 6.89 981.4925 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.91 0.593 7.47 981.9862 1,961.96 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.12 0.59 7.89 981.9919 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.02 0.574 5.12 981.9926 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.67 0.578 6.72 981.9928 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 12 5.40% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.31 0.591 6.4 981.9929 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GFSGLDGAKGDAGPAGPK 95.00% 2.46 0.431 0 534.6019 1,600.78 1,601.79 3
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GQAGVmGFPGPK 95.00% 2.72 0.368 0 m6: Oxidation (+15.99) 581.2874 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GQAGVmGFPGPK 95.00% 2.85 0.403 1.24 m6: Oxidation (+15.99) 581.2876 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GQAGVmGFPGPK 95.00% 2.95 0.348 3.96 m6: Oxidation (+15.99) 581.2876 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GQAGVmGFPGPK 95.00% 2.91 0.405 2.48 m6: Oxidation (+15.99) 581.2882 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GQAGVmGFPGPK 95.00% 2.77 0.322 2.12 m6: Oxidation (+15.99) 581.2884 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GQAGVmGFPGPK 95.00% 2.96 0.419 1.89 m6: Oxidation (+15.99) 581.2885 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GQAGVmGFPGPK 95.00% 2.87 0.39 2.26 m6: Oxidation (+15.99) 581.2887 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GQAGVmGFPGPK 95.00% 2.69 0.309 2.7 m6: Oxidation (+15.99) 581.2888 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GQAGVmGFPGPK 95.00% 2.71 0.38 2.24 m6: Oxidation (+15.99) 581.2888 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GQAGVmGFPGPK 95.00% 2.61 0.406 1.44 m6: Oxidation (+15.99) 581.2889 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GQAGVmGFPGPK 95.00% 3.04 0.396 2.31 m6: Oxidation (+15.99) 581.2893 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GQAGVmGFPGPK 95.00% 2.36 0.341 2.4 m6: Oxidation (+15.99) 581.2894 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GESGPSGPAGPTGAR 95.00% 2.35 0.296 0 649.3138 1,296.61 1,297.61 2
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.95 0.523 3.92 654.6623 1,960.96 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.34 0.55 4.21 654.6634 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.89 0.537 4.11 654.6635 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.76 0.519 4.17 654.6637 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.55 0.537 6.17 654.664 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.88 0.466 5.55 654.6641 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.09 0.525 3.62 654.6644 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.23 0.506 4.08 654.9974 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.94 0.232 3.49 654.9976 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.92 0.517 4.46 654.9979 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.96 0.245 3 654.998 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.14 0.478 4.12 654.9983 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.49 0.53 4.08 654.9984 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.46 0.417 4.28 654.9985 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.11 0.514 4.96 654.9988 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.33 0.376 3.4 654.9991 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.4 0.536 4.26 654.9993 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% GETGPAGPAGPVGPVGAR 95.00% 3.92 0.499 2.55 773.9021 1,545.79 1,546.80 2
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% STGGISVPGPMGPSGPR 95.00% 2.32 0.347 2.92 777.3886 1,552.76 1,553.77 2
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% STGGISVPGPMGPSGPR 95.00% 2.35 0.415 3.11 777.3892 1,552.76 1,553.77 2
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% STGGISVPGPMGPSGPR 95.00% 2.38 0.437 4.59 777.3899 1,552.76 1,553.77 2
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% STGGISVPGPMGPSGPR 95.00% 2.54 0.426 2.96 777.3902 1,552.76 1,553.77 2
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% STGGISVPGPMGPSGPR 95.00% 2.32 0.314 1.52 777.3932 1,552.77 1,553.77 2
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% STGGISVPGPMGPSGPR 95.00% 2.57 0.49 3.7 777.8921 1,553.77 1,553.77 2
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% STGGISVPGPMGPSGPR 95.00% 2.49 0.42 2.74 777.8935 1,553.77 1,553.77 2
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.42 0.595 7.4 981.4909 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.7 0.566 7.01 981.4917 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.34 0.577 5.06 981.9903 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.16 0.571 6.8 981.9909 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.85 0.587 7.05 981.9923 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.12 0.581 5.92 981.9923 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.73 0.578 7.59 981.9927 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.1 0.58 6.51 981.9936 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.81 0.568 7.26 981.9952 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.94 0.563 6.85 981.9962 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 4 10 5.74% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.53 0.583 6.89 981.997 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GETGPAGPAGPVGPVGAR 95.00% 3.23 0.453 1.66 516.6033 1,546.79 1,546.80 3
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GVPGPPGAVGPAGK 95.00% 1.74 0.44 0 580.8226 1,159.63 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GVPGPPGAVGPAGK 95.00% 1.49 0.515 0 580.8232 1,159.63 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GVPGPPGAVGPAGK 95.00% 1.54 0.463 0 580.8244 1,159.63 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GVPGPPGAVGPAGK 95.00% 1.72 0.546 0 580.8247 1,159.63 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GVPGPPGAVGPAGK 95.00% 1.48 0.48 0 580.825 1,159.63 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.66 0.349 1.19 m6: Oxidation (+15.99) 581.2866 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.9 0.426 1.89 m6: Oxidation (+15.99) 581.2871 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.54 0.295 1.89 m6: Oxidation (+15.99) 581.288 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.98 0.392 1.72 m6: Oxidation (+15.99) 581.2883 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.6 0.354 1.92 m6: Oxidation (+15.99) 581.2883 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.76 0.398 0 m6: Oxidation (+15.99) 581.2885 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.63 0.377 1.35 m6: Oxidation (+15.99) 581.2886 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.98 0.41 2.64 m6: Oxidation (+15.99) 581.2887 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 3.03 0.408 1.68 m6: Oxidation (+15.99) 581.2889 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.99 0.395 2.48 m6: Oxidation (+15.99) 581.289 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.89 0.383 3.06 m6: Oxidation (+15.99) 581.289 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.15 0.236 0 m6: Oxidation (+15.99) 581.2891 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.66 0.357 1.14 m6: Oxidation (+15.99) 581.2894 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.81 0.389 2.82 m6: Oxidation (+15.99) 581.2901 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.87 0.43 2.43 m6: Oxidation (+15.99) 581.2901 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GQAGVmGFPGPK 95.00% 2.38 0.205 1.28 m6: Oxidation (+15.99) 581.7898 1,161.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GESGPSGPAGPTGAR 95.00% 2.55 0.458 0 649.3056 1,296.60 1,297.61 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GESGPSGPAGPTGAR 95.00% 2.4 0.365 0 649.3099 1,296.60 1,297.61 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GESGPSGPAGPTGAR 95.00% 2.68 0.446 1.44 649.3123 1,296.61 1,297.61 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GESGPSGPAGPTGAR 95.00% 2.9 0.413 0 649.3123 1,296.61 1,297.61 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GESGPSGPAGPTGAR 95.00% 2.26 0.263 0 649.3145 1,296.61 1,297.61 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.57 0.519 3.62 654.6632 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.93 0.511 4.16 654.6639 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.65 0.527 5.17 654.664 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.4 0.525 6.27 654.6641 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.57 0.53 4.74 654.6641 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.89 0.399 2.35 654.6642 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.42 0.53 6.01 654.6642 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.36 0.519 4.31 654.6644 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.09 0.566 4.24 654.665 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.93 0.382 3.3 654.9967 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.96 0.492 3.51 654.9976 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.98 0.473 5.49 654.9981 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.7 0.29 1.96 654.9984 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.04 0.478 4.89 654.9985 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.01 0.512 4.8 654.9986 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.21 0.479 3.74 654.9986 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.34 0.463 3.44 654.9987 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.49 0.495 4.14 654.9988 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.96 0.484 4.29 654.9991 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.47 0.347 1.04 654.9994 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.19 0.158 1.42 654.9996 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.37 0.41 2.41 654.9999 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.71 0.464 3.92 655.0001 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.15 0.399 2.11 655.0002 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.81 0.473 2.77 655.0027 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GETGPAGPAGPVGPVGAR 95.00% 3.52 0.405 3.17 774.4015 1,546.79 1,546.80 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GETGPAGPAGPVGPVGAR 95.00% 3.75 0.48 2.92 774.4035 1,546.79 1,546.80 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% STGGISVPGPMGPSGPR 95.00% 2.49 0.455 3.8 777.3896 1,552.76 1,553.77 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% STGGISVPGPMGPSGPR 95.00% 2.26 0.371 3.55 777.3897 1,552.76 1,553.77 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% STGGISVPGPMGPSGPR 95.00% 2.84 0.472 3.51 777.3902 1,552.76 1,553.77 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% STGGISVPGPMGPSGPR 95.00% 2.14 0.413 3.35 777.3907 1,552.77 1,553.77 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% STGGISVPGPMGPSGPR 95.00% 1.84 0.0959 3.35 777.3911 1,552.77 1,553.77 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% STGGISVPGPMGPSGPR 95.00% 2.57 0.455 3.05 777.3913 1,552.77 1,553.77 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% STGGISVPGPMGPSGPR 95.00% 2.52 0.428 3 777.3914 1,552.77 1,553.77 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% STGGISVPGPMGPSGPR 95.00% 2.46 0.47 3.38 777.3915 1,552.77 1,553.77 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% STGGISVPGPMGPSGPR 95.00% 2.62 0.416 3.08 777.3916 1,552.77 1,553.77 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% STGGISVPGPMGPSGPR 95.00% 2.59 0.189 1.77 777.3933 1,552.77 1,553.77 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GFSGLDGAKGDAGPAGPK 95.00% 3.55 0.449 4.66 801.3989 1,600.78 1,601.79 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GFSGLDGAKGDAGPAGPK 95.00% 4.05 0.472 7.85 801.399 1,600.78 1,601.79 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% GFSGLDGAKGDAGPAGPK 95.00% 4.05 0.523 7.2 801.3994 1,600.78 1,601.79 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% DGEAGAQGPPGPAGPAGER 95.00% 3.95 0.538 3.35 845.89 1,689.76 1,690.78 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% DGEAGAQGPPGPAGPAGER 95.00% 4.06 0.621 3.35 845.8909 1,689.77 1,690.78 2
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.7 0.57 7.14 981.49 1,960.96 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.37 0.596 8.15 981.4904 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.03 0.58 7.02 981.491 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.66 0.575 7.05 981.4922 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.76 0.589 6.64 981.4956 1,960.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.96 0.566 7.14 981.9912 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.71 0.564 5.59 981.9919 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.05 0.596 5.72 981.9923 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.32 0.587 7.23 981.9931 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.99 0.596 6.09 981.9933 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3 Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 5 6 23 7.99% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.18 0.578 7.72 981.9942 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GETGPAGPAGPVGPVGAR 95.00% 3.48 0.415 4.34 516.6034 1,546.79 1,546.80 3
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GFSGLDGAKGDAGPAGPK 95.00% 2.89 0.533 1.44 534.6014 1,600.78 1,601.79 3
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GFSGLDGAKGDAGPAGPK 95.00% 3.69 0.533 1.66 534.9362 1,601.79 1,601.79 3
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GVPGPPGAVGPAGK 95.00% 1.51 0.449 0 580.8237 1,159.63 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GVPGPPGAVGPAGK 95.00% 1.42 0.464 0 580.8238 1,159.63 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GVPGPPGAVGPAGK 95.00% 1.5 0.374 0 580.8238 1,159.63 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 1.91 0.306 0 m6: Oxidation (+15.99) 581.2852 1,160.55 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.82 0.421 0 m6: Oxidation (+15.99) 581.2868 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.92 0.446 1.44 m6: Oxidation (+15.99) 581.2869 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.81 0.363 3.04 m6: Oxidation (+15.99) 581.2877 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.81 0.366 0 m6: Oxidation (+15.99) 581.2878 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.73 0.37 2.02 m6: Oxidation (+15.99) 581.2879 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.14 0.297 0 m6: Oxidation (+15.99) 581.2879 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.5 0.309 0 m6: Oxidation (+15.99) 581.2882 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.66 0.329 0 m6: Oxidation (+15.99) 581.2882 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.73 0.413 1.17 m6: Oxidation (+15.99) 581.2885 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.84 0.352 1.82 m6: Oxidation (+15.99) 581.2887 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.86 0.4 1.77 m6: Oxidation (+15.99) 581.2888 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.84 0.359 1.72 m6: Oxidation (+15.99) 581.2889 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.76 0.412 0 m6: Oxidation (+15.99) 581.2893 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.93 0.338 1.89 m6: Oxidation (+15.99) 581.2893 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.52 0.333 0 m6: Oxidation (+15.99) 581.2896 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.36 0.392 0 m6: Oxidation (+15.99) 581.2897 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.78 0.422 2.8 m6: Oxidation (+15.99) 581.2897 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GQAGVmGFPGPK 95.00% 2.4 0.392 0 m6: Oxidation (+15.99) 581.2897 1,160.56 1,161.57 2 MUC16_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GVPGPPGAVGPAGK 95.00% 1.51 0.368 1.19 581.3238 1,160.63 1,160.64 2 LRP1_HUMAN,HNRPU_HUMAN,DESM_HUMAN,SPTA2_HUMAN,ACTC_HUMAN,ACTB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GESGPSGPAGPTGAR 95.00% 2.41 0.313 0 649.3093 1,296.60 1,297.61 2
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GESGPSGPAGPTGAR 95.00% 2.32 0.398 0 649.3105 1,296.61 1,297.61 2
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GESGPSGPAGPTGAR 95.00% 2.71 0.433 1.34 649.3132 1,296.61 1,297.61 2
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GESGPSGPAGPTGAR 95.00% 2.38 0.436 0 649.3133 1,296.61 1,297.61 2
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.45 0.515 5.92 654.6633 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.5 0.55 4.19 654.6636 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.9 0.483 4.32 654.6639 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.93 0.493 7.12 654.6641 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.47 0.556 5.15 654.6641 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.13 0.504 3.85 654.6644 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.24 0.504 4.8 654.6646 1,960.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.78 0.47 3.46 654.6664 1,960.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.64 0.476 5.39 654.9971 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.89 0.477 5.03 654.9974 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.25 0.488 5.68 654.9974 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.95 0.451 4.62 654.9974 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.44 0.533 6.04 654.998 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 3.8 0.47 3.6 654.9982 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.2 0.513 5.41 654.9982 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.43 0.529 3.8 654.9988 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.23 0.54 6.85 654.999 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.01 0.548 4.77 654.999 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.08 0.544 5.92 654.999 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.32 0.523 6.59 654.9992 1,961.97 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.15 0.485 4.8 654.9995 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 2.98 0.436 2.68 655.0005 1,961.98 1,961.98 3 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GETGPAGPAGPVGPVGAR 95.00% 3.49 0.546 2.4 774.4022 1,546.79 1,546.80 2
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% GETGPAGPAGPVGPVGAR 95.00% 3.75 0.459 3.1 774.4029 1,546.79 1,546.80 2
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% STGGISVPGPMGPSGPR 95.00% 2.35 0.406 3.96 777.3895 1,552.76 1,553.77 2
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% STGGISVPGPMGPSGPR 95.00% 2.51 0.439 3.39 777.3901 1,552.76 1,553.77 2
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% STGGISVPGPMGPSGPR 95.00% 2.22 0.339 3.37 777.3913 1,552.77 1,553.77 2
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% STGGISVPGPMGPSGPR 95.00% 2.35 0.341 1.68 777.392 1,552.77 1,553.77 2
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% STGGISVPGPMGPSGPR 95.00% 2.49 0.265 3.19 777.3927 1,552.77 1,553.77 2
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% STGGISVPGPMGPSGPR 95.00% 2.26 0.401 3.33 777.3929 1,552.77 1,553.77 2
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.84 0.577 7.33 981.4903 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.35 0.578 7.96 981.4906 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.05 0.587 8.1 981.4914 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.7 0.557 6.92 981.4917 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.62 0.539 6.03 981.4923 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.96 0.565 7.07 981.4928 1,960.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.16 0.556 7.29 981.9915 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5 0.585 6.62 981.9916 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.24 0.609 5.1 981.9924 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.86 0.567 8 981.9939 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.16 0.557 5.96 981.994 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 4.88 0.574 8.06 981.995 1,961.97 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 3R Collagen alpha-1(I) chain  COL1A1  CO1A1_HUMAN 138,893.40 100.00% 4 5 15 6.69% SGDRGETGPAGPAGPVGPVGAR 95.00% 5.13 0.557 7.02 981.997 1,961.98 1,961.98 2 MYLK_HUMAN,AHNK_HUMAN,HS90B_HUMAN,FBLN5_HUMAN
 SAMPLE 2 Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 7 1.80% ILYHGYSLLYVQGNER 95.00% 3.58 0.204 1.08 642.3359 1,923.98 1,924.99 3
 SAMPLE 2 Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 7 1.80% ILYHGYSLLYVQGNER 95.00% 3.78 0.206 0 642.6684 1,924.98 1,924.99 3
 SAMPLE 2 Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 7 1.80% ILYHGYSLLYVQGNER 95.00% 3.15 0.142 0 642.6708 1,924.99 1,924.99 3
 SAMPLE 2 Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 7 1.80% AHGQDLGTAGScLR 95.00% 3.55 0.475 6.82 c12: Carbamidomethyl (+57.02) 721.8438 1,441.67 1,442.68 2
 SAMPLE 2 Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 7 1.80% ILYHGYSLLYVQGNER 95.00% 5.13 0.473 4.49 963.499 1,924.98 1,924.99 2
 SAMPLE 2 Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 7 1.80% ILYHGYSLLYVQGNER 95.00% 5.22 0.49 4.32 963.4999 1,924.98 1,924.99 2
 SAMPLE 2 Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 7 1.80% ILYHGYSLLYVQGNER 95.00% 4.96 0.495 5.89 963.5016 1,924.99 1,924.99 2
 SAMPLE 2R Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 11 1.80% ILYHGYSLLYVQGNER 95.00% 3.82 0.234 2.33 642.3343 1,923.98 1,924.99 3
 SAMPLE 2R Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 11 1.80% ILYHGYSLLYVQGNER 95.00% 4.21 0.25 2.34 642.3361 1,923.98 1,924.99 3
 SAMPLE 2R Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 11 1.80% ILYHGYSLLYVQGNER 95.00% 3.93 0.226 2.04 642.3364 1,923.99 1,924.99 3
 SAMPLE 2R Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 11 1.80% ILYHGYSLLYVQGNER 95.00% 4.4 0.26 2.32 642.6696 1,924.99 1,924.99 3
 SAMPLE 2R Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 11 1.80% AHGQDLGTAGScLR 95.00% 2.84 0.527 4.27 c12: Carbamidomethyl (+57.02) 721.8399 1,441.66 1,442.68 2
 SAMPLE 2R Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 11 1.80% AHGQDLGTAGScLR 95.00% 3.72 0.508 7.19 c12: Carbamidomethyl (+57.02) 721.8437 1,441.67 1,442.68 2
 SAMPLE 2R Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 11 1.80% ILYHGYSLLYVQGNER 95.00% 2.75 0.433 0 962.9182 1,923.82 1,924.99 2
 SAMPLE 2R Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 11 1.80% ILYHGYSLLYVQGNER 95.00% 3.69 0.437 1.6 963.4207 1,924.83 1,924.99 2
 SAMPLE 2R Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 11 1.80% ILYHGYSLLYVQGNER 95.00% 4.94 0.504 4.46 963.4973 1,924.98 1,924.99 2
 SAMPLE 2R Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 11 1.80% ILYHGYSLLYVQGNER 95.00% 5.04 0.421 4.85 963.4998 1,924.98 1,924.99 2
 SAMPLE 2R Collagen alpha-1(IV) chain  COL4A1  CO4A1_HUMAN 160,599.50 99.80% 2 3 11 1.80% ILYHGYSLLYVQGNER 95.00% 5.21 0.456 3.96 963.501 1,924.99 1,924.99 2
 SAMPLE 3R Collagen alpha-1(V) chain  COL5A1  CO5A1_HUMAN 183,544.70 99.80% 2 2 12 1.63% GPAGPMGLTGR 95.00% 2.45 0.323 0 507.2619 1,012.51 1,013.52 2
 SAMPLE 3R Collagen alpha-1(V) chain  COL5A1  CO5A1_HUMAN 183,544.70 99.80% 2 2 12 1.63% GPAGPMGLTGR 95.00% 3.1 0.526 0 507.2622 1,012.51 1,013.52 2
 SAMPLE 3R Collagen alpha-1(V) chain  COL5A1  CO5A1_HUMAN 183,544.70 99.80% 2 2 12 1.63% GPAGPMGLTGR 95.00% 2.99 0.513 0 507.2624 1,012.51 1,013.52 2
 SAMPLE 3R Collagen alpha-1(V) chain  COL5A1  CO5A1_HUMAN 183,544.70 99.80% 2 2 12 1.63% GPAGPMGLTGR 95.00% 3.03 0.594 0 507.2625 1,012.51 1,013.52 2
 SAMPLE 3R Collagen alpha-1(V) chain  COL5A1  CO5A1_HUMAN 183,544.70 99.80% 2 2 12 1.63% GPAGPMGLTGR 95.00% 2.37 0.413 0 507.2625 1,012.51 1,013.52 2
 SAMPLE 3R Collagen alpha-1(V) chain  COL5A1  CO5A1_HUMAN 183,544.70 99.80% 2 2 12 1.63% GPAGPMGLTGR 95.00% 2.52 0.505 0 507.2627 1,012.51 1,013.52 2
 SAMPLE 3R Collagen alpha-1(V) chain  COL5A1  CO5A1_HUMAN 183,544.70 99.80% 2 2 12 1.63% GPAGPMGLTGR 95.00% 2.48 0.483 0 507.2628 1,012.51 1,013.52 2
 SAMPLE 3R Collagen alpha-1(V) chain  COL5A1  CO5A1_HUMAN 183,544.70 99.80% 2 2 12 1.63% GPAGPmGLTGR 95.00% 2.28 0.373 0 m6: Oxidation (+15.99) 515.2603 1,028.50 1,029.52 2
 SAMPLE 3R Collagen alpha-1(V) chain  COL5A1  CO5A1_HUMAN 183,544.70 99.80% 2 2 12 1.63% GPAGPmGLTGR 95.00% 1.96 0.322 0 m6: Oxidation (+15.99) 515.2607 1,028.51 1,029.52 2
 SAMPLE 3R Collagen alpha-1(V) chain  COL5A1  CO5A1_HUMAN 183,544.70 99.80% 2 2 12 1.63% GPAGPmGLTGR 95.00% 2.16 0.399 0 m6: Oxidation (+15.99) 515.2613 1,028.51 1,029.52 2
 SAMPLE 3R Collagen alpha-1(V) chain  COL5A1  CO5A1_HUMAN 183,544.70 99.80% 2 2 12 1.63% GPAGPmGLTGR 95.00% 2.11 0.373 0 m6: Oxidation (+15.99) 515.2617 1,028.51 1,029.52 2
 SAMPLE 3R Collagen alpha-1(V) chain  COL5A1  CO5A1_HUMAN 183,544.70 99.80% 2 2 12 1.63% GPMVSAQESQAQAILQQAR 95.00% 5.54 0.47 5.33 1,007.51 2,013.01 2,013.02 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.76 0.435 3.19 450.9315 1,349.77 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.15 0.404 2.85 450.9321 1,349.77 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.07 0.441 3.57 450.9322 1,349.77 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.46 0.473 3.37 450.9324 1,349.77 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.65 0.468 4.52 450.9325 1,349.77 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.39 0.36 2.44 450.9326 1,349.77 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.43 0.372 2.25 450.9327 1,349.77 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.89 0.449 4.72 450.9327 1,349.77 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.6 0.398 3.09 450.9327 1,349.77 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.97 0.365 2.8 450.9329 1,349.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.2 0.429 4.22 450.933 1,349.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.81 0.52 2.42 450.9332 1,349.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.31 0.423 2.77 450.9333 1,349.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.03 0.443 3.38 450.9335 1,349.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.23 0.427 4.85 450.9335 1,349.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.53 0.47 3.34 450.9335 1,349.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.62 0.411 2.92 450.9336 1,349.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.88 0.43 2.85 450.9337 1,349.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.62 0.442 2.12 450.9337 1,349.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.95 0.365 1.89 450.9341 1,349.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.52 0.395 0.959 450.9341 1,349.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.89 0.406 2.72 451.2667 1,350.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.32 0.379 1.05 451.2677 1,350.78 1,350.77 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 2.67 0.386 2.09 479.2693 956.5229 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 3.23 0.422 2.19 479.2906 956.5655 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 3.28 0.476 2.24 479.2906 956.5655 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 3.05 0.413 2.05 479.2914 956.5671 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 2.05 0.331 2.48 479.2914 956.5672 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 3.03 0.408 2 479.2917 956.5677 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 3.19 0.441 2.11 479.2917 956.5678 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 3.13 0.44 1.7 479.2917 956.5678 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 2.14 0.361 1.82 479.2926 956.5696 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 2 0.376 2.82 479.2928 956.57 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 3.06 0.422 1.6 479.2931 956.5705 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 2.35 0.341 0 479.2934 956.5711 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 2.8 0.389 2.17 479.2937 956.5717 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 2.1 0.34 1.85 479.294 956.5724 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 2.14 0.244 0 479.294 956.5724 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% IALVITDGR 95.00% 2.93 0.39 1.59 479.2952 956.5748 957.5735 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LSIIATDHTYRR 95.00% 2.36 0.177 0 482.6014 1,444.78 1,445.79 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% KGLEQLLVGGSHLK 95.00% 3.28 0.191 1.43 493.257 1,476.75 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% KGLEQLLVGGSHLK 95.00% 2.91 0.218 2.15 493.2579 1,476.75 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% KGLEQLLVGGSHLK 95.00% 3.22 0.148 0 493.6276 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% KGLEQLLVGGSHLK 95.00% 3.38 0.266 1.66 493.6278 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% KGLEQLLVGGSHLK 95.00% 4.13 0.323 2.59 493.6286 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% KGLEQLLVGGSHLK 95.00% 4.98 0.421 1.82 493.6288 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% KGLEQLLVGGSHLK 95.00% 2.85 0.222 0 493.629 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% KGLEQLLVGGSHLK 95.00% 4.26 0.28 3.02 493.6293 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% KGLEQLLVGGSHLK 95.00% 3.41 0.421 2.47 493.6299 1,477.87 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% KGLEQLLVGGSHLK 95.00% 2.72 0.339 0 493.63 1,477.87 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% KGLEQLLVGGSHLK 95.00% 4.23 0.285 3.47 493.9633 1,478.87 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GVFHQTVSR 95.00% 2.16 0.255 0 515.781 1,029.55 1,030.54 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% FLTAGRTDPAHDVR 95.00% 1.89 0.295 0 519.2735 1,554.80 1,555.80 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% FLTAGRTDPAHDVR 95.00% 2.28 0.306 0 519.2735 1,554.80 1,555.80 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% FLTAGRTDPAHDVR 95.00% 2.1 0.291 1.4 519.6077 1,555.80 1,555.80 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.22 0.144 1.96 523.8035 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.52 0.335 2 523.8037 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.89 0.469 2.32 523.8042 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.34 0.198 0 523.8042 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 3.04 0.47 1.89 523.8043 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.76 0.434 1.3 523.8044 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 3.03 0.496 1.96 523.8045 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.35 0.177 1.21 523.8045 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.92 0.491 1.68 523.8047 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.64 0.383 1.74 523.8047 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.89 0.336 0 523.8047 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.65 0.286 1.66 523.8047 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.36 0.324 1.48 523.8048 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 3.09 0.492 1.66 523.8049 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.24 0.184 2.17 523.8049 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 3.08 0.405 1.85 523.805 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.89 0.495 1.59 523.805 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.44 0.211 1.28 523.8051 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.9 0.393 1.57 523.8053 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.69 0.377 1.89 523.8053 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.88 0.383 2.62 523.8053 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.83 0.379 1.92 523.8057 1,045.60 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VPSYQALLR 95.00% 2.39 0.278 0 523.8073 1,045.60 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.51 0.307 1.6 527.6195 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.23 0.403 2.23 527.6196 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.45 0.403 1.89 527.6198 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.58 0.469 2 527.6199 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.48 0.308 0 527.6201 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.39 0.322 1.24 527.6201 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.53 0.31 1.54 527.6202 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.92 0.408 1.39 527.6204 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.68 0.312 1.43 527.6205 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.53 0.376 1.2 527.6205 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.01 0.384 2.82 527.6206 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.67 0.264 1.24 527.6206 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.29 0.347 3.01 527.6207 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.11 0.215 2.19 527.6207 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.42 0.246 2 527.6208 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.26 0.334 1.46 527.621 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.17 0.323 2.07 527.621 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.76 0.35 1.4 527.6211 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.05 0.351 1.39 527.6211 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.01 0.328 1.52 527.6212 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.64 0.309 1.14 527.6212 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.79 0.35 1.11 527.6214 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.02 0.362 0 527.6218 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.56 0.211 0 527.622 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.99 0.476 1.82 527.623 1,579.85 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.4 0.211 0 527.624 1,579.85 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.09 0.233 1.11 527.9556 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.34 0.274 0 527.9556 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.24 0.403 1.25 527.9558 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.22 0.459 0 527.9567 1,580.85 1,580.84 3 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% DALKSSVDAVKYFGK 95.00% 3 0.326 0 543.243 1,626.71 1,627.87 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% DALKSSVDAVKYFGK 95.00% 2.46 0.235 0 543.2438 1,626.71 1,627.87 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LKPYGALVDK 95.00% 2.59 0.352 0 551.8138 1,101.61 1,103.65 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 3.1 0.299 0 568.6378 1,702.89 1,703.90 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 3.25 0.425 1.7 568.6387 1,702.89 1,703.90 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 2.84 0.205 0 568.6388 1,702.89 1,703.90 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 2.93 0.443 1.08 568.6394 1,702.89 1,703.90 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 3.74 0.461 1.43 568.6398 1,702.90 1,703.90 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 3.75 0.439 1.36 568.6398 1,702.90 1,703.90 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 1.86 0.306 0 568.6429 1,702.91 1,703.90 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 3.12 0.484 1.31 568.974 1,703.90 1,703.90 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 3.11 0.419 0 568.9743 1,703.90 1,703.90 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 2.79 0.393 1.39 574.6575 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 4.39 0.591 1.54 574.6576 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 4.46 0.607 2.59 574.6578 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 3.17 0.508 3.57 574.6579 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 5.17 0.611 1.82 574.658 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 4.58 0.558 1.66 574.658 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 3.3 0.445 3.92 574.6585 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 4.1 0.509 1.77 574.6587 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 4.7 0.505 1.59 574.9911 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 3.96 0.543 1.08 574.9913 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 3.79 0.517 1.54 574.9916 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 3.72 0.484 2.01 574.9922 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 3.95 0.565 2.59 574.9927 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 3.17 0.366 0 574.9932 1,721.96 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.14 0.471 1.96 586.61 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 2.33 0.226 0 586.61 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 2.81 0.494 2.08 586.6102 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.64 0.396 1.92 586.6103 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.09 0.423 1.66 586.6103 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.05 0.411 1.12 586.6104 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.19 0.436 1.68 586.6105 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.16 0.387 0 586.6107 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.19 0.368 2.85 586.6108 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.69 0.409 1.74 586.6108 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 2.56 0.325 1.52 586.611 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.03 0.366 1.39 586.611 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.48 0.411 1.11 586.6113 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.65 0.467 1.15 586.6114 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 2.98 0.446 1.7 586.6114 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 2.53 0.303 0 586.6117 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.3 0.561 2.2 586.6124 1,756.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 2.99 0.402 2.64 586.6132 1,756.82 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.55 0.481 2.25 586.9444 1,757.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.01 0.383 1.19 586.9446 1,757.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.2 0.462 0 586.9448 1,757.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 3.42 0.468 2.96 586.9453 1,757.81 1,757.81 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 2.34 0.267 0 592.3127 1,773.91 1,774.92 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 3.34 0.601 3.89 592.3127 1,773.91 1,774.92 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 2.9 0.568 3.02 592.3135 1,773.92 1,774.92 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 3.19 0.586 4.72 592.3138 1,773.92 1,774.92 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 2.93 0.577 2.4 592.3138 1,773.92 1,774.92 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 2.79 0.574 4.44 592.3141 1,773.92 1,774.92 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 2.95 0.576 3.38 592.3144 1,773.92 1,774.92 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 2.7 0.499 3.89 592.3147 1,773.92 1,774.92 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 1.88 0.214 2.06 592.6476 1,774.92 1,774.92 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 2.89 0.548 4 592.6485 1,774.92 1,774.92 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% DQLLPPSPNNR 95.00% 2.52 0.241 0 625.8291 1,249.64 1,250.65 2 IQGA1_HUMAN,AHNK_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% DQLLPPSPNNR 95.00% 2.27 0.262 0 625.8293 1,249.64 1,250.65 2 IQGA1_HUMAN,AHNK_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% DQLLPPSPNNR 95.00% 2.36 0.191 1.31 625.8294 1,249.64 1,250.65 2 IQGA1_HUMAN,AHNK_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% DQLLPPSPNNR 95.00% 2.21 0.262 1.85 625.8295 1,249.64 1,250.65 2 IQGA1_HUMAN,AHNK_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% DQLLPPSPNNR 95.00% 2.36 0.283 1.54 625.8297 1,249.64 1,250.65 2 IQGA1_HUMAN,AHNK_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% DQLLPPSPNNR 95.00% 2.48 0.376 0 625.83 1,249.64 1,250.65 2 IQGA1_HUMAN,AHNK_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% DQLLPPSPNNR 95.00% 2.23 0.223 2.72 626.3216 1,250.63 1,250.65 2 IQGA1_HUMAN,AHNK_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 3.22 0.324 0 644.676 1,931.00 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 3.78 0.477 2.57 644.6762 1,931.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 2.42 0.303 0 644.6772 1,931.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 3.18 0.352 0 645.0101 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 2.64 0.322 0 645.0101 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 4.67 0.456 2.64 645.0107 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 3.05 0.399 0 645.0107 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 3.96 0.471 1.12 645.0107 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 3.25 0.309 0 645.0109 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 3.56 0.462 1.05 645.0112 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 3.64 0.386 1.43 645.0112 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 4.38 0.484 1.68 645.012 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 5.89 0.53 6.68 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.6161 1,996.82 1,997.83 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 4.32 0.521 4.96 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.6166 1,996.83 1,997.83 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 5.56 0.545 3.74 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.9487 1,997.82 1,997.83 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 5.75 0.549 3.51 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.9499 1,997.83 1,997.83 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 6.19 0.532 4.62 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.95 1,997.83 1,997.83 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 5.53 0.544 4.6 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.9501 1,997.83 1,997.83 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.82 0.47 3 675.8913 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.43 0.385 0 675.8915 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.34 0.404 0 675.8916 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.77 0.424 2.51 675.892 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.88 0.472 3.22 675.8922 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.83 0.389 2.68 675.8924 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.24 0.385 1.3 675.8924 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.4 0.376 2.7 675.8927 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.46 0.408 3.33 675.8928 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 4.2 0.519 1.74 675.893 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 3.59 0.513 2.7 675.8934 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 2.72 0.301 2.59 675.8941 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLK 95.00% 4.29 0.477 4.28 675.8949 1,349.77 1,350.77 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% RLLLFSDGNSQGATPAAIEK 95.00% 4.17 0.483 2.35 696.7097 2,087.11 2,088.11 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% RLLLFSDGNSQGATPAAIEK 95.00% 4.93 0.331 2.11 696.7098 2,087.11 2,088.11 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% RLLLFSDGNSQGATPAAIEK 95.00% 4.11 0.429 1.57 696.7107 2,087.11 2,088.11 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% RLLLFSDGNSQGATPAAIEK 95.00% 4.67 0.577 2.66 697.0425 2,088.10 2,088.11 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% RLLLFSDGNSQGATPAAIEK 95.00% 2.96 0.381 0 697.0428 2,088.10 2,088.11 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% RLLLFSDGNSQGATPAAIEK 95.00% 4.16 0.471 0 697.043 2,088.11 2,088.11 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% RLLLFSDGNSQGATPAAIEK 95.00% 5.4 0.622 3.62 697.0433 2,088.11 2,088.11 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% RLLLFSDGNSQGATPAAIEK 95.00% 5.32 0.558 2.05 697.0436 2,088.11 2,088.11 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% RLLLFSDGNSQGATPAAIEK 95.00% 3.6 0.475 1.85 697.0444 2,088.11 2,088.11 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% RLLLFSDGNSQGATPAAIEK 95.00% 2.82 0.373 1.64 697.0449 2,088.11 2,088.11 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% RLLLFSDGNSQGATPAAIEK 95.00% 4.21 0.549 3.07 697.0454 2,088.11 2,088.11 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% KGLEQLLVGGSHLK 95.00% 2.96 0.375 0 739.9471 1,477.88 1,478.87 2 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% EPcGGLEDAVNEAK 95.00% 3.29 0.498 2.23 c3: Carbamidomethyl (+57.02) 744.8379 1,487.66 1,488.66 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% EPcGGLEDAVNEAK 95.00% 3.18 0.451 2.72 c3: Carbamidomethyl (+57.02) 744.8385 1,487.66 1,488.66 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% EPcGGLEDAVNEAK 95.00% 2.95 0.469 2.34 c3: Carbamidomethyl (+57.02) 744.8391 1,487.66 1,488.66 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% EPcGGLEDAVNEAK 95.00% 2.95 0.429 1.74 c3: Carbamidomethyl (+57.02) 744.8394 1,487.66 1,488.66 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% FLTAGRTDPAHDVR 95.00% 2.3 0.12 1.59 778.4069 1,554.80 1,555.80 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% FLTAGRTDPAHDVR 95.00% 2.28 0.191 1.85 778.9096 1,555.80 1,555.80 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.59 0.505 3.37 790.927 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.57 0.497 2.64 790.9276 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.77 0.52 2.1 790.9278 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.5 0.476 2.38 790.9285 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.69 0.503 2.46 790.9286 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.26 0.506 2.77 790.9292 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.62 0.496 3.19 790.93 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 1.86 0.497 1.8 791.0201 1,580.02 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 1.91 0.487 0 791.0204 1,580.03 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.36 0.474 1.22 791.0207 1,580.03 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 1.94 0.397 0 791.0207 1,580.03 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 1.72 0.442 0 791.0215 1,580.03 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.33 0.473 0 791.0216 1,580.03 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 1.98 0.433 1.29 791.0216 1,580.03 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.47 0.548 0 791.0218 1,580.03 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.79 0.478 2.06 791.0222 1,580.03 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 3.16 0.421 1.43 791.4305 1,580.85 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VFSVAITPDHLEPR 95.00% 2.36 0.378 0 791.4334 1,580.85 1,580.84 2 LRP1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 5.25 0.478 5.12 852.4565 1,702.90 1,703.90 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 5.04 0.545 4.16 852.4591 1,702.90 1,703.90 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 5 0.588 3.32 852.4602 1,702.90 1,703.90 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 5.04 0.545 3.85 852.956 1,703.90 1,703.90 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% YLIVVTDGHPLEGYK 95.00% 4.92 0.51 3.85 852.958 1,703.90 1,703.90 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 4.3 0.426 3.51 861.4813 1,720.95 1,721.96 2 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 4.19 0.412 4.46 861.4852 1,720.95 1,721.96 2 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 3.02 0.408 0 861.4857 1,720.96 1,721.96 2 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 4.23 0.392 4.29 861.9872 1,721.96 1,721.96 2 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% GLEQLLVGGSHLKENK 95.00% 2.27 0.316 0 861.9875 1,721.96 1,721.96 2 CO5A1_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.91 0.613 4.96 879.4117 1,756.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.76 0.606 5.15 879.4117 1,756.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.92 0.625 6.25 879.4119 1,756.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.88 0.612 5.89 879.412 1,756.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.78 0.606 6.08 879.4127 1,756.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.67 0.609 5.41 879.4128 1,756.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.8 0.602 3.82 879.4129 1,756.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.78 0.591 4.7 879.413 1,756.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.69 0.604 6.12 879.4134 1,756.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 5.35 0.647 4.89 879.4135 1,756.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 5 0.583 4.89 879.4167 1,756.82 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 5.13 0.618 5.62 879.9118 1,757.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.88 0.622 5.77 879.912 1,757.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.56 0.627 6.28 879.9121 1,757.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.75 0.595 5 879.9133 1,757.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.98 0.614 5.51 879.9134 1,757.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 5.48 0.631 5.72 879.9142 1,757.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.87 0.581 5.09 879.9144 1,757.81 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% TAEYDVAYGESHLFR 95.00% 4.42 0.654 5.43 879.9179 1,757.82 1,757.81 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 3 0.177 1.21 887.9648 1,773.91 1,774.92 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 2.98 0.161 1.49 887.9651 1,773.91 1,774.92 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 3.23 0.265 0 887.9659 1,773.92 1,774.92 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 3.03 0.209 0 887.9663 1,773.92 1,774.92 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 3.07 0.188 0 887.9667 1,773.92 1,774.92 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 3.06 0.208 0 887.9668 1,773.92 1,774.92 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 3.19 0.215 0 887.9675 1,773.92 1,774.92 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% VAVVQYSGTGQQRPER 95.00% 3.06 0.218 1.74 887.9675 1,773.92 1,774.92 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% FEPGQSYAGVVQYSHSQMQEHVSLR 95.00% 1.76 0.19 4.77 955.7889 2,864.34 2,864.34 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% FEPGQSYAGVVQYSHSQMQEHVSLR 95.00% 1.65 0.341 3.48 955.7891 2,864.34 2,864.34 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% FEPGQSYAGVVQYSHSQmQEHVSLR 95.00% 1.5 0.357 1.82 m18: Oxidation (+15.99) 961.1227 2,880.34 2,880.34 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.26 0.622 6.14 966.508 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.42 0.584 5.68 966.5082 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 5.52 0.572 4.92 966.5083 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.38 0.592 5.72 966.5084 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.44 0.604 5.17 966.5086 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.42 0.594 5.35 966.5092 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.33 0.572 6.36 966.5102 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 5.81 0.588 4.41 966.5106 1,931.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.18 0.595 4.85 966.5108 1,931.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.6 0.484 5.21 967.0077 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.22 0.482 5.59 967.0083 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% eASSGAAKKRLLLFSDGNSQGATPAAIEK 95.00% 0 0 3.59 e1: Pyro_glu (-18.01) 967.0084 2,898.00 2,899.53 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.68 0.518 5.05 967.0089 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.55 0.514 5.24 967.01 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.18 0.493 4.96 967.01 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.77 0.503 5.85 967.0103 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.35 0.531 5.6 967.0105 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6 0.488 4.46 967.0109 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.53 0.515 4.92 967.0109 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.42 0.526 3.96 967.0109 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% eASSGAAKKRLLLFSDGNSQGATPAAIEK 95.00% 0 0 3.28 e1: Pyro_glu (-18.01) 967.011 2,898.01 2,899.53 3
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.52 0.504 4.89 967.0111 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.31 0.487 4.89 967.0116 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.5 0.534 5.28 967.0117 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.63 0.49 4.82 967.0119 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 6.18 0.514 5.06 967.0123 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 5.41 0.413 4.03 967.0141 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% LLLFSDGNSQGATPAAIEK 95.00% 5.42 0.375 2.62 967.0149 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 5.05 0.499 5.68 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4172 1,996.82 1,997.83 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 4.93 0.51 5.96 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4178 1,996.82 1,997.83 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 4.97 0.574 5.38 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4179 1,996.82 1,997.83 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 5.05 0.506 5.47 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4183 1,996.82 1,997.83 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 4.98 0.573 5.6 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4188 1,996.82 1,997.83 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 5.16 0.569 5.64 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4223 1,996.83 1,997.83 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 5.37 0.544 5.36 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9181 1,997.82 1,997.83 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 4.85 0.543 4.49 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.919 1,997.82 1,997.83 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 5.46 0.57 4.68 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9197 1,997.82 1,997.83 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 5.3 0.522 3.89 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9206 1,997.83 1,997.83 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% NNVEQVccSFEcQPAR 95.00% 4.89 0.542 4.54 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9227 1,997.83 1,997.83 2
 SAMPLE 4 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 19 27 263 26.20% SLQWMAGGTFTGEALQYTR 95.00% 6.69 0.66 5.62 1,059.51 2,117.01 2,117.01 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.9 0.333 2.92 450.9317 1,349.77 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.93 0.252 2.03 450.9319 1,349.77 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.1 0.413 2.77 450.9321 1,349.77 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.35 0.358 2.55 450.9321 1,349.77 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.04 0.324 2.32 450.9322 1,349.77 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.9 0.394 1.82 450.9323 1,349.77 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.26 0.391 2.17 450.9325 1,349.77 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.85 0.354 2.55 450.9326 1,349.77 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.69 0.416 1.64 450.9327 1,349.77 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.25 0.487 2.52 450.9329 1,349.78 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.01 0.393 2.28 450.9331 1,349.78 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.81 0.362 4 450.9332 1,349.78 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.87 0.381 3.66 450.9332 1,349.78 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.93 0.409 2.82 450.9333 1,349.78 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.17 0.435 1.49 450.9333 1,349.78 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.98 0.487 2.38 450.9334 1,349.78 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.88 0.451 2.09 450.9337 1,349.78 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.76 0.398 2.47 450.9391 1,349.79 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.92 0.351 2.55 451.2662 1,350.78 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.72 0.424 2.06 451.2664 1,350.78 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.39 0.293 2.57 451.2678 1,350.78 1,350.77 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 1.53 0.245 1.7 479.2905 956.5654 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.02 0.45 2.7 479.2906 956.5655 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.11 0.46 2.89 479.2908 956.566 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.06 0.412 2.8 479.2908 956.566 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 2.18 0.341 3.22 479.2909 956.5661 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.11 0.453 2.28 479.291 956.5664 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 2.02 0.347 3 479.2915 956.5674 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.05 0.395 0 479.2915 956.5674 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.44 0.46 1.66 479.2915 956.5674 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.34 0.475 1.68 479.2918 956.5679 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.16 0.41 1.92 479.2918 956.568 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 2.82 0.371 1.43 479.2923 956.5689 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 2.75 0.392 0 479.2924 956.5691 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.05 0.447 2.1 479.2924 956.5692 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.19 0.446 2.05 479.2924 956.5692 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 2.9 0.376 2.12 479.2926 956.5696 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.01 0.402 0 479.2927 956.5697 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 2.88 0.38 1.37 479.293 956.5703 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.29 0.45 1.96 479.293 956.5704 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 2.72 0.377 0 479.2937 956.5718 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 2.86 0.415 1.19 479.2942 956.5728 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% IALVITDGR 95.00% 3.1 0.396 1.48 479.295 956.5744 957.5735 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LSRDELVK 95.00% 2.57 0.18 0 480.282 958.5484 959.5527 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LSIIATDHTYRR 95.00% 2.16 0.2 0 482.601 1,444.78 1,445.79 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LSIIATDHTYRR 95.00% 2.43 0.166 0 482.6017 1,444.78 1,445.79 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LSIIATDHTYRR 95.00% 2.14 0.205 0 482.6019 1,444.78 1,445.79 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% KGLEQLLVGGSHLK 95.00% 4.55 0.322 1.15 493.6279 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% KGLEQLLVGGSHLK 95.00% 3.91 0.275 2.23 493.6284 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% KGLEQLLVGGSHLK 95.00% 3.9 0.232 1.38 493.6286 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% KGLEQLLVGGSHLK 95.00% 4.44 0.242 3.49 493.6291 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% KGLEQLLVGGSHLK 95.00% 3.77 0.352 2.03 493.6292 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% KGLEQLLVGGSHLK 95.00% 4.27 0.214 1.8 493.6294 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% KGLEQLLVGGSHLK 95.00% 4.31 0.276 1.38 493.6297 1,477.87 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% KGLEQLLVGGSHLK 95.00% 3.64 0.393 2.49 493.6303 1,477.87 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% KGLEQLLVGGSHLK 95.00% 3.63 0.391 1.68 493.631 1,477.87 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% KGLEQLLVGGSHLK 95.00% 4.19 0.317 1.55 493.9641 1,478.87 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GVFHQTVSR 95.00% 2.08 0.3 0 515.7769 1,029.54 1,030.54 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GVFHQTVSR 95.00% 1.88 0.277 0 515.7791 1,029.54 1,030.54 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% FLTAGRTDPAHDVR 95.00% 2 0.366 1.48 519.272 1,554.79 1,555.80 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% FLTAGRTDPAHDVR 95.00% 2 0.22 1.11 519.2726 1,554.79 1,555.80 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% FLTAGRTDPAHDVR 95.00% 2.02 0.33 0 519.2729 1,554.80 1,555.80 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% FLTAGRTDPAHDVR 95.00% 2.01 0.308 0 519.274 1,554.80 1,555.80 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 3.05 0.449 1.92 523.8036 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.46 0.239 1.52 523.804 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.78 0.38 1.41 523.8042 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.89 0.487 1.96 523.8044 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 3.13 0.514 1.48 523.8044 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.97 0.422 1.33 523.8044 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.43 0.392 0 523.8045 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.33 0.306 1.82 523.8045 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.76 0.478 1.72 523.8046 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.95 0.469 2.1 523.8047 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 3.1 0.466 1.77 523.8047 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.79 0.3 1.92 523.8047 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.93 0.421 1.66 523.8048 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.97 0.5 2.28 523.8048 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.49 0.264 2.57 523.8048 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.98 0.462 1.66 523.8048 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.23 0.186 2.41 523.8049 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.15 0.232 2.59 523.8049 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.63 0.395 1.54 523.805 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.94 0.466 0 523.8051 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.82 0.401 1.55 523.8052 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.93 0.495 1.29 523.8053 1,045.60 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VPSYQALLR 95.00% 2.78 0.199 1.72 523.8061 1,045.60 1,046.60 2 C1QT5_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.48 0.465 2.08 527.6198 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.78 0.345 1.38 527.62 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.4 0.38 1.44 527.6202 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.78 0.435 1.05 527.6202 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.09 0.285 0 527.6203 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.04 0.436 1.37 527.6204 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.69 0.411 2.09 527.6204 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.92 0.275 0 527.6205 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.94 0.473 2.28 527.6205 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.19 0.42 1.85 527.6206 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.96 0.194 0 527.6207 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.49 0.376 2.15 527.6207 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.91 0.319 1.19 527.6208 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.58 0.411 0 527.6209 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.89 0.354 1.43 527.621 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.1 0.267 1.54 527.621 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.38 0.372 1.54 527.6212 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.7 0.295 1.92 527.6212 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.62 0.337 1.66 527.6212 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.75 0.328 2.19 527.6213 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.53 0.246 0 527.6214 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.91 0.318 1.39 527.6215 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.87 0.291 1.11 527.9539 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.13 0.271 0 527.9541 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.63 0.266 1.22 527.9544 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.59 0.39 1.64 527.955 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.72 0.253 1.7 527.9551 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LKPYGALVDK 95.00% 2.24 0.247 0 552.3282 1,102.64 1,103.65 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 2.71 0.215 0 568.6385 1,702.89 1,703.90 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 2.26 0.262 0 568.6395 1,702.90 1,703.90 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 3.51 0.428 1.66 568.6396 1,702.90 1,703.90 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 3.17 0.352 0 568.6398 1,702.90 1,703.90 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 2.86 0.377 0 568.6405 1,702.90 1,703.90 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 2.6 0.278 0 568.6413 1,702.90 1,703.90 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 3.31 0.402 0 568.9727 1,703.89 1,703.90 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 2.8 0.373 1.11 568.9733 1,703.90 1,703.90 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 2.73 0.308 0 568.9736 1,703.90 1,703.90 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 2.73 0.503 1.6 568.9739 1,703.90 1,703.90 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 3.75 0.51 1.04 574.6573 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 3.92 0.522 1.47 574.6578 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 3.81 0.514 2.28 574.6581 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 4.34 0.551 2.04 574.6581 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 3.51 0.487 2.41 574.6584 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 3.2 0.453 0.959 574.659 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 2.62 0.31 0 574.9902 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 3.95 0.438 1.96 574.9911 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 3.83 0.547 1.34 574.992 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 3.35 0.393 1.46 574.9922 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 3.81 0.571 1.92 574.9922 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 2.34 0.19 0 586.6093 1,756.80 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 4.06 0.537 1.21 586.6099 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.18 0.532 1.43 586.61 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.09 0.417 0 586.6104 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.14 0.382 0 586.6105 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.45 0.528 1.8 586.6106 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.1 0.453 2.07 586.6107 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.65 0.493 0 586.6107 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.23 0.37 0 586.6109 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.28 0.429 3.66 586.6111 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.36 0.436 0 586.6111 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 2.78 0.316 0 586.6113 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.54 0.564 5 586.6115 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.27 0.38 0 586.6115 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 2.88 0.379 0 586.6116 1,756.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 2.03 0.243 0 586.944 1,757.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.54 0.544 3 586.9446 1,757.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 2.96 0.325 0 586.9451 1,757.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 3.07 0.441 1.12 586.9451 1,757.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 2.82 0.298 0 586.9456 1,757.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 2.96 0.396 2.39 586.9457 1,757.81 1,757.81 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 2.28 0.266 1.18 592.3118 1,773.91 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 2.91 0.563 3.34 592.3129 1,773.92 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 2.14 0.389 1.57 592.3131 1,773.92 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 2.67 0.52 2.68 592.3135 1,773.92 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 2.91 0.556 3.8 592.3135 1,773.92 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 2.93 0.473 1.92 592.3138 1,773.92 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 3.18 0.566 3.4 592.3139 1,773.92 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 3.11 0.635 4.96 592.314 1,773.92 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 3.12 0.604 3.19 592.3141 1,773.92 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 2.65 0.54 3.68 592.3143 1,773.92 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 2.74 0.565 3.92 592.3143 1,773.92 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 2.58 0.428 1.74 592.3149 1,773.92 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 2.05 0.314 1.52 592.6472 1,774.92 1,774.92 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% DQLLPPSPNNR 95.00% 1.79 0.209 2.24 625.828 1,249.64 1,250.65 2 IQGA1_HUMAN,AHNK_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% DQLLPPSPNNR 95.00% 3 0.267 2.49 625.8296 1,249.64 1,250.65 2 IQGA1_HUMAN,AHNK_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% DQLLPPSPNNR 95.00% 2.44 0.338 0 625.8311 1,249.65 1,250.65 2 IQGA1_HUMAN,AHNK_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% AGIEIFVVVVGR 95.00% 3.03 0.411 0 629.8815 1,257.75 1,258.75 2 CO5A1_HUMAN,MYH9_HUMAN,AHNK_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% AGIEIFVVVVGR 95.00% 2.43 0.498 1.24 629.8817 1,257.75 1,258.75 2 CO5A1_HUMAN,MYH9_HUMAN,AHNK_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% AGIEIFVVVVGR 95.00% 2.97 0.471 0 629.8822 1,257.75 1,258.75 2 CO5A1_HUMAN,MYH9_HUMAN,AHNK_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% AGIEIFVVVVGR 95.00% 2.75 0.449 2.52 629.8824 1,257.75 1,258.75 2 CO5A1_HUMAN,MYH9_HUMAN,AHNK_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% AGIEIFVVVVGR 95.00% 2.56 0.481 1.34 629.8825 1,257.75 1,258.75 2 CO5A1_HUMAN,MYH9_HUMAN,AHNK_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% AGIEIFVVVVGR 95.00% 2.96 0.381 0 630.3818 1,258.75 1,258.75 2 CO5A1_HUMAN,MYH9_HUMAN,AHNK_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 2.51 0.206 0 644.6766 1,931.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 3.92 0.49 0 644.6769 1,931.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 3.26 0.308 0 644.6772 1,931.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 3.58 0.472 0 644.6775 1,931.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 3.61 0.439 0 644.6776 1,931.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 4.72 0.547 5.54 645.0097 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 3.29 0.456 0 645.0101 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 2.89 0.384 0 645.0112 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 3.51 0.441 0 645.0113 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 3.54 0.415 0.959 645.0118 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LSIIATDHTYR 95.00% 2.79 0.425 0 645.3458 1,288.68 1,289.69 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LSIIATDHTYR 95.00% 3.23 0.398 2.8 645.3477 1,288.68 1,289.69 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LSIIATDHTYR 95.00% 2.54 0.375 0 645.3477 1,288.68 1,289.69 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LSIIATDHTYR 95.00% 3.34 0.446 3.12 645.3485 1,288.68 1,289.69 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LSIIATDHTYR 95.00% 2.19 0.357 3.8 645.7821 1,289.55 1,289.69 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 5.78 0.555 5.82 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.6155 1,996.82 1,997.83 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 5.11 0.477 3.59 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.6155 1,996.82 1,997.83 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 5.29 0.54 4 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.6156 1,996.82 1,997.83 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 5.58 0.493 3.68 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.616 1,996.82 1,997.83 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 2.49 0.2 0 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.9484 1,997.82 1,997.83 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 5.1 0.531 4.18 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.9495 1,997.82 1,997.83 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 3.4 0.411 3.21 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.9496 1,997.83 1,997.83 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.42 0.482 2.66 675.8925 1,349.77 1,350.77 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.74 0.437 3.34 675.8925 1,349.77 1,350.77 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 4.01 0.513 2.52 675.8926 1,349.77 1,350.77 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.09 0.409 3.48 675.8926 1,349.77 1,350.77 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.66 0.443 2.22 675.8928 1,349.77 1,350.77 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.59 0.518 2.92 675.8929 1,349.77 1,350.77 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.77 0.463 4 675.893 1,349.77 1,350.77 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.54 0.451 4.28 675.8931 1,349.77 1,350.77 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.22 0.443 3.77 675.8934 1,349.77 1,350.77 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 2.68 0.44 3 675.8938 1,349.77 1,350.77 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.66 0.446 3.19 675.907 1,349.80 1,350.77 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLK 95.00% 3.77 0.466 2.96 676.394 1,350.77 1,350.77 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% RLLLFSDGNSQGATPAAIEK 95.00% 4.95 0.502 1.57 697.0438 2,088.11 2,088.11 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% RLLLFSDGNSQGATPAAIEK 95.00% 5.48 0.566 1.96 697.0449 2,088.11 2,088.11 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% RLLLFSDGNSQGATPAAIEK 95.00% 4.28 0.555 1.92 697.0456 2,088.11 2,088.11 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% DTTPLNVLcSPGIQVVSVGIK 95.00% 3.7 0.383 3.8 c9: Carbamidomethyl (+57.02) 733.4036 2,197.19 2,197.19 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% DTTPLNVLcSPGIQVVSVGIK 95.00% 4.95 0.399 2.85 c9: Carbamidomethyl (+57.02) 733.4038 2,197.19 2,197.19 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% DTTPLNVLcSPGIQVVSVGIK 95.00% 2.7 0.351 0 c9: Carbamidomethyl (+57.02) 733.4069 2,197.20 2,197.19 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% EPcGGLEDAVNEAK 95.00% 3.29 0.503 2.66 c3: Carbamidomethyl (+57.02) 744.8375 1,487.66 1,488.66 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% EPcGGLEDAVNEAK 95.00% 3.25 0.454 2.25 c3: Carbamidomethyl (+57.02) 744.8385 1,487.66 1,488.66 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% EPcGGLEDAVNEAK 95.00% 2.84 0.454 3.1 c3: Carbamidomethyl (+57.02) 744.8387 1,487.66 1,488.66 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% EPcGGLEDAVNEAK 95.00% 2.81 0.48 2.74 c3: Carbamidomethyl (+57.02) 744.8394 1,487.66 1,488.66 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% FLTAGRTDPAHDVR 95.00% 2.53 0.206 0 778.405 1,554.79 1,555.80 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% FLTAGRTDPAHDVR 95.00% 2.85 0.226 0 778.4082 1,554.80 1,555.80 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.45 0.471 2.64 790.9263 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.09 0.472 2.57 790.9275 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.58 0.486 2.28 790.9281 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.25 0.499 1.96 790.9282 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.85 0.509 1.85 790.9283 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.28 0.536 1.32 790.9284 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.98 0.488 3.01 790.9286 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.47 0.496 1.96 790.9287 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.6 0.535 2.13 790.9288 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.38 0.459 2.62 790.9294 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.28 0.505 2.14 790.9305 1,579.85 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.24 0.551 1.57 790.9308 1,579.85 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.09 0.453 0 791.0213 1,580.03 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.63 0.41 0 791.0219 1,580.03 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.69 0.362 1.42 791.0223 1,580.03 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2 0.433 0 791.0229 1,580.03 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 2.88 0.436 2.36 791.4294 1,580.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.26 0.463 2.8 791.4298 1,580.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VFSVAITPDHLEPR 95.00% 3.6 0.434 2.59 791.4305 1,580.85 1,580.84 2 LRP1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 4.52 0.515 3.64 852.4544 1,702.89 1,703.90 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 5.03 0.491 3.8 852.4549 1,702.89 1,703.90 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 4.94 0.554 4.13 852.4615 1,702.91 1,703.90 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% YLIVVTDGHPLEGYK 95.00% 5.09 0.515 3.4 852.9575 1,703.90 1,703.90 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 4.27 0.411 3.36 861.4831 1,720.95 1,721.96 2 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 3.92 0.307 2.57 861.4838 1,720.95 1,721.96 2 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% GLEQLLVGGSHLKENK 95.00% 3.82 0.341 3.37 861.4851 1,720.95 1,721.96 2 CO5A1_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NLVWNAGALHYSDEVEIIQGLTR 95.00% 4.42 0.427 1.85 867.1186 2,598.33 2,598.33 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 4.63 0.629 5.77 879.4098 1,756.80 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 4.52 0.609 5.92 879.4107 1,756.81 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 4.63 0.603 3.8 879.411 1,756.81 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 5.08 0.612 6.1 879.4123 1,756.81 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 4.67 0.608 6.17 879.4123 1,756.81 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 5.21 0.596 5.72 879.4123 1,756.81 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 4.78 0.626 6.28 879.4131 1,756.81 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 4.68 0.599 5.85 879.4131 1,756.81 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 4.69 0.62 5.77 879.4135 1,756.81 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 4.96 0.599 5.8 879.4153 1,756.81 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 4.51 0.623 6.17 879.914 1,757.81 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 5.27 0.623 6.09 879.9145 1,757.81 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% TAEYDVAYGESHLFR 95.00% 4.66 0.618 6.09 879.9146 1,757.81 1,757.81 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 3.15 0.168 0 887.9653 1,773.92 1,774.92 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 3.1 0.218 0 887.9657 1,773.92 1,774.92 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 3.22 0.219 2.17 887.9659 1,773.92 1,774.92 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 3.26 0.264 0 887.9662 1,773.92 1,774.92 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 3.2 0.242 0 887.9664 1,773.92 1,774.92 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 3 0.189 0 887.967 1,773.92 1,774.92 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 3.02 0.202 0 887.9671 1,773.92 1,774.92 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% VAVVQYSGTGQQRPER 95.00% 3.07 0.207 0 888.4696 1,774.92 1,774.92 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% FEPGQSYAGVVQYSHSQMQEHVSLR 95.00% 1.5 0.352 3.72 955.7885 2,864.34 2,864.34 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% FEPGQSYAGVVQYSHSQMQEHVSLR 95.00% 0 0 3.82 956.1214 2,865.34 2,864.34 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 5.94 0.604 5.96 966.5082 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.66 0.616 6.22 966.5089 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.35 0.605 6.29 966.5092 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.16 0.608 5.85 966.5094 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.16 0.578 6.32 966.5099 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.37 0.596 5.57 966.5103 1,931.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 4 0.505 3 966.5107 1,931.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.36 0.611 6.59 966.5114 1,931.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 5.09 0.534 4.3 967.0054 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.47 0.497 6.42 967.0102 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6 0.581 5.89 967.0103 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.71 0.509 5.77 967.0103 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 5.84 0.481 4.51 967.0103 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.34 0.547 6.52 967.0104 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.8 0.518 5.35 967.0107 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.44 0.53 4.8 967.011 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.48 0.491 5.51 967.011 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.27 0.508 6.05 967.0113 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% eASSGAAKKRLLLFSDGNSQGATPAAIEK 95.00% 0 0 3.57 e1: Pyro_glu (-18.01) 967.0114 2,898.01 2,899.53 3
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.04 0.485 5.2 967.0114 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.68 0.48 6.48 967.0114 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.63 0.499 6.11 967.0116 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.49 0.487 6.3 967.0117 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.32 0.502 5.6 967.0121 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.23 0.486 5 967.0129 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.43 0.519 6.01 967.013 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.28 0.504 6.28 967.0136 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% LLLFSDGNSQGATPAAIEK 95.00% 6.67 0.484 4.8 967.0141 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 3.87 0.544 4.29 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4175 1,996.82 1,997.83 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 5.09 0.524 4.72 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4179 1,996.82 1,997.83 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 4.94 0.558 5.16 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4185 1,996.82 1,997.83 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 5.03 0.535 5.17 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4185 1,996.82 1,997.83 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 5.4 0.567 4.68 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4192 1,996.82 1,997.83 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 5.02 0.557 4.8 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4206 1,996.83 1,997.83 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 5.27 0.525 4.39 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9196 1,997.82 1,997.83 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 4.68 0.571 4.47 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9198 1,997.82 1,997.83 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 5.36 0.545 4.6 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9198 1,997.82 1,997.83 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% NNVEQVccSFEcQPAR 95.00% 4.51 0.439 4.14 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9237 1,997.83 1,997.83 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% SLQWMAGGTFTGEALQYTR 95.00% 6.3 0.637 5.24 1,059.51 2,117.01 2,117.01 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% SLQWMAGGTFTGEALQYTR 95.00% 6.51 0.626 5.92 1,059.51 2,117.01 2,117.01 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% DTTPLNVLcSPGIQVVSVGIK 95.00% 4.86 0.514 5.82 c9: Carbamidomethyl (+57.02) 1,099.60 2,197.19 2,197.19 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% DTTPLNVLcSPGIQVVSVGIK 95.00% 4.67 0.522 7.44 c9: Carbamidomethyl (+57.02) 1,099.60 2,197.19 2,197.19 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% DTTPLNVLcSPGIQVVSVGIK 95.00% 4.9 0.55 7.12 c9: Carbamidomethyl (+57.02) 1,099.60 2,197.19 2,197.19 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% DTTPLNVLcSPGIQVVSVGIK 95.00% 4.72 0.48 6.21 c9: Carbamidomethyl (+57.02) 1,099.60 2,197.19 2,197.19 2
 SAMPLE 4R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 22 31 263 30.90% DTTPLNVLcSPGIQVVSVGIK 95.00% 4.79 0.492 7.06 c9: Carbamidomethyl (+57.02) 1,099.60 2,197.19 2,197.19 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% GLEQLLVGGSHLK 95.00% 2.78 0.405 4.4 450.93 1,349.77 1,350.77 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% GLEQLLVGGSHLK 95.00% 2.93 0.37 1.38 450.9305 1,349.77 1,350.77 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% GLEQLLVGGSHLK 95.00% 3.01 0.416 1.89 450.931 1,349.77 1,350.77 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% GLEQLLVGGSHLK 95.00% 3.08 0.381 2.02 450.9312 1,349.77 1,350.77 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% GLEQLLVGGSHLK 95.00% 2.4 0.393 1.12 450.9319 1,349.77 1,350.77 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% GLEQLLVGGSHLK 95.00% 3.28 0.365 3.23 450.9319 1,349.77 1,350.77 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% IALVITDGR 95.00% 2.77 0.34 0 479.289 956.5623 957.5735 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% IALVITDGR 95.00% 3.14 0.444 1.28 479.29 956.5643 957.5735 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% IALVITDGR 95.00% 3.07 0.436 1.68 479.29 956.5644 957.5735 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% IALVITDGR 95.00% 2.83 0.372 1.52 479.2901 956.5645 957.5735 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% IALVITDGR 95.00% 2.52 0.397 0 479.2903 956.5649 957.5735 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% IALVITDGR 95.00% 3.01 0.401 2.14 479.2907 956.5658 957.5735 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% IALVITDGR 95.00% 2.54 0.352 1.17 479.2917 956.5677 957.5735 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% IALVITDGR 95.00% 2.39 0.41 2 479.2918 956.568 957.5735 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% IALVITDGR 95.00% 3.12 0.367 2.66 479.2923 956.569 957.5735 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% IALVITDGR 95.00% 2.58 0.358 1.74 479.2927 956.5697 957.5735 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VPSYQALLR 95.00% 2.22 0.38 1.47 523.8008 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VPSYQALLR 95.00% 2.76 0.473 1.82 523.8008 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VPSYQALLR 95.00% 2.48 0.29 1.24 523.8018 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VPSYQALLR 95.00% 2.85 0.457 2.02 523.8019 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VPSYQALLR 95.00% 2.98 0.491 1.42 523.8022 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VPSYQALLR 95.00% 2.44 0.4 0 523.8023 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VPSYQALLR 95.00% 2.92 0.478 1.64 523.8027 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VPSYQALLR 95.00% 2.74 0.347 1.92 523.8074 1,045.60 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 2.35 0.304 1.82 527.6183 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 2.51 0.221 1.19 527.6184 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 2.82 0.363 2.16 527.6186 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 2.88 0.298 1.05 527.6188 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 2.43 0.348 0 527.6191 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 2.76 0.324 1.05 527.6194 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 2.87 0.412 1.72 527.6194 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 2.69 0.47 1.89 527.6195 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 3.15 0.45 1.03 527.6202 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 3.44 0.425 2.15 527.9515 1,580.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 3.05 0.401 1.43 527.9528 1,580.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 1.92 0.312 0 527.9532 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% GLEQLLVGGSHLKENK 95.00% 2.93 0.447 1.4 574.6538 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% GLEQLLVGGSHLKENK 95.00% 2.51 0.33 0 574.6545 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% TAEYDVAYGESHLFR 95.00% 3.52 0.514 1.7 586.6082 1,756.80 1,757.81 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% TAEYDVAYGESHLFR 95.00% 3.55 0.425 3.02 586.6085 1,756.80 1,757.81 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% TAEYDVAYGESHLFR 95.00% 3.39 0.486 3.4 586.6086 1,756.80 1,757.81 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% TAEYDVAYGESHLFR 95.00% 3.39 0.439 0 586.6088 1,756.80 1,757.81 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% TAEYDVAYGESHLFR 95.00% 3.06 0.465 0 586.9441 1,757.81 1,757.81 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VAVVQYSGTGQQRPER 95.00% 2.48 0.411 1.1 592.3099 1,773.91 1,774.92 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VAVVQYSGTGQQRPER 95.00% 1.98 0.215 0 592.3116 1,773.91 1,774.92 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VAVVQYSGTGQQRPER 95.00% 3.01 0.545 3.41 592.6454 1,774.91 1,774.92 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% LSIIATDHTYR 95.00% 3.08 0.509 2.66 645.3451 1,288.67 1,289.69 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% LSIIATDHTYR 95.00% 3.39 0.487 2.39 645.3457 1,288.68 1,289.69 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% LSIIATDHTYR 95.00% 3.11 0.462 2.82 645.3461 1,288.68 1,289.69 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% LSIIATDHTYR 95.00% 3.25 0.501 3.51 645.3466 1,288.68 1,289.69 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% LSIIATDHTYR 95.00% 2.44 0.341 0 645.8784 1,289.74 1,289.69 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% LSIIATDHTYR 95.00% 2.5 0.32 0 645.8797 1,289.74 1,289.69 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% GLEQLLVGGSHLK 95.00% 2.4 0.393 1.51 675.8894 1,349.76 1,350.77 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% GLEQLLVGGSHLK 95.00% 3.81 0.539 2.92 676.3908 1,350.77 1,350.77 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% VFSVAITPDHLEPR 95.00% 3.07 0.45 0 790.9254 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% TAEYDVAYGESHLFR 95.00% 4.62 0.625 7.59 879.4065 1,756.80 1,757.81 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% TAEYDVAYGESHLFR 95.00% 4.46 0.589 6.8 879.4074 1,756.80 1,757.81 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% TAEYDVAYGESHLFR 95.00% 4.68 0.597 5.34 879.9106 1,757.81 1,757.81 2
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% LLLFSDGNSQGATPAAIEK 95.00% 5.58 0.605 4.96 966.5038 1,930.99 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% LLLFSDGNSQGATPAAIEK 95.00% 6.06 0.587 5 966.5211 1,931.03 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% LLLFSDGNSQGATPAAIEK 95.00% 5.6 0.594 3.89 966.5254 1,931.04 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% LLLFSDGNSQGATPAAIEK 95.00% 6.15 0.551 4.68 967.0066 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% eASSGAAKKRLLLFSDGNSQGATPAAIEK 95.00% 0 0 3.8 e1: Pyro_glu (-18.01) 967.0067 2,898.00 2,899.53 3
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% LLLFSDGNSQGATPAAIEK 95.00% 6.29 0.485 4.74 967.0092 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% LLLFSDGNSQGATPAAIEK 95.00% 5.52 0.532 3.37 967.0135 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 13 60 13.10% NNVEQVccSFEcQPAR 95.00% 4.85 0.512 3.96 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9152 1,997.81 1,997.83 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% GLEQLLVGGSHLK 95.00% 3.18 0.365 2.66 450.9303 1,349.77 1,350.77 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% GLEQLLVGGSHLK 95.00% 2.63 0.466 2.04 450.931 1,349.77 1,350.77 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% GLEQLLVGGSHLK 95.00% 2.75 0.445 2.09 450.9312 1,349.77 1,350.77 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% GLEQLLVGGSHLK 95.00% 2.64 0.352 2.32 450.9313 1,349.77 1,350.77 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% GLEQLLVGGSHLK 95.00% 2.23 0.25 1.96 450.9314 1,349.77 1,350.77 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% GLEQLLVGGSHLK 95.00% 2.58 0.495 2.15 450.9314 1,349.77 1,350.77 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% GLEQLLVGGSHLK 95.00% 2.55 0.408 1.27 450.932 1,349.77 1,350.77 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% GLEQLLVGGSHLK 95.00% 3.03 0.448 4.17 450.9322 1,349.77 1,350.77 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% GLEQLLVGGSHLK 95.00% 3.04 0.448 3.57 450.9327 1,349.77 1,350.77 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% IALVITDGR 95.00% 2.45 0.28 1.82 479.2885 956.5613 957.5735 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% IALVITDGR 95.00% 2.6 0.377 2.27 479.2896 956.5636 957.5735 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% IALVITDGR 95.00% 3.04 0.414 2.26 479.29 956.5644 957.5735 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% IALVITDGR 95.00% 3.1 0.413 0 479.2902 956.5647 957.5735 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% IALVITDGR 95.00% 2.21 0.365 3.09 479.2912 956.5667 957.5735 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% IALVITDGR 95.00% 2.16 0.371 2.06 479.2917 956.5677 957.5735 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% IALVITDGR 95.00% 2.26 0.369 1.77 479.2936 956.5716 957.5735 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VPSYQALLR 95.00% 2.94 0.508 1.54 523.8025 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VPSYQALLR 95.00% 3.01 0.45 1.27 523.8028 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VPSYQALLR 95.00% 2.53 0.304 0 523.8034 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VPSYQALLR 95.00% 2.47 0.36 0 523.8034 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VPSYQALLR 95.00% 2.17 0.374 0 523.8036 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VPSYQALLR 95.00% 2.03 0.305 1.36 523.8048 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VPSYQALLR 95.00% 2.74 0.347 1.72 523.8074 1,045.60 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VPSYQALLR 95.00% 2.9 0.43 1.85 523.8117 1,045.61 1,046.60 2 C1QT5_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VFSVAITPDHLEPR 95.00% 2.82 0.425 2.24 527.6174 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VFSVAITPDHLEPR 95.00% 2.66 0.359 0 527.618 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VFSVAITPDHLEPR 95.00% 2.75 0.336 1.23 527.6186 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VFSVAITPDHLEPR 95.00% 3.05 0.403 0.959 527.6186 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VFSVAITPDHLEPR 95.00% 2.22 0.306 0 527.6188 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VFSVAITPDHLEPR 95.00% 2.72 0.455 2.13 527.6194 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VFSVAITPDHLEPR 95.00% 2.61 0.317 0 527.9518 1,580.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VFSVAITPDHLEPR 95.00% 3.57 0.255 1.01 527.9527 1,580.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VFSVAITPDHLEPR 95.00% 2.69 0.429 1.28 527.9528 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VFSVAITPDHLEPR 95.00% 2.27 0.325 1.05 527.9531 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VFSVAITPDHLEPR 95.00% 2.51 0.413 0 527.9534 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% GLEQLLVGGSHLKENK 95.00% 2.41 0.34 1.43 574.6533 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% GLEQLLVGGSHLKENK 95.00% 3.48 0.465 2.7 574.6545 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% TAEYDVAYGESHLFR 95.00% 2.71 0.424 0 586.6069 1,756.80 1,757.81 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% TAEYDVAYGESHLFR 95.00% 3.57 0.426 1.1 586.6082 1,756.80 1,757.81 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% TAEYDVAYGESHLFR 95.00% 3.22 0.496 0 586.6102 1,756.81 1,757.81 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% TAEYDVAYGESHLFR 95.00% 3.05 0.445 3 586.9432 1,757.81 1,757.81 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% TAEYDVAYGESHLFR 95.00% 3.45 0.46 0 586.9434 1,757.81 1,757.81 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VAVVQYSGTGQQRPER 95.00% 1.98 0.25 1.01 592.3115 1,773.91 1,774.92 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VAVVQYSGTGQQRPER 95.00% 2.19 0.283 2.31 592.6454 1,774.91 1,774.92 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% VAVVQYSGTGQQRPER 95.00% 3.01 0.545 3.04 592.6454 1,774.91 1,774.92 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% LLLFSDGNSQGATPAAIEK 95.00% 2.48 0.351 0 644.6732 1,931.00 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% LLLFSDGNSQGATPAAIEK 95.00% 2.75 0.336 0 645.0085 1,932.00 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% LSIIATDHTYR 95.00% 2.89 0.517 3 645.3452 1,288.67 1,289.69 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% LSIIATDHTYR 95.00% 3.04 0.54 2.89 645.3456 1,288.68 1,289.69 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% GLEQLLVGGSHLK 95.00% 2.69 0.369 3.28 675.89 1,349.76 1,350.77 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% TAEYDVAYGESHLFR 95.00% 4.61 0.606 6.36 879.4083 1,756.80 1,757.81 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% TAEYDVAYGESHLFR 95.00% 4.83 0.626 7.66 879.4104 1,756.81 1,757.81 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% LLLFSDGNSQGATPAAIEK 95.00% 6.06 0.587 4.82 966.5211 1,931.03 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% LLLFSDGNSQGATPAAIEK 95.00% 6.17 0.508 4.48 967.0076 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% LLLFSDGNSQGATPAAIEK 95.00% 6.41 0.518 5.92 967.0098 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% eASSGAAKKRLLLFSDGNSQGATPAAIEK 95.00% 0 0 3.92 e1: Pyro_glu (-18.01) 967.0099 2,898.01 2,899.53 3
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% LLLFSDGNSQGATPAAIEK 95.00% 5.41 0.426 4.27 967.0108 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% LLLFSDGNSQGATPAAIEK 95.00% 5.52 0.532 4 967.0135 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% LLLFSDGNSQGATPAAIEK 95.00% 6.01 0.484 6.21 967.0269 1,932.04 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% NNVEQVccSFEcQPAR 95.00% 4.13 0.487 3.92 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.914 1,997.81 1,997.83 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% NNVEQVccSFEcQPAR 95.00% 4.79 0.559 4.96 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9156 1,997.82 1,997.83 2
 SAMPLE 1R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 13 54 15.20% DTTPLNVLcSPGIQVVSVGIK 95.00% 4.06 0.523 8.54 c9: Carbamidomethyl (+57.02) 1,099.61 2,197.20 2,197.19 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.47 0.443 3.96 450.9301 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.33 0.385 2.57 450.9302 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.89 0.399 3.37 450.9304 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 3.19 0.428 6 450.9305 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.9 0.401 1.72 450.9308 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.49 0.424 0.959 450.9308 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 3.06 0.321 2.96 450.931 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.76 0.395 1.85 450.9312 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.74 0.331 2.34 450.9312 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.55 0.233 2.36 450.9313 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.86 0.333 2.74 450.9316 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.82 0.393 2.57 450.9318 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.86 0.368 2.44 450.9319 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.48 0.406 3.06 450.9322 1,349.77 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 2.73 0.383 3.47 450.9334 1,349.78 1,350.77 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% IALVITDGR 95.00% 3.13 0.453 3 479.289 956.5624 957.5735 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% IALVITDGR 95.00% 3.21 0.407 2.08 479.2892 956.5627 957.5735 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% IALVITDGR 95.00% 3.33 0.461 1.62 479.2892 956.5628 957.5735 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% IALVITDGR 95.00% 2.52 0.294 1.57 479.2892 956.5628 957.5735 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% IALVITDGR 95.00% 3.1 0.439 1.66 479.2896 956.5635 957.5735 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% IALVITDGR 95.00% 2.07 0.361 2.08 479.2904 956.5652 957.5735 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% IALVITDGR 95.00% 2.19 0.381 3.12 479.2905 956.5653 957.5735 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% IALVITDGR 95.00% 1.78 0.234 1.57 479.291 956.5663 957.5735 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% IALVITDGR 95.00% 2.85 0.356 1.85 479.2917 956.5677 957.5735 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% IALVITDGR 95.00% 2.76 0.389 1.89 479.2957 956.5758 957.5735 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% KGLEQLLVGGSHLK 95.00% 4.29 0.323 1.43 493.627 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% KGLEQLLVGGSHLK 95.00% 4.16 0.307 2.12 493.6271 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% FLTAGRTDPAHDVR 95.00% 2.12 0.213 0 519.2692 1,554.78 1,555.80 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VPSYQALLR 95.00% 2.61 0.387 1.77 523.8021 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VPSYQALLR 95.00% 2.98 0.442 1.64 523.8023 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VPSYQALLR 95.00% 2.99 0.507 1.34 523.8026 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VPSYQALLR 95.00% 2.85 0.314 1.57 523.8026 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VPSYQALLR 95.00% 3.08 0.448 1.92 523.8028 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VPSYQALLR 95.00% 2.91 0.445 1.39 523.8028 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VPSYQALLR 95.00% 2.93 0.373 2.02 523.8029 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VPSYQALLR 95.00% 2.74 0.356 1.37 523.8032 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VPSYQALLR 95.00% 2.99 0.412 2.49 524.2927 1,046.57 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VPSYQALLR 95.00% 2.82 0.292 3.66 524.2945 1,046.57 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.27 0.276 1.02 527.6173 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.05 0.361 1.57 527.6186 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 2.63 0.277 0 527.6186 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.09 0.519 2 527.6191 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.56 0.381 1.59 527.9519 1,580.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.06 0.179 0 527.9526 1,580.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 2.56 0.315 1.21 527.9527 1,580.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.17 0.521 1.96 527.9529 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.1 0.468 0 527.9529 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 2.61 0.345 0 527.9529 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.4 0.469 2.24 527.953 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 2.67 0.316 1.64 527.9534 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.06 0.391 1.27 527.9536 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 2.62 0.321 1.74 527.9539 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.21 0.476 2 527.954 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 2.66 0.364 1.7 527.9544 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% YLIVVTDGHPLEGYK 95.00% 2.84 0.318 0 568.9713 1,703.89 1,703.90 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLKENK 95.00% 4.44 0.578 1.82 574.6539 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLKENK 95.00% 4.09 0.605 0.959 574.6551 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLKENK 95.00% 3.13 0.398 1.1 574.6553 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLKENK 95.00% 2.86 0.384 0 574.6555 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLKENK 95.00% 2.09 0.267 1.52 574.6556 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLKENK 95.00% 2.77 0.346 0 574.6558 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLKENK 95.00% 3.96 0.555 1.35 574.989 1,721.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLKENK 95.00% 3.08 0.388 1.57 574.989 1,721.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLKENK 95.00% 2.74 0.422 0 574.9908 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 3.64 0.473 2 586.6086 1,756.80 1,757.81 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 3.4 0.466 0 586.6089 1,756.80 1,757.81 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 3.42 0.41 0 586.6089 1,756.80 1,757.81 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 3.75 0.446 3.82 586.6089 1,756.80 1,757.81 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 2.7 0.364 1.17 586.6091 1,756.80 1,757.81 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 2.32 0.31 0 586.7884 1,757.34 1,757.81 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 2.17 0.279 0 586.8367 1,757.49 1,757.81 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 3.31 0.491 2.14 586.942 1,757.80 1,757.81 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 3.76 0.544 2.09 586.9429 1,757.81 1,757.81 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 3.43 0.395 1 586.943 1,757.81 1,757.81 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 3.31 0.449 2.26 586.9431 1,757.81 1,757.81 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 2.36 0.296 0 586.9434 1,757.81 1,757.81 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VAVVQYSGTGQQRPER 95.00% 3.37 0.583 2.07 592.3107 1,773.91 1,774.92 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VAVVQYSGTGQQRPER 95.00% 2.64 0.526 3.68 592.311 1,773.91 1,774.92 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VAVVQYSGTGQQRPER 95.00% 3.14 0.591 3 592.3112 1,773.91 1,774.92 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VAVVQYSGTGQQRPER 95.00% 2.86 0.561 2.77 592.6457 1,774.91 1,774.92 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LLLFSDGNSQGATPAAIEK 95.00% 3.55 0.434 0 644.6736 1,931.00 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LSIIATDHTYR 95.00% 2.32 0.306 1.52 645.3443 1,288.67 1,289.69 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LSIIATDHTYR 95.00% 3.56 0.449 2.51 645.3448 1,288.67 1,289.69 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LSIIATDHTYR 95.00% 3.47 0.464 3.07 645.3452 1,288.67 1,289.69 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LSIIATDHTYR 95.00% 3.34 0.404 3.21 645.3452 1,288.67 1,289.69 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LSIIATDHTYR 95.00% 3.67 0.416 2.77 645.3452 1,288.67 1,289.69 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LSIIATDHTYR 95.00% 3.38 0.421 3.4 645.3454 1,288.68 1,289.69 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LSIIATDHTYR 95.00% 3.48 0.452 2.68 645.3456 1,288.68 1,289.69 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LSIIATDHTYR 95.00% 3.6 0.46 2.92 645.3457 1,288.68 1,289.69 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LSIIATDHTYR 95.00% 3.59 0.471 3.39 645.346 1,288.68 1,289.69 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LSIIATDHTYR 95.00% 3.26 0.491 2.72 645.3461 1,288.68 1,289.69 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LSIIATDHTYR 95.00% 3.35 0.484 2.92 645.3463 1,288.68 1,289.69 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LSIIATDHTYR 95.00% 3.29 0.506 3.11 645.3472 1,288.68 1,289.69 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% NNVEQVccSFEcQPAR 95.00% 4.65 0.501 2.85 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.6133 1,996.82 1,997.83 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% NNVEQVccSFEcQPAR 95.00% 3.99 0.432 2 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.9476 1,997.82 1,997.83 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% NNVEQVccSFEcQPAR 95.00% 3.22 0.361 0 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.9482 1,997.82 1,997.83 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% NNVEQVccSFEcQPAR 95.00% 4.99 0.504 3.17 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.949 1,997.82 1,997.83 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 3.84 0.412 2.74 675.89 1,349.76 1,350.77 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 3.76 0.455 2.66 675.8919 1,349.77 1,350.77 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 3.21 0.209 2.21 675.8946 1,349.77 1,350.77 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 3.44 0.493 3.92 676.3912 1,350.77 1,350.77 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 3.38 0.422 3.46 676.3936 1,350.77 1,350.77 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLK 95.00% 3.42 0.454 3.31 676.396 1,350.78 1,350.77 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% RLLLFSDGNSQGATPAAIEK 95.00% 4.99 0.561 2.08 697.0417 2,088.10 2,088.11 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.7 0.504 2.82 790.924 1,579.83 1,580.84 2 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.47 0.44 2.96 790.9242 1,579.83 1,580.84 2 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.55 0.523 2.24 790.9254 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.18 0.468 2.29 790.9264 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 3.22 0.486 2.02 790.9275 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VFSVAITPDHLEPR 95.00% 2.25 0.37 2.89 791.0536 1,580.09 1,580.84 2 LRP1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLKENK 95.00% 3.91 0.454 3.36 861.9815 1,721.95 1,721.96 2 CO5A1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% GLEQLLVGGSHLKENK 95.00% 3.6 0.436 4.39 861.9829 1,721.95 1,721.96 2 CO5A1_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 4.58 0.621 5.96 879.4073 1,756.80 1,757.81 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 5.04 0.601 6.07 879.4082 1,756.80 1,757.81 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 4.57 0.606 6.49 879.4088 1,756.80 1,757.81 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 4.68 0.606 4.96 879.4095 1,756.80 1,757.81 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 5.21 0.611 6.42 879.4095 1,756.80 1,757.81 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 4.57 0.606 6.11 879.4096 1,756.80 1,757.81 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% TAEYDVAYGESHLFR 95.00% 4.84 0.611 6.59 879.9095 1,757.80 1,757.81 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VAVVQYSGTGQQRPER 95.00% 3.21 0.25 0 887.9616 1,773.91 1,774.92 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VAVVQYSGTGQQRPER 95.00% 3.21 0.25 1.2 887.9621 1,773.91 1,774.92 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VAVVQYSGTGQQRPER 95.00% 3.03 0.229 1.38 888.4637 1,774.91 1,774.92 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% VAVVQYSGTGQQRPER 95.00% 3 0.219 0 888.4647 1,774.91 1,774.92 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LLLFSDGNSQGATPAAIEK 95.00% 6.43 0.617 4.49 966.506 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LLLFSDGNSQGATPAAIEK 95.00% 6.48 0.587 4.43 966.5069 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LLLFSDGNSQGATPAAIEK 95.00% 6.49 0.503 4.77 967.0056 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LLLFSDGNSQGATPAAIEK 95.00% 6.49 0.508 4.85 967.006 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LLLFSDGNSQGATPAAIEK 95.00% 6.17 0.517 5.05 967.0066 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LLLFSDGNSQGATPAAIEK 95.00% 6.47 0.524 4.72 967.007 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% eASSGAAKKRLLLFSDGNSQGATPAAIEK 95.00% 0 0 3.43 e1: Pyro_glu (-18.01) 967.0071 2,898.00 2,899.53 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LLLFSDGNSQGATPAAIEK 95.00% 6.75 0.499 5.15 967.0074 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% eASSGAAKKRLLLFSDGNSQGATPAAIEK 95.00% 0 0 3.43 e1: Pyro_glu (-18.01) 967.0074 2,898.00 2,899.53 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% LLLFSDGNSQGATPAAIEK 95.00% 6.48 0.504 5.23 967.008 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% eASSGAAKKRLLLFSDGNSQGATPAAIEK 95.00% 0 0 3.16 e1: Pyro_glu (-18.01) 967.0081 2,898.00 2,899.53 3
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% NNVEQVccSFEcQPAR 95.00% 5.23 0.546 5.2 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4143 1,996.81 1,997.83 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% NNVEQVccSFEcQPAR 95.00% 5.28 0.562 5.92 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4157 1,996.82 1,997.83 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% NNVEQVccSFEcQPAR 95.00% 4.85 0.549 5.77 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9159 1,997.82 1,997.83 2
 SAMPLE 2 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 13 19 127 16.10% NNVEQVccSFEcQPAR 95.00% 5.36 0.528 4.4 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9163 1,997.82 1,997.83 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 2.7 0.284 1.92 450.9301 1,349.77 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 3.16 0.341 2.41 450.9304 1,349.77 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 2.7 0.444 3.46 450.9305 1,349.77 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 2.34 0.29 1.38 450.9306 1,349.77 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 2.94 0.371 3.29 450.9306 1,349.77 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 2.95 0.398 2.48 450.9307 1,349.77 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 2.82 0.319 2.41 450.9308 1,349.77 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 3.17 0.395 1.92 450.9308 1,349.77 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 2.62 0.291 2.47 450.9309 1,349.77 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 2.99 0.357 3.37 450.931 1,349.77 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 2.52 0.432 3.7 450.9315 1,349.77 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 3.01 0.352 3.14 450.9316 1,349.77 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 2.48 0.399 2.51 450.9331 1,349.78 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 3.06 0.362 2 451.2663 1,350.78 1,350.77 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% IALVITDGR 95.00% 2.14 0.295 1.48 479.2714 956.5271 957.5735 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% IALVITDGR 95.00% 2.49 0.396 2.05 479.2878 956.5599 957.5735 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% IALVITDGR 95.00% 3.29 0.467 2.51 479.2892 956.5627 957.5735 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% IALVITDGR 95.00% 2.94 0.417 2.57 479.2892 956.5627 957.5735 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% IALVITDGR 95.00% 3.14 0.448 1.74 479.2892 956.5628 957.5735 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% IALVITDGR 95.00% 2.25 0.258 2.28 479.2893 956.563 957.5735 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% IALVITDGR 95.00% 3.1 0.401 2.15 479.2898 956.5639 957.5735 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% IALVITDGR 95.00% 2.73 0.367 1.66 479.2905 956.5653 957.5735 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% IALVITDGR 95.00% 2.87 0.365 1.24 479.2905 956.5653 957.5735 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% IALVITDGR 95.00% 1.97 0.301 2.05 479.291 956.5664 957.5735 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% IALVITDGR 95.00% 2.75 0.355 2.24 479.2921 956.5686 957.5735 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% IALVITDGR 95.00% 1.86 0.232 1.96 479.2926 956.5696 957.5735 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LSIIATDHTYRR 95.00% 2.49 0.202 0 482.5986 1,444.77 1,445.79 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% KGLEQLLVGGSHLK 95.00% 3.59 0.244 2.64 493.6277 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% KGLEQLLVGGSHLK 95.00% 3.84 0.347 3.06 493.6278 1,477.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% KGLEQLLVGGSHLK 95.00% 4.36 0.277 3.15 493.9615 1,478.86 1,478.87 3 TENX_HUMAN,EMIL1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GVFHQTVSR 95.00% 2.31 0.251 0 515.7744 1,029.53 1,030.54 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% FLTAGRTDPAHDVR 95.00% 2.04 0.248 0.959 519.2696 1,554.79 1,555.80 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 2.49 0.419 1.64 523.8011 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 2.55 0.34 1.96 523.8017 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 2.55 0.293 0 523.8019 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 2.67 0.402 1.4 523.802 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 2.56 0.369 0 523.802 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 2.76 0.333 1.46 523.8022 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 2.86 0.389 1.46 523.8023 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 3.06 0.433 1.85 523.8024 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 2.16 0.223 0 523.8025 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 3.08 0.455 1.34 523.8026 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 3.07 0.478 1.54 523.8028 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 2.83 0.469 1.35 523.8028 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 2.62 0.467 1.82 523.803 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VPSYQALLR 95.00% 1.96 0.331 0 523.8031 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 2.23 0.253 1.1 527.618 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 2.89 0.479 2 527.618 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 2.33 0.369 0 527.6186 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 3.3 0.39 1.72 527.6186 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 2.4 0.367 1.36 527.6187 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 2.84 0.448 1.59 527.6189 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 2.67 0.333 1.31 527.619 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 2.16 0.293 0.959 527.6191 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 3.33 0.49 1.82 527.6193 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 2.9 0.459 1.8 527.6194 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 3.25 0.471 0 527.952 1,580.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 2.5 0.41 0 527.9527 1,580.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 3.27 0.386 1.02 527.9547 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LKPYGALVDK 95.00% 2.18 0.273 0 552.3258 1,102.64 1,103.65 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% YLIVVTDGHPLEGYK 95.00% 2.41 0.303 0 568.6362 1,702.89 1,703.90 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLKENK 95.00% 3.72 0.475 1.57 574.6528 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLKENK 95.00% 2.77 0.197 1.44 574.6532 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLKENK 95.00% 3.78 0.472 1.7 574.655 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLKENK 95.00% 2.58 0.259 0 574.6562 1,720.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLKENK 95.00% 3.71 0.467 1.49 574.9891 1,721.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLKENK 95.00% 2.59 0.27 0 574.9895 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLKENK 95.00% 3.59 0.429 0 574.9899 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLKENK 95.00% 3.71 0.525 2.09 574.9899 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 3.04 0.353 0 586.6077 1,756.80 1,757.81 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 2.71 0.433 0 586.6085 1,756.80 1,757.81 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 3.1 0.411 1.62 586.6088 1,756.80 1,757.81 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 2.75 0.36 0 586.6089 1,756.80 1,757.81 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 3.32 0.563 4.24 586.6091 1,756.80 1,757.81 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 3.38 0.487 1.28 586.6091 1,756.80 1,757.81 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 3.08 0.418 0 586.6092 1,756.80 1,757.81 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 2.86 0.429 0 586.6105 1,756.81 1,757.81 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 2.39 0.197 0 586.9429 1,757.81 1,757.81 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 2.76 0.353 1 586.9436 1,757.81 1,757.81 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VAVVQYSGTGQQRPER 95.00% 2.39 0.447 2.3 592.3123 1,773.91 1,774.92 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VAVVQYSGTGQQRPER 95.00% 2.57 0.475 0 592.3124 1,773.91 1,774.92 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VAVVQYSGTGQQRPER 95.00% 2.91 0.506 2.68 592.6449 1,774.91 1,774.92 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 2.29 0.24 0 644.674 1,931.00 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 2.82 0.242 0 644.674 1,931.00 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 4.11 0.507 2.64 644.6746 1,931.00 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 4.3 0.493 2.26 645.0063 1,932.00 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 3.54 0.473 0 645.0074 1,932.00 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LSIIATDHTYR 95.00% 3.27 0.442 2.68 645.3444 1,288.67 1,289.69 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LSIIATDHTYR 95.00% 3.33 0.478 3.14 645.3448 1,288.67 1,289.69 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LSIIATDHTYR 95.00% 3.46 0.492 3.05 645.3452 1,288.67 1,289.69 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LSIIATDHTYR 95.00% 3.52 0.468 3.42 645.3457 1,288.68 1,289.69 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LSIIATDHTYR 95.00% 3.39 0.367 3.35 645.3459 1,288.68 1,289.69 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LSIIATDHTYR 95.00% 3.3 0.471 2.25 645.346 1,288.68 1,289.69 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LSIIATDHTYR 95.00% 3.14 0.495 4.43 645.346 1,288.68 1,289.69 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LSIIATDHTYR 95.00% 3.31 0.446 3.54 645.3466 1,288.68 1,289.69 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LSIIATDHTYR 95.00% 2.31 0.297 0 645.3478 1,288.68 1,289.69 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% NNVEQVccSFEcQPAR 95.00% 4.19 0.471 1.82 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.6107 1,996.81 1,997.83 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% NNVEQVccSFEcQPAR 95.00% 3.09 0.41 2.24 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.6138 1,996.82 1,997.83 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% NNVEQVccSFEcQPAR 95.00% 3.61 0.418 2.55 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.6144 1,996.82 1,997.83 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% NNVEQVccSFEcQPAR 95.00% 4.4 0.523 1.47 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.9482 1,997.82 1,997.83 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 3.98 0.501 3.26 675.8903 1,349.77 1,350.77 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 2.36 0.294 1.8 675.8905 1,349.77 1,350.77 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 3.65 0.402 3.85 675.8908 1,349.77 1,350.77 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 3.82 0.413 2.24 675.8908 1,349.77 1,350.77 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% GLEQLLVGGSHLK 95.00% 2.29 0.35 2.12 675.8909 1,349.77 1,350.77 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% RLLLFSDGNSQGATPAAIEK 95.00% 3.65 0.369 0 697.0406 2,088.10 2,088.11 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 3.15 0.484 2.8 790.9242 1,579.83 1,580.84 2 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 3.4 0.546 2.35 790.926 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VFSVAITPDHLEPR 95.00% 2.51 0.444 0 791.3842 1,580.75 1,580.84 2 LRP1_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 4.41 0.595 5.15 879.4073 1,756.80 1,757.81 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 4.63 0.602 6.11 879.4079 1,756.80 1,757.81 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 4.52 0.592 5.19 879.4088 1,756.80 1,757.81 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 4.5 0.607 6.12 879.4101 1,756.80 1,757.81 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 4.54 0.617 7.1 879.4101 1,756.80 1,757.81 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 4.77 0.592 5.85 879.4125 1,756.81 1,757.81 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 4.44 0.594 7.09 879.9084 1,757.80 1,757.81 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% TAEYDVAYGESHLFR 95.00% 4.86 0.608 6.37 879.9099 1,757.80 1,757.81 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VAVVQYSGTGQQRPER 95.00% 2.96 0.199 0 887.9621 1,773.91 1,774.92 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VAVVQYSGTGQQRPER 95.00% 3.25 0.223 1.15 887.9635 1,773.91 1,774.92 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% VAVVQYSGTGQQRPER 95.00% 3.11 0.231 1.43 887.9638 1,773.91 1,774.92 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.46 0.609 4.92 966.5047 1,930.99 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.01 0.595 5.11 966.5058 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 4.26 0.485 2.7 966.5064 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.12 0.614 5.62 966.5064 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.39 0.486 5.17 967.0049 1,931.99 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.1 0.52 5.42 967.0059 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.53 0.494 6.55 967.0061 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.27 0.487 5.17 967.0071 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.08 0.505 5.15 967.0073 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 5.32 0.564 3.7 967.0077 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.45 0.524 5.14 967.0078 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.65 0.54 5.29 967.0079 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.26 0.48 4.2 967.008 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% eASSGAAKKRLLLFSDGNSQGATPAAIEK 95.00% 0 0 4.11 e1: Pyro_glu (-18.01) 967.0081 2,898.00 2,899.53 3
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.02 0.564 4.96 967.0081 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.27 0.484 4.89 967.0085 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% LLLFSDGNSQGATPAAIEK 95.00% 6.7 0.493 6.74 967.0085 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% NNVEQVccSFEcQPAR 95.00% 5.32 0.556 5.77 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4142 1,996.81 1,997.83 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% NNVEQVccSFEcQPAR 95.00% 5.25 0.556 5.6 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9147 1,997.81 1,997.83 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% NNVEQVccSFEcQPAR 95.00% 4.87 0.571 5.85 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9165 1,997.82 1,997.83 2
 SAMPLE 2R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 16 21 117 18.00% NNVEQVccSFEcQPAR 95.00% 5.02 0.568 6.89 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9179 1,997.82 1,997.83 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 2.15 0.337 2.17 450.9299 1,349.77 1,350.77 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 3.12 0.345 1.89 450.9301 1,349.77 1,350.77 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 3.18 0.401 2.8 450.9303 1,349.77 1,350.77 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 2.9 0.448 1.82 450.9304 1,349.77 1,350.77 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 3.04 0.463 1.82 450.9305 1,349.77 1,350.77 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 3.17 0.425 1.82 450.9307 1,349.77 1,350.77 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 2.85 0.432 1.92 450.9308 1,349.77 1,350.77 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 2.92 0.426 1.96 450.931 1,349.77 1,350.77 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 2.89 0.301 2.24 450.9312 1,349.77 1,350.77 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 3.25 0.432 1.66 450.9312 1,349.77 1,350.77 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 2.62 0.409 1.68 450.9322 1,349.77 1,350.77 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 3.08 0.396 2.13 451.2644 1,350.77 1,350.77 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% IALVITDGR 95.00% 2.54 0.365 1.46 479.2883 956.561 957.5735 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% IALVITDGR 95.00% 2.48 0.431 0 479.2894 956.5632 957.5735 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% IALVITDGR 95.00% 3.01 0.432 1.74 479.2903 956.5649 957.5735 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% IALVITDGR 95.00% 2.97 0.415 1.55 479.2906 956.5655 957.5735 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% IALVITDGR 95.00% 2.2 0.259 1.82 479.2912 956.5667 957.5735 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% IALVITDGR 95.00% 2.7 0.415 1.72 479.2915 956.5674 957.5735 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% IALVITDGR 95.00% 2.81 0.339 1.48 479.2921 956.5685 957.5735 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.45 0.307 2.68 523.8014 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.85 0.433 2.41 523.8015 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.69 0.311 2.39 523.8018 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 3.02 0.443 2.54 523.8019 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.46 0.24 0 523.8019 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.74 0.401 2.48 523.8021 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.29 0.289 0 523.8022 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 3.11 0.52 1.82 523.8022 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.79 0.41 1.92 523.8024 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.71 0.327 1.96 523.8024 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.7 0.468 2.55 523.8025 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.81 0.503 1.77 523.8025 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.13 0.213 1.92 523.8026 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.91 0.437 2.15 523.8026 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.8 0.419 2.7 523.8028 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.57 0.469 1.92 523.8028 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.39 0.208 2.01 523.8031 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VPSYQALLR 95.00% 2.38 0.389 2.07 523.8031 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 2.11 0.242 0 527.6182 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 2.34 0.377 1.92 527.6182 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 2.89 0.401 1.82 527.6183 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 2.83 0.459 0 527.6186 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 2.78 0.367 1.49 527.6188 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 2.72 0.264 1.34 527.6191 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 2.67 0.514 1.15 527.6192 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 3.25 0.358 1.48 527.6194 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 3.32 0.529 2.28 527.6195 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 3.07 0.5 3.06 527.6197 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 3.08 0.57 2.37 527.6198 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 2.71 0.333 0 527.6205 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 2.4 0.248 1.21 527.9526 1,580.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 3.46 0.414 1.09 527.9541 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 2.29 0.32 0 527.9552 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLKENK 95.00% 3.58 0.523 1.25 574.6542 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLKENK 95.00% 2.99 0.501 0 574.6552 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLKENK 95.00% 3.65 0.555 1.35 574.656 1,720.94 1,721.96 3 CO5A1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLKENK 95.00% 2.49 0.292 0 574.9896 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLKENK 95.00% 2.43 0.415 0 574.9899 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 2.53 0.283 0 586.6078 1,756.80 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 2.59 0.313 0 586.608 1,756.80 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 3.19 0.373 0 586.6083 1,756.80 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 3.32 0.459 1.7 586.6084 1,756.80 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 2.66 0.237 0 586.6086 1,756.80 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 3.28 0.434 0 586.6088 1,756.80 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 3.03 0.557 2.82 586.6089 1,756.80 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 3.95 0.549 1 586.943 1,757.81 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 2.9 0.384 0 586.943 1,757.81 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 2.75 0.352 0 586.9432 1,757.81 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 2.87 0.354 0.959 586.9433 1,757.81 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 2.87 0.369 1.19 586.9436 1,757.81 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 2.72 0.313 0 586.944 1,757.81 1,757.81 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VAVVQYSGTGQQRPER 95.00% 2.44 0.476 1.7 592.3102 1,773.91 1,774.92 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VAVVQYSGTGQQRPER 95.00% 2.61 0.532 2.43 592.3103 1,773.91 1,774.92 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VAVVQYSGTGQQRPER 95.00% 3.07 0.564 1.33 592.3109 1,773.91 1,774.92 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VAVVQYSGTGQQRPER 95.00% 3.34 0.518 3.77 592.6445 1,774.91 1,774.92 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LSIIATDHTYR 95.00% 2.47 0.421 1.7 645.3441 1,288.67 1,289.69 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LSIIATDHTYR 95.00% 2.6 0.429 2.92 645.3442 1,288.67 1,289.69 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LSIIATDHTYR 95.00% 3.49 0.497 3 645.3446 1,288.67 1,289.69 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LSIIATDHTYR 95.00% 3.4 0.499 3.14 645.3448 1,288.67 1,289.69 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LSIIATDHTYR 95.00% 3.47 0.405 2.57 645.3456 1,288.68 1,289.69 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LSIIATDHTYR 95.00% 3.03 0.478 2.72 645.3456 1,288.68 1,289.69 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LSIIATDHTYR 95.00% 3.16 0.488 2.52 645.3457 1,288.68 1,289.69 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LSIIATDHTYR 95.00% 3.29 0.459 3.04 645.3464 1,288.68 1,289.69 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% NNVEQVccSFEcQPAR 95.00% 3.95 0.363 0 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.9477 1,997.82 1,997.83 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 3.78 0.4 2.82 675.8896 1,349.76 1,350.77 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 3.85 0.422 2.92 675.89 1,349.76 1,350.77 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% GLEQLLVGGSHLK 95.00% 3.21 0.436 1.92 675.8905 1,349.77 1,350.77 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 3.56 0.49 2.38 790.9276 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VFSVAITPDHLEPR 95.00% 3.3 0.401 2.77 791.4276 1,580.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 4.81 0.611 7.15 879.4079 1,756.80 1,757.81 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 5.17 0.612 8.37 879.9084 1,757.80 1,757.81 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 5.14 0.612 7.21 879.9098 1,757.80 1,757.81 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% TAEYDVAYGESHLFR 95.00% 4.69 0.565 5.7 879.9102 1,757.80 1,757.81 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VAVVQYSGTGQQRPER 95.00% 3.18 0.202 0 887.9613 1,773.91 1,774.92 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VAVVQYSGTGQQRPER 95.00% 2.81 0.182 0 887.9622 1,773.91 1,774.92 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VAVVQYSGTGQQRPER 95.00% 3.17 0.189 0 887.9624 1,773.91 1,774.92 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% VAVVQYSGTGQQRPER 95.00% 3.14 0.227 1.8 887.9626 1,773.91 1,774.92 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LLLFSDGNSQGATPAAIEK 95.00% 5.71 0.608 4.55 966.5048 1,930.99 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LLLFSDGNSQGATPAAIEK 95.00% 6.49 0.508 4.46 967.0055 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LLLFSDGNSQGATPAAIEK 95.00% 6.1 0.48 5.15 967.0056 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% eASSGAAKKRLLLFSDGNSQGATPAAIEK 95.00% 0 0 4.05 e1: Pyro_glu (-18.01) 967.0057 2,897.99 2,899.53 3
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LLLFSDGNSQGATPAAIEK 95.00% 6.26 0.494 4.17 967.007 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LLLFSDGNSQGATPAAIEK 95.00% 6.5 0.491 4.35 967.0075 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% LLLFSDGNSQGATPAAIEK 95.00% 6.52 0.558 5.35 967.0076 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% NNVEQVccSFEcQPAR 95.00% 5.14 0.557 3.57 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4113 1,996.81 1,997.83 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% NNVEQVccSFEcQPAR 95.00% 4.87 0.52 4.62 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.4169 1,996.82 1,997.83 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% NNVEQVccSFEcQPAR 95.00% 5.28 0.544 3.68 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9168 1,997.82 1,997.83 2
 SAMPLE 3 Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 10 15 101 13.10% NNVEQVccSFEcQPAR 95.00% 5.42 0.522 3.82 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9171 1,997.82 1,997.83 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.84 0.409 2.31 450.9301 1,349.77 1,350.77 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.79 0.407 2.89 450.9303 1,349.77 1,350.77 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.44 0.33 1.82 450.9308 1,349.77 1,350.77 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.87 0.359 0 450.9308 1,349.77 1,350.77 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.72 0.445 2.28 450.9308 1,349.77 1,350.77 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.72 0.384 2 450.9309 1,349.77 1,350.77 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.62 0.373 2.32 450.9314 1,349.77 1,350.77 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 3.12 0.392 2.64 450.9315 1,349.77 1,350.77 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.68 0.431 2.89 450.9315 1,349.77 1,350.77 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.96 0.408 1.49 450.9316 1,349.77 1,350.77 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.88 0.435 1.62 450.9317 1,349.77 1,350.77 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% IALVITDGR 95.00% 2.95 0.409 2.43 479.2886 956.5616 957.5735 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% IALVITDGR 95.00% 3 0.415 2.11 479.2889 956.5622 957.5735 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% IALVITDGR 95.00% 2.45 0.415 0 479.2894 956.5631 957.5735 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% IALVITDGR 95.00% 2.01 0.25 0 479.2922 956.5688 957.5735 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% FLTAGRTDPAHDVR 95.00% 2.23 0.212 0 519.2689 1,554.78 1,555.80 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% FLTAGRTDPAHDVR 95.00% 1.86 0.298 0 519.6029 1,555.79 1,555.80 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.35 0.335 1.3 523.8014 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.79 0.431 2.15 523.802 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.73 0.509 1.6 523.8023 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.67 0.47 1.8 523.8023 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.78 0.425 2.31 523.8025 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.34 0.225 0 523.8025 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.45 0.299 0 523.8026 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.52 0.396 1.22 523.8027 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.4 0.272 1.85 523.8027 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.49 0.423 1.3 523.8027 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.55 0.367 2.04 523.8028 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.98 0.445 1.6 523.8028 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 3.18 0.47 1.62 523.8028 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.69 0.449 0 523.8029 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.81 0.449 2.16 523.803 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.61 0.368 1.55 523.8031 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.51 0.317 0 523.8034 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VPSYQALLR 95.00% 2.67 0.386 1.74 523.8043 1,045.59 1,046.60 2 C1QT5_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 1.94 0.358 0 527.6178 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 2.69 0.363 0 527.6185 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 2.85 0.481 1.28 527.6187 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 2.46 0.331 1.25 527.6188 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 2.6 0.352 1.47 527.619 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 2.29 0.424 0 527.619 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 2.4 0.367 0 527.6193 1,579.83 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 2.44 0.438 0 527.6198 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 2.02 0.285 0 527.6199 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 2.26 0.311 0.959 527.6199 1,579.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 3.15 0.224 1.17 527.9529 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 2.92 0.385 0 527.9529 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 3.37 0.265 0 527.9534 1,580.84 1,580.84 3 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLKENK 95.00% 2.42 0.26 1.21 574.9895 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLKENK 95.00% 3 0.389 1.03 574.9896 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLKENK 95.00% 3.04 0.306 0 574.9899 1,721.95 1,721.96 3 CO5A1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 2.57 0.355 0 586.3016 1,755.88 1,757.81 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 2.53 0.36 0 586.6082 1,756.80 1,757.81 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 3.1 0.486 2.12 586.6083 1,756.80 1,757.81 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 2.62 0.354 0 586.6083 1,756.80 1,757.81 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 3.47 0.52 2.57 586.6087 1,756.80 1,757.81 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 2.85 0.365 0 586.6089 1,756.80 1,757.81 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 2.78 0.384 0 586.6089 1,756.80 1,757.81 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 2.87 0.192 0 586.9424 1,757.80 1,757.81 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 2.59 0.181 0 586.9432 1,757.81 1,757.81 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 3.07 0.433 0 586.9433 1,757.81 1,757.81 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 2.84 0.301 0 586.9436 1,757.81 1,757.81 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VAVVQYSGTGQQRPER 95.00% 2.58 0.436 0 592.3101 1,773.91 1,774.92 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VAVVQYSGTGQQRPER 95.00% 2.3 0.453 1.72 592.3104 1,773.91 1,774.92 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VAVVQYSGTGQQRPER 95.00% 2.76 0.521 2.32 592.3106 1,773.91 1,774.92 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VAVVQYSGTGQQRPER 95.00% 3.12 0.51 2.29 592.645 1,774.91 1,774.92 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LLLFSDGNSQGATPAAIEK 95.00% 2.19 0.243 0 645.0104 1,932.01 1,932.01 3 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LSIIATDHTYR 95.00% 2.45 0.375 0 645.3446 1,288.67 1,289.69 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LSIIATDHTYR 95.00% 3.11 0.471 1.52 645.3448 1,288.67 1,289.69 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LSIIATDHTYR 95.00% 2.34 0.265 0 645.3456 1,288.68 1,289.69 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LSIIATDHTYR 95.00% 3.34 0.507 4.14 645.3456 1,288.68 1,289.69 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LSIIATDHTYR 95.00% 2.06 0.361 0 645.3461 1,288.68 1,289.69 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LSIIATDHTYR 95.00% 2.9 0.353 3.74 645.3463 1,288.68 1,289.69 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LSIIATDHTYR 95.00% 2.49 0.399 3.29 645.3463 1,288.68 1,289.69 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LSIIATDHTYR 95.00% 3.1 0.471 3.59 645.3465 1,288.68 1,289.69 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LSIIATDHTYR 95.00% 2.45 0.482 3.21 645.3466 1,288.68 1,289.69 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LSIIATDHTYR 95.00% 2.48 0.35 1.31 645.3466 1,288.68 1,289.69 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% NNVEQVccSFEcQPAR 95.00% 3.37 0.394 1.15 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.949 1,997.82 1,997.83 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% NNVEQVccSFEcQPAR 95.00% 4.07 0.512 1.42 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 666.9494 1,997.82 1,997.83 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 3.61 0.409 2.39 675.8885 1,349.76 1,350.77 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.17 0.341 1.64 675.8891 1,349.76 1,350.77 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.37 0.284 2.2 675.8905 1,349.77 1,350.77 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 3.1 0.454 2.13 675.8911 1,349.77 1,350.77 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% GLEQLLVGGSHLK 95.00% 2.55 0.389 1.96 676.3929 1,350.77 1,350.77 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 3.3 0.435 2.42 790.9266 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VFSVAITPDHLEPR 95.00% 3.17 0.468 2.25 790.9278 1,579.84 1,580.84 2 LRP1_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 4.63 0.611 7.64 879.4079 1,756.80 1,757.81 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 4.66 0.602 6.68 879.4085 1,756.80 1,757.81 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 4.55 0.57 7.77 879.4093 1,756.80 1,757.81 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 4.21 0.586 5.57 879.4095 1,756.80 1,757.81 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 4.74 0.599 6.8 879.9108 1,757.81 1,757.81 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% TAEYDVAYGESHLFR 95.00% 4.05 0.621 4.07 879.9148 1,757.81 1,757.81 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% VAVVQYSGTGQQRPER 95.00% 3.15 0.144 0 887.9611 1,773.91 1,774.92 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LLLFSDGNSQGATPAAIEK 95.00% 6.3 0.6 5.36 966.505 1,930.99 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LLLFSDGNSQGATPAAIEK 95.00% 5.8 0.581 5.68 966.5069 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LLLFSDGNSQGATPAAIEK 95.00% 6.56 0.61 7.24 966.507 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LLLFSDGNSQGATPAAIEK 95.00% 5.95 0.611 5.49 966.5072 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LLLFSDGNSQGATPAAIEK 95.00% 6.27 0.608 6.62 966.5075 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LLLFSDGNSQGATPAAIEK 95.00% 6.09 0.6 5.39 966.5086 1,931.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LLLFSDGNSQGATPAAIEK 95.00% 6.36 0.515 5.11 967.0068 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% eASSGAAKKRLLLFSDGNSQGATPAAIEK 95.00% 0 0 3.38 e1: Pyro_glu (-18.01) 967.0069 2,898.00 2,899.53 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LLLFSDGNSQGATPAAIEK 95.00% 6.14 0.575 6.28 967.007 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% eASSGAAKKRLLLFSDGNSQGATPAAIEK 94.70% 0 0 3 e1: Pyro_glu (-18.01) 967.0071 2,898.00 2,899.53 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LLLFSDGNSQGATPAAIEK 95.00% 5.92 0.564 4.15 967.008 1,932.00 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LLLFSDGNSQGATPAAIEK 95.00% 5.8 0.528 5.77 967.0105 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% LLLFSDGNSQGATPAAIEK 95.00% 6.25 0.509 5.64 967.0107 1,932.01 1,932.01 2 SPTA2_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% eASSGAAKKRLLLFSDGNSQGATPAAIEK 95.00% 0 0 3.39 e1: Pyro_glu (-18.01) 967.0107 2,898.01 2,899.53 3
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% NNVEQVccSFEcQPAR 95.00% 4.89 0.516 4.96 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9131 1,997.81 1,997.83 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% NNVEQVccSFEcQPAR 95.00% 5.06 0.542 3.4 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9149 1,997.81 1,997.83 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% NNVEQVccSFEcQPAR 95.00% 5.2 0.527 4.72 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.9154 1,997.82 1,997.83 2
 SAMPLE 3R Collagen alpha-1(VI) chain  COL6A1  CO6A1_HUMAN 108,512.90 100.00% 11 16 99 14.50% NNVEQVccSFEcQPAR 95.00% 5.15 0.539 5.31 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 999.919 1,997.82 1,997.83 2
 SAMPLE 2 Collagen alpha-1(VIII) chain  COL8A1  CO8A1_HUMAN 73,348.50 100.00% 3 3 8 5.78% GGNVWVALFK 95.00% 2.95 0.357 1.82 545.8046 1,089.59 1,090.61 2
 SAMPLE 2 Collagen alpha-1(VIII) chain  COL8A1  CO8A1_HUMAN 73,348.50 100.00% 3 3 8 5.78% GGNVWVALFK 95.00% 3.56 0.452 2.27 545.8053 1,089.60 1,090.61 2
 SAMPLE 2 Collagen alpha-1(VIII) chain  COL8A1  CO8A1_HUMAN 73,348.50 100.00% 3 3 8 5.78% GGNVWVALFK 95.00% 3.11 0.381 2.7 545.8056 1,089.60 1,090.61 2
 SAMPLE 2 Collagen alpha-1(VIII) chain  COL8A1  CO8A1_HUMAN 73,348.50 100.00% 3 3 8 5.78% GGNVWVALFK 95.00% 3.53 0.464 2 545.8057 1,089.60 1,090.61 2
 SAMPLE 2 Collagen alpha-1(VIII) chain  COL8A1  CO8A1_HUMAN 73,348.50 100.00% 3 3 8 5.78% GGNVWVALFK 95.00% 3.28 0.407 0 545.8058 1,089.60 1,090.61 2
 SAMPLE 2 Collagen alpha-1(VIII) chain  COL8A1  CO8A1_HUMAN 73,348.50 100.00% 3 3 8 5.78% GGNVWVALFK 95.00% 3.51 0.427 2.07 545.8062 1,089.60 1,090.61 2
 SAMPLE 2 Collagen alpha-1(VIII) chain  COL8A1  CO8A1_HUMAN 73,348.50 100.00% 3 3 8 5.78% NNEPVMYTYDEYKK 95.00% 3.01 0.379 0 598.6068 1,792.80 1,793.81 3
 SAMPLE 2 Collagen alpha-1(VIII) chain  COL8A1  CO8A1_HUMAN 73,348.50 100.00% 3 3 8 5.78% GFLDQASGSAVLLLRPGDR 95.00% 3.21 0.405 3.23 658.3588 1,972.05 1,972.06 3
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% IVEVFDIGPK 95.00% 3.29 0.533 1.64 558.8178 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% IVEVFDIGPK 95.00% 3.46 0.501 0 558.8178 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% ALALGALQNIR 95.00% 2.78 0.316 1.35 570.3469 1,138.68 1,139.69 2
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% ALALGALQNIR 95.00% 3.22 0.355 1.64 570.3469 1,138.68 1,139.69 2
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% ALALGALQNIR 95.00% 2.35 0.359 1.24 570.627 1,139.24 1,139.69 2
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% ALALGALQNIR 95.00% 2.11 0.306 0 570.6278 1,139.24 1,139.69 2
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% SLLQAVANLPYK 95.00% 2.51 0.256 0 658.8833 1,315.75 1,316.76 2
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% SLLQAVANLPYK 95.00% 2.45 0.381 2.57 658.8844 1,315.75 1,316.76 2
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% VYDPSTSTLNVR 95.00% 2.25 0.424 0 676.3466 1,350.68 1,351.69 2
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% WDPAPGPVLQYR 95.00% 2.3 0.418 2.85 699.8603 1,397.71 1,398.72 2
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% WDPAPGPVLQYR 95.00% 2.6 0.388 3.38 699.8617 1,397.71 1,398.72 2
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% IYIDcYEIIEK 95.00% 3.06 0.278 3.8 c5: Carbamidomethyl (+57.02) 729.8611 1,457.71 1,458.72 2
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% VSWDPSPSPVLGYK 95.00% 3.42 0.393 3.6 766.3946 1,530.77 1,531.78 2
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% VSWDPSPSPVLGYK 95.00% 3.19 0.387 3.13 766.3976 1,530.78 1,531.78 2
 SAMPLE 1 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 8 8 15 3.17% NVQVYNPTPNSLDVR 95.00% 4.61 0.417 3.25 858.9409 1,715.87 1,715.87 2
 SAMPLE 1R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 4 4 9 1.53% IVEVFDIGPK 95.00% 3.19 0.497 1.92 558.817 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 1R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 4 4 9 1.53% IVEVFDIGPK 95.00% 2.56 0.379 0 558.8183 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 1R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 4 4 9 1.53% IVEVFDIGPK 95.00% 2.24 0.284 1.33 558.8188 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 1R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 4 4 9 1.53% IVEVFDIGPK 95.00% 2.63 0.404 1.96 558.8202 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 1R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 4 4 9 1.53% ALALGALQNIR 95.00% 2.02 0.326 1.47 570.6253 1,139.24 1,139.69 2
 SAMPLE 1R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 4 4 9 1.53% ALALGALQNIR 95.00% 2.14 0.289 0 570.6255 1,139.24 1,139.69 2
 SAMPLE 1R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 4 4 9 1.53% VYDPSTSTLNVR 95.00% 3.08 0.425 3.35 676.3464 1,350.68 1,351.69 2
 SAMPLE 1R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 4 4 9 1.53% VYDPSTSTLNVR 95.00% 2.32 0.319 0 676.3482 1,350.68 1,351.69 2
 SAMPLE 1R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 4 4 9 1.53% VSWDPSPSPVLGYK 95.00% 2.78 0.279 2.54 766.3933 1,530.77 1,531.78 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% IVEVFDIGPK 95.00% 3.34 0.571 0 558.8161 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% IVEVFDIGPK 95.00% 2.45 0.294 0 558.8183 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% ITEVTSEGFR 95.00% 2.64 0.419 0 569.7889 1,137.56 1,138.57 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% ITEVTSEGFR 95.00% 3.01 0.422 2.27 569.7894 1,137.56 1,138.57 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% ITEVTSEGFR 95.00% 2.76 0.427 1.57 569.7902 1,137.56 1,138.57 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% ITEVTSEGFR 95.00% 2.79 0.394 1.32 569.7906 1,137.57 1,138.57 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% ALALGALQNIR 95.00% 3.04 0 3.7 569.7997 1,137.58 1,139.69 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% ALALGALQNIR 95.00% 3.02 0 3.68 569.8 1,137.58 1,139.69 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% ALALGALQNIR 95.00% 3.45 0.0782 2.49 570.3473 1,138.68 1,139.69 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% ALALGALQNIR 95.00% 4.25 0.38 2.26 570.3476 1,138.68 1,139.69 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% ALALGALQNIR 95.00% 3.68 0.305 2.33 570.3477 1,138.68 1,139.69 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% ALALGALQNIR 95.00% 3.69 0.232 2.8 570.3479 1,138.68 1,139.69 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% ALALGALQNIR 95.00% 4.37 0.385 2.21 570.3483 1,138.68 1,139.69 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% ALALGALQNIR 95.00% 2.04 0.244 1.37 570.9607 1,139.91 1,139.69 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% VYDPSTSTLNVR 95.00% 2.98 0.487 3.82 676.3452 1,350.67 1,351.69 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% VYDPSTSTLNVR 95.00% 3.15 0.521 4.96 676.3452 1,350.67 1,351.69 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% VYDPSTSTLNVR 95.00% 2.16 0.333 2.77 676.3474 1,350.68 1,351.69 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% TYQIGWDTFcVK 95.00% 3.75 0.565 3.62 c10: Carbamidomethyl (+57.02) 759.3598 1,516.70 1,517.71 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% VSWDPSPSPVLGYK 95.00% 2.73 0.319 2.85 766.3947 1,530.77 1,531.78 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% VSWDPSPSPVLGYK 95.00% 3.25 0.403 2.8 766.3958 1,530.78 1,531.78 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% VSWDPSPSPVLGYK 95.00% 3.15 0.374 3.06 766.8945 1,531.77 1,531.78 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% VSWDPSPSPVLGYK 95.00% 2.94 0.341 2.1 766.8971 1,531.78 1,531.78 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% VVYSPVDGTRPSESIVVPGNTR 95.00% 4.69 0.398 2.18 777.412 2,329.21 2,329.22 3
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% IVDDLTINLcNSVK 95.00% 3.9 0.547 3.72 c10: Carbamidomethyl (+57.02) 802.422 1,602.83 1,603.84 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% GPGDLEAPSNLVISER 95.00% 3.56 0.542 2.55 827.4289 1,652.84 1,653.85 2
 SAMPLE 2 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 10 10 26 4.44% NVQVYNPTPNSLDVR 95.00% 4.34 0.455 2.51 858.9389 1,715.86 1,715.87 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% IVEVFDIGPK 95.00% 3.18 0.517 1.74 558.8183 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% IVEVFDIGPK 95.00% 3.01 0.466 1.29 558.8185 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% ITEVTSEGFR 95.00% 2.7 0.443 1.25 569.7892 1,137.56 1,138.57 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% ITEVTSEGFR 95.00% 2.55 0.438 1.89 569.7896 1,137.56 1,138.57 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% ITEVTSEGFR 95.00% 2.82 0.479 3.6 569.7896 1,137.56 1,138.57 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% ITEVTSEGFR 95.00% 2.88 0.424 3.14 569.7904 1,137.57 1,138.57 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% ITEVTSEGFR 95.00% 2.48 0.361 1.72 569.7906 1,137.57 1,138.57 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% ITEVTSEGFR 95.00% 2.59 0.357 2.44 569.7913 1,137.57 1,138.57 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% ALALGALQNIR 94.70% 2.63 0 1.38 569.7996 1,137.58 1,139.69 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% ALALGALQNIR 95.00% 3.64 0.199 1.96 570.3479 1,138.68 1,139.69 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% ALALGALQNIR 95.00% 3.43 0.153 2.19 570.3485 1,138.68 1,139.69 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% ALALGALQNIR 95.00% 3.24 0.179 2.01 570.3499 1,138.68 1,139.69 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% ALALGALQNIR 95.00% 2.63 0.37 2.24 570.6271 1,139.24 1,139.69 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% ALALGALQNIR 95.00% 2.37 0.325 1.62 570.6272 1,139.24 1,139.69 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% SLLQAVANLPYK 95.00% 3.35 0.457 1.48 658.8813 1,315.75 1,316.76 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% SLLQAVANLPYK 95.00% 1.98 0.214 1.28 658.882 1,315.75 1,316.76 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% VYDPSTSTLNVR 95.00% 2.86 0.464 3.96 676.3453 1,350.68 1,351.69 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% VYDPSTSTLNVR 95.00% 1.86 0.329 1.64 676.3457 1,350.68 1,351.69 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% VYDPSTSTLNVR 95.00% 2.32 0.464 4.39 676.3458 1,350.68 1,351.69 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% TYQIGWDTFcVK 95.00% 3.13 0.482 2.36 c10: Carbamidomethyl (+57.02) 759.3602 1,516.70 1,517.71 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% VSWDPSPSPVLGYK 95.00% 2.79 0.26 3.39 766.398 1,530.78 1,531.78 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% VVYSPVDGTRPSESIVVPGNTR 95.00% 5.39 0.488 3.24 777.4113 2,329.21 2,329.22 3
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% LKPDTPYTITVSSLYPDGEGGR 95.00% 3.89 0.461 0 789.7346 2,366.18 2,366.19 3
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% IVDDLTINLcNSVK 95.00% 2.19 0.256 0 c10: Carbamidomethyl (+57.02) 802.4214 1,602.83 1,603.84 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% IVDDLTINLcNSVK 95.00% 2.94 0.383 2 c10: Carbamidomethyl (+57.02) 802.4242 1,602.83 1,603.84 2
 SAMPLE 2R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 26 5.03% NVQVYNPTPNSLDVR 95.00% 4.22 0.407 4.77 858.9424 1,715.87 1,715.87 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% VLVVVTDGR 95.00% 2.57 0.189 1.49 479.2895 956.5633 957.5734 2 GLYG_HUMAN,RP1L1_HUMAN,MYH11_HUMAN
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% VLVVVTDGR 95.00% 2.25 0.229 1.39 479.2899 956.5642 957.5734 2 GLYG_HUMAN,RP1L1_HUMAN,MYH11_HUMAN
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% IVEVFDIGPK 95.00% 3.18 0.563 2.54 558.8182 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% IVEVFDIGPK 95.00% 3.33 0.551 2.42 558.8184 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% IVEVFDIGPK 95.00% 3.4 0.537 2.21 558.8185 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% ALALGALQNIR 95.00% 2.92 0 2.82 569.7987 1,137.58 1,139.69 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% ALALGALQNIR 95.00% 3.76 0.369 3.41 570.3463 1,138.68 1,139.69 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% ALALGALQNIR 95.00% 3.87 0.235 2.74 570.3475 1,138.68 1,139.69 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% ALALGALQNIR 95.00% 4.28 0.373 2.8 570.3478 1,138.68 1,139.69 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% VYDPSTSTLNVR 95.00% 2.51 0.419 4.66 676.3455 1,350.68 1,351.69 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% VYDPSTSTLNVR 95.00% 1.83 0.232 1.21 676.3463 1,350.68 1,351.69 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% VYDPSTSTLNVR 95.00% 2.09 0.401 3.09 676.3464 1,350.68 1,351.69 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% ITVIAVYEDGDGGHLTGNGR 95.00% 3.03 0.38 0 682.3409 2,044.00 2,044.01 3
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% WDPAPGPVLQYR 95.00% 2.98 0.554 3.41 699.8598 1,397.70 1,398.72 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% WDPAPGPVLQYR 95.00% 3.39 0.568 3.43 699.8607 1,397.71 1,398.72 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% WDPAPGPVLQYR 95.00% 2.25 0.38 1.89 700.3635 1,398.71 1,398.72 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% VQIALAQYSGDPR 95.00% 3.19 0.593 2.96 709.377 1,416.74 1,417.74 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% TYQIGWDTFcVK 95.00% 3.9 0.569 3.68 c10: Carbamidomethyl (+57.02) 759.859 1,517.70 1,517.71 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% VSWDPSPSPVLGYK 95.00% 3.18 0.353 3.92 766.393 1,530.77 1,531.78 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% VSWDPSPSPVLGYK 95.00% 2.21 0.27 3 766.3946 1,530.77 1,531.78 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% VSWDPSPSPVLGYK 95.00% 3.08 0.323 4.7 766.395 1,530.77 1,531.78 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% LKPDTPYTITVSSLYPDGEGGR 95.00% 4.04 0.415 0 789.7365 2,366.19 2,366.19 3
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% GEVQTVTFDTEEVK 95.00% 2.95 0.227 0 791.386 1,580.76 1,581.77 2
 SAMPLE 3 Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 11 11 22 5.35% NNVILQPLQPDTPYK 95.00% 4.27 0.55 3.57 870.9693 1,739.92 1,739.93 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% VLVVVTDGR 95.00% 2.03 0.225 2.16 479.2902 956.5648 957.5734 2 GLYG_HUMAN,RP1L1_HUMAN,MYH11_HUMAN
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% IVEVFDIGPK 95.00% 3.01 0.54 1.36 558.8158 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% IVEVFDIGPK 95.00% 3.29 0.49 1.26 558.8178 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% IVEVFDIGPK 95.00% 3.24 0.508 3.21 558.818 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% IVEVFDIGPK 95.00% 2.89 0.476 2.12 558.8181 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% IVEVFDIGPK 95.00% 3.11 0.441 2.1 558.8183 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% IVEVFDIGPK 95.00% 3.08 0.54 2.47 558.8184 1,115.62 1,116.63 2 IGHG3_HUMAN,REV1_HUMAN
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% ITEVTSEGFR 95.00% 2.95 0.428 3.39 569.7898 1,137.56 1,138.57 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% ITEVTSEGFR 95.00% 3.05 0.504 2.27 569.7907 1,137.57 1,138.57 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% ALALGALQNIR 95.00% 2.81 0 3.72 569.798 1,137.58 1,139.69 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% ALALGALQNIR 95.00% 2.95 0 3.85 569.7997 1,137.58 1,139.69 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% ALALGALQNIR 95.00% 3.69 0.315 2.82 570.3461 1,138.68 1,139.69 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% ALALGALQNIR 95.00% 3.47 0.234 2.82 570.3464 1,138.68 1,139.69 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% ALALGALQNIR 95.00% 2.94 0.133 2.89 570.3469 1,138.68 1,139.69 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% ALALGALQNIR 95.00% 4.1 0.266 2.66 570.3477 1,138.68 1,139.69 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% ALALGALQNIR 95.00% 3.94 0.272 2.59 570.3481 1,138.68 1,139.69 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% ALALGALQNIR 95.00% 1.84 0.281 1.52 570.6269 1,139.24 1,139.69 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% ALALGALQNIR 95.00% 2.44 0.341 0 570.9608 1,139.91 1,139.69 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% ALALGALQNIR 95.00% 2.52 0.347 2.1 570.9611 1,139.91 1,139.69 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% SLLQAVANLPYK 95.00% 2.5 0.157 1.66 658.8814 1,315.75 1,316.76 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% SLLQAVANLPYK 95.00% 2.68 0.323 3.14 658.8817 1,315.75 1,316.76 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% SLLQAVANLPYK 95.00% 2.38 0.219 1.49 658.8822 1,315.75 1,316.76 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% VYDPSTSTLNVR 95.00% 2.3 0.322 2.27 676.3479 1,350.68 1,351.69 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% WDPAPGPVLQYR 95.00% 2.15 0.409 1.72 699.86 1,397.70 1,398.72 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% GGNTLTGMALNFIR 95.00% 2.75 0.473 3.01 732.8855 1,463.76 1,464.76 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% GGNTLTGMALNFIR 95.00% 2.39 0.401 2.96 732.8865 1,463.76 1,464.76 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% GGNTLTGMALNFIR 95.00% 3.54 0.478 2.1 733.3838 1,464.75 1,464.76 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% TYQIGWDTFcVK 95.00% 2.99 0.503 2.47 c10: Carbamidomethyl (+57.02) 759.3584 1,516.70 1,517.71 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% TYQIGWDTFcVK 95.00% 3.22 0.574 2.51 c10: Carbamidomethyl (+57.02) 759.3588 1,516.70 1,517.71 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% VSWDPSPSPVLGYK 95.00% 1.91 0.0414 3.33 766.395 1,530.77 1,531.78 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% VSWDPSPSPVLGYK 95.00% 3.51 0.441 3.55 766.896 1,531.78 1,531.78 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% VSWDPSPSPVLGYK 95.00% 3.33 0.364 4.23 766.8965 1,531.78 1,531.78 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% LKPDTPYTITVSSLYPDGEGGR 95.00% 3.92 0.464 0 789.7354 2,366.18 2,366.19 3
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% LKPDTPYTITVSSLYPDGEGGR 95.00% 4.13 0.365 0 789.7375 2,366.19 2,366.19 3
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% IVDDLTINLcNSVK 95.00% 3 0.402 3.48 c10: Carbamidomethyl (+57.02) 802.4231 1,602.83 1,603.84 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% NVQVYNPTPNSLDVR 95.00% 4.37 0.503 3.72 858.4398 1,714.86 1,715.87 2
 SAMPLE 3R Collagen alpha-1(XII) chain  COL12A1  COCA1_HUMAN 333,127.30 100.00% 12 12 36 5.45% NVQVYNPTPNSLDVR 95.00% 4.1 0.515 2.46 858.4428 1,714.87 1,715.87 2
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% TLPSSGPQNLR 95.00% 1.84 0.389 1.59 585.3187 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% IGLAQYSGDPR 95.00% 2.58 0.34 2.03 588.8053 1,175.59 1,176.60 2
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% IGLAQYSGDPR 95.00% 2.71 0.397 0 588.8059 1,175.60 1,176.60 2
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% ITWDPPSSPVK 95.00% 2.14 0.267 0 613.8266 1,225.64 1,226.64 2
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% ESGVELFAIGVK 95.00% 2.53 0.325 1.57 624.8468 1,247.68 1,248.68 2
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% ESGVELFAIGVK 95.00% 2.91 0.397 2.11 624.8474 1,247.68 1,248.68 2
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% ASAHAITGPPTELITSEVTAR 95.00% 3.21 0.52 1.14 708.0442 2,121.11 2,122.11 3
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% ASAHAITGPPTELITSEVTAR 95.00% 3.89 0.337 2.52 708.3785 2,122.11 2,122.11 3
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% ASAHAITGPPTELITSEVTAR 95.00% 4.18 0.395 1.89 708.3793 2,122.11 2,122.11 3
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% ASAHAITGPPTELITSEVTAR 95.00% 2.94 0.255 0 708.3797 2,122.12 2,122.11 3
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% ASAHAITGPPTELITSEVTAR 95.00% 2.98 0.175 1.05 708.3797 2,122.12 2,122.11 3
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% ASAHAITGPPTELITSEVTAR 95.00% 3.92 0.406 0 708.3798 2,122.12 2,122.11 3
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% NSDPLVGVILDNGGK 95.00% 3.89 0.554 4.43 749.4007 1,496.79 1,497.79 2 CO6A2_HUMAN
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% NSDPLVGVILDNGGK 95.00% 2.11 0.483 3.85 749.4024 1,496.79 1,497.79 2 CO6A2_HUMAN
 SAMPLE 4 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.51% NSDPLVGVILDNGGK 95.00% 4.34 0.59 6.2 749.9034 1,497.79 1,497.79 2 CO6A2_HUMAN
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% TLPSSGPQNLR 95.00% 1.89 0.322 1.64 585.3192 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% IGLAQYSGDPR 95.00% 2.05 0.291 0 588.8067 1,175.60 1,176.60 2
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% IGLAQYSGDPR 95.00% 2.48 0.313 0 588.807 1,175.60 1,176.60 2
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% IGLAQYSGDPR 95.00% 2.47 0.258 0 588.8071 1,175.60 1,176.60 2
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% ESGVELFAIGVK 95.00% 2.31 0.245 0 624.847 1,247.68 1,248.68 2
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% ESGVELFAIGVK 95.00% 2.58 0.369 0 624.847 1,247.68 1,248.68 2
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% ESGVELFAIGVK 95.00% 2.75 0.165 0 624.8473 1,247.68 1,248.68 2
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% ESGVELFAIGVK 95.00% 2.44 0.303 0 624.8483 1,247.68 1,248.68 2
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% TLFLGVTNLQAK 95.00% 3.42 0.515 2.04 652.8853 1,303.75 1,304.76 2
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% ASAHAITGPPTELITSEVTAR 95.00% 2.97 0.176 0.959 708.3793 2,122.11 2,122.11 3
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% ASAHAITGPPTELITSEVTAR 95.00% 3.21 0.242 1.2 708.3799 2,122.12 2,122.11 3
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% ASAHAITGPPTELITSEVTAR 95.00% 3.22 0.27 1.77 708.3801 2,122.12 2,122.11 3
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% ASAHAITGPPTELITSEVTAR 95.00% 2.67 0.184 1.24 708.3802 2,122.12 2,122.11 3
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% ASAHAITGPPTELITSEVTAR 95.00% 2.86 0.23 1 708.381 2,122.12 2,122.11 3
 SAMPLE 4R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 5 5 14 4.57% NSDPLVGVILDNGGK 95.00% 3.8 0.518 6.27 749.4029 1,496.79 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% IGILITDGK 95.00% 2.67 0.119 2.62 465.2857 928.5558 929.5675 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% IGILITDGK 95.00% 2.69 0.11 2.23 465.2864 928.5572 929.5675 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% IGILITDGK 95.00% 3.26 0.1 2.55 465.2876 928.5595 929.5675 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% IGILITDGK 95.00% 3.36 0.1 2 465.288 928.5604 929.5675 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% DGIDLAGFK 95.00% 3.05 0.316 2.12 468.245 934.4743 935.4841 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% DGIDLAGFK 95.00% 2.66 0.402 2.09 468.2454 934.4751 935.4841 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% DGIDLAGFK 95.00% 2.74 0.343 2.41 468.2459 934.4762 935.4841 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% DGIDLAGFK 95.00% 2.55 0.346 1.4 468.2465 934.4773 935.4841 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% DGIDLAGFK 95.00% 2.71 0.407 1.44 468.2469 934.4782 935.4841 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% DGIDLAGFK 95.00% 2.93 0.453 2.46 468.2473 934.479 935.4841 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VIVVITDGR 95.00% 3.07 0.435 0 486.2965 970.5774 971.5891 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VIVVITDGR 95.00% 3.12 0.406 0 486.2971 970.5785 971.5891 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VIVVITDGR 95.00% 2.98 0.443 0 486.2973 970.5789 971.5891 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VIVVITDGR 95.00% 2.94 0.382 0 486.2973 970.579 971.5891 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VIVVITDGR 95.00% 3.22 0.47 0 486.2976 970.5795 971.5891 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VIVVITDGR 95.00% 3.23 0.468 0 486.2977 970.5797 971.5891 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% LTWDPTSR 95.00% 1.89 0.269 0 488.2485 974.4813 975.4901 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% IISFLYSTVGALNK 95.00% 2.57 0.235 0 509.2921 1,524.85 1,525.86 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VVIESLQDR 95.00% 2.55 0.406 0 529.7946 1,057.57 1,058.58 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VVIESLQDR 95.00% 2.84 0.463 0 529.795 1,057.57 1,058.58 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VVIESLQDR 95.00% 2.66 0.435 0 529.795 1,057.57 1,058.58 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VVIESLQDR 95.00% 2.78 0.401 0 529.7952 1,057.57 1,058.58 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VVIESLQDR 95.00% 2.59 0.397 0 529.7953 1,057.58 1,058.58 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% QVcEQLIQSHMAR 95.00% 3.3 0.383 0 c3: Carbamidomethyl (+57.02) 534.2626 1,599.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% HcFYGLQPDSEYK 95.00% 2.05 0 1.68 c2: Carbamidomethyl (+57.02) 548.9111 1,643.71 1,643.72 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% GDLQSQAMVR 95.00% 2.19 0.31 1.37 552.7754 1,103.54 1,104.55 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% LMWIPVYGGK 95.00% 2.8 0.191 0 582.3164 1,162.62 1,163.63 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% LMWIPVYGGK 95.00% 2.55 0.258 0 582.3165 1,162.62 1,163.63 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% LMWIPVYGGK 95.00% 2.77 0.241 0 582.3166 1,162.62 1,163.63 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% LMWIPVYGGK 95.00% 2.45 0.221 0 582.3167 1,162.62 1,163.63 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% TLPSSGPQNLR 95.00% 2.01 0.364 1.96 585.3159 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% TLPSSGPQNLR 95.00% 1.77 0.273 1.7 585.3163 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% TLPSSGPQNLR 95.00% 1.68 0.264 2.12 585.3165 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% TLPSSGPQNLR 95.00% 1.84 0.307 2.62 585.3167 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% TLPSSGPQNLR 95.00% 1.9 0.33 3.52 585.3168 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% TLPSSGPQNLR 95.00% 1.84 0.279 2.54 585.3174 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% YTAILNQIPSHSSSIR 95.00% 2.55 0.219 0.959 596.3016 1,785.88 1,786.95 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% YTAILNQIPSHSSSIR 95.00% 2.46 0.39 0 596.316 1,785.92 1,786.95 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% YTAILNQIPSHSSSIR 95.00% 3.16 0.515 0 596.3184 1,785.93 1,786.95 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% YTAILNQIPSHSSSIR 95.00% 2.41 0.328 1.26 596.3195 1,785.93 1,786.95 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% YTAILNQIPSHSSSIR 95.00% 3.17 0.425 2.09 596.6522 1,786.93 1,786.95 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% YTAILNQIPSHSSSIR 95.00% 3.39 0.435 2 596.6531 1,786.94 1,786.95 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% YTAILNQIPSHSSSIR 95.00% 2.22 0.213 1.46 596.6534 1,786.94 1,786.95 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% YTAILNQIPSHSSSIR 95.00% 3.76 0.298 2.74 596.6536 1,786.94 1,786.95 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% DTLFTAESGTR 95.00% 2.3 0.344 0 599.2885 1,196.56 1,197.58 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% DTLFTAESGTR 95.00% 2.8 0.368 0 599.29 1,196.56 1,197.58 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% HFLENLVTAFDVGSEK 95.00% 4.15 0.511 3.26 602.64 1,804.90 1,805.91 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% HFLENLVTAFDVGSEK 95.00% 4.5 0.504 3.47 602.9754 1,805.90 1,805.91 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ITWDPPSSPVK 95.00% 2.63 0.354 2 613.823 1,225.63 1,226.64 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ITWDPPSSPVK 95.00% 2.84 0.324 1.66 613.8232 1,225.63 1,226.64 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ITWDPPSSPVK 95.00% 2.76 0.351 2.66 613.8235 1,225.63 1,226.64 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ITWDPPSSPVK 95.00% 2.72 0.388 2.59 613.8235 1,225.63 1,226.64 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ITWDPPSSPVK 95.00% 2.83 0.322 2.4 613.8237 1,225.63 1,226.64 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ITWDPPSSPVK 95.00% 2.79 0.358 1.54 613.824 1,225.63 1,226.64 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ITWDPPSSPVK 95.00% 2.39 0.373 0 613.8245 1,225.63 1,226.64 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ITWDPPSSPVK 95.00% 2.55 0.372 2.08 613.8249 1,225.63 1,226.64 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% LHIVVSETLVK 95.00% 1.85 0.227 1.8 619.3777 1,236.74 1,237.75 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% LHIVVSETLVK 95.00% 2.44 0.343 2.96 619.8802 1,237.74 1,237.75 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ESGVELFAIGVK 95.00% 3.5 0.446 2.27 624.8443 1,247.67 1,248.68 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ESGVELFAIGVK 95.00% 3.64 0.434 2.7 624.8443 1,247.67 1,248.68 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ESGVELFAIGVK 95.00% 3.46 0.43 1.74 624.8447 1,247.67 1,248.68 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ESGVELFAIGVK 95.00% 3.3 0.431 1.7 624.8449 1,247.67 1,248.68 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ESGVELFAIGVK 95.00% 3.16 0.364 0 624.8452 1,247.67 1,248.68 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% GGKPDEVVVDGTVSSTVLK 95.00% 3.2 0.294 1.7 630.0049 1,886.99 1,887.01 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% GGKPDEVVVDGTVSSTVLK 95.00% 4.08 0.514 2.96 630.0076 1,887.00 1,887.01 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% GGKPDEVVVDGTVSSTVLK 95.00% 3.45 0.383 0 630.0078 1,887.00 1,887.01 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% GGKPDEVVVDGTVSSTVLK 95.00% 3.75 0.41 2.32 630.0083 1,887.00 1,887.01 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ASAHAITGPPTELITSEVTAR 95.00% 4.88 0.448 1.74 708.3759 2,122.10 2,122.11 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ASAHAITGPPTELITSEVTAR 95.00% 4.7 0.348 0 708.3766 2,122.11 2,122.11 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ASAHAITGPPTELITSEVTAR 95.00% 3.22 0.285 1.8 708.3768 2,122.11 2,122.11 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% ASAHAITGPPTELITSEVTAR 95.00% 3.56 0.28 0 708.3771 2,122.11 2,122.11 3
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% NSDPLVGVILDNGGK 95.00% 4.95 0.57 5.28 749.3972 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% NSDPLVGVILDNGGK 95.00% 2.87 0.247 4.21 749.398 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% NSDPLVGVILDNGGK 95.00% 5.03 0.572 4.54 749.3985 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% NSDPLVGVILDNGGK 95.00% 5.13 0.596 5.06 749.3986 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% NSDPLVGVILDNGGK 95.00% 4.83 0.549 5.44 749.3988 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% NSDPLVGVILDNGGK 95.00% 4.48 0.527 3.82 749.3989 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% LQEIEGPSVSIMEK 95.00% 4.36 0.474 4.3 780.4015 1,558.79 1,559.80 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% LQEIEGPSVSIMEK 95.00% 4.35 0.494 5.15 780.4027 1,558.79 1,559.80 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% LQEIEGPSVSIMEK 95.00% 2.82 0.211 1.46 780.4039 1,558.79 1,559.80 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% YTAILNQIPSHSSSIR 95.00% 5.1 0.534 2.24 893.9749 1,785.93 1,786.95 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% YTAILNQIPSHSSSIR 95.00% 4.7 0.529 1.92 893.9762 1,785.94 1,786.95 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% IFASQASGFSDALTGMVK 95.00% 5.23 0.552 7.15 915.4565 1,828.90 1,829.91 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% IFASQASGFSDALTGMVK 95.00% 5.6 0.57 9.8 915.9604 1,829.91 1,829.91 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% IGTDGTQVAMVQFTDDPR 95.00% 4.37 0.568 4.66 975.9622 1,949.91 1,950.92 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VTVTPIYTDGEGVSVSAPGK 95.00% 5.39 0.664 7.46 989.011 1,976.01 1,977.02 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VTVTPIYTDGEGVSVSAPGK 95.00% 4.85 0.678 8.52 989.0117 1,976.01 1,977.02 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VTVTPIYTDGEGVSVSAPGK 95.00% 4.19 0.641 6.62 989.0136 1,976.01 1,977.02 2
 SAMPLE 1 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 23 24 83 17.70% VTVTPIYTDGEGVSVSAPGK 95.00% 4.95 0.637 5.2 989.5153 1,977.02 1,977.02 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% IGILITDGK 95.00% 3.24 0.114 2.17 465.2874 928.5592 929.5675 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% IGILITDGK 95.00% 3 0.108 2.57 465.289 928.5624 929.5675 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% DGIDLAGFK 95.00% 2.42 0.372 1.8 468.2447 934.4737 935.4841 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% DGIDLAGFK 95.00% 2.68 0.342 2.28 468.2453 934.4749 935.4841 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% DGIDLAGFK 95.00% 1.95 0.295 2.7 468.2457 934.4757 935.4841 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% DGIDLAGFK 95.00% 2.58 0.342 3.17 468.2458 934.476 935.4841 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% DGIDLAGFK 95.00% 2.62 0.377 2.96 468.2462 934.4768 935.4841 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% DGIDLAGFK 95.00% 2.73 0.459 1.46 468.2462 934.4768 935.4841 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VIVVITDGR 95.00% 2.75 0.374 0 486.2965 970.5773 971.5891 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VIVVITDGR 95.00% 2.89 0.396 0 486.2966 970.5775 971.5891 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VIVVITDGR 95.00% 2.81 0.374 0 486.297 970.5783 971.5891 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VIVVITDGR 95.00% 3.3 0.425 0 486.2972 970.5787 971.5891 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VIVVITDGR 95.00% 2.84 0.394 1.19 486.2977 970.5798 971.5891 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VVIESLQDR 95.00% 2.47 0.34 0 529.7948 1,057.57 1,058.58 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VVIESLQDR 95.00% 2.7 0.452 0 529.7948 1,057.57 1,058.58 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VVIESLQDR 95.00% 2.56 0.407 1.43 529.7954 1,057.58 1,058.58 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VTWHPLSADEGLHK 95.00% 2.51 0.263 0 530.607 1,588.80 1,589.81 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VTWHPLSADEGLHK 95.00% 2.77 0.343 0 530.6074 1,588.80 1,589.81 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% HVFFVDDFDAFKK 95.00% 3.68 0.458 0 539.2701 1,614.79 1,614.80 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VSEEWYNR 95.00% 2.47 0.296 0 541.7484 1,081.48 1,082.49 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% GDLQSQAMVR 95.00% 2.11 0.286 0 552.7762 1,103.54 1,104.55 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% LMWIPVYGGK 95.00% 2.39 0.271 0 582.3154 1,162.62 1,163.63 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% LMWIPVYGGK 95.00% 2.45 0.288 0 582.3163 1,162.62 1,163.63 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% LMWIPVYGGK 95.00% 2.65 0.248 0 582.3166 1,162.62 1,163.63 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% LMWIPVYGGK 95.00% 2.39 0.276 0 582.3174 1,162.62 1,163.63 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% TLPSSGPQNLR 95.00% 2.13 0.411 1.89 585.3144 1,168.61 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% TLPSSGPQNLR 95.00% 2.18 0.415 2.89 585.3167 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% TLPSSGPQNLR 95.00% 1.76 0.191 1.44 585.3169 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% TLPSSGPQNLR 95.00% 2.04 0.387 3.43 585.3171 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% YTAILNQIPSHSSSIR 95.00% 3.18 0.525 2.92 596.3185 1,785.93 1,786.95 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% YTAILNQIPSHSSSIR 95.00% 2.78 0.485 0 596.3193 1,785.93 1,786.95 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% YTAILNQIPSHSSSIR 95.00% 2.93 0.413 1.64 596.3196 1,785.94 1,786.95 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% YTAILNQIPSHSSSIR 95.00% 3.01 0.462 1.72 596.3197 1,785.94 1,786.95 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% YTAILNQIPSHSSSIR 95.00% 2.85 0.447 1.38 596.6544 1,786.94 1,786.95 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% YTAILNQIPSHSSSIR 95.00% 2.3 0.221 0 596.6546 1,786.94 1,786.95 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% DTLFTAESGTR 95.00% 3.36 0.429 1.96 599.2906 1,196.57 1,197.58 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% HFLENLVTAFDVGSEK 95.00% 3.79 0.466 4.89 602.64 1,804.90 1,805.91 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% IFASQASGFSDALTGMVK 95.00% 3.5 0.427 2.96 610.9767 1,829.91 1,829.91 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% ITWDPPSSPVK 95.00% 2.88 0.428 1.43 613.823 1,225.63 1,226.64 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% ITWDPPSSPVK 95.00% 2.64 0.35 1.92 613.8233 1,225.63 1,226.64 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% ITWDPPSSPVK 95.00% 2.76 0.31 2.57 613.8236 1,225.63 1,226.64 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% ESGVELFAIGVK 95.00% 2.84 0.232 0 624.8438 1,247.67 1,248.68 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% ESGVELFAIGVK 95.00% 3.72 0.436 2.68 624.8446 1,247.67 1,248.68 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% ESGVELFAIGVK 95.00% 3.34 0.273 2.3 624.8446 1,247.67 1,248.68 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% ESGVELFAIGVK 95.00% 2.53 0.126 1.26 624.8446 1,247.67 1,248.68 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% ESGVELFAIGVK 95.00% 3.09 0.392 1.89 624.8452 1,247.67 1,248.68 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% GGKPDEVVVDGTVSSTVLK 95.00% 3.83 0.345 1.96 630.0083 1,887.00 1,887.01 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% TLFLGVTNLQAK 95.00% 4.38 0.557 2.33 652.8819 1,303.75 1,304.76 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% TLFLGVTNLQAK 95.00% 4 0.525 2.96 652.8826 1,303.75 1,304.76 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% ASAHAITGPPTELITSEVTAR 95.00% 3.15 0.25 0 708.3748 2,122.10 2,122.11 3
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% NSDPLVGVILDNGGK 95.00% 4.73 0.56 5.68 749.3969 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% NSDPLVGVILDNGGK 95.00% 4.28 0.509 4.02 749.3971 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% NSDPLVGVILDNGGK 95.00% 4.7 0.582 5.44 749.3977 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% NSDPLVGVILDNGGK 95.00% 4.34 0.55 5.21 749.3983 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% NSDPLVGVILDNGGK 95.00% 4.63 0.561 6.38 749.3985 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% NSDPLVGVILDNGGK 95.00% 5.02 0.575 4.4 749.3991 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% LQEIEGPSVSIMEK 95.00% 4.08 0.486 5.06 780.4007 1,558.79 1,559.80 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% LQEIEGPSVSIMEK 95.00% 4.35 0.464 3.96 780.401 1,558.79 1,559.80 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% YTAILNQIPSHSSSIR 95.00% 4.92 0.554 2.55 894.4752 1,786.93 1,786.95 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% YTAILNQIPSHSSSIR 95.00% 5.02 0.554 2.62 894.4783 1,786.94 1,786.95 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% YTAILNQIPSHSSSIR 95.00% 4.01 0.481 1.3 894.4815 1,786.95 1,786.95 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% HFLENLVTAFDVGSEK 95.00% 5.5 0.643 5.34 903.4531 1,804.89 1,805.91 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% IFASQASGFSDALTGMVK 95.00% 3.92 0.575 7.05 915.4555 1,828.90 1,829.91 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% IFASQASGFSDALTGMVK 95.00% 4.57 0.563 6.15 915.4599 1,828.90 1,829.91 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% IFASQASGFSDALTGMVK 95.00% 5.35 0.512 6.57 915.9575 1,829.90 1,829.91 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VTVTPIYTDGEGVSVSAPGK 95.00% 4.66 0.648 8.11 989.5052 1,976.99 1,977.02 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VTVTPIYTDGEGVSVSAPGK 95.00% 5.5 0.643 9.46 989.5089 1,977.00 1,977.02 2
 SAMPLE 1R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 21 24 64 16.00% VTVTPIYTDGEGVSVSAPGK 95.00% 5.29 0.649 8.7 989.5115 1,977.01 1,977.02 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ETLLDAIK 95.00% 2 0.247 0 451.7652 901.5148 902.5201 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGILITDGK 95.00% 3.19 0.0935 2.59 465.2863 928.557 929.5675 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGILITDGK 95.00% 3.11 0.0955 3.06 465.2867 928.5577 929.5675 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGILITDGK 95.00% 2.78 0.104 2.42 465.2868 928.558 929.5675 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGILITDGK 95.00% 3.38 0.0926 2.89 465.2875 928.5594 929.5675 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGILITDGK 95.00% 3.31 0.0949 2.37 465.2876 928.5596 929.5675 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGILITDGK 95.00% 3.43 0.099 2.46 465.2884 928.5611 929.5675 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% DGIDLAGFK 95.00% 2.31 0.288 1.64 468.2457 934.4757 935.4841 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% DGIDLAGFK 95.00% 3.08 0.331 2.72 468.2457 934.4758 935.4841 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% DGIDLAGFK 95.00% 3.18 0.307 2.15 468.2458 934.4759 935.4841 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% DGIDLAGFK 95.00% 2.54 0.416 2.77 468.2459 934.4761 935.4841 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% DGIDLAGFK 95.00% 3.57 0.398 1.64 468.246 934.4763 935.4841 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% DGIDLAGFK 95.00% 2.3 0.383 2.05 468.2465 934.4774 935.4841 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% DGIDLAGFK 95.00% 3.41 0.303 2.26 468.2468 934.4779 935.4841 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% DGIDLAGFK 95.00% 3 0.328 1.77 468.2469 934.4781 935.4841 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% GERGDLQSQAMVR 94.80% 2.13 0.188 0 482.9088 1,445.70 1,446.71 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VIVVITDGR 95.00% 2.31 0.325 0 485.932 969.8484 971.5891 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VIVVITDGR 95.00% 2.96 0.42 0 486.2971 970.5785 971.5891 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VIVVITDGR 95.00% 3.12 0.463 0 486.2971 970.5786 971.5891 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VIVVITDGR 95.00% 2.44 0.262 1.33 486.2975 970.5793 971.5891 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LTWDPTSR 95.00% 1.92 0.307 0 488.2474 974.4792 975.4901 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LTWDPTSR 94.80% 1.89 0.304 0 488.2478 974.4799 975.4901 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% HVFFVDDFDAFK 95.00% 3.11 0.376 1.59 496.2373 1,485.69 1,486.70 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% HVFFVDDFDAFK 95.00% 3.38 0.446 1.4 496.2382 1,485.69 1,486.70 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ISNVGSNSAR 95.00% 2.34 0.251 2.77 502.7622 1,003.51 1,004.51 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IISFLYSTVGALNK 95.00% 2.74 0.215 0 509.2915 1,524.85 1,525.86 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VVIESLQDR 95.00% 2.51 0.33 0 529.7948 1,057.57 1,058.58 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VVIESLQDR 95.00% 2.79 0.434 0 529.7948 1,057.57 1,058.58 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VVIESLQDR 95.00% 2.77 0.461 0 529.7951 1,057.57 1,058.58 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VVIESLQDR 95.00% 2.62 0.378 0 529.7951 1,057.57 1,058.58 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VVIESLQDR 95.00% 2.64 0.447 0 529.7951 1,057.57 1,058.58 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VVIESLQDR 95.00% 2.59 0.44 0 529.7953 1,057.57 1,058.58 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VVIESLQDR 95.00% 2.93 0.465 0 529.7953 1,057.58 1,058.58 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VVIESLQDR 95.00% 2.8 0.407 0 529.7956 1,057.58 1,058.58 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% QVcEQLIQSHMAR 95.00% 3.14 0.274 0 c3: Carbamidomethyl (+57.02) 533.9274 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% QVcEQLIQSHMAR 95.00% 3.53 0.449 0 c3: Carbamidomethyl (+57.02) 533.9279 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% QVcEQLIQSHMAR 95.00% 3.11 0.385 0 c3: Carbamidomethyl (+57.02) 533.9285 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% QVcEQLIQSHMAR 95.00% 3.34 0.399 0 c3: Carbamidomethyl (+57.02) 533.9289 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% QVcEQLIQSHMAR 95.00% 3.24 0.458 0 c3: Carbamidomethyl (+57.02) 533.9289 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% HVFFVDDFDAFKK 95.00% 5.04 0.57 3.92 538.9351 1,613.78 1,614.80 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% HVFFVDDFDAFKK 95.00% 4.92 0.584 3.33 538.9362 1,613.79 1,614.80 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% HVFFVDDFDAFKK 95.00% 4.75 0.537 2.66 539.27 1,614.79 1,614.80 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VSEEWYNR 95.00% 2.68 0.376 0 541.7472 1,081.48 1,082.49 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VSEEWYNR 95.00% 2.73 0.35 0 541.7479 1,081.48 1,082.49 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VSEEWYNR 95.00% 2.71 0.328 1.36 541.7487 1,081.48 1,082.49 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% HcFYGLQPDSEYK 95.00% 2.16 0.112 1.55 c2: Carbamidomethyl (+57.02) 548.5759 1,642.70 1,643.72 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LMWIPVYGGK 95.00% 2.55 0.192 0 582.3168 1,162.62 1,163.63 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LMWIPVYGGK 95.00% 2.82 0.288 0 582.3174 1,162.62 1,163.63 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LMWIPVYGGK 95.00% 2.47 0.223 0 582.3174 1,162.62 1,163.63 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LMWIPVYGGK 95.00% 2.91 0.278 0 582.3175 1,162.62 1,163.63 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LMWIPVYGGK 95.00% 2.6 0.235 0 582.3177 1,162.62 1,163.63 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TLPSSGPQNLR 95.00% 1.86 0.338 1.64 585.3162 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TLPSSGPQNLR 95.00% 1.97 0.39 1.8 585.3166 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TLPSSGPQNLR 95.00% 2 0.386 1.59 585.3167 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TLPSSGPQNLR 95.00% 1.97 0.361 1.62 585.3168 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TLPSSGPQNLR 95.00% 2.14 0.413 2.19 585.3169 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TLPSSGPQNLR 95.00% 1.77 0.289 2.25 585.3171 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TLPSSGPQNLR 95.00% 1.93 0.337 0 585.3171 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TLPSSGPQNLR 95.00% 1.69 0.265 3.28 585.3175 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TLPSSGPQNLR 95.00% 1.71 0.248 1.74 585.3175 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TLPSSGPQNLR 95.00% 2.09 0.366 1.52 585.3177 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGLAQYSGDPR 95.00% 2.34 0.191 1.14 588.8033 1,175.59 1,176.60 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGLAQYSGDPR 95.00% 3.28 0.523 2.09 588.8036 1,175.59 1,176.60 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGLAQYSGDPR 95.00% 2.59 0.434 1.62 588.8037 1,175.59 1,176.60 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGLAQYSGDPR 95.00% 2.12 0.262 1.22 588.8038 1,175.59 1,176.60 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGLAQYSGDPR 95.00% 2.93 0.487 1.62 588.8039 1,175.59 1,176.60 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGLAQYSGDPR 95.00% 2.61 0.36 1.52 588.8046 1,175.59 1,176.60 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGLAQYSGDPR 95.00% 2.63 0.449 1.37 588.8048 1,175.59 1,176.60 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGLAQYSGDPR 95.00% 2.72 0.371 2.07 588.8057 1,175.60 1,176.60 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 3.18 0.505 1.08 596.319 1,785.93 1,786.95 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 3.84 0.428 1.52 596.3204 1,785.94 1,786.95 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 2.97 0.395 1.1 596.3206 1,785.94 1,786.95 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 3.03 0.411 3.15 596.6533 1,786.94 1,786.95 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 3.6 0.396 1.82 596.6534 1,786.94 1,786.95 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 3.74 0.428 1.32 596.6537 1,786.94 1,786.95 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 2.88 0.409 0 596.6537 1,786.94 1,786.95 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 3.18 0.361 1.03 596.6541 1,786.94 1,786.95 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 3.4 0.493 0 596.6542 1,786.94 1,786.95 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% DTLFTAESGTR 95.00% 3.39 0.362 2.7 599.2883 1,196.56 1,197.58 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% DTLFTAESGTR 95.00% 3.27 0.375 1.8 599.2906 1,196.57 1,197.58 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ITWDPPSSPVK 95.00% 2.77 0.35 2.57 613.8233 1,225.63 1,226.64 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ITWDPPSSPVK 95.00% 2.72 0.383 2.7 613.8235 1,225.63 1,226.64 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ITWDPPSSPVK 95.00% 2.56 0.353 2.64 613.8238 1,225.63 1,226.64 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ITWDPPSSPVK 95.00% 3.08 0.404 2.08 613.8239 1,225.63 1,226.64 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ITWDPPSSPVK 95.00% 2.78 0.322 2.62 613.8239 1,225.63 1,226.64 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ITWDPPSSPVK 95.00% 2.56 0.335 1.77 613.8241 1,225.63 1,226.64 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ITWDPPSSPVK 95.00% 2.93 0.372 2.01 613.8242 1,225.63 1,226.64 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ITWDPPSSPVK 95.00% 2.81 0.416 2.47 613.8242 1,225.63 1,226.64 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LHIVVSETLVK 95.00% 2.9 0.35 2.12 619.3768 1,236.74 1,237.75 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LHIVVSETLVK 95.00% 2.44 0.371 1.7 619.3772 1,236.74 1,237.75 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LHIVVSETLVK 95.00% 2.94 0.324 2.68 619.3779 1,236.74 1,237.75 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LHIVVSETLVK 95.00% 3.2 0.392 2.57 619.3783 1,236.74 1,237.75 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LHIVVSETLVK 95.00% 2.92 0.357 2.68 619.3803 1,236.75 1,237.75 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LHIVVSETLVK 95.00% 2.69 0.334 2.14 619.3818 1,236.75 1,237.75 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ESGVELFAIGVK 95.00% 3.52 0.458 3.12 624.8441 1,247.67 1,248.68 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ESGVELFAIGVK 95.00% 3.49 0.432 2.48 624.8445 1,247.67 1,248.68 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ESGVELFAIGVK 95.00% 3.4 0.412 2.82 624.8447 1,247.67 1,248.68 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ESGVELFAIGVK 95.00% 3.44 0.44 2.44 624.8451 1,247.67 1,248.68 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ESGVELFAIGVK 95.00% 3.73 0.46 3.09 624.8453 1,247.68 1,248.68 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ESGVELFAIGVK 95.00% 3.35 0.467 3.47 624.8453 1,247.68 1,248.68 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ESGVELFAIGVK 95.00% 3.41 0.437 2.92 624.8454 1,247.68 1,248.68 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ESGVELFAIGVK 95.00% 2.87 0.333 2.38 624.8456 1,247.68 1,248.68 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ESGVELFAIGVK 95.00% 3.03 0.403 1.6 624.8457 1,247.68 1,248.68 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ESGVELFAIGVK 95.00% 3.27 0.421 2.51 624.8459 1,247.68 1,248.68 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% GGKPDEVVVDGTVSSTVLK 95.00% 3.33 0.367 0.921 629.6731 1,886.00 1,887.01 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% GGKPDEVVVDGTVSSTVLK 95.00% 3.01 0.389 0 629.6732 1,886.00 1,887.01 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% GGKPDEVVVDGTVSSTVLK 95.00% 3.03 0.193 1.37 629.6735 1,886.00 1,887.01 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% GGKPDEVVVDGTVSSTVLK 95.00% 3.82 0.447 2.74 629.6737 1,886.00 1,887.01 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% GGKPDEVVVDGTVSSTVLK 95.00% 3.92 0.376 1.96 629.6738 1,886.00 1,887.01 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% GGKPDEVVVDGTVSSTVLK 95.00% 4.07 0.444 2.28 630.0078 1,887.00 1,887.01 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% GGKPDEVVVDGTVSSTVLK 95.00% 2.67 0.227 0 630.0079 1,887.00 1,887.01 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% GGKPDEVVVDGTVSSTVLK 95.00% 2.72 0.368 0 630.009 1,887.00 1,887.01 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TNQLNLQNTATK 95.00% 3.51 0.421 1.48 673.349 1,344.68 1,345.71 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TNQLNLQNTATK 95.00% 3.44 0.43 3.22 673.356 1,344.70 1,345.71 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TNQLNLQNTATK 95.00% 3.56 0.4 2.96 673.3567 1,344.70 1,345.71 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% TNQLNLQNTATK 95.00% 3.46 0.494 2.03 673.3573 1,344.70 1,345.71 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGILITDGKSQDDIIPPSR 95.00% 3.53 0.379 1.47 680.0441 2,037.11 2,038.12 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGILITDGKSQDDIIPPSR 95.00% 3.67 0.35 1.25 680.378 2,038.11 2,038.12 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NLVVGDETTSSLR 95.00% 3.44 0.562 4.37 695.8621 1,389.71 1,390.72 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NLVVGDETTSSLR 95.00% 3.85 0.608 4.8 695.8623 1,389.71 1,390.72 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NLVVGDETTSSLR 95.00% 3.67 0.526 4.57 695.8624 1,389.71 1,390.72 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NLVVGDETTSSLR 95.00% 3.69 0.539 3.64 695.8638 1,389.71 1,390.72 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ASAHAITGPPTELITSEVTAR 95.00% 3.37 0.249 1.13 708.3758 2,122.10 2,122.11 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ASAHAITGPPTELITSEVTAR 95.00% 2.88 0.22 0.959 708.3763 2,122.11 2,122.11 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ASAHAITGPPTELITSEVTAR 95.00% 4.83 0.374 0 708.3766 2,122.11 2,122.11 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ASAHAITGPPTELITSEVTAR 95.00% 3.36 0.22 0 708.3771 2,122.11 2,122.11 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ASAHAITGPPTELITSEVTAR 95.00% 4.77 0.355 0 708.3772 2,122.11 2,122.11 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ASAHAITGPPTELITSEVTAR 95.00% 3.06 0.24 0 708.3778 2,122.11 2,122.11 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% HVFFVDDFDAFK 95.00% 3.95 0.63 5.04 743.8527 1,485.69 1,486.70 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% HVFFVDDFDAFK 95.00% 3.87 0.646 4.96 743.8537 1,485.69 1,486.70 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% HVFFVDDFDAFK 95.00% 2.54 0.418 2.13 743.8539 1,485.69 1,486.70 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% HVFFVDDFDAFK 95.00% 4.52 0.513 4.82 744.3526 1,486.69 1,486.70 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NSDPLVGVILDNGGK 95.00% 3.51 0.539 4.1 749.3977 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NSDPLVGVILDNGGK 95.00% 4.7 0.606 4.19 749.3983 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NSDPLVGVILDNGGK 95.00% 5.26 0.585 5.68 749.3985 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NSDPLVGVILDNGGK 95.00% 4.75 0.585 4.6 749.3985 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NSDPLVGVILDNGGK 95.00% 4.94 0.594 4.85 749.3988 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NSDPLVGVILDNGGK 95.00% 4 0.44 4.51 749.3994 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NSDPLVGVILDNGGK 95.00% 4.5 0.574 4.82 749.3994 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NSDPLVGVILDNGGK 95.00% 4.82 0.56 4.8 749.3994 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% NSDPLVGVILDNGGK 95.00% 4.91 0.547 6.23 749.8994 1,497.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IISFLYSTVGALNK 95.00% 4.91 0.524 3.92 763.4334 1,524.85 1,525.86 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IISFLYSTVGALNK 95.00% 4.76 0.494 3.51 763.4339 1,524.85 1,525.86 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IISFLYSTVGALNK 95.00% 5.02 0.544 3.82 763.4346 1,524.85 1,525.86 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IISFLYSTVGALNK 95.00% 4.77 0.524 4.12 763.4351 1,524.85 1,525.86 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IISFLYSTVGALNK 95.00% 5.08 0.54 5.02 763.4353 1,524.85 1,525.86 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IISFLYSTVGALNK 95.00% 4.9 0.51 4.16 763.9366 1,525.86 1,525.86 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LQEIEGPSVSIMEK 95.00% 3.81 0.469 3.77 780.4005 1,558.79 1,559.80 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LQEIEGPSVSIMEK 95.00% 4.34 0.483 4.51 780.401 1,558.79 1,559.80 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LQEIEGPSVSIMEK 95.00% 4.77 0.499 3.16 780.401 1,558.79 1,559.80 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LQEIEGPSVSIMEK 95.00% 4.38 0.506 3.52 780.4025 1,558.79 1,559.80 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LQEIEGPSVSIMEK 95.00% 4.41 0.514 3.7 780.4029 1,558.79 1,559.80 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LQEIEGPSVSIMEK 95.00% 4.26 0.504 5.18 780.4035 1,558.79 1,559.80 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LQEIEGPSVSIMEK 95.00% 4.51 0.483 5.19 780.4038 1,558.79 1,559.80 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LQEIEGPSVSIMEK 95.00% 4.55 0.488 5.16 780.9047 1,559.79 1,559.80 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LQEIEGPSVSImEK 95.00% 2.61 0.311 0 m12: Oxidation (+15.99) 788.4016 1,574.79 1,575.79 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LQEIEGPSVSImEK 95.00% 3.77 0.456 5.15 m12: Oxidation (+15.99) 788.9002 1,575.78 1,575.79 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% LQEIEGPSVSImEK 95.00% 3.63 0.364 2.19 m12: Oxidation (+15.99) 788.9029 1,575.79 1,575.79 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% QVcEQLIQSHMAR 95.00% 3.8 0.57 2.47 c3: Carbamidomethyl (+57.02) 800.3896 1,598.76 1,599.77 2 IQGA1_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% QVcEQLIQSHMAR 95.00% 3.46 0.56 2.3 c3: Carbamidomethyl (+57.02) 800.3912 1,598.77 1,599.77 2 IQGA1_HUMAN
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGTDGTQVAMVQFTDDPRTEFK 95.00% 3.5 0.502 1.14 819.733 2,456.18 2,456.18 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% HcFYGLQPDSEYK 95.00% 4.53 0.511 5.72 c2: Carbamidomethyl (+57.02) 822.3618 1,642.71 1,643.72 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% HcFYGLQPDSEYK 95.00% 4.56 0.527 6.12 c2: Carbamidomethyl (+57.02) 822.3623 1,642.71 1,643.72 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VKWDISDSDVQQFR 95.00% 4.71 0.597 6.17 861.926 1,721.84 1,722.85 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VKWDISDSDVQQFR 95.00% 5.16 0.569 6.28 862.426 1,722.84 1,722.85 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VKWDISDSDVQQFR 95.00% 4.34 0.508 7.12 862.4283 1,722.84 1,722.85 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 4.83 0.52 3.77 893.9742 1,785.93 1,786.95 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 4.5 0.498 1.24 893.9752 1,785.93 1,786.95 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 4.59 0.534 1.96 893.9756 1,785.94 1,786.95 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 5.28 0.522 2.06 894.4765 1,786.94 1,786.95 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 5.09 0.521 4.2 894.4769 1,786.94 1,786.95 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% YTAILNQIPSHSSSIR 95.00% 5 0.461 2.49 894.4776 1,786.94 1,786.95 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IFASQASGFSDALTGMVK 95.00% 3.85 0.496 3.17 915.4551 1,828.89 1,829.91 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IFASQASGFSDALTGMVK 95.00% 5.23 0.611 6.42 915.4575 1,828.90 1,829.91 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IFASQASGFSDALTGMVK 95.00% 5.54 0.595 6.66 915.4576 1,828.90 1,829.91 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IFASQASGFSDALTGMVK 95.00% 5.22 0.545 6.33 915.4579 1,828.90 1,829.91 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IFASQASGFSDALTGMVK 95.00% 4.87 0.482 5.66 915.9583 1,829.90 1,829.91 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IFASQASGFSDALTGMVK 95.00% 5.87 0.599 6.14 915.9585 1,829.90 1,829.91 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IFASQASGFSDALTGMVK 95.00% 5.79 0.575 6.55 915.959 1,829.90 1,829.91 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IVYNNADGTEINEVEVDPITTFPLK 95.00% 5.32 0.65 3.96 931.4748 2,791.40 2,791.40 3
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% GGKPDEVVVDGTVSSTVLK 95.00% 5.07 0.544 6.02 944.0082 1,886.00 1,887.01 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% GGKPDEVVVDGTVSSTVLK 95.00% 4.67 0.499 4.3 944.5058 1,887.00 1,887.01 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% GGKPDEVVVDGTVSSTVLK 95.00% 5.16 0.475 5.22 944.5075 1,887.00 1,887.01 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGTDGTQVAMVQFTDDPR 95.00% 4.28 0.565 6.24 975.9621 1,949.91 1,950.92 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGTDGTQVAMVQFTDDPR 95.00% 4.25 0.561 5.92 975.9633 1,949.91 1,950.92 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGTDGTQVAMVQFTDDPR 95.00% 4.66 0.503 6.42 975.9641 1,949.91 1,950.92 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGTDGTQVAMVQFTDDPR 95.00% 4.35 0.568 7.39 975.9652 1,949.91 1,950.92 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGTDGTQVAMVQFTDDPR 95.00% 4.24 0.47 6.96 976.4626 1,950.91 1,950.92 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGTDGTQVAMVQFTDDPR 95.00% 4.71 0.549 7.09 976.4648 1,950.91 1,950.92 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% IGTDGTQVAMVQFTDDPR 95.00% 3.38 0.505 5.52 976.4666 1,950.92 1,950.92 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VTVTPIYTDGEGVSVSAPGK 95.00% 4.39 0.639 7.46 989.0105 1,976.01 1,977.02 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VTVTPIYTDGEGVSVSAPGK 95.00% 5.08 0.676 5.34 989.0113 1,976.01 1,977.02 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VTVTPIYTDGEGVSVSAPGK 95.00% 5.2 0.668 9.52 989.0123 1,976.01 1,977.02 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VTVTPIYTDGEGVSVSAPGK 95.00% 5.26 0.636 6.37 989.5096 1,977.00 1,977.02 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VTVTPIYTDGEGVSVSAPGK 95.00% 5.75 0.642 6.7 989.5118 1,977.01 1,977.02 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VTVTPIYTDGEGVSVSAPGK 95.00% 5.4 0.655 5.42 989.5126 1,977.01 1,977.02 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VTVTPIYTDGEGVSVSAPGK 95.00% 5.38 0.641 7.09 989.5132 1,977.01 1,977.02 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% VTVTPIYTDGEGVSVSAPGK 95.00% 4.91 0.642 5.11 989.515 1,977.01 1,977.02 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ASAHAITGPPTELITSEVTAR 95.00% 6.21 0.544 5.42 1,062.06 2,122.10 2,122.11 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ASAHAITGPPTELITSEVTAR 95.00% 6.15 0.558 6.96 1,062.06 2,122.10 2,122.11 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ASAHAITGPPTELITSEVTAR 95.00% 6.15 0.588 7 1,062.06 2,122.11 2,122.11 2
 SAMPLE 2 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 34 41 192 24.10% ASAHAITGPPTELITSEVTAR 95.00% 6 0.546 8.85 1,062.06 2,122.11 2,122.11 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGILITDGK 95.00% 2.33 0.115 2.23 465.2867 928.5578 929.5675 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGILITDGK 95.00% 3.29 0.0882 2.21 465.287 928.5584 929.5675 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGILITDGK 95.00% 3.14 0.102 3.06 465.2872 928.5587 929.5675 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGILITDGK 95.00% 3.31 0.0964 2.38 465.2876 928.5596 929.5675 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGILITDGK 95.00% 2.93 0.113 2.08 465.2877 928.5598 929.5675 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGILITDGK 95.00% 1.81 0.0527 3.64 465.2885 928.5614 929.5675 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGILITDGK 95.00% 3.24 0.0629 2.85 465.2889 928.5622 929.5675 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGILITDGK 95.00% 2.69 0.101 2.42 465.2891 928.5625 929.5675 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DEVIEAVR 95.00% 2.16 0.249 0 465.7473 929.4789 930.4897 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DEVIEAVR 95.00% 2.21 0.216 0 465.7481 929.4806 930.4897 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DGIDLAGFK 95.00% 2.58 0.479 2.46 468.2432 934.4708 935.4841 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DGIDLAGFK 95.00% 2.98 0.307 1.96 468.2455 934.4753 935.4841 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DGIDLAGFK 95.00% 2.23 0.409 3.21 468.2456 934.4755 935.4841 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DGIDLAGFK 95.00% 3.19 0.448 2.39 468.2456 934.4756 935.4841 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DGIDLAGFK 95.00% 2.87 0.358 2.55 468.2463 934.477 935.4841 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DGIDLAGFK 95.00% 2.73 0.418 2.32 468.2463 934.477 935.4841 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DGIDLAGFK 95.00% 3.01 0.32 1.89 468.247 934.4783 935.4841 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DGIDLAGFK 95.00% 1.98 0.286 1.82 468.2485 934.4814 935.4841 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VIVVITDGR 95.00% 2.86 0.292 0 486.2961 970.5765 971.5891 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VIVVITDGR 95.00% 2.68 0.426 0 486.2969 970.5782 971.5891 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VIVVITDGR 95.00% 2.92 0.398 1.72 486.2972 970.5788 971.5891 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VIVVITDGR 95.00% 3.29 0.458 0 486.2973 970.579 971.5891 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VIVVITDGR 95.00% 2.98 0.469 0 486.2974 970.5792 971.5891 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LTWDPTSR 95.00% 1.83 0.318 0 488.2475 974.4794 975.4901 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HVFFVDDFDAFK 95.00% 3.26 0.132 1.17 496.5724 1,486.69 1,486.70 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VVIESLQDR 95.00% 2.67 0.469 1.2 529.7941 1,057.57 1,058.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VVIESLQDR 95.00% 2.86 0.461 0 529.7944 1,057.57 1,058.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VVIESLQDR 95.00% 2.95 0.461 0 529.795 1,057.57 1,058.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VVIESLQDR 95.00% 2.44 0.405 0 529.7953 1,057.58 1,058.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VVIESLQDR 95.00% 2.72 0.43 0 529.7953 1,057.58 1,058.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VVIESLQDR 95.00% 2.86 0.467 0 529.7955 1,057.58 1,058.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VVIESLQDR 95.00% 2.7 0.444 0 529.7955 1,057.58 1,058.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VVIESLQDR 95.00% 2.86 0.451 1.57 529.7957 1,057.58 1,058.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VTWHPLSADEGLHK 95.00% 2.6 0.438 0 530.608 1,588.80 1,589.81 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% QVcEQLIQSHMAR 95.00% 3.33 0.289 0 c3: Carbamidomethyl (+57.02) 533.9266 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% QVcEQLIQSHMAR 95.00% 3.17 0.15 0 c3: Carbamidomethyl (+57.02) 533.928 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% QVcEQLIQSHMAR 95.00% 2.91 0.255 0 c3: Carbamidomethyl (+57.02) 533.9282 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% QVcEQLIQSHMAR 95.00% 2.86 0.342 0 c3: Carbamidomethyl (+57.02) 533.9283 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HVFFVDDFDAFKK 95.00% 4.7 0.605 4.13 538.9353 1,613.78 1,614.80 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HVFFVDDFDAFKK 95.00% 4.4 0.607 4.62 538.9372 1,613.79 1,614.80 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HVFFVDDFDAFKK 95.00% 4.47 0.595 0 538.9385 1,613.79 1,614.80 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HVFFVDDFDAFKK 95.00% 4.91 0.589 3.85 539.2704 1,614.79 1,614.80 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HVFFVDDFDAFKK 95.00% 4.78 0.568 3.74 539.2704 1,614.79 1,614.80 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VSEEWYNR 95.00% 2.6 0.336 1.13 541.7483 1,081.48 1,082.49 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VSEEWYNR 95.00% 2.63 0.341 1.25 541.7483 1,081.48 1,082.49 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GDLQSQAMVR 95.00% 2.48 0.299 0 552.7755 1,103.54 1,104.55 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GDLQSQAMVR 95.00% 2.95 0.37 1.37 552.776 1,103.54 1,104.55 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GDLQSQAMVR 95.00% 2.64 0.39 1.31 553.2749 1,104.53 1,104.55 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LMWIPVYGGK 95.00% 2.49 0.258 0 582.3165 1,162.62 1,163.63 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LMWIPVYGGK 95.00% 2.71 0.196 0 582.3166 1,162.62 1,163.63 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LMWIPVYGGK 95.00% 2.39 0.227 0 582.3177 1,162.62 1,163.63 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LMWIPVYGGK 95.00% 2.38 0.217 1.13 582.3178 1,162.62 1,163.63 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% TLPSSGPQNLR 95.00% 1.88 0.315 0 585.3163 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% TLPSSGPQNLR 95.00% 1.77 0.273 1.21 585.3164 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% TLPSSGPQNLR 95.00% 1.75 0.225 1.57 585.3167 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% TLPSSGPQNLR 95.00% 1.93 0.366 1.48 585.317 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% TLPSSGPQNLR 95.00% 1.76 0.279 1.24 585.3174 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% TLPSSGPQNLR 95.00% 1.91 0.362 1.8 585.3175 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% TLPSSGPQNLR 95.00% 1.84 0.334 0 585.3182 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% TLPSSGPQNLR 95.00% 1.92 0.392 1.14 585.319 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGLAQYSGDPR 95.00% 2.44 0.407 1.77 588.8037 1,175.59 1,176.60 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGLAQYSGDPR 95.00% 2.53 0.461 1.29 588.8038 1,175.59 1,176.60 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGLAQYSGDPR 95.00% 2.3 0.246 2.02 588.8041 1,175.59 1,176.60 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGLAQYSGDPR 95.00% 2.71 0.424 0 588.805 1,175.59 1,176.60 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGLAQYSGDPR 95.00% 2.89 0.484 0 588.8056 1,175.60 1,176.60 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 2.49 0.406 1.12 596.3177 1,785.93 1,786.95 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 3.68 0.53 1.59 596.3182 1,785.93 1,786.95 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 2.39 0.328 0 596.3186 1,785.93 1,786.95 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 3.5 0.516 0 596.32 1,785.94 1,786.95 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 2.98 0.325 0 596.6531 1,786.94 1,786.95 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 3 0.375 0 596.6534 1,786.94 1,786.95 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 2.47 0.262 1.31 596.654 1,786.94 1,786.95 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 2.87 0.366 0 596.6545 1,786.94 1,786.95 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 3.21 0.372 0 596.6548 1,786.94 1,786.95 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DTLFTAESGTR 95.00% 3.29 0.443 2.59 599.288 1,196.56 1,197.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DTLFTAESGTR 95.00% 3.82 0.365 4.05 599.2897 1,196.56 1,197.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DTLFTAESGTR 95.00% 3.06 0.412 1.96 599.2904 1,196.57 1,197.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DTLFTAESGTR 95.00% 3.72 0.391 3.6 599.2907 1,196.57 1,197.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DTLFTAESGTR 95.00% 3.46 0.399 2.36 599.2913 1,196.57 1,197.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DTLFTAESGTR 95.00% 3.93 0.376 4.4 599.2915 1,196.57 1,197.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DTLFTAESGTR 95.00% 2.38 0.335 0 599.2927 1,196.57 1,197.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% DTLFTAESGTR 95.00% 3.16 0.449 2.92 599.2937 1,196.57 1,197.58 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HFLENLVTAFDVGSEK 95.00% 3.77 0.504 2.89 602.6392 1,804.89 1,805.91 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HFLENLVTAFDVGSEK 95.00% 3.64 0.457 2.92 602.6402 1,804.90 1,805.91 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HFLENLVTAFDVGSEK 95.00% 4.36 0.529 2.7 602.9735 1,805.90 1,805.91 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HFLENLVTAFDVGSEK 95.00% 4.82 0.545 3.44 602.974 1,805.90 1,805.91 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HFLENLVTAFDVGSEK 95.00% 4.16 0.43 2.74 602.9743 1,805.90 1,805.91 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HFLENLVTAFDVGSEK 95.00% 4.37 0.483 2.96 602.9749 1,805.90 1,805.91 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGMVK 95.00% 5.07 0.552 4.47 610.6408 1,828.90 1,829.91 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGMVK 95.00% 3.08 0.395 3.34 610.6417 1,828.90 1,829.91 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGMVK 95.00% 5.47 0.499 3.52 610.9751 1,829.90 1,829.91 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGMVK 95.00% 4.08 0.395 1.8 610.9764 1,829.91 1,829.91 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ITWDPPSSPVK 95.00% 2.67 0.355 2.46 613.8224 1,225.63 1,226.64 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ITWDPPSSPVK 95.00% 2.78 0.321 2.92 613.823 1,225.63 1,226.64 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ITWDPPSSPVK 95.00% 2.71 0.385 2.44 613.8234 1,225.63 1,226.64 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ITWDPPSSPVK 95.00% 2.6 0.377 2.8 613.8238 1,225.63 1,226.64 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ITWDPPSSPVK 95.00% 2.52 0.371 1.48 613.8239 1,225.63 1,226.64 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ITWDPPSSPVK 95.00% 2.68 0.363 2.11 613.8241 1,225.63 1,226.64 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ITWDPPSSPVK 95.00% 2.67 0.319 2.57 613.8242 1,225.63 1,226.64 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ITWDPPSSPVK 95.00% 2.61 0.359 1.32 613.825 1,225.63 1,226.64 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LHIVVSETLVK 95.00% 2.94 0.373 2.66 619.3781 1,236.74 1,237.75 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LHIVVSETLVK 95.00% 2.44 0.362 1.54 619.3786 1,236.74 1,237.75 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LHIVVSETLVK 95.00% 2.77 0.325 3.36 619.379 1,236.74 1,237.75 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LHIVVSETLVK 95.00% 3.06 0.359 3.17 619.8806 1,237.75 1,237.75 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ESGVELFAIGVK 95.00% 3.18 0.381 2.49 624.843 1,247.67 1,248.68 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ESGVELFAIGVK 95.00% 2.99 0.343 2.12 624.8434 1,247.67 1,248.68 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ESGVELFAIGVK 95.00% 3.41 0.427 2.14 624.8441 1,247.67 1,248.68 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ESGVELFAIGVK 95.00% 3.36 0.423 1.28 624.8443 1,247.67 1,248.68 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ESGVELFAIGVK 95.00% 3.39 0.429 2.28 624.8443 1,247.67 1,248.68 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ESGVELFAIGVK 95.00% 2.95 0.312 0 624.8445 1,247.67 1,248.68 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ESGVELFAIGVK 95.00% 3.24 0.364 1.43 624.8451 1,247.67 1,248.68 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ESGVELFAIGVK 95.00% 3.4 0.421 1.6 624.8452 1,247.67 1,248.68 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ESGVELFAIGVK 95.00% 3.29 0.428 2.07 624.8453 1,247.68 1,248.68 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GGKPDEVVVDGTVSSTVLK 95.00% 3.4 0.331 0 629.6734 1,886.00 1,887.01 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GGKPDEVVVDGTVSSTVLK 95.00% 4.27 0.531 2.96 629.6741 1,886.00 1,887.01 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GGKPDEVVVDGTVSSTVLK 95.00% 4.07 0.404 2.23 630.0072 1,887.00 1,887.01 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GGKPDEVVVDGTVSSTVLK 95.00% 3.71 0.475 1.51 630.0074 1,887.00 1,887.01 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GGKPDEVVVDGTVSSTVLK 95.00% 3.21 0.303 1.42 630.0079 1,887.00 1,887.01 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GGKPDEVVVDGTVSSTVLK 95.00% 3.47 0.465 2.82 630.0085 1,887.00 1,887.01 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VTVTPIYTDGEGVSVSAPGK 95.00% 2.62 0.355 0 660.0115 1,977.01 1,977.02 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% TNQLNLQNTATK 95.00% 3.31 0.349 2.48 673.3562 1,344.70 1,345.71 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGILITDGKSQDDIIPPSR 95.00% 3.77 0.381 2.8 680.3781 2,038.11 2,038.12 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% NLVVGDETTSSLR 95.00% 4.2 0.543 4.6 695.8617 1,389.71 1,390.72 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% NLVVGDETTSSLR 95.00% 3.87 0.47 4.26 695.8619 1,389.71 1,390.72 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ASAHAITGPPTELITSEVTAR 95.00% 4.61 0.475 0 708.3764 2,122.11 2,122.11 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ASAHAITGPPTELITSEVTAR 95.00% 4.77 0.47 0 708.3765 2,122.11 2,122.11 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ASAHAITGPPTELITSEVTAR 95.00% 4.8 0.42 1.7 708.377 2,122.11 2,122.11 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ASAHAITGPPTELITSEVTAR 95.00% 4.74 0.439 0 708.377 2,122.11 2,122.11 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ILPDTPQEPFALWEILNK 95.00% 2.78 0.321 0 709.0511 2,124.13 2,124.14 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HVFFVDDFDAFK 95.00% 4.24 0.609 6.36 743.8524 1,485.69 1,486.70 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HVFFVDDFDAFK 95.00% 3.46 0.599 6.54 743.8535 1,485.69 1,486.70 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HVFFVDDFDAFK 95.00% 4.22 0.623 6.6 743.8541 1,485.69 1,486.70 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% NSDPLVGVILDNGGK 95.00% 4.53 0.55 4.48 749.3974 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% NSDPLVGVILDNGGK 95.00% 4.78 0.603 5.52 749.3974 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% NSDPLVGVILDNGGK 95.00% 4.58 0.585 5.74 749.3974 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% NSDPLVGVILDNGGK 95.00% 2.97 0.514 3.51 749.3976 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% NSDPLVGVILDNGGK 95.00% 2.14 0.337 2.24 749.3976 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% NSDPLVGVILDNGGK 95.00% 4.91 0.592 4.82 749.398 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% NSDPLVGVILDNGGK 95.00% 4.18 0.542 4.05 749.3983 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% NSDPLVGVILDNGGK 95.00% 4.64 0.563 5.22 749.3991 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% NSDPLVGVILDNGGK 95.00% 4.84 0.578 6.05 749.3991 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% NSDPLVGVILDNGGK 95.00% 4.69 0.57 3.74 749.3994 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IISFLYSTVGALNK 95.00% 4.04 0.166 2.96 763.4315 1,524.85 1,525.86 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IISFLYSTVGALNK 95.00% 4.32 0.434 3.33 763.4326 1,524.85 1,525.86 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IISFLYSTVGALNK 95.00% 4.22 0.463 3.8 763.4328 1,524.85 1,525.86 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IISFLYSTVGALNK 95.00% 4.84 0.528 5.11 763.433 1,524.85 1,525.86 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IISFLYSTVGALNK 95.00% 4.27 0.413 4.18 763.433 1,524.85 1,525.86 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IISFLYSTVGALNK 95.00% 4.49 0.251 3.54 763.4338 1,524.85 1,525.86 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IISFLYSTVGALNK 95.00% 4.98 0.528 3.89 763.4346 1,524.85 1,525.86 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IISFLYSTVGALNK 95.00% 4.06 0.448 3.77 763.4349 1,524.85 1,525.86 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LQEIEGPSVSIMEK 95.00% 4.51 0.483 4.22 780.4001 1,558.78 1,559.80 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LQEIEGPSVSIMEK 95.00% 4.24 0.474 4.17 780.4024 1,558.79 1,559.80 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LQEIEGPSVSIMEK 95.00% 4.38 0.503 3.8 780.4024 1,558.79 1,559.80 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LQEIEGPSVSIMEK 95.00% 3.99 0.511 3.48 780.4026 1,558.79 1,559.80 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LQEIEGPSVSIMEK 95.00% 4.16 0.517 4.11 780.4027 1,558.79 1,559.80 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LQEIEGPSVSIMEK 95.00% 4.57 0.524 3.12 780.4038 1,558.79 1,559.80 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LQEIEGPSVSIMEK 95.00% 3.36 0.375 2 780.404 1,558.79 1,559.80 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LQEIEGPSVSIMEK 95.00% 4.32 0.453 2.92 780.4044 1,558.79 1,559.80 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LQEIEGPSVSIMEK 95.00% 4.05 0.495 3.72 780.4048 1,558.79 1,559.80 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% LQEIEGPSVSImEK 95.00% 2.7 0.282 0 m12: Oxidation (+15.99) 788.4011 1,574.79 1,575.79 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% QVcEQLIQSHMAR 95.00% 3.89 0.535 2.21 c3: Carbamidomethyl (+57.02) 800.3911 1,598.77 1,599.77 2 IQGA1_HUMAN
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HcFYGLQPDSEYK 95.00% 4.67 0.524 6.41 c2: Carbamidomethyl (+57.02) 822.3582 1,642.70 1,643.72 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HcFYGLQPDSEYK 95.00% 4.24 0.557 6.8 c2: Carbamidomethyl (+57.02) 822.3616 1,642.71 1,643.72 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HcFYGLQPDSEYK 95.00% 4.07 0.546 5.82 c2: Carbamidomethyl (+57.02) 822.3626 1,642.71 1,643.72 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IEDELITFVcETASATcPVVHK 95.00% 4.2 0.402 2.66 c10: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 840.7416 2,519.20 2,519.22 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IEDELITFVcETASATcPVVHK 95.00% 4.7 0.496 1.85 c10: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 840.7449 2,519.21 2,519.22 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IEDELITFVcETASATcPVVHK 95.00% 3.81 0.339 2.54 c10: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 840.746 2,519.21 2,519.22 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VKWDISDSDVQQFR 95.00% 4.75 0.583 6.51 861.9242 1,721.83 1,722.85 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VKWDISDSDVQQFR 95.00% 4.48 0.528 5.1 861.9276 1,721.84 1,722.85 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VKWDISDSDVQQFR 95.00% 4.19 0.546 5 861.9284 1,721.84 1,722.85 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VKWDISDSDVQQFR 95.00% 4.78 0.571 6.38 862.4279 1,722.84 1,722.85 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GGNTLTGLALNYIFENSFKPEAGSR 95.00% 3.92 0.528 2.28 886.4493 2,656.32 2,656.34 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GGNTLTGLALNYIFENSFKPEAGSR 95.00% 5.32 0.611 2.19 886.4508 2,656.33 2,656.34 3
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 4.59 0.518 2.54 893.9748 1,785.93 1,786.95 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 4.42 0.484 2.1 893.9756 1,785.94 1,786.95 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 4.87 0.534 1.22 893.977 1,785.94 1,786.95 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 4.88 0.521 2.64 894.4746 1,786.93 1,786.95 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% YTAILNQIPSHSSSIR 95.00% 4.43 0.519 2.57 894.4773 1,786.94 1,786.95 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HFLENLVTAFDVGSEK 95.00% 5.23 0.661 6.1 903.4539 1,804.89 1,805.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HFLENLVTAFDVGSEK 95.00% 5.98 0.654 8.64 903.4555 1,804.90 1,805.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HFLENLVTAFDVGSEK 95.00% 5.48 0.566 5.47 903.9558 1,805.90 1,805.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HFLENLVTAFDVGSEK 95.00% 6 0.614 7.3 903.9569 1,805.90 1,805.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HFLENLVTAFDVGSEK 95.00% 5.34 0.477 6.12 903.9583 1,805.90 1,805.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% HFLENLVTAFDVGSEK 95.00% 6.09 0.582 6.43 903.9587 1,805.90 1,805.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGMVK 95.00% 5.59 0.58 6.96 915.456 1,828.90 1,829.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGMVK 95.00% 5.83 0.648 6.82 915.4564 1,828.90 1,829.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGMVK 95.00% 4.88 0.498 6.89 915.4577 1,828.90 1,829.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGMVK 95.00% 5.09 0.599 6.64 915.4585 1,828.90 1,829.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGMVK 95.00% 5.56 0.503 5.96 915.9582 1,829.90 1,829.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGMVK 95.00% 5.67 0.553 6.19 915.9586 1,829.90 1,829.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGMVK 95.00% 5.58 0.632 6.82 915.9599 1,829.90 1,829.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGMVK 95.00% 5.11 0.47 6.96 915.96 1,829.90 1,829.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGmVK 95.00% 3.94 0.431 1.92 m16: Oxidation (+15.99) 923.9485 1,845.88 1,845.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IFASQASGFSDALTGmVK 95.00% 4.84 0.647 7.29 m16: Oxidation (+15.99) 923.9565 1,845.90 1,845.91 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GGKPDEVVVDGTVSSTVLK 95.00% 5.24 0.524 6.03 944.5071 1,887.00 1,887.01 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% GGKPDEVVVDGTVSSTVLK 95.00% 5.24 0.524 6.24 944.5093 1,887.00 1,887.01 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGTDGTQVAMVQFTDDPR 95.00% 3.83 0.595 5.74 975.9656 1,949.92 1,950.92 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% IGTDGTQVAMVQFTDDPR 95.00% 4.34 0.495 6.37 976.4658 1,950.92 1,950.92 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VTVTPIYTDGEGVSVSAPGK 95.00% 4.47 0.637 7.64 989.0103 1,976.00 1,977.02 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VTVTPIYTDGEGVSVSAPGK 95.00% 4.84 0.661 7.37 989.0128 1,976.01 1,977.02 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VTVTPIYTDGEGVSVSAPGK 95.00% 4.8 0.673 6.72 989.0136 1,976.01 1,977.02 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VTVTPIYTDGEGVSVSAPGK 95.00% 5.26 0.64 6.3 989.5128 1,977.01 1,977.02 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VTVTPIYTDGEGVSVSAPGK 95.00% 5 0.609 6.68 989.5133 1,977.01 1,977.02 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% VTVTPIYTDGEGVSVSAPGK 95.00% 5.07 0.605 6.26 989.5133 1,977.01 1,977.02 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ASAHAITGPPTELITSEVTAR 95.00% 5.38 0.596 5.96 1,062.06 2,122.09 2,122.11 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ASAHAITGPPTELITSEVTAR 95.00% 6.42 0.628 5.82 1,062.06 2,122.10 2,122.11 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ASAHAITGPPTELITSEVTAR 95.00% 6.22 0.597 6.04 1,062.06 2,122.11 2,122.11 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ASAHAITGPPTELITSEVTAR 95.00% 5.6 0.533 4.64 1,062.06 2,122.11 2,122.11 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ILPDTPQEPFALWEILNK 95.00% 4.43 0.462 4.17 1,063.07 2,124.13 2,124.14 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ILPDTPQEPFALWEILNK 95.00% 4.14 0.445 5.07 1,063.07 2,124.13 2,124.14 2
 SAMPLE 2R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 36 45 203 27.00% ILPDTPQEPFALWEILNK 95.00% 4.45 0.534 4.7 1,063.07 2,124.13 2,124.14 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ETLLDAIK 95.00% 2.03 0.297 0 451.764 901.5124 902.5201 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ETLLDAIK 95.00% 1.92 0.303 0 451.7642 901.5128 902.5201 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGILITDGK 95.00% 2.18 0.109 2.25 465.2858 928.5559 929.5675 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGILITDGK 95.00% 2.62 0.108 2.89 465.2881 928.5606 929.5675 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGILITDGK 95.00% 2.42 0.113 2.47 465.2881 928.5606 929.5675 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% DGIDLAGFK 95.00% 3.13 0.483 2.66 468.245 934.4743 935.4841 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% DGIDLAGFK 95.00% 2.93 0.338 2.17 468.246 934.4764 935.4841 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% DGIDLAGFK 95.00% 2.85 0.267 2.77 468.2463 934.4769 935.4841 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% DGIDLAGFK 95.00% 1.95 0.271 3.06 468.2468 934.4779 935.4841 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% DGIDLAGFK 95.00% 3.01 0.297 1.89 468.2472 934.4787 935.4841 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% DGIDLAGFK 95.00% 3.1 0.329 1.92 468.2474 934.4792 935.4841 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VIVVITDGR 95.00% 2.61 0.338 0 486.2966 970.5775 971.5891 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VIVVITDGR 95.00% 2.94 0.454 0 486.2968 970.578 971.5891 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VIVVITDGR 95.00% 3.06 0.479 0 486.2969 970.5782 971.5891 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VIVVITDGR 95.00% 3 0.407 1.52 486.2972 970.5788 971.5891 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VIVVITDGR 95.00% 3.18 0.481 1.13 486.2975 970.5793 971.5891 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VIVVITDGR 95.00% 3.06 0.411 1.3 486.2976 970.5795 971.5891 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VIVVITDGR 95.00% 2.98 0.25 1.46 486.2976 970.5796 971.5891 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VIVVITDGR 95.00% 2.71 0.423 0 486.2978 970.58 971.5891 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LTWDPTSR 95.00% 2 0.308 0 488.2473 974.479 975.4901 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LTWDPTSR 95.00% 1.79 0.271 0 488.2477 974.4798 975.4901 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LTWDPTSR 95.00% 1.92 0.308 0 488.2482 974.4808 975.4901 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% HVFFVDDFDAFK 95.00% 3.54 0.305 0 496.5716 1,486.69 1,486.70 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% HVFFVDDFDAFK 95.00% 3.44 0.324 0 496.573 1,486.70 1,486.70 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VVIESLQDR 95.00% 2.56 0.422 0 529.7946 1,057.57 1,058.58 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VVIESLQDR 95.00% 2.83 0.479 0 529.7946 1,057.57 1,058.58 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VVIESLQDR 95.00% 2.73 0.45 0 529.7947 1,057.57 1,058.58 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VVIESLQDR 95.00% 2.6 0.39 0 529.7951 1,057.57 1,058.58 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VVIESLQDR 95.00% 2.63 0.38 0 529.7954 1,057.58 1,058.58 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VTWHPLSADEGLHK 95.00% 2.47 0.357 0 530.6072 1,588.80 1,589.81 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% QVcEQLIQSHMAR 95.00% 3.46 0.457 0 c3: Carbamidomethyl (+57.02) 533.9273 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% QVcEQLIQSHMAR 95.00% 3.52 0.451 1.03 c3: Carbamidomethyl (+57.02) 533.9284 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% HVFFVDDFDAFKK 95.00% 4.89 0.569 4.33 538.9357 1,613.78 1,614.80 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% HVFFVDDFDAFKK 95.00% 5.03 0.58 4.28 539.2703 1,614.79 1,614.80 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% GDLQSQAMVR 95.00% 2.11 0.224 1.62 552.7743 1,103.53 1,104.55 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% GDLQSQAMVR 95.00% 2.71 0.425 1.12 552.7752 1,103.53 1,104.55 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% GDLQSQAMVR 95.00% 2.41 0.362 1.55 552.7762 1,103.54 1,104.55 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% GDLQSQAMVR 95.00% 2.36 0.339 1.24 552.7763 1,103.54 1,104.55 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% TKETLLDAIK 95.00% 2.54 0.242 0 566.3324 1,130.65 1,131.66 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% TKETLLDAIK 95.00% 2.32 0.212 0 566.3332 1,130.65 1,131.66 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VKWDISDSDVQQFR 95.00% 4.15 0.406 2.21 574.9537 1,721.84 1,722.85 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VKWDISDSDVQQFR 95.00% 3.93 0.305 2.16 574.9542 1,721.84 1,722.85 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LMWIPVYGGK 95.00% 2.78 0.286 0 582.3169 1,162.62 1,163.63 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LMWIPVYGGK 95.00% 2.64 0.228 1.57 582.317 1,162.62 1,163.63 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LMWIPVYGGK 95.00% 2.78 0.275 0 582.3172 1,162.62 1,163.63 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LMWIPVYGGK 95.00% 2.61 0.235 0 582.3173 1,162.62 1,163.63 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LMWIPVYGGK 95.00% 2.63 0.212 1.22 582.3175 1,162.62 1,163.63 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LMWIPVYGGK 95.00% 2.42 0.263 0 582.3178 1,162.62 1,163.63 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LMWIPVYGGK 95.00% 2.5 0.229 0 582.3179 1,162.62 1,163.63 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LMWIPVYGGK 95.00% 2.78 0.201 0 582.318 1,162.62 1,163.63 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LMWIPVYGGK 95.00% 2.36 0.239 0 582.3185 1,162.62 1,163.63 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% TLPSSGPQNLR 95.00% 1.82 0.302 2.29 585.3164 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% TLPSSGPQNLR 95.00% 1.87 0.297 2.11 585.3165 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% TLPSSGPQNLR 95.00% 1.74 0.271 2 585.3167 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% TLPSSGPQNLR 95.00% 1.88 0.315 2.42 585.3169 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% TLPSSGPQNLR 95.00% 1.9 0.331 0 585.3171 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% TLPSSGPQNLR 95.00% 1.92 0.346 2.34 585.3174 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% TLPSSGPQNLR 95.00% 2.22 0.349 0 585.3177 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% TLPSSGPQNLR 95.00% 2.12 0.22 1.59 585.3185 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGLAQYSGDPR 95.00% 2.19 0.284 0 588.8031 1,175.59 1,176.60 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGLAQYSGDPR 95.00% 2.48 0.314 0 588.8034 1,175.59 1,176.60 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGLAQYSGDPR 95.00% 3.3 0.446 1.66 588.8038 1,175.59 1,176.60 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGLAQYSGDPR 95.00% 2.68 0.445 1.15 588.8039 1,175.59 1,176.60 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGLAQYSGDPR 95.00% 2.67 0.398 2.48 588.804 1,175.59 1,176.60 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGLAQYSGDPR 95.00% 2.34 0.414 0 588.8041 1,175.59 1,176.60 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGLAQYSGDPR 95.00% 3.58 0.539 1.38 588.8041 1,175.59 1,176.60 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGLAQYSGDPR 95.00% 2.67 0.45 0 588.8042 1,175.59 1,176.60 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 3.38 0.513 0 596.3195 1,785.94 1,786.95 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 3.57 0.511 0.959 596.3196 1,785.94 1,786.95 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 3.43 0.468 1.59 596.3197 1,785.94 1,786.95 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 3.2 0.427 1.39 596.3199 1,785.94 1,786.95 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 2.71 0.372 1.7 596.3221 1,785.94 1,786.95 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 3.46 0.429 1.36 596.654 1,786.94 1,786.95 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 2.51 0.285 1.34 596.6544 1,786.94 1,786.95 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IFASQASGFSDALTGMVK 95.00% 4.37 0.488 2.32 610.6413 1,828.90 1,829.91 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IFASQASGFSDALTGMVK 95.00% 4.45 0.506 2.49 610.6413 1,828.90 1,829.91 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ITWDPPSSPVK 95.00% 2.97 0.385 2.17 613.8225 1,225.63 1,226.64 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ITWDPPSSPVK 95.00% 2.91 0.351 1.72 613.8231 1,225.63 1,226.64 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ITWDPPSSPVK 95.00% 2.76 0.359 2.2 613.8237 1,225.63 1,226.64 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ITWDPPSSPVK 95.00% 2.68 0.324 1.92 613.8238 1,225.63 1,226.64 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ITWDPPSSPVK 95.00% 2.97 0.401 1.59 613.8238 1,225.63 1,226.64 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ITWDPPSSPVK 95.00% 2.53 0.261 1.66 613.8239 1,225.63 1,226.64 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ITWDPPSSPVK 95.00% 2.85 0.366 1.48 613.8242 1,225.63 1,226.64 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ITWDPPSSPVK 95.00% 3.02 0.416 2.64 613.8244 1,225.63 1,226.64 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LHIVVSETLVK 95.00% 2.8 0.369 3.07 619.3789 1,236.74 1,237.75 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LHIVVSETLVK 95.00% 3.18 0.369 3.12 619.3795 1,236.74 1,237.75 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ESGVELFAIGVK 95.00% 3.37 0.391 2.06 624.8437 1,247.67 1,248.68 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ESGVELFAIGVK 95.00% 3.53 0.443 2.34 624.8443 1,247.67 1,248.68 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ESGVELFAIGVK 95.00% 3.49 0.42 1.77 624.8447 1,247.67 1,248.68 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ESGVELFAIGVK 95.00% 3.76 0.488 2.09 624.8449 1,247.67 1,248.68 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ESGVELFAIGVK 95.00% 3.53 0.467 2.32 624.8457 1,247.68 1,248.68 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ESGVELFAIGVK 95.00% 3.75 0.463 1.44 624.8459 1,247.68 1,248.68 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% GGKPDEVVVDGTVSSTVLK 95.00% 2.98 0.339 1.8 629.6734 1,886.00 1,887.01 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% GGKPDEVVVDGTVSSTVLK 95.00% 3.76 0.428 1.8 629.6737 1,886.00 1,887.01 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% GGKPDEVVVDGTVSSTVLK 95.00% 2.86 0.276 1.55 629.6739 1,886.00 1,887.01 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% GGKPDEVVVDGTVSSTVLK 95.00% 3.44 0.372 2.89 629.6739 1,886.00 1,887.01 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% GGKPDEVVVDGTVSSTVLK 95.00% 3.84 0.42 2.28 629.6741 1,886.00 1,887.01 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% GGKPDEVVVDGTVSSTVLK 95.00% 3.57 0.289 1.02 630.0086 1,887.00 1,887.01 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% TLFLGVTNLQAK 95.00% 4.49 0.553 2.77 652.8812 1,303.75 1,304.76 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% TLFLGVTNLQAK 95.00% 4.52 0.547 2.02 652.8817 1,303.75 1,304.76 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ASAHAITGPPTELITSEVTAR 95.00% 5.02 0.471 1.47 708.3762 2,122.11 2,122.11 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ASAHAITGPPTELITSEVTAR 95.00% 5.34 0.46 2.23 708.3767 2,122.11 2,122.11 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ASAHAITGPPTELITSEVTAR 95.00% 5.3 0.484 2.14 708.3768 2,122.11 2,122.11 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ASAHAITGPPTELITSEVTAR 95.00% 4.96 0.397 0 708.3776 2,122.11 2,122.11 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% HVFFVDDFDAFK 95.00% 4.11 0.644 6 743.853 1,485.69 1,486.70 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% HVFFVDDFDAFK 95.00% 3.17 0.535 3.64 743.8537 1,485.69 1,486.70 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% HVFFVDDFDAFK 95.00% 4.24 0.625 4.8 743.8547 1,485.69 1,486.70 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% HVFFVDDFDAFK 95.00% 3.95 0.53 6.08 744.3562 1,486.70 1,486.70 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% NSDPLVGVILDNGGK 95.00% 2.69 0.285 3.35 749.3978 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% NSDPLVGVILDNGGK 95.00% 5.18 0.581 4.05 749.3982 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% NSDPLVGVILDNGGK 95.00% 4.77 0.566 3.32 749.3986 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% NSDPLVGVILDNGGK 95.00% 4.86 0.604 5.24 749.3987 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% NSDPLVGVILDNGGK 95.00% 5.24 0.571 3.74 749.399 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% NSDPLVGVILDNGGK 95.00% 4.69 0.58 6.4 749.3994 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LQEIEGPSVSIMEK 95.00% 4.63 0.51 6.07 780.4026 1,558.79 1,559.80 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LQEIEGPSVSIMEK 95.00% 4.57 0.487 5.47 780.4027 1,558.79 1,559.80 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LQEIEGPSVSIMEK 95.00% 3.98 0.39 4.96 780.4028 1,558.79 1,559.80 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LQEIEGPSVSIMEK 95.00% 4.51 0.491 4.64 780.4037 1,558.79 1,559.80 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LQEIEGPSVSIMEK 95.00% 4.71 0.48 4.92 780.4039 1,558.79 1,559.80 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LQEIEGPSVSIMEKTQSLPTR 95.00% 3 0.402 0 781.4026 2,341.18 2,343.22 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LQEIEGPSVSIMEKTQSLPTR 95.00% 2.81 0.372 0 781.4036 2,341.19 2,343.22 3
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LQEIEGPSVSImEK 95.00% 2.97 0.371 2.37 m12: Oxidation (+15.99) 788.4018 1,574.79 1,575.79 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% LQEIEGPSVSImEK 95.00% 3.02 0.452 4.59 m12: Oxidation (+15.99) 788.4038 1,574.79 1,575.79 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VKWDISDSDVQQFR 95.00% 4.5 0.557 6.2 861.9278 1,721.84 1,722.85 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VKWDISDSDVQQFR 95.00% 4.27 0.59 8 862.4265 1,722.84 1,722.85 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 3.68 0.454 0 893.9726 1,785.93 1,786.95 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 4.61 0.556 2.96 893.9743 1,785.93 1,786.95 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 4.48 0.521 1.89 893.9752 1,785.93 1,786.95 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 4.95 0.563 1.92 893.976 1,785.94 1,786.95 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 4.46 0.53 1.6 894.4763 1,786.94 1,786.95 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% YTAILNQIPSHSSSIR 95.00% 4.44 0.501 3.38 894.4774 1,786.94 1,786.95 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IFASQASGFSDALTGMVK 95.00% 4.04 0.58 4.24 915.4564 1,828.90 1,829.91 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IFASQASGFSDALTGMVK 95.00% 5.79 0.613 6.89 915.4571 1,828.90 1,829.91 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IFASQASGFSDALTGMVK 95.00% 5.77 0.584 8.41 915.9591 1,829.90 1,829.91 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IFASQASGFSDALTGMVK 95.00% 5.99 0.673 6.49 915.9596 1,829.90 1,829.91 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IFASQASGFSDALTGMVK 95.00% 6.04 0.594 7.37 915.9596 1,829.90 1,829.91 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IFASQASGFSDALTGmVK 95.00% 5.35 0.611 5.89 m16: Oxidation (+15.99) 923.9555 1,845.90 1,845.91 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGTDGTQVAMVQFTDDPR 95.00% 4.5 0.489 6.02 975.9619 1,949.91 1,950.92 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGTDGTQVAMVQFTDDPR 95.00% 4.52 0.516 4.74 975.9653 1,949.92 1,950.92 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGTDGTQVAMVQFTDDPR 95.00% 3.15 0.484 3.43 976.4601 1,950.90 1,950.92 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGTDGTQVAMVQFTDDPR 95.00% 4.38 0.563 5.51 976.4652 1,950.91 1,950.92 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% IGTDGTQVAMVQFTDDPR 95.00% 4.5 0.508 4.96 976.4674 1,950.92 1,950.92 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VTVTPIYTDGEGVSVSAPGK 95.00% 4.44 0.669 6.68 989.0114 1,976.01 1,977.02 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VTVTPIYTDGEGVSVSAPGK 95.00% 4.54 0.619 7.21 989.0138 1,976.01 1,977.02 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VTVTPIYTDGEGVSVSAPGK 95.00% 5.39 0.63 6.92 989.5112 1,977.01 1,977.02 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VTVTPIYTDGEGVSVSAPGK 95.00% 5.15 0.621 6.48 989.512 1,977.01 1,977.02 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VTVTPIYTDGEGVSVSAPGK 95.00% 5.69 0.626 5.89 989.5126 1,977.01 1,977.02 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VTVTPIYTDGEGVSVSAPGK 95.00% 5.55 0.606 7.17 989.513 1,977.01 1,977.02 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% VTVTPIYTDGEGVSVSAPGK 95.00% 3.23 0.532 3.85 989.5149 1,977.01 1,977.02 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ASAHAITGPPTELITSEVTAR 95.00% 5.94 0.586 5.96 1,062.06 2,122.10 2,122.11 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ASAHAITGPPTELITSEVTAR 95.00% 6.2 0.578 7.32 1,062.06 2,122.11 2,122.11 2
 SAMPLE 3 Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 28 33 144 19.20% ASAHAITGPPTELITSEVTAR 95.00% 5.96 0.526 5.39 1,062.06 2,122.11 2,122.11 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IGILITDGK 95.00% 2.71 0.0994 1.82 465.2874 928.5592 929.5675 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IGILITDGK 95.00% 2.65 0.0935 1.96 465.2879 928.5602 929.5675 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DGIDLAGFK 95.00% 3.39 0.427 1.8 468.2449 934.4742 935.4841 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DGIDLAGFK 95.00% 2.89 0.295 2.4 468.2451 934.4746 935.4841 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DGIDLAGFK 95.00% 3.08 0.445 2.28 468.2455 934.4754 935.4841 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DGIDLAGFK 95.00% 2.77 0.274 2.39 468.2462 934.4767 935.4841 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DGIDLAGFK 95.00% 3.41 0.437 2.36 468.2466 934.4775 935.4841 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DGIDLAGFK 95.00% 2.82 0.35 2.52 468.2478 934.4799 935.4841 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VIVVITDGR 95.00% 2.84 0.309 1.41 486.297 970.5783 971.5891 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VIVVITDGR 95.00% 2.59 0.221 1.66 486.2972 970.5788 971.5891 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VIVVITDGR 95.00% 3.03 0.432 0 486.2972 970.5788 971.5891 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VIVVITDGR 95.00% 3.04 0.45 1.19 486.2972 970.5788 971.5891 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VIVVITDGR 95.00% 2.83 0.455 0 486.2973 970.579 971.5891 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VIVVITDGR 95.00% 2.32 0.37 0 486.2973 970.579 971.5891 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LTWDPTSR 95.00% 1.9 0.346 0 488.2476 974.4795 975.4901 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LTWDPTSR 95.00% 1.99 0.276 0 488.2476 974.4795 975.4901 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LTWDPTSR 95.00% 1.87 0.298 1.21 488.2481 974.4805 975.4901 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HVFFVDDFDAFK 95.00% 2.62 0.209 0 496.2377 1,485.69 1,486.70 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HVFFVDDFDAFK 95.00% 3.77 0.46 1.92 496.2379 1,485.69 1,486.70 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HVFFVDDFDAFK 95.00% 3.65 0.405 1.13 496.5714 1,486.69 1,486.70 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VVIESLQDR 95.00% 2.15 0.303 0 529.7943 1,057.57 1,058.58 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VVIESLQDR 95.00% 2.65 0.434 0 529.7951 1,057.57 1,058.58 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VVIESLQDR 95.00% 2.67 0.451 0 529.7956 1,057.58 1,058.58 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VTWHPLSADEGLHK 95.00% 2.22 0.247 0 530.6064 1,588.80 1,589.81 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VTWHPLSADEGLHK 95.00% 2.4 0.372 0 530.6069 1,588.80 1,589.81 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% QVcEQLIQSHMAR 95.00% 2.85 0.296 0 c3: Carbamidomethyl (+57.02) 533.9286 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% QVcEQLIQSHMAR 95.00% 3.4 0.436 0 c3: Carbamidomethyl (+57.02) 533.929 1,598.76 1,599.77 3 IQGA1_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% QVcEQLIQSHMAR 95.00% 2.64 0.254 0 c3: Carbamidomethyl (+57.02) 534.2633 1,599.77 1,599.77 3 IQGA1_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HVFFVDDFDAFKK 95.00% 4.24 0.646 3.29 538.9352 1,613.78 1,614.80 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HVFFVDDFDAFKK 95.00% 4.49 0.591 3.6 538.9368 1,613.79 1,614.80 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HVFFVDDFDAFKK 95.00% 4.63 0.572 3.05 539.2701 1,614.79 1,614.80 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HVFFVDDFDAFKK 95.00% 4.73 0.572 3.4 539.2707 1,614.79 1,614.80 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% TKETLLDAIK 95.00% 2.31 0.203 0 566.3338 1,130.65 1,131.66 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VKWDISDSDVQQFR 95.00% 3.62 0.344 1.47 574.9531 1,721.84 1,722.85 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VKWDISDSDVQQFR 95.00% 3.28 0.288 0 574.9548 1,721.84 1,722.85 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VKWDISDSDVQQFR 95.00% 2.76 0.309 0 574.9556 1,721.84 1,722.85 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VKWDISDSDVQQFR 95.00% 3.48 0.273 2.74 575.2888 1,722.84 1,722.85 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LMWIPVYGGK 95.00% 2.28 0.236 0 582.3163 1,162.62 1,163.63 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LMWIPVYGGK 95.00% 2.43 0.252 0 582.3166 1,162.62 1,163.63 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LMWIPVYGGK 95.00% 2.64 0.258 0 582.3169 1,162.62 1,163.63 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LMWIPVYGGK 95.00% 2.44 0.263 0 582.3169 1,162.62 1,163.63 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LMWIPVYGGK 95.00% 2.62 0.268 0 582.3174 1,162.62 1,163.63 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LMWIPVYGGK 95.00% 2.43 0.25 0 582.3178 1,162.62 1,163.63 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% TLPSSGPQNLR 95.00% 1.86 0.317 1.29 585.3133 1,168.61 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% TLPSSGPQNLR 95.00% 2.25 0.43 2.33 585.3163 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% TLPSSGPQNLR 95.00% 1.98 0.362 2.31 585.3176 1,168.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% TLPSSGPQNLR 95.00% 1.93 0.356 2.19 585.8182 1,169.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% TLPSSGPQNLR 95.00% 1.93 0.307 1.33 585.8202 1,169.62 1,169.63 2 CO6A1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IGLAQYSGDPR 95.00% 2.8 0.364 1.49 588.803 1,175.59 1,176.60 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IGLAQYSGDPR 95.00% 2.95 0.522 1.26 588.8033 1,175.59 1,176.60 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IGLAQYSGDPR 95.00% 3 0.478 2 588.8034 1,175.59 1,176.60 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IGLAQYSGDPR 95.00% 2.36 0.463 1.7 588.8046 1,175.59 1,176.60 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IGLAQYSGDPR 95.00% 1.99 0.262 1.66 588.8054 1,175.60 1,176.60 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 2.36 0.275 0 596.3183 1,785.93 1,786.95 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 3.45 0.437 1.72 596.3196 1,785.94 1,786.95 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 3.02 0.392 0 596.3198 1,785.94 1,786.95 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 3.1 0.416 1.29 596.3212 1,785.94 1,786.95 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 2.58 0.374 1.17 596.3233 1,785.95 1,786.95 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 2.84 0.33 0 596.6539 1,786.94 1,786.95 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 2.27 0.337 0 596.6539 1,786.94 1,786.95 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 2.64 0.409 0 596.6541 1,786.94 1,786.95 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 2.45 0.358 0 596.6541 1,786.94 1,786.95 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DTLFTAESGTR 95.00% 2.34 0.354 1.41 599.2875 1,196.56 1,197.58 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DTLFTAESGTR 95.00% 2.96 0.365 1.27 599.2879 1,196.56 1,197.58 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DTLFTAESGTR 95.00% 3.61 0.403 2.8 599.2884 1,196.56 1,197.58 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DTLFTAESGTR 95.00% 2.89 0.397 1.8 599.2887 1,196.56 1,197.58 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DTLFTAESGTR 95.00% 3.59 0.422 2.42 599.2914 1,196.57 1,197.58 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DTLFTAESGTR 95.00% 3.65 0.391 3.38 599.2921 1,196.57 1,197.58 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DTLFTAESGTR 95.00% 3.05 0.185 1.13 599.7954 1,197.58 1,197.58 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% DTLFTAESGTR 95.00% 3.06 0.43 1.32 599.7959 1,197.58 1,197.58 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HFLENLVTAFDVGSEK 95.00% 3.84 0.402 2.51 602.6388 1,804.89 1,805.91 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HFLENLVTAFDVGSEK 95.00% 3.37 0.488 3 602.64 1,804.90 1,805.91 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HFLENLVTAFDVGSEK 95.00% 4.87 0.603 2.85 602.6403 1,804.90 1,805.91 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HFLENLVTAFDVGSEK 95.00% 5.31 0.582 3.89 602.6406 1,804.90 1,805.91 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HFLENLVTAFDVGSEK 95.00% 3.72 0.367 2.89 602.6412 1,804.90 1,805.91 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HFLENLVTAFDVGSEK 95.00% 4.67 0.513 2.96 602.9745 1,805.90 1,805.91 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IFASQASGFSDALTGMVK 95.00% 4.6 0.477 2.55 610.6418 1,828.90 1,829.91 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IFASQASGFSDALTGMVK 95.00% 4.98 0.573 3.82 610.9757 1,829.90 1,829.91 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ITWDPPSSPVK 95.00% 2.74 0.316 1.92 613.823 1,225.63 1,226.64 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ITWDPPSSPVK 95.00% 2.64 0.327 1.74 613.8236 1,225.63 1,226.64 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ITWDPPSSPVK 95.00% 2.48 0.312 1.8 613.8236 1,225.63 1,226.64 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ITWDPPSSPVK 95.00% 2.76 0.385 2.11 613.8238 1,225.63 1,226.64 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ITWDPPSSPVK 95.00% 2.31 0.205 0 613.8239 1,225.63 1,226.64 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ITWDPPSSPVK 95.00% 2.86 0.358 1.89 613.8241 1,225.63 1,226.64 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ITWDPPSSPVK 95.00% 2.12 0.413 0 613.8242 1,225.63 1,226.64 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ITWDPPSSPVK 95.00% 2.72 0.364 1.72 613.8245 1,225.63 1,226.64 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ITWDPPSSPVK 95.00% 2.8 0.35 2.32 613.8246 1,225.63 1,226.64 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ITWDPPSSPVK 95.00% 2.64 0.374 1.54 613.8246 1,225.63 1,226.64 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LHIVVSETLVK 95.00% 3.01 0.28 1.62 619.3791 1,236.74 1,237.75 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LHIVVSETLVK 95.00% 3 0.267 1.92 619.3801 1,236.74 1,237.75 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ESGVELFAIGVK 95.00% 3.33 0.437 2.16 624.8437 1,247.67 1,248.68 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ESGVELFAIGVK 95.00% 3.44 0.471 2.55 624.8441 1,247.67 1,248.68 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ESGVELFAIGVK 95.00% 2.75 0.269 0 624.8443 1,247.67 1,248.68 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ESGVELFAIGVK 95.00% 2.78 0.288 1.62 624.8444 1,247.67 1,248.68 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ESGVELFAIGVK 95.00% 3.42 0.425 2.03 624.8445 1,247.67 1,248.68 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ESGVELFAIGVK 95.00% 2.42 0.217 1.21 624.8449 1,247.67 1,248.68 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ESGVELFAIGVK 95.00% 3.13 0.409 1.64 624.8453 1,247.68 1,248.68 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% GGKPDEVVVDGTVSSTVLK 95.00% 3.55 0.424 1.96 630.0081 1,887.00 1,887.01 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% GGKPDEVVVDGTVSSTVLK 95.00% 3.14 0.286 2.18 630.0085 1,887.00 1,887.01 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% TLFLGVTNLQAK 95.00% 3.27 0.466 3.33 652.8806 1,303.75 1,304.76 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ASAHAITGPPTELITSEVTAR 95.00% 5.07 0.497 1.3 708.3773 2,122.11 2,122.11 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ASAHAITGPPTELITSEVTAR 95.00% 5.25 0.47 0 708.3777 2,122.11 2,122.11 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HVFFVDDFDAFK 95.00% 3.48 0.621 5.33 743.8496 1,485.68 1,486.70 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HVFFVDDFDAFK 95.00% 3.03 0.577 4.28 743.8521 1,485.69 1,486.70 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HVFFVDDFDAFK 95.00% 3.36 0.613 6.08 743.8547 1,485.69 1,486.70 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HVFFVDDFDAFK 95.00% 3.95 0.52 6.23 744.3541 1,486.69 1,486.70 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% NSDPLVGVILDNGGK 95.00% 4.04 0.575 5.01 749.3979 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% NSDPLVGVILDNGGK 95.00% 4.58 0.578 5.3 749.3981 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% NSDPLVGVILDNGGK 95.00% 5.02 0.561 5.8 749.3987 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% NSDPLVGVILDNGGK 95.00% 4.11 0.541 6.12 749.3993 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% NSDPLVGVILDNGGK 95.00% 2.09 0.254 1.41 749.3998 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% NSDPLVGVILDNGGK 95.00% 3.96 0.531 5.36 749.4001 1,496.78 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% NSDPLVGVILDNGGK 95.00% 5.09 0.62 6.51 749.9023 1,497.79 1,497.79 2 CO6A2_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IISFLYSTVGALNK 95.00% 3.92 0.459 2.64 763.434 1,524.85 1,525.86 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IISFLYSTVGALNK 95.00% 3.51 0.423 1.85 763.4344 1,524.85 1,525.86 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IISFLYSTVGALNK 95.00% 3.92 0.515 3.33 763.436 1,524.86 1,525.86 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IISFLYSTVGALNK 95.00% 2.74 0.175 0 763.4378 1,524.86 1,525.86 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IISFLYSTVGALNK 95.00% 3.75 0.516 4.04 763.9363 1,525.86 1,525.86 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LQEIEGPSVSIMEK 95.00% 4.34 0.455 4.43 780.4026 1,558.79 1,559.80 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LQEIEGPSVSIMEK 95.00% 4.62 0.492 2.96 780.4026 1,558.79 1,559.80 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LQEIEGPSVSIMEK 95.00% 4.59 0.476 4.37 780.4033 1,558.79 1,559.80 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LQEIEGPSVSIMEK 95.00% 3.53 0.411 2.92 780.4037 1,558.79 1,559.80 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% LQEIEGPSVSIMEK 95.00% 4.61 0.508 3.42 780.4043 1,558.79 1,559.80 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% QVcEQLIQSHMAR 95.00% 2.43 0.209 0 c3: Carbamidomethyl (+57.02) 800.391 1,598.77 1,599.77 2 IQGA1_HUMAN
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HcFYGLQPDSEYK 95.00% 3.91 0.571 5.11 c2: Carbamidomethyl (+57.02) 822.8589 1,643.70 1,643.72 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IEDELITFVcETASATcPVVHK 95.00% 5.02 0.539 1.44 c10: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 840.7445 2,519.21 2,519.22 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IEDELITFVcETASATcPVVHK 95.00% 3.79 0.378 0.959 c10: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 840.7447 2,519.21 2,519.22 3
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VKWDISDSDVQQFR 95.00% 4.52 0.547 6.17 861.927 1,721.84 1,722.85 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VKWDISDSDVQQFR 95.00% 4.26 0.584 4.52 861.9273 1,721.84 1,722.85 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VKWDISDSDVQQFR 95.00% 3.91 0.464 5.72 862.4272 1,722.84 1,722.85 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 3.85 0.528 0 893.9726 1,785.93 1,786.95 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 3.83 0.51 1.48 893.9749 1,785.93 1,786.95 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 4.71 0.56 4.23 893.9751 1,785.93 1,786.95 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 4.41 0.496 2.12 893.9753 1,785.94 1,786.95 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 4.46 0.49 2.82 894.4766 1,786.94 1,786.95 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% YTAILNQIPSHSSSIR 95.00% 4.33 0.482 2.68 894.4792 1,786.94 1,786.95 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HFLENLVTAFDVGSEK 95.00% 4.94 0.592 5.01 903.4516 1,804.89 1,805.91 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HFLENLVTAFDVGSEK 95.00% 5.39 0.65 9.6 903.4538 1,804.89 1,805.91 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% HFLENLVTAFDVGSEK 95.00% 5.75 0.659 5.85 903.4568 1,804.90 1,805.91 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IFASQASGFSDALTGMVK 95.00% 5.23 0.619 6.77 915.456 1,828.90 1,829.91 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IFASQASGFSDALTGMVK 95.00% 5.63 0.615 7.08 915.458 1,828.90 1,829.91 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IFASQASGFSDALTGMVK 95.00% 4.42 0.622 6.57 915.458 1,828.90 1,829.91 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IFASQASGFSDALTGMVK 95.00% 5.06 0.603 7.46 915.9583 1,829.90 1,829.91 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IFASQASGFSDALTGMVK 95.00% 5.53 0.546 6.44 915.9586 1,829.90 1,829.91 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IFASQASGFSDALTGMVK 95.00% 5.77 0.602 6.04 915.9588 1,829.90 1,829.91 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IFASQASGFSDALTGmVK 95.00% 5 0.626 6.17 m16: Oxidation (+15.99) 923.9582 1,845.90 1,845.91 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IGTDGTQVAMVQFTDDPR 95.00% 3.4 0.419 5.38 975.9628 1,949.91 1,950.92 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IGTDGTQVAMVQFTDDPR 95.00% 4.14 0.549 5.8 976.4661 1,950.92 1,950.92 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% IGTDGTQVAMVQFTDDPR 95.00% 4.19 0.456 5.38 976.4663 1,950.92 1,950.92 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VTVTPIYTDGEGVSVSAPGK 95.00% 3.63 0.538 3.01 989.0107 1,976.01 1,977.02 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VTVTPIYTDGEGVSVSAPGK 95.00% 4.92 0.663 8.96 989.0157 1,976.02 1,977.02 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VTVTPIYTDGEGVSVSAPGK 95.00% 4.67 0.633 5.82 989.5094 1,977.00 1,977.02 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VTVTPIYTDGEGVSVSAPGK 95.00% 5.17 0.628 8.03 989.5135 1,977.01 1,977.02 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VTVTPIYTDGEGVSVSAPGK 95.00% 5.28 0.649 5.52 989.5141 1,977.01 1,977.02 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% VTVTPIYTDGEGVSVSAPGK 95.00% 4.41 0.633 7.8 989.5166 1,977.02 1,977.02 2
 SAMPLE 3R Collagen alpha-1(XIV) chain  COL14A1  COEA1_HUMAN 193,498.10 100.00% 30 37 151 22.40% ASAHAITGPPTELITSEVTAR 95.00% 6.04 0.634 5.77 1,062.06 2,122.11 2,122.11 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% AAGLLSTYR 95.00% 1.91 0.33 2.11 476.2652 950.5148 951.5264 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% AAGLLSTYR 95.00% 2.81 0.304 2.52 476.2657 950.5157 951.5264 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% AAGLLSTYR 95.00% 2.74 0.365 2.3 476.2657 950.5157 951.5264 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% AAGLLSTYR 95.00% 2.57 0.342 2.54 476.2657 950.5157 951.5264 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% YSLPIVNLK 95.00% 2.18 0.258 1.89 523.8144 1,045.61 1,046.63 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% YSLPIVNLK 95.00% 2.37 0.291 1.96 523.8155 1,045.62 1,046.63 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% YSLPIVNLK 95.00% 2.29 0.353 1.55 523.8155 1,045.62 1,046.63 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% YSLPIVNLK 95.00% 2.4 0.329 2.31 523.8157 1,045.62 1,046.63 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% AFLSSHLQDLSTIVR 95.00% 3.17 0.464 2.21 563.3113 1,686.91 1,686.92 3
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% AFLSSHLQDLSTIVR 95.00% 2.42 0.33 0 563.3113 1,686.91 1,686.92 3
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% FTGSLQQLTVHPDPR 95.00% 2.57 0.345 1 565.9646 1,694.87 1,695.88 3
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% FTGSLQQLTVHPDPR 95.00% 3.61 0.49 1.74 566.2982 1,695.87 1,695.88 3
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% FTGSLQQLTVHPDPR 95.00% 2.73 0.328 0 566.2989 1,695.87 1,695.88 3
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% DIMTDPSWPQK 95.00% 2.26 0.241 0 659.3103 1,316.60 1,317.62 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% DIMTDPSWPQK 95.00% 2.81 0.398 1.21 659.8103 1,317.61 1,317.62 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% TADTAVTGLASPLSTGK 95.00% 5.3 0.654 5.48 795.4217 1,588.83 1,589.84 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% TADTAVTGLASPLSTGK 95.00% 5.35 0.647 6.22 795.422 1,588.83 1,589.84 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% TADTAVTGLASPLSTGK 95.00% 5.25 0.651 7.48 795.4229 1,588.83 1,589.84 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% TADTAVTGLASPLSTGK 95.00% 4.26 0.48 3.74 795.9179 1,589.82 1,589.84 2
 SAMPLE 1 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 20 5.48% TADTAVTGLASPLSTGK 95.00% 5.68 0.565 4.43 795.9237 1,589.83 1,589.84 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% AAGLLSTYR 95.00% 2.55 0.302 1.89 476.2646 950.5136 951.5264 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% AAGLLSTYR 95.00% 2.72 0.39 1.89 476.2657 950.5157 951.5264 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% AAGLLSTYR 95.00% 2.86 0.337 2.27 476.2667 950.5178 951.5264 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% AAGLLSTYR 95.00% 2.6 0.413 2.48 476.269 950.5224 951.5264 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% DSTEFFIR 95.00% 2.25 0.285 0 507.7476 1,013.48 1,014.49 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% DSTEFFIR 95.00% 2.22 0.266 0 507.7477 1,013.48 1,014.49 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% YSLPIVNLK 95.00% 2.15 0.393 1.85 523.8142 1,045.61 1,046.63 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% YSLPIVNLK 95.00% 2.14 0.219 0 523.815 1,045.61 1,046.63 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% YSLPIVNLK 95.00% 2.24 0.304 2.29 523.8163 1,045.62 1,046.63 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% AFLSSHLQDLSTIVR 95.00% 3.71 0.564 1.77 562.9755 1,685.90 1,686.92 3
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% AFLSSHLQDLSTIVR 95.00% 3.32 0.52 2.43 562.9764 1,685.91 1,686.92 3
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% FTGSLQQLTVHPDPR 95.00% 3.08 0.329 0 565.9647 1,694.87 1,695.88 3
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% FTGSLQQLTVHPDPR 95.00% 3.78 0.485 0 566.2989 1,695.87 1,695.88 3
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% LVDNYcEAWR 95.00% 2.72 0.487 1.22 c6: Carbamidomethyl (+57.02) 663.299 1,324.58 1,325.59 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% LVDNYcEAWR 95.00% 2.09 0.375 0 c6: Carbamidomethyl (+57.02) 663.2992 1,324.58 1,325.59 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% GGVLFAITDAFQK 95.00% 4.3 0.507 2.72 683.8712 1,365.73 1,366.74 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% GGVLFAITDAFQK 95.00% 4.54 0.496 3.08 683.8715 1,365.73 1,366.74 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% GGVLFAITDAFQK 95.00% 4.17 0.515 5.12 683.872 1,365.73 1,366.74 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% GGVLFAITDAFQK 95.00% 4.08 0.551 3.62 683.8728 1,365.73 1,366.74 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% GGVLFAITDAFQK 95.00% 2.32 0.282 1.64 683.8766 1,365.74 1,366.74 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% TADTAVTGLASPLSTGK 95.00% 5.15 0.625 6.89 795.4221 1,588.83 1,589.84 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% TADTAVTGLASPLSTGK 95.00% 4.87 0.633 4.62 795.4226 1,588.83 1,589.84 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% TADTAVTGLASPLSTGK 95.00% 5.16 0.672 5.08 795.424 1,588.83 1,589.84 2
 SAMPLE 1R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 8 8 24 6.92% TADTAVTGLASPLSTGK 95.00% 5.56 0.586 4.12 795.9218 1,589.83 1,589.84 2
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% AAGLLSTYR 95.00% 2.63 0.426 2.41 476.2655 950.5154 951.5264 2
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% AAGLLSTYR 95.00% 2.06 0.174 1.43 476.2663 950.5169 951.5264 2
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% AAGLLSTYR 95.00% 2.79 0.405 2.24 476.2665 950.5173 951.5264 2
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% YSLPIVNLK 95.00% 2.43 0.325 1.96 523.8157 1,045.62 1,046.63 2
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% AFLSSHLQDLSTIVR 95.00% 3.86 0.537 2.51 562.9736 1,685.90 1,686.92 3
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% FTGSLQQLTVHPDPR 95.00% 2.66 0.205 0 565.965 1,694.87 1,695.88 3
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% LVDNYcEAWR 95.00% 2.53 0.43 1.2 c6: Carbamidomethyl (+57.02) 663.2995 1,324.58 1,325.59 2
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% LVDNYcEAWR 95.00% 2.95 0.537 2.28 c6: Carbamidomethyl (+57.02) 663.3003 1,324.59 1,325.59 2
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% LVDNYcEAWR 95.00% 3.08 0.558 3.22 c6: Carbamidomethyl (+57.02) 663.3007 1,324.59 1,325.59 2
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% LVDNYcEAWR 95.00% 3.29 0.566 2.01 c6: Carbamidomethyl (+57.02) 663.8012 1,325.59 1,325.59 2
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% TADTAVTGLASPLSTGK 95.00% 5.45 0.637 6.07 795.4232 1,588.83 1,589.84 2
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% TADTAVTGLASPLSTGK 95.00% 4.96 0.615 4.7 795.4239 1,588.83 1,589.84 2
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% TADTAVTGLASPLSTGK 95.00% 5.1 0.633 5.33 795.4241 1,588.83 1,589.84 2
 SAMPLE 2 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 6 6 14 5.40% TADTAVTGLASPLSTGK 95.00% 5.61 0.6 4.08 795.9226 1,589.83 1,589.84 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% AAGLLSTYR 95.00% 2.39 0.417 2 476.265 950.5144 951.5264 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% AAGLLSTYR 95.00% 2.65 0.374 2.04 476.2659 950.5162 951.5264 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% AAGLLSTYR 95.00% 2.5 0.303 1.64 476.2661 950.5166 951.5264 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% AAGLLSTYR 95.00% 2.58 0.382 1.6 476.2669 950.5181 951.5264 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% YSLPIVNLK 95.00% 2.46 0.379 2.38 523.8148 1,045.61 1,046.63 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% TLIPSTFFR 95.00% 1.78 0.292 1.36 541.3052 1,080.59 1,081.60 2 FBN1_HUMAN
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% FTGSLQQLTVHPDPR 95.00% 2.49 0.25 0 565.9656 1,694.87 1,695.88 3
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% DIMTDPSWPQK 95.00% 2.52 0.248 0 660.0114 1,318.01 1,317.62 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% LVDNYcEAWR 95.00% 2.56 0.562 0 c6: Carbamidomethyl (+57.02) 663.2997 1,324.58 1,325.59 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% LVDNYcEAWR 95.00% 1.87 0.342 1.55 c6: Carbamidomethyl (+57.02) 663.3 1,324.58 1,325.59 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% GGVLFAITDAFQK 95.00% 4.11 0.462 4 683.8717 1,365.73 1,366.74 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% GGVLFAITDAFQK 95.00% 4.18 0.489 3.33 684.3713 1,366.73 1,366.74 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% TADTAVTGLASPLSTGK 95.00% 4.93 0.656 5.57 795.4221 1,588.83 1,589.84 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% TADTAVTGLASPLSTGK 95.00% 4.67 0.681 5.44 795.4226 1,588.83 1,589.84 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% TADTAVTGLASPLSTGK 95.00% 5.58 0.638 4.47 795.9229 1,589.83 1,589.84 2
 SAMPLE 2R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 7 7 15 6.70% TADTAVTGLASPLSTGK 95.00% 5.17 0.589 5.23 795.923 1,589.83 1,589.84 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AAGLLSTYR 95.00% 1.89 0.329 1.38 476.265 950.5143 951.5264 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AAGLLSTYR 95.00% 2.81 0.363 2.46 476.2652 950.5148 951.5264 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AAGLLSTYR 95.00% 2.78 0.28 1.85 476.2654 950.5151 951.5264 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AAGLLSTYR 95.00% 1.59 0.302 1.54 476.2655 950.5153 951.5264 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AAGLLSTYR 95.00% 2.5 0.361 1.72 476.2655 950.5154 951.5264 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AAGLLSTYR 95.00% 2.87 0.338 1.92 476.2659 950.5162 951.5264 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AAGLLSTYR 95.00% 2.95 0.256 3.03 476.266 950.5163 951.5264 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AAGLLSTYR 95.00% 3 0.323 1.72 476.2662 950.5168 951.5264 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AAGLLSTYR 95.00% 2.54 0.307 2.09 476.2665 950.5173 951.5264 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AAGLLSTYR 95.00% 2.43 0.386 2.32 476.2671 950.5185 951.5264 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AAGLLSTYR 95.00% 2.24 0.36 1.29 476.2673 950.5189 951.5264 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% DFAISVVVKPSSTR 95.00% 2.65 0.372 0 502.6153 1,504.82 1,505.83 3
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% DFAISVVVKPSSTR 95.00% 2 0.277 0 502.6155 1,504.82 1,505.83 3
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% DSTEFFIR 95.00% 2.31 0.383 0 507.7474 1,013.48 1,014.49 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% DSTEFFIR 95.00% 2.29 0.27 0 507.7475 1,013.48 1,014.49 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% YSLPIVNLK 95.00% 2.31 0.352 2.18 523.815 1,045.61 1,046.63 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% YSLPIVNLK 95.00% 2.49 0.321 2.16 523.8153 1,045.61 1,046.63 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% TLIPSTFFR 95.00% 1.84 0.258 1.15 541.3049 1,080.59 1,081.60 2 FBN1_HUMAN
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% TLIPSTFFR 95.00% 1.84 0.337 1.66 541.3056 1,080.60 1,081.60 2 FBN1_HUMAN
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AFLSSHLQDLSTIVR 95.00% 3.4 0.459 2.24 562.9756 1,685.90 1,686.92 3
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AFLSSHLQDLSTIVR 95.00% 3.49 0.523 2.85 562.9756 1,685.90 1,686.92 3
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AFLSSHLQDLSTIVR 95.00% 3.3 0.49 2.64 562.9769 1,685.91 1,686.92 3
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AFLSSHLQDLSTIVR 95.00% 3.52 0.451 1.92 563.3093 1,686.90 1,686.92 3
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% FTGSLQQLTVHPDPR 95.00% 2.4 0.342 1.01 565.9645 1,694.87 1,695.88 3
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% FTGSLQQLTVHPDPR 95.00% 2.22 0.286 0 565.9645 1,694.87 1,695.88 3
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% FTGSLQQLTVHPDPR 95.00% 2.91 0.447 2.04 565.9647 1,694.87 1,695.88 3
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% FTGSLQQLTVHPDPR 95.00% 3.37 0.261 2 565.965 1,694.87 1,695.88 3
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% FTGSLQQLTVHPDPR 95.00% 1.96 0.425 1.28 566.302 1,695.88 1,695.88 3
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% LVDNYcEAWR 95.00% 3.14 0.491 0 c6: Carbamidomethyl (+57.02) 663.299 1,324.58 1,325.59 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% LVDNYcEAWR 95.00% 2.76 0.465 0 c6: Carbamidomethyl (+57.02) 663.2996 1,324.58 1,325.59 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% LVDNYcEAWR 95.00% 3.6 0.592 3.1 c6: Carbamidomethyl (+57.02) 663.2999 1,324.58 1,325.59 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% LVDNYcEAWR 95.00% 3.03 0.549 2.01 c6: Carbamidomethyl (+57.02) 663.3007 1,324.59 1,325.59 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% LVDNYcEAWR 95.00% 3.39 0.605 2.66 c6: Carbamidomethyl (+57.02) 663.3009 1,324.59 1,325.59 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% LVDNYcEAWR 95.00% 3.27 0.54 1.77 c6: Carbamidomethyl (+57.02) 663.3012 1,324.59 1,325.59 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% DFAISVVVKPSSTR 95.00% 2.75 0.498 0 753.42 1,504.82 1,505.83 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% TADTAVTGLASPLSTGK 95.00% 5.1 0.615 5.55 795.4205 1,588.83 1,589.84 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% TADTAVTGLASPLSTGK 95.00% 5.35 0.669 6.26 795.4225 1,588.83 1,589.84 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% TADTAVTGLASPLSTGK 95.00% 5.27 0.632 4.62 795.4231 1,588.83 1,589.84 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% TADTAVTGLASPLSTGK 95.00% 4.84 0.659 6.17 795.4232 1,588.83 1,589.84 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% TADTAVTGLASPLSTGK 95.00% 5.26 0.638 5.38 795.4236 1,588.83 1,589.84 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% TADTAVTGLASPLSTGK 95.00% 5.47 0.665 5.15 795.4239 1,588.83 1,589.84 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% TADTAVTGLASPLSTGK 95.00% 5.18 0.591 4.64 795.9232 1,589.83 1,589.84 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% TADTAVTGLASPLSTGK 95.00% 4.24 0.586 2.89 795.9242 1,589.83 1,589.84 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% TADTAVTGLASPLSTGK 95.00% 5.26 0.624 4.44 795.9244 1,589.83 1,589.84 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% AFLSSHLQDLSTIVR 95.00% 4.41 0.534 2.82 844.4597 1,686.90 1,686.92 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% FTGSLQQLTVHPDPR 95.00% 2.69 0.364 1.89 848.4462 1,694.88 1,695.88 2
 SAMPLE 3 Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 45 8.72% NLVTAFSNmDDMLQK 95.00% 4.33 0.557 4.44 m9: Oxidation (+15.99) 871.9107 1,741.81 1,742.81 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% GGVLFAITDAFQK 95.00% 2.42 0.257 0 456.251 1,365.73 1,366.74 3
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% GGVLFAITDAFQK 95.00% 3.51 0.313 1.05 456.5866 1,366.74 1,366.74 3
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AAGLLSTYR 95.00% 2.71 0.253 2.23 476.2656 950.5155 951.5264 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AAGLLSTYR 95.00% 2.89 0.266 2.28 476.2657 950.5158 951.5264 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AAGLLSTYR 95.00% 2.1 0.366 2.42 476.2662 950.5168 951.5264 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AAGLLSTYR 95.00% 2.5 0.354 2.46 476.2663 950.5169 951.5264 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AAGLLSTYR 95.00% 2.2 0.336 2.48 476.2663 950.5169 951.5264 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AAGLLSTYR 95.00% 2.84 0.325 2.66 476.2664 950.5171 951.5264 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AAGLLSTYR 95.00% 2.74 0.362 3.74 476.2666 950.5176 951.5264 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AAGLLSTYR 95.00% 2.61 0.27 3.82 476.2674 950.5191 951.5264 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AAGLLSTYR 95.00% 2.99 0.319 2.74 476.2682 950.5207 951.5264 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AAGLLSTYR 95.00% 1.86 0.324 0 476.9259 951.8362 951.5264 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% DFAISVVVKPSSTR 95.00% 2.66 0.222 1.37 502.6142 1,504.82 1,505.83 3
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% DFAISVVVKPSSTR 95.00% 2.49 0.36 0 502.6153 1,504.82 1,505.83 3
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% YSLPIVNLK 95.00% 2.27 0.424 1.74 523.8148 1,045.61 1,046.63 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% TADTAVTGLASPLSTGK 95.00% 2.66 0.283 0 530.6166 1,588.83 1,589.84 3
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AFLSSHLQDLSTIVR 95.00% 3 0.228 0 562.9741 1,685.90 1,686.92 3
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AFLSSHLQDLSTIVR 95.00% 3.03 0.376 1.07 562.9758 1,685.90 1,686.92 3
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AFLSSHLQDLSTIVR 95.00% 3.26 0.472 0 563.3091 1,686.90 1,686.92 3
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% AFLSSHLQDLSTIVR 95.00% 4.28 0.472 2.51 563.3109 1,686.91 1,686.92 3
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% FTGSLQQLTVHPDPR 95.00% 3.37 0.464 3.03 565.9645 1,694.87 1,695.88 3
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% FTGSLQQLTVHPDPR 95.00% 2.22 0.15 1.64 565.9647 1,694.87 1,695.88 3
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% FTGSLQQLTVHPDPR 95.00% 2.68 0.553 1.29 565.9649 1,694.87 1,695.88 3
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% LVDNYcEAWR 95.00% 3.02 0.516 2.1 c6: Carbamidomethyl (+57.02) 663.298 1,324.58 1,325.59 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% LVDNYcEAWR 95.00% 3.3 0.548 1.85 c6: Carbamidomethyl (+57.02) 663.2995 1,324.58 1,325.59 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% LVDNYcEAWR 95.00% 2.29 0.271 0 c6: Carbamidomethyl (+57.02) 663.3014 1,324.59 1,325.59 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% GGVLFAITDAFQK 95.00% 2.41 0.273 2.03 683.8686 1,365.72 1,366.74 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% GGVLFAITDAFQK 95.00% 3.41 0.261 1.57 683.8708 1,365.73 1,366.74 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% GGVLFAITDAFQK 95.00% 3.44 0.346 2.47 683.871 1,365.73 1,366.74 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% GGVLFAITDAFQK 95.00% 4.26 0.521 2.96 683.8714 1,365.73 1,366.74 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% GGVLFAITDAFQK 95.00% 4.28 0.52 3.28 683.8714 1,365.73 1,366.74 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% GGVLFAITDAFQK 95.00% 2.65 0.387 2.1 683.8716 1,365.73 1,366.74 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% GGVLFAITDAFQK 95.00% 3.69 0.386 2.77 683.872 1,365.73 1,366.74 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% GGVLFAITDAFQK 95.00% 3.26 0.432 3.44 683.8736 1,365.73 1,366.74 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% TADTAVTGLASPLSTGK 95.00% 4.85 0.64 5.68 795.4211 1,588.83 1,589.84 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% TADTAVTGLASPLSTGK 95.00% 4.71 0.625 6.19 795.4215 1,588.83 1,589.84 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% TADTAVTGLASPLSTGK 95.00% 4.76 0.62 5.4 795.4226 1,588.83 1,589.84 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% TADTAVTGLASPLSTGK 95.00% 4.56 0.606 2.85 795.423 1,588.83 1,589.84 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% TADTAVTGLASPLSTGK 95.00% 3.69 0.582 2.1 795.4236 1,588.83 1,589.84 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% TADTAVTGLASPLSTGK 95.00% 4.81 0.591 4.89 795.4238 1,588.83 1,589.84 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% TADTAVTGLASPLSTGK 95.00% 4.98 0.62 5.26 795.4239 1,588.83 1,589.84 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% TADTAVTGLASPLSTGK 95.00% 4.79 0.606 5.04 795.4239 1,588.83 1,589.84 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% FTGSLQQLTVHPDPR 95.00% 3.29 0.478 2.54 848.4466 1,694.88 1,695.88 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% NLVTAFSNMDDMLQK 95.00% 4.09 0.57 5.1 863.9114 1,725.81 1,726.81 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% NLVTAFSNMDDMLQK 95.00% 4.54 0.39 4.25 863.9114 1,725.81 1,726.81 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% NLVTAFSNMDDMLQK 95.00% 4.86 0.505 5.85 864.4114 1,726.81 1,726.81 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% NLVTAFSNmDDMLQK 95.00% 4.41 0.536 3.62 m9: Oxidation (+15.99) 872.4082 1,742.80 1,742.81 2
 SAMPLE 3R Collagen alpha-1(XV) chain  COL15A1  COFA1_HUMAN 141,704.50 100.00% 9 12 48 8.43% NLVTAFSNmDDMLQK 95.00% 4.32 0.578 3.89 m9: Oxidation (+15.99) 872.4095 1,742.80 1,742.81 2
 SAMPLE 4 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 99.80% 2 2 4 1.31% ELLREETGAALKPR 95.00% 4.6 0.438 3.14 528.6376 1,582.89 1,582.89 3
 SAMPLE 4 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 99.80% 2 2 4 1.31% LQDLYSIVR 95.00% 2.57 0.334 1.17 553.8147 1,105.61 1,106.62 2
 SAMPLE 4 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 99.80% 2 2 4 1.31% LQDLYSIVR 95.00% 2.43 0.302 0 553.8155 1,105.62 1,106.62 2
 SAMPLE 4 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 99.80% 2 2 4 1.31% LQDLYSIVR 94.90% 2.19 0.201 0 553.8165 1,105.62 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% ADDILASPPR 95.00% 3.28 0.461 0 527.7788 1,053.54 1,054.55 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% ADDILASPPR 95.00% 3.34 0.447 0 527.7789 1,053.54 1,054.55 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% ADDILASPPR 95.00% 3 0.42 0 527.7793 1,053.54 1,054.55 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% ADDILASPPR 95.00% 2.85 0.42 0 527.7793 1,053.54 1,054.55 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% ADDILASPPR 95.00% 3.25 0.363 0 527.7806 1,053.55 1,054.55 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% ADDILASPPR 95.00% 2.37 0.34 0 527.7812 1,053.55 1,054.55 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% ELLREETGAALKPR 95.00% 5.39 0.502 3.38 528.3008 1,581.88 1,582.89 3
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% ELLREETGAALKPR 95.00% 5.09 0.523 3.82 528.301 1,581.88 1,582.89 3
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% ELLREETGAALKPR 95.00% 5.26 0.472 3.51 528.3011 1,581.88 1,582.89 3
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% ELLREETGAALKPR 95.00% 5.46 0.477 3.96 528.302 1,581.88 1,582.89 3
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.24 0.366 0 553.8126 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.04 0.318 1.66 553.8127 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.39 0.333 1.47 553.8127 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.31 0.301 1.96 553.8128 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.41 0.346 1.31 553.8128 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.33 0.339 1.8 553.8129 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.39 0.423 1.68 553.813 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 2.79 0.319 1.89 553.813 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.32 0.346 1.92 553.813 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.35 0.354 1.23 553.813 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.55 0.363 1.66 553.8131 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.44 0.359 2.44 553.8133 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.31 0.34 1.51 553.8133 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.37 0.357 0 553.8136 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 3.55 0.368 1.92 553.8138 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 2.12 0.275 0 553.8143 1,105.61 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 2.85 0.31 0 553.8159 1,105.62 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LQDLYSIVR 95.00% 2.87 0.343 0 553.8196 1,105.62 1,106.62 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% IFSFDGKDVLR 95.00% 2.87 0.489 2.46 648.8488 1,295.68 1,296.70 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% IFSFDGKDVLR 95.00% 3.55 0.487 1.96 648.849 1,295.68 1,296.70 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% IFSFDGKDVLR 95.00% 3.39 0.499 1.62 648.849 1,295.68 1,296.70 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% IFSFDGKDVLR 95.00% 3.1 0.514 1.38 648.8492 1,295.68 1,296.70 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% IFSFDGKDVLR 95.00% 3.06 0.512 2.1 648.8494 1,295.68 1,296.70 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% IFSFDGKDVLR 95.00% 3.01 0.534 1.66 648.8496 1,295.68 1,296.70 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% IFSFDGKDVLR 95.00% 3.19 0.502 1.57 648.8497 1,295.68 1,296.70 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% IFSFDGKDVLR 95.00% 3.13 0.48 2.28 648.8506 1,295.69 1,296.70 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% IFSFDGKDVLR 95.00% 3.76 0.496 2.77 648.8506 1,295.69 1,296.70 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% IFSFDGKDVLR 95.00% 3.73 0.453 2.85 648.851 1,295.69 1,296.70 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% GADFQcFQQAR 95.00% 2.46 0.451 0 c6: Carbamidomethyl (+57.02) 663.9944 1,325.97 1,327.59 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% GADFQcFQQAR 95.00% 2.73 0.33 0 c6: Carbamidomethyl (+57.02) 664.2944 1,326.57 1,327.59 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% GADFQcFQQAR 95.00% 3.38 0.436 2.55 c6: Carbamidomethyl (+57.02) 664.2945 1,326.57 1,327.59 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% GADFQcFQQAR 95.00% 3.15 0.403 1.74 c6: Carbamidomethyl (+57.02) 664.2961 1,326.58 1,327.59 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% GADFQcFQQAR 95.00% 2.97 0.332 0 c6: Carbamidomethyl (+57.02) 664.3265 1,326.64 1,327.59 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% GADFQcFQQAR 95.00% 2.48 0.426 0 c6: Carbamidomethyl (+57.02) 664.3272 1,326.64 1,327.59 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LTESYcETWR 95.00% 2.58 0.4 1.13 c6: Carbamidomethyl (+57.02) 672.7959 1,343.58 1,344.59 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LTESYcETWR 95.00% 2.92 0.458 2.54 c6: Carbamidomethyl (+57.02) 672.7961 1,343.58 1,344.59 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LTESYcETWR 95.00% 2.92 0.488 2.89 c6: Carbamidomethyl (+57.02) 672.7961 1,343.58 1,344.59 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LTESYcETWR 95.00% 2.79 0.441 0 c6: Carbamidomethyl (+57.02) 672.7973 1,343.58 1,344.59 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LTESYcETWR 95.00% 2.8 0.458 0 c6: Carbamidomethyl (+57.02) 672.7976 1,343.58 1,344.59 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% LTESYcETWR 95.00% 2.38 0.294 0 c6: Carbamidomethyl (+57.02) 672.7978 1,343.58 1,344.59 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% ELLREETGAALKPR 95.00% 3.28 0.0602 2.29 791.9491 1,581.88 1,582.89 2
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 4.68 0.603 7.06 801.9059 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 4.61 0.563 7.7 801.9062 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 4.84 0.552 8.04 801.9063 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 5.41 0.582 8.26 801.9063 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 4.86 0.519 8.89 801.9067 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 4.69 0.598 7.6 801.9071 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 4.92 0.582 7.31 801.9073 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 5.22 0.573 7.25 801.9078 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 4.61 0.557 6.55 801.9078 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 4.82 0.557 7.19 801.9081 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 2.66 0.392 2.05 801.9093 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 5.21 0.584 7.64 801.9098 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 4.14 0.565 3.77 801.91 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% TEAPSATGQASSLLGGR 95.00% 4.96 0.599 7.96 802.407 1,602.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.42 0.463 3.64 873.4376 2,617.29 2,617.30 3
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.79 0.499 2.96 873.4382 2,617.29 2,617.30 3
 SAMPLE 1 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 8 9 68 6.04% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.81 0.475 1.74 873.4385 2,617.29 2,617.30 3
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% AAVPIVNLK 95.00% 1.89 0.378 0 462.7981 923.5806 924.5883 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% ADDILASPPR 95.00% 2.86 0.351 0 527.7782 1,053.54 1,054.55 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% ADDILASPPR 95.00% 2.9 0.37 0 527.7787 1,053.54 1,054.55 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% ADDILASPPR 95.00% 3.12 0.443 1.57 527.7787 1,053.54 1,054.55 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% ADDILASPPR 95.00% 2.9 0.393 0 527.7793 1,053.54 1,054.55 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% ADDILASPPR 95.00% 3.21 0.409 1.39 527.7794 1,053.54 1,054.55 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% ADDILASPPR 95.00% 2.37 0.34 0 527.7812 1,053.55 1,054.55 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% ELLREETGAALKPR 95.00% 3.98 0.237 0 528.3015 1,581.88 1,582.89 3
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% ELLREETGAALKPR 95.00% 4.56 0.275 1.8 528.3018 1,581.88 1,582.89 3
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% ELLREETGAALKPR 95.00% 5.16 0.406 2.24 528.6351 1,582.88 1,582.89 3
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% ELLREETGAALKPR 95.00% 4.88 0.424 2.57 528.6358 1,582.88 1,582.89 3
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 3.59 0.369 1.54 553.8123 1,105.61 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 2.92 0.22 1.22 553.8126 1,105.61 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 2.99 0.303 1.21 553.8126 1,105.61 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 3.37 0.36 2.06 553.8128 1,105.61 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 3.09 0.328 1.85 553.813 1,105.61 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 3.16 0.305 1.22 553.8133 1,105.61 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 3.31 0.279 1.7 553.8134 1,105.61 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 2.95 0.342 1.19 553.8138 1,105.61 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 3.18 0.319 1.66 553.8148 1,105.61 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 2.54 0.28 0 553.815 1,105.61 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 2.85 0.31 0 553.8159 1,105.62 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 2.87 0.343 1.21 553.8196 1,105.62 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LQDLYSIVR 95.00% 3.17 0.326 1.64 553.8241 1,105.63 1,106.62 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% IFSFDGKDVLR 95.00% 3.09 0.521 0 648.8489 1,295.68 1,296.70 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% IFSFDGKDVLR 95.00% 3.32 0.491 1.48 648.849 1,295.68 1,296.70 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% IFSFDGKDVLR 95.00% 3.51 0.455 2.62 648.8495 1,295.68 1,296.70 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% IFSFDGKDVLR 95.00% 3.29 0.435 0 648.8496 1,295.68 1,296.70 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% IFSFDGKDVLR 95.00% 2.82 0.462 1.24 648.8506 1,295.69 1,296.70 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% IFSFDGKDVLR 95.00% 3.03 0.463 1.14 648.851 1,295.69 1,296.70 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% IFSFDGKDVLR 95.00% 2.39 0.381 0 648.8514 1,295.69 1,296.70 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% IFSFDGKDVLR 95.00% 2.69 0.499 0 648.8626 1,295.71 1,296.70 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% IFSFDGKDVLR 95.00% 2.91 0.487 2.15 649.3505 1,296.69 1,296.70 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% GADFQcFQQAR 95.00% 3.11 0.345 0 c6: Carbamidomethyl (+57.02) 664.294 1,326.57 1,327.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% GADFQcFQQAR 95.00% 2.98 0.293 0 c6: Carbamidomethyl (+57.02) 664.2948 1,326.57 1,327.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% GADFQcFQQAR 95.00% 3.58 0.443 0 c6: Carbamidomethyl (+57.02) 664.295 1,326.57 1,327.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% GADFQcFQQAR 95.00% 3.17 0.397 0 c6: Carbamidomethyl (+57.02) 664.2955 1,326.58 1,327.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% GADFQcFQQAR 95.00% 3.42 0.46 0 c6: Carbamidomethyl (+57.02) 664.2956 1,326.58 1,327.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% GADFQcFQQAR 95.00% 3.35 0.325 0 c6: Carbamidomethyl (+57.02) 664.2964 1,326.58 1,327.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% GADFQcFQQAR 95.00% 2.71 0.242 0 c6: Carbamidomethyl (+57.02) 664.2967 1,326.58 1,327.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% GADFQcFQQAR 95.00% 2.69 0.345 0 c6: Carbamidomethyl (+57.02) 664.2973 1,326.58 1,327.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% GADFQcFQQAR 95.00% 3.35 0.523 2.51 c6: Carbamidomethyl (+57.02) 664.3042 1,326.59 1,327.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LTESYcETWR 95.00% 2.45 0.313 1.2 c6: Carbamidomethyl (+57.02) 672.7926 1,343.57 1,344.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LTESYcETWR 95.00% 2.54 0.397 1.96 c6: Carbamidomethyl (+57.02) 672.7933 1,343.57 1,344.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LTESYcETWR 95.00% 2.8 0.458 0 c6: Carbamidomethyl (+57.02) 672.7976 1,343.58 1,344.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LTESYcETWR 95.00% 2.38 0.294 0 c6: Carbamidomethyl (+57.02) 672.7978 1,343.58 1,344.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% LTESYcETWR 95.00% 2.43 0.234 0 c6: Carbamidomethyl (+57.02) 673.2931 1,344.57 1,344.59 2
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% TEAPSATGQASSLLGGR 95.00% 2.37 0.337 0 801.7054 1,601.40 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% TEAPSATGQASSLLGGR 95.00% 4.79 0.602 5.77 801.9058 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% TEAPSATGQASSLLGGR 95.00% 5.41 0.594 7.02 801.9062 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% TEAPSATGQASSLLGGR 95.00% 4.8 0.589 3.62 801.9063 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% TEAPSATGQASSLLGGR 95.00% 5.41 0.596 4.35 801.9064 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% TEAPSATGQASSLLGGR 95.00% 5.37 0.582 7.42 801.907 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% TEAPSATGQASSLLGGR 95.00% 4.47 0.524 4.14 801.907 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% TEAPSATGQASSLLGGR 95.00% 4.57 0.49 3.68 801.9071 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% TEAPSATGQASSLLGGR 95.00% 4.61 0.582 4.32 801.9077 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% TEAPSATGQASSLLGGR 95.00% 4.65 0.586 4.29 802.4074 1,602.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% TEAPSATGQASSLLGGR 95.00% 4.77 0.589 6.47 802.4088 1,602.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.11 0.542 3.51 873.436 2,617.28 2,617.30 3
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.48 0.489 1.92 873.4371 2,617.29 2,617.30 3
 SAMPLE 1R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 9 9 61 6.56% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.83 0.449 2.59 873.439 2,617.29 2,617.30 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ADDILASPPR 95.00% 2.56 0.397 0 527.7799 1,053.54 1,054.55 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 3.55 0.357 1.6 528.2905 1,581.85 1,582.89 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 4.27 0.41 2.22 528.3004 1,581.88 1,582.89 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 4.68 0.454 2.92 528.3013 1,581.88 1,582.89 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 4.68 0.444 2.09 528.3014 1,581.88 1,582.89 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 5.22 0.485 3.08 528.3015 1,581.88 1,582.89 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 5 0.452 3.14 528.3016 1,581.88 1,582.89 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 5.03 0.427 2.48 528.3016 1,581.88 1,582.89 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 5.16 0.477 2.47 528.3018 1,581.88 1,582.89 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 5.04 0.431 3 528.6352 1,582.88 1,582.89 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 4.65 0.406 2.92 528.636 1,582.88 1,582.89 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.01 0.303 1.18 553.8121 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.23 0.274 1.35 553.8124 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.38 0.344 0 553.8125 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.23 0.36 1.72 553.8126 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.45 0.348 1.66 553.8127 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.2 0.35 1.25 553.8128 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.1 0.346 0 553.8128 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.07 0.211 0 553.8128 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 2.81 0.294 1.28 553.813 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.27 0.316 0 553.8131 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.25 0.343 0 553.8131 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.08 0.356 0 553.8131 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.47 0.361 1.24 553.8132 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.29 0.325 1.47 553.8134 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.52 0.358 0 553.8134 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.57 0.34 1.21 553.8134 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 2.98 0.205 1.17 553.8134 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 3.34 0.335 0 553.8135 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 2.27 0.144 1.72 553.8135 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 2.84 0.244 0 553.8142 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LQDLYSIVR 95.00% 2.12 0.231 0 553.8145 1,105.61 1,106.62 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% DFSLLFHIR 95.00% 2.38 0.295 0 574.3152 1,146.61 1,147.63 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% IFSFDGKDVLR 95.00% 3.02 0.46 1.62 648.8482 1,295.68 1,296.70 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% IFSFDGKDVLR 95.00% 3.34 0.424 2.19 648.8499 1,295.68 1,296.70 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% IFSFDGKDVLR 95.00% 2.49 0.515 0 648.8501 1,295.68 1,296.70 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% IFSFDGKDVLR 95.00% 3.12 0.504 2.04 648.8507 1,295.69 1,296.70 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% IFSFDGKDVLR 95.00% 3 0.493 1.62 648.8507 1,295.69 1,296.70 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% IFSFDGKDVLR 95.00% 2.8 0.434 1.44 648.8508 1,295.69 1,296.70 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% IFSFDGKDVLR 95.00% 3.14 0.451 2.31 648.8509 1,295.69 1,296.70 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% IFSFDGKDVLR 95.00% 2.44 0.44 1.26 648.851 1,295.69 1,296.70 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% IFSFDGKDVLR 95.00% 3.56 0.478 2.07 648.8513 1,295.69 1,296.70 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% IFSFDGKDVLR 95.00% 3 0.493 1.7 648.8517 1,295.69 1,296.70 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% IFSFDGKDVLR 95.00% 3.55 0.465 2.3 649.3523 1,296.69 1,296.70 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 2.75 0.489 0 c6: Carbamidomethyl (+57.02) 663.9934 1,325.97 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 3.13 0.339 0 c6: Carbamidomethyl (+57.02) 664.2935 1,326.57 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 3.5 0.446 0 c6: Carbamidomethyl (+57.02) 664.294 1,326.57 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 3.46 0.395 0 c6: Carbamidomethyl (+57.02) 664.2941 1,326.57 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 3.47 0.45 1.46 c6: Carbamidomethyl (+57.02) 664.2943 1,326.57 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 2.92 0.275 0 c6: Carbamidomethyl (+57.02) 664.2945 1,326.57 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 3.38 0.482 1.28 c6: Carbamidomethyl (+57.02) 664.295 1,326.57 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 3.77 0.493 2.08 c6: Carbamidomethyl (+57.02) 664.295 1,326.57 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 3.32 0.46 1.16 c6: Carbamidomethyl (+57.02) 664.295 1,326.57 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 3.7 0.406 1.47 c6: Carbamidomethyl (+57.02) 664.2951 1,326.57 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 3.33 0.434 1.6 c6: Carbamidomethyl (+57.02) 664.2952 1,326.57 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 3.95 0.506 1.25 c6: Carbamidomethyl (+57.02) 664.2953 1,326.58 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 3.78 0.448 1.59 c6: Carbamidomethyl (+57.02) 664.2956 1,326.58 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GADFQcFQQAR 95.00% 3.5 0.41 1.36 c6: Carbamidomethyl (+57.02) 664.2957 1,326.58 1,327.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LTESYcETWR 95.00% 2.56 0.389 0 c6: Carbamidomethyl (+57.02) 672.7937 1,343.57 1,344.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LTESYcETWR 95.00% 2.98 0.454 1.77 c6: Carbamidomethyl (+57.02) 672.7961 1,343.58 1,344.59 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 3.69 0.231 2.96 791.9482 1,581.88 1,582.89 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 3.93 0.195 2.85 791.9484 1,581.88 1,582.89 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% ELLREETGAALKPR 95.00% 3.83 0.302 3.11 791.9492 1,581.88 1,582.89 2
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 4.89 0.531 7.55 801.9057 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 5.75 0.604 9.31 801.9062 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 5.39 0.604 8.13 801.9065 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 3.61 0.489 6.38 801.9065 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 5.12 0.592 8.33 801.9066 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 5.22 0.585 8.64 801.9071 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 5.39 0.609 8.4 801.9071 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 5.18 0.584 10.2 801.9074 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 4.74 0.552 9.13 801.9076 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 5.4 0.597 8.37 801.9077 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 4.96 0.59 8.62 801.9085 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 4.85 0.564 6.46 801.9099 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 3.63 0.612 7.38 801.9099 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 5.1 0.552 6.1 802.4079 1,602.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 5.26 0.559 7.28 802.4095 1,602.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% TEAPSATGQASSLLGGR 95.00% 4.8 0.542 6.01 802.412 1,602.81 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.34 0.5 2.6 873.4369 2,617.29 2,617.30 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.33 0.537 2.77 873.4374 2,617.29 2,617.30 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.99 0.51 3.21 873.4379 2,617.29 2,617.30 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.79 0.467 1.68 873.438 2,617.29 2,617.30 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.32 0.511 2.82 873.4387 2,617.29 2,617.30 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.2 0.511 3.11 873.4388 2,617.29 2,617.30 3
 SAMPLE 2 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 10 11 86 8.27% LSGVQDGHQDISLLYTEPGAGQTHTAASFR 95.00% 6.87 0.623 5.55 1,053.18 3,156.52 3,156.54 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% RLTESYcETWR 95.00% 2.15 0.239 0 c7: Carbamidomethyl (+57.02) 500.9023 1,499.68 1,500.69 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% ELLREETGAALKPR 95.00% 4.97 0.439 2.64 528.3009 1,581.88 1,582.89 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% ELLREETGAALKPR 95.00% 4.76 0.468 3.3 528.3017 1,581.88 1,582.89 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% ELLREETGAALKPR 95.00% 5.15 0.48 2.82 528.3018 1,581.88 1,582.89 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% ELLREETGAALKPR 95.00% 4.88 0.446 2.37 528.302 1,581.88 1,582.89 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% ELLREETGAALKPR 95.00% 4.63 0.482 3.33 528.302 1,581.88 1,582.89 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% ELLREETGAALKPR 95.00% 4.75 0.458 2.74 528.3022 1,581.88 1,582.89 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% ELLREETGAALKPR 95.00% 3.96 0.16 0 528.6369 1,582.89 1,582.89 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 3 0.251 1.89 553.8125 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 3.09 0.343 2.02 553.8127 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 2.93 0.255 1.39 553.8129 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 3.21 0.349 0 553.8129 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 3.3 0.287 1.72 553.813 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 2.88 0.119 1.14 553.8132 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 3.37 0.323 1.57 553.8133 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 3.32 0.284 1.33 553.8133 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 3.06 0.319 1.54 553.8133 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 3.44 0.341 1.89 553.8133 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 94.90% 2.47 0.196 0 553.8134 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 2.93 0.307 1.68 553.8134 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 3.38 0.342 0 553.8135 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 2.73 0.109 1.36 553.8135 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 2.75 0.273 1.15 553.8136 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 2.09 0.123 1.4 553.8136 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 3.52 0.359 1.66 553.8138 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LQDLYSIVR 95.00% 2.8 0.368 1.36 553.8138 1,105.61 1,106.62 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% DFSLLFHIR 95.00% 2.52 0.304 0 574.3149 1,146.61 1,147.63 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% DFSLLFHIR 95.00% 2.36 0.305 0 574.3155 1,146.62 1,147.63 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% IFSFDGKDVLR 95.00% 2.28 0.398 0 648.849 1,295.68 1,296.70 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% IFSFDGKDVLR 95.00% 2.73 0.419 0 648.8495 1,295.68 1,296.70 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% IFSFDGKDVLR 95.00% 2.45 0.411 0 648.8495 1,295.68 1,296.70 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% IFSFDGKDVLR 95.00% 3 0.509 1.96 648.8501 1,295.68 1,296.70 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% IFSFDGKDVLR 95.00% 3.18 0.46 2 648.8503 1,295.69 1,296.70 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% IFSFDGKDVLR 95.00% 3.04 0.496 2.33 648.8503 1,295.69 1,296.70 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% IFSFDGKDVLR 95.00% 2.56 0.48 0 648.8503 1,295.69 1,296.70 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% IFSFDGKDVLR 95.00% 3.59 0.438 2.09 648.8504 1,295.69 1,296.70 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% IFSFDGKDVLR 95.00% 3.34 0.45 2.13 648.8508 1,295.69 1,296.70 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% IFSFDGKDVLR 95.00% 2.39 0.477 1.4 648.8509 1,295.69 1,296.70 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% IFSFDGKDVLR 95.00% 2.64 0.441 1.48 648.8517 1,295.69 1,296.70 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GADFQcFQQAR 95.00% 3.55 0.42 1.14 c6: Carbamidomethyl (+57.02) 664.2939 1,326.57 1,327.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GADFQcFQQAR 95.00% 2.71 0.309 1.11 c6: Carbamidomethyl (+57.02) 664.2943 1,326.57 1,327.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GADFQcFQQAR 95.00% 2.71 0.365 0 c6: Carbamidomethyl (+57.02) 664.2944 1,326.57 1,327.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GADFQcFQQAR 95.00% 3.72 0.395 2.13 c6: Carbamidomethyl (+57.02) 664.2953 1,326.57 1,327.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GADFQcFQQAR 95.00% 3.73 0.471 1.46 c6: Carbamidomethyl (+57.02) 664.2953 1,326.58 1,327.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GADFQcFQQAR 95.00% 3.78 0.484 0 c6: Carbamidomethyl (+57.02) 664.2953 1,326.58 1,327.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GADFQcFQQAR 95.00% 3.71 0.465 1.31 c6: Carbamidomethyl (+57.02) 664.2957 1,326.58 1,327.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GADFQcFQQAR 95.00% 3.61 0.447 0 c6: Carbamidomethyl (+57.02) 664.2957 1,326.58 1,327.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GADFQcFQQAR 95.00% 3.97 0.48 1.34 c6: Carbamidomethyl (+57.02) 664.296 1,326.58 1,327.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GADFQcFQQAR 95.00% 2.81 0.304 1.17 c6: Carbamidomethyl (+57.02) 664.2961 1,326.58 1,327.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GADFQcFQQAR 95.00% 3.49 0.393 1.27 c6: Carbamidomethyl (+57.02) 664.7981 1,327.58 1,327.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LTESYcETWR 95.00% 2.7 0.343 1.37 c6: Carbamidomethyl (+57.02) 672.7939 1,343.57 1,344.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LTESYcETWR 95.00% 2.67 0.438 2.05 c6: Carbamidomethyl (+57.02) 672.7956 1,343.58 1,344.59 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% ELLREETGAALKPR 95.00% 3.77 0.184 3.02 792.4496 1,582.88 1,582.89 2
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 4.27 0.608 7.29 801.9055 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 4.91 0.595 7.66 801.906 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 4.53 0.574 6.44 801.9064 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 4.88 0.612 6.7 801.9064 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 5.29 0.588 7.41 801.9065 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 4.92 0.531 6.89 801.907 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 4.71 0.569 6.1 801.9071 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 5.69 0.613 6.55 801.9074 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 4.8 0.584 6.29 801.9087 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 5.11 0.577 7.19 801.9088 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 5.11 0.571 8.77 801.909 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 3.77 0.478 2.52 801.9091 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 3.63 0.457 1.52 801.9102 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% TEAPSATGQASSLLGGR 95.00% 5.26 0.537 7.19 802.4091 1,602.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.74 0.512 3.36 873.4365 2,617.29 2,617.30 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.54 0.487 2.32 873.4373 2,617.29 2,617.30 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.27 0.527 2.59 873.4381 2,617.29 2,617.30 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.52 0.503 2.1 873.4387 2,617.29 2,617.30 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.04 0.461 3.54 873.4388 2,617.29 2,617.30 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.05 0.41 2.46 873.4398 2,617.30 2,617.30 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% GLELEPGAGLFVAQAGGADPDKFQGVIAELK 95.00% 2.61 0.526 4.74 1,033.54 3,097.61 3,097.62 3
 SAMPLE 2R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 11 12 75 9.52% LSGVQDGHQDISLLYTEPGAGQTHTAASFR 95.00% 7 0.615 4.46 1,053.18 3,156.53 3,156.54 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% DVLRHPTWPQK 95.00% 2.94 0.309 0 459.586 1,375.73 1,376.74 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% AAVPIVNLK 95.00% 1.93 0.419 0 462.795 923.5744 924.5883 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% AAVPIVNLK 95.00% 1.83 0.323 0 462.7987 923.5818 924.5883 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ADDILASPPR 95.00% 3.13 0.445 0 527.7791 1,053.54 1,054.55 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ADDILASPPR 95.00% 2.97 0.449 0 527.7792 1,053.54 1,054.55 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ADDILASPPR 95.00% 3.15 0.43 0 527.7793 1,053.54 1,054.55 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ADDILASPPR 95.00% 3.23 0.422 0 527.7793 1,053.54 1,054.55 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ADDILASPPR 95.00% 3.29 0.492 0 527.7793 1,053.54 1,054.55 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ADDILASPPR 95.00% 3.04 0.41 1.16 527.7795 1,053.54 1,054.55 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ELLREETGAALKPR 95.00% 4.91 0.427 2.41 528.3003 1,581.88 1,582.89 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ELLREETGAALKPR 95.00% 4.81 0.523 4.07 528.3004 1,581.88 1,582.89 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ELLREETGAALKPR 95.00% 5.35 0.497 4.47 528.301 1,581.88 1,582.89 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ELLREETGAALKPR 95.00% 5.14 0.477 3.59 528.3013 1,581.88 1,582.89 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ELLREETGAALKPR 95.00% 4.93 0.453 4 528.3015 1,581.88 1,582.89 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ELLREETGAALKPR 95.00% 4.89 0.487 2.7 528.3016 1,581.88 1,582.89 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ELLREETGAALKPR 95.00% 5.48 0.494 3.43 528.3017 1,581.88 1,582.89 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ELLREETGAALKPR 95.00% 4.67 0.473 2.82 528.3017 1,581.88 1,582.89 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ELLREETGAALKPR 95.00% 5.17 0.384 3.49 528.6356 1,582.88 1,582.89 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 2.56 0.245 0 534.9408 1,601.80 1,602.81 3 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 4.36 0.397 2.05 535.2747 1,602.80 1,602.81 3 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 3.38 0.326 1.55 553.8125 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 3.46 0.354 1.44 553.8128 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 3.3 0.333 1.49 553.813 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 3.28 0.315 1.42 553.813 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 2.77 0.0882 1.7 553.813 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 3.01 0.298 1.11 553.8132 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 3.49 0.341 1.38 553.8133 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 3.04 0.322 1.43 553.8133 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 2.95 0.125 0 553.8133 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 3.4 0.339 1.34 553.8134 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 2.59 0.369 1.19 553.8134 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 3.27 0.331 1.17 553.814 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LQDLYSIVR 95.00% 2.44 0.298 0 553.8143 1,105.61 1,106.62 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% DFSLLFHIR 95.00% 2.35 0.198 0 574.3167 1,146.62 1,147.63 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% DFSLLFHIR 95.00% 2.29 0.281 0 574.318 1,146.62 1,147.63 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 2.92 0.448 2.54 648.8494 1,295.68 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 2.92 0.43 1.89 648.8498 1,295.68 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 3.79 0.435 2.52 648.85 1,295.68 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 2.39 0.332 0 648.8502 1,295.68 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 3.17 0.458 1.7 648.8504 1,295.69 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 3.17 0.436 2.6 648.8505 1,295.69 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 3.49 0.456 1.41 648.8507 1,295.69 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 3.32 0.48 2.51 648.8507 1,295.69 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 2.33 0.276 0 648.8507 1,295.69 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 2.66 0.452 2.03 648.8507 1,295.69 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 2.86 0.465 1.42 648.8507 1,295.69 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 3.13 0.443 2.39 648.851 1,295.69 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 3.43 0.383 1.8 648.8512 1,295.69 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 3.61 0.476 1.96 648.8512 1,295.69 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% IFSFDGKDVLR 95.00% 2.77 0.332 0 648.8514 1,295.69 1,296.70 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 3.02 0.399 1.14 c6: Carbamidomethyl (+57.02) 664.294 1,326.57 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 3.95 0.516 1.14 c6: Carbamidomethyl (+57.02) 664.2946 1,326.57 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 3.92 0.484 1.55 c6: Carbamidomethyl (+57.02) 664.2951 1,326.57 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 3.92 0.491 1.12 c6: Carbamidomethyl (+57.02) 664.2951 1,326.57 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 3.85 0.482 0 c6: Carbamidomethyl (+57.02) 664.2952 1,326.57 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 3.8 0.482 0 c6: Carbamidomethyl (+57.02) 664.2952 1,326.57 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 3.03 0.387 1.24 c6: Carbamidomethyl (+57.02) 664.2953 1,326.57 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 3.54 0.356 1.39 c6: Carbamidomethyl (+57.02) 664.2955 1,326.58 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 3.73 0.47 1.82 c6: Carbamidomethyl (+57.02) 664.2961 1,326.58 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 2.61 0.23 0 c6: Carbamidomethyl (+57.02) 664.2963 1,326.58 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 3.54 0.433 0 c6: Carbamidomethyl (+57.02) 664.2964 1,326.58 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 2.58 0.319 0 c6: Carbamidomethyl (+57.02) 664.2968 1,326.58 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 3.51 0.445 1.51 c6: Carbamidomethyl (+57.02) 664.2971 1,326.58 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GADFQcFQQAR 95.00% 3.11 0.3 0 c6: Carbamidomethyl (+57.02) 664.7967 1,327.58 1,327.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LTESYcETWR 95.00% 2.81 0.449 0 c6: Carbamidomethyl (+57.02) 672.7945 1,343.57 1,344.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LTESYcETWR 95.00% 2.19 0.322 0 c6: Carbamidomethyl (+57.02) 672.7948 1,343.57 1,344.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LTESYcETWR 95.00% 3.11 0.45 2.96 c6: Carbamidomethyl (+57.02) 672.7954 1,343.58 1,344.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LTESYcETWR 95.00% 2.61 0.453 1.26 c6: Carbamidomethyl (+57.02) 672.7962 1,343.58 1,344.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LTESYcETWR 95.00% 2.49 0.393 0 c6: Carbamidomethyl (+57.02) 672.7982 1,343.58 1,344.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% LTESYcETWR 95.00% 2.77 0.45 1.89 c6: Carbamidomethyl (+57.02) 673.2978 1,344.58 1,344.59 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% RLTESYcETWR 95.00% 3.47 0.209 2.2 c7: Carbamidomethyl (+57.02) 750.8469 1,499.68 1,500.69 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% RLTESYcETWR 95.00% 3.7 0.228 2.54 c7: Carbamidomethyl (+57.02) 750.8477 1,499.68 1,500.69 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% RLTESYcETWR 95.00% 3.54 0.216 2.68 c7: Carbamidomethyl (+57.02) 750.8479 1,499.68 1,500.69 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% RLTESYcETWR 95.00% 3.83 0.178 2.92 c7: Carbamidomethyl (+57.02) 750.8481 1,499.68 1,500.69 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% RLTESYcETWR 95.00% 3.4 0.0487 2.4 c7: Carbamidomethyl (+57.02) 750.8481 1,499.68 1,500.69 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% RLTESYcETWR 95.00% 2.95 0.359 0 c7: Carbamidomethyl (+57.02) 750.849 1,499.68 1,500.69 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% RLTESYcETWR 95.00% 3.67 0.239 2.7 c7: Carbamidomethyl (+57.02) 751.3492 1,500.68 1,500.69 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ELLREETGAALKPR 95.00% 3.85 0.188 2.52 791.9485 1,581.88 1,582.89 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% ELLREETGAALKPR 95.00% 3.84 0.192 2.47 792.4508 1,582.89 1,582.89 2
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.82 0.628 8.64 801.9062 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.04 0.579 8.44 801.9063 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.81 0.633 8.85 801.9064 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.3 0.576 8.52 801.9065 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.71 0.597 8.46 801.9067 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.03 0.612 4.74 801.9069 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 4.47 0.531 9.09 801.907 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.32 0.586 7.44 801.9071 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.61 0.613 8.6 801.9072 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.87 0.62 5.92 801.9073 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.16 0.553 8.62 801.9074 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.14 0.6 5.7 801.9076 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.22 0.584 5.04 801.9082 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 5.31 0.56 9.89 801.9082 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 4.92 0.557 6 801.9088 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% TEAPSATGQASSLLGGR 95.00% 4.82 0.501 4.17 802.4114 1,602.81 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.44 0.535 2.96 873.4363 2,617.29 2,617.30 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.72 0.462 2.92 873.4368 2,617.29 2,617.30 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.23 0.503 3.64 873.4372 2,617.29 2,617.30 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.72 0.487 0 873.4372 2,617.29 2,617.30 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.52 0.569 3.77 873.438 2,617.29 2,617.30 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.21 0.415 2.03 873.4385 2,617.29 2,617.30 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.47 0.478 3.24 873.4387 2,617.29 2,617.30 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.88 0.506 3.92 873.4398 2,617.30 2,617.30 3
 SAMPLE 3 Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 12 14 104 7.53% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.84 0.455 2.4 873.4401 2,617.30 2,617.30 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% RLTESYcETWR 95.00% 3.05 0.25 0 c7: Carbamidomethyl (+57.02) 501.2364 1,500.69 1,500.69 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ADDILASPPR 95.00% 2.94 0.414 0 527.7786 1,053.54 1,054.55 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ADDILASPPR 95.00% 2.83 0.361 0 527.7792 1,053.54 1,054.55 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ADDILASPPR 95.00% 2.85 0.409 0 527.7792 1,053.54 1,054.55 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ADDILASPPR 95.00% 3.21 0.454 0 527.7792 1,053.54 1,054.55 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ADDILASPPR 95.00% 3.24 0.431 0 527.7793 1,053.54 1,054.55 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ADDILASPPR 95.00% 2.88 0.308 0 527.7795 1,053.54 1,054.55 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ADDILASPPR 95.00% 3.1 0.238 0 527.7796 1,053.54 1,054.55 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ADDILASPPR 95.00% 3.14 0.47 0 527.7798 1,053.54 1,054.55 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ADDILASPPR 95.00% 3.39 0.428 0 527.7799 1,053.54 1,054.55 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ADDILASPPR 95.00% 2.99 0.338 0 527.7802 1,053.54 1,054.55 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ADDILASPPR 95.00% 2.93 0.383 0 527.7807 1,053.55 1,054.55 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 4.64 0.428 2.89 528.301 1,581.88 1,582.89 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 5.02 0.454 3.07 528.3013 1,581.88 1,582.89 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 4.31 0.476 1.32 528.3013 1,581.88 1,582.89 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 4.61 0.503 2.26 528.3013 1,581.88 1,582.89 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 4.12 0.298 0 528.3016 1,581.88 1,582.89 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 5.15 0.489 3.02 528.3016 1,581.88 1,582.89 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 4.28 0.321 1.09 528.3019 1,581.88 1,582.89 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 4.86 0.46 2.4 528.3019 1,581.88 1,582.89 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 2.71 0.269 0 528.6075 1,582.80 1,582.89 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 2.4 0.218 0 528.6082 1,582.80 1,582.89 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 4.3 0.437 2.6 528.6362 1,582.89 1,582.89 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 2.62 0.101 1.12 534.9395 1,601.80 1,602.81 3 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 2.41 0.228 0 534.9404 1,601.80 1,602.81 3 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 3.37 0.26 1.41 553.8125 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 3.19 0.278 0 553.8128 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 2.6 0.299 1.32 553.8129 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 3.23 0.304 2.46 553.8129 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 3.37 0.348 1.35 553.813 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 2.93 0.193 1.35 553.813 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 3.45 0.334 0 553.8131 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 2.96 0.364 1.28 553.8131 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 3.03 0.318 2.15 553.8133 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 3.37 0.291 1.27 553.8133 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 2.88 0.337 1.22 553.8134 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 3.4 0.333 1.35 553.8134 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 3.38 0.379 1.29 553.8135 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 3.3 0.371 0 553.8135 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 3.04 0.341 1.96 553.8136 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LQDLYSIVR 95.00% 2.44 0.255 1.24 553.8138 1,105.61 1,106.62 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% DFSLLFHIR 95.00% 2.1 0.26 0 574.3153 1,146.61 1,147.63 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% SVWHGSDPNGR 95.00% 2.1 0.38 0 606.2818 1,210.55 1,211.56 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% IFSFDGKDVLR 95.00% 2.75 0.403 0 648.8487 1,295.68 1,296.70 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% IFSFDGKDVLR 95.00% 3.15 0.47 2.59 648.8498 1,295.68 1,296.70 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% IFSFDGKDVLR 95.00% 3.07 0.435 2 648.85 1,295.68 1,296.70 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% IFSFDGKDVLR 95.00% 2.61 0.479 2.05 648.8501 1,295.68 1,296.70 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% IFSFDGKDVLR 95.00% 3.04 0.379 1.38 648.8504 1,295.69 1,296.70 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% IFSFDGKDVLR 95.00% 3.14 0.424 1.47 648.8506 1,295.69 1,296.70 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% IFSFDGKDVLR 95.00% 3.26 0.497 2.3 648.851 1,295.69 1,296.70 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% IFSFDGKDVLR 95.00% 2.67 0.4 1.31 648.851 1,295.69 1,296.70 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% IFSFDGKDVLR 95.00% 3.03 0.473 1.82 648.8513 1,295.69 1,296.70 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% IFSFDGKDVLR 95.00% 2.74 0.407 1.77 648.8513 1,295.69 1,296.70 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% IFSFDGKDVLR 95.00% 2.66 0.449 1.38 648.8515 1,295.69 1,296.70 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GADFQcFQQAR 95.00% 4.06 0.478 0 c6: Carbamidomethyl (+57.02) 664.2942 1,326.57 1,327.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GADFQcFQQAR 95.00% 3.27 0.365 0 c6: Carbamidomethyl (+57.02) 664.295 1,326.57 1,327.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GADFQcFQQAR 95.00% 3.62 0.416 2.08 c6: Carbamidomethyl (+57.02) 664.2954 1,326.58 1,327.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GADFQcFQQAR 95.00% 3.85 0.433 1.37 c6: Carbamidomethyl (+57.02) 664.2954 1,326.58 1,327.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GADFQcFQQAR 95.00% 3.03 0.483 0 c6: Carbamidomethyl (+57.02) 664.2955 1,326.58 1,327.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GADFQcFQQAR 95.00% 3.68 0.472 0 c6: Carbamidomethyl (+57.02) 664.2956 1,326.58 1,327.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GADFQcFQQAR 95.00% 3.56 0.458 1.51 c6: Carbamidomethyl (+57.02) 664.2957 1,326.58 1,327.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GADFQcFQQAR 95.00% 3.7 0.416 1.14 c6: Carbamidomethyl (+57.02) 664.2964 1,326.58 1,327.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GADFQcFQQAR 95.00% 2.93 0.166 0 c6: Carbamidomethyl (+57.02) 664.3582 1,326.70 1,327.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GADFQcFQQAR 95.00% 2.7 0.149 0 c6: Carbamidomethyl (+57.02) 664.36 1,326.70 1,327.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LTESYcETWR 95.00% 2.01 0.293 0 c6: Carbamidomethyl (+57.02) 672.7935 1,343.57 1,344.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LTESYcETWR 95.00% 2.94 0.475 1.25 c6: Carbamidomethyl (+57.02) 672.7959 1,343.58 1,344.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LTESYcETWR 95.00% 2.79 0.44 1.8 c6: Carbamidomethyl (+57.02) 672.7964 1,343.58 1,344.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LTESYcETWR 95.00% 2.31 0.302 0 c6: Carbamidomethyl (+57.02) 672.7967 1,343.58 1,344.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LTESYcETWR 95.00% 3.12 0.472 3 c6: Carbamidomethyl (+57.02) 672.7968 1,343.58 1,344.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LTESYcETWR 95.00% 2.24 0.378 0 c6: Carbamidomethyl (+57.02) 672.7981 1,343.58 1,344.59 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% DFQPVLHLVALNSPLSGGMR 95.00% 4 0.517 1.92 718.0499 2,151.13 2,151.14 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% DFQPVLHLVALNSPLSGGMR 95.00% 4.37 0.613 2.42 718.0513 2,151.13 2,151.14 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% DFQPVLHLVALNSPLSGGMR 95.00% 3.24 0.363 0 718.0521 2,151.13 2,151.14 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% DFQPVLHLVALNSPLSGGMR 95.00% 2.68 0.343 0 718.0526 2,151.13 2,151.14 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% RLTESYcETWR 95.00% 3.56 0.182 2.89 c7: Carbamidomethyl (+57.02) 750.8475 1,499.68 1,500.69 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% RLTESYcETWR 95.00% 3.6 0.168 1.92 c7: Carbamidomethyl (+57.02) 750.8482 1,499.68 1,500.69 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% RLTESYcETWR 95.00% 3.42 0.282 2.18 c7: Carbamidomethyl (+57.02) 750.8503 1,499.69 1,500.69 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% RLTESYcETWR 95.00% 3.65 0.212 4.32 c7: Carbamidomethyl (+57.02) 751.3485 1,500.68 1,500.69 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% RLTESYcETWR 95.00% 3.67 0.193 3.59 c7: Carbamidomethyl (+57.02) 751.3517 1,500.69 1,500.69 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 3.85 0.168 1.92 792.4502 1,582.88 1,582.89 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% ELLREETGAALKPR 95.00% 3.62 0.21 2.07 792.4528 1,582.89 1,582.89 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 5.36 0.598 8 801.9052 1,601.79 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 4.96 0.544 8.31 801.9065 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 5.54 0.55 7.6 801.9067 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 5.3 0.557 6.89 801.9067 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 4.59 0.59 8.3 801.907 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 5.08 0.565 6.02 801.9072 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 5.51 0.601 7.7 801.9073 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 5 0.578 7.2 801.9074 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 4.85 0.591 8.27 801.9074 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 4.49 0.49 3.89 801.9076 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 4.23 0.532 5.16 801.9081 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 4.66 0.561 6.59 801.9082 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 4.95 0.602 9.05 801.9086 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 4.44 0.545 4.92 801.909 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 5.21 0.587 7.89 801.9093 1,601.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 5.28 0.605 7.37 802.4093 1,602.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 4.71 0.526 6.24 802.4102 1,602.80 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% TEAPSATGQASSLLGGR 95.00% 5.43 0.553 5.8 802.4111 1,602.81 1,602.81 2 CPXM2_HUMAN,MIME_HUMAN,FBLI1_HUMAN
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.06 0.38 1.48 873.4356 2,617.28 2,617.30 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.41 0.522 3.57 873.4356 2,617.28 2,617.30 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.01 0.419 2.13 873.4374 2,617.29 2,617.30 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.05 0.562 3.89 873.4376 2,617.29 2,617.30 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.13 0.52 4.2 873.4384 2,617.29 2,617.30 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.54 0.465 1.96 873.4384 2,617.29 2,617.30 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.73 0.517 3.39 873.4385 2,617.29 2,617.30 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.13 0.528 2.06 873.4391 2,617.29 2,617.30 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.5 0.405 2.6 873.4393 2,617.29 2,617.30 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.16 0.492 2.96 873.4395 2,617.29 2,617.30 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 5.06 0.501 2.96 873.4396 2,617.30 2,617.30 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LSGVQDGHQDISLLYTEPGAGQTHTAASFR 95.00% 2.84 0.356 0 1,053.04 3,156.11 3,156.54 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% LSGVQDGHQDISLLYTEPGAGQTHTAASFR 95.00% 3.58 0.462 0 1,053.05 3,156.12 3,156.54 3
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% DFQPVLHLVALNSPLSGGMR 95.00% 6.02 0.666 7.26 1,076.07 2,150.13 2,151.14 2
 SAMPLE 3R Collagen alpha-1(XVIII) chain  COL18A1  COIA1_HUMAN 178,169.70 100.00% 13 18 114 10.10% GTDNEVAALQPPVVQLHDSNPYPR 95.00% 4.87 0.546 7.51 1,309.66 2,617.30 2,617.30 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 3.08 0.34 2.66 516.6035 1,546.79 1,547.79 3
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 3.07 0.414 2.82 516.9371 1,547.79 1,547.79 3
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% EGLRGPRGDQGPVGR 95.00% 2.93 0.257 1.3 517.2672 1,548.78 1,550.82 3
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% EGLRGPRGDQGPVGR 95.00% 2.93 0.222 0 517.6022 1,549.78 1,550.82 3
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.31 0.297 0 521.603 1,561.79 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.35 0.364 2.3 521.9374 1,562.79 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.09 0.296 1.55 521.9375 1,562.79 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEAGAAGPAGPAGPR 95.00% 2.9 0.441 1.66 618.3128 1,234.61 1,235.61 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEAGAAGPAGPAGPR 95.00% 2.82 0.461 3.08 618.3139 1,234.61 1,235.61 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEAGAAGPAGPAGPR 95.00% 2.63 0.443 1.82 618.3141 1,234.61 1,235.61 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEAGAAGPAGPAGPR 95.00% 2.1 0.325 0 618.3329 1,234.65 1,235.61 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEAGAAGPAGPAGPR 95.00% 2.08 0.282 0 618.3374 1,234.66 1,235.61 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEAGAAGPAGPAGPR 95.00% 2.51 0.328 0 618.3427 1,234.67 1,235.61 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEAGAAGPAGPAGPR 95.00% 2.59 0.393 3.15 618.8041 1,235.59 1,235.61 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEAGAAGPAGPAGPR 95.00% 3.05 0.355 1.18 618.8142 1,235.61 1,235.61 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 6.7 0.645 7.72 676.3447 2,026.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 6.12 0.644 6.19 676.3447 2,026.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 6.38 0.651 8.92 676.3451 2,026.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.71 0.62 5.96 676.346 2,026.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.83 0.591 8.92 676.6762 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 3.38 0.388 2.11 676.6779 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.9 0.539 4.85 676.6788 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.89 0.577 6.32 676.6792 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 6.18 0.617 9.14 676.6793 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.82 0.613 8.52 676.6795 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 6.06 0.603 9.54 676.6798 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.76 0.54 6.31 676.6799 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.65 0.578 4.96 676.6799 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.75 0.59 4.89 676.6808 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.39 0.386 6.48 676.681 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.58 0.598 6.41 676.6812 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.87 0.529 8.37 676.6814 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.83 0.568 5 676.6815 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 3.5 0.569 3.96 774.4013 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.29 0.573 5.59 774.4015 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.75 0.485 6.55 774.4015 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.77 0.523 5.17 774.4018 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.79 0.547 5.8 774.4018 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.76 0.525 4.96 774.4019 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.66 0.579 8.54 774.4023 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 3.97 0.569 6.66 774.4023 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.46 0.575 5.72 774.4024 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.71 0.491 8.92 774.4024 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.01 0.608 4.77 774.4025 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.6 0.497 5.21 774.4028 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.01 0.424 5.96 774.4036 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.5 0.546 5.82 774.4048 1,546.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.8 0.561 6.05 774.9041 1,547.79 1,547.79 2
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.45 0.279 0 781.4063 1,560.80 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.39 0.506 5.77 781.9012 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.71 0.494 4.89 781.9016 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.72 0.495 5.17 781.9016 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.9 0.457 4.96 781.9018 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.29 0.489 5.8 781.9018 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.11 0.418 7.17 781.902 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.33 0.459 5 781.9022 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.15 0.45 6.44 781.9024 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.15 0.469 4.96 781.9027 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.01 0.361 0 781.9027 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.93 0.461 5.68 781.9027 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.11 0.486 4.54 781.9029 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.22 0.42 6.03 781.9029 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.19 0.435 6.28 781.903 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.28 0.475 5.24 781.9032 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.84 0.496 7 781.9032 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.31 0.435 6.29 781.9035 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.54 0.491 3.28 781.9038 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.22 0.483 4.92 781.9043 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.17 0.502 7.03 781.9044 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.37 0.296 0 781.9057 1,561.80 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.85 0.313 1.3 781.9068 1,561.80 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.21 0.332 0 781.9123 1,561.81 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.74 0.357 1.8 781.9174 1,561.82 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.13 0.427 4.89 782.4027 1,562.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.83 0.471 2.11 782.4028 1,562.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.39 0.487 6.4 782.4031 1,562.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.84 0.5 2.1 782.4054 1,562.80 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.55 0.588 4.41 1,014.01 2,026.01 2,027.02 2 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 27 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.19 0.555 2.19 1,014.51 2,027.01 2,027.02 2 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.11 0.487 4.62 516.6028 1,546.78 1,547.79 3
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.23 0.49 5.19 516.6036 1,546.79 1,547.79 3
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 2.83 0.395 2.31 516.605 1,546.79 1,547.79 3
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% EGLRGPRGDQGPVGR 95.00% 3 0.286 0 517.2678 1,548.78 1,550.82 3
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.27 0.198 0 521.6026 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.83 0.269 2.12 521.6027 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.34 0.384 3.47 521.6033 1,561.79 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.26 0.209 1 521.6035 1,561.79 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.55 0.427 2.96 521.9385 1,562.79 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEAGAAGPAGPAGPR 95.00% 2.01 0.29 1.64 618.3355 1,234.66 1,235.61 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEAGAAGPAGPAGPR 95.00% 2.27 0.324 1.74 618.3355 1,234.66 1,235.61 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEAGAAGPAGPAGPR 95.00% 2.09 0.376 1.85 618.3368 1,234.66 1,235.61 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEAGAAGPAGPAGPR 95.00% 2.24 0.352 2.96 618.3384 1,234.66 1,235.61 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEAGAAGPAGPAGPR 95.00% 2.72 0.383 2.11 618.3386 1,234.66 1,235.61 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEAGAAGPAGPAGPR 95.00% 1.94 0.27 1.96 618.3396 1,234.66 1,235.61 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEAGAAGPAGPAGPR 95.00% 2.27 0.296 1.54 618.3407 1,234.67 1,235.61 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 1.81 0.298 3.42 676.3229 2,025.95 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.31 0.527 4.82 676.3429 2,026.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.45 0.541 5.26 676.3466 2,026.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.7 0.571 6.92 676.3475 2,026.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 2.15 0.207 1.49 676.3497 2,026.03 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 2.61 0.246 1.68 676.373 2,026.10 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.63 0.587 9.13 676.6777 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.1 0.597 6.15 676.6794 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.26 0.587 6.4 676.6796 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 3.84 0.431 6.16 676.6806 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.15 0.553 6.96 676.6808 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.31 0.57 5 676.6819 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 6.21 0.624 6.35 676.6822 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.63 0.536 5.6 676.6835 2,027.03 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 0 0 7.85 677.0101 2,028.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 0 0 7.96 677.0104 2,028.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 0 0 4.19 677.0179 2,028.03 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 3.76 0.554 7.62 774.4015 1,546.79 1,547.79 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.62 0.513 6.72 774.4017 1,546.79 1,547.79 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.33 0.532 5.7 774.4019 1,546.79 1,547.79 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.68 0.532 6.13 774.4019 1,546.79 1,547.79 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.73 0.564 6.8 774.4021 1,546.79 1,547.79 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.67 0.567 7.55 774.4021 1,546.79 1,547.79 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.97 0.54 6.28 774.4021 1,546.79 1,547.79 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.52 0.555 8.18 774.4023 1,546.79 1,547.79 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.48 0.627 7.85 774.4024 1,546.79 1,547.79 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.29 0.606 6.89 774.4026 1,546.79 1,547.79 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.01 0.512 6.22 774.4031 1,546.79 1,547.79 2
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.12 0.458 6.27 781.9005 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.66 0.433 0 781.9008 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.23 0.48 2.96 781.9008 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.24 0.277 0 781.9012 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.86 0.488 4.34 781.9015 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.05 0.412 5.35 781.9017 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.99 0.408 6 781.9023 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.01 0.457 6.62 781.9025 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.04 0.444 5.7 781.9025 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.34 0.469 6.48 781.9026 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.64 0.492 4.72 781.9026 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.85 0.462 5.18 781.9026 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.19 0.43 6.85 781.9026 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.5 0.527 5.57 781.9026 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.76 0.459 6.05 781.9027 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.02 0.442 5.19 781.903 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.77 0.471 2.33 781.9034 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.49 0.521 6.14 781.9035 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.96 0.45 6.4 781.9037 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.68 0.499 2.8 781.9038 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.26 0.519 6.47 781.904 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.22 0.349 0 781.9046 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.69 0.476 4.96 781.9048 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.76 0.421 5.85 781.9054 1,561.80 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.99 0.482 4.92 781.906 1,561.80 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.26 0.511 6.2 781.9167 1,561.82 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.36 0.505 5.77 782.4041 1,562.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.07 0.389 1.68 782.4045 1,562.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.27 0.276 2.85 782.4068 1,562.80 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 22 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.35 0.465 1.85 782.417 1,562.82 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 2.73 0.314 2.35 521.6006 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 2.01 0.284 0 521.601 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 2.49 0.256 3.22 521.6011 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 2.95 0.329 1.23 521.6012 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.13 0.363 1.52 521.6015 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 2.54 0.294 2.13 521.9351 1,562.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GEAGAAGPAGPAGPR 95.00% 2.91 0.546 1.25 618.3111 1,234.61 1,235.61 2
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GEAGAAGPAGPAGPR 95.00% 2.5 0.441 0 618.3146 1,234.61 1,235.61 2
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.62 0.608 6.21 676.6765 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 6.56 0.653 5.89 676.6765 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 6.4 0.617 4.77 676.6769 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.94 0.589 5.43 676.6769 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 2.22 0.453 2.06 676.6777 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.37 0.636 5.28 774.3983 1,546.78 1,547.79 2
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.45 0.546 6.37 774.3985 1,546.78 1,547.79 2
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.65 0.554 6.44 774.399 1,546.78 1,547.79 2
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GEIGAVGNAGPAGPAGPR 95.00% 5.01 0.543 7.13 774.3991 1,546.78 1,547.79 2
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.75 0.55 6.28 774.3992 1,546.78 1,547.79 2
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.67 0.531 6.51 774.4002 1,546.78 1,547.79 2
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.81 0.551 5.42 774.9008 1,547.79 1,547.79 2
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.72 0.52 4.74 774.9021 1,547.79 1,547.79 2
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.61 0.466 6.64 781.8977 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 2.33 0.373 2.19 781.8978 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.5 0.515 5.52 781.898 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.34 0.481 5.33 781.8981 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.13 0.473 3.85 781.8985 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.67 0.479 4.21 781.8987 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.57 0.505 5.96 781.899 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.94 0.488 5.48 781.8993 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.52 0.466 5.07 781.8993 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.78 0.472 5.51 781.8994 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.88 0.473 6.32 781.9002 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.29 0.539 4.02 781.9005 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.24 0.454 4.82 781.9005 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.31 0.471 5.19 781.9005 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.17 0.441 6.92 781.9014 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 2.43 0.258 1.48 781.9041 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.37 0.489 3.64 781.9062 1,561.80 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 1R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 10 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.06 0.419 5.48 782.3991 1,562.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 2.7 0.273 1.22 521.6016 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.47 0.44 2.55 521.6019 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GEAGAAGPAGPAGPR 95.00% 2.34 0.412 1.72 618.3119 1,234.61 1,235.61 2
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.87 0.627 9.09 676.3417 2,026.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.76 0.596 7.38 676.3427 2,026.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 3.83 0.485 2.89 676.6745 2,027.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.48 0.544 5.35 676.6763 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.63 0.589 7.59 676.6766 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.36 0.586 5.38 676.6766 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.57 0.546 8.43 676.6768 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 6.59 0.669 9.89 676.6772 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.24 0.567 5.89 676.6779 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.73 0.56 4.89 676.678 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.82 0.557 4.68 676.6781 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.66 0.481 6.3 676.681 2,027.02 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% HGNRGETGPSGPVGPAGAVGPR 95.00% 0 0 5 677.0098 2,028.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.79 0.549 4.92 774.3986 1,546.78 1,547.79 2
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.52 0.542 6.4 774.3995 1,546.78 1,547.79 2
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.69 0.46 6.46 774.3999 1,546.78 1,547.79 2
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.73 0.523 5.92 774.3999 1,546.78 1,547.79 2
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.56 0.586 3.96 774.4001 1,546.78 1,547.79 2
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.57 0.564 4.82 774.4002 1,546.78 1,547.79 2
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.71 0.512 5.92 774.4005 1,546.79 1,547.79 2
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.67 0.542 4.21 774.4006 1,546.79 1,547.79 2
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.76 0.558 5.1 774.4007 1,546.79 1,547.79 2
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GEIGAVGNAGPAGPAGPR 95.00% 4.71 0.527 3.74 774.9013 1,547.79 1,547.79 2
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.29 0.456 4.21 781.8982 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.76 0.496 4.8 781.8987 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.87 0.405 5.47 781.899 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.01 0.446 5.05 781.8992 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.14 0.434 4.52 781.8994 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.4 0.431 4.52 781.8994 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.16 0.451 5.29 781.8995 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.83 0.466 5.01 781.8998 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.16 0.515 4.96 781.8999 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.18 0.523 4.32 781.8999 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.48 0.469 4.85 781.9001 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.25 0.513 3.68 781.9002 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.82 0.419 4.7 781.9003 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.27 0.453 4.48 781.9003 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.06 0.441 4.42 781.9005 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.61 0.489 3.92 781.9006 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 4.06 0.513 4.1 781.9007 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.96 0.528 5.42 782.3997 1,562.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 99.80% 2 2 11 4.03% GETGPSGPVGPAGAVGPR 95.00% 3.53 0.452 3.89 782.4001 1,562.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.12 0.369 1.4 521.6016 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.82 0.424 2.36 521.9355 1,562.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GEAGAAGPAGPAGPR 95.00% 2.75 0.485 0 618.8112 1,235.61 1,235.61 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 6.61 0.654 7.74 676.3427 2,026.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.92 0.55 6.15 676.3435 2,026.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.75 0.565 6.68 676.3447 2,026.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.22 0.59 3.42 676.345 2,026.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.73 0.595 5.31 676.6757 2,027.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 6.03 0.614 7.7 676.6758 2,027.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.56 0.554 1.82 676.6766 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.59 0.534 3.89 676.6768 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.81 0.598 7.72 676.6772 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.21 0.484 6.72 676.6774 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.18 0.65 4.08 676.6776 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.24 0.548 7.82 676.6786 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GVGLGPGPMGLMGPR 95.00% 2.72 0.508 1.47 698.3627 1,394.71 1,395.72 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GVGLGPGPMGLMGPR 95.00% 2.4 0.462 0 698.3644 1,394.71 1,395.72 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.56 0.562 5.04 774.3988 1,546.78 1,547.79 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.52 0.54 5.36 774.399 1,546.78 1,547.79 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.52 0.491 5.44 774.3994 1,546.78 1,547.79 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.67 0.505 6.35 774.3997 1,546.78 1,547.79 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.69 0.538 5.37 774.4001 1,546.78 1,547.79 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.86 0.524 7.16 774.4003 1,546.78 1,547.79 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GEIGAVGNAGPAGPAGPR 95.00% 3.99 0.285 4.19 774.4008 1,546.79 1,547.79 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.73 0.511 7.55 774.4008 1,546.79 1,547.79 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.34 0.551 5.8 774.4013 1,546.79 1,547.79 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.73 0.513 5.89 774.9004 1,547.79 1,547.79 2
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.96 0.463 0 781.8982 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.13 0.474 3.7 781.8982 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.57 0.496 4.21 781.8989 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.08 0.468 6.42 781.8992 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.17 0.493 5.82 781.8992 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.79 0.468 5.4 781.8992 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.23 0.493 4.22 781.8993 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.51 0.512 5.48 781.8995 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.33 0.475 5.77 781.8997 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.07 0.439 5.07 781.8998 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.77 0.452 4.89 781.9 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.75 0.393 5.42 781.9001 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.92 0.466 4.57 781.9001 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.57 0.457 4.66 781.9001 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.1 0.513 6 781.9004 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.79 0.473 5.51 781.9004 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.5 0.543 6.31 781.9005 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.79 0.425 5.8 781.9006 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.17 0.475 3.59 781.9012 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.09 0.475 5.7 781.9014 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.63 0.471 4.08 781.9016 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 3 13 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.03 0.452 5.34 782.4008 1,562.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEIGAVGNAGPAGPAGPR 95.00% 3.81 0.494 3 516.6031 1,546.79 1,547.79 3
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEIGAVGNAGPAGPAGPR 95.00% 3.7 0.432 4.74 516.9349 1,547.78 1,547.79 3
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.33 0.195 0 521.6018 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.82 0.449 2.17 521.6022 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEAGAAGPAGPAGPR 95.00% 3.48 0.424 2.05 618.3089 1,234.60 1,235.61 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEAGAAGPAGPAGPR 95.00% 2.71 0.361 2.64 618.3111 1,234.61 1,235.61 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEAGAAGPAGPAGPR 95.00% 2.39 0.466 3.22 618.3127 1,234.61 1,235.61 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.96 0.597 4.57 676.3403 2,026.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.69 0.457 4.33 676.3417 2,026.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 3.27 0.474 2.06 676.342 2,026.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.66 0.654 5.37 676.3431 2,026.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.77 0.574 3.89 676.3436 2,026.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 1.95 0.237 0 676.3658 2,026.07 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.32 0.573 6.02 676.676 2,027.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.21 0.536 2.59 676.6764 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.92 0.631 4.68 676.6764 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.22 0.587 3.44 676.6768 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 3.32 0.361 1.64 676.6771 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.61 0.573 6.51 676.6774 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.8 0.539 4.96 676.6776 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.59 0.608 7.77 676.6779 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.1 0.609 3.62 676.6794 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GVGLGPGPMGLMGPR 95.00% 4.04 0.555 4.68 698.3645 1,394.71 1,395.72 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GVGLGPGPMGLMGPR 95.00% 4.03 0.596 6.24 698.3654 1,394.72 1,395.72 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.58 0.538 8.21 774.3991 1,546.78 1,547.79 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.63 0.513 7.52 774.3991 1,546.78 1,547.79 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.91 0.509 6.92 774.3993 1,546.78 1,547.79 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.97 0.534 6.37 774.3993 1,546.78 1,547.79 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.74 0.51 5.85 774.3994 1,546.78 1,547.79 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.95 0.509 5.7 774.3994 1,546.78 1,547.79 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.49 0.554 6.21 774.4004 1,546.79 1,547.79 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.8 0.486 7.85 774.4007 1,546.79 1,547.79 2
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.27 0.466 5.82 781.8991 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.53 0.54 6.47 781.8991 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.34 0.48 5.16 781.8994 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.81 0.421 5.6 781.8996 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.98 0.448 5.7 781.8997 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.21 0.519 4.55 781.8997 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.25 0.473 5.72 781.9 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.03 0.466 4.68 781.9002 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.02 0.448 4.36 781.9003 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.35 0.486 5.15 781.9005 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.61 0.5 4.57 781.9007 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.18 0.472 6.42 781.9007 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.25 0.451 6.77 781.9008 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.29 0.477 5.33 781.9015 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.82 0.458 4.66 781.9018 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.1 0.225 1.29 781.9178 1,561.82 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.41 0.462 5.23 782.4005 1,562.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.86 0.507 4.07 782.401 1,562.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.79 0.483 5.14 782.4016 1,562.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.22 0.524 5.08 782.4026 1,562.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.25 0.612 3.8 1,014.51 2,027.00 2,027.02 2 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.15 0.592 2.89 1,014.51 2,027.00 2,027.02 2 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 15 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.48 0.62 5 1,014.51 2,027.00 2,027.02 2 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEIGAVGNAGPAGPAGPR 95.00% 3.98 0.445 3.64 516.601 1,546.78 1,547.79 3
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEIGAVGNAGPAGPAGPR 95.00% 3.64 0.449 5.59 516.6015 1,546.78 1,547.79 3
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.85 0.274 1.23 521.6012 1,561.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.7 0.369 3.74 521.9359 1,562.78 1,562.79 3 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEAGAAGPAGPAGPR 95.00% 2.49 0.361 1.96 618.3083 1,234.60 1,235.61 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEAGAAGPAGPAGPR 95.00% 3.34 0.405 1.96 618.3096 1,234.60 1,235.61 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEAGAAGPAGPAGPR 95.00% 2.64 0.351 1.52 618.31 1,234.60 1,235.61 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEAGAAGPAGPAGPR 95.00% 2.37 0.41 2.46 618.3112 1,234.61 1,235.61 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEAGAAGPAGPAGPR 95.00% 2.34 0.405 2.64 618.3115 1,234.61 1,235.61 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEAGAAGPAGPAGPR 95.00% 2.66 0.452 1.44 618.3121 1,234.61 1,235.61 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEAGAAGPAGPAGPR 95.00% 3.2 0.416 1.96 618.3122 1,234.61 1,235.61 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.84 0.567 5.14 676.342 2,026.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.27 0.566 5.7 676.3425 2,026.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.86 0.666 5.62 676.6744 2,027.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.31 0.594 5.08 676.6758 2,027.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.85 0.572 3.96 676.6758 2,027.00 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.89 0.627 6.19 676.6766 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.53 0.634 6.29 676.6775 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.87 0.603 5.34 676.6776 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.13 0.581 7.13 676.6776 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.39 0.593 6.29 676.6776 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.43 0.593 6.82 676.6776 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.05 0.573 4.23 676.678 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 4.77 0.522 5.39 676.678 2,027.01 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 3.33 0.538 3.4 676.6844 2,027.03 2,027.02 3 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GVGLGPGPMGLMGPR 95.00% 3.54 0.585 5.52 698.3646 1,394.71 1,395.72 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GVGLGPGPMGLMGPR 95.00% 3.79 0.561 5.26 698.3647 1,394.71 1,395.72 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.73 0.539 5.6 774.3985 1,546.78 1,547.79 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.8 0.483 5.1 774.3988 1,546.78 1,547.79 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.78 0.52 7.26 774.3988 1,546.78 1,547.79 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.1 0.422 4.72 774.3991 1,546.78 1,547.79 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.53 0.581 5.11 774.3997 1,546.78 1,547.79 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.63 0.49 6.85 774.3997 1,546.78 1,547.79 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.61 0.575 7.15 774.4003 1,546.78 1,547.79 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.76 0.566 6.23 774.4003 1,546.78 1,547.79 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GEIGAVGNAGPAGPAGPR 95.00% 4.66 0.528 5.64 774.4007 1,546.79 1,547.79 2
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.62 0.484 5.72 781.8988 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.08 0.448 5.55 781.899 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.01 0.376 4.12 781.8991 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.11 0.468 7.18 781.8992 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.27 0.465 5.46 781.8996 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.9 0.397 5.96 781.8998 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.4 0.523 6.89 781.8999 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.93 0.447 5.82 781.9001 1,561.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.63 0.476 5.05 781.9004 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.79 0.475 6.43 781.9006 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.11 0.475 4.68 781.9007 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.79 0.484 6 781.9008 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.98 0.472 6.1 781.9009 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.53 0.425 1.51 781.9014 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.15 0.503 6.77 781.9015 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.7 0.427 5.34 781.902 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.89 0.487 4.72 781.902 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.78 0.474 4.48 781.9025 1,561.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 3.55 0.325 2.74 782.3993 1,562.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 2.86 0.405 1.59 782.3994 1,562.78 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.21 0.488 5.43 782.4009 1,562.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% GETGPSGPVGPAGAVGPR 95.00% 4.67 0.464 6.42 782.4018 1,562.79 1,562.79 2 FIL1L_HUMAN,AHNK_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.37 0.605 5.22 1,014.01 2,026.00 2,027.02 2 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(I) chain  COL1A2  CO1A2_HUMAN 129,270.60 100.00% 3 4 20 5.12% HGNRGETGPSGPVGPAGAVGPR 95.00% 5.22 0.629 5.05 1,014.51 2,027.01 2,027.02 2 SEPT9_HUMAN,RSU1_HUMAN,DYHC1_HUMAN,ATPG_HUMAN,STIP1_HUMAN,CALD1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% SVSIGYLLVK 95.00% 2.45 0.127 1.23 539.8298 1,077.64 1,078.65 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% SVSIGYLLVK 95.00% 3.07 0.402 2.74 539.83 1,077.64 1,078.65 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% SVSIGYLLVK 95.00% 2.22 0.315 0 539.83 1,077.64 1,078.65 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% SVSIGYLLVK 95.00% 2.77 0.276 1.37 539.8302 1,077.64 1,078.65 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% SVSIGYLLVK 95.00% 2.51 0.264 0 539.8305 1,077.65 1,078.65 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% SVSIGYLLVK 95.00% 2.83 0.339 2.05 539.8305 1,077.65 1,078.65 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% SVSIGYLLVK 95.00% 2.68 0.386 2.89 539.8308 1,077.65 1,078.65 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% SVSIGYLLVK 95.00% 3.09 0.36 2.21 539.8308 1,077.65 1,078.65 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% SVSIGYLLVK 95.00% 2.89 0.336 1.82 539.8308 1,077.65 1,078.65 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% SVSIGYLLVK 95.00% 2.67 0.309 0 539.8309 1,077.65 1,078.65 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% ATPFIEcNGGR 95.00% 2.3 0.273 0 c7: Carbamidomethyl (+57.02) 611.2881 1,220.56 1,221.57 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% ATPFIEcNGGR 95.00% 2.16 0.176 1.27 c7: Carbamidomethyl (+57.02) 611.2884 1,220.56 1,221.57 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% GLDGYQGPDGPR 95.00% 2.85 0.547 3.8 616.2888 1,230.56 1,231.57 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% IAVQPGTVGPQGR 95.00% 2.08 0.269 0 640.3602 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% IAVQPGTVGPQGR 95.00% 2.16 0.253 2.3 640.3603 1,278.71 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% IAVQPGTVGPQGR 95.00% 2.82 0.492 3.52 640.3606 1,278.71 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% IAVQPGTVGPQGR 95.00% 2.06 0.212 2.92 640.3613 1,278.71 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% IAVQPGTVGPQGR 95.00% 2.22 0.353 1.89 640.3617 1,278.71 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% IAVQPGTVGPQGR 95.00% 2.01 0.306 1.32 640.3618 1,278.71 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% IAVQPGTVGPQGR 95.00% 2.91 0.461 3.39 640.3619 1,278.71 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% IAVQPGTVGPQGR 95.00% 2.8 0.474 2.77 640.3623 1,278.71 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% IAVQPGTVGPQGR 95.00% 3.45 0.465 3.96 640.8647 1,279.71 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% AHNQDLGLAGScLAR 95.00% 4.56 0.503 4.12 c12: Carbamidomethyl (+57.02) 791.8949 1,581.77 1,582.78 2
 SAMPLE 4 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 4 15 3.56% AHNQDLGLAGScLAR 95.00% 3.88 0.502 3.82 c12: Carbamidomethyl (+57.02) 791.8968 1,581.78 1,582.78 2
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% SVSIGYLLVK 95.00% 2.38 0.358 1.39 539.8285 1,077.64 1,078.65 2
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% SVSIGYLLVK 95.00% 3 0.345 1.82 539.8296 1,077.64 1,078.65 2
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% SVSIGYLLVK 95.00% 2.48 0.171 2.74 539.83 1,077.64 1,078.65 2
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% SVSIGYLLVK 95.00% 2.92 0.326 1.82 539.8304 1,077.65 1,078.65 2
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% SVSIGYLLVK 95.00% 2.93 0.38 2.4 539.8304 1,077.65 1,078.65 2
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% SVSIGYLLVK 95.00% 2.59 0.275 1.43 539.8307 1,077.65 1,078.65 2
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% SVSIGYLLVK 95.00% 2.59 0.198 0 539.8307 1,077.65 1,078.65 2
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% SVSIGYLLVK 95.00% 2.74 0.234 1.96 539.8308 1,077.65 1,078.65 2
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% SVSIGYLLVK 95.00% 3.02 0.359 2.05 539.8308 1,077.65 1,078.65 2
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% SVSIGYLLVK 95.00% 2.7 0.39 1.43 539.8308 1,077.65 1,078.65 2
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% IAVQPGTVGPQGR 95.00% 1.77 0.385 1.89 640.36 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% IAVQPGTVGPQGR 95.00% 1.76 0.33 1.46 640.3603 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% IAVQPGTVGPQGR 95.00% 2.7 0.348 2.59 640.3609 1,278.71 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% IAVQPGTVGPQGR 95.00% 2.67 0.472 1.39 640.3614 1,278.71 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% IAVQPGTVGPQGR 95.00% 2.8 0.486 2.54 640.3615 1,278.71 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% IAVQPGTVGPQGR 95.00% 2.56 0.242 1.31 640.3616 1,278.71 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% AHNQDLGLAGScLAR 95.00% 4.12 0.468 5.17 c12: Carbamidomethyl (+57.02) 791.8957 1,581.78 1,582.78 2
 SAMPLE 4R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 3 3 12 3.27% GEQGFmGNTGPTGAVGDR 95.00% 4.04 0.637 4.57 m6: Oxidation (+15.99) 884.3962 1,766.78 1,766.78 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% AHNQDLGLAGScLAR 95.00% 3.13 0.282 1.92 c12: Carbamidomethyl (+57.02) 528.262 1,581.76 1,582.78 3
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% AHNQDLGLAGScLAR 95.00% 3.23 0.283 2.22 c12: Carbamidomethyl (+57.02) 528.2624 1,581.76 1,582.78 3
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% AHNQDLGLAGScLAR 95.00% 2.85 0.326 1.96 c12: Carbamidomethyl (+57.02) 528.2632 1,581.77 1,582.78 3
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% AHNQDLGLAGScLAR 95.00% 2.73 0.282 1.49 c12: Carbamidomethyl (+57.02) 528.2636 1,581.77 1,582.78 3
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% AHNQDLGLAGScLAR 95.00% 3.04 0.275 1.68 c12: Carbamidomethyl (+57.02) 528.2651 1,581.77 1,582.78 3
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% AHNQDLGLAGScLAR 95.00% 2.63 0.203 1.05 c12: Carbamidomethyl (+57.02) 528.2659 1,581.77 1,582.78 3
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% AHNQDLGLAGScLAR 95.00% 3.02 0.342 0 c12: Carbamidomethyl (+57.02) 528.2944 1,581.86 1,582.78 3
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% SVSIGYLLVK 95.00% 2.91 0.389 1.92 539.8274 1,077.64 1,078.65 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% SVSIGYLLVK 95.00% 2.71 0.33 3.51 539.8276 1,077.64 1,078.65 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% SVSIGYLLVK 95.00% 3 0.362 1.51 539.8276 1,077.64 1,078.65 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% SVSIGYLLVK 95.00% 3 0.392 2.7 539.8277 1,077.64 1,078.65 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% SVSIGYLLVK 95.00% 2.87 0.389 1.89 539.8277 1,077.64 1,078.65 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% SVSIGYLLVK 95.00% 2.9 0.377 1.68 539.8278 1,077.64 1,078.65 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% SVSIGYLLVK 95.00% 3 0.382 2.06 539.8278 1,077.64 1,078.65 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% SVSIGYLLVK 95.00% 2.37 0.216 0 539.8278 1,077.64 1,078.65 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% SVSIGYLLVK 95.00% 3.09 0.364 1.68 539.8278 1,077.64 1,078.65 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% SVSIGYLLVK 95.00% 3.07 0.375 1.92 539.8283 1,077.64 1,078.65 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% SVSIGYLLVK 95.00% 2.61 0.354 2.24 539.8285 1,077.64 1,078.65 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% SVSIGYLLVK 95.00% 2.89 0.362 2.11 539.837 1,077.66 1,078.65 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% ATPFIEcNGGR 95.00% 2.5 0.39 1.23 c7: Carbamidomethyl (+57.02) 611.2843 1,220.55 1,221.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% ATPFIEcNGGR 95.00% 2.37 0.398 1.17 c7: Carbamidomethyl (+57.02) 611.2852 1,220.55 1,221.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% ATPFIEcNGGR 95.00% 2.38 0.37 0 c7: Carbamidomethyl (+57.02) 611.2857 1,220.56 1,221.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% ATPFIEcNGGR 95.00% 2.62 0.368 1.32 c7: Carbamidomethyl (+57.02) 611.2861 1,220.56 1,221.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% ATPFIEcNGGR 95.00% 2.24 0.352 1.25 c7: Carbamidomethyl (+57.02) 611.2863 1,220.56 1,221.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% ATPFIEcNGGR 95.00% 2.57 0.424 0 c7: Carbamidomethyl (+57.02) 611.2864 1,220.56 1,221.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% ATPFIEcNGGR 95.00% 2.87 0.334 1.21 c7: Carbamidomethyl (+57.02) 611.2865 1,220.56 1,221.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% ATPFIEcNGGR 95.00% 2.48 0.336 1.22 c7: Carbamidomethyl (+57.02) 611.2873 1,220.56 1,221.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% ATPFIEcNGGR 95.00% 2.43 0.395 0 c7: Carbamidomethyl (+57.02) 611.2879 1,220.56 1,221.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% ATPFIEcNGGR 95.00% 2.65 0.38 1.13 c7: Carbamidomethyl (+57.02) 611.2879 1,220.56 1,221.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% GLDGYQGPDGPR 95.00% 3.07 0.575 3.55 616.286 1,230.56 1,231.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% GLDGYQGPDGPR 95.00% 2.41 0.48 1.68 616.286 1,230.56 1,231.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% GLDGYQGPDGPR 95.00% 2.95 0.308 4.82 616.2865 1,230.56 1,231.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% GLDGYQGPDGPR 95.00% 3.16 0.528 3.8 616.2877 1,230.56 1,231.57 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% IAVQPGTVGPQGR 95.00% 3.5 0.526 4.55 640.3584 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% IAVQPGTVGPQGR 95.00% 2.94 0.439 3.54 640.3589 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% IAVQPGTVGPQGR 95.00% 2.04 0.438 2.57 640.3589 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% IAVQPGTVGPQGR 95.00% 2.43 0.46 3.66 640.359 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% IAVQPGTVGPQGR 95.00% 2.12 0.42 2.7 640.3592 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% IAVQPGTVGPQGR 95.00% 2.99 0.479 3.55 640.3593 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% AHNQDLGLAGScLAR 95.00% 3.42 0.527 6.62 c12: Carbamidomethyl (+57.02) 791.8909 1,581.77 1,582.78 2
 SAMPLE 1 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 35 3.56% AHNQDLGLAGScLAR 95.00% 4.54 0.491 6.17 c12: Carbamidomethyl (+57.02) 791.8935 1,581.77 1,582.78 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% AHNQDLGLAGScLAR 95.00% 2.87 0.264 1.28 c12: Carbamidomethyl (+57.02) 528.2624 1,581.76 1,582.78 3
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% AHNQDLGLAGScLAR 95.00% 2.48 0.282 1.74 c12: Carbamidomethyl (+57.02) 528.2628 1,581.77 1,582.78 3
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% AHNQDLGLAGScLAR 95.00% 2.68 0.213 1.37 c12: Carbamidomethyl (+57.02) 528.2631 1,581.77 1,582.78 3
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% AHNQDLGLAGScLAR 95.00% 3.34 0.369 1.7 c12: Carbamidomethyl (+57.02) 528.2634 1,581.77 1,582.78 3
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% AHNQDLGLAGScLAR 95.00% 2.78 0.278 1.8 c12: Carbamidomethyl (+57.02) 528.2637 1,581.77 1,582.78 3
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% AHNQDLGLAGScLAR 95.00% 2.36 0.17 1.32 c12: Carbamidomethyl (+57.02) 528.2946 1,581.86 1,582.78 3
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% SVSIGYLLVK 95.00% 2.53 0.399 2.05 539.8261 1,077.64 1,078.65 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% SVSIGYLLVK 95.00% 2.88 0.404 3.11 539.8265 1,077.64 1,078.65 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% SVSIGYLLVK 95.00% 2.88 0.395 2.39 539.8277 1,077.64 1,078.65 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% SVSIGYLLVK 95.00% 2.3 0.258 1.62 539.8277 1,077.64 1,078.65 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% SVSIGYLLVK 95.00% 2.97 0.408 2.82 539.828 1,077.64 1,078.65 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% SVSIGYLLVK 95.00% 2.56 0.332 1.89 539.8282 1,077.64 1,078.65 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% SVSIGYLLVK 95.00% 2.92 0.383 2.38 539.8283 1,077.64 1,078.65 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% ATPFIEcNGGR 95.00% 2.13 0.386 1.6 c7: Carbamidomethyl (+57.02) 611.2851 1,220.55 1,221.57 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% ATPFIEcNGGR 95.00% 2.52 0.386 1.3 c7: Carbamidomethyl (+57.02) 611.2854 1,220.56 1,221.57 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% ATPFIEcNGGR 95.00% 2.7 0.36 0 c7: Carbamidomethyl (+57.02) 611.2854 1,220.56 1,221.57 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% ATPFIEcNGGR 95.00% 2.7 0.356 1.82 c7: Carbamidomethyl (+57.02) 611.2875 1,220.56 1,221.57 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% ATPFIEcNGGR 95.00% 2.15 0.313 0 c7: Carbamidomethyl (+57.02) 611.2876 1,220.56 1,221.57 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% ATPFIEcNGGR 95.00% 2.55 0.296 1.18 c7: Carbamidomethyl (+57.02) 611.2878 1,220.56 1,221.57 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% ATPFIEcNGGR 95.00% 2.43 0.395 1.26 c7: Carbamidomethyl (+57.02) 611.2879 1,220.56 1,221.57 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% GLDGYQGPDGPR 95.00% 2.79 0.271 2.6 616.286 1,230.56 1,231.57 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% GLDGYQGPDGPR 95.00% 3.14 0.55 4.51 616.287 1,230.56 1,231.57 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% GLDGYQGPDGPR 95.00% 3.14 0.519 3.74 616.2871 1,230.56 1,231.57 2
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% IAVQPGTVGPQGR 95.00% 1.84 0.353 2.21 640.3581 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% IAVQPGTVGPQGR 95.00% 3.07 0.542 4.68 640.3583 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% IAVQPGTVGPQGR 95.00% 2.8 0.439 3.64 640.3592 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% IAVQPGTVGPQGR 95.00% 2.7 0.347 2.15 640.8526 1,279.69 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% IAVQPGTVGPQGR 95.00% 2.53 0.417 1.13 640.8535 1,279.69 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 1R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 24 3.56% AHNQDLGLAGScLAR 95.00% 4.54 0.491 4.62 c12: Carbamidomethyl (+57.02) 791.8935 1,581.77 1,582.78 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 3.29 0.443 2.11 c12: Carbamidomethyl (+57.02) 528.2615 1,581.76 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 3.01 0.45 2.59 c12: Carbamidomethyl (+57.02) 528.2616 1,581.76 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 2.95 0.324 2.14 c12: Carbamidomethyl (+57.02) 528.2625 1,581.76 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 3.47 0.389 2.77 c12: Carbamidomethyl (+57.02) 528.2629 1,581.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 3.08 0.378 1.6 c12: Carbamidomethyl (+57.02) 528.2634 1,581.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 2.93 0.426 1.64 c12: Carbamidomethyl (+57.02) 528.2637 1,581.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 2.46 0.208 2.47 c12: Carbamidomethyl (+57.02) 528.2638 1,581.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 3.04 0.357 3.01 c12: Carbamidomethyl (+57.02) 528.2639 1,581.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 3.08 0.362 1.96 c12: Carbamidomethyl (+57.02) 528.2639 1,581.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 2.47 0.218 2.51 c12: Carbamidomethyl (+57.02) 528.264 1,581.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 2.99 0.44 2.06 c12: Carbamidomethyl (+57.02) 528.2643 1,581.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 3.32 0.337 1.64 c12: Carbamidomethyl (+57.02) 528.2644 1,581.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 2.29 0.301 1.28 c12: Carbamidomethyl (+57.02) 528.2648 1,581.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 2.48 0.192 1.47 c12: Carbamidomethyl (+57.02) 528.2655 1,581.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 3.41 0.382 2.06 c12: Carbamidomethyl (+57.02) 528.5974 1,582.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 2.84 0.203 1.14 c12: Carbamidomethyl (+57.02) 528.5977 1,582.77 1,582.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% SVSIGYLLVK 95.00% 2.87 0.329 2.77 539.8272 1,077.64 1,078.65 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% SVSIGYLLVK 95.00% 3.07 0.38 3 539.8273 1,077.64 1,078.65 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% SVSIGYLLVK 95.00% 3.06 0.391 2.6 539.8276 1,077.64 1,078.65 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% SVSIGYLLVK 95.00% 2.91 0.393 2.59 539.8279 1,077.64 1,078.65 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% SVSIGYLLVK 95.00% 2.83 0.403 2.36 539.828 1,077.64 1,078.65 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% SVSIGYLLVK 95.00% 2.66 0.367 2.6 539.8282 1,077.64 1,078.65 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% SVSIGYLLVK 95.00% 3.03 0.393 3 539.8282 1,077.64 1,078.65 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% SVSIGYLLVK 95.00% 3.01 0.361 2 539.8282 1,077.64 1,078.65 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% SVSIGYLLVK 95.00% 3.03 0.405 3.7 539.8284 1,077.64 1,078.65 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% SVSIGYLLVK 95.00% 2.78 0.38 2.7 539.8285 1,077.64 1,078.65 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% SVSIGYLLVK 95.00% 2.88 0.415 2.48 539.8286 1,077.64 1,078.65 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% ATPFIEcNGGR 95.00% 2.66 0.284 0 c7: Carbamidomethyl (+57.02) 611.2845 1,220.55 1,221.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% ATPFIEcNGGR 95.00% 2.57 0.397 0 c7: Carbamidomethyl (+57.02) 611.2854 1,220.56 1,221.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% ATPFIEcNGGR 95.00% 2.53 0.396 0 c7: Carbamidomethyl (+57.02) 611.2862 1,220.56 1,221.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% ATPFIEcNGGR 95.00% 2.23 0.314 1.17 c7: Carbamidomethyl (+57.02) 611.2866 1,220.56 1,221.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% ATPFIEcNGGR 95.00% 2.72 0.435 1.34 c7: Carbamidomethyl (+57.02) 611.2868 1,220.56 1,221.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% ATPFIEcNGGR 95.00% 2.7 0.431 1.23 c7: Carbamidomethyl (+57.02) 611.287 1,220.56 1,221.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% ATPFIEcNGGR 95.00% 2.71 0.415 1.66 c7: Carbamidomethyl (+57.02) 611.2873 1,220.56 1,221.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% ATPFIEcNGGR 95.00% 2.79 0.453 2.12 c7: Carbamidomethyl (+57.02) 611.2875 1,220.56 1,221.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% ATPFIEcNGGR 95.00% 2.64 0.353 1.82 c7: Carbamidomethyl (+57.02) 611.2877 1,220.56 1,221.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% ATPFIEcNGGR 95.00% 2.84 0.407 1.47 c7: Carbamidomethyl (+57.02) 611.2877 1,220.56 1,221.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% ATPFIEcNGGR 95.00% 2.54 0.389 0 c7: Carbamidomethyl (+57.02) 611.2878 1,220.56 1,221.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% ATPFIEcNGGR 95.00% 2.63 0.346 1.47 c7: Carbamidomethyl (+57.02) 611.7885 1,221.56 1,221.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GLDGYQGPDGPR 95.00% 2.35 0.427 1.7 616.2854 1,230.56 1,231.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GLDGYQGPDGPR 95.00% 2.6 0.341 2.03 616.2871 1,230.56 1,231.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GLDGYQGPDGPR 95.00% 2.9 0.472 3.85 616.2871 1,230.56 1,231.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GLDGYQGPDGPR 95.00% 2.72 0.443 2 616.2872 1,230.56 1,231.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GLDGYQGPDGPR 95.00% 3.04 0.537 2.6 616.2876 1,230.56 1,231.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GLDGYQGPDGPR 95.00% 2.66 0.462 1.6 616.2876 1,230.56 1,231.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GLDGYQGPDGPR 95.00% 2.83 0.447 1.82 616.2878 1,230.56 1,231.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GLDGYQGPDGPR 95.00% 2.45 0.534 2.03 616.2882 1,230.56 1,231.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GLDGYQGPDGPR 95.00% 2.09 0.315 1.22 616.2892 1,230.56 1,231.57 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% HSQTDQEPmcPVGMNK 95.00% 3.61 0.418 1.17 m9: Oxidation (+15.99), c10: Carbamidomethyl (+57.02) 625.9345 1,874.78 1,874.78 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% IAVQPGTVGPQGR 95.00% 2.42 0.401 1.48 640.3588 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% IAVQPGTVGPQGR 95.00% 3.41 0.505 5.66 640.3589 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% IAVQPGTVGPQGR 95.00% 3.12 0.53 3.96 640.3589 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% IAVQPGTVGPQGR 95.00% 3.29 0.569 4.6 640.3589 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% IAVQPGTVGPQGR 95.00% 2.63 0.316 3.07 640.3593 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% IAVQPGTVGPQGR 95.00% 3.42 0.486 5.6 640.3593 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% IAVQPGTVGPQGR 95.00% 3 0.498 5.8 640.3593 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% IAVQPGTVGPQGR 95.00% 3.35 0.523 3.77 640.3595 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% IAVQPGTVGPQGR 95.00% 3.3 0.575 4.92 640.3597 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GEQGFmGNTGPTGAVGDRGPK 95.00% 3.08 0.478 0.921 m6: Oxidation (+15.99) 683.987 2,048.94 2,048.95 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GEQGFmGNTGPTGAVGDRGPK 95.00% 2.41 0.482 0 m6: Oxidation (+15.99) 683.9877 2,048.94 2,048.95 3
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 4.85 0.512 3.38 c12: Carbamidomethyl (+57.02) 791.8894 1,581.76 1,582.78 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 5.28 0.512 4.28 c12: Carbamidomethyl (+57.02) 791.8902 1,581.76 1,582.78 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 5.32 0.466 5.89 c12: Carbamidomethyl (+57.02) 791.8908 1,581.77 1,582.78 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 4.89 0.513 7.85 c12: Carbamidomethyl (+57.02) 791.8918 1,581.77 1,582.78 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% AHNQDLGLAGScLAR 95.00% 4.3 0.513 7.74 c12: Carbamidomethyl (+57.02) 791.8924 1,581.77 1,582.78 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GEQGFmGNTGPTGAVGDR 95.00% 4.1 0.582 4.17 m6: Oxidation (+15.99) 883.8909 1,765.77 1,766.78 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GEQGFmGNTGPTGAVGDR 95.00% 4.72 0.62 4.54 m6: Oxidation (+15.99) 884.39 1,766.76 1,766.78 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GEQGFmGNTGPTGAVGDR 95.00% 4.47 0.643 5.07 m6: Oxidation (+15.99) 884.3905 1,766.77 1,766.78 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% GEQGFmGNTGPTGAVGDR 95.00% 3.88 0.51 3.77 m6: Oxidation (+15.99) 884.3926 1,766.77 1,766.78 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% HSQTDQEPmcPVGMNK 95.00% 3.86 0.532 2.72 m9: Oxidation (+15.99), c10: Carbamidomethyl (+57.02) 938.3933 1,874.77 1,874.78 2
 SAMPLE 2 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 62 5.72% HSQTDQEPmcPVGMNK 95.00% 4.27 0.55 3.92 m9: Oxidation (+15.99), c10: Carbamidomethyl (+57.02) 938.3974 1,874.78 1,874.78 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 3.14 0.306 1.89 c12: Carbamidomethyl (+57.02) 528.2618 1,581.76 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 3.2 0.437 2.23 c12: Carbamidomethyl (+57.02) 528.2622 1,581.76 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 2.36 0.258 1.06 c12: Carbamidomethyl (+57.02) 528.2625 1,581.76 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 2.75 0.355 2.09 c12: Carbamidomethyl (+57.02) 528.2625 1,581.76 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 3.04 0.356 2.57 c12: Carbamidomethyl (+57.02) 528.2631 1,581.77 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 2.49 0.363 1.42 c12: Carbamidomethyl (+57.02) 528.2631 1,581.77 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 3.08 0.327 2.54 c12: Carbamidomethyl (+57.02) 528.2632 1,581.77 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 3.4 0.465 1.68 c12: Carbamidomethyl (+57.02) 528.2633 1,581.77 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 2.8 0.315 2.37 c12: Carbamidomethyl (+57.02) 528.2634 1,581.77 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 3.41 0.45 1.92 c12: Carbamidomethyl (+57.02) 528.2639 1,581.77 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 2.93 0.38 2.24 c12: Carbamidomethyl (+57.02) 528.264 1,581.77 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 2.89 0.339 1.7 c12: Carbamidomethyl (+57.02) 528.2643 1,581.77 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 3.16 0.458 1.64 c12: Carbamidomethyl (+57.02) 528.5969 1,582.77 1,582.78 3
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% SVSIGYLLVK 95.00% 2.04 0.365 1.62 539.8278 1,077.64 1,078.65 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% SVSIGYLLVK 95.00% 2.99 0.355 2.8 539.8281 1,077.64 1,078.65 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% SVSIGYLLVK 95.00% 2.95 0.364 2 539.8282 1,077.64 1,078.65 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% SVSIGYLLVK 95.00% 2.72 0.375 2.89 539.8282 1,077.64 1,078.65 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% SVSIGYLLVK 95.00% 3.03 0.395 2.21 539.8284 1,077.64 1,078.65 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% SVSIGYLLVK 95.00% 2.86 0.352 2.82 539.8286 1,077.64 1,078.65 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% SVSIGYLLVK 95.00% 2.17 0.261 2.68 539.8288 1,077.64 1,078.65 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% ATPFIEcNGGR 95.00% 2.45 0.457 1.25 c7: Carbamidomethyl (+57.02) 611.2859 1,220.56 1,221.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% ATPFIEcNGGR 95.00% 2.63 0.389 1.24 c7: Carbamidomethyl (+57.02) 611.2863 1,220.56 1,221.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% ATPFIEcNGGR 95.00% 2.94 0.447 1.13 c7: Carbamidomethyl (+57.02) 611.2863 1,220.56 1,221.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% ATPFIEcNGGR 95.00% 2.88 0.387 2.08 c7: Carbamidomethyl (+57.02) 611.2865 1,220.56 1,221.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% ATPFIEcNGGR 95.00% 2.54 0.445 1.38 c7: Carbamidomethyl (+57.02) 611.2866 1,220.56 1,221.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% ATPFIEcNGGR 95.00% 2.67 0.419 2.3 c7: Carbamidomethyl (+57.02) 611.2868 1,220.56 1,221.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% ATPFIEcNGGR 95.00% 2.5 0.339 2 c7: Carbamidomethyl (+57.02) 611.287 1,220.56 1,221.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% ATPFIEcNGGR 95.00% 2.36 0.417 0 c7: Carbamidomethyl (+57.02) 611.2871 1,220.56 1,221.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% ATPFIEcNGGR 95.00% 2.45 0.426 1.38 c7: Carbamidomethyl (+57.02) 611.2876 1,220.56 1,221.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% ATPFIEcNGGR 95.00% 2.76 0.394 0 c7: Carbamidomethyl (+57.02) 611.2877 1,220.56 1,221.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% ATPFIEcNGGR 95.00% 2.68 0.398 2.49 c7: Carbamidomethyl (+57.02) 611.2885 1,220.56 1,221.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% GLDGYQGPDGPR 95.00% 2.65 0.331 2.85 616.2863 1,230.56 1,231.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% GLDGYQGPDGPR 95.00% 2.71 0.47 0 616.2866 1,230.56 1,231.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% GLDGYQGPDGPR 95.00% 2.78 0.475 2.74 616.2867 1,230.56 1,231.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% GLDGYQGPDGPR 95.00% 2.55 0.494 2.02 616.287 1,230.56 1,231.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% GLDGYQGPDGPR 95.00% 2.73 0.541 1.89 616.2873 1,230.56 1,231.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% GLDGYQGPDGPR 95.00% 2.65 0.406 2.89 616.2873 1,230.56 1,231.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% GLDGYQGPDGPR 95.00% 2.44 0.379 2.05 616.2883 1,230.56 1,231.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% GLDGYQGPDGPR 95.00% 2.98 0.491 2.96 616.2889 1,230.56 1,231.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% GLDGYQGPDGPR 95.00% 2.02 0.224 1.36 616.7877 1,231.56 1,231.57 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% IAVQPGTVGPQGR 95.00% 3.06 0.497 2.89 640.357 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% IAVQPGTVGPQGR 95.00% 2.45 0.234 2.96 640.3577 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% IAVQPGTVGPQGR 95.00% 3.23 0.539 4.92 640.3583 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% IAVQPGTVGPQGR 95.00% 2.66 0.48 4.07 640.3586 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% IAVQPGTVGPQGR 95.00% 2.55 0.469 2.21 640.359 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% IAVQPGTVGPQGR 95.00% 2.72 0.475 2.57 640.3595 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% IAVQPGTVGPQGR 95.00% 2.79 0.438 3.8 640.3596 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% IAVQPGTVGPQGR 95.00% 2.83 0.464 4.48 640.3598 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 4.89 0.496 4.3 c12: Carbamidomethyl (+57.02) 791.8909 1,581.77 1,582.78 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 4.92 0.488 5.64 c12: Carbamidomethyl (+57.02) 791.891 1,581.77 1,582.78 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 5.1 0.5 4.85 c12: Carbamidomethyl (+57.02) 792.3929 1,582.77 1,582.78 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% AHNQDLGLAGScLAR 95.00% 5.02 0.47 5.82 c12: Carbamidomethyl (+57.02) 792.3934 1,582.77 1,582.78 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% HSQTDQEPmcPVGMNK 95.00% 4.36 0.587 4.36 m9: Oxidation (+15.99), c10: Carbamidomethyl (+57.02) 937.896 1,873.78 1,874.78 2
 SAMPLE 2R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 5 6 46 4.50% HSQTDQEPmcPVGMNK 95.00% 4.22 0.561 4.66 m9: Oxidation (+15.99), c10: Carbamidomethyl (+57.02) 937.8988 1,873.78 1,874.78 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% AHNQDLGLAGScLAR 95.00% 2.79 0.309 1.85 c12: Carbamidomethyl (+57.02) 528.2615 1,581.76 1,582.78 3
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% AHNQDLGLAGScLAR 95.00% 3.75 0.462 1.47 c12: Carbamidomethyl (+57.02) 528.262 1,581.76 1,582.78 3
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% AHNQDLGLAGScLAR 95.00% 3.18 0.415 2 c12: Carbamidomethyl (+57.02) 528.2626 1,581.76 1,582.78 3
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% AHNQDLGLAGScLAR 95.00% 2.87 0.302 2.19 c12: Carbamidomethyl (+57.02) 528.2628 1,581.76 1,582.78 3
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% AHNQDLGLAGScLAR 95.00% 2.44 0.256 0 c12: Carbamidomethyl (+57.02) 528.2631 1,581.77 1,582.78 3
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% SVSIGYLLVK 95.00% 2.66 0.403 2.24 539.8264 1,077.64 1,078.65 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% SVSIGYLLVK 95.00% 2.05 0.302 0 539.8277 1,077.64 1,078.65 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% SVSIGYLLVK 95.00% 2.84 0.395 1.7 539.8279 1,077.64 1,078.65 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% SVSIGYLLVK 95.00% 2.71 0.372 1.66 539.8279 1,077.64 1,078.65 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% SVSIGYLLVK 95.00% 2.05 0.329 1.17 539.828 1,077.64 1,078.65 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% SVSIGYLLVK 95.00% 2.86 0.415 1.82 539.8282 1,077.64 1,078.65 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% SVSIGYLLVK 95.00% 2.64 0.387 1.26 539.8283 1,077.64 1,078.65 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% SVSIGYLLVK 95.00% 2.93 0.362 1.14 539.8287 1,077.64 1,078.65 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% ATPFIEcNGGR 95.00% 1.91 0.299 0 c7: Carbamidomethyl (+57.02) 611.2851 1,220.55 1,221.57 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% ATPFIEcNGGR 95.00% 2.49 0.371 1.28 c7: Carbamidomethyl (+57.02) 611.2863 1,220.56 1,221.57 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% ATPFIEcNGGR 95.00% 2.23 0.358 0 c7: Carbamidomethyl (+57.02) 611.2863 1,220.56 1,221.57 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% ATPFIEcNGGR 95.00% 2.36 0.371 1.72 c7: Carbamidomethyl (+57.02) 611.2865 1,220.56 1,221.57 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% GLDGYQGPDGPR 95.00% 2.33 0.361 1.34 616.2858 1,230.56 1,231.57 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% GLDGYQGPDGPR 95.00% 3.17 0.54 4.07 616.286 1,230.56 1,231.57 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% GLDGYQGPDGPR 95.00% 2.76 0.507 3.59 616.2861 1,230.56 1,231.57 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% GLDGYQGPDGPR 95.00% 2.51 0.222 2.74 616.2876 1,230.56 1,231.57 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% HSQTDQEPmcPVGMNK 95.00% 4 0.508 1.06 m9: Oxidation (+15.99), c10: Carbamidomethyl (+57.02) 625.5975 1,873.77 1,874.78 3
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% IAVQPGTVGPQGR 95.00% 1.97 0.326 1.18 640.3584 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% IAVQPGTVGPQGR 95.00% 2.52 0.486 4.19 640.3589 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% IAVQPGTVGPQGR 95.00% 2.38 0.457 3.38 640.359 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% GEQGFmGNTGPTGAVGDRGPK 95.00% 2.13 0.349 0 m6: Oxidation (+15.99) 683.9863 2,048.94 2,048.95 3
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% AHNQDLGLAGScLAR 95.00% 5.12 0.505 7.11 c12: Carbamidomethyl (+57.02) 791.8911 1,581.77 1,582.78 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% AHNQDLGLAGScLAR 95.00% 4.96 0.478 5.96 c12: Carbamidomethyl (+57.02) 791.8915 1,581.77 1,582.78 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% AHNQDLGLAGScLAR 95.00% 4.29 0.527 4.34 c12: Carbamidomethyl (+57.02) 791.8916 1,581.77 1,582.78 2
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% GISLKGEEGImGFPGLRGYPGLSGEK 95.00% 2.57 0.235 0 m11: Oxidation (+15.99) 888.9432 2,663.81 2,665.37 3
 SAMPLE 3 Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 7 9 28 7.24% HSQTDQEPmcPVGMNK 95.00% 4.16 0.601 2.2 m9: Oxidation (+15.99), c10: Carbamidomethyl (+57.02) 938.3968 1,874.78 1,874.78 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% AHNQDLGLAGScLAR 95.00% 3.18 0.421 2.72 c12: Carbamidomethyl (+57.02) 528.262 1,581.76 1,582.78 3
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% AHNQDLGLAGScLAR 95.00% 3.58 0.424 2.57 c12: Carbamidomethyl (+57.02) 528.2623 1,581.76 1,582.78 3
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% AHNQDLGLAGScLAR 95.00% 2.86 0.314 2.1 c12: Carbamidomethyl (+57.02) 528.5946 1,582.76 1,582.78 3
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% AHNQDLGLAGScLAR 95.00% 3.12 0.294 1.82 c12: Carbamidomethyl (+57.02) 528.597 1,582.77 1,582.78 3
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% SVSIGYLLVK 95.00% 2.47 0.363 1.72 539.8288 1,077.64 1,078.65 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% SVSIGYLLVK 95.00% 2.46 0.397 2.3 539.8289 1,077.64 1,078.65 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% SVSIGYLLVK 95.00% 2.57 0.321 2.22 539.8289 1,077.64 1,078.65 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% SVSIGYLLVK 95.00% 2.24 0.225 1.09 539.829 1,077.64 1,078.65 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% SVSIGYLLVK 95.00% 2.82 0.395 1.92 539.8293 1,077.64 1,078.65 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% ATPFIEcNGGR 95.00% 2.36 0.393 0 c7: Carbamidomethyl (+57.02) 611.2863 1,220.56 1,221.57 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% ATPFIEcNGGR 95.00% 2.76 0.375 1.12 c7: Carbamidomethyl (+57.02) 611.2868 1,220.56 1,221.57 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% ATPFIEcNGGR 95.00% 2.59 0.415 1.42 c7: Carbamidomethyl (+57.02) 611.289 1,220.56 1,221.57 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% GLDGYQGPDGPR 95.00% 2.58 0.539 3.47 616.2851 1,230.55 1,231.57 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% GLDGYQGPDGPR 95.00% 3 0.524 4.24 616.2859 1,230.56 1,231.57 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% GLDGYQGPDGPR 95.00% 2.18 0.177 1.42 616.2887 1,230.56 1,231.57 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% IAVQPGTVGPQGR 95.00% 2.2 0.483 3.32 640.3579 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% IAVQPGTVGPQGR 95.00% 2.15 0.403 3.19 640.3579 1,278.70 1,279.71 2 AHNK_HUMAN,MMP2_HUMAN
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% AHNQDLGLAGScLAR 95.00% 4.85 0.483 5.14 c12: Carbamidomethyl (+57.02) 791.8877 1,581.76 1,582.78 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% AHNQDLGLAGScLAR 95.00% 3.52 0.56 3.34 c12: Carbamidomethyl (+57.02) 791.8878 1,581.76 1,582.78 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% AHNQDLGLAGScLAR 95.00% 4.46 0.539 5.37 c12: Carbamidomethyl (+57.02) 791.8888 1,581.76 1,582.78 2
 SAMPLE 3R Collagen alpha-2(IV) chain  COL4A2  CO4A2_HUMAN 167,539.60 100.00% 4 5 19 3.56% AHNQDLGLAGScLAR 95.00% 4.91 0.536 3.21 c12: Carbamidomethyl (+57.02) 791.8927 1,581.77 1,582.78 2
 SAMPLE 2 Collagen alpha-2(V) chain  COL5A2  CO5A2_HUMAN 144,891.60 99.80% 2 2 3 2.54% PGEAGNAGVPGQRGAPGK 95.00% 2.14 0.32 0 540.2668 1,617.78 1,619.83 3
 SAMPLE 2 Collagen alpha-2(V) chain  COL5A2  CO5A2_HUMAN 144,891.60 99.80% 2 2 3 2.54% GQPGSMGLPGPKGSSGDPGKPGEAGNAGVPGQR 95.00% 2.71 0.448 0 1,001.51 3,001.50 3,001.46 3
 SAMPLE 2 Collagen alpha-2(V) chain  COL5A2  CO5A2_HUMAN 144,891.60 99.80% 2 2 3 2.54% GQPGSMGLPGPKGSSGDPGKPGEAGNAGVPGQR 95.00% 2.62 0.421 0 1,001.51 3,001.51 3,001.46 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% RFVEQVAR 95.00% 2.71 0.279 0 502.7851 1,003.55 1,004.56 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% RFVEQVAR 95.00% 3.4 0.297 0 502.7859 1,003.56 1,004.56 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% RFVEQVAR 95.00% 3.33 0.294 0 502.7866 1,003.56 1,004.56 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% RFVEQVAR 95.00% 2.51 0.194 0 502.7872 1,003.56 1,004.56 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% RFVEQVAR 95.00% 2.85 0.286 0 502.7883 1,003.56 1,004.56 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% RFVEQVAR 95.00% 2.54 0.293 0 502.7884 1,003.56 1,004.56 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% RFVEQVAR 95.00% 2.37 0.247 0 502.7887 1,003.56 1,004.56 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% RFVEQVAR 95.00% 2.42 0.296 0 502.7888 1,003.56 1,004.56 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% VMKHEAYGEcYK 95.00% 2.94 0.308 0 c10: Carbamidomethyl (+57.02) 505.5642 1,513.67 1,514.68 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.03 0 2.48 511.2709 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.48 0.376 0 511.2745 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.11 0.286 0 511.2747 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.78 0.399 1.15 511.2755 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.83 0.466 1.17 511.2757 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.08 0.316 0 511.2758 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.81 0.442 1.21 511.2759 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.77 0.428 0 511.2759 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.69 0.363 1.35 511.2761 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 3.03 0.458 0 511.2762 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.31 0.335 0 511.2764 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.73 0.439 0 511.2765 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.81 0.444 0 511.2765 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.49 0.416 0 511.2765 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.73 0.457 1.28 511.2765 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 2.88 0.429 0 511.2766 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLQGISSFR 95.00% 3.02 0.474 0 511.2791 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 2.31 0.305 0 537.8067 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.02 0.261 0 537.8068 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 2.57 0.317 0 537.807 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.19 0.305 0 537.8072 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 2.96 0.274 1.16 537.8073 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.14 0.266 0 537.8075 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.19 0.271 1.2 537.8075 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.04 0.264 0 537.8076 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.25 0.267 0 537.8076 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 2.8 0.298 0 537.8076 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 2.95 0.258 0 537.8078 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.21 0.277 0 537.808 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.07 0.276 0 537.808 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.07 0.266 0 537.808 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.03 0.26 0 537.808 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.23 0.294 0 537.8081 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.13 0.285 0 537.8082 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.11 0.271 0 537.8082 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.05 0.264 0 537.8082 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 2.82 0.238 0 537.8083 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 2.9 0.244 0 537.8083 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.02 0.29 0 537.8085 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 2.9 0.306 0 537.8089 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 3.33 0.281 0 537.8099 1,073.60 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NFVINVVNR 95.00% 2.53 0.224 0 538.2614 1,074.51 1,074.61 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% VFAVVITDGR 95.00% 2.62 0.218 0 538.8091 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% VFAVVITDGR 95.00% 3.67 0.34 0 538.8097 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% VFAVVITDGR 95.00% 3.78 0.409 0 538.8099 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% VFAVVITDGR 95.00% 3.85 0.395 0 538.8101 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% VFAVVITDGR 95.00% 2.24 0.253 0 538.8101 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% VFAVVITDGR 95.00% 3.73 0.378 0 538.8101 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DVTVTAIGIGDMFHEK 95.00% 3.43 0.469 3.09 578.2917 1,731.85 1,732.86 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DVTVTAIGIGDMFHEK 95.00% 3.56 0.593 1.82 578.292 1,731.85 1,732.86 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DVTVTAIGIGDMFHEK 95.00% 3.46 0.554 1.36 578.2922 1,731.85 1,732.86 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DVTVTAIGIGDMFHEK 95.00% 2.92 0.546 1.66 578.2924 1,731.85 1,732.86 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DVTVTAIGIGDMFHEK 95.00% 3.68 0.544 1.8 578.2924 1,731.85 1,732.86 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DVTVTAIGIGDMFHEK 95.00% 3.44 0.544 1.64 578.2924 1,731.85 1,732.86 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLKEQGLR 95.00% 2.62 0.301 0 600.3326 1,797.97 1,798.00 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLKEQGLR 95.00% 2.67 0.305 0 600.3326 1,797.97 1,798.00 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.86 0.184 1.7 607.8479 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.56 0.215 0 607.8488 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.76 0.0817 1.15 607.849 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.98 0.169 1.7 607.8492 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 3.01 0.228 1.52 607.8493 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.89 0.0923 2.12 607.8495 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.22 0.126 1.89 607.8495 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.89 0.189 1.74 607.8495 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 3.08 0.188 1.34 607.8496 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.85 0.152 0 607.8499 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 3.02 0.177 1.55 607.8499 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.8 0.174 2.02 607.8499 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.82 0.223 1.46 607.8499 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.74 0.147 1.62 607.8501 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.98 0.161 1.43 607.8501 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 3.17 0.236 2.17 607.8502 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.94 0.188 1.24 607.8502 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.95 0.138 1.7 607.8502 1,213.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.21 0.17 2.57 607.8503 1,213.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.87 0.158 1.36 607.8504 1,213.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.88 0.184 1.74 607.8504 1,213.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.97 0.184 1.62 607.8504 1,213.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 3.02 0.182 1.41 607.8505 1,213.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.78 0.156 1.34 607.8506 1,213.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.88 0.156 1.51 607.8506 1,213.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 3.21 0.197 1.51 607.8509 1,213.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 3.02 0.205 1.85 607.851 1,213.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.78 0.224 1.96 607.8517 1,213.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 3.13 0.215 1.66 607.8526 1,213.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.58 0.115 1.8 607.8528 1,213.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 3.11 0.0647 1.57 608.3456 1,214.68 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 3.04 0.13 1.74 608.3507 1,214.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLK 95.00% 2.66 0.178 1.8 608.3534 1,214.69 1,214.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% EQGLRDIASTPHELYR 95.00% 2.24 0.288 0 629.3279 1,884.96 1,884.96 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DIASTPHELYR 95.00% 3.01 0.456 3.66 651.3293 1,300.64 1,301.65 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DIASTPHELYR 95.00% 3.11 0.534 3.57 651.3296 1,300.64 1,301.65 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DIASTPHELYR 95.00% 3.26 0.529 3.51 651.3299 1,300.64 1,301.65 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DIASTPHELYR 95.00% 3.26 0.521 3.47 651.3299 1,300.64 1,301.65 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DIASTPHELYR 95.00% 3.47 0.543 2.7 651.3299 1,300.64 1,301.65 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DIASTPHELYR 95.00% 3.16 0.519 2.77 651.33 1,300.64 1,301.65 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DIASTPHELYR 95.00% 3.48 0.579 3.43 651.33 1,300.64 1,301.65 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DIASTPHELYR 95.00% 3 0.496 3.21 651.3301 1,300.64 1,301.65 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DIASTPHELYR 95.00% 3.23 0.526 3.23 651.3306 1,300.65 1,301.65 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DIASTPHELYR 95.00% 3.07 0.522 3.7 651.3314 1,300.65 1,301.65 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% VScLEIPGPSGPK 95.00% 2.75 0.262 1.96 c3: Carbamidomethyl (+57.02) 670.8493 1,339.68 1,340.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% VScLEIPGPSGPK 95.00% 2.81 0.44 3 c3: Carbamidomethyl (+57.02) 670.8493 1,339.68 1,340.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% VScLEIPGPSGPK 95.00% 3.1 0.441 3.66 c3: Carbamidomethyl (+57.02) 670.8502 1,339.68 1,340.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% HESENLYSIAcDKPQQVR 95.00% 5.56 0.613 5.33 c11: Carbamidomethyl (+57.02) 725.684 2,174.03 2,174.03 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% HESENLYSIAcDKPQQVR 95.00% 5.14 0.601 4.82 c11: Carbamidomethyl (+57.02) 725.6843 2,174.03 2,174.03 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% HESENLYSIAcDKPQQVR 95.00% 5.43 0.58 4.46 c11: Carbamidomethyl (+57.02) 725.6848 2,174.03 2,174.03 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% HESENLYSIAcDKPQQVR 95.00% 5.43 0.588 4.74 c11: Carbamidomethyl (+57.02) 725.6851 2,174.03 2,174.03 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% HESENLYSIAcDKPQQVR 95.00% 5.06 0.564 3 c11: Carbamidomethyl (+57.02) 725.6855 2,174.03 2,174.03 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% HESENLYSIAcDKPQQVR 95.00% 4.53 0.58 3.74 c11: Carbamidomethyl (+57.02) 725.686 2,174.03 2,174.03 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% HESENLYSIAcDKPQQVR 95.00% 5.57 0.634 4.05 c11: Carbamidomethyl (+57.02) 725.6863 2,174.04 2,174.03 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% HESENLYSIAcDKPQQVR 95.00% 5.03 0.616 3.03 c11: Carbamidomethyl (+57.02) 725.6875 2,174.04 2,174.03 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% YGGLHFSDQVEVFSPPGSDR 95.00% 3.49 0.281 0.959 732.3475 2,194.02 2,194.02 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% YGGLHFSDQVEVFSPPGSDR 95.00% 4.09 0.406 0.959 732.3481 2,194.02 2,194.02 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% YGGLHFSDQVEVFSPPGSDR 95.00% 4.34 0.356 0 732.3483 2,194.02 2,194.02 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% YGGLHFSDQVEVFSPPGSDR 95.00% 3.65 0.334 0 732.3492 2,194.02 2,194.02 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% YGGLHFSDQVEVFSPPGSDR 95.00% 4.57 0.404 0 732.3492 2,194.02 2,194.02 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.27 0.545 6.96 765.8475 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.73 0.574 6.6 765.8479 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 2.93 0.417 3.17 765.8482 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.01 0.596 6.96 765.8484 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.1 0.571 6.24 765.8484 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.3 0.528 6.68 765.8486 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.32 0.567 6.4 765.8486 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.1 0.529 3.4 765.8486 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.5 0.527 6.39 765.8487 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.58 0.543 6.85 765.8487 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.36 0.559 4.59 765.849 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.41 0.565 6.8 765.849 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 3.94 0.555 5.3 765.8494 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 3.45 0.492 3.66 765.8494 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.31 0.579 6.68 765.8496 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 3.97 0.549 4.72 765.8497 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.19 0.532 5.89 765.8497 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.02 0.518 5.51 765.8498 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.11 0.567 5.72 765.8499 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.53 0.565 5.43 765.8499 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 3.82 0.571 6 765.8501 1,529.68 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.15 0.584 6.16 766.3507 1,530.69 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.17 0.495 4.82 766.3514 1,530.69 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% DYDSLAQPGFFDR 95.00% 4.54 0.543 5.64 766.3515 1,530.69 1,530.69 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% GTVHFAVVITDGHVTGSPcGGIK 95.00% 4.75 0.582 5.35 c19: Carbamidomethyl (+57.02) 770.7305 2,309.17 2,309.17 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% GTVHFAVVITDGHVTGSPcGGIK 95.00% 4.6 0.57 5.08 c19: Carbamidomethyl (+57.02) 770.7317 2,309.17 2,309.17 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% GTVHFAVVITDGHVTGSPcGGIK 95.00% 5.08 0.592 2.31 c19: Carbamidomethyl (+57.02) 770.732 2,309.17 2,309.17 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% GTVHFAVVITDGHVTGSPcGGIK 95.00% 5.65 0.663 3.01 c19: Carbamidomethyl (+57.02) 770.7324 2,309.17 2,309.17 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NDYATMLPDSTEIDQDTINR 95.00% 4.21 0.591 2.03 771.687 2,312.04 2,312.04 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% AAVFHEKDYDSLAQPGFFDR 95.00% 3.84 0.397 0 772.0392 2,313.09 2,313.09 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% AAVFHEKDYDSLAQPGFFDR 95.00% 4.52 0.408 0 772.0396 2,313.10 2,313.09 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% SKGTVHFAVVITDGHVTGSPcGGIK 95.00% 3.98 0.375 3.36 c21: Carbamidomethyl (+57.02) 842.369 2,524.08 2,524.30 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLEWIAGGTWTPSALK 95.00% 4.52 0.518 4.82 872.4586 1,742.90 1,743.91 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLEWIAGGTWTPSALK 95.00% 5.67 0.599 4.8 872.4593 1,742.90 1,743.91 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLEWIAGGTWTPSALK 95.00% 5 0.553 5.3 872.4605 1,742.91 1,743.91 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLEWIAGGTWTPSALK 95.00% 3.06 0.499 2.17 872.4621 1,742.91 1,743.91 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLEWIAGGTWTPSALK 95.00% 6.21 0.562 4.92 872.9594 1,743.90 1,743.91 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLEWIAGGTWTPSALK 95.00% 5.97 0.548 5.21 872.9595 1,743.90 1,743.91 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NLEWIAGGTWTPSALK 95.00% 5.93 0.575 5.17 872.9601 1,743.90 1,743.91 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% RGDPGTKGSPGSDGPKGEKGDPGPEGPR 95.00% 0 0 3.52 897.4268 2,689.26 2,689.29 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% RGDPGTKGSPGSDGPKGEKGDPGPEGPR 95.00% 0 0 3.54 897.4348 2,689.28 2,689.29 3
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLKEQGLR 95.00% 2.56 0.214 4.28 899.9936 1,797.97 1,798.00 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% LFAVAPNQNLKEQGLR 95.00% 2.78 0.361 4.59 899.9956 1,797.98 1,798.00 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% YGGLHFSDQVEVFSPPGSDR 95.00% 6.33 0.616 6.55 1,098.02 2,194.02 2,194.02 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% YGGLHFSDQVEVFSPPGSDR 95.00% 5.86 0.617 5.32 1,098.02 2,194.02 2,194.02 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% YGGLHFSDQVEVFSPPGSDR 95.00% 6.16 0.627 4.77 1,098.02 2,194.02 2,194.02 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% YGGLHFSDQVEVFSPPGSDR 95.00% 6.11 0.627 6.47 1,098.02 2,194.02 2,194.02 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% YGGLHFSDQVEVFSPPGSDR 95.00% 6.06 0.632 4.42 1,098.02 2,194.02 2,194.02 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% YGGLHFSDQVEVFSPPGSDR 95.00% 6.43 0.629 5.02 1,098.02 2,194.02 2,194.02 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% YGGLHFSDQVEVFSPPGSDR 95.00% 5.59 0.628 4.89 1,098.02 2,194.02 2,194.02 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NDYATMLPDSTEIDQDTINR 95.00% 5.46 0.63 7.85 1,157.02 2,312.03 2,312.04 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NDYATMLPDSTEIDQDTINR 95.00% 5.56 0.606 7.62 1,157.03 2,312.04 2,312.04 2
 SAMPLE 4 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 19 22 172 24.60% NDYATmLPDSTEIDQDTINR 95.00% 5.17 0.651 6.11 m6: Oxidation (+15.99) 1,165.02 2,328.03 2,328.03 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LGEQNFHK 95.00% 2.03 0.256 0 486.7493 971.483 972.4904 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% RFVEQVAR 95.00% 2.9 0.292 0 502.786 1,003.56 1,004.56 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% RFVEQVAR 95.00% 2.95 0.296 0 502.7863 1,003.56 1,004.56 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% RFVEQVAR 95.00% 2.65 0.262 0 502.787 1,003.56 1,004.56 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% RFVEQVAR 95.00% 2.4 0.243 0 502.787 1,003.56 1,004.56 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% RFVEQVAR 95.00% 2.93 0.277 0 502.7875 1,003.56 1,004.56 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% RFVEQVAR 95.00% 2.42 0.248 0 502.7884 1,003.56 1,004.56 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% RFVEQVAR 94.90% 2.2 0.21 0 502.7892 1,003.56 1,004.56 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VMKHEAYGEcYK 95.00% 3.45 0.52 0 c10: Carbamidomethyl (+57.02) 505.5643 1,513.67 1,514.68 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VMKHEAYGEcYK 95.00% 2.61 0.266 0 c10: Carbamidomethyl (+57.02) 505.5658 1,513.67 1,514.68 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VMKHEAYGEcYK 95.00% 3.09 0.416 0 c10: Carbamidomethyl (+57.02) 505.5659 1,513.67 1,514.68 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VMKHEAYGEcYK 95.00% 3.21 0.281 0 c10: Carbamidomethyl (+57.02) 505.5662 1,513.68 1,514.68 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VMKHEAYGEcYK 95.00% 2.95 0.45 0 c10: Carbamidomethyl (+57.02) 505.5665 1,513.68 1,514.68 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VMKHEAYGEcYK 95.00% 3.44 0.422 0 c10: Carbamidomethyl (+57.02) 505.5667 1,513.68 1,514.68 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VMKHEAYGEcYK 95.00% 3.08 0.518 0 c10: Carbamidomethyl (+57.02) 505.5669 1,513.68 1,514.68 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 2.71 0.275 0 510.9009 1,529.68 1,530.69 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.77 0.415 0 511.2755 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.8 0.452 0 511.2755 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.92 0.431 1.59 511.2756 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.75 0.39 1.77 511.2757 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.71 0.458 1.22 511.2757 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 3.12 0.463 1.72 511.2758 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.74 0.38 0 511.2759 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.79 0.389 2.19 511.276 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.7 0.364 1.82 511.2761 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.42 0.344 1.51 511.2768 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.87 0.418 0 511.2768 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.76 0.442 1.33 511.2769 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.03 0.317 0 511.2775 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLQGISSFR 95.00% 2.53 0.285 0 511.2776 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.12 0.243 0 537.8064 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 3.2 0.276 0 537.8065 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.96 0.293 0 537.8069 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 3.15 0.272 0 537.807 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.73 0.273 0 537.8072 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 3.25 0.285 0 537.8073 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.89 0.283 0 537.8073 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 3.16 0.261 1.47 537.8074 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 3.19 0.27 0 537.8074 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.85 0.255 0 537.8077 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 3.37 0.318 1.28 537.8077 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.99 0.246 0 537.8078 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.94 0.252 0 537.8078 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 3.26 0.291 0 537.808 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 3.25 0.3 0 537.8081 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 3.01 0.261 0 537.8081 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 3.11 0.312 0 537.8081 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 3.2 0.28 0 537.8082 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.92 0.266 0 537.8083 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.85 0.278 0 537.8083 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.84 0.297 0 537.8083 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.49 0.259 0 537.8087 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.5 0.28 0 537.8087 1,073.60 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NFVINVVNR 95.00% 2.6 0.204 1.19 538.3004 1,074.59 1,074.61 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VFAVVITDGR 95.00% 3.78 0.406 0 538.8095 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VFAVVITDGR 95.00% 3.71 0.36 0 538.8098 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VFAVVITDGR 95.00% 3.9 0.376 0 538.81 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VFAVVITDGR 95.00% 3.55 0.364 0 538.8102 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VFAVVITDGR 95.00% 2.34 0.296 0 538.8103 1,075.61 1,076.61 2 TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VFAVVITDGR 95.00% 2.85 0.173 0 538.8108 1,075.61 1,076.61 2 TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VFAVVITDGR 95.00% 2.38 0.215 0 538.8108 1,075.61 1,076.61 2 TITIN_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DVTVTAIGIGDMFHEK 95.00% 3.18 0.469 1.1 578.2916 1,731.85 1,732.86 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DVTVTAIGIGDMFHEK 95.00% 3.27 0.504 0 578.2925 1,731.85 1,732.86 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DVTVTAIGIGDMFHEK 95.00% 3.15 0.456 1.82 578.2928 1,731.85 1,732.86 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DVTVTAIGIGDMFHEK 95.00% 2.92 0.47 1.08 578.293 1,731.86 1,732.86 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DVTVTAIGIGDMFHEK 95.00% 2.71 0.326 0 578.6258 1,732.85 1,732.86 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DVTVTAIGIGDMFHEK 95.00% 3.87 0.561 0 578.6263 1,732.86 1,732.86 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DVTVTAIGIGDMFHEK 95.00% 3.49 0.555 0 578.6268 1,732.86 1,732.86 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% HEAYGEcYK 95.00% 2.05 0.282 1.44 c7: Carbamidomethyl (+57.02) 578.7437 1,155.47 1,156.47 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% HEAYGEcYK 95.00% 1.78 0.266 2.28 c7: Carbamidomethyl (+57.02) 578.7439 1,155.47 1,156.47 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% HEAYGEcYK 95.00% 1.74 0.243 2.3 c7: Carbamidomethyl (+57.02) 578.7911 1,155.57 1,156.47 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLKEQGLR 95.00% 2.32 0.285 0 600.0619 1,797.16 1,798.00 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLKEQGLR 95.00% 2.82 0.24 0 600.3328 1,797.98 1,798.00 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLKEQGLR 95.00% 2.39 0.301 0 600.333 1,797.98 1,798.00 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLKEQGLR 95.00% 2.24 0.292 0 600.3337 1,797.98 1,798.00 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.42 0.163 2.08 607.8217 1,213.63 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.58 0.159 1.42 607.8471 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.58 0.0928 1.74 607.8488 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.97 0.197 2.41 607.8489 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 3.03 0.161 1.85 607.8489 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.87 0.175 1.51 607.8492 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.14 0.122 2.33 607.8493 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.97 0.15 2.46 607.8495 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.85 0.175 0 607.8495 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.95 0.163 1.38 607.8496 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.94 0.173 1.41 607.8497 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.51 0.0793 1.51 607.8497 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 3.12 0.221 2 607.8499 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.79 0.143 0 607.85 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.8 0.184 0 607.8501 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.96 0.19 1.31 607.8501 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.87 0.19 1.66 607.8501 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.72 0.191 1.82 607.8502 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 3.13 0.187 0 607.8502 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.79 0.144 0 607.8502 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.92 0.173 1.27 607.8502 1,213.68 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.93 0.195 0 607.8505 1,213.69 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 3.02 0.195 2.27 607.8506 1,213.69 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 3.05 0.172 1.64 607.8507 1,213.69 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.83 0.131 2.12 607.8507 1,213.69 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.93 0.193 1.7 607.8512 1,213.69 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.8 0.165 1.42 607.8528 1,213.69 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLK 95.00% 2.05 0.168 1.8 607.8531 1,213.69 1,214.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 2.1 0.259 0 651.2896 1,300.56 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 3.2 0.561 4.12 651.3282 1,300.64 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 3.03 0.503 3.19 651.3285 1,300.64 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 3.22 0.523 3.96 651.3295 1,300.64 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 3.13 0.462 2.85 651.3295 1,300.64 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 2.77 0.443 3.96 651.3295 1,300.64 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 3.05 0.497 3.04 651.3297 1,300.64 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 3.32 0.542 3.42 651.3311 1,300.65 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 3.2 0.497 4.01 651.3318 1,300.65 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 2.6 0.446 2.85 651.333 1,300.65 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 2.68 0.415 1.68 651.3338 1,300.65 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 2.48 0.33 0 651.3393 1,300.66 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DIASTPHELYR 95.00% 2.44 0.192 1.7 651.7832 1,301.55 1,301.65 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% TRVFAVVITDGR 95.00% 2.35 0.213 0 667.3477 1,332.68 1,333.76 2 IF4G3_HUMAN
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VScLEIPGPSGPK 95.00% 2.56 0.279 0 c3: Carbamidomethyl (+57.02) 670.8479 1,339.68 1,340.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VScLEIPGPSGPK 95.00% 2.68 0.249 1.92 c3: Carbamidomethyl (+57.02) 670.8488 1,339.68 1,340.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VScLEIPGPSGPK 95.00% 2.2 0.259 1.66 c3: Carbamidomethyl (+57.02) 670.8496 1,339.68 1,340.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VScLEIPGPSGPK 95.00% 2.95 0.312 1.44 c3: Carbamidomethyl (+57.02) 670.8496 1,339.68 1,340.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% VScLEIPGPSGPK 95.00% 3.14 0.409 3.28 c3: Carbamidomethyl (+57.02) 671.3513 1,340.69 1,340.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% HESENLYSIAcDKPQQVR 95.00% 4.96 0.625 3.59 c11: Carbamidomethyl (+57.02) 725.3505 2,173.03 2,174.03 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% HESENLYSIAcDKPQQVR 95.00% 5.02 0.614 4.16 c11: Carbamidomethyl (+57.02) 725.6836 2,174.03 2,174.03 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% HESENLYSIAcDKPQQVR 95.00% 4.95 0.558 3.77 c11: Carbamidomethyl (+57.02) 725.6849 2,174.03 2,174.03 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% PVDIVFLLDGSER 95.00% 4.49 0.687 0 730.3947 1,458.77 1,459.78 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% PVDIVFLLDGSER 95.00% 4.81 0.646 0 730.3949 1,458.77 1,459.78 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% PVDIVFLLDGSER 95.00% 4.41 0.681 0 730.3957 1,458.78 1,459.78 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% PVDIVFLLDGSER 95.00% 4.6 0.695 0 730.3962 1,458.78 1,459.78 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% PVDIVFLLDGSER 95.00% 3.71 0.62 0 730.3964 1,458.78 1,459.78 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% PVDIVFLLDGSER 95.00% 3.21 0.605 0 730.3988 1,458.78 1,459.78 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% YGGLHFSDQVEVFSPPGSDR 95.00% 4.6 0.38 1.19 732.3491 2,194.02 2,194.02 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% YGGLHFSDQVEVFSPPGSDR 95.00% 4.49 0.414 1.62 732.3496 2,194.03 2,194.02 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 3.44 0.559 1.96 765.847 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.16 0.571 6.52 765.8473 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.24 0.574 6.02 765.8476 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.48 0.537 6.43 765.8481 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.28 0.548 6.21 765.8483 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 3.58 0.559 2.72 765.8484 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.37 0.586 6.35 765.8484 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.54 0.573 5.55 765.8484 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.04 0.569 5.25 765.8485 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.26 0.566 6.89 765.8486 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.18 0.544 5.19 765.8495 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.16 0.571 6.68 765.8497 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.09 0.573 6.27 765.8498 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 3.52 0.526 3.04 765.8502 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.18 0.586 5.8 765.8502 1,529.68 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.39 0.577 5.82 765.8506 1,529.69 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.06 0.554 5.8 765.851 1,529.69 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 3.97 0.58 5.59 765.8513 1,529.69 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.24 0.586 7.68 765.8571 1,529.70 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% DYDSLAQPGFFDR 95.00% 4.31 0.54 6.82 765.8627 1,529.71 1,530.69 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% GTVHFAVVITDGHVTGSPcGGIK 95.00% 5.45 0.678 3.68 c19: Carbamidomethyl (+57.02) 770.397 2,308.17 2,309.17 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% GTVHFAVVITDGHVTGSPcGGIK 95.00% 5.59 0.661 3.89 c19: Carbamidomethyl (+57.02) 770.7319 2,309.17 2,309.17 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% AAVFHEKDYDSLAQPGFFDR 95.00% 3.64 0.172 1 772.04 2,313.10 2,313.09 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% AAVFHEKDYDSLAQPGFFDR 95.00% 3.8 0.365 0 772.0406 2,313.10 2,313.09 3
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLEWIAGGTWTPSALK 95.00% 3.58 0.55 4.02 872.461 1,742.91 1,743.91 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLEWIAGGTWTPSALK 95.00% 5.13 0.596 4.82 872.4612 1,742.91 1,743.91 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLEWIAGGTWTPSALK 95.00% 4.59 0.538 3.85 872.9605 1,743.91 1,743.91 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLEWIAGGTWTPSALK 95.00% 4.77 0.538 4.74 872.9608 1,743.91 1,743.91 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NLEWIAGGTWTPSALK 95.00% 4.63 0.525 4.28 872.9618 1,743.91 1,743.91 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLKEQGLR 95.00% 3.02 0.377 5.14 899.9954 1,797.98 1,798.00 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLKEQGLR 95.00% 2.87 0.337 5.09 899.9966 1,797.98 1,798.00 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% LFAVAPNQNLKEQGLR 95.00% 2.54 0.346 4.62 899.9991 1,797.98 1,798.00 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% YGGLHFSDQVEVFSPPGSDR 95.00% 6.13 0.625 4.89 1,097.51 2,193.01 2,194.02 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% YGGLHFSDQVEVFSPPGSDR 95.00% 6.09 0.67 6.1 1,098.01 2,194.01 2,194.02 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% YGGLHFSDQVEVFSPPGSDR 95.00% 5.96 0.646 4.19 1,098.01 2,194.01 2,194.02 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% YGGLHFSDQVEVFSPPGSDR 95.00% 5.96 0.638 5.92 1,098.02 2,194.02 2,194.02 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% YGGLHFSDQVEVFSPPGSDR 95.00% 6.04 0.657 4.82 1,098.02 2,194.02 2,194.02 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% YGGLHFSDQVEVFSPPGSDR 95.00% 6.16 0.63 3.7 1,098.02 2,194.02 2,194.02 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NDYATMLPDSTEIDQDTINR 95.00% 5.52 0.614 7.89 1,156.52 2,311.03 2,312.04 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NDYATMLPDSTEIDQDTINR 95.00% 5.59 0.617 6.57 1,157.02 2,312.03 2,312.04 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NDYATMLPDSTEIDQDTINR 95.00% 5.56 0.613 5.59 1,157.02 2,312.03 2,312.04 2
 SAMPLE 4R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 20 23 168 23.90% NDYATMLPDSTEIDQDTINR 95.00% 5.52 0.628 6.51 1,157.03 2,312.04 2,312.04 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NLQGISSFR 95.00% 2.48 0.273 0 511.2721 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NLQGISSFR 95.00% 2.63 0.296 0 511.2736 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NLQGISSFR 95.00% 2.65 0.37 0 511.274 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NLQGISSFR 95.00% 2.41 0.371 1.16 511.274 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NLQGISSFR 95.00% 2.2 0.242 2 511.2742 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NLQGISSFR 95.00% 2.62 0.388 0 511.2743 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NLQGISSFR 95.00% 2.68 0.446 2.07 511.2745 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NLQGISSFR 95.00% 2.48 0.33 1.47 511.2746 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NFVINVVNR 95.00% 3.08 0.238 0 537.8053 1,073.59 1,074.61 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NFVINVVNR 95.00% 2.75 0.273 0 537.8054 1,073.60 1,074.61 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NFVINVVNR 95.00% 3.02 0.276 0 537.8058 1,073.60 1,074.61 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NFVINVVNR 95.00% 2.69 0.288 0 537.8059 1,073.60 1,074.61 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NFVINVVNR 95.00% 2.47 0.213 0 537.806 1,073.60 1,074.61 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NFVINVVNR 95.00% 2.91 0.277 0 537.8061 1,073.60 1,074.61 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NFVINVVNR 95.00% 3.06 0.242 0 537.8061 1,073.60 1,074.61 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% VFAVVITDGR 95.00% 3.01 0.336 0 538.8078 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% VFAVVITDGR 95.00% 3.57 0.399 0 538.8084 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% LFAVAPNQNLK 95.00% 2.88 0.172 0 607.8477 1,213.68 1,214.69 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% LFAVAPNQNLK 95.00% 2.92 0.185 1.55 607.8477 1,213.68 1,214.69 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% DIASTPHELYR 95.00% 2.82 0.457 3.04 651.3267 1,300.64 1,301.65 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% DIASTPHELYR 95.00% 3.34 0.55 3.03 651.3269 1,300.64 1,301.65 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% DIASTPHELYR 95.00% 3.38 0.544 4.17 651.3274 1,300.64 1,301.65 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% DIASTPHELYR 95.00% 3.3 0.53 3.89 651.3289 1,300.64 1,301.65 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% DYDSLAQPGFFDR 95.00% 3.71 0.513 3.59 765.846 1,529.68 1,530.69 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% DYDSLAQPGFFDR 95.00% 3.75 0.572 6.07 765.8472 1,529.68 1,530.69 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% DYDSLAQPGFFDR 95.00% 3.97 0.57 3.13 766.3468 1,530.68 1,530.69 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% DYDSLAQPGFFDR 95.00% 4.28 0.532 6.96 766.3492 1,530.68 1,530.69 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NLEWIAGGTWTPSALK 95.00% 4.51 0.549 5.27 872.455 1,742.89 1,743.91 2
 SAMPLE 1 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 6 6 27 7.75% NLEWIAGGTWTPSALK 95.00% 4.11 0.216 3.96 872.4574 1,742.90 1,743.91 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% NLQGISSFR 95.00% 2.17 0.273 0 511.2739 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% NLQGISSFR 95.00% 2.25 0.244 0 511.2745 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% NFVINVVNR 95.00% 3.12 0.268 0 537.8054 1,073.60 1,074.61 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% NFVINVVNR 95.00% 2.47 0.276 0 537.8056 1,073.60 1,074.61 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% NFVINVVNR 95.00% 3 0.264 0 537.8056 1,073.60 1,074.61 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% NFVINVVNR 95.00% 2.74 0.264 0 537.8057 1,073.60 1,074.61 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% NFVINVVNR 95.00% 2.91 0.283 0 537.8059 1,073.60 1,074.61 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% NFVINVVNR 95.00% 3 0.263 0 537.8059 1,073.60 1,074.61 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% LFAVAPNQNLK 95.00% 2.98 0.186 0 607.847 1,213.68 1,214.69 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% LFAVAPNQNLK 95.00% 2.86 0.156 0 607.8474 1,213.68 1,214.69 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% DIASTPHELYR 95.00% 2.51 0.498 2.43 651.3266 1,300.64 1,301.65 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% DIASTPHELYR 95.00% 3.25 0.592 5.29 651.3276 1,300.64 1,301.65 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% DIASTPHELYR 95.00% 2.71 0.457 2.96 651.3277 1,300.64 1,301.65 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% DIASTPHELYR 95.00% 2.81 0.568 3.28 651.3284 1,300.64 1,301.65 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% DIASTPHELYR 95.00% 2.28 0.396 1.43 651.3286 1,300.64 1,301.65 2
 SAMPLE 1R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 5 5 16 5.20% DYDSLAQPGFFDR 95.00% 2.49 0.239 1.77 765.8464 1,529.68 1,530.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NLQGISSFR 95.00% 2.27 0.289 0 511.2733 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NLQGISSFR 95.00% 2.84 0.454 0 511.2737 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NLQGISSFR 95.00% 2.8 0.46 1.12 511.274 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NLQGISSFR 95.00% 2.86 0.455 0 511.2741 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NLQGISSFR 95.00% 2.72 0.281 1.36 511.2744 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NLQGISSFR 95.00% 2.08 0.345 0 511.2755 1,020.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NFVINVVNR 95.00% 2.41 0.255 0 537.8053 1,073.60 1,074.61 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NFVINVVNR 95.00% 3.08 0.291 0 537.8055 1,073.60 1,074.61 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NFVINVVNR 95.00% 3.1 0.273 0 537.8056 1,073.60 1,074.61 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NFVINVVNR 95.00% 3.08 0.249 0 537.8056 1,073.60 1,074.61 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NFVINVVNR 95.00% 3.02 0.28 0 537.8058 1,073.60 1,074.61 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NFVINVVNR 95.00% 2.99 0.252 0 537.8058 1,073.60 1,074.61 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NFVINVVNR 95.00% 3.11 0.277 0 537.8059 1,073.60 1,074.61 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NFVINVVNR 95.00% 3.21 0.283 0 537.8062 1,073.60 1,074.61 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NFVINVVNR 95.00% 2.57 0.291 0 537.8064 1,073.60 1,074.61 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NFVINVVNR 95.00% 2.83 0.249 0 537.8069 1,073.60 1,074.61 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% VFAVVITDGR 95.00% 2.84 0.302 0 538.8059 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% VFAVVITDGR 95.00% 3.9 0.368 0 538.8077 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% VFAVVITDGR 95.00% 3.05 0.185 0 538.808 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% VFAVVITDGR 95.00% 3.78 0.378 0 538.8081 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% VFAVVITDGR 95.00% 3.28 0.377 0 538.8084 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% VFAVVITDGR 95.00% 2.66 0.284 0 538.8089 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% LFAVAPNQNLK 95.00% 2.81 0.128 1.54 607.8448 1,213.67 1,214.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% LFAVAPNQNLK 95.00% 2.85 0.163 1.13 607.8465 1,213.68 1,214.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% LFAVAPNQNLK 95.00% 3.01 0.178 1.14 607.8474 1,213.68 1,214.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% LFAVAPNQNLK 95.00% 2.96 0.185 0 607.8474 1,213.68 1,214.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% LFAVAPNQNLK 95.00% 2.94 0.206 1.11 607.8476 1,213.68 1,214.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% LFAVAPNQNLK 95.00% 3.06 0.227 0 607.8477 1,213.68 1,214.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% LFAVAPNQNLK 95.00% 3.08 0.187 0 607.8479 1,213.68 1,214.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% LFAVAPNQNLK 95.00% 3.24 0.266 1.14 607.8483 1,213.68 1,214.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% LFAVAPNQNLK 94.90% 2.62 0 1.39 608.3394 1,214.66 1,214.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DIASTPHELYR 95.00% 2.13 0.28 0 651.3258 1,300.64 1,301.65 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DIASTPHELYR 95.00% 3.02 0.56 2.77 651.3271 1,300.64 1,301.65 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DIASTPHELYR 95.00% 2.92 0.477 2.96 651.3272 1,300.64 1,301.65 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DIASTPHELYR 95.00% 3.53 0.582 2.96 651.3273 1,300.64 1,301.65 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DIASTPHELYR 95.00% 3.33 0.569 3.05 651.3277 1,300.64 1,301.65 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DIASTPHELYR 95.00% 3.05 0.449 3.39 651.3277 1,300.64 1,301.65 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DIASTPHELYR 95.00% 3.33 0.497 3.09 651.3282 1,300.64 1,301.65 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DIASTPHELYR 95.00% 2.1 0.317 0 651.3282 1,300.64 1,301.65 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DIASTPHELYR 95.00% 2.69 0.472 4.03 651.3286 1,300.64 1,301.65 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% HESENLYSIAcDKPQQVR 95.00% 2.79 0.495 1.27 c11: Carbamidomethyl (+57.02) 724.8537 2,171.54 2,174.03 3
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% HESENLYSIAcDKPQQVR 95.00% 5.35 0.596 4.08 c11: Carbamidomethyl (+57.02) 725.681 2,174.02 2,174.03 3
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% HESENLYSIAcDKPQQVR 95.00% 5.34 0.566 3.85 c11: Carbamidomethyl (+57.02) 725.6835 2,174.03 2,174.03 3
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DYDSLAQPGFFDR 95.00% 3.76 0.586 4.52 765.8454 1,529.68 1,530.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DYDSLAQPGFFDR 95.00% 4.58 0.563 6.48 765.8459 1,529.68 1,530.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DYDSLAQPGFFDR 95.00% 4.6 0.533 7.02 765.846 1,529.68 1,530.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DYDSLAQPGFFDR 95.00% 3.55 0.546 3.72 765.8466 1,529.68 1,530.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DYDSLAQPGFFDR 95.00% 4.24 0.576 5.33 765.8467 1,529.68 1,530.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DYDSLAQPGFFDR 95.00% 3.93 0.547 5.62 765.847 1,529.68 1,530.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% DYDSLAQPGFFDR 95.00% 3.79 0.552 3.06 766.3486 1,530.68 1,530.69 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% VGVVQYSHEGTFEAIQLDDER 95.00% 3.69 0.47 0 798.3834 2,392.13 2,392.14 3
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NLEWIAGGTWTPSALK 95.00% 4.09 0.573 3.8 872.4591 1,742.90 1,743.91 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% NDYATMLPDSTEIDQDTINR 95.00% 4.8 0.554 5.89 1,156.52 2,311.02 2,312.04 2
 SAMPLE 2 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 10 10 48 16.30% RGDPGTKGSPGSDGPKGEKGDPGPEGPR 95.00% 0 0 4.42 1,345.63 2,689.25 2,689.29 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% RFVEQVAR 95.00% 2.52 0.271 0 502.7837 1,003.55 1,004.56 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VMKHEAYGEcYK 95.00% 2.5 0.359 0 c10: Carbamidomethyl (+57.02) 505.5655 1,513.67 1,514.68 3
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VMKHEAYGEcYK 95.00% 2.29 0.412 0 c10: Carbamidomethyl (+57.02) 505.8981 1,514.67 1,514.68 3
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NLQGISSFR 95.00% 2.31 0.345 0 511.2726 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NLQGISSFR 95.00% 2.04 0.261 0 511.2733 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NLQGISSFR 95.00% 2.31 0.276 0 511.274 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NLQGISSFR 95.00% 2.61 0.376 0 511.274 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NLQGISSFR 95.00% 2.58 0.449 0 511.2741 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NLQGISSFR 95.00% 2.1 0.352 0 511.2742 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NLQGISSFR 95.00% 2.07 0.396 0 511.2742 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NLQGISSFR 95.00% 2.42 0.405 1.35 511.2747 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NLQGISSFR 95.00% 2.2 0.359 0 511.2753 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NLQGISSFR 95.00% 2.51 0.357 0 511.7772 1,021.54 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NFVINVVNR 94.60% 2.4 0.195 0 537.805 1,073.59 1,074.61 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NFVINVVNR 95.00% 2.9 0.286 0 537.8055 1,073.60 1,074.61 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NFVINVVNR 95.00% 2.95 0.29 1.16 537.8055 1,073.60 1,074.61 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NFVINVVNR 95.00% 2.92 0.26 0 537.8056 1,073.60 1,074.61 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NFVINVVNR 95.00% 2.35 0.277 0 537.8059 1,073.60 1,074.61 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NFVINVVNR 95.00% 2.7 0.306 0 537.8067 1,073.60 1,074.61 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VFAVVITDGR 95.00% 3.33 0.253 0 538.8076 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VFAVVITDGR 95.00% 2.53 0.316 0 538.8079 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VFAVVITDGR 95.00% 3.85 0.399 1.85 538.808 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VFAVVITDGR 95.00% 3.32 0.227 0 538.8081 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VFAVVITDGR 95.00% 2.58 0.243 0 538.8082 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VFAVVITDGR 95.00% 3.15 0.311 0 538.8084 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VFAVVITDGR 95.00% 3.71 0.369 0 538.8085 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VFAVVITDGR 95.00% 3.68 0.394 0 538.8086 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VFAVVITDGR 95.00% 3.16 0.422 0 538.8088 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VFAVVITDGR 95.00% 2.48 0.246 0 538.8092 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% VFAVVITDGR 95.00% 2.73 0.346 0 538.8095 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% LFAVAPNQNLK 95.00% 2.46 0.229 0 607.7952 1,213.57 1,214.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% LFAVAPNQNLK 95.00% 2.57 0.28 0 607.7961 1,213.58 1,214.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% LFAVAPNQNLK 95.00% 3.03 0.181 0 607.8462 1,213.68 1,214.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% LFAVAPNQNLK 95.00% 2.39 0.121 1.34 607.8469 1,213.68 1,214.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% LFAVAPNQNLK 95.00% 3.04 0.22 0 607.8472 1,213.68 1,214.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% LFAVAPNQNLK 95.00% 3.26 0.245 1.28 607.8472 1,213.68 1,214.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% LFAVAPNQNLK 95.00% 2.92 0.212 0 607.8472 1,213.68 1,214.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% LFAVAPNQNLK 95.00% 3.19 0.216 0 607.8475 1,213.68 1,214.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% LFAVAPNQNLK 95.00% 2.91 0.159 0 607.8478 1,213.68 1,214.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% LFAVAPNQNLK 95.00% 2.98 0.171 0 607.8479 1,213.68 1,214.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% LFAVAPNQNLK 95.00% 2.97 0.131 1.37 607.8479 1,213.68 1,214.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% LFAVAPNQNLK 95.00% 3.07 0.243 1.11 607.8479 1,213.68 1,214.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DIASTPHELYR 95.00% 2.74 0.483 3.35 651.3269 1,300.64 1,301.65 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DIASTPHELYR 95.00% 3.41 0.536 3.3 651.3271 1,300.64 1,301.65 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DIASTPHELYR 95.00% 2.8 0.496 2.62 651.3272 1,300.64 1,301.65 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DIASTPHELYR 95.00% 3.23 0.581 3 651.3273 1,300.64 1,301.65 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DIASTPHELYR 95.00% 3.4 0.545 3.72 651.3273 1,300.64 1,301.65 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DIASTPHELYR 95.00% 3.17 0.437 2.82 651.3276 1,300.64 1,301.65 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DIASTPHELYR 95.00% 2.83 0.472 3.21 651.3283 1,300.64 1,301.65 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DIASTPHELYR 95.00% 2.78 0.443 3.43 651.3286 1,300.64 1,301.65 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DIASTPHELYR 95.00% 2.49 0.45 2.72 651.3298 1,300.64 1,301.65 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% HESENLYSIAcDKPQQVR 95.00% 3.12 0.514 1.17 c11: Carbamidomethyl (+57.02) 724.8538 2,171.54 2,174.03 3
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DYDSLAQPGFFDR 95.00% 3.71 0.562 4.72 765.8454 1,529.68 1,530.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DYDSLAQPGFFDR 95.00% 4.22 0.575 5.21 765.8459 1,529.68 1,530.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DYDSLAQPGFFDR 95.00% 3.46 0.52 2.1 765.846 1,529.68 1,530.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DYDSLAQPGFFDR 95.00% 4.39 0.573 6.64 765.846 1,529.68 1,530.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DYDSLAQPGFFDR 95.00% 3.74 0.572 5.02 765.8465 1,529.68 1,530.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% DYDSLAQPGFFDR 95.00% 3.71 0.549 3.82 765.8471 1,529.68 1,530.69 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NLEWIAGGTWTPSALK 95.00% 4.39 0.503 4.37 872.9568 1,743.90 1,743.91 2
 SAMPLE 2R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 49 11.50% NLEWIAGGTWTPSALK 95.00% 4.75 0.474 4.68 872.9581 1,743.90 1,743.91 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% VMKHEAYGEcYK 95.00% 2.02 0.328 0 c10: Carbamidomethyl (+57.02) 505.5652 1,513.67 1,514.68 3
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NLQGISSFR 95.00% 2.01 0.297 0 511.2737 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NLQGISSFR 95.00% 2.63 0.433 1.46 511.2739 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NLQGISSFR 95.00% 2.18 0.245 0 511.274 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NFVINVVNR 95.00% 3.22 0.278 0 537.8056 1,073.60 1,074.61 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NFVINVVNR 95.00% 3 0.23 0 537.8057 1,073.60 1,074.61 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NFVINVVNR 95.00% 2.86 0.271 1.2 537.8058 1,073.60 1,074.61 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NFVINVVNR 95.00% 2.9 0.257 0 537.8059 1,073.60 1,074.61 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NFVINVVNR 95.00% 2.76 0.268 0 537.8059 1,073.60 1,074.61 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NFVINVVNR 95.00% 3.06 0.268 0 537.806 1,073.60 1,074.61 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NFVINVVNR 95.00% 3.26 0.294 0 537.806 1,073.60 1,074.61 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NFVINVVNR 95.00% 2.69 0.303 0 537.8061 1,073.60 1,074.61 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NFVINVVNR 95.00% 3.09 0.3 0 537.8061 1,073.60 1,074.61 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% NFVINVVNR 95.00% 3.08 0.26 0 537.8064 1,073.60 1,074.61 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% VFAVVITDGR 95.00% 2.89 0.388 0 538.8075 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% VFAVVITDGR 95.00% 3.23 0.419 0 538.8088 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 2.97 0.357 0 607.7963 1,213.58 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 2.82 0.229 0 607.7967 1,213.58 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 2.81 0.19 1.51 607.8455 1,213.68 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 3.18 0.251 1.11 607.847 1,213.68 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 2.91 0.189 0 607.8471 1,213.68 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 2.83 0.159 1.72 607.8473 1,213.68 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 2.89 0.173 1.28 607.8474 1,213.68 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 2.93 0.167 1.23 607.8475 1,213.68 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 2.94 0.194 1.27 607.8475 1,213.68 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 2.9 0.178 0 607.8476 1,213.68 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 3 0.21 0 607.8477 1,213.68 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 2.95 0.173 1.08 607.8479 1,213.68 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 3.16 0.226 0 607.848 1,213.68 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% LFAVAPNQNLK 95.00% 2.82 0.136 0 607.8481 1,213.68 1,214.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% DIASTPHELYR 95.00% 2.32 0.429 2.41 651.3255 1,300.64 1,301.65 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% DIASTPHELYR 95.00% 3.1 0.532 3.46 651.327 1,300.64 1,301.65 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% DIASTPHELYR 95.00% 2.71 0.41 2.62 651.3272 1,300.64 1,301.65 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% DIASTPHELYR 95.00% 2.97 0.435 3.82 651.3274 1,300.64 1,301.65 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% DIASTPHELYR 95.00% 3.08 0.507 3.74 651.328 1,300.64 1,301.65 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% DIASTPHELYR 95.00% 3.45 0.546 3.32 651.3282 1,300.64 1,301.65 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% DIASTPHELYR 95.00% 3.06 0.462 5.06 651.8288 1,301.64 1,301.65 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% HESENLYSIAcDKPQQVR 95.00% 3.13 0.458 0 c11: Carbamidomethyl (+57.02) 725.355 2,173.04 2,174.03 3
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% DYDSLAQPGFFDR 95.00% 2.77 0.46 0 765.8452 1,529.67 1,530.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% DYDSLAQPGFFDR 95.00% 3.54 0.574 4.54 765.8477 1,529.68 1,530.69 2
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% RGDPGTKGSPGSDGPKGEKGDPGPEGPR 95.00% 0 0 3.38 897.4236 2,689.25 2,689.29 3
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% RGDPGTKGSPGSDGPKGEKGDPGPEGPR 95.00% 0 0 3.25 897.4242 2,689.25 2,689.29 3
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% RGDPGTKGSPGSDGPKGEKGDPGPEGPR 95.00% 0 0 3.57 897.4247 2,689.25 2,689.29 3
 SAMPLE 3 Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 9 9 42 13.80% YGGLHFSDQVEVFSPPGSDR 95.00% 5.88 0.58 6.06 1,098.01 2,194.01 2,194.02 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% VMKHEAYGEcYK 95.00% 2.23 0.319 0 c10: Carbamidomethyl (+57.02) 505.9 1,514.68 1,514.68 3
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% NLQGISSFR 94.70% 1.99 0.232 0 511.2733 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% NLQGISSFR 95.00% 1.94 0.319 0 511.2734 1,020.53 1,021.54 2 IF4G3_HUMAN,HNRPC_HUMAN
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% NFVINVVNR 95.00% 3 0.301 0 537.8052 1,073.59 1,074.61 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% NFVINVVNR 95.00% 2.56 0.247 0 537.8054 1,073.60 1,074.61 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% NFVINVVNR 95.00% 3.08 0.314 0 537.8059 1,073.60 1,074.61 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% NFVINVVNR 95.00% 2.34 0.302 1.11 537.8059 1,073.60 1,074.61 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% VFAVVITDGR 95.00% 2.1 0.237 0 538.8053 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% VFAVVITDGR 95.00% 3.75 0.395 0 538.8078 1,075.60 1,076.61 2 TITIN_HUMAN
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLKEQGLR 95.00% 2.24 0.271 0 600.332 1,797.97 1,798.00 3
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 2.61 0.282 0 607.7965 1,213.58 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 2.96 0.202 0 607.8462 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 2.81 0.266 0 607.8468 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 2.75 0.157 0 607.8469 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 3.13 0.263 1.11 607.847 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 2.51 0.0892 1.23 607.847 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 3.23 0.246 1.51 607.8471 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 2.96 0.199 1.17 607.8474 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 2.78 0.14 1.35 607.8474 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 3.25 0.241 1.17 607.8475 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 2.86 0.341 0 607.8476 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 2.91 0.2 0 607.8477 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 3.2 0.259 0 607.848 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 2.81 0.212 1.13 607.8487 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% LFAVAPNQNLK 95.00% 2.67 0.209 1.3 607.8501 1,213.68 1,214.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DIASTPHELYR 95.00% 2.89 0.475 3.33 651.3257 1,300.64 1,301.65 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DIASTPHELYR 95.00% 1.78 0.201 1.33 651.3264 1,300.64 1,301.65 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DIASTPHELYR 95.00% 3.01 0.513 2.66 651.3275 1,300.64 1,301.65 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DIASTPHELYR 95.00% 2.23 0.362 0 651.3276 1,300.64 1,301.65 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DIASTPHELYR 95.00% 3.38 0.502 2.74 651.3277 1,300.64 1,301.65 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DIASTPHELYR 95.00% 3.08 0.509 2.64 651.3278 1,300.64 1,301.65 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DIASTPHELYR 95.00% 2.69 0.52 1.89 651.3283 1,300.64 1,301.65 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DIASTPHELYR 95.00% 2.04 0.342 1.68 651.7815 1,301.55 1,301.65 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DIASTPHELYR 95.00% 3.32 0.554 3.59 651.8286 1,301.64 1,301.65 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DYDSLAQPGFFDR 95.00% 3.91 0.578 6.55 765.8476 1,529.68 1,530.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DYDSLAQPGFFDR 95.00% 2.59 0.357 0 765.8488 1,529.68 1,530.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DYDSLAQPGFFDR 95.00% 4.09 0.541 5 766.347 1,530.68 1,530.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% DYDSLAQPGFFDR 95.00% 4.1 0.564 4.26 766.3479 1,530.68 1,530.69 2
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% RGDPGTKGSPGSDGPKGEKGDPGPEGPR 95.00% 0 0 3.48 897.4258 2,689.25 2,689.29 3
 SAMPLE 3R Collagen alpha-2(VI) chain  COL6A2  CO6A2_HUMAN 108,562.80 100.00% 8 8 38 10.60% RGDPGTKGSPGSDGPKGEKGDPGPEGPR 95.00% 0 0 4.32 897.7572 2,690.25 2,689.29 3
 SAMPLE 2 Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 99.80% 2 2 6 3.27% GTNVWVALYK 95.00% 3.09 0.449 1.59 575.8151 1,149.61 1,150.63 2
 SAMPLE 2 Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 99.80% 2 2 6 3.27% GTNVWVALYK 95.00% 2.38 0.381 2.09 575.8154 1,149.62 1,150.63 2
 SAMPLE 2 Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 99.80% 2 2 6 3.27% GTNVWVALYK 95.00% 3.29 0.438 1.89 575.817 1,149.62 1,150.63 2
 SAMPLE 2 Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 99.80% 2 2 6 3.27% NNVPATYTYDEYK 95.00% 2.93 0.471 2.74 789.3587 1,576.70 1,577.71 2
 SAMPLE 2 Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 99.80% 2 2 6 3.27% NNVPATYTYDEYK 95.00% 3.84 0.526 4.32 789.362 1,576.71 1,577.71 2
 SAMPLE 2 Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 99.80% 2 2 6 3.27% NNVPATYTYDEYK 95.00% 3.97 0.481 2.74 789.8617 1,577.71 1,577.71 2
 SAMPLE 2R Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 100.00% 3 3 8 6.26% GTNVWVALYK 95.00% 2.64 0.458 1.42 575.8147 1,149.61 1,150.63 2
 SAMPLE 2R Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 100.00% 3 3 8 6.26% GTNVWVALYK 95.00% 2.25 0.368 1.46 575.8156 1,149.62 1,150.63 2
 SAMPLE 2R Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 100.00% 3 3 8 6.26% GTNVWVALYK 95.00% 3 0.381 2.15 575.816 1,149.62 1,150.63 2
 SAMPLE 2R Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 100.00% 3 3 8 6.26% GTNVWVALYK 95.00% 3.34 0.428 1.85 575.8164 1,149.62 1,150.63 2
 SAMPLE 2R Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 100.00% 3 3 8 6.26% GTNVWVALYK 95.00% 1.64 0 1.74 576.2942 1,150.57 1,150.63 2
 SAMPLE 2R Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 100.00% 3 3 8 6.26% GPPGPKGEAGPGGPPGVPGIR 95.00% 1.45 0.289 1 617.9611 1,850.86 1,850.99 3
 SAMPLE 2R Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 100.00% 3 3 8 6.26% NNVPATYTYDEYK 95.00% 3.92 0.515 3.82 789.3579 1,576.70 1,577.71 2
 SAMPLE 2R Collagen alpha-2(VIII) chain  COL8A2  CO8A2_HUMAN 67,227.50 100.00% 3 3 8 6.26% NNVPATYTYDEYK 95.00% 3.87 0.459 3.36 789.8619 1,577.71 1,577.71 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GFESKVDAILNR 95.00% 3.1 0.455 1.7 450.2481 1,347.72 1,348.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GFESKVDAILNR 95.00% 3.57 0.45 1.21 450.2485 1,347.72 1,348.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GFESKVDAILNR 95.00% 2.92 0.377 1.59 450.2486 1,347.72 1,348.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GFESKVDAILNR 95.00% 3.51 0.5 2.85 450.2487 1,347.72 1,348.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GFESKVDAILNR 95.00% 3.94 0.454 1.36 450.2489 1,347.72 1,348.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GFESKVDAILNR 95.00% 3.21 0.481 1.12 450.2491 1,347.72 1,348.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GFESKVDAILNR 95.00% 3.55 0.497 2.38 450.2498 1,347.73 1,348.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GFESKVDAILNR 95.00% 2.66 0.299 0 450.5834 1,348.73 1,348.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 2.61 0.211 0 456.2563 1,365.75 1,366.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.29 0.443 0.959 456.2564 1,365.75 1,366.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 2.9 0.458 0 456.2567 1,365.75 1,366.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.14 0.276 1.37 456.2569 1,365.75 1,366.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.89 0.461 1.3 456.2573 1,365.75 1,366.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.64 0.445 2.44 456.2574 1,365.75 1,366.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.43 0.466 1.92 456.2574 1,365.75 1,366.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 2.82 0.39 0 456.2576 1,365.75 1,366.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.02 0.366 0 456.258 1,365.75 1,366.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 2.83 0.378 1.15 456.2581 1,365.75 1,366.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLVLITGGK 95.00% 2.77 0.361 0 457.3095 912.6034 913.6089 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLVLITGGK 95.00% 2.89 0.372 0 457.3098 912.604 913.6089 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLVLITGGK 95.00% 3.14 0.356 1.21 457.3098 912.604 913.6089 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLVLITGGK 95.00% 2.91 0.391 0 457.3101 912.6045 913.6089 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLVLITGGK 95.00% 3.16 0.287 0 457.3101 912.6046 913.6089 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLVLITGGK 95.00% 2.57 0.419 0 457.3103 912.605 913.6089 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLVLITGGK 95.00% 2.8 0.354 0 457.3104 912.6051 913.6089 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLVLITGGK 95.00% 2.77 0.363 0 457.3108 912.6059 913.6089 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLVLITGGK 95.00% 2.6 0.391 0 457.3108 912.6059 913.6089 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLVLITGGK 95.00% 2.83 0.227 0 457.3111 912.6066 913.6089 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLVLITGGK 95.00% 2.98 0.367 0 457.3115 912.6073 913.6089 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLVLITGGK 95.00% 2.8 0.37 0 457.312 912.6084 913.6089 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 2.18 0.231 0 468.6033 1,402.79 1,403.79 3 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 3.09 0.368 2.23 468.6042 1,402.79 1,403.79 3 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QIIDAINKVVYK 95.00% 2.25 0.186 0 468.6154 1,402.82 1,403.83 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QIIDAINKVVYK 95.00% 2.44 0.273 0 468.6154 1,402.82 1,403.83 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QIIDAINKVVYK 95.00% 2.17 0.2 0 468.6161 1,402.82 1,403.83 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QIIDAINKVVYK 95.00% 2.32 0.234 0 468.6163 1,402.83 1,403.83 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SGFPLLKEFVQR 95.00% 2.74 0.375 1.54 474.2725 1,419.79 1,420.80 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SGFPLLKEFVQR 95.00% 2.34 0.191 0 474.2728 1,419.80 1,420.80 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SGFPLLKEFVQR 95.00% 1.9 0.461 0 474.2733 1,419.80 1,420.80 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.72 0.226 0 477.9128 1,430.72 1,431.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.44 0.254 0 477.9133 1,430.72 1,431.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.79 0.235 0 477.9136 1,430.72 1,431.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.63 0.218 0 477.9136 1,430.72 1,431.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.74 0.179 0 477.9137 1,430.72 1,431.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.38 0.183 0 477.9139 1,430.72 1,431.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.58 0.213 0 477.9139 1,430.72 1,431.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.68 0.264 0 477.914 1,430.72 1,431.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.42 0.24 0 477.9141 1,430.72 1,431.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.5 0.308 0 477.9141 1,430.72 1,431.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.6 0.164 0 477.9144 1,430.72 1,431.72 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 2.46 0.438 0 487.2881 972.5605 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 2.56 0.486 1.36 487.2881 972.5605 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 2.57 0.442 0 487.2885 972.5614 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 2.62 0.423 1.46 487.2886 972.5616 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 1.93 0.312 0 487.2888 972.562 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 2.59 0.374 2 487.2888 972.562 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 2.68 0.366 1.82 487.2889 972.5622 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 2.42 0.303 0 487.2891 972.5625 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 2.5 0.393 0 487.2892 972.5628 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 2.22 0.409 1.4 487.2893 972.563 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 2.39 0.372 0 487.2895 972.5633 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 2.31 0.312 0 487.2901 972.5645 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NLQVALTSK 95.00% 2.25 0.403 0 487.2901 972.5645 973.5683 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 3.01 0.425 0 487.2934 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.67 0.395 1.11 487.2934 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 3.12 0.485 1.52 487.2935 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.24 0.303 0 487.2936 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.7 0.431 1.04 487.2938 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.87 0.428 0 487.2939 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.73 0.423 1.96 487.2939 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.48 0.407 0 487.2942 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 3.32 0.424 1.21 487.2943 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.91 0.445 0 487.2943 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 3.21 0.51 1.36 487.2943 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.9 0.42 0 487.2943 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 3.25 0.469 1.68 487.2944 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.9 0.401 1.09 487.2944 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 3.31 0.483 1.96 487.2944 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 3.07 0.447 0 487.2945 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.31 0.413 2.24 487.2945 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.87 0.371 1.59 487.2946 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.6 0.41 0 487.2948 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 3.36 0.473 1.15 487.2949 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 3.48 0.37 0 487.2957 1,458.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.52 0.307 0 487.6284 1,459.86 1,459.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAMSFVAR 95.00% 3.49 0.404 3.15 489.9147 1,466.72 1,467.73 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAMSFVAR 95.00% 2.6 0.249 0 489.9148 1,466.72 1,467.73 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAMSFVAR 95.00% 3.56 0.476 2.3 489.9148 1,466.72 1,467.73 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDRVR 95.00% 1.71 0.266 0 491.2675 1,470.78 1,471.79 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDRVR 95.00% 1.8 0.314 1 491.2681 1,470.78 1,471.79 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDRVR 95.00% 1.69 0.275 0 491.2683 1,470.78 1,471.79 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDRVR 95.00% 1.85 0.275 0 491.269 1,470.78 1,471.79 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDRVR 95.00% 1.92 0.389 1.51 491.6022 1,471.78 1,471.79 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.05 0.317 1.23 492.3159 982.6161 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.36 0.304 0 492.3162 982.6168 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.35 0.303 0 492.3164 982.6172 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.32 0.319 0 492.3166 982.6176 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.38 0.302 1.22 492.3166 982.6176 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.93 0.327 0 492.3167 982.6177 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.21 0.312 0 492.3167 982.6178 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.96 0.342 1.24 492.3168 982.6179 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.12 0.326 1.35 492.3168 982.618 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.1 0.262 0 492.3169 982.6181 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.47 0.316 0 492.3169 982.6181 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.91 0.34 1.42 492.3169 982.6181 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.95 0.336 0 492.3169 982.6181 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.14 0.339 0 492.317 982.6183 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.1 0.336 0 492.317 982.6184 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.16 0.287 0 492.3171 982.6185 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 1.75 0.301 2.46 492.3171 982.6185 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.48 0.323 0 492.3171 982.6185 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.24 0.318 1.41 492.3171 982.6186 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.2 0.29 0 492.3172 982.6187 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.53 0.395 0 492.3172 982.6187 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.36 0.308 1.35 492.3172 982.6188 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.24 0.363 0 492.3172 982.6188 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.37 0.308 0 492.3173 982.6189 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.15 0.311 0 492.3173 982.619 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3 0.341 1.48 492.3175 982.6194 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.09 0.332 1.16 492.3179 982.6202 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.55 0.326 1.22 492.3179 982.6202 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 3.15 0.335 1.17 492.3179 982.6202 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.64 0.3 0 492.3181 982.6205 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.42 0.334 1.46 492.3183 982.621 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.15 0.395 1.21 492.3184 982.6212 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.27 0.373 1.23 492.3185 982.6214 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.32 0.332 1.62 492.3195 982.6233 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.21 0.212 0 492.3228 982.63 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLER 95.00% 2.22 0.269 2.13 492.8222 983.6288 983.6255 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.01 0.383 0 495.2748 1,482.80 1,483.81 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 2.39 0.323 2.14 495.276 1,482.80 1,483.81 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.17 0.413 1.6 495.276 1,482.80 1,483.81 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.31 0.294 1.15 495.2767 1,482.81 1,483.81 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 2.49 0.367 0 495.2768 1,482.81 1,483.81 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.14 0.331 0 495.2768 1,482.81 1,483.81 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 2.65 0.209 0 495.277 1,482.81 1,483.81 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 2.56 0.289 1.47 495.2772 1,482.81 1,483.81 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.67 0.449 1.28 495.6113 1,483.81 1,483.81 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.05 0.302 0 495.6118 1,483.81 1,483.81 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% DSFQEVLR 95.00% 2.93 0.341 0 497.2538 992.492 993.5006 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% DSFQEVLR 95.00% 2.91 0.337 0 497.2542 992.4928 993.5006 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% DSFQEVLR 95.00% 2.92 0.32 0 497.2545 992.4934 993.5006 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% DSFQEVLR 95.00% 2.8 0.319 0 497.2547 992.4938 993.5006 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% DSFQEVLR 95.00% 2.71 0.332 0 497.2549 992.4941 993.5006 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% DSFQEVLR 95.00% 2.47 0.324 0 497.255 992.4943 993.5006 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% DSFQEVLR 95.00% 2.65 0.312 0 497.255 992.4944 993.5006 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% DSFQEVLR 95.00% 3.06 0.321 0 497.2551 992.4945 993.5006 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% DSFQEVLR 95.00% 2.29 0.272 0 497.2552 992.4948 993.5006 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% DSFQEVLR 95.00% 2.33 0.292 0 497.2562 992.4967 993.5006 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ELPNIEER 95.00% 1.82 0.383 0 500.2598 998.5039 999.5112 2 SPTA2_HUMAN,TITIN_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LMHLEFGR 95.00% 2.16 0.367 0 501.7625 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LMHLEFGR 95.00% 2.18 0.346 0 501.764 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LMHLEFGR 95.00% 2.14 0.353 0 501.7642 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LMHLEFGR 95.00% 2.07 0.357 0 501.7644 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LMHLEFGR 95.00% 2.06 0.272 0 501.7645 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LMHLEFGR 95.00% 2.18 0.289 0 501.7646 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LMHLEFGR 95.00% 2 0.282 0 501.766 1,001.52 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LMHLEFGR 95.00% 2.08 0.253 0 501.7692 1,001.52 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LMHLEFGR 95.00% 2.25 0.312 0 502.2672 1,002.52 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.08 0.371 0 505.257 1,512.75 1,513.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 2.66 0.139 0 505.2572 1,512.75 1,513.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 3.56 0.367 0 505.2575 1,512.75 1,513.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 3.8 0.329 0 505.5919 1,513.75 1,513.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQHPYVLTEDTLK 95.00% 3.45 0.354 1.3 511.2661 1,530.77 1,530.78 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQHPYVLTEDTLK 95.00% 3.75 0.346 1 511.2666 1,530.78 1,530.78 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% AcNLDVILGFDGSR 95.00% 2.39 0.214 0 c2: Carbamidomethyl (+57.02) 512.9208 1,535.74 1,536.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% AcNLDVILGFDGSR 95.00% 2.56 0.164 1.07 c2: Carbamidomethyl (+57.02) 512.9219 1,535.74 1,536.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% AcNLDVILGFDGSR 95.00% 2.94 0.275 2.52 c2: Carbamidomethyl (+57.02) 512.922 1,535.74 1,536.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% AcNLDVILGFDGSR 95.00% 2.82 0.285 1 c2: Carbamidomethyl (+57.02) 512.9221 1,535.74 1,536.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% AcNLDVILGFDGSR 95.00% 3.35 0.385 1.22 c2: Carbamidomethyl (+57.02) 512.9224 1,535.74 1,536.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% AcNLDVILGFDGSR 95.00% 2.02 0.233 0 c2: Carbamidomethyl (+57.02) 512.9229 1,535.75 1,536.75 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IASNSATAFR 95.00% 2.51 0.389 2.66 519.273 1,036.53 1,037.54 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IASNSATAFR 95.00% 1.87 0.286 1.2 519.2737 1,036.53 1,037.54 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 1.95 0.31 1.3 529.6485 1,585.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 2.48 0.323 0 529.6489 1,585.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 2.03 0.238 0 529.6489 1,585.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 1.78 0.294 1.1 529.6489 1,585.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 1.85 0.319 2.07 529.6489 1,585.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 2.39 0.297 0 529.649 1,585.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 2.15 0.302 1.46 529.6492 1,585.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 2.36 0.316 1.46 529.9819 1,586.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 1.84 0.269 1.28 529.9826 1,586.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 2.14 0.228 0 529.9827 1,586.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.49 0.341 1.28 535.3045 1,068.59 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.85 0.418 1.89 535.3048 1,068.59 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 3.25 0.425 2 535.3048 1,068.59 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.8 0.336 2.19 535.3049 1,068.59 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 3.25 0.41 1.57 535.3051 1,068.59 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.89 0.379 1.41 535.3051 1,068.59 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.43 0.375 1.28 535.3051 1,068.59 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 3.11 0.405 1.64 535.3051 1,068.59 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 3.01 0.396 1.96 535.3052 1,068.59 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.4 0.361 1.74 535.3053 1,068.59 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.84 0.407 1.77 535.3054 1,068.60 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.8 0.365 1.55 535.3054 1,068.60 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.2 0.292 2 535.3054 1,068.60 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.89 0.387 1.55 535.3056 1,068.60 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 1.83 0.299 2.1 535.3058 1,068.60 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.58 0.374 0 535.3079 1,068.60 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.48 0.327 2.01 535.3086 1,068.60 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQAPVLDAIR 95.00% 2.79 0.363 2.03 535.8059 1,069.60 1,069.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 2.3 0.349 0 538.6209 1,612.84 1,613.85 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 2.47 0.224 0 538.6223 1,612.84 1,613.85 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 2.02 0.294 0 538.6227 1,612.84 1,613.85 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 2.53 0.32 0 538.6228 1,612.84 1,613.85 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 1.93 0.221 0 538.6229 1,612.85 1,613.85 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 2.02 0.228 0 538.623 1,612.85 1,613.85 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 2.32 0.226 0 538.6239 1,612.85 1,613.85 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 2.43 0.335 0 538.9581 1,613.85 1,613.85 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 2.31 0.202 0 538.9596 1,613.86 1,613.85 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.71 0.486 1.42 544.6125 1,630.81 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.43 0.463 2.72 544.6132 1,630.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.01 0.408 1.18 544.6133 1,630.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.13 0.442 3.03 544.6133 1,630.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.57 0.439 2.17 544.6134 1,630.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 3.5 0.427 0 544.6138 1,630.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.41 0.443 1.8 544.6141 1,630.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.96 0.487 1.6 544.6144 1,630.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.46 0.488 2.31 544.6144 1,630.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 3.74 0.38 0 544.6144 1,630.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.35 0.458 3.13 544.6149 1,630.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.01 0.482 1.34 544.6149 1,630.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.79 0.408 2.16 544.9489 1,631.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.49 0.49 1.37 544.9493 1,631.82 1,631.82 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.43 0.296 1.35 558.6592 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.25 0.325 1.04 558.6592 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.34 0.359 2.03 558.6594 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.33 0.36 1.96 558.6595 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.15 0.343 1.57 558.6595 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.14 0.263 0 558.6595 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.19 0.239 0 558.6595 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.08 0.28 1.02 558.6597 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.48 0.304 1.48 558.6597 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.35 0.277 1.33 558.6597 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 2.92 0.237 1.33 558.6597 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.24 0.328 1.7 558.6602 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.05 0.217 0 558.6602 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.09 0.318 1.8 558.6603 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.43 0.321 1.89 558.9926 1,673.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.42 0.283 1.17 558.9935 1,673.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.16 0.356 0 558.9937 1,673.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.02 0.19 1.31 558.994 1,673.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.38 0.265 1.25 558.9941 1,673.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.19 0.336 1.3 558.9942 1,673.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.1 0.244 1.62 558.9946 1,673.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TRPEFYLNSYmNK 95.00% 2.61 0.247 0 m11: Oxidation (+15.99) 560.271 1,677.79 1,678.79 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TRPEFYLNSYmNK 95.00% 2.79 0.252 0 m11: Oxidation (+15.99) 560.2723 1,677.79 1,678.79 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IAVAQYSDDVKVESR 95.00% 3.54 0.343 1.57 560.6255 1,678.85 1,679.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IAVAQYSDDVKVESR 95.00% 3.08 0.36 1.28 560.6258 1,678.85 1,679.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IAVAQYSDDVKVESR 95.00% 3.4 0.46 1.32 560.6262 1,678.86 1,679.86 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 3.89 0.496 1.96 562.6622 1,684.96 1,685.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.48 0.472 2.64 562.6624 1,684.96 1,685.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.52 0.466 3.12 562.6624 1,684.96 1,685.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.86 0.507 2.3 562.6627 1,684.96 1,685.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.29 0.472 3.05 562.6629 1,684.97 1,685.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 3.9 0.494 2.47 562.6635 1,684.97 1,685.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 2.58 0.389 0 562.9963 1,685.97 1,685.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLERVVNLER 95.00% 3.44 0.48 0 565.3501 1,693.03 1,694.03 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLERVVNLER 95.00% 3.64 0.596 2.28 565.3502 1,693.03 1,694.03 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLERVVNLER 95.00% 3.4 0.377 0 565.3505 1,693.03 1,694.03 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLERVVNLER 95.00% 3.14 0.458 1.24 565.3507 1,693.03 1,694.03 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALILVGLERVVNLER 95.00% 3.42 0.371 1.31 565.3509 1,693.03 1,694.03 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSIMAFAIGNK 95.00% 3.43 0.49 3.15 569.8003 1,137.59 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSIMAFAIGNK 95.00% 3.72 0.491 3 569.8006 1,137.59 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSIMAFAIGNK 95.00% 3.65 0.48 2.64 569.8006 1,137.59 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSIMAFAIGNK 95.00% 3.58 0.5 3.08 569.8018 1,137.59 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSIMAFAIGNK 95.00% 2.52 0.322 1.2 569.8037 1,137.59 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 3.03 0.301 1.43 569.9748 1,706.90 1,707.89 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KADIVFLLDGSINFR 95.00% 2.78 0.387 2.31 570.3021 1,707.88 1,707.94 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 2.96 0.333 1.72 570.3068 1,707.90 1,707.89 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 3.35 0.282 0 570.307 1,707.90 1,707.89 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 3.96 0.447 2.21 570.3077 1,707.90 1,707.89 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSIMAFAIGNK 95.00% 0 0 3.17 570.627 1,139.24 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 2.97 0.262 3.82 573.8092 1,145.60 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.57 0.417 4.08 573.8098 1,145.60 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.24 0.409 4.36 573.8103 1,145.60 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.54 0.409 6.07 573.8104 1,145.61 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.64 0.394 4.89 573.8108 1,145.61 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.9 0.43 4.24 573.8108 1,145.61 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.5 0.385 4.85 573.8109 1,145.61 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.74 0.404 4.6 573.8109 1,145.61 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.22 0.366 3.55 573.8114 1,145.61 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.06 0.409 3.96 573.8116 1,145.61 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.33 0.365 4.96 573.8119 1,145.61 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.75 0.387 3.89 573.812 1,145.61 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.57 0.37 3.55 573.8124 1,145.61 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.46 0.383 4.24 573.8147 1,145.61 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.03 0.443 3.49 573.948 1,145.88 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 2.73 0.392 1.85 574.2834 1,146.55 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SSGIVSLGVGDR 95.00% 3.63 0.36 4.11 574.3131 1,146.61 1,146.61 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% RDSFQEVLR 95.00% 2.62 0.152 0 575.3047 1,148.59 1,149.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% RDSFQEVLR 95.00% 2.93 0.156 0 575.3048 1,148.59 1,149.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% RDSFQEVLR 95.00% 3.01 0.142 0 575.3053 1,148.60 1,149.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% RDSFQEVLR 95.00% 3.07 0.148 1.66 575.3057 1,148.60 1,149.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% RDSFQEVLR 95.00% 2.98 0.183 0 575.3061 1,148.60 1,149.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% RDSFQEVLR 95.00% 3.15 0.18 1.7 575.3061 1,148.60 1,149.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% RDSFQEVLR 95.00% 2.95 0.184 0 575.3063 1,148.60 1,149.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% RDSFQEVLR 95.00% 2.86 0.19 0 575.3065 1,148.60 1,149.60 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.39 0.467 1.27 581.3363 1,740.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.62 0.503 1.03 581.3373 1,740.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 5.05 0.496 1.96 581.3374 1,740.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.9 0.397 1.14 581.3374 1,740.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.64 0.448 0 581.3378 1,740.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 5.03 0.436 1.48 581.3381 1,740.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 5.09 0.521 1.52 581.3382 1,740.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.2 0.492 0 581.3385 1,740.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 5.64 0.519 0 581.3386 1,740.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.92 0.461 2.3 581.3389 1,740.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.98 0.405 2.52 581.339 1,740.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.94 0.408 1.49 581.6721 1,741.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.87 0.432 1.3 581.6721 1,741.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.6 0.504 1.49 581.6723 1,741.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.96 0.461 0 581.6725 1,741.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 5.11 0.468 1.42 581.6725 1,741.99 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.78 0.468 1.41 581.6729 1,742.00 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.57 0.447 0 581.673 1,742.00 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 5.77 0.547 1.48 581.6732 1,742.00 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.7 0.405 0 581.6732 1,742.00 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.68 0.458 1.47 581.6732 1,742.00 1,742.00 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDRTELQTITNDPR 95.00% 3.21 0.424 0 595.9761 1,784.90 1,785.91 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDRTELQTITNDPR 95.00% 3.42 0.366 1.08 595.9763 1,784.91 1,785.91 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDRTELQTITNDPR 95.00% 2.48 0.242 0 595.9764 1,784.91 1,785.91 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDRTELQTITNDPR 95.00% 3.37 0.473 0 595.9768 1,784.91 1,785.91 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDRTELQTITNDPR 95.00% 3.05 0.327 0 595.977 1,784.91 1,785.91 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDRTELQTITNDPR 95.00% 2.37 0.248 0 595.9777 1,784.91 1,785.91 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDRTELQTITNDPR 95.00% 2.23 0.254 0 595.978 1,784.91 1,785.91 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDRTELQTITNDPR 95.00% 3.68 0.385 0 596.3105 1,785.91 1,785.91 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIKDK 95.00% 2.15 0.325 0 c7: Carbamidomethyl (+57.02) 597.6383 1,789.89 1,790.90 3 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% FDEHQSKPEILNLVK 95.00% 3.24 0.319 0 599.6586 1,795.95 1,796.95 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QFGVAPFTIAR 95.00% 2.17 0.227 0 603.8359 1,205.66 1,206.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QFGVAPFTIAR 95.00% 2.26 0.296 0 603.836 1,205.66 1,206.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QFGVAPFTIAR 95.00% 2.11 0.244 0 603.8363 1,205.66 1,206.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QFGVAPFTIAR 95.00% 2.15 0.237 0 603.8364 1,205.66 1,206.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QFGVAPFTIAR 95.00% 2.06 0.266 0 603.8364 1,205.66 1,206.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QFGVAPFTIAR 95.00% 2.31 0.316 0 603.8365 1,205.66 1,206.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QFGVAPFTIAR 95.00% 2.36 0.263 0 603.8365 1,205.66 1,206.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QFGVAPFTIAR 95.00% 2.19 0.241 0 603.8366 1,205.66 1,206.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QFGVAPFTIAR 95.00% 2.04 0.289 0 603.8367 1,205.66 1,206.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QFGVAPFTIAR 95.00% 2.16 0.269 0 603.8368 1,205.66 1,206.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QFGVAPFTIAR 95.00% 2.33 0.3 1.74 603.8369 1,205.66 1,206.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VNHFVPEAGSR 95.00% 2.26 0.381 0 606.8154 1,211.62 1,212.61 2 AHNK_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IKNLQVALTSK 95.00% 2.26 0.266 0 607.8825 1,213.75 1,214.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDR 95.00% 3.61 0.554 4.1 608.8113 1,215.61 1,216.62 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDR 95.00% 3.59 0.61 4.08 608.8131 1,215.61 1,216.62 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDR 95.00% 3.4 0.585 2.74 608.8136 1,215.61 1,216.62 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDR 95.00% 3.79 0.598 3.82 608.8139 1,215.61 1,216.62 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDR 95.00% 3.53 0.576 3.06 608.814 1,215.61 1,216.62 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDR 95.00% 3.5 0.559 3.44 608.8141 1,215.61 1,216.62 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDR 95.00% 3.72 0.563 2.2 608.8142 1,215.61 1,216.62 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDR 95.00% 3.15 0.547 4.24 608.8145 1,215.61 1,216.62 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDR 95.00% 3.44 0.54 3.7 608.8145 1,215.61 1,216.62 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVIQFSDDPK 95.00% 2.66 0.41 2.72 609.8228 1,217.63 1,218.64 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVIQFSDDPK 95.00% 3.51 0.451 3 609.823 1,217.63 1,218.64 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVIQFSDDPK 95.00% 3.5 0.501 2.23 609.8232 1,217.63 1,218.64 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVIQFSDDPK 95.00% 3.13 0.43 2.72 609.8233 1,217.63 1,218.64 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVIQFSDDPK 95.00% 3.38 0.47 2.72 609.8233 1,217.63 1,218.64 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVIQFSDDPK 95.00% 3.6 0.54 3.35 609.8239 1,217.63 1,218.64 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVIQFSDDPK 95.00% 3.6 0.505 2.43 609.8241 1,217.63 1,218.64 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVIQFSDDPK 95.00% 3.11 0.458 2.47 609.8241 1,217.63 1,218.64 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVIQFSDDPK 95.00% 3.14 0.516 3.55 609.8241 1,217.63 1,218.64 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVIQFSDDPK 95.00% 2.55 0.352 0 609.825 1,217.63 1,218.64 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVIQFSDDPK 95.00% 2.86 0.361 2.26 610.325 1,218.63 1,218.64 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 1.86 0.394 1.19 614.8017 1,227.59 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 1.71 0.413 1.48 614.8044 1,227.59 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 2.97 0.406 1.77 615.2976 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 2.68 0.3 1.31 615.2978 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 3.13 0.415 1.7 615.2987 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 3.08 0.325 0 615.2993 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 3.09 0.403 2.24 615.2995 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 2.49 0.41 1.62 615.3001 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 2.85 0.394 1.47 615.3001 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 2.99 0.411 2.4 615.3003 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 3.08 0.422 1.92 615.3004 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 3.32 0.47 2.29 615.3006 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 2.98 0.378 1.39 615.3006 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 3.16 0.47 2.32 615.3006 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 3.39 0.516 2.08 615.3007 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 3.28 0.438 2.46 615.3008 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 3.22 0.433 1.89 615.3008 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 3.18 0.45 2.48 615.3014 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NNLFTSSAGYR 95.00% 3.34 0.456 2.23 615.3018 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.7 0.442 1.82 615.3656 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.62 0.515 3.72 615.3665 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.69 0.577 4.29 615.3669 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.95 0.518 2 615.3669 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.14 0.594 2.08 615.3669 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.23 0.509 2.8 615.367 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.23 0.467 0 615.367 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.4 0.605 4.49 615.3671 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.9 0.567 1.92 615.3673 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.25 0.589 0 615.3673 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.86 0.621 2.96 615.3675 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.68 0.593 3.96 615.3675 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.56 0.581 4.59 615.3676 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.72 0.579 3.85 615.3678 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.79 0.611 3.96 615.3678 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.87 0.557 3.66 615.3678 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.58 0.574 4.14 615.3679 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.71 0.598 4.39 615.368 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.79 0.627 3.68 615.3681 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.49 0.548 3.6 615.3682 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.74 0.563 3.85 615.3687 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.19 0.613 4.21 615.3689 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.29 0.568 1.89 615.3689 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.92 0.493 2.72 615.369 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.2 0.551 3.92 615.3697 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.14 0.561 2.92 615.3697 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.97 0.605 2.36 615.3697 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.19 0.53 1.89 615.37 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.57 0.578 2.44 615.37 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.35 0.396 2.32 615.3703 1,228.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.24 0.461 0 615.3716 1,228.73 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.26 0.476 1.41 615.6106 1,229.21 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 3.64 0.591 3.33 615.8685 1,229.72 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.12 0.395 1.49 615.8709 1,229.73 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.19 0.474 0 615.8717 1,229.73 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VPQIAFVITGGK 95.00% 2.16 0.442 0 615.8723 1,229.73 1,229.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.39 0.512 4.12 619.8313 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.46 0.558 2.82 619.8315 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.25 0.457 2.16 619.8315 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.66 0.582 2.77 619.8316 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.38 0.557 2.55 619.8316 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.32 0.531 3.3 619.8317 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.16 0.426 2.32 619.8318 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.48 0.525 2.27 619.8319 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.42 0.561 2.47 619.8319 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.59 0.54 2.28 619.8319 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.47 0.582 3.38 619.8319 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.5 0.476 2.51 619.8321 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.22 0.526 2.08 619.8321 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.19 0.496 2.19 619.8321 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.47 0.551 2.52 619.8322 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.22 0.511 3.77 619.8322 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.41 0.543 4.68 619.8322 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.36 0.518 2.72 619.8324 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.29 0.552 2.19 619.8325 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.42 0.534 3.06 619.8326 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.47 0.514 2.89 619.8328 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.37 0.49 2.14 619.8334 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.39 0.497 2.64 619.8337 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 3.21 0.476 2.54 619.8346 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 2.39 0.217 0 619.8353 1,237.65 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVFFSNTPTR 95.00% 2.2 0.288 0 619.8371 1,237.66 1,238.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% FAQVIRSSGIVSLGVGDR 95.00% 2.07 0.198 1.34 621.2944 1,860.86 1,861.03 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% FAQVIRSSGIVSLGVGDR 95.00% 2.15 0.243 1.29 621.2947 1,860.86 1,861.03 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% FAQVIRSSGIVSLGVGDR 95.00% 3.42 0.42 2.89 621.3516 1,861.03 1,861.03 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VEFLLNAHSSK 95.00% 2.3 0.321 0 622.8362 1,243.66 1,244.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VEFLLNAHSSK 95.00% 3.35 0.447 1.52 622.8371 1,243.66 1,244.66 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVLLDKIKNLQVALTSK 95.00% 3.47 0.456 1.29 624.0525 1,869.13 1,870.14 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVLLDKIKNLQVALTSK 95.00% 3.47 0.468 1.38 624.0529 1,869.14 1,870.14 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVLLDKIKNLQVALTSK 95.00% 3.8 0.463 1.72 624.0533 1,869.14 1,870.14 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVLLDKIKNLQVALTSK 95.00% 4.12 0.435 1.51 624.0534 1,869.14 1,870.14 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVLLDKIKNLQVALTSK 95.00% 4.05 0.522 1.74 624.3852 1,870.13 1,870.14 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVLLDKIKNLQVALTSK 95.00% 2.43 0.343 1.48 624.3859 1,870.13 1,870.14 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVLLDKIKNLQVALTSK 95.00% 4.16 0.477 2.35 624.3866 1,870.14 1,870.14 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVLLDKIKNLQVALTSK 95.00% 4.62 0.494 2.18 624.3868 1,870.14 1,870.14 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVLLDKIKNLQVALTSK 95.00% 4.29 0.522 1.49 624.3873 1,870.14 1,870.14 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVLLDKIKNLQVALTSK 95.00% 4.51 0.508 2.29 624.3874 1,870.14 1,870.14 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVLLDKIKNLQVALTSK 95.00% 4.74 0.495 1.96 624.3875 1,870.14 1,870.14 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVLLDKIKNLQVALTSK 95.00% 4.87 0.459 1.85 624.3875 1,870.14 1,870.14 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GNRGDSIDQcALIQSIK 95.00% 1.88 0.263 1.05 c10: Carbamidomethyl (+57.02) 625.6515 1,873.93 1,874.94 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GNRGDSIDQcALIQSIK 95.00% 1.94 0.24 1.89 c10: Carbamidomethyl (+57.02) 625.652 1,873.93 1,874.94 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 2.08 0.163 2.29 644.3307 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.64 0.41 3.17 644.3315 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.11 0.415 3.77 644.3316 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.67 0.406 3.54 644.3321 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.68 0.464 2.33 644.3322 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.25 0.384 2.77 644.3323 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.6 0.467 3.24 644.3326 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.21 0.424 2.72 644.3327 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 2.7 0.421 1.66 644.3327 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.34 0.462 2.64 644.3327 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 2.91 0.348 2.59 644.3327 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.67 0.456 2.2 644.3328 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.01 0.388 2.92 644.333 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 2.62 0.403 2.72 644.3332 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.65 0.463 2.54 644.3333 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.29 0.408 3.51 644.3333 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.48 0.404 3.85 644.3343 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 2.6 0.306 0 644.3344 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 3.15 0.4 2.8 644.3344 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% TELQTITNDPR 95.00% 2.83 0.378 3.41 644.3346 1,286.65 1,287.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTRQEDR 95.00% 2.75 0.25 0 645.0146 1,932.02 1,932.02 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 4.95 0.55 2.72 650.9962 1,949.97 1,950.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 4.56 0.552 4.09 650.999 1,949.97 1,950.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 6.34 0.555 4.06 651.3298 1,950.97 1,950.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 4.47 0.539 4.68 651.33 1,950.97 1,950.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.4 0.517 4.52 651.3303 1,950.97 1,950.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.04 0.498 2.82 651.3304 1,950.97 1,950.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 6 0.548 5.41 651.3309 1,950.97 1,950.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.49 0.53 4.72 651.3311 1,950.97 1,950.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 6.31 0.597 4.24 651.3314 1,950.97 1,950.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.49 0.552 5.48 651.3315 1,950.97 1,950.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 6.06 0.499 4.23 651.3316 1,950.97 1,950.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 3.23 0.48 3.01 651.3348 1,950.98 1,950.97 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.31 0.46 3.6 660.8698 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.12 0.369 2.09 660.87 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.67 0.468 2.89 660.8701 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.47 0.425 2.41 660.8706 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.7 0.427 3.25 660.8706 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.56 0.463 2.82 660.8707 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.67 0.478 1.82 660.8708 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.5 0.478 2.82 660.8709 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.41 0.437 2.33 660.8709 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 3.1 0.497 1.96 660.8709 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.56 0.461 2.8 660.8709 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.6 0.464 3.37 660.871 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.59 0.408 3.12 660.8711 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.62 0.428 3.14 660.8711 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.28 0.424 2.68 660.8711 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.65 0.425 3.17 660.8712 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.67 0.449 2.82 660.8712 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.64 0.45 3.19 660.8712 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.28 0.359 0 660.8714 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.72 0.434 3.55 660.8716 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.81 0.347 1.8 660.8717 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QSGVVPFIFQAK 95.00% 2.46 0.424 1.33 661.3726 1,320.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 2.83 0.194 0 670.3377 2,007.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 4.42 0.586 2.85 670.3389 2,007.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 2.77 0.488 2.28 670.3392 2,007.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 4.24 0.535 3 670.6724 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 4.07 0.547 3 670.6724 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 4.97 0.606 4.62 670.6725 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 4.72 0.559 2.31 670.6726 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 4.88 0.595 4.32 670.6729 2,009.00 2,008.99 3 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 2.91 0.392 4.19 670.6732 2,009.00 2,008.99 3 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 4.43 0.563 3.74 670.6733 2,009.00 2,008.99 3 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 3.24 0.43 2.39 670.6735 2,009.00 2,008.99 3 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GFESKVDAILNR 95.00% 3.29 0.523 2.96 674.867 1,347.72 1,348.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GFESKVDAILNR 95.00% 3.37 0.513 2.96 674.867 1,347.72 1,348.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GFESKVDAILNR 95.00% 3.36 0.485 2.66 674.867 1,347.72 1,348.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GFESKVDAILNR 95.00% 3.48 0.522 3.82 674.867 1,347.72 1,348.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 2.82 0.479 3.03 679.3763 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 2.07 0.341 0 679.3764 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 3.25 0.478 3.64 679.3767 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 2.82 0.471 2.85 679.3769 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 3.17 0.458 3.02 679.3769 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 3.17 0.53 3.34 679.3772 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 2.91 0.476 2.42 679.3773 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 2.64 0.485 3.29 679.3775 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 2.84 0.512 3.8 679.3775 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 2.33 0.486 2.85 679.3777 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 3.15 0.516 2.48 679.3784 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 2.72 0.452 1.82 679.3788 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QLGTVQQVISER 95.00% 2.61 0.375 0 679.3798 1,356.74 1,357.74 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 2.46 0.404 0 683.8156 1,365.62 1,366.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 1.95 0.293 0 683.816 1,365.62 1,366.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.96 0.612 3.66 683.8792 1,365.74 1,366.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.38 0.462 3.6 683.8792 1,365.74 1,366.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.71 0.506 4.07 683.8793 1,365.74 1,366.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.49 0.597 3.01 683.8794 1,365.74 1,366.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.58 0.55 3.62 683.8795 1,365.74 1,366.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.2 0.56 3.25 683.8802 1,365.74 1,366.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.62 0.505 5.4 683.8813 1,365.75 1,366.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% KVAVFFSNTPTR 95.00% 3.13 0.541 3.47 684.3807 1,366.75 1,366.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% qIIDAINKVVYK 95.00% 0 0 3.64 n-term: Pyro-cmC (-17.03) 693.9048 1,385.79 1,386.80 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% qIIDAINKVVYK 95.00% 0 0 3.66 n-term: Pyro-cmC (-17.03) 693.9054 1,385.80 1,386.80 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.52 0.54 4.33 702.3991 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.11 0.478 3.92 702.3994 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 3.27 0.404 1.7 702.3997 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.22 0.508 4.12 702.3998 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.42 0.521 3.8 702.4 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.39 0.546 4.77 702.4001 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.34 0.542 4.6 702.4002 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.6 0.573 4.85 702.4003 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.37 0.532 4.07 702.4003 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.08 0.521 4.39 702.4004 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.36 0.534 4.03 702.4004 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.29 0.494 4.05 702.4005 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.32 0.573 4.17 702.4006 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.18 0.492 4.8 702.4007 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.34 0.516 4.24 702.4007 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.26 0.517 4.05 702.4007 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 3.38 0.487 3.55 702.4011 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QIIDAINKVVYK 95.00% 2.68 0.305 2.15 702.4178 1,402.82 1,403.83 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QIIDAINKVVYK 95.00% 2.84 0.346 1.8 702.4185 1,402.82 1,403.83 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QIIDAINKVVYK 95.00% 2.68 0.3 0 702.4185 1,402.82 1,403.83 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QIIDAINKVVYK 95.00% 1.92 0.279 0 702.4187 1,402.82 1,403.83 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QIIDAINKVVYK 95.00% 3.21 0.353 1.36 702.4192 1,402.82 1,403.83 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QIIDAINKVVYK 95.00% 2.18 0.24 1.72 702.4196 1,402.82 1,403.83 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QIIDAINKVVYK 95.00% 2.23 0.3 0 702.4223 1,402.83 1,403.83 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LSDAGITPLFLTR 95.00% 4.16 0.462 3.92 702.9037 1,403.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GNRGDSIDQcALIQSIKDK 95.00% 4.11 0.284 2 c10: Carbamidomethyl (+57.02) 707.033 2,118.08 2,118.06 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 3.88 0.534 3.36 714.7117 2,141.11 2,141.11 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 4.15 0.462 4.17 714.7118 2,141.11 2,141.11 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 4.74 0.531 3.82 714.7118 2,141.11 2,141.11 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SDDEVDDPAVELK 95.00% 3.35 0.401 3.01 716.3292 1,430.64 1,431.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SDDEVDDPAVELK 95.00% 3.68 0.43 2.17 716.3294 1,430.64 1,431.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SDDEVDDPAVELK 95.00% 3.59 0.429 2.18 716.3294 1,430.64 1,431.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SDDEVDDPAVELK 95.00% 4.35 0.406 0 716.3297 1,430.64 1,431.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SDDEVDDPAVELK 95.00% 4.04 0.394 3.46 716.3297 1,430.64 1,431.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SDDEVDDPAVELK 95.00% 3.2 0.428 3.47 716.3302 1,430.64 1,431.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SDDEVDDPAVELK 95.00% 4.03 0.377 1.92 716.3302 1,430.64 1,431.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SDDEVDDPAVELK 95.00% 4.02 0.362 2.4 716.3306 1,430.65 1,431.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SDDEVDDPAVELK 95.00% 3.13 0.341 2 716.331 1,430.65 1,431.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SDDEVDDPAVELK 95.00% 3.5 0.426 2.3 716.331 1,430.65 1,431.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SDDEVDDPAVELK 95.00% 3.95 0.355 1.96 716.3366 1,430.66 1,431.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 3.35 0.293 0 716.3655 1,430.72 1,431.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SDDEVDDPAVELK 95.00% 3.7 0.243 1.85 716.3668 1,430.72 1,431.65 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 3.23 0.293 0 716.3677 1,430.72 1,431.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.97 0.32 0 716.3678 1,430.72 1,431.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.95 0.182 1.28 716.3681 1,430.72 1,431.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 3.3 0.223 0 716.3686 1,430.72 1,431.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 3.04 0.23 0 716.3686 1,430.72 1,431.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 3.09 0.331 1.36 716.3695 1,430.72 1,431.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% EFRELPNIEER 95.00% 2.99 0.336 1.26 716.3696 1,430.72 1,431.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.67 0.119 2 730.4329 1,458.85 1,459.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.93 0.337 0 730.4333 1,458.85 1,459.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.79 0.183 0 730.4345 1,458.85 1,459.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.7 0.253 1.48 730.4353 1,458.86 1,459.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.96 0.265 1.39 730.4354 1,458.86 1,459.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.81 0.281 1.6 730.4356 1,458.86 1,459.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 3.2 0.347 2.38 730.4357 1,458.86 1,459.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.58 0.264 1.15 730.4372 1,458.86 1,459.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.7 0.25 2.19 730.4375 1,458.86 1,459.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IGDLHPQIVNLLK 95.00% 2.68 0.302 0 730.9385 1,459.86 1,459.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QINVGNALEYVSR 95.00% 3.82 0.547 4.17 731.8875 1,461.76 1,462.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QINVGNALEYVSR 95.00% 3.72 0.573 4.27 731.8875 1,461.76 1,462.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QINVGNALEYVSR 95.00% 3.76 0.54 3.82 731.8879 1,461.76 1,462.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QINVGNALEYVSR 95.00% 3.66 0.513 3.28 731.8879 1,461.76 1,462.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QINVGNALEYVSR 95.00% 3.57 0.52 4.16 731.888 1,461.76 1,462.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QINVGNALEYVSR 95.00% 3.38 0.403 1.96 731.8885 1,461.76 1,462.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QINVGNALEYVSR 95.00% 3.73 0.544 3.8 731.8889 1,461.76 1,462.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QINVGNALEYVSR 95.00% 3.47 0.5 3.47 731.8893 1,461.76 1,462.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QINVGNALEYVSR 95.00% 3.55 0.552 3.77 731.8903 1,461.76 1,462.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QINVGNALEYVSR 95.00% 2.69 0.42 2.77 732.3907 1,462.77 1,462.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAMSFVAR 95.00% 3.43 0.556 3.3 734.3677 1,466.72 1,467.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAMSFVAR 95.00% 3 0.48 0 734.3679 1,466.72 1,467.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAMSFVAR 95.00% 3.69 0.512 0 734.3679 1,466.72 1,467.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAMSFVAR 95.00% 2.93 0.404 0 734.3681 1,466.72 1,467.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAMSFVAR 95.00% 3.5 0.505 3.37 734.3683 1,466.72 1,467.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAMSFVAR 95.00% 3.45 0.486 2.03 734.3687 1,466.72 1,467.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAMSFVAR 95.00% 2.79 0.374 0 734.3693 1,466.72 1,467.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALNLGYALDYAQR 95.00% 4.29 0.549 3.01 734.3855 1,466.76 1,467.76 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALNLGYALDYAQR 95.00% 4.65 0.583 4.02 734.386 1,466.76 1,467.76 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALNLGYALDYAQR 95.00% 4.34 0.579 3.29 734.3861 1,466.76 1,467.76 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALNLGYALDYAQR 95.00% 4.74 0.584 2.74 734.3863 1,466.76 1,467.76 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALNLGYALDYAQR 95.00% 4.58 0.588 4.3 734.3863 1,466.76 1,467.76 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% ALNLGYALDYAQR 95.00% 4.68 0.609 4.03 734.3865 1,466.76 1,467.76 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAMSFVAR 95.00% 3.37 0.327 0 734.8692 1,467.72 1,467.73 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDRVR 95.00% 3.09 0.345 0 736.3987 1,470.78 1,471.79 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVESLDVGQDRVR 95.00% 3.05 0.286 0 736.9019 1,471.79 1,471.79 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAmSFVAR 95.00% 2.31 0.287 0 m8: Oxidation (+15.99) 742.3669 1,482.72 1,483.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAmSFVAR 95.00% 3.21 0.54 2.12 m8: Oxidation (+15.99) 742.367 1,482.72 1,483.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAmSFVAR 95.00% 2.92 0.488 0 m8: Oxidation (+15.99) 742.3683 1,482.72 1,483.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.23 0.255 0 742.4109 1,482.81 1,483.81 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.66 0.397 1.51 742.4117 1,482.81 1,483.81 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.75 0.371 2.66 742.4124 1,482.81 1,483.81 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.5 0.231 3.54 742.4125 1,482.81 1,483.81 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 2.57 0.295 2.42 742.4127 1,482.81 1,483.81 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.43 0.299 3.72 742.4127 1,482.81 1,483.81 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.36 0.35 2.38 742.4134 1,482.81 1,483.81 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IIDELNVKPEGTR 95.00% 3.54 0.284 2.57 742.4135 1,482.81 1,483.81 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% QQSLETAmSFVAR 95.00% 3.11 0.375 0 m8: Oxidation (+15.99) 742.8711 1,483.73 1,483.72 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.69 0.42 5.52 757.3808 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.65 0.468 6.25 757.3813 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.56 0.493 6.22 757.3816 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.67 0.452 5.89 757.3817 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 5 0.447 5.82 757.3821 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.37 0.457 6.05 757.3822 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.76 0.44 6.31 757.3822 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.66 0.495 5.15 757.3823 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.63 0.493 6.29 757.3824 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.53 0.465 6.34 757.3825 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.52 0.431 7.08 757.3827 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 3.17 0.487 3.64 757.3827 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 3.92 0.486 6.54 757.3828 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.65 0.492 6.59 757.383 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.33 0.462 5.6 757.3831 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 4.52 0.481 6.42 757.3832 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 1.91 0.0769 3.72 757.3834 1,512.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LVDYLDVGFDTTR 95.00% 3.7 0.518 5.66 757.8849 1,513.75 1,513.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VEFLLNAHSSKDEVQNAVQR 95.00% 2.93 0.349 0 762.062 2,283.16 2,284.17 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VEFLLNAHSSKDEVQNAVQR 95.00% 4.64 0.506 2.11 762.3931 2,284.16 2,284.17 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VEFLLNAHSSKDEVQNAVQR 95.00% 5.58 0.535 3.32 762.3943 2,284.16 2,284.17 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VEFLLNAHSSKDEVQNAVQR 95.00% 5.33 0.505 2.82 762.3968 2,284.17 2,284.17 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VEFLLNAHSSKDEVQNAVQR 95.00% 5.51 0.471 3.02 762.3988 2,284.17 2,284.17 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VEFLLNAHSSKDEVQNAVQR 95.00% 5.79 0.493 2.7 762.4006 2,284.18 2,284.17 3
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQHPYVLTEDTLK 95.00% 2.96 0.531 6.77 765.895 1,529.77 1,530.78 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQHPYVLTEDTLK 95.00% 3.45 0.531 5.96 765.8971 1,529.78 1,530.78 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQHPYVLTEDTLK 95.00% 3.42 0.528 5.44 765.8972 1,529.78 1,530.78 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SQHPYVLTEDTLK 95.00% 3.39 0.54 3.32 766.3968 1,530.78 1,530.78 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% AcNLDVILGFDGSR 95.00% 3.94 0.507 4.74 c2: Carbamidomethyl (+57.02) 768.88 1,535.74 1,536.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% AcNLDVILGFDGSR 95.00% 4.17 0.458 2.59 c2: Carbamidomethyl (+57.02) 768.8832 1,535.75 1,536.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% AcNLDVILGFDGSR 95.00% 4.27 0.483 4.64 c2: Carbamidomethyl (+57.02) 768.8837 1,535.75 1,536.75 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 3 0.427 1.72 c7: Carbamidomethyl (+57.02) 774.3904 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 3.06 0.399 1.92 c7: Carbamidomethyl (+57.02) 774.3906 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 4.12 0.349 1.55 c7: Carbamidomethyl (+57.02) 774.3923 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 3.78 0.335 1.66 c7: Carbamidomethyl (+57.02) 774.3927 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 3.38 0.36 1.82 c7: Carbamidomethyl (+57.02) 774.3927 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 4.02 0.303 2.02 c7: Carbamidomethyl (+57.02) 774.3929 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 3.9 0.361 2.03 c7: Carbamidomethyl (+57.02) 774.3935 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 3.22 0.381 2.68 c7: Carbamidomethyl (+57.02) 774.394 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 3.01 0.333 1.35 c7: Carbamidomethyl (+57.02) 774.3943 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 3.55 0.397 1.57 c7: Carbamidomethyl (+57.02) 774.3945 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 3.83 0.376 2.22 c7: Carbamidomethyl (+57.02) 774.3949 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 3.53 0.319 2.14 c7: Carbamidomethyl (+57.02) 774.3951 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 3.12 0.32 2.35 c7: Carbamidomethyl (+57.02) 774.3952 1,546.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIK 95.00% 3.4 0.319 1.39 c7: Carbamidomethyl (+57.02) 774.8952 1,547.77 1,547.77 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 4.03 0.526 4.17 793.9682 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.62 0.556 2.77 793.9684 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.8 0.572 3.39 793.9687 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.92 0.508 4.24 793.9689 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.98 0.546 3.57 793.9692 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 4.38 0.539 3.33 793.9694 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.9 0.56 4.17 793.9695 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 4.16 0.557 3.74 793.9695 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 4.36 0.546 4.12 793.9695 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.84 0.576 4.49 793.9697 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.7 0.58 2.07 793.9698 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.6 0.486 3.2 793.9702 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.96 0.527 2.89 793.9704 1,585.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.73 0.54 4.34 793.9707 1,585.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 4.04 0.542 3.8 793.9707 1,585.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.14 0.484 3.46 793.9709 1,585.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.96 0.563 3.14 793.9712 1,585.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.91 0.497 3.85 794.4712 1,586.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LQPVLQPLPSPGVGGK 95.00% 3.86 0.534 3.85 794.4728 1,586.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 3.95 0.455 0 807.4322 1,612.85 1,613.85 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 4.02 0.428 0 807.4337 1,612.85 1,613.85 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 2.76 0.406 0 807.4345 1,612.85 1,613.85 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 3.49 0.361 0 807.4369 1,612.86 1,613.85 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SLDEISQPAQELKR 95.00% 3.33 0.313 0 807.437 1,612.86 1,613.85 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.58 0.518 3.92 816.4173 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.36 0.52 3.96 816.4176 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.57 0.53 4.28 816.4176 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.43 0.532 3.68 816.4178 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.53 0.504 4.37 816.4182 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.55 0.51 4.21 816.4183 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.49 0.548 4.07 816.4184 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.58 0.515 4.4 816.4184 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.46 0.543 4.37 816.4185 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.35 0.527 7.44 816.4188 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.27 0.495 4.12 816.4189 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.49 0.535 4.29 816.4189 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.94 0.454 4.44 816.419 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.4 0.536 5.68 816.419 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.25 0.52 4.29 816.4191 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.39 0.513 4.51 816.4193 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.36 0.528 4.28 816.4196 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.96 0.463 4.3 816.42 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.58 0.442 4.8 816.4201 1,630.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 4.57 0.409 4.62 816.421 1,630.83 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.38 0.528 3.8 816.4219 1,630.83 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% SVEDAQDVSLALTQR 95.00% 5.39 0.534 4.08 816.9196 1,631.82 1,631.82 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% AAPLQGmLPGLLAPLR 95.00% 3.11 0.464 2.28 m7: Oxidation (+15.99) 817.4799 1,632.94 1,633.95 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% AAPLQGmLPGLLAPLR 95.00% 3.33 0.433 2.6 m7: Oxidation (+15.99) 817.9795 1,633.94 1,633.95 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.31 0.466 3.89 837.4842 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.33 0.481 4.66 837.4845 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.27 0.43 5.55 837.4845 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.32 0.415 5.2 837.4845 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.03 0.441 6.21 837.4846 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.68 0.423 3.57 837.4846 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.34 0.489 3.77 837.4847 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.06 0.442 4.24 837.4851 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.77 0.47 4.06 837.4852 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.41 0.447 4.04 837.4853 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.35 0.404 4.85 837.4855 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.03 0.371 3.12 837.4856 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.36 0.448 3.8 837.4856 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.21 0.407 4.62 837.4856 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.32 0.444 4.32 837.4858 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.3 0.444 3.92 837.4861 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.27 0.393 3.46 837.4862 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.5 0.396 4.59 837.4867 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.86 0.481 5.07 837.9865 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.34 0.412 6.28 837.9868 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.15 0.424 4.38 837.9868 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 4.37 0.467 5.42 837.9875 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.99 0.371 3.38 837.9876 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IEDGVPQHLVLVLGGK 95.00% 3.78 0.4 1.68 837.9892 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IAVAQYSDDVKVESR 95.00% 5.19 0.599 3.89 840.4359 1,678.86 1,679.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IAVAQYSDDVKVESR 95.00% 4.66 0.554 4 840.4364 1,678.86 1,679.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IAVAQYSDDVKVESR 95.00% 4.91 0.582 4.32 840.4367 1,678.86 1,679.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IAVAQYSDDVKVESR 95.00% 4.61 0.572 3.82 840.4368 1,678.86 1,679.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IAVAQYSDDVKVESR 95.00% 4.76 0.609 4.14 840.4386 1,678.86 1,679.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% IAVAQYSDDVKVESR 95.00% 4.93 0.601 3.92 840.9376 1,679.86 1,679.86 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.9 0.537 4.74 843.4876 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.79 0.545 4.92 843.4885 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 5.16 0.557 5.64 843.4886 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 5.42 0.55 4.8 843.4889 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.98 0.532 5.21 843.489 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.94 0.525 5 843.4893 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.96 0.533 4.92 843.4898 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 5.1 0.54 5.15 843.4898 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 3.44 0.475 4.51 843.4898 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.79 0.531 4.92 843.4899 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.87 0.558 4.8 843.4899 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.82 0.566 6.02 843.4899 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 5.14 0.513 4.74 843.4901 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 3.89 0.438 3.74 843.4902 1,684.96 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 3.29 0.465 3.62 843.4903 1,684.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 5.01 0.552 4.47 843.4907 1,684.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.92 0.57 4.6 843.491 1,684.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.91 0.511 4.3 843.4911 1,684.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.53 0.591 3.4 843.4918 1,684.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 5.01 0.513 5.01 843.4919 1,684.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 2.81 0.356 0 843.4925 1,684.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.68 0.476 3.35 843.4943 1,684.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.62 0.547 4.49 843.4944 1,684.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 3.67 0.508 3.24 843.5 1,684.98 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 5.26 0.491 4.36 843.9909 1,685.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 5.37 0.518 4.37 843.9911 1,685.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 5.16 0.505 4.59 843.9911 1,685.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.92 0.491 4.68 843.9914 1,685.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.73 0.443 4.39 843.9935 1,685.97 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LLTPITTLTSEQIQK 95.00% 4.34 0.531 3.72 843.9968 1,685.98 1,685.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 4.87 0.54 5.15 854.4525 1,706.89 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 4.81 0.518 6.64 854.4533 1,706.89 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 4.67 0.508 5.92 854.4537 1,706.89 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 4.25 0.478 5.31 854.4544 1,706.89 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 4.88 0.407 5.72 854.4571 1,706.90 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 4.04 0.509 4.23 854.9419 1,707.87 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 4.26 0.517 4.14 854.9423 1,707.87 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 4.02 0.524 4.38 854.9433 1,707.87 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 5.18 0.511 5.43 854.955 1,707.89 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 4.84 0.531 4.1 854.9571 1,707.90 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 4.75 0.503 4.96 854.9574 1,707.90 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 4.44 0.404 3.8 854.9594 1,707.90 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VAVVTYNNEVTTEIR 95.00% 4.59 0.374 3.8 854.9607 1,707.91 1,707.89 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.75 0.456 3.82 871.5024 1,740.99 1,742.00 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.64 0.456 3.07 871.5038 1,740.99 1,742.00 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 3.9 0.476 4.72 871.5066 1,741.00 1,742.00 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.52 0.394 3.24 872.0062 1,742.00 1,742.00 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.55 0.472 4.26 872.0063 1,742.00 1,742.00 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% LDQRVPQIAFVITGGK 95.00% 4.24 0.377 4.13 872.0088 1,742.00 1,742.00 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIKDK 95.00% 3.84 0.406 2.32 c7: Carbamidomethyl (+57.02) 895.9497 1,789.88 1,790.90 2 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIKDK 95.00% 4.36 0.528 2.44 c7: Carbamidomethyl (+57.02) 895.952 1,789.89 1,790.90 2 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIKDK 95.00% 4.33 0.51 2.07 c7: Carbamidomethyl (+57.02) 895.9536 1,789.89 1,790.90 2 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIKDK 95.00% 4.35 0.526 3.44 c7: Carbamidomethyl (+57.02) 895.9549 1,789.89 1,790.90 2 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIKDK 95.00% 4.54 0.566 1.55 c7: Carbamidomethyl (+57.02) 896.4532 1,790.89 1,790.90 2 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIKDK 95.00% 3.91 0.546 1.89 c7: Carbamidomethyl (+57.02) 896.4535 1,790.89 1,790.90 2 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GDSIDQcALIQSIKDK 95.00% 4.68 0.532 2.92 c7: Carbamidomethyl (+57.02) 896.4569 1,790.90 1,790.90 2 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% FDEHQSKPEILNLVK 95.00% 3.77 0.434 3.46 898.9831 1,795.95 1,796.95 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% FDEHQSKPEILNLVK 95.00% 2.36 0.371 0 898.9834 1,795.95 1,796.95 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% FDEHQSKPEILNLVK 95.00% 3.87 0.549 4.1 898.9843 1,795.95 1,796.95 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% FDEHQSKPEILNLVK 95.00% 3.5 0.473 2.7 898.9846 1,795.95 1,796.95 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% FDEHQSKPEILNLVK 95.00% 3.63 0.506 2.72 899.4808 1,796.95 1,796.95 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% FAQVIRSSGIVSLGVGDR 95.00% 4.52 0.506 6.82 931.5229 1,861.03 1,861.03 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GNRGDSIDQcALIQSIK 95.00% 5.23 0.337 5.35 c10: Carbamidomethyl (+57.02) 937.9757 1,873.94 1,874.94 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GNRGDSIDQcALIQSIK 95.00% 5.24 0.334 4.8 c10: Carbamidomethyl (+57.02) 937.9759 1,873.94 1,874.94 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GNRGDSIDQcALIQSIK 95.00% 5.29 0.323 4.55 c10: Carbamidomethyl (+57.02) 938.4787 1,874.94 1,874.94 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.69 0.626 8.35 975.9876 1,949.96 1,950.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.56 0.636 7.89 975.9884 1,949.96 1,950.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.66 0.618 8.55 975.9889 1,949.96 1,950.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.97 0.628 8.6 975.9892 1,949.96 1,950.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.77 0.649 8.92 975.99 1,949.96 1,950.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.39 0.621 8.2 976.4893 1,950.96 1,950.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.96 0.646 8.82 976.4907 1,950.97 1,950.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.56 0.608 7.37 976.4909 1,950.97 1,950.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 5.01 0.571 4.96 976.4952 1,950.97 1,950.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% VVIHFTDGADGDLADLHR 95.00% 4.63 0.605 4.38 976.496 1,950.98 1,950.97 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 6.48 0.623 6.4 1,005.00 2,007.99 2,008.99 2 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 6.47 0.601 5.82 1,005.51 2,008.99 2,008.99 2 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% NIDSEEVGKIASNSATAFR 95.00% 6.29 0.605 5.08 1,005.51 2,009.00 2,008.99 2 MUC16_HUMAN
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 5.9 0.681 7.02 1,071.56 2,141.11 2,141.11 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 6.13 0.709 5.64 1,071.56 2,141.11 2,141.11 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 6.16 0.708 7.32 1,071.56 2,141.11 2,141.11 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 5.89 0.674 6.18 1,071.56 2,141.11 2,141.11 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 5.95 0.7 7.62 1,071.56 2,141.11 2,141.11 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 5.96 0.659 7.64 1,071.56 2,141.11 2,141.11 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 6.25 0.695 6.96 1,071.56 2,141.11 2,141.11 2
 SAMPLE 4 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 57 82 792 21.00% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 6 0.689 6.72 1,071.57 2,141.12 2,141.11 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GFESKVDAILNR 95.00% 2.78 0.302 2.03 450.2487 1,347.72 1,348.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GFESKVDAILNR 95.00% 3.29 0.477 1.82 450.249 1,347.72 1,348.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GFESKVDAILNR 95.00% 3.35 0.455 2.01 450.2494 1,347.72 1,348.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GFESKVDAILNR 95.00% 3.45 0.518 1.82 450.2496 1,347.73 1,348.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GFESKVDAILNR 95.00% 3.22 0.464 0 450.2504 1,347.73 1,348.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 2.91 0.44 1.28 456.2563 1,365.75 1,366.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 2.82 0.389 0 456.257 1,365.75 1,366.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 2.87 0.361 1.04 456.2574 1,365.75 1,366.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 3.07 0.388 0 456.2575 1,365.75 1,366.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 2.8 0.425 0 456.2583 1,365.75 1,366.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 2.78 0.303 1.05 456.592 1,366.75 1,366.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 3.65 0.43 0 456.5924 1,366.75 1,366.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLVLITGGK 95.00% 3.14 0.315 0 457.3094 912.6032 913.6089 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLVLITGGK 95.00% 2.75 0.4 1.28 457.3101 912.6046 913.6089 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLVLITGGK 95.00% 2.37 0.333 0 457.3103 912.6049 913.6089 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLVLITGGK 95.00% 2.95 0.312 0 457.3104 912.6051 913.6089 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLVLITGGK 95.00% 2.79 0.384 0 457.3105 912.6053 913.6089 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLVLITGGK 95.00% 3.19 0.35 1.7 457.3106 912.6056 913.6089 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLVLITGGK 95.00% 2.98 0.345 1.7 457.3107 912.6057 913.6089 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLVLITGGK 95.00% 2.64 0.421 1.28 457.3108 912.606 913.6089 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLVLITGGK 95.00% 3.04 0.31 0 457.311 912.6064 913.6089 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLVLITGGK 95.00% 3.19 0.34 0 457.3116 912.6075 913.6089 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLVLITGGK 95.00% 2.8 0.312 0 457.3117 912.6078 913.6089 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLVLITGGK 95.00% 2.63 0.346 0 457.3127 912.6097 913.6089 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 2.79 0.426 0 468.6017 1,402.78 1,403.79 3 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 2.16 0.3 0 468.6026 1,402.78 1,403.79 3 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 1.91 0.227 0 468.6029 1,402.79 1,403.79 3 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 2.83 0.341 1.64 468.6032 1,402.79 1,403.79 3 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 2.84 0.36 1.28 468.6046 1,402.79 1,403.79 3 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 2.87 0.424 0 468.6047 1,402.79 1,403.79 3 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QIIDAINKVVYK 95.00% 2.18 0.234 0 468.6157 1,402.82 1,403.83 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QIIDAINKVVYK 95.00% 2.44 0.285 0 468.6161 1,402.82 1,403.83 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QIIDAINKVVYK 95.00% 2.32 0.292 0 468.6166 1,402.83 1,403.83 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QIIDAINKVVYK 95.00% 2.28 0.2 0 468.6166 1,402.83 1,403.83 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 3.66 0.451 2.28 468.9385 1,403.79 1,403.79 3 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SGFPLLKEFVQR 95.00% 2.75 0.521 1.57 474.2714 1,419.79 1,420.80 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SGFPLLKEFVQR 95.00% 2.33 0.438 1.37 474.2719 1,419.79 1,420.80 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SGFPLLKEFVQR 95.00% 2.74 0.308 1.92 474.2724 1,419.79 1,420.80 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SGFPLLKEFVQR 95.00% 3.07 0.443 1.6 474.2735 1,419.80 1,420.80 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 2.44 0.152 0 477.9136 1,430.72 1,431.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 2.94 0.291 0 477.9137 1,430.72 1,431.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 2.7 0.246 0 477.9138 1,430.72 1,431.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 2.65 0.235 0 477.9138 1,430.72 1,431.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 2.36 0.167 0 477.9139 1,430.72 1,431.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 2.68 0.248 0 477.9139 1,430.72 1,431.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 2.74 0.203 0 477.9147 1,430.72 1,431.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 2.62 0.304 0 478.2484 1,431.72 1,431.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 2.81 0.3 0 478.2485 1,431.72 1,431.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 2.35 0.249 0 478.2497 1,431.73 1,431.72 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.81 0.415 0 487.2879 972.5602 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.91 0.408 0 487.2879 972.5602 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.75 0.438 0 487.288 972.5603 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.52 0.452 0 487.2885 972.5614 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.55 0.308 0 487.2885 972.5614 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.32 0.371 1.4 487.2887 972.5617 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.48 0.438 0 487.2888 972.5619 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.44 0.365 1.24 487.2888 972.562 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.1 0.328 1.49 487.2888 972.562 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.14 0.321 2.16 487.2889 972.5622 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.24 0.401 1.66 487.289 972.5624 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.21 0.358 2.77 487.289 972.5624 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.4 0.345 1.19 487.2891 972.5626 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.21 0.305 0 487.2893 972.563 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.59 0.326 1.57 487.2894 972.5632 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NLQVALTSK 95.00% 2.2 0.389 0 487.2924 972.5691 973.5683 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.67 0.315 0 487.2928 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.27 0.327 1.27 487.2932 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 3.18 0.379 1.21 487.2933 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 3.06 0.27 0 487.2937 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 3.02 0.476 1.41 487.2938 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.85 0.39 0.959 487.2938 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 3.24 0.383 0 487.2941 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.87 0.356 0 487.2942 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 3.29 0.469 0 487.2942 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.74 0.41 0 487.2943 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.56 0.298 0 487.2943 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 3.21 0.405 0 487.2944 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 3.5 0.518 1.37 487.2945 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 3.05 0.469 1.19 487.2946 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.72 0.389 0 487.2946 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.9 0.46 0 487.295 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.59 0.294 0 487.295 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.43 0.293 0 487.2951 1,458.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 3.14 0.441 0 487.6278 1,459.86 1,459.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 2.95 0.404 1.55 489.9142 1,466.72 1,467.73 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 2.96 0.422 2.96 489.9148 1,466.72 1,467.73 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALNLGYALDYAQR 95.00% 3.04 0.299 1.31 489.9252 1,466.75 1,467.76 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALNLGYALDYAQR 95.00% 2.81 0.335 1.05 489.9258 1,466.75 1,467.76 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 2.65 0.306 0 490.2496 1,467.73 1,467.73 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALNLGYALDYAQR 95.00% 3.33 0.319 0 490.2603 1,467.76 1,467.76 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDRVR 95.00% 1.92 0.306 0 491.2681 1,470.78 1,471.79 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDRVR 95.00% 1.79 0.278 0 491.2683 1,470.78 1,471.79 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDRVR 95.00% 1.84 0.314 0 491.2694 1,470.78 1,471.79 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDRVR 95.00% 1.86 0.253 0 491.6027 1,471.78 1,471.79 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.37 0.342 1.39 492.316 982.6164 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.32 0.306 0 492.3163 982.617 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.44 0.312 0 492.3165 982.6173 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3 0.355 0 492.3166 982.6176 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.19 0.344 0 492.3167 982.6177 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.3 0.329 1.74 492.3167 982.6178 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3 0.332 0 492.3167 982.6178 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.32 0.31 0 492.3169 982.6181 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.95 0.339 0 492.3169 982.6181 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.96 0.35 0 492.3169 982.6181 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.8 0.35 0 492.3169 982.6181 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.39 0.358 1.38 492.317 982.6183 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.02 0.353 0 492.317 982.6184 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.9 0.315 1.22 492.3171 982.6186 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.3 0.333 1.72 492.3171 982.6186 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.02 0.355 1.32 492.3171 982.6186 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.68 0.368 0 492.3171 982.6186 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.28 0.307 1.2 492.3171 982.6186 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.18 0.326 0 492.3172 982.6187 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.02 0.325 0 492.3172 982.6187 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.13 0.326 0 492.3172 982.6188 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.13 0.312 0 492.3172 982.6188 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.18 0.325 0 492.3173 982.6189 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.38 0.321 0 492.3173 982.6189 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.55 0.335 0 492.3173 982.619 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.95 0.363 1.48 492.3174 982.6191 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.03 0.322 0 492.3174 982.6191 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.78 0.338 1.24 492.3174 982.6192 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.87 0.368 0 492.3175 982.6194 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.48 0.246 0 492.3176 982.6195 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.35 0.233 1.27 492.3177 982.6197 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.67 0.395 1.21 492.3177 982.6198 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.07 0.331 0 492.3178 982.62 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.38 0.302 0 492.3179 982.6202 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 3.15 0.353 0 492.3181 982.6205 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.23 0.19 1.59 492.3181 982.6205 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLER 95.00% 2.65 0.217 1.8 492.8186 983.6215 983.6255 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 2.74 0.258 1.17 495.2753 1,482.80 1,483.81 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 3.06 0.371 1.01 495.2761 1,482.80 1,483.81 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 2.73 0.309 0.959 495.2761 1,482.80 1,483.81 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 3.1 0.368 1.16 495.2762 1,482.81 1,483.81 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 2.54 0.339 1.51 495.2764 1,482.81 1,483.81 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 2.97 0.334 1.24 495.2765 1,482.81 1,483.81 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 3.17 0.353 1.08 495.6103 1,483.81 1,483.81 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.01 0.269 0 497.2528 992.49 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.29 0.277 0 497.2529 992.4901 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.14 0.244 0 497.2534 992.4912 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.28 0.259 0 497.2537 992.4917 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.89 0.312 1.21 497.2541 992.4926 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.34 0.236 0 497.2542 992.4928 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 3.07 0.369 1.23 497.2543 992.493 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.59 0.336 0 497.2544 992.4931 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.55 0.307 0 497.2545 992.4933 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.65 0.255 0 497.2547 992.4938 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.59 0.329 0 497.2548 992.4939 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.43 0.357 0 497.2549 992.4941 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.33 0.315 0 497.2551 992.4945 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.7 0.323 0 497.2557 992.4958 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DSFQEVLR 95.00% 2.44 0.218 0 497.2562 992.4967 993.5006 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ELPNIEER 95.00% 1.7 0.351 0 500.2599 998.5041 999.5112 2 SPTA2_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ELPNIEER 95.00% 1.79 0.351 0 500.2603 998.5049 999.5112 2 SPTA2_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ELPNIEER 95.00% 1.73 0.297 0 500.2603 998.505 999.5112 2 SPTA2_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ELPNIEER 95.00% 1.91 0.346 0 500.2605 998.5053 999.5112 2 SPTA2_HUMAN,TITIN_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LMHLEFGR 95.00% 2.42 0.314 0 501.7637 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LMHLEFGR 95.00% 2.33 0.334 0 501.7639 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LMHLEFGR 95.00% 2.13 0.349 0 501.764 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LMHLEFGR 95.00% 2.34 0.339 0 501.7642 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LMHLEFGR 95.00% 2.13 0.252 0 501.7643 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LMHLEFGR 95.00% 1.77 0.349 0 501.7644 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LMHLEFGR 95.00% 2.06 0.346 0 501.7647 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LMHLEFGR 95.00% 2.16 0.331 0 501.7647 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 2.98 0.387 0 505.257 1,512.75 1,513.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 3 0.346 0 505.2577 1,512.75 1,513.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 3.43 0.304 0 505.5913 1,513.75 1,513.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 2.29 0.278 0 510.932 1,529.77 1,530.78 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 3.74 0.386 1.77 510.9323 1,529.77 1,530.78 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 2.04 0.34 0 510.9324 1,529.77 1,530.78 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 3.07 0.383 1.27 510.9324 1,529.77 1,530.78 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 3.08 0.243 0 510.9326 1,529.77 1,530.78 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 2.89 0.305 0 510.9333 1,529.78 1,530.78 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 2.78 0.32 2.41 511.2666 1,530.78 1,530.78 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 4 0.368 0 511.2674 1,530.78 1,530.78 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 2.83 0.195 0 c2: Carbamidomethyl (+57.02) 512.9207 1,535.74 1,536.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 2.65 0.268 3.1 c2: Carbamidomethyl (+57.02) 512.9213 1,535.74 1,536.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 2.23 0.159 1.48 c2: Carbamidomethyl (+57.02) 512.9221 1,535.74 1,536.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 2.58 0.29 1.14 c2: Carbamidomethyl (+57.02) 512.923 1,535.75 1,536.75 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIK 95.00% 3.04 0.297 0 c7: Carbamidomethyl (+57.02) 516.5978 1,546.77 1,547.77 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIK 95.00% 2.75 0.222 0 c7: Carbamidomethyl (+57.02) 516.5978 1,546.77 1,547.77 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVQYSDR 95.00% 1.91 0.316 0 519.2716 1,036.53 1,036.54 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVQYSDR 95.00% 1.93 0.302 0 519.272 1,036.53 1,036.54 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IASNSATAFR 95.00% 2.33 0.307 0 519.2722 1,036.53 1,037.54 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IASNSATAFR 95.00% 2.49 0.319 0 519.2746 1,036.53 1,037.54 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AAEGIPKLLVLITGGK 95.00% 2.71 0.279 1.96 527.3319 1,578.97 1,579.98 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AAEGIPKLLVLITGGK 95.00% 3.43 0.378 1.8 527.6678 1,579.98 1,579.98 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 2.56 0.141 2.74 529.6486 1,585.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 2.34 0.252 2.04 529.6486 1,585.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 1.99 0.252 1.33 529.6487 1,585.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 1.86 0.191 0.959 529.6489 1,585.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 2.31 0.21 1.7 529.9827 1,586.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 2.35 0.31 2.19 529.9833 1,586.93 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DEVQNAVQR 95.00% 3.11 0.142 1.7 530.2717 1,058.53 1,058.52 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.47 0.369 1.64 535.3036 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.51 0.366 1.74 535.3037 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.97 0.38 1.23 535.3042 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.34 0.352 0 535.3044 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.77 0.354 1.4 535.3047 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.39 0.351 1.62 535.3047 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.52 0.381 1.68 535.3047 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.29 0.286 1.92 535.3047 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 3.03 0.391 2.06 535.3048 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.67 0.388 1.8 535.3048 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 3.17 0.444 1.85 535.3048 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.49 0.352 1.82 535.3048 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.32 0.351 2.43 535.3048 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.67 0.387 2 535.3049 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.56 0.401 2.3 535.3051 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.77 0.4 1.96 535.3051 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.02 0.29 1.4 535.3053 1,068.59 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 1.9 0.252 1.89 535.3054 1,068.60 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.7 0.367 1.54 535.3054 1,068.60 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQAPVLDAIR 95.00% 2.89 0.369 0 535.3057 1,068.60 1,069.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SLDEISQPAQELKR 95.00% 2.36 0.31 0 538.6223 1,612.84 1,613.85 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SLDEISQPAQELKR 95.00% 2.32 0.182 0 538.6225 1,612.84 1,613.85 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SLDEISQPAQELKR 95.00% 2.34 0.216 0 538.6228 1,612.84 1,613.85 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SLDEISQPAQELKR 95.00% 2.37 0.212 0 538.6229 1,612.85 1,613.85 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SLDEISQPAQELKR 95.00% 2.32 0.253 0 538.6236 1,612.85 1,613.85 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SLDEISQPAQELKR 95.00% 2.42 0.275 0 538.6237 1,612.85 1,613.85 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SLDEISQPAQELKR 95.00% 2.28 0.236 0 538.9566 1,613.85 1,613.85 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SLDEISQPAQELKR 95.00% 2.18 0.277 0 538.9575 1,613.85 1,613.85 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AAPLQGMLPGLLAPLR 95.00% 2.49 0.173 1.49 539.9904 1,616.95 1,617.95 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AAPLQGMLPGLLAPLR 95.00% 3.14 0.346 1.54 539.991 1,616.95 1,617.95 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.47 0.475 2.64 544.6127 1,630.81 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.5 0.498 1.39 544.6129 1,630.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 3.77 0.441 1.54 544.6131 1,630.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.4 0.439 1.39 544.6133 1,630.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 3.74 0.392 1.36 544.6133 1,630.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.5 0.524 2.17 544.6134 1,630.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.62 0.421 2.82 544.614 1,630.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 3.9 0.427 2.51 544.6143 1,630.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 3.75 0.468 1.64 544.6145 1,630.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.27 0.457 3.1 544.6149 1,630.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.04 0.495 1.19 544.6152 1,630.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.88 0.518 1.74 544.6245 1,630.85 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.45 0.438 2.04 544.9482 1,631.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.43 0.471 1.96 544.9487 1,631.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.01 0.496 1.17 544.9488 1,631.82 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.6 0.423 2.62 544.9499 1,631.83 1,631.82 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.34 0.292 1.2 558.6566 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.03 0.163 0 558.6591 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.36 0.267 0 558.6592 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.27 0.214 0 558.6593 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.56 0.344 1.96 558.6594 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.09 0.325 1.26 558.6594 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.28 0.264 1.25 558.6595 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 2.79 0.238 1.7 558.6597 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.18 0.155 0 558.6597 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.37 0.192 1.43 558.6599 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.14 0.201 1.59 558.6599 1,672.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.2 0.216 1.52 558.9926 1,673.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.12 0.164 0 558.993 1,673.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 2.92 0.221 0 558.9936 1,673.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 2.85 0.188 0 558.9937 1,673.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.01 0.171 1.34 558.9937 1,673.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.12 0.253 1.16 558.9938 1,673.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 2.86 0.299 1.02 558.9944 1,673.96 1,673.96 3 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TRPEFYLNSYmNK 95.00% 3.09 0.302 0 m11: Oxidation (+15.99) 560.2691 1,677.78 1,678.79 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TRPEFYLNSYmNK 95.00% 3.27 0.136 0 m11: Oxidation (+15.99) 560.6026 1,678.78 1,678.79 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IAVAQYSDDVKVESR 95.00% 2.95 0.48 2.12 560.6251 1,678.85 1,679.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IAVAQYSDDVKVESR 95.00% 3.44 0.483 1.72 560.6263 1,678.86 1,679.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IAVAQYSDDVKVESR 95.00% 3.6 0.53 2.23 560.6268 1,678.86 1,679.86 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.58 0.513 3.26 562.6616 1,684.96 1,685.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.69 0.473 3.19 562.6619 1,684.96 1,685.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.58 0.507 3.11 562.662 1,684.96 1,685.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 3.84 0.42 2.3 562.6625 1,684.96 1,685.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.55 0.48 1.92 562.6625 1,684.96 1,685.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.23 0.429 2.33 562.6626 1,684.96 1,685.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.54 0.48 2.92 562.6627 1,684.96 1,685.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.59 0.407 2.31 562.6629 1,684.97 1,685.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.49 0.471 2.85 562.6633 1,684.97 1,685.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.59 0.42 2.35 562.9974 1,685.97 1,685.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLERVVNLER 95.00% 2 0.319 0 565.3481 1,693.02 1,694.03 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLERVVNLER 95.00% 2.87 0.379 1.1 565.3497 1,693.03 1,694.03 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLERVVNLER 95.00% 3.27 0.407 1.54 565.3497 1,693.03 1,694.03 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLERVVNLER 95.00% 3.41 0.501 1.33 565.35 1,693.03 1,694.03 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLERVVNLER 95.00% 4.2 0.525 1.89 565.6838 1,694.03 1,694.03 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLERVVNLER 95.00% 3.75 0.456 1.74 565.6841 1,694.03 1,694.03 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALILVGLERVVNLER 95.00% 3.29 0.487 1.92 565.6843 1,694.03 1,694.03 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSIMAFAIGNK 95.00% 3.81 0.517 2.44 569.8007 1,137.59 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSIMAFAIGNK 95.00% 2.99 0.449 2.38 569.8009 1,137.59 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSIMAFAIGNK 95.00% 3.58 0.488 2.72 569.8016 1,137.59 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSIMAFAIGNK 95.00% 2.83 0.51 2.32 569.8016 1,137.59 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSIMAFAIGNK 95.00% 2.8 0.448 2 569.802 1,137.59 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSIMAFAIGNK 95.00% 2.54 0.401 1.8 569.8028 1,137.59 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSIMAFAIGNK 95.00% 2.18 0.244 0 569.804 1,137.59 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 2.53 0.28 0 569.9253 1,706.75 1,707.89 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 2.86 0.378 0 569.9727 1,706.89 1,707.89 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.79 0.575 6.26 572.6583 1,714.95 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 3.81 0.364 2.32 572.6584 1,714.95 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.65 0.481 4.27 572.6587 1,714.95 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.24 0.517 3.57 572.6588 1,714.95 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 5.19 0.491 5 572.659 1,714.95 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.64 0.457 4.72 572.6595 1,714.96 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 5.08 0.559 4.32 572.6599 1,714.96 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 5.12 0.536 4.2 572.9912 1,715.95 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.76 0.545 5.22 572.993 1,715.96 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 5.49 0.562 3.05 572.9933 1,715.96 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 5.13 0.544 4 572.9934 1,715.96 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 5.04 0.507 3.14 572.9941 1,715.96 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 5.12 0.556 4.09 572.9941 1,715.96 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.14 0.431 2.7 572.9949 1,715.96 1,715.96 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.43 0.421 5.89 573.8089 1,145.60 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.23 0.378 4.04 573.8098 1,145.60 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.04 0.272 4.77 573.8106 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.41 0.284 3.47 573.8106 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.73 0.409 4.6 573.8106 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.71 0.422 3.8 573.8107 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.64 0.402 3.55 573.8108 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.64 0.425 3.11 573.8109 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.85 0.429 3.18 573.8111 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.61 0.402 4.06 573.8112 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.61 0.428 5.68 573.8112 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.86 0.416 3.64 573.8112 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.11 0.306 3.89 573.8114 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.37 0.396 4.09 573.8119 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SSGIVSLGVGDR 95.00% 3.7 0.447 4.77 573.812 1,145.61 1,146.61 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% RDSFQEVLR 95.00% 2.87 0.143 0 575.3051 1,148.59 1,149.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% RDSFQEVLR 95.00% 2.79 0.164 1.29 575.3054 1,148.60 1,149.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% RDSFQEVLR 95.00% 2.74 0.0888 1.19 575.306 1,148.60 1,149.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% RDSFQEVLR 95.00% 2.88 0.175 1.77 575.3061 1,148.60 1,149.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% RDSFQEVLR 95.00% 2.79 0.13 0 575.3065 1,148.60 1,149.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% RDSFQEVLR 95.00% 3.14 0.171 0 575.3073 1,148.60 1,149.60 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 2.09 0.257 0 578.3033 1,731.89 1,731.90 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 3.35 0.359 0 578.3034 1,731.89 1,731.90 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.71 0.407 1.92 580.0098 1,737.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.65 0.459 2.04 580.0099 1,737.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.7 0.37 2.05 580.0102 1,737.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.29 0.452 1.96 580.0103 1,737.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.62 0.452 1.36 580.0104 1,737.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.96 0.421 3.25 580.0105 1,737.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 2.79 0.539 1.24 580.0116 1,737.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 2.97 0.337 1.28 580.0125 1,737.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.87 0.375 1.2 580.3437 1,738.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.17 0.412 1.12 580.3437 1,738.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.63 0.413 1.62 580.3442 1,738.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.81 0.405 1.4 580.3447 1,738.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.95 0.386 2.96 580.3449 1,738.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.6 0.388 0 580.3449 1,738.01 1,738.01 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.52 0.478 1.62 581.3366 1,740.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.29 0.479 1.35 581.337 1,740.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.81 0.483 0 581.3375 1,740.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.59 0.466 1.28 581.3375 1,740.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 5.03 0.517 1.7 581.3379 1,740.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.6 0.433 0 581.338 1,740.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.54 0.42 1.8 581.338 1,740.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.81 0.499 1.44 581.338 1,740.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 5.05 0.467 1.8 581.3381 1,740.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.49 0.474 2.28 581.3381 1,740.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.89 0.446 0 581.3382 1,740.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.72 0.411 1.41 581.3382 1,740.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.74 0.38 2.18 581.6722 1,741.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.47 0.465 2.07 581.6723 1,741.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.64 0.447 1.85 581.6724 1,741.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 3.99 0.436 0 581.6728 1,741.99 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 5.27 0.461 1.4 581.6733 1,742.00 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.84 0.505 2.55 581.6735 1,742.00 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.66 0.474 3.55 581.6735 1,742.00 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.69 0.516 1.66 581.6737 1,742.00 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 5.32 0.49 1.1 581.6738 1,742.00 1,742.00 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDRTELQTITNDPR 95.00% 3.11 0.479 0 595.9769 1,784.91 1,785.91 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDRTELQTITNDPR 95.00% 2.86 0.292 0 595.9782 1,784.91 1,785.91 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDRTELQTITNDPR 95.00% 2.43 0.338 0 595.9802 1,784.92 1,785.91 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDRTELQTITNDPR 95.00% 2.58 0.321 0 595.982 1,784.92 1,785.91 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDRTELQTITNDPR 95.00% 3.24 0.258 0 596.3109 1,785.91 1,785.91 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% FDEHQSKPEILNLVK 95.00% 3.86 0.258 0 599.6572 1,795.95 1,796.95 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% FDEHQSKPEILNLVK 95.00% 3.41 0.296 0 599.9927 1,796.95 1,796.95 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QFGVAPFTIAR 95.00% 2.69 0.304 0 603.8361 1,205.66 1,206.66 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QFGVAPFTIAR 95.00% 2.29 0.27 0 603.8362 1,205.66 1,206.66 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QFGVAPFTIAR 95.00% 2.24 0.257 0 603.8364 1,205.66 1,206.66 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QFGVAPFTIAR 95.00% 2.29 0.274 0 603.8368 1,205.66 1,206.66 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QFGVAPFTIAR 95.00% 2.15 0.289 0 603.8368 1,205.66 1,206.66 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QFGVAPFTIAR 95.00% 2.55 0.298 0 603.8369 1,205.66 1,206.66 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QFGVAPFTIAR 95.00% 2.26 0.237 0 603.8369 1,205.66 1,206.66 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QFGVAPFTIAR 95.00% 2.3 0.245 0 603.8373 1,205.66 1,206.66 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VNHFVPEAGSR 95.00% 2.36 0.365 0 606.8125 1,211.61 1,212.61 2 AHNK_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VNHFVPEAGSR 95.00% 2.21 0.384 0 606.8129 1,211.61 1,212.61 2 AHNK_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IKNLQVALTSK 95.00% 3.04 0.389 2.64 607.8781 1,213.74 1,214.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDR 95.00% 3.17 0.61 4.62 608.8131 1,215.61 1,216.62 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDR 95.00% 3.5 0.556 3.6 608.8134 1,215.61 1,216.62 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDR 95.00% 3.74 0.562 1.8 608.8137 1,215.61 1,216.62 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDR 95.00% 2.68 0.506 2.85 608.8139 1,215.61 1,216.62 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDR 95.00% 3.16 0.593 2.38 608.8141 1,215.61 1,216.62 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDR 95.00% 3.65 0.579 3.68 608.8141 1,215.61 1,216.62 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDR 95.00% 3.72 0.595 3.33 608.8143 1,215.61 1,216.62 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDR 95.00% 3.7 0.577 3.57 608.8146 1,215.61 1,216.62 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDR 95.00% 3.53 0.555 2.74 608.815 1,215.61 1,216.62 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDR 95.00% 3.28 0.564 3.82 608.8153 1,215.62 1,216.62 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVIQFSDDPK 95.00% 3.18 0.538 2 609.8216 1,217.63 1,218.64 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVIQFSDDPK 95.00% 3.42 0.513 3.21 609.8233 1,217.63 1,218.64 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVIQFSDDPK 95.00% 3.33 0.447 2.77 609.8236 1,217.63 1,218.64 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVIQFSDDPK 95.00% 2.91 0.413 2.09 609.8236 1,217.63 1,218.64 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVIQFSDDPK 95.00% 2.21 0.347 2.57 609.824 1,217.63 1,218.64 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVIQFSDDPK 95.00% 3.24 0.496 3.01 609.8242 1,217.63 1,218.64 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVIQFSDDPK 95.00% 3.14 0.525 3.32 609.8248 1,217.63 1,218.64 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVIQFSDDPK 95.00% 2.32 0.282 2.04 609.825 1,217.63 1,218.64 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVIQFSDDPK 95.00% 2.69 0.221 2.72 610.3232 1,218.63 1,218.64 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVIQFSDDPK 95.00% 2.6 0.5 3.46 610.3236 1,218.63 1,218.64 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 2.51 0.327 2.1 615.299 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 3.02 0.433 0 615.2993 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 2.87 0.345 1.51 615.2994 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 2.67 0.298 2.48 615.2997 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 3.27 0.404 0 615.2998 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 3.12 0.401 1.74 615.3002 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 2.59 0.398 1.38 615.3003 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 3.01 0.348 2.96 615.3004 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 2.8 0.365 1.96 615.3004 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 2.9 0.377 1.31 615.3005 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 3.2 0.475 1.77 615.3006 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 3.4 0.458 2.08 615.3006 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 3.34 0.424 2.02 615.3008 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 3.5 0.441 1.55 615.3008 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 3.02 0.398 0 615.302 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NNLFTSSAGYR 95.00% 3.11 0.395 1.43 615.3032 1,228.59 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 2.1 0.33 0 615.3636 1,228.71 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.35 0.547 3.21 615.366 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.54 0.596 3.1 615.3661 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.01 0.491 0 615.3662 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.68 0.631 4.64 615.3666 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 2.12 0.378 0 615.3667 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.34 0.537 4.38 615.3667 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.33 0.473 4.41 615.3673 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.39 0.56 3.28 615.3673 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.55 0.612 3.47 615.3674 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.79 0.58 4.8 615.3674 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.55 0.565 4.82 615.3675 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.58 0.585 3.72 615.3675 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.57 0.563 3.89 615.3676 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.36 0.556 2.89 615.3676 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.85 0.605 4.36 615.3678 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.76 0.597 4.17 615.3678 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.77 0.64 3.52 615.3678 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 2.93 0.603 3.41 615.3678 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.41 0.545 2.85 615.3678 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.72 0.604 3.77 615.3679 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.47 0.553 4.24 615.368 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.62 0.611 3.28 615.3681 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.52 0.573 3.82 615.3681 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.66 0.587 3.57 615.3682 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 2.93 0.499 0 615.3683 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.47 0.6 3.68 615.3684 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.88 0.6 3.39 615.3684 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.77 0.586 3.92 615.3684 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.86 0.599 4.59 615.3686 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.64 0.561 3.66 615.3686 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.28 0.498 2.8 615.3686 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.39 0.503 4.19 615.3688 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 2.54 0.523 2.64 615.3692 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.07 0.507 1.46 615.3693 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.1 0.5 3.32 615.3694 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.35 0.565 2.92 615.3695 1,228.72 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 2.7 0.509 1.24 615.3705 1,228.73 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 2.72 0.46 2.34 615.3708 1,228.73 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.24 0.585 4.54 615.3709 1,228.73 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 2.8 0.514 1.23 615.371 1,228.73 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 2.92 0.555 3 615.3715 1,228.73 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 3.36 0.442 4.6 615.8717 1,229.73 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 2.26 0.566 1.89 615.9443 1,229.87 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VPQIAFVITGGK 95.00% 1.73 0.372 0 615.946 1,229.88 1,229.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 2.85 0.449 1.8 619.8287 1,237.64 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 2.48 0.507 2.57 619.8304 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 2.28 0.376 1.31 619.8307 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 2.76 0.512 1.82 619.831 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.37 0.507 2.54 619.8311 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.36 0.419 2.39 619.8316 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 2.86 0.312 1.57 619.8316 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 2.3 0.227 1.96 619.8318 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.42 0.494 2.49 619.8321 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.3 0.49 1.6 619.8321 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.4 0.486 1.54 619.8322 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.43 0.433 2.12 619.8322 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.45 0.548 2.28 619.8322 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.57 0.522 2.57 619.8322 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.41 0.524 1.92 619.8323 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.17 0.556 2.85 619.8323 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.48 0.555 1.62 619.8324 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.48 0.465 2.1 619.8325 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.28 0.408 2.54 619.8325 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.29 0.509 2.14 619.8327 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.3 0.535 2.52 619.8328 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.16 0.532 2.35 619.8329 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.38 0.466 2.17 619.8331 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.32 0.55 1.43 619.8337 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.05 0.513 1.68 619.8338 1,237.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.35 0.53 2.35 620.3344 1,238.65 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVFFSNTPTR 95.00% 3.24 0.435 1.85 620.3355 1,238.66 1,238.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 4.12 0.505 1.41 624.0509 1,869.13 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 2.85 0.356 0 624.052 1,869.13 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 4.51 0.493 0 624.0521 1,869.13 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 3.12 0.437 1.6 624.0521 1,869.13 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 3.76 0.497 1.4 624.0524 1,869.13 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 3.88 0.494 1.21 624.0532 1,869.14 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 4.53 0.489 1.26 624.0536 1,869.14 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 4.15 0.533 0 624.0648 1,869.17 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 4.18 0.509 1.57 624.3856 1,870.13 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 4.09 0.474 2.11 624.3864 1,870.14 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 4.2 0.529 2.05 624.3864 1,870.14 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 4.31 0.567 3.05 624.3875 1,870.14 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 4.29 0.485 1.46 624.3881 1,870.14 1,870.14 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GNRGDSIDQcALIQSIK 95.00% 4.37 0.337 1.8 c10: Carbamidomethyl (+57.02) 625.6522 1,873.93 1,874.94 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GNRGDSIDQcALIQSIK 95.00% 4.55 0.367 1.64 c10: Carbamidomethyl (+57.02) 625.6527 1,873.93 1,874.94 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 2.23 0.438 1.3 643.815 1,285.61 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 3.74 0.448 2.92 644.3316 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 3.9 0.428 3.38 644.3316 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 3 0.419 3.51 644.3317 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 2.67 0.401 3.41 644.3318 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 3.3 0.435 2.54 644.3319 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 2.99 0.391 3.17 644.3324 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 3.22 0.458 3.54 644.3325 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 2.19 0.289 0 644.3326 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 3.55 0.43 3.85 644.3327 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 3.69 0.458 3.85 644.3331 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 2.97 0.426 2.77 644.3332 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 3.51 0.438 3.02 644.3332 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 3.37 0.397 3.41 644.3339 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 2.3 0.232 0 644.3343 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% TELQTITNDPR 95.00% 2.72 0.411 2.57 644.3345 1,286.65 1,287.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 4.94 0.574 4.64 650.9953 1,949.96 1,950.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 6.9 0.643 3.68 650.9955 1,949.96 1,950.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 4.87 0.576 4.51 651.3292 1,950.96 1,950.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 5.69 0.529 5.12 651.3293 1,950.96 1,950.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 6.14 0.617 5.19 651.3297 1,950.97 1,950.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 5.15 0.501 4.3 651.3298 1,950.97 1,950.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 6.13 0.567 6.48 651.3302 1,950.97 1,950.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 6.73 0.568 5.14 651.3307 1,950.97 1,950.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 6.3 0.605 6.68 651.3309 1,950.97 1,950.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 6.4 0.628 4.68 651.331 1,950.97 1,950.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 6.31 0.613 5.27 651.3312 1,950.97 1,950.97 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.2 0.44 3.41 660.8695 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.48 0.414 2.06 660.8707 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.35 0.502 2.17 660.8707 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.4 0.476 1.23 660.8709 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.51 0.412 3.34 660.871 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.56 0.447 5.13 660.871 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.4 0.421 3.96 660.8711 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.7 0.423 3.21 660.8711 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.59 0.408 0 660.8711 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.59 0.437 4.11 660.8711 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.44 0.427 4.04 660.8713 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.61 0.433 2.4 660.8713 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.4 0.426 2.8 660.8714 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.28 0.367 1.42 660.8714 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.69 0.425 3.27 660.8715 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.42 0.22 0 660.8719 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.55 0.247 1.44 660.8719 1,319.73 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QSGVVPFIFQAK 95.00% 2.1 0.375 0 661.0309 1,320.05 1,320.73 2 ITA7_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 2.75 0.293 0 663.6801 1,988.02 1,988.02 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 3.96 0.512 3.54 670.3381 2,007.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 3.53 0.327 4.05 670.3382 2,007.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 3.72 0.597 3.96 670.3386 2,007.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 3.4 0.625 3.4 670.3387 2,007.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 4.42 0.65 3.23 670.339 2,007.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 3.54 0.492 2.39 670.6537 2,008.94 2,008.99 3 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 3.59 0.564 3.06 670.6718 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 4.45 0.522 3.51 670.6721 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 5.09 0.629 4.21 670.6725 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 4.15 0.47 3.02 670.6725 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 4.94 0.541 4.14 670.6726 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GFESKVDAILNR 95.00% 3.03 0.485 1.89 674.8657 1,347.72 1,348.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GFESKVDAILNR 95.00% 3.1 0.442 3.54 674.8669 1,347.72 1,348.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GFESKVDAILNR 95.00% 3.33 0.573 2.77 674.867 1,347.72 1,348.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GFESKVDAILNR 95.00% 3.31 0.464 3.89 674.8678 1,347.72 1,348.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 3.06 0.453 1.92 679.3768 1,356.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 2.8 0.419 1.96 679.3769 1,356.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 2.86 0.494 2.82 679.377 1,356.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 2.92 0.45 1.7 679.3771 1,356.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 3.29 0.49 3.39 679.3772 1,356.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 2.67 0.387 2.2 679.3772 1,356.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 2.65 0.496 1.46 679.3773 1,356.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 3.12 0.519 3.32 679.3776 1,356.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 2.39 0.451 2.13 679.3778 1,356.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 3.2 0.462 2.96 679.378 1,356.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 2.32 0.379 0 679.3781 1,356.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 2.58 0.301 1.33 679.3783 1,356.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QLGTVQQVISER 95.00% 2.1 0.24 1.51 679.8785 1,357.74 1,357.74 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 1.82 0.332 0 683.8154 1,365.62 1,366.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 3.11 0.533 2.4 683.8783 1,365.74 1,366.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 3.86 0.604 5 683.8785 1,365.74 1,366.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 3.85 0.597 4.72 683.8791 1,365.74 1,366.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 4.06 0.594 4.33 683.8792 1,365.74 1,366.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 4.02 0.579 3.72 683.8797 1,365.74 1,366.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 3.53 0.537 3.66 683.8802 1,365.74 1,366.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 3.84 0.581 2.89 683.8803 1,365.74 1,366.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% KVAVFFSNTPTR 95.00% 3.5 0.593 3.7 683.8824 1,365.75 1,366.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% qIIDAINKVVYK 95.00% 0 0 3.29 n-term: Pyro-cmC (-17.03) 693.9027 1,385.79 1,386.80 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 2.47 0.322 0 702.3977 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 2.49 0.295 1.96 702.3979 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 3 0.499 2.17 702.3993 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 3.93 0.447 2.74 702.3998 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 4.09 0.491 3.82 702.3999 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 4.33 0.512 3.82 702.3999 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 2.64 0.375 2.59 702.4 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 3.65 0.393 2.82 702.4 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 4.42 0.534 4.64 702.4 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 3.45 0.372 2.85 702.4001 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 4.15 0.492 3.04 702.4002 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 4.34 0.513 3.08 702.4002 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 4.33 0.495 3.62 702.4002 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 4.44 0.542 3.07 702.4003 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 2.07 0.285 0 702.4004 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 4.64 0.536 2.92 702.4005 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 4.41 0.513 4.89 702.4007 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 3.98 0.51 3.92 702.4009 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 4.06 0.51 5.52 702.4011 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 3.94 0.464 3.72 702.4011 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 2.5 0.408 1.42 702.4012 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 3.75 0.542 2.7 702.4012 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 3.64 0.521 3.8 702.4018 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 4.04 0.364 4.23 702.4018 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 2.97 0.375 2.7 702.4023 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QIIDAINKVVYK 95.00% 2.85 0.381 1.47 702.4171 1,402.82 1,403.83 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QIIDAINKVVYK 95.00% 2.75 0.26 1.77 702.418 1,402.82 1,403.83 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QIIDAINKVVYK 95.00% 2.05 0.208 1.52 702.418 1,402.82 1,403.83 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QIIDAINKVVYK 95.00% 2.53 0.304 1.77 702.4184 1,402.82 1,403.83 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LSDAGITPLFLTR 95.00% 2.68 0.473 1.92 702.9055 1,403.80 1,403.79 2 TLN1_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DVVLSIVNDLTIAESNcPR 95.00% 5.4 0.653 1.54 c17: Carbamidomethyl (+57.02) 705.6981 2,114.07 2,115.08 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DVVLSIVNDLTIAESNcPR 95.00% 5.72 0.631 1.32 c17: Carbamidomethyl (+57.02) 705.6982 2,114.07 2,115.08 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DVVLSIVNDLTIAESNcPR 95.00% 6.37 0.55 4.17 c17: Carbamidomethyl (+57.02) 706.0313 2,115.07 2,115.08 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% DVVLSIVNDLTIAESNcPR 95.00% 7.51 0.622 5.24 c17: Carbamidomethyl (+57.02) 706.032 2,115.07 2,115.08 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SGFPLLKEFVQR 95.00% 2.31 0.273 0 710.9032 1,419.79 1,420.80 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 4.89 0.577 5.11 714.7095 2,141.10 2,141.11 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 3.83 0.497 2.92 714.7114 2,141.11 2,141.11 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 3.29 0.328 1.05 714.7119 2,141.11 2,141.11 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SDDEVDDPAVELK 95.00% 3 0.242 0 716.3287 1,430.64 1,431.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SDDEVDDPAVELK 95.00% 3.78 0.411 3.05 716.3288 1,430.64 1,431.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SDDEVDDPAVELK 95.00% 3.78 0.451 3.7 716.3288 1,430.64 1,431.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SDDEVDDPAVELK 95.00% 3.09 0.266 0 716.3293 1,430.64 1,431.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SDDEVDDPAVELK 95.00% 3.48 0.446 3.46 716.3298 1,430.64 1,431.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SDDEVDDPAVELK 95.00% 4.24 0.415 2.85 716.33 1,430.64 1,431.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SDDEVDDPAVELK 95.00% 3.82 0.358 2.12 716.3304 1,430.65 1,431.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SDDEVDDPAVELK 95.00% 4.21 0.4 2.96 716.3304 1,430.65 1,431.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SDDEVDDPAVELK 95.00% 3.44 0.475 2 716.3305 1,430.65 1,431.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SDDEVDDPAVELK 95.00% 3.06 0.358 1.41 716.338 1,430.66 1,431.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 3.35 0.289 0 716.3662 1,430.72 1,431.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 3.22 0.252 0 716.3667 1,430.72 1,431.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 3.35 0.319 1.24 716.3686 1,430.72 1,431.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 3.06 0.311 0 716.3687 1,430.72 1,431.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 3.49 0.317 1.38 716.3689 1,430.72 1,431.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 2.94 0.203 0 716.3691 1,430.72 1,431.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% EFRELPNIEER 95.00% 2.87 0.243 0 716.3695 1,430.72 1,431.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SDDEVDDPAVELK 95.00% 3.15 0.0555 1.89 716.37 1,430.72 1,431.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SDDEVDDPAVELK 95.00% 3.56 0.245 1.64 716.8651 1,431.71 1,431.65 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% qQSLETAMSFVAR 95.00% 0 0 4.07 n-term: Pyro-cmC (-17.03) 725.8563 1,449.70 1,450.70 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.68 0.278 1.89 730.4324 1,458.85 1,459.86 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.84 0.289 1.92 730.4347 1,458.85 1,459.86 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 3.14 0.352 1.89 730.4359 1,458.86 1,459.86 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IGDLHPQIVNLLK 95.00% 2.75 0.294 1.85 730.436 1,458.86 1,459.86 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QINVGNALEYVSR 95.00% 3.77 0.547 3.2 731.8878 1,461.76 1,462.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QINVGNALEYVSR 95.00% 3.48 0.494 3.42 731.888 1,461.76 1,462.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QINVGNALEYVSR 95.00% 3.57 0.478 3 731.888 1,461.76 1,462.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QINVGNALEYVSR 95.00% 3.32 0.429 2.72 731.8883 1,461.76 1,462.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QINVGNALEYVSR 95.00% 2.65 0.339 3.89 731.8886 1,461.76 1,462.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QINVGNALEYVSR 95.00% 2.85 0.304 1.92 732.3495 1,462.68 1,462.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QINVGNALEYVSR 95.00% 3.28 0.439 4 732.3877 1,462.76 1,462.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QINVGNALEYVSR 95.00% 3.56 0.48 3.04 732.3896 1,462.76 1,462.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QINVGNALEYVSR 95.00% 3.4 0.412 3.15 732.3908 1,462.77 1,462.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 3.4 0.462 2.38 734.3675 1,466.72 1,467.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 2.42 0.321 0 734.3675 1,466.72 1,467.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 3.39 0.489 1.48 734.3685 1,466.72 1,467.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 3.47 0.47 1.55 734.3686 1,466.72 1,467.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 3.15 0.425 1.39 734.3688 1,466.72 1,467.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 3.3 0.343 2.39 734.3692 1,466.72 1,467.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 3.23 0.464 1.2 734.3696 1,466.72 1,467.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 3.18 0.395 2.18 734.3697 1,466.72 1,467.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 3.16 0.468 1.27 734.3713 1,466.73 1,467.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAMSFVAR 95.00% 3.3 0.415 0 734.3716 1,466.73 1,467.73 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALNLGYALDYAQR 95.00% 4.02 0.569 4.2 734.3842 1,466.75 1,467.76 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALNLGYALDYAQR 95.00% 4.52 0.606 4.51 734.3844 1,466.75 1,467.76 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALNLGYALDYAQR 95.00% 4.51 0.615 3.54 734.3846 1,466.75 1,467.76 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALNLGYALDYAQR 95.00% 4.34 0.567 4.82 734.3854 1,466.76 1,467.76 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALNLGYALDYAQR 95.00% 4.33 0.583 3.92 734.3864 1,466.76 1,467.76 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ALNLGYALDYAQR 95.00% 4.1 0.602 4.59 734.8854 1,467.76 1,467.76 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDRVR 95.00% 2.86 0.346 0 736.3979 1,470.78 1,471.79 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDRVR 95.00% 3.59 0.41 0 736.3988 1,470.78 1,471.79 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDRVR 95.00% 2.93 0.347 0 736.399 1,470.78 1,471.79 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVESLDVGQDRVR 95.00% 3.13 0.381 0 736.9015 1,471.79 1,471.79 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAmSFVAR 95.00% 3.26 0.496 3.28 m8: Oxidation (+15.99) 742.3668 1,482.72 1,483.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% QQSLETAmSFVAR 95.00% 2.97 0.549 1.8 m8: Oxidation (+15.99) 742.3673 1,482.72 1,483.72 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 3.32 0.246 0 742.4109 1,482.81 1,483.81 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 3.58 0.393 2.6 742.412 1,482.81 1,483.81 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 3.5 0.346 2.89 742.4126 1,482.81 1,483.81 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 3.39 0.28 2.68 742.4126 1,482.81 1,483.81 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 3.71 0.32 1.74 742.4129 1,482.81 1,483.81 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IIDELNVKPEGTR 95.00% 3.54 0.336 3.74 742.9127 1,483.81 1,483.81 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.29 0.467 6.05 757.3819 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.57 0.464 6.1 757.382 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.68 0.439 6.21 757.3821 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.48 0.438 7.11 757.3823 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.4 0.454 5.74 757.383 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 3.81 0.451 6.22 757.3832 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.62 0.509 6.12 757.3833 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.34 0.531 6.22 757.3833 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 3.69 0.398 6.82 757.3836 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.07 0.506 7.02 757.3838 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.36 0.514 7.39 757.3838 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.38 0.449 5.68 757.3838 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 2.33 0.395 1.89 757.3841 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.33 0.439 7.51 757.3841 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 3.69 0.544 6.6 757.3844 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 1.97 0.199 2.74 757.3844 1,512.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.44 0.541 7.77 757.3975 1,512.78 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.78 0.419 5.85 757.8845 1,513.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.01 0.378 6.1 757.8846 1,513.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.42 0.427 8.39 757.8847 1,513.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 3.86 0.289 4.74 757.8849 1,513.75 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LVDYLDVGFDTTR 95.00% 4.39 0.414 6.09 757.8859 1,513.76 1,513.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VEFLLNAHSSKDEVQNAVQR 95.00% 4.09 0.532 2.48 762.0604 2,283.16 2,284.17 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VEFLLNAHSSKDEVQNAVQR 95.00% 3.4 0.419 0 762.3951 2,284.16 2,284.17 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VEFLLNAHSSKDEVQNAVQR 95.00% 5.94 0.522 2.96 762.3979 2,284.17 2,284.17 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VEFLLNAHSSKDEVQNAVQR 95.00% 5.58 0.471 3.07 762.4002 2,284.18 2,284.17 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 3.49 0.511 3.07 765.8941 1,529.77 1,530.78 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 3.29 0.568 6.57 765.8957 1,529.78 1,530.78 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 3.46 0.495 5.85 765.8975 1,529.78 1,530.78 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 2.52 0.431 3.26 765.8988 1,529.78 1,530.78 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 2.74 0.4 1.89 765.8994 1,529.78 1,530.78 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SQHPYVLTEDTLK 95.00% 3.73 0.481 7 766.3979 1,530.78 1,530.78 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 3.61 0.509 3.32 c2: Carbamidomethyl (+57.02) 768.8788 1,535.74 1,536.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 3.57 0.514 3.11 c2: Carbamidomethyl (+57.02) 768.8788 1,535.74 1,536.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 3.4 0.494 3.21 c2: Carbamidomethyl (+57.02) 768.879 1,535.74 1,536.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 4.52 0.571 4.36 c2: Carbamidomethyl (+57.02) 768.8795 1,535.74 1,536.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 4.56 0.587 3.02 c2: Carbamidomethyl (+57.02) 768.8797 1,535.74 1,536.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 4.47 0.591 4.96 c2: Carbamidomethyl (+57.02) 768.8797 1,535.74 1,536.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 3.33 0.479 3.72 c2: Carbamidomethyl (+57.02) 768.8801 1,535.74 1,536.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 4.56 0.611 3.57 c2: Carbamidomethyl (+57.02) 768.8807 1,535.75 1,536.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 3.31 0.514 3.6 c2: Carbamidomethyl (+57.02) 768.8821 1,535.75 1,536.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AcNLDVILGFDGSR 95.00% 4.42 0.452 4.34 c2: Carbamidomethyl (+57.02) 769.3799 1,536.74 1,536.75 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIK 95.00% 3.74 0.368 1.96 c7: Carbamidomethyl (+57.02) 774.3926 1,546.77 1,547.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIK 95.00% 2.84 0.326 3 c7: Carbamidomethyl (+57.02) 774.3927 1,546.77 1,547.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIK 95.00% 3.39 0.318 1.82 c7: Carbamidomethyl (+57.02) 774.3927 1,546.77 1,547.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIK 95.00% 3.06 0.298 1.64 c7: Carbamidomethyl (+57.02) 774.3929 1,546.77 1,547.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIK 95.00% 3.92 0.334 1.92 c7: Carbamidomethyl (+57.02) 774.393 1,546.77 1,547.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIK 95.00% 3.02 0.385 1.47 c7: Carbamidomethyl (+57.02) 774.3931 1,546.77 1,547.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIK 95.00% 3.61 0.345 2.06 c7: Carbamidomethyl (+57.02) 774.3933 1,546.77 1,547.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIK 95.00% 3.05 0.356 2 c7: Carbamidomethyl (+57.02) 774.3941 1,546.77 1,547.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIK 95.00% 2.96 0.331 1.77 c7: Carbamidomethyl (+57.02) 774.3946 1,546.77 1,547.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIK 95.00% 3.55 0.364 2.82 c7: Carbamidomethyl (+57.02) 774.4071 1,546.80 1,547.77 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.62 0.567 4.92 793.9679 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 4.09 0.524 3.14 793.9687 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.59 0.521 3.82 793.9689 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 4.27 0.521 3.68 793.969 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 4.44 0.502 4 793.9692 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.85 0.529 5.51 793.9695 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.99 0.492 2.85 793.9698 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 4.33 0.486 4.8 793.9699 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.88 0.57 2.62 793.9699 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.73 0.565 2.52 793.9699 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.01 0.502 3.85 793.9701 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.81 0.496 2.62 793.9701 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.95 0.463 4.16 793.9701 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.9 0.501 2.77 793.9703 1,585.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.95 0.557 2.96 793.9706 1,585.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.84 0.521 4.01 793.9708 1,585.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.87 0.566 5.44 793.9709 1,585.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.37 0.544 2.12 793.971 1,585.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 3.63 0.491 3.13 793.9826 1,585.95 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 4.1 0.54 3 794.4713 1,586.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LQPVLQPLPSPGVGGK 95.00% 4.26 0.534 3.35 794.4729 1,586.93 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% MRDVVLSIVNDLTIAESNcPR 95.00% 4.56 0.493 2.19 c19: Carbamidomethyl (+57.02) 801.7481 2,402.22 2,402.22 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% MRDVVLSIVNDLTIAESNcPR 95.00% 5.3 0.526 1.15 c19: Carbamidomethyl (+57.02) 801.7482 2,402.22 2,402.22 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% MRDVVLSIVNDLTIAESNcPR 95.00% 4.73 0.505 1.29 c19: Carbamidomethyl (+57.02) 801.7486 2,402.22 2,402.22 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% MRDVVLSIVNDLTIAESNcPR 95.00% 4.53 0.532 0.959 c19: Carbamidomethyl (+57.02) 801.7503 2,402.23 2,402.22 3
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SLDEISQPAQELKR 95.00% 3.55 0.335 0 807.432 1,612.85 1,613.85 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SLDEISQPAQELKR 95.00% 3.89 0.417 0 807.432 1,612.85 1,613.85 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SLDEISQPAQELKR 95.00% 3.35 0.411 0 807.4322 1,612.85 1,613.85 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SLDEISQPAQELKR 95.00% 3.62 0.392 0 807.4373 1,612.86 1,613.85 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AAPLQGMLPGLLAPLR 95.00% 4.13 0.544 5.08 809.4821 1,616.95 1,617.95 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AAPLQGMLPGLLAPLR 95.00% 5.1 0.534 5.39 809.4823 1,616.95 1,617.95 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AAPLQGMLPGLLAPLR 95.00% 4.57 0.567 5.7 809.4826 1,616.95 1,617.95 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AAPLQGMLPGLLAPLR 95.00% 4.7 0.573 6.85 809.4828 1,616.95 1,617.95 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AAPLQGMLPGLLAPLR 95.00% 4.65 0.505 5.08 809.4829 1,616.95 1,617.95 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AAPLQGMLPGLLAPLR 95.00% 4.31 0.486 4.31 809.9818 1,617.95 1,617.95 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% AAPLQGMLPGLLAPLR 95.00% 4.64 0.523 5.11 809.9853 1,617.95 1,617.95 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.32 0.536 3.89 816.4155 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.28 0.51 4.82 816.4167 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.47 0.527 4.82 816.4168 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.25 0.51 4.34 816.4171 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.4 0.521 3.74 816.4172 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.07 0.505 4.2 816.4173 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.49 0.534 4.62 816.4174 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.34 0.516 4.44 816.4176 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.28 0.52 4.34 816.4177 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.59 0.545 4.15 816.4177 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.6 0.52 3.82 816.4178 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.32 0.533 4.17 816.418 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.19 0.493 3.4 816.4182 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.4 0.539 3.7 816.4183 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.42 0.53 3.96 816.4184 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.43 0.526 3.96 816.4184 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.56 0.511 4.17 816.4185 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.41 0.509 4.01 816.4189 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.07 0.498 4.34 816.4191 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.36 0.518 4.37 816.4195 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 4.71 0.46 4.36 816.4195 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.29 0.522 4.15 816.4199 1,630.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.28 0.519 4 816.9178 1,631.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVEDAQDVSLALTQR 95.00% 5.51 0.506 4.17 816.9189 1,631.82 1,631.82 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.22 0.391 3.31 837.4829 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.01 0.432 4.26 837.4839 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.42 0.448 3.23 837.4841 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.11 0.479 3.66 837.4842 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.45 0.467 3.33 837.4842 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.14 0.438 4.59 837.4848 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.24 0.386 4.37 837.4848 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.9 0.492 3.15 837.485 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.25 0.435 3.66 837.4853 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.3 0.376 2.68 837.4853 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.07 0.428 4.11 837.4854 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.86 0.482 4.89 837.4854 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.23 0.445 3.82 837.4859 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.31 0.437 3.55 837.4861 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.28 0.471 3.32 837.4879 1,672.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.49 0.454 3.15 837.9856 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.16 0.397 4.42 837.9861 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.32 0.449 3 837.9866 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.23 0.403 3.21 837.987 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.4 0.459 3.72 837.9871 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.13 0.418 4.11 837.9872 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.1 0.29 1.49 837.9875 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 4.41 0.432 3.64 837.9884 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEDGVPQHLVLVLGGK 95.00% 3.92 0.379 1.64 837.9891 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IAVAQYSDDVKVESR 95.00% 4.91 0.569 3.52 840.4336 1,678.85 1,679.86 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IAVAQYSDDVKVESR 95.00% 4.82 0.593 4.43 840.4344 1,678.85 1,679.86 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IAVAQYSDDVKVESR 95.00% 4.33 0.577 4.16 840.4369 1,678.86 1,679.86 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IAVAQYSDDVKVESR 95.00% 4.24 0.547 4.55 840.4383 1,678.86 1,679.86 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.06 0.543 4.89 843.4884 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.37 0.525 3.02 843.4891 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.1 0.539 4.89 843.4892 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.1 0.516 4.68 843.4892 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.23 0.529 4.66 843.4895 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.68 0.439 4.05 843.4899 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.75 0.528 4.96 843.4899 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.11 0.522 5.35 843.49 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.08 0.497 4.66 843.49 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.35 0.52 5.13 843.4901 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.33 0.449 3.74 843.4901 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.97 0.565 4.66 843.4902 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.13 0.498 4.24 843.4902 1,684.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.1 0.527 4.77 843.4904 1,684.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.51 0.404 4.62 843.4904 1,684.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.34 0.517 3.31 843.4908 1,684.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.82 0.542 5.59 843.4909 1,684.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.92 0.542 3.16 843.4911 1,684.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.27 0.519 6 843.4918 1,684.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 4.43 0.408 2.8 843.4926 1,684.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.11 0.487 4.02 843.4927 1,684.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 3.59 0.451 3.17 843.4928 1,684.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.15 0.503 4.7 843.9903 1,685.96 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 3.61 0.536 2.29 843.9916 1,685.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.02 0.495 4.74 843.9916 1,685.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.33 0.504 3.25 843.9917 1,685.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.43 0.505 5.11 843.992 1,685.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.04 0.545 3.66 843.9925 1,685.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LLTPITTLTSEQIQK 95.00% 5.33 0.514 3.08 843.9926 1,685.97 1,685.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 3.41 0.37 1.27 854.4485 1,706.88 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.59 0.532 4.66 854.4519 1,706.89 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.69 0.53 4.8 854.4531 1,706.89 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.2 0.521 3.55 854.4537 1,706.89 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.73 0.53 4 854.4538 1,706.89 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.6 0.498 4.44 854.4575 1,706.90 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.14 0.465 3.27 854.4586 1,706.90 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.56 0.393 4.22 854.46 1,706.90 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.29 0.35 3.47 854.4613 1,706.91 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.44 0.327 2.52 854.464 1,706.91 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.09 0.519 3.7 854.9475 1,707.88 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.04 0.408 2.52 854.9522 1,707.89 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.71 0.511 4.08 854.955 1,707.89 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.53 0.534 3.25 854.9575 1,707.90 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 4.38 0.419 4.89 854.9582 1,707.90 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VAVVTYNNEVTTEIR 95.00% 3.31 0.478 1.54 854.9621 1,707.91 1,707.89 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.41 0.614 6.19 858.4826 1,714.95 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.39 0.642 6.85 858.4842 1,714.95 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.3 0.645 7.27 858.4843 1,714.95 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.2 0.637 6.52 858.4843 1,714.95 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.23 0.65 7.6 858.4851 1,714.95 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 3.98 0.614 7.31 858.4861 1,714.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.29 0.628 7.51 858.4861 1,714.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.54 0.588 5.68 858.4866 1,714.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.49 0.583 7.23 858.4867 1,714.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.11 0.613 5.55 858.4867 1,714.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.6 0.587 6.24 858.4868 1,714.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.62 0.561 7.08 858.9861 1,715.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.09 0.628 7.89 858.987 1,715.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.5 0.646 5.64 858.987 1,715.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.28 0.594 5.74 858.9876 1,715.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.34 0.634 7.04 858.9877 1,715.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.26 0.619 6.01 858.9881 1,715.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 4.21 0.614 5.1 858.99 1,715.96 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% IEEGVPQFLVLISSGK 95.00% 3.01 0.425 1.51 858.992 1,715.97 1,715.96 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 3.32 0.419 2.47 866.4511 1,730.89 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 2.72 0.441 0 866.4513 1,730.89 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 3.1 0.418 1.82 866.4529 1,730.89 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 4.38 0.448 2.92 866.453 1,730.89 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 3.43 0.456 1.31 866.4536 1,730.89 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 3.9 0.449 4.08 866.4536 1,730.89 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 4.26 0.433 4.39 866.4542 1,730.89 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 3.07 0.489 1.6 866.4543 1,730.89 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 3.7 0.459 3.49 866.4557 1,730.90 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 4.47 0.414 3.55 866.953 1,731.89 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 3.04 0.349 0 866.9532 1,731.89 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 3.89 0.442 3.74 866.955 1,731.89 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 4.26 0.453 1.74 866.9554 1,731.90 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ISLSPEYVFSVSTFR 95.00% 3.7 0.549 4.8 866.9579 1,731.90 1,731.90 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.85 0.584 5.19 869.5116 1,737.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.94 0.556 4.77 869.5119 1,737.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.54 0.571 4.37 869.5121 1,737.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.94 0.636 4.85 869.5125 1,737.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.94 0.599 4.96 869.5127 1,737.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.99 0.595 4.34 869.5129 1,737.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.66 0.569 5.14 869.513 1,737.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.85 0.631 5.68 869.5131 1,737.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.86 0.56 5.85 869.5131 1,737.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.96 0.593 3.89 869.5139 1,737.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.98 0.619 4.34 869.5145 1,737.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.71 0.441 2.68 869.5149 1,737.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.65 0.562 4.27 869.5155 1,737.02 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 3.88 0.495 4.7 869.5166 1,737.02 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.82 0.598 4.35 870.0134 1,738.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.69 0.552 2.85 870.0149 1,738.01 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.69 0.528 2.89 870.0154 1,738.02 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% ITEGVPQLLIVLTADR 95.00% 4.44 0.527 4.59 870.0169 1,738.02 1,738.01 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.69 0.506 3.4 871.505 1,740.99 1,742.00 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.62 0.439 4.89 871.5056 1,741.00 1,742.00 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.52 0.446 2.96 872.0022 1,741.99 1,742.00 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.56 0.381 4.7 872.0057 1,742.00 1,742.00 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.31 0.452 5.27 872.0069 1,742.00 1,742.00 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.59 0.427 3.92 872.0072 1,742.00 1,742.00 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.3 0.376 2.72 872.0077 1,742.00 1,742.00 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% LDQRVPQIAFVITGGK 95.00% 4.47 0.42 4.1 872.0089 1,742.00 1,742.00 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIKDK 95.00% 3.89 0.444 1.96 c7: Carbamidomethyl (+57.02) 895.9525 1,789.89 1,790.90 2 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIKDK 95.00% 3.72 0.4 0 c7: Carbamidomethyl (+57.02) 895.9537 1,789.89 1,790.90 2 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIKDK 95.00% 4.09 0.476 0 c7: Carbamidomethyl (+57.02) 895.9551 1,789.89 1,790.90 2 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIKDK 95.00% 3.95 0.449 1.72 c7: Carbamidomethyl (+57.02) 895.9556 1,789.90 1,790.90 2 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GDSIDQcALIQSIKDK 95.00% 4.37 0.541 1.66 c7: Carbamidomethyl (+57.02) 896.4486 1,790.88 1,790.90 2 K1602_HUMAN,CO1A2_HUMAN,TITIN_HUMAN,HSP74_HUMAN,FLNA_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% FDEHQSKPEILNLVK 95.00% 3.61 0.47 3.06 898.9837 1,795.95 1,796.95 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% FDEHQSKPEILNLVK 95.00% 4 0.502 4.25 899.4857 1,796.96 1,796.95 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% FDEHQSKPEILNLVK 95.00% 3.68 0.509 3.8 899.4875 1,796.96 1,796.95 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% SVLLDKIKNLQVALTSK 95.00% 4.67 0.501 6.32 936.0786 1,870.14 1,870.14 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GNRGDSIDQcALIQSIK 95.00% 3.5 0.232 3.52 c10: Carbamidomethyl (+57.02) 937.9721 1,873.93 1,874.94 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GNRGDSIDQcALIQSIK 95.00% 4.84 0.358 5.96 c10: Carbamidomethyl (+57.02) 937.9747 1,873.93 1,874.94 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GNRGDSIDQcALIQSIK 95.00% 4.89 0.329 5.74 c10: Carbamidomethyl (+57.02) 938.4752 1,874.93 1,874.94 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 5.93 0.646 8.68 975.9861 1,949.96 1,950.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 5.71 0.638 9.04 975.9875 1,949.96 1,950.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 5.79 0.637 8.57 975.9883 1,949.96 1,950.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 5.72 0.614 7.48 976.4878 1,950.96 1,950.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 5.79 0.625 7.51 976.4898 1,950.96 1,950.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 5.79 0.633 7.68 976.4906 1,950.97 1,950.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 5.77 0.624 6.96 976.4909 1,950.97 1,950.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 5.57 0.645 9.57 976.491 1,950.97 1,950.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 5.83 0.633 10 976.4914 1,950.97 1,950.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VVIHFTDGADGDLADLHR 95.00% 5.63 0.624 8.41 976.4929 1,950.97 1,950.97 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 4.91 0.553 3.44 994.5141 1,987.01 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5.71 0.52 4.82 994.5153 1,987.01 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5.62 0.502 3.8 994.5159 1,987.02 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5.61 0.502 4 994.5163 1,987.02 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 4.35 0.557 6.96 995.0121 1,988.01 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5.7 0.428 4.52 995.0124 1,988.01 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5.8 0.437 6.25 995.0154 1,988.02 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5 0.487 4.7 995.0157 1,988.02 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5.08 0.432 4.74 995.0158 1,988.02 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5.78 0.458 3.62 995.0166 1,988.02 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5.82 0.448 4.18 995.0172 1,988.02 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5.89 0.408 5.6 995.0177 1,988.02 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5.59 0.471 2.74 995.0179 1,988.02 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5.74 0.424 4.42 995.0183 1,988.02 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% VGVVQFSNDVFPEFYLK 95.00% 5.84 0.446 5.35 995.0188 1,988.02 1,988.02 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 6.28 0.638 7.42 1,005.00 2,007.99 2,008.99 2 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 6.29 0.625 5 1,005.50 2,008.99 2,008.99 2 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% NIDSEEVGKIASNSATAFR 95.00% 5.59 0.613 3.15 1,005.51 2,009.00 2,008.99 2 MUC16_HUMAN
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 4.98 0.648 4.66 1,071.56 2,141.11 2,141.11 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 6.2 0.684 7.25 1,071.56 2,141.11 2,141.11 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 5.96 0.707 7.21 1,071.56 2,141.11 2,141.11 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 5.93 0.671 7.77 1,071.56 2,141.11 2,141.11 2
 SAMPLE 4R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 61 94 906 23.40% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 5.92 0.703 7.57 1,071.57 2,141.11 2,141.11 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% NLQVALTSK 95.00% 2.2 0.256 0 487.2877 972.5597 973.5683 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% NLQVALTSK 95.00% 2.27 0.315 0 487.2877 972.5597 973.5683 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IGDLHPQIVNLLK 95.00% 2.56 0.218 0 487.2898 1,458.85 1,459.86 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IGDLHPQIVNLLK 95.00% 3.22 0.373 0 487.291 1,458.85 1,459.86 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IGDLHPQIVNLLK 95.00% 3.14 0.257 0 487.291 1,458.85 1,459.86 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IGDLHPQIVNLLK 95.00% 2.48 0.355 1.11 487.2914 1,458.85 1,459.86 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IGDLHPQIVNLLK 95.00% 2.75 0.394 0 487.2918 1,458.85 1,459.86 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IGDLHPQIVNLLK 95.00% 2.89 0.388 0 487.2919 1,458.85 1,459.86 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IGDLHPQIVNLLK 95.00% 2.32 0.255 0 487.2932 1,458.86 1,459.86 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% ALILVGLER 95.00% 3.02 0.346 0 492.3145 982.6134 983.6255 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% ALILVGLER 95.00% 2.78 0.366 0 492.3146 982.6136 983.6255 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% ALILVGLER 95.00% 3.11 0.341 1.39 492.315 982.6143 983.6255 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% ALILVGLER 95.00% 2.91 0.32 1.29 492.315 982.6143 983.6255 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% ALILVGLER 95.00% 3.19 0.33 1.33 492.315 982.6143 983.6255 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% ALILVGLER 95.00% 3.24 0.343 0 492.3151 982.6145 983.6255 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% ALILVGLER 95.00% 2.38 0.357 1.14 492.3151 982.6145 983.6255 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% ALILVGLER 95.00% 3.06 0.344 0 492.3155 982.6153 983.6255 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% ALILVGLER 95.00% 2.97 0.387 1.41 492.3156 982.6156 983.6255 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% ALILVGLER 95.00% 3.03 0.328 0 492.3158 982.616 983.6255 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% ALILVGLER 95.00% 3.15 0.334 1.25 492.3159 982.6161 983.6255 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% ALILVGLER 95.00% 3.06 0.312 1.44 492.3163 982.617 983.6255 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IIDELNVKPEGTR 95.00% 2.25 0.244 0 495.2747 1,482.80 1,483.81 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IIDELNVKPEGTR 95.00% 2.8 0.388 0 495.6082 1,483.80 1,483.81 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% DSFQEVLR 95.00% 2.56 0.341 0 497.2501 992.4845 993.5006 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% DSFQEVLR 95.00% 2.94 0.349 0 497.2513 992.4869 993.5006 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SQHPYVLTEDTLK 95.00% 3.35 0.34 0 510.9306 1,529.77 1,530.78 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SQAPVLDAIR 95.00% 2.3 0.352 1.77 535.3022 1,068.59 1,069.60 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SQAPVLDAIR 95.00% 2.69 0.38 1.26 535.3031 1,068.59 1,069.60 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SQAPVLDAIR 95.00% 2.68 0.409 1.64 535.3034 1,068.59 1,069.60 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SQAPVLDAIR 95.00% 2.77 0.362 1.92 535.3035 1,068.59 1,069.60 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SQAPVLDAIR 95.00% 2.64 0.361 2.07 535.3037 1,068.59 1,069.60 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IEDGVPQHLVLVLGGK 95.00% 3.66 0.369 0 558.6567 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IEDGVPQHLVLVLGGK 95.00% 2.77 0.251 0 558.9909 1,673.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LLTPITTLTSEQIQK 95.00% 4.39 0.461 2.74 562.6611 1,684.96 1,685.97 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LLTPITTLTSEQIQK 95.00% 4.73 0.371 2.89 562.9944 1,685.96 1,685.97 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LLTPITTLTSEQIQK 95.00% 3.82 0.266 1.28 562.9958 1,685.96 1,685.97 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SSGIVSLGVGDR 95.00% 3.33 0.374 4.46 573.8073 1,145.60 1,146.61 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SSGIVSLGVGDR 95.00% 3.67 0.426 3.3 573.8079 1,145.60 1,146.61 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SSGIVSLGVGDR 95.00% 3.34 0.42 4.51 573.8084 1,145.60 1,146.61 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SSGIVSLGVGDR 95.00% 3.2 0.39 4.04 573.8087 1,145.60 1,146.61 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SSGIVSLGVGDR 95.00% 3.4 0.41 3.74 573.8091 1,145.60 1,146.61 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SSGIVSLGVGDR 95.00% 3.22 0.39 2.27 573.8091 1,145.60 1,146.61 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SSGIVSLGVGDR 95.00% 2.84 0.381 1.2 573.8136 1,145.61 1,146.61 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LDQRVPQIAFVITGGK 95.00% 4.22 0.396 1.29 581.6713 1,741.99 1,742.00 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% NIDRTELQTITNDPR 95.00% 2.87 0.308 0 595.9746 1,784.90 1,785.91 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VPQIAFVITGGK 95.00% 3.59 0.599 4.15 615.3643 1,228.71 1,229.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VPQIAFVITGGK 95.00% 3.5 0.616 5.82 615.3644 1,228.71 1,229.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VPQIAFVITGGK 95.00% 3.57 0.581 4.03 615.3647 1,228.71 1,229.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VPQIAFVITGGK 95.00% 4.13 0.595 4.06 615.365 1,228.71 1,229.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VPQIAFVITGGK 95.00% 3.43 0.604 3.62 615.3653 1,228.71 1,229.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VPQIAFVITGGK 95.00% 3.92 0.552 5.43 615.3654 1,228.72 1,229.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VPQIAFVITGGK 95.00% 3.68 0.601 4.39 615.3656 1,228.72 1,229.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VPQIAFVITGGK 95.00% 3.74 0.597 4.46 615.3656 1,228.72 1,229.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VPQIAFVITGGK 95.00% 3.76 0.584 4.41 615.366 1,228.72 1,229.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VPQIAFVITGGK 95.00% 2.36 0.329 1.15 615.3672 1,228.72 1,229.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VPQIAFVITGGK 95.00% 2.36 0.479 0 615.3714 1,228.73 1,229.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VAVFFSNTPTR 95.00% 3.05 0.515 2.62 619.8262 1,237.64 1,238.65 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VAVFFSNTPTR 95.00% 3.4 0.553 2.48 619.8293 1,237.64 1,238.65 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VAVFFSNTPTR 95.00% 3.35 0.563 2.62 619.8299 1,237.64 1,238.65 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VAVFFSNTPTR 95.00% 2.04 0.422 0 619.8303 1,237.64 1,238.65 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VAVFFSNTPTR 95.00% 3.31 0.523 3.24 619.8304 1,237.65 1,238.65 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VAVFFSNTPTR 95.00% 2.58 0.515 1.7 619.8307 1,237.65 1,238.65 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VAVFFSNTPTR 95.00% 3.28 0.509 2.14 619.8307 1,237.65 1,238.65 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VAVFFSNTPTR 95.00% 3.37 0.513 3.08 619.8316 1,237.65 1,238.65 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VAVFFSNTPTR 95.00% 3.32 0.507 2.11 619.8319 1,237.65 1,238.65 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VAVFFSNTPTR 95.00% 2.31 0.347 1.12 620.3032 1,238.59 1,238.65 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VVIHFTDGADGDLADLHR 95.00% 6.7 0.588 5.49 651.328 1,950.96 1,950.97 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% VVIHFTDGADGDLADLHR 95.00% 5.74 0.585 5.22 651.3281 1,950.96 1,950.97 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QSGVVPFIFQAK 95.00% 2.16 0.295 0 660.8671 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QSGVVPFIFQAK 95.00% 2.02 0.41 1.15 660.8683 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QSGVVPFIFQAK 95.00% 2.32 0.439 1.7 660.8683 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QSGVVPFIFQAK 95.00% 2.48 0.47 0 660.8684 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QSGVVPFIFQAK 95.00% 2.19 0.389 1.54 660.8687 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% NIDSEEVGKIASNSATAFR 95.00% 3.48 0.46 3.92 670.6697 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% NIDSEEVGKIASNSATAFR 95.00% 3.19 0.428 1.7 670.6704 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QLGTVQQVISER 95.00% 2.38 0.426 2.18 679.3747 1,356.73 1,357.74 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QLGTVQQVISER 95.00% 2.64 0.493 2.92 679.375 1,356.73 1,357.74 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LSDAGITPLFLTR 95.00% 2.87 0.336 3.15 702.3964 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LSDAGITPLFLTR 95.00% 4.02 0.464 3.72 702.3966 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LSDAGITPLFLTR 95.00% 4.06 0.485 5.72 702.3968 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LSDAGITPLFLTR 95.00% 3.98 0.53 4.64 702.397 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LSDAGITPLFLTR 95.00% 3.98 0.467 4.26 702.3976 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LSDAGITPLFLTR 95.00% 3.64 0.477 2.6 702.3977 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LSDAGITPLFLTR 95.00% 2.36 0.353 0 702.4011 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LSDAGITPLFLTR 95.00% 3.26 0.462 2.96 702.4023 1,402.79 1,403.79 2 TLN1_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LSDAGITPLFLTR 95.00% 3.42 0.366 1.77 702.4055 1,402.80 1,403.79 2 TLN1_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LSDAGITPLFLTR 95.00% 3.53 0.486 4.01 702.4085 1,402.80 1,403.79 2 TLN1_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LSDAGITPLFLTR 95.00% 4.13 0.531 5.13 702.412 1,402.81 1,403.79 2 TLN1_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LSDAGITPLFLTR 95.00% 2.45 0.271 1.24 702.4122 1,402.81 1,403.79 2 TLN1_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% SAGSRIEDGVPQHLVLVLGGK 95.00% 2.52 0.27 0 711.7205 2,132.14 2,132.18 3
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QINVGNALEYVSR 95.00% 2.79 0.337 3.14 731.8836 1,461.75 1,462.77 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QINVGNALEYVSR 95.00% 3.46 0.479 3.42 731.8841 1,461.75 1,462.77 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QINVGNALEYVSR 95.00% 3.49 0.486 2.82 731.8845 1,461.75 1,462.77 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QINVGNALEYVSR 95.00% 3.12 0.516 2.72 731.8861 1,461.76 1,462.77 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QINVGNALEYVSR 95.00% 3.53 0.52 3.8 731.8862 1,461.76 1,462.77 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QINVGNALEYVSR 95.00% 2.99 0.513 2.43 731.8865 1,461.76 1,462.77 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QINVGNALEYVSR 95.00% 3 0.427 2.8 731.8867 1,461.76 1,462.77 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QQSLETAMSFVAR 95.00% 2.67 0.362 0 734.3654 1,466.72 1,467.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QQSLETAMSFVAR 95.00% 2.82 0.426 1.24 734.3655 1,466.72 1,467.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QQSLETAMSFVAR 95.00% 3.06 0.446 1.47 734.3658 1,466.72 1,467.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QQSLETAMSFVAR 95.00% 2.79 0.416 0 734.3662 1,466.72 1,467.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QQSLETAMSFVAR 95.00% 2.94 0.452 2.59 734.3669 1,466.72 1,467.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QQSLETAMSFVAR 95.00% 3.17 0.538 1.68 734.3683 1,466.72 1,467.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% QQSLETAMSFVAR 95.00% 2.69 0.367 1.68 734.3688 1,466.72 1,467.73 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LVDYLDVGFDTTR 95.00% 3.36 0.0609 5.06 757.4025 1,512.79 1,513.75 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LVDYLDVGFDTTR 95.00% 3.32 0 3.06 757.4033 1,512.79 1,513.75 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LVDYLDVGFDTTR 94.80% 0 0 3.36 758.4205 1,514.83 1,513.75 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% GDSIDQcALIQSIK 94.90% 2.5 0.214 0 c7: Carbamidomethyl (+57.02) 774.3905 1,546.77 1,547.77 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LQPVLQPLPSPGVGGK 95.00% 3.37 0.58 4.7 793.9679 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IEDGVPQHLVLVLGGK 95.00% 3.82 0.28 3.54 837.482 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IEDGVPQHLVLVLGGK 95.00% 4.26 0.417 3.82 837.4827 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IEDGVPQHLVLVLGGK 95.00% 3.79 0.373 2.23 837.9828 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IEDGVPQHLVLVLGGK 95.00% 4.17 0.444 4.47 837.9848 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% IEDGVPQHLVLVLGGK 95.00% 4.35 0.279 3.19 837.9862 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LLTPITTLTSEQIQK 95.00% 5.1 0.514 7 843.4851 1,684.95 1,685.97 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LLTPITTLTSEQIQK 95.00% 4.83 0.541 6.09 843.4867 1,684.96 1,685.97 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LLTPITTLTSEQIQK 95.00% 5.24 0.535 3.85 843.487 1,684.96 1,685.97 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LLTPITTLTSEQIQK 95.00% 4.76 0.555 5.7 843.4874 1,684.96 1,685.97 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LLTPITTLTSEQIQK 95.00% 4.83 0.502 3.43 843.4876 1,684.96 1,685.97 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LLTPITTLTSEQIQK 95.00% 4.59 0.397 3.11 843.4892 1,684.96 1,685.97 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LLTPITTLTSEQIQK 95.00% 5.13 0.504 5.09 843.9883 1,685.96 1,685.97 2
 SAMPLE 1 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 24 26 121 9.69% LLTPITTLTSEQIQK 95.00% 5.31 0.524 4.26 843.9887 1,685.96 1,685.97 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLVLITGGK 95.00% 2.12 0.236 0 457.3063 912.597 913.6089 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLVLITGGK 95.00% 2.38 0.366 0 457.3081 912.6005 913.6089 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% NLQVALTSK 95.00% 1.91 0.251 1.13 487.2868 972.5579 973.5683 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% NLQVALTSK 95.00% 2.17 0.25 1.29 487.2874 972.5592 973.5683 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IGDLHPQIVNLLK 95.00% 2.57 0.428 1.21 487.2914 1,458.85 1,459.86 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IGDLHPQIVNLLK 95.00% 2.68 0.323 0 487.2915 1,458.85 1,459.86 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IGDLHPQIVNLLK 95.00% 2.9 0.377 0 487.2916 1,458.85 1,459.86 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IGDLHPQIVNLLK 95.00% 3.08 0.397 1.27 487.292 1,458.85 1,459.86 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IGDLHPQIVNLLK 95.00% 2.48 0.207 0 487.2923 1,458.85 1,459.86 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IGDLHPQIVNLLK 95.00% 3.11 0.312 0 487.2924 1,458.85 1,459.86 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IGDLHPQIVNLLK 95.00% 3.27 0.45 2 487.2925 1,458.85 1,459.86 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ALILVGLER 95.00% 2.79 0.346 1.92 492.3135 982.6114 983.6255 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ALILVGLER 95.00% 2.81 0.362 1.11 492.3139 982.6122 983.6255 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ALILVGLER 95.00% 2.79 0.335 1.25 492.3147 982.6138 983.6255 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ALILVGLER 95.00% 2.46 0.35 0 492.3148 982.6139 983.6255 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ALILVGLER 95.00% 2.68 0.375 1.82 492.3149 982.6142 983.6255 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ALILVGLER 95.00% 2.94 0.34 0 492.315 982.6143 983.6255 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ALILVGLER 95.00% 2.79 0.367 0 492.315 982.6144 983.6255 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ALILVGLER 95.00% 2.71 0.32 1.72 492.3152 982.6147 983.6255 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ALILVGLER 95.00% 2.55 0.431 1.25 492.3155 982.6153 983.6255 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ALILVGLER 95.00% 3.04 0.338 1.59 492.3161 982.6166 983.6255 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ALILVGLER 95.00% 3.28 0.372 1.92 492.3168 982.6179 983.6255 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IIDELNVKPEGTR 95.00% 2.32 0.32 0 495.2741 1,482.80 1,483.81 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% DSFQEVLR 95.00% 2.22 0.288 0 497.2484 992.4811 993.5006 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% DSFQEVLR 95.00% 2.33 0.352 0 497.2511 992.4866 993.5006 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% DSFQEVLR 95.00% 2.55 0.327 0 497.2512 992.4868 993.5006 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% DSFQEVLR 95.00% 2.17 0.197 0 497.2665 992.5173 993.5006 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% SQHPYVLTEDTLK 95.00% 2.68 0.29 0 510.9307 1,529.77 1,530.78 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% SQAPVLDAIR 95.00% 2.35 0.374 2 535.3021 1,068.59 1,069.60 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% SQAPVLDAIR 95.00% 2.48 0.311 1.96 535.3022 1,068.59 1,069.60 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% SQAPVLDAIR 95.00% 2.48 0.351 2.23 535.3026 1,068.59 1,069.60 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% SQAPVLDAIR 95.00% 2.49 0.384 1.7 535.3029 1,068.59 1,069.60 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% SQAPVLDAIR 95.00% 2.66 0.336 2.21 535.3031 1,068.59 1,069.60 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% SQAPVLDAIR 95.00% 2.07 0.263 2.11 535.3036 1,068.59 1,069.60 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEDGVPQHLVLVLGGK 95.00% 3 0.341 1.52 558.6686 1,672.98 1,673.96 3 ANXA2_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEDGVPQHLVLVLGGK 95.00% 3.26 0.29 0 558.9905 1,673.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEDGVPQHLVLVLGGK 95.00% 3.21 0.445 0 558.9909 1,673.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEDGVPQHLVLVLGGK 95.00% 2.53 0.327 1.25 558.9917 1,673.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEDGVPQHLVLVLGGK 95.00% 2.7 0.311 0 559.0016 1,673.98 1,673.96 3 ANXA2_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 2.49 0.311 0 562.6599 1,684.96 1,685.97 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 3.91 0.461 1.85 562.6602 1,684.96 1,685.97 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 2.95 0.446 0 562.6605 1,684.96 1,685.97 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 3.75 0.363 0 562.6607 1,684.96 1,685.97 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 4.03 0.397 0 562.9949 1,685.96 1,685.97 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 4.35 0.407 1.49 562.9956 1,685.96 1,685.97 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEEGVPQFLVLISSGK 95.00% 4.16 0.444 3.22 572.6573 1,714.95 1,715.96 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEEGVPQFLVLISSGK 95.00% 3.59 0.467 2.52 572.9914 1,715.95 1,715.96 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEEGVPQFLVLISSGK 95.00% 4.56 0.514 4.29 572.9927 1,715.95 1,715.96 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% SSGIVSLGVGDR 95.00% 3.18 0.31 3.4 573.8097 1,145.60 1,146.61 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% SSGIVSLGVGDR 95.00% 3.05 0.365 3.92 573.8103 1,145.60 1,146.61 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% SSGIVSLGVGDR 95.00% 2.84 0.381 1.21 573.8136 1,145.61 1,146.61 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ITEGVPQLLIVLTADR 95.00% 2.46 0.27 1.41 580.0069 1,737.00 1,738.01 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ITEGVPQLLIVLTADR 95.00% 3.04 0.323 0 580.0076 1,737.00 1,738.01 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ITEGVPQLLIVLTADR 95.00% 3.19 0.353 0 580.0088 1,737.00 1,738.01 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LDQRVPQIAFVITGGK 95.00% 3.49 0.431 0.959 581.6689 1,741.98 1,742.00 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% NIDRTELQTITNDPR 95.00% 2.39 0.286 0 595.9771 1,784.91 1,785.91 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% NIDRTELQTITNDPR 95.00% 3.24 0.27 0 596.3105 1,785.91 1,785.91 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VVESLDVGQDR 95.00% 3.02 0.55 3.59 608.8127 1,215.61 1,216.62 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 2.43 0.306 0 615.3639 1,228.71 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 3.51 0.572 3.31 615.3643 1,228.71 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 3.61 0.552 4.48 615.3645 1,228.71 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 3.38 0.575 3.7 615.3646 1,228.71 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 3.48 0.568 3.77 615.3649 1,228.71 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 3.57 0.564 3.42 615.3652 1,228.71 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 3.85 0.574 4.68 615.3654 1,228.72 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 3.72 0.583 4.12 615.3656 1,228.72 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 3.54 0.591 3.3 615.3659 1,228.72 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 2.36 0.329 0 615.3672 1,228.72 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 2.36 0.479 0 615.3714 1,228.73 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 3.37 0.566 4.55 615.3773 1,228.74 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VPQIAFVITGGK 95.00% 3.09 0.517 5.31 615.3773 1,228.74 1,229.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VAVFFSNTPTR 95.00% 3.01 0.551 3 619.8292 1,237.64 1,238.65 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VAVFFSNTPTR 95.00% 3.35 0.529 3.04 619.8299 1,237.64 1,238.65 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VAVFFSNTPTR 95.00% 2.84 0.504 2.82 619.8299 1,237.64 1,238.65 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VAVFFSNTPTR 95.00% 2.46 0.516 3.1 619.8299 1,237.64 1,238.65 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VAVFFSNTPTR 95.00% 3.21 0.515 3.49 619.8302 1,237.64 1,238.65 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VAVFFSNTPTR 95.00% 2.98 0.463 2.27 619.8302 1,237.64 1,238.65 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VAVFFSNTPTR 95.00% 3.04 0.542 3.12 619.8302 1,237.64 1,238.65 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VAVFFSNTPTR 95.00% 3.24 0.49 2.57 619.8303 1,237.64 1,238.65 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VAVFFSNTPTR 95.00% 3.13 0.472 2.96 619.8321 1,237.65 1,238.65 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VAVFFSNTPTR 95.00% 2.96 0.514 2.77 619.833 1,237.65 1,238.65 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% VVIHFTDGADGDLADLHR 95.00% 5.45 0.579 5.64 651.3276 1,950.96 1,950.97 3
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QSGVVPFIFQAK 95.00% 2.42 0.394 0 660.8684 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QSGVVPFIFQAK 95.00% 2.12 0.425 1.12 660.8695 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% NIDSEEVGKIASNSATAFR 95.00% 2.1 0.311 0 670.6701 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QLGTVQQVISER 95.00% 2.69 0.463 2.07 679.3733 1,356.73 1,357.74 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QLGTVQQVISER 95.00% 2.38 0.438 1.96 679.3742 1,356.73 1,357.74 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LSDAGITPLFLTR 95.00% 3.54 0.46 3.43 702.3964 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LSDAGITPLFLTR 95.00% 4.02 0.501 3.62 702.3971 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LSDAGITPLFLTR 95.00% 3.49 0.389 3.54 702.3974 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LSDAGITPLFLTR 95.00% 3.99 0.491 3.92 702.3978 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LSDAGITPLFLTR 95.00% 3.53 0.486 3.7 702.4085 1,402.80 1,403.79 2 TLN1_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LSDAGITPLFLTR 95.00% 3.68 0.481 5.39 702.4114 1,402.81 1,403.79 2 TLN1_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LSDAGITPLFLTR 95.00% 3.77 0.523 3.22 702.4121 1,402.81 1,403.79 2 TLN1_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LSDAGITPLFLTR 95.00% 3.68 0.482 4.28 702.4124 1,402.81 1,403.79 2 TLN1_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LSDAGITPLFLTR 95.00% 3.03 0.416 1.89 702.8981 1,403.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QINVGNALEYVSR 95.00% 3.38 0.484 3.13 731.8848 1,461.75 1,462.77 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QINVGNALEYVSR 95.00% 3.28 0.424 3.48 731.8853 1,461.75 1,462.77 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QINVGNALEYVSR 95.00% 3.27 0.356 3.19 731.8853 1,461.76 1,462.77 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QINVGNALEYVSR 95.00% 2.8 0.471 2.38 731.8855 1,461.76 1,462.77 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QINVGNALEYVSR 95.00% 2.85 0.41 4.51 731.8861 1,461.76 1,462.77 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QINVGNALEYVSR 95.00% 2.85 0.433 2.92 731.8867 1,461.76 1,462.77 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QINVGNALEYVSR 95.00% 2.2 0.3 0 731.899 1,461.78 1,462.77 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QQSLETAMSFVAR 95.00% 2.9 0.401 1.57 734.3666 1,466.72 1,467.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QQSLETAMSFVAR 95.00% 2.17 0.258 0 734.3667 1,466.72 1,467.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QQSLETAMSFVAR 95.00% 3.12 0.443 0 734.367 1,466.72 1,467.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% QQSLETAMSFVAR 95.00% 3.21 0.458 2.13 734.3692 1,466.72 1,467.73 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LVDYLDVGFDTTR 95.00% 3.01 0.545 3.01 757.3766 1,512.74 1,513.75 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LVDYLDVGFDTTR 95.00% 3.77 0.534 6 757.3766 1,512.74 1,513.75 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LVDYLDVGFDTTR 95.00% 3.66 0.252 5.74 757.4013 1,512.79 1,513.75 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LVDYLDVGFDTTR 95.00% 3.29 0 4.15 757.4038 1,512.79 1,513.75 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% AAPLQGMLPGLLAPLR 95.00% 2.83 0.362 2.31 810.1047 1,618.19 1,617.95 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEDGVPQHLVLVLGGK 95.00% 4.35 0.394 3.24 837.4806 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEDGVPQHLVLVLGGK 95.00% 4.2 0.347 1.85 837.4807 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEDGVPQHLVLVLGGK 95.00% 4.13 0.361 2.23 837.4822 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEDGVPQHLVLVLGGK 95.00% 4.12 0.38 2.51 837.4844 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEDGVPQHLVLVLGGK 95.00% 2.94 0.408 0 837.4989 1,672.98 1,673.96 2 ANXA2_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEDGVPQHLVLVLGGK 95.00% 4.09 0.376 3.42 837.9789 1,673.94 1,673.96 2 ANXA2_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEDGVPQHLVLVLGGK 95.00% 4.3 0.376 2.15 837.9809 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 5.2 0.497 5.55 843.4864 1,684.96 1,685.97 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 4.74 0.53 6.01 843.4864 1,684.96 1,685.97 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 5.09 0.521 5.74 843.4866 1,684.96 1,685.97 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 4.71 0.537 3.8 843.4871 1,684.96 1,685.97 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 4.76 0.538 3.51 843.4875 1,684.96 1,685.97 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 4.68 0.527 3.06 843.4878 1,684.96 1,685.97 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 4.73 0.497 4 843.4898 1,684.96 1,685.97 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 5.09 0.509 6.09 843.9884 1,685.96 1,685.97 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% LLTPITTLTSEQIQK 95.00% 5.12 0.486 4 843.9904 1,685.97 1,685.97 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEEGVPQFLVLISSGK 95.00% 4.13 0.551 4.13 858.4832 1,714.95 1,715.96 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEEGVPQFLVLISSGK 95.00% 3.55 0.419 2.17 858.4842 1,714.95 1,715.96 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEEGVPQFLVLISSGK 95.00% 4.14 0.434 3.6 858.9831 1,715.95 1,715.96 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% IEEGVPQFLVLISSGK 95.00% 3.84 0.435 2.57 858.9847 1,715.95 1,715.96 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ITEGVPQLLIVLTADR 95.00% 4.8 0.601 5.32 869.5082 1,737.00 1,738.01 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ITEGVPQLLIVLTADR 95.00% 4.75 0.545 2.74 870.0091 1,738.00 1,738.01 2
 SAMPLE 1R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 27 31 135 10.70% ITEGVPQLLIVLTADR 95.00% 4.19 0.496 0 870.0143 1,738.01 1,738.01 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GFESKVDAILNR 95.00% 2.61 0.295 0 450.2461 1,347.71 1,348.72 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% KVAVFFSNTPTR 95.00% 2.72 0.289 0 456.2541 1,365.74 1,366.75 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% KVAVFFSNTPTR 95.00% 3.49 0.495 0 456.2545 1,365.74 1,366.75 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% KVAVFFSNTPTR 95.00% 3.21 0.306 0 456.2546 1,365.74 1,366.75 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% KVAVFFSNTPTR 95.00% 3.04 0.305 0 456.2552 1,365.74 1,366.75 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% KVAVFFSNTPTR 95.00% 3.81 0.523 0 456.2553 1,365.74 1,366.75 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% KVAVFFSNTPTR 95.00% 2.43 0.331 0 456.2561 1,365.74 1,366.75 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% KVAVFFSNTPTR 95.00% 3.46 0.464 0 456.5883 1,366.74 1,366.75 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLVLITGGK 95.00% 2.92 0.38 0 457.3076 912.5996 913.6089 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLVLITGGK 95.00% 3.25 0.35 0 457.3077 912.5997 913.6089 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLVLITGGK 95.00% 2.01 0.28 0 457.3079 912.6001 913.6089 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLVLITGGK 95.00% 3 0.236 0 457.3079 912.6002 913.6089 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLVLITGGK 95.00% 3.35 0.397 0 457.308 912.6003 913.6089 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLVLITGGK 95.00% 2.95 0.357 0 457.308 912.6004 913.6089 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLVLITGGK 95.00% 2.59 0.439 0 457.3086 912.6015 913.6089 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLVLITGGK 95.00% 2.2 0.309 0 457.3086 912.6016 913.6089 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLVLITGGK 95.00% 3.09 0.361 0 457.3092 912.6027 913.6089 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLVLITGGK 95.00% 3.06 0.327 0 457.3096 912.6036 913.6089 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SGDDVRNPSVVVK 95.00% 2.69 0.25 0 457.9144 1,370.72 1,371.72 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QIIDAINKVVYK 95.00% 2.15 0.203 0 468.6138 1,402.82 1,403.83 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% EFRELPNIEER 95.00% 2.82 0.202 0 477.9136 1,430.72 1,431.72 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NLQVALTSK 95.00% 2.33 0.324 0 487.2866 972.5575 973.5683 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NLQVALTSK 95.00% 2.66 0.399 0 487.2868 972.558 973.5683 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NLQVALTSK 95.00% 2.35 0.311 0 487.2869 972.5581 973.5683 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NLQVALTSK 95.00% 2.67 0.309 0 487.287 972.5583 973.5683 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NLQVALTSK 95.00% 2.66 0.364 1.44 487.2872 972.5587 973.5683 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NLQVALTSK 95.00% 2.53 0.4 0 487.2872 972.5588 973.5683 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NLQVALTSK 95.00% 2.48 0.339 0 487.2872 972.5588 973.5683 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NLQVALTSK 95.00% 3.01 0.385 0 487.2873 972.5589 973.5683 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NLQVALTSK 95.00% 2.41 0.311 0 487.2873 972.5589 973.5683 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NLQVALTSK 95.00% 2.62 0.325 0 487.2873 972.559 973.5683 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 2.97 0.394 0 487.2914 1,458.85 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 2.45 0.421 0 487.2917 1,458.85 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 3 0.443 0 487.2917 1,458.85 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 2.86 0.398 0 487.2917 1,458.85 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 3.39 0.579 1.38 487.2918 1,458.85 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 2.33 0.414 0 487.2919 1,458.85 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 2.38 0.384 1.36 487.2919 1,458.85 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 2.86 0.46 1.24 487.292 1,458.85 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 3.17 0.462 1.68 487.2921 1,458.85 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 2.9 0.456 0.959 487.2921 1,458.85 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 3.05 0.459 2.27 487.2921 1,458.85 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 2.83 0.242 0 487.2923 1,458.85 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 2.74 0.368 0 487.6263 1,459.86 1,459.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 4.43 0.406 1.37 488.2591 1,461.75 1,462.77 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 2.58 0.259 0 489.9133 1,466.72 1,467.73 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 2.71 0.346 0 489.9135 1,466.72 1,467.73 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDRVR 95.00% 2.14 0.386 1.3 491.2663 1,470.78 1,471.79 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDRVR 95.00% 1.98 0.412 0 491.2664 1,470.78 1,471.79 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDRVR 95.00% 2.42 0.209 0 491.6 1,471.78 1,471.79 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 3.13 0.322 1.36 492.3143 982.613 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 3.08 0.339 0 492.3146 982.6135 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 3.06 0.346 0 492.3146 982.6136 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 3.02 0.321 1.39 492.3149 982.6142 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 2.91 0.343 1.35 492.3151 982.6145 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 2.88 0.341 0 492.3151 982.6146 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 3.05 0.33 0 492.3152 982.6148 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 3.17 0.312 0 492.3153 982.6149 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 3.05 0.314 0 492.3153 982.615 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 3.1 0.346 1.33 492.3154 982.6151 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 3.05 0.333 0 492.3154 982.6152 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 3.1 0.326 1.15 492.3155 982.6153 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALILVGLER 95.00% 2.3 0.359 1.19 492.3161 982.6165 983.6255 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IIDELNVKPEGTR 95.00% 2.7 0.162 0 495.2745 1,482.80 1,483.81 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IIDELNVKPEGTR 95.00% 3.1 0.338 1.43 495.2749 1,482.80 1,483.81 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IIDELNVKPEGTR 95.00% 2.68 0.138 0 495.2749 1,482.80 1,483.81 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IIDELNVKPEGTR 95.00% 2.83 0.333 0 495.275 1,482.80 1,483.81 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IIDELNVKPEGTR 95.00% 2.87 0.145 0 495.2751 1,482.80 1,483.81 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IIDELNVKPEGTR 95.00% 3.02 0.285 1.74 495.2754 1,482.80 1,483.81 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IIDELNVKPEGTR 95.00% 2.52 0.192 0.921 495.2762 1,482.81 1,483.81 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% DSFQEVLR 95.00% 2.52 0.331 0 497.2515 992.4873 993.5006 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% DSFQEVLR 95.00% 2.65 0.242 0 497.2523 992.4889 993.5006 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% DSFQEVLR 95.00% 2.63 0.314 0 497.2524 992.4891 993.5006 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% DSFQEVLR 95.00% 2.54 0.318 0 497.2524 992.4892 993.5006 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ELPNIEER 95.00% 1.7 0.307 0 500.2578 998.5 999.5112 2 SPTA2_HUMAN,TITIN_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 3.55 0.304 0 510.9305 1,529.77 1,530.78 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 2.8 0.334 0 510.931 1,529.77 1,530.78 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 3.15 0.308 0 510.931 1,529.77 1,530.78 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 2.92 0.257 0 510.9312 1,529.77 1,530.78 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 2.68 0.308 0 511.2646 1,530.77 1,530.78 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 3.64 0.354 0 511.2648 1,530.77 1,530.78 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 3.3 0.348 0 511.2654 1,530.77 1,530.78 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LQPVLQPLPSPGVGGK 95.00% 2.22 0.263 0 529.6467 1,585.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQAPVLDAIR 95.00% 2.14 0.297 2.48 535.3026 1,068.59 1,069.60 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQAPVLDAIR 95.00% 2.77 0.37 1.42 535.3028 1,068.59 1,069.60 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQAPVLDAIR 95.00% 2.98 0.376 1.82 535.3028 1,068.59 1,069.60 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQAPVLDAIR 95.00% 3.06 0.384 1.89 535.3028 1,068.59 1,069.60 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQAPVLDAIR 95.00% 2.63 0.386 2.1 535.3028 1,068.59 1,069.60 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQAPVLDAIR 95.00% 2.97 0.393 1.52 535.3029 1,068.59 1,069.60 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQAPVLDAIR 95.00% 2.66 0.386 2.28 535.3029 1,068.59 1,069.60 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQAPVLDAIR 95.00% 3.13 0.4 0 535.303 1,068.59 1,069.60 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQAPVLDAIR 95.00% 2.36 0.314 2.74 535.3033 1,068.59 1,069.60 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SLDEISQPAQELKR 95.00% 2.41 0.204 0 538.6202 1,612.84 1,613.85 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SLDEISQPAQELKR 95.00% 2.8 0.342 0 538.6208 1,612.84 1,613.85 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SLDEISQPAQELKR 95.00% 2.42 0.299 0 538.6208 1,612.84 1,613.85 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SLDEISQPAQELKR 95.00% 2.31 0.311 0 538.621 1,612.84 1,613.85 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SLDEISQPAQELKR 95.00% 2.3 0.226 0 538.6213 1,612.84 1,613.85 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SLDEISQPAQELKR 95.00% 2.26 0.236 0 538.9548 1,613.84 1,613.85 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 3.72 0.442 1.42 544.6088 1,630.80 1,631.82 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 2.79 0.409 0 544.6123 1,630.81 1,631.82 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 3.1 0.273 0 544.6143 1,630.82 1,631.82 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 4.24 0.457 1.48 544.9453 1,631.81 1,631.82 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 4.45 0.447 1.13 544.9453 1,631.81 1,631.82 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 2.65 0.261 0 558.6569 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 3.14 0.21 0 558.6569 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 2.81 0.178 0 558.6577 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 3.04 0.271 1.05 558.6582 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 2.92 0.363 0 558.6584 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 2.81 0.259 0 558.9919 1,673.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IAVAQYSDDVKVESR 95.00% 3.97 0.527 2.07 560.6243 1,678.85 1,679.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IAVAQYSDDVKVESR 95.00% 3.73 0.57 2.64 560.9586 1,679.85 1,679.86 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 4.01 0.421 1.39 562.6604 1,684.96 1,685.97 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 4.42 0.496 2.64 562.6605 1,684.96 1,685.97 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 4.14 0.494 1.39 562.6605 1,684.96 1,685.97 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 4.16 0.499 2.46 562.6606 1,684.96 1,685.97 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 4.58 0.446 2.11 562.6608 1,684.96 1,685.97 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 4.4 0.447 1.77 562.6608 1,684.96 1,685.97 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 4.34 0.446 1.68 562.9947 1,685.96 1,685.97 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 4.36 0.443 1.36 562.9954 1,685.96 1,685.97 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 4.55 0.484 2.72 562.9954 1,685.96 1,685.97 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SSGIVSLGVGDR 95.00% 3.27 0.369 4.11 573.8061 1,145.60 1,146.61 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SSGIVSLGVGDR 95.00% 3.47 0.395 3.92 573.8083 1,145.60 1,146.61 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SSGIVSLGVGDR 95.00% 3.75 0.437 4.35 573.8085 1,145.60 1,146.61 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SSGIVSLGVGDR 95.00% 3.64 0.42 5.2 573.8087 1,145.60 1,146.61 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SSGIVSLGVGDR 95.00% 3.53 0.418 4.04 573.8087 1,145.60 1,146.61 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SSGIVSLGVGDR 95.00% 3.43 0.396 4.46 573.8088 1,145.60 1,146.61 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LDQRVPQIAFVITGGK 95.00% 4.3 0.5 1.68 581.3364 1,740.99 1,742.00 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LDQRVPQIAFVITGGK 95.00% 3.25 0.418 0 581.6707 1,741.99 1,742.00 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% FDEHQSKPEILNLVK 95.00% 4.35 0.499 1.18 599.656 1,795.94 1,796.95 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% FDEHQSKPEILNLVK 95.00% 3.18 0.258 0 599.9899 1,796.95 1,796.95 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% FDEHQSKPEILNLVK 95.00% 3.22 0.156 0 599.9902 1,796.95 1,796.95 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% FDEHQSKPEILNLVK 95.00% 3.14 0.283 0 599.9902 1,796.95 1,796.95 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QFGVAPFTIAR 95.00% 2.2 0.261 0 603.8319 1,205.65 1,206.66 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QFGVAPFTIAR 95.00% 2.23 0.227 0 603.8329 1,205.65 1,206.66 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QFGVAPFTIAR 95.00% 2.31 0.237 0 603.8331 1,205.65 1,206.66 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDR 95.00% 2.11 0.405 2.15 608.8095 1,215.60 1,216.62 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDR 95.00% 3.29 0.603 4.31 608.8098 1,215.60 1,216.62 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDR 95.00% 3.36 0.57 3.33 608.8104 1,215.61 1,216.62 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDR 95.00% 3.67 0.588 2.92 608.8109 1,215.61 1,216.62 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDR 95.00% 3.68 0.592 3.49 608.8111 1,215.61 1,216.62 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDR 95.00% 3.53 0.511 4.27 608.8112 1,215.61 1,216.62 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDR 95.00% 3.94 0.573 2.92 608.8114 1,215.61 1,216.62 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDR 95.00% 3.81 0.56 3.18 608.8116 1,215.61 1,216.62 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDR 95.00% 3.3 0.556 3.49 608.8117 1,215.61 1,216.62 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDR 95.00% 3.55 0.527 4.14 608.8125 1,215.61 1,216.62 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NNLFTSSAGYR 95.00% 3.12 0.407 2.68 615.2964 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NNLFTSSAGYR 95.00% 3.13 0.354 1.96 615.2975 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NNLFTSSAGYR 95.00% 2.99 0.423 2.66 615.2981 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NNLFTSSAGYR 95.00% 3.12 0.39 3 615.2981 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NNLFTSSAGYR 95.00% 3 0.408 2.7 615.2982 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NNLFTSSAGYR 95.00% 3.27 0.476 2.14 615.299 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.8 0.598 4.12 615.3647 1,228.71 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.84 0.575 4.59 615.3647 1,228.71 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.59 0.571 4.09 615.3648 1,228.71 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.27 0.54 3.33 615.365 1,228.71 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.59 0.61 4.3 615.3653 1,228.72 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.75 0.584 3.17 615.3656 1,228.72 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.09 0.536 2.46 615.3656 1,228.72 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.51 0.6 2.82 615.3657 1,228.72 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.87 0.577 4.7 615.3658 1,228.72 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.77 0.56 4.37 615.3661 1,228.72 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.78 0.574 3.96 615.3664 1,228.72 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.75 0.596 3.92 615.3664 1,228.72 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.74 0.564 5.44 615.3665 1,228.72 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 4.04 0.57 4.64 615.3667 1,228.72 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.71 0.593 4.48 615.3667 1,228.72 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VPQIAFVITGGK 95.00% 3.34 0.56 3.39 615.367 1,228.72 1,229.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 2.76 0.549 2.49 619.8271 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 3.27 0.519 2.7 619.8282 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 3.4 0.536 1.92 619.8284 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 3.44 0.57 2.7 619.8288 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 3.4 0.572 3.02 619.8288 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 3.37 0.565 3.41 619.8293 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 3.26 0.561 2.14 619.8293 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 3.09 0.557 2.62 619.8294 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 3.06 0.497 2.8 619.8296 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 3.48 0.577 3.82 619.8298 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 2.92 0.53 3.55 619.8299 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 3.02 0.532 2.6 619.8299 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 3.45 0.54 3.15 619.83 1,237.64 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVFFSNTPTR 95.00% 3.44 0.523 2.92 619.831 1,237.65 1,238.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GNRGDSIDQcALIQSIK 95.00% 3.22 0.412 0 c10: Carbamidomethyl (+57.02) 625.985 1,874.93 1,874.94 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% TELQTITNDPR 95.00% 2.13 0.274 0 644.3285 1,286.64 1,287.65 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVIHFTDGADGDLADLHR 95.00% 4.6 0.477 3.68 651.3271 1,950.96 1,950.97 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QSGVVPFIFQAK 95.00% 2.6 0.442 2.92 660.8679 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QSGVVPFIFQAK 95.00% 2.47 0.434 3.33 660.8682 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QSGVVPFIFQAK 95.00% 2.64 0.433 3.6 660.8685 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QSGVVPFIFQAK 95.00% 2.58 0.458 4.46 660.8687 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QSGVVPFIFQAK 95.00% 2.13 0.286 0 660.8692 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NIDSEEVGKIASNSATAFR 95.00% 4.18 0.583 4.51 670.3335 2,007.98 2,008.99 3 MUC16_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NIDSEEVGKIASNSATAFR 95.00% 3.58 0.535 2.8 670.3345 2,007.98 2,008.99 3 MUC16_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NIDSEEVGKIASNSATAFR 95.00% 4.33 0.587 2.89 670.6685 2,008.98 2,008.99 3 MUC16_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NIDSEEVGKIASNSATAFR 95.00% 2.11 0.302 0 670.6701 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NIDSEEVGKIASNSATAFR 95.00% 3.4 0.459 2.08 670.6703 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NIDSEEVGKIASNSATAFR 95.00% 3.59 0.551 2.68 670.6706 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QLGTVQQVISER 95.00% 2.88 0.516 2.72 679.3745 1,356.73 1,357.74 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QLGTVQQVISER 95.00% 2.48 0.515 2.27 679.3746 1,356.73 1,357.74 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QLGTVQQVISER 95.00% 2.96 0.494 2.48 679.3747 1,356.73 1,357.74 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QLGTVQQVISER 95.00% 2.8 0.521 2.37 679.3747 1,356.73 1,357.74 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QLGTVQQVISER 95.00% 2.93 0.497 2.62 679.3747 1,356.73 1,357.74 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QLGTVQQVISER 95.00% 2.94 0.414 3.07 679.375 1,356.73 1,357.74 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QLGTVQQVISER 95.00% 2.85 0.517 2.44 679.375 1,356.73 1,357.74 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QLGTVQQVISER 95.00% 2.77 0.503 2.49 679.3753 1,356.73 1,357.74 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QLGTVQQVISER 95.00% 2.79 0.501 2.82 679.3757 1,356.74 1,357.74 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QLGTVQQVISER 95.00% 2.9 0.516 1.85 679.3775 1,356.74 1,357.74 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% MKPLDGSALYTGSALDFVR 95.00% 3.37 0.377 1.64 681.353 2,041.04 2,041.04 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% MKPLDGSALYTGSALDFVR 95.00% 3.95 0.367 2.96 681.3538 2,041.04 2,041.04 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% KVAVFFSNTPTR 95.00% 2.78 0.371 1.54 683.8762 1,365.74 1,366.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% KVAVFFSNTPTR 95.00% 3.18 0.586 1.89 683.8771 1,365.74 1,366.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% KVAVFFSNTPTR 95.00% 2.3 0.312 0 683.8781 1,365.74 1,366.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 4.24 0.516 3.8 702.3962 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 3.9 0.486 3.92 702.3969 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 3.97 0.499 4.33 702.3972 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 4.41 0.528 3.96 702.3972 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 2.47 0.403 2.12 702.3974 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 4.4 0.54 3.89 702.3974 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 3.91 0.452 4.35 702.3974 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 4.48 0.571 3.96 702.3974 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 4.01 0.49 3.28 702.3976 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 4.23 0.528 4.05 702.3978 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 4.18 0.498 4.3 702.3979 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 4.32 0.502 4.41 702.3979 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 4.52 0.55 3.82 702.398 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 4.37 0.5 3.44 702.3981 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 4.43 0.539 3.74 702.3985 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LSDAGITPLFLTR 95.00% 3.99 0.45 3.85 702.3986 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IGDLHPQIVNLLK 95.00% 3.02 0.354 1.66 730.4346 1,458.85 1,459.86 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 2.57 0.354 1.82 731.8835 1,461.75 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.18 0.529 1.82 731.8844 1,461.75 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.7 0.569 3.02 731.8856 1,461.76 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.23 0.45 1.54 731.8857 1,461.76 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.45 0.448 1.42 731.8857 1,461.76 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.76 0.578 4.01 731.8857 1,461.76 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 2.72 0.445 1.74 731.8861 1,461.76 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.68 0.487 2.96 731.8861 1,461.76 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.65 0.46 2.89 731.8863 1,461.76 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.48 0.503 3.64 731.8864 1,461.76 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.21 0.447 2.57 731.8864 1,461.76 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.45 0.445 1.92 731.8865 1,461.76 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.35 0.448 2.12 731.8869 1,461.76 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.71 0.466 2.51 732.3823 1,462.75 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QINVGNALEYVSR 95.00% 3.59 0.489 3.01 732.3884 1,462.76 1,462.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 3.53 0.524 2.23 734.3648 1,466.71 1,467.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 3.75 0.562 2.89 734.3654 1,466.72 1,467.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 3.49 0.448 0 734.3656 1,466.72 1,467.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 3.26 0.546 2.36 734.3659 1,466.72 1,467.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 3.56 0.562 2.48 734.3664 1,466.72 1,467.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 2.97 0.479 1.37 734.3664 1,466.72 1,467.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 3.58 0.533 2.6 734.3665 1,466.72 1,467.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 3.21 0.479 0 734.3667 1,466.72 1,467.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 3.48 0.531 3.64 734.3669 1,466.72 1,467.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 3.52 0.508 2.6 734.367 1,466.72 1,467.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% QQSLETAMSFVAR 95.00% 3.62 0.519 2.15 734.3681 1,466.72 1,467.73 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALNLGYALDYAQR 95.00% 4.45 0.542 3.77 734.378 1,466.74 1,467.76 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% ALNLGYALDYAQR 95.00% 4.52 0.612 4.4 734.3811 1,466.75 1,467.76 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDRVR 95.00% 2.92 0.37 0 736.396 1,470.78 1,471.79 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVESLDVGQDRVR 95.00% 2.9 0.383 0 736.3971 1,470.78 1,471.79 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IIDELNVKPEGTR 95.00% 3.41 0.35 1.28 742.4087 1,482.80 1,483.81 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LVDYLDVGFDTTR 95.00% 4.03 0.443 5.15 757.3756 1,512.74 1,513.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LVDYLDVGFDTTR 95.00% 4.47 0.528 4.77 757.3769 1,512.74 1,513.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LVDYLDVGFDTTR 95.00% 4.36 0.475 6.32 757.3772 1,512.74 1,513.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LVDYLDVGFDTTR 95.00% 4.29 0.534 4.85 757.3778 1,512.74 1,513.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LVDYLDVGFDTTR 95.00% 4.33 0.456 5.12 757.378 1,512.74 1,513.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LVDYLDVGFDTTR 95.00% 4.23 0.442 5.27 757.3787 1,512.74 1,513.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LVDYLDVGFDTTR 95.00% 3.72 0.509 5.33 757.3789 1,512.74 1,513.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LVDYLDVGFDTTR 95.00% 4.35 0.478 4.89 757.3791 1,512.74 1,513.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LVDYLDVGFDTTR 95.00% 4.47 0.46 4.89 757.3794 1,512.74 1,513.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LVDYLDVGFDTTR 95.00% 4.05 0.414 5.02 757.8817 1,513.75 1,513.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VEFLLNAHSSKDEVQNAVQR 95.00% 4.1 0.383 1.16 762.3965 2,284.17 2,284.17 3
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 3.42 0.534 6.8 765.8928 1,529.77 1,530.78 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 3.84 0.467 6.24 765.8933 1,529.77 1,530.78 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 3.69 0.536 7.17 765.8935 1,529.77 1,530.78 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 3.93 0.504 3.85 765.8935 1,529.77 1,530.78 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 3.85 0.526 2.85 765.8936 1,529.77 1,530.78 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SQHPYVLTEDTLK 95.00% 3.68 0.559 6.47 765.8938 1,529.77 1,530.78 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% AcNLDVILGFDGSR 95.00% 4.33 0.517 3 c2: Carbamidomethyl (+57.02) 768.8755 1,535.74 1,536.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% AcNLDVILGFDGSR 95.00% 3.24 0.384 1.6 c2: Carbamidomethyl (+57.02) 768.8766 1,535.74 1,536.75 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 3.1 0.276 0 c7: Carbamidomethyl (+57.02) 774.3883 1,546.76 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 3.22 0.307 1.59 c7: Carbamidomethyl (+57.02) 774.3893 1,546.76 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 3.58 0.253 1.29 c7: Carbamidomethyl (+57.02) 774.3894 1,546.76 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 3.75 0.371 2.46 c7: Carbamidomethyl (+57.02) 774.3896 1,546.76 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 3.68 0.305 2.04 c7: Carbamidomethyl (+57.02) 774.3897 1,546.76 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 3.22 0.277 1.82 c7: Carbamidomethyl (+57.02) 774.39 1,546.76 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 3.62 0.3 1.4 c7: Carbamidomethyl (+57.02) 774.3908 1,546.77 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 2.75 0.256 0 c7: Carbamidomethyl (+57.02) 774.391 1,546.77 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 2.5 0.257 0 c7: Carbamidomethyl (+57.02) 774.3917 1,546.77 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 2.75 0.296 1.6 c7: Carbamidomethyl (+57.02) 774.3924 1,546.77 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 3.48 0.322 0 c7: Carbamidomethyl (+57.02) 774.3933 1,546.77 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 3.41 0.321 1.85 c7: Carbamidomethyl (+57.02) 774.8916 1,547.77 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GDSIDQcALIQSIK 95.00% 3.58 0.293 1.77 c7: Carbamidomethyl (+57.02) 774.8917 1,547.77 1,547.77 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LQPVLQPLPSPGVGGK 95.00% 4.04 0.549 4.11 793.9657 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LQPVLQPLPSPGVGGK 95.00% 4.09 0.539 3.7 793.9659 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LQPVLQPLPSPGVGGK 95.00% 3.96 0.573 3.46 793.9662 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LQPVLQPLPSPGVGGK 95.00% 3.94 0.501 4.1 793.9669 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LQPVLQPLPSPGVGGK 95.00% 3.85 0.545 4.77 793.9671 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LQPVLQPLPSPGVGGK 95.00% 4.33 0.539 3.8 794.4697 1,586.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SLDEISQPAQELKR 95.00% 3.18 0.369 1.21 807.4271 1,612.84 1,613.85 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 4.32 0.368 1.8 816.4126 1,630.81 1,631.82 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 4.35 0.514 3.3 816.4131 1,630.81 1,631.82 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 4.36 0.512 3.92 816.4139 1,630.81 1,631.82 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 5.19 0.472 3.8 816.4143 1,630.81 1,631.82 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 4.13 0.468 2.89 816.4146 1,630.81 1,631.82 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 4.44 0.475 2.77 816.4147 1,630.81 1,631.82 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 5.17 0.494 3.72 816.4155 1,630.82 1,631.82 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 5.23 0.486 3.62 816.4157 1,630.82 1,631.82 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% SVEDAQDVSLALTQR 95.00% 5.26 0.453 2.57 816.4178 1,630.82 1,631.82 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% TRPEFYLNSYMNK 95.00% 4.52 0.521 5.15 831.903 1,661.79 1,662.80 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% TRPEFYLNSYMNK 95.00% 4.29 0.48 3.7 832.4026 1,662.79 1,662.80 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 3.54 0.36 1.7 837.4795 1,672.94 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 4.41 0.442 4.46 837.4808 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 4.36 0.404 2.7 837.4812 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 4.1 0.358 2.92 837.4814 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 4.51 0.422 4.52 837.4815 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 4.26 0.467 3.68 837.4816 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 4.13 0.463 3.74 837.4826 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 4.14 0.443 3.89 837.4832 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% IEDGVPQHLVLVLGGK 95.00% 4.33 0.322 3.55 837.9831 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 4.95 0.575 5.07 843.4864 1,684.96 1,685.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 5.18 0.509 5.38 843.487 1,684.96 1,685.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 5.11 0.534 4.8 843.4872 1,684.96 1,685.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 5.09 0.53 5.4 843.4872 1,684.96 1,685.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 5.35 0.55 4.7 843.4873 1,684.96 1,685.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 5.27 0.547 4.28 843.4873 1,684.96 1,685.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 4.72 0.522 4.34 843.4875 1,684.96 1,685.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 5.17 0.538 3 843.4875 1,684.96 1,685.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 4.5 0.514 3.74 843.4884 1,684.96 1,685.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% LLTPITTLTSEQIQK 95.00% 5.34 0.535 3.82 843.9881 1,685.96 1,685.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVVTYNNEVTTEIR 95.00% 4.35 0.196 2.72 854.4566 1,706.90 1,707.89 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVVTYNNEVTTEIR 95.00% 4.3 0.465 4.41 854.4572 1,706.90 1,707.89 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVVTYNNEVTTEIR 95.00% 4.49 0.367 5.8 854.4589 1,706.90 1,707.89 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVVTYNNEVTTEIR 95.00% 4.4 0.285 3.66 854.9573 1,707.90 1,707.89 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVVTYNNEVTTEIR 95.00% 4.32 0.432 4.28 854.9574 1,707.90 1,707.89 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVVTYNNEVTTEIR 95.00% 4.61 0.344 3.05 854.9601 1,707.90 1,707.89 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VAVVTYNNEVTTEIR 95.00% 4.8 0.399 5.57 854.9632 1,707.91 1,707.89 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GNRGDSIDQcALIQSIK 95.00% 4.34 0.144 1.77 c10: Carbamidomethyl (+57.02) 938.471 1,874.93 1,874.94 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVIHFTDGADGDLADLHR 95.00% 5.06 0.566 5.23 976.4793 1,950.94 1,950.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVIHFTDGADGDLADLHR 95.00% 5.7 0.636 9.89 976.4858 1,950.96 1,950.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% VVIHFTDGADGDLADLHR 95.00% 5.33 0.62 8.49 976.487 1,950.96 1,950.97 2
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% NIDSEEVGKIASNSATAFR 95.00% 6.21 0.63 6.77 1,005.00 2,007.98 2,008.99 2 MUC16_HUMAN
 SAMPLE 2 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 44 58 326 18.00% GAQGPAGPAGPPGLIGEQGISGPR 95.00% 6.04 0.689 6.96 1,071.56 2,141.11 2,141.11 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% KVAVFFSNTPTR 95.00% 3.24 0.322 0 456.2549 1,365.74 1,366.75 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% KVAVFFSNTPTR 95.00% 3.51 0.456 0 456.2549 1,365.74 1,366.75 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% KVAVFFSNTPTR 95.00% 2.79 0.344 0 456.2553 1,365.74 1,366.75 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% KVAVFFSNTPTR 95.00% 3.11 0.383 0 456.2554 1,365.74 1,366.75 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% KVAVFFSNTPTR 95.00% 3.24 0.399 0 456.256 1,365.74 1,366.75 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLVLITGGK 95.00% 2.96 0.385 0 457.3081 912.6005 913.6089 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLVLITGGK 95.00% 2.95 0.373 0 457.3083 912.6009 913.6089 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLVLITGGK 95.00% 2.89 0.393 0 457.3084 912.6011 913.6089 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLVLITGGK 95.00% 2.88 0.387 0 457.3086 912.6015 913.6089 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLVLITGGK 95.00% 2.69 0.341 0 457.3087 912.6018 913.6089 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLVLITGGK 95.00% 2.8 0.389 0 457.3088 912.602 913.6089 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLVLITGGK 95.00% 3.01 0.369 0 457.3091 912.6025 913.6089 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLVLITGGK 95.00% 3.38 0.408 0 457.3095 912.6034 913.6089 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 3.04 0.418 1.92 468.9349 1,403.78 1,403.79 3 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 2.92 0.42 1.51 468.935 1,403.78 1,403.79 3 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 3.03 0.405 0 468.9368 1,403.79 1,403.79 3 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% EFRELPNIEER 95.00% 2.31 0.161 0 477.9118 1,430.71 1,431.72 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% EFRELPNIEER 95.00% 2.91 0.167 0 477.9139 1,430.72 1,431.72 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% EFRELPNIEER 95.00% 2.4 0.204 0 478.2456 1,431.71 1,431.72 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NLQVALTSK 95.00% 2.41 0.335 0 487.2856 972.5555 973.5683 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NLQVALTSK 95.00% 2.25 0.363 0 487.2863 972.557 973.5683 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NLQVALTSK 95.00% 2.35 0.314 1.42 487.2867 972.5578 973.5683 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NLQVALTSK 95.00% 2.56 0.365 1.17 487.2869 972.5581 973.5683 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NLQVALTSK 95.00% 2.39 0.363 1.18 487.287 972.5583 973.5683 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NLQVALTSK 95.00% 2.3 0.318 1.46 487.287 972.5583 973.5683 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NLQVALTSK 95.00% 2.32 0.299 0 487.2872 972.5588 973.5683 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NLQVALTSK 95.00% 2.55 0.29 0 487.2873 972.5589 973.5683 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NLQVALTSK 95.00% 2.62 0.376 0 487.2875 972.5593 973.5683 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 3.27 0.466 0 487.2912 1,458.85 1,459.86 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 3.55 0.438 0 487.2916 1,458.85 1,459.86 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 2.85 0.321 0 487.2918 1,458.85 1,459.86 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 3.65 0.48 0 487.2919 1,458.85 1,459.86 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 2.18 0.306 1.01 487.292 1,458.85 1,459.86 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 2.79 0.438 0 487.2922 1,458.85 1,459.86 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 2.24 0.321 0 487.2923 1,458.85 1,459.86 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 2.61 0.359 0 487.2924 1,458.85 1,459.86 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 2.92 0.471 2 487.2925 1,458.85 1,459.86 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 2.8 0.364 0.959 487.2929 1,458.86 1,459.86 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 3 0.456 0.959 487.2939 1,458.86 1,459.86 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVESLDVGQDRVR 95.00% 2.38 0.286 1.3 491.2674 1,470.78 1,471.79 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 2.4 0.362 1.51 492.3145 982.6133 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 2.84 0.336 1.32 492.3145 982.6134 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 2.89 0.339 0 492.3148 982.614 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 2.9 0.363 0 492.3148 982.614 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 3.14 0.331 0 492.3149 982.6142 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 2.19 0.34 1.32 492.315 982.6144 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 3.27 0.337 1.24 492.3151 982.6145 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 2.94 0.343 0 492.3151 982.6146 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 2.96 0.327 1.38 492.3151 982.6146 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 2.99 0.298 0 492.3153 982.6149 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 2.56 0.39 0 492.3154 982.6151 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 2.94 0.346 0 492.3155 982.6153 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 2.49 0.36 1.11 492.3156 982.6156 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 2.42 0.432 1.36 492.3157 982.6157 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALILVGLER 95.00% 3.03 0.336 1.41 492.3157 982.6158 983.6255 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IIDELNVKPEGTR 95.00% 2.97 0.291 1.05 495.2747 1,482.80 1,483.81 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IIDELNVKPEGTR 95.00% 2.96 0.327 1.4 495.2747 1,482.80 1,483.81 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IIDELNVKPEGTR 95.00% 2.76 0.224 1.18 495.2749 1,482.80 1,483.81 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IIDELNVKPEGTR 95.00% 2.68 0.265 0 495.2755 1,482.80 1,483.81 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IIDELNVKPEGTR 95.00% 2.57 0.382 0 495.2757 1,482.80 1,483.81 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% DSFQEVLR 95.00% 2.26 0.222 0 497.2469 992.4782 993.5006 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% DSFQEVLR 95.00% 2.81 0.336 0 497.2498 992.484 993.5006 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% DSFQEVLR 95.00% 2.7 0.336 0 497.2517 992.4878 993.5006 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% DSFQEVLR 95.00% 2.76 0.251 0 497.2519 992.4881 993.5006 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% DSFQEVLR 95.00% 2.69 0.302 0 497.2519 992.4882 993.5006 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQHPYVLTEDTLK 95.00% 3.73 0.325 0 510.9305 1,529.77 1,530.78 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQHPYVLTEDTLK 95.00% 3.38 0.374 0 510.9309 1,529.77 1,530.78 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQHPYVLTEDTLK 95.00% 3.38 0.403 0 510.9311 1,529.77 1,530.78 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQHPYVLTEDTLK 95.00% 3.12 0.279 0 510.9312 1,529.77 1,530.78 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% AcNLDVILGFDGSR 95.00% 2.48 0.223 0 c2: Carbamidomethyl (+57.02) 512.9196 1,535.74 1,536.75 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% AcNLDVILGFDGSR 95.00% 3.06 0.327 1.74 c2: Carbamidomethyl (+57.02) 512.9202 1,535.74 1,536.75 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LQPVLQPLPSPGVGGK 95.00% 3.28 0.364 0 529.9813 1,586.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQAPVLDAIR 95.00% 2.3 0.318 1.89 535.3022 1,068.59 1,069.60 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQAPVLDAIR 95.00% 2.74 0.403 2.02 535.3024 1,068.59 1,069.60 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQAPVLDAIR 95.00% 2.49 0.425 1.82 535.3025 1,068.59 1,069.60 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQAPVLDAIR 95.00% 2.42 0.378 2.04 535.3027 1,068.59 1,069.60 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQAPVLDAIR 95.00% 2.75 0.368 2 535.3028 1,068.59 1,069.60 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQAPVLDAIR 95.00% 2.74 0.377 2.1 535.3029 1,068.59 1,069.60 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQAPVLDAIR 95.00% 2.86 0.426 1.2 535.3034 1,068.59 1,069.60 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQAPVLDAIR 95.00% 2.87 0.384 1.92 535.3034 1,068.59 1,069.60 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQAPVLDAIR 95.00% 2.7 0.378 1.74 535.3035 1,068.59 1,069.60 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SLDEISQPAQELKR 95.00% 2.31 0.225 0 538.6213 1,612.84 1,613.85 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SLDEISQPAQELKR 95.00% 2.76 0.264 0 538.9559 1,613.84 1,613.85 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% AAPLQGMLPGLLAPLR 95.00% 3.65 0.332 2.1 539.9882 1,616.94 1,617.95 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% AAPLQGMLPGLLAPLR 95.00% 3.73 0.358 2.54 539.9882 1,616.94 1,617.95 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 3.04 0.332 1.55 544.6088 1,630.80 1,631.82 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 3.26 0.344 1.33 544.6099 1,630.81 1,631.82 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 3.61 0.448 1 544.6099 1,630.81 1,631.82 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 3.86 0.315 1.15 544.6111 1,630.81 1,631.82 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 3.25 0.337 0 544.946 1,631.81 1,631.82 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 2.41 0.237 1.49 558.6557 1,672.94 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 2.47 0.279 0 558.6561 1,672.94 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 3.12 0.44 0 558.6563 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 2.83 0.245 1.28 558.6566 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 2.94 0.28 1.57 558.6574 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 2.85 0.247 1.17 558.9913 1,673.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 3.08 0.274 0 558.9918 1,673.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IAVAQYSDDVKVESR 95.00% 2.57 0.388 0 560.6263 1,678.86 1,679.86 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 4.39 0.447 2.7 562.6595 1,684.96 1,685.97 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 4.1 0.506 2.1 562.6597 1,684.96 1,685.97 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 4.47 0.51 2.07 562.6602 1,684.96 1,685.97 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 4.27 0.502 4.72 562.6609 1,684.96 1,685.97 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 4.43 0.364 2.33 562.9948 1,685.96 1,685.97 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 4.24 0.468 3.8 562.9948 1,685.96 1,685.97 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 4.45 0.478 0 562.9949 1,685.96 1,685.97 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 4.01 0.508 1.51 562.9949 1,685.96 1,685.97 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SSIMAFAIGNK 95.00% 2.55 0.212 1.57 569.7972 1,137.58 1,138.59 2 AHNK_HUMAN,FMOD_HUMAN,CRIP2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 5.05 0.531 4.64 572.6573 1,714.95 1,715.96 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 4.47 0.527 4.92 572.991 1,715.95 1,715.96 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 3.96 0.422 2.55 572.9916 1,715.95 1,715.96 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 5.16 0.595 4.22 572.9919 1,715.95 1,715.96 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SSGIVSLGVGDR 95.00% 2.95 0.34 3.77 573.8066 1,145.60 1,146.61 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SSGIVSLGVGDR 95.00% 3.04 0.362 2.8 573.8069 1,145.60 1,146.61 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SSGIVSLGVGDR 95.00% 3.69 0.433 3.92 573.8081 1,145.60 1,146.61 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SSGIVSLGVGDR 95.00% 3.34 0.446 4 573.8084 1,145.60 1,146.61 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SSGIVSLGVGDR 95.00% 3.4 0.401 4.8 573.8087 1,145.60 1,146.61 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SSGIVSLGVGDR 95.00% 3.15 0.401 3.32 573.8091 1,145.60 1,146.61 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SSGIVSLGVGDR 95.00% 3.62 0.425 3.34 573.8094 1,145.60 1,146.61 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ISLSPEYVFSVSTFR 95.00% 2.81 0.249 0 578.3039 1,731.89 1,731.90 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 3.3 0.445 1.34 580.007 1,737.00 1,738.01 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 3.82 0.417 2.15 580.0076 1,737.00 1,738.01 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 3.72 0.515 0 580.0077 1,737.00 1,738.01 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 2.49 0.384 0 580.0092 1,737.00 1,738.01 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 3.59 0.365 2.4 580.0095 1,737.00 1,738.01 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 2.88 0.228 0 580.3414 1,738.00 1,738.01 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 3.75 0.429 1.47 580.3417 1,738.00 1,738.01 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LDQRVPQIAFVITGGK 95.00% 4.23 0.407 1.24 581.6696 1,741.99 1,742.00 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LDQRVPQIAFVITGGK 95.00% 3.43 0.455 0 581.6717 1,741.99 1,742.00 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% FDEHQSKPEILNLVK 95.00% 3.21 0.327 0 599.6536 1,795.94 1,796.95 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% FDEHQSKPEILNLVK 95.00% 3.69 0.272 0 599.6543 1,795.94 1,796.95 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% FDEHQSKPEILNLVK 95.00% 3.1 0.351 0 599.6559 1,795.94 1,796.95 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% FDEHQSKPEILNLVK 95.00% 3.74 0.329 0.959 599.6562 1,795.95 1,796.95 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QFGVAPFTIAR 95.00% 2.2 0.25 0 603.8334 1,205.65 1,206.66 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVESLDVGQDR 95.00% 3.43 0.538 4.33 608.8098 1,215.60 1,216.62 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVESLDVGQDR 95.00% 3.32 0.536 3.92 608.8101 1,215.60 1,216.62 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVESLDVGQDR 95.00% 3.23 0.509 4.39 608.8103 1,215.61 1,216.62 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVESLDVGQDR 95.00% 3.08 0.521 3.77 608.8105 1,215.61 1,216.62 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVESLDVGQDR 95.00% 3.33 0.548 3.55 608.811 1,215.61 1,216.62 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVESLDVGQDR 95.00% 3.12 0.537 2.57 608.8114 1,215.61 1,216.62 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVESLDVGQDR 95.00% 3.48 0.561 3.74 608.8115 1,215.61 1,216.62 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVESLDVGQDR 95.00% 3.54 0.56 4.15 608.8115 1,215.61 1,216.62 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVESLDVGQDR 95.00% 3.71 0.582 3.14 608.8119 1,215.61 1,216.62 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NNLFTSSAGYR 95.00% 3.26 0.399 2.85 615.2982 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NNLFTSSAGYR 95.00% 2.75 0.23 2.32 615.2984 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NNLFTSSAGYR 95.00% 3.1 0.444 2.19 615.2988 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.7 0.59 5.44 615.3652 1,228.71 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.71 0.538 4.96 615.3653 1,228.71 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.8 0.566 5.6 615.3655 1,228.72 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.36 0.56 5.38 615.3656 1,228.72 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.94 0.554 4.47 615.3658 1,228.72 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.68 0.513 4.92 615.3659 1,228.72 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.33 0.618 3.62 615.3659 1,228.72 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.75 0.589 4.68 615.3661 1,228.72 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.33 0.552 4.17 615.3662 1,228.72 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.62 0.564 2.89 615.3667 1,228.72 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.6 0.527 3.21 615.3667 1,228.72 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.22 0.558 2.44 615.3681 1,228.72 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 3.52 0.559 3.64 615.3683 1,228.72 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VPQIAFVITGGK 95.00% 2.8 0.344 1.66 615.8343 1,229.65 1,229.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 2.71 0.578 2.55 619.8275 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 2.33 0.497 0 619.8279 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 3.21 0.548 2.11 619.8281 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 2.96 0.546 3.01 619.8286 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 3.24 0.486 3.48 619.8288 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 3.43 0.565 2.23 619.8289 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 3.3 0.547 2.09 619.8289 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 3.2 0.556 2.57 619.8293 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 2.88 0.471 2.92 619.8294 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 3.26 0.476 3.01 619.8295 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 2.91 0.406 2.77 619.8297 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 3.3 0.579 2.55 619.8299 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 3.56 0.591 3.01 619.83 1,237.64 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 3.35 0.538 2.92 619.8304 1,237.65 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 3.14 0.502 2.64 619.8304 1,237.65 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVFFSNTPTR 95.00% 3.23 0.539 2.68 619.8305 1,237.65 1,238.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% GNRGDSIDQcALIQSIK 95.00% 2.87 0.357 0 c10: Carbamidomethyl (+57.02) 625.6492 1,873.92 1,874.94 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% GNRGDSIDQcALIQSIK 95.00% 2.66 0.389 0 c10: Carbamidomethyl (+57.02) 625.9846 1,874.93 1,874.94 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% GNRGDSIDQcALIQSIK 95.00% 2.26 0.239 0 c10: Carbamidomethyl (+57.02) 625.9863 1,874.94 1,874.94 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% TELQTITNDPR 95.00% 2.06 0.296 1.54 644.3321 1,286.65 1,287.65 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVIHFTDGADGDLADLHR 95.00% 6.39 0.595 4.92 651.3273 1,950.96 1,950.97 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVIHFTDGADGDLADLHR 95.00% 6.62 0.56 4.77 651.3275 1,950.96 1,950.97 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QSGVVPFIFQAK 95.00% 2.18 0.472 0 660.8681 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QSGVVPFIFQAK 95.00% 2.59 0.483 2.85 660.8684 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QSGVVPFIFQAK 95.00% 2.55 0.47 5 660.8687 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QSGVVPFIFQAK 95.00% 2.43 0.471 3.12 660.8697 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NIDSEEVGKIASNSATAFR 95.00% 2.59 0.405 0 670.6687 2,008.98 2,008.99 3 MUC16_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% NIDSEEVGKIASNSATAFR 95.00% 3.77 0.544 3.08 670.6691 2,008.98 2,008.99 3 MUC16_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLGTVQQVISER 95.00% 2.53 0.455 2.15 679.3736 1,356.73 1,357.74 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLGTVQQVISER 95.00% 2.45 0.449 2.7 679.3739 1,356.73 1,357.74 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLGTVQQVISER 95.00% 3.18 0.504 2.51 679.3744 1,356.73 1,357.74 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLGTVQQVISER 95.00% 2.33 0.492 2.28 679.3745 1,356.73 1,357.74 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLGTVQQVISER 95.00% 2.9 0.523 2.44 679.3748 1,356.73 1,357.74 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLGTVQQVISER 95.00% 2.88 0.509 2.96 679.375 1,356.73 1,357.74 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLGTVQQVISER 95.00% 2.67 0.439 2.66 679.3754 1,356.74 1,357.74 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLGTVQQVISER 95.00% 3 0.506 1.7 679.3761 1,356.74 1,357.74 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLGTVQQVISER 95.00% 2.77 0.532 1.43 679.376 1,356.74 1,357.74 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLGTVQQVISER 95.00% 2.35 0.405 1.55 679.8764 1,357.74 1,357.74 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% MKPLDGSALYTGSALDFVR 95.00% 2.82 0.268 1.85 681.3545 2,041.04 2,041.04 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% KVAVFFSNTPTR 95.00% 2.77 0.319 1.55 683.876 1,365.74 1,366.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% KVAVFFSNTPTR 95.00% 2.62 0.517 1.51 683.8763 1,365.74 1,366.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% KVAVFFSNTPTR 95.00% 2.24 0.313 0 683.8773 1,365.74 1,366.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 3.47 0.404 3.12 702.397 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 3.83 0.459 4.38 702.3972 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 4.53 0.529 5.47 702.3974 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 3.4 0.439 3.42 702.3976 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 3.93 0.47 2.89 702.3977 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 4.38 0.569 3.47 702.3978 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 4.35 0.49 4.31 702.3979 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 4.03 0.472 5.09 702.3979 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 3.33 0.413 3.28 702.3981 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LSDAGITPLFLTR 95.00% 3.58 0.468 3.49 702.3989 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% DVVLSIVNDLTIAESNcPR 95.00% 4.33 0.574 1.66 c17: Carbamidomethyl (+57.02) 706.0283 2,115.06 2,115.08 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% DVVLSIVNDLTIAESNcPR 95.00% 6.39 0.644 3.32 c17: Carbamidomethyl (+57.02) 706.0298 2,115.07 2,115.08 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% DVVLSIVNDLTIAESNcPR 95.00% 4.64 0.538 1.85 c17: Carbamidomethyl (+57.02) 706.0302 2,115.07 2,115.08 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% DVVLSIVNDLTIAESNcPR 95.00% 3.79 0.333 0 c17: Carbamidomethyl (+57.02) 706.0303 2,115.07 2,115.08 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLTLLGGPTPNTGAALEFVLR 95.00% 4.13 0.511 2.42 723.7407 2,168.20 2,168.21 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 3.43 0.36 2.59 730.435 1,458.85 1,459.86 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IGDLHPQIVNLLK 95.00% 2.82 0.319 1.47 730.4353 1,458.85 1,459.86 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 3.05 0.425 1.72 731.8833 1,461.75 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 3.11 0.421 3.66 731.8849 1,461.75 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 2.67 0.317 2.19 731.885 1,461.75 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 3.51 0.481 2.89 731.8851 1,461.75 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 3.46 0.398 1.82 731.8852 1,461.75 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 3.38 0.571 3.72 731.8858 1,461.76 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 3.34 0.483 2.92 731.8862 1,461.76 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 3.47 0.507 2.09 731.8863 1,461.76 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 3.73 0.58 4.2 731.8864 1,461.76 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 3.24 0.483 1.74 731.8864 1,461.76 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 2.83 0.492 3.2 731.8866 1,461.76 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 2.64 0.369 2.34 731.8868 1,461.76 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 2.55 0.374 2.66 731.8871 1,461.76 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 2.98 0.355 2.55 731.8874 1,461.76 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 3.35 0.407 2.74 732.3864 1,462.76 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QINVGNALEYVSR 95.00% 3.57 0.515 4.06 732.3866 1,462.76 1,462.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QQSLETAMSFVAR 95.00% 3.42 0.544 2.96 734.3654 1,466.72 1,467.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QQSLETAMSFVAR 95.00% 3.09 0.418 0 734.3656 1,466.72 1,467.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QQSLETAMSFVAR 95.00% 2.5 0.353 0 734.3662 1,466.72 1,467.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QQSLETAMSFVAR 95.00% 3.29 0.493 3.66 734.3662 1,466.72 1,467.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QQSLETAMSFVAR 95.00% 3.46 0.48 2.05 734.3663 1,466.72 1,467.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QQSLETAMSFVAR 95.00% 3.29 0.423 2 734.3665 1,466.72 1,467.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QQSLETAMSFVAR 95.00% 3.17 0.457 0 734.3667 1,466.72 1,467.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QQSLETAMSFVAR 95.00% 3.44 0.548 3.08 734.3669 1,466.72 1,467.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QQSLETAMSFVAR 95.00% 3.6 0.515 2 734.3672 1,466.72 1,467.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QQSLETAMSFVAR 95.00% 3.42 0.541 4.19 734.3677 1,466.72 1,467.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALNLGYALDYAQR 95.00% 2.88 0.492 3.82 734.3822 1,466.75 1,467.76 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALNLGYALDYAQR 95.00% 4.12 0.592 4.72 734.3827 1,466.75 1,467.76 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ALNLGYALDYAQR 95.00% 4.22 0.585 3.96 734.3836 1,466.75 1,467.76 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QQSLETAMSFVAR 95.00% 3.31 0.527 4.64 734.8683 1,467.72 1,467.73 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVESLDVGQDRVR 95.00% 2.62 0.319 0 736.3966 1,470.78 1,471.79 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVESLDVGQDRVR 95.00% 2.69 0.39 0 736.8955 1,471.78 1,471.79 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IIDELNVKPEGTR 95.00% 3.21 0.358 2.07 742.4094 1,482.80 1,483.81 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LVDYLDVGFDTTR 95.00% 3.99 0.45 5.68 757.378 1,512.74 1,513.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LVDYLDVGFDTTR 95.00% 4.06 0.466 6.46 757.3781 1,512.74 1,513.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LVDYLDVGFDTTR 95.00% 4.05 0.541 6.07 757.3782 1,512.74 1,513.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LVDYLDVGFDTTR 95.00% 4.24 0.53 6.85 757.3784 1,512.74 1,513.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LVDYLDVGFDTTR 95.00% 3.81 0.522 7.04 757.3791 1,512.74 1,513.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LVDYLDVGFDTTR 95.00% 4.61 0.486 5.82 757.38 1,512.74 1,513.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LVDYLDVGFDTTR 95.00% 4.4 0.488 5.52 757.3804 1,512.75 1,513.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LVDYLDVGFDTTR 95.00% 4.53 0.477 5.8 757.88 1,513.74 1,513.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQHPYVLTEDTLK 95.00% 3.21 0.491 6.54 765.8919 1,529.77 1,530.78 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQHPYVLTEDTLK 95.00% 3.72 0.542 5.92 765.8933 1,529.77 1,530.78 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQHPYVLTEDTLK 95.00% 3.86 0.534 5.54 765.894 1,529.77 1,530.78 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SQHPYVLTEDTLK 95.00% 3.55 0.534 4.22 766.3947 1,530.77 1,530.78 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% AcNLDVILGFDGSR 95.00% 4.68 0.52 4.72 c2: Carbamidomethyl (+57.02) 768.8767 1,535.74 1,536.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% AcNLDVILGFDGSR 95.00% 4.03 0.556 2.82 c2: Carbamidomethyl (+57.02) 768.8773 1,535.74 1,536.75 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% GDSIDQcALIQSIK 95.00% 3.49 0.318 1.28 c7: Carbamidomethyl (+57.02) 774.3899 1,546.76 1,547.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% GDSIDQcALIQSIK 95.00% 3.23 0.34 1.96 c7: Carbamidomethyl (+57.02) 774.3903 1,546.77 1,547.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% GDSIDQcALIQSIK 95.00% 4.01 0.314 2.85 c7: Carbamidomethyl (+57.02) 774.3904 1,546.77 1,547.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% GDSIDQcALIQSIK 95.00% 2.98 0.367 1.32 c7: Carbamidomethyl (+57.02) 774.3908 1,546.77 1,547.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% GDSIDQcALIQSIK 95.00% 3.38 0.314 2.92 c7: Carbamidomethyl (+57.02) 774.3913 1,546.77 1,547.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% GDSIDQcALIQSIK 95.00% 2.63 0.292 1.11 c7: Carbamidomethyl (+57.02) 774.3913 1,546.77 1,547.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% GDSIDQcALIQSIK 95.00% 2.67 0.279 0 c7: Carbamidomethyl (+57.02) 774.3915 1,546.77 1,547.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% GDSIDQcALIQSIK 95.00% 3.72 0.363 1.74 c7: Carbamidomethyl (+57.02) 774.8902 1,547.76 1,547.77 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LQPVLQPLPSPGVGGK 95.00% 4.1 0.554 4.55 793.9674 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LQPVLQPLPSPGVGGK 95.00% 3.66 0.549 3.55 793.9677 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LQPVLQPLPSPGVGGK 95.00% 3.68 0.543 3.6 793.9685 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LQPVLQPLPSPGVGGK 95.00% 3.86 0.546 4.4 794.4649 1,586.91 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LQPVLQPLPSPGVGGK 95.00% 4.05 0.515 2.2 794.4673 1,586.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LQPVLQPLPSPGVGGK 95.00% 3.95 0.575 4.96 794.4674 1,586.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% MRDVVLSIVNDLTIAESNcPR 95.00% 5.17 0.463 1.22 c19: Carbamidomethyl (+57.02) 801.7457 2,402.21 2,402.22 3
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% AAPLQGMLPGLLAPLR 95.00% 4.36 0.569 5.07 809.4783 1,616.94 1,617.95 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% AAPLQGMLPGLLAPLR 95.00% 4.45 0.612 5.89 809.4788 1,616.94 1,617.95 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% AAPLQGMLPGLLAPLR 95.00% 4.1 0.579 4.96 809.4803 1,616.95 1,617.95 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% AAPLQGMLPGLLAPLR 95.00% 4.01 0.478 4.74 809.9764 1,617.94 1,617.95 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% AAPLQGMLPGLLAPLR 95.00% 4.36 0.543 4.51 809.9779 1,617.94 1,617.95 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% AAPLQGMLPGLLAPLR 95.00% 4.94 0.58 4.07 809.9782 1,617.94 1,617.95 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 4.28 0.412 2.82 816.4123 1,630.81 1,631.82 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 3.97 0.519 2.92 816.4127 1,630.81 1,631.82 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 4.49 0.394 2.72 816.414 1,630.81 1,631.82 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 3.72 0.381 2.82 816.4141 1,630.81 1,631.82 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 4.94 0.503 4.39 816.4143 1,630.81 1,631.82 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 4.95 0.48 5.77 816.4143 1,630.81 1,631.82 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 5.05 0.468 4.21 816.4147 1,630.81 1,631.82 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 4.13 0.467 3.19 816.4168 1,630.82 1,631.82 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 3.24 0.381 2.12 816.4178 1,630.82 1,631.82 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% SVEDAQDVSLALTQR 95.00% 4.88 0.462 4.96 816.916 1,631.82 1,631.82 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% TRPEFYLNSYMNK 95.00% 4.41 0.527 3.92 831.9003 1,661.78 1,662.80 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% TRPEFYLNSYMNK 95.00% 4.39 0.496 3.48 832.4043 1,662.79 1,662.80 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 4.02 0.406 3.36 837.4803 1,672.94 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 4.07 0.393 3.92 837.4817 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 4.19 0.444 4 837.4819 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 4.19 0.463 4.34 837.4821 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 4.32 0.363 4.1 837.4842 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 4.56 0.446 3.66 837.9828 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 4.37 0.385 2.85 837.9833 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 4.22 0.456 4.48 837.9834 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 3.88 0.381 2.85 837.984 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEDGVPQHLVLVLGGK 95.00% 4.31 0.436 2.54 837.9842 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 4.83 0.545 5.57 843.4867 1,684.96 1,685.97 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 5.15 0.496 5.74 843.4867 1,684.96 1,685.97 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 5.27 0.498 5.57 843.4868 1,684.96 1,685.97 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 5.13 0.502 5.82 843.4872 1,684.96 1,685.97 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 5.08 0.543 5.59 843.4872 1,684.96 1,685.97 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 5.02 0.524 6.35 843.4874 1,684.96 1,685.97 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 4.84 0.519 3.55 843.4882 1,684.96 1,685.97 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 4.83 0.522 6.4 843.4885 1,684.96 1,685.97 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 5.34 0.532 5.3 843.9886 1,685.96 1,685.97 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% LLTPITTLTSEQIQK 95.00% 5.14 0.527 4.24 843.9894 1,685.96 1,685.97 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVVTYNNEVTTEIR 95.00% 4.32 0.433 3.96 854.4549 1,706.89 1,707.89 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVVTYNNEVTTEIR 95.00% 4.32 0.457 2.52 854.4558 1,706.90 1,707.89 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVVTYNNEVTTEIR 95.00% 4.28 0.399 3.59 854.4563 1,706.90 1,707.89 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVVTYNNEVTTEIR 95.00% 4.35 0.237 2.3 854.4585 1,706.90 1,707.89 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVVTYNNEVTTEIR 95.00% 4.43 0.481 3.62 854.4594 1,706.90 1,707.89 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVVTYNNEVTTEIR 95.00% 2.59 0.293 0 854.7662 1,707.52 1,707.89 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVVTYNNEVTTEIR 95.00% 4.54 0.332 3.05 854.9575 1,707.90 1,707.89 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVVTYNNEVTTEIR 95.00% 4.28 0.316 2.09 854.9581 1,707.90 1,707.89 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VAVVTYNNEVTTEIR 95.00% 4.18 0.352 3.32 854.961 1,707.91 1,707.89 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 4.08 0.652 6.21 858.4801 1,714.94 1,715.96 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 4.23 0.59 7.21 858.4813 1,714.95 1,715.96 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 4.22 0.588 5.68 858.4823 1,714.95 1,715.96 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 4.06 0.611 7.14 858.4824 1,714.95 1,715.96 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 4.41 0.572 7.89 858.4826 1,714.95 1,715.96 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 3.97 0.599 6.33 858.4835 1,714.95 1,715.96 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 4.24 0.591 5.8 858.4836 1,714.95 1,715.96 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 4.35 0.539 4.74 858.4837 1,714.95 1,715.96 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 4.36 0.607 5.31 858.9833 1,715.95 1,715.96 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 4.55 0.591 4.25 858.9844 1,715.95 1,715.96 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% IEEGVPQFLVLISSGK 95.00% 4.24 0.577 6.33 858.9848 1,715.95 1,715.96 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ISLSPEYVFSVSTFR 95.00% 4.13 0.563 4.38 866.4489 1,730.88 1,731.90 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ISLSPEYVFSVSTFR 95.00% 3.96 0.526 5.19 866.4502 1,730.88 1,731.90 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ISLSPEYVFSVSTFR 95.00% 3.09 0.471 1.24 866.95 1,731.88 1,731.90 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ISLSPEYVFSVSTFR 95.00% 2.89 0.342 0 866.9518 1,731.89 1,731.90 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ISLSPEYVFSVSTFR 95.00% 3.68 0.503 2.89 866.9522 1,731.89 1,731.90 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 4.5 0.545 6.01 869.5074 1,737.00 1,738.01 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 4.92 0.575 5.19 869.5078 1,737.00 1,738.01 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 4.95 0.603 5.27 869.5081 1,737.00 1,738.01 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 5.07 0.574 7.25 869.5085 1,737.00 1,738.01 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 4.69 0.557 6.2 869.5085 1,737.00 1,738.01 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 4.94 0.621 5.28 869.5085 1,737.00 1,738.01 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 4.6 0.628 6.04 869.5089 1,737.00 1,738.01 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 4.85 0.594 4.47 869.5092 1,737.00 1,738.01 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 4.51 0.512 4.51 869.5104 1,737.01 1,738.01 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 4.89 0.538 6.48 870.0086 1,738.00 1,738.01 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% ITEGVPQLLIVLTADR 95.00% 4.89 0.548 5.38 870.0119 1,738.01 1,738.01 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVIHFTDGADGDLADLHR 95.00% 5.13 0.603 6.85 975.9857 1,949.96 1,950.97 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VVIHFTDGADGDLADLHR 95.00% 5.47 0.613 7.52 976.4857 1,950.96 1,950.97 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VGVVQFSNDVFPEFYLK 95.00% 4.31 0.552 4.74 994.509 1,987.00 1,988.02 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VGVVQFSNDVFPEFYLK 95.00% 5.93 0.445 3.74 995.0078 1,988.00 1,988.02 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VGVVQFSNDVFPEFYLK 95.00% 5.37 0.461 3.38 995.0113 1,988.01 1,988.02 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% VGVVQFSNDVFPEFYLK 95.00% 6.03 0.463 5.22 995.0116 1,988.01 1,988.02 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLTLLGGPTPNTGAALEFVLR 95.00% 5.39 0.631 5.62 1,085.11 2,168.20 2,168.21 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% QLTLLGGPTPNTGAALEFVLR 95.00% 5.71 0.652 5.8 1,085.11 2,168.20 2,168.21 2
 SAMPLE 2R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 48 64 352 20.30% DVVFLIDGSQSAGPEFQYVR 95.00% 5.63 0.64 7.85 1,114.55 2,227.09 2,227.10 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% KVAVFFSNTPTR 95.00% 2.93 0.304 0 456.2548 1,365.74 1,366.75 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% KVAVFFSNTPTR 95.00% 2.5 0.35 0 456.5894 1,366.74 1,366.75 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLVLITGGK 95.00% 2.44 0.401 0 457.3079 912.6001 913.6089 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLVLITGGK 95.00% 2.61 0.267 0 457.3081 912.6006 913.6089 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLVLITGGK 95.00% 2.81 0.353 0 457.3086 912.6015 913.6089 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLVLITGGK 95.00% 3.23 0.352 0 457.3088 912.602 913.6089 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLVLITGGK 95.00% 2.57 0.436 0 457.3089 912.6021 913.6089 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLVLITGGK 95.00% 2.8 0.344 0 457.3089 912.6022 913.6089 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLVLITGGK 95.00% 3.01 0.391 0 457.309 912.6023 913.6089 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLVLITGGK 95.00% 2.99 0.367 0 457.309 912.6024 913.6089 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLVLITGGK 95.00% 2.45 0.239 0 457.309 912.6024 913.6089 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NLQVALTSK 95.00% 2.47 0.403 0 487.2861 972.5566 973.5683 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NLQVALTSK 95.00% 2.17 0.301 0 487.2867 972.5577 973.5683 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NLQVALTSK 95.00% 2.78 0.397 0 487.2869 972.5581 973.5683 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NLQVALTSK 95.00% 2.52 0.333 0 487.2869 972.5582 973.5683 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NLQVALTSK 95.00% 2.13 0.314 0 487.287 972.5583 973.5683 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NLQVALTSK 95.00% 2.61 0.357 0 487.2871 972.5585 973.5683 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NLQVALTSK 95.00% 2.64 0.348 0 487.2873 972.5589 973.5683 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NLQVALTSK 95.00% 2.68 0.357 0 487.2876 972.5596 973.5683 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NLQVALTSK 95.00% 2.42 0.405 1.09 487.2877 972.5597 973.5683 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NLQVALTSK 95.00% 2.28 0.268 0 487.2887 972.5617 973.5683 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IGDLHPQIVNLLK 95.00% 2.95 0.34 0 487.2922 1,458.85 1,459.86 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QQSLETAMSFVAR 95.00% 2.66 0.369 0 489.9138 1,466.72 1,467.73 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% ALILVGLER 95.00% 3.19 0.325 1.12 492.3145 982.6133 983.6255 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% ALILVGLER 95.00% 2.96 0.33 0 492.3149 982.6141 983.6255 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% ALILVGLER 95.00% 2.95 0.314 1.74 492.315 982.6143 983.6255 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% ALILVGLER 95.00% 3.06 0.337 1.82 492.3152 982.6147 983.6255 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% ALILVGLER 95.00% 3.12 0.318 0 492.3152 982.6147 983.6255 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% ALILVGLER 95.00% 3.18 0.313 0 492.3153 982.615 983.6255 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% ALILVGLER 95.00% 3.1 0.331 1.23 492.3153 982.615 983.6255 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% ALILVGLER 95.00% 3.2 0.336 1.2 492.3154 982.6151 983.6255 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% ALILVGLER 95.00% 3.06 0.318 1.22 492.3156 982.6155 983.6255 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% ALILVGLER 95.00% 3.1 0.342 0 492.3158 982.6159 983.6255 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IIDELNVKPEGTR 95.00% 1.89 0.287 0 495.2732 1,482.80 1,483.81 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IIDELNVKPEGTR 95.00% 3.02 0.255 1.43 495.2747 1,482.80 1,483.81 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IIDELNVKPEGTR 95.00% 3.34 0.261 1.89 495.2751 1,482.80 1,483.81 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IIDELNVKPEGTR 95.00% 2.96 0.371 0 495.2751 1,482.80 1,483.81 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IIDELNVKPEGTR 95.00% 2.83 0.323 1.07 495.2753 1,482.80 1,483.81 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IIDELNVKPEGTR 95.00% 2.8 0.279 1.21 495.2756 1,482.80 1,483.81 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% DSFQEVLR 95.00% 2.8 0.341 0 497.2505 992.4854 993.5006 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% DSFQEVLR 95.00% 2.43 0.315 0 497.2515 992.4873 993.5006 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% DSFQEVLR 95.00% 2.15 0.308 0 497.2515 992.4873 993.5006 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% DSFQEVLR 95.00% 2.42 0.33 0 497.2517 992.4877 993.5006 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% DSFQEVLR 95.00% 3.03 0.335 0 497.252 992.4883 993.5006 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% DSFQEVLR 95.00% 2.76 0.299 0 497.2521 992.4886 993.5006 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% DSFQEVLR 95.00% 2.71 0.33 0 497.2526 992.4896 993.5006 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LMHLEFGR 95.00% 2.02 0.301 0 501.7621 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SQHPYVLTEDTLK 95.00% 2.27 0.37 0 510.9308 1,529.77 1,530.78 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LQPVLQPLPSPGVGGK 95.00% 2.8 0.356 1.28 529.9799 1,586.92 1,586.93 3 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SQAPVLDAIR 95.00% 3 0.395 2.08 535.3025 1,068.59 1,069.60 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SQAPVLDAIR 95.00% 2.06 0.219 1.41 535.3026 1,068.59 1,069.60 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SQAPVLDAIR 95.00% 2.27 0.376 2.05 535.3028 1,068.59 1,069.60 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SQAPVLDAIR 95.00% 2.56 0.388 1.11 535.3028 1,068.59 1,069.60 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SQAPVLDAIR 95.00% 2.14 0.172 1.28 535.3029 1,068.59 1,069.60 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SQAPVLDAIR 95.00% 2.74 0.373 1.41 535.3031 1,068.59 1,069.60 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SQAPVLDAIR 95.00% 3.04 0.4 1.24 535.3032 1,068.59 1,069.60 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IEDGVPQHLVLVLGGK 95.00% 2.75 0.34 0.959 558.657 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IEDGVPQHLVLVLGGK 95.00% 3.3 0.414 1.15 558.6571 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IEDGVPQHLVLVLGGK 95.00% 3.25 0.3 0 558.6572 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IEDGVPQHLVLVLGGK 95.00% 2.72 0.285 0 558.658 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLTPITTLTSEQIQK 95.00% 4.08 0.494 2.09 562.6602 1,684.96 1,685.97 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLTPITTLTSEQIQK 95.00% 4.25 0.458 2.64 562.6609 1,684.96 1,685.97 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SSGIVSLGVGDR 95.00% 3.15 0.393 4.38 573.8075 1,145.60 1,146.61 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SSGIVSLGVGDR 95.00% 3.12 0.439 3.08 573.8082 1,145.60 1,146.61 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NIDRTELQTITNDPR 95.00% 3.17 0.338 1.55 595.9743 1,784.90 1,785.91 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NIDRTELQTITNDPR 95.00% 4.07 0.401 1.54 596.3087 1,785.90 1,785.91 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NIDRTELQTITNDPR 95.00% 2.95 0.265 0 596.3089 1,785.90 1,785.91 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NIDRTELQTITNDPR 95.00% 2.77 0.252 0 596.3094 1,785.90 1,785.91 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% FDEHQSKPEILNLVK 95.00% 3.88 0.353 0 599.6557 1,795.94 1,796.95 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% FDEHQSKPEILNLVK 95.00% 3.62 0.355 0 599.6563 1,795.95 1,796.95 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% FDEHQSKPEILNLVK 95.00% 3.78 0.417 1.27 599.6566 1,795.95 1,796.95 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% FDEHQSKPEILNLVK 95.00% 3.32 0.322 1.04 599.6571 1,795.95 1,796.95 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% FDEHQSKPEILNLVK 95.00% 3.46 0.342 0 599.9893 1,796.94 1,796.95 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% FDEHQSKPEILNLVK 95.00% 3.85 0.417 0 599.9901 1,796.95 1,796.95 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IAVAQYSDDVK 95.00% 3.06 0.492 4.4 604.8098 1,207.60 1,208.62 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VVESLDVGQDR 95.00% 3.29 0.594 3.51 608.8103 1,215.61 1,216.62 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VVESLDVGQDR 95.00% 3.28 0.535 3.7 608.8114 1,215.61 1,216.62 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VVESLDVGQDR 95.00% 3.31 0.493 3.16 608.8123 1,215.61 1,216.62 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VVESLDVGQDR 95.00% 3.07 0.454 2.96 608.8127 1,215.61 1,216.62 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NNLFTSSAGYR 95.00% 2.71 0.203 1.8 615.2959 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NNLFTSSAGYR 95.00% 2.66 0.331 1.72 615.2981 1,228.58 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VPQIAFVITGGK 95.00% 3.64 0.591 5.35 615.3634 1,228.71 1,229.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VPQIAFVITGGK 95.00% 3.84 0.592 4.51 615.365 1,228.71 1,229.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VPQIAFVITGGK 95.00% 3.85 0.583 3.82 615.3655 1,228.72 1,229.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VPQIAFVITGGK 95.00% 3.8 0.595 4.74 615.3655 1,228.72 1,229.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VPQIAFVITGGK 95.00% 3.81 0.575 5.38 615.3656 1,228.72 1,229.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VPQIAFVITGGK 95.00% 3.71 0.552 4.17 615.3656 1,228.72 1,229.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VPQIAFVITGGK 95.00% 3.75 0.51 5.31 615.3657 1,228.72 1,229.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VPQIAFVITGGK 95.00% 3.75 0.596 4.55 615.366 1,228.72 1,229.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VPQIAFVITGGK 95.00% 3.76 0.589 4.89 615.3662 1,228.72 1,229.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VAVFFSNTPTR 95.00% 2.63 0.394 2.59 619.8287 1,237.64 1,238.65 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VAVFFSNTPTR 95.00% 3.37 0.568 2.42 619.8288 1,237.64 1,238.65 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VAVFFSNTPTR 95.00% 2.79 0.545 3.01 619.8289 1,237.64 1,238.65 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VAVFFSNTPTR 95.00% 3.42 0.481 2.89 619.829 1,237.64 1,238.65 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VAVFFSNTPTR 95.00% 3 0.505 2.92 619.8292 1,237.64 1,238.65 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VAVFFSNTPTR 95.00% 3.17 0.54 2.41 619.8293 1,237.64 1,238.65 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VAVFFSNTPTR 95.00% 3.23 0.543 2.68 619.8293 1,237.64 1,238.65 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VAVFFSNTPTR 95.00% 3.32 0.486 2.64 619.8294 1,237.64 1,238.65 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VAVFFSNTPTR 95.00% 3.31 0.52 2.7 619.8296 1,237.64 1,238.65 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VVIHFTDGADGDLADLHR 95.00% 5.52 0.532 4.21 651.3273 1,950.96 1,950.97 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VVIHFTDGADGDLADLHR 95.00% 5.78 0.526 5.85 651.3274 1,950.96 1,950.97 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QSGVVPFIFQAK 95.00% 2.26 0.475 1.8 660.8682 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QSGVVPFIFQAK 95.00% 2.72 0.443 2.72 660.8684 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QSGVVPFIFQAK 95.00% 2.62 0.491 2.96 660.8684 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QSGVVPFIFQAK 95.00% 2.89 0.451 3.82 660.8684 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QSGVVPFIFQAK 95.00% 2.5 0.512 2.7 660.8687 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QSGVVPFIFQAK 95.00% 2.53 0.497 3.25 660.869 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NIDSEEVGKIASNSATAFR 95.00% 2.38 0.322 0 670.6683 2,008.98 2,008.99 3 MUC16_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NIDSEEVGKIASNSATAFR 95.00% 3.8 0.47 3.72 670.6707 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% NIDSEEVGKIASNSATAFR 95.00% 3.36 0.477 1.72 670.6708 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QLGTVQQVISER 95.00% 2.24 0.42 1.15 679.3743 1,356.73 1,357.74 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QLGTVQQVISER 95.00% 2.94 0.384 0 679.3744 1,356.73 1,357.74 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QLGTVQQVISER 95.00% 2.47 0.471 2.6 679.3745 1,356.73 1,357.74 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QLGTVQQVISER 95.00% 3.14 0.497 3 679.3748 1,356.73 1,357.74 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QLGTVQQVISER 95.00% 2.71 0.472 2.24 679.3749 1,356.73 1,357.74 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QLGTVQQVISER 95.00% 2.28 0.415 0 679.3753 1,356.74 1,357.74 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QLGTVQQVISER 95.00% 2.77 0.494 3.74 679.3759 1,356.74 1,357.74 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% MKPLDGSALYTGSALDFVR 95.00% 3.56 0.36 0 681.3521 2,041.03 2,041.04 3
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% KVAVFFSNTPTR 95.00% 2.64 0.458 2.06 683.8744 1,365.73 1,366.75 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% KVAVFFSNTPTR 95.00% 2.56 0.491 1.77 683.8759 1,365.74 1,366.75 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LSDAGITPLFLTR 95.00% 4.2 0.513 4.36 702.3966 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LSDAGITPLFLTR 95.00% 3.99 0.468 3.48 702.3972 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LSDAGITPLFLTR 95.00% 3.88 0.477 4 702.3972 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LSDAGITPLFLTR 95.00% 4.29 0.52 3.8 702.3972 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LSDAGITPLFLTR 95.00% 4.33 0.538 3.68 702.3973 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LSDAGITPLFLTR 95.00% 4.25 0.506 3.8 702.3973 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LSDAGITPLFLTR 95.00% 3.74 0.456 3.02 702.3973 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LSDAGITPLFLTR 95.00% 4.18 0.506 4.21 702.3977 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LSDAGITPLFLTR 95.00% 4.48 0.523 4.39 702.3977 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LSDAGITPLFLTR 95.00% 3.89 0.434 4.33 702.398 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LSDAGITPLFLTR 95.00% 3.8 0.482 3.89 702.3988 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LSDAGITPLFLTR 95.00% 4.04 0.435 5.31 702.8991 1,403.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QINVGNALEYVSR 95.00% 2.33 0.315 2.92 731.884 1,461.75 1,462.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QINVGNALEYVSR 95.00% 3.51 0.529 2.82 731.8853 1,461.75 1,462.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QINVGNALEYVSR 95.00% 3.82 0.582 4 731.8854 1,461.76 1,462.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QINVGNALEYVSR 95.00% 3.41 0.499 1.82 731.8861 1,461.76 1,462.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QINVGNALEYVSR 95.00% 3.06 0.417 2 731.8865 1,461.76 1,462.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QINVGNALEYVSR 95.00% 3.66 0.536 2.7 731.8866 1,461.76 1,462.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QINVGNALEYVSR 95.00% 3.52 0.523 3.22 731.8867 1,461.76 1,462.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QINVGNALEYVSR 95.00% 3.55 0.528 3.48 731.8867 1,461.76 1,462.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QINVGNALEYVSR 95.00% 3.74 0.547 2.89 731.8872 1,461.76 1,462.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QINVGNALEYVSR 95.00% 2.58 0.467 2.21 731.8878 1,461.76 1,462.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QINVGNALEYVSR 95.00% 3.33 0.457 2.32 732.3866 1,462.76 1,462.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QQSLETAMSFVAR 95.00% 2.78 0.425 1.42 734.3647 1,466.71 1,467.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QQSLETAMSFVAR 95.00% 3.43 0.525 3.38 734.3663 1,466.72 1,467.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QQSLETAMSFVAR 95.00% 3.58 0.573 4.82 734.3663 1,466.72 1,467.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QQSLETAMSFVAR 95.00% 2.51 0.324 1.23 734.3665 1,466.72 1,467.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QQSLETAMSFVAR 95.00% 3.16 0.446 1.8 734.3665 1,466.72 1,467.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QQSLETAMSFVAR 95.00% 3.05 0.508 3.29 734.3666 1,466.72 1,467.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QQSLETAMSFVAR 95.00% 3.33 0.522 2.7 734.3667 1,466.72 1,467.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QQSLETAMSFVAR 95.00% 3.37 0.538 4.23 734.3668 1,466.72 1,467.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% QQSLETAMSFVAR 95.00% 3.56 0.521 2.89 734.3672 1,466.72 1,467.73 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% ALNLGYALDYAQR 95.00% 2.49 0.381 2.08 734.3855 1,466.76 1,467.76 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VVESLDVGQDRVR 95.00% 2.67 0.369 0 736.3954 1,470.78 1,471.79 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LVDYLDVGFDTTR 95.00% 3.97 0.525 5.92 757.3745 1,512.73 1,513.75 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LVDYLDVGFDTTR 95.00% 4.21 0.425 7.36 757.3765 1,512.74 1,513.75 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% AcNLDVILGFDGSR 95.00% 4.03 0.549 4.54 c2: Carbamidomethyl (+57.02) 768.8782 1,535.74 1,536.75 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% AcNLDVILGFDGSR 95.00% 4.92 0.555 4.48 c2: Carbamidomethyl (+57.02) 768.8787 1,535.74 1,536.75 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% AcNLDVILGFDGSR 95.00% 4.18 0.508 4.33 c2: Carbamidomethyl (+57.02) 769.3772 1,536.74 1,536.75 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% AcNLDVILGFDGSR 95.00% 4.88 0.516 4.85 c2: Carbamidomethyl (+57.02) 769.3774 1,536.74 1,536.75 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% GDSIDQcALIQSIK 95.00% 2.55 0.308 1.7 c7: Carbamidomethyl (+57.02) 774.3885 1,546.76 1,547.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% GDSIDQcALIQSIK 95.00% 3.03 0.338 2.01 c7: Carbamidomethyl (+57.02) 774.3893 1,546.76 1,547.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% GDSIDQcALIQSIK 95.00% 3.35 0.313 1.42 c7: Carbamidomethyl (+57.02) 774.3895 1,546.76 1,547.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% GDSIDQcALIQSIK 95.00% 2.76 0.292 0 c7: Carbamidomethyl (+57.02) 774.3896 1,546.76 1,547.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% GDSIDQcALIQSIK 95.00% 2.44 0.193 1.57 c7: Carbamidomethyl (+57.02) 774.3905 1,546.77 1,547.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% GDSIDQcALIQSIK 95.00% 2.9 0.359 1.52 c7: Carbamidomethyl (+57.02) 774.3907 1,546.77 1,547.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% GDSIDQcALIQSIK 95.00% 3.75 0.327 2.17 c7: Carbamidomethyl (+57.02) 774.3908 1,546.77 1,547.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% GDSIDQcALIQSIK 95.00% 2.62 0.312 1.52 c7: Carbamidomethyl (+57.02) 774.3916 1,546.77 1,547.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% GDSIDQcALIQSIK 95.00% 2.82 0.398 0 c7: Carbamidomethyl (+57.02) 774.3932 1,546.77 1,547.77 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LQPVLQPLPSPGVGGK 95.00% 4.06 0.506 3.96 793.9659 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LQPVLQPLPSPGVGGK 95.00% 3.12 0.433 2.96 793.9661 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LQPVLQPLPSPGVGGK 95.00% 4.19 0.521 3.92 793.9662 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LQPVLQPLPSPGVGGK 95.00% 4.07 0.547 2.15 794.4677 1,586.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LQPVLQPLPSPGVGGK 95.00% 3.93 0.569 3.07 794.469 1,586.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LQPVLQPLPSPGVGGK 95.00% 3.81 0.548 3.12 794.4701 1,586.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SLDEISQPAQELKR 95.00% 3.54 0.447 2.4 807.4276 1,612.84 1,613.85 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SLDEISQPAQELKR 95.00% 3.94 0.381 2.82 807.429 1,612.84 1,613.85 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SVEDAQDVSLALTQR 95.00% 3.44 0.374 1.8 816.4109 1,630.81 1,631.82 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SVEDAQDVSLALTQR 95.00% 4.9 0.485 4.77 816.4118 1,630.81 1,631.82 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SVEDAQDVSLALTQR 95.00% 3.77 0.327 1.62 816.4124 1,630.81 1,631.82 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SVEDAQDVSLALTQR 95.00% 4.39 0.398 2.39 816.4135 1,630.81 1,631.82 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SVEDAQDVSLALTQR 95.00% 4.05 0.403 1.46 816.4144 1,630.81 1,631.82 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% SVEDAQDVSLALTQR 95.00% 4.94 0.439 4.4 816.9157 1,631.82 1,631.82 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% TRPEFYLNSYMNK 95.00% 4.51 0.498 5.49 831.9005 1,661.79 1,662.80 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IEDGVPQHLVLVLGGK 95.00% 4.44 0.413 3.8 837.4815 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IEDGVPQHLVLVLGGK 95.00% 4.23 0.411 4.72 837.4818 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IEDGVPQHLVLVLGGK 95.00% 4.23 0.446 3.89 837.4821 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IEDGVPQHLVLVLGGK 95.00% 3.88 0.358 2.64 837.9821 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IEDGVPQHLVLVLGGK 95.00% 4.25 0.399 4.54 837.9848 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% IEDGVPQHLVLVLGGK 95.00% 4.2 0.45 3.92 837.9872 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLTPITTLTSEQIQK 95.00% 5.22 0.53 4.44 843.4864 1,684.96 1,685.97 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLTPITTLTSEQIQK 95.00% 4.49 0.556 3.41 843.4865 1,684.96 1,685.97 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLTPITTLTSEQIQK 95.00% 4.96 0.535 5.07 843.4867 1,684.96 1,685.97 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLTPITTLTSEQIQK 95.00% 5.09 0.522 5.62 843.4868 1,684.96 1,685.97 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLTPITTLTSEQIQK 95.00% 5.45 0.549 4.82 843.4871 1,684.96 1,685.97 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLTPITTLTSEQIQK 95.00% 4.66 0.578 5.18 843.4879 1,684.96 1,685.97 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLTPITTLTSEQIQK 95.00% 4.98 0.519 5.38 843.4881 1,684.96 1,685.97 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLTPITTLTSEQIQK 95.00% 5.03 0.508 5.43 843.9884 1,685.96 1,685.97 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% LLTPITTLTSEQIQK 95.00% 4.65 0.4 3.39 843.9888 1,685.96 1,685.97 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VAVVTYNNEVTTEIR 95.00% 4.23 0.4 3.62 854.456 1,706.90 1,707.89 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VAVVTYNNEVTTEIR 95.00% 3.57 0.161 4.09 854.4603 1,706.90 1,707.89 2
 SAMPLE 3 Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 35 39 192 14.80% VAVVTYNNEVTTEIR 95.00% 4.6 0.304 4.7 854.4621 1,706.91 1,707.89 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% KVAVFFSNTPTR 95.00% 1.84 0.232 0 456.2549 1,365.74 1,366.75 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% KVAVFFSNTPTR 95.00% 3.01 0.398 0 456.5897 1,366.75 1,366.75 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLVLITGGK 95.00% 2.68 0.428 0 457.3078 912.6 913.6089 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLVLITGGK 95.00% 2.62 0.38 0 457.308 912.6003 913.6089 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLVLITGGK 95.00% 2.68 0.354 0 457.3083 912.6009 913.6089 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLVLITGGK 95.00% 2.88 0.386 0 457.3084 912.6011 913.6089 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLVLITGGK 95.00% 2.8 0.461 0 457.3084 912.6012 913.6089 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLVLITGGK 95.00% 2.97 0.29 0 457.3084 912.6012 913.6089 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLVLITGGK 95.00% 2.01 0.26 0 457.309 912.6023 913.6089 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% EFRELPNIEER 95.00% 2.17 0.177 0 477.9121 1,430.71 1,431.72 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% EFRELPNIEER 95.00% 2.31 0.189 0 477.9126 1,430.71 1,431.72 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NLQVALTSK 95.00% 1.99 0.271 0 487.286 972.5564 973.5683 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NLQVALTSK 95.00% 1.88 0.31 0 487.2863 972.557 973.5683 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NLQVALTSK 95.00% 2.72 0.36 0 487.2867 972.5578 973.5683 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NLQVALTSK 95.00% 2.05 0.32 0 487.2869 972.5582 973.5683 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NLQVALTSK 95.00% 2.41 0.325 0 487.2872 972.5587 973.5683 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NLQVALTSK 95.00% 2.39 0.37 0 487.2872 972.5588 973.5683 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NLQVALTSK 95.00% 2.39 0.307 0 487.2873 972.5589 973.5683 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NLQVALTSK 95.00% 2.53 0.406 0 487.2873 972.559 973.5683 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NLQVALTSK 95.00% 2.55 0.413 0 487.2881 972.5606 973.5683 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NLQVALTSK 95.00% 2.09 0.253 0 487.2885 972.5613 973.5683 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 2.6 0.227 0 487.2912 1,458.85 1,459.86 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 2.79 0.408 0 487.2914 1,458.85 1,459.86 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 2.9 0.497 1.54 487.2914 1,458.85 1,459.86 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 2.92 0.449 0 487.2917 1,458.85 1,459.86 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 3.4 0.431 0 487.2917 1,458.85 1,459.86 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 2.44 0.288 0 487.2917 1,458.85 1,459.86 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 2.66 0.397 0 487.292 1,458.85 1,459.86 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 3.21 0.471 1.27 487.292 1,458.85 1,459.86 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 3.33 0.488 1.96 487.2921 1,458.85 1,459.86 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 3.11 0.444 1.08 487.2924 1,458.85 1,459.86 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 2.4 0.324 0 487.2927 1,458.85 1,459.86 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 3.54 0.499 0.959 487.2931 1,458.86 1,459.86 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QQSLETAMSFVAR 95.00% 2.73 0.275 1.19 489.913 1,466.72 1,467.73 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QQSLETAMSFVAR 95.00% 3.24 0.477 1.62 489.9133 1,466.72 1,467.73 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QQSLETAMSFVAR 95.00% 2.92 0.461 1.48 490.2462 1,467.72 1,467.73 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VVESLDVGQDRVR 95.00% 1.82 0.228 1.74 491.2664 1,470.78 1,471.79 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALILVGLER 95.00% 3 0.321 1.38 492.3139 982.6121 983.6255 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALILVGLER 95.00% 3.08 0.303 0 492.3149 982.6141 983.6255 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALILVGLER 95.00% 3.09 0.324 1.6 492.3152 982.6148 983.6255 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALILVGLER 95.00% 2.56 0.35 1.64 492.3152 982.6148 983.6255 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALILVGLER 95.00% 3.02 0.229 1.38 492.3153 982.615 983.6255 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALILVGLER 95.00% 3.04 0.347 1.1 492.3154 982.6151 983.6255 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALILVGLER 95.00% 3.04 0.282 1.6 492.3154 982.6152 983.6255 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALILVGLER 95.00% 2.96 0.263 1.08 492.3155 982.6154 983.6255 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALILVGLER 95.00% 3.16 0.314 1.41 492.3155 982.6154 983.6255 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALILVGLER 95.00% 2.77 0.347 2 492.3158 982.6159 983.6255 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALILVGLER 95.00% 2.29 0.344 1.68 492.3178 982.6199 983.6255 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IIDELNVKPEGTR 95.00% 2.75 0.22 0 495.2746 1,482.80 1,483.81 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IIDELNVKPEGTR 95.00% 2.54 0.236 0 495.2758 1,482.80 1,483.81 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IIDELNVKPEGTR 95.00% 2.63 0.316 0 495.6094 1,483.80 1,483.81 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% DSFQEVLR 95.00% 2.51 0.327 0 497.2508 992.4859 993.5006 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% DSFQEVLR 95.00% 2.34 0.369 0 497.251 992.4864 993.5006 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% DSFQEVLR 95.00% 2.36 0.353 0 497.2511 992.4865 993.5006 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% DSFQEVLR 95.00% 2.28 0.328 0 497.2514 992.4872 993.5006 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% DSFQEVLR 95.00% 2.87 0.339 0 497.2521 992.4886 993.5006 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% DSFQEVLR 95.00% 2.71 0.313 0 497.2525 992.4894 993.5006 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% DSFQEVLR 95.00% 2.76 0.336 0 497.2526 992.4896 993.5006 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% DSFQEVLR 95.00% 2.22 0.276 0 497.2529 992.4901 993.5006 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LMHLEFGR 94.80% 1.8 0.263 0 501.763 1,001.51 1,002.52 2 DYHC1_HUMAN,PSB5_HUMAN,TITIN_HUMAN,MYH10_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SQHPYVLTEDTLK 95.00% 2.31 0.259 0 510.9304 1,529.77 1,530.78 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SQHPYVLTEDTLK 95.00% 2.4 0.301 0 510.9307 1,529.77 1,530.78 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SQHPYVLTEDTLK 95.00% 2.57 0.227 0 510.9307 1,529.77 1,530.78 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SQAPVLDAIR 95.00% 2.26 0.315 2.24 535.302 1,068.59 1,069.60 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SQAPVLDAIR 95.00% 2.28 0.239 1.52 535.3029 1,068.59 1,069.60 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SQAPVLDAIR 95.00% 2.94 0.415 1.85 535.3031 1,068.59 1,069.60 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SQAPVLDAIR 95.00% 2.72 0.351 1.72 535.3032 1,068.59 1,069.60 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SQAPVLDAIR 95.00% 2.62 0.376 1.49 535.3033 1,068.59 1,069.60 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SQAPVLDAIR 95.00% 2.49 0.392 2.4 535.3033 1,068.59 1,069.60 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SQAPVLDAIR 95.00% 2.45 0.36 1.15 535.3034 1,068.59 1,069.60 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SQAPVLDAIR 95.00% 2.28 0.322 1.68 535.3037 1,068.59 1,069.60 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SLDEISQPAQELKR 95.00% 2.64 0.222 0 538.62 1,612.84 1,613.85 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SLDEISQPAQELKR 95.00% 2.28 0.27 0 538.6204 1,612.84 1,613.85 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SLDEISQPAQELKR 95.00% 2.21 0.257 0 538.621 1,612.84 1,613.85 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% AAPLQGMLPGLLAPLR 95.00% 2.11 0.239 0 540.3224 1,617.94 1,617.95 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEDGVPQHLVLVLGGK 95.00% 2.74 0.275 1.14 558.6572 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEDGVPQHLVLVLGGK 95.00% 2.88 0.267 0 558.659 1,672.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEDGVPQHLVLVLGGK 95.00% 2.58 0.258 0 558.9896 1,673.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEDGVPQHLVLVLGGK 95.00% 3.15 0.325 0 558.9919 1,673.95 1,673.96 3 ANXA2_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLTPITTLTSEQIQK 95.00% 4.48 0.425 1.34 562.9943 1,685.96 1,685.97 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLTPITTLTSEQIQK 95.00% 4.1 0.382 0 562.9946 1,685.96 1,685.97 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEEGVPQFLVLISSGK 95.00% 4.3 0.479 3.96 572.657 1,714.95 1,715.96 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEEGVPQFLVLISSGK 95.00% 3.8 0.443 2.33 572.6577 1,714.95 1,715.96 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEEGVPQFLVLISSGK 95.00% 5.13 0.555 4.8 572.9907 1,715.95 1,715.96 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEEGVPQFLVLISSGK 95.00% 4.42 0.523 3.24 572.9912 1,715.95 1,715.96 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SSGIVSLGVGDR 95.00% 3.48 0.368 3.59 573.8092 1,145.60 1,146.61 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SSGIVSLGVGDR 95.00% 3.15 0.379 2.74 573.8095 1,145.60 1,146.61 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 3.46 0.396 1.96 580.0067 1,737.00 1,738.01 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 3.13 0.419 1 580.0084 1,737.00 1,738.01 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 3.23 0.297 1.52 580.0088 1,737.00 1,738.01 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 3.55 0.504 1.14 580.3415 1,738.00 1,738.01 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 3.47 0.422 1.49 580.3418 1,738.00 1,738.01 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 3.11 0.385 1.57 580.3418 1,738.00 1,738.01 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 3.39 0.415 1.96 580.3427 1,738.00 1,738.01 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 3.9 0.402 2.66 580.3428 1,738.00 1,738.01 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 3.41 0.416 0 580.3431 1,738.01 1,738.01 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LDQRVPQIAFVITGGK 95.00% 2.34 0.249 0 581.3373 1,740.99 1,742.00 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LDQRVPQIAFVITGGK 95.00% 4.05 0.55 1.17 581.3377 1,740.99 1,742.00 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NIDRTELQTITNDPR 95.00% 2.91 0.352 0 595.9738 1,784.90 1,785.91 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NIDRTELQTITNDPR 95.00% 3.71 0.418 1.4 595.9744 1,784.90 1,785.91 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NIDRTELQTITNDPR 95.00% 2.09 0.259 0 595.9769 1,784.91 1,785.91 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NIDRTELQTITNDPR 95.00% 2.15 0.255 0 595.9775 1,784.91 1,785.91 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NIDRTELQTITNDPR 95.00% 3.27 0.362 0 596.3086 1,785.90 1,785.91 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NIDRTELQTITNDPR 95.00% 2.84 0.209 0 596.3092 1,785.90 1,785.91 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% FDEHQSKPEILNLVK 95.00% 2.33 0.239 0 599.6558 1,795.94 1,796.95 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% FDEHQSKPEILNLVK 95.00% 4.05 0.382 0 599.6564 1,795.95 1,796.95 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% FDEHQSKPEILNLVK 95.00% 3.79 0.371 1.09 599.6568 1,795.95 1,796.95 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% FDEHQSKPEILNLVK 95.00% 3.26 0.316 0 599.9891 1,796.94 1,796.95 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% FDEHQSKPEILNLVK 95.00% 3.66 0.314 1.17 599.9904 1,796.95 1,796.95 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IAVAQYSDDVK 95.00% 2.77 0.447 3.3 604.8115 1,207.61 1,208.62 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VVESLDVGQDR 95.00% 3.18 0.473 4.2 608.8127 1,215.61 1,216.62 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VVESLDVGQDR 95.00% 3.01 0.499 3.06 608.8134 1,215.61 1,216.62 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VVESLDVGQDR 95.00% 2.99 0.441 3.06 608.8156 1,215.62 1,216.62 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VVESLDVGQDR 95.00% 3.1 0.454 3.7 609.3148 1,216.61 1,216.62 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 1.86 0.185 1.89 615.3202 1,228.62 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 2.71 0.391 1.41 615.364 1,228.71 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 2.93 0.521 3.74 615.364 1,228.71 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 3.61 0.612 3.51 615.3642 1,228.71 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 3.55 0.584 3.96 615.3647 1,228.71 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 3.31 0.573 3.92 615.3649 1,228.71 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 2.76 0.535 1.66 615.365 1,228.71 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 3.82 0.588 4.43 615.3651 1,228.71 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 3.63 0.604 4.68 615.3652 1,228.71 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 3.3 0.592 3.28 615.3652 1,228.71 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 3.73 0.563 4.85 615.3653 1,228.71 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 2.9 0.562 1.89 615.3655 1,228.72 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 3.7 0.561 5.32 615.3656 1,228.72 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 3.52 0.601 4.66 615.3664 1,228.72 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 3.27 0.616 2.96 615.3669 1,228.72 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NNLFTSSAGYR 95.00% 2.73 0.201 1.21 615.794 1,229.57 1,229.59 2 MAP1B_HUMAN,CO6A2_HUMAN,TITIN_HUMAN,MYH11_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VPQIAFVITGGK 95.00% 2.2 0.254 1.44 615.969 1,229.92 1,229.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 2 0.403 1.43 619.8252 1,237.63 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 3.04 0.545 1.3 619.8282 1,237.64 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 3.3 0.564 3.14 619.8288 1,237.64 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 3.04 0.538 1.27 619.8291 1,237.64 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 3.4 0.539 3.25 619.8292 1,237.64 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 2.67 0.569 2.26 619.8296 1,237.64 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 3 0.458 2.82 619.8296 1,237.64 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 3.32 0.558 2.34 619.8297 1,237.64 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 3.35 0.556 2.51 619.8298 1,237.64 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 2.75 0.416 3.27 619.8299 1,237.64 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 3.13 0.552 2.62 619.8299 1,237.64 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 3 0.54 2.33 619.8299 1,237.64 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 2.8 0.397 1.82 619.8304 1,237.65 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 2.71 0.599 1.96 619.8307 1,237.65 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVFFSNTPTR 95.00% 2.49 0.295 1.72 619.833 1,237.65 1,238.65 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QSGVVPFIFQAK 95.00% 2.35 0.496 3.11 660.8686 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QSGVVPFIFQAK 95.00% 1.91 0.389 0 660.8687 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QSGVVPFIFQAK 95.00% 2.44 0.482 3.85 660.8688 1,319.72 1,320.73 2 ITA7_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NIDSEEVGKIASNSATAFR 95.00% 2.62 0.359 0 670.3338 2,007.98 2,008.99 3 MUC16_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% NIDSEEVGKIASNSATAFR 95.00% 3.6 0.459 2.27 670.671 2,008.99 2,008.99 3 MUC16_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QLGTVQQVISER 95.00% 2.3 0.338 0 679.3739 1,356.73 1,357.74 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QLGTVQQVISER 95.00% 2.73 0.49 2.43 679.374 1,356.73 1,357.74 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QLGTVQQVISER 95.00% 2.63 0.461 1.8 679.3744 1,356.73 1,357.74 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QLGTVQQVISER 95.00% 2.29 0.358 1.3 679.3746 1,356.73 1,357.74 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QLGTVQQVISER 95.00% 2.45 0.486 1.77 679.3751 1,356.73 1,357.74 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QLGTVQQVISER 95.00% 3.18 0.492 2.38 679.3752 1,356.73 1,357.74 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QLGTVQQVISER 95.00% 3.09 0.518 2.39 679.3763 1,356.74 1,357.74 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 3.93 0.467 4.96 702.3966 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 3.85 0.474 5.92 702.3966 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 4.41 0.523 3.89 702.3967 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 4.25 0.548 5.02 702.3968 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 3.57 0.474 3.74 702.3969 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 4.11 0.485 4.05 702.3969 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 4.21 0.494 3.42 702.397 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 4.27 0.56 4.41 702.3972 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 4.59 0.539 4.82 702.3972 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 3.72 0.481 2.37 702.3976 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 4.3 0.527 3.85 702.3976 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 4.06 0.507 3.89 702.3977 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 4.45 0.478 4.21 702.3979 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LSDAGITPLFLTR 95.00% 2.7 0.275 0 702.3983 1,402.78 1,403.79 2 TLN1_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% DVVLSIVNDLTIAESNcPR 95.00% 3.95 0.534 1.92 c17: Carbamidomethyl (+57.02) 706.0319 2,115.07 2,115.08 3
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 3.11 0.371 2 730.4351 1,458.85 1,459.86 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IGDLHPQIVNLLK 95.00% 3.15 0.403 2.09 730.4355 1,458.86 1,459.86 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 2.87 0.476 3.03 731.8846 1,461.75 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 3.07 0.481 3.15 731.8851 1,461.75 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 3.06 0.531 3.92 731.8852 1,461.75 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 3.35 0.527 3.31 731.8853 1,461.76 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 2.4 0.339 2.82 731.8855 1,461.76 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 3.04 0.427 2.89 731.8857 1,461.76 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 3.36 0.507 3.54 731.8858 1,461.76 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 3.14 0.491 3.51 731.8858 1,461.76 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 3.4 0.486 3.6 731.8864 1,461.76 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 3.13 0.465 3.21 731.8869 1,461.76 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 2.96 0.418 4.32 731.8871 1,461.76 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 2.58 0.402 3.24 731.8874 1,461.76 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QINVGNALEYVSR 95.00% 2.52 0.408 3.02 732.3846 1,462.75 1,462.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QQSLETAMSFVAR 95.00% 2.33 0.403 0 734.3632 1,466.71 1,467.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QQSLETAMSFVAR 95.00% 3.5 0.58 2.85 734.3653 1,466.72 1,467.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QQSLETAMSFVAR 95.00% 3.17 0.483 2.57 734.3659 1,466.72 1,467.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QQSLETAMSFVAR 95.00% 2.67 0.338 0 734.3666 1,466.72 1,467.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QQSLETAMSFVAR 95.00% 2.71 0.395 0 734.3667 1,466.72 1,467.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% QQSLETAMSFVAR 95.00% 3.84 0.526 3.29 734.3672 1,466.72 1,467.73 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALNLGYALDYAQR 95.00% 3.17 0.544 3.2 734.3858 1,466.76 1,467.76 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ALNLGYALDYAQR 95.00% 3.78 0.484 3.38 734.8853 1,467.75 1,467.76 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IIDELNVKPEGTR 95.00% 1.94 0.444 0 742.4071 1,482.80 1,483.81 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LVDYLDVGFDTTR 95.00% 3.65 0.548 6.28 757.3767 1,512.74 1,513.75 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LVDYLDVGFDTTR 95.00% 4.1 0.402 5.77 757.3775 1,512.74 1,513.75 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LVDYLDVGFDTTR 95.00% 3.85 0.488 5.74 757.378 1,512.74 1,513.75 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LVDYLDVGFDTTR 95.00% 3.02 0.533 3.89 757.3782 1,512.74 1,513.75 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LVDYLDVGFDTTR 95.00% 3.52 0.505 5.4 757.3791 1,512.74 1,513.75 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LVDYLDVGFDTTR 95.00% 2.02 0.355 1.74 757.7392 1,513.46 1,513.75 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% GDSIDQcALIQSIK 95.00% 2.82 0.269 1.96 c7: Carbamidomethyl (+57.02) 774.3916 1,546.77 1,547.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% GDSIDQcALIQSIK 95.00% 2.65 0.209 0 c7: Carbamidomethyl (+57.02) 774.3916 1,546.77 1,547.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% GDSIDQcALIQSIK 95.00% 2.67 0.295 1.46 c7: Carbamidomethyl (+57.02) 774.3924 1,546.77 1,547.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% GDSIDQcALIQSIK 95.00% 3.61 0.363 1.62 c7: Carbamidomethyl (+57.02) 774.8906 1,547.77 1,547.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% GDSIDQcALIQSIK 95.00% 2.35 0.212 1.32 c7: Carbamidomethyl (+57.02) 774.8907 1,547.77 1,547.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% GDSIDQcALIQSIK 95.00% 3.43 0.295 1.29 c7: Carbamidomethyl (+57.02) 774.8917 1,547.77 1,547.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% GDSIDQcALIQSIK 95.00% 3.27 0.298 1.7 c7: Carbamidomethyl (+57.02) 774.8929 1,547.77 1,547.77 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LQPVLQPLPSPGVGGK 95.00% 3.79 0.534 2.62 793.9659 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LQPVLQPLPSPGVGGK 95.00% 3.5 0.544 2.52 793.9667 1,585.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LQPVLQPLPSPGVGGK 95.00% 3.98 0.527 3.46 794.4674 1,586.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LQPVLQPLPSPGVGGK 95.00% 4.33 0.571 4.54 794.4701 1,586.92 1,586.93 2 DYHC1_HUMAN,PGBM_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% AAPLQGMLPGLLAPLR 95.00% 4.03 0.545 4.41 809.4773 1,616.94 1,617.95 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% AAPLQGMLPGLLAPLR 95.00% 4.12 0.597 5.1 809.4789 1,616.94 1,617.95 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% AAPLQGMLPGLLAPLR 95.00% 4.82 0.531 5.11 809.4816 1,616.95 1,617.95 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% AAPLQGMLPGLLAPLR 95.00% 3.63 0.514 5.29 809.4821 1,616.95 1,617.95 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SVEDAQDVSLALTQR 95.00% 4.07 0.457 2.62 816.4101 1,630.80 1,631.82 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SVEDAQDVSLALTQR 95.00% 3.86 0.376 1.96 816.4117 1,630.81 1,631.82 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SVEDAQDVSLALTQR 95.00% 4.07 0.463 2.77 816.4121 1,630.81 1,631.82 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SVEDAQDVSLALTQR 95.00% 4.61 0.446 3.62 816.4123 1,630.81 1,631.82 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% SVEDAQDVSLALTQR 95.00% 4.98 0.424 4.62 816.915 1,631.81 1,631.82 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% TRPEFYLNSYMNK 95.00% 3.6 0.439 4.19 831.9008 1,661.79 1,662.80 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEDGVPQHLVLVLGGK 95.00% 4.15 0.414 3.28 837.4822 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEDGVPQHLVLVLGGK 95.00% 4.2 0.395 3.92 837.4825 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEDGVPQHLVLVLGGK 95.00% 3.93 0.353 3.43 837.4831 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEDGVPQHLVLVLGGK 95.00% 4.03 0.346 3.12 837.4851 1,672.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEDGVPQHLVLVLGGK 95.00% 3.73 0.367 2.47 837.9831 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEDGVPQHLVLVLGGK 95.00% 4.38 0.394 2.36 837.9839 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEDGVPQHLVLVLGGK 95.00% 4.08 0.47 4.31 837.9849 1,673.95 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEDGVPQHLVLVLGGK 95.00% 4.16 0.451 2.82 837.9859 1,673.96 1,673.96 2 ANXA2_HUMAN
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLTPITTLTSEQIQK 95.00% 4.91 0.557 4.28 843.4863 1,684.96 1,685.97 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLTPITTLTSEQIQK 95.00% 4.77 0.452 5.57 843.4864 1,684.96 1,685.97 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLTPITTLTSEQIQK 95.00% 4.91 0.507 5 843.4868 1,684.96 1,685.97 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLTPITTLTSEQIQK 95.00% 4.89 0.526 4.68 843.4869 1,684.96 1,685.97 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLTPITTLTSEQIQK 95.00% 4.86 0.498 4.07 843.4871 1,684.96 1,685.97 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLTPITTLTSEQIQK 95.00% 4.84 0.499 5.18 843.4871 1,684.96 1,685.97 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLTPITTLTSEQIQK 95.00% 5.03 0.537 4.32 843.4872 1,684.96 1,685.97 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLTPITTLTSEQIQK 95.00% 4.84 0.491 4.66 843.4895 1,684.96 1,685.97 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% LLTPITTLTSEQIQK 95.00% 4.8 0.501 5.19 843.4897 1,684.96 1,685.97 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVVTYNNEVTTEIR 95.00% 4.18 0.363 3.15 854.4518 1,706.89 1,707.89 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVVTYNNEVTTEIR 95.00% 4.53 0.424 2.92 854.4574 1,706.90 1,707.89 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVVTYNNEVTTEIR 95.00% 4.21 0.348 3.55 854.4577 1,706.90 1,707.89 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVVTYNNEVTTEIR 95.00% 4.34 0.216 3.89 854.4579 1,706.90 1,707.89 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VAVVTYNNEVTTEIR 95.00% 3.57 0.28 3.04 854.4637 1,706.91 1,707.89 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEEGVPQFLVLISSGK 95.00% 4.49 0.566 3.64 858.4801 1,714.94 1,715.96 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEEGVPQFLVLISSGK 95.00% 4.5 0.583 5.8 858.9815 1,715.95 1,715.96 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEEGVPQFLVLISSGK 95.00% 4.08 0.569 5.18 858.9837 1,715.95 1,715.96 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% IEEGVPQFLVLISSGK 95.00% 3.78 0.449 3.74 858.9843 1,715.95 1,715.96 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ISLSPEYVFSVSTFR 95.00% 3.03 0.432 1.09 866.9531 1,731.89 1,731.90 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 4.89 0.581 5.03 869.5074 1,737.00 1,738.01 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 5.11 0.582 5.03 869.509 1,737.00 1,738.01 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 5.07 0.574 4.92 869.5094 1,737.00 1,738.01 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 5.06 0.604 3.85 869.5102 1,737.00 1,738.01 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 5.02 0.593 6.57 870.0098 1,738.00 1,738.01 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 5.02 0.582 6.66 870.0114 1,738.01 1,738.01 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 5.03 0.56 7.03 870.0117 1,738.01 1,738.01 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% ITEGVPQLLIVLTADR 95.00% 4.76 0.569 5.47 870.0127 1,738.01 1,738.01 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VGVVQFSNDVFPEFYLK 95.00% 4.41 0.488 2.68 995.0121 1,988.01 1,988.02 2
 SAMPLE 3R Collagen alpha-3(VI) chain  COL6A3  CO6A3_HUMAN 343,645.40 100.00% 40 48 255 16.80% VGVVQFSNDVFPEFYLK 95.00% 4.78 0.557 3.64 995.0134 1,988.01 1,988.02 2
 SAMPLE 1R Collagen alpha-6(IV) chain  COL4A6  CO4A6_HUMAN 163,794.00 99.80% 2 2 2 2.96% GSQGSAGSNGFPGPRGDKGEAGR 95.00% 2.39 0.29 0 715.9181 2,144.73 2,146.00 3
 SAMPLE 1R Collagen alpha-6(IV) chain  COL4A6  CO4A6_HUMAN 163,794.00 99.80% 2 2 2 2.96% GDVGLPGPAGPPPSTGELEFMGFPKGK 95.00% 2 0.267 0 880.7497 2,639.23 2,639.32 3
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% TINVPLRR 95.00% 2.19 0.196 0 484.8021 967.5886 968.6006 2 RP1L1_HUMAN
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% TINVPLRR 95.00% 2.09 0.179 2.13 484.8027 967.5898 968.6006 2 RP1L1_HUMAN
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% GNLcVNLMR 95.00% 2.33 0.288 1.89 c4: Carbamidomethyl (+57.02) 538.7695 1,075.52 1,076.53 2
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% GNLcVNLMR 95.00% 1.83 0.17 1.37 c4: Carbamidomethyl (+57.02) 538.7697 1,075.52 1,076.53 2
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% GNLcVNLMR 95.00% 2.87 0.435 1.31 c4: Carbamidomethyl (+57.02) 538.7701 1,075.52 1,076.53 2
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% GNLcVNLMR 95.00% 3 0.44 1.23 c4: Carbamidomethyl (+57.02) 538.7703 1,075.52 1,076.53 2
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% GNLcVNLMR 95.00% 2.51 0.373 1.66 c4: Carbamidomethyl (+57.02) 538.7709 1,075.53 1,076.53 2
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% VPGLYYFTYHASSR 95.00% 3.57 0.389 1.36 554.2728 1,659.79 1,660.81 3
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% VPGLYYFTYHASSR 95.00% 2.82 0.459 1.51 554.2736 1,659.80 1,660.81 3
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% VPGLYYFTYHASSR 95.00% 2.8 0.373 0 554.2742 1,659.80 1,660.81 3
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% FDHVITNMNNNYEPR 95.00% 3.49 0.395 2.52 622.2878 1,863.84 1,863.84 3
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% FDHVITNMNNNYEPR 95.00% 3.81 0.471 1.7 622.2881 1,863.84 1,863.84 3
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% FDHVITNmNNNYEPR 95.00% 2.99 0.274 2.1 m8: Oxidation (+15.99) 627.2829 1,878.83 1,879.84 3
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% FDHVITNmNNNYEPR 95.00% 3.45 0.294 1.92 m8: Oxidation (+15.99) 627.6172 1,879.83 1,879.84 3
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% LEQGENVFLQATDK 95.00% 4.25 0.578 5.14 796.3974 1,590.78 1,591.80 2
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% LEQGENVFLQATDK 95.00% 4.99 0.56 5.48 796.3994 1,590.78 1,591.80 2
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% VPGLYYFTYHASSR 95.00% 3.99 0.535 3.39 830.9077 1,659.80 1,660.81 2
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% VPGLYYFTYHASSR 95.00% 3.97 0.529 3.47 830.9084 1,659.80 1,660.81 2
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% FDHVITNMNNNYEPR 95.00% 5.06 0.53 6.31 932.4235 1,862.83 1,863.84 2
 SAMPLE 3 Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 18 23.90% FDHVITNMNNNYEPR 95.00% 4.83 0.521 8.31 932.4253 1,862.84 1,863.84 2
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% TINVPLRR 95.00% 1.92 0.197 1.22 484.8029 967.5901 968.6006 2 RP1L1_HUMAN
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% GNLcVNLMR 95.00% 2.4 0.31 1.1 c4: Carbamidomethyl (+57.02) 538.7486 1,075.48 1,076.53 2
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% GNLcVNLMR 95.00% 2.03 0.275 0 c4: Carbamidomethyl (+57.02) 538.7652 1,075.51 1,076.53 2
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% GNLcVNLMR 95.00% 2.78 0.418 1.23 c4: Carbamidomethyl (+57.02) 538.7695 1,075.52 1,076.53 2
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% GNLcVNLMR 95.00% 2.25 0.282 0 c4: Carbamidomethyl (+57.02) 538.7696 1,075.52 1,076.53 2
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% GNLcVNLMR 95.00% 2.76 0.376 1.54 c4: Carbamidomethyl (+57.02) 538.7708 1,075.53 1,076.53 2
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% VPGLYYFTYHASSR 95.00% 3.35 0.409 1.89 554.2746 1,659.80 1,660.81 3
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% VPGLYYFTYHASSR 95.00% 3.03 0.397 1.17 554.2752 1,659.80 1,660.81 3
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% FDHVITNMNNNYEPR 95.00% 3.32 0.288 2.24 621.9523 1,862.83 1,863.84 3
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% FDHVITNMNNNYEPR 95.00% 2.37 0.39 1.16 622.2869 1,863.84 1,863.84 3
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% FDHVITNMNNNYEPR 95.00% 3.02 0.368 1.92 622.2896 1,863.85 1,863.84 3
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% FDHVITNMNNNYEPR 95.00% 2.09 0.256 0 622.2896 1,863.85 1,863.84 3
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% LEQGENVFLQATDK 95.00% 4.88 0.559 5.21 796.3998 1,590.78 1,591.80 2
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% LEQGENVFLQATDK 95.00% 4.96 0.58 5.82 796.4001 1,590.78 1,591.80 2
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% VPGLYYFTYHASSR 95.00% 4.32 0.567 5.17 830.9082 1,659.80 1,660.81 2
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% VPGLYYFTYHASSR 95.00% 4.25 0.566 4.96 830.9085 1,659.80 1,660.81 2
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% FDHVITNMNNNYEPR 95.00% 4.88 0.53 8.17 932.4217 1,862.83 1,863.84 2
 SAMPLE 3R Complement C1q subcomponent subunit B  C1QB  C1QB_HUMAN 26,442.40 100.00% 4 6 17 23.90% FDHVITNMNNNYEPR 95.00% 5.15 0.554 7 932.4259 1,862.84 1,863.84 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% QTHQPPAPNSLIR 95.00% 2.77 0.291 0 486.9314 1,457.77 1,458.78 3
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% QTHQPPAPNSLIR 95.00% 2.82 0.362 0 486.9314 1,457.77 1,458.78 3
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% FQSVFTVTR 95.00% 2.59 0.315 1.74 542.7911 1,083.57 1,084.58 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% FQSVFTVTR 95.00% 2.85 0.38 1.37 542.7919 1,083.57 1,084.58 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% FQSVFTVTR 95.00% 2.76 0.36 1.1 542.7923 1,083.57 1,084.58 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% VVTFcGHTSK 95.00% 1.78 0.267 1.43 c5: Carbamidomethyl (+57.02) 568.2819 1,134.55 1,135.56 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% TNQVNSGGVLLR 95.00% 2.72 0.32 2.07 629.3484 1,256.68 1,257.69 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% TNQVNSGGVLLR 95.00% 3.21 0.41 2.24 629.349 1,256.68 1,257.69 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% TNQVNSGGVLLR 95.00% 3.74 0.454 1.47 629.3492 1,256.68 1,257.69 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% TNQVNSGGVLLR 95.00% 3.62 0.421 1.42 629.3494 1,256.68 1,257.69 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% FNAVLTNPQGDYDTSTGK 95.00% 2.87 0.284 0 643.6418 1,927.90 1,927.90 3
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% QKFQSVFTVTR 95.00% 2.87 0.423 2.03 670.8675 1,339.72 1,340.73 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% QKFQSVFTVTR 95.00% 2.75 0.425 1.43 670.8694 1,339.72 1,340.73 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% QTHQPPAPNSLIR 95.00% 2.46 0.341 0 729.8926 1,457.77 1,458.78 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% QTHQPPAPNSLIR 95.00% 2.01 0.315 2.74 729.8941 1,457.77 1,458.78 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% QTHQPPAPNSLIR 95.00% 1.95 0.223 2.59 729.8942 1,457.77 1,458.78 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% QTHQPPAPNSLIR 95.00% 2.2 0.298 1.64 729.8944 1,457.77 1,458.78 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% QTHQPPAPNSLIR 95.00% 2.63 0.366 1.51 729.8956 1,457.78 1,458.78 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% QTHQPPAPNSLIR 95.00% 2 0.3 1.15 729.8957 1,457.78 1,458.78 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% FNAVLTNPQGDYDTSTGK 95.00% 5.74 0.556 5.25 964.452 1,926.89 1,927.90 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% FNAVLTNPQGDYDTSTGK 95.00% 5.97 0.591 5.02 964.4533 1,926.89 1,927.90 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% FNAVLTNPQGDYDTSTGK 95.00% 5.63 0.587 5.04 964.456 1,926.90 1,927.90 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% FNAVLTNPQGDYDTSTGK 95.00% 5.25 0.554 6.7 964.9534 1,927.89 1,927.90 2
 SAMPLE 3 Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 6 8 24 26.10% FNAVLTNPQGDYDTSTGK 95.00% 5.44 0.531 4.52 964.9557 1,927.90 1,927.90 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% QTHQPPAPNSLIR 95.00% 2.58 0.313 0 486.931 1,457.77 1,458.78 3
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% QTHQPPAPNSLIR 95.00% 2.53 0.316 0 486.9312 1,457.77 1,458.78 3
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% FQSVFTVTR 95.00% 2.71 0.389 1.4 542.7918 1,083.57 1,084.58 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% FQSVFTVTR 95.00% 2.54 0.355 1.09 542.7919 1,083.57 1,084.58 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% FQSVFTVTR 95.00% 2.68 0.35 0 542.7923 1,083.57 1,084.58 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% FQSVFTVTR 95.00% 2.57 0.361 1.51 542.7929 1,083.57 1,084.58 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% FQSVFTVTR 95.00% 2.61 0.358 0 542.793 1,083.57 1,084.58 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% FQSVFTVTR 95.00% 2.72 0.374 0 542.794 1,083.57 1,084.58 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% TNQVNSGGVLLR 95.00% 2.82 0.313 0 629.3477 1,256.68 1,257.69 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% TNQVNSGGVLLR 95.00% 3.74 0.418 1.89 629.349 1,256.68 1,257.69 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% TNQVNSGGVLLR 95.00% 3.73 0.432 1.74 629.3494 1,256.68 1,257.69 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% TNQVNSGGVLLR 95.00% 3.33 0.453 0 629.3495 1,256.68 1,257.69 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% QKFQSVFTVTR 95.00% 2.52 0.441 0 670.8679 1,339.72 1,340.73 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% QKFQSVFTVTR 95.00% 2.49 0.376 0 670.8687 1,339.72 1,340.73 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% QTHQPPAPNSLIR 95.00% 2.39 0.334 2.47 729.8936 1,457.77 1,458.78 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% QTHQPPAPNSLIR 95.00% 2.36 0.306 2.48 729.8946 1,457.77 1,458.78 2
 SAMPLE 3R Complement C1q subcomponent subunit C  C1QC  C1QC_HUMAN 25,756.00 100.00% 5 6 17 22.00% FNAVLTNPQGDYDTSTGK 95.00% 5.3 0.586 7.48 964.9546 1,927.89 1,927.90 2
 SAMPLE 2 Complement C1q tumor necrosis factor-related protein 5  C1QTNF5  C1QT5_HUMAN 25,280.50 99.80% 2 2 2 9.05% ASLQFDLVK 95.00% 2.6 0.274 0 511.2687 1,020.52 1,020.57 2
 SAMPLE 2 Complement C1q tumor necrosis factor-related protein 5  C1QTNF5  C1QT5_HUMAN 25,280.50 99.80% 2 2 2 9.05% VPPPSDAPLPFDR 95.00% 2.17 0.279 3.28 704.3652 1,406.71 1,407.73 2
 SAMPLE 3 Complement C1r subcomponent  C1R  C1R_HUMAN 80,101.60 99.80% 2 2 3 4.11% cLPVcGKPVNPVEQR 95.00% 2.33 0.175 1.19 c1: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 584.9681 1,751.88 1,752.89 3
 SAMPLE 3 Complement C1r subcomponent  C1R  C1R_HUMAN 80,101.60 99.80% 2 2 3 4.11% LPVANPQAcENWLR 95.00% 3.5 0.491 3.66 c9: Carbamidomethyl (+57.02) 834.4177 1,666.82 1,667.83 2
 SAMPLE 3 Complement C1r subcomponent  C1R  C1R_HUMAN 80,101.60 99.80% 2 2 3 4.11% LPVANPQAcENWLR 95.00% 3.91 0.536 4.35 c9: Carbamidomethyl (+57.02) 834.4178 1,666.82 1,667.83 2
 SAMPLE 3 Complement C3  C3  CO3_HUMAN 187,131.10 99.70% 2 2 2 1.80% SGIPIVTSPYQIHFTK 94.60% 1.7 0.298 0 596.6604 1,786.96 1,787.97 3
 SAMPLE 3 Complement C3  C3  CO3_HUMAN 187,131.10 99.70% 2 2 2 1.80% IPIEDGSGEVVLSR 95.00% 2.66 0.424 3.15 735.8937 1,469.77 1,470.78 2
 SAMPLE 3 Complement component C8 beta chain  C8B  CO8B_HUMAN 67,028.90 99.80% 2 2 2 5.08% LPLEYSYGEYR 95.00% 2.06 0.361 0 695.3387 1,388.66 1,389.67 2
 SAMPLE 3 Complement component C8 beta chain  C8B  CO8B_HUMAN 67,028.90 99.80% 2 2 2 5.08% EVSScHcAPcQGNGVPVLK 95.00% 2.33 0.391 0 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 700.6547 2,098.94 2,098.95 3
 SAMPLE 2R Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 99.80% 2 2 5 12.90% QLYGDTGVLGR 95.00% 2.22 0.27 0 589.809 1,177.60 1,178.62 2
 SAMPLE 2R Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 99.80% 2 2 5 12.90% QLYGDTGVLGR 95.00% 2.38 0.328 0 589.8113 1,177.61 1,178.62 2
 SAMPLE 2R Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 99.80% 2 2 5 12.90% SLPVSDSVLSGFEQR 95.00% 4.38 0.586 4 810.9127 1,619.81 1,620.82 2
 SAMPLE 2R Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 99.80% 2 2 5 12.90% SLPVSDSVLSGFEQR 95.00% 4.34 0.573 4.6 810.9145 1,619.81 1,620.82 2
 SAMPLE 2R Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 99.80% 2 2 5 12.90% SLPVSDSVLSGFEQR 95.00% 4.44 0.561 4.41 811.414 1,620.81 1,620.82 2
 SAMPLE 3 Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 100.00% 3 3 6 18.80% QLYGDTGVLGR 95.00% 2.56 0.401 1.92 589.8102 1,177.60 1,178.62 2
 SAMPLE 3 Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 100.00% 3 3 6 18.80% QLYGDTGVLGR 95.00% 2.8 0.35 1.89 589.8105 1,177.61 1,178.62 2
 SAMPLE 3 Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 100.00% 3 3 6 18.80% RPASPISTIQPK 95.00% 2.89 0.313 1.47 647.8763 1,293.74 1,294.75 2
 SAMPLE 3 Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 100.00% 3 3 6 18.80% RPASPISTIQPK 95.00% 2.69 0.279 0 647.8769 1,293.74 1,294.75 2
 SAMPLE 3 Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 100.00% 3 3 6 18.80% SLPVSDSVLSGFEQR 95.00% 4.38 0.605 4.25 810.9153 1,619.81 1,620.82 2
 SAMPLE 3 Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 100.00% 3 3 6 18.80% SLPVSDSVLSGFEQR 95.00% 4.62 0.56 4.85 811.4133 1,620.81 1,620.82 2
 SAMPLE 3R Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 99.80% 2 2 6 12.90% QLYGDTGVLGR 95.00% 2.47 0.415 1.15 589.8099 1,177.60 1,178.62 2
 SAMPLE 3R Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 99.80% 2 2 6 12.90% QLYGDTGVLGR 95.00% 2.28 0.231 0 589.8107 1,177.61 1,178.62 2
 SAMPLE 3R Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 99.80% 2 2 6 12.90% SLPVSDSVLSGFEQR 95.00% 4.55 0.596 5.33 810.9148 1,619.81 1,620.82 2
 SAMPLE 3R Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 99.80% 2 2 6 12.90% SLPVSDSVLSGFEQR 95.00% 4.27 0.55 3.33 810.9149 1,619.81 1,620.82 2
 SAMPLE 3R Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 99.80% 2 2 6 12.90% SLPVSDSVLSGFEQR 95.00% 4.12 0.535 3.15 811.4166 1,620.82 1,620.82 2
 SAMPLE 3R Complement component C8 gamma chain  C8G  CO8G_HUMAN 22,259.30 99.80% 2 2 6 12.90% SLPVSDSVLSGFEQR 95.00% 4.54 0.555 4.66 811.4167 1,620.82 1,620.82 2
 SAMPLE 3 Complement component C9  C9  CO9_HUMAN 63,156.80 99.80% 2 2 3 5.01% AEQccEETASSISLHGK 95.00% 3.66 0.556 0 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 636.6154 1,906.82 1,906.83 3
 SAMPLE 3 Complement component C9  C9  CO9_HUMAN 63,156.80 99.80% 2 2 3 5.01% DRVVEESELAR 95.00% 2.63 0.302 0 651.3302 1,300.64 1,302.67 2
 SAMPLE 3 Complement component C9  C9  CO9_HUMAN 63,156.80 99.80% 2 2 3 5.01% DRVVEESELAR 95.00% 3 0.32 0 651.8319 1,301.65 1,302.67 2
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% SLGNVIMVcR 95.00% 3.11 0.529 1.15 c9: Carbamidomethyl (+57.02) 574.7983 1,147.58 1,148.59 2 ANK3_HUMAN
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% SLGNVIMVcR 95.00% 2.9 0.517 0 c9: Carbamidomethyl (+57.02) 574.7992 1,147.58 1,148.59 2 ANK3_HUMAN
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% cTSTGWIPAPR 95.00% 2.17 0.281 1.64 c1: Carbamidomethyl (+57.02) 623.3048 1,244.59 1,245.61 2
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% cTSTGWIPAPR 95.00% 3.21 0.455 2.96 c1: Carbamidomethyl (+57.02) 623.305 1,244.59 1,245.61 2
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% KGEWVALNPLR 95.00% 2.41 0.39 1.7 641.8661 1,281.72 1,282.73 2
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% ScDIPVFMNAR 95.00% 2.41 0.489 1.72 c2: Carbamidomethyl (+57.02) 655.3057 1,308.60 1,309.60 2
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% ScDIPVFMNAR 95.00% 2.66 0.446 0 c2: Carbamidomethyl (+57.02) 655.3062 1,308.60 1,309.60 2
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% SSNLIILEEHLK 95.00% 2.66 0.322 0 698.3949 1,394.77 1,395.78 2
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% SSNLIILEEHLK 95.00% 2.59 0.396 0 698.3952 1,394.77 1,395.78 2
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% cFEGFGIDGPAIAK 95.00% 4.42 0.592 6.06 c1: Carbamidomethyl (+57.02) 741.8583 1,481.70 1,481.71 2
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% AGEQVTYTcATYYK 95.00% 4.33 0.575 4.54 c9: Carbamidomethyl (+57.02) 827.8741 1,653.73 1,654.74 2
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% VSVLcQENYLIQEGEEITcKDGR 95.00% 3.83 0.435 1.85 c5: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 914.4351 2,740.28 2,740.29 3
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% DTScVNPPTVQNAYIVSR 95.00% 4.69 0.555 7.36 c4: Carbamidomethyl (+57.02) 1,011.49 2,020.97 2,020.98 2
 SAMPLE 1 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 14 10.10% DTScVNPPTVQNAYIVSR 95.00% 3.56 0.395 2.72 c4: Carbamidomethyl (+57.02) 1,011.49 2,020.97 2,020.98 2
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% SSNLIILEEHLK 95.00% 3.72 0.271 0 465.9326 1,394.77 1,395.78 3
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% SSNLIILEEHLK 95.00% 2.97 0.303 0 465.9331 1,394.78 1,395.78 3
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% IDVHLVPDR 95.00% 2.25 0.222 0 532.2985 1,062.58 1,063.59 2
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% SLGNVIMVcR 95.00% 1.96 0.361 0 c9: Carbamidomethyl (+57.02) 574.2835 1,146.55 1,148.59 2 ANK3_HUMAN
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% TGESVEFVcK 95.00% 2.44 0.393 0 c9: Carbamidomethyl (+57.02) 578.2702 1,154.52 1,155.54 2
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% cTSTGWIPAPR 95.00% 2.86 0.424 1.14 c1: Carbamidomethyl (+57.02) 623.3056 1,244.60 1,245.61 2
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% cTSTGWIPAPR 95.00% 2.65 0.364 2.47 c1: Carbamidomethyl (+57.02) 623.306 1,244.60 1,245.61 2
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% KGEWVALNPLR 95.00% 2.24 0.298 1.41 641.8675 1,281.72 1,282.73 2
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% KGEWVALNPLR 95.00% 2.83 0.361 1.54 641.8675 1,281.72 1,282.73 2
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% cFEGFGIDGPAIAK 95.00% 3.52 0.571 4.89 c1: Carbamidomethyl (+57.02) 741.357 1,480.70 1,481.71 2
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% cFEGFGIDGPAIAK 95.00% 4.27 0.58 5.96 c1: Carbamidomethyl (+57.02) 741.8595 1,481.70 1,481.71 2
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% SIDVAcHPGYALPK 95.00% 2.67 0.432 0 c6: Carbamidomethyl (+57.02) 764.3836 1,526.75 1,527.76 2
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% VSVLcQENYLIQEGEEITcKDGR 95.00% 3.64 0.351 0 c5: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 914.4364 2,740.29 2,740.29 3
 SAMPLE 1R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 10 10 14 10.70% EcDTDGWTNDIPIcEVVK 95.00% 3.96 0.578 2.24 c2: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,076.47 2,150.93 2,150.94 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% SSNLIILEEHLK 95.00% 3.67 0.348 0 465.9331 1,394.78 1,395.78 3
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% SSNLIILEEHLK 95.00% 4.04 0.405 1.96 465.9336 1,394.78 1,395.78 3
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% SLGNVIMVcR 95.00% 2.84 0.542 1.62 c9: Carbamidomethyl (+57.02) 574.7996 1,147.58 1,148.59 2 ANK3_HUMAN
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% TGESVEFVcK 95.00% 1.96 0.265 0 c9: Carbamidomethyl (+57.02) 578.2692 1,154.52 1,155.54 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% cLPVTAPENGK 95.00% 2.14 0.231 0 c1: Carbamidomethyl (+57.02) 593.299 1,184.58 1,185.59 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% cLPVTAPENGK 95.00% 2.13 0.251 0 c1: Carbamidomethyl (+57.02) 593.3012 1,184.59 1,185.59 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% cTSTGWIPAPR 95.00% 3.13 0.345 2.85 c1: Carbamidomethyl (+57.02) 623.304 1,244.59 1,245.61 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% cTSTGWIPAPR 95.00% 2.66 0.349 1.54 c1: Carbamidomethyl (+57.02) 623.3053 1,244.59 1,245.61 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% KGEWVALNPLR 95.00% 2.9 0.39 2.96 641.8672 1,281.72 1,282.73 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% ScDIPVFMNAR 95.00% 3.01 0.474 2.8 c2: Carbamidomethyl (+57.02) 655.3049 1,308.59 1,309.60 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% SPDVINGSPISQK 95.00% 2.83 0.352 0 671.3535 1,340.69 1,341.70 2 CALD1_HUMAN
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% SPDVINGSPISQK 95.00% 2.97 0.388 0 671.3541 1,340.69 1,341.70 2 CALD1_HUMAN
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% EIMENYNIALR 95.00% 2.62 0.449 1.48 683.3445 1,364.67 1,365.68 2 FHR1_HUMAN
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% EIMENYNIALR 95.00% 2.34 0.287 0 683.3454 1,364.68 1,365.68 2 FHR1_HUMAN
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% EIMENYNIALR 95.00% 2.96 0.334 2.35 683.8454 1,365.68 1,365.68 2 FHR1_HUMAN
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% SSNLIILEEHLK 95.00% 3.47 0.377 2.26 698.3964 1,394.78 1,395.78 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% cFEGFGIDGPAIAK 95.00% 4.09 0.603 4.82 c1: Carbamidomethyl (+57.02) 741.3573 1,480.70 1,481.71 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% WSSPPQcEGLPcK 95.00% 2.41 0.38 1.49 c7: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 773.3435 1,544.67 1,545.68 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% LGYVTADGETSGSITcGK 95.00% 2.34 0.324 2.19 c16: Carbamidomethyl (+57.02) 908.9305 1,815.85 1,815.84 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% AQTTVTcMENGWSPTPR 95.00% 3.78 0.56 4.96 c7: Carbamidomethyl (+57.02) 968.4378 1,934.86 1,935.87 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% AQTTVTcMENGWSPTPR 95.00% 5.07 0.595 5.43 c7: Carbamidomethyl (+57.02) 968.934 1,935.85 1,935.87 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% EQVQScGPPPELLNGNVK 95.00% 4.72 0.46 2.89 c6: Carbamidomethyl (+57.02) 983.9866 1,965.96 1,965.97 2
 SAMPLE 3 Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 14 15 21 16.10% DTScVNPPTVQNAYIVSR 95.00% 4.62 0.529 5.82 c4: Carbamidomethyl (+57.02) 1,011.49 2,020.97 2,020.98 2
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% SSNLIILEEHLK 95.00% 3.9 0.362 1.43 465.9324 1,394.77 1,395.78 3
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% SSNLIILEEHLK 95.00% 4.09 0.37 1.6 465.9337 1,394.78 1,395.78 3
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% SLGNVIMVcR 95.00% 2.57 0.505 0 c9: Carbamidomethyl (+57.02) 574.7985 1,147.58 1,148.59 2 ANK3_HUMAN
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% SLGNVIMVcR 95.00% 2.45 0.437 0 c9: Carbamidomethyl (+57.02) 574.7992 1,147.58 1,148.59 2 ANK3_HUMAN
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% TGESVEFVcK 95.00% 2.65 0.374 2.64 c9: Carbamidomethyl (+57.02) 578.7717 1,155.53 1,155.54 2
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% cTSTGWIPAPR 95.00% 2.71 0.313 2.7 c1: Carbamidomethyl (+57.02) 623.3048 1,244.59 1,245.61 2
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% cTSTGWIPAPR 95.00% 2.64 0.404 3.52 c1: Carbamidomethyl (+57.02) 623.308 1,244.60 1,245.61 2
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% ScDIPVFMNAR 95.00% 2.73 0.48 0 c2: Carbamidomethyl (+57.02) 655.3044 1,308.59 1,309.60 2
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% ScDIPVFMNAR 95.00% 2.49 0.375 0 c2: Carbamidomethyl (+57.02) 655.305 1,308.59 1,309.60 2
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% SPDVINGSPISQK 95.00% 2.51 0.252 0 671.3535 1,340.69 1,341.70 2 CALD1_HUMAN
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% SPDVINGSPISQK 95.00% 2.65 0.299 0 671.3539 1,340.69 1,341.70 2 CALD1_HUMAN
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% EIMENYNIALR 95.00% 2.12 0.166 1.82 683.3441 1,364.67 1,365.68 2 FHR1_HUMAN
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% EIMENYNIALR 95.00% 2.57 0.323 1.72 683.3447 1,364.67 1,365.68 2 FHR1_HUMAN
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% EIMENYNIALR 95.00% 2.35 0.257 0 683.346 1,364.68 1,365.68 2 FHR1_HUMAN
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% cFEGFGIDGPAIAK 95.00% 3.48 0.598 3.92 c1: Carbamidomethyl (+57.02) 741.3567 1,480.70 1,481.71 2
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% cFEGFGIDGPAIAK 95.00% 4.31 0.583 4.92 c1: Carbamidomethyl (+57.02) 741.3581 1,480.70 1,481.71 2
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% SITcIHGVWTQLPQcVAIDK 95.00% 3.98 0.286 1.42 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 776.3965 2,326.17 2,326.17 3
 SAMPLE 3R Complement factor H  CFH  CFAH_HUMAN 139,078.20 100.00% 9 9 16 10.60% DTScVNPPTVQNAYIVSR 95.00% 3.94 0.449 5.7 c4: Carbamidomethyl (+57.02) 1,011.49 2,020.96 2,020.98 2
 SAMPLE 3R Complement factor H-related protein 1  CFHR1  FHR1_HUMAN 37,632.40 100.00% 3 3 4 17.30% EIMENYNIALR 95.00% 2.12 0.166 1.82 683.3441 1,364.67 1,365.68 2 CFAH_HUMAN
 SAMPLE 3R Complement factor H-related protein 1  CFHR1  FHR1_HUMAN 37,632.40 100.00% 3 3 4 17.30% EIMENYNIALR 95.00% 2.57 0.323 1.72 683.3447 1,364.67 1,365.68 2 CFAH_HUMAN
 SAMPLE 3R Complement factor H-related protein 1  CFHR1  FHR1_HUMAN 37,632.40 100.00% 3 3 4 17.30% EIMENYNIALR 95.00% 2.35 0.257 0 683.346 1,364.68 1,365.68 2 CFAH_HUMAN
 SAMPLE 3R Complement factor H-related protein 1  CFHR1  FHR1_HUMAN 37,632.40 100.00% 3 3 4 17.30% STDTScVNPPTVQNAHILSR 95.00% 3.34 0.408 0 c6: Carbamidomethyl (+57.02) 733.3629 2,197.07 2,197.07 3
 SAMPLE 3R Complement factor H-related protein 1  CFHR1  FHR1_HUMAN 37,632.40 100.00% 3 3 4 17.30% ITcTEEGWSPTPK 95.00% 4.18 0.482 2.37 c3: Carbamidomethyl (+57.02) 753.3509 1,504.69 1,505.69 2
 SAMPLE 3R Complement factor H-related protein 1  CFHR1  FHR1_HUMAN 37,632.40 100.00% 3 3 4 17.30% ITcTEEGWSPTPK 95.00% 4.03 0.501 2.26 c3: Carbamidomethyl (+57.02) 753.3536 1,504.69 1,505.69 2
 SAMPLE 3R Complement factor H-related protein 1  CFHR1  FHR1_HUMAN 37,632.40 100.00% 3 3 4 17.30% LQNNENNIScVER 95.00% 3.14 0.415 2.25 c10: Carbamidomethyl (+57.02) 795.3712 1,588.73 1,589.73 2
 SAMPLE 1 Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 3 8.23% NADPILISLK 95.00% 1.54 0.295 1.51 542.3239 1,082.63 1,083.64 2
 SAMPLE 1 Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 3 8.23% VTWDSSFcAVNPR 95.00% 2.4 0.329 2.05 c8: Carbamidomethyl (+57.02) 769.8568 1,537.70 1,538.71 2
 SAMPLE 1 Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 3 8.23% AIFLADGNVFTTGFSR 95.00% 5.68 0.552 6.96 858.9422 1,715.87 1,715.88 2
 SAMPLE 1R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 4 8.23% NADPILISLK 95.00% 2.13 0.369 0 542.3228 1,082.63 1,083.64 2
 SAMPLE 1R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 4 8.23% VTWDSSFcAVNPR 95.00% 3.83 0.454 3.54 c8: Carbamidomethyl (+57.02) 770.3548 1,538.69 1,538.71 2
 SAMPLE 1R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 4 8.23% AIFLADGNVFTTGFSR 95.00% 5.5 0.575 7.29 858.4411 1,714.87 1,715.88 2
 SAMPLE 1R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 4 8.23% AIFLADGNVFTTGFSR 95.00% 5.46 0.505 8.06 858.94 1,715.86 1,715.88 2
 SAMPLE 2 Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 3 7.81% RGLDVNKcEIAR 95.00% 2.59 0.307 0 c8: Carbamidomethyl (+57.02) 477.5883 1,429.74 1,430.75 3
 SAMPLE 2 Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 3 7.81% QLALWNPK 95.00% 1.55 0.375 0 485.2791 968.5425 969.5523 2
 SAMPLE 2 Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 3 7.81% HVFGQAVKNDQcYDDIR 95.00% 2.25 0.317 0 c12: Carbamidomethyl (+57.02) 689.3272 2,064.96 2,064.96 3
 SAMPLE 2R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 5 8.44% VGIVAWHPTAR 95.00% 2.15 0.34 0 603.8445 1,205.67 1,206.67 2
 SAMPLE 2R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 5 8.44% VGIVAWHPTAR 95.00% 2.03 0.315 0 603.8455 1,205.68 1,206.67 2
 SAMPLE 2R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 5 8.44% VTWDSSFcAVNPR 95.00% 2.98 0.363 3.96 c8: Carbamidomethyl (+57.02) 770.3568 1,538.70 1,538.71 2
 SAMPLE 2R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 5 8.44% AIFLADGNVFTTGFSR 95.00% 5.56 0.491 7.02 858.9383 1,715.86 1,715.88 2
 SAMPLE 2R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 5 8.44% AIFLADGNVFTTGFSR 95.00% 5.62 0.509 5.62 858.9436 1,715.87 1,715.88 2
 SAMPLE 3 Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 99.80% 2 2 2 4.43% QLALWNPK 95.00% 1.71 0.293 0 485.2794 968.5431 969.5523 2
 SAMPLE 3 Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 99.80% 2 2 2 4.43% VTWDSSFcAVNPR 95.00% 2.88 0.518 3.55 c8: Carbamidomethyl (+57.02) 769.8567 1,537.70 1,538.71 2
 SAMPLE 3R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 4 8.23% NADPILISLK 95.00% 1.93 0.284 0 542.3233 1,082.63 1,083.64 2
 SAMPLE 3R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 4 8.23% VTWDSSFcAVNPR 95.00% 2.26 0.326 2.36 c8: Carbamidomethyl (+57.02) 769.8589 1,537.70 1,538.71 2
 SAMPLE 3R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 4 8.23% AIFLADGNVFTTGFSR 95.00% 4.4 0.258 1.39 858.4366 1,714.86 1,715.88 2
 SAMPLE 3R Coronin-1C  CORO1C  COR1C_HUMAN 53,232.30 100.00% 3 3 4 8.23% AIFLADGNVFTTGFSR 95.00% 5.33 0.557 7.72 858.4386 1,714.86 1,715.88 2
 SAMPLE 4R Creatine kinase B-type  CKB  KCRB_HUMAN 42,627.10 99.80% 2 2 4 11.00% TFLVWVNEEDHLR 95.00% 2.36 0.267 0 553.2844 1,656.83 1,657.83 3
 SAMPLE 4R Creatine kinase B-type  CKB  KCRB_HUMAN 42,627.10 99.80% 2 2 4 11.00% TFLVWVNEEDHLR 95.00% 2.85 0.349 0 553.6181 1,657.83 1,657.83 3
 SAMPLE 4R Creatine kinase B-type  CKB  KCRB_HUMAN 42,627.10 99.80% 2 2 4 11.00% FcTGLTQIETLFK 95.00% 3.44 0.56 6.28 c2: Carbamidomethyl (+57.02) 779.4091 1,556.80 1,557.80 2
 SAMPLE 4R Creatine kinase B-type  CKB  KCRB_HUMAN 42,627.10 99.80% 2 2 4 11.00% FcTGLTQIETLFK 95.00% 3.78 0.522 4.66 c2: Carbamidomethyl (+57.02) 779.9075 1,557.80 1,557.80 2
 SAMPLE 4R Creatine kinase B-type  CKB  KCRB_HUMAN 42,627.10 99.80% 2 2 4 11.00% LAVEALSSLDGDLAGR 95.00% 4.69 0.633 7.92 793.9261 1,585.84 1,586.84 2 TBA4A_HUMAN,TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Creatine kinase B-type  CKB  KCRB_HUMAN 42,627.10 99.80% 2 2 4 11.00% LAVEALSSLDGDLAGR 95.00% 4.97 0.601 5.96 793.9267 1,585.84 1,586.84 2 TBA4A_HUMAN,TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Creatine kinase B-type  CKB  KCRB_HUMAN 42,627.10 99.80% 2 2 4 11.00% LAVEALSSLDGDLAGR 95.00% 5.19 0.61 6.48 793.927 1,585.84 1,586.84 2 TBA4A_HUMAN,TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Creatine kinase B-type  CKB  KCRB_HUMAN 42,627.10 99.80% 2 2 4 11.00% LAVEALSSLDGDLAGR 95.00% 4.83 0.615 5.39 794.4297 1,586.84 1,586.84 2 TBA4A_HUMAN,TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% ScFLcMVcK 95.00% 2.41 0.209 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.7534 1,203.49 1,204.50 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% ScFLcMVcK 95.00% 2.23 0.261 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.7559 1,203.50 1,204.50 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GLESTTLADKDGEIYcK 95.00% 3.72 0.438 2.48 c16: Carbamidomethyl (+57.02) 633.9733 1,898.90 1,899.90 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GLESTTLADKDGEIYcK 95.00% 3.94 0.411 2.82 c16: Carbamidomethyl (+57.02) 633.9737 1,898.90 1,899.90 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GLESTTLADKDGEIYcK 95.00% 3.16 0.417 2.09 c16: Carbamidomethyl (+57.02) 633.9749 1,898.90 1,899.90 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GLESTTLADKDGEIYcK 95.00% 4.76 0.492 3.47 c16: Carbamidomethyl (+57.02) 634.3076 1,899.90 1,899.90 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GLESTTLADKDGEIYcK 95.00% 2.3 0.359 0 c16: Carbamidomethyl (+57.02) 634.311 1,899.91 1,899.90 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% TVYFAEEVQcEGNSFHK 95.00% 1.95 0.424 0 c10: Carbamidomethyl (+57.02) 682.6442 2,044.91 2,044.91 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% TVYFAEEVQcEGNSFHK 95.00% 1.6 0.349 1 c10: Carbamidomethyl (+57.02) 682.6446 2,044.91 2,044.91 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% KNLDSTTVAVHGEEIYcK 95.00% 4.99 0.527 4.59 c17: Carbamidomethyl (+57.02) 688.6758 2,063.00 2,064.01 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% KNLDSTTVAVHGEEIYcK 95.00% 5.21 0.549 4.57 c17: Carbamidomethyl (+57.02) 689.0105 2,064.01 2,064.01 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% KNLDSTTVAVHGEEIYcK 95.00% 2.91 0.371 1.85 c17: Carbamidomethyl (+57.02) 689.0131 2,064.02 2,064.01 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GFGFGQGAGALVHSE 95.00% 4.23 0.614 5.89 717.3452 1,432.67 1,433.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GFGFGQGAGALVHSE 95.00% 3.52 0.524 4.57 717.3454 1,432.68 1,433.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GFGFGQGAGALVHSE 95.00% 3.9 0.528 4.77 717.3456 1,432.68 1,433.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GFGFGQGAGALVHSE 95.00% 4.32 0.615 5.85 717.3456 1,432.68 1,433.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GFGFGQGAGALVHSE 95.00% 4.49 0.564 6.37 717.3461 1,432.68 1,433.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GFGFGQGAGALVHSE 95.00% 4.16 0.582 5.32 717.3463 1,432.68 1,433.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GFGFGQGAGALVHSE 95.00% 3.19 0.519 5.74 717.8479 1,433.68 1,433.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GYGYGQGAGTLSTDKGESLGIK 95.00% 3.01 0.493 1.85 720.6954 2,159.06 2,159.06 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GYGYGQGAGTLSTDKGESLGIK 95.00% 2.83 0.358 1.59 720.6957 2,159.06 2,159.06 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GYGYGQGAGTLSTDKGESLGIK 95.00% 3.02 0.493 2.68 720.6958 2,159.06 2,159.06 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GYGYGQGAGTLSTDKGESLGIK 95.00% 3.26 0.42 1.35 720.6962 2,159.07 2,159.06 3
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GYGYGQGAGTLSTDK 95.00% 4.35 0.645 7.16 737.8457 1,473.68 1,474.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GYGYGQGAGTLSTDK 95.00% 4.05 0.6 5 737.8457 1,473.68 1,474.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GYGYGQGAGTLSTDK 95.00% 3.1 0.531 1.57 737.8459 1,473.68 1,474.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GYGYGQGAGTLSTDK 95.00% 4.29 0.609 6.49 737.8459 1,473.68 1,474.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GYGYGQGAGTLSTDK 95.00% 4.52 0.644 5.89 737.8462 1,473.68 1,474.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GYGYGQGAGTLSTDK 95.00% 3.59 0.52 4.23 738.3401 1,474.66 1,474.68 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GLESTTLADKDGEIYcK 95.00% 5.02 0.561 5.19 c16: Carbamidomethyl (+57.02) 950.4552 1,898.89 1,899.90 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GLESTTLADKDGEIYcK 95.00% 5.01 0.59 4.66 c16: Carbamidomethyl (+57.02) 950.4554 1,898.90 1,899.90 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GLESTTLADKDGEIYcK 95.00% 4.68 0.574 5.68 c16: Carbamidomethyl (+57.02) 950.9522 1,899.89 1,899.90 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% NLDSTTVAVHGEEIYcK 95.00% 5.03 0.549 6 c16: Carbamidomethyl (+57.02) 968.4563 1,934.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% NLDSTTVAVHGEEIYcK 95.00% 5.46 0.619 7.04 c16: Carbamidomethyl (+57.02) 968.9626 1,935.91 1,935.91 2 UN13B_HUMAN
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% NLDSTTVAVHGEEIYcK 95.00% 5.37 0.615 5.6 c16: Carbamidomethyl (+57.02) 968.9634 1,935.91 1,935.91 2 UN13B_HUMAN
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% NLDSTTVAVHGEEIYcK 95.00% 5.4 0.596 6.26 c16: Carbamidomethyl (+57.02) 968.9644 1,935.91 1,935.91 2 UN13B_HUMAN
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% TVYFAEEVQcEGNSFHK 95.00% 2.21 0.351 0 c10: Carbamidomethyl (+57.02) 1,022.44 2,042.86 2,044.91 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% TVYFAEEVQcEGNSFHK 95.00% 5.7 0.611 6.66 c10: Carbamidomethyl (+57.02) 1,023.46 2,044.90 2,044.91 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% TVYFAEEVQcEGNSFHK 95.00% 5.36 0.614 6.68 c10: Carbamidomethyl (+57.02) 1,023.46 2,044.90 2,044.91 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% TVYFAEEVQcEGNSFHK 95.00% 5.67 0.611 5.54 c10: Carbamidomethyl (+57.02) 1,023.46 2,044.90 2,044.91 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% TVYFAEEVQcEGNSFHK 95.00% 5.48 0.611 5.41 c10: Carbamidomethyl (+57.02) 1,023.46 2,044.91 2,044.91 2
 SAMPLE 4 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 11 42 50.80% GYGYGQGAGTLSTDKGESLGIK 95.00% 5.15 0.595 5.41 1,080.54 2,159.06 2,159.06 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% ScFLcmVcK 95.00% 2.14 0.341 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), m6: Oxidation (+15.99), c8: Carbamidomethyl (+57.02)610.7502 1,219.48 1,220.49 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% ScFLcmVcK 95.00% 2.17 0.343 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), m6: Oxidation (+15.99), c8: Carbamidomethyl (+57.02)610 752 1,219.49 1,220.49 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GLESTTLADKDGEIYcK 95.00% 2.15 0.36 0 c16: Carbamidomethyl (+57.02) 633.9741 1,898.90 1,899.90 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GLESTTLADKDGEIYcK 95.00% 4.88 0.382 2.74 c16: Carbamidomethyl (+57.02) 634.3079 1,899.90 1,899.90 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GLESTTLADKDGEIYcK 95.00% 4.49 0.464 2.96 c16: Carbamidomethyl (+57.02) 634.3086 1,899.90 1,899.90 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GLESTTLADKDGEIYcK 95.00% 2.72 0.343 0 c16: Carbamidomethyl (+57.02) 634.3099 1,899.91 1,899.90 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% NLDSTTVAVHGEEIYcK 95.00% 1.95 0.304 0 c16: Carbamidomethyl (+57.02) 645.9785 1,934.91 1,935.91 3 UN13B_HUMAN
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% TVYFAEEVQcEGNSFHK 95.00% 1.68 0.363 0.959 c10: Carbamidomethyl (+57.02) 682.6431 2,044.91 2,044.91 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% TVYFAEEVQcEGNSFHK 95.00% 2.52 0.379 0 c10: Carbamidomethyl (+57.02) 682.6436 2,044.91 2,044.91 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% TVYFAEEVQcEGNSFHK 94.60% 1.71 0.266 0 c10: Carbamidomethyl (+57.02) 682.6437 2,044.91 2,044.91 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% KNLDSTTVAVHGEEIYcK 95.00% 5 0.48 4.4 c17: Carbamidomethyl (+57.02) 689.0092 2,064.00 2,064.01 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% KNLDSTTVAVHGEEIYcK 95.00% 4.92 0.518 3.52 c17: Carbamidomethyl (+57.02) 689.0119 2,064.01 2,064.01 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GFGFGQGAGALVHSE 95.00% 3.51 0.524 5.64 717.3449 1,432.67 1,433.68 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GFGFGQGAGALVHSE 95.00% 4.14 0.579 6 717.3461 1,432.68 1,433.68 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GFGFGQGAGALVHSE 95.00% 3.77 0.604 7 717.3462 1,432.68 1,433.68 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GFGFGQGAGALVHSE 95.00% 3.38 0.571 2.49 717.3464 1,432.68 1,433.68 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GFGFGQGAGALVHSE 95.00% 4.08 0.58 5.6 717.3474 1,432.68 1,433.68 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GFGFGQGAGALVHSE 95.00% 3.77 0.54 3.82 717.3476 1,432.68 1,433.68 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GFGFGQGAGALVHSE 95.00% 1.95 0.373 1.28 717.8477 1,433.68 1,433.68 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GFGFGQGAGALVHSE 95.00% 3.31 0.435 4.13 717.8484 1,433.68 1,433.68 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GYGYGQGAGTLSTDKGESLGIK 95.00% 3 0.459 2.96 720.6951 2,159.06 2,159.06 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GYGYGQGAGTLSTDKGESLGIK 95.00% 3.27 0.462 3.05 720.6964 2,159.07 2,159.06 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GYGYGQGAGTLSTDKGESLGIK 95.00% 2.78 0.427 2.89 720.6965 2,159.07 2,159.06 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GYGYGQGAGTLSTDKGESLGIK 95.00% 3.26 0.374 1.47 720.697 2,159.07 2,159.06 3
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GYGYGQGAGTLSTDK 95.00% 4.31 0.627 5.47 737.845 1,473.67 1,474.68 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GYGYGQGAGTLSTDK 95.00% 4.2 0.659 4.48 737.8462 1,473.68 1,474.68 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GYGYGQGAGTLSTDK 95.00% 4.69 0.649 7.21 737.8468 1,473.68 1,474.68 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GYGYGQGAGTLSTDK 95.00% 4.48 0.651 4.92 738.3486 1,474.68 1,474.68 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GLESTTLADKDGEIYcK 95.00% 4.92 0.581 6.55 c16: Carbamidomethyl (+57.02) 950.4564 1,898.90 1,899.90 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GLESTTLADKDGEIYcK 95.00% 4.94 0.575 6.51 c16: Carbamidomethyl (+57.02) 950.9552 1,899.89 1,899.90 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GLESTTLADKDGEIYcK 95.00% 4.86 0.568 4.92 c16: Carbamidomethyl (+57.02) 950.9585 1,899.90 1,899.90 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% NLDSTTVAVHGEEIYcK 95.00% 5.41 0.584 7.04 c16: Carbamidomethyl (+57.02) 968.4639 1,934.91 1,935.91 2 UN13B_HUMAN
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% NLDSTTVAVHGEEIYcK 95.00% 5.48 0.599 6.4 c16: Carbamidomethyl (+57.02) 968.9615 1,935.91 1,935.91 2 UN13B_HUMAN
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% NLDSTTVAVHGEEIYcK 95.00% 5.22 0.562 5.46 c16: Carbamidomethyl (+57.02) 968.9633 1,935.91 1,935.91 2 UN13B_HUMAN
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% NLDSTTVAVHGEEIYcK 95.00% 5.55 0.581 5.38 c16: Carbamidomethyl (+57.02) 968.964 1,935.91 1,935.91 2 UN13B_HUMAN
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% TVYFAEEVQcEGNSFHK 95.00% 5.4 0.646 6.72 c10: Carbamidomethyl (+57.02) 1,022.96 2,043.90 2,044.91 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% TVYFAEEVQcEGNSFHK 95.00% 5.63 0.597 5.01 c10: Carbamidomethyl (+57.02) 1,022.96 2,043.91 2,044.91 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% TVYFAEEVQcEGNSFHK 95.00% 5.42 0.615 5.6 c10: Carbamidomethyl (+57.02) 1,023.46 2,044.91 2,044.91 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% TVYFAEEVQcEGNSFHK 95.00% 5.64 0.623 5.05 c10: Carbamidomethyl (+57.02) 1,023.46 2,044.91 2,044.91 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GYGYGQGAGTLSTDKGESLGIK 95.00% 5.02 0.598 5.55 1,080.54 2,159.06 2,159.06 2
 SAMPLE 4R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 8 12 41 50.80% GYGYGQGAGTLSTDKGESLGIK 95.00% 4.98 0.627 5.85 1,080.54 2,159.06 2,159.06 2
 SAMPLE 1 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 99.80% 2 2 12 16.60% GLESTTLADKDGEIYcK 95.00% 2.69 0.323 0 c16: Carbamidomethyl (+57.02) 634.3053 1,899.89 1,899.90 3
 SAMPLE 1 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 99.80% 2 2 12 16.60% GFGFGQGAGALVHSE 95.00% 4.42 0.515 6.14 717.342 1,432.67 1,433.68 2
 SAMPLE 1 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 99.80% 2 2 12 16.60% GFGFGQGAGALVHSE 95.00% 3.83 0.612 5.46 717.3421 1,432.67 1,433.68 2
 SAMPLE 1 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 99.80% 2 2 12 16.60% GFGFGQGAGALVHSE 95.00% 2.97 0.342 0 717.3425 1,432.67 1,433.68 2
 SAMPLE 1 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 99.80% 2 2 12 16.60% GFGFGQGAGALVHSE 95.00% 3.5 0.553 3.57 717.3429 1,432.67 1,433.68 2
 SAMPLE 1 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 99.80% 2 2 12 16.60% GFGFGQGAGALVHSE 95.00% 4.18 0.563 5.85 717.3432 1,432.67 1,433.68 2
 SAMPLE 1 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 99.80% 2 2 12 16.60% GFGFGQGAGALVHSE 95.00% 3.3 0.544 2.85 717.3454 1,432.68 1,433.68 2
 SAMPLE 1 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 99.80% 2 2 12 16.60% GFGFGQGAGALVHSE 95.00% 2.3 0.374 0 717.3459 1,432.68 1,433.68 2
 SAMPLE 1 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 99.80% 2 2 12 16.60% GFGFGQGAGALVHSE 95.00% 3.5 0.484 1.7 717.3479 1,432.68 1,433.68 2
 SAMPLE 1 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 99.80% 2 2 12 16.60% GFGFGQGAGALVHSE 95.00% 3.8 0.589 3.6 717.3538 1,432.69 1,433.68 2
 SAMPLE 1 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 99.80% 2 2 12 16.60% GFGFGQGAGALVHSE 95.00% 3.8 0.557 4.06 717.3543 1,432.69 1,433.68 2
 SAMPLE 1 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 99.80% 2 2 12 16.60% GFGFGQGAGALVHSE 95.00% 3.24 0.119 1.7 717.4352 1,432.85 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% ScFLcMVcK 95.00% 3.09 0.446 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.7619 1,203.51 1,204.50 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GLESTTLADKDGEIYcK 95.00% 2.69 0.323 0 c16: Carbamidomethyl (+57.02) 634.3053 1,899.89 1,899.90 3
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% TVYFAEEVQcEGNSFHK 95.00% 1.81 0.455 0 c10: Carbamidomethyl (+57.02) 682.6534 2,044.94 2,044.91 3
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GFGFGQGAGALVHSE 95.00% 2.74 0.374 1.57 717.341 1,432.67 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GFGFGQGAGALVHSE 95.00% 3.64 0.565 4.17 717.3435 1,432.67 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GFGFGQGAGALVHSE 95.00% 3.87 0.516 5.4 717.3437 1,432.67 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GFGFGQGAGALVHSE 95.00% 2.66 0.289 0 717.3469 1,432.68 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GFGFGQGAGALVHSE 95.00% 3.5 0.484 1.37 717.3479 1,432.68 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GFGFGQGAGALVHSE 95.00% 3.8 0.589 3.37 717.3538 1,432.69 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GFGFGQGAGALVHSE 95.00% 3.8 0.557 4.11 717.3543 1,432.69 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GFGFGQGAGALVHSE 95.00% 3.8 0.473 3.96 717.3544 1,432.69 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GFGFGQGAGALVHSE 95.00% 4.16 0.626 5.15 717.3556 1,432.70 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GFGFGQGAGALVHSE 95.00% 3.12 0.453 2.4 717.3567 1,432.70 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GFGFGQGAGALVHSE 95.00% 2.56 0.359 0 717.3569 1,432.70 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% GFGFGQGAGALVHSE 95.00% 3.05 0.195 2.28 717.8559 1,433.70 1,433.68 2
 SAMPLE 1R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 4 5 16 30.10% TVYFAEEVQcEGNSFHK 95.00% 5.53 0.623 4.77 c10: Carbamidomethyl (+57.02) 1,023.47 2,044.93 2,044.91 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% cSQAVYAAEK 95.00% 3.49 0.392 1.96 c1: Carbamidomethyl (+57.02) 563.7652 1,125.51 1,126.52 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% cSQAVYAAEK 95.00% 3.04 0.324 1.77 c1: Carbamidomethyl (+57.02) 563.7661 1,125.52 1,126.52 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% ScFLcMVcK 95.00% 2.8 0.363 1.51 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.7512 1,203.49 1,204.50 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% ScFLcMVcK 95.00% 3.24 0.46 1.59 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.7516 1,203.49 1,204.50 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% ScFLcMVcK 95.00% 2.83 0.36 1.49 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.7525 1,203.49 1,204.50 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% ScFLcMVcK 95.00% 3.02 0.409 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.753 1,203.49 1,204.50 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GLESTTLADKDGEIYcK 95.00% 4.19 0.43 4.16 c16: Carbamidomethyl (+57.02) 633.971 1,898.89 1,899.90 3
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GLESTTLADKDGEIYcK 95.00% 4.65 0.418 4.62 c16: Carbamidomethyl (+57.02) 634.3053 1,899.89 1,899.90 3
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GLESTTLADKDGEIYcK 95.00% 3.39 0.45 1.92 c16: Carbamidomethyl (+57.02) 634.3065 1,899.90 1,899.90 3
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% NLDSTTVAVHGEEIYcK 95.00% 2.25 0.286 0.959 c16: Carbamidomethyl (+57.02) 646.3088 1,935.90 1,935.91 3 UN13B_HUMAN
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% NLDSTTVAVHGEEIYcK 95.00% 2.5 0.36 1.14 c16: Carbamidomethyl (+57.02) 646.3093 1,935.90 1,935.91 3 UN13B_HUMAN
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% TVYFAEEVQcEGNSFHK 95.00% 1.67 0.328 0 c10: Carbamidomethyl (+57.02) 682.6409 2,044.90 2,044.91 3
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.51 0.546 5.6 c17: Carbamidomethyl (+57.02) 689.0068 2,064.00 2,064.01 3
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% KNLDSTTVAVHGEEIYcK 95.00% 4.7 0.475 6 c17: Carbamidomethyl (+57.02) 689.0074 2,064.00 2,064.01 3
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GFGFGQGAGALVHSE 95.00% 4.22 0.535 5.89 717.3417 1,432.67 1,433.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GFGFGQGAGALVHSE 95.00% 3.77 0.499 5.59 717.342 1,432.67 1,433.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GFGFGQGAGALVHSE 95.00% 3.72 0.499 2.37 717.3424 1,432.67 1,433.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GFGFGQGAGALVHSE 95.00% 4.07 0.557 5.32 717.3424 1,432.67 1,433.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GFGFGQGAGALVHSE 95.00% 4.72 0.541 5.8 717.3428 1,432.67 1,433.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GFGFGQGAGALVHSE 95.00% 4.18 0.608 5.36 717.3428 1,432.67 1,433.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GFGFGQGAGALVHSE 95.00% 3.74 0.537 4.07 717.343 1,432.67 1,433.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GFGFGQGAGALVHSE 95.00% 4.21 0.614 5.92 717.343 1,432.67 1,433.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GFGFGQGAGALVHSE 95.00% 4.32 0.55 6.19 717.3431 1,432.67 1,433.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GFGFGQGAGALVHSE 95.00% 3.74 0.602 6.24 717.344 1,432.67 1,433.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GFGFGQGAGALVHSE 95.00% 2.34 0.405 0 717.3443 1,432.67 1,433.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 3.23 0.488 2.21 720.692 2,159.05 2,159.06 3
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 3.52 0.456 2 720.6922 2,159.05 2,159.06 3
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GYGYGQGAGTLSTDK 95.00% 3.88 0.622 3.34 737.8411 1,473.67 1,474.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GYGYGQGAGTLSTDK 95.00% 3.89 0.611 2.59 737.8422 1,473.67 1,474.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GYGYGQGAGTLSTDK 95.00% 4.99 0.609 5.29 737.8423 1,473.67 1,474.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GYGYGQGAGTLSTDK 95.00% 4.58 0.666 5.68 737.8429 1,473.67 1,474.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GYGYGQGAGTLSTDK 95.00% 4.59 0.633 5.85 737.8429 1,473.67 1,474.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GYGYGQGAGTLSTDK 95.00% 4.08 0.61 4.21 737.8437 1,473.67 1,474.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GYGYGQGAGTLSTDK 95.00% 3.7 0.625 5.22 737.8448 1,473.67 1,474.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GYGYGQGAGTLSTDK 95.00% 3.65 0.494 4.68 737.8449 1,473.67 1,474.68 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% cSQAVYAAEKVIGAGK 95.00% 3.66 0.514 3.92 c1: Carbamidomethyl (+57.02) 826.4284 1,650.84 1,651.85 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GLESTTLADKDGEIYcKGcYAK 95.00% 5.07 0.231 3.49 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 827.3877 2,479.14 2,479.15 3
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GLESTTLADKDGEIYcKGcYAK 95.00% 5.85 0.436 4.89 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 827.3881 2,479.14 2,479.15 3
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GESLGIKHEEAPGHRPTTNPNASK 95.00% 3.61 0.477 1.55 843.4311 2,527.27 2,527.27 3
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GESLGIKHEEAPGHRPTTNPNASK 95.00% 3.05 0.402 0 843.4319 2,527.27 2,527.27 3
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GLESTTLADKDGEIYcK 95.00% 5.25 0.555 5.3 c16: Carbamidomethyl (+57.02) 950.9532 1,899.89 1,899.90 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GLESTTLADKDGEIYcK 95.00% 5.08 0.566 4.17 c16: Carbamidomethyl (+57.02) 950.9537 1,899.89 1,899.90 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GLESTTLADKDGEIYcK 95.00% 5.38 0.563 4.06 c16: Carbamidomethyl (+57.02) 950.9538 1,899.89 1,899.90 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GLESTTLADKDGEIYcK 95.00% 4.57 0.561 4.7 c16: Carbamidomethyl (+57.02) 950.9548 1,899.89 1,899.90 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GLESTTLADKDGEIYcK 95.00% 5.28 0.575 3.4 c16: Carbamidomethyl (+57.02) 950.9552 1,899.89 1,899.90 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.96 0.58 8.3 c16: Carbamidomethyl (+57.02) 968.4569 1,934.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.62 0.589 7.43 c16: Carbamidomethyl (+57.02) 968.4593 1,934.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.09 0.558 5.89 c16: Carbamidomethyl (+57.02) 968.956 1,935.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.5 0.624 8.54 c16: Carbamidomethyl (+57.02) 968.9581 1,935.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.94 0.61 8.68 c16: Carbamidomethyl (+57.02) 968.9596 1,935.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% TVYFAEEVQcEGNSFHK 95.00% 3.17 0.482 0 c10: Carbamidomethyl (+57.02) 1,022.43 2,042.85 2,044.91 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% TVYFAEEVQcEGNSFHK 95.00% 3.57 0.507 1.49 c10: Carbamidomethyl (+57.02) 1,022.43 2,042.85 2,044.91 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% TVYFAEEVQcEGNSFHK 95.00% 5.98 0.646 7.35 c10: Carbamidomethyl (+57.02) 1,022.95 2,043.89 2,044.91 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% TVYFAEEVQcEGNSFHK 95.00% 5.5 0.616 4.89 c10: Carbamidomethyl (+57.02) 1,022.95 2,043.89 2,044.91 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.6 0.556 9.3 c17: Carbamidomethyl (+57.02) 1,032.50 2,062.99 2,064.01 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.45 0.589 8.66 c17: Carbamidomethyl (+57.02) 1,033.00 2,063.99 2,064.01 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 4.99 0.656 3.62 1,080.53 2,159.05 2,159.06 2
 SAMPLE 2 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 58 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 5.08 0.596 4.03 1,080.53 2,159.05 2,159.06 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% cSQAVYAAEK 95.00% 2.87 0.445 1.66 c1: Carbamidomethyl (+57.02) 563.7646 1,125.51 1,126.52 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% cSQAVYAAEK 95.00% 3.23 0.415 2.07 c1: Carbamidomethyl (+57.02) 563.7653 1,125.52 1,126.52 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% cSQAVYAAEK 95.00% 2.04 0.317 0 c1: Carbamidomethyl (+57.02) 563.7655 1,125.52 1,126.52 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% ScFLcMVcK 95.00% 2.71 0.364 1.46 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.753 1,203.49 1,204.50 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GLESTTLADKDGEIYcK 95.00% 3.57 0.508 3.6 c16: Carbamidomethyl (+57.02) 633.9714 1,898.89 1,899.90 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GLESTTLADKDGEIYcK 95.00% 4.45 0.452 3.55 c16: Carbamidomethyl (+57.02) 633.9714 1,898.89 1,899.90 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GLESTTLADKDGEIYcK 95.00% 3.34 0.487 2.52 c16: Carbamidomethyl (+57.02) 634.3044 1,899.89 1,899.90 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GLESTTLADKDGEIYcK 95.00% 3.42 0.38 1.27 c16: Carbamidomethyl (+57.02) 634.3048 1,899.89 1,899.90 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GLESTTLADKDGEIYcK 95.00% 2.83 0.303 1.82 c16: Carbamidomethyl (+57.02) 634.3061 1,899.89 1,899.90 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% NLDSTTVAVHGEEIYcK 95.00% 2.4 0.298 0 c16: Carbamidomethyl (+57.02) 645.9752 1,934.90 1,935.91 3 UN13B_HUMAN
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% NLDSTTVAVHGEEIYcK 95.00% 1.91 0.331 0 c16: Carbamidomethyl (+57.02) 645.9752 1,934.90 1,935.91 3 UN13B_HUMAN
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% TVYFAEEVQcEGNSFHK 95.00% 1.8 0.292 0 c10: Carbamidomethyl (+57.02) 682.6401 2,044.90 2,044.91 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% TVYFAEEVQcEGNSFHK 95.00% 1.87 0.405 1.23 c10: Carbamidomethyl (+57.02) 682.6407 2,044.90 2,044.91 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.08 0.506 4.34 c17: Carbamidomethyl (+57.02) 688.6724 2,062.99 2,064.01 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% KNLDSTTVAVHGEEIYcK 95.00% 4.82 0.503 4.59 c17: Carbamidomethyl (+57.02) 689.0077 2,064.00 2,064.01 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GFGFGQGAGALVHSE 95.00% 3.95 0.416 2.39 717.3409 1,432.67 1,433.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GFGFGQGAGALVHSE 95.00% 4.07 0.599 6.3 717.3416 1,432.67 1,433.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GFGFGQGAGALVHSE 95.00% 4.28 0.592 8.08 717.342 1,432.67 1,433.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GFGFGQGAGALVHSE 95.00% 3.48 0.367 2.62 717.3421 1,432.67 1,433.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GFGFGQGAGALVHSE 95.00% 3.75 0.44 1.82 717.3422 1,432.67 1,433.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GFGFGQGAGALVHSE 95.00% 3.61 0.518 4.23 717.3423 1,432.67 1,433.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GFGFGQGAGALVHSE 95.00% 4.22 0.573 6.57 717.3424 1,432.67 1,433.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GFGFGQGAGALVHSE 95.00% 4.19 0.48 2.96 717.3425 1,432.67 1,433.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GFGFGQGAGALVHSE 95.00% 3.99 0.52 5.14 717.3428 1,432.67 1,433.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GFGFGQGAGALVHSE 95.00% 3.96 0.498 4.51 717.343 1,432.67 1,433.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GFGFGQGAGALVHSE 95.00% 3.33 0.521 2.27 717.3435 1,432.67 1,433.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GFGFGQGAGALVHSE 95.00% 3.81 0.521 4.48 717.3435 1,432.67 1,433.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 1.81 0.259 1.49 720.3577 2,158.05 2,159.06 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 3.2 0.519 3.17 720.6913 2,159.05 2,159.06 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 2.74 0.445 2.36 720.6929 2,159.06 2,159.06 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDK 95.00% 3.56 0.481 5.77 737.8415 1,473.67 1,474.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDK 95.00% 3.11 0.532 3.27 737.8421 1,473.67 1,474.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDK 95.00% 4.41 0.596 5.68 737.8423 1,473.67 1,474.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDK 95.00% 4.29 0.642 6.57 737.8426 1,473.67 1,474.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDK 95.00% 3.71 0.549 3.85 737.8426 1,473.67 1,474.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDK 95.00% 3.9 0.569 4.23 737.8432 1,473.67 1,474.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDK 95.00% 4.67 0.632 3.44 737.8434 1,473.67 1,474.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDK 95.00% 3.85 0.618 1.77 737.844 1,473.67 1,474.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDK 95.00% 4.23 0.598 4.32 737.8441 1,473.67 1,474.68 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% cSQAVYAAEKVIGAGK 95.00% 5.02 0.51 5.06 c1: Carbamidomethyl (+57.02) 826.4266 1,650.84 1,651.85 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% cSQAVYAAEKVIGAGK 95.00% 4.74 0.476 3.51 c1: Carbamidomethyl (+57.02) 826.4267 1,650.84 1,651.85 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GLESTTLADKDGEIYcKGcYAK 95.00% 5.95 0.378 3 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 827.3885 2,479.14 2,479.15 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GESLGIKHEEAPGHRPTTNPNASK 95.00% 3.59 0.467 0 843.4308 2,527.27 2,527.27 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GESLGIKHEEAPGHRPTTNPNASK 95.00% 3.32 0.439 0 843.4331 2,527.28 2,527.27 3
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GLESTTLADKDGEIYcK 95.00% 4.89 0.6 7.26 c16: Carbamidomethyl (+57.02) 950.4507 1,898.89 1,899.90 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GLESTTLADKDGEIYcK 95.00% 5.15 0.565 5.7 c16: Carbamidomethyl (+57.02) 950.4511 1,898.89 1,899.90 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GLESTTLADKDGEIYcK 95.00% 5.21 0.596 8.92 c16: Carbamidomethyl (+57.02) 950.4518 1,898.89 1,899.90 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GLESTTLADKDGEIYcK 95.00% 5.05 0.564 5.66 c16: Carbamidomethyl (+57.02) 950.4518 1,898.89 1,899.90 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GLESTTLADKDGEIYcK 95.00% 4.34 0.551 5.16 c16: Carbamidomethyl (+57.02) 950.4547 1,898.89 1,899.90 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.53 0.61 8.52 c16: Carbamidomethyl (+57.02) 968.4559 1,934.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.52 0.616 7.92 c16: Carbamidomethyl (+57.02) 968.4566 1,934.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.69 0.587 6.11 c16: Carbamidomethyl (+57.02) 968.9596 1,935.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.78 0.614 7.96 c16: Carbamidomethyl (+57.02) 968.9606 1,935.91 1,935.91 2 UN13B_HUMAN
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% TVYFAEEVQcEGNSFHK 95.00% 3.63 0.328 2.44 c10: Carbamidomethyl (+57.02) 1,022.43 2,042.85 2,044.91 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% TVYFAEEVQcEGNSFHK 95.00% 2.8 0.385 0 c10: Carbamidomethyl (+57.02) 1,022.44 2,042.86 2,044.91 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% TVYFAEEVQcEGNSFHK 95.00% 4.94 0.634 5.85 c10: Carbamidomethyl (+57.02) 1,022.44 2,042.86 2,044.91 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% TVYFAEEVQcEGNSFHK 95.00% 5.61 0.61 7.13 c10: Carbamidomethyl (+57.02) 1,022.95 2,043.89 2,044.91 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% TVYFAEEVQcEGNSFHK 95.00% 5.73 0.618 5.07 c10: Carbamidomethyl (+57.02) 1,023.45 2,044.89 2,044.91 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.25 0.542 6.82 c17: Carbamidomethyl (+57.02) 1,033.01 2,064.00 2,064.01 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 5 0.591 6.02 1,080.53 2,159.05 2,159.06 2
 SAMPLE 2R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 17 61 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 4.92 0.614 4.77 1,080.53 2,159.05 2,159.06 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% cSQAVYAAEKVIGAGK 95.00% 4.18 0.502 0 c1: Carbamidomethyl (+57.02) 551.2858 1,650.83 1,651.85 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% cSQAVYAAEKVIGAGK 95.00% 4.14 0.537 1.38 c1: Carbamidomethyl (+57.02) 551.287 1,650.84 1,651.85 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% cSQAVYAAEK 95.00% 3.04 0.391 2.7 c1: Carbamidomethyl (+57.02) 563.7646 1,125.51 1,126.52 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% ScFLcMVcK 95.00% 3.32 0.439 2 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.7512 1,203.49 1,204.50 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% ScFLcMVcK 95.00% 3.1 0.437 2.12 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.7523 1,203.49 1,204.50 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GLESTTLADKDGEIYcK 95.00% 5.38 0.528 4.46 c16: Carbamidomethyl (+57.02) 633.9699 1,898.89 1,899.90 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GLESTTLADKDGEIYcK 95.00% 3.98 0.43 4.25 c16: Carbamidomethyl (+57.02) 633.9714 1,898.89 1,899.90 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GLESTTLADKDGEIYcK 95.00% 2.86 0.468 0 c16: Carbamidomethyl (+57.02) 634.3055 1,899.89 1,899.90 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GLESTTLADKDGEIYcK 95.00% 3.98 0.321 3.4 c16: Carbamidomethyl (+57.02) 634.3055 1,899.89 1,899.90 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GLESTTLADKDGEIYcK 95.00% 3.53 0.343 2.28 c16: Carbamidomethyl (+57.02) 634.3072 1,899.90 1,899.90 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.52 0.573 5.37 c17: Carbamidomethyl (+57.02) 688.6732 2,063.00 2,064.01 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.32 0.52 4.03 c17: Carbamidomethyl (+57.02) 688.6737 2,063.00 2,064.01 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.5 0.469 4.8 c17: Carbamidomethyl (+57.02) 689.0074 2,064.00 2,064.01 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% KNLDSTTVAVHGEEIYcK 95.00% 4.99 0.48 5.43 c17: Carbamidomethyl (+57.02) 689.0077 2,064.00 2,064.01 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GFGFGQGAGALVHSE 95.00% 4.23 0.619 3.48 717.3409 1,432.67 1,433.68 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GFGFGQGAGALVHSE 95.00% 3.42 0.448 2.52 717.3415 1,432.67 1,433.68 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GFGFGQGAGALVHSE 95.00% 3.97 0.591 5.18 717.3424 1,432.67 1,433.68 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GFGFGQGAGALVHSE 95.00% 4.46 0.605 4.68 717.3424 1,432.67 1,433.68 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GFGFGQGAGALVHSE 95.00% 4.33 0.482 3.8 717.3427 1,432.67 1,433.68 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GFGFGQGAGALVHSE 95.00% 3.99 0.582 3.72 717.343 1,432.67 1,433.68 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GFGFGQGAGALVHSE 95.00% 3.62 0.516 4.24 717.3438 1,432.67 1,433.68 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GFGFGQGAGALVHSE 95.00% 4.47 0.536 3.4 717.8457 1,433.68 1,433.68 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 3 0.474 3.26 720.6916 2,159.05 2,159.06 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 3.09 0.458 2.05 720.6921 2,159.05 2,159.06 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 3.02 0.414 2.08 720.6927 2,159.05 2,159.06 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 2.69 0.457 2.8 720.693 2,159.06 2,159.06 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GYGYGQGAGTLSTDK 95.00% 4.45 0.637 7.8 737.8438 1,473.67 1,474.68 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GLESTTLADKDGEIYcKGcYAK 95.00% 5.47 0.509 4.92 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 827.3871 2,479.14 2,479.15 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GLESTTLADKDGEIYcKGcYAK 95.00% 5.23 0.461 3.82 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 827.3878 2,479.14 2,479.15 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GESLGIKHEEAPGHRPTTNPNASK 95.00% 5.05 0.518 1.17 843.4302 2,527.27 2,527.27 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GESLGIKHEEAPGHRPTTNPNASK 95.00% 3.74 0.472 1.14 843.4333 2,527.28 2,527.27 3
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GLESTTLADKDGEIYcK 95.00% 5.08 0.55 4.82 c16: Carbamidomethyl (+57.02) 950.4516 1,898.89 1,899.90 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GLESTTLADKDGEIYcK 95.00% 4.97 0.551 4.12 c16: Carbamidomethyl (+57.02) 950.4518 1,898.89 1,899.90 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GLESTTLADKDGEIYcK 95.00% 5.28 0.588 3.72 c16: Carbamidomethyl (+57.02) 950.4527 1,898.89 1,899.90 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GLESTTLADKDGEIYcK 95.00% 5.05 0.548 4.32 c16: Carbamidomethyl (+57.02) 950.9541 1,899.89 1,899.90 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.83 0.6 7.82 c16: Carbamidomethyl (+57.02) 968.456 1,934.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.74 0.589 5.68 c16: Carbamidomethyl (+57.02) 968.4563 1,934.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.47 0.62 7.68 c16: Carbamidomethyl (+57.02) 968.4568 1,934.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% NLDSTTVAVHGEEIYcK 95.00% 4.43 0.552 5.68 c16: Carbamidomethyl (+57.02) 968.9546 1,935.89 1,935.91 2 UN13B_HUMAN
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% NLDSTTVAVHGEEIYcK 95.00% 4.88 0.596 8.7 c16: Carbamidomethyl (+57.02) 968.9596 1,935.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.72 0.592 7.77 c16: Carbamidomethyl (+57.02) 968.9601 1,935.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% TVYFAEEVQcEGNSFHK 95.00% 2.64 0.391 1.59 c10: Carbamidomethyl (+57.02) 1,022.43 2,042.85 2,044.91 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% TVYFAEEVQcEGNSFHK 95.00% 3.33 0.52 1.89 c10: Carbamidomethyl (+57.02) 1,022.44 2,042.85 2,044.91 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% TVYFAEEVQcEGNSFHK 95.00% 4.24 0.594 1.49 c10: Carbamidomethyl (+57.02) 1,022.44 2,042.85 2,044.91 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% TVYFAEEVQcEGNSFHK 95.00% 4.08 0.575 1.64 c10: Carbamidomethyl (+57.02) 1,022.44 2,042.86 2,044.91 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% TVYFAEEVQcEGNSFHK 95.00% 5.6 0.611 4.52 c10: Carbamidomethyl (+57.02) 1,022.95 2,043.89 2,044.91 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% TVYFAEEVQcEGNSFHK 95.00% 5.39 0.612 4.36 c10: Carbamidomethyl (+57.02) 1,023.46 2,044.90 2,044.91 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.62 0.587 9.07 c17: Carbamidomethyl (+57.02) 1,032.50 2,062.99 2,064.01 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.56 0.562 8.6 c17: Carbamidomethyl (+57.02) 1,033.01 2,064.00 2,064.01 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 5.19 0.596 5.68 1,080.53 2,159.05 2,159.06 2
 SAMPLE 3 Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 15 51 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 5.17 0.622 6 1,080.53 2,159.05 2,159.06 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% cSQAVYAAEKVIGAGK 95.00% 3.65 0.566 0 c1: Carbamidomethyl (+57.02) 551.2861 1,650.83 1,651.85 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% cSQAVYAAEKVIGAGK 95.00% 4.37 0.491 0 c1: Carbamidomethyl (+57.02) 551.2863 1,650.84 1,651.85 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% cSQAVYAAEK 95.00% 1.89 0.304 0 c1: Carbamidomethyl (+57.02) 563.6324 1,125.25 1,126.52 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% cSQAVYAAEK 95.00% 3.09 0.374 1.33 c1: Carbamidomethyl (+57.02) 563.7647 1,125.51 1,126.52 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% ScFLcMVcK 95.00% 3.56 0.504 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.7513 1,203.49 1,204.50 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% ScFLcMVcK 95.00% 3.08 0.395 1.1 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.7516 1,203.49 1,204.50 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% ScFLcMVcK 95.00% 2.98 0.455 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.7517 1,203.49 1,204.50 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% ScFLcMVcK 95.00% 2.68 0.331 1.46 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 602.7522 1,203.49 1,204.50 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% ScFLcmVcK 95.00% 2.79 0.44 1.57 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), m6: Oxidation (+15.99), c8: Carbamidomethyl (+57.02)610.7497 1,219.48 1,220.49 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% ScFLcmVcK 95.00% 2.49 0.34 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), m6: Oxidation (+15.99), c8: Carbamidomethyl (+57.02)610.7498 1,219.48 1,220.49 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GLESTTLADKDGEIYcK 95.00% 3.21 0.399 1.8 c16: Carbamidomethyl (+57.02) 633.9705 1,898.89 1,899.90 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GLESTTLADKDGEIYcK 95.00% 3.25 0.51 3.15 c16: Carbamidomethyl (+57.02) 633.9708 1,898.89 1,899.90 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GLESTTLADKDGEIYcK 95.00% 4.02 0.557 2.44 c16: Carbamidomethyl (+57.02) 633.9713 1,898.89 1,899.90 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GLESTTLADKDGEIYcK 95.00% 3.61 0.399 2.77 c16: Carbamidomethyl (+57.02) 633.9716 1,898.89 1,899.90 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% NLDSTTVAVHGEEIYcK 95.00% 2.83 0.404 1.12 c16: Carbamidomethyl (+57.02) 645.9764 1,934.91 1,935.91 3 UN13B_HUMAN
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% NLDSTTVAVHGEEIYcK 95.00% 2.45 0.403 0 c16: Carbamidomethyl (+57.02) 646.307 1,935.90 1,935.91 3 UN13B_HUMAN
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% TVYFAEEVQcEGNSFHK 95.00% 2.14 0.385 0 c10: Carbamidomethyl (+57.02) 682.641 2,044.90 2,044.91 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.43 0.499 4.92 c17: Carbamidomethyl (+57.02) 689.0067 2,064.00 2,064.01 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.79 0.498 5.92 c17: Carbamidomethyl (+57.02) 689.007 2,064.00 2,064.01 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% KNLDSTTVAVHGEEIYcK 95.00% 4.84 0.551 4 c17: Carbamidomethyl (+57.02) 689.0076 2,064.00 2,064.01 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.01 0.533 4.37 c17: Carbamidomethyl (+57.02) 689.0083 2,064.00 2,064.01 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GFGFGQGAGALVHSE 95.00% 2.74 0.406 2.46 717.3409 1,432.67 1,433.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GFGFGQGAGALVHSE 95.00% 3.98 0.495 5.48 717.3422 1,432.67 1,433.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GFGFGQGAGALVHSE 95.00% 3.88 0.536 4.8 717.3429 1,432.67 1,433.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GFGFGQGAGALVHSE 95.00% 2.74 0.187 0 717.3429 1,432.67 1,433.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GFGFGQGAGALVHSE 95.00% 4.08 0.588 5.26 717.343 1,432.67 1,433.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GFGFGQGAGALVHSE 95.00% 2.47 0.279 0 717.3431 1,432.67 1,433.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GFGFGQGAGALVHSE 95.00% 4.05 0.551 5.09 717.3433 1,432.67 1,433.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GFGFGQGAGALVHSE 95.00% 4.02 0.56 6.26 717.3434 1,432.67 1,433.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GFGFGQGAGALVHSE 95.00% 2.07 0.444 1.09 717.3438 1,432.67 1,433.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GFGFGQGAGALVHSE 95.00% 3.46 0.507 3.41 717.3438 1,432.67 1,433.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GFGFGQGAGALVHSE 95.00% 2.88 0.347 0 717.344 1,432.67 1,433.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GFGFGQGAGALVHSE 95.00% 4.1 0.527 3.57 717.3444 1,432.67 1,433.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 3.79 0.417 2.77 720.6913 2,159.05 2,159.06 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 2.95 0.413 2.17 720.693 2,159.06 2,159.06 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GYGYGQGAGTLSTDK 95.00% 4 0.558 3.14 737.8408 1,473.67 1,474.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GYGYGQGAGTLSTDK 95.00% 4.5 0.583 6.55 737.844 1,473.67 1,474.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GYGYGQGAGTLSTDK 95.00% 4.31 0.583 6.48 737.8448 1,473.67 1,474.68 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% cSQAVYAAEKVIGAGK 95.00% 4.62 0.454 6.17 c1: Carbamidomethyl (+57.02) 826.4253 1,650.83 1,651.85 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GLESTTLADKDGEIYcKGcYAK 95.00% 5.44 0.385 2.82 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 827.3862 2,479.14 2,479.15 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GLESTTLADKDGEIYcKGcYAK 95.00% 5.17 0.337 4 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 827.3889 2,479.14 2,479.15 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GESLGIKHEEAPGHRPTTNPNASK 95.00% 3.63 0.331 0 843.424 2,527.25 2,527.27 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GESLGIKHEEAPGHRPTTNPNASK 95.00% 3.67 0.448 0 843.4264 2,527.26 2,527.27 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GESLGIKHEEAPGHRPTTNPNASK 95.00% 3.97 0.481 1.74 843.4296 2,527.27 2,527.27 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GESLGIKHEEAPGHRPTTNPNASK 95.00% 3.88 0.465 2.59 843.4305 2,527.27 2,527.27 3
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GLESTTLADKDGEIYcK 95.00% 5.05 0.528 3.28 c16: Carbamidomethyl (+57.02) 950.9505 1,899.89 1,899.90 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GLESTTLADKDGEIYcK 95.00% 5.28 0.552 4.06 c16: Carbamidomethyl (+57.02) 950.9533 1,899.89 1,899.90 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GLESTTLADKDGEIYcK 95.00% 5.51 0.543 4.4 c16: Carbamidomethyl (+57.02) 950.9542 1,899.89 1,899.90 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GLESTTLADKDGEIYcK 95.00% 5.2 0.539 4.1 c16: Carbamidomethyl (+57.02) 950.9551 1,899.89 1,899.90 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.67 0.603 6.92 c16: Carbamidomethyl (+57.02) 968.4599 1,934.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.94 0.613 8.6 c16: Carbamidomethyl (+57.02) 968.9577 1,935.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.7 0.597 7.11 c16: Carbamidomethyl (+57.02) 968.9594 1,935.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% NLDSTTVAVHGEEIYcK 95.00% 5.31 0.619 8.02 c16: Carbamidomethyl (+57.02) 968.9601 1,935.90 1,935.91 2 UN13B_HUMAN
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% TVYFAEEVQcEGNSFHK 95.00% 3.06 0.539 2.82 c10: Carbamidomethyl (+57.02) 1,022.43 2,042.85 2,044.91 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% TVYFAEEVQcEGNSFHK 95.00% 2.47 0.355 0 c10: Carbamidomethyl (+57.02) 1,022.44 2,042.86 2,044.91 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% TVYFAEEVQcEGNSFHK 95.00% 4.01 0.62 3.3 c10: Carbamidomethyl (+57.02) 1,022.44 2,042.86 2,044.91 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% TVYFAEEVQcEGNSFHK 95.00% 5.44 0.595 4.8 c10: Carbamidomethyl (+57.02) 1,023.46 2,044.90 2,044.91 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% TVYFAEEVQcEGNSFHK 95.00% 5.46 0.609 6.59 c10: Carbamidomethyl (+57.02) 1,023.46 2,044.90 2,044.91 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.73 0.593 7.92 c17: Carbamidomethyl (+57.02) 1,032.50 2,062.99 2,064.01 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% KNLDSTTVAVHGEEIYcK 95.00% 5.55 0.556 7.62 c17: Carbamidomethyl (+57.02) 1,033.00 2,063.99 2,064.01 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 4.67 0.598 5.21 1,080.53 2,159.05 2,159.06 2
 SAMPLE 3R Cysteine and glycine-rich protein 1  CSRP1  CSRP1_HUMAN 20,549.10 100.00% 12 18 62 70.50% GYGYGQGAGTLSTDKGESLGIK 95.00% 4.96 0.575 4.22 1,080.53 2,159.05 2,159.06 2
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% SLESTTLTEKEGEIYcK 95.00% 2.83 0.527 2.64 c16: Carbamidomethyl (+57.02) 663.3217 1,986.94 1,987.95 3
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% SLESTTLTEKEGEIYcK 95.00% 3.09 0.557 1.28 c16: Carbamidomethyl (+57.02) 663.322 1,986.94 1,987.95 3
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% NLDSTTVAIHDEEIYcK 95.00% 2.82 0.215 0 c16: Carbamidomethyl (+57.02) 670.3163 2,007.93 2,007.93 3
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% KNLDSTTVAIHDEEIYcK 95.00% 5.16 0.594 3.34 c17: Carbamidomethyl (+57.02) 713.0167 2,136.03 2,136.03 3
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% GFGYGQGAGALVHAQ 95.00% 4.76 0.667 6.54 716.8507 1,431.69 1,432.70 2
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% GFGYGQGAGALVHAQ 95.00% 4.75 0.649 7.72 716.8509 1,431.69 1,432.70 2
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% LGIKPESVQPHRPTTNPNTSK 95.00% 3.54 0.444 0.921 768.0824 2,301.22 2,301.23 3
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% LGIKPESVQPHRPTTNPNTSK 95.00% 3.37 0.44 0 768.0844 2,301.23 2,301.23 3
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% GYGYGQGAGTLNMDR 95.00% 4.41 0.56 5.64 780.3486 1,558.68 1,559.69 2 TITIN_HUMAN
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% GYGYGQGAGTLNMDR 95.00% 4.51 0.566 4.51 780.3492 1,558.68 1,559.69 2 TITIN_HUMAN
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% GYGYGQGAGTLNmDR 95.00% 4.05 0.604 2.26 m13: Oxidation (+15.99) 788.3474 1,574.68 1,575.69 2 TITIN_HUMAN
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% GYGYGQGAGTLNmDR 95.00% 3.75 0.63 3.07 m13: Oxidation (+15.99) 788.3495 1,574.68 1,575.69 2 TITIN_HUMAN
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% SLESTTLTEKEGEIYcK 95.00% 4.83 0.561 5.15 c16: Carbamidomethyl (+57.02) 994.4796 1,986.94 1,987.95 2
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% SLESTTLTEKEGEIYcK 95.00% 5.03 0.602 5.6 c16: Carbamidomethyl (+57.02) 994.9795 1,987.94 1,987.95 2
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% NLDSTTVAIHDEEIYcK 95.00% 5.19 0.602 5.8 c16: Carbamidomethyl (+57.02) 1,004.97 2,007.92 2,007.93 2
 SAMPLE 2 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 5 7 12 44.60% NLDSTTVAIHDEEIYcK 95.00% 5.67 0.594 5.7 c16: Carbamidomethyl (+57.02) 1,004.97 2,007.93 2,007.93 2
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% SLESTTLTEKEGEIYcK 95.00% 2.78 0.514 2.11 c16: Carbamidomethyl (+57.02) 663.6548 1,987.94 1,987.95 3
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% SLESTTLTEKEGEIYcK 95.00% 2.83 0.461 2.19 c16: Carbamidomethyl (+57.02) 663.655 1,987.94 1,987.95 3
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% NLDSTTVAIHDEEIYcK 95.00% 2.26 0.329 1.05 c16: Carbamidomethyl (+57.02) 670.3166 2,007.93 2,007.93 3
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% GFGYGQGAGALVHAQ 95.00% 4.41 0.647 6 716.85 1,431.68 1,432.70 2
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% GFGYGQGAGALVHAQ 95.00% 4.51 0.639 5.7 716.8512 1,431.69 1,432.70 2
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% LGIKPESVQPHRPTTNPNTSK 95.00% 3.48 0.355 1.47 768.0822 2,301.22 2,301.23 3
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% LGIKPESVQPHRPTTNPNTSK 95.00% 3.19 0.519 1.34 768.0852 2,301.23 2,301.23 3
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% GYGYGQGAGTLNMDR 95.00% 4.18 0.579 5.08 780.3479 1,558.68 1,559.69 2 TITIN_HUMAN
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% GYGYGQGAGTLNMDR 95.00% 4.21 0.586 4.52 780.3495 1,558.68 1,559.69 2 TITIN_HUMAN
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% SLESTTLTEKEGEIYcK 95.00% 4.92 0.596 3.19 c16: Carbamidomethyl (+57.02) 994.9761 1,987.94 1,987.95 2
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% SLESTTLTEKEGEIYcK 95.00% 4.94 0.589 4.43 c16: Carbamidomethyl (+57.02) 994.9785 1,987.94 1,987.95 2
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% NLDSTTVAIHDEEIYcK 95.00% 5.35 0.583 5.37 c16: Carbamidomethyl (+57.02) 1,004.97 2,007.92 2,007.93 2
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% NLDSTTVAIHDEEIYcK 95.00% 5.46 0.605 4.89 c16: Carbamidomethyl (+57.02) 1,004.97 2,007.93 2,007.93 2
 SAMPLE 2R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 4 7 12 44.00% LGIKPESVQPHRPTTNPNTSK 95.00% 3.56 0.481 2.07 1,151.62 2,301.22 2,301.23 2
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% SLESTTLTEK 95.00% 2.65 0.318 1.51 554.7896 1,107.56 1,108.57 2
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% ccFLcMVcR 95.00% 2.26 0.279 2.04c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02)653.2 42 1,304.49 1,305.50 2
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% NLDSTTVAIHDEEIYcK 95.00% 2.95 0.308 2.54 c16: Carbamidomethyl (+57.02) 670.3156 2,007.92 2,007.93 3
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% NLDSTTVAIHDEEIYcK 95.00% 2.37 0.263 0 c16: Carbamidomethyl (+57.02) 670.3168 2,007.93 2,007.93 3
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% GFGYGQGAGALVHAQ 95.00% 3.64 0.532 6.29 716.8502 1,431.68 1,432.70 2
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% GFGYGQGAGALVHAQ 95.00% 4.37 0.632 3.92 716.8509 1,431.69 1,432.70 2
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% GFGYGQGAGALVHAQ 95.00% 4.74 0.627 6.41 716.8514 1,431.69 1,432.70 2
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% GFGYGQGAGALVHAQ 95.00% 4.07 0.586 5.09 717.3529 1,432.69 1,432.70 2
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% LGIKPESVQPHRPTTNPNTSK 95.00% 3.77 0.514 0 768.0812 2,301.22 2,301.23 3
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% LGIKPESVQPHRPTTNPNTSK 95.00% 3.81 0.476 1.48 768.0818 2,301.22 2,301.23 3
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% GYGYGQGAGTLNMDR 95.00% 4.63 0.612 4.82 780.3485 1,558.68 1,559.69 2 TITIN_HUMAN
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% GYGYGQGAGTLNMDR 95.00% 4.49 0.586 3.23 780.349 1,558.68 1,559.69 2 TITIN_HUMAN
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% GYGYGQGAGTLNmDR 95.00% 4.2 0.625 2.64 m13: Oxidation (+15.99) 788.3473 1,574.68 1,575.69 2 TITIN_HUMAN
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% GYGYGQGAGTLNmDR 95.00% 3.9 0.596 3.05 m13: Oxidation (+15.99) 788.8492 1,575.68 1,575.69 2 TITIN_HUMAN
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% SLESTTLTEKEGEIYcK 95.00% 4.68 0.568 3.26 c16: Carbamidomethyl (+57.02) 994.4786 1,986.94 1,987.95 2
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% SLESTTLTEKEGEIYcK 95.00% 4.71 0.588 4.16 c16: Carbamidomethyl (+57.02) 994.9791 1,987.94 1,987.95 2
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% NLDSTTVAIHDEEIYcK 95.00% 5.58 0.599 5.72 c16: Carbamidomethyl (+57.02) 1,004.47 2,006.92 2,007.93 2
 SAMPLE 3 Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 7 14 48.70% NLDSTTVAIHDEEIYcK 95.00% 5.67 0.597 7.52 c16: Carbamidomethyl (+57.02) 1,004.97 2,007.92 2,007.93 2
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% ccFLcMVcR 95.00% 2.21 0.234 1.85c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02)653.2 27 1,304.49 1,305.50 2
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% ccFLcMVcR 95.00% 1.91 0.146 1.64c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02)653.2 66 1,304.50 1,305.50 2
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% KNLDSTTVAIHDEEIYcK 95.00% 5.36 0.599 3.7 c17: Carbamidomethyl (+57.02) 713.0169 2,136.03 2,136.03 3
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% GFGYGQGAGALVHAQ 95.00% 4.19 0.621 6.19 716.85 1,431.68 1,432.70 2
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% GFGYGQGAGALVHAQ 95.00% 4.41 0.587 5.19 716.8508 1,431.69 1,432.70 2
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% LGIKPESVQPHRPTTNPNTSK 95.00% 3.95 0.518 1.1 768.0819 2,301.22 2,301.23 3
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% LGIKPESVQPHRPTTNPNTSK 95.00% 3.24 0.482 2.31 768.0829 2,301.23 2,301.23 3
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% GYGYGQGAGTLNMDR 95.00% 4.49 0.615 4.3 780.349 1,558.68 1,559.69 2 TITIN_HUMAN
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% GYGYGQGAGTLNMDR 95.00% 4.38 0.584 6.64 780.3505 1,558.69 1,559.69 2 TITIN_HUMAN
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% GYGYGQGAGTLNmDR 95.00% 2.74 0.511 1.72 m13: Oxidation (+15.99) 788.3463 1,574.68 1,575.69 2 TITIN_HUMAN
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% GYGYGQGAGTLNmDR 95.00% 3.27 0.593 2.47 m13: Oxidation (+15.99) 788.3468 1,574.68 1,575.69 2 TITIN_HUMAN
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% SLESTTLTEKEGEIYcK 95.00% 4.77 0.594 3.82 c16: Carbamidomethyl (+57.02) 994.9815 1,987.95 1,987.95 2
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% NLDSTTVAIHDEEIYcK 95.00% 5.47 0.611 4.24 c16: Carbamidomethyl (+57.02) 1,004.47 2,006.92 2,007.93 2
 SAMPLE 3R Cysteine and glycine-rich protein 2  CSRP2  CSRP2_HUMAN 20,935.60 100.00% 6 6 10 49.20% NLDSTTVAIHDEEIYcK 95.00% 5.29 0.615 5.77 c16: Carbamidomethyl (+57.02) 1,004.47 2,006.92 2,007.93 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 3.51 0.399 2.36 666.9899 1,997.95 1,997.96 3
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 3.49 0.399 0 666.9927 1,997.95 1,997.96 3
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 3.65 0.382 2.01 666.995 1,997.96 1,997.96 3
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 2.45 0.279 1.54 666.9967 1,997.97 1,997.96 3
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDR 95.00% 3.87 0.573 3.89 736.3615 1,470.71 1,471.72 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDR 95.00% 3.34 0.498 1.62 736.3745 1,470.73 1,471.72 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDR 95.00% 4.3 0.612 3.54 736.8637 1,471.71 1,471.72 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDRDPEGKVQP 95.00% 3.3 0.356 1.62 775.0504 2,322.13 2,322.14 3
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDRDPEGKVQP 95.00% 3.54 0.39 1.66 775.0629 2,322.17 2,322.14 3
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% ASSVTTFTGEPNTcPR 95.00% 4.28 0.597 3.68 c14: Carbamidomethyl (+57.02) 862.8974 1,723.78 1,724.79 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% ASSVTTFTGEPNTcPR 95.00% 4.39 0.586 3.03 c14: Carbamidomethyl (+57.02) 862.8999 1,723.78 1,724.79 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% ASSVTTFTGEPNTcPR 95.00% 4.32 0.614 3.89 c14: Carbamidomethyl (+57.02) 862.9013 1,723.79 1,724.79 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% ASSVTTFTGEPNTcPR 95.00% 4.14 0.564 3.17 c14: Carbamidomethyl (+57.02) 862.9027 1,723.79 1,724.79 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% PLAEGPQVTGPIEVPAAR 95.00% 5.2 0.651 0 901.4925 1,800.97 1,801.98 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% PLAEGPQVTGPIEVPAAR 95.00% 5.32 0.639 0 901.9938 1,801.97 1,801.98 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% PLAEGPQVTGPIEVPAAR 95.00% 5.7 0.67 0 902.0031 1,801.99 1,801.98 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 4.04 0.503 4.02 999.4868 1,996.96 1,997.96 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 4.59 0.543 3.22 999.9834 1,997.95 1,997.96 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 2.81 0.425 2.62 999.9836 1,997.95 1,997.96 2
 SAMPLE 1 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 20 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 4.26 0.45 3.74 999.9941 1,997.97 1,997.96 2
 SAMPLE 1R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 11 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 3.49 0.399 0 666.9927 1,997.95 1,997.96 3
 SAMPLE 1R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 11 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 2.45 0.279 1.4 666.9967 1,997.97 1,997.96 3
 SAMPLE 1R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 11 26.90% GVNTGAVGSYIYDR 95.00% 3.34 0.498 1.74 736.3745 1,470.73 1,471.72 2
 SAMPLE 1R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 11 26.90% GVNTGAVGSYIYDRDPEGKVQP 95.00% 3.54 0.39 1.27 775.0629 2,322.17 2,322.14 3
 SAMPLE 1R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 11 26.90% ASSVTTFTGEPNTcPR 95.00% 4.32 0.614 4.06 c14: Carbamidomethyl (+57.02) 862.9013 1,723.79 1,724.79 2
 SAMPLE 1R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 11 26.90% ASSVTTFTGEPNTcPR 95.00% 4.14 0.564 3.11 c14: Carbamidomethyl (+57.02) 862.9027 1,723.79 1,724.79 2
 SAMPLE 1R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 11 26.90% PLAEGPQVTGPIEVPAAR 95.00% 3.45 0.512 0 901.5126 1,801.01 1,801.98 2
 SAMPLE 1R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 11 26.90% PLAEGPQVTGPIEVPAAR 95.00% 5.7 0.67 0 902.0031 1,801.99 1,801.98 2
 SAMPLE 1R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 11 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 2.81 0.425 2.3 999.9836 1,997.95 1,997.96 2
 SAMPLE 1R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 11 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 4.26 0.45 4.77 999.9941 1,997.97 1,997.96 2
 SAMPLE 1R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 11 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 2.47 0.487 2.24 1,000.00 1,997.99 1,997.96 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% PcYGILFGPK 95.00% 2.4 0.403 0 c2: Carbamidomethyl (+57.02) 576.2954 1,150.58 1,151.59 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% PLAEGPQVTGPIEVPAAR 95.00% 4.31 0.541 0 601.6646 1,801.97 1,801.98 3
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 3.43 0.387 2.38 666.6556 1,996.94 1,997.96 3
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 2.62 0.378 0.921 666.6561 1,996.94 1,997.96 3
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 3.22 0.406 2.07 666.6562 1,996.95 1,997.96 3
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 3.19 0.364 1.15 666.6569 1,996.95 1,997.96 3
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 3.63 0.449 1.46 666.9904 1,997.95 1,997.96 3
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 2.97 0.366 1.48 666.9908 1,997.95 1,997.96 3
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDR 95.00% 2.43 0.305 2.49 736.359 1,470.70 1,471.72 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDR 95.00% 4.1 0.555 4 736.3615 1,470.71 1,471.72 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDR 95.00% 3.7 0.516 3 736.3628 1,470.71 1,471.72 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGKVQP 95.00% 3.79 0.509 0 775.0508 2,322.13 2,322.14 3
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGKVQP 95.00% 3.91 0.405 2.62 775.0515 2,322.13 2,322.14 3
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% ASSVTTFTGEPNTcPR 95.00% 4.02 0.609 3.77 c14: Carbamidomethyl (+57.02) 862.8985 1,723.78 1,724.79 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% ASSVTTFTGEPNTcPR 95.00% 4.33 0.567 2.85 c14: Carbamidomethyl (+57.02) 862.899 1,723.78 1,724.79 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% ASSVTTFTGEPNTcPR 95.00% 4.75 0.562 4 c14: Carbamidomethyl (+57.02) 862.899 1,723.78 1,724.79 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% ASSVTTFTGEPNTcPR 95.00% 4.28 0.564 3.26 c14: Carbamidomethyl (+57.02) 862.8991 1,723.78 1,724.79 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% ASSVTTFTGEPNTcPR 95.00% 4.21 0.623 3.15 c14: Carbamidomethyl (+57.02) 862.9002 1,723.78 1,724.79 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% ASSVTTFTGEPNTcPR 95.00% 4.37 0.641 3.85 c14: Carbamidomethyl (+57.02) 863.3995 1,724.78 1,724.79 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% PLAEGPQVTGPIEVPAAR 95.00% 5.35 0.668 0 901.4921 1,800.97 1,801.98 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% PLAEGPQVTGPIEVPAAR 95.00% 5.03 0.701 0 901.4932 1,800.97 1,801.98 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% PLAEGPQVTGPIEVPAAR 95.00% 5.14 0.694 0 901.4949 1,800.97 1,801.98 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 4.38 0.541 2.74 999.479 1,996.94 1,997.96 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 4.64 0.518 3.66 999.4805 1,996.95 1,997.96 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 4.57 0.532 3.51 999.481 1,996.95 1,997.96 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 4.2 0.537 3.92 999.4817 1,996.95 1,997.96 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 4.51 0.526 2.59 999.9793 1,997.94 1,997.96 2
 SAMPLE 2 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 8 28 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 4.44 0.563 2.68 999.9803 1,997.94 1,997.96 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% PcYGILFGPK 95.00% 2.45 0.376 0 c2: Carbamidomethyl (+57.02) 576.2986 1,150.58 1,151.59 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 2.55 0.184 1.11 666.6566 1,996.95 1,997.96 3
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 3.49 0.378 2.21 666.6568 1,996.95 1,997.96 3
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 2.57 0.279 0 666.9902 1,997.95 1,997.96 3
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDR 95.00% 4.42 0.582 3.12 736.36 1,470.70 1,471.72 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDR 95.00% 4.47 0.529 5.03 736.3614 1,470.71 1,471.72 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDR 95.00% 3.32 0.426 2.7 736.3644 1,470.71 1,471.72 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDRDPEGKVQP 95.00% 3.34 0.46 0 775.0501 2,322.13 2,322.14 3
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDRDPEGKVQP 95.00% 3.47 0.375 2 775.0508 2,322.13 2,322.14 3
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% ASSVTTFTGEPNTcPR 95.00% 4.03 0.598 2.74 c14: Carbamidomethyl (+57.02) 862.8979 1,723.78 1,724.79 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% ASSVTTFTGEPNTcPR 95.00% 4.2 0.626 3.39 c14: Carbamidomethyl (+57.02) 862.8991 1,723.78 1,724.79 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% ASSVTTFTGEPNTcPR 95.00% 4.28 0.514 2.64 c14: Carbamidomethyl (+57.02) 862.8999 1,723.78 1,724.79 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% ASSVTTFTGEPNTcPR 95.00% 4.44 0.576 3.03 c14: Carbamidomethyl (+57.02) 862.9001 1,723.78 1,724.79 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% ASSVTTFTGEPNTcPR 95.00% 4.24 0.554 3.32 c14: Carbamidomethyl (+57.02) 862.9005 1,723.79 1,724.79 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% ASSVTTFTGEPNTcPR 95.00% 4.35 0.57 3.72 c14: Carbamidomethyl (+57.02) 863.4004 1,724.79 1,724.79 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% PLAEGPQVTGPIEVPAAR 95.00% 4.7 0.668 0 901.4912 1,800.97 1,801.98 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% PLAEGPQVTGPIEVPAAR 95.00% 5.09 0.646 0 901.4932 1,800.97 1,801.98 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% PLAEGPQVTGPIEVPAAR 95.00% 5.65 0.644 0 901.9938 1,801.97 1,801.98 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% PLAEGPQVTGPIEVPAAR 95.00% 5.2 0.628 0 901.994 1,801.97 1,801.98 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 4.57 0.45 4.27 999.9803 1,997.95 1,997.96 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 4.35 0.517 3.57 999.9803 1,997.95 1,997.96 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 4.17 0.527 3.18 999.9807 1,997.95 1,997.96 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 4.36 0.569 3.02 999.981 1,997.95 1,997.96 2
 SAMPLE 2R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 6 7 24 31.70% GVNTGAVGSYIYDRDPEGK 95.00% 4.11 0.478 3.15 999.9838 1,997.95 1,997.96 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 2.62 0.328 0 666.6566 1,996.95 1,997.96 3
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 4.08 0.432 1.82 666.9905 1,997.95 1,997.96 3
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 3.01 0.275 2.59 666.9906 1,997.95 1,997.96 3
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 3.89 0.381 1.28 666.991 1,997.95 1,997.96 3
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDR 95.00% 3.34 0.433 3.11 736.3604 1,470.71 1,471.72 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDR 95.00% 2.46 0.365 0 736.3615 1,470.71 1,471.72 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDR 95.00% 3.15 0.45 3.82 736.3624 1,470.71 1,471.72 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDRDPEGKVQP 95.00% 3.36 0.409 0 775.0508 2,322.13 2,322.14 3
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDRDPEGKVQP 95.00% 3.5 0.399 0 775.052 2,322.13 2,322.14 3
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% ASSVTTFTGEPNTcPR 95.00% 4.4 0.605 4.41 c14: Carbamidomethyl (+57.02) 862.8972 1,723.78 1,724.79 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% ASSVTTFTGEPNTcPR 95.00% 4.29 0.532 3.4 c14: Carbamidomethyl (+57.02) 862.898 1,723.78 1,724.79 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% ASSVTTFTGEPNTcPR 95.00% 4.31 0.618 3.43 c14: Carbamidomethyl (+57.02) 862.8985 1,723.78 1,724.79 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% ASSVTTFTGEPNTcPR 95.00% 3.88 0.541 4 c14: Carbamidomethyl (+57.02) 862.9007 1,723.79 1,724.79 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% ASSVTTFTGEPNTcPR 95.00% 4.67 0.601 3.14 c14: Carbamidomethyl (+57.02) 863.3958 1,724.78 1,724.79 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% ASSVTTFTGEPNTcPR 95.00% 4.52 0.584 2.77 c14: Carbamidomethyl (+57.02) 863.3995 1,724.78 1,724.79 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% PLAEGPQVTGPIEVPAAR 95.00% 5.14 0.674 0 901.4906 1,800.97 1,801.98 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% PLAEGPQVTGPIEVPAAR 95.00% 5.15 0.689 0 901.4917 1,800.97 1,801.98 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% PLAEGPQVTGPIEVPAAR 95.00% 5.51 0.687 0 901.9939 1,801.97 1,801.98 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% PLAEGPQVTGPIEVPAAR 95.00% 5.23 0.619 0 901.9954 1,801.98 1,801.98 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% PLAEGPQVTGPIEVPAAR 95.00% 4.04 0.517 0 901.9961 1,801.98 1,801.98 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% PLAEGPQVTGPIEVPAAR 95.00% 5.38 0.675 0 901.9962 1,801.98 1,801.98 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 4.9 0.571 3.68 999.4787 1,996.94 1,997.96 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 4.32 0.531 3.01 999.4801 1,996.94 1,997.96 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 4.3 0.52 4.31 999.4813 1,996.95 1,997.96 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 4.36 0.491 2.48 999.9809 1,997.95 1,997.96 2
 SAMPLE 3 Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 26 26.90% GVNTGAVGSYIYDRDPEGK 95.00% 4.33 0.552 3.8 999.9814 1,997.95 1,997.96 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% PcYGILFGPK 95.00% 1.89 0.395 0 c2: Carbamidomethyl (+57.02) 576.2953 1,150.58 1,151.59 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% PcYGILFGPK 95.00% 2.05 0.348 0 c2: Carbamidomethyl (+57.02) 576.6315 1,151.25 1,151.59 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% GVNTGAVGSYIYDRDPEGK 95.00% 3.04 0.401 1.35 666.9917 1,997.95 1,997.96 3
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% GVNTGAVGSYIYDR 95.00% 2.47 0.328 1.77 736.3621 1,470.71 1,471.72 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% ASSVTTFTGEPNTcPR 95.00% 4.81 0.591 3.85 c14: Carbamidomethyl (+57.02) 862.8984 1,723.78 1,724.79 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% ASSVTTFTGEPNTcPR 95.00% 4.46 0.586 4.44 c14: Carbamidomethyl (+57.02) 862.8984 1,723.78 1,724.79 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% ASSVTTFTGEPNTcPR 95.00% 4.34 0.57 4.2 c14: Carbamidomethyl (+57.02) 862.8987 1,723.78 1,724.79 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% ASSVTTFTGEPNTcPR 95.00% 4.36 0.503 4.49 c14: Carbamidomethyl (+57.02) 862.9002 1,723.78 1,724.79 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% ASSVTTFTGEPNTcPR 95.00% 4.01 0.513 3.57 c14: Carbamidomethyl (+57.02) 862.9007 1,723.79 1,724.79 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% ASSVTTFTGEPNTcPR 95.00% 4.39 0.56 3.04 c14: Carbamidomethyl (+57.02) 863.4021 1,724.79 1,724.79 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% PLAEGPQVTGPIEVPAAR 95.00% 4.97 0.638 0 901.4924 1,800.97 1,801.98 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% PLAEGPQVTGPIEVPAAR 95.00% 4.71 0.715 0 901.4926 1,800.97 1,801.98 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% PLAEGPQVTGPIEVPAAR 95.00% 5.11 0.654 0 901.4944 1,800.97 1,801.98 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% GVNTGAVGSYIYDRDPEGK 95.00% 4.32 0.547 3.14 999.4795 1,996.94 1,997.96 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% GVNTGAVGSYIYDRDPEGK 95.00% 4.37 0.53 3.21 999.9816 1,997.95 1,997.96 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% GVNTGAVGSYIYDRDPEGK 95.00% 4.35 0.54 3.05 999.9817 1,997.95 1,997.96 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% GVNTGAVGSYIYDRDPEGK 95.00% 4.27 0.55 3.49 999.9823 1,997.95 1,997.96 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% GVNTGAVGSYIYDRDPEGK 95.00% 4.42 0.531 2.46 999.9834 1,997.95 1,997.96 2
 SAMPLE 3R Cysteine-rich protein 2  CRIP2  CRIP2_HUMAN 22,474.50 100.00% 5 6 19 30.30% GVNTGAVGSYIYDRDPEGK 95.00% 4.31 0.488 3.05 999.9836 1,997.95 1,997.96 2
 SAMPLE 3 Cytochrome b-c1 complex subunit 2, mitochondrial  UQCRC2  QCR2_HUMAN 48,425.40 99.80% 2 2 4 5.74% QVAEQFLNMR 95.00% 2.1 0.353 0 618.3098 1,234.60 1,235.62 2
 SAMPLE 3 Cytochrome b-c1 complex subunit 2, mitochondrial  UQCRC2  QCR2_HUMAN 48,425.40 99.80% 2 2 4 5.74% QVAEQFLNMR 95.00% 2.11 0.325 0 618.3136 1,234.61 1,235.62 2
 SAMPLE 3 Cytochrome b-c1 complex subunit 2, mitochondrial  UQCRC2  QCR2_HUMAN 48,425.40 99.80% 2 2 4 5.74% TIAQGNLSNTDVQAAK 95.00% 4.47 0.144 0 815.922 1,629.83 1,630.84 2
 SAMPLE 3 Cytochrome b-c1 complex subunit 2, mitochondrial  UQCRC2  QCR2_HUMAN 48,425.40 99.80% 2 2 4 5.74% TIAQGNLSNTDVQAAK 95.00% 4.73 0.434 4.11 815.9232 1,629.83 1,630.84 2
 SAMPLE 2 Cytoplasmic dynein 1 heavy chain 1  DYNC1H1  DYHC1_HUMAN 532,387.60 99.80% 2 2 3 0.58% DLFQVAFNR 95.00% 2.34 0.277 1.29 555.2896 1,108.56 1,109.57 2
 SAMPLE 2 Cytoplasmic dynein 1 heavy chain 1  DYNC1H1  DYHC1_HUMAN 532,387.60 99.80% 2 2 3 0.58% FTQDTQPHYIYSPREMTR 95.00% 1.78 0.302 0 757.3773 2,269.11 2,270.07 3
 SAMPLE 2 Cytoplasmic dynein 1 heavy chain 1  DYNC1H1  DYHC1_HUMAN 532,387.60 99.80% 2 2 3 0.58% FTQDTQPHYIYSPREMTR 95.00% 2.25 0.215 0 757.3788 2,269.11 2,270.07 3
 SAMPLE 2R Cytoplasmic dynein 1 heavy chain 1  DYNC1H1  DYHC1_HUMAN 532,387.60 99.90% 2 2 2 0.41% DLFQVAFNR 95.00% 2.78 0.408 0 555.2881 1,108.56 1,109.57 2
 SAMPLE 2R Cytoplasmic dynein 1 heavy chain 1  DYNC1H1  DYHC1_HUMAN 532,387.60 99.90% 2 2 2 0.41% VTFVNFTVTR 95.00% 2.55 0.403 0 592.3284 1,182.64 1,183.65 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NQLKELPEKMPK 95.00% 4.38 0.373 1.14 485.6061 1,453.79 1,454.80 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NQLKELPEKMPK 95.00% 4.47 0.339 1.21 485.6071 1,453.80 1,454.80 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NQLKELPEKMPK 95.00% 4.07 0.317 1.14 485.6073 1,453.80 1,454.80 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NQLKELPEKMPK 95.00% 3.84 0.261 0 485.6083 1,453.80 1,454.80 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NQLKELPEKMPK 95.00% 3.89 0.351 1.31 485.6086 1,453.80 1,454.80 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NQLKELPEKMPK 95.00% 4.33 0.354 0 485.9413 1,454.80 1,454.80 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NQLKELPEKmPK 95.00% 2.6 0.285 0 m10: Oxidation (+15.99) 490.941 1,469.80 1,470.80 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NQLKELPEKmPK 95.00% 3.13 0.198 0 m10: Oxidation (+15.99) 490.9419 1,469.80 1,470.80 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NQLKELPEKmPK 95.00% 3.21 0.179 0 m10: Oxidation (+15.99) 490.9425 1,469.80 1,470.80 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NQLKELPEKmPK 95.00% 2.56 0.277 0 m10: Oxidation (+15.99) 491.2747 1,470.80 1,470.80 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% ITEIKDGDFKNLK 95.00% 2.69 0.315 0 507.6165 1,519.83 1,520.83 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% ITEIKDGDFKNLK 95.00% 2.7 0.471 0 507.6168 1,519.83 1,520.83 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 2.11 0.362 0 c4: Carbamidomethyl (+57.02) 519.9496 1,556.83 1,557.83 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 1.84 0.3 0 c4: Carbamidomethyl (+57.02) 519.95 1,556.83 1,557.83 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 2.56 0.45 1.33 c4: Carbamidomethyl (+57.02) 519.95 1,556.83 1,557.83 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 2.28 0.498 0.959 c4: Carbamidomethyl (+57.02) 519.9503 1,556.83 1,557.83 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 2.68 0.477 1.43 c4: Carbamidomethyl (+57.02) 519.9504 1,556.83 1,557.83 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 2.65 0.494 1.36 c4: Carbamidomethyl (+57.02) 519.9505 1,556.83 1,557.83 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNKISK 95.00% 3.68 0.484 0.959 526.3235 1,575.95 1,576.95 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNKISK 95.00% 4.06 0.479 2.01 526.324 1,575.95 1,576.95 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNKISK 95.00% 2.92 0.29 0 526.324 1,575.95 1,576.95 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNKISK 95.00% 3.53 0.44 0 526.3241 1,575.95 1,576.95 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNKISK 95.00% 3 0.344 0 526.6591 1,576.95 1,576.95 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLKNLHALILVNNK 95.00% 4.24 0.469 0 535.3271 1,602.96 1,603.96 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLKNLHALILVNNK 95.00% 4.49 0.518 0 535.6635 1,603.97 1,603.96 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VSPGAFTPLVK 95.00% 1.9 0.306 0 558.3271 1,114.64 1,115.65 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VSPGAFTPLVK 95.00% 1.93 0.277 0 558.3275 1,114.64 1,115.65 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VSPGAFTPLVK 95.00% 2.05 0.349 0 558.3277 1,114.64 1,115.65 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VSPGAFTPLVK 95.00% 2.11 0.314 1.57 558.3278 1,114.64 1,115.65 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VSPGAFTPLVK 95.00% 1.92 0.293 1.77 558.3281 1,114.64 1,115.65 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VSPGAFTPLVK 95.00% 2.01 0.356 0 558.3282 1,114.64 1,115.65 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VSPGAFTPLVK 95.00% 2.22 0.401 0 558.3285 1,114.64 1,115.65 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VSPGAFTPLVK 95.00% 1.59 0.322 1.74 558.3288 1,114.64 1,115.65 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% TLQELRAHENEITK 95.00% 2.83 0.432 0 561.3023 1,680.88 1,681.89 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% TLQELRAHENEITK 95.00% 2.58 0.513 1.62 561.637 1,681.89 1,681.89 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.24 0.393 3.33 566.2986 1,695.87 1,696.88 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.29 0.32 1.89 566.2989 1,695.87 1,696.88 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 2.94 0.433 2.72 566.3 1,695.88 1,696.88 3
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 3.63 0.51 2.28 c4: Carbamidomethyl (+57.02) 617.3124 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 2.3 0.343 0 c4: Carbamidomethyl (+57.02) 617.3125 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 2.15 0.29 2.1 c4: Carbamidomethyl (+57.02) 617.3128 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 3.54 0.542 2.89 c4: Carbamidomethyl (+57.02) 617.3129 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 2.5 0.407 1.92 c4: Carbamidomethyl (+57.02) 617.313 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 3.69 0.422 2.64 c4: Carbamidomethyl (+57.02) 617.313 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 3.3 0.431 2.14 c4: Carbamidomethyl (+57.02) 617.3131 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 3.38 0.409 2.68 c4: Carbamidomethyl (+57.02) 617.3132 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 3.79 0.453 3.33 c4: Carbamidomethyl (+57.02) 617.3132 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 3.54 0.514 1.72 c4: Carbamidomethyl (+57.02) 617.3136 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 3.62 0.538 2.14 c4: Carbamidomethyl (+57.02) 617.3138 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 2.7 0.321 0 c4: Carbamidomethyl (+57.02) 617.3144 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 3.46 0.441 2.68 c4: Carbamidomethyl (+57.02) 617.3148 1,232.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDK 95.00% 3.6 0.444 3.37 c4: Carbamidomethyl (+57.02) 617.8148 1,233.61 1,233.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNK 95.00% 4.05 0.505 1.72 624.8742 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNK 95.00% 3.88 0.429 1.41 624.8766 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNK 95.00% 4.13 0.524 2.44 624.8772 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNK 95.00% 3.95 0.513 2.06 624.8773 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNK 95.00% 4.02 0.519 2.14 624.8773 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNK 95.00% 4.08 0.527 1.82 624.8773 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNK 95.00% 3.99 0.516 1.8 624.8774 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNK 95.00% 3.95 0.518 2 624.8776 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NLHALILVNNK 95.00% 3.94 0.492 1.66 624.8776 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% SSGIENGAFQGMK 95.00% 4.13 0.57 2.35 663.3122 1,324.61 1,325.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% SSGIENGAFQGMK 95.00% 4.27 0.564 2.74 663.313 1,324.61 1,325.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% SSGIENGAFQGMK 95.00% 4.37 0.558 3.55 663.3134 1,324.61 1,325.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% SSGIENGAFQGMK 95.00% 4.08 0.58 2.77 663.3135 1,324.61 1,325.62 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% SSGIENGAFQGmK 95.00% 2.88 0.471 0 m12: Oxidation (+15.99) 671.3081 1,340.60 1,341.61 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NQLKELPEKMPK 95.00% 3.21 0.159 1.35 727.9073 1,453.80 1,454.80 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% NQLKELPEKMPK 95.00% 3.66 0.315 0 727.9076 1,453.80 1,454.80 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 4.38 0.472 2.92 c4: Carbamidomethyl (+57.02) 779.4207 1,556.83 1,557.83 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 4.35 0.454 2.82 c4: Carbamidomethyl (+57.02) 779.4208 1,556.83 1,557.83 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 4.39 0.482 3.48 c4: Carbamidomethyl (+57.02) 779.421 1,556.83 1,557.83 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 4.03 0.437 4.46 c4: Carbamidomethyl (+57.02) 779.4216 1,556.83 1,557.83 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 4.17 0.426 4.51 c4: Carbamidomethyl (+57.02) 779.4218 1,556.83 1,557.83 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 4.28 0.414 4.92 c4: Carbamidomethyl (+57.02) 779.4218 1,556.83 1,557.83 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 4.4 0.478 3.59 c4: Carbamidomethyl (+57.02) 779.422 1,556.83 1,557.83 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 4.35 0.405 3.17 c4: Carbamidomethyl (+57.02) 779.4221 1,556.83 1,557.83 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 4.15 0.429 5 c4: Carbamidomethyl (+57.02) 779.4229 1,556.83 1,557.83 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% VVQcSDLGLDKVPK 95.00% 4.29 0.427 2.85 c4: Carbamidomethyl (+57.02) 779.424 1,556.83 1,557.83 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% TLQELRAHENEITK 95.00% 3.44 0.188 2.59 841.449 1,680.88 1,681.89 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.71 0.478 0 848.9428 1,695.87 1,696.88 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.53 0.449 2.35 848.9438 1,695.87 1,696.88 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.64 0.488 2.05 848.9439 1,695.87 1,696.88 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.77 0.45 1.64 848.9439 1,695.87 1,696.88 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.6 0.504 2.07 848.9441 1,695.87 1,696.88 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.66 0.488 3.08 848.9441 1,695.87 1,696.88 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.66 0.479 2.44 848.9442 1,695.87 1,696.88 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.33 0.451 2.32 848.9444 1,695.87 1,696.88 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.62 0.478 2.68 848.9445 1,695.87 1,696.88 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.63 0.467 2.31 848.9445 1,695.87 1,696.88 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.54 0.468 2.31 848.9445 1,695.87 1,696.88 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 4.19 0.495 1.51 849.4453 1,696.87 1,696.88 2
 SAMPLE 4 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 11 15 92 29.50% DLPPDTTLLDLQNNK 95.00% 3.69 0.451 1.85 849.4463 1,696.88 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NQLKELPEKMPK 95.00% 3.4 0.248 0 485.6081 1,453.80 1,454.80 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NQLKELPEKMPK 95.00% 3.79 0.381 0 485.6089 1,453.80 1,454.80 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NQLKELPEKMPK 95.00% 3.45 0.171 0.959 485.6092 1,453.80 1,454.80 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NQLKELPEKMPK 95.00% 4.18 0.334 0.959 485.6094 1,453.80 1,454.80 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NQLKELPEKMPK 95.00% 4.07 0.23 1.47 485.9426 1,454.80 1,454.80 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NQLKELPEKmPK 95.00% 2.73 0.246 0 m10: Oxidation (+15.99) 490.9412 1,469.80 1,470.80 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NQLKELPEKmPK 95.00% 3.1 0.258 0 m10: Oxidation (+15.99) 491.2748 1,470.80 1,470.80 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NQLKELPEKmPK 95.00% 2.8 0.309 0 m10: Oxidation (+15.99) 491.2751 1,470.80 1,470.80 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% ITEIKDGDFKNLK 95.00% 2.38 0.257 0 507.6163 1,519.83 1,520.83 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% ITEIKDGDFKNLK 95.00% 2.39 0.246 0 507.6176 1,519.83 1,520.83 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 2.8 0.49 0 c4: Carbamidomethyl (+57.02) 519.9495 1,556.82 1,557.83 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 2.33 0.47 2.85 c4: Carbamidomethyl (+57.02) 519.9498 1,556.83 1,557.83 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 2.65 0.514 1.54 c4: Carbamidomethyl (+57.02) 519.9504 1,556.83 1,557.83 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 2.18 0.327 0 c4: Carbamidomethyl (+57.02) 519.9507 1,556.83 1,557.83 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNKISK 95.00% 4.78 0.455 2.34 526.3239 1,575.95 1,576.95 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNKISK 95.00% 3.24 0.454 0 526.324 1,575.95 1,576.95 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNKISK 95.00% 3.86 0.458 1.24 526.3256 1,575.95 1,576.95 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNKISK 95.00% 3.12 0.382 0 526.658 1,576.95 1,576.95 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLKNLHALILVNNK 95.00% 2.25 0.296 0 535.3048 1,602.89 1,603.96 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLKNLHALILVNNK 95.00% 2.53 0.365 0 535.3275 1,602.96 1,603.96 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLKNLHALILVNNK 95.00% 3.81 0.488 1 535.3292 1,602.96 1,603.96 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLKNLHALILVNNK 95.00% 3.29 0.286 0 535.6622 1,603.96 1,603.96 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VSPGAFTPLVK 95.00% 1.95 0.358 0 558.3278 1,114.64 1,115.65 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VSPGAFTPLVK 95.00% 1.99 0.311 0 558.3281 1,114.64 1,115.65 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VSPGAFTPLVK 95.00% 2.09 0.363 0 558.3282 1,114.64 1,115.65 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VSPGAFTPLVK 95.00% 2.26 0.356 0 558.3286 1,114.64 1,115.65 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VSPGAFTPLVK 95.00% 1.86 0.317 0 558.3286 1,114.64 1,115.65 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VSPGAFTPLVK 95.00% 2.23 0.387 0 558.3287 1,114.64 1,115.65 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VSPGAFTPLVK 95.00% 1.63 0.372 0 558.3289 1,114.64 1,115.65 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VSPGAFTPLVK 95.00% 1.72 0.332 1.38 558.3293 1,114.64 1,115.65 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% TLQELRAHENEITK 95.00% 2.47 0.457 0 561.3028 1,680.88 1,681.89 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% TLQELRAHENEITK 95.00% 3.03 0.345 0 561.3038 1,680.89 1,681.89 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.84 0.395 2.09 566.2987 1,695.87 1,696.88 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 2.81 0.439 2.47 566.2989 1,695.87 1,696.88 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.33 0.484 2.19 566.2996 1,695.88 1,696.88 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 2.67 0.489 1.52 566.2996 1,695.88 1,696.88 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 2.82 0.484 1.92 566.3002 1,695.88 1,696.88 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 2.6 0.473 2.18 566.301 1,695.88 1,696.88 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.95 0.433 1.49 566.6323 1,696.87 1,696.88 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 2.15 0.313 0 566.6324 1,696.87 1,696.88 3
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDK 95.00% 3.68 0.544 3.12 c4: Carbamidomethyl (+57.02) 617.3114 1,232.61 1,233.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDK 95.00% 3.32 0.459 2.74 c4: Carbamidomethyl (+57.02) 617.3127 1,232.61 1,233.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDK 95.00% 3.18 0.465 3.28 c4: Carbamidomethyl (+57.02) 617.313 1,232.61 1,233.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDK 95.00% 3.55 0.572 2.68 c4: Carbamidomethyl (+57.02) 617.3133 1,232.61 1,233.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDK 95.00% 3.7 0.545 2.46 c4: Carbamidomethyl (+57.02) 617.3133 1,232.61 1,233.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDK 95.00% 3.64 0.541 2.74 c4: Carbamidomethyl (+57.02) 617.3135 1,232.61 1,233.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDK 95.00% 3.74 0.532 3.17 c4: Carbamidomethyl (+57.02) 617.3136 1,232.61 1,233.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDK 95.00% 3.72 0.487 3.05 c4: Carbamidomethyl (+57.02) 617.3139 1,232.61 1,233.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDK 95.00% 3.69 0.508 3.85 c4: Carbamidomethyl (+57.02) 617.3141 1,232.61 1,233.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDK 95.00% 2.2 0.363 1.38 c4: Carbamidomethyl (+57.02) 617.3142 1,232.61 1,233.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDK 95.00% 2.37 0.326 1.89 c4: Carbamidomethyl (+57.02) 617.3143 1,232.61 1,233.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDK 95.00% 2.25 0.332 1.74 c4: Carbamidomethyl (+57.02) 617.3145 1,232.61 1,233.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNK 95.00% 3.36 0.396 3.24 624.8766 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNK 95.00% 3.84 0.481 1.96 624.877 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNK 95.00% 3.93 0.527 3.33 624.8771 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNK 95.00% 3.52 0.501 2.92 624.8773 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNK 95.00% 4.04 0.517 2.39 624.8773 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNK 95.00% 3.93 0.492 1.92 624.8773 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNK 95.00% 3.99 0.509 2.7 624.8773 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNK 95.00% 3.93 0.522 2.24 624.8775 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNK 95.00% 4.05 0.545 2.74 624.8775 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% NLHALILVNNK 95.00% 3.91 0.506 1.85 624.8784 1,247.74 1,248.74 2 PGK1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% SSGIENGAFQGMK 95.00% 4.16 0.586 4.14 663.3135 1,324.61 1,325.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% SSGIENGAFQGMK 95.00% 3.48 0.562 2.64 663.3136 1,324.61 1,325.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% SSGIENGAFQGMK 95.00% 3.89 0.561 2.49 663.3138 1,324.61 1,325.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% SSGIENGAFQGMK 95.00% 4 0.556 3.7 663.3138 1,324.61 1,325.62 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% SSGIENGAFQGmK 95.00% 2.7 0.386 2.2 m12: Oxidation (+15.99) 671.3115 1,340.61 1,341.61 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DFEPSLGPVcPFR 95.00% 2.75 0.321 1.46 c10: Carbamidomethyl (+57.02) 760.8672 1,519.72 1,520.72 2 CAP1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DFEPSLGPVcPFR 95.00% 3.2 0.362 2.57 c10: Carbamidomethyl (+57.02) 760.8675 1,519.72 1,520.72 2 CAP1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DFEPSLGPVcPFR 95.00% 3.53 0.551 2.96 c10: Carbamidomethyl (+57.02) 760.8675 1,519.72 1,520.72 2 CAP1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DFEPSLGPVcPFR 95.00% 3.63 0.571 2.96 c10: Carbamidomethyl (+57.02) 760.8677 1,519.72 1,520.72 2 CAP1_HUMAN
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 4.4 0.417 3.21 c4: Carbamidomethyl (+57.02) 779.4214 1,556.83 1,557.83 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 4.28 0.478 3.2 c4: Carbamidomethyl (+57.02) 779.4216 1,556.83 1,557.83 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 4.18 0.389 4.92 c4: Carbamidomethyl (+57.02) 779.4219 1,556.83 1,557.83 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 4.15 0.469 3.85 c4: Carbamidomethyl (+57.02) 779.422 1,556.83 1,557.83 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 4.13 0.415 5.19 c4: Carbamidomethyl (+57.02) 779.4221 1,556.83 1,557.83 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 4.19 0.422 3.21 c4: Carbamidomethyl (+57.02) 779.4222 1,556.83 1,557.83 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 4.33 0.447 3.38 c4: Carbamidomethyl (+57.02) 779.4223 1,556.83 1,557.83 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 3.77 0.359 2.52 c4: Carbamidomethyl (+57.02) 779.4231 1,556.83 1,557.83 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 4.14 0.41 2.33 c4: Carbamidomethyl (+57.02) 779.4234 1,556.83 1,557.83 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% VVQcSDLGLDKVPK 95.00% 4.13 0.443 3.23 c4: Carbamidomethyl (+57.02) 779.4272 1,556.84 1,557.83 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.52 0.504 2.47 848.9412 1,695.87 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.58 0.511 2.54 848.943 1,695.87 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.52 0.496 2.68 848.9432 1,695.87 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.55 0.507 3.15 848.9433 1,695.87 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.6 0.467 2.21 848.9434 1,695.87 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.73 0.459 2.24 848.9436 1,695.87 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.7 0.44 2.47 848.9439 1,695.87 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.56 0.437 1.72 848.9444 1,695.87 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.47 0.469 2.34 848.9444 1,695.87 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.59 0.457 1.77 848.9452 1,695.87 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.52 0.394 2.11 848.9462 1,695.88 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.64 0.494 2.47 848.9463 1,695.88 1,696.88 2
 SAMPLE 4R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 12 14 94 33.10% DLPPDTTLLDLQNNK 95.00% 3.61 0.499 2.07 849.4445 1,696.87 1,696.88 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% SSGIENGAFQGmKK 95.00% 2.49 0.267 0 m12: Oxidation (+15.99) 490.7503 1,469.23 1,469.71 3 TITIN_HUMAN
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% VVQcSDLGLDKVPK 95.00% 2.32 0.408 0 c4: Carbamidomethyl (+57.02) 519.9509 1,556.83 1,557.83 3
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DLPPDTTLLDLQNNK 95.00% 3.65 0.294 0 566.6296 1,696.87 1,696.88 3
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DLPPDTTLLDLQNNK 95.00% 3.87 0.363 0 566.631 1,696.87 1,696.88 3
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% VVQcSDLGLDK 95.00% 2.1 0.436 1.31 c4: Carbamidomethyl (+57.02) 617.3089 1,232.60 1,233.62 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% VVQcSDLGLDK 95.00% 3.74 0.472 3.11 c4: Carbamidomethyl (+57.02) 617.3089 1,232.60 1,233.62 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% VVQcSDLGLDK 95.00% 1.96 0.435 0 c4: Carbamidomethyl (+57.02) 617.3091 1,232.60 1,233.62 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% VVQcSDLGLDK 95.00% 3.24 0.468 2.06 c4: Carbamidomethyl (+57.02) 617.3111 1,232.61 1,233.62 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% VVQcSDLGLDK 95.00% 3.53 0.474 1.92 c4: Carbamidomethyl (+57.02) 617.3119 1,232.61 1,233.62 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% VVQcSDLGLDK 95.00% 2.6 0.389 1.52 c4: Carbamidomethyl (+57.02) 617.3133 1,232.61 1,233.62 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DFEPSLGPVcPFR 95.00% 3.66 0.611 3.37 c10: Carbamidomethyl (+57.02) 760.8625 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DFEPSLGPVcPFR 95.00% 3.71 0.596 2.4 c10: Carbamidomethyl (+57.02) 760.8639 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DFEPSLGPVcPFR 95.00% 2.55 0.37 0 c10: Carbamidomethyl (+57.02) 760.8665 1,519.72 1,520.72 2 CAP1_HUMAN
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DFEPSLGPVcPFR 95.00% 3.2 0.503 0 c10: Carbamidomethyl (+57.02) 760.867 1,519.72 1,520.72 2 CAP1_HUMAN
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DFEPSLGPVcPFR 95.00% 3.43 0.568 1.77 c10: Carbamidomethyl (+57.02) 760.8719 1,519.73 1,520.72 2 CAP1_HUMAN
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% VVQcSDLGLDKVPK 95.00% 4.43 0.45 4.55 c4: Carbamidomethyl (+57.02) 779.4176 1,556.82 1,557.83 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% VVQcSDLGLDKVPK 95.00% 4.21 0.478 4.64 c4: Carbamidomethyl (+57.02) 779.4236 1,556.83 1,557.83 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DLPPDTTLLDLQNNK 95.00% 3.79 0.455 2.89 848.9397 1,695.86 1,696.88 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DLPPDTTLLDLQNNK 95.00% 3.54 0.481 2.46 848.9403 1,695.87 1,696.88 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DLPPDTTLLDLQNNK 95.00% 3.53 0.479 2.7 848.9409 1,695.87 1,696.88 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DLPPDTTLLDLQNNK 95.00% 3.67 0.474 2.96 848.9424 1,695.87 1,696.88 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DLPPDTTLLDLQNNK 95.00% 3.87 0.477 2.54 848.9475 1,695.88 1,696.88 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DLPPDTTLLDLQNNK 95.00% 2.82 0.454 1.42 848.9511 1,695.89 1,696.88 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DLPPDTTLLDLQNNK 95.00% 3.53 0.434 2.21 848.9582 1,695.90 1,696.88 2
 SAMPLE 1 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 4 6 24 15.60% DLPPDTTLLDLQNNK 95.00% 2.68 0.434 1.35 849.4519 1,696.89 1,696.88 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% NQLKELPEKMPK 95.00% 4.53 0.328 0 485.6071 1,453.80 1,454.80 3
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% NQLKELPEKMPK 95.00% 3.48 0.236 0 485.9395 1,454.80 1,454.80 3
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% SSGIENGAFQGmKK 95.00% 2.12 0.247 0 m12: Oxidation (+15.99) 490.7504 1,469.23 1,469.71 3 TITIN_HUMAN
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DLPPDTTLLDLQNNK 95.00% 3.24 0.32 1.46 566.2961 1,695.87 1,696.88 3
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DLPPDTTLLDLQNNK 95.00% 3.28 0.278 1.1 566.629 1,696.86 1,696.88 3
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% VVQcSDLGLDK 95.00% 3.6 0.462 3.25 c4: Carbamidomethyl (+57.02) 617.3086 1,232.60 1,233.62 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% VVQcSDLGLDK 95.00% 3.76 0.468 1.57 c4: Carbamidomethyl (+57.02) 617.31 1,232.60 1,233.62 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% VVQcSDLGLDK 95.00% 3.24 0.468 1.25 c4: Carbamidomethyl (+57.02) 617.3111 1,232.61 1,233.62 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% VVQcSDLGLDK 95.00% 2.6 0.389 1.17 c4: Carbamidomethyl (+57.02) 617.3133 1,232.61 1,233.62 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DFEPSLGPVcPFR 95.00% 3.75 0.591 2.39 c10: Carbamidomethyl (+57.02) 760.8634 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DFEPSLGPVcPFR 95.00% 3.53 0.597 2.62 c10: Carbamidomethyl (+57.02) 760.8638 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DFEPSLGPVcPFR 95.00% 2.55 0.37 0 c10: Carbamidomethyl (+57.02) 760.8665 1,519.72 1,520.72 2 CAP1_HUMAN
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DFEPSLGPVcPFR 95.00% 3.2 0.503 0 c10: Carbamidomethyl (+57.02) 760.867 1,519.72 1,520.72 2 CAP1_HUMAN
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DFEPSLGPVcPFR 95.00% 3.43 0.568 2.19 c10: Carbamidomethyl (+57.02) 760.8719 1,519.73 1,520.72 2 CAP1_HUMAN
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DFEPSLGPVcPFR 95.00% 2.78 0.352 1.82 c10: Carbamidomethyl (+57.02) 760.8781 1,519.74 1,520.72 2 CAP1_HUMAN
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% VVQcSDLGLDKVPK 95.00% 4.26 0.467 5.09 c4: Carbamidomethyl (+57.02) 779.4189 1,556.82 1,557.83 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% VVQcSDLGLDKVPK 95.00% 4.14 0.446 4.01 c4: Carbamidomethyl (+57.02) 779.9196 1,557.82 1,557.83 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DLPPDTTLLDLQNNK 95.00% 3.67 0.488 2.77 848.94 1,695.86 1,696.88 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DLPPDTTLLDLQNNK 95.00% 3.87 0.477 2.48 848.9475 1,695.88 1,696.88 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DLPPDTTLLDLQNNK 95.00% 2.82 0.454 1.92 848.9511 1,695.89 1,696.88 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DLPPDTTLLDLQNNK 95.00% 3.59 0.535 1.92 848.9579 1,695.90 1,696.88 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DLPPDTTLLDLQNNK 95.00% 3.24 0.474 1.52 848.959 1,695.90 1,696.88 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DLPPDTTLLDLQNNK 95.00% 4.09 0.48 2.85 849.4408 1,696.87 1,696.88 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DLPPDTTLLDLQNNK 95.00% 3.31 0.43 2 849.4417 1,696.87 1,696.88 2
 SAMPLE 1R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 5 6 24 18.90% DLPPDTTLLDLQNNK 95.00% 2.68 0.434 1.96 849.4519 1,696.89 1,696.88 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% ELHLDNNKLTR 95.00% 2 0.231 0 451.9099 1,352.71 1,352.73 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% AHENEITK 95.00% 2.26 0.332 0 471.2401 940.4645 941.4693 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NQLKELPEKMPK 95.00% 3.98 0.29 0 485.6051 1,453.79 1,454.80 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NQLKELPEKMPK 95.00% 4.58 0.344 0 485.6055 1,453.79 1,454.80 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NQLKELPEKMPK 95.00% 3.74 0.286 1.57 485.6058 1,453.79 1,454.80 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NQLKELPEKMPK 95.00% 4.08 0.239 1.54 485.9404 1,454.80 1,454.80 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NQLKELPEKmPK 95.00% 3.51 0.306 0 m10: Oxidation (+15.99) 490.9389 1,469.79 1,470.80 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 1.97 0.283 1.57 c4: Carbamidomethyl (+57.02) 519.947 1,556.82 1,557.83 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 2.31 0.444 1.32 c4: Carbamidomethyl (+57.02) 519.9473 1,556.82 1,557.83 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 3.42 0.6 2.74 c4: Carbamidomethyl (+57.02) 519.9475 1,556.82 1,557.83 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 2.32 0.449 0 c4: Carbamidomethyl (+57.02) 519.9477 1,556.82 1,557.83 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 2.1 0.311 2 c4: Carbamidomethyl (+57.02) 519.9477 1,556.82 1,557.83 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 3.4 0.569 2.68 c4: Carbamidomethyl (+57.02) 519.9479 1,556.82 1,557.83 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 2.26 0.292 0 c4: Carbamidomethyl (+57.02) 519.9483 1,556.82 1,557.83 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NLHALILVNNKISK 95.00% 2.9 0.332 0 526.32 1,575.94 1,576.95 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NLHALILVNNKISK 95.00% 2.74 0.292 0 526.6572 1,576.95 1,576.95 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NLHALILVNNKISK 95.00% 2.97 0.329 0 526.6573 1,576.95 1,576.95 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VSPGAFTPLVK 95.00% 1.88 0.298 0 558.3258 1,114.64 1,115.65 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VSPGAFTPLVK 95.00% 2.27 0.361 0 558.6159 1,115.22 1,115.65 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% TLQELRAHENEITK 95.00% 2.78 0.434 0 561.2992 1,680.87 1,681.89 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% TLQELRAHENEITK 95.00% 2.52 0.296 0 561.2999 1,680.88 1,681.89 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% TLQELRAHENEITK 95.00% 2.89 0.411 0 561.6332 1,681.88 1,681.89 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 3.22 0.333 2.48 566.2953 1,695.86 1,696.88 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 2.9 0.248 0.959 566.2956 1,695.86 1,696.88 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 3.19 0.28 1.39 566.2959 1,695.86 1,696.88 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 3.42 0.318 1.34 566.2964 1,695.87 1,696.88 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 2.19 0.28 1 566.298 1,695.87 1,696.88 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 2.08 0.208 1.11 566.6295 1,696.86 1,696.88 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 2.62 0.31 0 566.6296 1,696.87 1,696.88 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 2.86 0.331 1.17 566.6302 1,696.87 1,696.88 3
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% ITEIKDGDFK 95.00% 2.57 0.393 1.21 583.3077 1,164.60 1,165.61 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% ITEIKDGDFK 95.00% 2.35 0.259 0 583.3078 1,164.60 1,165.61 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDK 95.00% 3.54 0.501 2.48 c4: Carbamidomethyl (+57.02) 617.308 1,232.60 1,233.62 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDK 95.00% 3.1 0.382 2.8 c4: Carbamidomethyl (+57.02) 617.3103 1,232.60 1,233.62 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDK 95.00% 3.63 0.546 3.2 c4: Carbamidomethyl (+57.02) 617.3103 1,232.61 1,233.62 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDK 95.00% 3.81 0.493 2.15 c4: Carbamidomethyl (+57.02) 617.3106 1,232.61 1,233.62 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDK 95.00% 3.74 0.537 3.59 c4: Carbamidomethyl (+57.02) 617.3107 1,232.61 1,233.62 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDK 95.00% 3.17 0.456 3.12 c4: Carbamidomethyl (+57.02) 617.3114 1,232.61 1,233.62 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDK 95.00% 3.34 0.439 3.14 c4: Carbamidomethyl (+57.02) 617.3119 1,232.61 1,233.62 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDK 95.00% 3.23 0.354 2.39 c4: Carbamidomethyl (+57.02) 617.3125 1,232.61 1,233.62 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NLHALILVNNK 95.00% 3.08 0.441 2.11 624.8728 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NLHALILVNNK 95.00% 3.43 0.475 2.62 624.873 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NLHALILVNNK 95.00% 3.68 0.423 1.85 624.8743 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NLHALILVNNK 95.00% 3.96 0.477 2.64 624.875 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NLHALILVNNK 95.00% 3.11 0.418 2.62 625.3716 1,248.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% SSGIENGAFQGMK 95.00% 4.37 0.539 2.7 663.3106 1,324.61 1,325.62 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% SSGIENGAFQGMK 95.00% 4.23 0.574 3.34 663.3108 1,324.61 1,325.62 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% ELHLDNNKLTR 95.00% 2.42 0.316 1.64 677.3593 1,352.70 1,352.73 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% ELHLDNNKLTR 95.00% 2.45 0.333 1.6 677.3597 1,352.70 1,352.73 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NQLKELPEKMPK 95.00% 3.8 0.185 1.59 727.904 1,453.79 1,454.80 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NQLKELPEKMPK 95.00% 3.43 0.295 2.07 727.9043 1,453.79 1,454.80 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NQLKELPEKMPK 95.00% 3.65 0.212 0 727.9044 1,453.79 1,454.80 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NQLKELPEKMPK 95.00% 3.8 0.203 0 728.4062 1,454.80 1,454.80 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% SSGIENGAFQGmKK 95.00% 3.19 0.391 1.28 m12: Oxidation (+15.99) 735.3556 1,468.70 1,469.71 2 TITIN_HUMAN
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DFEPSLGPVcPFR 95.00% 3.77 0.611 2.4 c10: Carbamidomethyl (+57.02) 760.8628 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DFEPSLGPVcPFR 95.00% 3.69 0.621 2.85 c10: Carbamidomethyl (+57.02) 760.8634 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DFEPSLGPVcPFR 95.00% 2.94 0.505 2.62 c10: Carbamidomethyl (+57.02) 760.8637 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% ITEIKDGDFKNLK 95.00% 3.01 0.179 0 760.9214 1,519.83 1,520.83 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DFEPSLGPVcPFR 95.00% 3.68 0.533 3 c10: Carbamidomethyl (+57.02) 761.3641 1,520.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 4 0.42 2.43 c4: Carbamidomethyl (+57.02) 779.4172 1,556.82 1,557.83 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 4.25 0.403 3.28 c4: Carbamidomethyl (+57.02) 779.4175 1,556.82 1,557.83 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 4.32 0.473 3.85 c4: Carbamidomethyl (+57.02) 779.4176 1,556.82 1,557.83 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 4.4 0.498 5.41 c4: Carbamidomethyl (+57.02) 779.4181 1,556.82 1,557.83 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 4.2 0.519 2.34 c4: Carbamidomethyl (+57.02) 779.4181 1,556.82 1,557.83 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 4.44 0.47 4.09 c4: Carbamidomethyl (+57.02) 779.4185 1,556.82 1,557.83 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% VVQcSDLGLDKVPK 95.00% 4.4 0.479 3.51 c4: Carbamidomethyl (+57.02) 779.9224 1,557.83 1,557.83 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NLHALILVNNKISK 95.00% 2.93 0.364 0 788.3727 1,574.73 1,576.95 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% NLHALILVNNKISK 95.00% 3.13 0.404 0 788.3739 1,574.73 1,576.95 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 3.64 0.451 3.38 848.9397 1,695.86 1,696.88 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 3.63 0.481 2.77 848.9398 1,695.86 1,696.88 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 3.7 0.479 2.59 848.9398 1,695.86 1,696.88 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 3.27 0.531 2.77 848.9403 1,695.86 1,696.88 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 3.44 0.478 4.48 848.9404 1,695.87 1,696.88 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 3.52 0.459 3.21 848.9405 1,695.87 1,696.88 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 3.65 0.486 4.44 848.9406 1,695.87 1,696.88 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 3.57 0.521 3.24 848.9407 1,695.87 1,696.88 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 4.39 0.478 1.96 849.4404 1,696.87 1,696.88 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNK 95.00% 3.91 0.462 2.74 849.4419 1,696.87 1,696.88 2
 SAMPLE 2 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 15 20 78 36.50% DLPPDTTLLDLQNNKITEIKDGDFK 95.00% 2.13 0.443 2.28 948.8273 2,843.46 2,843.47 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% NQLKELPEKMPK 95.00% 4.15 0.383 1.22 485.6052 1,453.79 1,454.80 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% NQLKELPEKMPK 95.00% 3.7 0.246 1.31 485.6054 1,453.79 1,454.80 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% NQLKELPEKMPK 95.00% 4.11 0.381 2.15 485.6063 1,453.80 1,454.80 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% NQLKELPEKMPK 95.00% 4.08 0.244 1.07 485.9402 1,454.80 1,454.80 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% NQLKELPEKmPK 95.00% 2.85 0.312 0 m10: Oxidation (+15.99) 490.9386 1,469.79 1,470.80 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% ELHLDNNK 95.00% 2.1 0.369 0 491.7514 981.4872 982.4959 2 PGS1_HUMAN
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% ITEIKDGDFKNLK 95.00% 2.66 0.387 0 507.6149 1,519.82 1,520.83 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% ITEIKDGDFKNLK 95.00% 3.17 0.526 1.32 507.9492 1,520.82 1,520.83 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDKVPK 95.00% 2.34 0.299 0 c4: Carbamidomethyl (+57.02) 519.9463 1,556.82 1,557.83 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDKVPK 95.00% 1.87 0.266 0 c4: Carbamidomethyl (+57.02) 519.9476 1,556.82 1,557.83 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDKVPK 95.00% 2.74 0.434 2.3 c4: Carbamidomethyl (+57.02) 519.9482 1,556.82 1,557.83 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDKVPK 95.00% 1.83 0.368 0 c4: Carbamidomethyl (+57.02) 519.9483 1,556.82 1,557.83 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDKVPK 95.00% 2.2 0.455 1.89 c4: Carbamidomethyl (+57.02) 519.9488 1,556.82 1,557.83 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% TLQELRAHENEITK 95.00% 2.77 0.342 0 561.2993 1,680.87 1,681.89 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% TLQELRAHENEITK 95.00% 2.21 0.266 0 561.3018 1,680.88 1,681.89 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% TLQELRAHENEITK 95.00% 2.41 0.497 0 561.6343 1,681.88 1,681.89 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% TLQELRAHENEITK 95.00% 2.68 0.51 0 561.635 1,681.88 1,681.89 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.07 0.305 2.28 566.2966 1,695.87 1,696.88 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.2 0.491 1.05 566.2969 1,695.87 1,696.88 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.09 0.385 1.77 566.6295 1,696.87 1,696.88 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.47 0.327 0 566.6304 1,696.87 1,696.88 3
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% ITEIKDGDFK 95.00% 2.5 0.361 0 583.3083 1,164.60 1,165.61 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% ITEIKDGDFK 95.00% 2.18 0.283 1.18 583.3083 1,164.60 1,165.61 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% ITEIKDGDFK 95.00% 2.27 0.312 0 583.3102 1,164.60 1,165.61 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDK 95.00% 3.56 0.545 2.8 c4: Carbamidomethyl (+57.02) 617.3105 1,232.61 1,233.62 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDK 95.00% 3.11 0.401 4.64 c4: Carbamidomethyl (+57.02) 617.3111 1,232.61 1,233.62 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDK 95.00% 2.84 0.424 2.74 c4: Carbamidomethyl (+57.02) 617.3112 1,232.61 1,233.62 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDK 95.00% 2.59 0.353 1.62 c4: Carbamidomethyl (+57.02) 617.3112 1,232.61 1,233.62 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDK 95.00% 2.8 0.302 0 c4: Carbamidomethyl (+57.02) 617.3113 1,232.61 1,233.62 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% NLHALILVNNK 95.00% 2.57 0.172 1.6 624.8733 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% NLHALILVNNK 95.00% 3.81 0.378 1.96 624.8747 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% SSGIENGAFQGMK 95.00% 4.48 0.578 2.74 663.3105 1,324.61 1,325.62 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% SSGIENGAFQGMK 95.00% 4.46 0.567 2.8 663.3111 1,324.61 1,325.62 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% ELHLDNNKLTR 95.00% 2.17 0.219 1.31 677.3587 1,352.70 1,352.73 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% ELHLDNNKLTR 95.00% 2.45 0.311 0 677.3612 1,352.71 1,352.73 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% NQLKELPEKMPK 95.00% 3.58 0.189 0 727.9045 1,453.79 1,454.80 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% NQLKELPEKMPK 95.00% 3.78 0.241 1.26 727.9045 1,453.79 1,454.80 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% NQLKELPEKMPK 95.00% 3.61 0.221 0 727.9065 1,453.80 1,454.80 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% NQLKELPEKMPK 95.00% 3.03 0.157 0 727.9085 1,453.80 1,454.80 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VSPGAFTPLVKLER 95.00% 3.42 0.477 2.74 757.4419 1,512.87 1,513.87 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DFEPSLGPVcPFR 95.00% 2.85 0.452 2.68 c10: Carbamidomethyl (+57.02) 760.862 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DFEPSLGPVcPFR 95.00% 3.78 0.619 2.82 c10: Carbamidomethyl (+57.02) 760.8641 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DFEPSLGPVcPFR 95.00% 3.87 0.611 2.77 c10: Carbamidomethyl (+57.02) 760.8642 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DFEPSLGPVcPFR 95.00% 3.29 0.49 0 c10: Carbamidomethyl (+57.02) 760.8642 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% ITEIKDGDFKNLK 95.00% 3.93 0.373 1.48 760.9184 1,519.82 1,520.83 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% ITEIKDGDFKNLK 95.00% 4.06 0.356 2.44 760.9212 1,519.83 1,520.83 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DFEPSLGPVcPFR 95.00% 3.61 0.517 1.82 c10: Carbamidomethyl (+57.02) 761.3665 1,520.72 1,520.72 2 CAP1_HUMAN
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDKVPK 95.00% 4.02 0.402 4.04 c4: Carbamidomethyl (+57.02) 779.4177 1,556.82 1,557.83 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDKVPK 95.00% 4.09 0.485 3.77 c4: Carbamidomethyl (+57.02) 779.4177 1,556.82 1,557.83 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDKVPK 95.00% 4.38 0.47 3.62 c4: Carbamidomethyl (+57.02) 779.418 1,556.82 1,557.83 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDKVPK 95.00% 4.3 0.474 4.46 c4: Carbamidomethyl (+57.02) 779.4181 1,556.82 1,557.83 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDKVPK 95.00% 4.29 0.455 4.21 c4: Carbamidomethyl (+57.02) 779.4185 1,556.82 1,557.83 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% VVQcSDLGLDKVPK 95.00% 4.2 0.419 4.85 c4: Carbamidomethyl (+57.02) 779.4191 1,556.82 1,557.83 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% NLHALILVNNKISK 95.00% 2.05 0.304 1.4 788.8744 1,575.73 1,576.95 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 4.1 0.469 2.25 848.9385 1,695.86 1,696.88 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.5 0.43 1.64 848.9398 1,695.86 1,696.88 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.76 0.453 2.96 848.9399 1,695.86 1,696.88 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.83 0.489 3.26 848.9407 1,695.87 1,696.88 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.74 0.466 2.62 848.9408 1,695.87 1,696.88 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.47 0.423 2.8 848.9415 1,695.87 1,696.88 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.55 0.49 2.19 848.9422 1,695.87 1,696.88 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.81 0.489 1.85 849.4365 1,696.86 1,696.88 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.78 0.422 2.51 849.4425 1,696.87 1,696.88 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 3.98 0.425 2.22 849.4433 1,696.87 1,696.88 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNK 95.00% 4.06 0.35 2.68 849.4455 1,696.88 1,696.88 2
 SAMPLE 2R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 14 18 65 37.00% DLPPDTTLLDLQNNKITEIKDGDFK 95.00% 1.57 0.332 0.959 948.8261 2,843.45 2,843.47 3
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% AHENEITK 95.00% 2.26 0.252 0 471.2399 940.4641 941.4693 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% NQLKELPEKMPK 95.00% 3.65 0.314 0 485.6057 1,453.79 1,454.80 3
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% NQLKELPEKMPK 95.00% 4.64 0.324 0 485.9401 1,454.80 1,454.80 3
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDKVPK 95.00% 2.5 0.38 2.6 c4: Carbamidomethyl (+57.02) 519.9471 1,556.82 1,557.83 3
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDKVPK 95.00% 2.07 0.306 1.64 c4: Carbamidomethyl (+57.02) 519.9478 1,556.82 1,557.83 3
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDKVPK 95.00% 2.35 0.362 1.92 c4: Carbamidomethyl (+57.02) 519.9478 1,556.82 1,557.83 3
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDKVPK 95.00% 2.79 0.573 2.25 c4: Carbamidomethyl (+57.02) 519.948 1,556.82 1,557.83 3
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDKVPK 95.00% 2.93 0.508 2.14 c4: Carbamidomethyl (+57.02) 519.9482 1,556.82 1,557.83 3
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDKVPK 95.00% 2.09 0.302 0 c4: Carbamidomethyl (+57.02) 520.2817 1,557.82 1,557.83 3
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% DLPPDTTLLDLQNNK 95.00% 2.86 0.265 2.01 566.63 1,696.87 1,696.88 3
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% DLPPDTTLLDLQNNK 95.00% 3.52 0.32 1.02 566.6309 1,696.87 1,696.88 3
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% ITEIKDGDFK 95.00% 2.49 0.415 1.17 583.3083 1,164.60 1,165.61 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% ITEIKDGDFK 95.00% 2.51 0.335 1.12 583.3084 1,164.60 1,165.61 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDK 95.00% 3.72 0.506 3.23 c4: Carbamidomethyl (+57.02) 617.31 1,232.60 1,233.62 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDK 95.00% 3.95 0.532 2.82 c4: Carbamidomethyl (+57.02) 617.3102 1,232.60 1,233.62 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDK 95.00% 3.8 0.481 3.47 c4: Carbamidomethyl (+57.02) 617.3106 1,232.61 1,233.62 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDK 95.00% 3.33 0.486 4.32 c4: Carbamidomethyl (+57.02) 617.3107 1,232.61 1,233.62 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDK 95.00% 3.38 0.382 2.38 c4: Carbamidomethyl (+57.02) 617.311 1,232.61 1,233.62 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDK 95.00% 3.53 0.471 3.03 c4: Carbamidomethyl (+57.02) 617.3114 1,232.61 1,233.62 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% NLHALILVNNK 95.00% 3.62 0.513 1.55 624.8736 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% NLHALILVNNK 95.00% 1.99 0.284 0 624.874 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% NLHALILVNNK 95.00% 3.43 0.495 2.36 624.8742 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% SSGIENGAFQGMK 95.00% 4.09 0.549 3.59 663.3108 1,324.61 1,325.62 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% SSGIENGAFQGMK 95.00% 4.46 0.571 5.1 663.3109 1,324.61 1,325.62 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% SSGIENGAFQGMK 95.00% 4.16 0.567 3.41 663.3112 1,324.61 1,325.62 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% DFEPSLGPVcPFR 95.00% 3.71 0.605 2.85 c10: Carbamidomethyl (+57.02) 760.864 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% DFEPSLGPVcPFR 95.00% 3.52 0.634 3.38 c10: Carbamidomethyl (+57.02) 760.8644 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDKVPK 95.00% 3.57 0.407 2.54 c4: Carbamidomethyl (+57.02) 779.4174 1,556.82 1,557.83 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDKVPK 95.00% 4.13 0.429 3 c4: Carbamidomethyl (+57.02) 779.4187 1,556.82 1,557.83 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDKVPK 95.00% 3.95 0.439 3.62 c4: Carbamidomethyl (+57.02) 779.419 1,556.82 1,557.83 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDKVPK 95.00% 4.21 0.448 4.37 c4: Carbamidomethyl (+57.02) 779.4193 1,556.82 1,557.83 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDKVPK 95.00% 4.25 0.52 4.36 c4: Carbamidomethyl (+57.02) 779.421 1,556.83 1,557.83 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% VVQcSDLGLDKVPK 95.00% 4.02 0.408 2.8 c4: Carbamidomethyl (+57.02) 779.921 1,557.83 1,557.83 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% DLPPDTTLLDLQNNK 95.00% 2.98 0.381 2.12 848.9405 1,695.87 1,696.88 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% DLPPDTTLLDLQNNK 95.00% 3.84 0.46 1.8 848.9405 1,695.87 1,696.88 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% DLPPDTTLLDLQNNK 95.00% 3.73 0.459 1.82 848.9407 1,695.87 1,696.88 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% DLPPDTTLLDLQNNK 95.00% 3.1 0.346 1.7 848.9408 1,695.87 1,696.88 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% DLPPDTTLLDLQNNK 95.00% 3.4 0.471 1.57 848.9413 1,695.87 1,696.88 2
 SAMPLE 3 Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 9 11 39 26.70% DLPPDTTLLDLQNNK 95.00% 3.35 0.435 2.89 848.9416 1,695.87 1,696.88 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% NQLKELPEKMPK 95.00% 4.11 0.349 1.57 485.6048 1,453.79 1,454.80 3
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% NQLKELPEKMPK 95.00% 4.11 0.308 0 485.605 1,453.79 1,454.80 3
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDKVPK 95.00% 1.73 0.176 1.35 c4: Carbamidomethyl (+57.02) 519.9476 1,556.82 1,557.83 3
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDKVPK 95.00% 2.06 0.373 0 c4: Carbamidomethyl (+57.02) 519.9479 1,556.82 1,557.83 3
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDKVPK 95.00% 2.06 0.434 0 c4: Carbamidomethyl (+57.02) 519.9484 1,556.82 1,557.83 3
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% DLPPDTTLLDLQNNK 95.00% 3.36 0.351 1.29 566.2966 1,695.87 1,696.88 3
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% DLPPDTTLLDLQNNK 95.00% 3.54 0.283 1.11 566.2966 1,695.87 1,696.88 3
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% DLPPDTTLLDLQNNK 95.00% 3.14 0.273 2.14 566.6289 1,696.86 1,696.88 3
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDK 95.00% 3.05 0.393 3.48 c4: Carbamidomethyl (+57.02) 617.3075 1,232.60 1,233.62 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDK 95.00% 3.75 0.479 2.92 c4: Carbamidomethyl (+57.02) 617.3091 1,232.60 1,233.62 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDK 95.00% 3.6 0.557 3.39 c4: Carbamidomethyl (+57.02) 617.3094 1,232.60 1,233.62 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDK 95.00% 3.59 0.483 3 c4: Carbamidomethyl (+57.02) 617.3097 1,232.60 1,233.62 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDK 95.00% 2.65 0.351 2.82 c4: Carbamidomethyl (+57.02) 617.3102 1,232.60 1,233.62 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDK 95.00% 2.73 0.377 1.27 c4: Carbamidomethyl (+57.02) 617.3108 1,232.61 1,233.62 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDK 95.00% 3.29 0.428 3.06 c4: Carbamidomethyl (+57.02) 617.3113 1,232.61 1,233.62 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDK 95.00% 3.65 0.497 3.28 c4: Carbamidomethyl (+57.02) 617.3116 1,232.61 1,233.62 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% NLHALILVNNK 95.00% 2.57 0.438 2.37 624.8737 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% NLHALILVNNK 95.00% 2.39 0.149 1.72 624.8744 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% NLHALILVNNK 95.00% 2.57 0.385 1.46 624.875 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% NLHALILVNNK 95.00% 3.05 0.409 2.06 624.8752 1,247.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% NLHALILVNNK 95.00% 2.18 0.232 2.42 625.3736 1,248.73 1,248.74 2 PGK1_HUMAN
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% SSGIENGAFQGMK 95.00% 3.95 0.517 2.44 663.3108 1,324.61 1,325.62 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% SSGIENGAFQGMK 95.00% 3.42 0.331 0 663.3109 1,324.61 1,325.62 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% SSGIENGAFQGMK 95.00% 4.04 0.568 0 663.3112 1,324.61 1,325.62 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% SSGIENGAFQGMK 95.00% 4.05 0.5 1.48 663.3112 1,324.61 1,325.62 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% DFEPSLGPVcPFR 95.00% 3.63 0.638 2.59 c10: Carbamidomethyl (+57.02) 760.8623 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% DFEPSLGPVcPFR 95.00% 3.65 0.606 2.19 c10: Carbamidomethyl (+57.02) 760.8626 1,519.71 1,520.72 2 CAP1_HUMAN
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDKVPK 95.00% 4.2 0.366 3.92 c4: Carbamidomethyl (+57.02) 779.4171 1,556.82 1,557.83 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDKVPK 95.00% 3.74 0.483 2.64 c4: Carbamidomethyl (+57.02) 779.4185 1,556.82 1,557.83 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDKVPK 95.00% 3.43 0.434 1.43 c4: Carbamidomethyl (+57.02) 779.4188 1,556.82 1,557.83 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDKVPK 95.00% 4.04 0.467 3.01 c4: Carbamidomethyl (+57.02) 779.419 1,556.82 1,557.83 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDKVPK 95.00% 4.25 0.494 3.7 c4: Carbamidomethyl (+57.02) 779.9204 1,557.83 1,557.83 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% VVQcSDLGLDKVPK 95.00% 4.36 0.387 4 c4: Carbamidomethyl (+57.02) 779.9207 1,557.83 1,557.83 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% DLPPDTTLLDLQNNK 95.00% 3.32 0.417 2.41 848.9398 1,695.86 1,696.88 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% DLPPDTTLLDLQNNK 95.00% 3.63 0.453 2.49 848.941 1,695.87 1,696.88 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% DLPPDTTLLDLQNNK 95.00% 2.93 0.35 2.47 848.9411 1,695.87 1,696.88 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% DLPPDTTLLDLQNNK 95.00% 3.62 0.447 2.25 848.9411 1,695.87 1,696.88 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% DLPPDTTLLDLQNNK 95.00% 3.61 0.448 2.15 848.9417 1,695.87 1,696.88 2
 SAMPLE 3R Decorin  DCN  PGS2_HUMAN 39,730.20 100.00% 7 9 39 21.70% DLPPDTTLLDLQNNK 95.00% 3.27 0.376 2.4 848.9426 1,695.87 1,696.88 2
 SAMPLE 1 Dedicator of cytokinesis protein 9  DOCK9  DOCK9_HUMAN 236,433.00 99.80% 2 2 2 1.98% DSDEEDSQPLKcIYGR 95.00% 2.71 0.203 0 c12: Carbamidomethyl (+57.02) 956.4408 1,910.87 1,911.84 2
 SAMPLE 1 Dedicator of cytokinesis protein 9  DOCK9  DOCK9_HUMAN 236,433.00 99.80% 2 2 2 1.98% KRIPVMYQHHTDLNPIEVAIDEMSK 95.00% 2.29 0.338 0 988.5421 2,962.60 2,964.51 3
 SAMPLE 2 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial  ECH1  ECH1_HUMAN 35,798.20 99.80% 2 2 2 8.23% YcAQDAFFQVK 95.00% 1.78 0.369 0 c2: Carbamidomethyl (+57.02) 688.3467 1,374.68 1,376.63 2
 SAMPLE 2 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial  ECH1  ECH1_HUMAN 35,798.20 99.80% 2 2 2 8.23% VIGNQSLVNELAFTAR 95.00% 3.97 0.586 4.64 866.4724 1,730.93 1,731.94 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% YFESVLDR 95.00% 2.14 0.346 0 514.7579 1,027.50 1,028.51 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.23 0.445 1.6 570.2888 1,138.56 1,139.57 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.43 0.458 1.15 570.2897 1,138.56 1,139.57 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.35 0.449 2.13 570.2897 1,138.56 1,139.57 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.74 0.459 2.38 570.2899 1,138.56 1,139.57 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.39 0.428 0 570.2899 1,138.56 1,139.57 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.4 0.426 2.17 570.2899 1,138.56 1,139.57 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.76 0.465 2.92 570.2903 1,138.57 1,139.57 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.42 0.42 2.42 570.2907 1,138.57 1,139.57 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 2.64 0.308 0 570.2917 1,138.57 1,139.57 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.08 0.363 1.37 570.7902 1,139.56 1,139.57 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% EWQFYccR 95.00% 2.3 0.292 0 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 624.7525 1,247.49 1,248.49 2 A1AT_HUMAN
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% EWQFYccR 95.00% 2.44 0.354 0 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 624.7527 1,247.49 1,248.49 2 A1AT_HUMAN
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% EWQFYccR 95.00% 2.27 0.32 1.18 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 624.7528 1,247.49 1,248.49 2 A1AT_HUMAN
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 3.71 0.473 0 c7: Carbamidomethyl (+57.02) 646.3317 1,935.97 1,936.97 3
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% MTEYDcEFANV 95.00% 3.46 0.618 3.89 c6: Carbamidomethyl (+57.02) 689.7699 1,377.52 1,378.53 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% MTEYDcEFANV 95.00% 3.52 0.605 3.77 c6: Carbamidomethyl (+57.02) 689.7713 1,377.53 1,378.53 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% mTEYDcEFANV 95.00% 2.2 0.421 0 m1: Oxidation (+15.99), c6: Carbamidomethyl (+57.02) 698.2826 1,394.55 1,394.52 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% mTEYDcEFANV 95.00% 1.93 0.357 0 m1: Oxidation (+15.99), c6: Carbamidomethyl (+57.02) 698.2835 1,394.55 1,394.52 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.06 0.581 2.72 c7: Carbamidomethyl (+57.02) 968.9914 1,935.97 1,936.97 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.13 0.621 4.92 c7: Carbamidomethyl (+57.02) 968.9922 1,935.97 1,936.97 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 4.88 0.576 3.96 c7: Carbamidomethyl (+57.02) 968.9923 1,935.97 1,936.97 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.01 0.545 3.38 c7: Carbamidomethyl (+57.02) 969.4906 1,936.97 1,936.97 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.07 0.537 4.77 c7: Carbamidomethyl (+57.02) 969.4939 1,936.97 1,936.97 2
 SAMPLE 4 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 4.97 0.545 4.74 c7: Carbamidomethyl (+57.02) 969.4973 1,936.98 1,936.97 2
 SAMPLE 1R Dermatopontin  DPT  DERM_HUMAN 23,986.70 100.00% 3 4 6 27.40% YFESVLDR 95.00% 2.26 0.246 0 514.7551 1,027.49 1,028.51 2
 SAMPLE 1R Dermatopontin  DPT  DERM_HUMAN 23,986.70 100.00% 3 4 6 27.40% YFESVLDR 95.00% 2.81 0.297 0 514.7644 1,027.51 1,028.51 2
 SAMPLE 1R Dermatopontin  DPT  DERM_HUMAN 23,986.70 100.00% 3 4 6 27.40% YFESVLDR 95.00% 2.14 0.255 0 515.2563 1,028.50 1,028.51 2
 SAMPLE 1R Dermatopontin  DPT  DERM_HUMAN 23,986.70 100.00% 3 4 6 27.40% GATTTFSAVER 95.00% 2.68 0.458 0 570.2994 1,138.58 1,139.57 2
 SAMPLE 1R Dermatopontin  DPT  DERM_HUMAN 23,986.70 100.00% 3 4 6 27.40% GATTTFSAVER 95.00% 2.99 0.418 0 570.7895 1,139.56 1,139.57 2
 SAMPLE 1R Dermatopontin  DPT  DERM_HUMAN 23,986.70 100.00% 3 4 6 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.16 0.518 2.52 c7: Carbamidomethyl (+57.02) 646.6744 1,937.00 1,936.97 3
 SAMPLE 1R Dermatopontin  DPT  DERM_HUMAN 23,986.70 100.00% 3 4 6 27.40% MTEYDcEFANV 95.00% 3.2 0.6 3.52 c6: Carbamidomethyl (+57.02) 689.7678 1,377.52 1,378.53 2
 SAMPLE 1R Dermatopontin  DPT  DERM_HUMAN 23,986.70 100.00% 3 4 6 27.40% MTEYDcEFANV 95.00% 3.02 0.473 4.51 c6: Carbamidomethyl (+57.02) 689.7801 1,377.54 1,378.53 2
 SAMPLE 1R Dermatopontin  DPT  DERM_HUMAN 23,986.70 100.00% 3 4 6 27.40% MTEYDcEFANV 95.00% 3.29 0.581 3.85 c6: Carbamidomethyl (+57.02) 689.7812 1,377.55 1,378.53 2
 SAMPLE 1R Dermatopontin  DPT  DERM_HUMAN 23,986.70 100.00% 3 4 6 27.40% mTEYDcEFANV 95.00% 2.71 0.441 2.49 m1: Oxidation (+15.99), c6: Carbamidomethyl (+57.02) 697.7788 1,393.54 1,394.52 2
 SAMPLE 1R Dermatopontin  DPT  DERM_HUMAN 23,986.70 100.00% 3 4 6 27.40% YFESVLDREWQFYccR 95.00% 2.38 0.3 0 c14: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 753.6808 2,258.02 2,257.98 3
 SAMPLE 1R Dermatopontin  DPT  DERM_HUMAN 23,986.70 100.00% 3 4 6 27.40% QGFSYQcPQGQVIVAVR 95.00% 4.42 0.557 2.3 c7: Carbamidomethyl (+57.02) 969.5075 1,937.00 1,936.97 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% YFESVLDR 95.00% 2.76 0.401 0 514.7543 1,027.49 1,028.51 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% YFESVLDR 95.00% 2.94 0.415 1.11 514.7548 1,027.49 1,028.51 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% YFESVLDR 95.00% 2.8 0.437 0 514.755 1,027.49 1,028.51 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% YFESVLDR 95.00% 3.05 0.471 0 514.7552 1,027.49 1,028.51 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% YFESVLDR 95.00% 2.16 0.412 0 514.7557 1,027.50 1,028.51 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% YFESVLDR 95.00% 2.12 0.417 1.7 514.7567 1,027.50 1,028.51 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.58 0.437 1.51 570.2841 1,138.55 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 2.38 0.221 0 570.2843 1,138.55 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.42 0.449 1.82 570.2861 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.5 0.448 1.57 570.2865 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 2.68 0.248 0 570.2869 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.62 0.469 1.42 570.287 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 2.75 0.355 0 570.2873 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.74 0.451 2.39 570.2875 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 2.6 0.291 0 570.2876 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.75 0.436 2.51 570.2877 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.71 0.468 1.21 570.2879 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.65 0.458 2.6 570.2882 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 2.53 0.345 0 570.2883 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 2.1 0.266 1.6 570.2895 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 2.62 0.341 0 570.2901 1,138.56 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 2.25 0.384 0 570.2927 1,138.57 1,139.57 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% EWQFYccR 95.00% 2.16 0.316 1.21 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 624.7484 1,247.48 1,248.49 2 A1AT_HUMAN
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% EWQFYccR 95.00% 2.44 0.337 0 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 624.7498 1,247.48 1,248.49 2 A1AT_HUMAN
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% QGFSYQcPQGQVIVAVR 95.00% 3.38 0.351 0 c7: Carbamidomethyl (+57.02) 646.3273 1,935.96 1,936.97 3
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.08 0.551 1.64 c7: Carbamidomethyl (+57.02) 646.6619 1,936.96 1,936.97 3
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% MTEYDcEFANV 95.00% 2.71 0.323 3.32 c6: Carbamidomethyl (+57.02) 689.7671 1,377.52 1,378.53 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% MTEYDcEFANV 95.00% 3.49 0.526 3.66 c6: Carbamidomethyl (+57.02) 689.7681 1,377.52 1,378.53 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% MTEYDcEFANV 95.00% 3.69 0.63 4.35 c6: Carbamidomethyl (+57.02) 689.7682 1,377.52 1,378.53 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.16 0.577 4.92 c7: Carbamidomethyl (+57.02) 968.9875 1,935.96 1,936.97 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% QGFSYQcPQGQVIVAVR 95.00% 4.98 0.546 3.8 c7: Carbamidomethyl (+57.02) 969.4872 1,936.96 1,936.97 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.08 0.545 6.04 c7: Carbamidomethyl (+57.02) 969.4886 1,936.96 1,936.97 2
 SAMPLE 2 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.02 0.527 3.59 c7: Carbamidomethyl (+57.02) 969.4906 1,936.97 1,936.97 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% YFESVLDR 95.00% 2.87 0.417 0 514.7545 1,027.49 1,028.51 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% YFESVLDR 95.00% 2.77 0.416 0 514.7547 1,027.49 1,028.51 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% YFESVLDR 95.00% 3.07 0.432 0 514.7547 1,027.49 1,028.51 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% YFESVLDR 95.00% 2.96 0.485 0 514.7547 1,027.49 1,028.51 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% YFESVLDR 95.00% 2.47 0.352 1.8 514.7549 1,027.49 1,028.51 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% YFESVLDR 95.00% 2.1 0.408 2.01 514.7563 1,027.50 1,028.51 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 2.69 0.308 0 570.2841 1,138.55 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 2.47 0.288 0 570.2841 1,138.55 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 2.44 0.365 0 570.2846 1,138.55 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 2.59 0.195 0 570.2856 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 2.35 0.24 0 570.2857 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 3.53 0.412 1.44 570.2873 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 3.63 0.451 1.85 570.2873 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 3.61 0.457 1.54 570.2873 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 2.39 0.303 1.52 570.2874 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 3.55 0.434 1.48 570.2875 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 3.71 0.427 1.68 570.2876 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 3.68 0.456 2.68 570.2877 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 3.59 0.46 2.57 570.2877 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 2.59 0.351 0 570.2879 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 3.54 0.462 2.21 570.288 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 2.79 0.327 1.13 570.2882 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 2.91 0.317 1.28 570.2891 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 2.42 0.33 1.32 570.2899 1,138.56 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 2.5 0.345 0 570.2909 1,138.57 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% GATTTFSAVER 95.00% 2.98 0.406 0 570.7914 1,139.57 1,139.57 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% EWQFYccR 95.00% 2.33 0.349 0 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 624.7495 1,247.48 1,248.49 2 A1AT_HUMAN
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% QGFSYQcPQGQVIVAVR 95.00% 3.44 0.376 1.54 c7: Carbamidomethyl (+57.02) 646.3276 1,935.96 1,936.97 3
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% QGFSYQcPQGQVIVAVR 95.00% 4.65 0.469 1.92 c7: Carbamidomethyl (+57.02) 646.662 1,936.96 1,936.97 3
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.23 0.513 1.64 c7: Carbamidomethyl (+57.02) 646.6621 1,936.96 1,936.97 3
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% MTEYDcEFANV 95.00% 3.7 0.486 3.72 c6: Carbamidomethyl (+57.02) 689.7663 1,377.52 1,378.53 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% MTEYDcEFANV 95.00% 2.18 0.463 2.54 c6: Carbamidomethyl (+57.02) 689.7672 1,377.52 1,378.53 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% MTEYDcEFANV 95.00% 3.59 0.307 4 c6: Carbamidomethyl (+57.02) 689.7673 1,377.52 1,378.53 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% MTEYDcEFANV 95.00% 3.59 0.608 3.96 c6: Carbamidomethyl (+57.02) 689.7675 1,377.52 1,378.53 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% MTEYDcEFANV 95.00% 3.15 0.437 3.82 c6: Carbamidomethyl (+57.02) 689.7683 1,377.52 1,378.53 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.2 0.62 3.92 c7: Carbamidomethyl (+57.02) 968.9873 1,935.96 1,936.97 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.13 0.553 4.52 c7: Carbamidomethyl (+57.02) 969.4873 1,936.96 1,936.97 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.05 0.534 3.92 c7: Carbamidomethyl (+57.02) 969.4907 1,936.97 1,936.97 2
 SAMPLE 2R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 13 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.03 0.527 4.37 c7: Carbamidomethyl (+57.02) 969.4908 1,936.97 1,936.97 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% YFESVLDR 95.00% 3.08 0.466 0 514.7548 1,027.49 1,028.51 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% YFESVLDR 95.00% 3.17 0.471 0 514.7558 1,027.50 1,028.51 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 2.93 0.417 0 570.2864 1,138.56 1,139.57 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.15 0.419 0 570.2874 1,138.56 1,139.57 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.22 0.402 0 570.2876 1,138.56 1,139.57 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.51 0.462 1.92 570.2877 1,138.56 1,139.57 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 3.71 0.436 2.85 570.2879 1,138.56 1,139.57 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% GATTTFSAVER 95.00% 2.7 0.405 0 570.2892 1,138.56 1,139.57 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% EWQFYccR 95.00% 2.32 0.337 0 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 624.7493 1,247.48 1,248.49 2 A1AT_HUMAN
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% EWQFYccR 95.00% 2.03 0.255 0 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 624.7495 1,247.48 1,248.49 2 A1AT_HUMAN
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 4.89 0.587 2.27 c7: Carbamidomethyl (+57.02) 646.3286 1,935.96 1,936.97 3
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.28 0.562 2.36 c7: Carbamidomethyl (+57.02) 646.6622 1,936.96 1,936.97 3
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% MTEYDcEFANV 95.00% 2.85 0.53 3.7 c6: Carbamidomethyl (+57.02) 689.7667 1,377.52 1,378.53 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% MTEYDcEFANV 95.00% 3.38 0.612 3.8 c6: Carbamidomethyl (+57.02) 689.7667 1,377.52 1,378.53 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% MTEYDcEFANV 95.00% 3.35 0.618 4.92 c6: Carbamidomethyl (+57.02) 689.7675 1,377.52 1,378.53 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% MTEYDcEFANV 95.00% 3.26 0.573 5 c6: Carbamidomethyl (+57.02) 689.768 1,377.52 1,378.53 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.12 0.584 4.02 c7: Carbamidomethyl (+57.02) 968.9876 1,935.96 1,936.97 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 4.7 0.566 3.85 c7: Carbamidomethyl (+57.02) 968.9878 1,935.96 1,936.97 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.05 0.515 4 c7: Carbamidomethyl (+57.02) 969.4874 1,936.96 1,936.97 2
 SAMPLE 3 Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 8 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.22 0.532 4.43 c7: Carbamidomethyl (+57.02) 969.4883 1,936.96 1,936.97 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% YFESVLDR 95.00% 2.78 0.456 0 514.7547 1,027.49 1,028.51 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% YFESVLDR 95.00% 2.14 0.221 0 514.7552 1,027.49 1,028.51 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% YFESVLDR 95.00% 2.91 0.486 0 514.7552 1,027.49 1,028.51 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% YFESVLDR 95.00% 3.06 0.46 0 514.7555 1,027.50 1,028.51 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% YFESVLDR 95.00% 2.83 0.434 0 514.756 1,027.50 1,028.51 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% YFESVLDR 95.00% 2.28 0.253 0 514.7561 1,027.50 1,028.51 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.37 0.442 1.39 570.287 1,138.56 1,139.57 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.49 0.44 2.74 570.2874 1,138.56 1,139.57 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.25 0.398 0 570.2875 1,138.56 1,139.57 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.34 0.433 1.55 570.2877 1,138.56 1,139.57 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% GATTTFSAVER 95.00% 3.43 0.448 1.68 570.2881 1,138.56 1,139.57 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% EWQFYccR 95.00% 2.36 0.241 0 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 624.7486 1,247.48 1,248.49 2 A1AT_HUMAN
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% QGFSYQcPQGQVIVAVR 95.00% 4.72 0.453 3.09 c7: Carbamidomethyl (+57.02) 646.6619 1,936.96 1,936.97 3
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% QGFSYQcPQGQVIVAVR 95.00% 3.59 0.372 1.85 c7: Carbamidomethyl (+57.02) 646.6628 1,936.96 1,936.97 3
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% MTEYDcEFANV 95.00% 3.16 0.523 4.39 c6: Carbamidomethyl (+57.02) 689.7678 1,377.52 1,378.53 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% MTEYDcEFANV 95.00% 3.21 0.564 3.47 c6: Carbamidomethyl (+57.02) 689.768 1,377.52 1,378.53 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% MTEYDcEFANV 95.00% 3.6 0.605 5.66 c6: Carbamidomethyl (+57.02) 690.2693 1,378.52 1,378.53 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.02 0.578 5.34 c7: Carbamidomethyl (+57.02) 968.989 1,935.96 1,936.97 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% QGFSYQcPQGQVIVAVR 95.00% 4.94 0.53 4.74 c7: Carbamidomethyl (+57.02) 969.4865 1,936.96 1,936.97 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% QGFSYQcPQGQVIVAVR 95.00% 5.04 0.513 4.16 c7: Carbamidomethyl (+57.02) 969.4886 1,936.96 1,936.97 2
 SAMPLE 3R Dermatopontin  DPT  DERM_HUMAN 23,986.70 99.80% 2 3 12 27.40% QGFSYQcPQGQVIVAVR 95.00% 4.82 0.528 5.27 c7: Carbamidomethyl (+57.02) 969.4895 1,936.96 1,936.97 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DIRAQYETIAAK 95.00% 3.15 0.254 1.96 460.2511 1,377.73 1,378.73 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DIRAQYETIAAK 95.00% 3.55 0.303 1.7 460.2519 1,377.73 1,378.73 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYRK 95.00% 3.53 0.473 1.66 470.5885 1,408.74 1,409.75 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYRK 95.00% 3.04 0.397 1.32 470.5885 1,408.74 1,409.75 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYRK 95.00% 2.8 0.418 0 470.5889 1,408.74 1,409.75 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYRK 95.00% 2.34 0.277 0 470.5907 1,408.75 1,409.75 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% mALDVEIATYRK 95.00% 2.59 0.243 0 m1: Oxidation (+15.99) 475.919 1,424.73 1,425.74 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% mALDVEIATYRK 95.00% 2.8 0.293 0 m1: Oxidation (+15.99) 475.9197 1,424.74 1,425.74 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% mALDVEIATYRK 95.00% 2.75 0.256 0 m1: Oxidation (+15.99) 475.9206 1,424.74 1,425.74 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% AQYETIAAK 95.00% 2.13 0.313 0 497.7665 993.5174 994.521 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% AQYETIAAK 95.00% 2.25 0.403 0 497.7673 993.519 994.521 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HLREYQDLLNVK 95.00% 4.52 0.401 1.11 509.9485 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HLREYQDLLNVK 95.00% 5.09 0.357 0 509.9492 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HLREYQDLLNVK 95.00% 3.57 0.267 0 509.9493 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HLREYQDLLNVK 95.00% 4.21 0.352 0 510.2816 1,527.82 1,527.83 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HLREYQDLLNVK 95.00% 4.88 0.382 0 510.282 1,527.82 1,527.83 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% IESLNEEIAFLKK 95.00% 3.09 0.344 0 511.9565 1,532.85 1,533.85 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% IESLNEEIAFLKK 95.00% 2.59 0.236 0 511.9567 1,532.85 1,533.85 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% IESLNEEIAFLKK 95.00% 4 0.439 0 511.9568 1,532.85 1,533.85 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% IESLNEEIAFLKK 95.00% 2.48 0.311 0 511.9569 1,532.85 1,533.85 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% IESLNEEIAFLKK 95.00% 3.33 0.369 0 511.957 1,532.85 1,533.85 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLK 95.00% 2.8 0.387 0 521.2916 1,560.85 1,561.86 3 PLEC1_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLK 95.00% 3.74 0.354 1.35 521.2916 1,560.85 1,561.86 3 PLEC1_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLK 95.00% 3.16 0.319 1.8 521.2919 1,560.85 1,561.86 3 PLEC1_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLK 95.00% 2.47 0.29 0 521.2922 1,560.85 1,561.86 3 PLEC1_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLK 95.00% 2.88 0.385 2.89 521.2923 1,560.85 1,561.86 3 PLEC1_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLK 95.00% 4.28 0.345 1.68 521.2926 1,560.85 1,561.86 3 PLEC1_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLK 95.00% 2.85 0.232 0 521.6266 1,561.86 1,561.86 3 PLEC1_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANK 95.00% 2.59 0.377 1.35 523.7815 1,045.55 1,046.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 3.9 0.314 0 529.9384 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 4.16 0.339 1.46 529.9384 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 3.67 0.38 0 529.9385 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 2.54 0.214 0 529.9385 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 4.07 0.29 1.02 529.9387 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 4.03 0.344 1.25 529.939 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 2.82 0.235 0 529.939 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 4.05 0.333 1.28 529.9391 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 3.59 0.329 0 529.9395 1,586.80 1,587.80 3 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% QVEVLTNQR 95.00% 2.61 0.294 0 543.7996 1,085.58 1,086.59 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% QVEVLTNQR 95.00% 2.38 0.241 0 543.8005 1,085.59 1,086.59 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELR 95.00% 2.41 0.509 0 550.2903 1,647.85 1,648.85 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELR 95.00% 2.85 0.525 0 550.2907 1,647.85 1,648.85 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELR 95.00% 2.65 0.504 0 550.2907 1,647.85 1,648.85 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELR 95.00% 2.44 0.456 1.34 550.2907 1,647.85 1,648.85 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELR 95.00% 2.6 0.521 1.35 550.2911 1,647.85 1,648.85 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELR 95.00% 2.75 0.544 0 550.6251 1,648.85 1,648.85 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELR 95.00% 3.01 0.52 1.08 550.6259 1,648.85 1,648.85 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% INLPIQTYSALNFR 95.00% 3.77 0.477 2.55 550.6403 1,648.90 1,649.90 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% INLPIQTYSALNFR 95.00% 4.38 0.591 2.55 550.6405 1,648.90 1,649.90 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% INLPIQTYSALNFR 95.00% 4.25 0.545 2.29 550.641 1,648.90 1,649.90 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% INLPIQTYSALNFR 95.00% 4.6 0.545 2.8 550.9742 1,649.90 1,649.90 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 3.22 0.331 0 551.2812 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 2.94 0.323 0 551.2815 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 3.07 0.288 0 551.2815 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 3.28 0.303 1.37 551.2816 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 2.29 0.335 1.43 551.2816 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 3.17 0.328 0 551.2818 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 3.08 0.327 0 551.282 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 2.84 0.311 0 551.2821 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 3.18 0.349 0 551.2821 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 3.3 0.363 0 551.2823 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 3.34 0.326 0 551.2824 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 3.26 0.322 0 551.2826 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 3.23 0.362 0 551.2826 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DNLLDDLQR 95.00% 3.12 0.323 1.21 551.2848 1,100.55 1,101.55 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VELQELNDR 95.00% 2.84 0.362 1.37 558.2888 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VELQELNDR 95.00% 2.64 0.272 1.6 558.2891 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VELQELNDR 95.00% 2.51 0.324 1.55 558.2893 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VELQELNDR 95.00% 3.25 0.355 0 558.2896 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VELQELNDR 95.00% 3.08 0.316 0 558.2898 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VELQELNDR 95.00% 2.87 0.328 1.24 558.29 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VELQELNDR 95.00% 2.63 0.312 1.19 558.2901 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VELQELNDR 95.00% 2.88 0.361 1.68 558.2902 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 4.01 0.368 0 558.6254 1,672.85 1,673.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 3.82 0.355 1.85 558.627 1,672.86 1,673.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 4.07 0.329 1.57 558.6271 1,672.86 1,673.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 3.13 0.228 0 558.6279 1,672.86 1,673.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 4.54 0.351 1.05 558.9608 1,673.86 1,673.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.21 0.364 0 561.2964 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.14 0.315 0 561.2966 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.18 0.304 0 561.2967 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.04 0.36 0 561.2968 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.22 0.387 1.42 561.2969 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.2 0.34 0 561.2969 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.11 0.39 0 561.2972 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.08 0.412 0 561.2972 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.14 0.32 0 561.2973 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.07 0.306 0 561.2973 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2 0.258 0 561.2975 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.23 0.369 0 561.2975 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.31 0.393 0 561.2975 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.16 0.353 0 561.2977 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EYQDLLNVK 95.00% 2.15 0.39 0 561.298 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 5.8 0.419 3.11 563.9902 1,688.95 1,689.95 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 5.69 0.439 2.89 563.9904 1,688.95 1,689.95 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 6.3 0.419 2.66 563.9904 1,688.95 1,689.95 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 5.74 0.398 2.34 563.9905 1,688.95 1,689.95 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 4.73 0.391 1.27 563.9907 1,688.95 1,689.95 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 5.81 0.397 2.89 563.9913 1,688.95 1,689.95 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 5.26 0.46 2.28 563.992 1,688.95 1,689.95 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 5.66 0.349 3.46 564.3239 1,689.95 1,689.95 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 4.36 0.348 1.6 564.3243 1,689.95 1,689.95 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 5.39 0.483 2.17 564.3246 1,689.95 1,689.95 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 4.04 0.401 0 564.3251 1,689.95 1,689.95 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 5.57 0.445 1.31 564.3251 1,689.95 1,689.95 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 4.17 0.319 1.05 567.2927 1,698.85 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.34 0.228 0 567.2928 1,698.85 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.82 0.31 0 567.2929 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 2.57 0.278 0 567.2929 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.73 0.368 0 567.293 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.39 0.317 0 567.293 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.31 0.353 0 567.2931 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.52 0.33 1.03 567.2931 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 4.47 0.344 0 567.2931 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.81 0.33 0 567.2932 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 4.38 0.354 0.959 567.2933 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.61 0.253 0 567.2933 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.91 0.37 0 567.2935 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.34 0.278 1 567.2935 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.51 0.236 0 567.2936 1,698.86 1,699.86 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 3.78 0.478 0 c8: Carbamidomethyl (+57.02) 569.2803 1,704.82 1,705.82 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 3.15 0.458 1.24 c8: Carbamidomethyl (+57.02) 569.2808 1,704.82 1,705.82 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 3.45 0.444 0 c8: Carbamidomethyl (+57.02) 569.2808 1,704.82 1,705.82 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 3.52 0.42 0 c8: Carbamidomethyl (+57.02) 569.2811 1,704.82 1,705.82 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 4.44 0.444 0 c8: Carbamidomethyl (+57.02) 569.615 1,705.82 1,705.82 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 3.73 0.45 0 c8: Carbamidomethyl (+57.02) 569.6162 1,705.83 1,705.82 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FANYIEKVR 95.00% 2.14 0.25 0 570.3153 1,138.62 1,139.62 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANKNNDALR 95.00% 4.16 0.388 0 577.3017 1,728.88 1,729.88 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANKNNDALR 95.00% 3.89 0.366 0 577.6369 1,729.89 1,729.88 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELRR 95.00% 3.14 0.36 0 602.3251 1,803.95 1,804.96 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELRR 95.00% 3.17 0.407 0 602.3252 1,803.95 1,804.96 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELRR 95.00% 2.69 0.23 1.12 602.3259 1,803.95 1,804.96 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELRR 95.00% 3.31 0.394 1.12 602.6592 1,804.95 1,804.96 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELRR 95.00% 3.23 0.34 0 602.6594 1,804.95 1,804.96 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELRR 95.00% 2.87 0.332 0 602.6597 1,804.96 1,804.96 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELRR 95.00% 3.09 0.351 0 602.6597 1,804.96 1,804.96 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELRR 95.00% 3.2 0.36 0 602.6598 1,804.96 1,804.96 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RQVEVLTNQR 95.00% 2.83 0.369 0 621.8553 1,241.70 1,242.69 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELR 95.00% 2.11 0.346 0 625.8176 1,249.62 1,250.63 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELR 95.00% 3.52 0.388 1.28 625.8183 1,249.62 1,250.63 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELR 95.00% 3.45 0.364 2.42 625.8185 1,249.62 1,250.63 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELR 95.00% 3.38 0.374 0 625.8186 1,249.62 1,250.63 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELR 95.00% 3.54 0.37 1.92 625.819 1,249.62 1,250.63 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELR 95.00% 3.05 0.358 1.52 625.8195 1,249.62 1,250.63 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELR 95.00% 3.14 0.414 1.82 625.8206 1,249.63 1,250.63 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELR 95.00% 3.55 0.363 2.11 626.3202 1,250.62 1,250.63 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EEAENNLAAFR 95.00% 2.81 0.491 2.07 632.3025 1,262.59 1,263.60 2 HSP74_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EEAENNLAAFR 95.00% 2.09 0.396 1.92 632.3033 1,262.59 1,263.60 2 HSP74_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EEAENNLAAFR 95.00% 2.46 0.48 2.1 632.3036 1,262.59 1,263.60 2 HSP74_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EEAENNLAAFR 95.00% 2.6 0.422 1.33 632.3039 1,262.59 1,263.60 2 HSP74_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% EEAENNLAAFR 95.00% 2.46 0.463 1.6 632.3062 1,262.60 1,263.60 2 HSP74_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% NISEAEEWYK 95.00% 3.42 0.403 0 634.794 1,267.57 1,268.58 2 EHD3_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% NISEAEEWYK 95.00% 3.42 0.376 0 634.7949 1,267.57 1,268.58 2 EHD3_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% NISEAEEWYK 95.00% 3.76 0.398 0 634.7954 1,267.58 1,268.58 2 EHD3_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% NISEAEEWYK 95.00% 3.34 0.382 1.39 634.7956 1,267.58 1,268.58 2 EHD3_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% NISEAEEWYK 95.00% 3.49 0.347 0 634.7956 1,267.58 1,268.58 2 EHD3_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% NISEAEEWYK 95.00% 2.79 0.329 0 634.7957 1,267.58 1,268.58 2 EHD3_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% NISEAEEWYK 95.00% 3.4 0.35 0 634.7957 1,267.58 1,268.58 2 EHD3_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% NISEAEEWYK 95.00% 3.06 0.387 1.31 634.7963 1,267.58 1,268.58 2 EHD3_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYR 95.00% 3.94 0.54 3.1 641.3305 1,280.65 1,281.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYR 95.00% 3.19 0.508 3.92 641.331 1,280.65 1,281.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYR 95.00% 4.07 0.577 3.77 641.3311 1,280.65 1,281.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYR 95.00% 4.15 0.55 3.01 641.3311 1,280.65 1,281.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYR 95.00% 3.88 0.543 2.85 641.3314 1,280.65 1,281.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYR 95.00% 3.97 0.57 3.7 641.3317 1,280.65 1,281.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYR 95.00% 3.38 0.546 3.18 641.3318 1,280.65 1,281.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYR 95.00% 3.64 0.545 4.01 641.3319 1,280.65 1,281.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYR 95.00% 3.43 0.513 3.74 641.3327 1,280.65 1,281.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ARVDVERDNLLDDLQR 95.00% 4.12 0.339 1.37 643.0067 1,926.00 1,927.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ARVDVERDNLLDDLQR 95.00% 3.96 0.319 0 643.3414 1,927.00 1,927.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ARVDVERDNLLDDLQR 95.00% 3.74 0.321 0 643.3414 1,927.00 1,927.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ARVDVERDNLLDDLQR 95.00% 3.34 0.321 0 643.3417 1,927.00 1,927.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VRFLEQQNAALAAEVNR 95.00% 5.04 0.15 2.72 643.684 1,928.03 1,929.03 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VRFLEQQNAALAAEVNR 95.00% 4.65 0.134 1.42 644.0184 1,929.03 1,929.03 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQRLK 95.00% 4.79 0.34 0 647.6867 1,940.04 1,941.04 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQRLK 95.00% 4.49 0.308 0 647.687 1,940.04 1,941.04 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% mALDVEIATYR 95.00% 2.65 0.355 2.46 m1: Oxidation (+15.99) 649.3263 1,296.64 1,297.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% mALDVEIATYR 95.00% 3.15 0.455 2.7 m1: Oxidation (+15.99) 649.3274 1,296.64 1,297.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% mALDVEIATYR 95.00% 3.46 0.375 2.68 m1: Oxidation (+15.99) 649.3292 1,296.64 1,297.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% mALDVEIATYR 95.00% 2.96 0.413 3.3 m1: Oxidation (+15.99) 649.3293 1,296.64 1,297.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% mALDVEIATYR 95.00% 3.56 0.455 3.2 m1: Oxidation (+15.99) 649.33 1,296.64 1,297.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% mALDVEIATYR 95.00% 3.61 0.489 3.03 m1: Oxidation (+15.99) 649.3302 1,296.64 1,297.65 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% SKVSDLTQAANKNNDALR 95.00% 3.79 0.426 3.8 649.3435 1,945.01 1,945.01 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% SKVSDLTQAANKNNDALR 95.00% 4.82 0.385 3.08 649.3436 1,945.01 1,945.01 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% SKVSDLTQAANKNNDALR 95.00% 4.24 0.463 4.21 649.3437 1,945.01 1,945.01 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% SKVSDLTQAANKNNDALR 95.00% 5.18 0.431 2.85 649.3441 1,945.01 1,945.01 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% SKVSDLTQAANKNNDALR 95.00% 4.37 0.477 0 649.3446 1,945.01 1,945.01 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% SKVSDLTQAANKNNDALR 95.00% 4.23 0.484 3.08 649.3447 1,945.01 1,945.01 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% SKVSDLTQAANKNNDALR 95.00% 4.46 0.364 3.24 649.3448 1,945.01 1,945.01 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% SKVSDLTQAANKNNDALR 95.00% 3.98 0.377 3.09 649.345 1,945.01 1,945.01 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VELQELNDRFANYIEK 95.00% 2.2 0.302 0 661.0084 1,980.00 1,981.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VELQELNDRFANYIEK 95.00% 2.54 0.316 0 661.3422 1,981.00 1,981.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% IESLNEEIAFLK 95.00% 4.85 0.381 3.05 703.3846 1,404.75 1,405.76 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% IESLNEEIAFLK 95.00% 4.43 0.441 2.28 703.3851 1,404.75 1,405.76 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYRK 95.00% 4.13 0.497 2.92 705.3786 1,408.74 1,409.75 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYRK 95.00% 3.09 0.445 1.4 705.3788 1,408.74 1,409.75 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYRK 95.00% 3.29 0.511 1.23 705.379 1,408.74 1,409.75 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% MALDVEIATYRK 95.00% 3.89 0.491 2.68 705.38 1,408.74 1,409.75 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% mALDVEIATYRK 95.00% 3.75 0.463 2.82 m1: Oxidation (+15.99) 713.3745 1,424.73 1,425.74 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% mALDVEIATYRK 95.00% 3.92 0.506 3.17 m1: Oxidation (+15.99) 713.3777 1,424.74 1,425.74 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ELEDRFASEASGYQDNIAR 95.00% 5.13 0.592 5.89 724.341 2,170.00 2,171.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ELEDRFASEASGYQDNIAR 95.00% 4.95 0.57 4.59 724.3416 2,170.00 2,171.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ELEDRFASEASGYQDNIAR 95.00% 4.48 0.533 4.24 724.6737 2,171.00 2,171.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ELEDRFASEASGYQDNIAR 95.00% 5.76 0.557 5.48 724.6739 2,171.00 2,171.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ELEDRFASEASGYQDNIAR 95.00% 6.07 0.563 4.04 724.6743 2,171.00 2,171.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ELEDRFASEASGYQDNIAR 95.00% 5.41 0.536 4.48 724.675 2,171.00 2,171.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ELEDRFASEASGYQDNIAR 95.00% 5.39 0.556 4.92 724.6759 2,171.00 2,171.00 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% NISEAEEWYKSK 95.00% 3.31 0.379 2.02 742.3583 1,482.70 1,483.71 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% NISEAEEWYKSK 95.00% 3.58 0.371 3.06 742.3596 1,482.70 1,483.71 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% NISEAEEWYKSK 95.00% 3.41 0.399 2.11 742.3622 1,482.71 1,483.71 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 5.52 0.55 3.85 749.0556 2,244.14 2,245.15 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 5.58 0.569 1.85 749.3903 2,245.15 2,245.15 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 5.91 0.552 3.74 749.3906 2,245.15 2,245.15 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 4.92 0.558 2.8 749.3909 2,245.15 2,245.15 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 5.86 0.571 4.77 749.3909 2,245.15 2,245.15 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 4.98 0.502 3.52 749.391 2,245.15 2,245.15 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 5.53 0.528 2.55 749.3911 2,245.15 2,245.15 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 5.11 0.53 1.72 749.3915 2,245.15 2,245.15 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 4.69 0.435 2.08 749.3924 2,245.15 2,245.15 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 5.47 0.541 3.55 749.3929 2,245.16 2,245.15 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HLREYQDLLNVK 95.00% 3.65 0.238 0 764.4214 1,526.83 1,527.83 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.92 0.578 5.92 764.8564 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.94 0.601 5 764.8565 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.61 0.623 5.57 764.8566 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 5.13 0.616 5.55 764.8567 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.61 0.613 5.64 764.8568 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.85 0.598 5.22 764.8568 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.71 0.608 6.17 764.8573 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.86 0.63 5.19 764.8573 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.75 0.613 6.82 764.8577 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 2.68 0.343 0 764.8578 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.65 0.585 5.92 764.8579 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.76 0.603 6.1 764.858 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.83 0.644 6.1 764.8584 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.87 0.6 5.74 764.8589 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.85 0.636 5.96 764.8595 1,527.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HLREYQDLLNVK 95.00% 3.52 0.173 1.51 764.9203 1,527.82 1,527.83 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HLREYQDLLNVK 95.00% 3.67 0.23 0 764.9208 1,527.83 1,527.83 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FASEASGYQDNIAR 95.00% 4.7 0.577 4.74 765.3603 1,528.70 1,528.70 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% IESLNEEIAFLKK 95.00% 4.48 0.328 2.89 767.4319 1,532.85 1,533.85 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% IESLNEEIAFLKK 95.00% 3.73 0.387 2.68 767.4319 1,532.85 1,533.85 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% IESLNEEIAFLKK 95.00% 4.52 0.294 3.13 767.4326 1,532.85 1,533.85 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% IESLNEEIAFLKK 95.00% 4.07 0.353 2.41 767.4334 1,532.85 1,533.85 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TIETRDGEVVSEATQQQHEVL 95.00% 1.73 0.307 1.82 790.728 2,369.16 2,369.16 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TIETRDGEVVSEATQQQHEVL 95.00% 2.02 0.346 1.62 790.7289 2,369.16 2,369.16 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 4.56 0.477 2.89 794.4044 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 4.29 0.459 2.29 794.4051 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 4.48 0.484 2.12 794.4054 1,586.80 1,587.80 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 4.5 0.469 3.38 794.4059 1,586.80 1,587.80 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 4.44 0.474 3.14 794.4064 1,586.80 1,587.80 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDR 95.00% 4.47 0.462 3 794.4074 1,586.80 1,587.80 2 VIME_HUMAN
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% AKLQEEIQLKEEAENNLAAFR 95.00% 3.14 0.419 1.1 815.7687 2,444.28 2,444.28 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% AKLQEEIQLKEEAENNLAAFR 95.00% 4.49 0.549 4.96 815.7703 2,444.29 2,444.28 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDRFANYIEK 95.00% 3.56 0.327 0 818.7524 2,453.23 2,453.23 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDRFANYIEK 95.00% 3.32 0.198 0 818.7529 2,453.24 2,453.23 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% TNEKVELQELNDRFANYIEK 95.00% 3.51 0.162 0 818.7534 2,453.24 2,453.23 3
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELR 94.50% 2.55 0.21 0 824.9337 1,647.85 1,648.85 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELR 95.00% 2.95 0.315 0 824.9341 1,647.85 1,648.85 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELR 95.00% 2.86 0.297 0 824.9353 1,647.86 1,648.85 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELR 95.00% 3.21 0.306 0 825.4359 1,648.86 1,648.85 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELR 95.00% 2.77 0.248 0 825.4371 1,648.86 1,648.85 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% INLPIQTYSALNFR 95.00% 3.76 0.562 4.8 825.4527 1,648.89 1,649.90 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% INLPIQTYSALNFR 95.00% 4.96 0.579 5.82 825.456 1,648.90 1,649.90 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% INLPIQTYSALNFR 95.00% 4.83 0.596 4.34 825.4562 1,648.90 1,649.90 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% INLPIQTYSALNFR 95.00% 4.69 0.572 6.89 825.4565 1,648.90 1,649.90 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% INLPIQTYSALNFR 95.00% 4.48 0.549 4.8 825.4583 1,648.90 1,649.90 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% INLPIQTYSALNFR 95.00% 4.43 0.469 4.38 825.9562 1,649.90 1,649.90 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% INLPIQTYSALNFR 95.00% 4.54 0.552 5.23 825.9587 1,649.90 1,649.90 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% INLPIQTYSALNFR 95.00% 4.65 0.558 5.62 825.9601 1,649.90 1,649.90 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 4.93 0.455 2.24 837.4324 1,672.85 1,673.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 4.27 0.245 2.12 837.4333 1,672.85 1,673.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 4.93 0.491 2.72 837.4366 1,672.86 1,673.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 4.78 0.49 1.8 837.4368 1,672.86 1,673.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 5.21 0.494 3.1 837.437 1,672.86 1,673.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 5.17 0.507 3.24 837.4372 1,672.86 1,673.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 5.02 0.491 2.31 837.4378 1,672.86 1,673.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 4.86 0.472 3.59 837.4384 1,672.86 1,673.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 4.88 0.431 2.36 837.9348 1,673.85 1,673.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 5.06 0.452 3.28 837.9386 1,673.86 1,673.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% FLEQQNAALAAEVNR 95.00% 5.25 0.444 2.59 837.9389 1,673.86 1,673.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 3.93 0.326 4.15 845.4826 1,688.95 1,689.95 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 3.75 0.367 2.27 845.4837 1,688.95 1,689.95 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% RIESLNEEIAFLKK 95.00% 3.81 0.314 2.7 845.9849 1,689.95 1,689.95 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.52 0.181 1.51 850.4361 1,698.86 1,699.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.22 0.146 0 850.4362 1,698.86 1,699.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.18 0.197 0 850.4377 1,698.86 1,699.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.48 0.248 0 850.4382 1,698.86 1,699.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.57 0.221 1.62 850.4386 1,698.86 1,699.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VDVERDNLLDDLQR 95.00% 3.44 0.215 0 850.4388 1,698.86 1,699.86 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 4.93 0.535 5.64 c8: Carbamidomethyl (+57.02) 853.416 1,704.82 1,705.82 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 4.62 0.587 6.36 c8: Carbamidomethyl (+57.02) 853.417 1,704.82 1,705.82 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 4.73 0.523 6.31 c8: Carbamidomethyl (+57.02) 853.4178 1,704.82 1,705.82 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 5.01 0.557 6.57 c8: Carbamidomethyl (+57.02) 853.4179 1,704.82 1,705.82 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 4.69 0.551 6.28 c8: Carbamidomethyl (+57.02) 853.4179 1,704.82 1,705.82 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 4.25 0.556 5.15 c8: Carbamidomethyl (+57.02) 853.4185 1,704.82 1,705.82 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 4.78 0.558 5.38 c8: Carbamidomethyl (+57.02) 853.4186 1,704.82 1,705.82 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 4.58 0.559 5.44 c8: Carbamidomethyl (+57.02) 853.4204 1,704.83 1,705.82 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 4.84 0.555 6.04 c8: Carbamidomethyl (+57.02) 853.919 1,705.82 1,705.82 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 4.97 0.546 5.92 c8: Carbamidomethyl (+57.02) 853.9192 1,705.82 1,705.82 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 4.8 0.564 6.85 c8: Carbamidomethyl (+57.02) 853.9205 1,705.83 1,705.82 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% HQIQSYTcEIDALK 95.00% 4.56 0.531 6.42 c8: Carbamidomethyl (+57.02) 853.9215 1,705.83 1,705.82 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANKNNDALR 95.00% 4.6 0.411 0 865.4477 1,728.88 1,729.88 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANKNNDALR 95.00% 4.55 0.429 2.4 865.448 1,728.88 1,729.88 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANKNNDALR 95.00% 4.56 0.417 2.16 865.4483 1,728.88 1,729.88 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANKNNDALR 95.00% 4.21 0.388 2.77 865.4487 1,728.88 1,729.88 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANKNNDALR 95.00% 4.33 0.41 2.41 865.4487 1,728.88 1,729.88 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANKNNDALR 95.00% 4.53 0.412 3.03 865.4491 1,728.88 1,729.88 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANKNNDALR 95.00% 4.53 0.428 0 865.4493 1,728.88 1,729.88 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANKNNDALR 95.00% 4.43 0.441 1.59 865.4509 1,728.89 1,729.88 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANKNNDALR 95.00% 4.29 0.376 1.51 865.9507 1,729.89 1,729.88 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VSDLTQAANKNNDALR 95.00% 4.27 0.367 1.21 865.9511 1,729.89 1,729.88 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DGEVVSEATQQQHEVL 95.00% 3.34 0.641 2.89 884.9218 1,767.83 1,768.84 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DGEVVSEATQQQHEVL 95.00% 3.72 0.659 3.7 884.9225 1,767.83 1,768.84 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DGEVVSEATQQQHEVL 95.00% 3.83 0.589 4.66 884.9228 1,767.83 1,768.84 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DGEVVSEATQQQHEVL 95.00% 3.5 0.589 3.82 884.9239 1,767.83 1,768.84 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DGEVVSEATQQQHEVL 95.00% 3.41 0.659 4.08 884.9257 1,767.84 1,768.84 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DGEVVSEATQQQHEVL 95.00% 4.2 0.612 4.1 885.4256 1,768.84 1,768.84 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% DGEVVSEATQQQHEVL 95.00% 3.85 0.609 2.28 885.4259 1,768.84 1,768.84 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VAELYEEELRELRR 95.00% 2.65 0.122 1.22 902.9841 1,803.95 1,804.96 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ARVDVERDNLLDDLQR 95.00% 3.41 0.298 0 964.507 1,927.00 1,927.00 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ARVDVERDNLLDDLQR 95.00% 3.37 0.326 1.21 964.5075 1,927.00 1,927.00 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% VELQELNDRFANYIEK 95.00% 4.46 0.471 3.37 991.507 1,981.00 1,981.00 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ELEDRFASEASGYQDNIAR 95.00% 4.7 0.463 3.43 1,086.51 2,171.00 2,171.00 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ELEDRFASEASGYQDNIAR 95.00% 4.54 0.433 5.6 1,086.51 2,171.00 2,171.00 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% ELEDRFASEASGYQDNIAR 95.00% 4.55 0.52 3.85 1,086.51 2,171.00 2,171.00 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 6.53 0.62 5.64 1,123.58 2,245.14 2,245.15 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 6.66 0.611 6.29 1,123.58 2,245.15 2,245.15 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 6.75 0.6 5 1,123.58 2,245.15 2,245.15 2
 SAMPLE 4 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 36 50 283 52.10% LQEEIQLKEEAENNLAAFR 95.00% 6.59 0.629 6.24 1,123.58 2,245.15 2,245.15 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DIRAQYETIAAK 95.00% 2.99 0.217 1.55 460.2519 1,377.73 1,378.73 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYRK 95.00% 2.91 0.385 0 470.5883 1,408.74 1,409.75 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYRK 95.00% 3.31 0.47 1.59 470.5886 1,408.74 1,409.75 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYRK 95.00% 3.48 0.473 1.23 470.5889 1,408.74 1,409.75 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYRK 95.00% 2.7 0.409 0 470.5889 1,408.74 1,409.75 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% mALDVEIATYRK 95.00% 2.36 0.258 0 m1: Oxidation (+15.99) 475.9201 1,424.74 1,425.74 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% mALDVEIATYRK 95.00% 2.77 0.406 0 m1: Oxidation (+15.99) 475.9203 1,424.74 1,425.74 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% mALDVEIATYRK 95.00% 2.82 0.401 0 m1: Oxidation (+15.99) 475.9207 1,424.74 1,425.74 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% mALDVEIATYRK 95.00% 2.2 0.156 0.959 m1: Oxidation (+15.99) 475.9209 1,424.74 1,425.74 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% mALDVEIATYRK 95.00% 2.11 0.315 0 m1: Oxidation (+15.99) 476.256 1,425.74 1,425.74 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% AQYETIAAK 95.00% 1.86 0.235 1.89 497.7663 993.517 994.521 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% AQYETIAAK 95.00% 2.3 0.369 1.18 497.7666 993.5175 994.521 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HLREYQDLLNVK 95.00% 3.37 0.245 0 509.9478 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HLREYQDLLNVK 95.00% 3.08 0.326 0 509.948 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HLREYQDLLNVK 95.00% 4.54 0.359 0 509.9496 1,526.83 1,527.83 3 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HLREYQDLLNVK 95.00% 4.27 0.35 0 509.95 1,526.83 1,527.83 3 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLKK 95.00% 3.11 0.302 0 511.9567 1,532.85 1,533.85 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLKK 95.00% 3.05 0.355 0 511.9571 1,532.85 1,533.85 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLK 95.00% 4.57 0.339 1.77 521.2929 1,560.86 1,561.86 3 PLEC1_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLK 95.00% 3.27 0.305 2 521.293 1,560.86 1,561.86 3 PLEC1_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLK 95.00% 4.07 0.373 1.49 521.6274 1,561.86 1,561.86 3 PLEC1_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANK 95.00% 2.98 0.43 1.2 523.7804 1,045.55 1,046.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANK 95.00% 3.15 0.457 2.4 523.7808 1,045.55 1,046.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANK 95.00% 2.69 0.412 2.11 523.7812 1,045.55 1,046.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 4.06 0.338 1.03 529.9381 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 4.01 0.322 0 529.9382 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 4.04 0.261 0 529.9384 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 4.84 0.395 0 529.9387 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 2.74 0.266 0 529.9389 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 3.98 0.308 0.959 529.939 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 3.14 0.307 0 529.9391 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 4.25 0.317 0 529.9397 1,586.80 1,587.80 3 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% KLLEGEESR 95.00% 2.1 0.243 0 530.7877 1,059.56 1,060.56 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% KLLEGEESR 95.00% 2.37 0.186 0 530.7914 1,059.57 1,060.56 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% QVEVLTNQR 95.00% 2.74 0.257 1.23 543.8017 1,085.59 1,086.59 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELR 95.00% 2.69 0.504 0.959 550.2898 1,647.85 1,648.85 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELR 95.00% 2.64 0.543 0 550.291 1,647.85 1,648.85 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELR 95.00% 2.76 0.551 0 550.2911 1,647.85 1,648.85 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELR 95.00% 3.17 0.505 1.34 550.2912 1,647.85 1,648.85 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELR 95.00% 2.79 0.472 0 550.6251 1,648.85 1,648.85 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELR 95.00% 2.81 0.571 0 550.6251 1,648.85 1,648.85 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 4.31 0.576 2.66 550.6403 1,648.90 1,649.90 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 3.9 0.558 2.72 550.6406 1,648.90 1,649.90 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 2.79 0.283 1.29 551.2804 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 2.67 0.271 0 551.2812 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 2.56 0.242 1.38 551.2815 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 3 0.304 0 551.2816 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 2.79 0.272 0 551.2818 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 3.21 0.335 0 551.2818 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 2.62 0.273 1.51 551.2819 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 2.89 0.278 0 551.2819 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 3.2 0.316 0 551.2819 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 3.11 0.328 0 551.282 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 3.21 0.333 0 551.2823 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 3.04 0.308 0 551.2823 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 2.71 0.321 1.32 551.2824 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 3.1 0.298 0 551.2826 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 3.11 0.314 0 551.2826 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 2.46 0.289 0 551.2829 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 2.28 0.258 0 551.2829 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 2.41 0.257 1.64 551.2837 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 2.71 0.306 0 551.2852 1,100.55 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DNLLDDLQR 95.00% 2.58 0.257 0 551.2854 1,100.56 1,101.55 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VELQELNDR 95.00% 2.8 0.304 0 558.2892 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VELQELNDR 95.00% 2.56 0.292 1.4 558.2895 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VELQELNDR 95.00% 2.97 0.309 0 558.2896 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VELQELNDR 95.00% 2.88 0.311 0 558.2896 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VELQELNDR 95.00% 2.61 0.323 0 558.2899 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VELQELNDR 95.00% 3.19 0.361 0 558.2901 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 4.44 0.391 1.19 558.6249 1,672.85 1,673.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 4.32 0.385 1.1 558.6262 1,672.86 1,673.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 3.86 0.42 1.28 558.6276 1,672.86 1,673.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 3.76 0.331 0 558.6276 1,672.86 1,673.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 2.05 0.266 0 561.2964 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 1.98 0.328 0 561.2965 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 2.2 0.382 0 561.2966 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 2.13 0.385 0 561.2969 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 2.13 0.309 0 561.2969 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 2.09 0.339 0 561.2971 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 2.11 0.34 0 561.2971 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 2.13 0.371 0 561.2972 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 2.33 0.375 0 561.2972 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 2.02 0.268 0 561.2972 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 2.25 0.408 0 561.2975 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 1.95 0.37 0 561.298 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EYQDLLNVK 95.00% 1.91 0.307 0 561.2985 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 4.31 0.402 1.72 563.9894 1,688.94 1,689.95 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 5.54 0.444 1.68 563.9901 1,688.95 1,689.95 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 5.32 0.457 2.17 563.9902 1,688.95 1,689.95 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 5.81 0.464 3.59 563.9904 1,688.95 1,689.95 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 5.56 0.487 1 563.9907 1,688.95 1,689.95 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 4.32 0.403 0 563.9908 1,688.95 1,689.95 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 5.52 0.457 1.96 563.9909 1,688.95 1,689.95 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 5.23 0.48 2.38 563.9911 1,688.95 1,689.95 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 4.79 0.481 1.57 564.3238 1,689.95 1,689.95 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 5.81 0.389 2 564.3248 1,689.95 1,689.95 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 5.33 0.42 1.54 564.3255 1,689.95 1,689.95 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 4.37 0.35 2.01 567.2928 1,698.85 1,699.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.64 0.315 0 567.2932 1,698.86 1,699.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 4.07 0.302 1.01 567.2936 1,698.86 1,699.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.04 0.297 0 567.2937 1,698.86 1,699.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.83 0.305 0 567.2938 1,698.86 1,699.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 2.74 0.164 0 567.2946 1,698.86 1,699.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.11 0.223 0 567.2991 1,698.87 1,699.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.52 0.268 0 567.6259 1,699.85 1,699.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 4.06 0.294 1.19 567.6272 1,699.86 1,699.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.77 0.296 0 567.6275 1,699.86 1,699.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 4.18 0.345 0 567.6277 1,699.86 1,699.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.66 0.304 0 567.6279 1,699.86 1,699.86 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 3.24 0.491 0 c8: Carbamidomethyl (+57.02) 569.2803 1,704.82 1,705.82 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 2.76 0.261 0 c8: Carbamidomethyl (+57.02) 569.281 1,704.82 1,705.82 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 2.94 0.392 0 c8: Carbamidomethyl (+57.02) 569.282 1,704.82 1,705.82 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 2.64 0.444 0 c8: Carbamidomethyl (+57.02) 569.2821 1,704.82 1,705.82 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 2.55 0.26 0 c8: Carbamidomethyl (+57.02) 569.2823 1,704.82 1,705.82 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 3.3 0.494 0 c8: Carbamidomethyl (+57.02) 569.2824 1,704.82 1,705.82 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 2.76 0.355 0 c8: Carbamidomethyl (+57.02) 569.2827 1,704.82 1,705.82 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 3.65 0.432 1.36 c8: Carbamidomethyl (+57.02) 569.614 1,705.82 1,705.82 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 3.59 0.439 0 c8: Carbamidomethyl (+57.02) 569.6144 1,705.82 1,705.82 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 4.15 0.419 0 c8: Carbamidomethyl (+57.02) 569.6157 1,705.82 1,705.82 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 2.92 0.389 0 c8: Carbamidomethyl (+57.02) 569.6179 1,705.83 1,705.82 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANKNNDALR 95.00% 3.81 0.397 1.59 577.3019 1,728.88 1,729.88 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANKNNDALR 95.00% 4.38 0.455 1.48 577.302 1,728.88 1,729.88 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELRR 95.00% 3.05 0.314 0 602.3253 1,803.95 1,804.96 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELRR 95.00% 2.81 0.288 0 602.3253 1,803.95 1,804.96 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELRR 95.00% 2.85 0.296 1.02 602.3262 1,803.96 1,804.96 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELRR 95.00% 2.51 0.162 0 602.3263 1,803.96 1,804.96 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELRR 95.00% 2.7 0.326 0 602.6595 1,804.96 1,804.96 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RQVEVLTNQR 95.00% 2.67 0.256 0 621.8564 1,241.70 1,242.69 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RQVEVLTNQR 95.00% 2.9 0.316 1.26 621.8572 1,241.70 1,242.69 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELR 95.00% 3.58 0.393 2.2 625.818 1,249.62 1,250.63 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELR 95.00% 3.45 0.392 1.54 625.8181 1,249.62 1,250.63 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELR 95.00% 3.42 0.374 1.8 625.8183 1,249.62 1,250.63 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELR 95.00% 3.18 0.338 1.37 625.8188 1,249.62 1,250.63 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELR 95.00% 3.35 0.359 3.24 625.8189 1,249.62 1,250.63 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELR 95.00% 3.25 0.363 2.32 625.8193 1,249.62 1,250.63 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELR 95.00% 2.67 0.358 1.49 625.8194 1,249.62 1,250.63 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELR 95.00% 2.47 0.397 0 626.3197 1,250.62 1,250.63 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EEAENNLAAFR 95.00% 2.32 0.471 1.68 632.3028 1,262.59 1,263.60 2 HSP74_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EEAENNLAAFR 95.00% 2.46 0.477 1.92 632.3031 1,262.59 1,263.60 2 HSP74_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% EEAENNLAAFR 95.00% 2.07 0.316 1.89 632.3037 1,262.59 1,263.60 2 HSP74_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% NISEAEEWYK 95.00% 3.03 0.253 0 634.7943 1,267.57 1,268.58 2 EHD3_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% NISEAEEWYK 95.00% 3.39 0.37 1.52 634.7943 1,267.57 1,268.58 2 EHD3_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% NISEAEEWYK 95.00% 3.28 0.386 2.24 634.7944 1,267.57 1,268.58 2 EHD3_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% NISEAEEWYK 95.00% 3.31 0.358 1.34 634.7945 1,267.57 1,268.58 2 EHD3_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% NISEAEEWYK 95.00% 2.11 0.26 0 634.7945 1,267.57 1,268.58 2 EHD3_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% NISEAEEWYK 95.00% 2.82 0.328 1.44 634.7948 1,267.57 1,268.58 2 EHD3_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% NISEAEEWYK 95.00% 3.58 0.377 0 634.7948 1,267.57 1,268.58 2 EHD3_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% NISEAEEWYK 95.00% 2.92 0.318 1.66 634.795 1,267.57 1,268.58 2 EHD3_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% NISEAEEWYK 95.00% 3.82 0.398 1.85 634.795 1,267.57 1,268.58 2 EHD3_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYR 95.00% 3.22 0.569 4.68 641.3299 1,280.64 1,281.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYR 95.00% 3.36 0.5 3.59 641.3308 1,280.65 1,281.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYR 95.00% 4.12 0.556 3.57 641.3311 1,280.65 1,281.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYR 95.00% 3.81 0.534 4.25 641.3314 1,280.65 1,281.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYR 95.00% 4.21 0.542 4.51 641.3315 1,280.65 1,281.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYR 95.00% 3.63 0.566 4.36 641.3316 1,280.65 1,281.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYR 95.00% 3.03 0.484 2.59 641.3318 1,280.65 1,281.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYR 95.00% 3.01 0.468 4.37 641.3326 1,280.65 1,281.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ARVDVERDNLLDDLQR 95.00% 3.73 0.415 0 643.0067 1,926.00 1,927.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ARVDVERDNLLDDLQR 95.00% 3.83 0.373 1.34 643.0068 1,926.00 1,927.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ARVDVERDNLLDDLQR 95.00% 3.67 0.439 1.19 643.0071 1,926.00 1,927.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ARVDVERDNLLDDLQR 95.00% 3.47 0.322 0 643.3403 1,927.00 1,927.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ARVDVERDNLLDDLQR 95.00% 3.78 0.304 0 643.3406 1,927.00 1,927.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ARVDVERDNLLDDLQR 95.00% 3.7 0.374 0.959 643.3409 1,927.00 1,927.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQRLK 95.00% 4.61 0.396 1.66 647.687 1,940.04 1,941.04 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQRLK 95.00% 4.61 0.407 0 648.0209 1,941.04 1,941.04 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% SKVSDLTQAANKNNDALR 95.00% 2.6 0.224 1.77 649.0092 1,944.00 1,945.01 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% SKVSDLTQAANKNNDALR 95.00% 3.56 0.361 2.41 649.0107 1,944.01 1,945.01 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% mALDVEIATYR 95.00% 2.9 0.476 4.96 m1: Oxidation (+15.99) 649.3277 1,296.64 1,297.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% mALDVEIATYR 95.00% 3.49 0.495 3.85 m1: Oxidation (+15.99) 649.3278 1,296.64 1,297.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% mALDVEIATYR 95.00% 3.44 0.472 3.55 m1: Oxidation (+15.99) 649.3289 1,296.64 1,297.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% mALDVEIATYR 95.00% 3.47 0.394 3.14 m1: Oxidation (+15.99) 649.3289 1,296.64 1,297.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% mALDVEIATYR 95.00% 3.43 0.394 4.24 m1: Oxidation (+15.99) 649.3293 1,296.64 1,297.65 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% SKVSDLTQAANKNNDALR 95.00% 3.29 0.368 1.38 649.3434 1,945.01 1,945.01 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% SKVSDLTQAANKNNDALR 95.00% 4.75 0.311 2.77 649.3437 1,945.01 1,945.01 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% SKVSDLTQAANKNNDALR 95.00% 4.28 0.375 3.25 649.3447 1,945.01 1,945.01 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% SKVSDLTQAANKNNDALR 95.00% 4.23 0.436 2.44 649.3448 1,945.01 1,945.01 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% SKVSDLTQAANKNNDALR 95.00% 4.83 0.538 3.21 649.3455 1,945.01 1,945.01 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TFGGAPGFPLGSPLSSPVFPR 95.00% 3.85 0.421 0 697.0396 2,088.10 2,088.09 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLK 95.00% 4.49 0.426 2.77 703.3836 1,404.75 1,405.76 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLK 95.00% 4.54 0.386 3.68 703.3847 1,404.75 1,405.76 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLK 95.00% 4.39 0.387 2.7 703.3847 1,404.75 1,405.76 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLK 95.00% 4.42 0.434 2.72 703.3849 1,404.75 1,405.76 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLK 95.00% 3.65 0.417 1.89 703.3849 1,404.75 1,405.76 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLK 95.00% 4.51 0.353 2.03 703.3852 1,404.75 1,405.76 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLK 95.00% 3.65 0.331 3.13 703.3853 1,404.75 1,405.76 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLK 95.00% 4.18 0.413 2.06 703.8871 1,405.76 1,405.76 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYRK 95.00% 3.15 0.448 0 705.3769 1,408.74 1,409.75 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYRK 95.00% 3.92 0.482 2.66 705.3777 1,408.74 1,409.75 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% MALDVEIATYRK 95.00% 4.03 0.457 1.46 705.3793 1,408.74 1,409.75 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% mALDVEIATYRK 95.00% 3.72 0.496 4.52 m1: Oxidation (+15.99) 713.3777 1,424.74 1,425.74 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ELEDRFASEASGYQDNIAR 95.00% 5.74 0.577 5.59 724.3398 2,170.00 2,171.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ELEDRFASEASGYQDNIAR 95.00% 5.04 0.554 3.33 724.6738 2,171.00 2,171.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ELEDRFASEASGYQDNIAR 95.00% 5.21 0.543 5.05 724.6738 2,171.00 2,171.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ELEDRFASEASGYQDNIAR 95.00% 5.92 0.562 5.22 724.6745 2,171.00 2,171.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ELEDRFASEASGYQDNIAR 95.00% 5.2 0.564 4.54 724.6745 2,171.00 2,171.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ELEDRFASEASGYQDNIAR 95.00% 4.85 0.498 4.46 724.6758 2,171.00 2,171.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ELEDRFASEASGYQDNIAR 95.00% 5.11 0.551 6.7 724.6758 2,171.00 2,171.00 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% LQEEIQLKEEAENNLAAFR 95.00% 5.03 0.513 3.92 749.056 2,244.14 2,245.15 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% LQEEIQLKEEAENNLAAFR 95.00% 6.02 0.598 3.59 749.3898 2,245.15 2,245.15 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% LQEEIQLKEEAENNLAAFR 95.00% 4.76 0.538 3.12 749.3901 2,245.15 2,245.15 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% LQEEIQLKEEAENNLAAFR 95.00% 4.84 0.563 2.46 749.3902 2,245.15 2,245.15 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% LQEEIQLKEEAENNLAAFR 95.00% 4.68 0.527 2.08 749.3906 2,245.15 2,245.15 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% LQEEIQLKEEAENNLAAFR 95.00% 5.74 0.576 4.85 749.3912 2,245.15 2,245.15 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% LQEEIQLKEEAENNLAAFR 95.00% 5.71 0.615 2.51 749.392 2,245.15 2,245.15 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% LQEEIQLKEEAENNLAAFR 95.00% 4.42 0.422 2.39 749.3925 2,245.15 2,245.15 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HLREYQDLLNVK 95.00% 3.95 0.258 1.35 764.42 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HLREYQDLLNVK 95.00% 3.66 0.301 2.25 764.4205 1,526.83 1,527.83 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HLREYQDLLNVK 95.00% 3.63 0.219 0 764.4207 1,526.83 1,527.83 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.44 0.597 5.19 764.8556 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 5.12 0.618 5.57 764.8566 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.29 0.627 4.55 764.8567 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.69 0.567 5.77 764.8568 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.5 0.605 4.68 764.8572 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.83 0.604 5.8 764.8573 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.92 0.633 4.96 764.8579 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.7 0.588 5.28 764.858 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.83 0.62 4.92 764.858 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.46 0.626 4.12 764.8582 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.59 0.56 6.29 764.8582 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.95 0.647 5.6 764.8585 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.76 0.611 6.68 764.8587 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.67 0.614 6.31 764.8593 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.79 0.589 5.62 764.86 1,527.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FASEASGYQDNIAR 95.00% 4.8 0.593 5.48 765.3602 1,528.70 1,528.70 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLKK 95.00% 4.27 0.313 3.42 767.4309 1,532.85 1,533.85 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLKK 95.00% 4.91 0.367 3.57 767.4325 1,532.85 1,533.85 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLKK 95.00% 3.56 0.393 2.55 767.4347 1,532.85 1,533.85 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% IESLNEEIAFLKK 95.00% 3.22 0.366 2.12 767.9328 1,533.85 1,533.85 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLK 95.00% 3.41 0.352 2.85 781.4361 1,560.86 1,561.86 2 PLEC1_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLK 95.00% 3.53 0.322 2.6 781.4364 1,560.86 1,561.86 2 PLEC1_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TIETRDGEVVSEATQQQHEVL 95.00% 1.56 0.311 1.15 790.7285 2,369.16 2,369.16 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TIETRDGEVVSEATQQQHEVL 95.00% 1.97 0.345 1.92 790.7298 2,369.17 2,369.16 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 4.22 0.491 3.77 794.4043 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 4.49 0.473 3.66 794.4048 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 4.39 0.473 3.44 794.405 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 4.22 0.476 3.28 794.4059 1,586.80 1,587.80 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 4.31 0.467 3.42 794.406 1,586.80 1,587.80 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 4.12 0.498 2.62 794.4065 1,586.80 1,587.80 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDR 95.00% 3.31 0.424 1.43 794.4076 1,586.80 1,587.80 2 VIME_HUMAN
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDRFANYIEK 95.00% 3.06 0.218 0 818.752 2,453.23 2,453.23 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDRFANYIEK 95.00% 4.12 0.342 0 818.7527 2,453.23 2,453.23 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TNEKVELQELNDRFANYIEK 95.00% 3.41 0.364 0 818.7527 2,453.23 2,453.23 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELR 95.00% 2.59 0.216 0 824.9351 1,647.85 1,648.85 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELR 95.00% 2.95 0.216 0 825.433 1,648.85 1,648.85 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELR 95.00% 3.07 0.269 0 825.4343 1,648.85 1,648.85 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELR 95.00% 2.62 0.234 0 825.4361 1,648.86 1,648.85 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 4.55 0.572 5.72 825.4566 1,648.90 1,649.90 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 4.05 0.524 6.28 825.4566 1,648.90 1,649.90 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 4.45 0.557 5.66 825.4568 1,648.90 1,649.90 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 4.66 0.568 5.11 825.4571 1,648.90 1,649.90 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 4.44 0.582 6.47 825.4572 1,648.90 1,649.90 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 4.5 0.582 5.96 825.4582 1,648.90 1,649.90 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 4.32 0.545 6.64 825.4587 1,648.90 1,649.90 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 3.73 0.531 4.42 825.9538 1,649.89 1,649.90 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 4.37 0.547 4.66 825.9557 1,649.90 1,649.90 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 4.48 0.51 4.89 825.9588 1,649.90 1,649.90 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 4.85 0.582 5.62 825.9596 1,649.90 1,649.90 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% INLPIQTYSALNFR 95.00% 4.39 0.537 8.09 825.9602 1,649.90 1,649.90 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 4.25 0.416 4.57 837.4304 1,672.85 1,673.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 4.81 0.356 4.05 837.4356 1,672.86 1,673.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 5.18 0.495 3.92 837.4364 1,672.86 1,673.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 4.93 0.442 2.77 837.4366 1,672.86 1,673.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 5.36 0.505 3.55 837.4367 1,672.86 1,673.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 5.37 0.484 3.57 837.4369 1,672.86 1,673.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 5.08 0.428 2.62 837.4371 1,672.86 1,673.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 5.38 0.496 4 837.4371 1,672.86 1,673.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 4.82 0.358 3.09 837.9375 1,673.86 1,673.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% FLEQQNAALAAEVNR 95.00% 5.38 0.473 3.11 837.9375 1,673.86 1,673.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 3.76 0.333 2.85 845.4818 1,688.95 1,689.95 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 3.67 0.329 2.68 845.4824 1,688.95 1,689.95 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 3.64 0.308 2.46 845.4829 1,688.95 1,689.95 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 3.36 0.219 1.64 845.9838 1,689.95 1,689.95 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% RIESLNEEIAFLKK 95.00% 3.71 0.316 2.02 845.9862 1,689.96 1,689.95 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.23 0.151 0 850.4371 1,698.86 1,699.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.23 0.162 0 850.4372 1,698.86 1,699.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.14 0.132 0 850.4373 1,698.86 1,699.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.32 0.246 0 850.4375 1,698.86 1,699.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.22 0.0955 1.18 850.4382 1,698.86 1,699.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.31 0.144 0 850.4384 1,698.86 1,699.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VDVERDNLLDDLQR 95.00% 3.22 0.1 1.3 850.9395 1,699.86 1,699.86 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 3.81 0.491 4.33 c8: Carbamidomethyl (+57.02) 853.4151 1,704.81 1,705.82 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 4.67 0.552 3.31 c8: Carbamidomethyl (+57.02) 853.4154 1,704.82 1,705.82 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 4.91 0.552 5.82 c8: Carbamidomethyl (+57.02) 853.4156 1,704.82 1,705.82 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 4.55 0.529 4.44 c8: Carbamidomethyl (+57.02) 853.4157 1,704.82 1,705.82 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 4.59 0.528 4.92 c8: Carbamidomethyl (+57.02) 853.4174 1,704.82 1,705.82 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 4.4 0.528 3.34 c8: Carbamidomethyl (+57.02) 853.4179 1,704.82 1,705.82 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 4.76 0.557 5.38 c8: Carbamidomethyl (+57.02) 853.4184 1,704.82 1,705.82 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 4.81 0.568 3.92 c8: Carbamidomethyl (+57.02) 853.4186 1,704.82 1,705.82 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 4.77 0.571 4 c8: Carbamidomethyl (+57.02) 853.4209 1,704.83 1,705.82 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 4.86 0.537 4.57 c8: Carbamidomethyl (+57.02) 853.9187 1,705.82 1,705.82 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALK 95.00% 4.57 0.564 6.74 c8: Carbamidomethyl (+57.02) 853.919 1,705.82 1,705.82 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% HQIQSYTcEIDALKGTNDSLMR 95.00% 4.84 0.419 2.72 c8: Carbamidomethyl (+57.02) 861.0819 2,580.22 2,580.22 3
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANKNNDALR 95.00% 4.44 0.441 2.39 865.4482 1,728.88 1,729.88 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANKNNDALR 95.00% 4.58 0.402 1.57 865.4489 1,728.88 1,729.88 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANKNNDALR 95.00% 4.49 0.365 2.96 865.4501 1,728.88 1,729.88 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANKNNDALR 95.00% 4.22 0.398 2.04 865.451 1,728.89 1,729.88 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANKNNDALR 95.00% 4.33 0.418 1.36 865.9493 1,729.88 1,729.88 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANKNNDALR 95.00% 4.35 0.336 1.55 865.9505 1,729.89 1,729.88 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANKNNDALR 95.00% 4.29 0.397 1.39 865.9507 1,729.89 1,729.88 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANKNNDALR 95.00% 4.21 0.347 1.77 865.9509 1,729.89 1,729.88 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANKNNDALR 95.00% 4.08 0.379 1.4 865.9511 1,729.89 1,729.88 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VSDLTQAANKNNDALR 95.00% 4.53 0.413 1.62 865.9511 1,729.89 1,729.88 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DGEVVSEATQQQHEVL 95.00% 3.55 0.627 3.62 884.9226 1,767.83 1,768.84 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DGEVVSEATQQQHEVL 95.00% 3.48 0.635 4.15 884.9229 1,767.83 1,768.84 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DGEVVSEATQQQHEVL 95.00% 3.27 0.582 1.92 884.9238 1,767.83 1,768.84 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DGEVVSEATQQQHEVL 95.00% 3.36 0.623 3.03 884.9239 1,767.83 1,768.84 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DGEVVSEATQQQHEVL 95.00% 3.05 0.621 3.8 884.9253 1,767.83 1,768.84 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DGEVVSEATQQQHEVL 95.00% 3.35 0.64 2.89 884.9269 1,767.84 1,768.84 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DGEVVSEATQQQHEVL 95.00% 2.73 0.498 0 884.9288 1,767.84 1,768.84 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DGEVVSEATQQQHEVL 95.00% 2.37 0.319 0 885.4234 1,768.83 1,768.84 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% DGEVVSEATQQQHEVL 95.00% 3.56 0.573 3.47 885.4272 1,768.84 1,768.84 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VAELYEEELRELRR 95.00% 3.51 0.184 0 903.4879 1,804.96 1,804.96 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ARVDVERDNLLDDLQR 95.00% 3.64 0.382 1.52 964.0045 1,925.99 1,927.00 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ARVDVERDNLLDDLQR 95.00% 3.78 0.381 2.89 964.0049 1,925.99 1,927.00 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ARVDVERDNLLDDLQR 95.00% 3.59 0.424 2.05 964.0112 1,926.01 1,927.00 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ARVDVERDNLLDDLQR 95.00% 3.52 0.327 0 964.5046 1,926.99 1,927.00 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VRFLEQQNAALAAEVNR 95.00% 5.62 0.367 5.89 965.0202 1,928.02 1,929.03 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VRFLEQQNAALAAEVNR 95.00% 5.58 0.345 6.14 965.5252 1,929.03 1,929.03 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VELQELNDRFANYIEK 95.00% 3.51 0.411 2.72 991.01 1,980.00 1,981.00 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% VELQELNDRFANYIEK 95.00% 4.16 0.434 4.74 991.5086 1,981.00 1,981.00 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TFGGAPGFPLGSPLSSPVFPR 95.00% 5.13 0.621 4.31 1,045.05 2,088.09 2,088.09 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% TFGGAPGFPLGSPLSSPVFPR 95.00% 5.06 0.622 5.37 1,045.06 2,088.10 2,088.09 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ELEDRFASEASGYQDNIAR 95.00% 4.6 0.465 4.72 1,086.01 2,169.99 2,171.00 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ELEDRFASEASGYQDNIAR 95.00% 4.47 0.462 4.35 1,086.51 2,171.00 2,171.00 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ELEDRFASEASGYQDNIAR 95.00% 4.55 0.475 4.46 1,086.51 2,171.00 2,171.00 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% ELEDRFASEASGYQDNIAR 95.00% 4.34 0.459 3.66 1,086.51 2,171.00 2,171.00 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% LQEEIQLKEEAENNLAAFR 95.00% 6.31 0.636 5.41 1,123.58 2,245.15 2,245.15 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% LQEEIQLKEEAENNLAAFR 95.00% 6.36 0.615 5.14 1,123.58 2,245.15 2,245.15 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% LQEEIQLKEEAENNLAAFR 95.00% 6.57 0.614 6.09 1,123.58 2,245.15 2,245.15 2
 SAMPLE 4R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 35 50 287 59.60% LQEEIQLKEEAENNLAAFR 95.00% 6.36 0.596 6.36 1,123.58 2,245.15 2,245.15 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% HLREYQDLLNVK 95.00% 4.41 0.313 0 509.9453 1,526.81 1,527.83 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% HLREYQDLLNVK 95.00% 5.06 0.342 0 509.9464 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% HLREYQDLLNVK 95.00% 4.97 0.418 0 509.9466 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% HLREYQDLLNVK 95.00% 2.73 0.219 0 510.2791 1,527.81 1,527.83 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 3.49 0.266 0.959 529.9357 1,586.78 1,587.80 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 3.21 0.33 1.25 529.9359 1,586.78 1,587.80 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.01 0.324 1.38 529.9359 1,586.78 1,587.80 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 3.25 0.306 1.92 529.9359 1,586.78 1,587.80 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 3.16 0.261 0 529.936 1,586.78 1,587.80 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.08 0.363 1.72 529.9362 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.43 0.326 1.28 529.9365 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.03 0.315 0 529.938 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 3.9 0.329 0 529.9389 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.32 0.366 1.11 529.9402 1,586.80 1,587.80 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 3.84 0.353 1.24 530.2705 1,587.79 1,587.80 3 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% KLLEGEESR 95.00% 2.64 0.178 0 530.7879 1,059.56 1,060.56 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% DNLLDDLQR 95.00% 2.91 0.314 0 551.2804 1,100.55 1,101.55 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% DNLLDDLQR 95.00% 2.38 0.195 0 551.2804 1,100.55 1,101.55 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% DNLLDDLQR 95.00% 3.08 0.31 0 551.2806 1,100.55 1,101.55 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% VELQELNDR 95.00% 2.22 0.221 0 558.2864 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% VELQELNDR 95.00% 2.42 0.29 0 558.2867 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% VELQELNDR 95.00% 2.11 0.241 0 558.2877 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% VELQELNDR 95.00% 2.48 0.183 0 558.2884 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.33 0.386 0 561.2931 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.02 0.278 0 561.2939 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 1.87 0.387 0 561.2939 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.08 0.394 0 561.2943 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.16 0.355 0 561.2943 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.06 0.307 0 561.2945 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.21 0.372 0 561.2945 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.17 0.339 0 561.2946 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.06 0.286 0 561.2946 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.3 0.371 0 561.2946 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.13 0.337 0 561.2948 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.01 0.274 0 561.2954 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.24 0.408 0 561.3018 1,120.59 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.14 0.357 0 561.3041 1,120.59 1,121.58 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% VDVERDNLLDDLQR 95.00% 3.75 0.353 0 567.291 1,698.85 1,699.86 3
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% VDVERDNLLDDLQR 95.00% 4.14 0.333 0 567.6252 1,699.85 1,699.86 3
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% HQIQSYTcEIDALK 95.00% 2.54 0.285 0 c8: Carbamidomethyl (+57.02) 569.2787 1,704.81 1,705.82 3
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% HQIQSYTcEIDALK 95.00% 2.81 0.312 0 c8: Carbamidomethyl (+57.02) 569.6118 1,705.81 1,705.82 3
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% VSDLTQAANKNNDALR 95.00% 1.59 0.324 0 577.2968 1,728.87 1,729.88 3
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% LQEEIQLKEEAENNLAAFR 95.00% 4.77 0.567 1.82 749.3892 2,245.14 2,245.15 3
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% HLREYQDLLNVK 95.00% 3.43 0.177 0 764.4159 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% HLREYQDLLNVK 95.00% 3.26 0.142 0 764.416 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% FASEASGYQDNIAR 95.00% 3.24 0.459 1.41 764.8524 1,527.69 1,528.70 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% FASEASGYQDNIAR 95.00% 4.58 0.599 5.92 764.8529 1,527.69 1,528.70 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% FASEASGYQDNIAR 95.00% 4.71 0.635 4 764.8534 1,527.69 1,528.70 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% FASEASGYQDNIAR 95.00% 4.68 0.58 5.64 764.8549 1,527.69 1,528.70 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% HLREYQDLLNVK 95.00% 3.93 0.221 0 764.9181 1,527.82 1,527.83 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% HLREYQDLLNVK 95.00% 3.69 0.218 1.55 764.9185 1,527.82 1,527.83 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.08 0.464 2.33 794.4007 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 2.78 0.447 2.62 794.4008 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.47 0.466 3.64 794.4017 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 3.71 0.473 1.64 794.402 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 3.23 0.468 0 794.4023 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.16 0.478 3.74 794.4041 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.37 0.467 2.39 794.4043 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.4 0.484 3.44 794.4043 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.31 0.453 2.13 794.4062 1,586.80 1,587.80 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.09 0.491 2.41 794.4066 1,586.80 1,587.80 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 4.45 0.486 3.1 794.9038 1,587.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% TNEKVELQELNDR 95.00% 3.92 0.429 2.27 794.9049 1,587.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% FLEQQNAALAAEVNR 95.00% 4.84 0.515 3.21 837.4323 1,672.85 1,673.86 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% VSDLTQAANKNNDALR 95.00% 4.33 0.406 3.11 865.4445 1,728.87 1,729.88 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% VSDLTQAANKNNDALR 95.00% 4.44 0.439 4.19 865.9435 1,729.87 1,729.88 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% DGEVVSEATQQQHEVL 95.00% 2.36 0.371 0 884.9207 1,767.83 1,768.84 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% DGEVVSEATQQQHEVL 95.00% 3.26 0.636 2.28 884.9207 1,767.83 1,768.84 2
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.3 0.216 1.05 1,122.50 1,121.49 1,121.58 1 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.26 0.285 1.15 1,123.00 1,121.99 1,121.58 1 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.51 0.285 0 1,123.00 1,121.99 1,121.58 1 VIME_HUMAN
 SAMPLE 1 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 8 9 18 30.20% EYQDLLNVK 95.00% 2.3 0.248 0.854 1,123.00 1,121.99 1,121.58 1 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 4.77 0.349 0 509.9463 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 4.64 0.315 0 509.9467 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 3.54 0.342 0 509.9467 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 4.99 0.4 0.959 509.9468 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 3.2 0.23 0 509.9469 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 3.33 0.223 0 510.2785 1,527.81 1,527.83 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 4.9 0.357 1.01 510.2809 1,527.82 1,527.83 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 3.99 0.292 1.02 529.9349 1,586.78 1,587.80 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 3.66 0.31 1.07 529.936 1,586.78 1,587.80 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 4.78 0.36 1.19 529.9364 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 3.96 0.313 1.11 529.9366 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 4.89 0.333 1.96 529.9371 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 3.95 0.378 0 529.9373 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 3.9 0.329 0.959 529.9389 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 4.32 0.366 0 529.9402 1,586.80 1,587.80 3 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% DNLLDDLQR 95.00% 2.85 0.309 0 551.2803 1,100.55 1,101.55 2
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% VELQELNDR 95.00% 3.07 0.331 0 558.2863 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% VELQELNDR 95.00% 2.42 0.29 0 558.2867 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% VELQELNDR 95.00% 3.05 0.317 0 558.2871 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 2.05 0.387 0 561.2932 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 2.15 0.379 0 561.2945 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 1.98 0.356 0 561.2946 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 2.12 0.333 0 561.2948 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 2.53 0.409 1.25 561.2949 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 2.65 0.322 0 561.295 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 2.12 0.365 0 561.2956 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 2.24 0.408 0 561.3018 1,120.59 1,121.58 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 2.14 0.357 0 561.3041 1,120.59 1,121.58 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% RIESLNEEIAFLKK 95.00% 3.13 0.213 0 563.6126 1,687.81 1,689.95 3
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% VDVERDNLLDDLQR 95.00% 3.43 0.343 0 567.2902 1,698.85 1,699.86 3
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% VDVERDNLLDDLQR 95.00% 3.12 0.344 0 567.2905 1,698.85 1,699.86 3
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% VSDLTQAANKNNDALR 95.00% 4.11 0.473 1.36 577.2989 1,728.87 1,729.88 3
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% VSDLTQAANKNNDALR 95.00% 3.42 0.474 2.09 577.3006 1,728.88 1,729.88 3
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% NISEAEEWYK 95.00% 2.87 0.467 1.68 635.2917 1,268.57 1,268.58 2 EHD3_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% LQEEIQLKEEAENNLAAFR 95.00% 4.76 0.63 2.02 749.3851 2,245.13 2,245.15 3
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 2.54 0.215 0 764.416 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 3.57 0.292 0 764.4164 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 3.72 0.218 1.62 764.417 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 3.43 0.186 0 764.4174 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% FASEASGYQDNIAR 95.00% 3 0.378 0 764.8495 1,527.68 1,528.70 2
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% FASEASGYQDNIAR 95.00% 3.32 0.511 0 764.8509 1,527.69 1,528.70 2
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% FASEASGYQDNIAR 95.00% 2.94 0.428 0 764.8513 1,527.69 1,528.70 2
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% FASEASGYQDNIAR 95.00% 3.72 0.575 2.68 764.8515 1,527.69 1,528.70 2
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 3.44 0.341 0 764.9145 1,527.81 1,527.83 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% HLREYQDLLNVK 95.00% 3.73 0.205 0 764.917 1,527.82 1,527.83 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 4.48 0.484 3.02 794.402 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 4.26 0.484 3.55 794.4027 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 4.44 0.481 3.7 794.4028 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 4.09 0.489 3.15 794.4034 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 4.45 0.468 3.55 794.4044 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 4.31 0.453 2.14 794.4062 1,586.80 1,587.80 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 4.09 0.491 2.55 794.4066 1,586.80 1,587.80 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 4.58 0.438 1.8 794.4108 1,586.81 1,587.80 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% TNEKVELQELNDR 95.00% 4.57 0.497 2.89 794.901 1,587.79 1,587.80 2 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% FLEQQNAALAAEVNR 95.00% 4.58 0.511 3.64 837.4331 1,672.85 1,673.86 2
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% FLEQQNAALAAEVNR 95.00% 4.96 0.488 3.59 837.9327 1,673.85 1,673.86 2
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% VSDLTQAANKNNDALR 95.00% 4.14 0.377 1.6 865.4435 1,728.87 1,729.88 2
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% VSDLTQAANKNNDALR 95.00% 3.81 0.376 0 865.4466 1,728.88 1,729.88 2
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% DGEVVSEATQQQHEVL 95.00% 3.11 0.644 3.8 884.9191 1,767.82 1,768.84 2
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% DGEVVSEATQQQHEVL 95.00% 2.92 0.505 2.39 884.9241 1,767.83 1,768.84 2
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 2.56 0.184 1.09 1,122.99 1,121.99 1,121.58 1 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 2.35 0.213 0.854 1,123.00 1,121.99 1,121.58 1 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 2.18 0.304 1.47 1,123.00 1,121.99 1,121.58 1 VIME_HUMAN
 SAMPLE 1R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 9 10 18 30.40% EYQDLLNVK 95.00% 2.19 0.413 1.62 1,123.00 1,121.99 1,121.58 1 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% LLEGEESR 95.00% 2.51 0.244 0 466.7379 931.4601 932.469 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% LLEGEESR 95.00% 2.44 0.248 0 466.7391 931.4626 932.469 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% HLREYQDLLNVK 95.00% 4.76 0.406 0 509.9468 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% HLREYQDLLNVK 95.00% 4.85 0.37 1 509.9471 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 2.97 0.23 0 529.8176 1,586.43 1,587.80 3 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 3.97 0.31 0 529.9355 1,586.78 1,587.80 3 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 3.57 0.328 0 529.9374 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 3.7 0.313 1.11 529.9376 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 4.01 0.322 1.02 529.9382 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 3.69 0.336 0 530.2711 1,587.79 1,587.80 3 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% KLLEGEESR 95.00% 2.56 0.229 1.38 530.7854 1,059.56 1,060.56 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% KLLEGEESR 95.00% 2.28 0.199 0 530.7872 1,059.56 1,060.56 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% VELQELNDR 95.00% 2.52 0.313 0 558.2866 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% VELQELNDR 95.00% 3.24 0.353 0 558.2874 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% VELQELNDR 95.00% 2.55 0.288 0 558.2874 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% VELQELNDR 95.00% 3.04 0.279 0 558.2876 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% VELQELNDR 95.00% 2.81 0.263 1.44 558.2878 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% VELQELNDR 95.00% 2.5 0.227 0 558.2885 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% EYQDLLNVK 95.00% 2.01 0.338 0 561.2945 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% EYQDLLNVK 95.00% 2.11 0.333 0 561.2946 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% EYQDLLNVK 95.00% 2.29 0.365 1.35 561.2946 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% EYQDLLNVK 95.00% 2.09 0.361 0 561.2948 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% EYQDLLNVK 95.00% 2.03 0.424 0 561.2949 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% EYQDLLNVK 95.00% 2.23 0.353 1.33 561.295 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% EYQDLLNVK 95.00% 2.09 0.322 0 561.2951 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% VSDLTQAANKNNDALR 95.00% 4.13 0.459 2.55 577.2991 1,728.87 1,729.88 3
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% VSDLTQAANKNNDALR 95.00% 4.4 0.442 1.42 577.2991 1,728.87 1,729.88 3
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% HLREYQDLLNVK 95.00% 4.06 0.265 0 764.4186 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% FASEASGYQDNIAR 95.00% 4.89 0.625 5.59 764.8549 1,527.69 1,528.70 2
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% FASEASGYQDNIAR 95.00% 4.67 0.614 5.77 764.8562 1,527.70 1,528.70 2
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% HLREYQDLLNVK 95.00% 3.83 0.296 2.64 764.9187 1,527.82 1,527.83 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 4.09 0.469 3.12 794.3995 1,586.78 1,587.80 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 4.2 0.455 2.85 794.4018 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 3.76 0.453 1.96 794.4019 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 4.06 0.445 1.17 794.4019 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 4.36 0.463 2.42 794.4022 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 4.22 0.444 2.57 794.4024 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 4.18 0.478 1.92 794.4033 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 4.08 0.45 2.92 794.4033 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 3.82 0.423 2.36 794.4044 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% TNEKVELQELNDR 95.00% 4.22 0.481 2.38 794.9043 1,587.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% FLEQQNAALAAEVNR 95.00% 2.6 0.25 0 837.4328 1,672.85 1,673.86 2
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% VSDLTQAANKNNDALR 95.00% 4.23 0.424 2.18 865.445 1,728.87 1,729.88 2
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% EYQDLLNVK 95.00% 2.47 0.216 0.538 1,123.00 1,121.99 1,121.58 1 VIME_HUMAN
 SAMPLE 2 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 4 6 16.80% EYQDLLNVK 95.00% 2.23 0.116 0.796 1,123.00 1,121.99 1,121.58 1 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% HLREYQDLLNVK 95.00% 4.11 0.35 0 509.9456 1,526.81 1,527.83 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% HLREYQDLLNVK 95.00% 3.65 0.257 0 509.9467 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% HLREYQDLLNVK 95.00% 3.95 0.421 0 509.9469 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% HLREYQDLLNVK 95.00% 4.88 0.392 0.959 509.9471 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% HLREYQDLLNVK 95.00% 2.57 0.183 0 509.9487 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% HLREYQDLLNVK 95.00% 3.75 0.327 0 510.2818 1,527.82 1,527.83 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 4.43 0.294 1.08 529.9366 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 3.47 0.32 0 529.9367 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 4.13 0.298 0 529.937 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 3.73 0.288 0 529.9371 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 4.46 0.286 0 529.9373 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 3.41 0.136 0 529.9373 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 3.9 0.325 1.07 530.27 1,587.79 1,587.80 3 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% DNLLDDLQR 95.00% 2.52 0.262 0 551.2804 1,100.55 1,101.55 2
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% EYQDLLNVK 95.00% 1.83 0.321 0 561.2942 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% EYQDLLNVK 95.00% 2.13 0.351 0 561.2949 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% EYQDLLNVK 95.00% 2.09 0.341 0 561.295 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% EYQDLLNVK 95.00% 2.09 0.36 0 561.2961 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% VSDLTQAANKNNDALR 95.00% 3.29 0.367 1.49 577.2979 1,728.87 1,729.88 3
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% VSDLTQAANKNNDALR 95.00% 3.46 0.43 1.13 577.6321 1,729.87 1,729.88 3
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% HLREYQDLLNVK 95.00% 3.79 0.283 1.35 764.4164 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% FASEASGYQDNIAR 95.00% 4.52 0.614 6.15 764.8541 1,527.69 1,528.70 2
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% HLREYQDLLNVK 95.00% 3.79 0.288 3.72 764.9202 1,527.82 1,527.83 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% FASEASGYQDNIAR 95.00% 4.58 0.583 4.12 765.354 1,528.69 1,528.70 2
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 3.91 0.41 2.57 794.4023 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 4.41 0.486 2.96 794.4031 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 4.16 0.485 2.77 794.4033 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 3.5 0.461 2.22 794.4034 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 4.28 0.475 3.01 794.4034 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 4.01 0.498 2.15 794.4034 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 3.94 0.508 2.59 794.4036 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 4.43 0.471 3.08 794.4041 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 2R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 3 3 5 13.60% TNEKVELQELNDR 95.00% 3.92 0.451 2.48 794.9028 1,587.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% LLEGEESR 95.00% 2.17 0.256 0 466.7375 931.4594 932.469 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% LLEGEESR 95.00% 2.4 0.257 0 466.7378 931.4599 932.469 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% LLEGEESR 95.00% 2.39 0.247 0 466.7381 931.4605 932.469 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 5.29 0.364 0 509.9459 1,526.81 1,527.83 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 4.22 0.343 0 509.9466 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 4.36 0.372 0 509.9467 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 5.54 0.35 0 509.9467 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 3.66 0.328 0 509.9467 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 3.76 0.286 0 509.9467 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 4.29 0.349 0 509.9468 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 2.87 0.277 0 509.9469 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 4.5 0.372 0 509.9469 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 2.84 0.202 0 509.9473 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 4.46 0.367 0 510.2805 1,527.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 4.48 0.306 0 510.2805 1,527.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.77 0.367 1.19 529.9362 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.01 0.352 0.959 529.9363 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.21 0.351 1 529.9365 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.25 0.326 0 529.9368 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 3.87 0.35 1.51 529.9368 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.71 0.377 1.68 529.9369 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 3.66 0.27 0 529.9371 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.15 0.269 0 529.9376 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 3.5 0.343 0 529.9385 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 2.83 0.319 0 529.9391 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 3.62 0.315 0 529.9393 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 3.09 0.385 0 529.9401 1,586.80 1,587.80 3 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% DNLLDDLQR 95.00% 2.87 0.312 0 551.2807 1,100.55 1,101.55 2
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% DNLLDDLQR 95.00% 2.68 0.289 0 551.2807 1,100.55 1,101.55 2
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% VELQELNDR 95.00% 2.92 0.329 1.64 558.287 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% VELQELNDR 95.00% 2.96 0.339 0 558.2871 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% VELQELNDR 95.00% 3.11 0.305 0 558.2879 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% VELQELNDR 95.00% 3.2 0.347 0 558.2879 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% VELQELNDR 95.00% 2.94 0.362 1.96 558.2879 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% VELQELNDR 95.00% 3.21 0.317 0 558.2879 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% VELQELNDR 95.00% 3.01 0.385 0 558.2882 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% VELQELNDR 95.00% 2.62 0.355 1.31 558.2883 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% EYQDLLNVK 95.00% 1.88 0.303 0 561.2943 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% EYQDLLNVK 95.00% 2.52 0.319 0 561.2944 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% EYQDLLNVK 95.00% 2.12 0.305 0 561.2944 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% EYQDLLNVK 95.00% 2.02 0.313 0 561.2945 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% EYQDLLNVK 95.00% 2.19 0.298 1.47 561.2945 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% EYQDLLNVK 95.00% 1.95 0.343 0 561.2946 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% EYQDLLNVK 95.00% 2.29 0.345 0 561.2946 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% EYQDLLNVK 95.00% 2.11 0.354 0 561.2948 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% EYQDLLNVK 95.00% 2.11 0.373 0 561.295 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% EYQDLLNVK 95.00% 1.88 0.341 0 561.2957 1,120.58 1,121.58 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% EYQDLLNVK 95.00% 2.16 0.336 0 561.7957 1,121.58 1,121.58 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 3.94 0.303 1.43 764.417 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 3.19 0.32 0 764.4175 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 3.62 0.267 0 764.4181 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 3.84 0.279 1.16 764.4192 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% FASEASGYQDNIAR 95.00% 4.8 0.618 5.62 764.857 1,527.70 1,528.70 2
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% FASEASGYQDNIAR 95.00% 4.8 0.598 5.14 764.8576 1,527.70 1,528.70 2
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% HLREYQDLLNVK 95.00% 3.82 0.268 1.82 764.9189 1,527.82 1,527.83 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.5 0.469 3.17 794.4007 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.53 0.461 3.49 794.4009 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.43 0.451 3.72 794.4012 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.25 0.461 2.96 794.4016 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 3.84 0.486 2.4 794.4016 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.3 0.463 2.54 794.4017 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.42 0.462 2.89 794.4019 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.49 0.479 3.68 794.4022 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 3.9 0.434 1.82 794.4024 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.17 0.461 3.62 794.4027 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.19 0.429 2.82 794.4027 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.07 0.45 3.03 794.4037 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 3.79 0.468 1.92 794.4039 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% TNEKVELQELNDR 95.00% 4.11 0.446 2.38 794.9044 1,587.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% INLPIQTYSALNFR 95.00% 4.34 0.546 6.4 825.4524 1,648.89 1,649.90 2
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% INLPIQTYSALNFR 95.00% 4.56 0.574 6.74 825.4526 1,648.89 1,649.90 2
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% DGEVVSEATQQQHEVL 95.00% 3.58 0.657 3.18 884.9214 1,767.83 1,768.84 2
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% DGEVVSEATQQQHEVL 95.00% 2.95 0.567 4.24 884.9229 1,767.83 1,768.84 2
 SAMPLE 3 Desmin  DES  DESM_HUMAN 53,518.60 100.00% 4 4 8 18.30% EYQDLLNVK 95.00% 2.35 0.248 0.602 1,123.00 1,121.99 1,121.58 1 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% LLEGEESR 95.00% 2.47 0.185 0 466.7379 931.4601 932.469 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% LLEGEESR 95.00% 2.61 0.243 0 466.7384 931.4612 932.469 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 4.68 0.385 0.959 509.9446 1,526.81 1,527.83 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 4.7 0.339 0 509.946 1,526.81 1,527.83 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 2.96 0.161 0 509.9463 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 4.67 0.33 0 509.9468 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 3.14 0.188 0 509.9468 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 4.47 0.381 0 509.9472 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 4.67 0.361 0 509.9473 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 4.58 0.355 0 509.9475 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 4.28 0.324 0 509.9477 1,526.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 3.9 0.429 0 510.2803 1,527.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 3.88 0.24 0 510.2808 1,527.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 4.46 0.373 0 510.2814 1,527.82 1,527.83 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% RIESLNEEIAFLK 95.00% 2.96 0.301 0 521.2888 1,560.84 1,561.86 3 PLEC1_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 3.54 0.312 0 529.9361 1,586.78 1,587.80 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.03 0.324 0 529.9362 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.07 0.354 1.42 529.9364 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.3 0.287 1.25 529.9365 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.3 0.357 0 529.9368 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 3.94 0.344 0 529.9371 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.11 0.295 0 529.9371 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.55 0.349 1.39 529.9371 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.19 0.311 0 529.9375 1,586.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.14 0.403 0 530.2709 1,587.79 1,587.80 3 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% VELQELNDR 95.00% 3.01 0.35 0 558.285 1,114.55 1,115.57 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% VELQELNDR 95.00% 2.74 0.317 0 558.2862 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% VELQELNDR 95.00% 3.06 0.329 0 558.2874 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% VELQELNDR 95.00% 3.2 0.289 0 558.2876 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% VELQELNDR 95.00% 3.15 0.318 0 558.2876 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% VELQELNDR 95.00% 2.72 0.312 0 558.2881 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% VELQELNDR 95.00% 2.89 0.363 0 558.289 1,114.56 1,115.57 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% EYQDLLNVK 95.00% 2.08 0.334 0 561.2941 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% EYQDLLNVK 95.00% 2.02 0.296 0 561.2942 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% EYQDLLNVK 95.00% 2.27 0.35 0 561.2943 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% EYQDLLNVK 95.00% 2.16 0.388 0 561.2947 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% EYQDLLNVK 95.00% 1.9 0.355 0 561.2947 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% EYQDLLNVK 95.00% 2.09 0.356 0 561.2949 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% EYQDLLNVK 95.00% 1.78 0.323 0 561.2953 1,120.57 1,121.58 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% VDVERDNLLDDLQR 95.00% 3.73 0.358 1.21 567.2907 1,698.85 1,699.86 3
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% VDVERDNLLDDLQR 95.00% 3.98 0.365 0 567.2911 1,698.85 1,699.86 3
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% LQEEIQLKEEAENNLAAFR 95.00% 3.63 0.457 1.92 749.3864 2,245.14 2,245.15 3
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 3.78 0.262 0 764.4156 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 3.82 0.284 1.59 764.4176 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 3.41 0.296 0 764.4187 1,526.82 1,527.83 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% FASEASGYQDNIAR 95.00% 4.87 0.638 4.72 764.8541 1,527.69 1,528.70 2
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% FASEASGYQDNIAR 95.00% 4.91 0.6 5.14 764.8548 1,527.69 1,528.70 2
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% HLREYQDLLNVK 95.00% 3.58 0.279 1.25 764.9201 1,527.82 1,527.83 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.34 0.464 3.7 794.3991 1,586.78 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.5 0.479 3.6 794.4014 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 3.8 0.466 3.82 794.4018 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.14 0.464 3.34 794.402 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.05 0.458 2.3 794.402 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.4 0.461 2.57 794.4022 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.23 0.5 2.3 794.4024 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 3.87 0.451 3.54 794.4025 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.26 0.476 3.34 794.4029 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.27 0.466 2.1 794.4029 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.4 0.466 3.42 794.4031 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 4.15 0.472 3.33 794.4033 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 3.8 0.437 2.77 794.4035 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 3.95 0.466 2.39 794.404 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TNEKVELQELNDR 95.00% 3.74 0.437 2.68 794.4047 1,586.79 1,587.80 2 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TFGGAPGFPLGSPLSSPVFPR 95.00% 2.9 0.298 0 1,045.05 2,088.08 2,088.09 2
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% TFGGAPGFPLGSPLSSPVFPR 95.00% 4.53 0.573 6.66 1,045.05 2,088.09 2,088.09 2
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% EYQDLLNVK 95.00% 2.33 0.202 0.569 1,122.50 1,121.49 1,121.58 1 VIME_HUMAN
 SAMPLE 3R Desmin  DES  DESM_HUMAN 53,518.60 100.00% 5 5 8 24.30% EYQDLLNVK 95.00% 2.34 0.178 0.658 1,123.00 1,121.99 1,121.58 1 VIME_HUMAN
 SAMPLE 4 Desmoplakin  DSP  DESP_HUMAN 331,763.40 99.80% 2 2 3 0.56% YIELLTR 94.50% 2.51 0.112 0 454.2684 906.5211 907.5254 2
 SAMPLE 4 Desmoplakin  DSP  DESP_HUMAN 331,763.40 99.80% 2 2 3 0.56% YIELLTR 95.00% 2.38 0.148 0 454.269 906.5224 907.5254 2
 SAMPLE 4 Desmoplakin  DSP  DESP_HUMAN 331,763.40 99.80% 2 2 3 0.56% IEVLEEELR 95.00% 2.6 0.274 0 565.3109 1,128.61 1,129.61 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% AALEALLGR 95.00% 2.76 0.196 0 457.2791 912.5425 913.5472 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% AALEALLGR 95.00% 2.92 0.194 0 457.2797 912.5438 913.5472 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LYDYVcR 95.00% 2.43 0.249 0 c6: Carbamidomethyl (+57.02) 494.7331 987.4505 988.4563 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LYDYVcR 95.00% 2.38 0.32 0 c6: Carbamidomethyl (+57.02) 494.7331 987.4505 988.4563 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LYDYVcR 95.00% 2.55 0.29 0 c6: Carbamidomethyl (+57.02) 494.7331 987.4506 988.4563 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LYDYVcR 95.00% 2.69 0.346 0 c6: Carbamidomethyl (+57.02) 494.7334 987.4511 988.4563 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LYDYVcR 95.00% 2.49 0.289 0 c6: Carbamidomethyl (+57.02) 494.7337 987.4518 988.4563 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LYDYVcR 95.00% 1.91 0.288 0 c6: Carbamidomethyl (+57.02) 494.7348 987.454 988.4563 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% EALGLEQLR 95.00% 2.22 0.198 0 514.7917 1,027.57 1,028.57 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% TFSPTYGLLR 95.00% 2.12 0.353 0 577.8151 1,153.61 1,154.62 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LQTGPEKAELQELNAR 95.00% 2.76 0.204 0 599.6554 1,795.94 1,796.95 3
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LQTGPEKAELQELNAR 95.00% 3.08 0.386 0 599.6564 1,795.95 1,796.95 3
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LQTGPEKAELQELNAR 95.00% 3.65 0.436 0 599.6568 1,795.95 1,796.95 3
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LQTGPEKAELQELNAR 95.00% 2.58 0.392 0 599.6569 1,795.95 1,796.95 3
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LQTGPEKAELQELNAR 95.00% 2.67 0.317 0 599.6576 1,795.95 1,796.95 3
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LQTGPEKAELQELNAR 95.00% 2.97 0.305 0 599.9914 1,796.95 1,796.95 3
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% TGLSLEVATYR 95.00% 2.17 0.232 1.17 605.3249 1,208.63 1,209.65 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% TGLSLEVATYR 95.00% 2.19 0.319 1.21 605.3275 1,208.64 1,209.65 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% TGLSLEVATYR 95.00% 2.69 0.522 1.74 605.3286 1,208.64 1,209.65 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% TGLSLEVATYR 95.00% 3.24 0.5 1.68 605.3291 1,208.64 1,209.65 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% TGLSLEVATYR 95.00% 2.97 0.444 1.66 605.3293 1,208.64 1,209.65 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% TGLSLEVATYR 95.00% 2.85 0.408 0 605.3293 1,208.64 1,209.65 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% TGLSLEVATYR 95.00% 2.67 0.422 0 605.3295 1,208.64 1,209.65 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% TGLSLEVATYR 95.00% 2.84 0.519 1.47 605.3303 1,208.64 1,209.65 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% TGLSLEVATYR 95.00% 2.77 0.376 1.89 605.3303 1,208.64 1,209.65 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% TGLSLEVATYR 95.00% 2.67 0.39 1.62 605.3307 1,208.65 1,209.65 2
 SAMPLE 4 Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 7 7 27 4.66% LcAQEAEALRR 95.00% 2.2 0.293 0 c2: Carbamidomethyl (+57.02) 658.8424 1,315.67 1,316.67 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% AALEALLGR 95.00% 2.8 0.194 0 457.2797 912.5437 913.5472 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% AALEALLGR 95.00% 2.92 0.191 0 457.28 912.5443 913.5472 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% SGEFHAEPTVIEK 95.00% 1.93 0.34 0 481.608 1,441.80 1,443.71 3
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% LYDYVcR 95.00% 2.5 0.367 0 c6: Carbamidomethyl (+57.02) 494.7326 987.4495 988.4563 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% LYDYVcR 95.00% 2.26 0.232 0 c6: Carbamidomethyl (+57.02) 494.7327 987.4497 988.4563 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% LYDYVcR 95.00% 2.06 0.247 0 c6: Carbamidomethyl (+57.02) 494.7333 987.451 988.4563 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% LYDYVcR 95.00% 2.22 0.241 0 c6: Carbamidomethyl (+57.02) 494.7336 987.4516 988.4563 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% LYDYVcR 95.00% 2.29 0.251 0 c6: Carbamidomethyl (+57.02) 494.7342 987.4527 988.4563 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% LYDYVcR 95.00% 2.31 0.305 0 c6: Carbamidomethyl (+57.02) 494.7355 987.4553 988.4563 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% ARLEDALLR 95.00% 2.43 0.0748 2.3 528.8136 1,055.61 1,056.62 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% ARLEDALLR 95.00% 3.45 0.125 0 529.3156 1,056.62 1,056.62 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% TFSPTYGLLR 95.00% 1.65 0.307 1.92 577.8158 1,153.62 1,154.62 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% LQTGPEKAELQELNAR 95.00% 3.26 0.441 0 599.6559 1,795.94 1,796.95 3
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% LQTGPEKAELQELNAR 95.00% 3.48 0.427 0 599.9916 1,796.95 1,796.95 3
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% LQTGPEKAELQELNAR 95.00% 3.2 0.337 0 599.9917 1,796.95 1,796.95 3
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% LQTGPEKAELQELNAR 95.00% 3.14 0.313 0 599.9925 1,796.95 1,796.95 3
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% LQTGPEKAELQELNAR 95.00% 2.26 0.283 0 599.9925 1,796.95 1,796.95 3
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% TGLSLEVATYR 95.00% 2.4 0.405 1.44 605.3271 1,208.64 1,209.65 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% TGLSLEVATYR 95.00% 2.12 0.259 0 605.3271 1,208.64 1,209.65 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% TGLSLEVATYR 95.00% 2.94 0.451 1.59 605.328 1,208.64 1,209.65 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% TGLSLEVATYR 95.00% 3.08 0.474 1.29 605.3288 1,208.64 1,209.65 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% TGLSLEVATYR 95.00% 2.39 0.402 0 605.3292 1,208.64 1,209.65 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% TGLSLEVATYR 95.00% 2.34 0.325 1.64 605.3293 1,208.64 1,209.65 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% TGLSLEVATYR 95.00% 2.48 0.404 1.74 605.3293 1,208.64 1,209.65 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% TGLSLEVATYR 95.00% 2.5 0.371 2.42 605.33 1,208.64 1,209.65 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% TGLSLEVATYR 95.00% 2.63 0.348 1.96 605.3307 1,208.65 1,209.65 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% TGLSLEVATYR 95.00% 2.17 0.372 0 605.3319 1,208.65 1,209.65 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% TGLSLEVATYR 95.00% 2.08 0.303 0 605.7563 1,209.50 1,209.65 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% LcAQEAEALRR 95.00% 2.19 0.292 0 c2: Carbamidomethyl (+57.02) 658.843 1,315.67 1,316.67 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% EVPVYIGEDSTIAR 95.00% 2.54 0.239 0 774.9004 1,547.79 1,548.79 2
 SAMPLE 4R Desmuslin  DMN  DMN_HUMAN 172,747.40 100.00% 9 9 31 6.39% EVPVYIGEDSTIAR 95.00% 2.78 0.3 2.01 774.902 1,547.79 1,548.79 2
 SAMPLE 3 Desmuslin  DMN  DMN_HUMAN 172,747.40 99.80% 2 2 2 1.15% AALEALLGR 95.00% 2.89 0.185 0 457.2774 912.5392 913.5472 2
 SAMPLE 3 Desmuslin  DMN  DMN_HUMAN 172,747.40 99.80% 2 2 2 1.15% DYQDLLQVK 95.00% 1.82 0.33 0 561.2943 1,120.57 1,121.58 2
 SAMPLE 2 Destrin  DSTN  DEST_HUMAN 18,488.20 99.80% 2 2 5 17.60% YALYDASFETK 95.00% 3.05 0.464 4.3 654.3101 1,306.60 1,307.62 2
 SAMPLE 2 Destrin  DSTN  DEST_HUMAN 18,488.20 99.80% 2 2 5 17.60% YALYDASFETK 95.00% 2.91 0.46 5 654.3103 1,306.61 1,307.62 2
 SAMPLE 2 Destrin  DSTN  DEST_HUMAN 18,488.20 99.80% 2 2 5 17.60% YALYDASFETK 95.00% 3.42 0.506 5.3 654.3106 1,306.61 1,307.62 2
 SAMPLE 2 Destrin  DSTN  DEST_HUMAN 18,488.20 99.80% 2 2 5 17.60% YALYDASFETK 95.00% 3.26 0.448 4.66 654.3113 1,306.61 1,307.62 2
 SAMPLE 2 Destrin  DSTN  DEST_HUMAN 18,488.20 99.80% 2 2 5 17.60% FQGIKHEcQANGPEDLNR 95.00% 4.55 0.388 2.34 c8: Carbamidomethyl (+57.02) 704.9998 2,111.98 2,112.99 3
 SAMPLE 2R Destrin  DSTN  DEST_HUMAN 18,488.20 99.80% 2 2 4 17.60% YALYDASFETK 95.00% 2.95 0.437 3.24 654.3104 1,306.61 1,307.62 2
 SAMPLE 2R Destrin  DSTN  DEST_HUMAN 18,488.20 99.80% 2 2 4 17.60% YALYDASFETK 95.00% 3.25 0.47 3.96 654.3105 1,306.61 1,307.62 2
 SAMPLE 2R Destrin  DSTN  DEST_HUMAN 18,488.20 99.80% 2 2 4 17.60% FQGIKHEcQANGPEDLNR 95.00% 4.96 0.479 1.1 c8: Carbamidomethyl (+57.02) 705.3326 2,112.97 2,112.99 3
 SAMPLE 2R Destrin  DSTN  DEST_HUMAN 18,488.20 99.80% 2 2 4 17.60% FQGIKHEcQANGPEDLNR 95.00% 4.85 0.517 0 c8: Carbamidomethyl (+57.02) 705.3333 2,112.98 2,112.99 3
 SAMPLE 3 Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 4 4 10 24.80% HFVGMLPEK 95.00% 2 0.251 0 529.2776 1,056.54 1,057.55 2
 SAMPLE 3 Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 4 4 10 24.80% YALYDASFETK 95.00% 3.29 0.458 4.19 654.3094 1,306.60 1,307.62 2
 SAMPLE 3 Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 4 4 10 24.80% YALYDASFETK 95.00% 3.06 0.501 4.04 654.3108 1,306.61 1,307.62 2
 SAMPLE 3 Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 4 4 10 24.80% YALYDASFETK 95.00% 3.44 0.516 4.43 654.3108 1,306.61 1,307.62 2
 SAMPLE 3 Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 4 4 10 24.80% YALYDASFETK 95.00% 3.1 0.454 4.46 654.3111 1,306.61 1,307.62 2
 SAMPLE 3 Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 4 4 10 24.80% FQGIKHEcQANGPEDLNR 95.00% 4.92 0.442 1.51 c8: Carbamidomethyl (+57.02) 704.9999 2,111.98 2,112.99 3
 SAMPLE 3 Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 4 4 10 24.80% FQGIKHEcQANGPEDLNR 95.00% 5.36 0.505 1.66 c8: Carbamidomethyl (+57.02) 705.0003 2,111.98 2,112.99 3
 SAMPLE 3 Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 4 4 10 24.80% FQGIKHEcQANGPEDLNR 95.00% 5.38 0.505 1.23 c8: Carbamidomethyl (+57.02) 705.3333 2,112.98 2,112.99 3
 SAMPLE 3 Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 4 4 10 24.80% FQGIKHEcQANGPEDLNR 95.00% 5.64 0.496 0.959 c8: Carbamidomethyl (+57.02) 705.3335 2,112.98 2,112.99 3
 SAMPLE 3 Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 4 4 10 24.80% YALYDASFETKESR 95.00% 2 0.495 0 840.4421 1,678.87 1,679.79 2
 SAMPLE 3R Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 3 3 8 19.40% YALYDASFETK 95.00% 3.08 0.464 5.66 654.311 1,306.61 1,307.62 2
 SAMPLE 3R Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 3 3 8 19.40% YALYDASFETK 95.00% 3.14 0.449 4.62 654.3111 1,306.61 1,307.62 2
 SAMPLE 3R Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 3 3 8 19.40% YALYDASFETK 95.00% 3.24 0.46 5.38 654.3114 1,306.61 1,307.62 2
 SAMPLE 3R Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 3 3 8 19.40% FQGIKHEcQANGPEDLNR 95.00% 5.35 0.559 0 c8: Carbamidomethyl (+57.02) 705.3336 2,112.98 2,112.99 3
 SAMPLE 3R Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 3 3 8 19.40% FQGIKHEcQANGPEDLNR 95.00% 5.33 0.523 1.24 c8: Carbamidomethyl (+57.02) 705.3346 2,112.98 2,112.99 3
 SAMPLE 3R Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 3 3 8 19.40% FQGIKHEcQANGPEDLNR 95.00% 5.4 0.508 1.89 c8: Carbamidomethyl (+57.02) 705.3356 2,112.98 2,112.99 3
 SAMPLE 3R Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 3 3 8 19.40% FQGIKHEcQANGPEDLNR 95.00% 5.64 0.485 0 c8: Carbamidomethyl (+57.02) 705.3359 2,112.98 2,112.99 3
 SAMPLE 3R Destrin  DSTN  DEST_HUMAN 18,488.20 100.00% 3 3 8 19.40% YALYDASFETKESR 95.00% 2.24 0.411 0 840.4433 1,678.87 1,679.79 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% VFNLYPR 95.00% 2.87 0.312 0 454.754 907.4924 908.4994 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% VFNLYPR 95.00% 2.84 0.356 0 454.7541 907.4925 908.4994 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% VFNLYPR 95.00% 2.78 0.382 0 454.7544 907.4931 908.4994 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% VFNLYPR 95.00% 2.9 0.296 0 454.7545 907.4933 908.4994 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% SSAEVIAQAR 95.00% 1.91 0.156 2.09 516.277 1,030.54 1,031.55 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% GSPLVVISQGK 95.00% 2.74 0.378 0 542.8189 1,083.62 1,084.64 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% GSPLVVISQGK 95.00% 2.85 0.375 0 542.821 1,083.63 1,084.64 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% IVLEDGTLHVTEGSGR 95.00% 1.9 0.24 2.77 561.627 1,681.86 1,682.87 3
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% IVLEDGTLHVTEGSGR 95.00% 1.78 0.301 1.72 561.6274 1,681.86 1,682.87 3
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% KPFPDFVYK 95.00% 2.63 0.404 0 570.8062 1,139.60 1,140.61 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% KPFPDFVYK 95.00% 2.51 0.321 0 570.8065 1,139.60 1,140.61 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% KPFPDFVYK 95.00% 2.66 0.399 0 570.807 1,139.60 1,140.61 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% KPFPDFVYK 95.00% 2.76 0.31 0 570.8072 1,139.60 1,140.61 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% QIGENLIVPGGVK 95.00% 2.3 0.452 1.48 662.3832 1,322.75 1,323.76 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% QIGENLIVPGGVK 95.00% 2.63 0.476 1.51 662.3836 1,322.75 1,323.76 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% QIGENLIVPGGVK 95.00% 2.57 0.403 1.49 662.3839 1,322.75 1,323.76 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% QIGENLIVPGGVK 95.00% 2.73 0.353 0 662.3842 1,322.75 1,323.76 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% GLYDGPVcEVSVTPK 95.00% 3.72 0.589 4.92 c8: Carbamidomethyl (+57.02) 810.8995 1,619.78 1,620.79 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% GLYDGPVcEVSVTPK 95.00% 3.68 0.592 6.29 c8: Carbamidomethyl (+57.02) 810.8997 1,619.78 1,620.79 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% GLYDGPVcEVSVTPK 95.00% 3.84 0.579 4.48 c8: Carbamidomethyl (+57.02) 810.9004 1,619.79 1,620.79 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% GLYDGPVcEVSVTPK 95.00% 3.49 0.614 4.48 c8: Carbamidomethyl (+57.02) 810.901 1,619.79 1,620.79 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% IVLEDGTLHVTEGSGR 95.00% 4.58 0.635 4.46 842.4404 1,682.87 1,682.87 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% IVLEDGTLHVTEGSGR 95.00% 4.38 0.628 5.54 842.4418 1,682.87 1,682.87 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% MDENQFVAVTSTNAAK 95.00% 5.26 0.05 0 863.4068 1,724.80 1,725.81 2 DPYL3_HUMAN
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% DNFTLIPEGTNGTEER 95.00% 3.64 0.449 2.77 897.4178 1,792.82 1,792.84 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% AITIANQTNcPLYITK 95.00% 4.93 0.649 5.24 c10: Carbamidomethyl (+57.02) 910.9794 1,819.94 1,820.96 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% AITIANQTNcPLYITK 95.00% 4.45 0.671 4 c10: Carbamidomethyl (+57.02) 910.981 1,819.95 1,820.96 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% AITIANQTNcPLYITK 95.00% 4.48 0.657 4.66 c10: Carbamidomethyl (+57.02) 910.9821 1,819.95 1,820.96 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% AITIANQTNcPLYITK 95.00% 4.75 0.637 4.47 c10: Carbamidomethyl (+57.02) 911.4831 1,820.95 1,820.96 2
 SAMPLE 1 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 10 11 29 25.70% IAVGSDADLVIWDPDSVK 95.00% 4.54 0.587 2.74 950.4867 1,898.96 1,899.97 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% VFNLYPR 95.00% 2.72 0.364 0 454.7531 907.4906 908.4994 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% VFNLYPR 95.00% 2.56 0.354 0 454.7533 907.491 908.4994 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% VFNLYPR 95.00% 2.76 0.426 0 454.7539 907.4921 908.4994 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% VFNLYPR 95.00% 2.74 0.349 0 454.7542 907.4928 908.4994 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% SSAEVIAQAR 95.00% 2.31 0.238 2.72 516.2772 1,030.54 1,031.55 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% GSPLVVISQGK 95.00% 2.76 0.348 1.13 542.8197 1,083.62 1,084.64 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% GSPLVVISQGK 95.00% 2.69 0.357 0 542.8202 1,083.62 1,084.64 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% KPFPDFVYK 95.00% 2.63 0.303 0 570.8053 1,139.60 1,140.61 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% KPFPDFVYK 95.00% 2.26 0.277 0 570.8061 1,139.60 1,140.61 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% KPFPDFVYK 95.00% 2.47 0.285 0 570.8064 1,139.60 1,140.61 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% KPFPDFVYK 95.00% 2.32 0.228 0 570.8067 1,139.60 1,140.61 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% QIGENLIVPGGVK 95.00% 2.28 0.453 1.38 662.3838 1,322.75 1,323.76 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% QIGENLIVPGGVK 95.00% 2.61 0.425 1.28 662.3842 1,322.75 1,323.76 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% DIGAIAQVHAENGDIIAEEQQR 95.00% 5.42 0.403 2.77 793.3956 2,377.16 2,377.18 3
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% GTVVYGEPITASLGTDGSHYWSK 95.00% 2.17 0.329 0 809.3945 2,425.16 2,425.17 3
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% GTVVYGEPITASLGTDGSHYWSK 95.00% 2.4 0.423 0 809.3948 2,425.16 2,425.17 3
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% GLYDGPVcEVSVTPK 95.00% 3.92 0.604 3.6 c8: Carbamidomethyl (+57.02) 810.8982 1,619.78 1,620.79 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% GLYDGPVcEVSVTPK 95.00% 3.69 0.574 3.62 c8: Carbamidomethyl (+57.02) 810.8999 1,619.78 1,620.79 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% GLYDGPVcEVSVTPK 95.00% 3.57 0.555 4.19 c8: Carbamidomethyl (+57.02) 810.9012 1,619.79 1,620.79 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% GLYDGPVcEVSVTPK 95.00% 3.89 0.575 4.05 c8: Carbamidomethyl (+57.02) 811.402 1,620.79 1,620.79 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% MDENQFVAVTSTNAAK 95.00% 5.54 0.0858 0 863.4089 1,724.80 1,725.81 2 DPYL3_HUMAN
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% MDENQFVAVTSTNAAK 95.00% 5.4 0.0958 0 863.4095 1,724.80 1,725.81 2 DPYL3_HUMAN
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% DNFTLIPEGTNGTEER 95.00% 3.17 0.273 2.59 897.4214 1,792.83 1,792.84 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% AITIANQTNcPLYITK 95.00% 4.26 0.632 4.6 c10: Carbamidomethyl (+57.02) 910.979 1,819.94 1,820.96 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% AITIANQTNcPLYITK 95.00% 4.85 0.632 4.34 c10: Carbamidomethyl (+57.02) 910.9823 1,819.95 1,820.96 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% AITIANQTNcPLYITK 95.00% 4.68 0.635 4.08 c10: Carbamidomethyl (+57.02) 911.4845 1,820.95 1,820.96 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% AITIANQTNcPLYITK 95.00% 5.09 0.548 4.77 c10: Carbamidomethyl (+57.02) 911.4846 1,820.95 1,820.96 2
 SAMPLE 1R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 11 11 26 30.80% IAVGSDADLVIWDPDSVK 95.00% 5.05 0.566 3.2 950.9896 1,899.96 1,899.97 2
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% VFNLYPR 95.00% 2.71 0.344 0 454.7541 907.4926 908.4994 2
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% VFNLYPR 95.00% 3 0.255 0 454.7544 907.4931 908.4994 2
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% GSPLVVISQGK 95.00% 2.79 0.361 0 542.8208 1,083.63 1,084.64 2
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% GSPLVVISQGK 95.00% 2.98 0.348 1.47 542.8208 1,083.63 1,084.64 2
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% KPFPDFVYK 95.00% 2.71 0.347 0 570.8053 1,139.59 1,140.61 2
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% KPFPDFVYK 95.00% 2.45 0.253 0 570.8054 1,139.60 1,140.61 2
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% QIGENLIVPGGVK 95.00% 2.27 0.339 0 662.3847 1,322.75 1,323.76 2
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% QIGENLIVPGGVK 95.00% 3.21 0.543 1.8 662.3847 1,322.75 1,323.76 2
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% NLHQSGFSLSGAQIDDNIPR 95.00% 3.52 0.366 0.921 724.0254 2,169.05 2,169.07 3
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% NLHQSGFSLSGAQIDDNIPR 95.00% 3.67 0.345 0 724.0276 2,169.06 2,169.07 3
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% DIGAIAQVHAENGDIIAEEQQR 95.00% 6.49 0.481 1.7 793.3961 2,377.16 2,377.18 3
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% DIGAIAQVHAENGDIIAEEQQR 95.00% 5.81 0.441 0 793.3972 2,377.17 2,377.18 3
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% GLYDGPVcEVSVTPK 95.00% 3.79 0.638 4.82 c8: Carbamidomethyl (+57.02) 810.9008 1,619.79 1,620.79 2
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% GLYDGPVcEVSVTPK 95.00% 3.58 0.563 4.57 c8: Carbamidomethyl (+57.02) 811.3983 1,620.78 1,620.79 2
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% MDENQFVAVTSTNAAK 95.00% 5.68 0.114 3 863.4067 1,724.80 1,725.81 2 DPYL3_HUMAN
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% MDENQFVAVTSTNAAK 95.00% 5.27 0.0932 3.62 863.4084 1,724.80 1,725.81 2 DPYL3_HUMAN
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% AITIANQTNcPLYITK 95.00% 4.77 0.674 3.54 c10: Carbamidomethyl (+57.02) 910.9818 1,819.95 1,820.96 2
 SAMPLE 2 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 16 22.60% AITIANQTNcPLYITK 95.00% 5.12 0.566 4.92 c10: Carbamidomethyl (+57.02) 911.4831 1,820.95 1,820.96 2
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% VFNLYPR 95.00% 2.96 0.318 0 454.7535 907.4914 908.4994 2
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% VFNLYPR 95.00% 2.68 0.373 0 454.7541 907.4926 908.4994 2
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% GSPLVVISQGK 95.00% 2.78 0.364 0 542.8205 1,083.63 1,084.64 2
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% GSPLVVISQGK 95.00% 2.82 0.351 1.17 542.8212 1,083.63 1,084.64 2
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% KPFPDFVYK 95.00% 2.58 0.257 0 570.8064 1,139.60 1,140.61 2
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% KPFPDFVYK 95.00% 2.67 0.27 0 570.8071 1,139.60 1,140.61 2
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% QIGENLIVPGGVK 95.00% 1.98 0.358 0 662.3844 1,322.75 1,323.76 2
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% NLHQSGFSLSGAQIDDNIPR 95.00% 3.7 0.302 1.7 724.0267 2,169.06 2,169.07 3
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% NLHQSGFSLSGAQIDDNIPR 95.00% 2.96 0.338 0 724.0276 2,169.06 2,169.07 3
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% DIGAIAQVHAENGDIIAEEQQR 95.00% 5.39 0.469 2.33 793.3989 2,377.17 2,377.18 3
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% GLYDGPVcEVSVTPK 95.00% 3.33 0.539 5.24 c8: Carbamidomethyl (+57.02) 810.8997 1,619.78 1,620.79 2
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% GLYDGPVcEVSVTPK 95.00% 3.67 0.586 5.96 c8: Carbamidomethyl (+57.02) 810.8999 1,619.78 1,620.79 2
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% MDENQFVAVTSTNAAK 95.00% 5.3 0.112 3.28 863.4074 1,724.80 1,725.81 2 DPYL3_HUMAN
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% MDENQFVAVTSTNAAK 95.00% 5.2 0.118 3.03 863.4079 1,724.80 1,725.81 2 DPYL3_HUMAN
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% AITIANQTNcPLYITK 95.00% 4.78 0.668 4.47 c10: Carbamidomethyl (+57.02) 910.9814 1,819.95 1,820.96 2
 SAMPLE 2R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 8 8 14 22.60% AITIANQTNcPLYITK 95.00% 4.24 0.608 5.74 c10: Carbamidomethyl (+57.02) 910.984 1,819.95 1,820.96 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% VFNLYPR 95.00% 2.79 0.424 0 454.7534 907.4912 908.4994 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% VFNLYPR 95.00% 2.8 0.388 0 454.7538 907.4919 908.4994 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% KPFPDFVYK 95.00% 2.72 0.339 0 570.8072 1,139.60 1,140.61 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% KPFPDFVYK 95.00% 2.74 0.365 0 570.8075 1,139.60 1,140.61 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% GIQEEMEALVK 95.00% 2.5 0.338 2.66 623.8197 1,245.62 1,246.64 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% QIGENLIVPGGVK 95.00% 2.37 0.451 1.48 662.3841 1,322.75 1,323.76 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% QIGENLIVPGGVK 95.00% 2.22 0.505 1.72 662.3842 1,322.75 1,323.76 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% NLHQSGFSLSGAQIDDNIPR 95.00% 3.21 0.256 0 724.0282 2,169.06 2,169.07 3
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% NLHQSGFSLSGAQIDDNIPR 95.00% 4.14 0.394 1.21 724.0288 2,169.06 2,169.07 3
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% DIGAIAQVHAENGDIIAEEQQR 95.00% 6.14 0.469 2.44 793.3979 2,377.17 2,377.18 3
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% GLYDGPVcEVSVTPK 95.00% 4.11 0.638 4.46 c8: Carbamidomethyl (+57.02) 810.8993 1,619.78 1,620.79 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% GLYDGPVcEVSVTPK 95.00% 3.8 0.555 4.28 c8: Carbamidomethyl (+57.02) 811.4006 1,620.79 1,620.79 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% MDENQFVAVTSTNAAK 95.00% 5.47 0.0928 0 863.4082 1,724.80 1,725.81 2 DPYL3_HUMAN
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% AITIANQTNcPLYITK 95.00% 4.05 0.576 4.06 c10: Carbamidomethyl (+57.02) 910.9809 1,819.95 1,820.96 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% AITIANQTNcPLYITK 95.00% 5.19 0.589 4.44 c10: Carbamidomethyl (+57.02) 911.484 1,820.95 1,820.96 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% IAVGSDADLVIWDPDSVK 95.00% 4.38 0.559 1.33 950.9884 1,899.96 1,899.97 2
 SAMPLE 3 Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 16 25.70% IAVGSDADLVIWDPDSVK 95.00% 4.57 0.587 2.08 950.9886 1,899.96 1,899.97 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% VFNLYPR 95.00% 2.76 0.43 0 454.7534 907.4911 908.4994 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% VFNLYPR 95.00% 2.76 0.428 0 454.7543 907.493 908.4994 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% IVLEDGTLHVTEGSGR 95.00% 1.79 0.317 2.13 561.6276 1,681.86 1,682.87 3
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% IVLEDGTLHVTEGSGR 95.00% 1.92 0.2 2.22 561.6281 1,681.86 1,682.87 3
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% KPFPDFVYK 95.00% 2.77 0.353 0 570.8073 1,139.60 1,140.61 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% KPFPDFVYK 95.00% 2.43 0.284 0 570.8082 1,139.60 1,140.61 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% GIQEEMEALVK 95.00% 2.26 0.343 1.82 623.8205 1,245.63 1,246.64 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% QIGENLIVPGGVK 95.00% 2.05 0.413 0 662.3844 1,322.75 1,323.76 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% QIGENLIVPGGVK 95.00% 2.12 0.244 0 662.3852 1,322.75 1,323.76 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% NLHQSGFSLSGAQIDDNIPR 95.00% 2.56 0.258 0 724.0254 2,169.05 2,169.07 3
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% NLHQSGFSLSGAQIDDNIPR 95.00% 3.35 0.337 0 724.0283 2,169.06 2,169.07 3
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% GLYDGPVcEVSVTPK 95.00% 3.14 0.497 4.37 c8: Carbamidomethyl (+57.02) 810.8981 1,619.78 1,620.79 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% GLYDGPVcEVSVTPK 95.00% 3.69 0.608 3.28 c8: Carbamidomethyl (+57.02) 810.9007 1,619.79 1,620.79 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% AITIANQTNcPLYITK 95.00% 3.98 0.658 4.32 c10: Carbamidomethyl (+57.02) 910.9812 1,819.95 1,820.96 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% AITIANQTNcPLYITK 95.00% 5.11 0.629 5.21 c10: Carbamidomethyl (+57.02) 911.4839 1,820.95 1,820.96 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% IAVGSDADLVIWDPDSVK 95.00% 4.63 0.58 2.59 950.989 1,899.96 1,899.97 2
 SAMPLE 3R Dihydropyrimidinase-related protein 2  DPYSL2  DPYL2_HUMAN 62,276.00 100.00% 9 9 17 21.90% IAVGSDADLVIWDPDSVK 95.00% 4.66 0.583 3.39 950.9908 1,899.97 1,899.97 2
 SAMPLE 4 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 3 3 6 4.91% IFNLYPR 95.00% 2.73 0.343 0 461.763 921.5104 922.5151 2
 SAMPLE 4 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 3 3 6 4.91% IFNLYPR 95.00% 2.67 0.333 0 461.7639 921.5122 922.5151 2
 SAMPLE 4 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 3 3 6 4.91% SAADLISQAR 95.00% 2.21 0.299 1.51 516.279 1,030.54 1,031.55 2
 SAMPLE 4 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 3 3 6 4.91% SAADLISQAR 95.00% 2.16 0.307 0 516.9452 1,031.87 1,031.55 2
 SAMPLE 4 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 3 3 6 4.91% SAADLISQAR 95.00% 2.62 0.304 0 516.9452 1,031.87 1,031.55 2
 SAMPLE 4 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 3 3 6 4.91% GAPLVVIcQGK 95.00% 3.13 0.351 1.32 c8: Carbamidomethyl (+57.02) 571.326 1,140.64 1,141.64 2
 SAMPLE 4R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 4 4 8 7.54% IFNLYPR 95.00% 2.45 0.231 0 461.7644 921.5131 922.5151 2
 SAMPLE 4R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 4 4 8 7.54% IFNLYPR 95.00% 2.19 0.206 0 461.7653 921.5149 922.5151 2
 SAMPLE 4R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 4 4 8 7.54% mADLHAVPR 95.00% 2.23 0.307 1.96 m1: Oxidation (+15.99) 513.2674 1,024.52 1,025.52 2
 SAMPLE 4R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 4 4 8 7.54% GAPLVVIcQGK 95.00% 3.51 0.446 0 c8: Carbamidomethyl (+57.02) 571.3238 1,140.63 1,141.64 2
 SAMPLE 4R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 4 4 8 7.54% GAPLVVIcQGK 95.00% 3.34 0.469 0 c8: Carbamidomethyl (+57.02) 571.3241 1,140.63 1,141.64 2
 SAMPLE 4R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 4 4 8 7.54% GAPLVVIcQGK 95.00% 2.97 0.392 1.68 c8: Carbamidomethyl (+57.02) 571.3264 1,140.64 1,141.64 2
 SAMPLE 4R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 4 4 8 7.54% GAPLVVIcQGK 95.00% 3.02 0.377 1.49 c8: Carbamidomethyl (+57.02) 571.328 1,140.64 1,141.64 2
 SAMPLE 4R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 4 4 8 7.54% MDENQFVAVTSTNAAK 95.00% 4.4 0.0832 2.7 863.4137 1,724.81 1,725.81 2 DPYL2_HUMAN
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% IFNLYPR 95.00% 2.7 0.31 0 461.7608 921.506 922.5151 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% IFNLYPR 95.00% 2.57 0.271 0 461.7611 921.5066 922.5151 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% IFNLYPR 95.00% 2.03 0.225 0 461.7612 921.5067 922.5151 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% IFNLYPR 95.00% 2.45 0.332 0 461.7614 921.5071 922.5151 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% IFNLYPR 95.00% 2.81 0.363 0 461.7616 921.5075 922.5151 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% SAADLISQAR 95.00% 3.92 0.454 2.27 516.2765 1,030.54 1,031.55 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% SAADLISQAR 95.00% 4.09 0.427 2.46 516.2766 1,030.54 1,031.55 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% SAADLISQAR 95.00% 3.05 0.416 0 516.7577 1,031.50 1,031.55 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% IMLEDGNLHVTQGAGR 95.00% 1.96 0.302 1.2 570.9574 1,709.85 1,710.86 3
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% IMLEDGNLHVTQGAGR 95.00% 1.78 0.236 0 570.9585 1,709.85 1,710.86 3
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% GAPLVVIcQGK 95.00% 2.49 0.304 1.39 c8: Carbamidomethyl (+57.02) 571.6253 1,141.23 1,141.64 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% QIGDNLIVPGGVK 95.00% 2.4 0.113 1.66 655.376 1,308.74 1,309.75 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% NLHQSGFSLSGTQVDEGVR 95.00% 3.61 0.509 1.72 677.6667 2,029.98 2,030.99 3
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% NLHQSGFSLSGTQVDEGVR 95.00% 3.37 0.457 1.6 678.0021 2,030.98 2,030.99 3
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% AIGKDNFTAIPEGTNGVEER 95.00% 2.9 0.373 1.42 707.0201 2,118.04 2,118.05 3
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% AIGKDNFTAIPEGTNGVEER 95.00% 3.77 0.427 1.55 707.0231 2,118.05 2,118.05 3
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% FIPcSPFSDYVYK 95.00% 2.47 0.224 1.49 c4: Carbamidomethyl (+57.02) 812.3824 1,622.75 1,622.76 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% GMYDGPVFDLTTTPK 95.00% 3.81 0.521 7.32 821.3935 1,640.77 1,641.78 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% GMYDGPVFDLTTTPK 95.00% 3.04 0.419 4.14 821.3947 1,640.77 1,641.78 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% MDENQFVAVTSTNAAK 95.00% 5.26 0.05 0 863.4068 1,724.80 1,725.81 2 DPYL2_HUMAN
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% DNFTAIPEGTNGVEER 95.00% 3.63 0.464 1.62 874.9046 1,747.79 1,748.81 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% DNFTAIPEGTNGVEER 95.00% 4.23 0.464 2.24 874.9079 1,747.80 1,748.81 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% AITIASQTNcPLYVTK 95.00% 3.88 0.682 3.24 c10: Carbamidomethyl (+57.02) 890.4668 1,778.92 1,779.93 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% AITIASQTNcPLYVTK 95.00% 3.98 0.647 2.7 c10: Carbamidomethyl (+57.02) 890.4697 1,778.92 1,779.93 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% ISVGSDSDLVIWDPDAVK 95.00% 5.21 0.489 4.74 958.4843 1,914.95 1,915.97 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% ISVGSDSDLVIWDPDAVK 95.00% 5.5 0.462 4.48 958.9846 1,915.95 1,915.97 2
 SAMPLE 1 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 30.50% NLHQSGFSLSGTQVDEGVR 95.00% 6.63 0.687 10 1,016.00 2,029.98 2,030.99 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% IFNLYPR 95.00% 2.61 0.282 0 461.7613 921.5069 922.5151 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% IFNLYPR 95.00% 2.53 0.319 0 461.7614 921.5072 922.5151 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% IFNLYPR 95.00% 2.53 0.29 0 461.7616 921.5076 922.5151 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% mADLHAVPR 95.00% 2.56 0.3 0 m1: Oxidation (+15.99) 513.2616 1,024.51 1,025.52 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% SAADLISQAR 95.00% 2.41 0.18 1.64 516.2757 1,030.54 1,031.55 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% SAADLISQAR 95.00% 3.31 0.331 1.43 516.2769 1,030.54 1,031.55 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% IMLEDGNLHVTQGAGR 95.00% 2.33 0.395 0 570.9578 1,709.85 1,710.86 3
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% IMLEDGNLHVTQGAGR 95.00% 2.02 0.264 0 571.2913 1,710.85 1,710.86 3
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% GAPLVVIcQGK 95.00% 3.15 0.338 0 c8: Carbamidomethyl (+57.02) 571.3187 1,140.62 1,141.64 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% GAPLVVIcQGK 95.00% 3.4 0.335 0 c8: Carbamidomethyl (+57.02) 571.3205 1,140.63 1,141.64 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% NHQSAAEYNIFEGMELR 95.00% 2.91 0.219 0 670.6437 2,008.91 2,008.92 3
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% AIGKDNFTAIPEGTNGVEER 95.00% 2.27 0.167 3.07 707.019 2,118.03 2,118.05 3
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% AIGKDNFTAIPEGTNGVEER 95.00% 2.99 0.316 0 707.0197 2,118.04 2,118.05 3
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% GMTTVDDFFQGTK 95.00% 2.42 0.383 0 723.831 1,445.65 1,446.66 2 SRBS2_HUMAN
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% FIPcSPFSDYVYK 95.00% 2.54 0.146 1.72 c4: Carbamidomethyl (+57.02) 812.3816 1,622.75 1,622.76 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% GMYDGPVFDLTTTPK 95.00% 3.07 0.405 4.96 821.3946 1,640.77 1,641.78 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% MDENQFVAVTSTNAAK 95.00% 5.54 0.0858 0 863.4089 1,724.80 1,725.81 2 DPYL2_HUMAN
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% MDENQFVAVTSTNAAK 95.00% 5.4 0.0958 0 863.4095 1,724.80 1,725.81 2 DPYL2_HUMAN
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% DNFTAIPEGTNGVEER 95.00% 3.45 0.44 3.3 874.9059 1,747.80 1,748.81 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% DNFTAIPEGTNGVEER 95.00% 3.48 0.514 2.34 874.9071 1,747.80 1,748.81 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% AITIASQTNcPLYVTK 95.00% 3.57 0.506 3.34 c10: Carbamidomethyl (+57.02) 890.4662 1,778.92 1,779.93 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% AITIASQTNcPLYVTK 95.00% 3.58 0.485 2.82 c10: Carbamidomethyl (+57.02) 890.4672 1,778.92 1,779.93 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% AITIASQTNcPLYVTK 95.00% 4 0.65 4.55 c10: Carbamidomethyl (+57.02) 890.4681 1,778.92 1,779.93 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% AITIASQTNcPLYVTK 95.00% 4.11 0.562 2.57 c10: Carbamidomethyl (+57.02) 890.4696 1,778.92 1,779.93 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% ISVGSDSDLVIWDPDAVK 95.00% 5.17 0.454 3.31 958.9847 1,915.95 1,915.97 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% ISVGSDSDLVIWDPDAVK 95.00% 5.41 0.505 4.36 958.9861 1,915.96 1,915.97 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% NLHQSGFSLSGTQVDEGVR 95.00% 6.12 0.67 10.1 1,016.00 2,029.98 2,030.99 2
 SAMPLE 1R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% NLHQSGFSLSGTQVDEGVR 95.00% 6.19 0.658 9.19 1,016.49 2,030.97 2,030.99 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% IFNLYPR 95.00% 2.5 0.294 0 461.7607 921.5058 922.5151 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% IFNLYPR 95.00% 2.69 0.358 0 461.7612 921.5068 922.5151 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% IFNLYPR 95.00% 2.56 0.3 0 461.7618 921.508 922.5151 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% IFNLYPR 95.00% 2.4 0.312 0 461.7623 921.5089 922.5151 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% mADLHAVPR 95.00% 2.85 0.465 2.14 m1: Oxidation (+15.99) 513.2633 1,024.51 1,025.52 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% mADLHAVPR 95.00% 2.4 0.436 2.22 m1: Oxidation (+15.99) 513.2636 1,024.51 1,025.52 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% SAADLISQAR 95.00% 3.37 0.433 1.44 516.2769 1,030.54 1,031.55 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% GAPLVVIcQGK 95.00% 3.63 0.48 2.54 c8: Carbamidomethyl (+57.02) 571.3216 1,140.63 1,141.64 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% GAPLVVIcQGK 95.00% 3.8 0.502 2.02 c8: Carbamidomethyl (+57.02) 571.3228 1,140.63 1,141.64 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% QIGDNLIVPGGVK 95.00% 2.25 0.377 1.15 655.3768 1,308.74 1,309.75 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% QIGDNLIVPGGVK 95.00% 2.49 0.435 0 655.3771 1,308.74 1,309.75 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% NHQSAAEYNIFEGMELR 95.00% 3.19 0.256 0 670.645 2,008.91 2,008.92 3
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% AIGKDNFTAIPEGTNGVEER 95.00% 3.65 0.47 3.05 706.6861 2,117.03 2,118.05 3
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% AIGKDNFTAIPEGTNGVEER 95.00% 3.7 0.302 1.64 707.0214 2,118.04 2,118.05 3
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% GMTTVDDFFQGTK 95.00% 3.76 0.572 3.44 723.8307 1,445.65 1,446.66 2 SRBS2_HUMAN
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% GMTTVDDFFQGTK 95.00% 3.61 0.547 4.41 723.8309 1,445.65 1,446.66 2 SRBS2_HUMAN
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% GMYDGPVFDLTTTPK 95.00% 3.75 0.626 5.85 821.8947 1,641.77 1,641.78 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% GMYDGPVFDLTTTPK 95.00% 4.21 0.625 6.89 821.8957 1,641.78 1,641.78 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% GmYDGPVFDLTTTPK 95.00% 4.04 0.126 3.01 m2: Oxidation (+15.99) 829.3938 1,656.77 1,657.78 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% IMLEDGNLHVTQGAGR 95.00% 5.42 0.546 6.89 855.9336 1,709.85 1,710.86 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% IMLEDGNLHVTQGAGR 95.00% 5.45 0.509 6.85 856.4332 1,710.85 1,710.86 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% MDENQFVAVTSTNAAK 95.00% 5.68 0.114 3 863.4067 1,724.80 1,725.81 2 DPYL2_HUMAN
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% MDENQFVAVTSTNAAK 95.00% 5.27 0.0932 3.62 863.4084 1,724.80 1,725.81 2 DPYL2_HUMAN
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% DNFTAIPEGTNGVEER 95.00% 4.07 0.43 4.54 874.9051 1,747.79 1,748.81 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% DNFTAIPEGTNGVEER 95.00% 3.88 0.486 3.77 874.9065 1,747.80 1,748.81 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% ISVGSDSDLVIWDPDAVK 95.00% 5.31 0.495 3.14 958.485 1,914.95 1,915.97 2
 SAMPLE 2 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 12 23 32.30% NLHQSGFSLSGTQVDEGVR 95.00% 6.44 0.665 8.37 1,016.50 2,030.98 2,030.99 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% IFNLYPR 95.00% 2.56 0.287 0 461.7609 921.5061 922.5151 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% IFNLYPR 95.00% 2.07 0.219 0 461.7619 921.5081 922.5151 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% IFNLYPR 95.00% 2.35 0.284 0 461.762 921.5083 922.5151 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% IFNLYPR 95.00% 2.71 0.257 0 461.7621 921.5085 922.5151 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% mADLHAVPR 95.00% 2.46 0.457 2.39 m1: Oxidation (+15.99) 513.2629 1,024.51 1,025.52 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% SAADLISQAR 95.00% 2.59 0.289 0 516.2778 1,030.54 1,031.55 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% GAPLVVIcQGK 95.00% 3.13 0.416 0 c8: Carbamidomethyl (+57.02) 571.3221 1,140.63 1,141.64 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% GAPLVVIcQGK 95.00% 2.87 0.404 0 c8: Carbamidomethyl (+57.02) 571.3222 1,140.63 1,141.64 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% QIGDNLIVPGGVK 95.00% 2.77 0.466 0 655.3764 1,308.74 1,309.75 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% QIGDNLIVPGGVK 95.00% 2.64 0.439 1.22 655.3767 1,308.74 1,309.75 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% NHQSAAEYNIFEGMELR 95.00% 3.09 0.377 0 670.6439 2,008.91 2,008.92 3
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% NHQSAAEYNIFEGMELR 95.00% 3.1 0.318 0 670.6442 2,008.91 2,008.92 3
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% AIGKDNFTAIPEGTNGVEER 95.00% 3.31 0.341 2.19 707.0201 2,118.04 2,118.05 3
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% AIGKDNFTAIPEGTNGVEER 95.00% 3.65 0.329 2.23 707.0208 2,118.04 2,118.05 3
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% GMTTVDDFFQGTK 95.00% 3.71 0.578 2.68 723.8316 1,445.65 1,446.66 2 SRBS2_HUMAN
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% GMTTVDDFFQGTK 95.00% 3.8 0.52 3.39 724.3315 1,446.65 1,446.66 2 SRBS2_HUMAN
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% GMYDGPVFDLTTTPK 95.00% 3.82 0.564 6.43 821.3965 1,640.78 1,641.78 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% GMYDGPVFDLTTTPK 95.00% 4.08 0.628 7.36 821.8957 1,641.78 1,641.78 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% IMLEDGNLHVTQGAGR 95.00% 4.99 0.512 7.15 856.4333 1,710.85 1,710.86 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% IMLEDGNLHVTQGAGR 95.00% 4.87 0.503 4.96 856.4349 1,710.85 1,710.86 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% MDENQFVAVTSTNAAK 95.00% 5.3 0.112 3.28 863.4074 1,724.80 1,725.81 2 DPYL2_HUMAN
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% MDENQFVAVTSTNAAK 95.00% 5.2 0.118 3.03 863.4079 1,724.80 1,725.81 2 DPYL2_HUMAN
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% DNFTAIPEGTNGVEER 95.00% 3.86 0.419 2 875.408 1,748.80 1,748.81 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% DNFTAIPEGTNGVEER 95.00% 3.3 0.429 1.92 875.4096 1,748.80 1,748.81 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% AITIASQTNcPLYVTK 95.00% 4.68 0.662 4.57 c10: Carbamidomethyl (+57.02) 890.4682 1,778.92 1,779.93 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% AITIASQTNcPLYVTK 95.00% 5 0.625 4.43 c10: Carbamidomethyl (+57.02) 890.9737 1,779.93 1,779.93 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% ISVGSDSDLVIWDPDAVK 95.00% 4.62 0.494 2.38 958.485 1,914.95 1,915.97 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% ISVGSDSDLVIWDPDAVK 95.00% 4.86 0.511 2.92 958.4855 1,914.96 1,915.97 2
 SAMPLE 2R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 13 13 25 35.10% NLHQSGFSLSGTQVDEGVR 95.00% 5.14 0.609 7.42 1,016.50 2,030.98 2,030.99 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% IFNLYPR 95.00% 2.56 0.31 0 461.7609 921.5061 922.5151 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% IFNLYPR 95.00% 2.72 0.31 0 461.7622 921.5087 922.5151 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% IFNLYPR 95.00% 2.69 0.351 0 461.7622 921.5088 922.5151 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% IFNLYPR 95.00% 2.68 0.357 0 461.7628 921.51 922.5151 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% MADLHAVPR 95.00% 3.13 0.527 1.35 505.265 1,008.51 1,009.53 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% MADLHAVPR 95.00% 3.1 0.5 2.1 505.2657 1,008.52 1,009.53 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% SAADLISQAR 95.00% 2.15 0.315 0 516.7581 1,031.50 1,031.55 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% SAADLISQAR 95.00% 2.15 0.178 1.08 516.7582 1,031.50 1,031.55 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% IMLEDGNLHVTQGAGR 95.00% 2.36 0.352 0 570.9575 1,709.85 1,710.86 3
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% IMLEDGNLHVTQGAGR 95.00% 2.51 0.381 1.96 570.9577 1,709.85 1,710.86 3
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% GAPLVVIcQGK 95.00% 2.86 0.364 0 c8: Carbamidomethyl (+57.02) 571.3209 1,140.63 1,141.64 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% QIGDNLIVPGGVK 95.00% 2.84 0.477 2.55 655.3763 1,308.74 1,309.75 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% QIGDNLIVPGGVK 95.00% 2.63 0.452 1.82 655.377 1,308.74 1,309.75 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% NHQSAAEYNIFEGMELR 95.00% 3.39 0.454 2.09 670.3102 2,007.91 2,008.92 3
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% NLHQSGFSLSGTQVDEGVR 95.00% 3.55 0.458 0 678.0015 2,030.98 2,030.99 3
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% NLHQSGFSLSGTQVDEGVR 95.00% 3.45 0.422 1.03 678.0019 2,030.98 2,030.99 3
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% AIGKDNFTAIPEGTNGVEER 95.00% 3.48 0.286 2 706.6854 2,117.03 2,118.05 3
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% AIGKDNFTAIPEGTNGVEER 95.00% 4.19 0.363 2.08 707.0201 2,118.04 2,118.05 3
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% GMTTVDDFFQGTK 95.00% 3.82 0.564 4.11 723.8308 1,445.65 1,446.66 2 SRBS2_HUMAN
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% GMTTVDDFFQGTK 95.00% 3.79 0.581 4 723.8309 1,445.65 1,446.66 2 SRBS2_HUMAN
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% FIPcSPFSDYVYK 95.00% 1.98 0.192 1.72 c4: Carbamidomethyl (+57.02) 811.8807 1,621.75 1,622.76 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% FIPcSPFSDYVYK 95.00% 2.14 0.254 2.96 c4: Carbamidomethyl (+57.02) 811.8811 1,621.75 1,622.76 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% IMLEDGNLHVTQGAGR 95.00% 4.9 0.473 5.49 856.431 1,710.85 1,710.86 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% IMLEDGNLHVTQGAGR 95.00% 5.67 0.49 6.29 856.4328 1,710.85 1,710.86 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% MDENQFVAVTSTNAAK 95.00% 5.47 0.0928 0 863.4082 1,724.80 1,725.81 2 DPYL2_HUMAN
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% DNFTAIPEGTNGVEER 95.00% 3.92 0.404 1.46 874.9037 1,747.79 1,748.81 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% DNFTAIPEGTNGVEER 95.00% 3.84 0.366 2.74 874.9059 1,747.80 1,748.81 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% ISVGSDSDLVIWDPDAVK 95.00% 5.33 0.562 4.47 958.4843 1,914.95 1,915.97 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% ISVGSDSDLVIWDPDAVK 95.00% 5.29 0.502 3.54 958.9857 1,915.96 1,915.97 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% NLHQSGFSLSGTQVDEGVR 95.00% 6.4 0.689 8.26 1,015.99 2,029.97 2,030.99 2
 SAMPLE 3 Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 12 13 25 31.90% NLHQSGFSLSGTQVDEGVR 95.00% 5.81 0.644 8.6 1,016.50 2,030.98 2,030.99 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% IFNLYPR 95.00% 2.55 0.297 0 461.7608 921.506 922.5151 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% IFNLYPR 95.00% 2.37 0.288 0 461.7614 921.5071 922.5151 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% IFNLYPR 95.00% 2.77 0.329 0 461.7633 921.5109 922.5151 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% IFNLYPR 95.00% 2.48 0.275 0 461.7634 921.5111 922.5151 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% MADLHAVPR 95.00% 2.76 0.419 1.37 505.2649 1,008.51 1,009.53 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% MADLHAVPR 95.00% 3.02 0.496 1.89 505.2652 1,008.51 1,009.53 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% mADLHAVPR 95.00% 2.74 0.418 2.07 m1: Oxidation (+15.99) 513.2628 1,024.51 1,025.52 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% mADLHAVPR 95.00% 2.58 0.29 1.6 m1: Oxidation (+15.99) 513.263 1,024.51 1,025.52 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% SAADLISQAR 95.00% 2.76 0.272 0 516.2768 1,030.54 1,031.55 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% IMLEDGNLHVTQGAGR 95.00% 2.69 0.4 1.49 570.9578 1,709.85 1,710.86 3
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% IMLEDGNLHVTQGAGR 95.00% 2.38 0.388 1.02 571.2916 1,710.85 1,710.86 3
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% QIGDNLIVPGGVK 95.00% 2.7 0.454 2.55 655.3766 1,308.74 1,309.75 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% QIGDNLIVPGGVK 95.00% 2.64 0.382 0 655.3771 1,308.74 1,309.75 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% NHQSAAEYNIFEGMELR 95.00% 3.7 0.382 1.66 670.6447 2,008.91 2,008.92 3
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% NLHQSGFSLSGTQVDEGVR 95.00% 3.24 0.361 1.51 678.0011 2,030.98 2,030.99 3
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% NLHQSGFSLSGTQVDEGVR 95.00% 3.35 0.445 1.59 678.0022 2,030.98 2,030.99 3
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% AIGKDNFTAIPEGTNGVEER 95.00% 3.73 0.449 2.38 707.0201 2,118.04 2,118.05 3
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% AIGKDNFTAIPEGTNGVEER 95.00% 4.16 0.395 2.68 707.0214 2,118.04 2,118.05 3
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% GMTTVDDFFQGTK 95.00% 3.86 0.554 3.43 723.8313 1,445.65 1,446.66 2 SRBS2_HUMAN
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% GMTTVDDFFQGTK 95.00% 3.84 0.568 3.72 723.8314 1,445.65 1,446.66 2 SRBS2_HUMAN
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% GMYDGPVFDLTTTPK 95.00% 3.17 0.545 3.68 821.396 1,640.78 1,641.78 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% GMYDGPVFDLTTTPK 95.00% 3.01 0.515 5.23 821.8953 1,641.77 1,641.78 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% IMLEDGNLHVTQGAGR 95.00% 5.64 0.524 6.31 855.9333 1,709.85 1,710.86 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% IMLEDGNLHVTQGAGR 95.00% 4.97 0.515 6.89 856.4377 1,710.86 1,710.86 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% DNFTAIPEGTNGVEER 95.00% 3.87 0.353 1.8 874.9058 1,747.80 1,748.81 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% DNFTAIPEGTNGVEER 95.00% 3.66 0.417 2 875.4062 1,748.80 1,748.81 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% AITIASQTNcPLYVTK 95.00% 4 0.63 3.77 c10: Carbamidomethyl (+57.02) 890.9699 1,779.92 1,779.93 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% ISVGSDSDLVIWDPDAVK 95.00% 5.3 0.514 3.49 958.4865 1,914.96 1,915.97 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% ISVGSDSDLVIWDPDAVK 95.00% 5.66 0.515 3.82 958.9854 1,915.96 1,915.97 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% NHQSAAEYNIFEGMELR 95.00% 5.5 0.663 6.38 1,005.46 2,008.91 2,008.92 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% NLHQSGFSLSGTQVDEGVR 95.00% 6.08 0.633 7.74 1,016.50 2,030.98 2,030.99 2
 SAMPLE 3R Dihydropyrimidinase-related protein 3  DPYSL3  DPYL3_HUMAN 61,946.10 100.00% 11 13 26 30.40% NLHQSGFSLSGTQVDEGVR 95.00% 6.3 0.635 9.08 1,016.50 2,030.98 2,030.99 2
 SAMPLE 4 DNA repair protein REV1  REV1  REV1_HUMAN 138,231.80 99.80% 2 2 2 3.12% TLPGAcGSPQKLIDGFLK 95.00% 2.26 0.31 0 c6: Carbamidomethyl (+57.02) 634.3453 1,900.01 1,902.02 3
 SAMPLE 4 DNA repair protein REV1  REV1  REV1_HUMAN 138,231.80 99.80% 2 2 2 3.12% IIGKAmLNmFHTMKLNISDmR 95.00% 2.87 0.235 0 m6: Oxidation (+15.99), m9: Oxidation (+15.99), m20: Oxidation (+15.99) 838.0953 2,511.26 2,512.26 3
 SAMPLE 1 Drebrin  DBN1  DREB_HUMAN 71,410.60 99.80% 2 3 7 5.24% LREDENAEPVGTTYQK 95.00% 3.07 0.287 1.41 617.3 1,848.88 1,849.89 3
 SAMPLE 1 Drebrin  DBN1  DREB_HUMAN 71,410.60 99.80% 2 3 7 5.24% LREDENAEPVGTTYQK 95.00% 2.79 0.251 0 617.3012 1,848.88 1,849.89 3
 SAMPLE 1 Drebrin  DBN1  DREB_HUMAN 71,410.60 99.80% 2 3 7 5.24% LREDENAEPVGTTYQK 95.00% 2.81 0.273 0 617.6366 1,849.89 1,849.89 3
 SAMPLE 1 Drebrin  DBN1  DREB_HUMAN 71,410.60 99.80% 2 3 7 5.24% LREDENAEPVGTTYQK 95.00% 3.32 0.348 0 617.6373 1,849.89 1,849.89 3
 SAMPLE 1 Drebrin  DBN1  DREB_HUMAN 71,410.60 99.80% 2 3 7 5.24% LREDENAEPVGTTYQK 95.00% 4.45 0.441 4.85 925.9451 1,849.87 1,849.89 2
 SAMPLE 1 Drebrin  DBN1  DREB_HUMAN 71,410.60 99.80% 2 3 7 5.24% LREDENAEPVGTTYQK 95.00% 5.01 0.587 7.16 925.9522 1,849.89 1,849.89 2
 SAMPLE 1 Drebrin  DBN1  DREB_HUMAN 71,410.60 99.80% 2 3 7 5.24% SPSDSSTASTPVAEQIER 95.00% 4.15 0.567 3.36 931.9396 1,861.86 1,861.88 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% cVNHYGGYLcLPK 95.00% 4.31 0.483 0 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 527.5812 1,579.72 1,580.74 3
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% cVNHYGGYLcLPK 95.00% 4.88 0.543 1.89 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 527.5826 1,579.72 1,580.74 3
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% LNcEDIDEcR 95.00% 2.39 0.282 1.32 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 662.2674 1,322.52 1,323.53 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% QTSPVSAMLVLVK 95.00% 2.69 0.197 0 686.8941 1,371.77 1,372.79 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% QTSPVSAMLVLVK 95.00% 2.39 0.388 0 686.8946 1,371.77 1,372.79 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% QTSPVSAMLVLVK 95.00% 2.82 0.375 0 686.8966 1,371.78 1,372.79 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% QTSPVSAMLVLVK 95.00% 2.58 0.282 0 686.9109 1,371.81 1,372.79 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% GSFAcQcPPGYQK 95.00% 3.77 0.506 2.34 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.321 1,498.63 1,499.64 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% GSFAcQcPPGYQK 95.00% 4.59 0.469 3.89 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.323 1,498.63 1,499.64 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% GSFAcQcPPGYQK 95.00% 4.67 0.472 2.62 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.3238 1,498.63 1,499.64 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% GSFAcQcPPGYQK 95.00% 2.54 0.441 0 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.3246 1,498.63 1,499.64 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% GSFAcQcPPGYQK 95.00% 4.1 0.464 3 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.3248 1,498.63 1,499.64 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% NPcQDPYILTPENR 95.00% 4.4 0.398 1.51 c3: Carbamidomethyl (+57.02) 858.9002 1,715.78 1,716.80 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% NPcQDPYILTPENR 95.00% 4.55 0.416 2.16 c3: Carbamidomethyl (+57.02) 858.9006 1,715.79 1,716.80 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% NPcQDPYILTPENR 95.00% 4.28 0.428 1.7 c3: Carbamidomethyl (+57.02) 858.9014 1,715.79 1,716.80 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% NPcQDPYILTPENR 95.00% 4.18 0.409 1.77 c3: Carbamidomethyl (+57.02) 859.4046 1,716.79 1,716.80 2
 SAMPLE 1 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 13 12.80% NPcQDPYILTPENR 95.00% 3.17 0.403 1.17 c3: Carbamidomethyl (+57.02) 859.414 1,716.81 1,716.80 2
 SAMPLE 1R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 9 12.80% LNcEDIDEcR 95.00% 2.62 0.3 1.72 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 662.2666 1,322.52 1,323.53 2
 SAMPLE 1R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 9 12.80% QTSPVSAMLVLVK 95.00% 2.3 0.512 1.41 686.896 1,371.78 1,372.79 2
 SAMPLE 1R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 9 12.80% QTSPVSAMLVLVK 95.00% 2.49 0.422 0 686.8976 1,371.78 1,372.79 2
 SAMPLE 1R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 9 12.80% QTSPVSAMLVLVK 95.00% 2.34 0.275 1.36 687.3957 1,372.78 1,372.79 2
 SAMPLE 1R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 9 12.80% GSFAcQcPPGYQK 95.00% 4.64 0.501 3.62 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.3228 1,498.63 1,499.64 2
 SAMPLE 1R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 9 12.80% GSFAcQcPPGYQK 95.00% 4.61 0.485 4.1 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.3228 1,498.63 1,499.64 2
 SAMPLE 1R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 9 12.80% GSFAcQcPPGYQK 95.00% 2.54 0.441 0 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.3246 1,498.63 1,499.64 2
 SAMPLE 1R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 9 12.80% GSFAcQcPPGYQK 95.00% 4.1 0.464 2.64 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.3248 1,498.63 1,499.64 2
 SAMPLE 1R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 9 12.80% DIDEcDIVPDAcK 95.00% 1.82 0.368 2.48 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 775.3393 1,548.66 1,549.65 2
 SAMPLE 1R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 9 12.80% NPcQDPYILTPENR 95.00% 4.01 0.403 2.2 c3: Carbamidomethyl (+57.02) 858.8969 1,715.78 1,716.80 2
 SAMPLE 1R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 9 12.80% NPcQDPYILTPENR 95.00% 4.36 0.428 1.66 c3: Carbamidomethyl (+57.02) 858.9026 1,715.79 1,716.80 2
 SAMPLE 1R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 9 12.80% NPcQDPYILTPENR 95.00% 3.17 0.403 1.37 c3: Carbamidomethyl (+57.02) 859.414 1,716.81 1,716.80 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% cVNHYGGYLcLPK 95.00% 5.11 0.461 2.48 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 527.582 1,579.72 1,580.74 3
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% cVNHYGGYLcLPK 95.00% 5.38 0.504 2.47 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 527.582 1,579.72 1,580.74 3
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% cVNHYGGYLcLPK 95.00% 4.59 0.472 2.23 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 527.9162 1,580.73 1,580.74 3
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% LNcEDIDEcR 95.00% 2.74 0.411 2.57 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 662.2684 1,322.52 1,323.53 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% LNcEDIDEcR 95.00% 3.04 0.339 2.08 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 662.2688 1,322.52 1,323.53 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% cVcPVSNAMcR 95.00% 2.18 0.326 3.31 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 677.2794 1,352.54 1,353.55 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% cVcPVSNAMcR 95.00% 2.11 0.344 3.26 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 677.2818 1,352.55 1,353.55 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% QTSPVSAMLVLVK 95.00% 2.79 0.36 1.55 686.8954 1,371.78 1,372.79 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% QTSPVSAMLVLVK 95.00% 2.86 0.338 1.21 686.8956 1,371.78 1,372.79 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% QTSPVSAMLVLVK 95.00% 2.1 0.316 0 686.8963 1,371.78 1,372.79 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% QTSPVSAMLVLVK 95.00% 2.21 0.276 0 686.8963 1,371.78 1,372.79 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% QTSPVSAMLVLVK 95.00% 2.68 0.4 1.7 686.8969 1,371.78 1,372.79 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% QTSPVSAMLVLVK 95.00% 3.04 0.398 1.33 686.8974 1,371.78 1,372.79 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% QTSPVSAMLVLVK 95.00% 2.82 0.342 0 686.8979 1,371.78 1,372.79 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% QTSPVSAMLVLVK 95.00% 3.13 0.428 1.55 687.3943 1,372.77 1,372.79 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% GSFAcQcPPGYQK 95.00% 3.93 0.431 2.96 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.3202 1,498.62 1,499.64 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% GSFAcQcPPGYQK 95.00% 4.34 0.457 3.8 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.3211 1,498.63 1,499.64 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% GSFAcQcPPGYQK 95.00% 4.13 0.521 1.82 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.3232 1,498.63 1,499.64 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% DIDEcDIVPDAcK 95.00% 3.28 0.434 4.07 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 775.3286 1,548.64 1,549.65 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% DIDEcDIVPDAcK 95.00% 3.66 0.509 4.28 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 775.3296 1,548.64 1,549.65 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% cVNHYGGYLcLPK 95.00% 4 0.46 2.85 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 790.8705 1,579.73 1,580.74 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% cVNHYGGYLcLPK 95.00% 3.65 0.484 4.24 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 790.8728 1,579.73 1,580.74 2
 SAMPLE 2 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 6 7 15 17.60% NPcQDPYILTPENR 95.00% 4.76 0.485 2.55 c3: Carbamidomethyl (+57.02) 858.9063 1,715.80 1,716.80 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% cVNHYGGYLcLPK 95.00% 4.1 0.542 0 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 527.5827 1,579.72 1,580.74 3
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% cVNHYGGYLcLPK 95.00% 3.78 0.433 2.23 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 527.5829 1,579.73 1,580.74 3
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% LNcEDIDEcR 95.00% 2.75 0.391 1.89 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 662.2685 1,322.52 1,323.53 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% LNcEDIDEcR 95.00% 2.23 0.237 1.3 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 662.2687 1,322.52 1,323.53 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% QTSPVSAMLVLVK 95.00% 2.24 0.256 0 686.8943 1,371.77 1,372.79 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% QTSPVSAMLVLVK 95.00% 2.76 0.376 0 686.8961 1,371.78 1,372.79 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% QTSPVSAMLVLVK 95.00% 2.56 0.421 0 686.8962 1,371.78 1,372.79 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% QTSPVSAMLVLVK 95.00% 2.95 0.349 0 686.8966 1,371.78 1,372.79 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% QTSPVSAMLVLVK 95.00% 2.62 0.306 1.72 686.8969 1,371.78 1,372.79 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% GSFAcQcPPGYQK 95.00% 4.14 0.491 3.52 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 750.3215 1,498.63 1,499.64 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% DIDEcDIVPDAcK 95.00% 3.7 0.54 2.62 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 775.3286 1,548.64 1,549.65 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% DIDEcDIVPDAcK 95.00% 3.57 0.425 2.47 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 775.8305 1,549.65 1,549.65 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% NPcQDPYILTPENR 95.00% 4.27 0.404 0 c3: Carbamidomethyl (+57.02) 858.8977 1,715.78 1,716.80 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% NPcQDPYILTPENR 95.00% 4.37 0.401 1.24 c3: Carbamidomethyl (+57.02) 858.901 1,715.79 1,716.80 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% NPcQDPYILTPENR 95.00% 4.62 0.506 1.96 c3: Carbamidomethyl (+57.02) 858.9026 1,715.79 1,716.80 2
 SAMPLE 2R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 5 11 15.40% NPcQDPYILTPENR 95.00% 4.64 0.407 1.85 c3: Carbamidomethyl (+57.02) 859.4045 1,716.79 1,716.80 2
 SAMPLE 3 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 6 12.40% LNcEDIDEcR 95.00% 3.28 0.358 2.28 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 662.2667 1,322.52 1,323.53 2
 SAMPLE 3 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 6 12.40% LNcEDIDEcR 95.00% 3.23 0.373 1.66 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 662.2675 1,322.52 1,323.53 2
 SAMPLE 3 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 6 12.40% cVcPVSNAMcR 95.00% 2.02 0.321 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 677.2771 1,352.54 1,353.55 2
 SAMPLE 3 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 6 12.40% cVcPVSNAMcR 95.00% 2.4 0.43 1.36 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 677.2812 1,352.55 1,353.55 2
 SAMPLE 3 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 6 12.40% QTSPVSAMLVLVK 95.00% 2.62 0.317 0 686.8969 1,371.78 1,372.79 2
 SAMPLE 3 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 6 12.40% cVNHYGGYLcLPK 95.00% 3.8 0.484 3.49 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 790.8691 1,579.72 1,580.74 2
 SAMPLE 3 EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 4 4 6 12.40% NPcQDPYILTPENR 95.00% 4.24 0.372 0 c3: Carbamidomethyl (+57.02) 858.9028 1,715.79 1,716.80 2
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% cVNHYGGYLcLPK 95.00% 4.52 0.545 2.34 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 527.583 1,579.73 1,580.74 3
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% cVNHYGGYLcLPK 95.00% 4.35 0.559 1.08 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 527.5839 1,579.73 1,580.74 3
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% LNcEDIDEcR 95.00% 2.82 0.345 3 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 662.268 1,322.52 1,323.53 2
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% LNcEDIDEcR 95.00% 2.85 0.33 2.46 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 662.2691 1,322.52 1,323.53 2
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% cVcPVSNAMcR 95.00% 2.01 0.277 1.57 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 677.2777 1,352.54 1,353.55 2
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% cVcPVSNAMcR 95.00% 2.38 0.332 1.8 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 677.2797 1,352.54 1,353.55 2
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% QTSPVSAMLVLVK 95.00% 2.39 0.335 0 686.8963 1,371.78 1,372.79 2
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% QTSPVSAMLVLVK 95.00% 2.51 0.306 0 686.8969 1,371.78 1,372.79 2
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% DIDEcDIVPDAcK 95.00% 2.14 0.215 1.15 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 775.3283 1,548.64 1,549.65 2
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% DIDEcDIVPDAcK 95.00% 3.55 0.457 3.21 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 775.8307 1,549.65 1,549.65 2
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% cVNHYGGYLcLPK 95.00% 0 0 3.42 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 782.8941 1,563.77 1,563.71 2
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% cVNHYGGYLcLPK 95.00% 3.8 0.495 3.24 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 790.8698 1,579.72 1,580.74 2
 SAMPLE 3R EGF-containing fibulin-like extracellular matrix protein 1  EFEMP1  FBLN3_HUMAN 54,621.10 100.00% 5 6 11 15.00% NPcQDPYILTPENR 95.00% 4.42 0.405 1.37 c3: Carbamidomethyl (+57.02) 859.4059 1,716.80 1,716.80 2
 SAMPLE 2 EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 5 5 10 9.58% VVGTPEVLR 95.00% 2.25 0.34 0 485.2892 968.5627 969.5734 2
 SAMPLE 2 EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 5 5 10 9.58% VVGTPEVLR 95.00% 2.17 0.325 0 485.2899 968.5642 969.5734 2
 SAMPLE 2 EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 5 5 10 9.58% GYDFPAVLR 95.00% 2.27 0.496 2.38 519.2715 1,036.53 1,037.54 2
 SAMPLE 2 EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 5 5 10 9.58% GYDFPAVLR 95.00% 2.22 0.418 1.28 519.2734 1,036.53 1,037.54 2
 SAMPLE 2 EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 5 5 10 9.58% LEGHGLPANLPR 95.00% 3.05 0.528 3 637.354 1,272.69 1,273.70 2
 SAMPLE 2 EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 5 5 10 9.58% LEGHGLPANLPR 95.00% 2.82 0.514 4.36 637.3546 1,272.69 1,273.70 2
 SAMPLE 2 EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 5 5 10 9.58% LNPFGNTFLNR 95.00% 2.8 0.439 1.51 646.8406 1,291.67 1,292.68 2
 SAMPLE 2 EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 5 5 10 9.58% LNPFGNTFLNR 95.00% 2.7 0.424 0 646.8417 1,291.67 1,292.68 2
 SAMPLE 2 EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 5 5 10 9.58% LFELEEQDLFR 95.00% 3.82 0.496 2.51 719.8632 1,437.71 1,438.72 2
 SAMPLE 2 EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 5 5 10 9.58% LFELEEQDLFR 95.00% 3.66 0.422 3.64 719.8642 1,437.71 1,438.72 2
 SAMPLE 2R EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 6 7 10 13.60% VVGTPEVLR 95.00% 2.25 0.328 1.2 485.289 968.5624 969.5734 2
 SAMPLE 2R EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 6 7 10 13.60% VVGTPEVLR 95.00% 2 0.288 0 485.2897 968.5638 969.5734 2
 SAMPLE 2R EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 6 7 10 13.60% LLEALDEMLTHDIAK 95.00% 3 0.409 0 571.3019 1,710.88 1,711.89 3
 SAMPLE 2R EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 6 7 10 13.60% LLEALDEMLTHDIAK 95.00% 2.61 0.382 0 571.3019 1,710.88 1,711.89 3
 SAMPLE 2R EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 6 7 10 13.60% VHAYIISYLK 95.00% 2.2 0.254 0 603.8318 1,205.65 1,206.69 2
 SAMPLE 2R EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 6 7 10 13.60% LEGHGLPANLPR 95.00% 2.97 0.508 3.3 637.3551 1,272.69 1,273.70 2
 SAMPLE 2R EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 6 7 10 13.60% LNPFGNTFLNR 95.00% 2.58 0.315 0 646.8397 1,291.66 1,292.68 2
 SAMPLE 2R EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 6 7 10 13.60% LNPFGNTFLNR 95.00% 2.38 0.302 0 646.8402 1,291.66 1,292.68 2
 SAMPLE 2R EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 6 7 10 13.60% IQLEHHISPGDFPDcQK 95.00% 2.4 0.255 0 c15: Carbamidomethyl (+57.02) 674.6578 2,020.95 2,020.96 3
 SAMPLE 2R EH domain-containing protein 2  EHD2  EHD2_HUMAN 61,145.20 100.00% 6 7 10 13.60% LLEALDEMLTHDIAK 95.00% 4.35 0.515 5.27 856.451 1,710.89 1,711.89 2
 SAMPLE 2 EH domain-containing protein 3  EHD3  EHD3_HUMAN 61,880.70 99.80% 2 2 2 5.13% LNAFGNAFLNR 95.00% 2.46 0.33 1.12 618.8259 1,235.64 1,236.65 2
 SAMPLE 2 EH domain-containing protein 3  EHD3  EHD3_HUMAN 61,880.70 99.80% 2 2 2 5.13% DPEVFQTVSEGLKKLYK 95.00% 2.08 0.338 0 661.3275 1,980.96 1,981.06 3
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% LPLQDVYK 95.00% 2.4 0.163 1.92 488.2787 974.5418 975.5517 2
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% LPLQDVYK 95.00% 2.4 0.175 1.57 488.2806 974.5456 975.5517 2
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% LPLQDVYK 95.00% 2.13 0.264 1.26 488.281 974.5464 975.5517 2
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% LPLQDVYK 95.00% 2.21 0.236 2 488.2812 974.5468 975.5517 2
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% IGGIGTVPVGR 95.00% 3.52 0.484 2.92 513.3097 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% IGGIGTVPVGR 95.00% 2.66 0.338 2.07 513.3098 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% IGGIGTVPVGR 95.00% 2.05 0.249 0 513.3104 1,024.61 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% IGGIGTVPVGR 95.00% 3.53 0.46 2.46 513.3107 1,024.61 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% THINIVVIGHVDSGK 95.00% 3.1 0.517 2.96 530.2991 1,587.87 1,588.88 3 TITIN_HUMAN
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% THINIVVIGHVDSGK 95.00% 3.33 0.499 2.49 530.6351 1,588.88 1,588.88 3 TITIN_HUMAN
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% EHALLAYTLGVK 95.00% 3.44 0.602 4.29 657.8756 1,313.74 1,314.74 2
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% EHALLAYTLGVK 95.00% 3.21 0.592 4 657.8762 1,313.74 1,314.74 2
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% EHALLAYTLGVK 95.00% 3.3 0.555 3.35 657.8766 1,313.74 1,314.74 2
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% EHALLAYTLGVK 95.00% 2.55 0.536 1.85 657.8784 1,313.74 1,314.74 2
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% EHALLAYTLGVK 95.00% 3.52 0.608 4 658.3764 1,314.74 1,314.74 2
 SAMPLE 4 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 3 10 12.60% YYVTIIDAPGHR 95.00% 2.27 0.295 2.54 702.8676 1,403.72 1,404.73 2 CATG_HUMAN
 SAMPLE 4R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 99.80% 2 2 7 6.71% LPLQDVYK 95.00% 2.02 0.229 1.47 488.2784 974.5411 975.5517 2
 SAMPLE 4R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 99.80% 2 2 7 6.71% LPLQDVYK 95.00% 1.88 0.21 1.22 488.2806 974.5456 975.5517 2
 SAMPLE 4R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 99.80% 2 2 7 6.71% LPLQDVYK 95.00% 2.54 0.216 1.24 488.2813 974.547 975.5517 2
 SAMPLE 4R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 99.80% 2 2 7 6.71% LPLQDVYK 95.00% 2.41 0.196 1.62 488.2819 974.5481 975.5517 2
 SAMPLE 4R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 99.80% 2 2 7 6.71% IGGIGTVPVGR 95.00% 3.61 0.52 2.85 513.3094 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 4R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 99.80% 2 2 7 6.71% IGGIGTVPVGR 95.00% 3.86 0.492 3.22 513.31 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 4R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 99.80% 2 2 7 6.71% IGGIGTVPVGR 95.00% 3.33 0.512 3.24 513.3103 1,024.61 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 4R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 99.80% 2 2 7 6.71% IGGIGTVPVGR 95.00% 2.97 0.424 2.8 513.3106 1,024.61 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 4R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 99.80% 2 2 7 6.71% EHALLAYTLGVK 95.00% 3.39 0.597 3.85 657.8764 1,313.74 1,314.74 2
 SAMPLE 4R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 99.80% 2 2 7 6.71% EHALLAYTLGVK 95.00% 3.61 0.617 3.8 657.8776 1,313.74 1,314.74 2
 SAMPLE 4R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 99.80% 2 2 7 6.71% EHALLAYTLGVK 95.00% 3.12 0.515 2.06 658.378 1,314.74 1,314.74 2
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% QTVAVGVIK 95.00% 1.98 0.34 2.7 457.7878 913.56 914.5676 2
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% YYVTIIDAPGHR 95.00% 3.28 0.434 1.85 468.9129 1,403.72 1,404.73 3 CATG_HUMAN
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% YYVTIIDAPGHR 95.00% 3.16 0.352 1.8 468.9153 1,403.72 1,404.73 3 CATG_HUMAN
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% LPLQDVYK 95.00% 2.28 0.195 2.28 488.2798 974.544 975.5517 2
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% LPLQDVYK 95.00% 2.1 0.213 2.14 488.282 974.5484 975.5517 2
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% IGGIGTVPVGR 95.00% 3.41 0.457 2.51 513.3069 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% IGGIGTVPVGR 95.00% 3.59 0.453 2.92 513.3078 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% IGGIGTVPVGR 95.00% 3.32 0.451 2.42 513.3099 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% IGGIGTVPVGR 95.00% 3.27 0.445 2.6 513.3112 1,024.61 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% EHALLAYTLGVK 95.00% 3.38 0.504 0 657.8732 1,313.73 1,314.74 2
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% EHALLAYTLGVK 95.00% 2.85 0.391 1.89 658.3746 1,314.73 1,314.74 2
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% YYVTIIDAPGHR 95.00% 3.44 0.545 2.6 702.865 1,403.71 1,404.73 2 CATG_HUMAN
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% YYVTIIDAPGHR 95.00% 3.35 0.468 2.89 703.367 1,404.72 1,404.73 2 CATG_HUMAN
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% VETGVLKPGMVVTFAPVNVTTEVK 95.00% 4.54 0.524 5.28 839.4656 2,515.37 2,515.38 3
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% VETGVLKPGMVVTFAPVNVTTEVK 95.00% 4.17 0.444 2.52 839.4662 2,515.38 2,515.38 3
 SAMPLE 1 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 12 16.50% VETGVLKPGMVVTFAPVNVTTEVK 95.00% 3.28 0.298 1.77 839.4703 2,515.39 2,515.38 3
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% QTVAVGVIK 95.00% 1.86 0.308 1.62 457.7874 913.5591 914.5676 2
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% YYVTIIDAPGHR 95.00% 3.36 0.495 1.15 468.9125 1,403.71 1,404.73 3 CATG_HUMAN
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% YYVTIIDAPGHR 95.00% 3.53 0.434 3.72 468.9131 1,403.72 1,404.73 3 CATG_HUMAN
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% LPLQDVYK 95.00% 2.23 0.232 1.85 488.2801 974.5446 975.5517 2
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% IGGIGTVPVGR 95.00% 3.41 0.457 2.89 513.3069 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% IGGIGTVPVGR 95.00% 3.09 0.447 2.85 513.307 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% IGGIGTVPVGR 95.00% 3.52 0.569 3.21 513.307 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% IGGIGTVPVGR 95.00% 3.27 0.445 2.96 513.3112 1,024.61 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% THINIVVIGHVDSGK 95.00% 2.54 0.35 1.13 530.7822 1,589.32 1,588.88 3 TITIN_HUMAN
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% EHALLAYTLGVK 95.00% 3 0.408 0 657.8733 1,313.73 1,314.74 2
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% EHALLAYTLGVK 95.00% 2.88 0.425 0 657.8737 1,313.73 1,314.74 2
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% YYVTIIDAPGHR 95.00% 2.79 0.447 2.15 702.8647 1,403.71 1,404.73 2 CATG_HUMAN
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% YYVTIIDAPGHR 95.00% 3.26 0.433 1.59 703.3673 1,404.72 1,404.73 2 CATG_HUMAN
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% VETGVLKPGMVVTFAPVNVTTEVK 95.00% 4.18 0.454 2.7 839.4656 2,515.37 2,515.38 3
 SAMPLE 1R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 10 19.70% VETGVLKPGMVVTFAPVNVTTEVK 95.00% 4.96 0.403 3.31 839.4671 2,515.38 2,515.38 3
 SAMPLE 2 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 4 4 9 11.30% QTVAVGVIK 95.00% 1.69 0.291 1.47 457.788 913.5604 914.5676 2
 SAMPLE 2 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 4 4 9 11.30% YYVTIIDAPGHR 95.00% 3.6 0.363 1.41 468.9132 1,403.72 1,404.73 3 CATG_HUMAN
 SAMPLE 2 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 4 4 9 11.30% YYVTIIDAPGHR 95.00% 3.22 0.363 2.16 468.9142 1,403.72 1,404.73 3 CATG_HUMAN
 SAMPLE 2 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 4 4 9 11.30% LPLQDVYK 95.00% 2.1 0.221 0 488.2782 974.5408 975.5517 2
 SAMPLE 2 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 4 4 9 11.30% LPLQDVYK 95.00% 2.51 0.21 1.59 488.2787 974.5418 975.5517 2
 SAMPLE 2 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 4 4 9 11.30% LPLQDVYK 95.00% 2.47 0.196 0 488.2789 974.5421 975.5517 2
 SAMPLE 2 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 4 4 9 11.30% LPLQDVYK 95.00% 2.04 0.195 1.21 488.2799 974.5441 975.5517 2
 SAMPLE 2 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 4 4 9 11.30% LPLQDVYK 95.00% 2.18 0.257 0 488.2824 974.5492 975.5517 2
 SAMPLE 2 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 4 4 9 11.30% IGGIGTVPVGR 95.00% 2.68 0.366 2.47 513.3069 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 2 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 4 4 9 11.30% IGGIGTVPVGR 95.00% 2.86 0.428 0 513.307 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 2 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 4 4 9 11.30% EHALLAYTLGVK 95.00% 3.5 0.572 4.68 657.8744 1,313.73 1,314.74 2
 SAMPLE 2R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 4 7 9.31% YYVTIIDAPGHR 95.00% 3.22 0.483 2.38 468.9133 1,403.72 1,404.73 3 CATG_HUMAN
 SAMPLE 2R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 4 7 9.31% YYVTIIDAPGHR 95.00% 2.56 0.395 0 468.9156 1,403.72 1,404.73 3 CATG_HUMAN
 SAMPLE 2R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 4 7 9.31% LPLQDVYK 95.00% 2.08 0.221 2.23 488.2798 974.544 975.5517 2
 SAMPLE 2R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 4 7 9.31% IGGIGTVPVGR 95.00% 3.03 0.395 2.89 513.3076 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 2R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 4 7 9.31% IGGIGTVPVGR 95.00% 2.85 0.375 2.74 513.3079 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 2R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 4 7 9.31% EHALLAYTLGVK 95.00% 2.59 0.259 0 657.8747 1,313.73 1,314.74 2
 SAMPLE 2R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 4 7 9.31% EHALLAYTLGVK 95.00% 2.3 0.313 0 657.8756 1,313.74 1,314.74 2
 SAMPLE 2R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 4 7 9.31% YYVTIIDAPGHR 95.00% 2.34 0.378 2.05 702.8636 1,403.71 1,404.73 2 CATG_HUMAN
 SAMPLE 2R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 3 4 7 9.31% YYVTIIDAPGHR 95.00% 2.2 0.243 1.24 702.8656 1,403.72 1,404.73 2 CATG_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% QTVAVGVIK 95.00% 1.76 0.329 0 457.7874 913.5591 914.5676 2
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% YYVTIIDAPGHR 95.00% 3.34 0.444 1.6 468.9125 1,403.71 1,404.73 3 CATG_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% YYVTIIDAPGHR 95.00% 3.61 0.267 1.68 468.9139 1,403.72 1,404.73 3 CATG_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% YYVTIIDAPGHR 95.00% 3.56 0.272 0 469.2477 1,404.72 1,404.73 3 CATG_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% LPLQDVYK 95.00% 2.37 0.185 1.28 488.2785 974.5413 975.5517 2
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% LPLQDVYK 95.00% 1.96 0.208 1.82 488.279 974.5423 975.5517 2
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% LPLQDVYK 95.00% 2.47 0.226 2.15 488.279 974.5423 975.5517 2
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% LPLQDVYK 95.00% 2.25 0.244 1.37 488.279 974.5424 975.5517 2
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% LPLQDVYK 95.00% 1.85 0.215 1.4 488.2794 974.5431 975.5517 2
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% LPLQDVYK 95.00% 2.23 0.236 1.35 488.2804 974.5451 975.5517 2
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% IGGIGTVPVGR 95.00% 2.97 0.343 0 513.307 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% IGGIGTVPVGR 95.00% 1.98 0.372 0 513.3073 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% IGGIGTVPVGR 95.00% 2.16 0.382 0 513.3074 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% IGGIGTVPVGR 95.00% 2.91 0.456 2.74 513.3075 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% IGGIGTVPVGR 95.00% 3.06 0.374 1.47 513.3076 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% IGGIGTVPVGR 95.00% 2.05 0.281 0 513.3076 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% IGGIGTVPVGR 95.00% 2.66 0.502 1.92 513.308 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% IGGIGTVPVGR 95.00% 2.72 0.431 0 513.3083 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% IGGIGTVPVGR 95.00% 2.94 0.442 0 513.3083 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% IGGIGTVPVGR 95.00% 3.28 0.474 2.22 513.3089 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% THINIVVIGHVDSGK 95.00% 3.02 0.531 1.72 530.2518 1,587.73 1,588.88 3 TITIN_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% THINIVVIGHVDSGK 95.00% 2.65 0.443 1.39 530.2962 1,587.87 1,588.88 3 TITIN_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% THINIVVIGHVDSGK 95.00% 2.8 0.254 3.17 530.5873 1,588.74 1,588.88 3 TITIN_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% EHALLAYTLGVK 95.00% 3.44 0.481 1.8 657.8717 1,313.73 1,314.74 2
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% EHALLAYTLGVK 95.00% 3.16 0.429 1.25 657.8748 1,313.73 1,314.74 2
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% YYVTIIDAPGHR 95.00% 2.05 0.153 1.39 702.866 1,403.72 1,404.73 2 CATG_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% YYVTIIDAPGHR 95.00% 2.82 0.415 2.92 702.8665 1,403.72 1,404.73 2 CATG_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% YYVTIIDAPGHR 95.00% 3.13 0.494 2.72 702.8667 1,403.72 1,404.73 2 CATG_HUMAN
 SAMPLE 3 Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 16 19.70% VETGVLKPGMVVTFAPVNVTTEVK 95.00% 4.25 0.493 3.39 839.4665 2,515.38 2,515.38 3
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% YYVTIIDAPGHR 95.00% 3.19 0.399 1.59 468.9136 1,403.72 1,404.73 3 CATG_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% YYVTIIDAPGHR 95.00% 3.54 0.418 1.03 468.9143 1,403.72 1,404.73 3 CATG_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% LPLQDVYK 95.00% 2.36 0.219 2 488.2795 974.5434 975.5517 2
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% LPLQDVYK 95.00% 2.03 0.173 1.41 488.2796 974.5435 975.5517 2
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% LPLQDVYK 95.00% 2.03 0.259 0 488.2804 974.5451 975.5517 2
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% LPLQDVYK 95.00% 2.07 0.255 0 488.2807 974.5458 975.5517 2
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% LPLQDVYK 95.00% 2.01 0.218 2.85 488.2809 974.5461 975.5517 2
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% IGGIGTVPVGR 95.00% 2.27 0.409 0 512.7961 1,023.58 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% IGGIGTVPVGR 95.00% 2.52 0.357 0 513.3066 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% IGGIGTVPVGR 95.00% 2.62 0.43 1.12 513.3073 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% IGGIGTVPVGR 95.00% 3.1 0.427 2.28 513.3081 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% IGGIGTVPVGR 95.00% 2.77 0.305 0 513.3085 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% IGGIGTVPVGR 95.00% 2.44 0.376 0 513.3086 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% IGGIGTVPVGR 95.00% 2.53 0.336 1.89 513.3087 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% IGGIGTVPVGR 95.00% 3.04 0.453 1.15 513.3089 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% IGGIGTVPVGR 95.00% 2.21 0.427 0 513.3089 1,024.60 1,025.61 2 TITIN_HUMAN,ITB1_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% THINIVVIGHVDSGK 95.00% 2.12 0.277 1.49 530.2974 1,587.87 1,588.88 3 TITIN_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% STTTGHLIYK 95.00% 1.95 0.368 0 560.8006 1,119.59 1,120.60 2
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% EHALLAYTLGVK 95.00% 2.98 0.429 0 657.8765 1,313.74 1,314.74 2
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% YYVTIIDAPGHR 95.00% 3.35 0.489 2.24 703.3687 1,404.72 1,404.73 2 CATG_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% YYVTIIDAPGHR 95.00% 3.03 0.494 3.62 703.3689 1,404.72 1,404.73 2 CATG_HUMAN
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% VETGVLKPGMVVTFAPVNVTTEVK 95.00% 4.91 0.477 4.14 839.4654 2,515.37 2,515.38 3
 SAMPLE 3R Elongation factor 1-alpha 1  EEF1A1  EF1A1_HUMAN,EF1A3_HUMAN 50,123.20 100.00% 5 6 13 19.90% VETGVLKPGMVVTFAPVNVTTEVK 95.00% 4.12 0.485 3.77 839.4664 2,515.38 2,515.38 3
 SAMPLE 4 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 5 4.53% LVGSGLHTVEAAGEAR 95.00% 2.78 0.284 0 523.2825 1,566.82 1,566.82 3
 SAMPLE 4 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 5 4.53% VQQLEEQVQSLTK 95.00% 2.16 0.374 0 765.4113 1,528.81 1,529.82 2
 SAMPLE 4 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 5 4.53% VQQLEEQVQSLTK 95.00% 4.32 0.538 5.09 765.4164 1,528.82 1,529.82 2
 SAMPLE 4 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 5 4.53% APAPASAPPGPSEELLR 95.00% 3.18 0.561 2.96 830.4398 1,658.86 1,659.87 2
 SAMPLE 4 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 5 4.53% APAPASAPPGPSEELLR 95.00% 3.97 0.54 4.3 830.4429 1,658.87 1,659.87 2
 SAMPLE 4R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 6 5.12% HVAGLWAGLR 95.00% 1.88 0.294 1.52 540.3114 1,078.61 1,079.61 2
 SAMPLE 4R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 6 5.12% HVAGLWAGLR 95.00% 2.03 0.4 0 540.3122 1,078.61 1,079.61 2
 SAMPLE 4R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 6 5.12% LDTVAGGLQGLR 95.00% 2.81 0.258 0 600.3357 1,198.66 1,199.68 2
 SAMPLE 4R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 6 5.12% VQQLEEQVQSLTK 95.00% 2.73 0.298 2.41 765.4123 1,528.81 1,529.82 2
 SAMPLE 4R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 6 5.12% VQQLEEQVQSLTK 95.00% 3.58 0.468 2.46 765.4154 1,528.82 1,529.82 2
 SAMPLE 4R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 6 5.12% APAPASAPPGPSEELLR 95.00% 3.54 0.475 2.57 830.9411 1,659.87 1,659.87 2
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LVGSGLHTVEAAGEAR 95.00% 2.99 0.489 1.18 522.9448 1,565.81 1,566.82 3
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LVGSGLHTVEAAGEAR 95.00% 2.59 0.186 0 522.9449 1,565.81 1,566.82 3
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LVGSGLHTVEAAGEAR 95.00% 3.06 0.384 1.31 522.9465 1,565.82 1,566.82 3
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LDTVAGGLQGLR 95.00% 3.66 0.426 2.49 600.3391 1,198.66 1,199.68 2
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LDTVAGGLQGLR 95.00% 3.51 0.425 1.82 600.3392 1,198.66 1,199.68 2
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LDTVAGGLQGLR 95.00% 3.04 0.285 1.18 600.3393 1,198.66 1,199.68 2
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LDTVAGGLQGLR 95.00% 3.63 0.44 1.18 600.3396 1,198.66 1,199.68 2
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LDTVAGGLQGLR 95.00% 3.82 0.444 2.82 600.3399 1,198.66 1,199.68 2
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LDTVAGGLQGLR 95.00% 3.7 0.447 2.36 600.3401 1,198.66 1,199.68 2
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LDTVAGGLQGLR 95.00% 2.95 0.244 1.82 600.3401 1,198.66 1,199.68 2
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LDTVAGGLQGLR 95.00% 3.6 0.44 4.1 600.3407 1,198.67 1,199.68 2
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LDTVAGGLQGLR 95.00% 3.51 0.314 2.28 600.3418 1,198.67 1,199.68 2
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% LQEScSVcLAGLDGFRR 95.00% 2.39 0.27 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 656.6508 1,966.93 1,967.94 3 ITA5_HUMAN,MY18B_HUMAN,IQGA1_HUMAN
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% APAPASAPPGPSEELLR 95.00% 4.21 0.536 4.48 830.4374 1,658.86 1,659.87 2
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% APAPASAPPGPSEELLR 95.00% 4.05 0.571 4.46 830.4386 1,658.86 1,659.87 2
 SAMPLE 1 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 15 6.10% APAPASAPPGPSEELLR 95.00% 4.19 0.556 4.89 830.4403 1,658.86 1,659.87 2
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% RLDVVAGSVTVLSGR 95.00% 2.62 0.322 0 510.2986 1,527.87 1,528.88 3
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% RLDVVAGSVTVLSGR 95.00% 2.62 0.272 0 510.2989 1,527.87 1,528.88 3
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% LVGSGLHTVEAAGEAR 95.00% 2.47 0.134 1.48 522.9446 1,565.81 1,566.82 3
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% LVGSGLHTVEAAGEAR 95.00% 3.06 0.463 0 522.9449 1,565.81 1,566.82 3
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% LVGSGLHTVEAAGEAR 95.00% 3.01 0.346 1.82 522.945 1,565.81 1,566.82 3
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% LVGSGLHTVEAAGEAR 95.00% 2.6 0.298 0 523.2793 1,566.81 1,566.82 3
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% LDTVAGGLQGLR 95.00% 3.44 0.39 2.04 600.337 1,198.66 1,199.68 2
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% LDTVAGGLQGLR 95.00% 3.35 0.425 0 600.3389 1,198.66 1,199.68 2
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% LDTVAGGLQGLR 95.00% 3.5 0.404 1.89 600.3391 1,198.66 1,199.68 2
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% LDTVAGGLQGLR 95.00% 3.46 0.305 1.36 600.34 1,198.66 1,199.68 2
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% LDTVAGGLQGLR 95.00% 3.72 0.399 2.39 600.3405 1,198.67 1,199.68 2
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% LDTVAGGLQGLR 95.00% 3.72 0.402 2.48 600.3412 1,198.67 1,199.68 2
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% LDTVAGGLQGLR 95.00% 3.06 0.288 1.31 600.3414 1,198.67 1,199.68 2
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% LDTVAGGLQGLR 95.00% 3.18 0.367 0 600.342 1,198.67 1,199.68 2
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% APAPASAPPGPSEELLR 95.00% 3.83 0.463 3.07 830.4373 1,658.86 1,659.87 2
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% APAPASAPPGPSEELLR 95.00% 3.88 0.503 5.33 830.4405 1,658.87 1,659.87 2
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% APAPASAPPGPSEELLR 95.00% 3.66 0.503 2 830.4406 1,658.87 1,659.87 2
 SAMPLE 1R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 18 5.91% APAPASAPPGPSEELLR 95.00% 4.18 0.544 3.25 830.9363 1,659.86 1,659.87 2
 SAMPLE 2 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 7 5.61% LVGSGLHTVEAAGEAR 95.00% 2.74 0.407 0 522.945 1,565.81 1,566.82 3
 SAMPLE 2 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 7 5.61% LVGSGLHTVEAAGEAR 95.00% 2.43 0.439 0 522.9453 1,565.81 1,566.82 3
 SAMPLE 2 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 7 5.61% YLLSAVLTGHR 95.00% 2.37 0.261 0 615.3529 1,228.69 1,229.70 2
 SAMPLE 2 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 7 5.61% VQQLEEQVQSLTK 95.00% 4.27 0.503 5.29 765.4085 1,528.80 1,529.82 2
 SAMPLE 2 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 7 5.61% VQQLEEQVQSLTK 95.00% 4.37 0.513 5.06 765.4115 1,528.81 1,529.82 2
 SAMPLE 2 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 7 5.61% VQQLEEQVQSLTK 95.00% 3.66 0.488 5.23 765.4122 1,528.81 1,529.82 2
 SAMPLE 2 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 4 4 7 5.61% APAPASAPPGPSEELLR 95.00% 4.29 0.594 5.12 830.443 1,658.87 1,659.87 2
 SAMPLE 2R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 4 3.64% LVGSGLHTVEAAGEAR 95.00% 2.61 0.168 0 522.9448 1,565.81 1,566.82 3
 SAMPLE 2R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 4 3.64% NWcAYVVTR 95.00% 2.43 0.353 1.7 c3: Carbamidomethyl (+57.02) 584.7797 1,167.54 1,168.56 2
 SAMPLE 2R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 4 3.64% LDTVAGGLQGLR 95.00% 2.8 0.283 0 600.335 1,198.65 1,199.68 2
 SAMPLE 2R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 3 3 4 3.64% LDTVAGGLQGLR 95.00% 2.65 0.258 0 600.6398 1,199.26 1,199.68 2
 SAMPLE 3 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 99.80% 2 2 3 2.76% LVGSGLHTVEAAGEAR 95.00% 2.83 0.413 1.15 523.2798 1,566.82 1,566.82 3
 SAMPLE 3 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 99.80% 2 2 3 2.76% LDTVAGGLQGLR 95.00% 3.85 0.33 1.6 600.3387 1,198.66 1,199.68 2
 SAMPLE 3 EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 99.80% 2 2 3 2.76% LDTVAGGLQGLR 95.00% 4.01 0.355 2.19 600.3398 1,198.66 1,199.68 2
 SAMPLE 3R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 5 5 5 6.69% LVGSGLHTVEAAGEAR 95.00% 2.92 0.36 0 523.28 1,566.82 1,566.82 3
 SAMPLE 3R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 5 5 5 6.69% NWcAYVVTR 95.00% 2.29 0.387 1.27 c3: Carbamidomethyl (+57.02) 584.7812 1,167.55 1,168.56 2
 SAMPLE 3R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 5 5 5 6.69% QATLEGLQEVVGR 95.00% 2.25 0.309 0 700.8753 1,399.73 1,399.75 2
 SAMPLE 3R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 5 5 5 6.69% VQQLEEQVQSLTK 95.00% 3.95 0.497 4.34 765.4151 1,528.81 1,529.82 2
 SAMPLE 3R EMILIN-1  EMILIN1  EMIL1_HUMAN 106,648.60 100.00% 5 5 5 6.69% APAPASAPPGPSEELLR 95.00% 3.64 0.392 2.85 830.9413 1,659.87 1,659.87 2
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% LIINSLYK 95.00% 2.86 0.286 0 482.2964 962.5771 963.588 2
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% LIINSLYK 95.00% 2.89 0.252 0 482.2972 962.5787 963.588 2
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% SGYLLPDTK 95.00% 2.98 0.367 1.66 497.2649 992.5141 993.5259 2
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% ELISNASDALDKIR 95.00% 1.64 0.279 0 515.6133 1,543.82 1,544.83 3 HS90B_HUMAN
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% IYFMAGSSR 95.00% 1.76 0.382 1.17 515.777 1,029.54 1,031.50 2
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% ELISNASDALDK 95.00% 3.58 0.513 1.29 638.3226 1,274.63 1,275.64 2 HS90B_HUMAN
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% ELISNASDALDK 95.00% 3.43 0.513 1.17 638.3236 1,274.63 1,275.64 2 HS90B_HUMAN
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% DISTNYYASQK 95.00% 3.56 0.558 2.46 645.3028 1,288.59 1,289.60 2
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% DISTNYYASQK 95.00% 3.3 0.538 2.68 645.3034 1,288.59 1,289.60 2
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% LISLTDENALSGNEELTVK 95.00% 2.46 0.297 0 683.0244 2,046.05 2,046.06 3
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% FQSSHHPTDITSLDQYVER 95.00% 5.19 0.519 3.54 754.3594 2,260.05 2,260.06 3
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% FQSSHHPTDITSLDQYVER 95.00% 5.14 0.524 3.19 754.3599 2,260.06 2,260.06 3
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% ELISNASDALDKIR 95.00% 3.78 0.499 4.29 772.9181 1,543.82 1,544.83 2 HS90B_HUMAN
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% LISLTDENALSGNEELTVK 95.00% 6.69 0.605 7.68 1,024.03 2,046.05 2,046.06 2
 SAMPLE 1 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 8 13 11.10% LISLTDENALSGNEELTVK 95.00% 6.51 0.607 7.8 1,024.03 2,046.05 2,046.06 2
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% LIINSLYK 95.00% 3.02 0.285 1.12 482.2969 962.5782 963.588 2
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% LIINSLYK 95.00% 2.9 0.29 0 482.2969 962.5782 963.588 2
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% SGYLLPDTK 95.00% 2.76 0.402 0 497.2653 992.515 993.5259 2
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% GLFDEYGSK 95.00% 1.77 0.328 1.6 508.2393 1,014.46 1,015.47 2
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% GLFDEYGSK 95.00% 1.87 0.383 1.48 508.2395 1,014.46 1,015.47 2
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% ELISNASDALDK 95.00% 3.47 0.441 0 638.3264 1,274.64 1,275.64 2 HS90B_HUMAN
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% DISTNYYASQK 95.00% 3.33 0.523 3.68 645.3028 1,288.59 1,289.60 2
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% DISTNYYASQK 95.00% 3.48 0.529 2.7 645.3031 1,288.59 1,289.60 2
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% LISLTDENALSGNEELTVK 95.00% 3.68 0.427 0 683.0234 2,046.05 2,046.06 3
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% ELISNASDALDKIR 95.00% 3.52 0.519 3.47 773.4179 1,544.82 1,544.83 2 HS90B_HUMAN
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% ELISNASDALDKIR 95.00% 3.81 0.491 4.28 773.4193 1,544.82 1,544.83 2 HS90B_HUMAN
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% LISLTDENALSGNEELTVK 95.00% 6.55 0.598 7.54 1,024.03 2,046.05 2,046.06 2
 SAMPLE 1R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 6 7 11 8.72% LISLTDENALSGNEELTVK 95.00% 6.53 0.593 6.21 1,024.03 2,046.05 2,046.06 2
 SAMPLE 2 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 5 5 9 6.97% LIINSLYK 95.00% 2.95 0.297 0 482.2966 962.5775 963.588 2
 SAMPLE 2 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 5 5 9 6.97% LIINSLYK 95.00% 3.29 0.326 0 482.2967 962.5777 963.588 2
 SAMPLE 2 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 5 5 9 6.97% SGYLLPDTK 95.00% 2.45 0.283 0 497.2651 992.5146 993.5259 2
 SAMPLE 2 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 5 5 9 6.97% SGYLLPDTK 95.00% 2.79 0.46 1.85 497.2655 992.5153 993.5259 2
 SAMPLE 2 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 5 5 9 6.97% ELISNASDALDKIR 95.00% 1.99 0.264 0 515.6133 1,543.82 1,544.83 3 HS90B_HUMAN
 SAMPLE 2 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 5 5 9 6.97% ELISNASDALDK 95.00% 3.41 0.486 0 638.3251 1,274.63 1,275.64 2 HS90B_HUMAN
 SAMPLE 2 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 5 5 9 6.97% ELISNASDALDK 95.00% 3.13 0.486 0 638.3255 1,274.64 1,275.64 2 HS90B_HUMAN
 SAMPLE 2 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 5 5 9 6.97% DISTNYYASQK 95.00% 2.87 0.534 1.6 645.3028 1,288.59 1,289.60 2
 SAMPLE 2 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 5 5 9 6.97% DISTNYYASQK 95.00% 2.27 0.408 0 645.3058 1,288.60 1,289.60 2
 SAMPLE 2 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 5 5 9 6.97% NLLHVTDTGVGMTR 95.00% 3.01 0.503 2.85 757.3928 1,512.77 1,513.78 2
 SAMPLE 2R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 7 10 9.84% LIINSLYK 95.00% 2.84 0.317 0 482.2985 962.5813 963.588 2
 SAMPLE 2R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 7 10 9.84% SGYLLPDTK 95.00% 2.76 0.398 1.52 497.2652 992.5147 993.5259 2
 SAMPLE 2R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 7 10 9.84% SGYLLPDTK 95.00% 2.19 0.362 1.59 497.2653 992.5149 993.5259 2
 SAMPLE 2R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 7 10 9.84% GLFDEYGSK 95.00% 2.15 0.305 1.19 508.2389 1,014.46 1,015.47 2
 SAMPLE 2R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 7 10 9.84% GLFDEYGSK 95.00% 1.81 0.315 0 508.2398 1,014.46 1,015.47 2
 SAMPLE 2R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 7 10 9.84% SILFVPTSAPR 95.00% 3.42 0.303 1.32 594.3421 1,186.67 1,187.68 2
 SAMPLE 2R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 7 10 9.84% ELISNASDALDK 95.00% 2.82 0.44 0 638.3239 1,274.63 1,275.64 2 HS90B_HUMAN
 SAMPLE 2R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 7 10 9.84% ELISNASDALDK 95.00% 3.01 0.446 1.7 638.3263 1,274.64 1,275.64 2 HS90B_HUMAN
 SAMPLE 2R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 7 10 9.84% DISTNYYASQK 95.00% 2.27 0.362 1.37 645.3013 1,288.59 1,289.60 2
 SAMPLE 2R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 7 7 10 9.84% LISLTDENALSGNEELTVK 95.00% 5.67 0.602 5.82 1,024.03 2,046.05 2,046.06 2
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% LIINSLYK 95.00% 3.01 0.296 0 482.2964 962.5771 963.588 2
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% LIINSLYK 95.00% 3.05 0.289 0 482.2967 962.5777 963.588 2
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% SGYLLPDTK 95.00% 3.17 0.389 1.72 497.2636 992.5115 993.5259 2
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% SGYLLPDTK 95.00% 3.17 0.366 0 497.265 992.5144 993.5259 2
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% NLLHVTDTGVGMTR 95.00% 2.89 0.387 0 505.2642 1,512.77 1,513.78 3
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% GLFDEYGSK 95.00% 2.47 0.467 1.3 508.2391 1,014.46 1,015.47 2
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% ELISNASDALDKIR 95.00% 2.03 0.231 0 515.6136 1,543.82 1,544.83 3 HS90B_HUMAN
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% ELISNASDALDKIR 95.00% 1.92 0.218 0 515.6136 1,543.82 1,544.83 3 HS90B_HUMAN
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% VFITDDFHDMMPK 95.00% 2.62 0.41 0 532.9127 1,595.71 1,595.72 3
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% LSLNIDPDAK 95.00% 2.61 0.342 1.49 543.294 1,084.57 1,085.58 2
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% EAESSPFVER 95.00% 2.52 0.275 0 575.7707 1,149.53 1,150.54 2
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% SILFVPTSAPR 95.00% 2.82 0.275 1.27 594.3417 1,186.67 1,187.68 2
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% ELISNASDALDK 95.00% 3.56 0.499 1.74 638.3239 1,274.63 1,275.64 2 HS90B_HUMAN
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% ELISNASDALDK 95.00% 3.46 0.48 1.55 638.3244 1,274.63 1,275.64 2 HS90B_HUMAN
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% NLLHVTDTGVGMTREELVK 95.00% 3.54 0.435 0 704.7092 2,111.10 2,112.11 3
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% NLLHVTDTGVGMTREELVK 95.00% 4.33 0.491 0 705.0426 2,112.10 2,112.11 3
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% GVVDSDDLPLNVSR 95.00% 3.23 0.319 2.44 743.3808 1,484.75 1,485.76 2
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% ELISNASDALDKIR 95.00% 3.76 0.497 3.33 772.917 1,543.82 1,544.83 2 HS90B_HUMAN
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% ELISNASDALDKIR 95.00% 3.81 0.483 4.15 772.9178 1,543.82 1,544.83 2 HS90B_HUMAN
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% LISLTDENALSGNEELTVK 95.00% 6.74 0.623 5.49 1,024.03 2,046.05 2,046.06 2
 SAMPLE 3 Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 13 13 17 19.30% FQSSHHPTDITSLDQYVER 95.00% 4.95 0.568 6.33 1,131.03 2,260.05 2,260.06 2
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% LIINSLYK 95.00% 2.9 0.298 0 482.2964 962.5771 963.588 2
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% LIINSLYK 95.00% 3.02 0.313 0 482.2965 962.5774 963.588 2
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% EAESSPFVER 95.00% 2.17 0.271 0 575.7709 1,149.53 1,150.54 2
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% EAESSPFVER 95.00% 2.18 0.259 0 575.7713 1,149.53 1,150.54 2
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% SILFVPTSAPR 95.00% 3.2 0.32 0 594.3418 1,186.67 1,187.68 2
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% SILFVPTSAPR 95.00% 3.14 0.311 1.14 594.3424 1,186.67 1,187.68 2
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% SILFVPTSAPR 95.00% 3 0.227 0 594.3442 1,186.67 1,187.68 2
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% ELISNASDALDK 95.00% 3.79 0.504 1.7 638.3245 1,274.63 1,275.64 2 HS90B_HUMAN
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% NLLHVTDTGVGMTREELVK 95.00% 3.29 0.358 0 705.0414 2,112.10 2,112.11 3
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% NLLHVTDTGVGMTREELVK 95.00% 4.07 0.31 0 705.0428 2,112.10 2,112.11 3
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% NLLHVTDTGVGMTR 95.00% 3.42 0.509 5.17 757.3961 1,512.78 1,513.78 2
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% ELISNASDALDKIR 95.00% 3.59 0.479 5.92 772.9171 1,543.82 1,544.83 2 HS90B_HUMAN
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% VFITDDFHDMMPK 95.00% 3.33 0.365 1.7 798.3619 1,594.71 1,595.72 2
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% LISLTDENALSGNEELTVK 95.00% 6.35 0.606 6.13 1,024.03 2,046.04 2,046.06 2
 SAMPLE 3R Endoplasmin  HSP90B1  ENPL_HUMAN 92,453.70 100.00% 8 8 14 11.70% LISLTDENALSGNEELTVK 95.00% 6.32 0.602 5.82 1,024.03 2,046.05 2,046.06 2
 SAMPLE 2R Epithelial cadherin  CDH1  CADH1_HUMAN 97,439.60 99.80% 2 2 3 2.38% TAYFSLDTR 95.00% 2.55 0.244 2.1 537.2643 1,072.51 1,073.53 2
 SAMPLE 2R Epithelial cadherin  CDH1  CADH1_HUMAN 97,439.60 99.80% 2 2 3 2.38% TAYFSLDTR 95.00% 2.82 0.299 2 537.2651 1,072.51 1,073.53 2
 SAMPLE 2R Epithelial cadherin  CDH1  CADH1_HUMAN 97,439.60 99.80% 2 2 3 2.38% FKVGTDGVITVK 95.00% 2.46 0.292 0 632.3679 1,262.72 1,263.73 2
 SAMPLE 1R Eukaryotic translation initiation factor 4 gamma 3  EIF4G3  IF4G3_HUMAN 176,637.90 99.80% 2 2 4 2.21% NDKPLPSATARPNTFmR 95.00% 2.45 0.191 2.02 m16: Oxidation (+15.99) 966.975 1,931.93 1,931.98 2
 SAMPLE 1R Eukaryotic translation initiation factor 4 gamma 3  EIF4G3  IF4G3_HUMAN 176,637.90 99.80% 2 2 4 2.21% NDKPLPSATARPNTFmR 95.00% 2.5 0.194 2.55 m16: Oxidation (+15.99) 966.9765 1,931.94 1,931.98 2
 SAMPLE 1R Eukaryotic translation initiation factor 4 gamma 3  EIF4G3  IF4G3_HUMAN 176,637.90 99.80% 2 2 4 2.21% TIEQIHKEAKIEEQEEQR 95.00% 2.9 0.319 0 1,119.61 2,237.20 2,238.14 2
 SAMPLE 1R Eukaryotic translation initiation factor 4 gamma 3  EIF4G3  IF4G3_HUMAN 176,637.90 99.80% 2 2 4 2.21% TIEQIHKEAKIEEQEEQR 95.00% 2.64 0.271 0 1,119.61 2,237.20 2,238.14 2
 SAMPLE 3R Eukaryotic translation initiation factor 4 gamma 3  EIF4G3  IF4G3_HUMAN 176,637.90 99.80% 2 2 6 2.21% NDKPLPSATARPNTFmR 95.00% 2.57 0.206 1.44 m16: Oxidation (+15.99) 966.4776 1,930.94 1,931.98 2
 SAMPLE 3R Eukaryotic translation initiation factor 4 gamma 3  EIF4G3  IF4G3_HUMAN 176,637.90 99.80% 2 2 6 2.21% NDKPLPSATARPNTFmR 95.00% 2.84 0.329 2.27 m16: Oxidation (+15.99) 966.4785 1,930.94 1,931.98 2
 SAMPLE 3R Eukaryotic translation initiation factor 4 gamma 3  EIF4G3  IF4G3_HUMAN 176,637.90 99.80% 2 2 6 2.21% NDKPLPSATARPNTFmR 95.00% 2.57 0.312 0 m16: Oxidation (+15.99) 966.4832 1,930.95 1,931.98 2
 SAMPLE 3R Eukaryotic translation initiation factor 4 gamma 3  EIF4G3  IF4G3_HUMAN 176,637.90 99.80% 2 2 6 2.21% NDKPLPSATARPNTFmR 95.00% 2.76 0.169 1.7 m16: Oxidation (+15.99) 966.9773 1,931.94 1,931.98 2
 SAMPLE 3R Eukaryotic translation initiation factor 4 gamma 3  EIF4G3  IF4G3_HUMAN 176,637.90 99.80% 2 2 6 2.21% NDKPLPSATARPNTFmR 95.00% 2.93 0.23 0 m16: Oxidation (+15.99) 966.9779 1,931.94 1,931.98 2
 SAMPLE 3R Eukaryotic translation initiation factor 4 gamma 3  EIF4G3  IF4G3_HUMAN 176,637.90 99.80% 2 2 6 2.21% TIEQIHKEAKIEEQEEQR 95.00% 2.53 0.286 0 1,119.58 2,237.15 2,238.14 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% AGLAASLAGPHSIVGR 95.00% 2.3 0.181 1.92 492.9456 1,475.81 1,476.83 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% AGLAASLAGPHSIVGR 95.00% 2.17 0.19 2.96 492.9459 1,475.81 1,476.83 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% AGLAASLAGPHSIVGR 95.00% 2.72 0.53 2.6 492.9473 1,475.82 1,476.83 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% YRAGLAASLAGPHSIVGR 95.00% 4.8 0.6 4.8 599.6681 1,795.98 1,795.99 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% YRAGLAASLAGPHSIVGR 95.00% 5.08 0.533 3.42 599.6699 1,795.99 1,795.99 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% LAccVVGVcGPGLWER 95.00% 2.18 0.216 0 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 611.3274 1,830.96 1,832.86 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% LAccVVGVcGPGLWER 95.00% 4.35 0.391 1.11 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 611.634 1,831.88 1,832.86 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% RLAccVVGVcGPGLWER 95.00% 2.93 0.339 0.959 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 663.6586 1,987.95 1,988.96 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% RLAccVVGVcGPGLWER 95.00% 4.25 0.422 3.07 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 663.6633 1,987.97 1,988.96 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% RLAccVVGVcGPGLWER 95.00% 4.22 0.383 3.17 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 663.9922 1,988.95 1,988.96 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% RLAccVVGVcGPGLWER 95.00% 5.15 0.441 2.15 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 663.9996 1,988.98 1,988.96 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% AVVVHAGEDDLGR 95.00% 3.95 0.631 5.24 669.3454 1,336.68 1,337.68 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% VTEIWQEVMQR 95.00% 4.17 0.497 2.24 709.8563 1,417.70 1,418.71 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% VTEIWQEVMQR 95.00% 4.35 0.507 1.27 709.8567 1,417.70 1,418.71 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% VTEIWQEVMQR 95.00% 4.14 0.468 1.92 709.8572 1,417.70 1,418.71 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% VTEIWQEVMQR 95.00% 4.09 0.492 1.89 709.8681 1,417.72 1,418.71 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% VTEIWQEVMQR 95.00% 3.4 0.475 3 709.8687 1,417.72 1,418.71 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% VTEIWQEVMQR 95.00% 4.22 0.481 1.57 709.8712 1,417.73 1,418.71 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% VTEIWQEVmQR 95.00% 3.24 0.361 2.74 m9: Oxidation (+15.99) 717.8535 1,433.69 1,434.71 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% VTEIWQEVmQR 95.00% 3.48 0.377 3.29 m9: Oxidation (+15.99) 717.8546 1,433.69 1,434.71 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% VTEIWQEVmQR 95.00% 3.2 0.426 1.42 m9: Oxidation (+15.99) 717.8565 1,433.70 1,434.71 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% VTEIWQEVmQR 95.00% 3.27 0.47 3.06 m9: Oxidation (+15.99) 717.8617 1,433.71 1,434.71 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% AGLAASLAGPHSIVGR 95.00% 4.08 0.611 5.37 738.9166 1,475.82 1,476.83 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% DDDGALHAAcQVQPSATLDAAQPR 95.00% 4.95 0.491 3.96 c10: Carbamidomethyl (+57.02) 836.7244 2,507.15 2,507.16 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% DDDGALHAAcQVQPSATLDAAQPR 95.00% 5.25 0.465 7.19 c10: Carbamidomethyl (+57.02) 836.7244 2,507.15 2,507.16 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% DDDGALHAAcQVQPSATLDAAQPR 95.00% 5.2 0.538 5.77 c10: Carbamidomethyl (+57.02) 836.7314 2,507.17 2,507.16 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% DDDGALHAAcQVQPSATLDAAQPR 95.00% 4.91 0.526 6.59 c10: Carbamidomethyl (+57.02) 836.7357 2,507.18 2,507.16 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% AVVVHAGEDDLGRGGNQASVENGNAGR 95.00% 4.36 0.559 4.64 884.0994 2,649.27 2,649.27 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% RDDDGALHAAcQVQPSATLDAAQPR 95.00% 5.84 0.592 6.89 c11: Carbamidomethyl (+57.02) 888.7565 2,663.25 2,663.26 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% RDDDGALHAAcQVQPSATLDAAQPR 95.00% 5.88 0.583 5.55 c11: Carbamidomethyl (+57.02) 888.7606 2,663.26 2,663.26 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% RDDDGALHAAcQVQPSATLDAAQPR 95.00% 4.04 0.568 1.96 c11: Carbamidomethyl (+57.02) 888.7621 2,663.26 2,663.26 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% RDDDGALHAAcQVQPSATLDAAQPR 95.00% 6.83 0.652 7.49 c11: Carbamidomethyl (+57.02) 888.7678 2,663.28 2,663.26 3
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% LAccVVGVcGPGLWER 95.00% 5.06 0.515 4.48 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 916.9323 1,831.85 1,832.86 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% LAccVVGVcGPGLWER 95.00% 4.86 0.515 4.8 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 916.9393 1,831.86 1,832.86 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% LAccVVGVcGPGLWER 95.00% 4.82 0.485 3.82 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 916.9421 1,831.87 1,832.86 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% LAccVVGVcGPGLWER 95.00% 5.19 0.478 3.33 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 917.4322 1,832.85 1,832.86 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% LAccVVGVcGPGLWER 95.00% 5.18 0.497 3.35 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 917.4333 1,832.85 1,832.86 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% LAccVVGVcGPGLWER 95.00% 4.42 0.409 3.28 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 917.4406 1,832.87 1,832.86 2
 SAMPLE 1 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 9 12 39 40.80% DDDGALHAAcQVQPSATLDAAQPR 95.00% 4.84 0.662 6.21 c10: Carbamidomethyl (+57.02) 1,254.58 2,507.15 2,507.16 2
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% VTEIWQEVMQR 95.00% 3.08 0.198 0 473.5826 1,417.72 1,418.71 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% AGLAASLAGPHSIVGR 95.00% 2.42 0.184 2.28 493.2554 1,476.74 1,476.83 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% AGLAASLAGPHSIVGR 94.60% 1.82 0.0145 3.12 493.2584 1,476.75 1,476.83 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% AGLAASLAGPHSIVGR 95.00% 2.65 0.433 3.29 493.2804 1,476.82 1,476.83 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% LAccVVGVcGPGLWER 95.00% 4.35 0.391 2.4 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 611.634 1,831.88 1,832.86 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% RLAccVVGVcGPGLWER 95.00% 4.25 0.422 3.17 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 663.6633 1,987.97 1,988.96 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% RLAccVVGVcGPGLWER 95.00% 5.15 0.441 2.21 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 663.9996 1,988.98 1,988.96 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% RLAccVVGVcGPGLWER 95.00% 4.7 0.454 3.46 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 664.005 1,988.99 1,988.96 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% AVVVHAGEDDLGR 95.00% 3.95 0.631 5.26 669.3454 1,336.68 1,337.68 2
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% VTEIWQEVMQR 95.00% 3.98 0.45 1.68 709.8563 1,417.70 1,418.71 2
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% VTEIWQEVMQR 95.00% 4.09 0.492 1.8 709.8681 1,417.72 1,418.71 2
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% VTEIWQEVMQR 95.00% 3.4 0.475 3.07 709.8687 1,417.72 1,418.71 2
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% VTEIWQEVMQR 95.00% 4.31 0.524 1.38 709.87 1,417.72 1,418.71 2
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% VTEIWQEVmQR 95.00% 3.2 0.426 1.14 m9: Oxidation (+15.99) 717.8565 1,433.70 1,434.71 2
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% VTEIWQEVmQR 95.00% 3.27 0.47 3.24 m9: Oxidation (+15.99) 717.8617 1,433.71 1,434.71 2
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% DDDGALHAAcQVQPSATLDAAQPR 95.00% 5.2 0.538 5.2 c10: Carbamidomethyl (+57.02) 836.7314 2,507.17 2,507.16 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% DDDGALHAAcQVQPSATLDAAQPR 95.00% 4.91 0.526 6.72 c10: Carbamidomethyl (+57.02) 836.7357 2,507.18 2,507.16 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% AVVVHAGEDDLGRGGNQASVENGNAGR 95.00% 4.36 0.559 5 884.0994 2,649.27 2,649.27 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% RDDDGALHAAcQVQPSATLDAAQPR 95.00% 4.04 0.568 2.02 c11: Carbamidomethyl (+57.02) 888.7621 2,663.26 2,663.26 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% RDDDGALHAAcQVQPSATLDAAQPR 95.00% 6.83 0.652 7.52 c11: Carbamidomethyl (+57.02) 888.7678 2,663.28 2,663.26 3
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% LAccVVGVcGPGLWER 95.00% 4.86 0.515 4.89 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 916.9393 1,831.86 1,832.86 2
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% LAccVVGVcGPGLWER 95.00% 4.82 0.485 3.46 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 916.9421 1,831.87 1,832.86 2
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% LAccVVGVcGPGLWER 95.00% 5.1 0.478 4.47 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 916.9507 1,831.89 1,832.86 2
 SAMPLE 1R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 8 10 24 40.00% LAccVVGVcGPGLWER 95.00% 4.42 0.409 3.11 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 917.4406 1,832.87 1,832.86 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 3.04 0.393 4.39 492.9468 1,475.82 1,476.83 3
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 3.13 0.378 2.74 492.947 1,475.82 1,476.83 3
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 3.69 0.526 2.54 492.9472 1,475.82 1,476.83 3
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AVVVHAGEDDLGR 95.00% 3.38 0.626 5.89 669.3426 1,336.67 1,337.68 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AVVVHAGEDDLGR 95.00% 3.42 0.62 4.54 669.3432 1,336.67 1,337.68 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AVVVHAGEDDLGR 95.00% 3.28 0.566 5.38 669.3445 1,336.67 1,337.68 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AVVVHAGEDDLGR 95.00% 3.49 0.607 5.34 669.3445 1,336.67 1,337.68 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AVVVHAGEDDLGR 95.00% 2.13 0.179 2.68 669.7506 1,337.49 1,337.68 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% VTEIWQEVMQR 95.00% 4.34 0.477 2.52 709.8568 1,417.70 1,418.71 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% VTEIWQEVMQR 95.00% 4.43 0.517 1.42 709.8576 1,417.70 1,418.71 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% VTEIWQEVmQR 95.00% 3.38 0.397 3.05 m9: Oxidation (+15.99) 717.8549 1,433.69 1,434.71 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% VTEIWQEVmQR 95.00% 3.57 0.348 3.18 m9: Oxidation (+15.99) 717.8553 1,433.70 1,434.71 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 4.17 0.588 4.85 738.9156 1,475.82 1,476.83 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 4.38 0.591 6 738.9163 1,475.82 1,476.83 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 3.24 0.614 3.77 738.9164 1,475.82 1,476.83 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% DDDGALHAAcQVQPSATLDAAQPR 95.00% 5.15 0.474 4.74 c10: Carbamidomethyl (+57.02) 836.7221 2,507.14 2,507.16 3
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% DDDGALHAAcQVQPSATLDAAQPR 95.00% 4.63 0.476 5.37 c10: Carbamidomethyl (+57.02) 836.7254 2,507.15 2,507.16 3
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AVVVHAGEDDLGRGGNQASVENGNAGR 95.00% 4.16 0.555 3.85 884.0953 2,649.26 2,649.27 3
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AVVVHAGEDDLGRGGNQASVENGNAGR 95.00% 3.82 0.51 3.8 884.096 2,649.26 2,649.27 3
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% LAccVVGVcGPGLWER 95.00% 4.82 0.451 3.22 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 917.4325 1,832.85 1,832.86 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% LAccVVGVcGPGLWER 95.00% 4.31 0.396 3.49 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 917.4343 1,832.85 1,832.86 2
 SAMPLE 2 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 7 8 22 39.60% AVVVHAGEDDLGRGGNQASVENGNAGRR 95.00% 4.88 0.503 3.89 936.1273 2,805.36 2,805.37 3
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 2.51 0.301 3.29 492.9454 1,475.81 1,476.83 3
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 3.58 0.503 3.42 492.9467 1,475.82 1,476.83 3
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 2.23 0.227 1.92 492.9469 1,475.82 1,476.83 3
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 2.92 0.307 3.24 492.9473 1,475.82 1,476.83 3
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 2.61 0.371 2.51 492.948 1,475.82 1,476.83 3
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% LAccVVGVcGPGLWER 95.00% 3.45 0.377 1.48 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 611.6234 1,831.85 1,832.86 3
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% LAccVVGVcGPGLWER 95.00% 4.51 0.458 1.18 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 611.9589 1,832.85 1,832.86 3
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% AVVVHAGEDDLGR 95.00% 3.19 0.627 5.42 669.3431 1,336.67 1,337.68 2
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% AVVVHAGEDDLGR 95.00% 3.48 0.613 4.51 669.3435 1,336.67 1,337.68 2
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% AVVVHAGEDDLGR 95.00% 3.07 0.431 3.96 669.3436 1,336.67 1,337.68 2
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% AVVVHAGEDDLGR 95.00% 2.31 0.179 3.24 669.753 1,337.49 1,337.68 2
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% VTEIWQEVMQR 95.00% 3.96 0.49 2.11 709.8569 1,417.70 1,418.71 2
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% VTEIWQEVMQR 95.00% 4.38 0.519 2.29 709.857 1,417.70 1,418.71 2
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% VTEIWQEVmQR 95.00% 2.18 0.306 0 m9: Oxidation (+15.99) 717.8565 1,433.70 1,434.71 2
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% VTEIWQEVmQR 95.00% 2.63 0.344 2.96 m9: Oxidation (+15.99) 718.3584 1,434.70 1,434.71 2
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 4.29 0.55 4 738.9159 1,475.82 1,476.83 2
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% AGLAASLAGPHSIVGR 95.00% 4 0.605 5.89 739.4151 1,476.81 1,476.83 2
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% AVVVHAGEDDLGRGGNQASVENGNAGR 95.00% 4.44 0.572 4 884.0958 2,649.26 2,649.27 3
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% RDDDGALHAAcQVQPSATLDAAQPR 95.00% 6.22 0.676 5.66 c11: Carbamidomethyl (+57.02) 888.7567 2,663.25 2,663.26 3
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% RDDDGALHAAcQVQPSATLDAAQPR 95.00% 6.26 0.663 5.96 c11: Carbamidomethyl (+57.02) 888.7588 2,663.25 2,663.26 3
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% LAccVVGVcGPGLWER 95.00% 4.92 0.464 5.04 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 916.9334 1,831.85 1,832.86 2
 SAMPLE 2R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 6 8 22 39.60% LAccVVGVcGPGLWER 95.00% 4.45 0.44 4.2 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 916.9336 1,831.85 1,832.86 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVMQR 95.00% 4.66 0.339 1.07 473.5739 1,417.70 1,418.71 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVMQR 95.00% 4.38 0.246 0 473.574 1,417.70 1,418.71 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 2.97 0.421 2.8 492.9463 1,475.82 1,476.83 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 3.25 0.536 3.62 492.9465 1,475.82 1,476.83 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 2.92 0.432 2.85 492.9471 1,475.82 1,476.83 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 3.12 0.376 2.55 492.9471 1,475.82 1,476.83 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 2.75 0.412 2.74 492.9478 1,475.82 1,476.83 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 3.01 0.492 3.12 492.9482 1,475.82 1,476.83 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% YRAGLAASLAGPHSIVGR 95.00% 4.77 0.589 4.02 599.3345 1,794.98 1,795.99 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% YRAGLAASLAGPHSIVGR 95.00% 4.54 0.533 2.7 599.3347 1,794.98 1,795.99 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% LAccVVGVcGPGLWER 95.00% 4.95 0.473 0 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 611.957 1,832.85 1,832.86 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% LAccVVGVcGPGLWER 95.00% 5 0.456 1.17 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 611.9579 1,832.85 1,832.86 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% RLAccVVGVcGPGLWER 95.00% 4.08 0.467 4.12 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 663.6578 1,987.95 1,988.96 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% RLAccVVGVcGPGLWER 95.00% 4.68 0.41 3.6 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 663.9918 1,988.95 1,988.96 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 3.6 0.575 5.8 669.3427 1,336.67 1,337.68 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 3.37 0.612 7.24 669.343 1,336.67 1,337.68 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 3.81 0.539 5.39 669.3431 1,336.67 1,337.68 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 3.38 0.618 5.16 669.3431 1,336.67 1,337.68 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 3.34 0.588 7.24 669.3438 1,336.67 1,337.68 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 3.38 0.589 4.7 669.8448 1,337.67 1,337.68 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVMQR 95.00% 4.45 0.507 1.59 709.8565 1,417.70 1,418.71 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVMQR 95.00% 4.59 0.505 1.72 709.857 1,417.70 1,418.71 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVMQR 95.00% 3.51 0.509 2.34 709.8573 1,417.70 1,418.71 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVmQR 95.00% 3.27 0.437 3.92 m9: Oxidation (+15.99) 717.855 1,433.69 1,434.71 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVmQR 95.00% 2.64 0.398 1.15 m9: Oxidation (+15.99) 717.8562 1,433.70 1,434.71 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 3.84 0.576 6.92 738.9158 1,475.82 1,476.83 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 3.15 0.572 5.08 738.917 1,475.82 1,476.83 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 4.15 0.603 5.14 738.9172 1,475.82 1,476.83 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 4.2 0.624 6.21 738.9174 1,475.82 1,476.83 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 3.92 0.607 4.92 738.9184 1,475.82 1,476.83 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 3.94 0.675 5.18 739.4198 1,476.82 1,476.83 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% DDDGALHAAcQVQPSATLDAAQPR 95.00% 5.01 0.527 7.18 c10: Carbamidomethyl (+57.02) 836.7244 2,507.15 2,507.16 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGRGGNQASVENGNAGR 95.00% 4.27 0.545 3.66 884.0946 2,649.26 2,649.27 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGRGGNQASVENGNAGR 95.00% 4.24 0.586 3.92 884.0948 2,649.26 2,649.27 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% RDDDGALHAAcQVQPSATLDAAQPR 95.00% 6.5 0.646 5.92 c11: Carbamidomethyl (+57.02) 888.7584 2,663.25 2,663.26 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% RDDDGALHAAcQVQPSATLDAAQPR 95.00% 6.63 0.652 8.21 c11: Carbamidomethyl (+57.02) 888.7587 2,663.25 2,663.26 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% LAccVVGVcGPGLWER 95.00% 4.87 0.452 5.06 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 916.9307 1,831.85 1,832.86 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% LAccVVGVcGPGLWER 95.00% 4.74 0.443 3.82 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 916.9314 1,831.85 1,832.86 2
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGRGGNQASVENGNAGRR 95.00% 4.69 0.511 2.6 936.1281 2,805.36 2,805.37 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGRGGNQASVENGNAGRR 95.00% 5.47 0.53 1.82 936.1299 2,805.37 2,805.37 3
 SAMPLE 3 Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% DDDGALHAAcQVQPSATLDAAQPR 95.00% 5.11 0.641 6.68 c10: Carbamidomethyl (+57.02) 1,254.58 2,507.14 2,507.16 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVMQR 95.00% 4.68 0.283 0 473.574 1,417.70 1,418.71 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVMQR 95.00% 4.33 0.351 0 473.5746 1,417.70 1,418.71 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 2.66 0.355 2.54 492.9467 1,475.82 1,476.83 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 3 0.408 2.62 492.9468 1,475.82 1,476.83 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 3.5 0.54 3.4 492.9468 1,475.82 1,476.83 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 3.57 0.541 4.2 492.9472 1,475.82 1,476.83 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% LAccVVGVcGPGLWER 95.00% 4.18 0.456 0 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 611.6248 1,831.85 1,832.86 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% LAccVVGVcGPGLWER 95.00% 4.85 0.448 1.07 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 611.959 1,832.85 1,832.86 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% RLAccVVGVcGPGLWER 95.00% 4.36 0.399 3.32 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 663.9919 1,988.95 1,988.96 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 2.13 0.164 1.92 668.8358 1,335.66 1,337.68 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 2.48 0.424 2.36 669.3416 1,336.67 1,337.68 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 3.53 0.574 4.54 669.3432 1,336.67 1,337.68 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 3.68 0.555 4.82 669.3434 1,336.67 1,337.68 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 3.27 0.613 4.43 669.3435 1,336.67 1,337.68 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 3.16 0.56 5.05 669.3446 1,336.67 1,337.68 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGR 95.00% 3.34 0.45 4.08 669.3447 1,336.67 1,337.68 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVMQR 95.00% 3.97 0.495 1.55 709.8569 1,417.70 1,418.71 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVMQR 95.00% 4.36 0.477 2 709.8571 1,417.70 1,418.71 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVMQR 95.00% 2.75 0.376 2.11 709.859 1,417.70 1,418.71 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVMQR 95.00% 2.41 0.368 1.48 709.8592 1,417.70 1,418.71 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVMQR 95.00% 3.1 0.413 2.34 709.86 1,417.70 1,418.71 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% VTEIWQEVmQR 95.00% 3.32 0.43 2.19 m9: Oxidation (+15.99) 717.8551 1,433.69 1,434.71 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 3.78 0.553 4.35 738.917 1,475.82 1,476.83 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 3.78 0.615 5.72 738.9171 1,475.82 1,476.83 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 4.26 0.589 4.2 738.9179 1,475.82 1,476.83 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 4.18 0.578 4.38 738.918 1,475.82 1,476.83 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 4.07 0.585 5.18 738.918 1,475.82 1,476.83 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AGLAASLAGPHSIVGR 95.00% 4.36 0.611 4.55 738.9187 1,475.82 1,476.83 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% DDDGALHAAcQVQPSATLDAAQPR 95.00% 5.32 0.549 5.05 c10: Carbamidomethyl (+57.02) 836.7239 2,507.15 2,507.16 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% DDDGALHAAcQVQPSATLDAAQPR 95.00% 4.66 0.496 5.66 c10: Carbamidomethyl (+57.02) 836.7255 2,507.15 2,507.16 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGRGGNQASVENGNAGR 95.00% 4.37 0.587 4.54 884.0944 2,649.26 2,649.27 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGRGGNQASVENGNAGR 95.00% 4.76 0.598 5.38 884.0953 2,649.26 2,649.27 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% RDDDGALHAAcQVQPSATLDAAQPR 95.00% 6.84 0.665 7.14 c11: Carbamidomethyl (+57.02) 888.7565 2,663.25 2,663.26 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% RDDDGALHAAcQVQPSATLDAAQPR 95.00% 6.93 0.683 7.4 c11: Carbamidomethyl (+57.02) 888.7573 2,663.25 2,663.26 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% YRAGLAASLAGPHSIVGR 95.00% 3.8 0.545 4.47 898.4977 1,794.98 1,795.99 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% LAccVVGVcGPGLWER 95.00% 4.92 0.433 4.42 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 917.4315 1,832.85 1,832.86 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% LAccVVGVcGPGLWER 95.00% 4.92 0.457 3.96 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 917.4342 1,832.85 1,832.86 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGRGGNQASVENGNAGRR 95.00% 4.84 0.533 1.92 936.1302 2,805.37 2,805.37 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% AVVVHAGEDDLGRGGNQASVENGNAGRR 95.00% 4.45 0.477 1.82 936.1306 2,805.37 2,805.37 3
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% RLAccVVGVcGPGLWER 95.00% 5.11 0.63 7.11 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 994.9889 1,987.96 1,988.96 2
 SAMPLE 3R Extracellular superoxide dismutase [Cu-Zn]  SOD3  SODE_HUMAN 25,832.30 100.00% 10 14 41 40.80% RLAccVVGVcGPGLWER 95.00% 5.42 0.601 5.72 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 995.4846 1,988.95 1,988.96 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% RLPPQQIEK 95.00% 2.12 0.21 1.51 554.8297 1,107.64 1,108.65 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% STLNEIYFGK 95.00% 2.54 0.451 1.15 586.2978 1,170.58 1,171.60 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% STLNEIYFGK 95.00% 2.15 0.342 0 586.6077 1,171.20 1,171.60 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% STLNEIYFGK 95.00% 2.7 0.474 2.06 586.6084 1,171.20 1,171.60 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% STLNEIYFGK 95.00% 2.02 0.384 1.57 586.9433 1,171.87 1,171.60 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% DKVVGKDYLLcDYNR 95.00% 3.74 0.452 1.62 c11: Carbamidomethyl (+57.02) 619.9761 1,856.90 1,857.92 3 TITIN_HUMAN
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% LVEDMENKIR 95.00% 3.03 0.467 1.46 623.8246 1,245.63 1,246.65 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% LVEDMENKIR 95.00% 2.97 0.431 1.3 623.826 1,245.64 1,246.65 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% SGSGTMNLGGSLTR 95.00% 3.22 0.409 3.52 669.3238 1,336.63 1,337.65 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% SGSGTMNLGGSLTR 95.00% 2.61 0.389 3.82 669.3257 1,336.64 1,337.65 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% LEVEANNAFDQYR 95.00% 4.3 0.581 4.09 784.8713 1,567.73 1,568.73 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% LEVEANNAFDQYR 95.00% 4.28 0.572 4.16 784.8716 1,567.73 1,568.73 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% GcWDSIHVVEVQEK 95.00% 4.34 0.411 3.89 c2: Carbamidomethyl (+57.02) 843.3991 1,684.78 1,685.80 2
 SAMPLE 2 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 13 30.70% GcWDSIHVVEVQEK 95.00% 4.48 0.423 1.62 c2: Carbamidomethyl (+57.02) 843.9011 1,685.79 1,685.80 2
 SAMPLE 2R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 7 7 11 32.50% LTSTVMLWLQTNK 95.00% 2.73 0.271 0 512.2829 1,533.83 1,534.83 3
 SAMPLE 2R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 7 7 11 32.50% STLNEIYFGK 95.00% 2.7 0.38 1.22 586.2994 1,170.58 1,171.60 2
 SAMPLE 2R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 7 7 11 32.50% STLNEIYFGK 95.00% 2.44 0.32 1.54 586.3014 1,170.59 1,171.60 2
 SAMPLE 2R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 7 7 11 32.50% STLNEIYFGK 95.00% 2.42 0.394 2.04 586.9429 1,171.87 1,171.60 2
 SAMPLE 2R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 7 7 11 32.50% DKVVGKDYLLcDYNR 95.00% 3.6 0.376 0 c11: Carbamidomethyl (+57.02) 619.9776 1,856.91 1,857.92 3 TITIN_HUMAN
 SAMPLE 2R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 7 7 11 32.50% LVEDMENKIR 95.00% 3.01 0.449 1.82 623.8266 1,245.64 1,246.65 2
 SAMPLE 2R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 7 7 11 32.50% LVEDMENKIR 95.00% 3.1 0.511 1.14 623.8272 1,245.64 1,246.65 2
 SAMPLE 2R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 7 7 11 32.50% SGSGTMNLGGSLTR 95.00% 2.83 0.282 2.62 669.3252 1,336.63 1,337.65 2
 SAMPLE 2R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 7 7 11 32.50% LEVEANNAFDQYR 95.00% 4.09 0.573 4.03 784.8698 1,567.72 1,568.73 2
 SAMPLE 2R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 7 7 11 32.50% LEVEANNAFDQYR 95.00% 3.85 0.582 4.25 784.8717 1,567.73 1,568.73 2
 SAMPLE 2R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 7 7 11 32.50% GcWDSIHVVEVQEK 95.00% 4.26 0.407 2.66 c2: Carbamidomethyl (+57.02) 843.4017 1,684.79 1,685.80 2
 SAMPLE 2R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 7 7 11 32.50% KLEVEANNAFDQYR 95.00% 4.52 0.534 5.52 848.9154 1,695.82 1,696.83 2
 SAMPLE 3 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 11 23.50% RLPPQQIEK 95.00% 2.17 0.237 2.15 554.8284 1,107.64 1,108.65 2
 SAMPLE 3 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 11 23.50% STLNEIYFGK 95.00% 3.08 0.514 1.74 586.3022 1,170.59 1,171.60 2
 SAMPLE 3 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 11 23.50% STLNEIYFGK 95.00% 3.16 0.477 2.42 586.3029 1,170.59 1,171.60 2
 SAMPLE 3 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 11 23.50% STLNEIYFGK 95.00% 2.3 0.425 1.74 586.6078 1,171.20 1,171.60 2
 SAMPLE 3 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 11 23.50% STLNEIYFGK 95.00% 2.42 0.429 1.66 586.6079 1,171.20 1,171.60 2
 SAMPLE 3 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 11 23.50% DYLLcDYNR 95.00% 2.24 0.239 1.57 c5: Carbamidomethyl (+57.02) 616.2732 1,230.53 1,231.54 2
 SAMPLE 3 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 11 23.50% LVEDMENKIR 95.00% 2.89 0.406 2.09 623.8243 1,245.63 1,246.65 2
 SAMPLE 3 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 11 23.50% LVEDMENKIR 95.00% 2.96 0.376 1.47 623.8257 1,245.64 1,246.65 2
 SAMPLE 3 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 11 23.50% SGSGTMNLGGSLTR 95.00% 3.69 0.447 4.17 669.3283 1,336.64 1,337.65 2
 SAMPLE 3 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 11 23.50% LEVEANNAFDQYR 95.00% 3.01 0.571 3.54 784.872 1,567.73 1,568.73 2
 SAMPLE 3 F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 6 6 11 23.50% LEVEANNAFDQYR 95.00% 3.51 0.533 3.59 785.3719 1,568.73 1,568.73 2
 SAMPLE 3R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 5 5 10 20.20% RLPPQQIEK 95.00% 2 0.28 0 554.8283 1,107.64 1,108.65 2
 SAMPLE 3R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 5 5 10 20.20% STLNEIYFGK 95.00% 2.65 0.485 1.37 586.3015 1,170.59 1,171.60 2
 SAMPLE 3R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 5 5 10 20.20% STLNEIYFGK 95.00% 2.55 0.398 1.4 586.3017 1,170.59 1,171.60 2
 SAMPLE 3R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 5 5 10 20.20% STLNEIYFGK 95.00% 2.95 0.459 2.09 586.3017 1,170.59 1,171.60 2
 SAMPLE 3R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 5 5 10 20.20% STLNEIYFGK 95.00% 2.82 0.521 2.09 586.3018 1,170.59 1,171.60 2
 SAMPLE 3R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 5 5 10 20.20% LVEDMENKIR 95.00% 2.9 0.427 1.8 623.8268 1,245.64 1,246.65 2
 SAMPLE 3R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 5 5 10 20.20% LVEDMENKIR 95.00% 3.03 0.452 1.55 623.8275 1,245.64 1,246.65 2
 SAMPLE 3R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 5 5 10 20.20% SGSGTMNLGGSLTR 95.00% 2.45 0.329 3.68 669.3272 1,336.64 1,337.65 2
 SAMPLE 3R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 5 5 10 20.20% SGSGTMNLGGSLTR 95.00% 3.61 0.463 3.8 669.3273 1,336.64 1,337.65 2
 SAMPLE 3R F-actin-capping protein subunit beta  CAPZB  CAPZB_HUMAN 31,333.60 100.00% 5 5 10 20.20% LTSTVMLWLQTNK 95.00% 3.12 0.385 1.13 767.9167 1,533.82 1,534.83 2
 SAMPLE 1 Far upstream element-binding protein 2  KHSRP  FUBP2_HUMAN 73,128.60 99.80% 2 2 2 3.52% SGEMIKKIQNDAGVR 95.00% 3.09 0.138 0 549.5566 1,645.65 1,645.87 3
 SAMPLE 1 Far upstream element-binding protein 2  KHSRP  FUBP2_HUMAN 73,128.60 99.80% 2 2 2 3.52% IINDLLQSLR 95.00% 3.29 0.369 0 592.8517 1,183.69 1,184.70 2
 SAMPLE 2 Ferritin heavy chain  FTH1  FRIH_HUMAN 21,208.20 100.00% 3 3 4 13.70% AIKELGDHVTNLR 95.00% 3.13 0.508 0 489.2755 1,464.80 1,465.81 3
 SAMPLE 2 Ferritin heavy chain  FTH1  FRIH_HUMAN 21,208.20 100.00% 3 3 4 13.70% AIKELGDHVTNLR 95.00% 3.52 0.538 0 489.2756 1,464.80 1,465.81 3
 SAMPLE 2 Ferritin heavy chain  FTH1  FRIH_HUMAN 21,208.20 100.00% 3 3 4 13.70% AIKELGDHVTNLRK 95.00% 3.55 0.447 0 532.308 1,593.90 1,593.91 3
 SAMPLE 2 Ferritin heavy chain  FTH1  FRIH_HUMAN 21,208.20 100.00% 3 3 4 13.70% NVNQSLLELHK 95.00% 3.37 0.426 1.82 647.8576 1,293.70 1,294.71 2
 SAMPLE 2R Ferritin heavy chain  FTH1  FRIH_HUMAN 21,208.20 99.80% 2 2 3 7.65% AIKELGDHVTNLR 95.00% 3.41 0.479 0 489.276 1,464.80 1,465.81 3
 SAMPLE 2R Ferritin heavy chain  FTH1  FRIH_HUMAN 21,208.20 99.80% 2 2 3 7.65% AIKELGDHVTNLRK 95.00% 2.51 0.174 0 531.9741 1,592.90 1,593.91 3
 SAMPLE 2R Ferritin heavy chain  FTH1  FRIH_HUMAN 21,208.20 99.80% 2 2 3 7.65% AIKELGDHVTNLRK 95.00% 3.19 0.404 0 531.9749 1,592.90 1,593.91 3
 SAMPLE 3 Ferritin heavy chain  FTH1  FRIH_HUMAN 21,208.20 99.80% 2 2 3 13.70% AIKELGDHVTNLRK 95.00% 2.73 0.379 0 531.9731 1,592.90 1,593.91 3
 SAMPLE 3 Ferritin heavy chain  FTH1  FRIH_HUMAN 21,208.20 99.80% 2 2 3 13.70% NVNQSLLELHK 95.00% 2.65 0.339 1.59 647.857 1,293.70 1,294.71 2
 SAMPLE 3 Ferritin heavy chain  FTH1  FRIH_HUMAN 21,208.20 99.80% 2 2 3 13.70% NVNQSLLELHK 95.00% 2.74 0.42 2.17 647.8579 1,293.70 1,294.71 2
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% DDVALEGVSHFFR 95.00% 2.73 0.307 0 497.9208 1,490.74 1,491.72 3
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% DDVALEGVSHFFR 95.00% 3.5 0.367 1.4 497.922 1,490.74 1,491.72 3
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% LNQALLDLHALGSAR 95.00% 3.55 0.39 0 531.3105 1,590.91 1,591.89 3
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% KLNQALLDLHALGSAR 95.00% 4.11 0.449 0 574.0099 1,719.01 1,719.99 3
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% KLNQALLDLHALGSAR 95.00% 4.22 0.553 1.49 574.0102 1,719.01 1,719.99 3
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% DDVALEGVSHFFR 95.00% 3.45 0.493 3.24 746.3768 1,490.74 1,491.72 2
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% DDVALEGVSHFFR 95.00% 3.29 0.489 3.82 746.3785 1,490.74 1,491.72 2
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% LNQALLDLHALGSAR 95.00% 4.19 0.603 4.59 796.4641 1,590.91 1,591.89 2
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% LGGPEAGLGEYLFER 95.00% 3.96 0.566 2.89 804.4079 1,606.80 1,607.81 2
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% LGGPEAGLGEYLFER 95.00% 3.84 0.556 2.89 804.4093 1,606.80 1,607.81 2
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% LGGPEAGLGEYLFER 95.00% 5.17 0.595 3.8 804.421 1,606.83 1,607.81 2
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% LGGPEAGLGEYLFER 95.00% 4.61 0.595 5.82 804.4216 1,606.83 1,607.81 2
 SAMPLE 1R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 100.00% 3 4 9 25.10% LGGPEAGLGEYLFER 95.00% 4.49 0.555 4.89 804.9104 1,607.81 1,607.81 2
 SAMPLE 2 Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 2 17.10% LNQALLDLHALGSAR 95.00% 4.6 0.507 4.38 796.4507 1,590.89 1,591.89 2
 SAMPLE 2 Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 2 17.10% LGGPEAGLGEYLFER 95.00% 4.45 0.53 4.96 804.9108 1,607.81 1,607.81 2
 SAMPLE 2R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 4 24.60% LNQALLDLHALGSAR 95.00% 3.62 0.383 1.15 531.3015 1,590.88 1,591.89 3
 SAMPLE 2R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 4 24.60% LNQALLDLHALGSAR 95.00% 3.46 0.451 0 531.3017 1,590.88 1,591.89 3
 SAMPLE 2R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 4 24.60% DDVALEGVSHFFR 95.00% 3.16 0.409 5.66 746.3622 1,490.71 1,491.72 2
 SAMPLE 2R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 4 24.60% LGGPEAGLGEYLFER 95.00% 4.37 0.542 4.15 804.4062 1,606.80 1,607.81 2
 SAMPLE 2R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 4 24.60% LGGPEAGLGEYLFER 95.00% 4.06 0.563 3.96 804.4073 1,606.80 1,607.81 2
 SAMPLE 3 Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 4 17.70% KLNQALLDLHALGSAR 95.00% 3.61 0.494 4.03 573.9988 1,718.97 1,719.99 3
 SAMPLE 3 Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 4 17.70% KLNQALLDLHALGSAR 95.00% 3.81 0.514 1.68 574.3345 1,719.98 1,719.99 3
 SAMPLE 3 Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 4 17.70% LGGPEAGLGEYLFER 95.00% 4.39 0.553 3.92 804.4059 1,606.80 1,607.81 2
 SAMPLE 3 Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 4 17.70% LGGPEAGLGEYLFER 95.00% 4.36 0.586 4.92 804.4064 1,606.80 1,607.81 2
 SAMPLE 3R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 3 17.70% KLNQALLDLHALGSAR 95.00% 2.61 0.368 0 573.9998 1,718.98 1,719.99 3
 SAMPLE 3R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 3 17.70% LGGPEAGLGEYLFER 95.00% 4.5 0.52 3.96 804.4051 1,606.79 1,607.81 2
 SAMPLE 3R Ferritin light chain  FTL  FRIL_HUMAN 20,002.60 99.80% 2 2 3 17.70% LGGPEAGLGEYLFER 95.00% 4.36 0.555 5 804.4079 1,606.80 1,607.81 2
 SAMPLE 4 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 8 8 12 3.31% GYILQEDGR 95.00% 2.8 0.112 0 525.7664 1,049.52 1,050.52 2
 SAMPLE 4 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 8 8 12 3.31% YNAYccPGWK 95.00% 2.61 0.328 0 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 659.7725 1,317.53 1,318.53 2
 SAMPLE 4 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 8 8 12 3.31% YNAYccPGWK 95.00% 2.58 0.292 0 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 659.7756 1,317.54 1,318.53 2
 SAMPLE 4 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 8 8 12 3.31% McccSYNIGR 95.00% 2.41 0.559 1.32 c2: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 660.7555 1,319.50 1,320.50 2
 SAMPLE 4 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 8 8 12 3.31% cScSPGWIGDGIK 95.00% 2.68 0.364 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 718.8203 1,435.63 1,436.63 2
 SAMPLE 4 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 8 8 12 3.31% cScSPGWIGDGIK 95.00% 2.68 0.43 1.96 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 718.8224 1,435.63 1,436.63 2
 SAMPLE 4 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 8 8 12 3.31% cPTGYYLNEDTR 95.00% 3.35 0.476 2.02 c1: Carbamidomethyl (+57.02) 744.8276 1,487.64 1,488.64 2
 SAMPLE 4 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 8 8 12 3.31% cPTGYYLNEDTR 95.00% 3.27 0.426 2.51 c1: Carbamidomethyl (+57.02) 744.8288 1,487.64 1,488.64 2
 SAMPLE 4 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 8 8 12 3.31% cEcPVGFFYNDK 95.00% 2.55 0.267 2.19 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 768.3231 1,534.63 1,535.63 2 MY18B_HUMAN,PDC6I_HUMAN,ECHB_HUMAN,MUC16_HUMAN
 SAMPLE 4 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 8 8 12 3.31% cEcPVGFFYNDK 95.00% 2.43 0.239 1.72 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 768.8221 1,535.63 1,535.63 2 MY18B_HUMAN,PDC6I_HUMAN,ECHB_HUMAN,MUC16_HUMAN
 SAMPLE 4 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 8 8 12 3.31% TcVDINEcLLEPR 95.00% 2.14 0.268 0 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 809.8866 1,617.76 1,618.76 2
 SAMPLE 4 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 8 8 12 3.31% NLIGTYmcIcGPGYQR 95.00% 4.6 0.592 5.38 m7: Oxidation (+15.99), c8: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 960.4394 1,918.86 1,918.86 2
 SAMPLE 4R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 10 2.37% cPVGYVLR 95.00% 2.04 0.332 2.01 c1: Carbamidomethyl (+57.02) 482.2577 962.4997 963.5087 2
 SAMPLE 4R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 10 2.37% GYILQEDGR 95.00% 2.44 0.198 1.55 525.7653 1,049.51 1,050.52 2
 SAMPLE 4R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 10 2.37% GYILQEDGR 95.00% 2.64 0.138 1.54 525.7661 1,049.52 1,050.52 2
 SAMPLE 4R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 10 2.37% cScSPGWIGDGIK 95.00% 2.16 0.318 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 718.8198 1,435.62 1,436.63 2
 SAMPLE 4R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 10 2.37% cScSPGWIGDGIK 95.00% 2.62 0.431 2.35 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 718.8203 1,435.62 1,436.63 2
 SAMPLE 4R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 10 2.37% cPPGFYTSPDGTR 95.00% 2.95 0.387 0 c1: Carbamidomethyl (+57.02) 727.823 1,453.63 1,454.64 2
 SAMPLE 4R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 10 2.37% cPPGFYTSPDGTR 95.00% 2.25 0.315 0 c1: Carbamidomethyl (+57.02) 727.8236 1,453.63 1,454.64 2
 SAMPLE 4R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 10 2.37% cPTGYYLNEDTR 95.00% 3.19 0.463 2.48 c1: Carbamidomethyl (+57.02) 744.8282 1,487.64 1,488.64 2
 SAMPLE 4R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 10 2.37% cPTGYYLNEDTR 95.00% 3.28 0.565 3.46 c1: Carbamidomethyl (+57.02) 744.8304 1,487.65 1,488.64 2
 SAMPLE 4R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 10 2.37% TcVDINEcLLEPR 95.00% 2.33 0.359 2.05 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 809.8832 1,617.75 1,618.76 2
 SAMPLE 1 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 9 2.44% GYILQEDGR 95.00% 2.87 0.0937 1.46 525.7629 1,049.51 1,050.52 2
 SAMPLE 1 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 9 2.44% GYILQEDGR 95.00% 2.74 0.0989 1.52 525.7639 1,049.51 1,050.52 2
 SAMPLE 1 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 9 2.44% cSNQLPQSITK 95.00% 3.17 0.418 4.66 c1: Carbamidomethyl (+57.02) 638.3201 1,274.62 1,275.64 2
 SAMPLE 1 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 9 2.44% cSNQLPQSITK 95.00% 3.4 0.381 3.16 c1: Carbamidomethyl (+57.02) 638.3202 1,274.62 1,275.64 2
 SAMPLE 1 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 9 2.44% cEcEIGYELDR 95.00% 2.5 0.403 3.59 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 722.2979 1,442.58 1,443.59 2
 SAMPLE 1 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 9 2.44% cPPGFYTSPDGTR 95.00% 3.35 0.629 3.85 c1: Carbamidomethyl (+57.02) 727.8197 1,453.62 1,454.64 2
 SAMPLE 1 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 9 2.44% cPPGFYTSPDGTR 95.00% 3.39 0.625 4.77 c1: Carbamidomethyl (+57.02) 727.8211 1,453.63 1,454.64 2
 SAMPLE 1 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 9 2.44% YEDEEcTLPIAGR 95.00% 3.22 0.469 2.51 c6: Carbamidomethyl (+57.02) 776.8555 1,551.70 1,552.70 2
 SAMPLE 1 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 6 6 9 2.44% TcVDINEcLLEPR 95.00% 3.55 0.517 3.72 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 810.3811 1,618.75 1,618.76 2
 SAMPLE 1R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 1.99% GYILQEDGR 95.00% 2.6 0.0802 1.15 525.7633 1,049.51 1,050.52 2
 SAMPLE 1R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 1.99% cSNQLPQSITK 95.00% 2.85 0.377 2.85 c1: Carbamidomethyl (+57.02) 638.3205 1,274.63 1,275.64 2
 SAMPLE 1R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 1.99% cSNQLPQSITK 95.00% 3.36 0.378 2.89 c1: Carbamidomethyl (+57.02) 638.3218 1,274.63 1,275.64 2
 SAMPLE 1R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 1.99% GTcWQTVIDGR 95.00% 2.22 0.351 1.14 c3: Carbamidomethyl (+57.02) 646.8036 1,291.59 1,292.61 2
 SAMPLE 1R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 1.99% cPPGFYTSPDGTR 95.00% 3.57 0.547 3.82 c1: Carbamidomethyl (+57.02) 727.8204 1,453.63 1,454.64 2
 SAMPLE 1R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 1.99% cPPGFYTSPDGTR 95.00% 3.25 0.601 2.89 c1: Carbamidomethyl (+57.02) 728.3224 1,454.63 1,454.64 2
 SAMPLE 1R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 1.99% YEDEEcTLPIAGR 95.00% 3.22 0.469 2.77 c6: Carbamidomethyl (+57.02) 776.8555 1,551.70 1,552.70 2
 SAMPLE 2 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 3 3 5 1.04% GYILQEDGR 95.00% 2.51 0.0807 1.32 525.7645 1,049.51 1,050.52 2
 SAMPLE 2 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 3 3 5 1.04% cSNQLPQSITK 95.00% 2.88 0.333 4.15 c1: Carbamidomethyl (+57.02) 638.3211 1,274.63 1,275.64 2
 SAMPLE 2 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 3 3 5 1.04% cSNQLPQSITK 95.00% 2.35 0.326 2.02 c1: Carbamidomethyl (+57.02) 638.3226 1,274.63 1,275.64 2
 SAMPLE 2 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 3 3 5 1.04% McccSYNIGR 95.00% 2.14 0.345 0 c2: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 660.9784 1,319.94 1,320.50 2
 SAMPLE 2 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 3 3 5 1.04% McccSYNIGR 95.00% 2.08 0.43 0 c2: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 661.3109 1,320.61 1,320.50 2
 SAMPLE 2R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 99.80% 2 2 2 1.01% cIDVRPGYcYTALTNGR 95.00% 2.2 0.279 2.17 c1: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 672.9806 2,015.92 2,015.94 3
 SAMPLE 2R Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 99.80% 2 2 2 1.01% cEcPVGFFYNDK 95.00% 3.1 0.361 5.34 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 768.3188 1,534.62 1,535.63 2 MY18B_HUMAN,PDC6I_HUMAN,ECHB_HUMAN,MUC16_HUMAN
 SAMPLE 3 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 2.09% SGNcYLDIRPR 95.00% 2.13 0.216 0 c4: Carbamidomethyl (+57.02) 450.8909 1,349.65 1,350.66 3
 SAMPLE 3 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 2.09% SGNcYLDIRPR 94.50% 1.87 0.232 0 c4: Carbamidomethyl (+57.02) 450.8922 1,349.65 1,350.66 3
 SAMPLE 3 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 2.09% GYILQEDGR 95.00% 2.82 0.118 1.28 525.764 1,049.51 1,050.52 2
 SAMPLE 3 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 2.09% cScSPGWIGDGIK 95.00% 0 0 3.18 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 720.0385 1,438.06 1,436.63 2
 SAMPLE 3 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 2.09% cPPGFYTSPDGTR 95.00% 3.01 0.562 2.38 c1: Carbamidomethyl (+57.02) 727.8203 1,453.63 1,454.64 2
 SAMPLE 3 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 2.09% cPPGFYTSPDGTR 95.00% 3.26 0.603 2.4 c1: Carbamidomethyl (+57.02) 728.323 1,454.63 1,454.64 2
 SAMPLE 3 Fibrillin-1  FBN1  FBN1_HUMAN 312,283.00 100.00% 5 5 7 2.09% cLcPEGFSLSSSGR 95.00% 3.07 0.509 4.03 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02) 778.8446 1,555.67 1,556.68 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% MKPVPDLVPGNFK 95.00% 2.14 0.205 1.15 481.2673 1,440.78 1,441.79 3 CO4A1_HUMAN
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% mELERPGGNEITR 95.00% 2.81 0.176 1.21 m1: Oxidation (+15.99) 506.5855 1,516.73 1,517.74 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% mELERPGGNEITR 95.00% 2.33 0.175 0 m1: Oxidation (+15.99) 506.5868 1,516.74 1,517.74 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% mELERPGGNEITR 95.00% 2.53 0.129 2.34 m1: Oxidation (+15.99) 506.5877 1,516.74 1,517.74 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% NSLFEYQK 95.00% 2.48 0.223 0 514.7576 1,027.50 1,028.51 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% ESSSHHPGIAEFPSR 95.00% 2.79 0.316 0 546.5942 1,636.76 1,637.77 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% RLEVDIDIK 95.00% 2.48 0.237 0 550.8208 1,099.63 1,100.63 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% VQHIQLLQK 95.00% 2.06 0.312 0 553.8387 1,105.66 1,106.67 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% VQHIQLLQK 95.00% 2.61 0.246 0 553.8393 1,105.66 1,106.67 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% VQHIQLLQK 95.00% 2.94 0.343 1.2 553.8394 1,105.66 1,106.67 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% VQHIQLLQK 95.00% 2.7 0.303 1.54 553.8394 1,105.66 1,106.67 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% VQHIQLLQK 95.00% 2.61 0.267 1.48 553.8394 1,105.66 1,106.67 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% MKGLIDEVNQDFTNR 95.00% 3.5 0.401 0 593.9622 1,778.86 1,779.87 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% MKGLIDEVNQDFTNR 95.00% 3.49 0.358 0 594.3002 1,779.88 1,779.87 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNRINK 95.00% 3.29 0.457 1.31 626.3267 1,875.96 1,875.96 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNRINK 95.00% 3.01 0.505 0 626.3271 1,875.96 1,875.96 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNRINK 95.00% 2.34 0.369 1.02 626.3272 1,875.96 1,875.96 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNRINK 95.00% 2.52 0.378 0 626.3273 1,875.96 1,875.96 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% LKNSLFEYQK 95.00% 3.11 0.21 1.7 635.3476 1,268.68 1,269.68 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% LKNSLFEYQK 95.00% 3.38 0.295 0 635.3479 1,268.68 1,269.68 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% LKNSLFEYQK 95.00% 3.1 0.336 1.59 635.3482 1,268.68 1,269.68 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% LKNSLFEYQK 95.00% 3.45 0.368 0 635.3484 1,268.68 1,269.68 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% NNKDSHSLTTNIMEILR 95.00% 3.22 0.462 0 663.0105 1,986.01 1,986.01 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% MKPVPDLVPGNFK 95.00% 2.25 0.459 0 721.3993 1,440.78 1,441.79 2 CO4A1_HUMAN
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% MKPVPDLVPGNFK 95.00% 2.6 0.202 0 721.4025 1,440.79 1,441.79 2 CO4A1_HUMAN
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% MELERPGGNEITR 95.00% 2.83 0.252 0 751.8825 1,501.75 1,501.74 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% EVDLKDYEDQQK 95.00% 4.11 0.359 3.13 755.3576 1,508.70 1,509.71 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% EVDLKDYEDQQK 95.00% 4.08 0.354 2.57 755.3594 1,508.70 1,509.71 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% EVDLKDYEDQQK 95.00% 3.81 0.319 2.68 755.3599 1,508.70 1,509.71 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% EVDLKDYEDQQK 95.00% 4.15 0.311 2.96 755.3602 1,508.70 1,509.71 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% EVDLKDYEDQQK 95.00% 3.98 0.321 3.72 755.3604 1,508.71 1,509.71 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% EVDLKDYEDQQK 95.00% 4.04 0.318 2.68 755.361 1,508.71 1,509.71 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% EVDLKDYEDQQK 95.00% 3.86 0.35 3.8 755.3634 1,508.71 1,509.71 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% EVDLKDYEDQQK 95.00% 3.99 0.323 1.8 755.8617 1,509.71 1,509.71 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNR 95.00% 4.26 0.521 2.52 760.8704 1,519.73 1,520.73 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNR 95.00% 3.85 0.546 3.28 760.8705 1,519.73 1,520.73 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNR 95.00% 4.32 0.542 2.48 760.8713 1,519.73 1,520.73 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNR 95.00% 4.55 0.503 2.15 760.8713 1,519.73 1,520.73 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNR 95.00% 4.15 0.54 2.8 760.8718 1,519.73 1,520.73 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNR 95.00% 4.07 0.544 2.49 760.872 1,519.73 1,520.73 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNR 95.00% 4.69 0.531 2.8 760.872 1,519.73 1,520.73 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNR 95.00% 4.64 0.54 2.77 760.8726 1,519.73 1,520.73 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNR 95.00% 4.44 0.542 1.92 760.8728 1,519.73 1,520.73 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNR 95.00% 4.32 0.556 4.96 760.873 1,519.73 1,520.73 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNR 95.00% 4.13 0.568 2.2 760.8733 1,519.73 1,520.73 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNR 95.00% 4.45 0.536 2.77 760.8736 1,519.73 1,520.73 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% EVDLKDYEDQQKQLEQVIAK 95.00% 4.61 0.483 1.24 807.4205 2,419.24 2,419.24 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% EVDLKDYEDQQKQLEQVIAK 95.00% 5.38 0.464 1.72 807.4217 2,419.24 2,419.24 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% EVDLKDYEDQQKQLEQVIAK 95.00% 3.8 0.492 1.31 807.423 2,419.25 2,419.24 3
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% DSHSLTTNIMEILR 95.00% 4.58 0.512 6.08 815.4173 1,628.82 1,629.83 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% DSHSLTTNIMEILR 95.00% 4.02 0.477 4.85 815.42 1,628.82 1,629.83 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% DSHSLTTNIMEILR 95.00% 4.13 0.428 5.41 815.4205 1,628.83 1,629.83 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% DSHSLTTNIMEILR 95.00% 4.2 0.416 4.6 815.9219 1,629.83 1,629.83 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNRINK 95.00% 4.51 0.469 3.51 938.485 1,874.95 1,875.96 2
 SAMPLE 4 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 13 15 51 14.30% GLIDEVNQDFTNRINK 95.00% 4.71 0.5 2.52 938.9867 1,875.96 1,875.96 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% mELERPGGNEITR 95.00% 2.52 0.236 1.72 m1: Oxidation (+15.99) 506.5863 1,516.74 1,517.74 3
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% mELERPGGNEITR 95.00% 2.08 0.198 0 m1: Oxidation (+15.99) 506.5877 1,516.74 1,517.74 3
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% DSHSLTTNIMEILR 95.00% 3.04 0.18 0 543.9487 1,628.82 1,629.83 3
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% DSHSLTTNImEILR 95.00% 3.59 0.337 1.52 m10: Oxidation (+15.99) 549.6151 1,645.82 1,645.82 3
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% VQHIQLLQK 95.00% 1.81 0.335 0 553.8381 1,105.66 1,106.67 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% VQHIQLLQK 95.00% 2.36 0.262 0 553.8382 1,105.66 1,106.67 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% VQHIQLLQK 95.00% 1.89 0.35 0 553.8389 1,105.66 1,106.67 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% VQHIQLLQK 95.00% 2.59 0.325 0 553.8393 1,105.66 1,106.67 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% VQHIQLLQK 95.00% 2.41 0.268 1.68 553.8394 1,105.66 1,106.67 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% VQHIQLLQK 95.00% 2.52 0.255 0 553.8396 1,105.66 1,106.67 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% VQHIQLLQK 95.00% 1.86 0.282 0 553.8399 1,105.66 1,106.67 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% VQHIQLLQK 95.00% 1.93 0.295 0 553.8406 1,105.67 1,106.67 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNRINK 95.00% 2.74 0.411 0 625.9939 1,874.96 1,875.96 3
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNRINK 95.00% 2.6 0.319 0 626.3264 1,875.96 1,875.96 3
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% LKNSLFEYQK 95.00% 3.21 0.238 1.24 635.3474 1,268.68 1,269.68 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% LKNSLFEYQK 95.00% 2.65 0.288 0 635.3479 1,268.68 1,269.68 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% LKNSLFEYQK 95.00% 3.41 0.386 2.26 635.3489 1,268.68 1,269.68 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% MKPVPDLVPGNFK 95.00% 2.27 0.28 1.42 721.4005 1,440.79 1,441.79 2 CO4A1_HUMAN
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% EVDLKDYEDQQK 95.00% 3.86 0.305 3.7 755.3586 1,508.70 1,509.71 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% EVDLKDYEDQQK 95.00% 4.04 0.358 3.43 755.3601 1,508.70 1,509.71 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% EVDLKDYEDQQK 95.00% 3.75 0.3 2.59 755.3604 1,508.71 1,509.71 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% EVDLKDYEDQQK 95.00% 3.85 0.329 3.24 755.3604 1,508.71 1,509.71 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% EVDLKDYEDQQK 95.00% 3.92 0.37 3.25 755.3609 1,508.71 1,509.71 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% EVDLKDYEDQQK 95.00% 4.02 0.322 2.8 755.3616 1,508.71 1,509.71 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% EVDLKDYEDQQK 95.00% 3.93 0.298 3.12 755.8595 1,509.70 1,509.71 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% EVDLKDYEDQQK 95.00% 4 0.288 3.37 755.8617 1,509.71 1,509.71 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNR 95.00% 4.11 0.555 2.57 760.8703 1,519.73 1,520.73 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNR 95.00% 4.32 0.547 3.42 760.8706 1,519.73 1,520.73 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNR 95.00% 4.29 0.524 2.09 760.8715 1,519.73 1,520.73 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNR 95.00% 3.99 0.54 2.03 760.8717 1,519.73 1,520.73 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNR 95.00% 3.75 0.595 1.62 760.8724 1,519.73 1,520.73 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNR 95.00% 4.51 0.572 2.62 760.8724 1,519.73 1,520.73 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNR 95.00% 4.31 0.527 2.31 760.8725 1,519.73 1,520.73 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNR 95.00% 4.28 0.568 2.43 760.8728 1,519.73 1,520.73 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNR 95.00% 4.25 0.544 2.12 760.8729 1,519.73 1,520.73 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNR 95.00% 4.48 0.547 1.59 760.8731 1,519.73 1,520.73 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNR 95.00% 4.65 0.546 2.39 760.8736 1,519.73 1,520.73 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNR 95.00% 4.1 0.517 2.92 761.3763 1,520.74 1,520.73 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% EVDLKDYEDQQKQLEQVIAK 95.00% 4.67 0.493 1.54 807.4217 2,419.24 2,419.24 3
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% EVDLKDYEDQQKQLEQVIAK 95.00% 5.07 0.474 2.3 807.422 2,419.24 2,419.24 3
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% EVDLKDYEDQQKQLEQVIAK 95.00% 4.7 0.481 1.37 807.4236 2,419.25 2,419.24 3
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% DSHSLTTNIMEILR 95.00% 3.92 0.428 4.96 815.4174 1,628.82 1,629.83 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% DSHSLTTNIMEILR 95.00% 3.75 0.445 5.15 815.4181 1,628.82 1,629.83 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% DSHSLTTNIMEILR 95.00% 4 0.464 5.54 815.4191 1,628.82 1,629.83 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% DSHSLTTNIMEILR 95.00% 4.22 0.468 5.6 815.4196 1,628.82 1,629.83 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% DSHSLTTNIMEILR 95.00% 3.75 0.429 6.2 815.4221 1,628.83 1,629.83 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% DSHSLTTNIMEILR 95.00% 4.38 0.434 5.15 815.4237 1,628.83 1,629.83 2
 SAMPLE 4R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 8 10 46 11.00% GLIDEVNQDFTNRINK 95.00% 4.39 0.489 3.38 938.485 1,874.95 1,875.96 2
 SAMPLE 2 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 11 3.93% VQHIQLLQK 95.00% 2.05 0.306 0 553.8357 1,105.66 1,106.67 2
 SAMPLE 2 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 11 3.93% VQHIQLLQK 95.00% 2.27 0.227 0 553.8359 1,105.66 1,106.67 2
 SAMPLE 2 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 11 3.93% VQHIQLLQK 95.00% 2.25 0.311 0 553.8372 1,105.66 1,106.67 2
 SAMPLE 2 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 11 3.93% VQHIQLLQK 95.00% 2.39 0.258 0 554.3347 1,106.65 1,106.67 2
 SAMPLE 2 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 11 3.93% EVDLKDYEDQQK 95.00% 3.73 0.33 3.08 755.359 1,508.70 1,509.71 2
 SAMPLE 2 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 11 3.93% GLIDEVNQDFTNR 95.00% 4.24 0.549 3.44 760.8675 1,519.72 1,520.73 2
 SAMPLE 2 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 11 3.93% GLIDEVNQDFTNR 95.00% 4.24 0.554 4.27 760.8695 1,519.72 1,520.73 2
 SAMPLE 2 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 11 3.93% GLIDEVNQDFTNR 95.00% 3.88 0.487 3.48 760.8698 1,519.72 1,520.73 2
 SAMPLE 2 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 11 3.93% GLIDEVNQDFTNR 95.00% 3.59 0.51 4.43 760.8698 1,519.72 1,520.73 2
 SAMPLE 2 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 11 3.93% GLIDEVNQDFTNR 95.00% 4.19 0.528 3.17 760.871 1,519.73 1,520.73 2
 SAMPLE 2 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 11 3.93% GLIDEVNQDFTNR 95.00% 3.97 0.521 4.38 760.8719 1,519.73 1,520.73 2
 SAMPLE 2R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 99.80% 2 2 8 2.54% VQHIQLLQK 95.00% 2.35 0.312 0 553.8362 1,105.66 1,106.67 2
 SAMPLE 2R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 99.80% 2 2 8 2.54% VQHIQLLQK 95.00% 2.24 0.334 0 553.8371 1,105.66 1,106.67 2
 SAMPLE 2R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 99.80% 2 2 8 2.54% GLIDEVNQDFTNR 95.00% 4.28 0.504 3.55 760.8693 1,519.72 1,520.73 2
 SAMPLE 2R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 99.80% 2 2 8 2.54% GLIDEVNQDFTNR 95.00% 4.07 0.513 4.28 760.8693 1,519.72 1,520.73 2
 SAMPLE 2R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 99.80% 2 2 8 2.54% GLIDEVNQDFTNR 95.00% 4.05 0.56 2.96 760.8697 1,519.72 1,520.73 2
 SAMPLE 2R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 99.80% 2 2 8 2.54% GLIDEVNQDFTNR 95.00% 4.3 0.555 2.96 760.8698 1,519.72 1,520.73 2
 SAMPLE 2R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 99.80% 2 2 8 2.54% GLIDEVNQDFTNR 95.00% 4.01 0.615 5.3 760.8705 1,519.73 1,520.73 2
 SAMPLE 2R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 99.80% 2 2 8 2.54% GLIDEVNQDFTNR 95.00% 3.7 0.528 4.12 760.8716 1,519.73 1,520.73 2
 SAMPLE 3 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 6 5.66% ESSSHHPGIAEFPSR 95.00% 2.83 0.269 0 546.5929 1,636.76 1,637.77 3
 SAMPLE 3 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 6 5.66% ESSSHHPGIAEFPSR 95.00% 3.16 0.378 0 546.5944 1,636.76 1,637.77 3
 SAMPLE 3 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 6 5.66% GLIDEVNQDFTNR 95.00% 3.8 0.481 3 760.8682 1,519.72 1,520.73 2
 SAMPLE 3 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 6 5.66% GLIDEVNQDFTNR 95.00% 4.06 0.562 2.41 760.8723 1,519.73 1,520.73 2
 SAMPLE 3 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 6 5.66% NPSSAGSWNSGSSGPGSTGNR 95.00% 1.91 0.442 0 981.9054 1,961.80 1,963.85 2
 SAMPLE 3 Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 100.00% 3 3 6 5.66% NPSSAGSWNSGSSGPGSTGNR 95.00% 5.58 0.658 6.66 982.9264 1,963.84 1,963.85 2
 SAMPLE 3R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 99.80% 2 2 3 3.12% DSHSLTTNIMEILR 95.00% 2.73 0.244 0 544.2807 1,629.82 1,629.83 3
 SAMPLE 3R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 99.80% 2 2 3 3.12% GLIDEVNQDFTNR 95.00% 4.11 0.563 2.46 760.8717 1,519.73 1,520.73 2
 SAMPLE 3R Fibrinogen alpha chain  FGA  FIBA_HUMAN 94,955.40 99.80% 2 2 3 3.12% GLIDEVNQDFTNR 95.00% 3.28 0.511 1.85 761.3707 1,520.73 1,520.73 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% AHYGGFTVQNEANK 95.00% 2.35 0.203 0 512.58 1,534.72 1,535.72 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% AHYGGFTVQNEANK 95.00% 3.22 0.309 0 512.5809 1,534.72 1,535.72 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% VKAHYGGFTVQNEANK 95.00% 3.36 0.167 0 588.3026 1,761.88 1,762.89 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% VKAHYGGFTVQNEANK 95.00% 4.06 0.373 0 588.3027 1,761.88 1,762.89 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% EDGGGWWYNR 95.00% 2.87 0.393 0 620.2638 1,238.51 1,239.52 2 MYO1C_HUMAN,K1C10_HUMAN,CFAH_HUMAN
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% EDGGGWWYNR 95.00% 2.87 0.368 0 620.2648 1,238.51 1,239.52 2 MYO1C_HUMAN,K1C10_HUMAN,CFAH_HUMAN
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% EDGGGWWYNR 95.00% 2.94 0.408 0 620.265 1,238.51 1,239.52 2 MYO1C_HUMAN,K1C10_HUMAN,CFAH_HUMAN
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% EDGGGWWYNR 95.00% 3.04 0.406 0 620.2655 1,238.52 1,239.52 2 MYO1C_HUMAN,K1C10_HUMAN,CFAH_HUMAN
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% DNDGWLTSDPR 95.00% 1.8 0.201 3.36 638.2847 1,274.55 1,275.56 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% DNDGWLTSDPR 95.00% 2.59 0.358 0 638.286 1,274.56 1,275.56 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% DNDGWLTSDPR 95.00% 2.43 0.419 2.8 638.2873 1,274.56 1,275.56 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% DNDGWLTSDPR 95.00% 1.8 0.305 0 638.2885 1,274.56 1,275.56 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% EEAPSLRPAPPPISGGGYR 95.00% 2.62 0.287 0 651.3416 1,951.00 1,951.00 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% EEAPSLRPAPPPISGGGYR 95.00% 3.59 0.531 1.89 651.3422 1,951.00 1,951.00 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% EEAPSLRPAPPPISGGGYR 95.00% 4 0.58 1.8 651.3423 1,951.00 1,951.00 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% IQKLESDVSAQmEYcR 95.00% 4.01 0.452 2.89 m12: Oxidation (+15.99), c15: Carbamidomethyl (+57.02) 658.6444 1,972.91 1,972.91 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% IQKLESDVSAQmEYcR 95.00% 4.11 0.521 2.48 m12: Oxidation (+15.99), c15: Carbamidomethyl (+57.02) 658.6447 1,972.91 1,972.91 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% KWDPYKQGFGNVATNTDGK 95.00% 3.86 0.456 0 709.351 2,125.03 2,126.03 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% KWDPYKQGFGNVATNTDGK 95.00% 3.3 0.394 2.8 709.6833 2,126.03 2,126.03 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% KWDPYKQGFGNVATNTDGK 95.00% 2.84 0.258 1.72 709.6842 2,126.03 2,126.03 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% KWDPYKQGFGNVATNTDGK 95.00% 2.88 0.361 1.44 709.6848 2,126.03 2,126.03 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% KWDPYKQGFGNVATNTDGK 95.00% 2.84 0.243 2.16 709.6849 2,126.03 2,126.03 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% KWDPYKQGFGNVATNTDGK 95.00% 3.75 0.422 0 709.6857 2,126.03 2,126.03 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% HQLYIDETVNSNIPTNLR 95.00% 4.21 0.342 1.04 709.701 2,126.08 2,127.08 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% HQLYIDETVNSNIPTNLR 95.00% 4.92 0.356 1.29 710.0352 2,127.08 2,127.08 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% HQLYIDETVNSNIPTNLR 95.00% 2.58 0.323 0 710.0359 2,127.08 2,127.08 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% HQLYIDETVNSNIPTNLR 95.00% 3.24 0.263 0 710.0375 2,127.09 2,127.08 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% AHYGGFTVQNEANK 95.00% 4.48 0.488 7.19 768.3676 1,534.72 1,535.72 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% AHYGGFTVQNEANK 95.00% 4.54 0.51 4.47 768.3682 1,534.72 1,535.72 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% AHYGGFTVQNEANK 95.00% 4.61 0.498 4.2 768.3682 1,534.72 1,535.72 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% AHYGGFTVQNEANK 95.00% 4.33 0.493 6.21 768.3689 1,534.72 1,535.72 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% AHYGGFTVQNEANK 95.00% 3.99 0.503 5.32 768.369 1,534.72 1,535.72 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% AHYGGFTVQNEANK 95.00% 4.09 0.496 2.89 768.3705 1,534.73 1,535.72 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% AHYGGFTVQNEANK 95.00% 4.14 0.513 5.17 768.8703 1,535.72 1,535.72 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% LESDVSAQMEYcR 95.00% 2.31 0.232 1.96 c12: Carbamidomethyl (+57.02) 794.3454 1,586.68 1,587.68 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% LESDVSAQMEYcR 95.00% 2.95 0.278 2.85 c12: Carbamidomethyl (+57.02) 794.3462 1,586.68 1,587.68 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% LESDVSAQMEYcR 95.00% 3.91 0.308 3.24 c12: Carbamidomethyl (+57.02) 794.8446 1,587.67 1,587.68 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% LESDVSAQmEYcR 95.00% 4.01 0.5 5.15 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3424 1,602.67 1,603.67 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% LESDVSAQmEYcR 95.00% 4.11 0.485 6.38 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3424 1,602.67 1,603.67 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% LESDVSAQmEYcR 95.00% 4.47 0.557 3.17 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3428 1,602.67 1,603.67 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% LESDVSAQmEYcR 95.00% 4.41 0.526 3.48 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3431 1,602.67 1,603.67 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% LESDVSAQmEYcR 95.00% 4.08 0.471 4.77 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3436 1,602.67 1,603.67 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% LESDVSAQmEYcR 95.00% 4.08 0.543 5.72 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3438 1,602.67 1,603.67 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% LESDVSAQmEYcR 95.00% 4.06 0.457 4.48 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3442 1,602.67 1,603.67 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGK 95.00% 3.99 0.528 5.12 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9026 1,617.79 1,618.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGK 95.00% 4.11 0.509 5.25 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.903 1,617.79 1,618.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGK 95.00% 3.93 0.561 4.85 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9038 1,617.79 1,618.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGK 95.00% 3.91 0.509 5.43 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.904 1,617.79 1,618.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGK 95.00% 3.95 0.512 5.02 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9043 1,617.79 1,618.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGK 95.00% 4.24 0.489 5.31 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9043 1,617.79 1,618.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGK 95.00% 4.19 0.561 5.21 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9046 1,617.79 1,618.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGK 95.00% 4.11 0.518 5.02 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9052 1,617.79 1,618.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGK 95.00% 4.14 0.539 5.14 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9052 1,617.79 1,618.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGK 95.00% 3.81 0.534 3.52 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 810.4065 1,618.80 1,618.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGKEcEEIIR 95.00% 4.73 0.591 3.38 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 850.4143 2,548.22 2,548.22 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGKEcEEIIR 95.00% 4.46 0.605 3.35 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 850.4152 2,548.22 2,548.22 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGKEcEEIIR 95.00% 4.73 0.563 4.21 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 850.4153 2,548.22 2,548.22 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% TPcTVScNIPVVSGKEcEEIIR 95.00% 4.5 0.577 3.08 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 850.4172 2,548.23 2,548.22 3
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% DNENVVNEYSSELEK 95.00% 4.27 0.465 5.37 884.8989 1,767.78 1,768.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% DNENVVNEYSSELEK 95.00% 5.22 0.517 5.6 884.8996 1,767.78 1,768.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% DNENVVNEYSSELEK 95.00% 5.53 0.52 5.72 884.9 1,767.78 1,768.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% DNENVVNEYSSELEK 95.00% 5.42 0.509 6.12 884.9002 1,767.78 1,768.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% DNENVVNEYSSELEK 95.00% 4.01 0.486 4.59 884.9009 1,767.79 1,768.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% DNENVVNEYSSELEK 95.00% 5.65 0.518 5.6 885.402 1,768.79 1,768.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% DNENVVNEYSSELEK 95.00% 5.01 0.469 5.46 885.4032 1,768.79 1,768.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% NYcGLPGEYWLGNDK 95.00% 3.32 0.566 2.85 c3: Carbamidomethyl (+57.02) 893.3999 1,784.78 1,785.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% NYcGLPGEYWLGNDK 95.00% 3.22 0.519 4.7 c3: Carbamidomethyl (+57.02) 893.4034 1,784.79 1,785.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% NYcGLPGEYWLGNDK 95.00% 3.91 0.607 5.03 c3: Carbamidomethyl (+57.02) 893.4055 1,784.80 1,785.79 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% EEAPSLRPAPPPISGGGYR 95.00% 2.97 0.385 0 976.0166 1,950.02 1,951.00 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% EEAPSLRPAPPPISGGGYR 95.00% 3.2 0.416 0 976.5082 1,951.00 1,951.00 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% EEAPSLRPAPPPISGGGYR 95.00% 3.53 0.467 2.24 976.5113 1,951.01 1,951.00 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% HQLYIDETVNSNIPTNLR 95.00% 5.32 0.59 7.09 1,064.55 2,127.08 2,127.08 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% VYcDMNTENGGWTVIQNR 95.00% 5.25 0.545 6.68 c3: Carbamidomethyl (+57.02) 1,078.98 2,155.95 2,156.95 2
 SAMPLE 4 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 15 68 36.50% VYcDMNTENGGWTVIQNR 95.00% 5.06 0.599 6.2 c3: Carbamidomethyl (+57.02) 1,079.48 2,156.94 2,156.95 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% AHYGGFTVQNEANK 95.00% 3.23 0.313 0 512.5812 1,534.72 1,535.72 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% QcSKEDGGGWWYNR 95.00% 2.31 0.216 0 c2: Carbamidomethyl (+57.02) 581.5837 1,741.73 1,742.73 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% QcSKEDGGGWWYNR 95.00% 2.41 0.336 0 c2: Carbamidomethyl (+57.02) 581.5848 1,741.73 1,742.73 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% VKAHYGGFTVQNEANK 95.00% 3.29 0.346 0 588.3035 1,761.89 1,762.89 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% EDGGGWWYNR 95.00% 2.49 0.392 0 620.2636 1,238.51 1,239.52 2 MYO1C_HUMAN,K1C10_HUMAN,CFAH_HUMAN
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% EDGGGWWYNR 95.00% 2.63 0.282 0 620.2652 1,238.51 1,239.52 2 MYO1C_HUMAN,K1C10_HUMAN,CFAH_HUMAN
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% EDGGGWWYNR 95.00% 2.55 0.349 0 620.2655 1,238.52 1,239.52 2 MYO1C_HUMAN,K1C10_HUMAN,CFAH_HUMAN
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% DNDGWLTSDPR 95.00% 3.73 0.474 2.15 638.2853 1,274.56 1,275.56 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% DNDGWLTSDPR 95.00% 3.38 0.45 1.64 638.2855 1,274.56 1,275.56 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% DNDGWLTSDPR 95.00% 2.53 0.454 2.36 638.2855 1,274.56 1,275.56 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% DNDGWLTSDPR 95.00% 3.9 0.511 2.85 638.2863 1,274.56 1,275.56 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% DNDGWLTSDPR 95.00% 3.45 0.51 3.13 638.2865 1,274.56 1,275.56 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% DNDGWLTSDPR 95.00% 2.21 0.33 0 638.2888 1,274.56 1,275.56 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% EEAPSLRPAPPPISGGGYR 95.00% 3.47 0.432 2.7 651.3411 1,951.00 1,951.00 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% EEAPSLRPAPPPISGGGYR 95.00% 2.88 0.451 1.74 651.3414 1,951.00 1,951.00 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% KWDPYKQGFGNVATNTDGK 95.00% 3.11 0.231 1.46 709.6857 2,126.03 2,126.03 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% KWDPYKQGFGNVATNTDGK 95.00% 3.47 0.326 1.6 709.6863 2,126.04 2,126.03 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% KWDPYKQGFGNVATNTDGK 95.00% 3.79 0.467 2.46 709.6864 2,126.04 2,126.03 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% HQLYIDETVNSNIPTNLR 95.00% 4.3 0.38 0 709.7022 2,126.08 2,127.08 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% HQLYIDETVNSNIPTNLR 95.00% 4.17 0.32 1 710.0349 2,127.08 2,127.08 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% AHYGGFTVQNEANK 95.00% 3.65 0.506 4.03 768.3672 1,534.72 1,535.72 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% AHYGGFTVQNEANK 95.00% 4.37 0.495 6.52 768.3675 1,534.72 1,535.72 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% AHYGGFTVQNEANK 95.00% 4.14 0.527 5.89 768.3677 1,534.72 1,535.72 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% AHYGGFTVQNEANK 95.00% 4.25 0.46 5.26 768.3681 1,534.72 1,535.72 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% AHYGGFTVQNEANK 95.00% 4.59 0.499 3.8 768.369 1,534.72 1,535.72 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% AHYGGFTVQNEANK 95.00% 3.45 0.539 3.62 768.3691 1,534.72 1,535.72 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% AHYGGFTVQNEANK 95.00% 4.48 0.507 7.1 768.3704 1,534.73 1,535.72 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% AHYGGFTVQNEANK 95.00% 4.42 0.514 5.03 768.3717 1,534.73 1,535.72 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% LESDVSAQMEYcR 95.00% 3.2 0.21 1.77 c12: Carbamidomethyl (+57.02) 794.3446 1,586.67 1,587.68 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% LESDVSAQMEYcR 95.00% 3.68 0.306 2.31 c12: Carbamidomethyl (+57.02) 794.349 1,586.68 1,587.68 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% LESDVSAQmEYcR 95.00% 4.32 0.516 5.4 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3419 1,602.67 1,603.67 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% LESDVSAQmEYcR 95.00% 4.49 0.539 5.48 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3424 1,602.67 1,603.67 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% LESDVSAQmEYcR 95.00% 4.03 0.473 3.28 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3424 1,602.67 1,603.67 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% LESDVSAQmEYcR 95.00% 4.06 0.495 4.3 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3427 1,602.67 1,603.67 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% LESDVSAQmEYcR 95.00% 3.94 0.567 4.51 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3431 1,602.67 1,603.67 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% LESDVSAQmEYcR 95.00% 4.01 0.539 6.17 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3434 1,602.67 1,603.67 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% LESDVSAQmEYcR 95.00% 3.85 0.504 3.12 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3435 1,602.67 1,603.67 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% LESDVSAQmEYcR 95.00% 4.05 0.482 6.05 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3451 1,602.67 1,603.67 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% LESDVSAQmEYcR 95.00% 3.8 0.478 3.51 m9: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 802.3465 1,602.68 1,603.67 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% TPcTVScNIPVVSGK 95.00% 3.97 0.524 4.92 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9009 1,617.79 1,618.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% TPcTVScNIPVVSGK 95.00% 3.58 0.485 6.41 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9024 1,617.79 1,618.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% TPcTVScNIPVVSGK 95.00% 4.3 0.598 5.96 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9028 1,617.79 1,618.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% TPcTVScNIPVVSGK 95.00% 3.94 0.491 5.51 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9037 1,617.79 1,618.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% TPcTVScNIPVVSGK 95.00% 4 0.529 5.52 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9042 1,617.79 1,618.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% TPcTVScNIPVVSGK 95.00% 4.05 0.532 5.96 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 809.9046 1,617.79 1,618.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% TPcTVScNIPVVSGK 95.00% 4 0.56 4.44 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 810.4049 1,618.79 1,618.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% TPcTVScNIPVVSGK 95.00% 4.13 0.466 4.15 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 810.406 1,618.80 1,618.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% TPcTVScNIPVVSGKEcEEIIR 95.00% 4.84 0.581 4.2 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 850.4145 2,548.22 2,548.22 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% TPcTVScNIPVVSGKEcEEIIR 95.00% 4.84 0.524 2.66 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 850.4147 2,548.22 2,548.22 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% TPcTVScNIPVVSGKEcEEIIR 95.00% 5.32 0.506 3.62 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 850.4156 2,548.22 2,548.22 3
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% DNENVVNEYSSELEK 95.00% 4.07 0.325 2.55 884.8982 1,767.78 1,768.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% DNENVVNEYSSELEK 95.00% 5.43 0.507 6.12 884.8988 1,767.78 1,768.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% DNENVVNEYSSELEK 95.00% 5.16 0.516 7.3 884.9006 1,767.79 1,768.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% DNENVVNEYSSELEK 95.00% 4.81 0.41 5.24 885.3997 1,768.78 1,768.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% DNENVVNEYSSELEK 95.00% 5.67 0.519 5.89 885.4005 1,768.79 1,768.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% DNENVVNEYSSELEK 95.00% 5.59 0.511 7.15 885.4024 1,768.79 1,768.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% NYcGLPGEYWLGNDK 95.00% 3.72 0.634 4.01 c3: Carbamidomethyl (+57.02) 893.4007 1,784.79 1,785.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% NYcGLPGEYWLGNDK 95.00% 3.99 0.637 3.85 c3: Carbamidomethyl (+57.02) 893.4017 1,784.79 1,785.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% NYcGLPGEYWLGNDK 95.00% 3.43 0.601 3.07 c3: Carbamidomethyl (+57.02) 893.4022 1,784.79 1,785.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% NYcGLPGEYWLGNDK 95.00% 3.14 0.546 1.96 c3: Carbamidomethyl (+57.02) 893.4026 1,784.79 1,785.79 2
 SAMPLE 4R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 12 14 58 33.00% HQLYIDETVNSNIPTNLR 95.00% 5.2 0.621 6.89 1,064.55 2,127.08 2,127.08 2
 SAMPLE 1 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 6 13.20% EDGGGWWYNR 95.00% 2.89 0.345 0 620.2619 1,238.51 1,239.52 2 MYO1C_HUMAN,K1C10_HUMAN,CFAH_HUMAN
 SAMPLE 1 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 6 13.20% EDGGGWWYNR 95.00% 2.84 0.413 0 620.2629 1,238.51 1,239.52 2 MYO1C_HUMAN,K1C10_HUMAN,CFAH_HUMAN
 SAMPLE 1 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 6 13.20% EEAPSLRPAPPPISGGGYR 95.00% 2.26 0.25 0 651.0057 1,949.99 1,951.00 3
 SAMPLE 1 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 6 13.20% EEAPSLRPAPPPISGGGYR 95.00% 3.08 0.49 0 651.3392 1,950.99 1,951.00 3
 SAMPLE 1 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 6 13.20% AHYGGFTVQNEANK 95.00% 4.15 0.499 4.55 768.3652 1,534.71 1,535.72 2
 SAMPLE 1 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 6 13.20% AHYGGFTVQNEANK 95.00% 4.45 0.491 4.29 768.8663 1,535.72 1,535.72 2
 SAMPLE 1 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 6 13.20% TPcTVScNIPVVSGKEcEEIIR 95.00% 4.63 0.583 4.03 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 849.9054 2,546.69 2,548.22 3
 SAMPLE 1 Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 6 13.20% TPcTVScNIPVVSGKEcEEIIR 95.00% 3.6 0.483 2.42 c3: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 850.4053 2,548.19 2,548.22 3
 SAMPLE 1R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 3 15.50% EDGGGWWYNR 95.00% 2.66 0.434 0 620.2607 1,238.51 1,239.52 2 MYO1C_HUMAN,K1C10_HUMAN,CFAH_HUMAN
 SAMPLE 1R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 3 15.50% EDGGGWWYNR 95.00% 2.85 0.413 0 620.2624 1,238.51 1,239.52 2 MYO1C_HUMAN,K1C10_HUMAN,CFAH_HUMAN
 SAMPLE 1R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 3 15.50% EEAPSLRPAPPPISGGGYR 95.00% 3.4 0.471 0 651.3387 1,950.99 1,951.00 3
 SAMPLE 1R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 3 15.50% AHYGGFTVQNEANK 95.00% 3.2 0.364 3.26 768.3643 1,534.71 1,535.72 2
 SAMPLE 1R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 3 15.50% NYcGLPGEYWLGNDK 95.00% 3.49 0.259 2.6 c3: Carbamidomethyl (+57.02) 893.3973 1,784.78 1,785.79 2
 SAMPLE 1R Fibrinogen beta chain  FGB  FIBB_HUMAN 55,910.60 100.00% 3 3 3 15.50% VYcDMNTENGGWTVIQNR 95.00% 4.39 0.526 2.43 c3: Carbamidomethyl (+57.02) 1,079.48 2,156.94 2,156.95 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 2.31 0.361 0.959 497.9202 1,490.74 1,491.74 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 2.15 0.283 0 497.9203 1,490.74 1,491.74 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 2.39 0.416 2.28 497.9204 1,490.74 1,491.74 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 1.81 0.274 1.43 497.9206 1,490.74 1,491.74 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 2.42 0.486 1.13 497.9206 1,490.74 1,491.74 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 2.22 0.39 1.82 497.9206 1,490.74 1,491.74 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 2.35 0.376 2.03 497.9208 1,490.74 1,491.74 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 2.44 0.425 1.49 497.9209 1,490.74 1,491.74 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 2.48 0.406 3.08 497.921 1,490.74 1,491.74 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 2.63 0.386 2.05 497.9211 1,490.74 1,491.74 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 2.39 0.375 2.11 497.9212 1,490.74 1,491.74 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 2.3 0.347 0 497.9231 1,490.75 1,491.74 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 3.2 0.389 1.48 559.2661 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 3.16 0.383 1.96 559.2681 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 2.84 0.37 0 559.2681 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 3.13 0.425 1.89 559.2684 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 3.19 0.371 1.74 559.2688 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 3.07 0.432 1.27 559.2689 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 3.17 0.36 0 559.2689 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 2.99 0.362 0 559.2689 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 2.82 0.279 1.25 559.269 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 3.14 0.428 0 559.269 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 3.07 0.373 1.52 559.2691 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 2.9 0.405 1.17 559.2692 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 2.91 0.374 1.41 559.2692 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 2.98 0.339 2.13 559.2693 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 1.83 0.307 0 559.2694 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 2.36 0.327 0 559.2694 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VELEDWNGR 95.00% 3.07 0.368 1.66 559.2696 1,116.52 1,117.53 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% IHLISTQSAIPYALR 95.00% 2.88 0.211 1.09 561.659 1,681.95 1,682.96 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% IHLISTQSAIPYALR 95.00% 3.46 0.256 1.82 561.6591 1,681.95 1,682.96 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% TSTADYAMFK 95.00% 2.17 0.48 1.96 567.7616 1,133.51 1,134.51 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% TSTADYAMFK 95.00% 2.37 0.601 2.7 567.7616 1,133.51 1,134.51 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% TSTADYAMFK 95.00% 2.5 0.556 2 567.7618 1,133.51 1,134.51 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% TSTADYAMFK 95.00% 2.13 0.523 0 567.7619 1,133.51 1,134.51 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% TSTADYAMFK 95.00% 2.34 0.364 1.49 567.7627 1,133.51 1,134.51 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% DNccILDER 95.00% 2.55 0.343 2.25 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7487 1,193.48 1,194.49 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% DNccILDER 95.00% 2.94 0.33 0 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7492 1,193.48 1,194.49 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% DNccILDER 95.00% 3.16 0.353 1.36 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7495 1,193.48 1,194.49 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% DNccILDER 95.00% 2.53 0.352 1.26 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7495 1,193.48 1,194.49 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% DNccILDER 95.00% 3.08 0.331 1.74 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7496 1,193.48 1,194.49 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% DNccILDER 95.00% 1.91 0.312 0 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7498 1,193.48 1,194.49 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% DNccILDER 95.00% 3.19 0.35 0 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7499 1,193.48 1,194.49 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% DTVQIHDITGK 95.00% 3.07 0.274 1.82 613.8269 1,225.64 1,226.64 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% DTVQIHDITGK 95.00% 3 0.243 1.51 613.8271 1,225.64 1,226.64 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% DTVQIHDITGK 95.00% 3.06 0.152 0 613.8273 1,225.64 1,226.64 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% DTVQIHDITGK 95.00% 2.6 0.242 0 614.3291 1,226.64 1,226.64 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 2.69 0.3 0 646.8676 1,291.72 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 3.02 0.284 0 646.8679 1,291.72 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 3.04 0.203 0 647.3835 1,292.75 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 2.86 0.151 0 647.384 1,292.75 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 2.83 0.18 0 647.384 1,292.75 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 3.01 0.271 1.29 647.3841 1,292.75 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 2.98 0.21 1.18 647.3842 1,292.75 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 2.84 0.226 0 647.3845 1,292.75 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 3.15 0.265 1.39 647.3846 1,292.75 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 3.05 0.137 2.6 647.3846 1,292.75 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 2.42 0.216 0 647.3846 1,292.75 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 2.98 0.204 1.6 647.3847 1,292.75 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 2.58 0.17 0 647.3855 1,292.76 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% QSGLYFIKPLK 95.00% 2.83 0.227 0 647.8853 1,293.75 1,293.76 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% cHAGHLNGVYYQGGTYSK 95.00% 2.16 0.195 1.92 c1: Carbamidomethyl (+57.02) 671.3096 2,010.91 2,011.91 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% cHAGHLNGVYYQGGTYSK 95.00% 4.07 0.508 2.66 c1: Carbamidomethyl (+57.02) 671.3105 2,010.91 2,011.91 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% cHAGHLNGVYYQGGTYSK 95.00% 4.17 0.543 3.7 c1: Carbamidomethyl (+57.02) 671.3128 2,010.91 2,011.91 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% cHAGHLNGVYYQGGTYSK 95.00% 4.39 0.564 3.24 c1: Carbamidomethyl (+57.02) 671.6434 2,011.91 2,011.91 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% cHAGHLNGVYYQGGTYSK 95.00% 4.51 0.538 2.42 c1: Carbamidomethyl (+57.02) 671.6448 2,011.91 2,011.91 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% cHAGHLNGVYYQGGTYSK 95.00% 3.99 0.516 3.54 c1: Carbamidomethyl (+57.02) 671.6457 2,011.91 2,011.91 3
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 3.18 0.418 1.82 746.3776 1,490.74 1,491.74 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 4.02 0.567 4.8 746.3777 1,490.74 1,491.74 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 3.54 0.485 2.28 746.378 1,490.74 1,491.74 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 3.69 0.504 1.68 746.3784 1,490.74 1,491.74 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 3.78 0.555 4.59 746.3785 1,490.74 1,491.74 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 3.94 0.552 3.96 746.3794 1,490.74 1,491.74 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 3.66 0.549 4.14 746.3799 1,490.74 1,491.74 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 3.92 0.51 3.89 746.3803 1,490.75 1,491.74 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YEASILTHDSSIR 95.00% 3.52 0.46 2.15 746.8814 1,491.75 1,491.74 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 3.26 0.351 0 757.3681 1,512.72 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 4.83 0.469 2.8 757.3692 1,512.72 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.51 0.44 2.72 757.3695 1,512.72 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.59 0.413 2.34 757.3701 1,512.72 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.47 0.418 3.24 757.3706 1,512.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.48 0.435 2.26 757.3706 1,512.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.54 0.425 2.92 757.3713 1,512.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.16 0.412 3.92 757.3716 1,512.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.39 0.405 2.64 757.3719 1,512.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.45 0.404 3.4 757.3719 1,512.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.07 0.45 2.43 757.372 1,512.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 4.92 0.411 2.15 757.372 1,512.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.23 0.447 2.33 757.3733 1,512.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.44 0.389 2.6 757.8711 1,513.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.68 0.409 4.09 757.8717 1,513.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.57 0.398 2.36 757.8718 1,513.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% YLQEIYNSNNQK 95.00% 5.48 0.423 3.44 757.8736 1,513.73 1,513.73 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VAQLEAQcQEPcK 95.00% 4.34 0.487 3.25 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 780.8643 1,559.71 1,560.72 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% VAQLEAQcQEPcK 95.00% 3.98 0.442 1.85 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 781.3644 1,560.71 1,560.72 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% IHLISTQSAIPYALR 95.00% 4.86 0.619 6.62 841.9843 1,681.95 1,682.96 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% IHLISTQSAIPYALR 95.00% 4.82 0.617 5.96 841.9862 1,681.96 1,682.96 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% IHLISTQSAIPYALR 95.00% 5.05 0.583 5.1 842.4865 1,682.96 1,682.96 2
 SAMPLE 4 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 10 12 99 26.70% IHLISTQSAIPYALR 95.00% 5.06 0.598 6.33 842.4868 1,682.96 1,682.96 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 2.39 0.395 1.59 497.9203 1,490.74 1,491.74 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 2.37 0.455 1.03 497.9203 1,490.74 1,491.74 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 2.87 0.432 1.08 497.9208 1,490.74 1,491.74 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 2.77 0.48 1.37 497.9208 1,490.74 1,491.74 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 1.97 0.228 1.05 497.921 1,490.74 1,491.74 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 2.12 0.32 0 497.9212 1,490.74 1,491.74 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 2.63 0.414 1.06 497.9213 1,490.74 1,491.74 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 2.54 0.367 1.41 497.9214 1,490.74 1,491.74 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 2.2 0.315 2.22 497.9215 1,490.74 1,491.74 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 2.12 0.254 0 497.9217 1,490.74 1,491.74 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 2.61 0.313 0 559.2675 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 3.06 0.436 1.31 559.2683 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 2.88 0.413 0 559.2684 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 3.08 0.365 0 559.2688 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 3.08 0.421 0 559.2688 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 2.96 0.409 0 559.2688 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 3.14 0.382 0 559.269 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 2.56 0.367 1.34 559.269 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 3.03 0.431 1.54 559.2691 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 2.73 0.364 0 559.2694 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 3.11 0.386 2.01 559.2694 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 3.04 0.389 1.28 559.2696 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 2.34 0.339 1.28 559.2697 1,116.52 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 2.59 0.356 0 559.2707 1,116.53 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 2.53 0.321 0 559.2707 1,116.53 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VELEDWNGR 95.00% 2.82 0.323 0 559.2708 1,116.53 1,117.53 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% IHLISTQSAIPYALR 95.00% 2.93 0.233 0 561.6587 1,681.95 1,682.96 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% IHLISTQSAIPYALR 95.00% 2.7 0.338 0 561.6598 1,681.96 1,682.96 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% TSTADYAMFK 95.00% 1.93 0.404 1.52 567.7621 1,133.51 1,134.51 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% TSTADYAMFK 95.00% 2.44 0.477 1.8 567.7623 1,133.51 1,134.51 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% DNccILDER 95.00% 3.41 0.372 1.66 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7489 1,193.48 1,194.49 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% DNccILDER 95.00% 3.32 0.365 1.77 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7497 1,193.48 1,194.49 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% DNccILDER 95.00% 3.34 0.333 2.11 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7502 1,193.48 1,194.49 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% DNccILDER 95.00% 2.84 0.319 2.52 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7504 1,193.49 1,194.49 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% DNccILDER 95.00% 3.08 0.322 1.89 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7505 1,193.49 1,194.49 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% DNccILDER 95.00% 3.01 0.359 1.49 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7505 1,193.49 1,194.49 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% DNccILDER 95.00% 2.85 0.387 0 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 598.2487 1,194.48 1,194.49 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% DTVQIHDITGK 95.00% 3.12 0.157 0 613.8274 1,225.64 1,226.64 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% DTVQIHDITGK 95.00% 3.09 0.193 0 613.8282 1,225.64 1,226.64 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% QSGLYFIKPLK 95.00% 3.12 0.299 0 647.383 1,292.75 1,293.76 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% QSGLYFIKPLK 95.00% 3.16 0.235 0 647.3831 1,292.75 1,293.76 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% QSGLYFIKPLK 95.00% 2.64 0.261 0 647.3838 1,292.75 1,293.76 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% QSGLYFIKPLK 95.00% 3.13 0.214 0 647.3838 1,292.75 1,293.76 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% QSGLYFIKPLK 95.00% 3.05 0.245 0 647.3839 1,292.75 1,293.76 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% QSGLYFIKPLK 95.00% 2.84 0.169 1.54 647.3842 1,292.75 1,293.76 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% QSGLYFIKPLK 95.00% 3.24 0.277 0 647.3844 1,292.75 1,293.76 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% QSGLYFIKPLK 95.00% 3.13 0.222 0 647.3844 1,292.75 1,293.76 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% QSGLYFIKPLK 95.00% 3.34 0.305 0 647.3844 1,292.75 1,293.76 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% QSGLYFIKPLK 95.00% 3.05 0.175 1.27 647.3845 1,292.75 1,293.76 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% QSGLYFIKPLK 95.00% 2.83 0.263 0 647.3849 1,292.75 1,293.76 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% cHAGHLNGVYYQGGTYSK 95.00% 3.92 0.511 0 c1: Carbamidomethyl (+57.02) 671.6426 2,011.90 2,011.91 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% cHAGHLNGVYYQGGTYSK 95.00% 3.99 0.587 1.8 c1: Carbamidomethyl (+57.02) 671.6431 2,011.91 2,011.91 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% cHAGHLNGVYYQGGTYSK 95.00% 3.69 0.554 2.28 c1: Carbamidomethyl (+57.02) 671.6441 2,011.91 2,011.91 3
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 3.8 0.545 3.17 746.3772 1,490.74 1,491.74 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 3.48 0.476 3.33 746.3773 1,490.74 1,491.74 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 3.29 0.462 1.92 746.3783 1,490.74 1,491.74 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 3.09 0.398 1.37 746.3786 1,490.74 1,491.74 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 3.99 0.52 1.85 746.3793 1,490.74 1,491.74 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 3.51 0.504 1.42 746.3797 1,490.74 1,491.74 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 3.77 0.549 3.92 746.38 1,490.74 1,491.74 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 3.76 0.499 1.74 746.3802 1,490.74 1,491.74 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 3.66 0.482 3.85 746.3814 1,490.75 1,491.74 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 3.61 0.549 3.96 746.8782 1,491.74 1,491.74 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YEASILTHDSSIR 95.00% 3.43 0.462 2.39 746.8784 1,491.74 1,491.74 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 4.21 0.457 2.23 757.3687 1,512.72 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.23 0.441 4.77 757.3697 1,512.72 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.29 0.416 2.48 757.3699 1,512.72 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.52 0.421 2.6 757.3704 1,512.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.4 0.441 3.41 757.3706 1,512.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.55 0.446 2.24 757.3709 1,512.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.32 0.42 4.08 757.371 1,512.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.54 0.441 3.96 757.3711 1,512.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.27 0.425 2.24 757.3713 1,512.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.37 0.438 3.8 757.3713 1,512.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.57 0.422 2.96 757.3714 1,512.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.44 0.441 1.89 757.3719 1,512.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.36 0.433 2.32 757.3729 1,512.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 3 0.344 0 757.373 1,512.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.46 0.393 2.92 757.8716 1,513.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% YLQEIYNSNNQK 95.00% 5.41 0.412 3.89 757.8742 1,513.73 1,513.73 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VAQLEAQcQEPcK 95.00% 3.92 0.42 5.43 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 780.8657 1,559.72 1,560.72 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VAQLEAQcQEPcK 95.00% 4.47 0.468 3.8 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 780.8659 1,559.72 1,560.72 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% IHLISTQSAIPYALR 95.00% 4.29 0.582 8.19 841.9853 1,681.96 1,682.96 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% IHLISTQSAIPYALR 95.00% 4.63 0.563 7.04 841.9857 1,681.96 1,682.96 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% IHLISTQSAIPYALR 95.00% 4.6 0.59 5.39 841.9859 1,681.96 1,682.96 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% IHLISTQSAIPYALR 95.00% 4.3 0.572 5.92 841.9875 1,681.96 1,682.96 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% IHLISTQSAIPYALR 95.00% 4.37 0.565 5.05 841.9875 1,681.96 1,682.96 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% IHLISTQSAIPYALR 95.00% 4.81 0.544 5.47 842.4883 1,682.96 1,682.96 2
 SAMPLE 4R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 11 13 89 26.70% VAQLEAQcQEPcKDTVQIHDITGK 95.00% 6.33 0.644 5 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 923.7846 2,768.33 2,768.34 3
 SAMPLE 1 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 3 3 5 9.05% VELEDWNGR 95.00% 2.41 0.289 1.11 559.2668 1,116.52 1,117.53 2
 SAMPLE 1 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 3 3 5 9.05% EGFGHLSPTGTTEFWLGNEK 95.00% 3.3 0.275 0 736.688 2,207.04 2,207.04 3
 SAMPLE 1 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 3 3 5 9.05% YLQEIYNSNNQK 95.00% 4 0.388 3.42 757.3659 1,512.72 1,513.73 2
 SAMPLE 1 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 3 3 5 9.05% YLQEIYNSNNQK 95.00% 4.64 0.399 5.15 757.369 1,512.72 1,513.73 2
 SAMPLE 1 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 3 3 5 9.05% YLQEIYNSNNQK 95.00% 5.07 0.434 2.96 757.3714 1,512.73 1,513.73 2
 SAMPLE 1R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 3 3 4 6.62% VELEDWNGR 95.00% 2.17 0.275 0 559.7717 1,117.53 1,117.53 2
 SAMPLE 1R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 3 3 4 6.62% DNccILDER 95.00% 2.29 0.373 0 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7478 1,193.48 1,194.49 2
 SAMPLE 1R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 3 3 4 6.62% YLQEIYNSNNQK 95.00% 4.86 0.43 2.82 757.3652 1,512.71 1,513.73 2
 SAMPLE 1R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 3 3 4 6.62% YLQEIYNSNNQK 95.00% 4.98 0.443 3.08 757.3662 1,512.72 1,513.73 2
 SAMPLE 2 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 99.80% 2 2 5 3.97% VELEDWNGR 95.00% 2.13 0.293 0 559.2636 1,116.51 1,117.53 2
 SAMPLE 2 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 99.80% 2 2 5 3.97% VELEDWNGR 95.00% 2.24 0.3 0 559.2675 1,116.52 1,117.53 2
 SAMPLE 2 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 99.80% 2 2 5 3.97% DNccILDER 95.00% 2.97 0.389 2.1 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7462 1,193.48 1,194.49 2
 SAMPLE 2 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 99.80% 2 2 5 3.97% DNccILDER 95.00% 2.46 0.358 0 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7473 1,193.48 1,194.49 2
 SAMPLE 2 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 99.80% 2 2 5 3.97% DNccILDER 95.00% 2.6 0.356 1.21 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7476 1,193.48 1,194.49 2
 SAMPLE 2R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 99.90% 2 2 2 3.97% VELEDWNGR 95.00% 2.01 0.272 0 559.2674 1,116.52 1,117.53 2
 SAMPLE 2R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 99.90% 2 2 2 3.97% DNccILDER 95.00% 2.88 0.377 0 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 598.2484 1,194.48 1,194.49 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% YEASILTHDSSIR 95.00% 2.28 0.299 1.52 497.9187 1,490.73 1,491.74 3
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% YEASILTHDSSIR 95.00% 2.07 0.325 1.55 497.9189 1,490.73 1,491.74 3
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% VELEDWNGR 95.00% 2.99 0.359 0 559.2657 1,116.52 1,117.53 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% VELEDWNGR 95.00% 3 0.384 0 559.2657 1,116.52 1,117.53 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% VELEDWNGR 95.00% 2.6 0.376 0 559.2674 1,116.52 1,117.53 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% VELEDWNGR 95.00% 2.9 0.403 1.89 559.2674 1,116.52 1,117.53 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% IHLISTQSAIPYALR 95.00% 3.19 0.339 1.55 561.6571 1,681.95 1,682.96 3
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% IHLISTQSAIPYALR 95.00% 3.32 0.341 0 561.6572 1,681.95 1,682.96 3
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% TSTADYAMFK 95.00% 2.56 0.602 2.03 567.7589 1,133.50 1,134.51 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% TSTADYAMFK 95.00% 2.87 0.617 2.66 567.7598 1,133.50 1,134.51 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% DNccILDER 95.00% 3 0.406 1.52 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.747 1,193.48 1,194.49 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% cHAGHLNGVYYQGGTYSK 95.00% 3.91 0.477 1.26 c1: Carbamidomethyl (+57.02) 671.64 2,011.90 2,011.91 3
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% cHAGHLNGVYYQGGTYSK 95.00% 4.26 0.534 2.82 c1: Carbamidomethyl (+57.02) 671.6409 2,011.90 2,011.91 3
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% YEASILTHDSSIR 95.00% 3.94 0.51 3 746.3767 1,490.74 1,491.74 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% YEASILTHDSSIR 95.00% 3.34 0.528 3.64 746.3769 1,490.74 1,491.74 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% YLQEIYNSNNQK 95.00% 5.47 0.426 2.72 757.3672 1,512.72 1,513.73 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% YLQEIYNSNNQK 95.00% 5.3 0.413 3.68 757.3675 1,512.72 1,513.73 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% YLQEIYNSNNQK 95.00% 4.7 0.423 3.74 757.3688 1,512.72 1,513.73 2
 SAMPLE 3 Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 7 8 19 19.00% YLQEIYNSNNQK 95.00% 4.79 0.432 4.55 757.3695 1,512.72 1,513.73 2
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% YEASILTHDSSIR 95.00% 2.25 0.227 0 497.9186 1,490.73 1,491.74 3
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% YEASILTHDSSIR 95.00% 2.27 0.302 0 497.9189 1,490.73 1,491.74 3
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% VELEDWNGR 95.00% 2.93 0.382 0 559.2666 1,116.52 1,117.53 2
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% VELEDWNGR 95.00% 2.88 0.342 0 559.2668 1,116.52 1,117.53 2
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% VELEDWNGR 95.00% 2.3 0.272 0 559.2672 1,116.52 1,117.53 2
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% IHLISTQSAIPYALR 95.00% 2.79 0.235 2.15 561.6571 1,681.95 1,682.96 3
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% IHLISTQSAIPYALR 95.00% 3.04 0.27 0 561.9924 1,682.95 1,682.96 3
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% TSTADYAMFK 95.00% 2.65 0.557 2.48 567.7601 1,133.50 1,134.51 2
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% DNccILDER 95.00% 2.76 0.42 0 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7477 1,193.48 1,194.49 2
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% DNccILDER 95.00% 2.93 0.401 1.55 c3: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 597.7497 1,193.48 1,194.49 2
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% cHAGHLNGVYYQGGTYSK 95.00% 3.92 0.489 1.82 c1: Carbamidomethyl (+57.02) 671.6417 2,011.90 2,011.91 3
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% cHAGHLNGVYYQGGTYSK 95.00% 2.72 0.4 0 c1: Carbamidomethyl (+57.02) 671.6428 2,011.91 2,011.91 3
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% YEASILTHDSSIR 95.00% 3.41 0.496 2.96 746.3764 1,490.74 1,491.74 2
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% YEASILTHDSSIR 95.00% 3.67 0.526 3.85 746.8759 1,491.74 1,491.74 2
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% YLQEIYNSNNQK 95.00% 5.14 0.463 3.17 757.3664 1,512.72 1,513.73 2
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% YLQEIYNSNNQK 95.00% 5.35 0.421 3.51 757.3684 1,512.72 1,513.73 2
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% YLQEIYNSNNQK 95.00% 4.52 0.365 2.42 757.3689 1,512.72 1,513.73 2
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% AIQLTYNPDESSKPNMIDAATLK 95.00% 2.38 0.366 0 840.9351 2,519.78 2,520.27 3
 SAMPLE 3R Fibrinogen gamma chain  FGG  FIBG_HUMAN 51,495.30 100.00% 8 9 19 24.10% AIQLTYNPDESSKPNMIDAATLK 95.00% 2.47 0.384 0 841.0929 2,520.26 2,520.27 3
 SAMPLE 1 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 11 10.40% YLPFVPSR 95.00% 1.73 0.328 1.16 489.774 977.5324 978.5413 2 LPP_HUMAN
 SAMPLE 1 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 11 10.40% SLRELHLDHNQISR 95.00% 4.94 0.518 2.48 573.3069 1,716.90 1,717.91 3
 SAMPLE 1 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 11 10.40% SLRELHLDHNQISR 95.00% 4.75 0.516 2.11 573.3079 1,716.90 1,717.91 3
 SAMPLE 1 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 11 10.40% SLRELHLDHNQISR 95.00% 5.02 0.439 2.25 573.3088 1,716.90 1,717.91 3
 SAMPLE 1 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 11 10.40% SLRELHLDHNQISR 95.00% 4.52 0.476 1.57 573.3091 1,716.90 1,717.91 3
 SAMPLE 1 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 11 10.40% IPPVNTNLENLYLQGNR 95.00% 3.12 0.311 0 652.3515 1,954.03 1,955.04 3
 SAMPLE 1 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 11 10.40% IPPVNTNLENLYLQGNR 95.00% 5.36 0.58 5.28 978.0186 1,954.02 1,955.04 2
 SAMPLE 1 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 11 10.40% IPPVNTNLENLYLQGNR 95.00% 5.39 0.608 6.59 978.0187 1,954.02 1,955.04 2
 SAMPLE 1 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 11 10.40% IPPVNTNLENLYLQGNR 95.00% 5.38 0.534 5.21 978.52 1,955.02 1,955.04 2
 SAMPLE 1 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 11 10.40% IPPVNTNLENLYLQGNR 95.00% 5.19 0.526 5.28 978.52 1,955.02 1,955.04 2
 SAMPLE 1 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 11 10.40% IPPVNTNLENLYLQGNR 95.00% 5.42 0.526 5.6 978.521 1,955.03 1,955.04 2
 SAMPLE 1 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 11 10.40% IPPVNTNLENLYLQGNR 95.00% 5.37 0.527 6.19 978.5222 1,955.03 1,955.04 2
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% SLRELHLDHNQISR 95.00% 4.97 0.543 2.17 573.3068 1,716.90 1,717.91 3
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% SLRELHLDHNQISR 95.00% 5.04 0.492 2.54 573.3078 1,716.90 1,717.91 3
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% SLRELHLDHNQISR 95.00% 5.13 0.501 2.01 573.6433 1,717.91 1,717.91 3
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% SLRELHLDHNQISR 95.00% 4.66 0.445 1.92 573.6458 1,717.91 1,717.91 3
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 5.26 0.526 3.07 652.3494 1,954.02 1,955.04 3
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 5.25 0.475 1.34 652.6819 1,955.02 1,955.04 3
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 4.17 0.411 0 652.6832 1,955.03 1,955.04 3
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 4.5 0.464 1.64 652.6835 1,955.03 1,955.04 3
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 5.6 0.585 5.19 978.0188 1,954.02 1,955.04 2
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 5.75 0.538 5.34 978.5199 1,955.02 1,955.04 2
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 5.38 0.487 5 978.5199 1,955.02 1,955.04 2
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 5.24 0.532 4.33 978.5203 1,955.02 1,955.04 2
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 5.47 0.526 4.8 978.5203 1,955.02 1,955.04 2
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 4.97 0.487 4.1 978.5207 1,955.03 1,955.04 2
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 4.68 0.56 5.24 978.5209 1,955.03 1,955.04 2
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 4.93 0.633 4.25 978.521 1,955.03 1,955.04 2
 SAMPLE 1R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 99.80% 2 3 17 8.24% IPPVNTNLENLYLQGNR 95.00% 5.4 0.517 5.16 978.5228 1,955.03 1,955.04 2
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% ELHLDHNQISR 95.00% 2.79 0.256 0 454.5698 1,360.69 1,361.69 3
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% ELHLDHNQISR 95.00% 2.6 0.261 0 454.5704 1,360.69 1,361.69 3
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% YLPFVPSR 95.00% 1.64 0.325 0 489.7732 977.5308 978.5413 2 LPP_HUMAN
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% SLRELHLDHNQISR 95.00% 4.85 0.523 2.25 573.3071 1,716.90 1,717.91 3
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% SLRELHLDHNQISR 95.00% 4.96 0.488 1.54 573.3076 1,716.90 1,717.91 3
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% IPPVNTNLENLYLQGNR 95.00% 5.4 0.495 2.3 652.3488 1,954.02 1,955.04 3
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% IPPVNTNLENLYLQGNR 95.00% 5.35 0.521 2.64 652.3492 1,954.02 1,955.04 3
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% IPPVNTNLENLYLQGNR 95.00% 4.09 0.499 0 652.3504 1,954.03 1,955.04 3
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% IPPVNTNLENLYLQGNR 95.00% 3.17 0.383 0 652.6831 1,955.03 1,955.04 3
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% SLRELHLDHNQISR 95.00% 4.69 0.495 2.38 859.9574 1,717.90 1,717.91 2
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% DcPQEcDcPPNFPTAMYcDNR 95.00% 4.73 0.428 5.12c : Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02)883.3312 2,646.97 2,646.98 3
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% DcPQEcDcPPNFPTAMYcDNR 95.00% 4.49 0.455 2.66c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02)883.3321 2,646.97 2,646.98 3
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% IPPVNTNLENLYLQGNR 95.00% 5.37 0.597 6.62 978.0184 1,954.02 1,955.04 2
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% IPPVNTNLENLYLQGNR 95.00% 5.34 0.578 4.43 978.0185 1,954.02 1,955.04 2
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% IPPVNTNLENLYLQGNR 95.00% 5.54 0.596 5.55 978.019 1,954.02 1,955.04 2
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% IPPVNTNLENLYLQGNR 95.00% 5.67 0.543 4.05 978.5193 1,955.02 1,955.04 2
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% IPPVNTNLENLYLQGNR 95.00% 5.25 0.63 4.66 978.5207 1,955.03 1,955.04 2
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% IPPVNTNLENLYLQGNR 95.00% 4.53 0.546 3.23 978.5232 1,955.03 1,955.04 2
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% DcPQEcDcPPNFPTAMYcDNR 95.00% 5.17 0.58 7.21c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02)1,324.49 2,646.97 2,646.98 2
 SAMPLE 3 Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 4 7 19 16.00% DcPQEcDcPPNFPTAMYcDNR 95.00% 5.24 0.572 7.11c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02)1,324.49 2,646.97 2,646.98 2
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% SLRELHLDHNQISR 95.00% 3.61 0.319 0 573.6456 1,717.91 1,717.91 3
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% IPPVNTNLENLYLQGNR 95.00% 4.4 0.509 1.82 652.3497 1,954.03 1,955.04 3
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% IPPVNTNLENLYLQGNR 95.00% 3.25 0.233 0 652.6827 1,955.02 1,955.04 3
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% IPPVNTNLENLYLQGNR 95.00% 4.94 0.435 1.41 652.6832 1,955.03 1,955.04 3
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% IPPVNTNLENLYLQGNR 95.00% 5.81 0.489 2 652.6833 1,955.03 1,955.04 3
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% IPPVNTNLENLYLQGNR 95.00% 5.13 0.455 1.6 652.6836 1,955.03 1,955.04 3
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% IPPVNTNLENLYLQGNR 95.00% 3.88 0.329 1.52 652.6838 1,955.03 1,955.04 3
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% IPPVNTNLENLYLQGNR 95.00% 3.75 0.285 1.05 652.6848 1,955.03 1,955.04 3
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% SLRELHLDHNQISR 95.00% 4.46 0.502 2.96 859.459 1,716.90 1,717.91 2
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% SLRELHLDHNQISR 95.00% 4.72 0.463 2.22 859.959 1,717.90 1,717.91 2
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% IPPVNTNLENLYLQGNR 95.00% 5.44 0.602 5.14 978.018 1,954.02 1,955.04 2
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% IPPVNTNLENLYLQGNR 95.00% 5.46 0.592 6.29 978.0182 1,954.02 1,955.04 2
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% IPPVNTNLENLYLQGNR 95.00% 4.61 0.559 3.72 978.519 1,955.02 1,955.04 2
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% IPPVNTNLENLYLQGNR 95.00% 4.61 0.589 4.59 978.5224 1,955.03 1,955.04 2
 SAMPLE 3R Fibromodulin  FMOD  FMOD_HUMAN 43,230.20 100.00% 3 5 15 13.80% DcPQEcDcPPNFPTAMYcDNR 95.00% 5.25 0.563 4.96c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02)1,324.49 2,646.97 2,646.98 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% HYQINQQWER 95.00% 3.41 0.145 0 467.8976 1,400.67 1,401.67 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% HYQINQQWER 95.00% 3.3 0.126 0 467.8976 1,400.67 1,401.67 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WSRPQAPITGYR 95.00% 3.61 0.325 1.42 477.9225 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WSRPQAPITGYR 95.00% 3.39 0.398 1.3 477.9225 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WSRPQAPITGYR 95.00% 3.66 0.305 2.59 477.9228 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WSRPQAPITGYR 95.00% 3.4 0.343 1.7 477.9228 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WSRPQAPITGYR 95.00% 3.57 0.277 1.89 477.9229 1,430.75 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WSRPQAPITGYR 95.00% 3.44 0.298 2.38 477.9229 1,430.75 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WSRPQAPITGYR 95.00% 3.42 0.382 1.89 477.923 1,430.75 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WSRPQAPITGYR 95.00% 3.7 0.355 2.44 477.9247 1,430.75 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WSRPQAPITGYR 95.00% 3.18 0.196 0 478.2567 1,431.75 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 2.48 0.341 0 531.2744 1,590.80 1,591.81 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 2.32 0.303 0 531.2746 1,590.80 1,591.81 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 2.83 0.429 0 531.2747 1,590.80 1,591.81 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 3.56 0.484 0 531.275 1,590.80 1,591.81 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 2.44 0.231 0 531.2758 1,590.80 1,591.81 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 3 0.477 0 531.6088 1,591.80 1,591.81 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 3.52 0.447 0 531.609 1,591.80 1,591.81 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 3.34 0.454 0 531.6091 1,591.80 1,591.81 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VDVIPVNLPGEHGQR 95.00% 2.5 0.32 1 543.9632 1,628.87 1,629.87 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VDVIPVNLPGEHGQR 95.00% 2.59 0.309 0 543.9635 1,628.87 1,629.87 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VDVIPVNLPGEHGQR 95.00% 2.59 0.337 0 543.9636 1,628.87 1,629.87 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VDVIPVNLPGEHGQR 95.00% 2.62 0.382 0 544.2985 1,629.87 1,629.87 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 4.25 0.41 4.04 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2659 1,650.77 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.99 0.388 3.35 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2661 1,650.77 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 4.04 0.381 2.96 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2661 1,650.77 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.29 0.361 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2663 1,650.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.44 0.434 1.28 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2664 1,650.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.76 0.359 2.42 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2665 1,650.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.47 0.408 2.96 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2676 1,650.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.14 0.387 2.54 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2677 1,650.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.54 0.396 4.07 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2679 1,650.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.39 0.417 1.64 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.268 1,650.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 2.17 0.216 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2681 1,650.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.26 0.327 1.09 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2682 1,650.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.92 0.387 3.13 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2682 1,650.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.96 0.388 3.89 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2682 1,650.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.74 0.367 2.3 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.6011 1,651.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.6 0.402 3.57 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.6017 1,651.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.66 0.35 3.11 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.6024 1,651.78 1,651.78 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% STTPDITGYR 95.00% 2.21 0.558 1.48 555.776 1,109.54 1,110.54 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% STTPDITGYR 95.00% 2.27 0.56 1.52 555.776 1,109.54 1,110.54 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% STTPDITGYR 95.00% 1.95 0.496 0 555.7761 1,109.54 1,110.54 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% STTPDITGYR 95.00% 2.12 0.389 0 555.7761 1,109.54 1,110.54 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% STTPDITGYR 95.00% 2.33 0.463 0 555.7763 1,109.54 1,110.54 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% STTPDITGYR 95.00% 2.36 0.519 1.28 555.7764 1,109.54 1,110.54 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% STTPDITGYR 95.00% 2.47 0.431 0 555.7769 1,109.54 1,110.54 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% STTPDITGYR 95.00% 2.46 0.473 0 555.777 1,109.54 1,110.54 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALKDQQR 95.00% 1.9 0.285 0 606.9965 1,817.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALKDQQR 95.00% 2.38 0.321 0 606.9967 1,817.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALKDQQR 95.00% 2.28 0.347 0 606.9969 1,817.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALKDQQR 95.00% 2.55 0.429 0 607.33 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALKDQQR 95.00% 2.65 0.481 0 607.3306 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALKDQQR 95.00% 2.41 0.366 0 607.3315 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALKDQQR 95.00% 2.7 0.387 0 607.3318 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALKDQQR 95.00% 2.57 0.393 0 607.3322 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALKDQQR 95.00% 2.54 0.363 0 607.3323 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WKEATIPGHLNSYTIK 95.00% 2.87 0.288 0 620.0024 1,856.98 1,857.99 3 MCF2L_HUMAN,F10A1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WKEATIPGHLNSYTIK 95.00% 2.7 0.193 0 620.3342 1,857.98 1,857.99 3 MCF2L_HUMAN,F10A1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% HTSVQTTSSGSGPFTDVR 95.00% 4.48 0.55 2.82 621.9666 1,862.88 1,863.88 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% HTSVQTTSSGSGPFTDVR 95.00% 4.15 0.528 1.82 621.9672 1,862.88 1,863.88 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% HTSVQTTSSGSGPFTDVR 95.00% 4.15 0.577 4.27 621.9689 1,862.88 1,863.88 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% HTSVQTTSSGSGPFTDVR 95.00% 3 0.427 0 622.2988 1,863.87 1,863.88 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% HTSVQTTSSGSGPFTDVR 95.00% 3.04 0.439 0 622.3004 1,863.88 1,863.88 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% HTSVQTTSSGSGPFTDVR 95.00% 4.87 0.534 2.59 622.3013 1,863.88 1,863.88 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% HTSVQTTSSGSGPFTDVR 95.00% 5.07 0.591 4 622.3016 1,863.88 1,863.88 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% HTSVQTTSSGSGPFTDVR 95.00% 3.51 0.552 0.959 622.3019 1,863.88 1,863.88 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% HTSVQTTSSGSGPFTDVR 95.00% 4.96 0.533 2.89 622.3026 1,863.88 1,863.88 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALK 95.00% 3.02 0.387 0 646.3669 1,290.72 1,291.73 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALK 95.00% 3.94 0.442 1.41 646.3675 1,290.72 1,291.73 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALK 95.00% 3.32 0.428 1.24 646.3678 1,290.72 1,291.73 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALK 95.00% 3.31 0.425 1.47 646.3682 1,290.72 1,291.73 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% DLQFVEVTDVK 95.00% 3.22 0.446 2.8 646.8427 1,291.67 1,292.67 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% DLQFVEVTDVK 95.00% 2.55 0.36 0 646.8427 1,291.67 1,292.67 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% DLQFVEVTDVK 95.00% 2.85 0.377 1.59 646.8437 1,291.67 1,292.67 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WLPSSSPVTGYR 95.00% 2.3 0.51 3.41 675.347 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WLPSSSPVTGYR 95.00% 2.47 0.475 1.68 675.3476 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WLPSSSPVTGYR 95.00% 2.51 0.439 1.89 675.3479 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WLPSSSPVTGYR 95.00% 2.38 0.378 2.89 675.3479 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WLPSSSPVTGYR 95.00% 2.33 0.469 3.07 675.3481 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WLPSSSPVTGYR 95.00% 1.87 0.268 1.64 675.3482 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WLPSSSPVTGYR 95.00% 2.35 0.462 2.72 675.3482 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WLPSSSPVTGYR 95.00% 2.57 0.392 1.96 675.3487 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WLPSSSPVTGYR 95.00% 2.49 0.3 1.64 675.349 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% WLPSSSPVTGYR 95.00% 2.74 0.466 3.27 675.8501 1,349.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 2.72 0.437 0 678.3509 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 3.5 0.429 1.64 678.3526 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 3.12 0.468 1.72 678.3529 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 3.72 0.441 1.8 678.3532 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 3.82 0.495 1.7 678.3533 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 3.69 0.465 1.7 678.3535 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 2.53 0.388 1.28 678.3536 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 3.9 0.446 2.06 678.3537 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 2.71 0.35 0 678.3539 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 4.11 0.467 2.07 678.354 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 3.05 0.479 0 678.3542 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 3.53 0.489 1.92 678.3543 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 3.45 0.458 0 678.3543 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 3.83 0.428 2.42 678.3545 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 2.79 0.372 0 678.3549 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 2.53 0.309 0 678.355 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 3.71 0.423 2.44 678.8542 1,355.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IYLYTLNDNAR 95.00% 4.14 0.459 3.28 678.8549 1,355.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IAWESPQGQVSR 95.00% 2.55 0.296 1.46 679.3456 1,356.68 1,357.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IAWESPQGQVSR 95.00% 2.99 0.353 1.54 679.347 1,356.68 1,357.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IAWESPQGQVSR 95.00% 2.84 0.263 1.85 679.3488 1,356.68 1,357.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IAWESPQGQVSR 95.00% 2.38 0.325 1.72 679.3492 1,356.68 1,357.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IAWESPQGQVSR 95.00% 3.08 0.329 2.82 679.3501 1,356.68 1,357.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IAWESPQGQVSR 95.00% 3.16 0.337 2.59 679.3502 1,356.68 1,357.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% IAWESPQGQVSR 95.00% 2.69 0.207 1.49 679.3652 1,356.71 1,357.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GLAFTDVDVDSIK 95.00% 3.86 0.558 2.35 690.3572 1,378.70 1,379.71 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GLAFTDVDVDSIK 95.00% 4.07 0.552 2 690.358 1,378.70 1,379.71 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GLAFTDVDVDSIK 95.00% 3.95 0.564 2.92 690.3586 1,378.70 1,379.71 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GLAFTDVDVDSIK 95.00% 2.59 0.343 2.24 690.3587 1,378.70 1,379.71 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GLAFTDVDVDSIK 95.00% 3.8 0.552 1.74 690.359 1,378.70 1,379.71 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GLAFTDVDVDSIK 95.00% 3.83 0.546 2.77 690.3591 1,378.70 1,379.71 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GLAFTDVDVDSIK 95.00% 2.99 0.462 0 690.3592 1,378.70 1,379.71 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 3.1 0.566 4.74 731.3971 1,460.78 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 3.91 0.666 6.92 731.4002 1,460.78 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 4.11 0.631 5.77 731.4005 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 4.36 0.642 5.96 731.4007 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 3.93 0.624 4.77 731.4008 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 4.18 0.663 5.7 731.4008 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 4.21 0.646 5 731.4013 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 4.24 0.651 4.85 731.4019 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 4.21 0.627 4.89 731.4019 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 3.97 0.622 4.16 731.4019 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 3.83 0.642 4.92 731.4021 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 4.05 0.598 4.74 731.4021 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 4.01 0.616 4 731.4022 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 3.81 0.582 7.31 731.4023 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 4.42 0.644 5.77 731.4024 1,460.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 3.42 0.371 5.19 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8482 1,461.68 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 3.42 0.405 4.01 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8492 1,461.68 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 2.93 0.344 4.15 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8495 1,461.68 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 3.59 0.282 4.96 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8496 1,461.68 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 3.83 0.354 4.64 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8498 1,461.68 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 4.02 0.341 5.74 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8504 1,461.69 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 3.74 0.332 5.08 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8507 1,461.69 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 3.8 0.338 4.64 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8507 1,461.69 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 4.16 0.349 5.19 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8508 1,461.69 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 3.72 0.383 4.72 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.851 1,461.69 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 3.59 0.395 4.7 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8515 1,461.69 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 4.07 0.317 5.25 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8515 1,461.69 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 3.5 0.37 4.37 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8518 1,461.69 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 2.89 0.274 3.89 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8518 1,461.69 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GNLLQcIcTGNGR 95.00% 3.6 0.331 5.23 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8519 1,461.69 1,462.69 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VPGTSTSATLTGLTR 95.00% 3.82 0.607 5.17 731.9043 1,461.79 1,461.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% QDGHLWcSTTSNYEQDQK 95.00% 2.87 0.27 0 c7: Carbamidomethyl (+57.02) 732.9837 2,195.93 2,196.93 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% QDGHLWcSTTSNYEQDQK 95.00% 3.71 0.438 1.54 c7: Carbamidomethyl (+57.02) 733.3185 2,196.93 2,196.93 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GEWTcIAYSQLR 95.00% 3.52 0.481 1.66 c5: Carbamidomethyl (+57.02) 742.3521 1,482.69 1,483.70 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GEWTcIAYSQLR 95.00% 3.56 0.448 1.33 c5: Carbamidomethyl (+57.02) 742.3526 1,482.69 1,483.70 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GEWTcIAYSQLR 95.00% 3.65 0.485 1.51 c5: Carbamidomethyl (+57.02) 742.3526 1,482.69 1,483.70 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GEWTcIAYSQLR 95.00% 3.57 0.47 1.77 c5: Carbamidomethyl (+57.02) 742.3527 1,482.69 1,483.70 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GEWTcIAYSQLR 95.00% 3.54 0.488 1.74 c5: Carbamidomethyl (+57.02) 742.3531 1,482.69 1,483.70 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GEWTcIAYSQLR 95.00% 3.74 0.466 1.7 c5: Carbamidomethyl (+57.02) 742.3532 1,482.69 1,483.70 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GEWTcIAYSQLR 95.00% 3.82 0.468 1.96 c5: Carbamidomethyl (+57.02) 742.3536 1,482.69 1,483.70 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GEWTcIAYSQLR 95.00% 3.77 0.453 2.01 c5: Carbamidomethyl (+57.02) 742.354 1,482.69 1,483.70 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GEWTcIAYSQLR 95.00% 3.78 0.471 2 c5: Carbamidomethyl (+57.02) 742.3543 1,482.69 1,483.70 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GEWTcIAYSQLR 95.00% 3.81 0.469 2.09 c5: Carbamidomethyl (+57.02) 742.3546 1,482.69 1,483.70 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GEWTcIAYSQLR 95.00% 3.76 0.459 1.37 c5: Carbamidomethyl (+57.02) 742.3554 1,482.70 1,483.70 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GEWTcIAYSQLR 95.00% 3.79 0.431 2.19 c5: Carbamidomethyl (+57.02) 742.8575 1,483.70 1,483.70 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SYTITGLQPGTDYK 95.00% 3.64 0.468 2.89 772.3871 1,542.76 1,543.76 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SYTITGLQPGTDYK 95.00% 4.06 0.26 0 772.3883 1,542.76 1,543.76 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SYTITGLQPGTDYK 95.00% 3.26 0.339 0 772.3913 1,542.77 1,543.76 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EATIPGHLNSYTIK 95.00% 2.65 0.349 2.23 772.4123 1,542.81 1,543.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EATIPGHLNSYTIK 95.00% 2.38 0.221 0 772.4124 1,542.81 1,543.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EATIPGHLNSYTIK 95.00% 2.47 0.336 2.36 772.4128 1,542.81 1,543.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SYTITGLQPGTDYK 95.00% 4.74 0.548 3.66 772.8891 1,543.76 1,543.76 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SYTITGLQPGTDYK 95.00% 4.54 0.481 3.15 772.89 1,543.76 1,543.76 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SYTITGLQPGTDYK 95.00% 3.65 0.414 1.15 772.8905 1,543.77 1,543.76 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SYTITGLQPGTDYK 95.00% 4.55 0.511 2.66 772.8905 1,543.77 1,543.76 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EATIPGHLNSYTIK 95.00% 2.59 0.275 0 772.9156 1,543.82 1,543.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 3.67 0.564 4.05 796.4074 1,590.80 1,591.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 3.94 0.557 4.05 796.4088 1,590.80 1,591.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 3.79 0.548 4.31 796.4093 1,590.80 1,591.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 3.77 0.553 3.37 796.4099 1,590.80 1,591.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 3.98 0.561 1.96 796.4102 1,590.80 1,591.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 3.8 0.545 4.48 796.4112 1,590.81 1,591.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 3.67 0.542 4.32 796.4112 1,590.81 1,591.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 4.17 0.596 3.52 796.4115 1,590.81 1,591.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GDSPASSKPISINYR 95.00% 4.06 0.607 3.77 796.412 1,590.81 1,591.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VTDATETTITISWR 95.00% 2.57 0.466 0 797.9128 1,593.81 1,593.81 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.26 0.634 4.51 799.7023 2,396.08 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.34 0.552 3.72 799.7032 2,396.09 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.15 0.6 5.39 799.7037 2,396.09 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.55 0.608 6.64 799.7039 2,396.09 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.8 0.616 6.64 799.704 2,396.09 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.35 0.593 5.54 799.704 2,396.09 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.87 0.542 5.36 799.7042 2,396.09 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.21 0.614 5.72 799.7048 2,396.09 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.32 0.601 4.96 799.705 2,396.09 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.94 0.61 5.7 799.7051 2,396.09 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.09 0.596 6.7 799.7052 2,396.09 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.24 0.607 5.05 799.7054 2,396.09 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.48 0.607 4.54 799.7054 2,396.09 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.65 0.559 3.77 799.7075 2,396.10 2,396.09 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VDVIPVNLPGEHGQR 95.00% 3.38 0.361 4.03 815.4406 1,628.87 1,629.87 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VDVIPVNLPGEHGQR 95.00% 3.76 0.423 4.72 815.9457 1,629.88 1,629.87 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% DDKESVPISDTIIPAVPPPTDLR 95.00% 3.42 0.319 0 826.1086 2,475.30 2,475.30 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 3.82 0.395 5.04 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.3946 1,650.77 1,651.78 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 4.2 0.445 3.3 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.3975 1,650.78 1,651.78 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% LLcQcLGFGSGHFR 95.00% 4.05 0.429 5.72 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.8994 1,651.78 1,651.78 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% DSmIWDcTcIGAGR 95.00% 3.95 0.472 4.51 m3: Oxidation (+15.99), c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 829.3465 1,656.68 1,657.68 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% PAQGVVTTLENVSPPR 95.00% 2.88 0.337 0 832.9507 1,663.89 1,664.90 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% PAQGVVTTLENVSPPR 95.00% 3.82 0.607 0 832.9511 1,663.89 1,664.90 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% PAQGVVTTLENVSPPR 95.00% 3.57 0.406 0 832.9538 1,663.89 1,664.90 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% PAQGVVTTLENVSPPR 95.00% 3.88 0.599 0 832.9548 1,663.89 1,664.90 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% PAQGVVTTLENVSPPR 95.00% 3.83 0.566 0 832.9572 1,663.90 1,664.90 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.58 0.542 3.52 858.4518 2,572.33 2,572.34 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TKTETITGFQVDAVPANGQTPIQR 95.00% 5.12 0.456 1.4 858.4529 2,572.34 2,572.34 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.19 0.329 3.22 858.4533 2,572.34 2,572.34 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TKTETITGFQVDAVPANGQTPIQR 95.00% 3.54 0.354 1.68 858.4534 2,572.34 2,572.34 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.32 0.404 4.06 858.4538 2,572.34 2,572.34 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.17 0.395 2.28 858.4547 2,572.34 2,572.34 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.48 0.42 2.03 858.4565 2,572.35 2,572.34 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.2 0.581 7.33 866.9784 1,731.94 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 3.73 0.554 3.31 866.9789 1,731.94 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.16 0.602 7.66 866.9792 1,731.94 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.51 0.611 7.08 866.9792 1,731.94 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.21 0.625 6.46 866.9794 1,731.94 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.55 0.602 7.64 866.9796 1,731.94 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.2 0.638 5.43 866.9797 1,731.94 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 3.93 0.613 7.21 866.9798 1,731.94 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.49 0.589 5.27 866.9798 1,731.94 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.59 0.586 7.41 866.9799 1,731.94 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.23 0.585 6.48 866.9803 1,731.95 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.95 0.571 6.8 867.4796 1,732.94 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.75 0.591 7.24 867.4806 1,732.95 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.4 0.583 5.04 867.4808 1,732.95 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.96 0.608 6.92 867.481 1,732.95 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% NLQPASEYTVSLVAIK 95.00% 4.32 0.605 6.27 867.4822 1,732.95 1,732.95 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TYLGNALVcTcYGGSR 95.00% 5.25 0.602 4.96 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4105 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TYLGNALVcTcYGGSR 95.00% 4.41 0.57 3.89 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4124 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TYLGNALVcTcYGGSR 95.00% 3.77 0.238 2.85 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4124 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TYLGNALVcTcYGGSR 95.00% 5.51 0.61 6.21 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4132 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TYLGNALVcTcYGGSR 95.00% 5.13 0.608 5.51 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4137 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TYLGNALVcTcYGGSR 95.00% 5.67 0.632 4.4 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4145 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TYLGNALVcTcYGGSR 95.00% 5.42 0.604 7.15 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4146 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TYLGNALVcTcYGGSR 95.00% 5.38 0.629 6.96 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4149 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TYLGNALVcTcYGGSR 95.00% 5.22 0.593 5.21 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4151 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TYLGNALVcTcYGGSR 95.00% 5.4 0.604 5.8 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4152 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TYLGNALVcTcYGGSR 95.00% 4.72 0.561 3.82 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9148 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% TYLGNALVcTcYGGSR 95.00% 3.25 0.565 0 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9165 1,791.82 1,791.82 2 TENX_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% VTIMWTPPESAVTGYR 95.00% 3.72 0.353 3.02 904.9591 1,807.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALKDQQR 95.00% 4.63 0.417 3.8 910.4938 1,818.97 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GATYNIIVEALKDQQR 95.00% 3.71 0.366 3.17 910.4945 1,818.97 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% HTSVQTTSSGSGPFTDVR 95.00% 5.41 0.601 13.1 932.4496 1,862.88 1,863.88 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 5.12 0.637 4.66 934.1689 2,799.48 2,799.48 3
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EYLGAIcScTcFGGQR 95.00% 4.8 0.628 4.7 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9015 1,877.79 1,878.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EYLGAIcScTcFGGQR 95.00% 4.76 0.629 3.92 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9018 1,877.79 1,878.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EYLGAIcScTcFGGQR 95.00% 4.98 0.625 4.96 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9038 1,877.79 1,878.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EYLGAIcScTcFGGQR 95.00% 4.2 0.565 4.77 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9046 1,877.79 1,878.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EYLGAIcScTcFGGQR 95.00% 5.19 0.609 5.09 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4021 1,878.79 1,878.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EYLGAIcScTcFGGQR 95.00% 4.9 0.647 6.03 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4026 1,878.79 1,878.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EYLGAIcScTcFGGQR 95.00% 5.23 0.616 6.21 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4032 1,878.79 1,878.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EYLGAIcScTcFGGQR 95.00% 5.63 0.633 3.82 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4041 1,878.79 1,878.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EYLGAIcScTcFGGQR 95.00% 4.99 0.618 4 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4043 1,878.79 1,878.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EYLGAIcScTcFGGQR 95.00% 5.23 0.603 3.72 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4064 1,878.80 1,878.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EYLGAIcScTcFGGQR 95.00% 2.41 0.373 0 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4175 1,878.82 1,878.79 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SSPVVIDASTAIDAPSNLR 95.00% 5.33 0.629 5.66 957.0038 1,911.99 1,913.00 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SSPVVIDASTAIDAPSNLR 95.00% 4.88 0.604 5.51 957.0049 1,911.99 1,913.00 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SSPVVIDASTAIDAPSNLR 95.00% 5.44 0.538 4.62 957.5037 1,912.99 1,913.00 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SSPVVIDASTAIDAPSNLR 95.00% 5.83 0.592 5.34 957.5065 1,913.00 1,913.00 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SSPVVIDASTAIDAPSNLR 95.00% 5.58 0.592 5.35 957.5069 1,913.00 1,913.00 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% SSPVVIDASTAIDAPSNLR 95.00% 5.74 0.576 5.34 957.5074 1,913.00 1,913.00 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% FLATTPNSLLVSWQPPR 95.00% 3.91 0.532 4 964.5262 1,927.04 1,927.04 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% FLATTPNSLLVSWQPPR 95.00% 3.99 0.545 4.34 964.5273 1,927.04 1,927.04 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% FLATTPNSLLVSWQPPR 95.00% 4.05 0.517 4.54 964.5287 1,927.04 1,927.04 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% FLATTPNSLLVSWQPPR 95.00% 4.11 0.511 3.49 964.5326 1,927.05 1,927.04 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EESPLLIGQQSTVSDVPR 95.00% 4.72 0.645 5.23 978.0086 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EESPLLIGQQSTVSDVPR 95.00% 4.74 0.569 4.09 978.0088 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EESPLLIGQQSTVSDVPR 95.00% 4.34 0.621 5.89 978.0091 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EESPLLIGQQSTVSDVPR 95.00% 4.44 0.585 4.3 978.0092 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EESPLLIGQQSTVSDVPR 95.00% 4.36 0.521 4.92 978.0097 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EESPLLIGQQSTVSDVPR 95.00% 4.26 0.56 4.89 978.0101 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EESPLLIGQQSTVSDVPR 95.00% 4.68 0.573 4.64 978.0116 1,954.01 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EESPLLIGQQSTVSDVPR 95.00% 4.69 0.529 4.1 978.5097 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% EESPLLIGQQSTVSDVPR 95.00% 4.77 0.595 3.89 978.511 1,955.01 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% ITYGETGGNSPVQEFTVPGSK 95.00% 5.83 0.568 6.27 1,085.03 2,168.04 2,168.05 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% ITYGETGGNSPVQEFTVPGSK 95.00% 5.87 0.565 4.59 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% ITYGETGGNSPVQEFTVPGSK 95.00% 5.52 0.504 5.07 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% ITYGETGGNSPVQEFTVPGSK 95.00% 4.61 0.487 4.89 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% ITYGETGGNSPVQEFTVPGSK 95.00% 5.68 0.561 4.85 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% ITYGETGGNSPVQEFTVPGSK 95.00% 5.68 0.582 5.66 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% ITYGETGGNSPVQEFTVPGSK 95.00% 6.14 0.562 6.26 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% ITYGETGGNSPVQEFTVPGSK 95.00% 6.04 0.557 4.09 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% ITYGETGGNSPVQEFTVPGSK 95.00% 5.99 0.54 5.68 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% ITYGETGGNSPVQEFTVPGSK 95.00% 5.93 0.543 3.82 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% ITYGETGGNSPVQEFTVPGSK 95.00% 5.16 0.552 4.57 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.79 0.544 6.15 1,199.05 2,396.08 2,396.09 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.7 0.55 6.32 1,199.05 2,396.08 2,396.09 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.58 0.576 7.77 1,199.05 2,396.09 2,396.09 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.82 0.582 6.74 1,199.05 2,396.09 2,396.09 2
 SAMPLE 4 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 36 42 295 22.40% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.96 0.553 8.77 1,199.05 2,396.09 2,396.09 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WSRPQAPITGYR 95.00% 3.76 0.321 2.12 477.922 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WSRPQAPITGYR 95.00% 3.75 0.414 2.35 477.9222 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WSRPQAPITGYR 95.00% 3.27 0.383 0 477.9222 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WSRPQAPITGYR 95.00% 2.57 0.244 0 477.9223 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WSRPQAPITGYR 95.00% 3.54 0.346 2.12 477.9223 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WSRPQAPITGYR 95.00% 3.29 0.302 1.54 477.9224 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WSRPQAPITGYR 95.00% 3.5 0.243 2.31 477.9225 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WSRPQAPITGYR 95.00% 2.51 0.205 0 477.9226 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WSRPQAPITGYR 95.00% 3.07 0.145 1.27 477.9226 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WSRPQAPITGYR 95.00% 2.72 0.236 0 477.9235 1,430.75 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WSRPQAPITGYR 95.00% 3.41 0.347 1.27 478.2556 1,431.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WSRPQAPITGYR 95.00% 3.73 0.339 2.33 478.2581 1,431.75 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GDSPASSKPISINYR 95.00% 2.67 0.373 1.62 531.2739 1,590.80 1,591.81 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GDSPASSKPISINYR 95.00% 1.97 0.269 0 531.2751 1,590.80 1,591.81 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GDSPASSKPISINYR 95.00% 2.82 0.454 0 531.6093 1,591.80 1,591.81 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GDSPASSKPISINYR 95.00% 3.49 0.354 0 531.6094 1,591.80 1,591.81 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GDSPASSKPISINYR 95.00% 3.28 0.359 1.35 531.6098 1,591.81 1,591.81 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GDSPASSKPISINYR 95.00% 3.21 0.323 1.2 531.6102 1,591.81 1,591.81 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VDVIPVNLPGEHGQR 95.00% 2.47 0.347 0 543.9637 1,628.87 1,629.87 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VDVIPVNLPGEHGQR 95.00% 2.44 0.332 1.38 543.9637 1,628.87 1,629.87 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VDVIPVNLPGEHGQR 95.00% 2.5 0.29 0 544.2993 1,629.87 1,629.87 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 3.45 0.435 1.62 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2659 1,650.77 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 3.86 0.341 2.24 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2659 1,650.77 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 3.79 0.418 1.72 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2663 1,650.78 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 4.2 0.432 4 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2664 1,650.78 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 3.84 0.485 3.16 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2668 1,650.78 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 3.6 0.362 4.01 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2668 1,650.78 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 3.56 0.295 2.29 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2669 1,650.78 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 3.73 0.398 2.24 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2671 1,650.78 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 3.67 0.381 2.64 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2676 1,650.78 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 2.75 0.413 1.74 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2682 1,650.78 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 3.51 0.388 2.47 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.6006 1,651.78 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 3.54 0.383 3.8 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.6013 1,651.78 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 2.86 0.415 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.6014 1,651.78 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 4 0.409 2.43 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.6022 1,651.78 1,651.78 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% STTPDITGYR 95.00% 2.08 0.51 0 555.7759 1,109.54 1,110.54 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% STTPDITGYR 95.00% 2.1 0.345 0 555.776 1,109.54 1,110.54 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% STTPDITGYR 95.00% 1.92 0.549 2 555.7764 1,109.54 1,110.54 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% STTPDITGYR 95.00% 1.99 0.417 1.3 555.7766 1,109.54 1,110.54 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% STTPDITGYR 95.00% 2.1 0.496 0 555.7767 1,109.54 1,110.54 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% STTPDITGYR 95.00% 2.28 0.499 1.37 555.7768 1,109.54 1,110.54 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% STTPDITGYR 95.00% 2.38 0.394 1.22 555.7768 1,109.54 1,110.54 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% STTPDITGYR 95.00% 1.55 0.359 1.22 555.7769 1,109.54 1,110.54 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% FTNIGPDTMR 95.00% 2.3 0.289 1.57 576.7824 1,151.55 1,151.55 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 2.65 0.445 0 606.9971 1,817.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 2.23 0.399 0 606.9973 1,817.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 2.71 0.363 0 606.9973 1,817.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 2.93 0.527 0 607.3308 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 2.52 0.492 0 607.331 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 2.21 0.441 0 607.3311 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 2.82 0.488 0 607.3316 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 2.98 0.353 0 607.3317 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 2.17 0.373 0 607.3317 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 2.66 0.295 0 607.3319 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 2.19 0.406 0 607.3321 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WKEATIPGHLNSYTIK 95.00% 2.27 0.378 0 620.3374 1,857.99 1,857.99 3 MCF2L_HUMAN,F10A1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WKEATIPGHLNSYTIK 95.00% 2.43 0.317 0 620.339 1,857.99 1,857.99 3 MCF2L_HUMAN,F10A1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% HTSVQTTSSGSGPFTDVR 95.00% 3.86 0.521 1.12 621.9676 1,862.88 1,863.88 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% HTSVQTTSSGSGPFTDVR 95.00% 4.76 0.556 2.43 621.9683 1,862.88 1,863.88 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% HTSVQTTSSGSGPFTDVR 95.00% 4.58 0.594 1 622.3016 1,863.88 1,863.88 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% HTSVQTTSSGSGPFTDVR 95.00% 4.68 0.554 2.64 622.3017 1,863.88 1,863.88 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% FLATTPNSLLVSWQPPR 95.00% 2.83 0.316 0 643.3567 1,927.05 1,927.04 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% FLATTPNSLLVSWQPPR 95.00% 3.24 0.372 0 643.3573 1,927.05 1,927.04 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALK 95.00% 2.62 0.351 0 646.3662 1,290.72 1,291.73 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALK 95.00% 3.5 0.428 0 646.3674 1,290.72 1,291.73 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALK 95.00% 2.97 0.396 0 646.3681 1,290.72 1,291.73 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALK 95.00% 3.3 0.468 0 646.3684 1,290.72 1,291.73 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% DLQFVEVTDVK 95.00% 3.09 0.497 2.21 646.8409 1,291.67 1,292.67 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% DLQFVEVTDVK 95.00% 3.26 0.49 2.05 646.842 1,291.67 1,292.67 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% DLQFVEVTDVK 95.00% 2.68 0.292 0 646.8427 1,291.67 1,292.67 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% DLQFVEVTDVK 95.00% 2.35 0.268 0 646.843 1,291.67 1,292.67 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% DLQFVEVTDVK 95.00% 2.44 0.285 0 646.8432 1,291.67 1,292.67 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WLPSSSPVTGYR 95.00% 2.35 0.485 1.6 675.3473 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WLPSSSPVTGYR 95.00% 2.31 0.407 1.46 675.3473 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WLPSSSPVTGYR 95.00% 1.94 0.389 1.85 675.3476 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WLPSSSPVTGYR 95.00% 2.3 0.438 2.32 675.3479 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WLPSSSPVTGYR 95.00% 2.13 0.333 2.3 675.348 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WLPSSSPVTGYR 95.00% 2.4 0.501 2.23 675.3481 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WLPSSSPVTGYR 95.00% 2.6 0.505 1.54 675.3487 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% WLPSSSPVTGYR 95.00% 2.47 0.464 1.64 675.8493 1,349.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 3.26 0.443 1.33 678.3528 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 2.89 0.413 2.4 678.3528 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 3.7 0.448 1.92 678.3529 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 2.92 0.312 0 678.353 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 3.73 0.439 3.29 678.3532 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 3.17 0.429 2.32 678.3532 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 3.49 0.421 2.11 678.3535 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 3.59 0.477 2.39 678.3535 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 4.13 0.466 1.66 678.3535 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 2.97 0.467 1.55 678.3538 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 3.72 0.418 1.85 678.3538 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 2.66 0.439 0 678.3539 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 3.85 0.481 1.68 678.3542 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 2.31 0.378 0 678.3548 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 2.55 0.292 0 678.3556 1,354.70 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 2.49 0.434 0 678.356 1,354.70 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IYLYTLNDNAR 95.00% 3.69 0.429 1.92 678.8543 1,355.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IAWESPQGQVSR 95.00% 2.47 0.405 0 679.0302 1,356.04 1,357.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IAWESPQGQVSR 95.00% 2.58 0.351 1.68 679.3469 1,356.68 1,357.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IAWESPQGQVSR 95.00% 3.09 0.231 1.43 679.3488 1,356.68 1,357.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IAWESPQGQVSR 95.00% 2.21 0.16 1.64 679.349 1,356.68 1,357.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IAWESPQGQVSR 95.00% 3.02 0.214 2.35 679.3498 1,356.68 1,357.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IAWESPQGQVSR 95.00% 2.84 0.322 1.28 679.3509 1,356.69 1,357.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% IAWESPQGQVSR 95.00% 2.61 0.328 2.82 679.3512 1,356.69 1,357.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GLAFTDVDVDSIK 95.00% 2.78 0.442 1.6 690.3575 1,378.70 1,379.71 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GLAFTDVDVDSIK 95.00% 3.64 0.565 2.82 690.3585 1,378.70 1,379.71 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GLAFTDVDVDSIK 95.00% 3.76 0.56 3.33 690.3585 1,378.70 1,379.71 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GLAFTDVDVDSIK 95.00% 3.52 0.5 2.17 690.3586 1,378.70 1,379.71 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GLAFTDVDVDSIK 95.00% 2.51 0.339 0 690.3587 1,378.70 1,379.71 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GLAFTDVDVDSIK 95.00% 3.58 0.523 3.09 690.3589 1,378.70 1,379.71 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GLAFTDVDVDSIK 95.00% 3.85 0.54 2.32 690.359 1,378.70 1,379.71 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GLAFTDVDVDSIK 95.00% 2.58 0.298 0 690.359 1,378.70 1,379.71 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GLAFTDVDVDSIK 95.00% 3.96 0.538 2.49 690.8587 1,379.70 1,379.71 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 4.04 0.612 6.06 731.4002 1,460.78 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 3.21 0.606 4.74 731.4004 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 4.12 0.599 8.14 731.4016 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 4 0.607 4.43 731.4018 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 3.78 0.538 5.68 731.4019 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 4.34 0.659 4.42 731.4019 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 3.69 0.657 5.72 731.4021 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 4.36 0.677 5.96 731.4021 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 3.07 0.537 4.96 731.4023 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 3.96 0.615 7.08 731.4024 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 4.31 0.622 5.25 731.4024 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 4.04 0.673 5.51 731.403 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 3.52 0.646 5.31 731.4032 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 3.88 0.625 5.57 731.4048 1,460.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GNLLQcIcTGNGR 95.00% 3.35 0.297 3.48 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8489 1,461.68 1,462.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GNLLQcIcTGNGR 95.00% 3.6 0.334 3.89 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8492 1,461.68 1,462.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GNLLQcIcTGNGR 95.00% 3.84 0.367 6.24 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8507 1,461.69 1,462.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GNLLQcIcTGNGR 95.00% 3.96 0.357 4.49 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8509 1,461.69 1,462.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GNLLQcIcTGNGR 95.00% 2.65 0.21 0 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8511 1,461.69 1,462.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GNLLQcIcTGNGR 95.00% 3.57 0.342 4.72 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8513 1,461.69 1,462.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GNLLQcIcTGNGR 95.00% 3.72 0.356 5.08 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8514 1,461.69 1,462.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GNLLQcIcTGNGR 95.00% 3.43 0.264 3.96 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8515 1,461.69 1,462.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GNLLQcIcTGNGR 95.00% 3.6 0.305 4.62 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8525 1,461.69 1,462.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GNLLQcIcTGNGR 95.00% 3.28 0.165 3.8 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8529 1,461.69 1,462.69 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 4.18 0.636 4.6 731.9012 1,461.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 3.57 0.634 5.27 731.9021 1,461.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 3.76 0.596 5.24 731.9023 1,461.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 3.79 0.59 4.77 731.9033 1,461.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VPGTSTSATLTGLTR 95.00% 3.94 0.611 5.07 731.904 1,461.79 1,461.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GEWTcIAYSQLR 95.00% 3.67 0.475 0 c5: Carbamidomethyl (+57.02) 742.3518 1,482.69 1,483.70 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GEWTcIAYSQLR 95.00% 3.09 0.441 0 c5: Carbamidomethyl (+57.02) 742.3526 1,482.69 1,483.70 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GEWTcIAYSQLR 95.00% 3.65 0.497 0 c5: Carbamidomethyl (+57.02) 742.3535 1,482.69 1,483.70 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GEWTcIAYSQLR 95.00% 3.48 0.488 1.62 c5: Carbamidomethyl (+57.02) 742.3537 1,482.69 1,483.70 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GEWTcIAYSQLR 95.00% 3.63 0.478 1.68 c5: Carbamidomethyl (+57.02) 742.3538 1,482.69 1,483.70 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GEWTcIAYSQLR 95.00% 3.77 0.485 1.38 c5: Carbamidomethyl (+57.02) 742.3545 1,482.69 1,483.70 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GEWTcIAYSQLR 95.00% 3.33 0.489 1.48 c5: Carbamidomethyl (+57.02) 742.3555 1,482.70 1,483.70 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GEWTcIAYSQLR 95.00% 3.48 0.418 0 c5: Carbamidomethyl (+57.02) 742.3576 1,482.70 1,483.70 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GEWTcIAYSQLR 95.00% 3.6 0.476 1.24 c5: Carbamidomethyl (+57.02) 742.856 1,483.70 1,483.70 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GEWTcIAYSQLR 95.00% 3.56 0.435 1.77 c5: Carbamidomethyl (+57.02) 742.8566 1,483.70 1,483.70 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GEWTcIAYSQLR 95.00% 3.7 0.418 1.96 c5: Carbamidomethyl (+57.02) 742.8575 1,483.70 1,483.70 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% SYTITGLQPGTDYK 95.00% 4.01 0.509 3.59 772.3869 1,542.76 1,543.76 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EATIPGHLNSYTIK 95.00% 2.01 0.326 2.49 772.4127 1,542.81 1,543.81 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EATIPGHLNSYTIK 95.00% 2.5 0.374 1.57 772.4137 1,542.81 1,543.81 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EATIPGHLNSYTIK 95.00% 2.28 0.186 1.36 772.4138 1,542.81 1,543.81 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% SYTITGLQPGTDYK 95.00% 4.51 0.497 3.8 772.8911 1,543.77 1,543.76 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% SYTITGLQPGTDYK 95.00% 3.54 0.365 0 772.8922 1,543.77 1,543.76 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% SYTITGLQPGTDYK 95.00% 3.09 0.253 0 772.8926 1,543.77 1,543.76 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GDSPASSKPISINYR 95.00% 3.93 0.571 3.13 796.4097 1,590.80 1,591.81 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GDSPASSKPISINYR 95.00% 4.1 0.564 3.85 796.4102 1,590.80 1,591.81 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GDSPASSKPISINYR 95.00% 4.23 0.575 2.96 796.4103 1,590.81 1,591.81 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GDSPASSKPISINYR 95.00% 3.93 0.547 4.02 796.4109 1,590.81 1,591.81 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GDSPASSKPISINYR 95.00% 4.21 0.603 3.37 796.411 1,590.81 1,591.81 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.79 0.621 6.04 799.7037 2,396.09 2,396.09 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.45 0.594 5.96 799.7039 2,396.09 2,396.09 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.86 0.566 5.32 799.704 2,396.09 2,396.09 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.18 0.618 4.62 799.7042 2,396.09 2,396.09 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.57 0.632 6.42 799.7043 2,396.09 2,396.09 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.83 0.57 5.14 799.7045 2,396.09 2,396.09 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.98 0.624 5.74 799.7046 2,396.09 2,396.09 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 6.03 0.614 8 799.7048 2,396.09 2,396.09 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.76 0.654 6.27 799.7054 2,396.09 2,396.09 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.12 0.599 4.77 799.7057 2,396.09 2,396.09 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.25 0.592 3.85 799.7062 2,396.10 2,396.09 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VDVIPVNLPGEHGQR 95.00% 3.43 0.281 4 815.4411 1,628.87 1,629.87 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.88 0.503 3.07 821.745 2,462.21 2,462.21 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% DDKESVPISDTIIPAVPPPTDLR 95.00% 2.95 0.288 2.49 826.107 2,475.30 2,475.30 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% DDKESVPISDTIIPAVPPPTDLR 95.00% 3.45 0.309 0 826.108 2,475.30 2,475.30 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% LLcQcLGFGSGHFR 95.00% 4.22 0.475 4.89 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.3993 1,650.78 1,651.78 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% PAQGVVTTLENVSPPR 95.00% 3.73 0.487 0 832.9538 1,663.89 1,664.90 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% PAQGVVTTLENVSPPR 95.00% 3.36 0.431 0 832.957 1,663.90 1,664.90 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.13 0.37 1.6 858.4517 2,572.33 2,572.34 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.41 0.456 3 858.4536 2,572.34 2,572.34 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TKTETITGFQVDAVPANGQTPIQR 95.00% 3.65 0.325 3 858.4543 2,572.34 2,572.34 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TKTETITGFQVDAVPANGQTPIQR 95.00% 3.67 0.354 1.96 858.4583 2,572.35 2,572.34 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 3.96 0.509 5.08 866.9771 1,731.94 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.1 0.604 6.09 866.9793 1,731.94 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.51 0.579 6.14 866.9799 1,731.94 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.36 0.546 5.6 866.9799 1,731.94 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 3.87 0.567 4 866.9799 1,731.94 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.04 0.598 5.62 866.9805 1,731.95 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.25 0.552 6.72 866.9807 1,731.95 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.76 0.544 5.66 866.9809 1,731.95 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.31 0.584 5.8 866.9817 1,731.95 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.62 0.612 5.77 867.4787 1,732.94 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.72 0.557 6.18 867.4801 1,732.94 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.18 0.594 4.62 867.4803 1,732.95 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.83 0.56 5.92 867.4803 1,732.95 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.62 0.562 5.92 867.4808 1,732.95 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.87 0.564 6.92 867.4811 1,732.95 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NLQPASEYTVSLVAIK 95.00% 4.1 0.606 5.3 867.4822 1,732.95 1,732.95 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TYLGNALVcTcYGGSR 95.00% 4.6 0.528 5.96 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4065 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TYLGNALVcTcYGGSR 95.00% 4.87 0.458 3.48 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4097 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TYLGNALVcTcYGGSR 95.00% 4.17 0.474 5.24 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4106 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TYLGNALVcTcYGGSR 95.00% 5.42 0.628 5.12 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4111 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TYLGNALVcTcYGGSR 95.00% 4.43 0.487 3.48 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4126 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TYLGNALVcTcYGGSR 95.00% 5.06 0.551 4.22 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.413 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TYLGNALVcTcYGGSR 95.00% 5.55 0.584 5.89 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4131 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TYLGNALVcTcYGGSR 95.00% 4.92 0.628 3.8 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.414 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TYLGNALVcTcYGGSR 95.00% 5.12 0.625 4.35 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4143 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% TYLGNALVcTcYGGSR 95.00% 5.67 0.576 5.32 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9149 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VTIMWTPPESAVTGYR 95.00% 3.06 0.413 2.36 904.4552 1,806.89 1,807.91 2 PDC6I_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 4.72 0.453 2.8 910.4922 1,818.97 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 4.32 0.444 3.8 910.4932 1,818.97 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 4.58 0.421 3.14 910.4935 1,818.97 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 4.51 0.402 3.24 910.4943 1,818.97 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GATYNIIVEALKDQQR 95.00% 4.45 0.491 3.41 910.4958 1,818.98 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VTImWTPPESAVTGYR 95.00% 3.09 0.473 2.07 m4: Oxidation (+15.99) 912.4522 1,822.89 1,823.90 2 PDC6I_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% VTImWTPPESAVTGYR 95.00% 3.22 0.469 2.41 m4: Oxidation (+15.99) 912.4576 1,822.90 1,823.90 2 PDC6I_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% HTSVQTTSSGSGPFTDVR 95.00% 5.5 0.524 9.11 932.9497 1,863.88 1,863.88 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 5.28 0.569 3.8 934.1646 2,799.47 2,799.48 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 4.96 0.665 4.31 934.1683 2,799.48 2,799.48 3
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EYLGAIcScTcFGGQR 95.00% 5.06 0.63 3.96 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8998 1,877.78 1,878.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EYLGAIcScTcFGGQR 95.00% 4.29 0.566 4.64 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9013 1,877.79 1,878.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EYLGAIcScTcFGGQR 95.00% 4.58 0.601 3.92 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9028 1,877.79 1,878.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EYLGAIcScTcFGGQR 95.00% 4.87 0.625 4.25 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9041 1,877.79 1,878.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EYLGAIcScTcFGGQR 95.00% 3.62 0.531 2.28 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9083 1,877.80 1,878.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EYLGAIcScTcFGGQR 95.00% 4.7 0.646 3.7 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3989 1,878.78 1,878.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EYLGAIcScTcFGGQR 95.00% 3.81 0.525 2.23 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4016 1,878.79 1,878.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EYLGAIcScTcFGGQR 95.00% 4.99 0.621 4.32 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4026 1,878.79 1,878.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EYLGAIcScTcFGGQR 95.00% 3.78 0.644 4.25 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4031 1,878.79 1,878.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EYLGAIcScTcFGGQR 95.00% 5.22 0.621 4.54 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4043 1,878.79 1,878.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EYLGAIcScTcFGGQR 95.00% 5.3 0.622 5.24 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4048 1,878.79 1,878.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EYLGAIcScTcFGGQR 95.00% 4.74 0.615 5.82 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4084 1,878.80 1,878.79 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% SSPVVIDASTAIDAPSNLR 95.00% 5.5 0.575 5.85 957.0044 1,911.99 1,913.00 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% SSPVVIDASTAIDAPSNLR 95.00% 4.49 0.544 4.24 957.005 1,911.99 1,913.00 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% SSPVVIDASTAIDAPSNLR 95.00% 4.13 0.606 4.2 957.0058 1,912.00 1,913.00 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% SSPVVIDASTAIDAPSNLR 95.00% 4.52 0.544 4.77 957.0064 1,912.00 1,913.00 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% SSPVVIDASTAIDAPSNLR 95.00% 5.31 0.561 5.52 957.5057 1,913.00 1,913.00 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% SSPVVIDASTAIDAPSNLR 95.00% 5.57 0.565 4.57 957.508 1,913.00 1,913.00 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% FLATTPNSLLVSWQPPR 95.00% 2.65 0.412 0 963.5525 1,925.09 1,927.04 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% FLATTPNSLLVSWQPPR 95.00% 4 0.573 2.41 964.5257 1,927.04 1,927.04 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% FLATTPNSLLVSWQPPR 95.00% 3.79 0.538 4.09 964.5277 1,927.04 1,927.04 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% FLATTPNSLLVSWQPPR 95.00% 4.2 0.554 4.85 964.5278 1,927.04 1,927.04 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% FLATTPNSLLVSWQPPR 95.00% 4.04 0.489 4.44 964.528 1,927.04 1,927.04 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% FLATTPNSLLVSWQPPR 95.00% 4.01 0.476 3.15 964.5302 1,927.04 1,927.04 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% FLATTPNSLLVSWQPPR 95.00% 3.41 0.621 0 964.5302 1,927.04 1,927.04 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% FLATTPNSLLVSWQPPR 95.00% 3.2 0.563 3.54 964.533 1,927.05 1,927.04 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EESPLLIGQQSTVSDVPR 95.00% 4.42 0.59 6.04 978.0086 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EESPLLIGQQSTVSDVPR 95.00% 4.09 0.587 5.6 978.0135 1,954.01 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EESPLLIGQQSTVSDVPR 95.00% 4.67 0.516 6.32 978.511 1,955.01 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EESPLLIGQQSTVSDVPR 95.00% 4.64 0.508 4.54 978.5114 1,955.01 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EESPLLIGQQSTVSDVPR 95.00% 4.33 0.564 5.39 978.5123 1,955.01 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EESPLLIGQQSTVSDVPR 95.00% 4.5 0.551 4.04 978.5127 1,955.01 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% EESPLLIGQQSTVSDVPR 95.00% 4.86 0.554 3.6 978.5128 1,955.01 1,955.01 2 MYPT2_HUMAN
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% NTFAEVTGLSPGVTYYFK 95.00% 2.87 0.491 0 997.5008 1,992.99 1,993.99 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% ITYGETGGNSPVQEFTVPGSK 95.00% 3.84 0.503 4.43 1,084.53 2,167.05 2,168.05 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% ITYGETGGNSPVQEFTVPGSK 95.00% 5.75 0.542 5.7 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% ITYGETGGNSPVQEFTVPGSK 95.00% 5.69 0.54 7.02 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% ITYGETGGNSPVQEFTVPGSK 95.00% 5.74 0.513 4.85 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% ITYGETGGNSPVQEFTVPGSK 95.00% 5.4 0.539 5.52 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% ITYGETGGNSPVQEFTVPGSK 95.00% 5.85 0.557 5.89 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% ITYGETGGNSPVQEFTVPGSK 95.00% 5.5 0.513 5.43 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% ITYGETGGNSPVQEFTVPGSK 95.00% 5.52 0.531 6.04 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% ITYGETGGNSPVQEFTVPGSK 95.00% 5.91 0.541 5.59 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% ITYGETGGNSPVQEFTVPGSK 95.00% 5.57 0.487 4.89 1,085.03 2,168.05 2,168.05 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.01 0.526 6 1,198.55 2,395.09 2,396.09 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.94 0.59 6.55 1,199.05 2,396.09 2,396.09 2
 SAMPLE 4R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 35 42 271 22.10% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.72 0.529 3.52 1,199.06 2,396.10 2,396.09 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IScTIANR 95.00% 2.04 0.258 0 c3: Carbamidomethyl (+57.02) 467.7435 933.4713 934.4781 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HYQINQQWER 95.00% 2.81 0.116 0 467.8942 1,400.66 1,401.67 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HYQINQQWER 95.00% 3.39 0.217 0 467.8956 1,400.66 1,401.67 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WSRPQAPITGYR 95.00% 3.26 0.208 2.59 477.921 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WSRPQAPITGYR 95.00% 2.5 0.342 0 477.9212 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WSRPQAPITGYR 95.00% 3.58 0.302 2.39 477.9214 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WSRPQAPITGYR 95.00% 3.44 0.315 2.77 477.9219 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WSRPQAPITGYR 95.00% 3.54 0.303 1.92 477.9219 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WSRPQAPITGYR 95.00% 3.59 0.301 2.77 477.9224 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WSRPQAPITGYR 95.00% 3.63 0.199 1.96 478.2549 1,431.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.31 0.465 1.66 c5: Carbamidomethyl (+57.02) 495.2372 1,482.69 1,483.70 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.73 0.474 2.8 c5: Carbamidomethyl (+57.02) 495.2378 1,482.69 1,483.70 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 4.41 0.572 2.24 c5: Carbamidomethyl (+57.02) 495.238 1,482.69 1,483.70 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.44 0.379 0 c5: Carbamidomethyl (+57.02) 495.5705 1,483.69 1,483.70 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.68 0.497 1.59 c5: Carbamidomethyl (+57.02) 495.5717 1,483.69 1,483.70 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.86 0.461 2 c5: Carbamidomethyl (+57.02) 495.5727 1,483.69 1,483.70 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 3.44 0.395 0 531.2724 1,590.79 1,591.81 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 3.4 0.511 1.74 531.2728 1,590.80 1,591.81 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 2.79 0.498 2.08 531.2729 1,590.80 1,591.81 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 2.26 0.326 1.82 531.2731 1,590.80 1,591.81 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 3.45 0.439 1.8 531.2731 1,590.80 1,591.81 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 2.88 0.454 2.23 531.2733 1,590.80 1,591.81 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 3.07 0.446 1.24 531.2738 1,590.80 1,591.81 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 3.25 0.404 1.2 531.2741 1,590.80 1,591.81 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 2.52 0.296 0 531.2744 1,590.80 1,591.81 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 3.26 0.472 1.26 531.6079 1,591.80 1,591.81 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% YEVSVYALK 95.00% 2.55 0.233 0 536.2884 1,070.56 1,071.57 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% YEVSVYALK 95.00% 2.6 0.241 1.19 536.2891 1,070.56 1,071.57 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% QYNVGPSVSKYPLR 95.00% 3.11 0.333 0 536.6221 1,606.84 1,607.85 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% QYNVGPSVSKYPLR 95.00% 2.84 0.399 0 536.6223 1,606.84 1,607.85 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% QYNVGPSVSKYPLR 95.00% 3.19 0.55 0 536.6223 1,606.84 1,607.85 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% QYNVGPSVSKYPLR 95.00% 3.64 0.567 1.55 536.9563 1,607.85 1,607.85 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VDVIPVNLPGEHGQR 95.00% 2.3 0.32 0 543.9619 1,628.86 1,629.87 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VDVIPVNLPGEHGQR 95.00% 1.72 0.244 0.959 543.9619 1,628.86 1,629.87 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.65 0.35 1.89 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2631 1,650.77 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 4.21 0.435 4.7 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2637 1,650.77 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.75 0.388 2.82 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2639 1,650.77 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 4.14 0.442 2.51 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.265 1,650.77 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.2 0.384 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2651 1,650.77 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.63 0.452 1.54 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2653 1,650.77 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.46 0.372 2.72 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2653 1,650.77 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.68 0.483 4.89 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.599 1,651.77 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.46 0.363 2.34 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5992 1,651.77 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.33 0.35 4.57 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5992 1,651.77 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.44 0.387 2.1 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5993 1,651.77 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.81 0.321 3.48 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.6001 1,651.78 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.65 0.384 1.62 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.6058 1,651.79 1,651.78 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 3.15 0.32 0 555.6358 1,663.88 1,664.90 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 3.42 0.209 0 555.6359 1,663.88 1,664.90 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 2.5 0.243 0 555.6359 1,663.88 1,664.90 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 3.37 0.366 0 555.636 1,663.88 1,664.90 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 2.6 0.298 0 555.6367 1,663.89 1,664.90 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 3.27 0.208 0 555.6381 1,663.89 1,664.90 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% STTPDITGYR 95.00% 1.94 0.383 0 555.7738 1,109.53 1,110.54 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% STTPDITGYR 95.00% 2.17 0.519 1.6 555.7741 1,109.53 1,110.54 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% STTPDITGYR 95.00% 2.3 0.45 0 555.7743 1,109.53 1,110.54 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% STTPDITGYR 95.00% 2.16 0.563 2.51 555.7745 1,109.53 1,110.54 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 3.72 0.262 0 555.9701 1,664.89 1,664.90 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 3.48 0.267 0 555.9707 1,664.89 1,664.90 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FTNIGPDTMR 95.00% 3.03 0.453 1.85 576.2758 1,150.54 1,151.55 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FTNIGPDTMR 95.00% 2.9 0.442 1.89 576.2784 1,150.54 1,151.55 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FTNIGPDTMR 95.00% 2.98 0.409 1.59 576.2785 1,150.54 1,151.55 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FTNIGPDTMR 95.00% 2.99 0.444 2.18 576.2787 1,150.54 1,151.55 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FTNIGPDTMR 95.00% 2.9 0.457 2.52 576.279 1,150.54 1,151.55 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FTNIGPDTMR 95.00% 2.79 0.369 1.25 576.279 1,150.54 1,151.55 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FTNIGPDTMR 95.00% 2.87 0.406 1.77 576.2793 1,150.54 1,151.55 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FTNIGPDTMR 95.00% 2.83 0.453 2.09 576.2795 1,150.54 1,151.55 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FTNIGPDTMR 95.00% 2.69 0.409 0 576.2816 1,150.55 1,151.55 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.33 0.473 1.52 578.319 1,731.93 1,732.95 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.66 0.426 2.72 578.3192 1,731.93 1,732.95 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.83 0.464 2.15 578.3199 1,731.94 1,732.95 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.81 0.431 3.8 578.3204 1,731.94 1,732.95 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 5.33 0.47 2.72 578.6547 1,732.94 1,732.95 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.98 0.391 3.09 578.6548 1,732.94 1,732.95 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% YEVSVYALKDTLTSR 95.00% 3.26 0.545 0 582.3076 1,743.90 1,744.91 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% YEVSVYALKDTLTSR 95.00% 3.45 0.533 0 582.6423 1,744.90 1,744.91 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FTNIGPDTmR 95.00% 2.56 0.283 0 m9: Oxidation (+15.99) 584.2748 1,166.53 1,167.55 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VTIMWTPPESAVTGYR 95.00% 4.19 0.588 1.13 603.6397 1,807.90 1,807.91 3 PDC6I_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VTIMWTPPESAVTGYR 95.00% 3.35 0.331 0 603.642 1,807.90 1,807.91 3 PDC6I_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 2.17 0.415 0 606.9942 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 2.31 0.366 0 606.9943 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 2.84 0.417 0 606.9947 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 2.1 0.399 0 606.9948 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 2.83 0.511 0 607.3251 1,818.95 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 2.87 0.409 0 607.328 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 2.37 0.407 0 607.3282 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 2.47 0.399 0 607.3286 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 2.78 0.44 0 607.3287 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 2.37 0.282 0 607.3298 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TFYScTTEGR 95.00% 1.75 0.505 0 c5: Carbamidomethyl (+57.02) 611.2607 1,220.51 1,221.52 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 4.21 0.56 2.11 621.9647 1,862.87 1,863.88 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 3.84 0.498 1.74 621.9648 1,862.87 1,863.88 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 4.18 0.55 1.39 621.965 1,862.87 1,863.88 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 4.53 0.517 1.77 621.965 1,862.87 1,863.88 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 3.33 0.52 2 621.9653 1,862.87 1,863.88 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 3.61 0.531 0 621.9653 1,862.87 1,863.88 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 3.8 0.526 1.02 622.2971 1,863.87 1,863.88 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 4.44 0.618 0 622.2975 1,863.87 1,863.88 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 4.38 0.516 0.959 622.2986 1,863.87 1,863.88 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 4.35 0.527 1.92 622.2994 1,863.87 1,863.88 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 4.08 0.455 2.14 622.3015 1,863.88 1,863.88 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 5.01 0.595 2.89 622.303 1,863.89 1,863.88 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 2.5 0.345 0 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 626.9363 1,877.79 1,878.79 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 2.58 0.414 0 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 627.2706 1,878.79 1,878.79 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SSPVVIDASTAIDAPSNLR 95.00% 2.44 0.26 0 638.3359 1,911.98 1,913.00 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SSPVVIDASTAIDAPSNLR 95.00% 4.71 0.538 3.7 638.3361 1,911.98 1,913.00 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SSPVVIDASTAIDAPSNLR 95.00% 5.06 0.498 4.02 638.3371 1,911.99 1,913.00 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SSPVVIDASTAIDAPSNLR 95.00% 4.15 0.5 1.66 638.6708 1,912.99 1,913.00 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SSPVVIDASTAIDAPSNLR 95.00% 4.2 0.513 1.15 638.6719 1,912.99 1,913.00 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.06 0.59 2.09 643.0178 1,926.03 1,927.04 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.16 0.618 2.74 643.019 1,926.03 1,927.04 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 5.38 0.552 2.29 643.3535 1,927.04 1,927.04 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 5.45 0.562 4.49 643.3538 1,927.04 1,927.04 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.74 0.556 3.28 643.3538 1,927.04 1,927.04 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.37 0.515 3.29 643.3539 1,927.04 1,927.04 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DLQFVEVTDVK 95.00% 3.75 0.539 2.15 646.8384 1,291.66 1,292.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DLQFVEVTDVK 95.00% 2.98 0.497 2.04 646.8391 1,291.66 1,292.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DLQFVEVTDVK 95.00% 4.11 0.513 2.64 646.8393 1,291.66 1,292.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DLQFVEVTDVK 95.00% 4.12 0.501 2.59 646.8394 1,291.66 1,292.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DLQFVEVTDVK 95.00% 3.92 0.512 2.17 646.8398 1,291.66 1,292.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DLQFVEVTDVK 95.00% 3.3 0.489 2.24 646.8401 1,291.66 1,292.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DLQFVEVTDVK 95.00% 3.96 0.496 2.57 646.8401 1,291.66 1,292.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DLQFVEVTDVK 95.00% 2.84 0.393 1.82 646.8407 1,291.67 1,292.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DLQFVEVTDVK 95.00% 2.65 0.329 0 647.3431 1,292.67 1,292.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EESPLLIGQQSTVSDVPR 95.00% 2.51 0.412 0 652.34 1,954.00 1,955.01 3 MYPT2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EESPLLIGQQSTVSDVPR 95.00% 3.68 0.548 0 652.6744 1,955.00 1,955.01 3 MYPT2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NTFAEVTGLSPGVTYYFK 95.00% 3.48 0.365 4.49 665.6684 1,993.98 1,993.99 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NTFAEVTGLSPGVTYYFK 95.00% 4.32 0.559 3.27 665.6689 1,993.98 1,993.99 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WLPSSSPVTGYR 95.00% 2.48 0.406 1.8 675.344 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WLPSSSPVTGYR 95.00% 2.41 0.447 2.55 675.3441 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WLPSSSPVTGYR 95.00% 2.54 0.491 1.8 675.3447 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WLPSSSPVTGYR 95.00% 2.47 0.414 2.29 675.3452 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WLPSSSPVTGYR 95.00% 2.34 0.456 0 675.3452 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WLPSSSPVTGYR 95.00% 2.8 0.527 1.3 675.3454 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WLPSSSPVTGYR 95.00% 2.17 0.408 1.8 675.3456 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WLPSSSPVTGYR 95.00% 2.72 0.439 2.74 675.3457 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WLPSSSPVTGYR 95.00% 2.48 0.484 1.82 675.3458 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 3.82 0.421 1.68 678.3495 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 3.56 0.461 2.27 678.3505 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 4.04 0.466 1.6 678.3505 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 3.84 0.464 1.85 678.3506 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 4.31 0.444 2 678.3507 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 4.22 0.477 2.31 678.3509 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 3.48 0.484 3.28 678.351 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 2.51 0.274 0 678.351 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 3.77 0.432 1.28 678.3512 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 3.84 0.38 1.92 678.3512 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 2.89 0.418 1.66 678.3514 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 4.05 0.461 2.13 678.3515 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 2.51 0.336 1.33 678.3515 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 3.67 0.476 2.72 678.3515 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% IYLYTLNDNAR 95.00% 2.98 0.355 1.21 678.3576 1,354.70 1,355.70 2 FBN1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GFNcESKPEAEETcFDK 95.00% 2.68 0.203 0 c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 683.2829 2,046.83 2,047.84 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GLAFTDVDVDSIK 95.00% 3.31 0.509 4.11 690.3546 1,378.69 1,379.71 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GLAFTDVDVDSIK 95.00% 2.92 0.497 2.57 690.3562 1,378.70 1,379.71 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GLAFTDVDVDSIK 95.00% 3.4 0.472 3.43 690.3571 1,378.70 1,379.71 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HYQINQQWER 95.00% 3.16 0.46 1.92 701.334 1,400.65 1,401.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HYQINQQWER 95.00% 2.73 0.441 2.17 701.334 1,400.65 1,401.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HYQINQQWER 95.00% 3.58 0.464 1.85 701.3348 1,400.65 1,401.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HYQINQQWER 95.00% 2.77 0.43 2.07 701.3365 1,400.66 1,401.67 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EINLAPDSSSVVVSGLMVATK 95.00% 4.28 0.539 3.04 706.7087 2,117.10 2,117.12 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% ITYGETGGNSPVQEFTVPGSK 95.00% 4.07 0.541 2.54 723.6879 2,168.04 2,168.05 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.22 0.64 4.54 731.3965 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.28 0.698 5.21 731.3967 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 3.99 0.632 4.51 731.3968 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.1 0.603 6.34 731.3969 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.25 0.6 5.54 731.3972 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.47 0.67 5.42 731.3975 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.19 0.679 6.82 731.3979 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.52 0.61 5.09 731.3979 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.19 0.661 5.62 731.398 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.08 0.643 4.72 731.3982 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.12 0.641 6.17 731.3985 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.46 0.628 4.31 731.3987 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.2 0.638 7.17 731.3988 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 3.09 0.61 3.68 731.3991 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 3.89 0.638 4.85 731.3993 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.16 0.652 6 731.3994 1,460.78 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 3.53 0.608 4 731.4005 1,460.79 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VPGTSTSATLTGLTR 95.00% 4.2 0.642 5.77 731.4052 1,460.79 1,461.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 4 0.327 4.96 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8456 1,461.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 3.99 0.223 3.6 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.846 1,461.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 3.97 0.332 4.52 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8468 1,461.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 4.26 0.367 5.24 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.847 1,461.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 4.36 0.368 5.32 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8471 1,461.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 4.29 0.333 5.28 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8472 1,461.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 4 0.373 4.42 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8473 1,461.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 4.19 0.363 5.2 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8474 1,461.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 3.84 0.359 4.7 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8477 1,461.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 3.99 0.371 4.89 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8481 1,461.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 4.11 0.391 4.55 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8481 1,461.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 4.04 0.372 5.49 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8482 1,461.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 3.95 0.38 4.85 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8559 1,461.70 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 3.96 0.353 4.08 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 732.3477 1,462.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 4 0.378 4.52 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 732.3498 1,462.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 2.79 0.286 2.18 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 732.35 1,462.68 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GNLLQcIcTGNGR 95.00% 4.08 0.314 4.77 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 732.3594 1,462.70 1,462.69 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% QDGHLWcSTTSNYEQDQK 95.00% 3.72 0.492 0 c7: Carbamidomethyl (+57.02) 732.9772 2,195.91 2,196.93 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% QDGHLWcSTTSNYEQDQK 95.00% 5.41 0.424 1.41 c7: Carbamidomethyl (+57.02) 733.3132 2,196.92 2,196.93 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% QDGHLWcSTTSNYEQDQK 95.00% 4.59 0.485 1.38 c7: Carbamidomethyl (+57.02) 733.314 2,196.92 2,196.93 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% QDGHLWcSTTSNYEQDQK 95.00% 5.38 0.477 2.3 c7: Carbamidomethyl (+57.02) 733.3152 2,196.92 2,196.93 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.61 0.467 0 c5: Carbamidomethyl (+57.02) 742.3483 1,482.68 1,483.70 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.78 0.483 1.85 c5: Carbamidomethyl (+57.02) 742.3499 1,482.68 1,483.70 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.83 0.47 1.21 c5: Carbamidomethyl (+57.02) 742.3502 1,482.68 1,483.70 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.81 0.467 0 c5: Carbamidomethyl (+57.02) 742.3504 1,482.69 1,483.70 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.85 0.47 2.04 c5: Carbamidomethyl (+57.02) 742.3512 1,482.69 1,483.70 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.97 0.492 1.13 c5: Carbamidomethyl (+57.02) 742.3515 1,482.69 1,483.70 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.08 0.489 0 c5: Carbamidomethyl (+57.02) 742.3526 1,482.69 1,483.70 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.7 0.471 2.01 c5: Carbamidomethyl (+57.02) 742.3527 1,482.69 1,483.70 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.85 0.428 1.39 c5: Carbamidomethyl (+57.02) 742.8539 1,483.69 1,483.70 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GEWTcIAYSQLR 95.00% 3.67 0.445 0 c5: Carbamidomethyl (+57.02) 742.8549 1,483.69 1,483.70 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SYTITGLQPGTDYK 95.00% 3.76 0.532 4.92 772.3828 1,542.75 1,543.76 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SYTITGLQPGTDYK 95.00% 4.54 0.57 7.24 772.3831 1,542.75 1,543.76 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SYTITGLQPGTDYK 95.00% 4.67 0.551 5.08 772.3844 1,542.75 1,543.76 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SYTITGLQPGTDYK 95.00% 3.42 0.475 3.35 772.3844 1,542.75 1,543.76 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SYTITGLQPGTDYK 95.00% 4.92 0.583 5.4 772.3847 1,542.75 1,543.76 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SYTITGLQPGTDYK 95.00% 3.27 0.533 3.39 772.3851 1,542.75 1,543.76 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SYTITGLQPGTDYK 95.00% 3.47 0.56 2.27 772.3853 1,542.75 1,543.76 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SYTITGLQPGTDYK 95.00% 2.53 0.318 0 772.3856 1,542.76 1,543.76 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SYTITGLQPGTDYK 95.00% 3.94 0.493 4.8 772.3858 1,542.76 1,543.76 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SYTITGLQPGTDYK 95.00% 3.88 0.545 4.62 772.3861 1,542.76 1,543.76 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SYTITGLQPGTDYK 95.00% 3.88 0.506 3.74 772.3935 1,542.77 1,543.76 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EATIPGHLNSYTIK 95.00% 3.08 0.457 2.62 772.408 1,542.80 1,543.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EATIPGHLNSYTIK 95.00% 2.57 0.381 2.32 772.4086 1,542.80 1,543.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EATIPGHLNSYTIK 95.00% 3.19 0.467 1.68 772.4091 1,542.80 1,543.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EATIPGHLNSYTIK 95.00% 3.05 0.355 2.51 772.4092 1,542.80 1,543.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EATIPGHLNSYTIK 95.00% 3.17 0.421 1.82 772.4093 1,542.80 1,543.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EATIPGHLNSYTIK 95.00% 3.35 0.339 4.07 772.4093 1,542.80 1,543.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EATIPGHLNSYTIK 95.00% 3.64 0.403 3.2 772.4094 1,542.80 1,543.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EATIPGHLNSYTIK 95.00% 2.93 0.375 1.74 772.4098 1,542.80 1,543.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EATIPGHLNSYTIK 95.00% 3.27 0.304 3.05 772.4106 1,542.81 1,543.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SYTITGLQPGTDYK 95.00% 3.94 0.519 3 772.8864 1,543.76 1,543.76 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DTLTSRPAQGVVTTLENVSPPR 95.00% 2.91 0.414 0 780.4174 2,338.23 2,338.24 3 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DTLTSRPAQGVVTTLENVSPPR 95.00% 2.99 0.372 1.42 780.4183 2,338.23 2,338.24 3 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DTLTSRPAQGVVTTLENVSPPR 95.00% 3.12 0.444 0 780.4183 2,338.23 2,338.24 3 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DTLTSRPAQGVVTTLENVSPPR 95.00% 3.05 0.502 2.38 780.4185 2,338.23 2,338.24 3 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WcGTTQNYDADQK 95.00% 2.97 0.333 1.12 c2: Carbamidomethyl (+57.02) 793.8293 1,585.64 1,586.65 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WcGTTQNYDADQK 95.00% 2.71 0.27 0 c2: Carbamidomethyl (+57.02) 793.8307 1,585.65 1,586.65 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 3.79 0.544 3.55 796.4051 1,590.79 1,591.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 3.98 0.574 4.05 796.4064 1,590.80 1,591.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 4.2 0.594 3.89 796.4072 1,590.80 1,591.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 4.1 0.585 4 796.4074 1,590.80 1,591.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 4.08 0.602 3.07 796.4077 1,590.80 1,591.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 3.88 0.569 4.89 796.4085 1,590.80 1,591.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 3.74 0.581 3.96 796.4088 1,590.80 1,591.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 3.95 0.584 4.96 796.906 1,591.80 1,591.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 4.14 0.578 3.27 796.9072 1,591.80 1,591.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 4.08 0.572 3.08 796.9076 1,591.80 1,591.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 4.02 0.532 3.92 796.9079 1,591.80 1,591.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GDSPASSKPISINYR 95.00% 3.8 0.566 4.22 796.9113 1,591.81 1,591.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VTDATETTITISWR 95.00% 3.42 0.52 5.74 797.4092 1,592.80 1,593.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VTDATETTITISWR 95.00% 3.05 0.452 3.28 797.4098 1,592.80 1,593.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VTDATETTITISWR 95.00% 2.37 0.403 2.08 798.0792 1,594.14 1,593.81 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.33 0.588 4.64 799.6975 2,396.07 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.77 0.565 5.39 799.6989 2,396.07 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.58 0.594 4.05 799.699 2,396.07 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.87 0.59 4.89 799.699 2,396.07 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.4 0.612 4.3 799.6991 2,396.07 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.41 0.526 4.06 799.6995 2,396.08 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.43 0.539 5.36 799.7003 2,396.08 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 3.8 0.545 1.92 799.7004 2,396.08 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.45 0.575 4.8 799.7004 2,396.08 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.96 0.625 5.59 799.7013 2,396.08 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.38 0.61 5.13 799.7014 2,396.08 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.96 0.595 4.92 799.7037 2,396.09 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.39 0.581 4.33 799.7078 2,396.10 2,396.09 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VDVIPVNLPGEHGQR 95.00% 3.77 0.459 4.31 815.4361 1,628.86 1,629.87 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VDVIPVNLPGEHGQR 95.00% 3.79 0.456 4.21 815.4375 1,628.86 1,629.87 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VDVIPVNLPGEHGQR 95.00% 3.68 0.502 5.14 815.4383 1,628.86 1,629.87 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VDVIPVNLPGEHGQR 95.00% 3.8 0.434 4.3 815.4389 1,628.86 1,629.87 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VDVIPVNLPGEHGQR 95.00% 3.73 0.408 4.12 815.4389 1,628.86 1,629.87 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VDVIPVNLPGEHGQR 95.00% 3.74 0.534 3.7 815.9398 1,629.86 1,629.87 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VDVIPVNLPGEHGQR 95.00% 3.37 0.42 3.92 815.9406 1,629.87 1,629.87 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VDVIPVNLPGEHGQR 95.00% 3.67 0.477 3.41 815.9428 1,629.87 1,629.87 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VDVIPVNLPGEHGQR 95.00% 3.68 0.548 4.62 815.9436 1,629.87 1,629.87 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DSMIWDcTcIGAGR 95.00% 3.46 0.331 1.59 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.344 1,640.67 1,641.68 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DSMIWDcTcIGAGR 95.00% 3.91 0.435 5.21 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3448 1,640.67 1,641.68 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.7 0.472 2.17 821.7407 2,462.20 2,462.21 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.12 0.492 3.11 821.7408 2,462.20 2,462.21 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.3 0.415 2.42 821.7411 2,462.20 2,462.21 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 6.31 0.494 4.21 821.7412 2,462.20 2,462.21 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.43 0.427 4.64 821.7413 2,462.20 2,462.21 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.51 0.45 3.48 821.7436 2,462.21 2,462.21 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DSMIWDcTcIGAGR 95.00% 4.21 0.542 4.44 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.8469 1,641.68 1,641.68 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DDKESVPISDTIIPAVPPPTDLR 95.00% 3.61 0.437 1.89 826.1041 2,475.29 2,475.30 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DDKESVPISDTIIPAVPPPTDLR 95.00% 3.97 0.401 1.2 826.1045 2,475.29 2,475.30 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.9 0.402 4.1 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.3936 1,650.77 1,651.78 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 4.44 0.516 3.43 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.3939 1,650.77 1,651.78 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 4.02 0.416 4.89 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.3947 1,650.77 1,651.78 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.99 0.397 3.7 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.3949 1,650.77 1,651.78 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 3.71 0.334 4.46 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.8935 1,651.77 1,651.78 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% LLcQcLGFGSGHFR 95.00% 4.11 0.44 4.39 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.8938 1,651.77 1,651.78 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DSmIWDcTcIGAGR 95.00% 4.25 0.567 4.52 m3: Oxidation (+15.99), c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 829.8435 1,657.67 1,657.68 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 2.45 0.344 0 832.3747 1,662.73 1,664.90 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 2.62 0.432 0 832.4493 1,662.88 1,664.90 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% DTLTSRPAQGVVTTLENVSPPRR 95.00% 2.97 0.42 0 832.4494 2,494.32 2,494.34 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 4.34 0.641 0 832.9502 1,663.88 1,664.90 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 4.53 0.644 0 832.9504 1,663.89 1,664.90 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% PAQGVVTTLENVSPPR 95.00% 3.74 0.59 0 832.9518 1,663.89 1,664.90 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.44 0.383 2.54 858.4491 2,572.32 2,572.34 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.6 0.413 2.92 858.4498 2,572.33 2,572.34 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.23 0.336 2.89 858.4501 2,572.33 2,572.34 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.41 0.452 2.08 858.4504 2,572.33 2,572.34 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.68 0.367 1.33 858.4505 2,572.33 2,572.34 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.23 0.286 2.23 858.451 2,572.33 2,572.34 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.37 0.401 2.55 858.4511 2,572.33 2,572.34 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.69 0.399 2.43 858.4523 2,572.33 2,572.34 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 5.11 0.464 2.49 858.4524 2,572.33 2,572.34 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.35 0.591 3.64 866.9754 1,731.94 1,732.95 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.83 0.578 3.01 866.9754 1,731.94 1,732.95 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.09 0.606 5.72 866.9757 1,731.94 1,732.95 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.83 0.621 8.17 866.9762 1,731.94 1,732.95 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.78 0.594 7 866.9768 1,731.94 1,732.95 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.39 0.632 5.96 866.9771 1,731.94 1,732.95 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.47 0.607 4.77 866.9771 1,731.94 1,732.95 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.71 0.637 6.96 866.9773 1,731.94 1,732.95 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.57 0.569 1.44 867.4748 1,732.93 1,732.95 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.37 0.494 1.24 867.4751 1,732.93 1,732.95 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.66 0.598 2.28 867.4771 1,732.94 1,732.95 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NLQPASEYTVSLVAIK 95.00% 4.76 0.573 1.54 867.4771 1,732.94 1,732.95 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.76 0.622 5.54 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4091 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.54 0.588 5.05 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4094 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.69 0.598 4.96 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4098 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.37 0.595 5.7 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.41 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.49 0.606 6.51 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4104 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.3 0.639 5.48 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4105 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.69 0.619 6.17 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4107 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.62 0.602 5.72 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4107 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.85 0.63 5.41 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4109 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.58 0.61 5.49 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4112 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.66 0.594 5.85 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4119 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.74 0.572 5.59 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4154 1,790.82 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 4.9 0.57 3.82 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9086 1,791.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.71 0.594 3.82 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9102 1,791.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 4.92 0.562 3.57 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.911 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.55 0.6 4.38 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9112 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TYLGNALVcTcYGGSR 95.00% 5.93 0.592 5.54 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.912 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FTQVTPTSLSAQWTPPNVQLTGYR 95.00% 4.44 0.556 3.77 898.4628 2,692.36 2,692.37 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VTIMWTPPESAVTGYR 95.00% 3.97 0.567 4.72 904.9534 1,807.89 1,807.91 2 PDC6I_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VTIMWTPPESAVTGYR 95.00% 3.78 0.532 4.57 904.955 1,807.89 1,807.91 2 PDC6I_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VTIMWTPPESAVTGYR 95.00% 4.19 0.601 4.46 904.9552 1,807.89 1,807.91 2 PDC6I_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VTIMWTPPESAVTGYR 95.00% 4.32 0.631 5.33 904.9562 1,807.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 4.47 0.462 2.68 909.9873 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 4.21 0.478 1.59 909.9881 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 4.74 0.449 3.14 909.9881 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 4.64 0.443 2.52 909.9889 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 4.58 0.419 1.82 910.4861 1,818.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 4.65 0.465 3.09 910.4886 1,818.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GATYNIIVEALKDQQR 95.00% 4.83 0.453 2.57 910.4895 1,818.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VTImWTPPESAVTGYR 95.00% 3.75 0.525 3.39 m4: Oxidation (+15.99) 912.451 1,822.89 1,823.90 2 PDC6I_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% VTImWTPPESAVTGYR 95.00% 3.38 0.383 3.92 m4: Oxidation (+15.99) 912.4511 1,822.89 1,823.90 2 PDC6I_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WKEATIPGHLNSYTIK 95.00% 4.42 0.472 5.66 929.4949 1,856.97 1,857.99 2 MCF2L_HUMAN,F10A1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% WKEATIPGHLNSYTIK 95.00% 4.31 0.362 4.12 929.9951 1,857.97 1,857.99 2 MCF2L_HUMAN,F10A1_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 5.53 0.589 14.2 932.4428 1,862.87 1,863.88 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 6.09 0.597 13.5 932.4433 1,862.87 1,863.88 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 5.19 0.545 6.39 932.4455 1,862.88 1,863.88 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 5.75 0.595 12 932.446 1,862.88 1,863.88 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 5.86 0.553 9.85 932.9438 1,863.87 1,863.88 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 4.92 0.581 6.77 932.9439 1,863.87 1,863.88 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% HTSVQTTSSGSGPFTDVR 95.00% 5.82 0.572 9.82 932.9449 1,863.87 1,863.88 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 4.58 0.567 4.82 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8969 1,877.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 5.11 0.615 4.59 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8974 1,877.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 5.13 0.625 5.6 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8975 1,877.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 4.84 0.608 4.34 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8979 1,877.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 5.02 0.629 5.08 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8979 1,877.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 5.01 0.622 4.85 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8981 1,877.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 5.3 0.578 6.32 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8991 1,877.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 5.06 0.571 4.96 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9031 1,877.79 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 5 0.54 3.96 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3957 1,878.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 5.17 0.605 4.35 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3971 1,878.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 5.04 0.62 3.82 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3987 1,878.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 5.11 0.632 4.89 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3987 1,878.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 4.97 0.612 5.52 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3995 1,878.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 5.08 0.623 4.04 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4 1,878.78 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 4.93 0.582 4.89 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4005 1,878.79 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EYLGAIcScTcFGGQR 95.00% 2.21 0.356 0 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4135 1,878.81 1,878.79 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% SSPVVIDASTAIDAPSNLR 95.00% 4.45 0.53 4.82 957.5075 1,913.00 1,913.00 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.1 0.532 5.74 964.0222 1,926.03 1,927.04 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.36 0.536 5.96 964.5236 1,927.03 1,927.04 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.98 0.553 5.77 964.5243 1,927.03 1,927.04 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.56 0.58 5.29 964.5246 1,927.03 1,927.04 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.93 0.518 4.82 964.5247 1,927.03 1,927.04 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.26 0.503 5.08 964.525 1,927.03 1,927.04 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.21 0.48 4.17 964.5256 1,927.04 1,927.04 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.44 0.504 3.51 964.5257 1,927.04 1,927.04 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.27 0.501 4.62 964.5259 1,927.04 1,927.04 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 4.91 0.572 6.52 964.5259 1,927.04 1,927.04 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% FLATTPNSLLVSWQPPR 95.00% 3.56 0.487 5.82 964.5265 1,927.04 1,927.04 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% GFNcESKPEAEETcFDKYTGNTYR 95.00% 5.65 0.458 4.82 c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 968.7437 2,903.21 2,903.23 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EESPLLIGQQSTVSDVPR 95.00% 4.87 0.534 5.15 978.0049 1,953.99 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EESPLLIGQQSTVSDVPR 95.00% 4.74 0.55 5.89 978.006 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EESPLLIGQQSTVSDVPR 95.00% 4.88 0.536 5.28 978.0064 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EESPLLIGQQSTVSDVPR 95.00% 5.04 0.539 4.44 978.5067 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EESPLLIGQQSTVSDVPR 95.00% 4.55 0.504 4.92 978.5067 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EESPLLIGQQSTVSDVPR 95.00% 4.88 0.529 3.96 978.5069 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EESPLLIGQQSTVSDVPR 95.00% 4.94 0.594 4.7 978.507 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NTFAEVTGLSPGVTYYFK 95.00% 4.52 0.358 4.31 997.496 1,992.98 1,993.99 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NTFAEVTGLSPGVTYYFK 95.00% 5.75 0.605 6.55 997.9976 1,993.98 1,993.99 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NTFAEVTGLSPGVTYYFK 95.00% 6.22 0.66 6.66 997.9979 1,993.98 1,993.99 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% NTFAEVTGLSPGVTYYFK 95.00% 6.02 0.657 6.08 997.9984 1,993.98 1,993.99 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TNTNVNcPIEcFMPLDVQADREDSRE 95.00% 4.77 0.615 2.74 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,037.79 3,110.35 3,110.36 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TNTNVNcPIEcFMPLDVQADREDSRE 95.00% 4.93 0.585 2.13 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,037.79 3,110.35 3,110.36 3
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EINLAPDSSSVVVSGLMVATK 95.00% 5.92 0.631 6.59 1,059.56 2,117.10 2,117.12 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% EINLAPDSSSVVVSGLMVATK 95.00% 5.96 0.6 10 1,059.56 2,117.11 2,117.12 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.42 0.51 5.48 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.35 0.517 5.49 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.37 0.515 4.8 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% ITYGETGGNSPVQEFTVPGSK 95.00% 6 0.553 4.19 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.64 0.524 4.27 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.51 0.572 5.21 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.65 0.463 3.92 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.75 0.517 4.92 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% ITYGETGGNSPVQEFTVPGSK 95.00% 4.66 0.571 5.03 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.72 0.529 4.92 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% QDGHLWcSTTSNYEQDQK 95.00% 3.71 0.529 2.7 c7: Carbamidomethyl (+57.02) 1,099.46 2,196.91 2,196.93 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% QDGHLWcSTTSNYEQDQK 95.00% 3.69 0.527 2.24 c7: Carbamidomethyl (+57.02) 1,099.47 2,196.92 2,196.93 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TETITGFQVDAVPANGQTPIQR 95.00% 5.26 0.628 6.15 1,172.60 2,343.18 2,343.19 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.86 0.565 6.57 1,199.05 2,396.08 2,396.09 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.6 0.571 5.17 1,199.05 2,396.08 2,396.09 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.79 0.562 5.82 1,199.05 2,396.08 2,396.09 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.99 0.525 5.59 1,232.11 2,462.20 2,462.21 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.88 0.57 4.52 1,232.11 2,462.20 2,462.21 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% STATISGLKPGVDYTITVYAVTGR 95.00% 4.92 0.564 4.92 1,236.16 2,470.31 2,470.32 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% STATISGLKPGVDYTITVYAVTGR 95.00% 4.87 0.594 5.05 1,236.16 2,470.31 2,470.32 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 6.63 0.687 8.08 1,287.17 2,572.32 2,572.34 2
 SAMPLE 1 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 51 72 426 30.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 6.67 0.701 8.6 1,287.17 2,572.32 2,572.34 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IScTIANR 95.00% 2.03 0.264 0 c3: Carbamidomethyl (+57.02) 467.7433 933.471 934.4781 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IScTIANR 95.00% 2.27 0.291 0 c3: Carbamidomethyl (+57.02) 467.7438 933.472 934.4781 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IScTIANR 95.00% 2.18 0.274 0 c3: Carbamidomethyl (+57.02) 467.7446 933.4735 934.4781 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HYQINQQWER 95.00% 3.22 0.257 0 467.8929 1,400.66 1,401.67 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HYQINQQWER 95.00% 3.6 0.232 0 467.8944 1,400.66 1,401.67 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HYQINQQWER 95.00% 2.9 0.147 0 467.8954 1,400.66 1,401.67 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HYQINQQWER 95.00% 3.18 0.244 0 467.8956 1,400.66 1,401.67 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WSRPQAPITGYR 95.00% 3.3 0.261 0.959 477.9188 1,430.73 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WSRPQAPITGYR 95.00% 3.48 0.364 2.51 477.9199 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WSRPQAPITGYR 95.00% 3.74 0.322 2.08 477.9209 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WSRPQAPITGYR 95.00% 3.51 0.401 2.18 477.9209 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WSRPQAPITGYR 95.00% 3.43 0.305 2.03 477.921 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WSRPQAPITGYR 95.00% 3.51 0.379 2.39 477.9212 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WSRPQAPITGYR 95.00% 3.56 0.275 1.96 477.9215 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WSRPQAPITGYR 95.00% 3.14 0.365 0 477.9216 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WSRPQAPITGYR 95.00% 2.67 0.327 0 477.922 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.74 0.4 1.35 c5: Carbamidomethyl (+57.02) 495.2363 1,482.69 1,483.70 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.61 0.496 2.47 c5: Carbamidomethyl (+57.02) 495.2372 1,482.69 1,483.70 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.84 0.504 0 c5: Carbamidomethyl (+57.02) 495.2375 1,482.69 1,483.70 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.61 0.427 1.72 c5: Carbamidomethyl (+57.02) 495.2382 1,482.69 1,483.70 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.27 0.526 1.85 c5: Carbamidomethyl (+57.02) 495.2384 1,482.69 1,483.70 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.27 0.416 2.18 c5: Carbamidomethyl (+57.02) 495.2386 1,482.69 1,483.70 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.56 0.425 0 c5: Carbamidomethyl (+57.02) 495.5726 1,483.69 1,483.70 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 2.85 0.413 1.47 531.2727 1,590.79 1,591.81 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 2.98 0.368 1.09 531.2729 1,590.80 1,591.81 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 3.27 0.348 1.49 531.273 1,590.80 1,591.81 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 2.77 0.502 2.15 531.2733 1,590.80 1,591.81 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 3.36 0.545 2.92 531.2733 1,590.80 1,591.81 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 2.44 0.375 0 531.2733 1,590.80 1,591.81 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 2.52 0.454 2.46 531.2739 1,590.80 1,591.81 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 2.96 0.343 1.08 531.274 1,590.80 1,591.81 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 2.55 0.3 0 531.6082 1,591.80 1,591.81 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 3.2 0.43 2.85 531.6083 1,591.80 1,591.81 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% YEVSVYALK 95.00% 2.29 0.234 2.17 536.2887 1,070.56 1,071.57 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% QYNVGPSVSKYPLR 95.00% 3.16 0.515 0 536.6223 1,606.84 1,607.85 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% QYNVGPSVSKYPLR 95.00% 2.71 0.22 0 536.6224 1,606.84 1,607.85 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% QYNVGPSVSKYPLR 95.00% 3 0.422 0 536.9555 1,607.84 1,607.85 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% QYNVGPSVSKYPLR 95.00% 3.16 0.484 0 536.9564 1,607.85 1,607.85 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VDVIPVNLPGEHGQR 95.00% 2.02 0.408 1.57 543.9611 1,628.86 1,629.87 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VDVIPVNLPGEHGQR 95.00% 2 0.402 2.43 543.962 1,628.86 1,629.87 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 3.31 0.45 2.02 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2638 1,650.77 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 3.84 0.368 2.44 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2638 1,650.77 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 2.6 0.321 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2643 1,650.77 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 3.66 0.355 1.89 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2643 1,650.77 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 2.7 0.33 1.09 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2644 1,650.77 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 3.74 0.475 3.6 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2648 1,650.77 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 4.22 0.387 5.41 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2651 1,650.77 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 3.82 0.376 1.68 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2652 1,650.77 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 3.95 0.453 5.89 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2653 1,650.77 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 3.79 0.451 3.68 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2656 1,650.77 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 4.09 0.441 3.66 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2747 1,650.80 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 3.25 0.356 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.599 1,651.77 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 3.65 0.384 1.51 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.6058 1,651.79 1,651.78 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPR 95.00% 2.53 0.339 0 555.6355 1,663.88 1,664.90 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPR 95.00% 2.96 0.19 0 555.6356 1,663.88 1,664.90 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPR 95.00% 3.27 0.249 0 555.6357 1,663.88 1,664.90 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPR 95.00% 2.78 0.222 0 555.6357 1,663.88 1,664.90 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPR 95.00% 2.77 0.161 0 555.6365 1,663.89 1,664.90 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPR 95.00% 2.93 0.345 0 555.637 1,663.89 1,664.90 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% STTPDITGYR 95.00% 1.93 0.458 1.14 555.7737 1,109.53 1,110.54 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% STTPDITGYR 95.00% 2.01 0.446 1.8 555.7738 1,109.53 1,110.54 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% STTPDITGYR 95.00% 1.79 0.354 2.36 555.7763 1,109.54 1,110.54 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FTNIGPDTMR 95.00% 2.87 0.437 1.7 576.2783 1,150.54 1,151.55 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FTNIGPDTMR 95.00% 2.85 0.425 1.54 576.2784 1,150.54 1,151.55 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FTNIGPDTMR 95.00% 3.27 0.441 1.72 576.2784 1,150.54 1,151.55 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FTNIGPDTMR 95.00% 2.94 0.414 1.66 576.2785 1,150.54 1,151.55 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FTNIGPDTMR 95.00% 2.69 0.365 0 576.2785 1,150.54 1,151.55 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FTNIGPDTMR 95.00% 2.85 0.435 1.72 576.2787 1,150.54 1,151.55 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FTNIGPDTMR 95.00% 2.22 0.354 1.59 576.2788 1,150.54 1,151.55 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FTNIGPDTMR 95.00% 2.89 0.405 2 576.2792 1,150.54 1,151.55 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FTNIGPDTMR 95.00% 2.78 0.437 1.55 576.2802 1,150.54 1,151.55 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 3.99 0.462 1.57 578.317 1,731.93 1,732.95 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.71 0.516 2.41 578.3185 1,731.93 1,732.95 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.76 0.542 2.3 578.3193 1,731.93 1,732.95 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.44 0.5 2.7 578.3196 1,731.94 1,732.95 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.54 0.448 2.17 578.6539 1,732.94 1,732.95 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 2.04 0.342 0 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 597.9425 1,790.80 1,791.82 3 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 2.83 0.403 2.33 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 598.2789 1,791.81 1,791.82 3 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VTIMWTPPESAVTGYR 95.00% 3.27 0.444 0 603.3056 1,806.89 1,807.91 3 PDC6I_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VTIMWTPPESAVTGYR 95.00% 4.06 0.558 1.72 603.6395 1,807.90 1,807.91 3 PDC6I_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 2.49 0.366 0 606.9931 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 2.18 0.255 0 606.994 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 2.26 0.326 0 606.9942 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 2.76 0.354 0 606.9945 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 2.25 0.439 0 606.9946 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 2.58 0.471 0 606.9947 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 2.29 0.267 0 606.9948 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 3.11 0.475 0 607.3285 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 2.44 0.357 0 607.3287 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 2.54 0.321 0 607.329 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 2.96 0.407 0 607.3293 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 2.29 0.246 0 607.3293 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPRR 95.00% 2.07 0.286 0 607.7955 1,820.36 1,821.00 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPRR 95.00% 2.77 0.338 0 608.0037 1,820.99 1,821.00 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WKEATIPGHLNSYTIK 95.00% 2.66 0.365 0 620.3345 1,857.98 1,857.99 3 MCF2L_HUMAN,F10A1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 4.17 0.608 1.33 621.9639 1,862.87 1,863.88 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 3.6 0.574 0 621.964 1,862.87 1,863.88 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 4.1 0.571 0 621.9651 1,862.87 1,863.88 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 4.96 0.566 2.7 622.2988 1,863.87 1,863.88 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 4.75 0.539 1.55 622.2993 1,863.87 1,863.88 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 3.75 0.534 0 622.2996 1,863.88 1,863.88 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 3.91 0.507 0 622.2997 1,863.88 1,863.88 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 4.08 0.455 1.8 622.3015 1,863.88 1,863.88 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 5.01 0.595 3.35 622.303 1,863.89 1,863.88 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 2.09 0.283 0 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 626.9326 1,877.77 1,878.79 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 4.6 0.577 2.89 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 627.2689 1,878.78 1,878.79 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SSPVVIDASTAIDAPSNLR 95.00% 3.99 0.48 1.64 638.3355 1,911.98 1,913.00 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SSPVVIDASTAIDAPSNLR 95.00% 4.7 0.513 2.85 638.3359 1,911.98 1,913.00 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SSPVVIDASTAIDAPSNLR 95.00% 3.49 0.414 0 638.3366 1,911.99 1,913.00 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SSPVVIDASTAIDAPSNLR 95.00% 4.76 0.5 3.82 638.6718 1,912.99 1,913.00 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 4.87 0.556 3.96 643.0195 1,926.03 1,927.04 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 2.63 0.269 0 643.3518 1,927.03 1,927.04 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 3.71 0.507 2.33 643.3531 1,927.04 1,927.04 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 5.47 0.604 2.54 643.3532 1,927.04 1,927.04 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 5.2 0.586 3.89 643.3533 1,927.04 1,927.04 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 5.38 0.582 2.13 643.3537 1,927.04 1,927.04 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 2.74 0.384 0 643.3554 1,927.04 1,927.04 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALK 95.00% 3.75 0.374 1.68 646.3654 1,290.72 1,291.73 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALK 95.00% 3.85 0.349 2.08 646.3659 1,290.72 1,291.73 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALK 95.00% 3.94 0.346 1.3 646.366 1,290.72 1,291.73 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALK 95.00% 3.77 0.381 1.25 646.3662 1,290.72 1,291.73 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DLQFVEVTDVK 95.00% 3.33 0.509 2.35 646.8393 1,291.66 1,292.67 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DLQFVEVTDVK 95.00% 3.5 0.475 3.19 646.8395 1,291.66 1,292.67 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DLQFVEVTDVK 95.00% 3.89 0.53 2.42 646.8398 1,291.66 1,292.67 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DLQFVEVTDVK 95.00% 3.72 0.527 2.49 646.8404 1,291.67 1,292.67 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DLQFVEVTDVK 95.00% 3.76 0.518 3.14 646.8405 1,291.67 1,292.67 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EESPLLIGQQSTVSDVPR 95.00% 3.79 0.503 0 652.6732 1,955.00 1,955.01 3 MYPT2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EESPLLIGQQSTVSDVPR 95.00% 3.25 0.432 0 652.6757 1,955.00 1,955.01 3 MYPT2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LGVRPSQGGEAPR 95.00% 2.23 0.33 0 662.3615 1,322.71 1,323.71 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NTFAEVTGLSPGVTYYFK 95.00% 3.15 0.428 1.8 665.3349 1,992.98 1,993.99 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NTFAEVTGLSPGVTYYFK 95.00% 2.94 0.422 0 665.6689 1,993.98 1,993.99 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WLPSSSPVTGYR 95.00% 2.29 0.409 1.55 675.3445 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WLPSSSPVTGYR 95.00% 2.69 0.482 1.89 675.3446 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WLPSSSPVTGYR 95.00% 3 0.484 1.37 675.3446 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WLPSSSPVTGYR 95.00% 2.44 0.539 1.82 675.3452 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WLPSSSPVTGYR 95.00% 2.25 0.349 0 675.3456 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WLPSSSPVTGYR 95.00% 2.55 0.465 1.57 675.3457 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WLPSSSPVTGYR 95.00% 2.06 0.349 1.27 675.3457 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IYLYTLNDNAR 95.00% 3.95 0.51 3.07 678.3498 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IYLYTLNDNAR 95.00% 3.67 0.382 2.48 678.3499 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IYLYTLNDNAR 95.00% 3.77 0.499 2.21 678.3506 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IYLYTLNDNAR 95.00% 4.15 0.466 1.89 678.3508 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IYLYTLNDNAR 95.00% 3.49 0.42 2.36 678.3509 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IYLYTLNDNAR 95.00% 3.46 0.489 1.85 678.351 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IYLYTLNDNAR 95.00% 3.63 0.491 2.42 678.3512 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IYLYTLNDNAR 95.00% 3.86 0.476 2.03 678.3517 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IYLYTLNDNAR 95.00% 3.7 0.49 1.42 678.352 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IYLYTLNDNAR 95.00% 3.24 0.456 2 678.3524 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IYLYTLNDNAR 95.00% 2.77 0.449 2.55 678.3526 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IYLYTLNDNAR 95.00% 2.98 0.355 0 678.3576 1,354.70 1,355.70 2 FBN1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% IAWESPQGQVSR 95.00% 2.93 0.198 1.52 679.3212 1,356.63 1,357.69 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GFNcESKPEAEETcFDK 95.00% 2.68 0.203 0 c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 683.2829 2,046.83 2,047.84 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GLAFTDVDVDSIK 95.00% 2.91 0.486 2.11 690.3557 1,378.70 1,379.71 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GLAFTDVDVDSIK 95.00% 2.98 0.457 2.85 690.3573 1,378.70 1,379.71 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HYQINQQWER 95.00% 3.07 0.415 1.7 701.3338 1,400.65 1,401.67 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HYQINQQWER 95.00% 3.04 0.455 2 701.3357 1,400.66 1,401.67 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HYQINQQWER 95.00% 2.34 0.345 0 701.3376 1,400.66 1,401.67 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% ITYGETGGNSPVQEFTVPGSK 95.00% 2.28 0.407 0 723.3542 2,167.04 2,168.05 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 4.07 0.642 4.54 731.3968 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 3.98 0.607 7.19 731.3971 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 4.19 0.607 5.92 731.3973 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 4.19 0.657 6.82 731.398 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 3.94 0.658 6.92 731.398 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 4.28 0.623 6.77 731.3982 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 4.37 0.61 6.89 731.3982 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 4 0.586 5.68 731.3983 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 4.17 0.622 5.54 731.3985 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 3.64 0.631 6.41 731.3985 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 4.17 0.642 6.21 731.3986 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 4.05 0.622 5.31 731.3987 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 3.94 0.597 5.3 731.3988 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 4.1 0.633 5.33 731.399 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 3.09 0.61 3.89 731.3991 1,460.78 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 2.52 0.385 1.48 731.4033 1,460.79 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VPGTSTSATLTGLTR 95.00% 4.2 0.642 5.68 731.4052 1,460.79 1,461.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GNLLQcIcTGNGR 95.00% 3.42 0.328 3.77 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8446 1,461.67 1,462.69 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GNLLQcIcTGNGR 95.00% 3.65 0.342 4.32 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8469 1,461.68 1,462.69 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GNLLQcIcTGNGR 95.00% 4.13 0.368 6 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8471 1,461.68 1,462.69 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GNLLQcIcTGNGR 95.00% 3.86 0.369 4.68 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8472 1,461.68 1,462.69 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GNLLQcIcTGNGR 95.00% 3.75 0.368 5.24 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8473 1,461.68 1,462.69 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GNLLQcIcTGNGR 95.00% 3.71 0.332 5.07 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8482 1,461.68 1,462.69 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GNLLQcIcTGNGR 95.00% 3.45 0.331 5.03 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8486 1,461.68 1,462.69 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GNLLQcIcTGNGR 95.00% 3.9 0.345 4.8 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8489 1,461.68 1,462.69 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GNLLQcIcTGNGR 95.00% 3.95 0.38 4.13 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8559 1,461.70 1,462.69 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GNLLQcIcTGNGR 95.00% 4.08 0.314 4.4 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 732.3594 1,462.70 1,462.69 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% QDGHLWcSTTSNYEQDQK 95.00% 4.88 0.423 1.26 c7: Carbamidomethyl (+57.02) 733.3114 2,196.91 2,196.93 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% QDGHLWcSTTSNYEQDQK 95.00% 4.59 0.476 0 c7: Carbamidomethyl (+57.02) 733.3125 2,196.91 2,196.93 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% QDGHLWcSTTSNYEQDQK 95.00% 4.64 0.461 1.17 c7: Carbamidomethyl (+57.02) 733.3149 2,196.92 2,196.93 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.25 0.496 1.28 c5: Carbamidomethyl (+57.02) 742.3495 1,482.68 1,483.70 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.59 0.475 1.68 c5: Carbamidomethyl (+57.02) 742.3507 1,482.69 1,483.70 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.5 0.496 2.06 c5: Carbamidomethyl (+57.02) 742.3515 1,482.69 1,483.70 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.63 0.475 2.11 c5: Carbamidomethyl (+57.02) 742.3521 1,482.69 1,483.70 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.41 0.471 1.68 c5: Carbamidomethyl (+57.02) 742.3523 1,482.69 1,483.70 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.16 0.462 0 c5: Carbamidomethyl (+57.02) 742.3526 1,482.69 1,483.70 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.25 0.483 1.96 c5: Carbamidomethyl (+57.02) 742.3528 1,482.69 1,483.70 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.01 0.465 1.36 c5: Carbamidomethyl (+57.02) 742.3527 1,482.69 1,483.70 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GEWTcIAYSQLR 95.00% 3.83 0.447 1.8 c5: Carbamidomethyl (+57.02) 742.3529 1,482.69 1,483.70 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SYTITGLQPGTDYK 95.00% 3.44 0.565 3.46 772.383 1,542.75 1,543.76 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SYTITGLQPGTDYK 95.00% 4.34 0.589 6.09 772.3838 1,542.75 1,543.76 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SYTITGLQPGTDYK 95.00% 4.64 0.556 6.05 772.3838 1,542.75 1,543.76 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SYTITGLQPGTDYK 95.00% 4.53 0.575 6.68 772.3839 1,542.75 1,543.76 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SYTITGLQPGTDYK 95.00% 4.84 0.57 4.51 772.3841 1,542.75 1,543.76 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SYTITGLQPGTDYK 95.00% 4.91 0.581 4.89 772.3845 1,542.75 1,543.76 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SYTITGLQPGTDYK 95.00% 3.43 0.535 2.82 772.3845 1,542.75 1,543.76 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SYTITGLQPGTDYK 95.00% 4.63 0.564 5.7 772.3846 1,542.75 1,543.76 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SYTITGLQPGTDYK 95.00% 3.37 0.475 1.92 772.3846 1,542.75 1,543.76 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SYTITGLQPGTDYK 95.00% 3.88 0.506 3.85 772.3935 1,542.77 1,543.76 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EATIPGHLNSYTIK 95.00% 3.28 0.371 1.68 772.4083 1,542.80 1,543.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EATIPGHLNSYTIK 95.00% 3.21 0.389 3.24 772.4088 1,542.80 1,543.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EATIPGHLNSYTIK 95.00% 3.42 0.438 1.96 772.4088 1,542.80 1,543.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EATIPGHLNSYTIK 95.00% 3.35 0.378 1.66 772.4091 1,542.80 1,543.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EATIPGHLNSYTIK 95.00% 3.2 0.43 1.57 772.4091 1,542.80 1,543.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EATIPGHLNSYTIK 95.00% 3.07 0.44 1.92 772.4101 1,542.80 1,543.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EATIPGHLNSYTIK 95.00% 2.88 0.349 1.62 772.4103 1,542.81 1,543.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SYTITGLQPGTDYK 95.00% 3.96 0.542 3.42 772.885 1,543.75 1,543.76 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SYTITGLQPGTDYK 95.00% 3.5 0.477 2.85 772.8891 1,543.76 1,543.76 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EATIPGHLNSYTIK 95.00% 3.41 0.37 2.57 772.9096 1,543.80 1,543.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EATIPGHLNSYTIK 95.00% 3.06 0.296 0 772.9154 1,543.82 1,543.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DTLTSRPAQGVVTTLENVSPPR 95.00% 2.65 0.444 2.68 780.4168 2,338.23 2,338.24 3 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DTLTSRPAQGVVTTLENVSPPR 95.00% 2.49 0.344 0 780.4182 2,338.23 2,338.24 3 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DTLTSRPAQGVVTTLENVSPPR 95.00% 2.73 0.446 1.47 780.4187 2,338.23 2,338.24 3 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 3.82 0.561 3.15 796.4061 1,590.80 1,591.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 4.21 0.586 3.96 796.4066 1,590.80 1,591.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 3.89 0.588 3.72 796.4068 1,590.80 1,591.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 4.19 0.602 3.54 796.4071 1,590.80 1,591.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 3.94 0.586 4.3 796.4071 1,590.80 1,591.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 3.79 0.583 4.28 796.4072 1,590.80 1,591.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 3.72 0.477 2.7 796.4077 1,590.80 1,591.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 3.86 0.53 5.25 796.4087 1,590.80 1,591.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 3.43 0.487 3.92 796.4092 1,590.80 1,591.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 4.3 0.596 4 796.9087 1,591.80 1,591.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 4.09 0.575 4 796.9095 1,591.80 1,591.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GDSPASSKPISINYR 95.00% 3.82 0.58 3.96 796.912 1,591.81 1,591.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VTDATETTITISWR 95.00% 3.09 0.388 3.28 797.4088 1,592.80 1,593.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VTDATETTITISWR 95.00% 3.25 0.45 2.62 797.4102 1,592.80 1,593.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VTDATETTITISWR 95.00% 2.68 0.478 3.25 797.4134 1,592.81 1,593.81 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.62 0.518 3.8 799.6962 2,396.07 2,396.09 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.1 0.625 3.23 799.6972 2,396.07 2,396.09 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 6.18 0.602 3.44 799.6985 2,396.07 2,396.09 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.49 0.602 4.36 799.6991 2,396.07 2,396.09 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.18 0.618 5.7 799.6998 2,396.08 2,396.09 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.72 0.587 3.96 799.7002 2,396.08 2,396.09 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.29 0.577 5.41 799.7006 2,396.08 2,396.09 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.04 0.605 4.17 799.7009 2,396.08 2,396.09 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.21 0.546 2.96 799.7024 2,396.08 2,396.09 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.96 0.595 4.02 799.7037 2,396.09 2,396.09 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.64 0.57 4.68 799.7049 2,396.09 2,396.09 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 0 0 3.43 800.0288 2,397.06 2,396.09 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VDVIPVNLPGEHGQR 95.00% 3.66 0.421 4.57 815.4372 1,628.86 1,629.87 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VDVIPVNLPGEHGQR 95.00% 3.85 0.423 4.33 815.4384 1,628.86 1,629.87 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VDVIPVNLPGEHGQR 95.00% 4.01 0.447 4.92 815.4388 1,628.86 1,629.87 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VDVIPVNLPGEHGQR 95.00% 3.57 0.509 2.89 815.4389 1,628.86 1,629.87 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VDVIPVNLPGEHGQR 95.00% 3.44 0.432 3.28 815.4407 1,628.87 1,629.87 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VDVIPVNLPGEHGQR 95.00% 3.48 0.545 4.29 815.442 1,628.87 1,629.87 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VDVIPVNLPGEHGQR 95.00% 3.52 0.461 3.34 815.939 1,629.86 1,629.87 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VDVIPVNLPGEHGQR 95.00% 3.68 0.47 3.48 815.9396 1,629.86 1,629.87 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DSMIWDcTcIGAGR 95.00% 2.76 0.382 2.85 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3424 1,640.67 1,641.68 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DSMIWDcTcIGAGR 95.00% 3.55 0.404 4.19 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3431 1,640.67 1,641.68 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DSMIWDcTcIGAGR 95.00% 2.87 0.356 2.96 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3431 1,640.67 1,641.68 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DSMIWDcTcIGAGR 95.00% 3.51 0.413 3.38 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3435 1,640.67 1,641.68 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DSMIWDcTcIGAGR 95.00% 3.62 0.517 5.44 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3449 1,640.67 1,641.68 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DSMIWDcTcIGAGR 95.00% 3.5 0.404 4.05 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3449 1,640.67 1,641.68 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DSMIWDcTcIGAGR 95.00% 3.47 0.367 3.96 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3451 1,640.67 1,641.68 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.59 0.411 3 821.7405 2,462.20 2,462.21 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TEIDKPSQMQVTDVQDNSISVK 95.00% 3.77 0.384 1.51 821.7408 2,462.20 2,462.21 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.6 0.47 3.6 821.741 2,462.20 2,462.21 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.2 0.464 2.43 821.7412 2,462.20 2,462.21 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TEIDKPSQMQVTDVQDNSISVK 95.00% 6.04 0.47 4.82 821.7415 2,462.20 2,462.21 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DDKESVPISDTIIPAVPPPTDLR 95.00% 3.97 0.481 1.29 826.1035 2,475.29 2,475.30 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DDKESVPISDTIIPAVPPPTDLR 95.00% 4.06 0.422 1.05 826.1041 2,475.29 2,475.30 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DDKESVPISDTIIPAVPPPTDLR 95.00% 3.86 0.378 0 826.1049 2,475.29 2,475.30 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 3.88 0.446 4.48 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.3927 1,650.77 1,651.78 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 3.94 0.474 6.35 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.3928 1,650.77 1,651.78 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 4.25 0.455 6.13 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.3961 1,650.78 1,651.78 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 3.88 0.347 6.21 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.8931 1,651.77 1,651.78 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% LLcQcLGFGSGHFR 95.00% 4.16 0.402 6.68 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.8969 1,651.78 1,651.78 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPR 95.00% 4.2 0.611 0 832.9507 1,663.89 1,664.90 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPR 95.00% 4.64 0.622 0 832.9516 1,663.89 1,664.90 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPR 95.00% 3.67 0.579 0 832.9519 1,663.89 1,664.90 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPR 95.00% 4.66 0.609 0 832.9522 1,663.89 1,664.90 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPR 95.00% 4.57 0.64 0 832.9525 1,663.89 1,664.90 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPR 95.00% 4.12 0.583 0 833.4556 1,664.90 1,664.90 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TKTETITGFQVDAVPANGQTPIQR 95.00% 3.46 0.287 2.66 858.4483 2,572.32 2,572.34 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.62 0.461 2.08 858.4492 2,572.32 2,572.34 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TKTETITGFQVDAVPANGQTPIQR 95.00% 5.02 0.437 3.66 858.4503 2,572.33 2,572.34 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TKTETITGFQVDAVPANGQTPIQR 95.00% 5.38 0.428 3.62 858.4506 2,572.33 2,572.34 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.9 0.408 4.74 858.4507 2,572.33 2,572.34 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.64 0.451 2.8 858.4512 2,572.33 2,572.34 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TKTETITGFQVDAVPANGQTPIQR 95.00% 3.84 0.392 1.82 858.4515 2,572.33 2,572.34 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.58 0.432 2.6 858.4517 2,572.33 2,572.34 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TKTETITGFQVDAVPANGQTPIQR 95.00% 0 0 4.55 858.7791 2,573.31 2,572.34 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 2.4 0.328 0 866.457 1,730.90 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 2.23 0.344 1.54 866.4588 1,730.90 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.4 0.616 4.35 866.9746 1,731.93 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.6 0.625 4.7 866.9756 1,731.94 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 3.23 0.4 1.85 866.9768 1,731.94 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.55 0.581 6.7 866.9768 1,731.94 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.29 0.614 3.96 866.977 1,731.94 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.81 0.61 6.72 866.977 1,731.94 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.58 0.575 1.59 867.4768 1,732.94 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.93 0.572 6.1 867.4773 1,732.94 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.53 0.588 8.31 867.4779 1,732.94 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.62 0.563 2.31 867.4779 1,732.94 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 5.03 0.585 6.89 867.4783 1,732.94 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 5.02 0.575 5.62 867.4787 1,732.94 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NLQPASEYTVSLVAIK 95.00% 4.66 0.569 3.6 867.4788 1,732.94 1,732.95 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.59 0.645 5.7 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4089 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.55 0.633 5.68 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.409 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.56 0.617 7.38 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4093 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.45 0.642 6.59 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4096 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.52 0.573 7.51 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4102 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.62 0.613 7.8 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4102 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.8 0.622 6.92 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4106 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.83 0.629 6.07 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.411 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.74 0.572 7.04 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4154 1,790.82 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.7 0.593 4.72 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9102 1,791.80 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.61 0.582 5.17 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9106 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.43 0.615 5.29 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9115 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TYLGNALVcTcYGGSR 95.00% 5.66 0.601 6.15 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9115 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FTQVTPTSLSAQWTPPNVQLTGYR 95.00% 4.12 0.539 3.29 898.4636 2,692.37 2,692.37 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FTQVTPTSLSAQWTPPNVQLTGYR 95.00% 4.13 0.48 4.15 898.464 2,692.37 2,692.37 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VTIMWTPPESAVTGYR 95.00% 3.35 0.559 3.62 904.455 1,806.89 1,807.91 2 PDC6I_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VTIMWTPPESAVTGYR 95.00% 3.78 0.566 4.66 904.9547 1,807.89 1,807.91 2 PDC6I_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VTIMWTPPESAVTGYR 95.00% 4.43 0.613 4.64 904.9555 1,807.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VTIMWTPPESAVTGYR 95.00% 4.14 0.584 4.8 904.9557 1,807.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 4.67 0.47 2.36 909.9872 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 4.41 0.446 2.25 909.9886 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 4.39 0.464 1.82 909.9886 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 4.58 0.493 2.15 909.9887 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 4.26 0.467 2.8 909.9889 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 4.38 0.463 1.8 909.9895 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 4.74 0.455 2.8 910.4888 1,818.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 4.73 0.467 2 910.4889 1,818.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 4.5 0.482 2.48 910.4891 1,818.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GATYNIIVEALKDQQR 95.00% 4.57 0.385 2.05 910.4904 1,818.97 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% PAQGVVTTLENVSPPRR 95.00% 3.23 0.476 0 911.0019 1,819.99 1,821.00 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VTImWTPPESAVTGYR 95.00% 2.96 0.362 2.44 m4: Oxidation (+15.99) 912.4524 1,822.89 1,823.90 2 PDC6I_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% VTImWTPPESAVTGYR 95.00% 3.99 0.534 5.92 m4: Oxidation (+15.99) 912.955 1,823.89 1,823.90 2 PDC6I_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WKEATIPGHLNSYTIK 95.00% 4.07 0.378 2.92 929.9951 1,857.97 1,857.99 2 MCF2L_HUMAN,F10A1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% WKEATIPGHLNSYTIK 95.00% 4.42 0.4 2.49 929.9976 1,857.98 1,857.99 2 MCF2L_HUMAN,F10A1_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 5.51 0.548 8.49 932.4446 1,862.87 1,863.88 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 5.52 0.616 9.74 932.4447 1,862.87 1,863.88 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 5.83 0.53 8.02 932.943 1,863.87 1,863.88 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% HTSVQTTSSGSGPFTDVR 95.00% 5.69 0.607 8.44 932.9441 1,863.87 1,863.88 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 5.6 0.642 4.19 934.1688 2,799.48 2,799.48 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 4.92 0.615 6.47 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8949 1,877.77 1,878.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 5.05 0.635 4.17 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8974 1,877.78 1,878.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 5.21 0.594 6.12 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.898 1,877.78 1,878.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 5.15 0.625 5.18 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8984 1,877.78 1,878.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 4.46 0.504 5.29 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8986 1,877.78 1,878.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 5.06 0.571 4.77 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9031 1,877.79 1,878.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 4.72 0.57 6 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9157 1,877.82 1,878.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 5.02 0.562 4.34 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.396 1,878.78 1,878.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 5.09 0.59 4.17 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3982 1,878.78 1,878.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 5.18 0.603 4 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3999 1,878.78 1,878.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 5.1 0.588 3.74 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4008 1,878.79 1,878.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EYLGAIcScTcFGGQR 95.00% 4.83 0.572 6.47 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4013 1,878.79 1,878.79 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SSPVVIDASTAIDAPSNLR 95.00% 5.49 0.572 6.38 957.0003 1,911.99 1,913.00 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SSPVVIDASTAIDAPSNLR 95.00% 5.78 0.578 4.29 957.5022 1,912.99 1,913.00 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SSPVVIDASTAIDAPSNLR 95.00% 5.78 0.577 4.89 957.5022 1,912.99 1,913.00 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% SSPVVIDASTAIDAPSNLR 95.00% 5.65 0.546 4.92 957.5052 1,912.99 1,913.00 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 4.03 0.519 4.51 964.0235 1,926.03 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 4.23 0.529 5.1 964.5224 1,927.03 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 4.08 0.543 4.31 964.5226 1,927.03 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 4.46 0.549 4.77 964.5228 1,927.03 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 3.99 0.602 5 964.5247 1,927.03 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 3.86 0.545 6.11 964.5251 1,927.03 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 4.32 0.511 5.96 964.5251 1,927.03 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 4.32 0.534 5.54 964.5255 1,927.04 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 4.54 0.503 5.92 964.5258 1,927.04 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 4.26 0.534 4.8 964.5258 1,927.04 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 4.52 0.497 5.29 964.5261 1,927.04 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 4.51 0.542 3.64 964.5288 1,927.04 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% FLATTPNSLLVSWQPPR 95.00% 4.29 0.5 4.57 964.5296 1,927.04 1,927.04 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GFNcESKPEAEETcFDKYTGNTYR 95.00% 6.19 0.442 3.77 c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 968.7456 2,903.21 2,903.23 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GFNcESKPEAEETcFDKYTGNTYR 95.00% 6.26 0.428 3.82 c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 968.7481 2,903.22 2,903.23 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EESPLLIGQQSTVSDVPR 95.00% 4.74 0.588 6.74 978.0048 1,953.99 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EESPLLIGQQSTVSDVPR 95.00% 4.09 0.559 2.85 978.5058 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EESPLLIGQQSTVSDVPR 95.00% 4.78 0.535 3.42 978.5063 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EESPLLIGQQSTVSDVPR 95.00% 4.82 0.538 5.49 978.5064 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EESPLLIGQQSTVSDVPR 95.00% 5 0.54 5.51 978.5072 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EESPLLIGQQSTVSDVPR 95.00% 4.82 0.54 4.04 978.5078 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NTFAEVTGLSPGVTYYFK 95.00% 3.63 0.241 2.27 997.4967 1,992.98 1,993.99 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NTFAEVTGLSPGVTYYFK 95.00% 5.88 0.652 6.21 997.998 1,993.98 1,993.99 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NTFAEVTGLSPGVTYYFK 95.00% 5.83 0.669 5.06 997.9987 1,993.98 1,993.99 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NTFAEVTGLSPGVTYYFK 95.00% 6.02 0.614 5.66 997.9988 1,993.98 1,993.99 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% NTFAEVTGLSPGVTYYFK 95.00% 5.88 0.634 5.36 997.9994 1,993.98 1,993.99 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% GFNcESKPEAEETcFDK 95.00% 4.65 0.58 5.07 c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,024.92 2,047.82 2,047.84 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TNTNVNcPIEcFMPLDVQADREDSRE 95.00% 4.36 0.576 2.96 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,037.79 3,110.35 3,110.36 3
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EINLAPDSSSVVVSGLMVATK 95.00% 4.23 0.527 4.57 1,059.56 2,117.11 2,117.12 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% EINLAPDSSSVVVSGLmVATK 95.00% 5.27 0.647 6.59 m17: Oxidation (+15.99) 1,067.56 2,133.10 2,133.11 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% ITYGETGGNSPVQEFTVPGSK 95.00% 5.11 0.56 4.39 1,084.52 2,167.03 2,168.05 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% ITYGETGGNSPVQEFTVPGSK 95.00% 5.62 0.547 6.33 1,085.02 2,168.03 2,168.05 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% ITYGETGGNSPVQEFTVPGSK 95.00% 5.17 0.504 4.55 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% ITYGETGGNSPVQEFTVPGSK 95.00% 5.94 0.572 6.15 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% ITYGETGGNSPVQEFTVPGSK 95.00% 5.63 0.533 6.82 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% ITYGETGGNSPVQEFTVPGSK 95.00% 5.7 0.508 5.96 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% ITYGETGGNSPVQEFTVPGSK 95.00% 4.74 0.516 3.92 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% ITYGETGGNSPVQEFTVPGSK 95.00% 5.99 0.573 6.47 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% ITYGETGGNSPVQEFTVPGSK 95.00% 5.65 0.512 4.82 1,085.03 2,168.04 2,168.05 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% QDGHLWcSTTSNYEQDQK 95.00% 3.53 0.558 1.96 c7: Carbamidomethyl (+57.02) 1,099.47 2,196.92 2,196.93 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% QDGHLWcSTTSNYEQDQK 95.00% 3.67 0.485 2.2 c7: Carbamidomethyl (+57.02) 1,099.47 2,196.92 2,196.93 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% DTLTSRPAQGVVTTLENVSPPR 95.00% 5.82 0.617 2.3 1,170.12 2,338.23 2,338.24 2 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TETITGFQVDAVPANGQTPIQR 95.00% 5.13 0.605 4.6 1,172.60 2,343.19 2,343.19 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.91 0.623 5.54 1,199.05 2,396.08 2,396.09 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.76 0.582 6.77 1,199.05 2,396.08 2,396.09 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.81 0.577 5.11 1,232.11 2,462.21 2,462.21 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.1 0.624 5.44 1,232.11 2,462.21 2,462.21 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% STATISGLKPGVDYTITVYAVTGR 95.00% 4.56 0.578 5.49 1,236.16 2,470.30 2,470.32 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TKTETITGFQVDAVPANGQTPIQR 95.00% 6.87 0.684 8.06 1,287.18 2,572.34 2,572.34 2
 SAMPLE 1R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 52 77 411 31.60% TKTETITGFQVDAVPANGQTPIQR 95.00% 6.82 0.707 9.18 1,287.18 2,572.34 2,572.34 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IScTIANR 95.00% 2.09 0.225 0 c3: Carbamidomethyl (+57.02) 467.7429 933.4702 934.4781 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 2.57 0.169 0 467.8943 1,400.66 1,401.67 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 3.69 0.169 0 467.8947 1,400.66 1,401.67 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 3.44 0.224 0 467.8949 1,400.66 1,401.67 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WSRPQAPITGYR 95.00% 2.73 0.14 1.2 477.9205 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WSRPQAPITGYR 95.00% 4.25 0.431 2.62 477.9206 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WSRPQAPITGYR 95.00% 3.24 0.223 1.21 477.921 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WSRPQAPITGYR 95.00% 3.22 0.273 1.89 477.9212 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WSRPQAPITGYR 95.00% 3.48 0.216 1.3 477.9212 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WSRPQAPITGYR 95.00% 3.25 0.302 1.37 477.9214 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WSRPQAPITGYR 95.00% 3.82 0.388 2.41 477.9217 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WSRPQAPITGYR 95.00% 2.94 0.366 0 477.9221 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WSRPQAPITGYR 95.00% 3.33 0.318 2.44 478.2553 1,431.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WSRPQAPITGYR 95.00% 3.76 0.374 2.49 478.2558 1,431.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.11 0.463 1.59 c5: Carbamidomethyl (+57.02) 495.2373 1,482.69 1,483.70 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.76 0.434 1.85 c5: Carbamidomethyl (+57.02) 495.2376 1,482.69 1,483.70 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 4.03 0.489 1.74 c5: Carbamidomethyl (+57.02) 495.2376 1,482.69 1,483.70 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.37 0.363 0.959 c5: Carbamidomethyl (+57.02) 495.2379 1,482.69 1,483.70 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3 0.396 0 c5: Carbamidomethyl (+57.02) 495.239 1,482.69 1,483.70 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 4.53 0.51 1.44 c5: Carbamidomethyl (+57.02) 495.5724 1,483.69 1,483.70 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 2.77 0.238 1.68 531.2729 1,590.80 1,591.81 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 3.21 0.484 1.82 531.2733 1,590.80 1,591.81 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 3.21 0.499 1.36 531.2733 1,590.80 1,591.81 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 3.1 0.496 1.89 531.2734 1,590.80 1,591.81 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 3.51 0.457 1 531.2736 1,590.80 1,591.81 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% QYNVGPSVSKYPLR 95.00% 3.35 0.329 0 536.9564 1,607.85 1,607.85 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% QYNVGPSVSKYPLR 95.00% 3.04 0.326 0 536.9566 1,607.85 1,607.85 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% QYNVGPSVSKYPLR 95.00% 3.09 0.496 1.19 536.9576 1,607.85 1,607.85 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VDVIPVNLPGEHGQR 95.00% 2.07 0.309 0 543.9608 1,628.86 1,629.87 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VDVIPVNLPGEHGQR 95.00% 2.92 0.407 0 543.9614 1,628.86 1,629.87 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VDVIPVNLPGEHGQR 95.00% 2.43 0.468 2.46 543.9617 1,628.86 1,629.87 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VDVIPVNLPGEHGQR 95.00% 2.15 0.315 0 543.9619 1,628.86 1,629.87 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VDVIPVNLPGEHGQR 95.00% 1.82 0.316 0 544.2959 1,629.86 1,629.87 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 2.46 0.374 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.0365 1,650.09 1,651.78 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 3.45 0.364 2.82 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2644 1,650.77 1,651.78 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 3.2 0.308 2.07 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2645 1,650.77 1,651.78 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 3.64 0.3 1.6 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2659 1,650.77 1,651.78 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 4.16 0.457 2.77 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2659 1,650.77 1,651.78 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 3.54 0.394 2.37 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.266 1,650.77 1,651.78 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 3.39 0.326 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5985 1,651.77 1,651.78 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 4.07 0.387 1.43 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5987 1,651.77 1,651.78 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 3.13 0.256 0.959 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5988 1,651.77 1,651.78 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 3.5 0.472 1.28 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5989 1,651.77 1,651.78 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 3.59 0.354 3.64 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5998 1,651.78 1,651.78 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 4.2 0.436 2.26 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.6002 1,651.78 1,651.78 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% PAQGVVTTLENVSPPR 95.00% 3.37 0.346 0 555.6344 1,663.88 1,664.90 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% PAQGVVTTLENVSPPR 95.00% 2.63 0.247 0 555.6372 1,663.89 1,664.90 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% STTPDITGYR 95.00% 2.15 0.514 0 555.7736 1,109.53 1,110.54 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% STTPDITGYR 95.00% 1.86 0.395 0 555.7738 1,109.53 1,110.54 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% STTPDITGYR 95.00% 1.85 0.31 1.85 555.7738 1,109.53 1,110.54 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% STTPDITGYR 95.00% 2.51 0.454 0 555.7739 1,109.53 1,110.54 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% STTPDITGYR 95.00% 2.3 0.569 1.27 555.774 1,109.53 1,110.54 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% STTPDITGYR 95.00% 1.81 0.337 1.54 555.7741 1,109.53 1,110.54 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% STTPDITGYR 95.00% 2.23 0.57 1.77 555.7744 1,109.53 1,110.54 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% STTPDITGYR 95.00% 1.8 0.37 1.3 555.7746 1,109.53 1,110.54 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% STTPDITGYR 95.00% 1.88 0.483 1.8 555.7746 1,109.53 1,110.54 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% STTPDITGYR 95.00% 1.94 0.431 0 555.7747 1,109.53 1,110.54 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% PAQGVVTTLENVSPPR 95.00% 2.79 0.311 0 555.9688 1,664.88 1,664.90 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% PAQGVVTTLENVSPPR 95.00% 2.97 0.319 0 555.9709 1,664.89 1,664.90 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FTNIGPDTMR 95.00% 2.62 0.439 0 576.2768 1,150.54 1,151.55 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FTNIGPDTMR 95.00% 2.63 0.371 0 576.2774 1,150.54 1,151.55 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FTNIGPDTMR 95.00% 2.68 0.433 1.85 576.2784 1,150.54 1,151.55 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FTNIGPDTMR 95.00% 2.94 0.435 0 576.2786 1,150.54 1,151.55 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FTNIGPDTMR 95.00% 3 0.426 1.49 576.2789 1,150.54 1,151.55 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FTNIGPDTMR 95.00% 2.8 0.41 1.62 576.279 1,150.54 1,151.55 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NLQPASEYTVSLVAIK 95.00% 4.48 0.41 2.35 578.3176 1,731.93 1,732.95 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NLQPASEYTVSLVAIK 95.00% 4.77 0.357 1.02 578.3205 1,731.94 1,732.95 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% YEVSVYALKDTLTSR 95.00% 2.39 0.244 0 582.3076 1,743.90 1,744.91 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% YEVSVYALKDTLTSR 95.00% 3.05 0.559 0 582.6424 1,744.90 1,744.91 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 2.68 0.372 0 606.9937 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 2.37 0.331 0 606.9943 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 2.27 0.379 0 606.9946 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 2.61 0.346 0 606.9946 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 2.27 0.424 0 606.9949 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 2.38 0.448 0 606.9956 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 2.69 0.455 0 606.9957 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 2.9 0.524 0 607.3275 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 2.18 0.25 0 607.3292 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 2.46 0.365 0 607.3293 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 2.94 0.428 0 607.3298 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 2.68 0.277 0 607.33 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% PAQGVVTTLENVSPPRR 95.00% 3.03 0.552 0 608.0033 1,820.99 1,821.00 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% PAQGVVTTLENVSPPRR 95.00% 3.09 0.513 0 608.0045 1,820.99 1,821.00 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WKEATIPGHLNSYTIK 95.00% 2.65 0.38 1.16 619.9996 1,856.98 1,857.99 3 MCF2L_HUMAN,F10A1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WKEATIPGHLNSYTIK 95.00% 2.96 0.441 0 620.3354 1,857.98 1,857.99 3 MCF2L_HUMAN,F10A1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 3.52 0.506 1.24 621.9652 1,862.87 1,863.88 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 3.01 0.494 0 621.9663 1,862.88 1,863.88 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 4.88 0.558 1.3 622.2997 1,863.88 1,863.88 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 4.46 0.535 0 622.2998 1,863.88 1,863.88 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 3.73 0.512 0 622.3004 1,863.88 1,863.88 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 4.09 0.513 1.02 622.3011 1,863.88 1,863.88 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 3.3 0.534 0 622.3014 1,863.88 1,863.88 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SSPVVIDASTAIDAPSNLR 95.00% 3.22 0.398 0 638.3368 1,911.99 1,913.00 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SSPVVIDASTAIDAPSNLR 95.00% 4.83 0.55 3.26 638.3376 1,911.99 1,913.00 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SSPVVIDASTAIDAPSNLR 95.00% 3.94 0.227 0 638.671 1,912.99 1,913.00 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SSPVVIDASTAIDAPSNLR 95.00% 5.6 0.561 5.01 638.6718 1,912.99 1,913.00 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SSPVVIDASTAIDAPSNLR 95.00% 3.35 0.355 0 638.6719 1,912.99 1,913.00 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SSPVVIDASTAIDAPSNLR 95.00% 4.74 0.533 2.44 638.6721 1,912.99 1,913.00 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 4.23 0.496 2.22 643.0176 1,926.03 1,927.04 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 5.07 0.596 2.62 643.0195 1,926.03 1,927.04 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 3.4 0.515 0 643.0206 1,926.04 1,927.04 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 4.58 0.534 1.74 643.3541 1,927.04 1,927.04 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DLQFVEVTDVK 95.00% 3.91 0.482 2.68 646.8391 1,291.66 1,292.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DLQFVEVTDVK 95.00% 4.01 0.492 2.8 646.8393 1,291.66 1,292.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DLQFVEVTDVK 95.00% 3.89 0.502 3.24 646.8393 1,291.66 1,292.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DLQFVEVTDVK 95.00% 4.41 0.499 1.8 646.8394 1,291.66 1,292.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DLQFVEVTDVK 95.00% 4.29 0.497 2.46 646.8398 1,291.66 1,292.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DLQFVEVTDVK 95.00% 3.98 0.513 2.51 646.84 1,291.66 1,292.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DLQFVEVTDVK 95.00% 4.07 0.486 3.89 646.8401 1,291.66 1,292.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DLQFVEVTDVK 95.00% 4.22 0.518 2.66 646.8401 1,291.66 1,292.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DLQFVEVTDVK 95.00% 3.17 0.315 0 646.8404 1,291.67 1,292.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DLQFVEVTDVK 95.00% 3.8 0.471 2.62 646.8408 1,291.67 1,292.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DLQFVEVTDVK 95.00% 4.26 0.47 2.92 647.343 1,292.67 1,292.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EESPLLIGQQSTVSDVPR 95.00% 3.5 0.511 0.921 652.6764 1,955.01 1,955.01 3 MYPT2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LGVRPSQGGEAPR 95.00% 2 0.301 0 662.3614 1,322.71 1,323.71 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WLPSSSPVTGYR 95.00% 2.2 0.369 1.48 675.3451 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WLPSSSPVTGYR 95.00% 2.47 0.448 2.19 675.3452 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WLPSSSPVTGYR 95.00% 2.39 0.185 1.64 675.3452 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WLPSSSPVTGYR 95.00% 2.32 0.412 1.7 675.3454 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WLPSSSPVTGYR 95.00% 2.54 0.439 1.77 675.3457 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WLPSSSPVTGYR 95.00% 2.28 0.508 2.64 675.3457 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WLPSSSPVTGYR 95.00% 2.3 0.479 2.35 675.3459 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WLPSSSPVTGYR 95.00% 2.49 0.414 2.44 675.3463 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WLPSSSPVTGYR 95.00% 2.44 0.405 1.46 675.3467 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 3.32 0.503 2.7 678.3496 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 3.72 0.483 2.85 678.3505 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 3.42 0.469 1.89 678.3507 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 3.72 0.488 2.59 678.3507 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 3.59 0.493 1.89 678.3507 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 3.75 0.473 1.96 678.3507 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 3.77 0.469 2.1 678.3508 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 3.69 0.465 2.07 678.3509 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 3.39 0.463 2.52 678.351 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 3.53 0.5 2.11 678.351 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 4.13 0.501 1.8 678.3512 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 3.64 0.486 1.44 678.3513 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IYLYTLNDNAR 95.00% 3.57 0.502 1.89 678.3514 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IAWESPQGQVSR 95.00% 3.56 0.319 3.24 679.3471 1,356.68 1,357.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% IAWESPQGQVSR 95.00% 3.37 0.322 2.66 679.3484 1,356.68 1,357.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 3.51 0.474 2.15 701.3339 1,400.65 1,401.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 3.03 0.487 2.85 701.3344 1,400.65 1,401.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 3.01 0.499 1.85 701.3349 1,400.65 1,401.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 3.21 0.384 2.12 701.3351 1,400.65 1,401.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 2.79 0.459 3 701.3354 1,400.66 1,401.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 3.07 0.507 1.96 701.3356 1,400.66 1,401.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 3.45 0.447 2.37 701.3358 1,400.66 1,401.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 2.76 0.371 1.8 701.3363 1,400.66 1,401.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 2.47 0.413 2.3 701.3371 1,400.66 1,401.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 3.54 0.449 2.33 701.8349 1,401.65 1,401.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 2.67 0.46 1.55 701.836 1,401.66 1,401.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HYQINQQWER 95.00% 3.48 0.406 2.01 701.8377 1,401.66 1,401.67 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% ITYGETGGNSPVQEFTVPGSK 95.00% 4.47 0.509 2.15 723.6893 2,168.04 2,168.05 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.44 0.672 4.82 731.3957 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 3.67 0.638 3.92 731.3972 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.19 0.666 5.07 731.3973 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.54 0.658 5.1 731.3978 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.19 0.611 6 731.398 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.44 0.666 5 731.3985 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.03 0.575 4.54 731.3985 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.18 0.667 3.8 731.3987 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 3.69 0.648 4.37 731.3988 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 3.95 0.645 6.37 731.399 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.34 0.671 4.62 731.3991 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.3 0.65 4.47 731.3992 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.37 0.646 5 731.3994 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.22 0.65 3.85 731.3994 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.25 0.573 5.68 731.3996 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 3.97 0.659 5.25 731.3999 1,460.78 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 4.01 0.322 4.68 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8451 1,461.67 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 4.01 0.358 6.21 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8454 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 3.3 0.346 5.19 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8459 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 3.94 0.382 5 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8462 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 3.88 0.414 5.52 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8469 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 3.91 0.302 4.96 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8469 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 3.76 0.299 5.82 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8471 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 3.95 0.361 5.74 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8476 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 3.84 0.362 7.96 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.848 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 3.95 0.254 4.85 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8481 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 4.03 0.32 5.35 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8483 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 3.95 0.349 4.8 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8483 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 3.55 0.31 4.74 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.849 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GNLLQcIcTGNGR 95.00% 4.18 0.316 4.77 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8497 1,461.68 1,462.69 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 4.19 0.649 5.96 731.9008 1,461.79 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VPGTSTSATLTGLTR 95.00% 3.87 0.593 3.54 731.9012 1,461.79 1,461.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% QDGHLWcSTTSNYEQDQK 95.00% 4.65 0.443 1.74 c7: Carbamidomethyl (+57.02) 733.3149 2,196.92 2,196.93 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.7 0.489 2.13 c5: Carbamidomethyl (+57.02) 742.3501 1,482.68 1,483.70 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.77 0.496 1.64 c5: Carbamidomethyl (+57.02) 742.3504 1,482.69 1,483.70 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.53 0.498 2.25 c5: Carbamidomethyl (+57.02) 742.3507 1,482.69 1,483.70 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.73 0.486 1.74 c5: Carbamidomethyl (+57.02) 742.3508 1,482.69 1,483.70 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.63 0.464 1.19 c5: Carbamidomethyl (+57.02) 742.351 1,482.69 1,483.70 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.81 0.492 2.49 c5: Carbamidomethyl (+57.02) 742.3511 1,482.69 1,483.70 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 2.62 0.283 0 c5: Carbamidomethyl (+57.02) 742.3515 1,482.69 1,483.70 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.61 0.466 2.54 c5: Carbamidomethyl (+57.02) 742.3516 1,482.69 1,483.70 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.83 0.48 2.43 c5: Carbamidomethyl (+57.02) 742.3524 1,482.69 1,483.70 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.87 0.454 1.8 c5: Carbamidomethyl (+57.02) 742.3531 1,482.69 1,483.70 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.83 0.448 1.41 c5: Carbamidomethyl (+57.02) 742.3534 1,482.69 1,483.70 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GEWTcIAYSQLR 95.00% 3.71 0.43 2.23 c5: Carbamidomethyl (+57.02) 742.8548 1,483.69 1,483.70 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SYTITGLQPGTDYK 95.00% 4.33 0.459 4.89 772.3817 1,542.75 1,543.76 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SYTITGLQPGTDYK 95.00% 3.36 0.488 2.68 772.3842 1,542.75 1,543.76 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SYTITGLQPGTDYK 95.00% 3.72 0.48 2.02 772.3844 1,542.75 1,543.76 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SYTITGLQPGTDYK 95.00% 4.64 0.573 5.64 772.3845 1,542.75 1,543.76 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SYTITGLQPGTDYK 95.00% 4.65 0.572 5.14 772.385 1,542.75 1,543.76 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SYTITGLQPGTDYK 95.00% 3.67 0.417 3.2 772.3872 1,542.76 1,543.76 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EATIPGHLNSYTIK 95.00% 2.9 0.472 1.59 772.4105 1,542.81 1,543.81 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SYTITGLQPGTDYK 95.00% 3.84 0.446 1.96 772.885 1,543.75 1,543.76 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SYTITGLQPGTDYK 95.00% 4.2 0.467 1.92 772.8853 1,543.76 1,543.76 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SYTITGLQPGTDYK 95.00% 3.41 0.426 1.74 772.8867 1,543.76 1,543.76 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EATIPGHLNSYTIK 95.00% 2.97 0.434 1.46 772.9115 1,543.81 1,543.81 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DTLTSRPAQGVVTTLENVSPPR 95.00% 2.08 0.439 1.28 780.4162 2,338.23 2,338.24 3 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DTLTSRPAQGVVTTLENVSPPR 95.00% 2.49 0.411 1.52 780.4187 2,338.23 2,338.24 3 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WcGTTQNYDADQK 95.00% 2.67 0.265 0 c2: Carbamidomethyl (+57.02) 793.8299 1,585.64 1,586.65 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% WcGTTQNYDADQK 95.00% 2.5 0.257 0 c2: Carbamidomethyl (+57.02) 793.8307 1,585.65 1,586.65 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 4.43 0.597 4.96 796.4057 1,590.80 1,591.81 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 4 0.529 3.8 796.4067 1,590.80 1,591.81 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 3.86 0.597 3.57 796.407 1,590.80 1,591.81 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 3.92 0.566 4.23 796.4071 1,590.80 1,591.81 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 3.93 0.557 4.12 796.4074 1,590.80 1,591.81 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 4.21 0.564 4.27 796.4075 1,590.80 1,591.81 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 3.79 0.583 2.66 796.4081 1,590.80 1,591.81 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GDSPASSKPISINYR 95.00% 4.14 0.548 3.42 796.4087 1,590.80 1,591.81 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.87 0.629 5.14 799.6992 2,396.07 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.78 0.546 5.28 799.6993 2,396.07 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.11 0.599 4.28 799.6993 2,396.07 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.66 0.598 3.42 799.6995 2,396.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.96 0.577 4.77 799.6996 2,396.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.18 0.602 6.36 799.6999 2,396.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.52 0.607 3.14 799.7004 2,396.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.34 0.614 4.39 799.7006 2,396.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.81 0.604 2.57 799.7007 2,396.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.36 0.521 5.22 799.7007 2,396.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.93 0.617 4.43 799.7007 2,396.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.12 0.593 3.68 799.7008 2,396.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.76 0.615 3.62 799.7013 2,396.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.79 0.582 3.7 799.702 2,396.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.57 0.612 3.37 799.7023 2,396.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.76 0.571 4.1 799.7036 2,396.09 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 0 0 5.96 800.0292 2,397.06 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 0 0 4.21 800.0294 2,397.06 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 0 0 4.49 800.0299 2,397.07 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 0 0 3.57 800.0302 2,397.07 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 0 0 4.77 800.0359 2,397.08 2,396.09 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VDVIPVNLPGEHGQR 95.00% 3.82 0.452 5.36 815.4384 1,628.86 1,629.87 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VDVIPVNLPGEHGQR 95.00% 3.73 0.449 4.44 815.4384 1,628.86 1,629.87 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VDVIPVNLPGEHGQR 95.00% 3.38 0.532 4.22 815.4389 1,628.86 1,629.87 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VDVIPVNLPGEHGQR 95.00% 3.88 0.416 3.22 815.4391 1,628.86 1,629.87 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VDVIPVNLPGEHGQR 95.00% 3.85 0.468 4.39 815.9388 1,629.86 1,629.87 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VDVIPVNLPGEHGQR 95.00% 3.83 0.458 4.06 815.94 1,629.86 1,629.87 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DSMIWDcTcIGAGR 95.00% 3.6 0.426 4.55 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3437 1,640.67 1,641.68 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DSMIWDcTcIGAGR 95.00% 3.82 0.492 5.54 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3448 1,640.67 1,641.68 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.72 0.371 3.72 821.7405 2,462.20 2,462.21 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.83 0.455 4.3 821.7418 2,462.20 2,462.21 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.64 0.462 1.92 821.742 2,462.20 2,462.21 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.69 0.486 3.42 821.7433 2,462.21 2,462.21 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DDKESVPISDTIIPAVPPPTDLR 95.00% 2.9 0.358 0 826.1038 2,475.29 2,475.30 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DDKESVPISDTIIPAVPPPTDLR 95.00% 3.23 0.388 0 826.1046 2,475.29 2,475.30 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% DDKESVPISDTIIPAVPPPTDLR 95.00% 3.5 0.436 1.89 826.1053 2,475.29 2,475.30 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% LLcQcLGFGSGHFR 95.00% 3.78 0.363 4.48 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.8946 1,651.77 1,651.78 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% PAQGVVTTLENVSPPR 95.00% 4.19 0.6 0 832.9494 1,663.88 1,664.90 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% PAQGVVTTLENVSPPR 95.00% 3.98 0.632 0 832.9519 1,663.89 1,664.90 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% PAQGVVTTLENVSPPR 95.00% 4.22 0.576 0 832.9535 1,663.89 1,664.90 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% PAQGVVTTLENVSPPR 95.00% 4.32 0.589 0 833.4511 1,664.89 1,664.90 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% PAQGVVTTLENVSPPR 95.00% 4.28 0.594 0 833.4564 1,664.90 1,664.90 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.54 0.448 1.8 858.4495 2,572.33 2,572.34 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.32 0.396 2.24 858.4496 2,572.33 2,572.34 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.67 0.494 3.39 858.45 2,572.33 2,572.34 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.44 0.461 2.74 858.4502 2,572.33 2,572.34 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.51 0.438 2.7 858.4504 2,572.33 2,572.34 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.62 0.391 3.52 858.4507 2,572.33 2,572.34 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.31 0.392 2.64 858.4515 2,572.33 2,572.34 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.14 0.349 1.89 858.4524 2,572.33 2,572.34 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.59 0.471 2.44 858.4524 2,572.33 2,572.34 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NLQPASEYTVSLVAIK 95.00% 4.23 0.609 7.55 866.976 1,731.94 1,732.95 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NLQPASEYTVSLVAIK 95.00% 4.43 0.607 6.38 866.9761 1,731.94 1,732.95 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NLQPASEYTVSLVAIK 95.00% 4.3 0.592 7.68 866.9765 1,731.94 1,732.95 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NLQPASEYTVSLVAIK 95.00% 4.46 0.589 4.96 866.9767 1,731.94 1,732.95 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NLQPASEYTVSLVAIK 95.00% 4.43 0.624 7.42 866.9767 1,731.94 1,732.95 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NLQPASEYTVSLVAIK 95.00% 4.52 0.599 7.43 866.9769 1,731.94 1,732.95 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NLQPASEYTVSLVAIK 95.00% 4.46 0.599 8.31 866.977 1,731.94 1,732.95 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NLQPASEYTVSLVAIK 95.00% 4.22 0.597 2.28 866.977 1,731.94 1,732.95 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NLQPASEYTVSLVAIK 95.00% 4.25 0.578 5.89 866.9775 1,731.94 1,732.95 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NLQPASEYTVSLVAIK 95.00% 4.27 0.62 3.89 867.4784 1,732.94 1,732.95 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.57 0.63 6.09 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4081 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.77 0.618 5.66 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4089 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.75 0.604 5.19 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4095 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.39 0.634 5.59 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4095 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.46 0.629 6.26 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4103 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.66 0.611 6.42 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.411 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.73 0.656 5.03 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4115 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.18 0.627 4.96 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4115 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.42 0.604 5.04 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4118 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.94 0.604 5.72 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4119 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.33 0.606 5.92 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4119 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.58 0.574 3.51 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9087 1,791.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.49 0.592 4.39 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9099 1,791.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.42 0.581 3.4 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9104 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.84 0.601 4.28 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9113 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.41 0.58 4.85 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9113 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.79 0.617 3.72 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9124 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TYLGNALVcTcYGGSR 95.00% 5.46 0.607 4.24 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.913 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VTIMWTPPESAVTGYR 95.00% 2.33 0.297 0 904.4558 1,806.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VTIMWTPPESAVTGYR 95.00% 4.19 0.62 5.38 904.456 1,806.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% VTIMWTPPESAVTGYR 95.00% 3.86 0.558 5.11 904.4561 1,806.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 4.04 0.509 2.21 909.9879 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 4.59 0.5 2.66 909.9887 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GATYNIIVEALKDQQR 95.00% 3.63 0.47 2.48 909.9893 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 5.88 0.58 10.2 932.4424 1,862.87 1,863.88 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 5.57 0.599 9.49 932.4438 1,862.87 1,863.88 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 5.69 0.616 10.4 932.4443 1,862.87 1,863.88 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 5.47 0.568 8.14 932.4445 1,862.87 1,863.88 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 5.92 0.582 10.7 932.4451 1,862.87 1,863.88 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 5.75 0.619 10 932.4456 1,862.88 1,863.88 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 5.78 0.579 9.89 932.446 1,862.88 1,863.88 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 5.4 0.596 8.44 932.4466 1,862.88 1,863.88 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 5.82 0.583 8.49 932.9445 1,863.87 1,863.88 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 5.75 0.552 10.9 932.9469 1,863.88 1,863.88 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% HTSVQTTSSGSGPFTDVR 95.00% 5.7 0.551 9.49 932.9471 1,863.88 1,863.88 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 5.54 0.653 6.6 934.1624 2,799.46 2,799.48 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 5.24 0.645 4.07 934.1631 2,799.47 2,799.48 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 5.81 0.653 4.89 934.1642 2,799.47 2,799.48 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 4.99 0.576 4.06 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8969 1,877.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 4.89 0.611 4.85 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8969 1,877.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 4.66 0.502 3.55 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8971 1,877.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 4.62 0.574 3.09 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8971 1,877.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 4.89 0.63 4.09 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8973 1,877.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 4.94 0.582 4.68 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.898 1,877.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 5.16 0.618 4.43 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8984 1,877.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 5.04 0.605 3.82 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8987 1,877.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 5.18 0.624 4.44 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8987 1,877.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 5.02 0.59 4 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8987 1,877.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 4.97 0.607 3.85 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8996 1,877.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 4.99 0.622 4.49 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8997 1,877.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 5.19 0.578 4.6 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3994 1,878.78 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 5.15 0.632 6.33 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4015 1,878.79 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 5.04 0.584 6.51 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4015 1,878.79 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 5.38 0.576 4.48 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4018 1,878.79 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EYLGAIcScTcFGGQR 95.00% 5.22 0.57 4.77 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4024 1,878.79 1,878.79 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SSPVVIDASTAIDAPSNLR 95.00% 5.75 0.573 8.28 957.0014 1,911.99 1,913.00 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SSPVVIDASTAIDAPSNLR 95.00% 5.88 0.559 7.05 957.0028 1,911.99 1,913.00 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% SSPVVIDASTAIDAPSNLR 95.00% 3.53 0.425 0 957.503 1,912.99 1,913.00 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 3.73 0.503 4.24 964.5232 1,927.03 1,927.04 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 4.48 0.571 3.89 964.5242 1,927.03 1,927.04 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 4.55 0.523 5.7 964.5244 1,927.03 1,927.04 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 4.25 0.484 5.74 964.5246 1,927.03 1,927.04 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 4.32 0.515 4.6 964.5246 1,927.03 1,927.04 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 4.39 0.536 4.85 964.5252 1,927.03 1,927.04 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 4.6 0.479 5.08 964.5255 1,927.04 1,927.04 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 3.98 0.485 4.49 964.5262 1,927.04 1,927.04 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% FLATTPNSLLVSWQPPR 95.00% 4.39 0.514 4.21 964.5271 1,927.04 1,927.04 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GFNcESKPEAEETcFDKYTGNTYR 95.00% 5.78 0.428 4.14 c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 968.7471 2,903.22 2,903.23 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GFNcESKPEAEETcFDKYTGNTYR 95.00% 5.63 0.367 3.34 c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 968.7522 2,903.23 2,903.23 3
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EESPLLIGQQSTVSDVPR 95.00% 4.81 0.6 4.89 978.006 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EESPLLIGQQSTVSDVPR 95.00% 4.32 0.577 5.52 978.5054 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EESPLLIGQQSTVSDVPR 95.00% 4.78 0.603 3.82 978.5064 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EESPLLIGQQSTVSDVPR 95.00% 4.62 0.577 3.82 978.5066 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EESPLLIGQQSTVSDVPR 95.00% 4.77 0.545 4.77 978.5075 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EESPLLIGQQSTVSDVPR 95.00% 4.82 0.529 4.55 978.508 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EESPLLIGQQSTVSDVPR 95.00% 4.65 0.563 3.68 978.5094 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NTFAEVTGLSPGVTYYFK 95.00% 6.25 0.507 6.1 997.4965 1,992.98 1,993.99 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NTFAEVTGLSPGVTYYFK 95.00% 5.3 0.613 5.8 997.9982 1,993.98 1,993.99 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% NTFAEVTGLSPGVTYYFK 95.00% 6 0.662 5.85 997.9984 1,993.98 1,993.99 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% GFNcESKPEAEETcFDK 95.00% 4.42 0.576 8.74 c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,024.92 2,047.82 2,047.84 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EINLAPDSSSVVVSGLMVATK 95.00% 5.75 0.593 9.92 1,059.56 2,117.11 2,117.12 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% EINLAPDSSSVVVSGLMVATK 95.00% 6.05 0.601 8.96 1,059.56 2,117.11 2,117.12 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% ITYGETGGNSPVQEFTVPGSK 95.00% 5.73 0.579 5.6 1,084.53 2,167.04 2,168.05 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% ITYGETGGNSPVQEFTVPGSK 95.00% 5.24 0.519 4.92 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% ITYGETGGNSPVQEFTVPGSK 95.00% 5.56 0.483 6.15 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% ITYGETGGNSPVQEFTVPGSK 95.00% 5.38 0.537 5.52 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% ITYGETGGNSPVQEFTVPGSK 95.00% 5.28 0.503 4.96 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% ITYGETGGNSPVQEFTVPGSK 95.00% 5.91 0.526 6.21 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% ITYGETGGNSPVQEFTVPGSK 95.00% 5.72 0.576 5.77 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% ITYGETGGNSPVQEFTVPGSK 95.00% 5.76 0.533 6.23 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% ITYGETGGNSPVQEFTVPGSK 95.00% 5.62 0.516 5.47 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% ITYGETGGNSPVQEFTVPGSK 95.00% 6.02 0.552 7.6 1,085.03 2,168.05 2,168.05 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.05 0.6 7.15 1,199.05 2,396.08 2,396.09 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.35 0.555 4.72 1,199.05 2,396.08 2,396.09 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.04 0.563 6.46 1,199.05 2,396.08 2,396.09 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.08 0.493 1.89 1,232.10 2,462.19 2,462.21 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.94 0.596 4.46 1,232.10 2,462.19 2,462.21 2
 SAMPLE 2 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 46 62 379 27.90% TKTETITGFQVDAVPANGQTPIQR 95.00% 6.35 0.682 7.46 1,287.17 2,572.33 2,572.34 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IScTIANR 95.00% 2.06 0.232 0 c3: Carbamidomethyl (+57.02) 467.7436 933.4716 934.4781 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HYQINQQWER 95.00% 2.96 0.163 0 467.8954 1,400.66 1,401.67 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HYQINQQWER 95.00% 3.39 0.0971 0 468.23 1,401.67 1,401.67 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WSRPQAPITGYR 95.00% 3.22 0.365 1.41 477.9202 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WSRPQAPITGYR 95.00% 2.85 0.212 0 477.9202 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WSRPQAPITGYR 95.00% 3.05 0.34 1.23 477.9203 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WSRPQAPITGYR 95.00% 2.92 0.282 0 477.9206 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WSRPQAPITGYR 95.00% 3.19 0.351 2.47 477.9207 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WSRPQAPITGYR 95.00% 3.57 0.312 2.6 477.9208 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WSRPQAPITGYR 95.00% 3.7 0.386 2.74 477.9214 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WSRPQAPITGYR 95.00% 3.17 0.285 2.49 477.9216 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WSRPQAPITGYR 95.00% 2.4 0.204 0 477.9222 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 3.48 0.357 1.02 c5: Carbamidomethyl (+57.02) 495.2368 1,482.69 1,483.70 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 4.14 0.45 1.38 c5: Carbamidomethyl (+57.02) 495.2372 1,482.69 1,483.70 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 4.07 0.404 1.68 c5: Carbamidomethyl (+57.02) 495.2376 1,482.69 1,483.70 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 2.39 0.264 0 531.2728 1,590.80 1,591.81 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 2.93 0.405 1.28 531.2733 1,590.80 1,591.81 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 2.62 0.307 0 531.2734 1,590.80 1,591.81 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 3.37 0.482 0 531.6084 1,591.80 1,591.81 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 2.7 0.309 1.14 531.6085 1,591.80 1,591.81 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% YEVSVYALK 95.00% 2.17 0.194 1.8 536.2876 1,070.56 1,071.57 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% YEVSVYALK 95.00% 2.09 0.177 1.82 536.2889 1,070.56 1,071.57 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% QYNVGPSVSKYPLR 95.00% 2.48 0.305 0 536.6237 1,606.85 1,607.85 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% QYNVGPSVSKYPLR 95.00% 3.31 0.441 0 536.9568 1,607.85 1,607.85 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VDVIPVNLPGEHGQR 95.00% 2.59 0.381 0 543.9603 1,628.86 1,629.87 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VDVIPVNLPGEHGQR 95.00% 2.49 0.413 2.47 543.9621 1,628.86 1,629.87 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VDVIPVNLPGEHGQR 95.00% 2.16 0.318 2.04 543.9621 1,628.86 1,629.87 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VDVIPVNLPGEHGQR 95.00% 2.18 0.275 1.28 544.2958 1,629.86 1,629.87 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% LLcQcLGFGSGHFR 95.00% 1.79 0.275 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.0321 1,650.07 1,651.78 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% LLcQcLGFGSGHFR 95.00% 2.15 0.292 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.0328 1,650.08 1,651.78 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% LLcQcLGFGSGHFR 95.00% 3 0.353 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2629 1,650.77 1,651.78 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% LLcQcLGFGSGHFR 95.00% 4.05 0.378 2.25 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2646 1,650.77 1,651.78 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% LLcQcLGFGSGHFR 95.00% 3.99 0.389 3.24 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2648 1,650.77 1,651.78 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% LLcQcLGFGSGHFR 95.00% 3.63 0.382 2.08 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2662 1,650.78 1,651.78 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% LLcQcLGFGSGHFR 95.00% 4.22 0.431 1.96 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5987 1,651.77 1,651.78 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% LLcQcLGFGSGHFR 95.00% 3.57 0.291 3.66 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5993 1,651.77 1,651.78 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% LLcQcLGFGSGHFR 95.00% 3.23 0.313 1.29 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.6008 1,651.78 1,651.78 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% PAQGVVTTLENVSPPR 95.00% 2.32 0.224 0 555.636 1,663.88 1,664.90 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% PAQGVVTTLENVSPPR 95.00% 2.29 0.258 0 555.6363 1,663.89 1,664.90 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% STTPDITGYR 95.00% 2.14 0.492 1.31 555.7728 1,109.53 1,110.54 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% STTPDITGYR 95.00% 2.67 0.585 2.41 555.7732 1,109.53 1,110.54 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% STTPDITGYR 95.00% 1.81 0.398 1.32 555.7739 1,109.53 1,110.54 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% STTPDITGYR 95.00% 2.27 0.503 3.18 555.7743 1,109.53 1,110.54 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% STTPDITGYR 95.00% 2.09 0.367 0 555.7743 1,109.53 1,110.54 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% STTPDITGYR 95.00% 2.15 0.511 0 555.7746 1,109.53 1,110.54 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% STTPDITGYR 95.00% 2.17 0.528 1.46 555.7748 1,109.53 1,110.54 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% STTPDITGYR 95.00% 1.85 0.344 1.54 555.7749 1,109.53 1,110.54 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% STTPDITGYR 95.00% 2.08 0.361 1.72 555.7751 1,109.53 1,110.54 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% PAQGVVTTLENVSPPR 95.00% 3.57 0.236 0 555.9696 1,664.89 1,664.90 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% PAQGVVTTLENVSPPR 95.00% 2.94 0.264 0 555.9699 1,664.89 1,664.90 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FTNIGPDTMR 95.00% 2.89 0.402 2.38 576.2768 1,150.54 1,151.55 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FTNIGPDTMR 95.00% 2.76 0.444 1.34 576.2779 1,150.54 1,151.55 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FTNIGPDTMR 95.00% 2.89 0.438 1.22 576.2782 1,150.54 1,151.55 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FTNIGPDTMR 95.00% 2.98 0.46 1.54 576.2784 1,150.54 1,151.55 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FTNIGPDTMR 95.00% 3.04 0.45 2.29 576.2785 1,150.54 1,151.55 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.27 0.392 0 578.3193 1,731.93 1,732.95 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.36 0.389 0 578.3193 1,731.93 1,732.95 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.7 0.389 1.14 578.3199 1,731.94 1,732.95 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.67 0.427 3 578.6537 1,732.94 1,732.95 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.71 0.402 1.54 578.6539 1,732.94 1,732.95 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.67 0.174 1.37 578.6553 1,732.94 1,732.95 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 2.45 0.407 0 606.9931 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 2.31 0.214 0 606.9941 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 2.22 0.243 0 606.9943 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 2.51 0.375 0 606.9947 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 2.19 0.389 0 606.9949 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 2.41 0.422 0 606.995 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 2.33 0.459 0 606.995 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 2.3 0.247 0 606.9951 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 2.76 0.301 0 607.3286 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 2.69 0.448 0 607.3286 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 2.42 0.411 0 607.3292 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 2.65 0.454 0 607.3296 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% PAQGVVTTLENVSPPRR 95.00% 2.17 0.293 0 607.7953 1,820.36 1,821.00 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% PAQGVVTTLENVSPPRR 95.00% 2.07 0.311 0 607.7962 1,820.37 1,821.00 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WKEATIPGHLNSYTIK 95.00% 2.21 0.22 0 620.3342 1,857.98 1,857.99 3 MCF2L_HUMAN,F10A1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 3.78 0.484 0 622.2997 1,863.88 1,863.88 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 3.86 0.488 1.85 622.2999 1,863.88 1,863.88 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 4.03 0.627 2.89 622.3004 1,863.88 1,863.88 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 3.74 0.546 2.19 622.301 1,863.88 1,863.88 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 3.28 0.484 0 622.301 1,863.88 1,863.88 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SSPVVIDASTAIDAPSNLR 95.00% 3.65 0.453 0 638.3375 1,911.99 1,913.00 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SSPVVIDASTAIDAPSNLR 95.00% 4.99 0.532 2.24 638.6693 1,912.98 1,913.00 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SSPVVIDASTAIDAPSNLR 95.00% 4.08 0.462 0 638.6702 1,912.99 1,913.00 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SSPVVIDASTAIDAPSNLR 95.00% 4.62 0.435 2.55 638.6711 1,912.99 1,913.00 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 3.69 0.521 1.04 643.019 1,926.03 1,927.04 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 3.92 0.529 1.02 643.019 1,926.03 1,927.04 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 2.53 0.351 0 643.0198 1,926.04 1,927.04 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 2.07 0.368 0 643.0206 1,926.04 1,927.04 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 2.89 0.412 0 643.3525 1,927.03 1,927.04 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 2.85 0.388 0 643.3529 1,927.04 1,927.04 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 5.16 0.535 3.21 643.3532 1,927.04 1,927.04 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 3.53 0.568 1.35 643.3537 1,927.04 1,927.04 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 5.39 0.577 2.26 643.3539 1,927.04 1,927.04 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 1.92 0.305 0 643.355 1,927.04 1,927.04 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALK 95.00% 2.88 0.367 0 646.3646 1,290.71 1,291.73 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALK 95.00% 3.18 0.433 1.35 646.3651 1,290.71 1,291.73 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALK 95.00% 2.82 0.409 1.14 646.3654 1,290.72 1,291.73 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALK 95.00% 3.36 0.395 2.55 646.3662 1,290.72 1,291.73 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALK 95.00% 3.08 0.365 0 646.3662 1,290.72 1,291.73 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALK 95.00% 3.71 0.421 3 646.3673 1,290.72 1,291.73 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DLQFVEVTDVK 95.00% 3.5 0.457 2.15 646.8383 1,291.66 1,292.67 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DLQFVEVTDVK 95.00% 3.41 0.419 3.28 646.8391 1,291.66 1,292.67 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DLQFVEVTDVK 95.00% 3.44 0.473 3.41 646.8393 1,291.66 1,292.67 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DLQFVEVTDVK 95.00% 3.28 0.392 2.25 646.8393 1,291.66 1,292.67 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DLQFVEVTDVK 95.00% 3.09 0.393 2.07 646.8403 1,291.67 1,292.67 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DLQFVEVTDVK 95.00% 3.6 0.484 2.59 646.8409 1,291.67 1,292.67 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EESPLLIGQQSTVSDVPR 95.00% 3.02 0.363 0 652.6769 1,955.01 1,955.01 3 MYPT2_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% LGVRPSQGGEAPR 95.00% 2.27 0.236 2.44 662.3606 1,322.71 1,323.71 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% LGVRPSQGGEAPR 95.00% 2.11 0.374 1.72 662.3625 1,322.71 1,323.71 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WLPSSSPVTGYR 95.00% 2.51 0.497 2.07 675.3441 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WLPSSSPVTGYR 95.00% 2.42 0.478 1.8 675.3445 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WLPSSSPVTGYR 95.00% 2.27 0.426 1.66 675.3449 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WLPSSSPVTGYR 95.00% 2.27 0.257 2.22 675.3457 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WLPSSSPVTGYR 95.00% 2.68 0.538 1.11 675.3461 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WLPSSSPVTGYR 95.00% 2.37 0.306 1.15 675.3464 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% WLPSSSPVTGYR 95.00% 2.15 0.3 0 675.3471 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 3.29 0.458 1.77 678.3498 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 3.46 0.473 2.09 678.3498 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 3.07 0.356 1.57 678.35 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 3.22 0.508 2.14 678.3504 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 3.64 0.464 1.55 678.3506 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 3.46 0.425 1.24 678.3507 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 2.79 0.418 2.28 678.3507 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 3.24 0.451 1.72 678.3509 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 3.53 0.454 1.92 678.3511 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 2.78 0.355 0 678.3511 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 3.84 0.455 1.92 678.3512 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 3.88 0.458 1.74 678.3512 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 3.56 0.466 1.68 678.3515 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% IYLYTLNDNAR 95.00% 3.47 0.455 1.47 678.3519 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HYQINQQWER 95.00% 3.11 0.502 2.7 701.3341 1,400.65 1,401.67 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HYQINQQWER 95.00% 3.17 0.472 2.42 701.3353 1,400.65 1,401.67 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HYQINQQWER 95.00% 3.26 0.504 2.57 701.3354 1,400.66 1,401.67 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HYQINQQWER 95.00% 3.18 0.494 2.29 701.3372 1,400.66 1,401.67 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 4.28 0.564 2.12 723.6884 2,168.04 2,168.05 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 4.02 0.579 2.6 723.69 2,168.05 2,168.05 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.22 0.662 6.68 731.3965 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 3.68 0.659 6.01 731.3973 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 3.71 0.618 4.29 731.3975 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.25 0.641 6.29 731.3977 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 3.87 0.596 7.34 731.3978 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.16 0.579 4.85 731.3983 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.31 0.629 5.57 731.3986 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.33 0.646 6.82 731.3987 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.26 0.662 5.77 731.399 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.34 0.655 5.39 731.3991 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 3.92 0.6 5.23 731.3993 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.16 0.631 5.82 731.3993 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.1 0.665 6.42 731.3994 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.48 0.634 6.66 731.3996 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.14 0.634 6.49 731.3996 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.29 0.66 5.6 731.4 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.13 0.624 6.54 731.4001 1,460.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GNLLQcIcTGNGR 95.00% 3.87 0.366 6.25 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8455 1,461.68 1,462.69 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GNLLQcIcTGNGR 95.00% 4.4 0.329 5.85 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8462 1,461.68 1,462.69 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GNLLQcIcTGNGR 95.00% 3.82 0.356 5.49 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8471 1,461.68 1,462.69 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GNLLQcIcTGNGR 95.00% 3.78 0.306 5.15 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8474 1,461.68 1,462.69 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GNLLQcIcTGNGR 95.00% 3.72 0.293 5.29 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8478 1,461.68 1,462.69 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GNLLQcIcTGNGR 95.00% 3.43 0.319 4.28 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8479 1,461.68 1,462.69 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GNLLQcIcTGNGR 95.00% 4.33 0.356 5.37 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8479 1,461.68 1,462.69 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GNLLQcIcTGNGR 95.00% 3.73 0.305 5.43 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.849 1,461.68 1,462.69 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GNLLQcIcTGNGR 95.00% 4.03 0.397 5.66 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8492 1,461.68 1,462.69 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VPGTSTSATLTGLTR 95.00% 4.49 0.667 4.47 731.8991 1,461.78 1,461.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GNLLQcIcTGNGR 95.00% 4 0.393 4.04 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 732.3478 1,462.68 1,462.69 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 3.61 0.442 1.46 c5: Carbamidomethyl (+57.02) 742.3485 1,482.68 1,483.70 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 3.47 0.479 1.54 c5: Carbamidomethyl (+57.02) 742.3496 1,482.68 1,483.70 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 3.4 0.397 1.12 c5: Carbamidomethyl (+57.02) 742.3505 1,482.69 1,483.70 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 3.54 0.457 1.13 c5: Carbamidomethyl (+57.02) 742.3507 1,482.69 1,483.70 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 3.68 0.494 1.77 c5: Carbamidomethyl (+57.02) 742.3509 1,482.69 1,483.70 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 3.27 0.455 1.49 c5: Carbamidomethyl (+57.02) 742.3518 1,482.69 1,483.70 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 3.34 0.475 1.29 c5: Carbamidomethyl (+57.02) 742.3519 1,482.69 1,483.70 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 3.54 0.49 1.29 c5: Carbamidomethyl (+57.02) 742.3527 1,482.69 1,483.70 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 3.73 0.477 1.64 c5: Carbamidomethyl (+57.02) 742.3529 1,482.69 1,483.70 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GEWTcIAYSQLR 95.00% 3.99 0.47 0 c5: Carbamidomethyl (+57.02) 742.3545 1,482.69 1,483.70 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SYTITGLQPGTDYK 95.00% 3.76 0.567 4.47 772.382 1,542.75 1,543.76 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SYTITGLQPGTDYK 95.00% 3.13 0.391 0 772.382 1,542.75 1,543.76 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SYTITGLQPGTDYK 95.00% 2.73 0.334 0 772.3838 1,542.75 1,543.76 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SYTITGLQPGTDYK 95.00% 4.25 0.576 5.96 772.3849 1,542.75 1,543.76 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SYTITGLQPGTDYK 95.00% 4.26 0.563 7.23 772.3859 1,542.76 1,543.76 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EATIPGHLNSYTIK 95.00% 2.85 0.412 0 772.4078 1,542.80 1,543.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EATIPGHLNSYTIK 95.00% 3.05 0.305 3.29 772.9115 1,543.81 1,543.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EATIPGHLNSYTIK 95.00% 3.46 0.399 2 772.9115 1,543.81 1,543.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DTLTSRPAQGVVTTLENVSPPR 95.00% 2.29 0.41 2.31 780.4178 2,338.23 2,338.24 3 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 4.29 0.586 5.17 796.407 1,590.80 1,591.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 4.04 0.558 3.6 796.4074 1,590.80 1,591.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 4.04 0.601 5.09 796.4075 1,590.80 1,591.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 4.03 0.597 4.96 796.4077 1,590.80 1,591.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 3.93 0.548 5.41 796.4077 1,590.80 1,591.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 3.68 0.538 4.96 796.408 1,590.80 1,591.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 3.82 0.585 4.44 796.4085 1,590.80 1,591.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 3.78 0.561 3.02 796.4085 1,590.80 1,591.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 3.85 0.559 3.82 796.4088 1,590.80 1,591.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GDSPASSKPISINYR 95.00% 3.91 0.559 4.09 796.9092 1,591.80 1,591.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VTDATETTITISWR 95.00% 3.13 0.556 2.68 797.9081 1,593.80 1,593.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VTDATETTITISWR 95.00% 2.82 0.526 2.68 797.914 1,593.81 1,593.81 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.6 0.589 5.09 799.6948 2,396.06 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.91 0.6 5 799.6985 2,396.07 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.97 0.589 2.85 799.6986 2,396.07 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.25 0.539 4.62 799.6995 2,396.07 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.02 0.608 6.68 799.6999 2,396.08 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.46 0.609 6.14 799.7001 2,396.08 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.88 0.617 4.55 799.7003 2,396.08 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.16 0.612 6 799.7009 2,396.08 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.37 0.579 1.96 799.701 2,396.08 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.43 0.58 2.7 799.701 2,396.08 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.45 0.548 4.19 799.7011 2,396.08 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.35 0.625 4.89 799.7012 2,396.08 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.41 0.582 6.64 799.7014 2,396.08 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5 0.545 2.62 799.702 2,396.08 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.31 0.611 6.85 799.7024 2,396.08 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.08 0.556 3.6 799.7031 2,396.09 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 0 0 3.46 800.0292 2,397.06 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 0 0 4.43 800.0315 2,397.07 2,396.09 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VDVIPVNLPGEHGQR 95.00% 3.63 0.485 4.28 815.4391 1,628.86 1,629.87 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VDVIPVNLPGEHGQR 95.00% 3.77 0.488 3.06 815.4391 1,628.86 1,629.87 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VDVIPVNLPGEHGQR 95.00% 3.89 0.472 4 815.9404 1,629.87 1,629.87 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VDVIPVNLPGEHGQR 95.00% 3.9 0.518 4.12 815.9407 1,629.87 1,629.87 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DSMIWDcTcIGAGR 95.00% 2.59 0.327 2.77 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3408 1,640.67 1,641.68 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DSMIWDcTcIGAGR 95.00% 3.09 0.501 3.77 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3437 1,640.67 1,641.68 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DSMIWDcTcIGAGR 95.00% 2.89 0.239 2.54 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3441 1,640.67 1,641.68 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DSMIWDcTcIGAGR 95.00% 3.54 0.44 4.66 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3445 1,640.67 1,641.68 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.94 0.468 3.19 821.7407 2,462.20 2,462.21 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.56 0.518 3.68 821.7414 2,462.20 2,462.21 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.38 0.452 2.47 821.7419 2,462.20 2,462.21 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.57 0.365 3.27 821.7425 2,462.20 2,462.21 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DSMIWDcTcIGAGR 95.00% 3.71 0.4 4.82 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.844 1,641.67 1,641.68 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DDKESVPISDTIIPAVPPPTDLR 95.00% 3.48 0.37 1.23 826.1044 2,475.29 2,475.30 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% DDKESVPISDTIIPAVPPPTDLR 95.00% 3.8 0.453 0 826.1057 2,475.29 2,475.30 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% PAQGVVTTLENVSPPR 95.00% 4.36 0.631 0 832.9495 1,663.88 1,664.90 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% PAQGVVTTLENVSPPR 95.00% 4.21 0.6 0 832.9505 1,663.89 1,664.90 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% PAQGVVTTLENVSPPR 95.00% 3.95 0.555 0 832.951 1,663.89 1,664.90 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% PAQGVVTTLENVSPPR 95.00% 3.95 0.473 0 832.9513 1,663.89 1,664.90 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% PAQGVVTTLENVSPPR 95.00% 4.52 0.611 0 832.9513 1,663.89 1,664.90 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% PAQGVVTTLENVSPPR 95.00% 4.67 0.629 0 833.4526 1,664.89 1,664.90 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.63 0.328 2.19 858.4494 2,572.32 2,572.34 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.5 0.416 1.22 858.4507 2,572.33 2,572.34 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.26 0.356 2.34 858.4513 2,572.33 2,572.34 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.03 0.365 2.3 858.4516 2,572.33 2,572.34 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.35 0.398 3.01 858.4517 2,572.33 2,572.34 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.04 0.441 2.14 858.4532 2,572.34 2,572.34 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.66 0.599 7 866.9757 1,731.94 1,732.95 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.43 0.59 4.92 866.9762 1,731.94 1,732.95 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.24 0.601 5.52 866.9766 1,731.94 1,732.95 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.72 0.628 7.8 866.9767 1,731.94 1,732.95 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.74 0.611 7.72 866.9768 1,731.94 1,732.95 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.25 0.586 6.66 866.9769 1,731.94 1,732.95 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.54 0.586 4.35 866.9772 1,731.94 1,732.95 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.79 0.594 6.41 866.9777 1,731.94 1,732.95 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.84 0.588 1.74 867.4791 1,732.94 1,732.95 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NLQPASEYTVSLVAIK 95.00% 4.77 0.594 0 867.4796 1,732.94 1,732.95 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.28 0.608 6.28 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4057 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.52 0.623 6.21 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.408 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.5 0.594 4.04 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4087 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.28 0.607 5.33 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4087 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.54 0.632 5.57 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4092 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.49 0.608 6.59 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4095 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.54 0.589 7.09 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4099 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.35 0.641 5.04 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4107 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.32 0.617 6.27 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4116 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.5 0.616 4.82 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4125 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.26 0.587 3.41 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9091 1,791.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.19 0.581 4.19 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9096 1,791.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.66 0.577 3.7 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9101 1,791.80 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.38 0.598 5.54 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9106 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.39 0.588 4.54 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9109 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.4 0.601 4.28 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9116 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 5.57 0.622 4.21 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.912 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TYLGNALVcTcYGGSR 95.00% 6.08 0.583 5.49 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9121 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VTIMWTPPESAVTGYR 95.00% 4.27 0.592 7.28 904.9561 1,807.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VTIMWTPPESAVTGYR 95.00% 4 0.556 4.64 904.9568 1,807.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VTIMWTPPESAVTGYR 95.00% 3.23 0.505 3.6 904.9569 1,807.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VTIMWTPPESAVTGYR 95.00% 3.39 0.505 2.18 904.9586 1,807.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 4.52 0.485 2.15 909.9881 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 4.35 0.426 2 909.9884 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 3.32 0.461 2.32 909.9885 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 4.45 0.456 1.55 909.9886 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 4.18 0.477 2.11 909.9896 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 4.23 0.462 2.33 909.9899 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 4.29 0.521 1.89 909.9904 1,817.97 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 4.52 0.458 1.55 910.4878 1,818.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 4.52 0.501 2.03 910.4883 1,818.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 4.5 0.447 2.29 910.4906 1,818.97 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GATYNIIVEALKDQQR 95.00% 4.28 0.436 1.49 910.4913 1,818.97 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 4.42 0.476 8.04 932.44 1,862.86 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 5.13 0.604 8.96 932.4428 1,862.87 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 4.39 0.487 4.8 932.4435 1,862.87 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 5.25 0.577 12 932.444 1,862.87 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 5.49 0.624 13.7 932.4441 1,862.87 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 5.77 0.606 11.7 932.4446 1,862.87 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 5.39 0.618 10 932.4452 1,862.87 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 5.84 0.585 13.2 932.4453 1,862.87 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 4.76 0.551 11.2 932.4454 1,862.88 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 5.38 0.556 10 932.4461 1,862.88 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 5.76 0.551 8.89 932.9444 1,863.87 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 5.61 0.548 8.8 932.9453 1,863.88 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 6.04 0.566 11.6 932.9453 1,863.88 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 6 0.588 9.12 932.9472 1,863.88 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% HTSVQTTSSGSGPFTDVR 95.00% 0 0 7.59 933.4622 1,864.91 1,863.88 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 5.47 0.651 4.96 934.1622 2,799.46 2,799.48 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 5.66 0.673 4.77 934.1646 2,799.47 2,799.48 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.8 0.603 5.32 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8973 1,877.78 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.76 0.558 6.28 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.898 1,877.78 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.6 0.636 4.06 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8992 1,877.78 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.62 0.594 5.92 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9 1,877.78 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.74 0.562 5.72 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9005 1,877.79 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.89 0.622 4.96 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3974 1,878.78 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.83 0.581 2.24 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3977 1,878.78 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 5.29 0.602 6.21 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3986 1,878.78 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.9 0.565 4.57 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3989 1,878.78 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.72 0.573 3.89 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3994 1,878.78 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.84 0.623 5.39 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3996 1,878.78 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.59 0.601 2.43 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4005 1,878.79 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.85 0.603 7.4 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4007 1,878.79 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 5 0.629 5.27 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4011 1,878.79 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EYLGAIcScTcFGGQR 95.00% 4.97 0.586 4.33 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4024 1,878.79 1,878.79 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SSPVVIDASTAIDAPSNLR 95.00% 5.82 0.618 6.57 957.0011 1,911.99 1,913.00 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SSPVVIDASTAIDAPSNLR 95.00% 5.55 0.584 6.14 957.0019 1,911.99 1,913.00 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SSPVVIDASTAIDAPSNLR 95.00% 5.89 0.526 5.27 957.5028 1,912.99 1,913.00 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% SSPVVIDASTAIDAPSNLR 95.00% 5.48 0.582 5.72 957.5031 1,912.99 1,913.00 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 4.02 0.586 4.29 964.0244 1,926.03 1,927.04 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 4.39 0.572 4.74 964.026 1,926.04 1,927.04 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VTWAPPPSIDLTNFLVR 95.00% 4.01 0.494 7.51 964.0277 1,926.04 1,926.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% VTWAPPPSIDLTNFLVR 95.00% 3.79 0.412 8.96 964.0284 1,926.04 1,926.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 4.06 0.51 4.64 964.5237 1,927.03 1,927.04 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 3.67 0.574 4.82 964.5238 1,927.03 1,927.04 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 4.31 0.524 3.33 964.5242 1,927.03 1,927.04 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 4.6 0.533 4.18 964.525 1,927.03 1,927.04 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 3.74 0.501 3.46 964.5256 1,927.04 1,927.04 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 3.69 0.522 5.16 964.5261 1,927.04 1,927.04 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 4.3 0.534 5.15 964.5261 1,927.04 1,927.04 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 4.06 0.487 4.33 964.5266 1,927.04 1,927.04 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% FLATTPNSLLVSWQPPR 95.00% 3.89 0.573 6.3 964.528 1,927.04 1,927.04 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GFNcESKPEAEETcFDKYTGNTYR 95.00% 5.75 0.401 5.21 c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 968.7477 2,903.22 2,903.23 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EESPLLIGQQSTVSDVPR 95.00% 4.44 0.562 4.39 978.5075 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EESPLLIGQQSTVSDVPR 95.00% 5.09 0.522 5 978.5083 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NTFAEVTGLSPGVTYYFK 95.00% 6.42 0.648 5.3 997.9984 1,993.98 1,993.99 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% NTFAEVTGLSPGVTYYFK 95.00% 6.23 0.598 5.01 997.9989 1,993.98 1,993.99 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% GFNcESKPEAEETcFDK 95.00% 4.33 0.5 3.82 c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,024.42 2,046.83 2,047.84 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TNTNVNcPIEcFMPLDVQADREDSRE 95.00% 4.02 0.599 3.54 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,037.79 3,110.35 3,110.36 3
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EINLAPDSSSVVVSGLMVATK 95.00% 6.15 0.608 6.77 1,059.06 2,116.11 2,117.12 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% EINLAPDSSSVVVSGLMVATK 95.00% 5.9 0.606 7.42 1,059.56 2,117.11 2,117.12 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.68 0.563 5.19 1,084.52 2,167.03 2,168.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.5 0.505 5.7 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.19 0.534 5.17 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.31 0.48 5.44 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.73 0.583 5.08 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 6.18 0.543 6.6 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 6.23 0.559 4.74 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.04 0.505 6.4 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.78 0.555 5.52 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 6.13 0.574 4.46 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.28 0.535 5.7 1,085.03 2,168.04 2,168.05 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.99 0.599 4.54 1,199.05 2,396.08 2,396.09 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.38 0.573 3.31 1,199.05 2,396.08 2,396.09 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 5 0.602 5.2 1,232.11 2,462.20 2,462.21 2
 SAMPLE 2R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 47 61 357 28.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.94 0.605 4.42 1,232.11 2,462.20 2,462.21 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% WSRPQAPITGYR 95.00% 3.41 0.331 2.08 477.9204 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% WSRPQAPITGYR 95.00% 3.55 0.359 1.96 477.9205 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% WSRPQAPITGYR 95.00% 3.44 0.378 1.14 477.9206 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% WSRPQAPITGYR 95.00% 3.39 0.334 2.16 477.9212 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% WSRPQAPITGYR 95.00% 2.81 0.213 0 477.9212 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% WSRPQAPITGYR 95.00% 3.28 0.419 2.05 477.9215 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% WSRPQAPITGYR 95.00% 3.21 0.277 0 477.9215 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% WSRPQAPITGYR 95.00% 3.11 0.182 2.51 477.9216 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GEWTcIAYSQLR 95.00% 3.8 0.534 2.09 c5: Carbamidomethyl (+57.02) 495.2378 1,482.69 1,483.70 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GEWTcIAYSQLR 95.00% 3.18 0.364 0 c5: Carbamidomethyl (+57.02) 495.5722 1,483.69 1,483.70 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GDSPASSKPISINYR 95.00% 3.02 0.477 1.96 531.2728 1,590.80 1,591.81 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GDSPASSKPISINYR 95.00% 3.05 0.422 0 531.2731 1,590.80 1,591.81 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GDSPASSKPISINYR 95.00% 2.69 0.379 0 531.2734 1,590.80 1,591.81 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GDSPASSKPISINYR 95.00% 3.11 0.426 1.7 531.2736 1,590.80 1,591.81 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GDSPASSKPISINYR 95.00% 2.99 0.417 1.38 531.2737 1,590.80 1,591.81 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GDSPASSKPISINYR 95.00% 3.46 0.417 1.57 531.2738 1,590.80 1,591.81 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GDSPASSKPISINYR 95.00% 3.04 0.416 1.49 531.274 1,590.80 1,591.81 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% YEVSVYALK 95.00% 2.08 0.231 1.34 536.289 1,070.56 1,071.57 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% YEVSVYALK 95.00% 2.14 0.227 1.59 536.2899 1,070.56 1,071.57 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VDVIPVNLPGEHGQR 95.00% 2.65 0.207 0 543.9613 1,628.86 1,629.87 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VDVIPVNLPGEHGQR 95.00% 2.49 0.321 0 543.9615 1,628.86 1,629.87 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VDVIPVNLPGEHGQR 95.00% 2.32 0.201 0 543.9621 1,628.86 1,629.87 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VDVIPVNLPGEHGQR 95.00% 2.39 0.336 0 543.9622 1,628.86 1,629.87 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VDVIPVNLPGEHGQR 95.00% 2.23 0.287 0 544.2963 1,629.87 1,629.87 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% LLcQcLGFGSGHFR 95.00% 3.49 0.391 2.32 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.264 1,650.77 1,651.78 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% LLcQcLGFGSGHFR 95.00% 3.51 0.45 3.96 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2646 1,650.77 1,651.78 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% LLcQcLGFGSGHFR 95.00% 3.87 0.363 3 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2651 1,650.77 1,651.78 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% LLcQcLGFGSGHFR 95.00% 3.97 0.275 2.05 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2653 1,650.77 1,651.78 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% LLcQcLGFGSGHFR 95.00% 3.65 0.48 2.96 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2654 1,650.77 1,651.78 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% LLcQcLGFGSGHFR 95.00% 4.1 0.372 2.25 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5991 1,651.77 1,651.78 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% LLcQcLGFGSGHFR 95.00% 3.38 0.381 1.66 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5992 1,651.77 1,651.78 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% LLcQcLGFGSGHFR 95.00% 4.08 0.365 3.04 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5995 1,651.78 1,651.78 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% PAQGVVTTLENVSPPR 95.00% 3.27 0.313 0 555.6359 1,663.88 1,664.90 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% PAQGVVTTLENVSPPR 95.00% 2.99 0.237 0 555.6375 1,663.89 1,664.90 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% STTPDITGYR 95.00% 2.22 0.526 0 555.7737 1,109.53 1,110.54 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% STTPDITGYR 95.00% 2.17 0.516 1.62 555.7743 1,109.53 1,110.54 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% STTPDITGYR 95.00% 2.24 0.588 2.19 555.7746 1,109.53 1,110.54 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% STTPDITGYR 95.00% 2.35 0.544 2.74 555.7758 1,109.54 1,110.54 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% PAQGVVTTLENVSPPR 95.00% 2.65 0.25 0 555.9689 1,664.88 1,664.90 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% PAQGVVTTLENVSPPR 95.00% 3.05 0.351 0 555.9698 1,664.89 1,664.90 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% FTNIGPDTMR 95.00% 2.81 0.403 1.19 576.2774 1,150.54 1,151.55 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% FTNIGPDTMR 95.00% 2.77 0.377 1.66 576.2775 1,150.54 1,151.55 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% FTNIGPDTMR 95.00% 2.64 0.405 0 576.2778 1,150.54 1,151.55 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% FTNIGPDTMR 95.00% 2.3 0.313 0 576.2779 1,150.54 1,151.55 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% FTNIGPDTMR 95.00% 2.69 0.46 0 576.2782 1,150.54 1,151.55 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% FTNIGPDTMR 95.00% 2.91 0.411 1.62 576.2783 1,150.54 1,151.55 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% FTNIGPDTMR 95.00% 2.68 0.456 0 576.2788 1,150.54 1,151.55 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% FTNIGPDTMR 95.00% 2.74 0.365 1.72 576.279 1,150.54 1,151.55 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% FTNIGPDTMR 95.00% 2.72 0.366 1.23 576.2796 1,150.54 1,151.55 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% FTNIGPDTMR 95.00% 2.84 0.413 1.62 576.2801 1,150.54 1,151.55 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% FTNIGPDTMR 94.60% 2.45 0.21 0 576.78 1,151.54 1,151.55 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GATYNIIVEALKDQQR 95.00% 2.13 0.444 0 606.9949 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GATYNIIVEALKDQQR 95.00% 2.38 0.442 0 606.9949 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GATYNIIVEALKDQQR 95.00% 2.66 0.467 0 606.9951 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GATYNIIVEALKDQQR 95.00% 2.81 0.318 0 607.3278 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GATYNIIVEALKDQQR 95.00% 2.45 0.262 0 607.3295 1,818.97 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% PAQGVVTTLENVSPPRR 95.00% 3.22 0.545 0 607.671 1,819.99 1,821.00 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% PAQGVVTTLENVSPPRR 95.00% 1.95 0.258 0 607.7964 1,820.37 1,821.00 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 3.53 0.545 0 621.9649 1,862.87 1,863.88 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 3.89 0.558 0 621.965 1,862.87 1,863.88 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 3.04 0.494 0 622.3 1,863.88 1,863.88 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 3.17 0.462 0 622.3 1,863.88 1,863.88 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 2.61 0.502 0 622.3005 1,863.88 1,863.88 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 4.12 0.567 2.02 622.3005 1,863.88 1,863.88 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 2.68 0.409 0 622.3015 1,863.88 1,863.88 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SSPVVIDASTAIDAPSNLR 95.00% 3.77 0.436 1.16 638.3363 1,911.99 1,913.00 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SSPVVIDASTAIDAPSNLR 95.00% 4.54 0.516 3.74 638.3367 1,911.99 1,913.00 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% DLQFVEVTDVK 95.00% 3.77 0.51 2.4 646.8394 1,291.66 1,292.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% DLQFVEVTDVK 95.00% 4.27 0.489 1.72 646.8396 1,291.66 1,292.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% DLQFVEVTDVK 95.00% 2.58 0.321 0 646.8398 1,291.66 1,292.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% DLQFVEVTDVK 95.00% 3.91 0.488 2.11 646.8403 1,291.67 1,292.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% DLQFVEVTDVK 95.00% 3.27 0.435 2.08 646.8404 1,291.67 1,292.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% DLQFVEVTDVK 95.00% 3.57 0.537 4.31 646.8407 1,291.67 1,292.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% WLPSSSPVTGYR 95.00% 2.31 0.168 1.57 675.3446 1,348.67 1,349.69 2 SYNP2_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% WLPSSSPVTGYR 95.00% 2.46 0.382 1.37 675.3456 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% WLPSSSPVTGYR 95.00% 2.67 0.529 2.55 675.3457 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% WLPSSSPVTGYR 95.00% 1.94 0.237 1.92 675.8463 1,349.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 3.11 0.426 1.74 678.3492 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 2.68 0.405 0 678.3495 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 3.43 0.477 1.85 678.3496 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 3.08 0.387 1.47 678.3497 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 3.7 0.484 2.12 678.35 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 3.93 0.483 2.34 678.3508 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 3.37 0.488 1.59 678.3509 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 3.77 0.495 2 678.3509 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 3.77 0.472 2.54 678.3509 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 3.38 0.476 2.29 678.351 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 2.75 0.394 1.46 678.351 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 3.44 0.474 2.28 678.351 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 3.39 0.498 1.92 678.3523 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% IYLYTLNDNAR 95.00% 3.75 0.467 3.07 678.8515 1,355.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GLAFTDVDVDSIK 95.00% 2.42 0.398 1.6 690.3556 1,378.70 1,379.71 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HYQINQQWER 95.00% 2.78 0.51 2.62 701.3342 1,400.65 1,401.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HYQINQQWER 95.00% 3.13 0.443 2.28 701.3351 1,400.65 1,401.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HYQINQQWER 95.00% 3.6 0.476 3.4 701.3353 1,400.65 1,401.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HYQINQQWER 95.00% 3.52 0.429 2.92 701.336 1,400.66 1,401.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HYQINQQWER 95.00% 2.83 0.401 1.31 701.3361 1,400.66 1,401.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HYQINQQWER 95.00% 3.61 0.414 2.77 701.3368 1,400.66 1,401.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HYQINQQWER 95.00% 2.73 0.398 2.44 701.3369 1,400.66 1,401.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HYQINQQWER 95.00% 3.39 0.45 2.37 701.3372 1,400.66 1,401.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HYQINQQWER 95.00% 3.2 0.435 3.41 701.8377 1,401.66 1,401.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HYQINQQWER 95.00% 2.62 0.45 2.06 701.8387 1,401.66 1,401.67 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 3.88 0.642 6.92 731.3966 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 3.78 0.595 5.68 731.3974 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 3.78 0.65 5.17 731.3975 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 4.42 0.656 7.1 731.3977 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 4.58 0.672 5.46 731.3979 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 3.9 0.678 6.14 731.3979 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 3.8 0.623 5.89 731.398 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 4.03 0.654 7.52 731.3982 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 3.72 0.627 6.7 731.3985 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 4.4 0.683 6.35 731.3987 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 3.88 0.653 5.74 731.3987 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 4.35 0.605 4.77 731.3987 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 4.16 0.575 6.4 731.3988 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 4.18 0.655 4.77 731.3991 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 3.61 0.545 5.82 731.3993 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 4.28 0.638 5.92 731.3994 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 3.79 0.661 5.52 731.3995 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 3.78 0.687 5.74 731.3999 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VPGTSTSATLTGLTR 95.00% 4.23 0.617 5.32 731.4001 1,460.78 1,461.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 3.27 0.251 4.05 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8457 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 3.66 0.332 4.62 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8473 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 3.87 0.293 6.1 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8473 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 3.32 0.289 3.59 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8473 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 3.28 0.279 4.96 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8474 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 3.53 0.277 3.77 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8474 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 3.58 0.308 5.41 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.848 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 4.04 0.369 5.15 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8486 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 3.24 0.28 6.31 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8491 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 3.77 0.348 5.77 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8491 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 3.6 0.255 4.89 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8492 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 3.49 0.331 5.49 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8493 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 2.79 0.292 0 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8493 1,461.68 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GNLLQcIcTGNGR 95.00% 3.76 0.367 6.29 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8507 1,461.69 1,462.69 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% QDGHLWcSTTSNYEQDQK 95.00% 5.1 0.542 1.39 c7: Carbamidomethyl (+57.02) 733.3137 2,196.92 2,196.93 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GEWTcIAYSQLR 95.00% 2.52 0.351 2 c5: Carbamidomethyl (+57.02) 742.3491 1,482.68 1,483.70 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GEWTcIAYSQLR 95.00% 3.24 0.507 2.21 c5: Carbamidomethyl (+57.02) 742.3502 1,482.68 1,483.70 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GEWTcIAYSQLR 95.00% 3.96 0.472 2.54 c5: Carbamidomethyl (+57.02) 742.3518 1,482.69 1,483.70 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GEWTcIAYSQLR 95.00% 2.74 0.444 2.05 c5: Carbamidomethyl (+57.02) 742.3523 1,482.69 1,483.70 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GEWTcIAYSQLR 95.00% 3.75 0.462 2.8 c5: Carbamidomethyl (+57.02) 742.3526 1,482.69 1,483.70 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GEWTcIAYSQLR 95.00% 3.6 0.49 2.68 c5: Carbamidomethyl (+57.02) 742.8529 1,483.69 1,483.70 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GEWTcIAYSQLR 95.00% 3.58 0.481 2.64 c5: Carbamidomethyl (+57.02) 742.8545 1,483.69 1,483.70 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SYTITGLQPGTDYK 95.00% 2.4 0.3 0 772.0392 1,542.06 1,543.76 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SYTITGLQPGTDYK 95.00% 2.39 0.283 0 772.0412 1,542.07 1,543.76 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SYTITGLQPGTDYK 95.00% 4.51 0.562 2.66 772.3808 1,542.75 1,543.76 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SYTITGLQPGTDYK 95.00% 4.33 0.549 3.59 772.3831 1,542.75 1,543.76 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SYTITGLQPGTDYK 95.00% 3.12 0.386 0 772.3844 1,542.75 1,543.76 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SYTITGLQPGTDYK 95.00% 4.71 0.512 4.59 772.385 1,542.75 1,543.76 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SYTITGLQPGTDYK 95.00% 4.12 0.545 3.1 772.3853 1,542.75 1,543.76 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EATIPGHLNSYTIK 95.00% 2.92 0.405 0 772.4089 1,542.80 1,543.81 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EATIPGHLNSYTIK 95.00% 3.39 0.42 3.49 772.4098 1,542.80 1,543.81 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EATIPGHLNSYTIK 95.00% 2.86 0.332 1.28 772.4105 1,542.81 1,543.81 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SYTITGLQPGTDYK 95.00% 3.75 0.179 1.64 772.8835 1,543.75 1,543.76 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SYTITGLQPGTDYK 95.00% 4.09 0.21 1.72 772.8855 1,543.76 1,543.76 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EATIPGHLNSYTIK 95.00% 3.51 0.345 2.14 772.9102 1,543.80 1,543.81 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% DTLTSRPAQGVVTTLENVSPPR 95.00% 3.37 0.522 1.49 780.4172 2,338.23 2,338.24 3 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GDSPASSKPISINYR 95.00% 3.22 0.564 4.1 796.4054 1,590.80 1,591.81 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GDSPASSKPISINYR 95.00% 4.37 0.588 3.57 796.4064 1,590.80 1,591.81 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GDSPASSKPISINYR 95.00% 3.76 0.546 3.27 796.407 1,590.80 1,591.81 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GDSPASSKPISINYR 95.00% 1.99 0.328 2.13 796.4088 1,590.80 1,591.81 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GDSPASSKPISINYR 95.00% 3.84 0.514 3.62 796.9096 1,591.80 1,591.81 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VTDATETTITISWR 95.00% 2.52 0.453 2.1 797.4103 1,592.81 1,593.81 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.5 0.556 4.19 799.6992 2,396.07 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.17 0.609 3.6 799.7 2,396.08 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.82 0.536 1.15 799.7 2,396.08 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.05 0.569 4.89 799.7003 2,396.08 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.37 0.624 4.57 799.7003 2,396.08 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.68 0.615 5.05 799.7003 2,396.08 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.45 0.617 4.34 799.7004 2,396.08 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.03 0.547 4.36 799.7005 2,396.08 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.63 0.593 5.32 799.7006 2,396.08 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.47 0.545 5.46 799.7008 2,396.08 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.43 0.63 6 799.701 2,396.08 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.71 0.589 4.89 799.702 2,396.08 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 0 0 3.82 800.0282 2,397.06 2,396.09 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VDVIPVNLPGEHGQR 95.00% 4.05 0.46 4.43 815.94 1,629.86 1,629.87 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VDVIPVNLPGEHGQR 95.00% 3.9 0.504 3.8 815.941 1,629.87 1,629.87 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% DSMIWDcTcIGAGR 95.00% 4.32 0.527 4.2 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3448 1,640.67 1,641.68 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% DSMIWDcTcIGAGR 95.00% 4.01 0.498 3.66 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3454 1,640.68 1,641.68 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.75 0.437 8.01 821.7399 2,462.20 2,462.21 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.67 0.503 4.19 821.741 2,462.20 2,462.21 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 5 0.451 3.08 821.7421 2,462.20 2,462.21 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.75 0.465 2.18 821.744 2,462.21 2,462.21 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% DSMIWDcTcIGAGR 95.00% 3.72 0.372 4.6 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.8454 1,641.68 1,641.68 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% LLcQcLGFGSGHFR 95.00% 3.67 0.448 5.12 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.395 1,650.77 1,651.78 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% LLcQcLGFGSGHFR 95.00% 3.9 0.369 4.12 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 826.8942 1,651.77 1,651.78 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% PAQGVVTTLENVSPPR 95.00% 2.86 0.374 0 832.7825 1,663.55 1,664.90 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% PAQGVVTTLENVSPPR 95.00% 4.4 0.612 0 832.9519 1,663.89 1,664.90 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% PAQGVVTTLENVSPPR 95.00% 4.15 0.594 0 832.9566 1,663.90 1,664.90 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% PAQGVVTTLENVSPPR 95.00% 4.84 0.584 0 833.4559 1,664.90 1,664.90 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.2 0.364 2.85 858.4487 2,572.32 2,572.34 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.37 0.445 2.72 858.4506 2,572.33 2,572.34 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.26 0.374 1.38 858.451 2,572.33 2,572.34 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.42 0.509 3.02 858.4512 2,572.33 2,572.34 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.74 0.489 3.66 858.4513 2,572.33 2,572.34 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.52 0.476 2.96 858.4515 2,572.33 2,572.34 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% NLQPASEYTVSLVAIK 95.00% 4.74 0.606 5.92 866.9759 1,731.94 1,732.95 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% NLQPASEYTVSLVAIK 95.00% 4.18 0.59 1.57 866.9765 1,731.94 1,732.95 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% NLQPASEYTVSLVAIK 95.00% 4.28 0.605 7.57 866.9766 1,731.94 1,732.95 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% NLQPASEYTVSLVAIK 95.00% 4.15 0.589 5.92 866.9766 1,731.94 1,732.95 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% NLQPASEYTVSLVAIK 95.00% 4.53 0.615 6.74 866.9773 1,731.94 1,732.95 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% NLQPASEYTVSLVAIK 95.00% 4.33 0.604 6.96 866.9778 1,731.94 1,732.95 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% NLQPASEYTVSLVAIK 95.00% 4.51 0.599 5.4 867.4774 1,732.94 1,732.95 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% NLQPASEYTVSLVAIK 95.00% 4.85 0.622 0 867.4784 1,732.94 1,732.95 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% NLQPASEYTVSLVAIK 95.00% 4.47 0.558 3.27 867.4785 1,732.94 1,732.95 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TYLGNALVcTcYGGSR 95.00% 5.12 0.599 4.12 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4092 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TYLGNALVcTcYGGSR 95.00% 4.7 0.654 6.4 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4101 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TYLGNALVcTcYGGSR 95.00% 4.69 0.581 4.24 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4102 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TYLGNALVcTcYGGSR 95.00% 5.21 0.638 5.31 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4107 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TYLGNALVcTcYGGSR 95.00% 5.38 0.655 5.09 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4107 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TYLGNALVcTcYGGSR 95.00% 3.05 0.476 2.59 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4113 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TYLGNALVcTcYGGSR 95.00% 5.78 0.591 4.72 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9096 1,791.80 1,791.82 2 TENX_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TYLGNALVcTcYGGSR 95.00% 5.74 0.622 4.46 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9105 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TYLGNALVcTcYGGSR 95.00% 5.44 0.624 4.77 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9111 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TYLGNALVcTcYGGSR 95.00% 5.57 0.624 4.82 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9116 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TYLGNALVcTcYGGSR 95.00% 5.74 0.614 4.4 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.912 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TYLGNALVcTcYGGSR 95.00% 5.45 0.572 4.44 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9133 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VTIMWTPPESAVTGYR 95.00% 3.6 0.54 2.42 904.4555 1,806.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% VTIMWTPPESAVTGYR 95.00% 4.16 0.624 3.92 904.9561 1,807.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GATYNIIVEALKDQQR 95.00% 3.84 0.474 3.64 909.987 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GATYNIIVEALKDQQR 95.00% 4.43 0.488 3.44 909.9886 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GATYNIIVEALKDQQR 95.00% 4.28 0.394 2.06 910.49 1,818.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 5.58 0.593 11 932.446 1,862.88 1,863.88 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 5.64 0.578 9.82 932.9431 1,863.87 1,863.88 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 5.88 0.578 7.89 932.9439 1,863.87 1,863.88 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 5.52 0.566 8.7 932.9444 1,863.87 1,863.88 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 5.7 0.621 8.42 932.9456 1,863.88 1,863.88 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 6.11 0.639 11.4 932.9461 1,863.88 1,863.88 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% HTSVQTTSSGSGPFTDVR 95.00% 5.85 0.569 10.9 932.9461 1,863.88 1,863.88 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 5.3 0.691 4.92 934.1646 2,799.47 2,799.48 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 5.32 0.639 4.04 934.165 2,799.47 2,799.48 3
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% QGENGQMMScTcLGNGK 95.00% 3.53 0.63 1.26 c10: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 936.3783 1,870.74 1,871.75 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EYLGAIcScTcFGGQR 95.00% 5.2 0.617 5.38 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8965 1,877.78 1,878.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EYLGAIcScTcFGGQR 95.00% 3.93 0.571 3.96 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8966 1,877.78 1,878.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EYLGAIcScTcFGGQR 95.00% 4.28 0.501 2.48 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8967 1,877.78 1,878.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EYLGAIcScTcFGGQR 95.00% 4.88 0.623 5.54 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8987 1,877.78 1,878.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EYLGAIcScTcFGGQR 95.00% 4.87 0.609 6.16 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9024 1,877.79 1,878.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EYLGAIcScTcFGGQR 95.00% 4.89 0.61 4.15 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3969 1,878.78 1,878.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EYLGAIcScTcFGGQR 95.00% 4.85 0.594 5.1 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3987 1,878.78 1,878.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EYLGAIcScTcFGGQR 95.00% 5.06 0.581 5.66 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3996 1,878.78 1,878.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EYLGAIcScTcFGGQR 95.00% 4.2 0.508 2.43 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4029 1,878.79 1,878.79 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SSPVVIDASTAIDAPSNLR 95.00% 5.42 0.622 6.62 957.0002 1,911.98 1,913.00 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SSPVVIDASTAIDAPSNLR 95.00% 5.07 0.602 5 957.0004 1,911.99 1,913.00 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SSPVVIDASTAIDAPSNLR 95.00% 5.57 0.58 7.2 957.0009 1,911.99 1,913.00 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SSPVVIDASTAIDAPSNLR 95.00% 5.12 0.579 5.92 957.0014 1,911.99 1,913.00 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SSPVVIDASTAIDAPSNLR 95.00% 4.36 0.546 5.05 957.0027 1,911.99 1,913.00 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% SSPVVIDASTAIDAPSNLR 95.00% 5.59 0.509 6.02 957.5028 1,912.99 1,913.00 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EESPLLIGQQSTVSDVPR 95.00% 4.73 0.598 5.16 978.0056 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EESPLLIGQQSTVSDVPR 95.00% 4.51 0.575 6.01 978.0064 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% NTFAEVTGLSPGVTYYFK 95.00% 5.53 0.481 6.72 997.494 1,992.97 1,993.99 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% NTFAEVTGLSPGVTYYFK 95.00% 6.45 0.668 5.59 997.9986 1,993.98 1,993.99 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EINLAPDSSSVVVSGLMVATK 95.00% 6.21 0.63 9.37 1,059.56 2,117.11 2,117.12 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% EINLAPDSSSVVVSGLMVATK 95.00% 5.13 0.65 4.51 1,059.56 2,117.11 2,117.12 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.75 0.511 5.46 1,084.53 2,167.04 2,168.05 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.43 0.523 7.4 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.65 0.57 6.66 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.83 0.526 4.68 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.33 0.466 5.47 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.55 0.529 4.7 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.22 0.507 4.57 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% ITYGETGGNSPVQEFTVPGSK 95.00% 4.73 0.512 5.8 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% ITYGETGGNSPVQEFTVPGSK 95.00% 5.4 0.582 5.52 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.04 0.561 6.43 1,199.05 2,396.08 2,396.09 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.74 0.556 4.85 1,199.05 2,396.08 2,396.09 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.83 0.585 3.04 1,199.05 2,396.08 2,396.09 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 6.58 0.666 7.49 1,287.17 2,572.33 2,572.34 2
 SAMPLE 3 Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 39 49 268 24.50% TKTETITGFQVDAVPANGQTPIQR 95.00% 6.41 0.681 7.18 1,287.17 2,572.33 2,572.34 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% WSRPQAPITGYR 95.00% 3.59 0.367 1.18 477.9201 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% WSRPQAPITGYR 95.00% 3.46 0.286 1.89 477.9203 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% WSRPQAPITGYR 95.00% 3.48 0.319 1.66 477.9208 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% WSRPQAPITGYR 95.00% 3.78 0.439 2.12 477.921 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% WSRPQAPITGYR 95.00% 3.08 0.261 1.7 477.9211 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% WSRPQAPITGYR 95.00% 2.92 0.223 1.6 477.9218 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% WSRPQAPITGYR 95.00% 3.47 0.264 0 477.9223 1,430.74 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% WSRPQAPITGYR 95.00% 2.49 0.228 0 477.9231 1,430.75 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% WSRPQAPITGYR 95.00% 3.47 0.381 1.77 478.2569 1,431.75 1,431.75 3 CADH1_HUMAN,CO8B_HUMAN,RP1L1_HUMAN,ANK3_HUMAN,RL24_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GEWTcIAYSQLR 95.00% 3.44 0.402 1.85 c5: Carbamidomethyl (+57.02) 495.2369 1,482.69 1,483.70 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GEWTcIAYSQLR 95.00% 3.84 0.493 1.59 c5: Carbamidomethyl (+57.02) 495.2388 1,482.69 1,483.70 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GDSPASSKPISINYR 95.00% 2.87 0.235 1.49 531.2733 1,590.80 1,591.81 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GDSPASSKPISINYR 95.00% 2.72 0.303 0 531.2734 1,590.80 1,591.81 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GDSPASSKPISINYR 95.00% 2.91 0.391 0 531.2736 1,590.80 1,591.81 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GDSPASSKPISINYR 95.00% 2.63 0.355 0 531.2739 1,590.80 1,591.81 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GDSPASSKPISINYR 95.00% 2.35 0.237 0 531.2739 1,590.80 1,591.81 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GDSPASSKPISINYR 95.00% 2.76 0.331 2.07 531.2745 1,590.80 1,591.81 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GDSPASSKPISINYR 95.00% 2.85 0.255 1.36 531.2752 1,590.80 1,591.81 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GDSPASSKPISINYR 95.00% 2.68 0.371 0 531.6078 1,591.80 1,591.81 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VDVIPVNLPGEHGQR 95.00% 2.52 0.326 0 543.9604 1,628.86 1,629.87 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VDVIPVNLPGEHGQR 95.00% 2.28 0.223 0 543.9611 1,628.86 1,629.87 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VDVIPVNLPGEHGQR 95.00% 1.93 0.332 2.31 543.9614 1,628.86 1,629.87 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VDVIPVNLPGEHGQR 95.00% 1.85 0.346 2.46 543.9621 1,628.86 1,629.87 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VDVIPVNLPGEHGQR 95.00% 2.14 0.222 0 544.2953 1,629.86 1,629.87 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% LLcQcLGFGSGHFR 95.00% 3.65 0.404 3.66 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2645 1,650.77 1,651.78 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% LLcQcLGFGSGHFR 95.00% 3.59 0.33 1.28 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.265 1,650.77 1,651.78 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% LLcQcLGFGSGHFR 95.00% 3.55 0.393 1.82 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2653 1,650.77 1,651.78 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% LLcQcLGFGSGHFR 95.00% 3.24 0.439 2.85 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2653 1,650.77 1,651.78 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% LLcQcLGFGSGHFR 95.00% 3.71 0.422 2.89 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2655 1,650.77 1,651.78 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% LLcQcLGFGSGHFR 95.00% 3.21 0.312 1.82 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.2656 1,650.77 1,651.78 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% LLcQcLGFGSGHFR 95.00% 4.31 0.394 1.92 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5992 1,651.77 1,651.78 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% LLcQcLGFGSGHFR 95.00% 2.7 0.391 2 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5993 1,651.77 1,651.78 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% LLcQcLGFGSGHFR 95.00% 3.35 0.281 2 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5995 1,651.78 1,651.78 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% LLcQcLGFGSGHFR 95.00% 3.48 0.317 2.1 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 551.5997 1,651.78 1,651.78 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% PAQGVVTTLENVSPPR 95.00% 2.28 0.246 0 555.6351 1,663.88 1,664.90 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% PAQGVVTTLENVSPPR 95.00% 2.4 0.183 0 555.6379 1,663.89 1,664.90 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% STTPDITGYR 95.00% 1.78 0.369 1.13 555.774 1,109.53 1,110.54 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% STTPDITGYR 95.00% 1.78 0.39 0 555.7743 1,109.53 1,110.54 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% STTPDITGYR 95.00% 1.98 0.407 0 555.7755 1,109.54 1,110.54 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% PAQGVVTTLENVSPPR 95.00% 2.93 0.274 0 555.9708 1,664.89 1,664.90 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FTNIGPDTMR 95.00% 2.84 0.417 1.54 576.2782 1,150.54 1,151.55 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FTNIGPDTMR 95.00% 2.41 0.416 0 576.2785 1,150.54 1,151.55 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FTNIGPDTMR 95.00% 2.89 0.421 1.47 576.2785 1,150.54 1,151.55 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FTNIGPDTMR 95.00% 2.83 0.41 1.38 576.2785 1,150.54 1,151.55 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FTNIGPDTMR 95.00% 2.82 0.423 1.22 576.2787 1,150.54 1,151.55 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FTNIGPDTMR 95.00% 2.33 0.329 1.49 576.2788 1,150.54 1,151.55 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FTNIGPDTMR 95.00% 2.96 0.401 1.64 576.2789 1,150.54 1,151.55 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FTNIGPDTMR 95.00% 2.89 0.428 1.39 576.2791 1,150.54 1,151.55 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FTNIGPDTMR 95.00% 2.81 0.408 2 576.2793 1,150.54 1,151.55 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FTNIGPDTMR 95.00% 2.97 0.441 2.62 576.2797 1,150.54 1,151.55 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FTNIGPDTMR 95.00% 2.3 0.244 1.29 576.2799 1,150.54 1,151.55 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FTNIGPDTMR 95.00% 2.49 0.356 1.92 576.28 1,150.54 1,151.55 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NLQPASEYTVSLVAIK 95.00% 3.96 0.389 1.15 578.3196 1,731.94 1,732.95 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NLQPASEYTVSLVAIK 95.00% 4.71 0.409 2.89 578.6556 1,732.94 1,732.95 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GATYNIIVEALKDQQR 95.00% 2.17 0.415 0 606.9943 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GATYNIIVEALKDQQR 95.00% 2.49 0.296 0 606.9945 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GATYNIIVEALKDQQR 95.00% 2.74 0.384 0 606.9948 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GATYNIIVEALKDQQR 95.00% 2.33 0.317 0 606.9949 1,817.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GATYNIIVEALKDQQR 95.00% 2.7 0.423 0 607.327 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GATYNIIVEALKDQQR 95.00% 2.6 0.328 0 607.3283 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GATYNIIVEALKDQQR 95.00% 2.21 0.241 0 607.3285 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GATYNIIVEALKDQQR 95.00% 2.56 0.432 0 607.3287 1,818.96 1,818.97 3 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% PAQGVVTTLENVSPPRR 95.00% 2.09 0.242 0 607.7966 1,820.37 1,821.00 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% PAQGVVTTLENVSPPRR 95.00% 2.25 0.255 0 607.8477 1,820.52 1,821.00 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HTSVQTTSSGSGPFTDVR 95.00% 4 0.565 1.8 622.3016 1,863.88 1,863.88 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HTSVQTTSSGSGPFTDVR 95.00% 3.7 0.43 1.2 622.3018 1,863.88 1,863.88 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SSPVVIDASTAIDAPSNLR 95.00% 3.72 0.485 2.89 638.3344 1,911.98 1,913.00 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SSPVVIDASTAIDAPSNLR 95.00% 4.12 0.471 3.22 638.3368 1,911.99 1,913.00 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FLATTPNSLLVSWQPPR 95.00% 3.41 0.54 2.09 643.0193 1,926.03 1,927.04 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FLATTPNSLLVSWQPPR 95.00% 2.98 0.349 0 643.3531 1,927.04 1,927.04 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FLATTPNSLLVSWQPPR 95.00% 5.1 0.52 1.82 643.3544 1,927.04 1,927.04 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DLQFVEVTDVK 95.00% 3.85 0.481 2.74 646.8394 1,291.66 1,292.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DLQFVEVTDVK 95.00% 3.44 0.452 2.21 646.84 1,291.66 1,292.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DLQFVEVTDVK 95.00% 3.19 0.373 1.92 646.8401 1,291.66 1,292.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DLQFVEVTDVK 95.00% 3.5 0.431 2.46 646.8401 1,291.66 1,292.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DLQFVEVTDVK 95.00% 3.52 0.443 2.43 646.8401 1,291.66 1,292.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DLQFVEVTDVK 95.00% 3.16 0.479 2.85 646.8402 1,291.66 1,292.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DLQFVEVTDVK 95.00% 3.4 0.472 2.57 646.8403 1,291.67 1,292.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DLQFVEVTDVK 95.00% 3.99 0.492 2.05 646.8409 1,291.67 1,292.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% WLPSSSPVTGYR 95.00% 2.21 0.407 2.18 675.3462 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% WLPSSSPVTGYR 95.00% 2.45 0.41 1.46 675.3463 1,348.68 1,349.69 2 SYNP2_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% IYLYTLNDNAR 95.00% 3.02 0.439 0 678.3501 1,354.68 1,355.70 2 FBN1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% IYLYTLNDNAR 95.00% 3.81 0.471 1.64 678.3504 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% IYLYTLNDNAR 95.00% 2.6 0.441 0 678.3508 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% IYLYTLNDNAR 95.00% 3.44 0.48 1.77 678.3508 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% IYLYTLNDNAR 95.00% 2.76 0.374 1.7 678.3509 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% IYLYTLNDNAR 95.00% 3.15 0.467 1.13 678.351 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% IYLYTLNDNAR 95.00% 4.04 0.47 1.89 678.3512 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% IYLYTLNDNAR 95.00% 3.35 0.443 1.89 678.3512 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% IYLYTLNDNAR 95.00% 2.65 0.477 1.85 678.3513 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% IYLYTLNDNAR 95.00% 2.61 0.47 0 678.3515 1,354.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% IYLYTLNDNAR 95.00% 3.73 0.428 1.96 678.8512 1,355.69 1,355.70 2 FBN1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GLAFTDVDVDSIK 95.00% 2.52 0.412 1.64 690.3567 1,378.70 1,379.71 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GLAFTDVDVDSIK 95.00% 2.99 0.474 3.11 690.3581 1,378.70 1,379.71 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HYQINQQWER 95.00% 3.45 0.439 1.74 701.3353 1,400.65 1,401.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HYQINQQWER 95.00% 3.36 0.492 2.66 701.3355 1,400.66 1,401.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HYQINQQWER 95.00% 3.5 0.431 2.19 701.3358 1,400.66 1,401.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HYQINQQWER 95.00% 3.27 0.499 2.55 701.336 1,400.66 1,401.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HYQINQQWER 95.00% 3.27 0.499 2.1 701.3362 1,400.66 1,401.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HYQINQQWER 95.00% 3.07 0.458 1.89 701.3368 1,400.66 1,401.67 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4.09 0.634 5.92 731.3965 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 3.93 0.601 5.92 731.3968 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 3.84 0.631 5.7 731.3969 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4.48 0.655 7.46 731.3974 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4.3 0.662 7.15 731.3974 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4.05 0.606 6.27 731.398 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4.18 0.695 5.04 731.398 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4.45 0.646 5.29 731.398 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4.04 0.642 5.77 731.3982 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 3.86 0.642 6.04 731.3983 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 3.66 0.647 5.14 731.3983 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 3.56 0.575 5.36 731.3985 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4.3 0.657 6.27 731.3986 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4.03 0.62 5.66 731.3988 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4.22 0.618 7.72 731.3991 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 3.31 0.659 3.04 731.4002 1,460.78 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4.13 0.663 5.12 731.4006 1,460.79 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4 0.679 4.05 731.401 1,460.79 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GNLLQcIcTGNGR 95.00% 3.43 0.315 4.89 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8478 1,461.68 1,462.69 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GNLLQcIcTGNGR 95.00% 3.73 0.323 6.08 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8481 1,461.68 1,462.69 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GNLLQcIcTGNGR 95.00% 3.16 0.312 4.4 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8482 1,461.68 1,462.69 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GNLLQcIcTGNGR 95.00% 2.87 0.342 1.85 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8484 1,461.68 1,462.69 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GNLLQcIcTGNGR 95.00% 3.67 0.389 7.33 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8487 1,461.68 1,462.69 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GNLLQcIcTGNGR 95.00% 2.87 0.27 3.48 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8488 1,461.68 1,462.69 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GNLLQcIcTGNGR 95.00% 2.39 0.255 1.07 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8489 1,461.68 1,462.69 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GNLLQcIcTGNGR 95.00% 2.79 0.285 1.42 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8489 1,461.68 1,462.69 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GNLLQcIcTGNGR 95.00% 2.64 0.197 3.8 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8492 1,461.68 1,462.69 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GNLLQcIcTGNGR 95.00% 2.6 0.234 2.32 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8496 1,461.68 1,462.69 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GNLLQcIcTGNGR 95.00% 3.51 0.273 3.72 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8501 1,461.68 1,462.69 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GNLLQcIcTGNGR 95.00% 3.14 0.248 3.39 c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 731.8512 1,461.69 1,462.69 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VPGTSTSATLTGLTR 95.00% 4.03 0.607 5.57 731.9004 1,461.79 1,461.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GEWTcIAYSQLR 95.00% 3.09 0.48 1.17 c5: Carbamidomethyl (+57.02) 742.3487 1,482.68 1,483.70 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GEWTcIAYSQLR 95.00% 2.69 0.372 1.82 c5: Carbamidomethyl (+57.02) 742.3492 1,482.68 1,483.70 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GEWTcIAYSQLR 95.00% 3.65 0.481 1.18 c5: Carbamidomethyl (+57.02) 742.3502 1,482.68 1,483.70 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GEWTcIAYSQLR 95.00% 3.24 0.404 2.38 c5: Carbamidomethyl (+57.02) 742.3514 1,482.69 1,483.70 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GEWTcIAYSQLR 95.00% 2.45 0.299 1.49 c5: Carbamidomethyl (+57.02) 742.3521 1,482.69 1,483.70 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GEWTcIAYSQLR 95.00% 3.82 0.46 1.35 c5: Carbamidomethyl (+57.02) 742.3524 1,482.69 1,483.70 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GEWTcIAYSQLR 95.00% 2.5 0.336 1.39 c5: Carbamidomethyl (+57.02) 742.3532 1,482.69 1,483.70 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GEWTcIAYSQLR 95.00% 3.77 0.456 1.96 c5: Carbamidomethyl (+57.02) 742.8542 1,483.69 1,483.70 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SYTITGLQPGTDYK 95.00% 4.34 0.53 3.8 772.3835 1,542.75 1,543.76 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SYTITGLQPGTDYK 95.00% 4.38 0.521 3.24 772.3835 1,542.75 1,543.76 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SYTITGLQPGTDYK 95.00% 3.58 0.456 3.14 772.3838 1,542.75 1,543.76 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SYTITGLQPGTDYK 95.00% 2.27 0.306 0 772.384 1,542.75 1,543.76 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SYTITGLQPGTDYK 95.00% 3.59 0.535 2.06 772.3841 1,542.75 1,543.76 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SYTITGLQPGTDYK 95.00% 4.38 0.513 3.51 772.385 1,542.75 1,543.76 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SYTITGLQPGTDYK 95.00% 3.39 0.497 2.74 772.3874 1,542.76 1,543.76 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SYTITGLQPGTDYK 95.00% 3.35 0.451 0 772.3875 1,542.76 1,543.76 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% EATIPGHLNSYTIK 95.00% 3.06 0.386 1.42 772.4091 1,542.80 1,543.81 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SYTITGLQPGTDYK 95.00% 3.27 0.253 0 772.8839 1,543.75 1,543.76 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SYTITGLQPGTDYK 95.00% 3.29 0.199 1.74 772.8853 1,543.76 1,543.76 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% EATIPGHLNSYTIK 95.00% 3.04 0.351 1.25 772.9115 1,543.81 1,543.81 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DTLTSRPAQGVVTTLENVSPPR 95.00% 2.07 0.316 1.1 780.4198 2,338.24 2,338.24 3 MAP4_HUMAN,CO1A2_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GDSPASSKPISINYR 95.00% 3.85 0.546 3.06 796.4078 1,590.80 1,591.81 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GDSPASSKPISINYR 95.00% 4.27 0.596 5 796.4078 1,590.80 1,591.81 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GDSPASSKPISINYR 95.00% 3.55 0.553 2.52 796.4091 1,590.80 1,591.81 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VTDATETTITISWR 95.00% 2.32 0.349 2.55 797.4131 1,592.81 1,593.81 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.1 0.598 4.37 799.6992 2,396.07 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.5 0.608 4.96 799.6995 2,396.07 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.65 0.597 3.62 799.6996 2,396.08 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.51 0.633 5.32 799.7 2,396.08 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.08 0.574 4.23 799.7003 2,396.08 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.54 0.627 4.14 799.7006 2,396.08 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.05 0.591 4.72 799.7007 2,396.08 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.63 0.627 4.47 799.7007 2,396.08 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.17 0.586 3.22 799.7007 2,396.08 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.12 0.577 3.74 799.7009 2,396.08 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.18 0.627 4.68 799.7009 2,396.08 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.89 0.628 3.31 799.701 2,396.08 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 5.25 0.589 5.25 799.7028 2,396.09 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 0 0 3.31 800.0353 2,397.08 2,396.09 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DSMIWDcTcIGAGR 95.00% 3.95 0.471 4.48 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3444 1,640.67 1,641.68 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DSMIWDcTcIGAGR 95.00% 3.83 0.563 5.06 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3448 1,640.67 1,641.68 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DSMIWDcTcIGAGR 95.00% 2.76 0.0717 2.7 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 821.3473 1,640.68 1,641.68 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.32 0.424 5.17 821.7415 2,462.20 2,462.21 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TEIDKPSQMQVTDVQDNSISVK 95.00% 3.98 0.385 2.33 821.7421 2,462.20 2,462.21 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TEIDKPSQMQVTDVQDNSISVK 95.00% 5.7 0.403 4.59 821.7431 2,462.21 2,462.21 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DDKESVPISDTIIPAVPPPTDLR 95.00% 4.25 0.432 0 826.1036 2,475.29 2,475.30 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% DDKESVPISDTIIPAVPPPTDLR 95.00% 3.41 0.412 0 826.1049 2,475.29 2,475.30 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% PAQGVVTTLENVSPPR 95.00% 4.3 0.624 0 832.9527 1,663.89 1,664.90 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% PAQGVVTTLENVSPPR 95.00% 4.61 0.573 0 833.4543 1,664.89 1,664.90 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TKTETITGFQVDAVPANGQTPIQR 95.00% 4.23 0.504 2.03 858.4512 2,572.33 2,572.34 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TKTETITGFQVDAVPANGQTPIQR 95.00% 3.86 0.35 1.68 858.4521 2,572.33 2,572.34 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TKTETITGFQVDAVPANGQTPIQR 95.00% 5.23 0.467 3.06 858.4526 2,572.33 2,572.34 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TKTETITGFQVDAVPANGQTPIQR 95.00% 3.95 0.408 2.27 858.4542 2,572.34 2,572.34 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NLQPASEYTVSLVAIK 95.00% 4.64 0.598 7.05 866.9758 1,731.94 1,732.95 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NLQPASEYTVSLVAIK 95.00% 4.25 0.613 5.57 866.9763 1,731.94 1,732.95 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NLQPASEYTVSLVAIK 95.00% 4.24 0.585 7.92 866.9763 1,731.94 1,732.95 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NLQPASEYTVSLVAIK 95.00% 4.4 0.572 7.34 866.9764 1,731.94 1,732.95 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NLQPASEYTVSLVAIK 95.00% 4.37 0.56 3.08 866.9767 1,731.94 1,732.95 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NLQPASEYTVSLVAIK 95.00% 4.23 0.572 6.12 866.9772 1,731.94 1,732.95 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NLQPASEYTVSLVAIK 95.00% 4.72 0.598 5.62 866.9777 1,731.94 1,732.95 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NLQPASEYTVSLVAIK 95.00% 4.86 0.583 5.27 867.4778 1,732.94 1,732.95 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NLQPASEYTVSLVAIK 95.00% 4.74 0.577 3.85 867.4782 1,732.94 1,732.95 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NLQPASEYTVSLVAIK 95.00% 4.44 0.6 5.54 867.4803 1,732.94 1,732.95 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 4.84 0.6 4.2 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4051 1,790.79 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 4.92 0.569 2.37 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4082 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 4.1 0.556 5.23 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4082 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 3.86 0.534 3.85 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4092 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 4.77 0.606 5.09 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4095 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 4.66 0.557 4.23 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4095 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 4.08 0.602 4 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4096 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 5 0.588 4.19 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4099 1,790.80 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 5.14 0.553 3.51 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4104 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 5.37 0.639 6.21 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4106 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 4.94 0.619 3.2 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.4131 1,790.81 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 5.61 0.626 4.96 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9094 1,791.80 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TYLGNALVcTcYGGSR 95.00% 5.87 0.6 3.7 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 896.9103 1,791.81 1,791.82 2 TENX_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VTIMWTPPESAVTGYR 95.00% 2.76 0.377 0 904.9551 1,807.89 1,807.91 2 PDC6I_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VTIMWTPPESAVTGYR 95.00% 3.76 0.538 5.14 904.9555 1,807.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% VTIMWTPPESAVTGYR 95.00% 4.11 0.588 5.54 904.9561 1,807.90 1,807.91 2 PDC6I_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GATYNIIVEALKDQQR 95.00% 2.53 0.345 2.04 909.7873 1,817.56 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GATYNIIVEALKDQQR 95.00% 4.47 0.507 3.12 909.9851 1,817.95 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GATYNIIVEALKDQQR 95.00% 4.2 0.442 2.6 909.9869 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GATYNIIVEALKDQQR 95.00% 4.79 0.512 3.3 909.9886 1,817.96 1,818.97 2 RS8_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HTSVQTTSSGSGPFTDVR 95.00% 5.43 0.608 11.5 932.4431 1,862.87 1,863.88 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HTSVQTTSSGSGPFTDVR 95.00% 5.62 0.59 8.72 932.4466 1,862.88 1,863.88 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HTSVQTTSSGSGPFTDVR 95.00% 5.54 0.593 10.3 932.4467 1,862.88 1,863.88 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HTSVQTTSSGSGPFTDVR 95.00% 5.9 0.617 9.66 932.9461 1,863.88 1,863.88 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HTSVQTTSSGSGPFTDVR 95.00% 5.54 0.617 9.55 932.9482 1,863.88 1,863.88 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% HTSVQTTSSGSGPFTDVR 95.00% 5.98 0.625 8.32 932.9488 1,863.88 1,863.88 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 5.48 0.679 3.66 934.1627 2,799.46 2,799.48 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% GLKPGVVYEGQLISIQQYGHQEVTR 95.00% 5.69 0.63 4.29 934.1635 2,799.47 2,799.48 3
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% EYLGAIcScTcFGGQR 95.00% 3.82 0.547 4.55 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.8965 1,877.78 1,878.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% EYLGAIcScTcFGGQR 95.00% 4.91 0.615 4.89 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 939.9011 1,877.79 1,878.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% EYLGAIcScTcFGGQR 95.00% 4.89 0.616 4.92 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3949 1,878.77 1,878.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% EYLGAIcScTcFGGQR 95.00% 4.93 0.581 5.12 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.3994 1,878.78 1,878.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% EYLGAIcScTcFGGQR 95.00% 5.09 0.569 5.89 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4007 1,878.79 1,878.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% EYLGAIcScTcFGGQR 95.00% 5.22 0.586 3.72 c7: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 940.4023 1,878.79 1,878.79 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SSPVVIDASTAIDAPSNLR 95.00% 4.58 0.588 4.4 957.0009 1,911.99 1,913.00 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SSPVVIDASTAIDAPSNLR 95.00% 3.34 0.44 2.7 957.0014 1,911.99 1,913.00 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SSPVVIDASTAIDAPSNLR 95.00% 6.14 0.565 6.96 957.5017 1,912.99 1,913.00 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SSPVVIDASTAIDAPSNLR 95.00% 5.59 0.55 3.8 957.5036 1,912.99 1,913.00 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SSPVVIDASTAIDAPSNLR 95.00% 6.14 0.572 8.03 957.5038 1,912.99 1,913.00 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% SSPVVIDASTAIDAPSNLR 95.00% 5.38 0.51 5.43 957.5051 1,912.99 1,913.00 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FLATTPNSLLVSWQPPR 95.00% 3.34 0.459 3.48 964.0232 1,926.03 1,927.04 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FLATTPNSLLVSWQPPR 95.00% 4.43 0.478 4 964.0238 1,926.03 1,927.04 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FLATTPNSLLVSWQPPR 95.00% 2.77 0.476 3.96 964.024 1,926.03 1,927.04 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FLATTPNSLLVSWQPPR 95.00% 4.28 0.46 4.48 964.5251 1,927.03 1,927.04 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FLATTPNSLLVSWQPPR 95.00% 3.49 0.42 2.1 964.5251 1,927.03 1,927.04 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FLATTPNSLLVSWQPPR 95.00% 3.89 0.484 3 964.5252 1,927.03 1,927.04 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FLATTPNSLLVSWQPPR 95.00% 3.79 0.523 6.4 964.5266 1,927.04 1,927.04 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FLATTPNSLLVSWQPPR 95.00% 4.26 0.531 5.29 964.5268 1,927.04 1,927.04 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% FLATTPNSLLVSWQPPR 95.00% 3.83 0.518 5.41 964.5287 1,927.04 1,927.04 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% EESPLLIGQQSTVSDVPR 95.00% 4.41 0.556 6.11 978.009 1,954.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% EESPLLIGQQSTVSDVPR 95.00% 4.37 0.538 3.96 978.5074 1,955.00 1,955.01 2 MYPT2_HUMAN
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NTFAEVTGLSPGVTYYFK 95.00% 3.58 0.429 1.74 997.9974 1,993.98 1,993.99 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NTFAEVTGLSPGVTYYFK 95.00% 6.13 0.639 6.02 997.9981 1,993.98 1,993.99 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% NTFAEVTGLSPGVTYYFK 95.00% 6.51 0.639 6.8 997.9993 1,993.98 1,993.99 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% EINLAPDSSSVVVSGLMVATK 95.00% 6.12 0.533 6.77 1,059.56 2,117.11 2,117.12 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% EINLAPDSSSVVVSGLMVATK 95.00% 5.96 0.612 6.41 1,059.56 2,117.11 2,117.12 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% ITYGETGGNSPVQEFTVPGSK 95.00% 4.43 0.582 5.57 1,084.53 2,167.04 2,168.05 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% ITYGETGGNSPVQEFTVPGSK 95.00% 4.73 0.538 4.89 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% ITYGETGGNSPVQEFTVPGSK 95.00% 5.48 0.559 4.01 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% ITYGETGGNSPVQEFTVPGSK 95.00% 5.64 0.525 4.54 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% ITYGETGGNSPVQEFTVPGSK 95.00% 5.57 0.467 5.33 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% ITYGETGGNSPVQEFTVPGSK 95.00% 5.45 0.582 3.14 1,085.03 2,168.04 2,168.05 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% ITYGETGGNSPVQEFTVPGSK 95.00% 5.8 0.573 5.74 1,085.03 2,168.05 2,168.05 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% RPGGEPSPEGTTGQSYNQYSQR 95.00% 4.75 0.556 5.4 1,199.05 2,396.08 2,396.09 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.84 0.604 4.27 1,232.11 2,462.20 2,462.21 2
 SAMPLE 3R Fibronectin  FN1  FINC_HUMAN 262,581.00 100.00% 38 48 260 24.30% TEIDKPSQMQVTDVQDNSISVK 95.00% 4.76 0.599 5.37 1,232.11 2,462.21 2,462.21 2
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% DSFDIIKR 95.00% 2.51 0.235 0 497.2696 992.5235 993.5371 2
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% DSFDIIKR 95.00% 2.1 0.274 0 497.271 992.5263 993.5371 2
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% LEMNYVVGGVVSHR 95.00% 3.66 0.479 1.96 520.604 1,558.79 1,559.80 3
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% LEMNYVVGGVVSHR 95.00% 3.66 0.484 2 520.9381 1,559.79 1,559.80 3
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% TGYYFDGISR 95.00% 2.18 0.36 0 589.7762 1,177.54 1,178.55 2 ILK_HUMAN,LAMC1_HUMAN
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% TGYYFDGISR 95.00% 3.36 0.542 2.16 589.7769 1,177.54 1,178.55 2 ILK_HUMAN,LAMC1_HUMAN
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% TGYYFDGISR 95.00% 3.52 0.549 2.34 589.777 1,177.54 1,178.55 2 ILK_HUMAN,LAMC1_HUMAN
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% DcSLPYATESK 95.00% 2.74 0.405 3.1 c2: Carbamidomethyl (+57.02) 635.7845 1,269.55 1,270.56 2
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% DcSLPYATESK 95.00% 2.86 0.397 2.55 c2: Carbamidomethyl (+57.02) 635.7852 1,269.55 1,270.56 2
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% McVDVNEcQR 95.00% 3.3 0.491 1.74 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 655.7672 1,309.52 1,310.53 2
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% McVDVNEcQR 95.00% 3.5 0.503 1.77 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 655.7674 1,309.52 1,310.53 2
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% cVDVDEcAPPAEPcGK 95.00% 4.16 0.332 3 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 902.871 1,803.73 1,803.74 2
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% cVDVDEcAPPAEPcGK 95.00% 4.41 0.35 4.1 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 902.8717 1,803.73 1,803.74 2
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% DSScGTGYELTEDNScK 95.00% 3.2 0.499 1.74 c4: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 961.8667 1,921.72 1,922.74 2
 SAMPLE 2 Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 7 7 12 14.50% IIEVEEEQEDPYLNDR 95.00% 5.13 0.6 4.8 995.9646 1,989.91 1,990.92 2
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% DSFDIIKR 95.00% 2.16 0.328 0 497.2699 992.5241 993.5371 2
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% DSFDIIKR 95.00% 2.05 0.304 0 497.2704 992.5251 993.5371 2
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% LEMNYVVGGVVSHR 95.00% 3.31 0.456 0 520.604 1,558.79 1,559.80 3
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% LEMNYVVGGVVSHR 95.00% 2.63 0.359 0.959 520.6045 1,558.79 1,559.80 3
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% TGYYFDGISR 95.00% 2.34 0.406 0 589.7766 1,177.54 1,178.55 2 ILK_HUMAN,LAMC1_HUMAN
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% TGYYFDGISR 95.00% 3.33 0.492 2.57 589.7768 1,177.54 1,178.55 2 ILK_HUMAN,LAMC1_HUMAN
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% TGYYFDGISR 95.00% 3.16 0.464 1.92 589.777 1,177.54 1,178.55 2 ILK_HUMAN,LAMC1_HUMAN
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% TGYYFDGISR 95.00% 2.3 0.417 0 589.7775 1,177.54 1,178.55 2 ILK_HUMAN,LAMC1_HUMAN
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% DcSLPYATESK 95.00% 2.22 0.31 2.72 c2: Carbamidomethyl (+57.02) 635.7841 1,269.55 1,270.56 2
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% McVDVNEcQR 95.00% 3.29 0.494 2.21 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 655.7672 1,309.52 1,310.53 2
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% McVDVNEcQR 95.00% 2.92 0.487 2.29 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 655.7682 1,309.52 1,310.53 2
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% AITPPHPASQANIIFDITEGNLR 95.00% 5.23 0.499 2.17 826.1038 2,475.29 2,475.30 3
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% AITPPHPASQANIIFDITEGNLR 95.00% 4.83 0.531 2.43 826.1041 2,475.29 2,475.30 3
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% cVDVDEcAPPAEPcGK 95.00% 3.96 0.443 3.12 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 902.3707 1,802.73 1,803.74 2
 SAMPLE 2R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 6 6 11 13.10% cVDVDEcAPPAEPcGK 95.00% 4.15 0.383 2.48 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 902.8741 1,803.73 1,803.74 2
 SAMPLE 3R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 2 2 3 6.12% TGYYFDGISR 95.00% 2.99 0.517 1.12 589.7769 1,177.54 1,178.55 2 ILK_HUMAN,LAMC1_HUMAN
 SAMPLE 3R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 2 2 3 6.12% TGYYFDGISR 95.00% 2.79 0.474 0 589.7771 1,177.54 1,178.55 2 ILK_HUMAN,LAMC1_HUMAN
 SAMPLE 3R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 2 2 3 6.12% McVDVNEcQR 95.00% 3.12 0.419 2.89 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 655.7677 1,309.52 1,310.53 2
 SAMPLE 3R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 2 2 3 6.12% McVDVNEcQR 95.00% 2.82 0.424 2.17 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 655.7678 1,309.52 1,310.53 2
 SAMPLE 3R Fibulin-1  FBLN1  FBLN1_HUMAN 77,193.60 100.00% 2 2 3 6.12% AITPPHPASQANIIFDITEGNLR 95.00% 4.84 0.576 1.72 826.1058 2,475.29 2,475.30 3
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% QTGPISATLVMTRPIK 95.00% 2.5 0.486 0 571.6614 1,711.96 1,712.97 3
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% QTGPISATLVMTRPIK 95.00% 2.48 0.296 0 571.6625 1,711.96 1,712.97 3
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% cIDPIRcEEPYLR 95.00% 2.7 0.288 0 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 574.2738 1,719.80 1,720.82 3
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% cIDPIRcEEPYLR 95.00% 2.86 0.369 0 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 574.2749 1,719.80 1,720.82 3
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% DQPFTILYR 95.00% 2.5 0.307 0 576.8047 1,151.59 1,152.61 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% DQPFTILYR 95.00% 2.39 0.337 0 576.8049 1,151.59 1,152.61 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% DQPFTILYR 95.00% 2.42 0.295 0 576.8051 1,151.59 1,152.61 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% DQPFTILYR 95.00% 2.96 0.446 0 576.8054 1,151.60 1,152.61 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% DQPFTILYR 95.00% 2.01 0.308 0 576.8056 1,151.60 1,152.61 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% DQPFTILYR 95.00% 2.69 0.472 0 576.8056 1,151.60 1,152.61 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% DQPFTILYR 95.00% 2.73 0.394 0 576.8056 1,151.60 1,152.61 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% DQPFTILYR 95.00% 2.74 0.318 0 576.8058 1,151.60 1,152.61 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% DQPFTILYR 95.00% 2.55 0.258 0 576.8059 1,151.60 1,152.61 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% DQPFTILYR 95.00% 1.98 0.305 0 576.808 1,151.60 1,152.61 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% DQPFTILYR 95.00% 2.56 0.357 0 576.8116 1,151.61 1,152.61 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% DQPFTILYR 95.00% 2.39 0.326 0 576.8149 1,151.61 1,152.61 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% YPGAYYIFQIK 95.00% 2.47 0.237 2.18 681.8506 1,361.69 1,362.71 2 LAMA4_HUMAN
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% YPGAYYIFQIK 95.00% 3.95 0.334 2.44 681.8568 1,361.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% YPGAYYIFQIK 95.00% 3.68 0.294 2.22 681.857 1,361.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% YPGAYYIFQIK 95.00% 2.75 0.298 1.52 681.8623 1,361.71 1,362.71 2 LAMA4_HUMAN
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% YPGAYYIFQIK 95.00% 3.67 0.232 2.68 682.3595 1,362.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% QSGQcLDIDEcR 95.00% 3.54 0.584 3.64 c5: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 740.8107 1,479.61 1,480.62 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% QSGQcLDIDEcR 95.00% 3.33 0.604 4 c5: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 740.8108 1,479.61 1,480.62 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% QSGQcLDIDEcR 95.00% 2.99 0.513 1.59 c5: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 740.8136 1,479.61 1,480.62 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% QSGQcLDIDEcR 95.00% 2.57 0.559 2 c5: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 740.8139 1,479.61 1,480.62 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% SVPADIFQMQATTR 95.00% 4.61 0.609 4.17 782.8915 1,563.77 1,564.78 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% SVPADIFQMQATTR 95.00% 4.52 0.597 3.8 782.8922 1,563.77 1,564.78 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% SVPADIFQMQATTR 95.00% 3.65 0.336 2.43 782.9036 1,563.79 1,564.78 2
 SAMPLE 1 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 5 24 16.70% SVPADIFQMQATTR 95.00% 3.78 0.374 3.49 783.3915 1,564.77 1,564.78 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% QTGPISATLVMTRPIK 95.00% 2.04 0.365 0 571.6605 1,711.96 1,712.97 3
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% QTGPISATLVMTRPIK 95.00% 2.02 0.258 0 571.6613 1,711.96 1,712.97 3
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 2.12 0.277 0 576.8032 1,151.59 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 2.12 0.259 0 576.8036 1,151.59 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 2.6 0.343 0 576.8041 1,151.59 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 2.52 0.258 0 576.8049 1,151.59 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 2.93 0.333 0 576.805 1,151.59 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 1.99 0.252 0 576.805 1,151.59 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 2.74 0.252 0 576.8053 1,151.60 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 2.03 0.313 0 576.8053 1,151.60 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 2.66 0.178 0 576.8055 1,151.60 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 2.14 0.232 0 576.8062 1,151.60 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 1.98 0.305 0 576.808 1,151.60 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 2.56 0.357 0 576.8116 1,151.61 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 2.51 0.346 0 576.816 1,151.62 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 3.13 0.438 0 576.8167 1,151.62 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% DQPFTILYR 95.00% 2.68 0.291 0 576.8175 1,151.62 1,152.61 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% YPGAYYIFQIK 95.00% 3.48 0.308 3.14 681.8566 1,361.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% YPGAYYIFQIK 95.00% 3.42 0.31 2.82 682.3576 1,362.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% YPGAYYIFQIK 95.00% 3.79 0.35 3.19 682.36 1,362.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% YPGAYYIFQIK 95.00% 3.65 0.283 3.21 682.3601 1,362.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% YPGAYYIFQIK 95.00% 3.36 0.371 2.64 682.3622 1,362.71 1,362.71 2 LAMA4_HUMAN
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% QSGQcLDIDEcR 95.00% 3.58 0.594 2.48 c5: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 740.8095 1,479.60 1,480.62 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% QSGQcLDIDEcR 95.00% 3.35 0.507 2.42 c5: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 740.8123 1,479.61 1,480.62 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% SVPADIFQMQATTR 95.00% 4.59 0.606 4.08 782.8923 1,563.77 1,564.78 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% SVPADIFQMQATTR 95.00% 3.65 0.336 2.89 782.9036 1,563.79 1,564.78 2
 SAMPLE 1R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 4 4 22 13.80% SVPADIFQMQATTR 95.00% 4.59 0.567 5.09 783.3941 1,564.77 1,564.78 2
 SAMPLE 2 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 7 10.70% QTGPISATLVMTRPIK 95.00% 2 0.291 0 571.9954 1,712.96 1,712.97 3
 SAMPLE 2 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 7 10.70% DQPFTILYR 95.00% 2.1 0.288 0 576.8042 1,151.59 1,152.61 2
 SAMPLE 2 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 7 10.70% DQPFTILYR 95.00% 2.17 0.337 0 576.8044 1,151.59 1,152.61 2
 SAMPLE 2 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 7 10.70% DQPFTILYR 95.00% 2.46 0.358 0 576.8048 1,151.59 1,152.61 2
 SAMPLE 2 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 7 10.70% DQPFTILYR 95.00% 2.41 0.284 0 576.8054 1,151.60 1,152.61 2
 SAMPLE 2 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 7 10.70% DQPFTILYR 95.00% 2.44 0.335 0 576.806 1,151.60 1,152.61 2
 SAMPLE 2 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 7 10.70% YPGAYYIFQIK 95.00% 3.42 0.302 2.29 681.8581 1,361.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 2 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 7 10.70% YPGAYYIFQIK 95.00% 2.46 0.234 1.62 681.8585 1,361.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 2 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 7 10.70% YPGAYYIFQIK 95.00% 3.3 0.293 2.66 682.3584 1,362.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 2 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 7 10.70% YPGAYYIFQIK 95.00% 3.56 0.294 3 682.3589 1,362.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 2 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 7 10.70% QSGQcLDIDEcR 95.00% 2.26 0.466 1.66 c5: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 740.8114 1,479.61 1,480.62 2
 SAMPLE 2R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 3 8.71% QTGPISATLVMTRPIK 95.00% 2.35 0.415 0 571.9954 1,712.96 1,712.97 3
 SAMPLE 2R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 3 8.71% DQPFTILYR 95.00% 2.05 0.436 0 576.8039 1,151.59 1,152.61 2
 SAMPLE 2R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 3 3 3 8.71% SVPADIFQMQATTR 95.00% 3.38 0.523 2.1 782.894 1,563.77 1,564.78 2
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% QTGPISATLVMTRPIK 95.00% 2.53 0.307 0 571.6625 1,711.96 1,712.97 3
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% QTGPISATLVMTRPIK 95.00% 2.81 0.402 0 571.9957 1,712.96 1,712.97 3
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% cIDPIRcEEPYLR 95.00% 2.66 0.232 0 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 574.6094 1,720.80 1,720.82 3
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% DQPFTILYR 95.00% 2.5 0.289 0 576.8029 1,151.59 1,152.61 2
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% DQPFTILYR 95.00% 2.73 0.347 0 576.8053 1,151.59 1,152.61 2
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% DQPFTILYR 95.00% 2.82 0.285 0 576.8053 1,151.60 1,152.61 2
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% DQPFTILYR 95.00% 2.49 0.243 0 576.8056 1,151.60 1,152.61 2
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% cMcPAENPGcR 95.00% 3.16 0.42 3.22 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 676.2537 1,350.49 1,351.50 2
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% cMcPAENPGcR 95.00% 3.27 0.447 3.6 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 676.2538 1,350.49 1,351.50 2
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% YPGAYYIFQIK 95.00% 3.76 0.338 3.59 681.8574 1,361.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% YPGAYYIFQIK 95.00% 3.86 0.291 3.96 681.8575 1,361.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% YPGAYYIFQIK 95.00% 3.54 0.304 3.04 681.8576 1,361.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% YPGAYYIFQIK 95.00% 3.42 0.313 3.21 681.8584 1,361.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% QSGQcLDIDEcR 95.00% 3.6 0.589 3.92 c5: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 740.8117 1,479.61 1,480.62 2
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% QSGQcLDIDEcR 95.00% 3.52 0.614 4.16 c5: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 740.8119 1,479.61 1,480.62 2
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% SVPADIFQMQATTR 95.00% 4.56 0.596 5.52 782.8919 1,563.77 1,564.78 2
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% SVPADIFQMQATTR 95.00% 4.57 0.603 5.38 782.8929 1,563.77 1,564.78 2
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% QTGPISATLVMTRPIK 95.00% 3.72 0.507 2.59 856.9892 1,711.96 1,712.97 2
 SAMPLE 3 Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 6 7 15 19.20% QTGPISATLVMTRPIK 95.00% 3.51 0.513 2.16 857.4899 1,712.96 1,712.97 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% QTGPISATLVMTRPIK 95.00% 2.86 0.321 0 571.6616 1,711.96 1,712.97 3
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% QTGPISATLVMTRPIK 95.00% 2.43 0.308 1 571.6617 1,711.96 1,712.97 3
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% QTGPISATLVMTRPIK 95.00% 1.89 0.297 0 571.9957 1,712.96 1,712.97 3
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% DQPFTILYR 95.00% 2.26 0.298 0 576.8045 1,151.59 1,152.61 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% DQPFTILYR 95.00% 2.09 0.27 0 576.8056 1,151.60 1,152.61 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% DQPFTILYR 95.00% 2.16 0.281 0 576.8059 1,151.60 1,152.61 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% DQPFTILYR 95.00% 2.51 0.272 0 576.8063 1,151.60 1,152.61 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% DQPFTILYR 95.00% 2.42 0.311 0 576.807 1,151.60 1,152.61 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% cMcPAENPGcR 95.00% 3.25 0.45 3.15 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 676.2528 1,350.49 1,351.50 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% cMcPAENPGcR 95.00% 3.3 0.439 2.64 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 676.2538 1,350.49 1,351.50 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% YPGAYYIFQIK 95.00% 3.35 0.354 3.16 681.8566 1,361.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% YPGAYYIFQIK 95.00% 3.57 0.288 2.92 681.8573 1,361.70 1,362.71 2 LAMA4_HUMAN
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% YPGAYYIFQIK 95.00% 2.8 0.299 2.77 682.3525 1,362.69 1,362.71 2 LAMA4_HUMAN
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% QSGQcLDIDEcR 95.00% 3.72 0.574 3.77 c5: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 740.8112 1,479.61 1,480.62 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% QSGQcLDIDEcR 95.00% 3.43 0.62 3.8 c5: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 741.3139 1,480.61 1,480.62 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% SVPADIFQMQATTR 95.00% 4.47 0.552 5.72 782.8933 1,563.77 1,564.78 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% SVPADIFQMQATTR 95.00% 4.69 0.591 5 782.8935 1,563.77 1,564.78 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% QTGPISATLVMTRPIK 95.00% 3.62 0.531 1.32 856.9902 1,711.96 1,712.97 2
 SAMPLE 3R Fibulin-5  FBLN5  FBLN5_HUMAN 50,162.10 100.00% 5 6 16 16.30% QTGPISATLVMTRPIK 95.00% 3.03 0.422 1.28 857.4917 1,712.97 1,712.97 2
 SAMPLE 1 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 99.80% 2 2 4 2.47% LKAEEEKGNDLLSR 95.00% 2.78 0.284 1.28 534.6187 1,600.83 1,601.85 3
 SAMPLE 1 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 99.80% 2 2 4 2.47% LKAEEEKGNDLLSR 95.00% 2.97 0.37 1.21 534.6205 1,600.84 1,601.85 3
 SAMPLE 1 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 99.80% 2 2 4 2.47% LKAEEEKGNDLLSR 95.00% 2.73 0.334 0 534.9552 1,601.84 1,601.85 3
 SAMPLE 1 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 99.80% 2 2 4 2.47% AQTPEScGSLTPER 95.00% 2.83 0.375 2.89 c7: Carbamidomethyl (+57.02) 766.8554 1,531.70 1,532.70 2
 SAMPLE 1R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 99.80% 2 2 4 2.47% LKAEEEKGNDLLSR 95.00% 2.85 0.265 1.7 534.6198 1,600.84 1,601.85 3
 SAMPLE 1R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 99.80% 2 2 4 2.47% LKAEEEKGNDLLSR 95.00% 3.05 0.406 0 534.6202 1,600.84 1,601.85 3
 SAMPLE 1R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 99.80% 2 2 4 2.47% LKAEEEKGNDLLSR 95.00% 2.92 0.319 1.13 534.6203 1,600.84 1,601.85 3
 SAMPLE 1R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 99.80% 2 2 4 2.47% AQTPEScGSLTPER 95.00% 2.63 0.39 2.35 c7: Carbamidomethyl (+57.02) 766.8571 1,531.70 1,532.70 2
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% LQSLEAIEKDFLK 95.00% 2.64 0.385 0 511.954 1,532.84 1,533.85 3
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% LQSLEAIEKDFLK 95.00% 2.63 0.431 0 511.9547 1,532.84 1,533.85 3
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% LKAEEEKGNDLLSR 95.00% 2.82 0.36 1.85 534.6202 1,600.84 1,601.85 3
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% LKAEEEKGNDLLSR 95.00% 2.99 0.334 1.36 534.6202 1,600.84 1,601.85 3
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% LKAEEEKGNDLLSR 95.00% 3.64 0.462 2.47 534.6204 1,600.84 1,601.85 3
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% LKAEEEKGNDLLSR 95.00% 3.12 0.316 0 534.6215 1,600.84 1,601.85 3
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% LKAEEEKGNDLLSR 95.00% 2.88 0.347 0 534.9537 1,601.84 1,601.85 3
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% TQGLINGALNK 95.00% 2.47 0.229 2.49 564.8202 1,127.62 1,128.64 2
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% TQGLINGALNK 95.00% 2.51 0.228 2.77 564.8213 1,127.63 1,128.64 2
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% IKELEAIESR 95.00% 3.4 0.286 0 594.333 1,186.65 1,187.66 2
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% IKELEAIESR 95.00% 3.08 0.284 0 594.3344 1,186.65 1,187.66 2
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% ITILQNASITPVK 95.00% 3.93 0.556 2.55 699.4214 1,396.83 1,397.84 2
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% ITILQNASITPVK 95.00% 4.3 0.542 3.68 699.4222 1,396.83 1,397.84 2
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% AQTPEScGSLTPER 95.00% 3.37 0.448 2.96 c7: Carbamidomethyl (+57.02) 766.8528 1,531.69 1,532.70 2
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% AQTPEScGSLTPER 95.00% 3.23 0.431 3.44 c7: Carbamidomethyl (+57.02) 766.8539 1,531.69 1,532.70 2
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% VTSSITITPTATPLPR 95.00% 3.8 0.565 1.74 827.9725 1,653.93 1,654.94 2
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% VTSSITITPTATPLPR 95.00% 4.16 0.576 3.66 828.4711 1,654.93 1,654.94 2
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% EVQTEAVDNEPPDYK 95.00% 3.55 0.371 2.8 867.396 1,732.78 1,733.79 2
 SAMPLE 3 Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 8 8 19 9.34% EVQTEAVDNEPPDYK 95.00% 3.71 0.447 2.96 867.8974 1,733.78 1,733.79 2
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% LKAEEEKGNDLLSR 95.00% 2.92 0.374 2.07 534.6202 1,600.84 1,601.85 3
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% LKAEEEKGNDLLSR 95.00% 3.04 0.34 0 534.6202 1,600.84 1,601.85 3
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% LKAEEEKGNDLLSR 95.00% 2.95 0.366 1.27 534.6207 1,600.84 1,601.85 3
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% LKAEEEKGNDLLSR 95.00% 2.99 0.29 0 534.6212 1,600.84 1,601.85 3
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% LKAEEEKGNDLLSR 95.00% 3.22 0.399 1.12 534.6214 1,600.84 1,601.85 3
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% LKAEEEKGNDLLSR 95.00% 2.59 0.383 0 534.6218 1,600.84 1,601.85 3
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% TQGLINGALNK 95.00% 2.41 0.206 1.62 564.8217 1,127.63 1,128.64 2
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% IKELEAIESR 95.00% 3.19 0.297 0 594.3342 1,186.65 1,187.66 2
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% IKELEAIESR 95.00% 2.83 0.273 0 594.3343 1,186.65 1,187.66 2
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% ITILQNASITPVK 95.00% 4.05 0.569 2.6 699.4213 1,396.83 1,397.84 2
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% ITILQNASITPVK 95.00% 3.87 0.543 2.04 699.4214 1,396.83 1,397.84 2
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% AQTPEScGSLTPER 95.00% 3.04 0.389 4.62 c7: Carbamidomethyl (+57.02) 766.8531 1,531.69 1,532.70 2
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% AQTPEScGSLTPER 95.00% 2.91 0.341 3.96 c7: Carbamidomethyl (+57.02) 766.8539 1,531.69 1,532.70 2
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% VTSSITITPTATPLPR 95.00% 3.57 0.554 0 827.9726 1,653.93 1,654.94 2
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% VTSSITITPTATPLPR 95.00% 3.95 0.546 1.74 827.9743 1,653.93 1,654.94 2
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% EVQTEAVDNEPPDYK 95.00% 3.73 0.459 3.52 867.3965 1,732.78 1,733.79 2
 SAMPLE 3R Filamin A-interacting protein 1-like  FILIP1L  FIL1L_HUMAN 130,367.60 100.00% 7 7 17 8.19% EVQTEAVDNEPPDYK 95.00% 3.72 0.468 3.66 867.3979 1,732.78 1,733.79 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LIALLEVLSQKK 95.00% 1.93 0.259 1.72 452.2964 1,353.87 1,354.87 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LIALLEVLSQKK 95.00% 1.86 0.297 0 452.2966 1,353.87 1,354.87 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LIALLEVLSQKK 95.00% 2.13 0.242 1.85 452.2968 1,353.87 1,354.87 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LIALLEVLSQKK 95.00% 2.58 0.243 0 452.2968 1,353.87 1,354.87 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LIALLEVLSQKK 95.00% 2.35 0.246 0 452.2968 1,353.87 1,354.87 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LIALLEVLSQKK 95.00% 1.77 0.157 2.72 452.2988 1,353.87 1,354.87 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LIALLEVLSQKK 95.00% 1.93 0.214 1.59 452.6302 1,354.87 1,354.87 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 1.97 0.375 0 455.5754 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 1.95 0.437 0 455.5755 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 2.64 0.383 0 455.5758 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 1.8 0.332 0 455.5762 1,363.71 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 1.9 0.397 0 455.5763 1,363.71 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 2.58 0.374 1.06 455.5764 1,363.71 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 1.75 0.407 1.54 455.5766 1,363.71 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3 0.491 3.02 460.5645 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 2.65 0.464 1.19 460.5645 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 2.29 0.41 1.24 460.5646 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 2.68 0.435 1.06 460.5647 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.66 0.528 0 460.5649 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.23 0.422 0 460.5653 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 2.99 0.424 2.14 460.5654 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 2.98 0.5 1.33 460.5654 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 2.74 0.397 2.62 460.5656 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.08 0.417 1.8 460.5657 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 2.88 0.425 2.25 460.5658 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.38 0.541 1.4 460.5661 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.29 0.518 2.55 460.5663 1,378.68 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 2.54 0.374 1.52 460.5664 1,378.68 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 2.59 0.429 2.03 460.8995 1,379.68 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.1 0.412 1.96 460.9005 1,379.68 1,379.68 3 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.54 0.289 1.12 471.8913 1,412.65 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.79 0.37 1.51 471.8914 1,412.65 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.64 0.38 1.74 471.8914 1,412.65 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.41 0.262 0 471.8915 1,412.65 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.71 0.354 2.38 471.8915 1,412.65 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.66 0.256 0 471.8916 1,412.65 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.39 0.372 1.44 471.8916 1,412.65 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.87 0.339 1.89 471.8917 1,412.65 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.72 0.324 1.8 471.8918 1,412.65 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.68 0.3 1.19 471.8922 1,412.65 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.86 0.251 2.06 471.8926 1,412.65 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 3.16 0.414 1.29 471.893 1,412.66 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.79 0.331 1.51 471.8935 1,412.66 1,413.66 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LRNGHVGISFVPK 95.00% 3.05 0.299 0 475.278 1,422.81 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LRNGHVGISFVPK 95.00% 2.81 0.394 1.13 475.2788 1,422.81 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LRNGHVGISFVPK 95.00% 2.71 0.16 0 475.2789 1,422.81 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LRNGHVGISFVPK 95.00% 3.29 0.404 1.21 475.2791 1,422.81 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LRNGHVGISFVPK 95.00% 3.03 0.384 0 475.2794 1,422.81 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LRNGHVGISFVPK 95.00% 2.22 0.19 1.18 475.606 1,423.79 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LRNGHVGISFVPK 95.00% 2.76 0.218 1.62 475.607 1,423.80 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VKETADFKVYTK 95.00% 2.87 0.416 0 476.9317 1,427.77 1,428.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VKETADFKVYTK 95.00% 2.28 0.332 1.27 476.9322 1,427.77 1,428.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AGNNMLLVGVHGPR 95.00% 3.69 0.474 1.37 478.927 1,433.76 1,434.76 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AGNNMLLVGVHGPR 95.00% 3.75 0.461 0 478.9272 1,433.76 1,434.76 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AGNNmLLVGVHGPR 95.00% 2.89 0.439 0 m5: Oxidation (+15.99) 484.2583 1,449.75 1,450.76 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AGNNmLLVGVHGPR 95.00% 3.41 0.549 0 m5: Oxidation (+15.99) 484.2585 1,449.75 1,450.76 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AGNNmLLVGVHGPR 95.00% 3.49 0.602 0 m5: Oxidation (+15.99) 484.2588 1,449.75 1,450.76 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AGNNmLLVGVHGPR 95.00% 3.17 0.516 1.17 m5: Oxidation (+15.99) 484.2591 1,449.75 1,450.76 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AGNNmLLVGVHGPR 95.00% 3.62 0.617 0 m5: Oxidation (+15.99) 484.2593 1,449.75 1,450.76 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AGNNmLLVGVHGPR 95.00% 2.97 0.511 0 m5: Oxidation (+15.99) 484.5912 1,450.75 1,450.76 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LLGWIQNK 95.00% 3.14 0.129 0 486.2877 970.5597 971.568 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LLGWIQNK 95.00% 2.95 0.166 0 486.2879 970.5602 971.568 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LLGWIQNK 95.00% 2.8 0.135 0 486.2881 970.5605 971.568 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LLGWIQNK 95.00% 2.88 0.105 0 486.2882 970.5607 971.568 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LLGWIQNK 95.00% 3.1 0.144 0 486.2882 970.5608 971.568 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LLGWIQNK 95.00% 2.93 0.0987 0 486.2883 970.5609 971.568 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LLGWIQNK 95.00% 3.24 0.172 0 486.2886 970.5615 971.568 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LLGWIQNK 95.00% 2.98 0.102 0 486.2886 970.5616 971.568 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LLGWIQNK 95.00% 2.93 0.154 0 486.2886 970.5616 971.568 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LLGWIQNK 95.00% 2.78 0.142 0 486.2887 970.5617 971.568 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LLGWIQNK 94.70% 2.79 0.0887 0 486.2889 970.5622 971.568 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LLGWIQNK 95.00% 2.34 0.238 0 486.2894 970.5632 971.568 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.3 0.367 2.12 505.9254 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.25 0.381 3.85 505.9259 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.22 0.347 3.57 505.926 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.37 0.392 1.52 505.926 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 2.8 0.375 1.89 505.926 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.53 0.456 2.96 505.9262 1,514.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.65 0.441 2.82 505.9262 1,514.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.03 0.377 2.01 505.9264 1,514.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.2 0.432 1.82 505.9266 1,514.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.22 0.393 1.85 505.9276 1,514.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 2.57 0.268 1.32 506.2603 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 2.86 0.368 1.72 506.2605 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.56 0.417 3.89 506.2605 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.25 0.402 3.03 506.2614 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.18 0.335 1.89 506.2616 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LSPFMADIR 95.00% 2.44 0.333 0 525.2768 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LSPFMADIR 95.00% 2.45 0.29 0 525.2768 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LSPFMADIR 95.00% 2.67 0.33 0 525.277 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LSPFMADIR 95.00% 2.41 0.287 1.34 525.277 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LSPFMADIR 95.00% 2.51 0.29 0 525.2771 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LSPFMADIR 95.00% 2.28 0.293 0 525.2774 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LSPFMADIR 95.00% 2.43 0.297 0 525.2777 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LSPFMADIR 95.00% 2.31 0.304 0 525.2779 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.76 0.457 1.49 534.9276 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 4.29 0.487 2.72 534.9278 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.95 0.417 2.7 534.9278 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.46 0.459 1.21 534.928 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.65 0.423 1.89 534.9281 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.68 0.329 2.48 534.9282 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 4.2 0.486 5.21 534.9282 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.48 0.375 1.1 534.9283 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 4.08 0.476 2.43 534.9283 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.87 0.432 3.03 534.9285 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 4.3 0.498 3.33 534.9286 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.53 0.463 1.92 534.9287 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.07 0.37 1.06 534.9288 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.47 0.423 1.55 534.9293 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.77 0.424 2.27 534.9293 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.62 0.406 2 534.9294 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.85 0.446 2.68 534.9294 1,601.76 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 4.07 0.45 1.96 535.2629 1,602.77 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 4 0.472 2.08 535.2629 1,602.77 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 4.04 0.432 2.16 535.263 1,602.77 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.4 0.376 2.41 535.2637 1,602.77 1,602.77 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 2.83 0.367 0 542.2713 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 2.84 0.295 0 542.2718 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3.23 0.475 1.72 542.2722 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3.24 0.471 0 542.2724 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3 0.451 0 542.2724 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3.21 0.489 0 542.2726 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3.22 0.49 0 542.2727 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3.04 0.484 0 542.2727 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3.05 0.458 0 542.273 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 2.9 0.464 1.36 542.2731 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3.01 0.439 0 542.2732 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3.28 0.477 0 542.2733 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3.13 0.433 0 542.2733 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3.3 0.491 1.21 542.2735 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 2.93 0.462 1.17 542.2737 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 2.93 0.502 0 542.2738 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3.11 0.492 0 542.2739 1,082.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TPcEEILVKHVGSR 95.00% 2.48 0.389 0 c3: Carbamidomethyl (+57.02) 542.2891 1,623.84 1,624.85 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDK 95.00% 3.1 0.451 0 542.7741 1,083.53 1,083.54 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LYSVSYLLK 95.00% 2.18 0.271 0 543.3164 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LYSVSYLLK 95.00% 2.25 0.223 0 543.3167 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LYSVSYLLK 95.00% 2.35 0.258 0 543.3168 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LYSVSYLLK 95.00% 2.39 0.292 0 543.3169 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LYSVSYLLK 95.00% 2.22 0.278 0 543.3171 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LYSVSYLLK 95.00% 2.15 0.342 0 543.3172 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LYSVSYLLK 95.00% 1.92 0.275 0 543.3172 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LYSVSYLLK 95.00% 2.27 0.201 0 543.3174 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LYSVSYLLK 95.00% 2.44 0.302 0 543.3175 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LYSVSYLLK 95.00% 2.29 0.261 0 543.3175 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LYSVSYLLK 95.00% 2.07 0.334 0 543.3175 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LYSVSYLLK 95.00% 2.37 0.305 0 543.3184 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TPcEEILVK 95.00% 2.75 0.238 0 c3: Carbamidomethyl (+57.02) 544.7873 1,087.56 1,088.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TPcEEILVK 95.00% 2.45 0.221 1.51 c3: Carbamidomethyl (+57.02) 544.7874 1,087.56 1,088.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TPcEEILVK 95.00% 2.76 0.196 0 c3: Carbamidomethyl (+57.02) 544.7879 1,087.56 1,088.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TPcEEILVK 95.00% 2.56 0.271 0 c3: Carbamidomethyl (+57.02) 544.7881 1,087.56 1,088.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TPcEEILVK 95.00% 2.93 0.291 0 c3: Carbamidomethyl (+57.02) 544.7884 1,087.56 1,088.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TPcEEILVK 95.00% 2.64 0.266 1.38 c3: Carbamidomethyl (+57.02) 544.7888 1,087.56 1,088.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TPcEEILVK 95.00% 2.69 0.343 0 c3: Carbamidomethyl (+57.02) 544.7888 1,087.56 1,088.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TPcEEILVK 95.00% 2.76 0.295 0 c3: Carbamidomethyl (+57.02) 544.7891 1,087.56 1,088.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 3.68 0.544 0 549.6308 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 3.98 0.551 2.15 549.6312 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 3.7 0.576 2.33 549.6313 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 4.04 0.558 1.85 549.6315 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 3.95 0.594 1.6 549.6317 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 3.65 0.521 1.96 549.6318 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 3.51 0.581 2.85 549.9648 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 3.89 0.573 2.74 549.965 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 4.22 0.576 3.03 549.9659 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 3.86 0.569 2.3 549.9661 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 3.73 0.545 2.25 549.9661 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 4.06 0.586 2 549.9664 1,646.88 1,646.88 3 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GTVEPQLEAR 95.00% 2.27 0.305 0 550.2921 1,098.57 1,099.57 2 TLN1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GTVEPQLEAR 95.00% 2.06 0.301 0 550.2926 1,098.57 1,099.57 2 TLN1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GTVEPQLEAR 95.00% 2.26 0.339 0 550.295 1,098.57 1,099.57 2 TLN1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 2.1 0.277 0 551.6265 1,651.86 1,652.86 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% APSVANVGSHcDLSLK 95.00% 2.37 0.472 1.03 c11: Carbamidomethyl (+57.02) 552.2799 1,653.82 1,654.82 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% APSVANVGSHcDLSLK 95.00% 2.16 0.36 2.03 c11: Carbamidomethyl (+57.02) 552.28 1,653.82 1,654.82 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% APSVANVGSHcDLSLK 95.00% 2.26 0.21 2.6 c11: Carbamidomethyl (+57.02) 552.2804 1,653.82 1,654.82 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% APSVANVGSHcDLSLK 95.00% 2.63 0.265 3.21 c11: Carbamidomethyl (+57.02) 552.2805 1,653.82 1,654.82 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% APSVANVGSHcDLSLK 95.00% 2.51 0.254 1.24 c11: Carbamidomethyl (+57.02) 552.2808 1,653.82 1,654.82 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% APSVANVGSHcDLSLK 95.00% 2.8 0.485 1.18 c11: Carbamidomethyl (+57.02) 552.2808 1,653.82 1,654.82 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% APSVANVGSHcDLSLK 95.00% 2.38 0.423 1.8 c11: Carbamidomethyl (+57.02) 552.2816 1,653.82 1,654.82 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% APSVANVGSHcDLSLK 95.00% 2.4 0.388 1.82 c11: Carbamidomethyl (+57.02) 552.6124 1,654.81 1,654.82 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% APSVANVGSHcDLSLK 95.00% 2.4 0.469 1 c11: Carbamidomethyl (+57.02) 552.6149 1,654.82 1,654.82 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% APSVANVGSHcDLSLK 95.00% 2.33 0.281 2 c11: Carbamidomethyl (+57.02) 552.6152 1,654.82 1,654.82 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 3.21 0.519 2.74 554.3059 1,106.60 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 3.04 0.523 3.26 554.3064 1,106.60 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 3.82 0.515 3.44 554.3064 1,106.60 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 3.21 0.51 3.27 554.3064 1,106.60 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 3.15 0.53 2.64 554.3067 1,106.60 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 3.49 0.535 2.96 554.3069 1,106.60 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 3.3 0.529 2.82 554.307 1,106.60 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 3.67 0.518 3.12 554.307 1,106.60 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 3.71 0.519 2.52 554.307 1,106.60 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 3.37 0.501 2.49 554.3072 1,106.60 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 3.13 0.425 3.15 554.8065 1,107.60 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 2.87 0.353 2.21 554.9802 1,107.94 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LDVQFSGLTK 95.00% 2.49 0.37 1.25 554.9803 1,107.94 1,107.61 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VKMDcQEcPEGYR 95.00% 2.54 0.299 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9039 1,670.69 1,671.69 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VKMDcQEcPEGYR 95.00% 2.79 0.352 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9052 1,670.69 1,671.69 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VKMDcQEcPEGYR 95.00% 2.88 0.272 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 558.239 1,671.69 1,671.69 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VKMDcQEcPEGYR 95.00% 2.47 0.241 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 558.2396 1,671.70 1,671.69 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VKmDcQEcPEGYR 95.00% 2.82 0.239 0 m3: Oxidation (+15.99), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 563.5729 1,687.70 1,687.69 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.67 0.368 0 566.9783 1,697.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.87 0.341 0 566.9783 1,697.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.04 0.38 1.41 566.9784 1,697.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.29 0.363 1.47 566.9786 1,697.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.61 0.259 0 566.9786 1,697.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.84 0.432 1.47 566.9788 1,697.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.75 0.355 1.02 566.9791 1,697.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.6 0.397 1.39 566.9792 1,697.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.96 0.345 0 566.9792 1,697.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.8 0.348 0 566.9793 1,697.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.78 0.354 0 566.9796 1,697.92 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.03 0.256 0 566.9796 1,697.92 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.44 0.402 0 567.3126 1,698.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.96 0.353 0 567.3127 1,698.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.19 0.359 1.12 567.3128 1,698.91 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.64 0.417 0 567.313 1,698.92 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.25 0.326 0 567.313 1,698.92 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.33 0.38 0 567.3133 1,698.92 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.06 0.311 1.14 567.3138 1,698.92 1,698.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGSGELKVTVK 95.00% 2.44 0.219 0 573.3288 1,144.64 1,145.65 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGSGELKVTVK 95.00% 2.9 0.316 1.57 573.3313 1,144.65 1,145.65 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGSGELKVTVK 95.00% 2.43 0.365 0 573.3325 1,144.65 1,145.65 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGSGELKVTVK 95.00% 2.83 0.392 0 573.3333 1,144.65 1,145.65 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ENGVYLIDVK 95.00% 2.51 0.343 0 575.3105 1,148.61 1,149.62 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ENGVYLIDVK 95.00% 2.51 0.284 0 575.3121 1,148.61 1,149.62 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ENGVYLIDVK 95.00% 2.52 0.4 0 575.3122 1,148.61 1,149.62 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ENGVYLIDVK 95.00% 2.72 0.411 0 575.3126 1,148.61 1,149.62 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ENGVYLIDVK 95.00% 2.91 0.444 1.25 575.3127 1,148.61 1,149.62 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ENGVYLIDVK 95.00% 2.84 0.477 1.2 575.3127 1,148.61 1,149.62 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ENGVYLIDVK 95.00% 2.72 0.447 0 575.3134 1,148.61 1,149.62 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ENGVYLIDVK 95.00% 2.79 0.442 0 575.3136 1,148.61 1,149.62 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ENGVYLIDVK 95.00% 2.2 0.349 0 575.3151 1,148.61 1,149.62 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ENGVYLIDVK 95.00% 2.1 0.311 0 575.8028 1,149.59 1,149.62 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ENGVYLIDVK 95.00% 2.45 0.383 1.48 575.8077 1,149.60 1,149.62 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.43 0.38 1.44 576.3191 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.51 0.3 0 576.3192 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.5 0.345 1.51 576.3195 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.69 0.369 1.24 576.3198 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.51 0.352 0 576.3199 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 3.07 0.386 3.1 576.32 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.55 0.256 0 576.32 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.63 0.319 0 576.3204 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.73 0.333 1.47 576.3208 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.49 0.306 1.8 576.3208 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.68 0.245 0 576.321 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.42 0.25 1.17 576.3213 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.65 0.342 0 576.3214 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DKGEYTLVVK 95.00% 2.62 0.326 0 576.3236 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% NGHVGISFVPK 95.00% 2.65 0.306 0 577.8205 1,153.63 1,154.63 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% NGHVGISFVPK 95.00% 2.6 0.336 0 577.8207 1,153.63 1,154.63 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% NGHVGISFVPK 95.00% 2.3 0.268 0 577.821 1,153.63 1,154.63 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% NGHVGISFVPK 95.00% 2.17 0.137 1.62 577.8211 1,153.63 1,154.63 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% NGHVGISFVPK 95.00% 2.43 0.294 1.54 577.8211 1,153.63 1,154.63 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% NGHVGISFVPK 95.00% 2.31 0.346 0 577.8214 1,153.63 1,154.63 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcK 95.00% 2.7 0.353 3.38 c11: Carbamidomethyl (+57.02) 578.3134 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcK 95.00% 2.59 0.442 3.82 c11: Carbamidomethyl (+57.02) 578.3138 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcK 95.00% 2.57 0.462 3.57 c11: Carbamidomethyl (+57.02) 578.3142 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcK 95.00% 1.91 0.336 0 c11: Carbamidomethyl (+57.02) 578.3142 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcK 95.00% 2.36 0.354 2.64 c11: Carbamidomethyl (+57.02) 578.3151 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcK 95.00% 2.37 0.385 4.29 c11: Carbamidomethyl (+57.02) 578.3153 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcK 95.00% 2.71 0.39 3.54 c11: Carbamidomethyl (+57.02) 578.3155 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcK 95.00% 2.65 0.42 4.59 c11: Carbamidomethyl (+57.02) 578.3155 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcK 95.00% 2.59 0.353 3.03 c11: Carbamidomethyl (+57.02) 578.3158 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcK 95.00% 2.55 0.439 3.44 c11: Carbamidomethyl (+57.02) 578.3162 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcK 95.00% 2.71 0.42 2.52 c11: Carbamidomethyl (+57.02) 578.3164 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcK 95.00% 2.57 0.361 3.57 c11: Carbamidomethyl (+57.02) 578.3169 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3.26 0.53 1.59 584.2982 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 2.85 0.496 1.92 584.3008 1,749.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3.17 0.474 2.34 584.634 1,750.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3.73 0.558 2.7 584.634 1,750.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3.44 0.519 1.25 584.634 1,750.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3.01 0.466 1.48 584.6341 1,750.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3.15 0.479 1.77 584.6345 1,750.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3 0.475 1.51 584.6345 1,750.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 2.62 0.277 1.55 586.2845 1,755.83 1,756.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 2.83 0.313 0 586.2853 1,755.83 1,756.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 2.46 0.233 2.6 586.286 1,755.83 1,756.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 4.58 0.491 1.39 586.2867 1,755.84 1,756.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 3.38 0.454 2.85 586.2872 1,755.84 1,756.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 3.5 0.401 3.14 586.6195 1,756.84 1,756.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DLAEDAPWKK 95.00% 2.24 0.199 1.19 586.8004 1,171.59 1,172.60 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DLAEDAPWKK 95.00% 2.36 0.27 0 586.8007 1,171.59 1,172.60 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DLAEDAPWKK 95.00% 2.25 0.22 1.6 586.803 1,171.59 1,172.60 2 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 2.82 0.438 0 588.6246 1,762.85 1,763.86 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 2.34 0.343 0 595.6195 1,783.84 1,784.85 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 2.44 0.209 0 595.6207 1,783.84 1,784.85 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 2.86 0.394 0 595.6208 1,783.84 1,784.85 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 2.37 0.301 0 595.6215 1,783.84 1,784.85 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 2.66 0.359 0 595.6226 1,783.84 1,784.85 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 2.78 0.359 0 595.9554 1,784.84 1,784.85 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 4.23 0.567 4.09 c12: Carbamidomethyl (+57.02) 604.3137 1,809.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 4.29 0.595 4.2 c12: Carbamidomethyl (+57.02) 604.3142 1,809.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 5.09 0.553 3.96 c12: Carbamidomethyl (+57.02) 604.3143 1,809.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 3.95 0.526 3.57 c12: Carbamidomethyl (+57.02) 604.3144 1,809.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 4.82 0.603 4 c12: Carbamidomethyl (+57.02) 604.3145 1,809.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 4.71 0.579 3.17 c12: Carbamidomethyl (+57.02) 604.3145 1,809.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 4.6 0.561 2.8 c12: Carbamidomethyl (+57.02) 604.3145 1,809.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 4.36 0.522 3.49 c12: Carbamidomethyl (+57.02) 604.3145 1,809.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 4.7 0.555 2.39 c12: Carbamidomethyl (+57.02) 604.3147 1,809.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 4.24 0.57 3.72 c12: Carbamidomethyl (+57.02) 604.3148 1,809.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 4.23 0.492 4.19 c12: Carbamidomethyl (+57.02) 604.3151 1,809.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 3.42 0.561 1.55 c12: Carbamidomethyl (+57.02) 604.6411 1,810.90 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 4.17 0.512 3.52 c12: Carbamidomethyl (+57.02) 604.6475 1,810.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 4.22 0.448 3.47 c12: Carbamidomethyl (+57.02) 604.6479 1,810.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% RAPSVANVGSHcDLSLK 95.00% 4.62 0.475 3.25 c12: Carbamidomethyl (+57.02) 604.6487 1,810.92 1,810.92 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 2.32 0.459 1.89 605.6594 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 2.54 0.329 1.48 605.6597 1,813.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 1.77 0.343 1.17 605.6607 1,813.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 1.9 0.306 2.23 605.6608 1,813.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 1.99 0.391 1.92 605.661 1,813.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 2.45 0.408 2.36 605.6613 1,813.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 2.06 0.376 1.68 605.9939 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 2.11 0.422 2.64 605.9941 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 2.25 0.373 1.7 605.9943 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 94.50% 1.72 0.268 0 605.9946 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 1.84 0.415 1.41 605.9948 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 2.15 0.347 1.74 605.9954 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GLGLSKAYVGQK 95.00% 2.65 0.354 1.23 610.8545 1,219.69 1,220.70 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GLGLSKAYVGQK 95.00% 2.23 0.229 0 610.8568 1,219.70 1,220.70 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.49 0.453 1.55 613.2893 1,224.56 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.58 0.444 1.7 613.2895 1,224.56 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.67 0.415 1.44 613.2897 1,224.56 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.43 0.395 1.28 613.2901 1,224.56 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.5 0.433 1.92 613.2902 1,224.56 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.46 0.446 1.7 613.2902 1,224.56 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.66 0.445 1.72 613.2902 1,224.56 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.42 0.359 1.57 613.2903 1,224.57 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.57 0.413 2.01 613.2905 1,224.57 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.41 0.43 2.02 613.2905 1,224.57 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.43 0.411 1.96 613.2906 1,224.57 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.54 0.436 1.77 613.2906 1,224.57 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.58 0.447 1.77 613.2907 1,224.57 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.33 0.356 1.68 613.2908 1,224.57 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.41 0.406 1.8 613.291 1,224.57 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EATTEFSVDAR 95.00% 3.45 0.415 0 613.2913 1,224.57 1,225.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.26 0.514 3.96 613.8307 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.09 0.547 4 613.8313 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.73 0.541 4.51 613.8315 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.93 0.58 4.3 613.8316 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.11 0.471 4.38 613.8317 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.9 0.517 4.4 613.8318 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 2.39 0.361 0 613.8318 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.64 0.542 3.64 613.8319 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.87 0.563 4.92 613.8319 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.98 0.549 2.96 613.8319 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.89 0.513 4.72 613.832 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.63 0.548 3.68 613.8321 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.89 0.539 4 613.8321 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.51 0.565 4.18 613.8321 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.99 0.588 4.15 613.8321 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 4.06 0.606 4.12 613.8321 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.89 0.56 4.85 613.8324 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 3.27 0.474 4.85 613.8325 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AWGPGLEGGVVGK 95.00% 2.3 0.273 1.92 613.8345 1,225.65 1,226.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AHVVPcFDASK 95.00% 2.47 0.396 2.51 c6: Carbamidomethyl (+57.02) 615.8026 1,229.59 1,230.59 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AHVVPcFDASK 95.00% 2.19 0.399 3.31 c6: Carbamidomethyl (+57.02) 615.8031 1,229.59 1,230.59 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AHVVPcFDASK 95.00% 2.09 0.36 3.8 c6: Carbamidomethyl (+57.02) 615.8032 1,229.59 1,230.59 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AHVVPcFDASK 95.00% 2.54 0.425 2.29 c6: Carbamidomethyl (+57.02) 615.8035 1,229.59 1,230.59 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AHVVPcFDASK 95.00% 1.95 0.336 1.52 c6: Carbamidomethyl (+57.02) 615.804 1,229.59 1,230.59 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AHVVPcFDASK 95.00% 2.46 0.414 3.52 c6: Carbamidomethyl (+57.02) 615.8043 1,229.59 1,230.59 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AHVVPcFDASK 95.00% 2.36 0.409 2.62 c6: Carbamidomethyl (+57.02) 615.8047 1,229.59 1,230.59 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% cSGPGLSPGmVR 95.00% 2.73 0.394 0 c1: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 617.2895 1,232.56 1,233.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% cSGPGLSPGmVR 95.00% 1.99 0.282 0 c1: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 617.2912 1,232.57 1,233.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% cSGPGLSPGmVR 95.00% 2.98 0.461 0 c1: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 617.2914 1,232.57 1,233.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% cSGPGLSPGmVR 95.00% 2.72 0.34 0 c1: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 617.2917 1,232.57 1,233.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% cSGPGLSPGmVR 95.00% 2.42 0.46 0 c1: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 617.2931 1,232.57 1,233.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% cSGPGLSPGmVR 95.00% 2.58 0.449 1.47 c1: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 617.2932 1,232.57 1,233.57 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 3.54 0.558 2.26 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.2882 1,866.84 1,867.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 4.33 0.569 2.85 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.6213 1,867.84 1,867.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 3.58 0.539 2.47 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.6215 1,867.84 1,867.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 3.01 0.483 0 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.6218 1,867.84 1,867.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 2.43 0.244 0 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.6219 1,867.84 1,867.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 4.09 0.527 2.6 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.6222 1,867.84 1,867.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 3.48 0.528 2.82 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.6223 1,867.84 1,867.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 4.33 0.603 2.39 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.6224 1,867.84 1,867.84 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LTVSSLQESGLK 95.00% 2.63 0.508 1.15 631.3546 1,260.69 1,261.70 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LTVSSLQESGLK 95.00% 2.21 0.349 0 631.3552 1,260.69 1,261.70 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LTVSSLQESGLK 95.00% 3.04 0.55 2.42 631.3571 1,260.70 1,261.70 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LTVSSLQESGLK 95.00% 2.98 0.465 2.59 631.3573 1,260.70 1,261.70 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTVLFAGQHIAK 95.00% 3.67 0.532 3.1 642.3778 1,282.74 1,283.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTVLFAGQHIAK 95.00% 3.91 0.52 3.85 642.3785 1,282.74 1,283.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTVLFAGQHIAK 95.00% 2.4 0.235 0 642.3791 1,282.74 1,283.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.45 0.269 0 643.3664 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.58 0.336 1.32 643.3677 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.83 0.36 1.77 643.368 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.74 0.421 4.07 643.3681 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.64 0.305 1.74 643.3684 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.85 0.299 2.1 643.3684 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 3.31 0.412 2.44 643.3685 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 3.14 0.41 1.72 643.3686 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 3.03 0.301 3.05 643.3687 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.43 0.322 1.89 643.3687 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 3.03 0.375 2.57 643.3689 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 3.21 0.378 1.77 643.3689 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 3.17 0.399 3.07 643.369 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.88 0.246 2.28 643.369 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.84 0.327 1.7 643.369 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.66 0.358 2.72 643.369 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.9 0.338 2.04 643.3691 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.84 0.343 2.77 643.3691 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 3.05 0.376 2.8 643.3692 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 3.03 0.398 2.51 643.3692 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.86 0.3 1.3 643.3694 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 2.62 0.308 2.77 643.3694 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LPQLPITNFSR 95.00% 3.17 0.402 1.51 643.3701 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.54 0.45 3.31 645.8281 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.34 0.431 0 645.8283 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.63 0.501 3.21 645.8285 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.63 0.503 2.51 645.8287 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.71 0.506 2.24 645.8288 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.54 0.488 2.11 645.8289 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.78 0.534 3.06 645.8289 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 4.1 0.458 3.36 645.8291 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.7 0.515 2.96 645.8292 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.47 0.472 3.06 645.8293 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.55 0.456 2.51 645.8296 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.69 0.524 2.92 645.8296 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.74 0.509 3.7 645.8297 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 4.17 0.483 2.42 645.8301 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.46 0.458 4.38 645.8302 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.62 0.531 2.01 645.8302 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 3.77 0.478 3.02 645.8304 1,289.65 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGQPVPNFPSK 95.00% 4.37 0.473 3.92 646.3296 1,290.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 3.65 0.461 2.92 646.6801 1,937.02 1,938.02 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GKLDVQFSGLTK 95.00% 2.79 0.437 2.12 646.8647 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GKLDVQFSGLTK 95.00% 2.88 0.421 1.49 646.8654 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GKLDVQFSGLTK 95.00% 3.11 0.355 3.2 646.8655 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GKLDVQFSGLTK 95.00% 2.64 0.361 0 646.8659 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GKLDVQFSGLTK 95.00% 2.62 0.367 0 646.866 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GKLDVQFSGLTK 95.00% 3.14 0.425 2.72 646.8662 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 4.55 0.526 3.28 647.0137 1,938.02 1,938.02 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 3.38 0.478 4.11 647.0138 1,938.02 1,938.02 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 4.01 0.458 4.51 647.0139 1,938.02 1,938.02 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 3.86 0.482 5.15 647.014 1,938.02 1,938.02 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 3.17 0.413 3.21 647.0144 1,938.02 1,938.02 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 2.96 0.38 3.03 647.0145 1,938.02 1,938.02 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 3.75 0.388 2 647.0159 1,938.02 1,938.02 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 3.22 0.313 1.77 651.3368 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 3.51 0.398 1.4 651.3372 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 3.01 0.299 1.8 651.3372 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 2.61 0.262 1.52 651.3374 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 2.83 0.312 0 651.3376 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 3.38 0.355 0 651.3378 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 2.75 0.294 0 651.338 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 3.41 0.328 2.36 651.3382 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 3.07 0.363 1.59 651.3382 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 2.63 0.224 0 651.3383 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 2.99 0.258 1.57 651.3385 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 2.4 0.306 0 651.3394 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNGTHIPGSPFK 95.00% 2.07 0.252 0 651.3415 1,300.67 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.27 0.316 2.47 656.8477 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 1.98 0.372 1.59 656.8477 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.76 0.498 1.31 656.8482 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.8 0.504 3.96 656.8482 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.74 0.473 3.8 656.8483 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.49 0.444 4.24 656.8484 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.54 0.462 3.33 656.8485 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.01 0.404 2.44 656.8485 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.19 0.399 3.48 656.8486 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.51 0.592 3.82 656.8486 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.47 0.466 4.39 656.8487 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.34 0.385 2.89 656.8487 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.41 0.464 2.44 656.8487 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.35 0.459 3.72 656.8488 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VEPGLGADNSVVR 95.00% 2.36 0.343 1.57 656.8489 1,311.68 1,312.69 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LIALLEVLSQKK 95.00% 2.62 0.466 2.35 677.9378 1,353.86 1,354.87 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LIALLEVLSQKK 95.00% 3.12 0.485 2.54 677.939 1,353.86 1,354.87 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LIALLEVLSQKK 95.00% 2.56 0.335 0 677.9393 1,353.86 1,354.87 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LIALLEVLSQKK 95.00% 3.8 0.506 2.55 677.9398 1,353.86 1,354.87 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LIALLEVLSQKK 95.00% 2.83 0.458 1.8 677.9405 1,353.87 1,354.87 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VSGLGEKVDVGKDQEFTVK 95.00% 3.93 0.44 2.07 679.0313 2,034.07 2,035.07 3 VINEX_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VSGLGEKVDVGKDQEFTVK 95.00% 2.98 0.436 1.96 679.3457 2,035.01 2,035.07 3 VINEX_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VSGLGEKVDVGKDQEFTVK 95.00% 2.27 0.302 1.13 679.347 2,035.02 2,035.07 3 VINEX_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VSGLGEKVDVGKDQEFTVK 95.00% 3.28 0.458 1.12 679.3653 2,035.07 2,035.07 3 VINEX_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.45 0.171 0 682.8556 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.61 0.281 0 682.8557 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.44 0.294 1.43 682.857 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.71 0.516 2.47 682.8578 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.54 0.487 2.8 682.8579 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.5 0.457 3.54 682.8581 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.74 0.475 2.64 682.8583 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.05 0.411 2.17 682.8584 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.63 0.51 2.4 682.8584 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.73 0.516 3.04 682.8587 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.85 0.5 3.89 682.8587 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 4.06 0.503 3.64 682.8587 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.43 0.489 2.14 682.859 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.5 0.512 3.47 682.8593 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDVGKDQEFTVK 95.00% 3.42 0.496 3.08 682.8598 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 3.35 0.462 1.62 c15: Carbamidomethyl (+57.02) 686.6505 2,056.93 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 3.79 0.546 2.55 c15: Carbamidomethyl (+57.02) 686.6507 2,056.93 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.28 0.514 4.09 c15: Carbamidomethyl (+57.02) 686.6514 2,056.93 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.62 0.555 3.17 c15: Carbamidomethyl (+57.02) 686.6516 2,056.93 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.51 0.538 4.48 c15: Carbamidomethyl (+57.02) 686.652 2,056.93 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.14 0.487 3.92 c15: Carbamidomethyl (+57.02) 686.9854 2,057.93 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.08 0.454 2.96 c15: Carbamidomethyl (+57.02) 686.9854 2,057.93 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 3.88 0.333 2.14 c15: Carbamidomethyl (+57.02) 686.9856 2,057.93 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 3.85 0.402 4.03 c15: Carbamidomethyl (+57.02) 686.9859 2,057.93 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.18 0.471 3.8 c15: Carbamidomethyl (+57.02) 686.986 2,057.93 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.1 0.368 2.77 c15: Carbamidomethyl (+57.02) 686.9862 2,057.94 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.3 0.407 2.85 c15: Carbamidomethyl (+57.02) 686.9862 2,057.94 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.25 0.554 2.42 c15: Carbamidomethyl (+57.02) 686.9864 2,057.94 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.19 0.407 3.96 c15: Carbamidomethyl (+57.02) 686.9866 2,057.94 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.17 0.462 4.47 c15: Carbamidomethyl (+57.02) 686.9867 2,057.94 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.24 0.485 2.1 c15: Carbamidomethyl (+57.02) 686.9868 2,057.94 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 4.52 0.507 4.82 c15: Carbamidomethyl (+57.02) 686.987 2,057.94 2,057.94 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.94 0.494 4.18 690.3413 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.67 0.51 4.15 690.3419 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 4.09 0.546 3.77 690.342 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.5 0.488 4.59 690.3424 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 4 0.528 3.37 690.3424 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.95 0.531 3.82 690.3426 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 4.07 0.465 3.04 690.3427 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 4.11 0.546 4.92 690.3427 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.9 0.553 3.13 690.3429 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.99 0.574 3.29 690.343 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 4.34 0.597 4.92 690.343 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 4.5 0.561 4.52 690.343 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 4.1 0.515 2.85 690.3432 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.59 0.476 3.72 690.3432 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.83 0.481 3.31 690.8446 1,379.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGPYHIGGSPFK 95.00% 3.99 0.49 3.96 690.8456 1,379.68 1,379.68 2 CALD1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.84 0.21 4.32 700.8291 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.38 0.194 3.74 700.8292 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.45 0.194 4.36 700.8293 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 4.03 0.138 5.15 700.8293 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.83 0.185 5.54 700.8293 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.43 0.202 4.55 700.8295 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.55 0.152 4.7 700.8297 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.84 0.171 3.89 700.8297 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.65 0.165 3.59 700.8298 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.77 0.162 4.82 700.8299 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.68 0.183 4.47 700.83 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.88 0.159 4.62 700.83 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.74 0.138 4.48 700.8302 1,399.64 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.41 0.148 5.01 700.8304 1,399.65 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.54 0.144 4.38 700.8304 1,399.65 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.64 0.14 5.92 700.8305 1,399.65 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.46 0.2 3.46 700.8311 1,399.65 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 2.06 0.247 1.48 700.8311 1,399.65 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YGGDEIPFSPYR 95.00% 3.18 0.191 3.39 700.8336 1,399.65 1,400.65 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.88 0.326 4.24 707.3318 1,412.65 1,413.66 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 3.31 0.429 3.55 707.3325 1,412.65 1,413.66 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.87 0.334 3.85 707.3331 1,412.65 1,413.66 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 3.02 0.416 3.4 707.3334 1,412.65 1,413.66 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 3.18 0.41 3.77 707.3339 1,412.65 1,413.66 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 3.22 0.42 3.74 707.3339 1,412.65 1,413.66 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.84 0.351 2.38 707.3353 1,412.65 1,413.66 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% WGDEHIPGSPYR 95.00% 2.82 0.46 2.52 707.8316 1,413.65 1,413.66 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 4.01 0.398 3.54 708.3783 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 2.83 0.506 2.07 708.3784 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 3.93 0.459 3.47 708.3787 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 2.75 0.328 3.8 708.3787 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 3.96 0.432 3.72 708.3789 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 1.95 0.242 1.51 708.3792 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 3.87 0.362 2.96 708.3795 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 3.85 0.404 3.74 708.3796 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 3.91 0.44 3.48 708.3796 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 4.04 0.436 2.74 708.3796 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 3.5 0.528 2.89 708.3797 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 3.85 0.425 3.49 708.3797 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 4.37 0.435 3.96 708.3803 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 3.99 0.406 3.48 708.3803 1,414.74 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 2.73 0.418 2.89 708.3803 1,414.75 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IANLQTDLSDGLR 95.00% 3.66 0.372 2.62 708.3811 1,414.75 1,415.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 4.11 0.604 4.08 713.8806 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 4.18 0.636 4.24 713.8817 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 4.59 0.597 4.52 713.8823 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 5.29 0.605 5.68 713.8824 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 3.55 0.52 4.62 713.8824 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 2.68 0.453 0 713.8825 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 4.76 0.568 5.03 713.8825 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 4.26 0.593 4.8 713.883 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 3.05 0.542 4.89 713.8832 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 4.68 0.603 5.13 713.8832 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 3.82 0.588 4.43 713.8832 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 4.72 0.599 5.16 713.8833 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 4.59 0.627 4.08 713.8838 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 4.11 0.554 4.38 713.8838 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 4.96 0.576 4.39 713.8841 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 3.98 0.653 3.85 713.8842 1,425.75 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSK 95.00% 2.36 0.362 1.35 713.8854 1,425.76 1,426.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.06 0.38 3.27 715.3634 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 3.88 0.408 3.48 715.3636 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.1 0.417 3.66 715.3638 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.35 0.438 3.54 715.3642 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.18 0.371 5.07 715.3642 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.48 0.394 3.3 715.3643 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 2.99 0.457 3.57 715.3646 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.4 0.431 3.66 715.3646 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 3.77 0.436 3.18 715.3647 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 2.63 0.387 0 715.3647 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.39 0.39 3.27 715.3647 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.29 0.392 3.34 715.3648 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.19 0.423 3.16 715.3648 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 3.99 0.404 3.03 715.3648 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 3.53 0.463 3.46 715.3649 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.22 0.404 3.74 715.3649 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.3 0.371 3.12 715.365 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.11 0.406 3.39 715.365 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4 0.393 4.01 715.3652 1,428.71 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.35 0.423 3.39 715.8654 1,429.72 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AFGPGLQGGSAGSPAR 95.00% 4.62 0.386 3.39 715.8673 1,429.72 1,429.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNMVK 95.00% 3.51 0.513 2.29 717.3594 1,432.70 1,433.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNMVK 95.00% 3.77 0.543 2.66 717.3603 1,432.70 1,433.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNMVK 95.00% 2.84 0.309 0 717.3603 1,432.71 1,433.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNMVK 95.00% 3.25 0.467 1.31 717.3615 1,432.71 1,433.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 3.56 0.517 3.01 717.866 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 3.91 0.582 3.06 717.8661 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 3.98 0.519 4.35 717.8661 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 4.55 0.501 3.74 717.8663 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 3.65 0.474 3.28 717.8664 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 3.77 0.515 3.35 717.8669 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 4 0.531 3.14 717.8669 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 4.27 0.572 4.8 717.8671 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 4.39 0.557 4.41 717.8675 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 4.21 0.577 3.62 717.8678 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 4.17 0.545 3.68 717.8678 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 3.78 0.554 4.47 717.868 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 2.92 0.404 2.74 717.8681 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 2.87 0.382 3.48 717.8682 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 3.74 0.53 3.37 717.8687 1,433.72 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 3 0.515 1.77 717.8708 1,433.73 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 3.19 0.491 2.72 717.8712 1,433.73 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 3.17 0.483 2.49 718.2803 1,434.55 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ANLPQSFQVDTSK 95.00% 3.28 0.414 2.68 718.2826 1,434.55 1,434.72 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% MDcQEcPEGYR 95.00% 3.92 0.555 6 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7714 1,443.53 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% MDcQEcPEGYR 95.00% 3.85 0.548 2.52 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7721 1,443.53 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% MDcQEcPEGYR 95.00% 3.89 0.502 4.06 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7722 1,443.53 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% MDcQEcPEGYR 95.00% 3.8 0.495 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7727 1,443.53 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNmVK 95.00% 3.39 0.453 1.38 m12: Oxidation (+15.99) 725.3571 1,448.70 1,449.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNmVK 95.00% 3.06 0.356 2.39 m12: Oxidation (+15.99) 725.3573 1,448.70 1,449.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNmVK 95.00% 3.59 0.435 2.49 m12: Oxidation (+15.99) 725.3574 1,448.70 1,449.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNmVK 95.00% 3.08 0.411 1.51 m12: Oxidation (+15.99) 725.3576 1,448.70 1,449.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNmVK 95.00% 3.54 0.472 2.06 m12: Oxidation (+15.99) 725.3579 1,448.70 1,449.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNmVK 95.00% 3.41 0.462 2.51 m12: Oxidation (+15.99) 725.3585 1,448.70 1,449.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNmVK 95.00% 3.47 0.436 2.03 m12: Oxidation (+15.99) 725.3585 1,448.70 1,449.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNmVK 95.00% 3.42 0.497 2.55 m12: Oxidation (+15.99) 725.3586 1,448.70 1,449.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNmVK 95.00% 3.59 0.454 1.85 m12: Oxidation (+15.99) 725.3586 1,448.70 1,449.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNmVK 95.00% 3.21 0.451 3 m12: Oxidation (+15.99) 725.3587 1,448.70 1,449.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNmVK 95.00% 2.89 0.289 0 m12: Oxidation (+15.99) 725.36 1,448.70 1,449.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AYGPGIEPTGNmVK 95.00% 3.34 0.409 2.08 m12: Oxidation (+15.99) 725.3605 1,448.71 1,449.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% mDcQEcPEGYR 95.00% 2.69 0.395 1.37 m1: Oxidation (+15.99), c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 730.7692 1,459.52 1,460.52 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% mDcQEcPEGYR 95.00% 3.91 0.536 3.23 m1: Oxidation (+15.99), c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 730.7705 1,459.53 1,460.52 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% mDcQEcPEGYR 95.00% 1.97 0.336 0 m1: Oxidation (+15.99), c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 730.7718 1,459.53 1,460.52 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% mDcQEcPEGYR 95.00% 3.58 0.475 2.8 m1: Oxidation (+15.99), c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 730.7724 1,459.53 1,460.52 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 5.36 0.675 5.3 734.0485 2,199.12 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 5.1 0.544 4.49 734.0511 2,199.13 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 3.63 0.39 1.89 734.3788 2,200.11 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 4.78 0.613 4.7 734.3821 2,200.12 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 4.77 0.526 4.57 734.3832 2,200.13 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 5.59 0.63 4.8 734.3835 2,200.13 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 5.03 0.612 4.74 734.3837 2,200.13 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 5.82 0.627 3.64 734.3841 2,200.13 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 5.47 0.636 4.52 734.3845 2,200.13 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 4.67 0.556 3.55 734.3853 2,200.13 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 3.9 0.526 3.09 734.3857 2,200.13 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 4.94 0.544 4.28 734.3875 2,200.14 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 0 0 3.46 734.7108 2,201.11 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 0 0 3.7 734.7138 2,201.12 2,200.13 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 5.65 0.57 3.33 750.8813 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 5.24 0.562 2.35 750.8822 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 5.69 0.592 3.68 750.8824 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 5.35 0.567 2.89 750.8826 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 4.91 0.516 4.96 750.8832 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 3.32 0.552 1.74 750.8832 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 5.43 0.59 2.64 750.8833 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 5.1 0.548 5.55 750.8834 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 5.24 0.555 3.27 750.8834 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 4.32 0.526 2.82 750.8834 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 5.3 0.546 3.39 750.8835 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 4.31 0.5 5.1 750.8838 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 4.02 0.572 3.68 750.8841 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 5.75 0.592 3.55 750.8841 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 5.48 0.6 6.77 750.8842 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 4.91 0.588 2.72 750.8842 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 4.82 0.55 4.25 750.8847 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 4.86 0.518 2.62 750.8849 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 5.52 0.578 3.24 750.8851 1,499.75 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGGLSLAIEGPSK 95.00% 4.91 0.555 2.41 751.3863 1,500.76 1,500.75 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEMGTHTVSVK 95.00% 3.55 0.531 3.28 751.8885 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEMGTHTVSVK 95.00% 3.32 0.453 7.1 751.8894 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEMGTHTVSVK 95.00% 3.74 0.546 5.28 751.8895 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEMGTHTVSVK 95.00% 3.77 0.553 3.49 751.8897 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEMGTHTVSVK 95.00% 4.32 0.522 4.77 751.8903 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEMGTHTVSVK 95.00% 4.25 0.513 5.62 751.8908 1,501.77 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEMGTHTVSVK 95.00% 3.85 0.51 4.37 751.891 1,501.77 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEMGTHTVSVK 95.00% 2.58 0.471 2.43 751.8913 1,501.77 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEMGTHTVSVK 95.00% 4.2 0.456 4.06 751.8914 1,501.77 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEMGTHTVSVK 95.00% 3.6 0.517 4.35 751.8914 1,501.77 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.11 0.488 5.47 751.8994 1,501.78 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 3.48 0.434 4.09 751.8999 1,501.78 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 3.84 0.489 4.77 751.8999 1,501.78 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.31 0.492 4.96 751.9013 1,501.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.27 0.483 5.17 751.9013 1,501.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 3.9 0.484 4.36 751.9016 1,501.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 3.95 0.512 4.96 751.902 1,501.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.12 0.522 5.64 751.9021 1,501.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.23 0.544 5.82 751.9023 1,501.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.32 0.492 4.57 751.9031 1,501.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 3.95 0.465 3.3 751.9034 1,501.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.65 0.566 5 751.9037 1,501.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.44 0.579 4.35 751.9045 1,501.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.5 0.565 4.14 751.9052 1,501.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.64 0.588 6.89 751.9054 1,501.80 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.98 0.564 4.2 751.9055 1,501.80 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.39 0.57 5.74 751.9079 1,501.80 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.36 0.52 5.42 751.9087 1,501.80 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEMGTHTVSVK 95.00% 3.75 0.501 3.96 752.3925 1,502.77 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 3.84 0.482 5.77 752.4044 1,502.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VNQPASFAVSLNGAK 95.00% 4.65 0.51 5.43 752.4048 1,502.79 1,502.80 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.76 0.407 3.7 758.3845 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.53 0.461 3.89 758.3856 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.65 0.403 3.01 758.3858 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.53 0.456 4.35 758.3859 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.55 0.455 3.14 758.3861 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.46 0.422 4.64 758.3865 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.64 0.398 2.6 758.3866 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.56 0.404 5.72 758.3872 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.48 0.308 3.31 758.3873 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.21 0.38 2.96 758.8863 1,515.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.62 0.374 3.92 758.8874 1,515.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FADQHVPGSPFSVK 95.00% 3.57 0.332 3.85 758.8893 1,515.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VHSPSGALEEcYVTEIDQDK 95.00% 5.31 0.516 1.52 c11: Carbamidomethyl (+57.02) 759.6842 2,276.03 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.52 0.493 3.44 m6: Oxidation (+15.99) 759.8856 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.86 0.566 5.1 m6: Oxidation (+15.99) 759.886 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3 0.495 4.07 m6: Oxidation (+15.99) 759.8867 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.47 0.521 3.44 m6: Oxidation (+15.99) 759.8867 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 2.49 0.21 0 m6: Oxidation (+15.99) 759.887 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 2.27 0.28 0 m6: Oxidation (+15.99) 759.8871 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.21 0.487 4.82 m6: Oxidation (+15.99) 759.8881 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.63 0.548 4.77 m6: Oxidation (+15.99) 759.8882 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.48 0.506 3 m6: Oxidation (+15.99) 759.8882 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.28 0.493 3.11 m6: Oxidation (+15.99) 759.8882 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.95 0.557 6.24 m6: Oxidation (+15.99) 759.8885 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.56 0.559 4.26 m6: Oxidation (+15.99) 759.8889 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.59 0.491 2.41 m6: Oxidation (+15.99) 759.8894 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.54 0.518 3.92 m6: Oxidation (+15.99) 759.8895 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VHSPSGALEEcYVTEIDQDK 95.00% 5.94 0.483 1.89 c11: Carbamidomethyl (+57.02) 760.0189 2,277.03 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VHSPSGALEEcYVTEIDQDK 95.00% 6.04 0.525 1.89 c11: Carbamidomethyl (+57.02) 760.0209 2,277.04 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.42 0.474 2.48 m6: Oxidation (+15.99) 760.3886 1,518.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FVPAEmGTHTVSVK 95.00% 3.59 0.527 6.36 m6: Oxidation (+15.99) 760.3905 1,518.77 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AEAGVPAEFSIWTR 95.00% 4.58 0.322 3 767.3899 1,532.76 1,533.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% AEAGVPAEFSIWTR 95.00% 4.7 0.382 6.46 767.3901 1,532.76 1,533.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.32 0.517 1.23 767.4082 1,532.80 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 3.73 0.505 0 767.4117 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.44 0.531 2.35 767.4126 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.94 0.489 2.96 767.4127 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.49 0.511 1.8 767.4129 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.75 0.534 1.96 767.413 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.33 0.512 1.51 767.4132 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.9 0.542 2.92 767.4137 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.83 0.503 3.22 767.4141 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.85 0.53 2.22 767.4142 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 5.06 0.538 2.6 767.4143 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.76 0.506 2.62 767.4145 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4 0.33 0 767.4145 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.48 0.53 2.92 767.4146 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.32 0.529 2.59 767.4148 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 5.02 0.518 3.17 767.9148 1,533.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFSVAVSPSLDLSK 95.00% 4.46 0.441 1.64 767.916 1,533.82 1,533.82 2 RL4_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.86 0.51 4.27 769.06 2,304.16 2,304.15 3 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.98 0.458 1.1 769.0607 2,304.16 2,304.15 3 FLNC_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGYGGLSLSIEGPSK 95.00% 4.54 0.431 3.68 775.8905 1,549.77 1,550.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGYGGLSLSIEGPSK 95.00% 5.19 0.553 3.96 775.8908 1,549.77 1,550.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGYGGLSLSIEGPSK 95.00% 4.57 0.427 3.01 775.8913 1,549.77 1,550.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGYGGLSLSIEGPSK 95.00% 4.65 0.451 3.68 775.8914 1,549.77 1,550.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGYGGLSLSIEGPSK 95.00% 4.56 0.444 3.48 775.8918 1,549.77 1,550.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGYGGLSLSIEGPSK 95.00% 5.27 0.538 3.96 775.8918 1,549.77 1,550.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGYGGLSLSIEGPSK 95.00% 4.53 0.472 2.77 775.8921 1,549.77 1,550.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGYGGLSLSIEGPSK 95.00% 4.93 0.464 4.89 775.8925 1,549.77 1,550.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGYGGLSLSIEGPSK 95.00% 4.51 0.491 4.31 775.893 1,549.77 1,550.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGYGGLSLSIEGPSK 95.00% 4.69 0.493 4.57 775.893 1,549.77 1,550.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.7 0.578 3.72 785.9092 1,569.80 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 5.05 0.558 3.72 785.9093 1,569.80 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.3 0.636 3.43 785.9095 1,569.80 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.98 0.559 3.01 785.9095 1,569.80 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 5.09 0.607 3.89 785.9096 1,569.80 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.9 0.62 3.92 785.9097 1,569.80 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 5.05 0.58 4.04 785.91 1,569.80 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.86 0.564 3.34 785.9101 1,569.80 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.97 0.599 3.28 785.9102 1,569.80 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.75 0.518 3.82 785.9105 1,569.81 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.81 0.549 3.35 785.911 1,569.81 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.92 0.534 3.03 785.9113 1,569.81 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.23 0.59 3.74 785.912 1,569.81 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.88 0.563 3.24 785.9121 1,569.81 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.7 0.572 4 785.9123 1,569.81 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.69 0.552 3.05 785.9128 1,569.81 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.29 0.561 2.33 785.9148 1,569.81 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 3.88 0.472 4.13 785.9164 1,569.82 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.69 0.599 3.35 786.409 1,570.80 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 5.02 0.576 4.82 786.4126 1,570.81 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GAGTGGLGLAVEGPSEAK 95.00% 4.99 0.572 3.19 786.4132 1,570.81 1,570.81 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YAPSEAGLHEMDIR 95.00% 3.79 0.422 4.1 794.8779 1,587.74 1,588.74 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YAPSEAGLHEMDIR 95.00% 3.49 0.38 2.64 794.8784 1,587.74 1,588.74 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DNGNGTYScSYVPR 95.00% 2.8 0.439 2 c9: Carbamidomethyl (+57.02) 795.3383 1,588.66 1,589.67 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DNGNGTYScSYVPR 95.00% 3.65 0.537 3.05 c9: Carbamidomethyl (+57.02) 795.339 1,588.66 1,589.67 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DNGNGTYScSYVPR 95.00% 3.23 0.473 2.6 c9: Carbamidomethyl (+57.02) 795.3391 1,588.66 1,589.67 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DNGNGTYScSYVPR 95.00% 3.39 0.517 2.8 c9: Carbamidomethyl (+57.02) 795.34 1,588.66 1,589.67 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DNGNGTYScSYVPR 95.00% 3.27 0.532 3.77 c9: Carbamidomethyl (+57.02) 795.3402 1,588.66 1,589.67 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DNGNGTYScSYVPR 95.00% 3.82 0.477 3.41 c9: Carbamidomethyl (+57.02) 795.3406 1,588.67 1,589.67 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DNGNGTYScSYVPR 95.00% 3.27 0.508 2.06 c9: Carbamidomethyl (+57.02) 795.3409 1,588.67 1,589.67 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DNGNGTYScSYVPR 95.00% 3.04 0.538 4.03 c9: Carbamidomethyl (+57.02) 795.3417 1,588.67 1,589.67 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DNGNGTYScSYVPR 95.00% 3.32 0.441 1.89 c9: Carbamidomethyl (+57.02) 795.8396 1,589.66 1,589.67 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DNGNGTYScSYVPR 95.00% 3.4 0.511 3.04 c9: Carbamidomethyl (+57.02) 795.8414 1,589.67 1,589.67 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.7 0.498 5.09 801.8882 1,601.76 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.89 0.534 4.89 801.8885 1,601.76 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 4 0.519 3.51 801.8886 1,601.76 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.64 0.46 5.96 801.889 1,601.76 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.54 0.539 5.14 801.8891 1,601.76 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.93 0.573 4.96 801.8891 1,601.76 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.92 0.571 4.85 801.8891 1,601.76 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.33 0.537 4.04 801.8892 1,601.76 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.26 0.466 5.47 801.8896 1,601.76 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.74 0.565 4.92 801.8903 1,601.76 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.71 0.526 3.48 801.8904 1,601.77 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.54 0.515 6.22 801.8905 1,601.77 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.61 0.516 4.27 801.8908 1,601.77 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.92 0.558 4.57 801.8912 1,601.77 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.89 0.44 3.72 802.3903 1,602.76 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YNEQHVPGSPFTAR 95.00% 3.83 0.464 4 802.3905 1,602.77 1,602.77 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.57 0.449 3.43 814.4033 2,440.19 2,440.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.29 0.449 3.05 814.4037 2,440.19 2,440.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.07 0.432 3 814.4038 2,440.19 2,440.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.27 0.379 3.11 814.4038 2,440.19 2,440.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.21 0.417 2.52 814.4041 2,440.19 2,440.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.49 0.502 4.13 814.4052 2,440.19 2,440.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.66 0.387 2.1 814.4055 2,440.19 2,440.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 0 0 3.33 814.7385 2,441.19 2,440.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.88 0.568 2.37 c11: Carbamidomethyl (+57.02) 817.436 2,449.28 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 5.14 0.548 2.17 c11: Carbamidomethyl (+57.02) 817.4362 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.84 0.605 3.52 c11: Carbamidomethyl (+57.02) 817.4366 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.88 0.499 2.01 c11: Carbamidomethyl (+57.02) 817.4367 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.11 0.517 1.6 c11: Carbamidomethyl (+57.02) 817.4368 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.54 0.525 2.7 c11: Carbamidomethyl (+57.02) 817.4368 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.5 0.542 2.6 c11: Carbamidomethyl (+57.02) 817.4371 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.72 0.491 2.55 c11: Carbamidomethyl (+57.02) 817.4373 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.85 0.524 1.02 c11: Carbamidomethyl (+57.02) 817.4374 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.69 0.486 3.46 c11: Carbamidomethyl (+57.02) 817.4376 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.77 0.392 2.41 c11: Carbamidomethyl (+57.02) 817.4378 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.47 0.517 2.51 c11: Carbamidomethyl (+57.02) 817.4382 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.47 0.521 2.8 c11: Carbamidomethyl (+57.02) 817.4383 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.91 0.46 2.82 c11: Carbamidomethyl (+57.02) 817.4386 2,449.29 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.37 0.559 3.02 c11: Carbamidomethyl (+57.02) 817.4398 2,449.30 2,449.29 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDINTEDLEDGTcR 95.00% 4.22 0.433 4.72 c13: Carbamidomethyl (+57.02) 818.8614 1,635.71 1,636.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDINTEDLEDGTcR 95.00% 4.38 0.531 7.38 c13: Carbamidomethyl (+57.02) 818.8622 1,635.71 1,636.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDINTEDLEDGTcR 95.00% 3.82 0.484 5.85 c13: Carbamidomethyl (+57.02) 818.8635 1,635.71 1,636.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDINTEDLEDGTcR 95.00% 4.6 0.396 4.92 c13: Carbamidomethyl (+57.02) 819.3634 1,636.71 1,636.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VDINTEDLEDGTcR 95.00% 4.27 0.385 4.66 c13: Carbamidomethyl (+57.02) 819.3679 1,636.72 1,636.71 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.66 0.349 3.35 823.4045 2,467.19 2,467.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.72 0.27 3 823.4047 2,467.19 2,467.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.21 0.372 4.64 823.405 2,467.19 2,467.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.35 0.296 3.8 823.4066 2,467.20 2,467.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FNEEHIPDSPFVVPVASPSGDAR 95.00% 0 0 3.52 823.7385 2,468.19 2,467.19 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 4.35 0.415 4.66 823.9431 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 4.45 0.414 4.37 823.9432 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 4.2 0.404 4.32 823.9439 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 4.04 0.419 3.96 823.9441 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 4.12 0.42 3.68 823.9442 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 4.44 0.376 4.19 823.9445 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 4.3 0.431 3.48 823.9447 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 4.54 0.392 4.14 823.945 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 4.18 0.402 3.74 823.9452 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 3.91 0.382 3.77 824.4445 1,646.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVAVNKPAEFTVDAK 95.00% 3.35 0.454 2.25 824.4469 1,646.88 1,646.88 2 MYLK_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 4.95 0.589 4.42 826.9358 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 4.92 0.609 4.19 826.9361 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 4.98 0.597 5.44 826.9361 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 5.08 0.601 4.48 826.9362 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 4.59 0.572 5.57 826.9364 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 5.09 0.61 4.46 826.9365 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 4.8 0.567 4.51 826.9366 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 5.18 0.604 4.59 826.9366 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 5.01 0.598 6.7 826.9366 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 5.32 0.565 5.77 826.9368 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 5.01 0.603 5.96 826.9369 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 5.13 0.613 5.18 826.9369 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 5.03 0.603 4.74 826.9373 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 4.96 0.606 5.15 826.9376 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 5.24 0.589 4.34 826.938 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 4.96 0.564 5.51 826.9381 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 5.21 0.579 4.7 826.9381 1,651.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTAQGPGLEPSGNIANK 95.00% 5.1 0.56 3.74 827.4379 1,652.86 1,652.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FIPRENGVYLIDVK 95.00% 3.54 0.29 1.49 832.469 1,662.92 1,662.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% FIPRENGVYLIDVK 95.00% 3.5 0.328 3.6 832.4695 1,662.92 1,662.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 4.69 0.474 3.33 835.1018 2,502.28 2,502.28 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 4.69 0.562 2.25 835.1019 2,502.28 2,502.28 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 5.02 0.491 3.03 835.1025 2,502.28 2,502.28 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 4.93 0.559 2.6 835.1036 2,502.29 2,502.28 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 4.95 0.558 3.1 835.1037 2,502.29 2,502.28 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 5.13 0.519 1.89 835.1068 2,502.30 2,502.28 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.57 0.506 2.21 849.0931 2,544.26 2,544.26 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 5.05 0.554 1.7 849.0936 2,544.26 2,544.26 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 5 0.573 2.22 849.0941 2,544.26 2,544.26 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 3.91 0.562 2.68 849.0942 2,544.26 2,544.26 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 5.1 0.628 4.85 849.0944 2,544.26 2,544.26 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4 0.468 3 849.9627 1,697.91 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.12 0.528 3.46 849.9633 1,697.91 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.23 0.5 4.54 849.9634 1,697.91 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.92 0.552 4.59 849.9638 1,697.91 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.23 0.523 3.96 849.964 1,697.91 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.34 0.556 3.8 849.9643 1,697.91 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.65 0.5 2.89 849.9643 1,697.91 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.6 0.548 3.42 849.9649 1,697.91 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.74 0.475 4 849.9651 1,697.91 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.22 0.523 4.38 849.9651 1,697.91 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.68 0.487 3.85 849.9655 1,697.92 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.13 0.505 5 849.9658 1,697.92 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 3.73 0.474 2.59 849.966 1,697.92 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.12 0.543 3.62 849.9661 1,697.92 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4 0.522 4.89 849.9663 1,697.92 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.1 0.532 3.44 849.9666 1,697.92 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.15 0.488 4.4 850.4655 1,698.92 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TGVELGKPTHFTVNAK 95.00% 4.04 0.499 3.92 850.4669 1,698.92 1,698.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% KTHIQDNHDGTYTVAYVPDVTGR 95.00% 4.82 0.6 2.92 863.4232 2,587.25 2,587.25 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% KTHIQDNHDGTYTVAYVPDVTGR 95.00% 5.28 0.617 3.11 863.4254 2,587.25 2,587.25 3
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTYTPMAPGSYLISIK 95.00% 3.83 0.513 3 871.4676 1,740.92 1,740.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTYTPMAPGSYLISIK 95.00% 3.69 0.472 2.28 871.4679 1,740.92 1,740.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3.88 0.572 0 875.9436 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3.51 0.557 0 875.945 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3.68 0.59 1.36 875.9452 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3.71 0.52 1.6 875.9461 1,749.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3.9 0.565 0 876.4464 1,750.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 4.08 0.534 0 876.4474 1,750.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% TFSVWYVPEVTGTHK 95.00% 3.79 0.542 0 876.4478 1,750.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 5.18 0.527 4.92 878.9237 1,755.83 1,756.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 5 0.531 6.04 878.9251 1,755.83 1,756.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 5.21 0.527 6.46 878.9254 1,755.84 1,756.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 5.21 0.526 5.92 879.4273 1,756.84 1,756.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 5.12 0.518 5.68 879.4275 1,756.84 1,756.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 5 0.496 7.37 879.4282 1,756.84 1,756.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 5.09 0.504 5.6 879.4287 1,756.84 1,756.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 5.03 0.507 5.17 879.4293 1,756.84 1,756.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPFEVYVDKSQGDASK 95.00% 4.77 0.518 4.64 879.4311 1,756.85 1,756.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 4.72 0.639 7 882.4331 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 4.96 0.666 7.66 882.4333 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.05 0.651 7.39 882.4338 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.18 0.619 7.43 882.4339 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.05 0.638 6.82 882.4339 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.2 0.643 6.96 882.434 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.02 0.647 7.06 882.4341 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.17 0.646 7.18 882.4342 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.1 0.626 6.17 882.4342 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 4.94 0.629 6.43 882.4344 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.36 0.649 7.09 882.4344 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.35 0.626 7.66 882.4345 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.16 0.613 7.41 882.4346 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.32 0.629 7.13 882.4348 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 4.95 0.677 7.57 882.4348 1,762.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.4 0.631 7.42 882.9339 1,763.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.4 0.617 7.13 882.935 1,763.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.21 0.582 5.7 882.935 1,763.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.28 0.606 6.29 882.935 1,763.85 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VANPSGNLTETYVQDR 95.00% 5.38 0.626 6.38 882.9366 1,763.86 1,763.86 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 4.14 0.573 3.48 892.9266 1,783.84 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 3.88 0.557 3.24 892.9273 1,783.84 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 4.37 0.609 4.01 892.9276 1,783.84 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 4.37 0.539 3.77 892.9282 1,783.84 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 3.88 0.574 1.24 892.9284 1,783.84 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 3.74 0.571 3.18 892.9286 1,783.84 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 4.07 0.575 3.05 892.9286 1,783.84 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 4.41 0.578 3.8 892.9292 1,783.84 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 4.3 0.602 3.68 892.9296 1,783.84 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 4.28 0.546 3.08 892.9301 1,783.84 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 3.68 0.55 4.66 892.9305 1,783.85 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 4.59 0.614 2.17 892.9325 1,783.85 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 4.32 0.578 3.42 c9: Carbamidomethyl (+57.02) 892.9444 1,783.87 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.46 0.571 4.26 c9: Carbamidomethyl (+57.02) 892.9466 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.78 0.57 4.15 c9: Carbamidomethyl (+57.02) 892.9474 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.6 0.587 4.96 c9: Carbamidomethyl (+57.02) 892.9475 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.52 0.571 4.48 c9: Carbamidomethyl (+57.02) 892.9476 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.66 0.579 4.64 c9: Carbamidomethyl (+57.02) 892.9477 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.59 0.561 4.7 c9: Carbamidomethyl (+57.02) 892.9478 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.35 0.592 3.42 c9: Carbamidomethyl (+57.02) 892.948 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.71 0.586 4 c9: Carbamidomethyl (+57.02) 892.948 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.66 0.563 5.68 c9: Carbamidomethyl (+57.02) 892.9481 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.66 0.59 4.52 c9: Carbamidomethyl (+57.02) 892.9484 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.67 0.566 5.4 c9: Carbamidomethyl (+57.02) 892.9485 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.7 0.547 3.08 c9: Carbamidomethyl (+57.02) 892.9486 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.65 0.575 4.72 c9: Carbamidomethyl (+57.02) 892.9487 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.68 0.559 4.55 c9: Carbamidomethyl (+57.02) 892.9489 1,783.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 4.41 0.607 3 c9: Carbamidomethyl (+57.02) 892.9533 1,783.89 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 3.97 0.531 2.1 893.4285 1,784.84 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DVDIIDHHDNTYTVK 95.00% 4.6 0.53 0 893.4297 1,784.84 1,784.85 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.87 0.536 3.89 c9: Carbamidomethyl (+57.02) 893.4475 1,784.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.71 0.535 4.42 c9: Carbamidomethyl (+57.02) 893.4494 1,784.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.54 0.553 4.55 c9: Carbamidomethyl (+57.02) 893.4497 1,784.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.46 0.548 4.27 c9: Carbamidomethyl (+57.02) 893.4502 1,784.88 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.89 0.526 3.72 c9: Carbamidomethyl (+57.02) 893.4511 1,784.89 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VQVQDNEGcPVEALVK 95.00% 5.35 0.423 5.04 c9: Carbamidomethyl (+57.02) 893.4546 1,784.89 1,784.89 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 4.42 0.46 5.96 907.9861 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 4.29 0.342 7.06 907.9864 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 4.39 0.452 5.36 907.9865 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 4.38 0.424 6.66 907.9872 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 4.28 0.451 7.35 907.9879 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 4.4 0.352 6.59 908.4854 1,814.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 4.3 0.441 4.36 908.4862 1,814.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 4.18 0.344 6.04 908.4864 1,814.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 4.6 0.395 7.25 908.4875 1,814.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 4.49 0.39 7 908.4885 1,814.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VAQPTITDNKDGTVTVR 95.00% 4.43 0.409 4.77 908.4886 1,814.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 4.01 0.472 3.52 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.427 1,866.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.47 0.537 4.82 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4273 1,866.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.47 0.544 4.92 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4277 1,866.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.14 0.545 4.57 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4281 1,866.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5 0.503 4.01 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4284 1,866.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.17 0.56 5.17 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4284 1,866.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 4.93 0.507 4.8 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4286 1,866.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.09 0.483 5.62 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.429 1,866.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.49 0.548 6.17 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9268 1,867.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.03 0.501 5.37 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9273 1,867.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.19 0.48 6.74 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9275 1,867.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.18 0.511 5.62 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9276 1,867.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 4.79 0.522 4.15 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9283 1,867.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.32 0.535 4.64 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9283 1,867.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.19 0.473 5.82 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9287 1,867.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.5 0.541 6.22 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9292 1,867.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.03 0.491 4.8 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9294 1,867.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.39 0.523 6.02 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9298 1,867.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 4.47 0.52 3.74 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9301 1,867.84 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SPYTVTVGQAcNPSAcR 95.00% 5.16 0.53 5.26 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9305 1,867.85 1,867.84 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTYcPTEPGNYIINIK 95.00% 4.37 0.586 4.48 c4: Carbamidomethyl (+57.02) 941.4749 1,880.93 1,881.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTYcPTEPGNYIINIK 95.00% 4.43 0.572 4.14 c4: Carbamidomethyl (+57.02) 941.4757 1,880.94 1,881.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTYcPTEPGNYIINIK 95.00% 4.38 0.575 3.28 c4: Carbamidomethyl (+57.02) 941.4781 1,880.94 1,881.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTYcPTEPGNYIINIK 95.00% 3.93 0.467 2.74 c4: Carbamidomethyl (+57.02) 941.9774 1,881.94 1,881.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTYcPTEPGNYIINIK 95.00% 4.08 0.509 5.74 c4: Carbamidomethyl (+57.02) 941.9778 1,881.94 1,881.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTYcPTEPGNYIINIK 95.00% 3.97 0.456 3.16 c4: Carbamidomethyl (+57.02) 941.9781 1,881.94 1,881.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTYcPTEPGNYIINIK 95.00% 4.5 0.513 3.96 c4: Carbamidomethyl (+57.02) 941.9785 1,881.94 1,881.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTYcPTEPGNYIINIK 95.00% 4.21 0.475 4 c4: Carbamidomethyl (+57.02) 941.9788 1,881.94 1,881.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTYcPTEPGNYIINIK 95.00% 4.28 0.493 4.6 c4: Carbamidomethyl (+57.02) 941.9796 1,881.94 1,881.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% VTYcPTEPGNYIINIK 95.00% 4.5 0.469 3.48 c4: Carbamidomethyl (+57.02) 941.9799 1,881.94 1,881.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EGPYSISVLYGDEEVPR 95.00% 5.23 0.584 5.3 955.4644 1,908.91 1,909.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EGPYSISVLYGDEEVPR 95.00% 5.07 0.582 5.51 955.4647 1,908.91 1,909.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EGPYSISVLYGDEEVPR 95.00% 4.57 0.543 4.7 955.4656 1,908.92 1,909.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EGPYSISVLYGDEEVPR 95.00% 5.28 0.558 4.66 955.9648 1,909.91 1,909.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EGPYSISVLYGDEEVPR 95.00% 5.1 0.546 4.92 955.9651 1,909.91 1,909.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EGPYSISVLYGDEEVPR 95.00% 5.27 0.54 4.25 955.966 1,909.92 1,909.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EGPYSISVLYGDEEVPR 95.00% 5.02 0.513 4.85 955.966 1,909.92 1,909.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% EGPYSISVLYGDEEVPR 95.00% 4.05 0.572 4.14 955.9671 1,909.92 1,909.92 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 4.51 0.404 5.57 969.5135 1,937.01 1,938.02 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 5.12 0.357 4.74 969.5135 1,937.01 1,938.02 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 5.21 0.386 5.57 969.5138 1,937.01 1,938.02 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 5.01 0.41 6.77 969.514 1,937.01 1,938.02 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 4.99 0.402 6.33 969.5143 1,937.01 1,938.02 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 5.2 0.46 4.57 969.5149 1,937.01 1,938.02 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 5.43 0.378 4.43 969.5152 1,937.01 1,938.02 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 4.9 0.394 4.51 969.5155 1,937.02 1,938.02 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 5.06 0.367 3.38 970.0139 1,938.01 1,938.02 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 5.18 0.41 4.1 970.016 1,938.02 1,938.02 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DAGEGLLAVQITDPEGKPK 95.00% 5.41 0.403 4.82 970.0177 1,938.02 1,938.02 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IPEISIQDMTAQVTSPSGK 95.00% 4.32 0.622 5.8 1,001.51 2,001.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IPEISIQDMTAQVTSPSGK 95.00% 5.94 0.724 8.8 1,001.51 2,001.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% IPEISIQDmTAQVTSPSGK 95.00% 5.19 0.635 7.89 m9: Oxidation (+15.99) 1,010.01 2,018.01 2,018.01 2 ITIH1_HUMAN
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 6.19 0.656 7.41 c15: Carbamidomethyl (+57.02) 1,029.47 2,056.93 2,057.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 5.86 0.621 9.24 c15: Carbamidomethyl (+57.02) 1,029.47 2,056.93 2,057.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 6.72 0.648 12.1 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 6.57 0.681 7.52 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 6.34 0.649 12.7 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 6.45 0.656 13.8 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 6.26 0.649 9.44 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 5.47 0.602 6.28 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 6.51 0.661 9.64 c15: Carbamidomethyl (+57.02) 1,029.98 2,057.94 2,057.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% THEAEIVEGENHTYcIR 95.00% 6.46 0.652 8.35 c15: Carbamidomethyl (+57.02) 1,029.98 2,057.94 2,057.94 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 6.29 0.612 4.48 1,100.57 2,199.13 2,200.13 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 5.97 0.624 7.52 1,101.07 2,200.13 2,200.13 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 6.41 0.642 4.44 1,101.07 2,200.13 2,200.13 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 6.12 0.624 6.27 1,101.07 2,200.13 2,200.13 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% LVSNHSLHETSSVFVDSLTK 95.00% 6.18 0.643 5.16 1,101.07 2,200.13 2,200.13 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DGScGVAYVVQEPGDYEVSVK 95.00% 5.42 0.651 5.57 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DGScGVAYVVQEPGDYEVSVK 95.00% 5.45 0.621 4.92 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DGScGVAYVVQEPGDYEVSVK 95.00% 4.81 0.666 5.62 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.03 2,258.03 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% DGScGVAYVVQEPGDYEVSVK 95.00% 5.2 0.649 6.57 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.03 2,258.03 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 3.49 0.69 5.92 1,143.05 2,284.08 2,286.18 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.35 0.664 5.16 1,144.09 2,286.17 2,286.18 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.33 0.663 6.34 1,144.09 2,286.17 2,286.18 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.66 0.674 5.17 1,144.09 2,286.17 2,286.18 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.59 0.669 6.6 1,144.10 2,286.18 2,286.18 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.52 0.655 4.43 1,144.10 2,286.18 2,286.18 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.22 0.662 5.59 1,144.10 2,286.18 2,286.18 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.44 0.669 6.85 1,144.10 2,286.18 2,286.18 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.43 0.664 5.01 1,144.10 2,286.19 2,286.18 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.47 0.667 5.96 1,144.10 2,286.19 2,286.18 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.42 0.597 5.72 1,157.56 2,313.10 2,313.10 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.26 0.629 8.11 1,157.56 2,313.10 2,313.10 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.44 0.564 6.85 1,157.56 2,313.10 2,313.10 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.37 0.581 5.17 1,157.56 2,313.10 2,313.10 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.32 0.622 6.43 1,157.56 2,313.10 2,313.10 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.06 0.614 7 1,172.12 2,342.22 2,342.22 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.19 0.705 6.92 1,273.14 2,544.26 2,544.26 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.49 0.711 10.3 1,273.14 2,544.26 2,544.26 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.23 0.729 8.21 1,273.14 2,544.26 2,544.26 2
 SAMPLE 4 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 105 1092 43.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.27 0.717 10.7 1,273.14 2,544.26 2,544.26 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 1.88 0.245 1.51 452.2957 1,353.86 1,354.87 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 2.25 0.151 1.96 452.2962 1,353.87 1,354.87 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 2.09 0.219 1.21 452.2967 1,353.87 1,354.87 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 2.07 0.145 1.62 452.2967 1,353.87 1,354.87 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 2.56 0.272 1.51 452.2976 1,353.87 1,354.87 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 1.72 0.343 0 452.6314 1,354.87 1,354.87 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 2.5 0.368 1.34 455.5754 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 2.63 0.405 2.36 455.5759 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 1.75 0.382 0 455.5766 1,363.71 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 1.87 0.457 1.6 455.5767 1,363.71 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 2.08 0.309 0 455.5768 1,363.71 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 1.99 0.259 0 455.5778 1,363.71 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 2.19 0.22 0 455.9085 1,364.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 2.46 0.46 1.57 455.9097 1,364.71 1,364.71 3 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.43 0.507 1.43 460.5647 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 2.7 0.443 1.6 460.5653 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.1 0.483 2.09 460.5654 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 2.54 0.309 0 460.5655 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.31 0.5 2.09 460.5656 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.11 0.423 0 460.566 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.21 0.479 1.72 460.5661 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 2.78 0.494 0 460.5661 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 2.4 0.308 0 460.5663 1,378.68 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 2.64 0.386 1.6 460.5665 1,378.68 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.34 0.433 2.06 460.5667 1,378.68 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 2.53 0.381 2.09 460.5668 1,378.68 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 2.92 0.486 1.54 460.567 1,378.68 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 2.97 0.495 0 460.5675 1,378.68 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.11 0.471 1.85 460.8993 1,379.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.22 0.46 2.09 460.8997 1,379.68 1,379.68 3 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 3.27 0.374 2.29 471.891 1,412.65 1,413.66 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.88 0.377 2.3 471.8914 1,412.65 1,413.66 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.67 0.311 1.54 471.8915 1,412.65 1,413.66 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 3.08 0.421 2.42 471.8916 1,412.65 1,413.66 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.84 0.392 1.39 471.8918 1,412.65 1,413.66 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.63 0.275 0 471.892 1,412.65 1,413.66 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.56 0.249 1.59 471.8921 1,412.65 1,413.66 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.72 0.367 1.22 471.8923 1,412.65 1,413.66 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.53 0.292 0 471.8923 1,412.65 1,413.66 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.47 0.247 1.68 471.8926 1,412.65 1,413.66 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.14 0.231 0 471.8929 1,412.66 1,413.66 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.92 0.315 0 471.8931 1,412.66 1,413.66 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LRNGHVGISFVPK 95.00% 2.9 0.395 0 475.2799 1,422.82 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LRNGHVGISFVPK 95.00% 2.73 0.299 0 475.2818 1,422.82 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LRNGHVGISFVPK 95.00% 3.08 0.318 0 475.6147 1,423.82 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VKETADFKVYTK 95.00% 2.36 0.373 0 476.9326 1,427.77 1,428.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AGNNMLLVGVHGPR 95.00% 3.96 0.434 0 478.9277 1,433.76 1,434.76 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AGNNMLLVGVHGPR 95.00% 3.99 0.497 0 478.9283 1,433.76 1,434.76 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AGNNMLLVGVHGPR 95.00% 4.39 0.452 0 479.2612 1,434.76 1,434.76 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AGNNMLLVGVHGPR 95.00% 3.6 0.364 0 479.2627 1,434.76 1,434.76 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AGNNmLLVGVHGPR 95.00% 3.58 0.602 0 m5: Oxidation (+15.99) 484.2585 1,449.75 1,450.76 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AGNNmLLVGVHGPR 95.00% 3.63 0.581 1.09 m5: Oxidation (+15.99) 484.2589 1,449.75 1,450.76 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AGNNmLLVGVHGPR 95.00% 3.45 0.579 0 m5: Oxidation (+15.99) 484.2592 1,449.75 1,450.76 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AGNNmLLVGVHGPR 95.00% 3.48 0.535 0 m5: Oxidation (+15.99) 484.2595 1,449.75 1,450.76 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LLGWIQNK 95.00% 2.61 0.157 0 486.2877 970.5598 971.568 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LLGWIQNK 95.00% 3.11 0.139 0 486.2881 970.5606 971.568 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LLGWIQNK 95.00% 2.86 0.0953 0 486.2882 970.5607 971.568 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LLGWIQNK 95.00% 2.68 0.182 0 486.2882 970.5608 971.568 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LLGWIQNK 94.80% 2.41 0.154 0 486.2882 970.5608 971.568 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LLGWIQNK 95.00% 2.97 0.174 0 486.2882 970.5608 971.568 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LLGWIQNK 95.00% 2.76 0.113 0 486.2884 970.5611 971.568 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LLGWIQNK 95.00% 2.88 0.19 0 486.2885 970.5614 971.568 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LLGWIQNK 95.00% 2.81 0.17 0 486.2887 970.5617 971.568 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 2.47 0.353 1.31 505.9249 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.34 0.381 3.08 505.9253 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.42 0.382 1.54 505.9256 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.34 0.306 2.35 505.9258 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.39 0.358 3.16 505.9259 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3 0.451 2.44 505.926 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.12 0.32 3 505.926 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.44 0.36 3.46 505.9263 1,514.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.63 0.441 3.28 505.9265 1,514.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 2.7 0.231 2.54 506.2582 1,515.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.18 0.415 3.47 506.2585 1,515.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 2.93 0.371 1.51 506.2595 1,515.75 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 2.86 0.277 2.96 506.2597 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.27 0.341 2.47 506.2598 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AEAGVPAEFSIWTR 95.00% 2.52 0.167 0 511.9285 1,532.76 1,533.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LSPFMADIR 95.00% 2.57 0.238 1.26 525.2768 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LSPFMADIR 95.00% 2.41 0.279 0 525.277 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LSPFMADIR 95.00% 2.47 0.265 0 525.2771 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LSPFMADIR 95.00% 2.47 0.297 0 525.2771 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LSPFMADIR 95.00% 2.38 0.341 1.28 525.2773 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LSPFMADIR 95.00% 2.45 0.248 1.33 525.2774 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LSPFMADIR 95.00% 2.08 0.161 1.18 525.2774 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LSPFMADIR 95.00% 2.35 0.284 0 525.2776 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.63 0.469 1.92 534.9258 1,601.75 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.28 0.33 2.44 534.9279 1,601.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.74 0.401 1.74 534.9279 1,601.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.95 0.456 2.96 534.928 1,601.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.83 0.47 2.41 534.928 1,601.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.88 0.437 2.09 534.9283 1,601.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.84 0.443 2.85 534.9283 1,601.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.62 0.394 2.46 534.9284 1,601.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.19 0.384 1.77 534.9285 1,601.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.58 0.392 2.06 534.9286 1,601.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.69 0.442 2.1 534.9288 1,601.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.97 0.469 2.37 534.9289 1,601.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.25 0.354 1.96 534.929 1,601.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.64 0.359 2.28 535.2601 1,602.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.84 0.404 2.26 535.2623 1,602.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.82 0.408 1.43 535.2625 1,602.76 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.3 0.365 0 535.2628 1,602.77 1,602.77 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 2.91 0.462 0 542.2715 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 2.98 0.469 0 542.272 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 2.83 0.279 0 542.2721 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 3.19 0.487 0 542.2724 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 2.69 0.28 1.2 542.2724 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 3.01 0.468 0 542.2725 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 3.2 0.456 0 542.2725 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 3.03 0.482 0 542.2725 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 3.14 0.495 0 542.2728 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 2.97 0.488 1.96 542.2729 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 3.19 0.497 2.42 542.273 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 3.01 0.474 0 542.273 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 3.14 0.463 0 542.2732 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 3.24 0.448 0 542.2733 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 3 0.491 0 542.2733 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 3.2 0.494 0 542.2735 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 3.22 0.479 0 542.2737 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 2.83 0.463 1.66 542.2744 1,082.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TPcEEILVKHVGSR 95.00% 2.75 0.51 0 c3: Carbamidomethyl (+57.02) 542.6223 1,624.84 1,624.85 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDK 95.00% 2.79 0.483 0 542.7735 1,083.53 1,083.54 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LYSVSYLLK 95.00% 2.16 0.293 0 543.3165 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LYSVSYLLK 95.00% 2.46 0.334 0 543.3167 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LYSVSYLLK 95.00% 1.95 0.314 0 543.3168 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LYSVSYLLK 95.00% 2.33 0.309 0 543.3169 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LYSVSYLLK 95.00% 2.19 0.253 0 543.3169 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LYSVSYLLK 95.00% 2.29 0.286 0 543.317 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LYSVSYLLK 95.00% 2.12 0.296 0 543.3175 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LYSVSYLLK 95.00% 1.99 0.25 0 543.3175 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LYSVSYLLK 95.00% 2.32 0.263 0 543.3175 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LYSVSYLLK 95.00% 2.11 0.279 0 543.3183 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TPcEEILVK 95.00% 2.68 0.267 0 c3: Carbamidomethyl (+57.02) 544.7874 1,087.56 1,088.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TPcEEILVK 95.00% 2.62 0.332 1.51 c3: Carbamidomethyl (+57.02) 544.7874 1,087.56 1,088.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TPcEEILVK 95.00% 2.95 0.318 0 c3: Carbamidomethyl (+57.02) 544.7887 1,087.56 1,088.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TPcEEILVK 95.00% 2.46 0.323 0 c3: Carbamidomethyl (+57.02) 544.7888 1,087.56 1,088.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TPcEEILVK 95.00% 2.69 0.292 0 c3: Carbamidomethyl (+57.02) 544.7888 1,087.56 1,088.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TPcEEILVK 95.00% 2.47 0.334 1.28 c3: Carbamidomethyl (+57.02) 544.7895 1,087.56 1,088.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TPcEEILVK 95.00% 2.75 0.291 0 c3: Carbamidomethyl (+57.02) 544.7897 1,087.56 1,088.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TPcEEILVK 95.00% 2.79 0.285 1.77 c3: Carbamidomethyl (+57.02) 544.7901 1,087.56 1,088.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 3.14 0.571 2.44 549.6303 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 3.72 0.489 2.92 549.6305 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 3.68 0.547 1.47 549.6306 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 3.27 0.513 2.15 549.6307 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 3.06 0.478 1.14 549.6309 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 3.96 0.54 2.72 549.631 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 3.74 0.623 1.11 549.6314 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 3.9 0.599 1.36 549.6317 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 3.88 0.579 2.49 549.6318 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 3.84 0.528 1.96 549.9653 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 3.9 0.559 2.29 549.9659 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 3.74 0.459 3.39 549.9659 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 2.86 0.295 0 549.9666 1,646.88 1,646.88 3 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 2.16 0.282 0 551.961 1,652.86 1,652.86 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 1.7 0.171 1.31 c11: Carbamidomethyl (+57.02) 552.2773 1,653.81 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 2.57 0.278 2.33 c11: Carbamidomethyl (+57.02) 552.2791 1,653.81 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 2.01 0.153 1.22 c11: Carbamidomethyl (+57.02) 552.2797 1,653.82 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 2.57 0.228 1.6 c11: Carbamidomethyl (+57.02) 552.28 1,653.82 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 2.4 0.389 0 c11: Carbamidomethyl (+57.02) 552.2802 1,653.82 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 2.19 0.422 1.46 c11: Carbamidomethyl (+57.02) 552.281 1,653.82 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 2.66 0.446 1.64 c11: Carbamidomethyl (+57.02) 552.2811 1,653.82 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 1.93 0.196 2.2 c11: Carbamidomethyl (+57.02) 552.2812 1,653.82 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 2.13 0.334 2.33 c11: Carbamidomethyl (+57.02) 552.2819 1,653.82 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 2.12 0.282 1.31 c11: Carbamidomethyl (+57.02) 552.6118 1,654.81 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 2.28 0.436 1.3 c11: Carbamidomethyl (+57.02) 552.6148 1,654.82 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 2.92 0.43 3.43 c11: Carbamidomethyl (+57.02) 552.6152 1,654.82 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 1.78 0.318 1.06 c11: Carbamidomethyl (+57.02) 552.6154 1,654.82 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 2.35 0.255 1.37 c11: Carbamidomethyl (+57.02) 552.6155 1,654.82 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% APSVANVGSHcDLSLK 95.00% 2.74 0.441 2.48 c11: Carbamidomethyl (+57.02) 552.6162 1,654.83 1,654.82 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 3.09 0.484 2.6 554.3049 1,106.59 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 3.31 0.488 2.72 554.3056 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 2.63 0.411 3.37 554.3058 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 3 0.476 2.68 554.3061 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 2.95 0.493 3.68 554.3063 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 3.33 0.492 3.8 554.3065 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 3.4 0.449 2.85 554.3067 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 2.76 0.486 3.17 554.3067 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 3.63 0.517 3.32 554.307 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 2.68 0.451 3 554.307 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 3.3 0.49 3.96 554.307 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 3.26 0.481 2.57 554.3073 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 3.54 0.541 2.8 554.3074 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 3.33 0.497 2.96 554.3076 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 3.56 0.539 2.51 554.3076 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LDVQFSGLTK 95.00% 3.45 0.505 3.77 554.3078 1,106.60 1,107.61 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VKMDcQEcPEGYR 95.00% 3.45 0.454 0.959 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9046 1,670.69 1,671.69 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VKMDcQEcPEGYR 95.00% 2.27 0.321 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9047 1,670.69 1,671.69 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VKMDcQEcPEGYR 95.00% 2.76 0.347 2.7 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9053 1,670.69 1,671.69 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VKMDcQEcPEGYR 95.00% 2.78 0.318 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 558.2399 1,671.70 1,671.69 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VKmDcQEcPEGYR 95.00% 3.61 0.282 2.49 m3: Oxidation (+15.99), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 563.2384 1,686.69 1,687.69 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VKmDcQEcPEGYR 94.70% 2.65 0.155 0 m3: Oxidation (+15.99), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 563.239 1,686.69 1,687.69 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VKmDcQEcPEGYR 95.00% 2.96 0.214 0 m3: Oxidation (+15.99), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 563.5709 1,687.69 1,687.69 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.66 0.425 0 566.9772 1,697.91 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.6 0.381 0 566.9781 1,697.91 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.67 0.41 0 566.9786 1,697.91 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.03 0.3 0 566.9788 1,697.91 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.62 0.335 0 566.979 1,697.91 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.79 0.42 0 566.9797 1,697.92 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.53 0.312 0 566.98 1,697.92 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.66 0.388 0 567.3117 1,698.91 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.48 0.347 0 567.3126 1,698.91 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.3 0.428 1.08 567.3127 1,698.91 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.21 0.399 0 567.3128 1,698.91 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.97 0.318 0 567.3128 1,698.91 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.07 0.456 1.38 567.313 1,698.92 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.33 0.423 0 567.3132 1,698.92 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.5 0.393 1 567.3132 1,698.92 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.74 0.353 0 567.3136 1,698.92 1,698.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGSGELKVTVK 95.00% 2.96 0.405 0 573.331 1,144.65 1,145.65 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGSGELKVTVK 95.00% 2.91 0.331 1.24 573.3321 1,144.65 1,145.65 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGSGELKVTVK 95.00% 3.09 0.421 1.6 573.3322 1,144.65 1,145.65 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGSGELKVTVK 95.00% 3.27 0.351 0 573.3327 1,144.65 1,145.65 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ENGVYLIDVK 95.00% 2.63 0.405 0 575.3121 1,148.61 1,149.62 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ENGVYLIDVK 95.00% 1.95 0.263 0 575.3132 1,148.61 1,149.62 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ENGVYLIDVK 95.00% 2.83 0.451 2.04 575.3133 1,148.61 1,149.62 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ENGVYLIDVK 95.00% 2.61 0.371 0 575.3133 1,148.61 1,149.62 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ENGVYLIDVK 95.00% 2.75 0.412 1.66 575.3134 1,148.61 1,149.62 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ENGVYLIDVK 95.00% 2.49 0.345 0 575.3136 1,148.61 1,149.62 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ENGVYLIDVK 95.00% 2.86 0.41 1.4 575.3137 1,148.61 1,149.62 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ENGVYLIDVK 95.00% 2.6 0.418 0 575.3138 1,148.61 1,149.62 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ENGVYLIDVK 95.00% 2.27 0.259 0 575.3139 1,148.61 1,149.62 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ENGVYLIDVK 95.00% 2.67 0.349 1.34 575.3142 1,148.61 1,149.62 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ENGVYLIDVK 95.00% 2.5 0.376 0 575.3145 1,148.61 1,149.62 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ENGVYLIDVK 95.00% 2.47 0.367 1.23 575.8117 1,149.61 1,149.62 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.52 0.326 0 576.3194 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.34 0.353 0 576.3197 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.69 0.307 0 576.3197 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.8 0.405 1.55 576.3204 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.69 0.384 1.21 576.3205 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.83 0.322 1.48 576.3205 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.21 0.321 0 576.3206 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.76 0.355 1.68 576.3206 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.88 0.371 1.27 576.3207 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.72 0.359 1.39 576.321 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.68 0.346 0 576.3211 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.8 0.351 0 576.3212 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DKGEYTLVVK 95.00% 2.36 0.321 0 576.3214 1,150.63 1,151.63 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% NGHVGISFVPK 95.00% 2.27 0.343 0 577.8206 1,153.63 1,154.63 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% NGHVGISFVPK 95.00% 2.5 0.346 0 577.8211 1,153.63 1,154.63 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% NGHVGISFVPK 95.00% 2.73 0.417 0 577.8213 1,153.63 1,154.63 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% NGHVGISFVPK 95.00% 2.37 0.366 0 577.8214 1,153.63 1,154.63 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% NGHVGISFVPK 95.00% 2.1 0.184 1.82 577.8216 1,153.63 1,154.63 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcK 95.00% 2.53 0.376 3.51 c11: Carbamidomethyl (+57.02) 578.3144 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcK 95.00% 2.58 0.438 3.85 c11: Carbamidomethyl (+57.02) 578.3147 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcK 95.00% 2.96 0.441 3.85 c11: Carbamidomethyl (+57.02) 578.3149 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcK 95.00% 2.23 0.373 1.36 c11: Carbamidomethyl (+57.02) 578.315 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcK 95.00% 2.5 0.408 2.57 c11: Carbamidomethyl (+57.02) 578.3155 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcK 95.00% 2.6 0.436 2.92 c11: Carbamidomethyl (+57.02) 578.3156 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcK 95.00% 2.12 0.206 1.24 c11: Carbamidomethyl (+57.02) 578.3158 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcK 95.00% 2.3 0.391 2.32 c11: Carbamidomethyl (+57.02) 578.3158 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcK 95.00% 2.58 0.446 3.34 c11: Carbamidomethyl (+57.02) 578.3159 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcK 95.00% 2.68 0.367 3.11 c11: Carbamidomethyl (+57.02) 578.3161 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcK 95.00% 2.21 0.38 1.68 c11: Carbamidomethyl (+57.02) 578.3169 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 2.84 0.544 1.54 584.2996 1,749.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 2.86 0.418 1.37 584.2997 1,749.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.23 0.478 0 584.3002 1,749.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3 0.445 1.96 584.3007 1,749.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 2.86 0.448 2.05 584.3008 1,749.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 2.98 0.436 0 584.6332 1,750.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.54 0.557 2 584.6338 1,750.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.17 0.556 1.54 584.6345 1,750.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.6 0.543 2 584.6345 1,750.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 2.77 0.491 1.66 584.6347 1,750.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 3.35 0.348 2.59 586.2844 1,755.83 1,756.84 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 2.9 0.206 1.26 586.2867 1,755.84 1,756.84 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 3.22 0.399 3.47 586.6192 1,756.83 1,756.84 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 2.46 0.204 0 586.6196 1,756.84 1,756.84 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DLAEDAPWKK 95.00% 2.38 0.242 0 586.8024 1,171.59 1,172.60 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DLAEDAPWKK 95.00% 2.28 0.226 0 586.8026 1,171.59 1,172.60 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DLAEDAPWKK 95.00% 2.27 0.184 1.57 586.803 1,171.59 1,172.60 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 3.24 0.371 0 595.6221 1,783.84 1,784.85 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 2.71 0.288 0 595.9542 1,784.84 1,784.85 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 2.62 0.257 0 595.9553 1,784.84 1,784.85 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 2.55 0.235 0 595.9559 1,784.84 1,784.85 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 2.29 0.256 0 595.956 1,784.84 1,784.85 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 2.78 0.272 0 595.9564 1,784.85 1,784.85 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 2.49 0.308 0 c9: Carbamidomethyl (+57.02) 595.9703 1,784.89 1,784.89 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ATcAPQHGAPGPGPADASK 95.00% 2.23 0.207 2.51 c3: Carbamidomethyl (+57.02) 597.2864 1,788.84 1,789.83 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ATcAPQHGAPGPGPADASK 95.00% 2.88 0.385 2.74 c3: Carbamidomethyl (+57.02) 597.6193 1,789.83 1,789.83 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 3.88 0.54 2.92 c12: Carbamidomethyl (+57.02) 604.3137 1,809.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 4.85 0.557 4.85 c12: Carbamidomethyl (+57.02) 604.3139 1,809.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 3.79 0.446 2.89 c12: Carbamidomethyl (+57.02) 604.3139 1,809.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 4.44 0.507 3.62 c12: Carbamidomethyl (+57.02) 604.3144 1,809.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 4.32 0.519 3.39 c12: Carbamidomethyl (+57.02) 604.3146 1,809.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 4.43 0.429 3.6 c12: Carbamidomethyl (+57.02) 604.3148 1,809.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 5.01 0.475 3.82 c12: Carbamidomethyl (+57.02) 604.3148 1,809.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 4.14 0.532 5.09 c12: Carbamidomethyl (+57.02) 604.3149 1,809.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 4.2 0.552 4.33 c12: Carbamidomethyl (+57.02) 604.3151 1,809.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 4.51 0.541 3.27 c12: Carbamidomethyl (+57.02) 604.3151 1,809.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 3.96 0.422 4.19 c12: Carbamidomethyl (+57.02) 604.3152 1,809.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 4.24 0.512 4.8 c12: Carbamidomethyl (+57.02) 604.3153 1,809.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RAPSVANVGSHcDLSLK 95.00% 4.11 0.538 4.62 c12: Carbamidomethyl (+57.02) 604.6467 1,810.92 1,810.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 2.53 0.409 1.77 605.6603 1,813.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 1.96 0.361 2.05 605.6604 1,813.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 1.81 0.176 1.37 605.6604 1,813.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 1.98 0.521 1.49 605.6604 1,813.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 2.23 0.373 2.34 605.6606 1,813.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 3.03 0.351 0 605.9939 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 2.45 0.405 2.05 605.9947 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 2.17 0.443 0 605.9949 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 2.08 0.394 2.52 605.9954 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GLGLSKAYVGQK 95.00% 2.16 0.323 0 611.3545 1,220.69 1,220.70 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.49 0.469 3.46 613.2892 1,224.56 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.43 0.458 1.85 613.2893 1,224.56 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.43 0.444 2.54 613.2897 1,224.56 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.58 0.425 2.33 613.2898 1,224.56 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.57 0.511 2.92 613.2901 1,224.56 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.62 0.401 2.92 613.2901 1,224.56 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.47 0.423 3.22 613.2902 1,224.56 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.48 0.457 2.18 613.2903 1,224.57 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.39 0.451 2.35 613.2904 1,224.57 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.64 0.435 2.25 613.2906 1,224.57 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.56 0.387 2.77 613.2906 1,224.57 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.66 0.4 2.06 613.2906 1,224.57 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.4 0.448 3.27 613.2907 1,224.57 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.38 0.369 0 613.2907 1,224.57 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.56 0.357 2.06 613.2907 1,224.57 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.48 0.362 1.77 613.2911 1,224.57 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.42 0.431 1.96 613.2913 1,224.57 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EATTEFSVDAR 95.00% 3.4 0.435 2.51 613.2914 1,224.57 1,225.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.47 0.558 3.35 613.8308 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.55 0.529 4.34 613.8312 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.67 0.559 5.89 613.8314 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.16 0.511 3.66 613.8318 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.83 0.581 4.66 613.8318 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.57 0.56 4.36 613.8319 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 4.02 0.6 3.54 613.8319 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.04 0.406 4.1 613.8319 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.73 0.555 3.72 613.8319 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.26 0.52 3.66 613.832 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.55 0.548 4.96 613.832 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 4.03 0.543 3.59 613.8321 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.8 0.568 4.17 613.8322 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.68 0.55 4.11 613.8323 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.88 0.563 6.24 613.8323 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.39 0.444 3.77 613.8323 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.55 0.549 3 613.8324 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AWGPGLEGGVVGK 95.00% 3.79 0.556 3.6 613.8326 1,225.65 1,226.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.57 0.526 1.37 613.8905 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.44 0.525 2.52 613.8907 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.43 0.525 1.92 613.891 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.44 0.542 2.62 613.8911 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.87 0.499 1.82 613.8911 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.27 0.535 2.24 613.8912 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.35 0.514 2.72 613.8912 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.49 0.524 1.66 613.8913 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.56 0.521 2.41 613.8913 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.16 0.511 2.54 613.8914 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.72 0.512 2.02 613.8916 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.34 0.517 1.96 613.8916 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.6 0.49 2.03 613.8916 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.52 0.53 2.25 613.8918 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.39 0.539 2.42 613.8919 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.45 0.507 2.34 613.892 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.44 0.505 2.02 613.8921 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.23 0.506 3.54 613.8923 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 2.98 0.487 1.7 613.8929 1,225.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQK 95.00% 3.71 0.554 2.6 614.3918 1,226.77 1,226.77 2 FLNC_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AHVVPcFDASK 95.00% 2.2 0.375 4.32 c6: Carbamidomethyl (+57.02) 615.8024 1,229.59 1,230.59 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AHVVPcFDASK 95.00% 2.44 0.422 5.16 c6: Carbamidomethyl (+57.02) 615.8028 1,229.59 1,230.59 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% cSGPGLSPGmVR 95.00% 2.58 0.437 0 c1: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 617.2915 1,232.57 1,233.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% cSGPGLSPGmVR 95.00% 2.55 0.22 0 c1: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 617.2917 1,232.57 1,233.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% cSGPGLSPGmVR 95.00% 2.54 0.451 0 c1: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 617.2918 1,232.57 1,233.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% cSGPGLSPGmVR 95.00% 2.65 0.35 0 c1: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 617.2919 1,232.57 1,233.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% cSGPGLSPGmVR 95.00% 2.47 0.301 0 c1: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 617.7935 1,233.57 1,233.57 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 2.93 0.307 0 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.2877 1,866.84 1,867.84 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 4.31 0.576 5.25 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.2889 1,866.84 1,867.84 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 2.12 0.152 1.07 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.2905 1,866.85 1,867.84 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LTVSSLQESGLK 95.00% 3.2 0.455 2.35 631.3562 1,260.70 1,261.70 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 2.68 0.345 0 637.3125 1,908.91 1,909.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 2.62 0.332 0 637.647 1,909.92 1,909.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 2.43 0.276 0 637.6478 1,909.92 1,909.92 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTVLFAGQHIAK 95.00% 2.27 0.273 0 642.3767 1,282.74 1,283.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTVLFAGQHIAK 95.00% 2.76 0.297 1.77 642.3805 1,282.75 1,283.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 2.49 0.383 1.6 643.3678 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 2.81 0.353 1.6 643.3679 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 3.35 0.405 2.19 643.3683 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 2.77 0.41 1.85 643.3683 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 2.89 0.378 1.74 643.3684 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 3.05 0.33 1.46 643.3684 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 3.02 0.41 0 643.3686 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 2.95 0.334 2.21 643.3686 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 3.1 0.333 3.49 643.3686 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 3.14 0.368 1.4 643.3688 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 2.85 0.319 2.1 643.3689 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 2.92 0.347 3.11 643.3689 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 2.88 0.291 2 643.369 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 3.1 0.389 2.47 643.369 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 2.7 0.307 1.8 643.369 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 3.03 0.371 1.39 643.3698 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 2.2 0.307 1.39 643.3698 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 2.98 0.339 2.2 643.3701 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LPQLPITNFSR 95.00% 2.76 0.286 2.6 643.3705 1,284.73 1,285.73 2 FIL1L_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 3.66 0.49 2.62 645.8278 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 3.72 0.476 3.18 645.8284 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 3.76 0.463 1.82 645.8285 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 3.8 0.424 2.17 645.8286 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 3.53 0.47 1.7 645.8289 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 3.74 0.5 3.2 645.8294 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 3.48 0.442 2.15 645.8296 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 4.09 0.447 2.64 645.8296 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 3.86 0.542 3.04 645.8298 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 4.21 0.468 2.92 645.8299 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 3.48 0.508 2.68 645.8302 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 3.9 0.561 3.28 645.8303 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGQPVPNFPSK 95.00% 4.31 0.496 3.92 645.8304 1,289.65 1,290.65 2 CO5A2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 2.97 0.354 1.77 646.68 1,937.02 1,938.02 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GKLDVQFSGLTK 95.00% 1.97 0.309 0 646.863 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GKLDVQFSGLTK 95.00% 2.26 0.336 1.49 646.8647 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GKLDVQFSGLTK 95.00% 2.42 0.375 1.38 646.8657 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GKLDVQFSGLTK 95.00% 3.22 0.403 1.92 646.8658 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GKLDVQFSGLTK 95.00% 3.42 0.344 3.03 646.8659 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GKLDVQFSGLTK 95.00% 2.18 0.335 0 646.8662 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GKLDVQFSGLTK 95.00% 3.16 0.425 2.17 646.8662 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GKLDVQFSGLTK 95.00% 3.3 0.417 2.66 646.8664 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GKLDVQFSGLTK 95.00% 3.16 0.425 2.92 646.8667 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GKLDVQFSGLTK 95.00% 2.85 0.484 2.37 646.8668 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 3.08 0.451 2.68 647.0136 1,938.02 1,938.02 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 3.2 0.496 4.66 647.0139 1,938.02 1,938.02 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 3.44 0.41 1.96 647.0142 1,938.02 1,938.02 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 3.46 0.402 2.89 647.0144 1,938.02 1,938.02 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 3.25 0.452 3.1 647.0144 1,938.02 1,938.02 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNGTHIPGSPFK 95.00% 2.57 0.31 0 651.3351 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNGTHIPGSPFK 95.00% 3.19 0.362 1.62 651.3368 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNGTHIPGSPFK 95.00% 3.02 0.204 0 651.3376 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNGTHIPGSPFK 95.00% 3.3 0.338 1.82 651.3376 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNGTHIPGSPFK 95.00% 2.91 0.254 1.35 651.3379 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNGTHIPGSPFK 95.00% 2.88 0.268 0 651.338 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNGTHIPGSPFK 95.00% 2.77 0.335 0 651.3383 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNGTHIPGSPFK 95.00% 2.67 0.319 0 651.3386 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNGTHIPGSPFK 95.00% 2.42 0.29 0 651.3391 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNGTHIPGSPFK 95.00% 2.74 0.258 0 651.3393 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNGTHIPGSPFK 95.00% 2.23 0.208 2.85 651.3414 1,300.67 1,301.66 2 DYHC1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.33 0.456 2.34 656.8478 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.45 0.432 1.96 656.8479 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.78 0.477 4.54 656.8482 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.9 0.521 4.09 656.8484 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.69 0.402 3.1 656.8485 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.54 0.456 3.82 656.8485 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.33 0.436 3.05 656.8485 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.45 0.425 2.72 656.8487 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.19 0.423 3.96 656.8487 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.46 0.491 3.46 656.8488 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.66 0.488 3.66 656.849 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 3.09 0.561 5 656.8491 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.17 0.375 1.24 656.8495 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.32 0.343 2.1 656.8496 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VEPGLGADNSVVR 95.00% 2.48 0.408 1.48 656.8501 1,311.68 1,312.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IPEISIQDMTAQVTSPSGK 95.00% 4.22 0.395 2.05 668.348 2,002.02 2,002.02 3 ITIH1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% cAPGVVGPAEADIDFDIIR 95.00% 3.88 0.428 0 c1: Carbamidomethyl (+57.02) 672.6698 2,014.99 2,014.99 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 2.88 0.496 3.06 677.9379 1,353.86 1,354.87 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 2.92 0.468 0 677.938 1,353.86 1,354.87 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 3.1 0.409 1.49 677.9389 1,353.86 1,354.87 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 2.31 0.262 1.77 677.9391 1,353.86 1,354.87 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 2.83 0.343 0 677.9394 1,353.86 1,354.87 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 3.64 0.554 2.6 677.9395 1,353.86 1,354.87 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 3.07 0.375 2.04 677.9397 1,353.86 1,354.87 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 3.53 0.533 3.42 677.9402 1,353.86 1,354.87 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LIALLEVLSQKK 95.00% 2.64 0.385 1.28 677.9403 1,353.87 1,354.87 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VSGLGEKVDVGKDQEFTVK 95.00% 3.53 0.469 2.54 679.0303 2,034.07 2,035.07 3 VINEX_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VSGLGEKVDVGKDQEFTVK 95.00% 2.55 0.328 0 679.347 2,035.02 2,035.07 3 VINEX_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VSGLGEKVDVGKDQEFTVK 95.00% 2.79 0.41 0 679.3489 2,035.02 2,035.07 3 VINEX_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VSGLGEKVDVGKDQEFTVK 95.00% 2.03 0.254 0 679.351 2,035.03 2,035.07 3 VINEX_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 3.65 0.36 2 682.8562 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 3.81 0.472 0 682.8575 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 3.85 0.486 0 682.8575 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 4.05 0.478 1.96 682.8581 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 3.34 0.428 3.37 682.8582 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDVGKDQEFTVK 95.00% 3.39 0.508 3.16 682.859 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 4.47 0.554 4.33 c15: Carbamidomethyl (+57.02) 686.6512 2,056.93 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 4.03 0.435 3.82 c15: Carbamidomethyl (+57.02) 686.6519 2,056.93 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 4.29 0.46 4.77 c15: Carbamidomethyl (+57.02) 686.652 2,056.93 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 3.96 0.486 3.57 c15: Carbamidomethyl (+57.02) 686.652 2,056.93 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 4.77 0.535 3.6 c15: Carbamidomethyl (+57.02) 686.652 2,056.93 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 4.3 0.461 3.66 c15: Carbamidomethyl (+57.02) 686.6523 2,056.93 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 4.07 0.423 2.03 c15: Carbamidomethyl (+57.02) 686.9849 2,057.93 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 4.13 0.445 3.48 c15: Carbamidomethyl (+57.02) 686.9855 2,057.93 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 3.91 0.414 3.07 c15: Carbamidomethyl (+57.02) 686.986 2,057.93 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 4.2 0.46 4.03 c15: Carbamidomethyl (+57.02) 686.986 2,057.93 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 4.51 0.486 3.32 c15: Carbamidomethyl (+57.02) 686.986 2,057.93 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 4.15 0.407 2.49 c15: Carbamidomethyl (+57.02) 686.9861 2,057.94 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 4.1 0.447 2.82 c15: Carbamidomethyl (+57.02) 686.9865 2,057.94 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 4.25 0.479 2.19 c15: Carbamidomethyl (+57.02) 686.9877 2,057.94 2,057.94 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.79 0.46 4 690.3413 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 4.56 0.572 3.28 690.3418 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.24 0.473 2.92 690.3421 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.83 0.449 5.52 690.3421 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.56 0.436 4.89 690.3423 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.45 0.436 4.36 690.3423 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.77 0.505 5.89 690.3426 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.36 0.481 3.49 690.343 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.39 0.488 4 690.343 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 4.31 0.558 4.32 690.343 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 4.62 0.574 4.3 690.3432 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.81 0.428 4.82 690.3437 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.62 0.496 4.38 690.844 1,379.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGPYHIGGSPFK 95.00% 3.72 0.434 2.4 690.8444 1,379.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.26 0.165 2.72 700.8286 1,399.64 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.17 0.159 4.82 700.8294 1,399.64 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.05 0.206 2.19 700.8297 1,399.64 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.29 0.209 2.55 700.8299 1,399.64 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.71 0.181 4.21 700.83 1,399.64 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.93 0.145 4.89 700.8302 1,399.64 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.85 0.138 5.16 700.8302 1,399.64 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 2.78 0.215 2.09 700.8303 1,399.64 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.48 0.151 4.72 700.8304 1,399.65 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.17 0.182 3.96 700.8304 1,399.65 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 2.42 0.239 3.36 700.8304 1,399.65 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.71 0.197 3.92 700.8304 1,399.65 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.07 0.208 3.8 700.8306 1,399.65 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.34 0.174 2.25 700.8314 1,399.65 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 2.76 0.156 1.85 700.8322 1,399.65 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.2 0.214 1.89 700.833 1,399.65 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 2.84 0.0989 1.8 700.8344 1,399.65 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 2.37 0.215 2.27 700.8438 1,399.67 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YGGDEIPFSPYR 95.00% 3.88 0.176 4.26 701.3316 1,400.65 1,400.65 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.87 0.351 2.89 707.3322 1,412.65 1,413.66 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.93 0.406 2.52 707.3322 1,412.65 1,413.66 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 3.13 0.402 2.7 707.3322 1,412.65 1,413.66 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.01 0.308 3.07 707.3329 1,412.65 1,413.66 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 3.28 0.442 2.21 707.333 1,412.65 1,413.66 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.89 0.357 4.09 707.3338 1,412.65 1,413.66 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% WGDEHIPGSPYR 95.00% 2.98 0.339 3.64 707.3351 1,412.65 1,413.66 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.88 0.462 4.7 708.3788 1,414.74 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 2.74 0.403 2.2 708.3789 1,414.74 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.56 0.436 4.39 708.379 1,414.74 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.65 0.384 3.02 708.379 1,414.74 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.77 0.422 4.29 708.3791 1,414.74 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 4.11 0.438 3.57 708.3792 1,414.74 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.87 0.451 4.04 708.3792 1,414.74 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.73 0.441 4.31 708.3799 1,414.74 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 4.16 0.423 2.64 708.38 1,414.74 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.71 0.458 4.11 708.38 1,414.74 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.89 0.413 3.24 708.3801 1,414.74 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.97 0.451 4.66 708.3802 1,414.74 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.89 0.487 2.74 708.3804 1,414.75 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 4.15 0.444 3.46 708.3806 1,414.75 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 4.07 0.441 3.59 708.3808 1,414.75 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.34 0.28 3.25 708.3808 1,414.75 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 4 0.449 4.38 708.3809 1,414.75 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.32 0.306 5.8 708.381 1,414.75 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IANLQTDLSDGLR 95.00% 3.9 0.419 2.77 708.3813 1,414.75 1,415.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% RLTVSSLQESGLK 95.00% 3.71 0.296 4.05 709.9066 1,417.80 1,417.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 2.91 0.516 3.09 713.8808 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 3.73 0.566 4.44 713.8811 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 3.03 0.486 1.35 713.8821 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 4.42 0.595 4.27 713.8823 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 4.94 0.595 5.55 713.8825 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 4.73 0.589 4.92 713.8827 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 4.59 0.562 5.85 713.8828 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 3.48 0.581 4.28 713.8831 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 3.63 0.567 3.96 713.8832 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 4.16 0.583 6.03 713.8833 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 4.6 0.608 4.28 713.8837 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 4.01 0.594 4.96 713.8837 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 5.02 0.598 6.19 713.8838 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 3.26 0.44 4.96 713.8841 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 4.78 0.577 5.11 713.8844 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 3.27 0.546 5.07 713.8851 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 4.65 0.582 5.6 713.8853 1,425.75 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSK 95.00% 3.57 0.557 4 713.8856 1,425.76 1,426.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 3.94 0.454 3.64 715.3638 1,428.71 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.19 0.4 5.24 715.3642 1,428.71 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.05 0.379 3.7 715.3643 1,428.71 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 3.72 0.438 4.72 715.3644 1,428.71 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.29 0.404 5.74 715.3644 1,428.71 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.08 0.435 3.43 715.3646 1,428.71 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 3.98 0.424 3.82 715.365 1,428.71 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 3.96 0.454 5.46 715.365 1,428.71 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.08 0.451 3.44 715.3651 1,428.71 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.08 0.47 3.41 715.3653 1,428.71 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.58 0.398 4.03 715.3653 1,428.72 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 3.91 0.43 5.38 715.3653 1,428.72 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.11 0.404 5.13 715.3654 1,428.72 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.19 0.449 5.59 715.3654 1,428.72 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.65 0.415 4.52 715.3662 1,428.72 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.36 0.398 4.29 715.3662 1,428.72 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.42 0.42 5.72 715.367 1,428.72 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 4.32 0.421 5.51 715.3672 1,428.72 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AFGPGLQGGSAGSPAR 95.00% 3.83 0.496 3.96 715.3673 1,428.72 1,429.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNMVK 95.00% 3.23 0.369 0 717.3606 1,432.71 1,433.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 3.82 0.449 2.92 717.8651 1,433.71 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 2.78 0.387 2.43 717.8659 1,433.72 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 4.52 0.584 4.03 717.8661 1,433.72 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 4.18 0.588 3.51 717.8664 1,433.72 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 4.43 0.535 4.77 717.8665 1,433.72 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 3.04 0.463 3.74 717.8665 1,433.72 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 2.92 0.375 1.72 717.8667 1,433.72 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 4.21 0.571 3.82 717.8674 1,433.72 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 3.28 0.485 3.22 717.8675 1,433.72 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 3.58 0.481 3.49 717.8682 1,433.72 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 4.09 0.561 5.03 717.8683 1,433.72 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 3.02 0.43 3.47 717.8713 1,433.73 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 3.47 0.497 2.96 718.282 1,434.55 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 1.77 0.347 2.05 718.2823 1,434.55 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ANLPQSFQVDTSK 95.00% 3.29 0.481 4.6 718.2844 1,434.55 1,434.72 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% MDcQEcPEGYR 95.00% 3.28 0.473 3.14 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.3415 1,442.67 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% MDcQEcPEGYR 95.00% 3.91 0.553 2.96 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7716 1,443.53 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% MDcQEcPEGYR 95.00% 3.39 0.502 2.03 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7724 1,443.53 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% MDcQEcPEGYR 95.00% 3.94 0.488 3.72 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7731 1,443.53 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% MDcQEcPEGYR 95.00% 3.82 0.568 4.11 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7732 1,443.53 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNmVK 95.00% 3.48 0.509 2.05 m12: Oxidation (+15.99) 725.3565 1,448.70 1,449.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNmVK 95.00% 3.21 0.44 1.57 m12: Oxidation (+15.99) 725.3575 1,448.70 1,449.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNmVK 95.00% 3.58 0.535 3.32 m12: Oxidation (+15.99) 725.3579 1,448.70 1,449.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNmVK 95.00% 3.22 0.346 0 m12: Oxidation (+15.99) 725.3587 1,448.70 1,449.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNmVK 95.00% 3.22 0.371 3.59 m12: Oxidation (+15.99) 725.3589 1,448.70 1,449.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNmVK 95.00% 3.38 0.463 2.72 m12: Oxidation (+15.99) 725.3591 1,448.70 1,449.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNmVK 95.00% 2.99 0.384 1.92 m12: Oxidation (+15.99) 725.3595 1,448.70 1,449.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNmVK 95.00% 3.09 0.409 1.39 m12: Oxidation (+15.99) 725.3596 1,448.70 1,449.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNmVK 95.00% 2.45 0.36 0 m12: Oxidation (+15.99) 725.3597 1,448.70 1,449.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNmVK 95.00% 3.15 0.397 3.49 m12: Oxidation (+15.99) 725.3598 1,448.70 1,449.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNmVK 95.00% 2.73 0.285 0 m12: Oxidation (+15.99) 725.3604 1,448.71 1,449.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AYGPGIEPTGNmVK 95.00% 2.88 0.296 1.89 m12: Oxidation (+15.99) 725.3605 1,448.71 1,449.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% ATcAPQHGAPGPGPADASKVVAK 95.00% 5.02 0.535 1.96 c3: Carbamidomethyl (+57.02) 730.0437 2,187.11 2,187.10 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% mDcQEcPEGYR 95.00% 3.62 0.504 2.48 m1: Oxidation (+15.99), c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 730.7705 1,459.53 1,460.52 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% mDcQEcPEGYR 95.00% 3.53 0.392 2.44 m1: Oxidation (+15.99), c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 730.7714 1,459.53 1,460.52 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LVSNHSLHETSSVFVDSLTK 95.00% 5.39 0.598 4.55 734.3826 2,200.12 2,200.13 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LVSNHSLHETSSVFVDSLTK 95.00% 5.14 0.635 3.3 734.3826 2,200.12 2,200.13 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LVSNHSLHETSSVFVDSLTK 95.00% 5.14 0.565 3.68 734.3842 2,200.13 2,200.13 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LVSNHSLHETSSVFVDSLTK 95.00% 5.03 0.482 4 734.3842 2,200.13 2,200.13 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LVSNHSLHETSSVFVDSLTK 95.00% 5.57 0.634 3.92 734.3842 2,200.13 2,200.13 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LVSNHSLHETSSVFVDSLTK 95.00% 4.74 0.583 4.24 734.3849 2,200.13 2,200.13 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LVSNHSLHETSSVFVDSLTK 95.00% 4.73 0.558 4.05 734.3852 2,200.13 2,200.13 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LVSNHSLHETSSVFVDSLTK 95.00% 0 0 3.33 734.7119 2,201.11 2,200.13 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LVSNHSLHETSSVFVDSLTK 95.00% 0 0 4.02 734.7131 2,201.12 2,200.13 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 5.12 0.566 3.35 750.8829 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 4.08 0.503 3.68 750.8831 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 4.76 0.561 4.36 750.8831 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 5.45 0.576 3.89 750.8832 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 5.62 0.592 4.05 750.8833 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 5.12 0.567 3.55 750.8833 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 4.39 0.522 3.57 750.8835 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 4.77 0.54 4.21 750.8835 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 3.49 0.372 2.62 750.8835 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 3 0.417 3.07 750.8838 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 5.15 0.571 3.4 750.8838 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 3.58 0.386 2.17 750.8839 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 5.64 0.582 4.44 750.8839 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 5.31 0.581 4.19 750.884 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 5.04 0.558 3.55 750.884 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 4.41 0.548 4.09 750.8841 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 4.83 0.612 3.46 750.8843 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 5.27 0.548 4.74 750.885 1,499.75 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 4.13 0.526 3.06 750.8855 1,499.76 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGGLSLAIEGPSK 95.00% 4.71 0.529 3.24 750.8856 1,499.76 1,500.75 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEMGTHTVSVK 95.00% 4.31 0.504 5.8 751.8875 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEMGTHTVSVK 95.00% 3.63 0.549 6.77 751.8886 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEMGTHTVSVK 95.00% 3.29 0.425 3.11 751.89 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEMGTHTVSVK 95.00% 3.8 0.475 4.89 751.8901 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEMGTHTVSVK 95.00% 2.34 0.486 3.44 751.8902 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEMGTHTVSVK 95.00% 3.85 0.521 5.42 751.8908 1,501.77 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEMGTHTVSVK 95.00% 3.87 0.497 3.8 751.8914 1,501.77 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEMGTHTVSVK 95.00% 3.92 0.539 6.66 751.8918 1,501.77 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEMGTHTVSVK 95.00% 2.69 0.352 0 751.8938 1,501.77 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.42 0.523 6.74 751.9001 1,501.78 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.23 0.533 5.7 751.9016 1,501.79 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.21 0.525 5.77 751.9022 1,501.79 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.06 0.542 5.68 751.9024 1,501.79 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 3.36 0.493 3.06 751.9025 1,501.79 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.57 0.529 4.6 751.9027 1,501.79 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.69 0.576 4.66 751.9032 1,501.79 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.39 0.551 4 751.9033 1,501.79 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 3.35 0.534 3.11 751.9038 1,501.79 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.52 0.564 5 751.9046 1,501.79 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.51 0.561 4.51 751.9049 1,501.79 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.42 0.57 4.85 751.9072 1,501.80 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEMGTHTVSVK 95.00% 4.11 0.532 5.19 752.3906 1,502.77 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEMGTHTVSVK 95.00% 3.63 0.51 5.55 752.3928 1,502.77 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 3.26 0.511 3.89 752.4019 1,502.79 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.78 0.576 5.23 752.4029 1,502.79 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.5 0.523 4.33 752.4054 1,502.80 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.76 0.544 4.24 752.4071 1,502.80 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VNQPASFAVSLNGAK 95.00% 4.27 0.507 3.92 752.4075 1,502.80 1,502.80 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 2.35 0 3.27 758.382 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.32 0.343 2.96 758.3846 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 2.75 0.165 1.48 758.3853 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.56 0.443 2.92 758.3854 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.68 0.468 4.92 758.3856 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.63 0.425 3.74 758.3861 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.83 0.431 4.57 758.3864 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.26 0.344 4.96 758.3867 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.63 0.345 4.62 758.3868 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 2.93 0.296 3.96 758.3873 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.42 0.347 2.59 758.3885 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.44 0.411 4.06 758.8867 1,515.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.65 0.401 3.43 758.8872 1,515.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FADQHVPGSPFSVK 95.00% 3.54 0.416 4.07 758.8877 1,515.76 1,515.76 2 MOES_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 2.51 0.336 0 m6: Oxidation (+15.99) 759.8867 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.5 0.529 3.85 m6: Oxidation (+15.99) 759.8871 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.51 0.508 3.04 m6: Oxidation (+15.99) 759.8875 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.38 0.523 5.47 m6: Oxidation (+15.99) 759.8875 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.76 0.56 3.06 m6: Oxidation (+15.99) 759.8888 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.65 0.503 5.82 m6: Oxidation (+15.99) 759.8889 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.02 0.508 5.35 m6: Oxidation (+15.99) 759.889 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.43 0.505 4.39 m6: Oxidation (+15.99) 759.8891 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.48 0.472 4.06 m6: Oxidation (+15.99) 759.8894 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.19 0.461 3.11 m6: Oxidation (+15.99) 759.8897 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.08 0.495 4 m6: Oxidation (+15.99) 759.8901 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VHSPSGALEEcYVTEIDQDK 95.00% 5.62 0.494 1.66 c11: Carbamidomethyl (+57.02) 760.0194 2,277.03 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VHSPSGALEEcYVTEIDQDK 95.00% 5.48 0.439 2.28 c11: Carbamidomethyl (+57.02) 760.0207 2,277.04 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.4 0.534 4.19 m6: Oxidation (+15.99) 760.3886 1,518.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.27 0.452 5 m6: Oxidation (+15.99) 760.3892 1,518.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.17 0.51 4.09 m6: Oxidation (+15.99) 760.39 1,518.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FVPAEmGTHTVSVK 95.00% 3.56 0.538 7.02 m6: Oxidation (+15.99) 760.3918 1,518.77 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AEAGVPAEFSIWTR 95.00% 3.85 0.278 2.85 767.3862 1,532.76 1,533.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AEAGVPAEFSIWTR 95.00% 4.47 0.369 3.46 767.3893 1,532.76 1,533.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AEAGVPAEFSIWTR 95.00% 4.43 0.337 4.14 767.3902 1,532.76 1,533.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% AEAGVPAEFSIWTR 95.00% 4.27 0.38 4.28 767.3906 1,532.77 1,533.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 3.63 0.565 1.38 767.4125 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 3.64 0.548 0 767.4125 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.42 0.524 2.55 767.4126 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.47 0.508 1.74 767.4127 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.38 0.406 1.29 767.4128 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.44 0.453 1.28 767.4132 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.55 0.467 1.34 767.4134 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.49 0.456 1.66 767.4135 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.66 0.488 0 767.4137 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.78 0.469 2.31 767.4137 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.85 0.508 4.17 767.4138 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.8 0.527 2.82 767.414 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.87 0.521 4.1 767.414 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.77 0.502 2.68 767.414 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.49 0.464 2.32 767.4145 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.59 0.529 4.55 767.4145 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.76 0.528 3.64 767.4148 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.06 0.473 1.89 767.4148 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFSVAVSPSLDLSK 95.00% 4.53 0.538 2.82 767.9147 1,533.81 1,533.82 2 RL4_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGYGGLSLSIEGPSK 95.00% 3.69 0.398 2.04 775.8901 1,549.76 1,550.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGYGGLSLSIEGPSK 95.00% 4.38 0.487 3.7 775.8907 1,549.77 1,550.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGYGGLSLSIEGPSK 95.00% 4.68 0.462 3.8 775.8915 1,549.77 1,550.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGYGGLSLSIEGPSK 95.00% 5.07 0.51 5.3 775.8917 1,549.77 1,550.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGYGGLSLSIEGPSK 95.00% 4.66 0.474 4.77 775.8919 1,549.77 1,550.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGYGGLSLSIEGPSK 95.00% 4.33 0.41 3.05 775.892 1,549.77 1,550.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGYGGLSLSIEGPSK 95.00% 3.92 0.463 5.17 775.8922 1,549.77 1,550.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGYGGLSLSIEGPSK 95.00% 4.18 0.453 4.36 775.8924 1,549.77 1,550.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGYGGLSLSIEGPSK 95.00% 4.06 0.418 1.68 775.8926 1,549.77 1,550.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGYGGLSLSIEGPSK 95.00% 4.53 0.493 3.55 775.893 1,549.77 1,550.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 3.84 0.539 3.28 785.9082 1,569.80 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 4.78 0.635 3.96 785.9087 1,569.80 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 5.08 0.622 3.82 785.9092 1,569.80 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 4.12 0.571 2.96 785.9092 1,569.80 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 4.59 0.596 3.44 785.9094 1,569.80 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 5 0.577 5.38 785.9096 1,569.80 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 4.48 0.571 3.82 785.9098 1,569.80 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 5.12 0.612 4.72 785.9099 1,569.80 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 4.84 0.585 2.85 785.9099 1,569.80 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 4.96 0.562 4.64 785.9103 1,569.81 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 4.82 0.576 3.96 785.9104 1,569.81 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 5.14 0.557 4.66 785.9106 1,569.81 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 4.47 0.567 3.77 785.9107 1,569.81 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 5.02 0.564 4.4 785.9107 1,569.81 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 4.5 0.527 3.64 785.9108 1,569.81 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 4.18 0.627 4 785.9113 1,569.81 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 4.7 0.629 3.92 786.4087 1,570.80 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 4.92 0.58 4.04 786.4125 1,570.81 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 5.07 0.55 4.15 786.4128 1,570.81 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GAGTGGLGLAVEGPSEAK 95.00% 5.12 0.576 4.32 786.4129 1,570.81 1,570.81 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DNGNGTYScSYVPR 95.00% 3.29 0.513 4.19 c9: Carbamidomethyl (+57.02) 795.3388 1,588.66 1,589.67 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DNGNGTYScSYVPR 95.00% 3.12 0.51 4.1 c9: Carbamidomethyl (+57.02) 795.3402 1,588.66 1,589.67 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DNGNGTYScSYVPR 95.00% 2.42 0.218 1.27 c9: Carbamidomethyl (+57.02) 795.3402 1,588.66 1,589.67 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DNGNGTYScSYVPR 95.00% 2.98 0.499 3.38 c9: Carbamidomethyl (+57.02) 795.3402 1,588.66 1,589.67 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DNGNGTYScSYVPR 95.00% 2.73 0.425 1.28 c9: Carbamidomethyl (+57.02) 795.3407 1,588.67 1,589.67 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DNGNGTYScSYVPR 95.00% 3.25 0.494 3.52 c9: Carbamidomethyl (+57.02) 795.3411 1,588.67 1,589.67 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DNGNGTYScSYVPR 95.00% 2.99 0.467 0 c9: Carbamidomethyl (+57.02) 795.3413 1,588.67 1,589.67 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DNGNGTYScSYVPR 95.00% 3.09 0.527 2.59 c9: Carbamidomethyl (+57.02) 795.3422 1,588.67 1,589.67 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DNGNGTYScSYVPR 95.00% 2.82 0.478 2.44 c9: Carbamidomethyl (+57.02) 795.3423 1,588.67 1,589.67 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DNGNGTYScSYVPR 95.00% 2.36 0.37 2.02 c9: Carbamidomethyl (+57.02) 795.3433 1,588.67 1,589.67 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.73 0.559 6.08 801.8881 1,601.76 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.66 0.548 3.72 801.8888 1,601.76 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.63 0.59 3.8 801.8891 1,601.76 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.11 0.478 4.37 801.8891 1,601.76 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.46 0.528 4.3 801.8895 1,601.76 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.57 0.495 5.7 801.8895 1,601.76 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.7 0.555 4.72 801.8899 1,601.76 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.63 0.467 4.85 801.89 1,601.76 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.65 0.494 3.96 801.8902 1,601.76 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.8 0.566 4.41 801.8902 1,601.76 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.74 0.495 4.96 801.8902 1,601.76 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 4.07 0.546 2.82 801.891 1,601.77 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.99 0.546 3.82 801.8913 1,601.77 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.62 0.549 3.12 802.3902 1,602.76 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.72 0.506 5.19 802.3909 1,602.77 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YNEQHVPGSPFTAR 95.00% 3.95 0.511 1.42 802.3937 1,602.77 1,602.77 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.41 0.41 2.35 814.4028 2,440.19 2,440.19 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.47 0.382 3.54 814.4035 2,440.19 2,440.19 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.5 0.36 2.82 814.4041 2,440.19 2,440.19 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.6 0.34 2.33 814.4064 2,440.20 2,440.19 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.78 0.35 3.13 814.4072 2,440.20 2,440.19 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.67 0.441 3.04 814.4078 2,440.20 2,440.19 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.31 0.541 1.92 c11: Carbamidomethyl (+57.02) 817.436 2,449.28 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.76 0.509 1.37 c11: Carbamidomethyl (+57.02) 817.4362 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.9 0.574 4.11 c11: Carbamidomethyl (+57.02) 817.4365 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.79 0.463 3.62 c11: Carbamidomethyl (+57.02) 817.4369 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.24 0.512 2.48 c11: Carbamidomethyl (+57.02) 817.437 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.58 0.555 1.49 c11: Carbamidomethyl (+57.02) 817.4371 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.64 0.572 2.82 c11: Carbamidomethyl (+57.02) 817.4371 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.01 0.469 2.49 c11: Carbamidomethyl (+57.02) 817.4372 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.79 0.504 2.59 c11: Carbamidomethyl (+57.02) 817.4379 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.14 0.501 3.04 c11: Carbamidomethyl (+57.02) 817.438 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.35 0.504 3.08 c11: Carbamidomethyl (+57.02) 817.4382 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.15 0.509 2.48 c11: Carbamidomethyl (+57.02) 817.4383 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.12 0.415 3.36 c11: Carbamidomethyl (+57.02) 817.4388 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.05 0.516 2.57 c11: Carbamidomethyl (+57.02) 817.4388 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.24 0.54 3 c11: Carbamidomethyl (+57.02) 817.439 2,449.29 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.1 0.448 4.32 c11: Carbamidomethyl (+57.02) 817.4395 2,449.30 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.73 0.493 1.44 c11: Carbamidomethyl (+57.02) 817.4404 2,449.30 2,449.29 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDINTEDLEDGTcR 95.00% 3.8 0.398 4 c13: Carbamidomethyl (+57.02) 818.8616 1,635.71 1,636.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDINTEDLEDGTcR 95.00% 3.25 0.385 2.59 c13: Carbamidomethyl (+57.02) 818.8618 1,635.71 1,636.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDINTEDLEDGTcR 95.00% 3.85 0.458 4.26 c13: Carbamidomethyl (+57.02) 818.8629 1,635.71 1,636.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDINTEDLEDGTcR 95.00% 3.96 0.47 5.21 c13: Carbamidomethyl (+57.02) 818.863 1,635.71 1,636.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDINTEDLEDGTcR 95.00% 4.12 0.561 4.4 c13: Carbamidomethyl (+57.02) 818.8631 1,635.71 1,636.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDINTEDLEDGTcR 95.00% 3.94 0.42 4.66 c13: Carbamidomethyl (+57.02) 818.8636 1,635.71 1,636.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDINTEDLEDGTcR 95.00% 3.49 0.473 3.55 c13: Carbamidomethyl (+57.02) 818.8638 1,635.71 1,636.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDINTEDLEDGTcR 95.00% 3.68 0.396 3.74 c13: Carbamidomethyl (+57.02) 819.365 1,636.71 1,636.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VDINTEDLEDGTcR 95.00% 4.35 0.385 4.32 c13: Carbamidomethyl (+57.02) 819.3665 1,636.72 1,636.71 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.87 0.293 2.96 823.404 2,467.19 2,467.19 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.27 0.354 3.14 823.4041 2,467.19 2,467.19 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.63 0.306 3.62 823.4047 2,467.19 2,467.19 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.85 0.369 3.82 823.4059 2,467.19 2,467.19 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.41 0.436 3 823.4061 2,467.19 2,467.19 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FNEEHIPDSPFVVPVASPSGDAR 95.00% 2.83 0.264 1.77 823.4075 2,467.20 2,467.19 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 4.07 0.384 5.52 823.9424 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 4.06 0.369 4.35 823.9428 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 4.3 0.401 4.03 823.9436 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 4.17 0.422 4.21 823.9436 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 4.36 0.393 3.62 823.9438 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 4.52 0.425 3.11 823.944 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 4.32 0.419 5.09 823.9442 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 4.05 0.446 5.03 823.9442 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 4.16 0.386 3.06 823.9445 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 4.42 0.419 4.15 823.9445 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 4.11 0.4 5.07 823.9452 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVAVNKPAEFTVDAK 95.00% 4.07 0.408 3.66 824.4463 1,646.88 1,646.88 2 MYLK_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 4.9 0.578 3.49 826.935 1,651.85 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 5.2 0.611 6.04 826.9359 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 5.13 0.602 6.07 826.9359 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 5 0.622 5.36 826.9361 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 5 0.567 4.85 826.9366 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 4.82 0.561 4.13 826.9366 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 4.95 0.598 3.82 826.937 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 5.02 0.613 5.8 826.9372 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 4.73 0.565 5.8 826.9373 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 5.07 0.583 5.15 826.9373 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 4.83 0.566 4.66 826.9373 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 4.9 0.623 6.25 826.9373 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 5.17 0.605 5.46 826.9375 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 4.89 0.629 4.7 826.9378 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 4.94 0.58 5.06 826.9379 1,651.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 5.02 0.573 5.12 827.4372 1,652.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 5.2 0.583 4.35 827.4377 1,652.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 5.31 0.561 4.36 827.4382 1,652.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 5.02 0.571 4.31 827.4389 1,652.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTAQGPGLEPSGNIANK 95.00% 5.13 0.577 4.32 827.4398 1,652.86 1,652.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FIPRENGVYLIDVK 95.00% 3.58 0.254 0 831.9663 1,661.92 1,662.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FIPRENGVYLIDVK 95.00% 3.47 0.271 2.08 832.4671 1,662.92 1,662.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% FIPRENGVYLIDVK 95.00% 3.56 0.316 2.4 832.4672 1,662.92 1,662.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 4.93 0.517 2.72 835.1014 2,502.28 2,502.28 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 4.99 0.527 2.13 835.1019 2,502.28 2,502.28 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 4.61 0.478 1.54 835.103 2,502.29 2,502.28 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 4.75 0.532 2.8 835.1038 2,502.29 2,502.28 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VKmDcQEcPEGYR 95.00% 2.83 0.438 1.28 m3: Oxidation (+15.99), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 844.8524 1,687.69 1,687.69 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 5.05 0.566 3.02 849.094 2,544.26 2,544.26 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.93 0.6 2.85 849.0941 2,544.26 2,544.26 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.13 0.553 3.96 849.0944 2,544.26 2,544.26 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.71 0.523 2.49 849.0947 2,544.26 2,544.26 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 3.54 0.452 0 849.0957 2,544.26 2,544.26 3
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.63 0.509 4 849.9632 1,697.91 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.08 0.526 3.68 849.964 1,697.91 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.09 0.493 4.57 849.964 1,697.91 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.28 0.537 4.85 849.9644 1,697.91 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.39 0.528 4.77 849.9648 1,697.91 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.15 0.466 3.72 849.9648 1,697.91 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.01 0.518 4.02 849.965 1,697.91 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.25 0.522 4.52 849.9656 1,697.92 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.49 0.495 3.54 849.9659 1,697.92 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.05 0.506 4.6 849.9659 1,697.92 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 3.77 0.472 4.96 849.9667 1,697.92 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.2 0.442 4.57 850.4654 1,698.92 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.04 0.507 3.82 850.466 1,698.92 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.39 0.534 4.89 850.466 1,698.92 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TGVELGKPTHFTVNAK 95.00% 4.17 0.521 4.24 850.4666 1,698.92 1,698.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYTPMAPGSYLISIK 95.00% 3.73 0.466 3.33 870.9694 1,739.92 1,740.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYTPMAPGSYLISIK 95.00% 2.95 0.424 0 870.9702 1,739.92 1,740.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYTPMAPGSYLISIK 95.00% 3.8 0.426 2.96 871.468 1,740.92 1,740.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.73 0.51 0 875.9439 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.74 0.52 1.27 875.9443 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.69 0.545 1.21 875.9465 1,749.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.5 0.483 0 875.9466 1,749.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.78 0.599 1.18 875.9469 1,749.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.15 0.534 0 875.9489 1,749.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.65 0.584 0 875.9519 1,749.89 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.58 0.55 0 876.4425 1,750.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.67 0.518 0 876.4459 1,750.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.96 0.54 0 876.4469 1,750.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 3.7 0.549 0 876.448 1,750.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% TFSVWYVPEVTGTHK 95.00% 4.07 0.584 0 876.4484 1,750.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 4.99 0.512 5.85 878.9242 1,755.83 1,756.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 5.11 0.545 5.34 878.9262 1,755.84 1,756.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 4.94 0.508 5.3 878.9262 1,755.84 1,756.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 4.86 0.505 6.3 878.9268 1,755.84 1,756.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 5.07 0.53 6.62 878.927 1,755.84 1,756.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 5.14 0.517 7.96 879.4206 1,756.83 1,756.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 5.1 0.553 5.85 879.4254 1,756.84 1,756.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 5.01 0.538 6.35 879.4258 1,756.84 1,756.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPFEVYVDKSQGDASK 95.00% 5.13 0.541 7.89 879.4273 1,756.84 1,756.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.06 0.653 6.52 882.4331 1,762.85 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.14 0.648 6.55 882.4332 1,762.85 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.31 0.653 5.77 882.4335 1,762.85 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.36 0.626 6.96 882.4336 1,762.85 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5 0.587 6.05 882.4339 1,762.85 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 4.86 0.604 8.07 882.4341 1,762.85 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 4.9 0.659 6.85 882.4342 1,762.85 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 4.94 0.656 4.7 882.4347 1,762.85 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 4.94 0.644 5.77 882.4352 1,762.85 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.25 0.643 6.77 882.4353 1,762.85 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.24 0.602 6.2 882.4359 1,762.86 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.23 0.658 7.05 882.4362 1,762.86 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 4.92 0.636 6.72 882.4366 1,762.86 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.35 0.638 6.89 882.9348 1,763.85 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.25 0.613 6.7 882.9353 1,763.85 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.03 0.606 6.89 882.9355 1,763.86 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.2 0.596 8.09 882.9359 1,763.86 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.43 0.619 7.21 882.9361 1,763.86 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VANPSGNLTETYVQDR 95.00% 5.13 0.65 7.11 882.9375 1,763.86 1,763.86 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 3.75 0.56 1.59 892.9263 1,783.84 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 4.11 0.609 2.68 892.9277 1,783.84 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 4.28 0.589 2.42 892.9279 1,783.84 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 3.2 0.478 2.64 892.9291 1,783.84 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 4.31 0.587 3.55 892.9298 1,783.84 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 4.13 0.547 3.15 892.9317 1,783.85 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 3.61 0.571 3.39 892.9323 1,783.85 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.55 0.554 4.41 c9: Carbamidomethyl (+57.02) 892.9464 1,783.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.01 0.584 4.77 c9: Carbamidomethyl (+57.02) 892.9466 1,783.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.5 0.576 5.11 c9: Carbamidomethyl (+57.02) 892.9473 1,783.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.59 0.581 4.72 c9: Carbamidomethyl (+57.02) 892.9474 1,783.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 4.85 0.608 5.44 c9: Carbamidomethyl (+57.02) 892.9475 1,783.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.6 0.592 5.96 c9: Carbamidomethyl (+57.02) 892.9477 1,783.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.3 0.539 4.38 c9: Carbamidomethyl (+57.02) 892.948 1,783.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.43 0.572 5.85 c9: Carbamidomethyl (+57.02) 892.9487 1,783.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.26 0.573 4.19 c9: Carbamidomethyl (+57.02) 892.9488 1,783.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.47 0.569 4.38 c9: Carbamidomethyl (+57.02) 892.9494 1,783.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.14 0.591 4.72 c9: Carbamidomethyl (+57.02) 892.95 1,783.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 4.49 0.554 2.68 893.4294 1,784.84 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 4.55 0.564 3.21 893.43 1,784.84 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 4.47 0.533 2.92 893.4307 1,784.85 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 4.44 0.562 2.96 893.4309 1,784.85 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 4.34 0.554 2.31 893.4309 1,784.85 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 4.08 0.537 2.44 893.4313 1,784.85 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 4.01 0.568 2.28 893.4315 1,784.85 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 3.97 0.526 3.52 893.4319 1,784.85 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DVDIIDHHDNTYTVK 95.00% 3.92 0.545 3 893.4329 1,784.85 1,784.85 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.62 0.531 5.09 c9: Carbamidomethyl (+57.02) 893.4487 1,784.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.41 0.529 5.14 c9: Carbamidomethyl (+57.02) 893.449 1,784.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.72 0.52 4.28 c9: Carbamidomethyl (+57.02) 893.4491 1,784.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 6.01 0.508 4.92 c9: Carbamidomethyl (+57.02) 893.4498 1,784.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.8 0.53 4 c9: Carbamidomethyl (+57.02) 893.4503 1,784.88 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.8 0.546 5.57 c9: Carbamidomethyl (+57.02) 893.4504 1,784.89 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.56 0.535 5.1 c9: Carbamidomethyl (+57.02) 893.4505 1,784.89 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 4.95 0.6 4.14 c9: Carbamidomethyl (+57.02) 893.4507 1,784.89 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VQVQDNEGcPVEALVK 95.00% 5.33 0.56 4.85 c9: Carbamidomethyl (+57.02) 893.451 1,784.89 1,784.89 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 4.27 0.389 5.57 907.9861 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 4.36 0.407 5.02 907.9862 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 3.89 0.524 3.57 907.9865 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 4.28 0.473 5.74 907.9867 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 4.38 0.439 5.89 907.9868 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 4.09 0.465 5.26 907.9874 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 4.27 0.424 4.46 907.9879 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 4.03 0.462 3.82 907.9881 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 3.33 0.484 5.05 907.9883 1,813.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 4.32 0.365 4.8 908.4887 1,814.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 4.46 0.366 5.43 908.4889 1,814.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 4.39 0.407 5.28 908.4898 1,814.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 4.54 0.41 5.55 908.4906 1,814.97 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VAQPTITDNKDGTVTVR 95.00% 4.54 0.397 5.52 908.4914 1,814.97 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.11 0.538 4.77 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4258 1,866.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.45 0.552 5.11 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4265 1,866.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.04 0.473 4.72 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4272 1,866.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.07 0.564 4.96 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4272 1,866.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.32 0.53 6.26 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4273 1,866.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.04 0.493 4.77 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4273 1,866.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.13 0.539 5.6 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4275 1,866.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 4.89 0.512 4.33 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4276 1,866.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.16 0.563 5.02 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4277 1,866.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.53 0.561 4.68 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.428 1,866.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.25 0.534 3.82 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4281 1,866.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.02 0.474 6.12 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9268 1,867.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.23 0.542 5.68 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9279 1,867.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.06 0.488 4.22 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9281 1,867.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.47 0.523 5.36 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9283 1,867.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SPYTVTVGQAcNPSAcR 95.00% 5.65 0.566 4.8 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9297 1,867.84 1,867.84 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 3.82 0.536 2.68 c4: Carbamidomethyl (+57.02) 941.4762 1,880.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.39 0.576 3.36 c4: Carbamidomethyl (+57.02) 941.4765 1,880.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 3.77 0.54 3.85 c4: Carbamidomethyl (+57.02) 941.4768 1,880.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 3.94 0.545 3.66 c4: Carbamidomethyl (+57.02) 941.4769 1,880.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.21 0.534 3.89 c4: Carbamidomethyl (+57.02) 941.4771 1,880.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.37 0.559 4.01 c4: Carbamidomethyl (+57.02) 941.4778 1,880.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.45 0.515 3.1 c4: Carbamidomethyl (+57.02) 941.9777 1,881.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.64 0.525 2.8 c4: Carbamidomethyl (+57.02) 941.9786 1,881.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.66 0.501 3.6 c4: Carbamidomethyl (+57.02) 941.979 1,881.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.56 0.512 3.07 c4: Carbamidomethyl (+57.02) 941.9791 1,881.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.23 0.463 3.54 c4: Carbamidomethyl (+57.02) 941.9794 1,881.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.2 0.466 3 c4: Carbamidomethyl (+57.02) 941.9798 1,881.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.04 0.461 4.04 c4: Carbamidomethyl (+57.02) 941.9799 1,881.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.48 0.499 2.62 c4: Carbamidomethyl (+57.02) 941.98 1,881.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.43 0.49 3.09 c4: Carbamidomethyl (+57.02) 941.98 1,881.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.14 0.466 4.34 c4: Carbamidomethyl (+57.02) 941.9801 1,881.94 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 4.71 0.525 3.17 c4: Carbamidomethyl (+57.02) 941.9804 1,881.95 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% VTYcPTEPGNYIINIK 95.00% 3.87 0.53 4.49 c4: Carbamidomethyl (+57.02) 941.9814 1,881.95 1,881.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 3.8 0.571 4.64 955.4668 1,908.92 1,909.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 4.77 0.561 4.7 955.9602 1,909.90 1,909.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 5.08 0.552 5.41 955.9648 1,909.91 1,909.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 5.52 0.551 4.46 955.9654 1,909.92 1,909.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 5.22 0.541 5.64 955.9654 1,909.92 1,909.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 4.93 0.563 5.35 955.9656 1,909.92 1,909.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 4.68 0.479 4.92 955.9657 1,909.92 1,909.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 5.27 0.556 3.85 955.9659 1,909.92 1,909.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 4.86 0.578 5.74 955.966 1,909.92 1,909.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% EGPYSISVLYGDEEVPR 95.00% 4.39 0.542 3.04 955.9687 1,909.92 1,909.92 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 5.23 0.434 4.7 969.5146 1,937.01 1,938.02 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 3.95 0.451 4.48 969.5177 1,937.02 1,938.02 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 4.87 0.391 4.8 970.0134 1,938.01 1,938.02 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 4.96 0.396 4.96 970.0146 1,938.01 1,938.02 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 5.21 0.374 5.92 970.0162 1,938.02 1,938.02 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 5.35 0.396 3.66 970.0164 1,938.02 1,938.02 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 5.36 0.397 3.34 970.0167 1,938.02 1,938.02 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 4.96 0.388 4.24 970.0168 1,938.02 1,938.02 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DAGEGLLAVQITDPEGKPK 95.00% 5.19 0.389 5.12 970.017 1,938.02 1,938.02 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IPEISIQDMTAQVTSPSGK 95.00% 3.94 0.568 5.17 1,001.51 2,001.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IPEISIQDMTAQVTSPSGK 95.00% 5.38 0.688 8.64 1,001.52 2,001.02 2,002.02 2 ITIH1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IPEISIQDMTAQVTSPSGK 95.00% 5.21 0.663 6.08 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IPEISIQDMTAQVTSPSGK 95.00% 5.48 0.537 7.01 1,002.02 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IPEISIQDMTAQVTSPSGK 95.00% 4.98 0.487 7.01 1,002.02 2,002.02 2,002.02 2 ITIH1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% cAPGVVGPAEADIDFDIIR 95.00% 5.67 0.604 8.38 c1: Carbamidomethyl (+57.02) 1,008.50 2,014.99 2,014.99 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% IPEISIQDmTAQVTSPSGK 95.00% 5.14 0.68 9.64 m9: Oxidation (+15.99) 1,010.01 2,018.01 2,018.01 2 ITIH1_HUMAN
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 6.46 0.669 7.66 c15: Carbamidomethyl (+57.02) 1,029.47 2,056.93 2,057.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 6.65 0.66 6.72 c15: Carbamidomethyl (+57.02) 1,029.47 2,056.93 2,057.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 6.26 0.64 4.89 c15: Carbamidomethyl (+57.02) 1,029.48 2,056.94 2,057.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 6.3 0.651 11 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 6.31 0.654 11.6 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 6.54 0.627 7.55 c15: Carbamidomethyl (+57.02) 1,029.98 2,057.93 2,057.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% THEAEIVEGENHTYcIR 95.00% 6.15 0.666 7.59 c15: Carbamidomethyl (+57.02) 1,029.98 2,057.94 2,057.94 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LVSNHSLHETSSVFVDSLTK 95.00% 6.04 0.643 4.6 1,101.07 2,200.12 2,200.13 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LVSNHSLHETSSVFVDSLTK 95.00% 6.39 0.586 8.09 1,101.07 2,200.12 2,200.13 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% LVSNHSLHETSSVFVDSLTK 95.00% 6.07 0.628 5.48 1,101.07 2,200.12 2,200.13 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DGScGVAYVVQEPGDYEVSVK 95.00% 5.13 0.661 5.62 c4: Carbamidomethyl (+57.02) 1,129.52 2,257.02 2,258.03 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DGScGVAYVVQEPGDYEVSVK 95.00% 5.17 0.643 5 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DGScGVAYVVQEPGDYEVSVK 95.00% 5.39 0.624 5.22 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DGScGVAYVVQEPGDYEVSVK 95.00% 5.29 0.61 5.3 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.03 2,258.03 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DGScGVAYVVQEPGDYEVSVK 95.00% 4.93 0.674 4.82 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.03 2,258.03 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DGScGVAYVVQEPGDYEVSVK 95.00% 4.71 0.637 5.57 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.03 2,258.03 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% DGScGVAYVVQEPGDYEVSVK 95.00% 5.2 0.657 6.02 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.03 2,258.03 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.42 0.686 4.32 1,144.10 2,286.18 2,286.18 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.29 0.63 7.09 1,144.10 2,286.18 2,286.18 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.49 0.674 5.37 1,144.10 2,286.18 2,286.18 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.42 0.626 4.59 1,144.10 2,286.18 2,286.18 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.44 0.662 6.17 1,144.10 2,286.18 2,286.18 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.49 0.678 8.17 1,144.10 2,286.18 2,286.18 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.4 0.653 6.74 1,144.10 2,286.18 2,286.18 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.42 0.672 5.31 1,144.11 2,286.20 2,286.18 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.55 0.549 5.96 1,157.55 2,313.09 2,313.10 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.46 0.617 6.77 1,157.56 2,313.10 2,313.10 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.52 0.578 6.46 1,157.56 2,313.10 2,313.10 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.33 0.638 7.21 1,157.56 2,313.11 2,313.10 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.36 0.7 16.7 1,273.14 2,544.26 2,544.26 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.24 0.717 14.2 1,273.14 2,544.26 2,544.26 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.17 0.704 10.2 1,273.14 2,544.26 2,544.26 2
 SAMPLE 4R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 86 110 1068 41.70% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 0 0 7.6 1,273.64 2,545.26 2,544.26 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LIALLEVLSQKK 95.00% 1.7 0.209 2.08 452.2953 1,353.86 1,354.87 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LIALLEVLSQKK 95.00% 1.79 0.134 1.8 452.2955 1,353.86 1,354.87 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LIALLEVLSQKK 95.00% 2.31 0.0778 1.35 452.2959 1,353.86 1,354.87 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LIALLEVLSQKK 95.00% 1.77 0.157 3.34 452.2961 1,353.86 1,354.87 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LIALLEVLSQKK 95.00% 1.92 0.207 2.39 452.2962 1,353.87 1,354.87 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 2.82 0.34 0 455.5732 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 2.03 0.427 1.03 455.5738 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 2.52 0.443 0 455.5741 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 2.46 0.315 0 455.5744 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 1.93 0.277 0 455.5747 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 2.46 0.373 0 455.5748 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 1.85 0.373 0 455.575 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 2.84 0.527 1.15 460.5627 1,378.66 1,379.68 3 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.04 0.432 1.08 460.5628 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.29 0.505 1.1 460.5629 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 2.2 0.348 1.62 460.5631 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.03 0.529 1.11 460.5633 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3 0.46 1.14 460.5634 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.18 0.515 2.19 460.5639 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.55 0.455 1.92 460.5653 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 2.99 0.505 1.38 460.5658 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.11 0.448 1.92 460.5677 1,378.68 1,379.68 3 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.18 0.443 3.07 460.898 1,379.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LRNGHVGISFVPK 95.00% 2.89 0.316 0 475.2779 1,422.81 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AGNNMLLVGVHGPR 95.00% 3.81 0.48 0 478.9247 1,433.75 1,434.76 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AGNNMLLVGVHGPR 95.00% 3.56 0.487 0 478.925 1,433.75 1,434.76 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AGNNMLLVGVHGPR 95.00% 3.41 0.523 0 478.9255 1,433.75 1,434.76 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AGNNMLLVGVHGPR 95.00% 3.72 0.508 0 478.9265 1,433.76 1,434.76 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AGNNMLLVGVHGPR 95.00% 3.96 0.476 1.8 478.9274 1,433.76 1,434.76 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AGNNMLLVGVHGPR 95.00% 3.21 0.413 0 479.2591 1,434.75 1,434.76 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AGNNMLLVGVHGPR 95.00% 3.55 0.448 0.959 479.2601 1,434.76 1,434.76 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LLGWIQNK 95.00% 2.86 0.14 0 486.2863 970.5569 971.568 2 FLNC_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LLGWIQNK 95.00% 2.96 0.16 0 486.2865 970.5573 971.568 2 FLNC_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LLGWIQNK 95.00% 2.51 0.15 0 486.2865 970.5573 971.568 2 FLNC_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LLGWIQNK 95.00% 2.98 0.151 0 486.2865 970.5573 971.568 2 FLNC_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LLGWIQNK 95.00% 2.93 0.155 0 486.2865 970.5573 971.568 2 FLNC_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LLGWIQNK 95.00% 2.95 0.187 0 486.2867 970.5577 971.568 2 FLNC_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LLGWIQNK 95.00% 2.66 0.183 0 486.287 970.5584 971.568 2 FLNC_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LLGWIQNK 95.00% 2.86 0.121 0 486.2877 970.5598 971.568 2 FLNC_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% KGEITGEVR 95.00% 2.19 0.319 0 494.7751 987.5346 988.5429 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 2.58 0.309 2.29 505.9236 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 3.51 0.39 2.77 505.924 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 3.44 0.459 2.57 505.9247 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 2.72 0.197 2.54 505.9254 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 3.64 0.383 2.85 506.2599 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 3.21 0.316 2.14 506.2604 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 2.72 0.311 4.11 506.2619 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LSPFMADIR 95.00% 2.75 0.271 1.74 525.2734 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LSPFMADIR 95.00% 2.13 0.296 0 525.274 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.74 0.425 2.17 534.9257 1,601.75 1,602.77 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.39 0.461 1.04 534.9257 1,601.75 1,602.77 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.71 0.397 2.04 534.926 1,601.75 1,602.77 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 4.21 0.489 3.4 534.9261 1,601.76 1,602.77 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.65 0.368 3.43 534.9263 1,601.76 1,602.77 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.74 0.419 2.77 534.9263 1,601.76 1,602.77 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.84 0.45 2.62 534.9265 1,601.76 1,602.77 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 4 0.442 4.35 534.9265 1,601.76 1,602.77 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 4.06 0.489 3.17 534.9268 1,601.76 1,602.77 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.88 0.384 2.92 535.2595 1,602.76 1,602.77 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 4.12 0.445 3.15 535.2602 1,602.76 1,602.77 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPFEVYVDK 95.00% 2.98 0.481 1.48 542.2706 1,082.53 1,083.54 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPFEVYVDK 95.00% 3.02 0.452 1.49 542.2707 1,082.53 1,083.54 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPFEVYVDK 95.00% 3.08 0.447 0 542.2711 1,082.53 1,083.54 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPFEVYVDK 95.00% 2.94 0.471 1.29 542.2719 1,082.53 1,083.54 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LYSVSYLLK 95.00% 2.21 0.254 0 543.3117 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LYSVSYLLK 95.00% 2.36 0.291 0 543.314 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LYSVSYLLK 95.00% 2.4 0.269 0 543.3143 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LYSVSYLLK 95.00% 2.33 0.26 0 543.3144 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LYSVSYLLK 95.00% 2.33 0.256 0 543.3145 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LYSVSYLLK 95.00% 2.41 0.267 0 543.3146 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LYSVSYLLK 95.00% 2.21 0.252 0 543.3147 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LYSVSYLLK 95.00% 2.25 0.244 0 543.3147 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LYSVSYLLK 95.00% 2.34 0.231 0 543.3151 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LYSVSYLLK 95.00% 2.29 0.236 0 543.3152 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LYSVSYLLK 95.00% 2.02 0.323 0 543.3222 1,084.63 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TPcEEILVK 95.00% 2.76 0.319 0 c3: Carbamidomethyl (+57.02) 544.7857 1,087.56 1,088.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TPcEEILVK 95.00% 2.64 0.313 0 c3: Carbamidomethyl (+57.02) 544.7863 1,087.56 1,088.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 3.72 0.596 3.6 549.629 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 3.51 0.48 2.48 549.6298 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 4.19 0.562 2.77 549.6299 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 3.05 0.47 4.4 549.9631 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 2.59 0.318 0 549.9635 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 4.06 0.579 3.82 549.964 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 4.11 0.543 4.19 549.9642 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% APSVANVGSHcDLSLK 95.00% 2.17 0.402 1.39 c11: Carbamidomethyl (+57.02) 552.277 1,653.81 1,654.82 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% APSVANVGSHcDLSLK 95.00% 2.06 0.391 1.33 c11: Carbamidomethyl (+57.02) 552.2779 1,653.81 1,654.82 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% APSVANVGSHcDLSLK 95.00% 2.57 0.523 1.12 c11: Carbamidomethyl (+57.02) 552.2783 1,653.81 1,654.82 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% APSVANVGSHcDLSLK 95.00% 3.12 0.532 2.29 c11: Carbamidomethyl (+57.02) 552.2784 1,653.81 1,654.82 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% APSVANVGSHcDLSLK 95.00% 2.19 0.419 1.38 c11: Carbamidomethyl (+57.02) 552.2787 1,653.81 1,654.82 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% APSVANVGSHcDLSLK 95.00% 2.55 0.371 1.08 c11: Carbamidomethyl (+57.02) 552.2788 1,653.81 1,654.82 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% APSVANVGSHcDLSLK 95.00% 2.42 0.367 1.42 c11: Carbamidomethyl (+57.02) 552.6118 1,654.81 1,654.82 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% APSVANVGSHcDLSLK 95.00% 2.16 0.283 0 c11: Carbamidomethyl (+57.02) 552.6124 1,654.81 1,654.82 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% APSVANVGSHcDLSLK 95.00% 2.17 0.311 0 c11: Carbamidomethyl (+57.02) 552.6135 1,654.82 1,654.82 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RAEFTVETR 95.00% 2.17 0.359 0 554.7908 1,107.57 1,108.58 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FIPRENGVYLIDVK 95.00% 2.69 0.195 0 554.9796 1,661.92 1,662.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FIPRENGVYLIDVK 95.00% 2.88 0.286 0 555.312 1,662.91 1,662.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VKMDcQEcPEGYR 95.00% 3.21 0.403 1 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9011 1,670.68 1,671.69 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VKMDcQEcPEGYR 95.00% 3.63 0.409 1.8 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9017 1,670.68 1,671.69 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 3.34 0.235 0 566.9753 1,697.90 1,698.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 3.9 0.281 0 566.9759 1,697.90 1,698.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 3.89 0.354 0 566.9761 1,697.90 1,698.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 3.61 0.467 0 566.9761 1,697.90 1,698.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 3.71 0.284 1.16 566.9767 1,697.91 1,698.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 3.89 0.381 1.22 566.9767 1,697.91 1,698.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 4.04 0.386 0 567.31 1,698.91 1,698.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 3.38 0.362 0 567.3107 1,698.91 1,698.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 3.92 0.334 0 567.3108 1,698.91 1,698.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 3.67 0.36 0 567.3109 1,698.91 1,698.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% ENGVYLIDVK 95.00% 2.51 0.308 0 575.2847 1,148.55 1,149.62 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% ENGVYLIDVK 95.00% 2.75 0.418 1.72 575.3101 1,148.60 1,149.62 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% ENGVYLIDVK 95.00% 2.65 0.423 1.48 575.311 1,148.61 1,149.62 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DKGEYTLVVK 95.00% 2.44 0.324 0 576.3174 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DKGEYTLVVK 95.00% 2.54 0.328 0 576.3175 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DKGEYTLVVK 95.00% 2.64 0.355 0 576.3175 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DKGEYTLVVK 95.00% 2.36 0.335 0 576.3178 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DKGEYTLVVK 95.00% 2.62 0.319 0 576.318 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% NGHVGISFVPK 95.00% 2.25 0.283 1.8 577.817 1,153.62 1,154.63 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% NGHVGISFVPK 95.00% 2.6 0.303 1.66 577.8172 1,153.62 1,154.63 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% NGHVGISFVPK 95.00% 2.64 0.307 0 577.8186 1,153.62 1,154.63 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% NGHVGISFVPK 95.00% 2.38 0.371 1.38 577.8186 1,153.62 1,154.63 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% NGHVGISFVPK 95.00% 2.5 0.377 0 577.8188 1,153.62 1,154.63 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% NGHVGISFVPK 95.00% 2.35 0.276 1.19 577.8188 1,153.62 1,154.63 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% NGHVGISFVPK 95.00% 2.46 0.275 0 577.8189 1,153.62 1,154.63 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% NGHVGISFVPK 95.00% 2.45 0.374 0 577.8191 1,153.62 1,154.63 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcK 95.00% 2 0.312 2.89 c11: Carbamidomethyl (+57.02) 578.3102 1,154.60 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcK 95.00% 2.56 0.445 2.77 c11: Carbamidomethyl (+57.02) 578.3112 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcK 95.00% 2.44 0.387 2.57 c11: Carbamidomethyl (+57.02) 578.3112 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcK 95.00% 2.18 0.248 2.42 c11: Carbamidomethyl (+57.02) 578.3117 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcK 95.00% 2.17 0.275 0 c11: Carbamidomethyl (+57.02) 578.3117 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcK 95.00% 2.6 0.437 4.38 c11: Carbamidomethyl (+57.02) 578.3118 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcK 95.00% 2.09 0.289 0 c11: Carbamidomethyl (+57.02) 578.312 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcK 95.00% 2.31 0.344 2.14 c11: Carbamidomethyl (+57.02) 578.3123 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcK 95.00% 3.17 0.425 4.24 c11: Carbamidomethyl (+57.02) 578.3125 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcK 95.00% 2.85 0.412 3.52 c11: Carbamidomethyl (+57.02) 578.3128 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcK 95.00% 2.66 0.443 3.38 c11: Carbamidomethyl (+57.02) 578.3132 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcK 95.00% 2.73 0.421 5.02 c11: Carbamidomethyl (+57.02) 578.8143 1,155.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYTPMAPGSYLISIK 95.00% 4.62 0.505 3.37 581.3125 1,740.91 1,740.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYTPMAPGSYLISIK 95.00% 4.24 0.499 3.2 581.313 1,740.92 1,740.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 2.88 0.528 2.57 584.2971 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 2.8 0.459 1.77 584.2974 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 3.08 0.492 1.89 584.2975 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 2.92 0.455 2.7 584.2975 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 3.17 0.573 2.82 584.298 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 3.38 0.561 1.85 584.299 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 2.94 0.55 1.89 584.6313 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 3.14 0.509 1.16 584.6315 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 3.02 0.489 1.77 584.6316 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 2.86 0.545 2.62 584.6321 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VQVQDNEGcPVEALVK 95.00% 2.59 0.187 0 c9: Carbamidomethyl (+57.02) 595.6341 1,783.88 1,784.89 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VQVQDNEGcPVEALVK 95.00% 2.38 0.252 0 c9: Carbamidomethyl (+57.02) 595.9677 1,784.88 1,784.89 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% ATcAPQHGAPGPGPADASK 95.00% 2.49 0.406 4.05 c3: Carbamidomethyl (+57.02) 597.6152 1,789.82 1,789.83 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RAPSVANVGSHcDLSLK 95.00% 4.06 0.548 2.13 c12: Carbamidomethyl (+57.02) 604.31 1,809.91 1,810.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RAPSVANVGSHcDLSLK 95.00% 4.81 0.567 3.12 c12: Carbamidomethyl (+57.02) 604.3112 1,809.91 1,810.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RAPSVANVGSHcDLSLK 95.00% 4.18 0.573 4.41 c12: Carbamidomethyl (+57.02) 604.3114 1,809.91 1,810.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RAPSVANVGSHcDLSLK 95.00% 5.07 0.56 3.24 c12: Carbamidomethyl (+57.02) 604.3116 1,809.91 1,810.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RAPSVANVGSHcDLSLK 95.00% 4.22 0.545 3.82 c12: Carbamidomethyl (+57.02) 604.3118 1,809.91 1,810.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RAPSVANVGSHcDLSLK 95.00% 4.87 0.543 3.96 c12: Carbamidomethyl (+57.02) 604.3118 1,809.91 1,810.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RAPSVANVGSHcDLSLK 95.00% 4.61 0.539 3.77 c12: Carbamidomethyl (+57.02) 604.3118 1,809.91 1,810.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RAPSVANVGSHcDLSLK 95.00% 4.48 0.554 3.08 c12: Carbamidomethyl (+57.02) 604.3119 1,809.91 1,810.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RAPSVANVGSHcDLSLK 95.00% 4.41 0.466 3.77 c12: Carbamidomethyl (+57.02) 604.3126 1,809.91 1,810.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RAPSVANVGSHcDLSLK 95.00% 4.14 0.511 3.77 c12: Carbamidomethyl (+57.02) 604.3131 1,809.92 1,810.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RAPSVANVGSHcDLSLK 95.00% 4.11 0.454 2.96 c12: Carbamidomethyl (+57.02) 604.6467 1,810.92 1,810.92 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VAQPTITDNKDGTVTVR 95.00% 2.01 0.474 0 605.6553 1,813.94 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VAQPTITDNKDGTVTVR 95.00% 1.87 0.212 1.2 605.6571 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VAQPTITDNKDGTVTVR 95.00% 1.99 0.347 0 605.6577 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VAQPTITDNKDGTVTVR 95.00% 2 0.44 1.7 605.6577 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VAQPTITDNKDGTVTVR 95.00% 2.66 0.38 2 605.658 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% cSGPGLSPGMVR 95.00% 3.23 0.445 2.39 c1: Carbamidomethyl (+57.02) 609.2903 1,216.57 1,217.58 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% cSGPGLSPGMVR 95.00% 3.39 0.423 2.07 c1: Carbamidomethyl (+57.02) 609.2912 1,216.57 1,217.58 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EATTEFSVDAR 95.00% 3.43 0.402 2.7 613.2852 1,224.55 1,225.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EATTEFSVDAR 95.00% 3.57 0.439 2.21 613.2865 1,224.56 1,225.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EATTEFSVDAR 95.00% 2.31 0.359 0 613.2866 1,224.56 1,225.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EATTEFSVDAR 95.00% 3.37 0.399 1.77 613.287 1,224.56 1,225.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EATTEFSVDAR 95.00% 3.42 0.43 1.96 613.2871 1,224.56 1,225.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EATTEFSVDAR 95.00% 3.63 0.416 1.89 613.2873 1,224.56 1,225.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EATTEFSVDAR 95.00% 2.86 0.422 1.49 613.2877 1,224.56 1,225.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EATTEFSVDAR 95.00% 2.66 0.314 0 613.2877 1,224.56 1,225.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EATTEFSVDAR 95.00% 3.63 0.473 1.7 613.2881 1,224.56 1,225.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EATTEFSVDAR 95.00% 3.34 0.366 1.7 613.2881 1,224.56 1,225.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EATTEFSVDAR 95.00% 3.57 0.474 2.14 613.2882 1,224.56 1,225.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EATTEFSVDAR 95.00% 2.45 0.37 1.96 613.2903 1,224.57 1,225.57 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AWGPGLEGGVVGK 95.00% 2.87 0.523 3.55 613.8282 1,225.64 1,226.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AWGPGLEGGVVGK 95.00% 2.59 0.475 3.11 613.8282 1,225.64 1,226.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AWGPGLEGGVVGK 95.00% 3.66 0.534 5.06 613.8291 1,225.64 1,226.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AWGPGLEGGVVGK 95.00% 3.5 0.518 5.43 613.8301 1,225.64 1,226.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AHVVPcFDASK 95.00% 2.47 0.349 2.2 c6: Carbamidomethyl (+57.02) 615.7996 1,229.58 1,230.59 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AHVVPcFDASK 95.00% 2.27 0.265 1.16 c6: Carbamidomethyl (+57.02) 615.7996 1,229.58 1,230.59 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AHVVPcFDASK 95.00% 2.42 0.369 2.6 c6: Carbamidomethyl (+57.02) 615.7997 1,229.58 1,230.59 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AHVVPcFDASK 95.00% 2.56 0.435 3.82 c6: Carbamidomethyl (+57.02) 615.7999 1,229.58 1,230.59 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AHVVPcFDASK 95.00% 2.34 0.25 1.39 c6: Carbamidomethyl (+57.02) 615.8 1,229.58 1,230.59 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AHVVPcFDASK 95.00% 2.2 0.301 1.18 c6: Carbamidomethyl (+57.02) 615.8001 1,229.58 1,230.59 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AHVVPcFDASK 95.00% 2.27 0.332 3.38 c6: Carbamidomethyl (+57.02) 615.8002 1,229.58 1,230.59 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPYTVTVGQAcNPSAcR 95.00% 2.97 0.411 0 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.6195 1,867.84 1,867.84 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 4.48 0.422 1.66 c4: Carbamidomethyl (+57.02) 628.3185 1,881.93 1,881.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 3.59 0.46 2.43 c4: Carbamidomethyl (+57.02) 628.3195 1,881.93 1,881.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LTVSSLQESGLK 95.00% 3.35 0.492 3.24 631.3537 1,260.69 1,261.70 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LTVSSLQESGLK 95.00% 3.53 0.466 3.48 631.354 1,260.69 1,261.70 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTVLFAGQHIAK 95.00% 3.31 0.438 2.89 642.3735 1,282.73 1,283.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LPQLPITNFSR 95.00% 2.85 0.291 1.96 643.3652 1,284.71 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LPQLPITNFSR 95.00% 3.12 0.333 2.8 643.3658 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LPQLPITNFSR 95.00% 2.8 0.264 2.08 643.366 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LPQLPITNFSR 95.00% 3.15 0.368 2.44 643.3662 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LPQLPITNFSR 95.00% 3.23 0.364 2.85 643.3663 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LPQLPITNFSR 95.00% 2.44 0.252 1.68 643.3664 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LPQLPITNFSR 95.00% 2.81 0.294 0 643.3692 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LPQLPITNFSR 95.00% 2.3 0.236 1.59 643.3743 1,284.73 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGQPVPNFPSK 95.00% 2.38 0.287 0 645.825 1,289.63 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGQPVPNFPSK 95.00% 2.89 0.483 1.51 645.826 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGQPVPNFPSK 95.00% 3.53 0.515 3.85 645.8261 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGQPVPNFPSK 95.00% 2.64 0.325 0 645.8263 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGQPVPNFPSK 95.00% 3.71 0.494 2.72 645.8277 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGQPVPNFPSK 95.00% 3.59 0.51 3.55 645.8278 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGQPVPNFPSK 95.00% 2.89 0.293 1.7 645.8282 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGLLAVQITDPEGKPK 95.00% 3.01 0.417 3.57 646.6769 1,937.01 1,938.02 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GKLDVQFSGLTK 95.00% 3.13 0.43 2.85 646.8618 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GKLDVQFSGLTK 95.00% 3.07 0.406 2.74 646.8629 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GKLDVQFSGLTK 95.00% 3.18 0.409 2.09 646.8634 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GKLDVQFSGLTK 95.00% 3.04 0.42 3.34 646.8637 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GKLDVQFSGLTK 95.00% 2.76 0.37 2.89 646.864 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGLLAVQITDPEGKPK 95.00% 3.34 0.229 1.7 647.0102 1,938.01 1,938.02 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGLLAVQITDPEGKPK 95.00% 3.88 0.487 3.92 647.0117 1,938.01 1,938.02 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GKLDVQFSGLTK 95.00% 2.87 0.494 1.12 647.2918 1,292.57 1,292.72 2 KTN1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GKLDVQFSGLTK 95.00% 2.86 0.401 2.12 647.3626 1,292.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNGTHIPGSPFK 95.00% 2.89 0.367 3.09 651.3335 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNGTHIPGSPFK 95.00% 2.76 0.355 1.85 651.3338 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNGTHIPGSPFK 95.00% 3.31 0.295 1.7 651.3339 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNGTHIPGSPFK 95.00% 3.42 0.328 2.28 651.3347 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNGTHIPGSPFK 95.00% 3.48 0.334 2.52 651.3354 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNGTHIPGSPFK 95.00% 2.82 0.353 2.17 651.3356 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNGTHIPGSPFK 95.00% 3.21 0.292 1.64 651.3356 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNGTHIPGSPFK 95.00% 3.28 0.282 2.14 651.3357 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNGTHIPGSPFK 95.00% 3.33 0.34 2.92 651.3365 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VEPGLGADNSVVR 95.00% 2.49 0.428 3.1 656.8448 1,311.67 1,312.69 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VEPGLGADNSVVR 95.00% 2.8 0.516 4.92 656.8453 1,311.68 1,312.69 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VEPGLGADNSVVR 95.00% 2.29 0.426 2.49 656.8456 1,311.68 1,312.69 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VEPGLGADNSVVR 95.00% 2.32 0.425 3.72 656.8456 1,311.68 1,312.69 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VEPGLGADNSVVR 95.00% 2.18 0.411 3.64 656.8457 1,311.68 1,312.69 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VEPGLGADNSVVR 95.00% 2.41 0.419 4.74 656.8457 1,311.68 1,312.69 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VEPGLGADNSVVR 95.00% 2.32 0.362 4.11 656.8458 1,311.68 1,312.69 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VEPGLGADNSVVR 95.00% 2.09 0.264 1.77 656.8463 1,311.68 1,312.69 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IPEISIQDMTAQVTSPSGK 95.00% 4.14 0.535 1.64 668.0098 2,001.01 2,002.02 3 ITIH1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IPEISIQDMTAQVTSPSGK 95.00% 4.35 0.604 1.92 668.3428 2,002.00 2,002.02 3 ITIH1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% cAPGVVGPAEADIDFDIIR 95.00% 4.23 0.552 2.68 c1: Carbamidomethyl (+57.02) 672.6681 2,014.98 2,014.99 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VSGLGEKVDVGKDQEFTVK 95.00% 3.92 0.404 0 679.3226 2,034.94 2,035.07 3 VINEX_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 3.47 0.478 2.7 682.8535 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 3.21 0.451 0 682.8544 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 3.38 0.315 1.43 682.8544 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 3.31 0.489 2.14 682.8546 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 3.61 0.513 1.4 682.8554 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 3.5 0.504 2.43 682.8555 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 3.66 0.513 0 682.8559 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDVGKDQEFTVK 95.00% 3.82 0.472 3.89 682.856 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 4.09 0.484 2.74 c15: Carbamidomethyl (+57.02) 686.6477 2,056.92 2,057.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 4.47 0.519 3.24 c15: Carbamidomethyl (+57.02) 686.6483 2,056.92 2,057.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 4.28 0.496 3.15 c15: Carbamidomethyl (+57.02) 686.6487 2,056.92 2,057.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 5.02 0.442 2.44 c15: Carbamidomethyl (+57.02) 686.6488 2,056.92 2,057.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 3.57 0.558 3.8 c15: Carbamidomethyl (+57.02) 686.6494 2,056.92 2,057.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 4.62 0.519 2.89 c15: Carbamidomethyl (+57.02) 686.9818 2,057.92 2,057.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 4.17 0.394 3.62 c15: Carbamidomethyl (+57.02) 686.9824 2,057.92 2,057.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 4.34 0.387 2.7 c15: Carbamidomethyl (+57.02) 686.9828 2,057.92 2,057.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 4.62 0.456 2.11 c15: Carbamidomethyl (+57.02) 686.9828 2,057.93 2,057.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 3.86 0.394 4.24 c15: Carbamidomethyl (+57.02) 686.9831 2,057.93 2,057.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 4.38 0.489 2.17 c15: Carbamidomethyl (+57.02) 686.9835 2,057.93 2,057.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 4.04 0.459 3.96 c15: Carbamidomethyl (+57.02) 686.9836 2,057.93 2,057.94 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.3 0.477 2.26 690.3358 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.84 0.47 3.68 690.3383 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 4.22 0.482 3.42 690.339 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.88 0.573 2.89 690.3392 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 4.27 0.589 3.77 690.34 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.61 0.483 4.77 690.3402 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 4.48 0.578 3.62 690.3402 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 4.24 0.546 4 690.3411 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.84 0.543 5 690.3412 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 4.04 0.479 2.7 690.3416 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGPYHIGGSPFK 95.00% 3.58 0.467 3.96 690.3424 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGDEIPFSPYR 95.00% 2.67 0.189 2.49 700.8267 1,399.64 1,400.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGDEIPFSPYR 95.00% 2.69 0.232 3.07 700.8269 1,399.64 1,400.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGDEIPFSPYR 95.00% 2.75 0.19 1.66 700.827 1,399.64 1,400.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGDEIPFSPYR 95.00% 3.32 0.145 3.08 700.8275 1,399.64 1,400.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGDEIPFSPYR 95.00% 2.87 0.232 2.4 700.8277 1,399.64 1,400.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGDEIPFSPYR 95.00% 2.98 0.16 1.89 700.8281 1,399.64 1,400.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGDEIPFSPYR 95.00% 2.68 0.192 0 700.8285 1,399.64 1,400.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGDEIPFSPYR 95.00% 2.61 0.164 1.12 700.8362 1,399.66 1,400.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGDEIPFSPYR 95.00% 3.55 0.159 3.38 700.8375 1,399.66 1,400.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGDEIPFSPYR 95.00% 3.27 0.186 1.89 701.3277 1,400.64 1,400.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YGGDEIPFSPYR 95.00% 3.97 0.13 1.57 701.3288 1,400.64 1,400.65 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% WGDEHIPGSPYR 95.00% 2.92 0.376 3.18 707.3296 1,412.64 1,413.66 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% WGDEHIPGSPYR 95.00% 3.2 0.382 4.15 707.3296 1,412.64 1,413.66 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% WGDEHIPGSPYR 95.00% 2.89 0.381 5 707.3297 1,412.64 1,413.66 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% WGDEHIPGSPYR 95.00% 2.67 0.388 3.44 707.3311 1,412.65 1,413.66 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% WGDEHIPGSPYR 95.00% 2.51 0.237 3.12 707.3318 1,412.65 1,413.66 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% WGDEHIPGSPYR 95.00% 2.47 0.315 2.82 707.3324 1,412.65 1,413.66 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% WGDEHIPGSPYR 95.00% 2.46 0.341 3.49 707.3327 1,412.65 1,413.66 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IANLQTDLSDGLR 95.00% 2.9 0.415 2.48 708.3765 1,414.74 1,415.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IANLQTDLSDGLR 95.00% 3.84 0.469 4.1 708.3767 1,414.74 1,415.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IANLQTDLSDGLR 95.00% 3.9 0.492 2.59 708.377 1,414.74 1,415.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IANLQTDLSDGLR 95.00% 2.26 0.445 2.89 708.3775 1,414.74 1,415.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IANLQTDLSDGLR 95.00% 3.01 0.279 4.57 708.3775 1,414.74 1,415.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IANLQTDLSDGLR 95.00% 2.6 0.339 3.37 708.3779 1,414.74 1,415.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IANLQTDLSDGLR 95.00% 2.35 0.46 2.64 708.3799 1,414.74 1,415.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RLTVSSLQESGLK 95.00% 3.4 0.459 4.03 709.4035 1,416.79 1,417.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% RLTVSSLQESGLK 95.00% 3.84 0.358 3.6 709.4037 1,416.79 1,417.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSK 95.00% 5.11 0.57 4.24 713.8779 1,425.74 1,426.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSK 95.00% 4 0.616 4.92 713.8784 1,425.74 1,426.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSK 95.00% 3.61 0.601 4.82 713.8791 1,425.74 1,426.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSK 95.00% 4.18 0.607 4.02 713.8794 1,425.74 1,426.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSK 95.00% 4.59 0.574 4.8 713.8794 1,425.74 1,426.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSK 95.00% 4.28 0.583 4.6 713.8795 1,425.74 1,426.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSK 95.00% 4.13 0.626 4.31 713.8797 1,425.74 1,426.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSK 95.00% 3.92 0.593 3.85 713.8802 1,425.74 1,426.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSK 95.00% 4.5 0.571 4.3 713.8803 1,425.74 1,426.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSK 95.00% 4.22 0.582 4.51 713.8804 1,425.75 1,426.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 4.89 0.435 3.49 715.3604 1,428.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 4.23 0.398 4.06 715.3608 1,428.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 4.25 0.383 4.77 715.3611 1,428.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 4.11 0.468 5.16 715.3614 1,428.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 3.97 0.432 4.06 715.3614 1,428.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 4.03 0.353 4.6 715.3617 1,428.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 4 0.397 4.25 715.3618 1,428.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 4.43 0.426 3.68 715.3622 1,428.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 3.95 0.465 4.46 715.3623 1,428.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 2.48 0.433 0 715.3626 1,428.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 4.12 0.355 4.48 715.3626 1,428.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 4.1 0.408 5.11 715.3626 1,428.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAEMPATEKDLAEDAPWKK 95.00% 3.88 0.418 0 715.6763 2,144.01 2,145.02 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AFGPGLQGGSAGSPAR 95.00% 4.28 0.327 4.37 715.8629 1,429.71 1,429.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAEMPATEKDLAEDAPWKK 95.00% 4.45 0.536 0 716.0106 2,145.01 2,145.02 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AYGPGIEPTGNMVK 95.00% 3.98 0.587 2.72 717.3561 1,432.70 1,433.71 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AYGPGIEPTGNMVK 95.00% 3.82 0.569 3.85 717.357 1,432.70 1,433.71 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AYGPGIEPTGNMVK 95.00% 3.03 0.365 1.89 717.3595 1,432.70 1,433.71 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AYGPGIEPTGNMVK 95.00% 3.77 0.384 1.72 717.3596 1,432.70 1,433.71 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AYGPGIEPTGNMVK 95.00% 3.49 0.372 1.8 717.8597 1,433.70 1,433.71 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% ANLPQSFQVDTSK 95.00% 3.51 0.541 4.7 717.8634 1,433.71 1,434.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% ANLPQSFQVDTSK 95.00% 2.25 0.396 1.96 717.8636 1,433.71 1,434.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% ANLPQSFQVDTSK 95.00% 3.62 0.427 4 717.8664 1,433.72 1,434.72 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AGNNMLLVGVHGPR 95.00% 2.97 0.356 3.31 717.8894 1,433.76 1,434.76 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LVSNHSLHETSSVFVDSLTK 95.00% 5.02 0.593 4.28 734.3784 2,200.11 2,200.13 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LVSNHSLHETSSVFVDSLTK 95.00% 5.06 0.612 4.57 734.3797 2,200.12 2,200.13 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LVSNHSLHETSSVFVDSLTK 95.00% 4.95 0.588 4.3 734.3797 2,200.12 2,200.13 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LVSNHSLHETSSVFVDSLTK 95.00% 5.48 0.614 4.38 734.3806 2,200.12 2,200.13 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LVSNHSLHETSSVFVDSLTK 95.00% 4.76 0.586 4.05 734.3808 2,200.12 2,200.13 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LVSNHSLHETSSVFVDSLTK 95.00% 5.16 0.563 4.06 734.3814 2,200.12 2,200.13 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LVSNHSLHETSSVFVDSLTK 95.00% 4.25 0.535 3.11 734.3814 2,200.12 2,200.13 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LVSNHSLHETSSVFVDSLTK 95.00% 4.46 0.554 4.66 734.3816 2,200.12 2,200.13 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LVSNHSLHETSSVFVDSLTK 95.00% 3.93 0.449 4.37 734.3892 2,200.14 2,200.13 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LVSNHSLHETSSVFVDSLTK 95.00% 0 0 3.38 734.7122 2,201.11 2,200.13 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 3.97 0.374 1.96 750.8775 1,499.74 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 4.45 0.499 2.38 750.8793 1,499.74 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 5.16 0.539 3.2 750.88 1,499.74 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 4.94 0.544 2.85 750.88 1,499.74 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 5.26 0.558 1.32 750.8801 1,499.74 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 5.17 0.547 2.85 750.8803 1,499.75 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 3.43 0.42 3.05 750.8804 1,499.75 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 4.59 0.554 1.66 750.8809 1,499.75 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 4.56 0.535 2.74 750.8809 1,499.75 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 5 0.553 3.39 750.8811 1,499.75 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 4.38 0.544 2.32 751.3803 1,500.75 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 5.13 0.537 2.32 751.3808 1,500.75 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGGLSLAIEGPSK 95.00% 5.57 0.558 2.43 751.381 1,500.75 1,500.75 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FVPAEMGTHTVSVK 95.00% 4.4 0.492 5.6 751.886 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FVPAEMGTHTVSVK 95.00% 3.47 0.518 4.55 751.8861 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FVPAEMGTHTVSVK 95.00% 4.13 0.512 7.04 751.8869 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FVPAEMGTHTVSVK 95.00% 4.13 0.492 5.55 751.8875 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FVPAEMGTHTVSVK 95.00% 3.39 0.485 6.04 751.8877 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.33 0.583 4.89 751.8996 1,501.78 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.15 0.574 4.44 751.8997 1,501.78 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.18 0.442 5.6 751.9002 1,501.78 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.22 0.575 4.66 751.9013 1,501.79 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.65 0.513 5.49 751.9016 1,501.79 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.54 0.555 5.57 751.9018 1,501.79 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.35 0.575 4.54 751.9018 1,501.79 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.79 0.584 6.17 751.9019 1,501.79 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.67 0.543 6.11 751.9019 1,501.79 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.62 0.596 5.89 751.9026 1,501.79 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.02 0.547 4.03 751.9063 1,501.80 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.35 0.555 4.24 751.9092 1,501.80 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FVPAEMGTHTVSVK 95.00% 4.3 0.506 5.39 752.3869 1,502.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.98 0.524 5.62 752.4021 1,502.79 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VNQPASFAVSLNGAK 95.00% 4.49 0.545 5.31 752.4055 1,502.80 1,502.80 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DGScGVAYVVQEPGDYEVSVK 95.00% 2.16 0.223 1.82 c4: Carbamidomethyl (+57.02) 753.6806 2,258.02 2,258.03 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 3.11 0.404 3 758.3799 1,514.74 1,515.76 2 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 2.86 0.369 3 758.3819 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 3.2 0.361 2.96 758.3826 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 3.6 0.39 4.49 758.3826 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 3.32 0.43 1.42 758.3831 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 3.36 0.343 3.04 758.3833 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 2.58 0.363 2.52 758.3836 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 3.31 0.401 3.7 758.3843 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FADQHVPGSPFSVK 95.00% 3.17 0.363 2.52 758.3844 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FVPAEmGTHTVSVK 95.00% 1.98 0.382 0 m6: Oxidation (+15.99) 759.339 1,516.66 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FVPAEmGTHTVSVK 95.00% 3.34 0.556 4.8 m6: Oxidation (+15.99) 759.8846 1,517.75 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FVPAEmGTHTVSVK 95.00% 3.56 0.518 5.51 m6: Oxidation (+15.99) 759.8849 1,517.75 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VHSPSGALEEcYVTEIDQDK 95.00% 5.47 0.456 2.13 c11: Carbamidomethyl (+57.02) 760.0167 2,277.03 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VHSPSGALEEcYVTEIDQDK 95.00% 5.74 0.537 1.52 c11: Carbamidomethyl (+57.02) 760.0167 2,277.03 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AEAGVPAEFSIWTR 95.00% 4.47 0.364 5.07 767.3832 1,532.75 1,533.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AEAGVPAEFSIWTR 95.00% 4.33 0.386 4.55 767.386 1,532.76 1,533.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AEAGVPAEFSIWTR 95.00% 4.54 0.399 4.68 767.3869 1,532.76 1,533.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AEAGVPAEFSIWTR 95.00% 4.25 0.418 6.01 767.3869 1,532.76 1,533.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AEAGVPAEFSIWTR 95.00% 4.18 0.337 4.85 767.3876 1,532.76 1,533.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AEAGVPAEFSIWTR 95.00% 3.33 0.14 3.57 767.3884 1,532.76 1,533.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AEAGVPAEFSIWTR 95.00% 4.17 0.394 3.74 767.3886 1,532.76 1,533.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AEAGVPAEFSIWTR 95.00% 2.49 0.273 1.82 767.3887 1,532.76 1,533.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AEAGVPAEFSIWTR 95.00% 3.16 0.412 1.37 767.3908 1,532.77 1,533.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% AEAGVPAEFSIWTR 95.00% 3.25 0.199 1.32 767.3952 1,532.77 1,533.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPFSVAVSPSLDLSK 95.00% 4.38 0.542 0 767.4115 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPFSVAVSPSLDLSK 95.00% 4.53 0.52 1.8 767.4115 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.89 0.509 1.57 769.0561 2,304.14 2,304.15 3 FLNC_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGYGGLSLSIEGPSK 95.00% 4.7 0.545 3.24 775.8871 1,549.76 1,550.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGYGGLSLSIEGPSK 95.00% 4.9 0.537 4.77 775.8888 1,549.76 1,550.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGYGGLSLSIEGPSK 95.00% 4.71 0.539 4.1 775.8893 1,549.76 1,550.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGYGGLSLSIEGPSK 95.00% 4.39 0.508 3.68 775.8909 1,549.77 1,550.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.27 0.581 3.74 785.9051 1,569.79 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.88 0.586 4.96 785.9057 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.58 0.631 4.51 785.9058 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.93 0.602 4.64 785.906 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.25 0.64 3.68 785.906 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.69 0.609 4.25 785.9064 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.63 0.618 3.48 785.9065 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.41 0.572 5 785.9067 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.68 0.619 4.4 785.9069 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 5.14 0.586 4.82 785.9071 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 3.42 0.558 4.3 785.9072 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.98 0.596 5 785.9073 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 3.55 0.527 4.38 785.9083 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.85 0.57 3.8 785.9098 1,569.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.97 0.614 4.92 786.4069 1,570.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 4.73 0.522 3.37 786.4081 1,570.80 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GAGTGGLGLAVEGPSEAK 95.00% 0 0 4.38 787.3249 1,572.63 1,570.81 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSKAEISFEDR 95.00% 4.03 0.561 3.32 792.4015 2,374.18 2,374.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YAPSEAGLHEMDIR 95.00% 2.39 0.319 2.82 794.8745 1,587.73 1,588.74 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YAPSEAGLHEMDIR 95.00% 3.45 0.433 2.4 794.8755 1,587.74 1,588.74 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DNGNGTYScSYVPR 95.00% 2.94 0.479 2.23 c9: Carbamidomethyl (+57.02) 795.3355 1,588.66 1,589.67 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DNGNGTYScSYVPR 95.00% 3.12 0.482 2.41 c9: Carbamidomethyl (+57.02) 795.3363 1,588.66 1,589.67 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DNGNGTYScSYVPR 95.00% 3.01 0.491 2.36 c9: Carbamidomethyl (+57.02) 795.3366 1,588.66 1,589.67 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DNGNGTYScSYVPR 95.00% 2.27 0.388 1.23 c9: Carbamidomethyl (+57.02) 795.337 1,588.66 1,589.67 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.08 0.498 2.72 801.8839 1,601.75 1,602.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.35 0.497 3.44 801.8857 1,601.76 1,602.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 4.21 0.547 7.08 801.8861 1,601.76 1,602.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.37 0.534 2.59 801.8862 1,601.76 1,602.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 2.41 0.232 2.3 801.8866 1,601.76 1,602.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 2.52 0.316 1.77 802.3863 1,602.76 1,602.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.71 0.512 4.96 802.3869 1,602.76 1,602.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.64 0.48 4.64 802.3877 1,602.76 1,602.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YNEQHVPGSPFTAR 95.00% 3.46 0.519 6 802.3882 1,602.76 1,602.77 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.16 0.4 3.1 814.3999 2,440.18 2,440.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.25 0.433 3.51 814.4 2,440.18 2,440.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 5.09 0.446 4.4 814.4013 2,440.18 2,440.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.44 0.454 4.46 814.4015 2,440.18 2,440.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.24 0.36 4.48 814.402 2,440.18 2,440.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.39 0.494 4.14 814.4027 2,440.18 2,440.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.61 0.247 4.06 814.4028 2,440.18 2,440.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.97 0.413 3.85 814.4034 2,440.19 2,440.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% NGQHVASSPIPVVISQSEIGDASR 95.00% 6.04 0.611 2.8 817.0861 2,448.23 2,448.25 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% NGQHVASSPIPVVISQSEIGDASR 95.00% 5.2 0.585 4.74 817.0864 2,448.24 2,448.25 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% NGQHVASSPIPVVISQSEIGDASR 95.00% 5.85 0.634 3.31 817.0875 2,448.24 2,448.25 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.38 0.422 2.77 c11: Carbamidomethyl (+57.02) 817.434 2,449.28 2,449.29 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.05 0.524 3.74 c11: Carbamidomethyl (+57.02) 817.4341 2,449.28 2,449.29 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.11 0.491 2.92 c11: Carbamidomethyl (+57.02) 817.4343 2,449.28 2,449.29 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.17 0.544 3.92 c11: Carbamidomethyl (+57.02) 817.4343 2,449.28 2,449.29 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 5.19 0.605 4.11 c11: Carbamidomethyl (+57.02) 817.4344 2,449.28 2,449.29 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.76 0.546 3.42 c11: Carbamidomethyl (+57.02) 817.4345 2,449.28 2,449.29 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.03 0.469 3.32 c11: Carbamidomethyl (+57.02) 817.4352 2,449.28 2,449.29 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.09 0.514 4.28 c11: Carbamidomethyl (+57.02) 817.4352 2,449.28 2,449.29 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.87 0.49 3.48 c11: Carbamidomethyl (+57.02) 817.4357 2,449.28 2,449.29 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDINTEDLEDGTcR 95.00% 4.66 0.507 4.22 c13: Carbamidomethyl (+57.02) 818.8597 1,635.70 1,636.71 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDINTEDLEDGTcR 95.00% 4.39 0.476 4.7 c13: Carbamidomethyl (+57.02) 818.8603 1,635.71 1,636.71 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VDINTEDLEDGTcR 95.00% 3.57 0.424 2.62 c13: Carbamidomethyl (+57.02) 818.8621 1,635.71 1,636.71 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.46 0.301 2.66 823.3998 2,467.18 2,467.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.93 0.331 3.15 823.4002 2,467.18 2,467.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.21 0.262 4.07 823.4008 2,467.18 2,467.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.96 0.375 2.82 823.4017 2,467.18 2,467.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.08 0.391 2.77 823.4018 2,467.18 2,467.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.59 0.299 4 823.4023 2,467.18 2,467.19 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 3.7 0.428 3.19 823.9392 1,645.86 1,646.88 2 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 4.01 0.459 4.17 823.9403 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 3.82 0.427 2.85 823.9404 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 4.22 0.423 3.96 823.9408 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 3.72 0.448 4.43 823.9411 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVAVNKPAEFTVDAK 95.00% 3.66 0.399 4.24 824.4426 1,646.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTAQGPGLEPSGNIANK 95.00% 4.66 0.55 4.59 826.9322 1,651.85 1,652.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTAQGPGLEPSGNIANK 95.00% 4.76 0.564 4.85 826.9323 1,651.85 1,652.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTAQGPGLEPSGNIANK 95.00% 3.47 0.482 1.46 826.9323 1,651.85 1,652.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTAQGPGLEPSGNIANK 95.00% 5.23 0.59 4.96 826.9328 1,651.85 1,652.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTAQGPGLEPSGNIANK 95.00% 5.12 0.576 5.77 826.933 1,651.85 1,652.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTAQGPGLEPSGNIANK 95.00% 4.61 0.576 5.85 826.9331 1,651.85 1,652.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTAQGPGLEPSGNIANK 95.00% 4.92 0.578 5 826.9335 1,651.85 1,652.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTAQGPGLEPSGNIANK 95.00% 5.1 0.591 5.37 826.9338 1,651.85 1,652.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTAQGPGLEPSGNIANK 95.00% 4.89 0.637 4.66 826.9339 1,651.85 1,652.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTAQGPGLEPSGNIANK 95.00% 4.46 0.499 3.92 826.9348 1,651.85 1,652.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTAQGPGLEPSGNIANK 95.00% 3.52 0.495 3.21 826.9391 1,651.86 1,652.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTAQGPGLEPSGNIANK 95.00% 4.56 0.564 2.26 827.4358 1,652.86 1,652.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 5.36 0.605 2.8 835.0994 2,502.27 2,502.28 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 5 0.522 2.82 835.0995 2,502.28 2,502.28 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VKMDcQEcPEGYR 95.00% 3.87 0.49 5.34 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 836.3482 1,670.68 1,671.69 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VKMDcQEcPEGYR 95.00% 3.96 0.456 4.66 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 836.3486 1,670.68 1,671.69 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 4.73 0.501 3.28 849.961 1,697.91 1,698.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 4.26 0.542 2.51 849.9619 1,697.91 1,698.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 4.65 0.468 3.51 850.463 1,698.91 1,698.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TGVELGKPTHFTVNAK 95.00% 4.14 0.41 2.8 850.4652 1,698.91 1,698.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYTPMAPGSYLISIK 95.00% 3.66 0.43 2.43 870.9629 1,739.91 1,740.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYTPMAPGSYLISIK 95.00% 3.8 0.539 3.04 870.9632 1,739.91 1,740.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYTPMAPGSYLISIK 95.00% 3.38 0.409 5.32 870.9649 1,739.91 1,740.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYTPMAPGSYLISIK 95.00% 3.82 0.457 2.62 871.4666 1,740.92 1,740.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYTPMAPGSYLISIK 95.00% 3.62 0.54 2.6 871.4696 1,740.92 1,740.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 2.79 0.309 0 875.9433 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 3.78 0.535 1.12 876.443 1,750.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% TFSVWYVPEVTGTHK 95.00% 3.52 0.493 0 876.443 1,750.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPFEVYVDKSQGDASK 95.00% 4.83 0.51 3.54 878.9209 1,755.83 1,756.84 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPFEVYVDKSQGDASK 95.00% 5.07 0.513 5.01 879.4229 1,756.83 1,756.84 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYTPmAPGSYLISIK 95.00% 4.07 0.565 2.46 m6: Oxidation (+15.99) 879.4644 1,756.91 1,756.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYTPmAPGSYLISIK 95.00% 3.73 0.426 1.2 m6: Oxidation (+15.99) 879.4646 1,756.91 1,756.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VANPSGNLTETYVQDR 95.00% 5.26 0.654 7.04 882.43 1,762.84 1,763.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VANPSGNLTETYVQDR 95.00% 5.27 0.612 5.68 882.4301 1,762.84 1,763.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VANPSGNLTETYVQDR 95.00% 5.07 0.651 6.89 882.4308 1,762.85 1,763.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VANPSGNLTETYVQDR 95.00% 5.26 0.632 6.77 882.4333 1,762.85 1,763.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VANPSGNLTETYVQDR 95.00% 5.36 0.627 5.49 882.9308 1,763.85 1,763.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VANPSGNLTETYVQDR 95.00% 5.43 0.639 6.74 882.9311 1,763.85 1,763.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VANPSGNLTETYVQDR 95.00% 5.18 0.619 6.14 882.932 1,763.85 1,763.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VANPSGNLTETYVQDR 95.00% 4.97 0.607 7.66 882.9322 1,763.85 1,763.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VANPSGNLTETYVQDR 95.00% 5.2 0.627 5.89 882.9326 1,763.85 1,763.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VANPSGNLTETYVQDR 95.00% 5.05 0.606 6 882.9339 1,763.85 1,763.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VANPSGNLTETYVQDR 95.00% 0 0 3.74 883.9008 1,765.79 1,763.86 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VQVQDNEGcPVEALVK 94.50% 3.23 0.17 0 c9: Carbamidomethyl (+57.02) 892.4955 1,782.98 1,784.89 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DVDIIDHHDNTYTVK 95.00% 4.04 0.606 2.77 892.9242 1,783.83 1,784.85 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DVDIIDHHDNTYTVK 95.00% 4.39 0.572 4.27 892.9254 1,783.84 1,784.85 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VQVQDNEGcPVEALVK 95.00% 5.49 0.563 4.38 c9: Carbamidomethyl (+57.02) 892.9439 1,783.87 1,784.89 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VQVQDNEGcPVEALVK 95.00% 5.46 0.57 5.68 c9: Carbamidomethyl (+57.02) 892.9442 1,783.87 1,784.89 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VQVQDNEGcPVEALVK 95.00% 5.6 0.579 2.96 c9: Carbamidomethyl (+57.02) 892.9443 1,783.87 1,784.89 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VQVQDNEGcPVEALVK 95.00% 5.33 0.561 5.55 c9: Carbamidomethyl (+57.02) 892.9445 1,783.87 1,784.89 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VQVQDNEGcPVEALVK 95.00% 5.47 0.586 4.74 c9: Carbamidomethyl (+57.02) 892.9449 1,783.87 1,784.89 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VQVQDNEGcPVEALVK 95.00% 5.16 0.59 5.89 c9: Carbamidomethyl (+57.02) 892.9458 1,783.88 1,784.89 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VQVQDNEGcPVEALVK 95.00% 4.79 0.584 6.44 c9: Carbamidomethyl (+57.02) 892.946 1,783.88 1,784.89 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DVDIIDHHDNTYTVK 95.00% 4.34 0.528 2.38 893.4254 1,784.84 1,784.85 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DVDIIDHHDNTYTVK 95.00% 3.94 0.547 3.64 893.4272 1,784.84 1,784.85 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VQVQDNEGcPVEALVK 95.00% 5.77 0.502 5.57 c9: Carbamidomethyl (+57.02) 893.4467 1,784.88 1,784.89 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VQVQDNEGcPVEALVK 95.00% 5.43 0.534 3.85 c9: Carbamidomethyl (+57.02) 893.4475 1,784.88 1,784.89 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VAQPTITDNKDGTVTVR 95.00% 4.31 0.445 5.74 907.9821 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VAQPTITDNKDGTVTVR 95.00% 4.46 0.43 4.44 908.4828 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VAQPTITDNKDGTVTVR 95.00% 3.94 0.425 1.85 908.4839 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VAQPTITDNKDGTVTVR 95.00% 4.54 0.405 4.96 908.484 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.39 0.558 3.48 c11: Carbamidomethyl (+57.02) 923.1039 2,766.29 2,766.30 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.6 0.503 4.62 c11: Carbamidomethyl (+57.02) 923.1043 2,766.29 2,766.30 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.87 0.454 4.48 c11: Carbamidomethyl (+57.02) 923.106 2,766.29 2,766.30 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.61 0.549 3.51 c11: Carbamidomethyl (+57.02) 923.1063 2,766.30 2,766.30 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.72 0.525 4.43 c11: Carbamidomethyl (+57.02) 923.1066 2,766.30 2,766.30 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.3 0.417 4.33 c11: Carbamidomethyl (+57.02) 923.1073 2,766.30 2,766.30 3
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPYTVTVGQAcNPSAcR 95.00% 4.69 0.494 7.02 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4221 1,866.83 1,867.84 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPYTVTVGQAcNPSAcR 95.00% 5 0.552 4.64 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4247 1,866.83 1,867.84 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPYTVTVGQAcNPSAcR 95.00% 5 0.551 6.64 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4247 1,866.83 1,867.84 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPYTVTVGQAcNPSAcR 95.00% 3.13 0.555 2.27 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4262 1,866.84 1,867.84 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPYTVTVGQAcNPSAcR 95.00% 5.09 0.49 6 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9231 1,867.83 1,867.84 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SPYTVTVGQAcNPSAcR 95.00% 5.16 0.533 7.04 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9248 1,867.83 1,867.84 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 3.11 0.409 3.4 c4: Carbamidomethyl (+57.02) 940.9586 1,879.90 1,881.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 4.22 0.553 2.92 c4: Carbamidomethyl (+57.02) 941.4721 1,880.93 1,881.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 4.44 0.597 3.82 c4: Carbamidomethyl (+57.02) 941.4731 1,880.93 1,881.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 4.23 0.504 4.51 c4: Carbamidomethyl (+57.02) 941.4737 1,880.93 1,881.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 3.38 0.539 3.23 c4: Carbamidomethyl (+57.02) 941.4744 1,880.93 1,881.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 4.17 0.472 2.72 c4: Carbamidomethyl (+57.02) 941.9744 1,881.93 1,881.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 4.18 0.494 4.74 c4: Carbamidomethyl (+57.02) 941.9751 1,881.93 1,881.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 4.34 0.496 2.92 c4: Carbamidomethyl (+57.02) 941.9752 1,881.93 1,881.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 4.41 0.478 3.3 c4: Carbamidomethyl (+57.02) 941.9752 1,881.93 1,881.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 4.34 0.488 3.47 c4: Carbamidomethyl (+57.02) 941.9755 1,881.94 1,881.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% VTYcPTEPGNYIINIK 95.00% 4.2 0.539 4.89 c4: Carbamidomethyl (+57.02) 941.9765 1,881.94 1,881.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EGPYSISVLYGDEEVPR 95.00% 5.18 0.578 5.42 955.4602 1,908.90 1,909.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EGPYSISVLYGDEEVPR 95.00% 4.74 0.583 6.11 955.4604 1,908.91 1,909.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EGPYSISVLYGDEEVPR 95.00% 4.9 0.574 5.64 955.461 1,908.91 1,909.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EGPYSISVLYGDEEVPR 95.00% 5 0.574 5.68 955.4618 1,908.91 1,909.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EGPYSISVLYGDEEVPR 95.00% 5.01 0.57 5.52 955.962 1,909.91 1,909.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EGPYSISVLYGDEEVPR 95.00% 4.44 0.5 2.57 955.9627 1,909.91 1,909.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% EGPYSISVLYGDEEVPR 95.00% 3.43 0.306 1.29 955.9688 1,909.92 1,909.92 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGLLAVQITDPEGKPK 95.00% 4.2 0 2.72 969.5168 1,937.02 1,938.02 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGLLAVQITDPEGKPK 95.00% 4.87 0.323 3.47 970.0121 1,938.01 1,938.02 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGLLAVQITDPEGKPK 95.00% 5.17 0.348 3.21 970.0136 1,938.01 1,938.02 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGLLAVQITDPEGKPK 95.00% 4.97 0.389 4.82 970.0139 1,938.01 1,938.02 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DAGEGLLAVQITDPEGKPK 95.00% 5.53 0.401 6.46 970.014 1,938.01 1,938.02 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IPEISIQDMTAQVTSPSGK 95.00% 4.89 0.699 11.6 1,001.51 2,001.00 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IPEISIQDMTAQVTSPSGK 95.00% 6.1 0.719 9.72 1,002.01 2,002.00 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IPEISIQDMTAQVTSPSGK 95.00% 6.48 0.675 9.1 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IPEISIQDMTAQVTSPSGK 95.00% 6.23 0.706 10.1 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% IPEISIQDMTAQVTSPSGK 95.00% 6.01 0.709 8.08 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% cAPGVVGPAEADIDFDIIR 95.00% 5.72 0.626 8.24 c1: Carbamidomethyl (+57.02) 1,008.00 2,013.98 2,014.99 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 6.37 0.649 8.72 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.92 2,057.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 6.48 0.642 10.1 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% THEAEIVEGENHTYcIR 95.00% 6.43 0.64 9.64 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LVSNHSLHETSSVFVDSLTK 95.00% 6.03 0.597 5.21 1,101.07 2,200.12 2,200.13 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LVSNHSLHETSSVFVDSLTK 95.00% 6.19 0.586 4.89 1,101.07 2,200.12 2,200.13 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DGScGVAYVVQEPGDYEVSVK 95.00% 4.45 0.652 3.55 c4: Carbamidomethyl (+57.02) 1,129.51 2,257.01 2,258.03 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DGScGVAYVVQEPGDYEVSVK 95.00% 4.97 0.589 4.05 c4: Carbamidomethyl (+57.02) 1,130.01 2,258.01 2,258.03 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.31 0.629 4.02 c4: Carbamidomethyl (+57.02) 1,130.01 2,258.01 2,258.03 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.53 0.62 3.57 c4: Carbamidomethyl (+57.02) 1,130.01 2,258.01 2,258.03 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.13 0.621 3.72 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.01 2,258.03 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.27 0.633 3.96 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.24 0.611 4.89 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.49 0.642 6.3 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.34 0.611 4.66 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.4 0.663 5.62 1,144.09 2,286.17 2,286.18 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.39 0.67 9.54 1,144.09 2,286.17 2,286.18 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.43 0.657 4.6 1,144.09 2,286.17 2,286.18 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.37 0.668 4.57 1,144.09 2,286.17 2,286.18 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.51 0.667 5.15 1,144.09 2,286.17 2,286.18 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.38 0.579 8.21 1,157.55 2,313.09 2,313.10 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.49 0.569 6.51 1,172.11 2,342.21 2,342.22 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.46 0.54 6.32 1,172.12 2,342.21 2,342.22 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.32 0.531 7 1,172.12 2,342.22 2,342.22 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.14 0.528 7.35 1,172.12 2,342.22 2,342.22 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6 0.715 8 1,273.13 2,544.24 2,544.26 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.39 0.728 9.05 1,273.13 2,544.25 2,544.26 2
 SAMPLE 1 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 107 608 45.40% LQVEPAVDTSGVQcYGPGIEGQGVFR 95.00% 6.32 0.703 8.42 c14: Carbamidomethyl (+57.02) 1,382.67 2,763.33 2,763.34 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQKK 95.00% 1.63 0.18 1.36 452.2947 1,353.86 1,354.87 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQKK 95.00% 2.17 0.284 1.59 452.2947 1,353.86 1,354.87 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQKK 95.00% 2.79 0.235 1.59 452.2949 1,353.86 1,354.87 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQKK 95.00% 1.12 0.0874 3.27 452.2952 1,353.86 1,354.87 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQKK 95.00% 1.77 0.281 0 452.6293 1,354.86 1,354.87 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQKK 95.00% 2.21 0.276 0 452.6297 1,354.87 1,354.87 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDVGKDQEFTVK 95.00% 2.54 0.43 0 455.5739 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDVGKDQEFTVK 95.00% 2.13 0.429 0 455.5741 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDVGKDQEFTVK 95.00% 1.99 0.39 0 455.5743 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDVGKDQEFTVK 95.00% 2.44 0.364 1.62 455.5743 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDVGKDQEFTVK 95.00% 2.24 0.445 1.92 455.5743 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDVGKDQEFTVK 95.00% 2.87 0.403 0 455.5744 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDVGKDQEFTVK 95.00% 2.13 0.217 0 455.5746 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDVGKDQEFTVK 95.00% 2.51 0.397 0 455.5748 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 2.73 0.45 1.57 460.5633 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 2.96 0.464 1.38 460.5634 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 2.93 0.518 2.28 460.5634 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.01 0.432 2.15 460.5639 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.32 0.492 1.8 460.5642 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.11 0.493 1.28 460.5648 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 2.99 0.505 1.29 460.5658 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.41 0.488 2.01 460.566 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.28 0.4 0 460.8977 1,379.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LRNGHVGISFVPK 95.00% 2.96 0.405 2.89 475.6055 1,423.79 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LRNGHVGISFVPK 95.00% 2.71 0.314 2.72 475.6056 1,423.79 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AGNNMLLVGVHGPR 95.00% 3.35 0.415 0 478.925 1,433.75 1,434.76 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AGNNMLLVGVHGPR 95.00% 3.13 0.379 0 478.9251 1,433.75 1,434.76 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AGNNMLLVGVHGPR 95.00% 3.2 0.504 0 478.9256 1,433.75 1,434.76 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AGNNMLLVGVHGPR 95.00% 2.41 0.249 0 478.9256 1,433.75 1,434.76 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AGNNMLLVGVHGPR 95.00% 3.92 0.537 0.959 478.9258 1,433.75 1,434.76 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AGNNMLLVGVHGPR 95.00% 3.73 0.508 0.959 478.9261 1,433.76 1,434.76 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AGNNMLLVGVHGPR 95.00% 3.84 0.451 0 478.9264 1,433.76 1,434.76 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AGNNMLLVGVHGPR 95.00% 3.94 0.555 0 478.9268 1,433.76 1,434.76 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AGNNMLLVGVHGPR 95.00% 3.78 0.426 0 478.9271 1,433.76 1,434.76 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AGNNMLLVGVHGPR 95.00% 3.37 0.448 0 479.2641 1,434.77 1,434.76 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LLGWIQNK 95.00% 2.71 0.171 0 486.2859 970.5561 971.568 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LLGWIQNK 95.00% 2.71 0.17 0 486.2866 970.5575 971.568 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LLGWIQNK 95.00% 2.85 0.167 0 486.2867 970.5578 971.568 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LLGWIQNK 95.00% 2.76 0.158 0 486.2869 970.5581 971.568 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LLGWIQNK 95.00% 2.67 0.19 0 486.2871 970.5585 971.568 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LLGWIQNK 95.00% 2.72 0.127 0 486.2873 970.5589 971.568 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LLGWIQNK 95.00% 2.72 0.125 0 486.2873 970.5589 971.568 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LLGWIQNK 95.00% 2.47 0.166 0 486.2877 970.5598 971.568 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 3.54 0.256 0 501.6034 1,501.79 1,502.80 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 2.21 0.18 1.51 505.9247 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 2.26 0.306 1.96 505.9248 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 2.72 0.217 1.77 506.2564 1,515.75 1,515.76 3 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 3.23 0.42 2.7 506.2594 1,515.75 1,515.76 3 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 2.04 0.297 0 506.2952 1,515.86 1,515.76 3 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 3.94 0.453 0 511.9268 1,532.76 1,533.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 3.67 0.462 0 511.9276 1,532.76 1,533.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 3.26 0.302 0 512.2609 1,533.76 1,533.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LSPFMADIR 95.00% 2.42 0.312 1.26 525.2738 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LSPFMADIR 95.00% 2.43 0.128 1.17 525.274 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LSPFMADIR 95.00% 2.19 0.228 0 525.2747 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LSPFMADIR 95.00% 2.43 0.271 0 525.2751 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 2.59 0.281 0 534.9248 1,601.75 1,602.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.12 0.384 0 534.9254 1,601.75 1,602.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.66 0.447 1.82 534.9256 1,601.75 1,602.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.16 0.226 2.12 534.9256 1,601.75 1,602.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.29 0.386 1.8 534.926 1,601.75 1,602.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.99 0.417 5.31 534.926 1,601.75 1,602.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.74 0.411 3.92 534.9263 1,601.76 1,602.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.12 0.319 4.17 534.9263 1,601.76 1,602.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.4 0.38 3.11 534.9264 1,601.76 1,602.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.5 0.396 2.47 534.9266 1,601.76 1,602.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 4.31 0.505 3.05 534.9266 1,601.76 1,602.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.85 0.468 2.33 534.9267 1,601.76 1,602.77 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFEVYVDK 95.00% 2.6 0.405 1.77 542.2692 1,082.52 1,083.54 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFEVYVDK 95.00% 2.82 0.458 1.52 542.2702 1,082.52 1,083.54 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFEVYVDK 95.00% 2.88 0.387 1.68 542.2711 1,082.53 1,083.54 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFEVYVDK 95.00% 2.46 0.417 1.64 542.2715 1,082.53 1,083.54 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFEVYVDK 95.00% 2.88 0.442 1.2 542.2718 1,082.53 1,083.54 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFEVYVDK 95.00% 2.74 0.458 1.46 542.2719 1,082.53 1,083.54 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFEVYVDK 95.00% 2.35 0.317 1.92 542.2721 1,082.53 1,083.54 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LYSVSYLLK 95.00% 2.21 0.254 0 543.3117 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LYSVSYLLK 95.00% 2.42 0.35 0 543.3145 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LYSVSYLLK 95.00% 2.27 0.2 0 543.3145 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LYSVSYLLK 95.00% 2.34 0.397 0 543.3146 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LYSVSYLLK 95.00% 2.4 0.271 0 543.3147 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LYSVSYLLK 95.00% 2.39 0.273 0 543.3148 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LYSVSYLLK 95.00% 2.37 0.318 0 543.315 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LYSVSYLLK 95.00% 2.32 0.254 0 543.3152 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LYSVSYLLK 95.00% 2.27 0.292 0 543.3162 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LYSVSYLLK 95.00% 2.02 0.323 0 543.3222 1,084.63 1,085.62 2 PDLI5_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVAVNKPAEFTVDAK 95.00% 3.42 0.426 1.37 549.627 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVAVNKPAEFTVDAK 95.00% 3.77 0.542 3.11 549.6282 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVAVNKPAEFTVDAK 95.00% 3.74 0.575 2.52 549.629 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVAVNKPAEFTVDAK 95.00% 3.68 0.559 2.55 549.6292 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVAVNKPAEFTVDAK 95.00% 3.72 0.606 1.15 549.9634 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVAVNKPAEFTVDAK 95.00% 3.43 0.558 2.77 549.9634 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVAVNKPAEFTVDAK 95.00% 2.79 0.358 1.07 549.9644 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% APSVANVGSHcDLSLK 95.00% 2.41 0.369 1.1 c11: Carbamidomethyl (+57.02) 552.2767 1,653.81 1,654.82 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% APSVANVGSHcDLSLK 95.00% 1.96 0.275 1.04 c11: Carbamidomethyl (+57.02) 552.2775 1,653.81 1,654.82 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% APSVANVGSHcDLSLK 95.00% 2.12 0.343 1.57 c11: Carbamidomethyl (+57.02) 552.2775 1,653.81 1,654.82 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% APSVANVGSHcDLSLK 95.00% 2.87 0.524 0 c11: Carbamidomethyl (+57.02) 552.2778 1,653.81 1,654.82 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% APSVANVGSHcDLSLK 95.00% 2.66 0.396 0.959 c11: Carbamidomethyl (+57.02) 552.2778 1,653.81 1,654.82 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% APSVANVGSHcDLSLK 95.00% 1.89 0.16 1.49 c11: Carbamidomethyl (+57.02) 552.2793 1,653.81 1,654.82 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LDVQFSGLTK 95.00% 2.72 0.374 3.12 554.6529 1,107.29 1,107.61 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LDVQFSGLTK 95.00% 2.55 0.263 0 554.6537 1,107.29 1,107.61 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VKMDcQEcPEGYR 95.00% 3.01 0.31 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.902 1,670.68 1,671.69 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VKMDcQEcPEGYR 95.00% 3.32 0.354 1.72 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 558.2359 1,671.68 1,671.69 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% eNGVYLIDVK 95.00% 0 0 3.57 e1: Pyro_glu (-18.01) 566.7971 1,131.58 1,131.61 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 3.32 0.361 0 566.9756 1,697.90 1,698.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 3.77 0.313 0 566.976 1,697.90 1,698.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 3.84 0.325 1.11 566.9764 1,697.91 1,698.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 3.85 0.328 0 566.9768 1,697.91 1,698.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 3.49 0.397 0 566.977 1,697.91 1,698.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 4.42 0.38 0 566.9775 1,697.91 1,698.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 2.88 0.229 0 567.3107 1,698.91 1,698.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 3.37 0.179 0 567.3109 1,698.91 1,698.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GAGSGELKVTVK 95.00% 2.34 0.353 0 573.9693 1,145.92 1,145.65 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ENGVYLIDVK 95.00% 2.58 0.327 1.19 575.3106 1,148.61 1,149.62 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ENGVYLIDVK 95.00% 2.87 0.394 1.14 575.3106 1,148.61 1,149.62 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ENGVYLIDVK 95.00% 2.91 0.42 2 575.3107 1,148.61 1,149.62 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ENGVYLIDVK 95.00% 2.55 0.321 1.21 575.3109 1,148.61 1,149.62 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DKGEYTLVVK 95.00% 2.81 0.422 2.59 576.3157 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DKGEYTLVVK 95.00% 2.65 0.335 0 576.3166 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DKGEYTLVVK 95.00% 2.62 0.307 1.38 576.3172 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DKGEYTLVVK 95.00% 2.63 0.344 0 576.3177 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DKGEYTLVVK 95.00% 2.7 0.373 1.62 576.318 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DKGEYTLVVK 95.00% 2.54 0.308 0 576.3181 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DKGEYTLVVK 95.00% 2.38 0.376 0 576.3181 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DKGEYTLVVK 95.00% 2.63 0.292 1.74 576.3189 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGHVGISFVPK 95.00% 2.17 0.292 0 577.816 1,153.62 1,154.63 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGHVGISFVPK 95.00% 2.16 0.309 1.27 577.8172 1,153.62 1,154.63 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGHVGISFVPK 95.00% 2.35 0.327 1.3 577.8174 1,153.62 1,154.63 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGHVGISFVPK 95.00% 2.62 0.308 0 577.8181 1,153.62 1,154.63 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGHVGISFVPK 95.00% 2.41 0.301 0 577.8181 1,153.62 1,154.63 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGHVGISFVPK 95.00% 2.2 0.276 1.34 577.8183 1,153.62 1,154.63 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGHVGISFVPK 95.00% 2.72 0.378 0 577.8185 1,153.62 1,154.63 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGHVGISFVPK 95.00% 2.66 0.299 0 577.8192 1,153.62 1,154.63 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcK 95.00% 2.33 0.339 2 c11: Carbamidomethyl (+57.02) 578.3108 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcK 95.00% 2.15 0.276 1.19 c11: Carbamidomethyl (+57.02) 578.3109 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcK 95.00% 2.16 0.29 1.19 c11: Carbamidomethyl (+57.02) 578.3112 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcK 95.00% 2.3 0.316 2.92 c11: Carbamidomethyl (+57.02) 578.3114 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcK 95.00% 2.46 0.36 3.14 c11: Carbamidomethyl (+57.02) 578.3117 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcK 95.00% 2.49 0.409 3.49 c11: Carbamidomethyl (+57.02) 578.3131 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcK 95.00% 2.46 0.415 3.96 c11: Carbamidomethyl (+57.02) 578.3134 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcK 95.00% 2.24 0.256 2.08 c11: Carbamidomethyl (+57.02) 578.3141 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcK 95.00% 2.37 0.363 2.57 c11: Carbamidomethyl (+57.02) 578.3141 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcK 95.00% 2.16 0.331 2.96 c11: Carbamidomethyl (+57.02) 578.3145 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcK 95.00% 2.48 0.384 5.19 c11: Carbamidomethyl (+57.02) 578.3159 1,154.62 1,155.62 2 SYNP2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYTPMAPGSYLISIK 95.00% 4.11 0.523 3.92 580.978 1,739.91 1,740.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYTPMAPGSYLISIK 95.00% 4.3 0.533 3.41 580.9786 1,739.91 1,740.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 2.85 0.496 1.36 584.297 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 2.74 0.423 0 584.2974 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 3.19 0.45 2.41 584.2975 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 3.27 0.545 2.36 584.2981 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VPVHDVTDASK 95.00% 2.11 0.314 0 584.3012 1,166.59 1,167.60 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 3.03 0.425 2.05 584.6315 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 2.88 0.423 1.89 584.6316 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 3.06 0.543 1.28 584.6316 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 3.63 0.588 1.43 584.6322 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 2.7 0.384 0 584.6323 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 3.64 0.558 1.59 584.6324 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFEVYVDKSQGDASK 95.00% 3.21 0.482 0 586.2844 1,755.83 1,756.84 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFEVYVDKSQGDASK 95.00% 3.11 0.416 1.68 586.6182 1,756.83 1,756.84 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DLAEDAPWKK 95.00% 2.33 0.225 0 586.7989 1,171.58 1,172.60 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ATcAPQHGAPGPGPADASK 95.00% 2.42 0.232 1.52 c3: Carbamidomethyl (+57.02) 597.2811 1,788.82 1,789.83 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% RAPSVANVGSHcDLSLK 95.00% 4.5 0.58 3 c12: Carbamidomethyl (+57.02) 604.3113 1,809.91 1,810.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% RAPSVANVGSHcDLSLK 95.00% 3.58 0.465 3.82 c12: Carbamidomethyl (+57.02) 604.3115 1,809.91 1,810.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% RAPSVANVGSHcDLSLK 95.00% 4.76 0.476 4 c12: Carbamidomethyl (+57.02) 604.3117 1,809.91 1,810.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% RAPSVANVGSHcDLSLK 95.00% 4.46 0.441 2.8 c12: Carbamidomethyl (+57.02) 604.3119 1,809.91 1,810.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% RAPSVANVGSHcDLSLK 95.00% 3.54 0.445 1.39 c12: Carbamidomethyl (+57.02) 604.312 1,809.91 1,810.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% RAPSVANVGSHcDLSLK 95.00% 4.65 0.585 2.38 c12: Carbamidomethyl (+57.02) 604.3121 1,809.91 1,810.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% RAPSVANVGSHcDLSLK 95.00% 4.8 0.446 2.92 c12: Carbamidomethyl (+57.02) 604.3128 1,809.91 1,810.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VAQPTITDNKDGTVTVR 95.00% 1.45 0.371 0 605.6573 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% cSGPGLSPGMVR 95.00% 2.94 0.356 1.96 c1: Carbamidomethyl (+57.02) 609.2904 1,216.57 1,217.58 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% cSGPGLSPGMVR 95.00% 3.25 0.396 2.31 c1: Carbamidomethyl (+57.02) 609.2905 1,216.57 1,217.58 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% cSGPGLSPGMVR 95.00% 3.04 0.373 2.11 c1: Carbamidomethyl (+57.02) 609.2916 1,216.57 1,217.58 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% cSGPGLSPGMVR 95.00% 3.01 0.367 1.92 c1: Carbamidomethyl (+57.02) 609.2917 1,216.57 1,217.58 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EATTEFSVDAR 95.00% 3.38 0.442 2.18 613.2854 1,224.56 1,225.57 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EATTEFSVDAR 95.00% 3.57 0.431 2.26 613.2869 1,224.56 1,225.57 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EATTEFSVDAR 95.00% 3.51 0.42 1.46 613.2873 1,224.56 1,225.57 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EATTEFSVDAR 95.00% 3.24 0.399 2.62 613.2873 1,224.56 1,225.57 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EATTEFSVDAR 95.00% 3.52 0.484 1.89 613.2873 1,224.56 1,225.57 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EATTEFSVDAR 95.00% 3.49 0.455 1.72 613.288 1,224.56 1,225.57 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EATTEFSVDAR 95.00% 3.54 0.457 3.92 613.2884 1,224.56 1,225.57 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EATTEFSVDAR 95.00% 3.36 0.434 2.49 613.2885 1,224.56 1,225.57 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AWGPGLEGGVVGK 95.00% 2.85 0.501 3.08 613.8291 1,225.64 1,226.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AWGPGLEGGVVGK 95.00% 3.28 0.496 4.11 613.8293 1,225.64 1,226.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AWGPGLEGGVVGK 95.00% 3.38 0.535 4.19 613.8293 1,225.64 1,226.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AWGPGLEGGVVGK 95.00% 3.31 0.55 4.82 613.8294 1,225.64 1,226.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AWGPGLEGGVVGK 95.00% 3.28 0.519 4.57 613.8294 1,225.64 1,226.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AWGPGLEGGVVGK 95.00% 2.53 0.397 3.43 613.8296 1,225.64 1,226.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AWGPGLEGGVVGK 95.00% 2.91 0.515 3.14 613.8302 1,225.64 1,226.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AWGPGLEGGVVGK 95.00% 2.84 0.48 3.21 613.8306 1,225.65 1,226.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQK 95.00% 2.46 0.362 2.18 613.8872 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQK 95.00% 3.3 0.544 2.74 613.8874 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQK 95.00% 3.61 0.536 2.96 613.8888 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQK 95.00% 3.46 0.569 2.85 613.8889 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQK 95.00% 2.74 0.255 1.29 613.8889 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQK 95.00% 3.6 0.521 2.59 613.8891 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQK 95.00% 3.61 0.487 2.22 613.8894 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQK 95.00% 3.49 0.527 2.46 613.8895 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQK 95.00% 3.74 0.497 2.35 613.8897 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LIALLEVLSQK 95.00% 2.34 0.259 0 614.3213 1,226.63 1,226.77 2 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AHVVPcFDASK 95.00% 2.15 0.388 1.96 c6: Carbamidomethyl (+57.02) 615.7973 1,229.58 1,230.59 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AHVVPcFDASK 95.00% 2.07 0.315 0 c6: Carbamidomethyl (+57.02) 615.7988 1,229.58 1,230.59 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AHVVPcFDASK 95.00% 2.39 0.33 0 c6: Carbamidomethyl (+57.02) 615.7991 1,229.58 1,230.59 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AHVVPcFDASK 95.00% 2.23 0.256 0 c6: Carbamidomethyl (+57.02) 615.7993 1,229.58 1,230.59 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AHVVPcFDASK 95.00% 2.25 0.308 1.33 c6: Carbamidomethyl (+57.02) 615.7993 1,229.58 1,230.59 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AHVVPcFDASK 95.00% 2.43 0.441 1.89 c6: Carbamidomethyl (+57.02) 615.7997 1,229.58 1,230.59 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYcPTEPGNYIINIK 95.00% 3.99 0.46 1.96 c4: Carbamidomethyl (+57.02) 628.3188 1,881.93 1,881.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYcPTEPGNYIINIK 95.00% 2.48 0.269 0 c4: Carbamidomethyl (+57.02) 628.3194 1,881.93 1,881.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EGPYSISVLYGDEEVPR 95.00% 2.46 0.401 0 637.645 1,909.91 1,909.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EGPYSISVLYGDEEVPR 95.00% 2.4 0.386 0 637.645 1,909.91 1,909.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EGPYSISVLYGDEEVPR 95.00% 2.48 0.436 0 637.6452 1,909.91 1,909.92 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LPQLPITNFSR 95.00% 2.11 0.346 0 643.3647 1,284.71 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LPQLPITNFSR 95.00% 2.89 0.375 2.66 643.3659 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LPQLPITNFSR 95.00% 3.09 0.322 2.68 643.3659 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LPQLPITNFSR 95.00% 3 0.428 1.77 643.3662 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LPQLPITNFSR 95.00% 2.79 0.332 3.96 643.3664 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LPQLPITNFSR 95.00% 3.24 0.331 3.02 643.3665 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LPQLPITNFSR 95.00% 3.17 0.437 3.09 643.3667 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LPQLPITNFSR 95.00% 2.92 0.337 3.18 643.3669 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LPQLPITNFSR 95.00% 3.02 0.289 2.29 643.3669 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LPQLPITNFSR 95.00% 2.62 0.448 3.13 643.3676 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LPQLPITNFSR 95.00% 1.96 0.346 0 643.3678 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LPQLPITNFSR 95.00% 2.81 0.294 0 643.3692 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGQPVPNFPSK 95.00% 3.62 0.409 1.68 645.8257 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGQPVPNFPSK 95.00% 3.62 0.391 1.25 645.8264 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGQPVPNFPSK 95.00% 3.69 0.448 3 645.8265 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGQPVPNFPSK 95.00% 3.55 0.43 2.74 645.8266 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGQPVPNFPSK 95.00% 3.26 0.436 1.6 645.8267 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGQPVPNFPSK 95.00% 3.45 0.458 2.89 645.8272 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGQPVPNFPSK 95.00% 3.54 0.488 2.92 645.8272 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGQPVPNFPSK 95.00% 3.4 0.488 2.74 645.8279 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GKLDVQFSGLTK 95.00% 3.11 0.428 2.01 646.8622 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GKLDVQFSGLTK 95.00% 2.9 0.42 1.92 646.8626 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GKLDVQFSGLTK 95.00% 2.85 0.422 2.8 646.8629 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GKLDVQFSGLTK 95.00% 2.89 0.38 2.82 646.8631 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GKLDVQFSGLTK 95.00% 2.86 0.454 2.72 646.8651 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGLLAVQITDPEGKPK 95.00% 3.83 0.502 2.48 647.0112 1,938.01 1,938.02 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGLLAVQITDPEGKPK 95.00% 3.36 0.326 2.14 647.0135 1,938.02 1,938.02 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GKLDVQFSGLTK 95.00% 2.28 0.318 0 647.2915 1,292.57 1,292.72 2 KTN1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNGTHIPGSPFK 95.00% 2.44 0.351 1.96 651.3336 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNGTHIPGSPFK 95.00% 2.54 0.317 1.8 651.3336 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNGTHIPGSPFK 95.00% 2.68 0.219 1.15 651.3349 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNGTHIPGSPFK 95.00% 2.68 0.241 0 651.3352 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNGTHIPGSPFK 95.00% 3.22 0.37 3.62 651.3352 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNGTHIPGSPFK 95.00% 3.87 0.467 3 651.3352 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNGTHIPGSPFK 95.00% 2.61 0.289 2.85 651.3354 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VEPGLGADNSVVR 95.00% 2.03 0.403 1.14 656.8443 1,311.67 1,312.69 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VEPGLGADNSVVR 95.00% 2.52 0.457 4.07 656.8448 1,311.67 1,312.69 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VEPGLGADNSVVR 95.00% 1.89 0.315 2.46 656.8449 1,311.67 1,312.69 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VEPGLGADNSVVR 95.00% 2.44 0.4 0 656.8451 1,311.67 1,312.69 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VEPGLGADNSVVR 95.00% 2.53 0.44 4.51 656.8452 1,311.67 1,312.69 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VEPGLGADNSVVR 95.00% 2.6 0.609 4.49 656.8454 1,311.68 1,312.69 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VEPGLGADNSVVR 95.00% 2.27 0.31 1.57 656.8458 1,311.68 1,312.69 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VEPGLGADNSVVR 95.00% 2.07 0.416 3.23 656.8459 1,311.68 1,312.69 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 3.12 0.492 0 668.0098 2,001.01 2,002.02 3 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 2.8 0.317 0 668.3415 2,002.00 2,002.02 3 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 4 0.519 0 668.3423 2,002.00 2,002.02 3 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 4.26 0.499 1.77 668.3423 2,002.00 2,002.02 3 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 4.29 0.623 1.74 668.3441 2,002.01 2,002.02 3 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VSGLGEKVDVGKDQEFTVK 95.00% 2.86 0.259 1.18 679.3213 2,034.94 2,035.07 3 VINEX_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDVGKDQEFTVK 95.00% 3.31 0.402 0 682.8536 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDVGKDQEFTVK 95.00% 3.74 0.478 2.89 682.8559 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDVGKDQEFTVK 95.00% 3.34 0.471 0 682.8562 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDVGKDQEFTVK 95.00% 3.55 0.481 2.27 682.8573 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 3.84 0.415 3.6 c15: Carbamidomethyl (+57.02) 686.6476 2,056.92 2,057.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 3.71 0.361 3.51 c15: Carbamidomethyl (+57.02) 686.6478 2,056.92 2,057.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 5 0.489 5.19 c15: Carbamidomethyl (+57.02) 686.6498 2,056.93 2,057.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 3.83 0.457 3.27 c15: Carbamidomethyl (+57.02) 686.65 2,056.93 2,057.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 4.14 0.431 2.54 c15: Carbamidomethyl (+57.02) 686.9814 2,057.92 2,057.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 3.89 0.463 3 c15: Carbamidomethyl (+57.02) 686.9825 2,057.92 2,057.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 3.92 0.453 1.19 c15: Carbamidomethyl (+57.02) 686.9827 2,057.92 2,057.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 4.85 0.479 4.18 c15: Carbamidomethyl (+57.02) 686.9827 2,057.92 2,057.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 5.06 0.482 3 c15: Carbamidomethyl (+57.02) 686.9827 2,057.92 2,057.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 4.19 0.544 3.17 c15: Carbamidomethyl (+57.02) 686.9828 2,057.92 2,057.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 3.22 0.489 0 c15: Carbamidomethyl (+57.02) 686.9835 2,057.93 2,057.94 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.73 0.514 3.6 690.3387 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 4.22 0.582 5.52 690.339 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.65 0.473 3.47 690.3391 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.33 0.489 3.92 690.3391 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 4.25 0.569 5.4 690.3392 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.5 0.478 2.1 690.3395 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.9 0.534 3.08 690.3398 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.53 0.509 4.31 690.3399 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 4.07 0.574 3.57 690.3402 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.74 0.532 4 690.341 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGPYHIGGSPFK 95.00% 3.58 0.467 1.47 690.3424 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGDEIPFSPYR 95.00% 3.01 0.222 1.23 700.826 1,399.64 1,400.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGDEIPFSPYR 95.00% 2.37 0.0971 2 700.8264 1,399.64 1,400.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGDEIPFSPYR 95.00% 2.2 0.244 1.24 700.8275 1,399.64 1,400.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGDEIPFSPYR 95.00% 3.55 0.159 2.19 700.8375 1,399.66 1,400.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YGGDEIPFSPYR 95.00% 3.65 0.169 1.74 701.3257 1,400.64 1,400.65 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% WGDEHIPGSPYR 95.00% 2.94 0.424 3.36 707.33 1,412.64 1,413.66 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IANLQTDLSDGLR 95.00% 3.38 0.395 2.6 708.3747 1,414.73 1,415.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IANLQTDLSDGLR 95.00% 2.52 0.182 3.05 708.3766 1,414.74 1,415.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IANLQTDLSDGLR 95.00% 3.44 0.284 3.62 708.3767 1,414.74 1,415.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IANLQTDLSDGLR 95.00% 3.95 0.428 3.13 708.3773 1,414.74 1,415.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IANLQTDLSDGLR 95.00% 3.87 0.454 3.42 708.378 1,414.74 1,415.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% RLTVSSLQESGLK 95.00% 3.63 0.457 2.6 709.4039 1,416.79 1,417.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EAGAGGLAIAVEGPSK 95.00% 3.79 0.602 5.2 713.8788 1,425.74 1,426.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EAGAGGLAIAVEGPSK 95.00% 3.37 0.642 4.92 713.8789 1,425.74 1,426.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EAGAGGLAIAVEGPSK 95.00% 3.79 0.614 4.92 713.8798 1,425.74 1,426.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EAGAGGLAIAVEGPSK 95.00% 4.55 0.565 4.7 713.8798 1,425.74 1,426.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EAGAGGLAIAVEGPSK 95.00% 3.83 0.554 4.16 713.88 1,425.74 1,426.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EAGAGGLAIAVEGPSK 95.00% 3.53 0.596 5.03 713.88 1,425.74 1,426.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EAGAGGLAIAVEGPSK 95.00% 3.61 0.558 3.46 713.8801 1,425.74 1,426.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EAGAGGLAIAVEGPSK 95.00% 4.24 0.611 4.37 713.8802 1,425.74 1,426.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EAGAGGLAIAVEGPSK 95.00% 2.6 0.408 3.35 713.8822 1,425.75 1,426.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AFGPGLQGGSAGSPAR 95.00% 4.16 0.359 4 715.3609 1,428.71 1,429.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AFGPGLQGGSAGSPAR 95.00% 4.27 0.438 4.24 715.3613 1,428.71 1,429.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AFGPGLQGGSAGSPAR 95.00% 4.12 0.361 3.06 715.3614 1,428.71 1,429.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AFGPGLQGGSAGSPAR 95.00% 4.38 0.395 4.15 715.3618 1,428.71 1,429.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AFGPGLQGGSAGSPAR 95.00% 3.8 0.451 3.8 715.3618 1,428.71 1,429.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AFGPGLQGGSAGSPAR 95.00% 3.81 0.432 4.15 715.3619 1,428.71 1,429.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AFGPGLQGGSAGSPAR 95.00% 4.16 0.406 4.55 715.3626 1,428.71 1,429.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AFGPGLQGGSAGSPAR 95.00% 4.1 0.418 3.36 715.3627 1,428.71 1,429.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AFGPGLQGGSAGSPAR 95.00% 4.39 0.358 4.66 715.3627 1,428.71 1,429.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AFGPGLQGGSAGSPAR 95.00% 4.14 0.389 3.85 715.363 1,428.71 1,429.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AYGPGIEPTGNMVK 95.00% 4.12 0.486 2.26 717.3572 1,432.70 1,433.71 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AYGPGIEPTGNMVK 95.00% 4.26 0.52 0 717.3575 1,432.70 1,433.71 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ANLPQSFQVDTSK 95.00% 2.45 0.374 2.48 717.8622 1,433.71 1,434.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ANLPQSFQVDTSK 95.00% 3.63 0.528 5.27 717.8625 1,433.71 1,434.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ANLPQSFQVDTSK 95.00% 3.61 0.548 4.01 717.8631 1,433.71 1,434.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ANLPQSFQVDTSK 95.00% 2.86 0.44 3.24 717.8636 1,433.71 1,434.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ANLPQSFQVDTSK 95.00% 4.33 0.499 4.43 717.8636 1,433.71 1,434.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ANLPQSFQVDTSK 95.00% 2.87 0.504 4.09 717.8643 1,433.71 1,434.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ANLPQSFQVDTSK 95.00% 2.4 0.392 2.64 717.8645 1,433.71 1,434.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ANLPQSFQVDTSK 95.00% 3.43 0.596 5.74 717.8656 1,433.72 1,434.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ANLPQSFQVDTSK 95.00% 3.62 0.427 3.43 717.8664 1,433.72 1,434.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AGNNMLLVGVHGPR 95.00% 3.16 0.466 2.96 717.8866 1,433.76 1,434.76 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ANLPQSFQVDTSK 95.00% 3.75 0.566 5.15 718.3631 1,434.71 1,434.72 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% MDcQEcPEGYR 95.00% 3.9 0.573 2.12 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7678 1,443.52 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% MDcQEcPEGYR 95.00% 3.89 0.597 2.47 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7679 1,443.52 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LVSNHSLHETSSVFVDSLTK 95.00% 5.38 0.628 5.47 734.0459 2,199.11 2,200.13 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LVSNHSLHETSSVFVDSLTK 95.00% 4.43 0.591 4.49 734.3793 2,200.11 2,200.13 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LVSNHSLHETSSVFVDSLTK 95.00% 5.17 0.548 3.72 734.3798 2,200.12 2,200.13 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LVSNHSLHETSSVFVDSLTK 95.00% 5.1 0.616 3.54 734.3798 2,200.12 2,200.13 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LVSNHSLHETSSVFVDSLTK 95.00% 5.2 0.678 4.7 734.3802 2,200.12 2,200.13 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LVSNHSLHETSSVFVDSLTK 95.00% 4.74 0.585 3.92 734.3803 2,200.12 2,200.13 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LVSNHSLHETSSVFVDSLTK 95.00% 4.54 0.584 4.29 734.3835 2,200.13 2,200.13 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LVSNHSLHETSSVFVDSLTK 95.00% 3.9 0.49 2.74 734.3839 2,200.13 2,200.13 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LVSNHSLHETSSVFVDSLTK 95.00% 3.93 0.449 4.49 734.3892 2,200.14 2,200.13 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGGLSLAIEGPSK 95.00% 3.55 0.425 2.28 750.877 1,499.74 1,500.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGGLSLAIEGPSK 95.00% 4.47 0.533 3.48 750.8789 1,499.74 1,500.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGGLSLAIEGPSK 95.00% 4.64 0.549 2.85 750.8792 1,499.74 1,500.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGGLSLAIEGPSK 95.00% 5.13 0.552 3.68 750.8792 1,499.74 1,500.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGGLSLAIEGPSK 95.00% 3.71 0.523 3.2 750.8797 1,499.74 1,500.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGGLSLAIEGPSK 95.00% 5.11 0.555 3.7 750.8803 1,499.75 1,500.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGGLSLAIEGPSK 95.00% 5.39 0.577 4.6 750.8806 1,499.75 1,500.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGGLSLAIEGPSK 95.00% 4.72 0.474 3.15 750.8816 1,499.75 1,500.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGGLSLAIEGPSK 95.00% 5.15 0.583 3 750.8818 1,499.75 1,500.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGGLSLAIEGPSK 95.00% 4.5 0.451 2.89 750.882 1,499.75 1,500.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGGLSLAIEGPSK 95.00% 4.51 0.509 3.33 750.8821 1,499.75 1,500.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGGLSLAIEGPSK 95.00% 2.72 0.365 2.49 750.8942 1,499.77 1,500.75 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FVPAEMGTHTVSVK 95.00% 4.04 0.464 4.89 751.8855 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FVPAEMGTHTVSVK 95.00% 4.05 0.517 5.07 751.8857 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FVPAEMGTHTVSVK 95.00% 3.95 0.532 6.05 751.8863 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FVPAEMGTHTVSVK 95.00% 1.91 0.361 0 751.8872 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FVPAEMGTHTVSVK 95.00% 4.11 0.502 6.7 751.8877 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FVPAEMGTHTVSVK 95.00% 2.48 0.347 0 751.8885 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 4.06 0.552 3.43 751.8996 1,501.78 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 4.34 0.532 4.52 751.9001 1,501.78 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 4.33 0.561 4.8 751.9009 1,501.79 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 3.7 0.525 3.04 751.9013 1,501.79 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 4.76 0.546 4.42 751.9016 1,501.79 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 5.08 0.586 4.21 751.9016 1,501.79 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 3.15 0.539 2.8 751.9019 1,501.79 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 4.36 0.543 4.68 751.9021 1,501.79 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 4.28 0.593 5.43 751.9031 1,501.79 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 4.68 0.536 4.1 751.9034 1,501.79 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 4.02 0.547 3.89 751.9063 1,501.80 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 4.35 0.555 4.57 751.9092 1,501.80 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VNQPASFAVSLNGAK 95.00% 4.21 0.507 4.55 752.404 1,502.79 1,502.80 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DGScGVAYVVQEPGDYEVSVK 95.00% 2.82 0.325 2.09 c4: Carbamidomethyl (+57.02) 753.6815 2,258.02 2,258.03 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 2.97 0.392 3.82 758.3811 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 2.68 0.332 2.32 758.3814 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 2.83 0.307 2.09 758.3818 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 3.55 0.431 4.06 758.3823 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 2.85 0.296 0 758.3825 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 3 0.37 2.6 758.384 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 3.29 0.369 2.85 758.3843 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 3.23 0.33 0 758.8847 1,515.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FADQHVPGSPFSVK 95.00% 3.62 0.391 4.14 758.8848 1,515.75 1,515.76 2 MOES_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FVPAEmGTHTVSVK 95.00% 3.52 0.528 3.62 m6: Oxidation (+15.99) 759.8836 1,517.75 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FVPAEmGTHTVSVK 95.00% 3.84 0.548 4.1 m6: Oxidation (+15.99) 759.8846 1,517.75 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VHSPSGALEEcYVTEIDQDK 95.00% 5.28 0.436 3.25 c11: Carbamidomethyl (+57.02) 760.0176 2,277.03 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 4.6 0.5 6.39 767.3852 1,532.75 1,533.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 4.88 0.461 5.68 767.386 1,532.76 1,533.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 4.17 0.425 4.02 767.3864 1,532.76 1,533.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 4.37 0.401 4.05 767.3883 1,532.76 1,533.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 4.37 0.428 7.72 767.3886 1,532.76 1,533.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 4.42 0.444 4.04 767.3886 1,532.76 1,533.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 2.49 0.273 1.89 767.3887 1,532.76 1,533.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 3.16 0.412 1.38 767.3908 1,532.77 1,533.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 3.25 0.199 2.16 767.3952 1,532.77 1,533.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 3.43 0.304 1.68 767.4008 1,532.79 1,533.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 2.94 0.289 2.21 767.4019 1,532.79 1,533.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% AEAGVPAEFSIWTR 95.00% 3.1 0.297 0 767.4024 1,532.79 1,533.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFSVAVSPSLDLSK 95.00% 4.69 0.512 1.82 767.4105 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFSVAVSPSLDLSK 95.00% 4.74 0.524 2.62 767.411 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFSVAVSPSLDLSK 95.00% 4.63 0.504 2.6 767.4116 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFSVAVSPSLDLSK 95.00% 4.56 0.51 2.38 767.4117 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFSVAVSPSLDLSK 95.00% 4.34 0.526 2.49 767.4118 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFSVAVSPSLDLSK 95.00% 4.7 0.55 2.46 767.4119 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFSVAVSPSLDLSK 95.00% 3.5 0.37 2.09 767.4138 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFSVAVSPSLDLSK 95.00% 3.42 0.359 2.77 767.4195 1,532.82 1,533.82 2 RL4_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.42 0.362 2.68 769.056 2,304.14 2,304.15 3 FLNC_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGYGGLSLSIEGPSK 95.00% 4.05 0.388 4.26 775.8857 1,549.76 1,550.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGYGGLSLSIEGPSK 95.00% 3.75 0.502 3.43 775.8872 1,549.76 1,550.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGYGGLSLSIEGPSK 95.00% 4.28 0.452 4.42 775.8882 1,549.76 1,550.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGYGGLSLSIEGPSK 95.00% 4.85 0.466 6.46 775.8883 1,549.76 1,550.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGYGGLSLSIEGPSK 95.00% 4.49 0.556 3.19 776.3898 1,550.76 1,550.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGYGGLSLSIEGPSK 95.00% 4.95 0.538 5.52 776.3905 1,550.77 1,550.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGYGGLSLSIEGPSK 95.00% 4.81 0.529 3.74 776.3908 1,550.77 1,550.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 3.46 0.503 1.3 781.7487 2,342.22 2,342.22 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GAGTGGLGLAVEGPSEAK 95.00% 4.3 0.62 4.34 785.904 1,569.79 1,570.81 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GAGTGGLGLAVEGPSEAK 95.00% 4.62 0.587 4.77 785.9043 1,569.79 1,570.81 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GAGTGGLGLAVEGPSEAK 95.00% 4.13 0.606 3.62 785.9049 1,569.79 1,570.81 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GAGTGGLGLAVEGPSEAK 95.00% 3.77 0.514 4.26 785.9051 1,569.79 1,570.81 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GAGTGGLGLAVEGPSEAK 95.00% 4.53 0.611 3.89 785.9054 1,569.80 1,570.81 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GAGTGGLGLAVEGPSEAK 95.00% 4.26 0.603 4 785.9058 1,569.80 1,570.81 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GAGTGGLGLAVEGPSEAK 95.00% 3.95 0.508 3.89 785.9067 1,569.80 1,570.81 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GAGTGGLGLAVEGPSEAK 95.00% 4.91 0.571 4.51 785.9076 1,569.80 1,570.81 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GAGTGGLGLAVEGPSEAK 95.00% 4.75 0.622 5.09 785.9078 1,569.80 1,570.81 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GAGTGGLGLAVEGPSEAK 95.00% 4.09 0.615 4.7 785.9101 1,569.80 1,570.81 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GAGTGGLGLAVEGPSEAK 95.00% 4.71 0.514 4.54 786.408 1,570.80 1,570.81 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YAPSEAGLHEMDIR 95.00% 3.76 0.459 2.44 794.8745 1,587.73 1,588.74 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DNGNGTYScSYVPR 95.00% 2.85 0.476 1.57 c9: Carbamidomethyl (+57.02) 795.336 1,588.66 1,589.67 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DNGNGTYScSYVPR 95.00% 2.99 0.543 1.8 c9: Carbamidomethyl (+57.02) 795.3369 1,588.66 1,589.67 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DNGNGTYScSYVPR 95.00% 2.22 0.353 0 c9: Carbamidomethyl (+57.02) 795.3377 1,588.66 1,589.67 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YAPSEAGLHEMDIR 95.00% 3.34 0.443 2.48 795.3758 1,588.74 1,588.74 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 2.53 0.42 0 801.885 1,601.75 1,602.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.84 0.529 4.7 801.8855 1,601.76 1,602.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.65 0.575 3.33 801.8857 1,601.76 1,602.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 2.36 0.355 0 801.8861 1,601.76 1,602.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.53 0.52 5.48 801.8863 1,601.76 1,602.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.4 0.49 4.6 801.8863 1,601.76 1,602.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.4 0.507 3.8 801.8871 1,601.76 1,602.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YNEQHVPGSPFTAR 95.00% 3.54 0.45 1.66 802.3865 1,602.76 1,602.77 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.87 0.348 4.05 814.4008 2,440.18 2,440.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.9 0.401 3.6 814.4008 2,440.18 2,440.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.86 0.506 4.41 814.4008 2,440.18 2,440.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.86 0.474 4.01 814.4011 2,440.18 2,440.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.32 0.416 3.17 814.4022 2,440.18 2,440.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.73 0.325 4.23 814.4036 2,440.19 2,440.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.7 0.364 3.82 814.4044 2,440.19 2,440.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGQHVASSPIPVVISQSEIGDASR 95.00% 6.11 0.548 4.92 817.0861 2,448.23 2,448.25 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGQHVASSPIPVVISQSEIGDASR 95.00% 5.61 0.609 5.39 817.0877 2,448.24 2,448.25 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGQHVASSPIPVVISQSEIGDASR 95.00% 4.76 0.54 4.92 817.0889 2,448.24 2,448.25 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGQHVASSPIPVVISQSEIGDASR 95.00% 5.56 0.619 3.38 817.0897 2,448.25 2,448.25 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.13 0.538 3.59 c11: Carbamidomethyl (+57.02) 817.4315 2,449.27 2,449.29 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.19 0.468 3.05 c11: Carbamidomethyl (+57.02) 817.4322 2,449.27 2,449.29 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.39 0.619 3.96 c11: Carbamidomethyl (+57.02) 817.4338 2,449.28 2,449.29 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.51 0.536 3.43 c11: Carbamidomethyl (+57.02) 817.434 2,449.28 2,449.29 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.68 0.537 2.48 c11: Carbamidomethyl (+57.02) 817.4345 2,449.28 2,449.29 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.79 0.48 2.62 c11: Carbamidomethyl (+57.02) 817.4352 2,449.28 2,449.29 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.21 0.495 3.1 c11: Carbamidomethyl (+57.02) 817.4356 2,449.28 2,449.29 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.76 0.543 4.68 c11: Carbamidomethyl (+57.02) 817.4359 2,449.28 2,449.29 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDINTEDLEDGTcR 95.00% 3.84 0.551 4.12 c13: Carbamidomethyl (+57.02) 818.8593 1,635.70 1,636.71 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VDINTEDLEDGTcR 95.00% 4.41 0.559 4.54 c13: Carbamidomethyl (+57.02) 819.3636 1,636.71 1,636.71 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.08 0.316 3.47 823.3987 2,467.17 2,467.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.88 0.44 2.96 823.4003 2,467.18 2,467.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.28 0.373 3.77 823.4009 2,467.18 2,467.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.81 0.32 3.74 823.4013 2,467.18 2,467.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.14 0.328 3.24 823.4014 2,467.18 2,467.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.23 0.353 2.96 823.4017 2,467.18 2,467.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.35 0.33 2.96 823.4023 2,467.18 2,467.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.21 0.262 2.29 823.4029 2,467.19 2,467.19 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVAVNKPAEFTVDAK 95.00% 3.66 0.381 2.21 824.4389 1,646.86 1,646.88 2 MYLK_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVAVNKPAEFTVDAK 95.00% 3.77 0.376 4.02 824.4422 1,646.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTAQGPGLEPSGNIANK 95.00% 5.09 0.62 5.09 826.9322 1,651.85 1,652.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTAQGPGLEPSGNIANK 95.00% 5.11 0.547 4.82 826.9322 1,651.85 1,652.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTAQGPGLEPSGNIANK 95.00% 5.2 0.586 4.85 826.933 1,651.85 1,652.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTAQGPGLEPSGNIANK 95.00% 4.74 0.554 5.96 826.9331 1,651.85 1,652.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTAQGPGLEPSGNIANK 95.00% 4.86 0.571 5.82 826.9333 1,651.85 1,652.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTAQGPGLEPSGNIANK 95.00% 4.98 0.58 5.62 826.9334 1,651.85 1,652.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTAQGPGLEPSGNIANK 95.00% 4.75 0.583 4.47 826.9334 1,651.85 1,652.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTAQGPGLEPSGNIANK 95.00% 4.88 0.593 6.62 826.9334 1,651.85 1,652.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTAQGPGLEPSGNIANK 95.00% 4.94 0.621 6.77 826.9338 1,651.85 1,652.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTAQGPGLEPSGNIANK 95.00% 5.04 0.597 5.48 826.9342 1,651.85 1,652.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTAQGPGLEPSGNIANK 95.00% 4.81 0.545 5.48 826.9358 1,651.86 1,652.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 5.08 0.569 3.21 835.0996 2,502.28 2,502.28 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 4.48 0.522 3.4 835.1003 2,502.28 2,502.28 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 5.18 0.53 3.49 835.102 2,502.28 2,502.28 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VKMDcQEcPEGYR 95.00% 4.16 0.478 4.05 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 836.3496 1,670.68 1,671.69 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VKMDcQEcPEGYR 95.00% 4.13 0.478 4.4 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 836.3506 1,670.69 1,671.69 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.74 0.565 1.62 849.0886 2,544.24 2,544.26 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.39 0.533 1.74 849.0903 2,544.25 2,544.26 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 3.66 0.513 3.62 849.9596 1,697.90 1,698.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 4.22 0.524 6.64 849.9616 1,697.91 1,698.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 4.83 0.481 4.42 849.9629 1,697.91 1,698.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 3.95 0.455 4.48 850.4619 1,698.91 1,698.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 3.93 0.483 5.28 850.4624 1,698.91 1,698.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TGVELGKPTHFTVNAK 95.00% 3.97 0.476 3.77 850.4654 1,698.92 1,698.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYTPMAPGSYLISIK 95.00% 3.83 0.559 4.49 870.9635 1,739.91 1,740.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYTPMAPGSYLISIK 95.00% 3.55 0.425 2.19 870.9637 1,739.91 1,740.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYTPMAPGSYLISIK 95.00% 3.88 0.546 3.59 870.9637 1,739.91 1,740.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYTPMAPGSYLISIK 95.00% 3.43 0.486 2.05 870.9641 1,739.91 1,740.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYTPMAPGSYLISIK 95.00% 3.53 0.473 1.46 870.9655 1,739.92 1,740.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYTPMAPGSYLISIK 95.00% 3.94 0.532 4.64 871.4644 1,740.91 1,740.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYTPMAPGSYLISIK 95.00% 0 0 4.21 872.4488 1,742.88 1,740.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 3.17 0.457 0 875.9405 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 3.17 0.422 0 875.9411 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 3.62 0.559 1.89 875.9425 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 3.62 0.557 1.82 875.9441 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% TFSVWYVPEVTGTHK 95.00% 3.71 0.528 1.14 876.4435 1,750.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFEVYVDKSQGDASK 95.00% 4.82 0.534 6.96 878.9227 1,755.83 1,756.84 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYTPmAPGSYLISIK 95.00% 4.05 0.565 1.49 m6: Oxidation (+15.99) 878.9601 1,755.90 1,756.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFEVYVDKSQGDASK 95.00% 4.75 0.48 5.6 879.4249 1,756.83 1,756.84 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPFEVYVDKSQGDASK 95.00% 4.81 0.496 4.48 879.4281 1,756.84 1,756.84 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYTPmAPGSYLISIK 95.00% 4.08 0.539 3.14 m6: Oxidation (+15.99) 879.4617 1,756.91 1,756.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYTPmAPGSYLISIK 95.00% 3.2 0.386 0 m6: Oxidation (+15.99) 879.4624 1,756.91 1,756.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VANPSGNLTETYVQDR 95.00% 4.62 0.62 6.7 882.4292 1,762.84 1,763.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VANPSGNLTETYVQDR 95.00% 5 0.641 6.62 882.4296 1,762.84 1,763.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VANPSGNLTETYVQDR 95.00% 4.38 0.609 7.92 882.4299 1,762.84 1,763.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VANPSGNLTETYVQDR 95.00% 5.12 0.634 7.52 882.4304 1,762.85 1,763.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VANPSGNLTETYVQDR 95.00% 4.79 0.584 7.2 882.4308 1,762.85 1,763.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VANPSGNLTETYVQDR 95.00% 5.13 0.654 7.3 882.4309 1,762.85 1,763.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VANPSGNLTETYVQDR 95.00% 4.99 0.622 6.77 882.9289 1,763.84 1,763.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VANPSGNLTETYVQDR 95.00% 5.18 0.635 5.89 882.9309 1,763.85 1,763.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VANPSGNLTETYVQDR 95.00% 5.11 0.584 5.54 882.9315 1,763.85 1,763.86 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VQVQDNEGcPVEALVK 95.00% 3.23 0.17 0 c9: Carbamidomethyl (+57.02) 892.4955 1,782.98 1,784.89 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DVDIIDHHDNTYTVK 95.00% 4.08 0.592 4 892.9273 1,783.84 1,784.85 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VQVQDNEGcPVEALVK 95.00% 5.06 0.596 6.21 c9: Carbamidomethyl (+57.02) 892.9435 1,783.87 1,784.89 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VQVQDNEGcPVEALVK 95.00% 5.1 0.577 3.92 c9: Carbamidomethyl (+57.02) 892.9444 1,783.87 1,784.89 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VQVQDNEGcPVEALVK 95.00% 5.07 0.591 4.17 c9: Carbamidomethyl (+57.02) 892.9446 1,783.87 1,784.89 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VQVQDNEGcPVEALVK 95.00% 5.27 0.59 3.92 c9: Carbamidomethyl (+57.02) 892.9447 1,783.87 1,784.89 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VQVQDNEGcPVEALVK 95.00% 5.34 0.583 3.8 c9: Carbamidomethyl (+57.02) 892.9455 1,783.88 1,784.89 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VQVQDNEGcPVEALVK 95.00% 5.37 0.584 4.6 c9: Carbamidomethyl (+57.02) 892.9461 1,783.88 1,784.89 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VQVQDNEGcPVEALVK 95.00% 3.62 0.551 2.89 c9: Carbamidomethyl (+57.02) 892.9471 1,783.88 1,784.89 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VQVQDNEGcPVEALVK 95.00% 4.99 0.603 3.96 c9: Carbamidomethyl (+57.02) 892.9472 1,783.88 1,784.89 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DVDIIDHHDNTYTVK 95.00% 4.48 0.506 1.24 893.4244 1,784.83 1,784.85 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VQVQDNEGcPVEALVK 95.00% 5.49 0.547 6.49 c9: Carbamidomethyl (+57.02) 893.4468 1,784.88 1,784.89 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VQVQDNEGcPVEALVK 95.00% 5.31 0.542 4.72 c9: Carbamidomethyl (+57.02) 893.448 1,784.88 1,784.89 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VAQPTITDNKDGTVTVR 95.00% 4 0.476 2.2 907.9836 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VAQPTITDNKDGTVTVR 95.00% 4.39 0.47 4.48 907.9842 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VAQPTITDNKDGTVTVR 95.00% 3.96 0.499 2.15 907.9844 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VAQPTITDNKDGTVTVR 95.00% 4.38 0.398 4.7 908.4835 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VAQPTITDNKDGTVTVR 95.00% 4.47 0.401 5.04 908.4846 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 5.11 0.496 5.48 c11: Carbamidomethyl (+57.02) 923.1052 2,766.29 2,766.30 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.44 0.48 6.77 c11: Carbamidomethyl (+57.02) 923.1053 2,766.29 2,766.30 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.54 0.565 7.85 c11: Carbamidomethyl (+57.02) 923.1059 2,766.29 2,766.30 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.43 0.438 7 c11: Carbamidomethyl (+57.02) 923.1071 2,766.30 2,766.30 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPYTVTVGQAcNPSAcR 95.00% 4.48 0.509 3.92 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4203 1,866.82 1,867.84 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPYTVTVGQAcNPSAcR 95.00% 5.1 0.559 5.02 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4207 1,866.83 1,867.84 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPYTVTVGQAcNPSAcR 95.00% 4.6 0.512 4.35 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4224 1,866.83 1,867.84 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPYTVTVGQAcNPSAcR 95.00% 5.15 0.567 4.29 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4234 1,866.83 1,867.84 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPYTVTVGQAcNPSAcR 95.00% 3.13 0.555 2.37 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4262 1,866.84 1,867.84 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPYTVTVGQAcNPSAcR 95.00% 4.9 0.535 4.04 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9239 1,867.83 1,867.84 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPYTVTVGQAcNPSAcR 95.00% 5.06 0.482 7.66 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9246 1,867.83 1,867.84 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SPYTVTVGQAcNPSAcR 95.00% 5.25 0.53 5.62 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9255 1,867.84 1,867.84 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYcPTEPGNYIINIK 95.00% 4.22 0.518 4.28 c4: Carbamidomethyl (+57.02) 941.4731 1,880.93 1,881.94 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYcPTEPGNYIINIK 95.00% 3.68 0.534 4.28 c4: Carbamidomethyl (+57.02) 941.4734 1,880.93 1,881.94 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYcPTEPGNYIINIK 95.00% 4.24 0.493 4.37 c4: Carbamidomethyl (+57.02) 941.4737 1,880.93 1,881.94 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYcPTEPGNYIINIK 95.00% 4.27 0.534 4.46 c4: Carbamidomethyl (+57.02) 941.9727 1,881.93 1,881.94 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYcPTEPGNYIINIK 95.00% 4.55 0.476 2.85 c4: Carbamidomethyl (+57.02) 941.9738 1,881.93 1,881.94 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYcPTEPGNYIINIK 95.00% 4.61 0.495 3.39 c4: Carbamidomethyl (+57.02) 941.974 1,881.93 1,881.94 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYcPTEPGNYIINIK 95.00% 3.98 0.492 3.6 c4: Carbamidomethyl (+57.02) 941.9745 1,881.93 1,881.94 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYcPTEPGNYIINIK 95.00% 4.43 0.429 3.43 c4: Carbamidomethyl (+57.02) 941.9749 1,881.93 1,881.94 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYcPTEPGNYIINIK 95.00% 4.64 0.493 3.42 c4: Carbamidomethyl (+57.02) 941.975 1,881.93 1,881.94 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% VTYcPTEPGNYIINIK 95.00% 4.69 0.493 3.33 c4: Carbamidomethyl (+57.02) 941.9752 1,881.93 1,881.94 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EGPYSISVLYGDEEVPR 95.00% 4.86 0.582 4.7 955.4603 1,908.90 1,909.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EGPYSISVLYGDEEVPR 95.00% 4.93 0.579 5.96 955.4618 1,908.91 1,909.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EGPYSISVLYGDEEVPR 95.00% 4.73 0.58 4.36 955.462 1,908.91 1,909.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EGPYSISVLYGDEEVPR 95.00% 3.78 0.513 3.8 955.4667 1,908.92 1,909.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EGPYSISVLYGDEEVPR 95.00% 3.86 0.559 3.89 955.9602 1,909.90 1,909.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EGPYSISVLYGDEEVPR 95.00% 4.9 0.552 5.48 955.9615 1,909.91 1,909.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EGPYSISVLYGDEEVPR 95.00% 5.11 0.551 5.11 955.9616 1,909.91 1,909.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EGPYSISVLYGDEEVPR 95.00% 5.07 0.552 5.1 955.9629 1,909.91 1,909.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% EGPYSISVLYGDEEVPR 95.00% 4.29 0.568 4.42 955.9644 1,909.91 1,909.92 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGLLAVQITDPEGKPK 95.00% 5.18 0.383 4.66 969.5119 1,937.01 1,938.02 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGLLAVQITDPEGKPK 95.00% 4.74 0.348 7.46 969.514 1,937.01 1,938.02 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGLLAVQITDPEGKPK 95.00% 5.04 0.39 3.24 970.013 1,938.01 1,938.02 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGLLAVQITDPEGKPK 95.00% 4.69 0.331 3.55 970.0153 1,938.02 1,938.02 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGLLAVQITDPEGKPK 95.00% 5.08 0.325 4.57 970.0154 1,938.02 1,938.02 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DAGEGLLAVQITDPEGKPK 95.00% 4.89 0.29 4.2 970.0166 1,938.02 1,938.02 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FGGEHVPNSPFQVTALAGDQPSVQPPLR 95.00% 5.02 0.505 6.12 982.8351 2,945.48 2,945.49 3
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 5.23 0.709 8.64 1,001.51 2,001.00 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 5.75 0.685 7.57 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 6.4 0.707 8.46 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 6.2 0.716 10.4 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 6.3 0.719 8.82 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 5.69 0.702 7 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 6.21 0.723 8.23 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDMTAQVTSPSGK 95.00% 6.32 0.7 7.37 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% cAPGVVGPAEADIDFDIIR 95.00% 4.41 0.518 3.14 c1: Carbamidomethyl (+57.02) 1,008.49 2,014.97 2,014.99 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% cAPGVVGPAEADIDFDIIR 95.00% 5.6 0.538 4.82 c1: Carbamidomethyl (+57.02) 1,008.50 2,014.98 2,014.99 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% cAPGVVGPAEADIDFDIIR 95.00% 5.71 0.565 6.09 c1: Carbamidomethyl (+57.02) 1,008.50 2,014.98 2,014.99 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% IPEISIQDmTAQVTSPSGK 95.00% 2.1 0.39 0 m9: Oxidation (+15.99) 1,009.42 2,016.82 2,018.01 2 ITIH1_HUMAN
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 6.65 0.651 9.37 c15: Carbamidomethyl (+57.02) 1,029.47 2,056.92 2,057.94 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% THEAEIVEGENHTYcIR 95.00% 6.41 0.669 11.2 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% LVSNHSLHETSSVFVDSLTK 95.00% 6.32 0.633 5.44 1,101.06 2,200.11 2,200.13 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DGScGVAYVVQEPGDYEVSVK 95.00% 4.54 0.585 3.35 c4: Carbamidomethyl (+57.02) 1,129.52 2,257.02 2,258.03 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.55 0.622 4.34 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.14 0.577 3.57 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.44 0.648 4.6 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.25 0.655 4.89 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.41 0.611 6.33 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.08 0.603 6.24 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% DGScGVAYVVQEPGDYEVSVK 95.00% 5.57 0.643 5.06 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.37 0.655 4.92 1,144.09 2,286.16 2,286.18 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.35 0.666 4.37 1,144.09 2,286.17 2,286.18 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.49 0.67 4.51 1,144.09 2,286.17 2,286.18 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.47 0.646 5.54 1,144.09 2,286.17 2,286.18 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SAGQGEVLVYVEDPAGHQEEAK 95.00% 4.73 0.649 6.72 1,157.55 2,313.08 2,313.10 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.15 0.637 6.14 1,157.55 2,313.09 2,313.10 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% SAGQGEVLVYVEDPAGHQEEAK 95.00% 4.76 0.594 5.49 1,157.56 2,313.09 2,313.10 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.54 0.546 7.36 1,172.11 2,342.21 2,342.22 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.27 0.517 6.64 1,172.12 2,342.22 2,342.22 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.27 0.552 7.52 1,172.12 2,342.22 2,342.22 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGQHVASSPIPVVISQSEIGDASR 95.00% 5.8 0.62 9.17 1,225.13 2,448.24 2,448.25 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% NGQHVASSPIPVVISQSEIGDASR 95.00% 5.36 0.634 8.68 1,225.13 2,448.25 2,448.25 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.7 0.531 5.55 1,234.60 2,467.17 2,467.19 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.48 0.536 6.34 1,234.60 2,467.18 2,467.19 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 5.89 0.735 8.48 1,272.63 2,543.24 2,544.26 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.28 0.727 7.29 1,273.13 2,544.25 2,544.26 2
 SAMPLE 1R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 110 614 44.40% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 5.7 0.713 8.62 1,273.14 2,544.26 2,544.26 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 1.64 0.303 1.92 452.2943 1,353.86 1,354.87 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 2.25 0.321 3 452.2946 1,353.86 1,354.87 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 2.46 0.241 1.6 452.2951 1,353.86 1,354.87 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 2.23 0.354 1.05 452.2955 1,353.86 1,354.87 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 2.27 0.131 1.22 452.2956 1,353.86 1,354.87 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 2.35 0.117 2.22 452.2959 1,353.86 1,354.87 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 2.48 0.394 0 455.5736 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 1.93 0.392 1.29 455.5737 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 2.09 0.415 0 455.5741 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 1.74 0.374 1.35 455.5745 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 1.87 0.385 2.22 455.5749 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 1.91 0.422 1.14 455.575 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 2.01 0.383 1.17 455.5752 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 1.89 0.366 0 455.5752 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.27 0.423 2.27 460.563 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 2.3 0.173 0 460.5635 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.39 0.494 2.01 460.5636 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 2.84 0.444 1.15 460.5637 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 2.98 0.492 1.38 460.5638 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 2.67 0.51 1.39 460.5639 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.13 0.382 2.06 460.5639 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.39 0.498 2.03 460.564 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.46 0.475 1.85 460.564 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 2.6 0.502 1.7 460.5643 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 2.93 0.47 1.33 460.5645 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.36 0.497 2.37 460.5648 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.19 0.455 0.921 460.8971 1,379.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 2.38 0.258 0 471.8901 1,412.65 1,413.66 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 2.4 0.295 0 471.8905 1,412.65 1,413.66 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 2.36 0.317 0 472.2234 1,413.65 1,413.66 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LRNGHVGISFVPK 95.00% 2.71 0.196 1.21 475.6043 1,423.79 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LRNGHVGISFVPK 95.00% 3.08 0.219 2.52 475.6049 1,423.79 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AEFTVETR 95.00% 2.28 0.393 1.51 476.74 951.4643 952.474 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VKETADFKVYTK 95.00% 3.54 0.463 0 476.929 1,427.76 1,428.77 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGNNMLLVGVHGPR 95.00% 3.32 0.403 0 478.925 1,433.75 1,434.76 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGNNMLLVGVHGPR 95.00% 3.57 0.518 0 478.9253 1,433.75 1,434.76 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGNNMLLVGVHGPR 95.00% 3.82 0.467 0.959 478.9255 1,433.75 1,434.76 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGNNMLLVGVHGPR 95.00% 3.47 0.5 0 478.9256 1,433.75 1,434.76 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGNNMLLVGVHGPR 95.00% 3.91 0.476 0 478.9263 1,433.76 1,434.76 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGNNMLLVGVHGPR 95.00% 4.02 0.543 0 478.9268 1,433.76 1,434.76 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGNNMLLVGVHGPR 95.00% 3.73 0.498 1.05 478.9269 1,433.76 1,434.76 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGNNMLLVGVHGPR 95.00% 3.67 0.506 0 478.928 1,433.76 1,434.76 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGNNmLLVGVHGPR 95.00% 3.59 0.582 1.62 m5: Oxidation (+15.99) 484.2566 1,449.75 1,450.76 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGNNmLLVGVHGPR 95.00% 3.34 0.513 0 m5: Oxidation (+15.99) 484.2569 1,449.75 1,450.76 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGNNmLLVGVHGPR 95.00% 3.19 0.481 0 m5: Oxidation (+15.99) 484.2573 1,449.75 1,450.76 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGNNmLLVGVHGPR 95.00% 3.29 0.561 0 m5: Oxidation (+15.99) 484.5727 1,450.69 1,450.76 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 2.9 0.133 0 486.285 970.5544 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 3.1 0.137 0 486.2858 970.5559 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 3.03 0.175 0 486.2859 970.5561 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 3.16 0.141 0 486.2861 970.5566 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 3.02 0.138 0 486.2863 970.5569 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 2.77 0.178 0 486.2863 970.557 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 2.83 0.203 0 486.2864 970.5572 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 2.59 0.152 0 486.2867 970.5577 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 2.77 0.183 0 486.2868 970.558 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 2.82 0.173 0 486.2869 970.5581 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 2.74 0.176 0 486.2871 970.5585 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 2.63 0.153 0 486.2871 970.5586 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LLGWIQNK 95.00% 2.97 0.203 0 486.2873 970.559 971.568 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% KGEITGEVR 95.00% 2.4 0.392 0 494.7744 987.5332 988.5429 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% KGEITGEVR 95.00% 2.26 0.353 0 494.7746 987.5336 988.5429 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% KGEITGEVR 95.00% 2.28 0.352 0 494.7747 987.5337 988.5429 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% KGEITGEVR 95.00% 2.16 0.256 0 494.7765 987.5374 988.5429 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 3.9 0.362 0 501.6023 1,501.78 1,502.80 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 2.99 0.349 0 501.6031 1,501.79 1,502.80 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 2.94 0.378 2.62 505.9237 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.75 0.377 2.17 505.9238 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 2.29 0.271 1.11 505.9241 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.54 0.475 2.92 505.9242 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 2.7 0.403 2.85 505.9243 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 2.34 0.334 1.36 505.9244 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.23 0.48 3.28 506.2582 1,515.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DLAEDAPWK 95.00% 2.46 0.198 0 522.7542 1,043.49 1,044.50 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LSPFMADIR 95.00% 2.5 0.324 1.15 525.2749 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LSPFMADIR 95.00% 2.42 0.316 0 525.2752 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LSPFMADIR 95.00% 2.33 0.271 0 525.7791 1,049.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 2.72 0.352 1.62 534.9256 1,601.75 1,602.77 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 3.99 0.44 3.41 534.926 1,601.75 1,602.77 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 2.57 0.296 2.2 534.9262 1,601.76 1,602.77 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 3.96 0.457 4.06 534.9263 1,601.76 1,602.77 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 3.95 0.448 3.34 534.9263 1,601.76 1,602.77 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 3.79 0.425 3.47 534.9264 1,601.76 1,602.77 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 3.68 0.453 2.62 534.9265 1,601.76 1,602.77 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 3.71 0.437 3.85 534.9266 1,601.76 1,602.77 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 3.81 0.48 2.42 534.9269 1,601.76 1,602.77 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 3.86 0.417 2.92 535.2597 1,602.76 1,602.77 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNVGAGSHPNK 95.00% 2.44 0.382 0 540.2847 1,078.55 1,079.56 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDK 95.00% 3.11 0.471 0 542.2699 1,082.52 1,083.54 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDK 95.00% 3.19 0.478 0 542.2708 1,082.53 1,083.54 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDK 95.00% 3.12 0.438 0 542.2711 1,082.53 1,083.54 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDK 95.00% 3.28 0.475 1.11 542.2711 1,082.53 1,083.54 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDK 95.00% 2.2 0.331 0 542.2711 1,082.53 1,083.54 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDK 95.00% 3.32 0.486 0 542.2711 1,082.53 1,083.54 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDK 95.00% 3.22 0.463 0 542.2715 1,082.53 1,083.54 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IEcDDKGDGScDVR 95.00% 2.97 0.366 0 c3: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 542.558 1,624.65 1,625.65 3 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.37 0.254 0 543.3143 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.33 0.276 0 543.3145 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.39 0.315 0 543.3145 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.31 0.268 0 543.3147 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.27 0.229 0 543.3147 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.36 0.271 0 543.3148 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.14 0.294 0 543.315 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.42 0.384 0 543.315 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.22 0.238 0 543.3151 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.49 0.398 0 543.3151 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.4 0.379 0 543.3153 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.32 0.293 0 543.3154 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LYSVSYLLK 95.00% 2.08 0.268 0 543.3158 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TPcEEILVK 95.00% 2.93 0.225 1.4 c3: Carbamidomethyl (+57.02) 544.7854 1,087.56 1,088.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TPcEEILVK 95.00% 2.65 0.352 0 c3: Carbamidomethyl (+57.02) 544.7857 1,087.56 1,088.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TPcEEILVK 95.00% 2.71 0.303 0 c3: Carbamidomethyl (+57.02) 544.7857 1,087.56 1,088.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TPcEEILVK 95.00% 2.98 0.293 0 c3: Carbamidomethyl (+57.02) 544.7861 1,087.56 1,088.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TPcEEILVK 95.00% 2.72 0.306 0 c3: Carbamidomethyl (+57.02) 544.7865 1,087.56 1,088.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TPcEEILVK 95.00% 2.86 0.235 0 c3: Carbamidomethyl (+57.02) 544.787 1,087.56 1,088.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TPcEEILVK 95.00% 2.26 0.222 1.66 c3: Carbamidomethyl (+57.02) 544.7872 1,087.56 1,088.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVAVNKPAEFTVDAK 95.00% 2.42 0.375 0 549.6281 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVAVNKPAEFTVDAK 95.00% 4.05 0.542 2.52 549.629 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVAVNKPAEFTVDAK 95.00% 3.98 0.57 4.3 549.9641 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% APSVANVGSHcDLSLK 95.00% 2.08 0.252 0 c11: Carbamidomethyl (+57.02) 552.276 1,653.80 1,654.82 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% APSVANVGSHcDLSLK 95.00% 2.16 0.216 1 c11: Carbamidomethyl (+57.02) 552.2762 1,653.81 1,654.82 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% APSVANVGSHcDLSLK 95.00% 2.45 0.34 0 c11: Carbamidomethyl (+57.02) 552.2776 1,653.81 1,654.82 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% APSVANVGSHcDLSLK 95.00% 2.77 0.472 0 c11: Carbamidomethyl (+57.02) 552.2778 1,653.81 1,654.82 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% APSVANVGSHcDLSLK 95.00% 1.67 0.257 1.77 c11: Carbamidomethyl (+57.02) 552.2779 1,653.81 1,654.82 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% APSVANVGSHcDLSLK 95.00% 2.21 0.37 1.14 c11: Carbamidomethyl (+57.02) 552.2779 1,653.81 1,654.82 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% APSVANVGSHcDLSLK 95.00% 2.78 0.456 2.41 c11: Carbamidomethyl (+57.02) 552.278 1,653.81 1,654.82 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% APSVANVGSHcDLSLK 95.00% 2.6 0.428 0 c11: Carbamidomethyl (+57.02) 552.278 1,653.81 1,654.82 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% APSVANVGSHcDLSLK 95.00% 2.33 0.473 3.17 c11: Carbamidomethyl (+57.02) 552.6123 1,654.81 1,654.82 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% RAEFTVETR 95.00% 2.93 0.364 1.74 554.7892 1,107.56 1,108.58 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% RAEFTVETR 95.00% 3.13 0.436 1.89 554.7897 1,107.56 1,108.58 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% RAEFTVETR 95.00% 2.45 0.415 1.51 554.7903 1,107.57 1,108.58 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ALTQTGGPHVK 95.00% 2.07 0.298 0 554.8098 1,107.60 1,108.61 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ALTQTGGPHVK 95.00% 2.49 0.46 0 554.8107 1,107.61 1,108.61 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ALTQTGGPHVK 95.00% 2.29 0.317 0 554.8116 1,107.61 1,108.61 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VKMDcQEcPEGYR 95.00% 3.43 0.327 2.59 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9007 1,670.68 1,671.69 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VKMDcQEcPEGYR 95.00% 3.66 0.381 1.36 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9012 1,670.68 1,671.69 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VKMDcQEcPEGYR 95.00% 2.65 0.376 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9019 1,670.68 1,671.69 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VKMDcQEcPEGYR 95.00% 3.73 0.334 1.38 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.902 1,670.68 1,671.69 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VKMDcQEcPEGYR 95.00% 3.67 0.387 2.4 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.902 1,670.68 1,671.69 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VKMDcQEcPEGYR 95.00% 3.1 0.393 1.74 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.902 1,670.68 1,671.69 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 4.51 0.323 0 566.9761 1,697.90 1,698.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.84 0.375 0 566.9762 1,697.91 1,698.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 4.02 0.439 0 566.9763 1,697.91 1,698.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.22 0.35 0 566.9763 1,697.91 1,698.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.62 0.244 0 566.9764 1,697.91 1,698.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.7 0.333 1.3 566.9764 1,697.91 1,698.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.49 0.389 0 566.9767 1,697.91 1,698.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.88 0.328 0 566.977 1,697.91 1,698.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.49 0.251 0 566.9774 1,697.91 1,698.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.45 0.336 0 567.3109 1,698.91 1,698.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.16 0.304 0 567.3109 1,698.91 1,698.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.89 0.346 0 567.3113 1,698.91 1,698.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGSGELKVTVK 95.00% 3.06 0.385 0 573.3293 1,144.64 1,145.65 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGSGELKVTVK 95.00% 2.8 0.413 2.03 573.3296 1,144.64 1,145.65 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ENGVYLIDVK 95.00% 2.71 0.357 1.57 575.3121 1,148.61 1,149.62 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DKGEYTLVVK 95.00% 2.71 0.344 1.17 576.3176 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DKGEYTLVVK 95.00% 2.74 0.328 0 576.3176 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DKGEYTLVVK 95.00% 2.4 0.35 1.66 576.3178 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DKGEYTLVVK 95.00% 2.76 0.291 1.32 576.318 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DKGEYTLVVK 95.00% 3.1 0.399 1.24 576.3181 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DKGEYTLVVK 95.00% 3.01 0.396 0 576.3184 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DKGEYTLVVK 95.00% 3.04 0.418 1.36 576.3186 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DKGEYTLVVK 95.00% 2.72 0.327 2.17 576.3187 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DKGEYTLVVK 95.00% 2.7 0.35 0 576.3188 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DKGEYTLVVK 95.00% 2.63 0.31 1.24 576.319 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DKGEYTLVVK 95.00% 2.5 0.321 0 576.319 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DKGEYTLVVK 95.00% 2.54 0.293 0 576.3195 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% NGHVGISFVPK 95.00% 2.64 0.309 0 577.8182 1,153.62 1,154.63 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% NGHVGISFVPK 95.00% 2.37 0.304 0 577.8184 1,153.62 1,154.63 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% NGHVGISFVPK 95.00% 2.32 0.231 0 577.8185 1,153.62 1,154.63 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% NGHVGISFVPK 95.00% 2.76 0.275 0 577.8185 1,153.62 1,154.63 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% NGHVGISFVPK 95.00% 2.79 0.359 0 577.8186 1,153.62 1,154.63 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% NGHVGISFVPK 95.00% 2.53 0.293 0 577.8189 1,153.62 1,154.63 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcK 95.00% 2.53 0.43 4.01 c11: Carbamidomethyl (+57.02) 578.3114 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcK 95.00% 2.23 0.389 2.57 c11: Carbamidomethyl (+57.02) 578.3116 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcK 95.00% 2.16 0.27 1.77 c11: Carbamidomethyl (+57.02) 578.3116 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcK 95.00% 2.76 0.454 3.4 c11: Carbamidomethyl (+57.02) 578.3118 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcK 95.00% 1.99 0.365 1.4 c11: Carbamidomethyl (+57.02) 578.3119 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcK 95.00% 2.66 0.439 3.57 c11: Carbamidomethyl (+57.02) 578.3123 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcK 95.00% 2.91 0.424 3.66 c11: Carbamidomethyl (+57.02) 578.3125 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcK 95.00% 3.04 0.463 3.6 c11: Carbamidomethyl (+57.02) 578.3126 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcK 95.00% 2.61 0.384 3.21 c11: Carbamidomethyl (+57.02) 578.3126 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcK 95.00% 2.96 0.459 3.77 c11: Carbamidomethyl (+57.02) 578.3127 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcK 95.00% 2.46 0.439 3.23 c11: Carbamidomethyl (+57.02) 578.3131 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcK 95.00% 2.72 0.448 3.54 c11: Carbamidomethyl (+57.02) 578.3136 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 2.95 0.418 0 584.2967 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.17 0.501 1.02 584.2975 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.29 0.473 1 584.2977 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.07 0.446 1.52 584.2983 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VPVHDVTDASK 95.00% 2.38 0.374 1.33 584.3023 1,166.59 1,167.60 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VPVHDVTDASK 95.00% 2.36 0.456 0 584.3071 1,166.60 1,167.60 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.26 0.519 1 584.6315 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.03 0.493 2.19 584.6317 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.34 0.55 1.8 584.6318 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.43 0.526 1.8 584.632 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 2.97 0.557 3.12 584.6323 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.06 0.46 2.43 584.6324 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.21 0.596 1.44 584.6324 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.36 0.535 2.4 584.6325 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 3.88 0.382 2.96 586.2831 1,755.83 1,756.84 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 3.96 0.505 3.74 586.2832 1,755.83 1,756.84 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 4.15 0.474 3.68 586.2834 1,755.83 1,756.84 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 2.25 0.291 1.8 586.284 1,755.83 1,756.84 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 3.99 0.508 2.89 586.285 1,755.83 1,756.84 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 2.85 0.309 0 586.6167 1,756.83 1,756.84 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 3.44 0.465 3.54 586.618 1,756.83 1,756.84 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 4.07 0.525 2.44 586.6185 1,756.83 1,756.84 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 2.37 0.3 0 586.6194 1,756.83 1,756.84 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DLAEDAPWKK 95.00% 2.53 0.284 0 586.8001 1,171.58 1,172.60 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DLAEDAPWKK 95.00% 2.66 0.282 0 586.8004 1,171.59 1,172.60 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DLAEDAPWKK 95.00% 2.22 0.285 0 586.802 1,171.59 1,172.60 2 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 2.58 0.373 0 595.6198 1,783.84 1,784.85 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 2.66 0.258 0 595.6198 1,783.84 1,784.85 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 2.65 0.343 0 595.6199 1,783.84 1,784.85 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 2.4 0.269 0 595.62 1,783.84 1,784.85 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 2.99 0.31 1.28 c9: Carbamidomethyl (+57.02) 595.6322 1,783.87 1,784.89 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 3.04 0.373 1.49 c9: Carbamidomethyl (+57.02) 595.6324 1,783.87 1,784.89 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 2.48 0.248 0 595.954 1,784.84 1,784.85 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 2.49 0.229 0 595.9542 1,784.84 1,784.85 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ATcAPQHGAPGPGPADASK 95.00% 3.62 0.335 3.11 c3: Carbamidomethyl (+57.02) 597.6171 1,789.83 1,789.83 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% RAPSVANVGSHcDLSLK 95.00% 4.65 0.521 3.68 c12: Carbamidomethyl (+57.02) 604.3117 1,809.91 1,810.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% RAPSVANVGSHcDLSLK 95.00% 4.74 0.545 3.08 c12: Carbamidomethyl (+57.02) 604.3121 1,809.91 1,810.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% RAPSVANVGSHcDLSLK 95.00% 4.47 0.525 4.49 c12: Carbamidomethyl (+57.02) 604.3124 1,809.91 1,810.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% RAPSVANVGSHcDLSLK 95.00% 4.62 0.587 4.08 c12: Carbamidomethyl (+57.02) 604.6459 1,810.91 1,810.92 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VAQPTITDNKDGTVTVR 95.00% 1.83 0.39 2.07 605.6569 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VAQPTITDNKDGTVTVR 95.00% 2.41 0.273 3.29 605.6577 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VAQPTITDNKDGTVTVR 95.00% 2.02 0.401 2.37 605.6578 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VAQPTITDNKDGTVTVR 95.00% 1.64 0.344 2.09 605.658 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VAQPTITDNKDGTVTVR 95.00% 1.63 0.32 0 605.6581 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VAQPTITDNKDGTVTVR 95.00% 2.07 0.418 2.55 605.6582 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VAQPTITDNKDGTVTVR 95.00% 2.06 0.334 1.44 605.9922 1,814.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VAQPTITDNKDGTVTVR 95.00% 1.59 0.376 1.01 605.9924 1,814.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EATTEFSVDAR 95.00% 3.32 0.475 2.25 613.287 1,224.56 1,225.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EATTEFSVDAR 95.00% 3.52 0.479 1.8 613.2876 1,224.56 1,225.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EATTEFSVDAR 95.00% 3.53 0.414 3.32 613.2877 1,224.56 1,225.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EATTEFSVDAR 95.00% 3.58 0.456 2.16 613.2879 1,224.56 1,225.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EATTEFSVDAR 95.00% 3.55 0.432 2.09 613.2879 1,224.56 1,225.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EATTEFSVDAR 95.00% 3.6 0.423 1.85 613.2879 1,224.56 1,225.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EATTEFSVDAR 95.00% 3.07 0.481 1.24 613.2881 1,224.56 1,225.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EATTEFSVDAR 95.00% 3.59 0.444 2.41 613.2881 1,224.56 1,225.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EATTEFSVDAR 95.00% 3.61 0.44 2.31 613.2882 1,224.56 1,225.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EATTEFSVDAR 95.00% 3.58 0.472 1.77 613.2884 1,224.56 1,225.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EATTEFSVDAR 95.00% 3.39 0.463 0 613.2885 1,224.56 1,225.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EATTEFSVDAR 95.00% 2.11 0.334 0 613.2963 1,224.58 1,225.57 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AWGPGLEGGVVGK 95.00% 1.92 0.253 1.28 613.8257 1,225.64 1,226.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AWGPGLEGGVVGK 95.00% 2.56 0.322 2.74 613.8272 1,225.64 1,226.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AWGPGLEGGVVGK 95.00% 2.6 0.4 3.74 613.8275 1,225.64 1,226.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AWGPGLEGGVVGK 95.00% 1.97 0.306 2.62 613.8286 1,225.64 1,226.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AWGPGLEGGVVGK 95.00% 2.61 0.413 1.43 613.829 1,225.64 1,226.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AWGPGLEGGVVGK 95.00% 3.71 0.584 3.62 613.8294 1,225.64 1,226.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AWGPGLEGGVVGK 95.00% 3.76 0.562 2.89 613.8296 1,225.64 1,226.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AHVVPcFDASK 95.00% 2.35 0.434 3.4 c6: Carbamidomethyl (+57.02) 615.8 1,229.58 1,230.59 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AHVVPcFDASK 95.00% 2.6 0.479 2.36 c6: Carbamidomethyl (+57.02) 615.8 1,229.58 1,230.59 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AHVVPcFDASK 95.00% 2.17 0.393 0 c6: Carbamidomethyl (+57.02) 615.8001 1,229.58 1,230.59 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AHVVPcFDASK 95.00% 2.18 0.297 0 c6: Carbamidomethyl (+57.02) 615.8002 1,229.58 1,230.59 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AHVVPcFDASK 95.00% 2.42 0.437 0 c6: Carbamidomethyl (+57.02) 615.8003 1,229.58 1,230.59 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AHVVPcFDASK 95.00% 2.4 0.359 1.8 c6: Carbamidomethyl (+57.02) 615.8005 1,229.59 1,230.59 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPYTVTVGQAcNPSAcR 95.00% 4.21 0.556 2.8 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.6198 1,867.84 1,867.84 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTVLFAGQHIAK 95.00% 3.99 0.5 2.68 642.3746 1,282.73 1,283.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTVLFAGQHIAK 95.00% 3.77 0.447 2.6 642.3763 1,282.74 1,283.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTVLFAGQHIAK 95.00% 3.75 0.484 2.8 642.3764 1,282.74 1,283.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTVLFAGQHIAK 95.00% 3.55 0.473 3.25 642.3766 1,282.74 1,283.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTVLFAGQHIAK 95.00% 3.8 0.509 1.92 642.3766 1,282.74 1,283.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTVLFAGQHIAK 95.00% 3.68 0.514 3.16 642.3767 1,282.74 1,283.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTVLFAGQHIAK 95.00% 3.76 0.505 2.49 642.3768 1,282.74 1,283.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTVLFAGQHIAK 95.00% 3.53 0.506 3.54 642.3769 1,282.74 1,283.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTVLFAGQHIAK 95.00% 3.75 0.482 2.09 642.3772 1,282.74 1,283.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTVLFAGQHIAK 95.00% 3.55 0.483 2.82 642.3772 1,282.74 1,283.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 2.65 0.288 1.85 643.3648 1,284.71 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 2.51 0.327 2.52 643.3658 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 3.04 0.385 2.47 643.366 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 2.98 0.319 3.08 643.3662 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 2.77 0.36 1.54 643.3664 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 2.9 0.339 3.34 643.3664 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 3 0.3 2.54 643.3665 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 3.11 0.301 3.35 643.3666 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 3.16 0.394 1.92 643.3668 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 2.85 0.39 2.38 643.367 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 3.07 0.357 2.8 643.367 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 2.77 0.308 3.7 643.3671 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 2.13 0.242 0 643.3673 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LPQLPITNFSR 95.00% 2.59 0.241 0 643.3713 1,284.73 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGQPVPNFPSK 95.00% 2.36 0.161 1.12 645.8261 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGQPVPNFPSK 95.00% 3.52 0.485 3.82 645.8271 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGQPVPNFPSK 95.00% 3.87 0.524 4.92 645.8272 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GKLDVQFSGLTK 95.00% 2.97 0.403 1.96 646.8625 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GKLDVQFSGLTK 95.00% 3.16 0.425 3.21 646.8627 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GKLDVQFSGLTK 95.00% 3.19 0.408 2.05 646.8628 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GKLDVQFSGLTK 95.00% 3.2 0.401 2.52 646.8631 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GKLDVQFSGLTK 95.00% 2.99 0.385 2 646.8632 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GKLDVQFSGLTK 95.00% 2.96 0.399 2.44 646.8635 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GKLDVQFSGLTK 95.00% 3.26 0.379 2.8 646.8638 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GKLDVQFSGLTK 95.00% 3.56 0.359 2.46 646.8639 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GKLDVQFSGLTK 95.00% 3.21 0.408 1.36 646.8639 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GKLDVQFSGLTK 95.00% 2.9 0.324 2.25 646.8649 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNGTHIPGSPFK 95.00% 3.17 0.319 2.66 651.3325 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNGTHIPGSPFK 95.00% 2.32 0.257 1.11 651.3344 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNGTHIPGSPFK 95.00% 3.04 0.273 1.21 651.3345 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNGTHIPGSPFK 95.00% 3.49 0.34 3.02 651.3345 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNGTHIPGSPFK 95.00% 3.18 0.354 2.74 651.3347 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNGTHIPGSPFK 95.00% 3.6 0.338 1.74 651.3347 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNGTHIPGSPFK 95.00% 3.48 0.333 2.82 651.3351 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNGTHIPGSPFK 95.00% 2.62 0.373 1.51 651.3356 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNGTHIPGSPFK 95.00% 3.26 0.355 3.11 651.3356 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNGTHIPGSPFK 95.00% 3.18 0.275 1.21 651.3362 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNGTHIPGSPFK 95.00% 3.55 0.332 2.85 651.3368 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNGTHIPGSPFK 95.00% 2.96 0.228 0 651.8352 1,301.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VEPGLGADNSVVR 95.00% 2.58 0.437 3.96 656.8454 1,311.68 1,312.69 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VEPGLGADNSVVR 95.00% 2.62 0.576 5.51 656.8457 1,311.68 1,312.69 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VEPGLGADNSVVR 95.00% 2.53 0.437 5.1 656.8457 1,311.68 1,312.69 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VEPGLGADNSVVR 95.00% 2.24 0.394 1.82 656.8457 1,311.68 1,312.69 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VEPGLGADNSVVR 95.00% 2.27 0.418 2.7 656.846 1,311.68 1,312.69 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VEPGLGADNSVVR 95.00% 2.4 0.445 1.49 656.846 1,311.68 1,312.69 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VEPGLGADNSVVR 95.00% 2.57 0.591 3.36 656.8462 1,311.68 1,312.69 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VEPGLGADNSVVR 95.00% 2.56 0.446 3.24 656.8464 1,311.68 1,312.69 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VEPGLGADNSVVR 95.00% 2.37 0.448 2.96 656.8466 1,311.68 1,312.69 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VEPGLGADNSVVR 95.00% 2.32 0.452 1.13 656.8468 1,311.68 1,312.69 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 3.79 0.455 2.77 677.9351 1,353.85 1,354.87 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 2.49 0.313 1.89 677.9366 1,353.86 1,354.87 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 2.67 0.443 2.21 677.9368 1,353.86 1,354.87 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 3.04 0.446 3.35 677.9368 1,353.86 1,354.87 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 3.73 0.512 4.1 677.9369 1,353.86 1,354.87 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 3.68 0.533 3.19 677.9371 1,353.86 1,354.87 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 3.79 0.523 3.59 677.9375 1,353.86 1,354.87 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 3.66 0.534 3.02 677.9376 1,353.86 1,354.87 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LIALLEVLSQKK 95.00% 0 0 4.49 678.8687 1,355.72 1,354.87 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VSGLGEKVDVGKDQEFTVK 95.00% 2.2 0.297 0 679.3248 2,034.95 2,035.07 3 VINEX_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VSGLGEKVDVGKDQEFTVK 95.00% 4.57 0.487 1.82 679.3633 2,035.07 2,035.07 3 VINEX_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 3.52 0.49 2.11 682.8544 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 3.27 0.465 1.43 682.8545 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 3.71 0.524 2.04 682.8551 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 3.86 0.502 1.72 682.8552 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 3.58 0.516 2.85 682.8553 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 3.85 0.521 1.74 682.8558 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 3.78 0.487 1.89 682.8562 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 3.55 0.504 2.37 682.857 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VDVGKDQEFTVK 95.00% 3.85 0.493 3.47 683.3575 1,364.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 4.55 0.553 2.27 c15: Carbamidomethyl (+57.02) 686.6486 2,056.92 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 4.57 0.515 2.49 c15: Carbamidomethyl (+57.02) 686.6489 2,056.92 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 4.21 0.502 2.66 c15: Carbamidomethyl (+57.02) 686.6494 2,056.92 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 3.22 0.469 2.36 c15: Carbamidomethyl (+57.02) 686.65 2,056.93 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 3.69 0.34 0 c15: Carbamidomethyl (+57.02) 686.9825 2,057.92 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 3.83 0.409 3.3 c15: Carbamidomethyl (+57.02) 686.9826 2,057.92 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 4.09 0.467 2.51 c15: Carbamidomethyl (+57.02) 686.9833 2,057.93 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 4.86 0.453 3.89 c15: Carbamidomethyl (+57.02) 686.9833 2,057.93 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 4.3 0.459 3.12 c15: Carbamidomethyl (+57.02) 686.9833 2,057.93 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 4.38 0.484 3.54 c15: Carbamidomethyl (+57.02) 686.9833 2,057.93 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 4.49 0.486 2.68 c15: Carbamidomethyl (+57.02) 686.9835 2,057.93 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 4.7 0.477 2.33 c15: Carbamidomethyl (+57.02) 686.9836 2,057.93 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 4.66 0.456 3.28 c15: Carbamidomethyl (+57.02) 686.9841 2,057.93 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 3.79 0.345 2.28 c15: Carbamidomethyl (+57.02) 686.9844 2,057.93 2,057.94 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3 0.457 3.96 690.3383 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.96 0.479 4.89 690.3385 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.97 0.596 4.72 690.3396 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.88 0.505 5.72 690.3399 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 4.25 0.574 5.05 690.3401 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 4.11 0.499 4.21 690.3401 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 4.32 0.562 5.77 690.3401 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.9 0.525 6.03 690.3403 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.89 0.474 4.55 690.3404 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.68 0.451 3.92 690.3404 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.98 0.466 5.34 690.3412 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.54 0.444 4.05 690.3424 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGPYHIGGSPFK 95.00% 3.99 0.544 3.34 690.8413 1,379.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGDEIPFSPYR 95.00% 2.89 0.269 3.02 700.8253 1,399.63 1,400.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGDEIPFSPYR 95.00% 2.53 0.217 2.89 700.8268 1,399.64 1,400.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGDEIPFSPYR 95.00% 3.19 0.191 2.8 700.827 1,399.64 1,400.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGDEIPFSPYR 95.00% 4.01 0.176 3.89 700.8273 1,399.64 1,400.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGDEIPFSPYR 95.00% 2.36 0.173 2.85 700.8283 1,399.64 1,400.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YGGDEIPFSPYR 95.00% 3.39 0.137 3.4 701.3285 1,400.64 1,400.65 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 3.24 0.403 2.89 707.3291 1,412.64 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 3.03 0.425 1.85 707.3294 1,412.64 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 3.24 0.392 3.92 707.3296 1,412.64 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 3.04 0.431 2.09 707.33 1,412.64 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 2.3 0.206 2.01 707.3303 1,412.64 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 2.88 0.365 2.29 707.3304 1,412.65 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 3.01 0.421 1.82 707.3305 1,412.65 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 3.21 0.427 1.96 707.3306 1,412.65 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 2.89 0.308 2 707.3306 1,412.65 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 2.62 0.404 1.89 707.3307 1,412.65 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 2.54 0.334 1.24 707.3315 1,412.65 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 3.16 0.439 2.44 707.3315 1,412.65 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 2.74 0.349 1.2 707.3324 1,412.65 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% WGDEHIPGSPYR 95.00% 2.95 0.29 1.82 707.8333 1,413.65 1,413.66 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 3.7 0.411 3.12 708.3757 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 3.89 0.44 3.8 708.3763 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 3.49 0.502 4.33 708.3763 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 3.2 0.505 2.92 708.3766 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 3.35 0.501 4.17 708.377 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 3.88 0.422 3.8 708.377 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 3.21 0.464 1.74 708.3771 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 3.47 0.426 3.52 708.3771 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 3.79 0.433 3.92 708.3772 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 2.43 0.316 2.64 708.3773 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 4.05 0.434 4.7 708.3775 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 4.24 0.435 4.92 708.3775 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IANLQTDLSDGLR 95.00% 3.52 0.425 4.43 708.3777 1,414.74 1,415.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSK 95.00% 4.94 0.586 4.25 713.8786 1,425.74 1,426.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSK 95.00% 5.02 0.569 5.07 713.8795 1,425.74 1,426.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSK 95.00% 3.98 0.631 4.72 713.8797 1,425.74 1,426.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSK 95.00% 4.87 0.552 5.46 713.8797 1,425.74 1,426.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSK 95.00% 3.36 0.51 4.7 713.8798 1,425.74 1,426.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSK 95.00% 4.28 0.591 4.38 713.8798 1,425.74 1,426.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSK 95.00% 4.52 0.576 5.04 713.8799 1,425.74 1,426.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSK 95.00% 4.91 0.573 5.17 713.88 1,425.74 1,426.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSK 95.00% 4.92 0.605 5.89 713.88 1,425.74 1,426.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSK 95.00% 4.79 0.569 4.57 713.8808 1,425.75 1,426.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSK 95.00% 4.1 0.588 4.7 713.8808 1,425.75 1,426.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSK 95.00% 4.97 0.565 4.57 713.8812 1,425.75 1,426.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 3.8 0.441 4.35 715.3609 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 3.99 0.431 4.37 715.3614 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.28 0.397 3.7 715.3614 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.38 0.416 4.48 715.3615 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.25 0.363 3.62 715.3618 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 3.93 0.45 3.89 715.3618 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.25 0.439 4.7 715.362 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.1 0.422 3.7 715.362 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.15 0.425 4.46 715.362 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.55 0.419 3.8 715.3622 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.26 0.394 3.96 715.3623 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.5 0.417 4 715.3624 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.23 0.443 3.54 715.3625 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.69 0.315 4.4 715.3627 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 3.83 0.512 4.27 715.3628 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 2.67 0.436 3.14 715.3628 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4 0.462 4.03 715.3629 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.75 0.423 4.3 715.3631 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AFGPGLQGGSAGSPAR 95.00% 4.1 0.392 4.54 715.3636 1,428.71 1,429.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAEMPATEKDLAEDAPWKK 95.00% 2.64 0.316 0 715.676 2,144.00 2,145.02 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAEMPATEKDLAEDAPWKK 95.00% 3.71 0.345 0 715.6777 2,144.01 2,145.02 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAEMPATEKDLAEDAPWKK 95.00% 4.36 0.51 0 715.6788 2,144.01 2,145.02 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAEMPATEKDLAEDAPWKK 95.00% 3.82 0.416 0 716.0101 2,145.01 2,145.02 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAEMPATEKDLAEDAPWKK 95.00% 4.12 0.352 1.39 716.0104 2,145.01 2,145.02 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAEMPATEKDLAEDAPWKK 95.00% 3.84 0.46 0 716.0107 2,145.01 2,145.02 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAEMPATEKDLAEDAPWKK 95.00% 4.25 0.417 0 716.011 2,145.01 2,145.02 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAEMPATEKDLAEDAPWKK 95.00% 4 0.384 0 716.0114 2,145.01 2,145.02 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAEMPATEKDLAEDAPWKK 95.00% 3.9 0.474 2.48 716.0115 2,145.01 2,145.02 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAEMPATEKDLAEDAPWKK 95.00% 4.7 0.474 2.05 716.0118 2,145.01 2,145.02 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 4.27 0.438 1.37 717.3571 1,432.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 3.84 0.539 3.72 717.3573 1,432.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 4.59 0.441 2.26 717.3573 1,432.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 3.74 0.327 0 717.3577 1,432.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 3.98 0.563 4.7 717.3579 1,432.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 4.46 0.404 2.59 717.3581 1,432.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 4.46 0.391 1.85 717.3582 1,432.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 4.24 0.463 2.54 717.3586 1,432.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 3.71 0.273 0 717.3587 1,432.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 3.11 0.135 0 717.3594 1,432.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 4.34 0.462 1.85 717.3595 1,432.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 4.1 0.331 0 717.3599 1,432.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNMVK 95.00% 4.34 0.505 4.18 717.8593 1,433.70 1,433.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ANLPQSFQVDTSK 95.00% 3.19 0.495 3.51 717.8605 1,433.71 1,434.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ANLPQSFQVDTSK 95.00% 4.08 0.517 4.47 717.8637 1,433.71 1,434.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ANLPQSFQVDTSK 95.00% 4.02 0.529 4.64 717.8645 1,433.71 1,434.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ANLPQSFQVDTSK 95.00% 2.36 0.388 2.21 717.8656 1,433.72 1,434.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ANLPQSFQVDTSK 95.00% 2.97 0.259 3.12 718.2775 1,434.54 1,434.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ANLPQSFQVDTSK 95.00% 2.77 0.484 3.24 718.365 1,434.71 1,434.72 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGQSAAGAAPGGGVDTR 95.00% 3.69 0.415 4.35 721.8554 1,441.70 1,442.70 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AGQSAAGAAPGGGVDTR 95.00% 4.26 0.535 3.57 721.8556 1,441.70 1,442.70 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% MDcQEcPEGYR 95.00% 3.75 0.597 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7668 1,443.52 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% MDcQEcPEGYR 95.00% 3 0.523 1.51 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7686 1,443.52 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% MDcQEcPEGYR 95.00% 3.23 0.573 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7691 1,443.52 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNmVK 95.00% 3.58 0.518 3.26 m12: Oxidation (+15.99) 725.3545 1,448.69 1,449.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNmVK 95.00% 2.47 0.27 1.96 m12: Oxidation (+15.99) 725.3554 1,448.70 1,449.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AYGPGIEPTGNmVK 95.00% 3.52 0.478 1.39 m12: Oxidation (+15.99) 725.8587 1,449.70 1,449.71 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 4.69 0.61 3.89 734.0483 2,199.12 2,200.13 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 4.75 0.604 3 734.0489 2,199.12 2,200.13 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 4.69 0.569 3.72 734.3799 2,200.12 2,200.13 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 5.09 0.571 3.74 734.3809 2,200.12 2,200.13 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 5.03 0.607 4.42 734.381 2,200.12 2,200.13 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 4.81 0.575 3.37 734.3812 2,200.12 2,200.13 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 5.39 0.634 4.85 734.3813 2,200.12 2,200.13 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 5.13 0.604 3.1 734.3815 2,200.12 2,200.13 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 4.63 0.607 3.43 734.3817 2,200.12 2,200.13 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 4.64 0.592 3.3 734.382 2,200.12 2,200.13 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 4.61 0.594 3.85 734.3835 2,200.13 2,200.13 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGGLSLAIEGPSK 95.00% 5.01 0.54 3.41 750.8792 1,499.74 1,500.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGGLSLAIEGPSK 95.00% 5.11 0.559 2.92 750.8795 1,499.74 1,500.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGGLSLAIEGPSK 95.00% 5.12 0.578 3.51 750.8805 1,499.75 1,500.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGGLSLAIEGPSK 95.00% 5.2 0.56 3.08 750.8805 1,499.75 1,500.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGGLSLAIEGPSK 95.00% 4.04 0.549 3.54 750.8806 1,499.75 1,500.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGGLSLAIEGPSK 95.00% 5.25 0.57 3.7 750.881 1,499.75 1,500.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGGLSLAIEGPSK 95.00% 4.65 0.519 3.26 750.8813 1,499.75 1,500.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGGLSLAIEGPSK 95.00% 4.83 0.516 3.62 750.8814 1,499.75 1,500.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGGLSLAIEGPSK 95.00% 5.79 0.592 6.35 750.8817 1,499.75 1,500.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGGLSLAIEGPSK 95.00% 3.84 0.489 3.51 750.8818 1,499.75 1,500.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGGLSLAIEGPSK 95.00% 4.55 0.546 4 750.882 1,499.75 1,500.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGGLSLAIEGPSK 95.00% 5.16 0.55 4.42 751.3808 1,500.75 1,500.75 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FVPAEMGTHTVSVK 95.00% 3.46 0.503 4.57 751.8849 1,501.75 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FVPAEMGTHTVSVK 95.00% 4.61 0.506 5.47 751.8864 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FVPAEMGTHTVSVK 95.00% 4.49 0.539 7.08 751.8875 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FVPAEMGTHTVSVK 95.00% 3.88 0.523 5.89 751.8877 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FVPAEMGTHTVSVK 95.00% 4.09 0.475 5.57 751.8878 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FVPAEMGTHTVSVK 95.00% 3.57 0.506 5.44 751.888 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FVPAEMGTHTVSVK 95.00% 3.85 0.545 5.44 751.8881 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FVPAEMGTHTVSVK 95.00% 4.49 0.532 6.35 751.8896 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 3.74 0.561 5.66 751.8977 1,501.78 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 4.07 0.534 4.89 751.8989 1,501.78 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 4.67 0.559 6.8 751.8997 1,501.78 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 4.62 0.54 4.89 751.9003 1,501.78 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 4.51 0.558 4.8 751.9006 1,501.79 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 4.82 0.562 4.17 751.9007 1,501.79 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 5.04 0.569 5.1 751.9013 1,501.79 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 4.77 0.578 6.03 751.9013 1,501.79 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 4.67 0.549 5.17 751.9015 1,501.79 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 4.83 0.554 3.49 751.9018 1,501.79 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 4.34 0.558 5.49 751.9047 1,501.79 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FVPAEMGTHTVSVK 95.00% 3.96 0.492 5.28 752.388 1,502.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FVPAEMGTHTVSVK 95.00% 4.23 0.518 5.82 752.3888 1,502.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 4.04 0.455 5.24 752.3951 1,502.77 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 4.09 0.479 4.13 752.3955 1,502.78 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VNQPASFAVSLNGAK 95.00% 3.34 0.435 1.47 752.4044 1,502.79 1,502.80 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DGScGVAYVVQEPGDYEVSVK 95.00% 3.59 0.445 2.19 c4: Carbamidomethyl (+57.02) 753.6819 2,258.02 2,258.03 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DGScGVAYVVQEPGDYEVSVK 95.00% 3.85 0.572 3.07 c4: Carbamidomethyl (+57.02) 753.683 2,258.03 2,258.03 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.28 0.42 1.89 758.3819 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.45 0.403 4.06 758.3824 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.55 0.484 4.68 758.3828 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.87 0.419 3.82 758.383 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.59 0.444 2.62 758.3832 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.26 0.382 2.35 758.3834 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.28 0.338 1.66 758.3835 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.45 0.432 3.51 758.3838 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.44 0.364 3.16 758.8863 1,515.76 1,515.76 2 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FADQHVPGSPFSVK 95.00% 3.28 0.333 3.36 758.8864 1,515.76 1,515.76 2 MOES_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FVPAEmGTHTVSVK 95.00% 3.07 0.537 3.31 m6: Oxidation (+15.99) 759.8847 1,517.75 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FVPAEmGTHTVSVK 95.00% 3.34 0.575 4.59 m6: Oxidation (+15.99) 759.8858 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VHSPSGALEEcYVTEIDQDK 95.00% 4.26 0.329 0 c11: Carbamidomethyl (+57.02) 760.017 2,277.03 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VHSPSGALEEcYVTEIDQDK 95.00% 4.9 0.523 2.22 c11: Carbamidomethyl (+57.02) 760.019 2,277.03 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.96 0.666 3.07 763.0686 2,286.18 2,286.18 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ANLPQSFQVDTSKAGVAPLQVK 95.00% 3.15 0.568 1.96 767.0877 2,298.24 2,298.25 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ANLPQSFQVDTSKAGVAPLQVK 95.00% 2 0.188 1.51 767.0881 2,298.24 2,298.25 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFSVAVSPSLDLSK 95.00% 4.82 0.543 2.72 767.4101 1,532.80 1,533.82 2 RL4_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFSVAVSPSLDLSK 95.00% 4.88 0.505 3.43 767.4104 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFSVAVSPSLDLSK 95.00% 4.71 0.538 3.21 767.4109 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFSVAVSPSLDLSK 95.00% 4.87 0.494 2.74 767.4109 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFSVAVSPSLDLSK 95.00% 4.96 0.526 3.66 767.4111 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFSVAVSPSLDLSK 95.00% 4.61 0.471 2.06 767.4113 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFSVAVSPSLDLSK 95.00% 4.8 0.538 3.59 767.4114 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFSVAVSPSLDLSK 95.00% 3.88 0.513 2.2 767.4124 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.32 0.415 2.8 769.0557 2,304.14 2,304.15 3 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.89 0.487 3.8 769.0571 2,304.15 2,304.15 3 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.55 0.462 3.28 769.0573 2,304.15 2,304.15 3 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.29 0.352 0 769.0585 2,304.15 2,304.15 3 FLNC_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGYGGLSLSIEGPSK 95.00% 3.38 0.363 1.59 775.8897 1,549.76 1,550.77 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGYGGLSLSIEGPSK 95.00% 3.97 0.444 4.18 775.8899 1,549.76 1,550.77 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGYGGLSLSIEGPSK 95.00% 4.43 0.534 3.44 775.8902 1,549.76 1,550.77 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 3.58 0.446 1.05 781.7506 2,342.23 2,342.22 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.09 0.619 2.96 785.9051 1,569.79 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.62 0.579 3.13 785.9055 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 5.11 0.591 4.17 785.9059 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 5.05 0.613 3.57 785.906 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.82 0.552 3.11 785.9063 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.92 0.598 4.35 785.9065 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.96 0.539 4.06 785.9066 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.34 0.571 3.4 785.9066 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.97 0.566 4.05 785.9069 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 3.36 0.493 3.44 785.9071 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.72 0.609 3.66 785.9073 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.15 0.596 3.8 785.9075 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.72 0.58 5.17 785.9076 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.36 0.624 3.64 785.9076 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 3.4 0.526 4.09 785.9077 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.32 0.606 3.06 785.9092 1,569.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GAGTGGLGLAVEGPSEAK 95.00% 4.67 0.598 3.82 786.4082 1,570.80 1,570.81 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YAPSEAGLHEMDIR 95.00% 3.47 0.459 3.11 794.8742 1,587.73 1,588.74 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YAPSEAGLHEMDIR 95.00% 3.24 0.391 2.92 794.8743 1,587.73 1,588.74 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YAPSEAGLHEMDIR 95.00% 3.36 0.419 2.8 794.8745 1,587.73 1,588.74 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YAPSEAGLHEMDIR 95.00% 3.84 0.478 3.28 794.8746 1,587.73 1,588.74 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YAPSEAGLHEMDIR 95.00% 3.55 0.435 2.57 794.8755 1,587.74 1,588.74 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DNGNGTYScSYVPR 95.00% 3.33 0.401 2.57 c9: Carbamidomethyl (+57.02) 795.3347 1,588.65 1,589.67 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DNGNGTYScSYVPR 95.00% 4.08 0.536 3.47 c9: Carbamidomethyl (+57.02) 795.3358 1,588.66 1,589.67 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DNGNGTYScSYVPR 95.00% 2.56 0.13 2.7 c9: Carbamidomethyl (+57.02) 795.3366 1,588.66 1,589.67 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DNGNGTYScSYVPR 95.00% 3.34 0.564 2.41 c9: Carbamidomethyl (+57.02) 795.3368 1,588.66 1,589.67 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DNGNGTYScSYVPR 95.00% 2.89 0.465 2.39 c9: Carbamidomethyl (+57.02) 795.3369 1,588.66 1,589.67 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DNGNGTYScSYVPR 95.00% 2.88 0.465 2.04 c9: Carbamidomethyl (+57.02) 795.3374 1,588.66 1,589.67 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DNGNGTYScSYVPR 95.00% 2.79 0.468 2.26 c9: Carbamidomethyl (+57.02) 795.3374 1,588.66 1,589.67 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DNGNGTYScSYVPR 95.00% 3.13 0.465 2.1 c9: Carbamidomethyl (+57.02) 795.3385 1,588.66 1,589.67 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DNGNGTYScSYVPR 95.00% 3.31 0.439 3.11 c9: Carbamidomethyl (+57.02) 795.3394 1,588.66 1,589.67 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YAPSEAGLHEMDIR 95.00% 3.4 0.423 2.77 795.3753 1,588.73 1,588.74 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DNGNGTYScSYVPR 95.00% 3.37 0.503 1.96 c9: Carbamidomethyl (+57.02) 795.837 1,589.66 1,589.67 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 4.17 0.474 5.19 801.8853 1,601.75 1,602.77 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 3.41 0.515 4.17 801.8853 1,601.76 1,602.77 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 4.03 0.512 4.6 801.8856 1,601.76 1,602.77 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 3.91 0.576 3.19 801.8858 1,601.76 1,602.77 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 4.52 0.539 5.92 801.8861 1,601.76 1,602.77 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 2.63 0.368 0 801.8863 1,601.76 1,602.77 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 3.93 0.57 2.6 801.8863 1,601.76 1,602.77 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YNEQHVPGSPFTAR 95.00% 2.45 0.298 0 801.8868 1,601.76 1,602.77 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.61 0.372 3.64 814.3998 2,440.18 2,440.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.27 0.491 3.72 814.4002 2,440.18 2,440.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.15 0.445 3.89 814.4012 2,440.18 2,440.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.72 0.387 3.28 814.402 2,440.18 2,440.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.66 0.49 4.46 814.4023 2,440.18 2,440.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.29 0.432 4.62 814.4031 2,440.19 2,440.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.66 0.493 4.18 814.4032 2,440.19 2,440.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.6 0.558 2.22 c11: Carbamidomethyl (+57.02) 817.4333 2,449.28 2,449.29 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.45 0.575 4.51 c11: Carbamidomethyl (+57.02) 817.4334 2,449.28 2,449.29 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.63 0.575 3.43 c11: Carbamidomethyl (+57.02) 817.4338 2,449.28 2,449.29 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.97 0.603 3.8 c11: Carbamidomethyl (+57.02) 817.4338 2,449.28 2,449.29 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.23 0.519 2.64 c11: Carbamidomethyl (+57.02) 817.4345 2,449.28 2,449.29 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.26 0.492 2.55 c11: Carbamidomethyl (+57.02) 817.4346 2,449.28 2,449.29 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.54 0.554 4 c11: Carbamidomethyl (+57.02) 817.4349 2,449.28 2,449.29 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.5 0.499 4.02 c11: Carbamidomethyl (+57.02) 817.4352 2,449.28 2,449.29 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.04 0.489 3.8 c11: Carbamidomethyl (+57.02) 817.4356 2,449.28 2,449.29 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.12 0.326 2.74 823.0667 2,466.18 2,467.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.59 0.343 2.82 823.4007 2,467.18 2,467.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.19 0.356 2.82 823.4008 2,467.18 2,467.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.87 0.304 3.22 823.4009 2,467.18 2,467.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.36 0.386 2.33 823.4016 2,467.18 2,467.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.12 0.355 3.51 823.402 2,467.18 2,467.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.63 0.348 2.89 823.402 2,467.18 2,467.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.37 0.308 3.35 823.4023 2,467.18 2,467.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVAVNKPAEFTVDAK 95.00% 4.1 0.446 3.43 823.9402 1,645.86 1,646.88 2 MYLK_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVAVNKPAEFTVDAK 95.00% 4.42 0.422 3.47 823.9406 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVAVNKPAEFTVDAK 95.00% 4.29 0.428 2.72 823.9408 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVAVNKPAEFTVDAK 95.00% 4.11 0.411 4.03 823.9408 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVAVNKPAEFTVDAK 95.00% 3.95 0.446 3.02 823.9427 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVAVNKPAEFTVDAK 95.00% 3.49 0.366 2.66 823.9431 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 4.83 0.628 5.09 826.9326 1,651.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 5.04 0.589 4.41 826.9326 1,651.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 5.15 0.583 4.51 826.9328 1,651.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 4.74 0.576 4.77 826.9328 1,651.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 4.63 0.525 3.39 826.9329 1,651.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 5 0.592 3.48 826.933 1,651.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 5.18 0.56 4.82 826.9332 1,651.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 5.17 0.575 4.14 826.9332 1,651.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 4.61 0.535 2.68 826.9342 1,651.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 4.92 0.613 4.6 826.9345 1,651.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 5.19 0.615 5.46 826.9345 1,651.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 5.17 0.609 2.96 826.9345 1,651.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 5.05 0.542 3.82 827.4352 1,652.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 5.2 0.563 3.24 827.4353 1,652.85 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTAQGPGLEPSGNIANK 95.00% 4.88 0.565 3.92 827.4372 1,652.86 1,652.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 4.38 0.411 1.68 835.0999 2,502.28 2,502.28 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EAGAGGLAIAVEGPSKAEISFEDRK 95.00% 4.28 0.474 3.05 835.1008 2,502.28 2,502.28 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YWPQEAGEYAVHVLcNSEDIR 95.00% 2.59 0.272 1.89 c15: Carbamidomethyl (+57.02) 846.3893 2,536.14 2,536.16 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YWPQEAGEYAVHVLcNSEDIR 95.00% 2.44 0.356 0 c15: Carbamidomethyl (+57.02) 846.3905 2,536.15 2,536.16 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YWPQEAGEYAVHVLcNSEDIR 95.00% 2.39 0.398 1.28 c15: Carbamidomethyl (+57.02) 846.3909 2,536.15 2,536.16 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.71 0.535 4.04 849.0899 2,544.25 2,544.26 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.56 0.588 5.25 849.0901 2,544.25 2,544.26 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.38 0.598 3.49 849.0903 2,544.25 2,544.26 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.28 0.591 2.6 849.0904 2,544.25 2,544.26 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.86 0.632 4.74 849.0915 2,544.25 2,544.26 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 4.47 0.479 3.52 849.9612 1,697.91 1,698.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.86 0.44 3.43 849.9615 1,697.91 1,698.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 4.59 0.549 4.19 849.9618 1,697.91 1,698.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.81 0.504 2.8 849.9623 1,697.91 1,698.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 4.67 0.554 3.66 849.9624 1,697.91 1,698.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 3.93 0.539 3.25 849.9632 1,697.91 1,698.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 4.06 0.561 4.31 850.4609 1,698.91 1,698.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 4 0.539 5.16 850.4619 1,698.91 1,698.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 4.45 0.578 4.32 850.4624 1,698.91 1,698.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 4.65 0.536 3.77 850.4632 1,698.91 1,698.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TGVELGKPTHFTVNAK 95.00% 4.48 0.448 4.82 850.4636 1,698.91 1,698.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% AHEPTYFTVDcAEAGQGDVSIGIK 95.00% 4.17 0.49 2.85 c11: Carbamidomethyl (+57.02) 856.0661 2,565.17 2,565.19 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% KTHIQDNHDGTYTVAYVPDVTGR 95.00% 4.49 0.493 1.96 863.4204 2,587.24 2,587.25 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YKGQHVPGSPFQFTVGPLGEGGAHK 95.00% 1.72 0.296 2.89 865.7303 2,594.17 2,595.31 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YKGQHVPGSPFQFTVGPLGEGGAHK 95.00% 5.4 0.448 3.74 866.1107 2,595.31 2,595.31 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYTPMAPGSYLISIK 95.00% 3.55 0.479 2.68 870.9641 1,739.91 1,740.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYTPMAPGSYLISIK 95.00% 3.67 0.525 2.72 870.9641 1,739.91 1,740.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYTPMAPGSYLISIK 95.00% 3.57 0.472 1.46 870.9652 1,739.91 1,740.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYTPMAPGSYLISIK 95.00% 3.77 0.52 2.89 870.9656 1,739.92 1,740.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYTPMAPGSYLISIK 95.00% 3.78 0.451 0 871.466 1,740.92 1,740.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYTPMAPGSYLISIK 95.00% 3.8 0.494 3.64 871.4663 1,740.92 1,740.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.4 0.48 0 875.942 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.86 0.514 0 875.9424 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.33 0.534 0 875.9438 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.09 0.49 0 876.442 1,750.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 2.96 0.457 0 876.4445 1,750.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.85 0.594 2.59 876.4447 1,750.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% TFSVWYVPEVTGTHK 95.00% 3.82 0.563 0 876.4457 1,750.88 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 5.52 0.55 6.89 878.9223 1,755.83 1,756.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 5.19 0.52 6.15 878.9223 1,755.83 1,756.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 5.38 0.519 5.39 878.9226 1,755.83 1,756.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPFEVYVDKSQGDASK 95.00% 5.14 0.497 5.82 879.4231 1,756.83 1,756.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 5.14 0.639 6.24 882.4292 1,762.84 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 4.94 0.622 6.92 882.4294 1,762.84 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 4.18 0.494 3.21 882.4298 1,762.84 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 5.22 0.594 5.09 882.4301 1,762.84 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 5.12 0.646 6.7 882.4302 1,762.84 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 5.24 0.623 9.1 882.4302 1,762.84 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 5.1 0.635 9.05 882.4307 1,762.85 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 5.25 0.618 7.04 882.4308 1,762.85 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 5.13 0.657 6.64 882.4312 1,762.85 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 5.16 0.639 6.16 882.4312 1,762.85 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 5.25 0.637 8.48 882.4315 1,762.85 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 5.3 0.635 7.66 882.4315 1,762.85 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VANPSGNLTETYVQDR 95.00% 2.9 0.357 0 882.4334 1,762.85 1,763.86 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 3.91 0.565 4.33 892.925 1,783.83 1,784.85 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 3.98 0.565 4.23 892.9253 1,783.83 1,784.85 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 4 0.537 3.25 892.9259 1,783.84 1,784.85 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 3.68 0.56 2.47 892.9263 1,783.84 1,784.85 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 3.68 0.583 4.37 892.9278 1,783.84 1,784.85 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 5.49 0.581 4.25 c9: Carbamidomethyl (+57.02) 892.9433 1,783.87 1,784.89 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 5.42 0.597 6.74 c9: Carbamidomethyl (+57.02) 892.944 1,783.87 1,784.89 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 5.75 0.574 4.8 c9: Carbamidomethyl (+57.02) 892.9445 1,783.87 1,784.89 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 5.76 0.563 5.41 c9: Carbamidomethyl (+57.02) 892.9445 1,783.87 1,784.89 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 5.52 0.581 4.59 c9: Carbamidomethyl (+57.02) 892.9449 1,783.87 1,784.89 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 5.57 0.59 3.08 c9: Carbamidomethyl (+57.02) 892.9449 1,783.87 1,784.89 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 5.49 0.566 4.15 c9: Carbamidomethyl (+57.02) 892.9449 1,783.87 1,784.89 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 5.35 0.592 4.42 c9: Carbamidomethyl (+57.02) 892.9453 1,783.88 1,784.89 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 5.35 0.583 3.7 c9: Carbamidomethyl (+57.02) 892.9455 1,783.88 1,784.89 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 5.21 0.599 4.03 c9: Carbamidomethyl (+57.02) 892.9455 1,783.88 1,784.89 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 4.4 0.56 2.68 893.4261 1,784.84 1,784.85 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 4.37 0.527 2.39 893.4264 1,784.84 1,784.85 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DVDIIDHHDNTYTVK 95.00% 4.31 0.58 3.68 893.4265 1,784.84 1,784.85 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VQVQDNEGcPVEALVK 95.00% 5.66 0.536 5 c9: Carbamidomethyl (+57.02) 893.4467 1,784.88 1,784.89 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% cSYQPTMEGVHTVHVTFAGVPIPR 95.00% 3.26 0.485 0.959 c1: Carbamidomethyl (+57.02) 895.442 2,683.30 2,683.31 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VAQPTITDNKDGTVTVR 95.00% 4.12 0.513 4.4 907.9827 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VAQPTITDNKDGTVTVR 95.00% 4.14 0.385 4.59 908.4846 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VAQPTITDNKDGTVTVR 95.00% 4.28 0.421 4.49 908.4855 1,814.96 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LQVEPAVDTSGVQcYGPGIEGQGVFR 95.00% 7.09 0.658 6.27 c14: Carbamidomethyl (+57.02) 922.1187 2,763.33 2,763.34 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LQVEPAVDTSGVQcYGPGIEGQGVFR 95.00% 6.52 0.657 6.85 c14: Carbamidomethyl (+57.02) 922.1208 2,763.34 2,763.34 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.57 0.468 4.46 c11: Carbamidomethyl (+57.02) 923.1046 2,766.29 2,766.30 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.25 0.453 4.34 c11: Carbamidomethyl (+57.02) 923.1058 2,766.29 2,766.30 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 5.22 0.642 3.39 c11: Carbamidomethyl (+57.02) 923.1059 2,766.29 2,766.30 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.3 0.503 3.6 c11: Carbamidomethyl (+57.02) 923.1061 2,766.29 2,766.30 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.48 0.459 3.06 c11: Carbamidomethyl (+57.02) 923.1063 2,766.30 2,766.30 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.64 0.514 3.6 c11: Carbamidomethyl (+57.02) 923.1075 2,766.30 2,766.30 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPYTVTVGQAcNPSAcR 95.00% 5.09 0.48 7.05 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.421 1,866.83 1,867.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPYTVTVGQAcNPSAcR 95.00% 5.23 0.496 5.38 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4222 1,866.83 1,867.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPYTVTVGQAcNPSAcR 95.00% 5.29 0.53 6.57 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.424 1,866.83 1,867.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPYTVTVGQAcNPSAcR 95.00% 5.55 0.529 5.59 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4245 1,866.83 1,867.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPYTVTVGQAcNPSAcR 95.00% 4.89 0.486 5.27 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9234 1,867.83 1,867.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPYTVTVGQAcNPSAcR 95.00% 5.01 0.467 6.7 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9244 1,867.83 1,867.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPYTVTVGQAcNPSAcR 95.00% 5.33 0.574 7.09 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9248 1,867.83 1,867.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPYTVTVGQAcNPSAcR 95.00% 5.23 0.508 4.17 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.925 1,867.83 1,867.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPYTVTVGQAcNPSAcR 95.00% 5.55 0.554 7.17 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.925 1,867.83 1,867.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPYTVTVGQAcNPSAcR 95.00% 5.45 0.605 4.1 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9251 1,867.83 1,867.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SPYTVTVGQAcNPSAcR 95.00% 5.18 0.533 5 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9251 1,867.83 1,867.84 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYcPTEPGNYIINIK 95.00% 4.35 0.576 4.14 c4: Carbamidomethyl (+57.02) 941.469 1,880.92 1,881.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYcPTEPGNYIINIK 95.00% 4.08 0.514 3.89 c4: Carbamidomethyl (+57.02) 941.4722 1,880.93 1,881.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYcPTEPGNYIINIK 95.00% 4.89 0.576 3.55 c4: Carbamidomethyl (+57.02) 941.4726 1,880.93 1,881.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYcPTEPGNYIINIK 95.00% 4.56 0.557 3.62 c4: Carbamidomethyl (+57.02) 941.4731 1,880.93 1,881.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYcPTEPGNYIINIK 95.00% 4.32 0.564 2.74 c4: Carbamidomethyl (+57.02) 941.4731 1,880.93 1,881.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYcPTEPGNYIINIK 95.00% 4.79 0.509 3.7 c4: Carbamidomethyl (+57.02) 941.974 1,881.93 1,881.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYcPTEPGNYIINIK 95.00% 4.45 0.5 2.96 c4: Carbamidomethyl (+57.02) 941.9749 1,881.93 1,881.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYcPTEPGNYIINIK 95.00% 4.35 0.495 2.8 c4: Carbamidomethyl (+57.02) 941.9751 1,881.93 1,881.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYcPTEPGNYIINIK 95.00% 4.26 0.485 3.72 c4: Carbamidomethyl (+57.02) 941.9753 1,881.94 1,881.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYcPTEPGNYIINIK 95.00% 4.24 0.502 3.68 c4: Carbamidomethyl (+57.02) 941.9756 1,881.94 1,881.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYcPTEPGNYIINIK 95.00% 4.29 0.478 3.55 c4: Carbamidomethyl (+57.02) 941.976 1,881.94 1,881.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% VTYcPTEPGNYIINIK 95.00% 4.8 0.497 3.54 c4: Carbamidomethyl (+57.02) 941.9768 1,881.94 1,881.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EGPYSISVLYGDEEVPR 95.00% 4.48 0.571 6.18 955.4609 1,908.91 1,909.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EGPYSISVLYGDEEVPR 95.00% 4.97 0.584 5.3 955.4621 1,908.91 1,909.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EGPYSISVLYGDEEVPR 95.00% 4.89 0.54 5.47 955.9616 1,909.91 1,909.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EGPYSISVLYGDEEVPR 95.00% 5.38 0.565 5.8 955.9621 1,909.91 1,909.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EGPYSISVLYGDEEVPR 95.00% 5.3 0.541 4.3 955.9621 1,909.91 1,909.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EGPYSISVLYGDEEVPR 95.00% 4.64 0.551 5.36 955.9626 1,909.91 1,909.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EGPYSISVLYGDEEVPR 95.00% 4.28 0.461 3.85 955.9626 1,909.91 1,909.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EGPYSISVLYGDEEVPR 95.00% 5.31 0.56 3.64 955.9634 1,909.91 1,909.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EGPYSISVLYGDEEVPR 95.00% 5.25 0.537 6.09 955.9636 1,909.91 1,909.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% EGPYSISVLYGDEEVPR 95.00% 5.12 0.515 4.23 955.9644 1,909.91 1,909.92 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGLLAVQITDPEGKPK 95.00% 4.93 0.476 8.19 969.5092 1,937.00 1,938.02 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGLLAVQITDPEGKPK 95.00% 4.67 0.395 7 969.5105 1,937.01 1,938.02 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGLLAVQITDPEGKPK 95.00% 4.94 0.353 7.14 969.5108 1,937.01 1,938.02 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGLLAVQITDPEGKPK 95.00% 5.05 0.338 6.92 970.0108 1,938.01 1,938.02 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGLLAVQITDPEGKPK 95.00% 4.92 0.366 6.36 970.0115 1,938.01 1,938.02 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGLLAVQITDPEGKPK 95.00% 5.05 0.393 5.47 970.0127 1,938.01 1,938.02 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGLLAVQITDPEGKPK 95.00% 5.08 0.399 6.85 970.013 1,938.01 1,938.02 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGLLAVQITDPEGKPK 95.00% 5.21 0.339 6.04 970.0135 1,938.01 1,938.02 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGLLAVQITDPEGKPK 95.00% 5.19 0.331 5.8 970.0135 1,938.01 1,938.02 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DAGEGLLAVQITDPEGKPK 95.00% 4.89 0.327 6.24 970.0153 1,938.02 1,938.02 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% HTAMVSWGGVSIPNSPFR 95.00% 5.27 0.638 8.59 972.4844 1,942.95 1,942.96 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FGGEHVPNSPFQVTALAGDQPSVQPPLR 95.00% 4.97 0.583 4.44 982.834 2,945.48 2,945.49 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FGGEHVPNSPFQVTALAGDQPSVQPPLR 95.00% 5.14 0.491 4.49 982.8353 2,945.48 2,945.49 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IPEISIQDMTAQVTSPSGK 95.00% 6.11 0.748 10.7 1,001.51 2,001.00 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IPEISIQDMTAQVTSPSGK 95.00% 6.3 0.746 8.19 1,001.51 2,001.00 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IPEISIQDMTAQVTSPSGK 95.00% 5.74 0.668 8.66 1,001.51 2,001.00 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% IPEISIQDMTAQVTSPSGK 95.00% 6.26 0.706 7.82 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% cAPGVVGPAEADIDFDIIR 95.00% 6.43 0.668 9.92 c1: Carbamidomethyl (+57.02) 1,007.99 2,013.97 2,014.99 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% cAPGVVGPAEADIDFDIIR 95.00% 4.87 0.616 7.6 c1: Carbamidomethyl (+57.02) 1,008.00 2,013.98 2,014.99 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% cAPGVVGPAEADIDFDIIR 95.00% 5.95 0.558 7.38 c1: Carbamidomethyl (+57.02) 1,008.50 2,014.98 2,014.99 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% cAPGVVGPAEADIDFDIIRNDNDTFTVK 95.00% 3.65 0.5 1.43 c1: Carbamidomethyl (+57.02) 1,017.49 3,049.45 3,049.46 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 6.64 0.65 7.02 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.92 2,057.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 6.07 0.626 7.4 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% THEAEIVEGENHTYcIR 95.00% 6.59 0.632 7.27 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ALGALVDScAPGLcPDWDSWDASKPVTNAR 95.00% 5.91 0.523 4.89 c9: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,077.51 3,229.49 3,229.51 3
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 5.82 0.626 5.52 1,100.56 2,199.11 2,200.13 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LVSNHSLHETSSVFVDSLTK 95.00% 5.78 0.626 4.66 1,101.07 2,200.12 2,200.13 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DGScGVAYVVQEPGDYEVSVK 95.00% 5.34 0.666 5.41 c4: Carbamidomethyl (+57.02) 1,129.52 2,257.02 2,258.03 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DGScGVAYVVQEPGDYEVSVK 95.00% 5.46 0.633 4.77 c4: Carbamidomethyl (+57.02) 1,130.01 2,258.01 2,258.03 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DGScGVAYVVQEPGDYEVSVK 95.00% 5.16 0.632 5.05 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.01 2,258.03 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DGScGVAYVVQEPGDYEVSVK 95.00% 5.51 0.619 3.66 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DGScGVAYVVQEPGDYEVSVK 95.00% 5.59 0.644 4.19 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DGScGVAYVVQEPGDYEVSVK 95.00% 5.65 0.624 4.66 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DGScGVAYVVQEPGDYEVSVK 95.00% 5.47 0.609 3.96 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DGScGVAYVVQEPGDYEVSVK 95.00% 5.55 0.632 5.22 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DGScGVAYVVQEPGDYEVSVK 95.00% 5.48 0.647 5.21 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% DGScGVAYVVQEPGDYEVSVK 95.00% 5.67 0.64 4.19 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YTPVQQGPVGVNVTYGGDPIPK 95.00% 3.92 0.64 4.41 1,143.55 2,285.08 2,286.18 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YTPVQQGPVGVNVTYGGDPIPK 95.00% 3.38 0.622 3.27 1,143.55 2,285.08 2,286.18 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.37 0.659 5.68 1,144.09 2,286.17 2,286.18 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.4 0.667 5.34 1,144.09 2,286.17 2,286.18 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.5 0.663 4.8 1,144.09 2,286.17 2,286.18 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.54 0.633 5.51 1,144.09 2,286.17 2,286.18 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.56 0.668 4.57 1,144.09 2,286.17 2,286.18 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.53 0.655 4.66 1,144.09 2,286.17 2,286.18 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.52 0.549 6.04 1,157.55 2,313.09 2,313.10 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.31 0.583 6.92 1,157.55 2,313.09 2,313.10 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SAGQGEVLVYVEDPAGHQEEAK 95.00% 4.86 0.596 6.64 1,157.55 2,313.09 2,313.10 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.18 0.582 5.89 1,157.55 2,313.09 2,313.10 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SAGQGEVLVYVEDPAGHQEEAK 95.00% 4.79 0.584 6.96 1,157.55 2,313.09 2,313.10 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.53 0.563 7.49 1,157.56 2,313.10 2,313.10 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.4 0.622 8.08 1,157.56 2,313.10 2,313.10 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.21 0.555 7.47 1,172.12 2,342.21 2,342.22 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.25 0.559 6.89 1,172.12 2,342.22 2,342.22 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.86 0.562 6.47 1,234.60 2,467.18 2,467.19 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.63 0.513 6.1 1,234.60 2,467.18 2,467.19 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.18 0.723 8.59 1,273.13 2,544.25 2,544.26 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.21 0.726 11.4 1,273.13 2,544.25 2,544.26 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.16 0.718 9.08 1,273.13 2,544.25 2,544.26 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.34 0.705 7.24 1,273.13 2,544.25 2,544.26 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.13 0.734 8.8 1,273.13 2,544.25 2,544.26 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.5 0.715 8.8 1,273.13 2,544.25 2,544.26 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LQVEPAVDTSGVQcYGPGIEGQGVFR 95.00% 6.43 0.724 6.89 c14: Carbamidomethyl (+57.02) 1,382.68 2,763.33 2,763.34 2
 SAMPLE 2 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 100 123 815 52.80% LQVEPAVDTSGVQcYGPGIEGQGVFR 95.00% 6.3 0.705 6.16 c14: Carbamidomethyl (+57.02) 1,382.68 2,763.34 2,763.34 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 2.15 0.239 2.55 452.2948 1,353.86 1,354.87 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 1.89 0.13 1.92 452.2951 1,353.86 1,354.87 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 1.74 0.242 1.77 452.2952 1,353.86 1,354.87 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 2.07 0.373 1.52 452.2953 1,353.86 1,354.87 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 2.81 0.173 1.06 452.2954 1,353.86 1,354.87 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 2.33 0.309 2.21 452.2954 1,353.86 1,354.87 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 2.26 0.261 2 452.2957 1,353.86 1,354.87 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 2.57 0.234 1.47 452.2959 1,353.86 1,354.87 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VDVGKDQEFTVK 95.00% 2.27 0.408 0 455.5738 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VDVGKDQEFTVK 95.00% 2.08 0.278 0 455.5747 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VDVGKDQEFTVK 95.00% 1.83 0.476 0 455.575 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VDVGKDQEFTVK 95.00% 2.87 0.338 0 455.575 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VDVGKDQEFTVK 95.00% 2.3 0.371 1.7 455.575 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.42 0.451 1.72 460.5632 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 2.84 0.492 0.959 460.5632 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.07 0.451 1.82 460.5634 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.22 0.497 1.36 460.5636 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 2.82 0.428 0 460.5636 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 2.66 0.499 1.52 460.5637 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.18 0.484 1.23 460.5638 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.7 0.56 1.72 460.5638 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 2.91 0.481 0 460.564 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 2.94 0.453 1.46 460.5641 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.2 0.548 1.38 460.5642 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 2.85 0.314 0 460.5644 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 2.95 0.442 1.36 460.565 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 2.51 0.24 1.68 471.8895 1,412.65 1,413.66 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 2.4 0.311 0 471.8898 1,412.65 1,413.66 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 2.44 0.244 0 471.8898 1,412.65 1,413.66 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 2.27 0.258 1.06 472.2239 1,413.65 1,413.66 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LRNGHVGISFVPK 95.00% 2.7 0.218 2.05 475.6042 1,423.79 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LRNGHVGISFVPK 95.00% 2.52 0.265 1.41 475.6051 1,423.79 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AEFTVETR 95.00% 1.79 0.332 0 476.7398 951.464 952.474 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AEFTVETR 95.00% 2.29 0.339 0 476.7399 951.4641 952.474 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AGNNMLLVGVHGPR 95.00% 3.54 0.53 1.21 478.9251 1,433.75 1,434.76 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AGNNMLLVGVHGPR 95.00% 3.25 0.467 0 478.9253 1,433.75 1,434.76 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AGNNMLLVGVHGPR 95.00% 3.58 0.474 0 478.9256 1,433.75 1,434.76 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AGNNMLLVGVHGPR 95.00% 3.48 0.52 0 478.9256 1,433.75 1,434.76 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AGNNMLLVGVHGPR 95.00% 3.66 0.469 0 478.9261 1,433.75 1,434.76 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AGNNMLLVGVHGPR 95.00% 3.48 0.509 0 478.9265 1,433.76 1,434.76 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AGNNMLLVGVHGPR 95.00% 1.78 0.244 0 478.9266 1,433.76 1,434.76 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AGNNMLLVGVHGPR 95.00% 3.58 0.423 1.28 479.2591 1,434.75 1,434.76 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AGNNMLLVGVHGPR 95.00% 3.76 0.459 0 479.2596 1,434.76 1,434.76 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AGNNmLLVGVHGPR 95.00% 2.81 0.386 0 m5: Oxidation (+15.99) 484.5903 1,450.75 1,450.76 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 3.01 0.117 0 486.2856 970.5556 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 2.85 0.152 0 486.2861 970.5565 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 2.73 0.165 0 486.2863 970.557 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 2.67 0.172 0 486.2864 970.5572 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 2.9 0.118 0 486.2866 970.5575 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 2.89 0.172 0 486.2867 970.5577 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 2.92 0.174 0 486.2867 970.5577 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 2.81 0.136 0 486.287 970.5584 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 3.12 0.161 0 486.2871 970.5586 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 2.93 0.157 0 486.2871 970.5586 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 2.67 0.134 0 486.2873 970.559 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 2.83 0.097 0 486.2874 970.5591 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LLGWIQNK 95.00% 2.48 0.193 0 486.2874 970.5592 971.568 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.14 0.366 2.51 505.9232 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.3 0.399 2.19 505.9233 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 2.82 0.358 2.74 505.9236 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.34 0.323 2.59 505.9239 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 2.73 0.269 3.02 505.924 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.27 0.383 3.36 505.9241 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.15 0.444 2.42 505.9242 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.33 0.396 3.48 505.9242 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LSPFMADIR 95.00% 2.64 0.333 0 525.2747 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LSPFMADIR 95.00% 2.2 0.277 0 525.275 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LSPFMADIR 95.00% 2.51 0.346 0 525.2753 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.31 0.363 1.66 534.9247 1,601.75 1,602.77 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.54 0.373 2.4 534.9261 1,601.75 1,602.77 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.74 0.419 2.68 534.9261 1,601.75 1,602.77 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 4.12 0.485 3.57 534.9261 1,601.75 1,602.77 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.83 0.429 3.32 534.9263 1,601.76 1,602.77 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 4.05 0.521 1.8 534.9266 1,601.76 1,602.77 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 4.16 0.494 3.14 534.9267 1,601.76 1,602.77 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.72 0.391 3.92 534.9268 1,601.76 1,602.77 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 4.14 0.425 1.82 534.9269 1,601.76 1,602.77 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.64 0.41 2.08 534.9269 1,601.76 1,602.77 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.56 0.391 1.64 534.9269 1,601.76 1,602.77 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.45 0.397 2.49 535.2603 1,602.76 1,602.77 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDK 95.00% 3.06 0.456 0 542.27 1,082.52 1,083.54 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDK 95.00% 3.17 0.468 0 542.2705 1,082.53 1,083.54 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDK 95.00% 3.25 0.46 0 542.2705 1,082.53 1,083.54 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDK 95.00% 3.27 0.457 0 542.2706 1,082.53 1,083.54 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDK 95.00% 2.96 0.416 0 542.271 1,082.53 1,083.54 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDK 95.00% 2.93 0.411 0 542.2711 1,082.53 1,083.54 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDK 95.00% 2.79 0.4 1.12 542.2711 1,082.53 1,083.54 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDK 95.00% 3.03 0.445 0 542.2712 1,082.53 1,083.54 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDK 95.00% 2.95 0.478 0 542.2715 1,082.53 1,083.54 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDK 95.00% 2.8 0.474 0 542.2717 1,082.53 1,083.54 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LYSVSYLLK 95.00% 2.08 0.28 0 543.3135 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LYSVSYLLK 95.00% 2.4 0.383 0 543.3137 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LYSVSYLLK 95.00% 2.12 0.256 0 543.3141 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LYSVSYLLK 95.00% 2.51 0.334 0 543.3145 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LYSVSYLLK 95.00% 2.04 0.314 0 543.3145 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LYSVSYLLK 95.00% 2.45 0.24 0 543.3145 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LYSVSYLLK 95.00% 2.45 0.252 0 543.3147 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LYSVSYLLK 95.00% 2.45 0.258 0 543.3149 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TPcEEILVK 95.00% 3.09 0.297 0 c3: Carbamidomethyl (+57.02) 544.7857 1,087.56 1,088.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TPcEEILVK 95.00% 2.38 0.206 1.46 c3: Carbamidomethyl (+57.02) 544.7863 1,087.56 1,088.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TPcEEILVK 95.00% 2.73 0.333 1.13 c3: Carbamidomethyl (+57.02) 544.7863 1,087.56 1,088.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TPcEEILVK 95.00% 2.81 0.304 0 c3: Carbamidomethyl (+57.02) 544.7865 1,087.56 1,088.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TPcEEILVK 95.00% 2.31 0.188 3.33 c3: Carbamidomethyl (+57.02) 544.7886 1,087.56 1,088.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVAVNKPAEFTVDAK 95.00% 3.08 0.542 0 549.6297 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVAVNKPAEFTVDAK 95.00% 2.98 0.444 0 549.9618 1,646.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVAVNKPAEFTVDAK 95.00% 3.53 0.485 0 549.964 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVAVNKPAEFTVDAK 95.00% 4.33 0.492 2 549.9644 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVAVNKPAEFTVDAK 95.00% 3.12 0.424 0 549.9659 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 2.53 0.404 2.41 551.6247 1,651.85 1,652.86 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 2.36 0.271 1.82 551.6251 1,651.85 1,652.86 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% APSVANVGSHcDLSLK 95.00% 2.88 0.354 1.21 c11: Carbamidomethyl (+57.02) 552.2769 1,653.81 1,654.82 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% APSVANVGSHcDLSLK 95.00% 2.3 0.491 2.15 c11: Carbamidomethyl (+57.02) 552.2772 1,653.81 1,654.82 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% APSVANVGSHcDLSLK 95.00% 2.66 0.432 1.38 c11: Carbamidomethyl (+57.02) 552.2777 1,653.81 1,654.82 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% RAEFTVETR 95.00% 2.84 0.375 2.48 554.7901 1,107.56 1,108.58 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% RAEFTVETR 95.00% 2.96 0.374 2.1 554.7902 1,107.56 1,108.58 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% RAEFTVETR 95.00% 2.03 0.242 1.24 554.791 1,107.57 1,108.58 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% RAEFTVETR 95.00% 2.26 0.33 0 554.7935 1,107.57 1,108.58 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LDVQFSGLTK 95.00% 2.4 0.272 0 554.9787 1,107.94 1,107.61 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VKMDcQEcPEGYR 95.00% 3.59 0.355 2.24 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.8996 1,670.68 1,671.69 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VKMDcQEcPEGYR 95.00% 2.89 0.288 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.8998 1,670.68 1,671.69 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VKMDcQEcPEGYR 95.00% 2.9 0.341 1.82 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.902 1,670.68 1,671.69 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VKMDcQEcPEGYR 95.00% 3.45 0.302 2.18 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9023 1,670.68 1,671.69 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VKMDcQEcPEGYR 95.00% 3.23 0.322 3 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 558.2348 1,671.68 1,671.69 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VKMDcQEcPEGYR 95.00% 3.22 0.289 2.3 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 558.2352 1,671.68 1,671.69 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 3.09 0.375 0 566.9761 1,697.90 1,698.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 3.35 0.28 0 566.9767 1,697.91 1,698.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 4.07 0.389 1.14 566.9772 1,697.91 1,698.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 3.75 0.332 1.1 566.9773 1,697.91 1,698.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 3.27 0.302 0 567.3099 1,698.91 1,698.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 3.23 0.412 0 567.3104 1,698.91 1,698.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 3.45 0.266 0 567.3107 1,698.91 1,698.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 3.51 0.242 0 567.3113 1,698.91 1,698.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGSGELKVTVK 95.00% 2.93 0.359 0 573.3305 1,144.65 1,145.65 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ENGVYLIDVK 95.00% 2.27 0.248 0 575.3092 1,148.60 1,149.62 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ENGVYLIDVK 95.00% 2.57 0.458 2.06 575.3107 1,148.61 1,149.62 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ENGVYLIDVK 95.00% 2.46 0.411 0 575.3109 1,148.61 1,149.62 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DKGEYTLVVK 95.00% 2.88 0.371 1.6 576.3177 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DKGEYTLVVK 95.00% 2.64 0.276 1.21 576.3179 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DKGEYTLVVK 95.00% 2.73 0.283 1.48 576.318 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DKGEYTLVVK 95.00% 2.7 0.374 2.02 576.318 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DKGEYTLVVK 95.00% 2.69 0.355 1.89 576.3183 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DKGEYTLVVK 95.00% 2.67 0.358 1.4 576.3184 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DKGEYTLVVK 95.00% 2.51 0.272 2 576.3184 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DKGEYTLVVK 95.00% 2.53 0.317 0 576.3187 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DKGEYTLVVK 95.00% 2.31 0.279 0 576.3187 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% NGHVGISFVPK 95.00% 2.09 0.279 0 577.8173 1,153.62 1,154.63 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% NGHVGISFVPK 95.00% 2.11 0.245 1.66 577.8178 1,153.62 1,154.63 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% NGHVGISFVPK 95.00% 2.64 0.302 0 577.8181 1,153.62 1,154.63 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% NGHVGISFVPK 95.00% 2.44 0.321 1.77 577.8187 1,153.62 1,154.63 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% NGHVGISFVPK 95.00% 2.53 0.302 0 577.819 1,153.62 1,154.63 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% NGHVGISFVPK 95.00% 2.6 0.37 1.72 577.819 1,153.62 1,154.63 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% NGHVGISFVPK 95.00% 2.36 0.43 1.66 577.8192 1,153.62 1,154.63 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% NGHVGISFVPK 95.00% 2.79 0.353 0 577.8193 1,153.62 1,154.63 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcK 95.00% 2.03 0.263 1.24 c11: Carbamidomethyl (+57.02) 578.3098 1,154.60 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcK 95.00% 2.3 0.297 1.47 c11: Carbamidomethyl (+57.02) 578.3114 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcK 95.00% 2.42 0.344 4 c11: Carbamidomethyl (+57.02) 578.3119 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcK 95.00% 2.85 0.455 3.22 c11: Carbamidomethyl (+57.02) 578.3122 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcK 95.00% 2.87 0.445 3.18 c11: Carbamidomethyl (+57.02) 578.3123 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcK 95.00% 2.63 0.445 3.23 c11: Carbamidomethyl (+57.02) 578.3127 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcK 95.00% 2.55 0.429 2.16 c11: Carbamidomethyl (+57.02) 578.3127 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcK 95.00% 2.49 0.38 2.89 c11: Carbamidomethyl (+57.02) 578.3128 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcK 95.00% 2.36 0.385 2.51 c11: Carbamidomethyl (+57.02) 578.3139 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcK 95.00% 2.39 0.429 3.43 c11: Carbamidomethyl (+57.02) 578.3142 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPMAPGSYLISIK 95.00% 3.99 0.496 1.74 580.9781 1,739.91 1,740.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 3 0.471 1.68 584.2968 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 3.6 0.513 1.14 584.2969 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 3.1 0.53 2.25 584.2972 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 3.12 0.457 1.32 584.2974 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 2.88 0.445 1.59 584.2975 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 3.88 0.544 2.35 584.298 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VPVHDVTDASK 95.00% 2.6 0.36 2.62 584.3042 1,166.59 1,167.60 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VPVHDVTDASK 95.00% 2.47 0.255 2.4 584.3056 1,166.60 1,167.60 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VPVHDVTDASK 95.00% 2.72 0.382 1.4 584.306 1,166.60 1,167.60 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VPVHDVTDASK 95.00% 2.38 0.382 1.46 584.306 1,166.60 1,167.60 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 2.83 0.445 0 584.6305 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 2.83 0.488 1.09 584.6313 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 2.85 0.464 1.6 584.6318 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 2.91 0.516 1.39 584.6319 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 3.14 0.462 0 584.6323 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 2.93 0.418 2.09 584.6324 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 2.59 0.463 0 584.6332 1,750.88 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDKSQGDASK 95.00% 3.57 0.523 3 586.2833 1,755.83 1,756.84 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDKSQGDASK 95.00% 2.98 0.383 1.55 586.284 1,755.83 1,756.84 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDKSQGDASK 95.00% 3.55 0.577 3.06 586.2842 1,755.83 1,756.84 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDKSQGDASK 95.00% 4.05 0.507 2.92 586.2844 1,755.83 1,756.84 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DLAEDAPWKK 95.00% 2.64 0.279 2.04 586.8 1,171.58 1,172.60 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DLAEDAPWKK 95.00% 2.58 0.295 0 586.8002 1,171.58 1,172.60 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 2.84 0.346 0 595.6181 1,783.83 1,784.85 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 3.03 0.417 0 595.62 1,783.84 1,784.85 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 3.31 0.436 0 595.62 1,783.84 1,784.85 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 3.67 0.445 2.04 c9: Carbamidomethyl (+57.02) 595.6324 1,783.87 1,784.89 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 3.58 0.396 2.62 c9: Carbamidomethyl (+57.02) 595.6332 1,783.88 1,784.89 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 2.73 0.343 1.74 c9: Carbamidomethyl (+57.02) 595.6338 1,783.88 1,784.89 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 2.15 0.224 2.28 c9: Carbamidomethyl (+57.02) 595.6344 1,783.88 1,784.89 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 2.87 0.314 0 595.9534 1,784.84 1,784.85 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 2.33 0.259 0 595.9538 1,784.84 1,784.85 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 2.73 0.365 0 595.954 1,784.84 1,784.85 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 3.32 0.359 0 c9: Carbamidomethyl (+57.02) 595.9682 1,784.88 1,784.89 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% RAPSVANVGSHcDLSLK 95.00% 5.11 0.56 5.72 c12: Carbamidomethyl (+57.02) 604.311 1,809.91 1,810.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% RAPSVANVGSHcDLSLK 95.00% 4.8 0.464 2.52 c12: Carbamidomethyl (+57.02) 604.3122 1,809.91 1,810.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% RAPSVANVGSHcDLSLK 95.00% 3.81 0.478 1.7 c12: Carbamidomethyl (+57.02) 604.6467 1,810.92 1,810.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 2.13 0.386 0 605.6578 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 1.95 0.418 0 605.6581 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 2.13 0.339 2.74 605.6592 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 1.93 0.373 1.74 605.9915 1,814.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 1.76 0.237 1.12 605.992 1,814.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 2.35 0.406 1.85 605.9923 1,814.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 1.72 0.341 1.25 605.9932 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% cSGPGLSPGMVR 95.00% 1.96 0.366 0 c1: Carbamidomethyl (+57.02) 608.6418 1,215.27 1,217.58 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% cSGPGLSPGMVR 95.00% 2.13 0.256 0 c1: Carbamidomethyl (+57.02) 609.2899 1,216.56 1,217.58 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% cSGPGLSPGMVR 95.00% 3.29 0.421 1.72 c1: Carbamidomethyl (+57.02) 609.2903 1,216.56 1,217.58 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% cSGPGLSPGMVR 95.00% 2.3 0.326 0 c1: Carbamidomethyl (+57.02) 609.2904 1,216.57 1,217.58 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% cSGPGLSPGMVR 95.00% 2.9 0.446 2.47 c1: Carbamidomethyl (+57.02) 609.2906 1,216.57 1,217.58 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EATTEFSVDAR 95.00% 3.27 0.442 2.62 613.2865 1,224.56 1,225.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EATTEFSVDAR 95.00% 3.55 0.443 1.68 613.2873 1,224.56 1,225.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EATTEFSVDAR 95.00% 3.25 0.413 2.47 613.2874 1,224.56 1,225.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EATTEFSVDAR 95.00% 3.52 0.502 2.54 613.2876 1,224.56 1,225.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EATTEFSVDAR 95.00% 3.53 0.466 1.96 613.2876 1,224.56 1,225.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EATTEFSVDAR 95.00% 3.59 0.474 2.31 613.2876 1,224.56 1,225.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EATTEFSVDAR 95.00% 3.6 0.462 3.32 613.2877 1,224.56 1,225.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EATTEFSVDAR 95.00% 3.78 0.472 1.89 613.2884 1,224.56 1,225.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EATTEFSVDAR 95.00% 3.48 0.454 2.66 613.2884 1,224.56 1,225.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EATTEFSVDAR 95.00% 3.1 0.421 3 613.2886 1,224.56 1,225.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EATTEFSVDAR 95.00% 3.4 0.404 1.66 613.2887 1,224.56 1,225.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EATTEFSVDAR 95.00% 3.38 0.446 2.29 613.7894 1,225.56 1,225.57 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AWGPGLEGGVVGK 95.00% 2.48 0.335 3.06 613.8277 1,225.64 1,226.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AWGPGLEGGVVGK 95.00% 2.33 0.44 2.96 613.8282 1,225.64 1,226.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AWGPGLEGGVVGK 95.00% 2.6 0.474 3.23 613.8293 1,225.64 1,226.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AWGPGLEGGVVGK 95.00% 3.35 0.55 3.51 613.8296 1,225.64 1,226.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AWGPGLEGGVVGK 95.00% 2.91 0.507 1.51 613.8298 1,225.64 1,226.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AWGPGLEGGVVGK 95.00% 3.45 0.587 3.51 613.83 1,225.64 1,226.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AWGPGLEGGVVGK 95.00% 2.84 0.473 1.66 613.8313 1,225.65 1,226.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.82 0.519 3.22 613.8877 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.4 0.526 1.14 613.888 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.81 0.546 1.57 613.8881 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.59 0.537 2.34 613.8885 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.26 0.52 2.74 613.8885 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.21 0.476 1.8 613.8886 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.42 0.528 1.72 613.8886 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.62 0.544 2.14 613.8888 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.26 0.514 2.08 613.8889 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.59 0.499 3.15 613.8891 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.54 0.53 2.21 613.8891 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.53 0.521 2.22 613.8893 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.84 0.562 2 613.8893 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.39 0.501 2.59 613.8894 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQK 95.00% 3.27 0.534 2.17 613.8902 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AHVVPcFDASK 95.00% 2.53 0.454 2.48 c6: Carbamidomethyl (+57.02) 615.7987 1,229.58 1,230.59 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AHVVPcFDASK 95.00% 2.62 0.337 2.92 c6: Carbamidomethyl (+57.02) 615.7992 1,229.58 1,230.59 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AHVVPcFDASK 95.00% 2.43 0.348 1.92 c6: Carbamidomethyl (+57.02) 615.7995 1,229.58 1,230.59 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AHVVPcFDASK 95.00% 2.15 0.309 0 c6: Carbamidomethyl (+57.02) 615.7995 1,229.58 1,230.59 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AHVVPcFDASK 95.00% 2.1 0.325 0 c6: Carbamidomethyl (+57.02) 615.7995 1,229.58 1,230.59 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AHVVPcFDASK 95.00% 2.53 0.468 2 c6: Carbamidomethyl (+57.02) 615.7997 1,229.58 1,230.59 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AHVVPcFDASK 95.00% 2.54 0.437 2.28 c6: Carbamidomethyl (+57.02) 615.7998 1,229.58 1,230.59 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AHVVPcFDASK 95.00% 2.45 0.348 3.68 c6: Carbamidomethyl (+57.02) 615.8001 1,229.58 1,230.59 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% KRAEFTVETR 94.90% 2.19 0.225 0 618.8389 1,235.66 1,236.67 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 2.44 0.253 0 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 623.6214 1,867.84 1,867.84 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 2.29 0.325 0 637.3103 1,908.91 1,909.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 3.11 0.479 1.24 637.3108 1,908.91 1,909.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 2.89 0.415 2 637.6429 1,909.91 1,909.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 3.95 0.565 2.07 637.6457 1,909.91 1,909.92 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTVLFAGQHIAK 95.00% 3 0.365 3.77 642.3737 1,282.73 1,283.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTVLFAGQHIAK 95.00% 3.65 0.491 2.55 642.3753 1,282.74 1,283.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTVLFAGQHIAK 95.00% 3.69 0.463 2.25 642.3756 1,282.74 1,283.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTVLFAGQHIAK 95.00% 3.35 0.492 3.6 642.3758 1,282.74 1,283.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTVLFAGQHIAK 95.00% 3.66 0.456 3.19 642.3759 1,282.74 1,283.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTVLFAGQHIAK 95.00% 3.74 0.477 2.37 642.3761 1,282.74 1,283.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTVLFAGQHIAK 95.00% 3.9 0.487 2.24 642.3766 1,282.74 1,283.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTVLFAGQHIAK 95.00% 4.11 0.52 2.12 642.3768 1,282.74 1,283.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTVLFAGQHIAK 95.00% 3.81 0.523 2.6 642.3769 1,282.74 1,283.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTVLFAGQHIAK 95.00% 3.62 0.522 2.36 642.3773 1,282.74 1,283.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 2.29 0.359 1.29 643.3648 1,284.71 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 2.72 0.351 2.23 643.3656 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 3.17 0.359 2.01 643.3658 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 2.94 0.32 2.72 643.3661 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 3.06 0.337 3.08 643.3661 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 2.49 0.285 1.59 643.3662 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 3.01 0.354 4 643.3663 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 2.78 0.329 2.14 643.3665 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 2.8 0.393 2.74 643.3665 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 3.17 0.363 3.89 643.3665 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 3.07 0.393 2.66 643.3665 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 3.19 0.397 3.39 643.3667 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 3.12 0.339 3.68 643.3668 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 3.09 0.259 2.8 643.3672 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 2.74 0.309 1.89 643.3677 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 2.81 0.323 1.54 643.8658 1,285.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LPQLPITNFSR 95.00% 2.37 0.311 2.4 643.8681 1,285.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGQPVPNFPSK 95.00% 3.55 0.503 1.38 645.8264 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGQPVPNFPSK 95.00% 3.62 0.513 3.1 645.8269 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGQPVPNFPSK 95.00% 3.62 0.481 2.37 645.8269 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGQPVPNFPSK 95.00% 4.12 0.467 3.55 645.8272 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGQPVPNFPSK 95.00% 3.74 0.45 1.38 645.8272 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGQPVPNFPSK 95.00% 3.57 0.499 3.46 645.8276 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GKLDVQFSGLTK 95.00% 2.8 0.335 3.12 646.8621 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GKLDVQFSGLTK 95.00% 3.13 0.425 2.62 646.8625 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GKLDVQFSGLTK 95.00% 2.87 0.351 2.85 646.8636 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GKLDVQFSGLTK 95.00% 2.99 0.387 2.41 646.8636 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GKLDVQFSGLTK 95.00% 3.06 0.47 2.8 646.8636 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GKLDVQFSGLTK 95.00% 2.95 0.376 2.42 646.8636 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GKLDVQFSGLTK 95.00% 3.24 0.422 2.48 646.8637 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GKLDVQFSGLTK 95.00% 2.93 0.382 3 646.8637 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GKLDVQFSGLTK 95.00% 2.52 0.219 1.49 646.8642 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GKLDVQFSGLTK 95.00% 3.33 0.358 1.92 646.8642 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGLLAVQITDPEGKPK 95.00% 3.28 0.448 3.24 647.0115 1,938.01 1,938.02 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGLLAVQITDPEGKPK 95.00% 3.22 0.388 1.82 647.0128 1,938.01 1,938.02 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% HTAMVSWGGVSIPNSPFR 95.00% 3.36 0.219 2.37 648.6583 1,942.95 1,942.96 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNGTHIPGSPFK 95.00% 2.67 0.344 1.89 651.3341 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNGTHIPGSPFK 95.00% 3.05 0.323 2.49 651.3347 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNGTHIPGSPFK 95.00% 3.2 0.304 2.46 651.3347 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNGTHIPGSPFK 95.00% 2.63 0.279 0 651.3349 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNGTHIPGSPFK 95.00% 3.37 0.3 2.66 651.3351 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNGTHIPGSPFK 95.00% 3.54 0.296 2.6 651.3352 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNGTHIPGSPFK 95.00% 3.54 0.333 3 651.3354 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNGTHIPGSPFK 95.00% 2.78 0.337 1.55 651.3357 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNGTHIPGSPFK 95.00% 2.89 0.289 2.47 651.3362 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNGTHIPGSPFK 95.00% 3.43 0.249 3.72 651.8364 1,301.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VEPSHDASKVKAEGPGLSR 95.00% 2.09 0.192 1.05 655.3455 1,963.01 1,964.02 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VEPSHDASKVKAEGPGLSR 95.00% 2.12 0.389 2.38 655.6774 1,964.01 1,964.02 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VEPGLGADNSVVR 95.00% 2.2 0.32 2.43 656.8451 1,311.67 1,312.69 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VEPGLGADNSVVR 95.00% 3.12 0.555 2.8 656.8453 1,311.68 1,312.69 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VEPGLGADNSVVR 95.00% 2.14 0.375 3.72 656.8454 1,311.68 1,312.69 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VEPGLGADNSVVR 95.00% 2.58 0.454 3.27 656.8454 1,311.68 1,312.69 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VEPGLGADNSVVR 95.00% 2.36 0.272 0 656.8456 1,311.68 1,312.69 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VEPGLGADNSVVR 95.00% 2.28 0.4 3.96 656.8458 1,311.68 1,312.69 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VEPGLGADNSVVR 95.00% 2.33 0.383 3.32 656.8459 1,311.68 1,312.69 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VEPGLGADNSVVR 95.00% 2.3 0.543 3.2 656.8459 1,311.68 1,312.69 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 2.72 0.398 0 668.0083 2,001.00 2,002.02 3 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 3.29 0.449 0 668.009 2,001.00 2,002.02 3 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 2.92 0.36 0 668.0103 2,001.01 2,002.02 3 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 3.26 0.37 0 668.3424 2,002.00 2,002.02 3 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 3.52 0.548 2.46 677.9358 1,353.86 1,354.87 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 3.89 0.518 3.15 677.9358 1,353.86 1,354.87 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 3.6 0.556 3.68 677.9359 1,353.86 1,354.87 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 3.68 0.509 3.22 677.9364 1,353.86 1,354.87 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 2.66 0.418 1.92 677.9364 1,353.86 1,354.87 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 3.18 0.488 2.85 677.9368 1,353.86 1,354.87 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 3.52 0.55 3.2 677.937 1,353.86 1,354.87 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LIALLEVLSQKK 95.00% 3.61 0.532 3.54 677.9375 1,353.86 1,354.87 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VDVGKDQEFTVK 95.00% 3.66 0.526 2.06 682.8549 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VDVGKDQEFTVK 95.00% 3.47 0.493 2.36 682.8555 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VDVGKDQEFTVK 95.00% 3.7 0.503 1.74 682.8557 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VDVGKDQEFTVK 95.00% 3.72 0.479 1.33 682.856 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VDVGKDQEFTVK 95.00% 3.66 0.534 2.48 682.8561 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VDVGKDQEFTVK 95.00% 3.54 0.489 2.23 682.8564 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 4.01 0.438 3.01 c15: Carbamidomethyl (+57.02) 686.6488 2,056.92 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 3.57 0.464 2.08 c15: Carbamidomethyl (+57.02) 686.6491 2,056.92 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 4.47 0.508 2.66 c15: Carbamidomethyl (+57.02) 686.6494 2,056.92 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 4.45 0.505 2.19 c15: Carbamidomethyl (+57.02) 686.6501 2,056.93 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 4.74 0.481 2.89 c15: Carbamidomethyl (+57.02) 686.9827 2,057.92 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 4.26 0.5 3.06 c15: Carbamidomethyl (+57.02) 686.9827 2,057.92 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 4.83 0.484 2.33 c15: Carbamidomethyl (+57.02) 686.9832 2,057.93 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 4.53 0.487 2.85 c15: Carbamidomethyl (+57.02) 686.9834 2,057.93 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 4.22 0.43 1.96 c15: Carbamidomethyl (+57.02) 686.9836 2,057.93 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 4.17 0.441 3.46 c15: Carbamidomethyl (+57.02) 686.9837 2,057.93 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 4.34 0.448 5.06 c15: Carbamidomethyl (+57.02) 686.9838 2,057.93 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 4.28 0.484 1 c15: Carbamidomethyl (+57.02) 686.984 2,057.93 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 4.28 0.52 1.96 c15: Carbamidomethyl (+57.02) 686.9846 2,057.93 2,057.94 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 4.01 0.533 4.33 690.3378 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.34 0.449 4.51 690.3384 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 2.52 0.333 1.38 690.3391 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 4.14 0.582 4.72 690.3391 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.47 0.504 4.23 690.3395 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.87 0.523 3.72 690.3397 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 4.22 0.574 3.82 690.3398 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 4.06 0.595 4.41 690.3399 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.63 0.398 3.54 690.3399 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.9 0.504 4.44 690.3402 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.67 0.458 4.74 690.3404 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.61 0.457 4 690.3406 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGPYHIGGSPFK 95.00% 3.9 0.413 3.96 690.3413 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGDEIPFSPYR 95.00% 2.84 0.156 1.19 700.8274 1,399.64 1,400.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGDEIPFSPYR 95.00% 3.47 0.198 2 700.8275 1,399.64 1,400.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGDEIPFSPYR 95.00% 2.61 0.188 2.28 700.8278 1,399.64 1,400.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGDEIPFSPYR 95.00% 2.22 0.225 2 700.829 1,399.64 1,400.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGDEIPFSPYR 95.00% 3.1 0.165 2.06 700.8297 1,399.64 1,400.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGDEIPFSPYR 95.00% 2.9 0.169 1.4 700.8298 1,399.64 1,400.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGDEIPFSPYR 95.00% 2.67 0.149 1.6 700.83 1,399.64 1,400.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGDEIPFSPYR 95.00% 3.5 0.186 2.31 700.8302 1,399.64 1,400.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGDEIPFSPYR 95.00% 3.19 0.18 1.25 700.8303 1,399.64 1,400.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YGGDEIPFSPYR 95.00% 3.11 0.186 1.8 701.33 1,400.64 1,400.65 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 2.62 0.41 2.42 707.3287 1,412.64 1,413.66 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 2.81 0.385 3.21 707.3291 1,412.64 1,413.66 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 2.56 0.284 3.51 707.3296 1,412.64 1,413.66 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 2.71 0.338 3.46 707.3298 1,412.64 1,413.66 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 3.05 0.411 3.39 707.3299 1,412.64 1,413.66 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 2.84 0.407 3.68 707.33 1,412.64 1,413.66 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 3.05 0.384 3.6 707.3307 1,412.65 1,413.66 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 2.55 0.321 0 707.3314 1,412.65 1,413.66 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% WGDEHIPGSPYR 95.00% 3.32 0.413 3.22 707.3318 1,412.65 1,413.66 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 3.12 0.428 3.96 708.3763 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 2.82 0.4 0 708.3764 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 4 0.421 4 708.3766 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 4.01 0.463 3.3 708.3767 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 4.01 0.455 3.03 708.3767 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 3.05 0.451 1.49 708.3769 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 3.15 0.483 2.74 708.3769 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 3.16 0.453 4.55 708.3773 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 3.4 0.499 4.07 708.3776 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 4.05 0.447 3.57 708.3777 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 4.01 0.444 4.13 708.3777 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 3.32 0.49 4.74 708.3782 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IANLQTDLSDGLR 95.00% 3.37 0.408 5.12 708.3783 1,414.74 1,415.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EAGAGGLAIAVEGPSK 95.00% 4.14 0.572 3.96 713.8792 1,425.74 1,426.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EAGAGGLAIAVEGPSK 95.00% 4.39 0.57 4.05 713.8793 1,425.74 1,426.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EAGAGGLAIAVEGPSK 95.00% 4.49 0.548 4.74 713.8797 1,425.74 1,426.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EAGAGGLAIAVEGPSK 95.00% 4.63 0.571 4.6 713.8802 1,425.74 1,426.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EAGAGGLAIAVEGPSK 95.00% 4.7 0.577 4.62 713.8802 1,425.74 1,426.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EAGAGGLAIAVEGPSK 95.00% 4.55 0.576 4.68 713.8804 1,425.75 1,426.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EAGAGGLAIAVEGPSK 95.00% 4.38 0.59 4.89 713.8805 1,425.75 1,426.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EAGAGGLAIAVEGPSK 95.00% 3.9 0.567 3.92 713.8817 1,425.75 1,426.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EAGAGGLAIAVEGPSK 95.00% 4.71 0.564 4.52 713.8819 1,425.75 1,426.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EAGAGGLAIAVEGPSK 95.00% 3.9 0.603 3.96 713.8825 1,425.75 1,426.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 4.49 0.433 5 715.3612 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 4.01 0.448 4.46 715.3618 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 4.39 0.404 4.36 715.362 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 4.53 0.474 3.72 715.3621 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 4.08 0.414 4.77 715.3622 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 4.25 0.42 4.8 715.3623 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 3.96 0.288 4.92 715.3623 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 4.29 0.332 5.43 715.3625 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 4.6 0.427 4.17 715.3627 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 4.32 0.397 5.15 715.3627 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 4.5 0.41 4.4 715.3628 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 4.21 0.41 4.04 715.3628 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 4.17 0.406 4.08 715.3631 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 2.89 0.332 3.7 715.3634 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AFGPGLQGGSAGSPAR 95.00% 2.8 0.535 4.3 715.3642 1,428.71 1,429.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAEMPATEKDLAEDAPWKK 95.00% 3.71 0.379 1.51 716.0114 2,145.01 2,145.02 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAEMPATEKDLAEDAPWKK 95.00% 4.02 0.432 0.959 716.0118 2,145.01 2,145.02 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAEMPATEKDLAEDAPWKK 95.00% 3.52 0.36 0 716.012 2,145.01 2,145.02 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 4.21 0.358 0 717.3564 1,432.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 3.78 0.425 1.62 717.357 1,432.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 4.4 0.503 3 717.3576 1,432.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 4.26 0.392 1.64 717.3579 1,432.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 2.49 0.248 0 717.358 1,432.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 4.46 0.481 2.96 717.3581 1,432.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 3.7 0.384 2.62 717.3587 1,432.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 4.14 0.403 2.26 717.3588 1,432.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 3.7 0.371 0 717.3589 1,432.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 3.31 0.256 2.09 717.359 1,432.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 3.65 0.288 1.62 717.3601 1,432.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 3.82 0.365 2.43 717.8578 1,433.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNMVK 95.00% 3.63 0.37 2 717.8585 1,433.70 1,433.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ANLPQSFQVDTSK 95.00% 4.01 0.548 4.6 717.8639 1,433.71 1,434.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ANLPQSFQVDTSK 95.00% 4.05 0.56 3.68 717.8653 1,433.72 1,434.72 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AGQSAAGAAPGGGVDTR 95.00% 3.84 0.474 3.09 721.8542 1,441.69 1,442.70 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNmVK 95.00% 3.35 0.487 3.66 m12: Oxidation (+15.99) 725.3543 1,448.69 1,449.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AYGPGIEPTGNmVK 95.00% 3.32 0.416 1.92 m12: Oxidation (+15.99) 725.3545 1,448.69 1,449.71 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 4.71 0.602 2.92 734.3784 2,200.11 2,200.13 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 5.15 0.602 3.11 734.3794 2,200.11 2,200.13 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 4.39 0.532 2.29 734.3804 2,200.12 2,200.13 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 5.37 0.618 3.82 734.3806 2,200.12 2,200.13 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 4.53 0.54 3.85 734.3806 2,200.12 2,200.13 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 5.1 0.596 3.28 734.3807 2,200.12 2,200.13 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 5.16 0.529 4.25 734.3807 2,200.12 2,200.13 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 5.58 0.601 3.13 734.3809 2,200.12 2,200.13 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 4.5 0.582 3.51 734.3815 2,200.12 2,200.13 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 4.41 0.513 2.36 734.382 2,200.12 2,200.13 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 4.68 0.538 3.49 734.3821 2,200.12 2,200.13 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGGLSLAIEGPSK 95.00% 2.94 0.383 2.16 750.8794 1,499.74 1,500.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGGLSLAIEGPSK 95.00% 4.85 0.558 2.64 750.8795 1,499.74 1,500.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGGLSLAIEGPSK 95.00% 5.38 0.588 3.03 750.8808 1,499.75 1,500.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGGLSLAIEGPSK 95.00% 5.05 0.553 3.85 750.8809 1,499.75 1,500.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGGLSLAIEGPSK 95.00% 4.37 0.517 4.72 750.881 1,499.75 1,500.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGGLSLAIEGPSK 95.00% 4.5 0.502 3.89 750.8816 1,499.75 1,500.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGGLSLAIEGPSK 95.00% 4.86 0.515 3.01 750.8817 1,499.75 1,500.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGGLSLAIEGPSK 95.00% 5.21 0.576 3.38 750.8817 1,499.75 1,500.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGGLSLAIEGPSK 95.00% 4.47 0.463 3.22 750.8817 1,499.75 1,500.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGGLSLAIEGPSK 95.00% 4.63 0.511 3 751.3817 1,500.75 1,500.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGGLSLAIEGPSK 95.00% 5.51 0.561 3.96 751.3821 1,500.75 1,500.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGGLSLAIEGPSK 95.00% 5.14 0.536 3.48 751.3832 1,500.75 1,500.75 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FVPAEMGTHTVSVK 95.00% 3.42 0.473 3.41 751.8859 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FVPAEMGTHTVSVK 95.00% 4.44 0.531 6.29 751.8863 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FVPAEMGTHTVSVK 95.00% 4.34 0.511 3.66 751.8865 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FVPAEMGTHTVSVK 95.00% 4.07 0.514 5.39 751.8866 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FVPAEMGTHTVSVK 95.00% 3.42 0.472 4.11 751.8869 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FVPAEMGTHTVSVK 95.00% 4.11 0.505 5.51 751.8872 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FVPAEMGTHTVSVK 95.00% 4.06 0.524 6.14 751.8878 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FVPAEMGTHTVSVK 95.00% 4.22 0.521 7.35 751.8878 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FVPAEMGTHTVSVK 95.00% 4.43 0.517 3.66 751.8896 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 3.96 0.531 4.82 751.8995 1,501.78 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 3.9 0.526 4.57 751.8998 1,501.78 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 4.73 0.552 5.21 751.8999 1,501.78 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 4.87 0.571 4.46 751.9001 1,501.78 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 4.83 0.541 4.23 751.9002 1,501.78 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 4.45 0.568 5.14 751.9004 1,501.79 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 5.3 0.571 3.04 751.901 1,501.79 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 4.41 0.56 5.48 751.9012 1,501.79 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 4.41 0.551 5.43 751.9012 1,501.79 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 4.69 0.6 6.07 751.9013 1,501.79 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 5.12 0.58 3.8 751.9014 1,501.79 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 4.6 0.571 4.04 751.9016 1,501.79 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 4.48 0.544 5.46 751.9019 1,501.79 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 4.18 0.56 5.54 751.903 1,501.79 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VNQPASFAVSLNGAK 95.00% 2.51 0.338 0 752.4052 1,502.79 1,502.80 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.49 0.43 4.22 758.3829 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.48 0.405 3.85 758.383 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.4 0.454 5.25 758.3839 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.5 0.417 3.21 758.384 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.58 0.433 4.72 758.3841 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.15 0.423 2.12 758.3842 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.21 0.377 2.92 758.8841 1,515.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.37 0.378 3.74 758.8846 1,515.75 1,515.76 2 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.17 0.295 2.32 758.8855 1,515.76 1,515.76 2 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.63 0.358 3.2 758.8874 1,515.76 1,515.76 2 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FADQHVPGSPFSVK 95.00% 3.09 0.283 3.92 758.8918 1,515.77 1,515.76 2 MOES_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VHSPSGALEEcYVTEIDQDK 95.00% 3.21 0.4 0 c11: Carbamidomethyl (+57.02) 759.6811 2,276.02 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FVPAEmGTHTVSVK 95.00% 3.11 0.581 6.21 m6: Oxidation (+15.99) 759.8833 1,517.75 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FVPAEmGTHTVSVK 95.00% 3.43 0.517 3.21 m6: Oxidation (+15.99) 759.8855 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.18 0.639 3.34 763.064 2,286.17 2,286.18 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.46 0.59 4.14 763.0663 2,286.18 2,286.18 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 3.55 0.531 1.44 763.0712 2,286.19 2,286.18 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGSYTIMVLFADQATPTSPIR 95.00% 5.35 0.567 2.74 766.3928 2,296.15 2,296.17 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGSYTIMVLFADQATPTSPIR 95.00% 4.89 0.573 3.14 766.3934 2,296.16 2,296.17 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ANLPQSFQVDTSKAGVAPLQVK 95.00% 2.76 0.312 2.08 767.0872 2,298.24 2,298.25 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ANLPQSFQVDTSKAGVAPLQVK 95.00% 2.18 0.283 1.74 767.0872 2,298.24 2,298.25 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AEAGVPAEFSIWTR 95.00% 3.41 0.327 3.77 767.3881 1,532.76 1,533.77 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFSVAVSPSLDLSK 95.00% 4.45 0.543 2.47 767.4096 1,532.80 1,533.82 2 RL4_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFSVAVSPSLDLSK 95.00% 5.16 0.515 3.42 767.4104 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFSVAVSPSLDLSK 95.00% 4.51 0.496 2.11 767.4113 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFSVAVSPSLDLSK 95.00% 4.37 0.54 2.15 767.4115 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFSVAVSPSLDLSK 95.00% 4.72 0.511 3.08 767.412 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFSVAVSPSLDLSK 95.00% 4.82 0.538 2.89 767.4123 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFSVAVSPSLDLSK 95.00% 4.5 0.522 1.77 767.9127 1,533.81 1,533.82 2 RL4_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.87 0.436 1.92 769.0567 2,304.15 2,304.15 3 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.87 0.437 2.3 769.0568 2,304.15 2,304.15 3 FLNC_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SAGQGEVLVYVEDPAGHQEEAK 95.00% 4.11 0.459 2.7 772.0374 2,313.09 2,313.10 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGYGGLSLSIEGPSK 95.00% 3.95 0.507 2.72 775.8883 1,549.76 1,550.77 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGYGGLSLSIEGPSK 95.00% 4.53 0.512 3.66 775.8896 1,549.76 1,550.77 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGYGGLSLSIEGPSK 95.00% 4.65 0.506 3.07 775.8913 1,549.77 1,550.77 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGYGGLSLSIEGPSK 95.00% 3.99 0.39 3.31 775.8922 1,549.77 1,550.77 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGYGGLSLSIEGPSK 95.00% 3.89 0.454 1.89 775.8924 1,549.77 1,550.77 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% QMQLENVSVALEFLDRESIK 95.00% 3.87 0.543 0 784.075 2,349.20 2,349.21 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% QMQLENVSVALEFLDRESIK 95.00% 4.01 0.54 0 784.077 2,349.21 2,349.21 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 4.18 0.569 5.1 785.9049 1,569.79 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 4.93 0.571 4.19 785.9055 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 5.01 0.605 4.37 785.9062 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 3.39 0.435 3.85 785.9065 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 3.61 0.575 3.25 785.9065 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 4.18 0.58 4.74 785.9066 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 3.98 0.589 4.46 785.9066 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 2.88 0.353 3.4 785.9068 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 4.03 0.584 4.15 785.9068 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 4.85 0.575 3.85 785.907 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 4.84 0.563 4.92 785.907 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 3.53 0.573 4.11 785.907 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 4.96 0.608 4.92 785.9072 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 3.38 0.498 3.48 785.9072 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 4.68 0.589 4.27 785.9073 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 4.07 0.611 4.85 785.9076 1,569.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 4.26 0.608 3.7 786.4089 1,570.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGTGGLGLAVEGPSEAK 95.00% 4.73 0.586 3.92 786.4101 1,570.80 1,570.81 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YAPSEAGLHEMDIR 95.00% 3.25 0.427 3.47 794.8738 1,587.73 1,588.74 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YAPSEAGLHEMDIR 95.00% 2.61 0.307 1.96 794.8739 1,587.73 1,588.74 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YAPSEAGLHEMDIR 95.00% 2.7 0.395 1.7 794.8741 1,587.73 1,588.74 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YAPSEAGLHEMDIR 95.00% 3.82 0.502 2.82 794.8742 1,587.73 1,588.74 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YAPSEAGLHEMDIR 95.00% 3.07 0.461 2.47 794.8747 1,587.73 1,588.74 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DNGNGTYScSYVPR 95.00% 2.92 0.482 2.6 c9: Carbamidomethyl (+57.02) 795.335 1,588.65 1,589.67 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DNGNGTYScSYVPR 95.00% 2.6 0.225 1.11 c9: Carbamidomethyl (+57.02) 795.3368 1,588.66 1,589.67 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DNGNGTYScSYVPR 95.00% 3.94 0.477 3.89 c9: Carbamidomethyl (+57.02) 795.3369 1,588.66 1,589.67 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DNGNGTYScSYVPR 95.00% 3.36 0.524 2.62 c9: Carbamidomethyl (+57.02) 795.3373 1,588.66 1,589.67 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DNGNGTYScSYVPR 95.00% 2.59 0.378 2.22 c9: Carbamidomethyl (+57.02) 795.3374 1,588.66 1,589.67 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DNGNGTYScSYVPR 95.00% 3.08 0.443 3.07 c9: Carbamidomethyl (+57.02) 795.3376 1,588.66 1,589.67 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YAPSEAGLHEMDIR 95.00% 3.11 0.409 3.21 795.3789 1,588.74 1,588.74 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.52 0.499 4.43 801.885 1,601.75 1,602.77 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.16 0.523 5.85 801.8863 1,601.76 1,602.77 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.59 0.584 6.68 801.8864 1,601.76 1,602.77 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.6 0.555 4 801.8867 1,601.76 1,602.77 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.91 0.535 5.17 801.8868 1,601.76 1,602.77 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YNEQHVPGSPFTAR 95.00% 3.04 0.31 0 801.8871 1,601.76 1,602.77 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.4 0.439 4.27 814.0684 2,439.18 2,440.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.32 0.371 4.15 814.401 2,440.18 2,440.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.54 0.457 3.96 814.4014 2,440.18 2,440.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.67 0.465 3.72 814.4017 2,440.18 2,440.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.9 0.506 3.82 814.402 2,440.18 2,440.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.51 0.439 4.31 814.4021 2,440.18 2,440.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.43 0.398 3.92 814.4025 2,440.18 2,440.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.41 0.425 4.07 814.4044 2,440.19 2,440.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% NGQHVASSPIPVVISQSEIGDASR 95.00% 2.63 0.299 0 816.9144 2,447.72 2,448.25 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% NGQHVASSPIPVVISQSEIGDASR 95.00% 5.03 0.536 4.09 817.087 2,448.24 2,448.25 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% NGQHVASSPIPVVISQSEIGDASR 95.00% 5.13 0.608 4.19 817.0881 2,448.24 2,448.25 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% NGQHVASSPIPVVISQSEIGDASR 95.00% 5.38 0.603 4.21 817.0896 2,448.25 2,448.25 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.88 0.555 4.28 c11: Carbamidomethyl (+57.02) 817.4331 2,449.28 2,449.29 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.46 0.451 1.64 c11: Carbamidomethyl (+57.02) 817.4335 2,449.28 2,449.29 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.44 0.545 4.12 c11: Carbamidomethyl (+57.02) 817.4335 2,449.28 2,449.29 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.68 0.548 4.68 c11: Carbamidomethyl (+57.02) 817.4337 2,449.28 2,449.29 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.61 0.582 3.3 c11: Carbamidomethyl (+57.02) 817.4339 2,449.28 2,449.29 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.6 0.596 4.23 c11: Carbamidomethyl (+57.02) 817.434 2,449.28 2,449.29 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.73 0.569 3.89 c11: Carbamidomethyl (+57.02) 817.4342 2,449.28 2,449.29 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.46 0.563 2.96 c11: Carbamidomethyl (+57.02) 817.4343 2,449.28 2,449.29 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.41 0.55 3.27 c11: Carbamidomethyl (+57.02) 817.435 2,449.28 2,449.29 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.06 0.505 2.59 c11: Carbamidomethyl (+57.02) 817.4352 2,449.28 2,449.29 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.04 0.336 3.04 823.4004 2,467.18 2,467.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.97 0.36 3.36 823.4006 2,467.18 2,467.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.97 0.374 3.8 823.4011 2,467.18 2,467.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.12 0.344 3.57 823.4012 2,467.18 2,467.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.72 0.228 3.05 823.4013 2,467.18 2,467.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.38 0.393 3.13 823.4014 2,467.18 2,467.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.2 0.487 2.77 823.4015 2,467.18 2,467.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.95 0.424 2.82 823.4017 2,467.18 2,467.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.91 0.313 3.28 823.4018 2,467.18 2,467.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVAVNKPAEFTVDAK 95.00% 3.99 0.42 4.41 823.9402 1,645.86 1,646.88 2 MYLK_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVAVNKPAEFTVDAK 95.00% 4.12 0.4 1.89 823.9408 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVAVNKPAEFTVDAK 95.00% 4.06 0.428 2.77 823.941 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVAVNKPAEFTVDAK 95.00% 4.12 0.364 2.92 823.9413 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVAVNKPAEFTVDAK 95.00% 4.12 0.411 2.96 823.942 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVAVNKPAEFTVDAK 95.00% 3.94 0.414 3.89 824.4436 1,646.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVAVNKPAEFTVDAK 95.00% 3.16 0.423 2.46 824.4473 1,646.88 1,646.88 2 MYLK_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 4.14 0.535 3.1 826.9319 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 5.03 0.609 7.4 826.9333 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 5.24 0.574 6.82 826.9333 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 5.03 0.569 5 826.9333 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 4.95 0.596 4.3 826.9336 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 5 0.585 3.49 826.9338 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 5.21 0.618 5.43 826.9339 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 2.39 0.389 0 826.9339 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 5.1 0.575 6.26 826.934 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 5.15 0.568 7.09 826.934 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 4.68 0.596 4.92 826.934 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 5.01 0.565 6.59 826.934 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 5.24 0.611 5.85 826.9341 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 5.22 0.582 5.55 826.9342 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 4.7 0.56 4.92 826.9347 1,651.85 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTAQGPGLEPSGNIANK 95.00% 4.75 0.591 5.54 826.9353 1,651.86 1,652.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YWPQEAGEYAVHVLcNSEDIR 95.00% 2.64 0.291 0 c15: Carbamidomethyl (+57.02) 846.0549 2,535.14 2,536.16 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 3.98 0.583 2.72 849.0906 2,544.25 2,544.26 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 5.03 0.614 3.59 849.0913 2,544.25 2,544.26 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 4.39 0.518 3.44 849.9602 1,697.90 1,698.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 4.32 0.554 3.6 849.9615 1,697.91 1,698.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 4.83 0.535 3 849.9619 1,697.91 1,698.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 4.67 0.55 3.4 849.9622 1,697.91 1,698.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 4.42 0.567 3.37 849.9622 1,697.91 1,698.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 4.1 0.536 2.96 849.9628 1,697.91 1,698.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 4.12 0.426 3.6 849.9637 1,697.91 1,698.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 3.82 0.496 3.82 849.9637 1,697.91 1,698.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 4.2 0.39 3.77 850.4598 1,698.90 1,698.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TGVELGKPTHFTVNAK 95.00% 4.21 0.434 4.89 850.4644 1,698.91 1,698.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AHEPTYFTVDcAEAGQGDVSIGIK 95.00% 2.85 0.229 0 c11: Carbamidomethyl (+57.02) 855.9666 2,564.88 2,565.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AHEPTYFTVDcAEAGQGDVSIGIK 95.00% 5.2 0.494 4.92 c11: Carbamidomethyl (+57.02) 856.0668 2,565.18 2,565.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% AHEPTYFTVDcAEAGQGDVSIGIK 95.00% 4.81 0.488 4.54 c11: Carbamidomethyl (+57.02) 856.069 2,565.18 2,565.19 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% KTHIQDNHDGTYTVAYVPDVTGR 95.00% 4.68 0.626 4.14 863.4233 2,587.25 2,587.25 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% KTHIQDNHDGTYTVAYVPDVTGR 95.00% 5.92 0.581 4.16 863.4249 2,587.25 2,587.25 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YKGQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.35 0.268 1.82 865.3967 2,593.17 2,595.31 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPMAPGSYLISIK 95.00% 3.73 0.501 3.22 870.9623 1,739.91 1,740.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPMAPGSYLISIK 95.00% 3.69 0.535 4.47 870.964 1,739.91 1,740.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPMAPGSYLISIK 95.00% 3.47 0.355 2.18 870.9643 1,739.91 1,740.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPMAPGSYLISIK 95.00% 3.11 0.156 1.68 871.4643 1,740.91 1,740.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPMAPGSYLISIK 95.00% 3.47 0.465 0 871.4645 1,740.91 1,740.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPMAPGSYLISIK 95.00% 3.65 0.463 1.49 871.4646 1,740.91 1,740.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPMAPGSYLISIK 95.00% 4.14 0.52 5.68 871.4657 1,740.92 1,740.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPMAPGSYLISIK 95.00% 4.14 0.497 3.47 871.4657 1,740.92 1,740.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPMAPGSYLISIK 95.00% 3.85 0.487 2.64 871.466 1,740.92 1,740.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPMAPGSYLISIK 95.00% 3.81 0.466 4.2 871.4665 1,740.92 1,740.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPMAPGSYLISIK 95.00% 4.04 0.54 3.24 871.4669 1,740.92 1,740.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 2.96 0.527 0 875.9425 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 3.15 0.446 0 875.9426 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 2.98 0.384 0 875.943 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 3.39 0.491 0 875.9431 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 3.82 0.577 2.13 875.9433 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 3.67 0.543 1.72 876.4427 1,750.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 3.03 0.381 0 876.4437 1,750.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% TFSVWYVPEVTGTHK 95.00% 3.03 0.424 0 876.4447 1,750.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDKSQGDASK 95.00% 5.26 0.544 3.96 878.9203 1,755.83 1,756.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDKSQGDASK 95.00% 5.41 0.528 5.46 878.9219 1,755.83 1,756.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDKSQGDASK 95.00% 5.29 0.519 5.96 878.9222 1,755.83 1,756.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDKSQGDASK 95.00% 5.18 0.529 6.18 878.9224 1,755.83 1,756.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDKSQGDASK 95.00% 5.1 0.509 5 878.924 1,755.83 1,756.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPmAPGSYLISIK 95.00% 2.95 0.374 1.52 m6: Oxidation (+15.99) 878.9606 1,755.91 1,756.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYTPmAPGSYLISIK 95.00% 2.96 0.36 1.2 m6: Oxidation (+15.99) 878.9638 1,755.91 1,756.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDKSQGDASK 95.00% 4.57 0.475 5.05 879.4229 1,756.83 1,756.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPFEVYVDKSQGDASK 95.00% 5.01 0.537 5.41 879.4236 1,756.83 1,756.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VANPSGNLTETYVQDR 95.00% 5.03 0.647 10 882.4303 1,762.84 1,763.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VANPSGNLTETYVQDR 95.00% 5.09 0.648 11.4 882.4303 1,762.85 1,763.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VANPSGNLTETYVQDR 95.00% 5.04 0.631 8.08 882.4305 1,762.85 1,763.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VANPSGNLTETYVQDR 95.00% 5.17 0.648 8.17 882.4308 1,762.85 1,763.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VANPSGNLTETYVQDR 95.00% 5.09 0.64 8.32 882.4308 1,762.85 1,763.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VANPSGNLTETYVQDR 95.00% 5.25 0.625 6.66 882.4311 1,762.85 1,763.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VANPSGNLTETYVQDR 95.00% 5.18 0.644 5.89 882.4311 1,762.85 1,763.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VANPSGNLTETYVQDR 95.00% 5.02 0.609 4.72 882.9306 1,763.85 1,763.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VANPSGNLTETYVQDR 95.00% 5.4 0.638 5.22 882.9311 1,763.85 1,763.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VANPSGNLTETYVQDR 95.00% 4.88 0.602 7.47 882.9311 1,763.85 1,763.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VANPSGNLTETYVQDR 95.00% 5.32 0.641 5.89 882.9311 1,763.85 1,763.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VANPSGNLTETYVQDR 95.00% 5.44 0.614 5.89 882.9323 1,763.85 1,763.86 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 4.3 0.59 2.89 892.9238 1,783.83 1,784.85 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 4.1 0.574 4.19 892.9246 1,783.83 1,784.85 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 5.26 0.562 3.77 c9: Carbamidomethyl (+57.02) 892.9438 1,783.87 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 5.63 0.568 4 c9: Carbamidomethyl (+57.02) 892.9441 1,783.87 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 5.58 0.598 3.27 c9: Carbamidomethyl (+57.02) 892.9445 1,783.87 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 5.37 0.592 4.7 c9: Carbamidomethyl (+57.02) 892.9446 1,783.87 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 5.5 0.537 6.05 c9: Carbamidomethyl (+57.02) 892.9451 1,783.87 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 4.85 0.595 5.19 c9: Carbamidomethyl (+57.02) 892.9453 1,783.87 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 4.86 0.592 3.54 c9: Carbamidomethyl (+57.02) 892.9467 1,783.88 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 4.5 0.556 3.37 893.4234 1,784.83 1,784.85 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 3.92 0.535 3.05 893.4267 1,784.84 1,784.85 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 4.3 0.566 4.35 893.4267 1,784.84 1,784.85 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 3.9 0.523 2.92 893.4271 1,784.84 1,784.85 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DVDIIDHHDNTYTVK 95.00% 4.26 0.561 3.51 893.4286 1,784.84 1,784.85 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 5.7 0.545 5.19 c9: Carbamidomethyl (+57.02) 893.4456 1,784.88 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 5.23 0.553 6.05 c9: Carbamidomethyl (+57.02) 893.446 1,784.88 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 5.7 0.537 5.66 c9: Carbamidomethyl (+57.02) 893.4477 1,784.88 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 5.62 0.53 4.26 c9: Carbamidomethyl (+57.02) 893.4477 1,784.88 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 5.47 0.559 3.6 c9: Carbamidomethyl (+57.02) 893.4483 1,784.88 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVK 95.00% 4.53 0.55 5.44 c9: Carbamidomethyl (+57.02) 893.4493 1,784.88 1,784.89 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% cSYQPTMEGVHTVHVTFAGVPIPR 95.00% 4.41 0.639 2.68 c1: Carbamidomethyl (+57.02) 895.4446 2,683.31 2,683.31 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SADFVVEAIGDDVGTLGFSVEGPSQAK 95.00% 5.21 0.622 2.59 899.443 2,695.31 2,695.31 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SADFVVEAIGDDVGTLGFSVEGPSQAK 95.00% 4.47 0.501 2.62 899.4446 2,695.31 2,695.31 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 3.2 0.466 3.92 907.982 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 4.31 0.447 5.02 907.9836 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 4.39 0.406 3.42 908.4838 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 4.42 0.432 4.55 908.4842 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 4.3 0.408 4.8 908.4845 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VAQPTITDNKDGTVTVR 95.00% 4.54 0.41 5.36 908.4851 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LQVEPAVDTSGVQcYGPGIEGQGVFR 95.00% 7.92 0.693 9.16 c14: Carbamidomethyl (+57.02) 922.1183 2,763.33 2,763.34 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LQVEPAVDTSGVQcYGPGIEGQGVFR 95.00% 7.61 0.682 7.72 c14: Carbamidomethyl (+57.02) 922.1189 2,763.33 2,763.34 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.74 0.515 4.96 c11: Carbamidomethyl (+57.02) 923.1041 2,766.29 2,766.30 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.66 0.529 4.92 c11: Carbamidomethyl (+57.02) 923.1041 2,766.29 2,766.30 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.53 0.497 5.05 c11: Carbamidomethyl (+57.02) 923.1042 2,766.29 2,766.30 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.38 0.495 5.55 c11: Carbamidomethyl (+57.02) 923.1045 2,766.29 2,766.30 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.73 0.464 4.8 c11: Carbamidomethyl (+57.02) 923.1052 2,766.29 2,766.30 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.24 0.513 4.92 c11: Carbamidomethyl (+57.02) 923.1052 2,766.29 2,766.30 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 5.09 0.556 4.66 c11: Carbamidomethyl (+57.02) 923.1066 2,766.30 2,766.30 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.62 0.532 5.89 c11: Carbamidomethyl (+57.02) 923.108 2,766.30 2,766.30 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 4.78 0.548 5.85 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.422 1,866.83 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 4.71 0.549 5.6 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.422 1,866.83 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 5.12 0.561 6.92 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4227 1,866.83 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 5.62 0.557 6.66 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4234 1,866.83 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 5.32 0.584 4.92 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4237 1,866.83 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 5.13 0.493 4.96 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4245 1,866.83 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 5.19 0.503 7.59 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4246 1,866.83 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 5.22 0.504 5.66 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9243 1,867.83 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 5.17 0.503 5.77 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9246 1,867.83 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 5.14 0.493 5.36 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9247 1,867.83 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 5.01 0.487 5.82 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9249 1,867.83 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 5.11 0.502 5.66 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9251 1,867.83 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 4.84 0.519 4.48 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9255 1,867.84 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SPYTVTVGQAcNPSAcR 95.00% 5.05 0.546 5.15 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9266 1,867.84 1,867.84 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.23 0.524 3.77 c4: Carbamidomethyl (+57.02) 941.4735 1,880.93 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.14 0.557 4.47 c4: Carbamidomethyl (+57.02) 941.4739 1,880.93 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.3 0.58 3.12 c4: Carbamidomethyl (+57.02) 941.4752 1,880.93 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.79 0.522 3.39 c4: Carbamidomethyl (+57.02) 941.9708 1,881.93 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.7 0.512 3.36 c4: Carbamidomethyl (+57.02) 941.9735 1,881.93 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.31 0.47 2.77 c4: Carbamidomethyl (+57.02) 941.9735 1,881.93 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.65 0.506 4.17 c4: Carbamidomethyl (+57.02) 941.9741 1,881.93 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.47 0.519 4.49 c4: Carbamidomethyl (+57.02) 941.9742 1,881.93 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.3 0.472 3.77 c4: Carbamidomethyl (+57.02) 941.9742 1,881.93 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.47 0.491 3.96 c4: Carbamidomethyl (+57.02) 941.9754 1,881.94 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.55 0.505 3.66 c4: Carbamidomethyl (+57.02) 941.9757 1,881.94 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.19 0.473 4.46 c4: Carbamidomethyl (+57.02) 941.9762 1,881.94 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VTYcPTEPGNYIINIK 95.00% 4.54 0.454 3.13 c4: Carbamidomethyl (+57.02) 941.9767 1,881.94 1,881.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 5.25 0.578 5.42 955.4607 1,908.91 1,909.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 5.11 0.564 5.62 955.4608 1,908.91 1,909.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 5.07 0.596 5.62 955.4617 1,908.91 1,909.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 4.89 0.554 4.62 955.9605 1,909.91 1,909.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 5.07 0.568 6.22 955.9623 1,909.91 1,909.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 5.25 0.555 5.74 955.9624 1,909.91 1,909.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 4.69 0.578 5.85 955.9626 1,909.91 1,909.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 5.24 0.549 5.8 955.9633 1,909.91 1,909.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 5.38 0.557 4.82 955.9636 1,909.91 1,909.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% EGPYSISVLYGDEEVPR 95.00% 5.03 0.568 5.57 955.9641 1,909.91 1,909.92 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VGSAADIPINISETDLSLLTATVVPPSGR 95.00% 3.1 0.318 1 965.5223 2,893.54 2,893.55 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGLLAVQITDPEGKPK 95.00% 4.67 0.392 5.92 969.512 1,937.01 1,938.02 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGLLAVQITDPEGKPK 95.00% 4.97 0.376 5.89 969.5146 1,937.01 1,938.02 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGLLAVQITDPEGKPK 95.00% 4.3 0.126 5.03 969.5189 1,937.02 1,938.02 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGLLAVQITDPEGKPK 95.00% 4.95 0.331 4.89 970.0104 1,938.01 1,938.02 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGLLAVQITDPEGKPK 95.00% 5.15 0.391 4.68 970.0124 1,938.01 1,938.02 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGLLAVQITDPEGKPK 95.00% 5.01 0.369 5.48 970.0127 1,938.01 1,938.02 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGLLAVQITDPEGKPK 95.00% 5.24 0.352 4.68 970.0131 1,938.01 1,938.02 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DAGEGLLAVQITDPEGKPK 95.00% 5.06 0.388 4.7 970.0147 1,938.01 1,938.02 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% HTAMVSWGGVSIPNSPFR 95.00% 5.9 0.674 6.01 972.4823 1,942.95 1,942.96 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% HTAMVSWGGVSIPNSPFR 95.00% 6.06 0.658 8.41 972.4857 1,942.96 1,942.96 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FGGEHVPNSPFQVTALAGDQPSVQPPLR 95.00% 3.7 0.286 2.01 982.8333 2,945.48 2,945.49 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FGGEHVPNSPFQVTALAGDQPSVQPPLR 95.00% 4.69 0.522 4.8 982.8352 2,945.48 2,945.49 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FGGEHVPNSPFQVTALAGDQPSVQPPLR 95.00% 5.39 0.56 4.15 982.8353 2,945.48 2,945.49 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 5.85 0.71 8.04 1,001.51 2,001.00 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 5.99 0.743 8.02 1,001.51 2,001.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 6.58 0.73 8.31 1,002.01 2,002.00 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 6.21 0.708 9.36 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 5.85 0.709 11 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 5.68 0.709 8.39 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 6.08 0.719 8.25 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 5.8 0.698 8.52 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDMTAQVTSPSGK 95.00% 6.04 0.728 6.66 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% cAPGVVGPAEADIDFDIIR 95.00% 5.21 0.572 6.17 c1: Carbamidomethyl (+57.02) 1,008.50 2,014.98 2,014.99 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% cAPGVVGPAEADIDFDIIR 95.00% 5.97 0.627 5.46 c1: Carbamidomethyl (+57.02) 1,008.50 2,014.98 2,014.99 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IPEISIQDmTAQVTSPSGK 95.00% 3.37 0.234 2.52 m9: Oxidation (+15.99) 1,009.54 2,017.07 2,018.01 2 ITIH1_HUMAN
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% cAPGVVGPAEADIDFDIIRNDNDTFTVK 95.00% 3.17 0.365 1.85 c1: Carbamidomethyl (+57.02) 1,017.49 3,049.44 3,049.46 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% cAPGVVGPAEADIDFDIIRNDNDTFTVK 95.00% 3.37 0.385 1.39 c1: Carbamidomethyl (+57.02) 1,017.49 3,049.44 3,049.46 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 6.54 0.657 5.85 c15: Carbamidomethyl (+57.02) 1,029.47 2,056.93 2,057.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 6.44 0.656 6.62 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.92 2,057.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% THEAEIVEGENHTYcIR 95.00% 6.34 0.641 6.59 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ALGALVDScAPGLcPDWDSWDASKPVTNAR 95.00% 5.42 0.493 6.2 c9: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,077.50 3,229.49 3,229.51 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 5.98 0.604 5.31 1,101.07 2,200.12 2,200.13 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LVSNHSLHETSSVFVDSLTK 95.00% 5.9 0.601 4.54 1,101.07 2,200.13 2,200.13 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% VQVQDNEGcPVEALVKDNGNGTYScSYVPR 95.00% 5.94 0.564 3.36 c9: Carbamidomethyl (+57.02), c25: Carbamidomethyl (+57.02) 1,119.51 3,355.51 3,355.53 3
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.14 0.681 6.11 c4: Carbamidomethyl (+57.02) 1,129.51 2,257.01 2,258.03 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.43 0.681 5.96 c4: Carbamidomethyl (+57.02) 1,129.52 2,257.02 2,258.03 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DGScGVAYVVQEPGDYEVSVK 95.00% 4.85 0.67 6.48 c4: Carbamidomethyl (+57.02) 1,129.52 2,257.02 2,258.03 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.31 0.63 5.12 c4: Carbamidomethyl (+57.02) 1,130.01 2,258.01 2,258.03 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.22 0.606 5.51 c4: Carbamidomethyl (+57.02) 1,130.01 2,258.01 2,258.03 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.42 0.64 4.96 c4: Carbamidomethyl (+57.02) 1,130.01 2,258.01 2,258.03 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.43 0.632 6.77 c4: Carbamidomethyl (+57.02) 1,130.01 2,258.01 2,258.03 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.52 0.617 3.66 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.01 2,258.03 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.2 0.625 4.7 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.24 0.592 6.66 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.37 0.673 5.66 1,144.09 2,286.17 2,286.18 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.49 0.684 4.64 1,144.09 2,286.17 2,286.18 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.65 0.679 5.96 1,144.09 2,286.17 2,286.18 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.22 0.643 5.21 1,144.09 2,286.17 2,286.18 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.47 0.653 5.77 1,144.09 2,286.17 2,286.18 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.54 0.68 4.52 1,144.10 2,286.18 2,286.18 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.36 0.642 5.77 1,144.10 2,286.18 2,286.18 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 0 0 4.31 1,144.59 2,287.17 2,286.18 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGSYTIMVLFADQATPTSPIR 95.00% 5.44 0.593 3.96 1,149.08 2,296.15 2,296.17 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GAGSYTIMVLFADQATPTSPIR 95.00% 5.42 0.595 3.31 1,149.08 2,296.15 2,296.17 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.17 0.628 6.52 1,157.55 2,313.08 2,313.10 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.37 0.564 7.12 1,157.55 2,313.09 2,313.10 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.56 0.576 6.21 1,157.55 2,313.09 2,313.10 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.18 0.601 6.17 1,157.55 2,313.09 2,313.10 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.19 0.657 8.38 1,157.56 2,313.10 2,313.10 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.23 0.575 6.15 1,172.11 2,342.21 2,342.22 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.47 0.556 8.22 1,172.12 2,342.22 2,342.22 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.4 0.575 7.62 1,172.12 2,342.22 2,342.22 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.06 0.522 7.52 1,172.12 2,342.22 2,342.22 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.27 0.519 5.25 1,172.12 2,342.22 2,342.22 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.77 0.591 3.48 c11: Carbamidomethyl (+57.02) 1,225.65 2,449.28 2,449.29 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.79 0.585 3.59 c11: Carbamidomethyl (+57.02) 1,225.65 2,449.28 2,449.29 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.69 0.515 6.92 1,234.60 2,467.18 2,467.19 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.99 0.551 4.85 1,234.60 2,467.18 2,467.19 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.57 0.723 9.23 1,273.13 2,544.25 2,544.26 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.26 0.72 9.06 1,273.13 2,544.25 2,544.26 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.23 0.725 8.96 1,273.13 2,544.25 2,544.26 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.09 0.716 7.96 1,273.13 2,544.25 2,544.26 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 5.88 0.704 8.34 1,273.13 2,544.25 2,544.26 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.17 0.727 9.89 1,273.14 2,544.26 2,544.26 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LQVEPAVDTSGVQcYGPGIEGQGVFR 95.00% 6.47 0.7 7.54 c14: Carbamidomethyl (+57.02) 1,382.67 2,763.33 2,763.34 2
 SAMPLE 2R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 102 131 837 55.60% LQVEPAVDTSGVQcYGPGIEGQGVFR 95.00% 6.26 0.708 8.02 c14: Carbamidomethyl (+57.02) 1,382.68 2,763.34 2,763.34 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDVGKDQEFTVK 95.00% 2.19 0.42 0 455.5731 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDVGKDQEFTVK 95.00% 2.21 0.269 0 455.5736 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDVGKDQEFTVK 95.00% 2.08 0.432 1.08 455.5743 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDVGKDQEFTVK 95.00% 2 0.374 0 455.5749 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDVGKDQEFTVK 95.00% 2.39 0.426 0 455.5751 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 2.93 0.462 0 460.5628 1,378.66 1,379.68 3 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 3.01 0.468 0 460.5632 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 3.45 0.48 2.89 460.5633 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 3.14 0.448 2.43 460.5635 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 3.06 0.475 1.14 460.5635 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 2.6 0.486 0 460.5637 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 2.68 0.46 1.19 460.5638 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 2.97 0.532 1.13 460.5641 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 2.93 0.504 1.82 460.5645 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 3.15 0.495 2.68 460.8981 1,379.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 3.44 0.466 2.24 460.8983 1,379.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 2.67 0.28 1.27 471.8891 1,412.64 1,413.66 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 2.29 0.331 2.1 471.8894 1,412.64 1,413.66 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 2.76 0.324 2.24 472.223 1,413.65 1,413.66 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LRNGHVGISFVPK 95.00% 2.53 0.138 1.49 475.6045 1,423.79 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LRNGHVGISFVPK 95.00% 2.35 0.198 1.89 475.607 1,423.80 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 3.3 0.487 0 478.925 1,433.75 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 3.7 0.374 0 478.9252 1,433.75 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 4.15 0.528 0 478.9253 1,433.75 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 3.07 0.453 1.43 478.9254 1,433.75 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 3.82 0.487 1.41 478.9256 1,433.75 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 3.92 0.473 0 478.9257 1,433.75 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 4.39 0.524 1.39 478.9263 1,433.76 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 3.55 0.462 0 478.9263 1,433.76 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 4.03 0.512 1.46 478.9264 1,433.76 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 3.13 0.41 0 478.9272 1,433.76 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 3.56 0.42 0 478.9273 1,433.76 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 3.59 0.47 0 479.2594 1,434.75 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 3.7 0.398 0 479.2594 1,434.75 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 3.52 0.495 0 479.2598 1,434.76 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AGNNMLLVGVHGPR 95.00% 1.94 0.263 0 479.2913 1,434.85 1,434.76 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AEISFEDR 95.00% 2.16 0.244 0 483.7296 965.4436 966.4533 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LLGWIQNK 95.00% 2.81 0.086 0 486.2861 970.5566 971.568 2 FLNC_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LLGWIQNK 95.00% 2.79 0.186 0 486.2863 970.557 971.568 2 FLNC_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LLGWIQNK 95.00% 2.92 0.175 0 486.2864 970.5571 971.568 2 FLNC_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LLGWIQNK 95.00% 2.98 0.166 0 486.2865 970.5573 971.568 2 FLNC_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LLGWIQNK 95.00% 2.88 0.169 0 486.2867 970.5577 971.568 2 FLNC_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LLGWIQNK 95.00% 2.65 0.185 0 486.2871 970.5586 971.568 2 FLNC_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LLGWIQNK 95.00% 2.65 0.183 0 486.2872 970.5587 971.568 2 FLNC_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LLGWIQNK 95.00% 3 0.19 0 486.2873 970.5589 971.568 2 FLNC_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LLGWIQNK 95.00% 2.62 0.176 0 486.2878 970.56 971.568 2 FLNC_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% KGEITGEVR 95.00% 2.26 0.228 0 494.7747 987.5338 988.5429 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% KGEITGEVR 95.00% 2.08 0.266 1.38 494.7762 987.5367 988.5429 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% KGEITGEVR 95.00% 2.19 0.232 0 494.7762 987.5367 988.5429 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% KGEITGEVR 95.00% 2.03 0.262 0 494.7764 987.5372 988.5429 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% KGEITGEVR 95.00% 2.07 0.31 0 494.7766 987.5376 988.5429 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 2.41 0.37 0 505.9236 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 3.31 0.381 3.15 505.9241 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 2.88 0.334 0 505.9246 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 3 0.354 1.24 505.925 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 2.95 0.362 2.77 506.2577 1,515.75 1,515.76 3 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 3.18 0.331 2.4 506.258 1,515.75 1,515.76 3 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 2.66 0.272 1.37 506.2587 1,515.75 1,515.76 3 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 2.64 0.279 1.92 506.2602 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 2.72 0.304 2.33 506.2607 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LSPFMADIR 95.00% 2.66 0.293 0 525.2747 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LSPFMADIR 95.00% 2.6 0.327 1.46 525.2748 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LSPFMADIR 95.00% 2.67 0.296 1.1 525.275 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LSPFMADIR 95.00% 2.4 0.291 1.32 525.2759 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.73 0.387 4.26 534.9259 1,601.75 1,602.77 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.69 0.434 3.44 534.926 1,601.75 1,602.77 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.57 0.389 2.05 534.926 1,601.75 1,602.77 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.49 0.384 3.55 534.9261 1,601.76 1,602.77 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.88 0.425 2.51 534.9261 1,601.76 1,602.77 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.94 0.434 2.28 534.9262 1,601.76 1,602.77 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.63 0.476 2.82 534.9263 1,601.76 1,602.77 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 4.07 0.487 2.14 535.2601 1,602.76 1,602.77 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.32 0.384 2.42 535.2603 1,602.76 1,602.77 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.45 0.372 2.09 535.2605 1,602.76 1,602.77 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDK 95.00% 2.96 0.416 0 542.2682 1,082.52 1,083.54 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDK 95.00% 2.54 0.438 0 542.2683 1,082.52 1,083.54 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDK 95.00% 2.22 0.339 1.14 542.2696 1,082.52 1,083.54 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDK 95.00% 2.43 0.468 0 542.2702 1,082.52 1,083.54 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDK 95.00% 2.48 0.439 0 542.2705 1,082.53 1,083.54 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDK 95.00% 2.73 0.431 1.24 542.2708 1,082.53 1,083.54 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDK 95.00% 2.9 0.506 1.08 542.2708 1,082.53 1,083.54 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDK 95.00% 3.29 0.428 0 542.2709 1,082.53 1,083.54 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDK 95.00% 3.22 0.489 0 542.2712 1,082.53 1,083.54 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDK 95.00% 2.44 0.42 1.68 542.2713 1,082.53 1,083.54 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LYSVSYLLK 95.00% 2.29 0.268 0 543.3142 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LYSVSYLLK 95.00% 2.45 0.314 0 543.3145 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LYSVSYLLK 95.00% 2.23 0.196 0 543.3148 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LYSVSYLLK 95.00% 2.34 0.291 0 543.3152 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVAVNKPAEFTVDAK 95.00% 3.72 0.587 1.15 549.6287 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVAVNKPAEFTVDAK 95.00% 3.34 0.477 1.52 549.6288 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVAVNKPAEFTVDAK 95.00% 3.65 0.589 1.85 549.629 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVAVNKPAEFTVDAK 95.00% 3.31 0.526 1.6 549.629 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVAVNKPAEFTVDAK 95.00% 3.48 0.539 0.959 549.6291 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVAVNKPAEFTVDAK 95.00% 3.94 0.6 2.2 549.6296 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVAVNKPAEFTVDAK 95.00% 3.5 0.567 0 549.9642 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GTVEPQLEAR 95.00% 2.17 0.315 1.18 550.2924 1,098.57 1,099.57 2 TLN1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GTVEPQLEAR 95.00% 2.45 0.338 0 550.2948 1,098.57 1,099.57 2 TLN1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% APSVANVGSHcDLSLK 95.00% 2.2 0.337 1.64 c11: Carbamidomethyl (+57.02) 552.2787 1,653.81 1,654.82 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% APSVANVGSHcDLSLK 95.00% 2.72 0.513 1.72 c11: Carbamidomethyl (+57.02) 552.6124 1,654.81 1,654.82 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% APSVANVGSHcDLSLK 95.00% 2.47 0.367 0 c11: Carbamidomethyl (+57.02) 552.6133 1,654.82 1,654.82 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LDVQFSGLTK 95.00% 2.87 0.513 1.21 554.3051 1,106.59 1,107.61 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ALTQTGGPHVK 95.00% 2.79 0.365 0 554.8098 1,107.60 1,108.61 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ALTQTGGPHVK 95.00% 2.57 0.379 1.57 555.3101 1,108.60 1,108.61 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VKMDcQEcPEGYR 95.00% 3.08 0.384 2.55 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9013 1,670.68 1,671.69 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VKMDcQEcPEGYR 95.00% 2.7 0.384 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9014 1,670.68 1,671.69 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VKMDcQEcPEGYR 95.00% 3.65 0.457 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9022 1,670.68 1,671.69 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VKMDcQEcPEGYR 95.00% 2.99 0.357 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9022 1,670.68 1,671.69 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VKMDcQEcPEGYR 95.00% 3.06 0.351 1.55 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9039 1,670.69 1,671.69 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VKMDcQEcPEGYR 95.00% 3.31 0.332 1.49 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 558.2357 1,671.68 1,671.69 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VKMDcQEcPEGYR 95.00% 3.27 0.351 1.96 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 558.237 1,671.69 1,671.69 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVELGKPTHFTVNAK 95.00% 3.63 0.276 0 566.9771 1,697.91 1,698.92 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVELGKPTHFTVNAK 95.00% 3.21 0.281 0 566.9772 1,697.91 1,698.92 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVELGKPTHFTVNAK 95.00% 3.64 0.346 0 566.9772 1,697.91 1,698.92 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVELGKPTHFTVNAK 95.00% 2.99 0.385 0 566.9773 1,697.91 1,698.92 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVELGKPTHFTVNAK 95.00% 3 0.261 0 567.3102 1,698.91 1,698.92 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVELGKPTHFTVNAK 95.00% 3.65 0.331 0 567.3112 1,698.91 1,698.92 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ETGEHLVHVK 95.00% 2.24 0.236 0 574.8076 1,147.60 1,148.61 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ETGEHLVHVK 95.00% 2.44 0.305 0 574.8096 1,147.60 1,148.61 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ENGVYLIDVK 95.00% 2.33 0.377 0 575.3097 1,148.60 1,149.62 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ENGVYLIDVK 95.00% 2.3 0.332 0 575.31 1,148.60 1,149.62 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DKGEYTLVVK 95.00% 2.67 0.305 0 576.3174 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DKGEYTLVVK 95.00% 2.19 0.216 0 576.3175 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DKGEYTLVVK 95.00% 3.02 0.396 0 576.3179 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DKGEYTLVVK 95.00% 2.58 0.264 0 576.3183 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DKGEYTLVVK 95.00% 2.42 0.232 0 576.3183 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DKGEYTLVVK 95.00% 2.52 0.245 0 576.3185 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DKGEYTLVVK 95.00% 2.46 0.249 0 576.3189 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DKGEYTLVVK 95.00% 2.43 0.287 0 576.3194 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DKGEYTLVVK 95.00% 2.68 0.257 0 576.8191 1,151.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% NGHVGISFVPK 95.00% 2.35 0.352 1.26 577.8181 1,153.62 1,154.63 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% NGHVGISFVPK 95.00% 2.37 0.306 1.26 577.8183 1,153.62 1,154.63 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% NGHVGISFVPK 95.00% 2.95 0.432 0 577.8185 1,153.62 1,154.63 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% NGHVGISFVPK 95.00% 3.21 0.368 0 577.8186 1,153.62 1,154.63 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% NGHVGISFVPK 95.00% 2.38 0.237 0 577.8191 1,153.62 1,154.63 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% NGHVGISFVPK 95.00% 2.53 0.278 0 577.8197 1,153.62 1,154.63 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcK 95.00% 2.43 0.369 3.1 c11: Carbamidomethyl (+57.02) 578.3119 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcK 95.00% 2.29 0.32 1.8 c11: Carbamidomethyl (+57.02) 578.3121 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcK 95.00% 2.71 0.473 4.16 c11: Carbamidomethyl (+57.02) 578.3123 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcK 95.00% 2.44 0.425 2.96 c11: Carbamidomethyl (+57.02) 578.3125 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcK 95.00% 2.24 0.306 1.21 c11: Carbamidomethyl (+57.02) 578.3127 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcK 95.00% 2.5 0.429 2.6 c11: Carbamidomethyl (+57.02) 578.3128 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcK 95.00% 2.6 0.392 2.77 c11: Carbamidomethyl (+57.02) 578.3128 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcK 95.00% 1.98 0.337 1.13 c11: Carbamidomethyl (+57.02) 578.3131 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcK 95.00% 2.69 0.296 2.82 c11: Carbamidomethyl (+57.02) 578.3132 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcK 95.00% 2.61 0.33 2.36 c11: Carbamidomethyl (+57.02) 578.3132 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYTPMAPGSYLISIK 95.00% 3.42 0.482 1.77 580.9783 1,739.91 1,740.92 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TFSVWYVPEVTGTHK 95.00% 2.59 0.37 0 584.2953 1,749.86 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TFSVWYVPEVTGTHK 95.00% 3.35 0.543 1.09 584.2968 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TFSVWYVPEVTGTHK 95.00% 2.51 0.425 0 584.2973 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TFSVWYVPEVTGTHK 95.00% 2.65 0.369 0 584.2975 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TFSVWYVPEVTGTHK 95.00% 3.06 0.526 1.25 584.298 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TFSVWYVPEVTGTHK 95.00% 3.38 0.54 1.89 584.2981 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VPVHDVTDASK 95.00% 2.78 0.457 2.68 584.302 1,166.59 1,167.60 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TFSVWYVPEVTGTHK 95.00% 3.13 0.521 1.68 584.6318 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TFSVWYVPEVTGTHK 95.00% 3.01 0.582 2.46 584.6318 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TFSVWYVPEVTGTHK 95.00% 3.28 0.423 1.92 584.6324 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TFSVWYVPEVTGTHK 95.00% 3.35 0.447 1.24 584.6324 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDKSQGDASK 95.00% 3 0.316 0 586.2808 1,755.82 1,756.84 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDKSQGDASK 95.00% 3.04 0.408 0.959 586.2841 1,755.83 1,756.84 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDKSQGDASK 95.00% 3.87 0.488 4 586.2842 1,755.83 1,756.84 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDKSQGDASK 95.00% 3.92 0.533 2.09 586.6187 1,756.83 1,756.84 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DLAEDAPWKK 95.00% 2.46 0.247 0 586.8009 1,171.59 1,172.60 2 FLNC_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DLAEDAPWKK 95.00% 2.63 0.237 1.31 586.8017 1,171.59 1,172.60 2 FLNC_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 2.34 0.219 0 c9: Carbamidomethyl (+57.02) 595.6338 1,783.88 1,784.89 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ATcAPQHGAPGPGPADASK 95.00% 2.49 0.248 0 c3: Carbamidomethyl (+57.02) 597.2819 1,788.82 1,789.83 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ATcAPQHGAPGPGPADASK 95.00% 2.33 0.292 1.09 c3: Carbamidomethyl (+57.02) 597.6171 1,789.83 1,789.83 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% RAPSVANVGSHcDLSLK 95.00% 3.75 0.418 1.66 c12: Carbamidomethyl (+57.02) 604.3113 1,809.91 1,810.92 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% RAPSVANVGSHcDLSLK 95.00% 4.06 0.499 3.62 c12: Carbamidomethyl (+57.02) 604.312 1,809.91 1,810.92 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VAQPTITDNKDGTVTVR 95.00% 2.64 0.405 1.6 605.6567 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VAQPTITDNKDGTVTVR 95.00% 2.28 0.369 3.31 605.6573 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VAQPTITDNKDGTVTVR 95.00% 1.65 0.308 0 605.6577 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VAQPTITDNKDGTVTVR 95.00% 1.77 0.237 1.09 605.658 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VAQPTITDNKDGTVTVR 95.00% 2.27 0.419 0 605.6581 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VAQPTITDNKDGTVTVR 95.00% 2.21 0.34 1.74 605.992 1,814.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% cSGPGLSPGMVR 95.00% 2.22 0.292 1.55 c1: Carbamidomethyl (+57.02) 609.2892 1,216.56 1,217.58 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% cSGPGLSPGMVR 95.00% 2.72 0.25 1.64 c1: Carbamidomethyl (+57.02) 609.2892 1,216.56 1,217.58 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EATTEFSVDAR 95.00% 3.42 0.434 1.82 613.2865 1,224.56 1,225.57 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EATTEFSVDAR 95.00% 3.14 0.394 2.29 613.287 1,224.56 1,225.57 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EATTEFSVDAR 95.00% 3.28 0.497 1.64 613.2874 1,224.56 1,225.57 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EATTEFSVDAR 95.00% 3.33 0.344 2.68 613.2875 1,224.56 1,225.57 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EATTEFSVDAR 95.00% 3.59 0.493 1.68 613.2877 1,224.56 1,225.57 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EATTEFSVDAR 95.00% 3.66 0.421 1.52 613.2877 1,224.56 1,225.57 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EATTEFSVDAR 95.00% 3.61 0.443 2.17 613.288 1,224.56 1,225.57 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EATTEFSVDAR 95.00% 3.37 0.506 2.17 613.2881 1,224.56 1,225.57 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EATTEFSVDAR 95.00% 3.27 0.428 2.48 613.2884 1,224.56 1,225.57 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EATTEFSVDAR 95.00% 3.32 0.429 2.92 613.2885 1,224.56 1,225.57 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EATTEFSVDAR 95.00% 2.57 0.264 2.05 613.2928 1,224.57 1,225.57 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AWGPGLEGGVVGK 95.00% 2.59 0.25 2.8 613.826 1,225.64 1,226.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AWGPGLEGGVVGK 95.00% 2.43 0.205 2.39 613.8271 1,225.64 1,226.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AWGPGLEGGVVGK 95.00% 2.45 0.391 2.82 613.8278 1,225.64 1,226.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AWGPGLEGGVVGK 95.00% 2.56 0.472 3.8 613.828 1,225.64 1,226.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AWGPGLEGGVVGK 95.00% 2.29 0.332 3.05 613.8282 1,225.64 1,226.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AWGPGLEGGVVGK 95.00% 3.03 0.52 2.77 613.8283 1,225.64 1,226.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AWGPGLEGGVVGK 95.00% 3.09 0.509 1.72 613.8291 1,225.64 1,226.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AHVVPcFDASK 95.00% 1.75 0.281 1.82 c6: Carbamidomethyl (+57.02) 615.7983 1,229.58 1,230.59 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AHVVPcFDASK 95.00% 2.46 0.456 3.29 c6: Carbamidomethyl (+57.02) 615.7996 1,229.58 1,230.59 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AHVVPcFDASK 95.00% 2.22 0.307 0 c6: Carbamidomethyl (+57.02) 615.7998 1,229.58 1,230.59 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AHVVPcFDASK 95.00% 2.65 0.407 2.38 c6: Carbamidomethyl (+57.02) 615.8 1,229.58 1,230.59 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AHVVPcFDASK 95.00% 2.24 0.351 0 c6: Carbamidomethyl (+57.02) 615.8 1,229.58 1,230.59 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTVLFAGQHIAK 95.00% 2.48 0.385 0 642.3766 1,282.74 1,283.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LPQLPITNFSR 95.00% 2.99 0.257 0 643.3647 1,284.71 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LPQLPITNFSR 95.00% 3.13 0.337 2.41 643.3649 1,284.71 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LPQLPITNFSR 95.00% 2.61 0.27 1.96 643.3651 1,284.71 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LPQLPITNFSR 95.00% 3.05 0.297 2.72 643.3661 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LPQLPITNFSR 95.00% 3.01 0.338 2.82 643.3662 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LPQLPITNFSR 95.00% 2.66 0.233 1.08 643.3662 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LPQLPITNFSR 95.00% 2.99 0.347 2.66 643.3662 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LPQLPITNFSR 95.00% 3.25 0.371 2.34 643.3664 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LPQLPITNFSR 95.00% 3.15 0.402 2.68 643.3665 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LPQLPITNFSR 95.00% 2.22 0.411 1.21 643.3665 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LPQLPITNFSR 95.00% 2.9 0.358 2.52 643.3667 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LPQLPITNFSR 95.00% 1.95 0.303 0 643.3675 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGQPVPNFPSK 95.00% 3.44 0.497 2.96 645.8267 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGQPVPNFPSK 95.00% 3.29 0.466 2.31 645.8268 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGQPVPNFPSK 95.00% 3.23 0.499 2.32 645.8271 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGQPVPNFPSK 95.00% 2.51 0.258 1.28 645.8283 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GKLDVQFSGLTK 95.00% 2.77 0.454 2.31 646.8621 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GKLDVQFSGLTK 95.00% 2.26 0.317 0 646.8628 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GKLDVQFSGLTK 95.00% 3.04 0.421 2.44 646.863 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GKLDVQFSGLTK 95.00% 3.07 0.382 2.64 646.863 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GKLDVQFSGLTK 95.00% 3.13 0.383 2.92 646.863 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GKLDVQFSGLTK 95.00% 3.09 0.458 3.48 646.8634 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GKLDVQFSGLTK 95.00% 2.51 0.243 3.01 646.8647 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGLLAVQITDPEGKPK 95.00% 3.15 0.44 3.82 647.0112 1,938.01 1,938.02 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GKLDVQFSGLTK 94.80% 2.23 0.262 0 647.3629 1,292.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FNGTHIPGSPFK 95.00% 3.4 0.339 2.14 651.334 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FNGTHIPGSPFK 95.00% 3.43 0.327 2.82 651.3346 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FNGTHIPGSPFK 95.00% 3.64 0.391 4.49 651.3346 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FNGTHIPGSPFK 95.00% 3.55 0.349 2.66 651.336 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FNGTHIPGSPFK 95.00% 2.19 0.195 2.57 651.3393 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FNGTHIPGSPFK 95.00% 2.63 0.255 0 651.838 1,301.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VEPGLGADNSVVR 95.00% 2.19 0.423 2.12 656.8443 1,311.67 1,312.69 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VEPGLGADNSVVR 95.00% 2.18 0.17 1.43 656.8452 1,311.67 1,312.69 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VEPGLGADNSVVR 95.00% 2.99 0.533 3.82 656.8456 1,311.68 1,312.69 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VEPGLGADNSVVR 95.00% 2.47 0.439 5.92 656.8456 1,311.68 1,312.69 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VEPGLGADNSVVR 95.00% 2.68 0.481 3.15 656.846 1,311.68 1,312.69 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VEPGLGADNSVVR 95.00% 2.2 0.528 3.51 656.8463 1,311.68 1,312.69 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VEPGLGADNSVVR 95.00% 2.61 0.435 3.2 656.8464 1,311.68 1,312.69 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LIALLEVLSQKK 95.00% 3.57 0.55 3.39 677.9359 1,353.86 1,354.87 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LIALLEVLSQKK 95.00% 3.83 0.524 3.33 677.9368 1,353.86 1,354.87 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDVGKDQEFTVK 95.00% 3.43 0.484 1.46 682.8527 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDVGKDQEFTVK 95.00% 3.38 0.47 1.92 682.8539 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDVGKDQEFTVK 95.00% 3.79 0.511 2.05 682.8544 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDVGKDQEFTVK 95.00% 3.37 0.453 3.12 682.8553 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDVGKDQEFTVK 95.00% 3.79 0.483 2.92 682.8556 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDVGKDQEFTVK 95.00% 3.76 0.526 2.7 682.857 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 4.21 0.463 2.92 c15: Carbamidomethyl (+57.02) 686.6492 2,056.92 2,057.94 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 1.96 0.24 0 c15: Carbamidomethyl (+57.02) 686.9819 2,057.92 2,057.94 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 4.85 0.474 3.24 c15: Carbamidomethyl (+57.02) 686.9819 2,057.92 2,057.94 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 4.03 0.526 3.16 c15: Carbamidomethyl (+57.02) 686.9827 2,057.92 2,057.94 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 2.25 0.39 0 c15: Carbamidomethyl (+57.02) 686.9828 2,057.93 2,057.94 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 4.52 0.437 3.74 c15: Carbamidomethyl (+57.02) 686.983 2,057.93 2,057.94 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 4.26 0.458 3.96 c15: Carbamidomethyl (+57.02) 686.983 2,057.93 2,057.94 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 4.53 0.502 3.51 c15: Carbamidomethyl (+57.02) 686.983 2,057.93 2,057.94 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 4.47 0.473 4.41 c15: Carbamidomethyl (+57.02) 686.9831 2,057.93 2,057.94 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 4.01 0.432 4 c15: Carbamidomethyl (+57.02) 686.9832 2,057.93 2,057.94 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 4.49 0.44 3.08 c15: Carbamidomethyl (+57.02) 686.9835 2,057.93 2,057.94 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 4.6 0.519 2.12 c15: Carbamidomethyl (+57.02) 686.9849 2,057.93 2,057.94 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 2.92 0.458 0 690.339 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 3.99 0.537 3.48 690.3397 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 3.89 0.57 3.59 690.3402 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 3.47 0.45 3.66 690.3406 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 3.98 0.559 5.19 690.3409 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 2.72 0.35 0 690.3409 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGPYHIGGSPFK 95.00% 2.61 0.27 0 690.3427 1,378.67 1,379.68 2 CALD1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGDEIPFSPYR 95.00% 2.94 0.206 1.52 700.8252 1,399.63 1,400.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGDEIPFSPYR 95.00% 2.25 0.239 1.89 700.826 1,399.64 1,400.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGDEIPFSPYR 95.00% 3.51 0.187 3.92 700.827 1,399.64 1,400.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGDEIPFSPYR 95.00% 2.56 0.203 2.31 700.8275 1,399.64 1,400.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGDEIPFSPYR 95.00% 2.56 0.158 2.07 700.8282 1,399.64 1,400.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGDEIPFSPYR 95.00% 2.7 0.158 2 700.8285 1,399.64 1,400.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YGGDEIPFSPYR 95.00% 3.44 0.167 2.66 701.3305 1,400.65 1,400.65 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 2.99 0.459 3.01 707.3277 1,412.64 1,413.66 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 3.38 0.417 2.66 707.3296 1,412.64 1,413.66 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 2.98 0.44 2.85 707.3298 1,412.64 1,413.66 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 2.95 0.44 2.51 707.3299 1,412.64 1,413.66 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 2.37 0.291 2.8 707.3305 1,412.65 1,413.66 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 3.06 0.425 2.82 707.3305 1,412.65 1,413.66 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 2.83 0.39 2.05 707.3305 1,412.65 1,413.66 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 2.77 0.354 3.66 707.3311 1,412.65 1,413.66 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 2.74 0.346 2.06 707.3315 1,412.65 1,413.66 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% WGDEHIPGSPYR 95.00% 3.61 0.389 2.47 707.8314 1,413.65 1,413.66 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IANLQTDLSDGLR 95.00% 3.33 0.402 5.1 708.3761 1,414.74 1,415.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IANLQTDLSDGLR 95.00% 3.11 0.35 5.13 708.3769 1,414.74 1,415.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IANLQTDLSDGLR 95.00% 2.81 0.429 2.2 708.3775 1,414.74 1,415.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IANLQTDLSDGLR 95.00% 4.06 0.436 3.85 708.3776 1,414.74 1,415.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IANLQTDLSDGLR 95.00% 4.05 0.44 4.16 708.3778 1,414.74 1,415.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IANLQTDLSDGLR 95.00% 3.38 0.359 4.4 708.3778 1,414.74 1,415.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IANLQTDLSDGLR 95.00% 3.82 0.381 4.04 708.3778 1,414.74 1,415.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IANLQTDLSDGLR 95.00% 3.56 0.384 3.06 708.378 1,414.74 1,415.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IANLQTDLSDGLR 95.00% 2.68 0.356 2.66 708.3781 1,414.74 1,415.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IANLQTDLSDGLR 95.00% 2.27 0.237 2.22 708.3792 1,414.74 1,415.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EAGAGGLAIAVEGPSK 95.00% 3.94 0.593 4.85 713.8797 1,425.74 1,426.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EAGAGGLAIAVEGPSK 95.00% 4.72 0.554 6.47 713.8797 1,425.74 1,426.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EAGAGGLAIAVEGPSK 95.00% 5.24 0.553 6.15 713.8799 1,425.74 1,426.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EAGAGGLAIAVEGPSK 95.00% 2.96 0.464 4.82 713.8803 1,425.75 1,426.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EAGAGGLAIAVEGPSK 95.00% 3.6 0.577 4.55 713.8806 1,425.75 1,426.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EAGAGGLAIAVEGPSK 95.00% 4.45 0.539 5.1 713.8806 1,425.75 1,426.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EAGAGGLAIAVEGPSK 95.00% 4.91 0.575 5.01 713.8809 1,425.75 1,426.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EAGAGGLAIAVEGPSK 95.00% 4.93 0.581 6 713.881 1,425.75 1,426.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 4.07 0.386 4.46 715.3614 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 4.14 0.324 4.7 715.3614 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 3.71 0.464 4.29 715.3615 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 4 0.407 4.74 715.3615 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 4.13 0.467 4.96 715.3616 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 4.36 0.382 5.96 715.3617 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 4.12 0.413 4.49 715.3618 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 4.18 0.299 3.82 715.3619 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 3.65 0.553 4.34 715.3623 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 4.02 0.375 4.36 715.3625 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 4.43 0.47 4.92 715.3626 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 4.2 0.424 4.51 715.3626 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 3.75 0.248 2.6 715.3629 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 4.38 0.369 4.25 715.3631 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 4.23 0.376 4.57 715.3636 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AFGPGLQGGSAGSPAR 95.00% 3.75 0.425 4.89 715.3639 1,428.71 1,429.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAEMPATEKDLAEDAPWKK 95.00% 3.23 0.326 0 716.01 2,145.01 2,145.02 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAEMPATEKDLAEDAPWKK 95.00% 4.31 0.496 0 716.0106 2,145.01 2,145.02 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAEMPATEKDLAEDAPWKK 95.00% 4.32 0.445 1.22 716.0118 2,145.01 2,145.02 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AYGPGIEPTGNMVK 95.00% 3.29 0.285 0 717.3577 1,432.70 1,433.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AYGPGIEPTGNMVK 95.00% 4.13 0.318 1.46 717.3583 1,432.70 1,433.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AYGPGIEPTGNMVK 95.00% 4.17 0.323 2.11 717.3584 1,432.70 1,433.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AYGPGIEPTGNMVK 95.00% 3.53 0.309 1.57 717.3586 1,432.70 1,433.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AYGPGIEPTGNMVK 95.00% 4.16 0.326 0 717.3588 1,432.70 1,433.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AYGPGIEPTGNMVK 95.00% 4.16 0.371 1.12 717.359 1,432.70 1,433.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AYGPGIEPTGNMVK 95.00% 3.83 0.259 0 717.3591 1,432.70 1,433.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AYGPGIEPTGNMVK 95.00% 3.62 0.263 0 717.3595 1,432.70 1,433.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AYGPGIEPTGNMVK 95.00% 3.79 0.363 1.7 717.36 1,432.70 1,433.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AYGPGIEPTGNMVK 95.00% 3.86 0.318 0 717.3604 1,432.71 1,433.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% AYGPGIEPTGNMVK 95.00% 3.3 0.206 0 717.3606 1,432.71 1,433.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ANLPQSFQVDTSK 95.00% 4.09 0.573 5.19 717.8614 1,433.71 1,434.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ANLPQSFQVDTSK 95.00% 2.12 0.409 3.21 717.8625 1,433.71 1,434.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ANLPQSFQVDTSK 95.00% 2.58 0.463 4.13 717.8628 1,433.71 1,434.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ANLPQSFQVDTSK 95.00% 2.91 0.428 2.43 717.863 1,433.71 1,434.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ANLPQSFQVDTSK 95.00% 2.44 0.218 0 717.8636 1,433.71 1,434.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ANLPQSFQVDTSK 95.00% 3.24 0.607 3.38 717.8638 1,433.71 1,434.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ANLPQSFQVDTSK 95.00% 2.74 0.439 3.52 717.8639 1,433.71 1,434.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ANLPQSFQVDTSK 95.00% 3.65 0.552 4.55 717.8643 1,433.71 1,434.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ANLPQSFQVDTSK 95.00% 3.82 0.524 4.68 717.8646 1,433.71 1,434.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ANLPQSFQVDTSK 95.00% 2.68 0.525 4.43 717.8651 1,433.71 1,434.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ANLPQSFQVDTSK 95.00% 3.56 0.464 3.19 717.8652 1,433.71 1,434.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ANLPQSFQVDTSK 95.00% 2 0.374 2.09 717.8667 1,433.72 1,434.72 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% MDcQEcPEGYR 95.00% 3.68 0.498 1.51 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7677 1,443.52 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% MDcQEcPEGYR 95.00% 4 0.607 1.72 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.769 1,443.52 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LVSNHSLHETSSVFVDSLTK 95.00% 4.96 0.637 3.8 734.0462 2,199.12 2,200.13 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LVSNHSLHETSSVFVDSLTK 95.00% 5.28 0.569 5.55 734.3774 2,200.11 2,200.13 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LVSNHSLHETSSVFVDSLTK 95.00% 5.17 0.664 4.96 734.3791 2,200.11 2,200.13 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LVSNHSLHETSSVFVDSLTK 95.00% 4.97 0.641 2.74 734.3801 2,200.12 2,200.13 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LVSNHSLHETSSVFVDSLTK 95.00% 5.1 0.567 2.6 734.3802 2,200.12 2,200.13 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LVSNHSLHETSSVFVDSLTK 95.00% 5.36 0.59 4.24 734.3803 2,200.12 2,200.13 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LVSNHSLHETSSVFVDSLTK 95.00% 5.1 0.589 2.85 734.3817 2,200.12 2,200.13 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LVSNHSLHETSSVFVDSLTK 95.00% 5.11 0.531 3.82 734.3822 2,200.12 2,200.13 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGGLSLAIEGPSK 95.00% 4.97 0.553 2.77 750.877 1,499.74 1,500.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGGLSLAIEGPSK 95.00% 3.36 0.274 1.18 750.8774 1,499.74 1,500.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGGLSLAIEGPSK 95.00% 3.92 0.441 1.12 750.8788 1,499.74 1,500.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGGLSLAIEGPSK 95.00% 3.07 0.361 1.09 750.8792 1,499.74 1,500.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGGLSLAIEGPSK 95.00% 4.7 0.572 2.52 750.8799 1,499.74 1,500.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGGLSLAIEGPSK 95.00% 5.09 0.578 2.66 750.8808 1,499.75 1,500.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGGLSLAIEGPSK 95.00% 4.02 0.466 3.05 750.8814 1,499.75 1,500.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGGLSLAIEGPSK 95.00% 4.92 0.564 2.19 750.8814 1,499.75 1,500.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGGLSLAIEGPSK 95.00% 4.81 0.556 4.05 750.8815 1,499.75 1,500.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGGLSLAIEGPSK 95.00% 3.57 0.457 2.21 750.8827 1,499.75 1,500.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGGLSLAIEGPSK 95.00% 4.13 0.573 2.4 750.8834 1,499.75 1,500.75 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FVPAEMGTHTVSVK 95.00% 4.25 0.438 5.57 751.8863 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FVPAEMGTHTVSVK 95.00% 3.14 0.417 4.03 751.8882 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FVPAEMGTHTVSVK 95.00% 3.48 0.567 6.39 751.8883 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FVPAEMGTHTVSVK 95.00% 3.11 0.431 5.66 751.8884 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FVPAEMGTHTVSVK 95.00% 4.28 0.465 7.89 751.8888 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FVPAEMGTHTVSVK 95.00% 3.02 0.428 2.82 751.8903 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VNQPASFAVSLNGAK 95.00% 3.28 0.451 4.17 751.896 1,501.78 1,502.80 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VNQPASFAVSLNGAK 95.00% 4.47 0.512 4.7 751.8988 1,501.78 1,502.80 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VNQPASFAVSLNGAK 95.00% 4.16 0.594 4.57 751.8991 1,501.78 1,502.80 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VNQPASFAVSLNGAK 95.00% 3.82 0.495 6 751.8991 1,501.78 1,502.80 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VNQPASFAVSLNGAK 95.00% 3.65 0.561 3.7 751.8996 1,501.78 1,502.80 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VNQPASFAVSLNGAK 95.00% 4.95 0.553 4.7 751.8997 1,501.78 1,502.80 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VNQPASFAVSLNGAK 95.00% 4.89 0.569 4.92 751.9 1,501.78 1,502.80 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VNQPASFAVSLNGAK 95.00% 4.48 0.555 5.82 751.9 1,501.78 1,502.80 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VNQPASFAVSLNGAK 95.00% 4.99 0.576 4.92 751.9004 1,501.79 1,502.80 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VNQPASFAVSLNGAK 95.00% 5.03 0.556 5.24 751.9006 1,501.79 1,502.80 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VNQPASFAVSLNGAK 95.00% 4.13 0.563 5.21 751.9025 1,501.79 1,502.80 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VNQPASFAVSLNGAK 95.00% 4.65 0.539 3.89 752.4016 1,502.79 1,502.80 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 3.56 0.452 1.72 758.3821 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 3.51 0.466 3.28 758.3821 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 3.46 0.418 3.15 758.3824 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 3.33 0.38 3.62 758.3825 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 3.5 0.416 4.89 758.3828 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 3.31 0.383 2.96 758.3837 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 3.39 0.386 3.48 758.8851 1,515.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FADQHVPGSPFSVK 95.00% 3.46 0.373 3.59 758.8879 1,515.76 1,515.76 2 MOES_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FVPAEmGTHTVSVK 95.00% 4.11 0.548 5.34 m6: Oxidation (+15.99) 759.8834 1,517.75 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FVPAEmGTHTVSVK 95.00% 4.14 0.546 4.11 m6: Oxidation (+15.99) 759.8836 1,517.75 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FVPAEmGTHTVSVK 95.00% 3.21 0.46 3 m6: Oxidation (+15.99) 759.8844 1,517.75 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VHSPSGALEEcYVTEIDQDK 95.00% 5.89 0.521 2.01 c11: Carbamidomethyl (+57.02) 760.0156 2,277.02 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VHSPSGALEEcYVTEIDQDK 95.00% 6.15 0.475 1.38 c11: Carbamidomethyl (+57.02) 760.0164 2,277.03 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFSVAVSPSLDLSK 95.00% 4.72 0.529 3.06 767.4095 1,532.80 1,533.82 2 RL4_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFSVAVSPSLDLSK 95.00% 4.73 0.507 2.1 767.4102 1,532.80 1,533.82 2 RL4_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFSVAVSPSLDLSK 95.00% 4.45 0.515 2.72 767.4105 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFSVAVSPSLDLSK 95.00% 4.79 0.485 2.25 767.4109 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFSVAVSPSLDLSK 95.00% 3.39 0.42 1.89 767.411 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFSVAVSPSLDLSK 95.00% 4.86 0.506 2.19 767.412 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFSVAVSPSLDLSK 95.00% 4.04 0.296 1.51 767.432 1,532.85 1,533.82 2 RL4_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SAGQGEVLVYVEDPAGHQEEAK 95.00% 4.27 0.553 3.41 772.0386 2,313.09 2,313.10 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SAGQGEVLVYVEDPAGHQEEAK 95.00% 4.42 0.554 2.55 772.0392 2,313.09 2,313.10 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SAGQGEVLVYVEDPAGHQEEAK 95.00% 3.52 0.499 1.07 772.0413 2,313.10 2,313.10 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGYGGLSLSIEGPSK 95.00% 3.82 0.509 5.36 775.8894 1,549.76 1,550.77 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGYGGLSLSIEGPSK 95.00% 4.86 0.554 4.74 775.8897 1,549.76 1,550.77 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGYGGLSLSIEGPSK 95.00% 4.31 0.485 5.03 775.8898 1,549.76 1,550.77 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGYGGLSLSIEGPSK 95.00% 0 0 4.18 777.0253 1,552.03 1,550.77 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 3.98 0.599 4.66 785.9023 1,569.79 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.31 0.587 3.36 785.9042 1,569.79 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.48 0.562 3.04 785.9059 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 3.63 0.566 3.64 785.906 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.86 0.615 3.66 785.9062 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.46 0.606 3.51 785.9064 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.41 0.576 3.21 785.9066 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 3.34 0.541 4.33 785.9067 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.5 0.613 4 785.9068 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.38 0.596 3 785.9071 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.76 0.621 4 785.9072 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.36 0.59 3.37 785.9077 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.51 0.615 4.85 785.9078 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.2 0.594 3.44 785.9081 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 3.76 0.606 2.82 785.9084 1,569.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.7 0.584 3.92 786.4057 1,570.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.35 0.596 3.55 786.4076 1,570.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GAGTGGLGLAVEGPSEAK 95.00% 4.74 0.562 4.33 786.4084 1,570.80 1,570.81 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YAPSEAGLHEMDIR 95.00% 3.3 0.487 2.34 794.8741 1,587.73 1,588.74 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YAPSEAGLHEMDIR 95.00% 1.96 0.282 3.18 794.8749 1,587.73 1,588.74 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YAPSEAGLHEMDIR 95.00% 2.61 0.342 2.38 794.875 1,587.73 1,588.74 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YAPSEAGLHEMDIR 95.00% 3.59 0.476 3.8 794.8763 1,587.74 1,588.74 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DNGNGTYScSYVPR 95.00% 3.49 0.495 3.21 c9: Carbamidomethyl (+57.02) 795.3345 1,588.65 1,589.67 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YAPSEAGLHEMDIR 95.00% 2.68 0.371 1.68 795.3758 1,588.74 1,588.74 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YAPSEAGLHEMDIR 95.00% 2.65 0.285 2.92 795.3758 1,588.74 1,588.74 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DNGNGTYScSYVPR 95.00% 3.61 0.443 2.47 c9: Carbamidomethyl (+57.02) 795.8367 1,589.66 1,589.67 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.63 0.563 3.89 801.885 1,601.75 1,602.77 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.8 0.53 2.36 801.8855 1,601.76 1,602.77 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 2.63 0.32 2.49 801.8856 1,601.76 1,602.77 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 2.9 0.493 2.92 801.8857 1,601.76 1,602.77 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 2.56 0.222 0 801.8861 1,601.76 1,602.77 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.39 0.576 3.33 801.8862 1,601.76 1,602.77 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 4.22 0.473 4.74 801.8867 1,601.76 1,602.77 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YNEQHVPGSPFTAR 95.00% 3.64 0.531 3.89 801.8872 1,601.76 1,602.77 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YAPSEAGLHEmDIR 95.00% 2.34 0.155 1.82 m11: Oxidation (+15.99) 802.8701 1,603.72 1,604.74 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.48 0.421 3.44 814.3991 2,440.17 2,440.19 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% NGQHVASSPIPVVISQSEIGDASR 95.00% 5.5 0.6 3.33 817.0878 2,448.24 2,448.25 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% NGQHVASSPIPVVISQSEIGDASR 95.00% 6.73 0.591 2.51 817.0879 2,448.24 2,448.25 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% NGQHVASSPIPVVISQSEIGDASR 95.00% 5.65 0.476 3.54 817.0884 2,448.24 2,448.25 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.24 0.506 3.43 c11: Carbamidomethyl (+57.02) 817.4335 2,449.28 2,449.29 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.9 0.552 4.29 c11: Carbamidomethyl (+57.02) 817.4335 2,449.28 2,449.29 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.7 0.562 4.62 c11: Carbamidomethyl (+57.02) 817.4338 2,449.28 2,449.29 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.94 0.421 3.8 c11: Carbamidomethyl (+57.02) 817.4338 2,449.28 2,449.29 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.84 0.574 2.82 c11: Carbamidomethyl (+57.02) 817.4344 2,449.28 2,449.29 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.2 0.51 3.92 c11: Carbamidomethyl (+57.02) 817.4346 2,449.28 2,449.29 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.95 0.468 3.02 c11: Carbamidomethyl (+57.02) 817.4348 2,449.28 2,449.29 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.4 0.57 2.96 c11: Carbamidomethyl (+57.02) 817.4355 2,449.28 2,449.29 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.28 0.492 4.19 c11: Carbamidomethyl (+57.02) 817.4357 2,449.28 2,449.29 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDINTEDLEDGTcR 95.00% 4.92 0.516 4.7 c13: Carbamidomethyl (+57.02) 818.8586 1,635.70 1,636.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VDINTEDLEDGTcR 95.00% 4.62 0.521 4.64 c13: Carbamidomethyl (+57.02) 818.8613 1,635.71 1,636.71 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.18 0.292 2.52 823.4001 2,467.18 2,467.19 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.78 0.335 3.92 823.4011 2,467.18 2,467.19 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.77 0.322 3.74 823.4013 2,467.18 2,467.19 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.75 0.348 3.49 823.4015 2,467.18 2,467.19 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.22 0.418 3.46 823.4017 2,467.18 2,467.19 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% FNEEHIPDSPFVVPVASPSGDAR 95.00% 2.92 0.22 1.62 823.404 2,467.19 2,467.19 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVAVNKPAEFTVDAK 95.00% 3.46 0.406 2.51 823.9403 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVAVNKPAEFTVDAK 95.00% 3.94 0.417 2.51 823.9405 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVAVNKPAEFTVDAK 95.00% 3.11 0.418 2.22 823.9409 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 5.07 0.562 5.28 826.933 1,651.85 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 5.19 0.589 4 826.9336 1,651.85 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 4.93 0.604 4.92 826.9337 1,651.85 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 4.64 0.616 5.41 826.9338 1,651.85 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 5.1 0.571 4.6 826.9339 1,651.85 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 4.68 0.608 5.51 826.9343 1,651.85 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 4.88 0.586 4.66 826.9344 1,651.85 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 4.68 0.582 3.54 826.9344 1,651.85 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 5.07 0.598 5.12 826.9348 1,651.85 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 5.16 0.596 4.85 826.9348 1,651.85 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 4.28 0.493 4.6 826.9367 1,651.86 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 4.59 0.507 4.72 826.9369 1,651.86 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 5.06 0.59 4.07 827.4346 1,652.85 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTAQGPGLEPSGNIANK 95.00% 4.71 0.56 3.37 827.435 1,652.85 1,652.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VKMDcQEcPEGYR 95.00% 3.85 0.526 4.89 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 836.3475 1,670.68 1,671.69 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VKMDcQEcPEGYR 95.00% 3.94 0.472 5.96 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 836.3505 1,670.69 1,671.69 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 5.54 0.558 4.7 849.0898 2,544.25 2,544.26 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.72 0.509 4.38 849.09 2,544.25 2,544.26 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 4.34 0.59 1.85 849.0912 2,544.25 2,544.26 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVELGKPTHFTVNAK 95.00% 3.97 0.508 3.47 849.9605 1,697.91 1,698.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVELGKPTHFTVNAK 95.00% 3.97 0.514 2.85 849.9613 1,697.91 1,698.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVELGKPTHFTVNAK 95.00% 3.79 0.525 2.44 849.9634 1,697.91 1,698.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TGVELGKPTHFTVNAK 95.00% 3.99 0.533 4.31 850.4636 1,698.91 1,698.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% KTHIQDNHDGTYTVAYVPDVTGR 95.00% 3.66 0.361 1.06 863.412 2,587.21 2,587.25 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYTPMAPGSYLISIK 95.00% 4.02 0.605 3.49 870.9635 1,739.91 1,740.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYTPMAPGSYLISIK 95.00% 3.44 0.455 2.8 870.9639 1,739.91 1,740.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYTPMAPGSYLISIK 95.00% 3.88 0.509 3.74 870.9649 1,739.91 1,740.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYTPMAPGSYLISIK 95.00% 3.62 0.474 2.21 870.9657 1,739.92 1,740.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYTPMAPGSYLISIK 95.00% 3.91 0.453 3.44 871.4659 1,740.92 1,740.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TFSVWYVPEVTGTHK 95.00% 3.7 0.574 0 875.9422 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% TFSVWYVPEVTGTHK 95.00% 3.75 0.509 1.1 876.4438 1,750.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDKSQGDASK 95.00% 4.14 0.523 1.59 878.9231 1,755.83 1,756.84 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDKSQGDASK 95.00% 4.09 0.52 1.66 878.924 1,755.83 1,756.84 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPFEVYVDKSQGDASK 95.00% 5.15 0.513 5.38 879.4231 1,756.83 1,756.84 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYTPmAPGSYLISIK 95.00% 3.9 0.407 2.89 m6: Oxidation (+15.99) 879.4641 1,756.91 1,756.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 5.04 0.633 6.89 882.4291 1,762.84 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 4.84 0.557 6.85 882.4293 1,762.84 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 3.86 0.631 6.34 882.4294 1,762.84 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 5.1 0.646 6.28 882.4303 1,762.85 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 5.12 0.64 6.72 882.4307 1,762.85 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 5 0.632 8 882.4308 1,762.85 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 5.02 0.652 6.57 882.4308 1,762.85 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 3.23 0.474 3.74 882.4314 1,762.85 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 5.07 0.609 6.74 882.4315 1,762.85 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 5.17 0.623 6.34 882.4316 1,762.85 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 5.03 0.629 8.14 882.4317 1,762.85 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 5.18 0.58 6.49 882.9302 1,763.84 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 5.08 0.587 6.36 882.9325 1,763.85 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VANPSGNLTETYVQDR 95.00% 4.87 0.618 5.3 882.9332 1,763.85 1,763.86 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 5.57 0.589 4.13 c9: Carbamidomethyl (+57.02) 892.9424 1,783.87 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 5.33 0.566 3.57 c9: Carbamidomethyl (+57.02) 892.9436 1,783.87 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 4.61 0.586 3.08 c9: Carbamidomethyl (+57.02) 892.9446 1,783.87 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 5.38 0.577 4.49 c9: Carbamidomethyl (+57.02) 892.9448 1,783.87 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 5.43 0.582 3.74 c9: Carbamidomethyl (+57.02) 892.9453 1,783.88 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 5.72 0.587 3.13 c9: Carbamidomethyl (+57.02) 892.9455 1,783.88 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 5 0.566 4.22 c9: Carbamidomethyl (+57.02) 892.9477 1,783.88 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 4.98 0.575 3.27 c9: Carbamidomethyl (+57.02) 892.9478 1,783.88 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 4.08 0.589 4.24 c9: Carbamidomethyl (+57.02) 892.9481 1,783.88 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 5.1 0.581 2.77 c9: Carbamidomethyl (+57.02) 892.9491 1,783.88 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DVDIIDHHDNTYTVK 95.00% 4.74 0.558 2.7 893.4256 1,784.84 1,784.85 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DVDIIDHHDNTYTVK 95.00% 4.07 0.534 2.64 893.4259 1,784.84 1,784.85 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 5.34 0.56 3.1 c9: Carbamidomethyl (+57.02) 893.4464 1,784.88 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 4.98 0.556 3.54 c9: Carbamidomethyl (+57.02) 893.4468 1,784.88 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VQVQDNEGcPVEALVK 95.00% 5.5 0.55 3.85 c9: Carbamidomethyl (+57.02) 893.4477 1,784.88 1,784.89 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ATcAPQHGAPGPGPADASK 95.00% 3.94 0.496 2.35 c3: Carbamidomethyl (+57.02) 895.9243 1,789.83 1,789.83 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VAQPTITDNKDGTVTVR 95.00% 4.53 0.426 4.68 907.9829 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VAQPTITDNKDGTVTVR 95.00% 4.1 0.488 5.82 907.9834 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VAQPTITDNKDGTVTVR 95.00% 4.45 0.452 5.21 907.9834 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VAQPTITDNKDGTVTVR 95.00% 4.7 0.437 4.08 908.4836 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VAQPTITDNKDGTVTVR 95.00% 4.47 0.4 3.82 908.484 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.93 0.499 4.14 c11: Carbamidomethyl (+57.02) 923.1049 2,766.29 2,766.30 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 5.06 0.568 5.04 c11: Carbamidomethyl (+57.02) 923.106 2,766.29 2,766.30 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 0 0 4.18 c11: Carbamidomethyl (+57.02) 923.4398 2,767.30 2,766.30 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 0 0 3.68 c11: Carbamidomethyl (+57.02) 923.4414 2,767.30 2,766.30 3
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPYTVTVGQAcNPSAcR 95.00% 4.66 0.469 4.4 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.423 1,866.83 1,867.84 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPYTVTVGQAcNPSAcR 95.00% 4.84 0.513 6.41 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4231 1,866.83 1,867.84 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPYTVTVGQAcNPSAcR 95.00% 5.24 0.52 5.4 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.424 1,866.83 1,867.84 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPYTVTVGQAcNPSAcR 95.00% 4.95 0.5 4.22 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4242 1,866.83 1,867.84 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SPYTVTVGQAcNPSAcR 95.00% 5.18 0.552 6.8 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4249 1,866.83 1,867.84 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYcPTEPGNYIINIK 95.00% 4.26 0.559 4.13 c4: Carbamidomethyl (+57.02) 941.4727 1,880.93 1,881.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYcPTEPGNYIINIK 95.00% 4.46 0.55 4.03 c4: Carbamidomethyl (+57.02) 941.4736 1,880.93 1,881.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYcPTEPGNYIINIK 95.00% 4.52 0.568 4.2 c4: Carbamidomethyl (+57.02) 941.9738 1,881.93 1,881.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYcPTEPGNYIINIK 95.00% 4.48 0.534 3.77 c4: Carbamidomethyl (+57.02) 941.9741 1,881.93 1,881.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYcPTEPGNYIINIK 95.00% 4.14 0.457 3.92 c4: Carbamidomethyl (+57.02) 941.9742 1,881.93 1,881.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYcPTEPGNYIINIK 95.00% 4.56 0.551 3.68 c4: Carbamidomethyl (+57.02) 941.9744 1,881.93 1,881.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYcPTEPGNYIINIK 95.00% 4.59 0.476 3.66 c4: Carbamidomethyl (+57.02) 941.9747 1,881.93 1,881.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYcPTEPGNYIINIK 95.00% 4.3 0.491 3.96 c4: Carbamidomethyl (+57.02) 941.9747 1,881.93 1,881.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYcPTEPGNYIINIK 95.00% 4.23 0.481 3.24 c4: Carbamidomethyl (+57.02) 941.9749 1,881.93 1,881.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VTYcPTEPGNYIINIK 95.00% 4.36 0.444 4 c4: Carbamidomethyl (+57.02) 941.9778 1,881.94 1,881.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EGPYSISVLYGDEEVPR 95.00% 5.07 0.563 6.3 955.4612 1,908.91 1,909.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EGPYSISVLYGDEEVPR 95.00% 5.13 0.583 5.96 955.4613 1,908.91 1,909.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EGPYSISVLYGDEEVPR 95.00% 4.45 0.595 5.77 955.4615 1,908.91 1,909.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EGPYSISVLYGDEEVPR 95.00% 4.81 0.579 6.06 955.4633 1,908.91 1,909.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% EGPYSISVLYGDEEVPR 95.00% 5.19 0.546 6.64 955.9624 1,909.91 1,909.92 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGLLAVQITDPEGKPK 95.00% 5.29 0.385 6 969.511 1,937.01 1,938.02 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGLLAVQITDPEGKPK 95.00% 4.75 0.445 8.74 969.5132 1,937.01 1,938.02 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGLLAVQITDPEGKPK 95.00% 5.01 0.345 5.08 969.5135 1,937.01 1,938.02 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGLLAVQITDPEGKPK 95.00% 3.94 0.179 7.15 969.5144 1,937.01 1,938.02 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGLLAVQITDPEGKPK 95.00% 4.86 0.407 5.52 970.0127 1,938.01 1,938.02 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DAGEGLLAVQITDPEGKPK 95.00% 5.26 0.359 5.55 970.0135 1,938.01 1,938.02 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IPEISIQDMTAQVTSPSGK 95.00% 5.96 0.727 8.33 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% IPEISIQDMTAQVTSPSGK 95.00% 6.35 0.717 6.6 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% cAPGVVGPAEADIDFDIIR 95.00% 5.5 0.577 4.68 c1: Carbamidomethyl (+57.02) 1,008.50 2,014.98 2,014.99 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 6.48 0.66 9.82 c15: Carbamidomethyl (+57.02) 1,029.47 2,056.93 2,057.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 6.53 0.642 8.7 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.92 2,057.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 6.58 0.636 9.4 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.92 2,057.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% THEAEIVEGENHTYcIR 95.00% 6.4 0.65 8.82 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LVSNHSLHETSSVFVDSLTK 95.00% 6.01 0.647 4.77 1,101.07 2,200.11 2,200.13 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LVSNHSLHETSSVFVDSLTK 95.00% 0 0 3.47 1,101.56 2,201.10 2,200.13 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% LVSNHSLHETSSVFVDSLTK 95.00% 0 0 5.08 1,101.56 2,201.10 2,200.13 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DGScGVAYVVQEPGDYEVSVK 95.00% 4.91 0.63 3.96 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.01 2,258.03 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DGScGVAYVVQEPGDYEVSVK 95.00% 5.64 0.639 5.96 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DGScGVAYVVQEPGDYEVSVK 95.00% 5.34 0.595 4.89 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DGScGVAYVVQEPGDYEVSVK 95.00% 5.29 0.631 5.92 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% DGScGVAYVVQEPGDYEVSVK 95.00% 5.39 0.615 4.47 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% VHSPSGALEEcYVTEIDQDK 95.00% 2.38 0.343 0 c11: Carbamidomethyl (+57.02) 1,139.47 2,276.92 2,277.03 2 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.23 0.68 5.64 1,143.60 2,285.18 2,286.18 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.56 0.671 8.85 1,144.09 2,286.16 2,286.18 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.48 0.686 6.59 1,144.09 2,286.17 2,286.18 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.35 0.635 4.03 1,144.09 2,286.17 2,286.18 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.48 0.658 5.32 1,144.09 2,286.17 2,286.18 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.73 0.663 5.25 1,144.10 2,286.17 2,286.18 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SAGQGEVLVYVEDPAGHQEEAK 95.00% 4.51 0.687 5.57 1,157.05 2,312.08 2,313.10 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SAGQGEVLVYVEDPAGHQEEAK 95.00% 4.98 0.599 7.11 1,157.55 2,313.09 2,313.10 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% SAGQGEVLVYVEDPAGHQEEAK 95.00% 4.88 0.594 5.66 1,157.55 2,313.09 2,313.10 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.12 0.546 7.26 1,172.12 2,342.22 2,342.22 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.47 0.539 7 1,172.12 2,342.22 2,342.22 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.13 0.701 6.09 1,273.13 2,544.25 2,544.26 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.48 0.739 7.32 1,273.13 2,544.25 2,544.26 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.26 0.723 7.19 1,273.13 2,544.25 2,544.26 2
 SAMPLE 3 Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 85 105 598 43.90% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.47 0.73 7.32 1,273.13 2,544.25 2,544.26 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQKK 95.00% 2.5 0.16 2.57 452.2939 1,353.86 1,354.87 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQKK 95.00% 2.43 0.17 0 452.2942 1,353.86 1,354.87 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQKK 95.00% 1.67 0.4 1.74 452.2945 1,353.86 1,354.87 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQKK 95.00% 2.5 0.237 1.64 452.2951 1,353.86 1,354.87 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQKK 95.00% 2.44 0.158 0 452.2979 1,353.87 1,354.87 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 2.33 0.33 0 455.5735 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 2.02 0.417 1.17 455.5738 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 2.35 0.362 1.24 455.5742 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 2.25 0.423 0 455.5744 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 2.55 0.441 0 455.5744 1,363.70 1,364.71 3 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3.09 0.48 2.54 460.5633 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3.61 0.561 2.47 460.5634 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 2.78 0.332 1.62 460.5635 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3.73 0.549 0 460.5635 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3.05 0.493 1.62 460.5636 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3.09 0.544 1.3 460.5638 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3.67 0.529 1.82 460.5638 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 2.92 0.515 1.49 460.5652 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3 0.41 0 460.5652 1,378.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 2.59 0.434 1.15 460.8974 1,379.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3.33 0.45 1.8 460.8978 1,379.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 2.41 0.275 1.25 460.8984 1,379.67 1,379.68 3 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% WGDEHIPGSPYR 95.00% 2.36 0.274 1.66 471.8892 1,412.64 1,413.66 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% WGDEHIPGSPYR 95.00% 2.42 0.233 1.24 471.8897 1,412.65 1,413.66 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LRNGHVGISFVPK 95.00% 2.42 0.272 1.59 475.6041 1,423.79 1,423.82 3 LAMB2_HUMAN,MYPT2_HUMAN,ANXA2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGNNMLLVGVHGPR 95.00% 2.48 0.164 0 478.9246 1,433.75 1,434.76 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGNNMLLVGVHGPR 95.00% 3.61 0.457 1.19 478.9252 1,433.75 1,434.76 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGNNMLLVGVHGPR 95.00% 3.3 0.443 0 478.9253 1,433.75 1,434.76 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGNNMLLVGVHGPR 95.00% 3.07 0.449 0 478.9253 1,433.75 1,434.76 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGNNMLLVGVHGPR 95.00% 4.19 0.507 1.47 478.9255 1,433.75 1,434.76 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGNNMLLVGVHGPR 95.00% 4.03 0.478 0 478.9261 1,433.75 1,434.76 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGNNMLLVGVHGPR 95.00% 3.35 0.407 1.42 478.9261 1,433.76 1,434.76 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGNNMLLVGVHGPR 95.00% 4.01 0.471 1.19 478.9262 1,433.76 1,434.76 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGNNMLLVGVHGPR 95.00% 3.17 0.475 0 478.9266 1,433.76 1,434.76 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGNNMLLVGVHGPR 95.00% 3.26 0.399 0 479.2606 1,434.76 1,434.76 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AEISFEDR 95.00% 2.67 0.357 0 483.7296 965.4436 966.4533 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AEISFEDR 95.00% 2.45 0.325 0 483.7299 965.4442 966.4533 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGNNmLLVGVHGPR 95.00% 2.85 0.397 0 m5: Oxidation (+15.99) 484.257 1,449.75 1,450.76 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGNNmLLVGVHGPR 95.00% 3.26 0.53 0 m5: Oxidation (+15.99) 484.2577 1,449.75 1,450.76 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LLGWIQNK 95.00% 2.51 0.132 0 486.2852 970.5547 971.568 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LLGWIQNK 95.00% 2.77 0.107 0 486.2853 970.555 971.568 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LLGWIQNK 95.00% 2.83 0.161 0 486.2862 970.5567 971.568 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LLGWIQNK 95.00% 2.7 0.148 0 486.2864 970.5571 971.568 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LLGWIQNK 95.00% 2.41 0.18 0 486.2864 970.5572 971.568 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LLGWIQNK 95.00% 2.57 0.152 0 486.2867 970.5577 971.568 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LLGWIQNK 95.00% 2.82 0.135 0 486.287 970.5583 971.568 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LLGWIQNK 95.00% 2.66 0.133 0 486.2871 970.5585 971.568 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LLGWIQNK 95.00% 3.05 0.172 0 486.2871 970.5585 971.568 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LLGWIQNK 95.00% 2.77 0.123 0 486.2872 970.5587 971.568 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% KGEITGEVR 95.00% 2.26 0.361 0 494.7745 987.5334 988.5429 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% KGEITGEVR 95.00% 2.26 0.228 1.08 494.7747 987.5338 988.5429 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% KGEITGEVR 95.00% 2.08 0.266 1.54 494.7762 987.5367 988.5429 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% KGEITGEVR 95.00% 2.03 0.262 0 494.7764 987.5372 988.5429 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 3.61 0.49 3.01 505.9229 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 2.82 0.402 3.15 505.9237 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 3.28 0.371 2.54 505.9238 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 2.93 0.333 2.36 505.9244 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 3.15 0.302 2.18 505.9245 1,514.75 1,515.76 3 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 2.48 0.386 1.19 506.2604 1,515.76 1,515.76 3 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFSVAVSPSLDLSK 95.00% 2.64 0.232 0 511.9423 1,532.80 1,533.82 3 RL4_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LSPFMADIR 95.00% 2.2 0.18 1.12 525.2747 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LSPFMADIR 95.00% 2.27 0.232 1.8 525.2751 1,048.53 1,049.55 2 LTB1S_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LSPFMADIR 95.00% 2.49 0.346 0 525.2756 1,048.54 1,049.55 2 LTB1S_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 4.24 0.463 3.8 534.9254 1,601.75 1,602.77 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.57 0.389 2.68 534.926 1,601.75 1,602.77 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.99 0.415 3.96 534.9261 1,601.75 1,602.77 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.71 0.461 2.1 534.9261 1,601.75 1,602.77 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 2.94 0.287 2.66 534.9261 1,601.76 1,602.77 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.94 0.431 3.3 534.9262 1,601.76 1,602.77 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.88 0.441 2.49 534.9263 1,601.76 1,602.77 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.59 0.461 1.77 534.9266 1,601.76 1,602.77 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.98 0.429 2.41 535.2609 1,602.76 1,602.77 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFEVYVDK 95.00% 2.91 0.44 0 542.2685 1,082.52 1,083.54 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFEVYVDK 95.00% 2.37 0.365 0 542.2694 1,082.52 1,083.54 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFEVYVDK 95.00% 3.21 0.413 0 542.2705 1,082.53 1,083.54 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFEVYVDK 95.00% 2.55 0.442 0 542.2708 1,082.53 1,083.54 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFEVYVDK 95.00% 2.47 0.415 1.66 542.2718 1,082.53 1,083.54 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFEVYVDK 95.00% 3.18 0.467 0 542.2719 1,082.53 1,083.54 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFEVYVDK 95.00% 2.71 0.46 1.48 542.7719 1,083.53 1,083.54 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LYSVSYLLK 95.00% 2.1 0.259 0 543.3145 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LYSVSYLLK 95.00% 2.3 0.276 0 543.3147 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LYSVSYLLK 95.00% 2.23 0.269 0 543.3147 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LYSVSYLLK 95.00% 2.2 0.231 0 543.3148 1,084.61 1,085.62 2 PDLI5_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LYSVSYLLK 95.00% 2.31 0.268 0 543.3154 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LYSVSYLLK 95.00% 2.57 0.353 0 543.3156 1,084.62 1,085.62 2 PDLI5_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TPcEEILVK 95.00% 2.66 0.299 0 c3: Carbamidomethyl (+57.02) 544.7854 1,087.56 1,088.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TPcEEILVK 95.00% 2.87 0.268 0 c3: Carbamidomethyl (+57.02) 544.786 1,087.56 1,088.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TPcEEILVK 95.00% 2.88 0.316 0 c3: Carbamidomethyl (+57.02) 544.7861 1,087.56 1,088.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TPcEEILVK 95.00% 2.57 0.287 0 c3: Carbamidomethyl (+57.02) 544.7862 1,087.56 1,088.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TPcEEILVK 95.00% 3 0.309 0 c3: Carbamidomethyl (+57.02) 544.7866 1,087.56 1,088.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 3.06 0.347 0 549.6284 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 3.16 0.468 1.52 549.6284 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 3.8 0.575 1.74 549.6289 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 2.84 0.391 0 549.629 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 3.04 0.412 0 549.6291 1,645.86 1,646.88 3 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 2.82 0.26 0.959 549.6298 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 2.94 0.542 0 549.6299 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 3.27 0.545 1.13 549.6305 1,645.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 3.2 0.516 1.03 549.9639 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 3.38 0.491 2.2 549.9647 1,646.87 1,646.88 3 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% APSVANVGSHcDLSLK 95.00% 2.32 0.388 1.59 c11: Carbamidomethyl (+57.02) 552.2784 1,653.81 1,654.82 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% APSVANVGSHcDLSLK 95.00% 1.92 0.295 1.68 c11: Carbamidomethyl (+57.02) 552.2786 1,653.81 1,654.82 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% APSVANVGSHcDLSLK 95.00% 1.86 0.284 0 c11: Carbamidomethyl (+57.02) 552.6121 1,654.81 1,654.82 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% APSVANVGSHcDLSLK 95.00% 2.34 0.456 0 c11: Carbamidomethyl (+57.02) 552.6126 1,654.81 1,654.82 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LDVQFSGLTK 95.00% 2.19 0.265 0 554.3036 1,106.59 1,107.61 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LDVQFSGLTK 95.00% 2.27 0.209 1.57 554.6531 1,107.29 1,107.61 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ALTQTGGPHVK 95.00% 2.62 0.305 2.31 554.8088 1,107.60 1,108.61 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ALTQTGGPHVK 95.00% 2.63 0.321 1.49 554.8101 1,107.60 1,108.61 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VKMDcQEcPEGYR 95.00% 2.74 0.271 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9011 1,670.68 1,671.69 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VKMDcQEcPEGYR 95.00% 3.05 0.414 1.16 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9017 1,670.68 1,671.69 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VKMDcQEcPEGYR 95.00% 3.53 0.484 1.1 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9021 1,670.68 1,671.69 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VKMDcQEcPEGYR 95.00% 2.77 0.283 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 557.9024 1,670.68 1,671.69 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VKMDcQEcPEGYR 95.00% 2.74 0.314 1.66 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 558.2356 1,671.68 1,671.69 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VKMDcQEcPEGYR 95.00% 3.61 0.379 1.89 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 558.236 1,671.68 1,671.69 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VKMDcQEcPEGYR 95.00% 3.42 0.298 1.36 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 558.2365 1,671.69 1,671.69 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VKmDcQEcPEGYR 95.00% 2.64 0.218 0 m3: Oxidation (+15.99), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 562.9066 1,685.70 1,687.69 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VKmDcQEcPEGYR 95.00% 3.31 0.366 0 m3: Oxidation (+15.99), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 563.2361 1,686.68 1,687.69 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VKmDcQEcPEGYR 95.00% 2.95 0.249 0 m3: Oxidation (+15.99), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 563.5693 1,687.68 1,687.69 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVELGKPTHFTVNAK 95.00% 2.23 0.288 0 566.7662 1,697.28 1,698.92 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVELGKPTHFTVNAK 95.00% 2.98 0.349 0 566.9767 1,697.91 1,698.92 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVELGKPTHFTVNAK 95.00% 3.82 0.31 0 566.977 1,697.91 1,698.92 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVELGKPTHFTVNAK 95.00% 2.82 0.295 0 567.3115 1,698.91 1,698.92 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ETGEHLVHVK 95.00% 2.4 0.218 0 574.8072 1,147.60 1,148.61 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ENGVYLIDVK 95.00% 2.24 0.36 1.15 575.3081 1,148.60 1,149.62 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ENGVYLIDVK 95.00% 2.45 0.288 0 575.3096 1,148.60 1,149.62 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ENGVYLIDVK 95.00% 2.41 0.273 1.1 575.31 1,148.60 1,149.62 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ENGVYLIDVK 95.00% 2.6 0.318 0 575.3101 1,148.60 1,149.62 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ENGVYLIDVK 95.00% 2.72 0.393 1.26 575.3102 1,148.60 1,149.62 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ENGVYLIDVK 95.00% 2.73 0.38 1.51 575.3104 1,148.61 1,149.62 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ENGVYLIDVK 95.00% 2.72 0.374 1.17 575.3106 1,148.61 1,149.62 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ENGVYLIDVK 95.00% 2.82 0.446 2.26 575.3107 1,148.61 1,149.62 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ENGVYLIDVK 95.00% 2.66 0.411 1.44 575.3113 1,148.61 1,149.62 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ENGVYLIDVK 95.00% 2.54 0.327 0 575.8132 1,149.61 1,149.62 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DKGEYTLVVK 95.00% 2.43 0.342 0 576.3169 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DKGEYTLVVK 95.00% 2.8 0.342 0 576.3177 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DKGEYTLVVK 95.00% 2.78 0.261 0 576.3185 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DKGEYTLVVK 95.00% 2.47 0.263 0 576.3187 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DKGEYTLVVK 95.00% 2.08 0.316 0 576.3195 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DKGEYTLVVK 95.00% 2.32 0.274 0 576.3195 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DKGEYTLVVK 95.00% 2.46 0.258 0 576.32 1,150.62 1,151.63 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% NGHVGISFVPK 95.00% 2.57 0.368 0 577.8188 1,153.62 1,154.63 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% NGHVGISFVPK 95.00% 2.01 0.201 1.41 577.8188 1,153.62 1,154.63 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcK 95.00% 1.88 0.196 2.03 c11: Carbamidomethyl (+57.02) 578.3109 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcK 95.00% 2.47 0.453 3.11 c11: Carbamidomethyl (+57.02) 578.3114 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcK 95.00% 2.93 0.412 2.96 c11: Carbamidomethyl (+57.02) 578.3119 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcK 95.00% 2.4 0.363 2 c11: Carbamidomethyl (+57.02) 578.3122 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcK 95.00% 2.32 0.396 2.72 c11: Carbamidomethyl (+57.02) 578.3122 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcK 95.00% 2.43 0.379 2.8 c11: Carbamidomethyl (+57.02) 578.3125 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcK 95.00% 2.28 0.342 1.92 c11: Carbamidomethyl (+57.02) 578.3126 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcK 95.00% 2.08 0.332 2.49 c11: Carbamidomethyl (+57.02) 578.3126 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcK 95.00% 2.31 0.346 2.59 c11: Carbamidomethyl (+57.02) 578.3127 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcK 95.00% 1.91 0.262 1.09 c11: Carbamidomethyl (+57.02) 578.3132 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcK 95.00% 1.98 0.315 1.39 c11: Carbamidomethyl (+57.02) 578.3133 1,154.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcK 95.00% 2.11 0.222 1.7 c11: Carbamidomethyl (+57.02) 578.8147 1,155.61 1,155.62 2 SYNP2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 3.29 0.481 0 584.2977 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 3.27 0.516 2.55 584.2979 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 3.31 0.532 1.14 584.2979 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 3.35 0.571 1.74 584.298 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 2.98 0.463 1.92 584.298 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 2.8 0.348 0 584.2982 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 3.16 0.436 1.1 584.2991 1,749.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VPVHDVTDASK 95.00% 2.3 0.344 0 584.3011 1,166.59 1,167.60 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VPVHDVTDASK 95.00% 2.74 0.384 1.17 584.3089 1,166.60 1,167.60 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 2.49 0.384 0 584.6281 1,750.86 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 3.33 0.551 1.3 584.6315 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 2.66 0.449 0 584.6316 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 3.21 0.557 0 584.6317 1,750.87 1,750.88 3 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFEVYVDKSQGDASK 95.00% 2.42 0.27 0 586.2836 1,755.83 1,756.84 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFEVYVDKSQGDASK 95.00% 3.8 0.518 2.68 586.2843 1,755.83 1,756.84 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFEVYVDKSQGDASK 95.00% 3.52 0.526 3.51 586.2844 1,755.83 1,756.84 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DVDIIDHHDNTYTVK 95.00% 2.47 0.24 0 595.6193 1,783.83 1,784.85 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DVDIIDHHDNTYTVK 95.00% 2.4 0.232 0 595.9557 1,784.84 1,784.85 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VQVQDNEGcPVEALVK 95.00% 2.59 0.275 0 c9: Carbamidomethyl (+57.02) 595.9695 1,784.89 1,784.89 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ATcAPQHGAPGPGPADASK 95.00% 2.49 0.248 1.35 c3: Carbamidomethyl (+57.02) 597.2819 1,788.82 1,789.83 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ATcAPQHGAPGPGPADASK 95.00% 3.53 0.469 2.18 c3: Carbamidomethyl (+57.02) 597.2828 1,788.83 1,789.83 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ATcAPQHGAPGPGPADASK 95.00% 2.65 0.354 2.72 c3: Carbamidomethyl (+57.02) 597.2836 1,788.83 1,789.83 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% RAPSVANVGSHcDLSLK 95.00% 4.81 0.519 3.96 c12: Carbamidomethyl (+57.02) 604.3105 1,809.91 1,810.92 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 1.67 0.189 1.39 605.6572 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 2.24 0.249 1.3 605.6576 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 1.81 0.18 1.03 605.6584 1,813.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 2.01 0.285 2.25 605.9911 1,814.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 2.15 0.33 0 605.9913 1,814.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 2.22 0.361 1.68 605.9917 1,814.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 2.1 0.438 0 605.9921 1,814.95 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 2.14 0.507 0 605.9929 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 1.65 0.294 1.85 605.993 1,814.96 1,814.96 3 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% cSGPGLSPGMVR 95.00% 2.09 0.304 0 c1: Carbamidomethyl (+57.02) 609.2904 1,216.57 1,217.58 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% cSGPGLSPGMVR 95.00% 2.37 0.376 1.34 c1: Carbamidomethyl (+57.02) 609.7909 1,217.57 1,217.58 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EATTEFSVDAR 95.00% 3.48 0.427 2.08 613.2862 1,224.56 1,225.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EATTEFSVDAR 95.00% 3.45 0.482 2.24 613.2863 1,224.56 1,225.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EATTEFSVDAR 95.00% 3.34 0.429 2.89 613.287 1,224.56 1,225.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EATTEFSVDAR 95.00% 3.2 0.413 2.48 613.2881 1,224.56 1,225.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EATTEFSVDAR 95.00% 3.01 0.424 1.68 613.2882 1,224.56 1,225.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EATTEFSVDAR 95.00% 3.51 0.518 1.62 613.2882 1,224.56 1,225.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EATTEFSVDAR 95.00% 3.55 0.409 1.85 613.2884 1,224.56 1,225.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EATTEFSVDAR 95.00% 3.2 0.463 2.15 613.2885 1,224.56 1,225.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EATTEFSVDAR 95.00% 3.42 0.459 2.32 613.2888 1,224.56 1,225.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EATTEFSVDAR 95.00% 2.67 0.37 1.19 613.2896 1,224.56 1,225.57 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AWGPGLEGGVVGK 95.00% 2.49 0.387 2.59 613.8281 1,225.64 1,226.65 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AWGPGLEGGVVGK 95.00% 2.91 0.499 3.55 613.8297 1,225.64 1,226.65 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AWGPGLEGGVVGK 95.00% 2.91 0.538 3.15 613.83 1,225.64 1,226.65 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AWGPGLEGGVVGK 95.00% 2.46 0.406 3.06 613.8302 1,225.64 1,226.65 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AWGPGLEGGVVGK 95.00% 2.74 0.535 4.2 613.8304 1,225.65 1,226.65 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AWGPGLEGGVVGK 95.00% 2.8 0.43 3.08 613.8311 1,225.65 1,226.65 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQK 95.00% 3.6 0.501 2.15 613.8886 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQK 95.00% 2.89 0.505 2.49 613.8886 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQK 95.00% 3.12 0.544 2.92 613.8886 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQK 95.00% 3.29 0.473 2.09 613.8888 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQK 95.00% 3.65 0.508 2.16 613.8888 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQK 95.00% 3.81 0.547 2.29 613.8889 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQK 95.00% 4.09 0.524 1.89 613.889 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQK 95.00% 3.62 0.528 1.96 613.8891 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQK 95.00% 3.39 0.524 2.13 613.8894 1,225.76 1,226.77 2 FLNC_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AHVVPcFDASK 95.00% 1.77 0.354 0 c6: Carbamidomethyl (+57.02) 615.7974 1,229.58 1,230.59 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AHVVPcFDASK 95.00% 2.42 0.366 2.17 c6: Carbamidomethyl (+57.02) 615.7997 1,229.58 1,230.59 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AHVVPcFDASK 95.00% 2.52 0.435 4.24 c6: Carbamidomethyl (+57.02) 615.8003 1,229.59 1,230.59 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AHVVPcFDASK 95.00% 2.13 0.315 1.35 c6: Carbamidomethyl (+57.02) 615.8004 1,229.59 1,230.59 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AHVVPcFDASK 95.00% 2.19 0.341 0 c6: Carbamidomethyl (+57.02) 615.8015 1,229.59 1,230.59 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AHVVPcFDASK 95.00% 2.1 0.328 0 c6: Carbamidomethyl (+57.02) 616.2984 1,230.58 1,230.59 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LTVSSLQESGLK 95.00% 2.78 0.388 0 631.8555 1,261.70 1,261.70 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EGPYSISVLYGDEEVPR 95.00% 2.4 0.35 0 637.646 1,909.91 1,909.92 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTVLFAGQHIAK 95.00% 3.48 0.517 3.07 642.3765 1,282.74 1,283.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTVLFAGQHIAK 95.00% 3.41 0.507 3 642.3766 1,282.74 1,283.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LPQLPITNFSR 95.00% 2.73 0.381 2.41 643.3653 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LPQLPITNFSR 95.00% 3.11 0.366 2.77 643.3657 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LPQLPITNFSR 95.00% 2.84 0.354 1.92 643.3658 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LPQLPITNFSR 95.00% 2.53 0.275 0 643.3659 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LPQLPITNFSR 95.00% 3.18 0.414 1.85 643.366 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LPQLPITNFSR 95.00% 3.09 0.371 3.11 643.3663 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LPQLPITNFSR 95.00% 2.93 0.331 1.92 643.3664 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LPQLPITNFSR 95.00% 3.25 0.427 3.18 643.3665 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LPQLPITNFSR 95.00% 3.12 0.305 3.06 643.3667 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LPQLPITNFSR 95.00% 3 0.349 2.82 643.3669 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LPQLPITNFSR 95.00% 2.91 0.37 2.18 643.3672 1,284.72 1,285.73 2 FIL1L_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGQPVPNFPSK 95.00% 2.55 0.365 0 645.8229 1,289.63 1,290.65 2 CO5A2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGQPVPNFPSK 95.00% 2.87 0.457 2.1 645.8253 1,289.63 1,290.65 2 CO5A2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGQPVPNFPSK 95.00% 2.83 0.451 1.15 645.8253 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGQPVPNFPSK 95.00% 3.24 0.473 2 645.8256 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGQPVPNFPSK 95.00% 3.45 0.391 1.44 645.8262 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGQPVPNFPSK 95.00% 3.43 0.347 2.2 645.8271 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGQPVPNFPSK 95.00% 2.52 0.283 0 645.8275 1,289.64 1,290.65 2 CO5A2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GKLDVQFSGLTK 95.00% 2.61 0.388 2.2 646.8628 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GKLDVQFSGLTK 95.00% 2.94 0.406 3.01 646.8631 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GKLDVQFSGLTK 95.00% 2.81 0.414 1.72 646.8636 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GKLDVQFSGLTK 95.00% 2.72 0.42 2.06 646.864 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GKLDVQFSGLTK 95.00% 2.83 0.483 3.14 646.8651 1,291.71 1,292.72 2 KTN1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GKLDVQFSGLTK 95.00% 2.38 0.375 1.6 646.8657 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GKLDVQFSGLTK 95.00% 2.48 0.29 2.48 646.8672 1,291.72 1,292.72 2 KTN1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNGTHIPGSPFK 95.00% 2.86 0.278 2.31 651.3342 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNGTHIPGSPFK 95.00% 2.96 0.334 1.59 651.3349 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNGTHIPGSPFK 95.00% 3.23 0.352 2.39 651.3351 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNGTHIPGSPFK 95.00% 2.65 0.31 2.21 651.3352 1,300.65 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNGTHIPGSPFK 95.00% 2.7 0.387 1.89 651.3355 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNGTHIPGSPFK 95.00% 2.5 0.292 1.72 651.3356 1,300.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNGTHIPGSPFK 95.00% 2.5 0.271 1.28 651.8363 1,301.66 1,301.66 2 DYHC1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VEPGLGADNSVVR 95.00% 2.45 0.434 2.36 656.8451 1,311.67 1,312.69 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VEPGLGADNSVVR 95.00% 2.42 0.434 4.36 656.8452 1,311.67 1,312.69 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VEPGLGADNSVVR 95.00% 2.33 0.329 1.62 656.8462 1,311.68 1,312.69 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VEPGLGADNSVVR 95.00% 2.87 0.496 3.24 656.8463 1,311.68 1,312.69 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VEPGLGADNSVVR 95.00% 2.29 0.338 2.04 656.8464 1,311.68 1,312.69 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VEPGLGADNSVVR 95.00% 2.54 0.466 1.39 656.8465 1,311.68 1,312.69 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VEPGLGADNSVVR 95.00% 2.69 0.486 2.72 656.8466 1,311.68 1,312.69 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VEPGLGADNSVVR 95.00% 2.04 0.342 1.57 656.8467 1,311.68 1,312.69 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VEPGLGADNSVVR 95.00% 2.38 0.408 2.14 657.3492 1,312.68 1,312.69 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IPEISIQDMTAQVTSPSGK 95.00% 3.19 0.494 0 668.0125 2,001.01 2,002.02 3 ITIH1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQKK 95.00% 2.5 0.341 1.27 677.9341 1,353.85 1,354.87 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQKK 95.00% 2.15 0.265 0 677.9358 1,353.86 1,354.87 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQKK 95.00% 3.66 0.516 1.6 677.9369 1,353.86 1,354.87 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQKK 95.00% 2.46 0.311 0 677.937 1,353.86 1,354.87 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LIALLEVLSQKK 95.00% 3.7 0.476 2.43 678.434 1,354.85 1,354.87 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 3.08 0.495 1.18 682.8549 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 3.51 0.519 1.12 682.855 1,363.69 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 3.14 0.526 1.74 682.8553 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 3.42 0.487 2.04 682.8554 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 3.41 0.469 0 682.8559 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 3.17 0.479 1.42 682.856 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 3.65 0.52 2.49 682.8571 1,363.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDVGKDQEFTVK 95.00% 3.71 0.479 2.1 683.3581 1,364.70 1,364.71 2 SRBS2_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 4.24 0.511 3.8 c15: Carbamidomethyl (+57.02) 686.6487 2,056.92 2,057.94 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 4.32 0.475 3.39 c15: Carbamidomethyl (+57.02) 686.6495 2,056.92 2,057.94 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 4.39 0.475 4.25 c15: Carbamidomethyl (+57.02) 686.6502 2,056.93 2,057.94 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 4.14 0.498 2.41 c15: Carbamidomethyl (+57.02) 686.9829 2,057.93 2,057.94 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 4.6 0.478 2.92 c15: Carbamidomethyl (+57.02) 686.9832 2,057.93 2,057.94 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 4.1 0.42 3.11 c15: Carbamidomethyl (+57.02) 686.9833 2,057.93 2,057.94 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 4.7 0.526 3.11 c15: Carbamidomethyl (+57.02) 686.9836 2,057.93 2,057.94 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 4.26 0.464 3.31 c15: Carbamidomethyl (+57.02) 686.9842 2,057.93 2,057.94 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 4.1 0.444 2.43 c15: Carbamidomethyl (+57.02) 686.9843 2,057.93 2,057.94 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 3.95 0.476 4.39 c15: Carbamidomethyl (+57.02) 686.9853 2,057.93 2,057.94 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 2.42 0.362 0 690.3378 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3.39 0.526 3.92 690.338 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3.88 0.575 3.92 690.3388 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 4.47 0.583 5.16 690.3393 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3.58 0.524 4.92 690.3396 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3.33 0.513 5.23 690.3399 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGPYHIGGSPFK 95.00% 3.64 0.462 5.15 690.34 1,378.66 1,379.68 2 CALD1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGDEIPFSPYR 95.00% 3.07 0.201 2.48 700.8253 1,399.64 1,400.65 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGDEIPFSPYR 95.00% 3.64 0.18 3.38 700.8276 1,399.64 1,400.65 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGDEIPFSPYR 95.00% 2.3 0.332 2.38 700.8284 1,399.64 1,400.65 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGDEIPFSPYR 95.00% 2.79 0.194 2.33 700.8298 1,399.64 1,400.65 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGDEIPFSPYR 95.00% 3.38 0.183 2.19 700.8306 1,399.65 1,400.65 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YGGDEIPFSPYR 95.00% 3.18 0.146 2.23 700.8344 1,399.65 1,400.65 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% WGDEHIPGSPYR 95.00% 2.66 0.394 2.92 707.3271 1,412.64 1,413.66 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% WGDEHIPGSPYR 95.00% 2.98 0.419 3.1 707.3291 1,412.64 1,413.66 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% WGDEHIPGSPYR 95.00% 3.06 0.41 2 707.3292 1,412.64 1,413.66 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% WGDEHIPGSPYR 95.00% 2.92 0.434 2.64 707.3295 1,412.64 1,413.66 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% WGDEHIPGSPYR 95.00% 2.57 0.419 0 707.3297 1,412.64 1,413.66 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% WGDEHIPGSPYR 95.00% 3.11 0.429 2.28 707.3297 1,412.64 1,413.66 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% WGDEHIPGSPYR 95.00% 3.43 0.505 2.8 707.3302 1,412.64 1,413.66 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% WGDEHIPGSPYR 95.00% 2.64 0.323 2.74 707.8311 1,413.65 1,413.66 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IANLQTDLSDGLR 95.00% 3.11 0.278 3.08 708.3754 1,414.74 1,415.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IANLQTDLSDGLR 95.00% 2.07 0.262 0 708.3772 1,414.74 1,415.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IANLQTDLSDGLR 95.00% 3.01 0.304 4.06 708.3773 1,414.74 1,415.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IANLQTDLSDGLR 95.00% 2.29 0.347 1.17 708.3775 1,414.74 1,415.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IANLQTDLSDGLR 95.00% 2.66 0.418 1.57 708.3776 1,414.74 1,415.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IANLQTDLSDGLR 95.00% 3.97 0.388 3.82 708.3776 1,414.74 1,415.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IANLQTDLSDGLR 95.00% 3.11 0.356 6.43 708.3786 1,414.74 1,415.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IANLQTDLSDGLR 95.00% 3.29 0.329 2.68 708.3791 1,414.74 1,415.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IANLQTDLSDGLR 95.00% 3.47 0.345 3.39 708.3794 1,414.74 1,415.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EAGAGGLAIAVEGPSK 95.00% 3.44 0.552 4.6 713.8789 1,425.74 1,426.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EAGAGGLAIAVEGPSK 95.00% 3.93 0.526 4.47 713.8794 1,425.74 1,426.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EAGAGGLAIAVEGPSK 95.00% 4.87 0.582 4.82 713.8797 1,425.74 1,426.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EAGAGGLAIAVEGPSK 95.00% 5.1 0.582 4.62 713.8797 1,425.74 1,426.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EAGAGGLAIAVEGPSK 95.00% 4.7 0.589 4.82 713.8797 1,425.74 1,426.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EAGAGGLAIAVEGPSK 95.00% 4.39 0.496 5.59 713.88 1,425.74 1,426.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EAGAGGLAIAVEGPSK 95.00% 4.54 0.578 4.42 713.8804 1,425.75 1,426.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EAGAGGLAIAVEGPSK 95.00% 3.14 0.426 2.05 713.8808 1,425.75 1,426.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 4.31 0.39 3.77 715.3594 1,428.70 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 4.24 0.462 3.8 715.3612 1,428.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 3.33 0.479 3.06 715.3614 1,428.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 4.48 0.524 4.05 715.3617 1,428.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 4.37 0.436 3.28 715.3617 1,428.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 3.9 0.282 2.92 715.3617 1,428.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 3.75 0.423 3.92 715.3618 1,428.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 4.49 0.435 3.64 715.3624 1,428.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 4.5 0.426 3.3 715.3626 1,428.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 4.29 0.434 4.38 715.3627 1,428.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 3.53 0.416 3.14 715.3628 1,428.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 3.9 0.413 3.68 715.3648 1,428.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAEMPATEKDLAEDAPWKK 95.00% 4.49 0.546 1.68 715.677 2,144.01 2,145.02 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 4.35 0.389 3.49 715.864 1,429.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 3.99 0.265 3.08 715.8651 1,429.71 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AFGPGLQGGSAGSPAR 95.00% 3.25 0 2.6 715.8727 1,429.73 1,429.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAEMPATEKDLAEDAPWKK 95.00% 4.35 0.394 0 716.0112 2,145.01 2,145.02 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AYGPGIEPTGNMVK 95.00% 4.04 0.38 2.09 717.3579 1,432.70 1,433.71 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AYGPGIEPTGNMVK 95.00% 3.7 0.366 2.7 717.3582 1,432.70 1,433.71 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AYGPGIEPTGNMVK 95.00% 3.75 0.273 0 717.359 1,432.70 1,433.71 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AYGPGIEPTGNMVK 95.00% 4.19 0.391 1.51 717.3598 1,432.70 1,433.71 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AYGPGIEPTGNMVK 95.00% 3.43 0.321 0 717.3598 1,432.70 1,433.71 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AYGPGIEPTGNMVK 95.00% 3.26 0.173 1.74 717.36 1,432.70 1,433.71 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AYGPGIEPTGNMVK 95.00% 3.98 0.306 0 717.3601 1,432.70 1,433.71 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AYGPGIEPTGNMVK 95.00% 3.57 0.306 1.24 717.8605 1,433.71 1,433.71 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ANLPQSFQVDTSK 95.00% 3.48 0.555 4.23 717.8614 1,433.71 1,434.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ANLPQSFQVDTSK 95.00% 3.13 0.405 2.77 717.8619 1,433.71 1,434.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ANLPQSFQVDTSK 95.00% 2.56 0.302 1.96 717.863 1,433.71 1,434.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ANLPQSFQVDTSK 95.00% 2.53 0.414 3.4 717.8633 1,433.71 1,434.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ANLPQSFQVDTSK 95.00% 2.35 0.336 0 717.8637 1,433.71 1,434.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ANLPQSFQVDTSK 95.00% 2.9 0.504 2.85 717.8642 1,433.71 1,434.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ANLPQSFQVDTSK 95.00% 2.32 0.263 3.16 717.8673 1,433.72 1,434.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ANLPQSFQVDTSK 95.00% 3.87 0.461 4.66 718.365 1,434.71 1,434.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ANLPQSFQVDTSK 95.00% 3.07 0.469 4.85 718.3676 1,434.72 1,434.72 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGQSAAGAAPGGGVDTR 95.00% 3.59 0.464 0 721.8518 1,441.69 1,442.70 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AGQSAAGAAPGGGVDTR 95.00% 3.42 0.46 0 722.3548 1,442.69 1,442.70 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% MDcQEcPEGYR 95.00% 3.83 0.523 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.769 1,443.52 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% MDcQEcPEGYR 95.00% 4.03 0.585 4.08 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 722.7697 1,443.52 1,444.53 2 TPIS_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LVSNHSLHETSSVFVDSLTK 95.00% 4.72 0.523 3.36 734.0429 2,199.11 2,200.13 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LVSNHSLHETSSVFVDSLTK 95.00% 3.56 0.555 2.06 734.3752 2,200.10 2,200.13 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LVSNHSLHETSSVFVDSLTK 95.00% 4.74 0.618 3.8 734.379 2,200.11 2,200.13 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LVSNHSLHETSSVFVDSLTK 95.00% 5.26 0.615 4.09 734.3798 2,200.12 2,200.13 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LVSNHSLHETSSVFVDSLTK 95.00% 5.01 0.578 4.08 734.3802 2,200.12 2,200.13 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LVSNHSLHETSSVFVDSLTK 95.00% 5.27 0.64 4.24 734.3809 2,200.12 2,200.13 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LVSNHSLHETSSVFVDSLTK 95.00% 5.29 0.634 3.77 734.3809 2,200.12 2,200.13 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LVSNHSLHETSSVFVDSLTK 95.00% 4.24 0.516 4.19 734.3812 2,200.12 2,200.13 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LVSNHSLHETSSVFVDSLTK 95.00% 4.74 0.593 4.15 734.3821 2,200.12 2,200.13 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% LVSNHSLHETSSVFVDSLTK 95.00% 0 0 3.14 734.7106 2,201.11 2,200.13 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGGLSLAIEGPSK 95.00% 3.97 0.446 3.34 750.8772 1,499.74 1,500.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGGLSLAIEGPSK 95.00% 4.46 0.538 3.8 750.8776 1,499.74 1,500.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGGLSLAIEGPSK 95.00% 4.16 0.538 3.18 750.8798 1,499.74 1,500.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGGLSLAIEGPSK 95.00% 3.6 0.362 2.22 750.8799 1,499.74 1,500.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGGLSLAIEGPSK 95.00% 5.18 0.572 2.72 750.8804 1,499.75 1,500.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGGLSLAIEGPSK 95.00% 4.45 0.507 3.59 750.8811 1,499.75 1,500.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGGLSLAIEGPSK 95.00% 4.75 0.575 4.09 750.8817 1,499.75 1,500.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGGLSLAIEGPSK 95.00% 4.64 0.498 3.85 751.3811 1,500.75 1,500.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGGLSLAIEGPSK 95.00% 5.16 0.533 3.31 751.3816 1,500.75 1,500.75 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FVPAEMGTHTVSVK 95.00% 4.25 0.424 4.85 751.8863 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FVPAEMGTHTVSVK 95.00% 3.31 0.4 3.82 751.8863 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FVPAEMGTHTVSVK 95.00% 4.15 0.459 5.7 751.8868 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FVPAEMGTHTVSVK 95.00% 2.77 0.432 3.7 751.8877 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FVPAEMGTHTVSVK 95.00% 3.93 0.458 3.8 751.8892 1,501.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 4.14 0.569 4.92 751.8983 1,501.78 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 4.28 0.56 4.54 751.9004 1,501.79 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 3.64 0.428 3.27 751.9004 1,501.79 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 4.77 0.569 4.7 751.9005 1,501.79 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 4.3 0.55 4.09 751.9008 1,501.79 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 3.74 0.478 5.06 751.9009 1,501.79 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 4.36 0.584 4.96 751.9011 1,501.79 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 3.98 0.525 5.01 751.9012 1,501.79 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 3.32 0.447 2.34 751.9012 1,501.79 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 4.98 0.553 4.03 751.9013 1,501.79 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FVPAEMGTHTVSVK 95.00% 3.76 0.526 4.8 752.39 1,502.76 1,502.77 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 4.47 0.531 4.85 752.4014 1,502.79 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 4.23 0.508 4.02 752.4017 1,502.79 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VNQPASFAVSLNGAK 95.00% 4.45 0.519 4.85 752.4031 1,502.79 1,502.80 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 3.09 0.317 3.14 758.383 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 2.82 0.34 3.92 758.383 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 3.56 0.444 4.38 758.3832 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 3.82 0.432 5.64 758.3833 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 3.03 0.393 3.17 758.3836 1,514.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 3.14 0.402 3.68 758.3858 1,514.76 1,515.76 2 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 3.19 0.298 1.59 758.8846 1,515.75 1,515.76 2 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FADQHVPGSPFSVK 95.00% 3.53 0.348 2.13 758.8867 1,515.76 1,515.76 2 MOES_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FVPAEmGTHTVSVK 95.00% 3.15 0.418 1.19 m6: Oxidation (+15.99) 759.8882 1,517.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VHSPSGALEEcYVTEIDQDK 95.00% 5.21 0.479 2.15 c11: Carbamidomethyl (+57.02) 760.0167 2,277.03 2,277.03 3 K1C14_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FVPAEmGTHTVSVK 95.00% 3.52 0.478 5 m6: Oxidation (+15.99) 760.3867 1,518.76 1,518.76 2 TARSH_HUMAN,ITIH2_HUMAN,LMNA_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AEAGVPAEFSIWTR 95.00% 3.76 0.23 2.28 767.3851 1,532.75 1,533.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AEAGVPAEFSIWTR 95.00% 3.75 0.306 3.39 767.3858 1,532.76 1,533.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AEAGVPAEFSIWTR 95.00% 3.43 0.237 4.42 767.3863 1,532.76 1,533.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AEAGVPAEFSIWTR 95.00% 4 0.371 3.6 767.387 1,532.76 1,533.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AEAGVPAEFSIWTR 95.00% 4.25 0.409 5.72 767.3873 1,532.76 1,533.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFSVAVSPSLDLSK 95.00% 4.27 0.531 1.57 767.4113 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFSVAVSPSLDLSK 95.00% 4.54 0.5 2.64 767.4118 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFSVAVSPSLDLSK 95.00% 4.2 0.52 2.52 767.4124 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFSVAVSPSLDLSK 95.00% 4.02 0.515 2.68 767.4131 1,532.81 1,533.82 2 RL4_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% AEAGVPAEFSIWTR 95.00% 4.23 0.227 2.07 767.8916 1,533.77 1,533.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGYGGLSLSIEGPSK 95.00% 4.28 0.46 3.8 775.8875 1,549.76 1,550.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGYGGLSLSIEGPSK 95.00% 4.94 0.501 4.4 775.888 1,549.76 1,550.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGYGGLSLSIEGPSK 95.00% 5.03 0.51 4.6 775.8883 1,549.76 1,550.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGYGGLSLSIEGPSK 95.00% 3.44 0.345 3.06 775.8889 1,549.76 1,550.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGYGGLSLSIEGPSK 95.00% 0 0 3.23 777.0251 1,552.03 1,550.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 3.79 0.573 4.51 785.9049 1,569.79 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 4.38 0.582 4.18 785.906 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 4.76 0.656 3.2 785.9062 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 4.45 0.583 4.46 785.9064 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 4.52 0.607 4.62 785.9065 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 3.82 0.51 4.04 785.9068 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 4.4 0.554 4.25 785.907 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 4.91 0.617 4.14 785.9073 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 3.91 0.536 4.24 785.9076 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 4.26 0.619 3.42 785.9079 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 4.45 0.593 4.62 785.9081 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 4.05 0.555 4.24 785.9087 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 4.32 0.588 4.49 785.9088 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 3.82 0.549 4.57 785.9098 1,569.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 4.14 0.658 3.77 785.9107 1,569.81 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GAGTGGLGLAVEGPSEAK 95.00% 4.42 0.534 3.59 786.4059 1,570.80 1,570.81 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YAPSEAGLHEMDIR 95.00% 3.2 0.424 4.32 794.8739 1,587.73 1,588.74 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YAPSEAGLHEMDIR 95.00% 3.75 0.485 4.17 794.8741 1,587.73 1,588.74 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YAPSEAGLHEMDIR 95.00% 2.46 0.244 2.08 794.8747 1,587.73 1,588.74 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YAPSEAGLHEMDIR 95.00% 3.36 0.444 4.22 794.8749 1,587.73 1,588.74 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DNGNGTYScSYVPR 95.00% 2.87 0.49 2.82 c9: Carbamidomethyl (+57.02) 795.3358 1,588.66 1,589.67 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DNGNGTYScSYVPR 95.00% 3.22 0.433 3.74 c9: Carbamidomethyl (+57.02) 795.337 1,588.66 1,589.67 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.69 0.501 5.04 801.8855 1,601.76 1,602.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 2.57 0.294 0 801.8857 1,601.76 1,602.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.16 0.548 2 801.8858 1,601.76 1,602.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.87 0.586 3.12 801.8865 1,601.76 1,602.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.45 0.51 3.85 801.8868 1,601.76 1,602.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.51 0.532 5.24 801.8869 1,601.76 1,602.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 2.75 0.281 0 801.8878 1,601.76 1,602.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YNEQHVPGSPFTAR 95.00% 3.1 0.538 1.36 801.8882 1,601.76 1,602.77 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.26 0.446 3.1 814.4006 2,440.18 2,440.19 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.26 0.293 4.01 814.4011 2,440.18 2,440.19 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VSGQGLHEGHTFEPAEFIIDTR 95.00% 3.57 0.415 3.54 814.4011 2,440.18 2,440.19 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VSGQGLHEGHTFEPAEFIIDTR 95.00% 4.53 0.403 2.96 814.4034 2,440.19 2,440.19 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% NGQHVASSPIPVVISQSEIGDASR 95.00% 6.25 0.639 3.02 817.0879 2,448.24 2,448.25 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% NGQHVASSPIPVVISQSEIGDASR 95.00% 5.96 0.63 4.37 817.0884 2,448.24 2,448.25 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.22 0.516 3 c11: Carbamidomethyl (+57.02) 817.4329 2,449.28 2,449.29 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.6 0.578 3.02 c11: Carbamidomethyl (+57.02) 817.433 2,449.28 2,449.29 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.26 0.559 2.92 c11: Carbamidomethyl (+57.02) 817.4332 2,449.28 2,449.29 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.01 0.477 2.6 c11: Carbamidomethyl (+57.02) 817.4332 2,449.28 2,449.29 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.96 0.487 3.85 c11: Carbamidomethyl (+57.02) 817.4342 2,449.28 2,449.29 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.38 0.574 3.47 c11: Carbamidomethyl (+57.02) 817.4354 2,449.28 2,449.29 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.01 0.52 2.85 c11: Carbamidomethyl (+57.02) 817.436 2,449.28 2,449.29 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 3.85 0.461 2.49 c11: Carbamidomethyl (+57.02) 817.436 2,449.28 2,449.29 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IVGPSGAAVPcKVEPGLGADNSVVR 95.00% 4.53 0.553 3.33 c11: Carbamidomethyl (+57.02) 817.4366 2,449.29 2,449.29 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDINTEDLEDGTcR 95.00% 3.6 0.483 2.82 c13: Carbamidomethyl (+57.02) 818.8606 1,635.71 1,636.71 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VDINTEDLEDGTcR 95.00% 4.32 0.477 3.51 c13: Carbamidomethyl (+57.02) 818.8614 1,635.71 1,636.71 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.75 0.322 3.11 823.3998 2,467.18 2,467.19 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.98 0.32 3.39 823.401 2,467.18 2,467.19 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.39 0.482 3.54 823.4019 2,467.18 2,467.19 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 4.01 0.341 2.82 823.4031 2,467.19 2,467.19 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.9 0.378 3.28 823.4033 2,467.19 2,467.19 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.86 0.369 2.15 823.4033 2,467.19 2,467.19 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 2.53 0.132 2.23 823.4049 2,467.19 2,467.19 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% FNEEHIPDSPFVVPVASPSGDAR 95.00% 3.33 0.365 3.12 823.4055 2,467.19 2,467.19 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 3.57 0.386 3.01 823.9409 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 3.9 0.419 3.96 823.9414 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVAVNKPAEFTVDAK 95.00% 3.4 0.425 1.89 823.9425 1,645.87 1,646.88 2 MYLK_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTAQGPGLEPSGNIANK 95.00% 4.97 0.598 4.49 826.9319 1,651.85 1,652.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTAQGPGLEPSGNIANK 95.00% 4.93 0.533 4 826.933 1,651.85 1,652.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTAQGPGLEPSGNIANK 95.00% 4.79 0.553 4.17 826.9334 1,651.85 1,652.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTAQGPGLEPSGNIANK 95.00% 5.06 0.63 4.66 826.934 1,651.85 1,652.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTAQGPGLEPSGNIANK 95.00% 5.14 0.598 4.74 826.9342 1,651.85 1,652.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTAQGPGLEPSGNIANK 95.00% 4.63 0.513 5.26 826.9345 1,651.85 1,652.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTAQGPGLEPSGNIANK 95.00% 4.92 0.607 4.31 826.9348 1,651.85 1,652.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTAQGPGLEPSGNIANK 95.00% 5.21 0.614 5.96 826.9348 1,651.85 1,652.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTAQGPGLEPSGNIANK 95.00% 4.7 0.616 4.74 826.9358 1,651.86 1,652.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTAQGPGLEPSGNIANK 95.00% 4.5 0.543 3.62 826.9363 1,651.86 1,652.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTAQGPGLEPSGNIANK 95.00% 5.05 0.555 3.89 827.436 1,652.86 1,652.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTAQGPGLEPSGNIANK 95.00% 4.99 0.591 4.17 827.4378 1,652.86 1,652.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 3.96 0.63 1.82 849.0888 2,544.24 2,544.26 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 3.57 0.506 1.44 849.0916 2,544.25 2,544.26 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVELGKPTHFTVNAK 95.00% 4.64 0.522 2.96 849.9624 1,697.91 1,698.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVELGKPTHFTVNAK 95.00% 3.55 0.357 2.96 849.9624 1,697.91 1,698.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVELGKPTHFTVNAK 95.00% 3.93 0.552 3.85 849.9631 1,697.91 1,698.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVELGKPTHFTVNAK 95.00% 3.94 0.478 2.21 850.4621 1,698.91 1,698.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TGVELGKPTHFTVNAK 95.00% 4.03 0.473 3.68 850.4637 1,698.91 1,698.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYTPMAPGSYLISIK 95.00% 3.56 0.28 0 870.9635 1,739.91 1,740.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYTPMAPGSYLISIK 95.00% 3.79 0.564 3.12 870.9643 1,739.91 1,740.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYTPMAPGSYLISIK 95.00% 3.68 0.501 3.17 870.9644 1,739.91 1,740.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYTPMAPGSYLISIK 95.00% 3.59 0.551 4.07 870.9644 1,739.91 1,740.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYTPMAPGSYLISIK 95.00% 3.46 0.448 2.77 870.9655 1,739.92 1,740.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 3.64 0.558 0 875.9437 1,749.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% TFSVWYVPEVTGTHK 95.00% 3.5 0.517 0 876.442 1,750.87 1,750.88 2 PRDX1_HUMAN,REV1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPFEVYVDKSQGDASK 95.00% 5.16 0.515 6.74 878.9213 1,755.83 1,756.84 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYTPmAPGSYLISIK 95.00% 3.85 0.524 1.57 m6: Oxidation (+15.99) 878.9615 1,755.91 1,756.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYTPmAPGSYLISIK 95.00% 3.82 0.516 1.89 m6: Oxidation (+15.99) 879.4634 1,756.91 1,756.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYTPmAPGSYLISIK 95.00% 3.48 0.34 2.68 m6: Oxidation (+15.99) 879.4643 1,756.91 1,756.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VANPSGNLTETYVQDR 95.00% 5.25 0.641 4.6 882.4287 1,762.84 1,763.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VANPSGNLTETYVQDR 95.00% 3.98 0.615 3.24 882.4289 1,762.84 1,763.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VANPSGNLTETYVQDR 95.00% 4.68 0.64 6.25 882.43 1,762.84 1,763.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VANPSGNLTETYVQDR 95.00% 4.82 0.639 5.92 882.4308 1,762.85 1,763.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VANPSGNLTETYVQDR 95.00% 5.13 0.659 6.43 882.4308 1,762.85 1,763.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VANPSGNLTETYVQDR 95.00% 4.83 0.627 4.85 882.4314 1,762.85 1,763.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VANPSGNLTETYVQDR 95.00% 4.49 0.659 4.19 882.4334 1,762.85 1,763.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VANPSGNLTETYVQDR 95.00% 5.23 0.603 5.26 882.9317 1,763.85 1,763.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VANPSGNLTETYVQDR 95.00% 5.26 0.641 4.64 882.9322 1,763.85 1,763.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VANPSGNLTETYVQDR 95.00% 5.35 0.634 5.17 882.9329 1,763.85 1,763.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VANPSGNLTETYVQDR 95.00% 4.79 0.662 5.32 882.9354 1,763.86 1,763.86 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DVDIIDHHDNTYTVK 95.00% 3.77 0.569 2.35 892.9262 1,783.84 1,784.85 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VQVQDNEGcPVEALVK 95.00% 5.04 0.604 2.77 c9: Carbamidomethyl (+57.02) 892.9455 1,783.88 1,784.89 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VQVQDNEGcPVEALVK 95.00% 5.45 0.577 4.02 c9: Carbamidomethyl (+57.02) 892.9456 1,783.88 1,784.89 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VQVQDNEGcPVEALVK 95.00% 5.48 0.593 5.74 c9: Carbamidomethyl (+57.02) 892.9457 1,783.88 1,784.89 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VQVQDNEGcPVEALVK 95.00% 4.44 0.546 2.77 c9: Carbamidomethyl (+57.02) 892.9463 1,783.88 1,784.89 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VQVQDNEGcPVEALVK 95.00% 5.25 0.601 3 c9: Carbamidomethyl (+57.02) 892.9467 1,783.88 1,784.89 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VQVQDNEGcPVEALVK 95.00% 2.28 0.358 0 c9: Carbamidomethyl (+57.02) 892.947 1,783.88 1,784.89 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DVDIIDHHDNTYTVK 95.00% 3.89 0.529 2.92 893.427 1,784.84 1,784.85 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VQVQDNEGcPVEALVK 95.00% 5.21 0.567 3.48 c9: Carbamidomethyl (+57.02) 893.446 1,784.88 1,784.89 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VQVQDNEGcPVEALVK 95.00% 5.33 0.587 5.14 c9: Carbamidomethyl (+57.02) 893.4475 1,784.88 1,784.89 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VQVQDNEGcPVEALVK 95.00% 5.51 0.526 5.08 c9: Carbamidomethyl (+57.02) 893.448 1,784.88 1,784.89 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VQVQDNEGcPVEALVK 95.00% 5.1 0.592 4.74 c9: Carbamidomethyl (+57.02) 893.4483 1,784.88 1,784.89 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VQVQDNEGcPVEALVK 95.00% 4.48 0.521 4.49 c9: Carbamidomethyl (+57.02) 893.4488 1,784.88 1,784.89 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ATcAPQHGAPGPGPADASK 95.00% 4.08 0.61 1.77 c3: Carbamidomethyl (+57.02) 895.4217 1,788.83 1,789.83 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ATcAPQHGAPGPGPADASK 95.00% 3.94 0.496 2.32 c3: Carbamidomethyl (+57.02) 895.9243 1,789.83 1,789.83 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 4.35 0.469 5.89 907.9839 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 4.04 0.501 5.57 907.984 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 4.46 0.399 5.19 907.9842 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 3.95 0.498 5.62 907.9848 1,813.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VAQPTITDNKDGTVTVR 95.00% 4.49 0.441 4.43 908.4845 1,814.95 1,814.96 2 ITIH2_HUMAN,ECHB_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.8 0.527 3.72 c11: Carbamidomethyl (+57.02) 923.1065 2,766.30 2,766.30 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.6 0.508 3.92 c11: Carbamidomethyl (+57.02) 923.1076 2,766.30 2,766.30 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VHSPSGALEEcYVTEIDQDKYAVR 95.00% 4.69 0.493 4.03 c11: Carbamidomethyl (+57.02) 923.1077 2,766.30 2,766.30 3
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPYTVTVGQAcNPSAcR 95.00% 5.33 0.556 5.21 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4218 1,866.83 1,867.84 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPYTVTVGQAcNPSAcR 95.00% 5.53 0.562 5.36 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4249 1,866.83 1,867.84 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPYTVTVGQAcNPSAcR 95.00% 4.4 0.51 5.52 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.4259 1,866.84 1,867.84 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPYTVTVGQAcNPSAcR 95.00% 4.81 0.467 4.46 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9227 1,867.83 1,867.84 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SPYTVTVGQAcNPSAcR 95.00% 4.87 0.575 8.29 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 934.9284 1,867.84 1,867.84 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYcPTEPGNYIINIK 95.00% 4.45 0.579 3.96 c4: Carbamidomethyl (+57.02) 941.471 1,880.93 1,881.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYcPTEPGNYIINIK 95.00% 4.46 0.556 3.6 c4: Carbamidomethyl (+57.02) 941.4737 1,880.93 1,881.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYcPTEPGNYIINIK 95.00% 3.74 0.537 2.2 c4: Carbamidomethyl (+57.02) 941.4737 1,880.93 1,881.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYcPTEPGNYIINIK 95.00% 4.24 0.52 2.89 c4: Carbamidomethyl (+57.02) 941.4751 1,880.93 1,881.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYcPTEPGNYIINIK 95.00% 4.07 0.442 3.96 c4: Carbamidomethyl (+57.02) 941.4756 1,880.94 1,881.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYcPTEPGNYIINIK 95.00% 4.48 0.53 4.8 c4: Carbamidomethyl (+57.02) 941.9731 1,881.93 1,881.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYcPTEPGNYIINIK 95.00% 4.64 0.481 2.44 c4: Carbamidomethyl (+57.02) 941.9737 1,881.93 1,881.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYcPTEPGNYIINIK 95.00% 4.51 0.588 4.28 c4: Carbamidomethyl (+57.02) 941.974 1,881.93 1,881.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYcPTEPGNYIINIK 95.00% 4.21 0.506 2.8 c4: Carbamidomethyl (+57.02) 941.9743 1,881.93 1,881.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYcPTEPGNYIINIK 95.00% 4.41 0.457 2.72 c4: Carbamidomethyl (+57.02) 941.9744 1,881.93 1,881.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYcPTEPGNYIINIK 95.00% 4.81 0.523 3.92 c4: Carbamidomethyl (+57.02) 941.9745 1,881.93 1,881.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% VTYcPTEPGNYIINIK 95.00% 4.41 0.5 3.51 c4: Carbamidomethyl (+57.02) 941.9752 1,881.93 1,881.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EGPYSISVLYGDEEVPR 95.00% 4.94 0.551 6.36 955.4597 1,908.90 1,909.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EGPYSISVLYGDEEVPR 95.00% 3.49 0.535 2.49 955.4632 1,908.91 1,909.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EGPYSISVLYGDEEVPR 95.00% 5.1 0.548 6.1 955.9616 1,909.91 1,909.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EGPYSISVLYGDEEVPR 95.00% 5.35 0.55 5.85 955.9616 1,909.91 1,909.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EGPYSISVLYGDEEVPR 95.00% 5.21 0.557 5.7 955.9626 1,909.91 1,909.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% EGPYSISVLYGDEEVPR 95.00% 5.04 0.575 5.3 955.9629 1,909.91 1,909.92 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGLLAVQITDPEGKPK 95.00% 4.76 0.411 7.66 969.5105 1,937.01 1,938.02 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGLLAVQITDPEGKPK 95.00% 4.62 0.255 4.02 969.5182 1,937.02 1,938.02 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGLLAVQITDPEGKPK 95.00% 5.48 0.428 3.92 970.0112 1,938.01 1,938.02 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DAGEGLLAVQITDPEGKPK 95.00% 4.9 0.358 4.68 970.0149 1,938.01 1,938.02 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IPEISIQDMTAQVTSPSGK 95.00% 6.09 0.703 7.46 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IPEISIQDMTAQVTSPSGK 95.00% 5.72 0.727 8.33 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IPEISIQDMTAQVTSPSGK 95.00% 6.17 0.709 7.96 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% IPEISIQDMTAQVTSPSGK 95.00% 5.81 0.692 8.38 1,002.01 2,002.01 2,002.02 2 ITIH1_HUMAN
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% cAPGVVGPAEADIDFDIIR 95.00% 3.75 0.461 1.32 c1: Carbamidomethyl (+57.02) 1,008.50 2,014.98 2,014.99 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 6.27 0.651 8.85 c15: Carbamidomethyl (+57.02) 1,029.47 2,056.92 2,057.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 6.72 0.647 9.13 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.92 2,057.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% THEAEIVEGENHTYcIR 95.00% 6.35 0.623 7.74 c15: Carbamidomethyl (+57.02) 1,029.97 2,057.93 2,057.94 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.18 0.667 6.57 c4: Carbamidomethyl (+57.02) 1,129.52 2,257.01 2,258.03 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DGScGVAYVVQEPGDYEVSVK 95.00% 4.3 0.645 2.89 c4: Carbamidomethyl (+57.02) 1,129.52 2,257.02 2,258.03 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DGScGVAYVVQEPGDYEVSVK 95.00% 4.85 0.694 6.55 c4: Carbamidomethyl (+57.02) 1,129.52 2,257.02 2,258.03 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.34 0.626 4.06 c4: Carbamidomethyl (+57.02) 1,130.01 2,258.01 2,258.03 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.38 0.625 4.77 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.5 0.629 4.85 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% DGScGVAYVVQEPGDYEVSVK 95.00% 5.28 0.642 6.22 c4: Carbamidomethyl (+57.02) 1,130.02 2,258.02 2,258.03 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.4 0.674 6.19 1,144.09 2,286.17 2,286.18 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.58 0.651 5.7 1,144.09 2,286.17 2,286.18 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.4 0.665 5.12 1,144.09 2,286.17 2,286.18 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% YTPVQQGPVGVNVTYGGDPIPK 95.00% 5.5 0.673 6.85 1,144.09 2,286.17 2,286.18 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SAGQGEVLVYVEDPAGHQEEAK 95.00% 5.7 0.612 5.85 1,157.55 2,313.09 2,313.10 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SAGQGEVLVYVEDPAGHQEEAK 95.00% 4.95 0.609 5.89 1,157.55 2,313.09 2,313.10 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% SAGQGEVLVYVEDPAGHQEEAK 95.00% 4.98 0.633 6.13 1,157.55 2,313.09 2,313.10 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.13 0.564 6.38 1,172.11 2,342.21 2,342.22 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.24 0.55 7.68 1,172.11 2,342.21 2,342.22 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% ASGPGLNTTGVPASLPVEFTIDAK 95.00% 5.42 0.591 8.38 1,172.11 2,342.21 2,342.22 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.34 0.722 5.68 1,273.13 2,544.24 2,544.26 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.36 0.726 8.33 1,273.13 2,544.25 2,544.26 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.15 0.73 9.2 1,273.13 2,544.25 2,544.26 2
 SAMPLE 3R Filamin-A  FLNA  FLNA_HUMAN 280,711.40 100.00% 87 106 606 44.60% GLVEPVDVVDNADGTQTVNYVPSR 95.00% 6.07 0.714 8.62 1,273.13 2,544.25 2,544.26 2
 SAMPLE 1 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 6 8 20.10% VASSVFITLAPPRR 95.00% 2.44 0.288 0 505.2996 1,512.88 1,513.89 3
 SAMPLE 1 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 6 8 20.10% QLAGQSFYQK 95.00% 2.68 0.407 0 585.2998 1,168.58 1,169.60 2
 SAMPLE 1 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 6 8 20.10% QLAGQSFYQK 95.00% 2.42 0.374 0 585.3047 1,168.59 1,169.60 2
 SAMPLE 1 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 6 8 20.10% FAPVcSIcENPIIPR 95.00% 3.58 0.47 3 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 591.6315 1,771.87 1,772.88 3
 SAMPLE 1 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 6 8 20.10% FAPVcSIcENPIIPR 95.00% 3.01 0.349 3.37 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 887.4154 1,772.82 1,772.88 2
 SAMPLE 1 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 6 8 20.10% TPEAGLAGRPSPWTTPGR 95.00% 3.05 0.237 2.23 925.9792 1,849.94 1,850.95 2
 SAMPLE 1 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 6 8 20.10% TPEAGLAGRPSPWTTPGR 95.00% 2.69 0.159 1.47 925.9826 1,849.95 1,850.95 2
 SAMPLE 1 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 6 8 20.10% ALGQAFHPScFTcVTcAR 95.00% 4.04 0.567 5 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 1,042.47 2,082.93 2,082.93 2
 SAMPLE 1R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 6 7 10 20.90% DVAVAEEVR 95.00% 2.41 0.412 1.34 494.2547 986.4937 987.5111 2
 SAMPLE 1R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 6 7 10 20.90% VASSVFITLAPPRR 95.00% 1.99 0.267 0 505.2987 1,512.87 1,513.89 3
 SAMPLE 1R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 6 7 10 20.90% QLAGQSFYQK 95.00% 2.51 0.401 1.19 585.301 1,168.59 1,169.60 2
 SAMPLE 1R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 6 7 10 20.90% QLAGQSFYQK 95.00% 2.59 0.368 0 585.302 1,168.59 1,169.60 2
 SAMPLE 1R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 6 7 10 20.90% FAPVcSIcENPIIPR 95.00% 3.12 0.512 2.46 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 591.6314 1,771.87 1,772.88 3
 SAMPLE 1R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 6 7 10 20.90% FAPVcSIcENPIIPR 95.00% 3.92 0.51 2.85 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 591.6315 1,771.87 1,772.88 3
 SAMPLE 1R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 6 7 10 20.90% TPEAGLAGRPSPWTTPGR 95.00% 4.15 0.624 3.26 617.9874 1,850.94 1,850.95 3
 SAMPLE 1R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 6 7 10 20.90% TPEAGLAGRPSPWTTPGR 95.00% 4.35 0.631 3.68 617.9886 1,850.94 1,850.95 3
 SAMPLE 1R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 6 7 10 20.90% GASTDIcAFcHK 95.00% 2.76 0.364 0 c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 683.7961 1,365.58 1,366.59 2
 SAMPLE 1R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 6 7 10 20.90% TPEAGLAGRPSPWTTPGR 95.00% 3.05 0.242 2.36 925.9789 1,849.94 1,850.95 2
 SAMPLE 2 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 5 9 18.80% VASSVFITLAPPRR 95.00% 2.11 0.314 0 505.2989 1,512.87 1,513.89 3
 SAMPLE 2 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 5 9 18.80% VASSVFITLAPPRR 95.00% 2.26 0.311 0 505.2995 1,512.88 1,513.89 3
 SAMPLE 2 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 5 9 18.80% QLAGQSFYQK 95.00% 2.57 0.297 0 585.2989 1,168.58 1,169.60 2
 SAMPLE 2 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 5 9 18.80% QLAGQSFYQK 95.00% 2.65 0.321 1.55 585.3011 1,168.59 1,169.60 2
 SAMPLE 2 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 5 9 18.80% GASTDIcAFcHK 95.00% 3 0.488 2.7 c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 683.7954 1,365.58 1,366.59 2
 SAMPLE 2 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 5 9 18.80% GASTDIcAFcHK 95.00% 3.33 0.445 1.8 c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 684.299 1,366.58 1,366.59 2
 SAMPLE 2 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 5 9 18.80% TPEAGLAGRPSPWTTPGR 95.00% 3.25 0.24 2.21 925.9793 1,849.94 1,850.95 2
 SAMPLE 2 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 5 9 18.80% TPEAGLAGRPSPWTTPGR 95.00% 2.68 0.207 1.62 926.4793 1,850.94 1,850.95 2
 SAMPLE 2 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 5 5 9 18.80% DGRPLcEPcYQDTLER 95.00% 3.41 0.522 4.52 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,005.45 2,008.88 2,008.89 2
 SAMPLE 2R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 4 4 7 14.70% QLAGQSFYQK 95.00% 2.54 0.357 0 585.3005 1,168.59 1,169.60 2
 SAMPLE 2R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 4 4 7 14.70% QLAGQSFYQK 95.00% 2.51 0.325 0 585.301 1,168.59 1,169.60 2
 SAMPLE 2R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 4 4 7 14.70% FAPVcSIcENPIIPR 95.00% 2.76 0.272 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 591.6335 1,771.88 1,772.88 3
 SAMPLE 2R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 4 4 7 14.70% GASTDIcAFcHK 95.00% 2.98 0.484 2.1 c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 683.7973 1,365.58 1,366.59 2
 SAMPLE 2R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 4 4 7 14.70% GASTDIcAFcHK 95.00% 2.97 0.438 2 c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 683.7979 1,365.58 1,366.59 2
 SAMPLE 2R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 4 4 7 14.70% TPEAGLAGRPSPWTTPGR 95.00% 3.23 0.33 0 925.9808 1,849.95 1,850.95 2
 SAMPLE 2R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 4 4 7 14.70% TPEAGLAGRPSPWTTPGR 95.00% 2.59 0.144 1.64 926.4783 1,850.94 1,850.95 2
 SAMPLE 3 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 7 7 11 26.80% DVAVAEEVR 95.00% 2.96 0.408 1.74 494.2583 986.501 987.5111 2
 SAMPLE 3 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 7 7 11 26.80% VASSVFITLAPPRR 95.00% 2.39 0.353 0 505.2983 1,512.87 1,513.89 3
 SAMPLE 3 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 7 7 11 26.80% VASSVFITLAPPRR 95.00% 2.04 0.295 0 505.2996 1,512.88 1,513.89 3
 SAMPLE 3 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 7 7 11 26.80% QLAGQSFYQK 95.00% 2.38 0.354 0 585.3009 1,168.59 1,169.60 2
 SAMPLE 3 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 7 7 11 26.80% QLAGQSFYQK 95.00% 2.27 0.298 0 585.3012 1,168.59 1,169.60 2
 SAMPLE 3 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 7 7 11 26.80% ALGQAFHPScFTcVTcAR 95.00% 4.83 0.57 4.19 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 695.3145 2,082.92 2,082.93 3
 SAMPLE 3 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 7 7 11 26.80% ALGQAFHPScFTcVTcAR 95.00% 5.64 0.61 3.77 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 695.3157 2,082.92 2,082.93 3
 SAMPLE 3 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 7 7 11 26.80% FAPVcSIcENPIIPR 95.00% 3.36 0.489 5.59 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 886.9439 1,771.87 1,772.88 2
 SAMPLE 3 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 7 7 11 26.80% TPEAGLAGRPSPWTTPGR 95.00% 2.98 0.221 1.92 925.9791 1,849.94 1,850.95 2
 SAMPLE 3 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 7 7 11 26.80% DGRPLcEPcYQDTLER 95.00% 3.71 0.503 3.18 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,005.44 2,008.87 2,008.89 2
 SAMPLE 3 Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 7 7 11 26.80% DGRPLcEPcYQDTLER 95.00% 3.33 0.488 2.68 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,005.45 2,008.88 2,008.89 2
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% DVAVAEEVR 95.00% 2.24 0.283 0 494.2507 986.4857 987.5111 2
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% VASSVFITLAPPRR 95.00% 2.23 0.259 0 505.2981 1,512.87 1,513.89 3
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% VASSVFITLAPPRR 95.00% 2.07 0.263 0 505.2991 1,512.87 1,513.89 3
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% QLAGQSFYQK 95.00% 2.36 0.359 0 585.3008 1,168.59 1,169.60 2
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% TPEAGLAGRPSPWTTPGR 95.00% 2.26 0.343 0 617.6547 1,849.94 1,850.95 3
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% TPEAGLAGRPSPWTTPGR 95.00% 3.94 0.52 3.06 617.9871 1,850.94 1,850.95 3
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% TPEAGLAGRPSPWTTPGR 95.00% 4.75 0.615 3.47 617.9887 1,850.94 1,850.95 3
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% TPEAGLAGRPSPWTTPGR 95.00% 2.67 0.456 0 617.9912 1,850.95 1,850.95 3
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% GASTDIcAFcHK 95.00% 2.26 0.324 0 c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 683.7971 1,365.58 1,366.59 2
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% GASTDIcAFcHK 95.00% 3.14 0.47 2.82 c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 683.7984 1,365.58 1,366.59 2
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% ALGQAFHPScFTcVTcAR 95.00% 4.67 0.636 3.92 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 695.3162 2,082.93 2,082.93 3
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% ALGQAFHPScFTcVTcAR 95.00% 4.9 0.664 3.35 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 695.3177 2,082.93 2,082.93 3
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% FAPVcSIcENPIIPR 95.00% 2.58 0.451 2.85 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 886.9425 1,771.87 1,772.88 2
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% FAPVcSIcENPIIPR 95.00% 3.8 0.504 6.54 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 887.4469 1,772.88 1,772.88 2
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% TPEAGLAGRPSPWTTPGR 95.00% 3.33 0.235 0 926.4817 1,850.95 1,850.95 2
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% DGRPLcEPcYQDTLER 95.00% 3.66 0.515 4.19 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,005.45 2,008.87 2,008.89 2
 SAMPLE 3R Filamin-binding LIM protein 1  FBLIM1  FBLI1_HUMAN 40,651.20 100.00% 8 10 17 30.00% ALGQAFHPScFTcVTcAR 95.00% 4.24 0.589 5.8 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 1,042.46 2,082.91 2,082.93 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% YGGPQHIVGSPFK 95.00% 3.64 0.478 0 462.9127 1,385.71 1,386.72 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% YGGPQHIVGSPFK 95.00% 2.91 0.44 1.44 462.9131 1,385.72 1,386.72 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% YGGPQHIVGSPFK 95.00% 3.45 0.457 1.39 462.9131 1,385.72 1,386.72 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% YGGPQHIVGSPFK 95.00% 3.97 0.489 1.42 462.9133 1,385.72 1,386.72 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% YGGPQHIVGSPFK 95.00% 3.65 0.525 2.13 462.9144 1,385.72 1,386.72 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% YGGPQHIVGSPFK 95.00% 3.39 0.476 1.38 463.2473 1,386.72 1,386.72 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LGSFGSITR 95.00% 1.88 0.308 0 469.2578 936.4999 937.5108 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LGSFGSITR 95.00% 2.5 0.441 1.22 469.2603 936.5049 937.5108 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LGSFGSITR 95.00% 1.94 0.302 0 469.2604 936.5051 937.5108 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LGSFGSITR 95.00% 2.27 0.419 1.77 469.2606 936.5055 937.5108 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LGSFGSITR 95.00% 2.39 0.429 1.38 469.2607 936.5057 937.5108 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LGSFGSITR 95.00% 2.19 0.387 1.66 469.261 936.5064 937.5108 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LGSFGSITR 95.00% 2.7 0.448 0 469.2611 936.5066 937.5108 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LGSFGSITR 95.00% 1.52 0.334 1.8 469.2611 936.5066 937.5108 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LGSFGSITR 95.00% 2.58 0.42 0 469.2615 936.5073 937.5108 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LGSFGSITR 95.00% 1.93 0.264 1.15 469.2616 936.5076 937.5108 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LGSFGSITR 95.00% 2.04 0.421 1.54 469.2618 936.5079 937.5108 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LGSFGSITR 95.00% 2.61 0.404 1.35 469.2618 936.508 937.5108 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LLGWIQNK 95.00% 3.14 0.129 0 486.2877 970.5597 971.568 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LLGWIQNK 95.00% 2.95 0.166 0 486.2879 970.5602 971.568 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LLGWIQNK 95.00% 2.8 0.135 0 486.2881 970.5605 971.568 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LLGWIQNK 95.00% 2.88 0.105 0 486.2882 970.5607 971.568 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LLGWIQNK 95.00% 3.1 0.144 0 486.2882 970.5608 971.568 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LLGWIQNK 95.00% 2.93 0.0987 0 486.2883 970.5609 971.568 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LLGWIQNK 95.00% 3.24 0.172 0 486.2886 970.5615 971.568 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LLGWIQNK 95.00% 2.98 0.102 0 486.2886 970.5616 971.568 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LLGWIQNK 95.00% 2.93 0.154 0 486.2886 970.5616 971.568 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LLGWIQNK 95.00% 2.78 0.142 0 486.2887 970.5617 971.568 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LLGWIQNK 94.70% 2.79 0.0887 0 486.2889 970.5622 971.568 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LLGWIQNK 95.00% 2.34 0.238 0 486.2894 970.5632 971.568 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% HTIIISWGGVNVPK 95.00% 2.78 0.396 0 507.6258 1,519.85 1,520.86 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% FADKHVPGSPFTVK 95.00% 2.41 0.2 0 510.6103 1,528.81 1,529.81 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TYAVSYVPK 95.00% 1.89 0.374 0 514.2765 1,026.54 1,027.55 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TYAVSYVPK 95.00% 2.16 0.254 0 514.2769 1,026.54 1,027.55 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% FDDKHIPGSPFTAK 95.00% 2.56 0.317 0 520.6008 1,558.78 1,559.79 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% FDDKHIPGSPFTAK 95.00% 2.72 0.354 1.07 520.601 1,558.78 1,559.79 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LDVQFAGTAK 95.00% 2.03 0.32 2.41 525.2862 1,048.56 1,049.56 2 MYO1D_HUMAN,PDIA1_HUMAN,CO4A1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% FIPHENGVHSIDVK 95.00% 2.41 0.266 0 531.2803 1,590.82 1,591.82 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VYNVTYTVK 95.00% 2.74 0.285 0 543.796 1,085.58 1,086.58 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VYNVTYTVK 95.00% 2.4 0.326 0 543.7962 1,085.58 1,086.58 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VYNVTYTVK 95.00% 3.02 0.31 1.28 543.7966 1,085.58 1,086.58 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFRVGVTEGcDPTR 95.00% 2.65 0.374 1.07 c11: Carbamidomethyl (+57.02) 559.7969 1,676.37 1,677.80 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 2.6 0.253 0 571.7933 1,712.36 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 2.87 0.4 0 571.9907 1,712.95 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 2.81 0.29 0 571.9908 1,712.95 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 3.42 0.448 0 571.9913 1,712.95 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 2.74 0.47 0 571.9918 1,712.95 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 3.53 0.488 0 571.9919 1,712.95 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 2.16 0.253 0 572.0438 1,713.11 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 2.43 0.206 0 572.0455 1,713.11 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 3.06 0.386 0 572.3235 1,713.95 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 3.23 0.449 0 572.3242 1,713.95 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 3.32 0.404 0 572.3252 1,713.95 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 2.98 0.463 0 572.3256 1,713.95 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TGVEVGKPTHFTVLTK 95.00% 3.1 0.426 0 572.3257 1,713.95 1,713.95 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGSGELKVTVK 95.00% 2.44 0.219 0 573.3288 1,144.64 1,145.65 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGSGELKVTVK 95.00% 2.9 0.316 1.57 573.3313 1,144.65 1,145.65 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGSGELKVTVK 95.00% 2.43 0.365 0 573.3325 1,144.65 1,145.65 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGSGELKVTVK 95.00% 2.83 0.392 0 573.3333 1,144.65 1,145.65 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DLAEDAPWKK 95.00% 2.24 0.199 1.19 586.8004 1,171.59 1,172.60 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DLAEDAPWKK 95.00% 2.36 0.27 0 586.8007 1,171.59 1,172.60 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DLAEDAPWKK 95.00% 2.25 0.22 1.6 586.803 1,171.59 1,172.60 2 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DTVEVALEDKGDSTFR 95.00% 2.02 0.266 0 594.624 1,780.85 1,781.86 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DTVEVALEDKGDSTFR 95.00% 3 0.258 0 594.6253 1,780.85 1,781.86 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GPGLSQAFVGQK 95.00% 3.33 0.524 2.96 594.8206 1,187.63 1,188.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GPGLSQAFVGQK 95.00% 3.35 0.573 3.03 594.8216 1,187.63 1,188.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GPGLSQAFVGQK 95.00% 3.49 0.557 3.8 594.8222 1,187.63 1,188.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GPGLSQAFVGQK 95.00% 2.94 0.54 1.92 594.8225 1,187.63 1,188.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GPGLSQAFVGQK 95.00% 2.42 0.335 0 594.8228 1,187.63 1,188.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GPGLSQAFVGQK 95.00% 3.34 0.565 4.01 594.8234 1,187.63 1,188.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GPGLSQAFVGQK 95.00% 3.41 0.573 2.7 594.8237 1,187.63 1,188.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GPGLSQAFVGQK 95.00% 3.31 0.573 3.7 594.8241 1,187.63 1,188.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DTVEVALEDKGDSTFR 95.00% 2.64 0.405 1.42 594.9583 1,781.85 1,781.86 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DTVEVALEDKGDSTFR 95.00% 2.83 0.442 0 594.959 1,781.85 1,781.86 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TARPNITDNKDGTITVR 95.00% 3.9 0.428 2.16 624.6718 1,870.99 1,871.99 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AKLDVQFAGTAK 95.00% 3.13 0.475 4.52 624.8518 1,247.69 1,248.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AKLDVQFAGTAK 95.00% 3.08 0.477 3.92 624.8526 1,247.69 1,248.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AKLDVQFAGTAK 95.00% 2.88 0.482 4.13 624.8529 1,247.69 1,248.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AKLDVQFAGTAK 95.00% 2.91 0.456 4 624.8531 1,247.69 1,248.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AKLDVQFAGTAK 95.00% 2.99 0.409 3.8 624.8534 1,247.69 1,248.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AKLDVQFAGTAK 95.00% 2.86 0.369 3.51 624.8535 1,247.69 1,248.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AKLDVQFAGTAK 95.00% 2.21 0.301 1.47 624.8543 1,247.69 1,248.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AKLDVQFAGTAK 95.00% 2.22 0.346 1.82 624.8548 1,247.69 1,248.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TARPNITDNKDGTITVR 95.00% 4.24 0.467 1.52 625.0066 1,872.00 1,871.99 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AFGPGLEGGLVNK 95.00% 3.76 0.42 0 629.8441 1,257.67 1,258.68 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AFGPGLEGGLVNK 95.00% 3.38 0.385 0 629.8442 1,257.67 1,258.68 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AFGPGLEGGLVNK 95.00% 3.84 0.496 1.55 629.8443 1,257.67 1,258.68 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AFGPGLEGGLVNK 95.00% 3.76 0.425 0 629.8445 1,257.67 1,258.68 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AFGPGLEGGLVNK 95.00% 3.73 0.408 0 629.8445 1,257.67 1,258.68 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AFGPGLEGGLVNK 95.00% 3.12 0.406 0 629.8449 1,257.67 1,258.68 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AFGPGLEGGLVNK 95.00% 3.36 0.461 5.29 629.8451 1,257.67 1,258.68 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AFGPGLEGGLVNK 95.00% 3.09 0.406 0 629.8451 1,257.67 1,258.68 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AFGPGLEGGLVNK 95.00% 3.75 0.502 1.49 629.8452 1,257.67 1,258.68 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AFGPGLEGGLVNK 95.00% 3.75 0.462 0 629.8455 1,257.68 1,258.68 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AFGPGLEGGLVNK 95.00% 3.67 0.49 0 629.8461 1,257.68 1,258.68 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% EVTTEFTVDAR 95.00% 2.52 0.359 1.49 634.3121 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% EVTTEFTVDAR 95.00% 3.01 0.469 2.26 634.3123 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% EVTTEFTVDAR 95.00% 2.4 0.485 2.08 634.3127 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% EVTTEFTVDAR 95.00% 2.46 0.278 1.85 634.3133 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% EVTTEFTVDAR 95.00% 2.15 0.33 1.47 634.3134 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% EVTTEFTVDAR 95.00% 2.05 0.305 0 634.3136 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% EVTTEFTVDAR 95.00% 2.76 0.455 2.12 634.3146 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% EVTTEFTVDAR 95.00% 2.17 0.309 0 634.3146 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% EVTTEFTVDAR 95.00% 2.19 0.4 1.52 634.3147 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% FNGAHIPGSPFK 95.00% 2.26 0.309 0 636.333 1,270.65 1,271.65 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% ILVGPSEIGDASK 95.00% 3.12 0.477 2.74 643.354 1,284.69 1,285.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% ILVGPSEIGDASK 95.00% 3.07 0.503 2.39 643.3541 1,284.69 1,285.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% ILVGPSEIGDASK 95.00% 3.21 0.514 2.68 643.3542 1,284.69 1,285.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% ILVGPSEIGDASK 95.00% 3.23 0.488 2.24 643.3548 1,284.69 1,285.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% ILVGPSEIGDASK 95.00% 3.76 0.607 5.74 643.3553 1,284.70 1,285.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% ILVGPSEIGDASK 95.00% 2.74 0.476 4.55 643.3554 1,284.70 1,285.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% ILVGPSEIGDASK 95.00% 3.64 0.592 3.77 643.356 1,284.70 1,285.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% ILVGPSEIGDASK 95.00% 4.12 0.584 5.64 643.356 1,284.70 1,285.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% ILVGPSEIGDASK 95.00% 4.01 0.549 5 643.3561 1,284.70 1,285.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% ILVGPSEIGDASK 95.00% 3.54 0.535 2.77 643.3561 1,284.70 1,285.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% ILVGPSEIGDASK 95.00% 3.24 0.521 2.35 643.3562 1,284.70 1,285.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% ILVGPSEIGDASK 95.00% 2.57 0.386 0 643.9276 1,285.84 1,285.70 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LTVTSLQETGLK 95.00% 2.86 0.412 1.96 645.3725 1,288.73 1,289.73 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFPVHVSEAcNPNAcR 95.00% 2.39 0.255 0 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 647.9623 1,940.86 1,941.87 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFPVHVSEAcNPNAcR 95.00% 4.36 0.355 1.48 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 647.9628 1,940.87 1,941.87 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFPVHVSEAcNPNAcR 95.00% 4 0.409 1.55 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 647.9634 1,940.87 1,941.87 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFPVHVSEAcNPNAcR 95.00% 3.08 0.334 0 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 648.2963 1,941.87 1,941.87 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFPVHVSEAcNPNAcR 95.00% 4.02 0.424 2.15 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 648.2969 1,941.87 1,941.87 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFPVHVSEAcNPNAcR 95.00% 4.66 0.432 1.04 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 648.2992 1,941.87 1,941.87 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VPQLPITNFNR 95.00% 2.04 0.336 0 649.8643 1,297.71 1,298.72 2 MYH10_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VPQLPITNFNR 95.00% 2.13 0.327 1.2 649.8655 1,297.72 1,298.72 2 MYH10_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VPQLPITNFNR 95.00% 2.47 0.309 2.1 649.8658 1,297.72 1,298.72 2 MYH10_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VPQLPITNFNR 95.00% 2.45 0.368 1.68 649.8667 1,297.72 1,298.72 2 MYH10_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VPQLPITNFNR 95.00% 2.39 0.407 1.8 649.8669 1,297.72 1,298.72 2 MYH10_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VPQLPITNFNR 95.00% 2.15 0.375 1.47 649.8678 1,297.72 1,298.72 2 MYH10_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.09 0.48 4.09 650.3401 1,298.66 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.69 0.534 3.34 650.3402 1,298.66 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.33 0.497 2.01 650.3403 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.33 0.457 4.37 650.3404 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.49 0.458 2.62 650.3404 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.07 0.507 2.74 650.3405 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 2.47 0.445 2.08 650.3405 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.74 0.555 2.77 650.3406 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 2.27 0.269 1.77 650.3407 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.48 0.474 2.6 650.3408 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.33 0.528 1.28 650.3409 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.47 0.474 4.33 650.3409 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.88 0.53 2.33 650.341 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.51 0.501 4.06 650.341 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 3.54 0.502 5.01 650.3412 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 1.81 0.32 1.23 650.3414 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 2.24 0.366 0 650.3431 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AWGPGLETGQVGK 95.00% 2.82 0.408 1.44 650.3432 1,298.67 1,299.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 3.1 0.491 2.19 652.3596 1,302.70 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 3.21 0.483 3.64 652.3601 1,302.70 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 3.28 0.479 3.35 652.3603 1,302.71 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 3.43 0.38 4.85 652.3603 1,302.71 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 3.98 0.452 3.25 652.3608 1,302.71 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 3.44 0.449 4.19 652.3613 1,302.71 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 3.74 0.448 4.41 652.3614 1,302.71 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 2.2 0.27 0 652.3615 1,302.71 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 2.87 0.478 3.35 652.3615 1,302.71 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 2.92 0.474 2.85 652.3619 1,302.71 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 2.98 0.412 3.15 652.3622 1,302.71 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 3.61 0.399 3.64 652.3623 1,302.71 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 3.69 0.421 4.11 652.3624 1,302.71 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VSGPGVEPHGVLR 95.00% 2.14 0.283 0 652.3631 1,302.71 1,303.71 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% WGDESVPGSPFK 95.00% 2.62 0.277 1.22 653.6908 1,305.37 1,305.61 2 TITIN_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APSGNEEPcLLK 95.00% 2.43 0.228 0 c9: Carbamidomethyl (+57.02) 657.8177 1,313.62 1,314.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APSGNEEPcLLK 95.00% 2.53 0.26 1.23 c9: Carbamidomethyl (+57.02) 657.821 1,313.63 1,314.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APSGNEEPcLLK 95.00% 2.86 0.363 1.34 c9: Carbamidomethyl (+57.02) 657.8218 1,313.63 1,314.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APSGNEEPcLLK 95.00% 2.74 0.296 0 c9: Carbamidomethyl (+57.02) 657.8224 1,313.63 1,314.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APSGNEEPcLLK 95.00% 2.48 0.358 1.74 c9: Carbamidomethyl (+57.02) 657.8224 1,313.63 1,314.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APSGNEEPcLLK 95.00% 2.74 0.366 1.62 c9: Carbamidomethyl (+57.02) 657.8225 1,313.63 1,314.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APSGNEEPcLLK 95.00% 3.25 0.331 1.8 c9: Carbamidomethyl (+57.02) 657.8226 1,313.63 1,314.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APSGNEEPcLLK 95.00% 3.6 0.372 1.7 c9: Carbamidomethyl (+57.02) 657.8231 1,313.63 1,314.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APSGNEEPcLLK 95.00% 3.24 0.352 1.68 c9: Carbamidomethyl (+57.02) 657.8233 1,313.63 1,314.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APSGNEEPcLLK 95.00% 3.47 0.364 1.7 c9: Carbamidomethyl (+57.02) 657.8236 1,313.63 1,314.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APSGNEEPcLLK 95.00% 2.73 0.377 2.1 c9: Carbamidomethyl (+57.02) 658.3242 1,314.63 1,314.64 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APLQVAVLGPTGVAEPVEVR 95.00% 4.48 0.565 3.7 668.3851 2,002.13 2,002.13 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APLQVAVLGPTGVAEPVEVR 95.00% 4.1 0.505 1.89 668.3876 2,002.14 2,002.13 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VHVQPAVDTSGVK 95.00% 2.14 0.404 2.46 668.8022 1,335.59 1,336.72 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VHVQPAVDTSGVK 95.00% 2.41 0.433 2.66 668.8025 1,335.59 1,336.72 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VHVQPAVDTSGVK 95.00% 2.72 0.419 2.28 668.8679 1,335.72 1,336.72 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VHVQPAVDTSGVK 95.00% 2.83 0.367 2.33 668.868 1,335.72 1,336.72 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VHVQPAVDTSGVK 95.00% 2.61 0.399 2.3 668.8686 1,335.72 1,336.72 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VHVQPAVDTSGVK 95.00% 2.84 0.421 3.1 668.8689 1,335.72 1,336.72 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GLSEGHTFQVAEFIVDTR 95.00% 2.97 0.409 0 669.3378 2,004.99 2,006.00 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GLSEGHTFQVAEFIVDTR 95.00% 2.36 0.239 0 669.6733 2,006.00 2,006.00 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GLSEGHTFQVAEFIVDTR 95.00% 3.04 0.347 0 669.6735 2,006.00 2,006.00 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 2.75 0.319 2.11 673.876 1,345.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 3.37 0.366 1.43 673.8763 1,345.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 2.67 0.151 2.27 673.8764 1,345.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 3.04 0.401 2.48 673.8769 1,345.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 3.53 0.341 1.68 673.8772 1,345.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 2.05 0.302 0 673.8775 1,345.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 3.62 0.274 2.62 673.8775 1,345.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 3.22 0.273 2.11 673.8775 1,345.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 3.17 0.341 2.64 673.8775 1,345.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 2.44 0.383 1.82 673.8782 1,345.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 3.92 0.327 2.19 674.378 1,346.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 2.79 0.272 0 674.3783 1,346.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VTVLFAGQNIER 95.00% 3.96 0.339 2.33 674.3786 1,346.74 1,346.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% YGGPQHIVGSPFK 95.00% 3.51 0.395 1.17 693.8637 1,385.71 1,386.72 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% YGGPQHIVGSPFK 95.00% 4.1 0.544 1.2 693.864 1,385.71 1,386.72 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% YGGPQHIVGSPFK 95.00% 3.33 0.41 0 693.8643 1,385.71 1,386.72 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% YGGPQHIVGSPFK 95.00% 3.87 0.54 0 694.3676 1,386.72 1,386.72 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LSGGHSLHETSTVLVETVTK 95.00% 4.46 0.49 2.59 699.3748 2,095.10 2,095.10 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LSGGHSLHETSTVLVETVTK 95.00% 4.75 0.482 3.12 699.3757 2,095.10 2,095.10 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LSGGHSLHETSTVLVETVTK 95.00% 4.2 0.483 3.16 699.3757 2,095.10 2,095.10 3
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GGLVGTPAPFSIDTK 95.00% 2.97 0.403 3.13 730.3968 1,458.78 1,459.78 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GGLVGTPAPFSIDTK 95.00% 2.39 0.326 0 730.3984 1,458.78 1,459.78 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DAGEGGLSLAVEGPSK 95.00% 2.62 0.235 0 743.8763 1,485.74 1,486.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DAGEGGLSLAVEGPSK 95.00% 4.03 0.409 2.1 743.8781 1,485.74 1,486.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DAGEGGLSLAVEGPSK 95.00% 3.82 0.342 1.92 743.8788 1,485.74 1,486.74 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GVAGVPAEFSIWTR 95.00% 4.11 0.552 5.37 745.3971 1,488.78 1,489.78 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GVAGVPAEFSIWTR 95.00% 3.27 0.508 2.77 745.3979 1,488.78 1,489.78 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GVAGVPAEFSIWTR 95.00% 3.06 0.444 3.64 745.3982 1,488.78 1,489.78 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GVAGVPAEFSIWTR 95.00% 3 0.509 2.57 745.8974 1,489.78 1,489.78 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 4.46 0.59 4.96 753.3891 1,504.76 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 3.83 0.569 3.15 753.39 1,504.76 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 3.6 0.537 3.22 753.3914 1,504.77 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 4.4 0.584 3.47 753.3914 1,504.77 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 3.4 0.554 4.11 753.3919 1,504.77 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 4.13 0.605 3.74 753.3924 1,504.77 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 4.46 0.61 3.66 753.3925 1,504.77 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 4.09 0.587 3.15 753.3929 1,504.77 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 3.24 0.547 3.01 753.8935 1,505.77 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 2.69 0.421 1.28 753.8945 1,505.77 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 4.3 0.572 4.29 753.8958 1,505.78 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 3.98 0.539 3.12 754.0374 1,506.06 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 0 0 3.19 754.3692 1,506.72 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 0 0 4.05 754.3707 1,506.73 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 0 0 4.6 754.371 1,506.73 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VAVGQEQAFSVNTR 95.00% 0 0 3.21 754.3711 1,506.73 1,505.77 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% IQIGQETVITVDAK 95.00% 2.13 0.307 0 757.9268 1,513.84 1,514.84 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% IQIGQETVITVDAK 95.00% 4.29 0.493 4 757.927 1,513.84 1,514.84 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% IQIGQETVITVDAK 95.00% 4.48 0.515 4.17 757.9272 1,513.84 1,514.84 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% IQIGQETVITVDAK 95.00% 4.6 0.535 4.36 757.9275 1,513.84 1,514.84 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% IQIGQETVITVDAK 95.00% 3.46 0.466 4.01 757.9277 1,513.84 1,514.84 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% IQIGQETVITVDAK 95.00% 3.96 0.463 4.64 757.9289 1,513.84 1,514.84 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% IQIGQETVITVDAK 95.00% 4.4 0.453 4.19 758.4282 1,514.84 1,514.84 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% IQIGQETVITVDAK 95.00% 4.12 0.5 3.57 758.429 1,514.84 1,514.84 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% NAGYGGLGLSIEGPSK 95.00% 4.29 0.227 3.96 760.3928 1,518.77 1,519.78 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% NAGYGGLGLSIEGPSK 95.00% 3.55 0.354 2.54 760.3933 1,518.77 1,519.78 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% NAGYGGLGLSIEGPSK 95.00% 4.23 0.268 3.72 760.394 1,518.77 1,519.78 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% NAGYGGLGLSIEGPSK 95.00% 3.82 0.26 3.85 760.3946 1,518.77 1,519.78 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% NAGYGGLGLSIEGPSK 95.00% 4.46 0.26 3.38 760.3946 1,518.77 1,519.78 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% NAGYGGLGLSIEGPSK 95.00% 3.15 0.305 2.49 760.395 1,518.77 1,519.78 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.71 0.398 1.28 767.39 2,299.15 2,300.23 3 ANK3_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.72 0.348 1.23 767.3902 2,299.15 2,300.23 3 ANK3_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.86 0.51 4.27 769.06 2,304.16 2,304.15 3 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.98 0.458 1.1 769.0607 2,304.16 2,304.15 3 FLNA_HUMAN
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TSQLNVGTSTDVSLK 95.00% 3.25 0.297 0 775.4126 1,548.81 1,549.81 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% FVPQEmGPHTVAVK 95.00% 2.53 0.233 0 m6: Oxidation (+15.99) 778.4025 1,554.79 1,555.79 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TDTYVTDNGDGTYR 95.00% 2.4 0.408 0 789.3415 1,576.67 1,577.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% TDTYVTDNGDGTYR 95.00% 3.6 0.546 3.06 789.3441 1,576.67 1,577.67 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LYAQDADGcPIDIK 95.00% 4.35 0.549 4.55 c9: Carbamidomethyl (+57.02) 789.8769 1,577.74 1,578.75 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LYAQDADGcPIDIK 95.00% 4.13 0.515 3.54 c9: Carbamidomethyl (+57.02) 789.879 1,577.74 1,578.75 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LYAQDADGcPIDIK 95.00% 4.42 0.538 3.92 c9: Carbamidomethyl (+57.02) 789.8795 1,577.74 1,578.75 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LYAQDADGcPIDIK 95.00% 4.55 0.494 5.26 c9: Carbamidomethyl (+57.02) 789.8799 1,577.74 1,578.75 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LYAQDADGcPIDIK 95.00% 4.23 0.524 4.03 c9: Carbamidomethyl (+57.02) 789.8801 1,577.74 1,578.75 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LYAQDADGcPIDIK 95.00% 4.64 0.535 4.44 c9: Carbamidomethyl (+57.02) 789.8802 1,577.74 1,578.75 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LYAQDADGcPIDIK 95.00% 4.09 0.553 4.77 c9: Carbamidomethyl (+57.02) 789.8809 1,577.75 1,578.75 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LYAQDADGcPIDIK 95.00% 4.44 0.517 4.24 c9: Carbamidomethyl (+57.02) 789.8817 1,577.75 1,578.75 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LYAQDADGcPIDIK 95.00% 2.8 0.29 0 c9: Carbamidomethyl (+57.02) 790.3577 1,578.70 1,578.75 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% LYAQDADGcPIDIK 95.00% 0 0 3.64 c9: Carbamidomethyl (+57.02) 790.6916 1,579.37 1,578.75 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.13 0.514 2.7 791.9472 1,581.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.08 0.526 2.68 791.9478 1,581.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.45 0.5 2.44 791.948 1,581.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.56 0.536 2.62 791.948 1,581.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.74 0.502 2.8 791.9481 1,581.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.55 0.487 2.51 791.9482 1,581.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4 0.423 2.32 791.9483 1,581.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.62 0.505 1.46 791.9483 1,581.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.5 0.441 2.77 791.9484 1,581.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.33 0.457 2.19 791.9487 1,581.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.11 0.44 2.12 791.9491 1,581.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.4 0.509 2.03 791.9503 1,581.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.09 0.474 1.48 791.9505 1,581.89 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.26 0.459 2.92 792.4486 1,582.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 3.55 0.339 0 792.4502 1,582.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 4.34 0.428 2.51 792.4502 1,582.88 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFVVNVAPPLDLSK 95.00% 3.58 0.432 2.96 792.4505 1,582.89 1,582.88 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLAIEGPSEAK 95.00% 4.96 0.586 4.36 792.9174 1,583.82 1,584.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLAIEGPSEAK 95.00% 4.69 0.554 3.44 792.9181 1,583.82 1,584.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLAIEGPSEAK 95.00% 4.61 0.582 4.15 792.9186 1,583.82 1,584.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLAIEGPSEAK 95.00% 4.78 0.564 5.48 792.9187 1,583.82 1,584.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLAIEGPSEAK 95.00% 4.65 0.598 4.64 792.919 1,583.82 1,584.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLAIEGPSEAK 95.00% 4.82 0.548 4.48 792.919 1,583.82 1,584.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLAIEGPSEAK 95.00% 4.49 0.558 5.03 792.9192 1,583.82 1,584.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLAIEGPSEAK 95.00% 4.81 0.607 4.19 792.9195 1,583.82 1,584.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLAIEGPSEAK 95.00% 4.38 0.51 4.4 792.9196 1,583.82 1,584.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLAIEGPSEAK 95.00% 4.37 0.606 4.33 792.9202 1,583.82 1,584.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLAIEGPSEAK 95.00% 4.38 0.564 5.08 792.9204 1,583.83 1,584.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLAIEGPSEAK 95.00% 4.72 0.552 4.33 793.4195 1,584.82 1,584.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% FIPHENGVHSIDVK 95.00% 3.53 0.501 2.36 796.4168 1,590.82 1,591.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% FIPHENGVHSIDVK 95.00% 3.47 0.431 0 796.9192 1,591.82 1,591.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVQVSPEAGVQK 95.00% 4.64 0.429 0 801.4143 1,600.81 1,601.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVQVSPEAGVQK 95.00% 4.1 0.486 1.7 801.4145 1,600.81 1,601.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVQVSPEAGVQK 95.00% 3.77 0.464 2.42 801.4153 1,600.81 1,601.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVQVSPEAGVQK 95.00% 4.09 0.478 1.42 801.4156 1,600.82 1,601.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVQVSPEAGVQK 95.00% 4.72 0.485 1.85 801.4156 1,600.82 1,601.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVQVSPEAGVQK 95.00% 4.22 0.47 1.77 801.4159 1,600.82 1,601.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVQVSPEAGVQK 95.00% 4.57 0.486 2.59 801.4162 1,600.82 1,601.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVQVSPEAGVQK 95.00% 4.98 0.466 1.62 801.9162 1,601.82 1,601.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVQVSPEAGVQK 95.00% 4.71 0.433 1.77 801.9184 1,601.82 1,601.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVQVSPEAGVQK 95.00% 4.6 0.465 0 801.9187 1,601.82 1,601.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVQVSPEAGVQK 95.00% 4.58 0.49 1.96 801.9199 1,601.82 1,601.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVQVSPEAGVQK 95.00% 4.83 0.425 2.33 801.9217 1,601.83 1,601.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVNVGmALGDANK 95.00% 4.12 0.431 5.57 m9: Oxidation (+15.99) 832.9032 1,663.79 1,664.80 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% SPFEVNVGmALGDANK 95.00% 3.88 0.453 3.42 m9: Oxidation (+15.99) 832.9076 1,663.80 1,664.80 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLTVEGPcEAK 95.00% 2.27 0.514 0 c15: Carbamidomethyl (+57.02) 837.0352 1,672.05 1,673.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLTVEGPcEAK 95.00% 4.22 0.574 5.72 c15: Carbamidomethyl (+57.02) 837.4108 1,672.81 1,673.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLTVEGPcEAK 95.00% 3.94 0.615 3.85 c15: Carbamidomethyl (+57.02) 837.4113 1,672.81 1,673.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLTVEGPcEAK 95.00% 4.38 0.618 4.11 c15: Carbamidomethyl (+57.02) 837.4127 1,672.81 1,673.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLTVEGPcEAK 95.00% 4.35 0.594 4.74 c15: Carbamidomethyl (+57.02) 837.4138 1,672.81 1,673.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLTVEGPcEAK 95.00% 4.03 0.593 4.64 c15: Carbamidomethyl (+57.02) 837.414 1,672.81 1,673.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLTVEGPcEAK 95.00% 4.42 0.592 5.19 c15: Carbamidomethyl (+57.02) 837.4149 1,672.81 1,673.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLTVEGPcEAK 95.00% 4.34 0.607 4.22 c15: Carbamidomethyl (+57.02) 837.4162 1,672.82 1,673.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLTVEGPcEAK 95.00% 4.36 0.559 4.55 c15: Carbamidomethyl (+57.02) 837.4164 1,672.82 1,673.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLTVEGPcEAK 95.00% 4.12 0.233 0 c15: Carbamidomethyl (+57.02) 837.9117 1,673.81 1,673.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% GAGTGGLGLTVEGPcEAK 95.00% 4.14 0.598 4.15 c15: Carbamidomethyl (+57.02) 837.917 1,673.82 1,673.82 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DTVEVALEDKGDSTFR 95.00% 2.96 0.412 1.17 891.4309 1,780.85 1,781.86 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DTVEVALEDKGDSTFR 95.00% 3.65 0.424 2.82 891.4336 1,780.85 1,781.86 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DTVEVALEDKGDSTFR 95.00% 3.57 0.469 2.92 891.4384 1,780.86 1,781.86 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% QAPSIATIGSTcDLNLK 95.00% 4.68 0.595 4.15 c12: Carbamidomethyl (+57.02) 894.9612 1,787.91 1,788.92 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% QAPSIATIGSTcDLNLK 95.00% 4.07 0.435 3 c12: Carbamidomethyl (+57.02) 894.963 1,787.91 1,788.92 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% QAPSIATIGSTcDLNLK 95.00% 4.23 0.53 3.82 c12: Carbamidomethyl (+57.02) 894.9649 1,787.91 1,788.92 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% QAPSIATIGSTcDLNLK 95.00% 2.34 0.345 0 c12: Carbamidomethyl (+57.02) 894.9666 1,787.92 1,788.92 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% QAPSIATIGSTcDLNLK 95.00% 3.38 0.417 3.18 c12: Carbamidomethyl (+57.02) 894.9673 1,787.92 1,788.92 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% QAPSIATIGSTcDLNLK 95.00% 3.05 0 3 c12: Carbamidomethyl (+57.02) 894.9693 1,787.92 1,788.92 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% QAPSIATIGSTcDLNLK 95.00% 4.49 0.539 3.92 c12: Carbamidomethyl (+57.02) 895.4646 1,788.91 1,788.92 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% QAPSIATIGSTcDLNLK 95.00% 4.81 0.541 4.66 c12: Carbamidomethyl (+57.02) 895.4664 1,788.92 1,788.92 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VEAAEIVEGEDSAYSVR 95.00% 5.18 0.659 5.49 912.4382 1,822.86 1,823.87 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VEAAEIVEGEDSAYSVR 95.00% 5.38 0.662 4.34 912.4389 1,822.86 1,823.87 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VEAAEIVEGEDSAYSVR 95.00% 5.4 0.645 4.7 912.9388 1,823.86 1,823.87 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VEAAEIVEGEDSAYSVR 95.00% 5.15 0.647 4.28 912.9412 1,823.87 1,823.87 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VEAAEIVEGEDSAYSVR 95.00% 5.43 0.621 4.35 912.9414 1,823.87 1,823.87 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% VEAAEIVEGEDSAYSVR 95.00% 5.69 0.633 4.38 912.942 1,823.87 1,823.87 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DFEIIDNHDYSYTVK 95.00% 5.14 0.521 5.92 930.4317 1,858.85 1,858.85 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% DFEIIDNHDYSYTVK 95.00% 4.96 0.533 4.6 930.433 1,858.85 1,858.85 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APLQVAVLGPTGVAEPVEVR 95.00% 5.1 0.648 6.96 1,001.57 2,001.13 2,002.13 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APLQVAVLGPTGVAEPVEVR 95.00% 5.19 0.655 7.32 1,002.07 2,002.13 2,002.13 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APLQVAVLGPTGVAEPVEVR 95.00% 5.66 0.653 7.74 1,002.07 2,002.13 2,002.13 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% APLQVAVLGPTGVAEPVEVR 95.00% 5.48 0.661 6.85 1,002.07 2,002.13 2,002.13 2
 SAMPLE 4 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 47 51 304 28.00% EAGDGVFEcEYYPVVPGK 95.00% 3.9 0.514 5.92 c9: Carbamidomethyl (+57.02) 1,008.96 2,015.90 2,015.91 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% YGGPQHIVGSPFK 95.00% 3.88 0.508 1.64 462.9127 1,385.71 1,386.72 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% YGGPQHIVGSPFK 95.00% 3.3 0.475 1.51 462.9141 1,385.72 1,386.72 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% YGGPQHIVGSPFK 95.00% 3.24 0.522 1.51 463.249 1,386.72 1,386.72 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LGSFGSITR 95.00% 1.86 0.236 1.4 469.2581 936.5006 937.5108 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LGSFGSITR 95.00% 2.12 0.432 0 469.2599 936.5042 937.5108 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LGSFGSITR 95.00% 2.12 0.387 0 469.2604 936.5051 937.5108 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LGSFGSITR 95.00% 2.24 0.448 0 469.2606 936.5056 937.5108 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LGSFGSITR 95.00% 2.35 0.405 0 469.261 936.5064 937.5108 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LGSFGSITR 95.00% 2.48 0.406 0 469.2612 936.5067 937.5108 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LGSFGSITR 95.00% 2.09 0.468 1.41 469.2616 936.5075 937.5108 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LGSFGSITR 95.00% 2.35 0.351 0 469.262 936.5083 937.5108 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LGSFGSITR 95.00% 2.06 0.389 1.38 469.2623 936.509 937.5108 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LLGWIQNK 95.00% 2.61 0.157 0 486.2877 970.5598 971.568 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LLGWIQNK 95.00% 3.11 0.139 0 486.2881 970.5606 971.568 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LLGWIQNK 95.00% 2.86 0.0953 0 486.2882 970.5607 971.568 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LLGWIQNK 95.00% 2.68 0.182 0 486.2882 970.5608 971.568 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LLGWIQNK 94.80% 2.41 0.154 0 486.2882 970.5608 971.568 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LLGWIQNK 95.00% 2.97 0.174 0 486.2882 970.5608 971.568 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LLGWIQNK 95.00% 2.76 0.113 0 486.2884 970.5611 971.568 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LLGWIQNK 95.00% 2.88 0.19 0 486.2885 970.5614 971.568 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LLGWIQNK 95.00% 2.81 0.17 0 486.2887 970.5617 971.568 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% FADKHVPGSPFTVK 95.00% 2.52 0.242 0 510.947 1,529.82 1,529.81 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% FDDKHIPGSPFTAK 95.00% 2.21 0.209 1 520.601 1,558.78 1,559.79 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% HVPGSPFTVK 95.00% 1.19 0 3.54 534.797 1,067.58 1,068.58 2 WDR1_HUMAN,SRBS2_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VYNVTYTVK 95.00% 2.78 0.259 1.62 543.7967 1,085.58 1,086.58 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TGVEVGKPTHFTVLTK 95.00% 2.84 0.406 0 571.9902 1,712.95 1,713.95 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TGVEVGKPTHFTVLTK 95.00% 3 0.396 0 571.9904 1,712.95 1,713.95 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TGVEVGKPTHFTVLTK 95.00% 2.96 0.377 0 571.9913 1,712.95 1,713.95 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TGVEVGKPTHFTVLTK 95.00% 3.65 0.509 0 571.9913 1,712.95 1,713.95 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TGVEVGKPTHFTVLTK 95.00% 2.82 0.311 0 571.9914 1,712.95 1,713.95 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TGVEVGKPTHFTVLTK 95.00% 3.08 0.338 0 571.9919 1,712.95 1,713.95 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TGVEVGKPTHFTVLTK 95.00% 2.71 0.446 0 572.3244 1,713.95 1,713.95 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TGVEVGKPTHFTVLTK 95.00% 3.22 0.44 0 572.3245 1,713.95 1,713.95 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TGVEVGKPTHFTVLTK 95.00% 2.93 0.351 0 572.3247 1,713.95 1,713.95 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TGVEVGKPTHFTVLTK 95.00% 3.79 0.585 0 572.3251 1,713.95 1,713.95 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGSGELKVTVK 95.00% 2.96 0.405 0 573.331 1,144.65 1,145.65 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGSGELKVTVK 95.00% 2.91 0.331 1.24 573.3321 1,144.65 1,145.65 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGSGELKVTVK 95.00% 3.09 0.421 1.6 573.3322 1,144.65 1,145.65 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGSGELKVTVK 95.00% 3.27 0.351 0 573.3327 1,144.65 1,145.65 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% DLAEDAPWKK 95.00% 2.38 0.242 0 586.8024 1,171.59 1,172.60 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% DLAEDAPWKK 95.00% 2.28 0.226 0 586.8026 1,171.59 1,172.60 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% DLAEDAPWKK 95.00% 2.27 0.184 1.57 586.803 1,171.59 1,172.60 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GPGLSQAFVGQK 95.00% 3.4 0.569 3.28 594.8204 1,187.63 1,188.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GPGLSQAFVGQK 95.00% 3.45 0.553 2.2 594.8214 1,187.63 1,188.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GPGLSQAFVGQK 95.00% 2.98 0.56 3.09 594.8227 1,187.63 1,188.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GPGLSQAFVGQK 95.00% 3.25 0.583 2.92 594.8232 1,187.63 1,188.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% DTVEVALEDKGDSTFR 95.00% 2.83 0.361 0 594.96 1,781.86 1,781.86 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% DTVEVALEDKGDSTFR 95.00% 2.73 0.238 0 594.9615 1,781.86 1,781.86 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% ARVPQTFTVDcSQAGR 95.00% 4.5 0.507 2.8 c11: Carbamidomethyl (+57.02) 598.6315 1,792.87 1,792.88 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VEAAEIVEGEDSAYSVR 95.00% 3.2 0.451 1.11 608.9637 1,823.87 1,823.87 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.57 0.526 1.37 613.8905 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.44 0.525 2.52 613.8907 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.43 0.525 1.92 613.891 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.44 0.542 2.62 613.8911 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.87 0.499 1.82 613.8911 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.27 0.535 2.24 613.8912 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.35 0.514 2.72 613.8912 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.49 0.524 1.66 613.8913 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.56 0.521 2.41 613.8913 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.16 0.511 2.54 613.8914 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.72 0.512 2.02 613.8916 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.34 0.517 1.96 613.8916 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.6 0.49 2.03 613.8916 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.52 0.53 2.25 613.8918 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.39 0.539 2.42 613.8919 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.45 0.507 2.34 613.892 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.44 0.505 2.02 613.8921 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.23 0.506 3.54 613.8923 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 2.98 0.487 1.7 613.8929 1,225.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LIALLEVLSQK 95.00% 3.71 0.554 2.6 614.3918 1,226.77 1,226.77 2 FLNA_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TARPNITDNKDGTITVR 95.00% 3.65 0.473 1.43 624.6706 1,870.99 1,871.99 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AKLDVQFAGTAK 95.00% 1.87 0.233 1.77 624.8511 1,247.69 1,248.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AKLDVQFAGTAK 95.00% 2.89 0.539 3.4 624.8521 1,247.69 1,248.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AKLDVQFAGTAK 95.00% 2.12 0.39 0 624.8539 1,247.69 1,248.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AKLDVQFAGTAK 95.00% 2.75 0.43 3.2 624.8541 1,247.69 1,248.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AKLDVQFAGTAK 95.00% 1.75 0.322 0 624.8545 1,247.69 1,248.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TARPNITDNKDGTITVR 95.00% 4.09 0.477 1.64 625.003 1,871.99 1,871.99 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TARPNITDNKDGTITVR 95.00% 4.26 0.416 0 625.0061 1,871.99 1,871.99 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TARPNITDNKDGTITVR 95.00% 3.82 0.485 1.02 625.007 1,872.00 1,871.99 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 2.1 0.346 0 629.8437 1,257.67 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 3.3 0.47 3.92 629.8444 1,257.67 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 3.14 0.486 2.21 629.8445 1,257.67 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 2.73 0.412 1.31 629.8445 1,257.67 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 3.78 0.518 0 629.8451 1,257.67 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 2.12 0.363 0 629.8451 1,257.67 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 3.57 0.491 1.68 629.8452 1,257.67 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 3.15 0.449 1.38 629.8453 1,257.68 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 3.54 0.432 2.49 629.8453 1,257.68 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 3.11 0.484 1.39 629.8453 1,257.68 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 3.19 0.366 1.8 629.8456 1,257.68 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 2.87 0.404 1.37 629.8456 1,257.68 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 3.3 0.36 2.96 629.8469 1,257.68 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AFGPGLEGGLVNK 95.00% 3.3 0.34 0 629.8517 1,257.69 1,258.68 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% EVTTEFTVDAR 95.00% 2 0.292 1.54 634.3127 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% EVTTEFTVDAR 95.00% 2.53 0.336 1.89 634.3128 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% EVTTEFTVDAR 95.00% 2.22 0.276 1.62 634.313 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% EVTTEFTVDAR 95.00% 2.69 0.362 1.85 634.314 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% EVTTEFTVDAR 95.00% 2.19 0.348 1.74 634.3143 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% EVTTEFTVDAR 95.00% 1.96 0.238 1.28 634.3147 1,266.61 1,267.62 2 COMP_HUMAN,TITIN_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% FNGAHIPGSPFK 95.00% 2.1 0.158 1.68 636.3325 1,270.65 1,271.65 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% ILVGPSEIGDASK 95.00% 2.87 0.472 1.25 643.3552 1,284.69 1,285.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% ILVGPSEIGDASK 95.00% 2.84 0.402 2.62 643.3553 1,284.69 1,285.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% ILVGPSEIGDASK 95.00% 3.84 0.573 5.1 643.3553 1,284.70 1,285.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% ILVGPSEIGDASK 95.00% 3.27 0.535 2.41 643.3555 1,284.70 1,285.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% ILVGPSEIGDASK 95.00% 3.72 0.592 4.09 643.3557 1,284.70 1,285.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% ILVGPSEIGDASK 95.00% 3.92 0.581 3.66 643.3559 1,284.70 1,285.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% ILVGPSEIGDASK 95.00% 2.32 0.435 0 643.3561 1,284.70 1,285.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% ILVGPSEIGDASK 95.00% 3.65 0.613 4.77 643.3561 1,284.70 1,285.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% ILVGPSEIGDASK 95.00% 2.38 0.348 1.54 643.3567 1,284.70 1,285.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% ILVGPSEIGDASK 95.00% 2.43 0.359 0 643.7254 1,285.44 1,285.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% ILVGPSEIGDASK 95.00% 2.81 0.42 0 643.7259 1,285.44 1,285.70 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFPVHVSEAcNPNAcR 95.00% 4.43 0.376 1.07 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 647.963 1,940.87 1,941.87 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFPVHVSEAcNPNAcR 95.00% 3.27 0.38 0 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 647.9654 1,940.87 1,941.87 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFPVHVSEAcNPNAcR 95.00% 3.67 0.429 1.49 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 648.2942 1,941.86 1,941.87 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFPVHVSEAcNPNAcR 95.00% 3.31 0.355 0 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 648.2957 1,941.86 1,941.87 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFPVHVSEAcNPNAcR 95.00% 5.31 0.424 3.41 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 648.2959 1,941.86 1,941.87 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFPVHVSEAcNPNAcR 95.00% 3.2 0.359 0 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 648.2975 1,941.87 1,941.87 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFPVHVSEAcNPNAcR 95.00% 4.65 0.467 1.82 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 648.2982 1,941.87 1,941.87 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFPVHVSEAcNPNAcR 95.00% 4.01 0.421 1.77 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 648.2983 1,941.87 1,941.87 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFPVHVSEAcNPNAcR 95.00% 4.49 0.514 1.85 c11: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 648.2989 1,941.87 1,941.87 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VPQLPITNFNR 95.00% 2.45 0.239 1.96 649.8659 1,297.72 1,298.72 2 MYH10_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VPQLPITNFNR 95.00% 2.4 0.433 2.37 649.8666 1,297.72 1,298.72 2 MYH10_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VPQLPITNFNR 95.00% 2.31 0.433 0 649.8667 1,297.72 1,298.72 2 MYH10_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VPQLPITNFNR 95.00% 2.45 0.283 1.92 649.8668 1,297.72 1,298.72 2 MYH10_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VPQLPITNFNR 95.00% 1.84 0.27 1.8 649.867 1,297.72 1,298.72 2 MYH10_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 1.77 0.266 1.36 650.3391 1,298.66 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 3.61 0.533 3.92 650.3396 1,298.66 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 1.93 0.314 2 650.3396 1,298.66 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 3.15 0.501 4.85 650.3401 1,298.66 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 3.63 0.464 4.47 650.3404 1,298.67 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 3.47 0.506 3.85 650.3406 1,298.67 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 4.15 0.514 3.96 650.3408 1,298.67 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 3.24 0.484 4.49 650.3409 1,298.67 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 2.28 0.436 2.68 650.3409 1,298.67 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 2.33 0.407 3.08 650.341 1,298.67 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 3.66 0.505 4.38 650.3413 1,298.67 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 2.67 0.403 1.64 650.3413 1,298.67 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 3.29 0.436 3.36 650.3418 1,298.67 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 2.01 0.411 0 650.342 1,298.67 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 3.34 0.469 4.55 650.3423 1,298.67 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AWGPGLETGQVGK 95.00% 3.5 0.528 4.92 650.8435 1,299.67 1,299.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VSGPGVEPHGVLR 95.00% 2.77 0.412 3.46 652.3582 1,302.70 1,303.71 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VSGPGVEPHGVLR 95.00% 2.87 0.443 3.85 652.3603 1,302.71 1,303.71 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VSGPGVEPHGVLR 95.00% 3.01 0.435 2.89 652.3607 1,302.71 1,303.71 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VSGPGVEPHGVLR 95.00% 3.65 0.437 3.68 652.3609 1,302.71 1,303.71 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VSGPGVEPHGVLR 95.00% 2.44 0.439 1.51 652.3611 1,302.71 1,303.71 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VSGPGVEPHGVLR 95.00% 3.58 0.439 3.66 652.3613 1,302.71 1,303.71 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VSGPGVEPHGVLR 95.00% 3.3 0.435 3 652.3617 1,302.71 1,303.71 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VSGPGVEPHGVLR 95.00% 3.13 0.494 2.44 652.3618 1,302.71 1,303.71 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VSGPGVEPHGVLR 95.00% 3.82 0.452 4.42 652.3623 1,302.71 1,303.71 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VSGPGVEPHGVLR 95.00% 3.45 0.397 4.25 652.3624 1,302.71 1,303.71 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VSGPGVEPHGVLR 95.00% 3.65 0.426 3.62 652.3626 1,302.71 1,303.71 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APSGNEEPcLLK 95.00% 2.54 0.352 0 c9: Carbamidomethyl (+57.02) 657.8222 1,313.63 1,314.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APSGNEEPcLLK 95.00% 3.59 0.333 1.89 c9: Carbamidomethyl (+57.02) 657.8228 1,313.63 1,314.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APSGNEEPcLLK 95.00% 3.67 0.425 1.85 c9: Carbamidomethyl (+57.02) 657.823 1,313.63 1,314.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APSGNEEPcLLK 95.00% 3.21 0.35 1.31 c9: Carbamidomethyl (+57.02) 657.823 1,313.63 1,314.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APSGNEEPcLLK 95.00% 3.38 0.413 1.82 c9: Carbamidomethyl (+57.02) 657.823 1,313.63 1,314.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APSGNEEPcLLK 95.00% 3.55 0.393 1.55 c9: Carbamidomethyl (+57.02) 657.8235 1,313.63 1,314.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APSGNEEPcLLK 95.00% 2.53 0.326 1.36 c9: Carbamidomethyl (+57.02) 657.8238 1,313.63 1,314.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APSGNEEPcLLK 95.00% 3.04 0.401 1.31 c9: Carbamidomethyl (+57.02) 657.8239 1,313.63 1,314.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APSGNEEPcLLK 95.00% 3.63 0.305 1.68 c9: Carbamidomethyl (+57.02) 657.8239 1,313.63 1,314.64 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APLQVAVLGPTGVAEPVEVR 95.00% 3.62 0.426 0 668.3857 2,002.13 2,002.13 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APLQVAVLGPTGVAEPVEVR 95.00% 3.85 0.484 1.34 668.3868 2,002.14 2,002.13 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APLQVAVLGPTGVAEPVEVR 95.00% 4.42 0.515 1.02 668.3871 2,002.14 2,002.13 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APLQVAVLGPTGVAEPVEVR 95.00% 3.75 0.472 1.49 668.3871 2,002.14 2,002.13 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APLQVAVLGPTGVAEPVEVR 95.00% 3.84 0.513 1.47 668.3881 2,002.14 2,002.13 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VHVQPAVDTSGVK 95.00% 3.18 0.424 2.6 668.8673 1,335.72 1,336.72 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VHVQPAVDTSGVK 95.00% 2.91 0.488 2.59 668.8678 1,335.72 1,336.72 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VHVQPAVDTSGVK 95.00% 2.93 0.48 3.28 668.8678 1,335.72 1,336.72 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VHVQPAVDTSGVK 95.00% 3.06 0.242 2.85 668.8682 1,335.72 1,336.72 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VHVQPAVDTSGVK 95.00% 2.69 0.33 2.89 668.8684 1,335.72 1,336.72 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GLSEGHTFQVAEFIVDTR 95.00% 2.71 0.285 0 669.3402 2,005.00 2,006.00 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GLSEGHTFQVAEFIVDTR 95.00% 2.39 0.231 0 669.6729 2,006.00 2,006.00 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VTVLFAGQNIER 95.00% 2.8 0.263 1.59 673.8761 1,345.74 1,346.74 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VTVLFAGQNIER 95.00% 2.68 0.203 0 673.8765 1,345.74 1,346.74 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VTVLFAGQNIER 95.00% 3.62 0.292 3 673.8767 1,345.74 1,346.74 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VTVLFAGQNIER 95.00% 3.47 0.363 1.42 673.877 1,345.74 1,346.74 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VTVLFAGQNIER 95.00% 2.92 0.354 0 673.8774 1,345.74 1,346.74 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VTVLFAGQNIER 95.00% 3.11 0.288 1.96 673.8777 1,345.74 1,346.74 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VTVLFAGQNIER 95.00% 2.47 0.257 1.23 673.8784 1,345.74 1,346.74 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VTVLFAGQNIER 95.00% 3.6 0.282 0 674.3749 1,346.73 1,346.74 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VTVLFAGQNIER 95.00% 3.13 0.311 3.44 674.3779 1,346.74 1,346.74 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% YGGPQHIVGSPFK 95.00% 3.81 0.469 1.68 693.8642 1,385.71 1,386.72 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% YGGPQHIVGSPFK 95.00% 3.65 0.444 1.8 693.8645 1,385.71 1,386.72 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% YGGPQHIVGSPFK 95.00% 2.41 0.249 1.54 693.8647 1,385.71 1,386.72 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% YGGPQHIVGSPFK 95.00% 3.4 0.461 2.06 693.8649 1,385.71 1,386.72 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% YGGPQHIVGSPFK 95.00% 3.34 0.461 1.62 693.8656 1,385.72 1,386.72 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% YGGPQHIVGSPFK 95.00% 3.2 0.5 2.54 693.8674 1,385.72 1,386.72 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% YGGPQHIVGSPFK 95.00% 2.86 0.259 0 694.375 1,386.73 1,386.72 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LSGGHSLHETSTVLVETVTK 95.00% 4.68 0.578 2.47 699.0411 2,094.10 2,095.10 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LSGGHSLHETSTVLVETVTK 95.00% 3.47 0.331 1.25 699.3755 2,095.10 2,095.10 3
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GGLVGTPAPFSIDTK 95.00% 2.71 0.317 2.07 730.4003 1,458.78 1,459.78 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GGLVGTPAPFSIDTK 95.00% 2.96 0.152 1.77 730.43 1,458.84 1,459.78 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GGLVGTPAPFSIDTK 95.00% 2.92 0.103 1.68 730.4309 1,458.85 1,459.78 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% DAGEGGLSLAVEGPSK 95.00% 2.98 0.152 0 743.8806 1,485.75 1,486.74 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% DAGEGGLSLAVEGPSK 95.00% 3.79 0.324 3.77 744.3771 1,486.74 1,486.74 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GVAGVPAEFSIWTR 95.00% 2.78 0.281 0 745.3957 1,488.78 1,489.78 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GVAGVPAEFSIWTR 95.00% 2.64 0.313 2.24 745.3969 1,488.78 1,489.78 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GVAGVPAEFSIWTR 95.00% 2.64 0.347 1.89 745.3988 1,488.78 1,489.78 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GVAGVPAEFSIWTR 95.00% 3.33 0.513 5.2 745.4011 1,488.79 1,489.78 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GVAGVPAEFSIWTR 95.00% 4.4 0.531 4.54 745.9008 1,489.79 1,489.78 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GVAGVPAEFSIWTR 95.00% 4.03 0.588 4.42 745.9024 1,489.79 1,489.78 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VAVGQEQAFSVNTR 95.00% 3.25 0.614 2.96 753.3914 1,504.77 1,505.77 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VAVGQEQAFSVNTR 95.00% 3.88 0.568 4.51 753.3918 1,504.77 1,505.77 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VAVGQEQAFSVNTR 95.00% 4.2 0.594 4.6 753.393 1,504.77 1,505.77 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VAVGQEQAFSVNTR 95.00% 3.79 0.507 3.57 753.3932 1,504.77 1,505.77 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VAVGQEQAFSVNTR 95.00% 3.9 0.501 4.68 753.3932 1,504.77 1,505.77 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VAVGQEQAFSVNTR 95.00% 3.54 0.528 3.49 753.3933 1,504.77 1,505.77 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VAVGQEQAFSVNTR 95.00% 3.3 0.522 3.39 753.394 1,504.77 1,505.77 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% IQIGQETVITVDAK 95.00% 2.97 0.436 1.52 757.9264 1,513.84 1,514.84 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% IQIGQETVITVDAK 95.00% 4.28 0.506 6.41 757.9275 1,513.84 1,514.84 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% IQIGQETVITVDAK 95.00% 3.75 0.483 4.44 757.9283 1,513.84 1,514.84 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% IQIGQETVITVDAK 95.00% 4.03 0.489 4.7 757.9285 1,513.84 1,514.84 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% IQIGQETVITVDAK 95.00% 4.2 0.486 3.57 757.929 1,513.84 1,514.84 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% IQIGQETVITVDAK 95.00% 4.34 0.467 3.08 758.4287 1,514.84 1,514.84 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% IQIGQETVITVDAK 95.00% 4.43 0.5 4.02 758.4307 1,514.85 1,514.84 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% NAGYGGLGLSIEGPSK 95.00% 2.71 0.247 2 760.3938 1,518.77 1,519.78 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% NAGYGGLGLSIEGPSK 95.00% 3.77 0.297 3.51 760.3955 1,518.78 1,519.78 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% NAGYGGLGLSIEGPSK 95.00% 4.09 0.241 3.44 760.8958 1,519.78 1,519.78 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.64 0.362 2.68 767.3894 2,299.14 2,300.23 3 ANK3_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.43 0.292 1.89 767.3903 2,299.15 2,300.23 3 ANK3_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.44 0.348 1.47 767.3907 2,299.15 2,300.23 3 ANK3_HUMAN
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TSQLNVGTSTDVSLK 95.00% 3.89 0.453 5.25 775.9127 1,549.81 1,549.81 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TDTYVTDNGDGTYR 95.00% 3.79 0.511 3.35 789.3409 1,576.67 1,577.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TDTYVTDNGDGTYR 95.00% 3.68 0.521 4.92 789.3416 1,576.67 1,577.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TDTYVTDNGDGTYR 95.00% 3.78 0.52 5.36 789.3416 1,576.67 1,577.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% TDTYVTDNGDGTYR 95.00% 3 0.479 3.82 789.3466 1,576.68 1,577.67 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LYAQDADGcPIDIK 95.00% 4.35 0.52 3.54 c9: Carbamidomethyl (+57.02) 789.8783 1,577.74 1,578.75 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LYAQDADGcPIDIK 95.00% 3.05 0.374 2.46 c9: Carbamidomethyl (+57.02) 789.8788 1,577.74 1,578.75 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LYAQDADGcPIDIK 95.00% 4.36 0.466 3.77 c9: Carbamidomethyl (+57.02) 789.8788 1,577.74 1,578.75 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LYAQDADGcPIDIK 95.00% 3.86 0.547 3.11 c9: Carbamidomethyl (+57.02) 789.8789 1,577.74 1,578.75 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LYAQDADGcPIDIK 95.00% 4.4 0.515 4.7 c9: Carbamidomethyl (+57.02) 789.8803 1,577.75 1,578.75 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LYAQDADGcPIDIK 95.00% 4.49 0.457 5.17 c9: Carbamidomethyl (+57.02) 790.3831 1,578.75 1,578.75 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% LYAQDADGcPIDIK 95.00% 4.37 0.405 2.22 c9: Carbamidomethyl (+57.02) 790.3848 1,578.75 1,578.75 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 3.99 0.47 2.72 791.9453 1,581.87 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 4.04 0.509 2.92 791.9475 1,581.88 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 4.05 0.477 3.35 791.9477 1,581.88 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 4.87 0.485 2.15 791.9478 1,581.88 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 3.76 0.516 2.68 791.9479 1,581.88 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 4.38 0.483 2.28 791.948 1,581.88 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 3.73 0.39 3.54 791.9486 1,581.88 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 4.12 0.503 2.43 791.9488 1,581.88 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 3.97 0.485 1.85 791.9489 1,581.88 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 3.8 0.468 2.31 791.9492 1,581.88 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 3.9 0.443 2.92 791.9497 1,581.88 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 3.69 0.461 2.41 791.9499 1,581.88 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 4.16 0.498 2.23 791.9507 1,581.89 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 3.02 0.408 0 791.951 1,581.89 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 2.69 0.293 0 791.9533 1,581.89 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 4.19 0.423 2.74 792.4497 1,582.88 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 4.5 0.384 3.27 792.4508 1,582.89 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 3.77 0.382 1.85 792.4509 1,582.89 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 4.66 0.445 1.85 792.4512 1,582.89 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFVVNVAPPLDLSK 95.00% 3.96 0.399 3.36 792.4516 1,582.89 1,582.88 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLAIEGPSEAK 95.00% 4.62 0.556 3.96 792.9164 1,583.82 1,584.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLAIEGPSEAK 95.00% 4.34 0.557 5.42 792.9178 1,583.82 1,584.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLAIEGPSEAK 95.00% 4.85 0.472 4.09 792.9184 1,583.82 1,584.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLAIEGPSEAK 95.00% 4.4 0.577 4.35 792.9198 1,583.82 1,584.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLAIEGPSEAK 95.00% 4.81 0.538 3.77 792.92 1,583.82 1,584.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLAIEGPSEAK 95.00% 4.6 0.567 4.38 792.9201 1,583.82 1,584.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLAIEGPSEAK 95.00% 4.82 0.539 4.07 793.4214 1,584.83 1,584.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFEVQVSPEAGVQK 95.00% 3.23 0.336 0 801.4097 1,600.80 1,601.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFEVQVSPEAGVQK 95.00% 4.23 0.471 0 801.4142 1,600.81 1,601.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFEVQVSPEAGVQK 95.00% 4.68 0.487 1.89 801.4143 1,600.81 1,601.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFEVQVSPEAGVQK 95.00% 4.38 0.472 1.43 801.4145 1,600.81 1,601.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFEVQVSPEAGVQK 95.00% 4.58 0.465 2.85 801.4164 1,600.82 1,601.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFEVQVSPEAGVQK 95.00% 4.19 0.44 2.41 801.4166 1,600.82 1,601.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFEVQVSPEAGVQK 95.00% 3.79 0.428 1.37 801.4181 1,600.82 1,601.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFEVQVSPEAGVQK 95.00% 3.45 0.431 0 801.4201 1,600.82 1,601.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFEVQVSPEAGVQK 95.00% 3.78 0.457 1.28 801.9176 1,601.82 1,601.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFEVQVSPEAGVQK 95.00% 4.7 0.448 1.66 801.9176 1,601.82 1,601.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFEVQVSPEAGVQK 95.00% 5.09 0.449 1.49 801.9181 1,601.82 1,601.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% IPGNWFQMVSAQER 95.00% 4.09 0.589 3.82 831.9095 1,661.80 1,662.81 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% SPFEVNVGmALGDANK 95.00% 3.65 0.42 5.22 m9: Oxidation (+15.99) 832.9026 1,663.79 1,664.80 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLTVEGPcEAK 95.00% 1.17 0.431 1.51 c15: Carbamidomethyl (+57.02) 837.0377 1,672.06 1,673.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLTVEGPcEAK 95.00% 4.03 0.587 4.05 c15: Carbamidomethyl (+57.02) 837.4111 1,672.81 1,673.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLTVEGPcEAK 95.00% 4.29 0.597 4.37 c15: Carbamidomethyl (+57.02) 837.4138 1,672.81 1,673.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLTVEGPcEAK 95.00% 4.25 0.567 3.92 c15: Carbamidomethyl (+57.02) 837.4158 1,672.82 1,673.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLTVEGPcEAK 95.00% 4.21 0.618 3.57 c15: Carbamidomethyl (+57.02) 837.4159 1,672.82 1,673.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLTVEGPcEAK 95.00% 3.96 0.594 3.85 c15: Carbamidomethyl (+57.02) 837.4162 1,672.82 1,673.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% GAGTGGLGLTVEGPcEAK 95.00% 4.28 0.616 3.59 c15: Carbamidomethyl (+57.02) 837.417 1,672.82 1,673.82 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% QAPSIATIGSTcDLNLK 95.00% 3.89 0.188 1.36 c12: Carbamidomethyl (+57.02) 894.9612 1,787.91 1,788.92 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% QAPSIATIGSTcDLNLK 95.00% 4 0.485 3.31 c12: Carbamidomethyl (+57.02) 894.9624 1,787.91 1,788.92 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% QAPSIATIGSTcDLNLK 95.00% 3.65 0.0525 2.4 c12: Carbamidomethyl (+57.02) 894.9639 1,787.91 1,788.92 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% QAPSIATIGSTcDLNLK 95.00% 3.32 0.52 3.23 c12: Carbamidomethyl (+57.02) 894.9644 1,787.91 1,788.92 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% QAPSIATIGSTcDLNLK 95.00% 3.72 0.467 2.85 c12: Carbamidomethyl (+57.02) 894.9709 1,787.93 1,788.92 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% QAPSIATIGSTcDLNLK 95.00% 5 0.612 4.7 c12: Carbamidomethyl (+57.02) 895.4642 1,788.91 1,788.92 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% QAPSIATIGSTcDLNLK 95.00% 5.2 0.549 3.72 c12: Carbamidomethyl (+57.02) 895.4655 1,788.92 1,788.92 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VEAAEIVEGEDSAYSVR 95.00% 4 0.591 4.92 912.4403 1,822.86 1,823.87 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VEAAEIVEGEDSAYSVR 95.00% 4.83 0.662 3.92 912.9394 1,823.86 1,823.87 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VEAAEIVEGEDSAYSVR 95.00% 4.68 0.639 4.89 912.9431 1,823.87 1,823.87 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% DFEIIDNHDYSYTVK 95.00% 4.71 0.535 4.6 930.4315 1,858.85 1,858.85 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% DFEIIDNHDYSYTVK 95.00% 4.4 0.556 4.77 930.432 1,858.85 1,858.85 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% VTYcPTEPGTYIINIK 95.00% 2.25 0.441 0 c4: Carbamidomethyl (+57.02) 934.9803 1,867.95 1,868.95 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APLQVAVLGPTGVAEPVEVR 95.00% 5.49 0.643 7 1,002.07 2,002.13 2,002.13 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APLQVAVLGPTGVAEPVEVR 95.00% 5.44 0.643 9.7 1,002.07 2,002.13 2,002.13 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APLQVAVLGPTGVAEPVEVR 95.00% 5.72 0.657 7.96 1,002.07 2,002.13 2,002.13 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APLQVAVLGPTGVAEPVEVR 95.00% 5.54 0.616 9.13 1,002.07 2,002.13 2,002.13 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APLQVAVLGPTGVAEPVEVR 95.00% 5.26 0.534 7.77 1,002.08 2,002.14 2,002.13 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% APLQVAVLGPTGVAEPVEVR 95.00% 5.39 0.633 6.48 1,002.08 2,002.14 2,002.13 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% EAGDGVFEcEYYPVVPGK 95.00% 3.42 0.574 2.34 c9: Carbamidomethyl (+57.02) 1,008.96 2,015.90 2,015.91 2
 SAMPLE 4R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 45 48 255 25.90% EAGDGVFEcEYYPVVPGK 95.00% 4.21 0.587 4.92 c9: Carbamidomethyl (+57.02) 1,008.96 2,015.91 2,015.91 2
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% LLGWIQNK 95.00% 2.86 0.14 0 486.2863 970.5569 971.568 2 FLNA_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% LLGWIQNK 95.00% 2.96 0.16 0 486.2865 970.5573 971.568 2 FLNA_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% LLGWIQNK 95.00% 2.51 0.15 0 486.2865 970.5573 971.568 2 FLNA_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% LLGWIQNK 95.00% 2.98 0.151 0 486.2865 970.5573 971.568 2 FLNA_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% LLGWIQNK 95.00% 2.93 0.155 0 486.2865 970.5573 971.568 2 FLNA_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% LLGWIQNK 95.00% 2.95 0.187 0 486.2867 970.5577 971.568 2 FLNA_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% LLGWIQNK 95.00% 2.66 0.183 0 486.287 970.5584 971.568 2 FLNA_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% LLGWIQNK 95.00% 2.86 0.121 0 486.2877 970.5598 971.568 2 FLNA_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% AFGPGLEGGLVNK 95.00% 2.79 0.221 0 629.8551 1,257.69 1,258.68 2
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% VHVQPAVDTSGVK 95.00% 1.62 0.312 1.37 668.9981 1,335.98 1,336.72 2
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.38 0.316 2.28 767.3833 2,299.13 2,300.23 3 ANK3_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.27 0.281 0 767.3861 2,299.13 2,300.23 3 ANK3_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.5 0.254 1.37 767.387 2,299.14 2,300.23 3 ANK3_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.46 0.364 1.96 767.387 2,299.14 2,300.23 3 ANK3_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.22 0.326 1.68 767.3877 2,299.14 2,300.23 3 ANK3_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.31 0.199 0 767.3887 2,299.14 2,300.23 3 ANK3_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.89 0.509 1.57 769.0561 2,304.14 2,304.15 3 FLNA_HUMAN
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% SPFVVNVAPPLDLSK 95.00% 4.3 0.48 2.57 792.4468 1,582.88 1,582.88 2
 SAMPLE 1 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 5 5 10 4.48% cAPGVVGPAEADIDFDIIKNDNDTFTVK 95.00% 2.99 0.309 0 c1: Carbamidomethyl (+57.02) 1,008.00 3,020.97 3,021.45 3
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LLGWIQNK 95.00% 2.71 0.171 0 486.2859 970.5561 971.568 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LLGWIQNK 95.00% 2.71 0.17 0 486.2866 970.5575 971.568 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LLGWIQNK 95.00% 2.85 0.167 0 486.2867 970.5578 971.568 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LLGWIQNK 95.00% 2.76 0.158 0 486.2869 970.5581 971.568 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LLGWIQNK 95.00% 2.67 0.19 0 486.2871 970.5585 971.568 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LLGWIQNK 95.00% 2.72 0.127 0 486.2873 970.5589 971.568 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LLGWIQNK 95.00% 2.72 0.125 0 486.2873 970.5589 971.568 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LLGWIQNK 95.00% 2.47 0.166 0 486.2877 970.5598 971.568 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% GAGSGELKVTVK 95.00% 2.34 0.353 0 573.9693 1,145.92 1,145.65 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% DLAEDAPWKK 95.00% 2.33 0.225 0 586.7989 1,171.58 1,172.60 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% GPGLSQAFVGQK 95.00% 2.61 0.392 2.11 594.8221 1,187.63 1,188.64 2
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LIALLEVLSQK 95.00% 2.46 0.362 2.18 613.8872 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LIALLEVLSQK 95.00% 3.3 0.544 2.74 613.8874 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LIALLEVLSQK 95.00% 3.61 0.536 2.96 613.8888 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LIALLEVLSQK 95.00% 3.46 0.569 2.85 613.8889 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LIALLEVLSQK 95.00% 2.74 0.255 1.29 613.8889 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LIALLEVLSQK 95.00% 3.6 0.521 2.59 613.8891 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LIALLEVLSQK 95.00% 3.61 0.487 2.22 613.8894 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LIALLEVLSQK 95.00% 3.49 0.527 2.46 613.8895 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LIALLEVLSQK 95.00% 3.74 0.497 2.35 613.8897 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% LIALLEVLSQK 95.00% 2.34 0.259 0 614.3213 1,226.63 1,226.77 2 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% AFGPGLEGGLVNK 95.00% 1.96 0.389 0 629.8548 1,257.69 1,258.68 2
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.55 0.355 1.15 767.3853 2,299.13 2,300.23 3 ANK3_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.76 0.349 1.57 767.3861 2,299.13 2,300.23 3 ANK3_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.14 0.158 1.44 767.3865 2,299.14 2,300.23 3 ANK3_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.16 0.155 1 767.3884 2,299.14 2,300.23 3 ANK3_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.23 0.239 3 767.3887 2,299.14 2,300.23 3 ANK3_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.42 0.362 2.68 769.056 2,304.14 2,304.15 3 FLNA_HUMAN
 SAMPLE 1R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 8 4.62% SPFVVNVAPPLDLSK 95.00% 3.52 0.458 2.44 791.946 1,581.88 1,582.88 2
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 2.9 0.133 0 486.285 970.5544 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 3.1 0.137 0 486.2858 970.5559 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 3.03 0.175 0 486.2859 970.5561 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 3.16 0.141 0 486.2861 970.5566 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 3.02 0.138 0 486.2863 970.5569 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 2.77 0.178 0 486.2863 970.557 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 2.83 0.203 0 486.2864 970.5572 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 2.59 0.152 0 486.2867 970.5577 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 2.77 0.183 0 486.2868 970.558 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 2.82 0.173 0 486.2869 970.5581 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 2.74 0.176 0 486.2871 970.5585 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 2.63 0.153 0 486.2871 970.5586 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% LLGWIQNK 95.00% 2.97 0.203 0 486.2873 970.559 971.568 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% DLAEDAPWK 95.00% 2.46 0.198 0 522.7542 1,043.49 1,044.50 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% IEcDDKGDGScDVR 95.00% 2.97 0.366 0 c3: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 542.558 1,624.65 1,625.65 3 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% GAGSGELKVTVK 95.00% 3.06 0.385 0 573.3293 1,144.64 1,145.65 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% GAGSGELKVTVK 95.00% 2.8 0.413 2.03 573.3296 1,144.64 1,145.65 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% DLAEDAPWKK 95.00% 2.53 0.284 0 586.8001 1,171.58 1,172.60 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% DLAEDAPWKK 95.00% 2.66 0.282 0 586.8004 1,171.59 1,172.60 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% DLAEDAPWKK 95.00% 2.22 0.285 0 586.802 1,171.59 1,172.60 2 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% GPGLSQAFVGQK 95.00% 2.63 0.4 1.89 594.8185 1,187.62 1,188.64 2
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% GPGLSQAFVGQK 95.00% 3.14 0.574 3.96 594.8202 1,187.62 1,188.64 2
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% GPGLSQAFVGQK 95.00% 2.97 0.483 2.8 594.8208 1,187.63 1,188.64 2
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.32 0.415 2.8 769.0557 2,304.14 2,304.15 3 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.89 0.487 3.8 769.0571 2,304.15 2,304.15 3 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.55 0.462 3.28 769.0573 2,304.15 2,304.15 3 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% GQHVPGSPFQFTVGPLGEGGAHK 95.00% 3.29 0.352 0 769.0585 2,304.15 2,304.15 3 FLNA_HUMAN
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% cAPGVVGPAEADIDFDIIKNDNDTFTVK 95.00% 3.49 0.438 1.3 c1: Carbamidomethyl (+57.02) 1,007.99 3,020.96 3,021.45 3
 SAMPLE 2 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.80% 2 2 5 3.93% cAPGVVGPAEADIDFDIIKNDNDTFTVK 95.00% 2.55 0.261 0 c1: Carbamidomethyl (+57.02) 1,008.00 3,020.97 3,021.45 3
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% YGGPQHIVGSPFK 95.00% 2.16 0.4 0 463.2763 1,386.81 1,386.72 3
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% YGGPQHIVGSPFK 95.00% 2.39 0.412 0 463.277 1,386.81 1,386.72 3
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% YGGPQHIVGSPFK 95.00% 2.06 0.279 0 463.277 1,386.81 1,386.72 3
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% YGGPQHIVGSPFK 95.00% 2 0.321 0 463.2783 1,386.81 1,386.72 3
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% YGGPQHIVGSPFK 95.00% 1.99 0.319 0 463.2798 1,386.82 1,386.72 3
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% LLGWIQNK 95.00% 2.81 0.086 0 486.2861 970.5566 971.568 2 FLNA_HUMAN
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% LLGWIQNK 95.00% 2.79 0.186 0 486.2863 970.557 971.568 2 FLNA_HUMAN
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% LLGWIQNK 95.00% 2.92 0.175 0 486.2864 970.5571 971.568 2 FLNA_HUMAN
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% LLGWIQNK 95.00% 2.98 0.166 0 486.2865 970.5573 971.568 2 FLNA_HUMAN
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% LLGWIQNK 95.00% 2.88 0.169 0 486.2867 970.5577 971.568 2 FLNA_HUMAN
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% LLGWIQNK 95.00% 2.65 0.185 0 486.2871 970.5586 971.568 2 FLNA_HUMAN
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% LLGWIQNK 95.00% 2.65 0.183 0 486.2872 970.5587 971.568 2 FLNA_HUMAN
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% LLGWIQNK 95.00% 3 0.19 0 486.2873 970.5589 971.568 2 FLNA_HUMAN
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% LLGWIQNK 95.00% 2.62 0.176 0 486.2878 970.56 971.568 2 FLNA_HUMAN
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% DLAEDAPWKK 95.00% 2.46 0.247 0 586.8009 1,171.59 1,172.60 2 FLNA_HUMAN
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% DLAEDAPWKK 95.00% 2.63 0.237 1.31 586.8017 1,171.59 1,172.60 2 FLNA_HUMAN
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% GPGLSQAFVGQK 95.00% 2.44 0.396 0 594.8189 1,187.62 1,188.64 2
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% GPGLSQAFVGQK 95.00% 3 0.483 2.96 594.82 1,187.62 1,188.64 2
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% GPGLSQAFVGQK 95.00% 3.3 0.479 2.3 594.8205 1,187.63 1,188.64 2
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% GPGLSQAFVGQK 95.00% 2.19 0.233 0 594.8206 1,187.63 1,188.64 2
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% GPGLSQAFVGQK 95.00% 3.27 0.544 3.09 594.8213 1,187.63 1,188.64 2
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% GPGLSQAFVGQK 95.00% 3.24 0.514 3.17 594.8214 1,187.63 1,188.64 2
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% GPGLSQAFVGQK 95.00% 2.19 0.345 0 594.8223 1,187.63 1,188.64 2
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% ILVGPSEIGDASK 95.00% 2.8 0.41 0 643.3523 1,284.69 1,285.70 2
 SAMPLE 3 Filamin-C  FLNC  FLNC_HUMAN 290,934.00 100.00% 4 4 14 2.53% AWGPGLETGQVGK 95.00% 1.86 0.396 1.18 650.3393 1,298.66 1,299.67 2
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LLGWIQNK 95.00% 2.51 0.132 0 486.2852 970.5547 971.568 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LLGWIQNK 95.00% 2.77 0.107 0 486.2853 970.555 971.568 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LLGWIQNK 95.00% 2.83 0.161 0 486.2862 970.5567 971.568 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LLGWIQNK 95.00% 2.7 0.148 0 486.2864 970.5571 971.568 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LLGWIQNK 95.00% 2.41 0.18 0 486.2864 970.5572 971.568 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LLGWIQNK 95.00% 2.57 0.152 0 486.2867 970.5577 971.568 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LLGWIQNK 95.00% 2.82 0.135 0 486.287 970.5583 971.568 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LLGWIQNK 95.00% 2.66 0.133 0 486.2871 970.5585 971.568 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LLGWIQNK 95.00% 3.05 0.172 0 486.2871 970.5585 971.568 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LLGWIQNK 95.00% 2.77 0.123 0 486.2872 970.5587 971.568 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% GPGLSQAFVGQK 95.00% 2.66 0.432 2.49 594.82 1,187.62 1,188.64 2
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% GPGLSQAFVGQK 95.00% 3.08 0.524 1.85 594.8202 1,187.62 1,188.64 2
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% GPGLSQAFVGQK 95.00% 3 0.466 2.41 594.8205 1,187.63 1,188.64 2
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LIALLEVLSQK 95.00% 3.6 0.501 2.15 613.8886 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LIALLEVLSQK 95.00% 2.89 0.505 2.49 613.8886 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LIALLEVLSQK 95.00% 3.12 0.544 2.92 613.8886 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LIALLEVLSQK 95.00% 3.29 0.473 2.09 613.8888 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LIALLEVLSQK 95.00% 3.65 0.508 2.16 613.8888 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LIALLEVLSQK 95.00% 3.81 0.547 2.29 613.8889 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LIALLEVLSQK 95.00% 4.09 0.524 1.89 613.889 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LIALLEVLSQK 95.00% 3.62 0.528 1.96 613.8891 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% LIALLEVLSQK 95.00% 3.39 0.524 2.13 613.8894 1,225.76 1,226.77 2 FLNA_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.28 0.249 0 767.3871 2,299.14 2,300.23 3 ANK3_HUMAN
 SAMPLE 3R Filamin-C  FLNC  FLNC_HUMAN 290,934.00 99.90% 2 2 5 1.94% AGRAGLERGVAGVPAEFSIWTR 95.00% 2.21 0.279 0 767.3874 2,299.14 2,300.23 3 ANK3_HUMAN
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% GEDFYcVTcHETK 95.00% 2.11 0.239 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2281 1,644.66 1,645.66 3
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% FDcHYcRDPLQGK 95.00% 2.81 0.269 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 565.9181 1,694.73 1,695.74 3
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% FDcHYcRDPLQGK 95.00% 2.87 0.289 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 565.9192 1,694.73 1,695.74 3
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% QVIGTGSFFPK 95.00% 2.23 0.379 1.68 590.8214 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% QVIGTGSFFPK 95.00% 2.55 0.383 2.57 590.8222 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% QVIGTGSFFPK 95.00% 2.55 0.263 4.06 590.8229 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% QVIGTGSFFPK 95.00% 2.68 0.454 2.06 590.8233 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% QVIGTGSFFPK 95.00% 2.49 0.442 1.54 590.8236 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% QVIGTGSFFPK 95.00% 2.56 0.458 2.66 590.8236 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% QVIGTGSFFPK 95.00% 2.61 0.489 3.49 590.8236 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% QVIGTGSFFPK 95.00% 2.52 0.436 3.25 590.8237 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% QVIGTGSFFPK 95.00% 2.35 0.15 1.92 590.8249 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% QVIGTGSFFPK 95.00% 2.78 0.29 1.92 591.3247 1,180.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% AIVAGDQNVEYK 95.00% 3.63 0.587 2.96 653.8383 1,305.66 1,306.66 2
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% AIVAGDQNVEYK 95.00% 3.8 0.609 2.92 653.8383 1,305.66 1,306.66 2
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% AIVAGDQNVEYK 95.00% 3.35 0.547 4.1 653.8387 1,305.66 1,306.66 2
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% AIVAGDQNVEYK 95.00% 3.69 0.606 2.82 653.8387 1,305.66 1,306.66 2
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% cLHPLANETFVAK 95.00% 0 0 4.27 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.8762 1,481.74 1,482.74 2
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% cLHPLANETFVAK 95.00% 0 0 5.35 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.8786 1,481.74 1,482.74 2
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% GEDFYcVTcHETK 95.00% 3.85 0.545 1.96 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3368 1,644.66 1,645.66 2
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% GEDFYcVTcHETK 95.00% 4.02 0.563 2.85 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3374 1,644.66 1,645.66 2
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% GEDFYcVTcHETK 95.00% 3.8 0.555 2.48 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3379 1,644.66 1,645.66 2
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% GEDFYcVTcHETK 95.00% 4 0.557 1.48 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3394 1,644.66 1,645.66 2
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% GEDFYcVTcHETK 95.00% 3.92 0.511 2.72 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.8367 1,645.66 1,645.66 2
 SAMPLE 4 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 4 5 15 19.20% GEDFYcVTcHETK 95.00% 3.99 0.544 2.72 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.8409 1,645.67 1,645.66 2
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% GEDFYcVTcHETK 95.00% 1.99 0.285 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.3057 1,644.89 1,645.66 3
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% FDcHYcRDPLQGK 95.00% 2.99 0.246 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 565.9183 1,694.73 1,695.74 3
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% FDcHYcRDPLQGK 95.00% 3.11 0.157 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 566.2526 1,695.73 1,695.74 3
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% QVIGTGSFFPK 95.00% 2.02 0.287 1.22 590.8222 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% QVIGTGSFFPK 95.00% 2.21 0.348 1.66 590.8225 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% QVIGTGSFFPK 95.00% 2.18 0.338 0 590.8227 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% QVIGTGSFFPK 95.00% 2.34 0.395 2 590.8229 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% QVIGTGSFFPK 95.00% 2.53 0.464 2.3 590.8229 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% QVIGTGSFFPK 95.00% 2.57 0.43 2.14 590.823 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% QVIGTGSFFPK 95.00% 2.47 0.453 2.85 590.8234 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% QVIGTGSFFPK 95.00% 2.34 0.403 0 590.8236 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% QVIGTGSFFPK 95.00% 2.66 0.265 2.06 590.8236 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% QVIGTGSFFPK 95.00% 2.5 0.324 0 590.8239 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% QVIGTGSFFPK 95.00% 2.63 0.463 2.15 590.824 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% GTVWHKDcFTcSNcK 95.00% 3.2 0.447 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 634.2717 1,899.79 1,899.79 3
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% GTVWHKDcFTcSNcK 95.00% 2.54 0.321 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 634.2731 1,899.80 1,899.79 3
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% AIVAGDQNVEYK 95.00% 3.8 0.621 3.74 653.8379 1,305.66 1,306.66 2
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% AIVAGDQNVEYK 95.00% 3.59 0.568 2.7 653.8382 1,305.66 1,306.66 2
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% AIVAGDQNVEYK 95.00% 3.72 0.608 3.27 653.8383 1,305.66 1,306.66 2
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% AIVAGDQNVEYK 95.00% 3.49 0.597 2.92 653.8386 1,305.66 1,306.66 2
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% cLHPLANETFVAK 95.00% 0 0 4.68 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.8764 1,481.74 1,482.74 2
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% cLHPLANETFVAK 95.00% 0 0 5.17 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.877 1,481.74 1,482.74 2
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% cLHPLANETFVAK 95.00% 0 0 3.49 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.8784 1,481.74 1,482.74 2
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% GEDFYcVTcHETK 95.00% 3.97 0.597 2.8 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.338 1,644.66 1,645.66 2
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% GEDFYcVTcHETK 95.00% 3.75 0.533 1.64 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3384 1,644.66 1,645.66 2
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% GEDFYcVTcHETK 95.00% 3.93 0.532 3.34 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3394 1,644.66 1,645.66 2
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% GEDFYcVTcHETK 95.00% 4.07 0.565 3.12 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.839 1,645.66 1,645.66 2
 SAMPLE 4R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 6 7 17 28.50% FTAVEDQYYcVDcYK 95.00% 3.51 0.488 4.15 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4156 1,960.82 1,960.81 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% GEDFYcVTcHETK 95.00% 2.19 0.352 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2235 1,644.65 1,645.66 3
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% GEDFYcVTcHETK 95.00% 2.33 0.28 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2247 1,644.65 1,645.66 3
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% FDcHYcRDPLQGK 95.00% 2.67 0.355 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 565.9145 1,694.72 1,695.74 3
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% qVIGTGSFFPK 95.00% 0 0 3.74 n-term: Pyro-cmC (-17.03) 582.3084 1,162.60 1,163.61 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.44 0.351 1.92 590.8185 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.04 0.304 1.85 590.8197 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.49 0.376 0 590.8198 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.21 0.25 1.38 590.8202 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.38 0.427 2.1 590.8206 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.22 0.298 1.34 590.8209 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.13 0.3 0 590.8209 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.34 0.375 0 590.821 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.32 0.434 1.38 590.8211 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.11 0.306 1.82 590.8211 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.36 0.412 1.21 590.8213 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.31 0.427 0 590.8266 1,179.64 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.61 0.466 2.05 590.828 1,179.64 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% QVIGTGSFFPK 95.00% 2.24 0.464 2.04 590.83 1,179.64 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% cLHPLANETFVAKDNK 95.00% 4.35 0.507 1.21 c1: Carbamidomethyl (+57.02) 619.6508 1,855.93 1,856.93 3
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% cLHPLANETFVAKDNK 95.00% 2.37 0.313 0 c1: Carbamidomethyl (+57.02) 619.9814 1,856.92 1,856.93 3
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% cFDKFcANTcVEcR 95.00% 3.81 0.435 1.47c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)622.918 1,865.73 1,866.74 3
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% cFDKFcANTcVEcR 95.00% 2.98 0.324 0c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)623.2526 1,866.73 1,866.74 3
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% GTVWHKDcFTcSNcK 95.00% 3.72 0.475 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 633.9365 1,898.79 1,899.79 3
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% AIVAGDQNVEYK 95.00% 3.37 0.557 2.18 653.8342 1,305.65 1,306.66 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% AIVAGDQNVEYK 95.00% 3.36 0.551 2.74 653.8351 1,305.65 1,306.66 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% AIVAGDQNVEYK 95.00% 3.28 0.582 2.32 653.8353 1,305.65 1,306.66 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% AIVAGDQNVEYK 95.00% 2.93 0.562 2.62 653.8356 1,305.66 1,306.66 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% AIVAGDQNVEYK 95.00% 3.11 0.503 2.77 653.8378 1,305.66 1,306.66 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% AIVAGDQNVEYK 95.00% 2.44 0.527 1.89 653.8381 1,305.66 1,306.66 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% FcANTcVEcR 95.00% 2.91 0.545 5.52 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7645 1,315.51 1,316.52 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% GEDFYcVTcHETK 95.00% 2.31 0.461 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3319 1,644.65 1,645.66 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% GEDFYcVTcHETK 95.00% 3.12 0.499 2 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3339 1,644.65 1,645.66 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% GEDFYcVTcHETK 95.00% 3.93 0.511 4.11 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3345 1,644.65 1,645.66 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% GEDFYcVTcHETK 95.00% 3.97 0.52 2.17 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3389 1,644.66 1,645.66 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% cFDKFcANTcVEcR 95.00% 0 0 3.52c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03)925.359 1,848.70 1,849.71 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% cFDKFcANTcVEcR 95.00% 0 0 4.06c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03)925.3739 1,848.73 1,849.71 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% cFDKFcANTcVEcR 95.00% 1.75 0.341 1.92c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)933.872 1,865.73 1,866.74 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% cFDKFcANTcVEcR 95.00% 2.22 0.462 2.54c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)933.8735 1,865.73 1,866.74 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% cFDKFcANTcVEcR 95.00% 3.4 0.596 4.48c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)934.3728 1,866.73 1,866.74 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% FTAVEDQYYcVDcYK 95.00% 4.65 0.612 4.96 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 980.9072 1,959.80 1,960.81 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% FTAVEDQYYcVDcYK 95.00% 5.83 0.594 6.26 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4066 1,960.80 1,960.81 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% FTAVEDQYYcVDcYK 95.00% 5.91 0.56 6.12 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4068 1,960.80 1,960.81 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% FTAVEDQYYcVDcYK 95.00% 5.28 0.603 5.29 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4105 1,960.81 1,960.81 2
 SAMPLE 1 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 8 10 29 33.70% FTAVEDQYYcVDcYK 95.00% 5.73 0.584 6.85 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.421 1,960.83 1,960.81 2
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% FDcHYcRDPLQGK 95.00% 2.67 0.355 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 565.9145 1,694.72 1,695.74 3
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.31 0.346 1.92 590.8184 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.32 0.417 1.46 590.8198 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.39 0.455 1.28 590.82 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.01 0.296 0 590.8203 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.09 0.345 1.17 590.8204 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.27 0.449 1.8 590.8205 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.35 0.436 1.82 590.8205 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.04 0.397 2.08 590.8206 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.31 0.426 0 590.8209 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.27 0.348 0 590.8211 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.31 0.427 0 590.8266 1,179.64 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.61 0.466 1.43 590.828 1,179.64 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.62 0.442 3.1 590.8311 1,179.65 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% QVIGTGSFFPK 95.00% 2.2 0.256 0 590.8327 1,179.65 1,180.64 2 DYHC1_HUMAN
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% cLHPLANETFVAKDNK 95.00% 4.35 0.507 1.39 c1: Carbamidomethyl (+57.02) 619.6508 1,855.93 1,856.93 3
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% GTVWHKDcFTcSNcK 95.00% 3.72 0.475 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 633.9365 1,898.79 1,899.79 3
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% AIVAGDQNVEYK 95.00% 3.28 0.604 3.25 653.835 1,305.65 1,306.66 2
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% AIVAGDQNVEYK 95.00% 3.26 0.511 3.82 653.8358 1,305.66 1,306.66 2
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% AIVAGDQNVEYK 95.00% 2.44 0.527 1.59 653.8381 1,305.66 1,306.66 2
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% FcANTcVEcR 95.00% 2.91 0.545 4.72 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7645 1,315.51 1,316.52 2
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% cLHPLANETFVAK 95.00% 3.75 0.551 3.37 c1: Carbamidomethyl (+57.02) 750.3976 1,498.78 1,499.77 2
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% GEDFYcVTcHETK 95.00% 3.93 0.511 3.85 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3345 1,644.65 1,645.66 2
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% GEDFYcVTcHETK 95.00% 3.97 0.52 2.28 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3389 1,644.66 1,645.66 2
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% cFDKFcANTcVEcR 95.00% 1.75 0.341 2.47c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)933.872 1,865.73 1,866.74 2
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% FTAVEDQYYcVDcYK 95.00% 5.91 0.56 6.89 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4068 1,960.80 1,960.81 2
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% FTAVEDQYYcVDcYK 95.00% 5.73 0.584 7.24 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.421 1,960.83 1,960.81 2
 SAMPLE 1R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 9 9 14 33.70% FTAVEDQYYcVDcYK 95.00% 5.45 0.62 7.21 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4261 1,960.84 1,960.81 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAK 95.00% 4.64 0.368 1.33 c1: Carbamidomethyl (+57.02) 500.5929 1,498.76 1,499.77 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAK 95.00% 4.64 0.381 1.7 c1: Carbamidomethyl (+57.02) 500.593 1,498.76 1,499.77 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAK 95.00% 4.34 0.385 1.66 c1: Carbamidomethyl (+57.02) 500.5931 1,498.76 1,499.77 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAK 95.00% 4.14 0.423 2.24 c1: Carbamidomethyl (+57.02) 500.5934 1,498.76 1,499.77 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 2.21 0.259 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2245 1,644.65 1,645.66 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 2.01 0.227 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2246 1,644.65 1,645.66 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 2.35 0.242 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2253 1,644.65 1,645.66 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 2.63 0.417 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.3013 1,644.88 1,645.66 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 2.09 0.216 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.3031 1,644.89 1,645.66 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FDcHYcRDPLQGK 95.00% 3.14 0.211 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 565.9156 1,694.72 1,695.74 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FDcHYcRDPLQGK 95.00% 3.2 0.257 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 565.9159 1,694.72 1,695.74 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FDcHYcRDPLQGK 95.00% 2.86 0.256 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 566.2504 1,695.73 1,695.74 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.24 0.327 0 590.8186 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.17 0.324 0 590.819 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.26 0.33 0 590.8201 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.3 0.389 0 590.8202 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.29 0.351 1.41 590.8203 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.21 0.268 0 590.8203 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.29 0.426 1.23 590.8204 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.15 0.359 1.47 590.8206 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.39 0.308 1.31 590.8206 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.51 0.497 1.68 590.8207 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.24 0.328 0 590.8208 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.45 0.509 2.44 590.8208 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.29 0.258 1.66 590.8209 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.59 0.469 3.26 590.8209 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.47 0.469 2.57 590.821 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.72 0.378 1.17 590.8211 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.21 0.367 0 590.8213 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% QVIGTGSFFPK 95.00% 2.47 0.369 0 590.8215 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FDcHYcRDPLQGKK 95.00% 3.7 0.355 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 608.6127 1,822.81 1,823.83 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FDcHYcRDPLQGKK 95.00% 3.04 0.32 1.06 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 608.6144 1,822.82 1,823.83 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAKDNK 95.00% 0 0 3.77 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 613.9691 1,838.88 1,839.91 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAKDNK 95.00% 0 0 4.29 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 613.9724 1,838.89 1,839.91 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAKDNK 95.00% 4.42 0.479 1.6 c1: Carbamidomethyl (+57.02) 619.9821 1,856.92 1,856.93 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAKDNK 95.00% 4.43 0.498 1.52 c1: Carbamidomethyl (+57.02) 619.9822 1,856.92 1,856.93 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAKDNK 95.00% 3.07 0.386 0 c1: Carbamidomethyl (+57.02) 619.9847 1,856.93 1,856.93 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cFDKFcANTcVEcR 95.00% 4.04 0.57 3.7c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)622.9165 1,865.73 1,866.74 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cFDKFcANTcVEcR 95.00% 4.26 0.584 2.89c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)622.9175 1,865.73 1,866.74 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cFDKFcANTcVEcR 95.00% 3.14 0.475 1.21c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)623.2515 1,866.73 1,866.74 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 2.38 0.474 2.6 653.8323 1,305.65 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 3.28 0.588 2.66 653.8342 1,305.65 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 3.25 0.577 2.38 653.8343 1,305.65 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 3.04 0.471 2.57 653.8346 1,305.65 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 2.99 0.54 5.35 653.8347 1,305.65 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 3.53 0.519 2.59 653.835 1,305.65 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 3.73 0.593 2.02 653.8351 1,305.65 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 3.22 0.544 2.37 653.8352 1,305.65 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 3.04 0.542 3.18 653.8354 1,305.66 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 3.66 0.603 2.17 653.8354 1,305.66 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 3.71 0.595 2.47 653.8354 1,305.66 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 3.53 0.567 3.85 653.8357 1,305.66 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 3.21 0.538 2.66 653.8359 1,305.66 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYK 95.00% 2.86 0.465 1.14 654.3358 1,306.66 1,306.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FcANTcVEcR 95.00% 1.8 0.423 2.39 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7599 1,315.50 1,316.52 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FcANTcVEcR 95.00% 3.23 0.589 3.92 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7614 1,315.51 1,316.52 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FcANTcVEcR 95.00% 3.29 0.523 3.51 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7619 1,315.51 1,316.52 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FcANTcVEcR 95.00% 3.1 0.563 3.43 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.762 1,315.51 1,316.52 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FcANTcVEcR 95.00% 3.24 0.571 3.09 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7622 1,315.51 1,316.52 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FcANTcVEcR 95.00% 3.35 0.581 3.41 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7625 1,315.51 1,316.52 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FcANTcVEcR 95.00% 3.32 0.544 3.46 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7628 1,315.51 1,316.52 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FcANTcVEcR 95.00% 1.77 0.257 1.46 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 659.3296 1,316.64 1,316.52 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYKGTVWHK 95.00% 2.48 0.325 2.47 672.6825 2,015.02 2,015.04 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% AIVAGDQNVEYKGTVWHK 95.00% 2.16 0.39 2.43 672.6825 2,015.02 2,015.04 3
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% NRFWHDTcFR 95.00% 2.68 0.41 0 c8: Carbamidomethyl (+57.02) 719.8241 1,437.63 1,438.64 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% NRFWHDTcFR 95.00% 2.47 0.183 1.51 c8: Carbamidomethyl (+57.02) 719.8249 1,437.63 1,438.64 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAK 95.00% 0 0 5.21 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.8732 1,481.73 1,482.74 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAK 95.00% 0 0 4.11 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 742.3751 1,482.73 1,482.74 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAK 95.00% 3.58 0.518 0 c1: Carbamidomethyl (+57.02) 750.3837 1,498.75 1,499.77 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAK 95.00% 3.72 0.469 2 c1: Carbamidomethyl (+57.02) 750.3858 1,498.76 1,499.77 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAK 95.00% 3.64 0.48 6.85 c1: Carbamidomethyl (+57.02) 750.3863 1,498.76 1,499.77 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAK 95.00% 3.77 0.469 3.17 c1: Carbamidomethyl (+57.02) 750.3863 1,498.76 1,499.77 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAK 95.00% 3.27 0.516 2.44 c1: Carbamidomethyl (+57.02) 750.3898 1,498.76 1,499.77 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 3.99 0.551 2.59 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3338 1,644.65 1,645.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 3.96 0.528 2.74 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3339 1,644.65 1,645.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 3.8 0.53 3.04 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.334 1,644.65 1,645.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 4.06 0.564 5.02 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3343 1,644.65 1,645.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 3.8 0.519 2.7 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3346 1,644.65 1,645.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 3.97 0.5 3.31 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3346 1,644.65 1,645.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 4.02 0.554 3.96 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3352 1,644.65 1,645.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 3.69 0.593 3.68 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3361 1,644.66 1,645.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 3.6 0.526 2.74 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.8347 1,645.65 1,645.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GEDFYcVTcHETK 95.00% 4.05 0.525 2.4 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.8373 1,645.66 1,645.66 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FDcHYcRDPLQGK 95.00% 2.7 0.387 1.44 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 848.3734 1,694.73 1,695.74 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FDcHYcRDPLQGK 95.00% 2.81 0.398 1.14 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 848.873 1,695.73 1,695.74 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cLHPLANETFVAKDNK 95.00% 4.66 0.519 4.74 c1: Carbamidomethyl (+57.02) 929.4686 1,856.92 1,856.93 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cFDKFcANTcVEcR 95.00% 3.48 0.586 3.85c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)933.8671 1,865.72 1,866.74 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cFDKFcANTcVEcR 95.00% 4.45 0.599 5.68c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)934.3726 1,866.73 1,866.74 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% cFDKFcANTcVEcR 95.00% 4.25 0.609 4.92c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)934.3735 1,866.73 1,866.74 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GTVWHKDcFTcSNcK 95.00% 4.53 0.625 4.62 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 950.3988 1,898.78 1,899.79 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% GTVWHKDcFTcSNcK 95.00% 4.39 0.644 4.52 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 950.8997 1,899.78 1,899.79 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FTAVEDQYYcVDcYK 95.00% 5.58 0.645 6.62 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 980.9071 1,959.80 1,960.81 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FTAVEDQYYcVDcYK 95.00% 5.47 0.619 5.18 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 980.9079 1,959.80 1,960.81 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FTAVEDQYYcVDcYK 95.00% 5.69 0.615 5.92 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4076 1,960.80 1,960.81 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FTAVEDQYYcVDcYK 95.00% 5.59 0.612 7.74 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4077 1,960.80 1,960.81 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FTAVEDQYYcVDcYK 95.00% 5.54 0.607 4.77 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.409 1,960.80 1,960.81 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FTAVEDQYYcVDcYK 95.00% 5.17 0.573 6.82 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4093 1,960.80 1,960.81 2
 SAMPLE 2 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 12 17 80 37.20% FTAVEDQYYcVDcYK 95.00% 5.06 0.651 6.66 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4095 1,960.80 1,960.81 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAK 95.00% 4.11 0.429 2.22 c1: Carbamidomethyl (+57.02) 500.5927 1,498.75 1,499.77 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAK 95.00% 4.01 0.432 2.07 c1: Carbamidomethyl (+57.02) 500.5929 1,498.76 1,499.77 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GEDFYcVTcHETK 95.00% 2.49 0.278 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2245 1,644.65 1,645.66 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GEDFYcVTcHETK 95.00% 2.18 0.252 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2252 1,644.65 1,645.66 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GEDFYcVTcHETK 95.00% 2.43 0.356 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2252 1,644.65 1,645.66 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GEDFYcVTcHETK 95.00% 2.58 0.369 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2261 1,644.65 1,645.66 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FDcHYcRDPLQGK 95.00% 2.63 0.216 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 565.9155 1,694.72 1,695.74 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FDcHYcRDPLQGK 95.00% 3.12 0.223 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 566.2502 1,695.73 1,695.74 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% qVIGTGSFFPK 95.00% 0 0 3.85 n-term: Pyro-cmC (-17.03) 581.816 1,161.62 1,163.61 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.5 0.431 1.22 590.8194 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.33 0.343 0 590.8199 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.26 0.354 1.19 590.8199 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.62 0.55 1.42 590.8203 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.25 0.424 0 590.8205 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.7 0.502 1.72 590.8206 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.17 0.408 1.14 590.8206 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.41 0.377 0 590.8206 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.82 0.461 2.47 590.8208 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.18 0.402 0 590.8209 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.4 0.354 0 590.821 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.34 0.383 1.4 590.8211 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.48 0.488 1.14 590.8212 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.18 0.427 1.46 590.8212 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.27 0.399 2.19 590.8216 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% QVIGTGSFFPK 95.00% 2.43 0.345 1.19 590.8219 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FDcHYcRDPLQGKK 95.00% 3.52 0.321 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 608.6138 1,822.82 1,823.83 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FDcHYcRDPLQGKK 95.00% 3.2 0.293 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 608.9493 1,823.82 1,823.83 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAKDNK 95.00% 3.89 0.465 1.49 c1: Carbamidomethyl (+57.02) 619.6479 1,855.92 1,856.93 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAKDNK 95.00% 2.81 0.321 0 c1: Carbamidomethyl (+57.02) 619.6495 1,855.92 1,856.93 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAKDNK 95.00% 4.13 0.449 0 c1: Carbamidomethyl (+57.02) 619.9827 1,856.92 1,856.93 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cFDKFcANTcVEcR 95.00% 3.06 0.552 1.15c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)622.9174 1,865.73 1,866.74 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cFDKFcANTcVEcR 95.00% 2.28 0.323 0c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)622.918 1,865.73 1,866.74 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cFDKFcANTcVEcR 95.00% 4.07 0.557 2.6c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)623.2 2 1,866.73 1,866.74 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cFDKFcANTcVEcR 95.00% 2.99 0.469 0c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)623.2532 1,866.74 1,866.74 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GTVWHKDcFTcSNcK 95.00% 3.71 0.47 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 633.9354 1,898.78 1,899.79 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GTVWHKDcFTcSNcK 95.00% 3.99 0.56 1.41 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 634.27 1,899.79 1,899.79 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYK 95.00% 3.13 0.581 2.89 653.8347 1,305.65 1,306.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYK 95.00% 3.42 0.574 3.18 653.8349 1,305.65 1,306.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYK 95.00% 3.05 0.525 2.68 653.8352 1,305.65 1,306.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYK 95.00% 3.53 0.592 3.29 653.8352 1,305.65 1,306.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYK 95.00% 3.49 0.612 3.01 653.8352 1,305.65 1,306.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYK 95.00% 3.74 0.601 3.02 653.8352 1,305.65 1,306.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYK 95.00% 3.54 0.547 2.37 653.8355 1,305.66 1,306.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYK 95.00% 3.44 0.556 3.96 653.8355 1,305.66 1,306.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYK 95.00% 3.68 0.571 3.2 653.8357 1,305.66 1,306.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYK 95.00% 3.51 0.586 3.31 653.836 1,305.66 1,306.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYK 95.00% 2.99 0.542 3.49 653.8368 1,305.66 1,306.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYK 95.00% 3.26 0.504 3 654.3374 1,306.66 1,306.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FcANTcVEcR 95.00% 3.09 0.552 2.8 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7618 1,315.51 1,316.52 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FcANTcVEcR 95.00% 3.23 0.566 2.44 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7622 1,315.51 1,316.52 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FcANTcVEcR 95.00% 3.56 0.599 3.19 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7627 1,315.51 1,316.52 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FcANTcVEcR 95.00% 3.47 0.539 3.77 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7628 1,315.51 1,316.52 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FcANTcVEcR 95.00% 2.94 0.547 2.55 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.763 1,315.51 1,316.52 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FcANTcVEcR 95.00% 1.85 0.195 2.85 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7652 1,315.51 1,316.52 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% AIVAGDQNVEYKGTVWHK 95.00% 2.11 0.165 1.57 672.3483 2,014.02 2,015.04 3
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAK 95.00% 0 0 3.89 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.8739 1,481.73 1,482.74 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAK 95.00% 0 0 3.77 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.8742 1,481.73 1,482.74 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAK 95.00% 3.24 0.353 3.02 c1: Carbamidomethyl (+57.02) 750.385 1,498.75 1,499.77 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAK 95.00% 2.93 0.474 0 c1: Carbamidomethyl (+57.02) 750.3882 1,498.76 1,499.77 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAK 95.00% 3.09 0.527 1.89 c1: Carbamidomethyl (+57.02) 750.3896 1,498.76 1,499.77 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAK 95.00% 3.1 0.459 1.11 c1: Carbamidomethyl (+57.02) 750.885 1,499.75 1,499.77 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GEDFYcVTcHETK 95.00% 4.03 0.502 3.28 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3333 1,644.65 1,645.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GEDFYcVTcHETK 95.00% 4.03 0.547 7 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3341 1,644.65 1,645.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GEDFYcVTcHETK 95.00% 3.89 0.552 2.4 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3343 1,644.65 1,645.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GEDFYcVTcHETK 95.00% 4.1 0.563 2.62 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.8359 1,645.66 1,645.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GEDFYcVTcHETK 95.00% 3.93 0.53 3.44 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.8364 1,645.66 1,645.66 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FDcHYcRDPLQGK 95.00% 2.9 0.45 1.43 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 848.3684 1,694.72 1,695.74 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FDcHYcRDPLQGK 95.00% 2.8 0.373 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 848.3706 1,694.73 1,695.74 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAKDNK 95.00% 4.33 0.518 3.34 c1: Carbamidomethyl (+57.02) 929.4684 1,856.92 1,856.93 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cLHPLANETFVAKDNK 95.00% 4.49 0.524 3.15 c1: Carbamidomethyl (+57.02) 929.4705 1,856.93 1,856.93 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cFDKFcANTcVEcR 95.00% 4.51 0.637 5.47c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)933.8714 1,865.73 1,866.74 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% cFDKFcANTcVEcR 95.00% 4.39 0.589 5.51c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)933.872 1,865.73 1,866.74 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GTVWHKDcFTcSNcK 95.00% 4.51 0.639 4.8 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 950.3988 1,898.78 1,899.79 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% GTVWHKDcFTcSNcK 95.00% 4.66 0.599 3.77 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 950.3989 1,898.78 1,899.79 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FTAVEDQYYcVDcYK 95.00% 4.35 0.606 6.85 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 980.9069 1,959.80 1,960.81 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FTAVEDQYYcVDcYK 95.00% 5.07 0.618 6.74 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 980.9077 1,959.80 1,960.81 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FTAVEDQYYcVDcYK 95.00% 5.7 0.624 7.77 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4039 1,960.79 1,960.81 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FTAVEDQYYcVDcYK 95.00% 5.53 0.606 6.29 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4071 1,960.80 1,960.81 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FTAVEDQYYcVDcYK 95.00% 5.44 0.648 6.18 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4077 1,960.80 1,960.81 2
 SAMPLE 2R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 17 63 34.10% FTAVEDQYYcVDcYK 95.00% 5.66 0.604 7.19 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4085 1,960.80 1,960.81 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% NRFWHDTcFR 95.00% 2.69 0.135 0 c8: Carbamidomethyl (+57.02) 480.2205 1,437.64 1,438.64 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% cLHPLANETFVAK 95.00% 3.39 0.453 1.72 c1: Carbamidomethyl (+57.02) 500.5937 1,498.76 1,499.77 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GEDFYcVTcHETK 95.00% 2.34 0.363 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2244 1,644.65 1,645.66 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GEDFYcVTcHETK 95.00% 2.25 0.296 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2245 1,644.65 1,645.66 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GEDFYcVTcHETK 95.00% 2.3 0.402 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.2249 1,644.65 1,645.66 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GEDFYcVTcHETK 95.00% 1.91 0.411 1.38 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 549.5591 1,645.65 1,645.66 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.45 0.331 1.32 590.8199 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.14 0.35 1.32 590.8202 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.38 0.289 1.52 590.8202 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.22 0.335 1.16 590.8203 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.67 0.478 1.92 590.8203 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.59 0.386 1.21 590.8206 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.41 0.38 0 590.8206 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.2 0.384 0 590.8206 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.18 0.326 0 590.8208 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.2 0.375 1.08 590.821 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.47 0.41 2.55 590.821 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.14 0.298 0 590.8211 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.39 0.452 2.31 590.8212 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.41 0.409 0 590.8214 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.28 0.417 1.14 590.8215 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.2 0.248 1.24 590.8218 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% QVIGTGSFFPK 95.00% 2.16 0.286 1.42 590.8237 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% FDcHYcRDPLQGKK 95.00% 4.1 0.312 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 608.6141 1,822.82 1,823.83 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% FDcHYcRDPLQGKK 95.00% 3.74 0.354 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 608.9485 1,823.82 1,823.83 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% cLHPLANETFVAKDNK 95.00% 3.28 0.402 0 c1: Carbamidomethyl (+57.02) 619.981 1,856.92 1,856.93 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% cFDKFcANTcVEcR 95.00% 3.01 0.568 1.28c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02)623.2498 1,866.73 1,866.74 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GTVWHKDcFTcSNcK 95.00% 3.29 0.445 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 633.9349 1,898.78 1,899.79 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GTVWHKDcFTcSNcK 95.00% 3.78 0.513 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 633.9349 1,898.78 1,899.79 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GTVWHKDcFTcSNcK 95.00% 3.31 0.32 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 634.2692 1,899.78 1,899.79 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GTVWHKDcFTcSNcK 95.00% 3.4 0.496 1.09 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 634.2697 1,899.79 1,899.79 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 2.68 0.452 2.64 653.8337 1,305.65 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 3.74 0.626 2.92 653.834 1,305.65 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 3.72 0.575 3.46 653.834 1,305.65 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 3.07 0.525 2.57 653.8344 1,305.65 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 3.39 0.491 2.68 653.8347 1,305.65 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 3.29 0.539 3.29 653.8348 1,305.65 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 3.12 0.567 2.44 653.8349 1,305.65 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 3.12 0.53 2.8 653.8349 1,305.65 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 3.81 0.621 3.26 653.8349 1,305.65 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 3.22 0.495 2.92 653.8352 1,305.65 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 3.29 0.498 2.24 653.8352 1,305.65 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 3.61 0.584 3.05 653.8355 1,305.66 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYK 95.00% 3.17 0.518 1.44 653.8372 1,305.66 1,306.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% FcANTcVEcR 95.00% 3 0.565 3.52 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7611 1,315.51 1,316.52 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% FcANTcVEcR 95.00% 3.05 0.544 3.16 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7613 1,315.51 1,316.52 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% FcANTcVEcR 95.00% 2.83 0.577 4.07 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7615 1,315.51 1,316.52 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% FcANTcVEcR 95.00% 2.94 0.579 3.64 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7627 1,315.51 1,316.52 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AIVAGDQNVEYKGTVWHK 95.00% 3.12 0.363 2.32 672.6824 2,015.02 2,015.04 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% cLHPLANETFVAK 95.00% 0 0 6.19 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.873 1,481.73 1,482.74 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% cLHPLANETFVAK 95.00% 0 0 5.8 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.8731 1,481.73 1,482.74 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% cLHPLANETFVAK 95.00% 0 0 4.13 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.8739 1,481.73 1,482.74 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GEDFYcVTcHETK 95.00% 4.06 0.548 3.85 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3331 1,644.65 1,645.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GEDFYcVTcHETK 95.00% 3.93 0.504 2.43 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3338 1,644.65 1,645.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GEDFYcVTcHETK 95.00% 4.04 0.549 5.52 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3341 1,644.65 1,645.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GEDFYcVTcHETK 95.00% 3.8 0.495 1.96 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3354 1,644.66 1,645.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GEDFYcVTcHETK 95.00% 3.48 0.565 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3366 1,644.66 1,645.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GEDFYcVTcHETK 95.00% 3.98 0.549 1.7 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3366 1,644.66 1,645.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GEDFYcVTcHETK 95.00% 3.84 0.509 3.17 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.8364 1,645.66 1,645.66 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% FDcHYcRDPLQGK 95.00% 2.84 0.338 2.28 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 848.3707 1,694.73 1,695.74 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% FDcHYcRDPLQGK 95.00% 2.72 0.456 3.26 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 848.3713 1,694.73 1,695.74 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% cFDKFcANTcVEcR 95.00% 0 0 3.29c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03)925.8573 1,849.70 1,849.71 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% cFDKFcANTcVEcR 95.00% 0 0 4.28c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03)925.8587 1,849.70 1,849.71 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% cLHPLANETFVAKDNK 95.00% 4.45 0.511 5.07 c1: Carbamidomethyl (+57.02) 928.9663 1,855.92 1,856.93 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% cLHPLANETFVAKDNK 95.00% 4.48 0.523 5.48 c1: Carbamidomethyl (+57.02) 928.9676 1,855.92 1,856.93 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GTVWHKDcFTcSNcK 95.00% 4.28 0.527 4.31 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 950.3963 1,898.78 1,899.79 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% GTVWHKDcFTcSNcK 95.00% 4.2 0.599 2.43 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 950.8999 1,899.78 1,899.79 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% FTAVEDQYYcVDcYK 95.00% 5.56 0.616 6.82 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4077 1,960.80 1,960.81 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% FTAVEDQYYcVDcYK 95.00% 5.68 0.626 5.74 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.41 1,960.80 1,960.81 2
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AITSGGITYQDQPWHADcFVcVTcSK 95.00% 4.51 0.604 3.57 c18: Carbamidomethyl (+57.02), c21: Carbamidomethyl (+57.02), c24: Carbamidomethyl (+57.02) 1,001.45 3,001.31 3,001.33 3
 SAMPLE 3 Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 13 18 54 45.20% AITSGGITYQDQPWHADcFVcVTcSK 95.00% 4.38 0.592 4.05 c18: Carbamidomethyl (+57.02), c21: Carbamidomethyl (+57.02), c24: Carbamidomethyl (+57.02) 1,001.45 3,001.31 3,001.33 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% cLHPLANETFVAK 95.00% 4.08 0.415 1.4 c1: Carbamidomethyl (+57.02) 500.5933 1,498.76 1,499.77 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% cLHPLANETFVAK 95.00% 3.53 0.388 0 c1: Carbamidomethyl (+57.02) 500.5934 1,498.76 1,499.77 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FDcHYcRDPLQGK 95.00% 2.52 0.206 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 565.916 1,694.72 1,695.74 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% QVIGTGSFFPK 95.00% 2.34 0.412 0 590.819 1,179.62 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% QVIGTGSFFPK 95.00% 2.25 0.433 1.92 590.8208 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% QVIGTGSFFPK 95.00% 2.42 0.387 1.11 590.8208 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% QVIGTGSFFPK 95.00% 2.62 0.483 2.92 590.8209 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% QVIGTGSFFPK 95.00% 2.75 0.426 2.32 590.8209 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% QVIGTGSFFPK 95.00% 2.5 0.418 1.41 590.821 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% QVIGTGSFFPK 95.00% 2.52 0.375 1.35 590.8211 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% QVIGTGSFFPK 95.00% 2.54 0.474 1.8 590.8211 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% QVIGTGSFFPK 95.00% 2.57 0.492 2.32 590.8213 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% QVIGTGSFFPK 95.00% 2.09 0.285 1.44 590.8214 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% QVIGTGSFFPK 95.00% 2 0.232 1.41 590.8221 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% QVIGTGSFFPK 95.00% 2.47 0.395 1.59 590.8221 1,179.63 1,180.64 2 DYHC1_HUMAN
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FDcHYcRDPLQGKK 95.00% 3.34 0.238 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 608.6139 1,822.82 1,823.83 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FDcHYcRDPLQGKK 95.00% 2.84 0.259 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 608.9488 1,823.82 1,823.83 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% cLHPLANETFVAKDNK 95.00% 4.01 0.393 3.33 c1: Carbamidomethyl (+57.02) 619.6478 1,855.92 1,856.93 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% cLHPLANETFVAKDNK 95.00% 2.8 0.309 0 c1: Carbamidomethyl (+57.02) 619.6483 1,855.92 1,856.93 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% cLHPLANETFVAKDNK 95.00% 3.98 0.39 1.33 c1: Carbamidomethyl (+57.02) 619.9828 1,856.93 1,856.93 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% GTVWHKDcFTcSNcK 95.00% 3.52 0.489 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 633.9332 1,898.78 1,899.79 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% GTVWHKDcFTcSNcK 95.00% 2.09 0.356 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 634.267 1,899.78 1,899.79 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AIVAGDQNVEYK 95.00% 3.22 0.521 2.85 653.8342 1,305.65 1,306.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AIVAGDQNVEYK 95.00% 3.16 0.542 2.41 653.8344 1,305.65 1,306.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AIVAGDQNVEYK 95.00% 3.66 0.588 3.6 653.8346 1,305.65 1,306.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AIVAGDQNVEYK 95.00% 3.31 0.587 2.55 653.8347 1,305.65 1,306.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AIVAGDQNVEYK 95.00% 3.79 0.605 2.59 653.8351 1,305.65 1,306.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AIVAGDQNVEYK 95.00% 3.67 0.593 3.92 653.8352 1,305.65 1,306.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AIVAGDQNVEYK 95.00% 3.77 0.57 3.47 653.8354 1,305.66 1,306.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AIVAGDQNVEYK 95.00% 3.9 0.611 3.13 653.8355 1,305.66 1,306.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AIVAGDQNVEYK 95.00% 3.34 0.509 2.77 653.8357 1,305.66 1,306.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AIVAGDQNVEYK 95.00% 3.39 0.545 3.12 653.8357 1,305.66 1,306.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AIVAGDQNVEYK 95.00% 3.59 0.546 4.04 653.8362 1,305.66 1,306.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FcANTcVEcR 95.00% 2.99 0.552 4.15 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7614 1,315.51 1,316.52 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FcANTcVEcR 95.00% 3.21 0.574 2.77 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7615 1,315.51 1,316.52 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FcANTcVEcR 95.00% 3.19 0.586 4.37 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7618 1,315.51 1,316.52 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FcANTcVEcR 95.00% 3.17 0.58 2.89 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.762 1,315.51 1,316.52 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FcANTcVEcR 95.00% 2.89 0.532 3.66 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 658.7629 1,315.51 1,316.52 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FcANTcVEcR 95.00% 2.75 0.539 2.82 c2: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 659.2645 1,316.51 1,316.52 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AIVAGDQNVEYKGTVWHK 95.00% 3.26 0.32 0 672.6837 2,015.03 2,015.04 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% cLHPLANETFVAK 95.00% 0 0 5.36 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.8725 1,481.73 1,482.74 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% cLHPLANETFVAK 95.00% 0 0 3.66 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 741.8748 1,481.73 1,482.74 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% cLHPLANETFVAK 95.00% 0 0 4.1 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 742.3743 1,482.73 1,482.74 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% GEDFYcVTcHETK 95.00% 3.75 0.48 1.11 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3337 1,644.65 1,645.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% GEDFYcVTcHETK 95.00% 4.13 0.546 3.34 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.3343 1,644.65 1,645.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% GEDFYcVTcHETK 95.00% 3.5 0.43 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 823.8382 1,645.66 1,645.66 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FDcHYcRDPLQGK 95.00% 2.98 0.382 2.46 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 848.3694 1,694.72 1,695.74 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FDcHYcRDPLQGK 95.00% 2.66 0.363 1.7 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 848.3711 1,694.73 1,695.74 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% cLHPLANETFVAKDNK 95.00% 4.23 0.515 2.96 c1: Carbamidomethyl (+57.02) 928.9692 1,855.92 1,856.93 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% cLHPLANETFVAKDNK 95.00% 4.91 0.532 4.92 c1: Carbamidomethyl (+57.02) 929.4699 1,856.92 1,856.93 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% GTVWHKDcFTcSNcK 95.00% 4.13 0.638 3.48 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 950.398 1,898.78 1,899.79 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% GTVWHKDcFTcSNcK 95.00% 4.25 0.535 3.12 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 950.8965 1,899.78 1,899.79 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FTAVEDQYYcVDcYK 95.00% 5.41 0.617 6.68 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 980.9074 1,959.80 1,960.81 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FTAVEDQYYcVDcYK 95.00% 4.86 0.665 4.77 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4074 1,960.80 1,960.81 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FTAVEDQYYcVDcYK 95.00% 5.32 0.557 6 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4077 1,960.80 1,960.81 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% FTAVEDQYYcVDcYK 95.00% 5.38 0.656 8.06 c10: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4078 1,960.80 1,960.81 2
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AITSGGITYQDQPWHADcFVcVTcSK 95.00% 4.7 0.501 3.7 c18: Carbamidomethyl (+57.02), c21: Carbamidomethyl (+57.02), c24: Carbamidomethyl (+57.02) 1,001.44 3,001.31 3,001.33 3
 SAMPLE 3R Four and a half LIM domains protein 1  FHL1  FHL1_HUMAN 36,244.00 100.00% 11 15 46 40.90% AITSGGITYQDQPWHADcFVcVTcSK 95.00% 0 0 4.02 c18: Carbamidomethyl (+57.02), c21: Carbamidomethyl (+57.02), c24: Carbamidomethyl (+57.02) 1,001.78 3,002.32 3,001.33 3
 SAMPLE 1 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 99.80% 2 2 4 6.81% YISFEER 95.00% 1.85 0.321 0 472.2338 942.4519 943.4525 2
 SAMPLE 1 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 99.80% 2 2 4 6.81% DNQNFcVPcYEK 95.00% 3.89 0.382 2.43 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 787.3268 1,572.64 1,573.64 2
 SAMPLE 1 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 99.80% 2 2 4 6.81% DNQNFcVPcYEK 95.00% 3.05 0.35 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 787.3309 1,572.65 1,573.64 2
 SAMPLE 1 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 99.80% 2 2 4 6.81% DNQNFcVPcYEK 95.00% 2.95 0.353 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 787.83 1,573.64 1,573.64 2
 SAMPLE 2 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 4 4 7 14.70% YISFEER 95.00% 2.12 0.32 0 472.2293 942.443 943.4525 2
 SAMPLE 2 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 4 4 7 14.70% YISFEER 95.00% 2.37 0.398 0 472.2308 942.446 943.4525 2
 SAMPLE 2 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 4 4 7 14.70% FDcHHcNESLFGK 95.00% 2.33 0.345 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 550.8979 1,649.67 1,650.68 3
 SAMPLE 2 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 4 4 7 14.70% FDcHHcNESLFGK 95.00% 2.82 0.324 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 551.2323 1,650.67 1,650.68 3
 SAMPLE 2 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 4 4 7 14.70% EcFVcTAcR 95.00% 2.48 0.382 1.77 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 601.7394 1,201.46 1,202.48 2
 SAMPLE 2 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 4 4 7 14.70% DNQNFcVPcYEK 95.00% 4.04 0.465 1.8 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 787.3231 1,572.63 1,573.64 2
 SAMPLE 2 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 4 4 7 14.70% DNQNFcVPcYEK 95.00% 3.73 0.434 1.77 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 787.3266 1,572.64 1,573.64 2
 SAMPLE 2R Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 5 5 7 24.00% YISFEER 95.00% 2.39 0.401 0 472.2312 942.4467 943.4525 2
 SAMPLE 2R Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 5 5 7 24.00% GSSWHETcFIcHR 95.00% 2.77 0.471 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 559.5718 1,675.69 1,676.71 3
 SAMPLE 2R Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 5 5 7 24.00% GSSWHETcFIcHR 95.00% 2.64 0.404 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 559.5718 1,675.69 1,676.71 3
 SAMPLE 2R Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 5 5 7 24.00% GFLTERDDILcPDcGKDI 95.00% 2.39 0.256 0 c11: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 708.664 2,122.97 2,123.97 3
 SAMPLE 2R Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 5 5 7 24.00% DNQNFcVPcYEK 95.00% 3.68 0.415 1.54 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 787.3247 1,572.63 1,573.64 2
 SAMPLE 2R Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 5 5 7 24.00% EDQLLcTDcYSNEYSSK 95.00% 5.07 0.619 8.6 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,056.93 2,111.85 2,111.85 2
 SAMPLE 2R Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 100.00% 5 5 7 24.00% EDQLLcTDcYSNEYSSK 95.00% 5.24 0.572 5.46 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,056.93 2,111.85 2,111.85 2
 SAMPLE 3 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 99.80% 2 2 2 7.17% YISFEER 95.00% 2.25 0.335 0 472.2289 942.4421 943.4525 2
 SAMPLE 3 Four and a half LIM domains protein 2  FHL2  FHL2_HUMAN 32,174.40 99.80% 2 2 2 7.17% FDcHHcNESLFGK 95.00% 2.87 0.453 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 551.2318 1,650.67 1,650.68 3
 SAMPLE 2 Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 4 4 6 20.80% cVAcSKPISGLTGAK 95.00% 3.58 0.364 1.92 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 516.9338 1,547.78 1,548.79 3
 SAMPLE 2 Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 4 4 6 20.80% cVAcSKPISGLTGAK 95.00% 1.92 0.3 0 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 517.2671 1,548.78 1,548.79 3
 SAMPLE 2 Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 4 4 6 20.80% VFSNYcEEcKKPIESDSK 95.00% 3.98 0.316 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 741.002 2,219.98 2,220.00 3
 SAMPLE 2 Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 4 4 6 20.80% ESGNYcVPcFEK 95.00% 3.17 0.456 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 745.306 1,488.60 1,489.61 2
 SAMPLE 2 Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 4 4 6 20.80% ESGNYcVPcFEK 95.00% 3.49 0.407 1.34 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 745.8101 1,489.60 1,489.61 2
 SAMPLE 2 Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 4 4 6 20.80% LLcTEcYSNEcSSK 95.00% 4.77 0.652 5.07 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 875.8566 1,749.70 1,750.71 2
 SAMPLE 2R Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 5 5 8 26.40% cVAcSKPISGLTGAK 95.00% 2.28 0.361 1.37 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 516.9327 1,547.77 1,548.79 3
 SAMPLE 2R Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 5 5 8 26.40% cVAcSKPISGLTGAK 95.00% 2.82 0.488 1.22 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 517.2675 1,548.78 1,548.79 3
 SAMPLE 2R Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 5 5 8 26.40% cNHSLVEKPFAAKDER 95.00% 3.43 0.489 0 c1: Carbamidomethyl (+57.02) 634.3162 1,899.93 1,900.93 3
 SAMPLE 2R Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 5 5 8 26.40% VFSNYcEEcKKPIESDSK 95.00% 4.38 0.377 1.1 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 741.0037 2,219.99 2,220.00 3
 SAMPLE 2R Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 5 5 8 26.40% ESGNYcVPcFEK 95.00% 3.12 0.427 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 745.3076 1,488.60 1,489.61 2
 SAMPLE 2R Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 5 5 8 26.40% ESGNYcVPcFEK 95.00% 3.54 0.396 1.11 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 745.8092 1,489.60 1,489.61 2
 SAMPLE 2R Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 5 5 8 26.40% LLcTEcYSNEcSSK 95.00% 5.06 0.655 6.96 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 876.3576 1,750.70 1,750.71 2
 SAMPLE 2R Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 5 5 8 26.40% LLcTEcYSNEcSSK 95.00% 4.33 0.634 5.96 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 876.3607 1,750.71 1,750.71 2
 SAMPLE 3 Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 3 3 4 14.40% cVAcSKPISGLTGAK 95.00% 2.01 0.311 1.66 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 516.9327 1,547.77 1,548.79 3
 SAMPLE 3 Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 3 3 4 14.40% ESGNYcVPcFEK 95.00% 2.54 0.349 1.31 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 745.3033 1,488.59 1,489.61 2
 SAMPLE 3 Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 3 3 4 14.40% LLcTEcYSNEcSSK 95.00% 4.53 0.641 8.08 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 875.8559 1,749.70 1,750.71 2
 SAMPLE 3 Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 100.00% 3 3 4 14.40% LLcTEcYSNEcSSK 95.00% 4.48 0.631 5.57 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 875.8576 1,749.70 1,750.71 2
 SAMPLE 3R Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 99.80% 2 2 2 10.20% cVAcSKPISGLTGAK 95.00% 2.84 0.321 0 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 517.2668 1,548.78 1,548.79 3
 SAMPLE 3R Four and a half LIM domains protein 5  FHL5  FHL5_HUMAN 32,701.20 99.80% 2 2 2 10.20% LLcTEcYSNEcSSK 95.00% 4.48 0.608 3.96 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 876.3591 1,750.70 1,750.71 2
 SAMPLE 2 Fructose-bisphosphate aldolase A  ALDOA  ALDOA_HUMAN 39,402.60 100.00% 4 4 6 17.90% QLLLTADDR 95.00% 2.33 0.255 1.15 522.788 1,043.56 1,044.57 2
 SAMPLE 2 Fructose-bisphosphate aldolase A  ALDOA  ALDOA_HUMAN 39,402.60 100.00% 4 4 6 17.90% YTPSGQAGAAASESLFVSNHAY 95.00% 5.03 0.648 5.55 1,114.52 2,227.02 2,228.03 2
 SAMPLE 2 Fructose-bisphosphate aldolase A  ALDOA  ALDOA_HUMAN 39,402.60 100.00% 4 4 6 17.90% ALANSLAcQGKYTPSGQAGAAASESLFVSNHAY 95.00% 3.38 0.388 0 c8: Carbamidomethyl (+57.02) 1,114.52 3,340.53 3,341.59 3
 SAMPLE 2 Fructose-bisphosphate aldolase A  ALDOA  ALDOA_HUMAN 39,402.60 100.00% 4 4 6 17.90% YTPSGQAGAAASESLFVSNHAY 95.00% 6.09 0.631 6.92 1,115.02 2,228.02 2,228.03 2
 SAMPLE 2 Fructose-bisphosphate aldolase A  ALDOA  ALDOA_HUMAN 39,402.60 100.00% 4 4 6 17.90% ALANSLAcQGKYTPSGQAGAAASESLFVSNHAY 95.00% 4.28 0.371 1.72 c8: Carbamidomethyl (+57.02) 1,115.02 3,342.03 3,341.59 3
 SAMPLE 2 Fructose-bisphosphate aldolase A  ALDOA  ALDOA_HUMAN 39,402.60 100.00% 4 4 6 17.90% GVVPLAGTNGETTTQGLDGLSER 95.00% 3.35 0.649 3.64 1,137.05 2,272.08 2,272.14 2
 SAMPLE 4 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 99.80% 2 2 2 20.00% DSNNLcLHFNPR 95.00% 2.37 0.253 0 c6: Carbamidomethyl (+57.02) 496.2358 1,485.68 1,486.69 3
 SAMPLE 4 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 99.80% 2 2 2 20.00% FNAHGDANTIVcNSK 95.00% 2.44 0.0963 1.25 c12: Carbamidomethyl (+57.02) 550.2539 1,647.74 1,647.76 3
 SAMPLE 4R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 99.80% 2 3 4 17.80% LPDGYEFKFPNR 95.00% 2.77 0.36 0 494.9189 1,481.73 1,482.74 3
 SAMPLE 4R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 99.80% 2 3 4 17.80% LPDGYEFKFPNR 95.00% 2.4 0.234 0 495.2531 1,482.74 1,482.74 3
 SAMPLE 4R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 99.80% 2 3 4 17.80% DSNNLcLHFNPR 95.00% 2.15 0.212 0 c6: Carbamidomethyl (+57.02) 496.2356 1,485.68 1,486.69 3
 SAMPLE 4R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 99.80% 2 3 4 17.80% DSNNLcLHFNPR 95.00% 3.1 0.437 1.44 c6: Carbamidomethyl (+57.02) 743.85 1,485.68 1,486.69 2
 SAMPLE 1 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 99.80% 2 2 2 20.00% FNAHGDANTIVcNSK 95.00% 2.38 0.156 1.68 c12: Carbamidomethyl (+57.02) 549.9268 1,646.76 1,647.76 3
 SAMPLE 1 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 99.80% 2 2 2 20.00% DSNNLcLHFNPR 95.00% 3.47 0.457 2.19 c6: Carbamidomethyl (+57.02) 743.8512 1,485.69 1,486.69 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% LPDGYEFKFPNR 95.00% 2.78 0.378 0 494.916 1,481.72 1,482.74 3
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% DSNNLcLHFNPR 95.00% 2.33 0.294 0 c6: Carbamidomethyl (+57.02) 496.2319 1,485.67 1,486.69 3
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% FNAHGDANTIVcNSK 95.00% 3.59 0.366 2.24 c12: Carbamidomethyl (+57.02) 549.9213 1,646.74 1,647.76 3
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% FNAHGDANTIVcNSK 95.00% 3.34 0.417 1.82 c12: Carbamidomethyl (+57.02) 549.9228 1,646.74 1,647.76 3
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% FNAHGDANTIVcNSK 95.00% 3.62 0.416 2.31 c12: Carbamidomethyl (+57.02) 549.9231 1,646.75 1,647.76 3
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% FNAHGDANTIVcNSK 95.00% 3.78 0.41 1.89 c12: Carbamidomethyl (+57.02) 549.9233 1,646.75 1,647.76 3
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% FNAHGDANTIVcNSK 95.00% 3.05 0.265 0 c12: Carbamidomethyl (+57.02) 550.2507 1,647.73 1,647.76 3
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% FNAHGDANTIVcNSK 95.00% 2.46 0.293 1.36 c12: Carbamidomethyl (+57.02) 550.2513 1,647.73 1,647.76 3
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% LPDGYEFKFPNR 95.00% 4.07 0.481 2.31 741.8714 1,481.73 1,482.74 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% LPDGYEFKFPNR 95.00% 3.85 0.44 2.77 741.8724 1,481.73 1,482.74 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% DSNNLcLHFNPR 95.00% 3.49 0.498 1.89 c6: Carbamidomethyl (+57.02) 743.8451 1,485.67 1,486.69 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% DSNNLcLHFNPR 95.00% 3.47 0.471 1.74 c6: Carbamidomethyl (+57.02) 743.8454 1,485.68 1,486.69 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% DSNNLcLHFNPR 95.00% 3.82 0.455 1.77 c6: Carbamidomethyl (+57.02) 743.8454 1,485.68 1,486.69 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% DSNNLcLHFNPR 95.00% 3.32 0.461 2.35 c6: Carbamidomethyl (+57.02) 743.8457 1,485.68 1,486.69 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% GEVAPDAKSFVLNLGK 95.00% 4.06 0.446 4.8 822.9513 1,643.89 1,644.90 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% GEVAPDAKSFVLNLGK 95.00% 3.99 0.425 6.15 822.9522 1,643.89 1,644.90 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% FNAHGDANTIVcNSK 95.00% 4.92 0.578 5.1 c12: Carbamidomethyl (+57.02) 824.3775 1,646.74 1,647.76 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% FNAHGDANTIVcNSK 95.00% 4.99 0.546 6.85 c12: Carbamidomethyl (+57.02) 824.3805 1,646.75 1,647.76 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% FNAHGDANTIVcNSK 95.00% 4.9 0.579 5.55 c12: Carbamidomethyl (+57.02) 824.3806 1,646.75 1,647.76 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% FNAHGDANTIVcNSK 95.00% 2.96 0.362 4.14 c12: Carbamidomethyl (+57.02) 824.8699 1,647.72 1,647.76 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% FNAHGDANTIVcNSK 95.00% 4.66 0.581 5.82 c12: Carbamidomethyl (+57.02) 824.8783 1,647.74 1,647.76 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% LNLEAINYmAADGDFK 95.00% 5 0.618 6.32 m9: Oxidation (+15.99) 900.927 1,799.84 1,800.85 2
 SAMPLE 2 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 23 52.60% LNLEAINYmAADGDFK 95.00% 5.83 0.559 5.52 m9: Oxidation (+15.99) 901.4296 1,800.84 1,800.85 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% LPDGYEFKFPNR 95.00% 1.96 0.275 0 494.9177 1,481.73 1,482.74 3
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% DSNNLcLHFNPR 95.00% 2.24 0.204 0 c6: Carbamidomethyl (+57.02) 496.2326 1,485.67 1,486.69 3
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% DSNNLcLHFNPR 95.00% 2.36 0.211 0 c6: Carbamidomethyl (+57.02) 496.2328 1,485.68 1,486.69 3
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% GEVAPDAKSFVLNLGK 95.00% 2.54 0.393 0 548.9694 1,643.88 1,644.90 3
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% GEVAPDAKSFVLNLGK 95.00% 2.94 0.363 0 548.9694 1,643.88 1,644.90 3
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% FNAHGDANTIVcNSK 95.00% 3.57 0.397 1.85 c12: Carbamidomethyl (+57.02) 549.9227 1,646.74 1,647.76 3
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% FNAHGDANTIVcNSK 95.00% 3.87 0.439 2.72 c12: Carbamidomethyl (+57.02) 549.9238 1,646.75 1,647.76 3
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% FNAHGDANTIVcNSK 95.00% 3.01 0.302 2.1 c12: Carbamidomethyl (+57.02) 550.2511 1,647.73 1,647.76 3
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% FNAHGDANTIVcNSK 95.00% 2.91 0.169 1.2 c12: Carbamidomethyl (+57.02) 550.2518 1,647.73 1,647.76 3
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% FNAHGDANTIVcNSK 95.00% 2.91 0.335 1.51 c12: Carbamidomethyl (+57.02) 550.2552 1,647.74 1,647.76 3
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% LPDGYEFKFPNR 95.00% 3.78 0.451 2.46 741.8713 1,481.73 1,482.74 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% LPDGYEFKFPNR 95.00% 3.59 0.378 1.82 742.3742 1,482.73 1,482.74 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% DSNNLcLHFNPR 95.00% 3.44 0.419 2.34 c6: Carbamidomethyl (+57.02) 743.8451 1,485.67 1,486.69 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% DSNNLcLHFNPR 95.00% 3.65 0.433 2.22 c6: Carbamidomethyl (+57.02) 743.8452 1,485.67 1,486.69 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% DSNNLcLHFNPR 95.00% 3.6 0.481 1.72 c6: Carbamidomethyl (+57.02) 743.8454 1,485.68 1,486.69 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% DSNNLcLHFNPR 95.00% 3.81 0.44 2.47 c6: Carbamidomethyl (+57.02) 743.8454 1,485.68 1,486.69 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% FNAHGDANTIVcNSK 95.00% 5.14 0.544 5.01 c12: Carbamidomethyl (+57.02) 824.3798 1,646.74 1,647.76 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% FNAHGDANTIVcNSK 95.00% 5 0.571 5.11 c12: Carbamidomethyl (+57.02) 824.38 1,646.74 1,647.76 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% FNAHGDANTIVcNSK 95.00% 4.52 0.508 5.1 c12: Carbamidomethyl (+57.02) 824.3802 1,646.74 1,647.76 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% FNAHGDANTIVcNSK 95.00% 4.11 0.432 4.96 c12: Carbamidomethyl (+57.02) 824.8736 1,647.73 1,647.76 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% FNAHGDANTIVcNSK 95.00% 4.3 0.507 6.92 c12: Carbamidomethyl (+57.02) 824.877 1,647.74 1,647.76 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% FNAHGDANTIVcNSK 95.00% 5.02 0.54 5.48 c12: Carbamidomethyl (+57.02) 824.8826 1,647.75 1,647.76 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% LNLEAINYmAADGDFK 95.00% 5.74 0.546 6.19 m9: Oxidation (+15.99) 901.4275 1,800.84 1,800.85 2
 SAMPLE 2R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 8 24 52.60% LNLEAINYmAADGDFK 95.00% 5.57 0.538 6 m9: Oxidation (+15.99) 901.4277 1,800.84 1,800.85 2
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% LPDGYEFK 95.00% 1.8 0.33 0 484.7405 967.4654 968.4731 2
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% GEVAPDAKSFVLNLGK 95.00% 2.59 0.357 0 548.9692 1,643.88 1,644.90 3
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% FNAHGDANTIVcNSK 95.00% 2.78 0.171 1.64 c12: Carbamidomethyl (+57.02) 550.2518 1,647.73 1,647.76 3
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% FNAHGDANTIVcNSK 95.00% 2.73 0.246 1.08 c12: Carbamidomethyl (+57.02) 550.2523 1,647.73 1,647.76 3
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% LPDGYEFKFPNR 95.00% 4.04 0.487 2.52 741.8701 1,481.72 1,482.74 2
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% LPDGYEFKFPNR 95.00% 4.02 0.452 2.51 741.8719 1,481.73 1,482.74 2
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% DSNNLcLHFNPR 95.00% 3.87 0.442 2.28 c6: Carbamidomethyl (+57.02) 743.8448 1,485.67 1,486.69 2
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% DSNNLcLHFNPR 95.00% 3.76 0.467 1.89 c6: Carbamidomethyl (+57.02) 743.8456 1,485.68 1,486.69 2
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% FNAHGDANTIVcNSK 95.00% 4.31 0.516 4.62 c12: Carbamidomethyl (+57.02) 824.3798 1,646.74 1,647.76 2
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% FNAHGDANTIVcNSK 95.00% 4.93 0.546 4.28 c12: Carbamidomethyl (+57.02) 824.3811 1,646.75 1,647.76 2
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% FNAHGDANTIVcNSK 95.00% 3.85 0.445 4.51 c12: Carbamidomethyl (+57.02) 824.8709 1,647.73 1,647.76 2
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% FNAHGDANTIVcNSK 95.00% 5.01 0.53 4.72 c12: Carbamidomethyl (+57.02) 824.8806 1,647.75 1,647.76 2
 SAMPLE 3 Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 5 6 13 40.70% FNAHGDANTIVcNSK 95.00% 4.43 0.51 4.96 c12: Carbamidomethyl (+57.02) 824.8832 1,647.75 1,647.76 2
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% LPDGYEFK 95.00% 2.52 0.404 0 484.7388 967.4619 968.4731 2
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% DSNNLcLHFNPR 95.00% 2.36 0.31 0 c6: Carbamidomethyl (+57.02) 496.2329 1,485.68 1,486.69 3
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% DGGAWGTEQR 95.00% 1.94 0.27 0 538.7404 1,075.47 1,076.48 2
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% GEVAPDAKSFVLNLGK 95.00% 2.59 0.247 0 549.3035 1,644.89 1,644.90 3
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% FNAHGDANTIVcNSK 95.00% 3.08 0.293 2.66 c12: Carbamidomethyl (+57.02) 549.9229 1,646.75 1,647.76 3
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% FNAHGDANTIVcNSK 95.00% 2.48 0.159 1.39 c12: Carbamidomethyl (+57.02) 550.2506 1,647.73 1,647.76 3
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% FNAHGDANTIVcNSK 95.00% 3.21 0.34 1.7 c12: Carbamidomethyl (+57.02) 550.2526 1,647.73 1,647.76 3
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% FNAHGDANTIVcNSK 95.00% 3.2 0.3 0 c12: Carbamidomethyl (+57.02) 550.2527 1,647.73 1,647.76 3
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% LPDGYEFKFPNR 95.00% 3.46 0.459 2.44 741.8712 1,481.73 1,482.74 2
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% LPDGYEFKFPNR 95.00% 3.94 0.466 2.3 742.3743 1,482.73 1,482.74 2
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% DSNNLcLHFNPR 95.00% 3.48 0.488 1.96 c6: Carbamidomethyl (+57.02) 743.8458 1,485.68 1,486.69 2
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% DSNNLcLHFNPR 95.00% 3.89 0.456 1.77 c6: Carbamidomethyl (+57.02) 743.8466 1,485.68 1,486.69 2
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% FNAHGDANTIVcNSK 95.00% 4.09 0.492 3.28 c12: Carbamidomethyl (+57.02) 824.3767 1,646.74 1,647.76 2
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% FNAHGDANTIVcNSK 95.00% 5.04 0.551 6.54 c12: Carbamidomethyl (+57.02) 824.3797 1,646.74 1,647.76 2
 SAMPLE 3R Galectin-1  LGALS1  LEG1_HUMAN 14,697.80 100.00% 6 8 15 48.10% FNAHGDANTIVcNSK 95.00% 4.34 0.534 5.51 c12: Carbamidomethyl (+57.02) 824.8794 1,647.74 1,647.76 2
 SAMPLE 2R Galectin-3  LGALS3  LEG3_HUMAN 26,134.80 99.80% 2 2 4 10.40% MLITILGTVKPNANR 95.00% 3.59 0.394 1.21 547.6538 1,639.94 1,640.95 3
 SAMPLE 2R Galectin-3  LGALS3  LEG3_HUMAN 26,134.80 99.80% 2 2 4 10.40% MLITILGTVKPNANR 95.00% 4.2 0.423 0 547.6553 1,639.94 1,640.95 3
 SAMPLE 2R Galectin-3  LGALS3  LEG3_HUMAN 26,134.80 99.80% 2 2 4 10.40% GNDVAFHFNPR 95.00% 2.11 0.399 1.37 637.305 1,272.59 1,273.61 2
 SAMPLE 2R Galectin-3  LGALS3  LEG3_HUMAN 26,134.80 99.80% 2 2 4 10.40% GNDVAFHFNPR 95.00% 2.2 0.25 1.92 637.3065 1,272.60 1,273.61 2
 SAMPLE 1 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 3 3 4 6.32% ELSEALGQIFDSQR 95.00% 3.12 0.445 0 531.6019 1,591.78 1,592.79 3
 SAMPLE 1 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 3 3 4 6.32% AVDTWSWGER 95.00% 2.21 0.433 0 603.7786 1,205.54 1,206.55 2
 SAMPLE 1 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 3 3 4 6.32% SDLAVPSELALLK 95.00% 2.47 0.148 1.32 678.3913 1,354.77 1,355.78 2
 SAMPLE 1 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 3 3 4 6.32% SDLAVPSELALLK 95.00% 2.37 0.156 2.13 678.3923 1,354.77 1,355.78 2
 SAMPLE 1R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 99.80% 2 2 3 4.10% AVDTWSWGER 95.00% 2.38 0.378 0 603.7813 1,205.55 1,206.55 2
 SAMPLE 1R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 99.80% 2 2 3 4.10% ELSEALGQIFDSQR 95.00% 4.12 0.463 2.92 796.8991 1,591.78 1,592.79 2
 SAMPLE 1R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 99.80% 2 2 3 4.10% ELSEALGQIFDSQR 95.00% 3.95 0.533 3.14 796.9009 1,591.79 1,592.79 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% RIDITLSSVK 95.00% 2.47 0.0919 1.33 566.3394 1,130.66 1,131.67 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% STSSFPcPAGHFNGFR 95.00% 2.27 0.181 0 c7: Carbamidomethyl (+57.02) 590.2668 1,767.78 1,768.79 3
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% STSSFPcPAGHFNGFR 95.00% 2.61 0.555 0 c7: Carbamidomethyl (+57.02) 590.6002 1,768.78 1,768.79 3
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% ASHEEVEGLVEK 95.00% 2.56 0.428 1.14 663.8295 1,325.64 1,326.65 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% ASHEEVEGLVEK 95.00% 3.03 0.438 2.72 663.8296 1,325.64 1,326.65 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% ASHEEVEGLVEK 95.00% 3.44 0.484 3.59 663.8302 1,325.64 1,326.65 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% ASHEEVEGLVEK 95.00% 2.49 0.38 1.12 663.8307 1,325.65 1,326.65 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% SDLAVPSELALLK 95.00% 2.57 0.379 2.05 678.3916 1,354.77 1,355.78 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% SDLAVPSELALLK 95.00% 2.2 0.241 1.57 678.3919 1,354.77 1,355.78 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% ELSEALGQIFDSQR 95.00% 3.02 0.398 2.33 796.8972 1,591.78 1,592.79 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% ELSEALGQIFDSQR 95.00% 5.02 0.56 3.96 796.8984 1,591.78 1,592.79 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% ELSEALGQIFDSQR 95.00% 5.04 0.574 3.11 796.8996 1,591.78 1,592.79 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% YSSDYFQAPSDYR 95.00% 3.78 0.555 6.28 799.8398 1,597.66 1,598.68 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% YSSDYFQAPSDYR 95.00% 2.73 0.458 4.8 799.8412 1,597.67 1,598.68 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% YSSDYFQAPSDYR 95.00% 3.81 0.617 4.62 799.8421 1,597.67 1,598.68 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% YSSDYFQAPSDYR 95.00% 0 0 3.18 801.4104 1,600.81 1,598.68 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% STSSFPcPAGHFNGFR 95.00% 3.79 0.505 3.26 c7: Carbamidomethyl (+57.02) 884.894 1,767.77 1,768.79 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% STSSFPcPAGHFNGFR 95.00% 3.9 0.6 5.03 c7: Carbamidomethyl (+57.02) 884.8942 1,767.77 1,768.79 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% STSSFPcPAGHFNGFR 95.00% 3.96 0.533 3.85 c7: Carbamidomethyl (+57.02) 884.8947 1,767.77 1,768.79 2
 SAMPLE 3 Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 6 7 20 13.30% STSSFPcPAGHFNGFR 95.00% 4.22 0.558 5.49 c7: Carbamidomethyl (+57.02) 885.3965 1,768.78 1,768.79 2
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% STSSFPcPAGHFNGFR 95.00% 2.38 0.451 0 c7: Carbamidomethyl (+57.02) 590.2662 1,767.78 1,768.79 3
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% STSSFPcPAGHFNGFR 95.00% 2.1 0.387 0 c7: Carbamidomethyl (+57.02) 590.2679 1,767.78 1,768.79 3
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% ASHEEVEGLVEK 95.00% 3.25 0.456 2.4 663.8305 1,325.65 1,326.65 2
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% ASHEEVEGLVEK 95.00% 3.4 0.498 2.46 663.8311 1,325.65 1,326.65 2
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% SDLAVPSELALLK 95.00% 2.26 0.284 0 678.3916 1,354.77 1,355.78 2
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% SDLAVPSELALLK 95.00% 2.89 0.349 2.96 678.3918 1,354.77 1,355.78 2
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% ELSEALGQIFDSQR 95.00% 4.88 0.594 3.8 796.8989 1,591.78 1,592.79 2
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% ELSEALGQIFDSQR 95.00% 4.73 0.477 3.85 797.4001 1,592.78 1,592.79 2
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% YSSDYFQAPSDYR 95.00% 3.65 0.533 3.85 799.841 1,597.67 1,598.68 2
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% YSSDYFQAPSDYR 95.00% 3.43 0.596 4.38 799.8434 1,597.67 1,598.68 2
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% STSSFPcPAGHFNGFR 95.00% 3.25 0.434 1.74 c7: Carbamidomethyl (+57.02) 884.898 1,767.78 1,768.79 2
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% STSSFPcPAGHFNGFR 95.00% 3.51 0.482 3.85 c7: Carbamidomethyl (+57.02) 885.3951 1,768.77 1,768.79 2
 SAMPLE 3R Galectin-3-binding protein  LGALS3BP  LG3BP_HUMAN 65,314.10 100.00% 5 6 13 11.60% STSSFPcPAGHFNGFR 95.00% 4.02 0.5 4.44 c7: Carbamidomethyl (+57.02) 885.3987 1,768.78 1,768.79 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% HVVPNEVVVQR 95.00% 1.68 0.324 2.42 638.3611 1,274.71 1,275.72 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% HVVPNEVVVQR 95.00% 2.68 0.382 3.89 638.3629 1,274.71 1,275.72 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% HVVPNEVVVQR 95.00% 2.93 0.482 3.12 638.3632 1,274.71 1,275.72 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% HVVPNEVVVQR 95.00% 2.78 0.494 4.03 638.3633 1,274.71 1,275.72 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% HVVPNEVVVQR 95.00% 3.41 0.522 3.29 638.3634 1,274.71 1,275.72 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% HVVPNEVVVQR 95.00% 3.14 0.547 3.82 638.3645 1,274.71 1,275.72 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% HVVPNEVVVQR 95.00% 3.2 0.438 4.59 638.3645 1,274.71 1,275.72 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% HVVPNEVVVQR 95.00% 3.29 0.47 3.54 638.3651 1,274.71 1,275.72 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% HVVPNEVVVQR 95.00% 1.68 0.276 1.57 638.3684 1,274.72 1,275.72 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% AGALNSNDAFVLK 95.00% 3.06 0.475 1.74 660.3529 1,318.69 1,319.70 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% AGALNSNDAFVLK 95.00% 3.33 0.488 2.32 660.353 1,318.69 1,319.70 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% AGALNSNDAFVLK 95.00% 2.81 0.457 0 660.3533 1,318.69 1,319.70 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% AGALNSNDAFVLK 95.00% 3.55 0.508 3.52 660.3535 1,318.69 1,319.70 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% AGALNSNDAFVLK 95.00% 3.65 0.505 2.8 660.3544 1,318.69 1,319.70 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% AGALNSNDAFVLK 95.00% 3.02 0.466 2.21 660.355 1,318.69 1,319.70 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% QTQVSVLPEGGETPLFK 95.00% 2.64 0.492 0 915.487 1,828.96 1,829.97 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% QTQVSVLPEGGETPLFK 95.00% 3.96 0.546 2.54 915.4906 1,828.97 1,829.97 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% QTQVSVLPEGGETPLFK 95.00% 4.17 0.55 3.17 915.9903 1,829.97 1,829.97 2
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% TPSAAYLWVGTGASEAEK 95.00% 2.87 0.385 0 919.453 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% TPSAAYLWVGTGASEAEK 95.00% 5.65 0.639 7.92 919.4543 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% TPSAAYLWVGTGASEAEK 95.00% 5.87 0.63 8.42 919.4554 1,836.90 1,837.90 2 CAP1_HUMAN
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% TPSAAYLWVGTGASEAEK 95.00% 6.21 0.605 3.96 919.9544 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% TPSAAYLWVGTGASEAEK 95.00% 5.98 0.644 7.92 919.9547 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% TPSAAYLWVGTGASEAEK 95.00% 5.52 0.609 6.54 919.955 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% TPSAAYLWVGTGASEAEK 95.00% 5.82 0.621 7.6 919.9555 1,837.90 1,837.90 2 CAP1_HUMAN
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% TPSAAYLWVGTGASEAEK 95.00% 6.18 0.628 7.16 919.956 1,837.90 1,837.90 2 CAP1_HUMAN
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% TPSAAYLWVGTGASEAEK 95.00% 6.66 0.612 7.34 919.9564 1,837.90 1,837.90 2 CAP1_HUMAN
 SAMPLE 4 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 28 7.54% TPSAAYLWVGTGASEAEK 95.00% 5.5 0.577 5.68 919.9567 1,837.90 1,837.90 2 CAP1_HUMAN
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% HVVPNEVVVQR 95.00% 2.55 0.456 4.24 638.3623 1,274.71 1,275.72 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% HVVPNEVVVQR 95.00% 2.62 0.374 3.49 638.3626 1,274.71 1,275.72 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% HVVPNEVVVQR 95.00% 2.71 0.449 2.77 638.3632 1,274.71 1,275.72 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% HVVPNEVVVQR 95.00% 2.41 0.432 3.28 638.3635 1,274.71 1,275.72 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% HVVPNEVVVQR 95.00% 3.45 0.525 4.59 638.3639 1,274.71 1,275.72 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% HVVPNEVVVQR 95.00% 1.85 0.45 3.33 638.364 1,274.71 1,275.72 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% HVVPNEVVVQR 95.00% 3.02 0.492 4.21 638.3648 1,274.71 1,275.72 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% HVVPNEVVVQR 95.00% 3.37 0.497 4.44 638.3652 1,274.71 1,275.72 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% HVVPNEVVVQR 95.00% 2.66 0.337 3.15 638.3653 1,274.72 1,275.72 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% HVVPNEVVVQR 95.00% 2.41 0.456 3.36 638.3659 1,274.72 1,275.72 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% AGALNSNDAFVLK 95.00% 2.45 0.237 0 660.3489 1,318.68 1,319.70 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% AGALNSNDAFVLK 95.00% 2.69 0.421 1.57 660.3523 1,318.69 1,319.70 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% AGALNSNDAFVLK 95.00% 2.58 0.436 1.96 660.3537 1,318.69 1,319.70 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% AGALNSNDAFVLK 95.00% 3.26 0.53 3.15 660.3537 1,318.69 1,319.70 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% AGALNSNDAFVLK 95.00% 2.85 0.408 0 660.3542 1,318.69 1,319.70 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% QTQVSVLPEGGETPLFK 94.70% 2.5 0.249 0 915.4882 1,828.96 1,829.97 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% QTQVSVLPEGGETPLFK 95.00% 3.03 0.511 1.64 915.49 1,828.96 1,829.97 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% QTQVSVLPEGGETPLFK 95.00% 3.44 0.492 1.21 915.4917 1,828.97 1,829.97 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% QTQVSVLPEGGETPLFK 95.00% 3.23 0.402 1.59 915.9893 1,829.96 1,829.97 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% QTQVSVLPEGGETPLFK 95.00% 4.43 0.548 2.54 915.9915 1,829.97 1,829.97 2
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% TPSAAYLWVGTGASEAEK 95.00% 5.24 0.614 3.82 919.4529 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% TPSAAYLWVGTGASEAEK 95.00% 6.09 0.63 6.8 919.4548 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% TPSAAYLWVGTGASEAEK 95.00% 5.76 0.58 6.55 919.4561 1,836.90 1,837.90 2 CAP1_HUMAN
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% TPSAAYLWVGTGASEAEK 95.00% 6.06 0.614 5.15 919.4589 1,836.90 1,837.90 2 CAP1_HUMAN
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% TPSAAYLWVGTGASEAEK 95.00% 6.32 0.625 6.47 919.9544 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 4R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 4 4 26 7.54% TPSAAYLWVGTGASEAEK 95.00% 5.85 0.624 6.11 919.9583 1,837.90 1,837.90 2 CAP1_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% YIETDPANR 95.00% 2.5 0.42 0 539.7606 1,077.51 1,078.52 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% YIETDPANR 95.00% 2.1 0.411 0 539.761 1,077.51 1,078.52 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% PALPAGTEDTAKEDAANR 95.00% 1.54 0.359 0 609.633 1,825.88 1,826.89 3 ATPB_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% TPSAAYLWVGTGASEAEK 95.00% 2.64 0.44 0 613.6362 1,837.89 1,837.90 3 CAP1_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGKEPGLQIWR 95.00% 2.9 0.371 2.6 627.8509 1,253.69 1,254.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGKEPGLQIWR 95.00% 2.78 0.399 2.77 627.8514 1,253.69 1,254.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% HVVPNEVVVQR 95.00% 3.09 0.484 4.66 638.3601 1,274.70 1,275.72 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% HVVPNEVVVQR 95.00% 2.04 0.331 3.55 638.3603 1,274.70 1,275.72 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% HVVPNEVVVQR 95.00% 1.35 0.447 1.26 638.3603 1,274.70 1,275.72 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% HVVPNEVVVQR 95.00% 2.37 0.511 2.68 638.3604 1,274.71 1,275.72 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% HVVPNEVVVQR 95.00% 3.13 0.508 3.92 638.3606 1,274.71 1,275.72 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% HVVPNEVVVQR 95.00% 2.95 0.492 3.29 638.3606 1,274.71 1,275.72 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% HVVPNEVVVQR 95.00% 3.22 0.558 4.28 638.3607 1,274.71 1,275.72 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% HVVPNEVVVQR 95.00% 2.81 0.412 3.8 638.3609 1,274.71 1,275.72 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% HVVPNEVVVQR 95.00% 3.23 0.488 3.64 638.3614 1,274.71 1,275.72 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% HVVPNEVVVQR 95.00% 2.75 0.421 3.34 638.3671 1,274.72 1,275.72 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% PALPAGTEDTAKEDAANRK 95.00% 1.82 0.419 0 652.6648 1,954.97 1,954.98 3
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% PALPAGTEDTAKEDAANRK 95.00% 1.76 0.387 0 652.6657 1,954.97 1,954.98 3
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGALNSNDAFVLK 95.00% 2.45 0.237 0 660.349 1,318.68 1,319.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGALNSNDAFVLK 95.00% 2.81 0.457 1.25 660.3504 1,318.69 1,319.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGALNSNDAFVLK 95.00% 4.38 0.521 3.21 660.3507 1,318.69 1,319.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGALNSNDAFVLK 95.00% 4.33 0.527 4.44 660.3507 1,318.69 1,319.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGALNSNDAFVLK 95.00% 4.11 0.503 3.42 660.3509 1,318.69 1,319.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGALNSNDAFVLK 95.00% 3.07 0.474 1.64 660.3509 1,318.69 1,319.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGALNSNDAFVLK 95.00% 4.08 0.513 3.4 660.3513 1,318.69 1,319.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGALNSNDAFVLK 95.00% 3.26 0.496 1.57 660.3518 1,318.69 1,319.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGALNSNDAFVLK 95.00% 3.04 0.422 1.52 660.3519 1,318.69 1,319.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGALNSNDAFVLK 95.00% 2.19 0.387 0 660.3576 1,318.70 1,319.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGALNSNDAFVLK 95.00% 2.87 0.493 1.43 660.3578 1,318.70 1,319.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% SEDcFILDHGK 95.00% 3.73 0.478 1.89 c4: Carbamidomethyl (+57.02) 660.7976 1,319.58 1,320.59 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% SEDcFILDHGK 95.00% 3.68 0.502 2.96 c4: Carbamidomethyl (+57.02) 660.7979 1,319.58 1,320.59 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AGALNSNDAFVLK 95.00% 3.31 0.512 2.89 660.8529 1,319.69 1,319.70 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% VPEARPNSMVVEHPEFLK 95.00% 4.48 0.345 1.68 694.0272 2,079.06 2,079.07 3
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% VPEARPNSMVVEHPEFLK 95.00% 4.9 0.411 1.11 694.028 2,079.06 2,079.07 3
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% VHVSEEGTEPEAMLQVLGPK 95.00% 2.55 0.415 0 717.3662 2,149.08 2,150.08 3
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% VHVSEEGTEPEAMLQVLGPK 95.00% 3.46 0.491 0 717.7004 2,150.08 2,150.08 3
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AQPVQVAEGSEPDGFWEALGGK 95.00% 4.79 0.611 4.46 758.0353 2,271.08 2,272.09 3
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AQPVQVAEGSEPDGFWEALGGK 95.00% 5.7 0.647 5.66 758.3667 2,272.08 2,272.09 3
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% PALPAGTEDTAKEDAANR 95.00% 4.64 0.624 0 913.9448 1,825.87 1,826.89 2 ATPB_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% PALPAGTEDTAKEDAANR 95.00% 4.64 0.609 0 913.9455 1,825.88 1,826.89 2 ATPB_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% QTQVSVLPEGGETPLFK 95.00% 3.65 0.578 1.64 915.4838 1,828.95 1,829.97 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% QTQVSVLPEGGETPLFK 95.00% 4.31 0.56 4.7 915.4838 1,828.95 1,829.97 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% QTQVSVLPEGGETPLFK 95.00% 4.2 0.558 5.8 915.485 1,828.95 1,829.97 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% QTQVSVLPEGGETPLFK 95.00% 4.55 0.577 4.01 915.984 1,829.95 1,829.97 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% QTQVSVLPEGGETPLFK 95.00% 4.28 0.485 4.31 915.9845 1,829.95 1,829.97 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% QTQVSVLPEGGETPLFK 95.00% 4.33 0.561 4.19 915.9853 1,829.95 1,829.97 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% QTQVSVLPEGGETPLFK 95.00% 4.47 0.542 4.19 915.9862 1,829.96 1,829.97 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% QTQVSVLPEGGETPLFK 95.00% 3.38 0.492 3.8 915.989 1,829.96 1,829.97 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% TPSAAYLWVGTGASEAEK 95.00% 5.68 0.547 5.51 919.4473 1,836.88 1,837.90 2 CAP1_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% TPSAAYLWVGTGASEAEK 95.00% 5.36 0.578 4.52 919.4494 1,836.88 1,837.90 2 CAP1_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% TPSAAYLWVGTGASEAEK 95.00% 5.73 0.594 8.34 919.4512 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% TPSAAYLWVGTGASEAEK 95.00% 6.17 0.632 6.29 919.4513 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% TPSAAYLWVGTGASEAEK 95.00% 5.17 0.658 2.64 919.4608 1,836.91 1,837.90 2 CAP1_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% TPSAAYLWVGTGASEAEK 95.00% 3.74 0.461 3.57 919.9503 1,837.88 1,837.90 2 CAP1_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% TPSAAYLWVGTGASEAEK 95.00% 5.75 0.622 4.6 919.9503 1,837.88 1,837.90 2 CAP1_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% TPSAAYLWVGTGASEAEK 95.00% 5.98 0.542 7.52 919.9505 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% TPSAAYLWVGTGASEAEK 95.00% 5.51 0.595 3.39 919.9519 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% TPSAAYLWVGTGASEAEK 95.00% 6.67 0.6 7.4 919.9519 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% VPFDAATLHTSTAMAAQHGMDDDGTGQK 95.00% 5.67 0.638 2.82 958.7648 2,873.27 2,873.28 3
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% VPFDAATLHTSTAMAAQHGMDDDGTGQK 95.00% 6.4 0.63 2.85 958.7656 2,873.27 2,873.28 3
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% PALPAGTEDTAKEDAANRK 95.00% 3.93 0.522 0 977.9965 1,953.98 1,954.98 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AQPVQVAEGSEPDGFWEALGGK 95.00% 6.79 0.669 8.55 1,137.04 2,272.07 2,272.09 2
 SAMPLE 1 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 63 25.20% AQPVQVAEGSEPDGFWEALGGK 95.00% 7.26 0.631 7.96 1,137.05 2,272.08 2,272.09 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% YIETDPANR 95.00% 2.18 0.399 0 539.7614 1,077.51 1,078.52 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% YIETDPANR 95.00% 2.17 0.433 0 539.7631 1,077.51 1,078.52 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% TPSAAYLWVGTGASEAEK 95.00% 2.46 0.253 0 613.3023 1,836.88 1,837.90 3 CAP1_HUMAN
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% TPSAAYLWVGTGASEAEK 95.00% 3.76 0.423 1.55 613.6376 1,837.89 1,837.90 3 CAP1_HUMAN
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AGKEPGLQIWR 95.00% 2.73 0.438 2 627.8504 1,253.69 1,254.70 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AGKEPGLQIWR 95.00% 2.81 0.396 2.31 627.8517 1,253.69 1,254.70 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% HVVPNEVVVQR 95.00% 1.85 0.319 1.85 638.3601 1,274.70 1,275.72 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% HVVPNEVVVQR 95.00% 2.5 0.447 2.59 638.3607 1,274.71 1,275.72 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% HVVPNEVVVQR 95.00% 2.26 0.322 3.51 638.3609 1,274.71 1,275.72 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% HVVPNEVVVQR 95.00% 2.94 0.465 3.92 638.361 1,274.71 1,275.72 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% HVVPNEVVVQR 95.00% 3.08 0.527 3.27 638.361 1,274.71 1,275.72 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% HVVPNEVVVQR 95.00% 3.09 0.538 3.85 638.3611 1,274.71 1,275.72 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% HVVPNEVVVQR 95.00% 3.11 0.447 4.04 638.3612 1,274.71 1,275.72 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% HVVPNEVVVQR 95.00% 3.01 0.469 3.29 638.3613 1,274.71 1,275.72 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% HVVPNEVVVQR 95.00% 3.27 0.502 4.6 638.3622 1,274.71 1,275.72 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% HVVPNEVVVQR 95.00% 2.75 0.421 3.05 638.3671 1,274.72 1,275.72 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% PALPAGTEDTAKEDAANRK 95.00% 1.76 0.477 0 652.3329 1,953.98 1,954.98 3
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% PALPAGTEDTAKEDAANRK 95.00% 2.34 0.5 0 652.6663 1,954.98 1,954.98 3
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AGALNSNDAFVLK 95.00% 3.03 0.434 1.89 660.3504 1,318.69 1,319.70 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AGALNSNDAFVLK 95.00% 3.53 0.444 3.28 660.3504 1,318.69 1,319.70 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AGALNSNDAFVLK 95.00% 3.63 0.476 3.22 660.3507 1,318.69 1,319.70 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AGALNSNDAFVLK 95.00% 2.35 0.404 0 660.351 1,318.69 1,319.70 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AGALNSNDAFVLK 95.00% 2.45 0.336 0 660.3537 1,318.69 1,319.70 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AGALNSNDAFVLK 95.00% 2.19 0.387 0 660.3576 1,318.70 1,319.70 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AGALNSNDAFVLK 95.00% 2.87 0.493 0 660.3578 1,318.70 1,319.70 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% SEDcFILDHGK 95.00% 3.43 0.54 3.25 c4: Carbamidomethyl (+57.02) 660.795 1,319.57 1,320.59 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% SEDcFILDHGK 95.00% 3.61 0.527 2.68 c4: Carbamidomethyl (+57.02) 660.7976 1,319.58 1,320.59 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% VPEARPNSMVVEHPEFLK 95.00% 4.25 0.29 1.12 694.0275 2,079.06 2,079.07 3
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% VPEARPNSMVVEHPEFLK 95.00% 4.08 0.309 0 694.0292 2,079.06 2,079.07 3
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% VHVSEEGTEPEAMLQVLGPK 95.00% 3.1 0.535 0 717.697 2,150.07 2,150.08 3
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% VHVSEEGTEPEAMLQVLGPK 95.00% 3.15 0.416 0 717.699 2,150.07 2,150.08 3
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AQPVQVAEGSEPDGFWEALGGK 95.00% 5.18 0.533 4.68 758.3669 2,272.08 2,272.09 3
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AQPVQVAEGSEPDGFWEALGGK 95.00% 5.06 0.549 4.38 758.3691 2,272.08 2,272.09 3
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% EVQGFESATFLGYFK 95.00% 4.13 0.605 5.34 861.9203 1,721.82 1,722.84 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% EVQGFESATFLGYFK 95.00% 4.8 0.597 4.77 862.4214 1,722.83 1,722.84 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% PALPAGTEDTAKEDAANR 95.00% 4.47 0.59 0 913.9464 1,825.88 1,826.89 2 ATPB_HUMAN
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% PALPAGTEDTAKEDAANR 95.00% 4.65 0.618 0 914.4479 1,826.88 1,826.89 2 ATPB_HUMAN
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% QTQVSVLPEGGETPLFK 95.00% 4.25 0.552 3.08 915.484 1,828.95 1,829.97 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% QTQVSVLPEGGETPLFK 95.00% 2.55 0.362 0 915.4842 1,828.95 1,829.97 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% QTQVSVLPEGGETPLFK 95.00% 4.21 0.526 3.22 915.4843 1,828.95 1,829.97 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% QTQVSVLPEGGETPLFK 95.00% 4.38 0.531 4.32 915.9849 1,829.95 1,829.97 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% QTQVSVLPEGGETPLFK 95.00% 2.98 0.313 0 915.9856 1,829.96 1,829.97 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% QTQVSVLPEGGETPLFK 95.00% 4.25 0.509 2.66 915.9862 1,829.96 1,829.97 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% QTQVSVLPEGGETPLFK 95.00% 4.21 0.535 6.24 915.9863 1,829.96 1,829.97 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% QTQVSVLPEGGETPLFK 95.00% 4.25 0.519 3.47 915.9866 1,829.96 1,829.97 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% QTQVSVLPEGGETPLFK 95.00% 4.42 0.545 5.27 915.9866 1,829.96 1,829.97 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% QTQVSVLPEGGETPLFK 95.00% 4.35 0.562 3.12 915.9867 1,829.96 1,829.97 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% TPSAAYLWVGTGASEAEK 95.00% 5.79 0.566 6.02 919.4486 1,836.88 1,837.90 2 CAP1_HUMAN
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% TPSAAYLWVGTGASEAEK 95.00% 6.34 0.626 6.06 919.4502 1,836.88 1,837.90 2 CAP1_HUMAN
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% TPSAAYLWVGTGASEAEK 95.00% 5.87 0.587 5.43 919.4515 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% TPSAAYLWVGTGASEAEK 95.00% 5.07 0.578 4.92 919.4533 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% TPSAAYLWVGTGASEAEK 95.00% 5.2 0.576 5.17 919.455 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% TPSAAYLWVGTGASEAEK 95.00% 5.17 0.658 2.92 919.4608 1,836.91 1,837.90 2 CAP1_HUMAN
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% TPSAAYLWVGTGASEAEK 95.00% 5.97 0.613 5.64 919.9514 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% TPSAAYLWVGTGASEAEK 95.00% 6.34 0.592 6.33 919.9538 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% VPFDAATLHTSTAMAAQHGMDDDGTGQK 95.00% 6.61 0.686 1.66 958.765 2,873.27 2,873.28 3
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% PALPAGTEDTAKEDAANRK 95.00% 4.13 0.512 0 978.498 1,954.98 1,954.98 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AQPVQVAEGSEPDGFWEALGGK 95.00% 6.27 0.65 7.66 1,137.04 2,272.07 2,272.09 2
 SAMPLE 1R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 14 17 59 27.10% AQPVQVAEGSEPDGFWEALGGK 95.00% 5.84 0.613 7.57 1,137.04 2,272.07 2,272.09 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% SEDcFILDHGKDGK 95.00% 2.34 0.24 0 c4: Carbamidomethyl (+57.02) 540.9142 1,619.72 1,620.73 3
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% DSQEEEKTEALTSAK 95.00% 4.88 0.496 4.82 555.9302 1,664.77 1,665.78 3
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% DSQEEEKTEALTSAK 95.00% 5.04 0.496 2.74 555.9313 1,664.77 1,665.78 3
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% PALPAGTEDTAKEDAANR 95.00% 1.8 0.357 0 609.9673 1,826.88 1,826.89 3 ATPB_HUMAN
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% TPSAAYLWVGTGASEAEK 95.00% 2.08 0.221 0 613.3031 1,836.89 1,837.90 3 CAP1_HUMAN
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% TPSAAYLWVGTGASEAEK 95.00% 3.4 0.442 1.12 613.6375 1,837.89 1,837.90 3 CAP1_HUMAN
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AGKEPGLQIWR 95.00% 2.53 0.314 1.74 627.8503 1,253.69 1,254.70 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AGKEPGLQIWR 95.00% 2.17 0.311 1.24 627.8507 1,253.69 1,254.70 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 2.37 0.397 2.38 638.3597 1,274.70 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 2.23 0.412 1.72 638.3597 1,274.70 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 3.1 0.51 2.72 638.3606 1,274.71 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 2.91 0.443 4.08 638.3608 1,274.71 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 2.75 0.429 3.55 638.3609 1,274.71 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 2.27 0.383 2.74 638.361 1,274.71 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 2.58 0.415 1.19 638.361 1,274.71 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 3.16 0.492 4 638.3611 1,274.71 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 3.09 0.465 3.92 638.3612 1,274.71 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 3.53 0.557 3.96 638.3614 1,274.71 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 3.13 0.508 3.44 638.3615 1,274.71 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 2.86 0.444 3.39 638.3615 1,274.71 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 3.08 0.532 3.92 638.3624 1,274.71 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% HVVPNEVVVQR 95.00% 2.13 0.248 1.8 638.8623 1,275.71 1,275.72 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% PALPAGTEDTAKEDAANRK 95.00% 1.81 0.349 0 652.6672 1,954.98 1,954.98 3
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AGALNSNDAFVLK 95.00% 4.07 0.511 2.43 660.35 1,318.68 1,319.70 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AGALNSNDAFVLK 95.00% 3.71 0.472 3.24 660.3504 1,318.69 1,319.70 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AGALNSNDAFVLK 95.00% 3.85 0.511 4.04 660.3506 1,318.69 1,319.70 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AGALNSNDAFVLK 95.00% 4.37 0.506 5.02 660.3511 1,318.69 1,319.70 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AGALNSNDAFVLK 95.00% 4.16 0.482 3.19 660.3512 1,318.69 1,319.70 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AGALNSNDAFVLK 95.00% 3.46 0.521 2.34 660.3517 1,318.69 1,319.70 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AGALNSNDAFVLK 95.00% 1.97 0.384 0 660.3528 1,318.69 1,319.70 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AGALNSNDAFVLK 95.00% 2.32 0.376 0 660.3529 1,318.69 1,319.70 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% SEDcFILDHGK 95.00% 3.65 0.498 2.6 c4: Carbamidomethyl (+57.02) 660.7975 1,319.58 1,320.59 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% SEDcFILDHGK 95.00% 3.59 0.502 3.11 c4: Carbamidomethyl (+57.02) 660.7978 1,319.58 1,320.59 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% SEDcFILDHGK 95.00% 3.2 0.363 0 c4: Carbamidomethyl (+57.02) 660.8003 1,319.59 1,320.59 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AQPVQVAEGSEPDGFWEALGGK 95.00% 5.27 0.562 4.7 758.3696 2,272.09 2,272.09 3
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% qTQVSVLPEGGETPLFK 95.00% 0 0 4.11 n-term: Pyro-cmC (-17.03) 907.471 1,812.93 1,812.94 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% PALPAGTEDTAKEDAANR 95.00% 4.9 0.554 0 914.4485 1,826.88 1,826.89 2 ATPB_HUMAN
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% QTQVSVLPEGGETPLFK 95.00% 4.39 0.538 6.62 915.4839 1,828.95 1,829.97 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% QTQVSVLPEGGETPLFK 95.00% 4.18 0.571 4.04 915.4839 1,828.95 1,829.97 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% QTQVSVLPEGGETPLFK 95.00% 4.3 0.536 4.82 915.484 1,828.95 1,829.97 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% QTQVSVLPEGGETPLFK 95.00% 4.07 0.563 3.41 915.485 1,828.95 1,829.97 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% QTQVSVLPEGGETPLFK 95.00% 4.11 0.511 3 915.9851 1,829.95 1,829.97 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% TPSAAYLWVGTGASEAEK 95.00% 4.82 0.527 3.68 919.4496 1,836.88 1,837.90 2 CAP1_HUMAN
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% TPSAAYLWVGTGASEAEK 95.00% 4.61 0.474 3.92 919.4507 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% TPSAAYLWVGTGASEAEK 95.00% 6.26 0.62 7.77 919.4518 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% TPSAAYLWVGTGASEAEK 95.00% 4.6 0.539 2.46 919.9465 1,837.88 1,837.90 2 CAP1_HUMAN
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% TPSAAYLWVGTGASEAEK 95.00% 6.33 0.61 6.51 919.9508 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% TPSAAYLWVGTGASEAEK 95.00% 6.62 0.609 5.7 919.9516 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% TPSAAYLWVGTGASEAEK 95.00% 6.18 0.6 6.7 919.9518 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% VPFDAATLHTSTAMAAQHGMDDDGTGQK 95.00% 6.66 0.662 2.32 958.7648 2,873.27 2,873.28 3
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% VPFDAATLHTSTAMAAQHGMDDDGTGQK 95.00% 6.86 0.678 2.89 958.7661 2,873.27 2,873.28 3
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AQPVQVAEGSEPDGFWEALGGK 95.00% 6.98 0.643 7.82 1,137.04 2,272.07 2,272.09 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AQPVQVAEGSEPDGFWEALGGK 95.00% 7.15 0.657 7.77 1,137.05 2,272.08 2,272.09 2
 SAMPLE 2 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 12 15 54 21.50% AQPVQVAEGSEPDGFWEALGGK 95.00% 7.48 0.641 6.7 1,137.05 2,272.08 2,272.09 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% YIETDPANR 95.00% 2.22 0.365 0 539.7607 1,077.51 1,078.52 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% DSQEEEKTEALTSAK 95.00% 4.97 0.387 2.96 555.9317 1,664.77 1,665.78 3
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% PALPAGTEDTAKEDAANR 95.00% 2.35 0.294 0 609.6334 1,825.88 1,826.89 3 ATPB_HUMAN
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% TPSAAYLWVGTGASEAEK 95.00% 2.25 0.215 0 613.303 1,836.89 1,837.90 3 CAP1_HUMAN
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% TPSAAYLWVGTGASEAEK 95.00% 3.76 0.45 0 613.6368 1,837.89 1,837.90 3 CAP1_HUMAN
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AGKEPGLQIWR 95.00% 2.32 0.243 0 627.8508 1,253.69 1,254.70 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AGKEPGLQIWR 95.00% 1.98 0.223 1.64 627.851 1,253.69 1,254.70 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AGKEPGLQIWR 95.00% 2.43 0.26 1.22 627.8511 1,253.69 1,254.70 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 2.72 0.481 3.21 638.3607 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 3.14 0.454 4.68 638.3608 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 2.94 0.444 3.28 638.3608 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 2.54 0.484 4.39 638.361 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 2.96 0.431 3.14 638.3611 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 2.9 0.457 4.12 638.3611 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 3.23 0.496 4.77 638.3612 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 3.09 0.509 3.82 638.3612 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 3 0.483 3.77 638.3615 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 2.65 0.468 1.26 638.3617 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 2.45 0.435 2.66 638.3617 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 1.91 0.298 1.36 638.3621 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 2.29 0.46 1.52 638.3631 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% HVVPNEVVVQR 95.00% 2 0.347 2.39 638.3634 1,274.71 1,275.72 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% PALPAGTEDTAKEDAANRK 95.00% 1.96 0.438 0 652.3307 1,953.97 1,954.98 3
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% PALPAGTEDTAKEDAANRK 95.00% 1.88 0.456 0 652.3326 1,953.97 1,954.98 3
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AGALNSNDAFVLK 95.00% 3.1 0.435 1.77 660.3501 1,318.68 1,319.70 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AGALNSNDAFVLK 95.00% 4.14 0.466 2.85 660.3505 1,318.69 1,319.70 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AGALNSNDAFVLK 95.00% 3.57 0.442 3.24 660.3506 1,318.69 1,319.70 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AGALNSNDAFVLK 95.00% 3.96 0.519 3.77 660.3506 1,318.69 1,319.70 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AGALNSNDAFVLK 95.00% 4.24 0.507 2.96 660.3512 1,318.69 1,319.70 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AGALNSNDAFVLK 95.00% 3.92 0.476 5.49 660.3512 1,318.69 1,319.70 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% SEDcFILDHGK 95.00% 3.55 0.503 2.37 c4: Carbamidomethyl (+57.02) 660.7975 1,319.58 1,320.59 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% SEDcFILDHGK 95.00% 3.52 0.463 2.2 c4: Carbamidomethyl (+57.02) 660.7977 1,319.58 1,320.59 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AQPVQVAEGSEPDGFWEALGGK 95.00% 4.61 0.518 3.17 758.3685 2,272.08 2,272.09 3
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AQPVQVAEGSEPDGFWEALGGK 95.00% 5.08 0.448 3.11 758.3705 2,272.09 2,272.09 3
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% DSQEEEKTEALTSAK 95.00% 3.83 0.443 4.04 833.3927 1,664.77 1,665.78 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% DSQEEEKTEALTSAK 95.00% 3.92 0.492 4.72 833.3935 1,664.77 1,665.78 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% EVQGFESATFLGYFK 95.00% 4.64 0.582 4.62 861.919 1,721.82 1,722.84 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% EVQGFESATFLGYFK 95.00% 4.99 0.539 4.43 862.4214 1,722.83 1,722.84 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% PALPAGTEDTAKEDAANR 95.00% 4.61 0.484 0 914.4505 1,826.89 1,826.89 2 ATPB_HUMAN
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% QTQVSVLPEGGETPLFK 95.00% 4.36 0.526 4.96 915.4847 1,828.95 1,829.97 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% QTQVSVLPEGGETPLFK 95.00% 2.51 0.462 0 915.4847 1,828.95 1,829.97 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% QTQVSVLPEGGETPLFK 95.00% 2.74 0.467 0 915.4856 1,828.96 1,829.97 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% QTQVSVLPEGGETPLFK 95.00% 4.41 0.526 3.82 915.9861 1,829.96 1,829.97 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% QTQVSVLPEGGETPLFK 95.00% 4.25 0.524 4.47 915.9865 1,829.96 1,829.97 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% QTQVSVLPEGGETPLFK 95.00% 4.3 0.538 3.49 915.9866 1,829.96 1,829.97 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% QTQVSVLPEGGETPLFK 95.00% 4.28 0.5 2.85 915.9875 1,829.96 1,829.97 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% QTQVSVLPEGGETPLFK 95.00% 4.41 0.49 3.31 915.9883 1,829.96 1,829.97 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% TPSAAYLWVGTGASEAEK 95.00% 4.05 0.544 2.7 919.4548 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% TPSAAYLWVGTGASEAEK 95.00% 6.41 0.63 6.77 919.9511 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% TPSAAYLWVGTGASEAEK 95.00% 6.59 0.618 7.1 919.9518 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% TPSAAYLWVGTGASEAEK 95.00% 6.09 0.585 6.2 919.9524 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% TPSAAYLWVGTGASEAEK 95.00% 6.34 0.622 6.85 919.9532 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% TPSAAYLWVGTGASEAEK 95.00% 4.99 0.578 4.92 919.9538 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% VPFDAATLHTSTAMAAQHGMDDDGTGQK 95.00% 6.15 0.602 3.17 958.7633 2,873.27 2,873.28 3
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% VPFDAATLHTSTAMAAQHGMDDDGTGQK 95.00% 6.86 0.649 2.41 958.7646 2,873.27 2,873.28 3
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AQPVQVAEGSEPDGFWEALGGK 95.00% 7.29 0.656 7.15 1,137.05 2,272.08 2,272.09 2
 SAMPLE 2R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 17 57 24.20% AQPVQVAEGSEPDGFWEALGGK 95.00% 7.3 0.635 8.38 1,137.05 2,272.08 2,272.09 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% YIETDPANR 95.00% 2.28 0.447 0 539.7588 1,077.50 1,078.52 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% YIETDPANR 95.00% 2.14 0.258 0 540.2581 1,078.50 1,078.52 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% SEDcFILDHGKDGK 95.00% 2.47 0.242 1.62 c4: Carbamidomethyl (+57.02) 540.9147 1,619.72 1,620.73 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% SEDcFILDHGKDGK 95.00% 2.5 0.274 1.44 c4: Carbamidomethyl (+57.02) 540.9153 1,619.72 1,620.73 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% DSQEEEKTEALTSAK 95.00% 4.89 0.459 4 555.9313 1,664.77 1,665.78 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% DSQEEEKTEALTSAK 95.00% 4.58 0.522 1.92 555.9315 1,664.77 1,665.78 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% DSQEEEKTEALTSAK 95.00% 4.46 0.476 3.01 555.9318 1,664.77 1,665.78 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% PALPAGTEDTAKEDAANR 95.00% 2.48 0.511 0 609.6331 1,825.88 1,826.89 3 ATPB_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% PALPAGTEDTAKEDAANR 95.00% 2.17 0.426 0 609.6337 1,825.88 1,826.89 3 ATPB_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% PALPAGTEDTAKEDAANR 95.00% 1.73 0.337 0 609.6338 1,825.88 1,826.89 3 ATPB_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% PALPAGTEDTAKEDAANR 95.00% 2.22 0.357 0 609.634 1,825.88 1,826.89 3 ATPB_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% TPSAAYLWVGTGASEAEK 95.00% 3.56 0.449 1.04 613.3021 1,836.88 1,837.90 3 CAP1_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% TPSAAYLWVGTGASEAEK 95.00% 3.47 0.437 1.47 613.6371 1,837.89 1,837.90 3 CAP1_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGKEPGLQIWR 95.00% 2.61 0.34 1.55 627.8509 1,253.69 1,254.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGKEPGLQIWR 95.00% 2.57 0.386 2.74 627.8512 1,253.69 1,254.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGKEPGLQIWR 95.00% 2.87 0.391 2.26 627.8514 1,253.69 1,254.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% HVVPNEVVVQR 95.00% 1.9 0.379 0 638.3596 1,274.70 1,275.72 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% HVVPNEVVVQR 95.00% 3.19 0.568 4.74 638.3604 1,274.71 1,275.72 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% HVVPNEVVVQR 95.00% 2.82 0.486 3.85 638.3606 1,274.71 1,275.72 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% HVVPNEVVVQR 95.00% 3.36 0.46 3.85 638.3607 1,274.71 1,275.72 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% HVVPNEVVVQR 95.00% 2.75 0.483 3.32 638.3607 1,274.71 1,275.72 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% HVVPNEVVVQR 95.00% 2.89 0.503 3.85 638.3612 1,274.71 1,275.72 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% HVVPNEVVVQR 95.00% 2.94 0.51 3.6 638.3615 1,274.71 1,275.72 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% HVVPNEVVVQR 95.00% 2.09 0.312 2.06 638.3615 1,274.71 1,275.72 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% HVVPNEVVVQR 95.00% 3.01 0.42 3 638.3615 1,274.71 1,275.72 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% HVVPNEVVVQR 95.00% 2.76 0.498 4.72 638.3616 1,274.71 1,275.72 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% HVVPNEVVVQR 95.00% 2.48 0.486 3.74 638.3617 1,274.71 1,275.72 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% HVVPNEVVVQR 95.00% 2.45 0.402 5.47 638.3617 1,274.71 1,275.72 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% PALPAGTEDTAKEDAANRK 95.00% 1.8 0.397 0 652.3334 1,953.98 1,954.98 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% PALPAGTEDTAKEDAANRK 95.00% 2.11 0.441 0 652.6665 1,954.98 1,954.98 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGALNSNDAFVLK 95.00% 4.25 0.516 3.72 660.3485 1,318.68 1,319.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGALNSNDAFVLK 95.00% 3.17 0.499 3.72 660.35 1,318.68 1,319.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGALNSNDAFVLK 95.00% 4.4 0.517 4.03 660.3504 1,318.69 1,319.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGALNSNDAFVLK 95.00% 4.12 0.463 4.74 660.3506 1,318.69 1,319.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGALNSNDAFVLK 95.00% 3.05 0.435 0 660.3506 1,318.69 1,319.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGALNSNDAFVLK 95.00% 3.4 0.531 2.82 660.3506 1,318.69 1,319.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGALNSNDAFVLK 95.00% 2.59 0.423 0 660.351 1,318.69 1,319.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGALNSNDAFVLK 95.00% 4.32 0.516 3.32 660.351 1,318.69 1,319.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGALNSNDAFVLK 95.00% 3.4 0.561 2.54 660.351 1,318.69 1,319.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AGALNSNDAFVLK 95.00% 2.32 0.287 0 660.3513 1,318.69 1,319.70 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% SEDcFILDHGK 95.00% 3.02 0.529 1.7 c4: Carbamidomethyl (+57.02) 660.7966 1,319.58 1,320.59 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% SEDcFILDHGK 95.00% 3.61 0.545 2.89 c4: Carbamidomethyl (+57.02) 660.7971 1,319.58 1,320.59 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% SEDcFILDHGK 95.00% 3.64 0.549 2.6 c4: Carbamidomethyl (+57.02) 660.7973 1,319.58 1,320.59 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% SEDcFILDHGK 95.00% 3.49 0.52 2.47 c4: Carbamidomethyl (+57.02) 660.7976 1,319.58 1,320.59 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% VPEARPNSMVVEHPEFLK 95.00% 4.03 0.35 0 694.0307 2,079.07 2,079.07 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% VHVSEEGTEPEAMLQVLGPK 95.00% 2.95 0.359 0 717.6996 2,150.08 2,150.08 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% VHVSEEGTEPEAMLQVLGPK 95.00% 2.92 0.483 0 717.7006 2,150.08 2,150.08 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AQPVQVAEGSEPDGFWEALGGK 95.00% 5.33 0.575 4.27 758.3679 2,272.08 2,272.09 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% SEDcFILDHGKDGK 95.00% 3.79 0.507 5.03 c4: Carbamidomethyl (+57.02) 810.869 1,619.72 1,620.73 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% SEDcFILDHGKDGK 95.00% 3.79 0.484 4.32 c4: Carbamidomethyl (+57.02) 810.8697 1,619.72 1,620.73 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% DSQEEEKTEALTSAK 95.00% 3.5 0.417 3.85 833.3903 1,664.77 1,665.78 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% DSQEEEKTEALTSAK 95.00% 4.03 0.495 4.12 833.3932 1,664.77 1,665.78 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% DSQEEEKTEALTSAK 95.00% 3.64 0.48 3.57 833.3935 1,664.77 1,665.78 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% DSQEEEKTEALTSAK 95.00% 3.98 0.443 3.19 833.3936 1,664.77 1,665.78 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% PALPAGTEDTAKEDAANR 95.00% 3.27 0.408 0 913.9485 1,825.88 1,826.89 2 ATPB_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% PALPAGTEDTAKEDAANR 95.00% 4.26 0.499 0 914.4472 1,826.88 1,826.89 2 ATPB_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% QTQVSVLPEGGETPLFK 95.00% 4.35 0.588 4.92 915.4839 1,828.95 1,829.97 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% QTQVSVLPEGGETPLFK 95.00% 4.18 0.55 5.47 915.484 1,828.95 1,829.97 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% QTQVSVLPEGGETPLFK 95.00% 3.17 0.477 2.66 915.485 1,828.95 1,829.97 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% QTQVSVLPEGGETPLFK 95.00% 4.35 0.564 5.29 915.9852 1,829.95 1,829.97 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% QTQVSVLPEGGETPLFK 95.00% 4.26 0.551 4.48 915.9863 1,829.96 1,829.97 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% QTQVSVLPEGGETPLFK 95.00% 4.35 0.52 4.92 915.9873 1,829.96 1,829.97 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% TPSAAYLWVGTGASEAEK 95.00% 6.15 0.612 6.57 919.4498 1,836.88 1,837.90 2 CAP1_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% TPSAAYLWVGTGASEAEK 95.00% 6.52 0.622 6.28 919.4501 1,836.88 1,837.90 2 CAP1_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% TPSAAYLWVGTGASEAEK 95.00% 6.46 0.623 5.22 919.4503 1,836.88 1,837.90 2 CAP1_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% TPSAAYLWVGTGASEAEK 95.00% 4.9 0.58 4.96 919.451 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% TPSAAYLWVGTGASEAEK 95.00% 5.2 0.583 3.49 919.9511 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% VPFDAATLHTSTAMAAQHGMDDDGTGQK 95.00% 6.73 0.648 4.74 958.7644 2,873.27 2,873.28 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% VPFDAATLHTSTAMAAQHGMDDDGTGQK 95.00% 6.57 0.666 1.92 958.7669 2,873.28 2,873.28 3
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AQPVQVAEGSEPDGFWEALGGK 95.00% 7.41 0.662 8.46 1,137.05 2,272.08 2,272.09 2
 SAMPLE 3 Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 15 20 71 27.50% AQPVQVAEGSEPDGFWEALGGK 95.00% 7.37 0.661 8.46 1,137.05 2,272.08 2,272.09 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% YIETDPANR 95.00% 2.12 0.361 0 539.7611 1,077.51 1,078.52 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% YIETDPANR 95.00% 2.4 0.357 0 539.7614 1,077.51 1,078.52 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% DSQEEEKTEALTSAK 95.00% 4.6 0.512 1.85 555.9308 1,664.77 1,665.78 3
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% DSQEEEKTEALTSAK 95.00% 4.77 0.43 2.01 555.9318 1,664.77 1,665.78 3
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% DSQEEEKTEALTSAK 95.00% 4.69 0.517 1.62 555.9323 1,664.77 1,665.78 3
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% PALPAGTEDTAKEDAANR 95.00% 2.2 0.473 0 609.6329 1,825.88 1,826.89 3 ATPB_HUMAN
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% PALPAGTEDTAKEDAANR 95.00% 1.55 0.276 0 609.6329 1,825.88 1,826.89 3 ATPB_HUMAN
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AGKEPGLQIWR 95.00% 2.26 0.288 1.27 627.8497 1,253.68 1,254.70 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AGKEPGLQIWR 95.00% 2.45 0.398 1.8 627.8502 1,253.68 1,254.70 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AGKEPGLQIWR 95.00% 2.4 0.329 1.46 627.8517 1,253.69 1,254.70 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AGKEPGLQIWR 95.00% 2.43 0.338 1.68 627.8518 1,253.69 1,254.70 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 2.66 0.399 2.85 638.3607 1,274.71 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 3.06 0.508 3.74 638.361 1,274.71 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 2.86 0.484 3.37 638.3612 1,274.71 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 3.09 0.451 3.74 638.3612 1,274.71 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 2.77 0.426 5.12 638.3613 1,274.71 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 3.13 0.477 2.32 638.3614 1,274.71 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 2.05 0.285 0 638.3615 1,274.71 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 3.33 0.534 4.06 638.3615 1,274.71 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 1.7 0.297 1.1 638.3619 1,274.71 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 3.03 0.475 3.47 638.362 1,274.71 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 3.41 0.536 5.28 638.3621 1,274.71 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 2.96 0.528 4 638.3624 1,274.71 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% HVVPNEVVVQR 95.00% 2.59 0.284 2.89 638.8572 1,275.70 1,275.72 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AGALNSNDAFVLK 95.00% 2.38 0.283 0 660.3495 1,318.68 1,319.70 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AGALNSNDAFVLK 95.00% 2.32 0.293 0 660.3503 1,318.69 1,319.70 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AGALNSNDAFVLK 95.00% 4.4 0.527 4.15 660.3505 1,318.69 1,319.70 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AGALNSNDAFVLK 95.00% 4.03 0.545 4.11 660.3506 1,318.69 1,319.70 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AGALNSNDAFVLK 95.00% 4.17 0.493 5.24 660.3506 1,318.69 1,319.70 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AGALNSNDAFVLK 95.00% 4.45 0.516 4.1 660.3509 1,318.69 1,319.70 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AGALNSNDAFVLK 95.00% 2.86 0.367 1.1 660.3529 1,318.69 1,319.70 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% SEDcFILDHGK 95.00% 3.36 0.558 2.46 c4: Carbamidomethyl (+57.02) 660.7971 1,319.58 1,320.59 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% SEDcFILDHGK 95.00% 3.32 0.513 2.68 c4: Carbamidomethyl (+57.02) 660.7979 1,319.58 1,320.59 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% SEDcFILDHGK 95.00% 3.42 0.51 2.77 c4: Carbamidomethyl (+57.02) 660.7983 1,319.58 1,320.59 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% SEDcFILDHGK 95.00% 3.38 0.46 2.22 c4: Carbamidomethyl (+57.02) 660.7987 1,319.58 1,320.59 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% VPEARPNSMVVEHPEFLK 95.00% 3.83 0.362 1.47 694.0272 2,079.06 2,079.07 3
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AQPVQVAEGSEPDGFWEALGGK 95.00% 5.37 0.584 3.68 758.3687 2,272.08 2,272.09 3
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AQPVQVAEGSEPDGFWEALGGK 95.00% 4.93 0.561 3.17 758.3688 2,272.08 2,272.09 3
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% DSQEEEKTEALTSAK 95.00% 3.81 0.468 3.28 833.3915 1,664.77 1,665.78 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% DSQEEEKTEALTSAK 95.00% 3.61 0.48 3.62 833.3932 1,664.77 1,665.78 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% DSQEEEKTEALTSAK 95.00% 4.11 0.493 5.26 833.3957 1,664.78 1,665.78 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% DSQEEEKTEALTSAK 95.00% 3.91 0.464 4.03 833.397 1,664.78 1,665.78 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% EVQGFESATFLGYFK 95.00% 4.42 0.597 6 861.9207 1,721.83 1,722.84 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% EVQGFESATFLGYFK 95.00% 3.45 0.487 1.7 861.9209 1,721.83 1,722.84 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% EVQGFESATFLGYFK 95.00% 4.11 0.58 5.33 861.9215 1,721.83 1,722.84 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% PALPAGTEDTAKEDAANR 95.00% 3.52 0.429 0 913.947 1,825.88 1,826.89 2 ATPB_HUMAN
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% QTQVSVLPEGGETPLFK 95.00% 3.6 0.465 3.21 915.4839 1,828.95 1,829.97 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% QTQVSVLPEGGETPLFK 95.00% 3.36 0.427 1.7 915.4843 1,828.95 1,829.97 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% QTQVSVLPEGGETPLFK 95.00% 4.29 0.563 6.05 915.4844 1,828.95 1,829.97 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% QTQVSVLPEGGETPLFK 95.00% 4.27 0.566 4.92 915.4845 1,828.95 1,829.97 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% QTQVSVLPEGGETPLFK 95.00% 3.44 0.395 1.1 915.9795 1,829.94 1,829.97 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% QTQVSVLPEGGETPLFK 95.00% 2.3 0.358 0 915.9864 1,829.96 1,829.97 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% QTQVSVLPEGGETPLFK 95.00% 4.32 0.532 3.64 915.9879 1,829.96 1,829.97 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% QTQVSVLPEGGETPLFK 95.00% 4.2 0.483 2.89 915.9881 1,829.96 1,829.97 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% QTQVSVLPEGGETPLFK 95.00% 4.29 0.489 3.82 915.9886 1,829.96 1,829.97 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% TPSAAYLWVGTGASEAEK 95.00% 6.18 0.627 6.57 919.45 1,836.88 1,837.90 2 CAP1_HUMAN
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% TPSAAYLWVGTGASEAEK 95.00% 3.8 0.567 1.48 919.4505 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% TPSAAYLWVGTGASEAEK 95.00% 6.5 0.627 6.92 919.4507 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% TPSAAYLWVGTGASEAEK 95.00% 6.57 0.626 8.96 919.4508 1,836.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% TPSAAYLWVGTGASEAEK 95.00% 5.3 0.493 2.82 919.9532 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% TPSAAYLWVGTGASEAEK 95.00% 6.29 0.621 6.49 919.9538 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% TPSAAYLWVGTGASEAEK 95.00% 5.14 0.572 4 919.9543 1,837.89 1,837.90 2 CAP1_HUMAN
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% VPFDAATLHTSTAMAAQHGMDDDGTGQK 95.00% 6.34 0.645 3.07 958.7634 2,873.27 2,873.28 3
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% VPFDAATLHTSTAMAAQHGMDDDGTGQK 95.00% 6.89 0.638 2.43 958.7654 2,873.27 2,873.28 3
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AQPVQVAEGSEPDGFWEALGGK 95.00% 5.32 0.63 6 1,136.54 2,271.07 2,272.09 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AQPVQVAEGSEPDGFWEALGGK 95.00% 7.05 0.649 7.4 1,137.05 2,272.08 2,272.09 2
 SAMPLE 3R Gelsolin  GSN  GELS_HUMAN 85,679.80 100.00% 13 16 67 26.30% AQPVQVAEGSEPDGFWEALGGK 95.00% 6.96 0.672 6.92 1,137.05 2,272.08 2,272.09 2
 SAMPLE 2 Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 4 3.79% LWEEQLAAAK 95.00% 3.51 0.416 2.04 579.8109 1,157.61 1,158.62 2
 SAMPLE 2 Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 4 3.79% LWEEQLAAAK 95.00% 3.51 0.421 1.82 579.8117 1,157.61 1,158.62 2
 SAMPLE 2 Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 4 3.79% SLEDQVEMLR 95.00% 3.39 0.349 0 610.3008 1,218.59 1,219.60 2
 SAMPLE 2 Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 4 3.79% SLEDQVEMLR 95.00% 3.37 0.387 1.18 610.3025 1,218.59 1,219.60 2
 SAMPLE 2R Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 3 3.79% LWEEQLAAAK 95.00% 3.34 0.396 1.92 579.8103 1,157.61 1,158.62 2
 SAMPLE 2R Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 3 3.79% LWEEQLAAAK 95.00% 3.39 0.412 2.82 579.8105 1,157.61 1,158.62 2
 SAMPLE 2R Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 3 3.79% SLEDQVEMLR 95.00% 2.91 0.321 0 610.3029 1,218.59 1,219.60 2
 SAMPLE 3 Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 3 4.36% SLEDQVEMLR 95.00% 2.52 0.223 0 610.302 1,218.59 1,219.60 2
 SAMPLE 3 Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 3 4.36% YEQGTGcWQGPNR 95.00% 3.76 0.592 4.51 c7: Carbamidomethyl (+57.02) 776.8352 1,551.65 1,552.66 2
 SAMPLE 3 Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 3 4.36% YEQGTGcWQGPNR 95.00% 3.41 0.581 2.49 c7: Carbamidomethyl (+57.02) 777.3352 1,552.65 1,552.66 2
 SAMPLE 3R Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 3 4.36% SLEDQVEMLR 95.00% 3.13 0.334 0 610.3015 1,218.59 1,219.60 2
 SAMPLE 3R Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 3 4.36% YEQGTGcWQGPNR 95.00% 3.79 0.554 4.62 c7: Carbamidomethyl (+57.02) 776.833 1,551.65 1,552.66 2
 SAMPLE 3R Glucosidase 2 subunit beta  PRKCSH  GLU2B_HUMAN 59,407.70 99.80% 2 2 3 4.36% YEQGTGcWQGPNR 95.00% 3.53 0.613 4.37 c7: Carbamidomethyl (+57.02) 776.8345 1,551.65 1,552.66 2
 SAMPLE 1 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 99.80% 2 2 4 9.32% YNLGLDLR 95.00% 2.33 0.251 1.64 482.2643 962.513 963.5265 2
 SAMPLE 1 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 99.80% 2 2 4 9.32% YNLGLDLR 95.00% 2.46 0.247 1.62 482.2656 962.5156 963.5265 2
 SAMPLE 1 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 99.80% 2 2 4 9.32% cAVVDVPFGGAK 95.00% 2.2 0.295 2.6 c1: Carbamidomethyl (+57.02) 610.3086 1,218.60 1,219.61 2
 SAMPLE 1 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 99.80% 2 2 4 9.32% cAVVDVPFGGAK 95.00% 2.65 0.386 1.85 c1: Carbamidomethyl (+57.02) 610.3106 1,218.61 1,219.61 2
 SAMPLE 1 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 99.80% 2 2 4 9.32% YSTDVSVDEVK 95.00% 2.4 0.58 3.89 621.2987 1,240.58 1,241.59 2 ASPN_HUMAN
 SAMPLE 1 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 99.80% 2 2 4 9.32% YSTDVSVDEVK 95.00% 2.66 0.512 3.35 621.299 1,240.58 1,241.59 2 ASPN_HUMAN
 SAMPLE 1 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 99.80% 2 2 4 9.32% IIAEGANGPTTPEADKIFLER 95.00% 3.61 0.235 0 748.3976 2,242.17 2,242.17 3
 SAMPLE 1 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 99.80% 2 2 4 9.32% IIAEGANGPTTPEADKIFLER 95.00% 3.71 0.328 0 748.3979 2,242.17 2,242.17 3
 SAMPLE 3 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 100.00% 4 4 5 10.90% GASIVEDKLVEDLR 95.00% 2.26 0.225 0 515.2812 1,542.82 1,543.83 3
 SAMPLE 3 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 100.00% 4 4 5 10.90% TAAYVNAIEK 95.00% 2.34 0.384 1.57 540.2899 1,078.56 1,079.57 2
 SAMPLE 3 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 100.00% 4 4 5 10.90% TAAYVNAIEK 95.00% 2.23 0.478 0 540.2909 1,078.57 1,079.57 2
 SAMPLE 3 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 100.00% 4 4 5 10.90% HGGTIPIVPTAEFQDR 95.00% 2.42 0.244 1.32 580.3018 1,737.88 1,737.89 3
 SAMPLE 3 Glutamate dehydrogenase 1, mitochondrial  GLUD1  DHE3_HUMAN 61,381.70 100.00% 4 4 5 10.90% IIAEGANGPTTPEADKIFLER 95.00% 3.7 0.503 2 748.0631 2,241.17 2,242.17 3
 SAMPLE 1 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 99.80% 2 2 3 8.85% MDILSYMR 95.00% 2.63 0.294 0 514.7591 1,027.50 1,028.49 2
 SAMPLE 1 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 99.80% 2 2 3 8.85% FLVGPDGIPIMR 95.00% 2.2 0.236 3.19 657.8765 1,313.74 1,314.72 2
 SAMPLE 1 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 99.80% 2 2 3 8.85% FLVGPDGIPIMR 95.00% 3.01 0.336 1.96 657.8772 1,313.74 1,314.72 2
 SAMPLE 1R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 3 3 5 16.40% MDILSYMR 95.00% 2.32 0.292 0 514.7593 1,027.50 1,028.49 2
 SAMPLE 1R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 3 3 5 16.40% MDILSYMR 95.00% 2.15 0.241 0 514.7594 1,027.50 1,028.49 2
 SAMPLE 1R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 3 3 5 16.40% QEPGENSEILPTLK 95.00% 3.32 0.43 1.89 777.914 1,553.81 1,554.80 2
 SAMPLE 1R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 3 3 5 16.40% NScPPTSELLGTSDR 95.00% 4.07 0.565 6.59 c3: Carbamidomethyl (+57.02) 817.3888 1,632.76 1,633.75 2
 SAMPLE 1R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 3 3 5 16.40% NScPPTSELLGTSDR 95.00% 2.77 0.454 3.1 c3: Carbamidomethyl (+57.02) 817.3889 1,632.76 1,633.75 2
 SAMPLE 2 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 3 3 4 18.10% FLVGPDGIPImR 95.00% 2.15 0.29 1.24 m11: Oxidation (+15.99) 665.8617 1,329.71 1,330.72 2
 SAMPLE 2 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 3 3 4 18.10% QEPGENSEILPTLK 95.00% 2.72 0.377 0 777.8983 1,553.78 1,554.80 2
 SAMPLE 2 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 3 3 4 18.10% NScPPTSELLGTSDR 95.00% 4.12 0.524 5.33 c3: Carbamidomethyl (+57.02) 817.3776 1,632.74 1,633.75 2
 SAMPLE 2 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 3 3 4 18.10% NScPPTSELLGTSDR 95.00% 4.12 0.584 5 c3: Carbamidomethyl (+57.02) 817.3798 1,632.74 1,633.75 2
 SAMPLE 2R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 99.80% 2 2 3 11.90% FLVGPDGIPImR 95.00% 2.53 0.298 1.52 m11: Oxidation (+15.99) 665.8652 1,329.71 1,330.72 2
 SAMPLE 2R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 99.80% 2 2 3 11.90% NScPPTSELLGTSDR 95.00% 4.44 0.591 5 c3: Carbamidomethyl (+57.02) 817.3763 1,632.74 1,633.75 2
 SAMPLE 2R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 99.80% 2 2 3 11.90% NScPPTSELLGTSDR 95.00% 4.22 0.58 4.66 c3: Carbamidomethyl (+57.02) 817.8762 1,633.74 1,633.75 2
 SAMPLE 3 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 11 21.70% MDILSYMR 95.00% 3.05 0.37 0 514.7467 1,027.48 1,028.49 2
 SAMPLE 3 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 11 21.70% MDILSYMR 95.00% 3.05 0.327 0 514.7481 1,027.48 1,028.49 2
 SAMPLE 3 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 11 21.70% FLVGPDGIPImR 95.00% 2.5 0.364 1.21 m11: Oxidation (+15.99) 665.8597 1,329.70 1,330.72 2
 SAMPLE 3 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 11 21.70% FLVGPDGIPImR 95.00% 2.66 0.348 2.48 m11: Oxidation (+15.99) 665.8623 1,329.71 1,330.72 2
 SAMPLE 3 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 11 21.70% QEPGENSEILPTLK 95.00% 3.2 0.424 1.22 777.8943 1,553.77 1,554.80 2
 SAMPLE 3 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 11 21.70% QEPGENSEILPTLK 95.00% 2.78 0.41 0 777.9019 1,553.79 1,554.80 2
 SAMPLE 3 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 11 21.70% QEPGENSEILPTLK 95.00% 2.4 0.343 0 777.9028 1,553.79 1,554.80 2
 SAMPLE 3 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 11 21.70% QEPGENSEILPTLK 95.00% 2.66 0.297 1.16 777.904 1,553.79 1,554.80 2
 SAMPLE 3 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 11 21.70% NScPPTSELLGTSDR 95.00% 3.2 0.347 5.18 c3: Carbamidomethyl (+57.02) 817.3768 1,632.74 1,633.75 2
 SAMPLE 3 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 11 21.70% NScPPTSELLGTSDR 95.00% 4.3 0.591 6.68 c3: Carbamidomethyl (+57.02) 817.3773 1,632.74 1,633.75 2
 SAMPLE 3 Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 11 21.70% NScPPTSELLGTSDR 95.00% 4.03 0.541 4.48 c3: Carbamidomethyl (+57.02) 817.3778 1,632.74 1,633.75 2
 SAMPLE 3R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 8 25.70% YVRPGGGFVPNFQLFEK 95.00% 2.86 0.397 1 652.3442 1,954.01 1,955.02 3
 SAMPLE 3R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 8 25.70% YVRPGGGFVPNFQLFEK 95.00% 2.77 0.243 1.52 652.6772 1,955.01 1,955.02 3
 SAMPLE 3R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 8 25.70% FLVGPDGIPImR 95.00% 2.5 0.357 1.55 m11: Oxidation (+15.99) 665.8601 1,329.70 1,330.72 2
 SAMPLE 3R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 8 25.70% FLVGPDGIPImR 95.00% 2.44 0.432 2.43 m11: Oxidation (+15.99) 665.8626 1,329.71 1,330.72 2
 SAMPLE 3R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 8 25.70% QEPGENSEILPTLK 95.00% 2.75 0.397 0 777.8967 1,553.78 1,554.80 2
 SAMPLE 3R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 8 25.70% QEPGENSEILPTLK 95.00% 3.33 0.486 1.11 777.9021 1,553.79 1,554.80 2
 SAMPLE 3R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 8 25.70% NScPPTSELLGTSDR 95.00% 3.84 0.598 4.96 c3: Carbamidomethyl (+57.02) 817.3758 1,632.74 1,633.75 2
 SAMPLE 3R Glutathione peroxidase 3  GPX3  GPX3_HUMAN 25,535.10 100.00% 4 4 8 25.70% NScPPTSELLGTSDR 95.00% 4.06 0.574 5.72 c3: Carbamidomethyl (+57.02) 817.3779 1,632.74 1,633.75 2
 SAMPLE 1R Glutathione S-transferase P  GSTP1  GSTP1_HUMAN 23,338.70 99.80% 2 2 4 17.10% FQDGDLTLYQSNTILR 95.00% 5.85 0.639 6.92 942.4978 1,882.98 1,883.95 2
 SAMPLE 1R Glutathione S-transferase P  GSTP1  GSTP1_HUMAN 23,338.70 99.80% 2 2 4 17.10% FQDGDLTLYQSNTILR 95.00% 5.76 0.645 6.85 942.4984 1,882.98 1,883.95 2
 SAMPLE 1R Glutathione S-transferase P  GSTP1  GSTP1_HUMAN 23,338.70 99.80% 2 2 4 17.10% ALPGQLKPFETLLSQNQGGK 95.00% 4.4 0.585 4.48 1,064.11 2,126.20 2,126.16 2
 SAMPLE 1R Glutathione S-transferase P  GSTP1  GSTP1_HUMAN 23,338.70 99.80% 2 2 4 17.10% ALPGQLKPFETLLSQNQGGK 95.00% 3.72 0.483 1.85 1,064.11 2,126.20 2,126.16 2
 SAMPLE 4 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 8 17.90% GALQNIIPASTGAAK 95.00% 3.34 0.424 3.68 706.4004 1,410.79 1,411.79 2
 SAMPLE 4 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 8 17.90% GALQNIIPASTGAAK 95.00% 3.82 0.415 4.05 706.4006 1,410.79 1,411.79 2
 SAMPLE 4 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 8 17.90% VPTANVSVVDLTcR 95.00% 3.91 0.65 4.68 c13: Carbamidomethyl (+57.02) 765.9034 1,529.79 1,530.80 2
 SAMPLE 4 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 8 17.90% VPTANVSVVDLTcR 95.00% 4.06 0.642 4.47 c13: Carbamidomethyl (+57.02) 765.9046 1,529.79 1,530.80 2
 SAMPLE 4 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 8 17.90% VPTANVSVVDLTcR 95.00% 2.21 0.323 3.82 c13: Carbamidomethyl (+57.02) 765.9057 1,529.80 1,530.80 2
 SAMPLE 4 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 8 17.90% LVINGNPITIFQER 95.00% 4.7 0.464 4.74 807.457 1,612.90 1,613.90 2
 SAMPLE 4 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 8 17.90% LVINGNPITIFQER 95.00% 3.13 0.388 2.96 807.4577 1,612.90 1,613.90 2
 SAMPLE 4 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 8 17.90% LVINGNPITIFQER 95.00% 3.96 0.521 3.15 807.4585 1,612.90 1,613.90 2
 SAMPLE 4 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 8 17.90% IISNAScTTNcLAPLAK 95.00% 4.42 0.539 8.19 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4647 1,832.91 1,833.92 2
 SAMPLE 4 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 8 17.90% IISNAScTTNcLAPLAK 95.00% 4.22 0.487 7.33 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9659 1,833.92 1,833.92 2
 SAMPLE 4 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 8 17.90% IISNAScTTNcLAPLAK 95.00% 4.19 0.547 6.96 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9693 1,833.92 1,833.92 2
 SAMPLE 4R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 10 13.70% GALQNIIPASTGAAK 95.00% 3.41 0.416 2.46 706.4011 1,410.79 1,411.79 2
 SAMPLE 4R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 10 13.70% GALQNIIPASTGAAK 95.00% 3.16 0.365 0 706.403 1,410.79 1,411.79 2
 SAMPLE 4R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 10 13.70% GALQNIIPASTGAAK 95.00% 3 0.314 1.82 706.9033 1,411.79 1,411.79 2
 SAMPLE 4R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 10 13.70% LVINGNPITIFQER 95.00% 4.34 0.38 2.44 807.4551 1,612.89 1,613.90 2
 SAMPLE 4R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 10 13.70% LVINGNPITIFQER 95.00% 3.71 0.541 2.8 807.4555 1,612.90 1,613.90 2
 SAMPLE 4R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 10 13.70% LVINGNPITIFQER 95.00% 3.66 0.363 2.19 807.4568 1,612.90 1,613.90 2
 SAMPLE 4R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 10 13.70% LVINGNPITIFQER 95.00% 4.7 0.519 3.74 807.9626 1,613.91 1,613.90 2
 SAMPLE 4R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 10 13.70% IISNAScTTNcLAPLAK 95.00% 4.12 0.555 6.07 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9652 1,833.91 1,833.92 2
 SAMPLE 4R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 10 13.70% IISNAScTTNcLAPLAK 95.00% 3.56 0.498 5.35 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9674 1,833.92 1,833.92 2
 SAMPLE 4R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 3 3 10 13.70% IISNAScTTNcLAPLAK 95.00% 4.89 0.527 8.82 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9682 1,833.92 1,833.92 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% VPTANVSVVDLTcR 95.00% 3.18 0.437 3.06 c13: Carbamidomethyl (+57.02) 510.935 1,529.78 1,530.80 3
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% VPTANVSVVDLTcR 95.00% 3.78 0.467 3.14 c13: Carbamidomethyl (+57.02) 510.9357 1,529.78 1,530.80 3
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% VPTANVSVVDLTcR 95.00% 3.48 0.435 2.74 c13: Carbamidomethyl (+57.02) 510.9392 1,529.79 1,530.80 3
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% VPTANVSVVDLTcR 95.00% 3.45 0.416 1.92 c13: Carbamidomethyl (+57.02) 510.9401 1,529.80 1,530.80 3
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQER 95.00% 4.18 0.389 1.82 538.6454 1,612.91 1,613.90 3
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% IISNAScTTNcLAPLAK 95.00% 3.71 0.362 2.12 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 611.978 1,832.91 1,833.92 3
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% IISNAScTTNcLAPLAK 95.00% 3.81 0.365 0 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 612.3129 1,833.92 1,833.92 3
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% VVDLMAHMASKE 95.00% 3.36 0.415 2.85 665.8278 1,329.64 1,330.65 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQERDPSK 95.00% 2.46 0.364 0 681.3733 2,041.10 2,041.11 3
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQERDPSK 95.00% 2.48 0.39 0 681.3733 2,041.10 2,041.11 3
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQERDPSK 95.00% 1.95 0.196 1.38 681.374 2,041.10 2,041.11 3
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQERDPSK 95.00% 2.18 0.253 1.05 681.3871 2,041.14 2,041.11 3
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% GALQNIIPASTGAAK 95.00% 4.04 0.423 4.66 706.3974 1,410.78 1,411.79 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% GALQNIIPASTGAAK 95.00% 4.02 0.441 3.64 706.3979 1,410.78 1,411.79 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% GALQNIIPASTGAAK 95.00% 2.59 0.395 0 706.3994 1,410.78 1,411.79 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% GALQNIIPASTGAAK 95.00% 3.34 0.395 2.57 706.405 1,410.79 1,411.79 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% GALQNIIPASTGAAK 95.00% 4 0.424 2.54 706.4054 1,410.80 1,411.79 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% VPTANVSVVDLTcR 95.00% 3.84 0.615 5.1 c13: Carbamidomethyl (+57.02) 765.8991 1,529.78 1,530.80 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% VPTANVSVVDLTcR 95.00% 4.33 0.648 6.38 c13: Carbamidomethyl (+57.02) 765.8992 1,529.78 1,530.80 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% VPTANVSVVDLTcR 95.00% 4.35 0.633 4.89 c13: Carbamidomethyl (+57.02) 765.9004 1,529.79 1,530.80 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% VPTANVSVVDLTcR 95.00% 4.52 0.622 5.29 c13: Carbamidomethyl (+57.02) 765.9087 1,529.80 1,530.80 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQER 95.00% 4.63 0.515 5.55 807.4508 1,612.89 1,613.90 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQER 95.00% 4.39 0.489 6.23 807.4519 1,612.89 1,613.90 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQER 95.00% 4.65 0.498 6.05 807.4524 1,612.89 1,613.90 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQER 95.00% 4.6 0.54 5.72 807.453 1,612.89 1,613.90 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQER 95.00% 3.65 0.449 3.11 807.4586 1,612.90 1,613.90 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQER 95.00% 2.77 0.392 2.24 807.4648 1,612.91 1,613.90 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQER 95.00% 4.67 0.508 7.14 807.4682 1,612.92 1,613.90 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQER 95.00% 4.11 0.538 3.68 807.4691 1,612.92 1,613.90 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQER 95.00% 2.92 0.412 1.12 807.4698 1,612.92 1,613.90 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQER 95.00% 3.56 0.502 3.74 807.4711 1,612.93 1,613.90 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQER 95.00% 3.75 0.5 2.92 807.9579 1,613.90 1,613.90 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LISWYDNEFGYSNR 95.00% 4.48 0.567 5.7 882.4033 1,762.79 1,763.80 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LISWYDNEFGYSNR 95.00% 4.31 0.622 4.27 882.4047 1,762.79 1,763.80 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LISWYDNEFGYSNR 95.00% 4.24 0.599 3.8 882.4051 1,762.79 1,763.80 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LISWYDNEFGYSNR 95.00% 3.98 0.57 3.82 882.4126 1,762.81 1,763.80 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LISWYDNEFGYSNR 95.00% 2.73 0.554 0 882.4141 1,762.81 1,763.80 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LISWYDNEFGYSNR 95.00% 4.36 0.601 3.8 882.4217 1,762.83 1,763.80 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LISWYDNEFGYSNR 95.00% 4.68 0.568 4.8 882.9204 1,763.83 1,763.80 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% IISNAScTTNcLAPLAK 95.00% 4.85 0.601 4.7 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4613 1,832.91 1,833.92 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% IISNAScTTNcLAPLAK 95.00% 4.66 0.601 5.92 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.462 1,832.91 1,833.92 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% IISNAScTTNcLAPLAK 95.00% 2.97 0.394 4.46 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4637 1,832.91 1,833.92 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% IISNAScTTNcLAPLAK 95.00% 4.34 0.546 5.85 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4727 1,832.93 1,833.92 2
 SAMPLE 1 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 9 36 26.90% LVINGNPITIFQERDPSK 95.00% 4.3 0.527 2.12 1,021.58 2,041.14 2,041.11 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% VPTANVSVVDLTcR 95.00% 3.48 0.435 2.6 c13: Carbamidomethyl (+57.02) 510.9392 1,529.79 1,530.80 3
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% VPTANVSVVDLTcR 95.00% 3.45 0.416 2.42 c13: Carbamidomethyl (+57.02) 510.9401 1,529.80 1,530.80 3
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% VPTANVSVVDLTcR 95.00% 2.67 0.376 0 c13: Carbamidomethyl (+57.02) 510.9449 1,529.81 1,530.80 3
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQER 95.00% 3.19 0.377 1.72 538.6373 1,612.89 1,613.90 3
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQER 95.00% 4.18 0.389 1.74 538.6454 1,612.91 1,613.90 3
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQER 95.00% 3.81 0.336 1.8 538.6484 1,612.92 1,613.90 3
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQERDPSK 95.00% 2.1 0.181 1.44 681.3867 2,041.14 2,041.11 3
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% GALQNIIPASTGAAK 95.00% 2.89 0.352 0 706.3959 1,410.78 1,411.79 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% GALQNIIPASTGAAK 95.00% 3.34 0.395 2.89 706.405 1,410.79 1,411.79 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% GALQNIIPASTGAAK 95.00% 4 0.424 3.59 706.4054 1,410.80 1,411.79 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% GALQNIIPASTGAAK 95.00% 3.04 0.369 1.85 706.4091 1,410.80 1,411.79 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% VPTANVSVVDLTcR 95.00% 3.84 0.615 4.19 c13: Carbamidomethyl (+57.02) 765.8991 1,529.78 1,530.80 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% VPTANVSVVDLTcR 95.00% 3.36 0.556 4.12 c13: Carbamidomethyl (+57.02) 765.9007 1,529.79 1,530.80 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% VPTANVSVVDLTcR 95.00% 4.52 0.622 5.49 c13: Carbamidomethyl (+57.02) 765.9087 1,529.80 1,530.80 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQER 95.00% 2.73 0.352 1.3 807.4515 1,612.89 1,613.90 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQER 95.00% 4.39 0.489 4.85 807.4519 1,612.89 1,613.90 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQER 95.00% 4.56 0.543 5.25 807.4524 1,612.89 1,613.90 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQER 95.00% 2.77 0.392 2.03 807.4648 1,612.91 1,613.90 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQER 95.00% 2.92 0.412 0 807.4698 1,612.92 1,613.90 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQER 95.00% 4.54 0.471 5.2 807.4698 1,612.92 1,613.90 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQER 95.00% 4.41 0.472 3.06 807.4699 1,612.92 1,613.90 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQER 95.00% 4.17 0.577 3.44 807.4699 1,612.92 1,613.90 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQER 95.00% 2.7 0.199 1.39 807.9572 1,613.90 1,613.90 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% VIHDNFGIVEGLMTTVHAITATQK 95.00% 6.17 0.641 2.89 866.1428 2,595.41 2,595.36 3
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% VIHDNFGIVEGLMTTVHAITATQK 95.00% 7.06 0.699 3.46 866.1437 2,595.41 2,595.36 3
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LISWYDNEFGYSNR 95.00% 4.24 0.599 2.82 882.4051 1,762.79 1,763.80 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LISWYDNEFGYSNR 95.00% 3.98 0.57 3.54 882.4126 1,762.81 1,763.80 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LISWYDNEFGYSNR 95.00% 2.73 0.554 0 882.4141 1,762.81 1,763.80 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LISWYDNEFGYSNR 95.00% 4.76 0.553 4.62 882.4201 1,762.82 1,763.80 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LISWYDNEFGYSNR 95.00% 4.44 0.616 4 882.4214 1,762.83 1,763.80 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% IISNAScTTNcLAPLAK 95.00% 4.34 0.546 7.05 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4727 1,832.93 1,833.92 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQERDPSK 95.00% 4.01 0.498 2.35 1,021.58 2,041.14 2,041.11 2
 SAMPLE 1R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 6 8 27 30.40% LVINGNPITIFQERDPSK 95.00% 4.15 0.568 1.42 1,021.58 2,041.14 2,041.11 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 3.04 0.347 0 c13: Carbamidomethyl (+57.02) 510.9359 1,529.78 1,530.80 3
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 3.72 0.486 0.959 c13: Carbamidomethyl (+57.02) 510.9361 1,529.78 1,530.80 3
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 2.35 0.209 0 c13: Carbamidomethyl (+57.02) 511.2579 1,530.75 1,530.80 3
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% LVINGNPITIFQER 95.00% 3.89 0.36 1.57 538.6381 1,612.89 1,613.90 3
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% LVINGNPITIFQER 95.00% 3.58 0.374 1.89 538.6394 1,612.89 1,613.90 3
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VVDLMAHMASK 95.00% 2.82 0.418 3.7 601.3057 1,200.60 1,201.61 2 LDB3_HUMAN
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% GALQNIIPASTGAAK 95.00% 3.63 0.431 3.06 706.3966 1,410.78 1,411.79 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% GALQNIIPASTGAAK 95.00% 3.7 0.397 4.55 706.3972 1,410.78 1,411.79 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% GALQNIIPASTGAAK 95.00% 3.82 0.395 3.28 706.3976 1,410.78 1,411.79 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% GALQNIIPASTGAAK 95.00% 3.58 0.446 2.85 706.398 1,410.78 1,411.79 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% GALQNIIPASTGAAK 95.00% 3.84 0.465 3.6 706.3985 1,410.78 1,411.79 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% GALQNIIPASTGAAK 95.00% 3.71 0.402 3.15 706.3985 1,410.78 1,411.79 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% GALQNIIPASTGAAK 95.00% 3.3 0.428 2.55 706.3988 1,410.78 1,411.79 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 2.73 0.473 4.52 c13: Carbamidomethyl (+57.02) 765.8983 1,529.78 1,530.80 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 3.87 0.551 5.11 c13: Carbamidomethyl (+57.02) 765.8987 1,529.78 1,530.80 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 4.23 0.611 4.3 c13: Carbamidomethyl (+57.02) 765.9004 1,529.79 1,530.80 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 3.91 0.605 5.15 c13: Carbamidomethyl (+57.02) 765.9005 1,529.79 1,530.80 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 3.86 0.631 5.09 c13: Carbamidomethyl (+57.02) 765.9009 1,529.79 1,530.80 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 4.13 0.647 4.72 c13: Carbamidomethyl (+57.02) 765.9012 1,529.79 1,530.80 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 4.04 0.647 3.3 c13: Carbamidomethyl (+57.02) 765.9012 1,529.79 1,530.80 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 3.57 0.604 4.47 c13: Carbamidomethyl (+57.02) 765.9015 1,529.79 1,530.80 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 3.42 0.515 3.54 c13: Carbamidomethyl (+57.02) 765.9029 1,529.79 1,530.80 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% VPTANVSVVDLTcR 95.00% 4.12 0.603 3.77 c13: Carbamidomethyl (+57.02) 766.4041 1,530.79 1,530.80 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% LVINGNPITIFQER 95.00% 3.07 0.535 3.14 807.4528 1,612.89 1,613.90 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% LVINGNPITIFQER 95.00% 4.98 0.506 4.22 807.453 1,612.89 1,613.90 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% LVINGNPITIFQER 95.00% 4.48 0.504 4 807.4536 1,612.89 1,613.90 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% LVINGNPITIFQER 95.00% 4.23 0.517 4.21 807.4544 1,612.89 1,613.90 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% LVINGNPITIFQER 95.00% 4.4 0.474 4.96 807.4552 1,612.89 1,613.90 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% LVINGNPITIFQER 95.00% 3.88 0.421 3.32 807.957 1,613.90 1,613.90 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% LISWYDNEFGYSNR 95.00% 4.37 0.565 3.82 882.4036 1,762.79 1,763.80 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% LISWYDNEFGYSNR 95.00% 4.86 0.554 4.02 882.9052 1,763.79 1,763.80 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% IISNAScTTNcLAPLAK 95.00% 4.31 0.53 4.24 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4614 1,832.91 1,833.92 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% IISNAScTTNcLAPLAK 95.00% 4.39 0.496 5.89 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4619 1,832.91 1,833.92 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% IISNAScTTNcLAPLAK 95.00% 3.74 0.541 5.66 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.462 1,832.91 1,833.92 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% IISNAScTTNcLAPLAK 95.00% 4.7 0.576 5.21 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4634 1,832.91 1,833.92 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% IISNAScTTNcLAPLAK 95.00% 4.35 0.493 6.47 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4638 1,832.91 1,833.92 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% IISNAScTTNcLAPLAK 95.00% 4.43 0.557 6.74 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9634 1,833.91 1,833.92 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% IISNAScTTNcLAPLAK 95.00% 4.3 0.568 5.4 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9643 1,833.91 1,833.92 2
 SAMPLE 2 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 26 25.40% IISNAScTTNcLAPLAK 95.00% 4.34 0.549 5.52 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9644 1,833.91 1,833.92 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 3.14 0.488 1.07 c13: Carbamidomethyl (+57.02) 510.9366 1,529.79 1,530.80 3
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 3.13 0.265 0 c13: Carbamidomethyl (+57.02) 511.2717 1,530.79 1,530.80 3
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 2.47 0.331 1.51 c13: Carbamidomethyl (+57.02) 511.2723 1,530.79 1,530.80 3
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LVINGNPITIFQER 95.00% 3.34 0.395 1.74 538.6391 1,612.89 1,613.90 3
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LVINGNPITIFQER 95.00% 4.32 0.497 2.3 538.9711 1,613.89 1,613.90 3
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% GALQNIIPASTGAAK 95.00% 3.86 0.403 3.18 706.3966 1,410.78 1,411.79 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% GALQNIIPASTGAAK 95.00% 3.5 0.422 3.6 706.3973 1,410.78 1,411.79 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% GALQNIIPASTGAAK 95.00% 3.68 0.464 4.25 706.3974 1,410.78 1,411.79 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% GALQNIIPASTGAAK 95.00% 4.09 0.438 4.4 706.3975 1,410.78 1,411.79 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% GALQNIIPASTGAAK 95.00% 2.69 0.441 0 706.3976 1,410.78 1,411.79 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% GALQNIIPASTGAAK 95.00% 3.01 0.395 1.28 706.3979 1,410.78 1,411.79 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% GALQNIIPASTGAAK 95.00% 3.03 0.411 2.05 706.3981 1,410.78 1,411.79 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% GALQNIIPASTGAAK 95.00% 3.58 0.413 4.77 706.3982 1,410.78 1,411.79 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% GALQNIIPASTGAAK 95.00% 2.68 0.465 0 706.3983 1,410.78 1,411.79 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 3.71 0.634 3.89 c13: Carbamidomethyl (+57.02) 765.8984 1,529.78 1,530.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 3.8 0.628 4.46 c13: Carbamidomethyl (+57.02) 765.899 1,529.78 1,530.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 4.28 0.642 4.11 c13: Carbamidomethyl (+57.02) 765.8999 1,529.78 1,530.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 3.8 0.587 2.89 c13: Carbamidomethyl (+57.02) 765.9002 1,529.78 1,530.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 2.56 0.452 3.92 c13: Carbamidomethyl (+57.02) 765.9004 1,529.79 1,530.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 3.87 0.562 3.82 c13: Carbamidomethyl (+57.02) 765.9004 1,529.79 1,530.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 3.35 0.608 4.72 c13: Carbamidomethyl (+57.02) 765.9005 1,529.79 1,530.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 4.15 0.621 3.92 c13: Carbamidomethyl (+57.02) 765.9007 1,529.79 1,530.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 3.75 0.617 4.66 c13: Carbamidomethyl (+57.02) 765.9026 1,529.79 1,530.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VPTANVSVVDLTcR 95.00% 3.83 0.506 3.89 c13: Carbamidomethyl (+57.02) 766.3993 1,530.78 1,530.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LVINGNPITIFQER 95.00% 3.63 0.546 2.77 807.4524 1,612.89 1,613.90 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LVINGNPITIFQER 95.00% 4.25 0.488 4.13 807.4528 1,612.89 1,613.90 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LVINGNPITIFQER 95.00% 3.48 0.412 1.89 807.4534 1,612.89 1,613.90 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LVINGNPITIFQER 95.00% 4.26 0.508 3.51 807.4539 1,612.89 1,613.90 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LVINGNPITIFQER 95.00% 4.33 0.478 3.8 807.4548 1,612.89 1,613.90 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LVINGNPITIFQER 95.00% 3.41 0.469 1.64 807.4572 1,612.90 1,613.90 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LVINGNPITIFQER 95.00% 3.81 0.441 3.68 807.9554 1,613.90 1,613.90 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LVINGNPITIFQER 95.00% 4.77 0.462 3.24 807.9561 1,613.90 1,613.90 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VIHDNFGIVEGLMTTVHAITATQK 95.00% 6.48 0.665 6.14 866.1234 2,595.35 2,595.36 3
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% VIHDNFGIVEGLMTTVHAITATQK 95.00% 7.13 0.697 7.51 866.1251 2,595.35 2,595.36 3
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LISWYDNEFGYSNR 95.00% 3.72 0.574 3.09 882.4039 1,762.79 1,763.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LISWYDNEFGYSNR 95.00% 3.88 0.598 3.7 882.4046 1,762.79 1,763.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% LISWYDNEFGYSNR 95.00% 4.56 0.552 5.82 882.9042 1,763.79 1,763.80 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% IISNAScTTNcLAPLAK 95.00% 3.74 0.498 4.6 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4627 1,832.91 1,833.92 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% IISNAScTTNcLAPLAK 95.00% 4.46 0.57 8.08 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4634 1,832.91 1,833.92 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% IISNAScTTNcLAPLAK 95.00% 4.69 0.559 6.22 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.464 1,832.91 1,833.92 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% IISNAScTTNcLAPLAK 95.00% 4.23 0.559 4.77 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9651 1,833.91 1,833.92 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% IISNAScTTNcLAPLAK 95.00% 4.66 0.55 5.7 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9657 1,833.92 1,833.92 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% IISNAScTTNcLAPLAK 95.00% 4.04 0.551 6.09 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9659 1,833.92 1,833.92 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% IISNAScTTNcLAPLAK 95.00% 4.55 0.518 4.28 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9666 1,833.92 1,833.92 2
 SAMPLE 2R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 5 6 32 29.30% IISNAScTTNcLAPLAK 95.00% 4.56 0.482 4.7 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9671 1,833.92 1,833.92 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% AGAHLQGGAK 95.00% 2.51 0.233 0 455.2507 908.4858 909.4908 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VPTANVSVVDLTcR 95.00% 3.11 0.403 3.39 c13: Carbamidomethyl (+57.02) 510.9353 1,529.78 1,530.80 3
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VPTANVSVVDLTcR 95.00% 2.48 0.391 2.16 c13: Carbamidomethyl (+57.02) 510.9361 1,529.78 1,530.80 3
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VPTANVSVVDLTcR 95.00% 3.37 0.332 2.82 c13: Carbamidomethyl (+57.02) 510.9378 1,529.79 1,530.80 3
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VPTANVSVVDLTcR 95.00% 3.49 0.399 3.2 c13: Carbamidomethyl (+57.02) 511.2701 1,530.79 1,530.80 3
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LVINGNPITIFQER 95.00% 2.08 0.233 0 538.6389 1,612.89 1,613.90 3
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VVDLMAHMASK 95.00% 3.23 0.517 4.44 601.3049 1,200.59 1,201.61 2 LDB3_HUMAN
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VVDLMAHMASK 95.00% 3.63 0.487 2.82 601.3062 1,200.60 1,201.61 2 LDB3_HUMAN
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% IISNAScTTNcLAPLAK 95.00% 2.5 0.265 0 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 611.9774 1,832.91 1,833.92 3
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% IISNAScTTNcLAPLAK 95.00% 4.02 0.37 2.37 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 611.9786 1,832.91 1,833.92 3
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% IISNAScTTNcLAPLAK 95.00% 2.78 0.354 0 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 612.3113 1,833.91 1,833.92 3
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% IISNAScTTNcLAPLAK 95.00% 3.03 0.263 0 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 612.3138 1,833.92 1,833.92 3
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VVDLMAHMASKE 95.00% 3.45 0.528 3.11 665.8261 1,329.64 1,330.65 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VVDLMAHMASKE 95.00% 3.55 0.531 3.59 665.8283 1,329.64 1,330.65 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LVINGNPITIFQERDPSK 95.00% 2.62 0.327 0 681.3743 2,041.10 2,041.11 3
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LVINGNPITIFQERDPSK 95.00% 2.71 0.29 1.49 681.3744 2,041.10 2,041.11 3
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VVDLmAHmASKE 95.00% 3.12 0.517 4.47 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 681.8222 1,361.63 1,362.64 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% GALQNIIPASTGAAK 95.00% 4.08 0.466 4.1 706.3962 1,410.78 1,411.79 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% GALQNIIPASTGAAK 95.00% 3.86 0.461 4 706.3972 1,410.78 1,411.79 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% GALQNIIPASTGAAK 95.00% 3.36 0.447 3.92 706.3976 1,410.78 1,411.79 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% GALQNIIPASTGAAK 95.00% 3.72 0.469 3.24 706.3977 1,410.78 1,411.79 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% GALQNIIPASTGAAK 95.00% 4.05 0.438 3.21 706.3978 1,410.78 1,411.79 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% GALQNIIPASTGAAK 95.00% 2.74 0.198 0 706.3981 1,410.78 1,411.79 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% GALQNIIPASTGAAK 95.00% 2.64 0.31 0 706.4024 1,410.79 1,411.79 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% GALQNIIPASTGAAK 95.00% 2.54 0.341 0 706.4033 1,410.79 1,411.79 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VPTANVSVVDLTcR 95.00% 3.91 0.623 5.49 c13: Carbamidomethyl (+57.02) 765.899 1,529.78 1,530.80 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VPTANVSVVDLTcR 95.00% 4.37 0.645 6.12 c13: Carbamidomethyl (+57.02) 765.9001 1,529.78 1,530.80 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VPTANVSVVDLTcR 95.00% 3.82 0.623 4.7 c13: Carbamidomethyl (+57.02) 765.9008 1,529.79 1,530.80 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VPTANVSVVDLTcR 95.00% 3.97 0.616 3.89 c13: Carbamidomethyl (+57.02) 765.901 1,529.79 1,530.80 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VPTANVSVVDLTcR 95.00% 4.1 0.62 4.28 c13: Carbamidomethyl (+57.02) 765.9022 1,529.79 1,530.80 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VPTANVSVVDLTcR 95.00% 3.13 0.391 2.38 c13: Carbamidomethyl (+57.02) 765.9041 1,529.79 1,530.80 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VPTANVSVVDLTcR 95.00% 4.23 0.627 5.59 c13: Carbamidomethyl (+57.02) 766.4019 1,530.79 1,530.80 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LVINGNPITIFQER 95.00% 4.02 0.493 4 807.4532 1,612.89 1,613.90 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LVINGNPITIFQER 95.00% 4.5 0.518 4.07 807.4538 1,612.89 1,613.90 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LVINGNPITIFQER 95.00% 4.23 0.539 3.64 807.4541 1,612.89 1,613.90 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LVINGNPITIFQER 95.00% 4.16 0.442 3.48 807.4541 1,612.89 1,613.90 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LVINGNPITIFQER 95.00% 3.33 0.405 2.1 807.4543 1,612.89 1,613.90 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LVINGNPITIFQER 95.00% 3.92 0.513 2.85 807.4547 1,612.89 1,613.90 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LVINGNPITIFQER 95.00% 4.44 0.518 3.92 807.455 1,612.89 1,613.90 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LISWYDNEFGYSNR 95.00% 4.03 0.599 4.85 882.4016 1,762.79 1,763.80 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LISWYDNEFGYSNR 95.00% 3.83 0.607 2.77 882.402 1,762.79 1,763.80 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LISWYDNEFGYSNR 95.00% 4.65 0.563 4.47 882.4033 1,762.79 1,763.80 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% LISWYDNEFGYSNR 95.00% 4.59 0.588 4.64 882.4037 1,762.79 1,763.80 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% IISNAScTTNcLAPLAK 95.00% 4.22 0.624 5.92 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.463 1,832.91 1,833.92 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% IISNAScTTNcLAPLAK 95.00% 4.17 0.568 8.2 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4632 1,832.91 1,833.92 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% IISNAScTTNcLAPLAK 95.00% 4.38 0.513 6.34 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4633 1,832.91 1,833.92 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% IISNAScTTNcLAPLAK 95.00% 3.01 0.41 4.29 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4686 1,832.92 1,833.92 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% IISNAScTTNcLAPLAK 95.00% 4.78 0.505 7.09 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.963 1,833.91 1,833.92 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% IISNAScTTNcLAPLAK 95.00% 4.43 0.566 7.17 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9634 1,833.91 1,833.92 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% IISNAScTTNcLAPLAK 95.00% 4.17 0.545 6.74 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.968 1,833.92 1,833.92 2
 SAMPLE 3 Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 9 11 40 36.10% VIISAPSADAPMFVMGVNHEK 95.00% 4.59 0.557 5.66 1,107.56 2,213.10 2,213.11 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VPTANVSVVDLTcR 95.00% 3.4 0.366 1.03 c13: Carbamidomethyl (+57.02) 510.9347 1,529.78 1,530.80 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VPTANVSVVDLTcR 95.00% 2.52 0.409 0 c13: Carbamidomethyl (+57.02) 510.9349 1,529.78 1,530.80 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VPTANVSVVDLTcR 95.00% 2.62 0.486 1.92 c13: Carbamidomethyl (+57.02) 510.9367 1,529.79 1,530.80 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VPTANVSVVDLTcR 95.00% 3.08 0.42 1.29 c13: Carbamidomethyl (+57.02) 511.27 1,530.79 1,530.80 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQER 95.00% 3.03 0.447 1.36 538.6378 1,612.89 1,613.90 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQER 95.00% 3.73 0.391 1.74 538.9713 1,613.89 1,613.90 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQER 95.00% 3.99 0.407 2.54 538.9718 1,613.89 1,613.90 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VVDLMAHMASK 95.00% 3.37 0.532 3.64 601.3055 1,200.60 1,201.61 2 LDB3_HUMAN
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VVDLMAHMASK 95.00% 3.58 0.486 1.96 601.3063 1,200.60 1,201.61 2 LDB3_HUMAN
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% IISNAScTTNcLAPLAK 95.00% 3.65 0.366 2.29 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 611.9784 1,832.91 1,833.92 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VVDLMAHMASKE 95.00% 3.53 0.565 3.62 665.8275 1,329.64 1,330.65 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQERDPSK 95.00% 2.8 0.409 0 681.3743 2,041.10 2,041.11 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQERDPSK 95.00% 2.25 0.323 1.33 681.3749 2,041.10 2,041.11 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQERDPSK 95.00% 2.72 0.308 0 681.3751 2,041.10 2,041.11 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VVDLmAHmASKE 95.00% 3.19 0.532 2.92 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 681.8236 1,361.63 1,362.64 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VVDLmAHmASKE 95.00% 3.17 0.586 2.3 m5: Oxidation (+15.99), m8: Oxidation (+15.99) 681.8243 1,361.63 1,362.64 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% GALQNIIPASTGAAK 95.00% 2.43 0.378 0 706.3961 1,410.78 1,411.79 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% GALQNIIPASTGAAK 95.00% 3.17 0.487 2.38 706.3974 1,410.78 1,411.79 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% GALQNIIPASTGAAK 95.00% 3.71 0.455 4 706.3977 1,410.78 1,411.79 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% GALQNIIPASTGAAK 95.00% 3.72 0.459 3.08 706.398 1,410.78 1,411.79 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% GALQNIIPASTGAAK 95.00% 2.85 0.459 1.11 706.3991 1,410.78 1,411.79 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% GALQNIIPASTGAAK 95.00% 3.02 0.433 1.96 706.4011 1,410.79 1,411.79 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% WGDAGAEYVVESTGVFTTMEK 95.00% 3.15 0.216 0 760.0181 2,277.03 2,277.04 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% WGDAGAEYVVESTGVFTTMEK 95.00% 2.96 0.387 0 760.0188 2,277.03 2,277.04 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VPTANVSVVDLTcR 95.00% 3.94 0.627 4.82 c13: Carbamidomethyl (+57.02) 765.8996 1,529.78 1,530.80 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VPTANVSVVDLTcR 95.00% 4 0.667 4.64 c13: Carbamidomethyl (+57.02) 765.9007 1,529.79 1,530.80 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VPTANVSVVDLTcR 95.00% 4.28 0.644 5.16 c13: Carbamidomethyl (+57.02) 765.9014 1,529.79 1,530.80 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VPTANVSVVDLTcR 95.00% 3.8 0.598 5.31 c13: Carbamidomethyl (+57.02) 765.9014 1,529.79 1,530.80 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VPTANVSVVDLTcR 95.00% 3.4 0.639 5.89 c13: Carbamidomethyl (+57.02) 765.9018 1,529.79 1,530.80 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VPTANVSVVDLTcR 95.00% 3.12 0.637 5.36 c13: Carbamidomethyl (+57.02) 765.9021 1,529.79 1,530.80 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VPTANVSVVDLTcR 95.00% 3.78 0.609 5.05 c13: Carbamidomethyl (+57.02) 765.9027 1,529.79 1,530.80 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VPTANVSVVDLTcR 95.00% 3.85 0.583 4.54 c13: Carbamidomethyl (+57.02) 766.4034 1,530.79 1,530.80 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQER 95.00% 4.07 0.486 2.46 807.4524 1,612.89 1,613.90 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQER 95.00% 2.53 0.456 2.08 807.4533 1,612.89 1,613.90 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQER 95.00% 4.64 0.523 3.1 807.4533 1,612.89 1,613.90 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQER 95.00% 4.76 0.516 4.85 807.4534 1,612.89 1,613.90 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQER 95.00% 4.1 0.502 2.74 807.4541 1,612.89 1,613.90 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQER 95.00% 4.43 0.513 3.8 807.4546 1,612.89 1,613.90 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQER 95.00% 4.5 0.52 3.25 807.4553 1,612.89 1,613.90 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQER 95.00% 4.18 0.48 3.23 807.4554 1,612.90 1,613.90 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LVINGNPITIFQER 95.00% 3.8 0.507 2.64 807.9553 1,613.89 1,613.90 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% IKWGDAGAEYVVESTGVFTTMEK 95.00% 4.06 0.308 3.82 840.4109 2,518.21 2,518.22 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% IKWGDAGAEYVVESTGVFTTMEK 95.00% 4.01 0.284 3.16 840.4124 2,518.21 2,518.22 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VIHDNFGIVEGLMTTVHAITATQK 95.00% 7.07 0.682 6.37 866.124 2,595.35 2,595.36 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VIHDNFGIVEGLMTTVHAITATQK 95.00% 7.1 0.663 3.38 866.1272 2,595.36 2,595.36 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% VIHDNFGIVEGLMTTVHAITATQK 95.00% 0 0 5.12 866.4579 2,596.35 2,595.36 3
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LISWYDNEFGYSNR 95.00% 4.36 0.611 4.41 882.4035 1,762.79 1,763.80 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LISWYDNEFGYSNR 95.00% 3.26 0.576 2.29 882.4045 1,762.79 1,763.80 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LISWYDNEFGYSNR 95.00% 4.91 0.554 3.39 882.9048 1,763.79 1,763.80 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% LISWYDNEFGYSNR 95.00% 4.33 0.601 3.32 882.9048 1,763.79 1,763.80 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% IISNAScTTNcLAPLAK 95.00% 4.12 0.564 6.12 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4628 1,832.91 1,833.92 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% IISNAScTTNcLAPLAK 95.00% 4.8 0.528 7.43 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.464 1,832.91 1,833.92 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% IISNAScTTNcLAPLAK 95.00% 4.24 0.534 6 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4643 1,832.91 1,833.92 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% IISNAScTTNcLAPLAK 95.00% 3.84 0.516 5.68 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.465 1,832.91 1,833.92 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% IISNAScTTNcLAPLAK 95.00% 4.5 0.559 7.28 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.4657 1,832.92 1,833.92 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% IISNAScTTNcLAPLAK 95.00% 3.91 0.555 5.92 c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 917.9639 1,833.91 1,833.92 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% WGDAGAEYVVESTGVFTTMEK 95.00% 6.73 0.642 8.96 1,139.52 2,277.03 2,277.04 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% WGDAGAEYVVESTGVFTTMEK 95.00% 6.16 0.662 10.6 1,139.52 2,277.03 2,277.04 2
 SAMPLE 3R Glyceraldehyde-3-phosphate dehydrogenase  GAPDH  G3P_HUMAN 36,035.30 100.00% 10 13 47 40.90% WGDAGAEYVVESTGVFTTMEK 95.00% 6.41 0.673 8.7 1,139.52 2,277.03 2,277.04 2
 SAMPLE 2R Glycogen phosphorylase, brain form  PYGB  PYGB_HUMAN 96,680.30 99.80% 2 2 3 2.85% GLAGLGDVAEVR 95.00% 2.55 0.323 1.3 578.8224 1,155.63 1,156.63 2
 SAMPLE 2R Glycogen phosphorylase, brain form  PYGB  PYGB_HUMAN 96,680.30 99.80% 2 2 3 2.85% GLAGLGDVAEVR 95.00% 2.35 0.222 1.96 578.8239 1,155.63 1,156.63 2
 SAMPLE 2R Glycogen phosphorylase, brain form  PYGB  PYGB_HUMAN 96,680.30 99.80% 2 2 3 2.85% VLYPNDNFFEGK 95.00% 1.73 0.379 0 722.3526 1,442.69 1,442.70 2
 SAMPLE 3 Glycogen phosphorylase, brain form  PYGB  PYGB_HUMAN 96,680.30 100.00% 3 3 3 4.98% GLAGLGDVAEVR 95.00% 3.29 0.475 3.19 578.8194 1,155.62 1,156.63 2
 SAMPLE 3 Glycogen phosphorylase, brain form  PYGB  PYGB_HUMAN 96,680.30 100.00% 3 3 3 4.98% LVTSIGDVVNHDPVVGDR 95.00% 2.32 0.334 2.08 631.6682 1,891.98 1,891.99 3
 SAMPLE 3 Glycogen phosphorylase, brain form  PYGB  PYGB_HUMAN 96,680.30 100.00% 3 3 3 4.98% VLYPNDNFFEGK 95.00% 1.91 0.402 0 721.8512 1,441.69 1,442.70 2
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% VKPWNYTYDPK 95.00% 2.69 0.302 1.09 470.9062 1,409.70 1,410.71 3
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% VKPWNYTYDPK 95.00% 3.04 0.321 0 471.2414 1,410.70 1,410.71 3
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% GALVLGSSLK 95.00% 3.21 0.419 0 472.792 943.5683 944.5782 2
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% GALVLGSSLK 95.00% 3.16 0.235 1.14 472.7935 943.5714 944.5782 2
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% LHcWSLTQYSK 95.00% 3.2 0.353 0 c3: Carbamidomethyl (+57.02) 474.8997 1,421.68 1,422.68 3
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% LHcWSLTQYSK 95.00% 3.36 0.165 1.32 c3: Carbamidomethyl (+57.02) 474.9007 1,421.68 1,422.68 3
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% RPELGVTLTK 95.00% 2.38 0.236 2.72 557.3336 1,112.65 1,113.66 2
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% RPELGVTLTK 95.00% 2.81 0.311 2.66 557.3341 1,112.65 1,113.66 2
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% RLVVLATPQVSDSMR 95.00% 3.65 0.442 3.19 557.9777 1,670.91 1,671.92 3
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% RLVVLATPQVSDSMR 95.00% 3.61 0.442 2.48 558.3134 1,671.92 1,671.92 3
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% LHcWSLTQYSK 95.00% 3.25 0.496 3.32 c3: Carbamidomethyl (+57.02) 711.844 1,421.67 1,422.68 2
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% LHcWSLTQYSK 95.00% 2.86 0.396 4.06 c3: Carbamidomethyl (+57.02) 711.8448 1,421.67 1,422.68 2
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% LVVLATPQVSDSMR 95.00% 3.96 0.523 6.11 758.4123 1,514.81 1,515.82 2
 SAMPLE 1 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 14 16.30% LVVLATPQVSDSMR 95.00% 3.96 0.506 5.82 758.4127 1,514.81 1,515.82 2
 SAMPLE 1R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 12 16.30% VKPWNYTYDPK 95.00% 2.56 0.286 0 470.907 1,409.70 1,410.71 3
 SAMPLE 1R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 12 16.30% GALVLGSSLK 95.00% 2.92 0.256 1.7 472.7915 943.5674 944.5782 2
 SAMPLE 1R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 12 16.30% GALVLGSSLK 95.00% 2.7 0.158 1.26 472.7919 943.5682 944.5782 2
 SAMPLE 1R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 12 16.30% LHcWSLTQYSK 95.00% 3.25 0.318 0 c3: Carbamidomethyl (+57.02) 474.8982 1,421.67 1,422.68 3
 SAMPLE 1R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 12 16.30% RPELGVTLTK 95.00% 2.31 0.146 3.04 557.3335 1,112.65 1,113.66 2
 SAMPLE 1R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 12 16.30% RPELGVTLTK 95.00% 2.61 0.285 1.96 557.3337 1,112.65 1,113.66 2
 SAMPLE 1R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 12 16.30% RLVVLATPQVSDSMR 95.00% 3.83 0.453 1.37 557.9776 1,670.91 1,671.92 3
 SAMPLE 1R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 12 16.30% RLVVLATPQVSDSMR 95.00% 3.46 0.382 1.51 557.9787 1,670.91 1,671.92 3
 SAMPLE 1R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 12 16.30% LHcWSLTQYSK 95.00% 2.6 0.417 4.29 c3: Carbamidomethyl (+57.02) 711.8444 1,421.67 1,422.68 2
 SAMPLE 1R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 12 16.30% LHcWSLTQYSK 95.00% 2.89 0.459 4.52 c3: Carbamidomethyl (+57.02) 711.8449 1,421.67 1,422.68 2
 SAMPLE 1R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 12 16.30% LVVLATPQVSDSMR 95.00% 4.22 0.539 6.18 758.4126 1,514.81 1,515.82 2
 SAMPLE 1R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 6 7 12 16.30% LVVLATPQVSDSMR 95.00% 4.13 0.517 5.77 758.414 1,514.81 1,515.82 2
 SAMPLE 3 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 3 3 6 9.71% GALVLGSSLK 95.00% 3.19 0.391 1.13 472.7929 943.5702 944.5782 2
 SAMPLE 3 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 3 3 6 9.71% GALVLGSSLK 95.00% 3.02 0.396 0 472.7939 943.5721 944.5782 2
 SAMPLE 3 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 3 3 6 9.71% RPELGVTLTK 95.00% 2.5 0.305 1.77 557.334 1,112.65 1,113.66 2
 SAMPLE 3 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 3 3 6 9.71% RPELGVTLTK 95.00% 2.14 0.152 3.12 557.3345 1,112.65 1,113.66 2
 SAMPLE 3 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 3 3 6 9.71% LVVLATPQVSDSMR 95.00% 3.54 0.559 6.72 758.4143 1,514.81 1,515.82 2
 SAMPLE 3 Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 3 3 6 9.71% LVVLATPQVSDSMR 95.00% 3.82 0.541 4.25 758.4143 1,514.81 1,515.82 2
 SAMPLE 3R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 3 3 6 9.71% GALVLGSSLK 95.00% 2.86 0.35 1.24 472.7921 943.5685 944.5782 2
 SAMPLE 3R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 3 3 6 9.71% GALVLGSSLK 95.00% 2.85 0.25 0 472.7928 943.57 944.5782 2
 SAMPLE 3R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 3 3 6 9.71% RPELGVTLTK 95.00% 1.76 0.173 4.17 557.3309 1,112.65 1,113.66 2
 SAMPLE 3R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 3 3 6 9.71% RPELGVTLTK 95.00% 2.12 0.16 3.22 557.334 1,112.65 1,113.66 2
 SAMPLE 3R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 3 3 6 9.71% LVVLATPQVSDSMR 95.00% 2.14 0 3.4 758.4151 1,514.81 1,515.82 2
 SAMPLE 3R Glycogenin-1  GYG1  GLYG_HUMAN 39,366.30 100.00% 3 3 6 9.71% LVVLATPQVSDSMR 95.00% 3.37 0.49 4.42 758.9144 1,515.81 1,515.82 2
 SAMPLE 1 GTP-binding nuclear protein Ran  RAN  RAN_HUMAN 24,405.10 99.80% 2 2 2 15.70% LVLVGDGGTGK 95.00% 1.93 0.291 0 508.2943 1,014.57 1,015.58 2 H15_HUMAN
 SAMPLE 1 GTP-binding nuclear protein Ran  RAN  RAN_HUMAN 24,405.10 99.80% 2 2 2 15.70% LVLVGDGGTGK 95.00% 2.54 0.194 3.21 508.295 1,014.57 1,015.58 2 H15_HUMAN
 SAMPLE 1 GTP-binding nuclear protein Ran  RAN  RAN_HUMAN 24,405.10 99.80% 2 2 2 15.70% NLQYYDISAK 95.00% 2.43 0.236 0 607.8092 1,213.60 1,214.61 2
 SAMPLE 1 GTP-binding nuclear protein Ran  RAN  RAN_HUMAN 24,405.10 99.80% 2 2 2 15.70% VcENIPIVLcGNK 95.00% 4.09 0.492 3.72 c2: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 758.3863 1,514.76 1,515.77 2
 SAMPLE 2 GTP-binding nuclear protein Ran  RAN  RAN_HUMAN 24,405.10 99.80% 2 2 4 10.60% NLQYYDISAK 95.00% 2.79 0.311 0 607.8047 1,213.59 1,214.61 2
 SAMPLE 2 GTP-binding nuclear protein Ran  RAN  RAN_HUMAN 24,405.10 99.80% 2 2 4 10.60% NLQYYDISAK 95.00% 2.66 0.313 2 607.805 1,213.59 1,214.61 2
 SAMPLE 2 GTP-binding nuclear protein Ran  RAN  RAN_HUMAN 24,405.10 99.80% 2 2 4 10.60% VcENIPIVLcGNK 95.00% 4.26 0.432 4.89 c2: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 758.3847 1,514.75 1,515.77 2
 SAMPLE 2 GTP-binding nuclear protein Ran  RAN  RAN_HUMAN 24,405.10 99.80% 2 2 4 10.60% VcENIPIVLcGNK 95.00% 4.33 0.432 4.13 c2: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 758.8875 1,515.76 1,515.77 2
 SAMPLE 2R GTP-binding nuclear protein Ran  RAN  RAN_HUMAN 24,405.10 99.80% 2 2 3 10.60% NLQYYDISAK 95.00% 2.37 0.342 1.41 607.8043 1,213.59 1,214.61 2
 SAMPLE 2R GTP-binding nuclear protein Ran  RAN  RAN_HUMAN 24,405.10 99.80% 2 2 3 10.60% NLQYYDISAK 95.00% 2.56 0.329 1.22 607.8055 1,213.60 1,214.61 2
 SAMPLE 2R GTP-binding nuclear protein Ran  RAN  RAN_HUMAN 24,405.10 99.80% 2 2 3 10.60% VcENIPIVLcGNK 95.00% 2.57 0.287 2.19 c2: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 758.3839 1,514.75 1,515.77 2
 SAMPLE 2 GTPase KRas  KRAS  RASK_HUMAN 21,638.10 99.80% 2 2 2 12.20% LVVVGAGGVGK 95.00% 2.22 0.326 1.33 478.2993 954.5829 955.5942 2
 SAMPLE 2 GTPase KRas  KRAS  RASK_HUMAN 21,638.10 99.80% 2 2 2 12.20% SYGIPFIETSAK 95.00% 2.55 0.208 1.25 656.8427 1,311.67 1,312.68 2
 SAMPLE 2R GTPase KRas  KRAS  RASK_HUMAN 21,638.10 99.80% 2 2 3 12.20% LVVVGAGGVGK 95.00% 2.52 0.336 1.7 478.3001 954.5846 955.5942 2
 SAMPLE 2R GTPase KRas  KRAS  RASK_HUMAN 21,638.10 99.80% 2 2 3 12.20% SYGIPFIETSAK 95.00% 2.22 0.303 1.64 656.8421 1,311.67 1,312.68 2
 SAMPLE 2R GTPase KRas  KRAS  RASK_HUMAN 21,638.10 99.80% 2 2 3 12.20% SYGIPFIETSAK 95.00% 2.3 0.315 0 656.8426 1,311.67 1,312.68 2
 SAMPLE 3 GTPase KRas  KRAS  RASK_HUMAN 21,638.10 99.80% 2 2 3 12.20% LVVVGAGGVGK 95.00% 2.63 0.402 2.13 478.3004 954.5852 955.5942 2
 SAMPLE 3 GTPase KRas  KRAS  RASK_HUMAN 21,638.10 99.80% 2 2 3 12.20% SYGIPFIETSAK 95.00% 2.22 0.123 2.74 656.8417 1,311.67 1,312.68 2
 SAMPLE 3 GTPase KRas  KRAS  RASK_HUMAN 21,638.10 99.80% 2 2 3 12.20% SYGIPFIETSAK 95.00% 2.45 0.192 1.72 656.8424 1,311.67 1,312.68 2
 SAMPLE 3R GTPase KRas  KRAS  RASK_HUMAN 21,638.10 100.00% 3 3 4 20.10% LVVVGAGGVGK 95.00% 2.2 0.205 2.37 478.3 954.5844 955.5942 2
 SAMPLE 3R GTPase KRas  KRAS  RASK_HUMAN 21,638.10 100.00% 3 3 4 20.10% LVVVGAGGVGK 95.00% 2.1 0.252 2.17 478.3015 954.5874 955.5942 2
 SAMPLE 3R GTPase KRas  KRAS  RASK_HUMAN 21,638.10 100.00% 3 3 4 20.10% SYGIPFIETSAK 95.00% 2.1 0.194 1.44 656.8427 1,311.67 1,312.68 2
 SAMPLE 3R GTPase KRas  KRAS  RASK_HUMAN 21,638.10 100.00% 3 3 4 20.10% TGEGFLcVFAINNTK 95.00% 4.39 0.458 3.11 c7: Carbamidomethyl (+57.02) 836.4123 1,670.81 1,670.82 2
 SAMPLE 3 Guanine nucleotide exchange factor DBS  MCF2L  MCF2L_HUMAN 128,094.00 99.80% 2 2 3 5.10% ASVLRIAASFPANLQLVLVLRPTGFFQR 95.00% 2.52 0.337 0 1,029.00 3,083.96 3,084.78 3
 SAMPLE 3 Guanine nucleotide exchange factor DBS  MCF2L  MCF2L_HUMAN 128,094.00 99.80% 2 2 3 5.10% EASQHRALEQSQSLPLPAPTSTSPSRGNSR 95.00% 2.16 0.225 0 1,064.00 3,188.98 3,189.60 3
 SAMPLE 3 Guanine nucleotide exchange factor DBS  MCF2L  MCF2L_HUMAN 128,094.00 99.80% 2 2 3 5.10% EASQHRALEQSQSLPLPAPTSTSPSRGNSR 95.00% 2.18 0.348 0 1,064.00 3,188.99 3,189.60 3
 SAMPLE 2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 5 10.60% LFVSGAcDASAK 95.00% 2.91 0.4 1.32 c7: Carbamidomethyl (+57.02) 613.2955 1,224.58 1,225.59 2
 SAMPLE 2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 5 10.60% LFVSGAcDASAK 95.00% 3 0.369 2.85 c7: Carbamidomethyl (+57.02) 613.2981 1,224.58 1,225.59 2
 SAMPLE 2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 5 10.60% LIIWDSYTTNK 95.00% 3.1 0.388 3.37 677.3535 1,352.69 1,353.71 2 GBB2_HUMAN
 SAMPLE 2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 5 10.60% LIIWDSYTTNK 95.00% 3.41 0.433 4.46 677.3548 1,352.69 1,353.71 2 GBB2_HUMAN
 SAMPLE 2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 5 10.60% LIIWDSYTTNK 95.00% 2.64 0.349 2.07 677.3549 1,352.69 1,353.71 2 GBB2_HUMAN
 SAMPLE 2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 5 10.60% LIIWDSYTTNK 95.00% 2.22 0.316 0 677.3556 1,352.70 1,353.71 2 GBB2_HUMAN
 SAMPLE 2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 5 10.60% ELAGHTGYLSccR 95.00% 2.44 0.241 0 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 762.3394 1,522.66 1,523.67 2
 SAMPLE 2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 5 10.60% ELAGHTGYLSccR 95.00% 3.57 0.51 3.8 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 762.3404 1,522.67 1,523.67 2
 SAMPLE 2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 5 10.60% ELAGHTGYLSccR 95.00% 3.38 0.553 1.54 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 762.3427 1,522.67 1,523.67 2
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 100.00% 3 3 4 13.80% LFVSGAcDASAK 95.00% 3.13 0.427 3.14 c7: Carbamidomethyl (+57.02) 613.2973 1,224.58 1,225.59 2
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 100.00% 3 3 4 13.80% IYAMHWGTDSR 95.00% 2.18 0.293 1.21 668.8081 1,335.60 1,336.61 2 GBB2_HUMAN
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 100.00% 3 3 4 13.80% LIIWDSYTTNK 95.00% 2.7 0.283 2.14 677.3549 1,352.69 1,353.71 2 GBB2_HUMAN
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 100.00% 3 3 4 13.80% LIIWDSYTTNK 95.00% 2.41 0.343 1.35 677.3551 1,352.69 1,353.71 2 GBB2_HUMAN
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 100.00% 3 3 4 13.80% LIIWDSYTTNK 95.00% 1.98 0.359 0 677.3554 1,352.70 1,353.71 2 GBB2_HUMAN
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 100.00% 3 3 4 13.80% ELAGHTGYLSccR 95.00% 3.39 0.583 4.59 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 762.3404 1,522.67 1,523.67 2
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 100.00% 3 3 4 13.80% ELAGHTGYLSccR 95.00% 3.56 0.6 4.46 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 762.8398 1,523.66 1,523.67 2
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 6 10.60% LFVSGAcDASAK 95.00% 3.01 0.445 2.24 c7: Carbamidomethyl (+57.02) 613.2962 1,224.58 1,225.59 2
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 6 10.60% LFVSGAcDASAK 95.00% 2.48 0.294 0 c7: Carbamidomethyl (+57.02) 613.2963 1,224.58 1,225.59 2
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 6 10.60% LFVSGAcDASAK 95.00% 3.44 0.463 2.57 c7: Carbamidomethyl (+57.02) 613.2972 1,224.58 1,225.59 2
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 6 10.60% LIIWDSYTTNK 95.00% 2.07 0.315 0 677.3553 1,352.69 1,353.71 2 GBB2_HUMAN
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 6 10.60% LIIWDSYTTNK 95.00% 2.24 0.267 0 677.356 1,352.70 1,353.71 2 GBB2_HUMAN
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 6 10.60% ELAGHTGYLSccR 95.00% 3.37 0.595 3.82 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 762.3398 1,522.66 1,523.67 2
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 6 10.60% ELAGHTGYLSccR 95.00% 3.25 0.543 3.54 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 762.3421 1,522.67 1,523.67 2
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  GNB1  GBB1_HUMAN 37,359.50 99.80% 2 2 6 10.60% ELAGHTGYLSccR 95.00% 3.04 0.506 1.72 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 762.3424 1,522.67 1,523.67 2
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  GNB2  GBB2_HUMAN 37,313.80 99.80% 2 2 3 13.80% TFVSGAcDASIK 95.00% 2.66 0.401 3.59 c7: Carbamidomethyl (+57.02) 628.3018 1,254.59 1,255.60 2
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  GNB2  GBB2_HUMAN 37,313.80 99.80% 2 2 3 13.80% TFVSGAcDASIK 95.00% 3.08 0.393 4.31 c7: Carbamidomethyl (+57.02) 628.3038 1,254.59 1,255.60 2
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  GNB2  GBB2_HUMAN 37,313.80 99.80% 2 2 3 13.80% IYAMHWGTDSR 95.00% 2.18 0.293 1.21 668.8081 1,335.60 1,336.61 2 GBB1_HUMAN
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  GNB2  GBB2_HUMAN 37,313.80 99.80% 2 2 3 13.80% LIIWDSYTTNK 95.00% 2.7 0.283 2.14 677.3549 1,352.69 1,353.71 2 GBB1_HUMAN
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  GNB2  GBB2_HUMAN 37,313.80 99.80% 2 2 3 13.80% LIIWDSYTTNK 95.00% 2.41 0.343 1.35 677.3551 1,352.69 1,353.71 2 GBB1_HUMAN
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  GNB2  GBB2_HUMAN 37,313.80 99.80% 2 2 3 13.80% LIIWDSYTTNK 95.00% 1.98 0.359 0 677.3554 1,352.70 1,353.71 2 GBB1_HUMAN
 SAMPLE 3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  GNB2  GBB2_HUMAN 37,313.80 99.80% 2 2 3 13.80% ELPGHTGYLSccR 95.00% 2.17 0.409 2.09 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 775.3479 1,548.68 1,549.69 2
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  GNB2  GBB2_HUMAN 37,313.80 99.80% 2 2 3 10.60% TFVSGAcDASIK 95.00% 3.01 0.458 3.92 c7: Carbamidomethyl (+57.02) 628.3026 1,254.59 1,255.60 2
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  GNB2  GBB2_HUMAN 37,313.80 99.80% 2 2 3 10.60% TFVSGAcDASIK 95.00% 2.88 0.434 3.7 c7: Carbamidomethyl (+57.02) 628.8036 1,255.59 1,255.60 2
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  GNB2  GBB2_HUMAN 37,313.80 99.80% 2 2 3 10.60% LIIWDSYTTNK 95.00% 2.07 0.315 0 677.3553 1,352.69 1,353.71 2 GBB1_HUMAN
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  GNB2  GBB2_HUMAN 37,313.80 99.80% 2 2 3 10.60% LIIWDSYTTNK 95.00% 2.24 0.267 0 677.356 1,352.70 1,353.71 2 GBB1_HUMAN
 SAMPLE 3R Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  GNB2  GBB2_HUMAN 37,313.80 99.80% 2 2 3 10.60% ELPGHTGYLSccR 95.00% 2.36 0.519 3.34 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 775.3479 1,548.68 1,549.69 2
 SAMPLE 1 Haptoglobin  HP  HPT_HUMAN 45,186.90 99.80% 2 2 4 4.19% GSFPWQAK 95.00% 1.98 0.268 0 460.7343 919.4529 920.4631 2
 SAMPLE 1 Haptoglobin  HP  HPT_HUMAN 45,186.90 99.80% 2 2 4 4.19% GSFPWQAK 95.00% 2.05 0.176 1.14 460.7348 919.4539 920.4631 2
 SAMPLE 1 Haptoglobin  HP  HPT_HUMAN 45,186.90 99.80% 2 2 4 4.19% VGYVSGWGR 95.00% 2.68 0.364 0 490.7502 979.4848 980.4954 2
 SAMPLE 1 Haptoglobin  HP  HPT_HUMAN 45,186.90 99.80% 2 2 4 4.19% VGYVSGWGR 95.00% 2.03 0.345 1.12 490.7507 979.4857 980.4954 2
 SAMPLE 1R Haptoglobin  HP  HPT_HUMAN 45,186.90 99.80% 2 2 3 4.68% VGYVSGWGR 95.00% 2.73 0.427 0 490.7503 979.4849 980.4954 2
 SAMPLE 1R Haptoglobin  HP  HPT_HUMAN 45,186.90 99.80% 2 2 3 4.68% VGYVSGWGR 95.00% 2.77 0.408 1.15 490.7512 979.4867 980.4954 2
 SAMPLE 1R Haptoglobin  HP  HPT_HUMAN 45,186.90 99.80% 2 2 3 4.68% VTSIQDWVQK 95.00% 3.19 0.395 0 602.3211 1,202.63 1,203.64 2
 SAMPLE 2 Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 4 5 9 7.39% LRTEGDGVYTLNDKK 95.00% 2.78 0.149 0 570.2867 1,707.84 1,708.89 3
 SAMPLE 2 Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 4 5 9 7.39% TEGDGVYTLNNEK 95.00% 3.15 0.536 2.14 720.3334 1,438.65 1,439.67 2
 SAMPLE 2 Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 4 5 9 7.39% TEGDGVYTLNDKK 95.00% 3.15 0.536 2.14 720.3334 1,438.65 1,439.70 2
 SAMPLE 2 Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 4 5 9 7.39% TEGDGVYTLNNEK 95.00% 3.71 0.517 2.24 720.3353 1,438.65 1,439.67 2
 SAMPLE 2 Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 4 5 9 7.39% TEGDGVYTLNDKK 95.00% 3.71 0.517 2.24 720.3353 1,438.65 1,439.70 2
 SAMPLE 2 Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 4 5 9 7.39% LRTEGDGVYTLNDKK 95.00% 4.19 0.401 4 854.9282 1,707.84 1,708.89 2
 SAMPLE 2 Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 4 5 9 7.39% LRTEGDGVYTLNNEK 95.00% 4.19 0.401 4 854.9282 1,707.84 1,708.85 2
 SAMPLE 2 Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 4 5 9 7.39% LRTEGDGVYTLNNEK 95.00% 4.14 0.442 2.17 854.9289 1,707.84 1,708.85 2
 SAMPLE 2 Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 4 5 9 7.39% LRTEGDGVYTLNDKK 95.00% 4.14 0.442 2.17 854.9289 1,707.84 1,708.89 2
 SAMPLE 2R Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 3 3 5 6.90% LRTEGDGVYTLNNEK 94.80% 2.73 0.139 0 570.2874 1,707.84 1,708.85 3
 SAMPLE 2R Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 3 3 5 6.90% TEGDGVYTLNDKK 95.00% 3.54 0.48 1.51 720.3365 1,438.66 1,439.70 2
 SAMPLE 2R Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 3 3 5 6.90% TEGDGVYTLNNEK 95.00% 3.54 0.48 1.51 720.3365 1,438.66 1,439.67 2
 SAMPLE 2R Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 3 3 5 6.90% TEGDGVYTLNNEK 95.00% 3.4 0.539 2.29 720.3373 1,438.66 1,439.67 2
 SAMPLE 2R Haptoglobin  HP  HPT_HUMAN 45,186.90 100.00% 3 3 5 6.90% TEGDGVYTLNDKK 95.00% 3.4 0.539 2.29 720.3373 1,438.66 1,439.70 2
 SAMPLE 4 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 3 3 9 6.55% ATAGDTHLGGEDFDNR 95.00% 2.59 0.468 0 559.249 1,674.72 1,675.73 3
 SAMPLE 4 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 3 3 9 6.55% ATAGDTHLGGEDFDNR 95.00% 2.35 0.328 0 559.2492 1,674.72 1,675.73 3
 SAMPLE 4 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 3 3 9 6.55% ATAGDTHLGGEDFDNR 95.00% 3.24 0.526 0 559.5836 1,675.73 1,675.73 3
 SAMPLE 4 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 3 3 9 6.55% ATAGDTHLGGEDFDNR 95.00% 2.62 0.343 0 559.5845 1,675.73 1,675.73 3
 SAMPLE 4 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 3 3 9 6.55% DAGVIAGLNVLR 95.00% 3.03 0.286 0 599.3531 1,196.69 1,197.70 2
 SAMPLE 4 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 3 3 9 6.55% DAGVIAGLNVLR 95.00% 3.5 0.295 2.04 599.3534 1,196.69 1,197.70 2
 SAMPLE 4 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 3 3 9 6.55% DAGVIAGLNVLR 95.00% 3.52 0.31 2.05 599.3535 1,196.69 1,197.70 2
 SAMPLE 4 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 3 3 9 6.55% DAGVIAGLNVLR 95.00% 3.01 0.262 0 599.3544 1,196.69 1,197.70 2
 SAMPLE 4 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 3 3 9 6.55% AQIHDLVLVGGSTR 95.00% 2.91 0.441 3.21 733.8885 1,465.76 1,465.81 2
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% LLQDFFNGR 95.00% 2.52 0.395 0 555.2895 1,108.56 1,109.57 2
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% LLQDFFNGR 95.00% 2.24 0.36 0 555.2914 1,108.57 1,109.57 2
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% LLQDFFNGR 95.00% 2.56 0.406 0 555.2919 1,108.57 1,109.57 2
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% LLQDFFNGR 95.00% 2.23 0.313 1.85 555.2923 1,108.57 1,109.57 2
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% LLQDFFNGR 95.00% 2.42 0.38 1.6 555.2926 1,108.57 1,109.57 2
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% LLQDFFNGR 95.00% 2.63 0.422 0 555.2928 1,108.57 1,109.57 2
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% ATAGDTHLGGEDFDNR 95.00% 2.43 0.386 0 559.5826 1,675.72 1,675.73 3
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% DAGVIAGLNVLR 95.00% 2.68 0.226 0 599.3468 1,196.68 1,197.70 2
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% DAGVIAGLNVLR 95.00% 2.9 0.243 1.62 599.3523 1,196.69 1,197.70 2
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% DAGVIAGLNVLR 95.00% 2.72 0.283 0 599.353 1,196.69 1,197.70 2
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% DAGVIAGLNVLR 95.00% 3.6 0.303 2.37 599.3534 1,196.69 1,197.70 2
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% DAGVIAGLNVLR 95.00% 3.39 0.292 3.14 599.3537 1,196.69 1,197.70 2
 SAMPLE 4R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 4 4 13 7.80% TTPSYVAFTDTER 95.00% 3.05 0.362 1.19 744.8604 1,487.71 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% LVNHFVEEFKR 95.00% 3.89 0.437 1.37 473.2548 1,416.74 1,417.76 3
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% LVNHFVEEFKR 95.00% 3.86 0.446 1.04 473.5915 1,417.75 1,417.76 3
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% AFYPEEISSMVLTK 95.00% 4.6 0.435 3.31 538.9415 1,613.80 1,614.81 3
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% LLQDFFNGR 95.00% 3.1 0.42 0 555.289 1,108.56 1,109.57 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% LLQDFFNGR 95.00% 2.53 0.411 0 555.2893 1,108.56 1,109.57 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% HWPFQVINDGDKPK 95.00% 4.4 0.489 0 560.9532 1,679.84 1,680.85 3
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% DAGVIAGLNVLR 95.00% 2.94 0.267 1.66 599.3496 1,196.68 1,197.70 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% DAGVIAGLNVLR 95.00% 3.91 0.383 3.82 599.3498 1,196.68 1,197.70 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% DAGVIAGLNVLR 95.00% 3.26 0.29 3.05 599.3506 1,196.69 1,197.70 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% DAGVIAGLNVLR 95.00% 3.85 0.338 3.59 599.3507 1,196.69 1,197.70 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% NQVALNPQNTVFDAKR 95.00% 2.24 0.388 0 605.6552 1,813.94 1,814.95 3
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% LDKAQIHDLVLVGGSTR 95.00% 3.5 0.333 0 608.3428 1,822.01 1,822.02 3
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% LDKAQIHDLVLVGGSTR 95.00% 2.86 0.27 0 608.3456 1,822.01 1,822.02 3
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% LVNHFVEEFK 95.00% 3.08 0.44 1.77 631.3324 1,260.65 1,261.66 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% LVNHFVEEFK 95.00% 3.21 0.524 0 631.3329 1,260.65 1,261.66 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% NALESYAFNMK 95.00% 3.42 0.446 3.55 644.3036 1,286.59 1,287.60 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% NALESYAFNMK 95.00% 3.84 0.473 2.82 644.3042 1,286.59 1,287.60 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% MVQEAEKYKAEDEVQR 95.00% 3.31 0.469 0 651.6476 1,951.92 1,952.94 3
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% MVQEAEKYKAEDEVQR 95.00% 3.34 0.486 0 651.6515 1,951.93 1,952.94 3
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% TTPSYVAFTDTER 95.00% 3.4 0.631 5.47 744.3509 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% TTPSYVAFTDTER 95.00% 2.89 0.583 2.8 744.3511 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% TTPSYVAFTDTER 95.00% 2.67 0.488 3.11 744.352 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% TTPSYVAFTDTER 95.00% 3.54 0.603 4.3 744.3521 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% TTPSYVAFTDTER 95.00% 3.49 0.642 4.89 744.3529 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% TTPSYVAFTDTER 95.00% 3.81 0.588 4.59 744.3532 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% TTPSYVAFTDTER 95.00% 3.18 0.591 2.27 744.3609 1,486.71 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% AFYPEEISSMVLTK 95.00% 3.8 0.536 7.52 807.9083 1,613.80 1,614.81 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% AFYPEEISSMVLTK 95.00% 3.88 0.532 5.82 807.9089 1,613.80 1,614.81 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% NQVALNPQNTVFDAK 95.00% 4.92 0.54 6.04 829.9272 1,657.84 1,658.85 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% NQVALNPQNTVFDAK 95.00% 4.93 0.54 6.01 829.9288 1,657.84 1,658.85 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% ATAGDTHLGGEDFDNR 95.00% 4.84 0.634 4.51 838.3681 1,674.72 1,675.73 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% ATAGDTHLGGEDFDNR 95.00% 4.36 0.581 4.24 838.8684 1,675.72 1,675.73 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% IINEPTAAAIAYGLDR 95.00% 5.32 0.646 7.96 844.4513 1,686.89 1,687.90 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% IINEPTAAAIAYGLDR 95.00% 5.44 0.648 6.52 844.4518 1,686.89 1,687.90 2
 SAMPLE 1 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 16 35 25.70% NQVALNPQNTVFDAKR 95.00% 4.21 0.485 4.32 908.4812 1,814.95 1,814.95 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% AFYPEEISSMVLTK 95.00% 4.86 0.503 2.51 539.2749 1,614.80 1,614.81 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% AFYPEEISSMVLTK 95.00% 5.07 0.467 2.85 539.2751 1,614.80 1,614.81 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% LLQDFFNGR 95.00% 2.14 0.36 0 555.2879 1,108.56 1,109.57 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% LLQDFFNGR 95.00% 3.12 0.42 1.33 555.289 1,108.56 1,109.57 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% LLQDFFNGR 95.00% 3.28 0.452 0 555.2894 1,108.56 1,109.57 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% LLQDFFNGR 95.00% 2.14 0.322 0 555.2899 1,108.56 1,109.57 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% ATAGDTHLGGEDFDNR 95.00% 3.52 0.568 1.77 559.2473 1,674.72 1,675.73 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% ATAGDTHLGGEDFDNR 95.00% 3.27 0.466 1.85 559.2474 1,674.72 1,675.73 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% ATAGDTHLGGEDFDNR 95.00% 2.54 0.456 1.1 559.248 1,674.72 1,675.73 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% ATAGDTHLGGEDFDNR 95.00% 3.13 0.48 0 559.2485 1,674.72 1,675.73 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% HWPFQVINDGDKPK 95.00% 4.16 0.507 0 560.9537 1,679.84 1,680.85 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% HWPFQVINDGDKPK 95.00% 4.43 0.52 0 561.2883 1,680.84 1,680.85 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% IINEPTAAAIAYGLDR 95.00% 4.63 0.536 2.89 563.6384 1,687.89 1,687.90 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% IINEPTAAAIAYGLDR 95.00% 4.35 0.498 3.14 563.639 1,687.89 1,687.90 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% DAGVIAGLNVLR 95.00% 1.87 0.315 1.7 599.0023 1,195.99 1,197.70 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% DAGVIAGLNVLR 95.00% 3.87 0.381 3.08 599.3498 1,196.68 1,197.70 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% DAGVIAGLNVLR 95.00% 3.91 0.375 4.06 599.3501 1,196.68 1,197.70 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% LDKAQIHDLVLVGGSTR 95.00% 3.54 0.38 1.07 608.0087 1,821.00 1,822.02 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% LDKAQIHDLVLVGGSTR 95.00% 3.81 0.376 1.66 608.0095 1,821.01 1,822.02 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% LVNHFVEEFK 95.00% 2.79 0.357 1.82 631.3329 1,260.65 1,261.66 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% NALESYAFNMK 95.00% 3.28 0.42 3.77 644.3033 1,286.59 1,287.60 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% NALESYAFNMK 95.00% 3.8 0.536 3.44 644.3049 1,286.59 1,287.60 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% MVQEAEKYKAEDEVQR 95.00% 3.74 0.473 1.51 651.6494 1,951.92 1,952.94 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% MVQEAEKYKAEDEVQR 95.00% 3.47 0.43 1.55 651.9843 1,952.93 1,952.94 3
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% AQIHDLVLVGGSTR 95.00% 4.21 0.534 5.12 733.9101 1,465.80 1,465.81 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% TTPSYVAFTDTER 95.00% 3.5 0.622 2.77 744.3537 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% TTPSYVAFTDTER 95.00% 3.44 0.637 3.2 744.354 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% TTPSYVAFTDTER 95.00% 3.18 0.591 1.82 744.3609 1,486.71 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% AFYPEEISSMVLTK 95.00% 3.79 0.552 8.19 807.9065 1,613.80 1,614.81 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% AFYPEEISSMVLTK 95.00% 3.6 0.506 6.06 807.9081 1,613.80 1,614.81 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% NQVALNPQNTVFDAK 95.00% 4.76 0.504 3.89 829.9274 1,657.84 1,658.85 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% NQVALNPQNTVFDAK 95.00% 5.34 0.555 3.68 829.9279 1,657.84 1,658.85 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% ATAGDTHLGGEDFDNR 95.00% 4.47 0.623 3.12 838.3659 1,674.72 1,675.73 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% ATAGDTHLGGEDFDNR 95.00% 4.85 0.596 4.89 838.3684 1,674.72 1,675.73 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% IINEPTAAAIAYGLDR 95.00% 3.67 0.537 3.59 844.449 1,686.88 1,687.90 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% IINEPTAAAIAYGLDR 95.00% 3.73 0.509 4.42 844.4497 1,686.88 1,687.90 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% IINEPTAAAIAYGLDR 95.00% 5.11 0.594 7.11 844.9516 1,687.89 1,687.90 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% IINEPTAAAIAYGLDR 95.00% 4.84 0.586 6.82 844.9546 1,687.89 1,687.90 2
 SAMPLE 1R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 14 17 39 25.60% NQVALNPQNTVFDAKR 95.00% 4.97 0.49 4.35 907.9749 1,813.93 1,814.95 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% KFGDPVVQSDMK 95.00% 2.55 0.197 0 450.8961 1,349.66 1,350.67 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% LVNHFVEEFKR 95.00% 3.15 0.443 1.92 473.2571 1,416.75 1,417.76 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% AQIHDLVLVGGSTR 95.00% 2.85 0.239 1.21 489.2747 1,464.80 1,465.81 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% AQIHDLVLVGGSTR 95.00% 3.4 0.264 1.33 489.2747 1,464.80 1,465.81 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% LLQDFFNGRDLNK 95.00% 2.08 0.299 0 527.2781 1,578.81 1,579.82 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% AFYPEEISSMVLTK 95.00% 4.36 0.447 3.09 538.9396 1,613.80 1,614.81 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% AFYPEEISSMVLTK 95.00% 4.99 0.483 2.66 538.9404 1,613.80 1,614.81 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% AFYPEEISSMVLTK 95.00% 3.89 0.446 2.8 539.2744 1,614.80 1,614.81 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% QATKDAGVIAGLNVLR 95.00% 3.4 0.387 1.77 542.6494 1,624.92 1,625.93 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% QATKDAGVIAGLNVLR 95.00% 3.69 0.263 2.02 542.9836 1,625.93 1,625.93 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% LLQDFFNGR 95.00% 2.47 0.365 1.14 555.2889 1,108.56 1,109.57 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% LLQDFFNGR 95.00% 2.88 0.381 1.21 555.2899 1,108.56 1,109.57 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% ATAGDTHLGGEDFDNR 95.00% 3.15 0.557 1.72 559.2468 1,674.72 1,675.73 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% ATAGDTHLGGEDFDNR 95.00% 3.36 0.564 0 559.2485 1,674.72 1,675.73 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% HWPFQVINDGDKPK 95.00% 4.83 0.498 2.01 560.9535 1,679.84 1,680.85 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% HWPFQVINDGDKPK 95.00% 4.09 0.501 2.15 560.9542 1,679.84 1,680.85 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% HWPFQVINDGDKPK 95.00% 4.09 0.508 3.06 560.9549 1,679.84 1,680.85 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% HWPFQVINDGDKPK 95.00% 4.76 0.485 2.17 561.2889 1,680.84 1,680.85 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% IINEPTAAAIAYGLDR 95.00% 3.79 0.49 2.7 563.3042 1,686.89 1,687.90 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% IINEPTAAAIAYGLDR 95.00% 4.12 0.525 3 563.3045 1,686.89 1,687.90 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% DAGVIAGLNVLR 95.00% 2.64 0.387 2.25 599.3494 1,196.68 1,197.70 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% DAGVIAGLNVLR 95.00% 3.85 0.36 3.15 599.3506 1,196.69 1,197.70 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% DAGVIAGLNVLR 95.00% 3.71 0.358 2.57 599.3506 1,196.69 1,197.70 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% DAGVIAGLNVLR 95.00% 4.08 0.409 2.96 599.3509 1,196.69 1,197.70 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% DAGVIAGLNVLR 95.00% 3.9 0.378 3.05 599.351 1,196.69 1,197.70 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% NQVALNPQNTVFDAKR 95.00% 2.58 0.333 0 605.6548 1,813.94 1,814.95 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% NQVALNPQNTVFDAKR 95.00% 2.17 0.437 0 605.9896 1,814.95 1,814.95 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% LVNHFVEEFK 95.00% 2.81 0.366 2.42 631.326 1,260.64 1,261.66 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% LVNHFVEEFK 95.00% 2.88 0.465 1.3 631.3311 1,260.65 1,261.66 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% LVNHFVEEFK 95.00% 2.68 0.504 1.74 631.3322 1,260.65 1,261.66 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% NALESYAFNMK 95.00% 3.3 0.405 3.44 644.3048 1,286.59 1,287.60 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% NALESYAFNMK 95.00% 3.27 0.411 3.03 644.3048 1,286.59 1,287.60 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% MVQEAEKYKAEDEVQR 95.00% 3.52 0.43 2.23 651.6494 1,951.92 1,952.94 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% MVQEAEKYKAEDEVQR 95.00% 3.96 0.444 1.51 651.6503 1,951.93 1,952.94 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% MVQEAEKYKAEDEVQR 95.00% 4.11 0.447 1.52 651.6515 1,951.93 1,952.94 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% MVQEAEKYKAEDEVQR 95.00% 3.12 0.441 0 651.9844 1,952.93 1,952.94 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% mVQEAEKYKAEDEVQR 95.00% 3.33 0.436 0 m1: Oxidation (+15.99) 657.3169 1,968.93 1,968.93 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% mVQEAEKYKAEDEVQR 95.00% 3.28 0.294 1.25 m1: Oxidation (+15.99) 657.3174 1,968.93 1,968.93 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% KFGDPVVQSDMK 95.00% 3.01 0.463 3.17 675.8389 1,349.66 1,350.67 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% KFGDPVVQSDMK 95.00% 3.14 0.465 3.64 675.8404 1,349.67 1,350.67 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% LVNHFVEEFKR 95.00% 2.2 0.373 1.77 709.3785 1,416.74 1,417.76 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% TTPSYVAFTDTER 95.00% 3.39 0.615 3.1 744.3513 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% TTPSYVAFTDTER 95.00% 3.52 0.637 3.09 744.3529 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% TTPSYVAFTDTER 95.00% 3.64 0.636 3.7 744.3532 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% TTPSYVAFTDTER 95.00% 3.54 0.644 2.92 744.354 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% MVQEAEKYKAEDEVQRER 95.00% 0 0 4.01 747.0328 2,238.07 2,238.08 3
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% LLQDFFNGRDLNK 95.00% 3.76 0.297 0 790.4124 1,578.81 1,579.82 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% LLQDFFNGRDLNK 95.00% 3.91 0.297 1.35 790.4161 1,578.82 1,579.82 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% AFYPEEISSMVLTK 95.00% 4.84 0.666 6.18 807.907 1,613.80 1,614.81 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% AFYPEEISSMVLTK 95.00% 3.89 0.585 4.96 807.9082 1,613.80 1,614.81 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% AFYPEEISSMVLTK 95.00% 3.85 0.568 5.33 807.9096 1,613.80 1,614.81 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% AFYPEEISSMVLTK 95.00% 3.74 0.564 7.46 808.4104 1,614.81 1,614.81 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% NQVALNPQNTVFDAK 95.00% 4.88 0.555 7.6 829.927 1,657.84 1,658.85 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% NQVALNPQNTVFDAK 95.00% 4.78 0.519 4.42 829.9279 1,657.84 1,658.85 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% NQVALNPQNTVFDAK 95.00% 4.79 0.577 4.48 829.9282 1,657.84 1,658.85 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% NQVALNPQNTVFDAK 95.00% 4.89 0.523 4.4 829.9301 1,657.84 1,658.85 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% ATAGDTHLGGEDFDNR 95.00% 4.11 0.54 3.32 838.3684 1,674.72 1,675.73 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% ATAGDTHLGGEDFDNR 95.00% 4.85 0.596 3.7 838.3692 1,674.72 1,675.73 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% ATAGDTHLGGEDFDNR 95.00% 4.87 0.585 4.23 838.3695 1,674.72 1,675.73 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% IINEPTAAAIAYGLDR 95.00% 4.34 0.605 4.47 844.4482 1,686.88 1,687.90 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% IINEPTAAAIAYGLDR 95.00% 5.38 0.644 7.03 844.4526 1,686.89 1,687.90 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% IINEPTAAAIAYGLDR 95.00% 5.48 0.651 6.7 844.4528 1,686.89 1,687.90 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% IINEPTAAAIAYGLDR 95.00% 4.81 0.57 6.02 844.9534 1,687.89 1,687.90 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% NQVALNPQNTVFDAKR 95.00% 4.69 0.499 3.6 908.4809 1,814.95 1,814.95 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% NQVALNPQNTVFDAKR 95.00% 4.68 0.497 4.04 908.4815 1,814.95 1,814.95 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% LDKAQIHDLVLVGGSTR 95.00% 4.49 0.584 4.89 911.5119 1,821.01 1,822.02 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% LDKAQIHDLVLVGGSTR 95.00% 4.96 0.634 4.7 912.0064 1,822.00 1,822.02 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% MVQEAEKYKAEDEVQR 95.00% 4.75 0.477 5 976.9737 1,951.93 1,952.94 2
 SAMPLE 2 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 19 27 69 29.20% MVQEAEKYKAEDEVQR 95.00% 4.86 0.426 4.57 977.474 1,952.93 1,952.94 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% KFGDPVVQSDMK 95.00% 2.56 0.269 0 450.8956 1,349.66 1,350.67 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% KFGDPVVQSDMK 95.00% 2.82 0.159 0 450.8959 1,349.66 1,350.67 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% AFYPEEISSMVLTK 95.00% 4.68 0.414 3.26 538.9414 1,613.80 1,614.81 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% AFYPEEISSMVLTK 95.00% 4.75 0.409 3.57 539.2742 1,614.80 1,614.81 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% AFYPEEISSMVLTK 95.00% 4.43 0.422 2.1 539.2762 1,614.81 1,614.81 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% QATKDAGVIAGLNVLR 95.00% 2.72 0.233 1.51 542.6474 1,624.92 1,625.93 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% QATKDAGVIAGLNVLR 95.00% 3.04 0.286 1.46 542.6479 1,624.92 1,625.93 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% LLQDFFNGR 95.00% 2.93 0.383 0 555.2888 1,108.56 1,109.57 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% LLQDFFNGR 95.00% 3.11 0.435 0 555.2889 1,108.56 1,109.57 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% LLQDFFNGR 95.00% 3.02 0.441 0 555.2899 1,108.56 1,109.57 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% LLQDFFNGR 95.00% 2.65 0.396 0 555.2907 1,108.57 1,109.57 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% ATAGDTHLGGEDFDNR 95.00% 2.52 0.385 0.959 559.2471 1,674.72 1,675.73 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% ATAGDTHLGGEDFDNR 95.00% 3.27 0.456 1.35 559.2479 1,674.72 1,675.73 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% HWPFQVINDGDKPK 95.00% 4.71 0.525 0 560.9535 1,679.84 1,680.85 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% HWPFQVINDGDKPK 95.00% 4.29 0.486 1.55 560.9537 1,679.84 1,680.85 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% HWPFQVINDGDKPK 95.00% 4.54 0.539 1.64 560.9542 1,679.84 1,680.85 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% HWPFQVINDGDKPK 95.00% 4.47 0.561 2.33 560.9547 1,679.84 1,680.85 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% IINEPTAAAIAYGLDR 95.00% 4.53 0.575 3.52 563.3044 1,686.89 1,687.90 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% IINEPTAAAIAYGLDR 95.00% 4.53 0.527 3.11 563.3047 1,686.89 1,687.90 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% DAGVIAGLNVLR 95.00% 2.72 0.283 0 599.3432 1,196.67 1,197.70 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% DAGVIAGLNVLR 95.00% 2.52 0.265 0 599.3441 1,196.67 1,197.70 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% DAGVIAGLNVLR 95.00% 3.58 0.379 1.89 599.3488 1,196.68 1,197.70 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% DAGVIAGLNVLR 95.00% 3.7 0.352 2.36 599.3493 1,196.68 1,197.70 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% DAGVIAGLNVLR 95.00% 3.77 0.362 3 599.3506 1,196.69 1,197.70 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% DAGVIAGLNVLR 95.00% 3.02 0.321 1.89 599.3506 1,196.69 1,197.70 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% DAGVIAGLNVLR 95.00% 3.83 0.387 3.27 599.3507 1,196.69 1,197.70 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% LVNHFVEEFK 95.00% 2.15 0.454 0 631.3297 1,260.64 1,261.66 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% LVNHFVEEFK 95.00% 2.04 0.388 1.37 631.3299 1,260.64 1,261.66 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% NALESYAFNMK 95.00% 2.94 0.425 2.77 644.3047 1,286.59 1,287.60 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% MVQEAEKYKAEDEVQR 95.00% 3.67 0.501 1.29 651.6505 1,951.93 1,952.94 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% MVQEAEKYKAEDEVQR 95.00% 3.62 0.485 1.82 651.9846 1,952.93 1,952.94 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% MVQEAEKYKAEDEVQR 95.00% 3.02 0.446 0 651.9852 1,952.93 1,952.94 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% mVQEAEKYKAEDEVQR 95.00% 2.41 0.196 0 m1: Oxidation (+15.99) 656.9832 1,967.93 1,968.93 3
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% KFGDPVVQSDMK 95.00% 3.01 0.43 2.66 675.8391 1,349.66 1,350.67 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% KFGDPVVQSDMK 95.00% 3.06 0.401 4.25 675.8396 1,349.66 1,350.67 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% TTPSYVAFTDTER 95.00% 3.84 0.57 4.55 744.3519 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% TTPSYVAFTDTER 95.00% 3.63 0.598 4.06 744.3532 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% TTPSYVAFTDTER 95.00% 3.19 0.617 3.92 744.3537 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% TTPSYVAFTDTER 95.00% 3.32 0.641 4.02 744.354 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% LLQDFFNGRDLNK 95.00% 3.85 0.266 1.43 790.4149 1,578.81 1,579.82 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% LLQDFFNGRDLNK 95.00% 3.76 0.25 0 790.4167 1,578.82 1,579.82 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% AFYPEEISSMVLTK 95.00% 3.91 0.597 8.28 807.9077 1,613.80 1,614.81 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% AFYPEEISSMVLTK 95.00% 3.19 0.4 6.3 807.9079 1,613.80 1,614.81 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% AFYPEEISSMVLTK 95.00% 4.06 0.588 5.85 807.908 1,613.80 1,614.81 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% AFYPEEISSMVLTK 95.00% 3.77 0.573 6.54 808.407 1,614.80 1,614.81 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% AFYPEEISSMVLTK 95.00% 0 0 4.43 809.4803 1,616.95 1,614.81 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% NQVALNPQNTVFDAK 95.00% 4.92 0.509 6 829.9276 1,657.84 1,658.85 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% NQVALNPQNTVFDAK 95.00% 5.24 0.558 5.06 829.9279 1,657.84 1,658.85 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% NQVALNPQNTVFDAK 95.00% 4.76 0.496 5.12 830.4305 1,658.85 1,658.85 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% NQVALNPQNTVFDAK 95.00% 4.65 0.506 5.62 830.4314 1,658.85 1,658.85 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% ATAGDTHLGGEDFDNR 95.00% 4.15 0.582 3.82 838.369 1,674.72 1,675.73 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% ATAGDTHLGGEDFDNR 95.00% 4.31 0.554 3.52 838.3694 1,674.72 1,675.73 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% ATAGDTHLGGEDFDNR 95.00% 4.53 0.561 2.8 838.8698 1,675.72 1,675.73 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% IINEPTAAAIAYGLDR 95.00% 4.49 0.585 5.38 844.4502 1,686.88 1,687.90 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% IINEPTAAAIAYGLDR 95.00% 5.22 0.65 7.33 844.4508 1,686.89 1,687.90 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% IINEPTAAAIAYGLDR 95.00% 5.37 0.647 6.89 844.4513 1,686.89 1,687.90 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% IINEPTAAAIAYGLDR 95.00% 4.57 0.581 5.3 844.4514 1,686.89 1,687.90 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% NQVALNPQNTVFDAKR 95.00% 4.7 0.562 5.33 907.9789 1,813.94 1,814.95 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% NQVALNPQNTVFDAKR 95.00% 5.07 0.551 5.57 908.4812 1,814.95 1,814.95 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% MVQEAEKYKAEDEVQR 95.00% 4.79 0.424 3.64 976.9678 1,951.92 1,952.94 2
 SAMPLE 2R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 15 20 61 26.10% MVQEAEKYKAEDEVQR 95.00% 4.6 0.429 2.68 977.4719 1,952.93 1,952.94 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LVNHFVEEFKR 95.00% 2.85 0.367 0 473.2569 1,416.75 1,417.76 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LVNHFVEEFKR 95.00% 2.66 0.403 0 473.2577 1,416.75 1,417.76 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% ITITNDKGR 95.00% 2.31 0.362 0 509.2911 1,016.57 1,017.57 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LLQDFFNGRDLNK 95.00% 2.09 0.302 0 527.2781 1,578.81 1,579.82 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LLQDFFNGRDLNK 95.00% 2.34 0.379 0 527.6121 1,579.81 1,579.82 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% AFYPEEISSMVLTK 95.00% 4.57 0.385 2.68 538.9399 1,613.80 1,614.81 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% AFYPEEISSMVLTK 95.00% 5.46 0.439 3.07 538.9402 1,613.80 1,614.81 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LLQDFFNGR 95.00% 2.05 0.41 0 555.2893 1,108.56 1,109.57 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LLQDFFNGR 95.00% 2.69 0.222 1.11 555.7817 1,109.55 1,109.57 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% ATAGDTHLGGEDFDNR 95.00% 3.41 0.583 0 559.2469 1,674.72 1,675.73 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% ATAGDTHLGGEDFDNR 95.00% 2.72 0.498 0 559.2475 1,674.72 1,675.73 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% ATAGDTHLGGEDFDNR 95.00% 3.31 0.556 2.89 559.248 1,674.72 1,675.73 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% ATAGDTHLGGEDFDNR 95.00% 3.3 0.521 2.82 559.2481 1,674.72 1,675.73 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% ATAGDTHLGGEDFDNR 95.00% 2.97 0.491 1.12 559.2485 1,674.72 1,675.73 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% ATAGDTHLGGEDFDNR 95.00% 3.2 0.485 1.15 559.5822 1,675.72 1,675.73 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% HWPFQVINDGDKPK 95.00% 3.41 0.508 1.52 560.9534 1,679.84 1,680.85 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% HWPFQVINDGDKPK 95.00% 4.22 0.484 1.42 560.9538 1,679.84 1,680.85 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% HWPFQVINDGDKPK 95.00% 4.6 0.459 2 561.2902 1,680.85 1,680.85 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% HWPFQVINDGDKPK 95.00% 4.1 0.506 1.07 561.2902 1,680.85 1,680.85 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% IINEPTAAAIAYGLDR 95.00% 4.67 0.595 2.82 563.3032 1,686.89 1,687.90 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% IINEPTAAAIAYGLDR 95.00% 3.26 0.41 0 563.3052 1,686.89 1,687.90 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% IINEPTAAAIAYGLDR 95.00% 4.47 0.5 3.96 563.6394 1,687.89 1,687.90 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% IINEPTAAAIAYGLDR 95.00% 3.89 0.375 1.34 563.6397 1,687.90 1,687.90 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% VQVSYKGETK 95.00% 2.12 0.258 0 569.8105 1,137.61 1,138.61 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% DAGVIAGLNVLR 95.00% 3.94 0.377 2.74 599.35 1,196.68 1,197.70 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% DAGVIAGLNVLR 95.00% 3.07 0.371 1.7 599.3501 1,196.68 1,197.70 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% DAGVIAGLNVLR 95.00% 3.66 0.388 3.19 599.3503 1,196.69 1,197.70 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% DAGVIAGLNVLR 95.00% 3.69 0.343 2.21 599.3505 1,196.69 1,197.70 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% DAGVIAGLNVLR 95.00% 3.86 0.338 2.26 599.3507 1,196.69 1,197.70 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% NQVALNPQNTVFDAKR 95.00% 2.25 0.305 0 605.6541 1,813.94 1,814.95 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% NQVALNPQNTVFDAKR 95.00% 2.58 0.262 0 605.6544 1,813.94 1,814.95 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% NQVALNPQNTVFDAKR 95.00% 1.93 0.362 0 605.6553 1,813.94 1,814.95 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% NQVALNPQNTVFDAKR 95.00% 2.3 0.253 0 605.9882 1,814.94 1,814.95 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LDKAQIHDLVLVGGSTR 95.00% 3.43 0.276 1.62 608.3441 1,822.01 1,822.02 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LDKAQIHDLVLVGGSTR 95.00% 4.67 0.388 3.11 608.3445 1,822.01 1,822.02 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LVNHFVEEFK 95.00% 2.33 0.374 1.28 631.3348 1,260.65 1,261.66 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LVNHFVEEFK 95.00% 2.96 0.418 0 631.8329 1,261.65 1,261.66 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% NALESYAFNMK 95.00% 3.02 0.375 2.77 644.3039 1,286.59 1,287.60 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% MVQEAEKYKAEDEVQR 95.00% 3.69 0.491 1.8 651.6459 1,951.91 1,952.94 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% MVQEAEKYKAEDEVQR 95.00% 4.18 0.478 1.57 651.65 1,951.93 1,952.94 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% MVQEAEKYKAEDEVQR 95.00% 3.56 0.493 0 651.6526 1,951.93 1,952.94 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% MVQEAEKYKAEDEVQR 95.00% 3.14 0.274 0 651.9841 1,952.93 1,952.94 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% MVQEAEKYKAEDEVQR 95.00% 3.37 0.434 0 651.9855 1,952.93 1,952.94 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% mVQEAEKYKAEDEVQR 95.00% 2.73 0.316 1.74 m1: Oxidation (+15.99) 657.3172 1,968.93 1,968.93 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% KFGDPVVQSDMK 95.00% 3.12 0.427 2.96 675.8385 1,349.66 1,350.67 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% KFGDPVVQSDMK 95.00% 3.2 0.445 2.01 675.839 1,349.66 1,350.67 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LVNHFVEEFKR 95.00% 2.75 0.401 1.74 709.3818 1,416.75 1,417.76 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LVNHFVEEFKR 95.00% 2.45 0.275 1.68 709.3819 1,416.75 1,417.76 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% AQIHDLVLVGGSTR 95.00% 4.21 0.625 4.6 733.4093 1,464.80 1,465.81 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% AQIHDLVLVGGSTR 95.00% 3.79 0.588 4.28 733.4094 1,464.80 1,465.81 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% TTPSYVAFTDTER 95.00% 3.37 0.63 3.44 744.3532 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% TTPSYVAFTDTER 95.00% 3.94 0.596 3.62 744.3535 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% TTPSYVAFTDTER 95.00% 3.55 0.664 3.68 744.3536 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% TTPSYVAFTDTER 95.00% 2.36 0.396 1.64 744.3555 1,486.70 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% TTPSYVAFTDTER 95.00% 2.61 0.401 2.96 744.3558 1,486.70 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% TTPSYVAFTDTER 95.00% 2.88 0.497 3.44 744.3578 1,486.70 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% TTPSYVAFTDTER 95.00% 2.96 0.606 1.7 744.8549 1,487.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% TTPSYVAFTDTER 95.00% 4.02 0.578 3.18 744.8557 1,487.70 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% AAAIGIDLGTTYScVGVFQHGK 95.00% 3.31 0.487 3.7 c14: Carbamidomethyl (+57.02) 756.0478 2,265.12 2,265.13 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% AAAIGIDLGTTYScVGVFQHGK 95.00% 2.84 0.391 0 c14: Carbamidomethyl (+57.02) 756.0496 2,265.13 2,265.13 3
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% ARFEELcSDLFR 95.00% 3.93 0.443 3.82 c7: Carbamidomethyl (+57.02) 771.8716 1,541.73 1,542.74 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% ARFEELcSDLFR 95.00% 4.01 0.407 3.89 c7: Carbamidomethyl (+57.02) 771.8716 1,541.73 1,542.74 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LLQDFFNGRDLNK 95.00% 3.41 0.216 0 790.4124 1,578.81 1,579.82 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LLQDFFNGRDLNK 95.00% 3.37 0.238 0 790.4141 1,578.81 1,579.82 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% AFYPEEISSMVLTK 95.00% 4 0.605 5.42 807.9063 1,613.80 1,614.81 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% AFYPEEISSMVLTK 95.00% 4.12 0.606 5.85 807.9065 1,613.80 1,614.81 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% AFYPEEISSMVLTK 95.00% 3.71 0.269 4.54 807.9101 1,613.80 1,614.81 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% NQVALNPQNTVFDAK 95.00% 5.63 0.57 5.31 829.9273 1,657.84 1,658.85 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% NQVALNPQNTVFDAK 95.00% 4.89 0.503 6.36 829.9284 1,657.84 1,658.85 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% NQVALNPQNTVFDAK 95.00% 4.96 0.569 4.85 830.4292 1,658.84 1,658.85 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% NQVALNPQNTVFDAK 95.00% 5.07 0.522 5.52 830.4304 1,658.85 1,658.85 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% ATAGDTHLGGEDFDNR 95.00% 4.81 0.594 5.51 838.3681 1,674.72 1,675.73 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% ATAGDTHLGGEDFDNR 95.00% 4.99 0.559 4.8 838.3682 1,674.72 1,675.73 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% HWPFQVINDGDKPK 95.00% 3.85 0.513 2.28 840.9258 1,679.84 1,680.85 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% HWPFQVINDGDKPK 95.00% 4.02 0.46 3.44 840.9279 1,679.84 1,680.85 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% IINEPTAAAIAYGLDR 95.00% 3.95 0.535 3.38 844.4499 1,686.88 1,687.90 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% IINEPTAAAIAYGLDR 95.00% 5.59 0.678 7.92 844.4525 1,686.89 1,687.90 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% IINEPTAAAIAYGLDR 95.00% 5.54 0.637 7.82 844.4526 1,686.89 1,687.90 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% NQVALNPQNTVFDAKR 95.00% 4.93 0.562 5.19 907.9759 1,813.94 1,814.95 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% NQVALNPQNTVFDAKR 95.00% 5.1 0.506 4.85 907.9771 1,813.94 1,814.95 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LDKAQIHDLVLVGGSTR 95.00% 4.4 0.619 4.28 911.5099 1,821.00 1,822.02 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% LDKAQIHDLVLVGGSTR 95.00% 5.01 0.632 3.96 912.0128 1,822.01 1,822.02 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% MVQEAEKYKAEDEVQR 95.00% 4.72 0.472 4.74 977.4731 1,952.93 1,952.94 2
 SAMPLE 3 Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 21 30 84 36.50% MVQEAEKYKAEDEVQR 95.00% 4.69 0.454 4.64 977.474 1,952.93 1,952.94 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% KFGDPVVQSDMK 95.00% 2.83 0.248 0 450.8969 1,349.67 1,350.67 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LVNHFVEEFKR 95.00% 2.96 0.281 0 473.257 1,416.75 1,417.76 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LVNHFVEEFKR 95.00% 2.41 0.358 0 473.2576 1,416.75 1,417.76 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% AQIHDLVLVGGSTR 95.00% 2.67 0.166 0 489.2746 1,464.80 1,465.81 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% AQIHDLVLVGGSTR 95.00% 3.06 0.341 0 489.6094 1,465.80 1,465.81 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% AFYPEEISSMVLTK 95.00% 5.09 0.466 4.74 538.94 1,613.80 1,614.81 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% AFYPEEISSMVLTK 95.00% 4.48 0.46 2.72 538.9406 1,613.80 1,614.81 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LLQDFFNGR 95.00% 2.97 0.384 1.85 555.2895 1,108.56 1,109.57 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LLQDFFNGR 95.00% 2.95 0.406 1.4 555.2899 1,108.56 1,109.57 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LLQDFFNGR 95.00% 3.14 0.405 0 555.2899 1,108.56 1,109.57 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LLQDFFNGR 95.00% 2.74 0.345 1.23 555.2904 1,108.57 1,109.57 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% ATAGDTHLGGEDFDNR 95.00% 2.76 0.39 0 559.2451 1,674.71 1,675.73 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% ATAGDTHLGGEDFDNR 95.00% 3.16 0.462 0 559.2462 1,674.72 1,675.73 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% ATAGDTHLGGEDFDNR 95.00% 2.29 0.251 0 559.2462 1,674.72 1,675.73 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% ATAGDTHLGGEDFDNR 95.00% 2.7 0.59 1.85 559.2476 1,674.72 1,675.73 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% ATAGDTHLGGEDFDNR 95.00% 2.44 0.308 0 559.5826 1,675.72 1,675.73 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% HWPFQVINDGDKPK 95.00% 4.64 0.499 2.12 560.954 1,679.84 1,680.85 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% HWPFQVINDGDKPK 95.00% 4.07 0.524 0 560.9545 1,679.84 1,680.85 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% HWPFQVINDGDKPK 95.00% 2.53 0.34 0.959 561.2944 1,680.86 1,680.85 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% HWPFQVINDGDKPK 95.00% 2.44 0.371 0 561.2947 1,680.86 1,680.85 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% IINEPTAAAIAYGLDR 95.00% 3.39 0.233 0 563.3042 1,686.89 1,687.90 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% IINEPTAAAIAYGLDR 95.00% 3.05 0.343 0 563.3044 1,686.89 1,687.90 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% IINEPTAAAIAYGLDR 95.00% 4.46 0.517 1.89 563.3044 1,686.89 1,687.90 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% IINEPTAAAIAYGLDR 95.00% 4.53 0.492 2.82 563.6392 1,687.89 1,687.90 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% VQVSYKGETK 95.00% 2.55 0.4 0 569.81 1,137.60 1,138.61 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 2.05 0.299 1.07 599.3485 1,196.68 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 3.62 0.35 2.54 599.3487 1,196.68 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 3.52 0.369 2.36 599.3498 1,196.68 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 3.66 0.359 2.33 599.3501 1,196.68 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 3.72 0.373 2 599.3504 1,196.69 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 2.34 0.309 1.15 599.3507 1,196.69 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 3.22 0.354 2.01 599.351 1,196.69 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 3.42 0.394 1.27 599.3512 1,196.69 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 3.17 0.361 1.09 599.3513 1,196.69 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 2.4 0.316 0 599.3514 1,196.69 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 3.09 0.343 0 599.3517 1,196.69 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 2.64 0.344 2.31 599.3526 1,196.69 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% DAGVIAGLNVLR 95.00% 2.67 0.349 2.74 599.3528 1,196.69 1,197.70 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% NQVALNPQNTVFDAKR 95.00% 2.15 0.258 0 605.9887 1,814.94 1,814.95 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% NQVALNPQNTVFDAKR 95.00% 2.34 0.403 0 605.9891 1,814.94 1,814.95 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% VEIIANDQGNR 94.50% 0 0 3.11 615.9706 1,229.93 1,228.63 2 HSP7C_HUMAN,HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LVNHFVEEFK 95.00% 2.75 0.442 1.34 631.3332 1,260.65 1,261.66 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LVNHFVEEFK 95.00% 2.59 0.368 1.68 631.3352 1,260.65 1,261.66 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% NALESYAFNMK 95.00% 3.08 0.441 2.46 644.3004 1,286.59 1,287.60 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% NALESYAFNMK 95.00% 3.44 0.477 2.32 644.3035 1,286.59 1,287.60 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% MVQEAEKYKAEDEVQR 95.00% 3.92 0.439 1.77 651.9844 1,952.93 1,952.94 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% MVQEAEKYKAEDEVQR 95.00% 3.75 0.444 0 651.9849 1,952.93 1,952.94 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% mVQEAEKYKAEDEVQR 95.00% 3.81 0.385 1.68 m1: Oxidation (+15.99) 657.317 1,968.93 1,968.93 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% mVQEAEKYKAEDEVQR 95.00% 3.83 0.416 0 m1: Oxidation (+15.99) 657.3178 1,968.93 1,968.93 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% KFGDPVVQSDMK 95.00% 3.27 0.451 4.27 675.838 1,349.66 1,350.67 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% KFGDPVVQSDMK 95.00% 3.48 0.421 2.92 675.8394 1,349.66 1,350.67 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LVNHFVEEFKR 95.00% 2.21 0.331 1.32 709.3827 1,416.75 1,417.76 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LVNHFVEEFKR 95.00% 2.43 0.351 1.82 709.3846 1,416.75 1,417.76 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% AQIHDLVLVGGSTR 95.00% 4.26 0.628 4.17 733.4088 1,464.80 1,465.81 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% AQIHDLVLVGGSTR 95.00% 3.91 0.622 4.26 733.409 1,464.80 1,465.81 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% TTPSYVAFTDTER 95.00% 2.09 0.285 1.1 744.3509 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% TTPSYVAFTDTER 95.00% 3.57 0.629 4.89 744.3535 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% TTPSYVAFTDTER 95.00% 3.66 0.609 4.41 744.354 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% TTPSYVAFTDTER 95.00% 3.66 0.585 4.08 744.8543 1,487.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% TTPSYVAFTDTER 95.00% 4.03 0.582 4.24 744.8552 1,487.69 1,487.70 2 HSP7C_HUMAN,HSP72_HUMAN
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% AAAIGIDLGTTYScVGVFQHGK 95.00% 4.36 0.635 3.8 c14: Carbamidomethyl (+57.02) 756.0521 2,265.13 2,265.13 3
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LLQDFFNGRDLNK 95.00% 3.55 0.24 0 790.4153 1,578.81 1,579.82 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LLQDFFNGRDLNK 95.00% 3.78 0.272 2.24 790.916 1,579.82 1,579.82 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% AFYPEEISSMVLTK 95.00% 4.01 0.606 8.57 807.9067 1,613.80 1,614.81 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% AFYPEEISSMVLTK 95.00% 3.1 0.177 3.38 807.9078 1,613.80 1,614.81 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% AFYPEEISSMVLTK 95.00% 4.24 0.562 5.48 808.4075 1,614.80 1,614.81 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% AFYPEEISSMVLTK 95.00% 3.64 0.456 5.34 808.4101 1,614.80 1,614.81 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% NQVALNPQNTVFDAK 95.00% 4.96 0.54 6.44 829.9282 1,657.84 1,658.85 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% NQVALNPQNTVFDAK 95.00% 4.57 0.557 4.54 829.9289 1,657.84 1,658.85 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% NQVALNPQNTVFDAK 95.00% 4.93 0.501 5.21 829.929 1,657.84 1,658.85 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% NQVALNPQNTVFDAK 95.00% 4.76 0.545 5.02 829.9292 1,657.84 1,658.85 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% ATAGDTHLGGEDFDNR 95.00% 4.98 0.586 3.92 838.3682 1,674.72 1,675.73 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% ATAGDTHLGGEDFDNR 95.00% 4.92 0.6 3.92 838.3696 1,674.72 1,675.73 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% IINEPTAAAIAYGLDR 95.00% 3.86 0.536 6.37 844.4504 1,686.89 1,687.90 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% IINEPTAAAIAYGLDR 95.00% 5.25 0.634 6.34 844.4533 1,686.89 1,687.90 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% IINEPTAAAIAYGLDR 95.00% 4.24 0.518 5.12 844.4561 1,686.90 1,687.90 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% IINEPTAAAIAYGLDR 95.00% 4.24 0.536 5.31 844.4573 1,686.90 1,687.90 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% IINEPTAAAIAYGLDR 95.00% 5.74 0.64 6.85 844.956 1,687.90 1,687.90 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% NQVALNPQNTVFDAKR 95.00% 4.91 0.537 7.42 907.9784 1,813.94 1,814.95 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% NQVALNPQNTVFDAKR 95.00% 5.08 0.585 5.49 907.9791 1,813.94 1,814.95 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LDKAQIHDLVLVGGSTR 95.00% 4.91 0.625 4.89 912.0101 1,822.00 1,822.02 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% LDKAQIHDLVLVGGSTR 95.00% 4.81 0.625 6.62 912.013 1,822.01 1,822.02 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% MVQEAEKYKAEDEVQR 95.00% 4.7 0.425 4.16 977.4704 1,952.93 1,952.94 2
 SAMPLE 3R Heat shock 70 kDa protein 1  HSPA1A  HSP71_HUMAN 70,036.00 100.00% 20 28 84 34.90% MVQEAEKYKAEDEVQR 95.00% 4.74 0.435 4.74 977.4706 1,952.93 1,952.94 2
 SAMPLE 3R Heat shock 70 kDa protein 4  HSPA4  HSP74_HUMAN 94,313.90 99.80% 2 2 2 3.33% AGGIETIANEYSDR 95.00% 3.2 0.446 2.89 748.3544 1,494.69 1,495.70 2
 SAMPLE 3R Heat shock 70 kDa protein 4  HSPA4  HSP74_HUMAN 94,313.90 99.80% 2 2 2 3.33% NFTTEQVTAMLLSK 95.00% 3.42 0.282 3.38 791.9126 1,581.81 1,582.82 2
 SAMPLE 4 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 8 5.73% LLQDFFNGK 95.00% 2.21 0.26 0 541.2884 1,080.56 1,081.57 2 HSP72_HUMAN
 SAMPLE 4 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 8 5.73% STAGDTHLGGEDFDNR 95.00% 2.42 0.41 0 564.5831 1,690.73 1,691.73 3 HSP72_HUMAN
 SAMPLE 4 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 8 5.73% STAGDTHLGGEDFDNR 95.00% 2.38 0.438 0 564.5841 1,690.73 1,691.73 3 HSP72_HUMAN
 SAMPLE 4 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 8 5.73% STAGDTHLGGEDFDNR 95.00% 2.2 0.371 0 564.5845 1,690.73 1,691.73 3 HSP72_HUMAN
 SAMPLE 4 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 8 5.73% STAGDTHLGGEDFDNR 95.00% 2.51 0.511 0 564.9165 1,691.73 1,691.73 3 HSP72_HUMAN
 SAMPLE 4 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 8 5.73% DAGTIAGLNVLR 95.00% 2.94 0.322 1.96 600.3401 1,198.66 1,199.68 2
 SAMPLE 4 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 8 5.73% DAGTIAGLNVLR 95.00% 3.22 0.296 0 600.3427 1,198.67 1,199.68 2
 SAMPLE 4 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 8 5.73% DAGTIAGLNVLR 95.00% 2.71 0.295 1.7 600.3427 1,198.67 1,199.68 2
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% LLQDFFNGK 95.00% 2.04 0.266 0 541.287 1,080.56 1,081.57 2 HSP72_HUMAN
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% STAGDTHLGGEDFDNR 95.00% 1.61 0.345 0 564.5814 1,690.72 1,691.73 3 HSP72_HUMAN
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% STAGDTHLGGEDFDNR 95.00% 2.16 0.292 1.33 564.5847 1,690.73 1,691.73 3 HSP72_HUMAN
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% STAGDTHLGGEDFDNR 95.00% 2.47 0.402 0 564.9151 1,691.72 1,691.73 3 HSP72_HUMAN
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% STAGDTHLGGEDFDNR 95.00% 2.4 0.372 0 564.9161 1,691.72 1,691.73 3 HSP72_HUMAN
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% DAGTIAGLNVLR 95.00% 2.99 0.294 0 600.3422 1,198.67 1,199.68 2
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% DAGTIAGLNVLR 95.00% 3.05 0.284 0 600.3426 1,198.67 1,199.68 2
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% DAGTIAGLNVLR 95.00% 3.13 0.287 0 600.3429 1,198.67 1,199.68 2
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% DAGTIAGLNVLR 95.00% 2.77 0.252 2.6 600.3431 1,198.67 1,199.68 2
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% DAGTIAGLNVLR 95.00% 2.95 0.281 0 600.3437 1,198.67 1,199.68 2
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% DAGTIAGLNVLR 95.00% 3.05 0.301 0 600.3439 1,198.67 1,199.68 2
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% DAGTIAGLNVLR 95.00% 2.59 0.216 0 600.3443 1,198.67 1,199.68 2
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% DAGTIAGLNVLR 95.00% 3.05 0.284 2.01 600.345 1,198.67 1,199.68 2
 SAMPLE 4R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 3 3 13 7.74% TTPSYVAFTDTER 95.00% 3.05 0.362 1.19 744.8604 1,487.71 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% ARFEELNADLFR 95.00% 4.02 0.329 0 494.2553 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% ARFEELNADLFR 95.00% 4.24 0.251 0 494.5901 1,480.75 1,480.75 3 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% ARFEELNADLFR 95.00% 3.32 0.267 0 494.5903 1,480.75 1,480.75 3 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% LLQDFFNGKELNK 95.00% 2.14 0.328 0 522.614 1,564.82 1,565.83 3 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% LLQDFFNGKELNK 95.00% 2.64 0.382 0 522.6143 1,564.82 1,565.83 3 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% LLQDFFNGK 95.00% 2.25 0.33 1.33 541.2853 1,080.56 1,081.57 2 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% LLQDFFNGK 95.00% 3.01 0.381 1.66 541.2856 1,080.56 1,081.57 2 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% IINEPTAAAIAYGLDK 95.00% 4.55 0.507 2.96 553.9674 1,658.88 1,659.90 3 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% STAGDTHLGGEDFDNR 95.00% 2.61 0.521 0 564.5787 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% STAGDTHLGGEDFDNR 95.00% 2.78 0.45 1.42 564.5788 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% STAGDTHLGGEDFDNR 95.00% 2.72 0.477 0 564.579 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% STAGDTHLGGEDFDNR 95.00% 2.12 0.358 0 564.914 1,691.72 1,691.73 3 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% DAGTIAGLNVLR 95.00% 3.78 0.315 2.72 600.3396 1,198.66 1,199.68 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% DAGTIAGLNVLR 95.00% 3.83 0.339 3.06 600.3398 1,198.66 1,199.68 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% DAGTIAGLNVLR 95.00% 2.51 0.249 2.39 600.3398 1,198.66 1,199.68 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% NQVAMNPTNTVFDAKR 95.00% 2.55 0.375 0 602.636 1,804.88 1,805.90 3
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% MVNHFIAEFK 95.00% 2.92 0.36 1.49 618.3144 1,234.61 1,235.62 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% MVNHFIAEFK 95.00% 3.05 0.423 2.59 618.3169 1,234.62 1,235.62 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% MKEIAEAYLGK 95.00% 3.35 0.398 2.43 626.8324 1,251.65 1,252.66 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% MKEIAEAYLGK 95.00% 3.71 0.405 2.09 626.8325 1,251.65 1,252.66 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% NSLESYAFNMK 95.00% 3.68 0.58 2.02 652.3006 1,302.59 1,303.60 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% NSLESYAFNMK 95.00% 3.84 0.468 4.04 652.3011 1,302.59 1,303.60 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% TVTNAVVTVPAYFNDSQR 95.00% 3.33 0.376 1.03 661.336 1,980.98 1,982.00 3
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% TVTNAVVTVPAYFNDSQR 95.00% 3.21 0.407 0 661.3375 1,980.99 1,982.00 3
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% RFDDAVVQSDMK 95.00% 2.96 0.486 3.17 705.8363 1,409.66 1,410.67 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% RFDDAVVQSDMK 95.00% 2.77 0.414 2.68 705.8384 1,409.66 1,410.67 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% ARFEELNADLFR 95.00% 2.98 0.269 2.66 740.8799 1,479.74 1,480.75 2 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% ARFEELNADLFR 95.00% 2.88 0.275 3.26 740.8803 1,479.75 1,480.75 2 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% SQIHDIVLVGGSTR 95.00% 4.29 0.644 6.14 741.4073 1,480.80 1,481.81 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% SQIHDIVLVGGSTR 95.00% 4.25 0.615 6.06 741.4074 1,480.80 1,481.81 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% TTPSYVAFTDTER 95.00% 3.4 0.631 5.47 744.3509 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% TTPSYVAFTDTER 95.00% 2.89 0.583 2.8 744.3511 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% TTPSYVAFTDTER 95.00% 2.67 0.488 3.11 744.352 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% TTPSYVAFTDTER 95.00% 3.54 0.603 4.3 744.3521 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% TTPSYVAFTDTER 95.00% 3.49 0.642 4.89 744.3529 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% TTPSYVAFTDTER 95.00% 3.81 0.588 4.59 744.3532 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% TTPSYVAFTDTER 95.00% 3.18 0.591 2.27 744.3609 1,486.71 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% GPAVGIDLGTTYScVGVFQHGK 95.00% 5.16 0.384 5.8 c14: Carbamidomethyl (+57.02) 755.377 2,263.11 2,263.12 3
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% GPAVGIDLGTTYScVGVFQHGK 95.00% 4.89 0.413 4.41 c14: Carbamidomethyl (+57.02) 755.3773 2,263.11 2,263.12 3
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% LLQDFFNGKELNK 95.00% 4.44 0.332 3.25 783.4182 1,564.82 1,565.83 2 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% LLQDFFNGKELNK 95.00% 4.5 0.33 2.15 783.4184 1,564.82 1,565.83 2 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% SFYPEEVSSMVLTK 95.00% 4.64 0.541 5.57 809.3963 1,616.78 1,616.79 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% SFYPEEVSSMVLTK 95.00% 4.46 0.571 5.62 809.3977 1,616.78 1,616.79 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% STAGDTHLGGEDFDNR 95.00% 4.29 0.601 3.92 846.3653 1,690.72 1,691.73 2 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% STAGDTHLGGEDFDNR 95.00% 4.19 0.587 3.72 846.3665 1,690.72 1,691.73 2 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% IINEPTAAAIAYGLDKK 95.00% 5.03 0.571 6.62 894.4965 1,786.98 1,787.99 2 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% IINEPTAAAIAYGLDKK 95.00% 4.89 0.484 5.24 894.4972 1,786.98 1,787.99 2 HSP72_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% LDKSQIHDIVLVGGSTR 95.00% 4.76 0.654 5.96 919.5062 1,837.00 1,838.01 2 FIBB_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% LDKSQIHDIVLVGGSTR 95.00% 5.06 0.39 7.26 920.01 1,838.00 1,838.01 2 FIBB_HUMAN
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% TVTNAVVTVPAYFNDSQR 95.00% 3.92 0.432 2.59 991.4996 1,980.98 1,982.00 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% TVTNAVVTVPAYFNDSQR 95.00% 4.22 0.419 3.42 991.9983 1,981.98 1,982.00 2
 SAMPLE 1 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 16 20 44 33.10% TVTNAVVTVPAYFNDSQR 95.00% 2.92 0.349 0 992.0017 1,981.99 1,982.00 2
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% ARFEELNADLFR 95.00% 4.21 0.398 0 494.2554 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% ARFEELNADLFR 95.00% 4.17 0.414 0 494.256 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% LLQDFFNGK 95.00% 2.46 0.31 1.72 541.2855 1,080.56 1,081.57 2 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% LLQDFFNGK 95.00% 2.42 0.358 1.43 541.2877 1,080.56 1,081.57 2 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% STAGDTHLGGEDFDNR 95.00% 2.9 0.539 1.07 564.5779 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% STAGDTHLGGEDFDNR 95.00% 2.89 0.498 0 564.5786 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% STAGDTHLGGEDFDNR 95.00% 3.07 0.544 0 564.5792 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% STAGDTHLGGEDFDNR 95.00% 2.32 0.522 0 564.5796 1,690.72 1,691.73 3 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% DAGTIAGLNVLR 95.00% 3.59 0.309 2.77 600.3391 1,198.66 1,199.68 2
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% DAGTIAGLNVLR 95.00% 3.66 0.316 3 600.3396 1,198.66 1,199.68 2
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% MKEIAEAYLGK 95.00% 2.15 0.255 2.17 626.8325 1,251.65 1,252.66 2
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% MKEIAEAYLGK 95.00% 3.38 0.416 2.24 626.8331 1,251.65 1,252.66 2
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% FEELNADLFR 95.00% 2.55 0.368 2.59 627.3103 1,252.60 1,253.62 2 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% RFDDAVVQSDMK 95.00% 2.77 0.486 1.89 705.8353 1,409.65 1,410.67 2
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% RFDDAVVQSDMK 95.00% 2.77 0.426 1.85 705.8385 1,409.66 1,410.67 2
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% ARFEELNADLFR 95.00% 3.32 0.244 3.54 740.8796 1,479.74 1,480.75 2 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% ARFEELNADLFR 95.00% 3.14 0.305 3.09 740.8797 1,479.74 1,480.75 2 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% SQIHDIVLVGGSTR 95.00% 4.09 0.588 5.8 741.4055 1,480.80 1,481.81 2
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% SQIHDIVLVGGSTR 95.00% 4.17 0.625 5.89 741.4067 1,480.80 1,481.81 2
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% TTPSYVAFTDTER 95.00% 3.5 0.622 2.77 744.3537 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% TTPSYVAFTDTER 95.00% 3.44 0.637 3.2 744.354 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% TTPSYVAFTDTER 95.00% 3.18 0.591 1.82 744.3609 1,486.71 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% GPAVGIDLGTTYScVGVFQHGK 95.00% 3.83 0.458 3.82 c14: Carbamidomethyl (+57.02) 755.3771 2,263.11 2,263.12 3
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% LLQDFFNGKELNK 95.00% 4.11 0.348 2.29 783.4194 1,564.82 1,565.83 2 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% LLQDFFNGKELNK 95.00% 4.28 0.314 3.24 783.9226 1,565.83 1,565.83 2 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% SFYPEEVSSMVLTK 95.00% 3.9 0.565 3.82 808.896 1,615.78 1,616.79 2
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% SFYPEEVSSMVLTK 95.00% 4.7 0.575 4.15 809.398 1,616.78 1,616.79 2
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% IINEPTAAAIAYGLDK 95.00% 4.69 0.525 6.62 830.4483 1,658.88 1,659.90 2 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% IINEPTAAAIAYGLDK 95.00% 4.34 0.564 5.77 830.4503 1,658.88 1,659.90 2 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% STAGDTHLGGEDFDNR 95.00% 4.38 0.556 4.7 846.3647 1,690.71 1,691.73 2 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% STAGDTHLGGEDFDNR 95.00% 4.09 0.6 4.48 846.365 1,690.71 1,691.73 2 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% IINEPTAAAIAYGLDKK 95.00% 4.5 0.542 4.25 894.4989 1,786.98 1,787.99 2 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% IINEPTAAAIAYGLDKK 95.00% 4.58 0.506 5.36 895.0005 1,787.99 1,787.99 2 HSP72_HUMAN
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% TVTNAVVTVPAYFNDSQR 95.00% 4.08 0.39 3.1 991.9994 1,981.98 1,982.00 2
 SAMPLE 1R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 15 30 26.90% TVTNAVVTVPAYFNDSQR 95.00% 4.42 0.339 4.22 992.002 1,981.99 1,982.00 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% ARFEELNADLFR 95.00% 4.05 0.368 0 494.2545 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% ARFEELNADLFR 95.00% 3.61 0.444 0 494.2549 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% ARFEELNADLFR 95.00% 4.19 0.331 1.66 494.2555 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% ARFEELNADLFR 95.00% 4.01 0.379 0 494.2562 1,479.75 1,480.75 3 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% STAGDTHLGGEDFDNR 95.00% 2.63 0.447 0 564.5778 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% STAGDTHLGGEDFDNR 95.00% 2.95 0.564 0 564.579 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% STAGDTHLGGEDFDNR 95.00% 2.45 0.327 0 564.5795 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% STAGDTHLGGEDFDNR 95.00% 2.58 0.284 0 564.5795 1,690.72 1,691.73 3 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% DAGTIAGLNVLR 95.00% 2.91 0.325 0 600.3391 1,198.66 1,199.68 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% DAGTIAGLNVLR 95.00% 2.92 0.326 0 600.3399 1,198.66 1,199.68 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% DAGTIAGLNVLR 95.00% 3.67 0.327 1.49 600.3404 1,198.67 1,199.68 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% DAGTIAGLNVLR 95.00% 3.78 0.306 2.42 600.3405 1,198.67 1,199.68 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% MVNHFIAEFK 95.00% 2.49 0.288 1.24 618.3147 1,234.61 1,235.62 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% MKEIAEAYLGK 95.00% 3.64 0.386 2.22 626.8328 1,251.65 1,252.66 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% MKEIAEAYLGK 95.00% 3.65 0.411 1.92 626.8332 1,251.65 1,252.66 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% NSLESYAFNMK 95.00% 2.91 0.432 2.3 652.3011 1,302.59 1,303.60 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% NSLESYAFNMK 95.00% 3.64 0.542 2.35 652.3017 1,302.59 1,303.60 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% NSLESYAFNMK 95.00% 3.78 0.557 4.29 652.302 1,302.59 1,303.60 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% NSLESYAFNMK 95.00% 2.35 0.293 0 652.3022 1,302.59 1,303.60 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% RFDDAVVQSDMK 95.00% 2.86 0.43 2.27 705.8373 1,409.66 1,410.67 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% RFDDAVVQSDMK 95.00% 2.98 0.473 1.68 705.8374 1,409.66 1,410.67 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% ARFEELNADLFR 95.00% 3.21 0.203 2.43 740.8801 1,479.74 1,480.75 2 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% SQIHDIVLVGGSTR 95.00% 4.36 0.641 6.03 741.9101 1,481.80 1,481.81 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% TTPSYVAFTDTER 95.00% 3.39 0.615 3.1 744.3513 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% TTPSYVAFTDTER 95.00% 3.52 0.637 3.09 744.3529 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% TTPSYVAFTDTER 95.00% 3.64 0.636 3.7 744.3532 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% TTPSYVAFTDTER 95.00% 3.54 0.644 2.92 744.354 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% LLQDFFNGKELNK 95.00% 4.06 0.327 1.44 783.4215 1,564.83 1,565.83 2 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% LLQDFFNGKELNK 95.00% 4.21 0.375 2 783.4228 1,564.83 1,565.83 2 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% LLQDFFNGKELNK 95.00% 4.1 0.313 1.77 783.4233 1,564.83 1,565.83 2 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% SFYPEEVSSMVLTK 95.00% 4.33 0.539 4.66 808.8952 1,615.77 1,616.79 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% SFYPEEVSSMVLTK 95.00% 4.21 0.571 3.28 808.8966 1,615.78 1,616.79 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% IINEPTAAAIAYGLDK 95.00% 3.68 0.542 3.33 830.4495 1,658.88 1,659.90 2 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% IINEPTAAAIAYGLDK 95.00% 4.37 0.572 4.74 830.4498 1,658.88 1,659.90 2 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% STAGDTHLGGEDFDNR 95.00% 4.08 0.6 4.32 846.3642 1,690.71 1,691.73 2 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% STAGDTHLGGEDFDNR 95.00% 4.57 0.607 4.4 846.3651 1,690.71 1,691.73 2 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% STAGDTHLGGEDFDNR 95.00% 3.83 0.578 2.52 846.3686 1,690.72 1,691.73 2 HSP72_HUMAN
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% TVTNAVVTVPAYFNDSQR 95.00% 3.25 0.21 1.68 991.5027 1,980.99 1,982.00 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% TVTNAVVTVPAYFNDSQR 95.00% 3.51 0.338 2.62 992.0028 1,981.99 1,982.00 2
 SAMPLE 2 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 11 13 34 26.60% TVTNAVVTVPAYFNDSQR 95.00% 4.12 0.408 3.62 992.0042 1,981.99 1,982.00 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% ARFEELNADLFR 95.00% 3.84 0.383 0 494.2551 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% ARFEELNADLFR 95.00% 3.84 0.414 0 494.2556 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% ARFEELNADLFR 95.00% 4.05 0.395 0 494.5898 1,480.75 1,480.75 3 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% ARFEELNADLFR 95.00% 3.95 0.296 0 494.5902 1,480.75 1,480.75 3 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% LLQDFFNGKELNK 95.00% 2.43 0.35 0 522.6132 1,564.82 1,565.83 3 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% LLQDFFNGKELNK 95.00% 2.89 0.367 0 522.615 1,564.82 1,565.83 3 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% LLQDFFNGKELNK 95.00% 1.95 0.222 0 522.6155 1,564.82 1,565.83 3 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% LLQDFFNGKELNK 95.00% 2.27 0.312 0 522.9496 1,565.83 1,565.83 3 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% LLQDFFNGK 95.00% 2.91 0.307 1.15 541.2861 1,080.56 1,081.57 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% LLQDFFNGK 95.00% 2.95 0.329 1.17 541.287 1,080.56 1,081.57 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% STAGDTHLGGEDFDNR 95.00% 2.95 0.482 0 564.5791 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% STAGDTHLGGEDFDNR 95.00% 2.9 0.427 0 564.5801 1,690.72 1,691.73 3 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% STAGDTHLGGEDFDNR 95.00% 2.43 0.378 1.1 564.914 1,691.72 1,691.73 3 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% DAGTIAGLNVLR 95.00% 3.47 0.31 1.59 600.3386 1,198.66 1,199.68 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% DAGTIAGLNVLR 95.00% 3.39 0.318 1.44 600.3407 1,198.67 1,199.68 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% DAGTIAGLNVLR 95.00% 3.47 0.273 1.8 600.3409 1,198.67 1,199.68 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% DAGTIAGLNVLR 95.00% 3.21 0.295 1.31 600.8405 1,199.67 1,199.68 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% MVNHFIAEFK 95.00% 2.81 0.346 2.41 618.3133 1,234.61 1,235.62 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% MVNHFIAEFK 95.00% 2.87 0.3 1.85 618.315 1,234.61 1,235.62 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% MKEIAEAYLGK 95.00% 3.58 0.345 2.2 626.8335 1,251.65 1,252.66 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% FEELNADLFR 95.00% 2.15 0.344 1.33 627.3098 1,252.60 1,253.62 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% FEELNADLFR 95.00% 2.56 0.382 2.21 627.3111 1,252.61 1,253.62 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% TVTNAVVTVPAYFNDSQR 95.00% 3.35 0.464 0 661.6708 1,981.99 1,982.00 3
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% RFDDAVVQSDMK 95.00% 2.8 0.48 1.8 705.8361 1,409.66 1,410.67 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% RFDDAVVQSDMK 95.00% 2.85 0.413 1.92 705.8365 1,409.66 1,410.67 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% ARFEELNADLFR 95.00% 2.87 0.178 1.44 740.8789 1,479.74 1,480.75 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% ARFEELNADLFR 95.00% 2.53 0.153 1.17 740.8796 1,479.74 1,480.75 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% ARFEELNADLFR 95.00% 2.36 0.133 1.89 740.8802 1,479.74 1,480.75 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% ARFEELNADLFR 95.00% 2.84 0.19 1.52 740.8805 1,479.75 1,480.75 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% TTPSYVAFTDTER 95.00% 3.84 0.57 4.55 744.3519 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% TTPSYVAFTDTER 95.00% 3.63 0.598 4.06 744.3532 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% TTPSYVAFTDTER 95.00% 3.19 0.617 3.92 744.3537 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% TTPSYVAFTDTER 95.00% 3.32 0.641 4.02 744.354 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% GPAVGIDLGTTYScVGVFQHGK 95.00% 4.74 0.42 2.89 c14: Carbamidomethyl (+57.02) 755.3764 2,263.11 2,263.12 3
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% LLQDFFNGKELNK 95.00% 4.04 0.325 4.03 783.9215 1,565.83 1,565.83 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% LLQDFFNGKELNK 95.00% 3.75 0.336 2.8 783.922 1,565.83 1,565.83 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% SFYPEEVSSMVLTK 95.00% 4.36 0.514 6.51 808.8952 1,615.77 1,616.79 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% SFYPEEVSSMVLTK 95.00% 4.16 0.546 6.02 808.8957 1,615.78 1,616.79 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% IINEPTAAAIAYGLDK 95.00% 4.2 0.565 4.35 830.4476 1,658.88 1,659.90 2 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% IINEPTAAAIAYGLDK 95.00% 4.43 0.554 5.89 830.9518 1,659.89 1,659.90 2 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% STAGDTHLGGEDFDNR 95.00% 4.68 0.623 3.35 846.3647 1,690.71 1,691.73 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% STAGDTHLGGEDFDNR 95.00% 4.33 0.602 4.15 846.3654 1,690.72 1,691.73 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% IINEPTAAAIAYGLDKK 95.00% 5.09 0.531 6.21 894.498 1,786.98 1,787.99 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% IINEPTAAAIAYGLDKK 95.00% 4.65 0.497 5.05 895.002 1,787.99 1,787.99 2 HSP72_HUMAN
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% TVTNAVVTVPAYFNDSQR 95.00% 3.45 0.331 2.82 992.0024 1,981.99 1,982.00 2
 SAMPLE 2R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 13 17 40 26.30% TVTNAVVTVPAYFNDSQR 95.00% 3.8 0.42 3.72 992.0039 1,981.99 1,982.00 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% RFDDAVVQSDMK 95.00% 2.34 0.182 0 470.8935 1,409.66 1,410.67 3
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% RFDDAVVQSDMK 95.00% 2.46 0.251 0 470.8935 1,409.66 1,410.67 3
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% ARFEELNADLFR 95.00% 4.04 0.343 0 494.2552 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% ARFEELNADLFR 95.00% 4.24 0.371 0 494.5921 1,480.75 1,480.75 3 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% ITITNDKGR 95.00% 2.31 0.362 0 509.2911 1,016.57 1,017.57 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% LLQDFFNGK 95.00% 2.74 0.317 0 541.2861 1,080.56 1,081.57 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% LLQDFFNGK 95.00% 3.04 0.361 1.37 541.2864 1,080.56 1,081.57 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% STAGDTHLGGEDFDNR 95.00% 2.18 0.398 0 564.5788 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% STAGDTHLGGEDFDNR 95.00% 2.64 0.362 0 564.5795 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% STAGDTHLGGEDFDNR 95.00% 2.77 0.482 2.01 564.5796 1,690.72 1,691.73 3 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% STAGDTHLGGEDFDNR 95.00% 3.03 0.506 0 564.5797 1,690.72 1,691.73 3 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% STAGDTHLGGEDFDNR 95.00% 2.42 0.438 0 564.58 1,690.72 1,691.73 3 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% DAGTIAGLNVLR 95.00% 3.83 0.343 2.34 600.3401 1,198.66 1,199.68 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% DAGTIAGLNVLR 95.00% 3.86 0.311 2 600.3404 1,198.67 1,199.68 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% NQVAMNPTNTVFDAKR 95.00% 2.37 0.374 0 602.9702 1,805.89 1,805.90 3
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% MVNHFIAEFK 95.00% 2.7 0.341 0 618.312 1,234.61 1,235.62 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% MVNHFIAEFK 95.00% 2.64 0.439 0 618.317 1,234.62 1,235.62 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% MKEIAEAYLGK 95.00% 3.51 0.415 1.92 626.8327 1,251.65 1,252.66 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% MKEIAEAYLGK 95.00% 2.89 0.36 2.44 626.8332 1,251.65 1,252.66 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% NSLESYAFNMK 95.00% 3.5 0.46 2.82 652.3011 1,302.59 1,303.60 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% NSLESYAFNMK 95.00% 3.62 0.492 4.43 652.3017 1,302.59 1,303.60 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% NSLESYAFNMK 95.00% 3.85 0.6 2.8 652.3028 1,302.59 1,303.60 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% NSLESYAFNMK 95.00% 4.12 0.545 2.92 652.3034 1,302.59 1,303.60 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TVTNAVVTVPAYFNDSQR 95.00% 4.01 0.421 0 661.3363 1,980.99 1,982.00 3
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% RFDDAVVQSDMK 95.00% 2.83 0.516 2.96 705.8372 1,409.66 1,410.67 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% RFDDAVVQSDMK 95.00% 2.85 0.476 1.52 705.8377 1,409.66 1,410.67 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% RFDDAVVQSDMK 95.00% 2.89 0.522 0 705.838 1,409.66 1,410.67 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% ARFEELNADLFR 95.00% 3.05 0.375 3.08 740.88 1,479.74 1,480.75 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% ARFEELNADLFR 95.00% 3.16 0.342 2.96 740.8808 1,479.75 1,480.75 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% ARFEELNADLFR 95.00% 3.43 0.349 3.27 740.8813 1,479.75 1,480.75 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% ARFEELNADLFR 95.00% 3.45 0.361 3.57 740.8833 1,479.75 1,480.75 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% SQIHDIVLVGGSTR 95.00% 3.94 0.614 4.55 741.4079 1,480.80 1,481.81 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TTPSYVAFTDTER 95.00% 3.37 0.63 3.44 744.3532 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TTPSYVAFTDTER 95.00% 3.94 0.596 3.62 744.3535 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TTPSYVAFTDTER 95.00% 3.55 0.664 3.68 744.3536 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TTPSYVAFTDTER 95.00% 2.36 0.396 1.64 744.3555 1,486.70 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TTPSYVAFTDTER 95.00% 2.61 0.401 2.96 744.3558 1,486.70 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TTPSYVAFTDTER 95.00% 2.88 0.497 3.44 744.3578 1,486.70 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TTPSYVAFTDTER 95.00% 2.96 0.606 1.7 744.8549 1,487.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TTPSYVAFTDTER 95.00% 4.02 0.578 3.18 744.8557 1,487.70 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% LLQDFFNGKELNK 95.00% 3.93 0.353 1.52 783.4203 1,564.82 1,565.83 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% SFYPEEVSSMVLTK 95.00% 4.39 0.474 5.62 808.8953 1,615.77 1,616.79 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% SFYPEEVSSMVLTK 95.00% 3.84 0.495 5.57 808.8962 1,615.78 1,616.79 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% SFYPEEVSSMVLTK 95.00% 4.51 0.505 5.43 809.3982 1,616.78 1,616.79 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% SFYPEEVSSMVLTK 95.00% 4.62 0.549 5.49 809.3991 1,616.78 1,616.79 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% NQVAMNPTNTVFDAK 95.00% 4.45 0.517 7.66 825.4026 1,648.79 1,649.80 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% NQVAMNPTNTVFDAK 95.00% 4.67 0.437 6.13 825.9001 1,649.78 1,649.80 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% IINEPTAAAIAYGLDK 95.00% 4.86 0.569 4.89 830.4499 1,658.88 1,659.90 2 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% IINEPTAAAIAYGLDK 95.00% 4.83 0.587 6.51 830.4511 1,658.89 1,659.90 2 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% IINEPTAAAIAYGLDK 95.00% 4.73 0.599 5.57 830.4518 1,658.89 1,659.90 2 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% STAGDTHLGGEDFDNR 95.00% 4.71 0.589 5.7 846.3652 1,690.71 1,691.73 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% STAGDTHLGGEDFDNR 95.00% 4.22 0.611 6.57 846.3656 1,690.72 1,691.73 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% STAGDTHLGGEDFDNR 95.00% 4.19 0.622 6.3 846.3661 1,690.72 1,691.73 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% STAGDTHLGGEDFDNR 95.00% 4.72 0.619 5.68 846.3667 1,690.72 1,691.73 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% IINEPTAAAIAYGLDKK 95.00% 5.26 0.574 3.54 894.4957 1,786.98 1,787.99 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% IINEPTAAAIAYGLDKK 95.00% 4.85 0.55 4.37 894.4981 1,786.98 1,787.99 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% IINEPTAAAIAYGLDKK 95.00% 5.29 0.563 5.03 894.4984 1,786.98 1,787.99 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% IINEPTAAAIAYGLDKK 95.00% 5.17 0.554 5.07 894.9989 1,787.98 1,787.99 2 HSP72_HUMAN
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TVTNAVVTVPAYFNDSQR 95.00% 4.22 0.4 2.48 991.5007 1,980.99 1,982.00 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TVTNAVVTVPAYFNDSQR 95.00% 4.1 0.433 2.1 992.0018 1,981.99 1,982.00 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TVTNAVVTVPAYFNDSQR 95.00% 4.09 0.388 1.59 992.0019 1,981.99 1,982.00 2
 SAMPLE 3 Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 15 19 50 30.70% TVTNAVVTVPAYFNDSQR 95.00% 4.34 0.43 3.29 992.0025 1,981.99 1,982.00 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% RFDDAVVQSDMK 95.00% 2.43 0.212 1.19 470.8945 1,409.66 1,410.67 3
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% ARFEELNADLFR 95.00% 3.89 0.374 0 494.2555 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% ARFEELNADLFR 95.00% 4.66 0.375 0 494.2557 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% ARFEELNADLFR 95.00% 4.01 0.331 0 494.256 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% ARFEELNADLFR 95.00% 4.07 0.338 0 494.2561 1,479.74 1,480.75 3 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% LLQDFFNGK 95.00% 2.98 0.333 0 541.2857 1,080.56 1,081.57 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% LLQDFFNGK 95.00% 3.14 0.352 1.66 541.2864 1,080.56 1,081.57 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% STAGDTHLGGEDFDNR 95.00% 2.63 0.372 0 564.5793 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% STAGDTHLGGEDFDNR 95.00% 2.27 0.305 0 564.5794 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% STAGDTHLGGEDFDNR 95.00% 3.35 0.534 0.959 564.5795 1,690.71 1,691.73 3 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% DAGTIAGLNVLR 95.00% 3.51 0.295 1.55 600.3404 1,198.67 1,199.68 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% DAGTIAGLNVLR 95.00% 3.38 0.31 1.23 600.3405 1,198.67 1,199.68 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% DAGTIAGLNVLR 95.00% 3.74 0.315 1.07 600.3412 1,198.67 1,199.68 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% NQVAMNPTNTVFDAKR 95.00% 2.21 0.247 0 602.6366 1,804.89 1,805.90 3
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% VEIIANDQGNR 94.50% 0 0 3.11 615.9706 1,229.93 1,228.63 2 HSP72_HUMAN,HSP71_HUMAN,GRP78_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% MVNHFIAEFK 95.00% 2.8 0.28 1.85 618.312 1,234.61 1,235.62 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% MVNHFIAEFK 95.00% 2.75 0.293 1.52 618.3168 1,234.62 1,235.62 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% MVNHFIAEFK 95.00% 2.78 0.324 1.6 618.3181 1,234.62 1,235.62 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% MVNHFIAEFK 95.00% 2.69 0.334 2.33 618.8176 1,235.62 1,235.62 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% MKEIAEAYLGK 95.00% 3.48 0.454 1.77 626.8325 1,251.65 1,252.66 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% MKEIAEAYLGK 95.00% 3.14 0.438 1.4 626.8329 1,251.65 1,252.66 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% MKEIAEAYLGK 95.00% 2.78 0.223 1.29 626.8335 1,251.65 1,252.66 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% FEELNADLFR 95.00% 2.58 0.397 1.57 627.3108 1,252.61 1,253.62 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% FEELNADLFR 95.00% 2.79 0.366 1.57 627.3109 1,252.61 1,253.62 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% NSLESYAFNMK 95.00% 3.25 0.38 2.48 652.3004 1,302.59 1,303.60 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% NSLESYAFNMK 95.00% 3.38 0.448 3.89 652.3023 1,302.59 1,303.60 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% NSLESYAFNMK 95.00% 3.22 0.444 1.82 652.8037 1,303.59 1,303.60 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% ARFEELNADLFR 95.00% 3.23 0.362 2.48 740.8801 1,479.74 1,480.75 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% ARFEELNADLFR 95.00% 2.96 0.261 2.13 740.8806 1,479.75 1,480.75 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% ARFEELNADLFR 95.00% 2.98 0.323 2 740.8808 1,479.75 1,480.75 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% ARFEELNADLFR 95.00% 3.54 0.359 3.85 741.3818 1,480.75 1,480.75 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% SQIHDIVLVGGSTR 95.00% 4.15 0.634 3.36 741.4077 1,480.80 1,481.81 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% SQIHDIVLVGGSTR 95.00% 4.24 0.661 2.96 741.4088 1,480.80 1,481.81 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% TTPSYVAFTDTER 95.00% 2.09 0.285 1.1 744.3509 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% TTPSYVAFTDTER 95.00% 3.57 0.629 4.89 744.3535 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% TTPSYVAFTDTER 95.00% 3.66 0.609 4.41 744.354 1,486.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% TTPSYVAFTDTER 95.00% 3.66 0.585 4.08 744.8543 1,487.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% TTPSYVAFTDTER 95.00% 4.03 0.582 4.24 744.8552 1,487.69 1,487.70 2 HSP72_HUMAN,HSP71_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% GPAVGIDLGTTYScVGVFQHGK 95.00% 4.95 0.41 2.55 c14: Carbamidomethyl (+57.02) 755.3783 2,263.11 2,263.12 3
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% GPAVGIDLGTTYScVGVFQHGK 95.00% 3.98 0.428 3.24 c14: Carbamidomethyl (+57.02) 755.3785 2,263.11 2,263.12 3
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% LLQDFFNGKELNK 95.00% 3.79 0.387 1.46 783.42 1,564.82 1,565.83 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% LLQDFFNGKELNK 95.00% 3.62 0.345 0 783.4202 1,564.82 1,565.83 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% LLQDFFNGKELNK 95.00% 3.82 0.311 1.89 783.4229 1,564.83 1,565.83 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% SFYPEEVSSMVLTK 95.00% 4.35 0.554 5.85 808.8953 1,615.77 1,616.79 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% SFYPEEVSSMVLTK 95.00% 4.3 0.522 4.77 808.8961 1,615.78 1,616.79 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% SFYPEEVSSMVLTK 95.00% 4.49 0.55 4.96 808.897 1,615.78 1,616.79 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% SFYPEEVSSMVLTK 95.00% 4.65 0.473 5.49 809.3985 1,616.78 1,616.79 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% NQVAMNPTNTVFDAK 95.00% 4.67 0.466 4.92 825.4012 1,648.79 1,649.80 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% NQVAMNPTNTVFDAK 95.00% 4.5 0.471 5.92 825.9037 1,649.79 1,649.80 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% IINEPTAAAIAYGLDK 95.00% 5.04 0.603 6.05 830.4508 1,658.89 1,659.90 2 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% IINEPTAAAIAYGLDK 95.00% 4.8 0.577 6.57 830.4514 1,658.89 1,659.90 2 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% IINEPTAAAIAYGLDK 95.00% 4.72 0.586 4.31 830.4518 1,658.89 1,659.90 2 HSP72_HUMAN,GRP78_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% STAGDTHLGGEDFDNR 95.00% 4.01 0.613 3.46 846.3637 1,690.71 1,691.73 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% STAGDTHLGGEDFDNR 95.00% 4.61 0.584 3.96 846.3651 1,690.71 1,691.73 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% STAGDTHLGGEDFDNR 95.00% 4.39 0.618 5.59 846.3656 1,690.72 1,691.73 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% STAGDTHLGGEDFDNR 95.00% 4.51 0.586 3.89 846.3673 1,690.72 1,691.73 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% IINEPTAAAIAYGLDKK 95.00% 5.16 0.579 6.59 894.497 1,786.98 1,787.99 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% IINEPTAAAIAYGLDKK 95.00% 4.59 0.568 5.8 894.498 1,786.98 1,787.99 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% IINEPTAAAIAYGLDKK 95.00% 4.87 0.554 6.74 894.4992 1,786.98 1,787.99 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% IINEPTAAAIAYGLDKK 95.00% 4.68 0.526 5.33 894.5001 1,786.98 1,787.99 2 HSP72_HUMAN
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% TVTNAVVTVPAYFNDSQR 95.00% 3.74 0.419 1.74 991.4998 1,980.98 1,982.00 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% TVTNAVVTVPAYFNDSQR 95.00% 3.47 0.329 3.2 991.5005 1,980.99 1,982.00 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% TVTNAVVTVPAYFNDSQR 95.00% 3.57 0.425 2.74 991.5031 1,980.99 1,982.00 2
 SAMPLE 3R Heat shock cognate 71 kDa protein  HSPA8  HSP7C_HUMAN 70,881.80 100.00% 17 19 55 34.40% TVTNAVVTVPAYFNDSQR 95.00% 3.91 0.458 2.7 992.0034 1,981.99 1,982.00 2
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% GPSWDPFR 95.00% 2.35 0.484 1.49 481.2309 960.4462 961.4533 2
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% GPSWDPFR 95.00% 2.17 0.46 1.28 481.2319 960.4481 961.4533 2
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% QLSSGVSEIR 95.00% 2.62 0.196 1.6 538.2918 1,074.57 1,075.57 2
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% QLSSGVSEIR 95.00% 2.59 0.167 2.06 538.2937 1,074.57 1,075.57 2
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% LFDQAFGLPR 95.00% 2.31 0.334 1.62 582.3155 1,162.62 1,163.62 2
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% LFDQAFGLPR 95.00% 2.86 0.39 1.16 582.3155 1,162.62 1,163.62 2
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% VSLDVNHFAPDELTVK 95.00% 2.74 0.348 0 595.3143 1,782.92 1,783.92 3 DESM_HUMAN
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% VSLDVNHFAPDELTVK 95.00% 3.03 0.393 1.3 595.3145 1,782.92 1,783.92 3 DESM_HUMAN
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% VSLDVNHFAPDELTVK 95.00% 2.46 0.29 0 595.6483 1,783.92 1,783.92 3 DESM_HUMAN
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% DGVVEITGKHEERQDEHGYISR 95.00% 3.86 0.479 1.43 852.4213 2,554.24 2,554.23 3
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% VSLDVNHFAPDELTVK 95.00% 5.27 0.594 3.96 892.4677 1,782.92 1,783.92 2 DESM_HUMAN
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% VSLDVNHFAPDELTVK 95.00% 5.01 0.556 2.36 892.9675 1,783.92 1,783.92 2 DESM_HUMAN
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% VSLDVNHFAPDELTVK 95.00% 5.24 0.561 3 892.9687 1,783.92 1,783.92 2 DESM_HUMAN
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% VSLDVNHFAPDELTVK 95.00% 4.87 0.566 2.48 892.9691 1,783.92 1,783.92 2 DESM_HUMAN
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% VSLDVNHFAPDELTVK 95.00% 4.57 0.559 3.77 892.9741 1,783.93 1,783.92 2 DESM_HUMAN
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% LATQSNEITIPVTFESR 95.00% 4.19 0.684 3.85 953.5032 1,904.99 1,905.99 2
 SAMPLE 4 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 5 9 40.50% LATQSNEITIPVTFESR 95.00% 4.47 0.636 3.8 954.0041 1,905.99 1,905.99 2
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% GPSWDPFR 95.00% 2.16 0.477 0 481.2325 960.4493 961.4533 2
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% GPSWDPFR 95.00% 2.15 0.489 0 481.2326 960.4495 961.4533 2
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% QLSSGVSEIR 95.00% 2.69 0.162 1.41 538.2929 1,074.57 1,075.57 2
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% QLSSGVSEIR 95.00% 2.58 0.144 1.33 538.293 1,074.57 1,075.57 2
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% LFDQAFGLPR 95.00% 2.72 0.373 0 582.3122 1,162.61 1,163.62 2
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% LFDQAFGLPR 95.00% 2.78 0.353 0 582.3131 1,162.61 1,163.62 2
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% LFDQAFGLPR 95.00% 3.1 0.401 0 582.8212 1,163.63 1,163.62 2
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% LFDQAFGLPR 95.00% 2.94 0.366 0 582.8222 1,163.63 1,163.62 2
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% VSLDVNHFAPDELTVK 95.00% 2.66 0.268 0 595.3137 1,782.92 1,783.92 3 DESM_HUMAN
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% VSLDVNHFAPDELTVK 95.00% 2.95 0.371 0 595.3139 1,782.92 1,783.92 3 DESM_HUMAN
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% VSLDVNHFAPDELTVK 95.00% 2.24 0.234 0 595.3148 1,782.92 1,783.92 3 DESM_HUMAN
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% VSLDVNHFAPDELTVK 95.00% 2.8 0.34 0 595.3151 1,782.92 1,783.92 3 DESM_HUMAN
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% VSLDVNHFAPDELTVK 95.00% 2.62 0.285 0 595.6483 1,783.92 1,783.92 3 DESM_HUMAN
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% VSLDVNHFAPDELTVK 95.00% 4.98 0.573 3.27 892.9665 1,783.92 1,783.92 2 DESM_HUMAN
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% VSLDVNHFAPDELTVK 95.00% 4.95 0.549 3.57 892.9678 1,783.92 1,783.92 2 DESM_HUMAN
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% VSLDVNHFAPDELTVK 95.00% 5.04 0.57 3.55 892.9679 1,783.92 1,783.92 2 DESM_HUMAN
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% VSLDVNHFAPDELTVK 95.00% 4.75 0.584 2.96 892.9708 1,783.93 1,783.92 2 DESM_HUMAN
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% LATQSNEITIPVTFESR 95.00% 3.75 0.626 3.59 953.5019 1,904.99 1,905.99 2
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% LATQSNEITIPVTFESR 95.00% 3.85 0.595 3.39 953.5026 1,904.99 1,905.99 2
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% LATQSNEITIPVTFESR 95.00% 3.67 0.66 3.1 953.5031 1,904.99 1,905.99 2
 SAMPLE 4R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 4 12 29.80% LATQSNEITIPVTFESR 95.00% 4.02 0.654 3.55 953.5036 1,904.99 1,905.99 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% GPSWDPFR 95.00% 2.37 0.356 1.35 481.2299 960.4441 961.4533 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% GPSWDPFR 95.00% 2.33 0.21 0 481.2304 960.4452 961.4533 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% GPSWDPFR 95.00% 2.35 0.345 0 481.2357 960.4557 961.4533 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% RVPFSLLR 95.00% 2.46 0.186 0 494.3081 986.6006 987.6104 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 2.35 0.398 1.3 582.3103 1,162.61 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 3.93 0.44 1.6 582.3122 1,162.61 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 3.84 0.407 1.59 582.3126 1,162.61 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 3.01 0.304 2.06 582.3134 1,162.61 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 2.83 0.366 1.51 582.3139 1,162.61 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 3.39 0.492 2.39 582.3148 1,162.61 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 2.92 0.399 1.4 582.315 1,162.61 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 2.46 0.31 0 582.3163 1,162.62 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 2.46 0.319 0 582.3176 1,162.62 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 3.94 0.419 1.48 582.3179 1,162.62 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 3.91 0.452 1.55 582.3209 1,162.63 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 3.74 0.36 2.59 582.3217 1,162.63 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 4 0.43 2.74 582.3232 1,162.63 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 3.71 0.469 2.7 582.3244 1,162.63 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LFDQAFGLPR 95.00% 3.4 0.395 1.62 582.3252 1,162.63 1,163.62 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% VSLDVNHFAPDELTVK 95.00% 2.03 0.33 0 595.317 1,782.93 1,783.92 3 DESM_HUMAN
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% VSLDVNHFAPDELTVK 95.00% 2.58 0.341 0 595.3176 1,782.93 1,783.92 3 DESM_HUMAN
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% VSLDVNHFAPDELTVK 95.00% 2.87 0.382 0 595.645 1,783.91 1,783.92 3 DESM_HUMAN
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% VSLDVNHFAPDELTVK 95.00% 2.52 0.2 0 595.6458 1,783.91 1,783.92 3 DESM_HUMAN
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% VSLDVNHFAPDELTVK 95.00% 2.86 0.392 2.43 595.6537 1,783.94 1,783.92 3 DESM_HUMAN
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LATQSNEITIPVTFESR 95.00% 2.21 0.277 0 636.0118 1,905.01 1,905.99 3
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% VSLDVNHFAPDELTVK 95.00% 4.97 0.572 3.77 892.4627 1,782.91 1,783.92 2 DESM_HUMAN
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% VSLDVNHFAPDELTVK 95.00% 4.77 0.561 3.15 892.4713 1,782.93 1,783.92 2 DESM_HUMAN
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% VSLDVNHFAPDELTVK 95.00% 4.64 0.495 2.85 892.9607 1,783.91 1,783.92 2 DESM_HUMAN
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% VSLDVNHFAPDELTVK 95.00% 4.94 0.557 2.89 892.9649 1,783.91 1,783.92 2 DESM_HUMAN
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% VSLDVNHFAPDELTVK 95.00% 4.53 0.531 1.96 892.9775 1,783.94 1,783.92 2 DESM_HUMAN
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LATQSNEITIPVTFESR 95.00% 4.01 0.675 4.66 953.5066 1,905.00 1,905.99 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LATQSNEITIPVTFESR 95.00% 4.08 0.68 5.92 953.5153 1,905.01 1,905.99 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LATQSNEITIPVTFESR 95.00% 4.37 0.644 4.39 953.9964 1,905.98 1,905.99 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LATQSNEITIPVTFESR 95.00% 4.25 0.647 4.17 953.9982 1,905.98 1,905.99 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LATQSNEITIPVTFESR 95.00% 4.2 0.57 4.37 954.007 1,906.00 1,905.99 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LATQSNEITIPVTFESR 95.00% 2.6 0.41 0 954.0078 1,906.00 1,905.99 2
 SAMPLE 1 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 4 5 27 28.80% LATQSNEITIPVTFESR 95.00% 2.94 0.606 3.11 954.0121 1,906.01 1,905.99 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% GPSWDPFR 95.00% 2.35 0.345 1.18 481.2357 960.4557 961.4533 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 2.35 0.398 1.19 582.3103 1,162.61 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 3.06 0.358 1.89 582.3122 1,162.61 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 2.92 0.383 2.09 582.3131 1,162.61 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 2.61 0.329 1.37 582.3133 1,162.61 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 2.87 0.451 1.23 582.3144 1,162.61 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 3.09 0.418 1.77 582.3146 1,162.61 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 2.46 0.31 0 582.3163 1,162.62 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 2.46 0.319 0 582.3176 1,162.62 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 3.94 0.419 2.17 582.3179 1,162.62 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 2.88 0.338 0 582.3213 1,162.63 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 4 0.43 2.43 582.3232 1,162.63 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 2.89 0.385 2.03 582.3238 1,162.63 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 3.71 0.409 2.57 582.3241 1,162.63 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 3 0.354 1.96 582.3241 1,162.63 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 3.69 0.465 2.15 582.3244 1,162.63 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 3.91 0.481 2.68 582.3247 1,162.63 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LFDQAFGLPR 95.00% 3.64 0.414 2.51 582.3255 1,162.64 1,163.62 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% VSLDVNHFAPDELTVK 95.00% 2.58 0.341 0 595.3176 1,782.93 1,783.92 3 DESM_HUMAN
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% VSLDVNHFAPDELTVK 95.00% 2.55 0.42 0 595.3232 1,782.95 1,783.92 3 DESM_HUMAN
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% VSLDVNHFAPDELTVK 95.00% 2.15 0.371 0 595.3233 1,782.95 1,783.92 3 DESM_HUMAN
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% VSLDVNHFAPDELTVK 95.00% 2.86 0.392 2.08 595.6537 1,783.94 1,783.92 3 DESM_HUMAN
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% VSLDVNHFAPDELTVK 95.00% 2.7 0.362 1.74 595.6568 1,783.95 1,783.92 3 DESM_HUMAN
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LATQSNEITIPVTFESR 95.00% 2.21 0.277 0 636.0118 1,905.01 1,905.99 3
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LATQSNEITIPVTFESR 95.00% 2.3 0.329 0 636.3486 1,906.02 1,905.99 3
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% VSLDVNHFAPDELTVK 95.00% 4.77 0.561 3.19 892.4713 1,782.93 1,783.92 2 DESM_HUMAN
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% VSLDVNHFAPDELTVK 95.00% 2.67 0.256 1.52 892.4787 1,782.94 1,783.92 2 DESM_HUMAN
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% VSLDVNHFAPDELTVK 95.00% 3.29 0.468 2.68 892.4804 1,782.95 1,783.92 2 DESM_HUMAN
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% VSLDVNHFAPDELTVK 95.00% 4.64 0.495 2.08 892.9607 1,783.91 1,783.92 2 DESM_HUMAN
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% VSLDVNHFAPDELTVK 95.00% 4.53 0.531 2.33 892.9775 1,783.94 1,783.92 2 DESM_HUMAN
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% VSLDVNHFAPDELTVK 95.00% 4.88 0.57 3.41 892.9828 1,783.95 1,783.92 2 DESM_HUMAN
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LATQSNEITIPVTFESR 95.00% 4.01 0.675 4.27 953.5066 1,905.00 1,905.99 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LATQSNEITIPVTFESR 95.00% 4.2 0.57 4.44 954.007 1,906.00 1,905.99 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LATQSNEITIPVTFESR 95.00% 2.6 0.41 0 954.0078 1,906.00 1,905.99 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LATQSNEITIPVTFESR 95.00% 2.94 0.606 2.66 954.0121 1,906.01 1,905.99 2
 SAMPLE 1R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 3 4 25 24.90% LATQSNEITIPVTFESR 95.00% 4.33 0.659 4.09 954.0172 1,906.02 1,905.99 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% GPSWDPFR 95.00% 2.17 0.459 1.59 481.2307 960.4457 961.4533 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% QLSSGVSEIR 95.00% 2.42 0.165 1.24 538.2893 1,074.56 1,075.57 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% QLSSGVSEIR 95.00% 2.49 0.176 1.41 538.2894 1,074.56 1,075.57 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% QLSSGVSEIR 95.00% 2.39 0.172 2.92 538.2899 1,074.56 1,075.57 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% QLSSGVSEIR 95.00% 2.68 0.169 1.46 538.2901 1,074.56 1,075.57 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% QLSSGVSEIR 95.00% 2.53 0.15 1.92 538.2901 1,074.56 1,075.57 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% QLSSGVSEIR 95.00% 2.63 0.159 1.46 538.2901 1,074.56 1,075.57 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% AQLGGPEAAKSDETAAK 95.00% 2.23 0.361 0.959 548.6148 1,642.82 1,643.82 3
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% LFDQAFGLPR 95.00% 3.13 0.397 2.47 582.3124 1,162.61 1,163.62 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% LFDQAFGLPR 95.00% 3.34 0.423 2.72 582.3127 1,162.61 1,163.62 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% LFDQAFGLPR 95.00% 3.66 0.413 2.23 582.3127 1,162.61 1,163.62 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% LFDQAFGLPR 95.00% 3.43 0.391 1.49 582.3128 1,162.61 1,163.62 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% VSLDVNHFAPDELTVK 95.00% 2.42 0.219 0 595.3088 1,782.90 1,783.92 3 DESM_HUMAN
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% VSLDVNHFAPDELTVK 95.00% 2.53 0.313 0 595.6439 1,783.91 1,783.92 3 DESM_HUMAN
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% VSLDVNHFAPDELTVK 95.00% 2.93 0.337 1.52 595.6454 1,783.91 1,783.92 3 DESM_HUMAN
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% VSLDVNHFAPDELTVK 95.00% 2.74 0.289 0 595.6456 1,783.91 1,783.92 3 DESM_HUMAN
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% VSLDVNHFAPDELTVK 95.00% 2.98 0.346 0 595.6458 1,783.91 1,783.92 3 DESM_HUMAN
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% VSLDVNHFAPDELTVK 95.00% 2.54 0.314 0 595.646 1,783.91 1,783.92 3 DESM_HUMAN
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% LATQSNEITIPVTFESR 95.00% 3.13 0.404 1.07 636.3345 1,905.98 1,905.99 3
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% LATQSNEITIPVTFESR 95.00% 3.04 0.392 2.59 636.3365 1,905.99 1,905.99 3
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% DGVVEITGKHEERQDEHGYISR 95.00% 3.86 0.454 1 852.4148 2,554.22 2,554.23 3
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% VSLDVNHFAPDELTVK 95.00% 5.07 0.586 3.82 892.4616 1,782.91 1,783.92 2 DESM_HUMAN
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% VSLDVNHFAPDELTVK 95.00% 4.75 0.584 4.28 892.463 1,782.91 1,783.92 2 DESM_HUMAN
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% VSLDVNHFAPDELTVK 95.00% 5.06 0.574 3.77 892.4644 1,782.91 1,783.92 2 DESM_HUMAN
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% VSLDVNHFAPDELTVK 95.00% 4.97 0.551 3.1 892.9633 1,783.91 1,783.92 2 DESM_HUMAN
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% VSLDVNHFAPDELTVK 95.00% 5.22 0.569 3.35 892.9651 1,783.91 1,783.92 2 DESM_HUMAN
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% VSLDVNHFAPDELTVK 95.00% 5.09 0.519 2.74 892.9656 1,783.92 1,783.92 2 DESM_HUMAN
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% LATQSNEITIPVTFESR 95.00% 4.5 0.631 4.15 953.4963 1,904.98 1,905.99 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% LATQSNEITIPVTFESR 95.00% 4.24 0.639 4.47 953.9967 1,905.98 1,905.99 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% LATQSNEITIPVTFESR 95.00% 4.54 0.588 4.17 953.9991 1,905.98 1,905.99 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% LATQSNEITIPVTFESR 95.00% 4.61 0.616 4.27 953.9993 1,905.98 1,905.99 2
 SAMPLE 2 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 6 7 20 48.80% LATQSNEITIPVTFESR 95.00% 3.95 0.589 3.6 954.0008 1,905.99 1,905.99 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% GPSWDPFR 95.00% 2.38 0.426 1.6 481.2289 960.4421 961.4533 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% GPSWDPFR 95.00% 2.22 0.448 2.32 481.2294 960.4432 961.4533 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% GPSWDPFR 95.00% 1.95 0.484 0 481.2633 960.5109 961.4533 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% QLSSGVSEIR 95.00% 2.57 0.159 2.66 538.2894 1,074.56 1,075.57 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% QLSSGVSEIR 95.00% 2.63 0.172 2.19 538.2896 1,074.56 1,075.57 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% QLSSGVSEIR 95.00% 2.47 0.17 1.96 538.2896 1,074.56 1,075.57 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% QLSSGVSEIR 95.00% 2.53 0.161 1.92 538.2896 1,074.56 1,075.57 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% QLSSGVSEIR 95.00% 2.31 0.155 1.38 538.29 1,074.56 1,075.57 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LFDQAFGLPR 95.00% 2.57 0.332 0 582.3097 1,162.60 1,163.62 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LFDQAFGLPR 95.00% 2.79 0.148 0 582.3103 1,162.61 1,163.62 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LFDQAFGLPR 95.00% 2.89 0.242 0 582.3104 1,162.61 1,163.62 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LFDQAFGLPR 95.00% 2.86 0.464 0 582.3125 1,162.61 1,163.62 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LFDQAFGLPR 95.00% 3.3 0.377 1.64 582.3125 1,162.61 1,163.62 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LFDQAFGLPR 95.00% 3.81 0.425 1.49 582.313 1,162.61 1,163.62 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LFDQAFGLPR 95.00% 3.82 0.44 2.3 582.3132 1,162.61 1,163.62 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LFDQAFGLPR 95.00% 3.59 0.394 1.85 582.3132 1,162.61 1,163.62 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LFDQAFGLPR 95.00% 3.8 0.406 2.25 582.3134 1,162.61 1,163.62 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LFDQAFGLPR 95.00% 3.85 0.441 1.85 582.3136 1,162.61 1,163.62 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LFDQAFGLPR 95.00% 2.6 0.363 0 582.3152 1,162.61 1,163.62 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% VSLDVNHFAPDELTVK 95.00% 2.67 0.32 1.66 595.3115 1,782.91 1,783.92 3 DESM_HUMAN
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% VSLDVNHFAPDELTVK 95.00% 2.7 0.331 0 595.6458 1,783.91 1,783.92 3 DESM_HUMAN
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LATQSNEITIPVTFESR 95.00% 2.8 0.329 1.4 636.3359 1,905.98 1,905.99 3
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LATQSNEITIPVTFESR 95.00% 2.86 0.423 1.3 636.3362 1,905.99 1,905.99 3
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% AQLGGPEAAKSDETAAK 95.00% 4.51 0.492 3.43 822.42 1,642.82 1,643.82 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% AQLGGPEAAKSDETAAK 95.00% 4.7 0.562 3.74 822.4215 1,642.83 1,643.82 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% VSLDVNHFAPDELTVK 95.00% 4.69 0.559 2.13 892.4622 1,782.91 1,783.92 2 DESM_HUMAN
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% VSLDVNHFAPDELTVK 95.00% 5.07 0.593 3.35 892.463 1,782.91 1,783.92 2 DESM_HUMAN
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% VSLDVNHFAPDELTVK 95.00% 4.79 0.559 1.51 892.4659 1,782.92 1,783.92 2 DESM_HUMAN
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% VSLDVNHFAPDELTVK 95.00% 5.19 0.558 2.54 892.4667 1,782.92 1,783.92 2 DESM_HUMAN
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% VSLDVNHFAPDELTVK 95.00% 5.05 0.586 4.57 892.467 1,782.92 1,783.92 2 DESM_HUMAN
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% VSLDVNHFAPDELTVK 95.00% 5.13 0.551 3.64 892.9653 1,783.92 1,783.92 2 DESM_HUMAN
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LATQSNEITIPVTFESR 95.00% 4.04 0.661 4.77 953.4966 1,904.98 1,905.99 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LATQSNEITIPVTFESR 95.00% 3.92 0.669 5.48 953.4969 1,904.98 1,905.99 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LATQSNEITIPVTFESR 95.00% 4.73 0.576 5.13 953.9991 1,905.98 1,905.99 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LATQSNEITIPVTFESR 95.00% 4.24 0.551 1.49 953.9996 1,905.98 1,905.99 2
 SAMPLE 2R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 5 6 28 38.00% LATQSNEITIPVTFESR 95.00% 4.28 0.625 4.28 954 1,905.98 1,905.99 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% GPSWDPFR 95.00% 2.22 0.488 0 481.2288 960.4419 961.4533 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% GPSWDPFR 95.00% 2.24 0.362 1.25 481.2294 960.4432 961.4533 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% GPSWDPFR 95.00% 2.46 0.474 1.72 481.2297 960.4438 961.4533 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% RVPFSLLR 95.00% 2.65 0.191 0 494.3068 986.5979 987.6104 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% RVPFSLLR 95.00% 2.55 0.2 0 494.3074 986.5992 987.6104 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% QLSSGVSEIR 95.00% 2.42 0.151 2.37 538.2888 1,074.56 1,075.57 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% QLSSGVSEIR 95.00% 2.64 0.145 1.38 538.2896 1,074.56 1,075.57 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% QLSSGVSEIR 95.00% 2.64 0.157 1.68 538.29 1,074.56 1,075.57 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% QLSSGVSEIR 95.00% 2.54 0.182 2.23 538.29 1,074.56 1,075.57 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% QLSSGVSEIR 95.00% 2.31 0.183 1.48 538.2906 1,074.57 1,075.57 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% QLSSGVSEIR 95.00% 2.59 0.148 2.17 538.2912 1,074.57 1,075.57 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% AQLGGPEAAKSDETAAK 95.00% 2.32 0.268 0 548.613 1,642.82 1,643.82 3
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LFDQAFGLPR 95.00% 3.86 0.399 2.1 582.3122 1,162.61 1,163.62 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LFDQAFGLPR 95.00% 4.09 0.427 0 582.3122 1,162.61 1,163.62 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LFDQAFGLPR 95.00% 3.65 0.42 1.8 582.3127 1,162.61 1,163.62 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LFDQAFGLPR 95.00% 3.54 0.409 2.08 582.3127 1,162.61 1,163.62 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LFDQAFGLPR 95.00% 3.16 0.448 1.57 582.313 1,162.61 1,163.62 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LFDQAFGLPR 95.00% 2.99 0.429 0 582.3136 1,162.61 1,163.62 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LFDQAFGLPR 95.00% 3.15 0.387 0 582.3152 1,162.61 1,163.62 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LFDQAFGLPR 95.00% 2.38 0.38 0 582.3154 1,162.62 1,163.62 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LFDQAFGLPR 95.00% 2.45 0.4 0 582.3156 1,162.62 1,163.62 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LFDQAFGLPR 95.00% 2.32 0.289 0 582.3167 1,162.62 1,163.62 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LFDQAFGLPR 95.00% 3.32 0.389 1.13 582.8138 1,163.61 1,163.62 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% VSLDVNHFAPDELTVK 95.00% 2.5 0.361 0 595.3121 1,782.91 1,783.92 3 DESM_HUMAN
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% VSLDVNHFAPDELTVK 95.00% 2.87 0.416 0 595.3124 1,782.91 1,783.92 3 DESM_HUMAN
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% VSLDVNHFAPDELTVK 95.00% 2.67 0.358 0 595.6422 1,783.90 1,783.92 3 DESM_HUMAN
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% VSLDVNHFAPDELTVK 95.00% 2.78 0.373 0 595.6445 1,783.91 1,783.92 3 DESM_HUMAN
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% PLPPAAIESPAVAAPAYSR 95.00% 2.83 0.386 0 626.6756 1,877.00 1,878.01 3
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% PLPPAAIESPAVAAPAYSR 95.00% 4.43 0.488 0 627.0092 1,878.00 1,878.01 3
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% PLPPAAIESPAVAAPAYSR 95.00% 3.65 0.376 0 627.0095 1,878.01 1,878.01 3
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LATQSNEITIPVTFESR 95.00% 2.87 0.412 1.7 636.3351 1,905.98 1,905.99 3
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LATQSNEITIPVTFESR 95.00% 2.86 0.431 1.22 636.3361 1,905.98 1,905.99 3
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LATQSNEITIPVTFESR 95.00% 2.65 0.372 0 636.3362 1,905.99 1,905.99 3
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% DGVVEITGKHEERQDEHGYISR 95.00% 4 0.466 1.2 852.4139 2,554.22 2,554.23 3
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% DGVVEITGKHEERQDEHGYISR 95.00% 4.34 0.526 1.07 852.4145 2,554.22 2,554.23 3
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% DGVVEITGKHEERQDEHGYISR 95.00% 4.24 0.49 1.39 852.4149 2,554.22 2,554.23 3
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% DGVVEITGKHEERQDEHGYISR 95.00% 3.95 0.456 1.92 852.4149 2,554.22 2,554.23 3
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% VSLDVNHFAPDELTVK 95.00% 5.13 0.62 3.55 892.4621 1,782.91 1,783.92 2 DESM_HUMAN
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% VSLDVNHFAPDELTVK 95.00% 4.4 0.525 4 892.4638 1,782.91 1,783.92 2 DESM_HUMAN
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% VSLDVNHFAPDELTVK 95.00% 4.93 0.572 3.2 892.4638 1,782.91 1,783.92 2 DESM_HUMAN
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% VSLDVNHFAPDELTVK 95.00% 5.15 0.573 3.54 892.9627 1,783.91 1,783.92 2 DESM_HUMAN
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% VSLDVNHFAPDELTVK 95.00% 5.19 0.544 4.47 892.9633 1,783.91 1,783.92 2 DESM_HUMAN
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% VSLDVNHFAPDELTVK 95.00% 4.91 0.544 2.72 892.9636 1,783.91 1,783.92 2 DESM_HUMAN
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% VSLDVNHFAPDELTVK 95.00% 5.07 0.533 3.06 892.965 1,783.91 1,783.92 2 DESM_HUMAN
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% PLPPAAIESPAVAAPAYSR 95.00% 4.62 0.672 0 940.01 1,878.00 1,878.01 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% PLPPAAIESPAVAAPAYSR 95.00% 4.57 0.563 0 940.0121 1,878.01 1,878.01 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LATQSNEITIPVTFESR 95.00% 4.14 0.651 3.39 953.4963 1,904.98 1,905.99 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LATQSNEITIPVTFESR 95.00% 4.13 0.642 4.4 953.4973 1,904.98 1,905.99 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LATQSNEITIPVTFESR 95.00% 3.86 0.608 4.43 953.4982 1,904.98 1,905.99 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LATQSNEITIPVTFESR 95.00% 4.49 0.636 4 953.9966 1,905.98 1,905.99 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LATQSNEITIPVTFESR 95.00% 4.41 0.614 3.64 953.9989 1,905.98 1,905.99 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LATQSNEITIPVTFESR 95.00% 4.42 0.632 3.89 953.9992 1,905.98 1,905.99 2
 SAMPLE 3 Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 8 10 42 62.00% LATQSNEITIPVTFESR 95.00% 4.47 0.633 3.41 954.0004 1,905.99 1,905.99 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% GPSWDPFR 95.00% 2.22 0.389 1.48 481.2297 960.4438 961.4533 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% RVPFSLLR 95.00% 2.42 0.211 0 493.7914 985.5672 987.6104 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% RVPFSLLR 95.00% 2.4 0.165 0 494.3076 986.5996 987.6104 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% RVPFSLLR 95.00% 2.5 0.184 0 494.3077 986.5998 987.6104 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% QLSSGVSEIR 95.00% 2.41 0.194 1.96 538.2894 1,074.56 1,075.57 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% QLSSGVSEIR 95.00% 2.51 0.171 1.89 538.2898 1,074.56 1,075.57 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% QLSSGVSEIR 95.00% 2.51 0.182 1.57 538.2899 1,074.56 1,075.57 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% QLSSGVSEIR 95.00% 2.5 0.184 1.68 538.2899 1,074.56 1,075.57 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% QLSSGVSEIR 95.00% 2.04 0.192 1.33 538.2899 1,074.56 1,075.57 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% QLSSGVSEIR 95.00% 2.5 0.141 1.62 538.29 1,074.56 1,075.57 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% QLSSGVSEIR 95.00% 2.44 0.156 1.2 538.2902 1,074.56 1,075.57 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% QLSSGVSEIR 95.00% 2.09 0.181 1.51 538.2921 1,074.57 1,075.57 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% TKDGVVEITGKHEER 95.00% 3.55 0.448 0 566.6352 1,696.88 1,697.88 3
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% TKDGVVEITGKHEER 95.00% 2.88 0.197 0 566.9673 1,697.88 1,697.88 3
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 2.62 0.375 1.22 582.3126 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 3.3 0.39 2.7 582.3126 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 3.62 0.44 1.47 582.3128 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 3.37 0.373 1.7 582.3128 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 3.63 0.41 1.33 582.313 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 3.12 0.385 1.96 582.3131 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 2.86 0.361 0 582.3134 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 3.48 0.458 1.57 582.3135 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 3.78 0.432 2.05 582.3137 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 3.31 0.45 1.08 582.3139 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 2.99 0.374 1.6 582.3142 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 3.21 0.355 0 582.3145 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 3.03 0.291 0 582.3151 1,162.61 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LFDQAFGLPR 95.00% 2.06 0.311 1.2 582.6703 1,163.33 1,163.62 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% VSLDVNHFAPDELTVK 95.00% 2.66 0.421 0 595.3107 1,782.91 1,783.92 3 DESM_HUMAN
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% VSLDVNHFAPDELTVK 95.00% 2.79 0.358 0 595.312 1,782.91 1,783.92 3 DESM_HUMAN
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% VSLDVNHFAPDELTVK 95.00% 2.69 0.333 1.43 595.3125 1,782.91 1,783.92 3 DESM_HUMAN
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% VSLDVNHFAPDELTVK 95.00% 2.73 0.287 1.12 595.644 1,783.91 1,783.92 3 DESM_HUMAN
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% VSLDVNHFAPDELTVK 95.00% 2.79 0.312 1.18 595.6453 1,783.91 1,783.92 3 DESM_HUMAN
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% PLPPAAIESPAVAAPAYSR 95.00% 2.19 0.257 0 627.0085 1,878.00 1,878.01 3
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% PLPPAAIESPAVAAPAYSR 95.00% 2.45 0.245 0 627.0095 1,878.01 1,878.01 3
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% PLPPAAIESPAVAAPAYSR 95.00% 2.66 0.252 0 627.0106 1,878.01 1,878.01 3
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LATQSNEITIPVTFESR 95.00% 2.48 0.376 0 636.3356 1,905.98 1,905.99 3
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LATQSNEITIPVTFESR 95.00% 2.57 0.414 2.7 636.3359 1,905.98 1,905.99 3
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% AQLGGPEAAKSDETAAK 95.00% 4.28 0.5 3.6 822.9187 1,643.82 1,643.82 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% DGVVEITGKHEERQDEHGYISR 95.00% 4.84 0.486 2.1 852.4141 2,554.22 2,554.23 3
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% DGVVEITGKHEERQDEHGYISR 95.00% 4.1 0.511 1.36 852.4146 2,554.22 2,554.23 3
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% DGVVEITGKHEERQDEHGYISR 95.00% 4.03 0.459 1.22 852.4146 2,554.22 2,554.23 3
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% DGVVEITGKHEERQDEHGYISR 95.00% 3.64 0.564 1.49 852.415 2,554.22 2,554.23 3
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% VSLDVNHFAPDELTVK 95.00% 5.11 0.573 4.52 892.4646 1,782.91 1,783.92 2 DESM_HUMAN
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% VSLDVNHFAPDELTVK 95.00% 4.85 0.504 3.05 892.9648 1,783.91 1,783.92 2 DESM_HUMAN
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% VSLDVNHFAPDELTVK 95.00% 4.94 0.556 4.6 892.9648 1,783.91 1,783.92 2 DESM_HUMAN
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% VSLDVNHFAPDELTVK 95.00% 5.15 0.578 2.8 892.9654 1,783.92 1,783.92 2 DESM_HUMAN
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% VSLDVNHFAPDELTVK 95.00% 4.95 0.578 4.16 892.9662 1,783.92 1,783.92 2 DESM_HUMAN
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LATQSNEITIPVTFESR 95.00% 4.41 0.609 4.15 953.4975 1,904.98 1,905.99 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LATQSNEITIPVTFESR 95.00% 4.5 0.643 3.85 953.9978 1,905.98 1,905.99 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LATQSNEITIPVTFESR 95.00% 4.85 0.558 4.11 953.9987 1,905.98 1,905.99 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LATQSNEITIPVTFESR 95.00% 4.66 0.63 3.96 953.999 1,905.98 1,905.99 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LATQSNEITIPVTFESR 95.00% 3.62 0.555 3.92 953.9995 1,905.98 1,905.99 2
 SAMPLE 3R Heat shock protein beta-1  HSPB1  HSPB1_HUMAN 22,764.60 100.00% 9 10 44 62.90% LATQSNEITIPVTFESR 95.00% 4.74 0.614 3.52 953.9996 1,905.98 1,905.99 2
 SAMPLE 2 Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 5 14.40% HFSPEEIAVK 95.00% 2.57 0.304 0 578.8013 1,155.59 1,156.60 2
 SAMPLE 2 Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 5 14.40% HFSPEEIAVK 95.00% 2.57 0.304 1.77 578.8034 1,155.59 1,156.60 2
 SAMPLE 2 Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 5 14.40% ASAPLPGLSAPGR 95.00% 2.44 0.485 3.35 597.3349 1,192.65 1,193.66 2
 SAMPLE 2 Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 5 14.40% ASAPLPGLSAPGR 95.00% 2.66 0.52 1.77 597.335 1,192.65 1,193.66 2
 SAMPLE 2 Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 5 14.40% ASAPLPGLSAPGR 95.00% 1.81 0.321 1.27 597.3359 1,192.66 1,193.66 2
 SAMPLE 2R Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 4 14.40% HFSPEEIAVK 95.00% 2.47 0.318 0 578.8032 1,155.59 1,156.60 2
 SAMPLE 2R Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 4 14.40% HFSPEEIAVK 95.00% 2.43 0.376 0 578.8036 1,155.59 1,156.60 2
 SAMPLE 2R Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 4 14.40% ASAPLPGLSAPGR 95.00% 2.61 0.514 2.02 597.3355 1,192.66 1,193.66 2
 SAMPLE 2R Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 4 14.40% ASAPLPGLSAPGR 95.00% 2.76 0.511 2.29 597.3372 1,192.66 1,193.66 2
 SAMPLE 3 Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 3 14.40% HFSPEEIAVK 95.00% 2.34 0.338 0 578.8012 1,155.59 1,156.60 2
 SAMPLE 3 Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 3 14.40% ASAPLPGLSAPGR 95.00% 2.83 0.488 1.59 597.3345 1,192.65 1,193.66 2
 SAMPLE 3 Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 3 14.40% ASAPLPGLSAPGR 95.00% 2.8 0.519 2.18 597.3367 1,192.66 1,193.66 2
 SAMPLE 3R Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 3 14.40% HFSPEEIAVK 95.00% 2.35 0.382 1.47 578.8007 1,155.59 1,156.60 2
 SAMPLE 3R Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 3 14.40% ASAPLPGLSAPGR 95.00% 2.82 0.504 2.37 597.3343 1,192.65 1,193.66 2
 SAMPLE 3R Heat shock protein beta-6  HSPB6  HSPB6_HUMAN 17,117.20 99.80% 2 2 3 14.40% ASAPLPGLSAPGR 95.00% 2.95 0.543 1.29 597.3353 1,192.65 1,193.66 2
 SAMPLE 3 Heat shock protein beta-7  HSPB7  HSPB7_HUMAN 18,592.70 99.80% 2 2 3 17.60% TLGDAYEFAVDVR 95.00% 4.14 0.551 2.33 728.3582 1,454.70 1,455.71 2
 SAMPLE 3 Heat shock protein beta-7  HSPB7  HSPB7_HUMAN 18,592.70 99.80% 2 2 3 17.60% TLGDAYEFAVDVR 95.00% 4.01 0.573 3.92 728.3583 1,454.70 1,455.71 2
 SAMPLE 3 Heat shock protein beta-7  HSPB7  HSPB7_HUMAN 18,592.70 99.80% 2 2 3 17.60% cQLPEDVDPTSVTSALR 95.00% 4.22 0.49 2.15 c1: Carbamidomethyl (+57.02) 944.9597 1,887.90 1,887.91 2
 SAMPLE 3R Heat shock protein beta-7  HSPB7  HSPB7_HUMAN 18,592.70 100.00% 3 3 7 22.40% LAADGTVMNTFAHK 95.00% 1.92 0.248 1.15 492.5833 1,474.73 1,475.73 3
 SAMPLE 3R Heat shock protein beta-7  HSPB7  HSPB7_HUMAN 18,592.70 100.00% 3 3 7 22.40% ALPAQDPPMEK 95.00% 1.94 0.48 1.16 598.801 1,195.59 1,196.60 2
 SAMPLE 3R Heat shock protein beta-7  HSPB7  HSPB7_HUMAN 18,592.70 100.00% 3 3 7 22.40% ALPAQDPPMEK 95.00% 2.31 0.561 1.17 598.8012 1,195.59 1,196.60 2
 SAMPLE 3R Heat shock protein beta-7  HSPB7  HSPB7_HUMAN 18,592.70 100.00% 3 3 7 22.40% TLGDAYEFAVDVR 95.00% 4.13 0.562 4.14 728.3581 1,454.70 1,455.71 2
 SAMPLE 3R Heat shock protein beta-7  HSPB7  HSPB7_HUMAN 18,592.70 100.00% 3 3 7 22.40% TLGDAYEFAVDVR 95.00% 4.01 0.562 2.66 728.3592 1,454.70 1,455.71 2
 SAMPLE 3R Heat shock protein beta-7  HSPB7  HSPB7_HUMAN 18,592.70 100.00% 3 3 7 22.40% TLGDAYEFAVDVR 95.00% 3.46 0.578 2.59 728.3618 1,454.71 1,455.71 2
 SAMPLE 3R Heat shock protein beta-7  HSPB7  HSPB7_HUMAN 18,592.70 100.00% 3 3 7 22.40% TLGDAYEFAVDVR 95.00% 4.57 0.586 3.38 728.8607 1,455.71 1,455.71 2
 SAMPLE 1 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 5 9.84% SLTNDWEDHLAVK 95.00% 2.45 0.247 0 509.9177 1,526.73 1,527.74 3 HS90B_HUMAN
 SAMPLE 1 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 5 9.84% DQVANSAFVER 95.00% 2.76 0.317 1.96 618.3037 1,234.59 1,235.60 2
 SAMPLE 1 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 5 9.84% DQVANSAFVER 95.00% 2.76 0.273 1.51 618.3038 1,234.59 1,235.60 2
 SAMPLE 1 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 5 9.84% ADLINNLGTIAK 95.00% 3.81 0.542 4.17 621.8554 1,241.70 1,242.71 2 HS90B_HUMAN
 SAMPLE 1 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 5 9.84% ADLINNLGTIAK 95.00% 3.98 0.529 4.39 621.856 1,241.70 1,242.71 2 HS90B_HUMAN
 SAMPLE 1 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 5 9.84% RAPFDLFENR 95.00% 2.52 0.379 1.35 632.8229 1,263.63 1,264.64 2
 SAMPLE 1 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 5 9.84% RAPFDLFENR 95.00% 2.54 0.289 0 632.8239 1,263.63 1,264.64 2
 SAMPLE 1 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 5 9.84% HFSVEGQLEFR 95.00% 2.24 0.205 1.66 675.3432 1,348.67 1,348.67 2 ,HS90B_HUMAN
 SAMPLE 1 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 5 9.84% NPDDITNEEYGEFYK 95.00% 5.39 0.513 5.29 917.894 1,833.77 1,833.78 2
 SAMPLE 1R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 4 4 6 10.50% SLTNDWEDHLAVK 95.00% 2.64 0.331 0 509.919 1,526.73 1,527.74 3 HS90B_HUMAN
 SAMPLE 1R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 4 4 6 10.50% APFDLFENR 95.00% 2.63 0.473 0 554.7738 1,107.53 1,108.54 2
 SAMPLE 1R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 4 4 6 10.50% DQVANSAFVER 95.00% 2.74 0.258 2.7 618.3032 1,234.59 1,235.60 2
 SAMPLE 1R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 4 4 6 10.50% DQVANSAFVER 95.00% 2.67 0.336 1.38 618.3036 1,234.59 1,235.60 2
 SAMPLE 1R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 4 4 6 10.50% ADLINNLGTIAK 95.00% 3.14 0.479 2.24 621.8546 1,241.69 1,242.71 2 HS90B_HUMAN
 SAMPLE 1R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 4 4 6 10.50% ADLINNLGTIAK 95.00% 3.7 0.535 3.54 621.856 1,241.70 1,242.71 2 HS90B_HUMAN
 SAMPLE 1R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 4 4 6 10.50% RAPFDLFENR 95.00% 2.67 0.36 0 632.8216 1,263.63 1,264.64 2
 SAMPLE 1R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 4 4 6 10.50% RAPFDLFENR 95.00% 2.36 0.406 0 632.8252 1,263.63 1,264.64 2
 SAMPLE 1R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 4 4 6 10.50% VILHLKEDQTEYLEER 95.00% 3.8 0.469 1.48 672.6866 2,015.04 2,015.05 3 HS90B_HUMAN
 SAMPLE 1R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 4 4 6 10.50% NPDDITNEEYGEFYK 95.00% 4.37 0.582 5.55 917.391 1,832.77 1,833.78 2
 SAMPLE 2 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 8.06% DQVANSAFVER 95.00% 2.51 0.383 1.89 618.3056 1,234.60 1,235.60 2
 SAMPLE 2 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 8.06% DQVANSAFVER 95.00% 2.69 0.376 3.32 618.8048 1,235.59 1,235.60 2
 SAMPLE 2 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 8.06% ADLINNLGTIAK 95.00% 3.45 0.493 3.72 621.8554 1,241.70 1,242.71 2 HS90B_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 8.06% ADLINNLGTIAK 95.00% 3.44 0.444 3.54 621.8563 1,241.70 1,242.71 2 HS90B_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 8.06% ADLINNLGTIAK 95.00% 3.79 0.459 3.29 621.8565 1,241.70 1,242.71 2 HS90B_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 8.06% ADLINNLGTIAK 95.00% 3.04 0.438 3.47 621.8568 1,241.70 1,242.71 2 HS90B_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 8.06% RAPFDLFENR 95.00% 2.73 0.274 0 633.3254 1,264.64 1,264.64 2
 SAMPLE 2 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 8.06% HFSVEGQLEFR 95.00% 2.19 0.431 1.66 675.3459 1,348.68 1,348.67 2 ,HS90B_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 8.06% NPDDITNEEYGEFYK 95.00% 4.35 0.542 5.64 917.8919 1,833.77 1,833.78 2
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% FYEQFSK 95.00% 2.44 0.282 1.09 474.7263 947.437 948.4467 2 FIL1L_HUMAN,LAMA5_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% FYEQFSK 95.00% 2.07 0.294 0 474.7277 947.4397 948.4467 2 FIL1L_HUMAN,LAMA5_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% SLTNDWEDHLAVK 95.00% 2.53 0.313 0 509.9185 1,526.73 1,527.74 3 HS90B_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% SLTNDWEDHLAVK 95.00% 2.62 0.44 0 509.919 1,526.73 1,527.74 3 HS90B_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% DQVANSAFVER 95.00% 3.2 0.455 1.54 618.304 1,234.59 1,235.60 2
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% DQVANSAFVER 95.00% 3.12 0.439 1.7 618.3053 1,234.59 1,235.60 2
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% ADLINNLGTIAK 95.00% 4.05 0.533 3.85 621.8551 1,241.69 1,242.71 2 HS90B_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% ADLINNLGTIAK 95.00% 3.79 0.477 4.62 621.8554 1,241.70 1,242.71 2 HS90B_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% ELISNSSDALDK 95.00% 2.43 0.203 1.08 646.8248 1,291.63 1,291.64 2
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% VILHLKEDQTEYLEER 95.00% 4.32 0.498 1.64 672.6876 2,015.04 2,015.05 3 HS90B_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% HFSVEGQLEFR 95.00% 2.27 0.341 0 675.3459 1,348.68 1,348.67 2 ,HS90B_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% TLTIVDTGIGMTK 95.00% 2.09 0.353 2.64 675.3695 1,348.72 1,349.74 2 HS90B_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 100.00% 3 3 4 15.00% NPDDITNEEYGEFYK 95.00% 5.45 0.553 4.77 917.3961 1,832.78 1,833.78 2
 SAMPLE 3R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 99.80% 2 2 4 9.29% FYEQFSK 95.00% 2.05 0.307 0 474.7261 947.4366 948.4467 2 FIL1L_HUMAN,LAMA5_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 99.80% 2 2 4 9.29% FYEQFSK 95.00% 1.92 0.273 0 474.7266 947.4375 948.4467 2 FIL1L_HUMAN,LAMA5_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 99.80% 2 2 4 9.29% SLTNDWEDHLAVK 95.00% 2.43 0.351 0 509.9187 1,526.73 1,527.74 3 HS90B_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 99.80% 2 2 4 9.29% SLTNDWEDHLAVK 95.00% 2.78 0.338 0 510.2527 1,527.73 1,527.74 3 HS90B_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 99.80% 2 2 4 9.29% APFDLFENR 95.00% 3.11 0.346 0 554.7736 1,107.53 1,108.54 2
 SAMPLE 3R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 99.80% 2 2 4 9.29% APFDLFENR 95.00% 3.14 0.451 0 554.7743 1,107.53 1,108.54 2
 SAMPLE 3R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 99.80% 2 2 4 9.29% DQVANSAFVER 95.00% 3.1 0.445 1.46 618.3042 1,234.59 1,235.60 2
 SAMPLE 3R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 99.80% 2 2 4 9.29% DQVANSAFVER 95.00% 3.13 0.454 1.41 618.3045 1,234.59 1,235.60 2
 SAMPLE 3R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 99.80% 2 2 4 9.29% ADLINNLGTIAK 95.00% 3.75 0.49 3.72 621.856 1,241.70 1,242.71 2 HS90B_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 99.80% 2 2 4 9.29% ADLINNLGTIAK 95.00% 3.43 0.453 3.03 621.8564 1,241.70 1,242.71 2 HS90B_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 99.80% 2 2 4 9.29% VILHLKEDQTEYLEER 95.00% 4.5 0.493 0 672.6864 2,015.04 2,015.05 3 HS90B_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-alpha  HSP90AA1  HS90A_HUMAN 84,645.20 99.80% 2 2 4 9.29% VILHLKEDQTEYLEER 95.00% 3.81 0.488 0 672.687 2,015.04 2,015.05 3 HS90B_HUMAN
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% SLTNDWEDHLAVK 95.00% 2.45 0.247 0 509.9177 1,526.73 1,527.74 3 HS90A_HUMAN
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% ELISNASDALDKIR 95.00% 1.64 0.279 0 515.6133 1,543.82 1,544.83 3 ENPL_HUMAN
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% HLEINPDHPIVETLR 95.00% 2.76 0.332 0 595.3213 1,782.94 1,782.95 3
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% IDIIPNPQER 95.00% 3.04 0.183 1.6 597.8266 1,193.64 1,194.65 2
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% IDIIPNPQER 95.00% 2.89 0.25 1.66 597.8268 1,193.64 1,194.65 2
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% ADLINNLGTIAK 95.00% 3.81 0.542 4.17 621.8554 1,241.70 1,242.71 2 HS90A_HUMAN
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% ADLINNLGTIAK 95.00% 3.98 0.529 4.39 621.856 1,241.70 1,242.71 2 HS90A_HUMAN
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% EQVANSAFVER 95.00% 1.77 0.339 0 625.3099 1,248.60 1,249.62 2
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% EQVANSAFVER 95.00% 1.96 0.432 0 625.3122 1,248.61 1,249.62 2
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% ELISNASDALDK 95.00% 3.58 0.513 1.29 638.3226 1,274.63 1,275.64 2 ENPL_HUMAN
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% ELISNASDALDK 95.00% 3.43 0.513 1.17 638.3236 1,274.63 1,275.64 2 ENPL_HUMAN
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% HFSVEGQLEFR 95.00% 2.24 0.205 1.66 675.3432 1,348.67 1,348.67 2 ,HS90A_HUMAN
 SAMPLE 1 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 8 11.90% ELISNASDALDKIR 95.00% 3.78 0.499 4.29 772.9181 1,543.82 1,544.83 2 ENPL_HUMAN
 SAMPLE 1R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 6 10.50% SLTNDWEDHLAVK 95.00% 2.64 0.331 0 509.919 1,526.73 1,527.74 3 HS90A_HUMAN
 SAMPLE 1R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 6 10.50% RAPFDLFENK 94.80% 2.36 0.203 0 618.8216 1,235.63 1,236.64 2
 SAMPLE 1R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 6 10.50% ADLINNLGTIAK 95.00% 3.14 0.479 2.24 621.8546 1,241.69 1,242.71 2 HS90A_HUMAN
 SAMPLE 1R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 6 10.50% ADLINNLGTIAK 95.00% 3.7 0.535 3.54 621.856 1,241.70 1,242.71 2 HS90A_HUMAN
 SAMPLE 1R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 6 10.50% EQVANSAFVER 95.00% 1.71 0.323 0 625.3098 1,248.60 1,249.62 2
 SAMPLE 1R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 6 10.50% ELISNASDALDK 95.00% 3.47 0.441 0 638.3264 1,274.64 1,275.64 2 ENPL_HUMAN
 SAMPLE 1R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 6 10.50% VILHLKEDQTEYLEER 95.00% 3.8 0.469 1.48 672.6866 2,015.04 2,015.05 3 HS90A_HUMAN
 SAMPLE 1R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 6 10.50% ELISNASDALDKIR 95.00% 3.52 0.519 3.47 773.4179 1,544.82 1,544.83 2 ENPL_HUMAN
 SAMPLE 1R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 6 10.50% ELISNASDALDKIR 95.00% 3.81 0.491 4.28 773.4193 1,544.82 1,544.83 2 ENPL_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 2 2 5 6.63% ELISNASDALDKIR 95.00% 1.99 0.264 0 515.6133 1,543.82 1,544.83 3 ENPL_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 2 2 5 6.63% ADLINNLGTIAK 95.00% 3.45 0.493 3.72 621.8554 1,241.70 1,242.71 2 HS90A_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 2 2 5 6.63% ADLINNLGTIAK 95.00% 3.44 0.444 3.54 621.8563 1,241.70 1,242.71 2 HS90A_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 2 2 5 6.63% ADLINNLGTIAK 95.00% 3.79 0.459 3.29 621.8565 1,241.70 1,242.71 2 HS90A_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 2 2 5 6.63% ADLINNLGTIAK 95.00% 3.04 0.438 3.47 621.8568 1,241.70 1,242.71 2 HS90A_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 2 2 5 6.63% EQVANSAFVER 95.00% 1.97 0.467 0 625.3101 1,248.60 1,249.62 2
 SAMPLE 2 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 2 2 5 6.63% ELISNASDALDK 95.00% 3.41 0.486 0 638.3251 1,274.63 1,275.64 2 ENPL_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 2 2 5 6.63% ELISNASDALDK 95.00% 3.13 0.486 0 638.3255 1,274.64 1,275.64 2 ENPL_HUMAN
 SAMPLE 2 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 2 2 5 6.63% HFSVEGQLEFR 95.00% 2.19 0.431 1.66 675.3459 1,348.68 1,348.67 2 ,HS90A_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% SLTNDWEDHLAVK 95.00% 2.53 0.313 0 509.9185 1,526.73 1,527.74 3 HS90A_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% SLTNDWEDHLAVK 95.00% 2.62 0.44 0 509.919 1,526.73 1,527.74 3 HS90A_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% ELISNASDALDKIR 95.00% 2.03 0.231 0 515.6136 1,543.82 1,544.83 3 ENPL_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% ELISNASDALDKIR 95.00% 1.92 0.218 0 515.6136 1,543.82 1,544.83 3 ENPL_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% IDIIPNPQER 95.00% 2.5 0.157 1.1 597.8251 1,193.63 1,194.65 2
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% IDIIPNPQER 95.00% 2.78 0.234 1.29 597.8256 1,193.64 1,194.65 2
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% ADLINNLGTIAK 95.00% 4.05 0.533 3.85 621.8551 1,241.69 1,242.71 2 HS90A_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% ADLINNLGTIAK 95.00% 3.79 0.477 4.62 621.8554 1,241.70 1,242.71 2 HS90A_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% EQVANSAFVER 95.00% 2.2 0.396 0 625.3105 1,248.61 1,249.62 2
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% EQVANSAFVER 95.00% 1.86 0.313 0 625.3108 1,248.61 1,249.62 2
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% ELISNASDALDK 95.00% 3.56 0.499 1.74 638.3239 1,274.63 1,275.64 2 ENPL_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% ELISNASDALDK 95.00% 3.46 0.48 1.55 638.3244 1,274.63 1,275.64 2 ENPL_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% VILHLKEDQTEYLEER 95.00% 4.32 0.498 1.64 672.6876 2,015.04 2,015.05 3 HS90A_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% HFSVEGQLEFR 95.00% 2.27 0.341 0 675.3459 1,348.68 1,348.67 2 ,HS90A_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% TLTLVDTGIGMTK 95.00% 2.09 0.353 2.64 675.3695 1,348.72 1,349.74 2 HS90A_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% ELISNASDALDKIR 95.00% 3.76 0.497 3.33 772.917 1,543.82 1,544.83 2 ENPL_HUMAN
 SAMPLE 3 Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 6 6 10 13.80% ELISNASDALDKIR 95.00% 3.81 0.483 4.15 772.9178 1,543.82 1,544.83 2 ENPL_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 9 10.40% SLTNDWEDHLAVK 95.00% 2.43 0.351 0 509.9187 1,526.73 1,527.74 3 HS90A_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 9 10.40% SLTNDWEDHLAVK 95.00% 2.78 0.338 0 510.2527 1,527.73 1,527.74 3 HS90A_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 9 10.40% IDIIPNPQER 95.00% 2.78 0.235 1.1 597.8266 1,193.64 1,194.65 2
 SAMPLE 3R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 9 10.40% IDIIPNPQER 95.00% 2.83 0.156 1.22 597.8286 1,193.64 1,194.65 2
 SAMPLE 3R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 9 10.40% RAPFDLFENK 95.00% 2.64 0.198 0 618.8246 1,235.63 1,236.64 2
 SAMPLE 3R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 9 10.40% ADLINNLGTIAK 95.00% 3.75 0.49 3.72 621.856 1,241.70 1,242.71 2 HS90A_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 9 10.40% ADLINNLGTIAK 95.00% 3.43 0.453 3.03 621.8564 1,241.70 1,242.71 2 HS90A_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 9 10.40% ELISNASDALDK 95.00% 3.79 0.504 1.7 638.3245 1,274.63 1,275.64 2 ENPL_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 9 10.40% VILHLKEDQTEYLEER 95.00% 4.5 0.493 0 672.6864 2,015.04 2,015.05 3 HS90A_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 9 10.40% VILHLKEDQTEYLEER 95.00% 3.81 0.488 0 672.687 2,015.04 2,015.05 3 HS90A_HUMAN
 SAMPLE 3R Heat shock protein HSP 90-beta  HSP90AB1  HS90B_HUMAN 83,249.30 100.00% 5 5 9 10.40% ELISNASDALDKIR 95.00% 3.59 0.479 5.92 772.9171 1,543.82 1,544.83 2 ENPL_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% ARFEELNADLFR 95.00% 4.02 0.329 0 494.2553 1,479.74 1,480.75 3 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% ARFEELNADLFR 95.00% 4.24 0.251 0 494.5901 1,480.75 1,480.75 3 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% ARFEELNADLFR 95.00% 3.32 0.267 0 494.5903 1,480.75 1,480.75 3 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% LLQDFFNGKELNK 95.00% 2.14 0.328 0 522.614 1,564.82 1,565.83 3 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% LLQDFFNGKELNK 95.00% 2.64 0.382 0 522.6143 1,564.82 1,565.83 3 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% LLQDFFNGK 95.00% 2.25 0.33 1.33 541.2853 1,080.56 1,081.57 2 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% LLQDFFNGK 95.00% 3.01 0.381 1.66 541.2856 1,080.56 1,081.57 2 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% IINEPTAAAIAYGLDK 95.00% 4.55 0.507 2.96 553.9674 1,658.88 1,659.90 3 HSP7C_HUMAN,GRP78_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% STAGDTHLGGEDFDNR 95.00% 2.61 0.521 0 564.5787 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% STAGDTHLGGEDFDNR 95.00% 2.78 0.45 1.42 564.5788 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% STAGDTHLGGEDFDNR 95.00% 2.72 0.477 0 564.579 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% STAGDTHLGGEDFDNR 95.00% 2.12 0.358 0 564.914 1,691.72 1,691.73 3 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% DAGTITGLNVLR 95.00% 3.49 0.422 2.28 615.3445 1,228.67 1,229.69 2
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% DAGTITGLNVLR 95.00% 3.32 0.416 3.57 615.3449 1,228.67 1,229.69 2
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% VHSAVITVPAYFNDSQR 95.00% 2.17 0.332 0 635.326 1,902.95 1,903.97 3
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% ARFEELNADLFR 95.00% 2.98 0.269 2.66 740.8799 1,479.74 1,480.75 2 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% ARFEELNADLFR 95.00% 2.88 0.275 3.26 740.8803 1,479.75 1,480.75 2 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% TTPSYVAFTDTER 95.00% 3.4 0.631 5.47 744.3509 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% TTPSYVAFTDTER 95.00% 2.89 0.583 2.8 744.3511 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% TTPSYVAFTDTER 95.00% 2.67 0.488 3.11 744.352 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% TTPSYVAFTDTER 95.00% 3.54 0.603 4.3 744.3521 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% TTPSYVAFTDTER 95.00% 3.49 0.642 4.89 744.3529 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% TTPSYVAFTDTER 95.00% 3.81 0.588 4.59 744.3532 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% TTPSYVAFTDTER 95.00% 3.18 0.591 2.27 744.3609 1,486.71 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% LLQDFFNGKELNK 95.00% 4.44 0.332 3.25 783.4182 1,564.82 1,565.83 2 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% LLQDFFNGKELNK 95.00% 4.5 0.33 2.15 783.4184 1,564.82 1,565.83 2 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% STAGDTHLGGEDFDNR 95.00% 4.29 0.601 3.92 846.3653 1,690.72 1,691.73 2 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% STAGDTHLGGEDFDNR 95.00% 4.19 0.587 3.72 846.3665 1,690.72 1,691.73 2 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% IINEPTAAAIAYGLDKK 95.00% 5.03 0.571 6.62 894.4965 1,786.98 1,787.99 2 HSP7C_HUMAN
 SAMPLE 1 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 15.60% IINEPTAAAIAYGLDKK 95.00% 4.89 0.484 5.24 894.4972 1,786.98 1,787.99 2 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% ARFEELNADLFR 95.00% 4.21 0.398 0 494.2554 1,479.74 1,480.75 3 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% ARFEELNADLFR 95.00% 4.17 0.414 0 494.256 1,479.74 1,480.75 3 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% LLQDFFNGK 95.00% 2.46 0.31 1.72 541.2855 1,080.56 1,081.57 2 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% LLQDFFNGK 95.00% 2.42 0.358 1.43 541.2877 1,080.56 1,081.57 2 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% STAGDTHLGGEDFDNR 95.00% 2.9 0.539 1.07 564.5779 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% STAGDTHLGGEDFDNR 95.00% 2.89 0.498 0 564.5786 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% STAGDTHLGGEDFDNR 95.00% 3.07 0.544 0 564.5792 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% STAGDTHLGGEDFDNR 95.00% 2.32 0.522 0 564.5796 1,690.72 1,691.73 3 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% DAGTITGLNVLR 95.00% 3.41 0.419 2.92 615.3458 1,228.68 1,229.69 2
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% DAGTITGLNVLR 95.00% 3.33 0.414 4.07 615.3464 1,228.68 1,229.69 2
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% FEELNADLFR 95.00% 2.55 0.368 2.59 627.3103 1,252.60 1,253.62 2 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% NALESYTYNIK 95.00% 2.27 0.3 0 658.3264 1,314.64 1,315.65 2
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% ARFEELNADLFR 95.00% 3.32 0.244 3.54 740.8796 1,479.74 1,480.75 2 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% ARFEELNADLFR 95.00% 3.14 0.305 3.09 740.8797 1,479.74 1,480.75 2 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% TTPSYVAFTDTER 95.00% 3.5 0.622 2.77 744.3537 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% TTPSYVAFTDTER 95.00% 3.44 0.637 3.2 744.354 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% TTPSYVAFTDTER 95.00% 3.18 0.591 1.82 744.3609 1,486.71 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% LLQDFFNGKELNK 95.00% 4.11 0.348 2.29 783.4194 1,564.82 1,565.83 2 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% LLQDFFNGKELNK 95.00% 4.28 0.314 3.24 783.9226 1,565.83 1,565.83 2 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% IINEPTAAAIAYGLDK 95.00% 4.69 0.525 6.62 830.4483 1,658.88 1,659.90 2 HSP7C_HUMAN,GRP78_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% IINEPTAAAIAYGLDK 95.00% 4.34 0.564 5.77 830.4503 1,658.88 1,659.90 2 HSP7C_HUMAN,GRP78_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% STAGDTHLGGEDFDNR 95.00% 4.38 0.556 4.7 846.3647 1,690.71 1,691.73 2 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% STAGDTHLGGEDFDNR 95.00% 4.09 0.6 4.48 846.365 1,690.71 1,691.73 2 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% IINEPTAAAIAYGLDKK 95.00% 4.5 0.542 4.25 894.4989 1,786.98 1,787.99 2 HSP7C_HUMAN
 SAMPLE 1R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 99.80% 2 2 3 14.70% IINEPTAAAIAYGLDKK 95.00% 4.58 0.506 5.36 895.0005 1,787.99 1,787.99 2 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% ARFEELNADLFR 95.00% 4.05 0.368 0 494.2545 1,479.74 1,480.75 3 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% ARFEELNADLFR 95.00% 3.61 0.444 0 494.2549 1,479.74 1,480.75 3 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% ARFEELNADLFR 95.00% 4.19 0.331 1.66 494.2555 1,479.74 1,480.75 3 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% ARFEELNADLFR 95.00% 4.01 0.379 0 494.2562 1,479.75 1,480.75 3 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% STAGDTHLGGEDFDNR 95.00% 2.63 0.447 0 564.5778 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% STAGDTHLGGEDFDNR 95.00% 2.95 0.564 0 564.579 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% STAGDTHLGGEDFDNR 95.00% 2.45 0.327 0 564.5795 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% STAGDTHLGGEDFDNR 95.00% 2.58 0.284 0 564.5795 1,690.72 1,691.73 3 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% DAGTITGLNVLR 95.00% 3.39 0.383 3.8 615.3441 1,228.67 1,229.69 2
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% DAGTITGLNVLR 95.00% 3.29 0.383 2.92 615.3452 1,228.67 1,229.69 2
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% DAGTITGLNVLR 95.00% 3.16 0.441 1.92 615.3453 1,228.68 1,229.69 2
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% DAGTITGLNVLR 95.00% 3.39 0.37 3.74 615.346 1,228.68 1,229.69 2
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% MKEIAEAYLGGK 95.00% 2.64 0.204 2.36 655.3432 1,308.67 1,309.68 2
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% ARFEELNADLFR 95.00% 3.21 0.203 2.43 740.8801 1,479.74 1,480.75 2 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% TTPSYVAFTDTER 95.00% 3.39 0.615 3.1 744.3513 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% TTPSYVAFTDTER 95.00% 3.52 0.637 3.09 744.3529 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% TTPSYVAFTDTER 95.00% 3.64 0.636 3.7 744.3532 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% TTPSYVAFTDTER 95.00% 3.54 0.644 2.92 744.354 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% LLQDFFNGKELNK 95.00% 4.06 0.327 1.44 783.4215 1,564.83 1,565.83 2 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% LLQDFFNGKELNK 95.00% 4.21 0.375 2 783.4228 1,564.83 1,565.83 2 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% LLQDFFNGKELNK 95.00% 4.1 0.313 1.77 783.4233 1,564.83 1,565.83 2 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% IINEPTAAAIAYGLDK 95.00% 3.68 0.542 3.33 830.4495 1,658.88 1,659.90 2 HSP7C_HUMAN,GRP78_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% IINEPTAAAIAYGLDK 95.00% 4.37 0.572 4.74 830.4498 1,658.88 1,659.90 2 HSP7C_HUMAN,GRP78_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% NQVAMNPTNTIFDAK 95.00% 3.97 0.474 4.28 832.4099 1,662.80 1,663.81 2
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% STAGDTHLGGEDFDNR 95.00% 4.08 0.6 4.32 846.3642 1,690.71 1,691.73 2 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% STAGDTHLGGEDFDNR 95.00% 4.57 0.607 4.4 846.3651 1,690.71 1,691.73 2 HSP7C_HUMAN
 SAMPLE 2 Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 6 17.10% STAGDTHLGGEDFDNR 95.00% 3.83 0.578 2.52 846.3686 1,690.72 1,691.73 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% ARFEELNADLFR 95.00% 3.84 0.383 0 494.2551 1,479.74 1,480.75 3 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% ARFEELNADLFR 95.00% 3.84 0.414 0 494.2556 1,479.74 1,480.75 3 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% ARFEELNADLFR 95.00% 4.05 0.395 0 494.5898 1,480.75 1,480.75 3 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% ARFEELNADLFR 95.00% 3.95 0.296 0 494.5902 1,480.75 1,480.75 3 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% LLQDFFNGKELNK 95.00% 2.43 0.35 0 522.6132 1,564.82 1,565.83 3 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% LLQDFFNGKELNK 95.00% 2.89 0.367 0 522.615 1,564.82 1,565.83 3 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% LLQDFFNGKELNK 95.00% 1.95 0.222 0 522.6155 1,564.82 1,565.83 3 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% LLQDFFNGKELNK 95.00% 2.27 0.312 0 522.9496 1,565.83 1,565.83 3 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% LLQDFFNGK 95.00% 2.91 0.307 1.15 541.2861 1,080.56 1,081.57 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% LLQDFFNGK 95.00% 2.95 0.329 1.17 541.287 1,080.56 1,081.57 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% STAGDTHLGGEDFDNR 95.00% 2.95 0.482 0 564.5791 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% STAGDTHLGGEDFDNR 95.00% 2.9 0.427 0 564.5801 1,690.72 1,691.73 3 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% STAGDTHLGGEDFDNR 95.00% 2.43 0.378 1.1 564.914 1,691.72 1,691.73 3 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% DAGTITGLNVLR 95.00% 3.32 0.335 1.82 615.3433 1,228.67 1,229.69 2
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% DAGTITGLNVLR 95.00% 3.61 0.453 2.1 615.3451 1,228.67 1,229.69 2
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% DAGTITGLNVLR 95.00% 3.3 0.333 2.72 615.3454 1,228.68 1,229.69 2
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% DAGTITGLNVLR 95.00% 3.73 0.439 2.2 615.3456 1,228.68 1,229.69 2
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% FEELNADLFR 95.00% 2.15 0.344 1.33 627.3098 1,252.60 1,253.62 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% FEELNADLFR 95.00% 2.56 0.382 2.21 627.3111 1,252.61 1,253.62 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% NALESYTYNIK 95.00% 2.23 0.268 0 658.3293 1,314.64 1,315.65 2
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% ARFEELNADLFR 95.00% 2.87 0.178 1.44 740.8789 1,479.74 1,480.75 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% ARFEELNADLFR 95.00% 2.53 0.153 1.17 740.8796 1,479.74 1,480.75 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% ARFEELNADLFR 95.00% 2.36 0.133 1.89 740.8802 1,479.74 1,480.75 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% ARFEELNADLFR 95.00% 2.84 0.19 1.52 740.8805 1,479.75 1,480.75 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% TTPSYVAFTDTER 95.00% 3.84 0.57 4.55 744.3519 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% TTPSYVAFTDTER 95.00% 3.63 0.598 4.06 744.3532 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% TTPSYVAFTDTER 95.00% 3.19 0.617 3.92 744.3537 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% TTPSYVAFTDTER 95.00% 3.32 0.641 4.02 744.354 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% LLQDFFNGKELNK 95.00% 4.04 0.325 4.03 783.9215 1,565.83 1,565.83 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% LLQDFFNGKELNK 95.00% 3.75 0.336 2.8 783.922 1,565.83 1,565.83 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% IINEPTAAAIAYGLDK 95.00% 4.2 0.565 4.35 830.4476 1,658.88 1,659.90 2 HSP7C_HUMAN,GRP78_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% IINEPTAAAIAYGLDK 95.00% 4.43 0.554 5.89 830.9518 1,659.89 1,659.90 2 HSP7C_HUMAN,GRP78_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% NQVAMNPTNTIFDAK 95.00% 3.37 0.14 3.72 832.9549 1,663.89 1,663.81 2
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% STAGDTHLGGEDFDNR 95.00% 4.68 0.623 3.35 846.3647 1,690.71 1,691.73 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% STAGDTHLGGEDFDNR 95.00% 4.33 0.602 4.15 846.3654 1,690.72 1,691.73 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% IINEPTAAAIAYGLDKK 95.00% 5.09 0.531 6.21 894.498 1,786.98 1,787.99 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% IINEPTAAAIAYGLDKK 95.00% 4.65 0.497 5.05 895.002 1,787.99 1,787.99 2 HSP7C_HUMAN
 SAMPLE 2R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 4 4 7 19.70% VHSAVITVPAYFNDSQR 95.00% 4 0.5 6.96 952.4906 1,902.97 1,903.97 2
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% ARFEELNADLFR 95.00% 3.89 0.374 0 494.2555 1,479.74 1,480.75 3 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% ARFEELNADLFR 95.00% 4.66 0.375 0 494.2557 1,479.74 1,480.75 3 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% ARFEELNADLFR 95.00% 4.01 0.331 0 494.256 1,479.74 1,480.75 3 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% ARFEELNADLFR 95.00% 4.07 0.338 0 494.2561 1,479.74 1,480.75 3 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% LLQDFFNGK 95.00% 2.98 0.333 0 541.2857 1,080.56 1,081.57 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% LLQDFFNGK 95.00% 3.14 0.352 1.66 541.2864 1,080.56 1,081.57 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% STAGDTHLGGEDFDNR 95.00% 2.63 0.372 0 564.5793 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% STAGDTHLGGEDFDNR 95.00% 2.27 0.305 0 564.5794 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% STAGDTHLGGEDFDNR 95.00% 3.35 0.534 0.959 564.5795 1,690.71 1,691.73 3 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% LDKGQIQEIVLVGGSTR 95.00% 3.02 0.449 0 605.3452 1,813.01 1,813.02 3
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% DAGTITGLNVLR 95.00% 3.47 0.445 2.24 615.3453 1,228.68 1,229.69 2
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% DAGTITGLNVLR 95.00% 3.36 0.447 1.77 615.3465 1,228.68 1,229.69 2
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% VEIIANDQGNR 94.50% 0 0 3.11 615.9706 1,229.93 1,228.63 2 HSP7C_HUMAN,HSP71_HUMAN,GRP78_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% FEELNADLFR 95.00% 2.58 0.397 1.57 627.3108 1,252.61 1,253.62 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% FEELNADLFR 95.00% 2.79 0.366 1.57 627.3109 1,252.61 1,253.62 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% ARFEELNADLFR 95.00% 3.23 0.362 2.48 740.8801 1,479.74 1,480.75 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% ARFEELNADLFR 95.00% 2.96 0.261 2.13 740.8806 1,479.75 1,480.75 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% ARFEELNADLFR 95.00% 2.98 0.323 2 740.8808 1,479.75 1,480.75 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% ARFEELNADLFR 95.00% 3.54 0.359 3.85 741.3818 1,480.75 1,480.75 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% TTPSYVAFTDTER 95.00% 2.09 0.285 1.1 744.3509 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% TTPSYVAFTDTER 95.00% 3.57 0.629 4.89 744.3535 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% TTPSYVAFTDTER 95.00% 3.66 0.609 4.41 744.354 1,486.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% TTPSYVAFTDTER 95.00% 3.66 0.585 4.08 744.8543 1,487.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% TTPSYVAFTDTER 95.00% 4.03 0.582 4.24 744.8552 1,487.69 1,487.70 2 HSP7C_HUMAN,HSP71_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% LLQDFFNGKELNK 95.00% 3.79 0.387 1.46 783.42 1,564.82 1,565.83 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% LLQDFFNGKELNK 95.00% 3.62 0.345 0 783.4202 1,564.82 1,565.83 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% LLQDFFNGKELNK 95.00% 3.82 0.311 1.89 783.4229 1,564.83 1,565.83 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% TFFPEEISSMVLTK 95.00% 2.77 0.489 3.4 814.9157 1,627.82 1,628.82 2
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% TFFPEEISSMVLTK 95.00% 3.28 0.548 6.82 814.9162 1,627.82 1,628.82 2
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% TFFPEEISSMVLTK 95.00% 3.62 0.507 6.72 814.9164 1,627.82 1,628.82 2
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% TFFPEEISSMVLTK 95.00% 2.26 0.374 0 815.4134 1,628.81 1,628.82 2
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% TFFPEEISSMVLTK 95.00% 2.93 0.459 5.48 815.4137 1,628.81 1,628.82 2
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% IINEPTAAAIAYGLDK 95.00% 5.04 0.603 6.05 830.4508 1,658.89 1,659.90 2 HSP7C_HUMAN,GRP78_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% IINEPTAAAIAYGLDK 95.00% 4.8 0.577 6.57 830.4514 1,658.89 1,659.90 2 HSP7C_HUMAN,GRP78_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% IINEPTAAAIAYGLDK 95.00% 4.72 0.586 4.31 830.4518 1,658.89 1,659.90 2 HSP7C_HUMAN,GRP78_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% STAGDTHLGGEDFDNR 95.00% 4.01 0.613 3.46 846.3637 1,690.71 1,691.73 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% STAGDTHLGGEDFDNR 95.00% 4.61 0.584 3.96 846.3651 1,690.71 1,691.73 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% STAGDTHLGGEDFDNR 95.00% 4.39 0.618 5.59 846.3656 1,690.72 1,691.73 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% STAGDTHLGGEDFDNR 95.00% 4.51 0.586 3.89 846.3673 1,690.72 1,691.73 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% IINEPTAAAIAYGLDKK 95.00% 5.16 0.579 6.59 894.497 1,786.98 1,787.99 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% IINEPTAAAIAYGLDKK 95.00% 4.59 0.568 5.8 894.498 1,786.98 1,787.99 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% IINEPTAAAIAYGLDKK 95.00% 4.87 0.554 6.74 894.4992 1,786.98 1,787.99 2 HSP7C_HUMAN
 SAMPLE 3R Heat shock-related 70 kDa protein 2  HSPA2  HSP72_HUMAN 70,005.00 100.00% 3 3 8 19.60% IINEPTAAAIAYGLDKK 95.00% 4.68 0.526 5.33 894.5001 1,786.98 1,787.99 2 HSP7C_HUMAN
 SAMPLE 4 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 2 30.30% TYFPHFDLSHGSAQVK 95.00% 2.42 0.248 0 612.306 1,833.89 1,833.89 3
 SAMPLE 4 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 2 30.30% FLASVSTVLTSK 95.00% 2.44 0.452 3.92 626.865 1,251.71 1,252.72 2
 SAMPLE 4 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 2 30.30% VGAHAGEYGAEALER 95.00% 3.84 0.556 3.7 765.3733 1,528.73 1,529.73 2 TPM1_HUMAN
 SAMPLE 4 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 2 30.30% VGAHAGEYGAEALER 95.00% 3.66 0.518 4.52 765.3742 1,528.73 1,529.73 2 TPM1_HUMAN
 SAMPLE 4R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 5 36.60% MFLSFPTTK 95.00% 2.15 0.269 0 536.2818 1,070.55 1,071.56 2
 SAMPLE 4R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 5 36.60% MFLSFPTTK 95.00% 2.08 0.284 0 536.2826 1,070.55 1,071.56 2
 SAMPLE 4R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 5 36.60% TYFPHFDLSHGSAQVK 95.00% 2.43 0.312 0 611.9719 1,832.89 1,833.89 3
 SAMPLE 4R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 5 36.60% FLASVSTVLTSK 95.00% 3.43 0.527 4.05 626.8635 1,251.71 1,252.72 2
 SAMPLE 4R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 5 36.60% FLASVSTVLTSK 95.00% 2.43 0.457 4.18 626.8644 1,251.71 1,252.72 2
 SAMPLE 4R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 5 36.60% VGAHAGEYGAEALER 95.00% 3.9 0.539 5.08 765.3769 1,528.74 1,529.73 2 TPM1_HUMAN
 SAMPLE 4R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 5 36.60% VGAHAGEYGAEALER 95.00% 3.75 0.513 3.24 765.8768 1,529.74 1,529.73 2 TPM1_HUMAN
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% VGAHAGEYGAEALER 95.00% 4.93 0.238 1.06 510.582 1,528.72 1,529.73 3 TPM1_HUMAN
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% VGAHAGEYGAEALER 95.00% 5.09 0.239 1.7 510.5822 1,528.72 1,529.73 3 TPM1_HUMAN
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% VGAHAGEYGAEALER 95.00% 3.45 0.167 1.33 510.5822 1,528.72 1,529.73 3 TPM1_HUMAN
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% VGAHAGEYGAEALER 95.00% 4.66 0.241 1.41 510.5823 1,528.72 1,529.73 3 TPM1_HUMAN
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% VGAHAGEYGAEALER 95.00% 2.27 0.281 0 510.8632 1,529.57 1,529.73 3 TPM1_HUMAN
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% VGAHAGEYGAEALER 95.00% 4.47 0.253 0 510.9167 1,529.73 1,529.73 3 TPM1_HUMAN
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% MFLSFPTTK 95.00% 2.58 0.411 0 536.2802 1,070.54 1,071.56 2
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% MFLSFPTTK 95.00% 2.63 0.386 1.12 536.2802 1,070.54 1,071.56 2
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% mFLSFPTTK 95.00% 2.03 0.141 1.82 m1: Oxidation (+15.99) 544.2765 1,086.54 1,087.55 2
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% mFLSFPTTK 95.00% 2.57 0.292 1.68 m1: Oxidation (+15.99) 544.2773 1,086.54 1,087.55 2
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% mFLSFPTTK 95.00% 2.53 0.299 1.46 m1: Oxidation (+15.99) 544.2774 1,086.54 1,087.55 2
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% TYFPHFDLSHGSAQVK 95.00% 1.9 0.31 0 611.9671 1,832.88 1,833.89 3
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% TYFPHFDLSHGSAQVK 95.00% 2.63 0.478 3.74 611.9684 1,832.88 1,833.89 3
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% TYFPHFDLSHGSAQVK 95.00% 3.01 0.491 3.52 611.9687 1,832.88 1,833.89 3
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% TYFPHFDLSHGSAQVK 95.00% 2.6 0.422 0 612.3019 1,833.88 1,833.89 3
 SAMPLE 2 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 10 36.60% FLASVSTVLTSK 95.00% 3.87 0.515 3.55 626.8588 1,251.70 1,252.72 2
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% VGAHAGEYGAEALER 95.00% 4.41 0.289 1.16 510.5825 1,528.72 1,529.73 3 TPM1_HUMAN
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% VGAHAGEYGAEALER 95.00% 3.76 0.209 1.49 510.5826 1,528.72 1,529.73 3 TPM1_HUMAN
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% VGAHAGEYGAEALER 95.00% 3.9 0.325 1.17 510.5831 1,528.73 1,529.73 3 TPM1_HUMAN
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% VGAHAGEYGAEALER 95.00% 4.58 0.212 1.04 510.9173 1,529.73 1,529.73 3 TPM1_HUMAN
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% MFLSFPTTK 95.00% 2.47 0.334 0 536.28 1,070.54 1,071.56 2
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% MFLSFPTTK 95.00% 1.98 0.289 0 536.2803 1,070.55 1,071.56 2
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% MFLSFPTTK 95.00% 2.61 0.366 1.23 536.2811 1,070.55 1,071.56 2
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% MFLSFPTTK 95.00% 2.3 0.293 0 536.2825 1,070.55 1,071.56 2
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% mFLSFPTTK 95.00% 2.26 0.264 0 m1: Oxidation (+15.99) 544.2781 1,086.54 1,087.55 2
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% TYFPHFDLSHGSAQVK 95.00% 3.39 0.531 1.47 611.9672 1,832.88 1,833.89 3
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% TYFPHFDLSHGSAQVK 95.00% 2.64 0.442 1.43 611.9675 1,832.88 1,833.89 3
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% FLASVSTVLTSK 95.00% 3.94 0.545 4.6 626.8598 1,251.70 1,252.72 2
 SAMPLE 2R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 100.00% 3 3 9 36.60% FLASVSTVLTSK 95.00% 3.41 0.532 3.17 626.8615 1,251.71 1,252.72 2
 SAMPLE 3 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 3 25.40% VGAHAGEYGAEALER 95.00% 4.23 0.243 1.24 510.5824 1,528.72 1,529.73 3 TPM1_HUMAN
 SAMPLE 3 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 3 25.40% VGAHAGEYGAEALER 95.00% 3.84 0.242 2.47 510.5826 1,528.72 1,529.73 3 TPM1_HUMAN
 SAMPLE 3 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 3 25.40% VGAHAGEYGAEALER 95.00% 4.67 0.325 1.66 510.5828 1,528.72 1,529.73 3 TPM1_HUMAN
 SAMPLE 3 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 3 25.40% VGAHAGEYGAEALER 95.00% 3.15 0.119 1.06 510.5828 1,528.73 1,529.73 3 TPM1_HUMAN
 SAMPLE 3 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 3 25.40% VGAHAGEYGAEALER 95.00% 4.23 0.182 1.54 510.5834 1,528.73 1,529.73 3 TPM1_HUMAN
 SAMPLE 3 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 3 25.40% VGAHAGEYGAEALER 95.00% 2.94 0.263 0 510.916 1,529.72 1,529.73 3 TPM1_HUMAN
 SAMPLE 3 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 3 25.40% MFLSFPTTK 95.00% 2.26 0.311 0 536.2799 1,070.54 1,071.56 2
 SAMPLE 3 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 3 25.40% FLASVSTVLTSK 95.00% 3.81 0.55 5.28 626.8599 1,251.70 1,252.72 2
 SAMPLE 3 Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 3 25.40% FLASVSTVLTSK 95.00% 3.7 0.5 4.39 626.8607 1,251.71 1,252.72 2
 SAMPLE 3R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 4 25.40% VGAHAGEYGAEALER 95.00% 3.54 0.262 1.47 510.5823 1,528.72 1,529.73 3 TPM1_HUMAN
 SAMPLE 3R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 4 25.40% VGAHAGEYGAEALER 95.00% 4.1 0.267 0 510.5824 1,528.72 1,529.73 3 TPM1_HUMAN
 SAMPLE 3R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 4 25.40% VGAHAGEYGAEALER 95.00% 4.41 0.292 0 510.5831 1,528.73 1,529.73 3 TPM1_HUMAN
 SAMPLE 3R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 4 25.40% VGAHAGEYGAEALER 95.00% 4.44 0.236 1.72 510.5834 1,528.73 1,529.73 3 TPM1_HUMAN
 SAMPLE 3R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 4 25.40% VGAHAGEYGAEALER 95.00% 4.18 0.229 0 510.5835 1,528.73 1,529.73 3 TPM1_HUMAN
 SAMPLE 3R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 4 25.40% VGAHAGEYGAEALER 95.00% 3.94 0.291 0 510.9164 1,529.73 1,529.73 3 TPM1_HUMAN
 SAMPLE 3R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 4 25.40% MFLSFPTTK 95.00% 2.46 0.346 0 536.28 1,070.54 1,071.56 2
 SAMPLE 3R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 4 25.40% MFLSFPTTK 95.00% 2.54 0.396 0 536.2803 1,070.55 1,071.56 2
 SAMPLE 3R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 4 25.40% FLASVSTVLTSK 95.00% 3.02 0.48 2.96 626.8606 1,251.71 1,252.72 2
 SAMPLE 3R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 4 25.40% FLASVSTVLTSK 95.00% 3.22 0.525 3.4 626.8609 1,251.71 1,252.72 2
 SAMPLE 3R Hemoglobin subunit alpha  HBA1  HBA_HUMAN 15,239.60 99.80% 2 2 4 25.40% VGAHAGEYGAEALER 95.00% 3.62 0.483 4.11 765.3695 1,528.72 1,529.73 2 TPM1_HUMAN
 SAMPLE 4 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 4 4 7 42.20% SAVTALWGK 95.00% 3.06 0.488 1.68 466.7657 931.5158 932.5206 2
 SAMPLE 4 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 4 4 7 42.20% SAVTALWGK 95.00% 2.82 0.486 1.4 466.7659 931.5161 932.5206 2
 SAMPLE 4 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 4 4 7 42.20% VVAGVANALAHKYH 95.00% 1.94 0.404 0 483.9395 1,448.80 1,449.80 3
 SAMPLE 4 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 4 4 7 42.20% VLGAFSDGLAHLDNLK 95.00% 1.97 0.328 1.14 557.3035 1,668.89 1,669.89 3
 SAMPLE 4 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 4 4 7 42.20% VLGAFSDGLAHLDNLK 95.00% 2.76 0.479 1.6 557.6376 1,669.89 1,669.89 3
 SAMPLE 4 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 4 4 7 42.20% LLVVYPWTQR 95.00% 2.2 0.265 0 637.8677 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 4 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 4 4 7 42.20% LLVVYPWTQR 95.00% 2.89 0.487 2.49 637.8687 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 4 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 4 4 7 42.20% LLVVYPWTQR 95.00% 2.87 0.469 1.77 637.869 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 4 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 4 4 7 42.20% LLVVYPWTQR 95.00% 2.75 0.526 2.46 637.8692 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 4 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 4 4 7 42.20% LLVVYPWTQR 95.00% 1.92 0.315 0 637.8695 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 4 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 4 4 7 42.20% VNVDEVGGEALGR 95.00% 4.04 0.541 2.25 657.8384 1,313.66 1,314.67 2
 SAMPLE 4 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 4 4 7 42.20% VNVDEVGGEALGR 95.00% 3.85 0.519 3.38 657.839 1,313.66 1,314.67 2
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% SAVTALWGK 95.00% 2.22 0.419 1.6 466.7659 931.5162 932.5206 2
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% SAVTALWGK 95.00% 2.77 0.509 0 466.7665 931.5174 932.5206 2
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% VVAGVANALAHKYH 95.00% 1.69 0.32 0 483.9398 1,448.80 1,449.80 3
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% VLGAFSDGLAHLDNLK 95.00% 2.58 0.401 2.33 557.3044 1,668.89 1,669.89 3
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% VLGAFSDGLAHLDNLK 95.00% 3.09 0.48 4.11 557.6372 1,669.89 1,669.89 3
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% VVAGVANALAHK 95.00% 3.16 0.447 6.47 575.3419 1,148.67 1,149.67 2
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% VVAGVANALAHK 95.00% 2.74 0.363 6.11 575.3421 1,148.67 1,149.67 2
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% LLVVYPWTQR 95.00% 2.83 0.478 2.96 637.8679 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% LLVVYPWTQR 95.00% 2.71 0.518 1.51 637.8686 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% LLVVYPWTQR 95.00% 2.83 0.49 2.8 637.8686 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% LLVVYPWTQR 95.00% 2.67 0.476 2.26 637.8698 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% LLVVYPWTQR 95.00% 2.28 0.294 2.59 637.8813 1,273.75 1,274.73 2 PLEC1_HUMAN
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% VNVDEVGGEALGR 95.00% 2.73 0.384 2.09 657.8387 1,313.66 1,314.67 2
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% VNVDEVGGEALGR 95.00% 3.33 0.405 2.14 658.3408 1,314.67 1,314.67 2
 SAMPLE 4R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 10 42.20% VLGAFSDGLAHLDNLK 95.00% 4.27 0.482 6.08 835.9513 1,669.89 1,669.89 2
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% SAVTALWGK 95.00% 2.89 0.458 1.59 466.7632 931.5107 932.5206 2
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% SAVTALWGK 95.00% 3.04 0.523 1.92 466.7642 931.5127 932.5206 2
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% SAVTALWGK 95.00% 2.97 0.485 0 466.7643 931.5129 932.5206 2
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% SAVTALWGK 95.00% 2.88 0.484 1.7 466.7661 931.5166 932.5206 2
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% VVAGVANALAHKYH 95.00% 1.67 0.223 1 483.9362 1,448.79 1,449.80 3
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% VLGAFSDGLAHLDNLK 95.00% 2.85 0.416 2.05 557.3007 1,668.88 1,669.89 3
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% VLGAFSDGLAHLDNLK 95.00% 2.9 0.491 2.62 557.6354 1,669.88 1,669.89 3
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% VVAGVANALAHK 95.00% 3.11 0.448 3.4 575.3392 1,148.66 1,149.67 2
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% VVAGVANALAHK 95.00% 2.92 0.409 6.72 575.3397 1,148.66 1,149.67 2
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% VVAGVANALAHK 95.00% 1.65 0.444 0 575.6035 1,149.19 1,149.67 2
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% LLVVYPWTQR 95.00% 2.6 0.494 0 637.8647 1,273.71 1,274.73 2 PLEC1_HUMAN
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% LLVVYPWTQR 95.00% 2.67 0.523 1.77 637.8655 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% LLVVYPWTQR 95.00% 2.83 0.507 2.74 637.8658 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% LLVVYPWTQR 95.00% 2.73 0.505 2.85 637.8659 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% LLVVYPWTQR 95.00% 2.66 0.471 0 637.8664 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% VNVDEVGGEALGR 95.00% 4.12 0.513 4.41 657.8327 1,313.65 1,314.67 2
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% VNVDEVGGEALGR 95.00% 4.2 0.52 3.92 657.8344 1,313.65 1,314.67 2
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% VNVDEVGGEALGR 95.00% 4.07 0.551 2.96 657.8349 1,313.65 1,314.67 2
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% VNVDEVGGEALGR 95.00% 4 0.515 2.8 657.8352 1,313.65 1,314.67 2
 SAMPLE 2 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 6 6 15 50.30% EFTPPVQAAYQK 95.00% 2.85 0.25 1.48 689.854 1,377.69 1,378.70 2
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% SAVTALWGK 95.00% 3.16 0.494 1.13 466.7646 931.5135 932.5206 2
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% SAVTALWGK 95.00% 3.13 0.474 1.24 466.7649 931.5142 932.5206 2
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% SAVTALWGK 95.00% 3.03 0.454 1.82 466.7652 931.5147 932.5206 2
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% SAVTALWGK 95.00% 2.96 0.536 1.66 466.7661 931.5165 932.5206 2
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% VLGAFSDGLAHLDNLK 95.00% 3.05 0.427 0 557.6349 1,669.88 1,669.89 3
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% VLGAFSDGLAHLDNLK 95.00% 2.79 0.441 0 557.6352 1,669.88 1,669.89 3
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% VVAGVANALAHK 95.00% 2.77 0.417 5.47 575.3391 1,148.66 1,149.67 2
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% LLVVYPWTQR 95.00% 2.5 0.469 2.32 637.8649 1,273.71 1,274.73 2 PLEC1_HUMAN
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% LLVVYPWTQR 95.00% 2.89 0.504 2.3 637.8656 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% LLVVYPWTQR 95.00% 2.52 0.509 2 637.8656 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% LLVVYPWTQR 95.00% 2.67 0.423 1.33 637.8659 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% LLVVYPWTQR 95.00% 2.78 0.522 2.47 637.8665 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% LLVVYPWTQR 95.00% 2.9 0.503 2.39 637.8668 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% VNVDEVGGEALGR 95.00% 3.72 0.497 4.31 657.8328 1,313.65 1,314.67 2
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% VNVDEVGGEALGR 95.00% 3.93 0.474 3.47 657.8336 1,313.65 1,314.67 2
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% VNVDEVGGEALGR 95.00% 4.29 0.514 3.42 657.835 1,313.65 1,314.67 2
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% VNVDEVGGEALGR 95.00% 4.01 0.491 2.39 657.8357 1,313.66 1,314.67 2
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% VVAGVANALAHKYH 95.00% 3.1 0.489 3.85 725.4013 1,448.79 1,449.80 2
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% VLGAFSDGLAHLDNLK 95.00% 4.57 0.4 3.96 835.4501 1,668.88 1,669.89 2
 SAMPLE 2R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 6 14 42.20% VLGAFSDGLAHLDNLK 95.00% 3.36 0.327 1.8 835.8675 1,669.72 1,669.89 2
 SAMPLE 3 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 3 3 6 29.90% SAVTALWGK 95.00% 2.59 0.44 1.39 466.7639 931.5121 932.5206 2
 SAMPLE 3 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 3 3 6 29.90% SAVTALWGK 95.00% 2.27 0.403 1.11 466.7641 931.5125 932.5206 2
 SAMPLE 3 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 3 3 6 29.90% SAVTALWGK 95.00% 2.93 0.464 1.82 466.7643 931.5129 932.5206 2
 SAMPLE 3 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 3 3 6 29.90% LLVVYPWTQR 95.00% 2.91 0.507 2.96 637.8657 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 3 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 3 3 6 29.90% LLVVYPWTQR 95.00% 2.91 0.497 2.06 637.8661 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 3 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 3 3 6 29.90% LLVVYPWTQR 95.00% 2.61 0.476 3 637.8665 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 3 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 3 3 6 29.90% LLVVYPWTQR 95.00% 2.74 0.392 3.12 637.8676 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 3 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 3 3 6 29.90% VNVDEVGGEALGR 95.00% 4.25 0.521 2.92 657.8347 1,313.65 1,314.67 2
 SAMPLE 3 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 3 3 6 29.90% VNVDEVGGEALGR 95.00% 4.09 0.482 3.48 657.8352 1,313.65 1,314.67 2
 SAMPLE 3 Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 3 3 6 29.90% EFTPPVQAAYQK 95.00% 2.47 0.323 0 689.8528 1,377.69 1,378.70 2
 SAMPLE 3R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 5 6 42.20% SAVTALWGK 95.00% 2.57 0.417 1.43 466.7638 931.5119 932.5206 2
 SAMPLE 3R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 5 6 42.20% VVAGVANALAHKYH 95.00% 2.08 0.221 0 483.9369 1,448.79 1,449.80 3
 SAMPLE 3R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 5 6 42.20% VVAGVANALAHK 95.00% 2.44 0.31 1.24 575.2685 1,148.52 1,149.67 2
 SAMPLE 3R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 5 6 42.20% LLVVYPWTQR 95.00% 2.83 0.504 2.89 637.8654 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 3R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 5 6 42.20% LLVVYPWTQR 95.00% 2.82 0.49 2.85 637.8656 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 3R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 5 6 42.20% LLVVYPWTQR 95.00% 2.2 0.457 1.64 637.8658 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 3R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 5 6 42.20% LLVVYPWTQR 95.00% 2.64 0.457 2.77 637.8665 1,273.72 1,274.73 2 PLEC1_HUMAN
 SAMPLE 3R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 5 6 42.20% VNVDEVGGEALGR 95.00% 4.16 0.529 3.13 657.8347 1,313.65 1,314.67 2
 SAMPLE 3R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 5 6 42.20% VNVDEVGGEALGR 95.00% 3.98 0.5 3.8 657.8355 1,313.66 1,314.67 2
 SAMPLE 3R Hemoglobin subunit beta  HBB  HBB_HUMAN 15,980.00 100.00% 5 5 6 42.20% VLGAFSDGLAHLDNLK 95.00% 2.74 0.206 0 835.8658 1,669.72 1,669.89 2
 SAMPLE 1 Hemopexin  HPX  HEMO_HUMAN 51,658.50 99.80% 2 2 4 5.84% SGAQATWTELPWPHEK 95.00% 3.41 0.454 1.49 613.2999 1,836.88 1,837.89 3
 SAMPLE 1 Hemopexin  HPX  HEMO_HUMAN 51,658.50 99.80% 2 2 4 5.84% SGAQATWTELPWPHEK 95.00% 4.53 0.383 1.19 613.6346 1,837.88 1,837.89 3
 SAMPLE 1 Hemopexin  HPX  HEMO_HUMAN 51,658.50 99.80% 2 2 4 5.84% YYcFQGNQFLR 95.00% 3.49 0.328 2.85 c3: Carbamidomethyl (+57.02) 748.3422 1,494.67 1,495.68 2
 SAMPLE 1 Hemopexin  HPX  HEMO_HUMAN 51,658.50 99.80% 2 2 4 5.84% YYcFQGNQFLR 95.00% 3.56 0.252 2.92 c3: Carbamidomethyl (+57.02) 748.3423 1,494.67 1,495.68 2
 SAMPLE 1R Hemopexin  HPX  HEMO_HUMAN 51,658.50 99.80% 2 2 4 5.84% SGAQATWTELPWPHEK 95.00% 2.92 0.345 1.72 613.3003 1,836.88 1,837.89 3
 SAMPLE 1R Hemopexin  HPX  HEMO_HUMAN 51,658.50 99.80% 2 2 4 5.84% SGAQATWTELPWPHEK 95.00% 3.48 0.284 1.09 613.3008 1,836.88 1,837.89 3
 SAMPLE 1R Hemopexin  HPX  HEMO_HUMAN 51,658.50 99.80% 2 2 4 5.84% YYcFQGNQFLR 95.00% 3.25 0.291 2.82 c3: Carbamidomethyl (+57.02) 748.343 1,494.67 1,495.68 2
 SAMPLE 1R Hemopexin  HPX  HEMO_HUMAN 51,658.50 99.80% 2 2 4 5.84% YYcFQGNQFLR 95.00% 3.44 0.31 2.77 c3: Carbamidomethyl (+57.02) 748.3438 1,494.67 1,495.68 2
 SAMPLE 1 Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 4 4.70% GASGSFVVVQK 95.00% 2.63 0.233 0 539.7983 1,077.58 1,078.59 2
 SAMPLE 1 Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 4 4.70% GASGSFVVVQK 95.00% 2.63 0.301 1.15 539.7987 1,077.58 1,078.59 2
 SAMPLE 1 Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 4 4.70% TIPSWATLSASQLAR 95.00% 4.29 0.505 5.41 801.4346 1,600.85 1,601.87 2
 SAMPLE 1 Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 4 4.70% TIPSWATLSASQLAR 95.00% 4.12 0.553 5.41 801.4353 1,600.85 1,601.87 2
 SAMPLE 1R Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 3 4.70% GASGSFVVVQK 95.00% 2.42 0.266 0 539.7998 1,077.58 1,078.59 2
 SAMPLE 1R Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 3 4.70% TIPSWATLSASQLAR 95.00% 4.26 0.511 4.82 801.4354 1,600.86 1,601.87 2
 SAMPLE 1R Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 3 4.70% TIPSWATLSASQLAR 95.00% 4.19 0.482 5.89 801.9392 1,601.86 1,601.87 2
 SAMPLE 2R Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 100.00% 3 3 4 5.79% GASGSFVVVQK 95.00% 2.25 0.15 1.57 539.7992 1,077.58 1,078.59 2
 SAMPLE 2R Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 100.00% 3 3 4 5.79% MDAILTEAIK 95.00% 2.29 0.308 0 552.8 1,103.58 1,104.60 2
 SAMPLE 2R Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 100.00% 3 3 4 5.79% LEDVLPLAFTR 95.00% 2.26 0.379 2.4 637.3611 1,272.71 1,273.72 2
 SAMPLE 2R Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 100.00% 3 3 4 5.79% LEDVLPLAFTR 95.00% 2.17 0.25 1.85 637.3612 1,272.71 1,273.72 2
 SAMPLE 3 Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 3 3.80% MDAILTEAIK 95.00% 2.56 0.322 0 552.8022 1,103.59 1,104.60 2
 SAMPLE 3 Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 3 3.80% LEDVLPLAFTR 95.00% 3.4 0.376 2.18 637.3609 1,272.71 1,273.72 2
 SAMPLE 3 Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 3 3.80% LEDVLPLAFTR 95.00% 3.04 0.301 3.66 637.361 1,272.71 1,273.72 2
 SAMPLE 3R Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 3 3.98% GASGSFVVVQK 95.00% 2.73 0.267 1.11 539.7983 1,077.58 1,078.59 2
 SAMPLE 3R Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 3 3.98% LEDVLPLAFTR 95.00% 3.1 0.392 1.96 637.3606 1,272.71 1,273.72 2
 SAMPLE 3R Heterochromatin protein 1-binding protein 3  HP1BP3  HP1B3_HUMAN 61,190.70 99.80% 2 2 3 3.98% LEDVLPLAFTR 95.00% 3.24 0.366 2.35 637.3609 1,272.71 1,273.72 2
 SAMPLE 3 Heterogeneous nuclear ribonucleoprotein G  RBMX  HNRPG_HUMAN 42,315.70 99.80% 2 2 3 7.42% AIKVEQATKPSFESGR 95.00% 2.86 0.402 1.47 583.7579 1,748.25 1,747.93 3
 SAMPLE 3 Heterogeneous nuclear ribonucleoprotein G  RBMX  HNRPG_HUMAN 42,315.70 99.80% 2 2 3 7.42% AIKVEQATKPSFESGR 95.00% 2.93 0.527 0 583.7585 1,748.25 1,747.93 3
 SAMPLE 3 Heterogeneous nuclear ribonucleoprotein G  RBMX  HNRPG_HUMAN 42,315.70 99.80% 2 2 3 7.42% LFIGGLNTETNEK 95.00% 2.77 0.403 0 718.3749 1,434.73 1,435.74 2
 SAMPLE 3 Heterogeneous nuclear ribonucleoprotein H2  HNRNPH2  HNRH2_HUMAN 49,246.10 99.80% 2 3 5 8.24% HTGPNSPDTANDGFVR 95.00% 4.6 0.415 2.6 562.26 1,683.76 1,684.77 3
 SAMPLE 3 Heterogeneous nuclear ribonucleoprotein H2  HNRNPH2  HNRH2_HUMAN 49,246.10 99.80% 2 3 5 8.24% HTGPNSPDTANDGFVR 95.00% 3.8 0.395 3.74 562.2604 1,683.76 1,684.77 3
 SAMPLE 3 Heterogeneous nuclear ribonucleoprotein H2  HNRNPH2  HNRH2_HUMAN 49,246.10 99.80% 2 3 5 8.24% PSGEAFVELESEEEVKLALKK 95.00% 2.38 0.221 0 778.3555 2,332.04 2,332.23 3
 SAMPLE 3 Heterogeneous nuclear ribonucleoprotein H2  HNRNPH2  HNRH2_HUMAN 49,246.10 99.80% 2 3 5 8.24% HTGPNSPDTANDGFVR 95.00% 4.17 0.595 5.57 842.8871 1,683.76 1,684.77 2
 SAMPLE 3 Heterogeneous nuclear ribonucleoprotein H2  HNRNPH2  HNRH2_HUMAN 49,246.10 99.80% 2 3 5 8.24% HTGPNSPDTANDGFVR 95.00% 4.53 0.58 6.33 843.3887 1,684.76 1,684.77 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% mGPAmGPALGAGIER 95.00% 2.09 0.202 0 m1: Oxidation (+15.99), m5: Oxidation (+15.99) 487.2783 1,458.81 1,459.70 3
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% INEILSNALK 95.00% 2.38 0.272 0 557.8256 1,113.64 1,114.65 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% INEILSNALK 95.00% 2.41 0.294 0 557.8262 1,113.64 1,114.65 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% NLPFDFTWK 95.00% 2.07 0.361 0 584.2921 1,166.57 1,167.58 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% NLPFDFTWK 95.00% 2.1 0.398 0 584.2946 1,166.57 1,167.58 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% AFITNIPFDVK 95.00% 2.59 0.358 2.18 632.8492 1,263.68 1,264.69 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% AFITNIPFDVK 95.00% 2.87 0.391 1.92 632.8497 1,263.68 1,264.69 2
 SAMPLE 2R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 3 3 5 4.11% INEILSNALK 95.00% 2.43 0.235 0 557.8276 1,113.64 1,114.65 2
 SAMPLE 2R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 3 3 5 4.11% INEILSNALK 95.00% 2.74 0.246 0 558.327 1,114.64 1,114.65 2
 SAMPLE 2R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 3 3 5 4.11% NLPFDFTWK 95.00% 2.09 0.268 0 584.2921 1,166.57 1,167.58 2
 SAMPLE 2R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 3 3 5 4.11% NLPFDFTWK 95.00% 1.82 0.382 0 584.294 1,166.57 1,167.58 2
 SAMPLE 2R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 3 3 5 4.11% AFITNIPFDVK 95.00% 2.47 0.282 0 632.8502 1,263.68 1,264.69 2
 SAMPLE 3 Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 99.80% 2 2 2 2.74% FESPEVAER 95.00% 2.07 0.303 0 532.2551 1,062.49 1,063.51 2
 SAMPLE 3 Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 99.80% 2 2 2 2.74% AFITNIPFDVK 95.00% 2.82 0.213 0 632.8501 1,263.68 1,264.69 2
 SAMPLE 3R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% FESPEVAER 95.00% 2.02 0.265 0 532.255 1,062.49 1,063.51 2
 SAMPLE 3R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% FESPEVAER 95.00% 2.12 0.262 0 532.2554 1,062.50 1,063.51 2
 SAMPLE 3R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% INEILSNALK 95.00% 2.58 0.281 0 557.8248 1,113.63 1,114.65 2
 SAMPLE 3R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% INEILSNALK 95.00% 2.62 0.248 0 557.8272 1,113.64 1,114.65 2
 SAMPLE 3R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% AFITNIPFDVK 95.00% 2.85 0.246 0 632.8495 1,263.68 1,264.69 2
 SAMPLE 3R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% AFITNIPFDVK 95.00% 2.59 0.237 0 632.8499 1,263.68 1,264.69 2
 SAMPLE 3R Heterogeneous nuclear ribonucleoprotein M  HNRNPM  HNRPM_HUMAN 77,499.30 100.00% 4 4 7 6.16% MGPAMGPALGAGIER 95.00% 2.07 0.29 1.57 714.3607 1,426.71 1,427.71 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein U  HNRNPU  HNRPU_HUMAN 90,496.10 99.80% 2 2 6 2.91% McLFAGFQR 95.00% 2.79 0.446 0 c2: Carbamidomethyl (+57.02) 565.2667 1,128.52 1,129.53 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein U  HNRNPU  HNRPU_HUMAN 90,496.10 99.80% 2 2 6 2.91% McLFAGFQR 95.00% 2.72 0.43 2.31 c2: Carbamidomethyl (+57.02) 565.269 1,128.52 1,129.53 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein U  HNRNPU  HNRPU_HUMAN 90,496.10 99.80% 2 2 6 2.91% NFILDQTNVSAAAQR 95.00% 4.42 0.317 6.14 824.4223 1,646.83 1,647.85 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein U  HNRNPU  HNRPU_HUMAN 90,496.10 99.80% 2 2 6 2.91% NFILDQTNVSAAAQR 95.00% 4.31 0.364 4.92 824.4243 1,646.83 1,647.85 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein U  HNRNPU  HNRPU_HUMAN 90,496.10 99.80% 2 2 6 2.91% NFILDQTNVSAAAQR 95.00% 5.01 0.43 4.12 824.9242 1,647.83 1,647.85 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoprotein U  HNRNPU  HNRPU_HUMAN 90,496.10 99.80% 2 2 6 2.91% NFILDQTNVSAAAQR 95.00% 4.78 0.403 4.02 824.9261 1,647.84 1,647.85 2
 SAMPLE 2R Heterogeneous nuclear ribonucleoprotein U  HNRNPU  HNRPU_HUMAN 90,496.10 100.00% 3 3 6 5.10% McLFAGFQR 95.00% 2.81 0.462 1.92 c2: Carbamidomethyl (+57.02) 565.269 1,128.52 1,129.53 2
 SAMPLE 2R Heterogeneous nuclear ribonucleoprotein U  HNRNPU  HNRPU_HUMAN 90,496.10 100.00% 3 3 6 5.10% NFILDQTNVSAAAQR 95.00% 2.56 0.241 0 824.4081 1,646.80 1,647.85 2
 SAMPLE 2R Heterogeneous nuclear ribonucleoprotein U  HNRNPU  HNRPU_HUMAN 90,496.10 100.00% 3 3 6 5.10% NFILDQTNVSAAAQR 95.00% 4.92 0.415 3.3 824.9254 1,647.84 1,647.85 2
 SAMPLE 2R Heterogeneous nuclear ribonucleoprotein U  HNRNPU  HNRPU_HUMAN 90,496.10 100.00% 3 3 6 5.10% NFILDQTNVSAAAQR 95.00% 4.93 0.398 4.36 824.9265 1,647.84 1,647.85 2
 SAMPLE 2R Heterogeneous nuclear ribonucleoprotein U  HNRNPU  HNRPU_HUMAN 90,496.10 100.00% 3 3 6 5.10% SSGPTSLFAVTVAPPGAR 95.00% 2.9 0.479 0 858.4642 1,714.91 1,714.91 2
 SAMPLE 2R Heterogeneous nuclear ribonucleoprotein U  HNRNPU  HNRPU_HUMAN 90,496.10 100.00% 3 3 6 5.10% SSGPTSLFAVTVAPPGAR 95.00% 2.29 0.4 1.21 858.4646 1,714.91 1,714.91 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoproteins C1/C2  HNRNPC  HNRPC_HUMAN 33,652.50 99.80% 2 2 3 7.52% VFIGNLNTLVVK 95.00% 2.86 0.294 1.39 658.9129 1,315.81 1,316.79 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoproteins C1/C2  HNRNPC  HNRPC_HUMAN 33,652.50 99.80% 2 2 3 7.52% VFIGNLNTLVVK 95.00% 2.88 0.344 3.49 658.9132 1,315.81 1,316.79 2
 SAMPLE 1R Heterogeneous nuclear ribonucleoproteins C1/C2  HNRNPC  HNRPC_HUMAN 33,652.50 99.80% 2 2 3 7.52% GFAFVQYVNER 95.00% 2.85 0.268 1.82 665.3421 1,328.67 1,329.66 2
 SAMPLE 2 High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 99.80% 2 2 3 12.60% IKGEHPGLSIGDVAK 95.00% 3.71 0.382 2.66 507.617 1,519.83 1,520.84 3
 SAMPLE 2 High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 99.80% 2 2 3 12.60% IKGEHPGLSIGDVAK 95.00% 3.68 0.391 1.64 507.6182 1,519.83 1,520.84 3
 SAMPLE 2 High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 99.80% 2 2 3 12.60% MSSYAFFVQTcR 95.00% 2.83 0.0984 1.22 c11: Carbamidomethyl (+57.02) 748.8383 1,495.66 1,496.67 2
 SAMPLE 2R High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 4 13.50% IKGEHPGLSIGDVAK 95.00% 3.03 0.352 1.11 507.6183 1,519.83 1,520.84 3
 SAMPLE 2R High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 4 13.50% IKGEHPGLSIGDVAK 95.00% 2.47 0.238 0 507.6193 1,519.83 1,520.84 3
 SAMPLE 2R High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 4 13.50% KHPDASVNFSEFSK 95.00% 3.41 0.267 0 531.9292 1,592.76 1,592.77 3
 SAMPLE 2R High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 4 13.50% GEHPGLSIGDVAK 95.00% 2.06 0.33 0 640.3351 1,278.65 1,279.66 2
 SAMPLE 3 High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 7 13.50% IKGEHPGLSIGDVAK 95.00% 2.53 0.234 0 507.6175 1,519.83 1,520.84 3
 SAMPLE 3 High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 7 13.50% IKGEHPGLSIGDVAK 95.00% 3.46 0.387 1.44 507.6178 1,519.83 1,520.84 3
 SAMPLE 3 High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 7 13.50% IKGEHPGLSIGDVAK 95.00% 3.83 0.418 1.96 507.618 1,519.83 1,520.84 3
 SAMPLE 3 High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 7 13.50% KHPDASVNFSEFSK 95.00% 3.91 0.549 3.08 531.5953 1,591.76 1,592.77 3
 SAMPLE 3 High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 7 13.50% KHPDASVNFSEFSK 95.00% 3.7 0.509 1.92 531.9279 1,592.76 1,592.77 3
 SAMPLE 3 High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 7 13.50% GEHPGLSIGDVAK 95.00% 2.58 0.448 2.2 640.3346 1,278.65 1,279.66 2
 SAMPLE 3 High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 7 13.50% GEHPGLSIGDVAK 95.00% 2.58 0.389 1.92 640.8386 1,279.66 1,279.66 2
 SAMPLE 3R High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 4 13.50% IKGEHPGLSIGDVAK 95.00% 2.44 0.231 0 507.6194 1,519.83 1,520.84 3
 SAMPLE 3R High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 4 13.50% KHPDASVNFSEFSK 95.00% 4.17 0.454 1.89 531.5947 1,591.76 1,592.77 3
 SAMPLE 3R High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 4 13.50% GEHPGLSIGDVAK 95.00% 2.58 0.307 0 640.3363 1,278.66 1,279.66 2
 SAMPLE 3R High mobility group protein B1  HMGB1  HMGB1_HUMAN 24,876.70 100.00% 3 3 4 13.50% GEHPGLSIGDVAK 95.00% 2.63 0.379 2.72 640.8357 1,279.66 1,279.66 2
 SAMPLE 1 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 99.80% 2 2 6 11.00% ALAAAGYDVEK 95.00% 3.14 0.578 3.42 554.2862 1,106.56 1,107.57 2
 SAMPLE 1 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 99.80% 2 2 6 11.00% ALAAAGYDVEK 95.00% 2.53 0.569 2.7 554.2863 1,106.56 1,107.57 2
 SAMPLE 1 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 99.80% 2 2 6 11.00% ALAAAGYDVEK 95.00% 2.85 0.549 3.77 554.2865 1,106.56 1,107.57 2
 SAMPLE 1 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 99.80% 2 2 6 11.00% ALAAAGYDVEK 95.00% 2.61 0.517 2.77 554.2866 1,106.56 1,107.57 2
 SAMPLE 1 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 99.80% 2 2 6 11.00% ALAAAGYDVEK 95.00% 2.94 0.542 3.23 554.2905 1,106.57 1,107.57 2
 SAMPLE 1 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 99.80% 2 2 6 11.00% KASGPPVSELITK 95.00% 2.31 0.402 0 663.8282 1,325.64 1,326.76 2
 SAMPLE 1R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 99.80% 2 2 4 11.00% ALAAAGYDVEK 95.00% 2.89 0.533 2.46 554.2863 1,106.56 1,107.57 2
 SAMPLE 1R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 99.80% 2 2 4 11.00% ALAAAGYDVEK 95.00% 3 0.543 2.7 554.2884 1,106.56 1,107.57 2
 SAMPLE 1R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 99.80% 2 2 4 11.00% ALAAAGYDVEK 95.00% 2.94 0.542 2.85 554.2905 1,106.57 1,107.57 2
 SAMPLE 1R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 99.80% 2 2 4 11.00% KASGPPVSELITK 95.00% 3.79 0.585 4.82 663.8858 1,325.76 1,326.76 2
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEKNNSR 95.00% 2.01 0.531 1.44 526.9319 1,577.77 1,578.79 3
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEKNNSR 95.00% 2.19 0.46 2.6 526.9324 1,577.77 1,578.79 3
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEKNNSR 95.00% 2.14 0.518 1.23 526.9327 1,577.77 1,578.79 3
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEKNNSR 95.00% 2.41 0.475 1.41 526.9333 1,577.78 1,578.79 3
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEKNNSR 95.00% 2.59 0.499 0 526.934 1,577.78 1,578.79 3
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEK 95.00% 3.42 0.621 2.68 554.287 1,106.56 1,107.57 2
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEK 95.00% 3.37 0.573 2.48 554.2871 1,106.56 1,107.57 2
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ASGPPVSELITK 95.00% 2.86 0.587 2.17 599.8308 1,197.65 1,198.67 2
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ASGPPVSELITK 95.00% 2.61 0.574 2.11 599.8337 1,197.65 1,198.67 2
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ASGPPVSELITK 95.00% 2.1 0.376 2.89 600.3361 1,198.66 1,198.67 2
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% SLVSKGTLVQTK 95.00% 2.75 0.434 3.13 630.879 1,259.74 1,260.75 2 H15_HUMAN
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% SLVSKGTLVQTK 95.00% 3.18 0.502 3.06 630.8793 1,259.74 1,260.75 2 H15_HUMAN
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEKNNSR 95.00% 4.51 0.589 6.31 789.894 1,577.77 1,578.79 2
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEKNNSR 95.00% 4.28 0.654 6.72 789.8953 1,577.77 1,578.79 2
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEKNNSR 95.00% 4.59 0.624 6.92 789.8954 1,577.78 1,578.79 2
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEKNNSR 95.00% 4.68 0.613 6.01 789.896 1,577.78 1,578.79 2
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEKNNSR 95.00% 4.42 0.614 6.54 789.8972 1,577.78 1,578.79 2
 SAMPLE 2 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 18 17.80% ALAAAGYDVEKNNSR 95.00% 4.04 0.571 4.66 789.8978 1,577.78 1,578.79 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% SGVSLAALKK 95.00% 2.34 0.228 0 487.3038 972.5919 973.6047 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 2.28 0.335 0 526.9315 1,577.77 1,578.79 3
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 1.88 0.38 0 526.9324 1,577.77 1,578.79 3
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 2.28 0.522 1.74 526.9327 1,577.77 1,578.79 3
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 2.3 0.379 0 526.9328 1,577.77 1,578.79 3
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 2.26 0.363 0 526.933 1,577.78 1,578.79 3
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 2.16 0.519 2.23 526.9332 1,577.78 1,578.79 3
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 2.34 0.392 0 527.2643 1,578.77 1,578.79 3
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEK 95.00% 2.62 0.523 2.59 554.2857 1,106.56 1,107.57 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEK 95.00% 3.17 0.548 3.4 554.2859 1,106.56 1,107.57 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEK 95.00% 3.39 0.547 2.43 554.2866 1,106.56 1,107.57 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEK 95.00% 3.31 0.552 2.82 554.2871 1,106.56 1,107.57 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEK 95.00% 2.79 0.542 2.68 554.2872 1,106.56 1,107.57 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEK 95.00% 3.12 0.56 2.11 554.2873 1,106.56 1,107.57 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ASGPPVSELITK 95.00% 2.81 0.442 2.37 599.8305 1,197.65 1,198.67 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ASGPPVSELITK 95.00% 2.94 0.466 2.89 599.8334 1,197.65 1,198.67 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% SLVSKGTLVQTK 95.00% 2.79 0.428 3.35 630.879 1,259.74 1,260.75 2 H15_HUMAN
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% SLVSKGTLVQTK 95.00% 2.75 0.476 3.39 630.8791 1,259.74 1,260.75 2 H15_HUMAN
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 4.27 0.618 5.66 789.8952 1,577.77 1,578.79 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 4.47 0.642 5.85 789.8961 1,577.78 1,578.79 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 4.28 0.641 4.92 789.8961 1,577.78 1,578.79 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 3.77 0.609 4.34 789.8963 1,577.78 1,578.79 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 4.25 0.615 4.31 790.3966 1,578.78 1,578.79 2
 SAMPLE 2R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 5 6 24 22.40% ALAAAGYDVEKNNSR 95.00% 4.49 0.59 6.52 790.4024 1,578.79 1,578.79 2
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% ALAAAGYDVEKNNSR 95.00% 1.71 0.389 0 526.9304 1,577.77 1,578.79 3
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% ALAAAGYDVEKNNSR 95.00% 2.25 0.546 1.54 526.9329 1,577.78 1,578.79 3
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% ALAAAGYDVEK 95.00% 3.14 0.596 2.28 554.2862 1,106.56 1,107.57 2
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% ALAAAGYDVEK 95.00% 3.47 0.608 3.68 554.2863 1,106.56 1,107.57 2
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% ALAAAGYDVEK 95.00% 2.82 0.525 2.03 554.2865 1,106.56 1,107.57 2
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% ALAAAGYDVEK 95.00% 3.19 0.567 2.48 554.287 1,106.56 1,107.57 2
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% ALAAAGYDVEK 95.00% 3.26 0.55 3.72 554.2873 1,106.56 1,107.57 2
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% ALAAAGYDVEK 95.00% 3.09 0.521 2.23 554.2874 1,106.56 1,107.57 2
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% SLVSKGTLVQTK 95.00% 3.07 0.432 3.96 630.8792 1,259.74 1,260.75 2 H15_HUMAN
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% SLVSKGTLVQTK 95.00% 3.38 0.468 3.48 630.8794 1,259.74 1,260.75 2 H15_HUMAN
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% ALAAAGYDVEKNNSR 95.00% 4.39 0.642 6.44 789.8952 1,577.77 1,578.79 2
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% ALAAAGYDVEKNNSR 95.00% 4.32 0.595 6.74 789.8959 1,577.78 1,578.79 2
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% ALAAAGYDVEKNNSR 95.00% 4.48 0.614 7.02 789.8963 1,577.78 1,578.79 2
 SAMPLE 3 Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 3 4 14 12.30% ALAAAGYDVEKNNSR 95.00% 4.22 0.599 4.2 789.8972 1,577.78 1,578.79 2
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% ALAAAGYDVEKNNSR 95.00% 1.93 0.515 0 526.932 1,577.77 1,578.79 3
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% ALAAAGYDVEKNNSR 95.00% 2.29 0.497 1.47 526.9333 1,577.78 1,578.79 3
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% ALAAAGYDVEK 95.00% 3.38 0.578 2.8 554.2867 1,106.56 1,107.57 2
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% ALAAAGYDVEK 95.00% 3.28 0.59 3.17 554.2871 1,106.56 1,107.57 2
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% ALAAAGYDVEK 95.00% 2.72 0.436 2.1 554.2892 1,106.56 1,107.57 2
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% ALAAAGYDVEK 95.00% 2.79 0.484 1.54 554.2895 1,106.56 1,107.57 2
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% SLVSKGTLVQTK 95.00% 3.07 0.44 3.01 630.8784 1,259.74 1,260.75 2 H15_HUMAN
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% SLVSKGTLVQTK 95.00% 2.91 0.503 3.07 630.8792 1,259.74 1,260.75 2 H15_HUMAN
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% KASGPPVSELITK 95.00% 3.85 0.561 1.32 663.8841 1,325.75 1,326.76 2
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% KASGPPVSELITK 95.00% 2.42 0.261 0 664.3767 1,326.74 1,326.76 2
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% ALAAAGYDVEKNNSR 95.00% 4.29 0.588 4.37 789.8949 1,577.77 1,578.79 2
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% ALAAAGYDVEKNNSR 95.00% 4.4 0.638 5.64 789.8958 1,577.78 1,578.79 2
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% ALAAAGYDVEKNNSR 95.00% 4.5 0.621 6.31 789.8968 1,577.78 1,578.79 2
 SAMPLE 3R Histone H1.4  HIST1H1E  H14_HUMAN 21,848.90 100.00% 4 5 14 18.30% ALAAAGYDVEKNNSR 95.00% 3.87 0.202 0 790.3949 1,578.77 1,578.79 2
 SAMPLE 3 Histone H1.5  HIST1H1B  H15_HUMAN 22,563.70 99.80% 2 2 2 15.50% ALAAGGYDVEK 95.00% 2.59 0.431 2.36 547.7821 1,093.55 1,093.55 2
 SAMPLE 3 Histone H1.5  HIST1H1B  H15_HUMAN 22,563.70 99.80% 2 2 2 15.50% ATGPPVSELITK 95.00% 2.04 0.358 1.28 606.8444 1,211.67 1,212.68 2
 SAMPLE 3 Histone H1.5  HIST1H1B  H15_HUMAN 22,563.70 99.80% 2 2 2 15.50% SLVSKGTLVQTK 95.00% 3.07 0.432 3.96 630.8792 1,259.74 1,260.75 2 H14_HUMAN
 SAMPLE 3 Histone H1.5  HIST1H1B  H15_HUMAN 22,563.70 99.80% 2 2 2 15.50% SLVSKGTLVQTK 95.00% 3.38 0.468 3.48 630.8794 1,259.74 1,260.75 2 H14_HUMAN
 SAMPLE 3R Histone H2A type 2-A  HIST2H2AA3  H2A2A_HUMAN,H2A2C_HUMAN 14,078.00 99.80% 2 2 3 30.00% AGLQFPVGR 95.00% 3.18 0.319 0 472.7687 943.5218 944.5319 2
 SAMPLE 3R Histone H2A type 2-A  HIST2H2AA3  H2A2A_HUMAN,H2A2C_HUMAN 14,078.00 99.80% 2 2 3 30.00% AGLQFPVGR 95.00% 3.16 0.299 0 472.769 943.5224 944.5319 2
 SAMPLE 3R Histone H2A type 2-A  HIST2H2AA3  H2A2A_HUMAN,H2A2C_HUMAN 14,078.00 99.80% 2 2 3 30.00% AGLQFPVGR 95.00% 3.25 0.342 0 472.7693 943.5229 944.5319 2
 SAMPLE 3R Histone H2A type 2-A  HIST2H2AA3  H2A2A_HUMAN,H2A2C_HUMAN 14,078.00 99.80% 2 2 3 30.00% AGLQFPVGR 95.00% 3.16 0.335 0 472.7699 943.5242 944.5319 2
 SAMPLE 3R Histone H2A type 2-A  HIST2H2AA3  H2A2A_HUMAN,H2A2C_HUMAN 14,078.00 99.80% 2 2 3 30.00% NDEELNKLLGK 95.00% 2.81 0.363 1.47 636.8432 1,271.67 1,272.68 2
 SAMPLE 3R Histone H2A type 2-A  HIST2H2AA3  H2A2A_HUMAN,H2A2C_HUMAN 14,078.00 99.80% 2 2 3 30.00% NDEELNKLLGK 95.00% 2.72 0.407 3.38 636.8433 1,271.67 1,272.68 2
 SAMPLE 3R Histone H2A type 2-A  HIST2H2AA3  H2A2A_HUMAN,H2A2C_HUMAN 14,078.00 99.80% 2 2 3 30.00% VTIAQGGVLPNIQAVLLPK 95.00% 3.4 0.369 1.96 966.0869 1,930.16 1,931.17 2
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% VLKQVHPDTGISSK 95.00% 2.43 0.273 0 503.6202 1,507.84 1,508.84 3 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% SRKESYSIYVYK 95.00% 2.98 0.419 0 508.2696 1,521.79 1,522.79 3
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% SRKESYSIYVYK 95.00% 3.6 0.335 0 508.6017 1,522.78 1,522.79 3
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% IAGEASRLAHYNKR 95.00% 3.06 0.175 0 529.2914 1,584.85 1,585.86 3 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% ESYSIYVYK 95.00% 1.76 0.407 0 576.2841 1,150.55 1,151.56 2
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% ESYSIYVYK 95.00% 1.82 0.381 0 576.2841 1,150.55 1,151.56 2
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% EIQTAVRLLLPGELAK 95.00% 2.98 0.198 0 584.6863 1,751.04 1,751.04 3 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% KESYSIYVYK 95.00% 3.1 0.371 2.51 640.3297 1,278.64 1,279.66 2
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% KESYSIYVYK 95.00% 3.45 0.465 3.19 640.3315 1,278.65 1,279.66 2
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% VLKQVHPDTGISSK 95.00% 3.15 0.406 2.01 754.9286 1,507.84 1,508.84 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% EIQTAVRLLLPGELAK 95.00% 3.91 0.451 2.31 876.0237 1,750.03 1,751.04 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% EIQTAVRLLLPGELAK 95.00% 4.35 0.5 2.48 876.5245 1,751.03 1,751.04 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% AmGImNSFVNDIFER 95.00% 3.07 0.376 2.8 m2: Oxidation (+15.99), m5: Oxidation (+15.99) 888.4073 1,774.80 1,775.81 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3 Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 100.00% 3 3 6 56.30% AmGImNSFVNDIFER 95.00% 4.61 0.459 3.47 m2: Oxidation (+15.99), m5: Oxidation (+15.99) 888.9102 1,775.80 1,775.81 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% LLLPGELAK 95.00% 2.53 0.208 0 477.3043 952.5929 953.6038 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,MIME_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% STITSREIQTAVR 95.00% 2.64 0.292 0 487.939 1,460.79 1,461.80 3 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% VLKQVHPDTGISSK 95.00% 2.31 0.244 1.43 503.621 1,507.84 1,508.84 3 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% ESYSIYVYK 95.00% 1.8 0.273 0 576.2834 1,150.55 1,151.56 2
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% ESYSIYVYK 95.00% 1.78 0.465 0 576.2845 1,150.55 1,151.56 2
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% KESYSIYVYK 95.00% 3.25 0.404 2.57 640.3309 1,278.65 1,279.66 2
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% KESYSIYVYK 95.00% 3.1 0.394 2.68 640.3317 1,278.65 1,279.66 2
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% VLKQVHPDTGISSK 95.00% 2.81 0.507 1.8 754.927 1,507.84 1,508.84 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% EIQTAVRLLLPGELAK 95.00% 4.34 0.497 3.46 876.0252 1,750.03 1,751.04 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% EIQTAVRLLLPGELAK 95.00% 4.32 0.507 2.74 876.0283 1,750.04 1,751.04 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% AmGImNSFVNDIFER 95.00% 4.44 0.487 4.49 m2: Oxidation (+15.99), m5: Oxidation (+15.99) 888.408 1,774.80 1,775.81 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% AmGImNSFVNDIFER 95.00% 4.31 0.424 4.29 m2: Oxidation (+15.99), m5: Oxidation (+15.99) 888.9081 1,775.80 1,775.81 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3R Histone H2B type 1-B  HIST1H2BB  H2B1B_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN13,932.80 99.80% 2 2 4 48.40% AmGImNSFVNDIFER 95.00% 4.48 0.471 3.33 m2: Oxidation (+15.99), m5: Oxidation (+15.99) 888.9106 1,775.81 1,775.81 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1H_HUMAN,H2B1N_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% STITSREIQTAVR 95.00% 2.98 0.252 0 487.9371 1,460.79 1,461.80 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% STITSREIQTAVR 95.00% 2.79 0.213 0 487.9394 1,460.79 1,461.80 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% SRKESYSVYVYK 95.00% 4.25 0.387 0 503.5954 1,507.76 1,508.77 3
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% SRKESYSVYVYK 95.00% 4.19 0.424 0 503.596 1,507.76 1,508.77 3
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% VLKQVHPDTGISSK 95.00% 2.31 0.362 0 503.6209 1,507.84 1,508.84 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% VLKQVHPDTGISSK 95.00% 2.59 0.263 0 503.9558 1,508.84 1,508.84 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% KESYSVYVYKVLK 95.00% 2.52 0.271 0 536.3021 1,605.88 1,605.89 3
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% ESYSVYVYK 95.00% 2.04 0.428 0 569.2747 1,136.53 1,137.55 2
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% ESYSVYVYK 95.00% 2.38 0.473 0 569.2758 1,136.54 1,137.55 2
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% ESYSVYVYK 95.00% 1.88 0.438 0 569.2759 1,136.54 1,137.55 2
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% EIQTAVRLLLPGELAK 95.00% 2.63 0.234 0 584.3522 1,750.03 1,751.04 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% EIQTAVRLLLPGELAK 95.00% 3.3 0.207 0 584.6864 1,751.04 1,751.04 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% KESYSVYVYK 95.00% 2.38 0.289 1.72 633.3222 1,264.63 1,265.64 2
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% KESYSVYVYK 95.00% 3.08 0.46 2.82 633.3226 1,264.63 1,265.64 2
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% KESYSVYVYK 95.00% 2.95 0.421 2.07 633.3227 1,264.63 1,265.64 2
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% KESYSVYVYK 95.00% 2.35 0.428 1.72 633.3241 1,264.63 1,265.64 2
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% KESYSVYVYK 95.00% 2.7 0.436 1.35 633.3244 1,264.63 1,265.64 2
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% EIQTAVRLLLPGELAK 95.00% 4.27 0.461 1.6 876.0247 1,750.03 1,751.04 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 11 38.40% EIQTAVRLLLPGELAK 95.00% 4.22 0.506 3.62 876.0249 1,750.03 1,751.04 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% STITSREIQTAVR 95.00% 2.38 0.18 0 487.9386 1,460.79 1,461.80 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% SRKESYSVYVYK 95.00% 4.31 0.455 0 503.5953 1,507.76 1,508.77 3
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% SRKESYSVYVYK 95.00% 3.74 0.457 0 503.5966 1,507.77 1,508.77 3
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% VLKQVHPDTGISSK 95.00% 2.41 0.333 0 503.6203 1,507.84 1,508.84 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% ESYSVYVYK 95.00% 1.98 0.438 0 569.2747 1,136.53 1,137.55 2
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% ESYSVYVYK 95.00% 1.88 0.34 0 569.2747 1,136.53 1,137.55 2
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% ESYSVYVYK 95.00% 1.82 0.33 0 569.2758 1,136.54 1,137.55 2
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% ESYSVYVYK 95.00% 2.09 0.384 0 569.2763 1,136.54 1,137.55 2
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% EIQTAVRLLLPGELAK 95.00% 2.42 0.226 0 584.3521 1,750.03 1,751.04 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% KESYSVYVYK 95.00% 2.26 0.409 2.2 633.322 1,264.63 1,265.64 2
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% KESYSVYVYK 95.00% 2.95 0.441 1.96 633.3225 1,264.63 1,265.64 2
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% KESYSVYVYK 95.00% 2.8 0.485 2.49 633.3252 1,264.63 1,265.64 2
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% KESYSVYVYK 95.00% 2.8 0.363 2.89 633.8255 1,265.64 1,265.64 2
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% EIQTAVRLLLPGELAK 95.00% 4.13 0.416 3.27 876.5248 1,751.03 1,751.04 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% EIQTAVRLLLPGELAK 95.00% 4.41 0.505 2.62 876.5263 1,751.04 1,751.04 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% AmGImNSFVNDIFER 95.00% 4.28 0.506 5.2 m2: Oxidation (+15.99), m5: Oxidation (+15.99) 888.4091 1,774.80 1,775.81 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 10 50.40% AmGImNSFVNDIFER 95.00% 4.67 0.427 3.42 m2: Oxidation (+15.99), m5: Oxidation (+15.99) 888.911 1,775.81 1,775.81 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% SRKESYSVYVYK 95.00% 4.29 0.45 0 503.5959 1,507.76 1,508.77 3
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% VLKQVHPDTGISSK 95.00% 2.43 0.273 0 503.6202 1,507.84 1,508.84 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% IAGEASRLAHYNKR 95.00% 3.06 0.175 0 529.2914 1,584.85 1,585.86 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% ESYSVYVYK 95.00% 2.01 0.479 0 569.2759 1,136.54 1,137.55 2
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% ESYSVYVYK 95.00% 2.16 0.485 1.8 569.2763 1,136.54 1,137.55 2
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% EIQTAVRLLLPGELAK 95.00% 2.98 0.198 0 584.6863 1,751.04 1,751.04 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% KESYSVYVYK 95.00% 2.57 0.29 1.96 633.3227 1,264.63 1,265.64 2
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% KESYSVYVYK 95.00% 3.3 0.405 3 633.3236 1,264.63 1,265.64 2
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% KESYSVYVYK 95.00% 2.97 0.405 2.25 633.324 1,264.63 1,265.64 2
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% KESYSVYVYK 95.00% 2.95 0.356 2.96 633.324 1,264.63 1,265.64 2
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% KESYSVYVYK 95.00% 3.11 0.385 2.74 633.3244 1,264.63 1,265.64 2
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% VLKQVHPDTGISSK 95.00% 3.15 0.406 2.01 754.9286 1,507.84 1,508.84 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% EIQTAVRLLLPGELAK 95.00% 3.91 0.451 2.31 876.0237 1,750.03 1,751.04 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% EIQTAVRLLLPGELAK 95.00% 4.35 0.5 2.48 876.5245 1,751.03 1,751.04 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% AmGImNSFVNDIFER 95.00% 3.07 0.376 2.8 m2: Oxidation (+15.99), m5: Oxidation (+15.99) 888.4073 1,774.80 1,775.81 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3 Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 3 3 8 56.80% AmGImNSFVNDIFER 95.00% 4.61 0.459 3.47 m2: Oxidation (+15.99), m5: Oxidation (+15.99) 888.9102 1,775.80 1,775.81 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% LLLPGELAK 95.00% 2.53 0.208 0 477.3043 952.5929 953.6038 2 ,H2B1J_HUMAN,H2B1O_HUMAN,AEBP1_HUMAN,MIME_HUMAN,H2B1B_HUMAN
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% STITSREIQTAVR 95.00% 2.64 0.292 0 487.939 1,460.79 1,461.80 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% SRKESYSVYVYK 95.00% 4.24 0.449 0 503.5954 1,507.76 1,508.77 3
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% VLKQVHPDTGISSK 95.00% 2.31 0.244 1.43 503.621 1,507.84 1,508.84 3 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% SRKESYSVYVYK 95.00% 4.14 0.471 0 503.9299 1,508.77 1,508.77 3
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% KESYSVYVYKVLK 95.00% 2.35 0.348 0 536.3018 1,605.88 1,605.89 3
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% ESYSVYVYK 95.00% 1.82 0.387 0 569.276 1,136.54 1,137.55 2
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% ESYSVYVYK 95.00% 2.01 0.466 1.32 569.2762 1,136.54 1,137.55 2
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% KESYSVYVYK 95.00% 3.03 0.432 2.38 633.3228 1,264.63 1,265.64 2
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% KESYSVYVYK 95.00% 2.59 0.326 1.77 633.3229 1,264.63 1,265.64 2
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% KESYSVYVYK 95.00% 3.48 0.49 2.04 633.3237 1,264.63 1,265.64 2
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% VLKQVHPDTGISSK 95.00% 2.81 0.507 1.8 754.927 1,507.84 1,508.84 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% EIQTAVRLLLPGELAK 95.00% 4.34 0.497 3.46 876.0252 1,750.03 1,751.04 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% EIQTAVRLLLPGELAK 95.00% 4.32 0.507 2.74 876.0283 1,750.04 1,751.04 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% AmGImNSFVNDIFER 95.00% 4.44 0.487 4.49 m2: Oxidation (+15.99), m5: Oxidation (+15.99) 888.408 1,774.80 1,775.81 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% AmGImNSFVNDIFER 95.00% 4.31 0.424 4.29 m2: Oxidation (+15.99), m5: Oxidation (+15.99) 888.9081 1,775.80 1,775.81 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 3R Histone H2B type 1-C/E/F/G/I  HIST1H2BC  H2B1C_HUMAN,H2B1D_HUMAN,H2B1H_HUMAN,H2B1K_HUMAN,H2B1M_HUMAN,H2B1N_HUMAN13,801.50 100.00% 4 4 8 50.40% AmGImNSFVNDIFER 95.00% 4.48 0.471 3.33 m2: Oxidation (+15.99), m5: Oxidation (+15.99) 888.9106 1,775.81 1,775.81 2 ,H2B1J_HUMAN,H2B1O_HUMAN,H2B1B_HUMAN
 SAMPLE 2 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 5 5 12 44.70% VFLENVIR 95.00% 2.55 0.291 0 495.2893 988.563 989.5784 2
 SAMPLE 2 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 5 5 12 44.70% VFLENVIR 95.00% 2.6 0.217 0 495.2914 988.5672 989.5784 2
 SAMPLE 2 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 5 5 12 44.70% VFLENVIR 95.00% 2.6 0.291 0 495.2917 988.5677 989.5784 2
 SAMPLE 2 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 5 5 12 44.70% ISGLIYEETR 95.00% 2.44 0.319 1.25 590.8121 1,179.61 1,180.62 2
 SAMPLE 2 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 5 5 12 44.70% ISGLIYEETR 95.00% 2.83 0.37 1.26 590.813 1,179.61 1,180.62 2
 SAMPLE 2 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 5 5 12 44.70% TVTAMDVVYALK 95.00% 3.13 0.271 2.89 655.8537 1,309.69 1,310.70 2
 SAMPLE 2 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 5 5 12 44.70% TVTAMDVVYALK 95.00% 3.48 0.437 4.17 656.3548 1,310.69 1,310.70 2
 SAMPLE 2 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 5 5 12 44.70% DNIQGITKPAIR 95.00% 2.79 0.228 1.36 663.3784 1,324.74 1,325.75 2
 SAMPLE 2 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 5 5 12 44.70% DNIQGITKPAIR 95.00% 2.76 0.219 1.92 663.3791 1,324.74 1,325.75 2
 SAMPLE 2 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 5 5 12 44.70% DNIQGITKPAIR 95.00% 3.21 0.234 1.6 663.3797 1,324.74 1,325.75 2
 SAMPLE 2 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 5 5 12 44.70% DNIQGITKPAIR 95.00% 2.66 0.219 1.51 663.38 1,324.74 1,325.75 2
 SAMPLE 2 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 5 5 12 44.70% ISGLIYEETRGVLK 95.00% 3.29 0.285 2.6 789.4469 1,576.88 1,577.89 2
 SAMPLE 2R Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 10 40.80% VFLENVIR 95.00% 2.68 0.308 0 495.2917 988.5677 989.5784 2
 SAMPLE 2R Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 10 40.80% VFLENVIR 95.00% 2.9 0.351 0 495.2917 988.5678 989.5784 2
 SAMPLE 2R Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 10 40.80% ISGLIYEETR 95.00% 3.33 0.442 3 590.8117 1,179.61 1,180.62 2
 SAMPLE 2R Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 10 40.80% TVTAMDVVYALK 95.00% 2.78 0.463 3.3 655.8528 1,309.69 1,310.70 2
 SAMPLE 2R Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 10 40.80% TVTAMDVVYALK 95.00% 2.99 0.436 3.57 655.8541 1,309.69 1,310.70 2
 SAMPLE 2R Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 10 40.80% TVTAMDVVYALK 95.00% 3.34 0.465 4.46 656.3578 1,310.70 1,310.70 2
 SAMPLE 2R Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 10 40.80% DNIQGITKPAIR 95.00% 2.73 0.229 1.41 663.3789 1,324.74 1,325.75 2
 SAMPLE 2R Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 10 40.80% DNIQGITKPAIR 95.00% 2.59 0.239 0 663.3795 1,324.74 1,325.75 2
 SAMPLE 2R Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 10 40.80% DNIQGITKPAIR 95.00% 2.98 0.243 1.59 663.3796 1,324.74 1,325.75 2
 SAMPLE 2R Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 10 40.80% DNIQGITKPAIR 95.00% 2.83 0.219 0 663.3797 1,324.74 1,325.75 2
 SAMPLE 3 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 8 40.80% VFLENVIR 95.00% 2.67 0.359 0 495.2916 988.5675 989.5784 2
 SAMPLE 3 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 8 40.80% VFLENVIR 95.00% 2.5 0.341 0 495.2921 988.5685 989.5784 2
 SAMPLE 3 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 8 40.80% ISGLIYEETR 95.00% 2.96 0.421 1.17 590.8133 1,179.61 1,180.62 2
 SAMPLE 3 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 8 40.80% ISGLIYEETR 95.00% 3.12 0.391 1.37 590.8144 1,179.61 1,180.62 2
 SAMPLE 3 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 8 40.80% TVTAMDVVYALK 95.00% 3.21 0.305 4.27 655.8543 1,309.69 1,310.70 2
 SAMPLE 3 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 8 40.80% TVTAMDVVYALK 95.00% 2.79 0.201 2.51 655.8544 1,309.69 1,310.70 2
 SAMPLE 3 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 8 40.80% DNIQGITKPAIR 95.00% 3 0.211 1.72 663.3788 1,324.74 1,325.75 2
 SAMPLE 3 Histone H4  HIST1H4A  H4_HUMAN 11,349.70 100.00% 4 4 8 40.80% DNIQGITKPAIR 95.00% 3.1 0.225 2.2 663.3791 1,324.74 1,325.75 2
 SAMPLE 1 Hsc70-interacting protein  ST13  F10A1_HUMAN 41,314.40 99.80% 2 2 4 6.50% AIDLFTDAIK 95.00% 2.53 0.357 1.92 553.8046 1,105.59 1,106.61 2
 SAMPLE 1 Hsc70-interacting protein  ST13  F10A1_HUMAN 41,314.40 99.80% 2 2 4 6.50% AIDLFTDAIK 95.00% 2.69 0.342 1.64 553.8071 1,105.60 1,106.61 2
 SAMPLE 1 Hsc70-interacting protein  ST13  F10A1_HUMAN 41,314.40 99.80% 2 2 4 6.50% VAAIEALNDGELQK 95.00% 4.2 0.467 3.29 735.8933 1,469.77 1,470.78 2
 SAMPLE 1 Hsc70-interacting protein  ST13  F10A1_HUMAN 41,314.40 99.80% 2 2 4 6.50% VAAIEALNDGELQK 95.00% 4.89 0.446 3.77 736.3938 1,470.77 1,470.78 2
 SAMPLE 1R Hsc70-interacting protein  ST13  F10A1_HUMAN 41,314.40 99.80% 2 2 4 6.50% AIDLFTDAIK 95.00% 2.82 0.3 1.43 553.8061 1,105.60 1,106.61 2
 SAMPLE 1R Hsc70-interacting protein  ST13  F10A1_HUMAN 41,314.40 99.80% 2 2 4 6.50% AIDLFTDAIK 95.00% 2.44 0.284 2.12 553.8068 1,105.60 1,106.61 2
 SAMPLE 1R Hsc70-interacting protein  ST13  F10A1_HUMAN 41,314.40 99.80% 2 2 4 6.50% VAAIEALNDGELQK 95.00% 4.2 0.458 4.44 735.893 1,469.77 1,470.78 2
 SAMPLE 1R Hsc70-interacting protein  ST13  F10A1_HUMAN 41,314.40 99.80% 2 2 4 6.50% VAAIEALNDGELQK 95.00% 4.53 0.474 2.96 735.894 1,469.77 1,470.78 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% cSPTEAAVR 95.00% 1.71 0.256 1.7 c1: Carbamidomethyl (+57.02) 496.2394 990.4632 990.4679 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 2.92 0.419 1.11 510.2853 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 2.74 0.474 1.19 510.2855 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 3.07 0.393 1.92 510.2857 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 3.48 0.416 1.57 510.286 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 2.77 0.38 0 510.2863 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 3.7 0.387 0 510.2863 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 3.84 0.391 1.38 510.2863 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 3.69 0.44 2.47 510.2867 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 3.48 0.377 2 510.2867 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 2.83 0.317 1.39 510.2868 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 3.86 0.402 1.22 510.2869 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 3.19 0.403 0 510.2869 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 3.18 0.353 1.21 510.2872 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 3.15 0.352 1.64 510.2912 1,018.57 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 3.43 0.349 1.51 510.2927 1,018.57 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% VGQIFAAWK 95.00% 3.46 0.452 0 510.2933 1,018.57 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYRDPTAFGSGIHK 95.00% 4.05 0.405 1.23 532.6028 1,594.79 1,595.80 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYRDPTAFGSGIHK 95.00% 3.43 0.428 0 532.6029 1,594.79 1,595.80 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYRDPTAFGSGIHK 95.00% 4.35 0.393 1.48 532.603 1,594.79 1,595.80 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYRDPTAFGSGIHK 95.00% 4.92 0.455 1 532.6031 1,594.79 1,595.80 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYRDPTAFGSGIHK 95.00% 3.96 0.407 0 532.6031 1,594.79 1,595.80 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYRDPTAFGSGIHK 95.00% 3.06 0.318 0 532.6041 1,594.79 1,595.80 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYRDPTAFGSGIHK 95.00% 4.66 0.55 1.77 532.6049 1,594.79 1,595.80 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LYGVYcFR 95.00% 3.09 0.296 0 c6: Carbamidomethyl (+57.02) 539.261 1,076.51 1,077.52 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LYGVYcFR 95.00% 2.92 0.257 0 c6: Carbamidomethyl (+57.02) 539.261 1,076.51 1,077.52 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LYGVYcFR 95.00% 2.67 0.21 1.42 c6: Carbamidomethyl (+57.02) 539.2613 1,076.51 1,077.52 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LYGVYcFR 95.00% 2.91 0.232 0 c6: Carbamidomethyl (+57.02) 539.2613 1,076.51 1,077.52 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LYGVYcFR 95.00% 2.87 0.239 0 c6: Carbamidomethyl (+57.02) 539.2616 1,076.51 1,077.52 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LYGVYcFR 95.00% 2.65 0.198 0 c6: Carbamidomethyl (+57.02) 539.2619 1,076.51 1,077.52 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LYGVYcFR 95.00% 3.03 0.287 0 c6: Carbamidomethyl (+57.02) 539.2621 1,076.51 1,077.52 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LYGVYcFR 95.00% 3.33 0.293 0 c6: Carbamidomethyl (+57.02) 539.2699 1,076.52 1,077.52 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% DPTAFGSGIHK 95.00% 2.45 0.348 0 565.2827 1,128.55 1,129.56 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% DPTAFGSGIHK 95.00% 2.52 0.419 0 565.2844 1,128.55 1,129.56 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% NYGFWDKDK 95.00% 2.28 0.285 0 586.7707 1,171.53 1,172.54 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% NYGFWDKDK 95.00% 2.62 0.386 2.74 586.771 1,171.53 1,172.54 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% NYGFWDKDK 95.00% 2.57 0.263 1.21 586.7713 1,171.53 1,172.54 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% NYGFWDKDK 95.00% 2.73 0.297 2 586.7714 1,171.53 1,172.54 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% NYGFWDKDK 95.00% 2.27 0.301 1.29 586.7715 1,171.53 1,172.54 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% NYGFWDKDK 95.00% 2.11 0.367 1.3 586.7718 1,171.53 1,172.54 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% NYGFWDKDK 95.00% 2.57 0.371 2.68 586.7732 1,171.53 1,172.54 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% NYGFWDKDK 95.00% 2.36 0.287 0 586.774 1,171.53 1,172.54 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% NYGFWDKDK 95.00% 2.63 0.387 3 586.7745 1,171.53 1,172.54 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYYLIHPTK 95.00% 2.84 0.408 1.59 591.3201 1,180.62 1,181.64 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYYLIHPTK 95.00% 2.41 0.311 1.44 591.3203 1,180.62 1,181.64 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYYLIHPTK 95.00% 2.66 0.32 1.28 591.3204 1,180.63 1,181.64 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYYLIHPTK 95.00% 2.86 0.455 1.7 591.3204 1,180.63 1,181.64 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYYLIHPTK 95.00% 2.84 0.462 1.17 591.3218 1,180.63 1,181.64 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% SRYDVFcFTSNFNGR 95.00% 2.69 0.188 0 c7: Carbamidomethyl (+57.02) 623.9487 1,868.82 1,869.83 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% SRYDVFcFTSNFNGR 95.00% 3.17 0.389 2 c7: Carbamidomethyl (+57.02) 624.2775 1,869.81 1,869.83 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% cDAGWLADGSVR 95.00% 1.92 0.255 2.41 c1: Carbamidomethyl (+57.02) 654.3324 1,306.65 1,306.59 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% EPcGGQNTVPGVR 95.00% 1.74 0.362 0 c3: Carbamidomethyl (+57.02) 685.8267 1,369.64 1,370.65 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% EPcGGQNTVPGVR 95.00% 1.62 0.264 1.59 c3: Carbamidomethyl (+57.02) 685.8271 1,369.64 1,370.65 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 3.66 0.509 2.09 c10: Carbamidomethyl (+57.02) 694.0041 2,078.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 4.42 0.495 1.55 c10: Carbamidomethyl (+57.02) 694.0047 2,078.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 4.63 0.523 1.23 c10: Carbamidomethyl (+57.02) 694.0057 2,078.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 3.68 0.398 0 c10: Carbamidomethyl (+57.02) 694.0057 2,078.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 2.8 0.356 0 c10: Carbamidomethyl (+57.02) 694.0109 2,079.01 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 4.03 0.459 1.4 c10: Carbamidomethyl (+57.02) 694.3375 2,079.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 5.21 0.51 3.49 c10: Carbamidomethyl (+57.02) 694.3379 2,079.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 5.74 0.564 3.92 c10: Carbamidomethyl (+57.02) 694.3384 2,079.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 4.63 0.495 1.49 c10: Carbamidomethyl (+57.02) 694.3386 2,079.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 3.3 0.487 2 c10: Carbamidomethyl (+57.02) 694.3386 2,079.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 4.86 0.575 3.82 c10: Carbamidomethyl (+57.02) 694.3387 2,079.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 3.91 0.417 0 c10: Carbamidomethyl (+57.02) 694.3388 2,079.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 3.47 0.419 2 c10: Carbamidomethyl (+57.02) 694.3393 2,079.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 4.45 0.515 3.15 c10: Carbamidomethyl (+57.02) 694.3394 2,079.99 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 4.88 0.543 3.01 c10: Carbamidomethyl (+57.02) 694.3395 2,080.00 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 5.41 0.566 3.26 c10: Carbamidomethyl (+57.02) 694.3494 2,080.02 2,080.00 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% AIHIQAENGPHLLVEAEQAK 95.00% 3.79 0.469 3.57 723.7134 2,168.12 2,168.15 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% AIHIQAENGPHLLVEAEQAK 95.00% 3.93 0.505 2.57 723.7139 2,168.12 2,168.15 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% AIHIQAENGPHLLVEAEQAK 95.00% 3.76 0.513 4.54 723.714 2,168.12 2,168.15 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% AIHIQAENGPHLLVEAEQAK 95.00% 0 0 3.3 724.0466 2,169.12 2,168.15 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% AIHIQAENGPHLLVEAEQAK 95.00% 0 0 3.32 724.0477 2,169.12 2,168.15 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% AIHIQAENGPHLLVEAEQAK 95.00% 0 0 3.4 724.0486 2,169.12 2,168.15 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% cDAGWLADGSVRYPISRPR 95.00% 3.89 0.505 2.85 c1: Carbamidomethyl (+57.02) 726.0301 2,175.07 2,176.07 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% cDAGWLADGSVRYPISRPR 95.00% 4.08 0.488 3.55 c1: Carbamidomethyl (+57.02) 726.3611 2,176.06 2,176.07 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 4.12 0.507 1.8 729.0141 2,184.02 2,184.03 3
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYRDPTAFGSGIHK 95.00% 3.6 0.391 5.12 798.3992 1,594.78 1,595.80 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYRDPTAFGSGIHK 95.00% 3.69 0.414 4.07 798.4006 1,594.79 1,595.80 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYRDPTAFGSGIHK 95.00% 3.54 0.433 4.06 798.4007 1,594.79 1,595.80 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% FYRDPTAFGSGIHK 95.00% 2.9 0.445 5.44 798.4046 1,594.79 1,595.80 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% YDVFcFTSNFNGR 95.00% 2.68 0.481 4.85 c5: Carbamidomethyl (+57.02) 814.344 1,626.67 1,626.70 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% YDVFcFTSNFNGR 95.00% 3.14 0.465 4.43 c5: Carbamidomethyl (+57.02) 814.3444 1,626.67 1,626.70 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% YDVFcFTSNFNGR 95.00% 2.98 0.393 4.7 c5: Carbamidomethyl (+57.02) 814.3446 1,626.67 1,626.70 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% YDVFcFTSNFNGR 95.00% 2.85 0.473 4.52 c5: Carbamidomethyl (+57.02) 814.3446 1,626.67 1,626.70 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% YDVFcFTSNFNGR 95.00% 2.92 0.558 3.48 c5: Carbamidomethyl (+57.02) 814.3451 1,626.67 1,626.70 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% YDVFcFTSNFNGR 95.00% 2.98 0.369 5 c5: Carbamidomethyl (+57.02) 814.3454 1,626.68 1,626.70 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% YDVFcFTSNFNGR 95.00% 2.74 0.467 5.38 c5: Carbamidomethyl (+57.02) 814.3457 1,626.68 1,626.70 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% YDVFcFTSNFNGR 95.00% 2.8 0.455 4.77 c5: Carbamidomethyl (+57.02) 814.3565 1,626.70 1,626.70 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% YDVFcFTSNFNGR 95.00% 2.5 0.489 3.48 c5: Carbamidomethyl (+57.02) 814.3582 1,626.70 1,626.70 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% YDVFcFTSNFNGR 95.00% 3.17 0.449 4.62 c5: Carbamidomethyl (+57.02) 814.3623 1,626.71 1,626.70 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% YDVFcFTSNFNGR 95.00% 3.07 0.472 3.28 c5: Carbamidomethyl (+57.02) 814.3626 1,626.71 1,626.70 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.5 0.63 5.59 c10: Carbamidomethyl (+57.02) 1,040.50 2,078.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 5.98 0.59 5.96 c10: Carbamidomethyl (+57.02) 1,040.50 2,078.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.23 0.624 6.28 c10: Carbamidomethyl (+57.02) 1,040.50 2,078.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.01 0.614 7.21 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.37 0.543 4.39 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.01 0.56 5.24 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.42 0.598 5.77 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.53 0.544 5.39 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.33 0.542 4.82 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.33 0.595 4.85 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.64 0.578 5.17 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.66 0.557 5.42 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.45 0.57 5.28 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.47 0.548 5.08 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.57 0.57 5.77 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.41 0.557 5.14 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 5.44 0.566 3.85 c10: Carbamidomethyl (+57.02) 1,041.01 2,080.00 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.76 0.604 5.66 c10: Carbamidomethyl (+57.02) 1,041.01 2,080.01 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.56 0.589 5.35 c10: Carbamidomethyl (+57.02) 1,041.02 2,080.02 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.61 0.519 6.89 c10: Carbamidomethyl (+57.02) 1,041.02 2,080.03 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% LTYDEAVQAcLNDGAQIAK 95.00% 6.58 0.558 6.03 c10: Carbamidomethyl (+57.02) 1,041.02 2,080.03 2,080.00 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 6.14 0.682 7.28 1,092.51 2,183.01 2,184.03 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 6.42 0.659 5.96 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 6.42 0.67 6.31 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 6.39 0.661 5.77 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 6.33 0.638 5.42 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 6.72 0.628 6.25 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 6.43 0.654 5.19 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 6.43 0.674 6.62 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 5.97 0.665 7.07 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 6.52 0.64 6.37 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 6.24 0.642 6.02 1,093.03 2,184.05 2,184.03 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 6.09 0.637 5.62 1,093.03 2,184.05 2,184.03 2
 SAMPLE 1 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 15 18 127 46.60% GGSDSDASLVITDLTLEDYGR 95.00% 6.46 0.667 6 1,093.04 2,184.07 2,184.03 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.54 0.422 1.92 510.2858 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.9 0.391 1.96 510.2859 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.68 0.355 1.52 510.2859 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.52 0.422 1.82 510.2863 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.56 0.404 1.82 510.2863 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.4 0.375 1.72 510.2867 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.7 0.398 2.48 510.2868 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.14 0.355 0 510.2869 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.04 0.42 2.28 510.287 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.4 0.393 1.31 510.2871 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.3 0.418 1.7 510.2872 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.46 0.412 1.22 510.2877 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 2.62 0.362 1.19 510.2898 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.43 0.349 1.89 510.2927 1,018.57 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.46 0.452 0 510.2933 1,018.57 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.27 0.316 1.27 510.295 1,018.57 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.81 0.388 1.37 510.2953 1,018.57 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% VGQIFAAWK 95.00% 3.38 0.393 2.28 510.2954 1,018.58 1,019.57 2 IF4G3_HUMAN
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYRDPTAFGSGIHK 95.00% 4.17 0.514 0 532.6021 1,594.78 1,595.80 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYRDPTAFGSGIHK 95.00% 4.29 0.513 1.64 532.6026 1,594.78 1,595.80 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYRDPTAFGSGIHK 95.00% 2.68 0.173 0 532.6029 1,594.79 1,595.80 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYRDPTAFGSGIHK 95.00% 4.18 0.365 2.07 532.603 1,594.79 1,595.80 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYRDPTAFGSGIHK 95.00% 4.41 0.42 1.89 532.6031 1,594.79 1,595.80 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LYGVYcFR 95.00% 2.92 0.257 1.19 c6: Carbamidomethyl (+57.02) 539.261 1,076.51 1,077.52 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LYGVYcFR 95.00% 2.88 0.223 0 c6: Carbamidomethyl (+57.02) 539.2617 1,076.51 1,077.52 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LYGVYcFR 95.00% 2.86 0.214 0 c6: Carbamidomethyl (+57.02) 539.2617 1,076.51 1,077.52 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LYGVYcFR 95.00% 2.71 0.212 0 c6: Carbamidomethyl (+57.02) 539.2621 1,076.51 1,077.52 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LYGVYcFR 95.00% 2.87 0.28 1.15 c6: Carbamidomethyl (+57.02) 539.2621 1,076.51 1,077.52 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LYGVYcFR 95.00% 2.91 0.196 0 c6: Carbamidomethyl (+57.02) 539.2622 1,076.51 1,077.52 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LYGVYcFR 95.00% 2.47 0.144 0 c6: Carbamidomethyl (+57.02) 539.2625 1,076.51 1,077.52 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LYGVYcFR 95.00% 3.33 0.293 0 c6: Carbamidomethyl (+57.02) 539.2699 1,076.52 1,077.52 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% DPTAFGSGIHK 95.00% 2.56 0.38 0 565.2833 1,128.55 1,129.56 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% DPTAFGSGIHK 95.00% 2.28 0.346 0 565.2835 1,128.55 1,129.56 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% NYGFWDKDK 95.00% 2.66 0.404 1.38 586.7713 1,171.53 1,172.54 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% NYGFWDKDK 95.00% 2.5 0.376 1.57 586.7713 1,171.53 1,172.54 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYYLIHPTK 95.00% 2.83 0.478 1.85 591.3196 1,180.62 1,181.64 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYYLIHPTK 95.00% 2.84 0.408 1.49 591.3201 1,180.62 1,181.64 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYYLIHPTK 95.00% 2.94 0.445 1.25 591.3204 1,180.63 1,181.64 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYYLIHPTK 95.00% 2.84 0.462 0 591.3218 1,180.63 1,181.64 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% SRYDVFcFTSNFNGR 95.00% 3.57 0.418 0 c7: Carbamidomethyl (+57.02) 624.2756 1,869.80 1,869.83 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% SRYDVFcFTSNFNGR 95.00% 3.31 0.43 1.14 c7: Carbamidomethyl (+57.02) 624.2765 1,869.81 1,869.83 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% EPcGGQNTVPGVR 95.00% 1.69 0.325 2.25 c3: Carbamidomethyl (+57.02) 685.8266 1,369.64 1,370.65 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 3.1 0.257 0 c10: Carbamidomethyl (+57.02) 694.0057 2,078.99 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 2.8 0.356 0 c10: Carbamidomethyl (+57.02) 694.0109 2,079.01 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 3.45 0.29 0 c10: Carbamidomethyl (+57.02) 694.0172 2,079.03 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 4.92 0.564 5.05 c10: Carbamidomethyl (+57.02) 694.3375 2,079.99 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 4.5 0.495 3 c10: Carbamidomethyl (+57.02) 694.3383 2,079.99 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 4.02 0.493 1.06 c10: Carbamidomethyl (+57.02) 694.3383 2,079.99 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 2.85 0.222 0 c10: Carbamidomethyl (+57.02) 694.3384 2,079.99 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 3.8 0.458 0 c10: Carbamidomethyl (+57.02) 694.339 2,079.99 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 2.96 0.26 0 c10: Carbamidomethyl (+57.02) 694.3391 2,079.99 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 5.22 0.583 3.2 c10: Carbamidomethyl (+57.02) 694.3391 2,079.99 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 3.98 0.51 1.82 c10: Carbamidomethyl (+57.02) 694.3392 2,079.99 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 4.44 0.46 2.8 c10: Carbamidomethyl (+57.02) 694.3393 2,079.99 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 4.88 0.543 4.41 c10: Carbamidomethyl (+57.02) 694.3395 2,080.00 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 3.86 0.413 1.32 c10: Carbamidomethyl (+57.02) 694.3398 2,080.00 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 5.41 0.566 3.39 c10: Carbamidomethyl (+57.02) 694.3494 2,080.02 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 5.21 0.558 3.66 c10: Carbamidomethyl (+57.02) 694.3526 2,080.03 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 3.87 0.534 1.15 c10: Carbamidomethyl (+57.02) 694.3529 2,080.04 2,080.00 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% AIHIQAENGPHLLVEAEQAK 95.00% 3.6 0.466 2.68 723.713 2,168.12 2,168.15 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% AIHIQAENGPHLLVEAEQAK 95.00% 3.9 0.547 4 723.7147 2,168.12 2,168.15 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% AIHIQAENGPHLLVEAEQAK 95.00% 0 0 3.77 724.0479 2,169.12 2,168.15 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% AIHIQAENGPHLLVEAEQAK 95.00% 0 0 4.3 724.0483 2,169.12 2,168.15 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% AIHIQAENGPHLLVEAEQAK 95.00% 0 0 4.09 724.0484 2,169.12 2,168.15 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% AIHIQAENGPHLLVEAEQAK 95.00% 0 0 3.57 724.056 2,169.14 2,168.15 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYRDPTAFGSGIHK 95.00% 4.37 0.41 4.42 798.3999 1,594.78 1,595.80 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYRDPTAFGSGIHK 95.00% 4.24 0.461 5.32 798.4005 1,594.79 1,595.80 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYRDPTAFGSGIHK 95.00% 3.7 0.408 4.4 798.4008 1,594.79 1,595.80 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% FYRDPTAFGSGIHK 95.00% 3.34 0.354 4.55 798.4021 1,594.79 1,595.80 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% YDVFcFTSNFNGR 95.00% 2.97 0.513 4.15 c5: Carbamidomethyl (+57.02) 814.3443 1,626.67 1,626.70 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% YDVFcFTSNFNGR 95.00% 2.86 0.428 6 c5: Carbamidomethyl (+57.02) 814.3444 1,626.67 1,626.70 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% YDVFcFTSNFNGR 95.00% 2.71 0.429 4.28 c5: Carbamidomethyl (+57.02) 814.3452 1,626.67 1,626.70 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% YDVFcFTSNFNGR 95.00% 2.69 0.463 3.85 c5: Carbamidomethyl (+57.02) 814.3452 1,626.67 1,626.70 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% YDVFcFTSNFNGR 95.00% 3.16 0.501 3.68 c5: Carbamidomethyl (+57.02) 814.3454 1,626.68 1,626.70 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% YDVFcFTSNFNGR 95.00% 2.67 0.297 4.29 c5: Carbamidomethyl (+57.02) 814.3456 1,626.68 1,626.70 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% YDVFcFTSNFNGR 95.00% 3.24 0.489 4.17 c5: Carbamidomethyl (+57.02) 814.3459 1,626.68 1,626.70 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% YDVFcFTSNFNGR 95.00% 2.8 0.455 4.42 c5: Carbamidomethyl (+57.02) 814.3565 1,626.70 1,626.70 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% YDVFcFTSNFNGR 95.00% 2.5 0.489 3.72 c5: Carbamidomethyl (+57.02) 814.3582 1,626.70 1,626.70 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% YDVFcFTSNFNGR 95.00% 3.29 0.443 4.3 c5: Carbamidomethyl (+57.02) 814.3606 1,626.71 1,626.70 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGLDWcNAGWLSDGSVQYPITKPR 95.00% 5.82 0.553 3.3 c6: Carbamidomethyl (+57.02) 893.4317 2,677.27 2,677.28 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGLDWcNAGWLSDGSVQYPITKPR 95.00% 5.83 0.558 5.43 c6: Carbamidomethyl (+57.02) 893.4318 2,677.27 2,677.28 3
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.28 0.541 5.15 c10: Carbamidomethyl (+57.02) 1,040.50 2,078.98 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.29 0.598 7.21 c10: Carbamidomethyl (+57.02) 1,040.50 2,078.99 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 5.68 0.61 7.19 c10: Carbamidomethyl (+57.02) 1,040.50 2,078.99 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 5.79 0.645 5.6 c10: Carbamidomethyl (+57.02) 1,040.51 2,078.99 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 5.98 0.575 6.85 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.39 0.574 6.03 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.55 0.551 5.28 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.54 0.554 6.42 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.41 0.574 4.96 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.59 0.558 5.28 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.67 0.577 5.74 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.44 0.594 5.42 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.77 0.577 5.74 c10: Carbamidomethyl (+57.02) 1,041.01 2,080.00 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.13 0.524 6.14 c10: Carbamidomethyl (+57.02) 1,041.01 2,080.00 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.47 0.558 5.39 c10: Carbamidomethyl (+57.02) 1,041.01 2,080.00 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 5.44 0.566 3.96 c10: Carbamidomethyl (+57.02) 1,041.01 2,080.00 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.76 0.604 6.22 c10: Carbamidomethyl (+57.02) 1,041.01 2,080.01 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.56 0.589 5.92 c10: Carbamidomethyl (+57.02) 1,041.02 2,080.02 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.61 0.519 6.7 c10: Carbamidomethyl (+57.02) 1,041.02 2,080.03 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.47 0.582 5.35 c10: Carbamidomethyl (+57.02) 1,041.02 2,080.03 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% LTYDEAVQAcLNDGAQIAK 95.00% 6.46 0.524 6.77 c10: Carbamidomethyl (+57.02) 1,041.03 2,080.04 2,080.00 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGSDSDASLVITDLTLEDYGR 95.00% 6.33 0.67 6.15 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGSDSDASLVITDLTLEDYGR 95.00% 6.34 0.642 5.82 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGSDSDASLVITDLTLEDYGR 95.00% 6.5 0.645 6.21 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGSDSDASLVITDLTLEDYGR 95.00% 6.64 0.654 5.41 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGSDSDASLVITDLTLEDYGR 95.00% 6.26 0.658 6.14 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGSDSDASLVITDLTLEDYGR 95.00% 6.44 0.648 6.22 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGSDSDASLVITDLTLEDYGR 95.00% 6.38 0.641 5.66 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGSDSDASLVITDLTLEDYGR 95.00% 6.4 0.646 5.1 1,093.02 2,184.02 2,184.03 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGSDSDASLVITDLTLEDYGR 95.00% 6.24 0.642 5.64 1,093.03 2,184.05 2,184.03 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGSDSDASLVITDLTLEDYGR 95.00% 6.09 0.637 6.52 1,093.03 2,184.05 2,184.03 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGSDSDASLVITDLTLEDYGR 95.00% 6.33 0.647 5.72 1,093.04 2,184.07 2,184.03 2
 SAMPLE 1R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 13 15 114 45.50% GGSDSDASLVITDLTLEDYGR 95.00% 6.42 0.665 5.11 1,093.04 2,184.07 2,184.03 2
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% VGQIFAAWK 95.00% 2.13 0.328 1.48 510.2859 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% VGQIFAAWK 95.00% 3.46 0.396 1.8 510.2862 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% VGQIFAAWK 95.00% 2.62 0.268 0 510.2862 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% VGQIFAAWK 95.00% 2.83 0.433 1.96 510.2862 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% VGQIFAAWK 95.00% 2.32 0.252 0 510.2864 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% VGQIFAAWK 95.00% 3.48 0.437 2.3 510.2864 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% VGQIFAAWK 95.00% 3.14 0.431 2.25 510.2865 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% VGQIFAAWK 95.00% 2.77 0.241 1.59 510.2867 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% VGQIFAAWK 95.00% 3.26 0.418 0 510.2872 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% LYGVYcFR 95.00% 2.85 0.228 0 c6: Carbamidomethyl (+57.02) 539.2608 1,076.51 1,077.52 2
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% LYGVYcFR 95.00% 2.77 0.208 0 c6: Carbamidomethyl (+57.02) 539.2612 1,076.51 1,077.52 2
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% DPTAFGSGIHK 95.00% 2.35 0.27 0 565.2854 1,128.56 1,129.56 2
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% FYYLIHPTK 95.00% 2.31 0.39 1.25 591.3213 1,180.63 1,181.64 2
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% FYYLIHPTK 95.00% 2.17 0.28 0 591.3217 1,180.63 1,181.64 2
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% LTYDEAVQAcLNDGAQIAK 95.00% 5.93 0.581 7.07 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% LTYDEAVQAcLNDGAQIAK 95.00% 6.09 0.563 6.39 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 2 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 5 5 17 15.80% LTYDEAVQAcLNDGAQIAK 95.00% 5.68 0.581 5.25 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% VGQIFAAWK 95.00% 3.31 0.408 1.72 510.2859 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% VGQIFAAWK 95.00% 2.31 0.273 0 510.2862 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% VGQIFAAWK 95.00% 3.03 0.445 1.89 510.2863 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% VGQIFAAWK 95.00% 2.86 0.407 2.77 510.2863 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% VGQIFAAWK 95.00% 2.66 0.283 0 510.2864 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% VGQIFAAWK 95.00% 2.5 0.413 2.31 510.2864 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% VGQIFAAWK 95.00% 2.72 0.298 1.3 510.2867 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% VGQIFAAWK 95.00% 2.7 0.371 2.1 510.2881 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% VGQIFAAWK 95.00% 3.17 0.407 1.62 510.2881 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% FYRDPTAFGSGIHK 95.00% 3.35 0.42 0 532.6038 1,594.79 1,595.80 3
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% LYGVYcFR 95.00% 2.69 0.201 0 c6: Carbamidomethyl (+57.02) 539.2616 1,076.51 1,077.52 2
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% DPTAFGSGIHK 95.00% 2.43 0.223 0 565.2832 1,128.55 1,129.56 2
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% DPTAFGSGIHK 95.00% 2.2 0.259 1.21 565.2848 1,128.55 1,129.56 2
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% FYYLIHPTK 95.00% 2.29 0.281 1.64 591.3206 1,180.63 1,181.64 2
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% EPcGGQNTVPGVR 95.00% 1.66 0.382 1.12 c3: Carbamidomethyl (+57.02) 685.8267 1,369.64 1,370.65 2
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% LTYDEAVQAcLNDGAQIAK 95.00% 5.6 0.572 4.96 c10: Carbamidomethyl (+57.02) 1,041.00 2,079.99 2,080.00 2
 SAMPLE 2R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 7 7 17 20.30% LTYDEAVQAcLNDGAQIAK 95.00% 5.66 0.619 6.85 c10: Carbamidomethyl (+57.02) 1,041.01 2,080.00 2,080.00 2
 SAMPLE 3 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 7 12.70% VGQIFAAWK 95.00% 2.55 0.349 0 510.2859 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 3 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 7 12.70% VGQIFAAWK 95.00% 2.1 0.301 0 510.2863 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 3 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 7 12.70% FYRDPTAFGSGIHK 95.00% 3.43 0.29 0 532.9355 1,595.78 1,595.80 3
 SAMPLE 3 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 7 12.70% FYYLIHPTK 95.00% 2.18 0.33 1.19 591.3205 1,180.63 1,181.64 2
 SAMPLE 3 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 7 12.70% FYYLIHPTK 95.00% 2.33 0.302 1.38 591.3213 1,180.63 1,181.64 2
 SAMPLE 3 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 7 12.70% EPcGGQNTVPGVR 95.00% 1.53 0.359 1.59 c3: Carbamidomethyl (+57.02) 685.826 1,369.64 1,370.65 2
 SAMPLE 3 Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 7 12.70% EPcGGQNTVPGVR 95.00% 1.63 0.306 1.85 c3: Carbamidomethyl (+57.02) 686.3292 1,370.64 1,370.65 2
 SAMPLE 3R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 11 12.40% VGQIFAAWK 95.00% 2.5 0.399 1.64 510.2856 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 3R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 11 12.40% VGQIFAAWK 95.00% 2.28 0.357 1.57 510.2861 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 3R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 11 12.40% VGQIFAAWK 95.00% 2.79 0.329 1.66 510.2865 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 3R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 11 12.40% VGQIFAAWK 95.00% 3.04 0.361 2.11 510.287 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 3R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 11 12.40% VGQIFAAWK 95.00% 2.41 0.423 1.66 510.2887 1,018.56 1,019.57 2 IF4G3_HUMAN
 SAMPLE 3R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 11 12.40% FYRDPTAFGSGIHK 95.00% 3.4 0.372 0 532.6013 1,594.78 1,595.80 3
 SAMPLE 3R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 11 12.40% FYRDPTAFGSGIHK 95.00% 3.33 0.357 0 532.6044 1,594.79 1,595.80 3
 SAMPLE 3R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 11 12.40% LYGVYcFR 95.00% 2.52 0.176 0 c6: Carbamidomethyl (+57.02) 539.2607 1,076.51 1,077.52 2
 SAMPLE 3R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 11 12.40% LYGVYcFR 95.00% 2.38 0.186 0 c6: Carbamidomethyl (+57.02) 539.263 1,076.51 1,077.52 2
 SAMPLE 3R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 11 12.40% LYGVYcFR 95.00% 2.64 0.151 0 c6: Carbamidomethyl (+57.02) 539.2631 1,076.51 1,077.52 2
 SAMPLE 3R Hyaluronan and proteoglycan link protein 1  HAPLN1  HPLN1_HUMAN 40,148.20 100.00% 4 4 11 12.40% EPcGGQNTVPGVR 95.00% 1.73 0.356 0 c3: Carbamidomethyl (+57.02) 685.8272 1,369.64 1,370.65 2
 SAMPLE 1 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 99.80% 2 2 2 8.22% TFTcTAAYPESK 95.00% 2.8 0.469 3.08 c4: Carbamidomethyl (+57.02) 688.3114 1,374.61 1,375.62 2
 SAMPLE 1 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 99.80% 2 2 2 8.22% QEPSQGTTTFAVTSILR 95.00% 4.15 0.577 5.02 918.4752 1,834.93 1,835.95 2
 SAMPLE 1R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 3 3 5 10.80% TPLTATLSK 95.00% 1.84 0.313 1.92 466.2765 930.5374 931.5466 2
 SAMPLE 1R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 3 3 5 10.80% TFTcTAAYPESK 95.00% 3.41 0.48 4.03 c4: Carbamidomethyl (+57.02) 688.3123 1,374.61 1,375.62 2
 SAMPLE 1R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 3 3 5 10.80% TFTcTAAYPESK 95.00% 2.95 0.507 3.27 c4: Carbamidomethyl (+57.02) 688.3129 1,374.61 1,375.62 2
 SAMPLE 1R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 3 3 5 10.80% QEPSQGTTTFAVTSILR 95.00% 4.02 0.605 2.22 918.4773 1,834.94 1,835.95 2
 SAMPLE 1R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 3 3 5 10.80% QEPSQGTTTFAVTSILR 95.00% 4.27 0.523 3.62 918.9772 1,835.94 1,835.95 2
 SAMPLE 2 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 4 4 8 15.30% WLQGSQELPR 95.00% 3.23 0.309 1.72 607.3197 1,212.62 1,213.63 2
 SAMPLE 2 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 4 4 8 15.30% WLQGSQELPR 95.00% 3.12 0.314 1.38 607.3197 1,212.62 1,213.63 2
 SAMPLE 2 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 4 4 8 15.30% TFTcTAAYPESK 95.00% 2.18 0.245 1.11 c4: Carbamidomethyl (+57.02) 688.3119 1,374.61 1,375.62 2
 SAMPLE 2 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 4 4 8 15.30% TFTcTAAYPESK 95.00% 2.98 0.415 2.54 c4: Carbamidomethyl (+57.02) 688.3132 1,374.61 1,375.62 2
 SAMPLE 2 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 4 4 8 15.30% DASGVTFTWTPSSGK 95.00% 4.76 0.538 1.66 770.8662 1,539.72 1,540.73 2
 SAMPLE 2 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 4 4 8 15.30% DASGVTFTWTPSSGK 95.00% 4.07 0.171 0 770.8672 1,539.72 1,540.73 2
 SAMPLE 2 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 4 4 8 15.30% QEPSQGTTTFAVTSILR 95.00% 4.42 0.578 4.96 918.4774 1,834.94 1,835.95 2
 SAMPLE 2 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 4 4 8 15.30% QEPSQGTTTFAVTSILR 95.00% 4.21 0.512 6.89 918.9764 1,835.94 1,835.95 2
 SAMPLE 2R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 5 6 9 15.90% WLQGSQELPREK 95.00% 2.61 0.264 0 491.2614 1,470.76 1,470.77 3
 SAMPLE 2R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 5 6 9 15.90% WLQGSQELPR 95.00% 2.61 0.293 1.74 607.3187 1,212.62 1,213.63 2
 SAMPLE 2R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 5 6 9 15.90% WLQGSQELPR 95.00% 2.65 0.234 1.89 607.3192 1,212.62 1,213.63 2
 SAMPLE 2R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 5 6 9 15.90% QEPSQGTTTFAVTSILR 95.00% 3.18 0.377 0 612.9888 1,835.94 1,835.95 3
 SAMPLE 2R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 5 6 9 15.90% TFTcTAAYPESK 95.00% 2.64 0.417 3.14 c4: Carbamidomethyl (+57.02) 688.3123 1,374.61 1,375.62 2
 SAMPLE 2R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 5 6 9 15.90% DASGVTFTWTPSSGK 95.00% 4.86 0.572 1.89 770.8676 1,539.72 1,540.73 2
 SAMPLE 2R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 5 6 9 15.90% DASGVTFTWTPSSGK 95.00% 4.51 0.57 2.35 770.8677 1,539.72 1,540.73 2
 SAMPLE 2R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 5 6 9 15.90% QEPSQGTTTFAVTSILR 95.00% 4.09 0.589 4.08 918.4743 1,834.93 1,835.95 2
 SAMPLE 2R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 5 6 9 15.90% QEPSQGTTTFAVTSILR 95.00% 3.78 0.526 5.57 918.4767 1,834.94 1,835.95 2
 SAMPLE 3 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 99.80% 2 2 3 8.22% TFTcTAAYPESK 95.00% 3.13 0.478 3.2 c4: Carbamidomethyl (+57.02) 688.3122 1,374.61 1,375.62 2
 SAMPLE 3 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 99.80% 2 2 3 8.22% TFTcTAAYPESK 95.00% 3.11 0.488 3.19 c4: Carbamidomethyl (+57.02) 688.3127 1,374.61 1,375.62 2
 SAMPLE 3 Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 99.80% 2 2 3 8.22% QEPSQGTTTFAVTSILR 95.00% 3.45 0.543 2.08 918.9791 1,835.94 1,835.95 2
 SAMPLE 3R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 3 3 4 12.50% TFTcTAAYPESK 95.00% 2.88 0.484 3.11 c4: Carbamidomethyl (+57.02) 688.3119 1,374.61 1,375.62 2
 SAMPLE 3R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 3 3 4 12.50% TFTcTAAYPESK 95.00% 2.84 0.45 3.82 c4: Carbamidomethyl (+57.02) 688.3135 1,374.61 1,375.62 2
 SAMPLE 3R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 3 3 4 12.50% DASGVTFTWTPSSGK 95.00% 3.63 0.457 1.38 770.8679 1,539.72 1,540.73 2
 SAMPLE 3R Ig alpha-1 chain C region  IGHA1  IGHA1_HUMAN 37,635.80 100.00% 3 3 4 12.50% QEPSQGTTTFAVTSILR 95.00% 3.23 0.512 2.96 918.4775 1,834.94 1,835.95 2
 SAMPLE 4 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 7 11.50% NQVSLTcLVK 95.00% 3.02 0.456 1.85 c7: Carbamidomethyl (+57.02) 581.319 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 4 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 7 11.50% NQVSLTcLVK 95.00% 2.71 0.333 0 c7: Carbamidomethyl (+57.02) 581.32 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 4 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 7 11.50% NQVSLTcLVK 95.00% 2.72 0.373 0 c7: Carbamidomethyl (+57.02) 581.3201 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 4 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 7 11.50% NQVSLTcLVK 95.00% 2.97 0.464 2 c7: Carbamidomethyl (+57.02) 581.3202 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 4 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 7 11.50% NQVSLTcLVK 95.00% 2.87 0.427 0 c7: Carbamidomethyl (+57.02) 581.3202 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 4 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 7 11.50% NQVSLTcLVK 95.00% 2.56 0.302 0 c7: Carbamidomethyl (+57.02) 581.3208 1,160.63 1,161.63 2 IGHG3_HUMAN
 SAMPLE 4 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 7 11.50% GPSVFPLAPSSK 95.00% 2.29 0.365 1.17 593.8284 1,185.64 1,186.65 2
 SAMPLE 4 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 7 11.50% GPSVFPLAPSSK 95.00% 2.27 0.331 0 593.8289 1,185.64 1,186.65 2
 SAMPLE 4 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 7 11.50% GPSVFPLAPSSK 95.00% 2.55 0.411 0 593.829 1,185.64 1,186.65 2
 SAMPLE 4 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 7 11.50% VVSVLTVLHQDWLNGK 95.00% 3.88 0.602 3.17 904.514 1,807.01 1,808.01 2 IGHG3_HUMAN
 SAMPLE 4R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 8 11.50% NQVSLTcLVK 95.00% 2.91 0.458 1.68 c7: Carbamidomethyl (+57.02) 581.3189 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 4R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 8 11.50% NQVSLTcLVK 95.00% 2.64 0.348 1.21 c7: Carbamidomethyl (+57.02) 581.3196 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 4R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 8 11.50% NQVSLTcLVK 95.00% 2.93 0.404 1.7 c7: Carbamidomethyl (+57.02) 581.3202 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 4R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 8 11.50% NQVSLTcLVK 95.00% 2.8 0.319 0 c7: Carbamidomethyl (+57.02) 581.3202 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 4R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 8 11.50% NQVSLTcLVK 95.00% 2.88 0.454 2.59 c7: Carbamidomethyl (+57.02) 581.3204 1,160.63 1,161.63 2 IGHG3_HUMAN
 SAMPLE 4R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 8 11.50% NQVSLTcLVK 95.00% 2.9 0.413 1.4 c7: Carbamidomethyl (+57.02) 581.3204 1,160.63 1,161.63 2 IGHG3_HUMAN
 SAMPLE 4R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 8 11.50% GPSVFPLAPSSK 95.00% 2.12 0.333 0 593.8284 1,185.64 1,186.65 2
 SAMPLE 4R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 8 11.50% GPSVFPLAPSSK 95.00% 2.72 0.396 0 593.8286 1,185.64 1,186.65 2
 SAMPLE 4R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 8 11.50% VVSVLTVLHQDWLNGK 95.00% 2.98 0.485 0 603.3426 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 4R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 99.80% 2 2 8 11.50% VVSVLTVLHQDWLNGK 95.00% 3.09 0.427 0 603.3431 1,807.01 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% FNWYVDGVEVHNAK 95.00% 3.65 0.485 2.89 559.9374 1,676.79 1,677.80 3
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% FNWYVDGVEVHNAK 95.00% 3.4 0.454 3.3 559.9374 1,676.79 1,677.80 3
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% FNWYVDGVEVHNAK 95.00% 2.66 0.385 0 559.9383 1,676.79 1,677.80 3
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% FNWYVDGVEVHNAK 95.00% 2.43 0.272 0 560.2717 1,677.79 1,677.80 3
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% FNWYVDGVEVHNAK 95.00% 2.99 0.394 0 560.2727 1,677.79 1,677.80 3
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% FNWYVDGVEVHNAK 95.00% 2.01 0.241 0 560.2734 1,677.80 1,677.80 3
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.74 0.337 1.13 c7: Carbamidomethyl (+57.02) 581.3153 1,160.61 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.84 0.428 0 c7: Carbamidomethyl (+57.02) 581.3163 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.95 0.4 1.48 c7: Carbamidomethyl (+57.02) 581.3166 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.83 0.477 1.6 c7: Carbamidomethyl (+57.02) 581.3166 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.7 0.364 0 c7: Carbamidomethyl (+57.02) 581.3166 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.47 0.355 1.96 c7: Carbamidomethyl (+57.02) 581.3166 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 3.01 0.463 1.82 c7: Carbamidomethyl (+57.02) 581.3167 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.73 0.45 0 c7: Carbamidomethyl (+57.02) 581.3169 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.73 0.444 1.8 c7: Carbamidomethyl (+57.02) 581.3169 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.45 0.251 0 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.72 0.389 1.96 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.48 0.421 1.11 c7: Carbamidomethyl (+57.02) 581.3175 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.46 0.359 1.77 c7: Carbamidomethyl (+57.02) 581.3185 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.9 0.395 0 c7: Carbamidomethyl (+57.02) 581.3186 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% NQVSLTcLVK 95.00% 2.44 0.331 1.55 c7: Carbamidomethyl (+57.02) 581.3212 1,160.63 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% GPSVFPLAPSSK 95.00% 2.59 0.424 0 593.8247 1,185.63 1,186.65 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% GPSVFPLAPSSK 95.00% 2.72 0.339 0 593.8251 1,185.63 1,186.65 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% GPSVFPLAPSSK 95.00% 2.42 0.384 1.38 593.8255 1,185.64 1,186.65 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% GPSVFPLAPSSK 95.00% 2.72 0.514 0 593.8255 1,185.64 1,186.65 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% GPSVFPLAPSSK 95.00% 2.12 0.324 0 593.826 1,185.64 1,186.65 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% GPSVFPLAPSSK 95.00% 3.04 0.418 0 593.8261 1,185.64 1,186.65 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% GPSVFPLAPSSK 95.00% 3.2 0.477 0 593.8262 1,185.64 1,186.65 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% GPSVFPLAPSSK 95.00% 2.45 0.415 1.52 593.8265 1,185.64 1,186.65 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% GPSVFPLAPSSK 95.00% 2.69 0.447 0 593.8266 1,185.64 1,186.65 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% GPSVFPLAPSSK 95.00% 2.34 0.381 0 593.9464 1,185.88 1,186.65 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% GPSVFPLAPSSK 95.00% 2.62 0.382 0 594.3275 1,186.64 1,186.65 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 2.91 0.553 2.07 603.3399 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 3.05 0.586 2.55 603.3399 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 2.74 0.496 2.82 603.6736 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 2.97 0.605 1.85 603.6737 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 2.88 0.573 2.1 603.6739 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 3.11 0.58 2.7 603.674 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 3.21 0.481 2.85 603.6741 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 2.82 0.572 1.82 603.6741 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 2.55 0.553 1.05 603.6794 1,808.01 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 2.36 0.322 0 603.6875 1,808.04 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 2 0.245 0 603.6875 1,808.04 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.74 0.572 1.77 625.6456 1,873.91 1,873.92 3
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% STSGGTAALGcLVK 95.00% 3.92 0.451 1.92 c11: Carbamidomethyl (+57.02) 661.3396 1,320.66 1,321.68 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% STSGGTAALGcLVK 95.00% 3.45 0.389 1.68 c11: Carbamidomethyl (+57.02) 661.3401 1,320.66 1,321.68 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% STSGGTAALGcLVK 95.00% 4.02 0.472 3.12 c11: Carbamidomethyl (+57.02) 661.3404 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% STSGGTAALGcLVK 95.00% 4.24 0.498 3.14 c11: Carbamidomethyl (+57.02) 661.3408 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% STSGGTAALGcLVK 95.00% 2.04 0.324 0 c11: Carbamidomethyl (+57.02) 661.3414 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% STSGGTAALGcLVK 95.00% 2.16 0.318 0 c11: Carbamidomethyl (+57.02) 661.3423 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.11 0.379 3.6 c6: Carbamidomethyl (+57.02) 714.014 2,139.02 2,139.03 3
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.28 0.401 3.28 c6: Carbamidomethyl (+57.02) 714.0142 2,139.02 2,139.03 3
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 3.62 0.34 3.47 c6: Carbamidomethyl (+57.02) 714.0143 2,139.02 2,139.03 3
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.01 0.373 3.59 c6: Carbamidomethyl (+57.02) 714.0144 2,139.02 2,139.03 3
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% FNWYVDGVEVHNAK 95.00% 4.9 0.519 5.28 839.4036 1,676.79 1,677.80 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% FNWYVDGVEVHNAK 95.00% 4.96 0.493 5.14 839.9039 1,677.79 1,677.80 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% FNWYVDGVEVHNAK 95.00% 4.96 0.51 6.28 839.904 1,677.79 1,677.80 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% FNWYVDGVEVHNAK 95.00% 4.84 0.518 5.4 839.9056 1,677.80 1,677.80 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 5.13 0.616 4.82 904.5045 1,806.99 1,808.01 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 4.32 0.668 4.3 904.5069 1,807.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% VVSVLTVLHQDWLNGK 95.00% 5.03 0.613 4.38 905.0049 1,807.99 1,808.01 2 IGHG3_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% EPQVYTLPPSRDELTK 95.00% 4.22 0.434 1.96 936.987 1,871.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% EPQVYTLPPSRDELTK 95.00% 3.99 0.426 0 936.9879 1,871.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.15 0.572 3.49 937.4583 1,872.90 1,873.92 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TTPPVLDSDGSFFLYSK 95.00% 2.74 0.349 3.31 937.4601 1,872.90 1,873.92 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.29 0.582 7.54 937.4608 1,872.91 1,873.92 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% EPQVYTLPPSRDELTK 95.00% 4.4 0.384 2.38 937.4879 1,872.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% EPQVYTLPPSRDELTK 95.00% 4.06 0.405 2.59 937.4919 1,872.97 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.38 0.457 4.68 937.9599 1,873.90 1,873.92 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.86 0.62 9.19 937.9613 1,873.91 1,873.92 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.7 0.576 8.72 937.9616 1,873.91 1,873.92 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.67 0.607 5.35 937.9632 1,873.91 1,873.92 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.47 0.578 7.62 937.964 1,873.91 1,873.92 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TTPPVLDSDGSFFLYSK 95.00% 2.76 0.498 2.92 937.9674 1,873.92 1,873.92 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 5.21 0.628 4.12 c6: Carbamidomethyl (+57.02) 1,070.01 2,138.01 2,139.03 2
 SAMPLE 1 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 61 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 5.58 0.621 6.09 c6: Carbamidomethyl (+57.02) 1,070.52 2,139.02 2,139.03 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% FNWYVDGVEVHNAK 95.00% 3.32 0.453 2.19 559.9376 1,676.79 1,677.80 3
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% FNWYVDGVEVHNAK 95.00% 3.42 0.463 2.1 559.9377 1,676.79 1,677.80 3
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% FNWYVDGVEVHNAK 95.00% 2.67 0.383 0 559.9379 1,676.79 1,677.80 3
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% FNWYVDGVEVHNAK 95.00% 1.85 0.262 0 559.9404 1,676.80 1,677.80 3
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% FNWYVDGVEVHNAK 95.00% 2.06 0.318 0 560.2725 1,677.79 1,677.80 3
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% NQVSLTcLVK 95.00% 2.59 0.401 0 c7: Carbamidomethyl (+57.02) 581.3152 1,160.61 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% NQVSLTcLVK 95.00% 2.58 0.27 1.55 c7: Carbamidomethyl (+57.02) 581.3166 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% NQVSLTcLVK 95.00% 2.75 0.444 0 c7: Carbamidomethyl (+57.02) 581.3167 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% NQVSLTcLVK 95.00% 2.27 0.334 0 c7: Carbamidomethyl (+57.02) 581.317 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% NQVSLTcLVK 95.00% 3.23 0.478 2.15 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% NQVSLTcLVK 95.00% 2.92 0.455 1.64 c7: Carbamidomethyl (+57.02) 581.3174 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% NQVSLTcLVK 95.00% 2.9 0.46 1.37 c7: Carbamidomethyl (+57.02) 581.3174 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% NQVSLTcLVK 95.00% 2.92 0.413 2.23 c7: Carbamidomethyl (+57.02) 581.3175 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% NQVSLTcLVK 95.00% 2.84 0.414 1.38 c7: Carbamidomethyl (+57.02) 581.3176 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% NQVSLTcLVK 95.00% 2.73 0.344 1.59 c7: Carbamidomethyl (+57.02) 581.3184 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% NQVSLTcLVK 95.00% 2.36 0.312 0 c7: Carbamidomethyl (+57.02) 581.3186 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% NQVSLTcLVK 95.00% 2.09 0.268 0 c7: Carbamidomethyl (+57.02) 581.3245 1,160.63 1,161.63 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% GPSVFPLAPSSK 95.00% 2.12 0.371 0 593.8247 1,185.63 1,186.65 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% GPSVFPLAPSSK 95.00% 2.05 0.268 1.14 593.8257 1,185.64 1,186.65 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% GPSVFPLAPSSK 95.00% 2.95 0.438 0 593.8257 1,185.64 1,186.65 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% GPSVFPLAPSSK 95.00% 2.26 0.384 0 593.826 1,185.64 1,186.65 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% GPSVFPLAPSSK 95.00% 2.22 0.321 0 593.8262 1,185.64 1,186.65 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% GPSVFPLAPSSK 95.00% 2.79 0.384 0 593.8262 1,185.64 1,186.65 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% GPSVFPLAPSSK 95.00% 2.86 0.435 0 593.8262 1,185.64 1,186.65 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% GPSVFPLAPSSK 95.00% 2.94 0.363 0 593.8265 1,185.64 1,186.65 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% GPSVFPLAPSSK 95.00% 2.38 0.291 0 593.8266 1,185.64 1,186.65 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% GPSVFPLAPSSK 95.00% 2.18 0.342 1.12 593.8266 1,185.64 1,186.65 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 3.13 0.572 2.68 603.3392 1,806.99 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 2.88 0.567 2.02 603.3403 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 2.77 0.553 2.49 603.6731 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 3.17 0.609 2.82 603.6734 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 3.28 0.539 1.77 603.6735 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 3.05 0.512 2.42 603.6736 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 2.45 0.507 1.6 603.6737 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 3.23 0.553 2.32 603.6741 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 2.55 0.553 1.72 603.6794 1,808.01 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 2.74 0.192 0 603.6876 1,808.04 1,808.01 3 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.77 0.556 1.96 625.6454 1,873.91 1,873.92 3
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% STSGGTAALGcLVK 95.00% 3.71 0.481 3.37 c11: Carbamidomethyl (+57.02) 661.3401 1,320.66 1,321.68 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% STSGGTAALGcLVK 95.00% 4.27 0.518 3.44 c11: Carbamidomethyl (+57.02) 661.3408 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% STSGGTAALGcLVK 95.00% 3.96 0.483 2.96 c11: Carbamidomethyl (+57.02) 661.341 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% STSGGTAALGcLVK 95.00% 4.1 0.483 3.24 c11: Carbamidomethyl (+57.02) 661.3414 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% STSGGTAALGcLVK 95.00% 2.75 0.412 2.21 c11: Carbamidomethyl (+57.02) 661.6598 1,321.30 1,321.68 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.12 0.363 2.77 c6: Carbamidomethyl (+57.02) 713.6786 2,138.01 2,139.03 3
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 3.79 0.368 2.06 c6: Carbamidomethyl (+57.02) 714.0142 2,139.02 2,139.03 3
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 2.73 0.296 0 c6: Carbamidomethyl (+57.02) 714.0143 2,139.02 2,139.03 3
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.03 0.424 3.21 c6: Carbamidomethyl (+57.02) 714.0146 2,139.02 2,139.03 3
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.02 0.442 1.55 c6: Carbamidomethyl (+57.02) 714.0148 2,139.02 2,139.03 3
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% FNWYVDGVEVHNAK 95.00% 4.45 0.503 5.89 839.4032 1,676.79 1,677.80 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% FNWYVDGVEVHNAK 95.00% 4.81 0.497 5.8 839.4049 1,676.79 1,677.80 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% FNWYVDGVEVHNAK 95.00% 4.89 0.483 5.15 839.906 1,677.80 1,677.80 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% FNWYVDGVEVHNAK 95.00% 5.51 0.525 5.03 839.9068 1,677.80 1,677.80 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 4.76 0.597 4.72 904.5041 1,806.99 1,808.01 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 5.08 0.557 3.66 905.003 1,807.99 1,808.01 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 4.67 0.614 4.64 905.0049 1,807.99 1,808.01 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% VVSVLTVLHQDWLNGK 95.00% 4.47 0.55 3.96 905.008 1,808.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% EPQVYTLPPSRDELTK 95.00% 4.14 0.467 2.92 936.9872 1,871.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TTPPVLDSDGSFFLYSK 95.00% 2.54 0.435 4.18 937.455 1,872.89 1,873.92 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.25 0.289 1.82 937.4584 1,872.90 1,873.92 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TTPPVLDSDGSFFLYSK 95.00% 2.9 0.542 7.72 937.4589 1,872.90 1,873.92 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% EPQVYTLPPSRDELTK 95.00% 3.91 0.4 1.27 937.487 1,872.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% EPQVYTLPPSRDELTK 95.00% 4.13 0.403 0 937.4887 1,872.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% EPQVYTLPPSRDELTK 95.00% 4.15 0.356 1.42 937.4895 1,872.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TTPPVLDSDGSFFLYSK 95.00% 2.6 0.389 5.34 937.9542 1,873.89 1,873.92 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.46 0.565 4.41 937.9584 1,873.90 1,873.92 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.26 0.274 2.43 937.9594 1,873.90 1,873.92 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.48 0.583 6.24 937.9605 1,873.91 1,873.92 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.99 0.58 3.22 937.961 1,873.91 1,873.92 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.99 0.628 6.28 937.9615 1,873.91 1,873.92 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TTPPVLDSDGSFFLYSK 95.00% 4.3 0.646 5.54 937.9663 1,873.92 1,873.92 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 5.42 0.61 5.09 c6: Carbamidomethyl (+57.02) 1,070.51 2,139.01 2,139.03 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 5.3 0.632 7.46 c6: Carbamidomethyl (+57.02) 1,070.51 2,139.01 2,139.03 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 5.02 0.581 5.07 c6: Carbamidomethyl (+57.02) 1,070.52 2,139.02 2,139.03 2
 SAMPLE 1R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 10 60 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.76 0.611 4.16 c6: Carbamidomethyl (+57.02) 1,070.52 2,139.02 2,139.03 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% FNWYVDGVEVHNAK 95.00% 3.22 0.426 1.57 559.9378 1,676.79 1,677.80 3
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% FNWYVDGVEVHNAK 95.00% 2.51 0.358 1.21 559.9382 1,676.79 1,677.80 3
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% FNWYVDGVEVHNAK 95.00% 3.69 0.508 1.12 559.9383 1,676.79 1,677.80 3
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% FNWYVDGVEVHNAK 95.00% 2.37 0.325 2.54 559.9385 1,676.79 1,677.80 3
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% FNWYVDGVEVHNAK 95.00% 2 0.218 0 559.939 1,676.79 1,677.80 3
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% FNWYVDGVEVHNAK 95.00% 2.69 0.389 0.959 560.2719 1,677.79 1,677.80 3
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% FNWYVDGVEVHNAK 95.00% 3.59 0.422 1.46 560.2723 1,677.79 1,677.80 3
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 2.51 0.407 0 c7: Carbamidomethyl (+57.02) 581.3134 1,160.61 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 2.92 0.474 1.55 c7: Carbamidomethyl (+57.02) 581.3163 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 2.95 0.47 1.49 c7: Carbamidomethyl (+57.02) 581.3165 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 2.26 0.391 0 c7: Carbamidomethyl (+57.02) 581.3167 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 2.72 0.381 1.22 c7: Carbamidomethyl (+57.02) 581.317 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 3.15 0.457 2.21 c7: Carbamidomethyl (+57.02) 581.3171 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 3.05 0.467 1.77 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 3.17 0.437 1.42 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 2.55 0.394 2.15 c7: Carbamidomethyl (+57.02) 581.3174 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 2.99 0.402 1.92 c7: Carbamidomethyl (+57.02) 581.3175 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 2.93 0.462 0 c7: Carbamidomethyl (+57.02) 581.3177 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 2.92 0.354 2.37 c7: Carbamidomethyl (+57.02) 581.3178 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 2.62 0.345 0 c7: Carbamidomethyl (+57.02) 581.3188 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% NQVSLTcLVK 95.00% 2.79 0.399 1.54 c7: Carbamidomethyl (+57.02) 581.3199 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.07 0.33 1.27 593.8257 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.48 0.25 0 593.8257 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.23 0.34 0 593.8259 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.02 0.349 1.55 593.826 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.28 0.386 1.7 593.826 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.69 0.278 0 593.826 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.86 0.407 0 593.8261 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.82 0.395 1.47 593.8262 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.64 0.415 1.28 593.8263 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 3 0.487 1.77 593.8263 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.71 0.429 0 593.8264 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.93 0.365 0 593.8264 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.45 0.276 0 593.8264 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.96 0.382 0 593.8264 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.93 0.526 1.19 593.8265 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.95 0.445 0 593.8266 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% GPSVFPLAPSSK 95.00% 2.78 0.426 1.22 593.8268 1,185.64 1,186.65 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 2.83 0.462 1.15 603.3397 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 3.04 0.527 2.39 603.34 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 3.35 0.596 3.68 603.3401 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 2.84 0.537 1.72 603.674 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 3.18 0.569 2.8 603.6743 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 2.49 0.56 2.54 603.6744 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 3.24 0.574 2.68 603.6747 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 3.04 0.528 1.96 603.6748 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 3.16 0.557 2.89 603.6752 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 2.43 0.349 1.48 603.6755 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.93 0.562 1.57 625.6453 1,873.91 1,873.92 3
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% STSGGTAALGcLVK 95.00% 3.32 0.505 3.33 c11: Carbamidomethyl (+57.02) 661.3409 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% STSGGTAALGcLVK 95.00% 3.81 0.462 3.96 c11: Carbamidomethyl (+57.02) 661.3416 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% STSGGTAALGcLVK 95.00% 3.57 0.475 2.85 c11: Carbamidomethyl (+57.02) 661.3417 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% STSGGTAALGcLVK 95.00% 3.56 0.447 3.06 c11: Carbamidomethyl (+57.02) 661.3421 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% STSGGTAALGcLVK 95.00% 3.1 0.407 2.47 c11: Carbamidomethyl (+57.02) 661.3422 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% STSGGTAALGcLVK 95.00% 3.21 0.468 2.52 c11: Carbamidomethyl (+57.02) 661.3426 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.1 0.433 3.23 c6: Carbamidomethyl (+57.02) 714.0134 2,139.02 2,139.03 3
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.67 0.435 3.96 c6: Carbamidomethyl (+57.02) 714.0151 2,139.02 2,139.03 3
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.12 0.389 2.64 c6: Carbamidomethyl (+57.02) 714.0152 2,139.02 2,139.03 3
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.13 0.291 3.12 c6: Carbamidomethyl (+57.02) 714.0167 2,139.03 2,139.03 3
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% FNWYVDGVEVHNAK 95.00% 5.36 0.524 4.68 839.4028 1,676.79 1,677.80 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% FNWYVDGVEVHNAK 95.00% 4.93 0.501 5.36 839.9054 1,677.80 1,677.80 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 4.63 0.603 3.24 904.504 1,806.99 1,808.01 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 4.8 0.621 4.16 904.5064 1,807.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 4.9 0.618 5 904.5066 1,807.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 5.01 0.578 5.77 905.0067 1,808.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 4.9 0.623 5.04 905.0074 1,808.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% VVSVLTVLHQDWLNGK 95.00% 4.52 0.593 3.59 905.0103 1,808.01 1,808.01 2 IGHG3_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% EPQVYTLPPSRDELTK 95.00% 3.79 0.395 0 936.9897 1,871.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.18 0.582 8.11 937.4583 1,872.90 1,873.92 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.17 0.568 5.96 937.4612 1,872.91 1,873.92 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.17 0.534 6.43 937.4619 1,872.91 1,873.92 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% EPQVYTLPPSRDELTK 95.00% 3.94 0.424 2.55 937.4901 1,872.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.57 0.594 7.06 937.9615 1,873.91 1,873.92 2
 SAMPLE 2 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 55 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.71 0.483 5.72 937.964 1,873.91 1,873.92 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% FNWYVDGVEVHNAK 95.00% 2.65 0.338 0 559.9384 1,676.79 1,677.80 3
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% FNWYVDGVEVHNAK 95.00% 2.94 0.371 0 560.271 1,677.79 1,677.80 3
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% FNWYVDGVEVHNAK 95.00% 2.76 0.443 0 560.2714 1,677.79 1,677.80 3
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% FNWYVDGVEVHNAK 95.00% 3.16 0.419 0 560.2718 1,677.79 1,677.80 3
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.1 0.302 0 c7: Carbamidomethyl (+57.02) 581.316 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.9 0.472 1.8 c7: Carbamidomethyl (+57.02) 581.3164 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.44 0.348 0 c7: Carbamidomethyl (+57.02) 581.317 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.62 0.313 1.17 c7: Carbamidomethyl (+57.02) 581.317 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.73 0.332 0 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.72 0.42 0 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.79 0.357 1.41 c7: Carbamidomethyl (+57.02) 581.3173 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.74 0.445 2 c7: Carbamidomethyl (+57.02) 581.3173 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.35 0.377 0 c7: Carbamidomethyl (+57.02) 581.3173 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.49 0.225 0 c7: Carbamidomethyl (+57.02) 581.3174 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.34 0.297 0 c7: Carbamidomethyl (+57.02) 581.3175 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 3 0.477 1.51 c7: Carbamidomethyl (+57.02) 581.3175 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.64 0.375 1.57 c7: Carbamidomethyl (+57.02) 581.3175 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.97 0.468 1.49 c7: Carbamidomethyl (+57.02) 581.3176 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.94 0.408 1.34 c7: Carbamidomethyl (+57.02) 581.3177 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.5 0.356 0 c7: Carbamidomethyl (+57.02) 581.3185 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.28 0.415 1.82 c7: Carbamidomethyl (+57.02) 581.3186 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% NQVSLTcLVK 95.00% 2.96 0.424 2.59 c7: Carbamidomethyl (+57.02) 581.3186 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 3.1 0.447 0 593.8258 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 2.39 0.394 1.52 593.8258 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 2.2 0.283 0 593.8259 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 3.17 0.475 1.36 593.8259 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 1.95 0.323 0 593.826 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 2.78 0.381 0 593.8261 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 2.49 0.416 1.66 593.8261 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 2.65 0.445 1.29 593.8264 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 2.78 0.437 1.36 593.8264 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 2.66 0.387 0 593.8264 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 2.68 0.482 0 593.8266 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 2.84 0.445 1.18 593.8267 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% GPSVFPLAPSSK 95.00% 2.6 0.453 0 593.8282 1,185.64 1,186.65 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 2.68 0.463 0 603.3395 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 3.39 0.56 2.8 603.3395 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 3.1 0.516 3.16 603.3398 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 3.09 0.517 2.8 603.3398 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 3.19 0.513 2 603.6728 1,807.99 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 2.54 0.463 2.17 603.6735 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 2.74 0.476 0 603.6738 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 2.14 0.233 0 603.6741 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 3.33 0.595 2.85 603.6742 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 2.26 0.242 0 603.6751 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 2.63 0.263 1.8 603.6752 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 2.88 0.265 0.959 603.6758 1,808.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% EPQVYTLPPSRDELTK 95.00% 2.3 0.358 0 624.8435 1,871.51 1,872.97 3 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.92 0.547 0 625.6461 1,873.91 1,873.92 3
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TTPPVLDSDGSFFLYSK 95.00% 2.87 0.226 1.03 625.6467 1,873.92 1,873.92 3
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% STSGGTAALGcLVK 95.00% 4.12 0.438 2.8 c11: Carbamidomethyl (+57.02) 661.3408 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% STSGGTAALGcLVK 95.00% 3.86 0.502 3.49 c11: Carbamidomethyl (+57.02) 661.3409 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% STSGGTAALGcLVK 95.00% 2.8 0.342 2.21 c11: Carbamidomethyl (+57.02) 661.3413 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% STSGGTAALGcLVK 95.00% 3.9 0.438 3.36 c11: Carbamidomethyl (+57.02) 661.3415 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% STSGGTAALGcLVK 95.00% 2.98 0.419 0 c11: Carbamidomethyl (+57.02) 661.3419 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% STSGGTAALGcLVK 95.00% 3.5 0.417 1.82 c11: Carbamidomethyl (+57.02) 661.3421 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% STSGGTAALGcLVK 95.00% 2.58 0.354 1.34 c11: Carbamidomethyl (+57.02) 661.3423 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% STSGGTAALGcLVK 95.00% 3.27 0.478 2.96 c11: Carbamidomethyl (+57.02) 661.3423 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% STSGGTAALGcLVK 95.00% 4 0.396 2.82 c11: Carbamidomethyl (+57.02) 661.8435 1,321.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 3.08 0.327 0 c6: Carbamidomethyl (+57.02) 713.5851 2,137.73 2,139.03 3
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 3.67 0.327 2.46 c6: Carbamidomethyl (+57.02) 713.6802 2,138.02 2,139.03 3
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.05 0.422 3.62 c6: Carbamidomethyl (+57.02) 714.0129 2,139.02 2,139.03 3
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 3.49 0.289 1.66 c6: Carbamidomethyl (+57.02) 714.0138 2,139.02 2,139.03 3
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.11 0.396 2.77 c6: Carbamidomethyl (+57.02) 714.0145 2,139.02 2,139.03 3
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.22 0.393 4.29 c6: Carbamidomethyl (+57.02) 714.0146 2,139.02 2,139.03 3
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% FNWYVDGVEVHNAK 95.00% 4.82 0.54 5.66 839.404 1,676.79 1,677.80 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% FNWYVDGVEVHNAK 95.00% 5.09 0.507 5.74 839.9034 1,677.79 1,677.80 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% FNWYVDGVEVHNAK 95.00% 4.7 0.514 4.3 839.9035 1,677.79 1,677.80 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 4.97 0.598 3.26 904.5049 1,806.99 1,808.01 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 4.63 0.603 4.28 904.5056 1,807.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 4.69 0.577 4.52 905.0069 1,808.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 4.46 0.592 5.25 905.0079 1,808.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% VVSVLTVLHQDWLNGK 95.00% 4.82 0.567 4.05 905.0082 1,808.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% EPQVYTLPPSRDELTK 95.00% 3.69 0.442 0 936.9872 1,871.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TTPPVLDSDGSFFLYSK 95.00% 2.67 0.401 6.85 937.4538 1,872.89 1,873.92 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.43 0.493 5.66 937.4577 1,872.90 1,873.92 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TTPPVLDSDGSFFLYSK 95.00% 3 0.517 8.17 937.4597 1,872.90 1,873.92 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TTPPVLDSDGSFFLYSK 95.00% 2.88 0.438 3.7 937.46 1,872.90 1,873.92 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% EPQVYTLPPSRDELTK 95.00% 3.84 0.33 1.49 937.4897 1,872.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.25 0 3.64 937.9599 1,873.90 1,873.92 2
 SAMPLE 2R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 9 65 35.80% TTPPVLDSDGSFFLYSK 95.00% 3.38 0.153 3.14 937.9615 1,873.91 1,873.92 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% FNWYVDGVEVHNAK 95.00% 2.69 0.386 0 559.9382 1,676.79 1,677.80 3
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% FNWYVDGVEVHNAK 95.00% 2.76 0.433 0 559.9387 1,676.79 1,677.80 3
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% FNWYVDGVEVHNAK 95.00% 3.18 0.39 1.14 560.2723 1,677.79 1,677.80 3
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% FNWYVDGVEVHNAK 95.00% 3.03 0.335 1.42 560.2725 1,677.79 1,677.80 3
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% FNWYVDGVEVHNAK 95.00% 2.24 0.296 0 560.2725 1,677.79 1,677.80 3
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% NQVSLTcLVK 95.00% 2.31 0.41 0 c7: Carbamidomethyl (+57.02) 581.3164 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% NQVSLTcLVK 95.00% 2.62 0.409 0 c7: Carbamidomethyl (+57.02) 581.3165 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% NQVSLTcLVK 95.00% 2.77 0.352 0 c7: Carbamidomethyl (+57.02) 581.3167 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% NQVSLTcLVK 95.00% 2.36 0.32 0 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% NQVSLTcLVK 95.00% 2.62 0.406 1.13 c7: Carbamidomethyl (+57.02) 581.3174 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% NQVSLTcLVK 95.00% 2.92 0.423 1.57 c7: Carbamidomethyl (+57.02) 581.3174 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% NQVSLTcLVK 95.00% 3.01 0.429 1.72 c7: Carbamidomethyl (+57.02) 581.3176 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% NQVSLTcLVK 95.00% 2.26 0.0997 1.38 c7: Carbamidomethyl (+57.02) 581.3195 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% GPSVFPLAPSSK 95.00% 2.59 0.365 0 593.8247 1,185.63 1,186.65 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% GPSVFPLAPSSK 95.00% 2.84 0.353 0 593.8254 1,185.64 1,186.65 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% GPSVFPLAPSSK 95.00% 2.61 0.428 0 593.8258 1,185.64 1,186.65 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% GPSVFPLAPSSK 95.00% 2.66 0.417 0 593.826 1,185.64 1,186.65 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% GPSVFPLAPSSK 95.00% 2.99 0.49 1.15 593.826 1,185.64 1,186.65 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% GPSVFPLAPSSK 95.00% 2.29 0.258 1.14 593.8262 1,185.64 1,186.65 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% GPSVFPLAPSSK 95.00% 2.49 0.425 0 593.8263 1,185.64 1,186.65 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% GPSVFPLAPSSK 95.00% 2.55 0.388 1.09 593.8265 1,185.64 1,186.65 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% GPSVFPLAPSSK 95.00% 2.54 0.331 0 593.8284 1,185.64 1,186.65 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% EPQVYTLPPSRDELTK 95.00% 2.19 0.227 0 624.9946 1,871.96 1,872.97 3 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% STSGGTAALGcLVK 95.00% 3.77 0.437 2.51 c11: Carbamidomethyl (+57.02) 661.3416 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% STSGGTAALGcLVK 95.00% 3.82 0.499 4.27 c11: Carbamidomethyl (+57.02) 661.3421 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% STSGGTAALGcLVK 95.00% 3.87 0.486 3.77 c11: Carbamidomethyl (+57.02) 661.3423 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% STSGGTAALGcLVK 95.00% 2.81 0.37 2.35 c11: Carbamidomethyl (+57.02) 661.343 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% STSGGTAALGcLVK 95.00% 2.49 0.385 1.38 c11: Carbamidomethyl (+57.02) 661.9937 1,321.97 1,321.68 2 IGHG3_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% TPEVTcVVVDVSHEDPEVK 95.00% 4.42 0.4 3.43 c6: Carbamidomethyl (+57.02) 714.0137 2,139.02 2,139.03 3
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% TPEVTcVVVDVSHEDPEVK 95.00% 3.81 0.336 3.44 c6: Carbamidomethyl (+57.02) 714.0149 2,139.02 2,139.03 3
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% TPEVTcVVVDVSHEDPEVK 95.00% 4.12 0.408 2.39 c6: Carbamidomethyl (+57.02) 714.0154 2,139.02 2,139.03 3
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% FNWYVDGVEVHNAK 95.00% 4.58 0.536 5.7 839.4032 1,676.79 1,677.80 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% FNWYVDGVEVHNAK 95.00% 4.37 0.577 4.96 839.404 1,676.79 1,677.80 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% EPQVYTLPPSRDELTK 95.00% 3.31 0.385 1.57 936.9892 1,871.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% TTPPVLDSDGSFFLYSK 95.00% 3.24 0.539 7.51 937.4625 1,872.91 1,873.92 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% TTPPVLDSDGSFFLYSK 95.00% 3.24 0.57 7.96 937.4637 1,872.91 1,873.92 2
 SAMPLE 3 Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 5 7 26 30.90% TPEVTcVVVDVSHEDPEVK 95.00% 5.22 0.614 6.6 c6: Carbamidomethyl (+57.02) 1,070.51 2,139.01 2,139.03 2
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% FNWYVDGVEVHNAK 95.00% 2.14 0.238 0 559.938 1,676.79 1,677.80 3
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% FNWYVDGVEVHNAK 95.00% 2.22 0.285 0 559.9384 1,676.79 1,677.80 3
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% FNWYVDGVEVHNAK 95.00% 2.24 0.223 0 559.939 1,676.79 1,677.80 3
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% FNWYVDGVEVHNAK 95.00% 2.83 0.405 1.62 560.2728 1,677.79 1,677.80 3
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% FNWYVDGVEVHNAK 95.00% 2.45 0.259 0 560.273 1,677.80 1,677.80 3
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% NQVSLTcLVK 95.00% 2.45 0.362 1.21 c7: Carbamidomethyl (+57.02) 581.3159 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% NQVSLTcLVK 95.00% 2.97 0.428 1.92 c7: Carbamidomethyl (+57.02) 581.3163 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% NQVSLTcLVK 95.00% 2.9 0.459 1.46 c7: Carbamidomethyl (+57.02) 581.3168 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% NQVSLTcLVK 95.00% 2.82 0.476 1.31 c7: Carbamidomethyl (+57.02) 581.317 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% NQVSLTcLVK 95.00% 2.88 0.451 1.49 c7: Carbamidomethyl (+57.02) 581.3174 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% NQVSLTcLVK 95.00% 2.26 0.341 0 c7: Carbamidomethyl (+57.02) 581.3177 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% NQVSLTcLVK 95.00% 2.92 0.446 1.8 c7: Carbamidomethyl (+57.02) 581.3178 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% NQVSLTcLVK 95.00% 2.08 0.291 0 c7: Carbamidomethyl (+57.02) 581.3187 1,160.62 1,161.63 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% GPSVFPLAPSSK 95.00% 2.66 0.447 0 593.8257 1,185.64 1,186.65 2
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% GPSVFPLAPSSK 95.00% 2.88 0.463 1.08 593.8257 1,185.64 1,186.65 2
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% GPSVFPLAPSSK 95.00% 2.23 0.394 0 593.8261 1,185.64 1,186.65 2
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% GPSVFPLAPSSK 95.00% 2.2 0.291 1.29 593.8269 1,185.64 1,186.65 2
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% GPSVFPLAPSSK 95.00% 2.51 0.376 0 593.8273 1,185.64 1,186.65 2
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% GPSVFPLAPSSK 95.00% 2.49 0.437 1.22 593.8274 1,185.64 1,186.65 2
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% GPSVFPLAPSSK 95.00% 2.06 0.25 0 593.828 1,185.64 1,186.65 2
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% GPSVFPLAPSSK 95.00% 2.04 0.277 1.15 594.3304 1,186.65 1,186.65 2
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% VVSVLTVLHQDWLNGK 95.00% 3.19 0.547 2.7 603.3398 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% VVSVLTVLHQDWLNGK 95.00% 3.15 0.534 1.89 603.34 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% VVSVLTVLHQDWLNGK 95.00% 3.54 0.539 1.47 603.3403 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% VVSVLTVLHQDWLNGK 95.00% 2.54 0.493 0 603.3411 1,807.00 1,808.01 3 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% STSGGTAALGcLVK 95.00% 3.34 0.449 3.23 c11: Carbamidomethyl (+57.02) 661.3404 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% STSGGTAALGcLVK 95.00% 2.12 0.162 1.68 c11: Carbamidomethyl (+57.02) 661.3412 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% STSGGTAALGcLVK 95.00% 2.43 0.31 0 c11: Carbamidomethyl (+57.02) 661.3415 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% STSGGTAALGcLVK 95.00% 2.57 0.348 0 c11: Carbamidomethyl (+57.02) 661.3416 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% STSGGTAALGcLVK 95.00% 3.08 0.413 1.96 c11: Carbamidomethyl (+57.02) 661.3423 1,320.67 1,321.68 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% TPEVTcVVVDVSHEDPEVK 95.00% 4.62 0.411 2.35 c6: Carbamidomethyl (+57.02) 714.0151 2,139.02 2,139.03 3
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% FNWYVDGVEVHNAK 95.00% 4.56 0.522 5.04 839.403 1,676.79 1,677.80 2
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% FNWYVDGVEVHNAK 95.00% 4.75 0.503 4.89 839.9049 1,677.79 1,677.80 2
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% VVSVLTVLHQDWLNGK 95.00% 4.21 0.617 7.29 904.5072 1,807.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% VVSVLTVLHQDWLNGK 95.00% 4.66 0.577 5.52 905.0086 1,808.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% VVSVLTVLHQDWLNGK 95.00% 3.9 0.59 6.07 905.0087 1,808.00 1,808.01 2 IGHG3_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% EPQVYTLPPSRDELTK 95.00% 3.21 0.348 0 936.9826 1,871.95 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% EPQVYTLPPSRDELTK 95.00% 3.94 0.466 0 936.9867 1,871.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% EPQVYTLPPSRDELTK 95.00% 3.92 0.383 1.54 937.4878 1,872.96 1,872.97 2 IF4G3_HUMAN,TENA_HUMAN
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% TTPPVLDSDGSFFLYSK 95.00% 4.1 0.631 8.18 937.9651 1,873.91 1,873.92 2
 SAMPLE 3R Ig gamma-1 chain C region  IGHG1  IGHG1_HUMAN 36,087.00 100.00% 6 8 30 35.80% TTPPVLDSDGSFFLYSK 95.00% 4.63 0.588 7.29 937.9657 1,873.92 1,873.92 2
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.74 0.337 1.13 c7: Carbamidomethyl (+57.02) 581.3153 1,160.61 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.84 0.428 0 c7: Carbamidomethyl (+57.02) 581.3163 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.95 0.4 1.48 c7: Carbamidomethyl (+57.02) 581.3166 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.83 0.477 1.6 c7: Carbamidomethyl (+57.02) 581.3166 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.7 0.364 0 c7: Carbamidomethyl (+57.02) 581.3166 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.47 0.355 1.96 c7: Carbamidomethyl (+57.02) 581.3166 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 3.01 0.463 1.82 c7: Carbamidomethyl (+57.02) 581.3167 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.73 0.45 0 c7: Carbamidomethyl (+57.02) 581.3169 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.73 0.444 1.8 c7: Carbamidomethyl (+57.02) 581.3169 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.45 0.251 0 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.72 0.389 1.96 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.48 0.421 1.11 c7: Carbamidomethyl (+57.02) 581.3175 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.46 0.359 1.77 c7: Carbamidomethyl (+57.02) 581.3185 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.9 0.395 0 c7: Carbamidomethyl (+57.02) 581.3186 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% NQVSLTcLVK 95.00% 2.44 0.331 1.55 c7: Carbamidomethyl (+57.02) 581.3212 1,160.63 1,161.63 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 2.91 0.553 2.07 603.3399 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 3.05 0.586 2.55 603.3399 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 2.74 0.496 2.82 603.6736 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 2.97 0.605 1.85 603.6737 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 2.88 0.573 2.1 603.6739 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 3.11 0.58 2.7 603.674 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 3.21 0.481 2.85 603.6741 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 2.82 0.572 1.82 603.6741 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 2.55 0.553 1.05 603.6794 1,808.01 1,808.01 3 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 2.36 0.322 0 603.6875 1,808.04 1,808.01 3 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 2 0.245 0 603.6875 1,808.04 1,808.01 3 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% GPSVFPLAPcSR 95.00% 2.8 0.443 1.37 c10: Carbamidomethyl (+57.02) 644.3274 1,286.64 1,287.65 2
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% GPSVFPLAPcSR 95.00% 2.45 0.277 0 c10: Carbamidomethyl (+57.02) 644.3281 1,286.64 1,287.65 2
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% GPSVFPLAPcSR 95.00% 3.15 0.436 1.66 c10: Carbamidomethyl (+57.02) 644.3282 1,286.64 1,287.65 2
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% GPSVFPLAPcSR 95.00% 2.05 0.342 1.24 c10: Carbamidomethyl (+57.02) 644.3286 1,286.64 1,287.65 2
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% GPSVFPLAPcSR 95.00% 2.74 0.361 1.4 c10: Carbamidomethyl (+57.02) 644.3287 1,286.64 1,287.65 2
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% GPSVFPLAPcSR 95.00% 2.51 0.31 0 c10: Carbamidomethyl (+57.02) 644.3295 1,286.64 1,287.65 2
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% STSGGTAALGcLVK 95.00% 3.92 0.451 1.92 c11: Carbamidomethyl (+57.02) 661.3396 1,320.66 1,321.68 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% STSGGTAALGcLVK 95.00% 3.45 0.389 1.68 c11: Carbamidomethyl (+57.02) 661.3401 1,320.66 1,321.68 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% STSGGTAALGcLVK 95.00% 4.02 0.472 3.12 c11: Carbamidomethyl (+57.02) 661.3404 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% STSGGTAALGcLVK 95.00% 4.24 0.498 3.14 c11: Carbamidomethyl (+57.02) 661.3408 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% STSGGTAALGcLVK 95.00% 2.04 0.324 0 c11: Carbamidomethyl (+57.02) 661.3414 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% STSGGTAALGcLVK 95.00% 2.16 0.318 0 c11: Carbamidomethyl (+57.02) 661.3423 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 5.13 0.616 4.82 904.5045 1,806.99 1,808.01 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 4.32 0.668 4.3 904.5069 1,807.00 1,808.01 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% VVSVLTVLHQDWLNGK 95.00% 5.03 0.613 4.38 905.0049 1,807.99 1,808.01 2 IGHG1_HUMAN
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% EPQVYTLPPSREEMTK 95.00% 2.77 0.387 0 953.1419 1,904.27 1,904.94 2
 SAMPLE 1 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 8 18.00% EPQVYTLPPSREEMTK 95.00% 2.63 0.295 0 953.1428 1,904.27 1,904.94 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 2.51 0.407 0 c7: Carbamidomethyl (+57.02) 581.3134 1,160.61 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 2.92 0.474 1.55 c7: Carbamidomethyl (+57.02) 581.3163 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 2.95 0.47 1.49 c7: Carbamidomethyl (+57.02) 581.3165 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 2.26 0.391 0 c7: Carbamidomethyl (+57.02) 581.3167 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 2.72 0.381 1.22 c7: Carbamidomethyl (+57.02) 581.317 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 3.15 0.457 2.21 c7: Carbamidomethyl (+57.02) 581.3171 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 3.05 0.467 1.77 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 3.17 0.437 1.42 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 2.55 0.394 2.15 c7: Carbamidomethyl (+57.02) 581.3174 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 2.99 0.402 1.92 c7: Carbamidomethyl (+57.02) 581.3175 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 2.93 0.462 0 c7: Carbamidomethyl (+57.02) 581.3177 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 2.92 0.354 2.37 c7: Carbamidomethyl (+57.02) 581.3178 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 2.62 0.345 0 c7: Carbamidomethyl (+57.02) 581.3188 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% NQVSLTcLVK 95.00% 2.79 0.399 1.54 c7: Carbamidomethyl (+57.02) 581.3199 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 2.83 0.462 1.15 603.3397 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 3.04 0.527 2.39 603.34 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 3.35 0.596 3.68 603.3401 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 2.84 0.537 1.72 603.674 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 3.18 0.569 2.8 603.6743 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 2.49 0.56 2.54 603.6744 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 3.24 0.574 2.68 603.6747 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 3.04 0.528 1.96 603.6748 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 3.16 0.557 2.89 603.6752 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 2.43 0.349 1.48 603.6755 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% EPQVYTLPPSREEMTK 95.00% 1.83 0.327 0 635.9868 1,904.94 1,904.94 3
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% GPSVFPLAPcSR 95.00% 2.94 0.415 0 c10: Carbamidomethyl (+57.02) 644.3277 1,286.64 1,287.65 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% GPSVFPLAPcSR 95.00% 3.19 0.418 0 c10: Carbamidomethyl (+57.02) 644.3277 1,286.64 1,287.65 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% GPSVFPLAPcSR 95.00% 2.96 0.464 1.48 c10: Carbamidomethyl (+57.02) 644.3279 1,286.64 1,287.65 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% GPSVFPLAPcSR 95.00% 2.73 0.419 1.19 c10: Carbamidomethyl (+57.02) 644.328 1,286.64 1,287.65 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% GPSVFPLAPcSR 95.00% 2.97 0.421 0 c10: Carbamidomethyl (+57.02) 644.3282 1,286.64 1,287.65 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% GPSVFPLAPcSR 95.00% 2.82 0.458 1.21 c10: Carbamidomethyl (+57.02) 644.3282 1,286.64 1,287.65 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% GPSVFPLAPcSR 95.00% 3.07 0.425 0 c10: Carbamidomethyl (+57.02) 644.3283 1,286.64 1,287.65 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% GPSVFPLAPcSR 95.00% 2.95 0.342 0 c10: Carbamidomethyl (+57.02) 644.3285 1,286.64 1,287.65 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% GPSVFPLAPcSR 95.00% 3.02 0.402 0 c10: Carbamidomethyl (+57.02) 644.3286 1,286.64 1,287.65 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% GPSVFPLAPcSR 95.00% 2.96 0.454 2.29 c10: Carbamidomethyl (+57.02) 644.3288 1,286.64 1,287.65 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% GPSVFPLAPcSR 95.00% 3.01 0.478 1.41 c10: Carbamidomethyl (+57.02) 644.3288 1,286.64 1,287.65 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% STSGGTAALGcLVK 95.00% 3.32 0.505 3.33 c11: Carbamidomethyl (+57.02) 661.3409 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% STSGGTAALGcLVK 95.00% 3.81 0.462 3.96 c11: Carbamidomethyl (+57.02) 661.3416 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% STSGGTAALGcLVK 95.00% 3.57 0.475 2.85 c11: Carbamidomethyl (+57.02) 661.3417 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% STSGGTAALGcLVK 95.00% 3.56 0.447 3.06 c11: Carbamidomethyl (+57.02) 661.3421 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% STSGGTAALGcLVK 95.00% 3.1 0.407 2.47 c11: Carbamidomethyl (+57.02) 661.3422 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% STSGGTAALGcLVK 95.00% 3.21 0.468 2.52 c11: Carbamidomethyl (+57.02) 661.3426 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 4.63 0.603 3.24 904.504 1,806.99 1,808.01 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 4.8 0.621 4.16 904.5064 1,807.00 1,808.01 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 4.9 0.618 5 904.5066 1,807.00 1,808.01 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 5.01 0.578 5.77 905.0067 1,808.00 1,808.01 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 4.9 0.623 5.04 905.0074 1,808.00 1,808.01 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% VVSVLTVLHQDWLNGK 95.00% 4.52 0.593 3.59 905.0103 1,808.01 1,808.01 2 IGHG1_HUMAN
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% EPQVYTLPPSREEMTK 95.00% 3.77 0.518 2.82 953.1425 1,904.27 1,904.94 2
 SAMPLE 2 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 14 18.00% EPQVYTLPPSREEMTK 95.00% 3.62 0.47 1.54 953.4784 1,904.94 1,904.94 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.1 0.302 0 c7: Carbamidomethyl (+57.02) 581.316 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.9 0.472 1.8 c7: Carbamidomethyl (+57.02) 581.3164 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.44 0.348 0 c7: Carbamidomethyl (+57.02) 581.317 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.62 0.313 1.17 c7: Carbamidomethyl (+57.02) 581.317 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.73 0.332 0 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.72 0.42 0 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.79 0.357 1.41 c7: Carbamidomethyl (+57.02) 581.3173 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.74 0.445 2 c7: Carbamidomethyl (+57.02) 581.3173 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.35 0.377 0 c7: Carbamidomethyl (+57.02) 581.3173 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.49 0.225 0 c7: Carbamidomethyl (+57.02) 581.3174 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.34 0.297 0 c7: Carbamidomethyl (+57.02) 581.3175 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 3 0.477 1.51 c7: Carbamidomethyl (+57.02) 581.3175 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.64 0.375 1.57 c7: Carbamidomethyl (+57.02) 581.3175 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.97 0.468 1.49 c7: Carbamidomethyl (+57.02) 581.3176 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.94 0.408 1.34 c7: Carbamidomethyl (+57.02) 581.3177 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.5 0.356 0 c7: Carbamidomethyl (+57.02) 581.3185 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.28 0.415 1.82 c7: Carbamidomethyl (+57.02) 581.3186 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% NQVSLTcLVK 95.00% 2.96 0.424 2.59 c7: Carbamidomethyl (+57.02) 581.3186 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 2.68 0.463 0 603.3395 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 3.39 0.56 2.8 603.3395 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 3.1 0.516 3.16 603.3398 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 3.09 0.517 2.8 603.3398 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 3.19 0.513 2 603.6728 1,807.99 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 2.54 0.463 2.17 603.6735 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 2.74 0.476 0 603.6738 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 2.14 0.233 0 603.6741 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 3.33 0.595 2.85 603.6742 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 2.26 0.242 0 603.6751 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 2.63 0.263 1.8 603.6752 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 2.88 0.265 0.959 603.6758 1,808.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% EPQVYTLPPSREEMTK 95.00% 2.27 0.279 0 635.986 1,904.93 1,904.94 3
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% GPSVFPLAPcSR 95.00% 2.01 0.173 1.72 c10: Carbamidomethyl (+57.02) 644.323 1,286.63 1,287.65 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% GPSVFPLAPcSR 95.00% 2.28 0.322 0 c10: Carbamidomethyl (+57.02) 644.327 1,286.64 1,287.65 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% GPSVFPLAPcSR 95.00% 2.49 0.407 0 c10: Carbamidomethyl (+57.02) 644.3277 1,286.64 1,287.65 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% GPSVFPLAPcSR 95.00% 1.99 0.327 0 c10: Carbamidomethyl (+57.02) 644.328 1,286.64 1,287.65 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% GPSVFPLAPcSR 95.00% 3.26 0.488 0 c10: Carbamidomethyl (+57.02) 644.3285 1,286.64 1,287.65 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% GPSVFPLAPcSR 95.00% 2.86 0.433 1.17 c10: Carbamidomethyl (+57.02) 644.3286 1,286.64 1,287.65 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% GPSVFPLAPcSR 95.00% 3.07 0.434 1.26 c10: Carbamidomethyl (+57.02) 644.3288 1,286.64 1,287.65 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% GPSVFPLAPcSR 95.00% 2.87 0.429 0 c10: Carbamidomethyl (+57.02) 644.3289 1,286.64 1,287.65 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% GPSVFPLAPcSR 95.00% 2.73 0.444 0 c10: Carbamidomethyl (+57.02) 644.329 1,286.64 1,287.65 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% GPSVFPLAPcSR 95.00% 2.86 0.442 1.89 c10: Carbamidomethyl (+57.02) 644.3291 1,286.64 1,287.65 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% GPSVFPLAPcSR 95.00% 2.53 0.358 0 c10: Carbamidomethyl (+57.02) 644.3296 1,286.64 1,287.65 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% GPSVFPLAPcSR 95.00% 2.14 0.416 0 c10: Carbamidomethyl (+57.02) 644.3311 1,286.65 1,287.65 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% STSGGTAALGcLVK 95.00% 4.12 0.438 2.8 c11: Carbamidomethyl (+57.02) 661.3408 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% STSGGTAALGcLVK 95.00% 3.86 0.502 3.49 c11: Carbamidomethyl (+57.02) 661.3409 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% STSGGTAALGcLVK 95.00% 2.8 0.342 2.21 c11: Carbamidomethyl (+57.02) 661.3413 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% STSGGTAALGcLVK 95.00% 3.9 0.438 3.36 c11: Carbamidomethyl (+57.02) 661.3415 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% STSGGTAALGcLVK 95.00% 2.98 0.419 0 c11: Carbamidomethyl (+57.02) 661.3419 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% STSGGTAALGcLVK 95.00% 3.5 0.417 1.82 c11: Carbamidomethyl (+57.02) 661.3421 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% STSGGTAALGcLVK 95.00% 2.58 0.354 1.34 c11: Carbamidomethyl (+57.02) 661.3423 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% STSGGTAALGcLVK 95.00% 3.27 0.478 2.96 c11: Carbamidomethyl (+57.02) 661.3423 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% STSGGTAALGcLVK 95.00% 4 0.396 2.82 c11: Carbamidomethyl (+57.02) 661.8435 1,321.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 4.97 0.598 3.26 904.5049 1,806.99 1,808.01 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 4.63 0.603 4.28 904.5056 1,807.00 1,808.01 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 4.69 0.577 4.52 905.0069 1,808.00 1,808.01 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 4.46 0.592 5.25 905.0079 1,808.00 1,808.01 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% VVSVLTVLHQDWLNGK 95.00% 4.82 0.567 4.05 905.0082 1,808.00 1,808.01 2 IGHG1_HUMAN
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% EPQVYTLPPSREEMTK 95.00% 3.42 0.495 1.26 953.1421 1,904.27 1,904.94 2
 SAMPLE 2R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 3 15 18.00% EPQVYTLPPSREEMTK 95.00% 3.76 0.51 2.26 953.144 1,904.27 1,904.94 2
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% NQVSLTcLVK 95.00% 2.31 0.41 0 c7: Carbamidomethyl (+57.02) 581.3164 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% NQVSLTcLVK 95.00% 2.62 0.409 0 c7: Carbamidomethyl (+57.02) 581.3165 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% NQVSLTcLVK 95.00% 2.77 0.352 0 c7: Carbamidomethyl (+57.02) 581.3167 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% NQVSLTcLVK 95.00% 2.36 0.32 0 c7: Carbamidomethyl (+57.02) 581.3172 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% NQVSLTcLVK 95.00% 2.62 0.406 1.13 c7: Carbamidomethyl (+57.02) 581.3174 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% NQVSLTcLVK 95.00% 2.92 0.423 1.57 c7: Carbamidomethyl (+57.02) 581.3174 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% NQVSLTcLVK 95.00% 3.01 0.429 1.72 c7: Carbamidomethyl (+57.02) 581.3176 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% NQVSLTcLVK 95.00% 2.26 0.0997 1.38 c7: Carbamidomethyl (+57.02) 581.3195 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% GPSVFPLAPcSR 95.00% 2.57 0.333 0 c10: Carbamidomethyl (+57.02) 644.327 1,286.64 1,287.65 2
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% GPSVFPLAPcSR 95.00% 2.15 0.401 0 c10: Carbamidomethyl (+57.02) 644.3274 1,286.64 1,287.65 2
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% GPSVFPLAPcSR 95.00% 3.04 0.387 0 c10: Carbamidomethyl (+57.02) 644.3274 1,286.64 1,287.65 2
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% GPSVFPLAPcSR 95.00% 1.91 0.335 0 c10: Carbamidomethyl (+57.02) 644.3285 1,286.64 1,287.65 2
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% GPSVFPLAPcSR 95.00% 2.84 0.349 1.44 c10: Carbamidomethyl (+57.02) 644.3286 1,286.64 1,287.65 2
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% GPSVFPLAPcSR 95.00% 2.96 0.402 1.33 c10: Carbamidomethyl (+57.02) 644.3288 1,286.64 1,287.65 2
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% STSGGTAALGcLVK 95.00% 3.77 0.437 2.51 c11: Carbamidomethyl (+57.02) 661.3416 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% STSGGTAALGcLVK 95.00% 3.82 0.499 4.27 c11: Carbamidomethyl (+57.02) 661.3421 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% STSGGTAALGcLVK 95.00% 3.87 0.486 3.77 c11: Carbamidomethyl (+57.02) 661.3423 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% STSGGTAALGcLVK 95.00% 2.81 0.37 2.35 c11: Carbamidomethyl (+57.02) 661.343 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% STSGGTAALGcLVK 95.00% 2.49 0.385 1.38 c11: Carbamidomethyl (+57.02) 661.9937 1,321.97 1,321.68 2 IGHG1_HUMAN
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% cPAPELLGGPSVFLFPPKPK 95.00% 4.99 0.582 4.62 c1: Carbamidomethyl (+57.02) 718.0612 2,151.16 2,151.17 3
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% cPAPELLGGPSVFLFPPKPK 95.00% 4.81 0.564 6.04 c1: Carbamidomethyl (+57.02) 718.0614 2,151.16 2,151.17 3
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% EPQVYTLPPSREEMTK 95.00% 3.46 0.549 3.05 953.1425 1,904.27 1,904.94 2
 SAMPLE 3 Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 100.00% 3 3 10 19.10% EPQVYTLPPSREEMTK 95.00% 3.6 0.556 2.09 953.1445 1,904.27 1,904.94 2
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% NQVSLTcLVK 95.00% 2.45 0.362 1.21 c7: Carbamidomethyl (+57.02) 581.3159 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% NQVSLTcLVK 95.00% 2.97 0.428 1.92 c7: Carbamidomethyl (+57.02) 581.3163 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% NQVSLTcLVK 95.00% 2.9 0.459 1.46 c7: Carbamidomethyl (+57.02) 581.3168 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% NQVSLTcLVK 95.00% 2.82 0.476 1.31 c7: Carbamidomethyl (+57.02) 581.317 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% NQVSLTcLVK 95.00% 2.88 0.451 1.49 c7: Carbamidomethyl (+57.02) 581.3174 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% NQVSLTcLVK 95.00% 2.26 0.341 0 c7: Carbamidomethyl (+57.02) 581.3177 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% NQVSLTcLVK 95.00% 2.92 0.446 1.8 c7: Carbamidomethyl (+57.02) 581.3178 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% NQVSLTcLVK 95.00% 2.08 0.291 0 c7: Carbamidomethyl (+57.02) 581.3187 1,160.62 1,161.63 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% VVSVLTVLHQDWLNGK 95.00% 3.19 0.547 2.7 603.3398 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% VVSVLTVLHQDWLNGK 95.00% 3.15 0.534 1.89 603.34 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% VVSVLTVLHQDWLNGK 95.00% 3.54 0.539 1.47 603.3403 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% VVSVLTVLHQDWLNGK 95.00% 2.54 0.493 0 603.3411 1,807.00 1,808.01 3 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% GPSVFPLAPcSR 95.00% 2.48 0.316 0 c10: Carbamidomethyl (+57.02) 644.327 1,286.64 1,287.65 2
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% GPSVFPLAPcSR 95.00% 2.91 0.443 0 c10: Carbamidomethyl (+57.02) 644.3285 1,286.64 1,287.65 2
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% GPSVFPLAPcSR 95.00% 2.92 0.445 0 c10: Carbamidomethyl (+57.02) 644.3287 1,286.64 1,287.65 2
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% GPSVFPLAPcSR 95.00% 2.84 0.38 0 c10: Carbamidomethyl (+57.02) 644.3292 1,286.64 1,287.65 2
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% STSGGTAALGcLVK 95.00% 3.34 0.449 3.23 c11: Carbamidomethyl (+57.02) 661.3404 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% STSGGTAALGcLVK 95.00% 2.12 0.162 1.68 c11: Carbamidomethyl (+57.02) 661.3412 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% STSGGTAALGcLVK 95.00% 2.43 0.31 0 c11: Carbamidomethyl (+57.02) 661.3415 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% STSGGTAALGcLVK 95.00% 2.57 0.348 0 c11: Carbamidomethyl (+57.02) 661.3416 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% STSGGTAALGcLVK 95.00% 3.08 0.413 1.96 c11: Carbamidomethyl (+57.02) 661.3423 1,320.67 1,321.68 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% VVSVLTVLHQDWLNGK 95.00% 4.21 0.617 7.29 904.5072 1,807.00 1,808.01 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% VVSVLTVLHQDWLNGK 95.00% 4.66 0.577 5.52 905.0086 1,808.00 1,808.01 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% VVSVLTVLHQDWLNGK 95.00% 3.9 0.59 6.07 905.0087 1,808.00 1,808.01 2 IGHG1_HUMAN
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% EPQVYTLPPSREEMTK 95.00% 3.36 0.553 2.25 953.1431 1,904.27 1,904.94 2
 SAMPLE 3R Ig gamma-3 chain C region  IGHG3  IGHG3_HUMAN 41,267.90 99.80% 2 2 6 18.00% EPQVYTLPPSREEMTK 95.00% 3.52 0.581 2 953.144 1,904.27 1,904.94 2
 SAMPLE 4R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 4 4 6 67.00% VYAcEVTHQGLSSPVTK 95.00% 3.27 0.55 1.36 c4: Carbamidomethyl (+57.02) 626.317 1,875.93 1,875.93 3
 SAMPLE 4R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 4 4 6 67.00% SGTASVVcLLNNFYPR 95.00% 3.49 0.504 5.64 c8: Carbamidomethyl (+57.02) 899.4541 1,796.89 1,797.90 2
 SAMPLE 4R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 4 4 6 67.00% SGTASVVcLLNNFYPR 95.00% 2.6 0.327 1.24 c8: Carbamidomethyl (+57.02) 899.4545 1,796.89 1,797.90 2
 SAMPLE 4R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 4 4 6 67.00% TVAAPSVFIFPPSDEQLK 95.00% 4.16 0.409 1.7 974.0253 1,946.03 1,946.03 2
 SAMPLE 4R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 4 4 6 67.00% VDNALQSGNSQESVTEQDSK 95.00% 5.89 0.631 6.92 1,069.00 2,135.98 2,135.97 2
 SAMPLE 4R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 4 4 6 67.00% VDNALQSGNSQESVTEQDSK 95.00% 5.8 0.643 7.66 1,069.00 2,135.98 2,135.97 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% SGTASVVcLLNNFYPR 95.00% 3.32 0.426 1.06 c8: Carbamidomethyl (+57.02) 599.978 1,796.91 1,797.90 3
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% SGTASVVcLLNNFYPR 95.00% 3.41 0.459 0 c8: Carbamidomethyl (+57.02) 600.3095 1,797.91 1,797.90 3
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% VYAcEVTHQGLSSPVTK 95.00% 4.3 0.59 1.21 c4: Carbamidomethyl (+57.02) 625.9847 1,874.93 1,875.93 3
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% VYAcEVTHQGLSSPVTK 95.00% 2.28 0.256 0 c4: Carbamidomethyl (+57.02) 625.9855 1,874.93 1,875.93 3
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% VYAcEVTHQGLSSPVTK 95.00% 3.31 0.547 0 c4: Carbamidomethyl (+57.02) 626.3144 1,875.92 1,875.93 3
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% VDNALQSGNSQESVTEQDSK 95.00% 4.78 0.518 0 712.9977 2,135.97 2,135.97 3
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% DSTYSLSSTLTLSK 95.00% 4.13 0.349 5.01 751.8803 1,501.75 1,502.76 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% DSTYSLSSTLTLSK 95.00% 3.65 0.376 5 751.8826 1,501.75 1,502.76 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% DSTYSLSSTLTLSK 95.00% 3.83 0.322 5.42 751.888 1,501.76 1,502.76 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% DSTYSLSSTLTLSK 95.00% 3.88 0.332 4.92 751.8933 1,501.77 1,502.76 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% SGTASVVcLLNNFYPR 95.00% 4.08 0.613 1.85 c8: Carbamidomethyl (+57.02) 899.4674 1,796.92 1,797.90 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% SGTASVVcLLNNFYPR 95.00% 4.36 0.511 4.1 c8: Carbamidomethyl (+57.02) 899.9498 1,797.88 1,797.90 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% SGTASVVcLLNNFYPR 95.00% 4.06 0.419 1.54 c8: Carbamidomethyl (+57.02) 899.9505 1,797.89 1,797.90 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% VYAcEVTHQGLSSPVTK 95.00% 2.18 0.396 3.49 c4: Carbamidomethyl (+57.02) 938.4614 1,874.91 1,875.93 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% VYAcEVTHQGLSSPVTK 95.00% 3.92 0.579 3.85 c4: Carbamidomethyl (+57.02) 938.4738 1,874.93 1,875.93 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.56 0.606 3.29 973.5142 1,945.01 1,946.03 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.38 0.614 4.74 973.5149 1,945.01 1,946.03 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% TVAAPSVFIFPPSDEQLK 95.00% 3.18 0.51 2.96 973.5165 1,945.02 1,946.03 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.57 0.593 2.92 974.015 1,946.01 1,946.03 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.75 0.543 4.57 974.016 1,946.02 1,946.03 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.28 0.614 2.66 974.0304 1,946.05 1,946.03 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.83 0.558 2.43 974.0366 1,946.06 1,946.03 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.98 0.588 1.77 974.0407 1,946.07 1,946.03 2
 SAMPLE 1 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 24 80.20% VDNALQSGNSQESVTEQDSK 95.00% 5.48 0.614 8.96 1,068.99 2,135.97 2,135.97 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% SGTASVVcLLNNFYPR 95.00% 3.32 0.426 1.17 c8: Carbamidomethyl (+57.02) 599.978 1,796.91 1,797.90 3
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% SGTASVVcLLNNFYPR 95.00% 3.86 0.474 0.959 c8: Carbamidomethyl (+57.02) 600.3026 1,797.88 1,797.90 3
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% SGTASVVcLLNNFYPR 95.00% 3.41 0.459 0 c8: Carbamidomethyl (+57.02) 600.3095 1,797.91 1,797.90 3
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% SGTASVVcLLNNFYPR 95.00% 3.78 0.475 1.19 c8: Carbamidomethyl (+57.02) 600.317 1,797.93 1,797.90 3
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% VYAcEVTHQGLSSPVTK 95.00% 4.3 0.59 1.08 c4: Carbamidomethyl (+57.02) 625.9847 1,874.93 1,875.93 3
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% VYAcEVTHQGLSSPVTK 95.00% 2.28 0.256 0 c4: Carbamidomethyl (+57.02) 625.9855 1,874.93 1,875.93 3
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% VYAcEVTHQGLSSPVTK 95.00% 3.78 0.537 1.49 c4: Carbamidomethyl (+57.02) 626.3175 1,875.93 1,875.93 3
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% VYAcEVTHQGLSSPVTK 95.00% 2.85 0.499 0 c4: Carbamidomethyl (+57.02) 626.3226 1,875.94 1,875.93 3
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% TVAAPSVFIFPPSDEQLK 95.00% 3.68 0.461 0 649.36 1,945.06 1,946.03 3
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% TVAAPSVFIFPPSDEQLK 95.00% 2.76 0.341 0 649.6948 1,946.06 1,946.03 3
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% VDNALQSGNSQESVTEQDSK 95.00% 4.78 0.518 0 712.9977 2,135.97 2,135.97 3
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% DSTYSLSSTLTLSK 95.00% 3.83 0.322 5.15 751.888 1,501.76 1,502.76 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% DSTYSLSSTLTLSK 95.00% 3.88 0.332 3.74 751.8933 1,501.77 1,502.76 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% DSTYSLSSTLTLSK 95.00% 2.71 0 1.44 751.8967 1,501.78 1,502.76 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% SGTASVVcLLNNFYPR 95.00% 3.61 0.464 0 c8: Carbamidomethyl (+57.02) 899.4504 1,796.89 1,797.90 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% SGTASVVcLLNNFYPR 95.00% 4.08 0.613 1.6 c8: Carbamidomethyl (+57.02) 899.4674 1,796.92 1,797.90 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% SGTASVVcLLNNFYPR 95.00% 3.82 0.55 2.15 c8: Carbamidomethyl (+57.02) 899.4706 1,796.93 1,797.90 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% SGTASVVcLLNNFYPR 95.00% 4.06 0.419 1.64 c8: Carbamidomethyl (+57.02) 899.9505 1,797.89 1,797.90 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% SGTASVVcLLNNFYPR 95.00% 4.07 0.531 4.29 c8: Carbamidomethyl (+57.02) 899.9507 1,797.89 1,797.90 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% SGTASVVcLLNNFYPR 95.00% 4.36 0.528 4.2 c8: Carbamidomethyl (+57.02) 899.9519 1,797.89 1,797.90 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% SGTASVVcLLNNFYPR 95.00% 3.83 0.504 2.33 c8: Carbamidomethyl (+57.02) 899.955 1,797.89 1,797.90 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% SGTASVVcLLNNFYPR 95.00% 4.38 0.481 1.82 c8: Carbamidomethyl (+57.02) 899.9729 1,797.93 1,797.90 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% VYAcEVTHQGLSSPVTK 95.00% 3.92 0.579 4.48 c4: Carbamidomethyl (+57.02) 938.4738 1,874.93 1,875.93 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.57 0.593 2.51 974.015 1,946.01 1,946.03 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.29 0.554 2.41 974.016 1,946.02 1,946.03 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.28 0.614 2.62 974.0304 1,946.05 1,946.03 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.75 0.636 1.36 974.0379 1,946.06 1,946.03 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.12 0.573 1.43 974.0395 1,946.06 1,946.03 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% TVAAPSVFIFPPSDEQLK 95.00% 4.34 0.574 2.29 974.0399 1,946.06 1,946.03 2
 SAMPLE 1R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 9 30 80.20% VDNALQSGNSQESVTEQDSK 95.00% 5.48 0.614 8.39 1,068.99 2,135.97 2,135.97 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VYAcEVTHQGLSSPVTK 95.00% 3.76 0.553 1.19 c4: Carbamidomethyl (+57.02) 625.9787 1,874.91 1,875.93 3
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VYAcEVTHQGLSSPVTK 95.00% 3.39 0.461 1.19 c4: Carbamidomethyl (+57.02) 625.98 1,874.92 1,875.93 3
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VYAcEVTHQGLSSPVTK 95.00% 3.27 0.553 1.7 c4: Carbamidomethyl (+57.02) 626.3137 1,875.92 1,875.93 3
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VYAcEVTHQGLSSPVTK 95.00% 3.85 0.523 2 c4: Carbamidomethyl (+57.02) 626.3148 1,875.92 1,875.93 3
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% TVAAPSVFIFPPSDEQLK 95.00% 3.48 0.393 1.52 649.6812 1,946.02 1,946.03 3
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% TVAAPSVFIFPPSDEQLK 95.00% 2.42 0.277 1.29 649.6815 1,946.02 1,946.03 3
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VDNALQSGNSQESVTEQDSK 95.00% 4.76 0.593 1.49 712.6602 2,134.96 2,135.97 3
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VDNALQSGNSQESVTEQDSK 95.00% 5.73 0.589 2.36 712.9943 2,135.96 2,135.97 3
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VDNALQSGNSQESVTEQDSK 95.00% 5.7 0.571 2.26 712.9949 2,135.96 2,135.97 3
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VDNALQSGNSQESVTEQDSK 95.00% 5.35 0.617 3.39 712.995 2,135.96 2,135.97 3
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% HKVYAcEVTHQGLSSPVTK 95.00% 5 0.574 4.8 c6: Carbamidomethyl (+57.02) 714.6985 2,141.07 2,141.08 3
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% HKVYAcEVTHQGLSSPVTK 95.00% 4.95 0.586 4.24 c6: Carbamidomethyl (+57.02) 714.699 2,141.07 2,141.08 3
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% DSTYSLSSTLTLSK 95.00% 4.17 0.371 4.77 751.8817 1,501.75 1,502.76 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% DSTYSLSSTLTLSK 95.00% 3.86 0.295 5.52 751.882 1,501.75 1,502.76 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% DSTYSLSSTLTLSK 95.00% 3.9 0.352 4.72 751.8825 1,501.75 1,502.76 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% DSTYSLSSTLTLSK 95.00% 4 0.375 4.12 751.8825 1,501.75 1,502.76 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% DSTYSLSSTLTLSK 95.00% 3.45 0.337 4.47 751.8826 1,501.75 1,502.76 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% DSTYSLSSTLTLSK 95.00% 3.39 0.28 3.47 751.8828 1,501.75 1,502.76 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VYAcEVTHQGLSSPVTK 95.00% 5.24 0.529 5.82 c4: Carbamidomethyl (+57.02) 938.465 1,874.91 1,875.93 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VYAcEVTHQGLSSPVTK 95.00% 5.03 0.599 6 c4: Carbamidomethyl (+57.02) 938.967 1,875.92 1,875.93 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VYAcEVTHQGLSSPVTK 95.00% 4.9 0.567 4.92 c4: Carbamidomethyl (+57.02) 938.9676 1,875.92 1,875.93 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VYAcEVTHQGLSSPVTK 95.00% 5.09 0.539 5.7 c4: Carbamidomethyl (+57.02) 938.9676 1,875.92 1,875.93 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VYAcEVTHQGLSSPVTK 95.00% 5.04 0.48 4.02 c4: Carbamidomethyl (+57.02) 938.9677 1,875.92 1,875.93 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% TVAAPSVFIFPPSDEQLK 95.00% 4.79 0.648 4 973.5165 1,945.02 1,946.03 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% TVAAPSVFIFPPSDEQLK 95.00% 4.63 0.587 1.47 974.0168 1,946.02 1,946.03 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% TVAAPSVFIFPPSDEQLK 95.00% 4.58 0.578 1.16 974.0171 1,946.02 1,946.03 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% TVAAPSVFIFPPSDEQLK 95.00% 4.58 0.548 1.8 974.0183 1,946.02 1,946.03 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VDNALQSGNSQESVTEQDSK 95.00% 5.01 0.679 6.06 1,068.48 2,134.95 2,135.97 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VDNALQSGNSQESVTEQDSK 95.00% 6.15 0.687 7.89 1,068.48 2,134.95 2,135.97 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VDNALQSGNSQESVTEQDSK 95.00% 6.14 0.638 7.46 1,068.99 2,135.96 2,135.97 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VDNALQSGNSQESVTEQDSK 95.00% 6.09 0.644 8.51 1,068.99 2,135.96 2,135.97 2
 SAMPLE 2 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 8 32 67.00% VDNALQSGNSQESVTEQDSK 95.00% 6.1 0.655 7.89 1,068.99 2,135.96 2,135.97 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% VDNALQSGNSQESVTEQDSK 95.00% 5.25 0.586 2.16 712.6608 2,134.96 2,135.97 3
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% VDNALQSGNSQESVTEQDSK 95.00% 5.07 0.596 2.38 712.9939 2,135.96 2,135.97 3
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% VDNALQSGNSQESVTEQDSK 95.00% 5.27 0.629 1.48 712.9948 2,135.96 2,135.97 3
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% VDNALQSGNSQESVTEQDSK 95.00% 5.66 0.608 2.48 712.9948 2,135.96 2,135.97 3
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% HKVYAcEVTHQGLSSPVTK 95.00% 3.75 0.346 3.44 c6: Carbamidomethyl (+57.02) 714.2927 2,139.85 2,141.08 3
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% HKVYAcEVTHQGLSSPVTK 95.00% 2.84 0.2 0 c6: Carbamidomethyl (+57.02) 714.2944 2,139.86 2,141.08 3
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% HKVYAcEVTHQGLSSPVTK 95.00% 4.27 0.5 1.82 c6: Carbamidomethyl (+57.02) 714.699 2,141.07 2,141.08 3
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% DSTYSLSSTLTLSK 95.00% 3.43 0.332 4 751.881 1,501.75 1,502.76 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% DSTYSLSSTLTLSK 95.00% 3.57 0.314 4.13 751.883 1,501.75 1,502.76 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% DSTYSLSSTLTLSK 95.00% 4.04 0.337 5.11 751.883 1,501.75 1,502.76 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% DSTYSLSSTLTLSK 95.00% 3.3 0.381 4.74 751.8839 1,501.75 1,502.76 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% SGTASVVcLLNNFYPR 95.00% 3.39 0.476 5.39 c8: Carbamidomethyl (+57.02) 899.4505 1,796.89 1,797.90 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% SGTASVVcLLNNFYPR 95.00% 4.38 0.527 2.34 c8: Carbamidomethyl (+57.02) 899.4539 1,796.89 1,797.90 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% SGTASVVcLLNNFYPR 95.00% 4.55 0.512 4.4 c8: Carbamidomethyl (+57.02) 899.9522 1,797.89 1,797.90 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% SGTASVVcLLNNFYPR 95.00% 3.64 0.443 2.96 c8: Carbamidomethyl (+57.02) 899.9544 1,797.89 1,797.90 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% SGTASVVcLLNNFYPR 95.00% 4.53 0.475 3 c8: Carbamidomethyl (+57.02) 899.9546 1,797.89 1,797.90 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% VYAcEVTHQGLSSPVTK 95.00% 4.99 0.602 6.51 c4: Carbamidomethyl (+57.02) 938.4654 1,874.92 1,875.93 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% VYAcEVTHQGLSSPVTK 95.00% 5.22 0.621 5.15 c4: Carbamidomethyl (+57.02) 938.4662 1,874.92 1,875.93 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% VYAcEVTHQGLSSPVTK 95.00% 5.02 0.604 4.92 c4: Carbamidomethyl (+57.02) 938.4671 1,874.92 1,875.93 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% VYAcEVTHQGLSSPVTK 95.00% 5 0.509 5.33 c4: Carbamidomethyl (+57.02) 938.968 1,875.92 1,875.93 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% TVAAPSVFIFPPSDEQLK 95.00% 4.45 0.629 2.68 973.5174 1,945.02 1,946.03 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% TVAAPSVFIFPPSDEQLK 95.00% 4.97 0.598 3.77 974.0161 1,946.02 1,946.03 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% TVAAPSVFIFPPSDEQLK 95.00% 4.39 0.599 2.55 974.0177 1,946.02 1,946.03 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% TVAAPSVFIFPPSDEQLK 95.00% 4.23 0.532 1.42 974.019 1,946.02 1,946.03 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% VDNALQSGNSQESVTEQDSK 95.00% 6.18 0.658 8.15 1,068.99 2,135.96 2,135.97 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% VDNALQSGNSQESVTEQDSK 95.00% 6.23 0.661 7.47 1,068.99 2,135.96 2,135.97 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% VDNALQSGNSQESVTEQDSK 95.00% 6.18 0.673 9.07 1,068.99 2,135.96 2,135.97 2
 SAMPLE 2R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 7 28 82.10% VDNALQSGNSQESVTEQDSK 95.00% 6.18 0.643 9.23 1,068.99 2,135.96 2,135.97 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% VYAcEVTHQGLSSPVTK 95.00% 2.58 0.228 0 c4: Carbamidomethyl (+57.02) 626.3145 1,875.92 1,875.93 3
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% VYAcEVTHQGLSSPVTK 95.00% 3.6 0.448 0.959 c4: Carbamidomethyl (+57.02) 626.3148 1,875.92 1,875.93 3
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% VDNALQSGNSQESVTEQDSK 95.00% 4.38 0.577 2.3 712.6604 2,134.96 2,135.97 3
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% VDNALQSGNSQESVTEQDSK 95.00% 5.5 0.62 2.92 712.994 2,135.96 2,135.97 3
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% HKVYAcEVTHQGLSSPVTK 95.00% 5.52 0.596 6.8 c6: Carbamidomethyl (+57.02) 714.3635 2,140.07 2,141.08 3
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% HKVYAcEVTHQGLSSPVTK 95.00% 4.97 0.525 7.15 c6: Carbamidomethyl (+57.02) 714.6979 2,141.07 2,141.08 3
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% DSTYSLSSTLTLSK 95.00% 3.48 0.362 3.1 751.8814 1,501.75 1,502.76 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% DSTYSLSSTLTLSK 95.00% 2.43 0.231 1.57 751.8817 1,501.75 1,502.76 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% DSTYSLSSTLTLSK 95.00% 3.44 0.342 5.07 751.8826 1,501.75 1,502.76 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% DSTYSLSSTLTLSK 95.00% 2.79 0.325 2.92 751.8839 1,501.75 1,502.76 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% VYAcEVTHQGLSSPVTK 95.00% 5.26 0.542 5.4 c4: Carbamidomethyl (+57.02) 938.4655 1,874.92 1,875.93 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% VYAcEVTHQGLSSPVTK 95.00% 5.48 0.558 5.68 c4: Carbamidomethyl (+57.02) 938.4665 1,874.92 1,875.93 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% VYAcEVTHQGLSSPVTK 95.00% 5.33 0.517 5.82 c4: Carbamidomethyl (+57.02) 938.9665 1,875.92 1,875.93 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% VYAcEVTHQGLSSPVTK 95.00% 5.36 0.564 5.82 c4: Carbamidomethyl (+57.02) 938.9676 1,875.92 1,875.93 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% TVAAPSVFIFPPSDEQLK 95.00% 4.58 0.577 2.52 974.0149 1,946.01 1,946.03 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% TVAAPSVFIFPPSDEQLK 95.00% 4.77 0.574 3.07 974.0155 1,946.02 1,946.03 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% TVAAPSVFIFPPSDEQLK 95.00% 4.55 0.539 2.05 974.0171 1,946.02 1,946.03 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% TVAAPSVFIFPPSDEQLK 95.00% 4.75 0.579 2.92 974.0171 1,946.02 1,946.03 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% VDNALQSGNSQESVTEQDSK 95.00% 6.3 0.667 8.89 1,068.49 2,134.96 2,135.97 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% VDNALQSGNSQESVTEQDSK 95.00% 6 0.665 11.7 1,068.49 2,134.96 2,135.97 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% VDNALQSGNSQESVTEQDSK 95.00% 6.03 0.649 7.82 1,068.99 2,135.96 2,135.97 2
 SAMPLE 3 Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 5 7 22 67.00% VDNALQSGNSQESVTEQDSK 95.00% 6.28 0.666 8.15 1,068.99 2,135.96 2,135.97 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VYAcEVTHQGLSSPVTK 95.00% 3.91 0.58 0 c4: Carbamidomethyl (+57.02) 625.9788 1,874.91 1,875.93 3
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VYAcEVTHQGLSSPVTK 95.00% 2.87 0.438 1.26 c4: Carbamidomethyl (+57.02) 625.9811 1,874.92 1,875.93 3
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VYAcEVTHQGLSSPVTK 95.00% 3.55 0.576 2.68 c4: Carbamidomethyl (+57.02) 626.3148 1,875.92 1,875.93 3
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VYAcEVTHQGLSSPVTK 95.00% 3.01 0.497 0 c4: Carbamidomethyl (+57.02) 626.3188 1,875.93 1,875.93 3
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% TVAAPSVFIFPPSDEQLK 95.00% 3.22 0.329 0 649.6794 1,946.01 1,946.03 3
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VDNALQSGNSQESVTEQDSK 95.00% 4.98 0.61 2.43 712.6611 2,134.96 2,135.97 3
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VDNALQSGNSQESVTEQDSK 95.00% 3.57 0.543 0 712.994 2,135.96 2,135.97 3
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VDNALQSGNSQESVTEQDSK 95.00% 3.87 0.516 1.07 712.9943 2,135.96 2,135.97 3
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VDNALQSGNSQESVTEQDSK 95.00% 5.51 0.625 3.44 712.9946 2,135.96 2,135.97 3
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% HKVYAcEVTHQGLSSPVTK 95.00% 5.2 0.608 7.24 c6: Carbamidomethyl (+57.02) 714.3647 2,140.07 2,141.08 3
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% HKVYAcEVTHQGLSSPVTK 95.00% 5.21 0.592 8.55 c6: Carbamidomethyl (+57.02) 714.6987 2,141.07 2,141.08 3
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% DSTYSLSSTLTLSK 95.00% 2.83 0.36 3.57 751.8811 1,501.75 1,502.76 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% DSTYSLSSTLTLSK 95.00% 3.42 0.332 4.24 751.8833 1,501.75 1,502.76 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% SGTASVVcLLNNFYPR 95.00% 4.13 0.54 2.31 c8: Carbamidomethyl (+57.02) 899.4498 1,796.88 1,797.90 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% SGTASVVcLLNNFYPR 95.00% 3.63 0.513 4.1 c8: Carbamidomethyl (+57.02) 899.4521 1,796.89 1,797.90 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% SGTASVVcLLNNFYPR 95.00% 3.56 0.442 2.54 c8: Carbamidomethyl (+57.02) 899.9526 1,797.89 1,797.90 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% SGTASVVcLLNNFYPR 95.00% 3.87 0.521 2.41 c8: Carbamidomethyl (+57.02) 899.9538 1,797.89 1,797.90 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VYAcEVTHQGLSSPVTK 95.00% 5.09 0.543 4.77 c4: Carbamidomethyl (+57.02) 938.4671 1,874.92 1,875.93 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VYAcEVTHQGLSSPVTK 95.00% 5.21 0.554 5.64 c4: Carbamidomethyl (+57.02) 938.9646 1,875.91 1,875.93 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VYAcEVTHQGLSSPVTK 95.00% 5.02 0.57 4.89 c4: Carbamidomethyl (+57.02) 938.9662 1,875.92 1,875.93 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VYAcEVTHQGLSSPVTK 95.00% 5.29 0.497 6.29 c4: Carbamidomethyl (+57.02) 938.9684 1,875.92 1,875.93 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% TVAAPSVFIFPPSDEQLK 95.00% 3.25 0.499 2.32 973.5107 1,945.01 1,946.03 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% TVAAPSVFIFPPSDEQLK 95.00% 3.95 0.582 2.23 973.5128 1,945.01 1,946.03 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% TVAAPSVFIFPPSDEQLK 95.00% 4.75 0.587 2.35 974.015 1,946.01 1,946.03 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% TVAAPSVFIFPPSDEQLK 95.00% 4.72 0.551 2.06 974.0187 1,946.02 1,946.03 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VDNALQSGNSQESVTEQDSK 95.00% 6.05 0.69 7.22 1,068.49 2,134.96 2,135.97 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VDNALQSGNSQESVTEQDSK 95.00% 6.08 0.671 11.8 1,068.99 2,135.96 2,135.97 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VDNALQSGNSQESVTEQDSK 95.00% 6.18 0.656 9.41 1,068.99 2,135.96 2,135.97 2
 SAMPLE 3R Ig kappa chain C region  IGKC  IGKC_HUMAN 11,590.50 100.00% 6 9 29 82.10% VDNALQSGNSQESVTEQDSK 95.00% 6.17 0.667 11.2 1,068.99 2,135.96 2,135.97 2
 SAMPLE 2R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 6 39.40% LLIYGASSR 95.00% 3.04 0.294 0 490.2814 978.5472 979.5577 2
 SAMPLE 2R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 6 39.40% LLIYGASSR 95.00% 2.59 0.284 0 490.2825 978.5494 979.5577 2
 SAMPLE 2R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 6 39.40% FSGSGSGTDFTLTISR 95.00% 4.43 0.651 3.36 816.8951 1,631.77 1,632.79 2
 SAMPLE 2R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 6 39.40% FSGSGSGTDFTLTISR 95.00% 4.31 0.647 3.31 816.8968 1,631.78 1,632.79 2
 SAMPLE 2R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 6 39.40% EIVLTQSPGTLSLSPGER 95.00% 4.77 0.627 5.46 942.5069 1,883.00 1,884.01 2
 SAMPLE 2R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 6 39.40% EIVLTQSPGTLSLSPGER 95.00% 5.61 0.639 6.15 942.5078 1,883.00 1,884.01 2
 SAMPLE 2R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 6 39.40% EIVLTQSPGTLSLSPGER 95.00% 5.23 0.611 4.96 943.0085 1,884.00 1,884.01 2
 SAMPLE 2R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 6 39.40% EIVLTQSPGTLSLSPGER 95.00% 6.18 0.626 5.49 943.0089 1,884.00 1,884.01 2
 SAMPLE 3 Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 3 39.40% LLIYGASSR 95.00% 2.56 0.242 0 490.2819 978.5482 979.5577 2
 SAMPLE 3 Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 3 39.40% FSGSGSGTDFTLTISR 95.00% 4.29 0.633 4.7 816.8966 1,631.78 1,632.79 2
 SAMPLE 3 Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 3 39.40% FSGSGSGTDFTLTISR 95.00% 4.54 0.621 5.38 817.397 1,632.78 1,632.79 2
 SAMPLE 3 Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 3 39.40% EIVLTQSPGTLSLSPGER 95.00% 5.27 0.644 5.96 943.0076 1,884.00 1,884.01 2
 SAMPLE 3 Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 3 39.40% EIVLTQSPGTLSLSPGER 95.00% 6.26 0.657 6.11 943.0086 1,884.00 1,884.01 2
 SAMPLE 3R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 3 39.40% LLIYGASSR 95.00% 2.92 0.303 0 490.2809 978.5461 979.5577 2
 SAMPLE 3R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 3 39.40% FSGSGSGTDFTLTISR 95.00% 4.14 0.574 3.14 816.8953 1,631.77 1,632.79 2
 SAMPLE 3R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 3 39.40% FSGSGSGTDFTLTISR 95.00% 4.15 0.647 4.72 816.8973 1,631.78 1,632.79 2
 SAMPLE 3R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 3 39.40% EIVLTQSPGTLSLSPGER 95.00% 5.51 0.653 5.96 942.5056 1,883.00 1,884.01 2
 SAMPLE 3R Ig kappa chain V-III region WOL OS=Homo sapiens  KV305_HUMAN 11,728.50 99.80% 2 2 3 39.40% EIVLTQSPGTLSLSPGER 95.00% 4.52 0.651 4.89 942.5092 1,883.00 1,884.01 2
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% AGVETTTPSK 95.00% 1.86 0.351 0 495.7588 989.5019 990.5109 2
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% SYScQVTHEGSTVEK 95.00% 1.91 0.307 0 c4: Carbamidomethyl (+57.02) 571.2596 1,710.76 1,711.76 3
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% SYScQVTHEGSTVEK 95.00% 2.01 0.401 0 c4: Carbamidomethyl (+57.02) 571.2596 1,710.76 1,711.76 3
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% AAPSVTLFPPSSEELQANK 95.00% 3.49 0.214 1.09 663.0112 1,986.01 1,986.02 3
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% AAPSVTLFPPSSEELQANK 95.00% 3.35 0.331 1.43 663.0112 1,986.01 1,986.02 3
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% ADSSPVKAGVETTTPSK 95.00% 2.79 0.358 2.24 837.9337 1,673.85 1,674.86 2
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% SYScQVTHEGSTVEK 95.00% 4.54 0.451 4.66 c4: Carbamidomethyl (+57.02) 856.3859 1,710.76 1,711.76 2
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% YAASSYLSLTPEQWK 95.00% 5.63 0.603 5.37 872.4305 1,742.85 1,743.86 2
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% YAASSYLSLTPEQWK 95.00% 5.19 0.594 5.03 872.4325 1,742.85 1,743.86 2
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% YAASSYLSLTPEQWK 95.00% 4.06 0.55 2.8 872.4328 1,742.85 1,743.86 2
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% AAPSVTLFPPSSEELQANK 95.00% 4.09 0.584 2.55 993.5131 1,985.01 1,986.02 2
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% AAPSVTLFPPSSEELQANK 95.00% 3.83 0.419 0 994.0109 1,986.01 1,986.02 2
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% AAPSVTLFPPSSEELQANK 95.00% 4.29 0.527 3.7 994.0136 1,986.01 1,986.02 2
 SAMPLE 2 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 7 62.90% AAPSVTLFPPSSEELQANK 95.00% 4.31 0.473 1.22 994.0139 1,986.01 1,986.02 2
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% SYScQVTHEGSTVEK 95.00% 1.81 0.278 0 c4: Carbamidomethyl (+57.02) 571.2598 1,710.76 1,711.76 3
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% SYScQVTHEGSTVEK 95.00% 1.9 0.411 0 c4: Carbamidomethyl (+57.02) 571.26 1,710.76 1,711.76 3
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% AAPSVTLFPPSSEELQANK 95.00% 2.73 0.273 0 663.0114 1,986.01 1,986.02 3
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% ADSSPVKAGVETTTPSK 95.00% 2.55 0.336 3.52 837.9329 1,673.85 1,674.86 2
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% ADSSPVKAGVETTTPSK 95.00% 3.56 0.558 2.39 838.4354 1,674.86 1,674.86 2
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% SYScQVTHEGSTVEK 95.00% 4.65 0.522 4.19 c4: Carbamidomethyl (+57.02) 856.3853 1,710.75 1,711.76 2
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% SYScQVTHEGSTVEK 95.00% 4.32 0.485 3.1 c4: Carbamidomethyl (+57.02) 856.3863 1,710.76 1,711.76 2
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% YAASSYLSLTPEQWK 95.00% 5.63 0.56 4.74 872.4308 1,742.85 1,743.86 2
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% YAASSYLSLTPEQWK 95.00% 5.38 0.597 5.64 872.4317 1,742.85 1,743.86 2
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% YAASSYLSLTPEQWK 95.00% 3.85 0.519 0 872.433 1,742.85 1,743.86 2
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% YAASSYLSLTPEQWK 95.00% 3.16 0.394 0 872.4375 1,742.86 1,743.86 2
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% AAPSVTLFPPSSEELQANK 95.00% 4.39 0.523 3.8 994.0123 1,986.01 1,986.02 2
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% AAPSVTLFPPSSEELQANK 95.00% 4.34 0.59 2.59 994.0142 1,986.01 1,986.02 2
 SAMPLE 2R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 100.00% 3 4 10 62.90% AAPSVTLFPPSSEELQANK 95.00% 3.76 0.366 0 994.0185 1,986.02 1,986.02 2
 SAMPLE 3 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 6 46.70% SYScQVTHEGSTVEK 95.00% 2.46 0.436 0 c4: Carbamidomethyl (+57.02) 571.2559 1,710.74 1,711.76 3
 SAMPLE 3 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 6 46.70% SYScQVTHEGSTVEK 95.00% 2.05 0.468 0 c4: Carbamidomethyl (+57.02) 571.2584 1,710.75 1,711.76 3
 SAMPLE 3 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 6 46.70% SYScQVTHEGSTVEK 95.00% 1.87 0.328 0 c4: Carbamidomethyl (+57.02) 571.2609 1,710.76 1,711.76 3
 SAMPLE 3 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 6 46.70% AAPSVTLFPPSSEELQANK 95.00% 2.63 0.311 0 663.012 1,986.01 1,986.02 3
 SAMPLE 3 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 6 46.70% SYScQVTHEGSTVEK 95.00% 3.63 0.368 0 c4: Carbamidomethyl (+57.02) 856.3888 1,710.76 1,711.76 2
 SAMPLE 3 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 6 46.70% SYScQVTHEGSTVEK 95.00% 4.01 0.328 0 c4: Carbamidomethyl (+57.02) 856.883 1,711.75 1,711.76 2
 SAMPLE 3 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 6 46.70% YAASSYLSLTPEQWK 95.00% 4.7 0.628 4.28 872.434 1,742.85 1,743.86 2
 SAMPLE 3 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 6 46.70% AAPSVTLFPPSSEELQANK 95.00% 4.21 0.493 2.68 993.5117 1,985.01 1,986.02 2
 SAMPLE 3 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 6 46.70% AAPSVTLFPPSSEELQANK 95.00% 4.54 0.509 3.08 994.0122 1,986.01 1,986.02 2
 SAMPLE 3 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 6 46.70% AAPSVTLFPPSSEELQANK 95.00% 3.97 0.231 0 994.0122 1,986.01 1,986.02 2
 SAMPLE 3 Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 6 46.70% AAPSVTLFPPSSEELQANK 95.00% 3.68 0.427 0 994.0144 1,986.01 1,986.02 2
 SAMPLE 3R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 5 46.70% SYScQVTHEGSTVEK 95.00% 1.85 0.437 0 c4: Carbamidomethyl (+57.02) 571.2581 1,710.75 1,711.76 3
 SAMPLE 3R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 5 46.70% AAPSVTLFPPSSEELQANK 95.00% 2.32 0.296 0 663.0115 1,986.01 1,986.02 3
 SAMPLE 3R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 5 46.70% SYScQVTHEGSTVEK 95.00% 4.31 0.424 1.72 c4: Carbamidomethyl (+57.02) 856.3855 1,710.76 1,711.76 2
 SAMPLE 3R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 5 46.70% SYScQVTHEGSTVEK 95.00% 4.48 0.513 1.77 c4: Carbamidomethyl (+57.02) 856.3867 1,710.76 1,711.76 2
 SAMPLE 3R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 5 46.70% YAASSYLSLTPEQWK 95.00% 4.52 0.608 4.66 872.4326 1,742.85 1,743.86 2
 SAMPLE 3R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 5 46.70% YAASSYLSLTPEQWK 95.00% 4.67 0.597 4 872.4331 1,742.85 1,743.86 2
 SAMPLE 3R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 5 46.70% AAPSVTLFPPSSEELQANK 95.00% 3.56 0.09 0 993.5144 1,985.01 1,986.02 2
 SAMPLE 3R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 5 46.70% AAPSVTLFPPSSEELQANK 95.00% 3.47 0.492 0 994.0104 1,986.01 1,986.02 2
 SAMPLE 3R Ig lambda chain C regions  IGLC1  LAC_HUMAN 11,218.10 99.80% 2 3 5 46.70% AAPSVTLFPPSSEELQANK 95.00% 3.93 0.509 1.32 994.0121 1,986.01 1,986.02 2
 SAMPLE 1 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 4 4 6 12.80% FTcTVTHTDLPSPLK 95.00% 2.03 0.345 0 c3: Carbamidomethyl (+57.02) 572.9577 1,715.85 1,716.86 3
 SAMPLE 1 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 4 4 6 12.80% GVALHRPDVYLLPPAR 95.00% 3.12 0.262 0.959 592.3414 1,774.00 1,774.01 3
 SAMPLE 1 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 4 4 6 12.80% LIcQATGFSPR 95.00% 2.92 0.416 3.12 c3: Carbamidomethyl (+57.02) 625.3197 1,248.62 1,249.64 2
 SAMPLE 1 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 4 4 6 12.80% LIcQATGFSPR 95.00% 3.02 0.397 2.47 c3: Carbamidomethyl (+57.02) 625.3197 1,248.62 1,249.64 2
 SAMPLE 1 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 4 4 6 12.80% QVGSGVTTDQVQAEAK 95.00% 4.74 0.504 5.74 809.4054 1,616.80 1,617.81 2
 SAMPLE 1 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 4 4 6 12.80% QVGSGVTTDQVQAEAK 95.00% 3.95 0.548 5.01 809.407 1,616.80 1,617.81 2
 SAMPLE 1R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 3 3 6 9.29% FTcTVTHTDLPSPLK 95.00% 2.28 0.209 0 c3: Carbamidomethyl (+57.02) 572.9581 1,715.85 1,716.86 3
 SAMPLE 1R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 3 3 6 9.29% FTcTVTHTDLPSPLK 95.00% 2.15 0.235 0 c3: Carbamidomethyl (+57.02) 572.9601 1,715.86 1,716.86 3
 SAMPLE 1R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 3 3 6 9.29% LIcQATGFSPR 95.00% 2.97 0.404 3.3 c3: Carbamidomethyl (+57.02) 625.3208 1,248.63 1,249.64 2
 SAMPLE 1R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 3 3 6 9.29% LIcQATGFSPR 95.00% 3.01 0.373 3.33 c3: Carbamidomethyl (+57.02) 625.3211 1,248.63 1,249.64 2
 SAMPLE 1R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 3 3 6 9.29% QVGSGVTTDQVQAEAK 95.00% 4.1 0.546 4.96 809.406 1,616.80 1,617.81 2
 SAMPLE 1R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 3 3 6 9.29% QVGSGVTTDQVQAEAK 95.00% 3.53 0.524 3.37 809.4069 1,616.80 1,617.81 2
 SAMPLE 2 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 99.80% 2 2 3 5.97% LIcQATGFSPR 95.00% 3.17 0.418 3.21 c3: Carbamidomethyl (+57.02) 625.32 1,248.62 1,249.64 2
 SAMPLE 2 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 99.80% 2 2 3 5.97% QVGSGVTTDQVQAEAK 95.00% 4.37 0.569 5.66 809.4073 1,616.80 1,617.81 2
 SAMPLE 2 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 99.80% 2 2 3 5.97% QVGSGVTTDQVQAEAK 95.00% 4.32 0.556 6.51 809.4077 1,616.80 1,617.81 2
 SAMPLE 2R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 99.90% 2 2 3 5.97% LIcQATGFSPR 95.00% 2.92 0.41 3.11 c3: Carbamidomethyl (+57.02) 625.3204 1,248.63 1,249.64 2
 SAMPLE 2R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 99.90% 2 2 3 5.97% LIcQATGFSPR 95.00% 2.85 0.467 3.54 c3: Carbamidomethyl (+57.02) 625.3214 1,248.63 1,249.64 2
 SAMPLE 2R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 99.90% 2 2 3 5.97% QVGSGVTTDQVQAEAK 95.00% 4.51 0.573 3.77 809.4062 1,616.80 1,617.81 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% DGFFGNPR 95.00% 2.81 0.503 0 455.2148 908.4139 909.422 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% DGFFGNPR 95.00% 2.2 0.238 0 455.2204 908.4251 909.422 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% GVALHRPDVYLLPPAR 95.00% 4.19 0.419 4.06 592.0093 1,773.00 1,774.01 3
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% GVALHRPDVYLLPPAR 95.00% 4.78 0.388 3.55 592.3437 1,774.01 1,774.01 3
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% LIcQATGFSPR 95.00% 3.21 0.417 2.24 c3: Carbamidomethyl (+57.02) 625.3212 1,248.63 1,249.64 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% LIcQATGFSPR 95.00% 3.5 0.404 2.92 c3: Carbamidomethyl (+57.02) 625.3214 1,248.63 1,249.64 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% YAATSQVLLPSK 95.00% 2.98 0.298 3.51 639.3595 1,276.70 1,277.71 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% YAATSQVLLPSK 95.00% 2.95 0.279 3.14 639.36 1,276.70 1,277.71 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% EGKQVGSGVTTDQVQAEAK 95.00% 3.88 0.42 2.77 644.6607 1,930.96 1,931.97 3
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% EGKQVGSGVTTDQVQAEAK 95.00% 4.19 0.191 1.07 644.9954 1,931.96 1,931.97 3
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% NVPLPVIAELPPK 95.00% 2.13 0.455 3.09 693.9205 1,385.83 1,386.84 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% NVPLPVIAELPPK 95.00% 1.91 0.377 2.68 693.9224 1,385.83 1,386.84 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% YVTSAPMPEPQAPGR 95.00% 3.56 0.597 4.26 800.8922 1,599.77 1,600.78 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% YVTSAPMPEPQAPGR 95.00% 3.05 0.544 3.37 800.8932 1,599.77 1,600.78 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% YVTSAPmPEPQAPGR 95.00% 3.79 0.544 3.59 m7: Oxidation (+15.99) 808.8893 1,615.76 1,616.77 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% YVTSAPmPEPQAPGR 95.00% 3.58 0.545 4.26 m7: Oxidation (+15.99) 808.8903 1,615.76 1,616.77 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% QVGSGVTTDQVQAEAK 95.00% 4.64 0.591 7.82 809.406 1,616.80 1,617.81 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% QVGSGVTTDQVQAEAK 95.00% 4.53 0.592 3.92 809.4072 1,616.80 1,617.81 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% FTcTVTHTDLPSPLK 95.00% 3.64 0.426 1.19 c3: Carbamidomethyl (+57.02) 859.4368 1,716.86 1,716.86 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% YAATSQVLLPSKDVMQGTDEHVVcK 95.00% 5.47 0.508 3.17 c24: Carbamidomethyl (+57.02) 926.461 2,776.36 2,776.37 3
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% EGKQVGSGVTTDQVQAEAK 95.00% 4.66 0.284 3.7 966.9873 1,931.96 1,931.97 2
 SAMPLE 3 Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 10 11 22 27.00% EGKQVGSGVTTDQVQAEAK 95.00% 5.06 0.354 5.72 966.9881 1,931.96 1,931.97 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% DGFFGNPR 95.00% 1.9 0.276 0 455.2139 908.4121 909.422 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% DGFFGNPR 95.00% 2.38 0.422 0 455.2154 908.4151 909.422 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% GVALHRPDVYLLPPAR 95.00% 4.16 0.333 2.96 592.0082 1,773.00 1,774.01 3
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% GVALHRPDVYLLPPAR 95.00% 3.53 0.333 3.43 592.3432 1,774.01 1,774.01 3
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% LIcQATGFSPR 95.00% 3.35 0.407 3.74 c3: Carbamidomethyl (+57.02) 625.3199 1,248.62 1,249.64 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% LIcQATGFSPR 95.00% 3.36 0.464 3.74 c3: Carbamidomethyl (+57.02) 625.3214 1,248.63 1,249.64 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% YAATSQVLLPSK 95.00% 3.03 0.288 2.89 639.358 1,276.70 1,277.71 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% YAATSQVLLPSK 95.00% 2.86 0.27 3.6 639.3581 1,276.70 1,277.71 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% EGKQVGSGVTTDQVQAEAK 95.00% 4.57 0.505 0 644.6583 1,930.95 1,931.97 3
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% NVPLPVIAELPPK 95.00% 1.9 0.354 0 693.9205 1,385.83 1,386.84 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% NVPLPVIAELPPK 95.00% 2.26 0.448 2.21 694.4215 1,386.83 1,386.84 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% YVTSAPMPEPQAPGR 95.00% 3.4 0.578 4.64 800.8922 1,599.77 1,600.78 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% YVTSAPMPEPQAPGR 95.00% 3.21 0.566 3 800.8931 1,599.77 1,600.78 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% QVGSGVTTDQVQAEAK 95.00% 4.49 0.605 5.04 809.4059 1,616.80 1,617.81 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% QVGSGVTTDQVQAEAK 95.00% 4.5 0.568 5.14 809.4062 1,616.80 1,617.81 2
 SAMPLE 3R Ig mu chain C region  IGHM  IGHM_HUMAN 49,287.70 100.00% 9 9 16 23.70% YAATSQVLLPSKDVMQGTDEHVVcK 95.00% 0 0 6.55 c24: Carbamidomethyl (+57.02) 926.7931 2,777.36 2,776.37 3
 SAMPLE 1R Inosine-5'-monophosphate dehydrogenase 2  IMPDH2  IMDH2_HUMAN 55,788.40 99.80% 2 2 5 5.84% NLIDAGVDALR 95.00% 2.21 0.237 0 578.8227 1,155.63 1,156.63 2
 SAMPLE 1R Inosine-5'-monophosphate dehydrogenase 2  IMPDH2  IMDH2_HUMAN 55,788.40 99.80% 2 2 5 5.84% IKVAQGVSGAVQDKGSIHK 95.00% 3.24 0.0795 2.11 641.6481 1,921.92 1,922.08 3
 SAMPLE 1R Inosine-5'-monophosphate dehydrogenase 2  IMPDH2  IMDH2_HUMAN 55,788.40 99.80% 2 2 5 5.84% IKVAQGVSGAVQDKGSIHK 95.00% 3.16 0.0718 3 641.6483 1,921.92 1,922.08 3
 SAMPLE 1R Inosine-5'-monophosphate dehydrogenase 2  IMPDH2  IMDH2_HUMAN 55,788.40 99.80% 2 2 5 5.84% IKVAQGVSGAVQDKGSIHK 95.00% 3 0 4.89 641.6508 1,921.93 1,922.08 3
 SAMPLE 1R Inosine-5'-monophosphate dehydrogenase 2  IMPDH2  IMDH2_HUMAN 55,788.40 99.80% 2 2 5 5.84% IKVAQGVSGAVQDKGSIHK 95.00% 0 0 5.08 641.9836 1,922.93 1,922.08 3
 SAMPLE 4R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 99.80% 2 2 3 11.00% GTcEQGPSIVTPPK 95.00% 2.8 0.187 1.33 c3: Carbamidomethyl (+57.02) 736.4029 1,470.79 1,470.73 2
 SAMPLE 4R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 99.80% 2 2 3 11.00% AGAAAGGPGVSGVcVcK 95.00% 4.56 0.52 5.6 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.3654 1,516.72 1,517.72 2
 SAMPLE 4R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 99.80% 2 2 3 11.00% AGAAAGGPGVSGVcVcK 95.00% 4.36 0.476 5.2 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.367 1,516.72 1,517.72 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVK 95.00% 2.38 0.44 0 478.6151 1,432.82 1,433.84 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVK 95.00% 2.03 0.311 1.04 478.6172 1,432.83 1,433.84 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVK 95.00% 2.33 0.364 0 478.6229 1,432.85 1,433.84 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% GKAGAAAGGPGVSGVcVcK 95.00% 2.35 0.203 0 c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 568.2855 1,701.83 1,702.84 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% TELLPGDRDNLAIQTR 95.00% 1.88 0.247 0 604.6579 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% TELLPGDRDNLAIQTR 95.00% 1.71 0.374 0 604.6581 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% TELLPGDRDNLAIQTR 95.00% 1.95 0.33 1.19 604.6647 1,810.97 1,811.96 3 TITIN_HUMAN
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% GGPEKHEVTGWVLVSPLSK 95.00% 4.29 0.449 1.82 674.3654 2,020.07 2,020.09 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% GGPEKHEVTGWVLVSPLSK 95.00% 4.47 0.465 3.33 674.3656 2,020.07 2,020.09 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% GGPEKHEVTGWVLVSPLSK 95.00% 3.91 0.476 2.68 674.3748 2,020.10 2,020.09 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.83 0.431 0 707.0638 2,118.17 2,118.18 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.37 0.478 0 707.0645 2,118.17 2,118.18 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.22 0.46 1.89 707.066 2,118.17 2,118.18 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.28 0.432 0 707.066 2,118.17 2,118.18 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.67 0.336 0 707.0749 2,118.20 2,118.18 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.31 0.384 0 707.0776 2,118.21 2,118.18 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVK 95.00% 3.55 0.508 2.96 717.4204 1,432.83 1,433.84 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVK 95.00% 3.87 0.433 3.46 717.4218 1,432.83 1,433.84 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVK 95.00% 3.59 0.39 1.85 717.429 1,432.84 1,433.84 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVK 95.00% 2.81 0.268 1.37 717.4294 1,432.84 1,433.84 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% ITVVDALHEIPVK 95.00% 3.82 0.422 2.43 717.4345 1,432.85 1,433.84 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% GTcEQGPSIVTPPK 95.00% 2.75 0.383 1.68 c3: Carbamidomethyl (+57.02) 735.865 1,469.71 1,470.73 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% GTcEQGPSIVTPPK 95.00% 4.07 0.365 3 c3: Carbamidomethyl (+57.02) 735.8657 1,469.72 1,470.73 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% GTcEQGPSIVTPPK 95.00% 3.23 0.347 2.41 c3: Carbamidomethyl (+57.02) 735.8702 1,469.72 1,470.73 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 3.33 0.146 5.02 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6742 2,261.00 2,261.01 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 4.04 0.337 4.85 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6744 2,261.00 2,261.01 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 3.98 0.339 4.33 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6762 2,261.01 2,261.01 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 4.34 0.36 3.72 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6782 2,261.01 2,261.01 3
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% AGAAAGGPGVSGVcVcK 95.00% 2.99 0.463 3.51 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.3619 1,516.71 1,517.72 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% HEVTGWVLVSPLSK 95.00% 4.8 0.661 7.64 776.4286 1,550.84 1,551.85 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% HEVTGWVLVSPLSK 95.00% 4.93 0.669 8.49 776.4294 1,550.84 1,551.85 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% HEVTGWVLVSPLSK 95.00% 4.13 0.664 9.29 776.432 1,550.85 1,551.85 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% HEVTGWVLVSPLSK 95.00% 3.65 0.594 5.85 776.4389 1,550.86 1,551.85 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% HEVTGWVLVSPLSK 95.00% 4.96 0.653 7.96 776.4418 1,550.87 1,551.85 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% TELLPGDRDNLAIQTR 95.00% 3.81 0.364 4.44 906.4827 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% TELLPGDRDNLAIQTR 95.00% 3.54 0.347 4.17 906.4831 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% TELLPGDRDNLAIQTR 95.00% 3.72 0.411 3.22 906.494 1,810.97 1,811.96 2 TITIN_HUMAN
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% TELLPGDRDNLAIQTR 95.00% 3.33 0.318 2 906.9946 1,811.97 1,811.96 2 TITIN_HUMAN
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% YPVcGSDGTTYPSGcQLR 95.00% 5.42 0.629 6.82 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.44 2,016.86 2,017.88 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% YPVcGSDGTTYPSGcQLR 95.00% 4.93 0.636 6.44 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.44 2,016.87 2,017.88 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% YPVcGSDGTTYPSGcQLR 95.00% 5.33 0.637 5.82 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.94 2,017.87 2,017.88 2
 SAMPLE 1 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 35 38.30% YPVcGSDGTTYPSGcQLR 95.00% 4.95 0.596 5.92 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.95 2,017.89 2,017.88 2
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% ITVVDALHEIPVK 95.00% 1.85 0.269 0 478.6164 1,432.83 1,433.84 3
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% ITVVDALHEIPVK 95.00% 2.33 0.364 0 478.6229 1,432.85 1,433.84 3
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% ITVVDALHEIPVK 95.00% 1.91 0.271 0 478.6255 1,432.85 1,433.84 3
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% GKAGAAAGGPGVSGVcVcK 95.00% 2.35 0.203 0 c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 568.2855 1,701.83 1,702.84 3
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% TELLPGDRDNLAIQTR 95.00% 1.95 0.33 1.49 604.6647 1,810.97 1,811.96 3 TITIN_HUMAN
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% GGPEKHEVTGWVLVSPLSK 95.00% 3.91 0.476 2 674.3748 2,020.10 2,020.09 3
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% GGPEKHEVTGWVLVSPLSK 95.00% 3.63 0.495 3.03 674.3821 2,020.12 2,020.09 3
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.22 0.46 1.7 707.066 2,118.17 2,118.18 3
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.28 0.432 0 707.066 2,118.17 2,118.18 3
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.08 0.287 0 707.0769 2,118.21 2,118.18 3
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 4.19 0.429 1.89 707.0779 2,118.21 2,118.18 3
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% ITVVDALHEIPVK 95.00% 3.59 0.39 2.77 717.429 1,432.84 1,433.84 2
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% ITVVDALHEIPVK 95.00% 2.81 0.268 1.48 717.4294 1,432.84 1,433.84 2
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% ITVVDALHEIPVK 95.00% 3.8 0.485 2.77 717.4345 1,432.85 1,433.84 2
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% ITVVDALHEIPVK 95.00% 3.77 0.481 3.92 717.4348 1,432.85 1,433.84 2
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% GTcEQGPSIVTPPK 95.00% 4.07 0.365 3.21 c3: Carbamidomethyl (+57.02) 735.8657 1,469.72 1,470.73 2
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% GTcEQGPSIVTPPK 95.00% 3.23 0.347 2.43 c3: Carbamidomethyl (+57.02) 735.8702 1,469.72 1,470.73 2
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 3.98 0.339 3.7 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6762 2,261.01 2,261.01 3
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 4.34 0.36 3.18 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6782 2,261.01 2,261.01 3
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% HEVTGWVLVSPLSK 95.00% 4.27 0.657 6.92 776.4388 1,550.86 1,551.85 2
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% HEVTGWVLVSPLSK 95.00% 3.65 0.594 5.77 776.4389 1,550.86 1,551.85 2
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% HEVTGWVLVSPLSK 95.00% 4.94 0.648 7.2 776.9425 1,551.87 1,551.85 2
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% ITVVDALHEIPVKK 95.00% 3.27 0.4 4.12 781.4828 1,560.95 1,561.93 2
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% TELLPGDRDNLAIQTR 95.00% 3.72 0.411 1.77 906.494 1,810.97 1,811.96 2 TITIN_HUMAN
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% TELLPGDRDNLAIQTR 95.00% 3.33 0.318 2.89 906.9946 1,811.97 1,811.96 2 TITIN_HUMAN
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% YPVcGSDGTTYPSGcQLR 95.00% 4.93 0.636 6.92 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.44 2,016.87 2,017.88 2
 SAMPLE 1R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 9 10 24 38.30% YPVcGSDGTTYPSGcQLR 95.00% 4.95 0.596 6.68 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.95 2,017.89 2,017.88 2
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% ITVVDALHEIPVK 95.00% 2.22 0.322 0 478.6166 1,432.83 1,433.84 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% ITVVDALHEIPVK 95.00% 2.47 0.424 1 478.6178 1,432.83 1,433.84 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% ITVVDALHEIPVK 95.00% 2.36 0.393 0 478.6179 1,432.83 1,433.84 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% ITVVDALHEIPVK 95.00% 1.94 0.296 0 478.6184 1,432.83 1,433.84 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% HEVTGWVLVSPLSK 95.00% 2.76 0.38 0 517.9548 1,550.84 1,551.85 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% GKAGAAAGGPGVSGVcVcK 95.00% 3.73 0.436 3.89 c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 568.2836 1,701.83 1,702.84 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% TELLPGDRDNLAIQTR 95.00% 1.84 0.265 0.921 604.6572 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% TELLPGDRDNLAIQTR 95.00% 1.92 0.322 1.02 604.6584 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% TELLPGDRDNLAIQTR 95.00% 2.01 0.33 0 604.6588 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% TELLPGDRDNLAIQTR 95.00% 1.94 0.317 0 604.6592 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% TELLPGDRDNLAIQTR 95.00% 1.97 0.34 0 604.9926 1,811.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% GGPEKHEVTGWVLVSPLSK 95.00% 4.09 0.532 2.34 674.3671 2,020.08 2,020.09 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% GGPEKHEVTGWVLVSPLSK 95.00% 4.63 0.558 4.68 674.3679 2,020.08 2,020.09 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.26 0.432 0 707.0632 2,118.17 2,118.18 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.72 0.518 1.41 707.0649 2,118.17 2,118.18 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.97 0.482 0 707.0657 2,118.17 2,118.18 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% GTcEQGPSIVTPPK 95.00% 3.04 0.363 3.85 c3: Carbamidomethyl (+57.02) 735.8638 1,469.71 1,470.73 2
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% GTcEQGPSIVTPPK 95.00% 3.92 0.342 4.14 c3: Carbamidomethyl (+57.02) 735.8642 1,469.71 1,470.73 2
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% GTcEQGPSIVTPPK 95.00% 3.5 0.356 3.33 c3: Carbamidomethyl (+57.02) 735.8646 1,469.71 1,470.73 2
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 3.9 0.308 5.6 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6744 2,261.00 2,261.01 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 3.88 0.386 4.09 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6752 2,261.00 2,261.01 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 4.21 0.447 5.07 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6754 2,261.00 2,261.01 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 4.35 0.418 4.68 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6754 2,261.00 2,261.01 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 4.59 0.381 4.48 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6758 2,261.00 2,261.01 3
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% AGAAAGGPGVSGVcVcK 95.00% 5.08 0.514 4.64 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.3623 1,516.71 1,517.72 2
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% AGAAAGGPGVSGVcVcK 95.00% 4.61 0.459 4.14 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.3634 1,516.71 1,517.72 2
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% HEVTGWVLVSPLSK 95.00% 4.12 0.607 6.74 776.4292 1,550.84 1,551.85 2
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% ITVVDALHEIPVKK 95.00% 3.5 0.412 4.57 781.4687 1,560.92 1,561.93 2
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% TELLPGDRDNLAIQTR 95.00% 3.85 0.372 4.8 906.4824 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% TELLPGDRDNLAIQTR 95.00% 3.44 0.321 2.41 906.4826 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% TELLPGDRDNLAIQTR 95.00% 3.04 0.45 2.42 906.4828 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% TELLPGDRDNLAIQTR 95.00% 3.18 0.31 1.57 906.4848 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% TELLPGDRDNLAIQTR 95.00% 3.77 0.374 2.23 906.9839 1,811.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% TELLPGDRDNLAIQTR 95.00% 3.7 0.393 2.32 906.9859 1,811.96 1,811.96 2 TITIN_HUMAN
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% YPVcGSDGTTYPSGcQLR 95.00% 5.57 0.577 8.28 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.44 2,016.87 2,017.88 2
 SAMPLE 2 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 11 25 38.30% YPVcGSDGTTYPSGcQLR 95.00% 5.52 0.571 6.32 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.94 2,017.86 2,017.88 2
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% ITVVDALHEIPVK 95.00% 2.19 0.271 0 478.6166 1,432.83 1,433.84 3
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% ITVVDALHEIPVK 95.00% 1.79 0.333 0 478.6176 1,432.83 1,433.84 3
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% ITVVDALHEIPVK 95.00% 2.06 0.229 1.33 478.6179 1,432.83 1,433.84 3
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% GKAGAAAGGPGVSGVcVcK 95.00% 3.77 0.417 2.47 c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 568.6176 1,702.83 1,702.84 3
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% TELLPGDRDNLAIQTR 95.00% 2.2 0.315 0 604.6577 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% TELLPGDRDNLAIQTR 95.00% 2.18 0.377 0 604.6579 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% TELLPGDRDNLAIQTR 95.00% 2.37 0.434 0 604.6586 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% TELLPGDRDNLAIQTR 95.00% 2 0.222 0 604.659 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% TELLPGDRDNLAIQTR 95.00% 2.17 0.361 0 604.6596 1,810.96 1,811.96 3 TITIN_HUMAN
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% ITVVDALHEIPVKKGEGAEL 95.00% 3.76 0.429 1.8 707.0649 2,118.17 2,118.18 3
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% ITVVDALHEIPVKKGEGAEL 95.00% 3.7 0.378 1.12 707.0656 2,118.17 2,118.18 3
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% ITVVDALHEIPVK 95.00% 3.75 0.514 4.27 717.4206 1,432.83 1,433.84 2
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% ITVVDALHEIPVK 95.00% 3.55 0.471 3.52 717.422 1,432.83 1,433.84 2
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% GTcEQGPSIVTPPK 95.00% 3.61 0.355 3.36 c3: Carbamidomethyl (+57.02) 735.8653 1,469.71 1,470.73 2
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% GTcEQGPSIVTPPK 95.00% 3.6 0.368 4.18 c3: Carbamidomethyl (+57.02) 735.8661 1,469.72 1,470.73 2
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% SRYPVcGSDGTTYPSGcQLR 95.00% 5.19 0.455 5.24 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6746 2,261.00 2,261.01 3
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% SRYPVcGSDGTTYPSGcQLR 95.00% 5.14 0.436 6.4 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6749 2,261.00 2,261.01 3
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% AGAAAGGPGVSGVcVcK 95.00% 4.61 0.52 6.25 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.3631 1,516.71 1,517.72 2
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% AGAAAGGPGVSGVcVcK 95.00% 4.87 0.502 4.89 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.3639 1,516.71 1,517.72 2
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% HEVTGWVLVSPLSK 95.00% 4.67 0.639 8.24 776.4286 1,550.84 1,551.85 2
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% HEVTGWVLVSPLSK 95.00% 4.88 0.636 6.72 776.43 1,550.84 1,551.85 2
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% TELLPGDRDNLAIQTR 95.00% 3.24 0.436 1.46 906.4815 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% TELLPGDRDNLAIQTR 95.00% 3.51 0.267 3.24 906.483 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% TELLPGDRDNLAIQTR 95.00% 2.37 0.272 0 906.4842 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% TELLPGDRDNLAIQTR 95.00% 3.65 0.38 2.85 906.486 1,810.96 1,811.96 2 TITIN_HUMAN
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% TELLPGDRDNLAIQTR 95.00% 3.4 0.318 2.89 906.4865 1,810.96 1,811.96 2 TITIN_HUMAN
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% TELLPGDRDNLAIQTR 95.00% 2.91 0.239 1.77 906.9889 1,811.96 1,811.96 2 TITIN_HUMAN
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% YPVcGSDGTTYPSGcQLR 95.00% 5.08 0.61 5.92 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.44 2,016.86 2,017.88 2
 SAMPLE 2R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 8 9 18 36.50% YPVcGSDGTTYPSGcQLR 95.00% 5.53 0.564 5.89 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.94 2,017.86 2,017.88 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% ITVVDALHEIPVKK 95.00% 2.3 0.272 0 521.3132 1,560.92 1,561.93 3
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% ITVVDALHEIPVKK 95.00% 2.21 0.456 2.51 521.3135 1,560.92 1,561.93 3
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% ITVVDALHEIPVKK 95.00% 2.35 0.369 0 521.3141 1,560.92 1,561.93 3
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% GKAGAAAGGPGVSGVcVcK 95.00% 3.71 0.539 2.04 c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 568.2822 1,701.82 1,702.84 3
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% GKAGAAAGGPGVSGVcVcK 95.00% 4.48 0.546 3.57 c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 568.2827 1,701.82 1,702.84 3
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% TELLPGDRDNLAIQTR 95.00% 2.5 0.455 1.12 604.6567 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% TELLPGDRDNLAIQTR 95.00% 2.47 0.403 1.82 604.6592 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% TELLPGDRDNLAIQTR 95.00% 2.07 0.331 0 604.9914 1,811.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% TELLPGDRDNLAIQTR 95.00% 1.98 0.271 1.39 604.9918 1,811.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% TELLPGDRDNLAIQTR 95.00% 2.31 0.278 1.43 604.9921 1,811.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% ITVVDALHEIPVKKGEGAEL 95.00% 3.29 0.324 0 706.73 2,117.17 2,118.18 3
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% ITVVDALHEIPVKKGEGAEL 95.00% 3.27 0.429 1.24 707.0645 2,118.17 2,118.18 3
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% ITVVDALHEIPVKKGEGAEL 95.00% 3.6 0.418 1.33 707.0654 2,118.17 2,118.18 3
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% GTcEQGPSIVTPPK 95.00% 3.22 0.294 3.66 c3: Carbamidomethyl (+57.02) 735.865 1,469.71 1,470.73 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% GTcEQGPSIVTPPK 95.00% 3.71 0.344 4.3 c3: Carbamidomethyl (+57.02) 735.8653 1,469.71 1,470.73 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% GTcEQGPSIVTPPK 95.00% 4.37 0.361 2.55 c3: Carbamidomethyl (+57.02) 735.8658 1,469.72 1,470.73 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% GTcEQGPSIVTPPK 95.00% 3.74 0.302 3.72 c3: Carbamidomethyl (+57.02) 735.867 1,469.72 1,470.73 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% SRYPVcGSDGTTYPSGcQLR 95.00% 4 0.341 4.96 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.3394 2,259.99 2,261.01 3
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% SRYPVcGSDGTTYPSGcQLR 95.00% 4.47 0.413 5.32 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6749 2,261.00 2,261.01 3
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% SRYPVcGSDGTTYPSGcQLR 95.00% 4.44 0.378 5.39 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.675 2,261.00 2,261.01 3
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% SRYPVcGSDGTTYPSGcQLR 95.00% 2.97 0.244 2.37 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6757 2,261.00 2,261.01 3
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% AGAAAGGPGVSGVcVcK 95.00% 5.05 0.487 6.92 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.3617 1,516.71 1,517.72 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% AGAAAGGPGVSGVcVcK 95.00% 4.84 0.508 5.82 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.3631 1,516.71 1,517.72 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% AGAAAGGPGVSGVcVcK 95.00% 5.03 0.478 6.46 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.3639 1,516.71 1,517.72 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% AGAAAGGPGVSGVcVcK 95.00% 0 0 4.08 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 760.8837 1,519.75 1,517.72 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% TELLPGDRDNLAIQTR 95.00% 3.62 0.255 2.72 906.4816 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% TELLPGDRDNLAIQTR 95.00% 3.97 0.34 3.59 906.4821 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% TELLPGDRDNLAIQTR 95.00% 3.75 0.349 3.25 906.4839 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% TELLPGDRDNLAIQTR 95.00% 2.9 0.358 2.62 906.485 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% TELLPGDRDNLAIQTR 95.00% 3.24 0.351 2.19 906.4898 1,810.96 1,811.96 2 TITIN_HUMAN
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% TELLPGDRDNLAIQTR 95.00% 3.6 0.262 1.85 906.9861 1,811.96 1,811.96 2 TITIN_HUMAN
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% YPVcGSDGTTYPSGcQLR 95.00% 5.49 0.583 5.7 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.94 2,017.86 2,017.88 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% YPVcGSDGTTYPSGcQLR 95.00% 5.81 0.559 4.77 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.94 2,017.86 2,017.88 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% YPVcGSDGTTYPSGcQLR 95.00% 5.35 0.563 4.72 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.94 2,017.86 2,017.88 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% YPVcGSDGTTYPSGcQLR 95.00% 5.56 0.564 5.2 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.94 2,017.87 2,017.88 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% SRYPVcGSDGTTYPSGcQLR 95.00% 5 0.567 4.37 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 1,131.51 2,261.00 2,261.01 2
 SAMPLE 3 Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 7 8 26 31.60% SRYPVcGSDGTTYPSGcQLR 95.00% 5.18 0.591 4.34 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 1,131.51 2,261.00 2,261.01 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% ITVVDALHEIPVK 95.00% 2.05 0.291 0 478.6171 1,432.83 1,433.84 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% HEVTGWVLVSPLSK 95.00% 2.23 0.18 0 517.9541 1,550.84 1,551.85 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% ITVVDALHEIPVKK 95.00% 2.82 0.477 0 521.3135 1,560.92 1,561.93 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% ITVVDALHEIPVKK 95.00% 2.26 0.305 0 521.3141 1,560.92 1,561.93 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% GKAGAAAGGPGVSGVcVcK 95.00% 4.49 0.596 3.04 c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 568.2825 1,701.82 1,702.84 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% GKAGAAAGGPGVSGVcVcK 95.00% 4.2 0.52 2.3 c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 568.2844 1,701.83 1,702.84 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% TELLPGDRDNLAIQTR 95.00% 1.79 0.274 0 604.6572 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% TELLPGDRDNLAIQTR 95.00% 2.54 0.439 1.18 604.6575 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% TELLPGDRDNLAIQTR 95.00% 2.14 0.29 0 604.6577 1,810.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% TELLPGDRDNLAIQTR 95.00% 2.22 0.347 0 604.6608 1,810.96 1,811.96 3 TITIN_HUMAN
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% TELLPGDRDNLAIQTR 95.00% 2.55 0.439 1.57 604.9919 1,811.95 1,811.96 3 TITIN_HUMAN
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 2.82 0.303 0 706.7296 2,117.17 2,118.18 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.87 0.458 0 707.0656 2,118.17 2,118.18 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 3.65 0.435 0 707.0659 2,118.17 2,118.18 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% ITVVDALHEIPVKKGEGAEL 95.00% 2.94 0.209 0 707.0661 2,118.17 2,118.18 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% ITVVDALHEIPVK 95.00% 3.21 0.157 1.96 717.42 1,432.82 1,433.84 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% GTcEQGPSIVTPPK 95.00% 3.89 0.339 3.64 c3: Carbamidomethyl (+57.02) 735.8647 1,469.71 1,470.73 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% GTcEQGPSIVTPPK 95.00% 3.79 0.372 2.85 c3: Carbamidomethyl (+57.02) 735.866 1,469.72 1,470.73 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 3.44 0.254 4.11 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.673 2,261.00 2,261.01 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 3.86 0.334 4.96 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6748 2,261.00 2,261.01 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 3.93 0.347 4.42 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.675 2,261.00 2,261.01 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 3.97 0.349 4.36 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6756 2,261.00 2,261.01 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 4.17 0.349 4.51 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 754.6757 2,261.00 2,261.01 3
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% AGAAAGGPGVSGVcVcK 95.00% 5.03 0.496 4.72 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.3627 1,516.71 1,517.72 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% AGAAAGGPGVSGVcVcK 95.00% 4.96 0.522 4.92 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.3628 1,516.71 1,517.72 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% AGAAAGGPGVSGVcVcK 95.00% 4.77 0.469 6.6 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.363 1,516.71 1,517.72 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% AGAAAGGPGVSGVcVcK 95.00% 4.73 0.495 5.96 c14: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 759.3638 1,516.71 1,517.72 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% ITVVDALHEIPVKK 95.00% 3.31 0.439 3.33 781.4669 1,560.92 1,561.93 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% GKAGAAAGGPGVSGVcVcK 95.00% 5.26 0.681 7.14 c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 851.9207 1,701.83 1,702.84 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% TELLPGDRDNLAIQTR 95.00% 3.33 0.369 2.31 906.482 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% TELLPGDRDNLAIQTR 95.00% 3.57 0.263 3.18 906.482 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% TELLPGDRDNLAIQTR 95.00% 3.67 0.352 3.77 906.4832 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% TELLPGDRDNLAIQTR 95.00% 3.52 0.337 2.96 906.4835 1,810.95 1,811.96 2 TITIN_HUMAN
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% YPVcGSDGTTYPSGcQLR 95.00% 5.24 0.602 5.85 c4: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,009.94 2,017.87 2,017.88 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% GGPEKHEVTGWVLVSPLSK 95.00% 5.91 0.693 5.64 1,011.05 2,020.09 2,020.09 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 4.88 0.625 4.52 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 1,131.01 2,260.00 2,261.01 2
 SAMPLE 3R Insulin-like growth factor-binding protein 7  IGFBP7  IBP7_HUMAN 29,111.80 100.00% 10 14 28 38.30% SRYPVcGSDGTTYPSGcQLR 95.00% 5.04 0.556 3.32 c6: Carbamidomethyl (+57.02), c17: Carbamidomethyl (+57.02) 1,131.50 2,260.99 2,261.01 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% AGASLWGGLR 95.00% 3.13 0.383 1.37 494.2719 986.5281 987.5377 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% AGASLWGGLR 95.00% 2.97 0.357 1.96 494.2719 986.5282 987.5377 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% AGASLWGGLR 95.00% 3.73 0.385 2.51 494.2723 986.5289 987.5377 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% AGASLWGGLR 95.00% 3.34 0.372 2.14 494.273 986.5304 987.5377 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% AGASLWGGLR 95.00% 3.19 0.404 2.17 494.2731 986.5306 987.5377 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% AGASLWGGLR 95.00% 3.39 0.343 1.28 494.2731 986.5306 987.5377 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% AGASLWGGLR 95.00% 3.23 0.396 2.43 494.2734 986.5312 987.5377 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% AGASLWGGLR 95.00% 3.63 0.442 3.59 494.2739 986.5321 987.5377 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% AGASLWGGLR 95.00% 3.14 0.377 2.14 494.2746 986.5336 987.5377 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% AGASLWGGLR 95.00% 3.3 0.413 2.06 494.2747 986.5337 987.5377 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% ILEYAPcR 95.00% 2.53 0.314 0 c7: Carbamidomethyl (+57.02) 511.2589 1,020.50 1,021.51 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% ILEYAPcR 95.00% 2.01 0.265 0 c7: Carbamidomethyl (+57.02) 511.2601 1,020.50 1,021.51 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% ILEYAPcR 95.00% 2.46 0.321 0 c7: Carbamidomethyl (+57.02) 511.2612 1,020.51 1,021.51 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% EHQPFSLQcEAVYK 95.00% 3.29 0.258 0 c9: Carbamidomethyl (+57.02) 579.2765 1,734.81 1,735.81 3
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% EHQPFSLQcEAVYK 95.00% 3.38 0.189 0 c9: Carbamidomethyl (+57.02) 579.612 1,735.81 1,735.81 3
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% SLQWFGATVR 95.00% 2.89 0.422 2.72 582.8128 1,163.61 1,164.62 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% SLQWFGATVR 95.00% 2.95 0.441 2.92 582.813 1,163.61 1,164.62 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% SLQWFGATVR 95.00% 2.94 0.393 2.8 582.8136 1,163.61 1,164.62 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% SLQWFGATVR 95.00% 3.19 0.434 2.72 582.8142 1,163.61 1,164.62 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% SLQWFGATVR 95.00% 3.44 0.392 2.96 582.8145 1,163.61 1,164.62 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% SLQWFGATVR 95.00% 3.64 0.415 3.43 582.8147 1,163.61 1,164.62 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% LLVcDLGNPMK 95.00% 2.53 0.198 1.16 c4: Carbamidomethyl (+57.02) 630.3294 1,258.64 1,259.65 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% VTAPPEAEYSGLVR 95.00% 2.96 0.576 2.6 744.8899 1,487.76 1,488.77 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% VTAPPEAEYSGLVR 95.00% 2.56 0.472 2.54 744.8905 1,487.77 1,488.77 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% VTAPPEAEYSGLVR 95.00% 3.33 0.605 3.26 744.8927 1,487.77 1,488.77 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% VTAPPEAEYSGLVR 95.00% 2.73 0.475 2.01 744.8949 1,487.77 1,488.77 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% VTAPPEAEYSGLVR 95.00% 3.51 0.394 2.59 744.8965 1,487.78 1,488.77 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% VTAPPEAEYSGLVR 95.00% 3.42 0.561 3.64 745.3929 1,488.77 1,488.77 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% VTAPPEAEYSGLVR 95.00% 2.82 0.443 3.82 745.3936 1,488.77 1,488.77 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% VTAPPEAEYSGLVR 95.00% 2.56 0.451 2.96 745.3938 1,488.77 1,488.77 2
 SAMPLE 4 Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 7 7 31 7.82% QATLTQTLLIQNGAR 95.00% 3.41 0.365 1.4 814.4651 1,626.91 1,627.91 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% AGASLWGGLR 95.00% 3.02 0.362 0 494.2717 986.5278 987.5377 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% AGASLWGGLR 95.00% 2.67 0.335 0 494.2717 986.5278 987.5377 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% AGASLWGGLR 95.00% 2.38 0.316 0 494.272 986.5284 987.5377 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% AGASLWGGLR 95.00% 2.14 0.374 0 494.2726 986.5296 987.5377 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% AGASLWGGLR 95.00% 2.82 0.389 1.24 494.2727 986.5298 987.5377 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% AGASLWGGLR 95.00% 2.31 0.318 0 494.2734 986.5311 987.5377 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% AGASLWGGLR 95.00% 2.14 0.264 1.19 494.274 986.5324 987.5377 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% ILEYAPcR 95.00% 2.31 0.391 0 c7: Carbamidomethyl (+57.02) 511.259 1,020.50 1,021.51 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% SLQWFGATVR 95.00% 3.47 0.447 2.82 582.8127 1,163.61 1,164.62 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% SLQWFGATVR 95.00% 3.42 0.417 3.48 582.8134 1,163.61 1,164.62 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% SLQWFGATVR 95.00% 3.13 0.413 3.54 582.8139 1,163.61 1,164.62 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% SLQWFGATVR 95.00% 3.41 0.464 3.24 582.8139 1,163.61 1,164.62 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% SLQWFGATVR 95.00% 2.83 0.414 2.85 582.8144 1,163.61 1,164.62 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% SLQWFGATVR 95.00% 2.92 0.36 2.77 582.8144 1,163.61 1,164.62 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% SLQWFGATVR 95.00% 3.22 0.393 2.46 582.8144 1,163.61 1,164.62 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% SLQWFGATVR 95.00% 3.11 0.244 2.2 582.8144 1,163.61 1,164.62 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% SLQWFGATVR 95.00% 3.03 0.386 3.08 582.8163 1,163.62 1,164.62 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% VTAPPEAEYSGLVR 95.00% 2.61 0.431 2.02 744.8908 1,487.77 1,488.77 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% VTAPPEAEYSGLVR 95.00% 2.69 0.609 3.11 744.8913 1,487.77 1,488.77 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% VTAPPEAEYSGLVR 95.00% 2.76 0.398 0 744.8921 1,487.77 1,488.77 2
 SAMPLE 4R Integrin alpha-5  ITGA5  ITA5_HUMAN 114,520.50 100.00% 4 4 21 4.00% VTAPPEAEYSGLVR 95.00% 2.63 0.445 2.33 744.8936 1,487.77 1,488.77 2
 SAMPLE 2 Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 99.80% 2 2 4 2.12% HPEATVPQYHAVK 95.00% 2.68 0.318 0 492.9237 1,475.75 1,476.76 3
 SAMPLE 2 Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 99.80% 2 2 4 2.12% HPEATVPQYHAVK 95.00% 3.13 0.463 0 492.9245 1,475.75 1,476.76 3
 SAMPLE 2 Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 99.80% 2 2 4 2.12% AEELSFVAGAPR 95.00% 3.44 0.443 3.14 623.8242 1,245.63 1,246.64 2
 SAMPLE 2 Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 99.80% 2 2 4 2.12% AEELSFVAGAPR 95.00% 3.22 0.428 2.64 623.825 1,245.63 1,246.64 2
 SAMPLE 2R Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 100.00% 3 3 5 3.47% HPEATVPQYHAVK 95.00% 2.44 0.332 0 492.9235 1,475.75 1,476.76 3
 SAMPLE 2R Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 100.00% 3 3 5 3.47% HPEATVPQYHAVK 95.00% 2.87 0.261 0 493.2591 1,476.75 1,476.76 3
 SAMPLE 2R Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 100.00% 3 3 5 3.47% ARPILHVSHEVSIAPR 95.00% 2.76 0.4 0 594.2693 1,779.78 1,782.01 3
 SAMPLE 2R Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 100.00% 3 3 5 3.47% AEELSFVAGAPR 95.00% 2.99 0.453 2.68 623.8239 1,245.63 1,246.64 2
 SAMPLE 2R Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 100.00% 3 3 5 3.47% AEELSFVAGAPR 95.00% 2.68 0.316 1.36 623.8266 1,245.64 1,246.64 2
 SAMPLE 3 Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 99.90% 2 2 2 2.03% HPEATVPQYHAVK 95.00% 2.9 0.345 0 492.9252 1,475.75 1,476.76 3
 SAMPLE 3 Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 99.90% 2 2 2 2.03% VDIDQGADMQK 95.00% 2.89 0.368 3.64 610.2826 1,218.55 1,219.56 2
 SAMPLE 3R Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 100.00% 4 4 5 4.32% HPEATVPQYHAVK 95.00% 2.31 0.237 0 492.9245 1,475.75 1,476.76 3
 SAMPLE 3R Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 100.00% 4 4 5 4.32% ARPILHVSHEVSIAPR 95.00% 3.09 0.408 0 595.0095 1,782.01 1,782.01 3
 SAMPLE 3R Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 100.00% 4 4 5 4.32% AEELSFVAGAPR 95.00% 2.66 0.319 2.74 623.8242 1,245.63 1,246.64 2
 SAMPLE 3R Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 100.00% 4 4 5 4.32% AEELSFVAGAPR 95.00% 3.42 0.476 2.96 623.8247 1,245.63 1,246.64 2
 SAMPLE 3R Integrin alpha-7  ITGA7  ITA7_HUMAN 128,912.00 100.00% 4 4 5 4.32% QRVDQILETR 95.00% 2.31 0.139 1.16 629.3484 1,256.68 1,257.69 2
 SAMPLE 2 Integrin alpha-8  ITGA8  ITA8_HUMAN 117,429.60 99.80% 2 2 4 2.07% LPEGSIAIK 95.00% 2.51 0.294 0 464.2794 926.5431 927.5517 2
 SAMPLE 2 Integrin alpha-8  ITGA8  ITA8_HUMAN 117,429.60 99.80% 2 2 4 2.07% LPEGSIAIK 95.00% 2.41 0.194 0 464.2801 926.5445 927.5517 2
 SAMPLE 2 Integrin alpha-8  ITGA8  ITA8_HUMAN 117,429.60 99.80% 2 2 4 2.07% EGLEVKPILNYYR 95.00% 2.24 0.289 0 531.9575 1,592.85 1,593.86 3
 SAMPLE 2 Integrin alpha-8  ITGA8  ITA8_HUMAN 117,429.60 99.80% 2 2 4 2.07% EGLEVKPILNYYR 95.00% 2.37 0.169 0 531.9581 1,592.85 1,593.86 3
 SAMPLE 3 Integrin alpha-8  ITGA8  ITA8_HUMAN 117,429.60 100.00% 3 3 4 3.10% VVAcAPLYHWR 95.00% 2.28 0.342 0 c4: Carbamidomethyl (+57.02) 457.9051 1,370.69 1,371.70 3
 SAMPLE 3 Integrin alpha-8  ITGA8  ITA8_HUMAN 117,429.60 100.00% 3 3 4 3.10% VVAcAPLYHWR 95.00% 2.57 0.403 0 c4: Carbamidomethyl (+57.02) 457.9056 1,370.69 1,371.70 3
 SAMPLE 3 Integrin alpha-8  ITGA8  ITA8_HUMAN 117,429.60 100.00% 3 3 4 3.10% LPEGSIAIK 95.00% 2.24 0.233 0 464.2783 926.541 927.5517 2
 SAMPLE 3 Integrin alpha-8  ITGA8  ITA8_HUMAN 117,429.60 100.00% 3 3 4 3.10% EGLEVKPILNYYR 95.00% 2.63 0.314 0 531.9587 1,592.85 1,593.86 3
 SAMPLE 3R Integrin alpha-8  ITGA8  ITA8_HUMAN 117,429.60 100.00% 3 3 4 3.10% VVAcAPLYHWR 95.00% 1.54 0.36 0 c4: Carbamidomethyl (+57.02) 457.9046 1,370.69 1,371.70 3
 SAMPLE 3R Integrin alpha-8  ITGA8  ITA8_HUMAN 117,429.60 100.00% 3 3 4 3.10% VVAcAPLYHWR 94.80% 1.78 0.218 0 c4: Carbamidomethyl (+57.02) 457.9075 1,370.70 1,371.70 3
 SAMPLE 3R Integrin alpha-8  ITGA8  ITA8_HUMAN 117,429.60 100.00% 3 3 4 3.10% LPEGSIAIK 95.00% 1.95 0.27 0 464.2809 926.5462 927.5517 2
 SAMPLE 3R Integrin alpha-8  ITGA8  ITA8_HUMAN 117,429.60 100.00% 3 3 4 3.10% EGLEVKPILNYYR 95.00% 2.82 0.28 0 532.2929 1,593.86 1,593.86 3
 SAMPLE 1 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 4 4 5 5.53% ILAcAPLYHWR 95.00% 2.37 0.333 0 c4: Carbamidomethyl (+57.02) 467.2476 1,398.72 1,399.73 3
 SAMPLE 1 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 4 4 5 5.53% MFLLVGAPK 95.00% 2.08 0.2 1.31 488.2855 974.5553 975.5703 2
 SAMPLE 1 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 4 4 5 5.53% AGTQLLAGLR 95.00% 3.01 0.197 0 500.8036 999.5915 999.5953 2
 SAMPLE 1 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 4 4 5 5.53% AGTQLLAGLR 95.00% 2.84 0.248 0 500.804 999.5924 999.5953 2
 SAMPLE 1 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 4 4 5 5.53% LNGFEVFAR 95.00% 2.45 0.32 1.33 526.7772 1,051.54 1,052.55 2
 SAMPLE 1 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 4 4 5 5.53% LNGFEVFAR 95.00% 2.4 0.234 1.6 526.7776 1,051.54 1,052.55 2
 SAMPLE 1 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 4 4 5 5.53% LNGFEVFAR 95.00% 2.74 0.327 2.85 526.7785 1,051.54 1,052.55 2
 SAMPLE 1 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 4 4 5 5.53% LNGFEVFAR 95.00% 2.55 0.378 2.8 526.7786 1,051.54 1,052.55 2
 SAMPLE 1 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 4 4 5 5.53% STGLNAVPSQILEGQWAAR 95.00% 4.37 0.508 5.96 1,000.02 1,998.03 1,998.04 2
 SAMPLE 1R Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 3 3 4 4.68% ILAcAPLYHWR 95.00% 2.37 0.431 0 c4: Carbamidomethyl (+57.02) 467.2458 1,398.71 1,399.73 3
 SAMPLE 1R Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 3 3 4 4.68% AGTQLLAGLR 95.00% 2.95 0.173 0 500.8038 999.592 999.5953 2
 SAMPLE 1R Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 3 3 4 4.68% AGTQLLAGLR 95.00% 2.97 0.197 0 500.8043 999.593 999.5953 2
 SAMPLE 1R Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 3 3 4 4.68% LNGFEVFAR 95.00% 2.61 0.273 1.8 526.7785 1,051.54 1,052.55 2
 SAMPLE 1R Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 3 3 4 4.68% LNGFEVFAR 95.00% 2.6 0.283 1.92 526.7793 1,051.54 1,052.55 2
 SAMPLE 1R Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 3 3 4 4.68% LNGFEVFAR 95.00% 2.64 0.221 1.89 527.2786 1,052.54 1,052.55 2
 SAMPLE 1R Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 100.00% 3 3 4 4.68% STGLNAVPSQILEGQWAAR 95.00% 4.52 0.589 6.54 1,000.02 1,998.03 1,998.04 2
 SAMPLE 3 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 99.80% 2 2 2 2.77% ILAcAPLYHWR 95.00% 2.62 0.403 0 c4: Carbamidomethyl (+57.02) 467.2489 1,398.72 1,399.73 3
 SAMPLE 3 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 99.80% 2 2 2 2.77% MFLLVGAPK 95.00% 2.72 0.481 1.48 488.2879 974.5602 975.5703 2
 SAMPLE 3 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 99.80% 2 2 2 2.77% LNGFEVFAR 95.00% 2.61 0.285 1.85 526.7771 1,051.54 1,052.55 2
 SAMPLE 3 Integrin alpha-V  ITGAV  ITAV_HUMAN 116,023.00 99.80% 2 2 2 2.77% LNGFEVFAR 95.00% 2.44 0.326 1.54 526.7792 1,051.54 1,052.55 2
 SAMPLE 4 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 4 4 5 6.52% IGFGSFVEK 95.00% 1.98 0.373 1.96 492.2653 982.5149 983.5203 2
 SAMPLE 4 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 4 4 5 6.52% IGFGSFVEK 95.00% 1.98 0.372 2.22 492.2663 982.5169 983.5203 2
 SAMPLE 4 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 4 4 5 6.52% GEVFNELVGK 94.60% 2.46 0.209 0 546.7945 1,091.57 1,091.57 2
 SAMPLE 4 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 4 4 5 6.52% DKLPQPVQPDPVSHcK 95.00% 3.03 0.391 2.06 c15: Carbamidomethyl (+57.02) 615.9816 1,844.92 1,844.93 3
 SAMPLE 4 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 4 4 5 6.52% LKPEDITQIQPQQLVLR 95.00% 3.23 0.395 2 674.0609 2,019.16 2,019.16 3
 SAMPLE 4R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 7 5.51% IGFGSFVEK 95.00% 1.63 0.294 1.72 492.2639 982.5121 983.5203 2
 SAMPLE 4R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 7 5.51% IGFGSFVEK 95.00% 2.11 0.355 2.24 492.2648 982.514 983.5203 2
 SAMPLE 4R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 7 5.51% IGFGSFVEK 95.00% 1.88 0.423 2.01 492.265 982.5143 983.5203 2
 SAMPLE 4R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 7 5.51% IGFGSFVEK 95.00% 2.11 0.328 1.64 492.2657 982.5158 983.5203 2
 SAMPLE 4R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 7 5.51% NVLSLTNKGEVFNELVGK 95.00% 2.24 0.276 0 654.6969 1,961.07 1,961.07 3
 SAMPLE 4R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 7 5.51% LKPEDITQIQPQQLVLR 95.00% 2.12 0.236 0.959 674.0612 2,019.16 2,019.16 3
 SAMPLE 4R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 7 5.51% LKPEDITQIQPQQLVLR 95.00% 2.89 0.315 2.26 674.0616 2,019.16 2,019.16 3
 SAMPLE 1R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 99.80% 2 2 5 3.26% IGFGSFVEK 95.00% 2.21 0.363 2.52 492.262 982.5083 983.5203 2
 SAMPLE 1R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 99.80% 2 2 5 3.26% IGFGSFVEK 95.00% 2.31 0.409 1.21 492.2627 982.5097 983.5203 2
 SAMPLE 1R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 99.80% 2 2 5 3.26% LKPEDITQIQPQQLVLR 95.00% 3.26 0.448 2.06 673.7233 2,018.15 2,019.16 3
 SAMPLE 1R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 99.80% 2 2 5 3.26% LKPEDITQIQPQQLVLR 95.00% 2.92 0.349 1.42 673.7239 2,018.15 2,019.16 3
 SAMPLE 1R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 99.80% 2 2 5 3.26% LKPEDITQIQPQQLVLR 95.00% 3.32 0.388 2.7 674.0568 2,019.15 2,019.16 3
 SAMPLE 2 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 9 4.64% IGFGSFVEK 95.00% 2.7 0.418 1.47 492.2622 982.5087 983.5203 2
 SAMPLE 2 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 9 4.64% IGFGSFVEK 95.00% 2.61 0.431 1.36 492.2622 982.5088 983.5203 2
 SAMPLE 2 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 9 4.64% IGFGSFVEK 95.00% 2.78 0.487 1.92 492.2627 982.5097 983.5203 2
 SAMPLE 2 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 9 4.64% IGFGSFVEK 95.00% 2.37 0.496 1.44 492.2629 982.5102 983.5203 2
 SAMPLE 2 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 9 4.64% IGFGSFVEK 95.00% 2.71 0.428 1.68 492.263 982.5103 983.5203 2
 SAMPLE 2 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 9 4.64% IGFGSFVEK 95.00% 2.6 0.44 1.28 492.263 982.5104 983.5203 2
 SAMPLE 2 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 9 4.64% WDTGENPIYK 95.00% 1.99 0.253 2.09 611.789 1,221.56 1,222.57 2
 SAMPLE 2 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 9 4.64% WDTGENPIYK 95.00% 2.37 0.328 3.42 611.7909 1,221.57 1,222.57 2
 SAMPLE 2 Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 9 4.64% NVLSLTNKGEVFNELVGK 95.00% 3.62 0.53 2.55 654.694 1,961.06 1,961.07 3
 SAMPLE 2R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 8 5.51% IGFGSFVEK 95.00% 2.29 0.415 1.15 492.2627 982.5098 983.5203 2
 SAMPLE 2R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 8 5.51% IGFGSFVEK 95.00% 2.56 0.408 1.49 492.2629 982.5101 983.5203 2
 SAMPLE 2R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 8 5.51% IGFGSFVEK 95.00% 2.56 0.445 2.38 492.2631 982.5105 983.5203 2
 SAMPLE 2R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 8 5.51% IGFGSFVEK 95.00% 2.18 0.384 1.7 492.2633 982.511 983.5203 2
 SAMPLE 2R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 8 5.51% IGFGSFVEK 95.00% 2.44 0.446 0 492.2638 982.5119 983.5203 2
 SAMPLE 2R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 8 5.51% IGFGSFVEK 95.00% 2.08 0.417 1.54 492.2642 982.5128 983.5203 2
 SAMPLE 2R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 8 5.51% NVLSLTNKGEVFNELVGK 95.00% 3.67 0.549 3.6 654.6942 1,961.06 1,961.07 3
 SAMPLE 2R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 100.00% 3 3 8 5.51% LKPEDITQIQPQQLVLR 95.00% 2.88 0.447 1.96 674.0596 2,019.16 2,019.16 3
 SAMPLE 3R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 99.80% 2 2 3 3.38% IGFGSFVEK 95.00% 2.53 0.476 1.82 492.2621 982.5086 983.5203 2
 SAMPLE 3R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 99.80% 2 2 3 3.38% IGFGSFVEK 95.00% 2.49 0.396 2.01 492.2625 982.5094 983.5203 2
 SAMPLE 3R Integrin beta-1  ITGB1  ITB1_HUMAN 88,397.10 99.80% 2 2 3 3.38% NVLSLTNKGEVFNELVGK 95.00% 3.34 0.483 1.8 654.6923 1,961.05 1,961.07 3
 SAMPLE 3 Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 4 4 8 13.50% GDDTPLHLAASHGHR 95.00% 3.96 0.428 4.72 528.5929 1,582.76 1,583.77 3
 SAMPLE 3 Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 4 4 8 13.50% GDDTPLHLAASHGHR 95.00% 3.47 0.478 2.96 528.593 1,582.76 1,583.77 3
 SAMPLE 3 Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 4 4 8 13.50% SAVVEMLIMR 95.00% 3.16 0.279 1.96 574.8121 1,147.61 1,148.62 2 FBLN1_HUMAN,LAMC1_HUMAN
 SAMPLE 3 Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 4 4 8 13.50% SAVVEMLIMR 95.00% 3.54 0.301 2.82 574.8123 1,147.61 1,148.62 2 FBLN1_HUMAN,LAMC1_HUMAN
 SAMPLE 3 Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 4 4 8 13.50% SVMIDEDMTAR 95.00% 2.66 0.38 1.21 634.2859 1,266.56 1,267.57 2
 SAMPLE 3 Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 4 4 8 13.50% SVMIDEDMTAR 95.00% 2.93 0.451 1.96 634.2895 1,266.56 1,267.57 2
 SAMPLE 3 Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 4 4 8 13.50% LNENHSGELWK 95.00% 3.23 0.352 1.92 663.8249 1,325.63 1,326.64 2
 SAMPLE 3 Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 4 4 8 13.50% LNENHSGELWK 95.00% 3.15 0.292 1.14 663.8257 1,325.64 1,326.64 2
 SAMPLE 3 Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 4 4 8 13.50% MYAPAWVAPEALQK 95.00% 2.84 0.505 2.22 787.903 1,573.79 1,574.80 2
 SAMPLE 3 Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 4 4 8 13.50% MYAPAWVAPEALQK 95.00% 4.01 0.628 4.51 787.9041 1,573.79 1,574.80 2
 SAMPLE 3R Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 5 5 8 15.90% GDDTPLHLAASHGHR 95.00% 3.54 0.481 3.07 528.5932 1,582.76 1,583.77 3
 SAMPLE 3R Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 5 5 8 15.90% GDDTPLHLAASHGHR 95.00% 3.48 0.442 2.62 528.9273 1,583.76 1,583.77 3
 SAMPLE 3R Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 5 5 8 15.90% SAVVEMLIMR 95.00% 2.27 0.0921 1.6 574.8109 1,147.61 1,148.62 2 FBLN1_HUMAN,LAMC1_HUMAN
 SAMPLE 3R Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 5 5 8 15.90% SAVVEMLIMR 95.00% 2.99 0.27 1.77 574.8114 1,147.61 1,148.62 2 FBLN1_HUMAN,LAMC1_HUMAN
 SAMPLE 3R Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 5 5 8 15.90% SAVVEMLIMR 95.00% 3.24 0.32 1.62 574.8117 1,147.61 1,148.62 2 FBLN1_HUMAN,LAMC1_HUMAN
 SAMPLE 3R Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 5 5 8 15.90% FDMIVPILEK 95.00% 2.4 0.368 0 602.834 1,203.65 1,204.67 2
 SAMPLE 3R Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 5 5 8 15.90% FDMIVPILEK 95.00% 2.29 0.339 0 602.8369 1,203.66 1,204.67 2
 SAMPLE 3R Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 5 5 8 15.90% SVMIDEDMTAR 95.00% 2.36 0.389 2.38 634.2851 1,266.55 1,267.57 2
 SAMPLE 3R Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 5 5 8 15.90% SVMIDEDMTAR 95.00% 2.75 0.414 1.49 634.287 1,266.56 1,267.57 2
 SAMPLE 3R Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 5 5 8 15.90% LNENHSGELWK 95.00% 3.03 0.281 1.96 663.8268 1,325.64 1,326.64 2
 SAMPLE 3R Integrin-linked protein kinase  ILK  ILK_HUMAN 51,401.70 100.00% 5 5 8 15.90% EVPFADLSNMEIGMK 95.00% 4.04 0.412 3.59 840.9044 1,679.79 1,680.80 2
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H1  ITIH1  ITIH1_HUMAN 101,371.80 99.90% 2 2 4 5.16% EVAFDLEIPK 95.00% 2.65 0.382 0 580.8123 1,159.61 1,160.62 2
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H1  ITIH1  ITIH1_HUMAN 101,371.80 99.90% 2 2 4 5.16% EVAFDLEIPK 95.00% 2.25 0.261 0 580.8127 1,159.61 1,160.62 2
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H1  ITIH1  ITIH1_HUMAN 101,371.80 99.90% 2 2 4 5.16% FAHYVVTSQVVNTANEAR 95.00% 2.89 0.233 0 669.6742 2,006.00 2,006.01 3
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H1  ITIH1  ITIH1_HUMAN 101,371.80 99.90% 2 2 4 5.16% FAHYVVTSQVVNTANEAR 95.00% 3.32 0.391 0 669.6747 2,006.00 2,006.01 3
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H1  ITIH1  ITIH1_HUMAN 101,371.80 99.90% 2 2 4 5.16% GSLVQASEANLQAAQDFVR 95.00% 5.23 0.586 7.96 1,002.51 2,003.01 2,004.02 2 FLNA_HUMAN
 SAMPLE 2R Inter-alpha-trypsin inhibitor heavy chain H1  ITIH1  ITIH1_HUMAN 101,371.80 100.00% 3 3 5 4.17% AAISGENAGLVR 95.00% 2.41 0.241 1.68 579.9779 1,157.94 1,157.63 2
 SAMPLE 2R Inter-alpha-trypsin inhibitor heavy chain H1  ITIH1  ITIH1_HUMAN 101,371.80 100.00% 3 3 5 4.17% EVAFDLEIPK 95.00% 2.66 0.413 0 580.8124 1,159.61 1,160.62 2
 SAMPLE 2R Inter-alpha-trypsin inhibitor heavy chain H1  ITIH1  ITIH1_HUMAN 101,371.80 100.00% 3 3 5 4.17% EVAFDLEIPK 95.00% 2.61 0.383 0 580.813 1,159.61 1,160.62 2
 SAMPLE 2R Inter-alpha-trypsin inhibitor heavy chain H1  ITIH1  ITIH1_HUMAN 101,371.80 100.00% 3 3 5 4.17% EVAFDLEIPK 95.00% 2.71 0.376 0 581.3139 1,160.61 1,160.62 2
 SAMPLE 2R Inter-alpha-trypsin inhibitor heavy chain H1  ITIH1  ITIH1_HUMAN 101,371.80 100.00% 3 3 5 4.17% GFSLDEATNLNGGLLR 95.00% 4.88 0.519 3.4 838.933 1,675.85 1,676.86 2
 SAMPLE 3 Inter-alpha-trypsin inhibitor heavy chain H1  ITIH1  ITIH1_HUMAN 101,371.80 99.80% 2 2 2 3.07% NHMQYEIVIK 95.00% 2.4 0.182 0 637.8319 1,273.65 1,274.66 2
 SAMPLE 3 Inter-alpha-trypsin inhibitor heavy chain H1  ITIH1  ITIH1_HUMAN 101,371.80 99.80% 2 2 2 3.07% FAHYVVTSQVVNTANEAR 95.00% 3.46 0.334 0 669.6743 2,006.00 2,006.01 3
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H2  ITIH2  ITIH2_HUMAN 106,420.50 99.80% 2 2 2 2.22% TEVNVLPGAK 95.00% 2.42 0.336 0 514.2913 1,026.57 1,027.58 2
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H2  ITIH2  ITIH2_HUMAN 106,420.50 99.80% 2 2 2 2.22% FYNQVSTPLLR 95.00% 2.63 0.389 0 669.8651 1,337.71 1,337.72 2
 SAMPLE 3R Inter-alpha-trypsin inhibitor heavy chain H2  ITIH2  ITIH2_HUMAN 106,420.50 99.80% 2 2 2 2.11% TEVNVLPGAK 95.00% 2.2 0.272 0 514.294 1,026.57 1,027.58 2
 SAMPLE 3R Inter-alpha-trypsin inhibitor heavy chain H2  ITIH2  ITIH2_HUMAN 106,420.50 99.80% 2 2 2 2.11% SSALDMENFR 95.00% 2.9 0.323 0 585.2665 1,168.52 1,169.53 2
 SAMPLE 1 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 10 4.14% TPLLSDIR 95.00% 2.29 0.325 0 457.7694 913.5231 914.5313 2
 SAMPLE 1 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 10 4.14% AQALAVSYR 95.00% 2.24 0 1.66 489.7715 977.5274 978.5372 2
 SAMPLE 1 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 10 4.14% AQALAVSYR 94.70% 1.96 0 1.38 489.7726 977.5296 978.5372 2
 SAMPLE 1 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 10 4.14% AQALAVSYR 95.00% 2.38 0.113 1.92 489.7729 977.5301 978.5372 2
 SAMPLE 1 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 10 4.14% FSIIGFSNR 95.00% 2.68 0.404 0 520.7793 1,039.54 1,040.55 2
 SAMPLE 1 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 10 4.14% FSIIGFSNR 95.00% 3.02 0.342 1.62 520.7794 1,039.54 1,040.55 2
 SAMPLE 1 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 10 4.14% FSIIGFSNR 95.00% 2.98 0.352 1.23 520.7799 1,039.54 1,040.55 2
 SAMPLE 1 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 10 4.14% FSIIGFSNR 95.00% 2.61 0.371 0 520.7801 1,039.54 1,040.55 2
 SAMPLE 1 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 10 4.14% IAQNGILGDFIIR 95.00% 3.68 0.531 2.4 715.411 1,428.81 1,429.82 2
 SAMPLE 1 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 10 4.14% IAQNGILGDFIIR 95.00% 3.82 0.502 3.85 715.4134 1,428.81 1,429.82 2
 SAMPLE 1R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 6 6 11 6.69% TPLLSDIR 95.00% 2 0.29 0 457.7696 913.5236 914.5313 2
 SAMPLE 1R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 6 6 11 6.69% AQALAVSYR 95.00% 2.31 0 2.12 489.7716 977.5276 978.5372 2
 SAMPLE 1R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 6 6 11 6.69% FSIIGFSNR 95.00% 2.92 0.369 1.7 520.7791 1,039.54 1,040.55 2
 SAMPLE 1R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 6 6 11 6.69% FSIIGFSNR 95.00% 2.61 0.393 0 520.78 1,039.54 1,040.55 2
 SAMPLE 1R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 6 6 11 6.69% YAFTTVScR 95.00% 2.07 0.428 1.96 c8: Carbamidomethyl (+57.02) 552.7617 1,103.51 1,104.51 2
 SAMPLE 1R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 6 6 11 6.69% YAFTTVScR 95.00% 2.16 0.469 1.8 c8: Carbamidomethyl (+57.02) 552.7621 1,103.51 1,104.51 2
 SAMPLE 1R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 6 6 11 6.69% DALFTILHDLRPQDR 95.00% 2.38 0.329 0 603.9912 1,808.95 1,809.96 3
 SAMPLE 1R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 6 6 11 6.69% IAQNGILGDFIIR 95.00% 3.74 0.573 3.46 715.4104 1,428.81 1,429.82 2
 SAMPLE 1R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 6 6 11 6.69% IAQNGILGDFIIR 95.00% 3.72 0.498 5.19 715.411 1,428.81 1,429.82 2
 SAMPLE 1R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 6 6 11 6.69% IAQNGILGDFIIR 95.00% 3.67 0.482 2.09 715.4112 1,428.81 1,429.82 2
 SAMPLE 1R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 6 6 11 6.69% IAQNGILGDFIIR 95.00% 3.6 0.541 2 715.4117 1,428.81 1,429.82 2
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 8 4.88% TPLLSDIR 95.00% 2.06 0.299 0 457.7698 913.524 914.5313 2
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 8 4.88% TPLLSDIR 95.00% 2.01 0.169 1.46 457.7706 913.5255 914.5313 2
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 8 4.88% FSIIGFSNR 95.00% 2.9 0.421 1.68 520.7786 1,039.54 1,040.55 2
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 8 4.88% IAQNGILGDFIIR 95.00% 3.72 0.555 2.74 715.4117 1,428.81 1,429.82 2
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 8 4.88% IAQNGILGDFIIR 95.00% 3.27 0.539 3.68 715.4118 1,428.81 1,429.82 2
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 8 4.88% IAQNGILGDFIIR 95.00% 3.22 0.532 2.03 715.4118 1,428.81 1,429.82 2
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 8 4.88% NVVFVLDSSASMVGTK 95.00% 2.87 0.3 2.7 827.3526 1,652.69 1,653.85 2
 SAMPLE 2 Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 4 4 8 4.88% NVVFVLDSSASMVGTK 95.00% 3.02 0.37 2.92 827.3539 1,652.69 1,653.85 2
 SAMPLE 2R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 2 2 6 2.34% FSIIGFSNR 95.00% 2.85 0.369 0 520.7796 1,039.54 1,040.55 2
 SAMPLE 2R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 2 2 6 2.34% FSIIGFSNR 95.00% 2.5 0.431 0 520.7798 1,039.54 1,040.55 2
 SAMPLE 2R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 2 2 6 2.34% IAQNGILGDFIIR 95.00% 3.71 0.491 3.12 715.4109 1,428.81 1,429.82 2
 SAMPLE 2R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 2 2 6 2.34% IAQNGILGDFIIR 95.00% 3.51 0.537 3.42 715.412 1,428.81 1,429.82 2
 SAMPLE 2R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 2 2 6 2.34% IAQNGILGDFIIR 95.00% 3.51 0.42 3.68 715.4121 1,428.81 1,429.82 2
 SAMPLE 2R Inter-alpha-trypsin inhibitor heavy chain H5  ITIH5  ITIH5_HUMAN 104,561.20 100.00% 2 2 6 2.34% IAQNGILGDFIIR 95.00% 3.43 0.56 3.36 715.4139 1,428.81 1,429.82 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% VLDELTLTK 95.00% 3.21 0.471 1.96 516.3031 1,030.59 1,031.60 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% VLDELTLTK 95.00% 3.36 0.496 2.36 516.3037 1,030.59 1,031.60 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% LASYLDKVR 95.00% 2.8 0.2 0 532.8089 1,063.60 1,064.61 2 K1C14_HUMAN
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% LASYLDKVR 95.00% 3.09 0.209 1.38 532.8105 1,063.61 1,064.61 2 K1C14_HUMAN
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% DAEAWFNEK 95.00% 2.52 0.318 0 555.2494 1,108.48 1,109.49 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% DAEAWFNEK 95.00% 2.99 0.272 0 555.2497 1,108.48 1,109.49 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% DAEAWFNEK 95.00% 2.1 0.318 0 555.2503 1,108.49 1,109.49 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% DAEAWFNEK 95.00% 2.49 0.278 0 555.2509 1,108.49 1,109.49 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% DAEAWFNEK 95.00% 2.88 0.283 0 555.2517 1,108.49 1,109.49 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% LENEIQTYR 95.00% 3.28 0.12 0 583.2967 1,164.58 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% LENEIQTYR 95.00% 3.42 0.14 1.44 583.2973 1,164.58 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% LKYENEVALR 95.00% 2.8 0.285 2.19 617.8451 1,233.67 1,234.68 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% LKYENEVALR 95.00% 2.94 0.278 2.28 617.8452 1,233.67 1,234.68 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% ALEESNYELEGK 95.00% 3.12 0.442 2.52 691.3289 1,380.64 1,381.65 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% ALEESNYELEGK 95.00% 3.16 0.485 2.72 691.3294 1,380.64 1,381.65 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% ALEESNYELEGK 95.00% 3.22 0.503 2.72 691.33 1,380.64 1,381.65 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% ALEESNYELEGK 95.00% 2.52 0.314 2.55 691.3308 1,380.65 1,381.65 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% GSLGGGFSSGGFSGGSFSR 95.00% 5.44 0.603 6.96 854.3915 1,706.77 1,707.77 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% GSLGGGFSSGGFSGGSFSR 95.00% 5.5 0.67 6.96 854.3918 1,706.77 1,707.77 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% AETEcQNTEYQQLLDIK 95.00% 5.51 0.452 3.62 c5: Carbamidomethyl (+57.02) 1,042.49 2,082.96 2,082.97 2
 SAMPLE 4 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 19 15.90% AETEcQNTEYQQLLDIK 95.00% 5.08 0.459 4.64 c5: Carbamidomethyl (+57.02) 1,042.49 2,082.97 2,082.97 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% VLDELTLTK 95.00% 2.46 0.431 2.23 516.3034 1,030.59 1,031.60 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% LASYLDKVR 95.00% 2.99 0.162 1.7 532.8098 1,063.60 1,064.61 2 K1C14_HUMAN
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% LASYLDKVR 95.00% 3.27 0.196 1.62 532.81 1,063.60 1,064.61 2 K1C14_HUMAN
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% DAEAWFNEK 95.00% 3.02 0.282 0 555.2496 1,108.48 1,109.49 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% DAEAWFNEK 95.00% 3 0.274 0 555.25 1,108.48 1,109.49 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% LENEIQTYR 95.00% 2.9 0.115 0 583.2962 1,164.58 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% LENEIQTYR 95.00% 3.35 0.0983 0 583.2967 1,164.58 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% LKYENEVALR 95.00% 2.66 0.279 1.82 617.8435 1,233.67 1,234.68 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% LKYENEVALR 95.00% 2.45 0.263 1.68 617.846 1,233.68 1,234.68 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% ALEESNYELEGK 95.00% 3.53 0.508 6.38 691.3286 1,380.64 1,381.65 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% ALEESNYELEGK 95.00% 2.27 0.192 1.26 691.329 1,380.64 1,381.65 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% ALEESNYELEGK 95.00% 3.52 0.543 3.28 691.3294 1,380.64 1,381.65 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% ALEESNYELEGK 95.00% 2.43 0.316 1.46 691.3313 1,380.65 1,381.65 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% GSLGGGFSSGGFSGGSFSR 95.00% 4.88 0.604 4.1 854.3907 1,706.77 1,707.77 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% GSLGGGFSSGGFSGGSFSR 95.00% 4.45 0.523 3.37 854.8957 1,707.78 1,707.77 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% AETEcQNTEYQQLLDIK 95.00% 5.1 0.507 5.34 c5: Carbamidomethyl (+57.02) 1,042.49 2,082.96 2,082.97 2
 SAMPLE 4R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 15 15.90% AETEcQNTEYQQLLDIK 95.00% 5.46 0.424 3.2 c5: Carbamidomethyl (+57.02) 1,042.49 2,082.97 2,082.97 2
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% QSVEADINGLRR 95.00% 1.71 0.268 0 453.2458 1,356.71 1,357.72 3 CSPG2_HUMAN
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% QSVEADINGLRR 95.00% 1.76 0.279 0 453.2484 1,356.72 1,357.72 3 CSPG2_HUMAN
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% VLDELTLTK 95.00% 2.93 0.455 1.48 516.3017 1,030.59 1,031.60 2
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% VLDELTLTK 95.00% 2.53 0.408 2.26 516.3029 1,030.59 1,031.60 2
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% DAEAWFNEK 95.00% 2.33 0.282 0 555.638 1,109.26 1,109.49 2
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% LENEIQTYR 95.00% 3.54 0.0999 0 583.2945 1,164.57 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% LKYENEVALR 95.00% 2.56 0.174 0 617.8429 1,233.67 1,234.68 2
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% ALEESNYELEGK 95.00% 4.16 0.49 3.6 691.3268 1,380.64 1,381.65 2
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% ALEESNYELEGK 95.00% 3.85 0.53 1.7 691.327 1,380.64 1,381.65 2
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% ALEESNYELEGK 95.00% 2.89 0.342 0 691.3271 1,380.64 1,381.65 2
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% QSLEASLAETEGR 95.00% 4.2 0.498 3.72 695.8429 1,389.67 1,390.68 2
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% QSLEASLAETEGR 95.00% 3.59 0.498 3.57 695.8431 1,389.67 1,390.68 2
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% GSLGGGFSSGGFSGGSFSR 95.00% 4.81 0.454 2.57 854.8857 1,707.76 1,707.77 2
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% AETEcQNTEYQQLLDIK 95.00% 5.76 0.496 4.85 c5: Carbamidomethyl (+57.02) 1,041.98 2,081.95 2,082.97 2
 SAMPLE 1 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 7 7 12 18.50% AETEcQNTEYQQLLDIK 95.00% 5.59 0.518 4.85 c5: Carbamidomethyl (+57.02) 1,042.49 2,082.96 2,082.97 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% VLDELTLTK 95.00% 2.44 0.39 2.3 516.3015 1,030.59 1,031.60 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% VLDELTLTK 95.00% 2.59 0.328 2.6 516.3015 1,030.59 1,031.60 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% DAEAWFNEK 95.00% 2.44 0.275 0 555.6355 1,109.26 1,109.49 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% DAEAWFNEK 95.00% 2.38 0.28 0 555.6356 1,109.26 1,109.49 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% LENEIQTYR 95.00% 2.97 0.0922 0 583.2911 1,164.57 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% LENEIQTYR 95.00% 3.22 0.0779 0 583.2949 1,164.57 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% QSVEADINGLR 95.00% 3.04 0.373 0 601.3163 1,200.62 1,201.62 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% ALEESNYELEGK 95.00% 4.48 0.511 1.59 691.3271 1,380.64 1,381.65 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% ALEESNYELEGK 95.00% 3.52 0.476 2.24 691.3273 1,380.64 1,381.65 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% QSLEASLAETEGR 95.00% 2.98 0.362 2.44 695.842 1,389.67 1,390.68 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% QSLEASLAETEGR 95.00% 3.29 0.411 2.89 695.8422 1,389.67 1,390.68 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% IRLENEIQTYR 95.00% 3.24 0.428 3.28 717.8886 1,433.76 1,434.77 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% GSLGGGFSSGGFSGGSFSR 95.00% 4.23 0.27 5.17 854.8828 1,707.75 1,707.77 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% AETEcQNTEYQQLLDIK 95.00% 5.68 0.48 4.38 c5: Carbamidomethyl (+57.02) 1,042.48 2,082.95 2,082.97 2
 SAMPLE 1R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 8 8 13 17.00% AETEcQNTEYQQLLDIK 95.00% 5.57 0.501 5.35 c5: Carbamidomethyl (+57.02) 1,042.48 2,082.95 2,082.97 2
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% LENEIQTYR 95.00% 3.09 0.0901 0 583.2948 1,164.57 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% LENEIQTYR 95.00% 3.24 0.095 0 583.2956 1,164.58 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% QSVEADINGLR 95.00% 2.39 0.251 0 601.3091 1,200.60 1,201.62 2
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% QSVEADINGLR 95.00% 3.03 0.393 0 601.3123 1,200.61 1,201.62 2
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% LKYENEVALR 95.00% 3 0.259 0 617.8416 1,233.67 1,234.68 2
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% LKYENEVALR 95.00% 3.14 0.337 1.66 617.8432 1,233.67 1,234.68 2
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% ALEESNYELEGK 95.00% 3.21 0.468 2.55 691.3264 1,380.64 1,381.65 2
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% ALEESNYELEGK 95.00% 3.83 0.506 1.44 691.3273 1,380.64 1,381.65 2
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% ALEESNYELEGK 95.00% 2.94 0.517 2.52 691.3274 1,380.64 1,381.65 2
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% ALEESNYELEGK 95.00% 3.82 0.525 1.92 691.328 1,380.64 1,381.65 2
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% ALEESNYELEGK 95.00% 3.34 0.474 2.37 691.3283 1,380.64 1,381.65 2
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% GSLGGGFSSGGFSGGSFSR 95.00% 5.02 0.641 5.01 854.8913 1,707.77 1,707.77 2
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% AETEcQNTEYQQLLDIK 95.00% 5.56 0.515 4.14 c5: Carbamidomethyl (+57.02) 1,041.99 2,081.96 2,082.97 2
 SAMPLE 2 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 12 13.20% AETEcQNTEYQQLLDIK 95.00% 5.79 0.478 4.82 c5: Carbamidomethyl (+57.02) 1,042.48 2,082.95 2,082.97 2
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% VLDELTLTK 95.00% 2.08 0.265 1.8 516.3017 1,030.59 1,031.60 2
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% VLDELTLTK 95.00% 1.86 0.222 1.17 516.3022 1,030.59 1,031.60 2
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% LENEIQTYR 95.00% 3.09 0.102 0 583.2957 1,164.58 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% LKYENEVALR 95.00% 2.58 0.296 0 617.8426 1,233.67 1,234.68 2
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% LKYENEVALR 95.00% 2.35 0.17 1.59 617.8435 1,233.67 1,234.68 2
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% ALEESNYELEGK 95.00% 2.66 0.384 0 691.3273 1,380.64 1,381.65 2
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% ALEESNYELEGK 95.00% 2.21 0.28 0 691.3273 1,380.64 1,381.65 2
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% ALEESNYELEGK 95.00% 3.47 0.492 3.21 691.3276 1,380.64 1,381.65 2
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% ALEESNYELEGK 95.00% 3.58 0.507 1.3 691.3277 1,380.64 1,381.65 2
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% ALEESNYELEGK 95.00% 3.79 0.536 2.57 691.3279 1,380.64 1,381.65 2
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% ALEESNYELEGK 95.00% 4.03 0.565 1.96 691.3282 1,380.64 1,381.65 2
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% AETEcQNTEYQQLLDIK 95.00% 5.66 0.5 5.06 c5: Carbamidomethyl (+57.02) 1,042.49 2,082.95 2,082.97 2
 SAMPLE 2R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 4 4 12 9.61% AETEcQNTEYQQLLDIK 95.00% 5.76 0.52 4.39 c5: Carbamidomethyl (+57.02) 1,042.49 2,082.95 2,082.97 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% VLDELTLTK 95.00% 2.37 0.29 1.4 516.3016 1,030.59 1,031.60 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% DAEAWFNEK 95.00% 2.34 0.251 0 555.2466 1,108.48 1,109.49 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% DAEAWFNEK 95.00% 2.54 0.238 0 555.2471 1,108.48 1,109.49 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% DAEAWFNEK 95.00% 2.64 0.269 0 555.2475 1,108.48 1,109.49 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% DAEAWFNEK 95.00% 2.34 0.185 0 555.2509 1,108.49 1,109.49 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% LENEIQTYR 95.00% 3.3 0.0724 0 583.2955 1,164.58 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% LENEIQTYR 95.00% 3.24 0.11 1.23 583.2961 1,164.58 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% LKYENEVALR 95.00% 2.87 0.296 0 617.8421 1,233.67 1,234.68 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% LKYENEVALR 95.00% 2.79 0.393 0 617.8423 1,233.67 1,234.68 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% ALEESNYELEGK 95.00% 3.39 0.506 6.03 691.3268 1,380.64 1,381.65 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% ALEESNYELEGK 95.00% 3.44 0.516 2.82 691.3273 1,380.64 1,381.65 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% ALEESNYELEGK 95.00% 2.76 0.261 3.17 691.328 1,380.64 1,381.65 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% ALEESNYELEGK 95.00% 3.16 0.475 0 691.3281 1,380.64 1,381.65 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% ALEESNYELEGK 95.00% 2.29 0.197 2.92 691.3307 1,380.65 1,381.65 2
 SAMPLE 3 Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 5 5 13 11.10% AETEcQNTEYQQLLDIK 95.00% 5.89 0.459 4.25 c5: Carbamidomethyl (+57.02) 1,042.49 2,082.96 2,082.97 2
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% VLDELTLTK 95.00% 1.93 0.281 0 516.3011 1,030.59 1,031.60 2
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% VLDELTLTK 95.00% 1.96 0.261 1.27 516.3022 1,030.59 1,031.60 2
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% LENEIQTYR 95.00% 3.17 0.0913 0 583.2946 1,164.57 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% LENEIQTYR 95.00% 3.24 0.0898 1.43 583.2951 1,164.57 1,165.59 2 CRYAB_HUMAN,SFPQ_HUMAN,AGRIN_HUMAN,CO6A2_HUMAN,RL17_HUMAN
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% QSVEADINGLR 95.00% 2.63 0.283 0 601.3192 1,200.62 1,201.62 2
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% LKYENEVALR 95.00% 2.71 0.376 1.46 617.843 1,233.67 1,234.68 2
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% LKYENEVALR 95.00% 2.74 0.353 2.51 617.8434 1,233.67 1,234.68 2
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% LKYENEVALR 95.00% 2.75 0.364 0 617.8444 1,233.67 1,234.68 2
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% ALEESNYELEGK 95.00% 2.19 0.343 0 691.3252 1,380.63 1,381.65 2
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% ALEESNYELEGK 95.00% 2.37 0.353 0 691.3262 1,380.64 1,381.65 2
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% ALEESNYELEGK 95.00% 3.38 0.494 2.85 691.3272 1,380.64 1,381.65 2
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% ALEESNYELEGK 95.00% 3.64 0.536 3.57 691.3275 1,380.64 1,381.65 2
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% ISSSKGSLGGGFSSGGFSGGSFSR 95.00% 3.66 0.535 2.89 737.6884 2,210.04 2,210.05 3
 SAMPLE 3R Keratin, type I cytoskeletal 10  KRT10  K1C10_HUMAN 59,494.30 100.00% 6 6 12 15.50% AETEcQNTEYQQLLDIK 95.00% 4.59 0.517 4.2 c5: Carbamidomethyl (+57.02) 1,041.99 2,081.96 2,082.97 2
 SAMPLE 4 Keratin, type I cytoskeletal 14  KRT14  K1C14_HUMAN 51,604.60 100.00% 3 3 3 12.10% TRLEQEIATYRR 95.00% 2.65 0.328 0 512.6146 1,534.82 1,535.83 3
 SAMPLE 4 Keratin, type I cytoskeletal 14  KRT14  K1C14_HUMAN 51,604.60 100.00% 3 3 3 12.10% VLDELTLAR 95.00% 3.93 0.463 1.39 515.3016 1,028.59 1,029.59 2
 SAMPLE 4 Keratin, type I cytoskeletal 14  KRT14  K1C14_HUMAN 51,604.60 100.00% 3 3 3 12.10% VLDELTLAR 95.00% 3.89 0.46 0 515.302 1,028.59 1,029.59 2
 SAMPLE 4 Keratin, type I cytoskeletal 14  KRT14  K1C14_HUMAN 51,604.60 100.00% 3 3 3 12.10% LASYLDKVR 95.00% 2.8 0.2 0 532.8089 1,063.60 1,064.61 2 K1C10_HUMAN
 SAMPLE 4 Keratin, type I cytoskeletal 14  KRT14  K1C14_HUMAN 51,604.60 100.00% 3 3 3 12.10% LASYLDKVR 95.00% 3.09 0.209 1.38 532.8105 1,063.61 1,064.61 2 K1C10_HUMAN
 SAMPLE 4 Keratin, type I cytoskeletal 14  KRT14  K1C14_HUMAN 51,604.60 100.00% 3 3 3 12.10% ALEEANADLEVK 95.00% 2.37 0.442 0 651.3356 1,300.66 1,301.66 2
 SAMPLE 4 Keratin, type I cytoskeletal 14  KRT14  K1C14_HUMAN 51,604.60 100.00% 3 3 3 12.10% APSTYGGGLSVSSSR 95.00% 2.88 0.585 4.77 713.3527 1,424.69 1,425.70 2
 SAMPLE 2 Keratin, type I cytoskeletal 14  KRT14  K1C14_HUMAN 51,604.60 99.80% 2 2 2 5.08% DAEEWFFTK 95.00% 3.02 0.383 0 586.7661 1,171.52 1,172.53 2
 SAMPLE 2 Keratin, type I cytoskeletal 14  KRT14  K1C14_HUMAN 51,604.60 99.80% 2 2 2 5.08% APSTYGGGLSVSSSR 95.00% 3.36 0.543 3.85 713.3534 1,424.69 1,425.70 2
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% TLLDIDNTR 95.00% 2.91 0.446 0 530.7861 1,059.56 1,060.56 2
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% TLLDIDNTR 95.00% 2.67 0.41 1.48 530.7861 1,059.56 1,060.56 2
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% TLLDIDNTR 95.00% 2.44 0.362 0 530.7863 1,059.56 1,060.56 2
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% TLLDIDNTR 95.00% 2.41 0.437 0 530.7868 1,059.56 1,060.56 2
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% TLLDIDNTR 95.00% 2.55 0.386 0 530.787 1,059.56 1,060.56 2
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% TLLDIDNTR 95.00% 2.57 0.456 1.82 530.7871 1,059.56 1,060.56 2
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% QGVDADINGLR 95.00% 2.87 0.394 1.85 579.3003 1,156.59 1,157.59 2
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% QGVDADINGLR 95.00% 3.03 0.391 1.37 579.3025 1,156.59 1,157.59 2
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% QVLDNLTmEK 95.00% 2.76 0.0814 1.55 m8: Oxidation (+15.99) 604.3081 1,206.60 1,206.60 2
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% HGVQELEIELQSQLSK 95.00% 4.23 0.411 1.04 613.3287 1,836.96 1,837.97 3
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% HGVQELEIELQSQLSK 95.00% 3.99 0.378 1.68 613.6628 1,837.96 1,837.97 3
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% TLNDMRQEYEQLIAK 95.00% 3.35 0.419 0 617.9832 1,850.93 1,851.93 3
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% TLNDMRQEYEQLIAK 95.00% 3.43 0.451 1.31 618.3167 1,851.93 1,851.93 3
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% TLNDmRQEYEQLIAK 95.00% 2.28 0.437 0 m5: Oxidation (+15.99) 623.3141 1,866.92 1,867.92 3
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% HGVQELEIELQSQLSKK 95.00% 2.16 0.307 0 656.0251 1,965.05 1,966.06 3
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% HGVQELEIELQSQLSKK 95.00% 5.4 0.436 0 656.3612 1,966.06 1,966.06 3
 SAMPLE 4 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 9.95% HGVQELEIELQSQLSKK 95.00% 5.13 0.406 0 656.3617 1,966.06 1,966.06 3
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLLDIDNTR 95.00% 2.22 0.278 1.55 530.7861 1,059.56 1,060.56 2
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLLDIDNTR 95.00% 2.79 0.415 1.46 530.7862 1,059.56 1,060.56 2
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLLDIDNTR 95.00% 2.92 0.437 1.19 530.7862 1,059.56 1,060.56 2
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLLDIDNTR 95.00% 2.15 0.329 0 530.7865 1,059.56 1,060.56 2
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLLDIDNTR 95.00% 2.39 0.409 1.47 530.7867 1,059.56 1,060.56 2
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLLDIDNTR 95.00% 2.24 0.399 0 530.7873 1,059.56 1,060.56 2
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLLDIDNTR 95.00% 2.43 0.305 1.82 530.7878 1,059.56 1,060.56 2
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLLDIDNTR 94.90% 1.83 0.276 0 530.7891 1,059.56 1,060.56 2
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% QGVDADINGLR 95.00% 2.89 0.385 1.19 579.3002 1,156.58 1,157.59 2
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% QGVDADINGLR 95.00% 3.17 0.405 0 579.3022 1,156.59 1,157.59 2
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% HGVQELEIELQSQLSK 95.00% 4.06 0.28 2.72 613.3281 1,836.96 1,837.97 3
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLNDMRQEYEQLIAK 95.00% 2.7 0.287 0 617.9833 1,850.93 1,851.93 3
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLNDMRQEYEQLIAK 95.00% 3.16 0.428 1.57 618.3182 1,851.93 1,851.93 3
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLNDmRQEYEQLIAK 95.00% 2.18 0.342 0 m5: Oxidation (+15.99) 623.3132 1,866.92 1,867.92 3
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLNDmRQEYEQLIAK 95.00% 2.06 0.232 0 m5: Oxidation (+15.99) 623.3139 1,866.92 1,867.92 3
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% HGVQELEIELQSQLSKK 95.00% 4.76 0.517 0 656.3616 1,966.06 1,966.06 3
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% EIETYHNLLEGGQEDFESSGAGK 95.00% 6.25 0.587 5.62 837.7184 2,510.13 2,510.13 3
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% EIETYHNLLEGGQEDFESSGAGK 95.00% 5.59 0.566 5.64 837.7192 2,510.13 2,510.13 3
 SAMPLE 4R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 7 19 12.00% TLNDmRQEYEQLIAK 95.00% 3.12 0.359 2.51 m5: Oxidation (+15.99) 934.9654 1,867.92 1,867.92 2
 SAMPLE 1 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% TLLDIDNTR 95.00% 2.17 0.334 0 530.7837 1,059.55 1,060.56 2
 SAMPLE 1 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% TLLDIDNTR 95.00% 2.73 0.465 1.54 530.7841 1,059.55 1,060.56 2
 SAMPLE 1 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% TLLDIDNTR 95.00% 1.84 0.309 0 530.7841 1,059.55 1,060.56 2
 SAMPLE 1 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% TLLDIDNTR 95.00% 2.68 0.409 1.48 530.7844 1,059.55 1,060.56 2
 SAMPLE 1 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% QGVDADINGLR 95.00% 3.02 0.423 1.38 579.2979 1,156.58 1,157.59 2
 SAMPLE 1 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% QGVDADINGLR 95.00% 2.94 0.43 0 579.299 1,156.58 1,157.59 2
 SAMPLE 1 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% HGVQELEIELQSQLSK 95.00% 3.64 0.288 0 613.3269 1,836.96 1,837.97 3
 SAMPLE 1 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% HGVQELEIELQSQLSK 95.00% 2.94 0.299 1.15 613.6595 1,837.96 1,837.97 3
 SAMPLE 1R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 9 5.78% TLLDIDNTR 95.00% 3.22 0.417 1.8 530.7839 1,059.55 1,060.56 2
 SAMPLE 1R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 9 5.78% TLLDIDNTR 95.00% 2.71 0.442 1.18 530.7841 1,059.55 1,060.56 2
 SAMPLE 1R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 9 5.78% TLLDIDNTR 95.00% 1.95 0.3 0 530.7841 1,059.55 1,060.56 2
 SAMPLE 1R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 9 5.78% TLLDIDNTR 95.00% 1.98 0.36 0 530.7851 1,059.55 1,060.56 2
 SAMPLE 1R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 9 5.78% TLLDIDNTR 95.00% 2.03 0.358 0 531.2893 1,060.56 1,060.56 2
 SAMPLE 1R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 9 5.78% QGVDADINGLR 95.00% 3.17 0.449 0 579.2982 1,156.58 1,157.59 2
 SAMPLE 1R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 9 5.78% QGVDADINGLR 95.00% 2.91 0.371 0 579.2992 1,156.58 1,157.59 2
 SAMPLE 1R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 9 5.78% HGVQELEIELQSQLSK 95.00% 3.48 0.315 0 613.3252 1,836.95 1,837.97 3
 SAMPLE 1R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 9 5.78% HGVQELEIELQSQLSK 95.00% 3.23 0.4 1.15 613.659 1,837.95 1,837.97 3
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% TLLDIDNTR 95.00% 2.68 0.425 1.64 530.7839 1,059.55 1,060.56 2
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% TLLDIDNTR 95.00% 3 0.435 1.51 530.784 1,059.55 1,060.56 2
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% TLLDIDNTR 95.00% 1.9 0.367 0 530.7842 1,059.55 1,060.56 2
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% TLLDIDNTR 95.00% 2.21 0.263 0 530.7842 1,059.55 1,060.56 2
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% TLLDIDNTR 95.00% 2.85 0.454 1.59 530.7844 1,059.55 1,060.56 2
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% TLLDIDNTR 95.00% 2.68 0.441 0 530.7845 1,059.55 1,060.56 2
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% TLLDIDNTR 95.00% 2.4 0.392 0 530.7847 1,059.55 1,060.56 2
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% TLLDIDNTR 95.00% 1.82 0.29 0 530.787 1,059.56 1,060.56 2
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% TLLDIDNTR 95.00% 2.25 0.321 0 531.2839 1,060.55 1,060.56 2
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% QGVDADINGLR 95.00% 2.69 0.349 0 579.2985 1,156.58 1,157.59 2
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% HGVQELEIELQSQLSK 95.00% 3.93 0.374 1.52 613.6597 1,837.96 1,837.97 3
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% HGVQELEIELQSQLSK 95.00% 4.19 0.346 1.15 613.6603 1,837.96 1,837.97 3
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% IKFEMEQNLR 95.00% 2.57 0.307 0 654.3423 1,306.67 1,307.68 2
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% HGVQELEIELQSQLSKK 95.00% 6.7 0.595 3.62 656.3584 1,966.05 1,966.06 3
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% HGVQELEIELQSQLSKK 95.00% 6.5 0.615 4 656.3589 1,966.05 1,966.06 3
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% EIETYHNLLEGGQEDFESSGAGK 95.00% 5.58 0.557 4.55 837.7147 2,510.12 2,510.13 3
 SAMPLE 2 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 6 6 17 11.20% EIETYHNLLEGGQEDFESSGAGK 95.00% 5.42 0.509 3.77 837.7158 2,510.12 2,510.13 3
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% mTLDDFR 95.00% 2.01 0.279 0 m1: Oxidation (+15.99) 457.2092 912.4028 913.4091 2
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% TLLDIDNTR 95.00% 2.54 0.422 0 530.7844 1,059.55 1,060.56 2
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% TLLDIDNTR 95.00% 2.24 0.312 0 530.7849 1,059.55 1,060.56 2
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% TLLDIDNTR 95.00% 2.22 0.247 0 530.7852 1,059.55 1,060.56 2
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% TLLDIDNTR 95.00% 2.01 0.294 0 530.786 1,059.56 1,060.56 2
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% TLLDIDNTR 95.00% 1.93 0.29 0 530.7862 1,059.56 1,060.56 2
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% TLLDIDNTR 95.00% 2.55 0.363 1.36 531.2854 1,060.56 1,060.56 2
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% QGVDADINGLR 95.00% 2.69 0.393 0 579.2986 1,156.58 1,157.59 2
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% QGVDADINGLR 95.00% 2.93 0.419 2.15 579.2986 1,156.58 1,157.59 2
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% HGVQELEIELQSQLSK 95.00% 4.09 0.404 3.47 613.3262 1,836.96 1,837.97 3
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% HGVQELEIELQSQLSK 95.00% 4.53 0.437 1.96 613.6594 1,837.95 1,837.97 3
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% FSSSSGYGGGSSR 95.00% 2.58 0.256 3.85 618.266 1,234.52 1,235.53 2
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% IKFEMEQNLR 95.00% 2.41 0.308 0 654.342 1,306.67 1,307.68 2
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% HGVQELEIELQSQLSKK 95.00% 6.35 0.613 3.92 656.0245 1,965.05 1,966.06 3
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% HGVQELEIELQSQLSKK 95.00% 5.86 0.55 3.34 656.3583 1,966.05 1,966.06 3
 SAMPLE 2R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 8 8 16 13.20% TLNDMRQEYEQLIAK 95.00% 3.05 0.308 3.02 926.9671 1,851.92 1,851.93 2
 SAMPLE 3 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 99.80% 2 2 6 3.21% TLLDIDNTR 95.00% 2.49 0.417 0 530.7841 1,059.55 1,060.56 2
 SAMPLE 3 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 99.80% 2 2 6 3.21% TLLDIDNTR 95.00% 2.61 0.379 0 530.7841 1,059.55 1,060.56 2
 SAMPLE 3 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 99.80% 2 2 6 3.21% TLLDIDNTR 95.00% 2.55 0.327 0 530.7843 1,059.55 1,060.56 2
 SAMPLE 3 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 99.80% 2 2 6 3.21% TLLDIDNTR 95.00% 2.52 0.345 0 530.7845 1,059.55 1,060.56 2
 SAMPLE 3 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 99.80% 2 2 6 3.21% QGVDADINGLR 95.00% 2.9 0.374 0 579.2986 1,156.58 1,157.59 2
 SAMPLE 3 Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 99.80% 2 2 6 3.21% QGVDADINGLR 95.00% 2.7 0.398 1.32 579.3 1,156.58 1,157.59 2
 SAMPLE 3R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% TLLDIDNTR 95.00% 2.27 0.345 0 530.7846 1,059.55 1,060.56 2
 SAMPLE 3R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% TLLDIDNTR 95.00% 2.34 0.31 0 530.7848 1,059.55 1,060.56 2
 SAMPLE 3R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% TLLDIDNTR 95.00% 2.22 0.346 0 530.7857 1,059.56 1,060.56 2
 SAMPLE 3R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% TLLDIDNTR 95.00% 2.31 0.309 0 530.7885 1,059.56 1,060.56 2
 SAMPLE 3R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% QGVDADINGLR 95.00% 2.72 0.281 1.16 579.2989 1,156.58 1,157.59 2
 SAMPLE 3R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% QGVDADINGLR 95.00% 2.92 0.422 0 579.299 1,156.58 1,157.59 2
 SAMPLE 3R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% QGVDADINGLR 95.00% 2.9 0.412 0 579.2994 1,156.58 1,157.59 2
 SAMPLE 3R Keratin, type I cytoskeletal 9  KRT9  K1C9_HUMAN 62,113.00 100.00% 3 3 8 5.78% HGVQELEIELQSQLSK 95.00% 3.55 0.345 2.02 613.3266 1,836.96 1,837.97 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 2.59 0.251 0 465.2498 1,392.73 1,393.73 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 3.4 0.463 0 465.2501 1,392.73 1,393.73 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 2.78 0.371 0 465.2509 1,392.73 1,393.73 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 3.45 0.423 0 465.2511 1,392.73 1,393.73 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 2.75 0.297 0 465.2511 1,392.73 1,393.73 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 2.51 0.304 1 465.2513 1,392.73 1,393.73 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 3.26 0.407 0 465.2517 1,392.73 1,393.73 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 2.65 0.331 0 465.252 1,392.73 1,393.73 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 2.74 0.313 0 465.2527 1,392.73 1,393.73 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 2.76 0.349 0 465.5836 1,393.73 1,393.73 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% IEISELNR 95.00% 2.95 0.141 0 487.2703 972.5249 973.5319 2 K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% IEISELNR 95.00% 3.07 0.16 0 487.2705 972.5254 973.5319 2 K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% IEISELNR 95.00% 3.12 0.146 0 487.2708 972.5259 973.5319 2 K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% IEISELNR 95.00% 2.86 0.139 0 487.271 972.5263 973.5319 2 K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% IEISELNRVIQR 95.00% 2.4 0.354 0 490.6204 1,468.84 1,469.84 3 K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% LLRDYQELmNTK 95.00% 2.62 0.208 0 m9: Oxidation (+15.99) 514.2688 1,539.78 1,539.78 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% NKLNDLEDALQQAK 95.00% 4.68 0.358 2.35 533.9508 1,598.83 1,599.83 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% NKLNDLEDALQQAK 95.00% 4.65 0.407 2.85 533.9518 1,598.83 1,599.83 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SLNNQFASFIDKVR 95.00% 2.86 0.328 1.68 546.9595 1,637.86 1,638.86 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SLNNQFASFIDKVR 95.00% 2.53 0.281 0 546.9598 1,637.86 1,638.86 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% QISNLQQSISDAEQR 95.00% 4.12 0.49 1.82 572.9571 1,715.85 1,716.85 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% QISNLQQSISDAEQR 95.00% 4.47 0.445 1.68 573.2912 1,716.85 1,716.85 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% YEELQITAGR 95.00% 3.72 0.316 1.64 590.3054 1,178.60 1,179.60 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% YEELQITAGR 95.00% 3.57 0.334 1.3 590.3054 1,178.60 1,179.60 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIK 95.00% 3.62 0.517 2.57 633.3236 1,264.63 1,265.64 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIK 95.00% 3.12 0.507 2.52 633.3238 1,264.63 1,265.64 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIK 95.00% 2.62 0.428 2.11 633.324 1,264.63 1,265.64 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIK 95.00% 2.28 0.424 1.19 633.3241 1,264.63 1,265.64 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIK 95.00% 2.36 0.341 0 633.3242 1,264.63 1,265.64 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIK 95.00% 2.06 0.343 0 633.3253 1,264.63 1,265.64 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% LALDLEIATYR 95.00% 2.75 0.365 1.82 639.3602 1,276.70 1,277.71 2 VDAC1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% LNDLEDALQQAK 95.00% 3.57 0.391 1.48 679.3492 1,356.68 1,357.70 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SLNNQFASFIDK 95.00% 3.97 0.492 1.6 692.3508 1,382.69 1,383.69 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SLNNQFASFIDK 95.00% 3.76 0.493 1.72 692.3508 1,382.69 1,383.69 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SLNNQFASFIDK 95.00% 3.67 0.478 0 692.3509 1,382.69 1,383.69 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SLNNQFASFIDK 95.00% 3.93 0.477 1.85 692.351 1,382.69 1,383.69 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SLNNQFASFIDK 95.00% 3.56 0.447 1.85 692.351 1,382.69 1,383.69 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SLNNQFASFIDK 95.00% 3.73 0.48 0 692.3511 1,382.69 1,383.69 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SLNNQFASFIDK 95.00% 3.53 0.471 1.21 692.3513 1,382.69 1,383.69 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SLNNQFASFIDK 95.00% 4.04 0.509 1.74 692.8523 1,383.69 1,383.69 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 3.46 0.393 2.19 697.3707 1,392.73 1,393.73 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 3.53 0.435 1.96 697.3717 1,392.73 1,393.73 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 3.38 0.443 1.7 697.3719 1,392.73 1,393.73 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 3.33 0.399 3.08 697.3719 1,392.73 1,393.73 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 3.65 0.369 3 697.3722 1,392.73 1,393.73 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% TNAENEFVTIKK 95.00% 3.47 0.411 2.96 697.8745 1,393.73 1,393.73 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% NKLNDLEDALQQAKEDLAR 95.00% 3.31 0.344 0 729.0504 2,184.13 2,184.13 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% NKLNDLEDALQQAKEDLAR 95.00% 2.66 0.313 0 729.0512 2,184.13 2,184.13 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% FLEQQNQVLQTK 95.00% 2.41 0.266 0 738.3498 1,474.68 1,475.79 2 K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% FLEQQNQVLQTK 95.00% 4.31 0.119 0 738.3936 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% FLEQQNQVLQTK 95.00% 4.2 0.0741 0 738.3954 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% FLEQQNQVLQTK 95.00% 3.49 0.159 0 738.3991 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% FLEQQNQVLQTK 95.00% 4.53 0.0537 0 738.3992 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% FLEQQNQVLQTK 95.00% 3.55 0.209 0 738.3998 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% FLEQQNQVLQTK 95.00% 4.46 0.106 0 738.3999 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% AEAESLYQSKYEELQITAGR 95.00% 4.6 0.415 3.15 763.0504 2,286.13 2,286.13 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% AEAESLYQSKYEELQITAGR 95.00% 4.84 0.347 3.44 763.051 2,286.13 2,286.13 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SLNNQFASFIDKVR 95.00% 4.21 0.564 2.89 819.935 1,637.85 1,638.86 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SLNNQFASFIDKVR 95.00% 3.66 0.552 2.64 819.9354 1,637.86 1,638.86 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SGGGFSSGSAGIINYQR 95.00% 4.32 0.5 5.21 829.4021 1,656.79 1,657.79 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SGGGFSSGSAGIINYQR 95.00% 4.61 0.443 5.37 829.9035 1,657.79 1,657.79 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SKAEAESLYQSKYEELQITAGR 95.00% 6.67 0.532 4.48 834.7577 2,501.25 2,501.25 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% SKAEAESLYQSKYEELQITAGR 95.00% 6.51 0.541 5.04 834.7588 2,501.25 2,501.25 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% MSGEcAPNVSVSVSTSHTTISGGGSR 95.00% 4.11 0.533 4.77 c5: Carbamidomethyl (+57.02) 856.0436 2,565.11 2,565.17 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% MSGEcAPNVSVSVSTSHTTISGGGSR 95.00% 3.29 0.328 2.96 c5: Carbamidomethyl (+57.02) 856.044 2,565.11 2,565.17 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% MSGEcAPNVSVSVSTSHTTISGGGSR 95.00% 3.41 0.531 1.28 c5: Carbamidomethyl (+57.02) 856.0459 2,565.11 2,565.17 3
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% QISNLQQSISDAEQR 95.00% 4.89 0.531 8.23 858.9319 1,715.85 1,716.85 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% QISNLQQSISDAEQR 95.00% 4.83 0.608 6.29 858.9319 1,715.85 1,716.85 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% QISNLQQSISDAEQR 95.00% 4.56 0.547 6.46 858.9334 1,715.85 1,716.85 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% QISNLQQSISDAEQR 95.00% 3.93 0.585 4.77 858.9337 1,715.85 1,716.85 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% QISNLQQSISDAEQR 95.00% 3.96 0.627 5.13 858.935 1,715.85 1,716.85 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% QISNLQQSISDAEQR 95.00% 4.56 0.547 6.64 859.433 1,716.85 1,716.85 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% QISNLQQSISDAEQR 95.00% 4.31 0.606 3.55 859.4359 1,716.86 1,716.85 2
 SAMPLE 4 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 19 22 74 29.80% FSScGGGGGSFGAGGGFGSR 95.00% 5.64 0.668 7.06 c4: Carbamidomethyl (+57.02) 883.3724 1,764.73 1,765.74 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 2.28 0.367 0 465.2499 1,392.73 1,393.73 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 2.68 0.449 0 465.2504 1,392.73 1,393.73 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 2.74 0.325 0 465.2506 1,392.73 1,393.73 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 2.64 0.4 0 465.2506 1,392.73 1,393.73 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 3.19 0.431 0 465.2511 1,392.73 1,393.73 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 3.03 0.422 0 465.2511 1,392.73 1,393.73 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 2.51 0.298 0 465.2519 1,392.73 1,393.73 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 2.67 0.303 0 465.254 1,392.74 1,393.73 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% IEISELNR 95.00% 2.98 0.159 0 487.2712 972.5267 973.5319 2 K22E_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% IEISELNRVIQR 95.00% 2.09 0.324 1.23 490.6207 1,468.84 1,469.84 3 K22E_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% LLRDYQELmNTK 95.00% 2.54 0.196 0 m9: Oxidation (+15.99) 513.9335 1,538.78 1,539.78 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% NKLNDLEDALQQAK 95.00% 4.76 0.414 3.64 533.9507 1,598.83 1,599.83 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% NKLNDLEDALQQAK 95.00% 4.81 0.429 2.17 533.9516 1,598.83 1,599.83 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDKVR 95.00% 2.58 0.281 0 546.9595 1,637.85 1,638.86 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDKVR 95.00% 2.1 0.315 1.96 546.9595 1,637.85 1,638.86 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDKVR 95.00% 2.31 0.267 0 547.294 1,638.86 1,638.86 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% QISNLQQSISDAEQR 95.00% 3.88 0.489 1.43 572.9568 1,715.85 1,716.85 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% QISNLQQSISDAEQR 95.00% 3.57 0.436 1.62 572.957 1,715.85 1,716.85 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% YEELQITAGR 95.00% 2.93 0.302 2.36 590.3048 1,178.59 1,179.60 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% YEELQITAGR 95.00% 3.28 0.298 1.96 590.3048 1,178.59 1,179.60 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% YEELQITAGR 95.00% 3.44 0.292 2.14 590.3054 1,178.60 1,179.60 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% YEELQITAGR 95.00% 3.65 0.321 2.19 590.3067 1,178.60 1,179.60 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% YEELQITAGR 95.00% 3.46 0.327 2.09 590.307 1,178.60 1,179.60 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% YEELQITAGR 95.00% 3.52 0.295 1.72 590.307 1,178.60 1,179.60 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% YEELQITAGR 95.00% 3.53 0.395 0 590.8073 1,179.60 1,179.60 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIK 95.00% 2.79 0.454 1.31 633.325 1,264.63 1,265.64 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% LALDLEIATYR 95.00% 1.92 0.293 1.8 639.3589 1,276.70 1,277.71 2 VDAC1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% LALDLEIATYR 95.00% 2.79 0.325 0 639.3605 1,276.71 1,277.71 2 VDAC1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% LALDLEIATYR 95.00% 2.45 0.373 2.52 639.3611 1,276.71 1,277.71 2 VDAC1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% LNDLEDALQQAKEDLAR 95.00% 3.8 0.467 2.34 648.3388 1,941.99 1,941.99 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% LNDLEDALQQAKEDLAR 95.00% 3.29 0.388 2.64 648.3391 1,941.99 1,941.99 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 3.15 0.383 2.8 651.8616 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 3.64 0.451 4.03 651.8625 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 3.23 0.44 3.26 651.8626 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 3.58 0.424 3.19 651.8627 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 4.26 0.464 3.82 651.8627 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 3.59 0.443 3.06 651.8628 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 4.04 0.455 3.92 651.8629 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 2.86 0.43 1.85 651.8631 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 4.29 0.466 3.62 651.8633 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 3.85 0.477 3 651.8634 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 3.74 0.421 3.26 651.8636 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 4.62 0.485 3.72 651.8637 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 4.86 0.47 3.02 651.8637 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 4.07 0.448 3.21 651.864 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 4.18 0.436 3.39 651.8642 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 2.98 0.346 0 651.8642 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 3.62 0.487 3.6 651.8643 1,301.71 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 4.05 0.469 3.4 651.8656 1,301.72 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLDLDSIIAEVK 95.00% 3.58 0.453 3.32 652.3665 1,302.72 1,302.72 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% LNDLEDALQQAK 95.00% 2.85 0.246 0 679.3534 1,356.69 1,357.70 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDK 95.00% 3.23 0.498 2.28 692.3498 1,382.68 1,383.69 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDK 95.00% 3.46 0.466 2.33 692.3499 1,382.68 1,383.69 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDK 95.00% 2.94 0.48 1.66 692.3499 1,382.68 1,383.69 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDK 95.00% 3.67 0.526 2.41 692.3507 1,382.69 1,383.69 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDK 95.00% 3.46 0.483 1.6 692.3508 1,382.69 1,383.69 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDK 95.00% 3.76 0.468 4.22 692.3509 1,382.69 1,383.69 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDK 95.00% 3.64 0.429 2.12 692.351 1,382.69 1,383.69 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDK 95.00% 3.7 0.44 1.48 692.3516 1,382.69 1,383.69 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDK 95.00% 3.02 0.37 1.51 692.8506 1,383.69 1,383.69 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDK 95.00% 3.36 0.315 1.18 692.8529 1,383.69 1,383.69 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 3.41 0.361 2.72 697.3706 1,392.73 1,393.73 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 3.26 0.471 2.08 697.3708 1,392.73 1,393.73 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 3.12 0.465 3.7 697.3711 1,392.73 1,393.73 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 3.35 0.414 2.85 697.3726 1,392.73 1,393.73 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 3.27 0.464 3.89 697.3727 1,392.73 1,393.73 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% TNAENEFVTIKK 95.00% 3.15 0.454 3.32 697.3737 1,392.73 1,393.73 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% NKLNDLEDALQQAKEDLAR 95.00% 3.89 0.33 0 729.0529 2,184.14 2,184.13 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% IEISELNRVIQR 95.00% 3.12 0.208 0 735.4286 1,468.84 1,469.84 2 K22E_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% FLEQQNQVLQTK 95.00% 3.36 0.197 0 738.3958 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% FLEQQNQVLQTK 95.00% 4.46 0.0903 0 738.3996 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% AEAESLYQSKYEELQITAGR 95.00% 4.21 0.39 2.4 763.0494 2,286.12 2,286.13 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% AEAESLYQSKYEELQITAGR 95.00% 4.25 0.411 2.01 763.0502 2,286.13 2,286.13 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% NKLNDLEDALQQAK 95.00% 4.98 0.482 4.54 800.4247 1,598.83 1,599.83 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% NKLNDLEDALQQAK 95.00% 4.59 0.425 4.89 800.9243 1,599.83 1,599.83 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDKVR 95.00% 4 0.547 2.7 819.9364 1,637.86 1,638.86 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SLNNQFASFIDKVR 95.00% 4.36 0.567 4.51 819.9369 1,637.86 1,638.86 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SGGGFSSGSAGIINYQR 95.00% 4.26 0.497 5.54 829.4021 1,656.79 1,657.79 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SGGGFSSGSAGIINYQR 95.00% 4.45 0.431 6.02 829.9056 1,657.80 1,657.79 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SKAEAESLYQSKYEELQITAGR 95.00% 6.59 0.537 3.33 834.7565 2,501.25 2,501.25 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% SKAEAESLYQSKYEELQITAGR 95.00% 6.25 0.525 4.96 834.7577 2,501.25 2,501.25 3
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% qISNLQQSISDAEQR 95.00% 0 0 5.82 n-term: Pyro-cmC (-17.03) 850.418 1,698.82 1,699.83 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% QISNLQQSISDAEQR 95.00% 4.06 0.519 3.82 858.9309 1,715.85 1,716.85 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% QISNLQQSISDAEQR 95.00% 4.67 0.549 6.54 858.9315 1,715.85 1,716.85 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% QISNLQQSISDAEQR 95.00% 4.55 0.577 3.23 858.9316 1,715.85 1,716.85 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% QISNLQQSISDAEQR 95.00% 4.47 0.629 4.92 858.9322 1,715.85 1,716.85 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% QISNLQQSISDAEQR 95.00% 4.43 0.559 6.34 858.9326 1,715.85 1,716.85 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% QISNLQQSISDAEQR 95.00% 4.36 0.496 4.09 859.4357 1,716.86 1,716.85 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% QISNLQQSISDAEQR 95.00% 4.44 0.513 3.4 859.4394 1,716.86 1,716.85 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% FSScGGGGGSFGAGGGFGSR 95.00% 5.4 0.66 7.42 c4: Carbamidomethyl (+57.02) 883.3701 1,764.72 1,765.74 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% FSScGGGGGSFGAGGGFGSR 95.00% 5.6 0.649 7.85 c4: Carbamidomethyl (+57.02) 883.8732 1,765.73 1,765.74 2
 SAMPLE 4R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 20 26 92 27.60% LNDLEDALQQAKEDLAR 95.00% 4.53 0.454 3.77 971.5019 1,940.99 1,941.99 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% TNAENEFVTIKK 95.00% 3.41 0.464 1.17 465.25 1,392.73 1,393.73 3
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% TNAENEFVTIKK 95.00% 3.12 0.439 0 465.251 1,392.73 1,393.73 3
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% IEISELNR 95.00% 2.73 0.176 0 487.2689 972.5222 973.5319 2 K22E_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% IEISELNR 95.00% 3.06 0.147 0 487.2694 972.5231 973.5319 2 K22E_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% IEISELNR 95.00% 2.99 0.133 0 487.2699 972.5241 973.5319 2 K22E_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% IEISELNRVIQR 95.00% 1.74 0.256 0 490.619 1,468.83 1,469.84 3 K22E_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% IEISELNRVIQR 95.00% 2.17 0.303 0 490.6192 1,468.83 1,469.84 3 K22E_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% NKLNDLEDALQQAK 95.00% 4.72 0.348 1.7 533.9493 1,598.82 1,599.83 3
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% NKLNDLEDALQQAK 95.00% 2.61 0.392 0 534.2825 1,599.82 1,599.83 3
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% NKLNDLEDALQQAK 95.00% 4.97 0.4 2.04 534.2833 1,599.83 1,599.83 3
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% SLNNQFASFIDKVR 95.00% 2.02 0.269 0 547.293 1,638.86 1,638.86 3
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% DYQELMNTK 95.00% 2.33 0.278 0 571.2626 1,140.51 1,141.52 2 HEMO_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% YEELQITAGR 95.00% 2.6 0.235 3.08 590.3019 1,178.59 1,179.60 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% YEELQITAGR 95.00% 3.36 0.331 0 590.3043 1,178.59 1,179.60 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% YEELQITAGR 95.00% 3.2 0.438 1.38 590.8053 1,179.60 1,179.60 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% TNAENEFVTIK 95.00% 3.26 0.511 3.44 633.3209 1,264.63 1,265.64 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% TNAENEFVTIK 95.00% 3.46 0.532 3.43 633.3214 1,264.63 1,265.64 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% LALDLEIATYR 95.00% 3.36 0.385 2 639.3579 1,276.70 1,277.71 2 VDAC1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% LALDLEIATYR 95.00% 3.07 0.369 1.82 639.3581 1,276.70 1,277.71 2 VDAC1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% LALDLEIATYR 95.00% 1.99 0.356 0 639.66 1,277.30 1,277.71 2 VDAC1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% SLDLDSIIAEVK 95.00% 3.43 0.424 1.89 651.8659 1,301.72 1,302.72 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% SLDLDSIIAEVK 95.00% 3.72 0.494 2.72 651.8678 1,301.72 1,302.72 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% SLNNQFASFIDK 95.00% 3.84 0.446 2 692.3471 1,382.68 1,383.69 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% SLNNQFASFIDK 95.00% 4.07 0.512 1.4 692.3482 1,382.68 1,383.69 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% SLNNQFASFIDK 95.00% 2.37 0.402 0 692.3485 1,382.68 1,383.69 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% SLNNQFASFIDK 95.00% 3.2 0.234 1.15 692.3607 1,382.71 1,383.69 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% SLNNQFASFIDK 95.00% 3.89 0.42 1.52 692.3619 1,382.71 1,383.69 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% SLNNQFASFIDK 95.00% 3.23 0.417 1.74 692.8471 1,383.68 1,383.69 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% FLEQQNQVLQTK 95.00% 4.26 0.0842 0 738.3942 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% FLEQQNQVLQTK 95.00% 3.14 0.162 0 738.3957 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% FLEQQNQVLQTK 95.00% 3.57 0.154 0 738.3961 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% FLEQQNQVLQTK 95.00% 4.42 0.102 0 738.3964 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% FLEQQNQVLQTK 95.00% 4.53 0.0572 0 738.3965 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% FLEQQNQVLQTK 95.00% 3.79 0.137 0 738.3983 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% FLEQQNQVLQTK 95.00% 3.89 0.187 0 738.8974 1,475.78 1,475.79 2 K22E_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% NKLNDLEDALQQAK 95.00% 4.77 0.472 4.2 800.4226 1,598.83 1,599.83 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% SGGGFSSGSAGIINYQR 95.00% 4.08 0.46 4.44 829.3999 1,656.78 1,657.79 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% SGGGFSSGSAGIINYQR 95.00% 3.34 0.468 3.59 829.4003 1,656.78 1,657.79 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% QISNLQQSISDAEQR 95.00% 4.49 0.617 5.06 858.9314 1,715.85 1,716.85 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% QISNLQQSISDAEQR 95.00% 4.81 0.56 6.14 859.4315 1,716.85 1,716.85 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% FSScGGGGGSFGAGGGFGSR 95.00% 5.42 0.639 6.28 c4: Carbamidomethyl (+57.02) 883.3697 1,764.72 1,765.74 2
 SAMPLE 1 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 15 16 42 24.50% FSScGGGGGSFGAGGGFGSR 95.00% 5.55 0.647 6.51 c4: Carbamidomethyl (+57.02) 883.3698 1,764.72 1,765.74 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% TNAENEFVTIKK 95.00% 2.72 0.319 0 465.2505 1,392.73 1,393.73 3
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% TNAENEFVTIKK 95.00% 3.24 0.344 0 465.2513 1,392.73 1,393.73 3
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% IEISELNR 95.00% 3.04 0.165 0 487.2687 972.5218 973.5319 2 K22E_HUMAN
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% IEISELNR 95.00% 3.05 0.141 0 487.2702 972.5248 973.5319 2 K22E_HUMAN
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% NKLNDLEDALQQAK 95.00% 4.4 0.4 1.62 533.9482 1,598.82 1,599.83 3
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% NKLNDLEDALQQAK 95.00% 4.05 0.42 1.57 533.9493 1,598.82 1,599.83 3
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLNNQFASFIDKVR 95.00% 2.44 0.421 0 546.9679 1,637.88 1,638.86 3
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLNNQFASFIDKVR 95.00% 2.3 0.245 1.17 546.9686 1,637.88 1,638.86 3
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% YEELQITAGR 95.00% 2.48 0.309 2.49 590.3018 1,178.59 1,179.60 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% YEELQITAGR 95.00% 2.58 0.299 1.42 590.3025 1,178.59 1,179.60 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% YEELQITAGR 95.00% 3.36 0.239 1.54 590.3034 1,178.59 1,179.60 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% YEELQITAGR 95.00% 3.34 0.306 1.33 590.3048 1,178.59 1,179.60 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% YEELQITAGR 95.00% 3.02 0.281 0 590.3049 1,178.59 1,179.60 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% YEELQITAGR 95.00% 2.64 0.313 2.01 590.3053 1,178.59 1,179.60 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% TNAENEFVTIK 95.00% 2.79 0.397 1.41 633.3183 1,264.62 1,265.64 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% TNAENEFVTIK 95.00% 3.11 0.489 2.6 633.3193 1,264.62 1,265.64 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% LALDLEIATYR 95.00% 3.4 0.346 0 639.3593 1,276.70 1,277.71 2 VDAC1_HUMAN
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% LALDLEIATYR 95.00% 2.95 0.334 0 639.3594 1,276.70 1,277.71 2 VDAC1_HUMAN
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 2.32 0.391 3.41 651.3115 1,300.61 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 4.05 0.399 3.72 651.8605 1,301.71 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 4.41 0.479 3.51 651.8606 1,301.71 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 4.07 0.484 3.4 651.8606 1,301.71 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 3.81 0.48 3.68 651.8609 1,301.71 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 4.07 0.475 3.4 651.8609 1,301.71 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 4.35 0.456 3.33 651.8611 1,301.71 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 3.69 0.415 4.49 651.8612 1,301.71 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 3.41 0.485 4.25 651.8612 1,301.71 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 4.05 0.478 3.18 651.8614 1,301.71 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 3.65 0.441 2.7 651.8616 1,301.71 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 4.43 0.498 3.62 651.8617 1,301.71 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 3.71 0.459 3.59 651.8623 1,301.71 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 3.72 0.494 3.16 651.8678 1,301.72 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 1.99 0.261 1.38 651.8722 1,301.73 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLDLDSIIAEVK 95.00% 3.77 0.505 3.89 651.8746 1,301.73 1,302.72 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% LNDLEDALQQAK 95.00% 4.13 0.391 2.54 679.3519 1,356.69 1,357.70 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% LNDLEDALQQAK 95.00% 4.13 0.406 2.38 679.3529 1,356.69 1,357.70 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLNNQFASFIDK 95.00% 3.77 0.518 1.7 692.3468 1,382.68 1,383.69 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLNNQFASFIDK 95.00% 3.59 0.485 1.66 692.3485 1,382.68 1,383.69 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLNNQFASFIDK 95.00% 3.94 0.439 2.31 692.3488 1,382.68 1,383.69 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLNNQFASFIDK 95.00% 2.33 0.14 1.52 692.3616 1,382.71 1,383.69 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLNNQFASFIDK 95.00% 2.82 0.272 0 692.3617 1,382.71 1,383.69 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% SLNNQFASFIDK 95.00% 3.79 0.449 2.57 692.8496 1,383.68 1,383.69 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% WELLQQVDTSTR 95.00% 4.35 0.406 3.8 738.3766 1,474.74 1,475.75 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% WELLQQVDTSTR 95.00% 4.09 0.444 4.18 738.3781 1,474.74 1,475.75 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% FLEQQNQVLQTK 95.00% 4.05 0.105 0 738.3933 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% FLEQQNQVLQTK 95.00% 3.83 0.159 0 738.3946 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% FLEQQNQVLQTK 95.00% 4.14 0.105 0 738.3958 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% FLEQQNQVLQTK 95.00% 4.6 0.0627 0 738.3964 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% FLEQQNQVLQTK 95.00% 4.37 0.0564 0 738.4053 1,474.80 1,475.79 2 K22E_HUMAN
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% NKLNDLEDALQQAK 95.00% 3.94 0.462 4.46 800.4185 1,598.82 1,599.83 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% NKLNDLEDALQQAK 95.00% 4.34 0.508 3.57 800.4243 1,598.83 1,599.83 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% QISNLQQSISDAEQR 95.00% 4.03 0.512 3.39 858.9275 1,715.84 1,716.85 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% QISNLQQSISDAEQR 95.00% 4.2 0.51 3.92 858.9298 1,715.84 1,716.85 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% FSScGGGGGSFGAGGGFGSR 95.00% 5.15 0.647 6.02 c4: Carbamidomethyl (+57.02) 883.3706 1,764.73 1,765.74 2
 SAMPLE 1R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 14 15 55 21.70% FSScGGGGGSFGAGGGFGSR 95.00% 5.24 0.614 6.34 c4: Carbamidomethyl (+57.02) 883.8737 1,765.73 1,765.74 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIKK 95.00% 2.65 0.357 0 465.2482 1,392.72 1,393.73 3
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIKK 95.00% 3.41 0.398 0 465.2491 1,392.72 1,393.73 3
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIKK 95.00% 2.69 0.423 0 465.2495 1,392.72 1,393.73 3
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIKK 95.00% 2.78 0.326 0 465.2501 1,392.73 1,393.73 3
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIKK 95.00% 3.11 0.481 1.23 465.251 1,392.73 1,393.73 3
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIKK 95.00% 3.46 0.431 0 465.2513 1,392.73 1,393.73 3
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIKK 95.00% 2.85 0.401 0 465.5827 1,393.72 1,393.73 3
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% IEISELNR 95.00% 2.92 0.113 0 487.2678 972.5199 973.5319 2 K22E_HUMAN
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% IEISELNR 95.00% 2.86 0.132 0 487.2687 972.5218 973.5319 2 K22E_HUMAN
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% YEELQITAGR 95.00% 2.72 0.323 1.92 590.3025 1,178.59 1,179.60 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% YEELQITAGR 95.00% 3.66 0.275 2.3 590.303 1,178.59 1,179.60 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% YEELQITAGR 95.00% 3.53 0.31 1.52 590.3032 1,178.59 1,179.60 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% YEELQITAGR 95.00% 3.52 0.31 2 590.304 1,178.59 1,179.60 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% YEELQITAGR 95.00% 2.54 0.337 1.89 590.3042 1,178.59 1,179.60 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% YEELQITAGR 95.00% 3.32 0.289 1.8 590.3049 1,178.59 1,179.60 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIK 95.00% 2.94 0.449 3.07 633.3197 1,264.62 1,265.64 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIK 95.00% 3.5 0.491 3.33 633.3209 1,264.63 1,265.64 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIK 95.00% 3.15 0.439 1.55 633.3211 1,264.63 1,265.64 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIK 95.00% 1.76 0.245 1.46 633.3216 1,264.63 1,265.64 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIK 95.00% 3.32 0.506 3 633.3219 1,264.63 1,265.64 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% NSKIEISELNR 95.00% 2.64 0.374 0 652.3537 1,302.69 1,302.70 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% LNDLEDALQQAK 95.00% 4.38 0.399 2.05 679.3502 1,356.68 1,357.70 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% LNDLEDALQQAK 95.00% 4.16 0.415 2 679.3502 1,356.68 1,357.70 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% LNDLEDALQQAK 95.00% 2.56 0.306 1.72 679.3524 1,356.69 1,357.70 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% SLNNQFASFIDK 95.00% 3.74 0.465 1.23 692.3446 1,382.67 1,383.69 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% SLNNQFASFIDK 95.00% 2.98 0.252 1.42 692.347 1,382.68 1,383.69 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% SLNNQFASFIDK 95.00% 4.17 0.527 0 692.3474 1,382.68 1,383.69 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% SLNNQFASFIDK 95.00% 3.89 0.486 0 692.3478 1,382.68 1,383.69 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% SLNNQFASFIDK 95.00% 3.02 0.331 1.33 692.3482 1,382.68 1,383.69 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% SLNNQFASFIDK 95.00% 3.67 0.388 0 692.3485 1,382.68 1,383.69 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% SLNNQFASFIDK 95.00% 3.33 0.335 1.64 692.3496 1,382.68 1,383.69 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIKK 95.00% 3.38 0.443 3 697.3709 1,392.73 1,393.73 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% TNAENEFVTIKK 95.00% 3.21 0.388 3.92 697.372 1,392.73 1,393.73 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FLEQQNQVLQTK 95.00% 3.11 0.182 0 738.3925 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FLEQQNQVLQTK 95.00% 3.91 0.105 0 738.3941 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FLEQQNQVLQTK 95.00% 4.63 0.0532 0 738.3946 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FLEQQNQVLQTK 95.00% 4.16 0.0894 0 738.3948 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FLEQQNQVLQTK 95.00% 4.42 0.0748 0 738.395 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FLEQQNQVLQTK 95.00% 4.36 0.0705 0 738.3959 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FLEQQNQVLQTK 95.00% 4.56 0.0673 0 738.3959 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FLEQQNQVLQTK 95.00% 3.51 0.205 0 738.3961 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FLEQQNQVLQTK 95.00% 3.75 0.162 0 738.3965 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% LLRDYQELMNTK 95.00% 3.19 0.301 0 762.4013 1,522.79 1,523.79 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% QISNLQQSISDAEQR 95.00% 4.89 0.566 5.35 858.9295 1,715.84 1,716.85 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% QISNLQQSISDAEQR 95.00% 4.98 0.548 4.77 858.93 1,715.84 1,716.85 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FSScGGGGGSFGAGGGFGSR 95.00% 5.38 0.675 7.34 c4: Carbamidomethyl (+57.02) 883.3689 1,764.72 1,765.74 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FSScGGGGGSFGAGGGFGSR 95.00% 5.28 0.647 5.11 c4: Carbamidomethyl (+57.02) 883.3696 1,764.72 1,765.74 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FSScGGGGGSFGAGGGFGSR 95.00% 4.71 0.597 5.55 c4: Carbamidomethyl (+57.02) 883.3707 1,764.73 1,765.74 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% FSScGGGGGSFGAGGGFGSR 95.00% 5.48 0.635 5.23 c4: Carbamidomethyl (+57.02) 883.3715 1,764.73 1,765.74 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 95.00% 5.57 0.716 8.42 1,192.98 2,383.94 2,383.95 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 95.00% 5.91 0.73 9.41 1,192.98 2,383.94 2,383.95 2
 SAMPLE 2 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 12 13 52 22.80% GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 95.00% 5.86 0.733 8.44 1,192.98 2,383.95 2,383.95 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% TNAENEFVTIKK 95.00% 2.37 0.181 0 465.2486 1,392.72 1,393.73 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% TNAENEFVTIKK 95.00% 2.9 0.405 0 465.2495 1,392.72 1,393.73 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% TNAENEFVTIKK 95.00% 2.6 0.354 0 465.2496 1,392.73 1,393.73 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% TNAENEFVTIKK 95.00% 2.31 0.25 0 465.2505 1,392.73 1,393.73 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% TNAENEFVTIKK 95.00% 2.55 0.312 0 465.2506 1,392.73 1,393.73 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% TNAENEFVTIKK 95.00% 2.64 0.363 0 465.2521 1,392.73 1,393.73 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% IEISELNR 95.00% 2.58 0.148 0 487.2682 972.5207 973.5319 2 K22E_HUMAN
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% NKLNDLEDALQQAK 95.00% 4.05 0.331 1.57 533.9483 1,598.82 1,599.83 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% NKLNDLEDALQQAK 95.00% 4.33 0.43 1.32 533.949 1,598.82 1,599.83 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLNNQFASFIDKVR 95.00% 2.45 0.333 0 546.9576 1,637.85 1,638.86 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLNNQFASFIDKVR 95.00% 2.56 0.385 1.19 547.2914 1,638.85 1,638.86 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% YEELQITAGR 95.00% 3.07 0.357 1.62 590.3022 1,178.59 1,179.60 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% YEELQITAGR 95.00% 2.99 0.29 2.07 590.3031 1,178.59 1,179.60 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% YEELQITAGR 95.00% 2.82 0.29 2.05 590.3032 1,178.59 1,179.60 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% YEELQITAGR 95.00% 3.63 0.319 2.12 590.3041 1,178.59 1,179.60 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% YEELQITAGR 95.00% 3.33 0.338 2.05 590.3041 1,178.59 1,179.60 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% YEELQITAGR 95.00% 3.34 0.336 1.18 590.3045 1,178.59 1,179.60 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% TNAENEFVTIK 95.00% 3.14 0.517 2.57 633.3207 1,264.63 1,265.64 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% TNAENEFVTIK 95.00% 2.84 0.419 2.29 633.3212 1,264.63 1,265.64 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% TNAENEFVTIK 95.00% 3.03 0.522 1.89 633.3214 1,264.63 1,265.64 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% TNAENEFVTIK 95.00% 2.71 0.336 2.64 633.3221 1,264.63 1,265.64 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% LALDLEIATYR 95.00% 3.52 0.376 2.3 639.3578 1,276.70 1,277.71 2 VDAC1_HUMAN
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% LALDLEIATYR 95.00% 3.54 0.402 1.7 639.3581 1,276.70 1,277.71 2 VDAC1_HUMAN
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% LNDLEDALQQAKEDLAR 95.00% 3.11 0.433 0 648 1,940.98 1,941.99 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% LNDLEDALQQAKEDLAR 95.00% 2.83 0.325 1.42 648.3362 1,941.99 1,941.99 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% NSKIEISELNR 95.00% 2.52 0.321 1.17 651.8547 1,301.69 1,302.70 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLDLDSIIAEVK 95.00% 4.55 0.463 2.48 651.86 1,301.70 1,302.72 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLDLDSIIAEVK 95.00% 4.56 0.497 3.74 651.8601 1,301.70 1,302.72 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLDLDSIIAEVK 95.00% 3.2 0.457 4.21 651.861 1,301.71 1,302.72 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLDLDSIIAEVK 95.00% 3.74 0.468 3.74 651.8611 1,301.71 1,302.72 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLDLDSIIAEVK 95.00% 4.75 0.482 2.62 651.8614 1,301.71 1,302.72 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLDLDSIIAEVK 95.00% 4.43 0.497 3.08 651.8619 1,301.71 1,302.72 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLDLDSIIAEVK 95.00% 3.13 0.367 2.35 652.3609 1,302.71 1,302.72 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLDLDSIIAEVK 95.00% 2.75 0.494 2.26 652.3651 1,302.71 1,302.72 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLDLDSIIAEVK 95.00% 3.87 0.468 3.12 652.3658 1,302.72 1,302.72 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% LNDLEDALQQAK 95.00% 3.97 0.408 3.44 679.3509 1,356.69 1,357.70 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% LNDLEDALQQAK 95.00% 4.31 0.392 2.57 679.3511 1,356.69 1,357.70 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% LNDLEDALQQAK 95.00% 2.89 0.337 1.19 679.3517 1,356.69 1,357.70 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLNNQFASFIDK 95.00% 2.64 0.312 1.36 692.3441 1,382.67 1,383.69 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLNNQFASFIDK 95.00% 4.1 0.516 2.57 692.3458 1,382.68 1,383.69 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLNNQFASFIDK 95.00% 3.91 0.457 1.52 692.347 1,382.68 1,383.69 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLNNQFASFIDK 95.00% 3.53 0.484 0 692.3477 1,382.68 1,383.69 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLNNQFASFIDK 95.00% 3.14 0.377 0 692.3492 1,382.68 1,383.69 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLNNQFASFIDK 95.00% 3.72 0.492 1.19 692.3492 1,382.68 1,383.69 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLNNQFASFIDK 95.00% 3.27 0.438 1.66 692.3498 1,382.68 1,383.69 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLNNQFASFIDK 95.00% 3.43 0.442 0 692.6999 1,383.38 1,383.69 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLNNQFASFIDK 95.00% 2.91 0.385 1.12 692.7001 1,383.38 1,383.69 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% SLNNQFASFIDK 95.00% 2.92 0.356 0 692.7007 1,383.39 1,383.69 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% TNAENEFVTIKK 95.00% 3.27 0.395 3.96 697.3716 1,392.73 1,393.73 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% TNAENEFVTIKK 95.00% 3.04 0.399 2.85 697.3723 1,392.73 1,393.73 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% NKLNDLEDALQQAKEDLAR 95.00% 4.13 0.393 1.18 729.0463 2,184.12 2,184.13 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% NKLNDLEDALQQAKEDLAR 95.00% 5.15 0.467 1.01 729.0472 2,184.12 2,184.13 3
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% FLEQQNQVLQTK 95.00% 4.12 0.12 0 738.3952 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% FLEQQNQVLQTK 95.00% 4.39 0.0863 0 738.3958 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% FLEQQNQVLQTK 95.00% 3.91 0.133 0 738.3965 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% FLEQQNQVLQTK 95.00% 4.58 0.0533 0 738.3965 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% FLEQQNQVLQTK 95.00% 3.98 0.139 0 738.3972 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% FLEQQNQVLQTK 95.00% 4.33 0.0874 0 738.3974 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% QISNLQQSISDAEQRGENALK 95.00% 2.58 0.339 0 777.3881 2,329.14 2,329.18 3 MYH11_HUMAN
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% QISNLQQSISDAEQR 95.00% 4.6 0.625 5.15 858.93 1,715.84 1,716.85 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% QISNLQQSISDAEQR 95.00% 4.63 0.58 6 858.9329 1,715.85 1,716.85 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 95.00% 5.97 0.716 8.44 1,192.98 2,383.95 2,383.95 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 95.00% 5.78 0.658 10.3 1,192.98 2,383.95 2,383.95 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 95.00% 5.04 0.71 10.3 1,192.98 2,383.95 2,383.95 2
 SAMPLE 2R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 16 17 64 23.80% GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 95.00% 5.39 0.635 9.57 1,192.98 2,383.95 2,383.95 2
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% TNAENEFVTIKK 95.00% 2.78 0.372 0 465.2486 1,392.72 1,393.73 3
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% TNAENEFVTIKK 95.00% 2.39 0.343 0 465.2492 1,392.72 1,393.73 3
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% TNAENEFVTIKK 95.00% 2.88 0.439 0 465.2507 1,392.73 1,393.73 3
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% TNAENEFVTIKK 95.00% 2.99 0.361 0 465.2509 1,392.73 1,393.73 3
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% TNAENEFVTIKK 95.00% 2.67 0.275 0 465.2513 1,392.73 1,393.73 3
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% YEELQITAGR 95.00% 3.32 0.311 2.49 590.3026 1,178.59 1,179.60 2
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% YEELQITAGR 95.00% 3.59 0.318 2.2 590.3031 1,178.59 1,179.60 2
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% YEELQITAGR 95.00% 3.66 0.292 1.28 590.3031 1,178.59 1,179.60 2
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% YEELQITAGR 95.00% 3.24 0.309 1.82 590.3032 1,178.59 1,179.60 2
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% LALDLEIATYR 95.00% 3.35 0.41 1.49 639.3577 1,276.70 1,277.71 2 VDAC1_HUMAN
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% LALDLEIATYR 95.00% 2.54 0.296 1.72 639.3586 1,276.70 1,277.71 2 VDAC1_HUMAN
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% SLNNQFASFIDK 95.00% 2.96 0.462 1.59 692.3484 1,382.68 1,383.69 2
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% SLNNQFASFIDK 95.00% 3.77 0.507 2.16 692.3487 1,382.68 1,383.69 2
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% SLNNQFASFIDK 95.00% 3.98 0.523 1.74 692.349 1,382.68 1,383.69 2
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% FLEQQNQVLQTK 95.00% 4.46 0.125 2.89 738.3939 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% FLEQQNQVLQTK 95.00% 4.29 0.0897 2 738.3946 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% FLEQQNQVLQTK 95.00% 4.47 0.0655 1.7 738.3949 1,474.77 1,475.79 2 K22E_HUMAN
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% FLEQQNQVLQTK 95.00% 4.4 0.0956 1.82 738.3954 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% QISNLQQSISDAEQR 95.00% 3.7 0.554 3.21 858.9314 1,715.85 1,716.85 2
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% FSScGGGGGSFGAGGGFGSR 95.00% 4.46 0.637 8.42 c4: Carbamidomethyl (+57.02) 883.3693 1,764.72 1,765.74 2
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% FSScGGGGGSFGAGGGFGSR 95.00% 4.61 0.584 5.54 c4: Carbamidomethyl (+57.02) 883.3731 1,764.73 1,765.74 2
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% FSScGGGGGSFGAGGGFGSR 95.00% 5.17 0.645 8.57 c4: Carbamidomethyl (+57.02) 883.87 1,765.72 1,765.74 2
 SAMPLE 3 Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 8 8 23 19.10% GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 95.00% 5.94 0.717 9.48 1,192.98 2,383.95 2,383.95 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% TNAENEFVTIKK 95.00% 2.74 0.321 0 465.2489 1,392.72 1,393.73 3
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% TNAENEFVTIKK 95.00% 3.04 0.321 0 465.2489 1,392.72 1,393.73 3
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% TNAENEFVTIKK 95.00% 2.53 0.394 0 465.2497 1,392.73 1,393.73 3
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% TNAENEFVTIKK 95.00% 2.82 0.31 0 465.251 1,392.73 1,393.73 3
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% YEELQITAGR 95.00% 2.81 0.33 1.46 590.303 1,178.59 1,179.60 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% YEELQITAGR 95.00% 2.97 0.327 2.34 590.3031 1,178.59 1,179.60 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% YEELQITAGR 95.00% 3.54 0.314 0 590.3037 1,178.59 1,179.60 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% YEELQITAGR 95.00% 3.56 0.293 0 590.3038 1,178.59 1,179.60 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% LALDLEIATYR 95.00% 2.57 0.375 1.25 639.3545 1,276.69 1,277.71 2 VDAC1_HUMAN
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% LALDLEIATYR 95.00% 3.26 0.401 1.16 639.3576 1,276.70 1,277.71 2 VDAC1_HUMAN
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% SLDLDSIIAEVK 95.00% 2.07 0.317 0 651.8604 1,301.71 1,302.72 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% SLDLDSIIAEVK 95.00% 4.62 0.479 3.59 651.8606 1,301.71 1,302.72 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% SLDLDSIIAEVK 95.00% 3.91 0.478 2.77 651.8608 1,301.71 1,302.72 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% SLDLDSIIAEVK 95.00% 4.15 0.474 3.2 651.8623 1,301.71 1,302.72 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% SLDLDSIIAEVK 95.00% 3.9 0.465 3.41 652.3654 1,302.72 1,302.72 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% SLNNQFASFIDK 95.00% 3.49 0.471 2.37 692.3471 1,382.68 1,383.69 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% SLNNQFASFIDK 95.00% 3.56 0.489 1.74 692.3474 1,382.68 1,383.69 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% SLNNQFASFIDK 95.00% 3.1 0.451 0 692.3484 1,382.68 1,383.69 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% SLNNQFASFIDK 95.00% 2.99 0.304 1.34 692.3486 1,382.68 1,383.69 2
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% FLEQQNQVLQTK 95.00% 3.54 0.169 0 738.3963 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% FLEQQNQVLQTK 95.00% 2.99 0.21 0 738.3971 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% FLEQQNQVLQTK 95.00% 3.86 0.0968 0 738.3979 1,474.78 1,475.79 2 K22E_HUMAN
 SAMPLE 3R Keratin, type II cytoskeletal 1  KRT1  K2C1_HUMAN 66,001.20 100.00% 7 7 23 13.00% QISNLQQSISDAEQR 95.00% 2.48 0.449 1.25 858.9306 1,715.85 1,716.85 2
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% IEISELNR 95.00% 2.95 0.141 0 487.2703 972.5249 973.5319 2 K2C1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% IEISELNR 95.00% 3.07 0.16 0 487.2705 972.5254 973.5319 2 K2C1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% IEISELNR 95.00% 3.12 0.146 0 487.2708 972.5259 973.5319 2 K2C1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% IEISELNR 95.00% 2.86 0.139 0 487.271 972.5263 973.5319 2 K2C1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% IEISELNRVIQR 95.00% 2.4 0.354 0 490.6204 1,468.84 1,469.84 3 K2C1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% YLDGLTAER 95.00% 2.68 0.28 1.54 519.2671 1,036.52 1,037.53 2
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% YLDGLTAER 95.00% 2.78 0.279 1.47 519.2684 1,036.52 1,037.53 2
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% FASFIDKVR 95.00% 2.38 0.329 0 541.8042 1,081.59 1,082.60 2 ,K2C5_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% FASFIDKVR 95.00% 2.73 0.333 1.72 541.805 1,081.59 1,082.60 2 ,K2C5_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% TAAENDFVTLK 95.00% 2.53 0.366 1.18 605.316 1,208.62 1,208.62 2
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% FLEQQNQVLQTK 95.00% 2.41 0.266 0 738.3498 1,474.68 1,475.79 2 K2C1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% FLEQQNQVLQTK 95.00% 4.31 0.119 0 738.3936 1,474.77 1,475.79 2 K2C1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% FLEQQNQVLQTK 95.00% 4.2 0.0741 0 738.3954 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% FLEQQNQVLQTK 95.00% 3.49 0.159 0 738.3991 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% FLEQQNQVLQTK 95.00% 4.53 0.0537 0 738.3992 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% FLEQQNQVLQTK 95.00% 3.55 0.209 0 738.3998 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.80% 2 2 3 8.22% FLEQQNQVLQTK 95.00% 4.46 0.106 0 738.3999 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% IEISELNR 95.00% 2.98 0.159 0 487.2712 972.5267 973.5319 2 K2C1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% IEISELNRVIQR 95.00% 2.09 0.324 1.23 490.6207 1,468.84 1,469.84 3 K2C1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% YLDGLTAER 95.00% 3 0.317 1.96 519.2682 1,036.52 1,037.53 2
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% TLNNKFASFIDKVR 95.00% 4.11 0.296 0 551.9769 1,652.91 1,652.91 3 ,K2C5_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% TLNNKFASFIDKVR 95.00% 4.29 0.281 0 551.9776 1,652.91 1,652.91 3 ,K2C5_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% NLDLDSIIAEVK 94.60% 2.46 0.191 0 665.3665 1,328.72 1,329.73 2 DYHC1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% NLDLDSIIAEVK 95.00% 2.76 0.194 1.77 665.3675 1,328.72 1,329.73 2 DYHC1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% NLDLDSIIAEVK 95.00% 3.01 0.444 3.35 665.3681 1,328.72 1,329.73 2 DYHC1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% NLDLDSIIAEVK 95.00% 2.29 0.327 1.89 665.3682 1,328.72 1,329.73 2 DYHC1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% NLDLDSIIAEVK 95.00% 3.78 0.378 2.89 665.3684 1,328.72 1,329.73 2 DYHC1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% NLDLDSIIAEVK 95.00% 2.22 0.307 0 665.3684 1,328.72 1,329.73 2 DYHC1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% NLDLDSIIAEVK 95.00% 3.05 0.421 2.13 665.3684 1,328.72 1,329.73 2 DYHC1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% NLDLDSIIAEVK 95.00% 3.68 0.419 2.48 665.3688 1,328.72 1,329.73 2 DYHC1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% NLDLDSIIAEVK 95.00% 1.95 0.283 1.64 665.369 1,328.72 1,329.73 2 DYHC1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% NLDLDSIIAEVK 95.00% 3.18 0.417 2.48 665.3691 1,328.72 1,329.73 2 DYHC1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% IEISELNRVIQR 95.00% 3.12 0.208 0 735.4286 1,468.84 1,469.84 2 K2C1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% FLEQQNQVLQTK 95.00% 3.36 0.197 0 738.3958 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% FLEQQNQVLQTK 95.00% 4.46 0.0903 0 738.3996 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 99.90% 2 2 2 13.50% QSGSRGGSGGGGSISGGGYGSGGGSGGR 95.00% 1.57 0.117 3.38 753.1142 2,256.32 2,256.99 3
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% IEISELNR 95.00% 2.73 0.176 0 487.2689 972.5222 973.5319 2 K2C1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% IEISELNR 95.00% 3.06 0.147 0 487.2694 972.5231 973.5319 2 K2C1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% IEISELNR 95.00% 2.99 0.133 0 487.2699 972.5241 973.5319 2 K2C1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% IEISELNRVIQR 95.00% 1.74 0.256 0 490.619 1,468.83 1,469.84 3 K2C1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% IEISELNRVIQR 95.00% 2.17 0.303 0 490.6192 1,468.83 1,469.84 3 K2C1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% YLDGLTAER 95.00% 2.92 0.385 1.96 519.2657 1,036.52 1,037.53 2
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% TAAENDFVTLK 95.00% 2.45 0.408 0 604.8097 1,207.60 1,208.62 2
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% FLEQQNQVLQTK 95.00% 4.26 0.0842 0 738.3942 1,474.77 1,475.79 2 K2C1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% FLEQQNQVLQTK 95.00% 3.14 0.162 0 738.3957 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% FLEQQNQVLQTK 95.00% 3.57 0.154 0 738.3961 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% FLEQQNQVLQTK 95.00% 4.42 0.102 0 738.3964 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% FLEQQNQVLQTK 95.00% 4.53 0.0572 0 738.3965 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% FLEQQNQVLQTK 95.00% 3.79 0.137 0 738.3983 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 1 Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 6.82% FLEQQNQVLQTK 95.00% 3.89 0.187 0 738.8974 1,475.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 3R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 7.29% YGSGGGSKGGSISGGGYGSGGGK 94.60% 1.8 0.22 1.09 630.9656 1,889.87 1,890.86 3
 SAMPLE 3R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 7.29% VDLLNQEIEFLK 95.00% 2.99 0.231 3.72 730.9019 1,459.79 1,460.80 2
 SAMPLE 3R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 7.29% FLEQQNQVLQTK 95.00% 3.54 0.169 0 738.3963 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 3R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 7.29% FLEQQNQVLQTK 95.00% 2.99 0.21 0 738.3971 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 3R Keratin, type II cytoskeletal 2 epidermal  KRT2  K22E_HUMAN 65,848.40 100.00% 2 2 2 7.29% FLEQQNQVLQTK 95.00% 3.86 0.0968 0 738.3979 1,474.78 1,475.79 2 K2C1_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 3 3 6 5.93% FASFIDKVR 95.00% 2.38 0.329 0 541.8042 1,081.59 1,082.60 2 ,K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 3 3 6 5.93% FASFIDKVR 95.00% 2.73 0.333 1.72 541.805 1,081.59 1,082.60 2 ,K22E_HUMAN
 SAMPLE 4 Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 3 3 6 5.93% ISISTSGGSFR 95.00% 3.03 0.431 3.38 556.2909 1,110.57 1,111.57 2
 SAMPLE 4 Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 3 3 6 5.93% ISISTSGGSFR 95.00% 2.88 0.448 3.4 556.2916 1,110.57 1,111.57 2
 SAMPLE 4 Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 3 3 6 5.93% VLDTKWTLLQEQGTK 95.00% 3.98 0.415 1.85 587.3257 1,758.95 1,759.96 3
 SAMPLE 4 Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 3 3 6 5.93% VLDTKWTLLQEQGTK 95.00% 4.1 0.479 1.89 587.3273 1,758.96 1,759.96 3
 SAMPLE 4 Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 3 3 6 5.93% WTLLQEQGTK 95.00% 2.94 0.393 1.35 602.3224 1,202.63 1,203.64 2
 SAMPLE 4 Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 3 3 6 5.93% WTLLQEQGTK 95.00% 2.9 0.35 1.82 602.3246 1,202.63 1,203.64 2
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% TLNNKFASFIDKVR 95.00% 4.11 0.296 0 551.9769 1,652.91 1,652.91 3 ,K22E_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% TLNNKFASFIDKVR 95.00% 4.29 0.281 0 551.9776 1,652.91 1,652.91 3 ,K22E_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% ISISTSGGSFR 95.00% 2.94 0.388 3.21 556.2905 1,110.57 1,111.57 2
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% ISISTSGGSFR 95.00% 2.82 0.412 2.7 556.2914 1,110.57 1,111.57 2
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% VLDTKWTLLQEQGTK 95.00% 4.32 0.373 1 587.6606 1,759.96 1,759.96 3
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% VLDTKWTLLQEQGTK 95.00% 3.82 0.386 1.09 587.6608 1,759.96 1,759.96 3
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% NLDLDSIIAEVK 94.60% 2.46 0.191 0 665.3665 1,328.72 1,329.73 2 K22E_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% NLDLDSIIAEVK 95.00% 2.76 0.194 1.77 665.3675 1,328.72 1,329.73 2 K22E_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% NLDLDSIIAEVK 95.00% 3.01 0.444 3.35 665.3681 1,328.72 1,329.73 2 K22E_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% NLDLDSIIAEVK 95.00% 2.29 0.327 1.89 665.3682 1,328.72 1,329.73 2 K22E_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% NLDLDSIIAEVK 95.00% 3.78 0.378 2.89 665.3684 1,328.72 1,329.73 2 K22E_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% NLDLDSIIAEVK 95.00% 2.22 0.307 0 665.3684 1,328.72 1,329.73 2 K22E_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% NLDLDSIIAEVK 95.00% 3.05 0.421 2.13 665.3684 1,328.72 1,329.73 2 K22E_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% NLDLDSIIAEVK 95.00% 3.68 0.419 2.48 665.3688 1,328.72 1,329.73 2 K22E_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% NLDLDSIIAEVK 95.00% 1.95 0.283 1.64 665.369 1,328.72 1,329.73 2 K22E_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 100.00% 2 2 4 8.81% NLDLDSIIAEVK 95.00% 3.18 0.417 2.48 665.3691 1,328.72 1,329.73 2 K22E_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 99.80% 2 2 2 3.39% LAELEEALQK 95.00% 3.3 0.386 3.03 572.3152 1,142.61 1,143.63 2
 SAMPLE 2 Keratin, type II cytoskeletal 5  KRT5  K2C5_HUMAN 62,361.60 99.80% 2 2 2 3.39% WTLLQEQGTK 95.00% 2.73 0.328 1.15 602.3228 1,202.63 1,203.64 2
 SAMPLE 1R Kinectin  KTN1  KTN1_HUMAN 156,258.20 100.00% 2 2 3 2.06% QNDQVSFASLVEELKK 95.00% 2.73 0.337 0 612.322 1,833.94 1,834.96 3
 SAMPLE 1R Kinectin  KTN1  KTN1_HUMAN 156,258.20 100.00% 2 2 3 2.06% SVEELLEAELLK 95.00% 3.32 0.481 0 686.8815 1,371.75 1,372.76 2
 SAMPLE 1R Kinectin  KTN1  KTN1_HUMAN 156,258.20 100.00% 2 2 3 2.06% SVEELLEAELLK 95.00% 2.81 0.396 0 686.8817 1,371.75 1,372.76 2
 SAMPLE 4 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 3 3 10 5.05% ALQELQAAQAR 95.00% 3.06 0.317 2 599.8274 1,197.64 1,198.65 2
 SAMPLE 4 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 3 3 10 5.05% ALQELQAAQAR 95.00% 3.53 0.382 2 599.8306 1,197.65 1,198.65 2
 SAMPLE 4 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 3 3 10 5.05% ALQELQAAQAR 95.00% 3.7 0.428 1.92 599.8321 1,197.65 1,198.65 2
 SAMPLE 4 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 3 3 10 5.05% ALQELQAAQAR 95.00% 3.54 0.385 1.85 599.8331 1,197.65 1,198.65 2
 SAMPLE 4 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 3 3 10 5.05% ALQELQAAQAR 95.00% 2.7 0.293 2.57 599.8333 1,197.65 1,198.65 2
 SAMPLE 4 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 3 3 10 5.05% ALQELQAAQAR 95.00% 3.1 0.369 2.55 599.8336 1,197.65 1,198.65 2
 SAMPLE 4 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 3 3 10 5.05% ALQELQAAQAR 95.00% 3.17 0.362 0 599.8336 1,197.65 1,198.65 2
 SAMPLE 4 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 3 3 10 5.05% YLDNPNALTER 95.00% 1.94 0.354 2.89 653.8316 1,305.65 1,305.64 2
 SAMPLE 4 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 3 3 10 5.05% YLDNPNALTER 95.00% 2.71 0.362 0 654.0085 1,306.00 1,305.64 2
 SAMPLE 4 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 3 3 10 5.05% QAASQESEEAGGTGGPPAGVR 95.00% 5.53 0.63 6.11 978.9594 1,955.90 1,955.91 2
 SAMPLE 4R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 99.80% 2 2 6 4.00% ALQELQAAQAR 95.00% 3.26 0.364 2.31 599.8308 1,197.65 1,198.65 2
 SAMPLE 4R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 99.80% 2 2 6 4.00% ALQELQAAQAR 95.00% 3 0.311 1.35 599.8317 1,197.65 1,198.65 2
 SAMPLE 4R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 99.80% 2 2 6 4.00% ALQELQAAQAR 95.00% 3.61 0.437 1.82 599.8324 1,197.65 1,198.65 2
 SAMPLE 4R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 99.80% 2 2 6 4.00% ALQELQAAQAR 95.00% 3.43 0.359 2.27 599.8325 1,197.65 1,198.65 2
 SAMPLE 4R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 99.80% 2 2 6 4.00% ALQELQAAQAR 95.00% 3.38 0.381 1.25 599.8333 1,197.65 1,198.65 2
 SAMPLE 4R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 99.80% 2 2 6 4.00% MNIKcSFAPMSDDESPTSSSAEE 95.00% 2.28 0.287 0 c5: Carbamidomethyl (+57.02) 840.9398 2,519.80 2,520.02 3
 SAMPLE 1R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 2 2 3 3.17% VAYTTVLQEWLR 95.00% 3.07 0.434 2 739.9044 1,477.79 1,478.80 2
 SAMPLE 1R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 2 2 3 3.17% VAYTTVLQEWLR 95.00% 2.85 0.255 1.18 739.9052 1,477.79 1,478.80 2
 SAMPLE 1R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 2 2 3 3.17% AGYSPIMLTALATLK 95.00% 2.69 0.385 2.34 775.4386 1,548.86 1,549.87 2
 SAMPLE 2 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 99.80% 2 2 3 3.17% ALQELQAAQAR 95.00% 3.44 0.375 1.92 599.8299 1,197.64 1,198.65 2
 SAMPLE 2 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 99.80% 2 2 3 3.17% ALQELQAAQAR 95.00% 3.78 0.383 1.96 599.8307 1,197.65 1,198.65 2
 SAMPLE 2 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 99.80% 2 2 3 3.17% EVEVVASTAAGAPAQR 95.00% 2 0.203 1.17 778.4062 1,554.80 1,555.81 2
 SAMPLE 2R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 6 11 9.75% ALQELQAAQAR 95.00% 3.54 0.384 1.8 599.83 1,197.64 1,198.65 2
 SAMPLE 2R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 6 11 9.75% ALQELQAAQAR 95.00% 3.44 0.347 1.62 599.8302 1,197.64 1,198.65 2
 SAMPLE 2R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 6 11 9.75% YLDNPNALTER 95.00% 2.62 0.346 1.74 653.3268 1,304.64 1,305.64 2
 SAMPLE 2R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 6 11 9.75% VAYTTVLQEWLR 95.00% 3.51 0.426 2.85 739.9033 1,477.79 1,478.80 2
 SAMPLE 2R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 6 11 9.75% VAYTTVLQEWLR 95.00% 3.99 0.431 3.17 739.9039 1,477.79 1,478.80 2
 SAMPLE 2R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 6 11 9.75% AGYSPIMLTALATLK 95.00% 4.79 0.542 2.38 775.4372 1,548.86 1,549.87 2
 SAMPLE 2R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 6 11 9.75% AGYSPIMLTALATLK 95.00% 4.85 0.539 4.27 775.4377 1,548.86 1,549.87 2
 SAMPLE 2R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 6 11 9.75% TQDDIETVLQLFR 95.00% 4.35 0.479 3.8 789.4107 1,576.81 1,577.82 2
 SAMPLE 2R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 6 11 9.75% TQDDIETVLQLFR 95.00% 4.82 0.463 4.31 789.9131 1,577.81 1,577.82 2
 SAMPLE 2R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 6 11 9.75% QAASQESEEAGGTGGPPAGVR 95.00% 6.09 0.58 7.25 978.9579 1,955.90 1,955.91 2
 SAMPLE 2R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 6 11 9.75% QAASQESEEAGGTGGPPAGVR 95.00% 6.14 0.62 5.77 978.9602 1,955.90 1,955.91 2
 SAMPLE 3 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 4 4 10 8.11% YLDNPNALTER 95.00% 2.74 0.423 1.33 653.3238 1,304.63 1,305.64 2
 SAMPLE 3 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 4 4 10 8.11% YLDNPNALTER 95.00% 3.09 0.468 1.85 653.3251 1,304.63 1,305.64 2
 SAMPLE 3 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 4 4 10 8.11% YLDNPNALTER 95.00% 2.66 0.458 0 653.3262 1,304.64 1,305.64 2
 SAMPLE 3 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 4 4 10 8.11% YLDNPNALTER 95.00% 2.22 0.347 0 653.3262 1,304.64 1,305.64 2
 SAMPLE 3 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 4 4 10 8.11% ESQHIPTAEGASGSNTEEEIR 95.00% 2.76 0.396 2.26 748.011 2,241.01 2,242.02 3
 SAMPLE 3 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 4 4 10 8.11% EVEVVASTAAGAPAQR 95.00% 2.64 0.369 1.49 778.9121 1,555.81 1,555.81 2
 SAMPLE 3 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 4 4 10 8.11% QAASQESEEAGGTGGPPAGVR 95.00% 6.41 0.599 8.32 978.458 1,954.90 1,955.91 2
 SAMPLE 3 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 4 4 10 8.11% QAASQESEEAGGTGGPPAGVR 95.00% 6.19 0.601 8.66 978.9562 1,955.90 1,955.91 2
 SAMPLE 3 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 4 4 10 8.11% QAASQESEEAGGTGGPPAGVR 95.00% 6.45 0.557 6.64 978.9567 1,955.90 1,955.91 2
 SAMPLE 3 KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 4 4 10 8.11% QAASQESEEAGGTGGPPAGVR 95.00% 6.34 0.579 5.92 978.9569 1,955.90 1,955.91 2
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% ALQELQAAQAR 95.00% 3.81 0.401 1.6 599.8296 1,197.64 1,198.65 2
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% ALQELQAAQAR 95.00% 3.52 0.426 2.18 599.8307 1,197.65 1,198.65 2
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% VPSVAEAPQLRPAGTAAAK 95.00% 2.12 0.182 2.21 612.3452 1,834.01 1,834.02 3
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% QAASQESEEAGGTGGPPAGVR 95.00% 2.17 0.313 0 652.9729 1,955.90 1,955.91 3
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% YLDNPNALTER 95.00% 2.88 0.361 2 653.324 1,304.63 1,305.64 2
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% YLDNPNALTER 95.00% 2.8 0.386 1.89 653.325 1,304.63 1,305.64 2
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% VAYTTVLQEWLR 95.00% 2.88 0.144 2.21 739.9055 1,477.80 1,478.80 2
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% TQDDIETVLQLFR 95.00% 3.2 0.454 3.25 789.4098 1,576.80 1,577.82 2
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% TQDDIETVLQLFR 95.00% 2.57 0.346 2.72 789.4144 1,576.81 1,577.82 2
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% QAASQESEEAGGTGGPPAGVR 95.00% 6.25 0.627 8.3 978.4556 1,954.90 1,955.91 2
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% QAASQESEEAGGTGGPPAGVR 95.00% 6.05 0.597 7.33 978.4569 1,954.90 1,955.91 2
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% QAASQESEEAGGTGGPPAGVR 95.00% 6.04 0.615 7.05 978.9589 1,955.90 1,955.91 2
 SAMPLE 3R KN motif and ankyrin repeat domain-containing protein 2  KANK2  KANK2_HUMAN 91,155.80 100.00% 6 7 13 10.20% QAASQESEEAGGTGGPPAGVR 95.00% 5.78 0.573 7.17 978.9602 1,955.90 1,955.91 2
 SAMPLE 4R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 99.80% 2 2 5 5.43% EVTGIITQGAR 95.00% 2.69 0.258 1.48 572.8209 1,143.63 1,144.63 2
 SAMPLE 4R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 99.80% 2 2 5 5.43% EVTGIITQGAR 95.00% 2.67 0.237 0 572.8222 1,143.63 1,144.63 2
 SAMPLE 4R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 99.80% 2 2 5 5.43% EVTGIITQGAR 95.00% 3.22 0.228 1.7 572.8229 1,143.63 1,144.63 2
 SAMPLE 4R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 99.80% 2 2 5 5.43% EVTGIITQGAR 95.00% 3.46 0.305 1.43 572.8232 1,143.63 1,144.63 2
 SAMPLE 4R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 99.80% 2 2 5 5.43% NLFETPILAR 95.00% 2.36 0.292 0 587.3365 1,172.66 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% ILPVAWHNR 95.00% 2.24 0.328 2.82 553.3194 1,104.62 1,105.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 2.84 0.153 0 572.8168 1,143.62 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 2.93 0.203 0 572.8178 1,143.62 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 3.09 0.221 0 572.8181 1,143.62 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 3.55 0.261 1.64 572.8185 1,143.62 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 3.44 0.303 1.16 572.8186 1,143.62 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 4.01 0.34 1.8 572.8189 1,143.62 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 3.87 0.361 2.06 572.8189 1,143.62 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 3.97 0.374 1.72 572.8194 1,143.62 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 3.29 0.258 2.34 572.8194 1,143.62 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 2.87 0.23 1.21 572.8197 1,143.62 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 3.14 0.437 1.33 572.8203 1,143.62 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 3.46 0.31 0 572.8224 1,143.63 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 3.28 0.348 1.8 572.8226 1,143.63 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% EVTGIITQGAR 95.00% 2.51 0.217 2.23 573.3089 1,144.60 1,144.63 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% KNLFETPILARYVR 95.00% 3.18 0.217 0 573.9886 1,718.94 1,719.99 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% IALRLELLGc 95.00% 2.68 0.448 0 c10: Carbamidomethyl (+57.02) 579.3366 1,156.66 1,157.67 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% IALRLELLGc 95.00% 2.99 0.36 1.62 c10: Carbamidomethyl (+57.02) 579.3378 1,156.66 1,157.67 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% IALRLELLGc 95.00% 2.6 0.396 2.6 c10: Carbamidomethyl (+57.02) 579.3383 1,156.66 1,157.67 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% IALRLELLGc 95.00% 2.9 0.391 0 c10: Carbamidomethyl (+57.02) 579.3456 1,156.68 1,157.67 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% IALRLELLGc 95.00% 2.3 0.31 0 c10: Carbamidomethyl (+57.02) 579.3509 1,156.69 1,157.67 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% IALRLELLGc 95.00% 2.59 0.336 0 c10: Carbamidomethyl (+57.02) 579.8534 1,157.69 1,157.67 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.69 0.315 0 587.3328 1,172.65 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.65 0.361 0 587.3331 1,172.65 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.6 0.312 1.33 587.334 1,172.65 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.64 0.24 0 587.3341 1,172.65 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.42 0.269 0 587.3343 1,172.65 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.6 0.274 0 587.3346 1,172.65 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.21 0.233 0 587.336 1,172.66 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.34 0.348 1.12 587.3397 1,172.66 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.61 0.305 0 587.3416 1,172.67 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.74 0.27 0 587.3419 1,172.67 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.44 0.216 0 587.3434 1,172.67 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.67 0.341 0 587.3446 1,172.67 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NLFETPILAR 95.00% 2.5 0.166 1.42 587.8065 1,173.60 1,173.66 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VTFLGLQHWVPELAR 95.00% 2.89 0.47 3 589.3287 1,764.96 1,765.98 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VTFLGLQHWVPELAR 95.00% 3.78 0.508 3.39 589.3293 1,764.96 1,765.98 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VTFLGLQHWVPELAR 95.00% 2.6 0.348 0 589.3298 1,764.97 1,765.98 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VTFLGLQHWVPELAR 95.00% 2.41 0.353 2.05 589.6622 1,765.96 1,765.98 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VTFLGLQHWVPELAR 95.00% 4.06 0.472 3.96 589.6639 1,765.97 1,765.98 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VTFLGLQHWVPELAR 95.00% 2.85 0.354 1.38 589.6687 1,765.98 1,765.98 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VTFLGLQHWVPELAR 95.00% 2.94 0.491 0 589.6688 1,765.98 1,765.98 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VTFLGLQHWVPELAR 95.00% 3.04 0.282 1.72 589.6763 1,766.01 1,765.98 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NPcHNGGLcEEISQEVR 95.00% 4.66 0.324 1.8 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 666.9631 1,997.87 1,998.88 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NPcHNGGLcEEISQEVR 95.00% 4.31 0.284 1.77 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 667.2992 1,998.87 1,998.88 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% FELLGcELNGcANPLGLK 95.00% 3.76 0.556 2.38 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 669.3338 2,004.98 2,004.99 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NFGSVQFVASYK 95.00% 2.69 0.548 1.82 673.8378 1,345.66 1,346.67 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NFGSVQFVASYK 95.00% 3.9 0.601 3.66 673.8389 1,345.66 1,346.67 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NFGSVQFVASYK 95.00% 3.09 0.543 3.62 673.8397 1,345.66 1,346.67 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NFGSVQFVASYK 95.00% 3.25 0.491 2.85 673.8402 1,345.66 1,346.67 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NFGSVQFVASYK 95.00% 3.31 0.553 2.8 673.8404 1,345.67 1,346.67 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NFGSVQFVASYK 95.00% 3.44 0.501 2.8 673.8412 1,345.67 1,346.67 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% MWVTGVVTQGASR 95.00% 3.89 0.398 1.19 696.3568 1,390.70 1,391.71 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% MWVTGVVTQGASR 95.00% 2.84 0.395 2.92 696.3571 1,390.70 1,391.71 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% MWVTGVVTQGASR 95.00% 4.65 0.536 4.85 696.3575 1,390.70 1,391.71 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% MWVTGVVTQGASR 95.00% 3.05 0.403 2.77 696.3576 1,390.70 1,391.71 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% MWVTGVVTQGASR 95.00% 4.31 0.544 5.57 696.3579 1,390.70 1,391.71 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% MWVTGVVTQGASR 95.00% 3.54 0.455 4.41 696.358 1,390.70 1,391.71 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NAVHVNLFETPVEAQYVR 95.00% 2.97 0.319 1.43 696.3619 2,086.06 2,086.07 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NAVHVNLFETPVEAQYVR 95.00% 4.02 0.465 2.85 696.3621 2,086.06 2,086.07 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NAVHVNLFETPVEAQYVR 95.00% 4.72 0.445 2.48 696.3624 2,086.06 2,086.07 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NAVHVNLFETPVEAQYVR 95.00% 4.84 0.563 1.85 696.3625 2,086.06 2,086.07 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% MWVTGVVTQGASR 95.00% 3.84 0.466 3.33 696.3676 1,390.72 1,391.71 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NAVHVNLFETPVEAQYVR 95.00% 4.15 0.42 2.96 696.3752 2,086.10 2,086.07 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NAVHVNLFETPVEAQYVR 95.00% 3.22 0.387 2.41 696.3762 2,086.11 2,086.07 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VAYSLNGHEFDFIHDVNK 95.00% 3.63 0.557 0 702.3404 2,104.00 2,105.01 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VAYSLNGHEFDFIHDVNK 95.00% 3.64 0.557 2.68 702.6758 2,105.00 2,105.01 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% mWVTGVVTQGASR 95.00% 4.2 0.514 3.11 m1: Oxidation (+15.99) 704.3562 1,406.70 1,407.71 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% mWVTGVVTQGASR 95.00% 3.97 0.488 3.57 m1: Oxidation (+15.99) 704.3572 1,406.70 1,407.71 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VAYSLNGHEFDFIHDVNKK 95.00% 4.12 0.593 2.48 745.0392 2,232.09 2,233.10 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VAYSLNGHEFDFIHDVNKK 95.00% 3.86 0.626 2.89 745.3738 2,233.10 2,233.10 3
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% GDVFPSYTcTcLK 95.00% 2.79 0.506 2.59 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3441 1,546.67 1,547.69 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% GDVFPSYTcTcLK 95.00% 3.47 0.459 3.02 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3456 1,546.68 1,547.69 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% GDVFPSYTcTcLK 95.00% 2.63 0.434 0 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3458 1,546.68 1,547.69 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% GDVFPSYTcTcLK 95.00% 3.14 0.464 2.15 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3462 1,546.68 1,547.69 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% GDVFPSYTcTcLK 95.00% 3.38 0.454 2.82 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3465 1,546.68 1,547.69 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% LYPTScHTAcTLR 95.00% 2.15 0.384 2.66 c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 790.3703 1,578.73 1,579.74 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% LYPTScHTAcTLR 95.00% 2.19 0.504 1.62 c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 790.8728 1,579.73 1,579.74 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VTFLGLQHWVPELAR 95.00% 4.3 0.483 2.7 883.4913 1,764.97 1,765.98 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% VTFLGLQHWVPELAR 95.00% 4.52 0.511 3.57 883.4914 1,764.97 1,765.98 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NPcHNGGLcEEISQEVR 95.00% 5.06 0.545 5.57 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 999.939 1,997.86 1,998.88 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NPcHNGGLcEEISQEVR 95.00% 5.25 0.507 5.96 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,000.44 1,998.87 1,998.88 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% FELLGcELNGcANPLGLK 95.00% 5.73 0.519 7.96 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,003.50 2,004.98 2,004.99 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% FELLGcELNGcANPLGLK 95.00% 5.8 0.519 7 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,003.50 2,004.98 2,004.99 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NAVHVNLFETPVEAQYVR 95.00% 5.62 0.524 6.82 1,044.04 2,086.06 2,086.07 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% NAVHVNLFETPVEAQYVR 95.00% 5.27 0.508 10.2 1,044.04 2,086.06 2,086.07 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% cVEPLGMENGNIANSQIAASSVR 95.00% 0 0 7.12 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,200.60 2,399.19 2,400.13 2
 SAMPLE 1 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 18 80 53.00% cVEPLGMENGNIANSQIAASSVR 95.00% 0 0 7.8 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,200.61 2,399.20 2,400.13 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% ILPVAWHNR 95.00% 2.24 0.328 2.68 553.3194 1,104.62 1,105.63 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% EVTGIITQGAR 95.00% 3.08 0.165 0 572.8176 1,143.62 1,144.63 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% EVTGIITQGAR 95.00% 3.74 0.305 1.77 572.8177 1,143.62 1,144.63 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% EVTGIITQGAR 95.00% 3.93 0.313 1.74 572.8178 1,143.62 1,144.63 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% EVTGIITQGAR 95.00% 2.71 0.309 0 572.8181 1,143.62 1,144.63 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% EVTGIITQGAR 95.00% 3.29 0.258 2.21 572.8194 1,143.62 1,144.63 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% EVTGIITQGAR 95.00% 3.34 0.288 1.24 572.8197 1,143.62 1,144.63 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% EVTGIITQGAR 95.00% 3.46 0.31 0 572.8224 1,143.63 1,144.63 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% EVTGIITQGAR 95.00% 3.28 0.348 1.66 572.8226 1,143.63 1,144.63 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% IALRLELLGc 95.00% 2.68 0.448 0 c10: Carbamidomethyl (+57.02) 579.3366 1,156.66 1,157.67 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% IALRLELLGc 95.00% 2.91 0.338 1.77 c10: Carbamidomethyl (+57.02) 579.3379 1,156.66 1,157.67 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% IALRLELLGc 95.00% 3.12 0.329 2.54 c10: Carbamidomethyl (+57.02) 579.3389 1,156.66 1,157.67 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% IALRLELLGc 95.00% 2.6 0.416 0 c10: Carbamidomethyl (+57.02) 579.3394 1,156.66 1,157.67 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% IALRLELLGc 95.00% 2.9 0.391 1.24 c10: Carbamidomethyl (+57.02) 579.3456 1,156.68 1,157.67 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% IALRLELLGc 95.00% 2.26 0.389 0 c10: Carbamidomethyl (+57.02) 579.3493 1,156.68 1,157.67 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% IALRLELLGc 95.00% 2.21 0.398 0 c10: Carbamidomethyl (+57.02) 579.3495 1,156.68 1,157.67 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.95 0.358 0 587.3332 1,172.65 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 3.04 0.359 0 587.3334 1,172.65 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.67 0.327 0 587.3337 1,172.65 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.8 0.348 1.26 587.3338 1,172.65 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.63 0.371 0 587.334 1,172.65 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.64 0.24 0 587.3341 1,172.65 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.49 0.336 0 587.3343 1,172.65 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.61 0.366 0 587.3344 1,172.65 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.61 0.305 0 587.3416 1,172.67 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.74 0.27 0 587.3419 1,172.67 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.87 0.405 0 587.3429 1,172.67 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.09 0.394 0 587.3432 1,172.67 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.53 0.373 0 587.3444 1,172.67 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NLFETPILAR 95.00% 2.35 0.352 0 587.3444 1,172.67 1,173.66 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 2.56 0.543 2.03 589.3289 1,764.96 1,765.98 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 2.56 0.506 1.54 589.3295 1,764.96 1,765.98 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 2.22 0.419 0 589.3318 1,764.97 1,765.98 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 2.55 0.496 0 589.332 1,764.97 1,765.98 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 2.94 0.512 2.12 589.6628 1,765.97 1,765.98 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 3.38 0.374 1.16 589.6633 1,765.97 1,765.98 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 2.91 0.48 1.14 589.6633 1,765.97 1,765.98 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 2.88 0.383 1.89 589.6644 1,765.97 1,765.98 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 3.57 0.465 0 589.6646 1,765.97 1,765.98 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 2.67 0.494 1.96 589.665 1,765.97 1,765.98 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 2.85 0.354 1.31 589.6687 1,765.98 1,765.98 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 2.94 0.491 0 589.6688 1,765.98 1,765.98 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NPcHNGGLcEEISQEVR 95.00% 4.3 0.305 3 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 667.2955 1,998.86 1,998.88 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NPcHNGGLcEEISQEVR 95.00% 4.18 0.263 1.8 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 667.2971 1,998.87 1,998.88 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NPcHNGGLcEEISQEVR 95.00% 2.19 0.305 0 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 667.3286 1,998.96 1,998.88 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NFGSVQFVASYK 95.00% 3.23 0.559 3.89 673.8383 1,345.66 1,346.67 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NFGSVQFVASYK 95.00% 4.05 0.55 3.72 673.8398 1,345.66 1,346.67 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NFGSVQFVASYK 95.00% 2.67 0.341 1.42 673.8399 1,345.66 1,346.67 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NFGSVQFVASYK 95.00% 2.54 0.432 2.31 674.382 1,346.75 1,346.67 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% MWVTGVVTQGASR 95.00% 3.89 0.398 1.32 696.3568 1,390.70 1,391.71 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% MWVTGVVTQGASR 95.00% 3.15 0.415 4.1 696.3571 1,390.70 1,391.71 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% MWVTGVVTQGASR 95.00% 2.59 0.323 1.4 696.3575 1,390.70 1,391.71 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% MWVTGVVTQGASR 95.00% 4.64 0.546 4.3 696.3575 1,390.70 1,391.71 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% MWVTGVVTQGASR 95.00% 4.75 0.552 3.21 696.3575 1,390.70 1,391.71 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% MWVTGVVTQGASR 95.00% 2.54 0.255 2.64 696.3576 1,390.70 1,391.71 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NAVHVNLFETPVEAQYVR 95.00% 2.35 0.236 1.19 696.3605 2,086.06 2,086.07 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% MWVTGVVTQGASR 95.00% 3.84 0.466 4.52 696.3676 1,390.72 1,391.71 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NAVHVNLFETPVEAQYVR 95.00% 4.2 0.386 2.48 696.375 2,086.10 2,086.07 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NAVHVNLFETPVEAQYVR 95.00% 4.15 0.42 2.85 696.3752 2,086.10 2,086.07 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VAYSLNGHEFDFIHDVNK 95.00% 3.92 0.557 1.47 702.6761 2,105.01 2,105.01 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% mWVTGVVTQGASR 95.00% 4.12 0.534 3.64 m1: Oxidation (+15.99) 704.3544 1,406.69 1,407.71 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% mWVTGVVTQGASR 95.00% 3.4 0.486 4.6 m1: Oxidation (+15.99) 704.3554 1,406.70 1,407.71 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VAYSLNGHEFDFIHDVNKK 95.00% 3.79 0.583 1.2 745.0388 2,232.09 2,233.10 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VAYSLNGHEFDFIHDVNKK 95.00% 4.2 0.604 2.42 745.3727 2,233.09 2,233.10 3
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% GDVFPSYTcTcLK 95.00% 3.23 0.404 2.43 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3456 1,546.68 1,547.69 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% GDVFPSYTcTcLK 95.00% 3.34 0.369 3.03 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3456 1,546.68 1,547.69 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% LYPTScHTAcTLR 95.00% 2.94 0.538 3.6 c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 790.3705 1,578.73 1,579.74 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% LYPTScHTAcTLR 95.00% 3.3 0.539 3.11 c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 790.3722 1,578.73 1,579.74 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 4.07 0.466 2.44 883.9919 1,765.97 1,765.98 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% VTFLGLQHWVPELAR 95.00% 4.34 0.468 2.18 883.9928 1,765.97 1,765.98 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NPcHNGGLcEEISQEVR 95.00% 5.1 0.515 5.51 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,000.44 1,998.86 1,998.88 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NPcHNGGLcEEISQEVR 95.00% 5.26 0.509 3.52 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,000.44 1,998.86 1,998.88 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% FELLGcELNGcANPLGLK 95.00% 5.64 0.503 5.72 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,003.49 2,004.97 2,004.99 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% FELLGcELNGcANPLGLK 95.00% 4.65 0.448 5.66 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,003.49 2,004.97 2,004.99 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NAVHVNLFETPVEAQYVR 95.00% 4.43 0.475 2.7 1,044.04 2,086.06 2,086.07 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NAVHVNLFETPVEAQYVR 95.00% 4.97 0.51 3.96 1,044.04 2,086.06 2,086.07 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NAVHVNLFETPVEAQYVR 95.00% 4.3 0.456 2.66 1,044.06 2,086.11 2,086.07 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% NAVHVNLFETPVEAQYVR 95.00% 4.18 0.451 1.96 1,044.06 2,086.11 2,086.07 2
 SAMPLE 1R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 14 16 72 51.90% cVEPLGMENGNIANSQIAASSVR 95.00% 0 0 7.13 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,200.60 2,399.19 2,400.13 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% ILPVAWHNR 95.00% 2.3 0.314 1.51 553.3149 1,104.61 1,105.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% ILPVAWHNR 95.00% 1.95 0.408 2.02 553.3156 1,104.62 1,105.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% ILPVAWHNR 95.00% 2.05 0.374 1.96 553.3156 1,104.62 1,105.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% ILPVAWHNR 95.00% 2.27 0.338 1.68 553.3159 1,104.62 1,105.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% ILPVAWHNR 95.00% 2.25 0.327 1.96 553.3163 1,104.62 1,105.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% ILPVAWHNR 95.00% 2.21 0.332 2.77 553.3163 1,104.62 1,105.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% EVTGIITQGAR 95.00% 3.01 0.233 0 572.8178 1,143.62 1,144.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% EVTGIITQGAR 95.00% 2.92 0.268 0 572.8181 1,143.62 1,144.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% EVTGIITQGAR 95.00% 3.93 0.353 2.12 572.8183 1,143.62 1,144.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% EVTGIITQGAR 95.00% 3.8 0.356 2.21 572.8186 1,143.62 1,144.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% EVTGIITQGAR 95.00% 3.82 0.378 1.96 572.8186 1,143.62 1,144.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% EVTGIITQGAR 95.00% 3.98 0.348 2.26 572.8189 1,143.62 1,144.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% EVTGIITQGAR 95.00% 2.2 0.297 0 572.9749 1,143.93 1,144.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% EVTGIITQGAR 95.00% 2.33 0.285 1.15 572.9756 1,143.94 1,144.63 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% IALRLELLGc 95.00% 3.02 0.388 3.92 c10: Carbamidomethyl (+57.02) 579.3369 1,156.66 1,157.67 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% IALRLELLGc 95.00% 3.16 0.357 3.43 c10: Carbamidomethyl (+57.02) 579.3384 1,156.66 1,157.67 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% IALRLELLGc 95.00% 2.46 0.386 2.55 c10: Carbamidomethyl (+57.02) 579.3391 1,156.66 1,157.67 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% IALRLELLGc 95.00% 2.4 0.389 0 c10: Carbamidomethyl (+57.02) 579.3394 1,156.66 1,157.67 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NLFETPILAR 95.00% 2.74 0.366 1.4 587.3336 1,172.65 1,173.66 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NLFETPILAR 95.00% 2.87 0.313 0 587.3341 1,172.65 1,173.66 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NLFETPILAR 95.00% 2.75 0.358 1.27 587.3346 1,172.65 1,173.66 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NLFETPILAR 95.00% 2.82 0.237 0 587.3347 1,172.65 1,173.66 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% VTFLGLQHWVPELAR 95.00% 3.18 0.377 2.89 589.6628 1,765.97 1,765.98 3
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% VTFLGLQHWVPELAR 95.00% 3.93 0.492 3.11 589.6637 1,765.97 1,765.98 3
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% VTFLGLQHWVPELAR 95.00% 2.67 0.401 1.24 589.6642 1,765.97 1,765.98 3
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NFGSVQFVASYK 95.00% 3.9 0.6 4.09 673.8389 1,345.66 1,346.67 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NFGSVQFVASYK 95.00% 3.71 0.588 4.26 673.8396 1,345.66 1,346.67 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NFGSVQFVASYK 95.00% 2.82 0.517 1.37 673.8397 1,345.66 1,346.67 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NFGSVQFVASYK 95.00% 3.63 0.467 3.82 673.8398 1,345.66 1,346.67 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NFGSVQFVASYK 95.00% 4.14 0.574 4.39 673.8398 1,345.66 1,346.67 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NFGSVQFVASYK 95.00% 3.64 0.566 4.44 673.8399 1,345.66 1,346.67 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NFGSVQFVASYK 95.00% 3.62 0.557 3.7 673.8403 1,345.67 1,346.67 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NFGSVQFVASYK 95.00% 2.64 0.446 0 673.8409 1,345.67 1,346.67 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% MWVTGVVTQGASR 95.00% 2.7 0.374 0 696.3551 1,390.69 1,391.71 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% MWVTGVVTQGASR 95.00% 2.51 0.333 1.34 696.3567 1,390.70 1,391.71 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% MWVTGVVTQGASR 95.00% 4.27 0.522 3.26 696.3575 1,390.70 1,391.71 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% MWVTGVVTQGASR 95.00% 2.84 0.298 1.2 696.3579 1,390.70 1,391.71 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% MWVTGVVTQGASR 95.00% 4.3 0.543 3.8 696.358 1,390.70 1,391.71 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% MWVTGVVTQGASR 95.00% 3.05 0.325 0 696.3582 1,390.70 1,391.71 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NAVHVNLFETPVEAQYVR 95.00% 4.81 0.524 2.72 696.3624 2,086.06 2,086.07 3
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NAVHVNLFETPVEAQYVR 95.00% 4.89 0.505 3.42 696.364 2,086.07 2,086.07 3
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% LYPTScHTAcTLR 95.00% 3.47 0.516 1.57 c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 790.3689 1,578.72 1,579.74 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% LYPTScHTAcTLR 95.00% 3.33 0.533 2.1 c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 790.3717 1,578.73 1,579.74 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% VTFLGLQHWVPELAR 95.00% 4.41 0.517 3.06 883.4879 1,764.96 1,765.98 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% VTFLGLQHWVPELAR 95.00% 4.1 0.441 2.6 883.4912 1,764.97 1,765.98 2
 SAMPLE 2 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 9 10 44 33.10% NPcHNGGLcEEISQEVR 95.00% 3.86 0.466 1.4 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,000.44 1,998.86 1,998.88 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% ILPVAWHNR 95.00% 2.39 0.349 0 553.3162 1,104.62 1,105.63 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% ILPVAWHNR 95.00% 2.17 0.371 1.82 553.3169 1,104.62 1,105.63 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% ILPVAWHNR 95.00% 1.87 0.351 1.24 553.3176 1,104.62 1,105.63 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% ILPVAWHNR 95.00% 2.23 0.243 1.46 553.318 1,104.62 1,105.63 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% EVTGIITQGAR 95.00% 3.73 0.37 1.64 572.8185 1,143.62 1,144.63 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% EVTGIITQGAR 95.00% 3.9 0.359 1.89 572.8188 1,143.62 1,144.63 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% EVTGIITQGAR 95.00% 2.99 0.33 1.85 572.8189 1,143.62 1,144.63 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% EVTGIITQGAR 95.00% 3.76 0.324 1.31 572.8189 1,143.62 1,144.63 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% EVTGIITQGAR 95.00% 3.6 0.305 1.24 572.8192 1,143.62 1,144.63 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% EVTGIITQGAR 95.00% 2.76 0.375 2 572.8195 1,143.62 1,144.63 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% IALRLELLGc 95.00% 3.3 0.453 3.28 c10: Carbamidomethyl (+57.02) 579.3385 1,156.66 1,157.67 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% IALRLELLGc 95.00% 3.2 0.336 4.31 c10: Carbamidomethyl (+57.02) 579.3388 1,156.66 1,157.67 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% IALRLELLGc 95.00% 2.33 0.413 1.24 c10: Carbamidomethyl (+57.02) 579.3393 1,156.66 1,157.67 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% IALRLELLGc 95.00% 2.25 0.444 0 c10: Carbamidomethyl (+57.02) 579.3393 1,156.66 1,157.67 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NLFETPILAR 95.00% 2.71 0.296 1.29 587.3341 1,172.65 1,173.66 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NLFETPILAR 95.00% 2.97 0.306 1.38 587.3341 1,172.65 1,173.66 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NLFETPILAR 95.00% 2.4 0.274 0 587.335 1,172.65 1,173.66 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% VTFLGLQHWVPELAR 95.00% 2.95 0.415 3.02 589.6628 1,765.97 1,765.98 3
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% VTFLGLQHWVPELAR 95.00% 2.85 0.405 2.92 589.6635 1,765.97 1,765.98 3
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% VTFLGLQHWVPELAR 95.00% 3.3 0.392 2.74 589.6636 1,765.97 1,765.98 3
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% VTFLGLQHWVPELAR 95.00% 2.51 0.298 1.03 589.6638 1,765.97 1,765.98 3
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NFGSVQFVASYK 95.00% 3.98 0.563 4.3 673.8396 1,345.66 1,346.67 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NFGSVQFVASYK 95.00% 3.58 0.572 3.85 673.8397 1,345.66 1,346.67 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NFGSVQFVASYK 95.00% 3.51 0.554 3.46 673.8398 1,345.66 1,346.67 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NFGSVQFVASYK 95.00% 3.33 0.553 4.23 673.8398 1,345.66 1,346.67 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NFGSVQFVASYK 95.00% 3.78 0.534 3.66 673.8399 1,345.66 1,346.67 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NFGSVQFVASYK 95.00% 3.09 0.542 3.24 673.84 1,345.66 1,346.67 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NFGSVQFVASYK 95.00% 2.11 0.309 0 673.84 1,345.66 1,346.67 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NFGSVQFVASYK 95.00% 3.78 0.584 4.02 673.8401 1,345.66 1,346.67 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% MWVTGVVTQGASR 95.00% 3.58 0.458 3.92 696.3548 1,390.69 1,391.71 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% MWVTGVVTQGASR 95.00% 2.73 0.352 0 696.3567 1,390.70 1,391.71 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% MWVTGVVTQGASR 95.00% 3.84 0.461 4.51 696.3571 1,390.70 1,391.71 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NAVHVNLFETPVEAQYVR 95.00% 4.48 0.486 2.89 696.3614 2,086.06 2,086.07 3
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NAVHVNLFETPVEAQYVR 95.00% 4.82 0.414 2.62 696.3624 2,086.06 2,086.07 3
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% MWVTGVVTQGASR 95.00% 3.09 0.434 3.28 696.8616 1,391.71 1,391.71 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% GDVFPSYTcTcLK 95.00% 2.41 0.425 2.82 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.345 1,546.67 1,547.69 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% LYPTScHTAcTLR 95.00% 3.31 0.519 2.74 c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 790.3711 1,578.73 1,579.74 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% LYPTScHTAcTLR 95.00% 3.27 0.486 2.1 c6: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 790.8734 1,579.73 1,579.74 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% VTFLGLQHWVPELAR 95.00% 4.38 0.467 2.85 883.9928 1,765.97 1,765.98 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% VTFLGLQHWVPELAR 95.00% 4.14 0.418 2.77 883.9929 1,765.97 1,765.98 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NPcHNGGLcEEISQEVR 95.00% 4.68 0.52 5 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,000.44 1,998.86 1,998.88 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% FELLGcELNGcANPLGLK 95.00% 5.73 0.551 8.2 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,003.50 2,004.98 2,004.99 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% FELLGcELNGcANPLGLK 95.00% 5.73 0.498 8.51 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,003.50 2,004.98 2,004.99 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NAVHVNLFETPVEAQYVR 95.00% 5.43 0.519 6.14 1,044.04 2,086.06 2,086.07 2
 SAMPLE 2R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 11 12 41 41.10% NAVHVNLFETPVEAQYVR 95.00% 5.57 0.539 5.37 1,044.04 2,086.06 2,086.07 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% ILPVAWHNR 95.00% 2.2 0.427 1.46 553.3155 1,104.62 1,105.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% ILPVAWHNR 95.00% 2.2 0.432 1.85 553.3162 1,104.62 1,105.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% ILPVAWHNR 95.00% 2.52 0.371 1.89 553.3163 1,104.62 1,105.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% ILPVAWHNR 95.00% 2.36 0.367 1.52 553.3164 1,104.62 1,105.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% ILPVAWHNR 95.00% 2.13 0.329 1.62 553.3165 1,104.62 1,105.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% ILPVAWHNR 95.00% 2.68 0.339 1.59 553.3166 1,104.62 1,105.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% ILPVAWHNR 95.00% 2.18 0.371 2.36 553.3167 1,104.62 1,105.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% ILPVAWHNR 95.00% 2.05 0.219 1.96 553.3169 1,104.62 1,105.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 2.31 0.254 0 572.5941 1,143.17 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 2.4 0.229 0 572.8167 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 3.39 0.344 1.55 572.8172 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 2.82 0.171 0 572.8178 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 3.88 0.365 1.92 572.8179 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 3.16 0.221 1.18 572.8182 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 2.87 0.203 0 572.8183 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 3.45 0.287 2 572.8185 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 3.39 0.325 2 572.8187 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 3.04 0.177 1.08 572.8188 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 3.46 0.327 1.51 572.8188 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 4 0.364 2.3 572.8191 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 3.67 0.311 2 572.8192 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 3.66 0.388 1.54 572.8194 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 3.13 0.366 1.8 572.8195 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 3.88 0.358 2.42 572.8197 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 2.71 0.198 0 572.82 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 3.45 0.304 1.43 572.82 1,143.62 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 2.72 0.319 0 572.8205 1,143.63 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 2.72 0.215 0 572.821 1,143.63 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% EVTGIITQGAR 95.00% 2.41 0.205 0 572.8235 1,143.63 1,144.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% IALRLELLGc 95.00% 2.61 0.37 2.09 c10: Carbamidomethyl (+57.02) 579.3387 1,156.66 1,157.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% IALRLELLGc 95.00% 2.74 0.361 2.8 c10: Carbamidomethyl (+57.02) 579.3391 1,156.66 1,157.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% IALRLELLGc 95.00% 2.27 0.44 2.68 c10: Carbamidomethyl (+57.02) 579.3396 1,156.66 1,157.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% IALRLELLGc 95.00% 2.68 0.403 2.08 c10: Carbamidomethyl (+57.02) 579.3399 1,156.66 1,157.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 2.96 0.338 0 587.3325 1,172.65 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 2.98 0.356 0 587.3325 1,172.65 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 2.9 0.331 0 587.3332 1,172.65 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 3.05 0.372 0 587.3336 1,172.65 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 2.99 0.363 0 587.3339 1,172.65 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 3.04 0.342 1.18 587.3339 1,172.65 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 2.86 0.291 0 587.3343 1,172.65 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 3.13 0.378 0 587.3344 1,172.65 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 3.07 0.369 0 587.3345 1,172.65 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 3 0.336 0 587.3345 1,172.65 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 2.68 0.327 1.39 587.3348 1,172.65 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 2.56 0.322 0 587.3349 1,172.65 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 2.57 0.211 0 587.3354 1,172.66 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 2.69 0.275 0 587.3358 1,172.66 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 2.12 0.289 0 587.3369 1,172.66 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NLFETPILAR 95.00% 2.56 0.245 0 587.8367 1,173.66 1,173.66 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% VTFLGLQHWVPELAR 95.00% 1.93 0.307 0 589.3311 1,764.97 1,765.98 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% VTFLGLQHWVPELAR 95.00% 3.16 0.414 1.24 589.6633 1,765.97 1,765.98 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% VTFLGLQHWVPELAR 95.00% 3.41 0.46 1.49 589.664 1,765.97 1,765.98 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% HKEFVGNWNK 95.00% 3.17 0.322 1.15 629.8183 1,257.62 1,258.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% HKEFVGNWNK 95.00% 3.05 0.418 0 629.8185 1,257.62 1,258.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% HKEFVGNWNK 95.00% 3.35 0.424 2.96 629.8197 1,257.62 1,258.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% HKEFVGNWNK 95.00% 2.89 0.413 2.33 630.3206 1,258.63 1,258.63 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NPcHNGGLcEEISQEVR 95.00% 4.83 0.316 2.92 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 666.9633 1,997.87 1,998.88 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NPcHNGGLcEEISQEVR 95.00% 3.89 0.281 0 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 667.2946 1,998.86 1,998.88 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NPcHNGGLcEEISQEVR 95.00% 3.54 0.173 1.32 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 667.2953 1,998.86 1,998.88 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NPcHNGGLcEEISQEVR 95.00% 4.61 0.228 2.42 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 667.2971 1,998.87 1,998.88 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 3.73 0.574 3.64 673.8384 1,345.66 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 3.55 0.57 2.72 673.839 1,345.66 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 4.06 0.573 3.7 673.8392 1,345.66 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 4.18 0.58 4.29 673.8393 1,345.66 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 3.06 0.449 3.6 673.8393 1,345.66 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 4.2 0.504 3.51 673.8396 1,345.66 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 3.67 0.594 3.64 673.8398 1,345.66 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 4.47 0.59 3.72 673.8399 1,345.66 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 3.4 0.617 4 673.8402 1,345.66 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 4.24 0.551 3.42 673.8402 1,345.66 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 3.73 0.588 3.6 673.8407 1,345.67 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 2.48 0.338 1.89 673.8408 1,345.67 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NFGSVQFVASYK 95.00% 3.8 0.59 3.46 674.3414 1,346.67 1,346.67 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 3.19 0.341 2.1 696.028 2,085.06 2,086.07 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 4.24 0.522 3.28 696.3567 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 3.02 0.412 2.59 696.357 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 4.16 0.525 3.72 696.3575 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 3.65 0.496 3.52 696.3575 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 4.07 0.59 3.59 696.3576 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 3.03 0.398 2.74 696.3576 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 3.62 0.5 3.17 696.3576 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 4.27 0.509 3.34 696.3578 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 3.88 0.525 3.85 696.3579 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 3.79 0.492 3.82 696.3581 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 4.04 0.557 3.85 696.3581 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 3.87 0.496 3.74 696.3583 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 3.72 0.476 3.7 696.3589 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 4.05 0.558 3.92 696.359 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% MWVTGVVTQGASR 95.00% 2.72 0.429 2.44 696.3596 1,390.70 1,391.71 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 5.24 0.494 3.3 696.3618 2,086.06 2,086.07 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 5.05 0.441 2.46 696.3619 2,086.06 2,086.07 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 3.9 0.457 2.14 696.3622 2,086.06 2,086.07 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 3.74 0.39 3.55 696.3625 2,086.06 2,086.07 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 3.09 0.37 2.31 696.3629 2,086.07 2,086.07 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 3.74 0.403 2.4 696.3633 2,086.07 2,086.07 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% IFPGNWDNHSHK 95.00% 3.4 0.3 0 726.8448 1,451.67 1,451.68 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% VAYSLNGHEFDFIHDVNKK 95.00% 3.97 0.558 2.15 745.3731 2,233.10 2,233.10 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% VAYSLNGHEFDFIHDVNKK 95.00% 3.95 0.542 2.19 745.3734 2,233.10 2,233.10 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% VAYSLNGHEFDFIHDVNKK 95.00% 4.52 0.628 2 745.3737 2,233.10 2,233.10 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% VAYSLNGHEFDFIHDVNKK 95.00% 4.61 0.59 2.54 745.3743 2,233.10 2,233.10 3
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% GDVFPSYTcTcLK 95.00% 3.27 0.432 2.13 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3456 1,546.68 1,547.69 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% GDVFPSYTcTcLK 95.00% 3.41 0.478 3.89 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3456 1,546.68 1,547.69 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% GDVFPSYTcTcLK 95.00% 2.55 0.372 1.39 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3456 1,546.68 1,547.69 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% GDVFPSYTcTcLK 95.00% 3.41 0.456 2.74 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3458 1,546.68 1,547.69 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% GDVFPSYTcTcLK 95.00% 3.12 0.388 2.8 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3461 1,546.68 1,547.69 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% GDVFPSYTcTcLK 95.00% 3.06 0.374 3.03 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3462 1,546.68 1,547.69 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% GDVFPSYTcTcLK 95.00% 2.85 0.402 1.49 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3463 1,546.68 1,547.69 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% GDVFPSYTcTcLK 95.00% 3.22 0.332 2.14 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3464 1,546.68 1,547.69 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% GDVFPSYTcTcLK 95.00% 3.23 0.456 3.72 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3464 1,546.68 1,547.69 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% GDVFPSYTcTcLK 95.00% 3.07 0.349 3.28 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3466 1,546.68 1,547.69 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% IFPGNWDNHSHKK 95.00% 3.15 0.552 0 790.3906 1,578.77 1,579.78 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% IFPGNWDNHSHKK 95.00% 3.46 0.456 0 790.3932 1,578.77 1,579.78 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% VTFLGLQHWVPELAR 95.00% 3.56 0.432 1.17 883.4911 1,764.97 1,765.98 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NPcHNGGLcEEISQEVR 95.00% 5.27 0.493 5.01 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,000.44 1,998.87 1,998.88 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NPcHNGGLcEEISQEVR 95.00% 5.05 0.521 4.17 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,000.44 1,998.87 1,998.88 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% VAYSNDSANWTEYQDPR 95.00% 4.67 0.598 7.04 1,008.94 2,015.86 2,015.87 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 5.8 0.549 4.85 1,043.54 2,085.06 2,086.07 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 6.05 0.529 5.33 1,044.04 2,086.06 2,086.07 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 5.97 0.547 5.4 1,044.04 2,086.06 2,086.07 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 5.47 0.546 4.49 1,044.04 2,086.06 2,086.07 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 5.75 0.552 5.09 1,044.04 2,086.06 2,086.07 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% NAVHVNLFETPVEAQYVR 95.00% 5.92 0.514 7.29 1,044.04 2,086.07 2,086.07 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% cVEPLGMENGNIANSQIAASSVR 95.00% 0 0 8.62 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,200.60 2,399.19 2,400.13 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% cVEPLGMENGNIANSQIAASSVR 95.00% 0 0 5.57 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,200.60 2,399.19 2,400.13 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% cVEPLGMENGNIANSQIAASSVR 95.00% 0 0 7.64 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,200.61 2,399.20 2,400.13 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% cVEPLGMENGNIANSQIAASSVR 95.00% 6.5 0.632 10.3 c1: Carbamidomethyl (+57.02) 1,209.58 2,417.14 2,417.16 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% cVEPLGMENGNIANSQIAASSVR 95.00% 6.4 0.632 7.92 c1: Carbamidomethyl (+57.02) 1,209.58 2,417.15 2,417.16 2
 SAMPLE 3 Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 15 17 115 54.30% cVEPLGMENGNIANSQIAASSVR 95.00% 6.63 0.595 9.03 c1: Carbamidomethyl (+57.02) 1,209.58 2,417.15 2,417.16 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% LASHEYLK 95.00% 1.99 0.254 0 480.7609 959.5061 960.5155 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% ILPVAWHNR 95.00% 2.09 0.23 1.7 553.3154 1,104.62 1,105.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% ILPVAWHNR 95.00% 2.11 0.374 0 553.3158 1,104.62 1,105.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% ILPVAWHNR 95.00% 2.28 0.382 0 553.3161 1,104.62 1,105.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% ILPVAWHNR 95.00% 2.18 0.339 2.08 553.3163 1,104.62 1,105.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% ILPVAWHNR 95.00% 2.13 0.45 2.32 553.3163 1,104.62 1,105.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% ILPVAWHNR 95.00% 2.17 0.274 1.2 553.3166 1,104.62 1,105.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% ILPVAWHNR 95.00% 2.01 0.2 1.18 553.3167 1,104.62 1,105.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% ILPVAWHNR 95.00% 2.03 0.266 0 553.3175 1,104.62 1,105.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 3.47 0.372 1.74 572.8184 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 2.97 0.309 1.35 572.8184 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 2.43 0.349 1.18 572.8186 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 2.68 0.179 0 572.8188 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 4.01 0.329 2.02 572.8189 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 3.93 0.387 1.85 572.819 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 4.08 0.38 1.89 572.819 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 3.61 0.392 1.66 572.8192 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 3.98 0.362 2.08 572.8192 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 3.45 0.353 1.46 572.8193 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 2.86 0.17 0 572.8195 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 3.51 0.371 1.08 572.8195 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 3.54 0.385 1.48 572.8199 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 3.9 0.331 2.19 572.8199 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 3.18 0.238 1.96 572.8201 1,143.62 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 2.98 0.292 0 572.8203 1,143.63 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% EVTGIITQGAR 95.00% 3.03 0.347 1.6 572.8212 1,143.63 1,144.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% IALRLELLGc 95.00% 2.25 0.293 0 c10: Carbamidomethyl (+57.02) 579.3377 1,156.66 1,157.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% IALRLELLGc 95.00% 2.63 0.404 1.3 c10: Carbamidomethyl (+57.02) 579.3379 1,156.66 1,157.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% IALRLELLGc 95.00% 1.61 0.364 0 c10: Carbamidomethyl (+57.02) 579.338 1,156.66 1,157.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% IALRLELLGc 95.00% 2.35 0.259 0 c10: Carbamidomethyl (+57.02) 579.339 1,156.66 1,157.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% IALRLELLGc 95.00% 2.44 0.395 1.85 c10: Carbamidomethyl (+57.02) 579.339 1,156.66 1,157.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% IALRLELLGc 95.00% 2.62 0.403 0 c10: Carbamidomethyl (+57.02) 579.3394 1,156.66 1,157.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% IALRLELLGc 95.00% 2.48 0.456 2.27 c10: Carbamidomethyl (+57.02) 579.3395 1,156.66 1,157.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% IALRLELLGc 95.00% 2.66 0.422 1.8 c10: Carbamidomethyl (+57.02) 579.3396 1,156.66 1,157.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.89 0.343 0 587.3327 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.62 0.307 0 587.333 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.75 0.384 0 587.3334 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.67 0.344 0 587.3337 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.95 0.364 0 587.3337 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.87 0.361 0 587.3338 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.88 0.302 0 587.3338 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.55 0.351 0 587.334 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.82 0.348 0 587.3342 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.59 0.327 0 587.3343 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.68 0.349 0 587.3344 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.88 0.359 0 587.3345 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.8 0.339 0 587.3346 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NLFETPILAR 95.00% 2.97 0.386 0 587.3346 1,172.65 1,173.66 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 2.09 0.287 0 589.3287 1,764.96 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 2.22 0.449 0 589.329 1,764.96 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 2.53 0.571 1.52 589.3312 1,764.97 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 2.11 0.411 0 589.3314 1,764.97 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 2.01 0.312 0 589.3315 1,764.97 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 2.2 0.304 0 589.663 1,765.97 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 3.23 0.475 2.57 589.663 1,765.97 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 2.47 0.361 1.3 589.6634 1,765.97 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 4.08 0.469 3.32 589.6636 1,765.97 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 2.96 0.411 1.92 589.6636 1,765.97 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 2.1 0.265 0 589.6638 1,765.97 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 3.82 0.485 2.92 589.6639 1,765.97 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 3.2 0.491 2.82 589.6643 1,765.97 1,765.98 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% TWGLHLFSWNPSYAR 95.00% 4.3 0.454 4.57 612.3042 1,833.89 1,834.90 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% TWGLHLFSWNPSYAR 95.00% 4.36 0.406 3.64 612.6387 1,834.89 1,834.90 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% TWGLHLFSWNPSYAR 95.00% 4.4 0.396 5.85 612.6398 1,834.90 1,834.90 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% TWGLHLFSWNPSYAR 95.00% 4.4 0.418 4.7 612.6398 1,834.90 1,834.90 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% HKEFVGNWNK 95.00% 3.02 0.341 1.42 629.8171 1,257.62 1,258.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% HKEFVGNWNK 95.00% 3.47 0.427 2.24 629.8189 1,257.62 1,258.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% HKEFVGNWNK 95.00% 2.5 0.347 0 629.819 1,257.62 1,258.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% HKEFVGNWNK 95.00% 2.76 0.382 2.36 629.8191 1,257.62 1,258.63 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NPcHNGGLcEEISQEVR 95.00% 4.93 0.331 2.37 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 667.2963 1,998.87 1,998.88 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NPcHNGGLcEEISQEVR 95.00% 3.86 0.254 0 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 667.2972 1,998.87 1,998.88 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% FELLGcELNGcANPLGLK 95.00% 3.51 0.411 0 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 669.001 2,003.98 2,004.99 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% FELLGcELNGcANPLGLK 95.00% 3.15 0.41 0 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 669.3348 2,004.98 2,004.99 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NFGSVQFVASYK 95.00% 2.34 0.152 1.23 673.8376 1,345.66 1,346.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NFGSVQFVASYK 95.00% 2.73 0.396 1.44 673.8378 1,345.66 1,346.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NFGSVQFVASYK 95.00% 3.27 0.573 4.1 673.8392 1,345.66 1,346.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NFGSVQFVASYK 95.00% 2.25 0.385 0 673.8397 1,345.66 1,346.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NFGSVQFVASYK 95.00% 3.48 0.473 3.36 673.8398 1,345.66 1,346.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NFGSVQFVASYK 95.00% 3.62 0.572 4.28 673.8398 1,345.66 1,346.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NFGSVQFVASYK 95.00% 4.32 0.547 3.11 673.8399 1,345.66 1,346.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NFGSVQFVASYK 95.00% 3.13 0.46 4.1 673.84 1,345.66 1,346.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NFGSVQFVASYK 95.00% 3.38 0.387 2.72 673.8404 1,345.67 1,346.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NFGSVQFVASYK 95.00% 2.7 0.519 3 673.8412 1,345.67 1,346.67 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 4.37 0.433 2.38 696.0281 2,085.06 2,086.07 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 3.44 0.392 4.59 696.3562 1,390.70 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 3.76 0.495 3.38 696.3568 1,390.70 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 3.42 0.294 0 696.357 1,390.70 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 4.06 0.499 1.21 696.358 1,390.70 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 3.45 0.543 4 696.3581 1,390.70 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 4.19 0.546 4.59 696.3585 1,390.70 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 3.56 0.522 2.77 696.3586 1,390.70 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 3.73 0.545 3.68 696.3586 1,390.70 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 3.92 0.503 3.77 696.3592 1,390.70 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 3.23 0.446 2.64 696.3595 1,390.70 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 3.07 0.394 2.85 696.3596 1,390.70 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 5.13 0.498 3.43 696.3616 2,086.06 2,086.07 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 5.17 0.491 2.92 696.3622 2,086.06 2,086.07 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 5.47 0.468 2.49 696.3624 2,086.06 2,086.07 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 4.97 0.444 3.42 696.3627 2,086.06 2,086.07 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 2.45 0.171 2.96 696.3629 2,086.07 2,086.07 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 4.26 0.357 3.66 696.3631 2,086.07 2,086.07 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 2.6 0.375 0 696.3632 2,086.07 2,086.07 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 4.46 0.551 3.85 696.8607 1,391.71 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% MWVTGVVTQGASR 95.00% 4.43 0.512 5.96 696.861 1,391.71 1,391.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% mWVTGVVTQGASR 95.00% 3.39 0.576 3.02 m1: Oxidation (+15.99) 704.3545 1,406.69 1,407.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% mWVTGVVTQGASR 95.00% 2.72 0.408 2.82 m1: Oxidation (+15.99) 704.3557 1,406.70 1,407.71 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% IFPGNWDNHSHK 95.00% 2.83 0.256 0 726.3429 1,450.67 1,451.68 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% IFPGNWDNHSHK 95.00% 2.79 0.166 0 726.3471 1,450.68 1,451.68 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VAYSLNGHEFDFIHDVNKK 95.00% 3.91 0.56 1.6 745.0381 2,232.09 2,233.10 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VAYSLNGHEFDFIHDVNKK 95.00% 4.01 0.607 2.54 745.0397 2,232.10 2,233.10 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VAYSLNGHEFDFIHDVNKK 95.00% 3.65 0.559 2.54 745.3739 2,233.10 2,233.10 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VAYSLNGHEFDFIHDVNKK 95.00% 4.69 0.628 3 745.3748 2,233.10 2,233.10 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% GDVFPSYTcTcLK 95.00% 2.44 0.336 2 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3455 1,546.68 1,547.69 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% GDVFPSYTcTcLK 95.00% 3.59 0.472 2.74 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3456 1,546.68 1,547.69 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% GDVFPSYTcTcLK 95.00% 3.27 0.467 4.24 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3462 1,546.68 1,547.69 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% GDVFPSYTcTcLK 95.00% 2.46 0.426 2.1 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3465 1,546.68 1,547.69 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% GDVFPSYTcTcLK 95.00% 2.52 0.38 1.59 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3466 1,546.68 1,547.69 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% GDVFPSYTcTcLK 95.00% 3.22 0.342 3.74 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3468 1,546.68 1,547.69 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% GDVFPSYTcTcLK 95.00% 3.23 0.344 4.25 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3471 1,546.68 1,547.69 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% GDVFPSYTcTcLK 95.00% 3.28 0.37 2.4 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3473 1,546.68 1,547.69 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% GDVFPSYTcTcLK 95.00% 3.16 0.449 2.25 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.3481 1,546.68 1,547.69 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% GDVFPSYTcTcLK 95.00% 2.54 0.379 1.55 c9: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 774.8496 1,547.68 1,547.69 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% IFPGNWDNHSHKK 95.00% 3 0.374 0 790.3937 1,578.77 1,579.78 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% IFPGNWDNHSHKK 95.00% 3.25 0.573 1.62 790.3951 1,578.77 1,579.78 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% cVEPLGMENGNIANSQIAASSVR 95.00% 3.08 0.401 1.42 c1: Carbamidomethyl (+57.02) 806.723 2,417.15 2,417.16 3
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 4.19 0.532 3.57 883.4895 1,764.96 1,765.98 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 4.45 0.481 2.55 883.9908 1,765.97 1,765.98 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% VTFLGLQHWVPELAR 95.00% 4.15 0.474 2.89 883.9921 1,765.97 1,765.98 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NPcHNGGLcEEISQEVR 95.00% 5.38 0.573 4.3 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 999.9408 1,997.87 1,998.88 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NPcHNGGLcEEISQEVR 95.00% 5.42 0.565 5.07 c3: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,000.44 1,998.87 1,998.88 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% FELLGcELNGcANPLGLK 95.00% 5.52 0.549 6.26 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,002.99 2,003.97 2,004.99 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% FELLGcELNGcANPLGLK 95.00% 6 0.51 8.32 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,003.50 2,004.98 2,004.99 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% FELLGcELNGcANPLGLK 95.00% 5.75 0.485 7.07 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,003.50 2,004.98 2,004.99 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% FELLGcELNGcANPLGLK 95.00% 4.59 0.481 2.57 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,003.50 2,004.98 2,004.99 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% FELLGcELNGcANPLGLK 95.00% 5.11 0.6 7.15 c6: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 1,003.50 2,004.98 2,004.99 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 5.76 0.545 6.89 1,044.04 2,086.06 2,086.07 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 5.72 0.553 6.57 1,044.04 2,086.06 2,086.07 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 5.85 0.555 5.03 1,044.04 2,086.06 2,086.07 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 5.99 0.555 6.08 1,044.04 2,086.07 2,086.07 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% NAVHVNLFETPVEAQYVR 95.00% 5.36 0.525 4.64 1,044.04 2,086.07 2,086.07 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% cVEPLGMENGNIANSQIAASSVR 95.00% 0 0 8.34 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,200.10 2,398.19 2,400.13 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% cVEPLGMENGNIANSQIAASSVR 95.00% 0 0 8.54 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,200.60 2,399.19 2,400.13 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% cVEPLGMENGNIANSQIAASSVR 95.00% 0 0 6.44 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 1,200.61 2,399.20 2,400.13 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% cVEPLGMENGNIANSQIAASSVR 95.00% 6.57 0.617 7.66 c1: Carbamidomethyl (+57.02) 1,209.58 2,417.14 2,417.16 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% cVEPLGMENGNIANSQIAASSVR 95.00% 6.6 0.571 8.19 c1: Carbamidomethyl (+57.02) 1,209.58 2,417.14 2,417.16 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% cVEPLGMENGNIANSQIAASSVR 95.00% 6.4 0.649 7.96 c1: Carbamidomethyl (+57.02) 1,209.58 2,417.15 2,417.16 2
 SAMPLE 3R Lactadherin  MFGE8  MFGM_HUMAN 43,104.90 100.00% 17 21 134 60.50% cVEPLGMENGNIANSQIAASSVR 95.00% 0 0 9.96 c1: Carbamidomethyl (+57.02) 1,210.08 2,418.15 2,417.16 2
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% LADALQELR 95.00% 2.76 0.309 1.24 514.7903 1,027.56 1,028.57 2
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% LADALQELR 95.00% 3.58 0.32 0 514.7906 1,027.57 1,028.57 2
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% LADALQELR 95.00% 3.16 0.259 0 514.7906 1,027.57 1,028.57 2
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% LADALQELR 95.00% 3.6 0.287 0 514.7912 1,027.57 1,028.57 2
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% LADALQELR 95.00% 2.82 0.293 0 514.7912 1,027.57 1,028.57 2
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% LADALQELR 95.00% 3.51 0.209 0 514.7913 1,027.57 1,028.57 2
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% LADALQELR 95.00% 3.3 0.183 0 514.7917 1,027.57 1,028.57 2
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% NSNLVGAAHEELQQSR 95.00% 2.23 0.252 0 584.9611 1,751.86 1,752.86 3
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% NSNLVGAAHEELQQSR 95.00% 2.74 0.348 0 584.9612 1,751.86 1,752.86 3
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% NSNLVGAAHEELQQSR 95.00% 2.99 0.466 0 584.9613 1,751.86 1,752.86 3
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% NSNLVGAAHEELQQSR 95.00% 2.73 0.461 0 584.9615 1,751.86 1,752.86 3
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% LRDLEDSLAR 95.00% 2.75 0.286 0 594.3232 1,186.63 1,187.64 2
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% LRDLEDSLAR 95.00% 2.45 0.277 0 594.3241 1,186.63 1,187.64 2
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% NSNLVGAAHEELQQSR 95.00% 4.82 0.578 2.8 877.4387 1,752.86 1,752.86 2
 SAMPLE 4 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 15 5.27% NSNLVGAAHEELQQSR 95.00% 4.76 0.593 3.05 877.4416 1,752.87 1,752.86 2
 SAMPLE 4R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 10 5.27% LADALQELR 95.00% 3.08 0.276 1.24 514.7908 1,027.57 1,028.57 2
 SAMPLE 4R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 10 5.27% LADALQELR 95.00% 3.1 0.2 1.28 514.7911 1,027.57 1,028.57 2
 SAMPLE 4R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 10 5.27% LADALQELR 95.00% 3.25 0.274 0 514.7917 1,027.57 1,028.57 2
 SAMPLE 4R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 10 5.27% LADALQELR 95.00% 2.97 0.184 0 514.7919 1,027.57 1,028.57 2
 SAMPLE 4R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 10 5.27% NSNLVGAAHEELQQSR 95.00% 3.09 0.489 0 584.9606 1,751.86 1,752.86 3
 SAMPLE 4R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 10 5.27% NSNLVGAAHEELQQSR 95.00% 2.64 0.194 0 584.9625 1,751.86 1,752.86 3
 SAMPLE 4R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 10 5.27% NSNLVGAAHEELQQSR 95.00% 2.81 0.381 0 585.293 1,752.86 1,752.86 3
 SAMPLE 4R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 10 5.27% NSNLVGAAHEELQQSR 95.00% 2.46 0.392 0 585.2949 1,752.86 1,752.86 3
 SAMPLE 4R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 10 5.27% LRDLEDSLAR 95.00% 2.4 0.16 1.43 594.3244 1,186.63 1,187.64 2
 SAMPLE 4R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 3 4 10 5.27% NSNLVGAAHEELQQSR 95.00% 4.77 0.594 4.09 876.939 1,751.86 1,752.86 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% KLLEGEEERLR 95.00% 2.46 0.274 0 457.9247 1,370.75 1,371.76 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% KLLEGEEERLR 95.00% 2.9 0.259 0 457.927 1,370.76 1,371.76 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% DLEDSLAR 95.00% 2.56 0.281 0 459.7306 917.4455 918.4534 2 FBLN3_HUMAN
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% DLEDSLAR 95.00% 2.73 0.267 0 459.731 917.4464 918.4534 2 FBLN3_HUMAN
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LRITESEEVVSR 95.00% 3.79 0.229 0 473.2594 1,416.75 1,417.77 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LRITESEEVVSR 95.00% 3.68 0.227 0 473.2606 1,416.76 1,417.77 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LQTMKEELDFQK 95.00% 2.49 0.378 0 503.9243 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LQTMKEELDFQK 95.00% 2.55 0.39 1.34 503.9244 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NIYSEELR 95.00% 1.94 0.276 1.23 512.257 1,022.50 1,023.51 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NIYSEELR 95.00% 2.4 0.279 1.38 512.2583 1,022.50 1,023.51 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LADALQELR 95.00% 3.29 0.299 1.49 514.7888 1,027.56 1,028.57 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LADALQELR 95.00% 2.96 0.265 1.6 514.789 1,027.56 1,028.57 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LADALQELR 95.00% 3.49 0.304 0 514.7892 1,027.56 1,028.57 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LADALQELR 95.00% 3.61 0.346 1.44 514.7893 1,027.56 1,028.57 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LADALQELR 95.00% 3.9 0.338 1.54 514.7896 1,027.56 1,028.57 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LADALQELR 95.00% 2.69 0.271 0 514.7896 1,027.56 1,028.57 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LADALQELR 95.00% 3.78 0.246 1.49 514.7896 1,027.56 1,028.57 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LADALQELR 95.00% 2.67 0.289 0 514.7899 1,027.56 1,028.57 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LADALQELR 95.00% 2.96 0.313 1.89 514.7899 1,027.56 1,028.57 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LADALQELR 95.00% 3.56 0.255 2.06 514.7914 1,027.57 1,028.57 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LEAALGEAKK 95.00% 2.21 0.245 0 515.2998 1,028.58 1,029.59 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LEAALGEAKK 95.00% 2.04 0.314 0 515.8012 1,029.59 1,029.59 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% VAVEEVDEEGKFVR 95.00% 2.53 0.205 0 535.9406 1,604.80 1,605.81 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% VAVEEVDEEGKFVR 95.00% 3.14 0.382 0 536.2765 1,605.81 1,605.81 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LQEKEDLQELNDR 95.00% 3.73 0.3 0 544.274 1,629.80 1,629.81 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TLEGELHDLRGQVAK 95.00% 1.66 0.285 0 555.9677 1,664.88 1,665.89 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TLEGELHDLRGQVAK 95.00% 1.9 0.316 1.89 555.9678 1,664.88 1,665.89 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TLEGELHDLRGQVAK 95.00% 1.86 0.291 0 555.9681 1,664.88 1,665.89 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TLEGELHDLRGQVAK 95.00% 1.97 0.311 0 556.3015 1,665.88 1,665.89 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TLEGELHDLRGQVAK 95.00% 2.11 0.262 0 556.3036 1,665.89 1,665.89 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% SNEDQSMGNWQIKR 95.00% 2.53 0.325 0 564.929 1,691.76 1,692.78 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% SNEDQSMGNWQIKR 95.00% 2.56 0.279 0 564.9293 1,691.76 1,692.78 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% IRIDSLSAQLSQLQK 95.00% 3.86 0.245 0 567.3235 1,698.95 1,699.97 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% IRIDSLSAQLSQLQK 95.00% 4.33 0.314 0 567.3263 1,698.96 1,699.97 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% IRIDSLSAQLSQLQK 95.00% 4.49 0.282 1.11 567.3264 1,698.96 1,699.97 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% IRIDSLSAQLSQLQK 95.00% 3.92 0.342 0 567.327 1,698.96 1,699.97 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% IRIDSLSAQLSQLQK 95.00% 4.27 0.273 1.09 567.3276 1,698.96 1,699.97 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% IRIDSLSAQLSQLQK 95.00% 3.91 0.317 0 567.3282 1,698.96 1,699.97 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% IRIDSLSAQLSQLQK 95.00% 4.35 0.293 0 567.6616 1,699.96 1,699.97 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% IRIDSLSAQLSQLQK 95.00% 3.99 0.294 0 567.663 1,699.97 1,699.97 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% ITESEEVVSR 95.00% 2.56 0.416 1.59 574.7924 1,147.57 1,148.58 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% ITESEEVVSR 95.00% 3.02 0.488 1.54 574.7934 1,147.57 1,148.58 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% AAYEAELGDAR 95.00% 2.19 0.495 1.4 582.6351 1,163.25 1,165.55 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 3.18 0.396 0 584.9575 1,751.85 1,752.86 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 3.11 0.505 0 584.9585 1,751.85 1,752.86 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 1.96 0.248 0 584.9588 1,751.85 1,752.86 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 2.65 0.385 0 585.2932 1,752.86 1,752.86 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 2.21 0.308 0 585.2941 1,752.86 1,752.86 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% QNGDDPLLTYRFPPK 95.00% 2.32 0.343 1.48 587.6362 1,759.89 1,760.90 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% QNGDDPLLTYRFPPK 95.00% 2.71 0.374 3.68 587.6364 1,759.89 1,760.90 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% QNGDDPLLTYRFPPK 95.00% 2.91 0.331 1.64 587.9697 1,760.89 1,760.90 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TLEGELHDLR 95.00% 2.32 0.348 0 591.8088 1,181.60 1,182.61 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TLEGELHDLR 95.00% 2.85 0.389 1.8 591.8089 1,181.60 1,182.61 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TLEGELHDLR 95.00% 2.08 0.391 0 591.8092 1,181.60 1,182.61 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TLEGELHDLR 95.00% 2.32 0.364 0 592.3072 1,182.60 1,182.61 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TLEGELHDLR 95.00% 2.84 0.393 0 592.3095 1,182.60 1,182.61 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LRDLEDSLAR 95.00% 2.63 0.215 1.49 594.3203 1,186.63 1,187.64 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LRDLEDSLAR 95.00% 3.17 0.376 0 594.3207 1,186.63 1,187.64 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LRDLEDSLAR 95.00% 2.58 0.218 1.7 594.3217 1,186.63 1,187.64 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LRDLEDSLAR 95.00% 2.65 0.243 1.37 594.3227 1,186.63 1,187.64 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LKDLEALLNSK 95.00% 2.56 0.421 1.36 622.3627 1,242.71 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LKDLEALLNSK 95.00% 2.62 0.382 1.68 622.3655 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% QNGDDPLLTYR 95.00% 1.98 0.28 0 646.3152 1,290.61 1,291.63 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% QNGDDPLLTYR 95.00% 2.98 0.521 2.39 646.3167 1,290.62 1,291.63 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% QNGDDPLLTYR 95.00% 2.8 0.545 2.52 646.3169 1,290.62 1,291.63 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% QNGDDPLLTYR 95.00% 2.69 0.432 1.39 646.8169 1,291.62 1,291.63 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% AQHEDQVEQYKKELEK 95.00% 3.32 0.482 2.32 668.3337 2,001.98 2,001.99 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% AQHEDQVEQYKKELEK 95.00% 3.72 0.521 3.25 668.3337 2,001.98 2,001.99 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% SGAQASSTPLSPTR 95.00% 3.26 0.53 1.89 680.3467 1,358.68 1,359.69 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% AQNTWGcGNSLR 95.00% 3.65 0.493 2.68 c7: Carbamidomethyl (+57.02) 682.3109 1,362.61 1,363.62 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% AQNTWGcGNSLR 95.00% 3.4 0.47 3.01 c7: Carbamidomethyl (+57.02) 682.3116 1,362.61 1,363.62 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TVLcGTcGQPADK 95.00% 3.02 0.512 2.23 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 703.8213 1,405.63 1,406.64 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% IDSLSAQLSQLQK 95.00% 2.94 0.259 0 715.8943 1,429.77 1,430.79 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% IDSLSAQLSQLQK 95.00% 3.22 0.338 0 715.8962 1,429.78 1,430.79 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TALINSTGEEVAMR 95.00% 4.41 0.643 6.04 746.3767 1,490.74 1,491.75 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TALINSTGEEVAMR 95.00% 4.25 0.647 5.62 746.3774 1,490.74 1,491.75 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TALINSTGEEVAMR 95.00% 3.82 0.632 6.2 746.3774 1,490.74 1,491.75 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TALINSTGEEVAMR 95.00% 1.87 0.328 0 746.3777 1,490.74 1,491.75 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TALINSTGEEVAMR 95.00% 3.92 0.61 5.3 746.3792 1,490.74 1,491.75 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TALINSTGEEVAMR 95.00% 2.49 0.433 3.74 746.3797 1,490.74 1,491.75 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TALINSTGEEVAmR 95.00% 3.62 0.541 4.17 m13: Oxidation (+15.99) 754.3739 1,506.73 1,507.74 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TALINSTGEEVAmR 95.00% 3.78 0.533 5.02 m13: Oxidation (+15.99) 754.3752 1,506.73 1,507.74 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LQTmKEELDFQK 95.00% 3.39 0.357 2.68 m4: Oxidation (+15.99) 763.3795 1,524.74 1,525.76 2 FBLN3_HUMAN
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% SNEDQSMGNWQIK 95.00% 3.48 0.371 3.74 768.84 1,535.66 1,536.68 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% SNEDQSMGNWQIK 95.00% 3.96 0.394 2.18 769.341 1,536.67 1,536.68 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% SVGGSGGGSFGDNLVTR 95.00% 4.75 0.584 5.24 783.8773 1,565.74 1,566.75 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% SVGGSGGGSFGDNLVTR 95.00% 4.08 0.563 2.8 783.878 1,565.74 1,566.75 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% SVGGSGGGSFGDNLVTR 95.00% 4.84 0.554 3.74 783.8786 1,565.74 1,566.75 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% SVGGSGGGSFGDNLVTR 95.00% 4.3 0.576 3.49 783.8794 1,565.74 1,566.75 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 5.4 0.611 6.49 789.3906 2,365.15 2,365.16 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.03 0.581 7.06 789.3915 2,365.15 2,365.16 3
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% VAVEEVDEEGKFVR 95.00% 4.11 0.576 3.7 803.4057 1,604.80 1,605.81 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% VAVEEVDEEGKFVR 95.00% 4.21 0.574 4.59 803.4075 1,604.80 1,605.81 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% VAVEEVDEEGKFVR 95.00% 3.87 0.577 3.59 803.4103 1,604.81 1,605.81 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% VAVEEVDEEGKFVR 95.00% 4.12 0.55 3.15 803.4137 1,604.81 1,605.81 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% VAVEEVDEEGKFVR 95.00% 4.21 0.593 2.85 803.9076 1,605.80 1,605.81 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LQEKEDLQELNDR 95.00% 4.96 0.397 3.44 815.4059 1,628.80 1,629.81 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LQEKEDLQELNDR 95.00% 4.75 0.378 3.39 815.4062 1,628.80 1,629.81 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% LQEKEDLQELNDR 95.00% 4.14 0.337 4 815.4128 1,628.81 1,629.81 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TLEGELHDLRGQVAK 95.00% 4.47 0.517 3.1 833.4478 1,664.88 1,665.89 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% TLEGELHDLRGQVAK 95.00% 4.82 0.513 3.34 833.4492 1,664.88 1,665.89 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% SNEDQSMGNWQIKR 95.00% 3.6 0.326 1.77 847.3921 1,692.77 1,692.78 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% SNEDQSMGNWQIKR 95.00% 3.48 0.371 1.32 847.3932 1,692.77 1,692.78 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% IRIDSLSAQLSQLQK 95.00% 4.16 0.407 1.32 850.9889 1,699.96 1,699.97 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 4.96 0.531 5.34 876.9328 1,751.85 1,752.86 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 5.29 0.566 6.85 876.9335 1,751.85 1,752.86 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 5.09 0.563 4.85 876.9341 1,751.85 1,752.86 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 5.15 0.603 5.55 876.9344 1,751.85 1,752.86 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 4.54 0.574 5.01 876.9349 1,751.85 1,752.86 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 4.89 0.594 4.89 876.9361 1,751.86 1,752.86 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 4.29 0.577 5.08 876.9365 1,751.86 1,752.86 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 4.72 0.607 3.48 877.4313 1,752.85 1,752.86 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% NSNLVGAAHEELQQSR 95.00% 4.81 0.582 5.59 877.4348 1,752.85 1,752.86 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% MQQQLDEYQELLDIK 95.00% 5.5 0.462 5.06 947.4614 1,892.91 1,893.93 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% MQQQLDEYQELLDIK 95.00% 5.11 0.467 3.46 947.4642 1,892.91 1,893.93 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% MQQQLDEYQELLDIK 95.00% 4.7 0.436 5.49 947.9668 1,893.92 1,893.93 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.32 0.574 9.55 1,183.58 2,365.15 2,365.16 2
 SAMPLE 1 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 30 38 118 48.80% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.3 0.541 10.2 1,183.58 2,365.15 2,365.16 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% KLLEGEEERLR 95.00% 2.5 0.271 0 457.9258 1,370.75 1,371.76 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% KLLEGEEERLR 95.00% 2.14 0.257 0 457.9258 1,370.75 1,371.76 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% DLEDSLAR 95.00% 2.63 0.26 0 459.7291 917.4426 918.4534 2 FBLN3_HUMAN
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% DLEDSLAR 95.00% 2.6 0.279 0 459.7302 917.4447 918.4534 2 FBLN3_HUMAN
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LRITESEEVVSR 95.00% 3.68 0.257 0 473.2594 1,416.75 1,417.77 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LRITESEEVVSR 95.00% 3.77 0.279 0 473.2597 1,416.76 1,417.77 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% RQNGDDPLLTYR 95.00% 2.76 0.285 0 483.2477 1,446.72 1,447.73 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% DLEALLNSK 95.00% 2.36 0.364 0 501.7766 1,001.54 1,002.55 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LQTMKEELDFQK 95.00% 2.29 0.235 0 503.924 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LQTMKEELDFQK 95.00% 2.45 0.409 0 503.924 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LQTmKEELDFQK 95.00% 1.87 0.259 0 m4: Oxidation (+15.99) 509.5897 1,525.75 1,525.76 3 FBLN3_HUMAN
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% NIYSEELR 95.00% 2.34 0.291 0 512.2578 1,022.50 1,023.51 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LADALQELR 95.00% 3.34 0.296 0 514.789 1,027.56 1,028.57 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LADALQELR 95.00% 3.61 0.285 1.26 514.7893 1,027.56 1,028.57 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LADALQELR 95.00% 3.61 0.364 0 514.7894 1,027.56 1,028.57 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LADALQELR 95.00% 3.38 0.334 0 514.7896 1,027.56 1,028.57 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LADALQELR 95.00% 2.57 0.235 1.48 514.7899 1,027.56 1,028.57 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LADALQELR 95.00% 2.72 0.29 2.17 514.79 1,027.56 1,028.57 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LADALQELR 95.00% 3.56 0.255 1.62 514.7914 1,027.57 1,028.57 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LEAALGEAKK 95.00% 2.18 0.237 0 515.3024 1,028.59 1,029.59 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% VAVEEVDEEGKFVR 95.00% 3.19 0.324 0 535.9407 1,604.80 1,605.81 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% VAVEEVDEEGKFVR 95.00% 3.27 0.255 0 535.941 1,604.80 1,605.81 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TALINSTGEEVAMRK 95.00% 2.62 0.313 0 540.617 1,618.83 1,619.84 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TLEGELHDLRGQVAK 95.00% 1.87 0.33 0 555.967 1,664.88 1,665.89 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TLEGELHDLRGQVAK 95.00% 2.08 0.348 0 555.9678 1,664.88 1,665.89 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TLEGELHDLRGQVAK 95.00% 1.94 0.267 0 555.9679 1,664.88 1,665.89 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TLEGELHDLRGQVAK 95.00% 1.67 0.26 0 555.9681 1,664.88 1,665.89 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% SNEDQSMGNWQIKR 95.00% 2.66 0.334 0 564.9285 1,691.76 1,692.78 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% SNEDQSMGNWQIKR 95.00% 2.85 0.355 0 564.9291 1,691.76 1,692.78 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IRIDSLSAQLSQLQK 95.00% 3.77 0.389 1.27 567.3267 1,698.96 1,699.97 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IRIDSLSAQLSQLQK 95.00% 3.28 0.352 0 567.3268 1,698.96 1,699.97 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IRIDSLSAQLSQLQK 95.00% 3.31 0.296 1.1 567.3275 1,698.96 1,699.97 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IRIDSLSAQLSQLQK 95.00% 3.38 0.312 0 567.3275 1,698.96 1,699.97 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IRIDSLSAQLSQLQK 95.00% 3.74 0.278 0.959 567.3276 1,698.96 1,699.97 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IRIDSLSAQLSQLQK 95.00% 3.95 0.273 1.62 567.3276 1,698.96 1,699.97 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IRIDSLSAQLSQLQK 95.00% 4 0.324 0 567.3283 1,698.96 1,699.97 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IRIDSLSAQLSQLQK 95.00% 3.69 0.299 1.04 567.3286 1,698.96 1,699.97 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IRIDSLSAQLSQLQK 95.00% 3.73 0.275 0 567.6605 1,699.96 1,699.97 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% ITESEEVVSR 95.00% 3.3 0.445 2.21 574.7927 1,147.57 1,148.58 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% ITESEEVVSR 95.00% 2.97 0.44 1.85 574.7927 1,147.57 1,148.58 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% NSNLVGAAHEELQQSR 95.00% 2.85 0.518 0 584.9573 1,751.85 1,752.86 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% NSNLVGAAHEELQQSR 95.00% 2.64 0.395 0 584.9592 1,751.85 1,752.86 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% NSNLVGAAHEELQQSR 95.00% 2.72 0.178 0 584.9604 1,751.86 1,752.86 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% NSNLVGAAHEELQQSR 95.00% 2.11 0.385 0 585.2934 1,752.86 1,752.86 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% NSNLVGAAHEELQQSR 95.00% 2.12 0.247 0 585.2936 1,752.86 1,752.86 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% QNGDDPLLTYRFPPK 95.00% 2.9 0.383 1.64 587.9705 1,760.89 1,760.90 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% QNGDDPLLTYRFPPK 95.00% 3.25 0.39 1.52 587.9709 1,760.89 1,760.90 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TLEGELHDLR 95.00% 2.98 0.393 0 591.8063 1,181.60 1,182.61 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TLEGELHDLR 95.00% 3.06 0.42 1.49 591.808 1,181.60 1,182.61 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LRDLEDSLAR 95.00% 2.84 0.342 1.32 594.3186 1,186.62 1,187.64 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LRDLEDSLAR 95.00% 3.07 0.354 1.43 594.3205 1,186.63 1,187.64 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LRDLEDSLAR 95.00% 2.9 0.274 1.72 594.3206 1,186.63 1,187.64 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LRDLEDSLAR 95.00% 2.16 0.153 1.8 594.3208 1,186.63 1,187.64 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LRDLEDSLAR 95.00% 2.94 0.308 2.03 594.3215 1,186.63 1,187.64 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LRDLEDSLAR 95.00% 2.56 0.207 1.46 594.3234 1,186.63 1,187.64 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LKDLEALLNSK 95.00% 2.69 0.132 2.72 621.8482 1,241.68 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LKDLEALLNSK 95.00% 2.7 0.158 2.46 621.8484 1,241.68 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LKDLEALLNSK 95.00% 2.77 0.458 0 622.3627 1,242.71 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LKDLEALLNSK 95.00% 3.27 0.377 1.13 622.3653 1,242.71 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LKDLEALLNSK 95.00% 3.15 0.278 0 622.367 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LKDLEALLNSK 95.00% 2.17 0.256 0 622.3684 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% MQQQLDEYQELLDIK 95.00% 2.87 0.204 0 632.3115 1,893.91 1,893.93 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% QNGDDPLLTYR 95.00% 2.93 0.527 2.49 646.3164 1,290.62 1,291.63 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% QNGDDPLLTYR 95.00% 2.65 0.548 2.46 646.317 1,290.62 1,291.63 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% AQHEDQVEQYKKELEK 95.00% 4.01 0.582 2.15 667.9999 2,000.98 2,001.99 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% AQHEDQVEQYKKELEK 95.00% 3.86 0.568 2.37 668.334 2,001.98 2,001.99 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% SGAQASSTPLSPTR 95.00% 3.25 0.423 2.46 680.3465 1,358.68 1,359.69 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% AQNTWGcGNSLR 95.00% 3.45 0.515 3.62 c7: Carbamidomethyl (+57.02) 682.3108 1,362.61 1,363.62 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% AQNTWGcGNSLR 95.00% 3.39 0.504 3.06 c7: Carbamidomethyl (+57.02) 682.3111 1,362.61 1,363.62 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IDSLSAQLSQLQK 95.00% 3.9 0.295 2.96 715.8943 1,429.77 1,430.79 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IDSLSAQLSQLQK 95.00% 2.37 0.213 0 715.8954 1,429.78 1,430.79 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IDSLSAQLSQLQK 95.00% 3.64 0.384 2.85 715.8958 1,429.78 1,430.79 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IDSLSAQLSQLQK 95.00% 3.16 0.291 0 715.8965 1,429.78 1,430.79 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TALINSTGEEVAMR 95.00% 4.25 0.638 6.39 746.3752 1,490.73 1,491.75 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TALINSTGEEVAMR 95.00% 4.72 0.639 6.92 746.3769 1,490.74 1,491.75 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TALINSTGEEVAMR 95.00% 3.36 0.569 5.12 746.3774 1,490.74 1,491.75 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TALINSTGEEVAMR 95.00% 3.58 0.603 5.11 746.3774 1,490.74 1,491.75 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TALINSTGEEVAmR 95.00% 3.68 0.578 4.82 m13: Oxidation (+15.99) 754.3757 1,506.74 1,507.74 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TALINSTGEEVAmR 95.00% 3.66 0.561 5.54 m13: Oxidation (+15.99) 754.3758 1,506.74 1,507.74 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% SNEDQSMGNWQIK 95.00% 3.79 0.485 3.44 768.8395 1,535.66 1,536.68 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% SNEDQSMGNWQIK 95.00% 3.56 0.41 2.8 768.8412 1,535.67 1,536.68 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% SVGGSGGGSFGDNLVTR 95.00% 4.12 0.577 3.48 783.8775 1,565.74 1,566.75 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% SVGGSGGGSFGDNLVTR 95.00% 4.52 0.557 4.13 783.8778 1,565.74 1,566.75 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% SVGGSGGGSFGDNLVTR 95.00% 4.5 0.58 4.89 783.8783 1,565.74 1,566.75 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% SVGGSGGGSFGDNLVTR 95.00% 4.35 0.55 3.48 783.88 1,565.74 1,566.75 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 5 0.587 5.46 789.3909 2,365.15 2,365.16 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 5.07 0.588 5.49 789.3927 2,365.15 2,365.16 3
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% VAVEEVDEEGKFVR 95.00% 4.07 0.538 3.46 803.4032 1,604.79 1,605.81 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% VAVEEVDEEGKFVR 95.00% 4.35 0.573 5.59 803.4061 1,604.80 1,605.81 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% VAVEEVDEEGKFVR 95.00% 3.59 0.571 4.32 803.4108 1,604.81 1,605.81 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% VAVEEVDEEGKFVR 95.00% 4.03 0.557 4.16 803.909 1,605.80 1,605.81 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TALINSTGEEVAMRK 95.00% 3.66 0.436 3 810.4236 1,618.83 1,619.84 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LQEKEDLQELNDR 95.00% 4.71 0.366 3.82 815.406 1,628.80 1,629.81 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LQEKEDLQELNDR 95.00% 4.92 0.379 4.08 815.4064 1,628.80 1,629.81 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% LQEKEDLQELNDR 95.00% 4.14 0.337 4.21 815.4128 1,628.81 1,629.81 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TALINSTGEEVAmRK 95.00% 3.71 0.421 2.4 m13: Oxidation (+15.99) 818.4201 1,634.82 1,635.84 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TLEGELHDLRGQVAK 95.00% 4.95 0.597 2.8 833.4482 1,664.88 1,665.89 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% TLEGELHDLRGQVAK 95.00% 4.63 0.532 3.09 833.4486 1,664.88 1,665.89 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% SNEDQSMGNWQIKR 95.00% 3.42 0.367 1.43 846.8909 1,691.77 1,692.78 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% SNEDQSMGNWQIKR 95.00% 3.48 0.358 2.23 846.891 1,691.77 1,692.78 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IRIDSLSAQLSQLQK 95.00% 4.75 0.413 4.41 850.9883 1,699.96 1,699.97 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% IRIDSLSAQLSQLQK 95.00% 4.42 0.44 3.89 850.9886 1,699.96 1,699.97 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% NSNLVGAAHEELQQSR 95.00% 5.36 0.598 3.7 876.9326 1,751.85 1,752.86 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% NSNLVGAAHEELQQSR 95.00% 5.38 0.577 5.04 876.9328 1,751.85 1,752.86 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% NSNLVGAAHEELQQSR 95.00% 5.1 0.59 4.89 876.933 1,751.85 1,752.86 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% NSNLVGAAHEELQQSR 95.00% 5.06 0.582 4.08 876.933 1,751.85 1,752.86 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% NSNLVGAAHEELQQSR 95.00% 4.93 0.574 4.09 876.9341 1,751.85 1,752.86 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% NSNLVGAAHEELQQSR 95.00% 5.17 0.55 5.8 876.9358 1,751.86 1,752.86 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% MQQQLDEYQELLDIK 95.00% 5.28 0.485 3.96 947.4653 1,892.92 1,893.93 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% MQQQLDEYQELLDIK 95.00% 5.03 0.396 4.38 947.9666 1,893.92 1,893.93 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.4 0.577 9.02 1,183.58 2,365.15 2,365.16 2
 SAMPLE 1R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 31 39 112 45.30% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.14 0.58 10 1,183.58 2,365.15 2,365.16 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% KLLEGEEERLR 95.00% 2.46 0.225 0 457.9244 1,370.75 1,371.76 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% KLLEGEEERLR 95.00% 2.48 0.237 0 457.925 1,370.75 1,371.76 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% KLLEGEEERLR 95.00% 2.36 0.188 0 457.9265 1,370.76 1,371.76 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% KLLEGEEERLR 95.00% 2.38 0.207 0 457.9268 1,370.76 1,371.76 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% DLEDSLAR 95.00% 2.61 0.309 0 459.73 917.4444 918.4534 2 FBLN3_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% DLEDSLAR 95.00% 2.69 0.288 0 459.731 917.4464 918.4534 2 FBLN3_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% DLEDSLAR 95.00% 2.33 0.206 0 459.7314 917.4471 918.4534 2 FBLN3_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NIYSEELRETK 95.00% 1.36 0.304 0 461.2379 1,380.69 1,381.70 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LRITESEEVVSR 95.00% 3.96 0.184 0 473.2591 1,416.75 1,417.77 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LRITESEEVVSR 95.00% 3.63 0.169 0 473.2597 1,416.76 1,417.77 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LRITESEEVVSR 95.00% 3.55 0.188 0 473.2601 1,416.76 1,417.77 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LQTMKEELDFQK 95.00% 2.74 0.347 1.36 503.9242 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LQTMKEELDFQK 95.00% 3.27 0.497 1.42 503.9247 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LQTMKEELDFQK 95.00% 2.77 0.309 0 503.9251 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LQTMKEELDFQK 95.00% 2.92 0.45 0 504.2605 1,509.76 1,509.76 3 FBLN3_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NIYSEELR 95.00% 2.04 0.25 0 512.2577 1,022.50 1,023.51 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NIYSEELR 95.00% 2.25 0.298 1.46 512.2578 1,022.50 1,023.51 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NIYSEELR 95.00% 2.3 0.273 1.19 512.2583 1,022.50 1,023.51 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NIYSEELR 95.00% 2.26 0.284 2.36 512.2586 1,022.50 1,023.51 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LADALQELR 95.00% 3.56 0.302 1.66 514.7887 1,027.56 1,028.57 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LADALQELR 95.00% 2.26 0.246 0 514.7888 1,027.56 1,028.57 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LADALQELR 95.00% 3.88 0.328 1.44 514.7897 1,027.56 1,028.57 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LADALQELR 95.00% 3.92 0.329 1.29 514.7898 1,027.56 1,028.57 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LADALQELR 95.00% 3.82 0.359 1.48 514.7898 1,027.56 1,028.57 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LADALQELR 95.00% 4.1 0.341 1.41 514.7898 1,027.56 1,028.57 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LADALQELR 95.00% 3.74 0.32 1.72 514.7898 1,027.56 1,028.57 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LADALQELR 95.00% 2.98 0.323 0 515.3119 1,028.61 1,028.57 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% EGDLIAAQAR 95.00% 2.2 0.254 0 522.2788 1,042.54 1,043.55 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% VAVEEVDEEGKFVR 95.00% 2.25 0.292 0 535.9405 1,604.80 1,605.81 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% VAVEEVDEEGKFVR 95.00% 2.83 0.132 0 535.9409 1,604.80 1,605.81 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% VAVEEVDEEGKFVR 95.00% 2.42 0.277 0 535.9412 1,604.80 1,605.81 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% VAVEEVDEEGKFVR 95.00% 2.56 0.322 1.16 535.9412 1,604.80 1,605.81 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TALINSTGEEVAMRK 95.00% 2.94 0.285 0 540.6184 1,618.83 1,619.84 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TALINSTGEEVAMRK 95.00% 3.06 0.314 1.59 540.6188 1,618.83 1,619.84 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LQEKEDLQELNDR 95.00% 4.13 0.274 0 543.9395 1,628.80 1,629.81 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LQEKEDLQELNDR 95.00% 4.28 0.281 0 543.9409 1,628.80 1,629.81 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLRGQVAK 95.00% 1.57 0.28 0 555.9674 1,664.88 1,665.89 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLRGQVAK 95.00% 2.3 0.387 0 555.9679 1,664.88 1,665.89 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLRGQVAK 95.00% 2.15 0.327 1.6 555.9683 1,664.88 1,665.89 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLRGQVAK 95.00% 1.94 0.278 0 555.9687 1,664.88 1,665.89 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLRGQVAK 95.00% 2.44 0.359 0 556.3026 1,665.88 1,665.89 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SNEDQSMGNWQIKR 95.00% 2.55 0.329 0 564.9295 1,691.77 1,692.78 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SNEDQSMGNWQIKR 95.00% 3.07 0.446 0 564.9297 1,691.77 1,692.78 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SNEDQSMGNWQIKR 95.00% 2.38 0.334 0 565.2626 1,692.76 1,692.78 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SNEDQSMGNWQIKR 95.00% 2.7 0.434 0 565.2643 1,692.77 1,692.78 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 4.15 0.319 0 567.327 1,698.96 1,699.97 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 4.38 0.283 1.39 567.3275 1,698.96 1,699.97 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 4.59 0.365 0 567.3277 1,698.96 1,699.97 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 4.18 0.358 1 567.3282 1,698.96 1,699.97 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 2.99 0.294 0 567.3287 1,698.96 1,699.97 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 3.81 0.236 1.57 567.329 1,698.96 1,699.97 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 4.24 0.25 1.8 567.6608 1,699.96 1,699.97 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 4.36 0.164 0 567.6617 1,699.96 1,699.97 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 4.27 0.285 0 567.6621 1,699.96 1,699.97 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% ITESEEVVSR 95.00% 3.37 0.502 1.6 574.7926 1,147.57 1,148.58 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% ITESEEVVSR 95.00% 3.34 0.466 1.28 574.7926 1,147.57 1,148.58 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% ITESEEVVSR 95.00% 3.38 0.479 0 574.7927 1,147.57 1,148.58 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% AAYEAELGDAR 95.00% 2.94 0.349 2.37 583.2756 1,164.54 1,165.55 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% AAYEAELGDAR 95.00% 3.26 0.482 1.74 583.2763 1,164.54 1,165.55 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 3.98 0.567 0 584.958 1,751.85 1,752.86 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 2.72 0.46 0 584.9583 1,751.85 1,752.86 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 3.23 0.522 0 584.9587 1,751.85 1,752.86 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 2.76 0.431 0 584.9596 1,751.86 1,752.86 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 4.06 0.538 0 585.2927 1,752.85 1,752.86 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% QNGDDPLLTYRFPPK 95.00% 2.74 0.234 0 587.317 1,758.93 1,760.90 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% QNGDDPLLTYRFPPK 95.00% 2.65 0.394 0 587.6377 1,759.89 1,760.90 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% QNGDDPLLTYRFPPK 95.00% 2.92 0.3 1.6 587.9705 1,760.89 1,760.90 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLR 95.00% 2.76 0.399 0 591.8089 1,181.60 1,182.61 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLR 95.00% 2.26 0.338 0 591.8089 1,181.60 1,182.61 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLR 95.00% 2.62 0.372 0 591.8094 1,181.60 1,182.61 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLR 95.00% 2.78 0.404 1.82 592.3091 1,182.60 1,182.61 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LRDLEDSLAR 95.00% 3.09 0.336 1.3 594.3208 1,186.63 1,187.64 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LRDLEDSLAR 95.00% 3.08 0.387 1.77 594.3216 1,186.63 1,187.64 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LRDLEDSLAR 95.00% 2.89 0.347 1.85 594.3219 1,186.63 1,187.64 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LRDLEDSLAR 95.00% 2.81 0.296 1.2 594.322 1,186.63 1,187.64 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LRDLEDSLAR 95.00% 2.93 0.294 0 594.3222 1,186.63 1,187.64 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LRDLEDSLAR 95.00% 3.02 0.371 1.8 594.3224 1,186.63 1,187.64 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LLEGEEERLR 95.00% 3.06 0.248 0 622.3339 1,242.65 1,243.66 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LLEGEEERLR 95.00% 3.11 0.289 0 622.3341 1,242.65 1,243.66 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LKDLEALLNSK 95.00% 2.45 0.405 2.07 622.3648 1,242.71 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LKDLEALLNSK 95.00% 3.76 0.407 2.96 622.3651 1,242.71 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LKDLEALLNSK 95.00% 3.24 0.426 0 622.3652 1,242.71 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LKDLEALLNSK 95.00% 2.9 0.396 2 622.3656 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LKDLEALLNSK 95.00% 3.48 0.433 1.24 622.3656 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LKDLEALLNSK 95.00% 3.38 0.416 2 622.3665 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LKDLEALLNSK 95.00% 3.47 0.344 0 622.3671 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LKDLEALLNSK 95.00% 3.61 0.453 1.36 622.3682 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NKSNEDQSMGNWQIKR 95.00% 3.89 0.512 0 645.9772 1,934.91 1,934.91 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% QNGDDPLLTYR 95.00% 2.8 0.531 2.48 646.3151 1,290.61 1,291.63 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% QNGDDPLLTYR 95.00% 2.63 0.412 2 646.3161 1,290.62 1,291.63 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% AQHEDQVEQYKKELEK 95.00% 3.17 0.528 1.59 668.0005 2,000.98 2,001.99 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% AQHEDQVEQYKKELEK 95.00% 4.28 0.504 0 668.3339 2,001.98 2,001.99 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% AQNTWGcGNSLR 95.00% 2.72 0.342 2.32 c7: Carbamidomethyl (+57.02) 682.3099 1,362.60 1,363.62 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% AQNTWGcGNSLR 95.00% 3.43 0.492 3.26 c7: Carbamidomethyl (+57.02) 682.3109 1,362.61 1,363.62 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% AQNTWGcGNSLR 95.00% 3.72 0.545 3.52 c7: Carbamidomethyl (+57.02) 682.311 1,362.61 1,363.62 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% AQNTWGcGNSLR 95.00% 3.69 0.489 2.72 c7: Carbamidomethyl (+57.02) 682.311 1,362.61 1,363.62 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% AQNTWGcGNSLR 95.00% 3.87 0.413 3.12 c7: Carbamidomethyl (+57.02) 682.311 1,362.61 1,363.62 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% AQNTWGcGNSLR 95.00% 3.69 0.484 3 c7: Carbamidomethyl (+57.02) 682.3112 1,362.61 1,363.62 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% KLLEGEEERLR 95.00% 3.4 0.254 1.42 686.3817 1,370.75 1,371.76 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NIYSEELRETK 95.00% 3.13 0.35 1.2 691.35 1,380.68 1,381.70 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NIYSEELRETK 95.00% 3.46 0.44 1.52 691.351 1,380.69 1,381.70 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IDSLSAQLSQLQK 95.00% 2.37 0.294 0 715.8934 1,429.77 1,430.79 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IDSLSAQLSQLQK 95.00% 2.7 0.179 0 715.8936 1,429.77 1,430.79 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IDSLSAQLSQLQK 95.00% 4 0.381 3.09 715.8947 1,429.77 1,430.79 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IDSLSAQLSQLQK 95.00% 4.07 0.354 3.47 715.896 1,429.78 1,430.79 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TALINSTGEEVAMR 95.00% 4.34 0.634 6.23 746.377 1,490.74 1,491.75 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TALINSTGEEVAMR 95.00% 4.47 0.639 6.72 746.3777 1,490.74 1,491.75 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TALINSTGEEVAMR 95.00% 3.39 0.57 5.77 746.3782 1,490.74 1,491.75 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TALINSTGEEVAMR 95.00% 4.31 0.646 6.36 746.3782 1,490.74 1,491.75 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LQTMKEELDFQK 95.00% 4.23 0.435 1.74 755.3839 1,508.75 1,509.76 2 FBLN3_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LQTMKEELDFQK 95.00% 4.28 0.453 2.08 755.384 1,508.75 1,509.76 2 FBLN3_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LQTMKEELDFQK 95.00% 4.21 0.459 1.8 755.3849 1,508.75 1,509.76 2 FBLN3_HUMAN
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SNEDQSMGNWQIK 95.00% 3.95 0.497 3.17 768.8401 1,535.66 1,536.68 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SNEDQSMGNWQIK 95.00% 4.37 0.478 4.13 768.8401 1,535.66 1,536.68 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SNEDQSMGNWQIK 95.00% 3.9 0.441 2.57 768.8401 1,535.66 1,536.68 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SNEDQSMGNWQIK 95.00% 4.01 0.435 3.85 769.3411 1,536.67 1,536.68 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SVGGSGGGSFGDNLVTR 95.00% 4.55 0.568 6.02 783.8782 1,565.74 1,566.75 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SVGGSGGGSFGDNLVTR 95.00% 4.43 0.576 3.43 783.8783 1,565.74 1,566.75 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SVGGSGGGSFGDNLVTR 95.00% 4.42 0.579 5.08 783.8784 1,565.74 1,566.75 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SVGGSGGGSFGDNLVTR 95.00% 4.49 0.55 3.4 783.8785 1,565.74 1,566.75 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.19 0.597 6.09 789.3907 2,365.15 2,365.16 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 4.01 0.442 2.17 789.3925 2,365.15 2,365.16 3
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% VAVEEVDEEGKFVR 95.00% 4.28 0.603 3.05 803.4095 1,604.80 1,605.81 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% VAVEEVDEEGKFVR 95.00% 4.68 0.583 4.48 803.4096 1,604.80 1,605.81 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% VAVEEVDEEGKFVR 95.00% 4.48 0.573 3.72 803.4097 1,604.80 1,605.81 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% VAVEEVDEEGKFVR 95.00% 4.5 0.571 4.49 803.9105 1,605.81 1,605.81 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LQEKEDLQELNDR 95.00% 4.71 0.367 4 815.4079 1,628.80 1,629.81 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% LQEKEDLQELNDR 95.00% 4.91 0.391 5.15 815.4088 1,628.80 1,629.81 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TALINSTGEEVAmRK 95.00% 3.62 0.358 1.8 m13: Oxidation (+15.99) 818.4202 1,634.82 1,635.84 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLRGQVAK 95.00% 4.02 0.182 1.96 833.4455 1,664.88 1,665.89 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLRGQVAK 95.00% 4.49 0.569 2.74 833.4482 1,664.88 1,665.89 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLRGQVAK 95.00% 4.41 0.514 1.89 833.95 1,665.88 1,665.89 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% TLEGELHDLRGQVAK 95.00% 5.14 0.545 3.28 833.951 1,665.89 1,665.89 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SNEDQSMGNWQIKR 95.00% 3.46 0.399 1.46 846.8901 1,691.76 1,692.78 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SNEDQSMGNWQIKR 95.00% 3.57 0.35 0 846.8909 1,691.77 1,692.78 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SNEDQSMGNWQIKR 95.00% 3.58 0.373 0 846.893 1,691.77 1,692.78 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% SNEDQSMGNWQIKR 95.00% 3.46 0.338 1.59 847.3931 1,692.77 1,692.78 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 4.66 0.431 3.62 850.4877 1,698.96 1,699.97 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 4.52 0.421 4.77 850.488 1,698.96 1,699.97 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 4.78 0.442 4.28 850.4881 1,698.96 1,699.97 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% IRIDSLSAQLSQLQK 95.00% 4.72 0.449 3.74 850.4887 1,698.96 1,699.97 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 5.15 0.561 4.02 876.9312 1,751.85 1,752.86 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 5.26 0.565 4.52 876.9326 1,751.85 1,752.86 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 5.04 0.584 3.8 876.9331 1,751.85 1,752.86 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 5.12 0.588 3.48 876.9339 1,751.85 1,752.86 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 5.13 0.577 5.18 876.9364 1,751.86 1,752.86 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 4.9 0.571 5.47 877.4332 1,752.85 1,752.86 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 4.86 0.595 6.18 877.435 1,752.85 1,752.86 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% NSNLVGAAHEELQQSR 95.00% 5.13 0.556 3.33 877.4357 1,752.86 1,752.86 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% MQQQLDEYQELLDIK 95.00% 4.44 0.465 5.85 947.4636 1,892.91 1,893.93 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% MQQQLDEYQELLDIK 95.00% 5.38 0.46 4.31 947.4652 1,892.91 1,893.93 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% MQQQLDEYQELLDIK 95.00% 5.12 0.402 5.6 947.9665 1,893.92 1,893.93 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.18 0.54 9.74 1,183.58 2,365.15 2,365.16 2
 SAMPLE 2 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 32 43 154 45.60% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.38 0.577 10.1 1,183.58 2,365.15 2,365.16 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% KLLEGEEERLR 95.00% 2.31 0.266 0 457.9257 1,370.75 1,371.76 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% KLLEGEEERLR 95.00% 2.14 0.212 0 457.926 1,370.75 1,371.76 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% KLLEGEEERLR 95.00% 2.23 0.287 0 457.9264 1,370.76 1,371.76 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% KLLEGEEERLR 95.00% 2.14 0.24 0 457.9274 1,370.76 1,371.76 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% DLEDSLAR 95.00% 2.29 0.289 0 459.7302 917.4447 918.4534 2 FBLN3_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% DLEDSLAR 95.00% 2.46 0.262 0 459.7305 917.4454 918.4534 2 FBLN3_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LRITESEEVVSR 95.00% 3.52 0.153 0 473.2595 1,416.76 1,417.77 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LRITESEEVVSR 95.00% 3.46 0.19 0 473.2599 1,416.76 1,417.77 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LRITESEEVVSR 95.00% 3.69 0.135 0 473.26 1,416.76 1,417.77 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LRITESEEVVSR 95.00% 3.62 0.18 0 473.5944 1,417.76 1,417.77 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% DLEALLNSK 95.00% 2.25 0.28 0 501.7757 1,001.54 1,002.55 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQTMKEELDFQK 95.00% 2.96 0.442 1.41 503.9233 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQTMKEELDFQK 95.00% 2.06 0.302 0 503.9242 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQTMKEELDFQK 95.00% 3.63 0.544 0 503.9243 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQTMKEELDFQK 95.00% 2.88 0.343 0 503.9244 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQTmKEELDFQK 95.00% 2.21 0.191 0 m4: Oxidation (+15.99) 509.2537 1,524.74 1,525.76 3 FBLN3_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NIYSEELR 95.00% 2.11 0.292 1.35 512.258 1,022.50 1,023.51 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NIYSEELR 95.00% 2.28 0.304 1.74 512.2582 1,022.50 1,023.51 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NIYSEELR 95.00% 1.84 0.29 0 512.2583 1,022.50 1,023.51 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NIYSEELR 95.00% 2.06 0.243 1.59 512.2586 1,022.50 1,023.51 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LADALQELR 95.00% 3.5 0.293 1.18 514.7886 1,027.56 1,028.57 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LADALQELR 95.00% 3.86 0.342 0 514.7893 1,027.56 1,028.57 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LADALQELR 95.00% 3.69 0.343 0 514.7893 1,027.56 1,028.57 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LADALQELR 95.00% 3.81 0.343 1.17 514.7894 1,027.56 1,028.57 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LADALQELR 95.00% 3.63 0.297 1.57 514.7897 1,027.56 1,028.57 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LADALQELR 95.00% 2.65 0.22 0 514.7898 1,027.56 1,028.57 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LADALQELR 95.00% 3.88 0.243 1.42 514.79 1,027.56 1,028.57 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LEAALGEAKK 95.00% 2.32 0.28 0 515.303 1,028.59 1,029.59 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% VAVEEVDEEGKFVR 95.00% 3.19 0.416 1.28 535.9407 1,604.80 1,605.81 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% VAVEEVDEEGKFVR 95.00% 2.36 0.305 0 535.9409 1,604.80 1,605.81 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% VAVEEVDEEGKFVR 95.00% 2.93 0.347 0 535.941 1,604.80 1,605.81 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% VAVEEVDEEGKFVR 95.00% 2.52 0.243 0 535.9413 1,604.80 1,605.81 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% VAVEEVDEEGKFVR 95.00% 2.92 0.276 0 535.9423 1,604.80 1,605.81 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% VAVEEVDEEGKFVR 95.00% 2.48 0.238 0 536.2761 1,605.80 1,605.81 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TALINSTGEEVAMRK 95.00% 2.74 0.355 0 540.618 1,618.83 1,619.84 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TALINSTGEEVAMRK 95.00% 2.84 0.317 0 540.6182 1,618.83 1,619.84 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TALINSTGEEVAMRK 95.00% 3.18 0.379 0 540.6186 1,618.83 1,619.84 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQEKEDLQELNDR 95.00% 4.25 0.342 0 543.9398 1,628.80 1,629.81 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQEKEDLQELNDR 95.00% 3.6 0.29 0 543.9406 1,628.80 1,629.81 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQEKEDLQELNDR 95.00% 4.43 0.254 0 543.9409 1,628.80 1,629.81 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQEKEDLQELNDR 95.00% 3.31 0.191 0 543.9431 1,628.81 1,629.81 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQEKEDLQELNDR 95.00% 3.85 0.327 0 544.2745 1,629.80 1,629.81 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TLEGELHDLRGQVAK 95.00% 2.25 0.259 0 555.9675 1,664.88 1,665.89 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TLEGELHDLRGQVAK 95.00% 2.25 0.392 0 555.9675 1,664.88 1,665.89 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TLEGELHDLRGQVAK 95.00% 1.88 0.281 0 555.968 1,664.88 1,665.89 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TLEGELHDLRGQVAK 95.00% 1.68 0.265 0 555.9686 1,664.88 1,665.89 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TLEGELHDLRGQVAK 95.00% 1.99 0.271 0 556.3048 1,665.89 1,665.89 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SNEDQSMGNWQIKR 95.00% 2.49 0.235 0 564.9296 1,691.77 1,692.78 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SNEDQSMGNWQIKR 95.00% 2.73 0.265 0 564.9301 1,691.77 1,692.78 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SNEDQSMGNWQIKR 95.00% 2.56 0.412 0 564.9305 1,691.77 1,692.78 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SNEDQSMGNWQIKR 95.00% 2.79 0.444 0 565.2636 1,692.77 1,692.78 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IRIDSLSAQLSQLQK 95.00% 4.17 0.299 0 567.3262 1,698.96 1,699.97 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IRIDSLSAQLSQLQK 95.00% 4.45 0.287 1 567.3275 1,698.96 1,699.97 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IRIDSLSAQLSQLQK 95.00% 3.57 0.27 0 567.3278 1,698.96 1,699.97 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IRIDSLSAQLSQLQK 95.00% 3.95 0.269 0 567.3284 1,698.96 1,699.97 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IRIDSLSAQLSQLQK 95.00% 3.63 0.279 1 567.6613 1,699.96 1,699.97 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IRIDSLSAQLSQLQK 95.00% 4.19 0.203 1.05 567.6628 1,699.97 1,699.97 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% ITESEEVVSR 95.00% 3.39 0.472 1.24 574.7925 1,147.57 1,148.58 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% ITESEEVVSR 95.00% 3.08 0.437 1.62 574.7932 1,147.57 1,148.58 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% ITESEEVVSR 95.00% 3.18 0.429 0 574.7935 1,147.57 1,148.58 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% ITESEEVVSR 95.00% 3.22 0.49 1.66 574.7943 1,147.57 1,148.58 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% AAYEAELGDAR 95.00% 3.68 0.454 3.17 583.2755 1,164.54 1,165.55 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% AAYEAELGDAR 95.00% 3 0.463 3 583.2757 1,164.54 1,165.55 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% AAYEAELGDAR 95.00% 3.86 0.436 1.89 583.2771 1,164.54 1,165.55 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NSNLVGAAHEELQQSR 95.00% 3.02 0.462 0 584.9579 1,751.85 1,752.86 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NSNLVGAAHEELQQSR 95.00% 2.69 0.243 0 584.9587 1,751.85 1,752.86 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NSNLVGAAHEELQQSR 95.00% 2.81 0.463 0 584.9593 1,751.85 1,752.86 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NSNLVGAAHEELQQSR 95.00% 2.42 0.418 0 585.293 1,752.86 1,752.86 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NSNLVGAAHEELQQSR 95.00% 3.64 0.452 0 585.2932 1,752.86 1,752.86 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% QNGDDPLLTYRFPPK 95.00% 2.75 0.236 1 587.9697 1,760.89 1,760.90 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% QNGDDPLLTYRFPPK 95.00% 2.62 0.265 0 587.9711 1,760.89 1,760.90 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% ITESEEVVSREVSGIK 95.00% 2.72 0.382 1.2 587.978 1,760.91 1,761.92 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TLEGELHDLR 95.00% 2.79 0.363 0 591.808 1,181.60 1,182.61 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TLEGELHDLR 95.00% 2.95 0.439 0 591.8084 1,181.60 1,182.61 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TLEGELHDLR 95.00% 3.01 0.38 0 591.8084 1,181.60 1,182.61 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LRDLEDSLAR 95.00% 2.87 0.217 1.72 594.3211 1,186.63 1,187.64 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LRDLEDSLAR 95.00% 3.08 0.334 1.31 594.3217 1,186.63 1,187.64 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LRDLEDSLAR 95.00% 3.16 0.337 1.51 594.3217 1,186.63 1,187.64 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LRDLEDSLAR 95.00% 2.72 0.203 1.49 594.3219 1,186.63 1,187.64 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LRDLEDSLAR 95.00% 3.03 0.359 1.11 594.3222 1,186.63 1,187.64 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LRDLEDSLAR 95.00% 2.87 0.206 1.55 594.3224 1,186.63 1,187.64 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LVEIDNGKQREFESR 95.00% 2.54 0.254 0 607.6429 1,819.91 1,819.93 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LKDLEALLNSK 95.00% 2.22 0.397 0 622.3626 1,242.71 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LKDLEALLNSK 95.00% 3.78 0.43 1.96 622.3659 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LKDLEALLNSK 95.00% 3.7 0.406 1.57 622.3666 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LKDLEALLNSK 95.00% 3.52 0.382 2.11 622.3666 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% QNGDDPLLTYR 95.00% 2.54 0.491 2.37 646.3142 1,290.61 1,291.63 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% QNGDDPLLTYR 95.00% 2.6 0.495 2.49 646.3166 1,290.62 1,291.63 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LALDMEIHAYR 95.00% 2.23 0.316 2.12 666.341 1,330.67 1,331.68 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% AQHEDQVEQYKKELEK 95.00% 4.02 0.517 0 668.3331 2,001.98 2,001.99 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% AQHEDQVEQYKKELEK 95.00% 4.78 0.46 1.3 668.3351 2,001.98 2,001.99 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% AQNTWGcGNSLR 95.00% 3.56 0.491 3.68 c7: Carbamidomethyl (+57.02) 682.3106 1,362.61 1,363.62 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% AQNTWGcGNSLR 95.00% 3.69 0.473 3.07 c7: Carbamidomethyl (+57.02) 682.3109 1,362.61 1,363.62 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% AQNTWGcGNSLR 95.00% 3.7 0.504 3.62 c7: Carbamidomethyl (+57.02) 682.3111 1,362.61 1,363.62 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% AQNTWGcGNSLR 95.00% 3.57 0.506 3.59 c7: Carbamidomethyl (+57.02) 682.3112 1,362.61 1,363.62 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% AQNTWGcGNSLR 95.00% 3.17 0.398 3.09 c7: Carbamidomethyl (+57.02) 682.3127 1,362.61 1,363.62 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NIYSEELRETK 95.00% 3.12 0.396 1.21 691.35 1,380.68 1,381.70 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NIYSEELRETK 95.00% 3.2 0.42 0 691.3512 1,380.69 1,381.70 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IDSLSAQLSQLQK 95.00% 3.93 0.302 3.47 715.8944 1,429.77 1,430.79 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IDSLSAQLSQLQK 95.00% 3.63 0.245 3.21 715.8953 1,429.77 1,430.79 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IDSLSAQLSQLQK 95.00% 3.85 0.261 2.85 715.8956 1,429.78 1,430.79 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IDSLSAQLSQLQK 95.00% 3.72 0.328 1.89 715.8956 1,429.78 1,430.79 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TALINSTGEEVAMR 95.00% 4.38 0.623 6 746.3769 1,490.74 1,491.75 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TALINSTGEEVAMR 95.00% 4.53 0.615 6.39 746.377 1,490.74 1,491.75 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TALINSTGEEVAMR 95.00% 4.18 0.662 6.96 746.377 1,490.74 1,491.75 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TALINSTGEEVAMR 95.00% 4.03 0.588 5.48 746.3792 1,490.74 1,491.75 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TALINSTGEEVAmR 95.00% 3.26 0.418 5.17 m13: Oxidation (+15.99) 754.8786 1,507.74 1,507.74 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQTMKEELDFQK 95.00% 4.25 0.434 2.01 755.3838 1,508.75 1,509.76 2 FBLN3_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQTMKEELDFQK 95.00% 3.94 0.412 1.74 755.3864 1,508.76 1,509.76 2 FBLN3_HUMAN
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SNEDQSMGNWQIK 95.00% 3.03 0.363 3.12 768.8402 1,535.66 1,536.68 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SNEDQSMGNWQIK 95.00% 3.8 0.473 4.02 768.8403 1,535.67 1,536.68 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SNEDQSMGNWQIK 95.00% 4.13 0.457 4.42 768.8435 1,535.67 1,536.68 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SNEDQSMGNWQIK 95.00% 3.75 0.451 2.44 769.3419 1,536.67 1,536.68 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SVGGSGGGSFGDNLVTR 95.00% 4.6 0.568 3.74 783.8784 1,565.74 1,566.75 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SVGGSGGGSFGDNLVTR 95.00% 4.32 0.557 2.74 783.8789 1,565.74 1,566.75 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SVGGSGGGSFGDNLVTR 95.00% 4.38 0.572 4.09 783.8794 1,565.74 1,566.75 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 4.59 0.536 4.68 789.3916 2,365.15 2,365.16 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 4.12 0.563 4.12 789.392 2,365.15 2,365.16 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 5.07 0.61 4.72 789.3931 2,365.16 2,365.16 3
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% VAVEEVDEEGKFVR 95.00% 4.37 0.585 4.13 803.4079 1,604.80 1,605.81 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% VAVEEVDEEGKFVR 95.00% 4.47 0.598 4.6 803.4092 1,604.80 1,605.81 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% VAVEEVDEEGKFVR 95.00% 4.31 0.586 4.22 803.4099 1,604.80 1,605.81 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% VAVEEVDEEGKFVR 95.00% 4.32 0.531 4.08 803.9107 1,605.81 1,605.81 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TALINSTGEEVAMRK 95.00% 3.61 0.463 3.02 810.4259 1,618.84 1,619.84 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQEKEDLQELNDR 95.00% 4.59 0.38 4.04 815.4068 1,628.80 1,629.81 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQEKEDLQELNDR 95.00% 4.79 0.365 4.41 815.4082 1,628.80 1,629.81 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQEKEDLQELNDR 95.00% 4.44 0.428 3.32 815.4091 1,628.80 1,629.81 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% LQEKEDLQELNDR 95.00% 4.75 0.366 4.62 815.9092 1,629.80 1,629.81 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TLEGELHDLRGQVAK 95.00% 3.98 0.282 3.16 833.4437 1,664.87 1,665.89 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TLEGELHDLRGQVAK 95.00% 4.13 0.521 3.11 833.45 1,664.88 1,665.89 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TLEGELHDLRGQVAK 95.00% 4.59 0.539 2.68 833.948 1,665.88 1,665.89 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% TLEGELHDLRGQVAK 95.00% 3.99 0.466 2.6 833.9512 1,665.89 1,665.89 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SNEDQSMGNWQIKR 95.00% 3.82 0.37 0 846.8905 1,691.77 1,692.78 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SNEDQSMGNWQIKR 95.00% 3.7 0.327 1.28 846.8907 1,691.77 1,692.78 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SNEDQSMGNWQIKR 95.00% 3.39 0.427 1.68 846.8932 1,691.77 1,692.78 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% SNEDQSMGNWQIKR 95.00% 3.61 0.326 2.27 847.3914 1,692.77 1,692.78 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IRIDSLSAQLSQLQK 95.00% 4.27 0.458 3.92 850.4865 1,698.96 1,699.97 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IRIDSLSAQLSQLQK 95.00% 5.04 0.446 3.44 850.4875 1,698.96 1,699.97 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IRIDSLSAQLSQLQK 95.00% 4.71 0.452 4.28 850.4878 1,698.96 1,699.97 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IRIDSLSAQLSQLQK 95.00% 4.79 0.441 3.68 850.4889 1,698.96 1,699.97 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IRIDSLSAQLSQLQK 95.00% 4.21 0.436 3.42 850.4889 1,698.96 1,699.97 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% IRIDSLSAQLSQLQK 95.00% 4.74 0.427 4.12 850.4894 1,698.96 1,699.97 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NSNLVGAAHEELQQSR 95.00% 5.01 0.596 6.08 876.9337 1,751.85 1,752.86 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NSNLVGAAHEELQQSR 95.00% 5.01 0.597 6.68 876.9341 1,751.85 1,752.86 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NSNLVGAAHEELQQSR 95.00% 5.24 0.596 5.06 876.9346 1,751.85 1,752.86 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NSNLVGAAHEELQQSR 95.00% 5.1 0.595 3.24 876.9363 1,751.86 1,752.86 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NSNLVGAAHEELQQSR 95.00% 4.98 0.597 3.92 877.4338 1,752.85 1,752.86 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% NSNLVGAAHEELQQSR 95.00% 5.05 0.57 3.48 877.4352 1,752.85 1,752.86 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% MQQQLDEYQELLDIK 95.00% 5.05 0.465 4.62 947.4653 1,892.92 1,893.93 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% MQQQLDEYQELLDIK 95.00% 5.55 0.376 6.02 947.9654 1,893.92 1,893.93 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% MQQQLDEYQELLDIK 95.00% 5.78 0.401 6.42 947.9669 1,893.92 1,893.93 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.25 0.561 6.85 1,183.58 2,365.15 2,365.16 2
 SAMPLE 2R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 34 43 153 50.20% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.44 0.576 10.6 1,183.58 2,365.15 2,365.16 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% KLLEGEEERLR 95.00% 2.6 0.327 0 457.9253 1,370.75 1,371.76 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% KLLEGEEERLR 95.00% 2.29 0.271 0 457.9263 1,370.76 1,371.76 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% DLEDSLAR 95.00% 2.11 0.268 0 459.7301 917.4446 918.4534 2 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% DLEDSLAR 95.00% 2.74 0.26 0 459.7305 917.4454 918.4534 2 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% DLEDSLAR 95.00% 2.51 0.267 0 459.7309 917.4462 918.4534 2 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% DLEDSLAR 95.00% 2.37 0.309 0 459.7319 917.4481 918.4534 2 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LRITESEEVVSR 95.00% 3.42 0.2 0 473.2594 1,416.75 1,417.77 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LRITESEEVVSR 95.00% 3.12 0.301 0 473.2596 1,416.76 1,417.77 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LRITESEEVVSR 95.00% 3.4 0.327 0 473.2597 1,416.76 1,417.77 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IDSLSAQLSQLQK 95.00% 3.37 0.343 1.19 477.5996 1,429.78 1,430.79 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% RQNGDDPLLTYR 95.00% 3.51 0.439 1.59 483.5806 1,447.72 1,447.73 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQTMKEELDFQK 95.00% 3.9 0.468 1.96 503.9247 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQTMKEELDFQK 95.00% 2.4 0.31 1.7 503.925 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQTmKEELDFQK 95.00% 2.5 0.305 0 m4: Oxidation (+15.99) 509.2558 1,524.74 1,525.76 3 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NIYSEELR 95.00% 2.25 0.289 0 512.2582 1,022.50 1,023.51 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NIYSEELR 95.00% 2.11 0.279 0 512.2582 1,022.50 1,023.51 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NIYSEELR 95.00% 1.94 0.272 1.6 512.2583 1,022.50 1,023.51 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NIYSEELR 95.00% 1.91 0.302 1.09 512.2585 1,022.50 1,023.51 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LADALQELR 95.00% 2.22 0.275 1.85 514.7888 1,027.56 1,028.57 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LADALQELR 95.00% 2.6 0.234 0 514.7888 1,027.56 1,028.57 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LADALQELR 95.00% 3.18 0.054 1.14 514.789 1,027.56 1,028.57 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LADALQELR 95.00% 3.31 0.297 0 514.7892 1,027.56 1,028.57 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LADALQELR 95.00% 2.45 0.336 1.35 514.7892 1,027.56 1,028.57 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LADALQELR 95.00% 3.61 0.294 0 514.7895 1,027.56 1,028.57 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LADALQELR 95.00% 2.41 0.201 0 514.7896 1,027.56 1,028.57 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LADALQELR 95.00% 3.49 0.299 1.41 514.7898 1,027.56 1,028.57 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LADALQELR 95.00% 3.96 0.337 1.46 514.7898 1,027.56 1,028.57 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LADALQELR 95.00% 3.94 0.333 1.43 514.7901 1,027.56 1,028.57 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LEAALGEAKK 95.00% 2.52 0.326 1.74 515.2994 1,028.58 1,029.59 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LEAALGEAKK 95.00% 2.55 0.328 1.36 515.2996 1,028.58 1,029.59 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% EGDLIAAQAR 95.00% 2.92 0.414 0 522.2782 1,042.54 1,043.55 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% EGDLIAAQAR 95.00% 2.4 0.304 0 522.2814 1,042.55 1,043.55 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% ARLQLELSK 95.00% 2.28 0.166 1.12 529.3202 1,056.62 1,057.64 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% VAVEEVDEEGKFVR 95.00% 2.74 0.182 0 535.9413 1,604.80 1,605.81 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% VAVEEVDEEGKFVR 95.00% 3.05 0.236 2.02 535.9413 1,604.80 1,605.81 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% VAVEEVDEEGKFVR 95.00% 2.63 0.283 0 535.942 1,604.80 1,605.81 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 2.27 0.211 0 543.9388 1,628.79 1,629.81 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 4.43 0.266 0 543.9399 1,628.80 1,629.81 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 3.88 0.281 0 544.2722 1,629.79 1,629.81 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 4.19 0.215 0 544.2733 1,629.80 1,629.81 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 4.93 0.239 0 544.2737 1,629.80 1,629.81 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLRGQVAK 95.00% 1.89 0.325 0 555.9678 1,664.88 1,665.89 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLRGQVAK 95.00% 1.96 0.285 1.24 555.9682 1,664.88 1,665.89 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLRGQVAK 95.00% 1.78 0.245 0 555.9684 1,664.88 1,665.89 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLRGQVAK 95.00% 2.49 0.457 0 555.9685 1,664.88 1,665.89 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLRGQVAK 95.00% 2.66 0.277 1.64 555.9686 1,664.88 1,665.89 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLRGQVAK 95.00% 2.58 0.426 0 556.3023 1,665.88 1,665.89 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% EAALSTALSEK 95.00% 2.8 0.411 1.51 560.2969 1,118.58 1,119.59 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% EAALSTALSEK 95.00% 2.68 0.329 1.48 560.2972 1,118.58 1,119.59 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SNEDQSMGNWQIKR 95.00% 2.7 0.435 0 564.9296 1,691.77 1,692.78 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SNEDQSMGNWQIKR 95.00% 2.66 0.449 0 564.9299 1,691.77 1,692.78 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SNEDQSMGNWQIKR 95.00% 2.76 0.438 0 565.2628 1,692.76 1,692.78 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SNEDQSMGNWQIKR 95.00% 2.88 0.445 0 565.2637 1,692.77 1,692.78 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IRIDSLSAQLSQLQK 95.00% 3.42 0.333 0 567.3269 1,698.96 1,699.97 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IRIDSLSAQLSQLQK 95.00% 3.76 0.291 1.1 567.3275 1,698.96 1,699.97 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IRIDSLSAQLSQLQK 95.00% 3.54 0.206 0 567.3277 1,698.96 1,699.97 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IRIDSLSAQLSQLQK 95.00% 3.49 0.322 0 567.3278 1,698.96 1,699.97 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IRIDSLSAQLSQLQK 95.00% 4.2 0.28 0 567.3278 1,698.96 1,699.97 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IRIDSLSAQLSQLQK 95.00% 3.59 0.373 0 567.3281 1,698.96 1,699.97 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IRIDSLSAQLSQLQK 95.00% 3.58 0.32 1.09 567.3282 1,698.96 1,699.97 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IRIDSLSAQLSQLQK 95.00% 3.92 0.301 1.09 567.3286 1,698.96 1,699.97 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% ITESEEVVSR 95.00% 3.13 0.483 1.13 574.7906 1,147.57 1,148.58 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% ITESEEVVSR 95.00% 3.5 0.477 1.7 574.7912 1,147.57 1,148.58 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% ITESEEVVSR 95.00% 3.48 0.491 1.18 574.7922 1,147.57 1,148.58 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% ITESEEVVSR 95.00% 3.26 0.46 0 574.7924 1,147.57 1,148.58 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% ITESEEVVSR 95.00% 3.04 0.465 1.38 574.7927 1,147.57 1,148.58 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% ITESEEVVSR 95.00% 3.1 0.46 1.09 574.7936 1,147.57 1,148.58 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% ITESEEVVSR 95.00% 3.31 0.444 1.12 574.7937 1,147.57 1,148.58 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AAYEAELGDAR 95.00% 2.1 0.417 0 582.6198 1,163.22 1,165.55 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AAYEAELGDAR 95.00% 2.45 0.147 1.19 582.6203 1,163.22 1,165.55 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AAYEAELGDAR 95.00% 2.74 0.327 2.32 582.6206 1,163.23 1,165.55 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AAYEAELGDAR 95.00% 1.78 0.416 0 582.9693 1,163.92 1,165.55 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AAYEAELGDAR 95.00% 1.68 0.476 0 582.9695 1,163.92 1,165.55 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AAYEAELGDAR 95.00% 1.72 0.25 1.31 582.9706 1,163.93 1,165.55 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AAYEAELGDAR 95.00% 3.52 0.495 2.07 583.2762 1,164.54 1,165.55 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AAYEAELGDAR 95.00% 3.92 0.438 1.8 583.277 1,164.54 1,165.55 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 3.68 0.452 0 584.9582 1,751.85 1,752.86 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 3.62 0.5 0 584.9584 1,751.85 1,752.86 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 3.33 0.534 0 584.9586 1,751.85 1,752.86 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 3.23 0.487 1.32 584.9586 1,751.85 1,752.86 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 2.4 0.472 1.13 584.959 1,751.85 1,752.86 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 3.03 0.494 1.15 584.9591 1,751.85 1,752.86 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 3.22 0.253 0 584.9608 1,751.86 1,752.86 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 3.7 0.518 1.46 585.2922 1,752.85 1,752.86 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 3.07 0.458 0 585.2932 1,752.86 1,752.86 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% QNGDDPLLTYRFPPK 95.00% 2.62 0.199 0 587.6365 1,759.89 1,760.90 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% QNGDDPLLTYRFPPK 95.00% 2.7 0.337 2.14 587.9702 1,760.89 1,760.90 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% QNGDDPLLTYRFPPK 95.00% 2.74 0.328 0 587.9712 1,760.89 1,760.90 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% QNGDDPLLTYRFPPK 95.00% 2.81 0.282 1.25 587.9726 1,760.89 1,760.90 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLR 95.00% 2.64 0.348 0 591.8054 1,181.60 1,182.61 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLR 95.00% 2.12 0.226 0 591.8062 1,181.60 1,182.61 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLR 95.00% 3.25 0.42 0 591.8081 1,181.60 1,182.61 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLR 95.00% 2.77 0.431 1.42 591.8084 1,181.60 1,182.61 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLR 95.00% 3.33 0.412 1.13 591.8086 1,181.60 1,182.61 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLR 95.00% 2.78 0.25 0 591.8086 1,181.60 1,182.61 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLR 95.00% 2.39 0.323 0 591.8087 1,181.60 1,182.61 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLR 95.00% 2.49 0.369 0 591.8104 1,181.61 1,182.61 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLR 95.00% 2.47 0.255 0 592.3028 1,182.59 1,182.61 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LRDLEDSLAR 95.00% 2.49 0.22 1.33 594.3203 1,186.63 1,187.64 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LRDLEDSLAR 95.00% 2.98 0.345 2.12 594.3215 1,186.63 1,187.64 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LRDLEDSLAR 95.00% 3 0.288 1.24 594.3216 1,186.63 1,187.64 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LRDLEDSLAR 95.00% 2.98 0.371 2.02 594.3217 1,186.63 1,187.64 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LRDLEDSLAR 95.00% 3.07 0.299 1.68 594.3219 1,186.63 1,187.64 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LRDLEDSLAR 95.00% 2.63 0.229 1.19 594.3219 1,186.63 1,187.64 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LRDLEDSLAR 95.00% 3.14 0.373 1.22 594.3221 1,186.63 1,187.64 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LRDLEDSLAR 95.00% 2.48 0.165 1.68 594.3228 1,186.63 1,187.64 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LKDLEALLNSK 95.00% 3.91 0.459 1.82 622.3646 1,242.71 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LKDLEALLNSK 95.00% 4.39 0.462 1.24 622.365 1,242.71 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LKDLEALLNSK 95.00% 3.41 0.325 2.1 622.3654 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LKDLEALLNSK 95.00% 3.19 0.375 1.77 622.3661 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LKDLEALLNSK 95.00% 4.14 0.409 1.64 622.3662 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LKDLEALLNSK 95.00% 3.89 0.42 1.66 622.3663 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LKDLEALLNSK 95.00% 3.75 0.373 1.47 622.3663 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LKDLEALLNSK 95.00% 3.07 0.388 2.07 622.3664 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LKDLEALLNSK 95.00% 4.03 0.416 0 622.3665 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LKDLEALLNSK 95.00% 3.3 0.48 2.51 622.3669 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% QNGDDPLLTYR 95.00% 2.62 0.558 2.85 646.3163 1,290.62 1,291.63 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% QNGDDPLLTYR 95.00% 2.84 0.52 2.42 646.3163 1,290.62 1,291.63 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% QNGDDPLLTYR 95.00% 2.72 0.562 2.96 646.3169 1,290.62 1,291.63 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% QNGDDPLLTYR 95.00% 2.93 0.52 2.55 646.3176 1,290.62 1,291.63 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AAYEAELGDARK 95.00% 2.82 0.345 0 647.3241 1,292.63 1,293.64 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LALDMEIHAYR 95.00% 2.17 0.33 0 666.3418 1,330.67 1,331.68 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LALDMEIHAYR 95.00% 1.93 0.324 1.96 666.342 1,330.67 1,331.68 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AQHEDQVEQYKKELEK 95.00% 4.2 0.607 2.74 668.3315 2,001.97 2,001.99 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AQHEDQVEQYKKELEK 95.00% 4.16 0.58 0 668.3339 2,001.98 2,001.99 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AQNTWGcGNSLR 95.00% 3.53 0.532 3.59 c7: Carbamidomethyl (+57.02) 682.3108 1,362.61 1,363.62 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AQNTWGcGNSLR 95.00% 3.68 0.541 2.92 c7: Carbamidomethyl (+57.02) 682.3109 1,362.61 1,363.62 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AQNTWGcGNSLR 95.00% 3.88 0.469 2.89 c7: Carbamidomethyl (+57.02) 682.3112 1,362.61 1,363.62 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AQNTWGcGNSLR 95.00% 3 0.473 3.33 c7: Carbamidomethyl (+57.02) 682.3114 1,362.61 1,363.62 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AQNTWGcGNSLR 95.00% 4.11 0.465 3.05 c7: Carbamidomethyl (+57.02) 682.3116 1,362.61 1,363.62 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AQNTWGcGNSLR 95.00% 2.41 0.43 1.32 c7: Carbamidomethyl (+57.02) 682.3117 1,362.61 1,363.62 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AQNTWGcGNSLR 95.00% 2.61 0.468 2.09 c7: Carbamidomethyl (+57.02) 682.3129 1,362.61 1,363.62 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NIYSEELRETK 95.00% 3.42 0.408 0 691.3511 1,380.69 1,381.70 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IDSLSAQLSQLQK 95.00% 3.37 0.278 2.24 715.8938 1,429.77 1,430.79 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IDSLSAQLSQLQK 95.00% 2.71 0.217 1.34 715.8938 1,429.77 1,430.79 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IDSLSAQLSQLQK 95.00% 2.96 0.267 1.48 715.895 1,429.77 1,430.79 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 3.37 0.504 5.72 746.3753 1,490.73 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 4.85 0.644 6.82 746.3764 1,490.74 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 4.49 0.607 6.96 746.3764 1,490.74 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 3.72 0.605 4.8 746.3765 1,490.74 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 3.72 0.62 5.44 746.3767 1,490.74 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 2.6 0.445 4.27 746.3771 1,490.74 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 4.53 0.653 7.62 746.3772 1,490.74 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 2.39 0.333 4.15 746.3772 1,490.74 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 3.8 0.664 5.8 746.3773 1,490.74 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 4.28 0.631 6.42 746.3777 1,490.74 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 3.37 0.573 5.28 746.3788 1,490.74 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 3.42 0.39 4.47 746.8779 1,491.74 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAMR 95.00% 4.22 0.578 6.68 746.8799 1,491.74 1,491.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAmR 95.00% 3.47 0.547 5.03 m13: Oxidation (+15.99) 754.3746 1,506.73 1,507.74 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TALINSTGEEVAmR 95.00% 2.8 0.446 4 m13: Oxidation (+15.99) 754.3767 1,506.74 1,507.74 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQTMKEELDFQK 95.00% 3.79 0.437 1.38 755.3841 1,508.75 1,509.76 2 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQTMKEELDFQK 95.00% 4.12 0.375 2.3 755.3844 1,508.75 1,509.76 2 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQTMKEELDFQK 95.00% 4.05 0.372 1.74 755.3845 1,508.75 1,509.76 2 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQTMKEELDFQK 95.00% 4.07 0.465 2 755.3857 1,508.76 1,509.76 2 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQTMKEELDFQK 95.00% 3.88 0.448 1.68 755.3859 1,508.76 1,509.76 2 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQTMKEELDFQK 95.00% 3.97 0.392 1.23 755.8847 1,509.75 1,509.76 2 FBLN3_HUMAN
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SNEDQSMGNWQIK 95.00% 4.06 0.443 3.96 768.8402 1,535.66 1,536.68 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SNEDQSMGNWQIK 95.00% 4.09 0.466 4.77 768.8409 1,535.67 1,536.68 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SNEDQSMGNWQIK 95.00% 3.58 0.47 2.44 768.8413 1,535.67 1,536.68 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SNEDQSMGNWQIK 95.00% 3.23 0.422 2.46 768.8418 1,535.67 1,536.68 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SVGGSGGGSFGDNLVTR 95.00% 4.27 0.568 3.27 783.8778 1,565.74 1,566.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SVGGSGGGSFGDNLVTR 95.00% 4.76 0.597 3.49 783.878 1,565.74 1,566.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SVGGSGGGSFGDNLVTR 95.00% 4.73 0.509 3.57 783.8789 1,565.74 1,566.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SVGGSGGGSFGDNLVTR 95.00% 4.37 0.569 3.19 783.8789 1,565.74 1,566.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SVGGSGGGSFGDNLVTR 95.00% 4.5 0.569 2.85 783.8795 1,565.74 1,566.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SVGGSGGGSFGDNLVTR 95.00% 3.59 0.437 0 784.3791 1,566.74 1,566.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SVGGSGGGSFGDNLVTR 95.00% 4.42 0.597 3.24 784.3791 1,566.74 1,566.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SVGGSGGGSFGDNLVTR 95.00% 4.4 0.561 3.29 784.3792 1,566.74 1,566.75 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 5.36 0.606 5.85 789.3915 2,365.15 2,365.16 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 5.96 0.645 6.96 789.3922 2,365.15 2,365.16 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% VAVEEVDEEGKFVR 95.00% 3.63 0.585 4.77 803.4071 1,604.80 1,605.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% VAVEEVDEEGKFVR 95.00% 4.47 0.559 4.39 803.4082 1,604.80 1,605.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% VAVEEVDEEGKFVR 95.00% 4.06 0.488 2.72 803.4086 1,604.80 1,605.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% VAVEEVDEEGKFVR 95.00% 4.55 0.558 5.17 803.4094 1,604.80 1,605.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% VAVEEVDEEGKFVR 95.00% 4.16 0.459 2.48 803.4096 1,604.80 1,605.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% VAVEEVDEEGKFVR 95.00% 3.58 0.428 3.21 803.4125 1,604.81 1,605.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% VAVEEVDEEGKFVR 95.00% 4.31 0.585 3.96 803.9104 1,605.81 1,605.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% VAVEEVDEEGKFVR 95.00% 4.47 0.624 5.03 803.9113 1,605.81 1,605.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% VAVEEVDEEGKFVR 95.00% 4.21 0.513 2.17 803.9116 1,605.81 1,605.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 4.63 0.416 3.29 815.4048 1,628.79 1,629.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 4.74 0.363 2.57 815.4055 1,628.80 1,629.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 5.12 0.393 2.05 815.4064 1,628.80 1,629.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 4.92 0.388 1.96 815.4071 1,628.80 1,629.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 4.65 0.374 2.7 815.4074 1,628.80 1,629.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 4.9 0.394 1.82 815.4075 1,628.80 1,629.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 4.56 0.393 3.74 815.4081 1,628.80 1,629.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% LQEKEDLQELNDR 95.00% 4.33 0.427 2.82 815.4085 1,628.80 1,629.81 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLRGQVAK 95.00% 4.72 0.51 2.37 833.4456 1,664.88 1,665.89 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLRGQVAK 95.00% 4.68 0.474 2.8 833.4507 1,664.89 1,665.89 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% TLEGELHDLRGQVAK 95.00% 4.48 0.472 2.57 833.9511 1,665.89 1,665.89 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% AGQVVTIWAAGAGATHSPPTDLVWK 95.00% 4.1 0.557 2.62 845.4451 2,533.31 2,533.32 3
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SNEDQSMGNWQIKR 95.00% 3.4 0.346 0 846.8905 1,691.77 1,692.78 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SNEDQSMGNWQIKR 95.00% 3.88 0.374 1.16 846.8926 1,691.77 1,692.78 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% SNEDQSMGNWQIKR 95.00% 3.77 0.418 1.7 846.8927 1,691.77 1,692.78 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IRIDSLSAQLSQLQK 95.00% 4.8 0.424 4.41 850.4873 1,698.96 1,699.97 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% IRIDSLSAQLSQLQK 95.00% 4.79 0.46 4.41 850.489 1,698.96 1,699.97 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 4.58 0.569 4.85 876.9322 1,751.85 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 5.17 0.606 6.82 876.933 1,751.85 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 4.97 0.6 5.3 876.9331 1,751.85 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 5.2 0.588 8.07 876.9333 1,751.85 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 4.53 0.57 4.4 876.9337 1,751.85 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 5.03 0.591 7.43 876.9339 1,751.85 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 5.09 0.582 7.15 876.935 1,751.85 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 5.02 0.596 5.7 876.9355 1,751.86 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 5.05 0.572 6.39 876.9388 1,751.86 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 4.58 0.572 3.38 877.4343 1,752.85 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 4.17 0.542 3.32 877.4348 1,752.85 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 5.02 0.572 3.8 877.4349 1,752.85 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% NSNLVGAAHEELQQSR 95.00% 4.73 0.566 4.77 877.435 1,752.85 1,752.86 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% MQQQLDEYQELLDIK 95.00% 4.8 0.5 4.07 947.4641 1,892.91 1,893.93 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% MQQQLDEYQELLDIK 95.00% 4.93 0.488 5.82 947.4642 1,892.91 1,893.93 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.21 0.581 9.92 1,183.58 2,365.15 2,365.16 2
 SAMPLE 3 Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 45 214 55.30% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.1 0.546 11.6 1,183.58 2,365.15 2,365.16 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% KLLEGEEERLR 95.00% 2.52 0.25 0 457.9255 1,370.75 1,371.76 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% KLLEGEEERLR 95.00% 2.46 0.284 0 457.9258 1,370.75 1,371.76 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% DLEDSLAR 95.00% 2.62 0.214 0 459.7302 917.4447 918.4534 2 FBLN3_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% DLEDSLAR 95.00% 2.68 0.28 0 459.7304 917.4452 918.4534 2 FBLN3_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% DLEDSLAR 95.00% 2.17 0.221 0 459.7306 917.4455 918.4534 2 FBLN3_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LRITESEEVVSR 95.00% 2.93 0.141 0 473.2593 1,416.75 1,417.77 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LRITESEEVVSR 95.00% 3.63 0.202 1.09 473.2595 1,416.76 1,417.77 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LRITESEEVVSR 95.00% 2.94 0.139 0 473.2597 1,416.76 1,417.77 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% RQNGDDPLLTYR 95.00% 2.73 0.253 1.36 483.2485 1,446.72 1,447.73 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% RQNGDDPLLTYR 95.00% 2.73 0.301 1.48 483.5807 1,447.72 1,447.73 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% DLEALLNSK 95.00% 1.89 0.258 0 501.7762 1,001.54 1,002.55 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% DLEALLNSK 95.00% 2.08 0.264 0 501.7764 1,001.54 1,002.55 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQTMKEELDFQK 95.00% 2.84 0.378 0 503.9249 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQTMKEELDFQK 95.00% 3.56 0.489 0 503.9251 1,508.75 1,509.76 3 FBLN3_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NIYSEELR 95.00% 2.15 0.321 1.46 512.2583 1,022.50 1,023.51 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NIYSEELR 95.00% 1.97 0.252 1.59 512.2588 1,022.50 1,023.51 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LADALQELR 95.00% 3.07 0.289 0 514.7888 1,027.56 1,028.57 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LADALQELR 95.00% 2.28 0.191 0 514.789 1,027.56 1,028.57 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LADALQELR 95.00% 3.12 0.32 1.24 514.7892 1,027.56 1,028.57 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LADALQELR 95.00% 2.98 0.287 0 514.7893 1,027.56 1,028.57 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LADALQELR 95.00% 3.1 0.238 1.19 514.7894 1,027.56 1,028.57 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LADALQELR 95.00% 3.71 0.346 1.47 514.7897 1,027.56 1,028.57 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LADALQELR 95.00% 2.9 0.311 0 514.7897 1,027.56 1,028.57 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LADALQELR 95.00% 3.33 0.288 0 514.7899 1,027.56 1,028.57 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LADALQELR 95.00% 3.4 0.306 0 514.7901 1,027.56 1,028.57 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LADALQELR 95.00% 3.47 0.301 1.29 514.7903 1,027.56 1,028.57 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LEAALGEAKK 95.00% 2.33 0.365 1.16 515.3005 1,028.59 1,029.59 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LEAALGEAKK 95.00% 2.51 0.32 0 515.3017 1,028.59 1,029.59 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LADALQELR 95.00% 2.74 0.256 0 515.3123 1,028.61 1,028.57 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% EGDLIAAQAR 95.00% 2.7 0.341 0 522.2766 1,042.54 1,043.55 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 2.36 0.197 0 535.9395 1,604.80 1,605.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 2.54 0.217 0 535.94 1,604.80 1,605.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 3.29 0.216 0 535.9404 1,604.80 1,605.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 2.75 0.2 0 535.9406 1,604.80 1,605.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 3.23 0.204 0 535.9407 1,604.80 1,605.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 3.03 0.326 0 535.9407 1,604.80 1,605.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 2.79 0.222 0 535.9409 1,604.80 1,605.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 2.55 0.224 0 535.9412 1,604.80 1,605.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 2.57 0.32 1.68 535.9413 1,604.80 1,605.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 3 0.337 0 535.9422 1,604.80 1,605.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TALINSTGEEVAMRK 95.00% 2.54 0.205 0 540.6186 1,618.83 1,619.84 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQEKEDLQELNDR 95.00% 4.37 0.28 0 543.9397 1,628.80 1,629.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQEKEDLQELNDR 95.00% 3.41 0.32 0 543.9398 1,628.80 1,629.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQEKEDLQELNDR 95.00% 2.26 0.258 0 543.9401 1,628.80 1,629.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQEKEDLQELNDR 95.00% 4.52 0.302 0 543.9404 1,628.80 1,629.81 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TLEGELHDLRGQVAK 95.00% 1.88 0.361 0 555.968 1,664.88 1,665.89 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TLEGELHDLRGQVAK 95.00% 2.03 0.334 0 555.9683 1,664.88 1,665.89 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TLEGELHDLRGQVAK 95.00% 2.12 0.374 0.959 555.9685 1,664.88 1,665.89 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TLEGELHDLRGQVAK 95.00% 2.22 0.344 0 555.9686 1,664.88 1,665.89 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SNEDQSMGNWQIKR 95.00% 2.35 0.347 0 564.929 1,691.76 1,692.78 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SNEDQSMGNWQIKR 95.00% 2.46 0.404 0 564.9296 1,691.77 1,692.78 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SNEDQSMGNWQIKR 95.00% 2.72 0.376 0 564.9298 1,691.77 1,692.78 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SNEDQSMGNWQIKR 95.00% 2.42 0.392 0 565.2634 1,692.77 1,692.78 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% EDLQELNDR 95.00% 2.42 0.193 0 566.2653 1,130.51 1,131.53 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 3.09 0.267 0 567.3253 1,698.95 1,699.97 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 2.5 0.18 0 567.327 1,698.96 1,699.97 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 3.63 0.299 0 567.3274 1,698.96 1,699.97 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 3.91 0.29 0 567.3275 1,698.96 1,699.97 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 4.24 0.219 0 567.3279 1,698.96 1,699.97 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 3.94 0.16 0 567.3279 1,698.96 1,699.97 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 4.22 0.214 1 567.3279 1,698.96 1,699.97 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 4.28 0.198 0 567.6613 1,699.96 1,699.97 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 3.96 0.343 1.23 567.6615 1,699.96 1,699.97 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 3.3 0.313 0 567.6627 1,699.96 1,699.97 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 3.67 0.245 1.21 567.6632 1,699.97 1,699.97 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% ITESEEVVSR 95.00% 2.9 0.495 1.1 574.792 1,147.57 1,148.58 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% ITESEEVVSR 95.00% 3 0.462 1.11 574.7921 1,147.57 1,148.58 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% ITESEEVVSR 95.00% 3.43 0.473 2.27 574.7926 1,147.57 1,148.58 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% ITESEEVVSR 95.00% 3.61 0.477 1.66 574.7935 1,147.57 1,148.58 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% ITESEEVVSR 95.00% 2.98 0.343 1.77 574.794 1,147.57 1,148.58 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% ITESEEVVSR 95.00% 2.72 0.304 1.15 575.2973 1,148.58 1,148.58 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AAYEAELGDAR 95.00% 2.46 0.286 2.2 582.6195 1,163.22 1,165.55 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AAYEAELGDAR 95.00% 2.68 0.402 1.89 582.6196 1,163.22 1,165.55 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AAYEAELGDAR 95.00% 1.92 0.33 0 582.6369 1,163.26 1,165.55 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AAYEAELGDAR 95.00% 3.16 0.439 3.24 583.2747 1,164.53 1,165.55 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AAYEAELGDAR 95.00% 3.02 0.384 2.89 583.2763 1,164.54 1,165.55 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AAYEAELGDAR 95.00% 3.01 0.39 2.82 583.2768 1,164.54 1,165.55 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AAYEAELGDAR 95.00% 3.87 0.436 2.11 583.2768 1,164.54 1,165.55 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AAYEAELGDAR 95.00% 3.46 0.445 2.14 583.2769 1,164.54 1,165.55 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 3.06 0.461 0 584.9579 1,751.85 1,752.86 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 2.77 0.408 0 584.9581 1,751.85 1,752.86 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 3 0.403 0 584.9586 1,751.85 1,752.86 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 3.37 0.43 0 584.9587 1,751.85 1,752.86 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 2.56 0.274 0 584.959 1,751.85 1,752.86 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 3.14 0.426 0 585.2913 1,752.85 1,752.86 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 2.85 0.462 0 585.2915 1,752.85 1,752.86 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 2.42 0.33 0 585.2924 1,752.85 1,752.86 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% QNGDDPLLTYRFPPK 95.00% 2.45 0.251 1.12 587.6372 1,759.89 1,760.90 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TLEGELHDLR 95.00% 2.16 0.271 0 591.8076 1,181.60 1,182.61 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TLEGELHDLR 95.00% 2.3 0.314 0 591.8076 1,181.60 1,182.61 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TLEGELHDLR 95.00% 2.92 0.375 1.74 591.8081 1,181.60 1,182.61 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TLEGELHDLR 95.00% 2.73 0.423 0 591.8083 1,181.60 1,182.61 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TLEGELHDLR 95.00% 2.92 0.418 1.96 591.8085 1,181.60 1,182.61 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TLEGELHDLR 95.00% 3.11 0.438 1.62 591.8088 1,181.60 1,182.61 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LRDLEDSLAR 95.00% 2.85 0.279 1.28 594.3216 1,186.63 1,187.64 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LRDLEDSLAR 95.00% 3.06 0.322 1.23 594.3218 1,186.63 1,187.64 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LRDLEDSLAR 95.00% 2.68 0.235 1.41 594.3219 1,186.63 1,187.64 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LRDLEDSLAR 95.00% 3.11 0.293 2.11 594.322 1,186.63 1,187.64 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LRDLEDSLAR 95.00% 2.45 0.151 1.35 594.3224 1,186.63 1,187.64 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LRDLEDSLAR 95.00% 2.39 0.196 0 594.323 1,186.63 1,187.64 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LKDLEALLNSK 95.00% 4.15 0.445 2 622.365 1,242.71 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LKDLEALLNSK 95.00% 2.35 0.273 0 622.3653 1,242.71 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LKDLEALLNSK 95.00% 3.89 0.424 2.2 622.3655 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LKDLEALLNSK 95.00% 4.1 0.402 2.28 622.3657 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LKDLEALLNSK 95.00% 3.86 0.389 1.46 622.3661 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LKDLEALLNSK 95.00% 3.8 0.377 1.24 622.3662 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LKDLEALLNSK 94.50% 2.15 0.238 0 622.3666 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LKDLEALLNSK 95.00% 2.04 0.269 0 622.3669 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LKDLEALLNSK 95.00% 3.17 0.332 1.11 622.3676 1,242.72 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LKDLEALLNSK 95.00% 2.43 0.42 0 622.3716 1,242.73 1,243.73 2 TPM1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% QNGDDPLLTYR 95.00% 2.56 0.538 1.23 646.3155 1,290.62 1,291.63 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% QNGDDPLLTYR 95.00% 2.81 0.398 0 646.3161 1,290.62 1,291.63 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% QNGDDPLLTYR 95.00% 2.74 0.502 2.64 646.3166 1,290.62 1,291.63 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% QNGDDPLLTYR 95.00% 2.7 0.55 2.6 646.3167 1,290.62 1,291.63 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AAYEAELGDARK 95.00% 3.19 0.334 0 647.3254 1,292.64 1,293.64 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AAYEAELGDARK 95.00% 3.23 0.457 0 647.3256 1,292.64 1,293.64 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AQHEDQVEQYKKELEK 95.00% 3.83 0.538 1.19 668.3334 2,001.98 2,001.99 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AQHEDQVEQYKKELEK 95.00% 3.69 0.468 2.51 668.3347 2,001.98 2,001.99 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AQNTWGcGNSLR 95.00% 2.95 0.454 3.46 c7: Carbamidomethyl (+57.02) 682.3109 1,362.61 1,363.62 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AQNTWGcGNSLR 95.00% 4 0.432 3.29 c7: Carbamidomethyl (+57.02) 682.3111 1,362.61 1,363.62 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AQNTWGcGNSLR 95.00% 2.33 0.435 1.85 c7: Carbamidomethyl (+57.02) 682.3112 1,362.61 1,363.62 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AQNTWGcGNSLR 95.00% 3.2 0.488 2.48 c7: Carbamidomethyl (+57.02) 682.3116 1,362.61 1,363.62 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AQNTWGcGNSLR 95.00% 3.59 0.466 3.33 c7: Carbamidomethyl (+57.02) 682.3116 1,362.61 1,363.62 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AQNTWGcGNSLR 95.00% 3.39 0.494 3.85 c7: Carbamidomethyl (+57.02) 682.3116 1,362.61 1,363.62 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AQNTWGcGNSLR 95.00% 2.91 0.422 2.44 c7: Carbamidomethyl (+57.02) 682.3131 1,362.61 1,363.62 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NIYSEELRETK 95.00% 3.27 0.421 0 691.3488 1,380.68 1,381.70 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NIYSEELRETK 95.00% 3.38 0.433 1.21 691.3501 1,380.68 1,381.70 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IDSLSAQLSQLQK 95.00% 2.51 0.233 0 715.8924 1,429.77 1,430.79 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IDSLSAQLSQLQK 95.00% 2.72 0.309 1.44 715.8952 1,429.77 1,430.79 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TALINSTGEEVAMR 95.00% 3.57 0.572 4.42 746.3758 1,490.74 1,491.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TALINSTGEEVAMR 95.00% 4.69 0.622 6.4 746.3761 1,490.74 1,491.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TALINSTGEEVAMR 95.00% 2.96 0.493 4.22 746.3761 1,490.74 1,491.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TALINSTGEEVAMR 95.00% 2.51 0.41 0 746.3763 1,490.74 1,491.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TALINSTGEEVAMR 95.00% 4.22 0.632 4.66 746.377 1,490.74 1,491.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TALINSTGEEVAMR 95.00% 3.03 0.486 3.44 746.3773 1,490.74 1,491.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TALINSTGEEVAMR 95.00% 4.56 0.649 6.54 746.3775 1,490.74 1,491.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TALINSTGEEVAMR 95.00% 4.21 0.636 5.6 746.3782 1,490.74 1,491.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TALINSTGEEVAMR 95.00% 3.15 0.593 4.26 746.3792 1,490.74 1,491.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TALINSTGEEVAMR 95.00% 3.73 0.564 3.24 746.8842 1,491.75 1,491.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TALINSTGEEVAmR 95.00% 3.07 0.423 4.62 m13: Oxidation (+15.99) 754.378 1,506.74 1,507.74 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQTMKEELDFQK 95.00% 3.84 0.449 1.39 755.3836 1,508.75 1,509.76 2 FBLN3_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQTMKEELDFQK 95.00% 3.78 0.418 1.62 755.3847 1,508.75 1,509.76 2 FBLN3_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQTMKEELDFQK 95.00% 3.71 0.472 1.62 755.3848 1,508.75 1,509.76 2 FBLN3_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQTMKEELDFQK 95.00% 3.82 0.445 1.34 755.3858 1,508.76 1,509.76 2 FBLN3_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQTMKEELDFQK 95.00% 3.94 0.447 2.48 755.8852 1,509.75 1,509.76 2 FBLN3_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQTMKEELDFQK 95.00% 3.94 0.412 2.14 755.8859 1,509.76 1,509.76 2 FBLN3_HUMAN
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SNEDQSMGNWQIK 95.00% 3.09 0.427 2.17 768.839 1,535.66 1,536.68 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SNEDQSMGNWQIK 95.00% 3.7 0.498 3.44 768.8412 1,535.67 1,536.68 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SNEDQSMGNWQIK 95.00% 4.09 0.452 3.37 768.8412 1,535.67 1,536.68 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SVGGSGGGSFGDNLVTR 95.00% 4.1 0.552 3.8 783.8775 1,565.74 1,566.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SVGGSGGGSFGDNLVTR 95.00% 4.15 0.575 4.05 783.8777 1,565.74 1,566.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SVGGSGGGSFGDNLVTR 95.00% 4.26 0.614 2.6 783.8778 1,565.74 1,566.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SVGGSGGGSFGDNLVTR 95.00% 4.47 0.585 5 783.8784 1,565.74 1,566.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SVGGSGGGSFGDNLVTR 95.00% 4.38 0.548 4.29 783.8789 1,565.74 1,566.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SVGGSGGGSFGDNLVTR 95.00% 4.23 0.59 3 783.8802 1,565.74 1,566.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SVGGSGGGSFGDNLVTR 95.00% 4.27 0.527 2.54 784.3828 1,566.75 1,566.75 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 5.56 0.651 5.02 789.3918 2,365.15 2,365.16 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 5.21 0.563 6.03 789.3923 2,365.15 2,365.16 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 4.42 0.586 4.72 803.4095 1,604.80 1,605.81 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 4.07 0.492 3.12 803.4098 1,604.80 1,605.81 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 4.32 0.502 4.16 803.4098 1,604.80 1,605.81 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 4.25 0.555 3.85 803.4113 1,604.81 1,605.81 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 4.15 0.557 3.77 803.4118 1,604.81 1,605.81 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% VAVEEVDEEGKFVR 95.00% 3.11 0.384 2.13 803.911 1,605.81 1,605.81 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQEKEDLQELNDR 95.00% 5.02 0.39 3.92 815.4058 1,628.80 1,629.81 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQEKEDLQELNDR 95.00% 4.62 0.367 4.27 815.4059 1,628.80 1,629.81 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQEKEDLQELNDR 95.00% 4.63 0.39 3.54 815.4059 1,628.80 1,629.81 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQEKEDLQELNDR 95.00% 4.72 0.358 2.26 815.4073 1,628.80 1,629.81 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQEKEDLQELNDR 95.00% 4.68 0.377 2.33 815.4079 1,628.80 1,629.81 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% LQEKEDLQELNDR 95.00% 4.74 0.389 3.92 815.4081 1,628.80 1,629.81 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TLEGELHDLRGQVAK 95.00% 4.28 0.494 2.52 833.451 1,664.89 1,665.89 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% TLEGELHDLRGQVAK 95.00% 4.44 0.507 3.3 833.4526 1,664.89 1,665.89 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AGQVVTIWAAGAGATHSPPTDLVWK 95.00% 3.92 0.541 1.36 845.4449 2,533.31 2,533.32 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% AGQVVTIWAAGAGATHSPPTDLVWK 95.00% 4.17 0.578 2.96 845.4451 2,533.31 2,533.32 3
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SNEDQSMGNWQIKR 95.00% 3.75 0.303 1.2 846.8895 1,691.76 1,692.78 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SNEDQSMGNWQIKR 95.00% 3.78 0.322 1.51 846.8924 1,691.77 1,692.78 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% SNEDQSMGNWQIKR 95.00% 3.45 0.3 1.13 847.3924 1,692.77 1,692.78 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 4.28 0.425 2.89 850.4876 1,698.96 1,699.97 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% IRIDSLSAQLSQLQK 95.00% 4.62 0.434 3.11 850.4884 1,698.96 1,699.97 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 4.53 0.546 3.34 876.9309 1,751.85 1,752.86 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 5.14 0.608 7.12 876.9337 1,751.85 1,752.86 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 5.47 0.591 6.49 876.9339 1,751.85 1,752.86 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 5.32 0.581 4.02 876.9341 1,751.85 1,752.86 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 5.21 0.615 5.41 876.9344 1,751.85 1,752.86 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 5.2 0.586 6.18 876.9347 1,751.85 1,752.86 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 5.09 0.598 3.48 876.9359 1,751.86 1,752.86 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 4.82 0.576 3.68 876.9403 1,751.86 1,752.86 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 4.31 0.584 2.2 877.4331 1,752.85 1,752.86 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 5.17 0.572 2.11 877.4336 1,752.85 1,752.86 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 4.76 0.552 5.38 877.4344 1,752.85 1,752.86 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% NSNLVGAAHEELQQSR 95.00% 4.72 0.54 3.8 877.4381 1,752.86 1,752.86 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% MQQQLDEYQELLDIK 95.00% 3.15 0.226 0 947.4624 1,892.91 1,893.93 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% MQQQLDEYQELLDIK 95.00% 4.58 0.515 4.36 947.4639 1,892.91 1,893.93 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% MQQQLDEYQELLDIK 95.00% 5.04 0.481 4.57 947.4651 1,892.91 1,893.93 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% MQQQLDEYQELLDIK 95.00% 5.58 0.38 4.21 947.9666 1,893.92 1,893.93 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 5.65 0.594 8.05 1,183.08 2,364.14 2,365.16 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.13 0.577 10.8 1,183.08 2,364.15 2,365.16 2
 SAMPLE 3R Lamin-A/C  LMNA  LMNA_HUMAN 74,122.60 100.00% 36 44 198 50.80% ASASGSGAQVGGPISSGSSASSVTVTR 95.00% 6.21 0.571 9.33 1,183.58 2,365.15 2,365.16 2
 SAMPLE 1R Lamin-B2  LMNB2  LMNB2_HUMAN 67,671.70 99.80% 2 2 2 3.83% GLESDVAELR 95.00% 2.84 0.312 0 544.782 1,087.55 1,088.56 2
 SAMPLE 1R Lamin-B2  LMNB2  LMNB2_HUMAN 67,671.70 99.80% 2 2 2 3.83% LQEKEELRELNDR 95.00% 2.8 0.213 0 558.2942 1,671.86 1,671.87 3
 SAMPLE 2 Lamin-B2  LMNB2  LMNB2_HUMAN 67,671.70 99.80% 2 2 2 4.17% ALYESELADAR 95.00% 2.92 0.383 2.32 619.3078 1,236.60 1,237.61 2
 SAMPLE 2 Lamin-B2  LMNB2  LMNB2_HUMAN 67,671.70 99.80% 2 2 2 4.17% TVLVNADGEEVAMR 95.00% 3.14 0.395 6.6 752.3759 1,502.74 1,503.75 2
 SAMPLE 2R Lamin-B2  LMNB2  LMNB2_HUMAN 67,671.70 100.00% 2 2 3 4.00% LQEKEELRELNDR 95.00% 3.01 0.177 0 557.959 1,670.85 1,671.87 3
 SAMPLE 2R Lamin-B2  LMNB2  LMNB2_HUMAN 67,671.70 100.00% 2 2 3 4.00% ALYESELADAR 95.00% 2.83 0.37 2.38 619.3072 1,236.60 1,237.61 2
 SAMPLE 2R Lamin-B2  LMNB2  LMNB2_HUMAN 67,671.70 100.00% 2 2 3 4.00% ALYESELADAR 95.00% 2.64 0.296 1.54 619.3075 1,236.60 1,237.61 2
 SAMPLE 3 Lamin-B2  LMNB2  LMNB2_HUMAN 67,671.70 100.00% 3 3 3 5.50% MAQALEELR 95.00% 2.44 0.212 0 530.7751 1,059.53 1,060.55 2
 SAMPLE 3 Lamin-B2  LMNB2  LMNB2_HUMAN 67,671.70 100.00% 3 3 3 5.50% GLESDVAELR 95.00% 2.69 0.241 0 544.7831 1,087.55 1,088.56 2
 SAMPLE 3 Lamin-B2  LMNB2  LMNB2_HUMAN 67,671.70 100.00% 3 3 3 5.50% TVLVNADGEEVAMR 95.00% 3.8 0.465 4.42 752.8803 1,503.75 1,503.75 2
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% VDRDVEVEDFQR 95.00% 3.48 0.362 0 502.9123 1,505.71 1,506.72 3
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% VDRDVEVEDFQR 95.00% 2.61 0.215 0 502.9131 1,505.72 1,506.72 3
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% VDRDVEVEDFQR 95.00% 2.36 0.246 0 503.246 1,506.71 1,506.72 3
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% VDRDVEVEDFQR 95.00% 3.98 0.346 0 503.2468 1,506.72 1,506.72 3
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% LAALSIEEGK 95.00% 2.63 0.244 2.82 515.7933 1,029.57 1,030.58 2
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% LAALSIEEGK 95.00% 2.96 0.413 1.8 515.7939 1,029.57 1,030.58 2
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% LAALSIEEGK 95.00% 2.56 0.44 2.55 515.7941 1,029.57 1,030.58 2
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% AHLPLDINFR 95.00% 1.97 0.175 1.18 598.3321 1,194.65 1,195.66 2
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% AHLPLDINFR 95.00% 1.67 0.205 2.08 598.3344 1,194.65 1,195.66 2
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% AHLPLDINFR 95.00% 1.85 0.233 1.42 598.3349 1,194.65 1,195.66 2
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% LSDLQEALDQALNHVR 95.00% 5.48 0.523 3.11 607.9882 1,820.94 1,821.95 3
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% LSDLQEALDQALNHVR 95.00% 5.16 0.556 2.3 608.3223 1,821.94 1,821.95 3
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% QYNDGLSHFVISSVSPTR 95.00% 2.46 0.298 0 670.0046 2,006.99 2,006.99 3
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% NDNLVYVYNLGTK 95.00% 2.43 0.307 0 756.8889 1,511.76 1,512.77 2
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% LSDLQEALDQALNHVR 95.00% 4.91 0.62 5.89 911.9797 1,821.94 1,821.95 2
 SAMPLE 4 Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 6 7 16 4.33% LSDLQEALDQALNHVR 95.00% 5.13 0.611 7.3 911.9801 1,821.94 1,821.95 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% VDRDVEVEDFQR 95.00% 3.07 0.393 0 502.9114 1,505.71 1,506.72 3
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% VDRDVEVEDFQR 95.00% 3.19 0.314 0 502.9133 1,505.72 1,506.72 3
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% LAALSIEEGK 95.00% 2.29 0.385 0 515.2769 1,028.54 1,030.58 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% LAALSIEEGK 95.00% 2.34 0.375 2.09 516.2942 1,030.57 1,030.58 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% LSDLQEALDQALNHVR 95.00% 2.71 0.269 0 607.7983 1,820.37 1,821.95 3
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% TLFPVVLEQLDDYNAK 95.00% 4.03 0.411 1.19 622.6657 1,864.97 1,864.97 3
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% SLLSDVEELVEK 95.00% 2.22 0.286 0 680.8655 1,359.72 1,360.72 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% SLLSDVEELVEK 95.00% 3.1 0.416 3.1 680.8659 1,359.72 1,360.72 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% SLLSDVEELVEK 95.00% 2.99 0.45 2.74 680.8662 1,359.72 1,360.72 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% SLLSDVEELVEK 95.00% 2.84 0.49 3.09 680.8666 1,359.72 1,360.72 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% SLLSDVEELVEK 95.00% 2.72 0.436 2.33 681.3667 1,360.72 1,360.72 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% SLLSDVEELVEK 95.00% 3.12 0.442 3.03 681.3678 1,360.72 1,360.72 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% SLLSDVEELVEKENQASR 95.00% 4.34 0.51 1.16 683.0201 2,046.04 2,046.04 3
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% SLLSDVEELVEKENQASR 95.00% 3.4 0.499 2.03 683.0201 2,046.04 2,046.04 3
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% NDNLVYVYNLGTK 95.00% 2.2 0.331 2.04 756.894 1,511.77 1,512.77 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% NDNLVYVYNLGTK 95.00% 2.97 0.394 0 757.3916 1,512.77 1,512.77 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% NDNLVYVYNLGTK 95.00% 3.22 0.537 2.3 757.3957 1,512.78 1,512.77 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% AYFNGQSFIASIQK 95.00% 3.53 0.433 4.3 787.4079 1,572.80 1,573.80 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% AYFNGQSFIASIQK 95.00% 3.14 0.41 0 787.4114 1,572.81 1,573.80 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% VFLTVPSLSSTAEEK 95.00% 3.16 0.421 0 804.4323 1,606.85 1,607.85 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% VFLTVPSLSSTAEEK 95.00% 4.3 0.433 3.02 804.9333 1,607.85 1,607.85 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% LSDLQEALDQALNHVR 95.00% 4.09 0.587 4.07 911.4787 1,820.94 1,821.95 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% LSDLQEALDQALNHVR 95.00% 5.35 0.597 7.68 911.9774 1,821.94 1,821.95 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% TLFPVVLEQLDDYNAK 95.00% 4.81 0.664 6.8 932.9889 1,863.96 1,864.97 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% TLFPVVLEQLDDYNAK 95.00% 4.92 0.674 7.27 932.9899 1,863.96 1,864.97 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% TLFPVVLEQLDDYNAK 95.00% 4.49 0.683 7.1 932.9917 1,863.97 1,864.97 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% TLFPVVLEQLDDYNAK 95.00% 4.53 0.632 6.06 933.4903 1,864.96 1,864.97 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% TLFPVVLEQLDDYNAK 95.00% 5.84 0.649 5.85 933.4907 1,864.97 1,864.97 2
 SAMPLE 4R Laminin subunit alpha-4  LAMA4  LAMA4_HUMAN 202,512.40 100.00% 10 12 29 7.19% cAPGYYGNPLLIGSTcK 95.00% 4.41 0.632 4.96 c1: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 936.4391 1,870.86 1,870.88 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DTLASVFR 95.00% 2.2 0.3 2.4 454.7476 907.4795 908.4842 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DTLASVFR 95.00% 2.23 0.344 0 454.748 907.4803 908.4842 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DTLASVFR 95.00% 1.88 0.265 1.35 454.749 907.4824 908.4842 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DTLASVFR 95.00% 2.08 0.481 0 454.7491 907.4825 908.4842 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DTLASVFR 95.00% 2.37 0.355 1.64 454.7499 907.4842 908.4842 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% AGALLPAIHEQLR 95.00% 2.49 0.306 0 463.6071 1,387.80 1,388.80 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% AGALLPAIHEQLR 95.00% 2.79 0.4 0 463.6079 1,387.80 1,388.80 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% AGALLPAIHEQLR 95.00% 2.56 0.181 0 463.6081 1,387.80 1,388.80 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% AGALLPAIHEQLR 95.00% 2.39 0.299 1.17 463.6084 1,387.80 1,388.80 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% AGALLPAIHEQLR 95.00% 2.55 0.342 0 463.6088 1,387.80 1,388.80 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% AGALLPAIHEQLR 95.00% 2.39 0.338 0 463.6095 1,387.81 1,388.80 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FGPQTLER 95.00% 2.02 0.409 0 474.2519 946.4882 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FGPQTLER 95.00% 2.07 0.35 0 474.2519 946.4882 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FGPQTLER 95.00% 2.07 0.334 0 474.252 946.4884 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FGPQTLER 95.00% 2.25 0.387 0 474.2525 946.4893 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FGPQTLER 95.00% 2.04 0.264 0 474.2526 946.4896 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FGPQTLER 95.00% 2.11 0.321 0 474.2529 946.4902 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FGPQTLER 95.00% 2.1 0.28 0 474.2533 946.491 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FGPQTLER 95.00% 1.94 0.315 0 474.2534 946.4912 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FGPQTLER 95.00% 2.03 0.277 0 474.2534 946.4912 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FGPQTLER 95.00% 2.25 0.316 0 474.2538 946.4919 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LELEEAATPEGHAVR 95.00% 2.83 0.246 1.12 541.2758 1,620.80 1,621.82 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LELEEAATPEGHAVR 95.00% 3.77 0.393 2 541.2786 1,620.81 1,621.82 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LELEEAATPEGHAVR 95.00% 3.09 0.398 0 541.2794 1,620.81 1,621.82 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LELEEAATPEGHAVR 95.00% 2.54 0.35 1.55 541.2795 1,620.82 1,621.82 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LELEEAATPEGHAVR 95.00% 3.7 0.43 0 541.2798 1,620.82 1,621.82 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FANSPRPDLWVLER 95.00% 3.47 0.428 0 567.3026 1,698.88 1,699.89 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FANSPRPDLWVLER 95.00% 3.01 0.414 0 567.3046 1,698.89 1,699.89 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% FANSPRPDLWVLER 95.00% 2.93 0.489 0 567.6388 1,699.89 1,699.89 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% WQGQYEGLR 95.00% 1.96 0.256 0 568.7775 1,135.54 1,136.55 2 MCF2L_HUMAN,MY18B_HUMAN,COCA1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% WQGQYEGLR 95.00% 1.93 0.258 1.82 568.7798 1,135.54 1,136.55 2 MCF2L_HUMAN,MY18B_HUMAN,COCA1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% WWQSPPLSR 95.00% 2.52 0.304 0 578.7992 1,155.58 1,156.59 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% WWQSPPLSR 95.00% 2.29 0.311 0 578.7995 1,155.58 1,156.59 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% WWQSPPLSR 95.00% 2.15 0.283 0 578.7996 1,155.58 1,156.59 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% WWQSPPLSR 95.00% 2.04 0.308 0 578.7997 1,155.58 1,156.59 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% WWQSPPLSR 95.00% 2.43 0.317 0 578.7997 1,155.58 1,156.59 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% WWQSPPLSR 95.00% 2.28 0.359 0 578.8001 1,155.58 1,156.59 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% AIQVFLLGGSR 95.00% 2.23 0.434 2.18 580.8445 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% AIQVFLLGGSR 95.00% 3.01 0.411 1.74 581.3454 1,160.68 1,160.68 2 ANK3_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% ITRDDAAIcTTEYSR 95.00% 3.49 0.321 0 c9: Carbamidomethyl (+57.02) 591.2812 1,770.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% ITRDDAAIcTTEYSR 95.00% 3.49 0.245 1.05 c9: Carbamidomethyl (+57.02) 591.2819 1,770.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% ITRDDAAIcTTEYSR 95.00% 3.32 0.323 0 c9: Carbamidomethyl (+57.02) 591.2831 1,770.83 1,771.83 3 TINAL_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% ITRDDAAIcTTEYSR 95.00% 3.16 0.206 0 c9: Carbamidomethyl (+57.02) 591.6158 1,771.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% ITRDDAAIcTTEYSR 95.00% 3.59 0.273 0 c9: Carbamidomethyl (+57.02) 591.617 1,771.83 1,771.83 3 TINAL_HUMAN
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DQASQLLAGTEATLGHAK 95.00% 2.71 0.432 0 604.6501 1,810.93 1,810.93 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DQASQLLAGTEATLGHAK 95.00% 3.11 0.352 0 604.6506 1,810.93 1,810.93 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DQASQLLAGTEATLGHAK 95.00% 2.67 0.316 0 604.6508 1,810.93 1,810.93 3
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 4.25 0.439 0 627.8701 1,253.72 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 3.2 0.443 3.27 627.8701 1,253.72 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 3.85 0.511 0 627.8702 1,253.72 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 4.2 0.472 1.48 627.8705 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 3.42 0.483 0 627.8708 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 3.12 0.485 0 627.8709 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 3.89 0.489 1.41 627.8709 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 4 0.445 0 627.871 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 3.9 0.494 1.52 627.8711 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 3.88 0.514 0 627.8712 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 3.96 0.496 1.3 627.8712 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 4.02 0.447 0 627.8715 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 3.11 0.419 2.72 627.872 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 3.85 0.455 1.8 627.8726 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 2.64 0.428 1.59 627.8728 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 3.45 0.469 1.46 627.873 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% LGLVWAALQGAR 95.00% 4.11 0.439 1.32 627.8738 1,253.73 1,254.73 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLADLAAYTALK 95.00% 4.04 0.582 4.19 632.843 1,263.67 1,264.68 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLADLAAYTALK 95.00% 3.11 0.55 3.14 632.8437 1,263.67 1,264.68 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLADLAAYTALK 95.00% 3.84 0.58 5.15 632.844 1,263.67 1,264.68 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLADLAAYTALK 95.00% 3.31 0.448 3.48 632.8442 1,263.67 1,264.68 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLADLAAYTALK 95.00% 3.36 0.555 3.92 632.8443 1,263.67 1,264.68 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLADLAAYTALK 95.00% 3.49 0.555 4.03 632.8445 1,263.67 1,264.68 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLADLAAYTALK 95.00% 3.94 0.624 5.92 632.8445 1,263.67 1,264.68 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLADLAAYTALK 95.00% 4.57 0.587 4.6 632.846 1,263.68 1,264.68 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLADLAAYTALK 95.00% 2.08 0.278 1.57 632.8463 1,263.68 1,264.68 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% GPPPELQPQPEGPPR 95.00% 3.99 0.54 3.39 798.4167 1,594.82 1,595.82 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% GPPPELQPQPEGPPR 95.00% 4.15 0.486 5.8 798.9164 1,595.82 1,595.82 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLGAPQAAAEAELAAAQR 95.00% 4.9 0.525 6.55 876.9491 1,751.88 1,752.89 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLGAPQAAAEAELAAAQR 95.00% 5.71 0.575 5.82 876.9494 1,751.88 1,752.89 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLGAPQAAAEAELAAAQR 95.00% 5.59 0.559 8.16 876.9502 1,751.88 1,752.89 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLGAPQAAAEAELAAAQR 95.00% 4.87 0.582 7.11 876.9511 1,751.89 1,752.89 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLGAPQAAAEAELAAAQR 95.00% 5.93 0.62 6.42 877.4508 1,752.89 1,752.89 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLGAPQAAAEAELAAAQR 95.00% 5.45 0.532 5.19 877.4509 1,752.89 1,752.89 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLGAPQAAAEAELAAAQR 95.00% 5.79 0.536 5.03 877.4516 1,752.89 1,752.89 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLGAPQAAAEAELAAAQR 95.00% 5.49 0.516 8.37 877.4522 1,752.89 1,752.89 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLGAPQAAAEAELAAAQR 95.00% 2.16 0.346 3.66 877.4523 1,752.89 1,752.89 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLGAPQAAAEAELAAAQR 95.00% 5.53 0.522 9.1 877.453 1,752.89 1,752.89 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% DLGAPQAAAEAELAAAQR 95.00% 5.21 0.572 8.89 877.454 1,752.89 1,752.89 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% EcAPGYWGLPEQGcR 95.00% 2.32 0.401 0 c2: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 890.3889 1,778.76 1,779.76 2
 SAMPLE 4 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 14 14 86 5.20% EcAPGYWGLPEQGcR 95.00% 2.93 0.521 4.47 c2: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 890.8844 1,779.75 1,779.76 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DTLASVFR 95.00% 1.87 0.238 1.32 454.7463 907.477 908.4842 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DTLASVFR 95.00% 1.95 0.334 1.43 454.7476 907.4795 908.4842 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DTLASVFR 95.00% 1.96 0.253 1.55 454.7477 907.4797 908.4842 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DTLASVFR 95.00% 1.86 0.2 1.96 454.7481 907.4806 908.4842 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DTLASVFR 95.00% 2.6 0.395 1.37 454.7491 907.4826 908.4842 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DTLASVFR 95.00% 2.36 0.294 0 454.7556 907.4956 908.4842 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% AGALLPAIHEQLR 95.00% 2.79 0.361 0 463.6069 1,387.80 1,388.80 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% AGALLPAIHEQLR 95.00% 2.68 0.311 1.17 463.6074 1,387.80 1,388.80 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% AGALLPAIHEQLR 95.00% 2.52 0.314 0 463.6081 1,387.80 1,388.80 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% AGALLPAIHEQLR 95.00% 2.44 0.304 0 463.6082 1,387.80 1,388.80 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% AGALLPAIHEQLR 95.00% 3.06 0.465 1.19 463.6089 1,387.80 1,388.80 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% AGALLPAIHEQLR 95.00% 2.5 0.308 0 463.6091 1,387.80 1,388.80 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% AGALLPAIHEQLR 95.00% 2.63 0.309 1.15 463.6148 1,387.82 1,388.80 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% FGPQTLER 95.00% 2.08 0.282 0 474.2522 946.4887 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% FGPQTLER 95.00% 2.04 0.377 0 474.2523 946.4889 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% FGPQTLER 95.00% 2.26 0.365 0 474.2523 946.489 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% FGPQTLER 95.00% 1.78 0.346 0 474.2525 946.4894 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% FGPQTLER 95.00% 2.06 0.3 0 474.2528 946.49 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% FGPQTLER 95.00% 2.19 0.365 0 474.2529 946.4901 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% FGPQTLER 95.00% 2.17 0.371 0 474.253 946.4904 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% FGPQTLER 95.00% 2.15 0.346 0 474.2532 946.4908 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% FGPQTLER 95.00% 2.16 0.359 0 474.2544 946.4932 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LELEEAATPEGHAVR 95.00% 2.8 0.357 1.74 541.2788 1,620.81 1,621.82 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LELEEAATPEGHAVR 95.00% 2.54 0.358 0 541.2794 1,620.81 1,621.82 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LELEEAATPEGHAVR 95.00% 3.55 0.461 0 541.28 1,620.82 1,621.82 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LELEEAATPEGHAVR 95.00% 3 0.243 2.08 541.2812 1,620.82 1,621.82 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LELEEAATPEGHAVR 95.00% 3.4 0.343 0 541.6133 1,621.82 1,621.82 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% FANSPRPDLWVLER 95.00% 3.23 0.545 0 567.3007 1,698.88 1,699.89 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% FANSPRPDLWVLER 95.00% 2.27 0.25 0 567.3036 1,698.89 1,699.89 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% FANSPRPDLWVLER 95.00% 3.36 0.476 1.57 567.6386 1,699.89 1,699.89 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% WWQSPPLSR 95.00% 2.15 0.239 0 578.7972 1,155.58 1,156.59 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% WWQSPPLSR 95.00% 2.13 0.295 0 578.7994 1,155.58 1,156.59 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% WWQSPPLSR 95.00% 2.29 0.337 0 578.8003 1,155.58 1,156.59 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% WWQSPPLSR 95.00% 2.36 0.351 0 578.8005 1,155.59 1,156.59 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% ITRDDAAIcTTEYSR 95.00% 3.5 0.257 0 c9: Carbamidomethyl (+57.02) 591.2815 1,770.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% ITRDDAAIcTTEYSR 95.00% 2.93 0.189 0 c9: Carbamidomethyl (+57.02) 591.2817 1,770.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% ITRDDAAIcTTEYSR 95.00% 2.5 0.17 0 c9: Carbamidomethyl (+57.02) 591.2822 1,770.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% ITRDDAAIcTTEYSR 95.00% 3.26 0.294 0 c9: Carbamidomethyl (+57.02) 591.6168 1,771.83 1,771.83 3 TINAL_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% ITRDDAAIcTTEYSR 95.00% 3.27 0.232 0 c9: Carbamidomethyl (+57.02) 591.618 1,771.83 1,771.83 3 TINAL_HUMAN
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DQASQLLAGTEATLGHAK 95.00% 2.7 0.316 0 604.3163 1,809.93 1,810.93 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DQASQLLAGTEATLGHAK 95.00% 2.5 0.255 0 604.6507 1,810.93 1,810.93 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DQASQLLAGTEATLGHAK 95.00% 2.62 0.337 0 604.6511 1,810.93 1,810.93 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DQASQLLAGTEATLGHAK 95.00% 2.75 0.223 0 604.6523 1,810.93 1,810.93 3
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 2.42 0.29 0 627.8705 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 2.97 0.512 2.54 627.8706 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 2.91 0.446 1.51 627.8707 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 2.7 0.356 0 627.8708 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 3.75 0.487 1.55 627.8709 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 3.46 0.536 2.66 627.8713 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 3.16 0.505 1.51 627.8714 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 3.65 0.492 2.09 627.8716 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 3.54 0.532 2.72 627.8716 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 3.78 0.489 0 627.8717 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 3.52 0.505 1.52 627.8719 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 3.47 0.503 1.28 627.8722 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 2.41 0.295 0 627.8723 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 3.73 0.497 2.72 627.8723 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% LGLVWAALQGAR 95.00% 3.48 0.413 3.14 627.8744 1,253.73 1,254.73 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% GQLQLVEGNFR 95.00% 2.36 0.42 0 630.6474 1,259.28 1,260.67 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% GQLQLVEGNFR 95.00% 2.98 0.484 1.64 630.8389 1,259.66 1,260.67 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% GQLQLVEGNFR 95.00% 2.77 0.364 0 630.8395 1,259.66 1,260.67 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% GQLQLVEGNFR 95.00% 3.06 0.479 1.85 630.841 1,259.67 1,260.67 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLADLAAYTALK 95.00% 2.18 0.368 1.37 632.8435 1,263.67 1,264.68 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLADLAAYTALK 95.00% 3.7 0.569 4.32 632.8444 1,263.67 1,264.68 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLADLAAYTALK 95.00% 3.81 0.465 4.89 632.8446 1,263.67 1,264.68 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLADLAAYTALK 95.00% 3.73 0.586 4.77 632.8446 1,263.67 1,264.68 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLADLAAYTALK 95.00% 2.98 0.428 3.46 632.8448 1,263.67 1,264.68 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLADLAAYTALK 95.00% 2.99 0.47 3.34 632.8452 1,263.67 1,264.68 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLADLAAYTALK 95.00% 4.67 0.566 5.1 632.8453 1,263.67 1,264.68 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLADLAAYTALK 95.00% 1.94 0.224 1.44 632.8453 1,263.68 1,264.68 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLADLAAYTALK 95.00% 3.51 0.531 4.33 632.8459 1,263.68 1,264.68 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% GPPPELQPQPEGPPR 95.00% 3.87 0.441 4.35 798.9148 1,595.81 1,595.82 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% GPPPELQPQPEGPPR 95.00% 3.83 0.49 1.92 798.9195 1,595.82 1,595.82 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLGAPQAAAEAELAAAQR 95.00% 5.2 0.563 10.5 876.951 1,751.89 1,752.89 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLGAPQAAAEAELAAAQR 95.00% 5.09 0.61 9.21 876.9511 1,751.89 1,752.89 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLGAPQAAAEAELAAAQR 95.00% 5.22 0.58 9.66 876.9517 1,751.89 1,752.89 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLGAPQAAAEAELAAAQR 95.00% 5.12 0.545 8.39 877.4502 1,752.88 1,752.89 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLGAPQAAAEAELAAAQR 95.00% 5.46 0.587 7.41 877.4522 1,752.89 1,752.89 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DLGAPQAAAEAELAAAQR 95.00% 4.98 0.523 6.39 877.4539 1,752.89 1,752.89 2
 SAMPLE 4R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 80 4.55% DQASQLLAGTEATLGHAK 95.00% 3.84 0.495 1.7 905.9717 1,809.93 1,810.93 2
 SAMPLE 1 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 6 6 10 2.49% LGLVWAALQGAR 95.00% 3.51 0.406 3 627.8677 1,253.72 1,254.73 2
 SAMPLE 1 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 6 6 10 2.49% LGLVWAALQGAR 95.00% 3.76 0.47 2.62 627.8682 1,253.72 1,254.73 2
 SAMPLE 1 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 6 6 10 2.49% LGLVWAALQGAR 95.00% 2.86 0.261 2.89 627.8701 1,253.72 1,254.73 2
 SAMPLE 1 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 6 6 10 2.49% GQLQLVEGNFR 95.00% 2.58 0.373 2.7 630.8354 1,259.66 1,260.67 2
 SAMPLE 1 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 6 6 10 2.49% GQLQLVEGNFR 95.00% 2.63 0.442 3.06 630.8371 1,259.66 1,260.67 2
 SAMPLE 1 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 6 6 10 2.49% DLADLAAYTALK 95.00% 3.95 0.567 4.66 632.8429 1,263.67 1,264.68 2
 SAMPLE 1 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 6 6 10 2.49% SVEVHGAVGASGcPAA 95.00% 3.57 0.585 3.36 c13: Carbamidomethyl (+57.02) 734.8465 1,467.68 1,468.69 2
 SAMPLE 1 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 6 6 10 2.49% DQLEAHIQAAQAmLAmDTDETSK 95.00% 2.19 0.263 0 m13: Oxidation (+15.99), m16: Oxidation (+15.99) 849.9664 2,546.88 2,549.15 3
 SAMPLE 1 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 6 6 10 2.49% DQLEAHIQAAQAmLAmDTDETSK 95.00% 2.21 0.277 0 m13: Oxidation (+15.99), m16: Oxidation (+15.99) 849.9679 2,546.88 2,549.15 3
 SAMPLE 1 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 6 6 10 2.49% DLGAPQAAAEAELAAAQR 95.00% 3.13 0.437 0 877.1468 1,752.28 1,752.89 2
 SAMPLE 1R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 5 5 9 1.87% AIQVFLLGGSR 95.00% 2.91 0.411 2.01 580.8419 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 1R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 5 5 9 1.87% AIQVFLLGGSR 95.00% 2.78 0.207 1.41 580.8425 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 1R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 5 5 9 1.87% LGLVWAALQGAR 95.00% 2.83 0.181 1.35 627.8675 1,253.72 1,254.73 2
 SAMPLE 1R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 5 5 9 1.87% DLADLAAYTALK 95.00% 3.14 0.449 2.92 632.8404 1,263.67 1,264.68 2
 SAMPLE 1R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 5 5 9 1.87% DLADLAAYTALK 95.00% 4.13 0.499 4.04 632.8405 1,263.67 1,264.68 2
 SAMPLE 1R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 5 5 9 1.87% DLADLAAYTALK 95.00% 3.3 0.506 3.4 632.8419 1,263.67 1,264.68 2
 SAMPLE 1R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 5 5 9 1.87% SVEVHGAVGASGcPAA 95.00% 3.57 0.585 3.92 c13: Carbamidomethyl (+57.02) 734.8465 1,467.68 1,468.69 2
 SAMPLE 1R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 5 5 9 1.87% DLGAPQAAAEAELAAAQR 95.00% 3.07 0.42 3.12 877.1461 1,752.28 1,752.89 2
 SAMPLE 1R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 5 5 9 1.87% DLGAPQAAAEAELAAAQR 95.00% 3.33 0.467 3.85 877.148 1,752.28 1,752.89 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% FGPQTLER 95.00% 2.14 0.333 0 474.2516 946.4875 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% FGPQTLER 95.00% 2.01 0.292 0 474.2521 946.4885 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% ILLVTDGAR 95.00% 2.93 0.191 0 479.2898 956.5639 957.5735 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% AIQVFLLGGSR 95.00% 3.15 0.444 2.01 580.8427 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% AIQVFLLGGSR 95.00% 3.44 0.498 1.74 580.8429 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% ITRDDAAIcTTEYSR 95.00% 3.84 0.356 0 c9: Carbamidomethyl (+57.02) 591.614 1,771.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% ITRDDAAIcTTEYSR 95.00% 3.37 0.295 2.19 c9: Carbamidomethyl (+57.02) 591.6142 1,771.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% DQASQLLAGTEATLGHAK 95.00% 2.91 0.271 1.25 604.3145 1,809.92 1,810.93 3
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% DQASQLLAGTEATLGHAK 95.00% 3.12 0.415 0 604.3149 1,809.92 1,810.93 3
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% DQASQLLAGTEATLGHAK 95.00% 2.27 0.271 0 604.6393 1,810.89 1,810.93 3
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% DQASQLLAGTEATLGHAK 95.00% 2.54 0.378 0 604.648 1,810.92 1,810.93 3
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% TQcLcKPGYAGAScER 95.00% 2.58 0.349 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 620.2729 1,857.80 1,857.80 3
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% LGLVWAALQGAR 95.00% 2.42 0.347 2.12 627.8681 1,253.72 1,254.73 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% LGLVWAALQGAR 95.00% 3.93 0.478 2.55 627.8683 1,253.72 1,254.73 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% LGLVWAALQGAR 95.00% 4.11 0.465 2.47 627.8684 1,253.72 1,254.73 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% LGLVWAALQGAR 95.00% 4.26 0.425 1.3 627.8684 1,253.72 1,254.73 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% LGLVWAALQGAR 95.00% 4.07 0.479 1.51 627.8687 1,253.72 1,254.73 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% LGLVWAALQGAR 95.00% 4.03 0.475 1.4 627.8689 1,253.72 1,254.73 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% LGLVWAALQGAR 95.00% 4.29 0.46 1.23 627.8692 1,253.72 1,254.73 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% LGLVWAALQGAR 95.00% 4.27 0.448 0 627.8692 1,253.72 1,254.73 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% LGLVWAALQGAR 95.00% 3.28 0.406 1.77 627.8697 1,253.72 1,254.73 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% LPVTVGFSGcVK 95.00% 1.82 0.435 0 c10: Carbamidomethyl (+57.02) 632.3444 1,262.67 1,263.68 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% SVEVHGAVGASGcPAA 95.00% 3.58 0.589 5.29 c13: Carbamidomethyl (+57.02) 734.8453 1,467.68 1,468.69 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% SVEVHGAVGASGcPAA 95.00% 2.05 0.282 1.7 c13: Carbamidomethyl (+57.02) 734.8454 1,467.68 1,468.69 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% SVEVHGAVGASGcPAA 95.00% 3.15 0.498 3.6 c13: Carbamidomethyl (+57.02) 734.8469 1,467.68 1,468.69 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% GPPPELQPQPEGPPR 95.00% 3.68 0.453 2.92 798.4102 1,594.80 1,595.82 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% GPPPELQPQPEGPPR 95.00% 3.35 0.396 2.59 798.9084 1,595.80 1,595.82 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% DLGAPQAAAEAELAAAQR 95.00% 5.01 0.563 9.51 877.4477 1,752.88 1,752.89 2
 SAMPLE 2 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 11 11 29 4.06% DLGAPQAAAEAELAAAQR 95.00% 5.64 0.613 6.24 877.4497 1,752.88 1,752.89 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% DTLASVFR 95.00% 2.01 0.133 1.4 454.7481 907.4805 908.4842 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% ILLVTDGAR 95.00% 2.72 0.194 0 479.2902 956.5647 957.5735 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% ILLVTDGAR 95.00% 2.77 0.195 0 479.2905 956.5653 957.5735 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% FANSPRPDLWVLER 95.00% 3.42 0.394 0 567.6351 1,699.88 1,699.89 3
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% FANSPRPDLWVLER 95.00% 3.09 0.341 0 567.6363 1,699.89 1,699.89 3
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% AIQVFLLGGSR 95.00% 2.85 0.429 0 580.838 1,159.66 1,160.68 2 ANK3_HUMAN
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% AIQVFLLGGSR 95.00% 3 0.424 2.35 580.8403 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% AIQVFLLGGSR 95.00% 2.73 0.304 1.51 580.8403 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% AIQVFLLGGSR 95.00% 3.31 0.459 2.07 580.8423 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% ITRDDAAIcTTEYSR 95.00% 3.12 0.276 1.37 c9: Carbamidomethyl (+57.02) 591.6125 1,771.81 1,771.83 3 TINAL_HUMAN
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% DQASQLLAGTEATLGHAK 95.00% 2.5 0.214 0 604.3135 1,809.92 1,810.93 3
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% LGLVWAALQGAR 95.00% 2.61 0.351 3.11 627.8683 1,253.72 1,254.73 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% LGLVWAALQGAR 95.00% 3.92 0.448 2.35 627.8683 1,253.72 1,254.73 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% LGLVWAALQGAR 95.00% 3.13 0.439 2.24 627.8684 1,253.72 1,254.73 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% LGLVWAALQGAR 95.00% 4.3 0.441 0 627.8686 1,253.72 1,254.73 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% LGLVWAALQGAR 95.00% 3.88 0.459 2.3 627.8694 1,253.72 1,254.73 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% LGLVWAALQGAR 95.00% 3.95 0.483 1.22 627.8695 1,253.72 1,254.73 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% LGLVWAALQGAR 95.00% 3.61 0.45 1.55 627.8698 1,253.72 1,254.73 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% GQLQLVEGNFR 95.00% 3.17 0.495 2.08 630.8376 1,259.66 1,260.67 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% GQLQLVEGNFR 95.00% 2.93 0.503 1.82 630.8379 1,259.66 1,260.67 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% DLADLAAYTALK 95.00% 4.11 0.524 5.01 632.8418 1,263.67 1,264.68 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% DLADLAAYTALK 95.00% 3.94 0.581 4.04 632.8418 1,263.67 1,264.68 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% DLADLAAYTALK 95.00% 3.9 0.584 4.31 632.8419 1,263.67 1,264.68 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% DLADLAAYTALK 95.00% 3.92 0.581 4.8 632.843 1,263.67 1,264.68 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% DLADLAAYTALK 94.80% 0 0 3.27 633.9851 1,265.95 1,264.68 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% SVEVHGAVGASGcPAA 95.00% 2.76 0.497 2.09 c13: Carbamidomethyl (+57.02) 734.8453 1,467.68 1,468.69 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% SVEVHGAVGASGcPAA 95.00% 3.55 0.551 5.47 c13: Carbamidomethyl (+57.02) 734.8459 1,467.68 1,468.69 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% GPPPELQPQPEGPPR 95.00% 3.52 0.454 2.52 798.4116 1,594.81 1,595.82 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% DLGAPQAAAEAELAAAQR 95.00% 5.28 0.511 8.89 877.4455 1,752.88 1,752.89 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% DQASQLLAGTEATLGHAK 95.00% 3.47 0.478 0 906.4569 1,810.90 1,810.93 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% DQASQLLAGTEATLGHAK 95.00% 3.77 0.331 0 906.4601 1,810.90 1,810.93 2
 SAMPLE 2R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 13 14 32 4.84% GQDLGQAVLDAGHSVSTLEK 95.00% 5.15 0.663 6.21 1,013.51 2,025.00 2,025.03 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% AGALLPAIHEQLR 95.00% 2.88 0.26 0 463.6062 1,387.80 1,388.80 3
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% AGALLPAIHEQLR 95.00% 2.75 0.288 0 463.6071 1,387.80 1,388.80 3
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% ILLVTDGAR 95.00% 2.89 0.221 0 479.2905 956.5653 957.5735 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% LLHSLDQAKEELER 95.00% 2.25 0.348 0 561.3018 1,680.88 1,680.89 3
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% WQGQYEGLR 95.00% 2.09 0.269 0 569.2791 1,136.54 1,136.55 2 MCF2L_HUMAN,MY18B_HUMAN,COCA1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% WWQSPPLSR 95.00% 2.43 0.278 0 578.7972 1,155.58 1,156.59 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% WWQSPPLSR 95.00% 2.56 0.229 0 578.7978 1,155.58 1,156.59 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% WWQSPPLSR 95.00% 2.24 0.272 0 578.798 1,155.58 1,156.59 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% WWQSPPLSR 95.00% 2.55 0.307 0 578.7981 1,155.58 1,156.59 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% WWQSPPLSR 95.00% 2.52 0.173 0 578.7986 1,155.58 1,156.59 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% WWQSPPLSR 95.00% 2.27 0.228 0 579.2982 1,156.58 1,156.59 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% AIQVFLLGGSR 95.00% 3.31 0.439 1.38 580.8414 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% ITRDDAAIcTTEYSR 95.00% 3.59 0.373 0 c9: Carbamidomethyl (+57.02) 591.2799 1,770.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% ITRDDAAIcTTEYSR 95.00% 3.51 0.313 1.09 c9: Carbamidomethyl (+57.02) 591.2809 1,770.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% ITRDDAAIcTTEYSR 95.00% 3.73 0.274 0 c9: Carbamidomethyl (+57.02) 591.6149 1,771.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% DQASQLLAGTEATLGHAK 95.00% 2.46 0.273 0 604.6478 1,810.92 1,810.93 3
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% DQASQLLAGTEATLGHAK 95.00% 2.34 0.296 0 604.6481 1,810.92 1,810.93 3
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% DQASQLLAGTEATLGHAK 95.00% 2.64 0.246 0 604.6487 1,810.92 1,810.93 3
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% DQASQLLAGTEATLGHAK 95.00% 2.96 0.264 0 604.649 1,810.92 1,810.93 3
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% DQASQLLAGTEATLGHAK 95.00% 2.63 0.233 0 604.6491 1,810.92 1,810.93 3
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% LGLVWAALQGAR 95.00% 2.67 0.206 0 627.8713 1,253.73 1,254.73 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% GQLQLVEGNFR 95.00% 2.89 0.539 2.85 630.8375 1,259.66 1,260.67 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% GQLQLVEGNFR 95.00% 3.18 0.529 3.14 630.8382 1,259.66 1,260.67 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% LPVTVGFSGcVK 95.00% 2.11 0.344 2.37 c10: Carbamidomethyl (+57.02) 632.3402 1,262.66 1,263.68 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% DLADLAAYTALK 95.00% 3.45 0.376 2.34 632.8437 1,263.67 1,264.68 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% IAASATcGEEAPAR 95.00% 2.47 0.402 2.77 c7: Carbamidomethyl (+57.02) 702.3326 1,402.65 1,403.66 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% GPPPELQPQPEGPPR 95.00% 3.82 0.43 3.33 798.4169 1,594.82 1,595.82 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% ASPDGLcQVSLQQGR 95.00% 2.53 0.225 0 c7: Carbamidomethyl (+57.02) 808.3934 1,614.77 1,615.79 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% ASPDGLcQVSLQQGR 95.00% 3.62 0.448 1.96 c7: Carbamidomethyl (+57.02) 808.3986 1,614.78 1,615.79 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% HETAQQLEVLEQQSTSLGQDAR 95.00% 3.4 0.395 0 823.7396 2,468.20 2,468.20 3
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% DLGAPQAAAEAELAAAQR 95.00% 5.6 0.592 10.2 876.9469 1,751.88 1,752.89 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% DLGAPQAAAEAELAAAQR 95.00% 5.55 0.615 7.54 876.9482 1,751.88 1,752.89 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% DLGAPQAAAEAELAAAQR 95.00% 5.52 0.57 8.77 877.4474 1,752.88 1,752.89 2
 SAMPLE 3 Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 16 17 33 6.20% DQASQLLAGTEATLGHAK 95.00% 4.77 0.535 2.13 905.9698 1,809.92 1,810.93 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% AGALLPAIHEQLR 95.00% 2.39 0.252 0 463.6057 1,387.79 1,388.80 3
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% AGALLPAIHEQLR 95.00% 3.25 0.35 0 463.606 1,387.79 1,388.80 3
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% FGPQTLER 95.00% 1.87 0.319 0 474.2528 946.49 947.4952 2 HS90A_HUMAN,FIL1L_HUMAN
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% ILLVTDGAR 95.00% 2.58 0.174 0 479.2892 956.5627 957.5735 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% WWQSPPLSR 95.00% 2.3 0.301 0 578.7984 1,155.58 1,156.59 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% AIQVFLLGGSR 95.00% 3.21 0.472 1.59 580.8413 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% AIQVFLLGGSR 95.00% 2.99 0.415 2.09 580.8416 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% AIQVFLLGGSR 95.00% 2.67 0.392 2.77 580.8423 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% AIQVFLLGGSR 95.00% 3.66 0.504 1.28 580.8424 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% AIQVFLLGGSR 95.00% 3.49 0.46 3.05 580.8433 1,159.67 1,160.68 2 ANK3_HUMAN
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% ITRDDAAIcTTEYSR 95.00% 3.58 0.296 0 c9: Carbamidomethyl (+57.02) 591.2803 1,770.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% ITRDDAAIcTTEYSR 95.00% 3.11 0.211 0 c9: Carbamidomethyl (+57.02) 591.282 1,770.82 1,771.83 3 TINAL_HUMAN
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% AVAAEAQDTATR 95.00% 2.12 0.261 0 602.2784 1,202.54 1,203.60 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% DQASQLLAGTEATLGHAK 95.00% 2.68 0.319 0 604.3162 1,809.93 1,810.93 3
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% DQASQLLAGTEATLGHAK 95.00% 2.74 0.341 0 604.6478 1,810.92 1,810.93 3
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% TLAEVERLLWEMRAR 95.00% 2.4 0.222 0 625.2797 1,872.82 1,873.01 3
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% LGLVWAALQGAR 95.00% 3.63 0.46 1.38 627.8679 1,253.72 1,254.73 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% LGLVWAALQGAR 95.00% 3.28 0.5 2.29 627.868 1,253.72 1,254.73 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% LGLVWAALQGAR 95.00% 3.42 0.421 2.66 627.8684 1,253.72 1,254.73 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% LGLVWAALQGAR 95.00% 2.84 0.379 0 627.8688 1,253.72 1,254.73 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% LGLVWAALQGAR 95.00% 3.1 0.451 2.17 627.869 1,253.72 1,254.73 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% LGLVWAALQGAR 95.00% 3.32 0.416 2.35 627.8692 1,253.72 1,254.73 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% LGLVWAALQGAR 95.00% 2.17 0.321 0 627.8695 1,253.72 1,254.73 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% LGLVWAALQGAR 95.00% 3.39 0.392 3.21 627.8698 1,253.72 1,254.73 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% LGLVWAALQGAR 95.00% 3.03 0.337 1.59 628.3814 1,254.75 1,254.73 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% DLADLAAYTALK 95.00% 4.11 0.62 5.4 632.8418 1,263.67 1,264.68 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% DLADLAAYTALK 95.00% 3.22 0.473 3.36 632.842 1,263.67 1,264.68 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% DLADLAAYTALK 95.00% 3.95 0.566 4.51 632.8422 1,263.67 1,264.68 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% DLADLAAYTALK 95.00% 2.46 0.26 0 632.8426 1,263.67 1,264.68 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% DLADLAAYTALK 95.00% 3.82 0.571 4.27 632.843 1,263.67 1,264.68 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% DLGAPQAAAEAELAAAQR 95.00% 5.01 0.538 8.77 876.9461 1,751.88 1,752.89 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% DLGAPQAAAEAELAAAQR 95.00% 5.4 0.586 8.03 876.9471 1,751.88 1,752.89 2
 SAMPLE 3R Laminin subunit alpha-5  LAMA5  LAMA5_HUMAN 399,709.10 100.00% 12 12 33 4.11% DLGAPQAAAEAELAAAQR 95.00% 5.11 0.533 8.05 876.9485 1,751.88 1,752.89 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LHTLGDNLLDPR 95.00% 2.13 0.236 0 455.2522 1,362.73 1,363.73 3
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% DLLQAAQDK 95.00% 2.01 0.268 0 501.2684 1,000.52 1,001.53 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% DLLQAAQDK 95.00% 2.06 0.328 0 501.2684 1,000.52 1,001.53 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GQVLDVVER 95.00% 2.36 0.297 1.2 507.7823 1,013.55 1,014.56 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GQVLDVVER 95.00% 2.31 0.25 0 507.7824 1,013.55 1,014.56 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GQVLDVVER 95.00% 2.18 0.275 0 507.7829 1,013.55 1,014.56 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GQVLDVVER 95.00% 2.64 0.392 0 507.7833 1,013.55 1,014.56 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GQVLDVVER 95.00% 2.38 0.207 0 507.7836 1,013.55 1,014.56 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GQVLDVVER 95.00% 2.55 0.311 0 507.7837 1,013.55 1,014.56 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GQVLDVVER 95.00% 2.44 0.238 1.55 507.7837 1,013.55 1,014.56 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GQVLDVVER 95.00% 2.46 0.277 0 507.7838 1,013.55 1,014.56 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% ALAEGGSILSR 95.00% 2.27 0.263 2.85 537.2893 1,072.56 1,073.60 2 TITIN_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% ALAEGGSILSR 95.00% 2.72 0.366 3.74 537.2895 1,072.56 1,073.60 2 TITIN_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% ALAEGGSILSR 95.00% 1.86 0.37 0 537.2906 1,072.57 1,073.60 2 TITIN_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% ALAEGGSILSR 95.00% 2.24 0.35 1.42 537.2906 1,072.57 1,073.60 2 TITIN_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% ALAEGGSILSR 95.00% 2.15 0.37 2.92 537.3022 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% ALAEGGSILSR 95.00% 2.7 0.347 2.74 537.3028 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% ALAEGGSILSR 95.00% 3.25 0.339 3.13 537.3034 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% ALAEGGSILSR 95.00% 3.37 0.408 2.12 537.3035 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% ALAEGGSILSR 95.00% 3.15 0.384 3.06 537.6247 1,073.23 1,073.60 2 TITIN_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.23 0.475 2.33 541.8378 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 2.8 0.499 1.96 541.8379 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.46 0.501 2.12 541.838 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.09 0.464 2.96 541.838 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.15 0.407 1.8 541.838 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.41 0.508 3.48 541.8381 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 2.71 0.449 1.8 541.8382 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.51 0.463 4 541.8383 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.24 0.448 2.6 541.8384 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.72 0.479 4.19 541.8385 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.66 0.486 3.77 541.8387 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.83 0.508 3.02 541.8388 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 2.63 0.372 2.89 541.8388 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.56 0.476 3.19 541.8389 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.79 0.503 4 541.8391 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.46 0.391 2.2 541.8392 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.66 0.489 3.47 541.8393 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.41 0.488 3.43 541.8394 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.38 0.503 4.38 541.8395 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LGIVQGIVGAR 95.00% 3.3 0.494 3.74 541.8398 1,081.66 1,082.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GQWGFPScR 95.00% 2.37 0.274 0 c8: Carbamidomethyl (+57.02) 547.7467 1,093.48 1,094.48 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% AMDYDLLLR 95.00% 3.22 0.344 1.57 555.2863 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% AMDYDLLLR 95.00% 3.49 0.347 0 555.2874 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% AMDYDLLLR 95.00% 3.36 0.378 0 555.2876 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% AMDYDLLLR 95.00% 3.19 0.383 1.4 555.2895 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.24 0.384 1.68 557.3299 1,112.64 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.45 0.396 1.7 557.3299 1,112.64 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.25 0.404 0 557.3302 1,112.64 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.45 0.369 0 557.3302 1,112.64 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.34 0.329 0 557.3303 1,112.64 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.28 0.339 0 557.3304 1,112.65 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.34 0.3 0 557.3304 1,112.65 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.18 0.423 1.57 557.3306 1,112.65 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.2 0.404 1.68 557.3306 1,112.65 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.33 0.387 0 557.3308 1,112.65 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.22 0.39 0 557.3309 1,112.65 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.19 0.409 1.89 557.331 1,112.65 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.48 0.372 0 557.3311 1,112.65 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.31 0.394 0 557.3311 1,112.65 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.37 0.385 1.46 557.3311 1,112.65 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% QLDALLEALK 95.00% 2.14 0.297 0 557.332 1,112.65 1,113.65 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% AmDYDLLLR 95.00% 1.77 0.236 1.64 m2: Oxidation (+15.99) 563.0199 1,124.02 1,125.56 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.72 0.396 1.82 572.323 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.9 0.382 2.8 572.323 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 4.06 0.434 1.96 572.3232 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.92 0.429 3 572.3233 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.94 0.392 2.47 572.3235 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.82 0.449 2.52 572.3235 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.99 0.406 2.42 572.3237 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.92 0.391 1.96 572.3237 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.9 0.409 2.44 572.3238 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.27 0.416 2.39 572.3238 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.58 0.356 2.39 572.324 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.85 0.404 2.52 572.3241 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.88 0.473 3.07 572.3241 1,142.63 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% SLADVDAILAR 95.00% 3.37 0.315 1.82 572.9985 1,143.98 1,143.64 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GPLGDQYQTVK 95.00% 2.78 0.503 2.82 603.313 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GPLGDQYQTVK 95.00% 3.16 0.554 2.77 603.3134 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GPLGDQYQTVK 95.00% 2.83 0.51 1.8 603.3136 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GPLGDQYQTVK 95.00% 3.03 0.586 3.38 603.3136 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GPLGDQYQTVK 95.00% 3 0.607 3.6 603.3138 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GPLGDQYQTVK 95.00% 2.96 0.556 2.82 603.314 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GPLGDQYQTVK 95.00% 3.06 0.635 2.92 603.314 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GPLGDQYQTVK 95.00% 2.75 0.573 2.89 603.3143 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GPLGDQYQTVK 95.00% 2.5 0.543 1.96 603.3147 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GPLGDQYQTVK 95.00% 2.96 0.557 3.15 603.3155 1,204.62 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% DGFFGLSISDR 95.00% 2.19 0.35 3.01 607.2971 1,212.58 1,213.59 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% DGFFGLSISDR 95.00% 3.47 0.475 2.44 607.2977 1,212.58 1,213.59 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% DGFFGLSISDR 95.00% 3.46 0.456 3.59 607.2979 1,212.58 1,213.59 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% DGFFGLSISDR 95.00% 2.65 0.309 4.55 607.2986 1,212.58 1,213.59 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% HWDDVVcESR 95.00% 2.74 0.514 2.08 c7: Carbamidomethyl (+57.02) 651.7804 1,301.55 1,302.55 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% HWDDVVcESR 95.00% 1.87 0.23 2.02 c7: Carbamidomethyl (+57.02) 651.7809 1,301.55 1,302.55 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% HWDDVVcESR 95.00% 2.44 0.521 2.28 c7: Carbamidomethyl (+57.02) 651.7822 1,301.55 1,302.55 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% HWDDVVcESR 95.00% 2.59 0.484 2.21 c7: Carbamidomethyl (+57.02) 651.7826 1,301.55 1,302.55 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% HWDDVVcESR 95.00% 2.19 0.469 2.85 c7: Carbamidomethyl (+57.02) 651.7832 1,301.55 1,302.55 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% IQNVVTSFAPQR 95.00% 3.25 0.487 4.72 680.3736 1,358.73 1,359.74 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% HSNFLGAYDSIR 95.00% 3.14 0.459 3.04 690.3393 1,378.66 1,379.67 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GScYPATGDLLVGR 95.00% 2.74 0.408 0 c3: Carbamidomethyl (+57.02) 733.3596 1,464.70 1,465.71 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GScYPATGDLLVGR 95.00% 2.9 0.488 3.19 c3: Carbamidomethyl (+57.02) 733.3607 1,464.71 1,465.71 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GScYPATGDLLVGR 95.00% 2.98 0.364 2.89 c3: Carbamidomethyl (+57.02) 733.3626 1,464.71 1,465.71 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GScYPATGDLLVGR 95.00% 2.49 0.392 3.2 c3: Carbamidomethyl (+57.02) 733.3628 1,464.71 1,465.71 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GScYPATGDLLVGR 95.00% 3.13 0.397 4.02 c3: Carbamidomethyl (+57.02) 733.8623 1,465.71 1,465.71 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GScYPATGDLLVGR 95.00% 2.97 0.411 3.59 c3: Carbamidomethyl (+57.02) 733.8634 1,465.71 1,465.71 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LQELEGTYEENER 95.00% 4.33 0.459 3.2 805.3715 1,608.73 1,609.73 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LQELEGTYEENER 95.00% 4.47 0.468 3.41 805.3736 1,608.73 1,609.73 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LQELEGTYEENER 95.00% 4.27 0.452 4.13 805.3752 1,608.73 1,609.73 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% VLDPAIPIPDPYSSR 95.00% 2.4 0.418 2.4 820.4403 1,638.87 1,639.87 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% VLDPAIPIPDPYSSR 95.00% 2.14 0.353 2.96 820.4406 1,638.87 1,639.87 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% VLDPAIPIPDPYSSR 95.00% 2.33 0.407 2.08 820.4408 1,638.87 1,639.87 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% VLDPAIPIPDPYSSR 95.00% 2.32 0.418 2.08 820.4411 1,638.87 1,639.87 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% VLDPAIPIPDPYSSR 95.00% 2.28 0.248 1.96 820.4426 1,638.87 1,639.87 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% VLDPAIPIPDPYSSR 95.00% 2.51 0.452 2.68 820.9406 1,639.87 1,639.87 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% VLDPAIPIPDPYSSR 95.00% 2.26 0.343 2 820.9411 1,639.87 1,639.87 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% VLDPAIPIPDPYSSR 95.00% 2.5 0.454 1.43 820.9428 1,639.87 1,639.87 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% VLDPAIPIPDPYSSR 95.00% 2.54 0.373 2.59 820.9428 1,639.87 1,639.87 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% YSEIEPSTEGEVIYR 95.00% 3.44 0.551 4.07 886.4244 1,770.83 1,771.84 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% YSEIEPSTEGEVIYR 95.00% 3.86 0.54 4.29 886.425 1,770.83 1,771.84 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% YSEIEPSTEGEVIYR 95.00% 4.8 0.514 3.54 886.425 1,770.83 1,771.84 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% YSEIEPSTEGEVIYR 95.00% 4.57 0.581 3.68 886.4255 1,770.84 1,771.84 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% YSEIEPSTEGEVIYR 95.00% 3.04 0.453 1.32 886.4257 1,770.84 1,771.84 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% YSEIEPSTEGEVIYR 95.00% 4.76 0.549 4.7 886.4266 1,770.84 1,771.84 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% YSEIEPSTEGEVIYR 95.00% 3.08 0.376 2.44 886.4278 1,770.84 1,771.84 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% YSEIEPSTEGEVIYR 95.00% 4.61 0.581 5.07 886.9265 1,771.84 1,771.84 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% YSEIEPSTEGEVIYR 95.00% 3.01 0.481 1.28 886.9266 1,771.84 1,771.84 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% YSEIEPSTEGEVIYR 95.00% 3.46 0.561 4.06 886.9274 1,771.84 1,771.84 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% YSEIEPSTEGEVIYR 95.00% 5.02 0.563 4.38 886.9274 1,771.84 1,771.84 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LVTPGETPSWTGSGFVR 95.00% 4.26 0.597 4.57 896.4612 1,790.91 1,790.91 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% LVTPGETPSWTGSGFVR 95.00% 4.51 0.572 3.66 896.4613 1,790.91 1,790.91 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% cGGLScNGAAATADLALGR 95.00% 4.3 0.581 4.74 c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 917.93 1,833.84 1,834.85 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% cGGLScNGAAATADLALGR 95.00% 4.94 0.608 4.82 c1: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 917.9323 1,833.85 1,834.85 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% AGNSLAASTAEETAGSAQGR 95.00% 6.16 0.641 6.8 925.4432 1,848.87 1,848.87 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% AGNSLAASTAEETAGSAQGR 95.00% 6.42 0.637 4.47 925.4441 1,848.87 1,848.87 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% cDSHDDPALGLVSGQcR 95.00% 0 0 5.92 c1: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 935.8992 1,869.78 1,869.79 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GTVPGSTPcDPNSGScYcK 95.00% 3.01 0.375 3.12 c9: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 1,022.91 2,043.81 2,043.82 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GTVPGSTPcDPNSGScYcK 95.00% 3.9 0.526 2.96 c9: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 1,022.92 2,043.82 2,043.82 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GTVPGSTPcDPNSGScYcK 95.00% 3.63 0.466 3.62 c9: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 1,022.92 2,043.82 2,043.82 2
 SAMPLE 4 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 21 21 123 16.50% GTVPGSTPcDPNSGScYcK 95.00% 3.76 0.471 5.89 c9: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 1,022.92 2,043.82 2,043.82 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LHTLGDNLLDPR 95.00% 2.49 0.24 1.19 455.2512 1,362.73 1,363.73 3
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LHTLGDNLLDPR 95.00% 2.32 0.263 0 455.2514 1,362.73 1,363.73 3
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LHTLGDNLLDPR 95.00% 2.39 0.325 0 455.2597 1,362.76 1,363.73 3
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVLDVVER 95.00% 2.5 0.287 0 507.7831 1,013.55 1,014.56 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVLDVVER 95.00% 2.39 0.203 0 507.7831 1,013.55 1,014.56 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVLDVVER 95.00% 2.53 0.344 0 507.7836 1,013.55 1,014.56 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVLDVVER 95.00% 2.37 0.314 0 507.7837 1,013.55 1,014.56 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVLDVVER 95.00% 2.26 0.285 0 507.784 1,013.55 1,014.56 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVLDVVER 95.00% 2.17 0.256 0 507.784 1,013.55 1,014.56 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVLDVVER 95.00% 2.44 0.312 0 507.7844 1,013.55 1,014.56 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 2.53 0.41 3.21 537.2896 1,072.56 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 2.17 0.303 2.68 537.2899 1,072.56 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 2.69 0.413 2.89 537.2907 1,072.57 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 2.03 0.341 1.85 537.2908 1,072.57 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 2.21 0.323 2.85 537.2911 1,072.57 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 2.14 0.269 2.52 537.3015 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 2.81 0.374 1.89 537.3024 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 3.38 0.412 3.64 537.3028 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 3.17 0.356 4.32 537.3029 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 3.4 0.456 4.3 537.303 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 2.31 0.286 2.4 537.3031 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 3.22 0.386 3.7 537.3031 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 2.85 0.341 2.39 537.304 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% ALAEGGSILSR 95.00% 2.25 0.241 2.57 537.6243 1,073.23 1,073.60 2 TITIN_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.57 0.524 4.59 541.8378 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.68 0.499 4.08 541.8379 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.52 0.515 3.2 541.8379 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.27 0.465 2.49 541.838 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.54 0.485 2.8 541.8382 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.46 0.487 2.19 541.8382 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.44 0.496 3.52 541.8382 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.5 0.499 2.43 541.8382 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.58 0.491 3.49 541.8388 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 2.79 0.366 1.96 541.839 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.53 0.492 2.68 541.839 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 2.63 0.437 1.6 541.8389 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.86 0.496 3.41 541.8392 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 2.89 0.455 2.12 541.8394 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.61 0.475 2.52 541.8394 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 3.18 0.476 2.1 541.8396 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LGIVQGIVGAR 95.00% 2.84 0.414 2.6 541.8401 1,081.66 1,082.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 2.74 0.256 4.68 547.2974 1,638.87 1,639.87 3
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 2.5 0.348 1.48 547.6305 1,639.87 1,639.87 3
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQWGFPScR 95.00% 2.41 0.254 0 c8: Carbamidomethyl (+57.02) 548.2471 1,094.48 1,094.48 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% AMDYDLLLR 95.00% 3.02 0.304 1.18 555.286 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% AMDYDLLLR 95.00% 3.47 0.373 0 555.2865 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% AMDYDLLLR 95.00% 3.65 0.394 0 555.287 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% AMDYDLLLR 95.00% 3.22 0.357 0 555.2874 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% AMDYDLLLR 95.00% 3.58 0.309 1.18 555.2876 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% AMDYDLLLR 95.00% 3.77 0.358 0 555.2876 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% AMDYDLLLR 95.00% 2.98 0.363 0 555.2877 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% AMDYDLLLR 95.00% 3.36 0.327 0 555.2881 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.25 0.39 0 557.3291 1,112.64 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.33 0.387 0 557.3301 1,112.64 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.25 0.433 2.14 557.3302 1,112.64 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.37 0.402 1.55 557.3303 1,112.64 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.16 0.428 2 557.3304 1,112.65 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.24 0.416 0 557.3304 1,112.65 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.2 0.414 1.24 557.3307 1,112.65 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.31 0.352 0 557.3307 1,112.65 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.07 0.284 0 557.3308 1,112.65 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.3 0.436 1.74 557.3308 1,112.65 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.36 0.424 0 557.3308 1,112.65 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.26 0.439 0 557.3308 1,112.65 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.39 0.38 0 557.3308 1,112.65 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% QLDALLEALK 95.00% 2.25 0.419 2.36 557.3311 1,112.65 1,113.65 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% SLADVDAILAR 95.00% 3.48 0.388 2.68 572.3224 1,142.63 1,143.64 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% SLADVDAILAR 95.00% 3.78 0.371 1.68 572.3233 1,142.63 1,143.64 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% SLADVDAILAR 95.00% 3.52 0.394 1.96 572.3233 1,142.63 1,143.64 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% SLADVDAILAR 95.00% 3.93 0.408 1.8 572.3234 1,142.63 1,143.64 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% SLADVDAILAR 95.00% 3.78 0.444 2.38 572.3235 1,142.63 1,143.64 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% SLADVDAILAR 95.00% 3.71 0.363 2.39 572.3235 1,142.63 1,143.64 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% SLADVDAILAR 95.00% 3.88 0.433 2.68 572.3238 1,142.63 1,143.64 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% SLADVDAILAR 95.00% 3.96 0.406 2.6 572.3238 1,142.63 1,143.64 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% SLADVDAILAR 95.00% 3.64 0.386 0 572.3239 1,142.63 1,143.64 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% SLADVDAILAR 95.00% 3.9 0.382 1.8 572.3239 1,142.63 1,143.64 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% SLADVDAILAR 95.00% 3.78 0.419 2.17 572.324 1,142.63 1,143.64 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% SLADVDAILAR 95.00% 3.81 0.37 2.29 572.3241 1,142.63 1,143.64 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 3.91 0.417 1.96 586.993 1,757.96 1,758.96 3 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 3.19 0.425 1.66 586.9935 1,757.96 1,758.96 3 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.15 0.47 1.7 586.9937 1,757.96 1,758.96 3 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 2.86 0.26 0 586.9943 1,757.96 1,758.96 3 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 3.62 0.431 1.55 586.9946 1,757.96 1,758.96 3 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 3.6 0.362 2.16 587.3286 1,758.96 1,758.96 3 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 2.92 0.234 0 587.3286 1,758.96 1,758.96 3 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.03 0.421 1.66 587.3298 1,758.97 1,758.96 3 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 2.73 0.182 1.62 587.3301 1,758.97 1,758.96 3 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLVLEMFSGGDAAALER 95.00% 4.71 0.528 2.7 593.314 1,776.92 1,777.92 3
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLVLEMFSGGDAAALER 95.00% 4.35 0.449 3.2 593.3141 1,776.92 1,777.92 3
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLVLEMFSGGDAAALER 95.00% 4.89 0.485 2.38 593.3145 1,776.92 1,777.92 3
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GPLGDQYQTVK 95.00% 2.69 0.472 3.57 603.3132 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GPLGDQYQTVK 95.00% 2.78 0.567 3.34 603.3136 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GPLGDQYQTVK 95.00% 2.97 0.485 4.11 603.3141 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GPLGDQYQTVK 95.00% 2.83 0.529 3.36 603.8107 1,205.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 2.37 0.374 3.51 607.2965 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 2.93 0.416 3.49 607.2969 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 3.19 0.428 2.3 607.2969 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 3.39 0.442 2.82 607.2975 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 2.37 0.426 4.36 607.2976 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 3.17 0.37 2.59 607.2977 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 2.53 0.426 3.38 607.2978 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 3.4 0.446 3.34 607.2979 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 3.37 0.46 3.52 607.2979 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 3.53 0.499 3 607.298 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 3.36 0.506 3.35 607.2981 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 3.36 0.415 2.96 607.2982 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 3.43 0.498 3.38 607.2985 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 3.17 0.504 3.96 607.2986 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 3.43 0.514 3.92 607.2987 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 2.73 0.485 3.39 607.2988 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 2.45 0.38 3.59 607.299 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 2.74 0.451 4.34 607.2993 1,212.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 2.56 0.444 4.46 607.3012 1,212.59 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% DGFFGLSISDR 95.00% 3.05 0.42 3.59 607.7982 1,213.58 1,213.59 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% HWDDVVcESR 95.00% 2.48 0.477 2.43 c7: Carbamidomethyl (+57.02) 651.7817 1,301.55 1,302.55 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% HWDDVVcESR 95.00% 2.33 0.486 1.38 c7: Carbamidomethyl (+57.02) 651.7823 1,301.55 1,302.55 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% HWDDVVcESR 95.00% 2.51 0.471 1.66 c7: Carbamidomethyl (+57.02) 652.2832 1,302.55 1,302.55 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVEQANQELQELIQSVK 95.00% 3.16 0.48 2.55 681.3603 2,041.06 2,041.06 3
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% HSNFLGAYDSIR 95.00% 2.63 0.471 4.51 690.34 1,378.66 1,379.67 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GScYPATGDLLVGR 95.00% 2.03 0.34 0 c3: Carbamidomethyl (+57.02) 733.359 1,464.70 1,465.71 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GScYPATGDLLVGR 95.00% 2.71 0.406 3.11 c3: Carbamidomethyl (+57.02) 733.3601 1,464.70 1,465.71 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GScYPATGDLLVGR 95.00% 2.13 0.355 2.24 c3: Carbamidomethyl (+57.02) 733.3605 1,464.71 1,465.71 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LPYGGQcRPcPcPEGPGSQR 95.00% 3.61 0.344 2.09 c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 758.675 2,273.00 2,273.00 3
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LPYGGQcRPcPcPEGPGSQR 95.00% 3.62 0.305 1.46 c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 758.6765 2,273.01 2,273.00 3
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 2.38 0.386 0 820.4408 1,638.87 1,639.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 2.11 0.336 0 820.4409 1,638.87 1,639.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 1.85 0.377 0 820.441 1,638.87 1,639.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 2.18 0.464 2.14 820.4413 1,638.87 1,639.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 2.54 0.333 0 820.4419 1,638.87 1,639.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 1.97 0.293 1.37 820.4427 1,638.87 1,639.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 2.34 0.349 0 820.9411 1,639.87 1,639.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 2.38 0.312 2.64 820.9425 1,639.87 1,639.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 2.26 0.27 1.62 820.9428 1,639.87 1,639.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 2.41 0.383 1.64 820.9431 1,639.87 1,639.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLDPAIPIPDPYSSR 95.00% 2.1 0.353 1.19 820.9439 1,639.87 1,639.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.9 0.618 6.01 879.9864 1,757.96 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.73 0.582 6.96 879.9877 1,757.96 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.79 0.601 6.19 879.9879 1,757.96 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 5.01 0.597 5.47 879.9881 1,757.96 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.79 0.536 5.15 879.9886 1,757.96 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.87 0.596 6.39 879.9898 1,757.96 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.26 0.577 6.02 879.9911 1,757.97 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.78 0.599 3.46 879.9914 1,757.97 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.54 0.546 6.03 880.4898 1,758.96 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.89 0.5 7.06 880.4906 1,758.97 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 5.14 0.586 7 880.4908 1,758.97 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 5.09 0.606 5.89 880.4908 1,758.97 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 5.04 0.564 7.89 880.4909 1,758.97 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.41 0.442 6.68 880.491 1,758.97 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.29 0.56 6.7 880.492 1,758.97 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LQEGQTLEFLVASVPK 95.00% 4.84 0.576 5.92 880.4926 1,758.97 1,758.96 2 KPYM_HUMAN
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% YSEIEPSTEGEVIYR 95.00% 4.11 0.551 3.11 886.4245 1,770.83 1,771.84 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% YSEIEPSTEGEVIYR 95.00% 4.49 0.579 3.72 886.4261 1,770.84 1,771.84 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% YSEIEPSTEGEVIYR 95.00% 4.59 0.545 4.02 886.4263 1,770.84 1,771.84 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% YSEIEPSTEGEVIYR 95.00% 2.93 0.479 0 886.4271 1,770.84 1,771.84 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% YSEIEPSTEGEVIYR 95.00% 3.24 0.496 1.57 886.9243 1,771.83 1,771.84 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% YSEIEPSTEGEVIYR 95.00% 3.62 0.52 5.3 886.9257 1,771.84 1,771.84 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% YSEIEPSTEGEVIYR 95.00% 4.82 0.548 3.68 886.9266 1,771.84 1,771.84 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLVLEMFSGGDAAALER 95.00% 5.03 0.649 6.52 889.4622 1,776.91 1,777.92 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLVLEMFSGGDAAALER 95.00% 5.04 0.637 7 889.4643 1,776.91 1,777.92 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLVLEMFSGGDAAALER 95.00% 3.79 0.592 5.68 889.4644 1,776.91 1,777.92 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLVLEMFSGGDAAALER 95.00% 5.51 0.628 8.02 889.9638 1,777.91 1,777.92 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLVLEMFSGGDAAALER 95.00% 5.69 0.622 7.66 889.9649 1,777.91 1,777.92 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLVLEMFSGGDAAALER 95.00% 5.75 0.632 6.72 889.9656 1,777.92 1,777.92 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLVLEMFSGGDAAALER 95.00% 5.56 0.634 7.48 889.9657 1,777.92 1,777.92 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% VLVLEMFSGGDAAALER 95.00% 5.66 0.63 6.4 889.9665 1,777.92 1,777.92 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LVTPGETPSWTGSGFVR 95.00% 3.96 0.681 2.19 895.9585 1,789.90 1,790.91 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LVTPGETPSWTGSGFVR 95.00% 3.6 0.618 3.28 895.9589 1,789.90 1,790.91 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LVTPGETPSWTGSGFVR 95.00% 4.13 0.596 1.85 896.4599 1,790.90 1,790.91 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LVTPGETPSWTGSGFVR 95.00% 3.81 0.57 2.44 896.4599 1,790.90 1,790.91 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LVTPGETPSWTGSGFVR 95.00% 4.3 0.608 3.05 896.4605 1,790.91 1,790.91 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% LVTPGETPSWTGSGFVR 95.00% 3.88 0.61 0 896.4623 1,790.91 1,790.91 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% AGNSLAASTAEETAGSAQGR 95.00% 6.14 0.693 6.49 924.9414 1,847.87 1,848.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% AGNSLAASTAEETAGSAQGR 95.00% 6.18 0.696 7 924.9425 1,847.87 1,848.87 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVEQANQELQELIQSVK 95.00% 6.29 0.622 6.36 1,021.03 2,040.05 2,041.06 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVEQANQELQELIQSVK 95.00% 6.46 0.579 6.24 1,021.53 2,041.05 2,041.06 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVEQANQELQELIQSVK 95.00% 6.3 0.577 7.28 1,021.53 2,041.05 2,041.06 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVEQANQELQELIQSVK 95.00% 6.54 0.546 8.18 1,021.53 2,041.05 2,041.06 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVEQANQELQELIQSVK 95.00% 6.45 0.56 4.59 1,021.54 2,041.06 2,041.06 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GQVEQANQELQELIQSVK 95.00% 5.86 0.578 7.43 1,021.54 2,041.06 2,041.06 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GTVPGSTPcDPNSGScYcK 95.00% 3.89 0.592 2.89 c9: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 1,022.42 2,042.83 2,043.82 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GTVPGSTPcDPNSGScYcK 95.00% 3.98 0.533 3.89 c9: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 1,022.92 2,043.82 2,043.82 2
 SAMPLE 4R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 20 24 161 16.50% GTVPGSTPcDPNSGScYcK 95.00% 3.62 0.449 6.02 c9: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 1,022.92 2,043.82 2,043.82 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% LGIVQGIVGAR 95.00% 2.31 0.295 0 541.8352 1,081.65 1,082.67 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% LGIVQGIVGAR 95.00% 3.19 0.451 2.8 541.8359 1,081.66 1,082.67 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% LGIVQGIVGAR 95.00% 3 0.442 0 541.8359 1,081.66 1,082.67 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% LGIVQGIVGAR 95.00% 3.42 0.472 3.85 541.836 1,081.66 1,082.67 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% LGIVQGIVGAR 95.00% 3.51 0.5 3.09 541.8363 1,081.66 1,082.67 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% LGIVQGIVGAR 95.00% 3.34 0.436 2.6 541.8366 1,081.66 1,082.67 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% LGIVQGIVGAR 95.00% 3.22 0.469 1.85 541.8367 1,081.66 1,082.67 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% LGIVQGIVGAR 95.00% 3.16 0.448 2 541.8368 1,081.66 1,082.67 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% LGIVQGIVGAR 95.00% 3.29 0.452 2.18 541.8373 1,081.66 1,082.67 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% QLDALLEALK 95.00% 2.43 0.34 1.12 557.3288 1,112.64 1,113.65 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% SLADVDAILAR 95.00% 3.41 0.413 1.43 572.3201 1,142.62 1,143.64 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% LVTPGETPSWTGSGFVR 95.00% 2.76 0.373 1.57 895.9578 1,789.90 1,790.91 2
 SAMPLE 1 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 4 4 13 2.73% LVTPGETPSWTGSGFVR 95.00% 3.21 0.546 2.55 896.4567 1,790.90 1,790.91 2
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% ALAEGGSILSR 95.00% 2.42 0.19 1.89 537.3011 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% LGIVQGIVGAR 95.00% 3.43 0.497 1.57 541.8359 1,081.66 1,082.67 2
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% LGIVQGIVGAR 95.00% 3.31 0.455 1.89 541.8359 1,081.66 1,082.67 2
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% LGIVQGIVGAR 95.00% 3.24 0.444 0 541.8366 1,081.66 1,082.67 2
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% LGIVQGIVGAR 95.00% 2.69 0.357 0 541.8372 1,081.66 1,082.67 2
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% AMDYDLLLR 95.00% 1.88 0.228 1.33 555.801 1,109.59 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% QLDALLEALK 95.00% 2.5 0.364 0 557.3283 1,112.64 1,113.65 2
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% SLADVDAILAR 95.00% 1.99 0.338 0 572.2867 1,142.56 1,143.64 2
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% SLADVDAILAR 95.00% 3.22 0.397 2 572.3211 1,142.63 1,143.64 2
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% SLADVDAILAR 95.00% 2.68 0.384 1.38 572.3215 1,142.63 1,143.64 2
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% SLADVDAILAR 95.00% 3.08 0.402 1.47 572.3216 1,142.63 1,143.64 2
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% SLADVDAILAR 95.00% 3.03 0.404 2.47 572.3226 1,142.63 1,143.64 2
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% LQEGQTLEFLVASVPK 95.00% 4.38 0.507 5.68 880.4829 1,758.95 1,758.96 2 KPYM_HUMAN
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% VLVLEMFSGGDAAALER 95.00% 3.19 0.481 1.4 889.9657 1,777.92 1,777.92 2
 SAMPLE 1R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 6 6 13 5.67% LVTPGETPSWTGSGFVR 95.00% 2.92 0.345 0 895.9571 1,789.90 1,790.91 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LGIVQGIVGAR 95.00% 3.54 0.492 1.24 541.8362 1,081.66 1,082.67 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LGIVQGIVGAR 95.00% 3.52 0.493 1.92 541.8365 1,081.66 1,082.67 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LGIVQGIVGAR 95.00% 3.52 0.462 2.85 541.8365 1,081.66 1,082.67 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LGIVQGIVGAR 95.00% 3.63 0.509 1.77 541.8365 1,081.66 1,082.67 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LGIVQGIVGAR 95.00% 3.56 0.481 2.38 541.8365 1,081.66 1,082.67 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LGIVQGIVGAR 95.00% 3.46 0.451 2.19 541.8366 1,081.66 1,082.67 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LGIVQGIVGAR 95.00% 3.45 0.435 3 541.8366 1,081.66 1,082.67 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LGIVQGIVGAR 95.00% 3.49 0.489 1.62 541.8372 1,081.66 1,082.67 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% AMDYDLLLR 95.00% 2.8 0.367 1.26 555.2863 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% QLDALLEALK 95.00% 2.24 0.434 0 557.3282 1,112.64 1,113.65 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% QLDALLEALK 95.00% 2.43 0.372 0 557.3286 1,112.64 1,113.65 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% QLDALLEALK 95.00% 2.08 0.3 0 557.3288 1,112.64 1,113.65 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% QLDALLEALK 95.00% 2.49 0.34 0 557.3289 1,112.64 1,113.65 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% QLDALLEALK 95.00% 2.59 0.351 0 557.3292 1,112.64 1,113.65 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% SLADVDAILAR 95.00% 2.44 0.424 2.22 572.3204 1,142.63 1,143.64 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% SLADVDAILAR 95.00% 2.95 0.368 0 572.321 1,142.63 1,143.64 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% SLADVDAILAR 95.00% 3.24 0.392 2.43 572.3211 1,142.63 1,143.64 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% SLADVDAILAR 95.00% 3.45 0.395 1.8 572.3219 1,142.63 1,143.64 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% GPLGDQYQTVK 95.00% 2 0.4 2.44 603.3108 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LPYGGQcRPcPcPEGPGSQR 95.00% 3.53 0.355 2.13 c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 758.673 2,273.00 2,273.00 3
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% YSEIEPSTEGEVIYR 95.00% 3.58 0.486 2.08 886.4193 1,770.82 1,771.84 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% YSEIEPSTEGEVIYR 95.00% 2.45 0.363 2.19 886.9251 1,771.83 1,771.84 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LVTPGETPSWTGSGFVR 95.00% 3.97 0.637 3.02 895.955 1,789.89 1,790.91 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LVTPGETPSWTGSGFVR 95.00% 2.7 0.347 0 895.9559 1,789.90 1,790.91 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LVTPGETPSWTGSGFVR 95.00% 3.71 0.587 2.38 895.956 1,789.90 1,790.91 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LVTPGETPSWTGSGFVR 95.00% 2.74 0.521 1.7 895.9568 1,789.90 1,790.91 2
 SAMPLE 2 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 7 26 5.78% LVTPGETPSWTGSGFVR 95.00% 4.68 0.606 4.89 896.4565 1,790.90 1,790.91 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% ALAEGGSILSR 95.00% 2.6 0.373 2.3 537.2998 1,072.58 1,073.60 2 TITIN_HUMAN
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LGIVQGIVGAR 95.00% 2.94 0.457 0 541.8357 1,081.66 1,082.67 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LGIVQGIVGAR 95.00% 3.46 0.44 1.49 541.8364 1,081.66 1,082.67 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LGIVQGIVGAR 95.00% 3.33 0.5 1.46 541.8371 1,081.66 1,082.67 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LGIVQGIVGAR 95.00% 3.26 0.47 1.49 541.8372 1,081.66 1,082.67 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LGIVQGIVGAR 95.00% 3.24 0.47 2.23 541.8377 1,081.66 1,082.67 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LGIVQGIVGAR 95.00% 3.35 0.483 1.72 541.8378 1,081.66 1,082.67 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% AMDYDLLLR 95.00% 2.59 0.28 0 555.2841 1,108.55 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% AMDYDLLLR 95.00% 2.51 0.273 0 555.2845 1,108.55 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% AMDYDLLLR 95.00% 2.15 0.331 1.47 555.287 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% AMDYDLLLR 95.00% 2.51 0.318 0 555.8024 1,109.59 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% QLDALLEALK 95.00% 2.18 0.244 0 557.327 1,112.64 1,113.65 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% QLDALLEALK 95.00% 2.43 0.285 0 557.3271 1,112.64 1,113.65 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% QLDALLEALK 95.00% 2.43 0.361 0 557.3277 1,112.64 1,113.65 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% QLDALLEALK 95.00% 2.22 0.342 0 557.3283 1,112.64 1,113.65 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% QLDALLEALK 95.00% 2.17 0.232 0 557.3283 1,112.64 1,113.65 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% QLDALLEALK 95.00% 2.31 0.292 0 557.3287 1,112.64 1,113.65 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% QLDALLEALK 95.00% 2.35 0.386 0 557.3292 1,112.64 1,113.65 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% SLADVDAILAR 95.00% 2.78 0.35 1.74 572.3192 1,142.62 1,143.64 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% SLADVDAILAR 95.00% 2.66 0.381 1.13 572.32 1,142.62 1,143.64 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% SLADVDAILAR 95.00% 3.04 0.36 2.82 572.3204 1,142.63 1,143.64 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% SLADVDAILAR 95.00% 3.42 0.406 3.42 572.3211 1,142.63 1,143.64 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% SLADVDAILAR 95.00% 2.61 0.358 2.24 572.3215 1,142.63 1,143.64 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% SLADVDAILAR 95.00% 2.68 0.422 2.6 572.3217 1,142.63 1,143.64 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% SLADVDAILAR 95.00% 2.15 0.283 0 572.3221 1,142.63 1,143.64 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LQEGQTLEFLVASVPK 95.00% 3.24 0.403 0 587.3283 1,758.96 1,758.96 3 KPYM_HUMAN
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% GPLGDQYQTVK 95.00% 2.49 0.517 2.42 603.3124 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% GPLGDQYQTVK 95.00% 2.51 0.556 2.92 603.3125 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% VLELSIPASAEQIQHLAGAIAER 95.00% 3.71 0.576 2.55 806.4462 2,416.32 2,416.32 3
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LQEGQTLEFLVASVPK 95.00% 4.75 0.58 4.96 879.9866 1,757.96 1,758.96 2 KPYM_HUMAN
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LQEGQTLEFLVASVPK 95.00% 4.53 0.511 6.28 880.4871 1,758.96 1,758.96 2 KPYM_HUMAN
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LVTPGETPSWTGSGFVR 95.00% 3.38 0.584 0 895.9556 1,789.90 1,790.91 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LVTPGETPSWTGSGFVR 95.00% 3.45 0.657 4.02 895.9558 1,789.90 1,790.91 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LVTPGETPSWTGSGFVR 95.00% 3.54 0.552 1.38 896.455 1,790.89 1,790.91 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LVTPGETPSWTGSGFVR 95.00% 2.62 0.387 2.28 896.4566 1,790.90 1,790.91 2
 SAMPLE 2R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 7 8 31 6.62% LVTPGETPSWTGSGFVR 95.00% 4.34 0.644 3.46 896.4599 1,790.90 1,790.91 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% ALAEGGSILSR 95.00% 3.07 0.38 2.15 537.2995 1,072.58 1,073.60 2 TITIN_HUMAN
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% ALAEGGSILSR 95.00% 2.96 0.363 2.96 537.2999 1,072.58 1,073.60 2 TITIN_HUMAN
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% ALAEGGSILSR 95.00% 3.12 0.404 2.96 537.3001 1,072.58 1,073.60 2 TITIN_HUMAN
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% ALAEGGSILSR 95.00% 2.59 0.383 4.64 537.3001 1,072.58 1,073.60 2 TITIN_HUMAN
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% ALAEGGSILSR 95.00% 3.02 0.342 3 537.3007 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% ALAEGGSILSR 95.00% 2.81 0.377 3.49 537.3008 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% LGIVQGIVGAR 95.00% 3.56 0.487 1.85 541.8363 1,081.66 1,082.67 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% LGIVQGIVGAR 95.00% 3.15 0.469 1.23 541.8365 1,081.66 1,082.67 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% LGIVQGIVGAR 95.00% 3.46 0.459 2.38 541.8368 1,081.66 1,082.67 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% LGIVQGIVGAR 95.00% 3.54 0.484 3.49 541.8368 1,081.66 1,082.67 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% LGIVQGIVGAR 95.00% 3.9 0.487 2.59 541.8369 1,081.66 1,082.67 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% LGIVQGIVGAR 95.00% 3.71 0.51 2.52 541.8369 1,081.66 1,082.67 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% LGIVQGIVGAR 95.00% 3.61 0.48 2.74 541.8369 1,081.66 1,082.67 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% LGIVQGIVGAR 95.00% 3.77 0.486 2.52 541.8371 1,081.66 1,082.67 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% LGIVQGIVGAR 95.00% 3.48 0.463 2.96 541.8376 1,081.66 1,082.67 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% LGIVQGIVGAR 95.00% 2.9 0.442 2.28 541.8377 1,081.66 1,082.67 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% AMDYDLLLR 95.00% 2.13 0.269 0 555.2868 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% QLDALLEALK 95.00% 2.3 0.381 0 557.3278 1,112.64 1,113.65 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% QLDALLEALK 95.00% 2.39 0.417 0 557.328 1,112.64 1,113.65 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% QLDALLEALK 95.00% 2.61 0.354 0 557.3281 1,112.64 1,113.65 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% QLDALLEALK 95.00% 2.3 0.407 0 557.3286 1,112.64 1,113.65 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% QLDALLEALK 95.00% 2.26 0.431 1.1 557.3288 1,112.64 1,113.65 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% QLDALLEALK 95.00% 2.45 0.379 0 557.3289 1,112.64 1,113.65 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% QLDALLEALK 95.00% 2.23 0.386 0 557.329 1,112.64 1,113.65 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% SLADVDAILAR 95.00% 3.64 0.424 2.3 572.3209 1,142.63 1,143.64 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% SLADVDAILAR 95.00% 3.35 0.406 0 572.321 1,142.63 1,143.64 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% SLADVDAILAR 95.00% 2.94 0.39 1.89 572.3213 1,142.63 1,143.64 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% SLADVDAILAR 95.00% 2.7 0.391 1.57 572.3214 1,142.63 1,143.64 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% SLADVDAILAR 95.00% 2.85 0.398 2.41 572.3214 1,142.63 1,143.64 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% SLADVDAILAR 95.00% 3.49 0.41 0 572.3216 1,142.63 1,143.64 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% YSEIEPSTEGEVIYR 95.00% 3.42 0.409 2.89 886.417 1,770.82 1,771.84 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% YSEIEPSTEGEVIYR 95.00% 3.32 0.484 2.46 886.4221 1,770.83 1,771.84 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% LVTPGETPSWTGSGFVR 95.00% 4.05 0.634 3.52 895.9561 1,789.90 1,790.91 2
 SAMPLE 3 Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 5 5 27 4.67% LVTPGETPSWTGSGFVR 95.00% 4.39 0.585 3.22 896.458 1,790.90 1,790.91 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% ALAEGGSILSR 95.00% 2.67 0.402 1.17 537.2961 1,072.58 1,073.60 2 TITIN_HUMAN
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% ALAEGGSILSR 95.00% 2.62 0.381 3.8 537.3004 1,072.59 1,073.60 2 TITIN_HUMAN
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% ALAEGGSILSR 95.00% 1.83 0.249 1.24 537.619 1,073.22 1,073.60 2 TITIN_HUMAN
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LGIVQGIVGAR 95.00% 3.2 0.479 1.59 541.8362 1,081.66 1,082.67 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LGIVQGIVGAR 95.00% 3.54 0.485 2.72 541.8364 1,081.66 1,082.67 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LGIVQGIVGAR 95.00% 3.32 0.462 3.2 541.8366 1,081.66 1,082.67 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LGIVQGIVGAR 95.00% 3.49 0.499 2.19 541.8366 1,081.66 1,082.67 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LGIVQGIVGAR 95.00% 3.03 0.489 0 541.8371 1,081.66 1,082.67 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LGIVQGIVGAR 95.00% 3.44 0.473 2.21 541.8376 1,081.66 1,082.67 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LGIVQGIVGAR 95.00% 3.38 0.466 2.51 541.8382 1,081.66 1,082.67 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LGIVQGIVGAR 95.00% 3.18 0.482 1.48 541.8385 1,081.66 1,082.67 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% AMDYDLLLR 95.00% 3.2 0.341 1.25 555.2844 1,108.55 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% AMDYDLLLR 95.00% 3.23 0.343 1.15 555.2871 1,108.56 1,109.57 2 VIME_HUMAN,MVP_HUMAN
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% QLDALLEALK 95.00% 2.2 0.258 0 557.3258 1,112.64 1,113.65 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% QLDALLEALK 95.00% 2.32 0.288 0 557.3271 1,112.64 1,113.65 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% QLDALLEALK 95.00% 2.14 0.259 0 557.3282 1,112.64 1,113.65 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% QLDALLEALK 95.00% 2.34 0.373 0 557.3286 1,112.64 1,113.65 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% QLDALLEALK 95.00% 2.2 0.352 0 557.3287 1,112.64 1,113.65 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% QLDALLEALK 95.00% 2.55 0.274 0 557.3289 1,112.64 1,113.65 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% QLDALLEALK 95.00% 2.26 0.295 0 557.3293 1,112.64 1,113.65 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% QLDALLEALK 95.00% 2.35 0.301 0 557.8297 1,113.64 1,113.65 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% SLADVDAILAR 95.00% 3.05 0.276 3.54 572.3205 1,142.63 1,143.64 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% SLADVDAILAR 95.00% 3.11 0.304 3.43 572.3206 1,142.63 1,143.64 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% SLADVDAILAR 95.00% 2.67 0 2.82 572.3214 1,142.63 1,143.64 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% SLADVDAILAR 95.00% 2.78 0.403 2.31 572.3232 1,142.63 1,143.64 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% GPLGDQYQTVK 95.00% 2.37 0.438 1.2 603.3115 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% GPLGDQYQTVK 95.00% 2.19 0.432 2.41 603.3117 1,204.61 1,205.62 2 RSU1_HUMAN,DHSA_HUMAN,THIO_HUMAN,SRBS1_HUMAN
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% DGFFGLSISDR 95.00% 2.77 0.425 1.24 607.2951 1,212.57 1,213.59 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% DGFFGLSISDR 95.00% 2.75 0.479 2.2 607.2963 1,212.58 1,213.59 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% DGFFGLSISDR 95.00% 2.6 0.388 2.4 607.2982 1,212.58 1,213.59 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% AGNSLAASTAEETAGSAQGR 95.00% 2.71 0.42 0 616.9593 1,847.85 1,848.87 3
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LQEGQTLEFLVASVPK 95.00% 4.62 0.584 7.41 879.9845 1,757.95 1,758.96 2 KPYM_HUMAN
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LQEGQTLEFLVASVPK 95.00% 4.6 0.553 8.19 880.4853 1,758.96 1,758.96 2 KPYM_HUMAN
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LQEGQTLEFLVASVPK 95.00% 5.26 0.531 5.52 880.4863 1,758.96 1,758.96 2 KPYM_HUMAN
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% YSEIEPSTEGEVIYR 95.00% 2.56 0.254 0 886.925 1,771.83 1,771.84 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% VLVLEMFSGGDAAALER 95.00% 4.46 0.646 6.34 889.4591 1,776.90 1,777.92 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% VLVLEMFSGGDAAALER 95.00% 4.91 0.651 7.89 889.9621 1,777.91 1,777.92 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LVTPGETPSWTGSGFVR 95.00% 3.54 0.617 3.54 895.9565 1,789.90 1,790.91 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LVTPGETPSWTGSGFVR 95.00% 2.83 0.403 0 896.4571 1,790.90 1,790.91 2
 SAMPLE 3R Laminin subunit beta-2  LAMB2  LAMB2_HUMAN 195,957.90 100.00% 10 10 35 8.84% LVTPGETPSWTGSGFVR 95.00% 4.76 0.605 3.36 896.4575 1,790.90 1,790.91 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.5 0.307 0.959 481.6013 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.37 0.285 0 481.6015 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.6 0.395 0 481.602 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 2.95 0.313 0 481.6024 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 3.8 0.342 1.18 481.6024 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.5 0.337 1.34 481.9369 1,442.79 1,442.79 3 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.08 0.363 1.39 492.7616 983.5075 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.81 0.436 0 492.7618 983.508 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.23 0.29 0 492.762 983.5083 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.62 0.365 1.37 492.762 983.5083 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.84 0.401 1.54 492.762 983.5083 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.89 0.378 1.49 492.762 983.5084 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 3.31 0.442 1.24 492.7622 983.5087 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 1.92 0.297 0 492.7622 983.5087 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 3.14 0.467 1.77 492.7624 983.5091 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.74 0.371 0 492.7625 983.5093 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.34 0.408 1.28 492.7625 983.5094 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.65 0.433 0 492.7626 983.5096 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.97 0.387 1.85 492.7626 983.5096 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.78 0.456 1.59 492.7627 983.5098 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 3 0.419 1.89 492.7652 983.5147 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.87 0.402 2.15 492.7659 983.5162 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% AFDITYVR 95.00% 2.24 0.32 1.66 493.2569 984.4982 984.5155 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% GKTEQQTADQLLAR 95.00% 3.24 0.211 0 520.6129 1,558.82 1,558.82 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% GKTEQQTADQLLAR 95.00% 3.35 0.198 0 520.6133 1,558.82 1,558.82 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKPGFFNLESSNPR 95.00% 3.24 0.262 1.89 c1: Carbamidomethyl (+57.02) 551.6002 1,651.78 1,652.79 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKPGFFNLESSNPR 95.00% 3.02 0.225 1.66 c1: Carbamidomethyl (+57.02) 551.6002 1,651.78 1,652.79 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKPGFFNLESSNPR 95.00% 3.6 0.316 1.6 c1: Carbamidomethyl (+57.02) 551.6009 1,651.78 1,652.79 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKPGFFNLESSNPR 95.00% 2.93 0.332 1.22 c1: Carbamidomethyl (+57.02) 551.6013 1,651.78 1,652.79 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKPGFFNLESSNPR 95.00% 2.68 0.189 1.04 c1: Carbamidomethyl (+57.02) 551.6022 1,651.78 1,652.79 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKPGFFNLESSNPR 95.00% 3.29 0.343 2.26 c1: Carbamidomethyl (+57.02) 551.6024 1,651.78 1,652.79 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKPGFFNLESSNPR 95.00% 3.26 0.29 1.89 c1: Carbamidomethyl (+57.02) 551.6031 1,651.79 1,652.79 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKPGFFNLESSNPR 95.00% 2.27 0.243 0 c1: Carbamidomethyl (+57.02) 551.6038 1,651.79 1,652.79 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKPGFFNLESSNPR 95.00% 3.29 0.168 1.68 c1: Carbamidomethyl (+57.02) 551.934 1,652.78 1,652.79 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKPGFFNLESSNPR 95.00% 2.39 0.171 1.51 c1: Carbamidomethyl (+57.02) 551.9389 1,652.79 1,652.79 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNEIEGTLNK 95.00% 3.02 0.243 0 565.8075 1,129.60 1,130.61 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNEIEGTLNK 95.00% 3.01 0.268 1.6 565.808 1,129.60 1,130.61 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% PALTPFEFQK 95.00% 1.88 0.38 0 589.3137 1,176.61 1,177.63 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% PALTPFEFQK 95.00% 2.04 0.448 0 589.3159 1,176.62 1,177.63 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% PALTPFEFQK 95.00% 1.88 0.469 0 589.3183 1,176.62 1,177.63 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% PALTPFEFQK 95.00% 2.22 0.399 0 589.8199 1,177.62 1,177.63 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKDGFFGNPLAPNPADK 95.00% 3.04 0.133 1.74 c1: Carbamidomethyl (+57.02) 616.9655 1,847.87 1,847.88 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKDGFFGNPLAPNPADK 95.00% 3.14 0.176 1.68 c1: Carbamidomethyl (+57.02) 616.9658 1,847.87 1,847.88 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKDGFFGNPLAPNPADK 95.00% 3.38 0.218 1.55 c1: Carbamidomethyl (+57.02) 616.9659 1,847.87 1,847.88 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% RcELcDDGYFGDPLGR 95.00% 2.82 0.319 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 643.9474 1,928.82 1,929.82 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% RcELcDDGYFGDPLGR 95.00% 4.04 0.343 2.08 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 644.2823 1,929.82 1,929.82 3
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% TEQQTADQLLAR 95.00% 2.91 0.18 2.11 687.3576 1,372.70 1,373.70 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 4.2 0.562 0 719.8634 1,437.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 4.58 0.575 0 719.8637 1,437.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 4.12 0.566 0 719.8638 1,437.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 3.59 0.467 0 719.8638 1,437.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 4.24 0.561 0 719.8639 1,437.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 4.36 0.576 0 719.864 1,437.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 4.1 0.579 0 719.8642 1,437.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 4.41 0.583 0 719.8645 1,437.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 4.61 0.579 0 719.8645 1,437.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 4.19 0.554 0 719.8645 1,437.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 3.11 0.499 0 719.8647 1,437.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 4.42 0.578 0 719.865 1,437.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 4.39 0.58 0 720.3652 1,438.71 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SAGYLDDVTLASAR 95.00% 3.67 0.489 0 720.3662 1,438.72 1,438.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.82 0.446 2.8 721.8968 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.86 0.49 3.09 721.8969 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.6 0.434 2.62 721.8974 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 5.02 0.482 2.74 721.8976 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.94 0.458 2.54 721.8977 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 5.05 0.436 2.96 721.898 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.7 0.464 3.19 721.8981 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.87 0.443 2.85 721.8983 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.93 0.486 2.96 721.8984 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.65 0.485 6.31 721.8986 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 2.87 0.377 0 721.8988 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 5.06 0.472 3.17 721.899 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.74 0.469 3.16 721.8996 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 3.84 0.422 3.07 721.9008 1,441.79 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.97 0.479 2.77 721.9009 1,441.79 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LSAEDLVLEGAGLR 95.00% 4.54 0.416 2.85 722.3985 1,442.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 3.95 0.584 4.27 748.3581 1,494.70 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 4.27 0.577 3.96 748.3582 1,494.70 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 4.37 0.573 2.25 748.3582 1,494.70 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 3.44 0.562 2.42 748.3584 1,494.70 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 4.57 0.558 2.72 748.3585 1,494.70 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 3.93 0.523 2.96 748.3586 1,494.70 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 2.92 0.406 2.01 748.3598 1,494.70 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 3.95 0.505 2.07 748.3601 1,494.70 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 2.99 0.499 1.54 748.3604 1,494.71 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 3.09 0.505 1.77 748.3607 1,494.71 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 4.29 0.553 2.59 748.3612 1,494.71 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 3.58 0.546 3.22 748.8602 1,495.70 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% LNTFGDEVFNDPK 95.00% 4.45 0.537 3.21 748.8608 1,495.71 1,495.71 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% QDIAVISDSYFPR 95.00% 4.63 0.595 3.68 755.8825 1,509.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% QDIAVISDSYFPR 95.00% 3.99 0.62 3.96 755.8826 1,509.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% QDIAVISDSYFPR 95.00% 4.15 0.597 3 755.8828 1,509.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% QDIAVISDSYFPR 95.00% 4.62 0.599 3.32 755.8833 1,509.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% QDIAVISDSYFPR 95.00% 4.07 0.638 4.25 755.8835 1,509.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% QDIAVISDSYFPR 95.00% 4.15 0.607 3.74 755.8835 1,509.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% QDIAVISDSYFPR 95.00% 2.74 0.522 3.38 756.3821 1,510.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% QDIAVISDSYFPR 95.00% 4.5 0.593 3.13 756.3848 1,510.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cIYNTAGFYcDR 95.00% 3.79 0.612 5.4 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 770.3235 1,538.63 1,539.64 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cIYNTAGFYcDR 95.00% 4.22 0.593 4.41 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 770.3237 1,538.63 1,539.64 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cIYNTAGFYcDR 95.00% 4.46 0.567 3 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 770.8264 1,539.64 1,539.64 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cIYNTAGFYcDR 95.00% 3.36 0.516 2.37 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 770.8287 1,539.64 1,539.64 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% NTIEETGNLAEQAR 95.00% 4.31 0.487 6.59 773.3826 1,544.75 1,545.75 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% GKTEQQTADQLLAR 95.00% 4.47 0.502 2.6 779.9153 1,557.81 1,558.82 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% GKTEQQTADQLLAR 95.00% 3.74 0.514 4.03 779.9155 1,557.82 1,558.82 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% GKTEQQTADQLLAR 95.00% 4.33 0.484 1.82 779.9163 1,557.82 1,558.82 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% GKTEQQTADQLLAR 95.00% 4.52 0.49 2.05 779.9164 1,557.82 1,558.82 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% GKTEQQTADQLLAR 95.00% 3.65 0.515 2.72 779.9185 1,557.82 1,558.82 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% DGFFGNPLAPNPADK 95.00% 4.39 0.618 3.68 780.3783 1,558.74 1,559.75 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% DGFFGNPLAPNPADK 95.00% 4.44 0.611 3.92 780.38 1,558.74 1,559.75 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% DGFFGNPLAPNPADK 95.00% 4.15 0.601 3.7 780.381 1,558.75 1,559.75 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% DGFFGNPLAPNPADK 95.00% 3.59 0.56 3.41 780.381 1,558.75 1,559.75 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% DGFFGNPLAPNPADK 95.00% 4.35 0.586 4.72 780.3811 1,558.75 1,559.75 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SYYYAISDFAVGGR 95.00% 2.65 0.423 0 784.8725 1,567.73 1,568.74 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SYYYAISDFAVGGR 95.00% 4.28 0.619 7.74 784.8733 1,567.73 1,568.74 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SYYYAISDFAVGGR 95.00% 4.41 0.592 5.85 784.8745 1,567.73 1,568.74 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SYYYAISDFAVGGR 95.00% 3.55 0.582 5.1 784.8745 1,567.73 1,568.74 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SYYYAISDFAVGGR 95.00% 2.16 0.26 0 784.8757 1,567.74 1,568.74 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SYYYAISDFAVGGR 95.00% 4.07 0.585 5.55 785.3754 1,568.74 1,568.74 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% DTLQEANDILNNLK 95.00% 5.16 0.467 1.8 800.9154 1,599.82 1,600.82 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% DTLQEANDILNNLK 95.00% 4.9 0.476 2.11 800.9155 1,599.82 1,600.82 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SQEcYFDPELYR 95.00% 3.77 0.595 3.18 c4: Carbamidomethyl (+57.02) 803.8473 1,605.68 1,606.68 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SQEcYFDPELYR 95.00% 4.13 0.573 3.14 c4: Carbamidomethyl (+57.02) 803.8481 1,605.68 1,606.68 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SQEcYFDPELYR 95.00% 3.9 0.645 2.92 c4: Carbamidomethyl (+57.02) 803.8482 1,605.68 1,606.68 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SQEcYFDPELYR 95.00% 3.43 0.533 3.42 c4: Carbamidomethyl (+57.02) 803.8487 1,605.68 1,606.68 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SQEcYFDPELYR 95.00% 3.64 0.583 1.96 c4: Carbamidomethyl (+57.02) 803.849 1,605.68 1,606.68 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SQEcYFDPELYR 95.00% 3.65 0.539 2.85 c4: Carbamidomethyl (+57.02) 803.8492 1,605.68 1,606.68 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SQEcYFDPELYR 95.00% 3.36 0.514 2.23 c4: Carbamidomethyl (+57.02) 803.8493 1,605.68 1,606.68 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SQEcYFDPELYR 95.00% 3.5 0.638 3.57 c4: Carbamidomethyl (+57.02) 803.8496 1,605.68 1,606.68 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SQEcYFDPELYR 95.00% 3.81 0.56 2.57 c4: Carbamidomethyl (+57.02) 804.3498 1,606.68 1,606.68 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SQEcYFDPELYR 95.00% 4.05 0.557 3.68 c4: Carbamidomethyl (+57.02) 804.3498 1,606.68 1,606.68 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% EAQQALGSAAADATEAK 95.00% 2.92 0.342 4.7 816.3988 1,630.78 1,631.79 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% EAQQALGSAAADATEAK 95.00% 5.41 0.609 10.5 816.3997 1,630.78 1,631.79 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% EAQQALGSAAADATEAK 95.00% 3.22 0.418 4.04 816.3999 1,630.78 1,631.79 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% EAQQALGSAAADATEAK 95.00% 5.41 0.669 10.7 816.4006 1,630.79 1,631.79 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% EAQQALGSAAADATEAK 95.00% 4.81 0.616 9.96 816.4006 1,630.79 1,631.79 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% EAQQALGSAAADATEAK 95.00% 5.48 0.638 10.1 816.4008 1,630.79 1,631.79 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% EAQQALGSAAADATEAK 95.00% 4.18 0.538 5.17 816.401 1,630.79 1,631.79 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% EAQQALGSAAADATEAK 95.00% 5.19 0.628 8.62 816.401 1,630.79 1,631.79 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% EAQQALGSAAADATEAK 95.00% 4.48 0.624 8.19 816.4018 1,630.79 1,631.79 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cKPGFFNLESSNPR 95.00% 0 0 3.89 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 818.3824 1,634.75 1,635.76 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% TLPSGcFNTPSIEKP 95.00% 3.92 0.439 3.6 c6: Carbamidomethyl (+57.02) 824.4072 1,646.80 1,647.81 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% TLPSGcFNTPSIEKP 95.00% 3.07 0.333 0 c6: Carbamidomethyl (+57.02) 824.4096 1,646.80 1,647.81 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% TLPSGcFNTPSIEKP 95.00% 2.7 0.318 0 c6: Carbamidomethyl (+57.02) 824.4103 1,646.81 1,647.81 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% TLPSGcFNTPSIEKP 95.00% 2.36 0.346 0 c6: Carbamidomethyl (+57.02) 824.4107 1,646.81 1,647.81 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% TLPSGcFNTPSIEKP 95.00% 3.08 0.398 1.96 c6: Carbamidomethyl (+57.02) 824.4127 1,646.81 1,647.81 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% TLPSGcFNTPSIEKP 95.00% 3.68 0.33 1.28 c6: Carbamidomethyl (+57.02) 824.9108 1,647.81 1,647.81 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% TLPSGcFNTPSIEKP 95.00% 3.86 0.492 3.54 c6: Carbamidomethyl (+57.02) 824.912 1,647.81 1,647.81 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SWPGcQEcPAcYR 95.00% 2.98 0.567 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 835.8338 1,669.65 1,670.65 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% SWPGcQEcPAcYR 95.00% 3.05 0.623 1.4 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 836.3308 1,670.65 1,670.65 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cELcDDGYFGDPLGR 95.00% 4.23 0.609 5.21 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 887.366 1,772.72 1,773.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cELcDDGYFGDPLGR 95.00% 3.85 0.501 4.52 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 887.366 1,772.72 1,773.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% cELcDDGYFGDPLGR 95.00% 5 0.524 5.55 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 887.8666 1,773.72 1,773.72 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% ATAESASEcLPcDcNGR 95.00% 4.9 0.615 3.82 c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 949.8808 1,897.75 1,897.75 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% ATAESASEcLPcDcNGR 95.00% 5.38 0.632 4.2 c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 949.8815 1,897.75 1,897.75 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 4.87 0.605 3.96 995.5294 1,989.04 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 5.19 0.649 6.7 995.531 1,989.05 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 4.99 0.668 4.14 995.5316 1,989.05 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 4.8 0.631 6.38 995.5367 1,989.06 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 4.34 0.331 0 995.5385 1,989.06 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 5.2 0.647 4.17 996.0297 1,990.04 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 5.15 0.646 3.54 996.0303 1,990.05 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 5.75 0.587 4.57 996.0307 1,990.05 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 5.15 0.629 4.3 996.031 1,990.05 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 5.26 0.604 3.89 996.0312 1,990.05 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 4.95 0.537 5.13 996.0312 1,990.05 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 5.14 0.622 3.48 996.0316 1,990.05 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 4.75 0.6 4.31 996.0323 1,990.05 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 5.04 0.58 2.55 996.0331 1,990.05 1,990.05 2
 SAMPLE 4 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 148 18.00% VSVPLIAQGNSYPSETTVK 95.00% 4.23 0.598 4.36 996.0341 1,990.05 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.4 0.334 1.43 481.6008 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.37 0.361 2.35 481.6013 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.25 0.355 1.1 481.6016 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 3.39 0.25 0 481.6018 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 3.65 0.337 0 481.6018 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.42 0.384 0 481.602 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.17 0.382 1.32 481.6021 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 3.54 0.319 0 481.6022 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 3.53 0.368 0 481.6062 1,441.80 1,442.79 3 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% AFDITYVR 95.00% 1.99 0.316 1.27 492.7607 983.5058 984.5155 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% AFDITYVR 95.00% 2.85 0.42 2.04 492.7616 983.5075 984.5155 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% AFDITYVR 95.00% 2.07 0.326 1.48 492.7619 983.5082 984.5155 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% AFDITYVR 95.00% 3.05 0.419 3.12 492.7619 983.5082 984.5155 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% AFDITYVR 95.00% 2.37 0.394 2.34 492.7623 983.5089 984.5155 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% AFDITYVR 95.00% 2.62 0.426 1.66 492.7624 983.5091 984.5155 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% AFDITYVR 95.00% 3.03 0.422 1.8 492.7625 983.5093 984.5155 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% AFDITYVR 95.00% 2.64 0.386 2 492.7625 983.5094 984.5155 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% AFDITYVR 95.00% 2.67 0.443 2 492.7628 983.5099 984.5155 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% AFDITYVR 95.00% 2.04 0.309 1.66 492.7628 983.51 984.5155 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% AFDITYVR 95.00% 2.72 0.42 0 492.763 983.5104 984.5155 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% AFDITYVR 95.00% 2.26 0.468 2.57 493.2624 984.5092 984.5155 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% GKTEQQTADQLLAR 95.00% 2.88 0.201 0 520.2784 1,557.81 1,558.82 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKPGFFNLESSNPR 95.00% 3.24 0.33 1.77 c1: Carbamidomethyl (+57.02) 551.5994 1,651.77 1,652.79 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKPGFFNLESSNPR 95.00% 2.97 0.294 1.02 c1: Carbamidomethyl (+57.02) 551.6003 1,651.78 1,652.79 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKPGFFNLESSNPR 95.00% 3.15 0.289 1.27 c1: Carbamidomethyl (+57.02) 551.6009 1,651.78 1,652.79 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKPGFFNLESSNPR 95.00% 2.69 0.187 0 c1: Carbamidomethyl (+57.02) 551.6012 1,651.78 1,652.79 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKPGFFNLESSNPR 95.00% 2.59 0.202 1.7 c1: Carbamidomethyl (+57.02) 551.6014 1,651.78 1,652.79 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKPGFFNLESSNPR 95.00% 3.36 0.35 1.08 c1: Carbamidomethyl (+57.02) 551.6014 1,651.78 1,652.79 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKPGFFNLESSNPR 95.00% 3.54 0.251 2.26 c1: Carbamidomethyl (+57.02) 551.935 1,652.78 1,652.79 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKPGFFNLESSNPR 95.00% 3.54 0.335 0 c1: Carbamidomethyl (+57.02) 551.9355 1,652.78 1,652.79 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNEIEGTLNK 95.00% 3.13 0.311 1.74 565.8064 1,129.60 1,130.61 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNEIEGTLNK 95.00% 2.97 0.285 0 565.8077 1,129.60 1,130.61 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% PALTPFEFQK 95.00% 2.03 0.453 0 589.3129 1,176.61 1,177.63 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% PALTPFEFQK 95.00% 2.19 0.445 0 589.3137 1,176.61 1,177.63 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cVcKDNVEGFNcER 95.00% 3.97 0.386 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 596.2499 1,785.73 1,786.73 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKDGFFGNPLAPNPADK 95.00% 3.03 0.248 0 c1: Carbamidomethyl (+57.02) 616.6312 1,846.87 1,847.88 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKDGFFGNPLAPNPADK 95.00% 2.88 0.179 0 c1: Carbamidomethyl (+57.02) 616.965 1,847.87 1,847.88 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKDGFFGNPLAPNPADK 95.00% 2.88 0.285 0 c1: Carbamidomethyl (+57.02) 616.9656 1,847.87 1,847.88 3
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SAGYLDDVTLASAR 95.00% 4.73 0.57 0 719.8608 1,437.71 1,438.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SAGYLDDVTLASAR 95.00% 4.49 0.566 0 719.8632 1,437.71 1,438.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SAGYLDDVTLASAR 95.00% 4.19 0.584 0 719.8633 1,437.71 1,438.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SAGYLDDVTLASAR 95.00% 3.95 0.551 0 719.8638 1,437.71 1,438.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SAGYLDDVTLASAR 95.00% 4.5 0.566 0 719.8639 1,437.71 1,438.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SAGYLDDVTLASAR 95.00% 4.4 0.569 0 719.8641 1,437.71 1,438.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SAGYLDDVTLASAR 95.00% 4.08 0.566 0 719.8644 1,437.71 1,438.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SAGYLDDVTLASAR 95.00% 3.95 0.526 0 719.8646 1,437.71 1,438.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SAGYLDDVTLASAR 95.00% 4.64 0.57 0 719.8647 1,437.71 1,438.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SAGYLDDVTLASAR 95.00% 4.57 0.572 0 719.8648 1,437.71 1,438.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SAGYLDDVTLASAR 95.00% 3.88 0.544 0 719.8651 1,437.71 1,438.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.81 0.472 5.59 721.8972 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.81 0.471 2.92 721.8979 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.24 0.465 4.59 721.8979 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.79 0.47 3.31 721.8979 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.73 0.467 3.85 721.898 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 5.05 0.494 3.19 721.8986 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.75 0.47 3.66 721.8987 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 2.35 0.291 1.21 721.8988 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 5 0.45 2.89 721.899 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.65 0.468 5.96 721.899 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.69 0.477 2.64 721.8994 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.57 0.484 3.41 721.9002 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.49 0.411 5.19 722.4004 1,442.79 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LSAEDLVLEGAGLR 95.00% 4.66 0.446 3.08 722.4019 1,442.79 1,442.79 2 TENX_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 2.2 0.291 1.43 747.8747 1,493.73 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 3.11 0.548 3.03 748.3575 1,494.70 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 4.09 0.536 2.74 748.3584 1,494.70 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 3.81 0.623 3.89 748.3586 1,494.70 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 3.79 0.546 3.29 748.3587 1,494.70 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 3.85 0.541 3.15 748.3591 1,494.70 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 3.61 0.571 3.14 748.3593 1,494.70 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 3.76 0.582 2.77 748.36 1,494.70 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 4.27 0.567 3.44 748.3601 1,494.70 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 4.25 0.463 3.54 748.3605 1,494.71 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 2.95 0.312 1.54 748.3606 1,494.71 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 3.25 0.52 1.77 748.3606 1,494.71 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 3.93 0.542 2.68 748.3607 1,494.71 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% LNTFGDEVFNDPK 95.00% 2.55 0.438 2.07 748.3616 1,494.71 1,495.71 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% QDIAVISDSYFPR 95.00% 4.54 0.611 6.82 755.8828 1,509.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% QDIAVISDSYFPR 95.00% 4.08 0.639 4.49 755.8837 1,509.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% QDIAVISDSYFPR 95.00% 3.86 0.572 5.15 755.8838 1,509.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% QDIAVISDSYFPR 95.00% 4.16 0.651 4.92 755.8839 1,509.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% QDIAVISDSYFPR 95.00% 4.01 0.538 5.04 755.8841 1,509.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% QDIAVISDSYFPR 95.00% 4.31 0.594 7.34 756.3833 1,510.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% QDIAVISDSYFPR 95.00% 4.45 0.637 4.85 756.3849 1,510.75 1,510.75 2 PYGB_HUMAN
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cIYNTAGFYcDR 95.00% 3.27 0.53 3.62 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 770.3244 1,538.63 1,539.64 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cIYNTAGFYcDR 95.00% 3.16 0.548 2.14 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 770.3247 1,538.63 1,539.64 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cIYNTAGFYcDR 95.00% 3.18 0.573 3.35 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 770.3248 1,538.63 1,539.64 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cIYNTAGFYcDR 95.00% 4.23 0.538 3.7 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 770.8254 1,539.64 1,539.64 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% NTIEETGNLAEQAR 95.00% 4.44 0.489 4.52 773.3821 1,544.75 1,545.75 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% GKTEQQTADQLLAR 95.00% 4.27 0.479 2.25 779.9152 1,557.81 1,558.82 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% GKTEQQTADQLLAR 95.00% 3.29 0.501 2.77 779.9173 1,557.82 1,558.82 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% GKTEQQTADQLLAR 95.00% 3.57 0.563 3.3 779.9178 1,557.82 1,558.82 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% DGFFGNPLAPNPADK 95.00% 2.76 0.373 2.07 780.3726 1,558.73 1,559.75 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% DGFFGNPLAPNPADK 95.00% 3.87 0.572 4.06 780.3797 1,558.74 1,559.75 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% DGFFGNPLAPNPADK 95.00% 4.55 0.619 3.8 780.3802 1,558.74 1,559.75 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% DGFFGNPLAPNPADK 95.00% 3.43 0.513 4.51 780.3805 1,558.75 1,559.75 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% DGFFGNPLAPNPADK 95.00% 4.12 0.55 4.62 780.3809 1,558.75 1,559.75 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% DGFFGNPLAPNPADK 95.00% 4.42 0.564 3.47 780.381 1,558.75 1,559.75 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% GKTEQQTADQLLAR 95.00% 3.92 0.444 2.77 780.4179 1,558.82 1,558.82 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% GKTEQQTADQLLAR 95.00% 3.86 0.501 3.35 780.4195 1,558.82 1,558.82 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% DGFFGNPLAPNPADK 95.00% 4.59 0.599 5.17 780.8824 1,559.75 1,559.75 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SYYYAISDFAVGGR 95.00% 3.49 0.544 5.02 784.8727 1,567.73 1,568.74 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SYYYAISDFAVGGR 95.00% 4.58 0.597 6.25 784.8733 1,567.73 1,568.74 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SYYYAISDFAVGGR 95.00% 4.47 0.601 5 784.8747 1,567.73 1,568.74 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SYYYAISDFAVGGR 95.00% 3.97 0.587 5.92 784.8749 1,567.73 1,568.74 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SYYYAISDFAVGGR 95.00% 3.72 0.622 5.08 784.8752 1,567.73 1,568.74 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SYYYAISDFAVGGR 95.00% 3.54 0.554 4.59 784.8753 1,567.73 1,568.74 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SYYYAISDFAVGGR 95.00% 4.07 0.585 4.48 785.3738 1,568.73 1,568.74 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SYYYAISDFAVGGR 95.00% 3.95 0.556 3.66 785.3745 1,568.73 1,568.74 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% mEAENLEQLIDQK 95.00% 3.7 0.202 2.15 m1: Oxidation (+15.99) 789.382 1,576.75 1,576.75 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% DTLQEANDILNNLK 95.00% 4.91 0.473 2.47 800.9145 1,599.81 1,600.82 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% DTLQEANDILNNLK 95.00% 4.53 0.497 2.12 800.9149 1,599.81 1,600.82 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% DTLQEANDILNNLK 95.00% 3.72 0.423 2 800.9149 1,599.81 1,600.82 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 2.9 0.46 1.43 c4: Carbamidomethyl (+57.02) 803.8468 1,605.68 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 3.64 0.592 2.51 c4: Carbamidomethyl (+57.02) 803.8474 1,605.68 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 3.48 0.518 3.62 c4: Carbamidomethyl (+57.02) 803.8476 1,605.68 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 3.46 0.49 3.21 c4: Carbamidomethyl (+57.02) 803.8482 1,605.68 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 3.58 0.622 3.27 c4: Carbamidomethyl (+57.02) 803.8489 1,605.68 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 3.77 0.573 3.23 c4: Carbamidomethyl (+57.02) 803.849 1,605.68 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 3.47 0.511 2.6 c4: Carbamidomethyl (+57.02) 803.8492 1,605.68 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 3.83 0.589 2.04 c4: Carbamidomethyl (+57.02) 803.8495 1,605.68 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 3.22 0.457 2 c4: Carbamidomethyl (+57.02) 803.8495 1,605.68 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 3.75 0.538 2.7 c4: Carbamidomethyl (+57.02) 804.3488 1,606.68 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 3.37 0.536 2.89 c4: Carbamidomethyl (+57.02) 804.3493 1,606.68 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 3.85 0.601 3.18 c4: Carbamidomethyl (+57.02) 804.3512 1,606.69 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% SQEcYFDPELYR 95.00% 3.68 0.592 4.39 c4: Carbamidomethyl (+57.02) 804.3516 1,606.69 1,606.68 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% EAQQALGSAAADATEAK 95.00% 4.96 0.612 8.55 816.3994 1,630.78 1,631.79 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% EAQQALGSAAADATEAK 95.00% 5.81 0.632 8.28 816.4007 1,630.79 1,631.79 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% EAQQALGSAAADATEAK 95.00% 5.83 0.651 8.47 816.401 1,630.79 1,631.79 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% EAQQALGSAAADATEAK 95.00% 5.44 0.628 9.68 816.4026 1,630.79 1,631.79 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% EAQQALGSAAADATEAK 95.00% 5.14 0.622 10.9 816.8991 1,631.78 1,631.79 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% EAQQALGSAAADATEAK 95.00% 4.98 0.64 7.28 816.9012 1,631.79 1,631.79 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% TLPSGcFNTPSIEKP 95.00% 2.64 0.375 0 c6: Carbamidomethyl (+57.02) 824.4079 1,646.80 1,647.81 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% TLPSGcFNTPSIEKP 95.00% 3.4 0.386 2.77 c6: Carbamidomethyl (+57.02) 824.4088 1,646.80 1,647.81 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% TLPSGcFNTPSIEKP 95.00% 3.94 0.421 2.8 c6: Carbamidomethyl (+57.02) 824.4102 1,646.80 1,647.81 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% TLPSGcFNTPSIEKP 95.00% 3.64 0.493 2.59 c6: Carbamidomethyl (+57.02) 824.4104 1,646.81 1,647.81 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cELcDDGYFGDPLGR 95.00% 4.43 0.647 5.51 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 887.365 1,772.71 1,773.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cELcDDGYFGDPLGR 95.00% 4.39 0.504 4.89 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 887.3684 1,772.72 1,773.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cELcDDGYFGDPLGR 95.00% 4.69 0.615 7.49 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 887.8659 1,773.72 1,773.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cELcDDGYFGDPLGR 95.00% 4.19 0.596 4.7 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 887.8667 1,773.72 1,773.72 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKDGFFGNPLAPNPADK 95.00% 0 0 4.85 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 915.9288 1,829.84 1,830.85 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% cKDGFFGNPLAPNPADK 95.00% 0 0 4.74 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 916.4328 1,830.85 1,830.85 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% ATAESASEcLPcDcNGR 95.00% 4.59 0.626 3.49 c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 949.3791 1,896.74 1,897.75 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% ATAESASEcLPcDcNGR 95.00% 5.04 0.64 5.28 c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 949.3808 1,896.75 1,897.75 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% TFAEVTDLDNEVNNMLK 95.00% 5.91 0.574 6.4 976.9696 1,951.92 1,952.93 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% TFAEVTDLDNEVNNMLK 95.00% 5.82 0.542 6.66 977.4682 1,952.92 1,952.93 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 4.96 0.608 5.36 995.5301 1,989.04 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 4.87 0.65 4.41 995.5316 1,989.05 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 4.76 0.563 3.85 995.5319 1,989.05 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 4.59 0.436 3.59 995.5358 1,989.06 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 5.03 0.64 3.92 996.0287 1,990.04 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 5.2 0.641 3.77 996.0305 1,990.05 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 5.04 0.596 3.23 996.0307 1,990.05 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 5.18 0.626 4.52 996.0309 1,990.05 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 5.04 0.625 3.47 996.0309 1,990.05 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 5.04 0.594 4.47 996.032 1,990.05 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 5.27 0.587 4.89 996.0325 1,990.05 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 4.53 0.507 3.43 996.0331 1,990.05 1,990.05 2
 SAMPLE 4R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 23 25 136 19.90% VSVPLIAQGNSYPSETTVK 95.00% 4.64 0.368 2.38 996.0342 1,990.05 1,990.05 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LSAEDLVLEGAGLR 95.00% 4.03 0.35 1.54 481.5985 1,441.77 1,442.79 3 TENX_HUMAN
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LSAEDLVLEGAGLR 95.00% 3.43 0.333 0.959 481.5994 1,441.77 1,442.79 3 TENX_HUMAN
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LSAEDLVLEGAGLR 95.00% 3.88 0.349 0 481.933 1,442.78 1,442.79 3 TENX_HUMAN
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% SAGYLDDVTLASAR 95.00% 2.68 0.474 0 719.8606 1,437.71 1,438.72 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% SAGYLDDVTLASAR 95.00% 1.86 0.332 0 719.8607 1,437.71 1,438.72 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% SAGYLDDVTLASAR 95.00% 2.4 0.413 0 719.8612 1,437.71 1,438.72 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% SAGYLDDVTLASAR 95.00% 2.9 0.463 0 719.8623 1,437.71 1,438.72 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% SAGYLDDVTLASAR 95.00% 3.53 0.559 0 720.3608 1,438.71 1,438.72 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LSAEDLVLEGAGLR 95.00% 3.51 0.377 3.23 721.8936 1,441.77 1,442.79 2 TENX_HUMAN
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LSAEDLVLEGAGLR 95.00% 4.73 0.481 3.74 721.8939 1,441.77 1,442.79 2 TENX_HUMAN
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LSAEDLVLEGAGLR 95.00% 3.72 0.377 2.6 721.8949 1,441.77 1,442.79 2 TENX_HUMAN
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LSAEDLVLEGAGLR 95.00% 4.24 0.425 4.23 721.8958 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LSAEDLVLEGAGLR 95.00% 4.63 0.41 4.28 722.3954 1,442.78 1,442.79 2 TENX_HUMAN
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LSAEDLVLEGAGLR 95.00% 4.3 0.209 2.66 722.3958 1,442.78 1,442.79 2 TENX_HUMAN
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LSAEDLVLEGAGLR 95.00% 4.78 0.415 1.15 722.3969 1,442.78 1,442.79 2 TENX_HUMAN
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LSAEDLVLEGAGLR 95.00% 4.5 0.387 1.62 722.3983 1,442.78 1,442.79 2 TENX_HUMAN
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LNTFGDEVFNDPK 95.00% 2.63 0.313 0 748.3551 1,494.69 1,495.71 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LNTFGDEVFNDPK 95.00% 2.84 0.339 1.33 748.3565 1,494.70 1,495.71 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LNTFGDEVFNDPK 95.00% 3.39 0.532 2.55 748.3568 1,494.70 1,495.71 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LNTFGDEVFNDPK 95.00% 2.85 0.376 0 748.358 1,494.70 1,495.71 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% LNTFGDEVFNDPK 95.00% 2.69 0.276 0 748.3596 1,494.70 1,495.71 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% SQEcYFDPELYR 95.00% 2.53 0.511 2.3 c4: Carbamidomethyl (+57.02) 803.8424 1,605.67 1,606.68 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% SQEcYFDPELYR 95.00% 3.17 0.485 1.96 c4: Carbamidomethyl (+57.02) 803.8432 1,605.67 1,606.68 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% SQEcYFDPELYR 95.00% 2.74 0.52 1.18 c4: Carbamidomethyl (+57.02) 803.8435 1,605.67 1,606.68 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% VSVPLIAQGNSYPSETTVK 95.00% 4.08 0.594 2.77 996.0275 1,990.04 1,990.05 2
 SAMPLE 1 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 4 4 15 4.47% VSVPLIAQGNSYPSETTVK 95.00% 4.39 0.625 2.74 996.0282 1,990.04 1,990.05 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% AFDITYVR 95.00% 2.16 0.342 2.33 492.7602 983.5047 984.5155 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% AFDITYVR 95.00% 2.28 0.399 1.77 492.7609 983.5061 984.5155 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% cKPGFFNLESSNPR 95.00% 2.35 0.256 1.25 c1: Carbamidomethyl (+57.02) 551.599 1,651.77 1,652.79 3
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% cKPGFFNLESSNPR 95.00% 2.98 0.198 0.921 c1: Carbamidomethyl (+57.02) 551.9316 1,652.77 1,652.79 3
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% cVcKDNVEGFNcER 95.00% 4.31 0.515 1.82 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 596.5816 1,786.72 1,786.73 3
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% SAGYLDDVTLASAR 95.00% 3.46 0.576 0 719.8599 1,437.70 1,438.72 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% SAGYLDDVTLASAR 95.00% 2.17 0.442 0 719.8608 1,437.71 1,438.72 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% SAGYLDDVTLASAR 95.00% 3.25 0.514 0 719.8616 1,437.71 1,438.72 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% SAGYLDDVTLASAR 95.00% 3.38 0.514 0 719.8618 1,437.71 1,438.72 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LSAEDLVLEGAGLR 95.00% 4.53 0.454 3.28 721.8949 1,441.77 1,442.79 2 TENX_HUMAN
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LSAEDLVLEGAGLR 95.00% 3.77 0.346 0 721.8958 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LSAEDLVLEGAGLR 95.00% 2.74 0.24 2.14 721.8966 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LSAEDLVLEGAGLR 95.00% 3.98 0.476 2.54 721.8971 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LSAEDLVLEGAGLR 95.00% 4.67 0.44 3.28 722.3974 1,442.78 1,442.79 2 TENX_HUMAN
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LSAEDLVLEGAGLR 95.00% 4.33 0.422 1.89 722.3979 1,442.78 1,442.79 2 TENX_HUMAN
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LNTFGDEVFNDPK 95.00% 3.31 0.55 2.33 748.3556 1,494.70 1,495.71 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LNTFGDEVFNDPK 95.00% 3.08 0.417 1.41 748.3559 1,494.70 1,495.71 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LNTFGDEVFNDPK 95.00% 3.4 0.484 3.18 748.3563 1,494.70 1,495.71 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LNTFGDEVFNDPK 95.00% 3.03 0.402 3 748.3565 1,494.70 1,495.71 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LNTFGDEVFNDPK 95.00% 3.32 0.547 3.68 748.3577 1,494.70 1,495.71 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LNTFGDEVFNDPK 95.00% 3.24 0.475 1.51 748.3595 1,494.70 1,495.71 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% LNTFGDEVFNDPK 95.00% 3.38 0.559 3.74 748.8566 1,495.70 1,495.71 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% NTIEETGNLAEQAR 95.00% 4.75 0.476 4.14 773.3786 1,544.74 1,545.75 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% GKTEQQTADQLLAR 95.00% 3.87 0.468 1.89 780.4136 1,558.81 1,558.82 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% SQEcYFDPELYR 95.00% 2.92 0.429 2.43 c4: Carbamidomethyl (+57.02) 803.8433 1,605.67 1,606.68 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% SQEcYFDPELYR 95.00% 2.59 0.496 1.54 c4: Carbamidomethyl (+57.02) 803.8452 1,605.67 1,606.68 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% SQEcYFDPELYR 95.00% 2.88 0.472 2.85 c4: Carbamidomethyl (+57.02) 803.8459 1,605.68 1,606.68 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% SQEcYFDPELYR 95.00% 3.44 0.547 3.89 c4: Carbamidomethyl (+57.02) 804.3495 1,606.68 1,606.68 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% EAQQALGSAAADATEAK 95.00% 5.31 0.636 9.59 816.3968 1,630.78 1,631.79 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% EAQQALGSAAADATEAK 95.00% 5.82 0.648 9.55 816.3974 1,630.78 1,631.79 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% EAQQALGSAAADATEAK 95.00% 3.82 0.588 5.64 816.399 1,630.78 1,631.79 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% EAQQALGSAAADATEAK 95.00% 4.94 0.618 8.18 816.899 1,631.78 1,631.79 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% TLPSGcFNTPSIEKP 95.00% 2.83 0.27 0 c6: Carbamidomethyl (+57.02) 824.4057 1,646.80 1,647.81 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% VSVPLIAQGNSYPSETTVK 95.00% 4.95 0.548 3.35 996.0257 1,990.04 1,990.05 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% VSVPLIAQGNSYPSETTVK 95.00% 4.8 0.624 5.17 996.0271 1,990.04 1,990.05 2
 SAMPLE 2 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 30 10.40% VSVPLIAQGNSYPSETTVK 95.00% 3.73 0.579 3.77 996.0284 1,990.04 1,990.05 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LSAEDLVLEGAGLR 95.00% 2.87 0.226 0 481.6006 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% AFDITYVR 95.00% 2.23 0.366 1.72 492.7609 983.5061 984.5155 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% GKTEQQTADQLLAR 95.00% 2.73 0.227 0 520.2762 1,557.81 1,558.82 3
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% cKPGFFNLESSNPR 95.00% 2.73 0.273 0 c1: Carbamidomethyl (+57.02) 551.9349 1,652.78 1,652.79 3
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% cVcKDNVEGFNcER 95.00% 4.15 0.434 1.12 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 596.5819 1,786.72 1,786.73 3
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% SAGYLDDVTLASAR 95.00% 2.24 0.357 0 719.8617 1,437.71 1,438.72 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% SAGYLDDVTLASAR 95.00% 2.58 0.441 0 719.862 1,437.71 1,438.72 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% SAGYLDDVTLASAR 95.00% 3.66 0.522 0 720.365 1,438.71 1,438.72 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LSAEDLVLEGAGLR 95.00% 4.15 0.468 2.85 721.895 1,441.77 1,442.79 2 TENX_HUMAN
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LSAEDLVLEGAGLR 95.00% 4.5 0.446 2.72 721.8955 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LSAEDLVLEGAGLR 95.00% 4.2 0.47 3.13 721.8957 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LSAEDLVLEGAGLR 95.00% 4.17 0.487 2.89 721.8965 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LSAEDLVLEGAGLR 95.00% 3.89 0.435 3.27 721.897 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LSAEDLVLEGAGLR 95.00% 4.07 0.436 2.82 722.3959 1,442.78 1,442.79 2 TENX_HUMAN
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LNTFGDEVFNDPK 95.00% 2.98 0.448 0 748.356 1,494.70 1,495.71 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LNTFGDEVFNDPK 95.00% 2.07 0.29 1.26 748.3565 1,494.70 1,495.71 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LNTFGDEVFNDPK 95.00% 2.89 0.344 0 748.3584 1,494.70 1,495.71 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LNTFGDEVFNDPK 95.00% 2.38 0.331 1.82 748.3587 1,494.70 1,495.71 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LNTFGDEVFNDPK 95.00% 2.68 0.271 0 748.8549 1,495.69 1,495.71 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LNTFGDEVFNDPK 95.00% 3.71 0.565 3.08 748.8587 1,495.70 1,495.71 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% LNTFGDEVFNDPK 95.00% 3.6 0.47 2.89 748.8589 1,495.70 1,495.71 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% QDIAVISDSYFPR 95.00% 2.18 0.346 0 756.3719 1,510.73 1,510.75 2 PYGB_HUMAN
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% QDIAVISDSYFPR 95.00% 2.53 0.45 3.15 756.3738 1,510.73 1,510.75 2 PYGB_HUMAN
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% GKTEQQTADQLLAR 95.00% 3.62 0.483 2.48 779.9127 1,557.81 1,558.82 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% GKTEQQTADQLLAR 95.00% 3.92 0.502 2.55 780.4172 1,558.82 1,558.82 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% SQEcYFDPELYR 95.00% 3.11 0.572 3.51 c4: Carbamidomethyl (+57.02) 803.8409 1,605.67 1,606.68 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% SQEcYFDPELYR 95.00% 2.13 0.304 0 c4: Carbamidomethyl (+57.02) 803.8481 1,605.68 1,606.68 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% EAQQALGSAAADATEAK 95.00% 5.86 0.636 8.6 816.3962 1,630.78 1,631.79 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% EAQQALGSAAADATEAK 95.00% 5.17 0.613 9.13 816.3963 1,630.78 1,631.79 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% TLPSGcFNTPSIEKP 95.00% 2.98 0.322 0 c6: Carbamidomethyl (+57.02) 824.4059 1,646.80 1,647.81 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% TLPSGcFNTPSIEKP 95.00% 3.67 0.341 2 c6: Carbamidomethyl (+57.02) 824.9065 1,647.80 1,647.81 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% VSVPLIAQGNSYPSETTVK 95.00% 4.81 0.663 3.8 996.0281 1,990.04 1,990.05 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% VSVPLIAQGNSYPSETTVK 95.00% 4.8 0.66 3.64 996.0293 1,990.04 1,990.05 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% VSVPLIAQGNSYPSETTVK 95.00% 4.21 0.649 2.66 996.0294 1,990.04 1,990.05 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% VSVPLIAQGNSYPSETTVK 95.00% 3.86 0.529 2.04 996.0294 1,990.04 1,990.05 2
 SAMPLE 2R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 12 29 10.40% VSVPLIAQGNSYPSETTVK 95.00% 4.16 0.667 1.7 996.0302 1,990.04 1,990.05 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LSAEDLVLEGAGLR 95.00% 3.86 0.404 0 481.599 1,441.77 1,442.79 3 TENX_HUMAN
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LSAEDLVLEGAGLR 95.00% 4.6 0.326 0 481.5991 1,441.77 1,442.79 3 TENX_HUMAN
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LSAEDLVLEGAGLR 95.00% 4.41 0.355 0 481.5996 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LSAEDLVLEGAGLR 95.00% 3.63 0.401 0 481.6005 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LSAEDLVLEGAGLR 95.00% 4.34 0.353 0 481.6011 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LSAEDLVLEGAGLR 95.00% 4.32 0.312 0 481.9336 1,442.78 1,442.79 3 TENX_HUMAN
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% AFDITYVR 95.00% 2.81 0.408 1.96 492.7592 983.5028 984.5155 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% AFDITYVR 95.00% 2.85 0.447 2.39 492.7599 983.5041 984.5155 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% AFDITYVR 95.00% 2.69 0.395 2.14 492.7603 983.5049 984.5155 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% AFDITYVR 95.00% 2.19 0.325 1.72 492.7603 983.505 984.5155 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% AFDITYVR 95.00% 2.78 0.429 2.18 492.7604 983.5051 984.5155 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% AFDITYVR 95.00% 1.94 0.183 2.72 492.7604 983.5052 984.5155 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% AFDITYVR 95.00% 2.54 0.335 1.82 492.7604 983.5052 984.5155 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% AFDITYVR 95.00% 2.28 0.239 2.68 492.7608 983.506 984.5155 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% AFDITYVR 95.00% 2.46 0.369 2 492.7609 983.5061 984.5155 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% GKTEQQTADQLLAR 95.00% 3.2 0.228 0 520.6122 1,558.81 1,558.82 3
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% cKPGFFNLESSNPR 95.00% 2.95 0.265 2.48 c1: Carbamidomethyl (+57.02) 551.598 1,651.77 1,652.79 3
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% cKPGFFNLESSNPR 95.00% 3.1 0.208 0.959 c1: Carbamidomethyl (+57.02) 551.599 1,651.77 1,652.79 3
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% cKPGFFNLESSNPR 95.00% 2.83 0.211 1.29 c1: Carbamidomethyl (+57.02) 551.6018 1,651.78 1,652.79 3
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% cKPGFFNLESSNPR 95.00% 3.44 0.278 2.41 c1: Carbamidomethyl (+57.02) 551.9337 1,652.78 1,652.79 3
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% SAGYLDDVTLASAR 95.00% 2.87 0.436 0 719.8602 1,437.70 1,438.72 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% SAGYLDDVTLASAR 95.00% 4.06 0.567 0 719.8611 1,437.71 1,438.72 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% SAGYLDDVTLASAR 95.00% 2.23 0.432 0 719.8614 1,437.71 1,438.72 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% SAGYLDDVTLASAR 95.00% 4.03 0.553 0 719.8614 1,437.71 1,438.72 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% SAGYLDDVTLASAR 95.00% 2.8 0.373 0 719.8623 1,437.71 1,438.72 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LSAEDLVLEGAGLR 95.00% 4.9 0.49 4.8 721.8958 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LSAEDLVLEGAGLR 95.00% 4.3 0.479 2.49 721.8961 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LSAEDLVLEGAGLR 95.00% 4.47 0.468 1.72 721.8967 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LSAEDLVLEGAGLR 95.00% 4.47 0.477 2.27 721.8969 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LSAEDLVLEGAGLR 95.00% 4.29 0.476 2.92 721.8969 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LSAEDLVLEGAGLR 95.00% 3.26 0.396 2.35 721.8976 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LNTFGDEVFNDPK 95.00% 4.64 0.542 3.24 748.3558 1,494.70 1,495.71 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LNTFGDEVFNDPK 95.00% 3.93 0.559 2.89 748.3561 1,494.70 1,495.71 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LNTFGDEVFNDPK 95.00% 4.01 0.579 2.01 748.3565 1,494.70 1,495.71 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% LNTFGDEVFNDPK 95.00% 4.23 0.507 2.96 748.3572 1,494.70 1,495.71 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% NTIEETGNLAEQAR 95.00% 3.91 0.512 4.12 773.3761 1,544.74 1,545.75 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% NTIEETGNLAEQAR 95.00% 4.16 0.49 3.96 773.3781 1,544.74 1,545.75 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% SQEcYFDPELYR 95.00% 3.82 0.574 2.51 c4: Carbamidomethyl (+57.02) 803.8448 1,605.67 1,606.68 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% SQEcYFDPELYR 95.00% 3.28 0.487 3.07 c4: Carbamidomethyl (+57.02) 803.8454 1,605.68 1,606.68 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% SQEcYFDPELYR 95.00% 3.05 0.507 2.7 c4: Carbamidomethyl (+57.02) 803.8462 1,605.68 1,606.68 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% SQEcYFDPELYR 95.00% 2.7 0.532 2.74 c4: Carbamidomethyl (+57.02) 803.8462 1,605.68 1,606.68 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% SQEcYFDPELYR 95.00% 3.96 0.624 3 c4: Carbamidomethyl (+57.02) 804.3477 1,606.68 1,606.68 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% EAQQALGSAAADATEAK 95.00% 5.21 0.648 6.7 816.3976 1,630.78 1,631.79 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% EAQQALGSAAADATEAK 95.00% 4.42 0.662 6 816.401 1,630.79 1,631.79 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% TLPSGcFNTPSIEKP 95.00% 2.88 0.254 0 c6: Carbamidomethyl (+57.02) 824.4057 1,646.80 1,647.81 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% VSVPLIAQGNSYPSETTVK 95.00% 4.33 0.355 2.51 995.532 1,989.05 1,990.05 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% VSVPLIAQGNSYPSETTVK 95.00% 4.72 0.634 3.21 996.0274 1,990.04 1,990.05 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% VSVPLIAQGNSYPSETTVK 95.00% 4.64 0.609 4.02 996.0285 1,990.04 1,990.05 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% VSVPLIAQGNSYPSETTVK 95.00% 5.17 0.651 3.72 996.0298 1,990.04 1,990.05 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% VSVPLIAQGNSYPSETTVK 95.00% 5.03 0.619 3.38 996.0301 1,990.04 1,990.05 2
 SAMPLE 3 Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 10 10 39 9.57% VSVPLIAQGNSYPSETTVK 95.00% 3.91 0.56 1.89 996.0301 1,990.04 1,990.05 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 3.5 0.296 0 481.5978 1,441.77 1,442.79 3 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 3.64 0.236 0 481.5982 1,441.77 1,442.79 3 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 3.94 0.362 0 481.5993 1,441.77 1,442.79 3 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 3.38 0.386 0 481.5995 1,441.77 1,442.79 3 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 4.23 0.376 0 481.6013 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 3.96 0.418 0 481.6014 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 3.06 0.257 0 481.6022 1,441.78 1,442.79 3 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 4.27 0.351 1 481.933 1,442.78 1,442.79 3 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% AFDITYVR 95.00% 2.61 0.411 1.24 492.7595 983.5033 984.5155 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% AFDITYVR 95.00% 1.83 0.305 2.02 492.76 983.5044 984.5155 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% AFDITYVR 95.00% 2.42 0.301 1.51 492.7602 983.5047 984.5155 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% AFDITYVR 95.00% 2.5 0.391 2 492.7604 983.5051 984.5155 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% AFDITYVR 95.00% 2.32 0.344 2.04 493.2555 984.4953 984.5155 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% cKPGFFNLESSNPR 95.00% 3.66 0.304 1 c1: Carbamidomethyl (+57.02) 551.933 1,652.78 1,652.79 3
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% cVcKDNVEGFNcER 95.00% 3.23 0.381 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 596.5787 1,786.71 1,786.73 3
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% SAGYLDDVTLASAR 95.00% 2.32 0.465 0 719.8618 1,437.71 1,438.72 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% SAGYLDDVTLASAR 95.00% 3.68 0.491 0 719.8623 1,437.71 1,438.72 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% SAGYLDDVTLASAR 95.00% 2.91 0.475 0 719.8632 1,437.71 1,438.72 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 3.88 0.466 2.44 721.8941 1,441.77 1,442.79 2 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 4.24 0.481 3.1 721.8958 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 4.76 0.494 3.03 721.8958 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 4.13 0.463 2.7 721.8959 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 4.29 0.467 2.85 721.8963 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 3.82 0.425 2.19 721.8963 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 4.07 0.437 2.89 721.8968 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 4.34 0.473 3.06 721.8976 1,441.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 3.81 0.0795 1.55 722.3961 1,442.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LSAEDLVLEGAGLR 95.00% 4.04 0.34 2.24 722.3975 1,442.78 1,442.79 2 TENX_HUMAN
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LNTFGDEVFNDPK 95.00% 2.74 0.466 0 748.3535 1,494.69 1,495.71 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LNTFGDEVFNDPK 95.00% 2.06 0.279 0 748.3549 1,494.69 1,495.71 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LNTFGDEVFNDPK 95.00% 4.15 0.571 3.54 748.356 1,494.70 1,495.71 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LNTFGDEVFNDPK 95.00% 2.5 0.462 0 748.3562 1,494.70 1,495.71 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LNTFGDEVFNDPK 95.00% 3.89 0.536 2.89 748.3567 1,494.70 1,495.71 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LNTFGDEVFNDPK 95.00% 3.92 0.587 3.38 748.3571 1,494.70 1,495.71 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LNTFGDEVFNDPK 95.00% 3.26 0.502 2.32 748.3572 1,494.70 1,495.71 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% LNTFGDEVFNDPK 95.00% 4.03 0.526 2.74 748.8594 1,495.70 1,495.71 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% NTIEETGNLAEQAR 95.00% 4.03 0.496 3.96 773.3783 1,544.74 1,545.75 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% SQEcYFDPELYR 95.00% 3.57 0.538 2.82 c4: Carbamidomethyl (+57.02) 803.8443 1,605.67 1,606.68 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% SQEcYFDPELYR 95.00% 3.27 0.578 3.57 c4: Carbamidomethyl (+57.02) 803.8456 1,605.68 1,606.68 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% SQEcYFDPELYR 95.00% 2.96 0.482 1.77 c4: Carbamidomethyl (+57.02) 803.8457 1,605.68 1,606.68 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% SQEcYFDPELYR 95.00% 2.76 0.439 0 c4: Carbamidomethyl (+57.02) 803.8469 1,605.68 1,606.68 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% SQEcYFDPELYR 95.00% 3.42 0.594 3.01 c4: Carbamidomethyl (+57.02) 803.8471 1,605.68 1,606.68 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% EAQQALGSAAADATEAK 95.00% 4.13 0.537 6.19 816.3961 1,630.78 1,631.79 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% TLPSGcFNTPSIEKP 95.00% 2.59 0.246 0 c6: Carbamidomethyl (+57.02) 824.4071 1,646.80 1,647.81 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% TFAEVTDLDNEVNNMLK 95.00% 3.89 0.525 4.7 976.9644 1,951.91 1,952.93 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% VSVPLIAQGNSYPSETTVK 95.00% 4.36 0.608 2.46 995.5267 1,989.04 1,990.05 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% VSVPLIAQGNSYPSETTVK 95.00% 4.51 0.557 3.6 995.5291 1,989.04 1,990.05 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% VSVPLIAQGNSYPSETTVK 95.00% 3.94 0.266 0 995.5327 1,989.05 1,990.05 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% VSVPLIAQGNSYPSETTVK 95.00% 5.13 0.627 3.17 996.0269 1,990.04 1,990.05 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% VSVPLIAQGNSYPSETTVK 95.00% 5.15 0.629 2.7 996.0286 1,990.04 1,990.05 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% VSVPLIAQGNSYPSETTVK 95.00% 5.03 0.361 2.12 996.0288 1,990.04 1,990.05 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% VSVPLIAQGNSYPSETTVK 95.00% 4.89 0.604 3.31 996.0299 1,990.04 1,990.05 2
 SAMPLE 3R Laminin subunit gamma-1  LAMC1  LAMC1_HUMAN 177,587.10 100.00% 11 11 35 10.60% VSVPLIAQGNSYPSETTVK 95.00% 4.37 0.497 3.92 996.0307 1,990.05 1,990.05 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% SGEPPRPLPPAAPR 95.00% 2.53 0.221 0 481.2673 1,440.78 1,441.79 3
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% SGEPPRPLPPAAPR 95.00% 3 0.339 0 481.268 1,440.78 1,441.79 3
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% SGEPPRPLPPAAPR 95.00% 2.43 0.26 0 481.2694 1,440.78 1,441.79 3
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% SGEPPRPLPPAAPR 95.00% 2.33 0.283 0 481.6027 1,441.78 1,441.79 3
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% SGEPPRPLPPAAPR 95.00% 2.49 0.217 0 481.6034 1,441.79 1,441.79 3
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% IVFTPTIcK 95.00% 2.06 0.276 0 c8: Carbamidomethyl (+57.02) 539.8001 1,077.58 1,078.60 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% EIcPAGHGYTYASSDIR 95.00% 2.28 0.233 0 c3: Carbamidomethyl (+57.02) 632.9565 1,895.85 1,896.86 3
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% EIcPAGHGYTYASSDIR 95.00% 2.06 0.209 0 c3: Carbamidomethyl (+57.02) 632.9578 1,895.85 1,896.86 3
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.55 0.339 1.54 665.6349 1,993.88 1,994.90 3 FHL2_HUMAN
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% GAGGQSMSEAPTGDHAPAPTR 95.00% 3.3 0.439 1.57 665.638 1,993.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.79 0.331 1.02 665.6385 1,993.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% GAGGQSMSEAPTGDHAPAPTR 95.00% 3.25 0.37 2.21 665.9716 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.95 0.421 1.34 665.9717 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.47 0.279 0 665.9741 1,994.90 1,994.90 3 FHL2_HUMAN
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% GAGGQSmSEAPTGDHAPAPTR 95.00% 2.62 0.255 0 m7: Oxidation (+15.99) 671.3038 2,010.89 2,010.89 3 FHL2_HUMAN
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% SLGPGTcTLPLAQR 95.00% 4.22 0.459 4.92 c7: Carbamidomethyl (+57.02) 735.89 1,469.76 1,470.77 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% SLGPGTcTLPLAQR 95.00% 2.61 0.411 0 c7: Carbamidomethyl (+57.02) 735.8928 1,469.77 1,470.77 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% SLGPGTcTLPLAQR 95.00% 3.75 0.443 3.21 c7: Carbamidomethyl (+57.02) 735.8929 1,469.77 1,470.77 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% SLGPGTcTLPLAQR 95.00% 2.95 0.422 3.51 c7: Carbamidomethyl (+57.02) 736.3907 1,470.77 1,470.77 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% SSEVYAQLcNVAR 95.00% 3.79 0.546 4.07 c9: Carbamidomethyl (+57.02) 748.861 1,495.71 1,496.72 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% SSEVYAQLcNVAR 95.00% 3.83 0.497 4.35 c9: Carbamidomethyl (+57.02) 748.8616 1,495.71 1,496.72 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% IYFcQIPcLNGGR 95.00% 3.95 0.435 2.72 c4: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 799.3847 1,596.75 1,597.76 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% EIcPAGHGYTYASSDIR 95.00% 4.04 0.492 5.41 c3: Carbamidomethyl (+57.02) 949.4295 1,896.84 1,896.86 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% EIcPAGHGYTYASSDIR 95.00% 4.49 0.536 8 c3: Carbamidomethyl (+57.02) 949.4313 1,896.85 1,896.86 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 8 9 25 6.43% cEEVIPDEEFDPQNSR 95.00% 4.62 0.49 1.74 c1: Carbamidomethyl (+57.02) 982.9219 1,963.83 1,963.83 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% SGEPPRPLPPAAPR 95.00% 2.33 0.239 0 481.2683 1,440.78 1,441.79 3
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% SGEPPRPLPPAAPR 95.00% 2.78 0.303 0 481.6018 1,441.78 1,441.79 3
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% cPLPGTEAFR 95.00% 2.36 0.231 1.55 c1: Carbamidomethyl (+57.02) 574.281 1,146.55 1,147.56 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% cPLPGTEAFR 95.00% 2.65 0.265 1.29 c1: Carbamidomethyl (+57.02) 574.2815 1,146.55 1,147.56 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% EIcPAGHGYTYASSDIR 95.00% 2.41 0.203 1.11 c3: Carbamidomethyl (+57.02) 633.2892 1,896.84 1,896.86 3
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% VTNDVcSEPLR 95.00% 2.35 0.447 1.64 c6: Carbamidomethyl (+57.02) 645.31 1,288.60 1,289.62 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.65 0.303 0 665.6367 1,993.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.23 0.403 0.959 665.9707 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.34 0.264 0 665.9711 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.72 0.3 1.36 665.9716 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% GAGGQSMSEAPTGDHAPAPTR 95.00% 3.33 0.485 1.17 665.9727 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% SLGPGTcTLPLAQR 95.00% 3.59 0.485 3.12 c7: Carbamidomethyl (+57.02) 735.8885 1,469.76 1,470.77 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% SLGPGTcTLPLAQR 95.00% 3.71 0.448 3.74 c7: Carbamidomethyl (+57.02) 735.8914 1,469.77 1,470.77 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% SLGPGTcTLPLAQR 95.00% 2.58 0.276 1.35 c7: Carbamidomethyl (+57.02) 735.8924 1,469.77 1,470.77 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% SSEVYAQLcNVAR 95.00% 3.5 0.523 3.47 c9: Carbamidomethyl (+57.02) 748.8614 1,495.71 1,496.72 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% SSEVYAQLcNVAR 95.00% 4.01 0.601 4.55 c9: Carbamidomethyl (+57.02) 748.8627 1,495.71 1,496.72 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% IYFcQIPcLNGGR 95.00% 3.24 0.452 2.11 c4: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 799.383 1,596.75 1,597.76 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% IYFcQIPcLNGGR 95.00% 3.49 0.437 3 c4: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 799.3851 1,596.75 1,597.76 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 9 9 19 7.08% cEEVIPDEEFDPQNSR 95.00% 3.68 0.261 0 c1: Carbamidomethyl (+57.02) 982.9227 1,963.83 1,963.83 2
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% SGEPPRPLPPAAPR 95.00% 2.77 0.263 0 481.2682 1,440.78 1,441.79 3
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% SGEPPRPLPPAAPR 95.00% 2.92 0.279 0 481.6023 1,441.78 1,441.79 3
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% IVFTPTIcK 95.00% 2.32 0.276 0 c8: Carbamidomethyl (+57.02) 539.8006 1,077.59 1,078.60 2
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% EIcPAGHGYTYASSDIR 95.00% 2.53 0.255 0 c3: Carbamidomethyl (+57.02) 633.2917 1,896.85 1,896.86 3
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.62 0.316 0 665.6371 1,993.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% GAGGQSMSEAPTGDHAPAPTR 95.00% 3.64 0.495 0 665.9705 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.68 0.388 1.21 665.9705 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% GAGGQSMSEAPTGDHAPAPTR 95.00% 3.38 0.494 0 665.9715 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% GAGGQSMSEAPTGDHAPAPTR 95.00% 3.51 0.383 0 665.9726 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% GAGGQSMSEAPTGDHAPAPTR 95.00% 3.26 0.444 0 665.9729 1,994.90 1,994.90 3 FHL2_HUMAN
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% SLGPGTcTLPLAQR 95.00% 3.49 0.452 0 c7: Carbamidomethyl (+57.02) 735.8893 1,469.76 1,470.77 2
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% SLGPGTcTLPLAQR 95.00% 2.68 0.405 0 c7: Carbamidomethyl (+57.02) 736.3913 1,470.77 1,470.77 2
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% EQDAPVAGLQPVER 95.00% 3.43 0.514 3.46 755.3904 1,508.77 1,508.77 2
 SAMPLE 2 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 7 14 4.89% EIcPAGHGYTYASSDIR 95.00% 4.04 0.545 3.27 c3: Carbamidomethyl (+57.02) 949.4283 1,896.84 1,896.86 2
 SAMPLE 2R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 6 10 5.11% SGEPPRPLPPAAPR 95.00% 2.68 0.215 0 481.2678 1,440.78 1,441.79 3
 SAMPLE 2R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 6 10 5.11% SGEPPRPLPPAAPR 95.00% 2.66 0.255 0 481.269 1,440.78 1,441.79 3
 SAMPLE 2R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 6 10 5.11% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.06 0.294 0 665.637 1,993.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 2R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 6 10 5.11% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.57 0.279 0 665.6371 1,993.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 2R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 6 10 5.11% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.72 0.445 0 665.6384 1,993.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 2R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 6 10 5.11% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.13 0.322 0 665.9719 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 2R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 6 10 5.11% SLGPGTcTLPLAQR 95.00% 3.61 0.38 1.85 c7: Carbamidomethyl (+57.02) 736.3936 1,470.77 1,470.77 2
 SAMPLE 2R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 6 10 5.11% SSEVYAQLcNVAR 95.00% 3.33 0.428 2.57 c9: Carbamidomethyl (+57.02) 749.3606 1,496.71 1,496.72 2
 SAMPLE 2R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 6 10 5.11% EQDAPVAGLQPVER 95.00% 2.19 0.285 0 754.8894 1,507.76 1,508.77 2
 SAMPLE 2R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 6 6 10 5.11% EIcPAGHGYTYASSDIR 95.00% 3.57 0.547 5.66 c3: Carbamidomethyl (+57.02) 948.9303 1,895.85 1,896.86 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% SGEPPRPLPPAAPR 95.00% 2.74 0.167 0 481.2671 1,440.78 1,441.79 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% SGEPPRPLPPAAPR 95.00% 2.57 0.204 0 481.603 1,441.79 1,441.79 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% cPLPGTEAFR 95.00% 2.58 0.277 1.8 c1: Carbamidomethyl (+57.02) 574.2808 1,146.55 1,147.56 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% cPLPGTEAFR 95.00% 2.53 0.28 2.31 c1: Carbamidomethyl (+57.02) 574.2809 1,146.55 1,147.56 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.12 0.349 0 665.6367 1,993.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.29 0.389 0 665.6368 1,993.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.2 0.393 0 665.6368 1,993.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.21 0.437 0 665.9693 1,994.88 1,994.90 3 FHL2_HUMAN
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% GAGGQSMSEAPTGDHAPAPTR 95.00% 3.56 0.477 0 665.9702 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.74 0.481 1.74 665.9716 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.88 0.42 0 665.9716 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% GAGGQSMSEAPTGDHAPAPTR 95.00% 3.04 0.453 0 665.972 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% GAGGQSmSEAPTGDHAPAPTR 95.00% 2.36 0.29 0 m7: Oxidation (+15.99) 671.3061 2,010.89 2,010.89 3 FHL2_HUMAN
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% SLGPGTcTLPLAQR 95.00% 4.07 0.498 2.72 c7: Carbamidomethyl (+57.02) 735.8904 1,469.77 1,470.77 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 4 4 15 3.24% SLGPGTcTLPLAQR 95.00% 4.14 0.422 2.24 c7: Carbamidomethyl (+57.02) 736.3914 1,470.77 1,470.77 2
 SAMPLE 3R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 5 5 10 3.95% SGEPPRPLPPAAPR 95.00% 2.4 0.258 0 481.2689 1,440.78 1,441.79 3
 SAMPLE 3R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 5 5 10 3.95% SGEPPRPLPPAAPR 95.00% 2.55 0.249 0 481.6021 1,441.78 1,441.79 3
 SAMPLE 3R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 5 5 10 3.95% cPLPGTEAFR 95.00% 2.58 0.248 0 c1: Carbamidomethyl (+57.02) 574.2804 1,146.55 1,147.56 2
 SAMPLE 3R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 5 5 10 3.95% cPLPGTEAFR 95.00% 2.57 0.223 1.74 c1: Carbamidomethyl (+57.02) 574.2818 1,146.55 1,147.56 2
 SAMPLE 3R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 5 5 10 3.95% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.33 0.351 0 665.6359 1,993.88 1,994.90 3 FHL2_HUMAN
 SAMPLE 3R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 5 5 10 3.95% GAGGQSMSEAPTGDHAPAPTR 95.00% 1.99 0.294 0 665.6362 1,993.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 3R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 5 5 10 3.95% GAGGQSMSEAPTGDHAPAPTR 95.00% 1.92 0.372 0 665.6374 1,993.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 3R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 5 5 10 3.95% GAGGQSMSEAPTGDHAPAPTR 95.00% 2.64 0.345 1.12 665.9718 1,994.89 1,994.90 3 FHL2_HUMAN
 SAMPLE 3R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 5 5 10 3.95% SLGPGTcTLPLAQR 95.00% 3.1 0.507 2.09 c7: Carbamidomethyl (+57.02) 735.8907 1,469.77 1,470.77 2
 SAMPLE 3R Latent-transforming growth factor beta-binding protein 2  LTBP2  LTBP2_HUMAN 195,038.50 100.00% 5 5 10 3.95% IYFcQIPcLNGGR 95.00% 2.44 0.316 0 c4: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 799.3831 1,596.75 1,597.76 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 6 6 10 5.05% DVDEcQLFR 95.00% 2.7 0.41 1.68 c5: Carbamidomethyl (+57.02) 591.2657 1,180.52 1,181.53 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 6 6 10 5.05% DVDEcQLFR 95.00% 2.35 0.381 2.66 c5: Carbamidomethyl (+57.02) 591.2663 1,180.52 1,181.53 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 6 6 10 5.05% GGEcASPLPGLR 95.00% 3.35 0.339 2.57 c4: Carbamidomethyl (+57.02) 607.3018 1,212.59 1,213.60 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 6 6 10 5.05% GGEcASPLPGLR 95.00% 3.27 0.353 3.31 c4: Carbamidomethyl (+57.02) 607.3028 1,212.59 1,213.60 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 6 6 10 5.05% SScISQHVISEAK 95.00% 3.62 0.429 2.66 c3: Carbamidomethyl (+57.02) 723.3559 1,444.70 1,445.71 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 6 6 10 5.05% SScISQHVISEAK 95.00% 3.57 0.449 4.11 c3: Carbamidomethyl (+57.02) 723.8559 1,445.70 1,445.71 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 6 6 10 5.05% GcQLcPPFGSEGFR 95.00% 2.63 0.388 1.27 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 807.0794 1,612.14 1,611.71 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 6 6 10 5.05% AEAAAPYTVLAQSAPR 95.00% 2.3 0.166 7.82 808.4265 1,614.84 1,615.84 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 6 6 10 5.05% AEAAAPYTVLAQSAPR 95.00% 2.92 0.515 9.46 808.9286 1,615.84 1,615.84 2
 SAMPLE 1 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 6 6 10 5.05% EcYFDTAAPDAcDNILAR 95.00% 4.46 0.521 1.89 c2: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 1,051.45 2,100.88 2,101.90 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 5 5 5 4.37% YNTRPLGQEPPR 95.00% 4.09 0.436 0 476.9192 1,427.73 1,427.74 3
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 5 5 5 4.37% GGEcASPLPGLR 95.00% 2.92 0.312 1.64 c4: Carbamidomethyl (+57.02) 607.3026 1,212.59 1,213.60 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 5 5 5 4.37% SScISQHVISEAK 95.00% 3.13 0.37 2.34 c3: Carbamidomethyl (+57.02) 723.354 1,444.69 1,445.71 2
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 5 5 5 4.37% IQQcPGTETAEYQSLcPHGR 95.00% 3.15 0.289 2.27 c4: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02) 778.0158 2,331.02 2,332.05 3
 SAMPLE 1R Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 5 5 5 4.37% GcQLcPPFGSEGFR 95.00% 2.46 0.372 0 c2: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 807.0808 1,612.15 1,611.71 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 3 3 4 2.09% YNTRPLGQEPPR 95.00% 4.15 0.356 0 476.5858 1,426.73 1,427.74 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 3 3 4 2.09% YNTRPLGQEPPR 95.00% 4.09 0.403 0 476.9181 1,427.73 1,427.74 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 3 3 4 2.09% DVDEcQLFR 95.00% 2.54 0.426 1.82 c5: Carbamidomethyl (+57.02) 591.265 1,180.51 1,181.53 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein 4  LTBP4  LTBP4_HUMAN 173,410.20 100.00% 3 3 4 2.09% SScISQHVISEAK 95.00% 2.55 0.331 0 c3: Carbamidomethyl (+57.02) 723.3589 1,444.70 1,445.71 2
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% LcQIPVHGASVPK 95.00% 2.59 0.31 1.72 c2: Carbamidomethyl (+57.02) 469.259 1,404.75 1,405.76 3
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% LcQIPVHGASVPK 95.00% 2.81 0.409 0 c2: Carbamidomethyl (+57.02) 469.2592 1,404.75 1,405.76 3
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% LcQIPVHGASVPK 95.00% 2.5 0.443 2.85 c2: Carbamidomethyl (+57.02) 469.2595 1,404.75 1,405.76 3
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% LcQIPVHGASVPK 95.00% 2.76 0.402 0 c2: Carbamidomethyl (+57.02) 469.2601 1,404.76 1,405.76 3
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% LcQIPVHGASVPK 95.00% 2.98 0.381 1.96 c2: Carbamidomethyl (+57.02) 469.2611 1,404.76 1,405.76 3
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% VVFTPSIcK 95.00% 1.9 0.413 0 c8: Carbamidomethyl (+57.02) 525.7846 1,049.55 1,050.57 2
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% VVFTPSIcK 95.00% 2.01 0.448 0 c8: Carbamidomethyl (+57.02) 525.7854 1,049.56 1,050.57 2
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% VVFTPSIcK 95.00% 1.93 0.375 0 c8: Carbamidomethyl (+57.02) 525.7856 1,049.56 1,050.57 2
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% VVFTPSIcK 95.00% 1.92 0.374 0 c8: Carbamidomethyl (+57.02) 525.7857 1,049.56 1,050.57 2
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% HPPEASVQIHQVSR 95.00% 2.77 0.397 0 528.9459 1,583.81 1,584.82 3
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% HPPEASVQIHQVSR 95.00% 3.01 0.487 1 528.9469 1,583.82 1,584.82 3
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% HPPEASVQIHQVSR 95.00% 2.63 0.333 0 528.947 1,583.82 1,584.82 3
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% HPPEASVQIHQVSR 95.00% 3.31 0.491 0 528.947 1,583.82 1,584.82 3
 SAMPLE 2 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 4 4 14 2.73% IKVVFTPSIcK 95.00% 2.58 0.406 1.24 c10: Carbamidomethyl (+57.02) 646.3747 1,290.73 1,291.75 2
 SAMPLE 2R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 2 2 6 1.94% LcQIPVHGASVPK 95.00% 3.23 0.433 1.42 c2: Carbamidomethyl (+57.02) 469.2582 1,404.75 1,405.76 3
 SAMPLE 2R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 2 2 6 1.94% LcQIPVHGASVPK 95.00% 2.42 0.292 2 c2: Carbamidomethyl (+57.02) 469.2599 1,404.76 1,405.76 3
 SAMPLE 2R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 2 2 6 1.94% LcQIPVHGASVPK 95.00% 2.13 0.191 1.66 c2: Carbamidomethyl (+57.02) 469.26 1,404.76 1,405.76 3
 SAMPLE 2R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 2 2 6 1.94% HPPEASVQIHQVSR 95.00% 2.91 0.291 0 528.9446 1,583.81 1,584.82 3
 SAMPLE 2R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 2 2 6 1.94% HPPEASVQIHQVSR 95.00% 3.43 0.455 2.15 528.9455 1,583.81 1,584.82 3
 SAMPLE 2R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 2 2 6 1.94% HPPEASVQIHQVSR 95.00% 3.11 0.418 0 529.2802 1,584.82 1,584.82 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% LcQIPVHGASVPK 95.00% 2.5 0.428 2.15 c2: Carbamidomethyl (+57.02) 469.2585 1,404.75 1,405.76 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% LcQIPVHGASVPK 95.00% 2.53 0.332 1.68 c2: Carbamidomethyl (+57.02) 469.2589 1,404.75 1,405.76 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% LcQIPVHGASVPK 95.00% 3.05 0.421 1.12 c2: Carbamidomethyl (+57.02) 469.259 1,404.75 1,405.76 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% LcQIPVHGASVPK 95.00% 2.77 0.408 2.82 c2: Carbamidomethyl (+57.02) 469.2602 1,404.76 1,405.76 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% LcQIPVHGASVPK 95.00% 2.59 0.255 0 c2: Carbamidomethyl (+57.02) 469.2603 1,404.76 1,405.76 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% VVFTPSIcK 95.00% 1.9 0.365 0 c8: Carbamidomethyl (+57.02) 525.7848 1,049.55 1,050.57 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% VVFTPSIcK 95.00% 1.75 0.309 0 c8: Carbamidomethyl (+57.02) 525.7855 1,049.56 1,050.57 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% VVFTPSIcK 95.00% 1.91 0.335 0 c8: Carbamidomethyl (+57.02) 525.7857 1,049.56 1,050.57 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% VVFTPSIcK 95.00% 1.84 0.31 0 c8: Carbamidomethyl (+57.02) 525.7859 1,049.56 1,050.57 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% HPPEASVQIHQVSR 95.00% 3.41 0.464 2 528.9447 1,583.81 1,584.82 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% HPPEASVQIHQVSR 95.00% 3.22 0.443 0 528.9451 1,583.81 1,584.82 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% HPPEASVQIHQVSR 95.00% 3.72 0.51 1.14 528.9456 1,583.81 1,584.82 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% HPPEASVQIHQVSR 95.00% 3.08 0.432 0 528.9472 1,583.82 1,584.82 3
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% IKVVFTPSIcK 95.00% 2.87 0.233 0 c10: Carbamidomethyl (+57.02) 646.3745 1,290.73 1,291.75 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% IKVVFTPSIcK 95.00% 2.88 0.312 1.1 c10: Carbamidomethyl (+57.02) 646.8781 1,291.74 1,291.75 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% LcQIPVHGASVPK 95.00% 3.08 0.35 1.35 c2: Carbamidomethyl (+57.02) 703.3829 1,404.75 1,405.76 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% LcQIPVHGASVPK 95.00% 3.25 0.422 0 c2: Carbamidomethyl (+57.02) 703.3835 1,404.75 1,405.76 2
 SAMPLE 3 Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 5 6 18 3.59% cFQETIGSQcGK 95.00% 2.85 0.357 2.77 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 708.345 1,414.67 1,414.61 2
 SAMPLE 3R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 3 3 10 2.58% LcQIPVHGASVPK 95.00% 2.77 0.458 2.15 c2: Carbamidomethyl (+57.02) 469.2584 1,404.75 1,405.76 3
 SAMPLE 3R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 3 3 10 2.58% LcQIPVHGASVPK 95.00% 2.31 0.284 1.22 c2: Carbamidomethyl (+57.02) 469.2588 1,404.75 1,405.76 3
 SAMPLE 3R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 3 3 10 2.58% LcQIPVHGASVPK 95.00% 2.66 0.319 1.89 c2: Carbamidomethyl (+57.02) 469.2602 1,404.76 1,405.76 3
 SAMPLE 3R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 3 3 10 2.58% LcQIPVHGASVPK 95.00% 3.25 0.42 2.21 c2: Carbamidomethyl (+57.02) 469.2624 1,404.76 1,405.76 3
 SAMPLE 3R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 3 3 10 2.58% VVFTPSIcK 95.00% 1.88 0.291 0 c8: Carbamidomethyl (+57.02) 525.7841 1,049.55 1,050.57 2
 SAMPLE 3R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 3 3 10 2.58% VVFTPSIcK 95.00% 1.98 0.266 0 c8: Carbamidomethyl (+57.02) 525.785 1,049.55 1,050.57 2
 SAMPLE 3R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 3 3 10 2.58% VVFTPSIcK 95.00% 1.95 0.318 0 c8: Carbamidomethyl (+57.02) 525.7852 1,049.55 1,050.57 2
 SAMPLE 3R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 3 3 10 2.58% HPPEASVQIHQVSR 95.00% 3.15 0.517 1.12 528.9463 1,583.82 1,584.82 3
 SAMPLE 3R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 3 3 10 2.58% HPPEASVQIHQVSR 95.00% 3.1 0.42 0 529.2795 1,584.82 1,584.82 3
 SAMPLE 3R Latent-transforming growth factor beta-binding protein, isoform 1S  LTBP1  LTB1S_HUMAN 152,767.20 100.00% 3 3 10 2.58% HPPEASVQIHQVSR 95.00% 2.83 0.311 1.33 529.2808 1,584.82 1,584.82 3
 SAMPLE 3 Left-right determination factor 1  LEFTY1  LFTY1_HUMAN,LFTY2_HUMAN 40,861.90 99.80% 2 2 4 4.64% VTVEWLR 95.00% 2.11 0.231 0 451.7588 901.5019 902.51 2
 SAMPLE 3 Left-right determination factor 1  LEFTY1  LFTY1_HUMAN,LFTY2_HUMAN 40,861.90 99.80% 2 2 4 4.64% VTVEWLR 95.00% 2.01 0.22 0 451.759 901.5024 902.51 2
 SAMPLE 3 Left-right determination factor 1  LEFTY1  LFTY1_HUMAN,LFTY2_HUMAN 40,861.90 99.80% 2 2 4 4.64% LVSVHESGWK 95.00% 2.23 0.353 0 571.3033 1,140.59 1,141.60 2
 SAMPLE 3 Left-right determination factor 1  LEFTY1  LFTY1_HUMAN,LFTY2_HUMAN 40,861.90 99.80% 2 2 4 4.64% LVSVHESGWK 95.00% 2.01 0.274 0 571.3064 1,140.60 1,141.60 2
 SAMPLE 1 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 4 4 7 8.17% MTVTNLLSR 95.00% 2.68 0.314 0 517.7859 1,033.56 1,034.57 2
 SAMPLE 1 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 4 4 7 8.17% MTVTNLLSR 95.00% 2.77 0.382 0 517.7859 1,033.56 1,034.57 2
 SAMPLE 1 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 4 4 7 8.17% ALLQNNTLTELR 95.00% 2.53 0.323 0 693.3883 1,384.76 1,385.78 2
 SAMPLE 1 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 4 4 7 8.17% ALLQNNTLTELR 95.00% 1.92 0.267 1.38 693.3897 1,384.76 1,385.78 2
 SAMPLE 1 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 4 4 7 8.17% FTEALEFNTVVK 95.00% 2.98 0.336 1.15 699.6804 1,397.35 1,397.73 2
 SAMPLE 1 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 4 4 7 8.17% FTEALEFNTVVK 95.00% 2.75 0.211 1.43 700.0183 1,398.02 1,397.73 2
 SAMPLE 1 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 4 4 7 8.17% ELDVVDPDGSVPVGLR 95.00% 4.53 0.496 4.64 833.9508 1,665.89 1,666.87 2
 SAMPLE 1R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 3 3 6 6.17% MTVTNLLSR 95.00% 2.27 0.35 0 517.7854 1,033.56 1,034.57 2
 SAMPLE 1R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 3 3 6 6.17% MTVTNLLSR 95.00% 2.11 0.288 0 517.7868 1,033.56 1,034.57 2
 SAMPLE 1R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 3 3 6 6.17% ALLQNNTLTELR 95.00% 2.22 0.304 0 693.387 1,384.76 1,385.78 2
 SAMPLE 1R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 3 3 6 6.17% ALLQNNTLTELR 95.00% 2.39 0.361 1.68 693.388 1,384.76 1,385.78 2
 SAMPLE 1R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 3 3 6 6.17% ELDVVDPDGSVPVGLR 95.00% 4.41 0.475 4.6 833.9522 1,665.89 1,666.87 2
 SAMPLE 1R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 3 3 6 6.17% ELDVVDPDGSVPVGLR 95.00% 4.24 0.451 4.82 833.9525 1,665.89 1,666.87 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% LFALANTR 95.00% 3.03 0.214 0 453.2643 904.5129 905.5209 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% LFALANTR 95.00% 3.05 0.19 0 453.265 904.5143 905.5209 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% HIcGGKTEMEIAK 95.00% 2.26 0.363 0 c3: Carbamidomethyl (+57.02) 491.9111 1,472.71 1,473.72 3
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% HIcGGKTEMEIAK 95.00% 3.08 0.475 1.24 c3: Carbamidomethyl (+57.02) 491.9116 1,472.71 1,473.72 3
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% MTVTNLLSR 95.00% 2.83 0.5 1.18 517.7856 1,033.56 1,034.57 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% MTVTNLLSR 95.00% 2.68 0.494 0 517.7858 1,033.56 1,034.57 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% LLKENTTLLK 95.00% 2.97 0.364 0 586.8651 1,171.71 1,172.73 2 ANK3_HUMAN,TPM4_HUMAN
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% LLKENTTLLK 95.00% 3.35 0.311 0 586.8657 1,171.72 1,172.73 2 ANK3_HUMAN,TPM4_HUMAN
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% LGYHFELAGPR 95.00% 3.35 0.478 1.19 630.3293 1,258.64 1,259.65 2 PLEC1_HUMAN,RS8_HUMAN
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% LGYHFELAGPR 95.00% 2.94 0.445 0 630.3299 1,258.64 1,259.65 2 PLEC1_HUMAN,RS8_HUMAN
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% ALLQNNTLTELR 95.00% 2.95 0.405 2.31 693.3884 1,384.76 1,385.78 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% ALLQNNTLTELR 95.00% 2.19 0.285 0 693.3894 1,384.76 1,385.78 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% ALLQNNTLTELR 95.00% 2.21 0.316 1.77 693.3896 1,384.76 1,385.78 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% ALLQNNTLTELR 95.00% 3.44 0.442 3.66 693.3897 1,384.76 1,385.78 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% ALLQNNTLTELR 94.60% 2.23 0.23 0 693.3906 1,384.77 1,385.78 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% FTEALEFNTVVK 95.00% 4.15 0.521 3.82 699.3692 1,396.72 1,397.73 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% FTEALEFNTVVK 95.00% 4.31 0.481 3.48 699.3696 1,396.72 1,397.73 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% TITSLNLDSNHITGK 95.00% 4.14 0.442 3.72 807.4292 1,612.84 1,613.85 2
 SAMPLE 2 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 17.70% ELDVVDPDGSVPVGLR 95.00% 4.34 0.431 3.66 834.4366 1,666.86 1,666.87 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% LFALANTR 95.00% 2.86 0.151 0 453.2643 904.513 905.5209 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% LFALANTR 95.00% 2.84 0.157 0 453.2646 904.5136 905.5209 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% HIcGGKTEMEIAK 95.00% 2.66 0.411 0 c3: Carbamidomethyl (+57.02) 492.2456 1,473.71 1,473.72 3
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% MTVTNLLSR 95.00% 2.64 0.412 0 517.7856 1,033.56 1,034.57 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% MTVTNLLSR 95.00% 2.74 0.507 0 517.7858 1,033.56 1,034.57 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% LGYHFELAGPR 95.00% 3.04 0.471 0 630.3288 1,258.64 1,259.65 2 PLEC1_HUMAN,RS8_HUMAN
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% ALLQNNTLTELR 95.00% 3.08 0.431 3.8 693.389 1,384.76 1,385.78 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% ALLQNNTLTELR 95.00% 3.39 0.431 4.57 693.3898 1,384.76 1,385.78 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% ALLQNNTLTELR 95.00% 1.91 0.21 1.2 693.3909 1,384.77 1,385.78 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% ALLQNNTLTELR 95.00% 2.29 0.252 3.03 693.8907 1,385.77 1,385.78 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% FTEALEFNTVVK 95.00% 3.8 0.523 3.14 699.3681 1,396.72 1,397.73 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% FTEALEFNTVVK 95.00% 4.15 0.524 3.23 699.3691 1,396.72 1,397.73 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% TITSLNLDSNHITGK 95.00% 3.86 0.459 3.57 807.4283 1,612.84 1,613.85 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% TITSLNLDSNHITGK 95.00% 3.98 0.41 3.33 807.9287 1,613.84 1,613.85 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% ELDVVDPDGSVPVGLR 95.00% 4.92 0.408 4.04 833.9342 1,665.85 1,666.87 2
 SAMPLE 2R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 15 16.00% ELDVVDPDGSVPVGLR 95.00% 4.12 0.454 3.21 833.935 1,665.85 1,666.87 2
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% DQLLAAIR 95.00% 2.7 0.155 0 450.269 898.5223 899.5316 2
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% DQLLAAIR 95.00% 2.71 0.131 0 450.2693 898.5229 899.5316 2
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% LFALANTR 95.00% 2.62 0.157 0 453.2638 904.512 905.5209 2
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% HIcGGKTEMEIAK 95.00% 2.57 0.294 0 c3: Carbamidomethyl (+57.02) 492.2459 1,473.71 1,473.72 3
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% MTVTNLLSR 95.00% 2.32 0.444 1.6 517.7835 1,033.55 1,034.57 2
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% MTVTNLLSR 95.00% 2.73 0.416 0 517.7846 1,033.55 1,034.57 2
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% MTVTNLLSR 95.00% 2.13 0.281 0 517.7854 1,033.56 1,034.57 2
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% MTVTNLLSR 95.00% 2.58 0.341 0 517.7854 1,033.56 1,034.57 2
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% TITSLNLDSNHITGK 95.00% 2.3 0.268 0 538.6212 1,612.84 1,613.85 3
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% LGYHFELAGPR 95.00% 1.85 0.335 0 630.329 1,258.64 1,259.65 2 PLEC1_HUMAN,RS8_HUMAN
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% ALLQNNTLTELR 95.00% 3.25 0.395 4.34 693.3868 1,384.76 1,385.78 2
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% ALLQNNTLTELR 95.00% 3.41 0.417 2.6 693.3889 1,384.76 1,385.78 2
 SAMPLE 3 Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 12 15.30% ELDVVDPDGSVPVGLR 95.00% 4.63 0.43 2.4 833.934 1,665.85 1,666.87 2
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% DQLLAAIR 95.00% 2.61 0.135 0 450.2694 898.5231 899.5316 2
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% LFALANTR 95.00% 2.86 0.187 0 453.2651 904.5146 905.5209 2
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% HIcGGKTEMEIAK 95.00% 2.78 0.418 1.37 c3: Carbamidomethyl (+57.02) 491.9123 1,472.71 1,473.72 3
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% HIcGGKTEMEIAK 95.00% 2.52 0.294 0 c3: Carbamidomethyl (+57.02) 491.9127 1,472.71 1,473.72 3
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% MTVTNLLSR 95.00% 2.46 0.432 0 517.784 1,033.55 1,034.57 2
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% MTVTNLLSR 95.00% 2.27 0.279 1.7 517.7858 1,033.56 1,034.57 2
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% MTVTNLLSR 95.00% 2.46 0.411 1.96 517.786 1,033.56 1,034.57 2
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% ALLQNNTLTELR 95.00% 3.28 0.409 2.7 693.3896 1,384.76 1,385.78 2
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% ALLQNNTLTELR 95.00% 3.23 0.336 2.8 693.8916 1,385.77 1,385.78 2
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% FTEALEFNTVVK 95.00% 2.61 0.379 0 699.3675 1,396.72 1,397.73 2
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% ELDVVDPDGSVPVGLR 95.00% 4.39 0.511 3.92 833.9357 1,665.86 1,666.87 2
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% ELDVVDPDGSVPVGLR 95.00% 4.2 0.43 3.51 833.9375 1,665.86 1,666.87 2
 SAMPLE 3R Leiomodin-1  LMOD1  LMOD1_HUMAN 67,027.50 100.00% 7 7 13 13.00% ELDVVDPDGSVPVGLR 95.00% 4.71 0.467 3.25 834.4375 1,666.86 1,666.87 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% GTcSGFEPHSWR 95.00% 2.38 0.359 0 c3: Carbamidomethyl (+57.02) 474.2097 1,419.61 1,420.61 3
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% GTcSGFEPHSWR 95.00% 2.54 0.483 2.13 c3: Carbamidomethyl (+57.02) 474.21 1,419.61 1,420.61 3
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% QWHPTcFVcAK 95.00% 2.25 0.306 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 478.5543 1,432.64 1,433.65 3
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% QWHPTcFVcAK 95.00% 2.1 0.38 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 478.5548 1,432.64 1,433.65 3
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% MSLGQLQSAR 95.00% 2.83 0.195 0 545.7892 1,089.56 1,090.57 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% MIMTNPIATGK 95.00% 1.95 0.204 1.19 588.8094 1,175.60 1,176.61 2 KV305_HUMAN,CH60_HUMAN
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% QLMHQLPIYDQDPSR 95.00% 4.18 0.412 0 614.3058 1,839.89 1,840.90 3
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% QLMHQLPIYDQDPSR 95.00% 3.6 0.37 0 614.3067 1,839.90 1,840.90 3
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% LGLQYMELIPK 95.00% 2.77 0.303 0 652.8656 1,303.72 1,304.73 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% LGLQYMELIPK 95.00% 3.69 0.402 2.2 652.8663 1,303.72 1,304.73 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% LGLQYMELIPK 95.00% 3.51 0.422 1.41 652.8673 1,303.72 1,304.73 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% LGLQYMELIPK 95.00% 2.93 0.254 0 652.8793 1,303.74 1,304.73 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% GAAPPDSPVVYSDR 95.00% 2.85 0.612 4.1 715.8481 1,429.68 1,430.69 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% GAAPPDSPVVYSDR 95.00% 3.33 0.581 4.03 715.8482 1,429.68 1,430.69 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% EKQPVTGTEGAFYR 95.00% 2.27 0.329 3.24 791.8956 1,581.78 1,582.79 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% EKQPVTGTEGAFYR 95.00% 2.53 0.446 2.55 791.8965 1,581.78 1,582.79 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% HFVcEGcEQLLSGR 95.00% 4.13 0.541 6.49 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 846.3844 1,690.75 1,691.76 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% HFVcEGcEQLLSGR 95.00% 4.31 0.537 6.96 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 846.3883 1,690.76 1,691.76 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% SEALGVGEVALPGQGGLPK 95.00% 4.55 0.687 6.19 889.984 1,777.95 1,778.97 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% SEALGVGEVALPGQGGLPK 95.00% 4.89 0.651 5.47 890.485 1,778.95 1,778.97 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% SEALGVGEVALPGQGGLPK 95.00% 4.46 0.607 3.46 890.4879 1,778.96 1,778.97 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% cSGcDEIIFAEDYQR 95.00% 4.88 0.558 4.16 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 931.8872 1,861.76 1,862.77 2
 SAMPLE 1 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 11 11 23 40.00% cSGcDEIIFAEDYQR 95.00% 5.14 0.56 5.85 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 932.3877 1,862.76 1,862.77 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% GTcSGFEPHSWR 95.00% 2.2 0.397 1.77 c3: Carbamidomethyl (+57.02) 474.2079 1,419.60 1,420.61 3
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% GTcSGFEPHSWR 95.00% 2.45 0.428 1.48 c3: Carbamidomethyl (+57.02) 474.2091 1,419.60 1,420.61 3
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% QWHPTcFVcAK 95.00% 2.17 0.385 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 478.5522 1,432.63 1,433.65 3
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% MSLGQLQSAR 95.00% 2.9 0.214 0 545.7853 1,089.56 1,090.57 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% MSLGQLQSAR 95.00% 2.73 0.135 0 545.7868 1,089.56 1,090.57 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% LGLQYMELIPK 95.00% 3.68 0.381 0 652.8673 1,303.72 1,304.73 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% LGLQYMELIPK 95.00% 3.48 0.412 1.89 652.8675 1,303.72 1,304.73 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% LGLQYMELIPK 95.00% 2.93 0.254 0 652.8793 1,303.74 1,304.73 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% cSQEDHcLTSDLEDDRK 95.00% 4.86 0.38 1.68 c1: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 703.6265 2,107.86 2,107.87 3
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% GTcSGFEPHSWR 95.00% 3.1 0.334 2.85 c3: Carbamidomethyl (+57.02) 710.8082 1,419.60 1,420.61 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% GAAPPDSPVVYSDR 95.00% 2.78 0.534 2.72 715.8468 1,429.68 1,430.69 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% GAAPPDSPVVYSDR 95.00% 2.86 0.548 1.68 715.8474 1,429.68 1,430.69 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% EKQPVTGTEGAFYR 95.00% 3.17 0.387 3.55 791.8979 1,581.78 1,582.79 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% EKQPVTGTEGAFYR 95.00% 3.23 0.27 3.42 791.8993 1,581.78 1,582.79 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% HFVcEGcEQLLSGR 95.00% 3.89 0.542 7.64 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 846.3844 1,690.75 1,691.76 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% SEALGVGEVALPGQGGLPK 95.00% 4.78 0.615 5.1 890.4845 1,778.95 1,778.97 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% SEALGVGEVALPGQGGLPK 95.00% 4.57 0.641 5.96 890.4851 1,778.95 1,778.97 2
 SAMPLE 1R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 10 11 18 37.50% QLMHQLPIYDQDPSR 95.00% 2.92 0.38 2.8 921.4583 1,840.90 1,840.90 2
 SAMPLE 2 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 3 3 5 11.00% GTcSGFEPHSWR 95.00% 2.52 0.314 0 c3: Carbamidomethyl (+57.02) 474.2058 1,419.59 1,420.61 3
 SAMPLE 2 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 3 3 5 11.00% GTcSGFEPHSWR 95.00% 2.45 0.399 1.02 c3: Carbamidomethyl (+57.02) 474.2071 1,419.60 1,420.61 3
 SAMPLE 2 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 3 3 5 11.00% GAAPPDSPVVYSDR 95.00% 2.83 0.599 2.22 715.8494 1,429.68 1,430.69 2
 SAMPLE 2 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 3 3 5 11.00% GAAPPDSPVVYSDR 95.00% 2.89 0.629 2.36 715.8505 1,429.69 1,430.69 2
 SAMPLE 2 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 3 3 5 11.00% EKQPVTGTEGAFYR 95.00% 3.06 0.288 2.24 791.8974 1,581.78 1,582.79 2
 SAMPLE 2R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 99.80% 2 2 2 6.85% LGLQYMELIPK 95.00% 2.44 0.315 0 652.8669 1,303.72 1,304.73 2
 SAMPLE 2R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 99.80% 2 2 2 6.85% EKQPVTGTEGAFYR 95.00% 2.55 0.245 1.8 791.8982 1,581.78 1,582.79 2
 SAMPLE 3 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 6 6 10 21.60% QWHPTcFVcAK 95.00% 1.83 0.352 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 478.5527 1,432.63 1,433.65 3
 SAMPLE 3 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 6 6 10 21.60% MSLGQLQSAR 95.00% 2.68 0.215 0 545.7877 1,089.56 1,090.57 2
 SAMPLE 3 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 6 6 10 21.60% MIMTNPIATGK 95.00% 2.16 0.275 1.13 588.8086 1,175.60 1,176.61 2 KV305_HUMAN,CH60_HUMAN
 SAMPLE 3 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 6 6 10 21.60% MIMTNPIATGK 95.00% 2.32 0.309 2.05 589.3101 1,176.60 1,176.61 2 KV305_HUMAN,CH60_HUMAN
 SAMPLE 3 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 6 6 10 21.60% GAAPPDSPVVYSDR 95.00% 2.19 0.339 0 715.846 1,429.68 1,430.69 2
 SAMPLE 3 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 6 6 10 21.60% GAAPPDSPVVYSDR 95.00% 2.72 0.603 3 715.8474 1,429.68 1,430.69 2
 SAMPLE 3 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 6 6 10 21.60% GAAPPDSPVVYSDR 95.00% 2.37 0.44 0 715.8488 1,429.68 1,430.69 2
 SAMPLE 3 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 6 6 10 21.60% GAAPPDSPVVYSDR 95.00% 2.7 0.599 3.13 715.8499 1,429.68 1,430.69 2
 SAMPLE 3 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 6 6 10 21.60% EKQPVTGTEGAFYR 95.00% 3.08 0.418 3.96 791.8963 1,581.78 1,582.79 2
 SAMPLE 3 LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 6 6 10 21.60% SEALGVGEVALPGQGGLPK 95.00% 2.67 0.383 3 889.9856 1,777.96 1,778.97 2
 SAMPLE 3R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 5 5 9 18.90% MIMTNPIATGK 95.00% 1.94 0.298 0 588.8089 1,175.60 1,176.61 2 KV305_HUMAN,CH60_HUMAN
 SAMPLE 3R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 5 5 9 18.90% LGLQYMELIPK 95.00% 2.72 0.331 0 652.8658 1,303.72 1,304.73 2
 SAMPLE 3R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 5 5 9 18.90% LGLQYMELIPK 95.00% 3.04 0.374 1.85 652.867 1,303.72 1,304.73 2
 SAMPLE 3R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 5 5 9 18.90% LGLQYMELIPK 95.00% 2.77 0.255 0 653.3702 1,304.72 1,304.73 2
 SAMPLE 3R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 5 5 9 18.90% GAAPPDSPVVYSDR 95.00% 2.84 0.639 3.08 715.8474 1,429.68 1,430.69 2
 SAMPLE 3R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 5 5 9 18.90% GAAPPDSPVVYSDR 95.00% 3.1 0.597 2.74 715.8502 1,429.68 1,430.69 2
 SAMPLE 3R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 5 5 9 18.90% EKQPVTGTEGAFYR 95.00% 2.96 0.356 2.66 791.896 1,581.78 1,582.79 2
 SAMPLE 3R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 5 5 9 18.90% EKQPVTGTEGAFYR 95.00% 3.05 0.373 1.77 792.3994 1,582.78 1,582.79 2
 SAMPLE 3R LIM and cysteine-rich domains protein 1  LMCD1  LMCD1_HUMAN 40,815.10 100.00% 5 5 9 18.90% SEALGVGEVALPGQGGLPK 95.00% 2.23 0.234 1.8 889.9866 1,777.96 1,778.97 2
 SAMPLE 3 LIM and senescent cell antigen-like-containing domain protein 2  LIMS2  LIMS2_HUMAN 38,897.40 99.80% 2 3 4 7.33% QWHVEHFVcAK 95.00% 2.27 0.309 0 c9: Carbamidomethyl (+57.02) 480.8985 1,439.67 1,440.68 3
 SAMPLE 3 LIM and senescent cell antigen-like-containing domain protein 2  LIMS2  LIMS2_HUMAN 38,897.40 99.80% 2 3 4 7.33% ELKGELYcLPcHDK 95.00% 3.03 0.317 1.1 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 587.9481 1,760.82 1,761.83 3
 SAMPLE 3 LIM and senescent cell antigen-like-containing domain protein 2  LIMS2  LIMS2_HUMAN 38,897.40 99.80% 2 3 4 7.33% ELKGELYcLPcHDK 95.00% 3.3 0.427 1.29 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 588.2826 1,761.82 1,761.83 3
 SAMPLE 3 LIM and senescent cell antigen-like-containing domain protein 2  LIMS2  LIMS2_HUMAN 38,897.40 99.80% 2 3 4 7.33% ELKGELYcLPcHDK 95.00% 4.03 0.354 1.77 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 881.9171 1,761.82 1,761.83 2
 SAMPLE 3R LIM and senescent cell antigen-like-containing domain protein 2  LIMS2  LIMS2_HUMAN 38,897.40 99.80% 2 2 3 8.50% ELKGELYcLPcHDK 95.00% 2.91 0.346 1.41 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 587.9471 1,760.82 1,761.83 3
 SAMPLE 3R LIM and senescent cell antigen-like-containing domain protein 2  LIMS2  LIMS2_HUMAN 38,897.40 99.80% 2 2 3 8.50% ELKGELYcLPcHDK 95.00% 2.9 0.357 0 c8: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 587.9473 1,760.82 1,761.83 3
 SAMPLE 3R LIM and senescent cell antigen-like-containing domain protein 2  LIMS2  LIMS2_HUMAN 38,897.40 99.80% 2 2 3 8.50% cELcDVELADLGFVK 95.00% 4.13 0.53 6.55 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 884.9189 1,767.82 1,767.83 2
 SAMPLE 2 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 9 15.70% EPAAPVSIQR 95.00% 1.9 0.336 1.17 534.2945 1,066.57 1,067.59 2
 SAMPLE 2 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 9 15.70% GFSVVADTPELQR 95.00% 3.3 0.444 2.25 709.8652 1,417.71 1,418.73 2
 SAMPLE 2 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 9 15.70% GFSVVADTPELQR 95.00% 3.07 0.457 1.85 709.866 1,417.72 1,418.73 2
 SAMPLE 2 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 9 15.70% GFSVVADTPELQR 95.00% 3.05 0.451 1.82 709.8661 1,417.72 1,418.73 2
 SAMPLE 2 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 9 15.70% GFSVVADTPELQR 95.00% 3.89 0.438 3.19 709.8664 1,417.72 1,418.73 2
 SAMPLE 2 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 9 15.70% GFSVVADTPELQR 95.00% 3.82 0.424 2.36 709.8664 1,417.72 1,418.73 2
 SAMPLE 2 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 9 15.70% GFSVVADTPELQR 95.00% 3.62 0.457 2.14 709.8666 1,417.72 1,418.73 2
 SAMPLE 2 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 9 15.70% GFSVVADTPELQR 95.00% 3.69 0.47 2.46 709.8681 1,417.72 1,418.73 2
 SAMPLE 2 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 9 15.70% TQDQISNIKYHEEFEKSR 95.00% 3.59 0.573 2.54 1,126.28 2,250.55 2,252.09 2
 SAMPLE 2R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 99.80% 2 2 8 16.50% TQDQISNIKYHEEFEK 95.00% 2.93 0.314 0 670.6603 2,008.96 2,008.96 3
 SAMPLE 2R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 99.80% 2 2 8 16.50% GFSVVADTPELQR 95.00% 3.31 0.417 2.17 709.8656 1,417.72 1,418.73 2
 SAMPLE 2R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 99.80% 2 2 8 16.50% GFSVVADTPELQR 95.00% 2.41 0.387 1.33 709.8658 1,417.72 1,418.73 2
 SAMPLE 2R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 99.80% 2 2 8 16.50% GFSVVADTPELQR 95.00% 3.35 0.484 2.74 709.8659 1,417.72 1,418.73 2
 SAMPLE 2R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 99.80% 2 2 8 16.50% GFSVVADTPELQR 95.00% 3.22 0.434 1.92 709.8667 1,417.72 1,418.73 2
 SAMPLE 2R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 99.80% 2 2 8 16.50% GFSVVADTPELQR 95.00% 2.81 0.406 2.16 709.8667 1,417.72 1,418.73 2
 SAMPLE 2R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 99.80% 2 2 8 16.50% GFSVVADTPELQR 95.00% 3.55 0.437 2.01 709.867 1,417.72 1,418.73 2
 SAMPLE 2R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 99.80% 2 2 8 16.50% GFSVVADTPELQR 95.00% 2.77 0.307 0 709.8672 1,417.72 1,418.73 2
 SAMPLE 2R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 99.80% 2 2 8 16.50% QSFTMVADTPENLR 95.00% 3.25 0.544 2.46 804.8892 1,607.76 1,608.77 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% MGPSGGEGMEPERR 95.00% 2.31 0.273 0 497.5562 1,489.65 1,489.65 3
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% EPAAPVSIQR 95.00% 2.11 0.33 0 534.2945 1,066.57 1,067.59 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% EPAAPVSIQR 95.00% 1.59 0.286 1.68 534.2946 1,066.57 1,067.59 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% EPAAPVSIQR 95.00% 1.69 0.318 0 534.2948 1,066.57 1,067.59 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% EPAAPVSIQR 95.00% 1.86 0.363 0 534.2951 1,066.57 1,067.59 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% TQDQISNIKYHEEFEK 95.00% 2.56 0.319 0 670.6595 2,008.96 2,008.96 3
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% GFSVVADTPELQR 95.00% 2.97 0.414 1.8 709.8648 1,417.71 1,418.73 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% GFSVVADTPELQR 95.00% 3.56 0.415 2.89 709.8658 1,417.72 1,418.73 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% GFSVVADTPELQR 95.00% 3.4 0.44 3.13 709.8661 1,417.72 1,418.73 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% GFSVVADTPELQR 95.00% 3.82 0.466 2.8 709.8665 1,417.72 1,418.73 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% GFSVVADTPELQR 95.00% 3.62 0.465 1.6 709.8665 1,417.72 1,418.73 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% GFSVVADTPELQR 95.00% 4.17 0.46 2.07 709.8666 1,417.72 1,418.73 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% GFSVVADTPELQR 95.00% 3.44 0.425 2.24 709.8673 1,417.72 1,418.73 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% GFSVVADTPELQR 95.00% 3.06 0.417 2 709.8674 1,417.72 1,418.73 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% LKQQSELQSQVR 95.00% 3.28 0.433 3.28 722.3953 1,442.77 1,443.79 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% QSFTMVADTPENLR 95.00% 4.44 0.588 4.85 804.8863 1,607.76 1,608.77 2
 SAMPLE 3 LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 5 5 15 30.30% QSFTMVADTPENLR 95.00% 4.53 0.574 3.82 804.8882 1,607.76 1,608.77 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% EPAAPVSIQR 95.00% 1.93 0.373 1.62 534.2947 1,066.57 1,067.59 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% EPAAPVSIQR 95.00% 2.15 0.318 1.26 534.2947 1,066.57 1,067.59 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% EPAAPVSIQR 95.00% 1.96 0.276 0 534.2952 1,066.57 1,067.59 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% EPAAPVSIQR 95.00% 1.89 0.322 1.51 534.2953 1,066.58 1,067.59 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% TQDQISNIKYHEEFEK 95.00% 3.1 0.38 0 670.6584 2,008.95 2,008.96 3
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% GFSVVADTPELQR 95.00% 3.26 0.453 3.11 709.8662 1,417.72 1,418.73 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% GFSVVADTPELQR 95.00% 3.28 0.475 2.33 709.8664 1,417.72 1,418.73 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% GFSVVADTPELQR 95.00% 3.18 0.462 2.68 709.8665 1,417.72 1,418.73 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% GFSVVADTPELQR 95.00% 2.19 0.275 0 709.8669 1,417.72 1,418.73 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% GFSVVADTPELQR 95.00% 4.08 0.447 2.54 709.867 1,417.72 1,418.73 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% GFSVVADTPELQR 95.00% 3.53 0.439 2.28 709.8672 1,417.72 1,418.73 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% GFSVVADTPELQR 95.00% 3.1 0.451 0 709.8676 1,417.72 1,418.73 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% QSFTMVADTPENLR 95.00% 3.93 0.493 2.54 804.8872 1,607.76 1,608.77 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% QSFTMVADTPENLR 95.00% 2.96 0.439 2.57 804.8891 1,607.76 1,608.77 2
 SAMPLE 3R LIM and SH3 domain protein 1  LASP1  LASP1_HUMAN 29,698.80 100.00% 3 3 12 20.30% QSFTMVADTPENLR 95.00% 4.17 0.524 4.49 804.8904 1,607.77 1,608.77 2
 SAMPLE 3 LIM domain-binding protein 3  LDB3  LDB3_HUMAN 77,117.40 99.80% 2 2 4 4.40% SQNKPEDEADEWARR 95.00% 2.97 0.303 0 610.9532 1,829.84 1,830.84 3
 SAMPLE 3 LIM domain-binding protein 3  LDB3  LDB3_HUMAN 77,117.40 99.80% 2 2 4 4.40% GGPAYTPAGPQVPPLAR 95.00% 4.41 0.463 3.74 824.9424 1,647.87 1,648.88 2
 SAMPLE 3 LIM domain-binding protein 3  LDB3  LDB3_HUMAN 77,117.40 99.80% 2 2 4 4.40% GGPAYTPAGPQVPPLAR 95.00% 4.29 0.549 5.92 824.9461 1,647.88 1,648.88 2
 SAMPLE 3 LIM domain-binding protein 3  LDB3  LDB3_HUMAN 77,117.40 99.80% 2 2 4 4.40% GGPAYTPAGPQVPPLAR 95.00% 4.51 0.536 4.72 825.4431 1,648.87 1,648.88 2
 SAMPLE 3R LIM domain-binding protein 3  LDB3  LDB3_HUMAN 77,117.40 100.00% 2 2 3 4.40% SQNKPEDEADEWARR 95.00% 2.65 0.223 0 610.9518 1,829.83 1,830.84 3
 SAMPLE 3R LIM domain-binding protein 3  LDB3  LDB3_HUMAN 77,117.40 100.00% 2 2 3 4.40% GGPAYTPAGPQVPPLAR 95.00% 4.25 0.451 5.05 824.9436 1,647.87 1,648.88 2
 SAMPLE 3R LIM domain-binding protein 3  LDB3  LDB3_HUMAN 77,117.40 100.00% 2 2 3 4.40% GGPAYTPAGPQVPPLAR 95.00% 4.58 0.481 4.11 824.9447 1,647.87 1,648.88 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% PTFNVQVK 95.00% 2.63 0.394 0 466.7633 931.511 932.5206 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% PTFNVQVK 95.00% 2.62 0.421 0 466.7639 931.5121 932.5206 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% GQPFYAVEK 95.00% 1.98 0.349 1.28 519.7636 1,037.51 1,038.53 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% GQPFYAVEK 95.00% 1.76 0.302 0 519.7653 1,037.51 1,038.53 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% NDSDPTYGQQGHPNTWK 95.00% 2.41 0.365 0 648.9528 1,943.83 1,944.85 3
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% NDSDPTYGQQGHPNTWK 95.00% 2.14 0.355 0 648.9532 1,943.84 1,944.85 3
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% NDSDPTYGQQGHPNTWK 95.00% 2.26 0.351 0 649.2872 1,944.84 1,944.85 3
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% KTYITDPVSAPcAPPLQPK 95.00% 4.9 0.531 4.64 c12: Carbamidomethyl (+57.02) 695.3649 2,083.07 2,083.09 3
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% KTYITDPVSAPcAPPLQPK 95.00% 2.56 0.42 0 c12: Carbamidomethyl (+57.02) 695.3687 2,083.08 2,083.09 3
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% KTYITDPVSAPcAPPLQPK 95.00% 4.58 0.533 3.89 c12: Carbamidomethyl (+57.02) 695.3692 2,083.08 2,083.09 3
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% KTYITDPVSAPcAPPLQPK 95.00% 3.27 0.309 3.04 c12: Carbamidomethyl (+57.02) 695.3695 2,083.09 2,083.09 3
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% KTYITDPVSAPcAPPLQPK 95.00% 2.41 0.389 1.74 c12: Carbamidomethyl (+57.02) 695.3698 2,083.09 2,083.09 3
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% MVIPNQPPLTATK 95.00% 2.64 0.517 2.21 705.3927 1,408.77 1,409.78 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% MVIPNQPPLTATK 95.00% 2.33 0.404 0 705.393 1,408.77 1,409.78 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% MVIPNQPPLTATK 95.00% 3.17 0.511 3.08 705.3934 1,408.77 1,409.78 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% MVIPNQPPLTATK 95.00% 2.54 0.5 0 705.3944 1,408.77 1,409.78 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% cSVcKEPIMPAPGQEETVR 95.00% 3.38 0.393 1.19 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.3443 2,188.01 2,188.02 3
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% METTHSFGNPSISVSTQQPPK 95.00% 2.92 0.365 1.68 758.7007 2,273.08 2,273.09 3
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% METTHSFGNPSISVSTQQPPKK 95.00% 5.88 0.575 2.41 801.3972 2,401.17 2,401.18 3
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% YYEGYYAAGPGYGGR 95.00% 4.42 0.682 6.66 822.3557 1,642.70 1,643.71 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% YYEGYYAAGPGYGGR 95.00% 5.05 0.624 7.4 822.3584 1,642.70 1,643.71 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% YYEGYYAAGPGYGGR 95.00% 4.81 0.655 6.74 822.3605 1,642.71 1,643.71 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% YYEGYYAAGPGYGGR 95.00% 4.77 0.649 4.7 822.8576 1,643.70 1,643.71 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% YYEGYYAAGPGYGGR 95.00% 5.15 0.619 5.85 822.8614 1,643.71 1,643.71 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% NDSDPTYGQQGHPNTWK 95.00% 4.35 0.488 4.04 972.9255 1,943.84 1,944.85 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% NDSDPTYGQQGHPNTWK 95.00% 4.3 0.447 2.77 973.4279 1,944.84 1,944.85 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% NDSDPTYGQQGHPNTWK 95.00% 4.25 0.484 2.77 973.4297 1,944.84 1,944.85 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% TYITDPVSAPcAPPLQPK 95.00% 3.71 0.54 5.55 c11: Carbamidomethyl (+57.02) 978.5023 1,954.99 1,955.00 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% KTYITDPVSAPcAPPLQPK 95.00% 4.67 0.605 8 c12: Carbamidomethyl (+57.02) 1,042.05 2,082.08 2,083.09 2
 SAMPLE 1 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 10 12 30 19.90% KTYITDPVSAPcAPPLQPK 95.00% 4.69 0.587 4.8 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.08 2,083.09 2
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% PTFNVQVK 95.00% 2.42 0.365 0 466.763 931.5104 932.5206 2
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% PTFNVQVK 95.00% 2.34 0.42 0 466.7637 931.5117 932.5206 2
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% PTFNVQVK 95.00% 1.99 0.32 0 466.7639 931.5122 932.5206 2
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% PTFNVQVK 95.00% 2.13 0.308 0 466.7642 931.5127 932.5206 2
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% NDSDPTYGQQGHPNTWK 95.00% 2.17 0.281 0 649.2867 1,944.84 1,944.85 3
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% NDSDPTYGQQGHPNTWK 95.00% 2.32 0.298 0 649.2876 1,944.84 1,944.85 3
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% NDSDPTYGQQGHPNTWK 95.00% 2.15 0.285 0 649.2877 1,944.84 1,944.85 3
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% KTYITDPVSAPcAPPLQPK 95.00% 3.46 0.398 2.77 c12: Carbamidomethyl (+57.02) 695.3671 2,083.08 2,083.09 3
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% KTYITDPVSAPcAPPLQPK 95.00% 3.97 0.458 4.17 c12: Carbamidomethyl (+57.02) 695.3681 2,083.08 2,083.09 3
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% KTYITDPVSAPcAPPLQPK 95.00% 2.56 0.42 0 c12: Carbamidomethyl (+57.02) 695.3687 2,083.08 2,083.09 3
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% KTYITDPVSAPcAPPLQPK 95.00% 3.27 0.309 3.08 c12: Carbamidomethyl (+57.02) 695.3695 2,083.09 2,083.09 3
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% MVIPNQPPLTATK 95.00% 3.19 0.515 4.02 705.3925 1,408.77 1,409.78 2
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% MVIPNQPPLTATK 95.00% 2.57 0.442 2.92 705.3926 1,408.77 1,409.78 2
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% cSVcKEPIMPAPGQEETVR 95.00% 3.54 0.415 1.15 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.3455 2,188.01 2,188.02 3
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% METTHSFGNPSISVSTQQPPK 95.00% 2.58 0.329 1.02 758.7007 2,273.08 2,273.09 3
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% YYEGYYAAGPGYGGR 95.00% 4.65 0.642 6.04 822.3591 1,642.70 1,643.71 2
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% YYEGYYAAGPGYGGR 95.00% 4.5 0.662 5.62 822.3602 1,642.70 1,643.71 2
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% YYEGYYAAGPGYGGR 95.00% 5.05 0.606 7.02 822.8603 1,643.71 1,643.71 2
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% NDSDPTYGQQGHPNTWK 95.00% 4.71 0.505 1.85 973.4275 1,944.84 1,944.85 2
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% KTYITDPVSAPcAPPLQPK 95.00% 4.81 0.543 7.46 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.08 2,083.09 2
 SAMPLE 1R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 7 9 21 18.30% KTYITDPVSAPcAPPLQPK 95.00% 4.94 0.586 5.66 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.08 2,083.09 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% PTFNVQVK 95.00% 2.26 0.384 0 466.7631 931.5105 932.5206 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% PTFNVQVK 95.00% 2.72 0.377 0 466.7634 931.5111 932.5206 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% PTFNVQVK 95.00% 2.32 0.358 0 466.7635 931.5114 932.5206 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% PTFNVQVK 95.00% 2.79 0.397 0 466.7637 931.5117 932.5206 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% GQPFYAVEK 95.00% 1.7 0.398 1.2 519.7659 1,037.52 1,038.53 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% GQPFYAVEK 95.00% 2.11 0.476 0 519.7664 1,037.52 1,038.53 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% YYEGYYAAGPGYGGR 95.00% 2.5 0.274 1.72 548.9077 1,643.70 1,643.71 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% YYEGYYAAGPGYGGR 95.00% 2.64 0.309 2.41 548.9088 1,643.70 1,643.71 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% NDSDPTYGQQGHPNTWK 95.00% 2.12 0.224 0 648.9517 1,943.83 1,944.85 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% NDSDPTYGQQGHPNTWK 95.00% 1.78 0.293 0 648.9535 1,943.84 1,944.85 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% NDSDPTYGQQGHPNTWK 95.00% 1.93 0.283 1.12 649.2876 1,944.84 1,944.85 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% KTYITDPVSAPcAPPLQPK 95.00% 3.37 0.352 3.47 c12: Carbamidomethyl (+57.02) 695.3673 2,083.08 2,083.09 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% KTYITDPVSAPcAPPLQPK 95.00% 4.46 0.481 3.77 c12: Carbamidomethyl (+57.02) 695.3682 2,083.08 2,083.09 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% KTYITDPVSAPcAPPLQPK 95.00% 4.63 0.562 3 c12: Carbamidomethyl (+57.02) 695.3683 2,083.08 2,083.09 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% MVIPNQPPLTATK 95.00% 2.62 0.41 1.55 705.3928 1,408.77 1,409.78 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% MVIPNQPPLTATK 95.00% 2.48 0.306 0 705.3945 1,408.77 1,409.78 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% MVIPNQPPLTATK 95.00% 2.9 0.474 1.96 705.3946 1,408.77 1,409.78 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% MVIPNQPPLTATK 95.00% 3 0.563 3.82 705.8938 1,409.77 1,409.78 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% MVIPNQPPLTATK 95.00% 2.52 0.481 1.11 705.8955 1,409.78 1,409.78 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% mVIPNQPPLTATK 95.00% 2.89 0.424 5.35 m1: Oxidation (+15.99) 713.3919 1,424.77 1,425.78 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% mVIPNQPPLTATK 95.00% 3.22 0.42 5.46 m1: Oxidation (+15.99) 713.3919 1,424.77 1,425.78 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% cSVcKEPIMPAPGQEETVR 95.00% 4.87 0.475 3 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.3458 2,188.01 2,188.02 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% cSVcKEPIMPAPGQEETVR 95.00% 3.83 0.454 2.66 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.3458 2,188.01 2,188.02 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% cSVcKEPImPAPGQEETVR 95.00% 3.08 0.417 2.02 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), m9: Oxidation (+15.99) 735.6771 2,204.01 2,204.02 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% METTHSFGNPSISVSTQQPPK 95.00% 3.46 0.441 2 758.7012 2,273.08 2,273.09 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% METTHSFGNPSISVSTQQPPK 95.00% 3.71 0.413 1.57 758.7019 2,273.08 2,273.09 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% STLKPQPAPQAGPIPVAPIGTLK 95.00% 3.9 0.514 0 761.449 2,281.32 2,281.33 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% STLKPQPAPQAGPIPVAPIGTLK 95.00% 4.24 0.429 0 761.4492 2,281.32 2,281.33 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% EPIMPAPGQEETVR 95.00% 2.22 0.467 0 777.3837 1,552.75 1,553.76 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% EPIMPAPGQEETVR 95.00% 2.16 0.471 1.64 777.385 1,552.75 1,553.76 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% EPImPAPGQEETVR 95.00% 2.45 0.227 1.96 m4: Oxidation (+15.99) 785.3836 1,568.75 1,569.76 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% METTHSFGNPSISVSTQQPPKK 95.00% 6.15 0.614 2.54 801.3986 2,401.17 2,401.18 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% METTHSFGNPSISVSTQQPPKK 95.00% 6.73 0.62 3.01 801.3997 2,401.18 2,401.18 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% YYEGYYAAGPGYGGR 95.00% 3.93 0.584 3.57 822.3586 1,642.70 1,643.71 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% YYEGYYAAGPGYGGR 95.00% 5.08 0.641 6.46 822.3593 1,642.70 1,643.71 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% YYEGYYAAGPGYGGR 95.00% 4.97 0.643 6.6 822.3593 1,642.70 1,643.71 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% YYEGYYAAGPGYGGR 95.00% 4.9 0.669 7.08 822.8612 1,643.71 1,643.71 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% GGHSGQLGPSSVAPSFRPEDELEHLTK 95.00% 4.71 0.486 3.82 945.1342 2,832.38 2,832.39 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% GGHSGQLGPSSVAPSFRPEDELEHLTK 95.00% 5.38 0.517 1.92 945.1342 2,832.38 2,832.39 3
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% NDSDPTYGQQGHPNTWK 95.00% 4.4 0.496 3.92 972.9251 1,943.83 1,944.85 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% NDSDPTYGQQGHPNTWK 95.00% 3.82 0.456 4.24 973.4258 1,944.84 1,944.85 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% NDSDPTYGQQGHPNTWK 95.00% 3.91 0.42 0 973.4262 1,944.84 1,944.85 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% MLYDMENPPADEYFGR 95.00% 5.18 0.562 6.85 974.4148 1,946.81 1,947.83 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% KTYITDPVSAPcAPPLQPK 95.00% 4.79 0.578 6 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.08 2,083.09 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% KTYITDPVSAPcAPPLQPK 95.00% 5.03 0.598 6.07 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.08 2,083.09 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% EPGYTPPGAGNQNPPGMYPVTGPK 95.00% 4.17 0.62 5.48 1,213.57 2,425.13 2,426.15 2
 SAMPLE 2 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 17 47 34.60% EPGYTPPGAGNQNPPGMYPVTGPK 95.00% 3.95 0.611 4.77 1,214.07 2,426.13 2,426.15 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% PTFNVQVK 95.00% 2.14 0.304 0 466.7623 931.5089 932.5206 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% PTFNVQVK 95.00% 2.77 0.35 0 466.7635 931.5114 932.5206 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% PTFNVQVK 95.00% 2.68 0.429 0 466.7646 931.5135 932.5206 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% GQPFYAVEK 95.00% 1.48 0.316 1.42 519.7652 1,037.51 1,038.53 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% GQPFYAVEK 95.00% 2.09 0.45 1.47 519.7655 1,037.52 1,038.53 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% IVALDRDFHVHcYR 95.00% 3.09 0.469 0 c12: Carbamidomethyl (+57.02) 600.971 1,799.89 1,800.90 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% IVALDRDFHVHcYR 95.00% 3.35 0.47 2.19 c12: Carbamidomethyl (+57.02) 601.3052 1,800.89 1,800.90 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% NDSDPTYGQQGHPNTWK 95.00% 2.48 0.349 0 648.9526 1,943.83 1,944.85 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% NDSDPTYGQQGHPNTWK 95.00% 2.43 0.308 0 648.9537 1,943.84 1,944.85 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% KTYITDPVSAPcAPPLQPK 95.00% 4.14 0.525 4.29 c12: Carbamidomethyl (+57.02) 695.0325 2,082.07 2,083.09 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% KTYITDPVSAPcAPPLQPK 95.00% 3.75 0.441 3.49 c12: Carbamidomethyl (+57.02) 695.3676 2,083.08 2,083.09 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% KTYITDPVSAPcAPPLQPK 95.00% 2.95 0.414 1.89 c12: Carbamidomethyl (+57.02) 695.369 2,083.08 2,083.09 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% NDSDPTYGQQGHPNTWKR 95.00% 2.46 0.378 0 701.3226 2,100.94 2,100.95 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% MVIPNQPPLTATK 95.00% 2.59 0.403 1.96 705.3921 1,408.77 1,409.78 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% MVIPNQPPLTATK 95.00% 2.67 0.503 2.54 705.3935 1,408.77 1,409.78 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% MVIPNQPPLTATK 95.00% 2.64 0.44 1.62 705.8944 1,409.77 1,409.78 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% MVIPNQPPLTATK 95.00% 2.89 0.512 2.55 705.8971 1,409.78 1,409.78 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% mVIPNQPPLTATK 95.00% 2.9 0.375 3.96 m1: Oxidation (+15.99) 713.3917 1,424.77 1,425.78 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% mVIPNQPPLTATK 95.00% 2.77 0.396 5.54 m1: Oxidation (+15.99) 713.3919 1,424.77 1,425.78 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% cSVcKEPIMPAPGQEETVR 95.00% 3.14 0.276 1.37 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.3442 2,188.01 2,188.02 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% cSVcKEPIMPAPGQEETVR 95.00% 3.68 0.356 3.13 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.345 2,188.01 2,188.02 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% cSVcKEPIMPAPGQEETVR 95.00% 4.57 0.5 3.07 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.3458 2,188.01 2,188.02 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% cSVcKEPImPAPGQEETVR 95.00% 3.98 0.557 3.16 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), m9: Oxidation (+15.99) 735.6772 2,204.01 2,204.02 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% METTHSFGNPSISVSTQQPPK 95.00% 3.14 0.392 0 758.7006 2,273.08 2,273.09 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% METTHSFGNPSISVSTQQPPK 95.00% 2.81 0.235 0 758.7007 2,273.08 2,273.09 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% EPIMPAPGQEETVR 95.00% 2.34 0.49 1.66 777.8852 1,553.75 1,553.76 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% EPIMPAPGQEETVR 95.00% 2.39 0.471 1.2 777.8855 1,553.76 1,553.76 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% METTHSFGNPSISVSTQQPPKK 95.00% 6.47 0.588 3.36 801.3989 2,401.17 2,401.18 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% METTHSFGNPSISVSTQQPPKK 95.00% 6.2 0.614 2.96 801.4001 2,401.18 2,401.18 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% mETTHSFGNPSISVSTQQPPKK 95.00% 5.38 0.441 4.85 m1: Oxidation (+15.99) 806.7305 2,417.17 2,417.18 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% YYEGYYAAGPGYGGR 95.00% 4.75 0.658 6.26 822.3587 1,642.70 1,643.71 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% YYEGYYAAGPGYGGR 95.00% 4.76 0.608 5.82 822.3598 1,642.70 1,643.71 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% REPGYTPPGAGNQNPPGMYPVTGPK 95.00% 4.97 0.497 4.55 861.752 2,582.23 2,582.25 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% REPGYTPPGAGNQNPPGMYPVTGPK 95.00% 4.37 0.471 3.96 861.755 2,582.24 2,582.25 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% NDSDPTYGQQGHPNTWK 95.00% 4.86 0.556 3.17 972.925 1,943.83 1,944.85 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% NDSDPTYGQQGHPNTWK 95.00% 4.55 0.503 3.1 973.4279 1,944.84 1,944.85 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% MLYDMENPPADEYFGR 95.00% 5.31 0.539 5.68 974.9156 1,947.82 1,947.83 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% MLYDMENPPADEYFGR 95.00% 5.34 0.514 4.82 974.9165 1,947.82 1,947.83 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% cEDcGGLLSEGDNQGcYPLDGHILcK 95.00% 5.65 0.605 2.96c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c16: Carbamidomethyl (+57.02), c25: Carbamidomethyl (+57.02)990.0824 2,967.22 2,967.24 3
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% KTYITDPVSAPcAPPLQPK 95.00% 4.84 0.641 8.21 c12: Carbamidomethyl (+57.02) 1,042.05 2,082.08 2,083.09 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% KTYITDPVSAPcAPPLQPK 95.00% 4.45 0.6 5.29 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.08 2,083.09 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% KTYITDPVSAPcAPPLQPK 95.00% 4.84 0.596 5.24 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.08 2,083.09 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% cSVcKEPIMPAPGQEETVR 95.00% 4.8 0.558 4.08 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 1,095.02 2,188.02 2,188.02 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% METTHSFGNPSISVSTQQPPK 95.00% 5.39 0.647 8.01 1,137.54 2,273.07 2,273.09 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% METTHSFGNPSISVSTQQPPK 95.00% 5.42 0.635 6.82 1,137.55 2,273.08 2,273.09 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% EPGYTPPGAGNQNPPGMYPVTGPK 95.00% 3.92 0.591 5.12 1,214.08 2,426.14 2,426.15 2
 SAMPLE 2R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 16 20 47 33.20% EPGYTPPGAGNQNPPGMYPVTGPK 95.00% 4.02 0.641 5.77 1,214.08 2,426.14 2,426.15 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% PTFNVQVK 95.00% 2.59 0.407 0 466.7634 931.5111 932.5206 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% PTFNVQVK 95.00% 2.68 0.417 0 466.7641 931.5126 932.5206 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% GQPFYAVEK 95.00% 1.66 0.378 1.54 519.7646 1,037.51 1,038.53 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% IVALDRDFHVHcYR 95.00% 3.74 0.495 2.31 c12: Carbamidomethyl (+57.02) 600.97 1,799.89 1,800.90 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% IVALDRDFHVHcYR 95.00% 3.77 0.355 1.82 c12: Carbamidomethyl (+57.02) 601.3021 1,800.88 1,800.90 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% IVALDRDFHVHcYR 95.00% 2.17 0.263 0 c12: Carbamidomethyl (+57.02) 601.3055 1,800.89 1,800.90 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% NDSDPTYGQQGHPNTWK 95.00% 2.06 0.254 1.57 648.9531 1,943.84 1,944.85 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% NDSDPTYGQQGHPNTWK 95.00% 2.15 0.254 0 649.287 1,944.84 1,944.85 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% NDSDPTYGQQGHPNTWK 95.00% 1.87 0.285 0 649.2875 1,944.84 1,944.85 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% NDSDPTYGQQGHPNTWK 95.00% 1.85 0.298 0 649.2876 1,944.84 1,944.85 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% NDSDPTYGQQGHPNTWK 95.00% 2.4 0.382 0.959 649.2879 1,944.84 1,944.85 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% KTYITDPVSAPcAPPLQPK 95.00% 3.89 0.508 4.6 c12: Carbamidomethyl (+57.02) 695.3672 2,083.08 2,083.09 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% KTYITDPVSAPcAPPLQPK 95.00% 3.36 0.257 1.6 c12: Carbamidomethyl (+57.02) 695.3675 2,083.08 2,083.09 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% KTYITDPVSAPcAPPLQPK 95.00% 4.36 0.473 4.26 c12: Carbamidomethyl (+57.02) 695.3678 2,083.08 2,083.09 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% KTYITDPVSAPcAPPLQPK 95.00% 4.64 0.501 4.77 c12: Carbamidomethyl (+57.02) 695.3685 2,083.08 2,083.09 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% NDSDPTYGQQGHPNTWKR 95.00% 2.44 0.313 0 700.99 2,099.95 2,100.95 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% NDSDPTYGQQGHPNTWKR 95.00% 2.42 0.34 0 701.3208 2,100.94 2,100.95 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% MVIPNQPPLTATK 95.00% 2.12 0.297 0 705.3909 1,408.77 1,409.78 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% MVIPNQPPLTATK 95.00% 2.72 0.467 2.64 705.3932 1,408.77 1,409.78 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% MVIPNQPPLTATK 95.00% 2.45 0.468 0 705.3933 1,408.77 1,409.78 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% MVIPNQPPLTATK 95.00% 2.82 0.521 1.92 705.3936 1,408.77 1,409.78 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% MVIPNQPPLTATK 95.00% 2.34 0.344 1.17 705.394 1,408.77 1,409.78 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% MVIPNQPPLTATK 95.00% 2.94 0.547 2.7 705.3943 1,408.77 1,409.78 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% MVIPNQPPLTATK 95.00% 2.96 0.535 2.7 705.3946 1,408.77 1,409.78 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% MVIPNQPPLTATK 95.00% 3.14 0.484 1.96 705.8963 1,409.78 1,409.78 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% mVIPNQPPLTATK 95.00% 3.07 0.417 4.35 m1: Oxidation (+15.99) 713.3929 1,424.77 1,425.78 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% mVIPNQPPLTATK 95.00% 2.81 0.381 4.24 m1: Oxidation (+15.99) 713.3933 1,424.77 1,425.78 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% cSVcKEPIMPAPGQEETVR 95.00% 4.15 0.452 3.09 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.345 2,188.01 2,188.02 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% cSVcKEPIMPAPGQEETVR 95.00% 4.03 0.375 1.82 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.3461 2,188.01 2,188.02 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% cSVcKEPIMPAPGQEETVR 95.00% 3.73 0.457 2.25 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.3471 2,188.02 2,188.02 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% cSVcKEPImPAPGQEETVR 95.00% 3.74 0.56 2.09 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), m9: Oxidation (+15.99) 735.6761 2,204.01 2,204.02 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% STLKPQPAPQAGPIPVAPIGTLK 95.00% 3.57 0.496 0 761.45 2,281.33 2,281.33 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% EPIMPAPGQEETVR 95.00% 2.1 0.437 2.52 777.3843 1,552.75 1,553.76 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% EPIMPAPGQEETVR 95.00% 2.05 0.323 1.42 777.3844 1,552.75 1,553.76 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% EPIMPAPGQEETVR 95.00% 2.05 0.433 1.38 777.3847 1,552.75 1,553.76 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% METTHSFGNPSISVSTQQPPKK 95.00% 7 0.618 3.02 801.3998 2,401.18 2,401.18 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% METTHSFGNPSISVSTQQPPKK 95.00% 6.46 0.618 3.92 801.4015 2,401.18 2,401.18 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% YYEGYYAAGPGYGGR 95.00% 5.19 0.676 7 822.3583 1,642.70 1,643.71 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% YYEGYYAAGPGYGGR 95.00% 4.67 0.676 5.06 822.3587 1,642.70 1,643.71 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% YYEGYYAAGPGYGGR 95.00% 5.3 0.64 6.11 822.3593 1,642.70 1,643.71 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% REPGYTPPGAGNQNPPGMYPVTGPK 95.00% 4.57 0.453 4.68 861.7558 2,582.24 2,582.25 3
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% NDSDPTYGQQGHPNTWK 95.00% 4.47 0.537 3.92 972.9256 1,943.84 1,944.85 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% NDSDPTYGQQGHPNTWK 95.00% 4.74 0.451 2.15 973.4259 1,944.84 1,944.85 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% NDSDPTYGQQGHPNTWK 95.00% 4.74 0.505 4.24 973.4273 1,944.84 1,944.85 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% NDSDPTYGQQGHPNTWK 95.00% 4.31 0.465 2.27 973.4275 1,944.84 1,944.85 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% KTYITDPVSAPcAPPLQPK 95.00% 4.59 0.632 8 c12: Carbamidomethyl (+57.02) 1,042.04 2,082.07 2,083.09 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% KTYITDPVSAPcAPPLQPK 95.00% 5.04 0.572 5.12 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.08 2,083.09 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% KTYITDPVSAPcAPPLQPK 95.00% 4.88 0.601 5.13 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.08 2,083.09 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% KTYITDPVSAPcAPPLQPK 95.00% 4.93 0.588 6.6 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.08 2,083.09 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% EPGYTPPGAGNQNPPGMYPVTGPK 95.00% 4.31 0.667 5.96 1,214.07 2,426.13 2,426.15 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% EPGYTPPGAGNQNPPGMYPVTGPK 95.00% 3.95 0.631 5.17 1,214.08 2,426.13 2,426.15 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% EPGYTPPGAGNQNPPGMYPVTGPK 95.00% 4.06 0.598 4.44 1,214.08 2,426.14 2,426.15 2
 SAMPLE 3 Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 16 53 30.10% EPGYTPPGAGNQNPPGMYPVTGPK 95.00% 4.26 0.632 6.85 1,214.08 2,426.14 2,426.15 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% PTFNVQVK 95.00% 2.46 0.363 0 466.7635 931.5113 932.5206 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% PTFNVQVK 95.00% 2.9 0.377 0 466.7651 931.5145 932.5206 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% MVIPNQPPLTATK 95.00% 2.2 0.248 0 470.5998 1,408.78 1,409.78 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% IVALDRDFHVHcYR 95.00% 3.07 0.288 1.39 c12: Carbamidomethyl (+57.02) 600.9699 1,799.89 1,800.90 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% IVALDRDFHVHcYR 95.00% 2.95 0.225 2.47 c12: Carbamidomethyl (+57.02) 601.3029 1,800.89 1,800.90 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% STGEPLGHVPAR 95.00% 2.3 0.317 3.27 610.9774 1,219.94 1,220.64 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% NDSDPTYGQQGHPNTWK 95.00% 2.38 0.296 0 648.9523 1,943.83 1,944.85 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% NDSDPTYGQQGHPNTWK 95.00% 2.17 0.353 0.959 649.2872 1,944.84 1,944.85 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% NDSDPTYGQQGHPNTWK 95.00% 1.74 0.348 0 649.2875 1,944.84 1,944.85 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% NDSDPTYGQQGHPNTWK 95.00% 2.19 0.292 0 649.2877 1,944.84 1,944.85 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% KTYITDPVSAPcAPPLQPK 95.00% 3.91 0.439 4.2 c12: Carbamidomethyl (+57.02) 695.3679 2,083.08 2,083.09 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% KTYITDPVSAPcAPPLQPK 95.00% 4.22 0.488 4.3 c12: Carbamidomethyl (+57.02) 695.3688 2,083.08 2,083.09 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% MVIPNQPPLTATK 95.00% 2.55 0.437 0 705.3932 1,408.77 1,409.78 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% MVIPNQPPLTATK 95.00% 2.7 0.371 1.48 705.3942 1,408.77 1,409.78 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% MVIPNQPPLTATK 95.00% 2.52 0.516 0 705.3982 1,408.78 1,409.78 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% MVIPNQPPLTATK 95.00% 3.68 0.539 4.16 705.8959 1,409.78 1,409.78 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% MVIPNQPPLTATK 95.00% 3.03 0.517 3.32 705.8965 1,409.78 1,409.78 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% mVIPNQPPLTATK 95.00% 2.98 0.394 4.7 m1: Oxidation (+15.99) 713.3925 1,424.77 1,425.78 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% mVIPNQPPLTATK 95.00% 3.34 0.481 3.52 m1: Oxidation (+15.99) 713.3928 1,424.77 1,425.78 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% cSVcKEPIMPAPGQEETVR 95.00% 3.96 0.413 2.64 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.3432 2,188.01 2,188.02 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% cSVcKEPIMPAPGQEETVR 95.00% 3.69 0.474 1.96 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.3439 2,188.01 2,188.02 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% cSVcKEPIMPAPGQEETVR 95.00% 4.25 0.46 3.62 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.3443 2,188.01 2,188.02 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% cSVcKEPIMPAPGQEETVR 95.00% 3.66 0.47 2.72 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 730.3476 2,188.02 2,188.02 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% EPIMPAPGQEETVR 95.00% 1.92 0.378 1.21 777.3817 1,552.75 1,553.76 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% EPIMPAPGQEETVR 95.00% 2.13 0.311 1.29 777.3838 1,552.75 1,553.76 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% EPIMPAPGQEETVR 95.00% 2.53 0.418 0 777.3857 1,552.76 1,553.76 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% EPIMPAPGQEETVR 95.00% 2.37 0.373 0 777.3865 1,552.76 1,553.76 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% METTHSFGNPSISVSTQQPPKK 95.00% 6.61 0.646 2.39 801.3998 2,401.18 2,401.18 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% METTHSFGNPSISVSTQQPPKK 95.00% 6.07 0.584 2.59 801.401 2,401.18 2,401.18 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% YYEGYYAAGPGYGGR 95.00% 4.16 0.667 5.82 822.3594 1,642.70 1,643.71 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% YYEGYYAAGPGYGGR 95.00% 3.6 0.509 1.74 822.3615 1,642.71 1,643.71 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% YYEGYYAAGPGYGGR 95.00% 4.97 0.637 5.34 822.8607 1,643.71 1,643.71 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% YYEGYYAAGPGYGGR 95.00% 4.87 0.622 4.92 822.8611 1,643.71 1,643.71 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% GGHSGQLGPSSVAPSFRPEDELEHLTK 95.00% 4.23 0.425 1.74 945.1349 2,832.38 2,832.39 3
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% NDSDPTYGQQGHPNTWK 95.00% 3.97 0.448 2.01 972.925 1,943.83 1,944.85 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% NDSDPTYGQQGHPNTWK 95.00% 4.74 0.503 2.77 972.9279 1,943.84 1,944.85 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% NDSDPTYGQQGHPNTWK 95.00% 3.44 0.281 0 972.9288 1,943.84 1,944.85 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% NDSDPTYGQQGHPNTWK 95.00% 4.65 0.466 2.74 973.4284 1,944.84 1,944.85 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% MLYDMENPPADEYFGR 95.00% 5.18 0.569 7.1 974.4143 1,946.81 1,947.83 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% MLYDMENPPADEYFGR 95.00% 4.89 0.597 6.41 974.4154 1,946.82 1,947.83 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% MLYDMENPPADEYFGR 95.00% 5.24 0.541 4.77 974.9165 1,947.82 1,947.83 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% MLYDMENPPADEYFGR 95.00% 5.46 0.535 5.96 974.9174 1,947.82 1,947.83 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% TYITDPVSAPcAPPLQPK 95.00% 4.41 0.548 6.92 c11: Carbamidomethyl (+57.02) 977.998 1,953.98 1,955.00 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% TYITDPVSAPcAPPLQPK 95.00% 4.47 0.638 5.34 c11: Carbamidomethyl (+57.02) 977.9995 1,953.98 1,955.00 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% TYITDPVSAPcAPPLQPK 95.00% 5.08 0.615 4.55 c11: Carbamidomethyl (+57.02) 978.5005 1,954.99 1,955.00 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% TYITDPVSAPcAPPLQPK 95.00% 4.33 0.519 3.64 c11: Carbamidomethyl (+57.02) 978.5017 1,954.99 1,955.00 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% KTYITDPVSAPcAPPLQPK 95.00% 4.63 0.567 5.16 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.08 2,083.09 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% KTYITDPVSAPcAPPLQPK 95.00% 4.84 0.575 5.33 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.08 2,083.09 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% KTYITDPVSAPcAPPLQPK 95.00% 4.43 0.598 4.19 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.09 2,083.09 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% KTYITDPVSAPcAPPLQPK 95.00% 4.66 0.54 5.62 c12: Carbamidomethyl (+57.02) 1,042.55 2,083.09 2,083.09 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% cSVcKEPIMPAPGQEETVR 95.00% 4.85 0.533 4.46 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 1,095.01 2,188.01 2,188.02 2
 SAMPLE 3R Lipoma-preferred partner  LPP  LPP_HUMAN 65,728.20 100.00% 14 18 52 33.70% EPGYTPPGAGNQNPPGMYPVTGPK 95.00% 4 0.603 5.28 1,214.08 2,426.14 2,426.15 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% FNALQYLR 95.00% 3.05 0.311 0 512.7828 1,023.55 1,024.56 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% FNALQYLR 95.00% 2.91 0.32 0 512.7831 1,023.55 1,024.56 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% FNALQYLR 95.00% 3.14 0.311 0 512.7835 1,023.55 1,024.56 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% FNALQYLR 95.00% 2.21 0.239 0 512.7837 1,023.55 1,024.56 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% FNALQYLR 95.00% 2.81 0.33 0 512.7841 1,023.55 1,024.56 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% SLEYLDLSFNQIAR 95.00% 3.19 0.328 2.62 557.3301 1,668.97 1,668.86 3 DOCK9_HUMAN
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% LKEDAVSAAFK 95.00% 3.09 0.312 2.07 589.8266 1,177.64 1,178.64 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% ISNIPDEYFK 95.00% 3.13 0.37 2 613.3108 1,224.61 1,225.61 2 RS5_HUMAN
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% SLEDLQLTHNK 95.00% 3.58 0.47 2.07 649.3411 1,296.67 1,297.68 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% SLEDLQLTHNK 95.00% 3.54 0.468 2.32 649.3416 1,296.67 1,297.68 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% SLEDLQLTHNK 95.00% 3.68 0.473 1.72 649.3429 1,296.67 1,297.68 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% SLEDLQLTHNK 95.00% 3.68 0.476 2.33 649.3429 1,296.67 1,297.68 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% SLEDLQLTHNK 95.00% 3.65 0.505 2.24 649.3433 1,296.67 1,297.68 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% SLEYLDLSFNQIAR 95.00% 4.5 0.485 4.03 834.9362 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% SLEYLDLSFNQIAR 95.00% 3.67 0.436 3.89 834.9371 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% SLEYLDLSFNQIAR 95.00% 4.75 0.469 2.66 834.9373 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% SLEYLDLSFNQIAR 95.00% 4.07 0.49 3.15 834.9377 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% SLEYLDLSFNQIAR 95.00% 4.31 0.494 3.3 834.9382 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% SLEYLDLSFNQIAR 95.00% 4.59 0.465 3.6 835.4387 1,668.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% ISETSLPPDMYEcLR 95.00% 3.08 0.481 3.55 c13: Carbamidomethyl (+57.02) 905.9232 1,809.83 1,810.84 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% ISETSLPPDMYEcLR 95.00% 2.92 0.498 2.89 c13: Carbamidomethyl (+57.02) 905.924 1,809.83 1,810.84 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% ISETSLPPDMYEcLR 95.00% 3.69 0.529 3.77 c13: Carbamidomethyl (+57.02) 906.4238 1,810.83 1,810.84 2
 SAMPLE 4 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 6 22 20.40% ISETSLPPDMYEcLR 95.00% 3.73 0.527 2.92 c13: Carbamidomethyl (+57.02) 906.4239 1,810.83 1,810.84 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% FNALQYLR 95.00% 2.87 0.286 0 512.7826 1,023.55 1,024.56 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% FNALQYLR 95.00% 2.66 0.281 1.46 512.7827 1,023.55 1,024.56 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% FNALQYLR 95.00% 2.45 0.268 1.3 512.7833 1,023.55 1,024.56 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% FNALQYLR 95.00% 3.1 0.312 0 512.7834 1,023.55 1,024.56 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% FNALQYLR 95.00% 2.71 0.32 1.54 512.7838 1,023.55 1,024.56 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% FNALQYLR 95.00% 3.05 0.301 0 512.7839 1,023.55 1,024.56 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% ISNIPDEYFK 95.00% 3.26 0.389 2.14 613.3109 1,224.61 1,225.61 2 RS5_HUMAN
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEDLQLTHNK 95.00% 3.7 0.481 2.28 649.3425 1,296.67 1,297.68 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEDLQLTHNK 95.00% 3.7 0.453 2.16 649.3429 1,296.67 1,297.68 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEDLQLTHNK 95.00% 3.65 0.448 2.41 649.3432 1,296.67 1,297.68 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEDLQLTHNK 95.00% 4.03 0.461 3.19 649.3432 1,296.67 1,297.68 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEDLQLTHNK 95.00% 3.57 0.474 2.05 649.3432 1,296.67 1,297.68 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEDLQLTHNK 95.00% 3.51 0.447 3.64 649.3438 1,296.67 1,297.68 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEDLQLTHNK 95.00% 3.44 0.362 2.03 649.8081 1,297.60 1,297.68 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEYLDLSFNQIAR 95.00% 4.25 0.481 4.21 834.9355 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEYLDLSFNQIAR 95.00% 4.28 0.473 3.57 834.9368 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEYLDLSFNQIAR 95.00% 4.23 0.461 2.82 834.9371 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEYLDLSFNQIAR 95.00% 4.46 0.472 2.68 834.9384 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEYLDLSFNQIAR 95.00% 4.3 0.467 2.8 834.9391 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% SLEYLDLSFNQIAR 95.00% 4.56 0.474 5.64 835.4381 1,668.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% ISETSLPPDMYEcLR 95.00% 3.17 0.505 3.43 c13: Carbamidomethyl (+57.02) 905.923 1,809.83 1,810.84 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% ISETSLPPDMYEcLR 95.00% 2.34 0.441 2.6 c13: Carbamidomethyl (+57.02) 905.9238 1,809.83 1,810.84 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% ISETSLPPDMYEcLR 95.00% 3.69 0.504 3.59 c13: Carbamidomethyl (+57.02) 906.4222 1,810.83 1,810.84 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% ISETSLPPDMYEcLR 95.00% 3.19 0.476 3.12 c13: Carbamidomethyl (+57.02) 906.4224 1,810.83 1,810.84 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% LPSGLPVSLLTLYLDNNK 95.00% 5.14 0.586 6.22 979.5611 1,957.11 1,957.10 2
 SAMPLE 4R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 5 5 25 22.50% LPSGLPVSLLTLYLDNNK 95.00% 5.26 0.557 7.16 979.5632 1,957.11 1,957.10 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISNIPDEYFKR 95.00% 3 0.344 0 461.2426 1,380.70 1,381.71 3
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISNIPDEYFKR 95.00% 2.51 0.185 0 461.2436 1,380.71 1,381.71 3
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISNIPDEYFKR 95.00% 2.71 0.311 0 461.2437 1,380.71 1,381.71 3
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% FNALQYLR 95.00% 2.34 0.221 0 512.7808 1,023.55 1,024.56 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% FNALQYLR 95.00% 2.36 0.284 1.31 512.7818 1,023.55 1,024.56 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% FNALQYLR 95.00% 2.61 0.294 1.37 512.7824 1,023.55 1,024.56 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% FNALQYLR 95.00% 2.3 0.247 0 513.2837 1,024.55 1,024.56 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEYLDLSFNQIAR 95.00% 5.91 0.536 4.21 556.957 1,667.85 1,668.86 3 DOCK9_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEYLDLSFNQIAR 95.00% 6.07 0.533 2.74 557.2917 1,668.85 1,668.86 3 DOCK9_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% LKEDAVSAAFK 95.00% 3.73 0.42 2.74 589.8237 1,177.63 1,178.64 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% LKEDAVSAAFK 95.00% 3.41 0.444 3.68 589.8246 1,177.63 1,178.64 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISETSLPPDMYEcLR 95.00% 2.74 0.327 0 c13: Carbamidomethyl (+57.02) 604.2819 1,809.82 1,810.84 3
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% NNQIDHIDEK 95.00% 2.38 0.258 0 613.296 1,224.58 1,225.58 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISNIPDEYFK 95.00% 2.3 0.213 0 613.3035 1,224.59 1,225.61 2 RS5_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISNIPDEYFK 95.00% 2.77 0.316 1.66 613.3065 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISNIPDEYFK 95.00% 2.73 0.319 0 613.3073 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISNIPDEYFK 95.00% 2.98 0.353 1.6 613.3079 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISNIPDEYFK 95.00% 2.85 0.261 0 613.308 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISNIPDEYFK 95.00% 3.02 0.376 2.89 613.3082 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISNIPDEYFK 95.00% 2.69 0.324 0 613.3084 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEDLQLTHNK 95.00% 3.67 0.469 2.44 649.3389 1,296.66 1,297.68 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEDLQLTHNK 95.00% 3.63 0.459 2.66 649.3397 1,296.66 1,297.68 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEDLQLTHNK 95.00% 3.64 0.433 2.05 649.3401 1,296.66 1,297.68 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEDLQLTHNK 95.00% 3.81 0.471 1.42 649.3404 1,296.67 1,297.68 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEDLQLTHNK 95.00% 3.91 0.466 1.92 649.3404 1,296.67 1,297.68 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEDLQLTHNK 95.00% 3.57 0.482 1.89 649.3407 1,296.67 1,297.68 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISNIPDEYFKR 95.00% 2.73 0.392 1.72 691.3582 1,380.70 1,381.71 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISNIPDEYFKR 95.00% 2.98 0.376 1.16 691.3588 1,380.70 1,381.71 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEDLQLTHNKITK 95.00% 4.39 0.516 4.49 820.4522 1,638.89 1,639.90 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEDLQLTHNKITK 95.00% 4.23 0.498 2.85 820.4528 1,638.89 1,639.90 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEDLQLTHNKITK 95.00% 4.26 0.526 3.62 820.4536 1,638.89 1,639.90 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEDLQLTHNKITK 95.00% 3.6 0.5 2.21 820.4547 1,638.89 1,639.90 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEYLDLSFNQIAR 95.00% 4.68 0.487 3.42 834.931 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEYLDLSFNQIAR 95.00% 3.87 0.41 4.37 834.9313 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEYLDLSFNQIAR 95.00% 4.93 0.499 4.23 834.9315 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEYLDLSFNQIAR 95.00% 4.75 0.491 3.57 834.9316 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEYLDLSFNQIAR 95.00% 4.54 0.488 3.1 834.9322 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEYLDLSFNQIAR 95.00% 4.29 0.447 3.4 834.9338 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEYLDLSFNQIAR 95.00% 2.96 0.482 0 834.9372 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEYLDLSFNQIAR 95.00% 4.83 0.447 4.47 835.4351 1,668.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% SLEYLDLSFNQIAR 95.00% 4.21 0.465 1.8 835.4369 1,668.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISETSLPPDMYEcLR 95.00% 2.57 0.485 1.17 c13: Carbamidomethyl (+57.02) 905.9174 1,809.82 1,810.84 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISETSLPPDMYEcLR 95.00% 3.11 0.507 3.46 c13: Carbamidomethyl (+57.02) 905.9188 1,809.82 1,810.84 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISETSLPPDMYEcLR 95.00% 3.34 0.511 2.31 c13: Carbamidomethyl (+57.02) 905.9192 1,809.82 1,810.84 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISETSLPPDMYEcLR 95.00% 2.59 0.422 3 c13: Carbamidomethyl (+57.02) 905.9194 1,809.82 1,810.84 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISETSLPPDMYEcLR 95.00% 2.78 0.454 1.12 c13: Carbamidomethyl (+57.02) 906.417 1,810.82 1,810.84 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISETSLPPDMYEcLR 95.00% 3.24 0.463 2.28 c13: Carbamidomethyl (+57.02) 906.4184 1,810.82 1,810.84 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% ISETSLPPDMYEcLR 95.00% 3.32 0.471 3.27 c13: Carbamidomethyl (+57.02) 906.4201 1,810.82 1,810.84 2
 SAMPLE 1 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 42 30.80% NIPTVNENLENYYLEVNQLEK 95.00% 6.18 0.525 4.39 1,269.13 2,536.25 2,536.26 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISNIPDEYFKR 95.00% 2.79 0.248 0 461.2417 1,380.70 1,381.71 3
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISNIPDEYFKR 95.00% 2.84 0.283 0 461.2421 1,380.70 1,381.71 3
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISNIPDEYFKR 95.00% 3.25 0.402 0 461.2423 1,380.70 1,381.71 3
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% FNALQYLR 95.00% 3.01 0.324 0 512.7793 1,023.54 1,024.56 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% FNALQYLR 95.00% 2.89 0.311 0 512.7803 1,023.55 1,024.56 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% FNALQYLR 95.00% 3.2 0.329 0 512.7809 1,023.55 1,024.56 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% FNALQYLR 95.00% 2.93 0.301 0 512.7813 1,023.55 1,024.56 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% FNALQYLR 95.00% 2.32 0.286 1.15 512.7821 1,023.55 1,024.56 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% FNALQYLR 95.00% 2.43 0.225 2.21 512.7828 1,023.55 1,024.56 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 5.74 0.552 2.96 556.9571 1,667.85 1,668.86 3 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 3.64 0.537 3.17 556.9577 1,667.85 1,668.86 3 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 5.02 0.537 2.36 557.2916 1,668.85 1,668.86 3 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 5.6 0.503 3.39 557.2917 1,668.85 1,668.86 3 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% LKEDAVSAAFK 95.00% 3.49 0.401 2.48 589.823 1,177.63 1,178.64 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% LKEDAVSAAFK 95.00% 3.3 0.387 3.37 589.8235 1,177.63 1,178.64 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% NNQIDHIDEK 95.00% 2.5 0.358 0 613.2909 1,224.57 1,225.58 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% NNQIDHIDEK 95.00% 2.48 0.209 0 613.2917 1,224.57 1,225.58 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISNIPDEYFK 95.00% 2.78 0.309 1.21 613.3075 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISNIPDEYFK 95.00% 2.89 0.263 1.89 613.3079 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISNIPDEYFK 95.00% 3 0.354 1.89 613.308 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISNIPDEYFK 95.00% 3.19 0.42 1.74 613.308 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISNIPDEYFK 95.00% 3.03 0.359 1.19 613.3082 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISNIPDEYFK 95.00% 3.2 0.409 1.8 613.3083 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISNIPDEYFK 95.00% 2.56 0.214 1.7 613.8089 1,225.60 1,225.61 2 RS5_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEDLQLTHNK 95.00% 3.46 0.46 2.01 649.3383 1,296.66 1,297.68 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEDLQLTHNK 95.00% 3.65 0.458 2.48 649.3399 1,296.66 1,297.68 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEDLQLTHNK 95.00% 3.33 0.435 3.47 649.3401 1,296.66 1,297.68 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEDLQLTHNK 95.00% 3.83 0.467 2.77 649.3401 1,296.66 1,297.68 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEDLQLTHNK 95.00% 2.9 0.448 1.77 649.3405 1,296.67 1,297.68 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEDLQLTHNK 95.00% 3.37 0.406 2.57 649.8414 1,297.67 1,297.68 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% LPSGLPVSLLTLYLDNNK 95.00% 4.76 0.407 3.48 653.373 1,957.10 1,957.10 3
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% LPSGLPVSLLTLYLDNNK 95.00% 5.13 0.409 4.06 653.3734 1,957.10 1,957.10 3
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISNIPDEYFKR 95.00% 2.66 0.243 2.21 691.3606 1,380.71 1,381.71 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEDLQLTHNKITK 95.00% 4.19 0.478 4 820.4537 1,638.89 1,639.90 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEDLQLTHNKITK 95.00% 4.09 0.405 4.37 820.9557 1,639.90 1,639.90 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 4.59 0.499 3.44 834.9314 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 4.76 0.483 2.09 834.9321 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 4.14 0.486 2.96 834.9326 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 4.19 0.51 2.82 834.933 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 2.96 0.482 0 834.9372 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 4.6 0.474 3.59 835.433 1,668.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 4.46 0.456 2.8 835.4335 1,668.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 4.29 0.472 2.77 835.4351 1,668.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% SLEYLDLSFNQIAR 95.00% 4.21 0.465 1.89 835.4369 1,668.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISETSLPPDMYEcLR 95.00% 3.62 0.52 4.14 c13: Carbamidomethyl (+57.02) 905.9193 1,809.82 1,810.84 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISETSLPPDMYEcLR 95.00% 3.21 0.556 4.27 c13: Carbamidomethyl (+57.02) 905.9194 1,809.82 1,810.84 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISETSLPPDMYEcLR 95.00% 3.44 0.517 4.23 c13: Carbamidomethyl (+57.02) 905.9206 1,809.83 1,810.84 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISETSLPPDMYEcLR 95.00% 3.02 0.333 1.22 c13: Carbamidomethyl (+57.02) 905.922 1,809.83 1,810.84 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISETSLPPDMYEcLR 95.00% 3.4 0.53 3.74 c13: Carbamidomethyl (+57.02) 906.4182 1,810.82 1,810.84 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISETSLPPDMYEcLR 95.00% 3.46 0.521 4.82 c13: Carbamidomethyl (+57.02) 906.4221 1,810.83 1,810.84 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% ISETSLPPDMYEcLR 95.00% 3.42 0.514 4.26 c13: Carbamidomethyl (+57.02) 906.4221 1,810.83 1,810.84 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% LPSGLPVSLLTLYLDNNK 95.00% 5.57 0.622 8.12 979.0539 1,956.09 1,957.10 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% LPSGLPVSLLTLYLDNNK 95.00% 4.35 0.582 6.27 979.0563 1,956.10 1,957.10 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% LPSGLPVSLLTLYLDNNK 95.00% 5.75 0.605 6.38 979.5525 1,957.09 1,957.10 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% LPSGLPVSLLTLYLDNNK 95.00% 5.87 0.623 7.82 979.5531 1,957.09 1,957.10 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% LPSGLPVSLLTLYLDNNK 95.00% 5.25 0.541 5.21 979.5533 1,957.09 1,957.10 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% LPSGLPVSLLTLYLDNNK 95.00% 5.95 0.616 7.12 979.5539 1,957.09 1,957.10 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% NIPTVNENLENYYLEVNQLEK 95.00% 6.06 0.505 6.12 1,269.13 2,536.25 2,536.26 2
 SAMPLE 1R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 52 36.10% NIPTVNENLENYYLEVNQLEK 95.00% 5.9 0.489 5.38 1,269.13 2,536.25 2,536.26 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFKR 95.00% 3.09 0.283 0 461.2418 1,380.70 1,381.71 3
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFKR 95.00% 3.42 0.307 0 461.2421 1,380.70 1,381.71 3
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFKR 95.00% 2.9 0.248 0 461.2438 1,380.71 1,381.71 3
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFKR 95.00% 2.54 0.199 0 461.244 1,380.71 1,381.71 3
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% FNALQYLR 95.00% 2.04 0.187 1.37 512.7802 1,023.54 1,024.56 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% FNALQYLR 95.00% 3.18 0.329 0 512.7805 1,023.55 1,024.56 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% FNALQYLR 95.00% 3.24 0.324 0 512.7809 1,023.55 1,024.56 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% FNALQYLR 95.00% 3.21 0.322 0 512.7812 1,023.55 1,024.56 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% FNALQYLR 95.00% 2.99 0.302 0 512.7817 1,023.55 1,024.56 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% FNALQYLR 95.00% 2.97 0.264 0 512.782 1,023.55 1,024.56 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% FNALQYLR 95.00% 3.2 0.318 0 512.7821 1,023.55 1,024.56 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% FNALQYLR 95.00% 3.17 0.315 0 512.7824 1,023.55 1,024.56 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEYLDLSFNQIAR 95.00% 6.21 0.564 3.68 556.9568 1,667.85 1,668.86 3 DOCK9_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEYLDLSFNQIAR 95.00% 5.65 0.531 4.07 556.9579 1,667.85 1,668.86 3 DOCK9_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEYLDLSFNQIAR 95.00% 6.19 0.534 3.72 556.9579 1,667.85 1,668.86 3 DOCK9_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEYLDLSFNQIAR 95.00% 6.33 0.523 3.3 556.9584 1,667.85 1,668.86 3 DOCK9_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% LKEDAVSAAFK 95.00% 2.42 0.274 1.92 589.8214 1,177.63 1,178.64 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% LKEDAVSAAFK 95.00% 3.35 0.347 2.37 589.8238 1,177.63 1,178.64 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% RFNALQYLR 95.00% 2.55 0.304 0 590.3159 1,178.62 1,180.66 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% RFNALQYLR 95.00% 2.7 0.322 0 590.3166 1,178.62 1,180.66 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISETSLPPDMYEcLR 95.00% 3.29 0.419 1.09 c13: Carbamidomethyl (+57.02) 604.2831 1,809.83 1,810.84 3
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISETSLPPDMYEcLR 95.00% 3.14 0.316 0 c13: Carbamidomethyl (+57.02) 604.2832 1,809.83 1,810.84 3
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISETSLPPDMYEcLR 95.00% 2.34 0.423 0 c13: Carbamidomethyl (+57.02) 604.6168 1,810.83 1,810.84 3
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% NNQIDHIDEK 95.00% 2.37 0.192 1.82 613.2916 1,224.57 1,225.58 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% NNQIDHIDEK 95.00% 2.42 0.204 0 613.2921 1,224.57 1,225.58 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% NNQIDHIDEK 95.00% 2.62 0.288 0 613.2965 1,224.58 1,225.58 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFK 95.00% 3.28 0.396 1.59 613.3078 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFK 95.00% 3 0.298 1.55 613.3078 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFK 95.00% 2.44 0.316 0 613.3081 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFK 95.00% 3.42 0.42 2.23 613.3081 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFK 95.00% 2.92 0.255 0 613.3083 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFK 95.00% 2.79 0.283 1.42 613.3092 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFK 95.00% 3.08 0.278 0 613.3095 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEDLQLTHNK 95.00% 3.61 0.484 2.6 649.3398 1,296.66 1,297.68 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEDLQLTHNK 95.00% 3.59 0.455 2.24 649.3402 1,296.66 1,297.68 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEDLQLTHNK 95.00% 3.86 0.492 2.31 649.3403 1,296.67 1,297.68 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEDLQLTHNK 95.00% 3.82 0.471 2.3 649.3406 1,296.67 1,297.68 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEDLQLTHNK 95.00% 3.89 0.453 2.2 649.3406 1,296.67 1,297.68 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEDLQLTHNK 95.00% 4.2 0.473 2.43 649.3408 1,296.67 1,297.68 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFKR 95.00% 3 0.372 2.7 691.3593 1,380.70 1,381.71 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISNIPDEYFKR 95.00% 3.32 0.268 2.15 691.8596 1,381.70 1,381.71 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEDLQLTHNKITK 95.00% 4.22 0.482 4.55 820.4538 1,638.89 1,639.90 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEDLQLTHNKITK 95.00% 4.38 0.483 3.57 820.9547 1,639.89 1,639.90 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEDLQLTHNKITK 95.00% 3.84 0.433 3.92 820.9554 1,639.90 1,639.90 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEDLQLTHNKITK 95.00% 4.09 0.471 3.29 820.9558 1,639.90 1,639.90 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEYLDLSFNQIAR 95.00% 4.94 0.483 3.77 834.9314 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEYLDLSFNQIAR 95.00% 4.91 0.492 3.02 834.9317 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEYLDLSFNQIAR 95.00% 4.58 0.48 3.37 834.932 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEYLDLSFNQIAR 95.00% 4.43 0.479 3 834.9325 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% SLEYLDLSFNQIAR 95.00% 4.82 0.497 2.57 834.9326 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISETSLPPDMYEcLR 95.00% 3.24 0.481 2.33 c13: Carbamidomethyl (+57.02) 905.918 1,809.82 1,810.84 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISETSLPPDMYEcLR 95.00% 3 0.479 3.42 c13: Carbamidomethyl (+57.02) 905.9185 1,809.82 1,810.84 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISETSLPPDMYEcLR 95.00% 3.18 0.47 2.64 c13: Carbamidomethyl (+57.02) 905.9187 1,809.82 1,810.84 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISETSLPPDMYEcLR 95.00% 3.36 0.511 3.55 c13: Carbamidomethyl (+57.02) 905.9196 1,809.82 1,810.84 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISETSLPPDMYEcLR 95.00% 2.75 0.45 2.41 c13: Carbamidomethyl (+57.02) 905.9209 1,809.83 1,810.84 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISETSLPPDMYEcLR 95.00% 3.61 0.504 3.7 c13: Carbamidomethyl (+57.02) 906.4196 1,810.82 1,810.84 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISETSLPPDMYEcLR 95.00% 3.15 0.389 1.64 c13: Carbamidomethyl (+57.02) 906.4198 1,810.82 1,810.84 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISETSLPPDmYEcLR 95.00% 3.07 0.445 3.82 m10: Oxidation (+15.99), c13: Carbamidomethyl (+57.02) 914.4196 1,826.82 1,826.83 2
 SAMPLE 2 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 9 12 52 24.60% ISETSLPPDmYEcLR 95.00% 3.12 0.415 1.92 m10: Oxidation (+15.99), c13: Carbamidomethyl (+57.02) 914.4198 1,826.82 1,826.83 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISNIPDEYFKR 95.00% 2.85 0.27 0 461.2417 1,380.70 1,381.71 3
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISNIPDEYFKR 95.00% 2.59 0.172 0 461.2425 1,380.70 1,381.71 3
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% FNALQYLR 95.00% 2.68 0.225 1.38 512.7785 1,023.54 1,024.56 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% FNALQYLR 95.00% 3.1 0.31 0 512.7799 1,023.54 1,024.56 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% FNALQYLR 95.00% 2.6 0.239 1.17 512.781 1,023.55 1,024.56 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% FNALQYLR 95.00% 3.14 0.287 0 512.781 1,023.55 1,024.56 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% FNALQYLR 95.00% 3.04 0.271 0 512.7811 1,023.55 1,024.56 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% FNALQYLR 95.00% 2.25 0.107 1.21 512.7812 1,023.55 1,024.56 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% FNALQYLR 95.00% 3.04 0.309 1.28 512.7813 1,023.55 1,024.56 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% FNALQYLR 95.00% 3.14 0.307 1.37 512.7817 1,023.55 1,024.56 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% FNALQYLR 95.00% 3.01 0.3 1.14 512.7818 1,023.55 1,024.56 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEYLDLSFNQIAR 95.00% 5.41 0.549 3.17 556.9572 1,667.85 1,668.86 3 DOCK9_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEYLDLSFNQIAR 95.00% 5.62 0.535 2.92 557.2931 1,668.86 1,668.86 3 DOCK9_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% LKEDAVSAAFK 95.00% 3.46 0.41 2.48 589.824 1,177.63 1,178.64 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% LKEDAVSAAFK 95.00% 2.71 0.223 2.64 589.8243 1,177.63 1,178.64 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% RFNALQYLR 95.00% 2.62 0.285 0 590.3152 1,178.61 1,180.66 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% RFNALQYLR 95.00% 2.41 0.243 0 590.3163 1,178.62 1,180.66 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% RFNALQYLR 95.00% 2.79 0.32 0 590.3164 1,178.62 1,180.66 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% RFNALQYLR 95.00% 2.05 0.26 0 590.6406 1,179.27 1,180.66 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISETSLPPDMYEcLR 95.00% 3.75 0.511 0 c13: Carbamidomethyl (+57.02) 604.2816 1,809.82 1,810.84 3
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISETSLPPDMYEcLR 95.00% 3.29 0.29 0 c13: Carbamidomethyl (+57.02) 604.2816 1,809.82 1,810.84 3
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISETSLPPDMYEcLR 95.00% 2.71 0.304 0 c13: Carbamidomethyl (+57.02) 604.6165 1,810.83 1,810.84 3
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% NNQIDHIDEK 95.00% 2.62 0.295 0 613.2937 1,224.57 1,225.58 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISNIPDEYFK 95.00% 2.9 0.227 1.26 613.3076 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISNIPDEYFK 95.00% 2.57 0.254 0 613.3076 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISNIPDEYFK 95.00% 3.37 0.369 1.51 613.3078 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISNIPDEYFK 95.00% 3.04 0.247 1.62 613.3083 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISNIPDEYFK 95.00% 3.09 0.313 2.09 613.3084 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISNIPDEYFK 95.00% 2.72 0.293 0 613.3105 1,224.61 1,225.61 2 RS5_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISNIPDEYFK 95.00% 2.63 0.316 0 613.311 1,224.61 1,225.61 2 RS5_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISNIPDEYFK 95.00% 2.47 0.166 1.57 613.3125 1,224.61 1,225.61 2 RS5_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEDLQLTHNK 95.00% 3.73 0.484 2.85 649.3404 1,296.67 1,297.68 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEDLQLTHNK 95.00% 3.71 0.453 1.17 649.3405 1,296.67 1,297.68 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEDLQLTHNK 95.00% 3.42 0.437 2.08 649.3406 1,296.67 1,297.68 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEDLQLTHNK 95.00% 3.82 0.47 2.72 649.3407 1,296.67 1,297.68 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEDLQLTHNK 95.00% 3.86 0.456 2.19 649.3407 1,296.67 1,297.68 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEDLQLTHNK 95.00% 3.41 0.462 2 649.3415 1,296.67 1,297.68 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISNIPDEYFKR 95.00% 2.79 0.374 1.68 691.359 1,380.70 1,381.71 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISNIPDEYFKR 95.00% 3.38 0.343 1.44 691.8599 1,381.70 1,381.71 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEDLQLTHNKITK 95.00% 4.11 0.488 2.89 820.4516 1,638.89 1,639.90 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEDLQLTHNKITK 95.00% 4.19 0.517 3.64 820.4538 1,638.89 1,639.90 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEDLQLTHNKITK 95.00% 4.1 0.489 3.74 820.4553 1,638.89 1,639.90 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEDLQLTHNKITK 95.00% 4.09 0.486 2.46 820.456 1,638.90 1,639.90 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEYLDLSFNQIAR 95.00% 3.75 0.435 4.07 834.9309 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEYLDLSFNQIAR 95.00% 4.71 0.507 4.08 834.9319 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEYLDLSFNQIAR 95.00% 4.51 0.477 3.25 834.932 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEYLDLSFNQIAR 95.00% 4.69 0.488 4.36 834.9324 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEYLDLSFNQIAR 95.00% 4.51 0.48 3.96 835.4346 1,668.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% SLEYLDLSFNQIAR 95.00% 4.17 0.422 4.36 835.4353 1,668.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISETSLPPDMYEcLR 95.00% 2.45 0.344 1.8 c13: Carbamidomethyl (+57.02) 905.9168 1,809.82 1,810.84 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISETSLPPDMYEcLR 95.00% 3.09 0.514 3.24 c13: Carbamidomethyl (+57.02) 905.9182 1,809.82 1,810.84 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISETSLPPDMYEcLR 95.00% 2.07 0.317 2.12 c13: Carbamidomethyl (+57.02) 905.9185 1,809.82 1,810.84 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISETSLPPDMYEcLR 95.00% 2.99 0.457 3.92 c13: Carbamidomethyl (+57.02) 905.9196 1,809.82 1,810.84 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISETSLPPDMYEcLR 95.00% 3.28 0.478 5.01 c13: Carbamidomethyl (+57.02) 906.4203 1,810.82 1,810.84 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISETSLPPDMYEcLR 95.00% 3.76 0.548 2.96 c13: Carbamidomethyl (+57.02) 906.4203 1,810.83 1,810.84 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISETSLPPDMYEcLR 95.00% 2.49 0.359 0 c13: Carbamidomethyl (+57.02) 906.4211 1,810.83 1,810.84 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% ISETSLPPDmYEcLR 95.00% 2.69 0.352 0 m10: Oxidation (+15.99), c13: Carbamidomethyl (+57.02) 914.4189 1,826.82 1,826.83 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% LPSGLPVSLLTLYLDNNK 95.00% 5.56 0.626 7.64 979.5536 1,957.09 1,957.10 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% LPSGLPVSLLTLYLDNNK 95.00% 5.7 0.596 7.89 979.5537 1,957.09 1,957.10 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% LPSGLPVSLLTLYLDNNK 95.00% 5.28 0.617 8.6 979.5548 1,957.09 1,957.10 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% LPSGLPVSLLTLYLDNNK 95.00% 5.68 0.598 8.14 979.5552 1,957.09 1,957.10 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% LPSGLPVSLLTLYLDNNK 95.00% 5.59 0.555 8.39 979.5559 1,957.10 1,957.10 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% LPSGLPVSLLTLYLDNNK 95.00% 5.68 0.556 9.64 979.5559 1,957.10 1,957.10 2
 SAMPLE 2R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 13 56 29.90% LPSGLPVSLLTLYLDNNK 95.00% 5.99 0.594 7.72 979.5567 1,957.10 1,957.10 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISNIPDEYFKR 95.00% 2.89 0.154 0 461.2428 1,380.71 1,381.71 3
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISNIPDEYFKR 95.00% 2.7 0.219 0 461.2429 1,380.71 1,381.71 3
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% FNALQYLR 95.00% 3.02 0.302 1.12 512.781 1,023.55 1,024.56 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% FNALQYLR 95.00% 3.08 0.32 0 512.7812 1,023.55 1,024.56 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% FNALQYLR 95.00% 3.15 0.322 0 512.7815 1,023.55 1,024.56 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% FNALQYLR 95.00% 3.11 0.311 0 512.7819 1,023.55 1,024.56 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% FNALQYLR 95.00% 3.14 0.312 0 512.782 1,023.55 1,024.56 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% FNALQYLR 95.00% 3.21 0.328 1.29 512.7823 1,023.55 1,024.56 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% LKEDAVSAAFK 95.00% 2.34 0.28 2.52 589.8213 1,177.63 1,178.64 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISETSLPPDMYEcLR 95.00% 3.14 0.458 0 c13: Carbamidomethyl (+57.02) 604.6154 1,810.82 1,810.84 3
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISETSLPPDMYEcLR 95.00% 2.9 0.41 0 c13: Carbamidomethyl (+57.02) 604.6182 1,810.83 1,810.84 3
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% NNQIDHIDEK 95.00% 2.67 0.211 2.89 613.2933 1,224.57 1,225.58 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% NNQIDHIDEK 95.00% 2.42 0.189 1.32 613.296 1,224.58 1,225.58 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% NNQIDHIDEK 95.00% 2.25 0.173 1.12 613.2964 1,224.58 1,225.58 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISNIPDEYFK 95.00% 2.98 0.297 1.11 613.3056 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISNIPDEYFK 95.00% 2.66 0.287 0 613.3078 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISNIPDEYFK 95.00% 2.68 0.254 0 613.3084 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISNIPDEYFK 95.00% 3.32 0.378 1.96 613.3085 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISNIPDEYFK 95.00% 2.39 0.216 0 613.3094 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% SLEDLQLTHNK 95.00% 3.76 0.437 2.6 649.3394 1,296.66 1,297.68 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% SLEDLQLTHNK 95.00% 3.59 0.465 2.59 649.3398 1,296.66 1,297.68 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% SLEDLQLTHNK 95.00% 3.61 0.504 2.4 649.3399 1,296.66 1,297.68 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% SLEDLQLTHNK 95.00% 3.06 0.409 2.11 649.3402 1,296.66 1,297.68 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% SLEDLQLTHNK 95.00% 3.59 0.505 2.19 649.3403 1,296.67 1,297.68 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% SLEDLQLTHNK 95.00% 3.76 0.446 2.21 649.3404 1,296.67 1,297.68 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% SLEDLQLTHNK 95.00% 3.85 0.46 2.17 649.3404 1,296.67 1,297.68 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% SLEDLQLTHNK 95.00% 3.84 0.453 2.43 649.3406 1,296.67 1,297.68 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISNIPDEYFKR 95.00% 2.06 0.246 1.44 691.3582 1,380.70 1,381.71 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISNIPDEYFKR 95.00% 2.94 0.317 1.64 691.3589 1,380.70 1,381.71 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISNIPDEYFKR 95.00% 2.91 0.327 1.72 691.3595 1,380.70 1,381.71 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% SLEDLQLTHNKITK 95.00% 4.2 0.516 3.47 820.4535 1,638.89 1,639.90 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% SLEDLQLTHNKITK 95.00% 4.08 0.422 3.24 820.4539 1,638.89 1,639.90 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% SLEDLQLTHNKITK 95.00% 4.27 0.439 3.2 820.4539 1,638.89 1,639.90 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% SLEDLQLTHNKITK 95.00% 3.81 0.442 1.57 820.955 1,639.89 1,639.90 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISETSLPPDMYEcLR 95.00% 3.21 0.475 3.17 c13: Carbamidomethyl (+57.02) 905.9187 1,809.82 1,810.84 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISETSLPPDMYEcLR 95.00% 3.3 0.534 3.23 c13: Carbamidomethyl (+57.02) 905.9196 1,809.82 1,810.84 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISETSLPPDMYEcLR 95.00% 3.39 0.488 3.7 c13: Carbamidomethyl (+57.02) 905.9204 1,809.83 1,810.84 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% ISETSLPPDMYEcLR 95.00% 3.43 0.481 3.1 c13: Carbamidomethyl (+57.02) 906.4225 1,810.83 1,810.84 2
 SAMPLE 3 Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 8 10 34 26.60% NIPTVNENLENYYLEVNQLEK 95.00% 5.67 0.547 4.6 1,269.13 2,536.25 2,536.26 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISNIPDEYFKR 95.00% 2.23 0.171 0 461.2424 1,380.70 1,381.71 3
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISNIPDEYFKR 95.00% 3.03 0.259 0 461.2434 1,380.71 1,381.71 3
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISNIPDEYFKR 95.00% 2.25 0.241 0 461.2438 1,380.71 1,381.71 3
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% FNALQYLR 95.00% 3.01 0.315 1.21 512.7807 1,023.55 1,024.56 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% FNALQYLR 95.00% 2.75 0.308 0 512.7816 1,023.55 1,024.56 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% FNALQYLR 95.00% 3 0.297 1.1 512.7818 1,023.55 1,024.56 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% FNALQYLR 95.00% 3.24 0.328 1.1 512.782 1,023.55 1,024.56 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% FNALQYLR 95.00% 3.09 0.319 0 512.782 1,023.55 1,024.56 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% LKEDAVSAAFK 95.00% 3.56 0.383 3.02 589.8235 1,177.63 1,178.64 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% LKEDAVSAAFK 95.00% 3.51 0.42 3.57 589.8245 1,177.63 1,178.64 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISETSLPPDMYEcLR 95.00% 2.73 0.369 1.62 c13: Carbamidomethyl (+57.02) 604.282 1,809.82 1,810.84 3
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISETSLPPDMYEcLR 95.00% 2.63 0.412 0 c13: Carbamidomethyl (+57.02) 604.2834 1,809.83 1,810.84 3
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISETSLPPDMYEcLR 95.00% 2.28 0.331 0 c13: Carbamidomethyl (+57.02) 604.6172 1,810.83 1,810.84 3
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISETSLPPDMYEcLR 95.00% 2.93 0.386 0 c13: Carbamidomethyl (+57.02) 604.6182 1,810.83 1,810.84 3
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% NNQIDHIDEK 95.00% 2.63 0.228 0 613.2939 1,224.57 1,225.58 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% NNQIDHIDEK 95.00% 2.61 0.19 0 613.2953 1,224.57 1,225.58 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% NNQIDHIDEK 95.00% 2.99 0.304 2.05 613.2964 1,224.58 1,225.58 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISNIPDEYFK 95.00% 2.72 0.21 0 613.3069 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISNIPDEYFK 95.00% 3.24 0.314 1.51 613.3074 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISNIPDEYFK 95.00% 3.39 0.39 1.96 613.3074 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISNIPDEYFK 95.00% 2.9 0.213 1.92 613.3081 1,224.60 1,225.61 2 RS5_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEDLQLTHNK 95.00% 3.56 0.479 2.26 649.3402 1,296.66 1,297.68 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEDLQLTHNK 95.00% 3.54 0.489 2.14 649.3403 1,296.67 1,297.68 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEDLQLTHNK 95.00% 3.64 0.474 2.2 649.3406 1,296.67 1,297.68 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEDLQLTHNK 95.00% 3.83 0.486 1.85 649.3406 1,296.67 1,297.68 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEDLQLTHNK 95.00% 3.72 0.435 2.1 649.3413 1,296.67 1,297.68 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEDLQLTHNK 95.00% 3.89 0.452 1.8 649.3415 1,296.67 1,297.68 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISNIPDEYFKR 95.00% 2.52 0.236 2.24 691.3584 1,380.70 1,381.71 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISNIPDEYFKR 95.00% 3.08 0.361 1.68 691.3604 1,380.71 1,381.71 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEDLQLTHNKITK 95.00% 4 0.458 3.8 820.4535 1,638.89 1,639.90 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEDLQLTHNKITK 95.00% 4.05 0.456 3.41 820.4544 1,638.89 1,639.90 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEDLQLTHNKITK 95.00% 4.11 0.495 2.66 820.4557 1,638.90 1,639.90 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEDLQLTHNKITK 95.00% 4.14 0.506 2.3 820.9547 1,639.89 1,639.90 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEYLDLSFNQIAR 95.00% 4.5 0.45 4.33 834.9302 1,667.84 1,668.86 2 DOCK9_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEYLDLSFNQIAR 95.00% 3.55 0.453 3.62 834.9308 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEYLDLSFNQIAR 95.00% 3.87 0.46 4.11 834.9317 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEYLDLSFNQIAR 95.00% 3.77 0.407 3.8 834.933 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEYLDLSFNQIAR 95.00% 3.61 0.35 3.74 834.9333 1,667.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEYLDLSFNQIAR 95.00% 3.66 0.403 4.51 834.9354 1,667.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEYLDLSFNQIAR 95.00% 4.17 0.458 3.74 835.4337 1,668.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEYLDLSFNQIAR 95.00% 4.15 0.424 3.7 835.4342 1,668.85 1,668.86 2 DOCK9_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEYLDLSFNQIAR 95.00% 4.37 0.448 3.89 835.4364 1,668.86 1,668.86 2 DOCK9_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% SLEYLDLSFNQIAR 95.00% 4.25 0.42 3.34 835.4419 1,668.87 1,668.86 2 DOCK9_HUMAN
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISETSLPPDMYEcLR 95.00% 3.44 0.581 3.92 c13: Carbamidomethyl (+57.02) 905.918 1,809.82 1,810.84 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISETSLPPDMYEcLR 95.00% 2.32 0.294 0 c13: Carbamidomethyl (+57.02) 905.9183 1,809.82 1,810.84 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISETSLPPDMYEcLR 95.00% 3.51 0.549 4.32 c13: Carbamidomethyl (+57.02) 905.9195 1,809.82 1,810.84 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISETSLPPDMYEcLR 95.00% 2.97 0.406 1.27 c13: Carbamidomethyl (+57.02) 905.92 1,809.82 1,810.84 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISETSLPPDMYEcLR 95.00% 3.71 0.494 3.59 c13: Carbamidomethyl (+57.02) 906.4205 1,810.83 1,810.84 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISETSLPPDMYEcLR 95.00% 3.34 0.501 2.68 c13: Carbamidomethyl (+57.02) 906.4206 1,810.83 1,810.84 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% ISETSLPPDMYEcLR 95.00% 2.22 0.372 0 c13: Carbamidomethyl (+57.02) 906.4223 1,810.83 1,810.84 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% LPSGLPVSLLTLYLDNNK 95.00% 5.89 0.591 7.59 979.5545 1,957.09 1,957.10 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% LPSGLPVSLLTLYLDNNK 95.00% 5.42 0.608 8.19 979.5546 1,957.09 1,957.10 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% NIPTVNENLENYYLEVNQLEK 95.00% 5.7 0.529 4.72 1,269.13 2,536.25 2,536.26 2
 SAMPLE 3R Lumican  LUM  LUM_HUMAN 38,413.50 100.00% 10 12 50 36.10% NIPTVNENLENYYLEVNQLEK 95.00% 5.72 0.527 4.1 1,269.14 2,536.26 2,536.26 2
 SAMPLE 2R Lutheran blood group glycoprotein  BCAM  LU_HUMAN 67,385.90 100.00% 4 4 5 8.12% EGDTVQLLcR 95.00% 2.33 0.225 0 c9: Carbamidomethyl (+57.02) 595.7945 1,189.57 1,190.58 2
 SAMPLE 2R Lutheran blood group glycoprotein  BCAM  LU_HUMAN 67,385.90 100.00% 4 4 5 8.12% LSVPPLVEVMR 95.00% 2.18 0.407 0 620.3606 1,238.71 1,239.71 2
 SAMPLE 2R Lutheran blood group glycoprotein  BCAM  LU_HUMAN 67,385.90 100.00% 4 4 5 8.12% VAYLDPLELSEGK 95.00% 2.91 0.333 2.48 717.3784 1,432.74 1,433.75 2
 SAMPLE 2R Lutheran blood group glycoprotein  BCAM  LU_HUMAN 67,385.90 100.00% 4 4 5 8.12% VAYLDPLELSEGK 95.00% 3.7 0.489 4.96 717.8813 1,433.75 1,433.75 2
 SAMPLE 2R Lutheran blood group glycoprotein  BCAM  LU_HUMAN 67,385.90 100.00% 4 4 5 8.12% LSWSQLGGSPAEPIPGR 95.00% 3.74 0.496 5.07 876.4543 1,750.89 1,751.91 2
 SAMPLE 3 Lutheran blood group glycoprotein  BCAM  LU_HUMAN 67,385.90 99.80% 2 2 3 3.34% EGDTVQLLcR 95.00% 2.33 0.202 1.31 c9: Carbamidomethyl (+57.02) 596.2935 1,190.57 1,190.58 2
 SAMPLE 3 Lutheran blood group glycoprotein  BCAM  LU_HUMAN 67,385.90 99.80% 2 2 3 3.34% LSVPPLVEVMR 95.00% 2.21 0.305 0 620.3602 1,238.70 1,239.71 2
 SAMPLE 3 Lutheran blood group glycoprotein  BCAM  LU_HUMAN 67,385.90 99.80% 2 2 3 3.34% LSVPPLVEVMR 95.00% 2.28 0.474 1.36 620.3607 1,238.71 1,239.71 2
 SAMPLE 1 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 99.80% 2 2 2 4.70% NQGTADFLPNRPR 95.00% 2.33 0.346 0 743.3752 1,484.73 1,485.76 2
 SAMPLE 1 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 99.80% 2 2 2 4.70% YIVLESDFTNNVVR 95.00% 5.13 0.519 5.41 835.4358 1,668.86 1,668.86 2
 SAMPLE 1R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 99.80% 2 2 2 4.53% VLLAGAPQAQQR 95.00% 1.93 0.318 0 626.3225 1,250.63 1,251.72 2
 SAMPLE 1R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 99.80% 2 2 2 4.53% YIVLESDFTNNVVR 95.00% 4.37 0.447 3.49 834.9303 1,667.85 1,668.86 2
 SAMPLE 2 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 4 6 9.06% QAPSLPLPGR 95.00% 1.7 0.352 0 518.3 1,034.58 1,035.60 2
 SAMPLE 2 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 4 6 9.06% EVAVGDSTGmAR 95.00% 2.58 0.434 4.16 m10: Oxidation (+15.99) 604.7841 1,207.55 1,208.56 2
 SAMPLE 2 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 4 6 9.06% VLLAGAPQAQQR 95.00% 3.24 0.448 4.8 626.36 1,250.70 1,251.72 2
 SAMPLE 2 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 4 6 9.06% VLLAGAPQAQQR 95.00% 3.22 0.461 3.28 626.3615 1,250.71 1,251.72 2
 SAMPLE 2 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 4 6 9.06% HGGSASSVSASAFASTYR 95.00% 6.13 0.673 11.7 871.9115 1,741.81 1,742.81 2
 SAMPLE 2 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 4 6 9.06% HGGSASSVSASAFASTYR 95.00% 6.22 0.694 11.8 872.4099 1,742.80 1,742.81 2
 SAMPLE 2R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 3 3 9 7.32% EVAVGDSTGmAR 95.00% 2.24 0.286 3.14 m10: Oxidation (+15.99) 604.7828 1,207.55 1,208.56 2
 SAMPLE 2R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 3 3 9 7.32% EVAVGDSTGmAR 95.00% 2.52 0.462 5.54 m10: Oxidation (+15.99) 604.7846 1,207.55 1,208.56 2
 SAMPLE 2R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 3 3 9 7.32% EVAVGDSTGmAR 95.00% 2.8 0.439 3.14 m10: Oxidation (+15.99) 604.7847 1,207.55 1,208.56 2
 SAMPLE 2R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 3 3 9 7.32% VLLAGAPQAQQR 95.00% 2.26 0.344 1.47 626.3603 1,250.71 1,251.72 2
 SAMPLE 2R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 3 3 9 7.32% VLLAGAPQAQQR 95.00% 3.17 0.49 4.96 626.3615 1,250.71 1,251.72 2
 SAMPLE 2R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 3 3 9 7.32% VLLAGAPQAQQR 95.00% 2.87 0.457 3.55 626.3621 1,250.71 1,251.72 2
 SAMPLE 2R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 3 3 9 7.32% VLLAGAPQAQQR 95.00% 3.3 0.427 3.89 626.3622 1,250.71 1,251.72 2
 SAMPLE 2R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 3 3 9 7.32% HGGSASSVSASAFASTYR 95.00% 5.91 0.702 12 871.9098 1,741.80 1,742.81 2
 SAMPLE 2R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 3 3 9 7.32% HGGSASSVSASAFASTYR 95.00% 6.14 0.701 11.7 872.4105 1,742.81 1,742.81 2
 SAMPLE 3 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 12 9.58% HGGSASSVSASAFASTYR 95.00% 2.64 0.31 1.74 581.6082 1,741.80 1,742.81 3
 SAMPLE 3 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 12 9.58% HGGSASSVSASAFASTYR 95.00% 3.14 0.348 0 581.6083 1,741.80 1,742.81 3
 SAMPLE 3 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 12 9.58% EVAVGDSTGMAR 95.00% 2.89 0.388 2.04 596.7839 1,191.55 1,192.56 2
 SAMPLE 3 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 12 9.58% EVAVGDSTGmAR 95.00% 2.64 0.501 1.85 m10: Oxidation (+15.99) 604.7848 1,207.55 1,208.56 2
 SAMPLE 3 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 12 9.58% VLLAGAPQAQQR 95.00% 3.21 0.379 3.82 626.3598 1,250.70 1,251.72 2
 SAMPLE 3 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 12 9.58% VLLAGAPQAQQR 95.00% 2.78 0.461 5.1 626.3603 1,250.70 1,251.72 2
 SAMPLE 3 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 12 9.58% VLLAGAPQAQQR 95.00% 2.79 0.466 5.49 626.3603 1,250.71 1,251.72 2
 SAMPLE 3 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 12 9.58% VLLAGAPQAQQR 95.00% 3.23 0.35 4.2 626.3614 1,250.71 1,251.72 2
 SAMPLE 3 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 12 9.58% VLLAGAPQAQQR 95.00% 1.84 0.318 0 626.6541 1,251.29 1,251.72 2
 SAMPLE 3 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 12 9.58% HPFGFGQVPDNWR 94.80% 1.95 0.274 0 778.8741 1,555.73 1,556.74 2
 SAMPLE 3 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 12 9.58% HGGSASSVSASAFASTYR 95.00% 6.11 0.689 11.2 871.9092 1,741.80 1,742.81 2
 SAMPLE 3 Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 12 9.58% HGGSASSVSASAFASTYR 95.00% 5.99 0.65 12.2 872.41 1,742.80 1,742.81 2
 SAMPLE 3R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 9 9.06% ALEPPYLPVR 95.00% 1.79 0.23 1.12 577.8327 1,153.65 1,154.66 2
 SAMPLE 3R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 9 9.06% HGGSASSVSASAFASTYR 95.00% 2.58 0.405 1.48 581.6074 1,741.80 1,742.81 3
 SAMPLE 3R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 9 9.06% HGGSASSVSASAFASTYR 95.00% 2.57 0.232 0 581.6091 1,741.80 1,742.81 3
 SAMPLE 3R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 9 9.06% EVAVGDSTGmAR 95.00% 2.85 0.431 3.08 m10: Oxidation (+15.99) 604.7846 1,207.55 1,208.56 2
 SAMPLE 3R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 9 9.06% VLLAGAPQAQQR 95.00% 3.19 0.43 4.55 626.3608 1,250.71 1,251.72 2
 SAMPLE 3R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 9 9.06% VLLAGAPQAQQR 95.00% 2.92 0.403 5.24 626.3617 1,250.71 1,251.72 2
 SAMPLE 3R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 9 9.06% VLLAGAPQAQQR 95.00% 2.41 0.463 2.92 626.3642 1,250.71 1,251.72 2
 SAMPLE 3R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 9 9.06% HGGSASSVSASAFASTYR 95.00% 6.12 0.669 12.2 872.4051 1,742.79 1,742.81 2
 SAMPLE 3R Lysyl oxidase homolog 1  LOXL1  LOXL1_HUMAN 63,090.70 100.00% 4 5 9 9.06% HGGSASSVSASAFASTYR 95.00% 5.93 0.698 11.6 872.4091 1,742.80 1,742.81 2
 SAMPLE 2 Major vault protein  MVP  MVP_HUMAN 99,308.00 99.80% 2 2 2 3.02% GPLEYVPSAK 95.00% 2.01 0.429 0 530.7876 1,059.56 1,060.57 2
 SAMPLE 2 Major vault protein  MVP  MVP_HUMAN 99,308.00 99.80% 2 2 2 3.02% QAIPLDENEGIYVQDVK 95.00% 3.91 0.472 2.12 966.494 1,930.97 1,930.98 2
 SAMPLE 3 Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 4 4 6 6.61% VPHNAAVQVYDYR 95.00% 3.25 0.258 0 511.5942 1,531.76 1,531.77 3
 SAMPLE 3 Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 4 4 6 6.61% LFSVPDFVGDAcK 95.00% 3.35 0.384 3.51 c12: Carbamidomethyl (+57.02) 727.8512 1,453.69 1,454.70 2
 SAMPLE 3 Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 4 4 6 6.61% LAQDPFPLYPGEVLEK 95.00% 4.22 0.569 5.49 908.9798 1,815.94 1,815.95 2
 SAMPLE 3 Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 4 4 6 6.61% QAIPLDENEGIYVQDVK 95.00% 4.34 0.515 3.64 965.9887 1,929.96 1,930.98 2
 SAMPLE 3 Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 4 4 6 6.61% QAIPLDENEGIYVQDVK 95.00% 3.33 0.384 2.54 966.485 1,930.95 1,930.98 2
 SAMPLE 3 Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 4 4 6 6.61% QAIPLDENEGIYVQDVK 95.00% 4.55 0.489 3.51 966.4893 1,930.96 1,930.98 2
 SAMPLE 3R Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 6 7 11 9.52% VPHNAAVQVYDYR 95.00% 2.3 0.181 0 511.2595 1,530.75 1,531.77 3
 SAMPLE 3R Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 6 7 11 9.52% KEVEVVEIIQATIIR 95.00% 3.41 0.201 1.62 580.68 1,739.02 1,740.03 3
 SAMPLE 3R Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 6 7 11 9.52% TAVFGFETSEAK 95.00% 2.15 0.241 0 643.8164 1,285.62 1,286.63 2
 SAMPLE 3R Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 6 7 11 9.52% LFSVPDFVGDAcK 95.00% 3.2 0.376 3 c12: Carbamidomethyl (+57.02) 727.8521 1,453.69 1,454.70 2
 SAMPLE 3R Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 6 7 11 9.52% LFSVPDFVGDAcK 95.00% 2.59 0.164 1.54 c12: Carbamidomethyl (+57.02) 727.8535 1,453.69 1,454.70 2
 SAMPLE 3R Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 6 7 11 9.52% VPHNAAVQVYDYR 95.00% 2.32 0.483 1.72 766.3861 1,530.76 1,531.77 2
 SAMPLE 3R Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 6 7 11 9.52% DAQGLVLFDVTGQVR 95.00% 3.63 0.534 4.12 809.432 1,616.85 1,617.86 2
 SAMPLE 3R Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 6 7 11 9.52% DAQGLVLFDVTGQVR 95.00% 3.41 0.429 3.54 809.4323 1,616.85 1,617.86 2
 SAMPLE 3R Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 6 7 11 9.52% QAIPLDENEGIYVQDVK 95.00% 2.41 0.232 0 965.9917 1,929.97 1,930.98 2
 SAMPLE 3R Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 6 7 11 9.52% QAIPLDENEGIYVQDVK 95.00% 3.21 0.449 0 965.9937 1,929.97 1,930.98 2
 SAMPLE 3R Major vault protein  MVP  MVP_HUMAN 99,308.00 100.00% 6 7 11 9.52% QAIPLDENEGIYVQDVK 95.00% 4.8 0.51 0 966.4915 1,930.97 1,930.98 2
 SAMPLE 3 Malate dehydrogenase, mitochondrial  MDH2  MDHM_HUMAN 35,485.70 99.80% 2 2 2 6.80% IFGVTTLDIVR 95.00% 3.25 0.306 1.8 617.3623 1,232.71 1,233.72 2
 SAMPLE 3 Malate dehydrogenase, mitochondrial  MDH2  MDHM_HUMAN 35,485.70 99.80% 2 2 2 6.80% TIIPLISQcTPK 95.00% 2.55 0.516 3.44 c9: Carbamidomethyl (+57.02) 686.3904 1,370.77 1,370.77 2
 SAMPLE 3R Malate dehydrogenase, mitochondrial  MDH2  MDHM_HUMAN 35,485.70 100.00% 4 4 5 16.90% IFGVTTLDIVR 95.00% 3.17 0.266 1.46 617.36 1,232.70 1,233.72 2
 SAMPLE 3R Malate dehydrogenase, mitochondrial  MDH2  MDHM_HUMAN 35,485.70 100.00% 4 4 5 16.90% IFGVTTLDIVR 95.00% 2.46 0.241 0 617.3634 1,232.71 1,233.72 2
 SAMPLE 3R Malate dehydrogenase, mitochondrial  MDH2  MDHM_HUMAN 35,485.70 100.00% 4 4 5 16.90% GYLGPEQLPDcLK 95.00% 2.41 0.276 0 c11: Carbamidomethyl (+57.02) 745.371 1,488.73 1,489.74 2
 SAMPLE 3R Malate dehydrogenase, mitochondrial  MDH2  MDHM_HUMAN 35,485.70 100.00% 4 4 5 16.90% VDFPQDQLTALTGR 95.00% 2.74 0.405 1.52 780.9029 1,559.79 1,560.80 2
 SAMPLE 3R Malate dehydrogenase, mitochondrial  MDH2  MDHM_HUMAN 35,485.70 100.00% 4 4 5 16.90% VAVLGASGGIGQPLSLLLK 95.00% 3.65 0.441 3.92 897.5509 1,793.09 1,793.09 2
 SAMPLE 4R Mast cell carboxypeptidase A  CPA3  CBPA3_HUMAN 48,683.90 99.80% 2 2 6 5.52% FGFLLPESR 95.00% 2.87 0.418 1.62 533.2914 1,064.57 1,065.57 2
 SAMPLE 4R Mast cell carboxypeptidase A  CPA3  CBPA3_HUMAN 48,683.90 99.80% 2 2 6 5.52% FGFLLPESR 95.00% 2.92 0.368 1.41 533.2921 1,064.57 1,065.57 2
 SAMPLE 4R Mast cell carboxypeptidase A  CPA3  CBPA3_HUMAN 48,683.90 99.80% 2 2 6 5.52% FGFLLPESR 95.00% 2.61 0.331 1.59 533.2926 1,064.57 1,065.57 2
 SAMPLE 4R Mast cell carboxypeptidase A  CPA3  CBPA3_HUMAN 48,683.90 99.80% 2 2 6 5.52% FGFLLPESR 95.00% 2.55 0.307 0 533.2943 1,064.57 1,065.57 2
 SAMPLE 4R Mast cell carboxypeptidase A  CPA3  CBPA3_HUMAN 48,683.90 99.80% 2 2 6 5.52% IGSTVEDNPLYVLK 95.00% 2.54 0.471 1.89 774.4236 1,546.83 1,547.83 2
 SAMPLE 4R Mast cell carboxypeptidase A  CPA3  CBPA3_HUMAN 48,683.90 99.80% 2 2 6 5.52% IGSTVEDNPLYVLK 95.00% 3.32 0.465 3.72 774.424 1,546.83 1,547.83 2
 SAMPLE 4R Matrilin-2  MATN2  MATN2_HUMAN 106,819.00 99.90% 2 2 3 2.30% VGLLQYGSTVK 95.00% 2.57 0.447 3.6 582.8359 1,163.66 1,164.66 2
 SAMPLE 4R Matrilin-2  MATN2  MATN2_HUMAN 106,819.00 99.90% 2 2 3 2.30% VGLLQYGSTVK 95.00% 2.77 0.512 4.35 582.8369 1,163.66 1,164.66 2
 SAMPLE 4R Matrilin-2  MATN2  MATN2_HUMAN 106,819.00 99.90% 2 2 3 2.30% ADLVFIIDSSR 95.00% 2.35 0.391 2.13 618.3372 1,234.66 1,235.66 2
 SAMPLE 3 Matrix Gla protein  MGP  MGP_HUMAN 12,335.60 99.90% 2 2 3 23.30% NANTFISPQQR 95.00% 2.39 0.301 0 638.3258 1,274.64 1,275.64 2
 SAMPLE 3 Matrix Gla protein  MGP  MGP_HUMAN 12,335.60 99.90% 2 2 3 23.30% NANTFISPQQR 95.00% 2.23 0.265 0 638.3264 1,274.64 1,275.64 2
 SAMPLE 3 Matrix Gla protein  MGP  MGP_HUMAN 12,335.60 99.90% 2 2 3 23.30% YAMVYGYNAAYNR 95.00% 3.42 0.284 4.32 778.3537 1,554.69 1,555.70 2
 SAMPLE 3R Matrix Gla protein  MGP  MGP_HUMAN 12,335.60 99.80% 2 2 3 23.30% NANTFISPQQR 95.00% 3.36 0.321 0 638.8196 1,275.62 1,275.64 2
 SAMPLE 3R Matrix Gla protein  MGP  MGP_HUMAN 12,335.60 99.80% 2 2 3 23.30% NANTFISPQQR 95.00% 3.44 0.335 0 638.8201 1,275.62 1,275.64 2
 SAMPLE 3R Matrix Gla protein  MGP  MGP_HUMAN 12,335.60 99.80% 2 2 3 23.30% YAMVYGYNAAYNR 95.00% 3.36 0.123 5.02 778.3536 1,554.69 1,555.70 2
 SAMPLE 4 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 8 4.19% NLVTMTTAPR 95.00% 2.39 0.306 0 552.8027 1,103.59 1,103.59 2
 SAMPLE 4 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 8 4.19% EALAIVFFGR 95.00% 3.22 0.479 1.36 561.8216 1,121.63 1,122.63 2
 SAMPLE 4 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 8 4.19% LGPGLVDAAQAR 95.00% 3.73 0.577 0 584.3284 1,166.64 1,167.65 2
 SAMPLE 4 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 8 4.19% LGPGLVDAAQAR 95.00% 3.41 0.433 0 584.3285 1,166.64 1,167.65 2
 SAMPLE 4 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 8 4.19% LGPGLVDAAQAR 95.00% 4.33 0.595 0 584.3288 1,166.64 1,167.65 2
 SAMPLE 4 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 8 4.19% LGPGLVDAAQAR 95.00% 3.37 0.484 0 584.3297 1,166.64 1,167.65 2
 SAMPLE 4 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 8 4.19% LGPGLVDAAQAR 95.00% 3.9 0.558 0 584.3299 1,166.64 1,167.65 2
 SAMPLE 4 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 8 4.19% LGPGLVDAAQAR 95.00% 3.06 0.42 0 584.3306 1,166.65 1,167.65 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 3.38 0.497 1.74 561.8186 1,121.62 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 3.23 0.474 2.6 561.8195 1,121.62 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 3.69 0.505 2.85 561.8199 1,121.62 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 3.34 0.436 2.38 561.82 1,121.62 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 3.32 0.445 1.85 561.8201 1,121.62 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 3.61 0.466 2.89 561.8203 1,121.62 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 3.43 0.486 2.82 561.8205 1,121.63 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 3.74 0.47 3.07 561.8206 1,121.63 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 3.98 0.466 3.06 561.8206 1,121.63 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 2.87 0.444 1.77 561.8208 1,121.63 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 3.2 0.446 2 561.8211 1,121.63 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 3.56 0.403 4.34 561.8214 1,121.63 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 2.68 0.226 0 561.8226 1,121.63 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% EALAIVFFGR 95.00% 3.77 0.457 3.37 562.3232 1,122.63 1,122.63 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% LGPGLVDAAQAR 95.00% 3.89 0.557 0 584.3279 1,166.64 1,167.65 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% LGPGLVDAAQAR 95.00% 3.68 0.523 0 584.3283 1,166.64 1,167.65 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% LGPGLVDAAQAR 95.00% 3.3 0.489 0 584.3294 1,166.64 1,167.65 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% LGPGLVDAAQAR 95.00% 3 0.297 0 584.3305 1,166.65 1,167.65 2
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% SPVPPGPAPPLQFYPQGPR 95.00% 2.82 0.315 0 668.0273 2,001.06 2,002.06 3
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% SPVPPGPAPPLQFYPQGPR 95.00% 4.18 0.297 2.52 668.3607 2,002.06 2,002.06 3
 SAMPLE 4R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 4 21 5.37% SPVPPGPAPPLQFYPQGPR 95.00% 2.9 0.506 0 1,001.53 2,001.05 2,002.06 2
 SAMPLE 1 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 4.98% EALAIVFFGR 95.00% 2.76 0.391 0 561.8175 1,121.62 1,122.63 2
 SAMPLE 1 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 4.98% EALAIVFFGR 95.00% 3.69 0.474 3.66 561.818 1,121.62 1,122.63 2
 SAMPLE 1 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 4.98% EALAIVFFGR 95.00% 2.84 0.406 2.92 561.818 1,121.62 1,122.63 2
 SAMPLE 1 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 4.98% EALAIVFFGR 95.00% 2.91 0.46 0 561.8182 1,121.62 1,122.63 2
 SAMPLE 1 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 4.98% EALAIVFFGR 95.00% 3.68 0.434 3.37 561.8191 1,121.62 1,122.63 2
 SAMPLE 1 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 4.98% EALAIVFFGR 95.00% 3.45 0.457 3.47 561.8193 1,121.62 1,122.63 2
 SAMPLE 1 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 4.98% EALAIVFFGR 95.00% 2.98 0.481 1.96 561.82 1,121.62 1,122.63 2
 SAMPLE 1 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 4.98% LGPGLVDAAQAR 95.00% 3.38 0.405 0 584.3241 1,166.63 1,167.65 2
 SAMPLE 1 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 4.98% LGPGLVDAAQAR 95.00% 3.72 0.551 0 584.3264 1,166.64 1,167.65 2
 SAMPLE 1 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 4.98% LGPGLVDAAQAR 95.00% 3.8 0.441 0 584.3265 1,166.64 1,167.65 2
 SAMPLE 1 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 4.98% DAFcVFEQNQGLPLRR 95.00% 2.21 0.247 1.54 c4: Carbamidomethyl (+57.02) 650.6591 1,948.95 1,949.97 3
 SAMPLE 1R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 12 4.98% EALAIVFFGR 95.00% 3.21 0.429 1.51 561.8176 1,121.62 1,122.63 2
 SAMPLE 1R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 12 4.98% EALAIVFFGR 95.00% 2.63 0.388 2.17 561.8178 1,121.62 1,122.63 2
 SAMPLE 1R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 12 4.98% EALAIVFFGR 95.00% 2.23 0.341 2 561.818 1,121.62 1,122.63 2
 SAMPLE 1R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 12 4.98% EALAIVFFGR 95.00% 3.51 0.482 2.29 561.8181 1,121.62 1,122.63 2
 SAMPLE 1R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 12 4.98% EALAIVFFGR 95.00% 3.33 0.455 2.77 561.8182 1,121.62 1,122.63 2
 SAMPLE 1R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 12 4.98% EALAIVFFGR 95.00% 3.01 0.431 1.77 561.8182 1,121.62 1,122.63 2
 SAMPLE 1R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 12 4.98% EALAIVFFGR 95.00% 3.35 0.35 4.03 561.8183 1,121.62 1,122.63 2
 SAMPLE 1R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 12 4.98% EALAIVFFGR 95.00% 3.34 0.316 3.19 561.8185 1,121.62 1,122.63 2
 SAMPLE 1R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 12 4.98% EALAIVFFGR 95.00% 2.29 0.435 2.08 561.8188 1,121.62 1,122.63 2
 SAMPLE 1R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 12 4.98% EALAIVFFGR 95.00% 2.84 0.41 1.3 561.8197 1,121.62 1,122.63 2
 SAMPLE 1R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 12 4.98% LGPGLVDAAQAR 95.00% 3.2 0.339 0 584.3275 1,166.64 1,167.65 2
 SAMPLE 1R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 12 4.98% DAFcVFEQNQGLPLRR 95.00% 2.19 0.25 1.17 c4: Carbamidomethyl (+57.02) 650.9949 1,949.96 1,949.97 3
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% YQLAVTQR 95.00% 2.69 0.16 0 489.7711 977.5266 978.5373 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% YQLAVTQR 95.00% 3.09 0.257 0 489.7712 977.5267 978.5373 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% YQLAVTQR 95.00% 2.88 0.278 0 489.7715 977.5273 978.5373 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% YQLAVTQR 95.00% 3.14 0.287 0 489.7718 977.5279 978.5373 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% YQLAVTQR 95.00% 3.16 0.256 0 489.7719 977.5282 978.5373 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% YQLAVTQR 95.00% 3.1 0.298 0 489.7719 977.5282 978.5373 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% YVDGGFGMGK 95.00% 2.29 0.324 1.52 515.737 1,029.46 1,030.47 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% NLVTMTTAPR 95.00% 2.32 0.433 0 552.802 1,103.59 1,103.59 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% NLVTmTTAPR 95.00% 2.54 0.418 1.21 m5: Oxidation (+15.99) 560.2934 1,118.57 1,119.58 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% NLVTmTTAPR 95.00% 2.53 0.462 1.14 m5: Oxidation (+15.99) 560.2947 1,118.57 1,119.58 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% LGPGLVDAAQAR 95.00% 4.03 0.576 0 584.3266 1,166.64 1,167.65 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% LGPGLVDAAQAR 95.00% 4.06 0.574 0 584.3269 1,166.64 1,167.65 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% LGPGLVDAAQAR 95.00% 3.95 0.552 0 584.3271 1,166.64 1,167.65 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% LGPGLVDAAQAR 95.00% 4.13 0.559 0 584.3272 1,166.64 1,167.65 2
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% DAFcVFEQNQGLPLRR 95.00% 3.18 0.537 2.19 c4: Carbamidomethyl (+57.02) 650.6598 1,948.96 1,949.97 3
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% DAFcVFEQNQGLPLRR 95.00% 3.2 0.495 1.12 c4: Carbamidomethyl (+57.02) 650.6599 1,948.96 1,949.97 3
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% DAFcVFEQNQGLPLRR 95.00% 3.54 0.562 2.15 c4: Carbamidomethyl (+57.02) 650.6602 1,948.96 1,949.97 3
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% DAFcVFEQNQGLPLRR 95.00% 2.84 0.521 0.921 c4: Carbamidomethyl (+57.02) 650.6602 1,948.96 1,949.97 3
 SAMPLE 2 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 5 5 19 7.34% DAFcVFEQNQGLPLRR 95.00% 3.33 0.549 2.41 c4: Carbamidomethyl (+57.02) 650.9949 1,949.96 1,949.97 3
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% YQLAVTQR 95.00% 2.78 0.241 0 489.7708 977.5259 978.5373 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% YQLAVTQR 95.00% 2.75 0.232 0 489.771 977.5263 978.5373 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% YQLAVTQR 95.00% 2.62 0.307 0 489.7711 977.5266 978.5373 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% YQLAVTQR 95.00% 2.54 0.287 0 489.7716 977.5275 978.5373 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% YQLAVTQR 95.00% 3.01 0.291 0 489.7716 977.5276 978.5373 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% YQLAVTQR 95.00% 2.59 0.273 0 489.773 977.5303 978.5373 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% NLVTMTTAPR 95.00% 2.3 0.272 0 552.2997 1,102.58 1,103.59 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% NLVTMTTAPR 95.00% 2.11 0.281 0 552.2998 1,102.58 1,103.59 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 3.79 0.482 3.14 561.8177 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 2.97 0.399 2.39 561.818 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 3.38 0.477 3.48 561.8181 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 3.14 0.464 3.43 561.8181 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 3.55 0.464 2.8 561.8183 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 3.45 0.489 2.66 561.8183 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 3.31 0.478 3.48 561.8185 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 2.83 0.303 2.1 561.8185 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 3.78 0.454 2.44 561.8186 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 2.92 0.391 2.04 561.8186 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 3.39 0.468 2.96 561.8187 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 3.84 0.45 2.49 561.8188 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 2.95 0.382 2.77 561.819 1,121.62 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 2.56 0.282 0 562.3417 1,122.67 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 2.89 0.389 1.89 562.343 1,122.67 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% EALAIVFFGR 95.00% 2.37 0.254 0 562.3432 1,122.67 1,122.63 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% LGPGLVDAAQAR 95.00% 4.23 0.524 0 584.3266 1,166.64 1,167.65 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% LGPGLVDAAQAR 95.00% 4.19 0.575 0 584.3272 1,166.64 1,167.65 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% LGPGLVDAAQAR 95.00% 4.1 0.56 0 584.3273 1,166.64 1,167.65 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% LGPGLVDAAQAR 95.00% 3.61 0.467 0 584.3275 1,166.64 1,167.65 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% LGPGLVDAAQAR 95.00% 3.78 0.493 0 584.3277 1,166.64 1,167.65 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% DAFcVFEQNQGLPLRR 95.00% 3.04 0.494 0 c4: Carbamidomethyl (+57.02) 650.6596 1,948.96 1,949.97 3
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% DAFcVFEQNQGLPLRR 95.00% 3.06 0.41 2.66 c4: Carbamidomethyl (+57.02) 650.6601 1,948.96 1,949.97 3
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% DAFcVFEQNQGLPLRR 95.00% 3.62 0.526 2.21 c4: Carbamidomethyl (+57.02) 650.9926 1,949.95 1,949.97 3
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% DAFcVFEQNQGLPLRR 95.00% 3.39 0.504 2.1 c4: Carbamidomethyl (+57.02) 650.9937 1,949.96 1,949.97 3
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% DAFcVFEQNQGLPLRR 95.00% 3.58 0.538 2.24 c4: Carbamidomethyl (+57.02) 650.9938 1,949.96 1,949.97 3
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% DAFcVFEQNQGLPLRR 95.00% 2.88 0.438 0 c4: Carbamidomethyl (+57.02) 650.9939 1,949.96 1,949.97 3
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% SPVPPGPAPPLQFYPQGPR 95.00% 3.72 0.309 1.64 668.3533 2,002.04 2,002.06 3
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% SPVPPGPAPPLQFYPQGPR 95.00% 3.48 0.374 2.77 668.3573 2,002.05 2,002.06 3
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% SPVPPGPAPPLQFYPQGPR 95.00% 3.91 0.255 3.08 668.3578 2,002.05 2,002.06 3
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% PSDNcVFSVELQLPPK 95.00% 4.04 0.565 0 c5: Carbamidomethyl (+57.02) 915.4614 1,828.91 1,829.91 2
 SAMPLE 2R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 7 8 40 11.90% SPVPPGPAPPLQFYPQGPR 95.00% 2.49 0.514 1.37 1,002.04 2,002.06 2,002.06 2
 SAMPLE 3 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 3.93% YQLAVTQR 95.00% 3 0.227 0 489.7694 977.5231 978.5373 2
 SAMPLE 3 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 3.93% YQLAVTQR 95.00% 2.71 0.124 0 489.7711 977.5266 978.5373 2
 SAMPLE 3 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 3.93% YQLAVTQR 95.00% 2.71 0.263 0 489.7717 977.5277 978.5373 2
 SAMPLE 3 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 3.93% YQLAVTQR 95.00% 2.66 0.268 1.48 489.7719 977.5281 978.5373 2
 SAMPLE 3 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 3.93% YQLAVTQR 95.00% 2.54 0.188 0 489.7719 977.5282 978.5373 2
 SAMPLE 3 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 3.93% YQLAVTQR 95.00% 2.44 0.303 0 489.7722 977.5287 978.5373 2
 SAMPLE 3 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 3.93% NLVTMTTAPR 95.00% 2.4 0.192 1.68 552.2975 1,102.58 1,103.59 2
 SAMPLE 3 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 3.93% LGPGLVDAAQAR 95.00% 3.65 0.524 0 584.3266 1,166.64 1,167.65 2
 SAMPLE 3 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 3.93% LGPGLVDAAQAR 95.00% 3.88 0.467 0 584.3266 1,166.64 1,167.65 2
 SAMPLE 3 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 3.93% LGPGLVDAAQAR 95.00% 3.09 0.485 0 584.3269 1,166.64 1,167.65 2
 SAMPLE 3 Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 3 3 11 3.93% LGPGLVDAAQAR 95.00% 3.25 0.421 0 584.3272 1,166.64 1,167.65 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% YQLAVTQR 95.00% 2.14 0.203 1.16 489.7705 977.5254 978.5373 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% YQLAVTQR 95.00% 2.01 0.28 0 489.7706 977.5255 978.5373 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% YQLAVTQR 95.00% 2.22 0.304 0 489.7713 977.527 978.5373 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% YQLAVTQR 95.00% 2.57 0.135 0 489.7717 977.5277 978.5373 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% NLVTMTTAPR 95.00% 2.16 0.356 0 552.2979 1,102.58 1,103.59 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% NLVTMTTAPR 95.00% 2.11 0.359 1.8 552.2997 1,102.58 1,103.59 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% EALAIVFFGR 95.00% 3.72 0.43 3.04 561.8183 1,121.62 1,122.63 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% EALAIVFFGR 95.00% 3.63 0.473 3.51 561.8186 1,121.62 1,122.63 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% EALAIVFFGR 95.00% 3.39 0.484 2.64 561.8186 1,121.62 1,122.63 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% EALAIVFFGR 95.00% 3.66 0.455 3.19 561.8188 1,121.62 1,122.63 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% EALAIVFFGR 95.00% 3.69 0.496 1.77 561.8188 1,121.62 1,122.63 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% EALAIVFFGR 95.00% 3.73 0.456 2.11 561.8191 1,121.62 1,122.63 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% EALAIVFFGR 95.00% 3.75 0.461 2.02 561.8192 1,121.62 1,122.63 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% EALAIVFFGR 95.00% 3.64 0.446 2.17 561.8195 1,121.62 1,122.63 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% EALAIVFFGR 95.00% 3.35 0.455 1.92 562.3451 1,122.67 1,122.63 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% LGPGLVDAAQAR 95.00% 3.78 0.505 0 584.3265 1,166.64 1,167.65 2
 SAMPLE 3R Membrane primary amine oxidase  AOC3  AOC3_HUMAN 84,604.10 100.00% 4 4 17 5.24% LGPGLVDAAQAR 95.00% 3.57 0.486 0 584.3274 1,166.64 1,167.65 2
 SAMPLE 1 Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 99.80% 2 2 3 11.40% EGPFGTLVYTIK 95.00% 2.59 0.318 0 662.873 1,323.73 1,324.72 2
 SAMPLE 1 Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 99.80% 2 2 3 11.40% EGPFGTLVYTIK 95.00% 2.74 0.436 5.03 662.8748 1,323.73 1,324.72 2
 SAMPLE 1 Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 99.80% 2 2 3 11.40% ScYYLPcFVTSK 95.00% 2.58 0.287 0 c2: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 762.8603 1,523.71 1,524.69 2
 SAMPLE 1R Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 99.80% 2 2 4 11.40% EGPFGTLVYTIK 95.00% 2.53 0.214 0 662.8607 1,323.71 1,324.72 2
 SAMPLE 1R Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 99.80% 2 2 4 11.40% EGPFGTLVYTIK 95.00% 2.66 0.423 2.68 662.8735 1,323.73 1,324.72 2
 SAMPLE 1R Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 99.80% 2 2 4 11.40% ScYYLPcFVTSK 95.00% 2.91 0.442 2.08 c2: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 762.8589 1,523.70 1,524.69 2
 SAMPLE 1R Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 99.80% 2 2 4 11.40% ScYYLPcFVTSK 95.00% 3.39 0.45 3.28 c2: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 762.8607 1,523.71 1,524.69 2
 SAMPLE 2 Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 4 4 7 21.30% LEVNKYQYLLTGR 95.00% 3.71 0.49 1.33 532.9614 1,595.86 1,596.88 3
 SAMPLE 2 Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 4 4 7 21.30% LEVNKYQYLLTGR 95.00% 4.19 0.496 1.18 532.9626 1,595.86 1,596.88 3
 SAMPLE 2 Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 4 4 7 21.30% WDQLTLSQR 95.00% 2.33 0.186 0 573.7994 1,145.58 1,146.59 2
 SAMPLE 2 Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 4 4 7 21.30% EGPFGTLVYTIK 95.00% 2.35 0.364 1.62 662.8605 1,323.71 1,324.72 2
 SAMPLE 2 Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 4 4 7 21.30% EGPFGTLVYTIK 95.00% 2.82 0.404 1.48 662.8612 1,323.71 1,324.72 2
 SAMPLE 2 Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 4 4 7 21.30% EGPFGTLVYTIK 95.00% 2.68 0.319 0 663.3617 1,324.71 1,324.72 2
 SAMPLE 2 Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 4 4 7 21.30% MYTGLcNFVER 95.00% 2.92 0.592 3.28 c6: Carbamidomethyl (+57.02) 695.3169 1,388.62 1,389.63 2
 SAMPLE 2R Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 3 3 7 15.20% WDQLTLSQR 95.00% 2.97 0.335 1.23 573.7973 1,145.58 1,146.59 2
 SAMPLE 2R Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 3 3 7 15.20% WDQLTLSQR 95.00% 3.19 0.39 1.55 573.7974 1,145.58 1,146.59 2
 SAMPLE 2R Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 3 3 7 15.20% WDQLTLSQR 95.00% 2.23 0.214 0 573.8019 1,145.59 1,146.59 2
 SAMPLE 2R Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 3 3 7 15.20% EGPFGTLVYTIK 95.00% 2.57 0.396 2.04 662.8594 1,323.70 1,324.72 2
 SAMPLE 2R Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 3 3 7 15.20% EGPFGTLVYTIK 95.00% 2.43 0.218 0 662.8603 1,323.71 1,324.72 2
 SAMPLE 2R Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 3 3 7 15.20% MYTGLcNFVER 95.00% 3.3 0.512 3.2 c6: Carbamidomethyl (+57.02) 695.3167 1,388.62 1,389.63 2
 SAMPLE 2R Metalloproteinase inhibitor 3  TIMP3  TIMP3_HUMAN 24,127.50 100.00% 3 3 7 15.20% MYTGLcNFVER 95.00% 3.05 0.471 3.29 c6: Carbamidomethyl (+57.02) 695.3169 1,388.62 1,389.63 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% GFYYSLKR 95.00% 2.37 0.398 0 517.2755 1,032.54 1,033.55 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% GFYYSLKR 95.00% 2.46 0.364 0 517.2756 1,032.54 1,033.55 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% GFYYSLKR 95.00% 2.22 0.437 0 517.2759 1,032.54 1,033.55 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% GFYYSLKR 95.00% 2.08 0.278 0 517.277 1,032.54 1,033.55 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% GFYYSLKR 95.00% 1.89 0.375 0 517.2784 1,032.54 1,033.55 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% FNGSVSFFR 95.00% 2.25 0.204 1.77 531.2535 1,060.49 1,060.52 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% FNGSVSFFR 95.00% 2.18 0.214 2.11 531.254 1,060.49 1,060.52 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% FNGSVSFFR 95.00% 2.27 0.175 1.52 531.2543 1,060.49 1,060.52 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% FNGSVSFFR 95.00% 2.24 0.2 2.26 531.2545 1,060.49 1,060.52 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% FNGSVSFFR 95.00% 2.28 0.172 1.59 531.2547 1,060.49 1,060.52 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% FNGSVSFFR 95.00% 2.56 0.263 0 531.2574 1,060.50 1,060.52 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% FNGSVSFFR 95.00% 2.32 0.293 0 531.2621 1,060.51 1,060.52 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% GWNDYKLGFGR 95.00% 3.54 0.47 3.24 656.8238 1,311.63 1,312.64 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% GWNDYKLGFGR 95.00% 3.34 0.447 2.43 656.8302 1,311.64 1,312.64 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% GWNDYKLGFGR 95.00% 3.56 0.463 2.96 656.8302 1,311.64 1,312.64 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% GWNDYKLGFGR 95.00% 3.63 0.471 2.74 657.3255 1,312.64 1,312.64 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.2 0.477 1.08 701.6952 2,102.06 2,102.07 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.12 0.466 2.47 701.696 2,102.06 2,102.07 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 2.78 0.415 0 701.6961 2,102.06 2,102.07 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 2.85 0.468 1.33 701.6963 2,102.07 2,102.07 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.19 0.486 0 701.6964 2,102.07 2,102.07 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.05 0.494 0 701.6971 2,102.07 2,102.07 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.07 0.406 0 701.7054 2,102.09 2,102.07 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNmHLLTLK 95.00% 2.32 0.46 0 m12: Oxidation (+15.99) 706.6927 2,117.05 2,118.07 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNmHLLTLK 95.00% 2.92 0.414 0 m12: Oxidation (+15.99) 706.6934 2,117.06 2,118.07 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNmHLLTLK 95.00% 3.12 0.474 1.01 m12: Oxidation (+15.99) 707.0284 2,118.06 2,118.07 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 3.24 0.363 2.14 c9: Carbamidomethyl (+57.02) 778.3753 2,332.10 2,332.08 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 4.37 0.46 3.08 c9: Carbamidomethyl (+57.02) 778.3769 2,332.11 2,332.08 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% FSTFDRDQDLFVQNcAALSSGAFWFR 95.00% 6.17 0.511 6.18 c15: Carbamidomethyl (+57.02) 1,029.48 3,085.42 3,085.43 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% FSTFDRDQDLFVQNcAALSSGAFWFR 95.00% 6.51 0.474 7.68 c15: Carbamidomethyl (+57.02) 1,029.49 3,085.46 3,085.43 3
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.45 0.614 3.89 1,051.54 2,101.06 2,102.07 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.61 0.559 4.89 1,052.04 2,102.06 2,102.07 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.55 0.554 4.3 1,052.04 2,102.06 2,102.07 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.33 0.516 4.39 1,052.04 2,102.06 2,102.07 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 4.94 0.566 3.14 1,052.04 2,102.07 2,102.07 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 4.3 0.538 3.62 1,052.04 2,102.07 2,102.07 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 4.03 0.392 3.12 1,052.04 2,102.07 2,102.07 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.72 0.447 1.28 1,052.04 2,102.07 2,102.07 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.45 0.572 4.13 1,052.04 2,102.07 2,102.07 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 4.92 0.571 4.18 1,052.05 2,102.09 2,102.07 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 2.95 0.377 2.27 1,052.05 2,102.09 2,102.07 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% ADGEYWLGLQNMHLLTLK 95.00% 4.72 0.574 4.17 1,052.07 2,102.12 2,102.07 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 6.19 0.663 7.8 c9: Carbamidomethyl (+57.02) 1,167.06 2,332.10 2,332.08 2
 SAMPLE 1 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 15 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 6.16 0.637 7.96 c9: Carbamidomethyl (+57.02) 1,167.06 2,332.11 2,332.08 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% GFYYSLKR 95.00% 2.15 0.256 0 517.2747 1,032.53 1,033.55 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% GFYYSLKR 95.00% 2.25 0.374 0 517.276 1,032.54 1,033.55 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% GFYYSLKR 95.00% 2.16 0.382 0 517.2763 1,032.54 1,033.55 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% GFYYSLKR 95.00% 1.97 0.375 0 517.2776 1,032.54 1,033.55 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% GFYYSLKR 95.00% 1.89 0.375 0 517.2784 1,032.54 1,033.55 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% GFYYSLKR 95.00% 2.08 0.35 0 517.2835 1,032.55 1,033.55 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FNGSVSFFR 95.00% 2.43 0.155 1.96 531.2533 1,060.49 1,060.52 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FNGSVSFFR 95.00% 2.18 0.252 1.33 531.2534 1,060.49 1,060.52 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FNGSVSFFR 95.00% 2.11 0.192 2.07 531.2547 1,060.49 1,060.52 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FNGSVSFFR 95.00% 2.32 0.257 2.51 531.2548 1,060.49 1,060.52 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FNGSVSFFR 95.00% 2.25 0.18 1.42 531.2549 1,060.49 1,060.52 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FNGSVSFFR 95.00% 2.28 0.208 2.7 531.255 1,060.49 1,060.52 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FNGSVSFFR 95.00% 2.34 0.123 1.35 531.2551 1,060.49 1,060.52 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FNGSVSFFR 95.00% 2.56 0.263 0 531.2574 1,060.50 1,060.52 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FNGSVSFFR 95.00% 2.32 0.293 1.16 531.2621 1,060.51 1,060.52 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FNGSVSFFR 95.00% 2.14 0.241 1.57 531.266 1,060.52 1,060.52 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FNGSVSFFR 95.00% 2.19 0.256 1.52 531.266 1,060.52 1,060.52 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FNGSVSFFR 95.00% 2.23 0.128 2.52 531.2662 1,060.52 1,060.52 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% GWNDYKLGFGR 95.00% 3.34 0.447 1.68 656.8302 1,311.64 1,312.64 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% GWNDYKLGFGR 95.00% 3.56 0.463 1.7 656.8302 1,311.64 1,312.64 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 2.48 0.441 0 701.3598 2,101.06 2,102.07 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 2.75 0.437 0 701.3602 2,101.06 2,102.07 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 2.79 0.198 0 701.6951 2,102.06 2,102.07 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 2.78 0.419 0 701.6953 2,102.06 2,102.07 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.03 0.436 1.29 701.696 2,102.06 2,102.07 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 2.93 0.332 0 701.6965 2,102.07 2,102.07 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.07 0.406 0 701.7054 2,102.09 2,102.07 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.29 0.396 0 701.7099 2,102.11 2,102.07 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNmHLLTLK 95.00% 2.39 0.385 0 m12: Oxidation (+15.99) 706.6938 2,117.06 2,118.07 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNmHLLTLK 95.00% 3.27 0.51 0 m12: Oxidation (+15.99) 707.0275 2,118.06 2,118.07 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNmHLLTLK 95.00% 2.92 0.47 2.04 m12: Oxidation (+15.99) 707.0276 2,118.06 2,118.07 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNmHLLTLK 95.00% 3.26 0.448 0 m12: Oxidation (+15.99) 707.0291 2,118.06 2,118.07 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 3.24 0.363 2.12 c9: Carbamidomethyl (+57.02) 778.3753 2,332.10 2,332.08 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 4.37 0.46 3.62 c9: Carbamidomethyl (+57.02) 778.3769 2,332.11 2,332.08 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FSTFDRDQDLFVQNcAALSSGAFWFR 95.00% 6.17 0.511 5.7 c15: Carbamidomethyl (+57.02) 1,029.48 3,085.42 3,085.43 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FSTFDRDQDLFVQNcAALSSGAFWFR 95.00% 6.51 0.474 8.4 c15: Carbamidomethyl (+57.02) 1,029.49 3,085.46 3,085.43 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% FSTFDRDQDLFVQNcAALSSGAFWFR 95.00% 0 0 4.6 c15: Carbamidomethyl (+57.02) 1,029.84 3,086.48 3,085.43 3
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.24 0.599 5.44 1,051.54 2,101.06 2,102.07 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.63 0.596 5.03 1,051.54 2,101.06 2,102.07 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.42 0.613 7.39 1,051.54 2,101.06 2,102.07 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.57 0.56 4.59 1,051.54 2,101.06 2,102.07 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.38 0.561 3.49 1,051.56 2,101.10 2,102.07 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.25 0.489 1.68 1,052.04 2,102.06 2,102.07 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.63 0.569 4.39 1,052.04 2,102.07 2,102.07 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 4.92 0.571 4.47 1,052.05 2,102.09 2,102.07 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.44 0.564 4.39 1,052.06 2,102.11 2,102.07 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNmHLLTLK 95.00% 4.6 0.444 4.05 m12: Oxidation (+15.99) 1,060.06 2,118.10 2,118.07 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% ADGEYWLGLQNmHLLTLK 95.00% 3.72 0.447 4.14 m12: Oxidation (+15.99) 1,060.06 2,118.11 2,118.07 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 5.82 0.659 8.06 c9: Carbamidomethyl (+57.02) 1,166.54 2,331.07 2,332.08 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 6.09 0.636 7.52 c9: Carbamidomethyl (+57.02) 1,167.04 2,332.07 2,332.08 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 6.19 0.663 7.72 c9: Carbamidomethyl (+57.02) 1,167.06 2,332.10 2,332.08 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 6.16 0.637 8.59 c9: Carbamidomethyl (+57.02) 1,167.06 2,332.11 2,332.08 2
 SAMPLE 1R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 18 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 5.48 0.582 7.28 c9: Carbamidomethyl (+57.02) 1,167.07 2,332.12 2,332.08 2
 SAMPLE 2R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 4 18.00% GFYYSLKR 95.00% 2.09 0.31 0 517.2769 1,032.54 1,033.55 2
 SAMPLE 2R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 4 18.00% GFYYSLKR 95.00% 2.16 0.242 0 517.2775 1,032.54 1,033.55 2
 SAMPLE 2R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 4 18.00% FNGSVSFFR 94.60% 1.86 0.204 1.37 531.2576 1,060.50 1,060.52 2
 SAMPLE 2R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 4 18.00% GWNDYKLGFGR 95.00% 3.44 0.46 2.68 656.8239 1,311.63 1,312.64 2
 SAMPLE 2R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 4 18.00% GWNDYKLGFGR 95.00% 3.42 0.448 2.21 656.8257 1,311.64 1,312.64 2
 SAMPLE 2R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 4 18.00% ADGEYWLGLQNMHLLTLK 95.00% 2.22 0.346 0 701.698 2,102.07 2,102.07 3
 SAMPLE 2R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 4 18.00% ADGEYWLGLQNMHLLTLK 95.00% 4.72 0.602 4.82 1,051.54 2,101.06 2,102.07 2
 SAMPLE 2R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 4 18.00% ADGEYWLGLQNMHLLTLK 95.00% 4.5 0.537 4.2 1,052.04 2,102.07 2,102.07 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% GFYYSLKR 95.00% 1.99 0.308 0 517.2747 1,032.53 1,033.55 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% GFYYSLKR 95.00% 2.32 0.477 0 517.2762 1,032.54 1,033.55 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% GFYYSLKR 95.00% 2.58 0.205 0 517.2763 1,032.54 1,033.55 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% GFYYSLKR 95.00% 2.43 0.408 0 517.2763 1,032.54 1,033.55 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% GFYYSLKR 95.00% 2.09 0.388 0 517.2766 1,032.54 1,033.55 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% FNGSVSFFR 95.00% 2.15 0.168 2.14 531.2541 1,060.49 1,060.52 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% FNGSVSFFR 95.00% 2.3 0.272 1.85 531.2547 1,060.49 1,060.52 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% FNGSVSFFR 95.00% 2.1 0.144 2.41 531.2549 1,060.49 1,060.52 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% GWNDYKLGFGR 95.00% 3.04 0.483 2.46 656.8227 1,311.63 1,312.64 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% GWNDYKLGFGR 95.00% 3.65 0.434 2.77 656.8246 1,311.63 1,312.64 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% GWNDYKLGFGR 95.00% 3.35 0.422 2.48 656.8247 1,311.63 1,312.64 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% GWNDYKLGFGR 95.00% 3.08 0.491 1.82 656.8253 1,311.64 1,312.64 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% GWNDYKLGFGR 95.00% 3.31 0.479 0 656.8257 1,311.64 1,312.64 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% GWNDYKLGFGR 95.00% 3.35 0.484 3.8 657.3248 1,312.63 1,312.64 2
 SAMPLE 3 Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 99.80% 2 2 11 18.00% ADGEYWLGLQNmHLLTLK 95.00% 4.18 0.468 3.96 m12: Oxidation (+15.99) 1,060.04 2,118.06 2,118.07 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% GFYYSLKR 95.00% 2.06 0.291 0 517.2757 1,032.54 1,033.55 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% GFYYSLKR 95.00% 2.15 0.386 0 517.2762 1,032.54 1,033.55 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% GFYYSLKR 95.00% 2.03 0.452 0 517.2762 1,032.54 1,033.55 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% GFYYSLKR 95.00% 1.94 0.343 0 517.2767 1,032.54 1,033.55 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% FNGSVSFFR 95.00% 2.2 0.143 1.51 531.2553 1,060.49 1,060.52 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% GWNDYKLGFGR 95.00% 2.72 0.422 1.92 656.8231 1,311.63 1,312.64 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% GWNDYKLGFGR 95.00% 2.8 0.415 0 656.8239 1,311.63 1,312.64 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% GWNDYKLGFGR 95.00% 3.44 0.433 1.72 656.8239 1,311.63 1,312.64 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% GWNDYKLGFGR 95.00% 3.18 0.483 1.89 656.8241 1,311.63 1,312.64 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% GWNDYKLGFGR 95.00% 3.44 0.483 2.17 656.8247 1,311.63 1,312.64 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% GWNDYKLGFGR 95.00% 3.31 0.473 1.96 657.3259 1,312.64 1,312.64 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.47 0.435 2.35 701.6954 2,102.06 2,102.07 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.49 0.5 1.52 701.6959 2,102.06 2,102.07 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.27 0.496 1.14 701.6959 2,102.06 2,102.07 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.05 0.446 0 701.696 2,102.06 2,102.07 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.59 0.476 0 701.6969 2,102.07 2,102.07 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 3.56 0.532 1.14 701.6971 2,102.07 2,102.07 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 2.95 0.385 2.14 701.6977 2,102.07 2,102.07 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNmHLLTLK 95.00% 2.73 0.345 0 m12: Oxidation (+15.99) 707.0285 2,118.06 2,118.07 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNmHLLTLK 95.00% 2.31 0.246 0 m12: Oxidation (+15.99) 707.0288 2,118.06 2,118.07 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNmHLLTLK 95.00% 3.35 0.395 0 m12: Oxidation (+15.99) 707.0302 2,118.07 2,118.07 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 3.67 0.498 2.44 c9: Carbamidomethyl (+57.02) 778.3674 2,332.08 2,332.08 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 2.87 0.281 1.28 c9: Carbamidomethyl (+57.02) 778.3693 2,332.08 2,332.08 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% FSTFDRDQDLFVQNcAALSSGAFWFR 95.00% 5.94 0.526 6.41 c15: Carbamidomethyl (+57.02) 1,029.48 3,085.41 3,085.43 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% FSTFDRDQDLFVQNcAALSSGAFWFR 95.00% 0 0 4.72 c15: Carbamidomethyl (+57.02) 1,029.81 3,086.41 3,085.43 3
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.44 0.547 4.77 1,052.04 2,102.06 2,102.07 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.76 0.569 4.11 1,052.04 2,102.06 2,102.07 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.3 0.557 7.27 1,052.04 2,102.07 2,102.07 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.2 0.533 4.85 1,052.04 2,102.07 2,102.07 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.48 0.579 4.82 1,052.04 2,102.07 2,102.07 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.23 0.571 4.96 1,052.04 2,102.07 2,102.07 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.35 0.569 5.12 1,052.04 2,102.07 2,102.07 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 4.82 0.575 4.09 1,052.04 2,102.07 2,102.07 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNMHLLTLK 95.00% 5.41 0.552 4.64 1,052.04 2,102.07 2,102.07 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% ADGEYWLGLQNmHLLTLK 95.00% 4.29 0.495 4.92 m12: Oxidation (+15.99) 1,060.04 2,118.06 2,118.07 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 6.41 0.611 6.21 c9: Carbamidomethyl (+57.02) 1,167.04 2,332.07 2,332.08 2
 SAMPLE 3R Microfibril-associated glycoprotein 4  MFAP4  MFAP4_HUMAN 28,631.30 100.00% 4 5 16 28.20% DQDLFVQNcAALSSGAFWFR 95.00% 6.33 0.596 11 c9: Carbamidomethyl (+57.02) 1,167.04 2,332.07 2,332.08 2
 SAMPLE 4R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.90% 2 2 2 0.93% AVLDALLEGK 95.00% 1.75 0.274 1.96 514.8044 1,027.59 1,028.60 2
 SAMPLE 4R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.90% 2 2 2 0.93% LSKPccYIFPGGR 95.00% 2.2 0.414 0 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 518.7245 1,553.15 1,554.76 3
 SAMPLE 1 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 10 1.86% AVLDALLEGK 95.00% 3.33 0.459 1.13 514.8012 1,027.59 1,028.60 2
 SAMPLE 1 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 10 1.86% AVLDALLEGK 95.00% 2.86 0.369 1.19 514.8015 1,027.59 1,028.60 2
 SAMPLE 1 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 10 1.86% AVLDALLEGK 95.00% 2.9 0.331 2.68 514.8019 1,027.59 1,028.60 2
 SAMPLE 1 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 10 1.86% AVLDALLEGK 95.00% 2.16 0.228 1.41 514.8059 1,027.60 1,028.60 2
 SAMPLE 1 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 10 1.86% AVLDALLEGK 95.00% 2.72 0.385 1.89 514.8094 1,027.60 1,028.60 2
 SAMPLE 1 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 10 1.86% AVLDALLEGK 95.00% 3.24 0.434 1.37 514.8097 1,027.60 1,028.60 2
 SAMPLE 1 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 10 1.86% SSYYVVSGNDPAAEEPSR 95.00% 4.65 0.592 5.89 964.44 1,926.86 1,927.87 2
 SAMPLE 1 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 10 1.86% SSYYVVSGNDPAAEEPSR 95.00% 4.83 0.584 6.05 964.9344 1,927.85 1,927.87 2
 SAMPLE 1 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 10 1.86% SSYYVVSGNDPAAEEPSR 95.00% 4.58 0.542 6.14 964.9362 1,927.86 1,927.87 2
 SAMPLE 1 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 10 1.86% VLFPGNSTQYNILEGLEK 95.00% 2.6 0.437 0 1,012.03 2,022.05 2,022.06 2
 SAMPLE 1R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.90% 2 2 6 1.13% AVLDALLEGK 95.00% 2.16 0.228 1.17 514.8059 1,027.60 1,028.60 2
 SAMPLE 1R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.90% 2 2 6 1.13% AVLDALLEGK 95.00% 2.72 0.385 1.77 514.8094 1,027.60 1,028.60 2
 SAMPLE 1R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.90% 2 2 6 1.13% AVLDALLEGK 95.00% 3.24 0.434 1.55 514.8097 1,027.60 1,028.60 2
 SAMPLE 1R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.90% 2 2 6 1.13% AVLDALLEGK 95.00% 3.41 0.371 2.04 514.8111 1,027.61 1,028.60 2
 SAMPLE 1R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.90% 2 2 6 1.13% AVLDALLEGK 95.00% 2.89 0.37 2.6 514.8115 1,027.61 1,028.60 2
 SAMPLE 1R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.90% 2 2 6 1.13% SSYYVVSGNDPAAEEPSR 95.00% 4.65 0.592 6.66 964.44 1,926.86 1,927.87 2
 SAMPLE 2 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.80% 2 2 5 1.13% AVLDALLEGK 95.00% 2.05 0.283 2.28 514.8014 1,027.59 1,028.60 2
 SAMPLE 2 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.80% 2 2 5 1.13% AVLDALLEGK 95.00% 3.51 0.493 1.24 514.8014 1,027.59 1,028.60 2
 SAMPLE 2 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.80% 2 2 5 1.13% AVLDALLEGK 95.00% 3.06 0.48 1.6 514.8016 1,027.59 1,028.60 2
 SAMPLE 2 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.80% 2 2 5 1.13% AVLDALLEGK 95.00% 2.76 0.395 2.2 514.8025 1,027.59 1,028.60 2
 SAMPLE 2 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 99.80% 2 2 5 1.13% SSYYVVSGNDPAAEEPSR 95.00% 4.99 0.544 3.42 964.9349 1,927.85 1,927.87 2
 SAMPLE 2R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 4 4 5 1.50% NVDVEFFK 95.00% 1.84 0.293 0 499.251 996.4864 997.4995 2
 SAMPLE 2R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 4 4 5 1.50% AVLDALLEGK 95.00% 3.28 0.468 2.85 514.8017 1,027.59 1,028.60 2
 SAMPLE 2R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 4 4 5 1.50% AVLDALLEGK 95.00% 2 0.291 1.44 514.8019 1,027.59 1,028.60 2
 SAMPLE 2R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 4 4 5 1.50% NVDVEFFKR 95.00% 2.83 0.372 1.23 577.3026 1,152.59 1,153.60 2
 SAMPLE 2R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 4 4 5 1.50% SSYYVVSGNDPAAEEPSR 95.00% 4.32 0.592 4.35 964.4355 1,926.86 1,927.87 2
 SAMPLE 3 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 4 4 7 2.15% AVLDALLEGK 95.00% 2.7 0.316 1.89 514.8009 1,027.59 1,028.60 2
 SAMPLE 3 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 4 4 7 2.15% AVLDALLEGK 95.00% 3.46 0.474 2.09 514.8015 1,027.59 1,028.60 2
 SAMPLE 3 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 4 4 7 2.15% AVLDALLEGK 95.00% 3.47 0.48 1.85 514.8024 1,027.59 1,028.60 2
 SAMPLE 3 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 4 4 7 2.15% TSDVGGYYYEK 95.00% 2.02 0.372 0 641.2877 1,280.56 1,281.56 2
 SAMPLE 3 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 4 4 7 2.15% TPDTSTYcYETAEK 95.00% 3.8 0.551 1.92 c8: Carbamidomethyl (+57.02) 833.8485 1,665.68 1,665.70 2
 SAMPLE 3 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 4 4 7 2.15% SSYYVVSGNDPAAEEPSR 95.00% 4.99 0.595 6.15 964.4356 1,926.86 1,927.87 2
 SAMPLE 3 Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 4 4 7 2.15% SSYYVVSGNDPAAEEPSR 95.00% 4.99 0.518 5.49 964.9375 1,927.86 1,927.87 2
 SAMPLE 3R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 8 1.86% AVLDALLEGK 95.00% 2.96 0.435 1.74 514.802 1,027.59 1,028.60 2
 SAMPLE 3R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 8 1.86% AVLDALLEGK 95.00% 2.05 0.211 2.13 514.8026 1,027.59 1,028.60 2
 SAMPLE 3R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 8 1.86% AVLDALLEGK 95.00% 2.43 0.254 2.33 514.8026 1,027.59 1,028.60 2
 SAMPLE 3R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 8 1.86% AVLDALLEGK 95.00% 2.03 0.197 2.24 514.8026 1,027.59 1,028.60 2
 SAMPLE 3R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 8 1.86% AVLDALLEGK 95.00% 1.94 0.212 1.46 514.8042 1,027.59 1,028.60 2
 SAMPLE 3R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 8 1.86% SSYYVVSGNDPAAEEPSR 95.00% 4.36 0.509 5.74 964.9384 1,927.86 1,927.87 2
 SAMPLE 3R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 8 1.86% VLFPGNSTQYNILEGLEK 95.00% 4.68 0.622 6.07 1,011.53 2,021.04 2,022.06 2
 SAMPLE 3R Microtubule-associated protein 1B  MAP1B  MAP1B_HUMAN 270,602.20 100.00% 3 3 8 1.86% VLFPGNSTQYNILEGLEK 95.00% 5.16 0.608 3.68 1,012.03 2,022.04 2,022.06 2
 SAMPLE 1 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 4 2.08% LATNTSAPDLK 95.00% 2.99 0.46 2.32 565.8039 1,129.59 1,130.61 2
 SAMPLE 1 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 4 2.08% LATNTSAPDLK 95.00% 2.81 0.383 1.18 565.8054 1,129.60 1,130.61 2
 SAMPLE 1 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 4 2.08% VALSSETEVALAR 95.00% 3.32 0.385 0 673.3662 1,344.72 1,345.73 2
 SAMPLE 1 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 4 2.08% VALSSETEVALAR 95.00% 2.58 0.201 1.47 673.3706 1,344.73 1,345.73 2
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% VGSLDNVGHLPAGGAVK 95.00% 2.25 0.355 2.37 530.9571 1,589.85 1,590.86 3
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% VGSLDNVGHLPAGGAVK 95.00% 2.43 0.367 2.32 530.9574 1,589.85 1,590.86 3
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% LATNTSAPDLK 95.00% 2.2 0.316 0 565.8011 1,129.59 1,130.61 2
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% LATNTSAPDLK 95.00% 2.23 0.379 0 565.8044 1,129.59 1,130.61 2
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% LATNTSAPDLK 95.00% 3.28 0.455 1.96 565.8044 1,129.59 1,130.61 2
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% LATNTSAPDLK 95.00% 2.51 0.286 0 565.8048 1,129.59 1,130.61 2
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% LATNTSAPDLK 95.00% 2.46 0.325 0 565.8054 1,129.60 1,130.61 2
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% LATNTSAPDLK 95.00% 2.67 0.344 2.15 565.8054 1,129.60 1,130.61 2
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% LATNTSAPDLK 95.00% 2.59 0.32 1.33 565.8056 1,129.60 1,130.61 2
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% LATNTSAPDLK 95.00% 2.86 0.408 2.07 565.8058 1,129.60 1,130.61 2
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% LATNTSAPDLK 95.00% 2.61 0.258 1.44 565.8059 1,129.60 1,130.61 2
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% LATNTSAPDLK 95.00% 2.41 0.352 0 566.2688 1,130.52 1,130.61 2
 SAMPLE 3 Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 3.47% QPAPTTIGGLNK 95.00% 1.86 0.352 0 598.8346 1,195.65 1,196.66 2 LU_HUMAN
 SAMPLE 3R Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 2.43% VGSLDNVGHLPAGGAVK 95.00% 2.3 0.179 0 530.9564 1,589.85 1,590.86 3
 SAMPLE 3R Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 2.43% VGSLDNVGHLPAGGAVK 95.00% 2.04 0.179 1.6 530.959 1,589.85 1,590.86 3
 SAMPLE 3R Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 2.43% LATNTSAPDLK 95.00% 2.54 0.339 0 565.8042 1,129.59 1,130.61 2
 SAMPLE 3R Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 2.43% LATNTSAPDLK 95.00% 2.62 0.365 2.26 565.8045 1,129.59 1,130.61 2
 SAMPLE 3R Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 2.43% LATNTSAPDLK 95.00% 2.25 0.25 0 565.8046 1,129.59 1,130.61 2
 SAMPLE 3R Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 2.43% LATNTSAPDLK 95.00% 2.79 0.391 0 565.805 1,129.59 1,130.61 2
 SAMPLE 3R Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 2.43% LATNTSAPDLK 95.00% 2.14 0.302 0 565.8051 1,129.59 1,130.61 2
 SAMPLE 3R Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 2.43% LATNTSAPDLK 95.00% 2.91 0.404 2.33 565.8054 1,129.60 1,130.61 2
 SAMPLE 3R Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 2.43% LATNTSAPDLK 95.00% 2.51 0.338 0 565.8057 1,129.60 1,130.61 2
 SAMPLE 3R Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 2.43% LATNTSAPDLK 95.00% 2.19 0.268 0 565.8059 1,129.60 1,130.61 2
 SAMPLE 3R Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 2.43% LATNTSAPDLK 95.00% 2.51 0.368 1.33 565.8065 1,129.60 1,130.61 2
 SAMPLE 3R Microtubule-associated protein 4  MAP4  MAP4_HUMAN 121,002.50 99.80% 2 2 12 2.43% LATNTSAPDLK 95.00% 2.46 0.221 0 565.8072 1,129.60 1,130.61 2
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% RLPIGSYF 95.00% 2.04 0.515 0 476.7679 951.5201 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% RLPIGSYF 95.00% 1.96 0.485 0 476.7679 951.5202 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% LEGNPIVLGK 95.00% 2.4 0.262 0 520.3123 1,038.61 1,039.62 2
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% LEGNPIVLGK 95.00% 3.04 0.375 1.15 520.3123 1,038.61 1,039.62 2
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% LEGNPIVLGK 95.00% 3.26 0.41 2.2 520.3124 1,038.61 1,039.62 2
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% LEGNPIVLGK 95.00% 3.11 0.453 1.33 520.3127 1,038.61 1,039.62 2
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% DFADIPNLR 95.00% 2.2 0.334 0 530.7751 1,059.53 1,060.54 2
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% DFADIPNLR 95.00% 2.24 0.382 0 530.7757 1,059.54 1,060.54 2
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% DFADIPNLR 95.00% 2.69 0.413 0 530.7758 1,059.54 1,060.54 2
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% DFADIPNLR 95.00% 2.58 0.423 1.38 530.7762 1,059.54 1,060.54 2
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% DFADIPNLR 95.00% 2.43 0.331 0 530.7766 1,059.54 1,060.54 2
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% HPNSFIcLK 95.00% 2.15 0.365 1.25 c7: Carbamidomethyl (+57.02) 558.2882 1,114.56 1,115.57 2
 SAMPLE 4 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 3 3 11 12.10% HPNSFIcLK 95.00% 1.88 0.289 0 c7: Carbamidomethyl (+57.02) 558.2888 1,114.56 1,115.57 2
 SAMPLE 4R Mimecan  OGN  MIME_HUMAN 33,907.00 99.90% 2 2 8 9.06% RLPIGSYF 95.00% 2.09 0.538 1.25 476.7685 951.5214 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 4R Mimecan  OGN  MIME_HUMAN 33,907.00 99.90% 2 2 8 9.06% RLPIGSYF 95.00% 2.14 0.542 1.33 476.7693 951.523 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 4R Mimecan  OGN  MIME_HUMAN 33,907.00 99.90% 2 2 8 9.06% LEGNPIVLGK 95.00% 2.49 0.208 0 520.3078 1,038.60 1,039.62 2
 SAMPLE 4R Mimecan  OGN  MIME_HUMAN 33,907.00 99.90% 2 2 8 9.06% LEGNPIVLGK 95.00% 3 0.489 1.55 520.3124 1,038.61 1,039.62 2
 SAMPLE 4R Mimecan  OGN  MIME_HUMAN 33,907.00 99.90% 2 2 8 9.06% LEGNPIVLGK 95.00% 2.75 0.427 1.77 520.3125 1,038.61 1,039.62 2
 SAMPLE 4R Mimecan  OGN  MIME_HUMAN 33,907.00 99.90% 2 2 8 9.06% DFADIPNLR 95.00% 2.49 0.406 0 530.7762 1,059.54 1,060.54 2
 SAMPLE 4R Mimecan  OGN  MIME_HUMAN 33,907.00 99.90% 2 2 8 9.06% DFADIPNLR 95.00% 2.49 0.363 1.46 530.7762 1,059.54 1,060.54 2
 SAMPLE 4R Mimecan  OGN  MIME_HUMAN 33,907.00 99.90% 2 2 8 9.06% DFADIPNLR 95.00% 2.59 0.394 0 530.7763 1,059.54 1,060.54 2
 SAMPLE 4R Mimecan  OGN  MIME_HUMAN 33,907.00 99.90% 2 2 8 9.06% DFADIPNLR 95.00% 2.72 0.413 2.06 530.7764 1,059.54 1,060.54 2
 SAMPLE 4R Mimecan  OGN  MIME_HUMAN 33,907.00 99.90% 2 2 8 9.06% DFADIPNLR 95.00% 2.25 0.28 1.82 530.7765 1,059.54 1,060.54 2
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% RLPIGSYF 95.00% 2.18 0.554 1.29 476.7655 951.5153 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% RLPIGSYF 95.00% 1.9 0.552 1.34 476.7657 951.5158 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% RLPIGSYF 95.00% 1.9 0.535 2.47 476.7696 951.5236 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% RLPIGSYF 95.00% 2.08 0.55 0 476.7715 951.5274 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% RLPIGSYF 95.00% 1.56 0.494 2.14 476.7725 951.5294 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% RLPIGSYF 95.00% 1.99 0.512 1.74 476.7728 951.5299 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% LPVLPPKLTLFNAK 95.00% 2.89 0.394 1.19 517.6578 1,549.95 1,550.97 3
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% LPVLPPKLTLFNAK 95.00% 3.04 0.446 2.08 517.6592 1,549.95 1,550.97 3
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% LPVLPPKLTLFNAK 95.00% 3.77 0.445 3.27 517.6663 1,549.98 1,550.97 3
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% DFADIPNLR 95.00% 2.55 0.401 1.25 530.7733 1,059.53 1,060.54 2
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% DFADIPNLR 95.00% 2.87 0.407 1.4 530.7735 1,059.53 1,060.54 2
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% DFADIPNLR 95.00% 2.84 0.371 1.66 530.7809 1,059.55 1,060.54 2
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% IEEIRLEGNPIVLGK 95.00% 3.67 0.395 3.77 840.4861 1,678.96 1,679.97 2
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% IEEIRLEGNPIVLGK 95.00% 3.88 0.465 4.82 840.487 1,678.96 1,679.97 2
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% IEEIRLEGNPIVLGK 95.00% 3.5 0.413 2.39 840.4952 1,678.97 1,679.97 2
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% IEEIRLEGNPIVLGK 95.00% 3.55 0.377 2.62 840.9888 1,679.96 1,679.97 2
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% LSLLEELSLAENQLLK 95.00% 3.54 0.474 1.34 907.0304 1,812.05 1,813.03 2
 SAMPLE 1 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 12 26.80% LDFTGNLIEDIEDGTFSK 95.00% 2.51 0.458 0 1,008.00 2,013.98 2,013.97 2
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% RLPIGSYF 95.00% 1.9 0.535 2.29 476.7696 951.5236 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% RLPIGSYF 95.00% 1.99 0.512 1.8 476.7728 951.5299 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% RLPIGSYF 94.70% 1.67 0.318 0 476.7745 951.5334 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% LPVLPPKLTLFNAK 95.00% 3.77 0.445 3.28 517.6663 1,549.98 1,550.97 3
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% DFADIPNLR 95.00% 2.27 0.313 0 530.7751 1,059.53 1,060.54 2
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% DFADIPNLR 95.00% 2.84 0.371 1.34 530.7809 1,059.55 1,060.54 2
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% DFADIPNLR 95.00% 2.96 0.388 1.85 530.7835 1,059.55 1,060.54 2
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% IEEIRLEGNPIVLGK 95.00% 3.88 0.465 4.16 840.487 1,678.96 1,679.97 2
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% IEEIRLEGNPIVLGK 95.00% 3.5 0.413 2.49 840.4952 1,678.97 1,679.97 2
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% IEEIRLEGNPIVLGK 95.00% 3.55 0.497 2.64 840.5025 1,678.99 1,679.97 2
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% LSLLEELSLAENQLLK 95.00% 3.74 0.474 0 907.0279 1,812.04 1,813.03 2
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% LSLLEELSLAENQLLK 95.00% 3.54 0.474 1.74 907.0304 1,812.05 1,813.03 2
 SAMPLE 1R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 5 10 26.80% LDFTGNLIEDIEDGTFSK 95.00% 2.51 0.458 1.32 1,008.00 2,013.98 2,013.97 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% RLPIGSYF 95.00% 2.24 0.549 1.21 476.7658 951.516 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% RLPIGSYF 95.00% 2.45 0.544 2.4 476.7659 951.5161 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% RLPIGSYF 95.00% 2.06 0.563 0 476.766 951.5163 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% RLPIGSYF 95.00% 2.14 0.525 1.68 476.7663 951.517 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% LTAKDFADIPNLR 95.00% 2.93 0.224 1 491.939 1,472.79 1,473.81 3
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% LTAKDFADIPNLR 95.00% 3.6 0.306 1.92 491.9402 1,472.80 1,473.81 3
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% LEGNPIVLGK 95.00% 2.19 0.436 0 520.3087 1,038.60 1,039.62 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% LEGNPIVLGK 95.00% 2.61 0.251 1.46 520.3087 1,038.60 1,039.62 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% LEGNPIVLGK 95.00% 3.27 0.427 1.36 520.3092 1,038.60 1,039.62 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% LEGNPIVLGK 95.00% 2.32 0.211 0 520.3092 1,038.60 1,039.62 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% LEGNPIVLGK 95.00% 3.11 0.443 1.35 520.31 1,038.60 1,039.62 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% LEGNPIVLGK 95.00% 3.33 0.487 1.46 520.3106 1,038.61 1,039.62 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% DFADIPNLR 95.00% 2.77 0.41 1.8 530.773 1,059.53 1,060.54 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% DFADIPNLR 95.00% 2.38 0.339 1.89 530.7732 1,059.53 1,060.54 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% DFADIPNLR 95.00% 2.62 0.405 1.48 530.7733 1,059.53 1,060.54 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% DFADIPNLR 95.00% 2.83 0.403 0 530.7738 1,059.53 1,060.54 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% DFADIPNLR 95.00% 2.82 0.409 1.28 530.7739 1,059.53 1,060.54 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% DFADIPNLR 95.00% 2.56 0.383 0 530.7739 1,059.53 1,060.54 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% DFADIPNLR 95.00% 2.57 0.41 1.4 530.7741 1,059.53 1,060.54 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% DFADIPNLR 95.00% 2.79 0.379 1.51 530.7741 1,059.53 1,060.54 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% DFADIPNLR 95.00% 2.74 0.417 1.68 530.7744 1,059.53 1,060.54 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% DFADIPNLR 95.00% 2.43 0.366 1.72 530.7748 1,059.53 1,060.54 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% KLTAKDFADIPNLR 95.00% 2.99 0.323 1.17 534.6381 1,600.89 1,601.90 3
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% DRIEEIRLEGNPIVLGK 95.00% 3.33 0.499 1.51 651.3698 1,951.09 1,951.10 3
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% DRIEEIRLEGNPIVLGK 95.00% 3.3 0.422 1.48 651.3715 1,951.09 1,951.10 3
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% LTAKDFADIPNLR 95.00% 3.75 0.419 0 737.9075 1,473.80 1,473.81 2
 SAMPLE 2 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 23 13.10% LTAKDFADIPNLR 95.00% 2.57 0.257 0 738.0398 1,474.06 1,473.81 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% RLPIGSYF 95.00% 1.86 0.562 1.64 476.7656 951.5155 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% RLPIGSYF 95.00% 1.62 0.358 0 476.7658 951.516 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% RLPIGSYF 95.00% 2.11 0.502 0 476.7659 951.5162 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% RLPIGSYF 95.00% 2 0.505 0 476.7668 951.5179 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% RLPIGSYF 95.00% 1.66 0.504 0 476.7678 951.52 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% LTAKDFADIPNLR 95.00% 2.49 0.203 0.959 491.9393 1,472.79 1,473.81 3
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% LTAKDFADIPNLR 95.00% 2.97 0.269 0 491.9398 1,472.80 1,473.81 3
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% LEGNPIVLGK 95.00% 2.4 0.291 1.38 520.3069 1,038.60 1,039.62 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% LEGNPIVLGK 95.00% 2.76 0.467 1.64 520.3096 1,038.60 1,039.62 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% LEGNPIVLGK 95.00% 2.92 0.461 1.28 520.3097 1,038.60 1,039.62 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% LEGNPIVLGK 95.00% 2.32 0.43 0 520.3101 1,038.60 1,039.62 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% LEGNPIVLGK 95.00% 2.8 0.399 1.28 520.3102 1,038.60 1,039.62 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% DFADIPNLR 95.00% 2.6 0.352 0 530.7728 1,059.53 1,060.54 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% DFADIPNLR 95.00% 2.16 0.284 0 530.7732 1,059.53 1,060.54 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% DFADIPNLR 95.00% 2.49 0.319 1.48 530.7737 1,059.53 1,060.54 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% DFADIPNLR 95.00% 2.62 0.454 1.46 530.7741 1,059.53 1,060.54 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% DFADIPNLR 95.00% 2.76 0.433 1.49 530.7741 1,059.53 1,060.54 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% DFADIPNLR 95.00% 2.73 0.299 1.52 530.7742 1,059.53 1,060.54 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% HPNSFIcLK 95.00% 2.15 0.266 0 c7: Carbamidomethyl (+57.02) 558.2856 1,114.56 1,115.57 2
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% DRIEEIRLEGNPIVLGK 95.00% 3.41 0.432 1.89 651.0368 1,950.09 1,951.10 3
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% DRIEEIRLEGNPIVLGK 95.00% 3.38 0.44 1.62 651.3716 1,951.09 1,951.10 3
 SAMPLE 2R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 5 6 17 15.80% LTAKDFADIPNLR 95.00% 2.7 0.368 0 737.7043 1,473.39 1,473.81 2
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% RLPIGSYF 95.00% 2.06 0.473 2.31 476.7654 951.5151 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% RLPIGSYF 95.00% 1.56 0.336 1.28 476.7657 951.5158 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% RLPIGSYF 95.00% 1.9 0.544 2.4 476.7669 951.5182 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% LTAKDFADIPNLR 95.00% 2.85 0.215 2.52 491.9394 1,472.79 1,473.81 3
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% LTAKDFADIPNLR 95.00% 3.18 0.24 1.66 492.2737 1,473.80 1,473.81 3
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% LPVLPPKLTLFNAK 95.00% 2.99 0.372 1.34 517.6593 1,549.95 1,550.97 3
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% LPVLPPKLTLFNAK 95.00% 2.99 0.391 2.82 517.6595 1,549.96 1,550.97 3
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% LEGNPIVLGK 95.00% 2.36 0.283 0 520.309 1,038.60 1,039.62 2
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% LEGNPIVLGK 95.00% 3.38 0.46 0 520.31 1,038.60 1,039.62 2
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% LEGNPIVLGK 95.00% 3.12 0.416 1.12 520.3102 1,038.60 1,039.62 2
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% DFADIPNLR 95.00% 2.66 0.379 0 530.7736 1,059.53 1,060.54 2
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% DFADIPNLR 95.00% 2.31 0.294 0 530.7737 1,059.53 1,060.54 2
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% DFADIPNLR 95.00% 2.62 0.345 0 530.774 1,059.53 1,060.54 2
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% KLTAKDFADIPNLR 95.00% 3.97 0.377 1.39 534.6393 1,600.89 1,601.90 3
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% KLTAKDFADIPNLR 95.00% 4.56 0.316 1.82 534.972 1,601.89 1,601.90 3
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% DRIEEIRLEGNPIVLGK 95.00% 3.5 0.46 1.62 651.3705 1,951.09 1,951.10 3
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% DRIEEIRLEGNPIVLGK 95.00% 3.47 0.411 1.38 651.3705 1,951.09 1,951.10 3
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% IEEIRLEGNPIVLGK 95.00% 3.66 0.429 3.54 840.4868 1,678.96 1,679.97 2
 SAMPLE 3 Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 7 7 16 17.80% IEEIRLEGNPIVLGK 95.00% 3.6 0.408 4 840.4875 1,678.96 1,679.97 2
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% RLPIGSYF 95.00% 2.11 0.561 2.43 476.7656 951.5155 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% RLPIGSYF 95.00% 2.04 0.489 0 476.7675 951.5194 952.5257 2 ,H2B1C_HUMAN,H2B1M_HUMAN,H2B1J_HUMAN,H2B1O_HUMAN,H2B1H_HUMAN,AEBP1_HUMAN,H2B1N_HUMAN,H2B1B_HUMAN,H2B1K_HUMAN,H2B1D_HUMAN
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% LTAKDFADIPNLR 95.00% 2.63 0.213 1.35 491.9398 1,472.80 1,473.81 3
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% LTAKDFADIPNLR 95.00% 2.49 0.194 1.4 492.274 1,473.80 1,473.81 3
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% LEGNPIVLGK 95.00% 2.6 0.311 0 520.3086 1,038.60 1,039.62 2
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% LEGNPIVLGK 95.00% 2.48 0.498 1.46 520.3094 1,038.60 1,039.62 2
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% LEGNPIVLGK 95.00% 3.11 0.426 1.64 520.3098 1,038.60 1,039.62 2
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% DFADIPNLR 95.00% 2.62 0.306 0 530.7728 1,059.53 1,060.54 2
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% DFADIPNLR 95.00% 2.32 0.335 0 530.7735 1,059.53 1,060.54 2
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% DFADIPNLR 95.00% 2.63 0.403 2.12 530.7738 1,059.53 1,060.54 2
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% DFADIPNLR 95.00% 2.69 0.379 1.42 530.774 1,059.53 1,060.54 2
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% DFADIPNLR 95.00% 2.3 0.404 1.14 530.7742 1,059.53 1,060.54 2
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% DFADIPNLR 95.00% 2.39 0.26 0 530.7751 1,059.53 1,060.54 2
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% KLTAKDFADIPNLR 95.00% 3.94 0.339 0 534.6374 1,600.89 1,601.90 3
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% KLTAKDFADIPNLR 95.00% 4.1 0.444 2.25 534.971 1,601.89 1,601.90 3
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% DRIEEIRLEGNPIVLGK 95.00% 3.44 0.412 1.19 651.0366 1,950.09 1,951.10 3
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% DRIEEIRLEGNPIVLGK 95.00% 3.41 0.424 1.15 651.371 1,951.09 1,951.10 3
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% IEEIRLEGNPIVLGK 95.00% 3.58 0.445 3.25 840.4862 1,678.96 1,679.97 2
 SAMPLE 3R Mimecan  OGN  MIME_HUMAN 33,907.00 100.00% 6 6 17 13.10% IEEIRLEGNPIVLGK 95.00% 3.47 0.401 2.19 840.4871 1,678.96 1,679.97 2
 SAMPLE 2 Mitochondrial inner membrane protein  IMMT  IMMT_HUMAN 83,661.00 99.80% 2 2 3 3.69% AVDEAADALLK 95.00% 2.65 0.287 1.66 558.3013 1,114.59 1,115.60 2
 SAMPLE 2 Mitochondrial inner membrane protein  IMMT  IMMT_HUMAN 83,661.00 99.80% 2 2 3 3.69% AVDEAADALLK 95.00% 3.14 0.313 1.57 558.8018 1,115.59 1,115.60 2
 SAMPLE 2 Mitochondrial inner membrane protein  IMMT  IMMT_HUMAN 83,661.00 99.80% 2 2 3 3.69% GIEQAVQSHAVAEEEAR 95.00% 3.37 0.346 2.32 608.6341 1,822.88 1,823.89 3
 SAMPLE 2R Mitochondrial inner membrane protein  IMMT  IMMT_HUMAN 83,661.00 99.80% 2 2 3 4.22% VVSQYHELVVQAR 95.00% 2.57 0.311 0 510.2809 1,527.82 1,527.83 3
 SAMPLE 2R Mitochondrial inner membrane protein  IMMT  IMMT_HUMAN 83,661.00 99.80% 2 2 3 4.22% VVSQYHELVVQAR 95.00% 2.61 0.333 0 510.2818 1,527.82 1,527.83 3
 SAMPLE 2R Mitochondrial inner membrane protein  IMMT  IMMT_HUMAN 83,661.00 99.80% 2 2 3 4.22% TSSAETPTIPLGSAVEAIK 95.00% 3.68 0.397 2.59 936.502 1,870.99 1,872.00 2
 SAMPLE 4R Moesin  MSN  MOES_HUMAN 67,803.80 99.80% 2 2 5 3.29% IGFPWSEIR 95.00% 2.4 0.331 0 552.7962 1,103.58 1,104.58 2
 SAMPLE 4R Moesin  MSN  MOES_HUMAN 67,803.80 99.80% 2 2 5 3.29% IGFPWSEIR 95.00% 2.48 0.366 0 552.7968 1,103.58 1,104.58 2
 SAMPLE 4R Moesin  MSN  MOES_HUMAN 67,803.80 99.80% 2 2 5 3.29% IGFPWSEIR 95.00% 2.38 0.324 1.21 553.298 1,104.58 1,104.58 2
 SAMPLE 4R Moesin  MSN  MOES_HUMAN 67,803.80 99.80% 2 2 5 3.29% APDFVFYAPR 95.00% 2.89 0.478 1.51 591.802 1,181.59 1,182.59 2
 SAMPLE 4R Moesin  MSN  MOES_HUMAN 67,803.80 99.80% 2 2 5 3.29% APDFVFYAPR 95.00% 2.34 0.364 1.96 592.3041 1,182.59 1,182.59 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% FVIKPIDK 95.00% 2.45 0.184 0 480.2991 958.5826 959.5932 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% ISQLEmAR 95.00% 2.16 0.24 0 m6: Oxidation (+15.99) 482.2486 962.4815 963.4934 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% AQMVQEDLEKTR 95.00% 2.33 0.345 0 483.2447 1,446.71 1,447.72 3
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% RKPDTIEVQQMK 95.00% 3.23 0.242 0 491.6013 1,471.78 1,472.79 3
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% RKPDTIEVQQMK 95.00% 3.67 0.414 0 491.6014 1,471.78 1,472.79 3
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% ALTSELANAR 95.00% 3.1 0.44 1.4 523.2835 1,044.55 1,045.56 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% ALTSELANAR 95.00% 3.37 0.45 1.57 523.2846 1,044.55 1,045.56 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% EDAVLEYLK 95.00% 2.43 0.401 0 540.2827 1,078.55 1,079.56 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% EDAVLEYLK 95.00% 2.31 0.415 0 540.2827 1,078.55 1,079.56 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% ALTSELANARDESKK 95.00% 1.84 0.296 0 544.9557 1,631.84 1,632.86 3
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% IGFPWSEIR 95.00% 2.87 0.373 1.46 552.794 1,103.57 1,104.58 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% IGFPWSEIR 95.00% 2.63 0.257 0 552.7941 1,103.57 1,104.58 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% IGFPWSEIR 95.00% 2.95 0.351 1.74 552.7946 1,103.57 1,104.58 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% IGFPWSEIR 95.00% 2.78 0.342 1.15 552.7947 1,103.57 1,104.58 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% IGFPWSEIR 95.00% 2.23 0.272 2.4 552.795 1,103.57 1,104.58 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% IGFPWSEIR 95.00% 2.26 0.242 0 552.802 1,103.59 1,104.58 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% IGFPWSEIR 95.00% 2.3 0.233 0 552.8024 1,103.59 1,104.58 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% IGFPWSEIR 95.00% 2.24 0.281 1.25 552.8049 1,103.59 1,104.58 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% IGFPWSEIR 95.00% 2.23 0.275 1.17 552.8053 1,103.60 1,104.58 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% TQEQLALEMAELTAR 95.00% 3.12 0.396 1.92 568.6253 1,702.85 1,703.86 3
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% APDFVFYAPR 95.00% 2.05 0.386 1.47 591.7984 1,181.58 1,182.59 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% APDFVFYAPR 95.00% 3.36 0.482 1.7 591.7992 1,181.58 1,182.59 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% APDFVFYAPR 95.00% 4.01 0.565 1.35 591.7993 1,181.58 1,182.59 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% APDFVFYAPR 95.00% 3.98 0.534 2.12 591.7997 1,181.58 1,182.59 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% KAPDFVFYAPR 95.00% 2.66 0.476 2.8 655.8476 1,309.68 1,310.69 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% KAPDFVFYAPR 95.00% 2.31 0.421 2.92 655.8492 1,309.68 1,310.69 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% ALTSELANARDESK 95.00% 3.6 0.401 3.46 752.882 1,503.75 1,504.76 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% ALTSELANARDESK 95.00% 3.73 0.49 7.06 752.8837 1,503.75 1,504.76 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% QEAEEAKEALLQASR 95.00% 4.44 0.503 1.85 836.9267 1,671.84 1,672.85 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% QEAEEAKEALLQASR 95.00% 4.07 0.376 0 836.9278 1,671.84 1,672.85 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% TQEQLALEMAELTAR 95.00% 5.26 0.577 6.85 852.4316 1,702.85 1,703.86 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% KTQEQLALEMAELTAR 95.00% 4.77 0.548 7.52 916.482 1,830.95 1,831.96 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% KTQEQLALEMAELTAR 95.00% 4.93 0.534 5.13 916.9816 1,831.95 1,831.96 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% ERQEAEEAKEALLQASR 95.00% 5.15 0.591 4.59 979.4972 1,956.98 1,957.99 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% ERQEAEEAKEALLQASR 95.00% 5.4 0.591 4.92 979.5007 1,956.99 1,957.99 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% VTTMDAELEFAIQPNTTGK 95.00% 5.32 0.6 4.42 1,033.51 2,064.99 2,066.01 2
 SAMPLE 1 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 17 37 23.60% VTTMDAELEFAIQPNTTGK 95.00% 4.98 0.593 3.08 1,033.51 2,065.00 2,066.01 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% SGYLAGDKLLPQR 95.00% 2.78 0.234 1.7 473.2653 1,416.77 1,417.78 3
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% SGYLAGDKLLPQR 95.00% 3.01 0.226 1 473.5989 1,417.77 1,417.78 3
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% FVIKPIDK 95.00% 2.46 0.175 0 480.2997 958.5838 959.5932 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% ISQLEmAR 95.00% 2.25 0.244 0 m6: Oxidation (+15.99) 482.25 962.4843 963.4934 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% ISQLEmAR 95.00% 2.21 0.278 1.19 m6: Oxidation (+15.99) 482.2501 962.4846 963.4934 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% AQMVQEDLEKTR 95.00% 2.42 0.319 0 483.2441 1,446.71 1,447.72 3
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% RKPDTIEVQQMK 95.00% 3.9 0.352 0 491.601 1,471.78 1,472.79 3
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% RKPDTIEVQQMK 95.00% 3.29 0.429 0 491.6013 1,471.78 1,472.79 3
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% ALTSELANAR 95.00% 2.67 0.397 1.49 523.2844 1,044.55 1,045.56 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% ALTSELANAR 95.00% 2.74 0.364 1.96 523.2846 1,044.55 1,045.56 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.64 0.344 1.16 552.7935 1,103.57 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.02 0.269 0 552.7937 1,103.57 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.05 0.259 1.57 552.794 1,103.57 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.91 0.362 1.92 552.794 1,103.57 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.66 0.157 0 552.794 1,103.57 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.94 0.337 1.47 552.7945 1,103.57 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.73 0.336 1.26 552.7946 1,103.57 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.12 0.211 1.4 552.795 1,103.57 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2 0.215 2 552.7953 1,103.57 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.11 0.265 1.51 552.7962 1,103.58 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.29 0.291 1.42 552.797 1,103.58 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.26 0.242 0 552.802 1,103.59 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.3 0.233 0 552.8024 1,103.59 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% IGFPWSEIR 95.00% 2.43 0.174 0 552.8044 1,103.59 1,104.58 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% TQEQLALEMAELTAR 95.00% 3.53 0.44 1.77 568.6255 1,702.85 1,703.86 3
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% APDFVFYAPR 95.00% 3.38 0.445 1.57 591.799 1,181.58 1,182.59 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% APDFVFYAPR 95.00% 3.91 0.547 1.96 591.7993 1,181.58 1,182.59 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% APDFVFYAPR 95.00% 3.89 0.535 1.92 591.7998 1,181.58 1,182.59 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% APDFVFYAPR 95.00% 3.18 0.415 1.68 591.8011 1,181.59 1,182.59 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% APDFVFYAPR 95.00% 2.62 0.421 2.17 591.8094 1,181.60 1,182.59 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% KAPDFVFYAPR 95.00% 2.21 0.437 0 655.8469 1,309.68 1,310.69 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% KAPDFVFYAPR 95.00% 2.71 0.565 2.44 655.8484 1,309.68 1,310.69 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% AQMVQEDLEKTR 95.00% 2.52 0.412 1.72 724.3637 1,446.71 1,447.72 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% ALTSELANARDESK 95.00% 3.65 0.389 5.41 752.8841 1,503.75 1,504.76 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% EVWFFGLQYQDTK 95.00% 3.84 0.532 4.17 830.9064 1,659.80 1,660.80 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% TQEQLALEMAELTAR 95.00% 5.34 0.58 6.1 852.4338 1,702.85 1,703.86 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% TQEQLALEMAELTAR 95.00% 5.2 0.58 6.22 852.4342 1,702.85 1,703.86 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% KTQEQLALEMAELTAR 95.00% 4.7 0.54 6.4 916.4777 1,830.94 1,831.96 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% KTQEQLALEMAELTAR 95.00% 4.49 0.546 5.68 916.9819 1,831.95 1,831.96 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% VTTMDAELEFAIQPNTTGK 95.00% 5.55 0.633 4.77 1,034.01 2,066.00 2,066.01 2
 SAMPLE 1R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 14 16 41 23.40% VTTMDAELEFAIQPNTTGK 95.00% 5.55 0.623 4.52 1,034.01 2,066.00 2,066.01 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% AQMVQEDLEKTR 95.00% 2.79 0.408 0 483.2444 1,446.71 1,447.72 3
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% EDAVLEYLK 95.00% 2.42 0.41 0 540.2835 1,078.55 1,079.56 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% EDAVLEYLK 95.00% 2.19 0.361 0 540.2848 1,078.55 1,079.56 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% IGFPWSEIR 95.00% 2.92 0.352 0 552.7941 1,103.57 1,104.58 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% IGFPWSEIR 95.00% 2.79 0.343 1.66 552.7942 1,103.57 1,104.58 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% IGFPWSEIR 95.00% 3 0.331 1.8 552.7944 1,103.57 1,104.58 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% APDFVFYAPR 95.00% 3.84 0.535 2.32 591.8001 1,181.58 1,182.59 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% APDFVFYAPR 95.00% 4.03 0.562 1.64 591.8001 1,181.58 1,182.59 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% AQMVQEDLEK 95.00% 2.72 0.429 1.59 595.7884 1,189.56 1,190.57 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% AQMVQEDLEK 95.00% 2.81 0.444 1.3 595.7892 1,189.56 1,190.57 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% KAPDFVFYAPR 95.00% 2.73 0.479 1.72 655.8464 1,309.68 1,310.69 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% KAPDFVFYAPR 95.00% 2.66 0.515 3.54 655.8484 1,309.68 1,310.69 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% ALTSELANARDESKK 95.00% 3.93 0.373 0 817.435 1,632.85 1,632.86 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% TQEQLALEMAELTAR 95.00% 5.64 0.566 5.89 852.9331 1,703.85 1,703.86 2
 SAMPLE 2 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 9 9 15 12.50% KTQEQLALEMAELTAR 95.00% 4.44 0.582 6.21 916.4814 1,830.95 1,831.96 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% SGYLAGDKLLPQR 95.00% 2.54 0.19 0 473.5988 1,417.77 1,417.78 3
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% ISQLEMAR 95.00% 2.31 0.225 0 474.5817 947.1477 947.4985 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% AQMVQEDLEKTR 95.00% 2.07 0.286 0 483.2445 1,446.71 1,447.72 3
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% AQMVQEDLEKTR 95.00% 2.56 0.326 0 483.246 1,446.71 1,447.72 3
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% RKPDTIEVQQMK 95.00% 3.3 0.331 0 491.5995 1,471.78 1,472.79 3
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% RKPDTIEVQQMK 95.00% 3.61 0.425 0 491.6017 1,471.78 1,472.79 3
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% IGFPWSEIR 95.00% 2.98 0.332 1.72 552.794 1,103.57 1,104.58 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% IGFPWSEIR 95.00% 2.97 0.345 1.33 552.7943 1,103.57 1,104.58 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% IGFPWSEIR 95.00% 2.5 0.28 0 552.7944 1,103.57 1,104.58 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% IGFPWSEIR 95.00% 2.6 0.358 1.7 552.7944 1,103.57 1,104.58 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% TQEQLALEMAELTAR 95.00% 3.67 0.31 1.8 568.9589 1,703.85 1,703.86 3
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% TQEQLALEMAELTAR 95.00% 4.02 0.318 2.82 568.9593 1,703.85 1,703.86 3
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% APDFVFYAPR 95.00% 4 0.567 1.62 591.7993 1,181.58 1,182.59 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% APDFVFYAPR 95.00% 4.01 0.55 0 591.7998 1,181.58 1,182.59 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% APDFVFYAPR 95.00% 3.21 0.431 1.24 591.8004 1,181.59 1,182.59 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% AQMVQEDLEK 95.00% 2.7 0.438 2.11 595.7892 1,189.56 1,190.57 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% TQEQLALEMAELTAR 95.00% 5.22 0.584 6.07 852.4325 1,702.85 1,703.86 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% TQEQLALEMAELTAR 95.00% 5.54 0.542 6.52 852.4342 1,702.85 1,703.86 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% KTQEQLALEMAELTAR 95.00% 4.35 0.561 6.82 916.4808 1,830.95 1,831.96 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% KTQEQLALEMAELTAR 95.00% 4.61 0.51 5.11 916.9828 1,831.95 1,831.96 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% ERQEAEEAKEALLQASR 95.00% 5.33 0.595 5.19 979.9987 1,957.98 1,957.99 2
 SAMPLE 2R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 11 12 22 20.10% VTTMDAELEFAIQPNTTGK 95.00% 4.34 0.598 2.62 1,034.01 2,066.00 2,066.01 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% TANDMIHAENMR 95.00% 1.95 0.307 0 468.2116 1,401.61 1,402.62 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% TANDMIHAENMR 95.00% 1.94 0.251 0 468.2118 1,401.61 1,402.62 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% SGYLAGDKLLPQR 95.00% 3.22 0.265 1.42 473.2642 1,416.77 1,417.78 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% SGYLAGDKLLPQR 95.00% 3.15 0.317 1.44 473.2663 1,416.78 1,417.78 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% ISQLEMAR 95.00% 2.59 0.137 0 474.2527 946.4897 947.4985 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% ISQLEMAR 95.00% 2.56 0.192 0 474.2536 946.4915 947.4985 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% FVIKPIDK 95.00% 2.54 0.208 0 480.2994 958.5831 959.5932 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% FVIKPIDK 95.00% 2.51 0.21 0 480.2995 958.5834 959.5932 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% AQMVQEDLEKTR 95.00% 2.12 0.25 0 483.2448 1,446.71 1,447.72 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% KTANDMIHAENMR 95.00% 3.28 0.358 0 510.9089 1,529.70 1,530.72 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% KTANDMIHAENMR 95.00% 3.79 0.403 0.959 511.244 1,530.71 1,530.72 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% EDAVLEYLK 95.00% 2.58 0.396 0 540.2835 1,078.55 1,079.56 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% EDAVLEYLK 95.00% 2.53 0.434 0 540.2838 1,078.55 1,079.56 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% IGFPWSEIR 95.00% 2.78 0.362 2.32 552.794 1,103.57 1,104.58 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% IGFPWSEIR 95.00% 2.11 0.311 0 552.7945 1,103.57 1,104.58 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% IGFPWSEIR 95.00% 3.03 0.342 1.24 552.7946 1,103.57 1,104.58 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% IGFPWSEIR 95.00% 2.95 0.332 1.46 552.795 1,103.57 1,104.58 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% IGFPWSEIR 95.00% 2.82 0.342 1.25 552.7951 1,103.57 1,104.58 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% QEAEEAKEALLQASR 95.00% 3.28 0.42 0 558.2874 1,671.84 1,672.85 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% TQEQLALEMAELTAR 95.00% 4.66 0.389 2.31 568.9595 1,703.86 1,703.86 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% AQMVQEDLEK 95.00% 2.93 0.434 1.38 595.7886 1,189.56 1,190.57 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% AQMVQEDLEK 95.00% 2.83 0.388 1.57 595.7893 1,189.56 1,190.57 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% VLEQHKLNKDQWEER 95.00% 3.16 0.217 1.3 651.6713 1,951.99 1,952.00 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% ERQEAEEAKEALLQASR 95.00% 4.83 0.532 2.66 653.3353 1,956.98 1,957.99 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% ERQEAEEAKEALLQASR 95.00% 4.68 0.513 3.1 653.6699 1,957.99 1,957.99 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% ERQEAEEAKEALLQASR 95.00% 3.01 0.351 1.64 653.6711 1,957.99 1,957.99 3
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% KAPDFVFYAPR 95.00% 2.88 0.512 3.01 655.8478 1,309.68 1,310.69 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% KAPDFVFYAPR 95.00% 2.9 0.38 3.48 655.8484 1,309.68 1,310.69 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% SGYLAGDKLLPQR 95.00% 2.03 0.246 2.47 709.3937 1,416.77 1,417.78 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% AQMVQEDLEKTR 95.00% 3.2 0.524 3.51 724.3653 1,446.71 1,447.72 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% AQMVQEDLEKTR 95.00% 3.02 0.507 2.82 724.3659 1,446.72 1,447.72 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% ALTSELANARDESK 95.00% 4 0.413 5.85 752.884 1,503.75 1,504.76 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% QEAEEAKEALLQASR 95.00% 4.57 0.569 2.74 836.9306 1,671.85 1,672.85 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% TQEQLALEMAELTAR 95.00% 5.65 0.6 6.25 852.4342 1,702.85 1,703.86 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% TQEQLALEMAELTAR 95.00% 5.36 0.595 5.77 852.4347 1,702.85 1,703.86 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% ERQEAEEAKEALLQASR 95.00% 5.61 0.593 2.89 980.0009 1,957.99 1,957.99 2
 SAMPLE 3 Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 16 21 37 28.20% VTTMDAELEFAIQPNTTGK 95.00% 5.64 0.615 4.89 1,034.01 2,066.00 2,066.01 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% TANDMIHAENMR 95.00% 1.89 0.255 0 468.2128 1,401.61 1,402.62 3
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% SGYLAGDKLLPQR 95.00% 2.46 0.358 0 473.2652 1,416.77 1,417.78 3
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% AQMVQEDLEKTR 95.00% 2.69 0.342 0 483.2454 1,446.71 1,447.72 3
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% AQMVQEDLEKTR 95.00% 2.16 0.277 0 483.5813 1,447.72 1,447.72 3
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% RKPDTIEVQQMK 95.00% 2.23 0.28 0 491.6013 1,471.78 1,472.79 3
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% KTANDMIHAENMR 95.00% 3.8 0.382 0 511.2422 1,530.70 1,530.72 3
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% ALTSELANAR 95.00% 3.39 0.441 2.01 523.285 1,044.55 1,045.56 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% ALTSELANAR 95.00% 3.03 0.426 1.96 523.2853 1,044.56 1,045.56 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% EDAVLEYLK 95.00% 2.56 0.334 0 540.284 1,078.55 1,079.56 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% EDAVLEYLK 95.00% 2.47 0.452 0 540.2845 1,078.55 1,079.56 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% IGFPWSEIR 95.00% 2.9 0.364 1.6 552.7944 1,103.57 1,104.58 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% IGFPWSEIR 95.00% 2.59 0.346 1.89 552.7944 1,103.57 1,104.58 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% IGFPWSEIR 95.00% 2.9 0.368 2 552.7947 1,103.57 1,104.58 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% IGFPWSEIR 95.00% 2.74 0.351 1.52 552.7948 1,103.57 1,104.58 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% IGFPWSEIR 95.00% 2 0.254 1.6 552.7959 1,103.58 1,104.58 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% APDFVFYAPR 95.00% 3.38 0.528 1.7 591.7999 1,181.58 1,182.59 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% APDFVFYAPR 95.00% 3.84 0.543 2.09 591.8006 1,181.59 1,182.59 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% APDFVFYAPR 95.00% 2.48 0.46 1.19 591.9666 1,181.92 1,182.59 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% AQMVQEDLEK 95.00% 2.89 0.45 1.24 595.7895 1,189.56 1,190.57 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% AQMVQEDLEK 95.00% 2.91 0.473 0 595.7898 1,189.56 1,190.57 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% KAPDFVFYAPR 95.00% 2.59 0.266 1.38 655.847 1,309.68 1,310.69 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% KAPDFVFYAPR 95.00% 2.75 0.522 2.27 655.8477 1,309.68 1,310.69 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% TANDMIHAENMR 95.00% 3.38 0.444 2.82 701.811 1,401.61 1,402.62 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% TANDMIHAENMR 95.00% 3.34 0.472 2.89 701.8144 1,401.61 1,402.62 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% SGYLAGDKLLPQR 95.00% 2.02 0.266 1.8 709.3919 1,416.77 1,417.78 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% AQMVQEDLEKTR 95.00% 2.27 0.412 1.85 724.3642 1,446.71 1,447.72 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% AQMVQEDLEKTR 95.00% 2.77 0.49 1.96 724.3661 1,446.72 1,447.72 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% TQEQLALEMAELTAR 95.00% 5.27 0.584 5.28 852.4331 1,702.85 1,703.86 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% TQEQLALEMAELTAR 95.00% 5.17 0.575 5.55 852.4355 1,702.86 1,703.86 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% KTQEQLALEMAELTAR 95.00% 5.21 0.539 5.24 916.9843 1,831.95 1,831.96 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% ERQEAEEAKEALLQASR 95.00% 5.24 0.581 4 980.0029 1,957.99 1,957.99 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% VTTMDAELEFAIQPNTTGK 95.00% 5.07 0.639 4.15 1,033.51 2,065.00 2,066.01 2
 SAMPLE 3R Moesin  MSN  MOES_HUMAN 67,803.80 100.00% 15 18 33 24.40% VTTMDAELEFAIQPNTTGK 95.00% 4.38 0.52 3.68 1,034.01 2,066.00 2,066.01 2
 SAMPLE 3R Mucin-16  MUC16  MUC16_HUMAN 2,353,420.80 99.80% 2 2 2 0.18% LVTSmVTSLAAKTSTTNR 95.00% 2.41 0.213 0 m5: Oxidation (+15.99) 632.8358 1,895.48 1,897.01 3
 SAMPLE 3R Mucin-16  MUC16  MUC16_HUMAN 2,353,420.80 99.80% 2 2 2 0.18% LRETSTSEETSLATEANTVLSK 95.00% 2.31 0.276 0 789.8884 2,366.64 2,367.19 3
 SAMPLE 4R Myeloblastin  PRTN3  PRTN3_HUMAN 27,788.50 99.80% 2 2 3 14.10% LVNVVLGAHNVR 95.00% 2.93 0.292 2.57 645.8839 1,289.75 1,290.76 2
 SAMPLE 4R Myeloblastin  PRTN3  PRTN3_HUMAN 27,788.50 99.80% 2 2 3 14.10% LVNVVLGAHNVR 95.00% 3.23 0.404 2.08 645.886 1,289.76 1,290.76 2
 SAMPLE 4R Myeloblastin  PRTN3  PRTN3_HUMAN 27,788.50 99.80% 2 2 3 14.10% mAHRPPSPALASVLLALLLSGAAR 95.00% 2.24 0.334 0 m1: Oxidation (+15.99) 810.4136 2,428.22 2,428.39 3
 SAMPLE 4 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 99.90% 2 2 7 1.36% AGESVELFGK 95.00% 2.54 0.207 2.82 518.7694 1,035.52 1,036.53 2
 SAMPLE 4 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 99.90% 2 2 7 1.36% AGESVELFGK 95.00% 2.49 0.214 2.47 518.7701 1,035.52 1,036.53 2
 SAMPLE 4 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 99.90% 2 2 7 1.36% AGESVELFGK 95.00% 2.19 0.219 2.62 518.7705 1,035.53 1,036.53 2
 SAMPLE 4 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 99.90% 2 2 7 1.36% AGESVELFGK 95.00% 2.45 0.203 2.89 518.7707 1,035.53 1,036.53 2
 SAMPLE 4 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 99.90% 2 2 7 1.36% AGESVELFGK 95.00% 2.32 0.218 1.24 518.771 1,035.53 1,036.53 2
 SAMPLE 4 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 99.90% 2 2 7 1.36% AGESVELFGK 95.00% 2.57 0.232 0 518.7715 1,035.53 1,036.53 2
 SAMPLE 4 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 99.90% 2 2 7 1.36% SSLPPVLGTESDATVK 95.00% 3.28 0.484 0 800.9257 1,599.84 1,600.84 2
 SAMPLE 1 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 4 4 5 2.46% LIDFGLAR 95.00% 2.59 0.22 0 452.7674 903.5191 904.5258 2 FHL5_HUMAN
 SAMPLE 1 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 4 4 5 2.46% LIDFGLAR 95.00% 2.72 0.22 0 452.7676 903.5196 904.5258 2 FHL5_HUMAN
 SAMPLE 1 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 4 4 5 2.46% AGESVELFGK 95.00% 1.95 0.247 2.21 518.7679 1,035.52 1,036.53 2
 SAMPLE 1 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 4 4 5 2.46% KKLPAENGSSSAETLNAK 95.00% 3.02 0.483 3.2 615.991 1,844.95 1,844.97 3
 SAMPLE 1 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 4 4 5 2.46% IIDEDFELTER 95.00% 2.34 0.229 1.6 690.3363 1,378.66 1,379.67 2
 SAMPLE 1R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 4 4 6 2.61% LIDFGLAR 95.00% 2.87 0.225 0 452.7671 903.5186 904.5258 2 FHL5_HUMAN
 SAMPLE 1R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 4 4 6 2.61% LIDFGLAR 95.00% 2.89 0.256 0 452.7673 903.519 904.5258 2 FHL5_HUMAN
 SAMPLE 1R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 4 4 6 2.61% TIRDLEVVEGSAAR 95.00% 3.01 0.273 1.09 505.9406 1,514.80 1,515.81 3
 SAMPLE 1R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 4 4 6 2.61% AGESVELFGK 95.00% 2.12 0.211 1.3 518.7682 1,035.52 1,036.53 2
 SAMPLE 1R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 4 4 6 2.61% AGESVELFGK 95.00% 2.23 0.189 1.96 518.7699 1,035.52 1,036.53 2
 SAMPLE 1R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 4 4 6 2.61% KKLPAENGSSSAETLNAK 95.00% 2.69 0.373 2.74 615.9922 1,844.95 1,844.97 3
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% LIDFGLAR 95.00% 2.33 0.219 0 452.7673 903.5189 904.5258 2 FHL5_HUMAN
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% LIDFGLAR 95.00% 2.49 0.191 0 452.7675 903.5194 904.5258 2 FHL5_HUMAN
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% LIDFGLAR 95.00% 2.36 0.184 0 452.7676 903.5195 904.5258 2 FHL5_HUMAN
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% LIDFGLAR 95.00% 2.96 0.201 0 452.7677 903.5197 904.5258 2 FHL5_HUMAN
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% AGESVELFGK 95.00% 2.85 0.203 2.6 518.7683 1,035.52 1,036.53 2
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% AGESVELFGK 95.00% 3 0.204 2.89 518.7683 1,035.52 1,036.53 2
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% KKLPAENGSSSAETLNAK 95.00% 3.46 0.464 3.55 615.9898 1,844.95 1,844.97 3
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% QISEGVEYIHK 95.00% 2.46 0.341 1.37 651.8367 1,301.66 1,302.67 2
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% LSSMAMISGLSGR 95.00% 2.82 0.351 2.04 655.3341 1,308.65 1,309.66 2
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% LSSMAMISGLSGR 95.00% 3.25 0.47 6.06 655.3343 1,308.65 1,309.66 2
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% LSSMAMISGLSGR 95.00% 2.74 0.38 6.57 655.8329 1,309.65 1,309.66 2
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% LSSMAMISGLSGR 95.00% 3.36 0.481 7.41 655.8361 1,309.66 1,309.66 2
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% LVQcVDAFEEK 95.00% 2.6 0.453 2.48 c4: Carbamidomethyl (+57.02) 669.3232 1,336.63 1,337.64 2
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% LVQcVDAFEEK 95.00% 2.57 0.38 2.54 c4: Carbamidomethyl (+57.02) 669.3236 1,336.63 1,337.64 2
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% IIDEDFELTER 95.00% 3.07 0.491 3.13 690.3357 1,378.66 1,379.67 2
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% IIDEDFELTER 95.00% 3.01 0.361 1.44 690.3363 1,378.66 1,379.67 2
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% SSLPPVLGTESDATVK 94.70% 2.64 0.193 0 800.9243 1,599.83 1,600.84 2
 SAMPLE 2 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 8 8 18 5.12% SSLPPVLGTESDATVK 95.00% 3.5 0.5 3.59 800.925 1,599.83 1,600.84 2
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% LIDFGLAR 95.00% 2.29 0.214 0 452.7672 903.5187 904.5258 2 FHL5_HUMAN
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% LIDFGLAR 95.00% 2.73 0.227 0 452.7677 903.5198 904.5258 2 FHL5_HUMAN
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% LIDFGLAR 95.00% 2.48 0.216 0 452.7681 903.5205 904.5258 2 FHL5_HUMAN
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% AGESVELFGK 95.00% 2.37 0.197 2.66 518.7671 1,035.52 1,036.53 2
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% AGESVELFGK 95.00% 2.21 0.22 2.29 518.7686 1,035.52 1,036.53 2
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% AGESVELFGK 95.00% 2.04 0.175 1.68 518.7688 1,035.52 1,036.53 2
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% LSSMAMISGLSGR 95.00% 2.05 0.364 3.59 655.3371 1,308.66 1,309.66 2
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% LSSMAMISGLSGR 95.00% 2.65 0.374 2.15 655.3382 1,308.66 1,309.66 2
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% LVQcVDAFEEK 95.00% 2.35 0.391 2.77 c4: Carbamidomethyl (+57.02) 669.3223 1,336.63 1,337.64 2
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% LVQcVDAFEEK 95.00% 3.05 0.493 2.96 c4: Carbamidomethyl (+57.02) 669.8238 1,337.63 1,337.64 2
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% SSLPPVLGTESDATVK 95.00% 3.26 0.355 2.19 801.4246 1,600.83 1,600.84 2
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% SSLPPVLGTESDATVK 95.00% 3.47 0.409 2.85 801.4262 1,600.84 1,600.84 2
 SAMPLE 2R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 6 6 13 3.81% AAMPPQIIQFPEDQK 95.00% 3.14 0.223 1.46 856.9347 1,711.85 1,712.87 2
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% LIDFGLAR 95.00% 2.81 0.25 0 452.7668 903.518 904.5258 2 FHL5_HUMAN
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% LIDFGLAR 95.00% 2.18 0.218 0 452.7672 903.5187 904.5258 2 FHL5_HUMAN
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% LIDFGLAR 95.00% 2.51 0.266 0 452.7675 903.5193 904.5258 2 FHL5_HUMAN
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% LIDFGLAR 95.00% 2.89 0.188 0 452.7678 903.5199 904.5258 2 FHL5_HUMAN
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% AGESVELFGK 95.00% 2.17 0.222 1.96 518.7687 1,035.52 1,036.53 2
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% AAMPPQIIQFPEDQK 95.00% 2.34 0.165 1.17 571.9608 1,712.86 1,712.87 3
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% KLPAENGSSSAETLNAK 95.00% 2.93 0.211 2.14 573.2908 1,716.85 1,716.88 3
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% LDcTQcLQHPWLMK 95.00% 2.74 0.313 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 610.9541 1,829.84 1,829.85 3
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% KKLPAENGSSSAETLNAK 95.00% 4.62 0.606 1.77 615.6609 1,843.96 1,844.97 3
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% KKLPAENGSSSAETLNAK 95.00% 3.74 0.54 1.49 615.9936 1,844.96 1,844.97 3
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% QISEGVEYIHK 95.00% 2.64 0.311 0 651.8379 1,301.66 1,302.67 2
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% QISEGVEYIHK 95.00% 2.19 0.277 0 651.8389 1,301.66 1,302.67 2
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% LSSMAMISGLSGR 95.00% 3.94 0.501 3.18 655.3335 1,308.65 1,309.66 2
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% LSSMAMISGLSGR 95.00% 3.61 0.464 3.01 655.334 1,308.65 1,309.66 2
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% LVQcVDAFEEK 95.00% 2.26 0.378 2.37 c4: Carbamidomethyl (+57.02) 669.3234 1,336.63 1,337.64 2
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% SSLPPVLGTESDATVK 95.00% 2.78 0.325 2.33 800.9256 1,599.84 1,600.84 2
 SAMPLE 3 Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 10 11 17 6.06% AAmPPQIIQFPEDQK 95.00% 2.15 0.3 0 m3: Oxidation (+15.99) 864.7699 1,727.52 1,728.86 2
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% LIDFGLAR 95.00% 2.16 0.229 0 452.7668 903.5179 904.5258 2 FHL5_HUMAN
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% LIDFGLAR 95.00% 2.75 0.247 0 452.767 903.5183 904.5258 2 FHL5_HUMAN
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% LIDFGLAR 95.00% 2.77 0.235 0 452.7672 903.5188 904.5258 2 FHL5_HUMAN
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% LIDFGLAR 95.00% 3 0.181 0 452.7673 903.519 904.5258 2 FHL5_HUMAN
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% TIRDLEVVEGSAAR 95.00% 3.55 0.4 0 505.9417 1,514.80 1,515.81 3
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% TIRDLEVVEGSAAR 95.00% 3.17 0.266 0 505.9423 1,514.80 1,515.81 3
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% AGESVELFGK 95.00% 2.32 0.213 2.27 518.7687 1,035.52 1,036.53 2
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% AGESVELFGK 95.00% 2.7 0.248 2.43 518.7692 1,035.52 1,036.53 2
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% LDcTQcLQHPWLMK 95.00% 2.29 0.256 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 610.6204 1,828.84 1,829.85 3
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% KKLPAENGSSSAETLNAK 95.00% 3.87 0.57 2.36 615.9904 1,844.95 1,844.97 3
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% KKLPAENGSSSAETLNAK 95.00% 3.51 0.514 1.44 615.9926 1,844.95 1,844.97 3
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% STSFNVQDLLPDHEYK 95.00% 2.15 0.309 0 631.9734 1,892.90 1,892.90 3
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% QISEGVEYIHK 95.00% 2.57 0.395 1.36 651.8375 1,301.66 1,302.67 2
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% QISEGVEYIHK 95.00% 2.05 0.347 0 651.839 1,301.66 1,302.67 2
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% PAETLKPMGNAKPDENLK 95.00% 3.09 0.428 0 652.0129 1,953.02 1,953.01 3
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% LSSMAMISGLSGR 95.00% 2.44 0.388 2.96 655.3335 1,308.65 1,309.66 2
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% LSSMAMISGLSGR 95.00% 2.23 0.276 1.82 655.3355 1,308.66 1,309.66 2
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% SSLPPVLGTESDATVK 95.00% 2.46 0.232 2.77 800.9243 1,599.83 1,600.84 2
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% SSLPPVLGTESDATVK 95.00% 3.21 0.286 1.49 801.4271 1,600.84 1,600.84 2
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% AAMPPQIIQFPEDQK 95.00% 3.01 0.0762 2.85 856.9362 1,711.86 1,712.87 2
 SAMPLE 3R Myosin light chain kinase, smooth muscle  MYLK  MYLK_HUMAN 210,753.90 100.00% 12 12 21 8.88% FIILSQEGSLcSVSIEK 95.00% 4.5 0.535 3.3 c11: Carbamidomethyl (+57.02) 956.0035 1,909.99 1,909.99 2
 SAMPLE 4 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% VFDKEGNGTVmGAEIR 95.00% 2.79 0.264 1.85 m11: Oxidation (+15.99) 580.2871 1,737.84 1,738.84 3
 SAMPLE 4 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% VFDKEGNGTVmGAEIR 95.00% 2.88 0.317 0 m11: Oxidation (+15.99) 580.288 1,737.84 1,738.84 3
 SAMPLE 4 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% NKDQGTYEDYVEGLR 95.00% 5.02 0.285 3.08 596.6161 1,786.82 1,786.83 3
 SAMPLE 4 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% NKDQGTYEDYVEGLR 95.00% 4.54 0.23 3.52 596.6164 1,786.83 1,786.83 3
 SAMPLE 4 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% ALGQNPTNAEVLK 95.00% 3.93 0.459 2.6 677.8729 1,353.73 1,354.73 2
 SAMPLE 4 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% ALGQNPTNAEVLK 95.00% 3.8 0.438 3.11 677.8734 1,353.73 1,354.73 2
 SAMPLE 4 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% ILYSQcGDVmR 95.00% 3.49 0.528 3.42 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3175 1,356.62 1,357.62 2
 SAMPLE 4 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% ILYSQcGDVmR 95.00% 3.47 0.523 3.77 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3185 1,356.62 1,357.62 2
 SAMPLE 4 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% DQGTYEDYVEGLR 95.00% 3.78 0.579 5.25 772.8507 1,543.69 1,544.69 2
 SAMPLE 4 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% DQGTYEDYVEGLR 95.00% 3.74 0.514 4.41 772.8513 1,543.69 1,544.69 2
 SAMPLE 4 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% NKDQGTYEDYVEGLR 95.00% 4.65 0.578 4.55 894.4211 1,786.83 1,786.83 2
 SAMPLE 4 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% NKDQGTYEDYVEGLR 95.00% 4.71 0.579 6.28 894.4217 1,786.83 1,786.83 2
 SAMPLE 4R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% VFDKEGNGTVmGAEIR 95.00% 2.71 0.303 1.11 m11: Oxidation (+15.99) 580.2861 1,737.83 1,738.84 3
 SAMPLE 4R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% VFDKEGNGTVmGAEIR 95.00% 2.27 0.243 1.05 m11: Oxidation (+15.99) 580.2875 1,737.84 1,738.84 3
 SAMPLE 4R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% NKDQGTYEDYVEGLR 95.00% 3.98 0.211 2.6 596.2816 1,785.82 1,786.83 3
 SAMPLE 4R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% NKDQGTYEDYVEGLR 95.00% 4.57 0.306 3.49 596.6165 1,786.83 1,786.83 3
 SAMPLE 4R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% ALGQNPTNAEVLK 95.00% 3.75 0.374 1.36 677.8725 1,353.73 1,354.73 2
 SAMPLE 4R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% ALGQNPTNAEVLK 95.00% 3.7 0.433 2.66 677.8731 1,353.73 1,354.73 2
 SAMPLE 4R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% ILYSQcGDVmR 95.00% 3.33 0.542 3.8 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3175 1,356.62 1,357.62 2
 SAMPLE 4R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% ILYSQcGDVmR 95.00% 3.14 0.566 2.59 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3221 1,356.63 1,357.62 2
 SAMPLE 4R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% DQGTYEDYVEGLR 95.00% 3.12 0.479 1.7 772.8487 1,543.68 1,544.69 2
 SAMPLE 4R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% DQGTYEDYVEGLR 95.00% 3.69 0.523 5.57 773.3496 1,544.68 1,544.69 2
 SAMPLE 4R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% NKDQGTYEDYVEGLR 95.00% 4.54 0.618 4.82 893.9186 1,785.82 1,786.83 2
 SAMPLE 4R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 5 6 12 36.40% NKDQGTYEDYVEGLR 95.00% 4.8 0.594 5.44 894.4225 1,786.83 1,786.83 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% EAFQLFDR 95.00% 2.66 0.134 0 513.2545 1,024.49 1,025.51 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% EAFQLFDR 95.00% 2.57 0.143 0 513.255 1,024.49 1,025.51 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% VFDKEGNGTVMGAEIR 95.00% 3.34 0.272 2.3 574.9534 1,721.84 1,722.85 3
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% VFDKEGNGTVMGAEIR 95.00% 3.48 0.283 3.68 574.9537 1,721.84 1,722.85 3
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% VFDKEGNGTVMGAEIR 95.00% 3.03 0.248 2.15 575.2858 1,722.83 1,722.85 3
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% VFDKEGNGTVmGAEIR 95.00% 2.73 0.339 0 m11: Oxidation (+15.99) 580.2821 1,737.82 1,738.84 3
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% VFDKEGNGTVmGAEIR 95.00% 2.75 0.327 0.959 m11: Oxidation (+15.99) 580.285 1,737.83 1,738.84 3
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% VFDKEGNGTVmGAEIR 95.00% 2.78 0.244 1.46 m11: Oxidation (+15.99) 580.6181 1,738.83 1,738.84 3
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% VFDKEGNGTVmGAEIR 95.00% 2.77 0.223 1.77 m11: Oxidation (+15.99) 580.6202 1,738.84 1,738.84 3
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% NKDQGTYEDYVEGLR 95.00% 5.36 0.396 5.04 596.2786 1,785.81 1,786.83 3
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% NKDQGTYEDYVEGLR 95.00% 4.95 0.359 2.89 596.2795 1,785.82 1,786.83 3
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% NKDQGTYEDYVEGLR 95.00% 5.03 0.409 3.12 596.6123 1,786.81 1,786.83 3
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% NKDQGTYEDYVEGLR 95.00% 4.79 0.26 4.57 596.6129 1,786.82 1,786.83 3
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% EGNGTVMGAEIR 95.00% 2.85 0.387 2.19 617.2988 1,232.58 1,233.59 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% EGNGTVmGAEIR 95.00% 1.84 0.25 2.21 m7: Oxidation (+15.99) 625.297 1,248.58 1,249.58 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% EGNGTVmGAEIR 95.00% 2.24 0.371 0 m7: Oxidation (+15.99) 625.2981 1,248.58 1,249.58 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ILYSQcGDVMR 95.00% 3.36 0.49 4.13 c6: Carbamidomethyl (+57.02) 671.3166 1,340.62 1,341.63 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ILYSQcGDVMR 95.00% 3.8 0.503 3.25 c6: Carbamidomethyl (+57.02) 671.3166 1,340.62 1,341.63 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ILYSQcGDVMR 95.00% 3.3 0.449 3.26 c6: Carbamidomethyl (+57.02) 671.3169 1,340.62 1,341.63 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ILYSQcGDVMR 95.00% 3.49 0.468 3.8 c6: Carbamidomethyl (+57.02) 671.3181 1,340.62 1,341.63 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ALGQNPTNAEVLK 95.00% 2.7 0.22 0 677.8677 1,353.72 1,354.73 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ALGQNPTNAEVLK 95.00% 3.8 0.373 3.22 677.8698 1,353.72 1,354.73 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ALGQNPTNAEVLK 95.00% 3.98 0.469 3.14 677.87 1,353.72 1,354.73 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ALGQNPTNAEVLK 95.00% 4 0.488 3.12 677.8704 1,353.73 1,354.73 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ALGQNPTNAEVLK 95.00% 3.84 0.423 4.33 677.8704 1,353.73 1,354.73 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ILYSQcGDVmR 95.00% 3.68 0.524 3.34 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3144 1,356.61 1,357.62 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ILYSQcGDVmR 95.00% 3.45 0.541 2.46 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3145 1,356.61 1,357.62 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ILYSQcGDVmR 95.00% 3.55 0.565 2.74 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3152 1,356.61 1,357.62 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ILYSQcGDVmR 95.00% 3.59 0.499 3.28 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3153 1,356.62 1,357.62 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% DQGTYEDYVEGLR 95.00% 4.14 0.54 3.68 772.8454 1,543.68 1,544.69 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% DQGTYEDYVEGLR 95.00% 4.11 0.546 4.27 772.8461 1,543.68 1,544.69 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% DQGTYEDYVEGLR 95.00% 4.16 0.502 4.68 772.8462 1,543.68 1,544.69 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% DQGTYEDYVEGLR 95.00% 4.17 0.519 4.28 772.8468 1,543.68 1,544.69 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% VFDKEGNGTVMGAEIR 95.00% 4.49 0.497 4.21 861.9277 1,721.84 1,722.85 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% VFDKEGNGTVmGAEIR 95.00% 4.37 0.5 4.22 m11: Oxidation (+15.99) 869.9248 1,737.83 1,738.84 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% VFDKEGNGTVmGAEIR 95.00% 4.62 0.525 4.37 m11: Oxidation (+15.99) 869.9275 1,737.84 1,738.84 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% NKDQGTYEDYVEGLR 95.00% 4.84 0.608 4.89 893.9142 1,785.81 1,786.83 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% NKDQGTYEDYVEGLR 95.00% 4.75 0.64 6.7 893.9153 1,785.81 1,786.83 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% NKDQGTYEDYVEGLR 95.00% 4.77 0.555 5.47 894.4121 1,786.81 1,786.83 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% NKDQGTYEDYVEGLR 95.00% 4.57 0.61 7.37 894.416 1,786.82 1,786.83 2
 SAMPLE 2 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 38 45.70% ALGQNPTNAEVLKVLGNPK 95.00% 5.21 0.648 8.14 982.5498 1,963.08 1,963.10 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% EAFQLFDR 95.00% 2.46 0.157 0 513.2551 1,024.49 1,025.51 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% EAFQLFDR 95.00% 2.86 0.179 0 513.2554 1,024.50 1,025.51 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% VFDKEGNGTVMGAEIR 95.00% 3.48 0.293 2.55 574.9536 1,721.84 1,722.85 3
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% VFDKEGNGTVMGAEIR 95.00% 3.58 0.342 3.21 574.9539 1,721.84 1,722.85 3
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% VFDKEGNGTVMGAEIR 95.00% 3.91 0.409 2.4 575.2874 1,722.84 1,722.85 3
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% VFDKEGNGTVMGAEIR 95.00% 3.74 0.313 1.96 575.2884 1,722.84 1,722.85 3
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% VFDKEGNGTVmGAEIR 95.00% 3.27 0.384 3.02 m11: Oxidation (+15.99) 580.2849 1,737.83 1,738.84 3
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% VFDKEGNGTVmGAEIR 95.00% 3.01 0.395 2.01 m11: Oxidation (+15.99) 580.2849 1,737.83 1,738.84 3
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% VFDKEGNGTVmGAEIR 95.00% 3.06 0.341 1.05 m11: Oxidation (+15.99) 580.6199 1,738.84 1,738.84 3
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% VFDKEGNGTVmGAEIR 95.00% 3.15 0.341 1.07 m11: Oxidation (+15.99) 580.6204 1,738.84 1,738.84 3
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% NKDQGTYEDYVEGLR 95.00% 5.57 0.434 4.48 596.2778 1,785.81 1,786.83 3
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% NKDQGTYEDYVEGLR 95.00% 5.16 0.391 3.8 596.613 1,786.82 1,786.83 3
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% NKDQGTYEDYVEGLR 95.00% 5.47 0.392 4.41 596.6134 1,786.82 1,786.83 3
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% NKDQGTYEDYVEGLR 95.00% 4.83 0.351 2.64 596.6143 1,786.82 1,786.83 3
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% ILYSQcGDVMR 95.00% 3.63 0.455 3.96 c6: Carbamidomethyl (+57.02) 671.3169 1,340.62 1,341.63 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% ILYSQcGDVMR 95.00% 3.51 0.468 3.8 c6: Carbamidomethyl (+57.02) 671.3171 1,340.62 1,341.63 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% ILYSQcGDVMR 95.00% 3.63 0.466 4.02 c6: Carbamidomethyl (+57.02) 671.3174 1,340.62 1,341.63 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% ILYSQcGDVMR 95.00% 3.23 0.499 3.15 c6: Carbamidomethyl (+57.02) 671.3183 1,340.62 1,341.63 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% ALGQNPTNAEVLK 95.00% 2.57 0.329 3.38 677.8684 1,353.72 1,354.73 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% ALGQNPTNAEVLK 95.00% 2.91 0.284 3 677.8686 1,353.72 1,354.73 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% ALGQNPTNAEVLK 95.00% 3.73 0.492 3.85 677.8699 1,353.72 1,354.73 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% ALGQNPTNAEVLK 95.00% 4.01 0.461 3.8 677.87 1,353.72 1,354.73 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% ALGQNPTNAEVLK 95.00% 3.82 0.401 3.72 677.8701 1,353.72 1,354.73 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% ILYSQcGDVmR 95.00% 3.42 0.506 4.36 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3146 1,356.61 1,357.62 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% ILYSQcGDVmR 95.00% 3.58 0.536 2.59 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3148 1,356.61 1,357.62 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% ILYSQcGDVmR 95.00% 3.44 0.494 3.85 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3151 1,356.61 1,357.62 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% DQGTYEDYVEGLR 95.00% 4.13 0.517 4.57 772.8457 1,543.68 1,544.69 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% DQGTYEDYVEGLR 95.00% 4.12 0.519 4.05 772.8468 1,543.68 1,544.69 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% VFDKEGNGTVMGAEIR 95.00% 4.5 0.496 3.55 862.4307 1,722.85 1,722.85 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% VFDKEGNGTVmGAEIR 95.00% 4.35 0.51 4.42 m11: Oxidation (+15.99) 869.9223 1,737.83 1,738.84 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% VFDKEGNGTVmGAEIR 95.00% 4.48 0.458 4.4 m11: Oxidation (+15.99) 870.4276 1,738.84 1,738.84 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% NKDQGTYEDYVEGLR 95.00% 4.74 0.616 6.68 893.9149 1,785.81 1,786.83 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% NKDQGTYEDYVEGLR 95.00% 4.84 0.631 5.59 893.915 1,785.81 1,786.83 2
 SAMPLE 2R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 34 41.70% NKDQGTYEDYVEGLR 95.00% 4.78 0.582 6.43 894.414 1,786.81 1,786.83 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% EAFQLFDR 95.00% 2.73 0.144 0 513.2544 1,024.49 1,025.51 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% EAFQLFDR 95.00% 2.77 0.144 0 513.2552 1,024.49 1,025.51 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% VFDKEGNGTVMGAEIR 95.00% 3.68 0.328 2.32 574.9526 1,721.83 1,722.85 3
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% VFDKEGNGTVMGAEIR 95.00% 2.83 0.25 3.09 575.2812 1,722.82 1,722.85 3
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% VFDKEGNGTVmGAEIR 95.00% 3.02 0.396 2.64 m11: Oxidation (+15.99) 580.2855 1,737.83 1,738.84 3
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% VFDKEGNGTVmGAEIR 95.00% 3.18 0.287 1.46 m11: Oxidation (+15.99) 580.6183 1,738.83 1,738.84 3
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% NKDQGTYEDYVEGLR 95.00% 5.02 0.222 3.6 596.2795 1,785.82 1,786.83 3
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% NKDQGTYEDYVEGLR 95.00% 4.93 0.313 4.54 596.2797 1,785.82 1,786.83 3
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% EGNGTVMGAEIR 95.00% 2.91 0.362 0 617.2967 1,232.58 1,233.59 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% EGNGTVMGAEIR 95.00% 3.33 0.43 1.37 617.2975 1,232.58 1,233.59 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% EGNGTVmGAEIR 95.00% 2.33 0.332 0 m7: Oxidation (+15.99) 625.296 1,248.58 1,249.58 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% EGNGTVmGAEIR 95.00% 2.37 0.35 0 m7: Oxidation (+15.99) 625.2977 1,248.58 1,249.58 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% ILYSQcGDVMR 95.00% 3.65 0.439 3.2 c6: Carbamidomethyl (+57.02) 671.3181 1,340.62 1,341.63 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% ILYSQcGDVMR 95.00% 3.68 0.445 3.29 c6: Carbamidomethyl (+57.02) 671.3183 1,340.62 1,341.63 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% ALGQNPTNAEVLK 95.00% 3.7 0.475 2.68 677.87 1,353.72 1,354.73 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% ALGQNPTNAEVLK 95.00% 3.37 0.385 1.68 677.8701 1,353.72 1,354.73 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% ILYSQcGDVmR 95.00% 3.49 0.541 3.4 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3152 1,356.61 1,357.62 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% ILYSQcGDVmR 95.00% 3.42 0.508 3.28 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3156 1,356.62 1,357.62 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% DQGTYEDYVEGLR 95.00% 3.94 0.541 5.57 772.8424 1,543.67 1,544.69 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% DQGTYEDYVEGLR 95.00% 4.25 0.527 4.57 772.8465 1,543.68 1,544.69 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% VFDKEGNGTVMGAEIR 95.00% 4.96 0.529 6.47 861.9273 1,721.84 1,722.85 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% VFDKEGNGTVMGAEIR 95.00% 4.89 0.526 3.41 861.9273 1,721.84 1,722.85 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% VFDKEGNGTVmGAEIR 95.00% 4.61 0.52 4.27 m11: Oxidation (+15.99) 869.9244 1,737.83 1,738.84 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% VFDKEGNGTVmGAEIR 95.00% 4.66 0.513 4.24 m11: Oxidation (+15.99) 869.927 1,737.84 1,738.84 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% NKDQGTYEDYVEGLR 95.00% 4.87 0.644 5.51 893.9135 1,785.81 1,786.83 2
 SAMPLE 3 Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 6 8 22 41.70% NKDQGTYEDYVEGLR 95.00% 4.81 0.651 5.08 893.9148 1,785.81 1,786.83 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% HVLVTLGEK 95.00% 2.11 0.377 0 498.2973 994.5789 995.5891 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% HVLVTLGEK 95.00% 2.13 0.337 1.44 498.2978 994.58 995.5891 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% EAFQLFDR 95.00% 2.58 0.158 0 513.2545 1,024.49 1,025.51 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% EAFQLFDR 95.00% 2.8 0.169 0 513.2547 1,024.49 1,025.51 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% VFDKEGNGTVMGAEIR 95.00% 3.56 0.34 3.1 574.9529 1,721.84 1,722.85 3
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% VFDKEGNGTVMGAEIR 95.00% 3.66 0.34 2.09 575.2884 1,722.84 1,722.85 3
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% VFDKEGNGTVmGAEIR 95.00% 2.84 0.41 2.82 m11: Oxidation (+15.99) 580.2853 1,737.83 1,738.84 3
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% VFDKEGNGTVmGAEIR 95.00% 3.18 0.392 3.08 m11: Oxidation (+15.99) 580.2854 1,737.83 1,738.84 3
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% NKDQGTYEDYVEGLR 95.00% 5.46 0.428 4.06 596.2792 1,785.81 1,786.83 3
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% NKDQGTYEDYVEGLR 95.00% 5.17 0.391 4.62 596.2795 1,785.82 1,786.83 3
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% EGNGTVmGAEIR 95.00% 2.33 0.416 0 m7: Oxidation (+15.99) 625.2955 1,248.58 1,249.58 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% ILYSQcGDVMR 95.00% 3.76 0.448 3.05 c6: Carbamidomethyl (+57.02) 671.3178 1,340.62 1,341.63 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% ILYSQcGDVMR 95.00% 2.55 0.255 3.15 c6: Carbamidomethyl (+57.02) 671.3188 1,340.62 1,341.63 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% ALGQNPTNAEVLK 95.00% 3.27 0.383 2 677.8683 1,353.72 1,354.73 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% ALGQNPTNAEVLK 95.00% 3.75 0.429 2.47 677.8698 1,353.72 1,354.73 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% ALGQNPTNAEVLK 95.00% 3.07 0.368 2.46 677.87 1,353.72 1,354.73 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% ALGQNPTNAEVLK 95.00% 3.73 0.417 2.46 677.8703 1,353.72 1,354.73 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% ALGQNPTNAEVLK 95.00% 2.85 0.225 1.54 677.8707 1,353.73 1,354.73 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% ALGQNPTNAEVLK 95.00% 3.12 0.399 1.59 677.8707 1,353.73 1,354.73 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% ILYSQcGDVmR 95.00% 3.43 0.449 3.3 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3145 1,356.61 1,357.62 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% ILYSQcGDVmR 95.00% 3.57 0.488 3.24 c6: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 679.3148 1,356.61 1,357.62 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% DQGTYEDYVEGLR 95.00% 4.13 0.493 4.85 772.8465 1,543.68 1,544.69 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% DQGTYEDYVEGLR 95.00% 4.28 0.499 5.11 772.8469 1,543.68 1,544.69 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% VFDKEGNGTVMGAEIR 95.00% 4.77 0.527 2.82 861.9275 1,721.84 1,722.85 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% VFDKEGNGTVMGAEIR 95.00% 4.94 0.525 3.57 861.9286 1,721.84 1,722.85 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% VFDKEGNGTVmGAEIR 95.00% 4.74 0.498 3.89 m11: Oxidation (+15.99) 869.9262 1,737.84 1,738.84 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% VFDKEGNGTVmGAEIR 95.00% 4.78 0.488 3.92 m11: Oxidation (+15.99) 869.927 1,737.84 1,738.84 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% NKDQGTYEDYVEGLR 95.00% 4.83 0.642 5.96 893.914 1,785.81 1,786.83 2
 SAMPLE 3R Myosin light polypeptide 6  MYL6  MYL6_HUMAN 16,911.80 100.00% 7 9 28 47.70% NKDQGTYEDYVEGLR 95.00% 4.73 0.636 5.02 893.9159 1,785.82 1,786.83 2
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% ELLTTMGDR 95.00% 2.67 0.349 1.11 518.2588 1,034.50 1,035.51 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% ELLTTMGDR 95.00% 2.57 0.357 2.39 518.2591 1,034.50 1,035.51 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% LNGTDPEDVIR 95.00% 1.78 0.247 1.64 614.8076 1,227.60 1,228.62 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% LNGTDPEDVIR 95.00% 3.12 0.345 2.47 614.8084 1,227.60 1,228.62 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% LNGTDPEDVIR 95.00% 3.46 0.469 3.38 614.8104 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% LNGTDPEDVIR 95.00% 3.89 0.41 2.11 614.8107 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% LNGTDPEDVIR 95.00% 3.57 0.441 1.37 614.8107 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% LNGTDPEDVIR 95.00% 2.83 0.378 0 614.8109 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% LNGTDPEDVIR 95.00% 2.8 0.405 2 614.8117 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% LNGTDPEDVIR 95.00% 2.04 -0.0632 1.66 615.2903 1,228.56 1,228.62 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% EAFNMIDQNR 95.00% 3.88 0.349 0 619.2844 1,236.55 1,237.56 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% EAFNMIDQNR 95.00% 3.98 0.351 0 619.285 1,236.55 1,237.56 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% EDLHDMLASLGK 95.00% 2.89 0.196 1.17 664.8296 1,327.64 1,328.65 2 MYL9_HUMAN
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% KGNFNYIEFTR 95.00% 3.09 0.46 2.27 694.8501 1,387.68 1,388.70 2
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% KGNFNYIEFTR 95.00% 3.58 0.544 1.82 694.8502 1,387.68 1,388.70 2
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% FTDEEVDELYR 95.00% 4.05 0.51 2.6 708.319 1,414.62 1,415.63 2
 SAMPLE 2 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 37.20% FTDEEVDELYR 95.00% 3.93 0.448 3.59 708.32 1,414.62 1,415.63 2
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% ELLTTMGDR 95.00% 2.62 0.353 2.1 518.2589 1,034.50 1,035.51 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% ELLTTMGDR 95.00% 2.56 0.373 1.92 518.2595 1,034.50 1,035.51 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% LNGTDPEDVIR 95.00% 2.3 0.181 1.42 614.3169 1,226.62 1,228.62 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% LNGTDPEDVIR 95.00% 3.57 0.402 3.82 614.8107 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% LNGTDPEDVIR 95.00% 3.05 0.366 2.4 614.8108 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% LNGTDPEDVIR 95.00% 3.69 0.426 1.55 614.8111 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% LNGTDPEDVIR 95.00% 3.54 0.446 1.14 614.8112 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% LNGTDPEDVIR 95.00% 3.51 0.42 2.01 614.8113 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% LNGTDPEDVIR 95.00% 3.15 0.416 1.44 614.8115 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% LNGTDPEDVIR 95.00% 2.38 0.165 1.43 614.8148 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% LNGTDPEDVIR 95.00% 3.37 0.365 2.44 615.3043 1,228.59 1,228.62 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% EAFNMIDQNR 95.00% 3.8 0.358 0 619.2836 1,236.55 1,237.56 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% EAFNMIDQNR 95.00% 3.65 0.419 0 619.2848 1,236.55 1,237.56 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% EAFNmIDQNR 95.00% 2.37 0.323 0 m5: Oxidation (+15.99) 627.2851 1,252.55 1,253.56 2 MYL9_HUMAN
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% KGNFNYIEFTR 95.00% 3.15 0.524 2.08 694.851 1,387.69 1,388.70 2
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% KGNFNYIEFTR 95.00% 2.38 0.28 1.48 695.3491 1,388.68 1,388.70 2
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% FTDEEVDELYR 95.00% 3.35 0.451 2.2 708.3177 1,414.62 1,415.63 2
 SAMPLE 2R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 4 30.20% FTDEEVDELYR 95.00% 4.15 0.463 3.85 708.3181 1,414.62 1,415.63 2
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% ELLTTMGDR 95.00% 2.36 0.391 2.42 518.2599 1,034.50 1,035.51 2 MYL9_HUMAN
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% ELLTTMGDR 95.00% 2.59 0.369 1.66 518.2599 1,034.50 1,035.51 2 MYL9_HUMAN
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% LNGTDPEDVIR 95.00% 3.45 0.445 3.66 614.8098 1,227.60 1,228.62 2 MYL9_HUMAN
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% LNGTDPEDVIR 95.00% 2.51 0.231 2.55 614.8106 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% LNGTDPEDVIR 95.00% 3.24 0.413 2.92 614.8112 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% LNGTDPEDVIR 95.00% 3.36 0.432 3.8 614.8116 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% LNGTDPEDVIR 95.00% 2.72 0.248 1.68 614.8117 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% EAFNMIDQNR 95.00% 3.74 0.395 1.31 619.2825 1,236.55 1,237.56 2 MYL9_HUMAN
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% EAFNMIDQNR 95.00% 4.05 0.393 0 619.2846 1,236.55 1,237.56 2 MYL9_HUMAN
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% EAFNMIDQNR 95.00% 3.52 0.351 0 619.2878 1,236.56 1,237.56 2 MYL9_HUMAN
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% EAFNMIDQNR 95.00% 3.19 0.362 0 619.7865 1,237.56 1,237.56 2 MYL9_HUMAN
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% GNFNYIEFTR 95.00% 3.18 0.279 1.51 630.8033 1,259.59 1,260.60 2
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% GNFNYIEFTR 95.00% 3.51 0.233 2.17 630.8036 1,259.59 1,260.60 2
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% KGNFNYIEFTR 95.00% 3.08 0.401 1.85 694.8495 1,387.68 1,388.70 2
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% FTDEEVDELYR 95.00% 4.37 0.427 3.28 708.3184 1,414.62 1,415.63 2
 SAMPLE 3 Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 100.00% 3 3 5 30.20% FTDEEVDELYR 95.00% 4.08 0.509 3.38 708.3193 1,414.62 1,415.63 2
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% ELLTTMGDR 95.00% 2.4 0.384 1.62 518.2596 1,034.50 1,035.51 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% ELLTTMGDR 95.00% 2.6 0.356 1.7 518.2602 1,034.50 1,035.51 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% ELLTTmGDR 95.00% 1.99 0.357 0 m6: Oxidation (+15.99) 526.2569 1,050.50 1,051.51 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% LNGTDPEDVIR 95.00% 3.28 0.407 3.89 614.8103 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% LNGTDPEDVIR 95.00% 3.5 0.476 1.96 614.8111 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% LNGTDPEDVIR 95.00% 3.34 0.444 1.43 614.8114 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% LNGTDPEDVIR 95.00% 3.37 0.406 1.7 614.8119 1,227.61 1,228.62 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% LNGTDPEDVIR 95.00% 3.19 0.355 2.27 615.3081 1,228.60 1,228.62 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% EAFNMIDQNR 95.00% 3.38 0.396 0 619.2836 1,236.55 1,237.56 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% EAFNMIDQNR 95.00% 3.85 0.414 0 619.284 1,236.55 1,237.56 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% EAFNMIDQNR 95.00% 3.25 0.426 0 619.2868 1,236.56 1,237.56 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% EAFNMIDQNR 95.00% 3.09 0.361 0 619.2892 1,236.56 1,237.56 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% EAFNmIDQNR 95.00% 2.34 0.336 0 m5: Oxidation (+15.99) 627.2815 1,252.55 1,253.56 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% EAFNmIDQNR 95.00% 2.29 0.204 0 m5: Oxidation (+15.99) 627.2818 1,252.55 1,253.56 2 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% DGFIDKEDLHDMLASLGK 95.00% 3.2 0.403 0 668.6622 2,002.96 2,003.98 3 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% DGFIDKEDLHDMLASLGK 95.00% 3.79 0.421 2.82 668.6628 2,002.97 2,003.98 3 MYL9_HUMAN
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% KGNFNYIEFTR 95.00% 2.72 0.359 0 694.8493 1,387.68 1,388.70 2
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% FTDEEVDELYR 95.00% 4.27 0.412 2.72 708.3186 1,414.62 1,415.63 2
 SAMPLE 3R Myosin regulatory light chain MRLC2  MYLC2B  MRLC2_HUMAN,MRLC3_HUMAN 19,762.30 99.80% 2 2 3 40.70% FTDEEVDELYR 95.00% 4.13 0.505 2.92 708.3192 1,414.62 1,415.63 2
 SAMPLE 4 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 9 12.20% LNGTDPEDVIR 95.00% 3.62 0.434 1.42 614.8125 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 4 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 9 12.20% LNGTDPEDVIR 95.00% 3.48 0.451 2.35 614.8138 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 4 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 9 12.20% LNGTDPEDVIR 95.00% 3.44 0.431 1.96 614.8138 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 4 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 9 12.20% LNGTDPEDVIR 95.00% 3.13 0.422 1.31 614.8142 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 4 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 9 12.20% LNGTDPEDVIR 95.00% 2.61 0.367 1.77 614.8159 1,227.62 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 4 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 9 12.20% GNFNYVEFTR 95.00% 3.3 0.586 2.51 623.7968 1,245.58 1,246.59 2
 SAMPLE 4 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 9 12.20% GNFNYVEFTR 95.00% 3.64 0.486 2.89 623.798 1,245.58 1,246.59 2
 SAMPLE 4 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 9 12.20% GNFNYVEFTR 95.00% 3.52 0.555 2.4 623.7981 1,245.58 1,246.59 2
 SAMPLE 4 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 9 12.20% GNFNYVEFTR 95.00% 3.62 0.538 2.92 623.7981 1,245.58 1,246.59 2
 SAMPLE 4R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 7 12.20% LNGTDPEDVIR 95.00% 3.34 0.432 2.1 614.8137 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 4R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 7 12.20% LNGTDPEDVIR 95.00% 3.47 0.44 2.43 614.8139 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 4R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 7 12.20% LNGTDPEDVIR 95.00% 3.47 0.414 2.55 614.8142 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 4R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 7 12.20% LNGTDPEDVIR 95.00% 3.26 0.42 1.89 614.8158 1,227.62 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 4R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 7 12.20% LNGTDPEDVIR 95.00% 2.29 0.258 2.11 614.8163 1,227.62 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 4R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 7 12.20% GNFNYVEFTR 95.00% 3.3 0.535 2.68 623.7981 1,245.58 1,246.59 2
 SAMPLE 4R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 99.80% 2 2 7 12.20% GNFNYVEFTR 95.00% 3.34 0.527 2.24 623.7987 1,245.58 1,246.59 2
 SAMPLE 1 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 3 3 5 27.90% GNFNYVEFTR 95.00% 3.66 0.559 2.51 623.7957 1,245.58 1,246.59 2
 SAMPLE 1 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 3 3 5 27.90% GNFNYVEFTR 95.00% 3.53 0.553 2.04 623.8015 1,245.59 1,246.59 2
 SAMPLE 1 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 3 3 5 27.90% DGFIDKEDLHDMLASLGK 95.00% 3.73 0.406 1.49 669.0101 2,004.01 2,003.98 3 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 1 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 3 3 5 27.90% DGFIDKEDLHDMLASLGK 95.00% 3.45 0.423 1.82 669.0103 2,004.01 2,003.98 3 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 1 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 3 3 5 27.90% NAFAcFDEEASGFIHEDHLR 95.00% 3.36 0.482 0 c5: Carbamidomethyl (+57.02) 789.3628 2,365.06 2,365.03 3
 SAMPLE 1R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 4 4 7 38.40% GNFNYVEFTR 95.00% 3.66 0.559 3.68 623.7957 1,245.58 1,246.59 2
 SAMPLE 1R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 4 4 7 38.40% GNFNYVEFTR 95.00% 2.34 0.414 1.13 623.8054 1,245.60 1,246.59 2
 SAMPLE 1R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 4 4 7 38.40% GNFNYVEFTR 95.00% 1.92 0.364 1.11 623.8086 1,245.60 1,246.59 2
 SAMPLE 1R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 4 4 7 38.40% DGFIDKEDLHDMLASLGK 95.00% 3.62 0.388 3.3 669.0106 2,004.01 2,003.98 3 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 1R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 4 4 7 38.40% DGFIDKEDLHDMLASLGK 95.00% 3.66 0.401 1.38 669.0109 2,004.01 2,003.98 3 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 1R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 4 4 7 38.40% NAFAcFDEEASGFIHEDHLR 95.00% 2.78 0.38 0 c5: Carbamidomethyl (+57.02) 789.3633 2,365.07 2,365.03 3
 SAMPLE 1R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 4 4 7 38.40% ATSNVFAMFDQSQIQEFK 95.00% 5.31 0.574 7.82 1,046.51 2,091.01 2,090.99 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% KGNFNYVEFTR 95.00% 2.81 0.16 0 458.8996 1,373.68 1,374.68 3 CO6A3_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% KGNFNYVEFTR 95.00% 3.1 0.186 0 458.8996 1,373.68 1,374.68 3 CO6A3_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% ELLTTMGDR 95.00% 2.67 0.349 1.11 518.2588 1,034.50 1,035.51 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% ELLTTMGDR 95.00% 2.57 0.357 2.39 518.2591 1,034.50 1,035.51 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% LNGTDPEDVIR 95.00% 1.78 0.247 1.64 614.8076 1,227.60 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% LNGTDPEDVIR 95.00% 3.12 0.345 2.47 614.8084 1,227.60 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% LNGTDPEDVIR 95.00% 3.46 0.469 3.38 614.8104 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% LNGTDPEDVIR 95.00% 3.89 0.41 2.11 614.8107 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% LNGTDPEDVIR 95.00% 3.57 0.441 1.37 614.8107 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% LNGTDPEDVIR 95.00% 2.83 0.378 0 614.8109 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% LNGTDPEDVIR 95.00% 2.8 0.405 2 614.8117 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% LNGTDPEDVIR 95.00% 2.04 -0.0632 1.66 615.2903 1,228.56 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% EAFNMIDQNR 95.00% 3.88 0.349 0 619.2844 1,236.55 1,237.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% EAFNMIDQNR 95.00% 3.98 0.351 0 619.285 1,236.55 1,237.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% GNFNYVEFTR 95.00% 2.42 0.466 2.24 623.7939 1,245.57 1,246.59 2
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% GNFNYVEFTR 95.00% 3.23 0.525 2.89 623.7948 1,245.57 1,246.59 2
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% GNFNYVEFTR 95.00% 3.25 0.507 2.48 623.7951 1,245.57 1,246.59 2
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% GNFNYVEFTR 95.00% 2.95 0.478 3.01 623.7956 1,245.58 1,246.59 2
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% GNFNYVEFTR 95.00% 3.88 0.546 1.92 623.7958 1,245.58 1,246.59 2
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% GNFNYVEFTR 95.00% 3.64 0.539 2.08 623.7959 1,245.58 1,246.59 2
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% GNFNYVEFTR 95.00% 3.13 0.547 3.33 624.2896 1,246.56 1,246.59 2
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% EDLHDMLASLGK 95.00% 2.89 0.196 1.17 664.8296 1,327.64 1,328.65 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% KGNFNYVEFTR 95.00% 3.72 0.5 2.46 687.8429 1,373.67 1,374.68 2 CO6A3_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% KGNFNYVEFTR 95.00% 3.71 0.524 1.74 687.843 1,373.67 1,374.68 2 CO6A3_HUMAN
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% FTDEEVDEmYR 95.00% 3.56 0.513 3.64 m9: Oxidation (+15.99) 725.2953 1,448.58 1,449.58 2
 SAMPLE 2 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 6 6 22 37.20% FTDEEVDEmYR 95.00% 3.53 0.534 3.64 m9: Oxidation (+15.99) 725.2958 1,448.58 1,449.58 2
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% KGNFNYVEFTR 95.00% 2.97 0.138 0 459.2326 1,374.67 1,374.68 3 CO6A3_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% ELLTTMGDR 95.00% 2.62 0.353 2.1 518.2589 1,034.50 1,035.51 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% ELLTTMGDR 95.00% 2.56 0.373 1.92 518.2595 1,034.50 1,035.51 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% LNGTDPEDVIR 95.00% 2.3 0.181 1.42 614.3169 1,226.62 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% LNGTDPEDVIR 95.00% 3.57 0.402 3.82 614.8107 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% LNGTDPEDVIR 95.00% 3.05 0.366 2.4 614.8108 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% LNGTDPEDVIR 95.00% 3.69 0.426 1.55 614.8111 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% LNGTDPEDVIR 95.00% 3.54 0.446 1.14 614.8112 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% LNGTDPEDVIR 95.00% 3.51 0.42 2.01 614.8113 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% LNGTDPEDVIR 95.00% 3.15 0.416 1.44 614.8115 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% LNGTDPEDVIR 95.00% 2.38 0.165 1.43 614.8148 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% LNGTDPEDVIR 95.00% 3.37 0.365 2.44 615.3043 1,228.59 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% EAFNMIDQNR 95.00% 3.8 0.358 0 619.2836 1,236.55 1,237.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% EAFNMIDQNR 95.00% 3.65 0.419 0 619.2848 1,236.55 1,237.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% GNFNYVEFTR 95.00% 1.99 0.28 1.52 623.7718 1,245.53 1,246.59 2
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% GNFNYVEFTR 95.00% 2.53 0.376 1.85 623.7924 1,245.57 1,246.59 2
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% GNFNYVEFTR 95.00% 3.74 0.54 1.35 623.7954 1,245.58 1,246.59 2
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% GNFNYVEFTR 95.00% 2.15 0.463 4.17 623.7955 1,245.58 1,246.59 2
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% GNFNYVEFTR 95.00% 3.91 0.56 1.54 623.7959 1,245.58 1,246.59 2
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% GNFNYVEFTR 95.00% 3.27 0.526 3 623.796 1,245.58 1,246.59 2
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% GNFNYVEFTR 95.00% 2.17 0.435 2.96 623.7974 1,245.58 1,246.59 2
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% EAFNmIDQNR 95.00% 2.37 0.323 0 m5: Oxidation (+15.99) 627.2851 1,252.55 1,253.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% KGNFNYVEFTR 95.00% 3.52 0.526 3.33 687.8419 1,373.67 1,374.68 2 CO6A3_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% KGNFNYVEFTR 95.00% 3.11 0.407 2.23 687.8426 1,373.67 1,374.68 2 CO6A3_HUMAN
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% FTDEEVDEmYR 95.00% 3.47 0.5 4.46 m9: Oxidation (+15.99) 725.2937 1,448.57 1,449.58 2
 SAMPLE 2R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 23 30.20% FTDEEVDEmYR 95.00% 3.57 0.522 4.44 m9: Oxidation (+15.99) 725.2946 1,448.57 1,449.58 2
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% ELLTTMGDR 95.00% 2.36 0.391 2.42 518.2599 1,034.50 1,035.51 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% ELLTTMGDR 95.00% 2.59 0.369 1.66 518.2599 1,034.50 1,035.51 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% LNGTDPEDVIR 95.00% 3.45 0.445 3.66 614.8098 1,227.60 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% LNGTDPEDVIR 95.00% 2.51 0.231 2.55 614.8106 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% LNGTDPEDVIR 95.00% 3.24 0.413 2.92 614.8112 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% LNGTDPEDVIR 95.00% 3.36 0.432 3.8 614.8116 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% LNGTDPEDVIR 95.00% 2.72 0.248 1.68 614.8117 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% EAFNMIDQNR 95.00% 3.74 0.395 1.31 619.2825 1,236.55 1,237.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% EAFNMIDQNR 95.00% 4.05 0.393 0 619.2846 1,236.55 1,237.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% EAFNMIDQNR 95.00% 3.52 0.351 0 619.2878 1,236.56 1,237.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% EAFNMIDQNR 95.00% 3.19 0.362 0 619.7865 1,237.56 1,237.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% GNFNYVEFTR 95.00% 3.41 0.444 2.36 623.7954 1,245.58 1,246.59 2
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% KGNFNYVEFTR 95.00% 3.51 0.452 3.02 687.8422 1,373.67 1,374.68 2 CO6A3_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% KGNFNYVEFTR 95.00% 3.28 0.449 2.25 687.8434 1,373.67 1,374.68 2 CO6A3_HUMAN
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% FTDEEVDEmYR 95.00% 3.63 0.535 3 m9: Oxidation (+15.99) 725.2924 1,448.57 1,449.58 2
 SAMPLE 3 Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 5 5 14 30.20% FTDEEVDEmYR 95.00% 3.6 0.553 3.77 m9: Oxidation (+15.99) 725.2946 1,448.57 1,449.58 2
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% ELLTTMGDR 95.00% 2.4 0.384 1.62 518.2596 1,034.50 1,035.51 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% ELLTTMGDR 95.00% 2.6 0.356 1.7 518.2602 1,034.50 1,035.51 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% ELLTTmGDR 95.00% 1.99 0.357 0 m6: Oxidation (+15.99) 526.2569 1,050.50 1,051.51 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% LNGTDPEDVIR 95.00% 3.28 0.407 3.89 614.8103 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% LNGTDPEDVIR 95.00% 3.5 0.476 1.96 614.8111 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% LNGTDPEDVIR 95.00% 3.34 0.444 1.43 614.8114 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% LNGTDPEDVIR 95.00% 3.37 0.406 1.7 614.8119 1,227.61 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% LNGTDPEDVIR 95.00% 3.19 0.355 2.27 615.3081 1,228.60 1,228.62 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% EAFNMIDQNR 95.00% 3.38 0.396 0 619.2836 1,236.55 1,237.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% EAFNMIDQNR 95.00% 3.85 0.414 0 619.284 1,236.55 1,237.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% EAFNMIDQNR 95.00% 3.25 0.426 0 619.2868 1,236.56 1,237.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% EAFNMIDQNR 95.00% 3.09 0.361 0 619.2892 1,236.56 1,237.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% GNFNYVEFTR 95.00% 3.71 0.512 2.6 623.7959 1,245.58 1,246.59 2
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% GNFNYVEFTR 95.00% 2.71 0.315 2.24 623.7973 1,245.58 1,246.59 2
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% GNFNYVEFTR 95.00% 1.89 0.221 2.59 624.2965 1,246.58 1,246.59 2
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% EAFNmIDQNR 95.00% 2.34 0.336 0 m5: Oxidation (+15.99) 627.2815 1,252.55 1,253.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% EAFNmIDQNR 95.00% 2.29 0.204 0 m5: Oxidation (+15.99) 627.2818 1,252.55 1,253.56 2 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% DGFIDKEDLHDMLASLGK 95.00% 3.2 0.403 0 668.6622 2,002.96 2,003.98 3 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% DGFIDKEDLHDMLASLGK 95.00% 3.79 0.421 2.82 668.6628 2,002.97 2,003.98 3 MRLC3_HUMAN,MRLC2_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% EAPIDKKGNFNYVEFTR 95.00% 2.49 0.489 0.959 676.6765 2,027.01 2,028.02 3
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% EAPIDKKGNFNYVEFTR 95.00% 2.62 0.449 0 677.0101 2,028.01 2,028.02 3
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% KGNFNYVEFTR 95.00% 3.47 0.4 2.96 687.8417 1,373.67 1,374.68 2 CO6A3_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% KGNFNYVEFTR 95.00% 3.24 0.33 2.89 687.844 1,373.67 1,374.68 2 CO6A3_HUMAN
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% FTDEEVDEmYR 95.00% 3.63 0.522 3.54 m9: Oxidation (+15.99) 725.2924 1,448.57 1,449.58 2
 SAMPLE 3R Myosin regulatory light polypeptide 9  MYL9  MYL9_HUMAN 19,810.10 100.00% 7 7 23 44.20% FTDEEVDEmYR 95.00% 3.6 0.524 3.08 m9: Oxidation (+15.99) 725.2932 1,448.57 1,449.58 2
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.57 0.392 0 469.7593 937.5029 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.54 0.366 0 469.7596 937.5035 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.18 0.288 0 469.7596 937.5036 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.45 0.397 0 469.7597 937.5038 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.59 0.271 0 469.76 937.5044 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.55 0.375 0 469.76 937.5044 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.6 0.344 0 469.7602 937.5047 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.47 0.387 0 469.7602 937.5048 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 1.91 0.242 0 469.7604 937.5051 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.7 0.335 0 469.7604 937.5051 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.28 0.401 0 469.7605 937.5053 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.21 0.413 0 469.7606 937.5055 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.62 0.395 0 469.7606 937.5056 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.4 0.381 0 469.7606 937.5056 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.48 0.366 0 469.7608 937.5059 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.8 0.368 0 469.7608 937.5059 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.36 0.362 0 469.761 937.5063 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.48 0.401 0 469.7614 937.5071 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.54 0.391 0 469.7614 937.5071 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.4 0.376 0 469.7616 937.5075 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.47 0.39 1.57 469.7626 937.5095 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% IVFQEFR 95.00% 2.45 0.365 0 469.7635 937.5113 938.51 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALEEALEAK 95.00% 2.76 0.366 0 487.2637 972.5117 973.5207 2 LRP1_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALEEALEAK 95.00% 3.06 0.461 0 487.2641 972.5126 973.5207 2 LRP1_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALEEALEAK 95.00% 2.65 0.341 0 487.2646 972.5136 973.5207 2 LRP1_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALEEALEAK 95.00% 3.29 0.372 0 487.2648 972.514 973.5207 2 LRP1_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALEEALEAK 95.00% 3.03 0.338 0 487.2652 972.5147 973.5207 2 LRP1_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALEEALEAK 95.00% 3.03 0.476 0 487.2657 972.5157 973.5207 2 LRP1_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% cNGVLEGIR 95.00% 2.52 0.278 0 c1: Carbamidomethyl (+57.02) 509.2618 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% cNGVLEGIR 95.00% 2.35 0.289 0 c1: Carbamidomethyl (+57.02) 509.2626 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% VKPLLQVTR 95.00% 1.9 0.204 1.27 527.3422 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% VKPLLQVTR 95.00% 1.91 0.263 0 527.3429 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% VKPLLQVTR 95.00% 1.89 0.327 0 527.3437 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% VKPLLQVTR 95.00% 1.97 0.374 0 527.3437 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% VKPLLQVTR 95.00% 1.89 0.318 0 527.3439 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% VKPLLQVTR 95.00% 1.99 0.316 0 527.344 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% VKPLLQVTR 95.00% 1.82 0.333 0 527.3441 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% VKPLLQVTR 95.00% 1.99 0.33 0 527.3441 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% VKPLLQVTR 95.00% 1.91 0.366 1.18 527.3442 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% VKPLLQVTR 95.00% 2.1 0.357 0 527.3443 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% VKPLLQVTR 95.00% 1.95 0.272 0 527.3445 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% VKPLLQVTR 95.00% 1.95 0.287 0 527.3448 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% FDQLLAEEK 95.00% 3.25 0.404 0 546.7832 1,091.55 1,092.56 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% FDQLLAEEK 95.00% 3.33 0.402 2.33 546.7835 1,091.55 1,092.56 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% FDQLLAEEK 95.00% 3.32 0.414 0 546.7838 1,091.55 1,092.56 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% FDQLLAEEK 95.00% 3.09 0.384 0 546.7845 1,091.55 1,092.56 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 2.19 0.235 0 602.321 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 2.2 0.272 0 602.3222 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 2.95 0.304 1.62 602.3228 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 2.93 0.277 1.68 602.323 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 3.14 0.288 1.64 602.3231 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 3.02 0.298 1.6 602.3231 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 3.12 0.3 2.26 602.3235 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 3.08 0.296 1.57 602.3236 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 3.07 0.304 1.51 602.3236 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 2.48 0.276 1.82 602.3236 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 3.14 0.296 2.68 602.3238 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 3.07 0.283 1.74 602.3238 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 2.88 0.304 0 602.3239 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 2.43 0.27 1.59 602.3257 1,202.64 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% ALELDPNLYR 95.00% 2.33 0.239 1.24 602.3258 1,202.64 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 2.69 0.193 1.62 610.8286 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 3.01 0.215 0 610.83 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 2.88 0.225 0 610.831 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 2.57 0.162 1.74 610.8311 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 3.03 0.296 0 610.8313 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 2.5 0.215 0 610.8315 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 2.61 0.19 0 610.8315 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 3 0.217 0 610.8315 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 2.89 0.285 0 610.8317 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 2.58 0.207 0 610.8318 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 2.7 0.2 0 610.8319 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 3.15 0.222 1.59 610.8319 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% KFDQLLAEEK 95.00% 2.96 0.208 0 610.8325 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 2.81 0.5 0 646.3302 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 2.38 0.508 0 646.3308 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 2.6 0.475 1.52 646.331 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 2.46 0.482 0 646.3311 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 3.17 0.424 1.72 646.3312 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 2.99 0.443 2.1 646.3316 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 3.59 0.464 1.7 646.3316 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 2.9 0.475 1.27 646.3316 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 2.31 0.463 0 646.3316 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 3.34 0.44 1.7 646.3319 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 2.24 0.421 1.55 646.3321 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 2.84 0.352 1.21 646.3323 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 3.01 0.474 2.19 646.3324 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EQADFAVEALAK 95.00% 2.97 0.501 1.24 646.3329 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% QLEEAEEEATRANASRR 95.00% 2.18 0.261 0 653.8317 1,958.47 1,959.95 3
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% TQLEELEDELQATEDAK 95.00% 2.86 0.266 0 654.6462 1,960.92 1,961.92 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% TQLEELEDELQATEDAK 95.00% 4.71 0.548 2.51 654.6469 1,960.92 1,961.92 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% TQLEELEDELQATEDAK 95.00% 5.03 0.549 3.96 654.647 1,960.92 1,961.92 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% TQLEELEDELQATEDAK 95.00% 5.45 0.532 3.77 654.9803 1,961.92 1,961.92 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% TQLEELEDELQATEDAK 95.00% 5.54 0.52 4.08 654.9812 1,961.92 1,961.92 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% TQLEELEDELQATEDAK 95.00% 3.67 0.457 0 654.9812 1,961.92 1,961.92 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EDQSILcTGESGAGK 95.00% 2.94 0.23 0 c7: Carbamidomethyl (+57.02) 776.3536 1,550.69 1,551.70 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EDQSILcTGESGAGK 95.00% 3.4 0.38 0 c7: Carbamidomethyl (+57.02) 776.3564 1,550.70 1,551.70 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% EDQSILcTGESGAGK 95.00% 2.47 0.299 0 c7: Carbamidomethyl (+57.02) 776.8557 1,551.70 1,551.70 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% TTLQVDTLNAELAAER 95.00% 4.08 0.532 5.66 872.9607 1,743.91 1,744.91 2
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% TQLEELEDELQATEDAK 95.00% 6.64 0.646 7.3 981.4644 1,960.91 1,961.92 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% TQLEELEDELQATEDAK 95.00% 7.23 0.65 6.68 981.4644 1,960.91 1,961.92 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% TQLEELEDELQATEDAK 95.00% 6.83 0.646 5.3 981.465 1,960.91 1,961.92 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% TQLEELEDELQATEDAK 95.00% 6.84 0.64 7.27 981.4652 1,960.91 1,961.92 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 99.80% 2 2 2 6.63% TQLEELEDELQATEDAK 95.00% 6.72 0.628 8.09 981.9659 1,961.92 1,961.92 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IVFQEFR 95.00% 2.86 0.343 0 469.7586 937.5015 938.51 2 MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IVFQEFR 95.00% 2.75 0.34 0 469.7597 937.5038 938.51 2 MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% LVWIPSER 95.00% 1.97 0.31 0 500.2836 998.5515 999.5628 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% cNGVLEGIR 95.00% 2.92 0.403 1.17 c1: Carbamidomethyl (+57.02) 509.2596 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% cNGVLEGIR 95.00% 2.88 0.41 1.25 c1: Carbamidomethyl (+57.02) 509.2601 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% cNGVLEGIR 95.00% 2.17 0.236 0 c1: Carbamidomethyl (+57.02) 509.2602 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% cNGVLEGIR 95.00% 2.3 0.281 0 c1: Carbamidomethyl (+57.02) 509.2605 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% VVSSVLQFGNISFK 95.00% 3.76 0.451 0 509.2859 1,524.83 1,524.84 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% QVLALQSQLADTKK 95.00% 2.31 0.287 0 514.9656 1,541.87 1,542.89 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% QVLALQSQLADTKK 95.00% 2.54 0.349 0 514.9664 1,541.88 1,542.89 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% QVLALQSQLADTKK 95.00% 1.96 0.308 0 515.2997 1,542.88 1,542.89 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% VKPLLQVTR 95.00% 2.06 0.301 0 527.3412 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% VKPLLQVTR 95.00% 2.08 0.291 0 527.3418 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% VKPLLQVTR 95.00% 1.96 0.291 0 527.342 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% VKPLLQVTR 95.00% 1.94 0.286 0 527.3423 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALEEALEAKEEFER 95.00% 2.58 0.456 1.77 555.2763 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALEEALEAKEEFER 95.00% 2.68 0.285 1.33 555.277 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALEEALEAKEEFER 95.00% 2.48 0.318 1.8 555.2773 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALEEALEAKEEFER 95.00% 2.88 0.238 0 555.2779 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALEEALEAKEEFER 95.00% 2.33 0.257 1.72 555.6104 1,663.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% KQELEEILHDLESR 95.00% 4.34 0.351 2.85 580.3033 1,737.89 1,738.90 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% KQELEEILHDLESR 95.00% 4.22 0.32 2.51 580.3036 1,737.89 1,738.90 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% KQELEEILHDLESR 95.00% 4.66 0.381 1.92 580.6368 1,738.89 1,738.90 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% AKLQELEGAVK 95.00% 2.53 0.261 0 593.3464 1,184.68 1,185.68 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% HATALEELSEQLEQAK 95.00% 3.11 0.246 0 599.9724 1,796.89 1,796.90 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALELDPNLYR 95.00% 2.74 0.251 2.2 602.3204 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALELDPNLYR 95.00% 2.82 0.254 1.2 602.3207 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALELDPNLYR 95.00% 2.82 0.266 2.21 602.3208 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALELDPNLYR 95.00% 2.75 0.245 2.39 602.3218 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALELDPNLYR 95.00% 2.77 0.27 2.11 602.322 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALELDPNLYR 95.00% 2.52 0.284 1.8 602.3227 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALELDPNLYR 95.00% 2.98 0.262 1.74 602.8224 1,203.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% KFDQLLAEEK 95.00% 2.97 0.259 0 610.8289 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% KFDQLLAEEK 95.00% 2.72 0.252 0 610.8295 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% KFDQLLAEEK 95.00% 2.5 0.199 0 610.8316 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALEQQVEEMR 95.00% 2.65 0.278 1.16 616.3067 1,230.60 1,232.59 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALEQQVEEMR 95.00% 2.64 0.278 0 616.8101 1,231.60 1,232.59 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% LLKDAEALSQR 95.00% 2.7 0.44 1.25 621.9652 1,241.91 1,243.70 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% LLKDAEALSQR 95.00% 2.42 0.247 0 622.2986 1,242.58 1,243.70 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% YEILTPNAIPK 95.00% 2.55 0.471 1.64 629.8545 1,257.69 1,258.70 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% YEILTPNAIPK 95.00% 2.72 0.436 2.08 629.8549 1,257.69 1,258.70 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% EQADFAVEALAK 95.00% 2.49 0.411 0 646.3283 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% EQADFAVEALAK 95.00% 3.36 0.474 1.72 646.3288 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% EQADFAVEALAK 95.00% 3.27 0.503 1.72 646.3288 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% EQADFAVEALAK 95.00% 2.94 0.468 0 646.3297 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% LQQELDDLTVDLDHQR 95.00% 2.99 0.355 0 646.6506 1,936.93 1,937.96 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% LQNELDNVSTLLEEAEK 95.00% 3.24 0.427 0 648.997 1,943.97 1,944.98 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% HATALEELSEQLEQAKR 95.00% 6.59 0.585 4.89 651.6718 1,951.99 1,953.00 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% HATALEELSEQLEQAKR 95.00% 6.26 0.635 3.48 651.6721 1,951.99 1,953.00 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% HATALEELSEQLEQAKR 95.00% 5.41 0.597 3.77 651.673 1,952.00 1,953.00 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% HATALEELSEQLEQAKR 95.00% 6.35 0.627 2.46 652.0053 1,952.99 1,953.00 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% HATALEELSEQLEQAKR 95.00% 6.01 0.588 3.14 652.0069 1,953.00 1,953.00 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ELQAQIAELQEDFESEK 95.00% 3.9 0.453 5.44 669.6566 2,005.95 2,006.96 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% VEEEEERNQILQNEKK 95.00% 4.34 0.41 0 672.7985 2,015.37 2,015.00 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% LQNELDNVSTLLEEAEKK 95.00% 3.22 0.412 0 692.0284 2,073.06 2,073.07 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% LQNELDNVSTLLEEAEKK 95.00% 3.05 0.389 1.85 692.0291 2,073.06 2,073.07 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IVGLDQVTGMTETAFGSAYK 95.00% 2.8 0.343 0 697.0156 2,088.02 2,088.03 3
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% QVLALQSQLADTK 95.00% 3.52 0.489 4.89 707.9002 1,413.78 1,414.79 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% QVLALQSQLADTK 95.00% 3.76 0.576 5.04 708.4 1,414.78 1,414.79 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% SDLLLEGFNNYR 95.00% 4.04 0.481 1.77 720.858 1,439.70 1,440.71 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% SDLLLEGFNNYR 95.00% 3.78 0.494 1.44 720.8586 1,439.70 1,440.71 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% SDLLLEGFNNYR 95.00% 3.76 0.474 3.15 720.859 1,439.70 1,440.71 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IGQLEEQLEQEAK 95.00% 2.48 0.43 1.34 757.7168 1,513.42 1,514.77 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IGQLEEQLEQEAK 95.00% 4.29 0.399 3.05 757.8861 1,513.76 1,514.77 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IGQLEEQLEQEAK 95.00% 4.62 0.388 2.96 757.8876 1,513.76 1,514.77 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IGQLEEQLEQEAK 95.00% 3.93 0.421 2.85 757.8876 1,513.76 1,514.77 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IGQLEEQLEQEAK 95.00% 3.79 0.449 3.1 757.8878 1,513.76 1,514.77 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IGQLEEQLEQEAK 95.00% 4.53 0.41 4.24 757.8885 1,513.76 1,514.77 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IGQLEEQLEQEAK 95.00% 3.95 0.436 4.05 757.8886 1,513.76 1,514.77 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IGQLEEQLEQEAK 95.00% 4.69 0.374 3.48 757.8886 1,513.76 1,514.77 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IGQLEEQLEQEAK 95.00% 4.07 0.4 3 757.8887 1,513.76 1,514.77 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IGQLEEQLEQEAK 95.00% 4.21 0.398 3.49 757.889 1,513.76 1,514.77 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ELDDATEANEGLSR 95.00% 4.12 0.582 2.92 760.346 1,518.68 1,519.69 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ELDDATEANEGLSR 95.00% 4.79 0.594 4.29 760.3473 1,518.68 1,519.69 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ELDDATEANEGLSR 95.00% 3.99 0.615 3.39 760.3483 1,518.68 1,519.69 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ELDDATEANEGLSR 95.00% 4.42 0.553 3.14 760.3485 1,518.68 1,519.69 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% AVIYNPATQADWTAK 95.00% 4.77 0.491 2.08 824.9191 1,647.82 1,648.83 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% AVIYNPATQADWTAK 95.00% 4.28 0.464 2.92 824.9199 1,647.82 1,648.83 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% AVIYNPATQADWTAK 95.00% 4.56 0.443 3.46 824.9201 1,647.82 1,648.83 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% AVIYNPATQADWTAK 95.00% 4.62 0.454 3.7 824.9204 1,647.83 1,648.83 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% AVIYNPATQADWTAK 95.00% 4.65 0.469 3.92 825.4216 1,648.83 1,648.83 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% AVIYNPATQADWTAK 95.00% 4.42 0.402 3.23 825.4222 1,648.83 1,648.83 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALEEALEAKEEFER 95.00% 3.12 0.432 1.96 832.4144 1,662.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% ALEEALEAKEEFER 95.00% 3.86 0.417 2.22 832.9112 1,663.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% FLSNGYIPIPGQQDK 95.00% 3.91 0.41 3.2 838.9351 1,675.85 1,676.87 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% FLSNGYIPIPGQQDK 95.00% 4.07 0.409 0 838.9359 1,675.86 1,676.87 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% FLSNGYIPIPGQQDK 95.00% 4.49 0.393 3 838.9367 1,675.86 1,676.87 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% FLSNGYIPIPGQQDK 95.00% 3.62 0.411 2.85 838.9369 1,675.86 1,676.87 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% FLSNGYIPIPGQQDK 95.00% 4.75 0.433 3.42 839.4358 1,676.86 1,676.87 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% FLSNGYIPIPGQQDK 95.00% 3.66 0.391 4.89 839.4374 1,676.86 1,676.87 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% QLLQANPILESFGNAK 95.00% 4.33 0.5 4.8 871.9771 1,741.94 1,742.94 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% QLLQANPILESFGNAK 95.00% 4.06 0.52 3.11 872.4784 1,742.94 1,742.94 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% TTLQVDTLNAELAAER 95.00% 4.56 0.519 3.82 872.9557 1,743.90 1,744.91 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% TTLQVDTLNAELAAER 95.00% 4.68 0.543 4.12 872.9561 1,743.90 1,744.91 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% TTLQVDTLNAELAAER 95.00% 4.53 0.54 4.17 872.9567 1,743.90 1,744.91 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% TTLQVDTLNAELAAER 95.00% 4.67 0.528 4.82 872.9589 1,743.90 1,744.91 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% TTLQVDTLNAELAAER 95.00% 4.77 0.562 5.38 872.9591 1,743.90 1,744.91 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% TTLQVDTLNAELAAER 95.00% 4.88 0.549 4.08 872.96 1,743.90 1,744.91 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% TTLQVDTLNAELAAER 95.00% 4.28 0.469 6 872.9604 1,743.91 1,744.91 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% TTLQVDTLNAELAAER 95.00% 4.74 0.532 4.48 873.4585 1,744.90 1,744.91 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% TTLQVDTLNAELAAER 95.00% 4.78 0.537 4.96 873.4594 1,744.90 1,744.91 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% TTLQVDTLNAELAAER 95.00% 5.18 0.57 4.55 873.4605 1,744.91 1,744.91 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% TTLQVDTLNAELAAER 95.00% 4.73 0.516 5.12 873.4629 1,744.91 1,744.91 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% IGQLEEQLEQEAKER 95.00% 4.07 0.452 1.62 900.9599 1,799.90 1,799.91 2
 SAMPLE 1 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 26 28 81 18.80% LQNELDNVSTLLEEAEK 95.00% 5.72 0.586 5.34 972.9911 1,943.97 1,944.98 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% IVFQEFR 95.00% 2.64 0.373 0 469.7592 937.5027 938.51 2 MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% IVFQEFR 95.00% 2.77 0.351 0 469.7606 937.5056 938.51 2 MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% LVWIPSER 95.00% 2.29 0.287 0 500.2838 998.5519 999.5628 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% KKLDAQVQELHAK 95.00% 3.3 0.421 1.06 503.2912 1,506.85 1,507.86 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% cNGVLEGIR 95.00% 2.63 0.404 1.85 c1: Carbamidomethyl (+57.02) 509.2597 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% VVSSVLQFGNISFK 95.00% 3.47 0.232 0 509.286 1,524.83 1,524.84 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% QVLALQSQLADTKK 95.00% 2.04 0.298 0 514.9666 1,541.88 1,542.89 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% QVLALQSQLADTKK 95.00% 2.02 0.292 0 515.3024 1,542.88 1,542.89 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% VKPLLQVTR 95.00% 1.85 0.284 0 527.3419 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALEEALEAKEEFER 95.00% 2.32 0.3 1.09 555.2776 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALEEALEAKEEFER 95.00% 2.52 0.182 0 555.2783 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALEEALEAKEEFER 95.00% 2.68 0.344 0 555.6124 1,663.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% KQELEEILHDLESR 95.00% 4.16 0.31 3.19 580.3029 1,737.89 1,738.90 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% KQELEEILHDLESR 95.00% 3.62 0.219 2.28 580.303 1,737.89 1,738.90 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% KQELEEILHDLESR 95.00% 3.33 0.327 2.28 580.3033 1,737.89 1,738.90 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% KQELEEILHDLESR 95.00% 3.66 0.292 3.47 580.304 1,737.89 1,738.90 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% KQELEEILHDLESR 95.00% 4.52 0.367 2.41 580.6367 1,738.89 1,738.90 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% TTLQVDTLNAELAAER 95.00% 3.06 0.308 2.07 582.3058 1,743.89 1,744.91 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% TTLQVDTLNAELAAER 95.00% 2.93 0.38 2.54 582.3058 1,743.89 1,744.91 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% TTLQVDTLNAELAAER 95.00% 3.8 0.414 3.64 582.6415 1,744.90 1,744.91 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% AKLQELEGAVK 95.00% 2.11 0.264 0 593.3434 1,184.67 1,185.68 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% AKLQELEGAVK 95.00% 2.45 0.256 0 593.3454 1,184.68 1,185.68 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% HATALEELSEQLEQAK 95.00% 3.89 0.327 0 599.972 1,796.89 1,796.90 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% HATALEELSEQLEQAK 95.00% 3.99 0.334 0 599.9723 1,796.89 1,796.90 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALELDPNLYR 95.00% 2.53 0.249 2.77 602.3199 1,202.62 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALELDPNLYR 95.00% 2.21 0.245 1.64 602.3202 1,202.62 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALELDPNLYR 95.00% 2.84 0.287 1.64 602.3202 1,202.62 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALELDPNLYR 95.00% 2.36 0.252 1.34 602.3207 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALELDPNLYR 95.00% 2.63 0.246 1.8 602.3219 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALELDPNLYR 95.00% 2.75 0.268 2.09 602.3219 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALELDPNLYR 95.00% 2.57 0.245 2.05 602.3221 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALELDPNLYR 95.00% 2.4 0.246 1.64 602.3222 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% KFDQLLAEEK 95.00% 2.53 0.204 0 610.8277 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% KFDQLLAEEK 95.00% 2.77 0.251 0 610.8283 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% KFDQLLAEEK 95.00% 2.6 0.209 0 610.8285 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% KFDQLLAEEK 95.00% 2.77 0.285 0 610.8295 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALEQQVEEMR 95.00% 2.18 0.249 1.31 616.3057 1,230.60 1,232.59 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALEQQVEEMR 95.00% 2.59 0.287 1.14 616.3063 1,230.60 1,232.59 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALEQQVEEMR 95.00% 2.94 0.267 0 616.8036 1,231.59 1,232.59 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALEQQVEEMR 95.00% 2.53 0.24 1.25 616.8097 1,231.60 1,232.59 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% YEILTPNAIPK 95.00% 2.63 0.478 2.46 629.8554 1,257.70 1,258.70 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% EQADFAVEALAK 95.00% 2.99 0.478 1.22 646.3286 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% EQADFAVEALAK 95.00% 2.59 0.405 0 646.3288 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% EQADFAVEALAK 95.00% 3.09 0.501 0 646.3289 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% EQADFAVEALAK 95.00% 3.03 0.527 1.27 646.3293 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% EQADFAVEALAK 95.00% 2.67 0.414 0 646.3299 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% EQADFAVEALAK 95.00% 2.61 0.341 0 646.3308 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% LQQELDDLTVDLDHQR 95.00% 3.81 0.377 0 646.9834 1,937.93 1,937.96 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% LQQELDDLTVDLDHQR 95.00% 2.39 0.227 0 646.9852 1,937.93 1,937.96 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% HATALEELSEQLEQAKR 95.00% 4.89 0.571 2.8 651.6718 1,951.99 1,953.00 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% HATALEELSEQLEQAKR 95.00% 4.91 0.55 2.6 651.6719 1,951.99 1,953.00 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% HATALEELSEQLEQAKR 95.00% 6.22 0.623 2.89 651.6736 1,952.00 1,953.00 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% HATALEELSEQLEQAKR 95.00% 6.57 0.632 3.37 652.0071 1,953.00 1,953.00 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% HATALEELSEQLEQAKR 95.00% 5.38 0.635 1.72 652.0084 1,953.00 1,953.00 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% TQLEELEDELQATEDAK 95.00% 2.9 0.204 0 654.6444 1,960.91 1,961.92 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% NKQGLETDNKELAcEVK 95.00% 3.8 0.483 0 c14: Carbamidomethyl (+57.02) 659.6627 1,975.96 1,975.98 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% NKQGLETDNKELAcEVK 95.00% 4.11 0.495 1.82 c14: Carbamidomethyl (+57.02) 659.6649 1,975.97 1,975.98 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% LQNELDNVSTLLEEAEKK 95.00% 3.05 0.382 0 692.0284 2,073.06 2,073.07 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% LQNELDNVSTLLEEAEKK 95.00% 2.81 0.348 0 692.0284 2,073.06 2,073.07 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% LQNELDNVSTLLEEAEKK 95.00% 2.88 0.273 0 692.0291 2,073.06 2,073.07 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% LQNELDNVSTLLEEAEKK 95.00% 3.08 0.407 0 692.0292 2,073.06 2,073.07 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% SDLLLEGFNNYR 95.00% 3.84 0.507 2.15 720.8569 1,439.70 1,440.71 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% SDLLLEGFNNYR 95.00% 3.7 0.495 0 720.8579 1,439.70 1,440.71 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% SDLLLEGFNNYR 95.00% 3.59 0.478 1.89 720.8583 1,439.70 1,440.71 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% SDLLLEGFNNYR 95.00% 2.39 0.289 0 720.8589 1,439.70 1,440.71 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% SDLLLEGFNNYR 95.00% 3.25 0.448 2.36 720.8592 1,439.70 1,440.71 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% SDLLLEGFNNYR 95.00% 2.57 0.446 3.39 720.8592 1,439.70 1,440.71 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% IGQLEEQLEQEAK 95.00% 3.74 0.411 3.7 757.8866 1,513.76 1,514.77 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% IGQLEEQLEQEAK 95.00% 4.33 0.424 3.08 757.8875 1,513.76 1,514.77 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% IGQLEEQLEQEAK 95.00% 4.02 0.44 4.49 757.888 1,513.76 1,514.77 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% IGQLEEQLEQEAK 95.00% 3.49 0.41 4.07 757.8885 1,513.76 1,514.77 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% IGQLEEQLEQEAK 95.00% 4.26 0.404 3.28 758.3889 1,514.76 1,514.77 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% IGQLEEQLEQEAK 95.00% 4.2 0.455 3.44 758.3893 1,514.76 1,514.77 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% IGQLEEQLEQEAK 95.00% 4.64 0.433 3.51 758.3902 1,514.76 1,514.77 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% IGQLEEQLEQEAK 95.00% 4.17 0.372 2.85 758.3903 1,514.77 1,514.77 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ELDDATEANEGLSR 95.00% 4.06 0.577 2.62 760.346 1,518.68 1,519.69 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ELDDATEANEGLSR 95.00% 4.35 0.578 5.59 760.3473 1,518.68 1,519.69 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ELDDATEANEGLSR 95.00% 3.68 0.51 2.8 760.3517 1,518.69 1,519.69 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ELDDATEANEGLSR 95.00% 4.21 0.563 3.68 760.8483 1,519.68 1,519.69 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% DAASLESQLQDTQELLQEETR 95.00% 6.78 0.506 2.31 802.3871 2,404.14 2,404.15 3
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% AVIYNPATQADWTAK 95.00% 4.14 0.441 4.34 824.92 1,647.82 1,648.83 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% AVIYNPATQADWTAK 95.00% 4.54 0.459 4.6 824.9211 1,647.83 1,648.83 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% AVIYNPATQADWTAK 95.00% 4.27 0.418 3.62 825.421 1,648.83 1,648.83 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% AVIYNPATQADWTAK 95.00% 4.45 0.419 3.44 825.4215 1,648.83 1,648.83 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ALEEALEAKEEFER 95.00% 3.63 0.409 2.41 832.916 1,663.82 1,663.82 2 PABP1_HUMAN
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% FLSNGYIPIPGQQDK 95.00% 3.66 0.385 4.6 838.9342 1,675.85 1,676.87 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% FLSNGYIPIPGQQDK 95.00% 3.48 0.453 2.62 838.9366 1,675.86 1,676.87 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% FLSNGYIPIPGQQDK 95.00% 4.39 0.478 4.39 838.937 1,675.86 1,676.87 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% FLSNGYIPIPGQQDK 95.00% 4.62 0.438 2.89 839.4362 1,676.86 1,676.87 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% FLSNGYIPIPGQQDK 95.00% 3.96 0.439 1.44 839.437 1,676.86 1,676.87 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% FLSNGYIPIPGQQDK 95.00% 4.52 0.407 4.89 839.4371 1,676.86 1,676.87 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% QLLQANPILESFGNAK 95.00% 4.48 0.551 4.8 871.9757 1,741.94 1,742.94 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% QLLQANPILESFGNAK 95.00% 3.75 0.268 3.07 871.9782 1,741.94 1,742.94 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% QLLQANPILESFGNAK 95.00% 4.67 0.551 3.14 872.4781 1,742.94 1,742.94 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% TTLQVDTLNAELAAER 95.00% 4.48 0.518 4.51 872.956 1,743.90 1,744.91 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% TTLQVDTLNAELAAER 95.00% 4.63 0.495 4.19 872.9568 1,743.90 1,744.91 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% TTLQVDTLNAELAAER 95.00% 5 0.531 4.13 872.9569 1,743.90 1,744.91 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% TTLQVDTLNAELAAER 95.00% 4.67 0.537 5.04 872.9581 1,743.90 1,744.91 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% TTLQVDTLNAELAAER 95.00% 4.5 0.534 3.8 872.9622 1,743.91 1,744.91 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% TTLQVDTLNAELAAER 95.00% 4.43 0.516 3.8 873.4587 1,744.90 1,744.91 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% TTLQVDTLNAELAAER 95.00% 4.48 0.501 4.64 873.4606 1,744.91 1,744.91 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% LQNELDNVSTLLEEAEK 95.00% 5.46 0.555 6.48 973.4907 1,944.97 1,944.98 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% LQNELDNVSTLLEEAEK 95.00% 5.68 0.555 6.09 973.4909 1,944.97 1,944.98 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ELQAQIAELQEDFESEK 95.00% 4.55 0.583 6.35 1,003.98 2,005.94 2,006.96 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% ELQAQIAELQEDFESEK 95.00% 4.38 0.54 5.82 1,004.48 2,006.94 2,006.96 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% IVGLDQVTGMTETAFGSAYK 95.00% 6.23 0.712 9 1,045.02 2,088.02 2,088.03 2
 SAMPLE 1R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 25 27 84 20.70% IVGLDQVTGMTETAFGSAYK 95.00% 6.17 0.665 8.85 1,045.02 2,088.02 2,088.03 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELEAELEDERK 95.00% 1.7 0.272 0.959 454.2259 1,359.65 1,360.66 3 DESP_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% FVAELWKDVDR 95.00% 2.05 0.419 1.19 459.9118 1,376.71 1,377.72 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% FVAELWKDVDR 95.00% 2.15 0.241 0 459.9119 1,376.71 1,377.72 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% FVAELWKDVDR 95.00% 1.67 0.401 1.11 459.9123 1,376.71 1,377.72 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVFQEFR 95.00% 2.08 0.269 0 469.7576 937.4996 938.51 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVFQEFR 95.00% 2.63 0.365 0 469.7579 937.5002 938.51 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVFQEFR 95.00% 2.94 0.335 0 469.7581 937.5006 938.51 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVFQEFR 95.00% 2.21 0.358 0 469.7584 937.5011 938.51 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVFQEFR 95.00% 1.94 0.271 1.12 469.7584 937.5011 938.51 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVFQEFR 95.00% 2.77 0.333 0 469.7584 937.5011 938.51 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVFQEFR 95.00% 2.39 0.305 0 469.7585 937.5014 938.51 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVFQEFR 95.00% 2.53 0.38 1.6 469.7587 937.5018 938.51 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVFQEFR 95.00% 2.53 0.382 1.39 469.7588 937.5019 938.51 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVFQEFR 95.00% 2.57 0.398 0 469.7594 937.5031 938.51 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVFQEFR 95.00% 2.31 0.387 1.64 469.7604 937.5052 938.51 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LRVELAEK 95.00% 2.46 0.169 0 479.2893 956.563 957.5734 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VIQYLAHVASSHK 95.00% 3.11 0.5 2 484.9373 1,451.79 1,452.80 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VIQYLAHVASSHK 95.00% 3.13 0.536 1.32 485.2717 1,452.79 1,452.80 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAK 95.00% 3.06 0.401 0 487.2628 972.51 973.5207 2 LRP1_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAK 95.00% 2.77 0.335 1.13 487.2632 972.5108 973.5207 2 LRP1_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAK 95.00% 1.92 0.292 0 487.2635 972.5114 973.5207 2 LRP1_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAK 95.00% 1.99 0.265 1.74 487.9138 973.812 973.5207 2 LRP1_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LQELEGAVK 95.00% 2.94 0.164 0 493.7786 985.5415 986.5524 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% GGPISFSSSR 95.00% 3.07 0.284 1.26 497.7502 993.4848 994.4958 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% GGPISFSSSR 95.00% 3.17 0.217 1.85 497.7507 993.4858 994.4958 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KKLDAQVQELHAK 95.00% 3.91 0.447 2.77 503.2902 1,506.85 1,507.86 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% cNGVLEGIR 95.00% 3.2 0.371 1.92 c1: Carbamidomethyl (+57.02) 509.2602 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% cNGVLEGIR 95.00% 3.06 0.265 1.96 c1: Carbamidomethyl (+57.02) 509.2603 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% cNGVLEGIR 95.00% 3.03 0.371 2.22 c1: Carbamidomethyl (+57.02) 509.2607 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% cNGVLEGIR 95.00% 3.17 0.389 2.41 c1: Carbamidomethyl (+57.02) 509.2607 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% DKADFcIIHYAGK 95.00% 2.8 0.162 1 c6: Carbamidomethyl (+57.02) 513.2524 1,536.73 1,537.75 3 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% DKADFcIIHYAGK 95.00% 3.17 0.342 0 c6: Carbamidomethyl (+57.02) 513.2529 1,536.74 1,537.75 3 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% DKADFcIIHYAGK 95.00% 3.49 0.229 0 c6: Carbamidomethyl (+57.02) 513.2541 1,536.74 1,537.75 3 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% DKADFcIIHYAGK 95.00% 3.34 0.281 0 c6: Carbamidomethyl (+57.02) 513.5873 1,537.74 1,537.75 3 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QVLALQSQLADTKK 95.00% 3.06 0.471 0 514.9659 1,541.87 1,542.89 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QVLALQSQLADTKK 95.00% 2.66 0.37 0 514.9663 1,541.88 1,542.89 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QVLALQSQLADTKK 95.00% 3.08 0.424 0 514.9664 1,541.88 1,542.89 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QVLALQSQLADTKK 95.00% 2.72 0.394 0 514.9665 1,541.88 1,542.89 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AGKLDPHLVLDQLR 95.00% 1.95 0.248 0 525.6384 1,573.89 1,574.90 3 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AGKLDPHLVLDQLR 95.00% 1.93 0.281 0 525.6384 1,573.89 1,574.90 3 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QTKVEGELEEMER 95.00% 2.82 0.167 0 526.5875 1,576.74 1,577.75 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AGVLAHLEEERDLK 95.00% 2.9 0.3 0 527.2855 1,578.83 1,579.84 3 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AGVLAHLEEERDLK 95.00% 3.15 0.305 1.59 527.2856 1,578.83 1,579.84 3 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AGVLAHLEEERDLK 95.00% 2.47 0.229 0 527.2857 1,578.83 1,579.84 3 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AGVLAHLEEERDLK 95.00% 3.37 0.415 2.05 527.2858 1,578.83 1,579.84 3 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VKPLLQVTR 95.00% 2 0.33 0 527.3416 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VKPLLQVTR 95.00% 2.23 0.362 0 527.3417 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VKPLLQVTR 95.00% 2.1 0.34 0 527.3422 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VKPLLQVTR 95.00% 2.13 0.371 0 527.3423 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELEAELEDERKQR 95.00% 1.92 0.353 0 548.9431 1,643.81 1,644.82 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELEAELEDERKQR 95.00% 2.05 0.329 0 548.9435 1,643.81 1,644.82 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELEAELEDERKQR 95.00% 2.09 0.325 0 548.9437 1,643.81 1,644.82 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELEAELEDERKQR 95.00% 1.92 0.38 0 549.2775 1,644.81 1,644.82 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 3.22 0.434 2.82 555.2763 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 3.61 0.483 1.18 555.2763 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 3.28 0.411 3.14 555.2765 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 3.9 0.485 1.28 555.277 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 3.35 0.411 3.14 555.2771 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 2.85 0.403 1.19 555.2775 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KLVWIPSER 95.00% 2.58 0.288 1.64 564.3301 1,126.64 1,127.66 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KLVWIPSER 95.00% 2.67 0.252 0 564.3311 1,126.65 1,127.66 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KLVWIPSER 95.00% 2.75 0.246 1.52 564.3316 1,126.65 1,127.66 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LKEIFMQVEDERR 95.00% 2.5 0.24 0 564.9633 1,691.87 1,692.87 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TGLEDPERYLFVDR 95.00% 2.74 0.284 1.77 570.6216 1,708.84 1,709.85 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LcHLLGMNVMEFTR 95.00% 3.83 0.342 1.49 c2: Carbamidomethyl (+57.02) 574.2817 1,719.82 1,720.83 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KQELEEILHDLESR 95.00% 4.01 0.327 2.24 580.3031 1,737.89 1,738.90 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KQELEEILHDLESR 95.00% 4.55 0.394 2.28 580.3038 1,737.89 1,738.90 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KQELEEILHDLESR 95.00% 4.47 0.336 2 580.3039 1,737.89 1,738.90 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KQELEEILHDLESR 95.00% 4.51 0.34 2.96 580.6365 1,738.89 1,738.90 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KQELEEILHDLESR 95.00% 4.29 0.311 2.92 580.6373 1,738.89 1,738.90 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KQELEEILHDLESR 95.00% 4.47 0.386 2.12 580.6376 1,738.89 1,738.90 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KQELEEILHDLESR 95.00% 4.46 0.353 1.49 580.6377 1,738.89 1,738.90 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KQELEEILHDLESR 95.00% 3.28 0.307 1.85 580.6384 1,738.89 1,738.90 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LLKDAEALSQRLEEK 95.00% 2.61 0.112 1.25 581.6602 1,741.96 1,742.97 3 PYGB_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TTLQVDTLNAELAAER 95.00% 4.14 0.462 2.47 582.3073 1,743.90 1,744.91 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TTLQVDTLNAELAAER 95.00% 3.97 0.348 2.8 582.3091 1,743.90 1,744.91 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TTLQVDTLNAELAAER 95.00% 3.8 0.344 3.17 582.6396 1,744.90 1,744.91 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TTLQVDTLNAELAAER 95.00% 5.5 0.375 3.6 582.6417 1,744.90 1,744.91 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AVIYNPATQADWTAKK 95.00% 1.91 0.312 1.55 593.3143 1,776.92 1,776.93 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AKLQELEGAVK 95.00% 3.31 0.374 0 593.3445 1,184.67 1,185.68 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AKLQELEGAVK 95.00% 3.15 0.337 0 593.3446 1,184.67 1,185.68 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AKLQELEGAVK 95.00% 3.31 0.353 0 593.3449 1,184.67 1,185.68 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% HATALEELSEQLEQAK 95.00% 4.42 0.411 2.09 599.6379 1,795.89 1,796.90 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% HATALEELSEQLEQAK 95.00% 3.85 0.408 1.4 599.6383 1,795.89 1,796.90 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALELDPNLYR 95.00% 2.97 0.267 2.19 602.3204 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALELDPNLYR 95.00% 2.2 0.351 2.59 602.3206 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALELDPNLYR 95.00% 2.9 0.266 1.96 602.3209 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALELDPNLYR 95.00% 2.86 0.26 1.66 602.3211 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALELDPNLYR 95.00% 2.71 0.267 1.43 602.3214 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALELDPNLYR 95.00% 3.19 0.327 3.27 602.3217 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALELDPNLYR 95.00% 2.87 0.29 1.89 602.3218 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALELDPNLYR 95.00% 2.83 0.281 1.12 602.3219 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KFDQLLAEEK 95.00% 2.82 0.273 0 610.8291 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KFDQLLAEEK 95.00% 2.73 0.187 0 610.8297 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KFDQLLAEEK 95.00% 2.56 0.205 0 610.8299 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KFDQLLAEEK 95.00% 3.05 0.273 0 610.8301 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AGVLAHLEEER 95.00% 3.12 0.387 1.92 612.3224 1,222.63 1,223.64 2 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AGVLAHLEEER 95.00% 3.3 0.413 1.43 612.8241 1,223.63 1,223.64 2 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEQQVEEMR 95.00% 2.49 0.241 1.82 616.3058 1,230.60 1,232.59 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEQQVEEMR 95.00% 2.55 0.321 1.96 616.3059 1,230.60 1,232.59 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LLKDAEALSQR 95.00% 2.13 0.395 1.51 621.9662 1,241.92 1,243.70 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LLKDAEALSQR 95.00% 2.41 0.185 1.89 622.826 1,243.64 1,243.70 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KTTLQVDTLNAELAAER 95.00% 2.29 0.234 0 625.3414 1,873.00 1,873.00 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VEEEEERNQILQNEK 95.00% 4.05 0.361 1.54 629.6403 1,885.90 1,886.91 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VEEEEERNQILQNEK 95.00% 4.3 0.389 2.09 629.6407 1,885.90 1,886.91 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% YEILTPNAIPK 95.00% 2.71 0.375 0 629.9834 1,257.95 1,258.70 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% EQADFAVEALAK 95.00% 2.32 0.415 0 646.328 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% EQADFAVEALAK 95.00% 2.6 0.39 1.19 646.329 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% EQADFAVEALAK 95.00% 2.58 0.443 1.17 646.3291 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% EQADFAVEALAK 95.00% 3.2 0.499 2.14 646.3294 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% EQADFAVEALAK 95.00% 2.6 0.316 0 646.3294 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% EQADFAVEALAK 95.00% 3.01 0.521 1.35 646.3296 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% EQADFAVEALAK 95.00% 2.99 0.49 0 646.3299 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% EQADFAVEALAK 95.00% 2.89 0.509 0 646.33 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% EQADFAVEALAK 95.00% 3.14 0.43 0 646.33 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% EQADFAVEALAK 95.00% 2.65 0.454 1.34 646.3324 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% EQADFAVEALAK 95.00% 2.21 0.322 0 647.0156 1,292.02 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% HATALEELSEQLEQAKR 95.00% 7.12 0.586 5.74 651.673 1,952.00 1,953.00 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% HATALEELSEQLEQAKR 95.00% 7.31 0.615 4.64 651.6731 1,952.00 1,953.00 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% HATALEELSEQLEQAKR 95.00% 5.86 0.651 2.85 651.6732 1,952.00 1,953.00 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% HATALEELSEQLEQAKR 95.00% 7.04 0.616 3.8 652.0054 1,952.99 1,953.00 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% HATALEELSEQLEQAKR 95.00% 6.61 0.586 2.92 652.007 1,953.00 1,953.00 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% HATALEELSEQLEQAKR 95.00% 6.29 0.607 3.54 652.0073 1,953.00 1,953.00 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% HATALEELSEQLEQAKR 95.00% 6.68 0.572 3.21 652.0084 1,953.00 1,953.00 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NKQGLETDNKELAcEVK 95.00% 4.04 0.48 0.921 c14: Carbamidomethyl (+57.02) 659.3297 1,974.97 1,975.98 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NKQGLETDNKELAcEVK 95.00% 4.38 0.444 1.06 c14: Carbamidomethyl (+57.02) 659.3299 1,974.97 1,975.98 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELQAQIAELQEDFESEK 95.00% 4.1 0.355 1.72 669.9882 2,006.94 2,006.96 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELQAQIAELQEDFESEK 95.00% 4.19 0.346 3.48 669.9916 2,006.95 2,006.96 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VEEEEERNQILQNEKK 95.00% 2.46 0.249 0 672.7977 2,015.37 2,015.00 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELEAELEDERK 95.00% 3.23 0.35 0 680.8313 1,359.65 1,360.66 2 DESP_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELEAELEDERK 95.00% 3.02 0.425 1.77 680.8316 1,359.65 1,360.66 2 DESP_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEETKNHEAQIQDmR 95.00% 2.6 0.364 0 m16: Oxidation (+15.99) 686.9902 2,057.95 2,057.96 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LQNELDNVSTLLEEAEKK 95.00% 2.44 0.206 0 691.6934 2,072.06 2,073.07 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LQNELDNVSTLLEEAEKK 95.00% 2.74 0.326 1.1 692.0284 2,073.06 2,073.07 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LQNELDNVSTLLEEAEKK 95.00% 2.28 0.26 1.28 692.0287 2,073.06 2,073.07 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LQNELDNVSTLLEEAEKK 95.00% 2.24 0.291 0.959 692.0289 2,073.06 2,073.07 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LQNELDNVSTLLEEAEKK 95.00% 2.53 0.276 1.68 692.0291 2,073.06 2,073.07 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LQNELDNVSTLLEEAEKK 95.00% 2.71 0.322 1.14 692.0291 2,073.06 2,073.07 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LQNELDNVSTLLEEAEKK 95.00% 3.25 0.336 0 692.0295 2,073.07 2,073.07 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LQNELDNVSTLLEEAEKK 95.00% 2.55 0.373 0 692.0302 2,073.07 2,073.07 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VDYKADEWLMK 95.00% 3 0.345 0 699.3409 1,396.67 1,397.68 2 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VDYKADEWLMK 95.00% 2.99 0.365 2.6 699.3413 1,396.67 1,397.68 2 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VDYKADEWLMK 95.00% 2.87 0.317 1.52 699.345 1,396.67 1,397.68 2 MYH9_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QVLALQSQLADTK 95.00% 2.42 0.389 0 707.8982 1,413.78 1,414.79 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QVLALQSQLADTK 95.00% 4.21 0.58 6.31 707.8984 1,413.78 1,414.79 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QVLALQSQLADTK 95.00% 4.42 0.504 6.02 707.899 1,413.78 1,414.79 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NMDPLNDNVATLLHQSSDR 95.00% 2.99 0.454 1.7 714.3401 2,140.00 2,140.01 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% SDLLLEGFNNYR 95.00% 3.84 0.509 2.74 720.8581 1,439.70 1,440.71 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% SDLLLEGFNNYR 95.00% 3.79 0.494 2 720.8583 1,439.70 1,440.71 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% SDLLLEGFNNYR 95.00% 3.23 0.536 2.38 720.8585 1,439.70 1,440.71 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% SDLLLEGFNNYR 95.00% 4.23 0.517 1.77 720.8587 1,439.70 1,440.71 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% SDLLLEGFNNYR 95.00% 3.88 0.498 2.14 720.8596 1,439.70 1,440.71 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% SDLLLEGFNNYR 95.00% 3.45 0.478 1.89 720.8601 1,439.70 1,440.71 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% HAEQERDELADEITNSASGK 95.00% 5.52 0.567 4.37 734.0093 2,199.00 2,200.01 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% HAEQERDELADEITNSASGK 95.00% 5.13 0.497 5.3 734.3423 2,200.00 2,200.01 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% HAEQERDELADEITNSASGK 95.00% 5.67 0.541 3.89 734.3436 2,200.01 2,200.01 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NRLQQELDDLTVDLDHQR 95.00% 2.34 0.36 0 737.0593 2,208.15 2,208.10 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TQLEELEDELQATEDAKLR 95.00% 3.45 0.438 1.08 744.7073 2,231.10 2,231.10 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% MQAHIQDLEEQLDEEEGAR 95.00% 4.76 0.288 1.47 748.0098 2,241.01 2,241.01 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% EDQSILcTGESGAGKTENTKK 95.00% 2.01 0.187 1.49 c7: Carbamidomethyl (+57.02) 752.0287 2,253.06 2,253.07 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IGQLEEQLEQEAK 95.00% 4.48 0.394 3 757.8844 1,513.75 1,514.77 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IGQLEEQLEQEAK 95.00% 3.77 0.395 3.82 757.8855 1,513.76 1,514.77 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IGQLEEQLEQEAK 95.00% 4.01 0.421 3.82 757.8867 1,513.76 1,514.77 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IGQLEEQLEQEAK 95.00% 4.07 0.4 3.31 757.8878 1,513.76 1,514.77 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IGQLEEQLEQEAK 95.00% 4.76 0.41 3.22 757.8882 1,513.76 1,514.77 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IGQLEEQLEQEAK 95.00% 4.75 0.414 2.82 757.8887 1,513.76 1,514.77 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IGQLEEQLEQEAK 95.00% 4.83 0.408 4.33 757.8888 1,513.76 1,514.77 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IGQLEEQLEQEAK 95.00% 4.62 0.42 3.11 758.3888 1,514.76 1,514.77 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IGQLEEQLEQEAK 95.00% 3.92 0.422 3.34 758.3926 1,514.77 1,514.77 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELDDATEANEGLSR 95.00% 4.78 0.566 3.21 760.3481 1,518.68 1,519.69 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELDDATEANEGLSR 95.00% 4.46 0.577 3.92 760.3484 1,518.68 1,519.69 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QVLALQSQLADTKK 95.00% 4.11 0.501 3.17 771.9472 1,541.88 1,542.89 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QVLALQSQLADTKK 95.00% 4.43 0.547 4.82 772.4477 1,542.88 1,542.89 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELQAQIAELQEDFESEKASR 95.00% 2.24 0.375 1 774.7144 2,321.12 2,321.13 3
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NKQEVMISDLEER 95.00% 3.54 0.424 2.34 795.8927 1,589.77 1,590.78 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NKQEVMISDLEER 95.00% 4.32 0.405 3.96 795.8931 1,589.77 1,590.78 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NTDQASMPENTVAQK 95.00% 4.9 0.544 3.89 817.3771 1,632.74 1,633.75 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NTDQASMPENTVAQK 95.00% 4.81 0.542 4.51 817.3775 1,632.74 1,633.75 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NTDQASMPENTVAQK 95.00% 5.16 0.537 3.59 817.3787 1,632.74 1,633.75 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NTDQASMPENTVAQK 95.00% 3.47 0.392 1.55 817.8808 1,633.75 1,633.75 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AVIYNPATQADWTAK 95.00% 4.25 0.528 5.6 824.919 1,647.82 1,648.83 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AVIYNPATQADWTAK 95.00% 4.61 0.512 5.42 824.9202 1,647.82 1,648.83 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AVIYNPATQADWTAK 95.00% 4.4 0.476 4.96 824.9212 1,647.83 1,648.83 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AVIYNPATQADWTAK 95.00% 4.23 0.435 4.33 824.9217 1,647.83 1,648.83 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% AVIYNPATQADWTAK 95.00% 4.41 0.496 5.82 824.922 1,647.83 1,648.83 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 3.98 0.414 3.13 832.4099 1,662.80 1,663.82 2 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 4.45 0.428 3.22 832.4104 1,662.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 4.47 0.464 3.39 832.4123 1,662.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 4.23 0.444 2.64 832.4126 1,662.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 3.61 0.366 1.77 832.4142 1,662.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 3.76 0.46 1.49 832.4143 1,662.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 4.23 0.438 3.15 832.9124 1,663.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEALEAKEEFER 95.00% 4.26 0.457 2.66 832.9131 1,663.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% FLSNGYIPIPGQQDK 95.00% 4.24 0.427 3.7 838.9347 1,675.85 1,676.87 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% FLSNGYIPIPGQQDK 95.00% 4.31 0.494 4.34 838.9359 1,675.86 1,676.87 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% FLSNGYIPIPGQQDK 95.00% 4.23 0.321 3.66 838.9362 1,675.86 1,676.87 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% FLSNGYIPIPGQQDK 95.00% 4.04 0.288 3.22 839.4356 1,676.86 1,676.87 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% FLSNGYIPIPGQQDK 95.00% 4.37 0.404 4.27 839.4367 1,676.86 1,676.87 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% FLSNGYIPIPGQQDK 95.00% 4.7 0.441 2.8 839.4371 1,676.86 1,676.87 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% MEEEILLLEDQNSK 95.00% 5.11 0.408 2.27 845.9108 1,689.81 1,690.82 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QGLETDNKELAcEVK 95.00% 2.82 0.534 1.41 c12: Carbamidomethyl (+57.02) 867.4242 1,732.83 1,733.84 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QLLQANPILESFGNAK 95.00% 4.57 0.541 4.03 871.974 1,741.93 1,742.94 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% QLLQANPILESFGNAK 95.00% 5.04 0.582 4.8 872.4772 1,742.94 1,742.94 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TTLQVDTLNAELAAER 95.00% 5.04 0.576 5.24 872.957 1,743.90 1,744.91 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TTLQVDTLNAELAAER 95.00% 5.06 0.567 5.7 872.9573 1,743.90 1,744.91 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TTLQVDTLNAELAAER 95.00% 4.71 0.552 5.96 872.9575 1,743.90 1,744.91 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TTLQVDTLNAELAAER 95.00% 4.86 0.528 5.25 872.9593 1,743.90 1,744.91 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TTLQVDTLNAELAAER 95.00% 4.55 0.491 4.92 872.9632 1,743.91 1,744.91 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TTLQVDTLNAELAAER 95.00% 4.84 0.568 5.13 873.4578 1,744.90 1,744.91 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NLPIYSENIIEMYR 95.00% 4.61 0.631 5.6 877.9406 1,753.87 1,754.88 2 AHNK_HUMAN,PDLI1_HUMAN,MYPT2_HUMAN,TITIN_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NLPIYSENIIEMYR 95.00% 4.61 0.604 4.7 877.9411 1,753.87 1,754.88 2 AHNK_HUMAN,PDLI1_HUMAN,MYPT2_HUMAN,TITIN_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% KVDDDLGTIESLEEAK 95.00% 5.93 0.467 8.25 881.9434 1,761.87 1,761.88 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IAEcSSQLAEEEEKAK 95.00% 3.4 0.485 3.11 c4: Carbamidomethyl (+57.02) 911.4287 1,820.84 1,821.85 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IAEcSSQLAEEEEKAK 95.00% 3.51 0.485 3.17 c4: Carbamidomethyl (+57.02) 911.43 1,820.84 1,821.85 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IAEcSSQLAEEEEKAK 95.00% 3.61 0.421 4.24 c4: Carbamidomethyl (+57.02) 911.9306 1,821.85 1,821.85 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VEEEEERNQILQNEK 95.00% 4.32 0.196 2.34 944.4568 1,886.90 1,886.91 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VEEEEERNQILQNEK 95.00% 4.16 0.208 1.8 944.4581 1,886.90 1,886.91 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VEEEEERNQILQNEK 95.00% 4.75 0.195 1.85 944.4581 1,886.90 1,886.91 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% VEEEEERNQILQNEK 95.00% 4.2 0.231 1.4 944.4586 1,886.90 1,886.91 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TQLEELEDELQATEDAK 95.00% 7.1 0.618 6.6 981.9608 1,961.91 1,961.92 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TQLEELEDELQATEDAK 95.00% 7.17 0.617 5.89 981.9624 1,961.91 1,961.92 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TQLEELEDELQATEDAK 95.00% 6.64 0.653 4.72 981.9633 1,961.91 1,961.92 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% TQLEELEDELQATEDAK 95.00% 6.78 0.629 4.89 981.9635 1,961.91 1,961.92 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NKQGLETDNKELAcEVK 95.00% 4.58 0.606 4.3 c14: Carbamidomethyl (+57.02) 988.4848 1,974.95 1,975.98 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NKQGLETDNKELAcEVK 95.00% 5.09 0.642 5.05 c14: Carbamidomethyl (+57.02) 988.4889 1,974.96 1,975.98 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NKQGLETDNKELAcEVK 95.00% 4.83 0.625 5.55 c14: Carbamidomethyl (+57.02) 988.4893 1,974.96 1,975.98 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NKQGLETDNKELAcEVK 95.00% 4.35 0.601 3.64 c14: Carbamidomethyl (+57.02) 988.9911 1,975.97 1,975.98 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% NKQGLETDNKELAcEVK 95.00% 0 0 3.92 c14: Carbamidomethyl (+57.02) 989.4929 1,976.97 1,975.98 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELQAQIAELQEDFESEK 95.00% 5.29 0.543 6.51 1,004.48 2,006.94 2,006.96 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ELQAQIAELQEDFESEK 95.00% 5.41 0.558 6.77 1,004.48 2,006.95 2,006.96 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% ALEEETKNHEAQIQDMR 95.00% 5.4 0.398 7.04 1,021.49 2,040.96 2,041.96 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% LQNELDNVSTLLEEAEKK 95.00% 5.22 0.555 2.85 1,037.54 2,073.06 2,073.07 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVGLDQVTGMTETAFGSAYK 95.00% 7.11 0.696 9.64 1,045.02 2,088.02 2,088.03 2
 SAMPLE 2 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 56 65 180 38.50% IVGLDQVTGMTETAFGSAYK 95.00% 5.95 0.686 8.68 1,045.02 2,088.03 2,088.03 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% FVAELWKDVDR 95.00% 2.31 0.326 0 459.9112 1,376.71 1,377.72 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% FVAELWKDVDR 95.00% 1.73 0.442 0 459.9126 1,376.71 1,377.72 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VDYKADEWLMK 95.00% 2.7 0.292 1.09 466.5638 1,396.67 1,397.68 3 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VDYKADEWLMK 95.00% 2.29 0.254 0 466.5646 1,396.67 1,397.68 3 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IVFQEFR 95.00% 2.54 0.384 0 469.7579 937.5002 938.51 2 MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IVFQEFR 95.00% 2.65 0.378 0 469.758 937.5003 938.51 2 MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IVFQEFR 95.00% 2.48 0.384 0 469.7583 937.5009 938.51 2 MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IVFQEFR 95.00% 1.98 0.275 0 469.7588 937.5019 938.51 2 MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IVFQEFR 95.00% 2.24 0.237 0 469.7589 937.5021 938.51 2 MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IVFQEFR 95.00% 2.58 0.367 0 469.7597 937.5037 938.51 2 MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LRVELAEK 95.00% 2.48 0.196 0 479.2892 956.5627 957.5734 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VIQYLAHVASSHK 95.00% 2.89 0.456 1.1 484.9367 1,451.79 1,452.80 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VIQYLAHVASSHK 95.00% 2.71 0.468 0.959 484.937 1,451.79 1,452.80 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAK 95.00% 2.97 0.393 0 487.2633 972.5109 973.5207 2 LRP1_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAK 95.00% 2.85 0.387 0 487.2638 972.512 973.5207 2 LRP1_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% GGPISFSSSR 95.00% 3.36 0.221 2.06 497.751 993.4864 994.4958 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% GGPISFSSSR 95.00% 2.82 0.218 1.92 497.7513 993.487 994.4958 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% GGPISFSSSR 95.00% 2.65 0.219 1.89 497.7516 993.4875 994.4958 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KKLDAQVQELHAK 95.00% 4.17 0.478 2.68 503.2901 1,506.85 1,507.86 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KKLDAQVQELHAK 95.00% 4.75 0.478 2.66 503.2904 1,506.85 1,507.86 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KKLDAQVQELHAK 95.00% 4.43 0.393 2.05 503.2917 1,506.85 1,507.86 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KKLDAQVQELHAK 95.00% 3.7 0.419 2.29 503.6262 1,507.86 1,507.86 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% cNGVLEGIR 95.00% 3.27 0.373 2.1 c1: Carbamidomethyl (+57.02) 509.2595 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% cNGVLEGIR 95.00% 3.12 0.371 1.29 c1: Carbamidomethyl (+57.02) 509.26 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% cNGVLEGIR 95.00% 2.74 0.391 1.3 c1: Carbamidomethyl (+57.02) 509.2606 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% cNGVLEGIR 95.00% 3.02 0.379 2.17 c1: Carbamidomethyl (+57.02) 509.2608 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% cNGVLEGIR 95.00% 3.14 0.408 2.04 c1: Carbamidomethyl (+57.02) 509.2612 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% DKADFcIIHYAGK 95.00% 3.13 0.362 0 c6: Carbamidomethyl (+57.02) 513.5856 1,537.73 1,537.75 3 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% DKADFcIIHYAGK 95.00% 3.29 0.335 0 c6: Carbamidomethyl (+57.02) 513.5876 1,537.74 1,537.75 3 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% QVLALQSQLADTKK 95.00% 2.5 0.202 0 514.9655 1,541.87 1,542.89 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% QVLALQSQLADTKK 95.00% 2.5 0.259 0 514.9657 1,541.87 1,542.89 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% QVLALQSQLADTKK 95.00% 2.21 0.402 0 515.3011 1,542.88 1,542.89 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AGKLDPHLVLDQLR 95.00% 2 0.308 0 525.6383 1,573.89 1,574.90 3 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AGKLDPHLVLDQLR 95.00% 1.7 0.208 1.09 525.9725 1,574.89 1,574.90 3 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% QTKVEGELEEMER 94.70% 2.68 0.159 0 526.9193 1,577.73 1,577.75 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% QTKVEGELEEMER 95.00% 2.42 0.236 0 526.921 1,577.74 1,577.75 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AGVLAHLEEERDLK 95.00% 2.51 0.283 0 527.2853 1,578.83 1,579.84 3 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AGVLAHLEEERDLK 95.00% 2.63 0.301 1.6 527.286 1,578.83 1,579.84 3 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VKPLLQVTR 95.00% 2.01 0.262 0 527.3416 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VKPLLQVTR 95.00% 1.99 0.327 0 527.3419 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VKPLLQVTR 95.00% 2.2 0.295 0 527.3421 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VKPLLQVTR 95.00% 2.06 0.315 0 527.3421 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ELEAELEDERKQR 95.00% 2.09 0.33 0 548.9435 1,643.81 1,644.82 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ELEAELEDERKQR 95.00% 2.13 0.385 0 548.944 1,643.81 1,644.82 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ELEAELEDERKQR 95.00% 2.1 0.29 0 549.2784 1,644.81 1,644.82 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AVIYNPATQADWTAK 95.00% 2.79 0.372 0 550.6166 1,648.83 1,648.83 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAKEEFER 95.00% 2.29 0.312 1.33 555.2744 1,662.80 1,663.82 3 PABP1_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAKEEFER 95.00% 3.36 0.444 2.04 555.2756 1,662.80 1,663.82 3 PABP1_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAKEEFER 95.00% 2.59 0.421 0.959 555.2756 1,662.80 1,663.82 3 PABP1_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAKEEFER 95.00% 3.04 0.384 1.2 555.2767 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAKEEFER 95.00% 3.56 0.399 1.48 555.2771 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAKEEFER 95.00% 3.19 0.33 1.36 555.6113 1,663.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KLVWIPSER 95.00% 2.69 0.39 0 564.3309 1,126.65 1,127.66 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KLVWIPSER 95.00% 2.48 0.267 0 564.3311 1,126.65 1,127.66 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KLVWIPSER 95.00% 2.18 0.244 0 564.3324 1,126.65 1,127.66 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% QEEELQAKDEELLK 95.00% 3.34 0.332 0 567.9547 1,700.84 1,701.86 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% QEEELQAKDEELLK 95.00% 2.75 0.331 0 567.9561 1,700.84 1,701.86 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LcHLLGMNVMEFTR 95.00% 3.5 0.41 0 c2: Carbamidomethyl (+57.02) 574.6164 1,720.83 1,720.83 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KQELEEILHDLESR 95.00% 4.13 0.367 2.4 580.3022 1,737.88 1,738.90 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KQELEEILHDLESR 95.00% 4.28 0.383 2.39 580.3028 1,737.88 1,738.90 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KQELEEILHDLESR 95.00% 3.77 0.301 2.4 580.303 1,737.89 1,738.90 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KQELEEILHDLESR 95.00% 4.09 0.332 2.2 580.3035 1,737.89 1,738.90 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KQELEEILHDLESR 95.00% 4.54 0.328 2.72 580.3036 1,737.89 1,738.90 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KQELEEILHDLESR 95.00% 3.9 0.335 1.8 580.6372 1,738.89 1,738.90 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KQELEEILHDLESR 95.00% 4.02 0.361 2.28 580.6373 1,738.89 1,738.90 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KQELEEILHDLESR 95.00% 4.37 0.339 2.21 580.6377 1,738.89 1,738.90 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TTLQVDTLNAELAAER 95.00% 4.8 0.295 4.18 582.3069 1,743.90 1,744.91 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TTLQVDTLNAELAAER 95.00% 4.12 0.335 3.21 582.3069 1,743.90 1,744.91 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TTLQVDTLNAELAAER 95.00% 3.82 0.404 2.85 582.3078 1,743.90 1,744.91 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TTLQVDTLNAELAAER 95.00% 4.26 0.439 3.57 582.6424 1,744.90 1,744.91 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AKLQELEGAVK 95.00% 2.96 0.333 0 593.3444 1,184.67 1,185.68 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AKLQELEGAVK 95.00% 2.87 0.302 0 593.3446 1,184.67 1,185.68 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AKLQELEGAVK 95.00% 3.04 0.362 0 593.3448 1,184.67 1,185.68 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AKLQELEGAVK 95.00% 3.13 0.211 0 593.3453 1,184.68 1,185.68 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% HATALEELSEQLEQAK 95.00% 3.58 0.394 1.39 599.6379 1,795.89 1,796.90 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% HATALEELSEQLEQAK 95.00% 4.66 0.437 1.89 599.6383 1,795.89 1,796.90 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% HATALEELSEQLEQAK 95.00% 4.51 0.389 2.11 599.9724 1,796.89 1,796.90 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% HATALEELSEQLEQAK 95.00% 4.13 0.333 2.28 599.9735 1,796.90 1,796.90 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IGQLEEQLEQEAKER 95.00% 3.88 0.197 0 600.6393 1,798.89 1,799.91 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IGQLEEQLEQEAKER 95.00% 3.93 0.369 0 600.9752 1,799.90 1,799.91 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% DLEAQIEAANK 95.00% 3.24 0.204 1.96 601.306 1,200.60 1,201.61 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% DLEAQIEAANK 95.00% 3.47 0.249 2.19 601.3069 1,200.60 1,201.61 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALELDPNLYR 95.00% 2.67 0.259 0 602.32 1,202.62 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALELDPNLYR 95.00% 2.8 0.267 0 602.3205 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALELDPNLYR 95.00% 2.74 0.278 1.72 602.3213 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALELDPNLYR 95.00% 2.61 0.268 1.74 602.3217 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALELDPNLYR 95.00% 2.76 0.276 2.72 602.3219 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALELDPNLYR 95.00% 2.72 0.269 2.62 602.3225 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KMEEEILLLEDQNSK 95.00% 2.57 0.226 0 607.3123 1,818.91 1,818.92 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VEGELEEMER 95.00% 2.74 0.387 1.89 610.7754 1,219.54 1,220.55 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KFDQLLAEEK 95.00% 2.65 0.166 0 610.8294 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KFDQLLAEEK 95.00% 2.59 0.163 0 610.8298 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KFDQLLAEEK 95.00% 2.59 0.186 0 610.8299 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KFDQLLAEEK 95.00% 2.52 0.232 0 610.8304 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AGVLAHLEEER 95.00% 3.52 0.362 2.19 612.3214 1,222.63 1,223.64 2 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AGVLAHLEEER 95.00% 3.28 0.293 1.29 612.323 1,222.63 1,223.64 2 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEQQVEEMR 95.00% 2.84 0.283 1.72 616.8033 1,231.59 1,232.59 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEQQVEEMR 95.00% 2.92 0.251 0 616.8036 1,231.59 1,232.59 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LLKDAEALSQR 95.00% 2.15 0.259 1.17 622.2997 1,242.58 1,243.70 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VEEEEERNQILQNEK 95.00% 4.2 0.423 2.11 629.6406 1,885.90 1,886.91 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VEEEEERNQILQNEK 95.00% 3.94 0.396 1.27 629.9755 1,886.90 1,886.91 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% EQADFAVEALAK 95.00% 2.6 0.457 0 646.3288 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% EQADFAVEALAK 95.00% 2.87 0.486 1.41 646.3297 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% EQADFAVEALAK 95.00% 2.95 0.502 0 646.3297 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% EQADFAVEALAK 95.00% 2.4 0.351 0 646.3298 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% EQADFAVEALAK 95.00% 2.33 0.322 0 646.3299 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% EQADFAVEALAK 95.00% 2.58 0.368 0 646.33 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% EQADFAVEALAK 95.00% 2.77 0.398 0 646.3302 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% HATALEELSEQLEQAKR 95.00% 6.38 0.601 4.43 651.6724 1,951.99 1,953.00 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% HATALEELSEQLEQAKR 95.00% 6.4 0.614 2.92 651.673 1,952.00 1,953.00 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% HATALEELSEQLEQAKR 95.00% 6.07 0.531 2.74 652.0064 1,953.00 1,953.00 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% HATALEELSEQLEQAKR 95.00% 6.89 0.554 4.21 652.0066 1,953.00 1,953.00 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% HATALEELSEQLEQAKR 95.00% 7.58 0.594 3.21 652.0068 1,953.00 1,953.00 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% HATALEELSEQLEQAKR 95.00% 6.93 0.588 3.92 652.0075 1,953.00 1,953.00 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% HATALEELSEQLEQAKR 95.00% 6.88 0.521 3.19 652.0087 1,953.00 1,953.00 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TFHIFYQLLSGAGEHLK 95.00% 3.47 0.154 1.72 654.3458 1,960.01 1,961.03 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TFHIFYQLLSGAGEHLK 95.00% 2.9 0.166 0.959 654.6822 1,961.02 1,961.03 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TQLEELEDELQATEDAK 95.00% 3.9 0.438 0 654.9778 1,961.91 1,961.92 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ELQAQIAELQEDFESEK 95.00% 4.22 0.364 4.51 669.9905 2,006.95 2,006.96 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ELQAQIAELQEDFESEK 95.00% 4.29 0.39 4.07 669.9909 2,006.95 2,006.96 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VEEEEERNQILQNEKK 95.00% 4.22 0.393 0 672.7974 2,015.37 2,015.00 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% SLEAEILQLQEELASSER 95.00% 3.35 0.458 0 682.3513 2,044.03 2,045.04 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% SLEAEILQLQEELASSER 95.00% 4.44 0.564 3.46 682.6865 2,045.04 2,045.04 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEKK 95.00% 3.45 0.436 0 691.6942 2,072.06 2,073.07 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEKK 95.00% 3.37 0.412 0 691.6942 2,072.06 2,073.07 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEKK 95.00% 2.85 0.386 1.41 691.6948 2,072.06 2,073.07 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEKK 95.00% 2.61 0.285 1.21 692.0286 2,073.06 2,073.07 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEKK 95.00% 3.58 0.497 0 692.0289 2,073.06 2,073.07 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEKK 95.00% 3.19 0.361 0 692.0294 2,073.06 2,073.07 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEKK 95.00% 3.06 0.358 0 692.0295 2,073.07 2,073.07 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% DAEALSQRLEEK 95.00% 2.74 0.238 0 694.8556 1,387.70 1,388.70 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IVGLDQVTGMTETAFGSAYK 95.00% 5.23 0.623 5.8 697.0145 2,088.02 2,088.03 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IVGLDQVTGMTETAFGSAYK 95.00% 4.65 0.642 3.92 697.0153 2,088.02 2,088.03 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VDYKADEWLMK 95.00% 2.37 0.384 1.57 699.3405 1,396.67 1,397.68 2 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VDYKADEWLMK 95.00% 2.51 0.312 0 699.3414 1,396.67 1,397.68 2 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% NMDPLNDNVATLLHQSSDR 95.00% 2.47 0.295 0 714.3417 2,140.00 2,140.01 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% NMDPLNDNVATLLHQSSDR 95.00% 2.55 0.308 1.4 714.3437 2,140.01 2,140.01 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% SDLLLEGFNNYR 95.00% 4 0.509 2.19 720.8562 1,439.70 1,440.71 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% SDLLLEGFNNYR 95.00% 3.93 0.491 2.57 720.8581 1,439.70 1,440.71 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% SDLLLEGFNNYR 95.00% 3.82 0.506 3.09 720.8587 1,439.70 1,440.71 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% SDLLLEGFNNYR 95.00% 4.02 0.544 2.89 720.859 1,439.70 1,440.71 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% SDLLLEGFNNYR 95.00% 3.88 0.519 2.57 720.8592 1,439.70 1,440.71 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% SDLLLEGFNNYR 95.00% 3.67 0.506 1.96 720.8593 1,439.70 1,440.71 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% HAEQERDELADEITNSASGK 95.00% 5.47 0.56 3.77 734.3437 2,200.01 2,200.01 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% NRLQQELDDLTVDLDHQR 95.00% 3.42 0.355 1.27 736.7235 2,207.15 2,208.10 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% NRLQQELDDLTVDLDHQR 95.00% 1.56 0.233 2.16 737.0588 2,208.15 2,208.10 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TQLEELEDELQATEDAKLR 95.00% 3.83 0.517 1.85 744.3731 2,230.10 2,231.10 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TQLEELEDELQATEDAKLR 95.00% 3.82 0.398 0 744.7079 2,231.10 2,231.10 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% MQAHIQDLEEQLDEEEGAR 95.00% 4.43 0.431 1.85 748.009 2,241.00 2,241.01 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KKLDAQVQELHAK 95.00% 4.7 0.545 7.47 754.4331 1,506.85 1,507.86 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KKLDAQVQELHAK 95.00% 4.76 0.525 5.49 754.4332 1,506.85 1,507.86 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IGQLEEQLEQEAK 95.00% 3.8 0.379 2.85 757.8831 1,513.75 1,514.77 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IGQLEEQLEQEAK 95.00% 4.48 0.394 2.64 757.8877 1,513.76 1,514.77 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IGQLEEQLEQEAK 95.00% 3.69 0.402 3.39 757.8885 1,513.76 1,514.77 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IGQLEEQLEQEAK 95.00% 3.97 0.411 3.68 757.8891 1,513.76 1,514.77 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IGQLEEQLEQEAK 95.00% 3.74 0.422 3.74 757.8902 1,513.76 1,514.77 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IGQLEEQLEQEAK 95.00% 4.59 0.412 4 758.388 1,514.76 1,514.77 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IGQLEEQLEQEAK 95.00% 4.73 0.395 3.21 758.3894 1,514.76 1,514.77 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% QVLALQSQLADTKK 95.00% 4.12 0.556 4.24 771.9447 1,541.87 1,542.89 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AGKLDPHLVLDQLR 95.00% 3.96 0.586 3.77 787.9527 1,573.89 1,574.90 2 MYH9_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% NKQEVMISDLEER 95.00% 4.27 0.464 3.59 795.8925 1,589.77 1,590.78 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% NKQEVMISDLEER 95.00% 4.08 0.417 3.28 795.8941 1,589.77 1,590.78 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% DAASLESQLQDTQELLQEETR 95.00% 4.23 0.404 1.02 802.3901 2,404.15 2,404.15 3
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% NTDQASMPENTVAQK 95.00% 4.8 0.553 3.96 817.3777 1,632.74 1,633.75 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% NTDQASMPENTVAQK 95.00% 4.94 0.524 4.47 817.3779 1,632.74 1,633.75 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ELEAELEDERKQR 95.00% 2.86 0.353 0 822.9135 1,643.81 1,644.82 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQQLFNHTMFILEQEEYQR 95.00% 3.16 0.364 0.959 823.4069 2,467.20 2,467.21 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQQLFNHTMFILEQEEYQR 95.00% 5.4 0.198 2.8 823.4079 2,467.20 2,467.21 3 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AVIYNPATQADWTAK 95.00% 4.33 0.454 4.54 824.9196 1,647.82 1,648.83 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AVIYNPATQADWTAK 95.00% 4.42 0.476 4.12 824.921 1,647.83 1,648.83 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AVIYNPATQADWTAK 95.00% 4.24 0.409 3.57 825.4215 1,648.83 1,648.83 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% AVIYNPATQADWTAK 95.00% 4.09 0.385 3.77 825.4222 1,648.83 1,648.83 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAKEEFER 95.00% 4.34 0.452 3.57 832.4084 1,662.80 1,663.82 2 PABP1_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAKEEFER 95.00% 4.36 0.47 3.82 832.4123 1,662.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAKEEFER 95.00% 3.63 0.419 2.09 832.4132 1,662.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAKEEFER 95.00% 3.01 0.154 1.25 832.4226 1,662.83 1,663.82 2 PABP1_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAKEEFER 95.00% 4.13 0.435 1.82 832.914 1,663.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEALEAKEEFER 95.00% 4 0.416 3.23 832.9142 1,663.81 1,663.82 2 PABP1_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% FLSNGYIPIPGQQDK 95.00% 4.22 0.344 2.62 838.9351 1,675.85 1,676.87 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% FLSNGYIPIPGQQDK 95.00% 4.7 0.437 4.33 838.9354 1,675.86 1,676.87 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% FLSNGYIPIPGQQDK 95.00% 4.18 0.378 2.62 838.9364 1,675.86 1,676.87 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% FLSNGYIPIPGQQDK 95.00% 3.91 0.316 2.89 838.937 1,675.86 1,676.87 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% FLSNGYIPIPGQQDK 95.00% 4.33 0.367 3.2 839.4356 1,676.86 1,676.87 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% FLSNGYIPIPGQQDK 95.00% 4.28 0.401 3.55 839.4362 1,676.86 1,676.87 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% FLSNGYIPIPGQQDK 95.00% 4.05 0.452 4.38 839.4375 1,676.86 1,676.87 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% qEEELQAKDEELLK 95.00% 0 0 4.02 n-term: Pyro-cmC (-17.03) 842.9161 1,683.82 1,684.83 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% MEEEILLLEDQNSK 95.00% 4.64 0.4 1.85 845.9146 1,689.81 1,690.82 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% MEEEILLLEDQNSK 95.00% 4.94 0.296 0 846.4139 1,690.81 1,690.82 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% QGLETDNKELAcEVK 95.00% 2.88 0.53 0 c12: Carbamidomethyl (+57.02) 867.4197 1,732.82 1,733.84 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% QLLQANPILESFGNAK 95.00% 4.77 0.534 3.85 872.4763 1,742.94 1,742.94 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% QLLQANPILESFGNAK 95.00% 4.58 0.539 3.4 872.4789 1,742.94 1,742.94 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TTLQVDTLNAELAAER 95.00% 4.75 0.539 4.89 872.9543 1,743.89 1,744.91 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TTLQVDTLNAELAAER 95.00% 4.3 0.535 5.26 872.9566 1,743.90 1,744.91 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TTLQVDTLNAELAAER 95.00% 4.89 0.573 5.04 872.9583 1,743.90 1,744.91 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TTLQVDTLNAELAAER 95.00% 4.9 0.564 6.29 872.9583 1,743.90 1,744.91 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TTLQVDTLNAELAAER 95.00% 4.36 0.518 6.07 872.9591 1,743.90 1,744.91 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TTLQVDTLNAELAAER 95.00% 4.52 0.501 4.11 872.9595 1,743.90 1,744.91 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TTLQVDTLNAELAAER 95.00% 4.28 0.564 3.62 872.9601 1,743.90 1,744.91 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% NLPIYSENIIEMYR 95.00% 4.85 0.552 5.06 878.4443 1,754.87 1,754.88 2 AHNK_HUMAN,PDLI1_HUMAN,MYPT2_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% NLPIYSENIIEMYR 95.00% 4.75 0.548 6.8 878.4455 1,754.88 1,754.88 2 AHNK_HUMAN,PDLI1_HUMAN,MYPT2_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KVDDDLGTIESLEEAK 95.00% 5.29 0.416 6.85 881.4428 1,760.87 1,761.88 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% KVDDDLGTIESLEEAK 95.00% 5.28 0.393 6.55 881.4439 1,760.87 1,761.88 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IGQLEEQLEQEAKER 95.00% 4.73 0.557 1.68 900.4589 1,798.90 1,799.91 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VEEEEERNQILQNEK 95.00% 4.08 0.209 2.44 943.9566 1,885.90 1,886.91 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VEEEEERNQILQNEK 95.00% 3.82 0.168 2.15 944.459 1,886.90 1,886.91 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VEEEEERNQILQNEK 95.00% 3.88 0.247 2 944.4591 1,886.90 1,886.91 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% VEEEEERNQILQNEK 95.00% 4.5 0.19 2.11 944.4592 1,886.90 1,886.91 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQQELDDLTVDLDHQR 95.00% 4.84 0.251 0 969.5192 1,937.02 1,937.96 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEK 95.00% 5.2 0.608 6.16 972.99 1,943.96 1,944.98 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEK 95.00% 5.36 0.587 7.7 972.9904 1,943.97 1,944.98 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEK 95.00% 4.51 0.569 6.74 972.9915 1,943.97 1,944.98 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEK 95.00% 5.5 0.552 6.66 973.4931 1,944.97 1,944.98 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEK 95.00% 5.66 0.534 5.51 973.4938 1,944.97 1,944.98 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% LQNELDNVSTLLEEAEK 95.00% 5.65 0.524 7.46 973.4952 1,944.97 1,944.98 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% TQLEELEDELQATEDAK 95.00% 6.58 0.621 8.01 981.9609 1,961.91 1,961.92 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% NKQGLETDNKELAcEVK 95.00% 5.12 0.647 2.96 c14: Carbamidomethyl (+57.02) 988.992 1,975.97 1,975.98 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ELQAQIAELQEDFESEK 95.00% 5.08 0.547 8.12 1,004.48 2,006.95 2,006.96 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ELQAQIAELQEDFESEK 95.00% 4.89 0.531 8.19 1,004.48 2,006.95 2,006.96 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ELQAQIAELQEDFESEK 95.00% 4.89 0.522 6.74 1,004.48 2,006.95 2,006.96 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% ALEEETKNHEAQIQDMR 95.00% 5.22 0.415 5.3 1,021.48 2,040.95 2,041.96 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% SLEAEILQLQEELASSER 95.00% 6.33 0.472 6.89 1,023.52 2,045.03 2,045.04 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% SLEAEILQLQEELASSER 95.00% 6.64 0.466 5.64 1,023.52 2,045.03 2,045.04 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IVGLDQVTGMTETAFGSAYK 95.00% 7.44 0.69 9.72 1,045.02 2,088.02 2,088.03 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% IVGLDQVTGMTETAFGSAYK 95.00% 7.16 0.693 10.5 1,045.02 2,088.02 2,088.03 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% DAASLESQLQDTQELLQEETR 95.00% 6.07 0.532 6.36 1,203.08 2,404.14 2,404.15 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% DAASLESQLQDTQELLQEETR 95.00% 6.54 0.536 7.44 1,203.08 2,404.14 2,404.15 2
 SAMPLE 2R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 55 70 185 39.00% DAASLESQLQDTQELLQEETR 95.00% 5.98 0.559 6.14 1,203.08 2,404.14 2,404.15 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% IVFQEFR 95.00% 2.46 0.398 0 469.7588 937.5019 938.51 2 MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% IVFQEFR 95.00% 2.44 0.397 0 469.7588 937.502 938.51 2 MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% IVFQEFR 95.00% 2.34 0.383 1.57 469.759 937.5024 938.51 2 MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% IVFQEFR 95.00% 2.46 0.375 0 469.7592 937.5027 938.51 2 MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% VKPLLQVTR 95.00% 2.03 0.272 0 527.3419 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% VKPLLQVTR 95.00% 2.12 0.325 0 527.3419 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% VKPLLQVTR 95.00% 2.15 0.299 0 527.3423 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% VKPLLQVTR 95.00% 2.17 0.344 0 527.3424 1,052.67 1,053.68 2 MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% ALEEALEAKEEFER 95.00% 2.34 0.242 1.54 555.2778 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% ALEEALEAKEEFER 95.00% 2.39 0.212 0 555.2786 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% ALEEALEAKEEFER 95.00% 2.43 0.252 0 555.2794 1,662.81 1,663.82 3 PABP1_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% KQELEEILHDLESR 95.00% 3.59 0.313 2.77 580.3018 1,737.88 1,738.90 3
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% KQELEEILHDLESR 95.00% 3.3 0.308 2.59 580.3041 1,737.89 1,738.90 3
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% HATALEELSEQLEQAK 95.00% 2.55 0.226 0 599.6381 1,795.89 1,796.90 3
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% DLEAQIEAANK 95.00% 3.4 0.265 1.74 601.3059 1,200.60 1,201.61 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% ALELDPNLYR 95.00% 2.36 0.273 2.49 602.3206 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% ALELDPNLYR 95.00% 2.95 0.294 2.28 602.321 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% ALELDPNLYR 95.00% 2.98 0.287 1.92 602.3213 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% ALELDPNLYR 95.00% 2.86 0.263 1.16 602.3216 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% ALELDPNLYR 95.00% 2.85 0.273 1.77 602.3225 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% KFDQLLAEEK 95.00% 2.57 0.221 0 610.8292 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% KFDQLLAEEK 95.00% 2.71 0.222 0 610.8293 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% KFDQLLAEEK 95.00% 2.78 0.229 0 610.8294 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% KFDQLLAEEK 95.00% 2.59 0.229 0 610.8296 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% KFDQLLAEEK 95.00% 2.39 0.182 0 610.8315 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% EQADFAVEALAK 95.00% 2.75 0.45 0 646.3288 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% EQADFAVEALAK 95.00% 2.69 0.509 1.39 646.3291 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% EQADFAVEALAK 95.00% 2.48 0.373 0 646.3293 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% EQADFAVEALAK 95.00% 2.91 0.485 1.46 646.3296 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% EQADFAVEALAK 95.00% 2.37 0.322 0 646.33 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% ADFcIIHYAGK 95.00% 2.59 0.397 0 c4: Carbamidomethyl (+57.02) 648.3166 1,294.62 1,294.63 2 MYH9_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% HATALEELSEQLEQAKR 95.00% 6.86 0.607 2.82 651.6719 1,951.99 1,953.00 3
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% HATALEELSEQLEQAKR 95.00% 5.49 0.585 3.09 651.6727 1,951.99 1,953.00 3
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% HATALEELSEQLEQAKR 95.00% 6.59 0.616 4.62 651.6729 1,952.00 1,953.00 3
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% HATALEELSEQLEQAKR 95.00% 2.52 0.295 0 651.8564 1,952.55 1,953.00 3
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% HATALEELSEQLEQAKR 95.00% 4.53 0.515 0 652.0072 1,953.00 1,953.00 3
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% LQNELDNVSTLLEEAEKK 95.00% 2.53 0.279 0 691.6956 2,072.06 2,073.07 3
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% LQNELDNVSTLLEEAEKK 95.00% 2.93 0.364 0 692.0295 2,073.07 2,073.07 3
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% VDYKADEWLMK 95.00% 2.36 0.338 0 699.3414 1,396.67 1,397.68 2 MYH9_HUMAN
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% SDLLLEGFNNYR 95.00% 3.49 0.502 2.03 720.8588 1,439.70 1,440.71 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% SDLLLEGFNNYR 95.00% 2.32 0.304 1.92 720.859 1,439.70 1,440.71 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% SDLLLEGFNNYR 95.00% 3.53 0.487 2.2 720.8598 1,439.70 1,440.71 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% IGQLEEQLEQEAK 95.00% 2.08 0.307 1.18 757.8916 1,513.77 1,514.77 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% NTDQASMPENTVAQK 95.00% 3.19 0.404 1.92 817.3772 1,632.74 1,633.75 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% AVIYNPATQADWTAK 95.00% 4.27 0.419 3.77 824.9196 1,647.82 1,648.83 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% AVIYNPATQADWTAK 95.00% 4.19 0.407 3.77 824.9212 1,647.83 1,648.83 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% FLSNGYIPIPGQQDK 95.00% 3.97 0.385 1.42 838.9358 1,675.86 1,676.87 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% QLLQANPILESFGNAK 95.00% 4.55 0.548 5.66 871.9767 1,741.94 1,742.94 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% QLLQANPILESFGNAK 95.00% 4.65 0.568 5.55 871.9767 1,741.94 1,742.94 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% QLLQANPILESFGNAK 95.00% 4.31 0.574 2.96 872.4767 1,742.94 1,742.94 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% TTLQVDTLNAELAAER 95.00% 4.53 0.49 4.62 872.9591 1,743.90 1,744.91 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% TTLQVDTLNAELAAER 95.00% 4.42 0.51 5.49 872.961 1,743.91 1,744.91 2
 SAMPLE 3 Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 15 15 30 12.40% TTLQVDTLNAELAAER 95.00% 4.46 0.494 7.24 872.9612 1,743.91 1,744.91 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% IVFQEFR 95.00% 2.32 0.333 0 469.7579 937.5002 938.51 2 MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% IVFQEFR 95.00% 2.61 0.371 0 469.7581 937.5005 938.51 2 MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% IVFQEFR 95.00% 2.08 0.241 0 469.7586 937.5016 938.51 2 MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% IVFQEFR 95.00% 1.83 0.287 0 469.7589 937.5022 938.51 2 MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% IVFQEFR 95.00% 2.62 0.367 0 469.7591 937.5025 938.51 2 MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% IVFQEFR 95.00% 2.39 0.329 0 469.7603 937.505 938.51 2 MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% cNGVLEGIR 95.00% 2.6 0.372 0 c1: Carbamidomethyl (+57.02) 509.2605 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% cNGVLEGIR 95.00% 2.95 0.391 1.59 c1: Carbamidomethyl (+57.02) 509.2605 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% cNGVLEGIR 95.00% 2.27 0.259 0 c1: Carbamidomethyl (+57.02) 509.2606 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% HATALEELSEQLEQAK 95.00% 3.16 0.295 0 599.9715 1,796.89 1,796.90 3
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% DLEAQIEAANK 95.00% 3.21 0.263 1.12 601.3062 1,200.60 1,201.61 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% DLEAQIEAANK 95.00% 3.44 0.341 2.06 601.8084 1,201.60 1,201.61 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% ALELDPNLYR 95.00% 2.08 0.277 1.82 602.3201 1,202.62 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% ALELDPNLYR 95.00% 2.38 0.244 1.85 602.321 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% ALELDPNLYR 95.00% 2.73 0.282 2.01 602.321 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% ALELDPNLYR 95.00% 2.8 0.325 0 602.3211 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% ALELDPNLYR 95.00% 2.92 0.26 1.96 602.3211 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% ALELDPNLYR 95.00% 2.44 0.253 1.68 602.3212 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% ALELDPNLYR 95.00% 2.72 0.23 2.25 602.3213 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% ALELDPNLYR 95.00% 2.54 0.279 2.21 602.3216 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% ALELDPNLYR 95.00% 2.18 0.343 1.2 602.3241 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% ALELDPNLYR 95.00% 2.57 0.265 1.74 602.8253 1,203.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% KFDQLLAEEK 95.00% 2.33 0.227 0 610.8296 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% KFDQLLAEEK 95.00% 2.89 0.223 0 610.83 1,219.64 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% KFDQLLAEEK 95.00% 2.63 0.145 0 610.8306 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% KFDQLLAEEK 95.00% 2.42 0.184 0 610.8309 1,219.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% KFDQLLAEEK 95.00% 2.19 0.17 1.52 611.3322 1,220.65 1,220.65 2 MYH9_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% YEILTPNAIPK 95.00% 2.27 0.326 0 629.9845 1,257.95 1,258.70 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% EQADFAVEALAK 95.00% 2.66 0.381 0 646.3294 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% EQADFAVEALAK 95.00% 2.54 0.359 0 646.3297 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% EQADFAVEALAK 95.00% 2.28 0.254 0 646.3299 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% EQADFAVEALAK 95.00% 3.26 0.476 1.17 646.33 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% EQADFAVEALAK 95.00% 2.7 0.427 0 646.3303 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% EQADFAVEALAK 95.00% 2.93 0.474 0 646.3307 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% HATALEELSEQLEQAKR 95.00% 6.33 0.61 2.02 651.6728 1,951.99 1,953.00 3
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% HATALEELSEQLEQAKR 95.00% 6.27 0.554 2.51 651.673 1,952.00 1,953.00 3
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% HATALEELSEQLEQAKR 95.00% 3.8 0.577 1.92 651.6736 1,952.00 1,953.00 3
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% HATALEELSEQLEQAKR 95.00% 5.78 0.581 2.96 652.0056 1,952.99 1,953.00 3
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% HATALEELSEQLEQAKR 95.00% 4.87 0.566 1.96 652.0082 1,953.00 1,953.00 3
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% HATALEELSEQLEQAKR 95.00% 4.54 0.587 1.37 652.0095 1,953.01 1,953.00 3
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% LQNELDNVSTLLEEAEKK 95.00% 2.46 0.265 0 692.0301 2,073.07 2,073.07 3
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% SDLLLEGFNNYR 95.00% 2.88 0.406 2.01 720.8568 1,439.70 1,440.71 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% SDLLLEGFNNYR 95.00% 2.52 0.416 0 720.8584 1,439.70 1,440.71 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% SDLLLEGFNNYR 95.00% 3.24 0.494 1.41 720.8594 1,439.70 1,440.71 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% ELDDATEANEGLSR 95.00% 3.51 0.501 2.23 760.3492 1,518.68 1,519.69 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% AVIYNPATQADWTAK 95.00% 3.81 0.411 3.34 824.9179 1,647.82 1,648.83 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% AVIYNPATQADWTAK 95.00% 4.15 0.41 2.82 824.9186 1,647.82 1,648.83 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% AVIYNPATQADWTAK 95.00% 4.06 0.373 3.27 824.9229 1,647.83 1,648.83 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% AVIYNPATQADWTAK 95.00% 3.84 0.331 3.38 825.4185 1,648.82 1,648.83 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% AVIYNPATQADWTAK 95.00% 4.28 0.431 2.51 825.4221 1,648.83 1,648.83 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% FLSNGYIPIPGQQDK 95.00% 4.6 0.411 2.16 838.9372 1,675.86 1,676.87 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% FLSNGYIPIPGQQDK 95.00% 4.43 0.465 3.82 838.9378 1,675.86 1,676.87 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% QLLQANPILESFGNAK 95.00% 3.85 0.512 3.48 871.978 1,741.94 1,742.94 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% QLLQANPILESFGNAK 95.00% 4.27 0.557 3.57 871.9783 1,741.94 1,742.94 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% QLLQANPILESFGNAK 95.00% 4.24 0.559 3.04 872.4778 1,742.94 1,742.94 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% QLLQANPILESFGNAK 95.00% 4.43 0.574 4.42 872.4786 1,742.94 1,742.94 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% TTLQVDTLNAELAAER 95.00% 4.33 0.49 4.02 872.9607 1,743.91 1,744.91 2
 SAMPLE 3R Myosin-10  MYH10  MYH10_HUMAN 228,987.30 100.00% 11 11 28 9.77% TTLQVDTLNAELAAER 95.00% 4.64 0.49 5.55 873.4596 1,744.90 1,744.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 2.44 0.223 1.52 467.4953 1,399.46 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.01 0.274 0 467.5976 1,399.77 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 3.97 0.217 1.05 467.5981 1,399.77 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.41 0.272 0 467.5982 1,399.77 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4 0.255 1.77 467.5983 1,399.77 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.05 0.21 1.44 467.5984 1,399.77 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.27 0.154 2 467.5986 1,399.77 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.57 0.208 0 467.5986 1,399.77 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 3.82 0.127 2.47 467.5991 1,399.77 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.5 0.254 0 467.5995 1,399.78 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.42 0.324 1.96 467.5996 1,399.78 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 3.92 0.0447 1.12 467.5998 1,399.78 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.51 0.316 2.72 467.5998 1,399.78 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 3.27 0.253 1.62 467.6002 1,399.78 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 3.44 0.287 1.34 467.6004 1,399.78 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 1.97 0.273 0 467.7467 1,400.22 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.25 0.21 1.32 467.9314 1,400.77 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 3.57 0.18 1.8 467.9346 1,400.78 1,400.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.57 0.392 0 469.7593 937.5029 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.54 0.366 0 469.7596 937.5035 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.18 0.288 0 469.7596 937.5036 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.45 0.397 0 469.7597 937.5038 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.59 0.271 0 469.76 937.5044 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.55 0.375 0 469.76 937.5044 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.6 0.344 0 469.7602 937.5047 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.47 0.387 0 469.7602 937.5048 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 1.91 0.242 0 469.7604 937.5051 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.7 0.335 0 469.7604 937.5051 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.28 0.401 0 469.7605 937.5053 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.21 0.413 0 469.7606 937.5055 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.62 0.395 0 469.7606 937.5056 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.4 0.381 0 469.7606 937.5056 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.48 0.366 0 469.7608 937.5059 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.8 0.368 0 469.7608 937.5059 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.36 0.362 0 469.761 937.5063 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.48 0.401 0 469.7614 937.5071 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.54 0.391 0 469.7614 937.5071 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.4 0.376 0 469.7616 937.5075 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.47 0.39 1.57 469.7626 937.5095 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVFQEFR 95.00% 2.45 0.365 0 469.7635 937.5113 938.51 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.46 0.375 1.74 472.2732 1,413.80 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.44 0.453 1.74 472.2741 1,413.80 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.01 0.33 0 472.2748 1,413.80 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 3.42 0.511 1.19 472.2748 1,413.80 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.98 0.473 0 472.2749 1,413.80 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.38 0.437 0 472.2751 1,413.80 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.3 0.433 0 472.2752 1,413.80 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.84 0.423 0 472.2754 1,413.80 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.46 0.249 0 472.2755 1,413.80 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.22 0.354 0 472.2761 1,413.80 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.24 0.202 0 472.2772 1,413.81 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.84 0.484 0 472.2774 1,413.81 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 3.02 0.444 0 472.2774 1,413.81 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.34 0.385 0 472.2775 1,413.81 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.65 0.37 1.19 472.2786 1,413.81 1,414.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LVWVPSEK 95.00% 2.18 0.254 1.37 479.2758 956.536 957.541 2 GLYG_HUMAN,RP1L1_HUMAN,COCA1_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LVWVPSEK 95.00% 2.15 0.239 0 479.2759 956.5362 957.541 2 GLYG_HUMAN,RP1L1_HUMAN,COCA1_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LVWVPSEK 95.00% 2 0.248 0 479.2773 956.5389 957.541 2 GLYG_HUMAN,RP1L1_HUMAN,COCA1_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 3.93 0.52 4.7 485.9322 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.43 0.468 2.89 485.9323 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.74 0.414 2.57 485.9326 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.89 0.474 2.51 485.9328 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.38 0.428 4.01 485.933 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.2 0.447 3.6 485.9331 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 2.7 0.383 1.52 485.9332 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.59 0.421 3.59 485.9334 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.21 0.387 3.33 485.9337 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.34 0.463 2.03 485.9339 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.35 0.459 3.21 485.9345 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAK 95.00% 2.76 0.366 0 487.2637 972.5117 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAK 95.00% 3.06 0.461 0 487.2641 972.5126 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAK 95.00% 2.65 0.341 0 487.2646 972.5136 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAK 95.00% 3.29 0.372 0 487.2648 972.514 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAK 95.00% 3.03 0.338 0 487.2652 972.5147 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAK 95.00% 3.03 0.476 0 487.2657 972.5157 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVGLDQMAK 95.00% 2.36 0.263 0 487.7699 973.5241 974.5347 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVGLDQMAK 95.00% 2.48 0.31 2.01 487.7714 973.5272 974.5347 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVGLDQMAK 95.00% 2.56 0.281 0 487.7717 973.5277 974.5347 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IVGLDQMAK 95.00% 2.5 0.279 0 487.773 973.5304 974.5347 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LDDEIAQKNNALK 95.00% 2.22 0.313 0 491.2651 1,470.77 1,471.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LDDEIAQKNNALK 95.00% 2.07 0.246 0 491.5989 1,471.77 1,471.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 3.91 0.406 0 495.6156 1,483.82 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 3.51 0.274 0 495.6159 1,483.82 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 3.2 0.295 0 495.6162 1,483.83 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 3.66 0.437 0 495.6164 1,483.83 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.4 0.329 1 495.6167 1,483.83 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.51 0.383 0 495.6168 1,483.83 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.34 0.41 1.01 495.6168 1,483.83 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.26 0.294 1.64 495.6168 1,483.83 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.21 0.403 0 495.6169 1,483.83 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.15 0.289 0 495.6169 1,483.83 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.17 0.403 0.959 495.617 1,483.83 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4 0.368 1.21 495.6173 1,483.83 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 3.56 0.291 0 495.619 1,483.83 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 3.8 0.438 0 495.6198 1,483.84 1,484.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QRYEILAANAIPK 95.00% 2.85 0.245 0 496.285 1,485.83 1,486.84 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QRYEILAANAIPK 95.00% 2.72 0.238 0 496.2852 1,485.83 1,486.84 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QRYEILAANAIPK 95.00% 3.92 0.409 1.09 496.2853 1,485.83 1,486.84 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QRYEILAANAIPK 95.00% 3.11 0.344 0 496.2854 1,485.83 1,486.84 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QRYEILAANAIPK 95.00% 2.96 0.35 0 496.2858 1,485.83 1,486.84 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QRYEILAANAIPK 95.00% 3.63 0.406 1.7 496.6192 1,486.83 1,486.84 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QRYEILAANAIPK 95.00% 3.65 0.412 0 496.6194 1,486.83 1,486.84 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QRYEILAANAIPK 95.00% 3.7 0.386 0 496.62 1,486.84 1,486.84 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DKTEFSIIHYAGK 95.00% 3.25 0.284 0 503.5966 1,507.77 1,508.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DKTEFSIIHYAGK 95.00% 3.53 0.131 0 503.5972 1,507.77 1,508.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DKTEFSIIHYAGK 95.00% 2.91 0.266 1.54 503.5972 1,507.77 1,508.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DKTEFSIIHYAGK 95.00% 2.55 0.188 0 503.5974 1,507.77 1,508.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DKTEFSIIHYAGK 95.00% 3.54 0.166 0 503.5975 1,507.77 1,508.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DKTEFSIIHYAGK 95.00% 3.09 0.174 0 503.5975 1,507.77 1,508.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DKTEFSIIHYAGK 95.00% 3.95 0.262 0 503.5981 1,507.77 1,508.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DKTEFSIIHYAGK 95.00% 3.78 0.31 2.66 503.6028 1,507.79 1,508.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DKTEFSIIHYAGK 95.00% 3.6 0.335 0 503.9349 1,508.78 1,508.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AAAYDKLEK 95.00% 2.25 0.308 0 504.7719 1,007.53 1,008.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AAAYDKLEK 95.00% 2.02 0.315 0 504.7737 1,007.53 1,008.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AAAYDKLEK 95.00% 1.98 0.401 0 504.7752 1,007.53 1,008.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% cNGVLEGIR 95.00% 2.52 0.278 0 c1: Carbamidomethyl (+57.02) 509.2618 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% cNGVLEGIR 95.00% 2.35 0.289 0 c1: Carbamidomethyl (+57.02) 509.2626 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 3.98 0.382 0 510.2948 1,527.86 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 4.42 0.337 0 510.2954 1,527.86 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 3.9 0.264 0 510.2956 1,527.86 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 4.52 0.341 0 510.2959 1,527.86 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 3.75 0.115 0 510.2961 1,527.86 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 3.33 0.37 1.27 510.2961 1,527.87 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 4.49 0.301 1.02 510.2963 1,527.87 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 4.18 0.322 1.09 510.2964 1,527.87 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 3.32 0.295 0 510.2965 1,527.87 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 3.47 0.234 0 510.2965 1,527.87 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 4.19 0.239 0 510.2965 1,527.87 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 3.97 0.342 0 510.2973 1,527.87 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 4.72 0.298 1 510.6286 1,528.86 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 3.71 0.308 0 510.6294 1,528.86 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 3.7 0.25 1 510.6301 1,528.87 1,528.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 3.4 0.232 0 514.9312 1,541.77 1,542.78 3 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KVIQYLAVVASSHK 95.00% 2.72 0.254 0 515.26 1,542.76 1,542.90 3 DESM_HUMAN,COCA1_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KVIQYLAVVASSHK 95.00% 2.9 0.225 0 515.2637 1,542.77 1,542.90 3 DESM_HUMAN,COCA1_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 3.85 0.383 0 c12: Carbamidomethyl (+57.02) 519.2512 1,554.73 1,555.74 3 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 4.37 0.46 1.01 c12: Carbamidomethyl (+57.02) 519.2529 1,554.74 1,555.74 3 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 2.8 0.411 0 c12: Carbamidomethyl (+57.02) 519.2539 1,554.74 1,555.74 3 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 4.21 0.473 1.44 c12: Carbamidomethyl (+57.02) 519.2544 1,554.74 1,555.74 3 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 3.98 0.447 0 c12: Carbamidomethyl (+57.02) 519.2546 1,554.74 1,555.74 3 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 4.39 0.413 0 c12: Carbamidomethyl (+57.02) 519.2548 1,554.74 1,555.74 3 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 3.77 0.381 0 c12: Carbamidomethyl (+57.02) 519.5877 1,555.74 1,555.74 3 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEVNMQALK 95.00% 2.81 0.223 1.43 523.2892 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEVNMQALK 95.00% 2.41 0.191 1.28 523.2893 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEVNMQALK 95.00% 3.18 0.262 0 523.2904 1,044.57 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEVNMQALK 95.00% 2.86 0.232 0 523.2905 1,044.57 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEVNMQALK 95.00% 3.07 0.256 0 523.291 1,044.57 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NKHESMISELEVR 95.00% 2.77 0.287 0 524.6005 1,570.78 1,571.79 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NKHESMISELEVR 95.00% 2.97 0.341 0 524.6022 1,570.78 1,571.79 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NKHESMISELEVR 95.00% 3.65 0.34 0 524.9357 1,571.78 1,571.79 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NKHESMISELEVR 95.00% 3.63 0.391 0 524.9359 1,571.78 1,571.79 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VKPLLQVTR 95.00% 1.9 0.204 1.27 527.3422 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VKPLLQVTR 95.00% 1.91 0.263 0 527.3429 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VKPLLQVTR 95.00% 1.89 0.327 0 527.3437 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VKPLLQVTR 95.00% 1.97 0.374 0 527.3437 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VKPLLQVTR 95.00% 1.89 0.318 0 527.3439 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VKPLLQVTR 95.00% 1.99 0.316 0 527.344 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VKPLLQVTR 95.00% 1.82 0.333 0 527.3441 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VKPLLQVTR 95.00% 1.99 0.33 0 527.3441 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VKPLLQVTR 95.00% 1.91 0.366 1.18 527.3442 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VKPLLQVTR 95.00% 2.1 0.357 0 527.3443 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VKPLLQVTR 95.00% 1.95 0.272 0 527.3445 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VKPLLQVTR 95.00% 1.95 0.287 0 527.3448 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSKK 95.00% 4.64 0.554 0 528.6307 1,582.87 1,583.88 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSKK 95.00% 5.4 0.588 2 528.631 1,582.87 1,583.88 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSKK 95.00% 4.44 0.571 1.4 528.6312 1,582.87 1,583.88 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSKK 95.00% 4.06 0.56 1.43 528.6312 1,582.87 1,583.88 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSKK 95.00% 4.69 0.535 0 528.9272 1,583.76 1,583.88 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSKK 95.00% 3.39 0.491 0 528.9308 1,583.77 1,583.88 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NKHESmISELEVR 95.00% 4.11 0.36 0 m6: Oxidation (+15.99) 529.9307 1,586.77 1,587.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NKHESmISELEVR 95.00% 3.89 0.359 0 m6: Oxidation (+15.99) 529.9327 1,586.77 1,587.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NKHESmISELEVR 95.00% 3.28 0.263 0 m6: Oxidation (+15.99) 529.9329 1,586.78 1,587.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NKHESmISELEVR 95.00% 3.23 0.324 0 m6: Oxidation (+15.99) 530.268 1,587.78 1,587.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 4.3 0.2 0 530.3071 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 4.08 0.222 1.47 530.3074 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 4.33 0.222 1.18 530.3075 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 4.62 0.234 0 530.3079 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 4.44 0.213 1.09 530.3081 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 4.35 0.218 1.13 530.3082 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 4.51 0.272 1.55 530.3083 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 4.45 0.276 1.34 530.3085 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 2.78 0.157 0 530.3085 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 4.64 0.221 0 530.3087 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 3.76 0.265 1.28 530.309 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 3.82 0.201 0 530.3101 1,587.91 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 4.06 0.254 1.14 530.6421 1,588.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 4.46 0.264 0 530.6425 1,588.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TGVLAHLEEERDLK 95.00% 2.46 0.178 0 537.2906 1,608.85 1,609.86 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TGVLAHLEEERDLK 95.00% 2.63 0.177 0 537.291 1,608.85 1,609.86 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TGVLAHLEEERDLK 95.00% 2.5 0.243 0 537.291 1,608.85 1,609.86 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TGVLAHLEEERDLK 95.00% 2.75 0.281 0 537.6253 1,609.85 1,609.86 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDERK 95.00% 3.05 0.25 0 538.6462 1,612.92 1,612.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSKDDVGK 95.00% 2.07 0.384 2.19 541.5922 1,621.75 1,622.76 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSKDDVGK 95.00% 1.74 0.261 2.08 541.5922 1,621.75 1,622.76 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSKDDVGK 95.00% 2.36 0.335 1.89 541.5923 1,621.75 1,622.76 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSKDDVGK 95.00% 2.04 0.265 2.52 541.5925 1,621.75 1,622.76 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 2.96 0.202 0 543.95 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.28 0.479 3.28 543.9503 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.28 0.451 2.05 543.9503 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 2.63 0.364 1.89 543.9504 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.44 0.385 2.37 543.9505 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.72 0.355 2.13 543.9505 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.69 0.42 3.26 543.9506 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.71 0.424 2.01 543.9507 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.86 0.323 1.44 543.9507 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.88 0.307 1.92 543.9508 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.75 0.407 2.96 543.9508 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.14 0.3 1.35 543.9509 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.41 0.25 1.77 543.951 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.17 0.302 1.96 543.9512 1,628.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ENADLAGELR 95.00% 2.35 0.204 0 544.2679 1,086.52 1,087.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ENADLAGELR 95.00% 2.55 0.256 0 544.2721 1,086.53 1,087.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ENADLAGELR 95.00% 2.25 0.287 0 544.2727 1,086.53 1,087.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ENADLAGELR 95.00% 2.42 0.293 0 544.2737 1,086.53 1,087.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 2.66 0.331 0 544.2842 1,629.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.27 0.353 1.7 544.2845 1,629.83 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.76 0.366 1.89 544.2862 1,629.84 1,629.83 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.34 0.466 3.68 546.2745 1,635.80 1,636.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.38 0.438 4.62 546.2747 1,635.80 1,636.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 3.58 0.408 2.89 546.2749 1,635.80 1,636.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.13 0.372 1.64 546.275 1,635.80 1,636.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.24 0.466 2.96 546.2751 1,635.80 1,636.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.76 0.463 3.14 546.2752 1,635.80 1,636.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.48 0.476 3.13 546.2753 1,635.80 1,636.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.28 0.396 4 546.2754 1,635.80 1,636.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 3.41 0.408 1.35 546.2761 1,635.80 1,636.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.56 0.43 1.51 546.6095 1,636.81 1,636.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DTSITGELEK 95.00% 2.57 0.244 1.59 546.7754 1,091.54 1,092.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DTSITGELEK 95.00% 2.28 0.269 0 546.7755 1,091.54 1,092.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DTSITGELEK 95.00% 2.49 0.176 1.29 546.7756 1,091.54 1,092.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DTSITGELEK 95.00% 2.43 0.261 1.46 546.7756 1,091.54 1,092.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DTSITGELEK 95.00% 2.18 0.203 1.6 546.7757 1,091.54 1,092.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DTSITGELEK 95.00% 2.3 0.215 1.29 546.7759 1,091.54 1,092.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DTSITGELEK 95.00% 2.26 0.203 1.59 546.7763 1,091.54 1,092.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% FDQLLAEEK 95.00% 3.25 0.404 0 546.7832 1,091.55 1,092.56 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% FDQLLAEEK 95.00% 3.33 0.402 2.33 546.7835 1,091.55 1,092.56 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% FDQLLAEEK 95.00% 3.32 0.414 0 546.7838 1,091.55 1,092.56 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% FDQLLAEEK 95.00% 3.09 0.384 0 546.7845 1,091.55 1,092.56 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% GNETSFVPSR 95.00% 2.96 0.387 1.85 547.2692 1,092.52 1,093.53 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSK 95.00% 2.26 0.395 0 554.764 1,107.51 1,108.52 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSK 95.00% 2.34 0.378 1.7 554.7646 1,107.51 1,108.52 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSK 95.00% 2.5 0.433 1.66 554.7647 1,107.51 1,108.52 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSK 95.00% 2.16 0.415 1.28 554.766 1,107.52 1,108.52 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VcHLMGINVTDFTR 95.00% 3.01 0.213 0 c2: Carbamidomethyl (+57.02) 554.9418 1,661.80 1,662.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VcHLMGINVTDFTR 95.00% 3.71 0.316 0 c2: Carbamidomethyl (+57.02) 554.9421 1,661.80 1,662.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VcHLMGINVTDFTR 95.00% 3.31 0.365 0 c2: Carbamidomethyl (+57.02) 554.9428 1,661.81 1,662.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VcHLMGINVTDFTR 95.00% 2.49 0.268 0 c2: Carbamidomethyl (+57.02) 554.9442 1,661.81 1,662.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSK 95.00% 2.48 0.379 1.85 555.2636 1,108.51 1,108.52 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VcHLMGINVTDFTR 95.00% 3.31 0.239 1.42 c2: Carbamidomethyl (+57.02) 555.2766 1,662.81 1,662.81 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% RLVWVPSEK 95.00% 2.56 0.334 0 557.3248 1,112.63 1,113.64 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 3.04 0.409 0 562.9611 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 2.51 0.476 1.68 562.9612 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 2.86 0.417 1.17 562.9613 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 2.7 0.468 0 562.9614 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 3.11 0.399 0 562.9614 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 2.99 0.474 0 562.9617 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 2.24 0.19 1.09 562.9619 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 2.71 0.41 0 562.962 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 2.77 0.491 0 562.9622 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 3.05 0.382 0 563.2953 1,686.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 2.51 0.398 0 563.2954 1,686.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 2.91 0.394 1.09 563.2964 1,686.87 1,686.87 3 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDER 95.00% 3.81 0.44 0 564.2578 1,689.75 1,690.76 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDER 95.00% 3.83 0.421 0 564.2586 1,689.75 1,690.76 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDER 95.00% 4.04 0.42 0 564.2587 1,689.75 1,690.76 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDER 95.00% 3.84 0.451 0 564.2587 1,689.75 1,690.76 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDER 95.00% 3.88 0.402 0 564.2591 1,689.75 1,690.76 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDER 95.00% 3.86 0.436 0 564.2593 1,689.75 1,690.76 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDER 95.00% 3.78 0.461 0 564.2593 1,689.75 1,690.76 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% MTESSLPSASK 95.00% 2.37 0.436 1.92 569.2765 1,136.54 1,137.55 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% MTESSLPSASK 95.00% 2.27 0.435 1.6 569.2788 1,136.54 1,137.55 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ASRDEIFATAKENEK 95.00% 3.46 0.337 1.28 570.2894 1,707.84 1,708.85 3 VINC_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ASRDEIFATAKENEK 95.00% 4.32 0.342 1.89 570.2897 1,707.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ASRDEIFATAKENEK 95.00% 4.36 0.386 1.52 570.2899 1,707.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ASRDEIFATAKENEK 95.00% 4.36 0.39 1.16 570.2901 1,707.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ASRDEIFATAKENEK 95.00% 3.61 0.282 1.92 570.2902 1,707.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ASRDEIFATAKENEK 95.00% 4.23 0.25 2.18 570.6237 1,708.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ASRDEIFATAKENEK 95.00% 3.71 0.3 1.6 570.6238 1,708.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ASRDEIFATAKENEK 95.00% 4.35 0.332 2.62 570.6241 1,708.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.14 0.403 2.15 m1: Oxidation (+15.99) 577.276 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.43 0.309 2.66 m1: Oxidation (+15.99) 577.2763 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.08 0.339 1.64 m1: Oxidation (+15.99) 577.2768 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.29 0.333 2.7 m1: Oxidation (+15.99) 577.2768 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 1.98 0.291 2.12 m1: Oxidation (+15.99) 577.2771 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.2 0.301 2.7 m1: Oxidation (+15.99) 577.2774 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.47 0.385 2.92 m1: Oxidation (+15.99) 577.2779 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.08 0.421 1.32 m1: Oxidation (+15.99) 577.278 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.65 0.405 2.96 m1: Oxidation (+15.99) 577.2781 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.1 0.242 1.48 m1: Oxidation (+15.99) 577.2783 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.34 0.367 2.27 m1: Oxidation (+15.99) 577.2784 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.39 0.244 1.89 m1: Oxidation (+15.99) 577.2792 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.6 0.366 2.15 m1: Oxidation (+15.99) 577.2794 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 1.87 0.339 2.17 m1: Oxidation (+15.99) 577.2796 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.36 0.404 1.49 m1: Oxidation (+15.99) 577.2802 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.13 0.181 1.82 m1: Oxidation (+15.99) 577.2803 1,152.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.05 0.352 1.92 m1: Oxidation (+15.99) 577.7779 1,153.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% mTESSLPSASK 95.00% 2.08 0.359 3.17 m1: Oxidation (+15.99) 577.7783 1,153.54 1,153.54 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QEEEMQAKEDELQK 95.00% 2.8 0.157 0 578.9387 1,733.79 1,734.79 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SFVEKLcTEQGSHPK 95.00% 2.31 0.347 0 c7: Carbamidomethyl (+57.02) 583.2899 1,746.85 1,746.85 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEKNISSK 95.00% 4.17 0.434 4.39 583.9851 1,748.93 1,749.94 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QEEEmQAKEDELQK 95.00% 1.95 0.258 0 m5: Oxidation (+15.99) 584.2695 1,749.78 1,750.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QEEEmQAKEDELQK 95.00% 2.34 0.0995 1.6 m5: Oxidation (+15.99) 584.2697 1,749.79 1,750.78 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEKNISSK 95.00% 2.78 0.291 0 584.3205 1,749.94 1,749.94 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 4.17 0.381 2.32 585.6305 1,753.87 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 4.39 0.376 2.62 585.6306 1,753.87 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 4.3 0.409 2.64 585.631 1,753.87 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 4.59 0.399 1.85 585.6311 1,753.87 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 4.11 0.346 1.96 585.6312 1,753.87 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 2.41 0.182 2.3 585.8078 1,754.40 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 3.8 0.359 3.02 585.9645 1,754.87 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 4.4 0.309 1.8 585.9648 1,754.87 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 4.59 0.386 2.68 585.965 1,754.87 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 4.29 0.376 2.85 585.9653 1,754.87 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 3.55 0.274 2.8 585.9656 1,754.87 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 3.47 0.263 1.92 585.9666 1,754.88 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 2.79 0.319 0 586.0578 1,755.15 1,754.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 2.92 0.348 0 596.9642 1,787.87 1,788.87 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 2.89 0.189 0 597.6401 1,789.90 1,790.90 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 3.2 0.261 0 597.6403 1,789.90 1,790.90 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 2.88 0.154 0 597.6409 1,789.90 1,790.90 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 2.92 0.268 0 597.6409 1,789.90 1,790.90 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 2.81 0.328 0 597.6471 1,789.92 1,790.90 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 2.92 0.169 1.35 597.9744 1,790.90 1,790.90 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 3 0.208 0 597.9763 1,790.91 1,790.90 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAREK 95.00% 3.05 0.421 0 600.6436 1,798.91 1,799.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAREK 95.00% 3.29 0.393 0 600.6437 1,798.91 1,799.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAREK 95.00% 3.11 0.392 0 600.6446 1,798.91 1,799.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DLELQADSAIK 95.00% 2.74 0.394 2.4 601.8181 1,201.62 1,202.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DLELQADSAIK 95.00% 2.88 0.339 1.52 601.8183 1,201.62 1,202.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DLELQADSAIK 95.00% 2.79 0.262 0 601.8183 1,201.62 1,202.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DLELQADSAIK 95.00% 3.21 0.407 1.21 601.8183 1,201.62 1,202.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DLELQADSAIK 95.00% 3.01 0.322 0 601.8185 1,201.62 1,202.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DLELQADSAIK 95.00% 2.95 0.357 1.59 601.8187 1,201.62 1,202.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DLELQADSAIK 95.00% 3.15 0.392 1.18 601.8188 1,201.62 1,202.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DLELQADSAIK 95.00% 3 0.333 0 601.8188 1,201.62 1,202.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DLELQADSAIK 95.00% 2.69 0.339 0 601.8191 1,201.62 1,202.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DLELQADSAIK 95.00% 2.74 0.273 1.55 601.8193 1,201.62 1,202.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% YEILAANAIPK 95.00% 3.37 0.416 2.09 601.8434 1,201.67 1,202.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% YEILAANAIPK 95.00% 3.53 0.36 2.28 601.8441 1,201.67 1,202.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% YEILAANAIPK 95.00% 3.43 0.419 2.3 601.8441 1,201.67 1,202.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% YEILAANAIPK 95.00% 3.52 0.489 2.44 601.8443 1,201.67 1,202.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% YEILAANAIPK 95.00% 3.42 0.468 1.47 601.8444 1,201.67 1,202.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% YEILAANAIPK 95.00% 3.14 0.469 1.52 601.8445 1,201.67 1,202.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% YEILAANAIPK 95.00% 3.84 0.4 1.77 601.8446 1,201.67 1,202.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% YEILAANAIPK 95.00% 3.07 0.462 1.36 601.8449 1,201.67 1,202.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 2.19 0.235 0 602.321 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 2.2 0.272 0 602.3222 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 2.95 0.304 1.62 602.3228 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 2.93 0.277 1.68 602.323 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 3.14 0.288 1.64 602.3231 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 3.02 0.298 1.6 602.3231 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 3.12 0.3 2.26 602.3235 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 3.08 0.296 1.57 602.3236 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 3.07 0.304 1.51 602.3236 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 2.48 0.276 1.82 602.3236 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 3.14 0.296 2.68 602.3238 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 3.07 0.283 1.74 602.3238 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 2.88 0.304 0 602.3239 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 2.43 0.27 1.59 602.3257 1,202.64 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALELDPNLYR 95.00% 2.33 0.239 1.24 602.3258 1,202.64 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% YEILAANAIPK 95.00% 3.41 0.428 2.68 602.3457 1,202.68 1,202.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALETQMEEMK 95.00% 3.3 0.437 2.64 605.2804 1,208.55 1,209.55 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALETQMEEMK 95.00% 3.16 0.52 2.96 605.2804 1,208.55 1,209.55 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALETQMEEMK 95.00% 3.33 0.468 3.19 605.2805 1,208.55 1,209.55 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALETQMEEMK 95.00% 3.14 0.4 2.6 605.2816 1,208.55 1,209.55 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALETQMEEMK 95.00% 2.21 0.374 0 605.7823 1,209.55 1,209.55 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDERK 95.00% 3.07 0.279 0 606.9561 1,817.84 1,818.85 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDERK 95.00% 2.87 0.322 0 606.9565 1,817.85 1,818.85 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDERK 95.00% 3.24 0.379 0 606.9573 1,817.85 1,818.85 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDERK 95.00% 3.03 0.352 0 607.2917 1,818.85 1,818.85 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEDEILVmDDQNNK 95.00% 2.92 0.4 0 m9: Oxidation (+15.99) 607.2964 1,818.87 1,819.88 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEEEEDRGQQLQAER 95.00% 3.28 0.343 0 610.628 1,828.86 1,829.86 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEEEEDRGQQLQAER 95.00% 3.96 0.352 0 610.6285 1,828.86 1,829.86 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEEEEDRGQQLQAER 95.00% 2.87 0.164 0 610.629 1,828.86 1,829.86 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEEEEDRGQQLQAER 95.00% 2.73 0.282 0 610.6296 1,828.87 1,829.86 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEEEEDRGQQLQAER 95.00% 2.69 0.191 0 610.63 1,828.87 1,829.86 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEEEEDRGQQLQAER 95.00% 2.8 0.277 0 610.6305 1,828.87 1,829.86 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 2.69 0.193 1.62 610.8286 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 3.01 0.215 0 610.83 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 2.88 0.225 0 610.831 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 2.57 0.162 1.74 610.8311 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 3.03 0.296 0 610.8313 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 2.5 0.215 0 610.8315 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 2.61 0.19 0 610.8315 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 3 0.217 0 610.8315 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 2.89 0.285 0 610.8317 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 2.58 0.207 0 610.8318 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 2.7 0.2 0 610.8319 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 3.15 0.222 1.59 610.8319 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KFDQLLAEEK 95.00% 2.96 0.208 0 610.8325 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEEEEDRGQQLQAER 95.00% 3.13 0.261 0 610.9636 1,829.87 1,829.86 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SKLHEMEGAVK 95.00% 2.63 0.357 1.21 614.8227 1,227.63 1,228.64 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEGDLKDLELQADSAIK 95.00% 4.12 0.455 2.03 619.9999 1,856.98 1,857.98 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEGDLKDLELQADSAIK 95.00% 4.01 0.432 1.21 620.0001 1,856.98 1,857.98 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEGDLKDLELQADSAIK 95.00% 4.08 0.468 2.77 620.0001 1,856.98 1,857.98 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEGDLKDLELQADSAIK 95.00% 3.3 0.351 1.55 620.0013 1,856.98 1,857.98 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEGDLKDLELQADSAIK 95.00% 4.07 0.452 1.92 620.3343 1,857.98 1,857.98 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 2.7 0.223 2.06 622.3307 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 3.42 0.32 2.35 622.331 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 3.18 0.252 1.47 622.3311 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 3.13 0.192 1.74 622.3315 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 2.85 0.0465 2.07 622.3315 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 2.6 0.203 1.21 622.3317 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 3.31 0.31 2.32 622.3317 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 3.2 0.183 2.8 622.3317 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 3.27 0.14 1.74 622.3319 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 3.5 0.269 1.21 622.3319 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 2.68 0.0479 1.17 622.3319 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 2.83 0.082 1.82 622.332 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EILLQVEDER 95.00% 2.85 0.172 1.27 622.3344 1,242.65 1,243.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TGVLAHLEEER 95.00% 2.66 0.312 2.46 627.3296 1,252.64 1,253.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TGVLAHLEEER 95.00% 2.57 0.26 1.19 627.3297 1,252.64 1,253.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TGVLAHLEEER 95.00% 2.77 0.334 1.7 627.3297 1,252.64 1,253.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TGVLAHLEEER 95.00% 2.73 0.382 1.35 627.3297 1,252.64 1,253.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TGVLAHLEEER 95.00% 2.75 0.369 1.82 627.3299 1,252.64 1,253.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TGVLAHLEEER 95.00% 2.67 0.363 1.57 627.3305 1,252.65 1,253.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TGVLAHLEEER 95.00% 2.89 0.356 2.12 627.3308 1,252.65 1,253.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KEEELQAALAR 95.00% 2.89 0.303 0 629.2899 1,256.56 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KEEELQAALAR 95.00% 2.68 0.325 0 629.29 1,256.56 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KEEELQAALAR 95.00% 2.86 0.329 0 629.2911 1,256.57 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KEEELQAALAR 95.00% 2.7 0.296 0 629.2914 1,256.57 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KEEELQAALAR 95.00% 2.07 0.39 0 629.2925 1,256.57 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KEEELQAALAR 95.00% 3.34 0.295 1.23 629.3451 1,256.67 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KEEELQAALAR 95.00% 3.13 0.304 1.57 629.3457 1,256.68 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KEEELQAALAR 95.00% 3.11 0.34 1.77 629.3457 1,256.68 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KEEELQAALAR 95.00% 2.82 0.324 2.11 629.3459 1,256.68 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KEEELQAALAR 95.00% 2.76 0.342 1.92 629.346 1,256.68 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGKK 95.00% 4.26 0.55 1.8 631.6728 1,891.99 1,893.00 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGKK 95.00% 5.64 0.574 2.29 631.6729 1,892.00 1,893.00 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGKK 95.00% 4.07 0.566 1.46 631.6736 1,892.00 1,893.00 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGKK 95.00% 4.09 0.155 0 632.0054 1,892.99 1,893.00 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGKK 95.00% 5.19 0.56 1.72 632.0074 1,893.00 1,893.00 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGKK 95.00% 6.42 0.557 3.2 632.0075 1,893.00 1,893.00 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TEFSIIHYAGK 95.00% 3.03 0.505 2.36 633.8311 1,265.65 1,265.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFK 95.00% 3.77 0.203 2.02 633.9878 1,898.94 1,899.95 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFK 95.00% 4.03 0.295 1.3 633.9887 1,898.94 1,899.95 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 3.66 0.483 1.89 634.3159 1,266.62 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 3.95 0.535 2.89 634.3191 1,266.62 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 4.01 0.514 2.85 634.3197 1,266.62 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 4.23 0.506 3.49 634.32 1,266.62 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 3.91 0.542 3.89 634.32 1,266.62 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 4.01 0.503 3.14 634.3201 1,266.62 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 3.76 0.544 3.4 634.3208 1,266.63 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 4.06 0.541 3.92 634.3211 1,266.63 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 3.34 0.48 3.92 634.3211 1,266.63 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 4.07 0.52 3.77 634.3214 1,266.63 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 3.84 0.523 2.44 634.3216 1,266.63 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 4.21 0.492 3.68 634.3216 1,266.63 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 2.06 0.365 0 634.3218 1,266.63 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 3.74 0.55 5.19 634.3222 1,266.63 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 3.25 0.48 0 634.3224 1,266.63 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFK 95.00% 4.52 0.224 1.57 634.3225 1,899.94 1,899.95 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFK 95.00% 4.61 0.261 1.47 634.3229 1,899.95 1,899.95 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 2.62 0.482 1.52 634.3233 1,266.63 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 2.74 0.399 0 634.3479 1,266.68 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VDYNASAWLTK 95.00% 3.45 0.503 3.32 634.8221 1,267.63 1,267.63 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 3.69 0.493 1.23 636.8441 1,271.67 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 3.54 0.538 3.34 636.8444 1,271.67 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 4.03 0.471 3.23 636.8446 1,271.67 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 3.9 0.52 3.4 636.8447 1,271.67 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 3.17 0.541 1.52 636.8449 1,271.67 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 4.04 0.509 2.38 636.8454 1,271.68 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 4.22 0.511 2.32 636.8455 1,271.68 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 3.99 0.508 1.92 636.8455 1,271.68 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 3.79 0.512 3.96 636.8456 1,271.68 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 4.09 0.503 1.7 636.8457 1,271.68 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 3.78 0.513 4.72 636.8461 1,271.68 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 3.87 0.488 3 636.8475 1,271.68 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEAQVQELQSK 95.00% 3.72 0.503 0 636.8482 1,271.68 1,272.68 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 4.06 0.469 2.11 638.3265 1,911.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 4.11 0.474 0 638.327 1,911.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 4.85 0.511 1.85 638.3273 1,911.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.07 0.557 2.03 638.3274 1,911.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 4.78 0.566 3 638.3278 1,911.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 3.75 0.468 2.42 638.3281 1,911.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 3.12 0.37 0 638.3284 1,911.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.39 0.472 2.48 638.6603 1,912.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.29 0.479 2.22 638.6613 1,912.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 4.71 0.448 1 638.6616 1,912.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.34 0.476 1.42 638.6619 1,912.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.1 0.498 2.04 638.6622 1,912.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 4.33 0.491 1.66 638.6625 1,912.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 2.49 0.208 1.02 638.6628 1,912.96 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 4.5 0.471 2.46 638.6629 1,912.97 1,912.96 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLEEAEEESQRINANR 95.00% 2.45 0.188 1.1 639.3107 1,914.91 1,915.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 4.74 0.436 1.31 639.662 1,915.96 1,916.97 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 4.64 0.473 1.37 639.6623 1,915.96 1,916.97 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 4.95 0.434 1.72 639.6629 1,915.97 1,916.97 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 4.88 0.471 1.02 639.6633 1,915.97 1,916.97 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 4.52 0.285 1.6 639.9958 1,916.96 1,916.97 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.02 0.424 1.54 639.9962 1,916.97 1,916.97 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 4.67 0.347 1.39 639.9964 1,916.97 1,916.97 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 4.9 0.351 1.46 639.9969 1,916.97 1,916.97 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.27 0.426 1.52 639.9972 1,916.97 1,916.97 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.01 0.424 1.42 639.9973 1,916.97 1,916.97 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKKR 95.00% 1.9 0.272 0 641.0055 1,919.99 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKKR 95.00% 2.86 0.411 0 641.0068 1,920.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKKR 95.00% 3.72 0.44 2.26 641.0076 1,920.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKKR 95.00% 2.37 0.38 0 641.0088 1,920.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKKR 95.00% 2.34 0.277 0 641.3412 1,921.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKKR 95.00% 2.32 0.303 0 641.3419 1,921.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKKR 95.00% 2.28 0.33 0 641.3419 1,921.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKKR 95.00% 2.49 0.29 0 641.3423 1,921.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKKR 95.00% 2.25 0.296 0 641.3427 1,921.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKKR 95.00% 1.96 0.3 0 641.3431 1,921.01 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKKR 95.00% 2.64 0.351 1.12 641.3433 1,921.01 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% FQKEIENLTQQYEEK 95.00% 4.63 0.379 4.36 643.3232 1,926.95 1,926.95 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NKQTLEKENADLAGELR 95.00% 4.79 0.487 3 644.0097 1,929.01 1,929.00 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 2.81 0.5 0 646.3302 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 2.38 0.508 0 646.3308 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 2.6 0.475 1.52 646.331 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 2.46 0.482 0 646.3311 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 3.17 0.424 1.72 646.3312 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 2.99 0.443 2.1 646.3316 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 3.59 0.464 1.7 646.3316 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 2.9 0.475 1.27 646.3316 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 2.31 0.463 0 646.3316 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 3.34 0.44 1.7 646.3319 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 2.24 0.421 1.55 646.3321 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 2.84 0.352 1.21 646.3323 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 3.01 0.474 2.19 646.3324 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EQADFAVEALAK 95.00% 2.97 0.501 1.24 646.3329 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 3.94 0.552 1.85 649.9833 1,946.93 1,947.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 4.86 0.551 3.01 649.9848 1,946.93 1,947.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 2.84 0.254 1.39 650.3181 1,947.93 1,947.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 4.82 0.551 4.08 650.3181 1,947.93 1,947.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 5.18 0.485 3.62 650.3194 1,947.93 1,947.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TQLEELEDELQATEDAK 95.00% 2.86 0.266 0 654.6462 1,960.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TQLEELEDELQATEDAK 95.00% 4.71 0.548 2.51 654.6469 1,960.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TQLEELEDELQATEDAK 95.00% 5.03 0.549 3.96 654.647 1,960.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TQLEELEDELQATEDAK 95.00% 5.45 0.532 3.77 654.9803 1,961.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TQLEELEDELQATEDAK 95.00% 5.54 0.52 4.08 654.9812 1,961.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TQLEELEDELQATEDAK 95.00% 3.67 0.457 0 654.9812 1,961.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 2.86 0.271 0 m11: Oxidation (+15.99) 655.313 1,962.92 1,963.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 2.85 0.291 0 m11: Oxidation (+15.99) 655.314 1,962.92 1,963.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 3.96 0.466 4.29 m11: Oxidation (+15.99) 655.3147 1,962.92 1,963.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 3.54 0.487 0 m11: Oxidation (+15.99) 655.317 1,962.93 1,963.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 4.22 0.475 3.29 m11: Oxidation (+15.99) 655.6485 1,963.92 1,963.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 4.77 0.558 3.47 m11: Oxidation (+15.99) 655.6496 1,963.93 1,963.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 4.76 0.527 1.22 m11: Oxidation (+15.99) 655.6496 1,963.93 1,963.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 4.23 0.461 2.6 m11: Oxidation (+15.99) 655.6498 1,963.93 1,963.93 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LRLEVNMQALK 95.00% 2.28 0.282 0 657.8806 1,313.75 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LRLEVNMQALK 95.00% 2.98 0.31 1.41 657.8833 1,313.75 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LRLEVNMQALK 95.00% 2.56 0.278 0 657.8838 1,313.75 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LRLEVNMQALK 95.00% 2.69 0.35 0 657.8843 1,313.75 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.11 0.328 0 662.3091 1,983.90 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.41 0.324 1.11 662.3094 1,983.90 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.13 0.309 1.04 662.3096 1,983.91 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.59 0.349 1.28 662.3097 1,983.91 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 3.87 0.283 0 662.3101 1,983.91 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.04 0.407 0 662.3109 1,983.91 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.32 0.468 0 662.6436 1,984.91 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.48 0.424 1.34 662.6436 1,984.91 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.43 0.329 1.12 662.6437 1,984.91 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.33 0.26 0 662.6439 1,984.91 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.12 0.404 0 662.6439 1,984.91 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.72 0.38 1.28 662.6443 1,984.91 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.16 0.378 0 662.6451 1,984.91 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.46 0.258 0 662.6468 1,984.92 1,984.91 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DLELQADSAIKGREEAIK 95.00% 3.25 0.419 0 663.0242 1,986.05 1,986.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 5.96 0.476 1.96 663.0315 1,986.07 1,986.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 6.15 0.459 2.6 663.0322 1,986.07 1,986.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 5.59 0.467 2.28 663.0323 1,986.07 1,986.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 5.19 0.495 2.25 663.0325 1,986.07 1,986.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 6.08 0.463 3.17 663.0327 1,986.07 1,986.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 4.93 0.479 2.92 663.0329 1,986.08 1,986.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 3.46 0.292 1.39 663.0334 1,986.08 1,986.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 5.17 0.543 3.21 663.0344 1,986.08 1,986.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AENELKELEQK 95.00% 2.75 0.109 1.82 665.8469 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AENELKELEQK 95.00% 2.97 0.133 0 665.8475 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AENELKELEQK 95.00% 2.87 0.184 0 665.8479 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AENELKELEQK 95.00% 2.87 0.136 0 665.8482 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALDEETRSHEAQVQEmR 95.00% 2.54 0.441 0 m16: Oxidation (+15.99) 682.3215 2,043.94 2,044.94 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TVGQLYKEQLGK 95.00% 3.06 0.492 0 682.3824 1,362.75 1,363.76 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TVGQLYKEQLGK 95.00% 3.33 0.418 1.16 682.3853 1,362.76 1,363.76 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TVGQLYKEQLGK 95.00% 2.39 0.258 0 682.3858 1,362.76 1,363.76 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALDEETRSHEAQVQEmR 95.00% 2.65 0.266 1.96 m16: Oxidation (+15.99) 682.6553 2,044.94 2,044.94 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 3.87 0.539 0 685.6047 2,053.79 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 7.36 0.664 4.02 686.0199 2,055.04 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 7.42 0.655 3.09 686.0215 2,055.04 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 5.86 0.654 3.92 686.3546 2,056.04 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 6.64 0.542 2.37 686.3553 2,056.04 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 7 0.65 5.49 686.3555 2,056.04 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 7.01 0.599 4.13 686.3557 2,056.04 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 7.45 0.666 3.57 686.3558 2,056.04 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 7.49 0.611 5.29 686.3559 2,056.04 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 6.74 0.568 4.21 686.3566 2,056.05 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 4.99 0.706 3.68 686.3569 2,056.05 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 2.41 0.425 0 686.3572 2,056.05 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 3.88 0.579 2.82 686.3585 2,056.05 2,056.05 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLEEAEEESQRINANRR 95.00% 2.45 0.218 0 691.3443 2,071.01 2,072.01 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLEEAEEESQRINANRR 95.00% 2.83 0.35 0 691.678 2,072.01 2,072.01 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLEEAEEESQRINANRR 95.00% 2.16 0.29 0 691.6799 2,072.02 2,072.01 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.3 0.538 3.33 700.8924 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.56 0.531 4.02 700.8927 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.59 0.513 4 700.8929 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.29 0.497 3.74 700.8929 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.25 0.536 3.48 700.8932 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.46 0.499 3.96 700.8933 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.64 0.535 4.08 700.8934 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.45 0.539 3.77 700.894 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.42 0.521 3.28 700.8941 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.23 0.495 3.92 700.8944 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.17 0.509 3.68 700.8944 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.05 0.48 3.59 700.8946 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEAQVQELQSK 95.00% 4.11 0.507 3.55 700.8947 1,399.77 1,400.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.96 0.507 2.92 707.9059 1,413.80 1,414.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 3.55 0.544 2.57 707.907 1,413.80 1,414.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 3 0.565 3.66 707.9071 1,413.80 1,414.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 3.91 0.54 3.11 707.9075 1,413.80 1,414.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 3.78 0.507 3.42 707.9082 1,413.80 1,414.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 3.85 0.563 3.17 707.909 1,413.80 1,414.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 3.16 0.529 3.54 707.9092 1,413.80 1,414.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.11 0.231 2.05 707.9095 1,413.80 1,414.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.34 0.437 1.7 707.9104 1,413.81 1,414.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 2.37 0.285 0 707.9107 1,413.81 1,414.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 3.44 0.544 2.46 707.9107 1,413.81 1,414.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DLELQADSAIKGR 95.00% 2.62 0.271 0 708.3761 1,414.74 1,415.75 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VIQYLAVVASSHK 95.00% 3.72 0.529 3.66 708.4099 1,414.80 1,414.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEDEILVMDDQNNKLSK 95.00% 4.33 0.523 2.18 711.7015 2,132.08 2,132.09 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEDEILVMDDQNNKLSK 95.00% 5.24 0.572 2.36 711.7023 2,132.08 2,132.09 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEDEILVMDDQNNKLSK 95.00% 3.73 0.56 0 711.704 2,132.09 2,132.09 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 3.45 0.487 0 725.6996 2,174.08 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 4.09 0.558 1.7 726.0325 2,175.07 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 3.85 0.504 1.27 726.0326 2,175.07 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 4.03 0.511 1.33 726.0328 2,175.07 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 4.29 0.559 1.68 726.0332 2,175.08 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 3.68 0.469 0 726.0334 2,175.08 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 2.69 0.258 0 726.0337 2,175.08 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 3.96 0.533 1.85 726.0338 2,175.08 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 4.28 0.523 1 726.0339 2,175.08 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 4.44 0.538 1.52 726.034 2,175.08 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 3.89 0.516 1.3 726.0341 2,175.08 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 3.26 0.449 1.02 726.0341 2,175.08 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 3.78 0.469 0 726.0343 2,175.08 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 3.85 0.521 1.24 726.0347 2,175.08 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 3.82 0.488 1.12 726.0352 2,175.08 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 2.88 0.432 1.2 726.0372 2,175.09 2,175.08 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.24 0.489 4.92 728.3935 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.3 0.623 4.59 728.3936 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.89 0.524 4.66 728.3942 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.44 0.52 6.2 728.3947 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.41 0.599 6.01 728.3949 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.53 0.445 5.23 728.3952 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.61 0.584 5.62 728.3955 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 5.11 0.539 5.18 728.3956 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.49 0.595 5.96 728.3957 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 3.85 0.545 4.66 728.3959 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.34 0.641 6.64 728.396 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 3.22 0.565 4.74 728.3963 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 2.4 0.276 1.59 728.3983 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 4.86 0.544 5.14 728.8975 1,455.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSK 95.00% 5.03 0.466 5.85 728.8977 1,455.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.32 0.38 3.52 742.922 1,483.83 1,484.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.34 0.407 2.28 742.9222 1,483.83 1,484.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.27 0.412 1.64 742.9223 1,483.83 1,484.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.62 0.438 4.14 742.9225 1,483.83 1,484.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.42 0.402 2 742.9229 1,483.83 1,484.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.44 0.43 3.55 742.9229 1,483.83 1,484.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 3.5 0.396 3.41 742.923 1,483.83 1,484.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 3.54 0.407 1.57 742.9239 1,483.83 1,484.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LKEILLQVEDER 95.00% 4.11 0.362 2.85 743.4211 1,484.83 1,484.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QRYEILAANAIPK 95.00% 2.32 0.229 0 743.9256 1,485.84 1,486.84 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QRYEILAANAIPK 95.00% 2.48 0.29 0 743.9256 1,485.84 1,486.84 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QRYEILAANAIPK 95.00% 2.8 0.258 2.25 744.4273 1,486.84 1,486.84 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QRYEILAANAIPK 95.00% 2.88 0.285 2.18 744.4278 1,486.84 1,486.84 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EELAEELASSLSGR 95.00% 2.7 0.354 2.68 745.361 1,488.71 1,490.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EELAEELASSLSGR 95.00% 3.29 0.452 5.68 745.8686 1,489.72 1,490.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EELAEELASSLSGR 95.00% 4.14 0.594 8.46 745.8698 1,489.72 1,490.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EELAEELASSLSGR 95.00% 3.62 0.592 4.35 745.8721 1,489.73 1,490.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAKNLTK 95.00% 4.03 0.42 2.14 750.0669 2,247.18 2,247.17 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IRELEGHISDLQEDLDSER 95.00% 5.84 0.551 4.28 752.3732 2,254.10 2,254.10 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IRELEGHISDLQEDLDSER 95.00% 5.77 0.528 3.89 752.3734 2,254.10 2,254.10 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IRELEGHISDLQEDLDSER 95.00% 5.8 0.503 3.13 752.3753 2,254.10 2,254.10 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% DKTEFSIIHYAGK 95.00% 1.34 0.57 0 754.3684 1,506.72 1,508.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 4.87 0.428 4.1 764.9397 1,527.86 1,528.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 5.4 0.392 4.4 764.9398 1,527.86 1,528.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 5.72 0.369 5.62 764.9406 1,527.87 1,528.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 5.53 0.391 4.64 764.9417 1,527.87 1,528.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 5.03 0.457 3.8 764.9423 1,527.87 1,528.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 4.91 0.413 4.28 765.4418 1,528.87 1,528.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KKLEAQVQELQSK 95.00% 4.98 0.402 4.74 765.4443 1,528.87 1,528.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 5.7 0.504 3.28 768.7294 2,303.16 2,303.17 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 4.95 0.523 4.43 768.7315 2,303.17 2,303.17 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 5.91 0.552 4.64 768.7317 2,303.17 2,303.17 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 5.29 0.517 3.06 768.7317 2,303.17 2,303.17 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 5.51 0.586 3.6 768.7321 2,303.17 2,303.17 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 5.07 0.454 2.57 768.7322 2,303.17 2,303.17 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 4.7 0.498 3.1 768.7325 2,303.17 2,303.17 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 5.19 0.514 4.82 768.7325 2,303.17 2,303.17 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 5.46 0.535 5.21 768.7325 2,303.17 2,303.17 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 5.29 0.501 4.1 768.7331 2,303.18 2,303.17 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 4.73 0.535 2.42 768.7353 2,303.18 2,303.17 3
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 3.79 0.422 3.82 771.892 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 5.05 0.403 3.72 771.893 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 5.02 0.451 2.85 771.8935 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 5.11 0.386 4 771.8936 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.97 0.421 3.44 771.8938 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.93 0.43 3.38 771.8943 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.75 0.414 2.96 771.8943 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.96 0.457 2.39 771.8943 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 5.08 0.389 3.33 771.8944 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 5.02 0.399 3.59 771.8944 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.82 0.424 3.49 771.8946 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.95 0.403 2.92 771.8947 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.69 0.405 4.57 771.895 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.33 0.45 2.96 771.895 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.47 0.412 3.85 771.8951 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.73 0.424 4.62 771.8952 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.66 0.417 3.89 771.8955 1,541.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.36 0.353 3.96 771.8959 1,541.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.97 0.424 2.96 771.896 1,541.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.19 0.462 2.66 771.8966 1,541.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.9 0.387 3.15 772.3975 1,542.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.67 0.387 2.8 772.3979 1,542.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAR 95.00% 4.65 0.374 3.52 772.3984 1,542.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELDEATESNEAMGR 95.00% 4.2 0.566 3.96 776.3364 1,550.66 1,551.66 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELDEATESNEAMGR 95.00% 3.29 0.541 5.31 776.3379 1,550.66 1,551.66 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELDEATESNEAMGR 95.00% 4.33 0.543 4 776.3391 1,550.66 1,551.66 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EDQSILcTGESGAGK 95.00% 2.94 0.23 0 c7: Carbamidomethyl (+57.02) 776.3536 1,550.69 1,551.70 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EDQSILcTGESGAGK 95.00% 3.4 0.38 0 c7: Carbamidomethyl (+57.02) 776.3564 1,550.70 1,551.70 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELDEATESNEAMGR 95.00% 4.64 0.531 4.22 776.838 1,551.66 1,551.66 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% EDQSILcTGESGAGK 95.00% 2.47 0.299 0 c7: Carbamidomethyl (+57.02) 776.8557 1,551.70 1,551.70 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 4.15 0.609 3.43 c12: Carbamidomethyl (+57.02) 778.3761 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 4.65 0.637 3.21 c12: Carbamidomethyl (+57.02) 778.3781 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 4.14 0.548 4.77 c12: Carbamidomethyl (+57.02) 778.3783 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 3.69 0.567 4.29 c12: Carbamidomethyl (+57.02) 778.3784 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 4.21 0.542 3.92 c12: Carbamidomethyl (+57.02) 778.3785 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 3.78 0.545 4.6 c12: Carbamidomethyl (+57.02) 778.3791 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 3.74 0.509 2.96 c12: Carbamidomethyl (+57.02) 778.3799 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 4.28 0.595 5.05 c12: Carbamidomethyl (+57.02) 778.38 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVIMAFQAMcR 95.00% 3.81 0.491 2.8 c12: Carbamidomethyl (+57.02) 778.8805 1,555.75 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELDEATESNEAmGR 95.00% 3.53 0.436 6.54 m12: Oxidation (+15.99) 784.3387 1,566.66 1,567.65 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVImAFQAMcR 95.00% 1.99 0.243 2.25 m6: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 786.374 1,570.73 1,571.74 2 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVImAFQAMcR 95.00% 3.07 0.545 4.6 m6: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 786.3745 1,570.73 1,571.74 2 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ITDVImAFQAMcR 95.00% 3.78 0.566 4.19 m6: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 786.3761 1,570.74 1,571.74 2 AGRIN_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSKK 95.00% 4.1 0.538 6.66 792.4426 1,582.87 1,583.88 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSKK 95.00% 3.02 0.539 3.39 792.4434 1,582.87 1,583.88 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HISTLNIQLSDSKK 95.00% 3.78 0.564 3.32 792.9422 1,583.87 1,583.88 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 5.2 0.546 3 794.9588 1,587.90 1,588.91 2 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% SGKLDAFLVLEQLR 95.00% 5.04 0.53 1.85 795.4616 1,588.91 1,588.91 2 SPTA2_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 4.58 0.529 3.72 796.39 1,590.76 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 5.27 0.547 5.51 796.3906 1,590.77 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 5.06 0.535 4.77 796.391 1,590.77 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 4.95 0.518 3.7 796.3913 1,590.77 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 5.05 0.538 4.32 796.3921 1,590.77 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 3.66 0.548 2.59 796.3923 1,590.77 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 5.42 0.552 4.85 796.3925 1,590.77 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 5.12 0.554 6.07 796.3925 1,590.77 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 5.25 0.546 5.09 796.3927 1,590.77 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 5.42 0.544 4.19 796.3929 1,590.77 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 4.72 0.541 3.77 796.3938 1,590.77 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 4.28 0.467 3.08 796.3957 1,590.78 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 4.6 0.548 3.21 796.8937 1,591.77 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEK 95.00% 4.65 0.525 4.2 796.8948 1,591.77 1,591.77 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSKDDVGK 95.00% 4.14 0.391 3.06 811.8841 1,621.75 1,622.76 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSKDDVGK 95.00% 3.98 0.395 4.15 811.8841 1,621.75 1,622.76 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSKDDVGK 95.00% 3.89 0.437 3.46 811.8853 1,621.76 1,622.76 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% AEMEDLVSSKDDVGK 95.00% 3.54 0.417 3.22 811.8865 1,621.76 1,622.76 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.8 0.441 2.62 815.4219 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.96 0.423 3.14 815.4219 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.5 0.42 2.52 815.4221 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.68 0.436 1.82 815.4222 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 5.17 0.407 3 815.4222 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.96 0.405 2.47 815.4224 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.98 0.396 2.12 815.4225 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.78 0.411 2.59 815.4228 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.71 0.428 2.2 815.423 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.55 0.413 2.82 815.4231 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.59 0.402 2.59 815.4236 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.85 0.451 5.24 815.4237 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 3.47 0.419 2.6 815.4239 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.3 0.406 1.8 815.424 1,628.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.66 0.424 3.41 815.4265 1,628.84 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.37 0.435 2.7 815.9233 1,629.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.95 0.421 2.89 815.9234 1,629.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 5.03 0.416 2.38 815.925 1,629.83 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ALEEALEAKEELER 95.00% 4.67 0.415 2.1 815.9265 1,629.84 1,629.83 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VVSSVLQLGNIVFKK 95.00% 4.31 0.477 2.7 816.0003 1,629.99 1,630.99 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VVSSVLQLGNIVFKK 95.00% 3.98 0.439 2.14 816.0013 1,629.99 1,630.99 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VVSSVLQLGNIVFKK 95.00% 4.15 0.475 3.05 816.0021 1,629.99 1,630.99 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VVSSVLQLGNIVFKK 95.00% 3.68 0.463 0 816.0022 1,629.99 1,630.99 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NFINSPVAQADWAAK 95.00% 4.29 0.466 3.52 816.4223 1,630.83 1,631.82 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VVSSVLQLGNIVFKK 95.00% 3.66 0.457 2.59 816.5019 1,630.99 1,630.99 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VVSSVLQLGNIVFKK 95.00% 3.88 0.463 2.47 816.5024 1,630.99 1,630.99 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% VVSSVLQLGNIVFKK 95.00% 4.19 0.468 2.24 816.5032 1,630.99 1,630.99 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NFINSPVAQADWAAK 95.00% 4.56 0.491 3 816.9184 1,631.82 1,631.82 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NFINSPVAQADWAAK 95.00% 4.35 0.502 2.18 816.919 1,631.82 1,631.82 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 5.15 0.522 5.7 818.9077 1,635.80 1,636.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 5.08 0.454 5.1 818.9082 1,635.80 1,636.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.73 0.497 7.38 818.9086 1,635.80 1,636.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.56 0.541 5.29 818.9087 1,635.80 1,636.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.7 0.556 5.33 818.9088 1,635.80 1,636.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.87 0.467 5.82 818.909 1,635.80 1,636.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.56 0.488 7.13 818.9092 1,635.80 1,636.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.17 0.467 4.77 818.9099 1,635.80 1,636.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 5.01 0.491 5.24 818.911 1,635.81 1,636.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 3.65 0.511 5.17 818.9115 1,635.81 1,636.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 4.71 0.512 5.7 818.9118 1,635.81 1,636.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGK 95.00% 5.09 0.474 4.6 819.4102 1,636.80 1,636.81 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEMEAK 95.00% 4.54 0.524 5.89 825.372 1,648.73 1,649.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEMEAK 95.00% 4.24 0.51 4.49 825.3723 1,648.73 1,649.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEMEAK 95.00% 4.34 0.443 4.39 825.3733 1,648.73 1,649.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEMEAK 95.00% 4.6 0.463 4.77 825.872 1,649.73 1,649.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEMEAK 95.00% 4.54 0.448 4.42 825.8736 1,649.73 1,649.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEMEAK 95.00% 4.48 0.443 5.57 825.8744 1,649.73 1,649.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEmEAK 95.00% 4.41 0.573 5.11 m11: Oxidation (+15.99) 833.369 1,664.72 1,665.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEmEAK 95.00% 4.31 0.558 5.47 m11: Oxidation (+15.99) 833.3694 1,664.72 1,665.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEmEAK 95.00% 4.41 0.567 5.89 m11: Oxidation (+15.99) 833.3694 1,664.72 1,665.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEmEAK 95.00% 4.14 0.571 5.48 m11: Oxidation (+15.99) 833.3695 1,664.72 1,665.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEmEAK 95.00% 4.81 0.592 6.15 m11: Oxidation (+15.99) 833.3716 1,664.73 1,665.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEmEAK 95.00% 4.33 0.556 4.92 m11: Oxidation (+15.99) 833.8682 1,665.72 1,665.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEmEAK 95.00% 4.33 0.529 6.11 m11: Oxidation (+15.99) 833.8697 1,665.72 1,665.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% NSLQDQLDEEmEAK 95.00% 4.15 0.531 4.82 m11: Oxidation (+15.99) 833.8718 1,665.73 1,665.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% qTLEKENADLAGELR 95.00% 0 0 3.44 n-term: Pyro-cmC (-17.03) 835.4272 1,668.84 1,669.84 2 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% qLHEYETELEDER 95.00% 0 0 5.41 n-term: Pyro-cmC (-17.03) 837.0382 1,672.06 1,673.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% qLHEYETELEDER 95.00% 0 0 3.7 n-term: Pyro-cmC (-17.03) 837.3676 1,672.72 1,673.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% qLHEYETELEDER 95.00% 0 0 4.42 n-term: Pyro-cmC (-17.03) 837.3695 1,672.72 1,673.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% qLHEYETELEDER 95.00% 0 0 3.8 n-term: Pyro-cmC (-17.03) 837.3695 1,672.72 1,673.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% qLHEYETELEDER 95.00% 0 0 3.89 n-term: Pyro-cmC (-17.03) 837.8714 1,673.73 1,673.73 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 3.32 0.494 3.06 843.9392 1,685.86 1,686.87 2 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 3.33 0.485 2.11 843.9405 1,685.87 1,686.87 2 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 3.38 0.496 3.37 843.941 1,685.87 1,686.87 2 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 3.44 0.495 1.66 843.9414 1,685.87 1,686.87 2 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 3.54 0.465 2.17 844.4373 1,686.86 1,686.87 2 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QTLEKENADLAGELR 95.00% 3.47 0.431 1.46 844.445 1,686.87 1,686.87 2 CO3_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDER 95.00% 3.35 0.45 3.89 845.8844 1,689.75 1,690.76 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDER 95.00% 3.27 0.415 5.96 845.8848 1,689.75 1,690.76 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDER 95.00% 3.21 0.337 3.44 845.8849 1,689.75 1,690.76 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDER 95.00% 3.45 0.428 2.37 845.8857 1,689.76 1,690.76 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLHEYETELEDER 95.00% 3.5 0.356 6.66 846.3874 1,690.76 1,690.76 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ASRDEIFATAKENEK 95.00% 4.2 0.438 5.05 855.4327 1,708.85 1,708.85 2 VINC_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ASRDEIFATAKENEK 95.00% 4.97 0.46 2.7 855.4336 1,708.85 1,708.85 2 VINC_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ASRDEIFATAKENEK 95.00% 4.68 0.452 3.62 855.4356 1,708.86 1,708.85 2 VINC_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QEEEMQAKEDELQK 95.00% 4.15 0.304 3 867.3795 1,732.74 1,734.79 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QEEEMQAKEDELQK 95.00% 3.74 0.309 2.14 867.3854 1,732.76 1,734.79 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QEEEMQAKEDELQK 95.00% 4.03 0.29 2.03 867.3857 1,732.76 1,734.79 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QEEEmQAKEDELQK 95.00% 2.39 0.168 1.42 m5: Oxidation (+15.99) 875.8993 1,749.78 1,750.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QEEEmQAKEDELQK 95.00% 3.6 0.192 2.27 m5: Oxidation (+15.99) 875.9015 1,749.79 1,750.78 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 4.8 0.408 2.74 877.9431 1,753.87 1,754.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 4.33 0.423 3.07 877.944 1,753.87 1,754.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQELEEILHEMEAR 95.00% 5.38 0.477 3.57 878.446 1,754.88 1,754.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGK 95.00% 5.55 0.557 6.28 882.9546 1,763.89 1,764.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGK 95.00% 5.74 0.589 6.59 882.9552 1,763.89 1,764.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGK 95.00% 5.65 0.576 6.39 882.9557 1,763.90 1,764.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGK 95.00% 5.52 0.593 5.09 882.9558 1,763.90 1,764.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKK 95.00% 4.5 0.524 7.4 882.9558 1,763.90 1,764.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGK 95.00% 5.72 0.565 6.7 882.9566 1,763.90 1,764.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGK 95.00% 5.66 0.597 5.96 882.9566 1,763.90 1,764.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGK 95.00% 5.19 0.589 5.92 882.9568 1,763.90 1,764.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGK 95.00% 3.37 0.57 4.92 882.9571 1,763.90 1,764.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGK 95.00% 5.69 0.577 6 882.9574 1,763.90 1,764.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGK 95.00% 5.86 0.566 5.96 883.4554 1,764.90 1,764.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLQDFASTVEALEEGK 95.00% 5.6 0.588 6.04 883.4578 1,764.90 1,764.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 4.14 0.592 6.01 894.9391 1,787.86 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 4.12 0.547 5.02 894.9411 1,787.87 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 5.45 0.594 5.37 894.9418 1,787.87 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 5.52 0.649 5.92 894.9419 1,787.87 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 5.52 0.641 6.35 894.9424 1,787.87 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 5.52 0.617 5.54 894.9426 1,787.87 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 5.42 0.635 5.8 894.9427 1,787.87 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 5.49 0.618 5.31 894.9427 1,787.87 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 5.48 0.646 5.43 894.9428 1,787.87 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 5.47 0.624 5.54 894.9431 1,787.87 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 5.61 0.613 5.54 895.4413 1,788.87 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 5.53 0.642 7.85 895.4438 1,788.87 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ATQQAEQLSNELATER 95.00% 5.74 0.636 6 895.4442 1,788.87 1,788.87 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 4.92 0.573 5.43 895.9558 1,789.90 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 4.67 0.563 3.59 895.9558 1,789.90 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 4.85 0.584 4.82 895.9562 1,789.90 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 4.84 0.595 4.92 895.9567 1,789.90 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 4.74 0.581 4.74 895.9574 1,789.90 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 4.14 0.512 2.85 895.9575 1,789.90 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 4.73 0.566 4.32 895.9582 1,789.90 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 3.56 0.371 0 895.9684 1,789.92 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 4.91 0.548 3.35 896.4589 1,790.90 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 4.6 0.572 4.8 896.4592 1,790.90 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 4.96 0.553 3.32 896.46 1,790.90 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 4.5 0.515 2.66 896.4601 1,790.90 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ISDLTTNLAEEEEKAK 95.00% 4.36 0.488 3.25 896.4601 1,790.90 1,790.90 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAREK 95.00% 4.94 0.526 3.8 900.4616 1,798.91 1,799.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAREK 95.00% 4.59 0.529 3.77 900.4637 1,798.91 1,799.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAREK 95.00% 4.97 0.442 4.29 900.4637 1,798.91 1,799.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAREK 95.00% 4.88 0.525 3.12 900.464 1,798.91 1,799.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAREK 95.00% 4.87 0.442 4.19 900.4648 1,798.91 1,799.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAREK 95.00% 4.99 0.43 2.62 900.962 1,799.91 1,799.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IAQLEEQVEQEAREK 95.00% 4.79 0.426 2.51 900.9641 1,799.91 1,799.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEDEILVMDDQNNK 95.00% 4.68 0.511 2.47 902.4442 1,802.87 1,803.88 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEDEILVMDDQNNK 95.00% 4.89 0.526 2.64 902.946 1,803.88 1,803.88 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEDEILVMDDQNNK 95.00% 5.12 0.528 2.19 902.9461 1,803.88 1,803.88 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEEEEDRGQQLQAER 95.00% 3.05 0.196 0 915.9405 1,829.87 1,829.86 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEEEEDRGQQLQAER 95.00% 3.15 0.158 1.23 915.9431 1,829.87 1,829.86 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEGDLKDLELQADSAIK 95.00% 4.99 0.592 6.34 929.9972 1,857.98 1,857.98 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEGDLKDLELQADSAIK 95.00% 5.47 0.549 6.24 929.9982 1,857.98 1,857.98 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEGDLKDLELQADSAIK 95.00% 4.97 0.546 5.57 929.9984 1,857.98 1,857.98 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LEGDLKDLELQADSAIK 95.00% 5.35 0.553 5.72 930.0015 1,857.99 1,857.98 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFK 95.00% 5.87 0.617 7.18 950.4781 1,898.94 1,899.95 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.44 0.609 4.22 956.9851 1,911.95 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.52 0.601 3.96 956.9856 1,911.96 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.79 0.619 3.6 956.9861 1,911.96 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.73 0.649 4.92 956.9862 1,911.96 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.03 0.652 4.38 956.9885 1,911.96 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.78 0.578 5.24 957.4854 1,912.96 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.65 0.582 5.62 957.4864 1,912.96 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.84 0.6 5.55 957.4867 1,912.96 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.77 0.595 3.8 957.4872 1,912.96 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.67 0.578 4.89 957.4872 1,912.96 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.96 0.596 5.55 957.4874 1,912.96 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 5.63 0.608 4.32 957.4883 1,912.96 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQQELDDLVVDLDNQR 95.00% 4.76 0.563 2.82 957.4884 1,912.96 1,912.96 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QLEEAEEESQRINANR 95.00% 2.42 0.311 0 958.4604 1,914.91 1,915.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 6.1 0.632 7.57 958.9886 1,915.96 1,916.97 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 3.97 0.507 2.49 958.9889 1,915.96 1,916.97 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.53 0.574 4.92 958.9893 1,915.96 1,916.97 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.82 0.655 7.72 958.9893 1,915.96 1,916.97 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.97 0.643 7.1 958.9894 1,915.96 1,916.97 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.96 0.623 8.55 958.9901 1,915.96 1,916.97 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.44 0.594 3.23 958.9904 1,915.97 1,916.97 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.5 0.637 6.46 959.4893 1,916.96 1,916.97 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.83 0.659 7.08 959.49 1,916.96 1,916.97 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.83 0.614 6.28 959.4916 1,916.97 1,916.97 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.84 0.627 6.26 959.4917 1,916.97 1,916.97 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KATQQAEQLSNELATER 95.00% 5.99 0.613 6.85 959.4919 1,916.97 1,916.97 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQDFASTVEALEEGKKR 95.00% 4.91 0.533 5.21 961.5074 1,921.00 1,921.00 2 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% FQKEIENLTQQYEEK 95.00% 4.92 0.471 5.62 963.9793 1,925.94 1,926.95 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% FQKEIENLTQQYEEK 95.00% 5.03 0.393 8.96 963.9828 1,925.95 1,926.95 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% FQKEIENLTQQYEEK 95.00% 4.48 0.408 5 964.4785 1,926.94 1,926.95 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% FQKEIENLTQQYEEK 95.00% 5.02 0.358 4.8 964.4814 1,926.95 1,926.95 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 5.7 0.587 7.36 974.471 1,946.93 1,947.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 6.12 0.635 8.21 974.4719 1,946.93 1,947.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 6.19 0.644 8.19 974.472 1,946.93 1,947.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 5.59 0.681 6.64 974.4721 1,946.93 1,947.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 5.88 0.676 7.48 974.4724 1,946.93 1,947.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 5.91 0.671 9.57 974.4725 1,946.93 1,947.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 5.36 0.667 8.34 974.4727 1,946.93 1,947.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 2.46 0.439 5.66 974.9707 1,947.93 1,947.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 5.87 0.625 8.49 974.9726 1,947.93 1,947.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 5.85 0.619 8.74 974.9727 1,947.93 1,947.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGMLNEAEGK 95.00% 6.38 0.623 9.77 974.974 1,947.93 1,947.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TELEDTLDSTATQQELR 95.00% 5.36 0.558 6.37 975.4699 1,948.92 1,949.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TELEDTLDSTATQQELR 95.00% 5.51 0.503 5.25 975.9726 1,949.93 1,949.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TELEDTLDSTATQQELR 95.00% 4.93 0.449 4.6 975.9738 1,949.93 1,949.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TELEDTLDSTATQQELR 95.00% 5.79 0.5 5.92 975.9741 1,949.93 1,949.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TELEDTLDSTATQQELR 95.00% 5.26 0.388 3.8 975.9746 1,949.93 1,949.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TQLEELEDELQATEDAK 95.00% 6.64 0.646 7.3 981.4644 1,960.91 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TQLEELEDELQATEDAK 95.00% 7.23 0.65 6.68 981.4644 1,960.91 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TQLEELEDELQATEDAK 95.00% 6.83 0.646 5.3 981.465 1,960.91 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TQLEELEDELQATEDAK 95.00% 6.84 0.64 7.27 981.4652 1,960.91 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% TQLEELEDELQATEDAK 95.00% 6.72 0.628 8.09 981.9659 1,961.92 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 5.51 0.649 6.62 m11: Oxidation (+15.99) 982.4666 1,962.92 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 6 0.617 9.23 m11: Oxidation (+15.99) 982.4684 1,962.92 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 6.1 0.657 7.89 m11: Oxidation (+15.99) 982.4695 1,962.92 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 5.7 0.656 8.06 m11: Oxidation (+15.99) 982.4712 1,962.93 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 5.71 0.665 9.7 m11: Oxidation (+15.99) 982.4712 1,962.93 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 4.67 0.642 1.92 m11: Oxidation (+15.99) 982.472 1,962.93 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 5.31 0.604 6.15 m11: Oxidation (+15.99) 982.9696 1,963.92 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 5.73 0.623 7.36 m11: Oxidation (+15.99) 982.9702 1,963.92 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 5.83 0.635 7.68 m11: Oxidation (+15.99) 982.9704 1,963.93 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 6.01 0.616 6.36 m11: Oxidation (+15.99) 982.9708 1,963.93 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 4.24 0.627 3.57 m11: Oxidation (+15.99) 982.9727 1,963.93 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 6.04 0.629 7.39 m11: Oxidation (+15.99) 982.9727 1,963.93 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% LQNEVESVTGmLNEAEGK 95.00% 5.96 0.634 7.12 m11: Oxidation (+15.99) 982.9735 1,963.93 1,963.93 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.58 0.528 3.55 992.959 1,983.90 1,984.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.37 0.543 4.39 992.9596 1,983.90 1,984.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 3.94 0.516 3.34 992.9614 1,983.91 1,984.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.78 0.511 3.01 993.4595 1,984.90 1,984.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 5.01 0.529 2.96 993.4603 1,984.90 1,984.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.85 0.544 2.8 993.4605 1,984.91 1,984.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 4.89 0.584 2.96 993.4613 1,984.91 1,984.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% ELEGHISDLQEDLDSER 95.00% 3.72 0.514 2.66 993.464 1,984.91 1,984.91 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 5.61 0.57 7 993.5434 1,985.07 1,986.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 5.78 0.589 6.21 994.0429 1,986.07 1,986.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 5.61 0.564 5.28 994.0439 1,986.07 1,986.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 5.83 0.562 6.18 994.0445 1,986.07 1,986.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KLEGDLKDLELQADSAIK 95.00% 5.57 0.539 4.89 994.0451 1,986.07 1,986.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 6.24 0.644 7.72 1,028.53 2,055.05 2,056.05 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 6.35 0.603 6.82 1,029.03 2,056.04 2,056.05 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 6.41 0.635 6.82 1,029.03 2,056.04 2,056.05 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 5.95 0.649 12 1,029.03 2,056.05 2,056.05 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% HAQAVEELTEQLEQFKR 95.00% 6.34 0.616 6.77 1,029.03 2,056.05 2,056.05 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% qADLEKEELAEELASSLSGR 95.00% 0 0 5.62 n-term: Pyro-cmC (-17.03) 1,080.03 2,158.05 2,158.05 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% qADLEKEELAEELASSLSGR 95.00% 0 0 7.89 n-term: Pyro-cmC (-17.03) 1,080.03 2,158.05 2,158.05 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% qADLEKEELAEELASSLSGR 95.00% 0 0 6.72 n-term: Pyro-cmC (-17.03) 1,080.03 2,158.05 2,158.05 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% qADLEKEELAEELASSLSGR 95.00% 0 0 6.62 n-term: Pyro-cmC (-17.03) 1,080.03 2,158.05 2,158.05 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% qADLEKEELAEELASSLSGR 95.00% 0 0 5.82 n-term: Pyro-cmC (-17.03) 1,080.03 2,158.05 2,158.05 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% qADLEKEELAEELASSLSGR 95.00% 0 0 6.41 n-term: Pyro-cmC (-17.03) 1,080.03 2,158.05 2,158.05 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 5.4 0.611 5.35 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 5.61 0.613 5.64 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 5.2 0.604 4.7 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 5.61 0.618 4.85 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 5.35 0.625 4.26 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 5.36 0.623 5.09 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 5.46 0.579 5.09 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 5.59 0.622 5.17 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% QADLEKEELAEELASSLSGR 95.00% 5.56 0.6 5.47 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IRELEGHISDLQEDLDSER 95.00% 6.03 0.6 5.44 1,128.05 2,254.09 2,254.10 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IRELEGHISDLQEDLDSER 95.00% 6.04 0.623 5.15 1,128.05 2,254.09 2,254.10 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% IRELEGHISDLQEDLDSER 95.00% 5.98 0.613 5.27 1,128.06 2,254.09 2,254.10 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% MAQQMLDLEEQLEEEEAAR 95.00% 5.07 0.517 3.77 1,132.52 2,263.03 2,263.02 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 6.65 0.588 11 1,152.59 2,303.17 2,303.17 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 6.52 0.6 11.2 1,152.59 2,303.17 2,303.17 2
 SAMPLE 4 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 98 137 1002 44.10% KQADLEKEELAEELASSLSGR 95.00% 6.16 0.58 9.21 1,152.59 2,303.17 2,303.17 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 3.57 0.182 0 467.5971 1,399.77 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 3.66 0.271 1.55 467.598 1,399.77 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 3.52 0.245 1.39 467.5982 1,399.77 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 3.36 0.138 1.19 467.5982 1,399.77 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.38 0.259 1.03 467.5986 1,399.77 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.04 0.262 2.51 467.5988 1,399.77 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.61 0.27 1.29 467.5989 1,399.77 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.19 0.241 0 467.599 1,399.77 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.02 0.221 0 467.5992 1,399.77 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 3.9 0.372 0.959 467.5992 1,399.77 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.18 0.342 1.11 467.5996 1,399.78 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 3.09 0.172 1.66 467.5996 1,399.78 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.02 0.223 1.52 467.5999 1,399.78 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 2.67 0.254 0 467.7442 1,400.21 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 2.24 0.236 0 467.7451 1,400.21 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.47 0.26 1.8 467.933 1,400.78 1,400.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.35 0.389 0 469.7596 937.5035 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.42 0.375 0 469.7596 937.5036 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.21 0.394 1.36 469.7599 937.5041 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.2 0.414 1.33 469.76 937.5043 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.99 0.326 1.66 469.7601 937.5045 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.7 0.353 0 469.7601 937.5046 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.59 0.399 0 469.7602 937.5047 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.49 0.38 0 469.7602 937.5048 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.79 0.328 0 469.7602 937.5048 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.21 0.412 2.39 469.7603 937.505 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.56 0.364 0 469.7604 937.5051 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.23 0.412 0 469.7605 937.5054 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.67 0.374 0 469.7606 937.5055 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.37 0.38 1.25 469.7607 937.5057 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.57 0.364 0 469.7607 937.5057 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.3 0.422 0 469.761 937.5064 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.74 0.353 0 469.761 937.5064 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVFQEFR 95.00% 2.59 0.384 0 469.7617 937.5077 938.51 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.55 0.415 0 472.2747 1,413.80 1,414.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.38 0.355 0 472.2748 1,413.80 1,414.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 1.93 0.247 0 472.2749 1,413.80 1,414.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.82 0.454 0 472.2751 1,413.80 1,414.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.36 0.338 0 472.2751 1,413.80 1,414.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.81 0.44 1.26 472.2752 1,413.80 1,414.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 3.18 0.414 1.01 472.2756 1,413.80 1,414.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 1.85 0.227 0 472.2758 1,413.80 1,414.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.54 0.324 0 472.2766 1,413.81 1,414.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.3 0.344 0 472.2842 1,413.83 1,414.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.16 0.413 1.08 472.6084 1,414.80 1,414.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.78 0.408 0 472.6085 1,414.80 1,414.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LVWVPSEK 95.00% 2.21 0.347 0 479.2746 956.5335 957.541 2 GLYG_HUMAN,RP1L1_HUMAN,COCA1_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LVWVPSEK 95.00% 1.8 0.196 1.35 479.2765 956.5374 957.541 2 GLYG_HUMAN,RP1L1_HUMAN,COCA1_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 3.08 0.305 2.96 485.9322 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 3.58 0.333 4.54 485.9325 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.05 0.451 3.89 485.9325 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.1 0.424 3.17 485.9326 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.88 0.377 2.59 485.9328 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 2.36 0.139 2.21 485.9332 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.95 0.436 2.51 485.9332 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 3.75 0.402 3.42 485.9336 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 3.94 0.386 3.96 485.9337 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.52 0.479 2.82 485.9338 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.23 0.313 3.28 485.9341 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 3.9 0.476 4.37 485.9341 1,454.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 2.6 0.512 2.4 485.9427 1,454.80 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.31 0.315 3.66 486.2675 1,455.78 1,455.78 3 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAK 95.00% 3.08 0.381 0 487.2648 972.514 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAK 95.00% 3.05 0.344 0 487.265 972.5144 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAK 95.00% 2.34 0.279 0 487.2652 972.5147 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAK 95.00% 2.31 0.302 1.23 487.266 972.5163 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVGLDQMAK 95.00% 2.1 0.269 1.21 487.7708 973.5259 974.5347 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVGLDQMAK 95.00% 2.43 0.271 1.96 487.7709 973.5261 974.5347 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IVGLDQMAK 95.00% 2.36 0.285 0 487.7716 973.5276 974.5347 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 3.86 0.447 0 495.6152 1,483.82 1,484.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 3.6 0.376 0 495.6159 1,483.82 1,484.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 3.87 0.307 1.57 495.6162 1,483.83 1,484.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 4.07 0.39 0 495.6164 1,483.83 1,484.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 4.06 0.357 0 495.6165 1,483.83 1,484.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 3.55 0.404 0 495.6165 1,483.83 1,484.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 4.65 0.429 1.21 495.6166 1,483.83 1,484.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 4.35 0.452 1.43 495.6166 1,483.83 1,484.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 3.82 0.364 0 495.6169 1,483.83 1,484.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 4.45 0.415 0 495.6169 1,483.83 1,484.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 4.23 0.417 1.36 495.9507 1,484.83 1,484.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QRYEILAANAIPK 95.00% 3.37 0.251 0 496.2848 1,485.83 1,486.84 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QRYEILAANAIPK 95.00% 2.37 0.23 1.52 496.2851 1,485.83 1,486.84 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QRYEILAANAIPK 95.00% 2.44 0.21 0 496.2855 1,485.83 1,486.84 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QRYEILAANAIPK 95.00% 3.43 0.336 0 496.2859 1,485.83 1,486.84 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QRYEILAANAIPK 95.00% 3.73 0.381 2.41 496.619 1,486.83 1,486.84 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QRYEILAANAIPK 95.00% 2.65 0.303 2.66 496.6193 1,486.83 1,486.84 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DKTEFSIIHYAGK 95.00% 3.35 0.186 0 503.5966 1,507.77 1,508.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DKTEFSIIHYAGK 95.00% 2.48 0.163 1.11 503.5982 1,507.77 1,508.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DKTEFSIIHYAGK 95.00% 2.62 0.259 0 503.5989 1,507.77 1,508.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DKTEFSIIHYAGK 95.00% 3.69 0.33 1.77 503.5996 1,507.78 1,508.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DKTEFSIIHYAGK 95.00% 2.74 0.228 0 503.9315 1,508.77 1,508.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DKTEFSIIHYAGK 95.00% 3.35 0.247 1.04 503.9319 1,508.77 1,508.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AAAYDKLEK 95.00% 2.4 0.324 0 504.7734 1,007.53 1,008.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AAAYDKLEK 95.00% 2.35 0.297 1.55 504.7738 1,007.53 1,008.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AAAYDKLEK 95.00% 2.13 0.352 0 504.774 1,007.53 1,008.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AAAYDKLEK 95.00% 2.39 0.363 0 504.7746 1,007.53 1,008.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AAAYDKLEK 95.00% 1.99 0.316 0 505.2766 1,008.54 1,008.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% cNGVLEGIR 95.00% 2.26 0.265 0 c1: Carbamidomethyl (+57.02) 509.2621 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 4.43 0.335 0 510.2951 1,527.86 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 3.74 0.295 0 510.2952 1,527.86 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 3.91 0.305 0 510.2956 1,527.86 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 4.51 0.314 1.08 510.2957 1,527.86 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 4.3 0.357 1.57 510.2958 1,527.86 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 3.92 0.41 1.41 510.296 1,527.86 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 4.42 0.328 0 510.2961 1,527.86 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 2.48 0.181 0 510.2962 1,527.87 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 4.1 0.371 1.03 510.2971 1,527.87 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 3.15 0.0758 1.03 510.2971 1,527.87 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 3.45 0.255 0 510.2977 1,527.87 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 3.76 0.316 0 510.6288 1,528.86 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 3.43 0.361 0 510.6289 1,528.86 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 4.01 0.333 0 510.6309 1,528.87 1,528.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 3.68 0.404 0 c12: Carbamidomethyl (+57.02) 519.2531 1,554.74 1,555.74 3 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 4.37 0.46 1.41 c12: Carbamidomethyl (+57.02) 519.2532 1,554.74 1,555.74 3 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 3.98 0.483 1.55 c12: Carbamidomethyl (+57.02) 519.2536 1,554.74 1,555.74 3 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 4.33 0.492 1.06 c12: Carbamidomethyl (+57.02) 519.2537 1,554.74 1,555.74 3 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEVNMQALK 95.00% 2.8 0.216 1.3 523.2899 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEVNMQALK 95.00% 2.82 0.281 0 523.2903 1,044.57 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEVNMQALK 95.00% 2.51 0.283 0 523.2906 1,044.57 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKHESMISELEVR 95.00% 3.25 0.369 0 524.9354 1,571.78 1,571.79 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKHESMISELEVR 95.00% 3.21 0.247 0 524.9363 1,571.79 1,571.79 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VKPLLQVTR 95.00% 1.85 0.286 0 527.3419 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VKPLLQVTR 95.00% 1.82 0.282 0 527.3439 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 4.95 0.583 2.15 528.6308 1,582.87 1,583.88 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 5.4 0.574 1.26 528.631 1,582.87 1,583.88 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 5.62 0.622 1.55 528.6312 1,582.87 1,583.88 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 5.1 0.579 1.66 528.6313 1,582.87 1,583.88 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 3.84 0.541 0 528.6313 1,582.87 1,583.88 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 4.1 0.519 1.43 528.6314 1,582.87 1,583.88 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 5.46 0.548 1.44 528.6315 1,582.87 1,583.88 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 2.76 0.313 0 528.9299 1,583.77 1,583.88 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 3.48 0.411 0 528.9308 1,583.77 1,583.88 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 2.89 0.307 0 528.9319 1,583.77 1,583.88 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 3.32 0.485 0 528.941 1,583.80 1,583.88 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 5.2 0.587 2.23 528.9657 1,583.87 1,583.88 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKHESmISELEVR 95.00% 3.3 0.295 0 m6: Oxidation (+15.99) 529.933 1,586.78 1,587.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKHESmISELEVR 95.00% 3.14 0.285 0 m6: Oxidation (+15.99) 529.9332 1,586.78 1,587.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKHESmISELEVR 95.00% 3.34 0.303 0 m6: Oxidation (+15.99) 529.9341 1,586.78 1,587.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKHESmISELEVR 95.00% 3.4 0.215 0 m6: Oxidation (+15.99) 529.9352 1,586.78 1,587.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKHESmISELEVR 95.00% 3.74 0.357 0 m6: Oxidation (+15.99) 530.266 1,587.77 1,587.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKHESmISELEVR 95.00% 3.31 0.253 0 m6: Oxidation (+15.99) 530.2673 1,587.78 1,587.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 4.19 0.213 0 530.3073 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 4.14 0.216 0 530.3077 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 4.26 0.239 0 530.3077 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 4.04 0.26 1.33 530.3078 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 4.12 0.249 1.62 530.3079 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 3.94 0.242 0 530.3082 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 4.09 0.198 2.85 530.3082 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 3.62 0.166 0 530.3082 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 3.98 0.275 0 530.3084 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 3.93 0.275 0 530.3086 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 3.62 0.205 1.49 530.31 1,587.91 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 4.05 0.204 0 530.6425 1,588.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 4.2 0.238 0 530.6428 1,588.91 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 4.68 0.256 0 530.643 1,588.91 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 4.24 0.218 0 530.6434 1,588.91 1,588.91 3 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TGVLAHLEEERDLK 95.00% 2.39 0.236 0 537.2916 1,608.85 1,609.86 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDERK 95.00% 4.23 0.378 1.17 538.3156 1,611.92 1,612.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AEMEDLVSSKDDVGK 95.00% 2.12 0.343 2 541.5918 1,621.75 1,622.76 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AEMEDLVSSKDDVGK 95.00% 2.42 0.399 1.57 541.592 1,621.75 1,622.76 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AEMEDLVSSKDDVGK 95.00% 1.76 0.349 1.2 541.5925 1,621.75 1,622.76 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AEMEDLVSSKDDVGK 95.00% 2.41 0.355 1.41 541.5925 1,621.75 1,622.76 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QELEEILHEMEAR 95.00% 2.62 0.375 0 542.9325 1,625.77 1,626.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QELEEILHEMEAR 95.00% 2.64 0.348 0 543.2664 1,626.78 1,626.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.34 0.384 2.92 543.9487 1,628.82 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.14 0.33 2.09 543.9497 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.81 0.316 1.96 543.95 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.33 0.421 2.02 543.9503 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.33 0.44 2.68 543.9503 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 2.9 0.353 1.17 543.9503 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.94 0.488 2.42 543.9504 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.05 0.362 2.62 543.9504 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.19 0.475 2.89 543.9505 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.15 0.429 0 543.9505 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.73 0.335 2.1 543.9506 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.86 0.393 2.08 543.9507 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.47 0.431 3.74 543.9508 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.95 0.455 3.82 543.9509 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.46 0.324 2.02 543.951 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.63 0.354 1.16 543.951 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.66 0.352 2.17 543.9512 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.98 0.455 2.64 543.9514 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.55 0.38 2.29 543.9515 1,628.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ENADLAGELR 95.00% 2.45 0.215 0 544.2727 1,086.53 1,087.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ENADLAGELR 95.00% 2.49 0.295 0 544.2729 1,086.53 1,087.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ENADLAGELR 95.00% 2.37 0.29 0 544.273 1,086.53 1,087.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ENADLAGELR 95.00% 2.48 0.234 0 544.2732 1,086.53 1,087.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 3.84 0.448 2.37 544.2852 1,629.83 1,629.83 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.19 0.446 3.46 546.274 1,635.80 1,636.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.19 0.428 3.11 546.2747 1,635.80 1,636.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.43 0.442 4.26 546.2748 1,635.80 1,636.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.73 0.503 3.14 546.2748 1,635.80 1,636.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.32 0.459 3.82 546.275 1,635.80 1,636.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 3.88 0.467 3.39 546.2753 1,635.80 1,636.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.38 0.46 2.77 546.2755 1,635.80 1,636.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 3.59 0.42 2.74 546.2758 1,635.80 1,636.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 3.78 0.43 2.28 546.6097 1,636.81 1,636.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.42 0.42 4.24 546.6101 1,636.81 1,636.81 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DTSITGELEK 95.00% 2.15 0.245 0 546.775 1,091.53 1,092.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DTSITGELEK 95.00% 2.13 0.232 0 546.7751 1,091.53 1,092.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% FDQLLAEEK 95.00% 3.03 0.422 0 546.7832 1,091.55 1,092.56 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% FDQLLAEEK 95.00% 3.09 0.406 0 546.7832 1,091.55 1,092.56 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% FDQLLAEEK 95.00% 3.06 0.395 0 546.7837 1,091.55 1,092.56 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% FDQLLAEEK 95.00% 3.03 0.362 1.31 546.7844 1,091.55 1,092.56 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QGFPNRIVFQEFR 95.00% 2.49 0.325 0 546.9593 1,637.85 1,637.86 3 MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% GNETSFVPSR 95.00% 2.77 0.404 1.4 547.2704 1,092.53 1,093.53 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% FDQLLAEEK 95.00% 2.63 0.212 0 547.2851 1,092.55 1,092.56 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AEMEDLVSSK 95.00% 1.92 0.284 0 554.7636 1,107.51 1,108.52 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AEMEDLVSSK 95.00% 2.31 0.408 0 554.7646 1,107.51 1,108.52 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AEMEDLVSSK 95.00% 2.46 0.39 0 554.7648 1,107.51 1,108.52 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AEMEDLVSSK 95.00% 2.24 0.269 1.96 554.7649 1,107.51 1,108.52 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 2.41 0.416 0 562.9604 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 3.12 0.417 0 562.9613 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 2.13 0.31 0 562.9614 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 3.09 0.47 0 562.9616 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 2.87 0.357 0 562.9617 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 3.07 0.351 0 562.9617 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 2.37 0.26 0 562.962 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 1.82 0.24 0 562.962 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 2.72 0.448 0 562.962 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 2.54 0.453 0 562.9623 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 3.27 0.392 1.8 563.296 1,686.86 1,686.87 3 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 2.81 0.321 0 563.2965 1,686.87 1,686.87 3 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 3.64 0.42 2.49 564.2552 1,689.74 1,690.76 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 3.44 0.435 1.92 564.258 1,689.75 1,690.76 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 3.71 0.465 0 564.2581 1,689.75 1,690.76 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 3.91 0.431 0 564.2581 1,689.75 1,690.76 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 4.18 0.386 0 564.2584 1,689.75 1,690.76 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 4.21 0.422 0 564.2584 1,689.75 1,690.76 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 4 0.427 1.39 564.2594 1,689.75 1,690.76 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 4.19 0.429 0 564.5931 1,690.76 1,690.76 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% MTESSLPSASK 95.00% 2.49 0.429 2.26 569.7781 1,137.54 1,137.55 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ASRDEIFATAKENEK 95.00% 3.65 0.306 2.17 570.2879 1,707.84 1,708.85 3 VINC_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ASRDEIFATAKENEK 95.00% 4.02 0.388 2.34 570.2891 1,707.84 1,708.85 3 VINC_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ASRDEIFATAKENEK 95.00% 3.93 0.383 2.16 570.29 1,707.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ASRDEIFATAKENEK 95.00% 4.35 0.386 2.24 570.2903 1,707.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ASRDEIFATAKENEK 95.00% 4.03 0.396 1.08 570.2904 1,707.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ASRDEIFATAKENEK 95.00% 3.71 0.245 2.06 570.2913 1,707.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ASRDEIFATAKENEK 95.00% 4.1 0.361 2.36 570.6236 1,708.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ASRDEIFATAKENEK 95.00% 3.56 0.31 1.92 570.6245 1,708.85 1,708.85 3 VINC_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 3.47 0.368 2.64 576.322 1,725.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 2.95 0.293 1.8 576.3222 1,725.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 3.45 0.445 1.31 576.3227 1,725.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 3.95 0.483 1.31 576.3231 1,725.95 1,726.95 3 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.07 0.499 5.37 576.3233 1,725.95 1,726.95 3 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 3.46 0.413 0 576.3234 1,725.95 1,726.95 3 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 3.67 0.337 1.01 576.6582 1,726.95 1,726.95 3 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 3.28 0.354 1.4 576.6586 1,726.95 1,726.95 3 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.76 0.407 2.29 576.6602 1,726.96 1,726.95 3 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.69 0.248 2.08 m1: Oxidation (+15.99) 577.2746 1,152.53 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.51 0.35 0 m1: Oxidation (+15.99) 577.275 1,152.53 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.59 0.301 1.46 m1: Oxidation (+15.99) 577.2752 1,152.53 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.85 0.453 3.51 m1: Oxidation (+15.99) 577.2753 1,152.53 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.56 0.385 1.44 m1: Oxidation (+15.99) 577.2762 1,152.54 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.24 0.399 1.51 m1: Oxidation (+15.99) 577.2769 1,152.54 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.61 0.341 1.85 m1: Oxidation (+15.99) 577.2771 1,152.54 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.65 0.369 1.96 m1: Oxidation (+15.99) 577.2777 1,152.54 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 1.93 0.331 0 m1: Oxidation (+15.99) 577.2779 1,152.54 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.16 0.366 0 m1: Oxidation (+15.99) 577.2782 1,152.54 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.44 0.408 2.24 m1: Oxidation (+15.99) 577.2787 1,152.54 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.15 0.337 1.48 m1: Oxidation (+15.99) 577.2791 1,152.54 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.53 0.345 2.4 m1: Oxidation (+15.99) 577.2796 1,152.54 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.46 0.414 3.27 m1: Oxidation (+15.99) 577.2801 1,152.54 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.09 0.322 0 m1: Oxidation (+15.99) 577.2805 1,152.55 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.81 0.291 0 m1: Oxidation (+15.99) 577.7762 1,153.54 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% mTESSLPSASK 95.00% 2.2 0.329 1.3 m1: Oxidation (+15.99) 577.7785 1,153.54 1,153.54 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEKNISSK 95.00% 3.81 0.431 2.28 583.9856 1,748.93 1,749.94 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEKNISSK 95.00% 4.39 0.416 3 584.3206 1,749.94 1,749.94 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QEEEmQAKEDELQK 95.00% 2.85 0.178 0 m5: Oxidation (+15.99) 584.6011 1,750.78 1,750.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QEEEmQAKEDELQK 95.00% 2.51 0.28 0 m5: Oxidation (+15.99) 584.6013 1,750.78 1,750.78 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 4.24 0.441 2.59 585.6307 1,753.87 1,754.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 4.2 0.458 2.34 585.6311 1,753.87 1,754.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 4.59 0.436 3.15 585.6312 1,753.87 1,754.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 3.93 0.407 2.92 585.6313 1,753.87 1,754.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 4.69 0.438 2.28 585.6314 1,753.87 1,754.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 4.33 0.43 2.92 585.6314 1,753.87 1,754.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 4.53 0.373 1.92 585.6315 1,753.87 1,754.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 4.92 0.432 3.09 585.6424 1,753.90 1,754.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 3.53 0.271 2.39 585.9653 1,754.87 1,754.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 3.84 0.375 1.48 585.9658 1,754.87 1,754.87 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 4.17 0.359 1.57 588.9739 1,763.90 1,764.90 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 4.35 0.357 1.41 588.9854 1,763.93 1,764.90 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 3.77 0.393 1.92 589.3079 1,764.90 1,764.90 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 4.62 0.361 2.29 589.308 1,764.90 1,764.90 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 4.85 0.319 2.64 589.3082 1,764.90 1,764.90 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 2.46 0.243 0 597.64 1,789.90 1,790.90 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 2.2 0.228 1.74 597.6401 1,789.90 1,790.90 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 2.92 0.198 1.64 597.6406 1,789.90 1,790.90 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 2.54 0.186 1.89 597.6412 1,789.90 1,790.90 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 2.98 0.196 0 597.9741 1,790.90 1,790.90 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAREK 95.00% 2.93 0.43 1.6 600.6436 1,798.91 1,799.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAREK 95.00% 2.73 0.364 1.19 600.6448 1,798.91 1,799.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAREK 95.00% 2.57 0.207 0 600.6448 1,798.91 1,799.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAREK 95.00% 3.06 0.358 0 600.645 1,798.91 1,799.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DLELQADSAIK 95.00% 2.52 0.301 1.62 601.818 1,201.62 1,202.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DLELQADSAIK 95.00% 2.6 0.279 0 601.8181 1,201.62 1,202.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DLELQADSAIK 95.00% 2.56 0.245 0 601.8182 1,201.62 1,202.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DLELQADSAIK 95.00% 2.74 0.345 2.38 601.8185 1,201.62 1,202.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DLELQADSAIK 95.00% 2.57 0.351 0 601.8185 1,201.62 1,202.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DLELQADSAIK 95.00% 2.2 0.177 1.44 601.8185 1,201.62 1,202.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DLELQADSAIK 95.00% 2.93 0.385 1.85 601.8185 1,201.62 1,202.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DLELQADSAIK 95.00% 2.69 0.34 0 601.8186 1,201.62 1,202.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DLELQADSAIK 95.00% 2.6 0.305 1.77 601.8188 1,201.62 1,202.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DLELQADSAIK 95.00% 2.95 0.34 0 601.8189 1,201.62 1,202.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DLELQADSAIK 95.00% 2.53 0.292 1.35 601.819 1,201.62 1,202.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DLELQADSAIK 95.00% 2.44 0.224 0 601.8194 1,201.62 1,202.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% YEILAANAIPK 95.00% 3.18 0.409 2.09 601.843 1,201.67 1,202.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% YEILAANAIPK 95.00% 3.27 0.446 1.92 601.8436 1,201.67 1,202.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% YEILAANAIPK 95.00% 3.67 0.408 2.28 601.8436 1,201.67 1,202.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% YEILAANAIPK 95.00% 3.73 0.401 2.54 601.8438 1,201.67 1,202.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% YEILAANAIPK 95.00% 3.28 0.449 2.62 601.844 1,201.67 1,202.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% YEILAANAIPK 95.00% 3.15 0.472 2.52 601.8441 1,201.67 1,202.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% YEILAANAIPK 95.00% 3.39 0.332 2.44 601.8443 1,201.67 1,202.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% YEILAANAIPK 95.00% 3.37 0.442 3.72 601.8446 1,201.67 1,202.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% YEILAANAIPK 95.00% 3.51 0.349 2.7 601.8448 1,201.67 1,202.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% YEILAANAIPK 95.00% 3.12 0.455 2.57 601.8449 1,201.67 1,202.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALELDPNLYR 95.00% 2.3 0.31 1.51 602.3217 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALELDPNLYR 95.00% 2.79 0.245 0 602.3217 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALELDPNLYR 95.00% 2.81 0.294 1.72 602.3226 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALELDPNLYR 95.00% 2.63 0.253 1.66 602.3228 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALELDPNLYR 95.00% 3.04 0.305 1.82 602.323 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALELDPNLYR 95.00% 2.83 0.281 1.77 602.3235 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALELDPNLYR 95.00% 2.95 0.303 2.21 602.3235 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALELDPNLYR 95.00% 2.78 0.261 0 602.3237 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALELDPNLYR 95.00% 2.25 0.256 2.27 602.3241 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALELDPNLYR 95.00% 2.26 0.24 1.64 602.3244 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALELDPNLYR 95.00% 2.44 0.325 0 602.3246 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALELDPNLYR 95.00% 2.45 0.289 1.82 602.3248 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% YEILAANAIPK 95.00% 2.62 0.336 1.41 602.3425 1,202.67 1,202.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALETQMEEMK 95.00% 2.51 0.32 2.8 605.2812 1,208.55 1,209.55 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDERK 95.00% 3.09 0.288 0 606.9564 1,817.85 1,818.85 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDERK 95.00% 2.74 0.303 0 606.9564 1,817.85 1,818.85 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDERK 95.00% 3.38 0.409 0 606.957 1,817.85 1,818.85 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDERK 95.00% 2.72 0.319 0 606.9578 1,817.85 1,818.85 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDERK 95.00% 3.23 0.366 0 607.2902 1,818.85 1,818.85 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDERK 95.00% 2.9 0.286 0 607.2909 1,818.85 1,818.85 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDERK 95.00% 3.02 0.226 0 607.2909 1,818.85 1,818.85 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDERK 95.00% 2.52 0.216 0 607.2914 1,818.85 1,818.85 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDERK 95.00% 2.93 0.321 0 607.2915 1,818.85 1,818.85 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDERK 95.00% 3.02 0.356 0 607.2922 1,818.85 1,818.85 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 3.01 0.227 0 610.6278 1,828.86 1,829.86 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 3.55 0.372 0 610.6284 1,828.86 1,829.86 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 2.76 0.259 0 610.6291 1,828.86 1,829.86 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 3.11 0.227 0 610.6296 1,828.87 1,829.86 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 3.47 0.301 0 610.6298 1,828.87 1,829.86 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 3.37 0.33 0 610.6307 1,828.87 1,829.86 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 2.66 0.217 0 610.6332 1,828.88 1,829.86 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEK 95.00% 2.33 0.218 0 610.8294 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEK 95.00% 3.22 0.29 0 610.83 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEK 95.00% 2.32 0.197 0 610.8301 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEK 95.00% 3.11 0.23 0 610.8307 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEK 95.00% 3.24 0.315 0 610.8313 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEK 95.00% 3.06 0.283 0 610.8313 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEK 95.00% 2.98 0.166 0 610.8315 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEK 95.00% 2.93 0.239 0 610.8316 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEK 95.00% 3.01 0.205 0 610.8316 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEK 95.00% 3.02 0.261 0 610.8318 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEK 95.00% 2.46 0.123 1.51 610.8322 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KFDQLLAEEK 95.00% 3.06 0.273 0 610.8322 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 3.88 0.342 0 610.9622 1,829.86 1,829.86 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 3.07 0.313 0 610.9628 1,829.87 1,829.86 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 3.25 0.209 0 610.9633 1,829.87 1,829.86 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SKLHEMEGAVK 95.00% 2.41 0.261 0 614.8247 1,227.63 1,228.64 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEGDLKDLELQADSAIK 95.00% 3.8 0.378 1 619.9993 1,856.97 1,857.98 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEGDLKDLELQADSAIK 95.00% 3.52 0.425 0 620 1,856.98 1,857.98 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEGDLKDLELQADSAIK 95.00% 4.2 0.454 2.36 620.0002 1,856.98 1,857.98 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEGDLKDLELQADSAIK 95.00% 3.93 0.418 1.24 620.0009 1,856.98 1,857.98 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEGDLKDLELQADSAIK 95.00% 3.39 0.448 0 620.0023 1,856.98 1,857.98 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEGDLKDLELQADSAIK 95.00% 4.04 0.47 1.96 620.3351 1,857.98 1,857.98 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEGDLKDLELQADSAIK 95.00% 4.26 0.443 1.85 620.3351 1,857.98 1,857.98 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EILLQVEDER 95.00% 3.46 0.289 0 622.3313 1,242.65 1,243.65 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EILLQVEDER 95.00% 2.83 0.262 1.3 622.3315 1,242.65 1,243.65 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EILLQVEDER 95.00% 3.01 0.253 2.57 622.3315 1,242.65 1,243.65 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EILLQVEDER 95.00% 2.77 0.232 0 622.3316 1,242.65 1,243.65 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EILLQVEDER 95.00% 2.93 0.0676 1.6 622.3316 1,242.65 1,243.65 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EILLQVEDER 95.00% 2.62 0.0327 1.85 622.3317 1,242.65 1,243.65 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EILLQVEDER 95.00% 3.41 0.196 0 622.3318 1,242.65 1,243.65 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EILLQVEDER 95.00% 2.67 0.092 1.59 622.3319 1,242.65 1,243.65 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TGVLAHLEEER 95.00% 2.86 0.337 1.31 627.3303 1,252.64 1,253.65 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KEEELQAALAR 95.00% 3.07 0.302 1.48 629.3446 1,256.67 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KEEELQAALAR 95.00% 3 0.356 1.47 629.3451 1,256.67 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KEEELQAALAR 95.00% 3.1 0.285 1.26 629.3452 1,256.67 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KEEELQAALAR 95.00% 3.16 0.289 0 629.3454 1,256.68 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KEEELQAALAR 95.00% 2.95 0.344 1.38 629.3454 1,256.68 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KEEELQAALAR 95.00% 2.89 0.331 1.19 629.3456 1,256.68 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KEEELQAALAR 95.00% 2.84 0.36 1.35 629.3459 1,256.68 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KEEELQAALAR 95.00% 2.85 0.354 1.22 629.346 1,256.68 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KEEELQAALAR 95.00% 2.83 0.326 1.22 629.3463 1,256.68 1,257.68 2 MYH9_HUMAN,RS3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLQDFASTVEALEEGK 95.00% 3.33 0.507 0 632.0051 1,892.99 1,893.00 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLQDFASTVEALEEGK 95.00% 2.57 0.313 0 632.0062 1,893.00 1,893.00 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFK 95.00% 4.06 0.227 1.77 633.9882 1,898.94 1,899.95 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFK 95.00% 4.32 0.317 1.41 633.9898 1,898.95 1,899.95 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.66 0.477 3.33 634.318 1,266.62 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.31 0.412 2.32 634.3186 1,266.62 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.78 0.49 2.77 634.3195 1,266.62 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.77 0.519 3.89 634.3201 1,266.62 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.99 0.533 3.57 634.3204 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.47 0.556 3.16 634.3204 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 2.58 0.429 0 634.3205 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.54 0.514 2.89 634.3205 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.69 0.534 4.03 634.3207 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.73 0.522 3.57 634.3208 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 2.28 0.325 0 634.3208 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.64 0.532 3.64 634.3212 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.12 0.512 3.24 634.3215 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.87 0.532 4.09 634.3216 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.99 0.535 3.23 634.3219 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.68 0.524 4.6 634.3222 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.13 0.478 3.33 634.3236 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 2.92 0.464 1.77 634.3249 1,266.63 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 3.64 0.531 2.72 634.3327 1,266.65 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TEFSIIHYAGK 95.00% 0 0 4 634.3422 1,266.67 1,265.65 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VDYNASAWLTK 95.00% 1.94 0.348 1.68 634.7937 1,267.57 1,267.63 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 3.63 0.516 2.92 636.8435 1,271.67 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 3.49 0.529 3.48 636.844 1,271.67 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 3.77 0.478 3.42 636.844 1,271.67 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 3.38 0.543 2.62 636.8443 1,271.67 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 3.8 0.526 3.07 636.8447 1,271.67 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 3.42 0.433 3 636.8449 1,271.67 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 2.75 0.486 3.11 636.845 1,271.67 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 3.65 0.486 1.8 636.8451 1,271.67 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 3.96 0.468 2.57 636.8452 1,271.67 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 3.77 0.484 1.38 636.8454 1,271.68 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 3.55 0.477 3.89 636.8456 1,271.68 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 4.14 0.488 3.34 636.8458 1,271.68 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 2.4 0.254 0 636.846 1,271.68 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 3.03 0.556 2.42 636.8473 1,271.68 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 2.69 0.243 0 636.8476 1,271.68 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEAQVQELQSK 95.00% 3.3 0.355 2.8 637.3441 1,272.67 1,272.68 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 4.81 0.5 1.06 638.3262 1,911.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 4.89 0.525 3.08 638.3268 1,911.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5 0.524 3.37 638.327 1,911.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 3.74 0.516 1.2 638.3271 1,911.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 3.43 0.467 0 638.3275 1,911.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 4.81 0.46 1.96 638.3277 1,911.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 4.57 0.491 2.07 638.3278 1,911.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 4.28 0.457 3.36 638.3279 1,911.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 4.33 0.476 0 638.3286 1,911.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 3.14 0.338 0 638.6603 1,912.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 2.28 0.269 0 638.6614 1,912.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.27 0.475 2.31 638.6617 1,912.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 3.16 0.357 0.959 638.6617 1,912.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.22 0.498 2.46 638.6617 1,912.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 4.92 0.437 2.6 638.6624 1,912.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 3.17 0.409 0 638.6626 1,912.96 1,912.96 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLEEAEEESQRINANR 95.00% 2.55 0.392 0 639.3108 1,914.91 1,915.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLEEAEEESQRINANR 95.00% 2.39 0.3 0 639.645 1,915.91 1,915.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLEEAEEESQRINANR 95.00% 2.3 0.25 0 639.6453 1,915.91 1,915.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 2.36 0.206 0 639.6624 1,915.96 1,916.97 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 4.6 0.441 1.6 639.6628 1,915.96 1,916.97 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 4.25 0.413 2 639.6639 1,915.97 1,916.97 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 3.89 0.402 0 639.6645 1,915.97 1,916.97 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 3.27 0.437 0 639.9963 1,916.97 1,916.97 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 4.87 0.351 1 639.9971 1,916.97 1,916.97 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 4.77 0.319 2.24 639.9973 1,916.97 1,916.97 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGKKR 95.00% 2.54 0.304 0 641.0082 1,920.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGKKR 95.00% 2.66 0.307 0 641.0092 1,920.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGKKR 95.00% 2.01 0.292 0 641.3414 1,921.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGKKR 95.00% 1.77 0.286 0 641.3425 1,921.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGKKR 95.00% 3.18 0.432 0 641.3425 1,921.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGKKR 95.00% 2.81 0.406 0 641.3428 1,921.01 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGKKR 95.00% 2.76 0.382 0 641.3433 1,921.01 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGKKR 95.00% 2.72 0.296 0 641.3433 1,921.01 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKQTLEKENADLAGELR 95.00% 4.47 0.441 2.72 643.6752 1,928.00 1,929.00 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKQTLEKENADLAGELR 95.00% 4.5 0.464 2.54 644.0077 1,929.00 1,929.00 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKQTLEKENADLAGELR 95.00% 4.59 0.472 1.26 644.0101 1,929.01 1,929.00 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKQTLEKENADLAGELR 95.00% 4.53 0.492 2.14 644.0103 1,929.01 1,929.00 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NKQTLEKENADLAGELR 95.00% 3.93 0.435 2 644.0112 1,929.01 1,929.00 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 2.48 0.462 0 646.3315 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 3 0.505 1.85 646.3316 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 2.9 0.486 1.74 646.3318 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 3.33 0.446 0 646.332 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 2.48 0.497 1.42 646.332 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 2.66 0.476 0 646.3321 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 3.07 0.489 2.39 646.3322 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 2.29 0.41 1.33 646.3322 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 2.56 0.518 1.48 646.3324 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 2.38 0.455 0 646.3324 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 2.47 0.468 1.27 646.3327 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 2.32 0.452 1.32 646.3329 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EQADFAVEALAK 95.00% 1.78 0.319 0 646.3371 1,290.66 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 2.77 0.31 0 649.9832 1,946.93 1,947.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 3.3 0.337 0 649.9842 1,946.93 1,947.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 3.54 0.535 3.3 649.9846 1,946.93 1,947.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 4.31 0.521 2.66 649.9849 1,946.93 1,947.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 3.33 0.388 0 649.9855 1,946.93 1,947.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 4.84 0.453 4.24 650.3181 1,947.93 1,947.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 4.11 0.473 4.68 650.3184 1,947.93 1,947.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 3.23 0.408 3.44 650.3187 1,947.93 1,947.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 4.99 0.491 4.21 650.3197 1,947.94 1,947.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 4.86 0.527 4.27 654.6456 1,960.91 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 5.19 0.52 2.77 654.6462 1,960.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 5.33 0.559 2.59 654.6464 1,960.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 4.17 0.518 2.25 654.6472 1,960.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 4.97 0.511 2.92 654.9799 1,961.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 4.75 0.516 2.89 654.9807 1,961.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 5.4 0.583 3.28 654.9809 1,961.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 5.1 0.486 2.51 654.981 1,961.92 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 3.3 0.417 2.48 m11: Oxidation (+15.99) 655.3157 1,962.92 1,963.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 3.3 0.481 1.21 m11: Oxidation (+15.99) 655.3158 1,962.92 1,963.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 3.9 0.42 0 m11: Oxidation (+15.99) 655.3163 1,962.93 1,963.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 2.92 0.361 0 m11: Oxidation (+15.99) 655.3188 1,962.93 1,963.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 3.77 0.454 0 m11: Oxidation (+15.99) 655.648 1,963.92 1,963.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 4.78 0.517 2.85 m11: Oxidation (+15.99) 655.6497 1,963.93 1,963.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 3.94 0.484 3.24 m11: Oxidation (+15.99) 655.6507 1,963.93 1,963.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 2.79 0.295 0 m11: Oxidation (+15.99) 655.6508 1,963.93 1,963.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 4.21 0.495 2.09 m11: Oxidation (+15.99) 655.6512 1,963.93 1,963.93 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LDAFLVLEQLR 95.00% 3.26 0.324 1.39 658.8809 1,315.75 1,316.76 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LDAFLVLEQLR 95.00% 2.96 0.313 0 658.8833 1,315.75 1,316.76 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.13 0.43 0 662.3091 1,983.90 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 3.38 0.324 0 662.3094 1,983.90 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.42 0.313 1.74 662.3094 1,983.90 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.35 0.422 1.85 662.311 1,983.91 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 2.9 0.363 0 662.6421 1,984.90 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.07 0.416 1 662.6434 1,984.91 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.59 0.394 0 662.6436 1,984.91 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.75 0.407 0 662.6438 1,984.91 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.27 0.402 0 662.644 1,984.91 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.25 0.417 1.08 662.6442 1,984.91 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 3.86 0.421 0 662.6442 1,984.91 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.25 0.412 0 662.6442 1,984.91 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 3.88 0.441 0 662.6442 1,984.91 1,984.91 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 3.87 0.397 1.6 662.6973 1,985.07 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 3.37 0.332 0 662.6981 1,985.07 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 6.05 0.547 4.26 662.6984 1,985.07 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 4.92 0.529 3.03 662.6987 1,985.07 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 5.66 0.532 3.89 662.6995 1,985.08 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 5.45 0.505 3.43 663.0317 1,986.07 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 3.89 0.343 0 663.0318 1,986.07 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 5.41 0.481 4.68 663.0319 1,986.07 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 4.86 0.449 3.24 663.0327 1,986.07 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 5.3 0.551 3.82 663.0328 1,986.08 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 5.97 0.551 2.92 663.033 1,986.08 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 5.36 0.493 2.89 663.0331 1,986.08 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 6.63 0.52 4.1 663.0333 1,986.08 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 3.98 0.391 0 663.0464 1,986.12 1,986.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AENELKELEQK 95.00% 2.96 0.118 2.26 665.8474 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AENELKELEQK 95.00% 2.61 0.169 1.24 665.8484 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AENELKELEQK 95.00% 2.76 0.0956 1.39 665.8487 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AENELKELEQK 95.00% 3.16 0.137 0 665.8495 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AENELKELEQK 95.00% 2.56 0.237 0 665.8496 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SLEADLmQLQEDLAAAER 95.00% 3.44 0.324 0 m7: Oxidation (+15.99) 673.6636 2,017.97 2,018.97 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SLEADLmQLQEDLAAAER 95.00% 2.83 0.379 2.89 m7: Oxidation (+15.99) 673.9974 2,018.97 2,018.97 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SLEADLmQLQEDLAAAER 95.00% 3.92 0.523 2.85 m7: Oxidation (+15.99) 673.9987 2,018.97 2,018.97 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SLEADLmQLQEDLAAAER 95.00% 2.55 0.39 0 m7: Oxidation (+15.99) 673.9991 2,018.97 2,018.97 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLEEAEEESQR 95.00% 3.19 0.286 1.36 674.3081 1,346.60 1,347.60 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLEEAEEESQR 95.00% 3.07 0.44 0 674.3093 1,346.60 1,347.60 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALDEETRSHEAQVQEmR 95.00% 2.64 0.416 0 m16: Oxidation (+15.99) 682.6569 2,044.95 2,044.94 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALDEETRSHEAQVQEmR 95.00% 2.76 0.388 1.33 m16: Oxidation (+15.99) 682.6581 2,044.95 2,044.94 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 7.04 0.623 2.92 686.0173 2,055.03 2,056.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 3.56 0.539 0 686.0195 2,055.03 2,056.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 7.05 0.633 4.62 686.022 2,055.04 2,056.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 7.02 0.64 3.08 686.0224 2,055.04 2,056.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 6.87 0.628 3.44 686.3538 2,056.04 2,056.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 6.92 0.662 4.52 686.3561 2,056.04 2,056.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 7.32 0.622 4.96 686.3562 2,056.05 2,056.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 7.21 0.566 5.11 686.3565 2,056.05 2,056.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 5.86 0.564 3.62 686.3568 2,056.05 2,056.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 2.34 0.329 0 686.3743 2,056.10 2,056.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 5.46 0.633 2.08 686.377 2,056.11 2,056.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EILLQVEDERK 95.00% 2.79 0.293 0 686.6671 1,371.32 1,371.75 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLEEAEEESQRINANRR 95.00% 2.62 0.262 0 691.3459 2,071.01 2,072.01 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLEEAEEESQRINANRR 95.00% 2.72 0.347 0 691.3461 2,071.01 2,072.01 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLEEAEEESQRINANRR 95.00% 3.37 0.258 0 691.6798 2,072.02 2,072.01 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.76 0.545 3.48 700.892 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.15 0.542 3.49 700.8921 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.56 0.499 4.06 700.8923 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.25 0.509 4 700.8924 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.56 0.543 3.39 700.8925 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.64 0.498 4.57 700.8927 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.17 0.534 3.47 700.893 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.03 0.493 4.02 700.893 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.32 0.511 4.06 700.893 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.4 0.559 4.31 700.8932 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.55 0.569 3.72 700.8933 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.51 0.542 4.33 700.8938 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.23 0.507 4.42 700.8939 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.51 0.524 3.74 700.894 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.21 0.504 4 700.8941 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.31 0.507 4.41 700.8945 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.17 0.472 4.24 700.895 1,399.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 2.44 0.273 0 701.0998 1,400.18 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSK 95.00% 4.31 0.511 5 701.3942 1,400.77 1,400.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEAQVQELQSKcSDGER 95.00% 2.29 0.272 0 c13: Carbamidomethyl (+57.02) 702.3401 2,104.00 2,105.03 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.43 0.253 3.28 707.9042 1,413.79 1,414.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.24 0.372 1.29 707.9067 1,413.80 1,414.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 1.81 0.302 1.48 707.9079 1,413.80 1,414.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.1 0.0884 3.26 707.9081 1,413.80 1,414.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 2.94 0.507 3.44 707.9103 1,413.81 1,414.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 4.14 0.523 3.11 708.4097 1,414.80 1,414.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 3.36 0.449 3.62 708.41 1,414.80 1,414.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 4.11 0.597 3.15 708.4101 1,414.80 1,414.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VIQYLAVVASSHK 95.00% 4.12 0.535 3.28 708.4117 1,414.81 1,414.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEDEILVMDDQNNKLSK 95.00% 4.93 0.548 2.24 711.7033 2,132.09 2,132.09 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEDEILVMDDQNNKLSK 95.00% 4.45 0.507 1.32 711.707 2,132.10 2,132.09 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qADLEKEELAEELASSLSGR 95.00% 0 0 3.48 n-term: Pyro-cmC (-17.03) 720.0244 2,157.05 2,158.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qADLEKEELAEELASSLSGR 95.00% 0 0 4.3 n-term: Pyro-cmC (-17.03) 720.3582 2,158.05 2,158.05 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 3.4 0.531 0 725.6997 2,174.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 3.57 0.46 1.41 725.7001 2,174.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 3.75 0.459 1.72 726.0328 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 3.25 0.431 1.04 726.0329 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 4.11 0.464 1.07 726.033 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 3.29 0.412 0 726.0333 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 3.62 0.462 0 726.0334 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 4.04 0.474 1.23 726.0336 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 3.7 0.468 0 726.0338 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 3.98 0.551 1.54 726.0341 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 4.43 0.488 0.959 726.0341 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 3.6 0.457 0 726.0342 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 4.15 0.589 1.21 726.0343 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 4.34 0.562 1.82 726.0344 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 3.55 0.506 0 726.0344 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 4.39 0.534 1.24 726.0361 2,175.08 2,175.08 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.46 0.519 7.64 728.3932 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.69 0.518 5.17 728.3952 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 5.14 0.52 6.37 728.3953 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 3.95 0.642 4.72 728.3954 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.4 0.626 4.38 728.3958 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.58 0.494 7.1 728.3958 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.77 0.618 4.89 728.3959 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.45 0.509 5.48 728.3961 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.25 0.617 5.55 728.3962 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.39 0.637 7.24 728.3965 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4 0.604 4.89 728.3965 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 2.23 0.425 4.36 728.3982 1,454.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 2.26 0.408 3.92 728.4107 1,454.81 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSK 95.00% 4.71 0.501 4.48 728.8961 1,455.78 1,455.78 2 TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 4.43 0.427 3.66 742.9207 1,483.83 1,484.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 2.3 0.177 1.96 742.921 1,483.83 1,484.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 4.7 0.376 3.08 742.9213 1,483.83 1,484.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 4.64 0.401 2.96 742.9217 1,483.83 1,484.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LKEILLQVEDER 95.00% 4.2 0.397 3.04 742.9228 1,483.83 1,484.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QRYEILAANAIPK 95.00% 3.58 0.344 2.43 744.4257 1,486.84 1,486.84 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QRYEILAANAIPK 95.00% 2.53 0.317 2.72 744.4281 1,486.84 1,486.84 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAKLR 95.00% 4.27 0.527 0 744.7088 2,231.10 2,231.10 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EELAEELASSLSGR 95.00% 2.24 0.194 2.29 745.8631 1,489.71 1,490.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EELAEELASSLSGR 95.00% 1.96 0.371 1.21 745.8643 1,489.71 1,490.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EELAEELASSLSGR 95.00% 3.32 0.489 7.38 745.868 1,489.72 1,490.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EELAEELASSLSGR 95.00% 2.27 0.427 3.8 745.8706 1,489.73 1,490.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EELAEELASSLSGR 95.00% 3.11 0.429 2.09 746.3698 1,490.72 1,490.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 2.05 0.235 1.32 751.9525 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 3.49 0.496 3.89 751.9528 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 4.54 0.509 4.48 751.9531 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 3.48 0.485 4.4 751.9536 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 3.34 0.477 3.38 751.9538 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 2.95 0.419 2.85 751.9539 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 2.4 0.253 2.29 751.9541 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 2.65 0.427 3.26 751.9541 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 3.19 0.477 4.09 751.9542 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 3.75 0.476 4.16 751.9546 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 4.01 0.508 4.27 751.9549 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 3.05 0.369 1.96 751.9549 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 3.75 0.484 3.62 751.9553 1,501.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 2.28 0.34 2.21 751.957 1,501.90 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 4.2 0.497 4.85 752.4541 1,502.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 4.51 0.534 3.8 752.4546 1,502.89 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 4.22 0.566 3.13 752.4555 1,502.90 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 4.23 0.514 3.82 752.4557 1,502.90 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFK 95.00% 4.12 0.499 4.28 752.4557 1,502.90 1,502.89 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 5.16 0.401 3.66 764.9402 1,527.86 1,528.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 5.13 0.406 3.28 764.941 1,527.87 1,528.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 4.73 0.446 4.77 764.9411 1,527.87 1,528.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 4.67 0.384 2.8 764.9418 1,527.87 1,528.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 5.2 0.402 3.72 764.9419 1,527.87 1,528.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 4.83 0.46 2.89 764.9425 1,527.87 1,528.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 5.57 0.433 4.02 765.44 1,528.86 1,528.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KKLEAQVQELQSK 95.00% 5.49 0.414 3.35 765.4427 1,528.87 1,528.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 5.36 0.524 3.09 768.7314 2,303.17 2,303.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 5.34 0.528 3.49 768.7317 2,303.17 2,303.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 5.2 0.475 2.82 768.7319 2,303.17 2,303.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 4.82 0.34 4.17 768.7321 2,303.17 2,303.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 6 0.514 5.29 768.7325 2,303.17 2,303.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 5.28 0.58 4.7 768.7325 2,303.17 2,303.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 4.92 0.371 3.17 768.7326 2,303.17 2,303.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 5.12 0.447 2.77 768.7326 2,303.17 2,303.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 4.64 0.44 3.92 768.7331 2,303.18 2,303.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 5.75 0.54 3.82 768.7336 2,303.18 2,303.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 4.97 0.538 4.82 768.7339 2,303.18 2,303.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 3.61 0.368 2.32 768.752 2,303.23 2,303.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 5.16 0.412 2.39 771.8932 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.89 0.412 2.68 771.8936 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 5.11 0.388 2.74 771.894 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.78 0.425 3 771.8942 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.5 0.473 2.89 771.8943 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.92 0.425 3.34 771.8943 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.75 0.415 2.7 771.8944 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.87 0.375 2.77 771.8944 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.9 0.385 2.57 771.8949 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.89 0.418 3.57 771.8949 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.47 0.497 2.92 771.8949 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.93 0.403 2.21 771.8952 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.77 0.413 2.38 771.8952 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.69 0.437 4.38 771.8955 1,541.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.05 0.471 2.52 771.8959 1,541.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 3.67 0.51 4.72 771.8982 1,541.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 3.18 0 1.72 772.386 1,542.76 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 3.28 0.279 3.8 772.3893 1,542.76 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 2.93 0.438 3.42 772.3894 1,542.76 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 4.59 0.35 3.3 772.3968 1,542.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 5.02 0.375 3.38 772.3972 1,542.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 3.39 0.426 2.1 772.3986 1,542.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 2.79 0.366 0 772.4002 1,542.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 0 0 3.85 773.4057 1,544.80 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 0 0 3.27 773.4061 1,544.80 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 0 0 3.72 773.4066 1,544.80 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAR 95.00% 0 0 4.07 773.4083 1,544.80 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELDEATESNEAMGR 95.00% 3.78 0.497 5.96 776.3366 1,550.66 1,551.66 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% EDQSILcTGESGAGK 95.00% 2.61 0.298 0 c7: Carbamidomethyl (+57.02) 776.3512 1,550.69 1,551.70 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELDEATESNEAMGR 95.00% 4.44 0.577 5.48 776.8391 1,551.66 1,551.66 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 3.74 0.596 5.19 c12: Carbamidomethyl (+57.02) 778.375 1,554.73 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 2.98 0.446 3.74 c12: Carbamidomethyl (+57.02) 778.3757 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 3.55 0.611 4.09 c12: Carbamidomethyl (+57.02) 778.3766 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 3.26 0.478 3.21 c12: Carbamidomethyl (+57.02) 778.3769 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 3.13 0.541 3.4 c12: Carbamidomethyl (+57.02) 778.3786 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 3.71 0.494 4.57 c12: Carbamidomethyl (+57.02) 778.3789 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 3.5 0.467 4.01 c12: Carbamidomethyl (+57.02) 778.379 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 3.52 0.479 4.49 c12: Carbamidomethyl (+57.02) 778.3795 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 3.89 0.509 4.25 c12: Carbamidomethyl (+57.02) 778.8793 1,555.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVIMAFQAMcR 95.00% 4.31 0.524 3.62 c12: Carbamidomethyl (+57.02) 778.8799 1,555.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELDEATESNEAmGR 95.00% 3.97 0.522 5.11 m12: Oxidation (+15.99) 784.3372 1,566.66 1,567.65 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELDEATESNEAmGR 95.00% 3.89 0.423 4.55 m12: Oxidation (+15.99) 784.8373 1,567.66 1,567.65 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVImAFQAMcR 95.00% 3.83 0.535 6.3 m6: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 786.3742 1,570.73 1,571.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVImAFQAMcR 95.00% 2.93 0.535 3.72 m6: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 786.3773 1,570.74 1,571.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ITDVImAFQAMcR 95.00% 4.16 0.645 5.29 m6: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 786.8745 1,571.73 1,571.74 2 AGRIN_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 3.57 0.562 2.17 792.4425 1,582.87 1,583.88 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 3.72 0.55 6.66 792.445 1,582.87 1,583.88 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HISTLNIQLSDSKK 95.00% 2.64 0.363 0 792.9004 1,583.79 1,583.88 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 3.3 0.418 2.64 794.956 1,587.90 1,588.91 2 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 4.78 0.512 4.6 794.9582 1,587.90 1,588.91 2 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SGKLDAFLVLEQLR 95.00% 4.87 0.503 3.44 795.4586 1,588.90 1,588.91 2 SPTA2_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEK 95.00% 4.64 0.53 3.23 796.3899 1,590.76 1,591.77 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEK 95.00% 5.3 0.542 3.21 796.3904 1,590.77 1,591.77 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEK 95.00% 5.33 0.554 3.52 796.3906 1,590.77 1,591.77 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEK 95.00% 4.77 0.553 3.19 796.3909 1,590.77 1,591.77 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEK 95.00% 3.93 0.512 2.92 796.3914 1,590.77 1,591.77 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEK 95.00% 5.3 0.554 3.89 796.3916 1,590.77 1,591.77 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEK 95.00% 4.3 0.565 3.19 796.3922 1,590.77 1,591.77 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEK 95.00% 4.8 0.542 3.54 796.3922 1,590.77 1,591.77 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEK 95.00% 4.76 0.559 4.21 796.3926 1,590.77 1,591.77 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEK 95.00% 3.74 0.489 2.17 796.3936 1,590.77 1,591.77 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEK 95.00% 4.61 0.533 2.6 796.8925 1,591.77 1,591.77 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEK 95.00% 4.7 0.513 2.21 796.8938 1,591.77 1,591.77 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 6.58 0.526 4.85 797.7288 2,390.16 2,390.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 5.74 0.474 2.31 797.7307 2,390.17 2,390.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 7.16 0.567 4.06 797.7313 2,390.17 2,390.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 5.55 0.513 2.44 797.7314 2,390.17 2,390.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 6.63 0.536 5.38 797.7315 2,390.17 2,390.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 6.77 0.519 7 797.7323 2,390.17 2,390.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 7.07 0.562 4.82 797.7329 2,390.18 2,390.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 6.33 0.563 2.49 797.7332 2,390.18 2,390.17 3
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qELEEILHEMEAR 95.00% 0 0 3.66 n-term: Pyro-cmC (-17.03) 805.3804 1,608.75 1,609.75 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AEMEDLVSSKDDVGK 95.00% 4.08 0.445 3.27 811.8844 1,621.75 1,622.76 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% AEMEDLVSSKDDVGK 95.00% 3.78 0.41 2.82 812.3883 1,622.76 1,622.76 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.28 0.417 2.68 815.421 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.14 0.444 2.32 815.4215 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.87 0.397 3.04 815.4218 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.87 0.403 2.74 815.4221 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.42 0.431 2.77 815.4222 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.68 0.441 1.62 815.4223 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.85 0.399 4.05 815.4223 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.48 0.443 2.51 815.4223 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.95 0.426 4.04 815.4225 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.61 0.436 2.24 815.4226 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 5.09 0.409 3.41 815.4228 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.82 0.431 2.48 815.4231 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.78 0.425 2 815.4233 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.61 0.402 1.92 815.424 1,628.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.72 0.416 2.54 815.426 1,628.84 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ALEEALEAKEELER 95.00% 4.01 0.397 2.89 815.9246 1,629.83 1,629.83 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFKK 95.00% 4.27 0.457 4.21 815.9989 1,629.98 1,630.99 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFKK 95.00% 3.49 0.553 2.27 816.0002 1,629.98 1,630.99 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFKK 95.00% 4.75 0.46 1.43 816.0015 1,629.99 1,630.99 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFKK 95.00% 4.09 0.52 1.82 816.002 1,629.99 1,630.99 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFKK 95.00% 3.79 0.477 1.8 816.0027 1,629.99 1,630.99 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NFINSPVAQADWAAK 95.00% 3.87 0.472 2.96 816.4213 1,630.83 1,631.82 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NFINSPVAQADWAAK 95.00% 3.36 0.262 0 816.4228 1,630.83 1,631.82 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFKK 95.00% 4.45 0.48 2.52 816.5024 1,630.99 1,630.99 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% VVSSVLQLGNIVFKK 95.00% 4.14 0.414 2.27 816.5035 1,630.99 1,630.99 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NFINSPVAQADWAAK 95.00% 3.95 0.313 2.21 816.9214 1,631.83 1,631.82 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 5.11 0.505 6.36 818.9082 1,635.80 1,636.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.5 0.551 6.28 818.909 1,635.80 1,636.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.63 0.505 5.74 818.909 1,635.80 1,636.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 5.01 0.491 6.12 818.9091 1,635.80 1,636.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.71 0.546 5.55 818.9094 1,635.80 1,636.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.42 0.538 6.96 818.9095 1,635.80 1,636.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.49 0.51 5.8 818.9095 1,635.80 1,636.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.11 0.443 5.26 818.9098 1,635.80 1,636.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.79 0.507 6.06 818.91 1,635.80 1,636.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 4.56 0.508 6.16 818.9101 1,635.80 1,636.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGK 95.00% 3.59 0.456 5.46 818.9105 1,635.81 1,636.81 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEMEAK 95.00% 4.51 0.512 3.96 825.3719 1,648.73 1,649.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEMEAK 95.00% 4.1 0.453 4.24 825.3722 1,648.73 1,649.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEMEAK 95.00% 4.58 0.511 4.47 825.3731 1,648.73 1,649.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEMEAK 95.00% 4.39 0.563 5.96 825.3731 1,648.73 1,649.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEMEAK 95.00% 4.42 0.531 4.41 825.3736 1,648.73 1,649.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEMEAK 95.00% 4.24 0.518 4.57 825.374 1,648.73 1,649.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEMEAK 95.00% 3.98 0.48 3.77 825.3753 1,648.73 1,649.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEMEAK 95.00% 4.44 0.389 3.77 825.8747 1,649.73 1,649.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEmEAK 95.00% 4.09 0.484 4.11 m11: Oxidation (+15.99) 833.3673 1,664.72 1,665.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEmEAK 95.00% 4.31 0.528 5.89 m11: Oxidation (+15.99) 833.3676 1,664.72 1,665.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEmEAK 95.00% 4.44 0.573 4.41 m11: Oxidation (+15.99) 833.37 1,664.72 1,665.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEmEAK 95.00% 4.44 0.581 4.72 m11: Oxidation (+15.99) 833.3712 1,664.73 1,665.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEmEAK 95.00% 4.45 0.552 5.1 m11: Oxidation (+15.99) 833.3715 1,664.73 1,665.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEmEAK 95.00% 4.6 0.549 6.17 m11: Oxidation (+15.99) 833.87 1,665.72 1,665.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEmEAK 95.00% 4.65 0.538 5.21 m11: Oxidation (+15.99) 833.8706 1,665.73 1,665.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEmEAK 95.00% 4.18 0.549 5.66 m11: Oxidation (+15.99) 833.8711 1,665.73 1,665.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% NSLQDQLDEEmEAK 95.00% 4.12 0.544 4.77 m11: Oxidation (+15.99) 833.8744 1,665.73 1,665.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qLHEYETELEDER 95.00% 0 0 3.44 n-term: Pyro-cmC (-17.03) 837.3659 1,672.72 1,673.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qLHEYETELEDER 95.00% 0 0 3.46 n-term: Pyro-cmC (-17.03) 837.3691 1,672.72 1,673.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qLHEYETELEDER 95.00% 0 0 4.43 n-term: Pyro-cmC (-17.03) 837.3696 1,672.72 1,673.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qLHEYETELEDER 95.00% 0 0 3.49 n-term: Pyro-cmC (-17.03) 837.3712 1,672.73 1,673.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qLHEYETELEDER 95.00% 0 0 3.89 n-term: Pyro-cmC (-17.03) 837.8722 1,673.73 1,673.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qLHEYETELEDER 95.00% 0 0 4.28 n-term: Pyro-cmC (-17.03) 837.8733 1,673.73 1,673.73 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 3.34 0.477 1.28 843.9376 1,685.86 1,686.87 2 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 3.25 0.473 2.52 843.9378 1,685.86 1,686.87 2 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 3.58 0.43 0 843.9384 1,685.86 1,686.87 2 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 3.42 0.502 1.89 843.9405 1,685.87 1,686.87 2 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QTLEKENADLAGELR 95.00% 3.4 0.433 2.19 844.441 1,686.87 1,686.87 2 CO3_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 3.09 0.348 2.34 845.8802 1,689.74 1,690.76 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 3.12 0.377 4.47 845.8827 1,689.75 1,690.76 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 3.31 0.387 5.21 845.8836 1,689.75 1,690.76 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 3.51 0.315 3.26 845.885 1,689.75 1,690.76 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 3.33 0.358 2.77 846.383 1,690.75 1,690.76 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLHEYETELEDER 95.00% 3.67 0.376 5.03 846.3863 1,690.76 1,690.76 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ASRDEIFATAKENEK 95.00% 4.67 0.432 2.85 854.9327 1,707.85 1,708.85 2 VINC_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.42 0.532 4.25 863.9792 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 5.16 0.576 5.85 863.9795 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.55 0.528 4.47 863.98 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.63 0.534 3.57 863.9801 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.74 0.563 6.38 863.9804 1,725.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.55 0.553 5.7 863.9807 1,725.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.77 0.556 6.07 863.9807 1,725.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.63 0.533 3.7 863.9813 1,725.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.62 0.537 4.92 863.9817 1,725.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.84 0.556 6.46 863.9817 1,725.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.62 0.561 3.33 863.9818 1,725.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.59 0.531 5.17 863.982 1,725.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.63 0.548 5.15 863.9821 1,725.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.04 0.546 4.66 863.9828 1,725.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.03 0.551 4.37 863.9834 1,725.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.67 0.517 3.3 864.4818 1,726.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.58 0.517 5.11 864.4824 1,726.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.32 0.533 3.6 864.4824 1,726.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.03 0.414 2.89 864.4824 1,726.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.56 0.481 2.89 864.4828 1,726.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.13 0.492 4.38 864.4831 1,726.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.4 0.419 3.64 864.4832 1,726.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QLLQANPILEAFGNAK 95.00% 4.37 0.522 3.44 864.4842 1,726.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QEEEMQAKEDELQK 95.00% 4.13 0.262 2.07 867.382 1,732.75 1,734.79 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QEEEMQAKEDELQK 95.00% 3.17 0.297 2.85 867.3855 1,732.76 1,734.79 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QEEEmQAKEDELQK 95.00% 2.77 0.216 0 m5: Oxidation (+15.99) 875.9019 1,749.79 1,750.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QEEEmQAKEDELQK 95.00% 2.87 0.0825 2 m5: Oxidation (+15.99) 876.4022 1,750.79 1,750.78 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 5.17 0.41 4.38 877.9413 1,753.87 1,754.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 4.91 0.439 3.82 877.9416 1,753.87 1,754.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 5.16 0.457 4.59 877.943 1,753.87 1,754.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 5.59 0.458 4.62 877.9447 1,753.87 1,754.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQELEEILHEMEAR 95.00% 4.85 0.456 4.14 878.4425 1,754.87 1,754.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 5.51 0.584 6.28 882.9552 1,763.89 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 5.57 0.608 6.14 882.9553 1,763.89 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 4.54 0.566 4.46 882.9555 1,763.90 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 5.62 0.563 5.4 882.9561 1,763.90 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 5.55 0.565 5.77 882.9561 1,763.90 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGKK 95.00% 3.62 0.518 3.38 882.9563 1,763.90 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 5.67 0.599 6.32 882.9565 1,763.90 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 5.77 0.571 6.7 882.9568 1,763.90 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 5.26 0.594 5.01 882.9571 1,763.90 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGKK 95.00% 4.3 0.5 2.24 882.9572 1,763.90 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 5.37 0.6 6.72 882.9582 1,763.90 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQDFASTVEALEEGKK 95.00% 4.48 0.513 5.89 883.4561 1,764.90 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 5.73 0.585 5.42 883.4574 1,764.90 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 5.54 0.569 6.42 883.4581 1,764.90 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLQDFASTVEALEEGK 95.00% 5.58 0.575 6.03 883.461 1,764.91 1,764.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ATQQAEQLSNELATER 95.00% 5.23 0.606 6.14 894.9411 1,787.87 1,788.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ATQQAEQLSNELATER 95.00% 5.41 0.637 5.77 894.9416 1,787.87 1,788.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ATQQAEQLSNELATER 95.00% 5.43 0.623 4.96 894.9416 1,787.87 1,788.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ATQQAEQLSNELATER 95.00% 5.53 0.633 7.6 894.9417 1,787.87 1,788.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ATQQAEQLSNELATER 95.00% 5.6 0.615 6.33 894.9419 1,787.87 1,788.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ATQQAEQLSNELATER 95.00% 3.88 0.568 4.85 894.9422 1,787.87 1,788.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ATQQAEQLSNELATER 95.00% 5.54 0.609 5.19 894.9426 1,787.87 1,788.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ATQQAEQLSNELATER 95.00% 5.33 0.608 5.52 895.4434 1,788.87 1,788.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ATQQAEQLSNELATER 95.00% 4.95 0.612 4.8 895.4446 1,788.87 1,788.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ATQQAEQLSNELATER 95.00% 4.58 0.599 5.26 895.446 1,788.88 1,788.87 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 4.52 0.565 4.82 895.9551 1,789.89 1,790.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 3.35 0.313 0 895.9555 1,789.90 1,790.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 3.86 0.515 0 895.9561 1,789.90 1,790.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 4.5 0.572 2.49 895.9567 1,789.90 1,790.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 4.74 0.578 3.12 895.9569 1,789.90 1,790.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 4.7 0.572 4.14 895.9572 1,789.90 1,790.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 4.46 0.562 3.92 895.9572 1,789.90 1,790.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 4.17 0.551 2.25 895.9577 1,789.90 1,790.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 4.21 0.527 3.33 895.9578 1,789.90 1,790.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 4.28 0.537 3.85 895.9581 1,789.90 1,790.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 4.63 0.552 4.48 896.4553 1,790.89 1,790.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ISDLTTNLAEEEEKAK 95.00% 4.71 0.544 2.8 896.4591 1,790.90 1,790.90 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAREK 95.00% 4.7 0.487 4.01 900.4626 1,798.91 1,799.91 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAREK 95.00% 4.77 0.457 2.74 900.9627 1,799.91 1,799.91 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAREK 95.00% 4.64 0.437 4.02 900.9653 1,799.92 1,799.91 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% IAQLEEQVEQEAREK 95.00% 4.92 0.454 4.7 900.9665 1,799.92 1,799.91 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qLHEYETELEDERK 95.00% 0 0 3.43 n-term: Pyro-cmC (-17.03) 901.9178 1,801.82 1,801.82 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEDEILVMDDQNNK 95.00% 5.36 0.609 5.03 902.4448 1,802.87 1,803.88 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEDEILVMDDQNNK 95.00% 5.63 0.597 4 902.4462 1,802.88 1,803.88 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEDEILVMDDQNNK 95.00% 5.33 0.567 4.8 902.9483 1,803.88 1,803.88 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 2.74 0.201 1.77 915.441 1,828.87 1,829.86 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 2.86 0.219 1.51 915.9408 1,829.87 1,829.86 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEEEEDRGQQLQAER 95.00% 3.12 0.205 2.05 915.9414 1,829.87 1,829.86 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEGDLKDLELQADSAIK 95.00% 5.17 0.563 4.27 929.4958 1,856.98 1,857.98 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEGDLKDLELQADSAIK 95.00% 5.11 0.509 4.64 929.997 1,857.98 1,857.98 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEGDLKDLELQADSAIK 95.00% 4.97 0.524 6.03 929.998 1,857.98 1,857.98 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LEGDLKDLELQADSAIK 95.00% 5.16 0.537 3.77 929.9994 1,857.98 1,857.98 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFK 95.00% 6.01 0.614 6.54 950.4789 1,898.94 1,899.95 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFK 95.00% 5.07 0.591 6.33 950.4806 1,898.95 1,899.95 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFK 95.00% 6.05 0.591 8.8 950.481 1,898.95 1,899.95 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFK 95.00% 5.98 0.614 8.12 950.9798 1,899.94 1,899.95 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFK 95.00% 5.85 0.614 7.92 950.9807 1,899.95 1,899.95 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFK 95.00% 6.02 0.619 8.72 950.9809 1,899.95 1,899.95 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 4.75 0.557 4.34 956.9843 1,911.95 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.53 0.584 3.96 956.9861 1,911.96 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.57 0.619 5.21 956.9868 1,911.96 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.47 0.632 3.96 956.9873 1,911.96 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.52 0.631 5.51 956.9876 1,911.96 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 4.57 0.516 2.89 957.484 1,912.95 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 4.9 0.534 3.49 957.4848 1,912.95 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.61 0.528 4.62 957.4855 1,912.96 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.84 0.595 4.54 957.4862 1,912.96 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.67 0.583 4.96 957.4865 1,912.96 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.88 0.566 4.22 957.4872 1,912.96 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 4.6 0.524 3.29 957.4876 1,912.96 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.69 0.583 4.38 957.4878 1,912.96 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.65 0.585 4.19 957.4878 1,912.96 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQQELDDLVVDLDNQR 95.00% 5.58 0.619 5.62 957.4891 1,912.96 1,912.96 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 5.87 0.629 4.89 958.9885 1,915.96 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 6.07 0.602 5.54 958.9893 1,915.96 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 5.8 0.641 9.34 958.9895 1,915.96 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 5.84 0.634 4.92 958.9897 1,915.96 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 5.97 0.633 4.8 958.9898 1,915.96 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 5.95 0.621 6.96 958.9898 1,915.96 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 5.86 0.616 5.52 958.9902 1,915.96 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 5.16 0.618 3.82 958.9933 1,915.97 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 6.07 0.633 6.19 959.4908 1,916.97 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 6.15 0.639 6.34 959.4914 1,916.97 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 5.76 0.627 4.74 959.4915 1,916.97 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 5.74 0.609 5.55 959.4915 1,916.97 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 5.54 0.59 4.62 959.4926 1,916.97 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 5.98 0.602 5.85 959.4931 1,916.97 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KATQQAEQLSNELATER 95.00% 5.64 0.64 6.49 959.494 1,916.97 1,916.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% FQKEIENLTQQYEEK 95.00% 4.87 0.44 5.64 964.4773 1,926.94 1,926.95 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% FQKEIENLTQQYEEK 95.00% 5.71 0.395 5.48 964.4803 1,926.95 1,926.95 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% FQKEIENLTQQYEEK 95.00% 5.11 0.354 6.74 964.4818 1,926.95 1,926.95 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 6.2 0.674 10.3 974.4696 1,946.92 1,947.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 5.84 0.636 8.82 974.4714 1,946.93 1,947.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 6.06 0.654 9.92 974.4717 1,946.93 1,947.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 6.11 0.634 9.8 974.4721 1,946.93 1,947.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 6.16 0.62 8.89 974.4729 1,946.93 1,947.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 6.17 0.602 9.64 974.9715 1,947.93 1,947.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 6.17 0.619 10.2 974.9726 1,947.93 1,947.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 6.12 0.559 7.48 974.9729 1,947.93 1,947.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 5.76 0.615 8.41 974.973 1,947.93 1,947.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 6 0.617 10.6 974.9738 1,947.93 1,947.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGMLNEAEGK 95.00% 6.14 0.623 9.21 974.9745 1,947.93 1,947.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TELEDTLDSTATQQELR 95.00% 5.21 0.58 4.16 975.4719 1,948.93 1,949.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TELEDTLDSTATQQELR 95.00% 5.82 0.531 5.8 975.974 1,949.93 1,949.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TELEDTLDSTATQQELR 95.00% 5.1 0.371 6.43 975.9742 1,949.93 1,949.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TELEDTLDSTATQQELR 95.00% 5.82 0.523 5.54 975.9763 1,949.94 1,949.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TELEDTLDSTATQQELR 95.00% 5.64 0.453 4.28 975.9779 1,949.94 1,949.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 5.13 0.638 6.09 981.4632 1,960.91 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 6.47 0.626 4.7 981.4642 1,960.91 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 6.94 0.637 5.22 981.4663 1,960.92 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 6.9 0.649 5.74 981.4664 1,960.92 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 6.56 0.609 7.37 981.964 1,961.91 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 5.45 0.621 3.29 981.9656 1,961.92 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% TQLEELEDELQATEDAK 95.00% 6.46 0.634 6.24 981.969 1,961.92 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 6.11 0.659 7.13 m11: Oxidation (+15.99) 982.468 1,962.92 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 5.67 0.622 7.47 m11: Oxidation (+15.99) 982.468 1,962.92 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 5.64 0.639 7.29 m11: Oxidation (+15.99) 982.4681 1,962.92 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 5.54 0.636 6.62 m11: Oxidation (+15.99) 982.4703 1,962.93 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 5.72 0.663 6.13 m11: Oxidation (+15.99) 982.4704 1,962.93 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 5.98 0.658 7.59 m11: Oxidation (+15.99) 982.4704 1,962.93 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 5.76 0.634 7.52 m11: Oxidation (+15.99) 982.4706 1,962.93 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 5.57 0.639 6.64 m11: Oxidation (+15.99) 982.471 1,962.93 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 1.9 0.5 1.21 m11: Oxidation (+15.99) 982.4915 1,962.97 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 5.71 0.635 5.62 m11: Oxidation (+15.99) 982.9721 1,963.93 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 5.8 0.625 5.47 m11: Oxidation (+15.99) 982.9721 1,963.93 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 6.05 0.621 6.15 m11: Oxidation (+15.99) 982.9724 1,963.93 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 5.66 0.635 8.23 m11: Oxidation (+15.99) 982.9726 1,963.93 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% LQNEVESVTGmLNEAEGK 95.00% 5.85 0.635 6.51 m11: Oxidation (+15.99) 982.9761 1,963.94 1,963.93 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.68 0.603 5 992.9575 1,983.90 1,984.91 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.45 0.534 3.96 992.9599 1,983.90 1,984.91 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.61 0.511 3.55 992.9607 1,983.91 1,984.91 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 3.9 0.526 3.17 992.9616 1,983.91 1,984.91 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.64 0.478 2.8 993.4602 1,984.90 1,984.91 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.49 0.5 4.31 993.4608 1,984.91 1,984.91 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.67 0.519 4.04 993.4621 1,984.91 1,984.91 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% ELEGHISDLQEDLDSER 95.00% 4.3 0.513 3.64 993.4622 1,984.91 1,984.91 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 5.74 0.567 6.62 994.0435 1,986.07 1,986.08 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 5.75 0.532 6.62 994.0444 1,986.07 1,986.08 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KLEGDLKDLELQADSAIK 95.00% 5.49 0.592 4.68 994.0468 1,986.08 1,986.08 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% SLEADLmQLQEDLAAAER 95.00% 5.51 0.538 4.89 m7: Oxidation (+15.99) 1,009.99 2,017.97 2,018.97 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 6.09 0.681 13.4 1,028.53 2,055.05 2,056.05 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 6.36 0.631 6.72 1,029.03 2,056.04 2,056.05 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% HAQAVEELTEQLEQFKR 95.00% 6.35 0.634 8.19 1,029.03 2,056.05 2,056.05 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qADLEKEELAEELASSLSGR 95.00% 0 0 6.21 n-term: Pyro-cmC (-17.03) 1,080.03 2,158.05 2,158.05 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qADLEKEELAEELASSLSGR 95.00% 0 0 5.85 n-term: Pyro-cmC (-17.03) 1,080.03 2,158.05 2,158.05 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qADLEKEELAEELASSLSGR 95.00% 0 0 6.1 n-term: Pyro-cmC (-17.03) 1,080.04 2,158.05 2,158.05 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% qADLEKEELAEELASSLSGR 95.00% 0 0 7.03 n-term: Pyro-cmC (-17.03) 1,080.04 2,158.06 2,158.05 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 5.3 0.612 4.66 1,088.04 2,174.07 2,175.08 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 5.35 0.632 4.8 1,088.55 2,175.07 2,175.08 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 5.33 0.541 5.21 1,088.55 2,175.07 2,175.08 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 5.42 0.576 5.48 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 5.72 0.586 5.68 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 5.71 0.563 4.14 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 5.49 0.61 7.12 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 5.39 0.607 5.31 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% QADLEKEELAEELASSLSGR 95.00% 5.48 0.618 4.77 1,088.55 2,175.08 2,175.08 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 6.63 0.594 10.6 1,152.59 2,303.17 2,303.17 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% KQADLEKEELAEELASSLSGR 95.00% 6.87 0.59 9.62 1,152.59 2,303.17 2,303.17 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 6.6 0.597 6.89 1,196.09 2,390.16 2,390.17 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 6.36 0.57 7.74 1,196.09 2,390.16 2,390.17 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 6.2 0.598 8.19 1,196.09 2,390.16 2,390.17 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 6.41 0.577 7.12 1,196.09 2,390.17 2,390.17 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 6.41 0.599 7.32 1,196.09 2,390.17 2,390.17 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 6.27 0.594 7.48 1,196.09 2,390.17 2,390.17 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 6.57 0.582 8.36 1,196.09 2,390.17 2,390.17 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 6.57 0.6 9 1,196.09 2,390.17 2,390.17 2
 SAMPLE 4R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 97 134 1024 43.10% DVASLSSQLQDTQELLQEETR 95.00% 5.96 0.582 8.1 1,196.10 2,390.17 2,390.17 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KLEAQVQELQSK 95.00% 4.2 0.235 0 467.597 1,399.77 1,400.78 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KLEAQVQELQSK 95.00% 4.35 0.212 1.14 467.5972 1,399.77 1,400.78 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KLEAQVQELQSK 95.00% 3.59 0.214 1.16 467.5977 1,399.77 1,400.78 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KLEAQVQELQSK 95.00% 3.92 0.209 1 467.5984 1,399.77 1,400.78 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IVFQEFR 95.00% 2.86 0.343 0 469.7586 937.5015 938.51 2 MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IVFQEFR 95.00% 2.75 0.34 0 469.7597 937.5038 938.51 2 MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VIQYLAVVASSHK 95.00% 2.92 0.516 0 472.2733 1,413.80 1,414.81 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VIQYLAVVASSHK 95.00% 1.97 0.462 0 472.2754 1,413.80 1,414.81 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VIQYLAVVASSHK 95.00% 3.69 0.51 2.36 472.6081 1,414.80 1,414.81 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LKEILLQVEDER 95.00% 2.45 0.205 1.49 495.612 1,483.81 1,484.83 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LKEILLQVEDER 95.00% 3.09 0.23 0 495.6121 1,483.81 1,484.83 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% DKTEFSIIHYAGK 95.00% 3.31 0.271 1 503.5964 1,507.77 1,508.78 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% cNGVLEGIR 95.00% 2.92 0.403 1.17 c1: Carbamidomethyl (+57.02) 509.2596 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% cNGVLEGIR 95.00% 2.88 0.41 1.25 c1: Carbamidomethyl (+57.02) 509.2601 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% cNGVLEGIR 95.00% 2.17 0.236 0 c1: Carbamidomethyl (+57.02) 509.2602 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% cNGVLEGIR 95.00% 2.3 0.281 0 c1: Carbamidomethyl (+57.02) 509.2605 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KKLEAQVQELQSK 95.00% 3.57 0.337 0 510.2922 1,527.85 1,528.87 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KKLEAQVQELQSK 95.00% 2.48 0.238 0 510.2935 1,527.86 1,528.87 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KKLEAQVQELQSK 95.00% 3.19 0.339 0 510.2937 1,527.86 1,528.87 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KKLEAQVQELQSK 95.00% 3.16 0.372 0 510.294 1,527.86 1,528.87 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VKPLLQVTR 95.00% 2.06 0.301 0 527.3412 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VKPLLQVTR 95.00% 2.08 0.291 0 527.3418 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VKPLLQVTR 95.00% 1.96 0.291 0 527.342 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VKPLLQVTR 95.00% 1.94 0.286 0 527.3423 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% SGKLDAFLVLEQLR 95.00% 4.6 0.185 2 530.3049 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% SGKLDAFLVLEQLR 95.00% 4.55 0.267 1.82 530.3058 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LKEILLQVEDERK 95.00% 4.02 0.397 0 538.3107 1,611.91 1,612.93 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LKEILLQVEDERK 95.00% 3.96 0.373 0 538.3135 1,611.92 1,612.93 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LKEILLQVEDERK 95.00% 3.97 0.367 0 538.6467 1,612.92 1,612.93 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LKEILLQVEDERK 95.00% 3.03 0.291 0 538.6475 1,612.92 1,612.93 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LKEILLQVEDERK 95.00% 3.62 0.423 0 538.6478 1,612.92 1,612.93 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 3.15 0.35 1.66 543.9484 1,628.82 1,629.83 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 3.16 0.374 1.92 543.9486 1,628.82 1,629.83 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 3.46 0.308 1.12 543.9487 1,628.82 1,629.83 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 3.49 0.348 1.51 543.9491 1,628.82 1,629.83 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 2.99 0.256 1.12 544.2827 1,629.82 1,629.83 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 3.2 0.336 1.68 544.2829 1,629.83 1,629.83 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 3.14 0.256 1.08 544.2838 1,629.83 1,629.83 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% QTLEKENADLAGELR 95.00% 2.55 0.373 0 562.9592 1,685.85 1,686.87 3 CO3_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% QTLEKENADLAGELR 95.00% 2.04 0.277 0 563.2945 1,686.86 1,686.87 3 CO3_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ASRDEIFATAKENEK 95.00% 3.68 0.339 1.51 570.2864 1,707.84 1,708.85 3 VINC_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ASRDEIFATAKENEK 95.00% 2.91 0.215 0 570.2867 1,707.84 1,708.85 3 VINC_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ASRDEIFATAKENEK 95.00% 3.59 0.189 1.55 570.2917 1,707.85 1,708.85 3 VINC_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ASRDEIFATAKENEK 95.00% 3.58 0.374 1.37 570.6205 1,708.84 1,708.85 3 VINC_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ASRDEIFATAKENEK 95.00% 3.4 0.195 0 570.6214 1,708.84 1,708.85 3 VINC_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KFDQLLAEEKNISSK 95.00% 3.09 0.309 0 584.3165 1,749.93 1,749.94 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ISDLTTNLAEEEEKAK 95.00% 3.56 0.207 0 597.6371 1,789.89 1,790.90 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ISDLTTNLAEEEEKAK 95.00% 2.63 0.202 0 597.6372 1,789.89 1,790.90 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ISDLTTNLAEEEEKAK 95.00% 2.26 0.226 0 597.6377 1,789.89 1,790.90 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ISDLTTNLAEEEEKAK 95.00% 2.84 0.177 0 597.6379 1,789.89 1,790.90 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ISDLTTNLAEEEEKAK 95.00% 2.43 0.267 0 597.9713 1,790.89 1,790.90 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IAQLEEQVEQEAREK 95.00% 2.48 0.376 0 600.6405 1,798.90 1,799.91 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IAQLEEQVEQEAREK 95.00% 2.23 0.211 0 600.6418 1,798.90 1,799.91 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IAQLEEQVEQEAREK 95.00% 2.44 0.25 0 600.6418 1,798.90 1,799.91 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% YEILAANAIPK 95.00% 3.09 0.447 2 601.841 1,201.67 1,202.68 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% YEILAANAIPK 95.00% 3.49 0.353 2.02 601.8412 1,201.67 1,202.68 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALELDPNLYR 95.00% 2.74 0.251 2.2 602.3204 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALELDPNLYR 95.00% 2.82 0.254 1.2 602.3207 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALELDPNLYR 95.00% 2.82 0.266 2.21 602.3208 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALELDPNLYR 95.00% 2.75 0.245 2.39 602.3218 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALELDPNLYR 95.00% 2.77 0.27 2.11 602.322 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALELDPNLYR 95.00% 2.52 0.284 1.8 602.3227 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALELDPNLYR 95.00% 2.98 0.262 1.74 602.8224 1,203.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LEEEEDRGQQLQAER 95.00% 2.46 0.232 0 610.6282 1,828.86 1,829.86 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KFDQLLAEEK 95.00% 2.97 0.259 0 610.8289 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KFDQLLAEEK 95.00% 2.72 0.252 0 610.8295 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KFDQLLAEEK 95.00% 2.5 0.199 0 610.8316 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% TGVLAHLEEER 95.00% 3.54 0.441 2.52 627.3277 1,252.64 1,253.65 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% TGVLAHLEEER 95.00% 3.16 0.421 3.41 627.3278 1,252.64 1,253.65 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VDYNASAWLTK 95.00% 3.52 0.479 2.96 634.3146 1,266.61 1,267.63 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VDYNASAWLTK 95.00% 3.97 0.522 2.74 634.3165 1,266.62 1,267.63 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VDYNASAWLTK 95.00% 4.17 0.518 4.68 634.317 1,266.62 1,267.63 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VDYNASAWLTK 95.00% 3.7 0.488 3.29 634.3172 1,266.62 1,267.63 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VDYNASAWLTK 95.00% 3.8 0.494 2.68 634.3181 1,266.62 1,267.63 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VDYNASAWLTK 95.00% 4.01 0.481 4.35 634.8175 1,267.62 1,267.63 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LEAQVQELQSK 95.00% 2.91 0.403 0 636.8434 1,271.67 1,272.68 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LEAQVQELQSK 95.00% 2.74 0.364 1.16 636.8436 1,271.67 1,272.68 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LEAQVQELQSK 95.00% 3.25 0.35 0 636.844 1,271.67 1,272.68 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 4.91 0.514 2.31 638.3233 1,911.95 1,912.96 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 4.92 0.472 1.39 638.3237 1,911.95 1,912.96 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 5 0.49 1.66 638.324 1,911.95 1,912.96 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 4.6 0.505 1.72 638.3244 1,911.95 1,912.96 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 4.52 0.496 2.01 638.3248 1,911.95 1,912.96 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 4.89 0.43 2.26 638.659 1,912.95 1,912.96 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KATQQAEQLSNELATER 95.00% 4.45 0.493 1.74 639.658 1,915.95 1,916.97 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KATQQAEQLSNELATER 95.00% 3.74 0.432 1.23 639.6595 1,915.96 1,916.97 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KATQQAEQLSNELATER 95.00% 5.04 0.362 1.02 639.6597 1,915.96 1,916.97 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KATQQAEQLSNELATER 95.00% 4.26 0.483 1.21 639.6601 1,915.96 1,916.97 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KATQQAEQLSNELATER 95.00% 4.46 0.477 0 639.6605 1,915.96 1,916.97 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KATQQAEQLSNELATER 95.00% 3.29 0.358 1.49 639.9937 1,916.96 1,916.97 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KATQQAEQLSNELATER 95.00% 4.98 0.443 1.35 639.9943 1,916.96 1,916.97 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KATQQAEQLSNELATER 95.00% 2.51 0.335 0 639.9947 1,916.96 1,916.97 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% EQADFAVEALAK 95.00% 2.49 0.411 0 646.3283 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% EQADFAVEALAK 95.00% 3.36 0.474 1.72 646.3288 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% EQADFAVEALAK 95.00% 3.27 0.503 1.72 646.3288 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% EQADFAVEALAK 95.00% 2.94 0.468 0 646.3297 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ELEGHISDLQEDLDSER 95.00% 3.2 0.287 0 662.643 1,984.91 1,984.91 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KLEGDLKDLELQADSAIK 95.00% 3.88 0.423 0 662.6965 1,985.07 1,986.08 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KLEGDLKDLELQADSAIK 95.00% 4.23 0.285 2.31 663.0283 1,986.06 1,986.08 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% HAQAVEELTEQLEQFKR 95.00% 2.61 0.356 0 686.3736 2,056.10 2,056.05 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KLEAQVQELQSK 95.00% 4.27 0.541 4.52 700.8897 1,399.76 1,400.78 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KLEAQVQELQSK 95.00% 4.08 0.562 4.43 700.8898 1,399.76 1,400.78 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VIQYLAVVASSHK 95.00% 3.04 0.223 3.8 707.901 1,413.79 1,414.81 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% VIQYLAVVASSHK 95.00% 2.47 0 5.09 707.9024 1,413.79 1,414.81 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KLEDEILVMDDQNNKLSK 95.00% 4.32 0.493 0 711.7026 2,132.08 2,132.09 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% QADLEKEELAEELASSLSGR 95.00% 2.68 0.389 0 725.6954 2,174.06 2,175.08 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% QADLEKEELAEELASSLSGR 95.00% 2.84 0.451 0 725.6982 2,174.07 2,175.08 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% QADLEKEELAEELASSLSGR 95.00% 3.67 0.452 0 726.0311 2,175.07 2,175.08 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% QADLEKEELAEELASSLSGR 95.00% 2.28 0.215 1.04 726.0322 2,175.07 2,175.08 3
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% HISTLNIQLSDSK 95.00% 3.38 0.585 4.54 728.3867 1,454.76 1,455.78 2 TITIN_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IAQLEEQVEQEAR 95.00% 4.53 0.43 3.16 771.8908 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IAQLEEQVEQEAR 95.00% 4.63 0.444 3 771.8909 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IAQLEEQVEQEAR 95.00% 4.88 0.452 3.12 771.891 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IAQLEEQVEQEAR 95.00% 4.62 0.416 3 771.8911 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IAQLEEQVEQEAR 95.00% 4.56 0.411 3.16 771.8918 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IAQLEEQVEQEAR 95.00% 4.71 0.412 3.26 771.8918 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IAQLEEQVEQEAR 95.00% 4.7 0.375 3.03 772.3931 1,542.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% IAQLEEQVEQEAR 95.00% 0 0 4.15 773.403 1,544.79 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ELDEATESNEAMGR 95.00% 4.07 0.567 4.21 776.3297 1,550.64 1,551.66 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ELDEATESNEAMGR 95.00% 4.09 0.575 4.46 776.3316 1,550.65 1,551.66 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ISDLTTNLAEEEEK 95.00% 2.34 0.332 1.14 796.3833 1,590.75 1,591.77 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 4.45 0.405 3.19 815.4182 1,628.82 1,629.83 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 4.49 0.41 3.14 815.4196 1,628.82 1,629.83 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 4.47 0.397 2.92 815.4205 1,628.83 1,629.83 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 4.44 0.445 3.62 815.4218 1,628.83 1,629.83 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 3.77 0.191 0 815.92 1,629.82 1,629.83 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ALEEALEAKEELER 95.00% 4.47 0.35 2.35 815.9221 1,629.83 1,629.83 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQDFASTVEALEEGK 95.00% 4.22 0.464 4.57 818.9061 1,635.80 1,636.81 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQDFASTVEALEEGK 95.00% 4.08 0.57 9.03 818.9066 1,635.80 1,636.81 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQDFASTVEALEEGK 95.00% 4.39 0.523 5.19 819.4049 1,636.79 1,636.81 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQDFASTVEALEEGK 95.00% 4.56 0.49 5.92 819.406 1,636.80 1,636.81 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQDFASTVEALEEGK 95.00% 4.64 0.513 4.96 819.4063 1,636.80 1,636.81 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQDFASTVEALEEGK 95.00% 3.24 0.52 5.35 819.4068 1,636.80 1,636.81 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% QLLQANPILEAFGNAK 95.00% 4.27 0.514 5.01 863.9759 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% QLLQANPILEAFGNAK 95.00% 4.84 0.509 5.08 863.9767 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% QLLQANPILEAFGNAK 95.00% 4.14 0.525 3.68 863.9767 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% QLLQANPILEAFGNAK 95.00% 2.86 0.4 1.47 863.9768 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% QLLQANPILEAFGNAK 95.00% 4.83 0.543 4.27 863.9778 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ISDLTTNLAEEEEKAK 95.00% 4.51 0.553 3.09 895.9528 1,789.89 1,790.90 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ISDLTTNLAEEEEKAK 95.00% 3.89 0.465 0 895.9531 1,789.89 1,790.90 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 5.5 0.587 5.52 956.9811 1,911.95 1,912.96 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 5.76 0.592 5.04 956.983 1,911.95 1,912.96 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 5.13 0.634 7.14 956.9835 1,911.95 1,912.96 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 5.52 0.615 5.28 956.9837 1,911.95 1,912.96 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 5.69 0.586 4.64 957.4834 1,912.95 1,912.96 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 5.72 0.566 4.04 957.4845 1,912.95 1,912.96 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% LQQELDDLVVDLDNQR 95.00% 5.77 0.584 5.3 957.4854 1,912.96 1,912.96 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% KATQQAEQLSNELATER 95.00% 5.77 0.629 6.57 959.4866 1,916.96 1,916.97 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ELEGHISDLQEDLDSER 95.00% 2.19 0.456 1.4 993.4947 1,984.97 1,984.91 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% ELEGHISDLQEDLDSER 95.00% 1.66 0.379 1.49 993.4958 1,984.98 1,984.91 2
 SAMPLE 1 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 38 45 151 23.00% DVASLSSQLQDTQELLQEETR 95.00% 5.82 0.567 6.6 1,196.09 2,390.17 2,390.17 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KLEAQVQELQSK 95.00% 4.01 0.212 0 467.5971 1,399.77 1,400.78 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KLEAQVQELQSK 95.00% 3.87 0.264 0 467.5974 1,399.77 1,400.78 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KLEAQVQELQSK 95.00% 3.43 0.0802 1.14 467.5976 1,399.77 1,400.78 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% IVFQEFR 95.00% 2.64 0.373 0 469.7592 937.5027 938.51 2 MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% IVFQEFR 95.00% 2.77 0.351 0 469.7606 937.5056 938.51 2 MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VIQYLAVVASSHK 95.00% 2.58 0.325 0 472.274 1,413.80 1,414.81 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VIQYLAVVASSHK 95.00% 2.97 0.511 1.24 472.2743 1,413.80 1,414.81 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VIQYLAVVASSHK 95.00% 2.83 0.48 1.49 472.2745 1,413.80 1,414.81 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VIQYLAVVASSHK 95.00% 2.35 0.406 1.44 472.6087 1,414.80 1,414.81 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% HISTLNIQLSDSK 95.00% 2.4 0.229 0 485.9315 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% HISTLNIQLSDSK 95.00% 2.44 0.349 0 485.9324 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% DKTEFSIIHYAGK 95.00% 3.06 0.179 0 503.5952 1,507.76 1,508.78 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% cNGVLEGIR 95.00% 2.63 0.404 1.85 c1: Carbamidomethyl (+57.02) 509.2597 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KKLEAQVQELQSK 95.00% 2.88 0.263 0 510.2914 1,527.85 1,528.87 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KKLEAQVQELQSK 95.00% 3.16 0.302 0 510.2942 1,527.86 1,528.87 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KKLEAQVQELQSK 95.00% 3.35 0.209 0 510.6289 1,528.86 1,528.87 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LEVNMQALK 95.00% 2.14 0.253 0 523.2879 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VKPLLQVTR 95.00% 1.85 0.284 0 527.3419 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% HISTLNIQLSDSKK 95.00% 3.7 0.454 2.1 528.6309 1,582.87 1,583.88 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% SGKLDAFLVLEQLR 95.00% 4.12 0.253 0 530.3055 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% SGKLDAFLVLEQLR 95.00% 3.56 0.216 0 530.3061 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% SGKLDAFLVLEQLR 95.00% 3.68 0.234 0 530.3071 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% SGKLDAFLVLEQLR 95.00% 4.39 0.192 0 530.6403 1,588.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LKEILLQVEDERK 95.00% 3.3 0.208 0 538.3145 1,611.92 1,612.93 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LKEILLQVEDERK 95.00% 3.37 0.443 0 538.3163 1,611.93 1,612.93 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALEEALEAKEELER 95.00% 3.48 0.297 1.35 543.9485 1,628.82 1,629.83 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALEEALEAKEELER 95.00% 2.95 0.267 1.23 544.2839 1,629.83 1,629.83 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALEEALEAKEELER 95.00% 3.37 0.245 1.51 544.2841 1,629.83 1,629.83 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQDFASTVEALEEGK 95.00% 2.02 0.246 0 546.2731 1,635.80 1,636.81 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QTLEKENADLAGELR 95.00% 2.06 0.359 0 562.9579 1,685.85 1,686.87 3 CO3_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QTLEKENADLAGELR 95.00% 2.17 0.399 0 562.9592 1,685.85 1,686.87 3 CO3_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QTLEKENADLAGELR 95.00% 2.43 0.444 0 562.9593 1,685.85 1,686.87 3 CO3_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QTLEKENADLAGELR 95.00% 2.94 0.38 0 563.297 1,686.87 1,686.87 3 CO3_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ASRDEIFATAKENEK 95.00% 2.74 0.212 0 570.2867 1,707.84 1,708.85 3 VINC_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ASRDEIFATAKENEK 95.00% 3.59 0.231 0 570.2888 1,707.84 1,708.85 3 VINC_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ASRDEIFATAKENEK 95.00% 3.51 0.261 1.07 570.6208 1,708.84 1,708.85 3 VINC_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ASRDEIFATAKENEK 95.00% 3.75 0.339 1.39 570.6222 1,708.84 1,708.85 3 VINC_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QLLQANPILEAFGNAK 95.00% 4.61 0.441 3.19 576.6544 1,726.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QLLQANPILEAFGNAK 95.00% 4.08 0.428 2.41 576.6545 1,726.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% mTESSLPSASK 95.00% 2.5 0.357 1.72 m1: Oxidation (+15.99) 577.2732 1,152.53 1,153.54 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% mTESSLPSASK 95.00% 2.41 0.38 2.14 m1: Oxidation (+15.99) 577.2748 1,152.53 1,153.54 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% mTESSLPSASK 95.00% 2.65 0.359 1.47 m1: Oxidation (+15.99) 577.2754 1,152.54 1,153.54 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% mTESSLPSASK 95.00% 2.75 0.421 1.44 m1: Oxidation (+15.99) 577.7794 1,153.54 1,153.54 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ATQQAEQLSNELATER 95.00% 2.66 0.275 0 597.2984 1,788.87 1,788.87 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ISDLTTNLAEEEEKAK 95.00% 3.63 0.322 0 597.6398 1,789.90 1,790.90 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ISDLTTNLAEEEEKAK 95.00% 2.8 0.244 0 597.9719 1,790.89 1,790.90 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ISDLTTNLAEEEEKAK 95.00% 2.61 0.254 0 597.9729 1,790.90 1,790.90 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% IAQLEEQVEQEAREK 95.00% 2.72 0.39 0 600.6404 1,798.90 1,799.91 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% IAQLEEQVEQEAREK 95.00% 2.88 0.3 0 600.6423 1,798.90 1,799.91 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% YEILAANAIPK 95.00% 3.35 0.387 1.89 601.8414 1,201.67 1,202.68 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% YEILAANAIPK 95.00% 3.01 0.399 1.49 601.8414 1,201.67 1,202.68 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% YEILAANAIPK 95.00% 2.21 0.192 1.12 602.3079 1,202.60 1,202.68 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALELDPNLYR 95.00% 2.53 0.249 2.77 602.3199 1,202.62 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALELDPNLYR 95.00% 2.21 0.245 1.64 602.3202 1,202.62 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALELDPNLYR 95.00% 2.84 0.287 1.64 602.3202 1,202.62 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALELDPNLYR 95.00% 2.36 0.252 1.34 602.3207 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALELDPNLYR 95.00% 2.63 0.246 1.8 602.3219 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALELDPNLYR 95.00% 2.75 0.268 2.09 602.3219 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALELDPNLYR 95.00% 2.57 0.245 2.05 602.3221 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALELDPNLYR 95.00% 2.4 0.246 1.64 602.3222 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KFDQLLAEEK 95.00% 2.53 0.204 0 610.8277 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KFDQLLAEEK 95.00% 2.77 0.251 0 610.8283 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KFDQLLAEEK 95.00% 2.6 0.209 0 610.8285 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KFDQLLAEEK 95.00% 2.77 0.285 0 610.8295 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% TGVLAHLEEER 95.00% 2.97 0.467 2.48 627.3271 1,252.64 1,253.65 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% TGVLAHLEEER 95.00% 2.78 0.444 1.92 627.3278 1,252.64 1,253.65 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VDYNASAWLTK 95.00% 3.73 0.511 3.13 634.317 1,266.62 1,267.63 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VDYNASAWLTK 95.00% 3.58 0.463 4.06 634.3174 1,266.62 1,267.63 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VDYNASAWLTK 95.00% 3.83 0.527 4.03 634.3177 1,266.62 1,267.63 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VDYNASAWLTK 95.00% 3.27 0.513 3.49 634.3185 1,266.62 1,267.63 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VDYNASAWLTK 95.00% 3.47 0.481 2.82 634.3189 1,266.62 1,267.63 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VDYNASAWLTK 95.00% 3.54 0.515 2.92 634.3191 1,266.62 1,267.63 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LEAQVQELQSK 95.00% 2.1 0.411 0 636.8403 1,271.67 1,272.68 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 3 0.271 0 638.6567 1,912.95 1,912.96 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 2.79 0.273 1.17 638.6578 1,912.95 1,912.96 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 4.73 0.479 1.62 638.658 1,912.95 1,912.96 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 3.63 0.414 1.49 638.659 1,912.95 1,912.96 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 4.43 0.444 1.55 638.6593 1,912.95 1,912.96 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KATQQAEQLSNELATER 95.00% 4.39 0.45 0 639.6566 1,915.95 1,916.97 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KATQQAEQLSNELATER 95.00% 4.43 0.456 1.25 639.66 1,915.96 1,916.97 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KATQQAEQLSNELATER 95.00% 4.05 0.364 1.26 639.6612 1,915.96 1,916.97 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KATQQAEQLSNELATER 95.00% 4.13 0.381 1.55 639.9933 1,916.96 1,916.97 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KATQQAEQLSNELATER 95.00% 4.37 0.354 1.3 639.994 1,916.96 1,916.97 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KATQQAEQLSNELATER 95.00% 4.69 0.392 0.959 639.9953 1,916.96 1,916.97 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% EQADFAVEALAK 95.00% 2.99 0.478 1.22 646.3286 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% EQADFAVEALAK 95.00% 2.59 0.405 0 646.3288 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% EQADFAVEALAK 95.00% 3.09 0.501 0 646.3289 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% EQADFAVEALAK 95.00% 3.03 0.527 1.27 646.3293 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% EQADFAVEALAK 95.00% 2.67 0.414 0 646.3299 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% EQADFAVEALAK 95.00% 2.61 0.341 0 646.3308 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% TQLEELEDELQATEDAK 95.00% 2.9 0.204 0 654.6444 1,960.91 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LDAFLVLEQLR 95.00% 3.06 0.177 0 658.8817 1,315.75 1,316.76 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LDAFLVLEQLR 95.00% 2.81 0.262 0 658.8825 1,315.75 1,316.76 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LDAFLVLEQLR 95.00% 2.95 0.309 0 658.8833 1,315.75 1,316.76 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% AENELKELEQK 95.00% 2.62 0.184 0 665.8461 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KLEAQVQELQSK 95.00% 4.3 0.503 5.4 700.8882 1,399.76 1,400.78 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KLEAQVQELQSK 95.00% 4.14 0.526 4.37 700.8907 1,399.77 1,400.78 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QADLEKEELAEELASSLSGR 95.00% 2.71 0.398 1.09 726.0307 2,175.07 2,175.08 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QADLEKEELAEELASSLSGR 95.00% 2.27 0.256 0 726.0309 2,175.07 2,175.08 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QADLEKEELAEELASSLSGR 95.00% 3.77 0.438 0 726.0322 2,175.07 2,175.08 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QADLEKEELAEELASSLSGR 95.00% 3.08 0.422 0 726.0322 2,175.07 2,175.08 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% HISTLNIQLSDSK 95.00% 3.67 0.536 5.52 728.3917 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% HISTLNIQLSDSK 95.00% 3.84 0.625 4.41 728.3938 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VVSSVLQLGNIVFK 95.00% 4.12 0.522 4.89 751.9496 1,501.88 1,502.89 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VVSSVLQLGNIVFK 95.00% 4.67 0.523 4.82 751.9507 1,501.89 1,502.89 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VVSSVLQLGNIVFK 95.00% 4.59 0.535 4.38 751.951 1,501.89 1,502.89 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VVSSVLQLGNIVFK 95.00% 2.22 0.298 1.7 751.9512 1,501.89 1,502.89 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VVSSVLQLGNIVFK 95.00% 4.21 0.516 4.92 751.9514 1,501.89 1,502.89 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% VVSSVLQLGNIVFK 95.00% 3.43 0.454 3.89 751.9528 1,501.89 1,502.89 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% IAQLEEQVEQEAR 95.00% 4.25 0.385 3.43 771.8904 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% IAQLEEQVEQEAR 95.00% 4.69 0.429 4.4 771.8905 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% IAQLEEQVEQEAR 95.00% 4.45 0.404 3.25 771.8905 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% IAQLEEQVEQEAR 95.00% 4.52 0.401 2.92 771.8907 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% IAQLEEQVEQEAR 95.00% 4.58 0.419 2.43 771.8912 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% IAQLEEQVEQEAR 95.00% 4.28 0.391 2.96 771.8932 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% IAQLEEQVEQEAR 95.00% 4.47 0.357 3.22 772.395 1,542.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% IAQLEEQVEQEAR 95.00% 3.18 0.384 3.12 772.3954 1,542.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% SGKLDAFLVLEQLR 95.00% 4.17 0.397 4.26 794.8891 1,587.76 1,588.91 2 SPTA2_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% DVASLSSQLQDTQELLQEETR 95.00% 7.35 0.565 6.17 797.7291 2,390.16 2,390.17 3
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALEEALEAKEELER 95.00% 4 0.397 4.4 815.42 1,628.82 1,629.83 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALEEALEAKEELER 95.00% 4.39 0.439 3.08 815.4209 1,628.83 1,629.83 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALEEALEAKEELER 95.00% 4.17 0.37 1.82 815.4211 1,628.83 1,629.83 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALEEALEAKEELER 95.00% 4.46 0.372 4.66 815.4212 1,628.83 1,629.83 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% ALEEALEAKEELER 95.00% 3.84 0.291 0 815.9221 1,629.83 1,629.83 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQDFASTVEALEEGK 95.00% 3.74 0.494 6.85 818.906 1,635.80 1,636.81 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQDFASTVEALEEGK 95.00% 4.46 0.499 5.64 818.906 1,635.80 1,636.81 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQDFASTVEALEEGK 95.00% 4.24 0.535 6.33 818.9063 1,635.80 1,636.81 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQDFASTVEALEEGK 95.00% 3.99 0.509 5.17 818.9068 1,635.80 1,636.81 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQDFASTVEALEEGK 95.00% 4.3 0.497 7.54 818.9079 1,635.80 1,636.81 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQDFASTVEALEEGK 95.00% 4.59 0.501 6.6 819.4068 1,636.80 1,636.81 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQDFASTVEALEEGK 95.00% 4.19 0.479 6.04 819.4082 1,636.80 1,636.81 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QLLQANPILEAFGNAK 95.00% 2.57 0.298 0 863.4591 1,724.90 1,726.95 2 MYH9_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QLLQANPILEAFGNAK 95.00% 3.41 0.304 0 863.9654 1,725.92 1,726.95 2 MYH9_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QLLQANPILEAFGNAK 95.00% 4.86 0.561 4.52 863.9758 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QLLQANPILEAFGNAK 95.00% 4.74 0.531 5.92 863.976 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QLLQANPILEAFGNAK 95.00% 4.59 0.535 4.24 863.9779 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QLLQANPILEAFGNAK 95.00% 4.53 0.461 3.17 864.4766 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QLLQANPILEAFGNAK 95.00% 4.63 0.54 4 864.4767 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QLLQANPILEAFGNAK 95.00% 4.97 0.518 5.18 864.4784 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% QLLQANPILEAFGNAK 95.00% 4.29 0.499 3.8 864.4804 1,726.95 1,726.95 2 MYH9_HUMAN
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KLQDFASTVEALEEGK 95.00% 4.91 0.589 5.8 882.9568 1,763.90 1,764.90 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 5.87 0.567 4.59 956.9818 1,911.95 1,912.96 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 4.91 0.607 4.26 956.9818 1,911.95 1,912.96 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 5.3 0.557 4.72 956.9828 1,911.95 1,912.96 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 5.6 0.591 3.82 956.984 1,911.95 1,912.96 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 5.8 0.594 5.92 956.9844 1,911.95 1,912.96 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 4.92 0.569 4.29 956.9878 1,911.96 1,912.96 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 5.32 0.587 4.28 957.4801 1,912.94 1,912.96 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 5.6 0.62 5.39 957.4822 1,912.95 1,912.96 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQQELDDLVVDLDNQR 95.00% 5.36 0.592 3.01 957.4843 1,912.95 1,912.96 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KATQQAEQLSNELATER 95.00% 5.78 0.628 6.8 958.989 1,915.96 1,916.97 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KATQQAEQLSNELATER 95.00% 5.59 0.624 6.34 958.9912 1,915.97 1,916.97 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KATQQAEQLSNELATER 95.00% 5.05 0.569 5.6 959.4862 1,916.96 1,916.97 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% KATQQAEQLSNELATER 95.00% 5.86 0.627 5.62 959.4892 1,916.96 1,916.97 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQNEVESVTGMLNEAEGK 95.00% 4.68 0.666 8.24 974.4687 1,946.92 1,947.93 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQNEVESVTGMLNEAEGK 95.00% 5.57 0.646 8.07 974.4694 1,946.92 1,947.93 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% LQNEVESVTGMLNEAEGK 95.00% 5.68 0.631 10.1 974.9695 1,947.92 1,947.93 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% DVASLSSQLQDTQELLQEETR 95.00% 6.55 0.568 8 1,196.08 2,390.15 2,390.17 2
 SAMPLE 1R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 39 48 159 21.90% DVASLSSQLQDTQELLQEETR 95.00% 6.31 0.585 7.31 1,196.09 2,390.16 2,390.17 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLEAQVQELQSK 95.00% 4.32 0.156 2.2 467.5965 1,399.77 1,400.78 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLEAQVQELQSK 95.00% 4.01 0.269 1.2 467.5968 1,399.77 1,400.78 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLEAQVQELQSK 95.00% 4.18 0.191 0 467.5969 1,399.77 1,400.78 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLEAQVQELQSK 95.00% 3.84 0.289 0 467.5969 1,399.77 1,400.78 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLEAQVQELQSK 95.00% 4.12 0.261 0 467.5982 1,399.77 1,400.78 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLEAQVQELQSK 95.00% 4.22 0.23 0 467.5983 1,399.77 1,400.78 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IVFQEFR 95.00% 2.08 0.269 0 469.7576 937.4996 938.51 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IVFQEFR 95.00% 2.63 0.365 0 469.7579 937.5002 938.51 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IVFQEFR 95.00% 2.94 0.335 0 469.7581 937.5006 938.51 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IVFQEFR 95.00% 2.21 0.358 0 469.7584 937.5011 938.51 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IVFQEFR 95.00% 1.94 0.271 1.12 469.7584 937.5011 938.51 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IVFQEFR 95.00% 2.77 0.333 0 469.7584 937.5011 938.51 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IVFQEFR 95.00% 2.39 0.305 0 469.7585 937.5014 938.51 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IVFQEFR 95.00% 2.53 0.38 1.6 469.7587 937.5018 938.51 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IVFQEFR 95.00% 2.53 0.382 1.39 469.7588 937.5019 938.51 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IVFQEFR 95.00% 2.57 0.398 0 469.7594 937.5031 938.51 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IVFQEFR 95.00% 2.31 0.387 1.64 469.7604 937.5052 938.51 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VIQYLAVVASSHK 95.00% 3.14 0.539 1.59 472.2729 1,413.80 1,414.81 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VIQYLAVVASSHK 95.00% 2.34 0.317 0 472.2735 1,413.80 1,414.81 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VIQYLAVVASSHK 95.00% 2.5 0.358 0 472.2737 1,413.80 1,414.81 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VIQYLAVVASSHK 95.00% 2.13 0.373 0 472.2741 1,413.80 1,414.81 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VIQYLAVVASSHK 95.00% 2.27 0.469 0 472.2752 1,413.80 1,414.81 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LVWVPSEK 95.00% 2.21 0.278 0 479.2737 956.5318 957.541 2 GLYG_HUMAN,RP1L1_HUMAN,COCA1_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% HISTLNIQLSDSK 95.00% 3.92 0.466 2.28 485.9309 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% HISTLNIQLSDSK 95.00% 4.44 0.387 1.2 485.9311 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% HISTLNIQLSDSK 95.00% 3.99 0.386 1.34 485.9314 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% HISTLNIQLSDSK 95.00% 3.16 0.403 0 485.9321 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% HISTLNIQLSDSK 95.00% 2.26 0.178 0 485.9323 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% HISTLNIQLSDSK 95.00% 3.94 0.485 3.62 486.2646 1,455.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAK 95.00% 3.06 0.401 0 487.2628 972.51 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAK 95.00% 2.77 0.335 1.13 487.2632 972.5108 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAK 95.00% 1.92 0.292 0 487.2635 972.5114 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAK 95.00% 1.99 0.265 1.74 487.9138 973.812 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LKEILLQVEDER 95.00% 3.47 0.399 0.921 495.6145 1,483.82 1,484.83 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LKEILLQVEDER 95.00% 2.96 0.306 0 495.6152 1,483.82 1,484.83 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QRYEILAANAIPK 95.00% 4.12 0.367 0 496.2834 1,485.83 1,486.84 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QRYEILAANAIPK 95.00% 3.12 0.287 0 496.2836 1,485.83 1,486.84 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QRYEILAANAIPK 95.00% 3.02 0.271 0.921 496.2843 1,485.83 1,486.84 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% DKTEFSIIHYAGK 95.00% 3.75 0.313 2.26 503.5957 1,507.76 1,508.78 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% DKTEFSIIHYAGK 95.00% 4.03 0.388 2.55 503.5957 1,507.76 1,508.78 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% DKTEFSIIHYAGK 95.00% 4.03 0.312 2.35 503.5957 1,507.76 1,508.78 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% DKTEFSIIHYAGK 95.00% 3.78 0.417 2.48 503.5959 1,507.76 1,508.78 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% DKTEFSIIHYAGK 95.00% 4.06 0.304 2.48 503.5959 1,507.76 1,508.78 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% DKTEFSIIHYAGK 95.00% 4.08 0.364 2.62 503.5962 1,507.77 1,508.78 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% cNGVLEGIR 95.00% 3.2 0.371 1.92 c1: Carbamidomethyl (+57.02) 509.2602 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% cNGVLEGIR 95.00% 3.06 0.265 1.96 c1: Carbamidomethyl (+57.02) 509.2603 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% cNGVLEGIR 95.00% 3.03 0.371 2.22 c1: Carbamidomethyl (+57.02) 509.2607 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% cNGVLEGIR 95.00% 3.17 0.389 2.41 c1: Carbamidomethyl (+57.02) 509.2607 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 3.12 0.285 0 510.2938 1,527.86 1,528.87 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 4.54 0.276 0 510.2939 1,527.86 1,528.87 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 4.01 0.337 0 510.2939 1,527.86 1,528.87 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 4.63 0.303 1.24 510.2941 1,527.86 1,528.87 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 2.36 0.207 0 510.2942 1,527.86 1,528.87 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 4.15 0.382 0.959 510.2946 1,527.86 1,528.87 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 3.58 0.384 0 510.6284 1,528.86 1,528.87 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 4.17 0.374 0 510.6285 1,528.86 1,528.87 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 3.56 0.298 0 510.629 1,528.86 1,528.87 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KVIQYLAVVASSHK 95.00% 2.76 0.27 0 515.2513 1,542.73 1,542.90 3 DESM_HUMAN,COCA1_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KVIQYLAVVASSHK 95.00% 4.42 0.476 1.68 515.3052 1,542.89 1,542.90 3 DESM_HUMAN,COCA1_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ITDVIMAFQAMcR 95.00% 3.17 0.395 0 c12: Carbamidomethyl (+57.02) 519.2517 1,554.73 1,555.74 3 AGRIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ITDVIMAFQAMcR 95.00% 3.2 0.36 0 c12: Carbamidomethyl (+57.02) 519.2517 1,554.73 1,555.74 3 AGRIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ITDVIMAFQAMcR 95.00% 3.06 0.292 0 c12: Carbamidomethyl (+57.02) 519.252 1,554.73 1,555.74 3 AGRIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TFHIFYYMIAGAK 95.00% 3.08 0.265 0 521.2645 1,560.77 1,561.79 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LEVNMQALK 95.00% 2.37 0.251 0 523.2877 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LEVNMQALK 95.00% 2.61 0.237 0 523.2885 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% NKHESMISELEVR 95.00% 3.29 0.352 0 524.5998 1,570.78 1,571.79 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VKPLLQVTR 95.00% 2 0.33 0 527.3416 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VKPLLQVTR 95.00% 2.23 0.362 0 527.3417 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VKPLLQVTR 95.00% 2.1 0.34 0 527.3422 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VKPLLQVTR 95.00% 2.13 0.371 0 527.3423 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% SGKLDAFLVLEQLR 95.00% 4.35 0.25 1.11 530.3054 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% SGKLDAFLVLEQLR 95.00% 3.51 0.167 1.14 530.3058 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% SGKLDAFLVLEQLR 95.00% 4.9 0.263 1.17 530.3061 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% SGKLDAFLVLEQLR 95.00% 4.09 0.256 0 530.3063 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% SGKLDAFLVLEQLR 95.00% 4.41 0.24 0 530.3066 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% SGKLDAFLVLEQLR 95.00% 4.51 0.241 0 530.6389 1,588.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% SGKLDAFLVLEQLR 95.00% 4.94 0.253 0 530.641 1,588.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LKEILLQVEDERK 95.00% 4.97 0.427 1.64 538.3137 1,611.92 1,612.93 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LKEILLQVEDERK 95.00% 4.42 0.437 0 538.3142 1,611.92 1,612.93 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LKEILLQVEDERK 95.00% 3.85 0.422 0 538.3145 1,611.92 1,612.93 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LKEILLQVEDERK 95.00% 4.47 0.447 0.921 538.6476 1,612.92 1,612.93 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% AEMEDLVSSKDDVGK 95.00% 1.91 0.35 1.26 541.5909 1,621.75 1,622.76 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 3.19 0.308 2.25 543.9483 1,628.82 1,629.83 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 3.23 0.382 2.16 543.9483 1,628.82 1,629.83 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 3.59 0.334 2.11 543.9484 1,628.82 1,629.83 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 3.58 0.438 2.68 543.9485 1,628.82 1,629.83 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 3.5 0.409 2.62 543.9487 1,628.82 1,629.83 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 2.96 0.291 2.3 543.9489 1,628.82 1,629.83 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% DTSITGELEK 95.00% 2.29 0.208 1.36 546.7743 1,091.53 1,092.54 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% DTSITGELEK 95.00% 2.38 0.238 1.37 546.7745 1,091.53 1,092.54 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% GQLSDDEKFLFVDK 95.00% 2.37 0.415 0 547.6098 1,639.81 1,640.82 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% GQLSDDEKFLFVDK 95.00% 2.28 0.338 0 547.9444 1,640.81 1,640.82 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% GQLSDDEKFLFVDK 95.00% 1.74 0.354 0.921 547.9448 1,640.81 1,640.82 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QTLEKENADLAGELR 95.00% 3.13 0.428 0 562.9595 1,685.85 1,686.87 3 CO3_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QTLEKENADLAGELR 95.00% 3.4 0.376 0 562.9597 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QTLEKENADLAGELR 95.00% 2.26 0.283 1.25 562.9601 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QTLEKENADLAGELR 95.00% 2.94 0.412 1.46 563.2936 1,686.86 1,686.87 3 CO3_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QLHEYETELEDER 95.00% 4.09 0.426 0 564.2565 1,689.75 1,690.76 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% MTESSLPSASK 95.00% 3.11 0.478 2.96 569.2758 1,136.54 1,137.55 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% MTESSLPSASK 95.00% 2.99 0.43 3.02 569.2758 1,136.54 1,137.55 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% MTESSLPSASK 95.00% 3.07 0.526 3.24 569.2759 1,136.54 1,137.55 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% MTESSLPSASK 95.00% 3.17 0.482 2.82 569.276 1,136.54 1,137.55 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% MTESSLPSASK 95.00% 2.97 0.472 3.16 569.2766 1,136.54 1,137.55 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% MTESSLPSASK 95.00% 2.9 0.522 2.85 569.2779 1,136.54 1,137.55 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ASRDEIFATAKENEK 95.00% 3.67 0.36 0 570.6218 1,708.84 1,708.85 3 VINC_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% mTESSLPSASK 95.00% 2.87 0.484 2.57 m1: Oxidation (+15.99) 577.2733 1,152.53 1,153.54 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% mTESSLPSASK 95.00% 2.48 0.42 0 m1: Oxidation (+15.99) 577.2745 1,152.53 1,153.54 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% mTESSLPSASK 95.00% 2.69 0.373 2.82 m1: Oxidation (+15.99) 577.2746 1,152.53 1,153.54 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% mTESSLPSASK 95.00% 2.27 0.313 1.82 m1: Oxidation (+15.99) 577.2752 1,152.53 1,153.54 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% mTESSLPSASK 95.00% 2.28 0.301 2.01 m1: Oxidation (+15.99) 577.2762 1,152.54 1,153.54 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QEEEMQAKEDELQK 95.00% 3.29 0.267 1.12 578.9324 1,733.77 1,734.79 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QEEEMQAKEDELQK 95.00% 3.34 0.341 1.47 578.9335 1,733.78 1,734.79 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QEEEMQAKEDELQK 95.00% 3.62 0.277 1.96 578.9338 1,733.78 1,734.79 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QEEEMQAKEDELQK 95.00% 3.51 0.311 2.48 578.934 1,733.78 1,734.79 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QEEEMQAKEDELQK 95.00% 3.33 0.333 2.18 578.9341 1,733.78 1,734.79 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QEEEMQAKEDELQK 95.00% 3.39 0.152 1.62 579.267 1,734.78 1,734.79 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ISDLTTNLAEEEEKAK 95.00% 2.71 0.228 0 597.6377 1,789.89 1,790.90 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ISDLTTNLAEEEEKAK 95.00% 2.49 0.104 1.6 597.6381 1,789.89 1,790.90 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ISDLTTNLAEEEEKAK 95.00% 3.05 0.243 0 597.6382 1,789.89 1,790.90 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ISDLTTNLAEEEEKAK 95.00% 3.13 0.218 0 597.6382 1,789.89 1,790.90 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ISDLTTNLAEEEEKAK 95.00% 2.78 0.249 0 597.6382 1,789.89 1,790.90 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IAQLEEQVEQEAREK 95.00% 2.16 0.255 0 600.9761 1,799.90 1,799.91 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% DLELQADSAIK 95.00% 2.38 0.11 1.77 601.8156 1,201.62 1,202.63 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% DLELQADSAIK 95.00% 2.68 0.213 0 601.8166 1,201.62 1,202.63 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% YEILAANAIPK 95.00% 3.35 0.444 1.89 601.8416 1,201.67 1,202.68 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% YEILAANAIPK 95.00% 3.44 0.492 1.82 601.8417 1,201.67 1,202.68 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% YEILAANAIPK 95.00% 3.32 0.407 1.64 601.8419 1,201.67 1,202.68 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% YEILAANAIPK 95.00% 3.45 0.484 1.52 601.8421 1,201.67 1,202.68 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% YEILAANAIPK 95.00% 2.68 0.412 1.68 601.8439 1,201.67 1,202.68 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALELDPNLYR 95.00% 2.97 0.267 2.19 602.3204 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALELDPNLYR 95.00% 2.2 0.351 2.59 602.3206 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALELDPNLYR 95.00% 2.9 0.266 1.96 602.3209 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALELDPNLYR 95.00% 2.86 0.26 1.66 602.3211 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALELDPNLYR 95.00% 2.71 0.267 1.43 602.3214 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALELDPNLYR 95.00% 3.19 0.327 3.27 602.3217 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALELDPNLYR 95.00% 2.87 0.29 1.89 602.3218 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALELDPNLYR 95.00% 2.83 0.281 1.12 602.3219 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLEDEILVMDDQNNK 95.00% 2.53 0.244 0 602.3229 1,803.95 1,803.88 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QLHEYETELEDERK 95.00% 3.26 0.344 0 607.2879 1,818.84 1,818.85 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QLHEYETELEDERK 95.00% 2.75 0.294 0 607.2881 1,818.84 1,818.85 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QLHEYETELEDERK 95.00% 2.75 0.253 0 607.2899 1,818.85 1,818.85 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KFDQLLAEEK 95.00% 2.82 0.273 0 610.8291 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KFDQLLAEEK 95.00% 2.73 0.187 0 610.8297 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KFDQLLAEEK 95.00% 2.56 0.205 0 610.8299 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KFDQLLAEEK 95.00% 3.05 0.273 0 610.8301 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LEEEEDRGQQLQAER 95.00% 2.31 0.144 1 610.9592 1,829.85 1,829.86 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EILLQVEDER 95.00% 2.65 0.116 1.15 622.3285 1,242.64 1,243.65 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TGVLAHLEEER 95.00% 2.73 0.322 0 627.3267 1,252.64 1,253.65 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TGVLAHLEEER 95.00% 2.94 0.323 1.21 627.3272 1,252.64 1,253.65 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TGVLAHLEEER 95.00% 3.49 0.43 3 627.3273 1,252.64 1,253.65 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TGVLAHLEEER 95.00% 3.56 0.423 2.4 627.3275 1,252.64 1,253.65 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TGVLAHLEEER 95.00% 2.65 0.277 0 627.3283 1,252.64 1,253.65 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TEFSIIHYAGK 95.00% 3.56 0.483 4.54 633.3294 1,264.64 1,265.65 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TEFSIIHYAGK 95.00% 3.17 0.547 4.4 633.3307 1,264.65 1,265.65 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VDYNASAWLTK 95.00% 4.08 0.552 2.89 634.3183 1,266.62 1,267.63 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VDYNASAWLTK 95.00% 4.12 0.526 2.74 634.3186 1,266.62 1,267.63 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VDYNASAWLTK 95.00% 3.94 0.456 2.7 634.3189 1,266.62 1,267.63 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VDYNASAWLTK 95.00% 4.08 0.529 2.92 634.3194 1,266.62 1,267.63 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VDYNASAWLTK 95.00% 4.3 0.536 2.68 634.3195 1,266.62 1,267.63 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VDYNASAWLTK 95.00% 2.74 0.422 0 634.3195 1,266.62 1,267.63 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LEAQVQELQSK 95.00% 4.04 0.536 1.59 636.8418 1,271.67 1,272.68 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LEAQVQELQSK 95.00% 3.57 0.456 4.41 636.8431 1,271.67 1,272.68 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LEAQVQELQSK 95.00% 3.83 0.517 2.7 636.8436 1,271.67 1,272.68 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LEAQVQELQSK 95.00% 3.94 0.506 2.96 636.8438 1,271.67 1,272.68 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LEAQVQELQSK 95.00% 3.76 0.46 1.66 636.8438 1,271.67 1,272.68 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 4.72 0.472 1.55 638.3245 1,911.95 1,912.96 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 4.97 0.535 3.72 638.3246 1,911.95 1,912.96 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 4.56 0.482 1.92 638.3246 1,911.95 1,912.96 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 4.55 0.471 2.59 638.3248 1,911.95 1,912.96 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 4.51 0.506 3.41 638.3248 1,911.95 1,912.96 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 3.59 0.448 0 638.325 1,911.95 1,912.96 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 4.91 0.531 2.38 638.3251 1,911.95 1,912.96 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 4.58 0.498 1.3 638.3252 1,911.95 1,912.96 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 4.46 0.5 1.23 638.3254 1,911.95 1,912.96 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QLEEAEEESQRINANR 95.00% 2.14 0.211 0 639.3076 1,914.90 1,915.91 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 4.63 0.411 2.74 639.6607 1,915.96 1,916.97 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 3.82 0.45 1.62 639.6607 1,915.96 1,916.97 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 4.1 0.437 2.03 639.6611 1,915.96 1,916.97 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 4.35 0.409 1.64 639.6611 1,915.96 1,916.97 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 4.63 0.412 2.02 639.6615 1,915.96 1,916.97 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 5.04 0.395 2.04 639.9938 1,916.96 1,916.97 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 3.88 0.429 1.59 639.9942 1,916.96 1,916.97 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 5.02 0.453 2.62 639.9945 1,916.96 1,916.97 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 4.36 0.366 1.66 639.9947 1,916.96 1,916.97 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 4.75 0.344 1.82 639.9947 1,916.96 1,916.97 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 4.48 0.415 1.92 639.9948 1,916.96 1,916.97 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQDFASTVEALEEGKKR 95.00% 2.83 0.478 0 641.006 1,919.99 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQDFASTVEALEEGKKR 95.00% 1.93 0.304 0 641.3385 1,920.99 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% FQKEIENLTQQYEEK 95.00% 3.89 0.327 2.96 642.9861 1,925.93 1,926.95 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% FQKEIENLTQQYEEK 95.00% 4.72 0.362 2.74 643.3203 1,926.94 1,926.95 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% FQKEIENLTQQYEEK 95.00% 4.92 0.425 3.06 643.3204 1,926.94 1,926.95 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% FQKEIENLTQQYEEK 95.00% 4.93 0.33 2.8 643.3209 1,926.94 1,926.95 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EQADFAVEALAK 95.00% 2.32 0.415 0 646.328 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EQADFAVEALAK 95.00% 2.6 0.39 1.19 646.329 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EQADFAVEALAK 95.00% 2.58 0.443 1.17 646.3291 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EQADFAVEALAK 95.00% 3.2 0.499 2.14 646.3294 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EQADFAVEALAK 95.00% 2.6 0.316 0 646.3294 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EQADFAVEALAK 95.00% 3.01 0.521 1.35 646.3296 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EQADFAVEALAK 95.00% 2.99 0.49 0 646.3299 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EQADFAVEALAK 95.00% 2.89 0.509 0 646.33 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EQADFAVEALAK 95.00% 3.14 0.43 0 646.33 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EQADFAVEALAK 95.00% 2.65 0.454 1.34 646.3324 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EQADFAVEALAK 95.00% 2.21 0.322 0 647.0156 1,292.02 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQNEVESVTGMLNEAEGK 95.00% 3.44 0.36 1.48 650.3164 1,947.93 1,947.93 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LRLEVNMQALK 95.00% 2.55 0.294 0 657.8797 1,313.74 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LRLEVNMQALK 95.00% 2.47 0.383 0 657.8804 1,313.75 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LRLEVNMQALK 95.00% 2.58 0.369 1.55 657.8813 1,313.75 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LRLEVNMQALK 95.00% 3.01 0.437 0 657.8817 1,313.75 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ELEGHISDLQEDLDSER 95.00% 4.19 0.361 1.37 662.3089 1,983.90 1,984.91 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ELEGHISDLQEDLDSER 95.00% 4.25 0.397 0 662.6407 1,984.90 1,984.91 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ELEGHISDLQEDLDSER 95.00% 3.6 0.402 0 662.6407 1,984.90 1,984.91 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ELEGHISDLQEDLDSER 95.00% 4.02 0.444 1.46 662.6426 1,984.90 1,984.91 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ELEGHISDLQEDLDSER 95.00% 4.37 0.398 0 662.6433 1,984.91 1,984.91 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLEGDLKDLELQADSAIK 95.00% 3.09 0.35 0 662.6958 1,985.06 1,986.08 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLEGDLKDLELQADSAIK 95.00% 5.83 0.492 3.55 663.0296 1,986.07 1,986.08 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLEGDLKDLELQADSAIK 95.00% 3.72 0.381 0 663.03 1,986.07 1,986.08 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% AENELKELEQK 95.00% 3.32 0.0858 0 665.8453 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% AENELKELEQK 95.00% 3.34 0.103 0 665.8453 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% AENELKELEQK 95.00% 3.05 0.161 0 665.8457 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VIQYLAVVASSHK 95.00% 4.23 0.375 3.7 707.9016 1,413.79 1,414.81 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VIQYLAVVASSHK 95.00% 3.79 0.204 3.92 707.9018 1,413.79 1,414.81 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VIQYLAVVASSHK 95.00% 3.74 0.451 3.28 707.9035 1,413.79 1,414.81 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLEDEILVMDDQNNKLSK 95.00% 5.92 0.507 3.04 711.7021 2,132.08 2,132.09 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLEDEILVMDDQNNKLSK 95.00% 6.13 0.548 2.32 711.7023 2,132.08 2,132.09 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QADLEKEELAEELASSLSGR 95.00% 3.55 0.402 1.23 726.03 2,175.07 2,175.08 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QADLEKEELAEELASSLSGR 95.00% 4 0.502 1.39 726.0307 2,175.07 2,175.08 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QADLEKEELAEELASSLSGR 95.00% 3.68 0.496 0 726.0313 2,175.07 2,175.08 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QADLEKEELAEELASSLSGR 95.00% 4.1 0.516 0.959 726.0316 2,175.07 2,175.08 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QADLEKEELAEELASSLSGR 95.00% 3.93 0.491 0 726.0318 2,175.07 2,175.08 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QADLEKEELAEELASSLSGR 95.00% 3.57 0.516 0 726.0326 2,175.07 2,175.08 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% HISTLNIQLSDSK 95.00% 4.35 0.494 4.82 728.3927 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% HISTLNIQLSDSK 95.00% 3.93 0.482 5.85 728.393 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% HISTLNIQLSDSK 95.00% 4.98 0.565 4.7 728.3931 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% HISTLNIQLSDSK 95.00% 4.93 0.544 4.92 728.3938 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LKEILLQVEDER 95.00% 3.47 0.399 2.72 742.9175 1,483.82 1,484.83 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LKEILLQVEDER 95.00% 3.69 0.358 1.92 742.9201 1,483.82 1,484.83 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LKEILLQVEDER 95.00% 4.02 0.413 3.22 742.9202 1,483.82 1,484.83 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LKEILLQVEDER 95.00% 3.84 0.371 2.24 742.9217 1,483.83 1,484.83 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QRYEILAANAIPK 95.00% 3.31 0.317 0 743.9213 1,485.83 1,486.84 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QRYEILAANAIPK 95.00% 3.18 0.278 1.77 743.9228 1,485.83 1,486.84 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QRYEILAANAIPK 95.00% 2.68 0.218 0 743.9234 1,485.83 1,486.84 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QRYEILAANAIPK 95.00% 3.6 0.356 1.74 743.9237 1,485.83 1,486.84 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TQLEELEDELQATEDAKLR 95.00% 3.45 0.438 1.08 744.7073 2,231.10 2,231.10 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% EDQSILcTGESGAGKTENTKK 95.00% 2.01 0.187 1.49 c7: Carbamidomethyl (+57.02) 752.0287 2,253.06 2,253.07 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% DKTEFSIIHYAGK 95.00% 3.71 0.449 2.62 754.8913 1,507.77 1,508.78 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% DKTEFSIIHYAGK 95.00% 4.2 0.504 3.92 754.8938 1,507.77 1,508.78 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 4.59 0.412 2.68 764.9379 1,527.86 1,528.87 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 5.65 0.4 5.13 764.9385 1,527.86 1,528.87 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 5.27 0.384 4.14 764.9392 1,527.86 1,528.87 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KKLEAQVQELQSK 95.00% 5.1 0.413 4.57 764.9395 1,527.86 1,528.87 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KQADLEKEELAEELASSLSGR 95.00% 5.43 0.573 3.68 768.7293 2,303.16 2,303.17 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KQADLEKEELAEELASSLSGR 95.00% 5.28 0.509 4.27 768.7309 2,303.17 2,303.17 3
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IAQLEEQVEQEAR 95.00% 4.84 0.409 3.96 771.8906 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IAQLEEQVEQEAR 95.00% 4.63 0.425 2.96 771.8908 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IAQLEEQVEQEAR 95.00% 4.94 0.404 3.55 771.8914 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IAQLEEQVEQEAR 95.00% 4.8 0.42 2.59 771.8914 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IAQLEEQVEQEAR 95.00% 4.6 0.387 3.46 771.8918 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IAQLEEQVEQEAR 95.00% 4.58 0.41 3.07 771.8918 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IAQLEEQVEQEAR 95.00% 5.08 0.443 3.44 771.8921 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IAQLEEQVEQEAR 95.00% 4.73 0.406 3.24 771.8923 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VEDMAELTcLNEASVLHNLR 95.00% 4.49 0.529 2.27 c9: Carbamidomethyl (+57.02) 772.3774 2,314.11 2,314.12 3 K2C1_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VEDMAELTcLNEASVLHNLR 95.00% 4.86 0.649 2.89 c9: Carbamidomethyl (+57.02) 772.379 2,314.11 2,314.12 3 K2C1_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IAQLEEQVEQEAR 95.00% 4.46 0.366 3.11 772.3933 1,542.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% IAQLEEQVEQEAR 95.00% 4.74 0.364 3.43 772.3936 1,542.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ELDEATESNEAMGR 95.00% 4.38 0.531 5.09 776.332 1,550.65 1,551.66 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ELDEATESNEAMGR 95.00% 4.75 0.53 4.47 776.332 1,550.65 1,551.66 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ELDEATESNEAMGR 95.00% 4.64 0.596 4.8 776.3331 1,550.65 1,551.66 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ELDEATESNEAMGR 95.00% 4.43 0.572 4.31 776.3344 1,550.65 1,551.66 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ITDVIMAFQAMcR 95.00% 3.54 0.542 4.21 c12: Carbamidomethyl (+57.02) 778.3727 1,554.73 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ITDVIMAFQAMcR 95.00% 4.1 0.581 3.66 c12: Carbamidomethyl (+57.02) 778.373 1,554.73 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ITDVIMAFQAMcR 95.00% 4.53 0.584 4.55 c12: Carbamidomethyl (+57.02) 778.3746 1,554.73 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ITDVIMAFQAMcR 95.00% 4.26 0.576 4.03 c12: Carbamidomethyl (+57.02) 778.3747 1,554.73 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ITDVIMAFQAMcR 95.00% 4.97 0.577 4.15 c12: Carbamidomethyl (+57.02) 778.3753 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ITDVIMAFQAMcR 95.00% 3.53 0.46 4.66 c12: Carbamidomethyl (+57.02) 778.3783 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ITDVIMAFQAMcR 95.00% 4.13 0.549 4.55 c12: Carbamidomethyl (+57.02) 778.3817 1,554.75 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% HISTLNIQLSDSKK 95.00% 4.04 0.542 5.19 792.4402 1,582.86 1,583.88 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% HISTLNIQLSDSKK 95.00% 3.99 0.522 5.13 792.4408 1,582.87 1,583.88 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% SGKLDAFLVLEQLR 95.00% 5.17 0.532 3.66 794.9574 1,587.90 1,588.91 2 SPTA2_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ISDLTTNLAEEEEK 95.00% 4.7 0.564 3.8 796.3895 1,590.76 1,591.77 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ISDLTTNLAEEEEK 95.00% 3.27 0.497 1.82 796.3918 1,590.77 1,591.77 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 4.79 0.439 2.13 815.419 1,628.82 1,629.83 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 4.93 0.394 2.04 815.4193 1,628.82 1,629.83 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 4.99 0.425 2.22 815.4199 1,628.82 1,629.83 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 4.66 0.395 2.02 815.4199 1,628.82 1,629.83 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 4.83 0.428 2.64 815.42 1,628.82 1,629.83 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 4.94 0.416 2.59 815.4204 1,628.83 1,629.83 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ALEEALEAKEELER 95.00% 4.71 0.43 2.04 815.4206 1,628.83 1,629.83 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% NFINSPVAQADWAAK 95.00% 4.77 0.518 4.36 816.4125 1,630.81 1,631.82 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% NFINSPVAQADWAAK 95.00% 4.59 0.48 3.62 816.9151 1,631.81 1,631.82 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% NFINSPVAQADWAAK 95.00% 3.38 0.407 0 817.1107 1,632.21 1,631.82 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQDFASTVEALEEGK 95.00% 4.75 0.431 7.12 818.9063 1,635.80 1,636.81 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQDFASTVEALEEGK 95.00% 5.04 0.526 5 818.9065 1,635.80 1,636.81 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQDFASTVEALEEGK 95.00% 4.48 0.526 5.77 818.9067 1,635.80 1,636.81 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQDFASTVEALEEGK 95.00% 4.64 0.518 5.59 818.9069 1,635.80 1,636.81 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQDFASTVEALEEGK 95.00% 4.73 0.487 5.39 818.9073 1,635.80 1,636.81 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQDFASTVEALEEGK 95.00% 5.06 0.484 5.89 818.9088 1,635.80 1,636.81 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQDFASTVEALEEGK 95.00% 3.47 0.527 4.96 819.4063 1,636.80 1,636.81 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% NSLQDQLDEEMEAK 95.00% 4.15 0.423 3.77 825.8705 1,649.73 1,649.73 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% VcHLMGINVTDFTR 95.00% 4.76 0.538 5.57 c2: Carbamidomethyl (+57.02) 831.9062 1,661.80 1,662.81 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QTLEKENADLAGELR 95.00% 3.48 0.492 2.14 843.9355 1,685.86 1,686.87 2 CO3_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QTLEKENADLAGELR 95.00% 3.67 0.436 1.48 844.4377 1,686.86 1,686.87 2 CO3_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QLLQANPILEAFGNAK 95.00% 4.85 0.558 5.59 864.479 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QLLQANPILEAFGNAK 95.00% 4.96 0.522 5.62 864.4798 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLQDFASTVEALEEGK 95.00% 5.69 0.601 4.66 882.951 1,763.89 1,764.90 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KLQDFASTVEALEEGK 95.00% 4.91 0.633 7.66 882.9563 1,763.90 1,764.90 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ISDLTTNLAEEEEKAK 95.00% 3.32 0.203 0 895.9502 1,789.88 1,790.90 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ISDLTTNLAEEEEKAK 95.00% 3.72 0.32 0 895.9517 1,789.89 1,790.90 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ISDLTTNLAEEEEKAK 95.00% 4.41 0.492 0 895.9525 1,789.89 1,790.90 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ISDLTTNLAEEEEKAK 95.00% 4.29 0.466 0 895.9527 1,789.89 1,790.90 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% ISDLTTNLAEEEEKAK 95.00% 4.01 0.392 0 896.4576 1,790.90 1,790.90 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 5.41 0.616 5.54 956.981 1,911.95 1,912.96 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 5.48 0.627 5 956.9824 1,911.95 1,912.96 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 5.65 0.625 5.43 956.9832 1,911.95 1,912.96 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 5.66 0.564 5.82 957.4831 1,912.95 1,912.96 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 5.59 0.592 5.49 957.4837 1,912.95 1,912.96 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 5.52 0.614 4.6 957.4837 1,912.95 1,912.96 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 5.72 0.622 5.15 957.484 1,912.95 1,912.96 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 6.05 0.595 4.41 957.4842 1,912.95 1,912.96 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 5.77 0.564 5.49 957.4843 1,912.95 1,912.96 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQQELDDLVVDLDNQR 95.00% 4.8 0.605 5.64 957.4846 1,912.95 1,912.96 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 4.14 0.487 3.82 958.9854 1,915.96 1,916.97 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 5.9 0.635 9.47 958.9859 1,915.96 1,916.97 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 4.59 0.622 4.28 958.9862 1,915.96 1,916.97 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 5.95 0.62 8.17 958.9865 1,915.96 1,916.97 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 5.49 0.592 5.85 958.9871 1,915.96 1,916.97 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% KATQQAEQLSNELATER 95.00% 5.85 0.591 7.85 959.4873 1,916.96 1,916.97 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% FQKEIENLTQQYEEK 95.00% 4.88 0.376 6.41 963.9747 1,925.93 1,926.95 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% FQKEIENLTQQYEEK 95.00% 5.2 0.373 6.02 964.4752 1,926.93 1,926.95 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% LQNEVESVTGMLNEAEGK 95.00% 5.87 0.61 7.62 974.9692 1,947.92 1,947.93 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TQLEELEDELQATEDAK 95.00% 7.1 0.618 6.6 981.9608 1,961.91 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TQLEELEDELQATEDAK 95.00% 7.17 0.617 5.89 981.9624 1,961.91 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TQLEELEDELQATEDAK 95.00% 6.64 0.653 4.72 981.9633 1,961.91 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% TQLEELEDELQATEDAK 95.00% 6.78 0.629 4.89 981.9635 1,961.91 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% NMDPLNDNVTSLLNASSDK 95.00% 4.91 0.511 3.41 1,024.98 2,047.94 2,047.96 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% NMDPLNDNVTSLLNASSDK 95.00% 5.23 0.605 5.46 1,024.98 2,047.95 2,047.96 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QADLEKEELAEELASSLSGR 95.00% 4.24 0.604 4.02 1,088.04 2,174.07 2,175.08 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% QADLEKEELAEELASSLSGR 95.00% 5.44 0.602 6.09 1,088.54 2,175.07 2,175.08 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% MAQQMLDLEEQLEEEEAAR 95.00% 6.2 0.542 5.06 1,132.01 2,262.01 2,263.02 2
 SAMPLE 2 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 72 88 339 38.10% MAQQMLDLEEQLEEEEAAR 95.00% 5.9 0.516 5.21 1,132.52 2,263.02 2,263.02 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEAQVQELQSK 95.00% 4.27 0.23 1.4 467.5961 1,399.76 1,400.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEAQVQELQSK 95.00% 4.14 0.211 0 467.5965 1,399.77 1,400.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEAQVQELQSK 95.00% 4.71 0.283 1.8 467.5967 1,399.77 1,400.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEAQVQELQSK 95.00% 4.35 0.271 1.82 467.597 1,399.77 1,400.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEAQVQELQSK 95.00% 4.3 0.195 1.8 467.9293 1,400.76 1,400.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEAQVQELQSK 95.00% 4.33 0.19 1.04 467.9296 1,400.77 1,400.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IVFQEFR 95.00% 2.54 0.384 0 469.7579 937.5002 938.51 2 MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IVFQEFR 95.00% 2.65 0.378 0 469.758 937.5003 938.51 2 MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IVFQEFR 95.00% 2.48 0.384 0 469.7583 937.5009 938.51 2 MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IVFQEFR 95.00% 1.98 0.275 0 469.7588 937.5019 938.51 2 MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IVFQEFR 95.00% 2.24 0.237 0 469.7589 937.5021 938.51 2 MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IVFQEFR 95.00% 2.58 0.367 0 469.7597 937.5037 938.51 2 MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 2.62 0.486 0 472.2726 1,413.79 1,414.81 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 2.85 0.446 1.26 472.2729 1,413.80 1,414.81 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 2.7 0.34 1.64 472.2736 1,413.80 1,414.81 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 2.94 0.547 1.92 472.274 1,413.80 1,414.81 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 3.36 0.495 2.04 472.274 1,413.80 1,414.81 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 2.31 0.359 1.03 472.2745 1,413.80 1,414.81 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 2 0.261 0 472.2745 1,413.80 1,414.81 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 2.56 0.33 0 472.2753 1,413.80 1,414.81 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% HISTLNIQLSDSK 95.00% 3.65 0.412 0 485.9307 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% HISTLNIQLSDSK 95.00% 2.66 0.306 1.19 485.9311 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% HISTLNIQLSDSK 95.00% 2.31 0.211 0 485.9312 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% HISTLNIQLSDSK 95.00% 3.82 0.396 1.85 485.9315 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% HISTLNIQLSDSK 95.00% 2.76 0.349 1.43 486.297 1,455.87 1,455.78 3 TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% HISTLNIQLSDSK 95.00% 2.09 0.33 1.48 486.2973 1,455.87 1,455.78 3 TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% HISTLNIQLSDSK 95.00% 2.09 0.235 0 486.2975 1,455.87 1,455.78 3 TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAK 95.00% 2.97 0.393 0 487.2633 972.5109 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAK 95.00% 2.85 0.387 0 487.2638 972.512 973.5207 2 LRP1_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IVGLDQMAK 95.00% 2.47 0.298 1.62 487.7693 973.523 974.5347 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IVGLDQMAK 95.00% 2.23 0.284 0 487.7696 973.5236 974.5347 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LKEILLQVEDER 95.00% 3.49 0.474 1.12 495.6146 1,483.82 1,484.83 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QRYEILAANAIPK 95.00% 3.74 0.223 0 496.6175 1,486.83 1,486.84 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 3.09 0.283 0 501.6356 1,501.88 1,502.89 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 3.91 0.414 1.02 501.6356 1,501.88 1,502.89 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 4.34 0.483 1.64 501.6359 1,501.88 1,502.89 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 2.72 0.205 0 501.6366 1,501.89 1,502.89 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 3.44 0.401 0 501.6369 1,501.89 1,502.89 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 3.99 0.375 0 501.9704 1,502.89 1,502.89 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 4.01 0.434 1.41 501.9709 1,502.89 1,502.89 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DKTEFSIIHYAGK 95.00% 3.67 0.33 3.62 503.5953 1,507.76 1,508.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DKTEFSIIHYAGK 95.00% 3.2 0.384 0 503.5955 1,507.76 1,508.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DKTEFSIIHYAGK 95.00% 3.84 0.352 2.09 503.5959 1,507.76 1,508.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DKTEFSIIHYAGK 95.00% 2.55 0.156 0 503.5961 1,507.76 1,508.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DKTEFSIIHYAGK 95.00% 2.81 0.294 0 503.5968 1,507.77 1,508.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DKTEFSIIHYAGK 95.00% 3.87 0.339 3.44 503.9286 1,508.76 1,508.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DKTEFSIIHYAGK 95.00% 4.18 0.348 1.8 503.9303 1,508.77 1,508.78 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% AAAYDKLEK 95.00% 2.16 0.298 0 504.7713 1,007.53 1,008.54 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% AAAYDKLEK 95.00% 2.37 0.416 0 504.7719 1,007.53 1,008.54 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% cNGVLEGIR 95.00% 3.27 0.373 2.1 c1: Carbamidomethyl (+57.02) 509.2595 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% cNGVLEGIR 95.00% 3.12 0.371 1.29 c1: Carbamidomethyl (+57.02) 509.26 1,016.50 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% cNGVLEGIR 95.00% 2.74 0.391 1.3 c1: Carbamidomethyl (+57.02) 509.2606 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% cNGVLEGIR 95.00% 3.02 0.379 2.17 c1: Carbamidomethyl (+57.02) 509.2608 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% cNGVLEGIR 95.00% 3.14 0.408 2.04 c1: Carbamidomethyl (+57.02) 509.2612 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KKLEAQVQELQSK 95.00% 4.46 0.351 1.42 510.2938 1,527.86 1,528.87 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KKLEAQVQELQSK 95.00% 3.16 0.249 0 510.2939 1,527.86 1,528.87 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KKLEAQVQELQSK 95.00% 3.12 0.273 0 510.2941 1,527.86 1,528.87 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KKLEAQVQELQSK 95.00% 2.2 0.264 0 510.2941 1,527.86 1,528.87 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KKLEAQVQELQSK 95.00% 3.09 0.21 0 510.2942 1,527.86 1,528.87 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KKLEAQVQELQSK 95.00% 4.02 0.307 1.03 510.2943 1,527.86 1,528.87 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KKLEAQVQELQSK 95.00% 4 0.363 0 510.2949 1,527.86 1,528.87 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KKLEAQVQELQSK 95.00% 3.53 0.325 0 510.2953 1,527.86 1,528.87 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KKLEAQVQELQSK 95.00% 3.04 0.139 0 510.2962 1,527.87 1,528.87 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KVIQYLAVVASSHK 95.00% 2.71 0.209 0 515.2508 1,542.73 1,542.90 3 DESM_HUMAN,COCA1_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KVIQYLAVVASSHK 95.00% 2.57 0.193 0 515.2521 1,542.73 1,542.90 3 DESM_HUMAN,COCA1_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ITDVIMAFQAMcR 95.00% 4.42 0.549 2.17 c12: Carbamidomethyl (+57.02) 519.2515 1,554.73 1,555.74 3 AGRIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ITDVIMAFQAMcR 95.00% 2.93 0.35 0 c12: Carbamidomethyl (+57.02) 519.2516 1,554.73 1,555.74 3 AGRIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ITDVIMAFQAMcR 95.00% 2.81 0.298 0 c12: Carbamidomethyl (+57.02) 519.5864 1,555.74 1,555.74 3 AGRIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TFHIFYYMIAGAK 95.00% 3.35 0.36 1.52 521.2652 1,560.77 1,561.79 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TFHIFYYMIAGAK 95.00% 3.56 0.373 1.77 521.6009 1,561.78 1,561.79 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TFHIFYYMIAGAK 95.00% 4 0.387 1.72 521.601 1,561.78 1,561.79 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TFHIFYYMIAGAK 95.00% 2.46 0.244 0 521.6013 1,561.78 1,561.79 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LEVNMQALK 95.00% 2.15 0.244 0 523.2876 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LEVNMQALK 95.00% 2.33 0.2 1.19 523.2884 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LEVNMQALK 95.00% 2.34 0.2 0 523.2888 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% NKHESMISELEVR 95.00% 2.49 0.276 0 524.6001 1,570.78 1,571.79 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VKPLLQVTR 95.00% 2.01 0.262 0 527.3416 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VKPLLQVTR 95.00% 1.99 0.327 0 527.3419 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VKPLLQVTR 95.00% 2.2 0.295 0 527.3421 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VKPLLQVTR 95.00% 2.06 0.315 0 527.3421 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% HISTLNIQLSDSKK 95.00% 3.56 0.534 0 528.6293 1,582.86 1,583.88 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.46 0.246 1 530.3052 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.13 0.242 0 530.3055 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.43 0.254 1.36 530.3057 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.08 0.241 1 530.3059 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.33 0.232 1.02 530.3062 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.85 0.2 0 530.6389 1,588.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.55 0.229 0 530.64 1,588.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.39 0.229 0 530.6408 1,588.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.08 0.238 0 530.6409 1,588.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 3.55 0.184 0 530.6411 1,588.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LKEILLQVEDERK 95.00% 4.51 0.486 0 538.3139 1,611.92 1,612.93 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LKEILLQVEDERK 95.00% 3.65 0.407 0 538.3148 1,611.92 1,612.93 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LKEILLQVEDERK 95.00% 4.4 0.455 0 538.6467 1,612.92 1,612.93 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% AEMEDLVSSKDDVGK 95.00% 2 0.295 0 541.5906 1,621.75 1,622.76 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 2.71 0.214 1.55 543.9483 1,628.82 1,629.83 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 3.37 0.427 1.74 543.9489 1,628.82 1,629.83 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 3.97 0.435 1.96 543.9489 1,628.82 1,629.83 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 2.57 0.214 0 544.2823 1,629.82 1,629.83 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 3.37 0.332 1.48 544.2825 1,629.82 1,629.83 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 3.55 0.397 1.82 544.2825 1,629.82 1,629.83 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 2.86 0.319 1.89 544.2828 1,629.83 1,629.83 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 3.37 0.259 1.16 544.2834 1,629.83 1,629.83 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGK 95.00% 4.06 0.43 3.74 546.2735 1,635.80 1,636.81 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGK 95.00% 2.21 0.19 0 546.2737 1,635.80 1,636.81 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DTSITGELEK 95.00% 2.38 0.149 1.49 546.7737 1,091.53 1,092.54 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VTVGKDDIQK 95.00% 2.21 0.284 0 551.8078 1,101.60 1,102.61 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VTVGKDDIQK 95.00% 2.33 0.362 1.26 551.8122 1,101.61 1,102.61 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VcHLMGINVTDFTR 95.00% 3.52 0.213 2.29 c2: Carbamidomethyl (+57.02) 554.9406 1,661.80 1,662.81 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VcHLMGINVTDFTR 95.00% 3.62 0.192 1.38 c2: Carbamidomethyl (+57.02) 554.9407 1,661.80 1,662.81 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QTLEKENADLAGELR 95.00% 2.58 0.321 0 562.9597 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QTLEKENADLAGELR 95.00% 2.64 0.293 0 562.9598 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QTLEKENADLAGELR 95.00% 2.66 0.344 0 562.9606 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QTLEKENADLAGELR 95.00% 2.38 0.278 0 563.2931 1,686.86 1,686.87 3 CO3_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QTLEKENADLAGELR 95.00% 2.7 0.368 0 563.2942 1,686.86 1,686.87 3 CO3_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QTLEKENADLAGELR 95.00% 2.8 0.34 0 563.2952 1,686.86 1,686.87 3 CO3_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLHEYETELEDER 95.00% 3.19 0.434 0 564.2546 1,689.74 1,690.76 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLHEYETELEDER 95.00% 3.62 0.371 0 564.2552 1,689.74 1,690.76 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLHEYETELEDER 95.00% 2.66 0.278 0 564.2567 1,689.75 1,690.76 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLHEYETELEDER 95.00% 3.58 0.424 0 564.2579 1,689.75 1,690.76 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% MTESSLPSASK 95.00% 3.04 0.476 2.17 569.2749 1,136.53 1,137.55 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% MTESSLPSASK 95.00% 2.91 0.436 2.42 569.2749 1,136.53 1,137.55 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% MTESSLPSASK 95.00% 3.03 0.493 2.68 569.2758 1,136.54 1,137.55 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% MTESSLPSASK 95.00% 3.25 0.503 3.44 569.2772 1,136.54 1,137.55 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ASRDEIFATAKENEK 95.00% 2.56 0.21 1.09 570.2849 1,707.83 1,708.85 3 VINC_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ASRDEIFATAKENEK 95.00% 3.83 0.386 1.68 570.2874 1,707.84 1,708.85 3 VINC_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ASRDEIFATAKENEK 95.00% 3.28 0.369 0 570.2901 1,707.85 1,708.85 3 VINC_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ASRDEIFATAKENEK 95.00% 2.96 0.231 0 570.2926 1,707.85 1,708.85 3 VINC_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ASRDEIFATAKENEK 95.00% 4.17 0.397 2.49 570.6214 1,708.84 1,708.85 3 VINC_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 2.68 0.304 0 576.3196 1,725.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.13 0.525 1.92 576.3197 1,725.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 3.86 0.48 3.54 576.3204 1,725.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.35 0.496 3.59 576.3217 1,725.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.13 0.461 1.8 576.654 1,726.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.2 0.466 2.46 576.6553 1,726.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% mTESSLPSASK 95.00% 2.44 0.339 2.85 m1: Oxidation (+15.99) 577.2728 1,152.53 1,153.54 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% mTESSLPSASK 95.00% 1.86 0.268 1.46 m1: Oxidation (+15.99) 577.2742 1,152.53 1,153.54 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% mTESSLPSASK 95.00% 2.79 0.418 2.55 m1: Oxidation (+15.99) 577.2744 1,152.53 1,153.54 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% mTESSLPSASK 95.00% 2.46 0.369 4.6 m1: Oxidation (+15.99) 577.2745 1,152.53 1,153.54 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% mTESSLPSASK 95.00% 2.62 0.376 2.28 m1: Oxidation (+15.99) 577.2762 1,152.54 1,153.54 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% mTESSLPSASK 95.00% 2.46 0.316 0 m1: Oxidation (+15.99) 577.2782 1,152.54 1,153.54 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QEEEMQAKEDELQK 95.00% 3.39 0.312 1.89 578.9326 1,733.77 1,734.79 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QEEEMQAKEDELQK 95.00% 2.91 0.312 1.77 578.9332 1,733.78 1,734.79 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QEEEMQAKEDELQK 95.00% 3.62 0.295 1.34 578.9332 1,733.78 1,734.79 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QEEEMQAKEDELQK 95.00% 3.02 0.359 0 578.9341 1,733.78 1,734.79 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KFDQLLAEEKNISSK 95.00% 3.55 0.416 2.31 584.318 1,749.93 1,749.94 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KFDQLLAEEKNISSK 95.00% 3.38 0.381 1.51 584.3187 1,749.93 1,749.94 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KQELEEILHEMEAR 95.00% 3.87 0.384 1.77 585.6284 1,753.86 1,754.87 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KQELEEILHEMEAR 95.00% 3.32 0.299 1.72 585.9634 1,754.87 1,754.87 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ISDLTTNLAEEEEKAK 95.00% 2.84 0.305 0 597.6383 1,789.89 1,790.90 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ISDLTTNLAEEEEKAK 95.00% 3.32 0.365 0 597.9714 1,790.89 1,790.90 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% YEILAANAIPK 95.00% 2.68 0.423 1.28 601.8414 1,201.67 1,202.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% YEILAANAIPK 95.00% 3.33 0.445 1.21 601.8417 1,201.67 1,202.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% YEILAANAIPK 95.00% 3.97 0.426 1.77 601.8417 1,201.67 1,202.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% YEILAANAIPK 95.00% 3.45 0.487 1.72 601.842 1,201.67 1,202.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% YEILAANAIPK 95.00% 3.63 0.434 1.28 601.8422 1,201.67 1,202.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALELDPNLYR 95.00% 2.67 0.259 0 602.32 1,202.62 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALELDPNLYR 95.00% 2.8 0.267 0 602.3205 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALELDPNLYR 95.00% 2.74 0.278 1.72 602.3213 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALELDPNLYR 95.00% 2.61 0.268 1.74 602.3217 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALELDPNLYR 95.00% 2.76 0.276 2.72 602.3219 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALELDPNLYR 95.00% 2.72 0.269 2.62 602.3225 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% YEILAANAIPK 95.00% 2.93 0.36 0 602.3415 1,202.67 1,202.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% YEILAANAIPK 95.00% 3.25 0.425 0 602.3425 1,202.67 1,202.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% YEILAANAIPK 95.00% 2.9 0.4 0 602.3446 1,202.67 1,202.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLHEYETELEDERK 95.00% 3.03 0.37 0 606.9546 1,817.84 1,818.85 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLHEYETELEDERK 95.00% 2.53 0.212 0 606.9555 1,817.84 1,818.85 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLHEYETELEDERK 95.00% 2.96 0.357 0 607.2889 1,818.84 1,818.85 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KFDQLLAEEK 95.00% 2.65 0.166 0 610.8294 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KFDQLLAEEK 95.00% 2.59 0.163 0 610.8298 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KFDQLLAEEK 95.00% 2.59 0.186 0 610.8299 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KFDQLLAEEK 95.00% 2.52 0.232 0 610.8304 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LEGDLKDLELQADSAIK 95.00% 3.1 0.159 0 620.333 1,857.98 1,857.98 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LEGDLKDLELQADSAIK 95.00% 3.83 0.432 0 620.3337 1,857.98 1,857.98 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TGVLAHLEEER 95.00% 2.49 0.321 0 627.3242 1,252.63 1,253.65 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TGVLAHLEEER 95.00% 3.37 0.366 1.92 627.3263 1,252.64 1,253.65 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TGVLAHLEEER 95.00% 3.06 0.369 1.89 627.3272 1,252.64 1,253.65 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TGVLAHLEEER 95.00% 2.55 0.252 1.68 627.3275 1,252.64 1,253.65 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TGVLAHLEEER 95.00% 3.17 0.389 2.31 627.3275 1,252.64 1,253.65 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TGVLAHLEEER 95.00% 3.42 0.397 2.27 627.328 1,252.64 1,253.65 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TEFSIIHYAGK 95.00% 3.02 0.531 2.15 633.3294 1,264.64 1,265.65 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TEFSIIHYAGK 95.00% 3.48 0.552 2.6 633.3298 1,264.64 1,265.65 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VDYNASAWLTK 95.00% 3.84 0.536 3.74 634.3178 1,266.62 1,267.63 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VDYNASAWLTK 95.00% 3.98 0.527 3.1 634.3181 1,266.62 1,267.63 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VDYNASAWLTK 95.00% 3.82 0.53 2.96 634.3184 1,266.62 1,267.63 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VDYNASAWLTK 95.00% 4.23 0.538 2.96 634.3187 1,266.62 1,267.63 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VDYNASAWLTK 95.00% 4.14 0.563 3.41 634.3191 1,266.62 1,267.63 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VDYNASAWLTK 95.00% 4.04 0.516 3.49 634.3191 1,266.62 1,267.63 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VDYNASAWLTK 95.00% 2.09 0.283 0 634.3196 1,266.62 1,267.63 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LEAQVQELQSK 95.00% 4.06 0.462 2.68 636.8426 1,271.67 1,272.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LEAQVQELQSK 95.00% 4.11 0.477 0 636.8427 1,271.67 1,272.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LEAQVQELQSK 95.00% 3.26 0.449 0 636.8429 1,271.67 1,272.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LEAQVQELQSK 95.00% 3.29 0.5 2.08 636.843 1,271.67 1,272.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LEAQVQELQSK 95.00% 2.82 0.414 1.35 636.8436 1,271.67 1,272.68 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 3.66 0.507 1.8 638.325 1,911.95 1,912.96 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 4.54 0.529 2.21 638.3251 1,911.95 1,912.96 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 4.43 0.484 1.85 638.3254 1,911.95 1,912.96 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 4.01 0.488 1.51 638.3257 1,911.95 1,912.96 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 4.29 0.451 2.09 638.6581 1,912.95 1,912.96 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 4.78 0.468 1.29 638.6592 1,912.95 1,912.96 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 3.56 0.386 1.7 639.6597 1,915.96 1,916.97 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 4.18 0.417 1.36 639.6608 1,915.96 1,916.97 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 2.55 0.22 0 639.6608 1,915.96 1,916.97 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 4.71 0.484 1.96 639.6611 1,915.96 1,916.97 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 4.83 0.423 0.959 639.6612 1,915.96 1,916.97 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 4.94 0.35 0 639.9938 1,916.96 1,916.97 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 3.04 0.227 1.66 639.994 1,916.96 1,916.97 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 2.9 0.3 1.37 639.9946 1,916.96 1,916.97 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 5.13 0.346 2 639.9946 1,916.96 1,916.97 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 2.6 0.257 0 639.9946 1,916.96 1,916.97 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 4.16 0.31 1.38 639.9956 1,916.96 1,916.97 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGKKR 95.00% 2.7 0.408 0 641.0062 1,920.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGKKR 95.00% 2.95 0.429 0 641.0065 1,920.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGKKR 95.00% 2.6 0.363 0 641.3396 1,921.00 1,921.00 3 THIO_HUMAN,RS9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% FQKEIENLTQQYEEK 95.00% 4.21 0.382 3.36 642.9864 1,925.94 1,926.95 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% FQKEIENLTQQYEEK 95.00% 4.59 0.375 2.96 643.3195 1,926.93 1,926.95 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% EQADFAVEALAK 95.00% 2.6 0.457 0 646.3288 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% EQADFAVEALAK 95.00% 2.87 0.486 1.41 646.3297 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% EQADFAVEALAK 95.00% 2.95 0.502 0 646.3297 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% EQADFAVEALAK 95.00% 2.4 0.351 0 646.3298 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% EQADFAVEALAK 95.00% 2.33 0.322 0 646.3299 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% EQADFAVEALAK 95.00% 2.58 0.368 0 646.33 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% EQADFAVEALAK 95.00% 2.77 0.398 0 646.3302 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TQLEELEDELQATEDAK 95.00% 3.9 0.438 0 654.9778 1,961.91 1,961.92 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LRLEVNMQALK 95.00% 2.31 0.289 0 657.8799 1,313.74 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LRLEVNMQALK 95.00% 2.62 0.319 0 657.8814 1,313.75 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LRLEVNMQALK 95.00% 2.46 0.397 0 657.8834 1,313.75 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LRLEVNMQALK 95.00% 2.54 0.362 0 657.8834 1,313.75 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LRLEVNMQALK 95.00% 2.45 0.293 0 658.384 1,314.75 1,314.76 2 KANK2_HUMAN,MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LDAFLVLEQLR 95.00% 3.59 0.417 0 658.8814 1,315.75 1,316.76 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LDAFLVLEQLR 95.00% 3.04 0.263 0 658.8816 1,315.75 1,316.76 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LDAFLVLEQLR 95.00% 2.57 0.302 0 658.8824 1,315.75 1,316.76 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LDAFLVLEQLR 95.00% 2.53 0.28 0 658.883 1,315.75 1,316.76 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ELEGHISDLQEDLDSER 95.00% 4.23 0.36 0 662.3088 1,983.90 1,984.91 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ELEGHISDLQEDLDSER 95.00% 4.42 0.489 0 662.6414 1,984.90 1,984.91 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ELEGHISDLQEDLDSER 95.00% 4.38 0.437 0 662.6418 1,984.90 1,984.91 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ELEGHISDLQEDLDSER 95.00% 4.21 0.422 0 662.6425 1,984.90 1,984.91 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEGDLKDLELQADSAIK 95.00% 3.7 0.344 0 663.0291 1,986.06 1,986.08 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEGDLKDLELQADSAIK 95.00% 5.2 0.502 4.62 663.0307 1,986.07 1,986.08 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEGDLKDLELQADSAIK 95.00% 3.56 0.39 0 663.0308 1,986.07 1,986.08 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEGDLKDLELQADSAIK 95.00% 4 0.472 3.04 663.0311 1,986.07 1,986.08 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% AENELKELEQK 95.00% 3.36 0.129 1.21 665.8459 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% AENELKELEQK 95.00% 3.31 0.111 0 665.846 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% AENELKELEQK 95.00% 3.25 0.11 1.68 665.8462 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% AENELKELEQK 95.00% 3.2 0.107 0 665.8462 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SLEADLMQLQEDLAAAER 95.00% 0 0 4.09 668.6622 2,002.96 2,002.98 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SLEADLMQLQEDLAAAER 95.00% 3.7 0.472 3.46 668.6638 2,002.97 2,002.98 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% HAQAVEELTEQLEQFKR 95.00% 6.64 0.67 4.82 686.353 2,056.04 2,056.05 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEAQVQELQSK 95.00% 4.54 0.514 4.92 700.8906 1,399.77 1,400.78 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEAQVQELQSK 95.00% 4.67 0.518 5 700.8907 1,399.77 1,400.78 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 3.64 0.337 4.49 707.9027 1,413.79 1,414.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 4.13 0.267 4.37 707.9027 1,413.79 1,414.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 3.93 0.346 4.21 707.9041 1,413.79 1,414.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 3.78 0.346 3.77 707.9041 1,413.79 1,414.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 3.94 0.156 4.55 707.9041 1,413.79 1,414.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VIQYLAVVASSHK 95.00% 3.2 0.401 5 707.9046 1,413.79 1,414.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEDEILVMDDQNNKLSK 95.00% 5.36 0.559 2.26 711.3675 2,131.08 2,132.09 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEDEILVMDDQNNKLSK 95.00% 5.82 0.487 2.12 711.7031 2,132.09 2,132.09 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QADLEKEELAEELASSLSGR 95.00% 3.64 0.497 0.959 726.0296 2,175.07 2,175.08 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QADLEKEELAEELASSLSGR 95.00% 4.05 0.517 1.77 726.0306 2,175.07 2,175.08 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QADLEKEELAEELASSLSGR 95.00% 3.92 0.399 0 726.0311 2,175.07 2,175.08 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QADLEKEELAEELASSLSGR 95.00% 3.86 0.549 1.14 726.0318 2,175.07 2,175.08 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QADLEKEELAEELASSLSGR 95.00% 3.48 0.477 0.959 726.0318 2,175.07 2,175.08 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QADLEKEELAEELASSLSGR 95.00% 3.98 0.51 0 726.0318 2,175.07 2,175.08 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QADLEKEELAEELASSLSGR 95.00% 3.97 0.544 0 726.0322 2,175.07 2,175.08 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QADLEKEELAEELASSLSGR 95.00% 3.65 0.551 1 726.0329 2,175.08 2,175.08 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% HISTLNIQLSDSK 95.00% 4.07 0.445 3.89 728.3928 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% HISTLNIQLSDSK 95.00% 4.96 0.58 4.51 728.3938 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% HISTLNIQLSDSK 95.00% 4.66 0.58 5.66 728.3939 1,454.77 1,455.78 2 TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% NRLQQELDDLVVDLDNQR 95.00% 3.29 0.394 0 728.7072 2,183.10 2,183.11 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LKEILLQVEDER 95.00% 3.18 0.433 1.37 742.9165 1,483.82 1,484.83 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LKEILLQVEDER 95.00% 3.25 0.385 1.51 742.9201 1,483.82 1,484.83 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LKEILLQVEDER 95.00% 3.74 0.387 2.7 742.923 1,483.83 1,484.83 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LKEILLQVEDER 95.00% 3.18 0.33 2.77 743.4154 1,484.82 1,484.83 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LKEILLQVEDER 95.00% 4.27 0.384 2.74 743.4205 1,484.83 1,484.83 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QRYEILAANAIPK 95.00% 2.77 0.258 0 743.9214 1,485.83 1,486.84 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TQLEELEDELQATEDAKLR 95.00% 3.83 0.517 1.85 744.3731 2,230.10 2,231.10 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QRYEILAANAIPK 95.00% 3.64 0.336 1.44 744.4238 1,486.83 1,486.84 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TQLEELEDELQATEDAKLR 95.00% 3.82 0.398 0 744.7079 2,231.10 2,231.10 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 3.67 0.531 4 751.9497 1,501.88 1,502.89 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 3.68 0.531 4.07 751.9497 1,501.88 1,502.89 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 4.85 0.541 5.32 751.9503 1,501.89 1,502.89 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 4.61 0.548 5.36 751.9505 1,501.89 1,502.89 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 3.28 0.431 3.82 751.951 1,501.89 1,502.89 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 4.44 0.514 4.68 751.9511 1,501.89 1,502.89 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 3.66 0.481 3.72 751.9513 1,501.89 1,502.89 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 3.4 0.564 5.02 751.9518 1,501.89 1,502.89 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 4.35 0.511 4.27 751.9518 1,501.89 1,502.89 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IRELEGHISDLQEDLDSER 95.00% 5.92 0.56 3.68 752.3665 2,254.08 2,254.10 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IRELEGHISDLQEDLDSER 95.00% 5.68 0.552 4.74 752.3683 2,254.08 2,254.10 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 3.93 0.537 4.34 752.4511 1,502.89 1,502.89 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 2.42 0.289 2 752.452 1,502.89 1,502.89 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFK 95.00% 4.6 0.514 4.55 752.4521 1,502.89 1,502.89 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% MAQQMLDLEEQLEEEEAAR 95.00% 4.63 0.465 0 755.3478 2,263.02 2,263.02 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DKTEFSIIHYAGK 95.00% 3.38 0.425 2.6 755.3928 1,508.77 1,508.78 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KKLEAQVQELQSK 95.00% 5.55 0.435 3.28 764.9378 1,527.86 1,528.87 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KKLEAQVQELQSK 95.00% 5.35 0.423 3.1 764.9386 1,527.86 1,528.87 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KKLEAQVQELQSK 95.00% 4.27 0.341 2.6 764.9402 1,527.86 1,528.87 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KQADLEKEELAEELASSLSGR 95.00% 5.23 0.498 2.92 768.3951 2,302.16 2,303.17 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 4.61 0.434 3.44 771.8908 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 4.86 0.427 2.33 771.8916 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 4.6 0.461 2.7 771.8916 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 4.82 0.4 3.55 771.8918 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 4.68 0.418 3.11 771.8918 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 4.84 0.436 2.68 771.8919 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 4.86 0.398 3.41 771.8922 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 4.77 0.411 2.8 771.8922 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 4.47 0.431 3.22 771.8924 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VEDMAELTcLNEASVLHNLR 95.00% 4.62 0.592 2.12 c9: Carbamidomethyl (+57.02) 772.3787 2,314.11 2,314.12 3 K2C1_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VEDMAELTcLNEASVLHNLR 95.00% 5.13 0.644 1.19 c9: Carbamidomethyl (+57.02) 772.3791 2,314.11 2,314.12 3 K2C1_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 4.75 0.356 3.57 772.3919 1,542.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 4.33 0.372 2.46 772.3937 1,542.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 2.57 0.299 0 772.3972 1,542.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEQVEQEAR 95.00% 2.94 0.366 1.85 772.3974 1,542.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ELDEATESNEAMGR 95.00% 4.77 0.525 5.21 776.3332 1,550.65 1,551.66 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ELDEATESNEAMGR 95.00% 4.54 0.595 6.68 776.8335 1,551.65 1,551.66 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ELDEATESNEAMGR 95.00% 3.25 0.444 1.35 776.8337 1,551.65 1,551.66 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ITDVIMAFQAMcR 95.00% 4.2 0.562 4.46 c12: Carbamidomethyl (+57.02) 778.3744 1,554.73 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ITDVIMAFQAMcR 95.00% 2.37 0.148 3.92 c12: Carbamidomethyl (+57.02) 778.3746 1,554.73 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ITDVIMAFQAMcR 95.00% 4.08 0.541 4.74 c12: Carbamidomethyl (+57.02) 778.3748 1,554.73 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ITDVIMAFQAMcR 95.00% 4.07 0.489 4.85 c12: Carbamidomethyl (+57.02) 778.3755 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ITDVIMAFQAMcR 95.00% 3.83 0.506 3.7 c12: Carbamidomethyl (+57.02) 778.3756 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ITDVIMAFQAMcR 95.00% 4.35 0.528 4.8 c12: Carbamidomethyl (+57.02) 778.3759 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ITDVIMAFQAMcR 95.00% 4.09 0.567 3.37 c12: Carbamidomethyl (+57.02) 778.8761 1,555.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TFHIFYYMIAGAK 95.00% 2.93 0.449 2.64 781.4001 1,560.78 1,561.79 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TFHIFYYMIAGAK 95.00% 2.92 0.363 1.52 781.8952 1,561.77 1,561.79 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.66 0.511 3.85 794.9541 1,587.89 1,588.91 2 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.85 0.589 4.09 794.9549 1,587.89 1,588.91 2 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.32 0.527 3.31 794.9551 1,587.89 1,588.91 2 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.52 0.512 3.16 794.9552 1,587.89 1,588.91 2 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.92 0.516 4.77 794.9567 1,587.90 1,588.91 2 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 4.98 0.523 4.01 794.9588 1,587.90 1,588.91 2 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 5.21 0.515 3.33 795.4535 1,588.89 1,588.91 2 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SGKLDAFLVLEQLR 95.00% 5.01 0.5 4.12 795.4573 1,588.90 1,588.91 2 SPTA2_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DVASLSSQLQDTQELLQEETR 95.00% 6.45 0.586 2.16 797.3943 2,389.16 2,390.17 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DVASLSSQLQDTQELLQEETR 95.00% 6.2 0.556 3.37 797.7278 2,390.16 2,390.17 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DVASLSSQLQDTQELLQEETR 95.00% 6.69 0.574 2.7 797.7288 2,390.16 2,390.17 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DVASLSSQLQDTQELLQEETR 95.00% 5.95 0.49 2.24 797.7289 2,390.16 2,390.17 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DVASLSSQLQDTQELLQEETR 95.00% 6.72 0.563 3 797.7297 2,390.17 2,390.17 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DVASLSSQLQDTQELLQEETR 95.00% 6.64 0.556 2.38 797.7298 2,390.17 2,390.17 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLEEERNSLQDQLDEEMEAK 95.00% 4.03 0.339 1.24 812.3739 2,434.10 2,434.10 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 5.03 0.426 2.68 815.4187 1,628.82 1,629.83 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 4.83 0.405 2.96 815.4191 1,628.82 1,629.83 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 4.52 0.408 2.48 815.4195 1,628.82 1,629.83 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 4.33 0.397 3.54 815.4196 1,628.82 1,629.83 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 3.76 0.331 2.3 815.4204 1,628.83 1,629.83 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALEEALEAKEELER 95.00% 4.62 0.377 2.41 815.9214 1,629.83 1,629.83 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% NFINSPVAQADWAAK 95.00% 4.55 0.518 3.44 816.4161 1,630.82 1,631.82 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VVSSVLQLGNIVFKK 95.00% 4.14 0.511 2.72 816.4984 1,630.98 1,630.99 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% NFINSPVAQADWAAK 95.00% 4.96 0.484 3.19 816.9143 1,631.81 1,631.82 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% IAQLEEELEEEQGNMEAMSDR 95.00% 4.56 0.639 3.52 818.0278 2,451.06 2,451.07 3
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGK 95.00% 4.03 0.497 8.24 818.9052 1,635.79 1,636.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGK 95.00% 4.25 0.511 6.39 818.9062 1,635.80 1,636.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGK 95.00% 4.79 0.482 6.12 818.9066 1,635.80 1,636.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGK 95.00% 4.47 0.474 7.55 818.9068 1,635.80 1,636.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGK 95.00% 4.56 0.518 7.36 818.9073 1,635.80 1,636.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGK 95.00% 3.66 0.49 6.31 818.9093 1,635.80 1,636.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGK 95.00% 4.3 0.53 8.12 819.4077 1,636.80 1,636.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGK 95.00% 4.63 0.507 8.18 819.408 1,636.80 1,636.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQDFASTVEALEEGK 95.00% 4.81 0.503 6.49 819.408 1,636.80 1,636.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% GQLSDDEKFLFVDK 95.00% 3.88 0.543 3.62 820.914 1,639.81 1,640.82 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQLFNHTMFILEQEEYQR 95.00% 3.16 0.364 0.959 823.4069 2,467.20 2,467.21 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQLFNHTMFILEQEEYQR 95.00% 5.4 0.198 2.8 823.4079 2,467.20 2,467.21 3 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VcHLMGINVTDFTR 95.00% 4.39 0.494 7.32 c2: Carbamidomethyl (+57.02) 831.9093 1,661.80 1,662.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% VcHLMGINVTDFTR 95.00% 4.35 0.555 7.32 c2: Carbamidomethyl (+57.02) 831.9102 1,661.80 1,662.81 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLHEYETELEDER 95.00% 3.68 0.396 4.26 845.8792 1,689.74 1,690.76 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.64 0.446 4.72 863.9651 1,725.91 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.41 0.559 3.82 863.9747 1,725.93 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.73 0.572 7.06 863.9763 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.89 0.554 2.77 863.977 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.32 0.52 3.54 863.9774 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 5.07 0.569 3.62 863.9787 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.66 0.534 3.4 863.9793 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.13 0.514 2.89 864.4738 1,726.93 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.7 0.496 4.77 864.4773 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.96 0.491 4.92 864.4776 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.36 0.458 4.18 864.479 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.69 0.498 3.41 864.4792 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% QLLQANPILEAFGNAK 95.00% 4.8 0.542 3.64 864.4798 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KQELEEILHEMEAR 95.00% 2.94 0.349 1.15 877.9398 1,753.86 1,754.87 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLQDFASTVEALEEGK 95.00% 5.31 0.584 5.42 883.4531 1,764.89 1,764.90 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLQDFASTVEALEEGK 95.00% 5.64 0.57 6.04 883.4548 1,764.89 1,764.90 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLQDFASTVEALEEGK 95.00% 5.59 0.569 7.68 883.457 1,764.90 1,764.90 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ISDLTTNLAEEEEKAK 95.00% 4.05 0.41 0 895.9513 1,789.89 1,790.90 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ISDLTTNLAEEEEKAK 95.00% 3.78 0.384 0 895.9521 1,789.89 1,790.90 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ISDLTTNLAEEEEKAK 95.00% 3.99 0.358 0 895.9535 1,789.89 1,790.90 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ISDLTTNLAEEEEKAK 95.00% 3.92 0.423 0 895.954 1,789.89 1,790.90 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ISDLTTNLAEEEEKAK 95.00% 3.62 0.407 0 895.9543 1,789.89 1,790.90 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ISDLTTNLAEEEEKAK 95.00% 4.26 0.376 0 896.4563 1,790.90 1,790.90 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KLEDEILVMDDQNNK 95.00% 3.38 0.403 1.62 902.4428 1,802.87 1,803.88 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 5.78 0.592 6.04 956.9825 1,911.95 1,912.96 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 5.2 0.567 5.24 956.9829 1,911.95 1,912.96 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 5.68 0.584 4.22 956.9832 1,911.95 1,912.96 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 4.72 0.583 4.42 956.9848 1,911.95 1,912.96 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 5.52 0.6 4.21 957.4834 1,912.95 1,912.96 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 5.48 0.596 4.96 957.4837 1,912.95 1,912.96 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 5.78 0.606 3.51 957.4843 1,912.95 1,912.96 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 5.79 0.571 4.42 957.4845 1,912.95 1,912.96 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 5.57 0.578 5.19 957.4846 1,912.95 1,912.96 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQQELDDLVVDLDNQR 95.00% 5.49 0.582 4.8 957.486 1,912.96 1,912.96 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 5.57 0.584 7.07 958.9841 1,915.95 1,916.97 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 5.62 0.614 6.28 958.9875 1,915.96 1,916.97 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 5.95 0.638 6.54 958.9878 1,915.96 1,916.97 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 5.91 0.587 7.27 959.4873 1,916.96 1,916.97 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% KATQQAEQLSNELATER 95.00% 5.75 0.627 5.92 959.4887 1,916.96 1,916.97 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% FQKEIENLTQQYEEK 95.00% 5.28 0.378 5.51 964.4773 1,926.94 1,926.95 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% FQKEIENLTQQYEEK 95.00% 5.4 0.389 6.38 964.4776 1,926.94 1,926.95 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQNEVESVTGMLNEAEGK 95.00% 5.21 0.652 7.04 974.4673 1,946.92 1,947.93 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQNEVESVTGMLNEAEGK 95.00% 5.88 0.656 6.82 974.4684 1,946.92 1,947.93 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQNEVESVTGMLNEAEGK 95.00% 5.64 0.627 8.4 974.469 1,946.92 1,947.93 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQNEVESVTGMLNEAEGK 95.00% 5.79 0.623 8.17 974.469 1,946.92 1,947.93 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQNEVESVTGMLNEAEGK 95.00% 5.47 0.552 8.15 974.9665 1,947.92 1,947.93 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% LQNEVESVTGMLNEAEGK 95.00% 4.8 0.643 7.12 974.9678 1,947.92 1,947.93 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% TQLEELEDELQATEDAK 95.00% 6.58 0.621 8.01 981.9609 1,961.91 1,961.92 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% SLEADLMQLQEDLAAAER 95.00% 5.39 0.56 4.1 1,002.49 2,002.97 2,002.98 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% ALDEETRSHEAQVQEMR 95.00% 2.93 0.344 2.16 1,015.47 2,028.93 2,028.94 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% NMDPLNDNVTSLLNASSDK 95.00% 5.65 0.585 8.28 1,024.98 2,047.94 2,047.96 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% MAQQMLDLEEQLEEEEAAR 95.00% 6.67 0.491 5 1,132.52 2,263.01 2,263.02 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DVASLSSQLQDTQELLQEETR 95.00% 6.24 0.571 7.92 1,196.09 2,390.16 2,390.17 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DVASLSSQLQDTQELLQEETR 95.00% 6.23 0.585 7.66 1,196.09 2,390.16 2,390.17 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DVASLSSQLQDTQELLQEETR 95.00% 6.12 0.568 8.34 1,196.09 2,390.16 2,390.17 2
 SAMPLE 2R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 81 106 422 44.40% DVASLSSQLQDTQELLQEETR 95.00% 6.29 0.599 7.52 1,196.09 2,390.17 2,390.17 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KLEAQVQELQSK 95.00% 3.77 0.226 1.14 467.5967 1,399.77 1,400.78 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KLEAQVQELQSK 95.00% 4.43 0.159 1.51 467.5978 1,399.77 1,400.78 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IVFQEFR 95.00% 2.46 0.398 0 469.7588 937.5019 938.51 2 MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IVFQEFR 95.00% 2.44 0.397 0 469.7588 937.502 938.51 2 MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IVFQEFR 95.00% 2.34 0.383 1.57 469.759 937.5024 938.51 2 MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IVFQEFR 95.00% 2.46 0.375 0 469.7592 937.5027 938.51 2 MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VIQYLAVVASSHK 95.00% 3.02 0.571 1.42 472.2723 1,413.79 1,414.81 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VIQYLAVVASSHK 95.00% 2.48 0.42 0 472.2727 1,413.79 1,414.81 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VIQYLAVVASSHK 95.00% 3.12 0.499 1.48 472.2756 1,413.80 1,414.81 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VIQYLAVVASSHK 95.00% 3.1 0.471 1.96 472.6078 1,414.80 1,414.81 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% HISTLNIQLSDSK 95.00% 2.49 0.338 0 486.2969 1,455.87 1,455.78 3 TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% HISTLNIQLSDSK 95.00% 2.09 0.264 0 486.297 1,455.87 1,455.78 3 TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IVGLDQMAK 95.00% 1.97 0.319 0 487.7715 973.5273 974.5347 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% NWQWWR 95.00% 2.2 0.254 0 488.2318 974.448 975.4589 2 MYH9_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% QRYEILAANAIPK 95.00% 3.68 0.379 0 496.2831 1,485.83 1,486.84 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% QRYEILAANAIPK 95.00% 3 0.299 1.05 496.2845 1,485.83 1,486.84 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% QRYEILAANAIPK 95.00% 3.78 0.382 1.54 496.618 1,486.83 1,486.84 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% DKTEFSIIHYAGK 95.00% 3.35 0.343 2.42 503.5953 1,507.76 1,508.78 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% DKTEFSIIHYAGK 95.00% 2.84 0.274 0 503.5956 1,507.76 1,508.78 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% DKTEFSIIHYAGK 95.00% 3.5 0.307 3.4 503.5958 1,507.76 1,508.78 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% DKTEFSIIHYAGK 95.00% 2.7 0.265 0 503.5963 1,507.77 1,508.78 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KKLEAQVQELQSK 95.00% 3.88 0.348 0 510.2931 1,527.86 1,528.87 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LEVNMQALK 95.00% 2.88 0.236 0 523.2884 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LEVNMQALK 95.00% 2.87 0.248 0 523.2888 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VKPLLQVTR 95.00% 2.03 0.272 0 527.3419 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VKPLLQVTR 95.00% 2.12 0.325 0 527.3419 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VKPLLQVTR 95.00% 2.15 0.299 0 527.3423 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VKPLLQVTR 95.00% 2.17 0.344 0 527.3424 1,052.67 1,053.68 2 MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% SGKLDAFLVLEQLR 95.00% 4.1 0.222 1.18 530.3057 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% SGKLDAFLVLEQLR 95.00% 4.41 0.258 1.46 530.3064 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% SGKLDAFLVLEQLR 95.00% 3.73 0.201 1.82 530.307 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% SGKLDAFLVLEQLR 95.00% 3.85 0.213 1.43 530.6426 1,588.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALEEALEAKEELER 95.00% 3.22 0.21 1.8 543.9483 1,628.82 1,629.83 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALEEALEAKEELER 95.00% 3 0.366 2.89 543.9485 1,628.82 1,629.83 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALEEALEAKEELER 95.00% 3.1 0.403 1.82 543.9488 1,628.82 1,629.83 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALEEALEAKEELER 95.00% 3.35 0.411 1.66 543.9488 1,628.82 1,629.83 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALEEALEAKEELER 95.00% 2.82 0.156 1.55 544.2833 1,629.83 1,629.83 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% DTSITGELEK 95.00% 2.49 0.265 1.96 546.7733 1,091.53 1,092.54 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% DTSITGELEK 95.00% 2.5 0.271 1.82 546.7746 1,091.53 1,092.54 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% QTLEKENADLAGELR 95.00% 2.3 0.358 0 562.96 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% MTESSLPSASK 95.00% 2.52 0.334 2.7 569.2746 1,136.53 1,137.55 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% mTESSLPSASK 95.00% 2.58 0.335 1.85 m1: Oxidation (+15.99) 577.2726 1,152.53 1,153.54 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% mTESSLPSASK 95.00% 2.95 0.463 4.72 m1: Oxidation (+15.99) 577.2733 1,152.53 1,153.54 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% mTESSLPSASK 95.00% 2.2 0.376 2.23 m1: Oxidation (+15.99) 577.2738 1,152.53 1,153.54 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% mTESSLPSASK 95.00% 2.8 0.445 4.07 m1: Oxidation (+15.99) 577.274 1,152.53 1,153.54 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% QEEEMQAKEDELQK 95.00% 3.44 0.259 1.1 578.9341 1,733.78 1,734.79 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ISDLTTNLAEEEEKAK 95.00% 2.64 0.18 0 597.637 1,789.89 1,790.90 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ISDLTTNLAEEEEKAK 95.00% 3.03 0.366 0 597.6376 1,789.89 1,790.90 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ISDLTTNLAEEEEKAK 95.00% 2.86 0.208 0 597.6381 1,789.89 1,790.90 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ISDLTTNLAEEEEKAK 95.00% 2.94 0.349 0 597.9725 1,790.89 1,790.90 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALELDPNLYR 95.00% 2.36 0.273 2.49 602.3206 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALELDPNLYR 95.00% 2.95 0.294 2.28 602.321 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALELDPNLYR 95.00% 2.98 0.287 1.92 602.3213 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALELDPNLYR 95.00% 2.86 0.263 1.16 602.3216 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALELDPNLYR 95.00% 2.85 0.273 1.77 602.3225 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KFDQLLAEEK 95.00% 2.57 0.221 0 610.8292 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KFDQLLAEEK 95.00% 2.71 0.222 0 610.8293 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KFDQLLAEEK 95.00% 2.78 0.229 0 610.8294 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KFDQLLAEEK 95.00% 2.59 0.229 0 610.8296 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KFDQLLAEEK 95.00% 2.39 0.182 0 610.8315 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% TGVLAHLEEER 95.00% 2.27 0.122 2.26 627.325 1,252.63 1,253.65 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% TGVLAHLEEER 95.00% 2.49 0.31 0 627.3264 1,252.64 1,253.65 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% TGVLAHLEEER 95.00% 2.77 0.341 1.39 627.3279 1,252.64 1,253.65 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% TGVLAHLEEER 95.00% 2.83 0.446 1.82 627.3282 1,252.64 1,253.65 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% TGVLAHLEEER 95.00% 2.85 0.406 2.05 627.3283 1,252.64 1,253.65 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% TEFSIIHYAGK 95.00% 2.68 0.364 0 633.328 1,264.64 1,265.65 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% TEFSIIHYAGK 95.00% 2.95 0.522 2.41 633.3304 1,264.65 1,265.65 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% TEFSIIHYAGK 95.00% 2.68 0.464 2.8 633.3306 1,264.65 1,265.65 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% TEFSIIHYAGK 95.00% 2.47 0.234 1.77 633.3318 1,264.65 1,265.65 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VDYNASAWLTK 95.00% 2.27 0.386 1.8 634.3177 1,266.62 1,267.63 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VDYNASAWLTK 95.00% 3.86 0.513 2.92 634.318 1,266.62 1,267.63 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VDYNASAWLTK 95.00% 2.85 0.473 2.03 634.3184 1,266.62 1,267.63 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VDYNASAWLTK 95.00% 3.96 0.494 2.82 634.3186 1,266.62 1,267.63 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VDYNASAWLTK 95.00% 3.98 0.537 3.11 634.3188 1,266.62 1,267.63 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VDYNASAWLTK 95.00% 3.12 0.513 3.55 634.3189 1,266.62 1,267.63 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQQELDDLVVDLDNQR 95.00% 4.11 0.503 1.59 638.3261 1,911.95 1,912.96 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQQELDDLVVDLDNQR 95.00% 4.73 0.464 1.66 638.6597 1,912.96 1,912.96 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQQELDDLVVDLDNQR 95.00% 3.55 0.345 0 638.6641 1,912.97 1,912.96 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KATQQAEQLSNELATER 95.00% 3.7 0.439 0 639.6613 1,915.96 1,916.97 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KATQQAEQLSNELATER 95.00% 4.26 0.455 0 639.6614 1,915.96 1,916.97 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KATQQAEQLSNELATER 95.00% 4.3 0.379 1.6 639.9947 1,916.96 1,916.97 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KATQQAEQLSNELATER 95.00% 4.24 0.343 1.44 639.9949 1,916.96 1,916.97 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KATQQAEQLSNELATER 95.00% 4.3 0.465 1.41 639.9952 1,916.96 1,916.97 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% EQADFAVEALAK 95.00% 2.75 0.45 0 646.3288 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% EQADFAVEALAK 95.00% 2.69 0.509 1.39 646.3291 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% EQADFAVEALAK 95.00% 2.48 0.373 0 646.3293 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% EQADFAVEALAK 95.00% 2.91 0.485 1.46 646.3296 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% EQADFAVEALAK 95.00% 2.37 0.322 0 646.33 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% AENELKELEQK 94.90% 2.39 0.0893 1.12 665.8456 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% HAQAVEELTEQLEQFKR 95.00% 5.25 0.598 0 686.3541 2,056.04 2,056.05 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% HAQAVEELTEQLEQFKR 95.00% 5.56 0.563 2.7 686.3542 2,056.04 2,056.05 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VIQYLAVVASSHK 95.00% 3.39 0.3 2.39 707.905 1,413.79 1,414.81 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% VIQYLAVVASSHK 95.00% 3.24 0.299 4.09 707.9054 1,413.80 1,414.81 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% QADLEKEELAEELASSLSGR 95.00% 4.02 0.56 1.85 726.0302 2,175.07 2,175.08 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% QADLEKEELAEELASSLSGR 95.00% 2.58 0.442 0 726.0317 2,175.07 2,175.08 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IRELEGHISDLQEDLDSER 95.00% 4.93 0.559 3.44 752.0339 2,253.08 2,254.10 3
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 95.00% 4.49 0.415 1.62 771.8909 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 95.00% 4.27 0.466 3.46 771.8911 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 95.00% 4.65 0.457 1.72 771.8913 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 95.00% 4.34 0.474 2.3 771.8913 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 95.00% 4.9 0.418 2.82 771.8914 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 95.00% 4.7 0.465 3.4 771.8917 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 95.00% 4.71 0.425 4.42 771.8919 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 95.00% 4.6 0.355 4.68 772.3919 1,542.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 95.00% 4.85 0.337 3.92 772.3929 1,542.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 95.00% 0 0 3.82 773.404 1,544.79 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 95.00% 0 0 3.74 773.4042 1,544.79 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 95.00% 0 0 3.25 773.4054 1,544.80 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% IAQLEEQVEQEAR 94.90% 0 0 3.17 773.4059 1,544.80 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ELDEATESNEAMGR 95.00% 4.24 0.52 4.52 776.3326 1,550.65 1,551.66 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ELDEATESNEAMGR 95.00% 4.24 0.571 5.41 776.3332 1,550.65 1,551.66 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALEEALEAKEELER 95.00% 3.51 0.446 2.1 815.416 1,628.82 1,629.83 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALEEALEAKEELER 95.00% 4.4 0.406 2.09 815.4187 1,628.82 1,629.83 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALEEALEAKEELER 95.00% 4.63 0.441 2.62 815.4203 1,628.82 1,629.83 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALEEALEAKEELER 95.00% 4.68 0.427 2.38 815.4207 1,628.83 1,629.83 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ALEEALEAKEELER 95.00% 4.32 0.422 2.52 815.4212 1,628.83 1,629.83 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% NFINSPVAQADWAAK 95.00% 3.84 0.481 3.14 816.4123 1,630.81 1,631.82 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQDFASTVEALEEGK 95.00% 3.07 0.426 5.96 818.9057 1,635.80 1,636.81 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQDFASTVEALEEGK 95.00% 3.77 0.523 5.4 818.9062 1,635.80 1,636.81 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQDFASTVEALEEGK 95.00% 4.06 0.537 6.7 818.9067 1,635.80 1,636.81 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQDFASTVEALEEGK 95.00% 3.67 0.438 6.41 818.9084 1,635.80 1,636.81 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQDFASTVEALEEGK 95.00% 4.44 0.53 6 818.9084 1,635.80 1,636.81 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQDFASTVEALEEGK 95.00% 3.89 0.489 5.03 818.9086 1,635.80 1,636.81 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQDFASTVEALEEGK 95.00% 3 0.435 4.6 818.9093 1,635.80 1,636.81 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQDFASTVEALEEGK 95.00% 3.99 0.482 5.96 819.4074 1,636.80 1,636.81 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQDFASTVEALEEGK 95.00% 4.23 0.499 5.28 819.4086 1,636.80 1,636.81 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% QTLEKENADLAGELR 95.00% 3.08 0.46 0 843.9361 1,685.86 1,686.87 2 CO3_HUMAN
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ISDLTTNLAEEEEKAK 95.00% 3.52 0.289 0 895.953 1,789.89 1,790.90 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% ISDLTTNLAEEEEKAK 95.00% 3.23 0.422 0 895.9568 1,789.90 1,790.90 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQQELDDLVVDLDNQR 95.00% 5.45 0.562 4.57 956.9838 1,911.95 1,912.96 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQQELDDLVVDLDNQR 95.00% 5.66 0.561 4.12 957.4826 1,912.95 1,912.96 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQQELDDLVVDLDNQR 95.00% 5.55 0.566 5.36 957.4831 1,912.95 1,912.96 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQQELDDLVVDLDNQR 95.00% 5.05 0.528 4.4 957.4832 1,912.95 1,912.96 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQQELDDLVVDLDNQR 95.00% 5.64 0.578 5.05 957.484 1,912.95 1,912.96 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KATQQAEQLSNELATER 95.00% 4.56 0.547 4.3 958.9877 1,915.96 1,916.97 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% KATQQAEQLSNELATER 95.00% 5.11 0.544 4.82 959.4911 1,916.97 1,916.97 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% FQKEIENLTQQYEEK 95.00% 4.49 0.351 4.07 964.4773 1,926.94 1,926.95 2
 SAMPLE 3 Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 36 42 138 22.50% LQNEVESVTGMLNEAEGK 95.00% 5.55 0.585 6.57 974.4693 1,946.92 1,947.93 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KLEAQVQELQSK 95.00% 3.97 0.124 1 467.5965 1,399.77 1,400.78 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KLEAQVQELQSK 95.00% 3.73 0.151 0 467.598 1,399.77 1,400.78 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IVFQEFR 95.00% 2.32 0.333 0 469.7579 937.5002 938.51 2 MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IVFQEFR 95.00% 2.61 0.371 0 469.7581 937.5005 938.51 2 MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IVFQEFR 95.00% 2.08 0.241 0 469.7586 937.5016 938.51 2 MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IVFQEFR 95.00% 1.83 0.287 0 469.7589 937.5022 938.51 2 MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IVFQEFR 95.00% 2.62 0.367 0 469.7591 937.5025 938.51 2 MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IVFQEFR 95.00% 2.39 0.329 0 469.7603 937.505 938.51 2 MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VIQYLAVVASSHK 95.00% 2.51 0.394 0 472.2735 1,413.80 1,414.81 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VIQYLAVVASSHK 95.00% 2.71 0.441 1.37 472.2741 1,413.80 1,414.81 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VIQYLAVVASSHK 95.00% 3.02 0.452 0 472.2747 1,413.80 1,414.81 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VIQYLAVVASSHK 95.00% 3.07 0.545 2.89 472.275 1,413.80 1,414.81 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VIQYLAVVASSHK 95.00% 3.31 0.47 1.04 472.6079 1,414.80 1,414.81 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% HISTLNIQLSDSK 95.00% 2.75 0.413 0 485.9314 1,454.77 1,455.78 3 TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% HISTLNIQLSDSK 95.00% 1.97 0.25 0 486.2973 1,455.87 1,455.78 3 TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% HISTLNIQLSDSK 95.00% 2.71 0.362 1.34 486.2974 1,455.87 1,455.78 3 TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IVGLDQMAK 95.00% 2.1 0.245 0 487.7697 973.5237 974.5347 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QRYEILAANAIPK 95.00% 3.07 0.306 0 496.2823 1,485.82 1,486.84 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QRYEILAANAIPK 95.00% 3.64 0.441 0 496.2836 1,485.83 1,486.84 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QRYEILAANAIPK 95.00% 3.4 0.328 1.96 496.2837 1,485.83 1,486.84 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QRYEILAANAIPK 95.00% 3.34 0.26 0 496.6176 1,486.83 1,486.84 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QRYEILAANAIPK 95.00% 3.37 0.397 1.52 496.6179 1,486.83 1,486.84 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QRYEILAANAIPK 95.00% 3.24 0.334 1.24 496.619 1,486.83 1,486.84 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VVSSVLQLGNIVFK 95.00% 2.86 0.307 0 501.6364 1,501.89 1,502.89 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% DKTEFSIIHYAGK 95.00% 3.46 0.296 0 503.5953 1,507.76 1,508.78 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% DKTEFSIIHYAGK 95.00% 3.55 0.29 0 503.5954 1,507.76 1,508.78 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% DKTEFSIIHYAGK 95.00% 3.35 0.485 0 503.5959 1,507.76 1,508.78 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% DKTEFSIIHYAGK 95.00% 2.88 0.243 0 503.5961 1,507.76 1,508.78 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% cNGVLEGIR 95.00% 2.6 0.372 0 c1: Carbamidomethyl (+57.02) 509.2605 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% cNGVLEGIR 95.00% 2.95 0.391 1.59 c1: Carbamidomethyl (+57.02) 509.2605 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% cNGVLEGIR 95.00% 2.27 0.259 0 c1: Carbamidomethyl (+57.02) 509.2606 1,016.51 1,017.52 2 ,MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% TFHIFYYMIAGAK 95.00% 2.47 0.332 0 521.6 1,561.78 1,561.79 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% TFHIFYYMIAGAK 95.00% 2.86 0.297 0 521.6017 1,561.78 1,561.79 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LEVNMQALK 95.00% 2.8 0.213 1.07 523.2886 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LEVNMQALK 95.00% 2.59 0.279 0 523.2888 1,044.56 1,045.57 2 NEXN_HUMAN,IQGA1_HUMAN,ANK3_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% SGKLDAFLVLEQLR 95.00% 4.49 0.258 0 530.3054 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% SGKLDAFLVLEQLR 95.00% 3.45 0.237 0 530.3057 1,587.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% SGKLDAFLVLEQLR 95.00% 3.2 0.19 0.959 530.3079 1,587.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% SGKLDAFLVLEQLR 95.00% 3.97 0.0798 0 530.6395 1,588.89 1,588.91 3 SPTA2_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% SGKLDAFLVLEQLR 95.00% 3.56 0.19 0 530.6408 1,588.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% SGKLDAFLVLEQLR 95.00% 4.34 0.171 0 530.6417 1,588.90 1,588.91 3 SPTA2_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% TGVLAHLEEERDLK 95.00% 2.73 0.201 0 537.6236 1,609.85 1,609.86 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALEEALEAKEELER 95.00% 3.17 0.322 2.16 543.9482 1,628.82 1,629.83 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALEEALEAKEELER 95.00% 2.54 0.199 0 543.9495 1,628.83 1,629.83 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALEEALEAKEELER 95.00% 3.85 0.336 1.06 544.2831 1,629.83 1,629.83 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALEEALEAKEELER 95.00% 2.95 0.293 0 544.2844 1,629.83 1,629.83 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQDFASTVEALEEGK 95.00% 1.99 0.207 1.3 546.2748 1,635.80 1,636.81 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% DTSITGELEK 95.00% 2.31 0.291 2.04 546.773 1,091.53 1,092.54 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% DTSITGELEK 95.00% 2.48 0.263 1.74 546.7731 1,091.53 1,092.54 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% DTSITGELEK 95.00% 2.18 0.217 0 546.7734 1,091.53 1,092.54 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QTLEKENADLAGELR 95.00% 2.37 0.416 0 562.9607 1,685.86 1,686.87 3 CO3_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% MTESSLPSASK 95.00% 2.28 0.402 3.3 569.2744 1,136.53 1,137.55 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% MTESSLPSASK 95.00% 2.66 0.445 2.06 569.2782 1,136.54 1,137.55 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QLLQANPILEAFGNAK 95.00% 3.03 0.291 1.6 576.3196 1,725.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QLLQANPILEAFGNAK 95.00% 4.88 0.443 2.64 576.6543 1,726.94 1,726.95 3 MYH9_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% mTESSLPSASK 95.00% 2.64 0.348 2.46 m1: Oxidation (+15.99) 577.274 1,152.53 1,153.54 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% mTESSLPSASK 95.00% 2.24 0.307 2.96 m1: Oxidation (+15.99) 577.2741 1,152.53 1,153.54 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QEEEMQAKEDELQK 95.00% 2.88 0.329 2.62 578.9322 1,733.77 1,734.79 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QEEEMQAKEDELQK 95.00% 3.21 0.386 3.28 578.9338 1,733.78 1,734.79 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ISDLTTNLAEEEEKAK 95.00% 2.75 0.139 0 597.6382 1,789.89 1,790.90 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ISDLTTNLAEEEEKAK 95.00% 2.54 0.233 0 597.6387 1,789.89 1,790.90 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ISDLTTNLAEEEEKAK 95.00% 2.71 0.228 0 597.6388 1,789.89 1,790.90 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ISDLTTNLAEEEEKAK 95.00% 2.54 0.262 0 597.6389 1,789.89 1,790.90 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% YEILAANAIPK 95.00% 3.45 0.378 1.25 601.8415 1,201.67 1,202.68 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% YEILAANAIPK 95.00% 2.44 0.404 0 601.8435 1,201.67 1,202.68 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALELDPNLYR 95.00% 2.08 0.277 1.82 602.3201 1,202.62 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALELDPNLYR 95.00% 2.38 0.244 1.85 602.321 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALELDPNLYR 95.00% 2.73 0.282 2.01 602.321 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALELDPNLYR 95.00% 2.8 0.325 0 602.3211 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALELDPNLYR 95.00% 2.92 0.26 1.96 602.3211 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALELDPNLYR 95.00% 2.44 0.253 1.68 602.3212 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALELDPNLYR 95.00% 2.72 0.23 2.25 602.3213 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALELDPNLYR 95.00% 2.54 0.279 2.21 602.3216 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALELDPNLYR 95.00% 2.18 0.343 1.2 602.3241 1,202.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALELDPNLYR 95.00% 2.57 0.265 1.74 602.8253 1,203.63 1,203.64 2 RS8_HUMAN,VINC_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KFDQLLAEEK 95.00% 2.33 0.227 0 610.8296 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KFDQLLAEEK 95.00% 2.89 0.223 0 610.83 1,219.64 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KFDQLLAEEK 95.00% 2.63 0.145 0 610.8306 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KFDQLLAEEK 95.00% 2.42 0.184 0 610.8309 1,219.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KFDQLLAEEK 95.00% 2.19 0.17 1.52 611.3322 1,220.65 1,220.65 2 MYH9_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% TGVLAHLEEER 95.00% 2.54 0.453 0 627.3264 1,252.64 1,253.65 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% TGVLAHLEEER 95.00% 2.29 0.314 1.54 627.3275 1,252.64 1,253.65 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% TGVLAHLEEER 95.00% 2.64 0.405 1.7 627.3277 1,252.64 1,253.65 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% TGVLAHLEEER 95.00% 2.5 0.288 1.59 627.8264 1,253.64 1,253.65 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% TGVLAHLEEER 95.00% 2.32 0.251 0 627.8278 1,253.64 1,253.65 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% TEFSIIHYAGK 95.00% 2.55 0.423 0 633.3283 1,264.64 1,265.65 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% TEFSIIHYAGK 95.00% 2.22 0.284 1.44 633.3299 1,264.64 1,265.65 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VDYNASAWLTK 95.00% 3.97 0.538 2.8 634.3191 1,266.62 1,267.63 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VDYNASAWLTK 95.00% 3.27 0.487 2.66 634.3194 1,266.62 1,267.63 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VDYNASAWLTK 95.00% 4.33 0.504 2.96 634.3195 1,266.62 1,267.63 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LEAQVQELQSK 95.00% 2.18 0.344 0 636.8462 1,271.68 1,272.68 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQQELDDLVVDLDNQR 95.00% 4.78 0.451 1.39 638.3251 1,911.95 1,912.96 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQQELDDLVVDLDNQR 95.00% 3.81 0.39 0 638.3252 1,911.95 1,912.96 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQQELDDLVVDLDNQR 95.00% 4.32 0.399 1.41 638.659 1,912.95 1,912.96 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQQELDDLVVDLDNQR 95.00% 3.96 0.416 2.27 638.6594 1,912.95 1,912.96 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KATQQAEQLSNELATER 95.00% 2.88 0.215 0 639.6602 1,915.96 1,916.97 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KATQQAEQLSNELATER 95.00% 4.28 0.464 1.12 639.661 1,915.96 1,916.97 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KATQQAEQLSNELATER 95.00% 2.85 0.302 0 639.994 1,916.96 1,916.97 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KATQQAEQLSNELATER 95.00% 3.99 0.327 1.16 639.9946 1,916.96 1,916.97 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KATQQAEQLSNELATER 95.00% 3.12 0.369 0 639.9949 1,916.96 1,916.97 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KATQQAEQLSNELATER 95.00% 4.37 0.364 0 639.9955 1,916.96 1,916.97 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KATQQAEQLSNELATER 95.00% 4.12 0.33 0 639.9955 1,916.96 1,916.97 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% EQADFAVEALAK 95.00% 2.66 0.381 0 646.3294 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% EQADFAVEALAK 95.00% 2.54 0.359 0 646.3297 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% EQADFAVEALAK 95.00% 2.28 0.254 0 646.3299 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% EQADFAVEALAK 95.00% 3.26 0.476 1.17 646.33 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% EQADFAVEALAK 95.00% 2.7 0.427 0 646.3303 1,290.64 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% EQADFAVEALAK 95.00% 2.93 0.474 0 646.3307 1,290.65 1,291.65 2 PABP1_HUMAN,COR1C_HUMAN,LAMA4_HUMAN,LAMA5_HUMAN,MYH10_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LDAFLVLEQLR 95.00% 3.12 0.275 0 658.8796 1,315.74 1,316.76 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LDAFLVLEQLR 95.00% 3.72 0.38 0 658.8815 1,315.75 1,316.76 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KLEGDLKDLELQADSAIK 95.00% 2.61 0.262 0 663.03 1,986.07 1,986.08 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% AENELKELEQK 95.00% 2.99 0.12 0 665.8449 1,329.67 1,330.69 2 RL13_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% AENELKELEQK 95.00% 2.99 0.17 1.34 665.846 1,329.68 1,330.69 2 RL13_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KLEAQVQELQSKcSDGER 95.00% 2.24 0.298 0 c13: Carbamidomethyl (+57.02) 702.3359 2,103.98 2,105.03 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KLEAQVQELQSKcSDGER 95.00% 2.09 0.218 0 c13: Carbamidomethyl (+57.02) 702.3387 2,103.99 2,105.03 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VIQYLAVVASSHK 95.00% 2.56 0.22 3.18 707.9054 1,413.80 1,414.81 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QADLEKEELAEELASSLSGR 95.00% 3.5 0.503 1.19 726.0313 2,175.07 2,175.08 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QADLEKEELAEELASSLSGR 95.00% 3.67 0.531 0 726.0315 2,175.07 2,175.08 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QADLEKEELAEELASSLSGR 95.00% 2.99 0.498 0 726.0316 2,175.07 2,175.08 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VVSSVLQLGNIVFK 95.00% 4.34 0.514 4.12 751.9497 1,501.88 1,502.89 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VVSSVLQLGNIVFK 95.00% 4.56 0.536 3.96 751.9497 1,501.88 1,502.89 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VVSSVLQLGNIVFK 95.00% 4.14 0.509 5.21 751.9505 1,501.89 1,502.89 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VVSSVLQLGNIVFK 95.00% 4.42 0.508 4.52 751.9513 1,501.89 1,502.89 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VVSSVLQLGNIVFK 95.00% 4.4 0.518 4.47 751.9519 1,501.89 1,502.89 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VVSSVLQLGNIVFK 95.00% 4.28 0.506 3.96 751.9523 1,501.89 1,502.89 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VVSSVLQLGNIVFK 95.00% 3.36 0.507 3.62 752.45 1,502.88 1,502.89 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% VVSSVLQLGNIVFK 95.00% 4.13 0.52 3.82 752.4523 1,502.89 1,502.89 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 4.33 0.382 3.42 771.8886 1,541.76 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 4.19 0.437 2.55 771.8907 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 4.5 0.431 2.66 771.8908 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 4.8 0.418 2.48 771.891 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 4.3 0.503 1.72 771.8911 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 4.26 0.474 3.21 771.8911 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 4.8 0.407 1.85 771.8916 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 4.34 0.425 2.89 771.8924 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 4.49 0.402 3.43 771.8929 1,541.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 4.56 0.38 2.55 772.3927 1,542.77 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 2.42 0.242 0 772.396 1,542.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 2.39 0.312 0 772.3965 1,542.78 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 0 0 3.74 773.4032 1,544.79 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 0 0 4 773.4035 1,544.79 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 0 0 3.92 773.4043 1,544.79 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% IAQLEEQVEQEAR 95.00% 0 0 3.62 773.4066 1,544.80 1,542.78 2 FBN1_HUMAN,TITIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ELDEATESNEAMGR 95.00% 3.77 0.539 3.23 776.3311 1,550.65 1,551.66 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ELDEATESNEAMGR 95.00% 3.71 0.525 3.41 776.332 1,550.65 1,551.66 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ITDVIMAFQAMcR 95.00% 2.13 0.212 1.47 c12: Carbamidomethyl (+57.02) 778.3727 1,554.73 1,555.74 2 AGRIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ITDVIMAFQAMcR 95.00% 3.82 0.536 4.03 c12: Carbamidomethyl (+57.02) 778.3745 1,554.73 1,555.74 2 AGRIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ITDVIMAFQAMcR 95.00% 3.52 0.529 2.96 c12: Carbamidomethyl (+57.02) 778.3758 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ITDVIMAFQAMcR 95.00% 2.28 0.26 3.66 c12: Carbamidomethyl (+57.02) 778.3776 1,554.74 1,555.74 2 AGRIN_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% SGKLDAFLVLEQLR 95.00% 4.73 0.511 4.59 794.9525 1,587.89 1,588.91 2 SPTA2_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% SGKLDAFLVLEQLR 95.00% 5.06 0.511 4.21 795.4554 1,588.90 1,588.91 2 SPTA2_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% SGKLDAFLVLEQLR 95.00% 4.69 0.491 3.72 795.4596 1,588.90 1,588.91 2 SPTA2_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% DVASLSSQLQDTQELLQEETR 95.00% 6.84 0.544 4.72 797.7279 2,390.16 2,390.17 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% DVASLSSQLQDTQELLQEETR 95.00% 6.68 0.515 2.68 797.7285 2,390.16 2,390.17 3
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALEEALEAKEELER 95.00% 4.5 0.4 3.46 815.4172 1,628.82 1,629.83 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALEEALEAKEELER 95.00% 4.59 0.415 2.57 815.4193 1,628.82 1,629.83 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ALEEALEAKEELER 95.00% 4.49 0.409 2.3 815.4206 1,628.83 1,629.83 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% NFINSPVAQADWAAK 95.00% 3.49 0.498 1.77 816.4166 1,630.82 1,631.82 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% NFINSPVAQADWAAK 95.00% 2.62 0.369 0 817.1108 1,632.21 1,631.82 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQDFASTVEALEEGK 95.00% 2.83 0.492 4.57 818.9039 1,635.79 1,636.81 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQDFASTVEALEEGK 95.00% 2.33 0.409 4.17 818.9067 1,635.80 1,636.81 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQDFASTVEALEEGK 95.00% 3.45 0.428 5.77 818.907 1,635.80 1,636.81 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQDFASTVEALEEGK 95.00% 3.96 0.483 5.8 818.9078 1,635.80 1,636.81 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQDFASTVEALEEGK 95.00% 3.51 0.417 4.54 818.9079 1,635.80 1,636.81 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQDFASTVEALEEGK 95.00% 4.5 0.505 5.3 818.9082 1,635.80 1,636.81 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQDFASTVEALEEGK 95.00% 4.43 0.445 5.64 819.4079 1,636.80 1,636.81 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQDFASTVEALEEGK 95.00% 2.94 0.424 4.04 819.4119 1,636.81 1,636.81 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QLLQANPILEAFGNAK 95.00% 4.76 0.359 4.51 863.9719 1,725.93 1,726.95 2 MYH9_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QLLQANPILEAFGNAK 95.00% 3.85 0.269 1.36 863.976 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QLLQANPILEAFGNAK 95.00% 5.06 0.536 4.42 863.977 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QLLQANPILEAFGNAK 95.00% 5.02 0.499 4.48 863.9776 1,725.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QLLQANPILEAFGNAK 95.00% 4.54 0.264 2.72 864.4746 1,726.93 1,726.95 2 MYH9_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QLLQANPILEAFGNAK 95.00% 5.05 0.195 3.89 864.4749 1,726.93 1,726.95 2 MYH9_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QLLQANPILEAFGNAK 95.00% 4.88 0.512 4.12 864.4758 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QLLQANPILEAFGNAK 95.00% 5.09 0.424 3 864.4767 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QLLQANPILEAFGNAK 95.00% 5.01 0.413 4.12 864.477 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% QLLQANPILEAFGNAK 95.00% 4.98 0.473 3.41 864.4787 1,726.94 1,726.95 2 MYH9_HUMAN
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ISDLTTNLAEEEEKAK 95.00% 3.71 0.399 0 895.9523 1,789.89 1,790.90 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% ISDLTTNLAEEEEKAK 95.00% 4.2 0.442 0 896.4549 1,790.89 1,790.90 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQQELDDLVVDLDNQR 95.00% 5.21 0.565 3.96 956.9842 1,911.95 1,912.96 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQQELDDLVVDLDNQR 95.00% 4.85 0.589 3.8 956.9851 1,911.95 1,912.96 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQQELDDLVVDLDNQR 95.00% 5.46 0.558 4.48 956.9885 1,911.96 1,912.96 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQQELDDLVVDLDNQR 95.00% 5.77 0.588 4.28 957.4839 1,912.95 1,912.96 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQQELDDLVVDLDNQR 95.00% 5.64 0.572 4 957.4856 1,912.96 1,912.96 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQQELDDLVVDLDNQR 95.00% 5.66 0.539 5.27 957.486 1,912.96 1,912.96 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% KATQQAEQLSNELATER 95.00% 5.51 0.565 4.39 959.4878 1,916.96 1,916.97 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQNEVESVTGMLNEAEGK 95.00% 5.57 0.665 8.12 974.4688 1,946.92 1,947.93 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQNEVESVTGMLNEAEGK 95.00% 5.43 0.595 6.89 974.4696 1,946.92 1,947.93 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% LQNEVESVTGMLNEAEGK 95.00% 5.12 0.59 6.7 974.969 1,947.92 1,947.93 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% DVASLSSQLQDTQELLQEETR 95.00% 6.53 0.59 6.32 1,196.08 2,390.15 2,390.17 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% DVASLSSQLQDTQELLQEETR 95.00% 4.92 0.568 7.54 1,196.08 2,390.15 2,390.17 2
 SAMPLE 3R Myosin-11  MYH11  MYH11_HUMAN 227,326.60 100.00% 42 52 192 24.80% DVASLSSQLQDTQELLQEETR 95.00% 5.54 0.576 7.89 1,196.09 2,390.16 2,390.17 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% LKDVLLQVDDERR 95.00% 2.96 0.24 1.16 533.6346 1,597.88 1,598.89 3
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% LKDVLLQVDDERR 95.00% 3.49 0.326 1.34 533.6353 1,597.88 1,598.89 3
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% FDQLLAEEK 95.00% 3.25 0.404 0 546.7832 1,091.55 1,092.56 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% FDQLLAEEK 95.00% 3.33 0.402 2.33 546.7835 1,091.55 1,092.56 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% FDQLLAEEK 95.00% 3.32 0.414 0 546.7838 1,091.55 1,092.56 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% FDQLLAEEK 95.00% 3.09 0.384 0 546.7845 1,091.55 1,092.56 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% ALEEAmEQKAELER 95.00% 2.53 0.425 0 m6: Oxidation (+15.99) 555.275 1,662.80 1,662.80 3
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% ALELDSNLYR 95.00% 1.91 0.339 1.89 597.3155 1,192.62 1,193.62 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% ALELDSNLYR 95.00% 2.5 0.284 0 597.6378 1,193.26 1,193.62 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% ALELDSNLYR 95.00% 2.35 0.275 0 597.6388 1,193.26 1,193.62 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% ALELDSNLYR 95.00% 2.12 0.328 0 597.6402 1,193.26 1,193.62 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% ALELDSNLYR 95.00% 2.66 0.35 1.38 597.9718 1,193.93 1,193.62 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% ALELDSNLYR 95.00% 2.45 0.372 0 597.9722 1,193.93 1,193.62 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% ALELDSNLYR 95.00% 2.51 0.394 2.66 597.9726 1,193.93 1,193.62 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% ALELDSNLYR 95.00% 2.55 0.347 0 597.9734 1,193.93 1,193.62 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% IAQLEEQLDNETKER 95.00% 2.6 0.327 0 605.9749 1,814.90 1,815.91 3
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 2.69 0.193 1.62 610.8286 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 3.01 0.215 0 610.83 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 2.88 0.225 0 610.831 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 2.57 0.162 1.74 610.8311 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 3.03 0.296 0 610.8313 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 2.5 0.215 0 610.8315 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 2.61 0.19 0 610.8315 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 3 0.217 0 610.8315 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 2.89 0.285 0 610.8317 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 2.58 0.207 0 610.8318 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 2.7 0.2 0 610.8319 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 3.15 0.222 1.59 610.8319 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KFDQLLAEEK 95.00% 2.96 0.208 0 610.8325 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KEEELQAALAR 95.00% 2.89 0.303 0 629.2899 1,256.56 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KEEELQAALAR 95.00% 2.68 0.325 0 629.29 1,256.56 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KEEELQAALAR 95.00% 2.86 0.329 0 629.2911 1,256.57 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KEEELQAALAR 95.00% 2.7 0.296 0 629.2914 1,256.57 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KEEELQAALAR 95.00% 2.07 0.39 0 629.2925 1,256.57 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KEEELQAALAR 95.00% 3.34 0.295 1.23 629.3451 1,256.67 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KEEELQAALAR 95.00% 3.13 0.304 1.57 629.3457 1,256.68 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KEEELQAALAR 95.00% 3.11 0.34 1.77 629.3457 1,256.68 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KEEELQAALAR 95.00% 2.82 0.324 2.11 629.3459 1,256.68 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% KEEELQAALAR 95.00% 2.76 0.342 1.92 629.346 1,256.68 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% LQQELDDLLVDLDHQR 95.00% 3.76 0.392 1.66 651.0054 1,949.99 1,949.99 3
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% LQQELDDLLVDLDHQR 95.00% 3.73 0.333 1 651.0055 1,949.99 1,949.99 3
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% TQLEELEDELQATEDAK 95.00% 2.86 0.266 0 654.6462 1,960.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% TQLEELEDELQATEDAK 95.00% 4.71 0.548 2.51 654.6469 1,960.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% TQLEELEDELQATEDAK 95.00% 5.03 0.549 3.96 654.647 1,960.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% TQLEELEDELQATEDAK 95.00% 5.45 0.532 3.77 654.9803 1,961.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% TQLEELEDELQATEDAK 95.00% 5.54 0.52 4.08 654.9812 1,961.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% TQLEELEDELQATEDAK 95.00% 3.67 0.457 0 654.9812 1,961.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% IAQLEEQLDNETK 95.00% 4.27 0.567 5.38 765.8902 1,529.76 1,530.77 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% EDQSILcTGESGAGK 95.00% 2.94 0.23 0 c7: Carbamidomethyl (+57.02) 776.3536 1,550.69 1,551.70 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% EDQSILcTGESGAGK 95.00% 3.4 0.38 0 c7: Carbamidomethyl (+57.02) 776.3564 1,550.70 1,551.70 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% EDQSILcTGESGAGK 95.00% 2.47 0.299 0 c7: Carbamidomethyl (+57.02) 776.8557 1,551.70 1,551.70 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% ANLQIDQINTDLNLER 95.00% 5.6 0.574 6 935.487 1,868.96 1,869.97 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% ANLQIDQINTDLNLER 95.00% 5.65 0.528 5.92 935.9883 1,869.96 1,869.97 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% LQVELDNVTGLLSQSDSK 95.00% 5.82 0.63 11.3 973.5113 1,945.01 1,946.01 2
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% TQLEELEDELQATEDAK 95.00% 6.64 0.646 7.3 981.4644 1,960.91 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% TQLEELEDELQATEDAK 95.00% 7.23 0.65 6.68 981.4644 1,960.91 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% TQLEELEDELQATEDAK 95.00% 6.83 0.646 5.3 981.465 1,960.91 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% TQLEELEDELQATEDAK 95.00% 6.84 0.64 7.27 981.4652 1,960.91 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 18 7.91% TQLEELEDELQATEDAK 95.00% 6.72 0.628 8.09 981.9659 1,961.92 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% LKDVLLQVDDERR 95.00% 2.87 0.276 0 533.6343 1,597.88 1,598.89 3
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% FDQLLAEEK 95.00% 3.03 0.422 0 546.7832 1,091.55 1,092.56 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% FDQLLAEEK 95.00% 3.09 0.406 0 546.7832 1,091.55 1,092.56 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% FDQLLAEEK 95.00% 3.06 0.395 0 546.7837 1,091.55 1,092.56 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% FDQLLAEEK 95.00% 3.03 0.362 1.31 546.7844 1,091.55 1,092.56 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% FDQLLAEEK 95.00% 2.63 0.212 0 547.2851 1,092.55 1,092.56 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 3.47 0.368 2.64 576.322 1,725.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 2.95 0.293 1.8 576.3222 1,725.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 3.45 0.445 1.31 576.3227 1,725.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 3.95 0.483 1.31 576.3231 1,725.95 1,726.95 3 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.07 0.499 5.37 576.3233 1,725.95 1,726.95 3 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 3.46 0.413 0 576.3234 1,725.95 1,726.95 3 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 3.67 0.337 1.01 576.6582 1,726.95 1,726.95 3 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 3.28 0.354 1.4 576.6586 1,726.95 1,726.95 3 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.76 0.407 2.29 576.6602 1,726.96 1,726.95 3 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% ALELDSNLYR 95.00% 2.57 0.4 2.54 597.313 1,192.61 1,193.62 2
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% ALELDSNLYR 95.00% 2.13 0.344 3.57 597.3133 1,192.61 1,193.62 2
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% IAQLEEQLDNETKER 95.00% 3.25 0.231 0 605.9759 1,814.90 1,815.91 3
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% IAQLEEQLDNETKER 95.00% 2.32 0.337 0 606.3101 1,815.91 1,815.91 3
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KFDQLLAEEK 95.00% 2.33 0.218 0 610.8294 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KFDQLLAEEK 95.00% 3.22 0.29 0 610.83 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KFDQLLAEEK 95.00% 2.32 0.197 0 610.8301 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KFDQLLAEEK 95.00% 3.11 0.23 0 610.8307 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KFDQLLAEEK 95.00% 3.24 0.315 0 610.8313 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KFDQLLAEEK 95.00% 3.06 0.283 0 610.8313 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KFDQLLAEEK 95.00% 2.98 0.166 0 610.8315 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KFDQLLAEEK 95.00% 2.93 0.239 0 610.8316 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KFDQLLAEEK 95.00% 3.01 0.205 0 610.8316 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KFDQLLAEEK 95.00% 3.02 0.261 0 610.8318 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KFDQLLAEEK 95.00% 2.46 0.123 1.51 610.8322 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KFDQLLAEEK 95.00% 3.06 0.273 0 610.8322 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KEEELQAALAR 95.00% 3.07 0.302 1.48 629.3446 1,256.67 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KEEELQAALAR 95.00% 3 0.356 1.47 629.3451 1,256.67 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KEEELQAALAR 95.00% 3.1 0.285 1.26 629.3452 1,256.67 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KEEELQAALAR 95.00% 3.16 0.289 0 629.3454 1,256.68 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KEEELQAALAR 95.00% 2.95 0.344 1.38 629.3454 1,256.68 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KEEELQAALAR 95.00% 2.89 0.331 1.19 629.3456 1,256.68 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KEEELQAALAR 95.00% 2.84 0.36 1.35 629.3459 1,256.68 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KEEELQAALAR 95.00% 2.85 0.354 1.22 629.346 1,256.68 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KEEELQAALAR 95.00% 2.83 0.326 1.22 629.3463 1,256.68 1,257.68 2 RS3_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 4.86 0.527 4.27 654.6456 1,960.91 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 5.19 0.52 2.77 654.6462 1,960.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 5.33 0.559 2.59 654.6464 1,960.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 4.17 0.518 2.25 654.6472 1,960.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 4.97 0.511 2.92 654.9799 1,961.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 4.75 0.516 2.89 654.9807 1,961.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 5.4 0.583 3.28 654.9809 1,961.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 5.1 0.486 2.51 654.981 1,961.92 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% KANLQIDQINTDLNLER 95.00% 3.38 0.42 1.49 667.0284 1,998.06 1,998.06 3
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAKLR 95.00% 4.27 0.527 0 744.7088 2,231.10 2,231.10 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% EDQSILcTGESGAGK 95.00% 2.61 0.298 0 c7: Carbamidomethyl (+57.02) 776.3512 1,550.69 1,551.70 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.42 0.532 4.25 863.9792 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 5.16 0.576 5.85 863.9795 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.55 0.528 4.47 863.98 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.63 0.534 3.57 863.9801 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.74 0.563 6.38 863.9804 1,725.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.55 0.553 5.7 863.9807 1,725.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.77 0.556 6.07 863.9807 1,725.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.63 0.533 3.7 863.9813 1,725.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.62 0.537 4.92 863.9817 1,725.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.84 0.556 6.46 863.9817 1,725.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.62 0.561 3.33 863.9818 1,725.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.59 0.531 5.17 863.982 1,725.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.63 0.548 5.15 863.9821 1,725.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.04 0.546 4.66 863.9828 1,725.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.03 0.551 4.37 863.9834 1,725.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.67 0.517 3.3 864.4818 1,726.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.58 0.517 5.11 864.4824 1,726.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.32 0.533 3.6 864.4824 1,726.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.03 0.414 2.89 864.4824 1,726.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.56 0.481 2.89 864.4828 1,726.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.13 0.492 4.38 864.4831 1,726.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.4 0.419 3.64 864.4832 1,726.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% QLLQANPILEAFGNAK 95.00% 4.37 0.522 3.44 864.4842 1,726.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% ANLQIDQINTDLNLER 95.00% 4.48 0.467 3.52 935.4917 1,868.97 1,869.97 2
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% LQVELDNVTGLLSQSDSK 95.00% 6.6 0.629 8.31 974.0135 1,946.01 1,946.01 2
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 5.13 0.638 6.09 981.4632 1,960.91 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 6.47 0.626 4.7 981.4642 1,960.91 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 6.94 0.637 5.22 981.4663 1,960.92 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 6.9 0.649 5.74 981.4664 1,960.92 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 6.56 0.609 7.37 981.964 1,961.91 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 5.45 0.621 3.29 981.9656 1,961.92 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 4R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 8 7.35% TQLEELEDELQATEDAK 95.00% 6.46 0.634 6.24 981.969 1,961.92 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% VVFQEFR 95.00% 2.25 0.22 1.59 462.751 923.4864 924.4943 2
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% cNGVLEGIR 95.00% 2.92 0.403 1.17 c1: Carbamidomethyl (+57.02) 509.2596 1,016.50 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% cNGVLEGIR 95.00% 2.88 0.41 1.25 c1: Carbamidomethyl (+57.02) 509.2601 1,016.50 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% ALELDSNLYR 95.00% 2.43 0.434 2.57 597.3084 1,192.60 1,193.62 2
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% ALELDSNLYR 95.00% 2.88 0.446 1.72 597.3105 1,192.61 1,193.62 2
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% ALELDSNLYR 95.00% 2.7 0.434 2.07 597.3108 1,192.61 1,193.62 2
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% ALELDSNLYR 95.00% 2.73 0.43 2.89 597.3112 1,192.61 1,193.62 2
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% ALELDSNLYR 95.00% 2.89 0.423 2.09 597.3114 1,192.61 1,193.62 2
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% ALELDSNLYR 95.00% 2.79 0.411 1.89 597.3116 1,192.61 1,193.62 2
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% KFDQLLAEEK 95.00% 2.97 0.259 0 610.8289 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% KFDQLLAEEK 95.00% 2.72 0.252 0 610.8295 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% KFDQLLAEEK 95.00% 2.5 0.199 0 610.8316 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% YEILTPNSIPK 95.00% 2.64 0.404 0 637.853 1,273.69 1,274.70 2
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% LQQELDDLLVDLDHQR 95.00% 3.62 0.414 2.09 651.0035 1,949.99 1,949.99 3
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% EQADFAIEALAK 95.00% 2.27 0.382 0 653.3366 1,304.66 1,305.67 2
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% EQADFAIEALAK 95.00% 2.51 0.427 1.51 653.3369 1,304.66 1,305.67 2
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% QLLQANPILEAFGNAK 95.00% 4.27 0.514 5.01 863.9759 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% QLLQANPILEAFGNAK 95.00% 4.84 0.509 5.08 863.9767 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% QLLQANPILEAFGNAK 95.00% 4.14 0.525 3.68 863.9767 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% QLLQANPILEAFGNAK 95.00% 2.86 0.4 1.47 863.9768 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% QLLQANPILEAFGNAK 95.00% 4.83 0.543 4.27 863.9778 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 1 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 6 6 12 5.56% LQVELDNVTGLLSQSDSK 95.00% 6.37 0.624 8.44 974.0077 1,946.00 1,946.01 2
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% cNGVLEGIR 95.00% 2.63 0.404 1.85 c1: Carbamidomethyl (+57.02) 509.2597 1,016.50 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% QLLQANPILEAFGNAK 95.00% 4.61 0.441 3.19 576.6544 1,726.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% QLLQANPILEAFGNAK 95.00% 4.08 0.428 2.41 576.6545 1,726.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% ALELDSNLYR 95.00% 2.47 0.357 1.77 597.3095 1,192.60 1,193.62 2
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% ALELDSNLYR 95.00% 2.79 0.411 3.46 597.3109 1,192.61 1,193.62 2
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% ALELDSNLYR 95.00% 2.46 0.385 3.51 597.3117 1,192.61 1,193.62 2
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% ALELDSNLYR 95.00% 2.39 0.367 1.57 597.3118 1,192.61 1,193.62 2
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% ALELDSNLYR 95.00% 2.41 0.354 0 597.312 1,192.61 1,193.62 2
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% ALELDSNLYR 95.00% 2.51 0.312 1.52 597.3131 1,192.61 1,193.62 2
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% KFDQLLAEEK 95.00% 2.53 0.204 0 610.8277 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% KFDQLLAEEK 95.00% 2.77 0.251 0 610.8283 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% KFDQLLAEEK 95.00% 2.6 0.209 0 610.8285 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% KFDQLLAEEK 95.00% 2.77 0.285 0 610.8295 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% LQQELDDLLVDLDHQR 95.00% 1.97 0.24 0 650.6691 1,948.98 1,949.99 3
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% LQQELDDLLVDLDHQR 95.00% 2.95 0.29 0 651.004 1,949.99 1,949.99 3
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% TQLEELEDELQATEDAK 95.00% 2.9 0.204 0 654.6444 1,960.91 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% VISGVLQLGNIVFK 95.00% 3.56 0.576 3.21 743.9521 1,485.89 1,486.90 2
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% VISGVLQLGNIVFK 95.00% 2.76 0.406 2.2 743.953 1,485.89 1,486.90 2
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% VISGVLQLGNIVFK 95.00% 2.84 0.56 3.8 743.9536 1,485.89 1,486.90 2
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% QLLQANPILEAFGNAK 95.00% 2.57 0.298 0 863.4591 1,724.90 1,726.95 2 MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% QLLQANPILEAFGNAK 95.00% 3.41 0.304 0 863.9654 1,725.92 1,726.95 2 MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% QLLQANPILEAFGNAK 95.00% 4.86 0.561 4.52 863.9758 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% QLLQANPILEAFGNAK 95.00% 4.74 0.531 5.92 863.976 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% QLLQANPILEAFGNAK 95.00% 4.59 0.535 4.24 863.9779 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% QLLQANPILEAFGNAK 95.00% 4.53 0.461 3.17 864.4766 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% QLLQANPILEAFGNAK 95.00% 4.63 0.54 4 864.4767 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% QLLQANPILEAFGNAK 95.00% 4.97 0.518 5.18 864.4784 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% QLLQANPILEAFGNAK 95.00% 4.29 0.499 3.8 864.4804 1,726.95 1,726.95 2 MYH11_HUMAN
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% ANLQIDQINTDLNLER 95.00% 0 0 3.59 936.4931 1,870.97 1,869.97 2
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% LQVELDNVTGLLSQSDSK 95.00% 6.44 0.601 11.5 974.0075 1,946.00 1,946.01 2
 SAMPLE 1R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 5 5 14 6.43% LQVELDNVTGLLSQSDSK 95.00% 4.19 0.551 4.09 974.008 1,946.00 1,946.01 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VVFQEFR 95.00% 2.33 0.209 0 462.7505 923.4854 924.4943 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VVFQEFR 95.00% 2.6 0.204 0 462.7506 923.4856 924.4943 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VVFQEFR 95.00% 2.34 0.243 0 462.7509 923.4861 924.4943 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VVFQEFR 95.00% 2.23 0.313 0 462.7509 923.4861 924.4943 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VVFQEFR 95.00% 2.5 0.279 0 462.7512 923.4867 924.4943 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VVFQEFR 95.00% 2.41 0.212 0 462.7512 923.4868 924.4943 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VVFQEFR 95.00% 2.23 0.213 0 462.7513 923.487 924.4943 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VVFQEFR 95.00% 2.57 0.184 0 462.7515 923.4873 924.4943 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VIQYLAYVASSHK 95.00% 2.26 0.366 0 493.6036 1,477.79 1,478.80 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VIQYLAYVASSHK 95.00% 2.65 0.433 1.7 493.604 1,477.79 1,478.80 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VIQYLAYVASSHK 95.00% 2.27 0.4 1.26 493.604 1,477.79 1,478.80 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VIQYLAYVASSHK 95.00% 1.85 0.299 0 493.9382 1,478.79 1,478.80 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VIQYLAYVASSHK 95.00% 2.69 0.446 0 493.9383 1,478.79 1,478.80 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% cNGVLEGIR 95.00% 3.2 0.371 1.92 c1: Carbamidomethyl (+57.02) 509.2602 1,016.50 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% cNGVLEGIR 95.00% 3.06 0.265 1.96 c1: Carbamidomethyl (+57.02) 509.2603 1,016.51 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% cNGVLEGIR 95.00% 3.03 0.371 2.22 c1: Carbamidomethyl (+57.02) 509.2607 1,016.51 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% cNGVLEGIR 95.00% 3.17 0.389 2.41 c1: Carbamidomethyl (+57.02) 509.2607 1,016.51 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% DKADFcIIHYAGK 95.00% 2.8 0.162 1 c6: Carbamidomethyl (+57.02) 513.2524 1,536.73 1,537.75 3 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% DKADFcIIHYAGK 95.00% 3.17 0.342 0 c6: Carbamidomethyl (+57.02) 513.2529 1,536.74 1,537.75 3 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% DKADFcIIHYAGK 95.00% 3.49 0.229 0 c6: Carbamidomethyl (+57.02) 513.2541 1,536.74 1,537.75 3 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% DKADFcIIHYAGK 95.00% 3.34 0.281 0 c6: Carbamidomethyl (+57.02) 513.5873 1,537.74 1,537.75 3 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KKVEAQLQELQVK 95.00% 3.69 0.223 0 514.3062 1,539.90 1,540.91 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KKVEAQLQELQVK 95.00% 4.44 0.268 0 514.3063 1,539.90 1,540.91 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KKVEAQLQELQVK 95.00% 3.6 0.335 0 514.3067 1,539.90 1,540.91 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KKVEAQLQELQVK 95.00% 4.53 0.407 1.42 514.6401 1,540.90 1,540.91 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QIATLHAQVADMKK 95.00% 2.59 0.321 0 518.6194 1,552.83 1,553.85 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QIATLHAQVADMKK 95.00% 2.37 0.335 0 518.6196 1,552.84 1,553.85 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QRYEILTPNSIPK 95.00% 2.73 0.218 0 520.2895 1,557.85 1,558.86 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QRYEILTPNSIPK 95.00% 2.98 0.304 0 520.6248 1,558.85 1,558.86 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VSHLLGINVTDFTR 95.00% 2.5 0.196 0 524.6223 1,570.84 1,571.85 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VSHLLGINVTDFTR 95.00% 2.63 0.267 1.13 524.6223 1,570.84 1,571.85 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VSHLLGINVTDFTR 95.00% 3.31 0.313 1.92 524.623 1,570.85 1,571.85 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VSHLLGINVTDFTR 95.00% 3.05 0.257 1.62 524.957 1,571.85 1,571.85 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AGKLDPHLVLDQLR 95.00% 1.95 0.248 0 525.6384 1,573.89 1,574.90 3 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AGKLDPHLVLDQLR 95.00% 1.93 0.281 0 525.6384 1,573.89 1,574.90 3 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AGVLAHLEEERDLK 95.00% 2.9 0.3 0 527.2855 1,578.83 1,579.84 3 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AGVLAHLEEERDLK 95.00% 3.15 0.305 1.59 527.2856 1,578.83 1,579.84 3 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AGVLAHLEEERDLK 95.00% 2.47 0.229 0 527.2857 1,578.83 1,579.84 3 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AGVLAHLEEERDLK 95.00% 3.37 0.415 2.05 527.2858 1,578.83 1,579.84 3 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KLVWVPSDK 95.00% 2.61 0.38 0 536.3128 1,070.61 1,071.62 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KLVWVPSDK 95.00% 2.64 0.392 0 536.3133 1,070.61 1,071.62 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ASREEILAQAKENEK 95.00% 3.95 0.378 1.26 572.6358 1,714.88 1,715.89 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ASREEILAQAKENEK 95.00% 4.37 0.339 0 572.9689 1,715.88 1,715.89 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ASREEILAQAKENEK 95.00% 4.36 0.368 0 572.971 1,715.89 1,715.89 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QTLENERGELANEVK 95.00% 2.3 0.226 0 577.2946 1,728.86 1,729.87 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QTLENERGELANEVK 95.00% 3.02 0.378 0 577.295 1,728.86 1,729.87 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QTLENERGELANEVK 95.00% 2.12 0.245 0 577.6291 1,729.86 1,729.87 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% RGDLPFVVPR 95.00% 2.77 0.215 1.23 578.3338 1,154.65 1,155.66 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% RGDLPFVVPR 95.00% 2.56 0.198 1.28 578.3343 1,154.65 1,155.66 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% RGDLPFVVPR 95.00% 2.46 0.197 0 578.3349 1,154.65 1,155.66 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KQELEEIcHDLEAR 95.00% 3.86 0.0837 0 c8: Carbamidomethyl (+57.02) 590.6206 1,768.84 1,769.85 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KQELEEIcHDLEAR 95.00% 3.55 0.155 0 c8: Carbamidomethyl (+57.02) 590.621 1,768.84 1,769.85 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KQELEEIcHDLEAR 95.00% 3.61 0.0764 1.14 c8: Carbamidomethyl (+57.02) 590.6212 1,768.84 1,769.85 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KQELEEIcHDLEAR 95.00% 3.25 0.15 0 c8: Carbamidomethyl (+57.02) 590.6232 1,768.85 1,769.85 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KQELEEIcHDLEAR 95.00% 4 0.131 1.32 c8: Carbamidomethyl (+57.02) 590.9549 1,769.84 1,769.85 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ALELDSNLYR 95.00% 2.71 0.422 2.7 597.3098 1,192.60 1,193.62 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ALELDSNLYR 95.00% 2.98 0.435 3.23 597.3098 1,192.60 1,193.62 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ALELDSNLYR 95.00% 3.17 0.453 1.89 597.3108 1,192.61 1,193.62 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ALELDSNLYR 95.00% 3.31 0.443 2.96 597.3109 1,192.61 1,193.62 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ALELDSNLYR 95.00% 3.48 0.424 2.41 597.3115 1,192.61 1,193.62 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ALELDSNLYR 95.00% 3.33 0.457 2.74 597.3117 1,192.61 1,193.62 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ALELDSNLYR 95.00% 3.01 0.414 2.77 597.312 1,192.61 1,193.62 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% IAQLEEQLDNETKER 95.00% 3.65 0.34 0 605.9736 1,814.90 1,815.91 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% IAQLEEQLDNETKER 95.00% 3.65 0.445 0 605.9736 1,814.90 1,815.91 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% IAQLEEQLDNETKER 95.00% 2.03 0.245 0 606.3089 1,815.90 1,815.91 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KFDQLLAEEK 95.00% 2.82 0.273 0 610.8291 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KFDQLLAEEK 95.00% 2.73 0.187 0 610.8297 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KFDQLLAEEK 95.00% 2.56 0.205 0 610.8299 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KFDQLLAEEK 95.00% 3.05 0.273 0 610.8301 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QLEEAEEEAQRANASR 95.00% 2.77 0.357 0 610.9543 1,829.84 1,830.86 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QLEEAEEEAQRANASR 95.00% 2.77 0.4 0 610.9562 1,829.85 1,830.86 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QLEEAEEEAQRANASR 95.00% 2.68 0.33 0 610.9566 1,829.85 1,830.86 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QLEEAEEEAQRANASR 95.00% 2.7 0.396 0 611.2906 1,830.85 1,830.86 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AGVLAHLEEER 95.00% 3.12 0.387 1.92 612.3224 1,222.63 1,223.64 2 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AGVLAHLEEER 95.00% 3.3 0.413 1.43 612.8241 1,223.63 1,223.64 2 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% HSQAVEELAEQLEQTK 95.00% 3.39 0.265 0 614.3048 1,839.89 1,839.91 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% IAEFTTNLTEEEEKSK 95.00% 2.21 0.268 0 623.6417 1,867.90 1,868.91 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% IAEFTTNLTEEEEKSK 95.00% 1.86 0.187 1.74 623.6423 1,867.90 1,868.91 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% IAEFTTNLTEEEEKSK 95.00% 2.22 0.235 0 623.976 1,868.90 1,868.91 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KLEEEQIILEDQNcK 95.00% 2.62 0.247 0 c14: Carbamidomethyl (+57.02) 630.316 1,887.92 1,888.93 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% YEILTPNSIPK 95.00% 3.11 0.494 0 637.8522 1,273.69 1,274.70 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% YEILTPNSIPK 95.00% 2.69 0.444 0 637.8527 1,273.69 1,274.70 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% YEILTPNSIPK 95.00% 3.1 0.496 1.77 637.8529 1,273.69 1,274.70 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% YEILTPNSIPK 95.00% 3.1 0.454 0 637.8535 1,273.69 1,274.70 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% YEILTPNSIPK 95.00% 2.97 0.455 1.72 637.8535 1,273.69 1,274.70 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% YEILTPNSIPK 95.00% 2.92 0.395 0 638.3547 1,274.69 1,274.70 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AKQTLENERGELANEVK 95.00% 3.7 0.319 1.28 643.6724 1,927.99 1,929.00 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AKQTLENERGELANEVK 95.00% 3.94 0.232 1.28 643.6728 1,927.99 1,929.00 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AKQTLENERGELANEVK 95.00% 2.67 0.275 1.2 644.006 1,928.99 1,929.00 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AKQTLENERGELANEVK 95.00% 3.77 0.404 2.36 644.0064 1,929.00 1,929.00 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AKQTLENERGELANEVK 95.00% 3.94 0.422 0 644.0093 1,929.00 1,929.00 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AKQTLENERGELANEVK 95.00% 2.92 0.277 0 644.0106 1,929.01 1,929.00 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% LQQELDDLLVDLDHQR 95.00% 4.18 0.515 2.96 651.0023 1,949.98 1,949.99 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% LQQELDDLLVDLDHQR 95.00% 4.39 0.452 2.89 651.0026 1,949.98 1,949.99 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% EQADFAIEALAK 95.00% 2.84 0.485 1.47 653.336 1,304.66 1,305.67 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% EQADFAIEALAK 95.00% 3.25 0.508 2.54 653.3365 1,304.66 1,305.67 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% EQADFAIEALAK 95.00% 2.41 0.225 1.74 653.3369 1,304.66 1,305.67 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% EQADFAIEALAK 95.00% 2.9 0.492 2.21 653.3372 1,304.66 1,305.67 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% EQADFAIEALAK 95.00% 3.06 0.475 2.82 653.338 1,304.66 1,305.67 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% HSQAVEELAEQLEQTKR 95.00% 6.01 0.622 2.85 666.0071 1,995.00 1,996.01 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% HSQAVEELAEQLEQTKR 95.00% 6.71 0.648 1.54 666.0072 1,995.00 1,996.01 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% HSQAVEELAEQLEQTKR 95.00% 5.89 0.648 2.55 666.0095 1,995.01 1,996.01 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% HSQAVEELAEQLEQTKR 95.00% 6.96 0.592 3.49 666.3395 1,996.00 1,996.01 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% HSQAVEELAEQLEQTKR 95.00% 6.19 0.608 3.07 666.3407 1,996.00 1,996.01 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% HSQAVEELAEQLEQTKR 95.00% 6.37 0.62 1.7 666.344 1,996.01 1,996.01 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% TLEEEAKTHEAQIQEMR 95.00% 2.82 0.475 1.35 681.6638 2,041.97 2,042.98 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% TLEEEAKTHEAQIQEMR 95.00% 3.97 0.479 2.21 681.9984 2,042.97 2,042.98 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% TLEEEAKTHEAQIQEMR 95.00% 2.72 0.485 0 682.0009 2,042.98 2,042.98 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% TVGQLYKEQLAK 95.00% 3.51 0.443 1.49 689.3907 1,376.77 1,377.77 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% TVGQLYKEQLAK 95.00% 3.4 0.369 1.85 689.3919 1,376.77 1,377.77 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QAQQERDELADEIANSSGK 95.00% 4.16 0.503 2.3 696.9964 2,087.97 2,088.98 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QAQQERDELADEIANSSGK 95.00% 4.66 0.565 2.8 697.331 2,088.97 2,088.98 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QAQQERDELADEIANSSGK 95.00% 5.09 0.553 2.59 697.3315 2,088.97 2,088.98 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QAQQERDELADEIANSSGK 95.00% 4.84 0.53 1.89 697.3326 2,088.97 2,088.98 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QAQQERDELADEIANSSGK 95.00% 3.75 0.416 2.31 697.3339 2,088.98 2,088.98 3
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VDYKADEWLMK 95.00% 3 0.345 0 699.3409 1,396.67 1,397.68 2 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VDYKADEWLMK 95.00% 2.99 0.365 2.6 699.3413 1,396.67 1,397.68 2 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VDYKADEWLMK 95.00% 2.87 0.317 1.52 699.345 1,396.67 1,397.68 2 MYH10_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VIQYLAYVASSHK 95.00% 4.43 0.578 4.44 739.904 1,477.79 1,478.80 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VIQYLAYVASSHK 95.00% 3.68 0.48 3.74 739.9041 1,477.79 1,478.80 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VIQYLAYVASSHK 95.00% 3.51 0.445 4.3 739.9041 1,477.79 1,478.80 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% TQLEELEDELQATEDAKLR 95.00% 3.45 0.438 1.08 744.7073 2,231.10 2,231.10 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% EDQSILcTGESGAGKTENTKK 95.00% 2.01 0.187 1.49 c7: Carbamidomethyl (+57.02) 752.0287 2,253.06 2,253.07 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KKVEAQLQELQVK 95.00% 5.18 0.507 5.59 770.9557 1,539.90 1,540.91 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KKVEAQLQELQVK 95.00% 5.05 0.427 1.21 770.9581 1,539.90 1,540.91 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ITDVIIGFQAccR 95.00% 2.19 0.193 2.24 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 776.8814 1,551.75 1,552.76 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ITDVIIGFQAccR 95.00% 3.73 0.394 2.77 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 776.8844 1,551.75 1,552.76 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VSHLLGINVTDFTR 95.00% 4.47 0.502 6.68 786.4297 1,570.84 1,571.85 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% VSHLLGINVTDFTR 95.00% 4.3 0.461 6.92 786.4317 1,570.85 1,571.85 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% IAEFTTNLTEEEEK 95.00% 4.77 0.513 2.21 827.3957 1,652.78 1,653.79 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% IAEFTTNLTEEEEK 95.00% 3.88 0.498 2.01 827.3965 1,652.78 1,653.79 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% IAEFTTNLTEEEEK 95.00% 4.34 0.444 2.47 827.8962 1,653.78 1,653.79 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% NFINNPLAQADWAAK 95.00% 4.58 0.416 3.92 836.9224 1,671.83 1,672.84 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% NFINNPLAQADWAAK 95.00% 5.27 0.401 6.03 837.4272 1,672.84 1,672.84 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% NLPIYSEEIVEMYK 95.00% 3.71 0.498 3.09 864.4306 1,726.85 1,727.86 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QLLQANPILEAFGNAK 95.00% 4.85 0.558 5.59 864.479 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QLLQANPILEAFGNAK 95.00% 4.96 0.522 5.62 864.4798 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% NLPIYSEEIVEMYK 95.00% 4.68 0.589 7.33 864.9319 1,727.85 1,727.86 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QTLENERGELANEVK 95.00% 3.62 0.261 0 865.4386 1,728.86 1,729.87 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KQELEEIcHDLEAR 95.00% 4.14 0.289 2.85 c8: Carbamidomethyl (+57.02) 885.9237 1,769.83 1,769.85 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% KQELEEIcHDLEAR 95.00% 4.02 0.341 2.92 c8: Carbamidomethyl (+57.02) 885.9278 1,769.84 1,769.85 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% IAQLEEQLDNETKER 95.00% 4.67 0.496 3.72 908.456 1,814.90 1,815.91 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% IAQLEEQLDNETKER 95.00% 4.66 0.454 4.06 908.4572 1,814.90 1,815.91 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ANLQIDQINTDLNLER 95.00% 5.19 0.579 8.68 935.4849 1,868.95 1,869.97 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ANLQIDQINTDLNLER 95.00% 5.86 0.592 6.92 935.4857 1,868.96 1,869.97 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% ANLQIDQINTDLNLER 95.00% 5.71 0.578 7.72 935.9855 1,869.96 1,869.97 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% AKQTLENERGELANEVK 95.00% 4.59 0.542 5.52 965.0023 1,927.99 1,929.00 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% LQVELDNVTGLLSQSDSK 95.00% 6.65 0.635 8.8 974.0063 1,946.00 1,946.01 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% LQVELDNVTGLLSQSDSK 95.00% 6.75 0.603 7.72 974.0067 1,946.00 1,946.01 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% LQVELDNVTGLLSQSDSK 95.00% 6.52 0.591 8.01 974.0068 1,946.00 1,946.01 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% LQVELDNVTGLLSQSDSK 95.00% 6.75 0.601 8.57 974.0077 1,946.00 1,946.01 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% LQVELDNVTGLLSQSDSK 95.00% 6.75 0.622 9.11 974.008 1,946.00 1,946.01 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% LQVELDNVTGLLSQSDSK 95.00% 4.59 0.541 6.6 974.0092 1,946.00 1,946.01 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% LQQELDDLLVDLDHQR 95.00% 5.76 0.506 4.13 976.0063 1,950.00 1,949.99 2
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% TQLEELEDELQATEDAK 95.00% 7.1 0.618 6.6 981.9608 1,961.91 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% TQLEELEDELQATEDAK 95.00% 7.17 0.617 5.89 981.9624 1,961.91 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% TQLEELEDELQATEDAK 95.00% 6.64 0.653 4.72 981.9633 1,961.91 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% TQLEELEDELQATEDAK 95.00% 6.78 0.629 4.89 981.9635 1,961.91 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 31 40 128 25.90% QAQQERDELADEIANSSGK 95.00% 4.34 0.585 4.55 1,044.99 2,087.97 2,088.98 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VVFQEFR 95.00% 2.41 0.211 0 462.75 923.4843 924.4943 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VVFQEFR 95.00% 2.42 0.179 0 462.751 923.4863 924.4943 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VVFQEFR 95.00% 2.56 0.221 0 462.7513 923.487 924.4943 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VVFQEFR 95.00% 2.43 0.226 1.62 462.7514 923.4872 924.4943 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VDYKADEWLMK 95.00% 2.7 0.292 1.09 466.5638 1,396.67 1,397.68 3 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VDYKADEWLMK 95.00% 2.29 0.254 0 466.5646 1,396.67 1,397.68 3 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VIQYLAYVASSHK 95.00% 2.21 0.31 0 493.6041 1,477.79 1,478.80 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VIQYLAYVASSHK 95.00% 2.27 0.385 0 493.6047 1,477.79 1,478.80 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VIQYLAYVASSHK 95.00% 1.91 0.309 0 493.6048 1,477.79 1,478.80 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VIQYLAYVASSHK 95.00% 2.32 0.351 0 493.6048 1,477.79 1,478.80 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VISGVLQLGNIVFK 95.00% 4.05 0.501 3.07 496.6392 1,486.89 1,486.90 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% cNGVLEGIR 95.00% 3.27 0.373 2.1 c1: Carbamidomethyl (+57.02) 509.2595 1,016.50 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% cNGVLEGIR 95.00% 3.12 0.371 1.29 c1: Carbamidomethyl (+57.02) 509.26 1,016.50 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% cNGVLEGIR 95.00% 2.74 0.391 1.3 c1: Carbamidomethyl (+57.02) 509.2606 1,016.51 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% cNGVLEGIR 95.00% 3.02 0.379 2.17 c1: Carbamidomethyl (+57.02) 509.2608 1,016.51 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% cNGVLEGIR 95.00% 3.14 0.408 2.04 c1: Carbamidomethyl (+57.02) 509.2612 1,016.51 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% DKADFcIIHYAGK 95.00% 3.13 0.362 0 c6: Carbamidomethyl (+57.02) 513.5856 1,537.73 1,537.75 3 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% DKADFcIIHYAGK 95.00% 3.29 0.335 0 c6: Carbamidomethyl (+57.02) 513.5876 1,537.74 1,537.75 3 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KKVEAQLQELQVK 95.00% 3.73 0.272 0 514.3053 1,539.89 1,540.91 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KKVEAQLQELQVK 95.00% 3.56 0.295 1.28 514.306 1,539.89 1,540.91 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KKVEAQLQELQVK 95.00% 4.17 0.36 0 514.306 1,539.89 1,540.91 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KKVEAQLQELQVK 95.00% 4 0.334 0 514.3063 1,539.90 1,540.91 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KKVEAQLQELQVK 95.00% 4.33 0.357 1.33 514.6409 1,540.90 1,540.91 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QIATLHAQVADMKK 95.00% 2.47 0.174 0 518.6191 1,552.83 1,553.85 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QIATLHAQVADMKK 95.00% 2.27 0.263 0 518.6201 1,552.84 1,553.85 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QRYEILTPNSIPK 95.00% 2.8 0.237 0 520.6255 1,558.85 1,558.86 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VSHLLGINVTDFTR 95.00% 2.53 0.272 0 524.6212 1,570.84 1,571.85 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VSHLLGINVTDFTR 95.00% 3.35 0.28 0 524.6217 1,570.84 1,571.85 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VSHLLGINVTDFTR 95.00% 3.35 0.261 1.64 524.6218 1,570.84 1,571.85 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VSHLLGINVTDFTR 95.00% 2.25 0.27 0 524.6221 1,570.84 1,571.85 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VSHLLGINVTDFTR 95.00% 3.14 0.306 0 524.6224 1,570.84 1,571.85 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% AGKLDPHLVLDQLR 95.00% 2 0.308 0 525.6383 1,573.89 1,574.90 3 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% AGKLDPHLVLDQLR 95.00% 1.7 0.208 1.09 525.9725 1,574.89 1,574.90 3 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% AGVLAHLEEERDLK 95.00% 2.51 0.283 0 527.2853 1,578.83 1,579.84 3 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% AGVLAHLEEERDLK 95.00% 2.63 0.301 1.6 527.286 1,578.83 1,579.84 3 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LKDVLLQVDDERR 95.00% 3.25 0.322 0 533.6333 1,597.88 1,598.89 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LKDVLLQVDDERR 95.00% 2.97 0.237 0 533.9662 1,598.88 1,598.89 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KLVWVPSDK 95.00% 2.33 0.36 0 536.3118 1,070.61 1,071.62 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KLVWVPSDK 95.00% 2.28 0.32 0 536.3124 1,070.61 1,071.62 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ASREEILAQAKENEK 95.00% 3.94 0.352 1.68 572.6333 1,714.88 1,715.89 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ASREEILAQAKENEK 95.00% 4.15 0.392 1 572.6337 1,714.88 1,715.89 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ASREEILAQAKENEK 95.00% 4.36 0.391 1.35 572.9689 1,715.88 1,715.89 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ASREEILAQAKENEK 95.00% 3.39 0.305 0 572.9695 1,715.89 1,715.89 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 2.68 0.304 0 576.3196 1,725.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.13 0.525 1.92 576.3197 1,725.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 3.86 0.48 3.54 576.3204 1,725.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.35 0.496 3.59 576.3217 1,725.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.13 0.461 1.8 576.654 1,726.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.2 0.466 2.46 576.6553 1,726.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% RGDLPFVVPR 95.00% 3.17 0.266 2.34 578.334 1,154.65 1,155.66 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% RGDLPFVVPR 95.00% 2.47 0.197 0 578.3344 1,154.65 1,155.66 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% RGDLPFVVPR 95.00% 2.81 0.229 1.16 578.3354 1,154.66 1,155.66 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KQELEEIcHDLEAR 95.00% 3.53 0.0929 0 c8: Carbamidomethyl (+57.02) 590.6199 1,768.84 1,769.85 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KQELEEIcHDLEAR 95.00% 3.7 0.124 0 c8: Carbamidomethyl (+57.02) 590.6212 1,768.84 1,769.85 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ALELDSNLYR 95.00% 3.03 0.451 1.74 597.3089 1,192.60 1,193.62 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ALELDSNLYR 95.00% 3.07 0.421 2.49 597.3098 1,192.60 1,193.62 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ALELDSNLYR 95.00% 3.05 0.448 1.92 597.3112 1,192.61 1,193.62 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ALELDSNLYR 95.00% 1.9 0.337 1.7 597.3114 1,192.61 1,193.62 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ALELDSNLYR 95.00% 3.16 0.454 2.11 597.3114 1,192.61 1,193.62 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ALELDSNLYR 95.00% 2.96 0.431 2.21 597.3116 1,192.61 1,193.62 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ALELDSNLYR 95.00% 3.03 0.444 2.82 597.3116 1,192.61 1,193.62 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ALELDSNLYR 95.00% 2.71 0.402 1.8 597.3117 1,192.61 1,193.62 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ALELDSNLYR 95.00% 2.77 0.432 2.51 597.3137 1,192.61 1,193.62 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ALEQQVEEMK 95.00% 3.08 0.496 1.96 602.7968 1,203.58 1,204.59 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ALEQQVEEMK 95.00% 3.15 0.512 1.89 602.797 1,203.58 1,204.59 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% TDLLLEPYNK 95.00% 3.06 0.403 1.51 603.3242 1,204.63 1,205.64 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% TDLLLEPYNK 95.00% 3 0.405 0 603.3247 1,204.63 1,205.64 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% IAQLEEQLDNETKER 95.00% 2.84 0.299 0 605.9739 1,814.90 1,815.91 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KFDQLLAEEK 95.00% 2.65 0.166 0 610.8294 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KFDQLLAEEK 95.00% 2.59 0.163 0 610.8298 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KFDQLLAEEK 95.00% 2.59 0.186 0 610.8299 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% KFDQLLAEEK 95.00% 2.52 0.232 0 610.8304 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLEEAEEEAQRANASR 95.00% 2.8 0.249 0 610.9564 1,829.85 1,830.86 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLEEAEEEAQRANASR 95.00% 3.16 0.423 1.27 610.9564 1,829.85 1,830.86 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% AGVLAHLEEER 95.00% 3.52 0.362 2.19 612.3214 1,222.63 1,223.64 2 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% AGVLAHLEEER 95.00% 3.28 0.293 1.29 612.323 1,222.63 1,223.64 2 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% IAEFTTNLTEEEEKSK 95.00% 2.2 0.218 0 623.6424 1,867.90 1,868.91 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ANLQIDQINTDLNLER 95.00% 2.27 0.266 0 624.3265 1,869.96 1,869.97 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% YEILTPNSIPK 95.00% 2.76 0.393 1.32 637.8525 1,273.69 1,274.70 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% YEILTPNSIPK 95.00% 2.98 0.475 1.55 637.8532 1,273.69 1,274.70 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% YEILTPNSIPK 95.00% 2.87 0.466 2.36 637.8534 1,273.69 1,274.70 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% YEILTPNSIPK 95.00% 2.55 0.403 2.47 637.8535 1,273.69 1,274.70 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% AKQTLENERGELANEVK 95.00% 4.21 0.411 2.21 643.6746 1,928.00 1,929.00 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% AKQTLENERGELANEVK 95.00% 4 0.337 0 644.0057 1,928.99 1,929.00 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% AKQTLENERGELANEVK 95.00% 3.27 0.273 2.74 644.0065 1,929.00 1,929.00 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% AKQTLENERGELANEVK 95.00% 3.05 0.292 0 644.0073 1,929.00 1,929.00 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% AKQTLENERGELANEVK 95.00% 4.74 0.482 1.89 644.0078 1,929.00 1,929.00 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQQELDDLLVDLDHQR 95.00% 4.37 0.426 1.96 650.6683 1,948.98 1,949.99 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQQELDDLLVDLDHQR 95.00% 2.98 0.332 2.51 651.0029 1,949.99 1,949.99 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQQELDDLLVDLDHQR 95.00% 3.77 0.431 3.38 651.0029 1,949.99 1,949.99 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQQELDDLLVDLDHQR 95.00% 3.17 0.347 3.01 651.0033 1,949.99 1,949.99 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQQELDDLLVDLDHQR 95.00% 4.05 0.492 2.09 651.0034 1,949.99 1,949.99 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQQELDDLLVDLDHQR 95.00% 4.69 0.527 3.05 651.0035 1,949.99 1,949.99 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% EQADFAIEALAK 95.00% 2.36 0.448 1.41 653.3355 1,304.66 1,305.67 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% EQADFAIEALAK 95.00% 2.92 0.457 2.57 653.3371 1,304.66 1,305.67 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% EQADFAIEALAK 95.00% 3.07 0.483 3.09 653.3372 1,304.66 1,305.67 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% EQADFAIEALAK 95.00% 2.84 0.478 2.89 653.3372 1,304.66 1,305.67 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% EQADFAIEALAK 95.00% 2.7 0.463 2.7 653.3378 1,304.66 1,305.67 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% TQLEELEDELQATEDAK 95.00% 3.9 0.438 0 654.9778 1,961.91 1,961.92 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% HSQAVEELAEQLEQTKR 95.00% 5.29 0.647 2.34 666.0069 1,995.00 1,996.01 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% HSQAVEELAEQLEQTKR 95.00% 5.96 0.599 2.96 666.3409 1,996.00 1,996.01 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% HSQAVEELAEQLEQTKR 95.00% 6.02 0.596 2.8 666.3423 1,996.00 1,996.01 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% HSQAVEELAEQLEQTKR 95.00% 6.02 0.579 2.27 666.3428 1,996.00 1,996.01 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% IIGLDQVAGMSETALPGAFK 95.00% 4.05 0.437 1.31 673.6929 2,018.06 2,018.06 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% TLEEEAKTHEAQIQEMR 95.00% 3.27 0.517 1.89 681.9984 2,042.97 2,042.98 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% TVGQLYKEQLAK 95.00% 2.94 0.342 0 689.3914 1,376.77 1,377.77 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% TVGQLYKEQLAK 95.00% 3.93 0.349 2.77 689.8917 1,377.77 1,377.77 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QAQQERDELADEIANSSGK 95.00% 4.48 0.531 1.92 697.3326 2,088.97 2,088.98 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QAQQERDELADEIANSSGK 95.00% 4.78 0.548 3.4 697.3329 2,088.98 2,088.98 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VDYKADEWLMK 95.00% 2.37 0.384 1.57 699.3405 1,396.67 1,397.68 2 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VDYKADEWLMK 95.00% 2.51 0.312 0 699.3414 1,396.67 1,397.68 2 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VIQYLAYVASSHK 95.00% 3.58 0.523 4.49 739.9038 1,477.79 1,478.80 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VIQYLAYVASSHK 95.00% 4.21 0.528 3.89 739.9046 1,477.79 1,478.80 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VIQYLAYVASSHK 95.00% 3.75 0.467 3.44 739.9052 1,477.79 1,478.80 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VISGVLQLGNIVFK 95.00% 4.32 0.581 4.05 743.9521 1,485.89 1,486.90 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VISGVLQLGNIVFK 95.00% 3.6 0.577 5.28 743.9527 1,485.89 1,486.90 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VISGVLQLGNIVFK 95.00% 4.64 0.603 4.25 743.9528 1,485.89 1,486.90 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VISGVLQLGNIVFK 95.00% 4.47 0.587 4.28 743.953 1,485.89 1,486.90 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VISGVLQLGNIVFK 95.00% 4.23 0.587 4.25 743.9533 1,485.89 1,486.90 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VISGVLQLGNIVFK 95.00% 2.7 0.362 2.85 743.9571 1,485.90 1,486.90 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% TQLEELEDELQATEDAKLR 95.00% 3.83 0.517 1.85 744.3731 2,230.10 2,231.10 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% TQLEELEDELQATEDAKLR 95.00% 3.82 0.398 0 744.7079 2,231.10 2,231.10 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ITDVIIGFQAccR 95.00% 3.7 0.464 2.96 c11: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 777.388 1,552.76 1,552.76 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VSHLLGINVTDFTR 95.00% 4.31 0.493 6.08 786.4295 1,570.84 1,571.85 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% VSHLLGINVTDFTR 95.00% 4.42 0.489 7.03 786.4315 1,570.85 1,571.85 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% AGKLDPHLVLDQLR 95.00% 3.96 0.586 3.77 787.9527 1,573.89 1,574.90 2 MYH10_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% IMGIPEEEQMGLLR 95.00% 2.91 0.392 1.85 808.4152 1,614.81 1,615.82 2 COEA1_HUMAN,ACTB_HUMAN,AHNK_HUMAN,RL27A_HUMAN,ACTG_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQQLFNHTMFILEQEEYQR 95.00% 3.16 0.364 0.959 823.4069 2,467.20 2,467.21 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQQLFNHTMFILEQEEYQR 95.00% 5.4 0.198 2.8 823.4079 2,467.20 2,467.21 3 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% IAEFTTNLTEEEEK 95.00% 4.64 0.507 3 827.395 1,652.77 1,653.79 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% IAEFTTNLTEEEEK 95.00% 4.58 0.513 2.7 827.3961 1,652.78 1,653.79 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% NFINNPLAQADWAAK 95.00% 4.95 0.438 5.17 836.9253 1,671.83 1,672.84 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% NFINNPLAQADWAAK 95.00% 5.03 0.42 6.46 836.9267 1,671.84 1,672.84 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.64 0.446 4.72 863.9651 1,725.91 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.41 0.559 3.82 863.9747 1,725.93 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.73 0.572 7.06 863.9763 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.89 0.554 2.77 863.977 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.32 0.52 3.54 863.9774 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 5.07 0.569 3.62 863.9787 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.66 0.534 3.4 863.9793 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% NLPIYSEEIVEMYK 95.00% 4.44 0.383 4.72 864.4326 1,726.85 1,727.86 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.13 0.514 2.89 864.4738 1,726.93 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.7 0.496 4.77 864.4773 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.96 0.491 4.92 864.4776 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.36 0.458 4.18 864.479 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.69 0.498 3.41 864.4792 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QLLQANPILEAFGNAK 95.00% 4.8 0.542 3.64 864.4798 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LTEMETLQSQLMAEK 95.00% 4.94 0.533 3.49 876.4315 1,750.85 1,751.86 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LTEMETLQSQLMAEK 95.00% 4.48 0.548 3.72 876.9323 1,751.85 1,751.86 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% IAQLEEQLDNETKER 95.00% 4.81 0.513 3.89 908.9595 1,815.90 1,815.91 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% DFSALESQLQDTQELLQEENRQK 95.00% 4.19 0.59 1.12 917.4451 2,749.31 2,749.33 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% DFSALESQLQDTQELLQEENRQK 95.00% 4.42 0.6 2.92 917.4484 2,749.32 2,749.33 3
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% EQLEEEEEAKHNLEK 95.00% 4.75 0.555 2.24 927.9404 1,853.87 1,854.87 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% EQLEEEEEAKHNLEK 95.00% 3.6 0.543 1.72 928.4367 1,854.86 1,854.87 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ANLQIDQINTDLNLER 95.00% 5.98 0.602 9.04 935.4854 1,868.96 1,869.97 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ANLQIDQINTDLNLER 95.00% 5.13 0.556 8.24 935.4861 1,868.96 1,869.97 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ANLQIDQINTDLNLER 95.00% 5.21 0.567 6.09 935.4862 1,868.96 1,869.97 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ANLQIDQINTDLNLER 95.00% 5.76 0.564 7.49 935.9876 1,869.96 1,869.97 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% ANLQIDQINTDLNLER 95.00% 0 0 3.64 936.5004 1,870.99 1,869.97 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQVELDNVTGLLSQSDSK 95.00% 6.11 0.644 7.62 973.5053 1,944.99 1,946.01 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQVELDNVTGLLSQSDSK 95.00% 6.67 0.618 7.41 974.0056 1,946.00 1,946.01 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQVELDNVTGLLSQSDSK 95.00% 6.79 0.612 9.08 974.0064 1,946.00 1,946.01 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQVELDNVTGLLSQSDSK 95.00% 6.61 0.612 7.59 974.007 1,946.00 1,946.01 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% LQVELDNVTGLLSQSDSK 95.00% 5.95 0.589 8.66 974.0074 1,946.00 1,946.01 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% TQLEELEDELQATEDAK 95.00% 6.58 0.621 8.01 981.9609 1,961.91 1,961.92 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% IIGLDQVAGMSETALPGAFK 95.00% 5.14 0.551 7.82 1,010.04 2,018.06 2,018.06 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% QAQQERDELADEIANSSGK 95.00% 4.39 0.527 4.96 1,045.49 2,088.96 2,088.98 2
 SAMPLE 2R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 37 44 120 31.80% DFSALESQLQDTQELLQEENR 95.00% 5.61 0.653 5.55 1,247.59 2,493.17 2,493.17 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% VVFQEFR 95.00% 2.19 0.247 0 462.7501 923.4846 924.4943 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% VVFQEFR 95.00% 2.23 0.351 0 462.7505 923.4853 924.4943 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% VVFQEFR 95.00% 2.33 0.197 0 462.7513 923.4869 924.4943 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% VVFQEFR 95.00% 2.28 0.194 0 462.7514 923.4872 924.4943 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% NWQWWR 95.00% 2.2 0.254 0 488.2318 974.448 975.4589 2 MYH11_HUMAN
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% ASREEILAQAKENEK 95.00% 2.37 0.266 0 572.9666 1,715.88 1,715.89 3
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% RGDLPFVVPR 95.00% 2.86 0.294 0 578.3329 1,154.65 1,155.66 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% RGDLPFVVPR 95.00% 2.55 0.238 0 578.3336 1,154.65 1,155.66 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% RGDLPFVVPR 95.00% 2.78 0.262 0 578.3346 1,154.65 1,155.66 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% KQELEEIcHDLEAR 95.00% 3.17 0.145 0 c8: Carbamidomethyl (+57.02) 590.6194 1,768.83 1,769.85 3
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% ALELDSNLYR 95.00% 2.86 0.438 2.62 597.3109 1,192.61 1,193.62 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% ALELDSNLYR 95.00% 2.91 0.425 1.7 597.3111 1,192.61 1,193.62 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% ALELDSNLYR 95.00% 2.75 0.445 2.38 597.3112 1,192.61 1,193.62 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% ALELDSNLYR 95.00% 3.02 0.446 2.09 597.3114 1,192.61 1,193.62 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% ALELDSNLYR 95.00% 2.69 0.434 2.17 597.312 1,192.61 1,193.62 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% ALELDSNLYR 95.00% 2.95 0.447 2.02 597.3123 1,192.61 1,193.62 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% IAQLEEQLDNETKER 95.00% 2.95 0.186 0 605.9744 1,814.90 1,815.91 3
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% KFDQLLAEEK 95.00% 2.57 0.221 0 610.8292 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% KFDQLLAEEK 95.00% 2.71 0.222 0 610.8293 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% KFDQLLAEEK 95.00% 2.78 0.229 0 610.8294 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% KFDQLLAEEK 95.00% 2.59 0.229 0 610.8296 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% KFDQLLAEEK 95.00% 2.39 0.182 0 610.8315 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% ADFcIIHYAGK 95.00% 2.59 0.397 0 c4: Carbamidomethyl (+57.02) 648.3166 1,294.62 1,294.63 2 MYH10_HUMAN
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% LQQELDDLLVDLDHQR 95.00% 3.37 0.432 0 650.6682 1,948.98 1,949.99 3
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% LQQELDDLLVDLDHQR 95.00% 3.89 0.468 3.32 651.0029 1,949.99 1,949.99 3
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% LQQELDDLLVDLDHQR 95.00% 3.78 0.445 2.96 651.0036 1,949.99 1,949.99 3
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% LQQELDDLLVDLDHQR 95.00% 3.45 0.384 0.959 651.0041 1,949.99 1,949.99 3
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% VDYKADEWLMK 95.00% 2.36 0.338 0 699.3414 1,396.67 1,397.68 2 MYH10_HUMAN
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% LQVELDNVTGLLSQSDSK 95.00% 5.6 0.607 9.39 973.5088 1,945.00 1,946.01 2
 SAMPLE 3 Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 8 8 22 7.30% LQVELDNVTGLLSQSDSK 95.00% 6.53 0.608 7.47 974.0085 1,946.00 1,946.01 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% VVFQEFR 95.00% 2.36 0.202 0 462.7512 923.4867 924.4943 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% VVFQEFR 95.00% 2.38 0.167 0 462.7513 923.4869 924.4943 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% VVFQEFR 95.00% 2.16 0.206 0 462.7515 923.4873 924.4943 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% VIQYLAYVASSHK 95.00% 2.62 0.361 0 493.6045 1,477.79 1,478.80 3
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% VIQYLAYVASSHK 95.00% 2.06 0.344 1 493.6057 1,477.79 1,478.80 3
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% cNGVLEGIR 95.00% 2.95 0.391 1.59 c1: Carbamidomethyl (+57.02) 509.2605 1,016.51 1,017.52 2 ,MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% QLLQANPILEAFGNAK 95.00% 3.03 0.291 1.6 576.3196 1,725.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% QLLQANPILEAFGNAK 95.00% 4.88 0.443 2.64 576.6543 1,726.94 1,726.95 3 MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% RGDLPFVVPR 95.00% 2.83 0.285 0 578.3351 1,154.65 1,155.66 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% RGDLPFVVPR 95.00% 2.83 0.333 0 578.3357 1,154.66 1,155.66 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% ALELDSNLYR 95.00% 2.7 0.357 2.21 597.3113 1,192.61 1,193.62 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% ALELDSNLYR 95.00% 2.64 0.472 1.89 597.3124 1,192.61 1,193.62 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% ALELDSNLYR 95.00% 2.35 0.321 2.2 597.3125 1,192.61 1,193.62 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% ALELDSNLYR 95.00% 2.3 0.353 1.34 597.3128 1,192.61 1,193.62 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% ALELDSNLYR 95.00% 2.64 0.435 2.43 597.3133 1,192.61 1,193.62 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% ALELDSNLYR 95.00% 2.82 0.37 1.72 597.3145 1,192.61 1,193.62 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% IAQLEEQLDNETKER 95.00% 2.58 0.22 0 605.972 1,814.89 1,815.91 3
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% KFDQLLAEEK 95.00% 2.33 0.227 0 610.8296 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% KFDQLLAEEK 95.00% 2.89 0.223 0 610.83 1,219.64 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% KFDQLLAEEK 95.00% 2.63 0.145 0 610.8306 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% KFDQLLAEEK 95.00% 2.42 0.184 0 610.8309 1,219.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% KFDQLLAEEK 95.00% 2.19 0.17 1.52 611.3322 1,220.65 1,220.65 2 MYH10_HUMAN,MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% YEILTPNSIPK 95.00% 1.81 0.364 0 638.354 1,274.69 1,274.70 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% LQQELDDLLVDLDHQR 95.00% 4.03 0.374 1.59 651.0031 1,949.99 1,949.99 3
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% LQQELDDLLVDLDHQR 95.00% 2.59 0.192 0 651.0034 1,949.99 1,949.99 3
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% LQQELDDLLVDLDHQR 95.00% 3.81 0.436 2.46 651.0036 1,949.99 1,949.99 3
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% HSQAVEELAEQLEQTKR 95.00% 2.97 0.474 0 666.0085 1,995.00 1,996.01 3
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% HSQAVEELAEQLEQTKR 95.00% 3.11 0.455 0 666.3409 1,996.00 1,996.01 3
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% QLLQANPILEAFGNAK 95.00% 4.76 0.359 4.51 863.9719 1,725.93 1,726.95 2 MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% QLLQANPILEAFGNAK 95.00% 3.85 0.269 1.36 863.976 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% QLLQANPILEAFGNAK 95.00% 5.06 0.536 4.42 863.977 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% QLLQANPILEAFGNAK 95.00% 5.02 0.499 4.48 863.9776 1,725.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% QLLQANPILEAFGNAK 95.00% 4.54 0.264 2.72 864.4746 1,726.93 1,726.95 2 MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% QLLQANPILEAFGNAK 95.00% 5.05 0.195 3.89 864.4749 1,726.93 1,726.95 2 MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% QLLQANPILEAFGNAK 95.00% 4.88 0.512 4.12 864.4758 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% QLLQANPILEAFGNAK 95.00% 5.09 0.424 3 864.4767 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% QLLQANPILEAFGNAK 95.00% 5.01 0.413 4.12 864.477 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% QLLQANPILEAFGNAK 95.00% 4.98 0.473 3.41 864.4787 1,726.94 1,726.95 2 MYH11_HUMAN
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% ANLQIDQINTDLNLER 95.00% 5.29 0.585 5.68 935.9892 1,869.96 1,869.97 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% LQVELDNVTGLLSQSDSK 95.00% 6.32 0.594 7.74 974.0079 1,946.00 1,946.01 2
 SAMPLE 3R Myosin-9  MYH9  MYH9_HUMAN 226,519.50 100.00% 10 10 23 8.57% LQVELDNVTGLLSQSDSK 95.00% 6.42 0.606 8.52 974.0099 1,946.00 1,946.01 2
 SAMPLE 2 Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 6 4.86% YLGLLENLR 95.00% 2.37 0.291 0 545.8159 1,089.62 1,090.63 2
 SAMPLE 2 Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 6 4.86% YLGLLENLR 95.00% 2.51 0.315 1.51 545.8163 1,089.62 1,090.63 2
 SAMPLE 2 Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 6 4.86% IIcDLVEEK 95.00% 2.44 0.257 0 c3: Carbamidomethyl (+57.02) 559.7898 1,117.56 1,118.58 2
 SAMPLE 2 Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 6 4.86% LLQSNPVLEAFGNAK 95.00% 4.74 0.549 6.07 800.9388 1,599.86 1,600.87 2
 SAMPLE 2 Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 6 4.86% LLQSNPVLEAFGNAK 95.00% 3.64 0.475 3.77 801.4408 1,600.87 1,600.87 2
 SAMPLE 2 Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 6 4.86% GEELLSPLNLEQAAYAR 95.00% 3.12 0.252 3.74 937.4613 1,872.91 1,873.97 2
 SAMPLE 2R Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 7 4.57% TSFLLNLR 95.00% 2.33 0.408 0 482.2839 962.5522 963.5628 2
 SAMPLE 2R Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 7 4.57% TSFLLNLR 95.00% 2.59 0.413 0 482.2843 962.5529 963.5628 2
 SAMPLE 2R Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 7 4.57% YLGLLENLR 95.00% 3.05 0.365 0 545.8145 1,089.61 1,090.63 2
 SAMPLE 2R Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 7 4.57% YLGLLENLR 95.00% 2.49 0.358 0 545.8171 1,089.62 1,090.63 2
 SAMPLE 2R Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 7 4.57% LLQSNPVLEAFGNAK 95.00% 4.7 0.588 5.07 800.9395 1,599.86 1,600.87 2
 SAMPLE 2R Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 7 4.57% LLQSNPVLEAFGNAK 95.00% 5.07 0.47 6.08 801.4373 1,600.86 1,600.87 2
 SAMPLE 2R Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 7 4.57% NVLDTSWPTPPPALR 95.00% 4.53 0.609 4.89 832.4426 1,662.87 1,663.88 2
 SAMPLE 3 Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 99.80% 2 2 3 2.43% NPQSYLYLVK 95.00% 2.74 0.403 0 612.834 1,223.65 1,224.66 2
 SAMPLE 3 Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 99.80% 2 2 3 2.43% NPQSYLYLVK 95.00% 2.51 0.307 0 612.8363 1,223.66 1,224.66 2
 SAMPLE 3 Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 99.80% 2 2 3 2.43% LLQSNPVLEAFGNAK 95.00% 2.11 0.186 1.2 800.9387 1,599.86 1,600.87 2
 SAMPLE 3R Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 5 4.57% cPENAFFLDHVR 95.00% 2.64 0.255 0 c1: Carbamidomethyl (+57.02) 502.2373 1,503.69 1,504.70 3
 SAMPLE 3R Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 5 4.57% YLGLLENLR 95.00% 2.49 0.295 0 545.8157 1,089.62 1,090.63 2
 SAMPLE 3R Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 5 4.57% NPQSYLYLVK 95.00% 2.99 0.373 0 612.8343 1,223.65 1,224.66 2
 SAMPLE 3R Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 5 4.57% NPQSYLYLVK 95.00% 2.75 0.392 1.09 612.8351 1,223.65 1,224.66 2
 SAMPLE 3R Myosin-Ic  MYO1C  MYO1C_HUMAN 117,934.80 100.00% 4 4 5 4.57% DGTIDFTPGSELLITK 95.00% 4.17 0.409 1.12 854.4448 1,706.87 1,706.89 2
 SAMPLE 2R Myosin-Id  MYO1D  MYO1D_HUMAN 116,188.20 99.90% 2 3 4 2.39% LFcWIVTR 95.00% 2.5 0.268 0 c3: Carbamidomethyl (+57.02) 547.7917 1,093.57 1,094.58 2
 SAMPLE 2R Myosin-Id  MYO1D  MYO1D_HUMAN 116,188.20 99.90% 2 3 4 2.39% LFcWIVTR 95.00% 2.47 0.161 0 c3: Carbamidomethyl (+57.02) 547.7934 1,093.57 1,094.58 2
 SAMPLE 2R Myosin-Id  MYO1D  MYO1D_HUMAN 116,188.20 99.90% 2 3 4 2.39% DIIDKQHTEQEASYGR 95.00% 2.07 0.305 0 630.9653 1,889.87 1,889.90 3
 SAMPLE 2R Myosin-Id  MYO1D  MYO1D_HUMAN 116,188.20 99.90% 2 3 4 2.39% DIIDKQHTEQEASYGR 95.00% 2.38 0.364 0 945.4441 1,888.87 1,889.90 2
 SAMPLE 2 Myosin-XVIIIb  MYO18B  MY18B_HUMAN 285,167.80 99.80% 2 2 2 1.40% IEYLEQSTVDRAIVSR 95.00% 2.24 0.325 0 626.8153 1,877.42 1,878.99 3
 SAMPLE 2 Myosin-XVIIIb  MYO18B  MY18B_HUMAN 285,167.80 99.80% 2 2 2 1.40% THPHDAPPcKTSPPATDTGK 95.00% 2.3 0.254 0 c9: Carbamidomethyl (+57.02) 705.8923 2,114.65 2,114.99 3
 SAMPLE 2 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7  NDUFA7  NDUA7_HUMAN 12,533.80 99.80% 2 2 4 16.80% ALVSGKPAESSAVAATEK 95.00% 3.73 0.527 2.48 572.9769 1,715.91 1,715.92 3
 SAMPLE 2 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7  NDUFA7  NDUA7_HUMAN 12,533.80 99.80% 2 2 4 16.80% ALVSGKPAESSAVAATEK 95.00% 3.66 0.525 0 572.9774 1,715.91 1,715.92 3
 SAMPLE 2 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7  NDUFA7  NDUA7_HUMAN 12,533.80 99.80% 2 2 4 16.80% ALVSGKPAESSAVAATEKK 95.00% 3.15 0.385 0 615.6765 1,844.01 1,844.01 3
 SAMPLE 2 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7  NDUFA7  NDUA7_HUMAN 12,533.80 99.80% 2 2 4 16.80% ALVSGKPAESSAVAATEKK 95.00% 3.35 0.391 0 615.6774 1,844.01 1,844.01 3
 SAMPLE 2R NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7  NDUFA7  NDUA7_HUMAN 12,533.80 99.80% 2 2 2 16.80% ALVSGKPAESSAVAATEK 95.00% 3.11 0.338 1.57 572.6429 1,714.91 1,715.92 3
 SAMPLE 2R NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7  NDUFA7  NDUA7_HUMAN 12,533.80 99.80% 2 2 2 16.80% ALVSGKPAESSAVAATEKK 95.00% 2.89 0.532 0 615.676 1,844.00 1,844.01 3
 SAMPLE 3 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7  NDUFA7  NDUA7_HUMAN 12,533.80 99.80% 2 2 2 16.80% ALVSGKPAESSAVAATEK 95.00% 3.38 0.522 2.14 572.6427 1,714.90 1,715.92 3
 SAMPLE 3 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7  NDUFA7  NDUA7_HUMAN 12,533.80 99.80% 2 2 2 16.80% ALVSGKPAESSAVAATEKK 95.00% 3.84 0.514 2.41 615.34 1,843.00 1,844.01 3
 SAMPLE 3R NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7  NDUFA7  NDUA7_HUMAN 12,533.80 99.80% 2 2 3 16.80% ALVSGKPAESSAVAATEK 95.00% 3.82 0.533 1.6 572.6445 1,714.91 1,715.92 3
 SAMPLE 3R NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7  NDUFA7  NDUA7_HUMAN 12,533.80 99.80% 2 2 3 16.80% ALVSGKPAESSAVAATEK 95.00% 3.48 0.495 3.33 572.9763 1,715.91 1,715.92 3
 SAMPLE 3R NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7  NDUFA7  NDUA7_HUMAN 12,533.80 99.80% 2 2 3 16.80% ALVSGKPAESSAVAATEKK 95.00% 3.09 0.477 0 615.3402 1,843.00 1,844.01 3
 SAMPLE 2 NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% LIDREIISHDTR 95.00% 2.44 0.309 1.39 489.9358 1,466.78 1,467.79 3
 SAMPLE 2 NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% LIDREIISHDTR 95.00% 2.45 0.358 1.17 489.9362 1,466.79 1,467.79 3
 SAMPLE 2 NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% LIDREIISHDTRR 95.00% 2.7 0.274 0 541.9684 1,622.88 1,623.89 3
 SAMPLE 2 NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% GPSGLLVYQGK 95.00% 3.73 0.516 2.52 559.8125 1,117.61 1,118.62 2
 SAMPLE 2 NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% GPSGLLVYQGK 95.00% 3.77 0.527 2.68 559.813 1,117.61 1,118.62 2
 SAMPLE 2 NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% STPAITLESPDIKYPLR 95.00% 3.22 0.538 2.74 634.3499 1,900.03 1,901.04 3 TES_HUMAN
 SAMPLE 2 NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% STPAITLESPDIKYPLR 95.00% 3.92 0.584 4.12 634.6837 1,901.03 1,901.04 3 TES_HUMAN
 SAMPLE 2 NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% STPAITLESPDIKYPLR 95.00% 4.55 0.579 4 951.5216 1,901.03 1,901.04 2 TES_HUMAN
 SAMPLE 2R NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% LIDREIISHDTR 95.00% 2.71 0.349 1.23 489.9366 1,466.79 1,467.79 3
 SAMPLE 2R NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% LIDREIISHDTRR 95.00% 2.84 0.275 0 541.9681 1,622.88 1,623.89 3
 SAMPLE 2R NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% LIDREIISHDTRR 95.00% 3.17 0.224 0 541.9695 1,622.89 1,623.89 3
 SAMPLE 2R NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% GPSGLLVYQGK 95.00% 3.54 0.46 2.15 559.8135 1,117.61 1,118.62 2
 SAMPLE 2R NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% GPSGLLVYQGK 95.00% 3.28 0.534 2.32 559.8139 1,117.61 1,118.62 2
 SAMPLE 2R NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% STPAITLESPDIKYPLR 95.00% 2.94 0.549 2.52 634.6843 1,901.03 1,901.04 3 TES_HUMAN
 SAMPLE 2R NADH-cytochrome b5 reductase 3  CYB5R3  NB5R3_HUMAN 34,218.30 100.00% 3 3 5 13.60% STPAITLESPDIKYPLR 95.00% 3.47 0.572 2.06 634.6863 1,901.04 1,901.04 3 TES_HUMAN
 SAMPLE 2R NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial  NDUFS1  NDUS1_HUMAN 79,450.50 99.80% 2 2 2 3.58% VAVTPPGLAR 95.00% 1.75 0.289 1.23 490.7982 979.5807 980.5894 2
 SAMPLE 2R NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial  NDUFS1  NDUS1_HUMAN 79,450.50 99.80% 2 2 2 3.58% NDGAAILAAVSSIAQK 95.00% 3.4 0.482 2.17 765.4215 1,528.83 1,528.83 2
 SAMPLE 4 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 2 2 2 0.48% AEGPEVDVNLPK 95.00% 2 0.327 0 634.3357 1,266.66 1,267.65 2 CO5A1_HUMAN
 SAMPLE 4 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 2 2 2 0.48% VDIDVPDVNIEGPDAK 95.00% 4.01 0.00695 2.28 848.4311 1,694.85 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GDVDVSLPK 95.00% 2.51 0.368 0 465.2511 928.4865 929.4946 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GDVDVSLPK 95.00% 2.35 0.36 0 465.2526 928.4895 929.4946 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIK 95.00% 3.12 0.127 0 466.9207 1,397.74 1,398.75 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIK 95.00% 3.12 0.127 0 466.9207 1,397.74 1,398.75 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIK 95.00% 2.96 0.156 1.52 467.255 1,398.74 1,398.75 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIK 95.00% 2.96 0.156 1.52 467.255 1,398.74 1,398.75 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GDVDISLPK 95.00% 2.5 0.162 2.05 472.2586 942.5016 943.5103 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VESEIKVPDVELK 95.00% 3.71 0.402 0 495.6106 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VESEIKVPDVELK 95.00% 3.52 0.388 0 495.6109 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VESEIKVPDVELK 95.00% 3.18 0.384 0 495.6111 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VESEIKVPDVELK 95.00% 4.01 0.373 0 495.6111 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VESEIKVPDVELK 95.00% 3.35 0.37 0 495.6114 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VESEIKVPDVELK 95.00% 3.38 0.361 0 495.6117 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VESEIKVPDVELK 95.00% 3.56 0.4 0.959 495.6123 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LDFEGPDAK 95.00% 2.35 0.393 0 496.2398 990.464 991.4739 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LDFEGPDAK 95.00% 2.61 0.363 0 496.2402 990.4647 991.4739 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LDFEGPDAK 95.00% 2.4 0.304 0 496.2406 990.4655 991.4739 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LDFEGPDAK 95.00% 2.33 0.319 0 496.241 990.4663 991.4739 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISIPDVDLDLKGPK 95.00% 2.29 0.219 0 503.9547 1,508.84 1,509.85 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISIPDVDLDLKGPK 95.00% 2.64 0.238 0 503.9548 1,508.84 1,509.85 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISIPDVDLDLKGPK 95.00% 2.76 0.248 0 503.9555 1,508.84 1,509.85 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISIPDVDLDLKGPK 95.00% 3.06 0.256 0 504.2888 1,509.84 1,509.85 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPEVDLNLKGPK 95.00% 2.75 0.102 1.51 514.284 1,539.83 1,540.84 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% MPTFSTPGAK 95.00% 1.67 0.423 1.74 518.7597 1,035.50 1,036.51 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% MPTFSTPGAK 95.00% 1.47 0.325 1.49 518.7599 1,035.50 1,036.51 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISmPDIDLNLKGPK 95.00% 3.57 0.164 0 m3: Oxidation (+15.99) 519.6154 1,555.82 1,556.84 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISmPDIDLNLKGPK 95.00% 3.57 0.164 0 m3: Oxidation (+15.99) 519.6154 1,555.82 1,556.84 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISmPDIDLNLKGPK 95.00% 3.38 0.117 0 m3: Oxidation (+15.99) 519.6155 1,555.82 1,556.84 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISmPDIDLNLKGPK 95.00% 3.38 0.117 0 m3: Oxidation (+15.99) 519.6155 1,555.82 1,556.84 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISmPDIDLNLKGPK 95.00% 3.24 0.123 0 m3: Oxidation (+15.99) 519.6168 1,555.83 1,556.84 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISmPDIDLNLKGPK 95.00% 3.24 0.123 0 m3: Oxidation (+15.99) 519.6168 1,555.83 1,556.84 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% IKGDVDVSVPEVEGK 95.00% 2.87 0.204 0 524.2826 1,569.82 1,570.83 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDFDLHLKGPK 95.00% 2.2 0.241 0 533.6193 1,597.83 1,597.84 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VPDVDIKGPK 95.00% 2.97 0.373 1.2 534.3063 1,066.60 1,067.61 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VPDVDIKGPK 95.00% 3.09 0.383 1.16 534.3068 1,066.60 1,067.61 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VPDVDIKGPK 95.00% 3.35 0.385 2 534.3073 1,066.60 1,067.61 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VPDVDIKGPK 95.00% 3.33 0.373 1.42 534.3081 1,066.60 1,067.61 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VPDVDIKGPK 95.00% 2.75 0.467 1.24 534.3083 1,066.60 1,067.61 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AVEVQGPSLESGDHGK 95.00% 2.01 0.136 1.09 537.265 1,608.77 1,609.78 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AGAISASGPELQGAGHSK 95.00% 1.77 0.287 0 546.6114 1,636.81 1,637.82 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AGAISASGPELQGAGHSK 95.00% 2.59 0.447 2.25 546.6115 1,636.81 1,637.82 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AGAISASGPELQGAGHSK 95.00% 1.88 0.224 0 546.6122 1,636.81 1,637.82 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AGAISASGPELQGAGHSK 95.00% 1.78 0.252 1.46 546.6126 1,636.81 1,637.82 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEADIKGPK 95.00% 3.07 0.438 0 551.6315 1,651.87 1,652.89 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEADIKGPK 95.00% 4.13 0.515 1.68 551.6317 1,651.87 1,652.89 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEADIKGPK 95.00% 4.01 0.516 1.66 551.6324 1,651.87 1,652.89 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEADIKGPK 95.00% 3.82 0.494 1.05 551.9677 1,652.88 1,652.89 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VGIDTPDIDIHGPEGK 95.00% 3.01 0.485 1.55 554.9469 1,661.82 1,662.83 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VGIDTPDIDIHGPEGK 95.00% 2.86 0.404 0 555.2823 1,662.82 1,662.83 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIKGPK 95.00% 4.07 0.365 2.46 560.9759 1,679.90 1,680.92 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIKGPK 95.00% 4.07 0.365 2.46 560.9759 1,679.90 1,680.92 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIKGPK 95.00% 3.72 0.465 1.77 560.9761 1,679.90 1,680.92 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIKGPK 95.00% 3.72 0.465 1.77 560.9761 1,679.90 1,680.92 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIKGPK 95.00% 3.44 0.393 0 560.9761 1,679.90 1,680.92 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIKGPK 95.00% 3.44 0.393 0 560.9761 1,679.90 1,680.92 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIKGPK 95.00% 4.19 0.402 4.14 560.9761 1,679.90 1,680.92 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIKGPK 95.00% 4.19 0.402 4.14 560.9761 1,679.90 1,680.92 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIKGPK 95.00% 3.96 0.395 2.19 561.3096 1,680.91 1,680.92 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIKGPK 95.00% 3.96 0.395 2.19 561.3096 1,680.91 1,680.92 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIKGPK 95.00% 3.97 0.414 1.54 561.311 1,680.91 1,680.92 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIKGPK 95.00% 3.97 0.414 1.54 561.311 1,680.91 1,680.92 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% IDVDAPDIDIHGPDAK 95.00% 3.57 0.419 3.34 564.2794 1,689.81 1,690.83 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% IDVDAPDIDIHGPDAK 95.00% 3.14 0.31 2.07 564.28 1,689.82 1,690.83 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% IDVDAPDIDIHGPDAK 95.00% 3.24 0.399 2.52 564.2805 1,689.82 1,690.83 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% IDVDAPDIDIHGPDAK 95.00% 3.38 0.444 2.54 564.2808 1,689.82 1,690.83 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% IDVDAPDIDIHGPDAK 95.00% 2.9 0.409 2.28 564.6143 1,690.82 1,690.83 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% IDVDAPDIDIHGPDAK 95.00% 2.67 0.343 2.36 564.6156 1,690.82 1,690.83 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LEGDLKGPEVDIKGPK 95.00% 4.4 0 3.08 565.982 1,694.92 1,694.93 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LEGDLKGPEVDIKGPK 95.00% 4.49 0 2.43 565.9835 1,694.93 1,694.93 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% APSLDIKGPEVDVSGPK 95.00% 3.64 0.505 3 570.3079 1,707.90 1,708.91 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% APSLDIKGPEVDVSGPK 95.00% 3.5 0.486 2.55 570.3085 1,707.90 1,708.91 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VKGDVDVSVPK 95.00% 3.06 0.415 1.66 571.822 1,141.63 1,142.64 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VKGDVDVSVPK 95.00% 2.25 0.386 2.01 571.8237 1,141.63 1,142.64 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDTPDIDIHGPEGK 95.00% 2.45 0.345 2.11 574.2825 1,719.82 1,720.84 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDTPDIDIHGPEGK 95.00% 3.17 0.495 1.35 574.6178 1,720.83 1,720.84 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDTPDIDIHGPEGK 95.00% 3.36 0.452 1.85 574.6181 1,720.83 1,720.84 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDTPDIDIHGPEGK 95.00% 3.12 0.51 1.96 574.6185 1,720.83 1,720.84 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% DIDISSPEFK 95.00% 2.01 0.396 0 575.7846 1,149.55 1,150.56 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% DIDISSPEFK 95.00% 2.31 0.461 0 575.7846 1,149.55 1,150.56 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% DIDISSPEFK 95.00% 2.29 0.38 0 575.7852 1,149.55 1,150.56 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% DIDISSPEFK 95.00% 2.29 0.28 0 576.2866 1,150.56 1,150.56 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LNVGAPDVTLR 94.50% 2.16 0.259 0 577.8298 1,153.64 1,154.65 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% FKAEAPLPSPK 95.00% 2.19 0.234 1.66 592.8364 1,183.66 1,184.67 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDVGLNLK 95.00% 2.42 0.226 2.25 593.8276 1,185.64 1,186.65 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDVGLNLK 95.00% 2.38 0.307 2.55 593.8278 1,185.64 1,186.65 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% MKGDVDVSLPK 95.00% 2.54 0 1.96 594.816 1,187.62 1,188.63 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% MKGDVDVSLPK 95.00% 2.49 0 2.07 594.8175 1,187.62 1,188.63 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VKGDmDVSVPK 95.00% 3.26 0 2.11 m5: Oxidation (+15.99) 595.8255 1,189.64 1,190.61 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VKGDFDVSVPK 95.00% 3.26 0 2.11 595.8255 1,189.64 1,190.64 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVNAPDVQAPDWHLK 95.00% 4.12 0.36 2.85 601.9706 1,802.89 1,803.90 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVNAPDVQAPDWHLK 95.00% 3.84 0.358 2.43 601.9731 1,802.90 1,803.90 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVNAPDVQAPDWHLK 95.00% 4.61 0.36 2.38 602.3052 1,803.89 1,803.90 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVNAPDVQAPDWHLK 95.00% 4.55 0.319 1.89 602.3066 1,803.90 1,803.90 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPDVAVDLPK 95.00% 3.78 0.472 3.72 605.8178 1,209.62 1,210.63 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPDVAVDLPK 95.00% 3.53 0.478 4.2 605.819 1,209.62 1,210.63 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDINAPDVDVR 95.00% 3.53 0.256 1.39 606.8123 1,211.61 1,212.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDINAPDVDVR 95.00% 2.91 0.205 1.82 606.8133 1,211.61 1,212.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDINAPDVDVR 95.00% 3.82 0.302 1.8 606.8136 1,211.61 1,212.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDINAPDVDVR 95.00% 3.65 0.303 1.54 606.8138 1,211.61 1,212.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LKGPQITGPSLEGDLGLK 95.00% 4.83 0.521 4.36 608.3451 1,822.01 1,823.03 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LKGPQITGPSLEGDLGLK 95.00% 4.3 0.553 3.05 608.6801 1,823.02 1,823.03 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LKGPQITGPSLEGDLGLK 95.00% 5.06 0.626 3.82 608.6803 1,823.02 1,823.03 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LKGPQITGPSLEGDLGLK 95.00% 3.36 0.371 0 608.6805 1,823.02 1,823.03 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LKGPQITGPSLEGDLGLK 95.00% 4.25 0.556 3.12 608.6816 1,823.02 1,823.03 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPDVDVTLPK 95.00% 2.55 0.37 2.17 614.3182 1,226.62 1,226.63 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VSMPDVDLNLK 95.00% 2.27 0.343 0 615.824 1,229.63 1,230.64 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VKGEYDVTVPK 95.00% 1.99 0.326 0 617.8361 1,233.66 1,234.67 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VKGEYDVTVPK 95.00% 2.49 0.37 1.31 617.8376 1,233.66 1,234.67 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% APDVEGQGLDWSLKIPK 95.00% 3.89 0.465 3.03 618.6644 1,852.97 1,852.98 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPDVDVNLPK 95.00% 3.26 0.361 4 620.3123 1,238.61 1,239.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPDVDVNLPK 95.00% 2.62 0.332 5.68 620.3123 1,238.61 1,239.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPDVDVNLPK 95.00% 2.88 0.289 4.1 620.3127 1,238.61 1,239.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPDVDVNLPK 95.00% 2.56 0.27 4.38 620.3141 1,238.61 1,239.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPDVDVNLPK 95.00% 2.6 0.313 4.6 620.3142 1,238.61 1,239.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LPTGQISGPEIK 95.00% 2.91 0.411 1.77 620.3485 1,238.68 1,239.70 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LPTGQISGPEIK 95.00% 3.71 0.385 1.7 620.3489 1,238.68 1,239.70 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LPTGQISGPEIK 95.00% 2.62 0.356 0 620.3494 1,238.68 1,239.70 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LPTGQISGPEIK 95.00% 3.45 0.473 1.44 620.3497 1,238.68 1,239.70 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LPTGQISGPEIK 95.00% 3.11 0.385 1.41 620.3498 1,238.68 1,239.70 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LPTGQISGPEIK 95.00% 4.06 0.492 2.77 620.3509 1,238.69 1,239.70 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPDVDVNLPK 95.00% 2.78 0.264 4.09 620.813 1,239.61 1,239.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPEVDVTLPK 95.00% 2.17 0.359 2.6 620.8246 1,239.63 1,240.64 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LEGGEVDLKGPK 95.00% 3.62 0.422 3.82 621.3393 1,240.66 1,241.67 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LEGGEVDLKGPK 95.00% 3.46 0.43 4.01 621.3412 1,240.67 1,241.67 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDVDLNLK 95.00% 2.79 0.422 1.55 622.3383 1,242.66 1,244.66 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDVDLNLK 95.00% 2.88 0.433 1.52 622.3388 1,242.66 1,244.66 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VSMPDVELNLK 95.00% 2.07 0.414 1.85 622.8297 1,243.64 1,244.66 2 LRP1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPEVDVNLPK 95.00% 3.18 0.427 3.82 627.3189 1,252.62 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPEVDVNLPK 95.00% 3.66 0.392 4.82 627.3194 1,252.62 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPEVDVNLPK 95.00% 2.43 0.129 2.64 627.3194 1,252.62 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPEVDVNLPK 95.00% 3.06 0.35 4.17 627.3203 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPEVDVNLPK 95.00% 3.08 0.385 3.82 627.3205 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPEVDVNLPK 95.00% 2.13 0.323 2.96 627.3208 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPEVDVNLPK 95.00% 2.65 0.319 4.22 627.3222 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% HELTEISNVDVETQSGK 95.00% 2.47 0.402 0 629.6427 1,885.90 1,885.91 3 TPM1_HUMAN,PLEC1_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDIDLNLK 95.00% 2.94 0.126 1.62 629.8386 1,257.66 1,258.67 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDIDLNLK 95.00% 2.94 0.126 1.62 629.8386 1,257.66 1,258.67 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDIDLNLK 95.00% 2.76 0.0911 2.6 629.8398 1,257.66 1,258.67 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDIDLNLK 95.00% 2.76 0.0911 2.6 629.8398 1,257.66 1,258.67 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPEVDVNLPK 95.00% 3.44 0.477 4.66 634.3295 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPEVDVNLPK 95.00% 3.46 0.437 4.59 634.3296 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPEVDVNLPK 95.00% 3.85 0.403 4.01 634.3298 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPEVDVNLPK 95.00% 3.5 0.434 3.85 634.3299 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPEVDVNLPK 95.00% 3.39 0.397 4.16 634.3299 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPEVDVNLPK 95.00% 3.3 0.414 4.24 634.3302 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPEVDVNLPK 95.00% 2.98 0.438 4.01 634.3304 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPEVDVNLPK 95.00% 4.08 0.457 4.64 634.3304 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPEVDVNLPK 95.00% 3.13 0.428 3.72 634.3305 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPEVDVNLPK 95.00% 2.04 0.319 0 634.3307 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AEGPEVDVNLPK 95.00% 2.81 0.37 3.21 634.3311 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPEIDLNLK 95.00% 2.58 0.307 2.62 636.8466 1,271.68 1,272.69 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPEIDLNLK 95.00% 2.44 0.246 0 636.8472 1,271.68 1,272.69 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPEIDLNLK 95.00% 2.53 0.334 1.66 636.8474 1,271.68 1,272.69 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDLDLHLK 95.00% 2.27 0.34 0 641.3457 1,280.68 1,281.69 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% FSVSGLKAEGPDVAVDLPK 95.00% 4.47 0.409 4.19 644.0154 1,929.02 1,929.03 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPEFDVNLSK 95.00% 2.56 0.389 2.17 646.3117 1,290.61 1,291.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPEFDVNLSK 95.00% 2.28 0.381 0 646.3119 1,290.61 1,291.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPEFDVNLSK 95.00% 3.38 0.451 3.92 646.3135 1,290.61 1,291.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GEGPEFDVNLSK 95.00% 3.17 0.382 3.06 646.807 1,291.60 1,291.62 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVSAPDVEAHGPEWNLK 95.00% 2.46 0.267 0 654.9904 1,961.95 1,962.96 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPGFKGEGPEVDVNLPK 95.00% 2.31 0.407 0 672.3484 2,014.02 2,014.03 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPGFKGEGPEVDVNLPK 95.00% 2.54 0.457 0 672.3486 2,014.02 2,014.03 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDINAPDVDVQGPDWHLK 95.00% 3.95 0.551 1.48 673.3372 2,016.99 2,018.00 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDINAPDVDVQGPDWHLK 95.00% 2.82 0.419 0 673.6694 2,017.98 2,018.00 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDINAPDVDVQGPDWHLK 95.00% 3.95 0.512 2.8 673.6711 2,017.99 2,018.00 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDINAPDVDVQGPDWHLK 95.00% 3.97 0.569 1.82 673.6716 2,017.99 2,018.00 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDINAPDVDVQGPDWHLK 95.00% 3.79 0.569 1.82 673.6724 2,017.99 2,018.00 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% FSMPGFKGEGPDVDVNLPK 95.00% 1.93 0.188 1 678.6707 2,032.99 2,034.00 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% FSMPGFKGEGPDVDVNLPK 95.00% 2.46 0.213 0 679.0053 2,033.99 2,034.00 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDINAPDVEVQGK 95.00% 2.65 0.443 3.06 692.3584 1,382.70 1,383.71 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDINAPDVEVQGK 95.00% 3.38 0.423 2.48 692.3592 1,382.70 1,383.71 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIK 95.00% 3.02 0.16 0 699.8739 1,397.73 1,398.75 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIK 95.00% 3.02 0.16 0 699.8739 1,397.73 1,398.75 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIK 95.00% 3.54 0.119 1.12 699.8764 1,397.74 1,398.75 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIK 95.00% 3.54 0.119 1.12 699.8764 1,397.74 1,398.75 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIK 95.00% 3.47 0.155 0 699.878 1,397.74 1,398.75 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VEGDLKGPEVDIK 95.00% 3.47 0.155 0 699.878 1,397.74 1,398.75 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDAPDVEVHDPDWHLK 95.00% 2.56 0.378 0 701.0064 2,100.00 2,100.00 3 PEDF_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDAPDVEVHDPDWHLK 95.00% 2.26 0.249 0 701.008 2,100.00 2,100.00 3 PEDF_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% SSGcDVNLPGVNVK 95.00% 2.12 0.29 1.25 c4: Carbamidomethyl (+57.02) 723.3556 1,444.70 1,445.71 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMSEVDLNVAAPK 95.00% 3.18 0.41 2.54 737.3853 1,472.76 1,473.76 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISAPNVDFNLEGPK 95.00% 2.7 0.544 2.24 750.8908 1,499.77 1,500.77 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISAPNVDFNLEGPK 95.00% 3.02 0.568 2.92 751.3883 1,500.76 1,500.77 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISIPDVDLDLKGPK 95.00% 2.55 0.489 1.19 755.4273 1,508.84 1,509.85 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% APDVEGQGLDWSLK 95.00% 3.68 0.535 4.28 757.8747 1,513.73 1,514.75 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% APDVEGQGLDWSLK 95.00% 4.09 0.537 6.18 757.8762 1,513.74 1,514.75 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% APDVEGQGLDWSLK 95.00% 3.37 0.537 5.37 757.8769 1,513.74 1,514.75 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% APDVEGQGLDWSLK 95.00% 4.03 0.562 4.82 757.8781 1,513.74 1,514.75 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% APNISMPDVDLNLK 95.00% 3.61 0.0986 3.09 763.8971 1,525.78 1,526.79 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% APNISMPDVDLNLK 95.00% 4.29 0.0936 5.59 763.8979 1,525.78 1,526.79 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDIDLNLKGPK 95.00% 2.71 0.0726 2.8 770.9219 1,539.83 1,540.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDLDLNLKGPK 95.00% 2.71 0.0726 2.8 770.9219 1,539.83 1,540.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDIDLNLKGPK 95.00% 3.07 0.0769 1.82 770.9226 1,539.83 1,540.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDLDLNLKGPK 95.00% 3.07 0.0769 1.82 770.9226 1,539.83 1,540.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDIDLNLKGPK 95.00% 2.65 0.1 1.49 770.9228 1,539.83 1,540.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDLDLNLKGPK 95.00% 2.65 0.1 1.49 770.9228 1,539.83 1,540.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDIDLNLKGPK 95.00% 3.06 0.0821 2.35 770.9231 1,539.83 1,540.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ISMPDLDLNLKGPK 95.00% 3.06 0.0821 2.35 770.9231 1,539.83 1,540.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% IKGDVPSVGLEGPDVDLQGPEAK 95.00% 4.99 0.539 4.72 774.4034 2,320.19 2,320.20 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GGVQVPAVDISSSLGGR 95.00% 4.24 0.639 6.85 799.9273 1,597.84 1,598.85 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GGVQVPAVDISSSLGGR 95.00% 4.5 0.648 5.55 799.9286 1,597.84 1,598.85 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GGVQVPAVDISSSLGGR 95.00% 4.18 0.64 7.13 799.9287 1,597.84 1,598.85 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GGVQVPAVDISSSLGGR 95.00% 4.85 0.684 7.27 799.929 1,597.84 1,598.85 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GGVQVPAVDISSSLGGR 95.00% 5.01 0.677 7.46 799.929 1,597.84 1,598.85 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GGVQVPAVDISSSLGGR 95.00% 4.5 0.674 7.35 799.929 1,597.84 1,598.85 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VNVEAPDVNLEGLGGK 95.00% 4.55 0.387 4.59 805.9209 1,609.83 1,610.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VNVEAPDVNLEGLGGK 95.00% 3.97 0.382 5.96 805.9231 1,609.83 1,610.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VNVEAPDVNLEGLGGK 95.00% 4.09 0.387 2.96 805.9235 1,609.83 1,610.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VNVEAPDVNLEGLGGK 95.00% 4.2 0.39 3.09 806.423 1,610.83 1,610.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VNVEAPDVNLEGLGGK 95.00% 4.57 0.356 4.07 806.4244 1,610.83 1,610.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VNVEAPDVNLEGLGGK 95.00% 4.29 0.385 3.68 806.4249 1,610.83 1,610.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% AGAISASGPELQGAGHSK 95.00% 3.41 0.496 1.16 819.4165 1,636.82 1,637.82 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VGVEVPDVNIEGPEGK 95.00% 3.89 0.633 2.74 819.423 1,636.83 1,637.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VGVEVPDVNIEGPEGK 95.00% 3.78 0.603 5.17 819.4231 1,636.83 1,637.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VGVEVPDVNIEGPEGK 95.00% 3.84 0.623 3.77 819.4238 1,636.83 1,637.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VGVEVPDVNIEGPEGK 95.00% 3.64 0.615 3.04 819.4248 1,636.83 1,637.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VGVEVPDVNIEGPEGK 95.00% 3.65 0.602 3.12 819.9232 1,637.83 1,637.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VGVEVPDVNIEGPEGK 95.00% 3.94 0.623 4.66 819.9238 1,637.83 1,637.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDAPDVSIEGPDAK 95.00% 4.03 0.569 4.52 820.9029 1,639.79 1,640.80 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDAPDVSIEGPDAK 95.00% 2.94 0.44 2.82 820.9037 1,639.79 1,640.80 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDAPDVSIEGPDAK 95.00% 4.25 0.518 3.96 820.9041 1,639.79 1,640.80 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDAPDVSIEGPDAK 95.00% 3.84 0.522 5.6 820.9049 1,639.79 1,640.80 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDTNAPDLSLEGPEGK 95.00% 3.89 0.439 3.34 821.4005 1,640.79 1,641.80 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDAPDVSIEGPDAK 95.00% 3.98 0.559 4.85 821.4053 1,640.80 1,640.80 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LPSGSGAASPTGSAVDIR 95.00% 3.99 0.361 5.29 821.9234 1,641.83 1,642.84 2 NID2_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% LPSGSGAASPTGSAVDIR 95.00% 4.02 0.386 6.24 822.4264 1,642.84 1,642.84 2 NID2_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVEGPDVNIEGPEGK 95.00% 4.78 0.55 6.55 827.4003 1,652.78 1,653.80 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVEGPDVNIEGPEGK 95.00% 4.86 0.577 5.36 827.4014 1,652.79 1,653.80 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIEAPDVSLEGPEGK 95.00% 3.58 0.565 2.85 827.911 1,653.81 1,654.82 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIEAPDVSLEGPEGK 95.00% 3.66 0.521 3.52 827.9111 1,653.81 1,654.82 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIEAPDVSLEGPEGK 95.00% 3.73 0.537 4.46 827.9112 1,653.81 1,654.82 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIEAPDVSLEGPEGK 95.00% 4.34 0.554 3.44 827.9124 1,653.81 1,654.82 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VGIDTPDIDIHGPEGK 95.00% 3.88 0.575 2.41 831.9185 1,661.82 1,662.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VGIDTPDIDIHGPEGK 95.00% 4.48 0.492 4.04 832.4219 1,662.83 1,662.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIEGPDVNIEGPEGK 95.00% 4.86 0.516 5.16 834.409 1,666.80 1,667.81 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIEGPDVNIEGPEGK 95.00% 4.49 0.531 4.03 834.4091 1,666.80 1,667.81 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIEGPDVNIEGPEGK 95.00% 4.86 0.568 4.77 834.4095 1,666.80 1,667.81 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIEGPDVNIEGPEGK 95.00% 4.95 0.534 4.82 834.4097 1,666.80 1,667.81 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIEGPDVNIEGPEGK 95.00% 4.64 0.486 3.6 834.912 1,667.81 1,667.81 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIEGPDVNIEGPEGK 95.00% 4.54 0.502 3.04 834.9121 1,667.81 1,667.81 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVEVPDVSLEGPEGK 95.00% 4.1 0.509 5.39 834.9185 1,667.82 1,668.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVEVPDVSLEGPEGK 95.00% 4.28 0.463 4.32 834.9186 1,667.82 1,668.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVEVPDVSLEGPEGK 95.00% 4.47 0.478 4.41 834.9188 1,667.82 1,668.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVEVPDVSLEGPEGK 95.00% 4.22 0.516 4.15 834.9191 1,667.82 1,668.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVEVPDVSLEGPEGK 95.00% 3.8 0.562 5.85 834.9192 1,667.82 1,668.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVEVPDVSLEGPEGK 95.00% 4.5 0.467 4.85 834.92 1,667.82 1,668.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVDVPDVNIEGPDAK 95.00% 4.24 0.505 4.62 841.4163 1,680.82 1,681.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ADVDVSGPKVDVEGPDVNIEGPEGK 95.00% 2.77 0.273 0 841.4164 2,521.23 2,522.23 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVDVPDVNIEGPDAK 95.00% 4.17 0.556 3.46 841.4169 1,680.82 1,681.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ADVDVSGPKVDVEGPDVNIEGPEGK 95.00% 2.32 0.278 0 841.417 2,521.23 2,522.23 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVDVPDVNIEGPDAK 95.00% 3.95 0.535 3.34 841.4176 1,680.82 1,681.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% ADVDVSGPKVDVEGPDVNIEGPEGK 95.00% 2.53 0.21 0 841.4177 2,521.23 2,522.23 3
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVDVPDVNIEGPDAK 95.00% 3.54 0.424 3.37 841.4181 1,680.82 1,681.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVDVPDVNIEGPDAK 95.00% 4.05 0.425 4.37 841.9183 1,681.82 1,681.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVDVPDVNIEGPDAK 95.00% 4.39 0.535 3.26 841.9191 1,681.82 1,681.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% MDVNVGDIDIEGPEGK 95.00% 4.51 0.562 3.7 844.3936 1,686.77 1,687.79 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% MDVNVGDIDIEGPEGK 95.00% 4.6 0.498 4.09 844.3945 1,686.77 1,687.79 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% MDVNVGDIDIEGPEGK 95.00% 4.44 0.553 3.57 844.395 1,686.77 1,687.79 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% MDVNVGDIDIEGPEGK 95.00% 4.47 0.549 4.54 844.3979 1,686.78 1,687.79 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% MDVNVGDIDIEGPEGK 95.00% 4.67 0.477 3.31 844.8991 1,687.78 1,687.79 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% MDVNVGDIDIEGPEGK 95.00% 5.03 0.463 4.28 844.9004 1,687.79 1,687.79 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% IDVDAPDIDIHGPDAK 95.00% 3.97 0.443 4.77 845.9184 1,689.82 1,690.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% IDVDAPDIDIHGPDAK 95.00% 3.69 0.434 4.05 846.4203 1,690.83 1,690.83 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPEGK 95.00% 3.24 0 1.68 848.4187 1,694.82 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPDAK 95.00% 3.3 0.0168 1.68 848.4187 1,694.82 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPDAK 95.00% 3.35 0 5.18 848.4234 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPDAK 95.00% 3.62 0.0262 3.09 848.4247 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPEGK 95.00% 3.52 0 3.09 848.4247 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPDAK 95.00% 4.09 0.0111 2.96 848.4248 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPDAK 95.00% 3.11 0 1.96 848.425 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPEGK 95.00% 3.29 0.0556 1.96 848.425 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPEGK 95.00% 3.9 0 4.05 848.4251 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPDAK 95.00% 4.03 0.0324 4.05 848.4251 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPDAK 95.00% 3.37 0.0198 4.54 848.4256 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPEGK 95.00% 3.77 0 2.68 848.9247 1,695.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPDAK 95.00% 3.81 0.00926 2.68 848.9247 1,695.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNIEGPDAK 95.00% 3.61 0 4.85 848.9258 1,695.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% IDVTAPDVSIEEPEGK 95.00% 3.68 0.497 2.77 850.4282 1,698.84 1,698.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDTPDINIEGSEGK 95.00% 3.96 0.594 3.64 851.4115 1,700.81 1,701.82 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDTPDINIEGSEGK 95.00% 4.72 0.579 3.46 851.4135 1,700.81 1,701.82 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNLEAPEGK 95.00% 3.6 0.392 0 855.4325 1,708.85 1,709.86 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNLEAPEGK 95.00% 3.65 0.426 1.62 855.9337 1,709.85 1,709.86 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDVPDVNLEAPEGK 95.00% 4.22 0.385 2.28 855.9348 1,709.85 1,709.86 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIETPNLEGTLTGPR 95.00% 2.75 0.289 0 856.4342 1,710.85 1,711.89 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIETPNLEGTLTGPR 95.00% 4.37 0.511 6.64 856.4456 1,710.88 1,711.89 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIETPNLEGTLTGPR 95.00% 4.25 0.428 4.6 856.4457 1,710.88 1,711.89 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIETPNLEGTLTGPR 95.00% 3.62 0.374 4.39 856.946 1,711.88 1,711.89 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDTPDIDIHGPEGK 95.00% 2.66 0.321 0 861.4301 1,720.84 1,720.84 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVEcPDVNIEGPEGK 95.00% 4.35 0.569 3.96 c5: Carbamidomethyl (+57.02) 879.4076 1,756.80 1,756.81 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVNAPDVQAPDWHLK 95.00% 3.66 0.541 4.14 902.4536 1,802.89 1,803.90 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVNAPDVQAPDWHLK 95.00% 4.6 0.528 3.85 902.9533 1,803.89 1,803.90 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VQANLGAPDINIEGLDAK 95.00% 5.08 0.569 8.35 919.4851 1,836.95 1,837.97 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VQANLGAPDINIEGLDAK 95.00% 4.84 0.547 7.16 919.4853 1,836.96 1,837.97 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GPSLDIDTPDVNIEGPEGK 95.00% 5.54 0.625 3.8 977.4754 1,952.94 1,952.95 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVSAPDVEAHGPEWNLK 95.00% 3.91 0.518 2.8 981.9809 1,961.95 1,962.96 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDVSAPDVEAHGPEWNLK 95.00% 4.11 0.392 2.01 982.4795 1,962.94 1,962.96 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDAPDVDVHGPDWHLK 95.00% 5.18 0.604 4.72 1,014.49 2,026.97 2,027.98 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDAPDVDVHGPDWHLK 95.00% 3.76 0.561 4.12 1,014.99 2,027.96 2,027.98 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDAPDVDVHGPDWHLK 95.00% 4.49 0.634 4.96 1,014.99 2,027.97 2,027.98 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% VDIDAPDVDVHGPDWHLK 95.00% 4.33 0.633 3.96 1,015.00 2,027.97 2,027.98 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GPFVEAEVPDVDLEcPDAK 95.00% 5.09 0.619 5.89 c15: Carbamidomethyl (+57.02) 1,044.48 2,086.95 2,086.96 2
 SAMPLE 1 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 91 102 302 20.60% GPFVEAEVPDVDLEcPDAK 95.00% 5.5 0.596 5.21 c15: Carbamidomethyl (+57.02) 1,044.49 2,086.96 2,086.96 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GDVDVSLPK 95.00% 2.37 0.408 0 465.249 928.4824 929.4946 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GDVDVSLPK 95.00% 2.31 0.28 0 465.2508 928.4859 929.4946 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GDVDVSLPK 95.00% 2.21 0.269 0 465.251 928.4863 929.4946 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GDVDVSLPK 95.00% 2.31 0.37 0 465.2512 928.4867 929.4946 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GDVDVSLPK 95.00% 2.56 0.412 0 465.2517 928.4878 929.4946 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GDVDVSLPK 95.00% 2.25 0.218 0 465.2524 928.4892 929.4946 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIK 95.00% 2.84 0.171 0 466.9201 1,397.74 1,398.75 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIK 95.00% 2.84 0.171 0 466.9201 1,397.74 1,398.75 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIK 95.00% 3.47 0.13 0 466.9207 1,397.74 1,398.75 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIK 95.00% 3.47 0.13 0 466.9207 1,397.74 1,398.75 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GDVDISLPK 95.00% 2.28 0.121 1.24 472.2593 942.503 943.5103 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VESEIKVPDVELK 95.00% 3.31 0.434 0 495.6104 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VESEIKVPDVELK 95.00% 3.66 0.429 1.12 495.6109 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VESEIKVPDVELK 95.00% 2.96 0.342 0 495.6118 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VESEIKVPDVELK 95.00% 3.34 0.293 2.03 495.6119 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VESEIKVPDVELK 95.00% 3.49 0.333 0 495.6119 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VESEIKVPDVELK 95.00% 2.87 0.345 0 495.9443 1,484.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VESEIKVPDVELK 95.00% 3.32 0.401 0 495.9453 1,484.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LDFEGPDAK 95.00% 2.59 0.351 0 496.2391 990.4626 991.4739 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LDFEGPDAK 95.00% 2.15 0.258 0 496.2395 990.4634 991.4739 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LDFEGPDAK 95.00% 1.9 0.339 0 496.2413 990.467 991.4739 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISmPDIDLNLKGPK 95.00% 2.15 0.187 0 m3: Oxidation (+15.99) 519.6146 1,555.82 1,556.84 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISmPDIDLNLKGPK 95.00% 2.15 0.187 0 m3: Oxidation (+15.99) 519.6146 1,555.82 1,556.84 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VKVPEVDVR 95.00% 2.25 0.278 0 520.8077 1,039.60 1,040.61 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VPDVDIKGPK 94.60% 2.03 0.319 0 533.8954 1,065.78 1,067.61 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VPDVDIKGPK 95.00% 3.1 0.383 2.48 534.307 1,066.60 1,067.61 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VPDVDIKGPK 95.00% 3.3 0.429 1.89 534.3072 1,066.60 1,067.61 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VPDVDIKGPK 95.00% 3 0.44 2.1 534.3072 1,066.60 1,067.61 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VPDVDIKGPK 95.00% 3.33 0.417 1.74 534.3074 1,066.60 1,067.61 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VPDVDIKGPK 95.00% 2.97 0.369 0 534.3081 1,066.60 1,067.61 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AVEVQGPSLESGDHGK 95.00% 2.28 0.279 0 537.2662 1,608.78 1,609.78 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AVEVQGPSLESGDHGK 95.00% 2.6 0.29 1.09 537.5985 1,609.77 1,609.78 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AGAISASGPELQGAGHSK 94.70% 1.85 0.226 0 546.6099 1,636.81 1,637.82 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AGAISASGPELQGAGHSK 95.00% 2.21 0.309 1.46 546.6113 1,636.81 1,637.82 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AGAISASGPELQGAGHSK 95.00% 2.29 0.305 0 546.6116 1,636.81 1,637.82 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AGAISASGPELQGAGHSK 95.00% 2.14 0.423 1.15 546.6117 1,636.81 1,637.82 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AGAISASGPELQGAGHSK 95.00% 1.83 0.142 1.54 546.6118 1,636.81 1,637.82 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AGAISASGPELQGAGHSK 95.00% 1.92 0.195 1.28 546.6124 1,636.81 1,637.82 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AGAISASGPELQGAGHSK 95.00% 2.06 0.192 2.19 546.9462 1,637.82 1,637.82 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEADIKGPK 95.00% 3.6 0.589 1.68 551.6326 1,651.87 1,652.89 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEADIKGPK 95.00% 4.25 0.525 2.64 551.9671 1,652.88 1,652.89 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 3.65 0.406 3.54 560.9753 1,679.90 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 3.65 0.406 3.54 560.9753 1,679.90 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 4.19 0.448 3.96 560.9758 1,679.90 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 4.19 0.448 3.96 560.9758 1,679.90 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 3.15 0.449 0 560.9761 1,679.90 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 3.15 0.449 0 560.9761 1,679.90 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 3.45 0.407 0 560.9764 1,679.91 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 3.45 0.407 0 560.9764 1,679.91 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 4.3 0.417 2.68 560.9766 1,679.91 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 4.3 0.417 2.68 560.9766 1,679.91 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 3.14 0.439 0 560.9766 1,679.91 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 3.14 0.439 0 560.9766 1,679.91 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 3.8 0.444 1.85 561.3094 1,680.90 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIKGPK 95.00% 3.8 0.444 1.85 561.3094 1,680.90 1,680.92 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% IDVDAPDIDIHGPDAK 95.00% 3.24 0.365 2.01 564.2797 1,689.82 1,690.83 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% IDVDAPDIDIHGPDAK 95.00% 3.28 0.38 3.01 564.2804 1,689.82 1,690.83 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% IDVDAPDIDIHGPDAK 95.00% 2.73 0.345 2.39 564.6136 1,690.82 1,690.83 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LEGDLKGPEVDIKGPK 95.00% 4.5 0 3.33 565.6475 1,693.92 1,694.93 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LEGDLKGPEVDIKGPK 95.00% 4.2 0 1.96 565.9833 1,694.93 1,694.93 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% APSLDIKGPEVDVSGPK 95.00% 3.84 0.481 1.37 570.3069 1,707.90 1,708.91 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% APSLDIKGPEVDVSGPK 95.00% 3.12 0.521 2.28 570.6411 1,708.90 1,708.91 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VKGDVDVSVPK 95.00% 2.77 0.431 2.07 571.8214 1,141.63 1,142.64 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VKGDVDVSVPK 95.00% 2.96 0.416 2.01 571.8235 1,141.63 1,142.64 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VKGDVDVSVPK 95.00% 2.29 0.225 1.41 571.8246 1,141.63 1,142.64 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDTPDIDIHGPEGK 95.00% 3.69 0.481 2.28 574.2836 1,719.83 1,720.84 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDTPDIDIHGPEGK 95.00% 3.16 0.468 2.14 574.2836 1,719.83 1,720.84 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDTPDIDIHGPEGK 95.00% 2.62 0.316 0 574.6176 1,720.83 1,720.84 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDTPDIDIHGPEGK 95.00% 3.51 0.486 2.44 574.6179 1,720.83 1,720.84 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% DIDISSPEFK 95.00% 2.39 0.441 0 575.7838 1,149.55 1,150.56 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% DIDISSPEFK 95.00% 1.98 0.413 0 575.7839 1,149.55 1,150.56 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% DIDISSPEFK 95.00% 2.21 0.359 0 575.7841 1,149.55 1,150.56 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% DIDISSPEFK 95.00% 2.1 0.36 1.33 575.7857 1,149.56 1,150.56 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LNVGAPDVTLR 95.00% 2.25 0.225 0 577.8291 1,153.64 1,154.65 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDMQVPDLDIKGPK 95.00% 2.64 0.279 1.6 581.2966 1,740.87 1,740.88 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDMQVPDLDIKGPK 95.00% 2.88 0.36 1.04 581.2996 1,740.88 1,740.88 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% mKGNVDISAPK 95.00% 2.83 0.403 0 m1: Oxidation (+15.99) 588.3075 1,174.60 1,175.61 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% mKGNVDISAPK 95.00% 2.35 0.334 1.21 m1: Oxidation (+15.99) 588.3105 1,174.61 1,175.61 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VTAYTVDVTGR 95.00% 2.66 0.436 0 591.3146 1,180.61 1,181.62 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% FKAEAPLPSPK 95.00% 1.75 0.273 1.92 593.3052 1,184.59 1,184.67 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPDVGLNLK 95.00% 1.99 0 1.85 593.8256 1,185.64 1,186.65 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VKGDMDVSLPK 95.00% 3.03 0.185 0 594.8152 1,187.61 1,188.63 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VKGDMDVSLPK 95.00% 2.63 0.102 1.54 594.8157 1,187.62 1,188.63 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VKGDMDVSLPK 95.00% 2.73 0.208 0 594.817 1,187.62 1,188.63 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVNAPDVQAPDWHLK 95.00% 4.43 0.423 1.68 601.9716 1,802.89 1,803.90 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVNAPDVQAPDWHLK 95.00% 3.69 0.314 2.6 601.9718 1,802.89 1,803.90 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVNAPDVQAPDWHLK 95.00% 3.94 0.359 0 602.308 1,803.90 1,803.90 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVNAPDVQAPDWHLK 95.00% 3.21 0.271 1.7 602.308 1,803.90 1,803.90 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AEGPDVAVDLPK 95.00% 3.46 0.458 2.92 605.8186 1,209.62 1,210.63 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AEGPDVAVDLPK 95.00% 3.19 0.457 3.35 605.8188 1,209.62 1,210.63 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDINAPDVDVR 95.00% 3.85 0.311 1.6 606.8129 1,211.61 1,212.62 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDINAPDVDVR 95.00% 3.31 0.276 1.31 606.8141 1,211.61 1,212.62 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDINAPDVDVR 95.00% 3.17 0.231 0 606.8144 1,211.61 1,212.62 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDINAPDVDVR 95.00% 3.67 0.329 1.72 606.8147 1,211.61 1,212.62 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LKGPQITGPSLEGDLGLK 95.00% 4.02 0.52 2.72 608.3452 1,822.01 1,823.03 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LKGPQITGPSLEGDLGLK 95.00% 4.14 0.536 1.33 608.3485 1,822.02 1,823.03 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LKGPQITGPSLEGDLGLK 95.00% 4.85 0.613 4.14 608.6798 1,823.02 1,823.03 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LKGPQITGPSLEGDLGLK 95.00% 3.23 0.387 1.09 608.6803 1,823.02 1,823.03 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LKGPQITGPSLEGDLGLK 95.00% 3.71 0.573 2.54 608.6807 1,823.02 1,823.03 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPDVDVTLPK 95.00% 2.29 0.346 3.24 613.817 1,225.62 1,226.63 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPDVDVNLPK 95.00% 2.34 0.28 2.02 620.3111 1,238.61 1,239.62 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPDVDVNLPK 95.00% 2.52 0.297 2.27 620.312 1,238.61 1,239.62 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPDVDVNLPK 95.00% 2.83 0.298 2.02 620.3122 1,238.61 1,239.62 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPDVDVNLPK 95.00% 2.96 0.347 2.37 620.3129 1,238.61 1,239.62 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPDVDVNLPK 95.00% 2.19 0.261 1.18 620.3167 1,238.62 1,239.62 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LPTGQISGPEIK 95.00% 3.5 0.454 2.13 620.3486 1,238.68 1,239.70 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LPTGQISGPEIK 95.00% 2.74 0.394 1.85 620.3492 1,238.68 1,239.70 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LPTGQISGPEIK 95.00% 3.9 0.445 1.92 620.3497 1,238.68 1,239.70 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LPTGQISGPEIK 95.00% 3.05 0.458 2 620.351 1,238.69 1,239.70 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPEVDVTLPK 95.00% 1.95 0.345 2.96 620.8246 1,239.63 1,240.64 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LEGGEVDLKGPK 95.00% 3.43 0.365 3.43 621.3394 1,240.66 1,241.67 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% LEGGEVDLKGPK 95.00% 2.48 0.343 3.11 621.3398 1,240.66 1,241.67 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPDVDLNLK 95.00% 2.43 0.245 1.11 622.3384 1,242.66 1,244.66 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPDVDLNLK 95.00% 2.34 0.275 0 622.3396 1,242.66 1,244.66 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VSMPDVELNLK 95.00% 2.33 0.416 1.7 622.829 1,243.64 1,244.66 2 LRP1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VSMPDVELNLK 95.00% 2.27 0.429 0 622.8299 1,243.64 1,244.66 2 LRP1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPEVDVNLPK 95.00% 3.07 0.362 3.36 627.3197 1,252.62 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPEVDVNLPK 95.00% 2.68 0.321 2.72 627.3202 1,252.62 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPEVDVNLPK 95.00% 2.95 0.345 3.92 627.3203 1,252.62 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPEVDVNLPK 95.00% 3 0.348 3.6 627.3211 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPEVDVNLPK 95.00% 2.12 0.236 2.52 627.3243 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPEVDLNLK 95.00% 2.33 0.132 1.24 629.8383 1,257.66 1,258.67 2 CO5A1_HUMAN,MYH9_HUMAN,CO6A1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPEVDLNLK 95.00% 2.32 0.119 1.54 629.8396 1,257.66 1,258.67 2 CO5A1_HUMAN,MYH9_HUMAN,CO6A1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AEGPEVDVNLPK 95.00% 2.24 0.389 1.62 634.3284 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AEGPEVDVNLPK 95.00% 3.71 0.494 5.43 634.3285 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AEGPEVDVNLPK 95.00% 3.93 0.419 3.85 634.3287 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AEGPEVDVNLPK 95.00% 3.54 0.458 4.12 634.3288 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AEGPEVDVNLPK 95.00% 3.31 0.434 5.55 634.3293 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AEGPEVDVNLPK 95.00% 2.88 0.492 3.51 634.3296 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AEGPEVDVNLPK 95.00% 2.94 0.408 2.8 634.3303 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AEGPEVDVNLPK 95.00% 2.42 0.175 3.55 634.3305 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AEGPEVDVNLPK 95.00% 2.54 0.378 2.44 634.3307 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% AEGPEVDVNLPK 95.00% 3.46 0.449 5.36 634.331 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPEIDLNLK 95.00% 2.15 0.278 0 636.8457 1,271.68 1,272.69 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPEIDLNLK 95.00% 2.34 0.297 0 636.846 1,271.68 1,272.69 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPEIDLNLK 95.00% 1.98 0.302 0 636.8479 1,271.68 1,272.69 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPDVDFNLK 95.00% 2.12 0.343 0 639.823 1,277.63 1,278.64 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% FSVSGLKAEGPDVAVDLPK 95.00% 4.25 0.337 4.07 644.0146 1,929.02 1,929.03 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% FSVSGLKAEGPDVAVDLPK 95.00% 4.49 0.449 4.09 644.0159 1,929.02 1,929.03 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPEFDVNLSK 95.00% 2.74 0.327 2.55 646.3131 1,290.61 1,291.62 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GEGPEFDVNLSK 95.00% 2.95 0.38 2.64 646.3136 1,290.61 1,291.62 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% IPMPDFDLHLK 95.00% 2.92 0.447 1.52 664.007 1,326.00 1,325.69 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% FSMPGFKGEGPDVDVSLPK 95.00% 2.44 0.336 0 670.0029 2,006.99 2,006.99 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDINAPDVDVQGPDWHLK 95.00% 3.28 0.446 1.77 673.6708 2,017.99 2,018.00 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDINAPDVDVQGPDWHLK 95.00% 3.56 0.431 0 673.6708 2,017.99 2,018.00 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDINAPDVDVQGPDWHLK 95.00% 4.01 0.505 1.35 673.6711 2,017.99 2,018.00 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDINAPDVDVQGPDWHLK 95.00% 3.82 0.596 0 673.6713 2,017.99 2,018.00 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDAPDVDVHGPDWHLK 95.00% 2.57 0.323 3.6 676.9992 2,027.97 2,027.98 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDAPDVDVHGPDWHLK 95.00% 2.78 0.37 2.25 676.9998 2,027.98 2,027.98 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% FSMPGFKGEGPEVDVNLPK 95.00% 2.17 0.425 0 683.6785 2,048.01 2,048.02 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% FSMPGFKGEGPEVDVNLPK 95.00% 2.32 0.365 1.28 683.6785 2,048.01 2,048.02 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDINAPDVEVQGK 95.00% 3.27 0.434 2.48 692.3582 1,382.70 1,383.71 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIK 95.00% 3.35 0.134 0 699.8755 1,397.74 1,398.75 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VEGDLKGPEVDIK 95.00% 3.35 0.134 0 699.8755 1,397.74 1,398.75 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VSVGAPDLSLEASEGSIKLPK 95.00% 2.04 0.259 0 700.0531 2,097.14 2,097.14 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GPQVSSALNLDTSK 95.00% 2.53 0.395 2.82 709.3726 1,416.73 1,416.73 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISAPNVDFNLEGPK 95.00% 3.2 0.592 2.05 750.8869 1,499.76 1,500.77 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISAPNVDFNLEGPK 95.00% 2.99 0.547 1.36 751.3905 1,500.77 1,500.77 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISIPDVDLDLKGPK 95.00% 2.03 0.279 0 755.4297 1,508.84 1,509.85 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISIPDVDLDLKGPK 95.00% 2.56 0.509 1.24 755.4307 1,508.85 1,509.85 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% APDVEGQGLDWSLK 95.00% 4.08 0.501 5.1 758.3778 1,514.74 1,514.75 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% APDVEGQGLDWSLK 95.00% 4.18 0.573 5.96 758.3798 1,514.74 1,514.75 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% APNISMPDVDLNLK 95.00% 4.24 0.0691 2.6 763.8964 1,525.78 1,526.79 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% APNISMPDVDLNLK 95.00% 3.99 0.0857 4.02 763.8968 1,525.78 1,526.79 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPDIDLNLKGPK 95.00% 3.13 0.0547 3.66 770.9207 1,539.83 1,540.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPDLDLNLKGPK 95.00% 3.13 0.0547 3.66 770.9207 1,539.83 1,540.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPDIDLNLKGPK 95.00% 2.49 0.0845 1.52 770.9212 1,539.83 1,540.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPDIDLNLKGPK 95.00% 2.49 0.0845 1.52 770.9212 1,539.83 1,540.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPDIDLNLKGPK 95.00% 3.19 0.0643 2.85 770.9224 1,539.83 1,540.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ISMPDLDLNLKGPK 95.00% 3.19 0.0643 2.85 770.9224 1,539.83 1,540.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GGVQVPAVDISSSLGGR 95.00% 4.86 0.671 6.68 799.9259 1,597.84 1,598.85 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GGVQVPAVDISSSLGGR 95.00% 3.38 0.483 3.31 799.9289 1,597.84 1,598.85 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GGVQVPAVDISSSLGGR 95.00% 4.46 0.693 6.96 799.9294 1,597.84 1,598.85 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GGVQVPAVDISSSLGGR 95.00% 2.95 0.545 3.29 800.4298 1,598.84 1,598.85 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GGVQVPAVDISSSLGGR 95.00% 3.9 0.608 5.57 800.431 1,598.85 1,598.85 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VNVEAPDVNLEGLGGK 95.00% 4.45 0.389 5.35 805.9217 1,609.83 1,610.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VNVEAPDVNLEGLGGK 95.00% 3.58 0.363 4.17 805.9221 1,609.83 1,610.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VNVEAPDVNLEGLGGK 95.00% 4.48 0.365 5.38 805.9222 1,609.83 1,610.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VNVEAPDVNLEGLGGK 95.00% 3.3 0.389 1.24 805.9223 1,609.83 1,610.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VNVEAPDVNLEGLGGK 95.00% 4.43 0.403 4.92 805.9232 1,609.83 1,610.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VNVEAPDVNLEGLGGK 95.00% 4.29 0.367 5.05 805.9234 1,609.83 1,610.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VGVEVPDVNIEGPEGK 95.00% 3.69 0.66 5.05 819.4219 1,636.83 1,637.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VGVEVPDVNIEGPEGK 95.00% 4 0.62 3.77 819.423 1,636.83 1,637.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VGVEVPDVNIEGPEGK 95.00% 3.77 0.529 3.41 819.9231 1,637.83 1,637.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VGVEVPDVNIEGPEGK 95.00% 4.04 0.6 4.92 819.9232 1,637.83 1,637.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VGVEVPDVNIEGPEGK 95.00% 3.68 0.616 2.49 819.924 1,637.83 1,637.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDAPDVSIEGPDAK 95.00% 3.47 0.505 4.06 820.9041 1,639.79 1,640.80 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDTNAPDLSLEGPEGK 95.00% 3.39 0.434 2.36 821.4003 1,640.78 1,641.80 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDTNAPDLSLEGPEGK 95.00% 3.82 0.5 2.37 821.4007 1,640.79 1,641.80 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDAPDVSIEGPDAK 95.00% 4.02 0.444 3.89 821.404 1,640.79 1,640.80 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDAPDVSIEGPDAK 95.00% 3.45 0.506 3.64 821.4054 1,640.80 1,640.80 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDAPDVSIEGPDAK 95.00% 3.91 0.511 3.68 821.4062 1,640.80 1,640.80 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDAPDVSIEGPDAK 95.00% 3.29 0.452 4.54 821.407 1,640.80 1,640.80 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDTNAPDLSLEGPEGK 95.00% 3.53 0.475 2.6 821.9013 1,641.79 1,641.80 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVEGPDVNIEGPEGK 95.00% 4.56 0.536 6 827.4015 1,652.79 1,653.80 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIEAPDVSLEGPEGK 95.00% 3.52 0.485 3.42 827.9107 1,653.81 1,654.82 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIEAPDVSLEGPEGK 95.00% 3.28 0.161 1.24 827.9193 1,653.82 1,654.82 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIEAPDVSLEGPEGK 95.00% 3.61 0.397 3.24 828.4145 1,654.81 1,654.82 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIEAPDVSLEGPEGK 95.00% 4.13 0.538 2.47 828.4163 1,654.82 1,654.82 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIEGPDVNIEGPEGK 95.00% 4.79 0.527 5.49 834.4079 1,666.80 1,667.81 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIEGPDVNIEGPEGK 95.00% 4.74 0.51 5.19 834.4085 1,666.80 1,667.81 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIEGPDVNIEGPEGK 95.00% 4.69 0.558 4.21 834.4098 1,666.80 1,667.81 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIEGPDVNIEGPEGK 95.00% 4.03 0.568 4.28 834.4112 1,666.81 1,667.81 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIEGPDVNIEGPEGK 95.00% 4.53 0.524 3.48 834.9107 1,667.81 1,667.81 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIEGPDVNIEGPEGK 95.00% 4.39 0.485 3.06 834.9107 1,667.81 1,667.81 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVEVPDVSLEGPEGK 95.00% 4.18 0.497 4.96 834.9181 1,667.82 1,668.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVEVPDVSLEGPEGK 95.00% 4.36 0.47 4.96 834.9184 1,667.82 1,668.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVEVPDVSLEGPEGK 95.00% 4.23 0.496 5.13 834.9199 1,667.82 1,668.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVEVPDVSLEGPEGK 95.00% 4.21 0.482 4.8 834.9203 1,667.83 1,668.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVEVPDVSLEGPEGK 95.00% 4.39 0.446 4.66 835.4204 1,668.83 1,668.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVEVPDVSLEGPEGK 95.00% 4.31 0.475 3.57 835.4229 1,668.83 1,668.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVDVPDVNIEGPDAK 95.00% 3.36 0.434 2.3 841.4165 1,680.82 1,681.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVDVPDVNIEGPDAK 95.00% 3.97 0.486 4.07 841.4167 1,680.82 1,681.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVDVPDVNIEGPDAK 95.00% 3.93 0.465 2.55 841.4168 1,680.82 1,681.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ADVDVSGPKVDVEGPDVNIEGPEGK 95.00% 2.71 0.315 0 841.4168 2,521.23 2,522.23 3
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVDVPDVNIEGPDAK 95.00% 4.09 0.494 2.7 841.4176 1,680.82 1,681.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVDVPDVNIEGPDAK 95.00% 3.49 0.431 3.62 841.4198 1,680.82 1,681.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVDVPDVNIEGPDAK 95.00% 4.13 0.508 4.08 841.9174 1,681.82 1,681.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVDVPDVNIEGPDAK 95.00% 4.22 0.449 3.12 841.9185 1,681.82 1,681.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVDVPDVNIEGPDAK 95.00% 4.24 0.453 3.3 841.919 1,681.82 1,681.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% MDVNVGDIDIEGPEGK 95.00% 4.05 0.547 2.96 844.3921 1,686.77 1,687.79 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% MDVNVGDIDIEGPEGK 95.00% 4.34 0.534 2.8 844.393 1,686.77 1,687.79 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% MDVNVGDIDIEGPEGK 95.00% 4.58 0.558 3.68 844.3938 1,686.77 1,687.79 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% MDVNVGDIDIEGPEGK 95.00% 4.9 0.5 3.4 844.8962 1,687.78 1,687.79 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% IDVDAPDIDIHGPDAK 95.00% 3.4 0.413 3.82 845.9168 1,689.82 1,690.83 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNIEGPDAK 95.00% 4.22 0.0129 3.96 848.4245 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNIEGPDAK 95.00% 3.25 0 4.19 848.4247 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNIEGPEGK 95.00% 3.31 0.0164 4.19 848.4247 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNIEGPDAK 95.00% 3.66 0.00548 4 848.4253 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNIEGPDAK 95.00% 3.15 0 4.52 848.4254 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNIEGPEGK 95.00% 3.26 0.0325 4.52 848.4254 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNIEGPDAK 95.00% 3.71 0 3.17 848.4256 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNIEGPEGK 95.00% 3.8 0.0252 3.17 848.4256 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNIEGPEGK 95.00% 3.96 0.02 2.05 848.4267 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNIEGPEGK 95.00% 3.9 0 3.01 848.4283 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% MDAEVPDVNIEGPDAK 95.00% 3.91 0.496 4.62 850.393 1,698.77 1,699.79 2 MAP1B_HUMAN,ANK3_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% MDAEVPDVNIEGPDAK 95.00% 4.03 0.496 4.06 850.3965 1,698.78 1,699.79 2 MAP1B_HUMAN,ANK3_HUMAN
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% IDVTAPDVSIEEPEGK 95.00% 3.72 0.51 2.46 850.4298 1,698.84 1,698.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNLEAPEGK 95.00% 3.39 0.312 0 855.4303 1,708.84 1,709.86 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNLEAPEGK 95.00% 3.84 0.345 1.13 855.4319 1,708.85 1,709.86 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNLEAPEGK 95.00% 3.57 0.287 0 855.433 1,708.85 1,709.86 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDVPDVNLEAPEGK 95.00% 3.59 0.328 0 855.435 1,708.85 1,709.86 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDTPDIDIHGPEGK 95.00% 3.32 0.573 2.16 861.4225 1,720.83 1,720.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDTPDIDIHGPEGK 95.00% 3.61 0.376 1.92 861.428 1,720.84 1,720.84 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% ASLGSLEGEAEAEASSPK 95.00% 4.67 0.544 4.31 867.415 1,732.81 1,732.82 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVNAPDVQAPDWHLK 95.00% 3.33 0.54 4.1 902.456 1,802.90 1,803.90 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VQANLGAPDINIEGLDAK 95.00% 5.43 0.555 8.8 919.4852 1,836.95 1,837.97 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VQANLGAPDINIEGLDAK 95.00% 5.47 0.528 7 919.9866 1,837.96 1,837.97 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VQANLGAPDINIEGLDAK 95.00% 4.53 0.555 5.92 919.9893 1,837.96 1,837.97 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDVSAPDVEAHGPEWNLK 95.00% 3.64 0.411 1.92 981.9785 1,961.94 1,962.96 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDAPDVDVHGPDWHLK 95.00% 4.29 0.63 4.3 1,014.49 2,026.97 2,027.98 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% VDIDAPDVDVHGPDWHLK 95.00% 4.37 0.633 4.26 1,014.99 2,027.97 2,027.98 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GPFVEAEVPDVDLEcPDAK 95.00% 4.85 0.584 4.92 c15: Carbamidomethyl (+57.02) 1,044.48 2,086.95 2,086.96 2
 SAMPLE 1R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 79 87 254 18.10% GPFVEAEVPDVDLEcPDAK 95.00% 5.29 0.572 5.08 c15: Carbamidomethyl (+57.02) 1,044.49 2,086.95 2,086.96 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GDVDVSLPK 95.00% 2.43 0.368 0 465.2509 928.4862 929.4946 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GDVDVSLPK 95.00% 2.52 0.374 0 465.2514 928.4872 929.4946 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GDVDVSLPK 95.00% 2.19 0.353 0 465.2518 928.4879 929.4946 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VEGDLKGPEVDIK 95.00% 2.95 0.0886 0.959 466.9205 1,397.74 1,398.75 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VEGDLKGPEVDIK 95.00% 2.95 0.0886 0.959 466.9205 1,397.74 1,398.75 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VESEIKVPDVELK 95.00% 3.26 0.388 0 495.6111 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VESEIKVPDVELK 95.00% 3.71 0.392 0 495.6111 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VESEIKVPDVELK 95.00% 2.92 0.374 0 495.6112 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VESEIKVPDVELK 95.00% 2.67 0.412 1.08 495.945 1,484.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ISIPDVDLDLKGPK 95.00% 2.79 0.385 0 503.9547 1,508.84 1,509.85 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ISIPDVDLDLKGPK 95.00% 2.91 0.272 0 503.9555 1,508.84 1,509.85 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ISIPDVDLDLKGPK 95.00% 2.19 0.381 2.39 503.9556 1,508.84 1,509.85 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ISMPDVDLNLKGPK 95.00% 3.13 0.348 0 509.6126 1,525.81 1,526.83 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% MSLPDVDLDLKGPK 95.00% 2.63 0.335 0 509.94 1,526.80 1,527.81 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% MSLPDVDLDLKGPK 95.00% 2.6 0.189 0 509.9411 1,526.80 1,527.81 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% MPTFSTPGAK 95.00% 1.74 0.376 1.22 518.7586 1,035.50 1,036.51 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% MPTFSTPGAK 95.00% 1.79 0.399 1.52 518.7596 1,035.50 1,036.51 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ISmPDIDLNLKGPK 94.80% 2.25 0.178 0 m3: Oxidation (+15.99) 519.6156 1,555.82 1,556.84 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ISmPDIDLNLKGPK 94.80% 2.25 0.178 0 m3: Oxidation (+15.99) 519.6156 1,555.82 1,556.84 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ISmPDIDLNLKGPK 95.00% 3.52 0.149 0 m3: Oxidation (+15.99) 519.6165 1,555.83 1,556.84 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ISmPDIDLNLKGPK 95.00% 3.52 0.149 0 m3: Oxidation (+15.99) 519.6165 1,555.83 1,556.84 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% IKGDVDVSVPEVEGK 95.00% 2.38 0.222 0 524.2836 1,569.83 1,570.83 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VPDVDIKGPK 95.00% 3.24 0.414 1.44 534.305 1,066.59 1,067.61 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VPDVDIKGPK 95.00% 2.98 0.37 1.7 534.3069 1,066.60 1,067.61 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VPDVDIKGPK 95.00% 3.07 0.441 1.68 534.3074 1,066.60 1,067.61 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VPDVDIKGPK 95.00% 3.32 0.391 1.85 534.3078 1,066.60 1,067.61 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AVEVQGPSLESGDHGK 95.00% 2.55 0.282 0 537.2637 1,608.77 1,609.78 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AVEVQGPSLESGDHGK 95.00% 2.22 0.269 1.8 537.264 1,608.77 1,609.78 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AVEVQGPSLESGDHGK 95.00% 2.21 0.268 1.92 537.2641 1,608.77 1,609.78 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AVEVQGPSLESGDHGK 95.00% 2.44 0.24 0 537.599 1,609.77 1,609.78 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VPDVEIKGPK 95.00% 2.49 0.369 0 541.315 1,080.61 1,081.63 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 2.29 0.241 1.62 546.6108 1,636.81 1,637.82 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 2.59 0.368 1.55 546.6115 1,636.81 1,637.82 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 2.1 0.332 2.19 546.6115 1,636.81 1,637.82 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 1.98 0.304 0 546.6116 1,636.81 1,637.82 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 2.22 0.327 0.921 546.6119 1,636.81 1,637.82 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 1.89 0.194 1.55 546.6119 1,636.81 1,637.82 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 2.45 0.253 1.92 546.6121 1,636.81 1,637.82 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 2.55 0.389 0 546.6124 1,636.81 1,637.82 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 1.72 0.19 0.959 546.6135 1,636.82 1,637.82 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 3.22 0.306 2.22 546.9476 1,637.82 1,637.82 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VEGDLKGPEADIKGPK 95.00% 3.65 0.484 0 551.6329 1,651.88 1,652.89 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VEGDLKGPEADIKGPK 95.00% 3.92 0.45 0 551.6338 1,651.88 1,652.89 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VEGDLKGPEADIKGPK 95.00% 2.99 0.28 1.27 551.9665 1,652.88 1,652.89 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VEGDLKGPEADIKGPK 95.00% 3.75 0.401 0 551.9674 1,652.88 1,652.89 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VEGDLKGPEVDIKGPK 95.00% 4.11 0.429 2.92 560.9743 1,679.90 1,680.92 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VEGDLKGPEVDIKGPK 95.00% 4.11 0.429 2.92 560.9743 1,679.90 1,680.92 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VEGDLKGPEVDIKGPK 95.00% 3.83 0.433 2.32 560.9762 1,679.91 1,680.92 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VEGDLKGPEVDIKGPK 95.00% 3.83 0.433 2.32 560.9762 1,679.91 1,680.92 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% IDVDAPDIDIHGPDAK 95.00% 2.93 0.349 1.68 564.2792 1,689.81 1,690.83 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% IDVDAPDIDIHGPDAK 95.00% 3.14 0.375 2 564.2794 1,689.81 1,690.83 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% IDVDAPDIDIHGPDAK 95.00% 2.85 0.352 1.6 564.28 1,689.82 1,690.83 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% IDVDAPDIDIHGPDAK 95.00% 3.04 0.365 2.25 564.28 1,689.82 1,690.83 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% LEGDLKGPEVDIKGPK 95.00% 4.06 0 2.37 565.9832 1,694.93 1,694.93 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% APSLDIKGPEVDVSGPK 95.00% 3.78 0.427 2.18 570.3079 1,707.90 1,708.91 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VKGDVDVSVPK 95.00% 3.06 0.373 2.21 571.8226 1,141.63 1,142.64 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VKGDVDVSVPK 95.00% 2.81 0.381 1.57 571.8241 1,141.63 1,142.64 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDTPDIDIHGPEGK 95.00% 2.85 0.371 1.85 574.2831 1,719.83 1,720.84 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDTPDIDIHGPEGK 95.00% 2.53 0.319 1.34 574.2835 1,719.83 1,720.84 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDTPDIDIHGPEGK 95.00% 3.22 0.466 0 574.2857 1,719.83 1,720.84 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDTPDIDIHGPEGK 95.00% 3.1 0.448 0 574.6166 1,720.83 1,720.84 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVNAPDVQAPDWHLK 95.00% 3.59 0.464 1.39 601.9714 1,802.89 1,803.90 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVNAPDVQAPDWHLK 95.00% 4.28 0.363 1.27 602.3051 1,803.89 1,803.90 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVNAPDVQAPDWHLK 95.00% 4.1 0.377 1.46 602.3058 1,803.89 1,803.90 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVNAPDVQAPDWHLK 95.00% 4.01 0.321 2.82 602.3062 1,803.90 1,803.90 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDINAPDVDVR 95.00% 3.46 0.31 1.4 606.8156 1,211.62 1,212.62 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDINAPDVDVR 95.00% 3.46 0.36 0 606.8164 1,211.62 1,212.62 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% LKGPQITGPSLEGDLGLK 95.00% 4.53 0.589 3.41 608.348 1,822.02 1,823.03 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% LKGPQITGPSLEGDLGLK 95.00% 4.42 0.559 2.68 608.3483 1,822.02 1,823.03 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% LKGPQITGPSLEGDLGLK 95.00% 4.67 0.524 3.02 608.6808 1,823.02 1,823.03 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VKGEYDVTVPK 95.00% 2.25 0.344 1.24 617.8359 1,233.66 1,234.67 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VKGEYDVTVPK 95.00% 2.32 0.446 0 617.8363 1,233.66 1,234.67 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VKGEYDVTVPK 95.00% 2.34 0.307 0 617.8367 1,233.66 1,234.67 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GEGPDVDVNLPK 95.00% 2.89 0.345 4.1 620.313 1,238.61 1,239.62 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GEGPDVDVNLPK 95.00% 2.78 0.3 2.11 620.3142 1,238.61 1,239.62 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GEGPDVDVNLPK 95.00% 2.79 0.317 3.17 620.3155 1,238.62 1,239.62 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% LPTGQISGPEIK 95.00% 2.88 0.419 1.66 620.3466 1,238.68 1,239.70 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% LPTGQISGPEIK 95.00% 3.56 0.483 2.07 620.3495 1,238.68 1,239.70 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% LPTGQISGPEIK 95.00% 3.23 0.446 1.68 620.3508 1,238.69 1,239.70 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% LPTGQISGPEIK 95.00% 3.12 0.378 0 620.8529 1,239.69 1,239.70 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% LEGGEVDLKGPK 95.00% 3.13 0.349 3.68 621.3401 1,240.66 1,241.67 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% LEGGEVDLKGPK 95.00% 2.79 0.385 3.8 621.9806 1,241.95 1,241.67 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% MKGDYDVTVPK 95.00% 1.9 0.367 0 626.8152 1,251.61 1,252.63 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GEGPEVDVNLPK 95.00% 2.47 0.245 3.13 627.3177 1,252.62 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GEGPEVDVNLPK 95.00% 2.65 0.279 3.03 627.3203 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GEGPEVDVNLPK 95.00% 2.77 0.278 3.59 627.3208 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GEGPEVDVNLPK 95.00% 2.8 0.258 4.14 627.3221 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ISMPDIDLNLK 95.00% 2.71 0.162 1.44 629.8394 1,257.66 1,258.67 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ISMPDIDLNLK 95.00% 2.71 0.162 1.44 629.8394 1,257.66 1,258.67 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AEGPEVDVNLPK 95.00% 3.92 0.402 5.27 634.3291 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AEGPEVDVNLPK 95.00% 3.08 0.424 2.34 634.3293 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AEGPEVDVNLPK 95.00% 3.03 0.384 4.07 634.33 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AEGPEVDVNLPK 95.00% 3.39 0.461 5.12 634.3311 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AEGPEVDVNLPK 95.00% 2.84 0.379 1.66 634.3333 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AEGPEVDVNLPK 95.00% 3.11 0.352 3.42 634.8305 1,267.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% FSVSGLKAEGPDVAVDLPK 95.00% 3.3 0.365 2.38 644.0157 1,929.02 1,929.03 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% FSVSGLKAEGPDVAVDLPK 95.00% 5.02 0.516 4.17 644.0161 1,929.02 1,929.03 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% FSVSGLKAEGPDVAVDLPK 95.00% 3.94 0.46 3.34 644.0168 1,929.03 1,929.03 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VHAPGLNLSGVGGK 95.00% 1.78 0.437 0 653.3658 1,304.72 1,305.73 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VHAPGLNLSGVGGK 95.00% 2.75 0.382 1.29 653.867 1,305.72 1,305.73 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ISMPGFKGEGPEVDVNLPK 95.00% 2.1 0.391 0 672.3482 2,014.02 2,014.03 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ISMPGFKGEGPEVDVNLPK 95.00% 2.12 0.416 0 672.3494 2,014.02 2,014.03 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDINAPDVDVQGPDWHLK 95.00% 3.6 0.435 0 673.671 2,017.99 2,018.00 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDINAPDVDVQGPDWHLK 95.00% 3.43 0.568 1.06 673.6713 2,017.99 2,018.00 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDINAPDVEVQGK 95.00% 3.03 0.519 1.6 692.3584 1,382.70 1,383.71 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDINAPDVEVQGK 95.00% 2.97 0.364 2.1 692.3591 1,382.70 1,383.71 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GGVQVPAVDISSSLGGR 95.00% 4.58 0.639 6.7 799.9295 1,597.84 1,598.85 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GGVQVPAVDISSSLGGR 95.00% 4.55 0.636 6.51 799.9296 1,597.84 1,598.85 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GGVQVPAVDISSSLGGR 95.00% 4.66 0.674 7.59 799.9301 1,597.84 1,598.85 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VNVEAPDVNLEGLGGK 95.00% 4.48 0.379 4.42 805.9214 1,609.83 1,610.84 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VNVEAPDVNLEGLGGK 95.00% 4.26 0.384 5.64 805.9232 1,609.83 1,610.84 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VNVEAPDVNLEGLGGK 95.00% 4.63 0.374 5.64 806.4233 1,610.83 1,610.84 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VNVEAPDVNLEGLGGK 95.00% 4.66 0.394 7.4 806.4236 1,610.83 1,610.84 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 3.73 0.562 4.8 819.4143 1,636.81 1,637.82 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 3.68 0.536 1.8 819.4162 1,636.82 1,637.82 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 3.04 0.474 1.59 819.4187 1,636.82 1,637.82 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VGVEVPDVNIEGPEGK 95.00% 3.98 0.659 4.51 819.4221 1,636.83 1,637.84 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VGVEVPDVNIEGPEGK 95.00% 3.89 0.627 5.15 819.4231 1,636.83 1,637.84 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VGVEVPDVNIEGPEGK 95.00% 4.19 0.595 4.35 819.4235 1,636.83 1,637.84 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VGVEVPDVNIEGPEGK 95.00% 4.02 0.634 4.4 819.4248 1,636.83 1,637.84 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% AGAISASGPELQGAGHSK 95.00% 4.12 0.516 3.59 819.9184 1,637.82 1,637.82 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDAPDVSIEGPDAK 95.00% 3.14 0.487 4.92 820.9038 1,639.79 1,640.80 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDTNAPDLSLEGPEGK 95.00% 4.04 0.515 3.14 821.4008 1,640.79 1,641.80 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDTNAPDLSLEGPEGK 95.00% 3.7 0.501 2.6 821.4018 1,640.79 1,641.80 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDAPDVSIEGPDAK 95.00% 3.39 0.495 3.52 821.4038 1,640.79 1,640.80 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDAPDVSIEGPDAK 95.00% 3.3 0.414 1.12 821.4058 1,640.80 1,640.80 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVEGPDVNIEGPEGK 95.00% 4.67 0.573 6.85 827.4016 1,652.79 1,653.80 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIEAPDVSLEGPEGK 95.00% 3.22 0.56 2.38 827.9102 1,653.80 1,654.82 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIEAPDVSLEGPEGK 95.00% 4.21 0.562 3.34 827.9115 1,653.81 1,654.82 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIEAPDVSLEGPEGK 95.00% 3.36 0.5 2.6 827.9124 1,653.81 1,654.82 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIEGPDVNIEGPEGK 95.00% 4.45 0.493 4.48 834.4088 1,666.80 1,667.81 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIEGPDVNIEGPEGK 95.00% 4.54 0.585 5.82 834.4091 1,666.80 1,667.81 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIEGPDVNIEGPEGK 95.00% 4.25 0.534 2 834.9112 1,667.81 1,667.81 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIEGPDVNIEGPEGK 95.00% 4.86 0.534 3.41 834.9115 1,667.81 1,667.81 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVEVPDVSLEGPEGK 95.00% 4.14 0.464 5.3 834.9192 1,667.82 1,668.83 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVEVPDVSLEGPEGK 95.00% 4.11 0.453 4.43 834.9196 1,667.82 1,668.83 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVEVPDVSLEGPEGK 95.00% 4.11 0.506 4.38 834.9205 1,667.83 1,668.83 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVEVPDVSLEGPEGK 95.00% 4.39 0.379 4.38 835.4198 1,668.82 1,668.83 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVEVPDVSLEGPEGK 95.00% 3.64 0.315 1.21 835.4202 1,668.82 1,668.83 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VEGDLKGPEVDIKGPK 95.00% 3.81 0.471 3.57 840.961 1,679.91 1,680.92 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VEGDLKGPEVDIKGPK 95.00% 3.81 0.471 3.57 840.961 1,679.91 1,680.92 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVDVPDVNIEGPDAK 95.00% 4.17 0.526 3.14 841.4171 1,680.82 1,681.83 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ADVDVSGPKVDVEGPDVNIEGPEGK 95.00% 2.65 0.312 0 841.4172 2,521.23 2,522.23 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVDVPDVNIEGPDAK 95.00% 4.22 0.523 4.29 841.4184 1,680.82 1,681.83 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ADVDVSGPKVDVEGPDVNIEGPEGK 95.00% 2.56 0.279 0 841.4185 2,521.23 2,522.23 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVDVPDVNIEGPDAK 95.00% 4.02 0.494 4.22 841.9195 1,681.82 1,681.83 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVDVPDVNIEGPDAK 95.00% 4.19 0.54 3.41 841.9197 1,681.82 1,681.83 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVDVPDVNIEGPDAK 95.00% 3.46 0.422 2.57 841.9211 1,681.83 1,681.83 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% MDVNVGDIDIEGPEGK 95.00% 4.82 0.52 3.8 844.3958 1,686.78 1,687.79 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDVPDVNIEGPEGK 95.00% 4.07 0 5.11 848.4234 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDVPDVNIEGPDAK 95.00% 4.09 0.0029 5.11 848.4234 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDVPDVNIEGPDAK 95.00% 3.77 0.0334 3.8 848.4247 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDVPDVNIEGPDAK 95.00% 3.33 0 2.21 848.4252 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDVPDVNIEGPEGK 95.00% 3.44 0.0336 2.21 848.4252 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDVPDVNIEGPEGK 95.00% 3.72 0 2.52 848.4256 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDVPDVNIEGPDAK 95.00% 3.76 0.0109 2.52 848.4256 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDVPDVNIEGPEGK 95.00% 3.88 0 1.96 848.9285 1,695.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDVPDVNIEGPDAK 95.00% 3.96 0.0191 1.96 848.9285 1,695.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% IDVTAPDVSIEEPEGK 95.00% 3.44 0.45 4.33 849.9252 1,697.83 1,698.84 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% MDAEVPDVNIEGPDAK 95.00% 3.3 0.158 1.57 850.393 1,698.77 1,699.79 2 MAP1B_HUMAN,ANK3_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% MDAEVPDVNIEGPDAK 95.00% 3.32 0.0861 1.8 850.3936 1,698.77 1,699.79 2 MAP1B_HUMAN,ANK3_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% MDAEVPDVNIEGPDAK 95.00% 4.07 0.45 3.3 850.3939 1,698.77 1,699.79 2 MAP1B_HUMAN,ANK3_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% IDVTAPDVSIEEPEGK 95.00% 3.69 0.5 4.02 850.4326 1,698.85 1,698.84 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% MDAEVPDVNIEGPDAK 95.00% 4.23 0.504 1.41 850.8968 1,699.78 1,699.79 2 MAP1B_HUMAN,ANK3_HUMAN
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIETPNLEGTLTGPR 95.00% 4.03 0.486 2.25 856.9441 1,711.87 1,711.89 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIETPNLEGTLTGPR 95.00% 3.34 0.464 3.46 856.9479 1,711.88 1,711.89 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDTPDIDIHGPEGK 95.00% 3.1 0.296 0 861.4297 1,720.84 1,720.84 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% ASLGSLEGEAEAEASSPK 95.00% 4.34 0.511 6.85 866.917 1,731.82 1,732.82 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% MPSMNIQTHKISMPDVGLNLKAPK 95.00% 2.13 0.278 0 883.9091 2,648.70 2,650.39 3
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDVNAPDVQAPDWHLK 95.00% 3.63 0.541 3.54 902.9586 1,803.90 1,803.90 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VQANLGAPDINIEGLDAK 95.00% 3.35 0.47 1.68 919.4853 1,836.95 1,837.97 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% VDIDAPDVDVHGPDWHLK 95.00% 3.91 0.619 4.11 1,014.50 2,026.98 2,027.98 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GPFVEAEVPDVDLEcPDAK 95.00% 5.61 0.609 4.07 c15: Carbamidomethyl (+57.02) 1,044.49 2,086.95 2,086.96 2
 SAMPLE 2 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 62 67 174 14.20% GPFVEAEVPDVDLEcPDAK 95.00% 4.52 0.627 4 c15: Carbamidomethyl (+57.02) 1,044.49 2,086.96 2,086.96 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GDVDVSLPK 95.00% 2.19 0.235 0 465.2509 928.4862 929.4946 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GDVDVSLPK 95.00% 2.04 0.278 0 465.2518 928.488 929.4946 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VESEIKVPDVELK 95.00% 3.91 0.296 0.959 495.61 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VESEIKVPDVELK 95.00% 2.22 0.265 0 495.6107 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VESEIKVPDVELK 95.00% 3.15 0.319 0 495.6117 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VESEIKVPDVELK 95.00% 3.42 0.346 0 495.9442 1,484.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% ISIPDVDLDLKGPK 95.00% 3.24 0.318 0 503.9543 1,508.84 1,509.85 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% ISIPDVDLDLKGPK 95.00% 2.56 0.258 0 503.9547 1,508.84 1,509.85 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% MSLPDVDLDLKGPK 95.00% 2.99 0.232 0 509.9398 1,526.80 1,527.81 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% MSLPDVDLDLKGPK 95.00% 3.1 0.338 0 509.9407 1,526.80 1,527.81 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% MSLPDVDLDLKGPK 95.00% 2.3 0.304 0 509.9409 1,526.80 1,527.81 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% MSLPDVDLDLKGPK 95.00% 2.15 0.243 0 510.2754 1,527.80 1,527.81 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VPDVDIKGPK 95.00% 2.93 0.439 1.49 534.3072 1,066.60 1,067.61 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VPDVDIKGPK 95.00% 3.22 0.384 2.55 534.3073 1,066.60 1,067.61 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VPDVDIKGPK 95.00% 3.13 0.433 1.44 534.3083 1,066.60 1,067.61 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VPDVDIKGPK 95.00% 3.17 0.436 1.82 534.3087 1,066.60 1,067.61 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AVEVQGPSLESGDHGK 95.00% 2.25 0.361 0.959 537.5983 1,609.77 1,609.78 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AVEVQGPSLESGDHGK 95.00% 2.42 0.251 0 537.5998 1,609.78 1,609.78 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AGAISASGPELQGAGHSK 95.00% 2.87 0.371 0 546.6121 1,636.81 1,637.82 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AGAISASGPELQGAGHSK 95.00% 2.69 0.411 0.959 546.6122 1,636.81 1,637.82 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AGAISASGPELQGAGHSK 95.00% 2.04 0.207 1.36 546.6124 1,636.81 1,637.82 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AGAISASGPELQGAGHSK 95.00% 2.14 0.236 0 546.6129 1,636.82 1,637.82 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AGAISASGPELQGAGHSK 95.00% 2 0.371 0 546.6131 1,636.82 1,637.82 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AGAISASGPELQGAGHSK 95.00% 2.39 0.352 1.32 546.9473 1,637.82 1,637.82 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VEGDLKGPEADIKGPK 95.00% 3.16 0.487 1.27 551.6318 1,651.87 1,652.89 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VEGDLKGPEVDIKGPK 95.00% 3.77 0.42 2.46 560.9757 1,679.90 1,680.92 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VEGDLKGPEVDIKGPK 95.00% 3.77 0.42 2.46 560.9757 1,679.90 1,680.92 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VEGDLKGPEVDIKGPK 95.00% 4.13 0.451 1.24 560.9766 1,679.91 1,680.92 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VEGDLKGPEVDIKGPK 95.00% 4.13 0.451 1.24 560.9766 1,679.91 1,680.92 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VEGDLKGPEVDIKGPK 95.00% 3.71 0.405 1.11 561.3104 1,680.91 1,680.92 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VEGDLKGPEVDIKGPK 95.00% 3.71 0.405 1.11 561.3104 1,680.91 1,680.92 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VEGDLKGPEVDIKGPK 95.00% 3.73 0.414 1.11 561.311 1,680.91 1,680.92 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VEGDLKGPEVDIKGPK 95.00% 3.73 0.414 1.11 561.311 1,680.91 1,680.92 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% IDVDAPDIDIHGPDAK 95.00% 3.39 0.414 1.74 564.2795 1,689.82 1,690.83 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% IDVDAPDIDIHGPDAK 95.00% 3.23 0.445 1.27 564.2806 1,689.82 1,690.83 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% IDVDAPDIDIHGPDAK 95.00% 3.65 0.388 1.4 564.6142 1,690.82 1,690.83 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% IDVDAPDIDIHGPDAK 95.00% 2.91 0.286 2.24 564.6147 1,690.82 1,690.83 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VKGDVDVSVPK 95.00% 1.94 0.285 1.64 571.8231 1,141.63 1,142.64 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VKGDVDVSVPK 95.00% 2.82 0.385 1.66 571.8248 1,141.63 1,142.64 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VKGDVDVTLPK 95.00% 2.6 0.115 1.51 585.8421 1,169.67 1,170.67 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% ISMPDVGLNLK 95.00% 2.31 0.262 2.25 593.827 1,185.64 1,186.65 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% ISMPDVGLNLK 95.00% 2.3 0.357 2.24 593.8277 1,185.64 1,186.65 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% ISMPDVGLNLK 95.00% 2.36 0.26 2.34 593.8279 1,185.64 1,186.65 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% ISMPDVGLNLK 95.00% 2.39 0.319 3.28 593.8286 1,185.64 1,186.65 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDVNAPDVQAPDWHLK 95.00% 4.4 0.428 0.959 602.3058 1,803.89 1,803.90 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDVNAPDVQAPDWHLK 95.00% 4.14 0.389 1.59 602.306 1,803.89 1,803.90 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% LKGPQITGPSLEGDLGLK 95.00% 4.16 0.58 2.77 608.3464 1,822.02 1,823.03 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% LKGPQITGPSLEGDLGLK 95.00% 4.51 0.592 2.62 608.3469 1,822.02 1,823.03 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% LKGPQITGPSLEGDLGLK 95.00% 2.58 0.317 0 608.3486 1,822.02 1,823.03 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% LKGPQITGPSLEGDLGLK 95.00% 2.54 0.295 0 608.6789 1,823.01 1,823.03 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% LKGPQITGPSLEGDLGLK 95.00% 3.7 0.469 1.64 608.6795 1,823.02 1,823.03 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% LKGPQITGPSLEGDLGLK 95.00% 3.24 0.347 0 608.6808 1,823.02 1,823.03 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GEGPDVDVNLPK 95.00% 2.27 0.24 2.68 620.3128 1,238.61 1,239.62 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% LPTGQISGPEIK 95.00% 3.39 0.456 3.3 620.3492 1,238.68 1,239.70 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% LPTGQISGPEIK 95.00% 3.02 0.439 1.6 620.3503 1,238.69 1,239.70 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% LPTGQISGPEIK 95.00% 3.02 0.431 2.31 620.3519 1,238.69 1,239.70 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% LPTGQISGPEIK 95.00% 2.57 0.366 1.19 620.8495 1,239.68 1,239.70 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% LEGGEVDLKGPK 95.00% 3.25 0.458 3.36 621.338 1,240.66 1,241.67 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% LEGGEVDLKGPK 95.00% 3.18 0.405 3.74 621.3398 1,240.66 1,241.67 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GEGPEVDVNLPK 95.00% 2.15 0.147 3.07 627.3193 1,252.62 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GEGPEVDVNLPK 95.00% 2.03 0.182 2.92 627.3242 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GEGPEVDVNLPK 95.00% 1.85 0.201 2.48 627.3261 1,252.64 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AEGPEVDVNLPK 95.00% 3.26 0.379 4.82 634.3285 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AEGPEVDVNLPK 95.00% 3.17 0.328 3.74 634.3287 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AEGPEVDVNLPK 95.00% 2.41 0.353 1.72 634.329 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AEGPEVDVNLPK 95.00% 2.7 0.438 3.32 634.3294 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AEGPEVDVNLPK 95.00% 2.49 0.229 1.57 634.3308 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AEGPEVDVNLPK 95.00% 2.96 0.383 4.32 634.3315 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% FSVSGLKAEGPDVAVDLPK 95.00% 4.8 0.476 2.92 644.0176 1,929.03 1,929.03 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% FSVSGLKAEGPDVAVDLPK 95.00% 3.38 0.386 2.82 644.0184 1,929.03 1,929.03 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GEGPEFDVNLSK 95.00% 2.74 0.334 0 646.3078 1,290.60 1,291.62 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VHAPGLNLSGVGGK 95.00% 1.83 0.398 0 653.3671 1,304.72 1,305.73 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% IPMPDFDLHLK 95.00% 2.1 0.268 1.28 664.0075 1,326.00 1,325.69 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDINAPDVDVQGPDWHLK 95.00% 2.74 0.346 0 673.6705 2,017.99 2,018.00 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDINAPDVDVQGPDWHLK 95.00% 3.73 0.507 1.44 673.6706 2,017.99 2,018.00 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDINAPDVDVQGPDWHLK 95.00% 4.14 0.462 1.41 673.6708 2,017.99 2,018.00 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDAPDVDVHGPDWHLK 95.00% 2.76 0.403 0.959 676.6655 2,026.97 2,027.98 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDAPDVDVHGPDWHLK 95.00% 3.16 0.448 2.66 676.9994 2,027.97 2,027.98 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDVPDVNVQGPDWHLK 95.00% 2.57 0.241 0 683.0105 2,046.01 2,046.03 3
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDINAPDVEVQGK 95.00% 2.47 0.377 1.29 692.3568 1,382.70 1,383.71 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDINAPDVEVQGK 95.00% 2.52 0.487 1.96 692.3581 1,382.70 1,383.71 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDINAPDVEVQGK 95.00% 2.7 0.423 0 692.3591 1,382.70 1,383.71 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VEGDLKGPEVDIK 95.00% 3.41 0.11 0 699.8752 1,397.73 1,398.75 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VEGDLKGPEVDIK 95.00% 3.41 0.11 0 699.8752 1,397.73 1,398.75 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GGVQVPAVDISSSLGGR 95.00% 2.73 0.486 0 799.9275 1,597.84 1,598.85 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GGVQVPAVDISSSLGGR 95.00% 4.04 0.656 6.04 799.9278 1,597.84 1,598.85 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GGVQVPAVDISSSLGGR 95.00% 3.18 0.539 4.38 799.929 1,597.84 1,598.85 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GGVQVPAVDISSSLGGR 95.00% 4.93 0.66 6.85 800.429 1,598.84 1,598.85 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GGVQVPAVDISSSLGGR 95.00% 4.72 0.648 8.4 800.4304 1,598.85 1,598.85 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VNVEAPDVNLEGLGGK 95.00% 4.23 0.383 4.66 805.9213 1,609.83 1,610.84 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VNVEAPDVNLEGLGGK 95.00% 4.17 0.435 4.77 805.9226 1,609.83 1,610.84 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VNVEAPDVNLEGLGGK 95.00% 4.61 0.398 7.19 805.9228 1,609.83 1,610.84 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VNVEAPDVNLEGLGGK 95.00% 4.24 0.429 4 806.4234 1,610.83 1,610.84 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VGVEVPDVNIEGPEGK 95.00% 3.79 0.611 2.38 819.4223 1,636.83 1,637.84 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VGVEVPDVNIEGPEGK 95.00% 3.25 0.566 2.89 819.4238 1,636.83 1,637.84 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VGVEVPDVNIEGPEGK 95.00% 3.87 0.648 2.7 819.424 1,636.83 1,637.84 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AGAISASGPELQGAGHSK 95.00% 3.46 0.537 1.96 819.9162 1,637.82 1,637.82 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AGAISASGPELQGAGHSK 95.00% 3.76 0.504 1.34 819.9189 1,637.82 1,637.82 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% AGAISASGPELQGAGHSK 95.00% 3.69 0.589 1.62 819.9196 1,637.82 1,637.82 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VGVEVPDVNIEGPEGK 95.00% 3.58 0.629 3.72 819.9236 1,637.83 1,637.84 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDAPDVSIEGPDAK 95.00% 3.12 0.521 4.12 820.9058 1,639.80 1,640.80 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDAPDVSIEGPDAK 95.00% 2.93 0.503 2.15 821.4046 1,640.79 1,640.80 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDAPDVSIEGPDAK 95.00% 2.84 0.345 1.96 821.4054 1,640.80 1,640.80 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDVEGPDVNIEGPEGK 95.00% 4.27 0.529 6.89 827.3996 1,652.78 1,653.80 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIEAPDVSLEGPEGK 95.00% 2.87 0.166 1.51 827.9164 1,653.82 1,654.82 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIEGPDVNIEGPEGK 95.00% 4.58 0.587 4 834.4095 1,666.80 1,667.81 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIEGPDVNIEGPEGK 95.00% 4.34 0.517 3.14 834.4098 1,666.80 1,667.81 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIEGPDVNIEGPEGK 95.00% 4.42 0.528 5.33 834.4101 1,666.80 1,667.81 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIEGPDVNIEGPEGK 95.00% 4.26 0.509 5.38 834.9118 1,667.81 1,667.81 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDVEVPDVSLEGPEGK 95.00% 4.35 0.485 3.92 834.919 1,667.82 1,668.83 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDVEVPDVSLEGPEGK 95.00% 4.41 0.458 4.52 834.9201 1,667.82 1,668.83 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDVEVPDVSLEGPEGK 95.00% 4.29 0.443 3.77 835.4197 1,668.82 1,668.83 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDVEVPDVSLEGPEGK 95.00% 4.34 0.473 4.62 835.4214 1,668.83 1,668.83 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDVDVPDVNIEGPDAK 95.00% 3.88 0.512 4.57 841.4158 1,680.82 1,681.83 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDVDVPDVNIEGPDAK 95.00% 3.87 0.473 3.74 841.4181 1,680.82 1,681.83 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDVDVPDVNIEGPDAK 95.00% 4.17 0.496 4.02 841.419 1,680.82 1,681.83 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% MDVNVGDIDIEGPEGK 95.00% 4.04 0.472 3.35 844.3943 1,686.77 1,687.79 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% MDVNVGDIDIEGPEGK 95.00% 4.69 0.565 4.82 844.3968 1,686.78 1,687.79 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDVPDVNIEGPDAK 95.00% 3.42 0.0566 4.07 848.4239 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDVPDVNIEGPEGK 95.00% 3.9 0 3.41 848.4243 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDVPDVNIEGPDAK 95.00% 3.94 0.0106 3.41 848.4243 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDVPDVNIEGPEGK 95.00% 3.84 0.0144 1.89 848.4253 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDVPDVNIEGPEGK 95.00% 3.39 0 2.77 848.4258 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDVPDVNIEGPDAK 95.00% 3.48 0.0259 2.77 848.4258 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDVPDVNIEGPDAK 95.00% 3.5 0.08 4.85 848.4261 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDVPDVNIEGPEGK 95.00% 3.6 0 4.6 848.4266 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDVPDVNIEGPDAK 95.00% 3.67 0.0192 4.6 848.4266 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIDVPDVNIEGPEGK 95.00% 3.94 0.0179 4.12 848.9251 1,695.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% IDVTAPDVSIEEPEGK 95.00% 3.9 0.568 3.54 849.9281 1,697.84 1,698.84 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% IDVTAPDVSIEEPEGK 95.00% 3.12 0.174 1.72 850.3867 1,698.76 1,698.84 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIETPNLEGTLTGPR 95.00% 3.61 0.404 2.02 856.4429 1,710.87 1,711.89 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VDIETPNLEGTLTGPR 95.00% 2.82 0.345 3.36 856.9439 1,711.87 1,711.89 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% VQANLGAPDINIEGLDAK 95.00% 4.97 0.546 7.82 919.9838 1,837.95 1,837.97 2
 SAMPLE 2R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 47 48 134 11.10% GPFVEAEVPDVDLEcPDAK 95.00% 5.19 0.648 5.43 c15: Carbamidomethyl (+57.02) 1,043.98 2,085.95 2,086.96 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GDVDVSLPK 95.00% 1.97 0.3 0 465.2516 928.4876 929.4946 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VESEIKVPDVELK 95.00% 3.87 0.441 0 495.6103 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VESEIKVPDVELK 95.00% 2.48 0.259 1.39 495.6113 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VESEIKVPDVELK 95.00% 2.74 0.335 0 495.6117 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VESEIKVPDVELK 95.00% 3.55 0.388 0 495.6118 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VESEIKVPDVELK 95.00% 3.53 0.25 0 495.944 1,484.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISIPDVDLDLKGPK 95.00% 3.35 0.352 1.52 504.2887 1,509.84 1,509.85 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% MSLPDVDLDLKGPK 95.00% 2.09 0.314 0 509.9399 1,526.80 1,527.81 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% MSLPDVDLDLKGPK 95.00% 2.61 0.337 0 509.9408 1,526.80 1,527.81 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% MSLPDVDLDLKGPK 95.00% 2.65 0.441 1.74 510.2751 1,527.80 1,527.81 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISmPDIDLNLKGPK 95.00% 3.55 0.163 0 m3: Oxidation (+15.99) 519.6161 1,555.82 1,556.84 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISmPDLDLNLKGPK 95.00% 3.55 0.163 0 m3: Oxidation (+15.99) 519.6161 1,555.82 1,556.84 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VPDVDIKGPK 95.00% 2.49 0.474 2.26 534.3058 1,066.60 1,067.61 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VPDVDIKGPK 95.00% 2.73 0.441 0 534.3072 1,066.60 1,067.61 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VPDVDIKGPK 95.00% 3.18 0.432 1.85 534.3079 1,066.60 1,067.61 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VPDVDIKGPK 95.00% 3.21 0.448 2.46 534.3083 1,066.60 1,067.61 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AVEVQGPSLESGDHGK 95.00% 2.15 0.202 0 537.2642 1,608.77 1,609.78 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AVEVQGPSLESGDHGK 95.00% 1.79 0.242 0 537.2643 1,608.77 1,609.78 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AVEVQGPSLESGDHGK 95.00% 2.22 0.31 0 537.5989 1,609.77 1,609.78 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AGAISASGPELQGAGHSK 95.00% 2.04 0.292 0 546.6114 1,636.81 1,637.82 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AGAISASGPELQGAGHSK 95.00% 2.36 0.305 1.21 546.6124 1,636.81 1,637.82 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AGAISASGPELQGAGHSK 95.00% 2.04 0.311 1.13 546.6136 1,636.82 1,637.82 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AGAISASGPELQGAGHSK 95.00% 2.24 0.248 0 546.9461 1,637.81 1,637.82 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AGAISASGPELQGAGHSK 95.00% 2.39 0.202 1.31 546.9465 1,637.82 1,637.82 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AGAISASGPELQGAGHSK 95.00% 2.41 0.231 0.959 546.9473 1,637.82 1,637.82 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VGIDTPDIDIHGPEGK 95.00% 2.54 0.331 0 554.9484 1,661.82 1,662.83 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VGIDTPDIDIHGPEGK 95.00% 3.18 0.405 2.15 554.9501 1,661.83 1,662.83 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VEGDLKGPEVDIKGPK 95.00% 3.56 0.4 3.01 560.976 1,679.90 1,680.92 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VEGDLKGPEVDIKGPK 95.00% 3.56 0.4 3.01 560.976 1,679.90 1,680.92 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VEGDLKGPEVDIKGPK 95.00% 3.81 0.391 2.52 560.9765 1,679.91 1,680.92 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VEGDLKGPEVDIKGPK 95.00% 3.81 0.391 2.52 560.9765 1,679.91 1,680.92 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VEGDLKGPEVDIKGPK 95.00% 3.96 0.392 0 561.3102 1,680.91 1,680.92 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VEGDLKGPEVDIKGPK 95.00% 3.96 0.392 0 561.3102 1,680.91 1,680.92 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VEGDLKGPEVDIKGPK 95.00% 4.27 0.428 1.51 561.312 1,680.91 1,680.92 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VEGDLKGPEVDIKGPK 95.00% 4.27 0.428 1.51 561.312 1,680.91 1,680.92 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% IDVDAPDIDIHGPDAK 95.00% 3.1 0.416 1.92 564.2804 1,689.82 1,690.83 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% IDVDAPDIDIHGPDAK 95.00% 3.22 0.37 1.02 564.6148 1,690.82 1,690.83 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VEGEIKAPDVDIKGPK 95.00% 4.05 0 2.6 565.6481 1,693.92 1,694.93 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VEGEIKAPDVDIKGPK 95.00% 3.84 0.0251 2.51 565.6489 1,693.92 1,694.93 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% APSLDIKGPEVDVSGPK 95.00% 3.48 0.503 0 570.3091 1,707.90 1,708.91 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% APSLDIKGPEVDVSGPK 95.00% 2.84 0.421 1.46 570.6433 1,708.91 1,708.91 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VKGDVDVSVPK 95.00% 2.08 0.346 1.8 571.821 1,141.63 1,142.64 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VKGDVDVSVPK 95.00% 2.04 0.342 1.42 571.8248 1,141.63 1,142.64 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% DIDISSPEFK 95.00% 2.14 0.414 0 575.7843 1,149.55 1,150.56 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VKGDVDVSLPK 95.00% 3.4 0.451 1.2 578.8318 1,155.65 1,156.66 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VKGDVDVSLPK 95.00% 3.54 0.443 1.54 578.8322 1,155.65 1,156.66 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% TPEMIIQKPK 95.00% 3.17 0.398 1.51 592.8393 1,183.66 1,184.67 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVNAPDVQAPDWHLK 95.00% 3.18 0.202 1.85 602.306 1,803.89 1,803.90 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVNAPDVQAPDWHLK 95.00% 3.51 0.262 1.74 602.3063 1,803.90 1,803.90 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVNAPDVQAPDWHLK 95.00% 3.94 0.432 1.59 602.3071 1,803.90 1,803.90 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVNAPDVQAPDWHLK 95.00% 3.06 0.162 1.03 602.3071 1,803.90 1,803.90 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVNAPDVQAPDWHLK 95.00% 4.13 0.379 1.92 602.3073 1,803.90 1,803.90 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVNAPDVQAPDWHLK 95.00% 3.88 0.423 1.38 602.3081 1,803.90 1,803.90 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LKGPQITGPSLEGDLGLK 95.00% 4 0.561 0 608.3475 1,822.02 1,823.03 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LKGPQITGPSLEGDLGLK 95.00% 2.46 0.309 0 608.6788 1,823.01 1,823.03 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LKGPQITGPSLEGDLGLK 95.00% 4.27 0.597 2.26 608.6795 1,823.02 1,823.03 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LKGPQITGPSLEGDLGLK 95.00% 4.42 0.576 3.04 608.6817 1,823.02 1,823.03 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LKGPQITGPSLEGDLGLK 95.00% 4.68 0.57 3.03 608.6824 1,823.02 1,823.03 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GEGPDVDVNLPK 95.00% 2.72 0.318 3.24 620.3134 1,238.61 1,239.62 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GEGPDVDVNLPK 95.00% 2.6 0.339 4 620.3136 1,238.61 1,239.62 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GEGPDVDVNLPK 95.00% 2.49 0.295 2.07 620.3138 1,238.61 1,239.62 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GEGPDVDVNLPK 95.00% 3.04 0.34 4.11 620.3139 1,238.61 1,239.62 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GEGPDVDVNLPK 95.00% 2.65 0.348 3.23 620.3143 1,238.61 1,239.62 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GEGPDVDVNLPK 95.00% 2.45 0.294 2.82 620.3152 1,238.61 1,239.62 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LPTGQISGPEIK 95.00% 2.58 0.381 1.92 620.3486 1,238.68 1,239.70 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LPTGQISGPEIK 95.00% 2.96 0.414 1.09 620.349 1,238.68 1,239.70 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LPTGQISGPEIK 95.00% 3.91 0.465 1.92 620.3493 1,238.68 1,239.70 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LPTGQISGPEIK 95.00% 2.84 0.38 0 620.3495 1,238.68 1,239.70 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LPTGQISGPEIK 95.00% 3.11 0.458 1.96 620.3498 1,238.68 1,239.70 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LPTGQISGPEIK 95.00% 3.34 0.405 1.77 620.3506 1,238.69 1,239.70 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LEGGEVDLKGPK 95.00% 1.86 0.297 2.74 621.6455 1,241.28 1,241.67 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% LEGGEVDLKGPK 95.00% 2.33 0.242 1.82 621.979 1,241.94 1,241.67 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISMPDVDLNLK 95.00% 2.34 0.366 0 622.3362 1,242.66 1,244.66 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GEGPEVDVNLPK 95.00% 3.51 0.358 2.7 627.3188 1,252.62 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GEGPEVDVNLPK 95.00% 3.12 0.298 3.44 627.3218 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISMPDIDLNLK 95.00% 2.41 0.112 1.59 629.8388 1,257.66 1,258.67 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISMPDIDLNLK 95.00% 2.41 0.112 1.59 629.8388 1,257.66 1,258.67 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISMPDIDLNLK 95.00% 2.72 0.121 1.17 629.8396 1,257.66 1,258.67 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISMPDIDLNLK 95.00% 2.72 0.121 1.17 629.8396 1,257.66 1,258.67 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AEGPEVDVNLPK 95.00% 2.96 0.454 2.85 634.3283 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AEGPEVDVNLPK 95.00% 3.13 0.446 4.15 634.3291 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AEGPEVDVNLPK 95.00% 3.88 0.421 3.47 634.3303 1,266.64 1,267.65 2 CO5A1_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISMPEIDLNLK 95.00% 2.05 0.274 0 636.8456 1,271.68 1,272.69 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GEGPEFDVNLSK 95.00% 3.19 0.453 1.8 646.8096 1,291.60 1,291.62 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISMPGFKGEGPEVDVNLPK 94.80% 1.9 0.248 0 672.3483 2,014.02 2,014.03 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISMPGFKGEGPEVDVNLPK 95.00% 2.22 0.451 1.74 672.3489 2,014.02 2,014.03 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDINAPDVDVQGPDWHLK 95.00% 4.14 0.541 1.37 673.6707 2,017.99 2,018.00 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDINAPDVDVQGPDWHLK 95.00% 3.58 0.495 0 673.6713 2,017.99 2,018.00 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDAPDVDVHGPDWHLK 95.00% 2.83 0.389 2.03 676.9983 2,027.97 2,027.98 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDAPDVDVHGPDWHLK 95.00% 3.05 0.436 3.32 677.0006 2,027.98 2,027.98 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% FSMPGFKAEGPEVDVNLPK 95.00% 2.79 0.345 0 688.3478 2,062.02 2,062.03 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VEGDLKGPEVDIK 95.00% 3.25 0.109 1.14 700.3785 1,398.74 1,398.75 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VEGDLKGPEVDIK 95.00% 3.25 0.109 1.14 700.3785 1,398.74 1,398.75 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VESEIKVPDVELK 95.00% 3.27 0.43 0 742.9129 1,483.81 1,484.82 2 PLCD1_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISMPDIDLNLKGPK 95.00% 2.7 0.0967 2.42 771.4261 1,540.84 1,540.84 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ISMPDLDLNLKGPK 95.00% 2.7 0.0967 2.42 771.4261 1,540.84 1,540.84 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GGVQVPAVDISSSLGGR 95.00% 4.02 0.688 6.49 799.9281 1,597.84 1,598.85 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GGVQVPAVDISSSLGGR 95.00% 3.96 0.661 7.57 799.9284 1,597.84 1,598.85 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GGVQVPAVDISSSLGGR 95.00% 3.81 0.674 4.72 799.9292 1,597.84 1,598.85 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GGVQVPAVDISSSLGGR 95.00% 4.53 0.668 6.72 800.4308 1,598.85 1,598.85 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VNVEAPDVNLEGLGGK 95.00% 3.86 0.39 2.55 806.4218 1,610.83 1,610.84 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VGVEVPDVNIEGPEGK 95.00% 2.64 0.423 2.51 819.422 1,636.83 1,637.84 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VGVEVPDVNIEGPEGK 95.00% 3.07 0.535 2.8 819.4239 1,636.83 1,637.84 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VGVEVPDVNIEGPEGK 95.00% 3.67 0.601 3.22 819.4244 1,636.83 1,637.84 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VGVEVPDVNIEGPEGK 95.00% 3.66 0.633 4.38 819.4248 1,636.83 1,637.84 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VGVEVPDVNIEGPEGK 95.00% 3.32 0.54 4.07 819.4251 1,636.83 1,637.84 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% AGAISASGPELQGAGHSK 95.00% 3.9 0.573 2.25 819.9174 1,637.82 1,637.82 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDAPDVSIEGPDAK 95.00% 2.39 0.341 1.27 820.9031 1,639.79 1,640.80 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDAPDVSIEGPDAK 95.00% 2.88 0.413 2.38 820.9038 1,639.79 1,640.80 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDTNAPDLSLEGPEGK 95.00% 3.35 0.448 3.03 821.4008 1,640.79 1,641.80 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDTNAPDLSLEGPEGK 95.00% 3.42 0.409 3.05 821.4015 1,640.79 1,641.80 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDTNAPDLSLEGPEGK 95.00% 4.08 0.478 2.92 821.9028 1,641.79 1,641.80 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIEAPDVSLEGPEGK 95.00% 4.05 0.528 2.96 827.9113 1,653.81 1,654.82 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIEAPDVSLEGPEGK 95.00% 2.65 0.411 0 827.9142 1,653.81 1,654.82 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIEAPDVSLEGPEGK 95.00% 4.29 0.563 3.21 828.4126 1,654.81 1,654.82 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIEAPDVSLEGPEGK 95.00% 3.73 0.558 2.55 828.4132 1,654.81 1,654.82 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIEAPDVSLEGPEGK 95.00% 3.97 0.555 2.57 828.4153 1,654.81 1,654.82 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VGIDTPDIDIHGPEGK 95.00% 3.1 0.413 1.92 831.9211 1,661.83 1,662.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIEGPDVNIEGPEGK 95.00% 4.2 0.522 5.15 834.4079 1,666.80 1,667.81 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIEGPDVNIEGPEGK 95.00% 4.51 0.57 4.11 834.4087 1,666.80 1,667.81 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIEGPDVNIEGPEGK 95.00% 4.38 0.538 3.54 834.4088 1,666.80 1,667.81 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIEGPDVNIEGPEGK 95.00% 4.08 0.561 4.89 834.4104 1,666.81 1,667.81 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIEGPDVNIEGPEGK 95.00% 3.35 0.256 0 834.9091 1,667.80 1,667.81 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVEVPDVSLEGPEGK 95.00% 4.69 0.49 4.89 834.9182 1,667.82 1,668.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVEVPDVSLEGPEGK 95.00% 4.05 0.44 5.14 834.9193 1,667.82 1,668.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVEVPDVSLEGPEGK 95.00% 4.44 0.461 4.02 834.9201 1,667.82 1,668.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVEVPDVSLEGPEGK 95.00% 3.89 0.474 5.15 834.9212 1,667.83 1,668.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVEVPDVSLEGPEGK 95.00% 4.24 0.461 4.15 835.4202 1,668.82 1,668.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVEVPDVSLEGPEGK 95.00% 4.49 0.439 3.59 835.421 1,668.83 1,668.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVDVPDVNIEGPDAK 95.00% 3.23 0.434 2.37 841.4164 1,680.82 1,681.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVDVPDVNIEGPDAK 95.00% 3.69 0.482 3.59 841.4167 1,680.82 1,681.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ADVDVSGPKVDVEGPDVNIEGPEGK 95.00% 2.44 0.268 0 841.4167 2,521.23 2,522.23 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVDVPDVNIEGPDAK 95.00% 3.95 0.449 4.16 841.417 1,680.82 1,681.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVDVPDVNIEGPDAK 95.00% 4.02 0.512 4.62 841.4173 1,680.82 1,681.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVDVPDVNIEGPDAK 95.00% 4.15 0.473 4.62 841.4179 1,680.82 1,681.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVDVPDVNIEGPDAK 95.00% 3.91 0.479 4.12 841.4186 1,680.82 1,681.83 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% ADVDVSGPKVDVEGPDVNIEGPEGK 95.00% 2.71 0.204 0 841.4187 2,521.23 2,522.23 3
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% MDVNVGDIDIEGPEGK 95.00% 4.13 0.528 4.25 844.3966 1,686.78 1,687.79 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% MDVNVGDIDIEGPEGK 95.00% 4.91 0.472 3.35 844.8971 1,687.78 1,687.79 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDVPDVNIEGPEGK 95.00% 3.02 0 3.7 848.4241 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDVPDVNIEGPDAK 95.00% 3.03 0.000415 3.7 848.4241 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDVPDVNIEGPDAK 95.00% 3.56 0 2.57 848.4247 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDVPDVNIEGPEGK 95.00% 3.63 0.0182 2.57 848.4247 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDVPDVNIEGPDAK 95.00% 3.34 0 3.48 848.4254 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDVPDVNIEGPDAK 95.00% 3.9 0.00816 3.39 848.4265 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDVPDVNIEGPEGK 95.00% 3.9 0 2.77 848.9267 1,695.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDVEcPDVNIEGPEGK 95.00% 3.78 0.545 2.52 c5: Carbamidomethyl (+57.02) 878.9106 1,755.81 1,756.81 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% DDGVFVQEVTQNSPAAR 95.00% 4.35 0.546 3.68 916.9458 1,831.88 1,832.88 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% DDGVFVQEVTQNSPAAR 95.00% 4.25 0.527 3.42 917.442 1,832.87 1,832.88 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDAPDVDVHGPDWHLK 95.00% 4.56 0.638 3.85 1,015.00 2,027.98 2,027.98 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% VDIDAPDVDVHGPDWHLK 95.00% 4.08 0.574 4.92 1,015.00 2,027.98 2,027.98 2
 SAMPLE 3 Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 53 59 152 12.00% GPFVEAEVPDVDLEcPDAK 95.00% 5.2 0.604 5.46 c15: Carbamidomethyl (+57.02) 1,043.98 2,085.95 2,086.96 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% GDVDVSLPK 95.00% 2.3 0.355 0 465.2501 928.4846 929.4946 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VESEIKVPDVELK 95.00% 2.52 0.402 0 495.6102 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VESEIKVPDVELK 95.00% 3.17 0.394 1.08 495.6115 1,483.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VESEIKVPDVELK 95.00% 3.21 0.446 0 495.9446 1,484.81 1,484.82 3 PLCD1_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VESEIKVPDVELK 95.00% 3.08 0.353 0 495.9462 1,484.82 1,484.82 3 PLCD1_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% ISIPDVDLDLKGPK 95.00% 2.49 0.211 0 503.9552 1,508.84 1,509.85 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% ISIPDVDLDLKGPK 95.00% 2.65 0.338 0 504.2888 1,509.84 1,509.85 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% MSLPDVDLDLKGPK 95.00% 2.47 0.183 0 509.9398 1,526.80 1,527.81 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% MSLPDVDLDLKGPK 95.00% 2.08 0.244 0 509.9413 1,526.80 1,527.81 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% MPTFSTPGAK 95.00% 1.68 0.365 0 518.7602 1,035.50 1,036.51 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% ISmPDIDLNLKGPK 95.00% 2.48 0.215 0 m3: Oxidation (+15.99) 519.9506 1,556.83 1,556.84 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% ISmPDIDLNLKGPK 95.00% 2.48 0.215 0 m3: Oxidation (+15.99) 519.9506 1,556.83 1,556.84 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VPDVDIKGPK 95.00% 2.32 0.502 0 534.3082 1,066.60 1,067.61 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VPDVDIKGPK 95.00% 3.24 0.408 2.1 534.3083 1,066.60 1,067.61 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VPDVDIKGPK 95.00% 2.67 0.437 1.44 534.3106 1,066.61 1,067.61 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% AVEVQGPSLESGDHGK 95.00% 2.06 0.313 0 537.5992 1,609.77 1,609.78 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% AVEVQGPSLESGDHGK 95.00% 2.45 0.29 0 537.5994 1,609.77 1,609.78 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% AGAISASGPELQGAGHSK 95.00% 2.1 0.279 1.48 546.6122 1,636.81 1,637.82 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% AGAISASGPELQGAGHSK 95.00% 2.01 0.284 1.05 546.6125 1,636.81 1,637.82 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% AGAISASGPELQGAGHSK 95.00% 1.93 0.282 0 546.6132 1,636.82 1,637.82 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% AGAISASGPELQGAGHSK 95.00% 2.73 0.403 0 546.9465 1,637.82 1,637.82 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% AGAISASGPELQGAGHSK 95.00% 2.12 0.27 1.11 546.9474 1,637.82 1,637.82 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VEGDLKGPEVDIKGPK 95.00% 3.58 0.465 1.57 560.9764 1,679.91 1,680.92 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VEGDLKGPEVDIKGPK 95.00% 3.58 0.465 1.57 560.9764 1,679.91 1,680.92 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VEGDLKGPEVDIKGPK 95.00% 3.74 0.503 1.57 560.9768 1,679.91 1,680.92 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VEGDLKGPEVDIKGPK 95.00% 3.74 0.503 1.57 560.9768 1,679.91 1,680.92 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VEGDLKGPEVDIKGPK 95.00% 4.07 0.414 1.66 561.3109 1,680.91 1,680.92 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VEGDLKGPEVDIKGPK 95.00% 4.07 0.414 1.66 561.3109 1,680.91 1,680.92 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VEGDLKGPEVDIKGPK 95.00% 3.65 0.409 1 561.3115 1,680.91 1,680.92 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VEGDLKGPEVDIKGPK 95.00% 3.65 0.409 1 561.3115 1,680.91 1,680.92 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% IDVDAPDIDIHGPDAK 95.00% 3.04 0.428 1.21 564.2806 1,689.82 1,690.83 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% IDVDAPDIDIHGPDAK 95.00% 3.03 0.426 2.82 564.2812 1,689.82 1,690.83 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% LEGDLKGPEVDIKGPK 95.00% 4.04 0 2.48 565.9821 1,694.92 1,694.93 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% APSLDIKGPEVDVSGPK 95.00% 3.58 0.453 0 570.3064 1,707.90 1,708.91 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% APSLDIKGPEVDVSGPK 95.00% 3.49 0.387 0 570.3088 1,707.90 1,708.91 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% APSLDIKGPEVDVSGPK 95.00% 3.06 0.377 1.38 570.6417 1,708.90 1,708.91 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VKGDVDVSVPK 95.00% 1.68 0.297 1.35 571.8241 1,141.63 1,142.64 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VKGDVDVSLPK 95.00% 3.45 0.456 1.82 578.8308 1,155.65 1,156.66 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VKGDVDVSLPK 95.00% 3.3 0.458 2.27 578.832 1,155.65 1,156.66 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VTAYTVDVTGR 95.00% 2.41 0.283 0 591.3125 1,180.61 1,181.62 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% ISMPDVGLNLK 95.00% 2.32 0.215 1.82 593.828 1,185.64 1,186.65 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVNAPDVQAPDWHLK 95.00% 3.67 0.504 0 601.9711 1,802.89 1,803.90 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVNAPDVQAPDWHLK 95.00% 2.94 0.317 0 601.9714 1,802.89 1,803.90 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVNAPDVQAPDWHLK 95.00% 3.89 0.402 2.21 601.9716 1,802.89 1,803.90 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVNAPDVQAPDWHLK 95.00% 3.36 0.368 1.15 602.3064 1,803.90 1,803.90 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVNAPDVQAPDWHLK 95.00% 3.09 0.25 1.44 602.3076 1,803.90 1,803.90 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% LKSEDGVEGDLGETQSR 95.00% 2.73 0.301 0 607.6268 1,819.86 1,819.87 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% LKGPQITGPSLEGDLGLK 95.00% 4.32 0.584 2.52 608.3461 1,822.01 1,823.03 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% LKGPQITGPSLEGDLGLK 95.00% 4.44 0.625 2.29 608.3477 1,822.02 1,823.03 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% GEGPDVDVNLPK 95.00% 2.48 0.303 1.82 620.3136 1,238.61 1,239.62 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% GEGPDVDVNLPK 95.00% 2.51 0.28 2 620.3138 1,238.61 1,239.62 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% GEGPDVDVNLPK 95.00% 2.54 0.323 1.82 620.3153 1,238.61 1,239.62 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% LPTGQISGPEIK 95.00% 2.77 0.374 0 620.3469 1,238.68 1,239.70 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% LPTGQISGPEIK 95.00% 2.62 0.391 0 620.3483 1,238.68 1,239.70 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% LPTGQISGPEIK 95.00% 2.97 0.452 0 620.3487 1,238.68 1,239.70 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% LPTGQISGPEIK 95.00% 2.77 0.394 0 620.3489 1,238.68 1,239.70 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% LPTGQISGPEIK 95.00% 3.27 0.468 1.32 620.3496 1,238.68 1,239.70 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% LPTGQISGPEIK 95.00% 3.07 0.428 0 620.3512 1,238.69 1,239.70 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% LPTGQISGPEIK 95.00% 2.85 0.384 0 620.3513 1,238.69 1,239.70 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% LPTGQISGPEIK 95.00% 2.47 0.307 0 620.3515 1,238.69 1,239.70 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% GEGPDVDVNLPK 95.00% 2.54 0.268 2.36 620.8161 1,239.62 1,239.62 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% GEGPEVDVNLPK 95.00% 1.84 0.204 1.2 627.3224 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% GEGPEVDVNLPK 95.00% 2.14 0.0832 3.21 627.3248 1,252.63 1,253.64 2 IQGA1_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,VINC_HUMAN,TITIN_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% ISMPDIDLNLK 95.00% 2.41 0.14 1.72 629.8391 1,257.66 1,258.67 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% ISMPDIDLNLK 95.00% 2.41 0.14 1.72 629.8391 1,257.66 1,258.67 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% AEGPEVDVNLPK 95.00% 3.26 0.412 2.8 634.3308 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% AEGPEVDVNLPK 95.00% 2.79 0.433 3.43 634.3311 1,266.65 1,267.65 2 CO5A1_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDINAPDVGVQGPDWHLK 95.00% 4.41 0.395 2.85 654.3341 1,959.98 1,959.99 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDINAPDVGVQGPDWHLK 95.00% 3.3 0.452 2.32 654.3356 1,959.98 1,959.99 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% ISMPGFKGEGPEVDVNLPK 95.00% 2.57 0.425 0 672.3485 2,014.02 2,014.03 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDINAPDVDVQGPDWHLK 95.00% 3.55 0.55 0 673.3375 2,016.99 2,018.00 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDINAPDVDVQGPDWHLK 95.00% 2.27 0.271 0 673.6705 2,017.99 2,018.00 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDINAPDVDVQGPDWHLK 95.00% 4.13 0.597 1.07 673.6716 2,017.99 2,018.00 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDAPDVDVHGPDWHLK 95.00% 2.73 0.358 1.12 676.9994 2,027.97 2,027.98 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDAPDVDVHGPDWHLK 95.00% 3.03 0.3 1.48 676.9996 2,027.98 2,027.98 3
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% GPQVSSALNLDTSK 95.00% 0 0 3.49 709.868 1,417.72 1,416.73 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% GGVQVPAVDISSSLGGR 95.00% 2.25 0.207 1.44 799.9315 1,597.85 1,598.85 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% GGVQVPAVDISSSLGGR 95.00% 4.19 0.643 6.35 800.427 1,598.84 1,598.85 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% GGVQVPAVDISSSLGGR 95.00% 4.51 0.632 6.35 800.4302 1,598.84 1,598.85 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VNVEAPDVNLEGLGGK 95.00% 3.57 0.377 3.17 805.922 1,609.83 1,610.84 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VNVEAPDVNLEGLGGK 95.00% 3.6 0.392 3.77 806.4241 1,610.83 1,610.84 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VGVEVPDVNIEGPEGK 95.00% 2.54 0.572 2.8 819.4218 1,636.83 1,637.84 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VGVEVPDVNIEGPEGK 95.00% 3.3 0.569 1.8 819.424 1,636.83 1,637.84 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VGVEVPDVNIEGPEGK 95.00% 3.17 0.57 2.55 819.4251 1,636.83 1,637.84 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% AGAISASGPELQGAGHSK 95.00% 4.17 0.587 2.15 819.9166 1,637.82 1,637.82 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VGVEVPDVNIEGPEGK 95.00% 3.72 0.601 4.38 819.9239 1,637.83 1,637.84 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VGVEVPDVNIEGPEGK 95.00% 3.27 0.558 3.34 819.9244 1,637.83 1,637.84 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VGVEVPDVNIEGPEGK 95.00% 3.63 0.475 2.09 819.9245 1,637.83 1,637.84 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDTNAPDLSLEGPEGK 95.00% 1.91 0.371 0 821.3991 1,640.78 1,641.80 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDAPDVSIEGPDAK 95.00% 2.38 0.37 2.89 821.4074 1,640.80 1,640.80 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDTNAPDLSLEGPEGK 95.00% 3.58 0.411 2.11 821.9032 1,641.79 1,641.80 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIEAPDVSLEGPEGK 95.00% 3.37 0.491 1.6 827.909 1,653.80 1,654.82 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIEAPDVSLEGPEGK 95.00% 3.57 0.392 2.01 827.913 1,653.81 1,654.82 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIEAPDVSLEGPEGK 95.00% 3.41 0.429 2.82 827.9131 1,653.81 1,654.82 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIEGPDVNIEGPEGK 95.00% 4.26 0.564 3.62 834.408 1,666.80 1,667.81 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIEGPDVNIEGPEGK 95.00% 4.39 0.523 4.14 834.4089 1,666.80 1,667.81 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIEGPDVNIEGPEGK 95.00% 4.11 0.57 3.85 834.4122 1,666.81 1,667.81 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIEGPDVNIEGPEGK 95.00% 3.62 0.462 1.68 834.9107 1,667.81 1,667.81 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIEGPDVNIEGPEGK 95.00% 4.59 0.524 4.1 834.9117 1,667.81 1,667.81 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVEVPDVSLEGPEGK 95.00% 4 0.498 4.92 834.9176 1,667.82 1,668.83 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVEVPDVSLEGPEGK 95.00% 4.45 0.523 4.08 834.919 1,667.82 1,668.83 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVEVPDVSLEGPEGK 95.00% 4.22 0.499 4.96 834.9194 1,667.82 1,668.83 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVEVPDVSLEGPEGK 95.00% 4.38 0.391 4.37 835.419 1,668.82 1,668.83 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVEVPDVSLEGPEGK 95.00% 4.04 0.46 5.02 835.4215 1,668.83 1,668.83 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVEVPDVSLEGPEGK 95.00% 4.39 0.4 4.34 835.4215 1,668.83 1,668.83 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVDVPDVNIEGPDAK 95.00% 3.56 0.484 3.7 841.4173 1,680.82 1,681.83 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVDVPDVNIEGPDAK 95.00% 3.9 0.483 4 841.4198 1,680.82 1,681.83 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVDVPDVNIEGPDAK 95.00% 4.2 0.477 2.46 841.9196 1,681.82 1,681.83 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDVDVPDVNIEGPDAK 95.00% 3.9 0.459 3.74 841.921 1,681.83 1,681.83 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% MDVNVGDIDIEGPEGK 95.00% 4.34 0.539 4.26 844.3961 1,686.78 1,687.79 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDVPDVNIEGPDAK 95.00% 2.56 0 3.64 848.4218 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDVPDVNIEGPEGK 95.00% 2.83 0.0944 3.64 848.4218 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDVPDVNIEGPDAK 95.00% 3.22 0 4.31 848.4238 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDVPDVNIEGPEGK 95.00% 3.24 0.00552 4.31 848.4238 1,694.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDVPDVNIEGPDAK 95.00% 3.58 0 2.92 848.4265 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDVPDVNIEGPEGK 95.00% 3.62 0.0118 2.92 848.4265 1,694.84 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDVPDVNIEGPEGK 95.00% 3.78 0 3.09 848.9221 1,695.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDVPDVNIEGPDAK 95.00% 3.82 0.0097 3.09 848.9221 1,695.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDVPDVNIEGPEGK 95.00% 3.7 0 3.31 848.9242 1,695.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIDVPDVNIEGPDAK 95.00% 3.79 0.0234 3.31 848.9242 1,695.83 1,695.84 2 CO6A3_HUMAN,RL11_HUMAN
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% VDIETPNLEGTLTGPR 95.00% 3.72 0.387 2.92 856.9425 1,711.87 1,711.89 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% ASLGSLEGEAEAEASSPK 95.00% 0 0 4.89 868.4218 1,734.83 1,732.82 2
 SAMPLE 3R Neuroblast differentiation-associated protein AHNAK  AHNAK  AHNK_HUMAN 629,086.40 100.00% 48 49 123 11.00% GPFVEAEVPDVDLEcPDAK 95.00% 5.64 0.586 4.39 c15: Carbamidomethyl (+57.02) 1,044.48 2,086.95 2,086.96 2
 SAMPLE 2 Neutrophil defensin 1  DEFA1  DEF1_HUMAN,DEF3_HUMAN 10,183.00 99.80% 2 2 4 19.10% IPAcIAGER 95.00% 2.04 0.156 1.51 c4: Carbamidomethyl (+57.02) 493.7579 985.5001 986.5095 2
 SAMPLE 2 Neutrophil defensin 1  DEFA1  DEF1_HUMAN,DEF3_HUMAN 10,183.00 99.80% 2 2 4 19.10% IPAcIAGER 95.00% 2.01 0.222 1.44 c4: Carbamidomethyl (+57.02) 493.7583 985.501 986.5095 2
 SAMPLE 2 Neutrophil defensin 1  DEFA1  DEF1_HUMAN,DEF3_HUMAN 10,183.00 99.80% 2 2 4 19.10% YGTcIYQGR 95.00% 2.71 0.38 2.42 c4: Carbamidomethyl (+57.02) 559.2584 1,116.50 1,117.51 2
 SAMPLE 2 Neutrophil defensin 1  DEFA1  DEF1_HUMAN,DEF3_HUMAN 10,183.00 99.80% 2 2 4 19.10% YGTcIYQGR 95.00% 2.84 0.483 1.59 c4: Carbamidomethyl (+57.02) 559.2587 1,116.50 1,117.51 2
 SAMPLE 1 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 4 4 9 7.56% LTFEELER 95.00% 2.5 0.279 0 518.7677 1,035.52 1,036.53 2
 SAMPLE 1 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 4 4 9 7.56% LTFEELER 95.00% 2.48 0.248 0 518.7683 1,035.52 1,036.53 2
 SAMPLE 1 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 4 4 9 7.56% LTFEELER 95.00% 2.31 0.32 0 518.7684 1,035.52 1,036.53 2
 SAMPLE 1 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 4 4 9 7.56% LTFEELER 95.00% 2.59 0.283 0 518.7685 1,035.52 1,036.53 2
 SAMPLE 1 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 4 4 9 7.56% TISQEFLTPGK 95.00% 2.5 0.46 2.64 610.8285 1,219.64 1,220.65 2
 SAMPLE 1 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 4 4 9 7.56% TISQEFLTPGK 95.00% 2.2 0.421 2.42 610.8291 1,219.64 1,220.65 2
 SAMPLE 1 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 4 4 9 7.56% EAENFHEEDDVDVRPAR 95.00% 3.41 0.436 1.35 676.9734 2,027.90 2,027.91 3
 SAMPLE 1 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 4 4 9 7.56% GSAASTcILTIESKN 95.00% 3.58 0.455 2.55 c7: Carbamidomethyl (+57.02) 776.3856 1,550.76 1,551.77 2
 SAMPLE 1 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 4 4 9 7.56% GSAASTcILTIESKN 95.00% 4.23 0.453 2.54 c7: Carbamidomethyl (+57.02) 776.3913 1,550.77 1,551.77 2
 SAMPLE 1R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 9.04% LTFEELER 95.00% 2.5 0.297 0 518.7678 1,035.52 1,036.53 2
 SAMPLE 1R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 9.04% LTFEELER 95.00% 2.49 0.306 0 518.7685 1,035.52 1,036.53 2
 SAMPLE 1R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 9.04% TISQEFLTPGK 95.00% 2.21 0.299 2.01 610.828 1,219.64 1,220.65 2
 SAMPLE 1R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 9.04% TISQEFLTPGK 95.00% 1.77 0.323 0 610.8312 1,219.65 1,220.65 2
 SAMPLE 1R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 9.04% LEINFEELLK 95.00% 2.8 0.264 0 624.3466 1,246.68 1,247.69 2
 SAMPLE 1R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 9.04% LEINFEELLK 95.00% 2.51 0.218 0 624.3501 1,246.68 1,247.69 2
 SAMPLE 1R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 9.04% EAENFHEEDDVDVRPAR 95.00% 3.4 0.427 0 676.974 2,027.90 2,027.91 3
 SAMPLE 1R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 9.04% GSAASTcILTIESKN 95.00% 3.53 0.474 2.15 c7: Carbamidomethyl (+57.02) 776.388 1,550.76 1,551.77 2
 SAMPLE 2 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 2 2 3 1.48% LTFEELER 95.00% 2.31 0.293 0 518.7685 1,035.52 1,036.53 2
 SAMPLE 2 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 2 2 3 1.48% LKLTFEELER 95.00% 2.47 0.377 1.44 639.3567 1,276.70 1,277.71 2
 SAMPLE 2 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 2 2 3 1.48% LKLTFEELER 95.00% 2.19 0.381 1.96 639.3573 1,276.70 1,277.71 2
 SAMPLE 3 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 8.15% LTFEELER 95.00% 2.38 0.288 0 518.7683 1,035.52 1,036.53 2
 SAMPLE 3 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 8.15% LTFEELER 95.00% 2.45 0.286 0 518.7686 1,035.52 1,036.53 2
 SAMPLE 3 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 8.15% LSFEEMER 95.00% 1.79 0.324 0 520.7381 1,039.46 1,040.47 2
 SAMPLE 3 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 8.15% LSFEEMER 95.00% 1.94 0.319 0 520.7385 1,039.46 1,040.47 2
 SAMPLE 3 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 8.15% TISQEFLTPGK 95.00% 2.22 0.386 2 610.829 1,219.64 1,220.65 2
 SAMPLE 3 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 8.15% NMVVDDDSPEMYK 95.00% 2.65 0.417 0 771.8249 1,541.63 1,542.65 2
 SAMPLE 3 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 8.15% NMVVDDDSPEMYK 95.00% 3.19 0.477 1.28 771.8271 1,541.64 1,542.65 2
 SAMPLE 3 Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 5 5 8 8.15% GSAASTcILTIESKN 95.00% 3.77 0.509 2.47 c7: Carbamidomethyl (+57.02) 776.8888 1,551.76 1,551.77 2
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% AEILLSSSKPVPK 95.00% 2.22 0.257 0 456.9426 1,367.80 1,368.81 3
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% AEILLSSSKPVPK 95.00% 2.54 0.279 0 456.944 1,367.81 1,368.81 3
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% LTFEELER 95.00% 2.09 0.255 0 518.7678 1,035.52 1,036.53 2
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% LTFEELER 95.00% 2.19 0.282 0 518.7681 1,035.52 1,036.53 2
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% LTFEELER 95.00% 2.12 0.256 0 518.7685 1,035.52 1,036.53 2
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% LTFEELER 95.00% 2.26 0.282 0 518.7688 1,035.52 1,036.53 2
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% NTSVVDSEPVR 95.00% 2.28 0.34 1.39 602.3111 1,202.61 1,202.60 2
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% TISQEFLTPGK 95.00% 2.13 0.288 0 610.8299 1,219.64 1,220.65 2
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% GSAASTcILTIESK 95.00% 2.5 0.386 0 c7: Carbamidomethyl (+57.02) 719.3272 1,436.64 1,437.73 2
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% GSAASTcILTIESKN 95.00% 3.23 0.474 2.72 c7: Carbamidomethyl (+57.02) 776.3899 1,550.76 1,551.77 2
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% GSAASTcILTIESKN 95.00% 3.85 0.452 3.01 c7: Carbamidomethyl (+57.02) 776.8926 1,551.77 1,551.77 2
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% QMVNEDEENQDTAK 95.00% 2.71 0.398 0 825.851 1,649.69 1,650.69 2
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% QMVNEDEENQDTAK 95.00% 1.81 0.425 0 825.8534 1,649.69 1,650.69 2
 SAMPLE 3R Nexilin  NEXN  NEXN_HUMAN 80,642.40 100.00% 7 7 14 10.70% QMVNEDEENQDTAK 95.00% 2.55 0.35 0 825.8541 1,649.69 1,650.69 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.58 0.306 1.39 451.2515 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.51 0.334 1.32 451.2516 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.62 0.358 2.09 451.2519 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.77 0.354 1.64 451.2523 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 1.95 0.178 1.04 451.2527 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.55 0.404 1.96 451.2531 1,350.74 1,351.73 3 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.31 0.246 1.08 451.2533 1,350.74 1,351.73 3 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.36 0.224 1.3 451.255 1,350.74 1,351.73 3 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EHILGAAGATDPQR 95.00% 2.43 0.249 0 479.2493 1,434.72 1,435.73 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EHILGAAGATDPQR 95.00% 2.37 0.253 0 479.2499 1,434.73 1,435.73 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EHILGAAGATDPQR 95.00% 2.98 0.304 0 479.2503 1,434.73 1,435.73 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% RVLFETDLVNPR 95.00% 3.18 0.288 0 486.9419 1,457.80 1,458.81 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% RVLFETDLVNPR 95.00% 3.43 0.268 1.03 486.942 1,457.80 1,458.81 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% IYTYQWR 95.00% 2.24 0.379 0 515.2614 1,028.51 1,029.52 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% IYTYQWR 95.00% 2.24 0.265 0 515.2622 1,028.51 1,029.52 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% IYTYQWR 95.00% 2.71 0.38 0 515.2628 1,028.51 1,029.52 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NLYFTDWK 95.00% 2.38 0.208 0 543.7674 1,085.52 1,086.53 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NLYFTDWK 95.00% 2.21 0.219 0 543.768 1,085.52 1,086.53 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 3.55 0.421 2.21 555.2849 1,662.83 1,663.84 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 3.62 0.475 1.89 555.2851 1,662.83 1,663.84 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 3.88 0.45 2.92 555.2855 1,662.83 1,663.84 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 4.01 0.521 5.96 555.2856 1,662.83 1,663.84 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 3.15 0.394 1.48 555.2856 1,662.83 1,663.84 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 3.84 0.482 3.52 555.2861 1,662.83 1,663.84 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 3.26 0.448 3.92 555.2862 1,662.84 1,663.84 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 3.81 0.51 4.2 555.2864 1,662.84 1,663.84 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 3.92 0.461 4.1 555.2868 1,662.84 1,663.84 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 4.06 0.501 2.44 555.2869 1,662.84 1,663.84 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 4.23 0.498 2.62 555.6196 1,663.84 1,663.84 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 3.32 0.481 4.44 555.621 1,663.84 1,663.84 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QAEVTFVGHPGNLVIK 95.00% 3.15 0.454 0 570.3191 1,707.93 1,708.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QAEVTFVGHPGNLVIK 95.00% 2.85 0.358 0 570.3192 1,707.93 1,708.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QAEVTFVGHPGNLVIK 95.00% 2.7 0.385 0 570.3196 1,707.94 1,708.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QAEVTFVGHPGNLVIK 95.00% 2.29 0.411 0 570.32 1,707.94 1,708.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QAEVTFVGHPGNLVIK 95.00% 2.73 0.267 0 570.653 1,708.94 1,708.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QAEVTFVGHPGNLVIK 95.00% 3.1 0.353 1.12 570.6536 1,708.94 1,708.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QAEVTFVGHPGNLVIK 95.00% 2.68 0.207 0 570.6539 1,708.94 1,708.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QAEVTFVGHPGNLVIK 95.00% 3.23 0.421 0 570.655 1,708.94 1,708.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EYTVTEPERDGASPSR 95.00% 1.79 0.384 1.07 598.6161 1,792.83 1,793.83 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EYTVTEPERDGASPSR 95.00% 2.03 0.346 0 598.6167 1,792.83 1,793.83 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EYTVTEPERDGASPSR 95.00% 2.03 0.414 0 598.951 1,793.83 1,793.83 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EYTVTEPERDGASPSR 95.00% 2.51 0.332 0 598.9511 1,793.83 1,793.83 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EYTVTEPERDGASPSR 95.00% 2.13 0.387 0 598.9511 1,793.83 1,793.83 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EYTVTEPERDGASPSR 95.00% 2.41 0.274 0 598.9515 1,793.83 1,793.83 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% KALEGLQYPFAVTSYGK 95.00% 2.75 0.276 0 625.0041 1,871.99 1,871.99 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NIFWTDSNLDRIEVAK 95.00% 2.28 0.403 0 641.0009 1,919.98 1,920.98 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NIFWTDSNLDRIEVAK 95.00% 2.89 0.513 1.47 641.3345 1,920.98 1,920.98 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NIFWTDSNLDRIEVAK 95.00% 2.65 0.496 1.41 641.3348 1,920.98 1,920.98 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NIFWTDSNLDRIEVAK 95.00% 2.69 0.425 0 641.3351 1,920.98 1,920.98 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NGFSITGGEFTR 95.00% 2.92 0.358 2.48 643.3134 1,284.61 1,285.62 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NGFSITGGEFTR 95.00% 2.72 0.245 3.62 643.3138 1,284.61 1,285.62 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NGFSITGGEFTR 95.00% 3.49 0.462 2.28 643.3138 1,284.61 1,285.62 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NGFSITGGEFTR 95.00% 1.93 0.295 2.92 643.8034 1,285.59 1,285.62 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 2.75 0 1.43 651.8551 1,301.69 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 2.68 0.496 2.77 651.858 1,301.70 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 3.51 0.492 2.16 651.8581 1,301.70 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 3.18 0.508 2.82 651.8582 1,301.70 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 3.88 0.474 2.54 651.8583 1,301.70 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 3.61 0.458 2.74 651.8584 1,301.70 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 2.48 0.496 2.01 651.8585 1,301.70 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 3.26 0.438 3.13 651.8585 1,301.70 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 3.67 0.45 2.92 651.8586 1,301.70 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 3.84 0.514 2.85 651.8586 1,301.70 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 3.34 0.415 2.41 651.8587 1,301.70 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 3.36 0.454 2.17 651.8595 1,301.70 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VLFETDLVNPR 95.00% 3.23 0.462 1.89 652.3605 1,302.71 1,302.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VIIGLAFDcVDK 95.00% 4.28 0.657 3.51 c9: Carbamidomethyl (+57.02) 675.3615 1,348.71 1,349.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VIIGLAFDcVDK 95.00% 4.27 0.671 4.92 c9: Carbamidomethyl (+57.02) 675.362 1,348.71 1,349.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VIIGLAFDcVDK 95.00% 4.16 0.684 3.27 c9: Carbamidomethyl (+57.02) 675.3622 1,348.71 1,349.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VIIGLAFDcVDK 95.00% 4.29 0.653 3.32 c9: Carbamidomethyl (+57.02) 675.3626 1,348.71 1,349.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VIIGLAFDcVDK 95.00% 4.21 0.681 4.34 c9: Carbamidomethyl (+57.02) 675.3627 1,348.71 1,349.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% VIIGLAFDcVDK 95.00% 3.96 0.651 5.8 c9: Carbamidomethyl (+57.02) 675.3628 1,348.71 1,349.71 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 3.27 0.511 1.34 676.3706 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 3.27 0.491 2.21 676.3708 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.51 0.448 1.74 676.3714 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.99 0.496 1.72 676.3714 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.5 0.422 2.57 676.3716 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 3.06 0.497 1.96 676.3717 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.01 0.271 1.59 676.3722 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.57 0.47 1.64 676.3725 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ASLHGGEPTTIIR 95.00% 2.35 0.472 1.77 676.3725 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% MNSVVALDLAISK 95.00% 3.03 0.431 3.39 680.878 1,359.74 1,360.75 2 FHL1_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% MNSVVALDLAISK 95.00% 4.07 0.468 5.66 680.881 1,359.75 1,360.75 2 FHL1_HUMAN
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NIFWTDSNLDR 95.00% 2.52 0.339 2.28 690.8313 1,379.65 1,380.65 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NIFWTDSNLDR 95.00% 3.25 0.512 2.48 690.8325 1,379.65 1,380.65 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NIFWTDSNLDR 95.00% 2.94 0.439 2.25 690.8336 1,379.65 1,380.65 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% PINYcETGLHNcDIPQR 95.00% 3.26 0.45 0 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 696.3217 2,085.94 2,086.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% PINYcETGLHNcDIPQR 95.00% 3.02 0.282 0 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 696.3223 2,085.94 2,086.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% PINYcETGLHNcDIPQR 95.00% 4.01 0.48 0 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 696.6542 2,086.94 2,086.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% PINYcETGLHNcDIPQR 95.00% 3.27 0.482 0 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 696.6545 2,086.94 2,086.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% PINYcETGLHNcDIPQR 95.00% 3.23 0.257 0 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 696.6553 2,086.94 2,086.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% PINYcETGLHNcDIPQR 95.00% 3.33 0.407 0 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 696.6557 2,086.94 2,086.94 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% FSGIDEHGHLTIDTELEGR 95.00% 5.43 0.551 1.8 709.6793 2,126.01 2,126.02 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% FSGIDEHGHLTIDTELEGR 95.00% 4.79 0.565 2.09 709.6798 2,126.02 2,126.02 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EHILGAAGATDPQR 95.00% 3.73 0.562 0 718.3699 1,434.72 1,435.73 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% TQFTcEcSIGFR 95.00% 3.66 0.465 3.4 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.331 1,504.65 1,505.65 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% TQFTcEcSIGFR 95.00% 3.12 0.475 2.59 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3322 1,504.65 1,505.65 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% TQFTcEcSIGFR 95.00% 4.07 0.457 3.51 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3324 1,504.65 1,505.65 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% TQFTcEcSIGFR 95.00% 3.72 0.481 4.02 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3326 1,504.65 1,505.65 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% TQFTcEcSIGFR 95.00% 3.93 0.457 3.32 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.333 1,504.65 1,505.65 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% TQFTcEcSIGFR 95.00% 3.58 0.531 3.28 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3332 1,504.65 1,505.65 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% TQFTcEcSIGFR 95.00% 4.09 0.476 2.64 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3332 1,504.65 1,505.65 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% TQFTcEcSIGFR 95.00% 3.75 0.396 3.62 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.8351 1,505.65 1,505.65 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% qDLGSPEGIAVDHLGR 95.00% 0 0 3.48 n-term: Pyro-cmC (-17.03) 823.912 1,645.81 1,646.81 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% qDLGSPEGIAVDHLGR 95.00% 0 0 3.57 n-term: Pyro-cmC (-17.03) 823.9126 1,645.81 1,646.81 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% qDLGSPEGIAVDHLGR 95.00% 0 0 3.8 n-term: Pyro-cmC (-17.03) 823.9138 1,645.81 1,646.81 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% qDLGSPEGIAVDHLGR 95.00% 0 0 4.54 n-term: Pyro-cmC (-17.03) 823.9141 1,645.81 1,646.81 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% qDLGSPEGIAVDHLGR 95.00% 0 0 5.6 n-term: Pyro-cmC (-17.03) 823.9151 1,645.81 1,646.81 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% qDLGSPEGIAVDHLGR 95.00% 0 0 3.52 n-term: Pyro-cmC (-17.03) 823.9155 1,645.82 1,646.81 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 3.3 0.488 2.28 832.4257 1,662.84 1,663.84 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 2.66 0.287 2.72 832.4261 1,662.84 1,663.84 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% QDLGSPEGIAVDHLGR 95.00% 2.93 0.457 2.28 832.4268 1,662.84 1,663.84 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% MVYWTDITEPSIGR 95.00% 4.25 0.612 3.72 834.4098 1,666.80 1,667.81 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% MVYWTDITEPSIGR 95.00% 4.14 0.583 3.77 834.4104 1,666.81 1,667.81 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% MVYWTDITEPSIGR 95.00% 4.12 0.608 3.55 834.4109 1,666.81 1,667.81 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% MVYWTDITEPSIGR 95.00% 3.58 0.435 2.92 834.4138 1,666.81 1,667.81 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% MVYWTDITEPSIGR 95.00% 4.38 0.565 4.47 834.9123 1,667.81 1,667.81 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% qAEVTFVGHPGNLVIK 95.00% 0 0 5.48 n-term: Pyro-cmC (-17.03) 846.4619 1,690.91 1,691.91 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ALEGLQYPFAVTSYGK 95.00% 3.92 0.609 5.01 872.4537 1,742.89 1,743.90 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ALEGLQYPFAVTSYGK 95.00% 4.64 0.638 5.77 872.4541 1,742.89 1,743.90 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ALEGLQYPFAVTSYGK 95.00% 4.87 0.594 5 872.9536 1,743.89 1,743.90 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ALEGLQYPFAVTSYGK 95.00% 4.81 0.598 5.3 872.955 1,743.89 1,743.90 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ALEGLQYPFAVTSYGK 95.00% 4.89 0.615 5.43 872.9556 1,743.90 1,743.90 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% ALEGLQYPFAVTSYGK 95.00% 4.2 0.549 4.77 872.956 1,743.90 1,743.90 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% GNLYWTDWNRDNPK 95.00% 3.58 0.477 2.59 890.421 1,778.83 1,778.83 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% GNLYWTDWNRDNPK 95.00% 3.48 0.214 1.44 890.4706 1,778.93 1,778.83 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EYTVTEPERDGASPSR 95.00% 2.59 0.363 0 897.4209 1,792.83 1,793.83 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EYTVTEPERDGASPSR 95.00% 2.78 0.38 0 897.4234 1,792.83 1,793.83 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EYTVTEPERDGASPSR 95.00% 3.28 0.361 0 897.9215 1,793.83 1,793.83 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% KALEGLQYPFAVTSYGK 95.00% 5.36 0.611 9.96 937.0038 1,871.99 1,871.99 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% KALEGLQYPFAVTSYGK 95.00% 5.25 0.675 7.85 937.0041 1,871.99 1,871.99 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% KALEGLQYPFAVTSYGK 95.00% 5.37 0.628 4.72 937.0049 1,871.99 1,871.99 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NIFWTDSNLDRIEVAK 95.00% 4.79 0.525 4.04 960.9968 1,919.98 1,920.98 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% NIFWTDSNLDRIEVAK 95.00% 4.62 0.523 3.6 961.4966 1,920.98 1,920.98 2
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EGSPDALQNPcYIGTHGcDTNAAcRPGPR 95.00% 3.9 0.519 2.66 c11: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02), c24: Carbamidomethyl (+57.02) 1,058.13 3,171.38 3,171.38 3
 SAMPLE 4 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 22 29 136 22.20% EGSPDALQNPcYIGTHGcDTNAAcRPGPR 95.00% 3.75 0.508 2.15 c11: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02), c24: Carbamidomethyl (+57.02) 1,058.13 3,171.38 3,171.38 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.36 0.276 1.59 451.2513 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.69 0.3 1.52 451.2515 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.24 0.292 1.62 451.2522 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.44 0.271 1.54 451.2524 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.18 0.314 1.89 451.2525 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.46 0.284 1.48 451.2527 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.49 0.222 0 451.2535 1,350.74 1,351.73 3 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EHILGAAGATDPQR 95.00% 2.76 0.331 0 479.5836 1,435.73 1,435.73 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% RVLFETDLVNPR 95.00% 2.88 0.34 0 486.9418 1,457.80 1,458.81 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% RVLFETDLVNPR 95.00% 2.48 0.307 0 486.942 1,457.80 1,458.81 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% IYTYQWR 95.00% 2.44 0.339 0 515.2621 1,028.51 1,029.52 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% IYTYQWR 95.00% 2.27 0.367 0 515.2631 1,028.51 1,029.52 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NLYFTDWK 95.00% 2.28 0.216 0 543.7673 1,085.52 1,086.53 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NLYFTDWK 95.00% 2.54 0.298 0 543.7674 1,085.52 1,086.53 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NLYFTDWK 95.00% 2.14 0.225 0 543.7683 1,085.52 1,086.53 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 3.72 0.5 4.25 555.285 1,662.83 1,663.84 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 4.1 0.468 3.82 555.2856 1,662.83 1,663.84 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 3.62 0.449 2.62 555.286 1,662.83 1,663.84 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 3.75 0.505 4.24 555.2861 1,662.83 1,663.84 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 3.45 0.359 2.51 555.2863 1,662.84 1,663.84 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 3.88 0.519 3.51 555.2866 1,662.84 1,663.84 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 4.48 0.505 4.23 555.2869 1,662.84 1,663.84 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 2.94 0.377 2.6 555.287 1,662.84 1,663.84 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 2.19 0.283 0 555.2872 1,662.84 1,663.84 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 3.44 0.371 1.27 555.2872 1,662.84 1,663.84 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 3.84 0.49 2.09 555.6195 1,663.84 1,663.84 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 3.91 0.433 2.44 555.6206 1,663.84 1,663.84 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QAEVTFVGHPGNLVIK 95.00% 2.6 0.36 0 570.3185 1,707.93 1,708.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QAEVTFVGHPGNLVIK 95.00% 2.39 0.349 0 570.3187 1,707.93 1,708.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QAEVTFVGHPGNLVIK 95.00% 2.68 0.31 0 570.3191 1,707.93 1,708.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QAEVTFVGHPGNLVIK 95.00% 2.93 0.318 0 570.3199 1,707.94 1,708.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QAEVTFVGHPGNLVIK 95.00% 2.03 0.25 0 570.3201 1,707.94 1,708.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QAEVTFVGHPGNLVIK 95.00% 2.51 0.206 0 570.6525 1,708.93 1,708.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QAEVTFVGHPGNLVIK 95.00% 3.15 0.436 0 570.6542 1,708.94 1,708.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QAEVTFVGHPGNLVIK 95.00% 3.14 0.499 0 570.6543 1,708.94 1,708.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QAEVTFVGHPGNLVIK 95.00% 2.77 0.246 0 570.6546 1,708.94 1,708.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EYTVTEPERDGASPSR 95.00% 2.11 0.326 0 598.6154 1,792.82 1,793.83 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EYTVTEPERDGASPSR 95.00% 2.54 0.324 0 598.6174 1,792.83 1,793.83 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EYTVTEPERDGASPSR 95.00% 2.23 0.34 0 598.6177 1,792.83 1,793.83 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EYTVTEPERDGASPSR 95.00% 2.59 0.529 0 598.9513 1,793.83 1,793.83 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EYTVTEPERDGASPSR 95.00% 2.22 0.299 0 598.9515 1,793.83 1,793.83 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EYTVTEPERDGASPSR 95.00% 2.58 0.379 0 598.952 1,793.83 1,793.83 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EYTVTEPERDGASPSR 95.00% 2.2 0.267 0 598.9525 1,793.83 1,793.83 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NIFWTDSNLDRIEVAK 95.00% 2.7 0.468 0 641.3345 1,920.98 1,920.98 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NIFWTDSNLDRIEVAK 95.00% 1.87 0.256 0 641.3348 1,920.98 1,920.98 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NIFWTDSNLDRIEVAK 95.00% 2.38 0.416 0.959 641.3349 1,920.98 1,920.98 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NIFWTDSNLDRIEVAK 95.00% 2.15 0.392 0 641.3359 1,920.98 1,920.98 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NGFSITGGEFTR 95.00% 3.14 0.385 2.62 643.3135 1,284.61 1,285.62 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NGFSITGGEFTR 95.00% 2.44 0.344 2.92 643.806 1,285.60 1,285.62 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NGFSITGGEFTR 95.00% 1.89 0.28 2.14 643.8062 1,285.60 1,285.62 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NGFSITGGEFTR 95.00% 2.14 0.193 2.35 643.8064 1,285.60 1,285.62 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VLFETDLVNPR 95.00% 2.46 0 1.48 651.8555 1,301.70 1,302.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VLFETDLVNPR 95.00% 3.64 0.447 2.8 651.8582 1,301.70 1,302.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VLFETDLVNPR 95.00% 2.52 0.525 2.7 651.8583 1,301.70 1,302.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VLFETDLVNPR 95.00% 3.84 0.468 3.02 651.8585 1,301.70 1,302.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VLFETDLVNPR 95.00% 3.18 0.403 3.06 651.8586 1,301.70 1,302.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VLFETDLVNPR 95.00% 2.22 0.422 1.82 651.8586 1,301.70 1,302.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VLFETDLVNPR 95.00% 3.24 0.423 3.12 651.8587 1,301.70 1,302.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VLFETDLVNPR 95.00% 3.27 0.502 2.62 651.8595 1,301.70 1,302.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VIIGLAFDcVDK 95.00% 3.64 0.671 5.34 c9: Carbamidomethyl (+57.02) 675.3616 1,348.71 1,349.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VIIGLAFDcVDK 95.00% 3.94 0.676 4.42 c9: Carbamidomethyl (+57.02) 675.3617 1,348.71 1,349.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VIIGLAFDcVDK 95.00% 3.86 0.63 4.41 c9: Carbamidomethyl (+57.02) 675.3618 1,348.71 1,349.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VIIGLAFDcVDK 95.00% 4.04 0.654 3.28 c9: Carbamidomethyl (+57.02) 675.3618 1,348.71 1,349.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VIIGLAFDcVDK 95.00% 3.84 0.658 4.38 c9: Carbamidomethyl (+57.02) 675.362 1,348.71 1,349.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VIIGLAFDcVDK 95.00% 3.71 0.644 5.1 c9: Carbamidomethyl (+57.02) 675.3623 1,348.71 1,349.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VIIGLAFDcVDK 95.00% 3.24 0.602 3.13 c9: Carbamidomethyl (+57.02) 675.3623 1,348.71 1,349.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VIIGLAFDcVDK 95.00% 4.24 0.676 5.48 c9: Carbamidomethyl (+57.02) 675.3628 1,348.71 1,349.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% VIIGLAFDcVDK 95.00% 2.58 0.527 2.8 c9: Carbamidomethyl (+57.02) 675.3744 1,348.73 1,349.71 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.31 0.447 1.21 676.3697 1,350.72 1,351.73 2 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.51 0.443 2.82 676.3712 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.28 0.423 1.82 676.3714 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.7 0.435 2.51 676.3717 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.98 0.528 3.48 676.3718 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.04 0.334 1.49 676.372 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.35 0.36 1.64 676.3721 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.78 0.462 0 676.3722 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.89 0.516 2.92 676.3724 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ASLHGGEPTTIIR 95.00% 2.7 0.486 3.02 676.373 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% MNSVVALDLAISK 95.00% 3.66 0.495 7.47 680.8808 1,359.75 1,360.75 2 FHL1_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% MNSVVALDLAISK 95.00% 2.74 0.201 2.13 680.881 1,359.75 1,360.75 2 FHL1_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% MNSVVALDLAISK 95.00% 3.87 0.462 4.62 680.8814 1,359.75 1,360.75 2 FHL1_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% MNSVVALDLAISK 95.00% 2.76 0.349 0 680.8817 1,359.75 1,360.75 2 FHL1_HUMAN
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NIFWTDSNLDR 95.00% 1.98 0.274 0 690.8304 1,379.65 1,380.65 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NIFWTDSNLDR 95.00% 2.22 0.353 2.48 690.8319 1,379.65 1,380.65 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% PINYcETGLHNcDIPQR 95.00% 3.61 0.417 0 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 696.6537 2,086.94 2,086.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% PINYcETGLHNcDIPQR 95.00% 2.86 0.441 0 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 696.6558 2,086.94 2,086.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% PINYcETGLHNcDIPQR 95.00% 3.07 0.45 0 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 696.6567 2,086.95 2,086.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% PINYcETGLHNcDIPQR 95.00% 3.35 0.408 0 c5: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 696.6571 2,086.95 2,086.94 3
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EHILGAAGATDPQR 95.00% 3.47 0.583 0 718.3705 1,434.73 1,435.73 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EHILGAAGATDPQR 95.00% 3.43 0.596 0 718.3722 1,434.73 1,435.73 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% RVLFETDLVNPR 95.00% 3.16 0.457 2.66 729.9083 1,457.80 1,458.81 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% RVLFETDLVNPR 95.00% 4.13 0.452 4.72 729.9087 1,457.80 1,458.81 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% RVLFETDLVNPR 95.00% 3.02 0.481 3.36 729.9102 1,457.80 1,458.81 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% RVLFETDLVNPR 95.00% 3.69 0.413 4.25 729.9115 1,457.81 1,458.81 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% TQFTcEcSIGFR 95.00% 3.71 0.536 3.68 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3304 1,504.65 1,505.65 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% TQFTcEcSIGFR 95.00% 3.53 0.482 4.21 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3306 1,504.65 1,505.65 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% TQFTcEcSIGFR 95.00% 3.38 0.469 4.17 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3321 1,504.65 1,505.65 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% TQFTcEcSIGFR 95.00% 3.64 0.537 4.47 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3322 1,504.65 1,505.65 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% TQFTcEcSIGFR 95.00% 3.56 0.516 3.06 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3327 1,504.65 1,505.65 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% TQFTcEcSIGFR 95.00% 3.67 0.546 3.23 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3327 1,504.65 1,505.65 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% TQFTcEcSIGFR 95.00% 3.73 0.49 4 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3335 1,504.65 1,505.65 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% TQFTcEcSIGFR 95.00% 3.24 0.479 3.8 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.334 1,504.65 1,505.65 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% qDLGSPEGIAVDHLGR 95.00% 0 0 4.31 n-term: Pyro-cmC (-17.03) 823.9109 1,645.81 1,646.81 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% qDLGSPEGIAVDHLGR 95.00% 0 0 5.29 n-term: Pyro-cmC (-17.03) 823.9135 1,645.81 1,646.81 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% qDLGSPEGIAVDHLGR 95.00% 0 0 6.04 n-term: Pyro-cmC (-17.03) 824.4134 1,646.81 1,646.81 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 2.39 0.307 0 832.4198 1,662.82 1,663.84 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 2.36 0.439 1.51 832.4239 1,662.83 1,663.84 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 2.46 0.354 0 832.4242 1,662.83 1,663.84 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 2.63 0.322 1.92 832.4271 1,662.84 1,663.84 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% QDLGSPEGIAVDHLGR 95.00% 3.07 0.357 2.01 832.9262 1,663.84 1,663.84 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% MVYWTDITEPSIGR 95.00% 4.56 0.605 4.55 834.4088 1,666.80 1,667.81 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% MVYWTDITEPSIGR 95.00% 4.27 0.535 5.1 834.4107 1,666.81 1,667.81 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% MVYWTDITEPSIGR 95.00% 3.96 0.601 4.68 834.411 1,666.81 1,667.81 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% MVYWTDITEPSIGR 95.00% 4.42 0.588 5.66 834.4112 1,666.81 1,667.81 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% qAEVTFVGHPGNLVIK 95.00% 0 0 6.23 n-term: Pyro-cmC (-17.03) 846.4607 1,690.91 1,691.91 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% qAEVTFVGHPGNLVIK 95.00% 0 0 5.29 n-term: Pyro-cmC (-17.03) 846.963 1,691.91 1,691.91 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% qAEVTFVGHPGNLVIK 95.00% 0 0 6.8 n-term: Pyro-cmC (-17.03) 846.9637 1,691.91 1,691.91 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% qAEVTFVGHPGNLVIK 95.00% 0 0 5.35 n-term: Pyro-cmC (-17.03) 846.9638 1,691.91 1,691.91 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ALEGLQYPFAVTSYGK 95.00% 4.74 0.63 5.19 872.4521 1,742.89 1,743.90 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ALEGLQYPFAVTSYGK 95.00% 4.77 0.626 7.82 872.4534 1,742.89 1,743.90 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ALEGLQYPFAVTSYGK 95.00% 3.72 0.581 3.62 872.4536 1,742.89 1,743.90 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ALEGLQYPFAVTSYGK 95.00% 4.45 0.594 6.47 872.454 1,742.89 1,743.90 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ALEGLQYPFAVTSYGK 95.00% 3.28 0.43 0 872.4547 1,742.89 1,743.90 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% ALEGLQYPFAVTSYGK 95.00% 4.71 0.551 4.82 872.9557 1,743.90 1,743.90 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EYTVTEPERDGASPSR 95.00% 2.84 0.441 0 897.4214 1,792.83 1,793.83 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EYTVTEPERDGASPSR 95.00% 2.77 0.345 0 897.4223 1,792.83 1,793.83 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EYTVTEPERDGASPSR 95.00% 2.61 0.321 0 897.9223 1,793.83 1,793.83 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% EYTVTEPERDGASPSR 95.00% 3.01 0.387 0 897.9237 1,793.83 1,793.83 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NIFWTDSNLDRIEVAK 95.00% 4.82 0.568 6.08 960.9959 1,919.98 1,920.98 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NIFWTDSNLDRIEVAK 95.00% 4.97 0.494 3.49 961.4971 1,920.98 1,920.98 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NIFWTDSNLDRIEVAK 95.00% 5.02 0.513 4.7 961.4995 1,920.98 1,920.98 2
 SAMPLE 4R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 18 25 132 17.20% NIFWTDSNLDRIEVAK 95.00% 5.15 0.489 2.74 961.4997 1,920.98 1,920.98 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% ASLHGGEPTTIIR 95.00% 2.29 0.227 1.77 451.2498 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% ASLHGGEPTTIIR 95.00% 2.17 0.198 2.25 451.2501 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% ASLHGGEPTTIIR 95.00% 2.38 0.291 1.82 451.2506 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% EHILGAAGATDPQR 95.00% 2.45 0.207 0 479.2488 1,434.72 1,435.73 3
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% RVLFETDLVNPR 95.00% 3.17 0.263 1.01 487.2739 1,458.80 1,458.81 3
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% QDLGSPEGIAVDHLGR 95.00% 4.06 0.501 3.48 555.2841 1,662.83 1,663.84 3
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% QDLGSPEGIAVDHLGR 95.00% 3.76 0.487 2.6 555.2842 1,662.83 1,663.84 3
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% QDLGSPEGIAVDHLGR 95.00% 3.17 0.446 1.89 555.6168 1,663.83 1,663.84 3
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% QDLGSPEGIAVDHLGR 95.00% 3.46 0.479 2.39 555.6172 1,663.83 1,663.84 3
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% QAEVTFVGHPGNLVIK 95.00% 3.17 0.292 0 570.3169 1,707.93 1,708.94 3
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% QAEVTFVGHPGNLVIK 95.00% 2.63 0.405 0 570.3171 1,707.93 1,708.94 3
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% QAEVTFVGHPGNLVIK 95.00% 2.93 0.401 0 570.6509 1,708.93 1,708.94 3
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% QAEVTFVGHPGNLVIK 95.00% 2.54 0.374 0 570.6516 1,708.93 1,708.94 3
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% EYTVTEPERDGASPSR 95.00% 1.89 0.295 0 598.6141 1,792.82 1,793.83 3
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% NIFWTDSNLDRIEVAK 95.00% 2.56 0.471 0 641.3331 1,920.98 1,920.98 3
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% VLFETDLVNPR 95.00% 2.06 0.297 1.23 651.8545 1,301.69 1,302.71 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% VLFETDLVNPR 95.00% 3.26 0.474 2.19 651.8557 1,301.70 1,302.71 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% VLFETDLVNPR 95.00% 3.5 0.435 2.8 651.8559 1,301.70 1,302.71 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% VLFETDLVNPR 95.00% 2.62 0.299 2.59 652.3583 1,302.70 1,302.71 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% MNSVVALDLAISK 95.00% 2.66 0.307 3.19 680.8784 1,359.74 1,360.75 2 FHL1_HUMAN
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% MNSVVALDLAISK 95.00% 3.37 0.373 2.04 681.3799 1,360.74 1,360.75 2 FHL1_HUMAN
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% EHILGAAGATDPQR 95.00% 3.01 0.646 0 718.367 1,434.72 1,435.73 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% TQFTcEcSIGFR 95.00% 2.87 0.381 3.11 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3272 1,504.64 1,505.65 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% TQFTcEcSIGFR 95.00% 2.16 0.444 0 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3272 1,504.64 1,505.65 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% TQFTcEcSIGFR 95.00% 3.22 0.438 3.52 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3288 1,504.64 1,505.65 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% MVYWTDITEPSIGR 95.00% 4.33 0.647 3.49 834.407 1,666.80 1,667.81 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% MVYWTDITEPSIGR 95.00% 3.85 0.584 3.08 834.9102 1,667.80 1,667.81 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% ALEGLQYPFAVTSYGK 95.00% 3.63 0.564 0 872.4507 1,742.89 1,743.90 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% EYTVTEPERDGASPSR 95.00% 2.89 0.429 0 897.4179 1,792.82 1,793.83 2
 SAMPLE 1 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 12 14 30 12.70% EYTVTEPERDGASPSR 95.00% 3.06 0.331 0 897.9187 1,793.82 1,793.83 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% ASLHGGEPTTIIR 95.00% 2.46 0.216 1.39 451.2502 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% ASLHGGEPTTIIR 95.00% 2.09 0.175 1.66 451.2511 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% RVLFETDLVNPR 95.00% 2.88 0.125 0 486.9395 1,457.80 1,458.81 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% RVLFETDLVNPR 95.00% 3.24 0.329 2.48 487.2746 1,458.80 1,458.81 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% NLYFTDWK 95.00% 2.24 0.189 0 543.7646 1,085.51 1,086.53 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% QDLGSPEGIAVDHLGR 95.00% 3.53 0.471 1.96 555.2821 1,662.82 1,663.84 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% QDLGSPEGIAVDHLGR 95.00% 3.22 0.445 1.05 555.2822 1,662.82 1,663.84 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% QDLGSPEGIAVDHLGR 95.00% 3.68 0.46 2.36 555.2826 1,662.82 1,663.84 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% QDLGSPEGIAVDHLGR 95.00% 3.21 0.438 1.32 555.6184 1,663.83 1,663.84 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% QAEVTFVGHPGNLVIK 95.00% 2.41 0.378 0 570.3175 1,707.93 1,708.94 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% QAEVTFVGHPGNLVIK 95.00% 2.86 0.376 0 570.3181 1,707.93 1,708.94 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% QAEVTFVGHPGNLVIK 95.00% 2.33 0.424 0 570.6511 1,708.93 1,708.94 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% QAEVTFVGHPGNLVIK 95.00% 2.33 0.345 0 570.6515 1,708.93 1,708.94 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% NIFWTDSNLDRIEVAK 95.00% 1.91 0.34 0 640.9971 1,919.97 1,920.98 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% NIFWTDSNLDRIEVAK 95.00% 1.89 0.326 0 640.9977 1,919.97 1,920.98 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% NIFWTDSNLDRIEVAK 95.00% 1.86 0.266 0 641.3317 1,920.97 1,920.98 3
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% VLFETDLVNPR 95.00% 2.73 0.388 1.21 651.8547 1,301.69 1,302.71 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% VLFETDLVNPR 95.00% 3.74 0.439 3.16 651.8554 1,301.70 1,302.71 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% VLFETDLVNPR 95.00% 3.37 0.451 2.77 651.8565 1,301.70 1,302.71 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% VLFETDLVNPR 95.00% 2.53 0.413 2.14 652.3405 1,302.67 1,302.71 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% EHILGAAGATDPQR 95.00% 3.67 0.588 0 718.3659 1,434.72 1,435.73 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% TQFTcEcSIGFR 95.00% 2.65 0.475 2.06 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3277 1,504.64 1,505.65 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% qDLGSPEGIAVDHLGR 95.00% 0 0 3.41 n-term: Pyro-cmC (-17.03) 823.9095 1,645.80 1,646.81 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% MVYWTDITEPSIGR 95.00% 3.51 0.527 2.82 834.4051 1,666.79 1,667.81 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% MVYWTDITEPSIGR 95.00% 4.13 0.534 4.55 834.9085 1,667.80 1,667.81 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% EYTVTEPERDGASPSR 95.00% 3.15 0.398 0 897.4189 1,792.82 1,793.83 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% EYTVTEPERDGASPSR 95.00% 2.88 0.328 0 897.9201 1,793.82 1,793.83 2
 SAMPLE 1R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 11 13 28 11.00% NIFWTDSNLDRIEVAK 95.00% 5.02 0.519 4.8 960.9924 1,919.97 1,920.98 2
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% ASLHGGEPTTIIR 95.00% 2.85 0.369 2.2 451.25 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% ASLHGGEPTTIIR 95.00% 2.28 0.177 1.57 451.25 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% ASLHGGEPTTIIR 95.00% 2.44 0.212 0 451.2505 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% ASLHGGEPTTIIR 95.00% 2.47 0.349 1.6 451.2513 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% EHILGAAGATDPQR 95.00% 2.92 0.307 0 479.5807 1,435.72 1,435.73 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% RVLFETDLVNPR 95.00% 3.23 0.272 0.921 486.9396 1,457.80 1,458.81 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% IYTYQWR 95.00% 2.33 0.324 0 515.2603 1,028.50 1,029.52 2
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% NLYFTDWK 95.00% 2.3 0.231 0 543.7657 1,085.52 1,086.53 2
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% QDLGSPEGIAVDHLGR 95.00% 3.95 0.451 4.57 555.2836 1,662.83 1,663.84 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% QDLGSPEGIAVDHLGR 95.00% 3.64 0.456 3.51 555.2839 1,662.83 1,663.84 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% QDLGSPEGIAVDHLGR 95.00% 2.87 0.396 2.85 555.2842 1,662.83 1,663.84 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% QDLGSPEGIAVDHLGR 95.00% 3.42 0.406 3.82 555.6186 1,663.83 1,663.84 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% QDLGSPEGIAVDHLGR 95.00% 3.7 0.49 3.52 555.619 1,663.83 1,663.84 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% QAEVTFVGHPGNLVIK 95.00% 2.71 0.368 0 570.3165 1,707.93 1,708.94 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% QAEVTFVGHPGNLVIK 95.00% 3.23 0.412 0 570.3171 1,707.93 1,708.94 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% QAEVTFVGHPGNLVIK 95.00% 2.66 0.38 0 570.3172 1,707.93 1,708.94 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% QAEVTFVGHPGNLVIK 95.00% 2.39 0.382 0 570.652 1,708.93 1,708.94 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% EYTVTEPERDGASPSR 95.00% 1.85 0.308 0 598.6152 1,792.82 1,793.83 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% NIFWTDSNLDRIEVAK 95.00% 2.49 0.392 0 640.9979 1,919.97 1,920.98 3
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% VLFETDLVNPR 95.00% 3.39 0.438 2.52 651.8558 1,301.70 1,302.71 2
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% VLFETDLVNPR 95.00% 3.79 0.5 2.4 651.8561 1,301.70 1,302.71 2
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% VIIGLAFDcVDK 95.00% 2.92 0.505 4.44 c9: Carbamidomethyl (+57.02) 675.6589 1,349.30 1,349.71 2
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% ASLHGGEPTTIIR 95.00% 2.71 0.506 3.12 676.3686 1,350.72 1,351.73 2 FIBA_HUMAN
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% ASLHGGEPTTIIR 95.00% 3.05 0.502 3.64 676.369 1,350.72 1,351.73 2 FIBA_HUMAN
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% MNSVVALDLAISK 95.00% 3.12 0.26 0 680.878 1,359.74 1,360.75 2 FHL1_HUMAN
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% MNSVVALDLAISK 95.00% 2.63 0.312 0 680.8784 1,359.74 1,360.75 2 FHL1_HUMAN
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% EHILGAAGATDPQR 95.00% 3.66 0.531 0 718.3673 1,434.72 1,435.73 2
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% TQFTcEcSIGFR 95.00% 3.24 0.54 3.55 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3283 1,504.64 1,505.65 2
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% TQFTcEcSIGFR 95.00% 2.8 0.504 2.41 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3284 1,504.64 1,505.65 2
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% QDLGSPEGIAVDHLGR 95.00% 3.14 0.405 4 832.4214 1,662.83 1,663.84 2
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% MVYWTDITEPSIGR 95.00% 4.41 0.585 5.4 834.4074 1,666.80 1,667.81 2
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% MVYWTDITEPSIGR 95.00% 3.94 0.528 3.89 834.4079 1,666.80 1,667.81 2
 SAMPLE 2 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 14 18 33 13.60% NIFWTDSNLDRIEVAK 95.00% 4.81 0.567 3.96 960.9926 1,919.97 1,920.98 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% ASLHGGEPTTIIR 95.00% 2.24 0.201 0 451.2492 1,350.72 1,351.73 3 FIBA_HUMAN
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% ASLHGGEPTTIIR 95.00% 2.24 0.168 1.28 451.2497 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% ASLHGGEPTTIIR 95.00% 2.26 0.283 1.34 451.2502 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% ASLHGGEPTTIIR 95.00% 2.61 0.17 1.23 451.2511 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% NLYFTDWK 95.00% 2.39 0.226 0 543.766 1,085.52 1,086.53 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% QDLGSPEGIAVDHLGR 95.00% 2.99 0.232 1.17 555.281 1,662.82 1,663.84 3
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% QDLGSPEGIAVDHLGR 95.00% 2.89 0.34 1.08 555.2829 1,662.83 1,663.84 3
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% QDLGSPEGIAVDHLGR 95.00% 4.07 0.442 2.13 555.2838 1,662.83 1,663.84 3
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% QDLGSPEGIAVDHLGR 95.00% 4.03 0.46 3.36 555.2845 1,662.83 1,663.84 3
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% QAEVTFVGHPGNLVIK 95.00% 2.86 0.394 0 570.3167 1,707.93 1,708.94 3
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% QAEVTFVGHPGNLVIK 95.00% 2.8 0.459 0 570.317 1,707.93 1,708.94 3
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% QAEVTFVGHPGNLVIK 95.00% 2.71 0.397 0 570.6516 1,708.93 1,708.94 3
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% EYTVTEPERDGASPSR 95.00% 1.92 0.329 0 598.6141 1,792.82 1,793.83 3
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% NIFWTDSNLDRIEVAK 95.00% 1.76 0.289 0 640.9981 1,919.97 1,920.98 3
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% NIFWTDSNLDRIEVAK 95.00% 2.1 0.341 0 640.9985 1,919.97 1,920.98 3
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% NGFSITGGEFTR 95.00% 2.88 0.355 2.57 643.3117 1,284.61 1,285.62 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% VLFETDLVNPR 95.00% 3.62 0.431 2.11 651.8565 1,301.70 1,302.71 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% VLFETDLVNPR 95.00% 3.85 0.496 2.51 651.8567 1,301.70 1,302.71 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% VIIGLAFDcVDK 95.00% 3.57 0.626 4.15 c9: Carbamidomethyl (+57.02) 675.3595 1,348.70 1,349.71 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% VIIGLAFDcVDK 95.00% 2.89 0.496 2.42 c9: Carbamidomethyl (+57.02) 675.6576 1,349.30 1,349.71 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% ASLHGGEPTTIIR 95.00% 2.93 0.529 3.59 676.3683 1,350.72 1,351.73 2 FIBA_HUMAN
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% ASLHGGEPTTIIR 95.00% 2.48 0.49 0 676.3716 1,350.73 1,351.73 2 FIBA_HUMAN
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% MNSVVALDLAISK 95.00% 2.97 0.287 2.92 680.8782 1,359.74 1,360.75 2 FHL1_HUMAN
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% MNSVVALDLAISK 95.00% 2.86 0.403 0 681.3803 1,360.75 1,360.75 2 FHL1_HUMAN
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% RVLFETDLVNPR 95.00% 3.35 0.468 3.21 729.9073 1,457.80 1,458.81 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% TQFTcEcSIGFR 95.00% 2.44 0.247 0 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3296 1,504.64 1,505.65 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% TQFTcEcSIGFR 95.00% 3.12 0.505 2.74 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3297 1,504.64 1,505.65 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% MVYWTDITEPSIGR 95.00% 4.42 0.595 4.04 834.4074 1,666.80 1,667.81 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% MVYWTDITEPSIGR 95.00% 4.43 0.603 4.51 834.4087 1,666.80 1,667.81 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% qAEVTFVGHPGNLVIK 95.00% 0 0 4.46 n-term: Pyro-cmC (-17.03) 846.4597 1,690.90 1,691.91 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% GNLYWTDWNRDNPK 95.00% 3.47 0.562 1.89 890.4182 1,778.82 1,778.83 2
 SAMPLE 2R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 17 32 15.30% KALEGLQYPFAVTSYGK 95.00% 5.5 0.574 7.51 936.9976 1,871.98 1,871.99 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% ASLHGGEPTTIIR 95.00% 2.23 0.243 1.12 451.2489 1,350.72 1,351.73 3 FIBA_HUMAN
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% ASLHGGEPTTIIR 95.00% 2.35 0.277 1.35 451.2506 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% ASLHGGEPTTIIR 95.00% 3.14 0.161 1.12 451.2506 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% ASLHGGEPTTIIR 95.00% 1.99 0.201 1.54 451.2513 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% ASLHGGEPTTIIR 95.00% 2.05 0.247 1.66 451.2516 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% IERLPLEGNTMR 95.00% 3.18 0.312 2.12 476.9249 1,427.75 1,428.76 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% IERLPLEGNTMR 95.00% 3.78 0.389 2.46 476.925 1,427.75 1,428.76 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% EHILGAAGATDPQR 95.00% 3.19 0.309 0 479.2478 1,434.72 1,435.73 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% EHILGAAGATDPQR 95.00% 3.52 0.248 0 479.2487 1,434.72 1,435.73 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% RVLFETDLVNPR 95.00% 4.21 0.328 1.09 486.9391 1,457.79 1,458.81 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% RVLFETDLVNPR 95.00% 3.3 0.359 0 486.9396 1,457.80 1,458.81 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% IYTYQWR 95.00% 2.06 0.234 0 515.2596 1,028.50 1,029.52 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% IYTYQWR 95.00% 2.3 0.304 0 515.2599 1,028.50 1,029.52 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% NLYFTDWK 95.00% 2.66 0.246 0 543.7654 1,085.52 1,086.53 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QDLGSPEGIAVDHLGR 95.00% 2.55 0.347 1.59 555.2802 1,662.82 1,663.84 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QDLGSPEGIAVDHLGR 95.00% 2.97 0.379 0 555.2837 1,662.83 1,663.84 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QDLGSPEGIAVDHLGR 95.00% 4.43 0.516 4.3 555.2842 1,662.83 1,663.84 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QDLGSPEGIAVDHLGR 95.00% 4.45 0.501 3.62 555.2844 1,662.83 1,663.84 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QDLGSPEGIAVDHLGR 95.00% 3.63 0.426 2.41 555.6185 1,663.83 1,663.84 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QAEVTFVGHPGNLVIK 95.00% 2.23 0.347 0 570.3164 1,707.93 1,708.94 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QAEVTFVGHPGNLVIK 95.00% 2.25 0.183 0 570.3178 1,707.93 1,708.94 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QAEVTFVGHPGNLVIK 95.00% 2.59 0.444 0 570.318 1,707.93 1,708.94 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QAEVTFVGHPGNLVIK 95.00% 3.11 0.345 0 570.6511 1,708.93 1,708.94 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QAEVTFVGHPGNLVIK 95.00% 2.55 0.376 0 570.6511 1,708.93 1,708.94 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QAEVTFVGHPGNLVIK 95.00% 2.67 0.191 0 570.6514 1,708.93 1,708.94 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QAEVTFVGHPGNLVIK 95.00% 2.51 0.379 0 570.6516 1,708.93 1,708.94 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% GNLYWTDWNRDNPK 95.00% 2.18 0.314 0 593.9463 1,778.82 1,778.83 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% EYTVTEPERDGASPSR 95.00% 1.95 0.386 0 598.614 1,792.82 1,793.83 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% EYTVTEPERDGASPSR 95.00% 1.97 0.3 0 598.6143 1,792.82 1,793.83 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% EYTVTEPERDGASPSR 95.00% 1.82 0.293 0 598.6143 1,792.82 1,793.83 3
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% IETSYMDGTNR 95.00% 2.48 0.404 0 643.7883 1,285.56 1,286.57 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% VLFETDLVNPR 95.00% 3.85 0.474 2.43 651.8556 1,301.70 1,302.71 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% VLFETDLVNPR 95.00% 3.55 0.389 3.15 651.8557 1,301.70 1,302.71 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% VLFETDLVNPR 95.00% 3.15 0.525 2.27 651.8564 1,301.70 1,302.71 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% VLFETDLVNPR 95.00% 3.41 0.486 1.89 651.8568 1,301.70 1,302.71 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% VIIGLAFDcVDK 95.00% 3.78 0.542 4.47 c9: Carbamidomethyl (+57.02) 675.3575 1,348.70 1,349.71 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% VIIGLAFDcVDK 95.00% 4.24 0.671 4.82 c9: Carbamidomethyl (+57.02) 675.3592 1,348.70 1,349.71 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% VIIGLAFDcVDK 95.00% 2.86 0.56 4.48 c9: Carbamidomethyl (+57.02) 675.3594 1,348.70 1,349.71 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% MNSVVALDLAISK 95.00% 3.93 0.537 4.21 680.8782 1,359.74 1,360.75 2 FHL1_HUMAN
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% MNSVVALDLAISK 95.00% 2.97 0.416 2.6 680.879 1,359.74 1,360.75 2 FHL1_HUMAN
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% EHILGAAGATDPQR 95.00% 3.62 0.528 0 718.3664 1,434.72 1,435.73 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% EHILGAAGATDPQR 95.00% 3.86 0.507 0 718.3675 1,434.72 1,435.73 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% RVLFETDLVNPR 95.00% 4.26 0.539 3.57 729.9084 1,457.80 1,458.81 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% RVLFETDLVNPR 95.00% 4.44 0.556 2.92 730.408 1,458.80 1,458.81 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% TQFTcEcSIGFR 95.00% 2.98 0.495 2.09 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3281 1,504.64 1,505.65 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% TQFTcEcSIGFR 95.00% 3.18 0.481 3.6 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3286 1,504.64 1,505.65 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% TQFTcEcSIGFR 95.00% 3.17 0.466 3.37 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 753.3293 1,504.64 1,505.65 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% qDLGSPEGIAVDHLGR 95.00% 0 0 5.03 n-term: Pyro-cmC (-17.03) 823.9101 1,645.80 1,646.81 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QDLGSPEGIAVDHLGR 95.00% 2.69 0.446 4 832.4214 1,662.83 1,663.84 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% QDLGSPEGIAVDHLGR 95.00% 2.9 0.257 2.96 832.9234 1,663.83 1,663.84 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% MVYWTDITEPSIGR 95.00% 4.14 0.467 3.82 834.9107 1,667.81 1,667.81 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% GNLYWTDWNRDNPK 95.00% 3.67 0.548 3 889.9153 1,777.81 1,778.83 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% GNLYWTDWNRDNPK 95.00% 3.4 0.49 2.13 890.4142 1,778.81 1,778.83 2
 SAMPLE 3 Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 17 21 54 17.60% EGSPDALQNPcYIGTHGcDTNAAcRPGPR 95.00% 3.66 0.478 2.11 c11: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02), c24: Carbamidomethyl (+57.02) 1,058.13 3,171.36 3,171.38 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% ASLHGGEPTTIIR 95.00% 2.43 0.219 0 451.2503 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% ASLHGGEPTTIIR 95.00% 2.05 0.346 0 451.2503 1,350.73 1,351.73 3 FIBA_HUMAN
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% IERLPLEGNTMR 95.00% 3.64 0.381 2.28 476.9255 1,427.75 1,428.76 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% IERLPLEGNTMR 95.00% 3.42 0.325 0 476.926 1,427.75 1,428.76 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% EHILGAAGATDPQR 95.00% 2.9 0.309 0 479.247 1,434.72 1,435.73 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% EHILGAAGATDPQR 95.00% 3.09 0.333 0 479.2485 1,434.72 1,435.73 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% RVLFETDLVNPR 95.00% 3.12 0.216 0 486.9394 1,457.79 1,458.81 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% RVLFETDLVNPR 95.00% 3.79 0.3 0 486.9397 1,457.80 1,458.81 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% NLYFTDWK 95.00% 2.36 0.184 0 543.7659 1,085.52 1,086.53 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% QDLGSPEGIAVDHLGR 95.00% 3.26 0.431 1.74 555.2838 1,662.83 1,663.84 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% QDLGSPEGIAVDHLGR 95.00% 4.5 0.483 3.44 555.2841 1,662.83 1,663.84 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% QDLGSPEGIAVDHLGR 95.00% 3.8 0.482 2.66 555.2847 1,662.83 1,663.84 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% QAEVTFVGHPGNLVIK 95.00% 2.15 0.228 0 570.3165 1,707.93 1,708.94 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% QAEVTFVGHPGNLVIK 95.00% 2.7 0.241 0 570.3168 1,707.93 1,708.94 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% QAEVTFVGHPGNLVIK 95.00% 2.68 0.391 0 570.6507 1,708.93 1,708.94 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% QAEVTFVGHPGNLVIK 95.00% 2.83 0.421 0 570.6512 1,708.93 1,708.94 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% QAEVTFVGHPGNLVIK 95.00% 2.23 0.382 0 570.6514 1,708.93 1,708.94 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% QAEVTFVGHPGNLVIK 95.00% 2.41 0.329 0 570.6514 1,708.93 1,708.94 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% NIFWTDSNLDRIEVAK 95.00% 1.71 0.27 0 640.998 1,919.97 1,920.98 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% NIFWTDSNLDRIEVAK 95.00% 2.4 0.442 0 641.3325 1,920.97 1,920.98 3
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% IETSYMDGTNR 95.00% 2.88 0.36 0 643.7867 1,285.56 1,286.57 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% VLFETDLVNPR 95.00% 3.54 0.422 2.51 651.8557 1,301.70 1,302.71 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% VLFETDLVNPR 95.00% 2.61 0.391 2.19 651.8559 1,301.70 1,302.71 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% VLFETDLVNPR 95.00% 3.72 0.495 2.52 651.8561 1,301.70 1,302.71 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% VLFETDLVNPR 95.00% 2.66 0.489 2.54 651.8568 1,301.70 1,302.71 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% VIIGLAFDcVDK 95.00% 4.19 0.652 5.74 c9: Carbamidomethyl (+57.02) 675.3594 1,348.70 1,349.71 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% VIIGLAFDcVDK 95.00% 3.89 0.648 3.6 c9: Carbamidomethyl (+57.02) 675.3599 1,348.70 1,349.71 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% MNSVVALDLAISK 95.00% 3.41 0.51 4.59 680.8777 1,359.74 1,360.75 2 FHL1_HUMAN
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% MNSVVALDLAISK 95.00% 3.02 0.412 4.07 680.8787 1,359.74 1,360.75 2 FHL1_HUMAN
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% EHILGAAGATDPQR 95.00% 3.52 0.562 0 718.3676 1,434.72 1,435.73 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% EHILGAAGATDPQR 95.00% 3.57 0.531 0 718.3685 1,434.72 1,435.73 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% RVLFETDLVNPR 95.00% 4.37 0.55 3.37 729.906 1,457.80 1,458.81 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% RVLFETDLVNPR 95.00% 4.17 0.535 4.62 729.906 1,457.80 1,458.81 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% qDLGSPEGIAVDHLGR 95.00% 0 0 6.74 n-term: Pyro-cmC (-17.03) 823.9104 1,645.81 1,646.81 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% QDLGSPEGIAVDHLGR 95.00% 2.62 0.178 1.57 832.4203 1,662.82 1,663.84 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% QDLGSPEGIAVDHLGR 95.00% 3.52 0.429 3.44 832.9232 1,663.83 1,663.84 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% qAEVTFVGHPGNLVIK 95.00% 0 0 5.44 n-term: Pyro-cmC (-17.03) 846.4594 1,690.90 1,691.91 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% ALEGLQYPFAVTSYGK 95.00% 4.01 0.435 2.77 872.4539 1,742.89 1,743.90 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% GNLYWTDWNRDNPK 95.00% 3.55 0.541 1.85 889.9148 1,777.81 1,778.83 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% NIFWTDSNLDRIEVAK 95.00% 3.86 0.465 0 960.9969 1,919.98 1,920.98 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% NIFWTDSNLDRIEVAK 95.00% 3.95 0.484 4.32 961.4939 1,920.97 1,920.98 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% NIFWTDSNLDRIEVAK 95.00% 4.52 0.547 6.12 961.5006 1,920.99 1,920.98 2
 SAMPLE 3R Nidogen-1  NID1  NID1_HUMAN 136,433.80 100.00% 15 20 43 16.20% EGSPDALQNPcYIGTHGcDTNAAcRPGPR 95.00% 4.12 0.5 1.89 c11: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02), c24: Carbamidomethyl (+57.02) 1,058.13 3,171.37 3,171.38 3
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% HPSFPTTQQLNVDR 95.00% 3.37 0.407 0 547.2787 1,638.81 1,639.82 3
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% HPSFPTTQQLNVDR 95.00% 4.15 0.42 2.25 547.6132 1,639.82 1,639.82 3
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% LLcWADAGTK 95.00% 2.42 0.272 0 c3: Carbamidomethyl (+57.02) 567.7857 1,133.56 1,134.56 2
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% LLcWADAGTK 95.00% 2.24 0.298 1.3 c3: Carbamidomethyl (+57.02) 567.786 1,133.56 1,134.56 2
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% MVYWTDVAGR 95.00% 2.48 0.419 2 599.2895 1,196.56 1,197.57 2
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% MVYWTDVAGR 95.00% 2.9 0.38 2.96 599.2907 1,196.57 1,197.57 2
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% MVYWTDVAGR 95.00% 3.02 0.352 2.51 599.2913 1,196.57 1,197.57 2
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% VFALYNDEER 95.00% 3.23 0.498 2.2 628.3028 1,254.59 1,255.60 2
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% VFALYNDEER 95.00% 3.28 0.485 0 628.3032 1,254.59 1,255.60 2
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% VFALYNDEER 95.00% 2.22 0.306 0 628.3047 1,254.59 1,255.60 2
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% VLFYTDLVNPR 95.00% 2.3 0.35 2.32 668.8683 1,335.72 1,336.73 2
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% VLFYTDLVNPR 95.00% 2.79 0.336 2.96 669.3377 1,336.66 1,336.73 2
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% ITQTAEGLDPENYLSIK 95.00% 5.51 0.501 3.38 946.9879 1,891.96 1,891.97 2
 SAMPLE 4 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 6 6 14 5.24% ITQTAEGLDPENYLSIK 95.00% 5.65 0.518 4.59 946.9904 1,891.97 1,891.97 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% HPSFPTTQQLNVDR 95.00% 3.66 0.398 0 547.6133 1,639.82 1,639.82 3
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% HPSFPTTQQLNVDR 95.00% 3.34 0.389 1.4 547.6146 1,639.82 1,639.82 3
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% LLcWADAGTK 95.00% 2.18 0.296 0 c3: Carbamidomethyl (+57.02) 567.7871 1,133.56 1,134.56 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% HSGQFTDEYLPEQR 95.00% 2.99 0.226 0 569.5977 1,705.77 1,706.78 3
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% HSGQFTDEYLPEQR 95.00% 2.63 0.185 0 569.5991 1,705.77 1,706.78 3
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% MVYWTDVAGR 95.00% 2.94 0.396 3.77 599.2904 1,196.57 1,197.57 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% MVYWTDVAGR 95.00% 2.76 0.405 2.92 599.2904 1,196.57 1,197.57 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% MVYWTDVAGR 95.00% 2.67 0.316 2.42 599.9886 1,197.96 1,197.57 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% ELYHYSDSTVTSTSSR 95.00% 2.32 0.311 0 611.9507 1,832.83 1,832.83 3
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% VFALYNDEER 95.00% 2.29 0.28 0 628.3032 1,254.59 1,255.60 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% VFALYNDEER 95.00% 3.39 0.514 1.68 628.3033 1,254.59 1,255.60 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% VFALYNDEER 95.00% 3.33 0.488 1.82 628.3036 1,254.59 1,255.60 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% VLFYTDLVNPR 95.00% 2.43 0.412 1.22 668.8688 1,335.72 1,336.73 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% VLFYTDLVNPR 95.00% 2.46 0.454 2.17 668.869 1,335.72 1,336.73 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% VLFYTDLVNPR 95.00% 2.66 0.369 1.92 669.3401 1,336.66 1,336.73 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% ITQTAEGLDPENYLSIK 95.00% 5.14 0.509 6.39 946.4873 1,890.96 1,891.97 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% ITQTAEGLDPENYLSIK 95.00% 5.7 0.526 3.68 946.4882 1,890.96 1,891.97 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% ITQTAEGLDPENYLSIK 95.00% 5.07 0.548 6.13 946.9907 1,891.97 1,891.97 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% ITQTAEGLDPENYLSIK 95.00% 4.55 0.29 2.66 946.9916 1,891.97 1,891.97 2
 SAMPLE 4R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 8 8 20 7.42% ITQTAEGLDPENYLSIK 95.00% 3.86 0.514 3.41 946.9924 1,891.97 1,891.97 2
 SAMPLE 1 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 6 4.00% LLcWADAGTK 95.00% 1.84 0.183 1.8 c3: Carbamidomethyl (+57.02) 567.7826 1,133.55 1,134.56 2
 SAMPLE 1 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 6 4.00% LLcWADAGTK 95.00% 1.95 0.288 0 c3: Carbamidomethyl (+57.02) 567.785 1,133.55 1,134.56 2
 SAMPLE 1 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 6 4.00% NcVDENEcATGFHR 95.00% 1.99 0.359 0 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 570.2298 1,707.67 1,708.68 3
 SAMPLE 1 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 6 4.00% HSGQFTDEYLPEQR 95.00% 2.69 0.414 0 854.4088 1,706.80 1,706.78 2
 SAMPLE 1 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 6 4.00% ITQTAEGLDPENYLSIK 95.00% 4.88 0.519 5.55 946.9834 1,891.95 1,891.97 2
 SAMPLE 1 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 6 4.00% ITQTAEGLDPENYLSIK 95.00% 5.37 0.513 6.47 946.9847 1,891.95 1,891.97 2
 SAMPLE 1R Nidogen-2  NID2  NID2_HUMAN 151,376.50 99.80% 2 2 4 2.04% VLFYTDLVNPR 95.00% 2.21 0.121 3.02 668.8648 1,335.71 1,336.73 2
 SAMPLE 1R Nidogen-2  NID2  NID2_HUMAN 151,376.50 99.80% 2 2 4 2.04% ITQTAEGLDPENYLSIK 95.00% 3.88 0.542 3.43 946.4844 1,890.95 1,891.97 2
 SAMPLE 1R Nidogen-2  NID2  NID2_HUMAN 151,376.50 99.80% 2 2 4 2.04% ITQTAEGLDPENYLSIK 95.00% 5.22 0.496 6.41 946.9855 1,891.96 1,891.97 2
 SAMPLE 1R Nidogen-2  NID2  NID2_HUMAN 151,376.50 99.80% 2 2 4 2.04% ITQTAEGLDPENYLSIK 95.00% 5.26 0.497 4.77 946.9865 1,891.96 1,891.97 2
 SAMPLE 2 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 4 3.85% KVLFYTDLVNPR 95.00% 2.87 0.386 0 489.2784 1,464.81 1,464.82 3
 SAMPLE 2 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 4 3.85% LLcWADAGTK 95.00% 2.35 0.337 1.68 c3: Carbamidomethyl (+57.02) 567.7824 1,133.55 1,134.56 2
 SAMPLE 2 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 4 3.85% NcVDENEcATGFHR 95.00% 2.82 0.294 1.12 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 570.2315 1,707.67 1,708.68 3
 SAMPLE 2 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 4 3.85% ITQTAEGLDPENYLSIK 95.00% 4.41 0.506 6.28 946.4861 1,890.96 1,891.97 2
 SAMPLE 2R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 6 3.13% KVLFYTDLVNPR 95.00% 2.39 0.342 0 489.2783 1,464.81 1,464.82 3
 SAMPLE 2R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 6 3.13% NcVDENEcATGFHR 95.00% 2.58 0.278 0 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 570.2301 1,707.67 1,708.68 3
 SAMPLE 2R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 6 3.13% NcVDENEcATGFHR 95.00% 2.01 0.238 0 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 570.5646 1,708.67 1,708.68 3
 SAMPLE 2R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 6 3.13% VLFYTDLVNPR 95.00% 2.16 0.302 3.62 668.8662 1,335.72 1,336.73 2
 SAMPLE 2R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 6 3.13% ITQTAEGLDPENYLSIK 95.00% 5.26 0.532 4.22 946.9849 1,891.95 1,891.97 2
 SAMPLE 2R Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 4 4 6 3.13% ITQTAEGLDPENYLSIK 95.00% 5.33 0.528 3.89 946.9882 1,891.96 1,891.97 2
 SAMPLE 3 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 5 5 5 4.80% NcVDENEcATGFHR 95.00% 2.36 0.265 0 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 570.5665 1,708.68 1,708.68 3
 SAMPLE 3 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 5 5 5 4.80% MVYWTDVAGR 95.00% 2.3 0.353 1.89 599.9862 1,197.96 1,197.57 2
 SAMPLE 3 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 5 5 5 4.80% VLFYTDLVNPR 95.00% 2.24 0.358 2.92 668.8659 1,335.72 1,336.73 2
 SAMPLE 3 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 5 5 5 4.80% HSGQFTDEYLPEQR 95.00% 2.55 0.399 0 854.4063 1,706.80 1,706.78 2
 SAMPLE 3 Nidogen-2  NID2  NID2_HUMAN 151,376.50 100.00% 5 5 5 4.80% ITQTAEGLDPENYLSIK 95.00% 3.89 0.474 3.62 946.4826 1,890.95 1,891.97 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% ENGVHSLIIEPVTSR 95.00% 2.63 0.259 0 550.9662 1,649.88 1,650.88 3
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% ENGVHSLIIEPVTSR 95.00% 2.92 0.327 1.21 550.9668 1,649.88 1,650.88 3
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% ENGVHSLIIEPVTSR 95.00% 3.1 0.328 0 551.3005 1,650.88 1,650.88 3
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% EDAGWYTVSAK 95.00% 2.32 0.402 0 613.3048 1,224.59 1,226.57 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% EDAGWYTVSAK 95.00% 2.54 0.363 2.55 613.7869 1,225.56 1,226.57 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% EDAGWYTVSAK 95.00% 2.3 0.212 0 613.7894 1,225.56 1,226.57 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% EDAGWYTVSAK 95.00% 2.25 0.279 1.68 613.79 1,225.56 1,226.57 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% EDAGWYTVSAK 95.00% 2.98 0.399 1.66 614.2927 1,226.57 1,226.57 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% YAALSDQGLDIK 95.00% 3.06 0.36 3.01 647.3393 1,292.66 1,293.67 2 ECHB_HUMAN
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% YAALSDQGLDIK 95.00% 2.85 0.203 2.64 647.3405 1,292.67 1,293.67 2 ECHB_HUMAN
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% DAGIYTcIATNR 95.00% 1.87 0.52 1.7 c7: Carbamidomethyl (+57.02) 678.3247 1,354.63 1,354.64 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% DAGIYTcIATNR 95.00% 2.49 0.546 1.23 c7: Carbamidomethyl (+57.02) 678.3249 1,354.63 1,354.64 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% DAGIYTcIATNR 95.00% 1.67 0.525 1.27 c7: Carbamidomethyl (+57.02) 678.3249 1,354.63 1,354.64 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% DAGIYTcIATNR 95.00% 1.84 0.529 1.77 c7: Carbamidomethyl (+57.02) 678.3251 1,354.63 1,354.64 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% DAGIYTcIATNR 95.00% 2.43 0.465 2.06 c7: Carbamidomethyl (+57.02) 678.3255 1,354.64 1,354.64 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% LDVYTQWHQQSQSTKPK 95.00% 2.15 0.391 0 692.3544 2,074.04 2,074.04 3
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% LDVYTQWHQQSQSTKPK 95.00% 2.36 0.231 0 692.3549 2,074.04 2,074.04 3
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% LQNTGVADGYPVR 95.00% 2.67 0.429 2.44 695.3619 1,388.71 1,389.71 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% LQNTGVADGYPVR 95.00% 3.1 0.557 3.44 695.362 1,388.71 1,389.71 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% LQNTGVADGYPVR 95.00% 3.45 0.472 4.72 695.3621 1,388.71 1,389.71 2
 SAMPLE 4 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 6 6 21 5.78% LQNTGVADGYPVR 95.00% 3.29 0.419 2.8 695.8636 1,389.71 1,389.71 2
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% ENGVHSLIIEPVTSR 95.00% 2.75 0.401 1.06 550.967 1,649.88 1,650.88 3
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% ENGVHSLIIEPVTSR 95.00% 3.18 0.313 0 551.3001 1,650.88 1,650.88 3
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% EDAGWYTVSAK 95.00% 2.51 0.375 2 613.7893 1,225.56 1,226.57 2
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% EDAGWYTVSAK 95.00% 2.76 0.389 1.72 614.2893 1,226.56 1,226.57 2
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% YAALSDQGLDIK 95.00% 3.01 0.403 3.8 647.3376 1,292.66 1,293.67 2 ECHB_HUMAN
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% YAALSDQGLDIK 95.00% 2.46 0.29 1.62 647.3402 1,292.66 1,293.67 2 ECHB_HUMAN
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% DAGIYTcIATNR 95.00% 2.47 0.532 1.18 c7: Carbamidomethyl (+57.02) 677.9902 1,353.96 1,354.64 2
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% DAGIYTcIATNR 95.00% 1.94 0.467 1.62 c7: Carbamidomethyl (+57.02) 678.3244 1,354.63 1,354.64 2
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% DAGIYTcIATNR 95.00% 1.99 0.561 1.44 c7: Carbamidomethyl (+57.02) 678.3249 1,354.63 1,354.64 2
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% DAGIYTcIATNR 95.00% 2.68 0.556 1.2 c7: Carbamidomethyl (+57.02) 678.3252 1,354.63 1,354.64 2
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% DAGIYTcIATNR 95.00% 2.5 0.502 1.96 c7: Carbamidomethyl (+57.02) 678.3255 1,354.64 1,354.64 2
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% DAGIYTcIATNR 95.00% 2.52 0.51 1.28 c7: Carbamidomethyl (+57.02) 678.3266 1,354.64 1,354.64 2
 SAMPLE 4R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 5 5 13 4.56% LQNTGVADGYPVR 95.00% 3.1 0.387 2.31 695.3625 1,388.71 1,389.71 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% FKEDLLNNGQPR 95.00% 3.76 0.375 1.92 477.5835 1,429.73 1,430.74 3
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% FKEDLLNNGQPR 95.00% 3.62 0.32 1.28 477.5839 1,429.73 1,430.74 3
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% FKEDLLNNGQPR 95.00% 3.26 0.242 0 477.584 1,429.73 1,430.74 3
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% FKEDLLNNGQPR 95.00% 4.01 0.299 0 477.5856 1,429.73 1,430.74 3
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% LISEIEYR 95.00% 2.02 0.284 0 511.7783 1,021.54 1,022.55 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% LISEIEYR 95.00% 2.28 0.32 0 511.7787 1,021.54 1,022.55 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% LMVQAVNQR 95.00% 2.61 0.236 0 529.7914 1,057.57 1,058.58 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% ENGVHSLIIEPVTSR 95.00% 3.52 0.31 1.51 550.9646 1,649.87 1,650.88 3
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% ENGVHSLIIEPVTSR 95.00% 3.21 0.367 1.96 550.9648 1,649.87 1,650.88 3
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% ENGVHSLIIEPVTSR 95.00% 3.39 0.415 1.37 550.9649 1,649.87 1,650.88 3
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% ENGVHSLIIEPVTSR 95.00% 3.33 0.37 2.03 551.2981 1,650.87 1,650.88 3
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% EDAGWYTVSAK 95.00% 3.36 0.434 2.21 613.786 1,225.56 1,226.57 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% EDAGWYTVSAK 95.00% 3.05 0.415 2.82 613.7867 1,225.56 1,226.57 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% EDAGWYTVSAK 95.00% 2.3 0.398 0 614.288 1,226.56 1,226.57 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% DAGIYTcIATNR 95.00% 2.49 0.509 2.12 c7: Carbamidomethyl (+57.02) 678.3216 1,354.63 1,354.64 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% DAGIYTcIATNR 95.00% 1.57 0.484 0 c7: Carbamidomethyl (+57.02) 678.3217 1,354.63 1,354.64 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% VLGVPPPQIFWK 95.00% 1.9 0.268 3.68 690.9044 1,379.79 1,380.80 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% VLGVPPPQIFWK 95.00% 2.09 0.342 3.68 690.9048 1,379.79 1,380.80 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% VLGVPPPQIFWK 95.00% 1.95 0.31 5.17 690.905 1,379.79 1,380.80 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% LQNTGVADGYPVR 95.00% 4.28 0.514 3.09 695.3578 1,388.70 1,389.71 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% LQNTGVADGYPVR 95.00% 3.2 0.206 1.82 695.3582 1,388.70 1,389.71 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% LQNTGVADGYPVR 95.00% 3.82 0.467 3.57 695.3587 1,388.70 1,389.71 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% LQNTGVADGYPVR 95.00% 3.7 0.534 4.68 695.3591 1,388.70 1,389.71 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% LQNTGVADGYPVR 95.00% 2.26 0.353 2.66 695.3603 1,388.70 1,389.71 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% IFEGMPVTFTcR 95.00% 3.82 0.526 3.8 c11: Carbamidomethyl (+57.02) 729.3493 1,456.68 1,457.69 2 REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% IFEGMPVTFTcR 95.00% 3.66 0.264 3.74 c11: Carbamidomethyl (+57.02) 729.3508 1,456.69 1,457.69 2 REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% FFRPHFLQAPGDLTVQEGK 95.00% 4.65 0.479 3.55 730.0488 2,187.12 2,187.14 3
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% IASDEEIQGTKDAVIQDLER 95.00% 6.17 0.473 4.51 744.0441 2,229.11 2,230.12 3
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% IASDEEIQGTKDAVIQDLER 95.00% 4.24 0.386 2.62 744.0449 2,229.11 2,230.12 3
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% IASDEEIQGTKDAVIQDLER 95.00% 5.09 0.489 3.89 744.3814 2,230.12 2,230.12 3
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% ENGVHSLIIEPVTSR 95.00% 4.47 0.622 1.2 825.9442 1,649.87 1,650.88 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% ENGVHSLIIEPVTSR 95.00% 3.93 0.574 0 826.4458 1,650.88 1,650.88 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% ENGVHSLIIEPVTSR 95.00% 4.07 0.495 0 826.4467 1,650.88 1,650.88 2
 SAMPLE 1 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 10 12 32 10.30% IASDEEIQGTKDAVIQDLER 95.00% 5.1 0.531 6.1 1,116.06 2,230.11 2,230.12 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% FKEDLLNNGQPR 95.00% 2.87 0.408 0 477.5836 1,429.73 1,430.74 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% FKEDLLNNGQPR 95.00% 3.26 0.301 1 477.5841 1,429.73 1,430.74 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% FKEDLLNNGQPR 95.00% 3.29 0.237 0 477.585 1,429.73 1,430.74 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% LMVQAVNQR 95.00% 2.45 0.261 0 529.7914 1,057.57 1,058.58 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% ENGVHSLIIEPVTSR 95.00% 3.02 0.435 0 550.9644 1,649.87 1,650.88 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% ENGVHSLIIEPVTSR 95.00% 2.74 0.43 0 550.9647 1,649.87 1,650.88 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% ENGVHSLIIEPVTSR 95.00% 2.9 0.348 0 551.2992 1,650.87 1,650.88 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% ENGVHSLIIEPVTSR 95.00% 2.63 0.285 0 551.2995 1,650.88 1,650.88 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% ENGVHSLIIEPVTSR 95.00% 2.6 0.22 0 551.3021 1,650.88 1,650.88 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% EDAGWYTVSAK 95.00% 2.48 0.36 1.12 613.7883 1,225.56 1,226.57 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% YAALSDQGLDIK 95.00% 2.48 0.238 0 647.3388 1,292.66 1,293.67 2 ECHB_HUMAN
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% LQNTGVADGYPVRLEcR 95.00% 2.56 0.21 0 c16: Carbamidomethyl (+57.02) 650.3269 1,947.96 1,947.97 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% DAGIYTcIATNR 95.00% 2.72 0.336 2.48 c7: Carbamidomethyl (+57.02) 677.8242 1,353.63 1,354.64 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% DAGIYTcIATNR 95.00% 2.69 0.497 1.8 c7: Carbamidomethyl (+57.02) 678.3226 1,354.63 1,354.64 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% VLGVPPPQIFWK 95.00% 2.17 0.359 1.85 690.9042 1,379.79 1,380.80 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% LQNTGVADGYPVR 95.00% 3.56 0.441 2.62 695.3564 1,388.70 1,389.71 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% LQNTGVADGYPVR 95.00% 2.13 0.412 2.17 695.3571 1,388.70 1,389.71 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% LQNTGVADGYPVR 95.00% 3.82 0.559 2.68 695.3577 1,388.70 1,389.71 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% LQNTGVADGYPVR 95.00% 3.68 0.474 3.49 695.3596 1,388.70 1,389.71 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% LQNTGVADGYPVR 95.00% 2.4 0.277 2.43 695.3596 1,388.70 1,389.71 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% LQNTGVADGYPVR 95.00% 3.71 0.403 2.41 695.3599 1,388.70 1,389.71 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% FKEDLLNNGQPR 95.00% 3.19 0.45 2.55 715.8702 1,429.72 1,430.74 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% IFEGMPVTFTcR 95.00% 3.73 0.461 3.89 c11: Carbamidomethyl (+57.02) 729.3493 1,456.68 1,457.69 2 REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% IFEGMPVTFTcR 95.00% 3.3 0.193 2.14 c11: Carbamidomethyl (+57.02) 729.3494 1,456.68 1,457.69 2 REV1_HUMAN,TITIN_HUMAN
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% FFRPHFLQAPGDLTVQEGK 95.00% 4.08 0.486 3.57 730.0507 2,187.13 2,187.14 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% IASDEEIQGTKDAVIQDLER 95.00% 3.53 0.334 3.14 744.0454 2,229.11 2,230.12 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% IASDEEIQGTKDAVIQDLER 95.00% 4.87 0.441 4.03 744.3784 2,230.11 2,230.12 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% IASDEEIQGTKDAVIQDLER 95.00% 4.99 0.463 4.68 744.3802 2,230.12 2,230.12 3
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% ENGVHSLIIEPVTSR 95.00% 3.75 0.526 2.74 825.9449 1,649.87 1,650.88 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% ENGVHSLIIEPVTSR 95.00% 4.22 0.569 2.49 825.9456 1,649.88 1,650.88 2
 SAMPLE 1R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 13 29 10.90% ENGVHSLIIEPVTSR 95.00% 3.8 0.511 2.92 825.9464 1,649.88 1,650.88 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% FKEDLLNNGQPR 95.00% 4.08 0.282 0 477.5844 1,429.73 1,430.74 3
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% FKEDLLNNGQPR 95.00% 3.91 0.37 0 477.5847 1,429.73 1,430.74 3
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% LMVQAVNQR 95.00% 2.94 0.286 0 529.7913 1,057.57 1,058.58 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% LMVQAVNQR 95.00% 2.96 0.291 0 529.7916 1,057.57 1,058.58 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% ENGVHSLIIEPVTSR 95.00% 3.77 0.432 1.82 550.965 1,649.87 1,650.88 3
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% ENGVHSLIIEPVTSR 95.00% 2.25 0.345 0 550.9651 1,649.87 1,650.88 3
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% ENGVHSLIIEPVTSR 95.00% 3.7 0.366 0 551.2991 1,650.87 1,650.88 3
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% YAALSDQGLDIK 95.00% 3.18 0.378 1.7 647.3372 1,292.66 1,293.67 2 ECHB_HUMAN
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% YAALSDQGLDIK 95.00% 2.63 0.306 2.13 647.3374 1,292.66 1,293.67 2 ECHB_HUMAN
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% YAALSDQGLDIK 95.00% 3.48 0.391 3.43 647.3376 1,292.66 1,293.67 2 ECHB_HUMAN
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% YAALSDQGLDIK 95.00% 2.88 0.326 4.07 647.3387 1,292.66 1,293.67 2 ECHB_HUMAN
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% DAGIYTcIATNR 95.00% 3.1 0.38 2.41 c7: Carbamidomethyl (+57.02) 677.8234 1,353.63 1,354.64 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% DAGIYTcIATNR 95.00% 3.47 0.545 2.32 c7: Carbamidomethyl (+57.02) 677.8235 1,353.63 1,354.64 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% DAGIYTcIATNR 95.00% 3.03 0.45 1.51 c7: Carbamidomethyl (+57.02) 678.321 1,354.63 1,354.64 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% VLGVPPPQIFWK 95.00% 1.89 0.337 4.77 690.9045 1,379.79 1,380.80 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% VLGVPPPQIFWK 95.00% 2.04 0.241 4.59 690.9048 1,379.79 1,380.80 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% VLGVPPPQIFWK 95.00% 1.92 0.353 2.62 691.4039 1,380.79 1,380.80 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% LQNTGVADGYPVR 95.00% 3.46 0.422 2.17 695.3581 1,388.70 1,389.71 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% LQNTGVADGYPVR 95.00% 4.23 0.543 2.85 695.3591 1,388.70 1,389.71 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% LQNTGVADGYPVR 95.00% 3.05 0.428 1.64 695.3598 1,388.70 1,389.71 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% FKEDLLNNGQPR 95.00% 3.63 0.454 4.02 715.8728 1,429.73 1,430.74 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% FKEDLLNNGQPR 95.00% 3.87 0.513 4 715.8728 1,429.73 1,430.74 2
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% IFEGMPVTFTcR 95.00% 3.14 0.375 1.96 c11: Carbamidomethyl (+57.02) 729.3492 1,456.68 1,457.69 2 REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% FFRPHFLQAPGDLTVQEGK 95.00% 5.04 0.553 5.57 729.7167 2,186.13 2,187.14 3
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% FFRPHFLQAPGDLTVQEGK 95.00% 4.89 0.479 4.68 730.0515 2,187.13 2,187.14 3
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% IASDEEIQGTKDAVIQDLER 95.00% 4.82 0.449 3.47 744.0443 2,229.11 2,230.12 3
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% IASDEEIQGTKDAVIQDLER 95.00% 6.28 0.434 3.82 744.3801 2,230.12 2,230.12 3
 SAMPLE 2 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 27 9.83% ENGVHSLIIEPVTSR 95.00% 4.42 0.593 1.41 825.9437 1,649.87 1,650.88 2
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% FKEDLLNNGQPR 95.00% 3.56 0.324 0 477.584 1,429.73 1,430.74 3
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% FKEDLLNNGQPR 95.00% 3.69 0.214 0 477.9199 1,430.74 1,430.74 3
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% LISEIEYR 95.00% 2.43 0.357 0 511.7784 1,021.54 1,022.55 2
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% LISEIEYR 95.00% 2.12 0.372 1.15 511.7784 1,021.54 1,022.55 2
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% LMVQAVNQR 95.00% 3.1 0.276 0 529.7919 1,057.57 1,058.58 2
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% LMVQAVNQR 95.00% 2.99 0.302 0 529.7923 1,057.57 1,058.58 2
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% ENGVHSLIIEPVTSR 95.00% 3.38 0.309 1.03 550.9642 1,649.87 1,650.88 3
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% ENGVHSLIIEPVTSR 95.00% 3.27 0.369 1.52 550.9649 1,649.87 1,650.88 3
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% YAALSDQGLDIK 95.00% 2.61 0.246 2.11 647.3424 1,292.67 1,293.67 2 ECHB_HUMAN
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% VLGVPPPQIFWK 95.00% 1.91 0.28 2.51 690.9045 1,379.79 1,380.80 2
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% VLGVPPPQIFWK 95.00% 2.01 0.264 3.06 690.9045 1,379.79 1,380.80 2
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% LQNTGVADGYPVR 95.00% 3.4 0.431 3.62 695.3578 1,388.70 1,389.71 2
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% LQNTGVADGYPVR 95.00% 3.9 0.539 4.13 695.3591 1,388.70 1,389.71 2
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% FKEDLLNNGQPR 95.00% 3.5 0.428 4.14 715.8711 1,429.73 1,430.74 2
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% FKEDLLNNGQPR 95.00% 3.76 0.45 4.11 715.8716 1,429.73 1,430.74 2
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% IFEGMPVTFTcR 95.00% 3.49 0.481 3.22 c11: Carbamidomethyl (+57.02) 729.347 1,456.68 1,457.69 2 REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% IFEGMPVTFTcR 95.00% 3.48 0.498 3.09 c11: Carbamidomethyl (+57.02) 729.3499 1,456.68 1,457.69 2 REV1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% FFRPHFLQAPGDLTVQEGK 95.00% 5.63 0.524 4.64 730.0506 2,187.13 2,187.14 3
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% FFRPHFLQAPGDLTVQEGK 95.00% 4.81 0.555 3.64 730.0507 2,187.13 2,187.14 3
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% IASDEEIQGTKDAVIQDLER 95.00% 4.65 0.434 4.08 744.0455 2,229.11 2,230.12 3
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% ENGVHSLIIEPVTSR 95.00% 4.68 0.547 2.92 825.9428 1,649.87 1,650.88 2
 SAMPLE 2R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 9 11 20 9.54% ENGVHSLIIEPVTSR 95.00% 3.86 0.286 2.44 825.944 1,649.87 1,650.88 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% FKEDLLNNGQPR 95.00% 4.24 0.347 0 477.5849 1,429.73 1,430.74 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LISEIEYR 95.00% 2.14 0.268 0 511.7788 1,021.54 1,022.55 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LISEIEYR 95.00% 2.3 0.292 0 511.779 1,021.54 1,022.55 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LMVQAVNQR 95.00% 2.49 0.266 0 529.7907 1,057.57 1,058.58 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LMVQAVNQR 95.00% 2.71 0.306 0 529.7908 1,057.57 1,058.58 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LMVQAVNQR 95.00% 3.04 0.292 0 529.7913 1,057.57 1,058.58 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LMVQAVNQR 95.00% 3.09 0.318 0 529.7916 1,057.57 1,058.58 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LMVQAVNQR 95.00% 2.74 0.332 0 529.7917 1,057.57 1,058.58 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LMVQAVNQR 95.00% 2.77 0.27 0 529.7917 1,057.57 1,058.58 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LMVQAVNQR 95.00% 2.56 0.295 0 529.7918 1,057.57 1,058.58 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% ENGVHSLIIEPVTSR 95.00% 3.49 0.371 1.8 550.9639 1,649.87 1,650.88 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% ENGVHSLIIEPVTSR 95.00% 3.6 0.387 1.04 550.9644 1,649.87 1,650.88 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% ENGVHSLIIEPVTSR 95.00% 2.9 0.272 0 551.2987 1,650.87 1,650.88 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% ENGVHSLIIEPVTSR 95.00% 3.05 0.371 0 551.2991 1,650.87 1,650.88 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% ENGVHSLIIEPVTSR 95.00% 2.71 0.314 0 551.3003 1,650.88 1,650.88 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% EDAGWYTVSAK 95.00% 3.36 0.463 1.82 613.7874 1,225.56 1,226.57 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% EDAGWYTVSAK 95.00% 3.19 0.495 2.52 613.7876 1,225.56 1,226.57 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% EDAGWYTVSAK 95.00% 2.34 0.24 1.24 613.7885 1,225.56 1,226.57 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LQNTGVADGYPVRLEcR 95.00% 2.91 0.333 0 c16: Carbamidomethyl (+57.02) 649.995 1,946.96 1,947.97 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LQNTGVADGYPVRLEcR 95.00% 2.51 0.227 0 c16: Carbamidomethyl (+57.02) 650.3281 1,947.96 1,947.97 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% DAGIYTcIATNR 95.00% 2.87 0.218 1.96 c7: Carbamidomethyl (+57.02) 677.8219 1,353.63 1,354.64 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% DAGIYTcIATNR 95.00% 2.68 0.351 2.49 c7: Carbamidomethyl (+57.02) 677.8224 1,353.63 1,354.64 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% DAGIYTcIATNR 95.00% 3.03 0.516 2.57 c7: Carbamidomethyl (+57.02) 677.8239 1,353.63 1,354.64 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LQNTGVADGYPVR 95.00% 3.56 0.454 3.62 695.3568 1,388.70 1,389.71 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LQNTGVADGYPVR 95.00% 4.3 0.556 3.24 695.3584 1,388.70 1,389.71 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LQNTGVADGYPVR 95.00% 2.25 0.424 1.36 695.359 1,388.70 1,389.71 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LQNTGVADGYPVR 95.00% 3.12 0.38 2.24 695.3598 1,388.70 1,389.71 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% LQNTGVADGYPVR 95.00% 3.45 0.474 2.41 695.36 1,388.70 1,389.71 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% FKEDLLNNGQPR 95.00% 3.57 0.352 2.62 715.872 1,429.73 1,430.74 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% FFRPHFLQAPGDLTVQEGK 95.00% 6.22 0.526 4.96 730.0498 2,187.13 2,187.14 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% FFRPHFLQAPGDLTVQEGK 95.00% 4.42 0.455 5.06 730.0504 2,187.13 2,187.14 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% FFRPHFLQAPGDLTVQEGK 95.00% 4.03 0.53 4.19 730.0506 2,187.13 2,187.14 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% FFRPHFLQAPGDLTVQEGK 95.00% 3.78 0.379 4.19 730.0507 2,187.13 2,187.14 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% IASDEEIQGTKDAVIQDLER 95.00% 4.65 0.414 2.85 744.3773 2,230.11 2,230.12 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% IASDEEIQGTKDAVIQDLER 95.00% 5.62 0.461 3.96 744.3795 2,230.12 2,230.12 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% IASDEEIQGTKDAVIQDLER 95.00% 5.38 0.476 3.42 744.38 2,230.12 2,230.12 3
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% SAPAMQSSGSFNYAR 95.00% 4.93 0.625 0 787.3565 1,572.70 1,573.71 2
 SAMPLE 3 Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 38 9.98% SAPAMQSSGSFNYAR 95.00% 4.6 0.558 0 787.358 1,572.70 1,573.71 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% FKEDLLNNGQPR 95.00% 3.75 0.307 0 477.5844 1,429.73 1,430.74 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% FKEDLLNNGQPR 95.00% 4.14 0.363 0 477.5846 1,429.73 1,430.74 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% LMVQAVNQR 95.00% 2.15 0.263 0 529.7905 1,057.57 1,058.58 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% LMVQAVNQR 95.00% 2.37 0.313 0 529.7908 1,057.57 1,058.58 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% LMVQAVNQR 95.00% 2.64 0.317 0 529.7909 1,057.57 1,058.58 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% LMVQAVNQR 95.00% 2.96 0.321 0 529.7919 1,057.57 1,058.58 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% LMVQAVNQR 95.00% 3.06 0.293 0 529.792 1,057.57 1,058.58 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% LMVQAVNQR 95.00% 2.53 0.353 0 529.7921 1,057.57 1,058.58 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% LMVQAVNQR 95.00% 2.67 0.3 0 529.7921 1,057.57 1,058.58 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% ENGVHSLIIEPVTSR 95.00% 3.27 0.379 1.55 550.9643 1,649.87 1,650.88 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% ENGVHSLIIEPVTSR 95.00% 3.31 0.312 1.64 550.9643 1,649.87 1,650.88 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% ENGVHSLIIEPVTSR 95.00% 2.67 0.316 1.21 550.9645 1,649.87 1,650.88 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% ENGVHSLIIEPVTSR 95.00% 2.66 0.285 0 550.9669 1,649.88 1,650.88 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% ENGVHSLIIEPVTSR 95.00% 2.36 0.306 0 551.3001 1,650.88 1,650.88 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% EDAGWYTVSAK 95.00% 2.16 0.241 0 613.7849 1,225.55 1,226.57 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% EDAGWYTVSAK 95.00% 3.25 0.431 2.12 613.7871 1,225.56 1,226.57 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% EDAGWYTVSAK 95.00% 3.18 0.391 2.62 613.7879 1,225.56 1,226.57 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% YAALSDQGLDIK 95.00% 2.88 0.407 2.89 647.337 1,292.66 1,293.67 2 ECHB_HUMAN
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% YAALSDQGLDIK 95.00% 3.17 0.398 4.13 647.3379 1,292.66 1,293.67 2 ECHB_HUMAN
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% EAHKPPVFIEK 95.00% 1.9 0.319 0 647.8602 1,293.70 1,294.72 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% DAGIYTcIATNR 95.00% 3.52 0.561 1.62 c7: Carbamidomethyl (+57.02) 677.8232 1,353.63 1,354.64 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% DAGIYTcIATNR 95.00% 3.31 0.385 1.8 c7: Carbamidomethyl (+57.02) 677.8254 1,353.64 1,354.64 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% LQNTGVADGYPVR 95.00% 2.76 0.418 1.8 695.3593 1,388.70 1,389.71 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% LQNTGVADGYPVR 95.00% 3.75 0.469 2.59 695.3598 1,388.70 1,389.71 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% LQNTGVADGYPVR 95.00% 3.17 0.456 2.4 695.3599 1,388.70 1,389.71 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% LQNTGVADGYPVR 95.00% 3.95 0.539 2.89 695.36 1,388.70 1,389.71 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% FKEDLLNNGQPR 95.00% 3.72 0.307 3.22 715.8747 1,429.73 1,430.74 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% FFRPHFLQAPGDLTVQEGK 95.00% 4.87 0.517 4.85 730.0503 2,187.13 2,187.14 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% FFRPHFLQAPGDLTVQEGK 95.00% 4.6 0.506 4.82 730.0515 2,187.13 2,187.14 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% IASDEEIQGTKDAVIQDLER 95.00% 3.59 0.361 1.44 744.0488 2,229.12 2,230.12 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% IASDEEIQGTKDAVIQDLER 95.00% 4.27 0.368 1.68 744.3776 2,230.11 2,230.12 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% IASDEEIQGTKDAVIQDLER 95.00% 5.23 0.45 4.07 744.3787 2,230.11 2,230.12 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% IASDEEIQGTKDAVIQDLER 95.00% 4.68 0.451 4.48 744.3796 2,230.12 2,230.12 3
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% SAPAMQSSGSFNYAR 95.00% 4.66 0.591 0 787.356 1,572.70 1,573.71 2
 SAMPLE 3R Palladin  PALLD  PALLD_HUMAN 150,519.80 100.00% 11 12 35 10.80% SAPAMQSSGSFNYAR 95.00% 4.83 0.629 0 787.3561 1,572.70 1,573.71 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% LVGGKDFEQPLAISR 95.00% 2.93 0.381 0 543.9694 1,628.88 1,629.90 3
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% LVGGKDFEQPLAISR 95.00% 2.8 0.355 0 543.9741 1,628.90 1,629.90 3
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% LVGGKDFEQPLAISR 95.00% 3.39 0.319 0 544.3043 1,629.89 1,629.90 3
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% cGTGIVGVFVK 95.00% 3.37 0.55 2.57 c1: Carbamidomethyl (+57.02) 568.8087 1,135.60 1,136.61 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% cGTGIVGVFVK 95.00% 3.34 0.539 3.01 c1: Carbamidomethyl (+57.02) 568.8095 1,135.60 1,136.61 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% cGTGIVGVFVK 95.00% 1.91 0.357 0 c1: Carbamidomethyl (+57.02) 568.8122 1,135.61 1,136.61 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% cGTGIVGVFVK 95.00% 3.52 0.475 3.21 c1: Carbamidomethyl (+57.02) 568.8159 1,135.62 1,136.61 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% cGTGIVGVFVK 95.00% 3.41 0.433 1.36 c1: Carbamidomethyl (+57.02) 568.8181 1,135.62 1,136.61 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% GcTDNLTLTVAR 95.00% 2.36 0.331 0 c2: Carbamidomethyl (+57.02) 660.8283 1,319.64 1,320.66 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% GcTDNLTLTVAR 95.00% 2.67 0.249 1.92 c2: Carbamidomethyl (+57.02) 660.8315 1,319.65 1,320.66 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% SAMPFTASPASSTTAR 95.00% 3.12 0.451 0 791.8804 1,581.75 1,582.75 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% SAMPFTASPASSTTAR 95.00% 4.35 0.431 3.85 791.8811 1,581.75 1,582.75 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% VTPPEGYEVVTVFPK 95.00% 2.56 0.481 4.85 831.4422 1,660.87 1,661.88 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% VTPPEGYEVVTVFPK 95.00% 2.03 0.475 3.47 831.4588 1,660.90 1,661.88 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% VTPPEGYEVVTVFPK 95.00% 1.96 0.428 3 831.4591 1,660.90 1,661.88 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% VTPPEGYEVVTVFPK 95.00% 2.86 0.53 5.72 831.9412 1,661.87 1,661.88 2
 SAMPLE 1 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 5 5 17 21.00% VTPPEGYEVVTVFPK 95.00% 2.68 0.572 5.3 831.942 1,661.87 1,661.88 2
 SAMPLE 1R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 4 4 9 16.70% LVGGKDFEQPLAISR 95.00% 2.8 0.355 0 543.9741 1,628.90 1,629.90 3
 SAMPLE 1R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 4 4 9 16.70% cGTGIVGVFVK 95.00% 1.91 0.357 0 c1: Carbamidomethyl (+57.02) 568.8122 1,135.61 1,136.61 2
 SAMPLE 1R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 4 4 9 16.70% cGTGIVGVFVK 95.00% 3.52 0.475 4.15 c1: Carbamidomethyl (+57.02) 568.8159 1,135.62 1,136.61 2
 SAMPLE 1R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 4 4 9 16.70% cGTGIVGVFVK 95.00% 3.41 0.433 1.38 c1: Carbamidomethyl (+57.02) 568.8181 1,135.62 1,136.61 2
 SAMPLE 1R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 4 4 9 16.70% IKGcTDNLTLTVAR 95.00% 1.9 0.302 0 c4: Carbamidomethyl (+57.02) 781.3835 1,560.75 1,561.84 2
 SAMPLE 1R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 4 4 9 16.70% VTPPEGYEVVTVFPK 95.00% 2.56 0.481 4.54 831.4422 1,660.87 1,661.88 2
 SAMPLE 1R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 4 4 9 16.70% VTPPEGYEVVTVFPK 95.00% 2.27 0.593 1.96 831.4583 1,660.90 1,661.88 2
 SAMPLE 1R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 4 4 9 16.70% VTPPEGYEVVTVFPK 95.00% 2.03 0.481 2.62 831.4595 1,660.90 1,661.88 2
 SAMPLE 1R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 4 4 9 16.70% VTPPEGYEVVTVFPK 95.00% 2.06 0.444 3.89 831.9452 1,661.87 1,661.88 2
 SAMPLE 2R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 3 3 6 12.80% LVGGKDFEQPLAISR 95.00% 2.31 0.259 0 543.97 1,628.89 1,629.90 3
 SAMPLE 2R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 3 3 6 12.80% cGTGIVGVFVK 95.00% 2.7 0.414 3.03 c1: Carbamidomethyl (+57.02) 568.8079 1,135.60 1,136.61 2
 SAMPLE 2R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 3 3 6 12.80% cGTGIVGVFVK 95.00% 3.04 0.453 2.26 c1: Carbamidomethyl (+57.02) 568.8097 1,135.60 1,136.61 2
 SAMPLE 2R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 3 3 6 12.80% cGTGIVGVFVK 95.00% 3.13 0.466 1.85 c1: Carbamidomethyl (+57.02) 568.81 1,135.60 1,136.61 2
 SAMPLE 2R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 3 3 6 12.80% cGTGIVGVFVK 95.00% 2.52 0.455 0 c1: Carbamidomethyl (+57.02) 568.8106 1,135.61 1,136.61 2
 SAMPLE 2R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 3 3 6 12.80% SAMPFTASPASSTTAR 95.00% 2.79 0.331 2.77 792.3789 1,582.74 1,582.75 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% VWSPLVTEEGKR 95.00% 2.14 0.378 0 467.59 1,399.75 1,400.75 3
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% VWSPLVTEEGKR 95.00% 2.57 0.367 0 467.5904 1,399.75 1,400.75 3
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% IKGcTDNLTLTVAR 95.00% 3.58 0.297 0 c4: Carbamidomethyl (+57.02) 521.283 1,560.83 1,561.84 3
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% IKGcTDNLTLTVAR 95.00% 2.88 0.175 1.03 c4: Carbamidomethyl (+57.02) 521.2834 1,560.83 1,561.84 3
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% IKGcTDNLTLTVAR 95.00% 3.19 0.254 1.1 c4: Carbamidomethyl (+57.02) 521.284 1,560.83 1,561.84 3
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% LVGGKDFEQPLAISR 95.00% 3.17 0.44 1.68 543.9689 1,628.88 1,629.90 3
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% LVGGKDFEQPLAISR 95.00% 3.03 0.322 1.38 543.9693 1,628.88 1,629.90 3
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% LVGGKDFEQPLAISR 95.00% 2.74 0.352 0 543.9694 1,628.88 1,629.90 3
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% LVGGKDFEQPLAISR 95.00% 3.29 0.331 0 544.3043 1,629.89 1,629.90 3
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% cGTGIVGVFVK 95.00% 3.43 0.504 2.54 c1: Carbamidomethyl (+57.02) 568.8098 1,135.60 1,136.61 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% cGTGIVGVFVK 95.00% 3.37 0.509 1.89 c1: Carbamidomethyl (+57.02) 569.3125 1,136.61 1,136.61 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% SEHKVWSPLVTEEGK 95.00% 2.49 0.198 0 575.9634 1,724.87 1,725.88 3
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% DFEQPLAISR 95.00% 2.41 0.246 0 588.3048 1,174.59 1,175.61 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% DFEQPLAISR 95.00% 3.05 0.395 2.22 588.3059 1,174.60 1,175.61 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% DFEQPLAISR 95.00% 2.74 0.307 1.19 588.3064 1,174.60 1,175.61 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% HPEcYVcTDcGTNLK 95.00% 3.76 0.452 2.1 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 618.5908 1,852.75 1,853.76 3
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% VWSPLVTEEGK 95.00% 2.23 0.301 1.52 622.829 1,243.64 1,244.65 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% GcTDNLTLTVAR 95.00% 2.99 0.436 2.47 c2: Carbamidomethyl (+57.02) 660.831 1,319.65 1,320.66 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% GcTDNLTLTVAR 95.00% 2.61 0.407 0 c2: Carbamidomethyl (+57.02) 660.8325 1,319.65 1,320.66 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% IKGcTDNLTLTVAR 95.00% 4.02 0.56 3 c4: Carbamidomethyl (+57.02) 781.4199 1,560.82 1,561.84 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% IKGcTDNLTLTVAR 95.00% 4.49 0.508 3.26 c4: Carbamidomethyl (+57.02) 781.4219 1,560.83 1,561.84 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% SAMPFTASPASSTTAR 95.00% 4.17 0.411 3.62 791.8787 1,581.74 1,582.75 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% SAMPFTASPASSTTAR 95.00% 4.05 0.429 2.89 791.8792 1,581.74 1,582.75 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% SAMPFTASPASSTTAR 95.00% 3.99 0.445 4.77 792.3827 1,582.75 1,582.75 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% SAmPFTASPASSTTAR 95.00% 4.39 0.673 4.55 m3: Oxidation (+15.99) 799.8759 1,597.74 1,598.75 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% SAmPFTASPASSTTAR 95.00% 5 0.673 3.38 m3: Oxidation (+15.99) 799.8783 1,597.74 1,598.75 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% LVGGKDFEQPLAISR 95.00% 4.87 0.461 2.68 815.4525 1,628.89 1,629.90 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% LVGGKDFEQPLAISR 95.00% 4.78 0.473 3.68 815.4525 1,628.89 1,629.90 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% VTPPEGYEVVTVFPK 95.00% 1.98 0.579 2.42 831.4431 1,660.87 1,661.88 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% VTPPEGYEVVTVFPK 95.00% 2.53 0.459 4.77 831.9437 1,661.87 1,661.88 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% GHFFVEDQIYcEK 95.00% 3.34 0.366 1.51 c11: Carbamidomethyl (+57.02) 836.9297 1,671.84 1,671.75 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% GHFFVEDQIYcEK 95.00% 3.56 0.412 2.92 c11: Carbamidomethyl (+57.02) 836.9312 1,671.85 1,671.75 2
 SAMPLE 3 PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 14 33 35.00% GHFFVEDQIYcEK 95.00% 3.22 0.278 1.17 c11: Carbamidomethyl (+57.02) 836.9504 1,671.89 1,671.75 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% VWSPLVTEEGKR 95.00% 1.78 0.272 0 467.5903 1,399.75 1,400.75 3
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% IKGcTDNLTLTVAR 95.00% 2.98 0.209 1.74 c4: Carbamidomethyl (+57.02) 521.2825 1,560.82 1,561.84 3
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% IKGcTDNLTLTVAR 95.00% 2.96 0.243 1.17 c4: Carbamidomethyl (+57.02) 521.2831 1,560.83 1,561.84 3
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% IKGcTDNLTLTVAR 95.00% 2.34 0.198 0 c4: Carbamidomethyl (+57.02) 521.2837 1,560.83 1,561.84 3
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% IKGcTDNLTLTVAR 95.00% 3.52 0.294 0 c4: Carbamidomethyl (+57.02) 521.6189 1,561.83 1,561.84 3
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% LVGGKDFEQPLAISR 95.00% 3.05 0.358 0 543.9687 1,628.88 1,629.90 3
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% LVGGKDFEQPLAISR 95.00% 3.04 0.417 1.07 543.9692 1,628.88 1,629.90 3
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% LVGGKDFEQPLAISR 95.00% 3.23 0.393 2.24 543.9703 1,628.89 1,629.90 3
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% VTPPEGYEVVTVFPK 95.00% 2.65 0.316 0 554.6294 1,660.86 1,661.88 3
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% VTPPEGYEVVTVFPK 95.00% 3.3 0.462 0 554.9663 1,661.88 1,661.88 3
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% cGTGIVGVFVK 95.00% 3.33 0.541 0 c1: Carbamidomethyl (+57.02) 568.8091 1,135.60 1,136.61 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% cGTGIVGVFVK 95.00% 3.43 0.494 1.92 c1: Carbamidomethyl (+57.02) 568.8094 1,135.60 1,136.61 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% DFEQPLAISR 95.00% 2.52 0.291 1.7 588.3027 1,174.59 1,175.61 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% DFEQPLAISR 95.00% 2.62 0.234 1.41 588.3039 1,174.59 1,175.61 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% DFEQPLAISR 95.00% 2.22 0.255 1.92 588.3055 1,174.60 1,175.61 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% DFEQPLAISR 95.00% 2.27 0.179 1.89 588.3087 1,174.60 1,175.61 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% HPEcYVcTDcGTNLK 95.00% 3.93 0.484 1.96 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 618.9229 1,853.75 1,853.76 3
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% VWSPLVTEEGK 95.00% 2.49 0.307 0 622.8294 1,243.64 1,244.65 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% GcTDNLTLTVAR 95.00% 2.43 0.423 2.07 c2: Carbamidomethyl (+57.02) 660.8317 1,319.65 1,320.66 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% GcTDNLTLTVAR 95.00% 3.01 0.449 1.96 c2: Carbamidomethyl (+57.02) 660.8318 1,319.65 1,320.66 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% IKGcTDNLTLTVAR 95.00% 4.29 0.5 4.68 c4: Carbamidomethyl (+57.02) 781.4208 1,560.83 1,561.84 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% IKGcTDNLTLTVAR 95.00% 4.1 0.503 3.44 c4: Carbamidomethyl (+57.02) 781.9248 1,561.83 1,561.84 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% SAMPFTASPASSTTAR 95.00% 3.98 0.439 3.77 791.8797 1,581.74 1,582.75 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% SAMPFTASPASSTTAR 95.00% 3.98 0.452 3.1 791.88 1,581.74 1,582.75 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% SAMPFTASPASSTTAR 95.00% 3.76 0.447 3.54 791.8805 1,581.75 1,582.75 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% SAMPFTASPASSTTAR 95.00% 3.02 0.475 2.35 791.882 1,581.75 1,582.75 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% SAmPFTASPASSTTAR 95.00% 4.22 0.614 2.46 m3: Oxidation (+15.99) 799.8812 1,597.75 1,598.75 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% SAmPFTASPASSTTAR 95.00% 4.55 0.574 1.43 m3: Oxidation (+15.99) 800.379 1,598.74 1,598.75 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% LVGGKDFEQPLAISR 95.00% 4.6 0.483 2.23 815.4546 1,628.89 1,629.90 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% LVGGKDFEQPLAISR 95.00% 4.66 0.465 2.06 815.4554 1,628.90 1,629.90 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% VTPPEGYEVVTVFPK 95.00% 2.17 0.5 2.08 831.4425 1,660.87 1,661.88 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% VTPPEGYEVVTVFPK 95.00% 2.3 0.574 4.01 831.4439 1,660.87 1,661.88 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% VTPPEGYEVVTVFPK 95.00% 2.69 0.57 6.33 831.9438 1,661.87 1,661.88 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% VTPPEGYEVVTVFPK 95.00% 2.99 0.639 5.16 831.9453 1,661.87 1,661.88 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% GHFFVEDQIYcEK 95.00% 3.88 0.435 3.68 c11: Carbamidomethyl (+57.02) 836.9291 1,671.84 1,671.75 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% GHFFVEDQIYcEK 95.00% 3.2 0.359 0 c11: Carbamidomethyl (+57.02) 836.9317 1,671.85 1,671.75 2
 SAMPLE 3R PDZ and LIM domain protein 1  PDLIM1  PDLI1_HUMAN 36,053.30 100.00% 12 15 37 43.20% AALANLcIGDVITAIDGENTSNMTHLEAQNR 95.00% 5.38 0.616 4.2 c7: Carbamidomethyl (+57.02) 1,105.20 3,312.57 3,312.60 3
 SAMPLE 1 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 99.80% 2 2 8 7.14% cGSGIVGAVVK 95.00% 3.14 0.377 2.15 c1: Carbamidomethyl (+57.02) 523.7883 1,045.56 1,046.57 2
 SAMPLE 1 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 99.80% 2 2 8 7.14% cGSGIVGAVVK 95.00% 2.82 0.294 2.44 c1: Carbamidomethyl (+57.02) 523.7887 1,045.56 1,046.57 2
 SAMPLE 1 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 99.80% 2 2 8 7.14% LSGGIDFNQPLVITR 95.00% 4.51 0.518 2.92 815.4501 1,628.88 1,629.90 2
 SAMPLE 1 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 99.80% 2 2 8 7.14% LSGGIDFNQPLVITR 95.00% 3.95 0.554 1.48 815.4509 1,628.89 1,629.90 2
 SAMPLE 1 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 99.80% 2 2 8 7.14% LSGGIDFNQPLVITR 95.00% 4.54 0.506 2.19 815.4588 1,628.90 1,629.90 2
 SAMPLE 1 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 99.80% 2 2 8 7.14% LSGGIDFNQPLVITR 95.00% 4.39 0.458 2.96 815.4618 1,628.91 1,629.90 2
 SAMPLE 1 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 99.80% 2 2 8 7.14% LSGGIDFNQPLVITR 95.00% 4.3 0.507 2.12 815.4662 1,628.92 1,629.90 2
 SAMPLE 1 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 99.80% 2 2 8 7.14% LSGGIDFNQPLVITR 95.00% 4.64 0.499 2.64 815.952 1,629.89 1,629.90 2
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% cGSGIVGAVVK 95.00% 2.66 0.277 2.41 c1: Carbamidomethyl (+57.02) 523.7851 1,045.55 1,046.57 2
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% cGSGIVGAVVK 95.00% 2.73 0.442 2.7 c1: Carbamidomethyl (+57.02) 523.7851 1,045.55 1,046.57 2
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% cGSGIVGAVVK 95.00% 3.68 0.386 3.26 c1: Carbamidomethyl (+57.02) 523.7856 1,045.56 1,046.57 2
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% cGSGIVGAVVK 95.00% 3.73 0.381 3.7 c1: Carbamidomethyl (+57.02) 523.7859 1,045.56 1,046.57 2
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% TKPPEGYDTVTLYPK 95.00% 3.74 0.441 2.49 570.6293 1,708.86 1,708.88 3
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% TKPPEGYDTVTLYPK 95.00% 3.43 0.402 2.57 570.6316 1,708.87 1,708.88 3
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% VLQGMVDDGSDDRPAGTR 95.00% 2.83 0.338 2.74 630.2977 1,887.87 1,888.88 3
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% VLQGMVDDGSDDRPAGTR 95.00% 2.29 0.384 2.23 630.2978 1,887.87 1,888.88 3
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% VLQGmVDDGSDDRPAGTR 95.00% 2.18 0.281 0 m5: Oxidation (+15.99) 635.6295 1,903.86 1,904.88 3
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% VLQGmVDDGSDDRPAGTR 95.00% 2.52 0.249 0 m5: Oxidation (+15.99) 635.634 1,903.88 1,904.88 3
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% VLQGmVDDGSDDRPAGTR 95.00% 2.8 0.47 0 m5: Oxidation (+15.99) 635.9651 1,904.87 1,904.88 3
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% IDRGETHLWSPQVSEDGK 95.00% 3.25 0.322 2.6 685.67 2,053.99 2,053.99 3
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% IDRGETHLWSPQVSEDGK 95.00% 3.83 0.355 3.35 685.6711 2,053.99 2,053.99 3
 SAMPLE 2 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 5 5 14 21.20% LSGGIDFNQPLVITR 95.00% 3.88 0.496 2.12 815.4543 1,628.89 1,629.90 2
 SAMPLE 2R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 4 4 10 17.00% cGSGIVGAVVK 95.00% 3.56 0.401 2.77 c1: Carbamidomethyl (+57.02) 523.7851 1,045.55 1,046.57 2
 SAMPLE 2R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 4 4 10 17.00% cGSGIVGAVVK 95.00% 2.73 0.309 1.51 c1: Carbamidomethyl (+57.02) 523.7856 1,045.56 1,046.57 2
 SAMPLE 2R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 4 4 10 17.00% cGSGIVGAVVK 95.00% 2.67 0.246 2.15 c1: Carbamidomethyl (+57.02) 523.7864 1,045.56 1,046.57 2
 SAMPLE 2R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 4 4 10 17.00% cGSGIVGAVVK 95.00% 3.56 0.359 2.64 c1: Carbamidomethyl (+57.02) 523.7866 1,045.56 1,046.57 2
 SAMPLE 2R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 4 4 10 17.00% VLQGMVDDGSDDRPAGTR 95.00% 2.56 0.272 2.74 630.2985 1,887.87 1,888.88 3
 SAMPLE 2R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 4 4 10 17.00% VLQGmVDDGSDDRPAGTR 95.00% 2.5 0.438 1.07 m5: Oxidation (+15.99) 635.6323 1,903.87 1,904.88 3
 SAMPLE 2R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 4 4 10 17.00% VLQGmVDDGSDDRPAGTR 95.00% 2.01 0.252 0 m5: Oxidation (+15.99) 635.6326 1,903.87 1,904.88 3
 SAMPLE 2R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 4 4 10 17.00% VLQGmVDDGSDDRPAGTR 95.00% 2.57 0.444 0 m5: Oxidation (+15.99) 635.9669 1,904.88 1,904.88 3
 SAMPLE 2R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 4 4 10 17.00% IDRGETHLWSPQVSEDGK 95.00% 3.88 0.45 2.43 685.6699 2,053.99 2,053.99 3
 SAMPLE 2R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 4 4 10 17.00% LSGGIDFNQPLVITR 95.00% 3.97 0.442 2.16 815.9533 1,629.89 1,629.90 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% cGSGIVGAVVK 95.00% 2.98 0.432 2.62 c1: Carbamidomethyl (+57.02) 523.7859 1,045.56 1,046.57 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% cGSGIVGAVVK 95.00% 3.93 0.365 2.15 c1: Carbamidomethyl (+57.02) 523.7859 1,045.56 1,046.57 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% cGSGIVGAVVK 95.00% 3.48 0.377 4.82 c1: Carbamidomethyl (+57.02) 523.7861 1,045.56 1,046.57 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% cGSGIVGAVVK 95.00% 3.71 0.383 3.47 c1: Carbamidomethyl (+57.02) 523.7861 1,045.56 1,046.57 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% TKPPEGYDTVTLYPKA 95.00% 2.22 0.386 0 593.9754 1,778.90 1,779.92 3
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% TKPPEGYDTVTLYPKA 95.00% 2.34 0.38 0 593.9758 1,778.90 1,779.92 3
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% TKPPEGYDTVTLYPKA 95.00% 1.85 0.281 0 593.9765 1,778.91 1,779.92 3
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGMVDDGSDDRPAGTR 95.00% 2.25 0.363 1.02 630.2964 1,887.87 1,888.88 3
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGMVDDGSDDRPAGTR 95.00% 2.37 0.336 2.07 630.6319 1,888.87 1,888.88 3
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGMVDDGSDDRPAGTR 95.00% 2.14 0.24 1.96 630.6323 1,888.87 1,888.88 3
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGMVDDGSDDRPAGTR 95.00% 2.76 0.398 3.06 630.6324 1,888.87 1,888.88 3
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGmVDDGSDDRPAGTR 95.00% 3.45 0.534 0 m5: Oxidation (+15.99) 635.6301 1,903.87 1,904.88 3
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGmVDDGSDDRPAGTR 95.00% 2.85 0.386 0 m5: Oxidation (+15.99) 635.6318 1,903.87 1,904.88 3
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% IDRGETHLWSPQVSEDGK 95.00% 3.43 0.427 3.51 685.669 2,053.98 2,053.99 3
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% LSGGIDFNQPLVITR 95.00% 4.51 0.509 3.28 815.4515 1,628.89 1,629.90 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% LSGGIDFNQPLVITR 95.00% 4.48 0.457 2.4 815.9514 1,629.89 1,629.90 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% TKPPEGYDTVTLYPK 95.00% 2.74 0.413 2.82 854.9428 1,707.87 1,708.88 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% TKPPEGYDTVTLYPK 95.00% 2.88 0.532 2.1 854.9432 1,707.87 1,708.88 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGMVDDGSDDRPAGTR 95.00% 4.46 0.519 2.37 944.9425 1,887.87 1,888.88 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGMVDDGSDDRPAGTR 95.00% 4.36 0.49 1.96 945.4436 1,888.87 1,888.88 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGmVDDGSDDRPAGTR 95.00% 2.92 0.489 1.66 m5: Oxidation (+15.99) 953.4366 1,904.86 1,904.88 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGmVDDGSDDRPAGTR 95.00% 2.93 0.46 1.14 m5: Oxidation (+15.99) 953.4411 1,904.87 1,904.88 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGmVDDGSDDRPAGTR 95.00% 3.28 0.499 1.57 m5: Oxidation (+15.99) 953.4437 1,904.87 1,904.88 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGmVDDGSDDRPAGTR 95.00% 3.41 0.529 2.04 m5: Oxidation (+15.99) 953.446 1,904.88 1,904.88 2
 SAMPLE 3 PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 6 7 25 21.40% VLQGmVDDGSDDRPAGTR 95.00% 3.06 0.457 0 m5: Oxidation (+15.99) 953.4502 1,904.88 1,904.88 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% cGSGIVGAVVK 95.00% 2.05 0.232 1.07 c1: Carbamidomethyl (+57.02) 523.7854 1,045.56 1,046.57 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% cGSGIVGAVVK 95.00% 3.52 0.376 3.7 c1: Carbamidomethyl (+57.02) 523.786 1,045.56 1,046.57 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% cGSGIVGAVVK 95.00% 3.84 0.364 2.96 c1: Carbamidomethyl (+57.02) 523.7863 1,045.56 1,046.57 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% cGSGIVGAVVK 95.00% 3.56 0.386 2.85 c1: Carbamidomethyl (+57.02) 523.7864 1,045.56 1,046.57 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% GETHLWSPQVSEDGK 95.00% 2.53 0.204 1.31 557.2626 1,668.76 1,669.78 3
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% TKPPEGYDTVTLYPKA 95.00% 2.63 0.285 0 593.975 1,778.90 1,779.92 3
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% TKPPEGYDTVTLYPKA 95.00% 2.29 0.354 0 593.9753 1,778.90 1,779.92 3
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% VLQGMVDDGSDDRPAGTR 95.00% 2.29 0.352 1.92 630.297 1,887.87 1,888.88 3
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% VLQGMVDDGSDDRPAGTR 95.00% 2.32 0.396 2.46 630.2974 1,887.87 1,888.88 3
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% VLQGMVDDGSDDRPAGTR 95.00% 2.77 0.345 1.46 630.6307 1,888.87 1,888.88 3
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% VLQGMVDDGSDDRPAGTR 95.00% 2.04 0.25 1.19 630.6316 1,888.87 1,888.88 3
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% VLQGmVDDGSDDRPAGTR 95.00% 2.13 0.239 0 m5: Oxidation (+15.99) 635.6317 1,903.87 1,904.88 3
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% VLQGmVDDGSDDRPAGTR 95.00% 3.46 0.411 1.96 m5: Oxidation (+15.99) 635.9655 1,904.87 1,904.88 3
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% IDRGETHLWSPQVSEDGK 95.00% 3.46 0.407 2.47 685.3328 2,052.97 2,053.99 3
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% LSGGIDFNQPLVITR 95.00% 4.54 0.516 3.14 815.4514 1,628.89 1,629.90 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% LSGGIDFNQPLVITR 95.00% 4.6 0.503 1.92 815.9522 1,629.89 1,629.90 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% TKPPEGYDTVTLYPK 95.00% 2.93 0.484 2.26 854.9442 1,707.87 1,708.88 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% TKPPEGYDTVTLYPK 95.00% 2.85 0.419 2.24 854.9461 1,707.88 1,708.88 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% TKPPEGYDTVTLYPK 95.00% 2.75 0.535 3.09 855.4442 1,708.87 1,708.88 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% TKPPEGYDTVTLYPK 95.00% 2.19 0.496 1.41 855.446 1,708.88 1,708.88 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% HPEcFVcADcNLNLK 95.00% 2.92 0.47 1.37 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 938.9074 1,875.80 1,876.81 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% VLQGMVDDGSDDRPAGTR 95.00% 4.46 0.511 2.54 945.4445 1,888.87 1,888.88 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% VLQGmVDDGSDDRPAGTR 95.00% 2.71 0.393 0 m5: Oxidation (+15.99) 953.4435 1,904.87 1,904.88 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% VLQGmVDDGSDDRPAGTR 95.00% 2.55 0.283 0 m5: Oxidation (+15.99) 953.4445 1,904.87 1,904.88 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% VLQGmVDDGSDDRPAGTR 95.00% 3.01 0.417 1.17 m5: Oxidation (+15.99) 953.4445 1,904.87 1,904.88 2
 SAMPLE 3R PDZ and LIM domain protein 3  PDLIM3  PDLI3_HUMAN 39,214.50 100.00% 8 9 26 25.50% VLQGmVDDGSDDRPAGTR 95.00% 2.92 0.334 0 m5: Oxidation (+15.99) 953.4452 1,904.87 1,904.88 2
 SAMPLE 1 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 99.80% 2 2 5 7.58% VDLGSEVYR 95.00% 1.93 0.25 1.16 519.2704 1,036.53 1,037.53 2
 SAMPLE 1 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 99.80% 2 2 5 7.58% VDLGSEVYR 95.00% 2.03 0.28 2.42 519.3014 1,036.59 1,037.53 2
 SAMPLE 1 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 99.80% 2 2 5 7.58% LGAPLSGLQGLPEcTR 95.00% 4.82 0.542 3.85 c14: Carbamidomethyl (+57.02) 834.9397 1,667.86 1,668.87 2
 SAMPLE 1 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 99.80% 2 2 5 7.58% LGAPLSGLQGLPEcTR 95.00% 3.85 0.582 1.96 c14: Carbamidomethyl (+57.02) 834.9502 1,667.88 1,668.87 2
 SAMPLE 1 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 99.80% 2 2 5 7.58% LGAPLSGLQGLPEcTR 95.00% 3.83 0.484 2.82 c14: Carbamidomethyl (+57.02) 835.4405 1,668.87 1,668.87 2
 SAMPLE 1R PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 2 2 2 7.27% GYFFLDER 95.00% 2.74 0.389 1.42 523.76 1,045.50 1,046.49 2
 SAMPLE 1R PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 2 2 2 7.27% LGAPLSGLQGLPEcTR 95.00% 3.85 0.582 1.74 c14: Carbamidomethyl (+57.02) 834.9502 1,667.88 1,668.87 2
 SAMPLE 3 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 9 19.70% MLREPAEPVAAEPK 95.00% 2.78 0.349 0 513.2711 1,536.79 1,537.81 3
 SAMPLE 3 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 9 19.70% MLREPAEPVAAEPK 95.00% 2.32 0.14 1.03 513.2713 1,536.79 1,537.81 3
 SAMPLE 3 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 9 19.70% GYFFLDER 95.00% 2.8 0.353 0 523.7495 1,045.48 1,046.49 2
 SAMPLE 3 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 9 19.70% DFSAPLTISR 95.00% 2.28 0.307 2.46 553.7953 1,105.57 1,106.58 2
 SAMPLE 3 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 9 19.70% DFSAPLTISR 95.00% 1.93 0.173 2.19 553.7958 1,105.58 1,106.58 2
 SAMPLE 3 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 9 19.70% VKPPEGYDVVAVYPNAK 95.00% 3.02 0.405 1.25 615.997 1,844.97 1,845.98 3
 SAMPLE 3 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 9 19.70% VKPPEGYDVVAVYPNAK 95.00% 3.51 0.413 0 616.3303 1,845.97 1,845.98 3
 SAMPLE 3 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 9 19.70% LGAPLSGLQGLPEcTR 95.00% 3.88 0.525 1.11 c14: Carbamidomethyl (+57.02) 835.4398 1,668.86 1,668.87 2
 SAMPLE 3 PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 9 19.70% LGAPLSGLQGLPEcTR 95.00% 3.26 0.513 1.89 c14: Carbamidomethyl (+57.02) 835.4416 1,668.87 1,668.87 2
 SAMPLE 3R PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 8 18.20% VDLGSEVYR 95.00% 1.81 0.29 2.42 519.9478 1,037.88 1,037.53 2
 SAMPLE 3R PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 8 18.20% VDLGSEVYR 95.00% 1.79 0.297 2 519.9483 1,037.88 1,037.53 2
 SAMPLE 3R PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 8 18.20% GYFFLDER 95.00% 2.37 0.401 0 523.7482 1,045.48 1,046.49 2
 SAMPLE 3R PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 8 18.20% GYFFLDER 95.00% 2.34 0.452 0 523.7489 1,045.48 1,046.49 2
 SAMPLE 3R PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 8 18.20% DFSAPLTISR 95.00% 2.14 0.22 1.64 553.7954 1,105.58 1,106.58 2
 SAMPLE 3R PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 8 18.20% DFSAPLTISR 95.00% 2.1 0.113 1.92 553.7962 1,105.58 1,106.58 2
 SAMPLE 3R PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 8 18.20% VKPPEGYDVVAVYPNAK 95.00% 3.01 0.327 0 616.3311 1,845.97 1,845.98 3
 SAMPLE 3R PDZ and LIM domain protein 4  PDLIM4  PDLI4_HUMAN 35,380.20 100.00% 5 5 8 18.20% LGAPLSGLQGLPEcTR 95.00% 2.42 0.417 2.21 c14: Carbamidomethyl (+57.02) 834.9409 1,667.87 1,668.87 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% GPFLVALGK 95.00% 1.72 0.236 1.77 450.9309 899.8462 901.5513 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% GPFLVALGK 95.00% 2.42 0.373 1.64 450.9351 899.8545 901.5513 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% GPFLVALGK 95.00% 2.97 0.376 1.12 451.2797 900.5438 901.5513 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% GPFLVALGK 95.00% 3.02 0.393 1.7 451.2801 900.5446 901.5513 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% GPFLVALGK 95.00% 3.05 0.391 0 451.2802 900.5447 901.5513 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% GPFLVALGK 95.00% 3.27 0.378 1.17 451.2809 900.5462 901.5513 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% GPFLVALGK 95.00% 2.91 0.404 0 451.2812 900.5467 901.5513 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% GPFLVALGK 95.00% 3.18 0.386 1.23 451.2812 900.5468 901.5513 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% GPFLVALGK 95.00% 3.08 0.383 1.12 451.2832 900.5508 901.5513 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% GPFLVALGK 95.00% 2.94 0.359 0 451.2853 900.555 901.5513 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% GPFLVALGK 95.00% 2.21 0.289 0 451.2863 900.557 901.5513 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% ILGEVINALK 95.00% 3.23 0.395 3.42 535.3312 1,068.65 1,069.66 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% ILGEVINALK 95.00% 3.17 0.39 2.43 535.3326 1,068.65 1,069.66 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% ILGEVINALK 95.00% 2.73 0.299 0 535.3398 1,068.66 1,069.66 2
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% SPSWQRPNQGVPSTGR 95.00% 3.27 0.252 0 585.2939 1,752.86 1,753.87 3
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% SPSWQRPNQGVPSTGR 95.00% 3.14 0.341 0 585.6277 1,753.86 1,753.87 3
 SAMPLE 1 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 17 7.72% GALYcELcYEK 95.00% 2.23 0.352 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 703.8122 1,405.61 1,405.61 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% GPFLVALGK 95.00% 2.42 0.373 0 450.9351 899.8545 901.5513 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% GPFLVALGK 95.00% 2.16 0.401 1.74 451.2804 900.5452 901.5513 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% GPFLVALGK 95.00% 2.48 0.422 0 451.281 900.5463 901.5513 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% GPFLVALGK 95.00% 2.72 0.405 0 451.2812 900.5467 901.5513 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% GPFLVALGK 95.00% 3.08 0.383 0 451.2832 900.5508 901.5513 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% GPFLVALGK 95.00% 2.94 0.359 0 451.2853 900.555 901.5513 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% GPFLVALGK 95.00% 2.21 0.289 0 451.2863 900.557 901.5513 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% GPFLVALGK 95.00% 3.23 0.343 1.33 451.2867 900.5577 901.5513 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% ILGEVINALK 95.00% 2.73 0.299 0 535.3398 1,068.66 1,069.66 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% ILGEVINALK 95.00% 2.81 0.401 1.11 535.3437 1,068.67 1,069.66 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% ILGEVINALK 95.00% 3.25 0.441 2.31 535.3438 1,068.67 1,069.66 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% ILGEVINALK 95.00% 2.61 0.314 1.68 535.3452 1,068.67 1,069.66 2
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% SPSWQRPNQGVPSTGR 95.00% 2.72 0.251 0 585.2947 1,752.86 1,753.87 3
 SAMPLE 1R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 4 4 14 7.72% GALYcELcYEK 95.00% 2.23 0.352 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 703.8122 1,405.61 1,405.61 2
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% GPFLVALGK 95.00% 2.79 0.351 0 451.2792 900.5427 901.5513 2
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% GPFLVALGK 95.00% 3.29 0.393 0 451.2798 900.5439 901.5513 2
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% GPFLVALGK 95.00% 3.31 0.349 0 451.2805 900.5454 901.5513 2
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% GPFLVALGK 95.00% 2.74 0.39 0 451.2808 900.5459 901.5513 2
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% FFAPEcGR 95.00% 2.07 0.325 0 c6: Carbamidomethyl (+57.02) 492.2234 982.4311 983.441 2 IQGA1_HUMAN
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% FFAPEcGR 95.00% 2.06 0.263 0 c6: Carbamidomethyl (+57.02) 492.2234 982.4312 983.441 2 IQGA1_HUMAN
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% FFAPEcGR 95.00% 2.25 0.35 1.15 c6: Carbamidomethyl (+57.02) 492.2238 982.4319 983.441 2 IQGA1_HUMAN
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% TPMcAHcNQVIR 95.00% 2.71 0.352 0 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 496.2271 1,485.66 1,486.67 3
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% TPMcAHcNQVIR 95.00% 3.15 0.454 0 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 496.2287 1,485.66 1,486.67 3
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% SWHPEEFNcAHcK 95.00% 3.25 0.441 0 c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 567.8998 1,700.68 1,701.69 3
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% SPSWQRPNQGVPSTGR 95.00% 2.72 0.293 0 585.2938 1,752.86 1,753.87 3
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% YTEFYHVPTHSDASK 95.00% 2.36 0.17 2.49 594.9454 1,781.81 1,781.81 3
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% GcTGSLNMTLQR 95.00% 2.66 0.314 0 c2: Carbamidomethyl (+57.02) 669.3189 1,336.62 1,337.63 2 UBIQ_HUMAN
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% EVVKPVPITSPAVSK 95.00% 3.89 0.531 3.55 775.9599 1,549.90 1,550.92 2
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% EVVKPVPITSPAVSK 95.00% 3.52 0.542 3.7 776.4638 1,550.91 1,550.92 2
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% SPSWQRPNQGVPSTGR 95.00% 3.7 0.254 2.04 877.4413 1,752.87 1,753.87 2
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% SPSWQRPNQGVPSTGR 95.00% 3.18 0.33 2.62 877.9425 1,753.87 1,753.87 2
 SAMPLE 2 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 7 9 15 16.80% YTEFYHVPTHSDASK 95.00% 3.78 0.583 3.96 891.4102 1,780.80 1,781.81 2
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% GPFLVALGK 95.00% 1.79 0.297 1.96 451.2662 900.5168 901.5513 2
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% GPFLVALGK 95.00% 2.97 0.381 0 451.2794 900.5431 901.5513 2
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% GPFLVALGK 95.00% 2.65 0.399 0 451.2795 900.5434 901.5513 2
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% GPFLVALGK 95.00% 3.32 0.353 0 451.28 900.5443 901.5513 2
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% GPFLVALGK 95.00% 3.1 0.343 0 451.2805 900.5453 901.5513 2
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% GPFLVALGK 95.00% 2.81 0.404 0 451.2814 900.5472 901.5513 2
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% GPFLVALGK 95.00% 3.05 0.356 0 451.2829 900.5501 901.5513 2
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% FFAPEcGR 95.00% 1.96 0.241 1.41 c6: Carbamidomethyl (+57.02) 492.2221 982.4285 983.441 2 IQGA1_HUMAN
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% FFAPEcGR 95.00% 2.16 0.238 0 c6: Carbamidomethyl (+57.02) 492.2237 982.4317 983.441 2 IQGA1_HUMAN
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% FFAPEcGR 95.00% 2.23 0.251 0 c6: Carbamidomethyl (+57.02) 492.2253 982.435 983.441 2 IQGA1_HUMAN
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% TPMcAHcNQVIR 95.00% 2.67 0.404 0 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 496.2273 1,485.66 1,486.67 3
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% ILGEVINALK 95.00% 2.51 0.375 0 535.3319 1,068.65 1,069.66 2
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% ILGEVINALK 95.00% 2.63 0.374 1.66 535.3321 1,068.65 1,069.66 2
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% ILGEVINALK 95.00% 2.93 0.321 0 535.3329 1,068.65 1,069.66 2
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% SPSWQRPNQGVPSTGR 95.00% 3.04 0.343 1.27 585.2952 1,752.86 1,753.87 3
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% SPSWQRPNQGVPSTGR 95.00% 3.23 0.356 1.15 585.6286 1,753.86 1,753.87 3
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% GcTGSLNMTLQR 95.00% 2.5 0.319 0 c2: Carbamidomethyl (+57.02) 669.3208 1,336.63 1,337.63 2 UBIQ_HUMAN
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% EVVKPVPITSPAVSK 95.00% 2.22 0.339 0 775.9586 1,549.90 1,550.92 2
 SAMPLE 2R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 6 7 16 13.80% SPSWQRPNQGVPSTGR 95.00% 3.39 0.27 2.8 877.9405 1,753.87 1,753.87 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% GPFLVALGK 95.00% 2.8 0.437 0 450.9298 899.8439 901.5513 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% GPFLVALGK 95.00% 3.35 0.373 0 451.28 900.5443 901.5513 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% GPFLVALGK 95.00% 3.39 0.372 1.54 451.2801 900.5445 901.5513 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% GPFLVALGK 95.00% 3.38 0.339 1.72 451.2805 900.5453 901.5513 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% GPFLVALGK 95.00% 3.28 0.382 0 451.2812 900.5468 901.5513 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% FFAPEcGR 95.00% 2.35 0.405 0 c6: Carbamidomethyl (+57.02) 492.2226 982.4296 983.441 2 IQGA1_HUMAN
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% FFAPEcGR 95.00% 2.02 0.24 0 c6: Carbamidomethyl (+57.02) 492.2228 982.4299 983.441 2 IQGA1_HUMAN
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% FFAPEcGR 95.00% 2.26 0.307 0 c6: Carbamidomethyl (+57.02) 492.2228 982.4299 983.441 2 IQGA1_HUMAN
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% TPMcAHcNQVIR 95.00% 2.73 0.423 0 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 496.2287 1,485.66 1,486.67 3
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% TPMcAHcNQVIR 95.00% 2.21 0.294 0 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 496.564 1,486.67 1,486.67 3
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% ILGEVINALK 95.00% 3.02 0.309 0 535.3329 1,068.65 1,069.66 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% ILGEVINALK 95.00% 3.76 0.45 2.82 535.333 1,068.65 1,069.66 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% ILGEVINALK 95.00% 3.15 0.404 2.42 535.3335 1,068.65 1,069.66 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% SWHPEEFNcAHcK 95.00% 3.38 0.445 0 c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 567.9006 1,700.68 1,701.69 3
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% SWHPEEFNcAHcK 95.00% 3.88 0.504 0 c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 567.9007 1,700.68 1,701.69 3
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% SWHPEEFNcAHcK 95.00% 3.71 0.531 1.24 c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 568.2352 1,701.68 1,701.69 3
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% SWHPEEFNcAHcK 95.00% 3.41 0.48 1.34 c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 568.2367 1,701.69 1,701.69 3
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% SPSWQRPNQGVPSTGR 95.00% 2.77 0.246 0 585.2943 1,752.86 1,753.87 3
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% SPSWQRPNQGVPSTGR 95.00% 3.35 0.405 1.54 585.2943 1,752.86 1,753.87 3
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% SPSWQRPNQGVPSTGR 95.00% 3.39 0.408 0 585.2946 1,752.86 1,753.87 3
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% SPSWQRPNQGVPSTGR 95.00% 2.67 0.177 0 585.6296 1,753.87 1,753.87 3
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% YTEFYHVPTHSDASK 95.00% 2.82 0.4 2.39 594.6082 1,780.80 1,781.81 3
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% YTEFYHVPTHSDASK 95.00% 2.91 0.35 1.44 594.9438 1,781.81 1,781.81 3
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% KILGEVINALK 95.00% 2.55 0.254 1.74 599.3792 1,196.74 1,197.76 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% KILGEVINALK 95.00% 2.55 0.307 0 599.3813 1,196.75 1,197.76 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% GALYcELcYEK 95.00% 3.42 0.545 1.17 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 703.3097 1,404.60 1,405.61 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% GALYcELcYEK 95.00% 2.79 0.524 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 703.3101 1,404.60 1,405.61 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% TPMcAHcNQVIR 95.00% 2.23 0.386 0 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 743.8413 1,485.67 1,486.67 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% SPSWQRPNQGVPSTGR 95.00% 3.48 0.314 1.62 877.9403 1,753.86 1,753.87 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% SPSWQRPNQGVPSTGR 95.00% 3.21 0.286 2.43 877.9421 1,753.87 1,753.87 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% KANNSQEPSPQLASSVASTR 95.00% 3.55 0.56 1.49 1,036.81 2,071.61 2,072.04 2
 SAMPLE 3 PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 11 29 19.30% KANNSQEPSPQLASSVASTR 95.00% 3.67 0.541 1.92 1,036.81 2,071.61 2,072.04 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% GPFLVALGK 95.00% 1.9 0.285 1.96 450.9307 899.8457 901.5513 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% GPFLVALGK 95.00% 3.16 0.377 1.29 451.2798 900.5439 901.5513 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% GPFLVALGK 95.00% 2.09 0.36 0 451.2801 900.5445 901.5513 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% GPFLVALGK 95.00% 2.93 0.455 1.22 451.2803 900.545 901.5513 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% GPFLVALGK 95.00% 2.88 0.458 0 451.2807 900.5457 901.5513 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% GPFLVALGK 95.00% 3.18 0.343 0 451.2808 900.5459 901.5513 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% FFAPEcGR 94.70% 2.09 0.2 0 c6: Carbamidomethyl (+57.02) 492.2227 982.4298 983.441 2 IQGA1_HUMAN
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% FFAPEcGR 95.00% 2.03 0.264 0 c6: Carbamidomethyl (+57.02) 492.2228 982.43 983.441 2 IQGA1_HUMAN
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% TPMcAHcNQVIR 95.00% 2.49 0.178 0 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 496.2261 1,485.65 1,486.67 3
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% TPMcAHcNQVIR 95.00% 2.48 0.357 0 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 496.2276 1,485.66 1,486.67 3
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% TPMcAHcNQVIR 95.00% 2.34 0.23 0 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 496.2288 1,485.66 1,486.67 3
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% TPMcAHcNQVIR 95.00% 2.37 0.332 0 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 496.2309 1,485.67 1,486.67 3
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% ILGEVINALK 95.00% 2.48 0.304 0 535.3325 1,068.65 1,069.66 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% ILGEVINALK 95.00% 3.52 0.432 1.7 535.3325 1,068.65 1,069.66 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% ILGEVINALK 95.00% 2.54 0.34 0 535.3326 1,068.65 1,069.66 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% ILGEVINALK 95.00% 2.81 0.275 1.7 535.3327 1,068.65 1,069.66 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% ILGEVINALK 95.00% 2.09 0.26 0 535.3335 1,068.65 1,069.66 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% ILGEVINALK 95.00% 3.38 0.433 2.46 535.3336 1,068.65 1,069.66 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% SWHPEEFNcAHcK 95.00% 3.04 0.393 1.15 c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 567.9004 1,700.68 1,701.69 3
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% SWHPEEFNcAHcK 95.00% 3.56 0.445 0 c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 568.236 1,701.68 1,701.69 3
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% SWHPEEFNcAHcK 95.00% 2.88 0.354 0 c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 568.2377 1,701.69 1,701.69 3
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% SPSWQRPNQGVPSTGR 95.00% 3.29 0.343 1.89 585.6277 1,753.86 1,753.87 3
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% SPSWQRPNQGVPSTGR 95.00% 3.19 0.285 1.3 585.6288 1,753.86 1,753.87 3
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% KILGEVINALK 95.00% 2.65 0.182 0 599.3756 1,196.74 1,197.76 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% KILGEVINALK 95.00% 2.64 0.291 1.25 599.3783 1,196.74 1,197.76 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% LQGGKDFNMPLTISSLK 95.00% 2.53 0.273 0 617.335 1,848.98 1,848.99 3
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% KANNSQEPSPQLASSVASTR 95.00% 2.83 0.234 1.47 691.683 2,072.03 2,072.04 3
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% GALYcELcYEK 95.00% 3.04 0.497 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 703.3084 1,404.60 1,405.61 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% GALYcELcYEK 95.00% 2.53 0.453 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 703.3123 1,404.61 1,405.61 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% SPSWQRPNQGVPSTGR 95.00% 3.1 0.321 2.72 877.4392 1,752.86 1,753.87 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% SPSWQRPNQGVPSTGR 95.00% 3.05 0.332 0 877.4426 1,752.87 1,753.87 2
 SAMPLE 3R PDZ and LIM domain protein 5  PDLIM5  PDLI5_HUMAN 63,983.10 100.00% 9 10 30 19.60% SPSWQRPNQGVPSTGR 95.00% 3.49 0.272 2.51 877.9417 1,753.87 1,753.87 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% YAPDKTSTVLTR 95.00% 1.65 0.281 0 451.2496 1,350.73 1,351.72 3
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% DFNVPLSISR 95.00% 2.75 0.222 1.51 574.3099 1,146.60 1,147.61 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% DFNVPLSISR 95.00% 2.83 0.318 1.68 574.3102 1,146.60 1,147.61 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% DFNVPLSISR 95.00% 2.7 0.302 2.07 574.3104 1,146.61 1,147.61 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VLEEGGFFEEK 95.00% 4.33 0.478 4.02 642.3114 1,282.61 1,283.62 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VLEEGGFFEEK 95.00% 2.31 0.272 0 642.3115 1,282.61 1,283.62 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VLEEGGFFEEK 95.00% 3.73 0.437 2.8 642.3117 1,282.61 1,283.62 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VLEEGGFFEEK 95.00% 3.08 0.394 2.62 642.3122 1,282.61 1,283.62 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VLEEGGFFEEK 95.00% 3.85 0.452 3.92 642.3127 1,282.61 1,283.62 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VLEEGGFFEEK 95.00% 4.12 0.468 3.07 642.313 1,282.61 1,283.62 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VLEEGGFFEEK 95.00% 3.95 0.478 2.06 642.3131 1,282.61 1,283.62 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VLEEGGFFEEK 95.00% 4 0.456 2.1 642.3133 1,282.61 1,283.62 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VLEEGGFFEEK 95.00% 4.35 0.523 1.89 642.3134 1,282.61 1,283.62 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VLEEGGFFEEK 95.00% 3.4 0.395 2.82 642.3136 1,282.61 1,283.62 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VLEEGGFFEEK 95.00% 4.2 0.492 1.92 642.3136 1,282.61 1,283.62 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VLEEGGFFEEK 95.00% 4.14 0.5 3 642.3136 1,282.61 1,283.62 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VVLEGPAPWGFR 95.00% 2.91 0.561 2.42 664.3626 1,326.71 1,327.72 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VVLEGPAPWGFR 95.00% 3.71 0.571 3 664.3633 1,326.71 1,327.72 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VVLEGPAPWGFR 95.00% 3.27 0.549 2.37 664.3636 1,326.71 1,327.72 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VVLEGPAPWGFR 95.00% 3.64 0.609 3.14 664.3637 1,326.71 1,327.72 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VVLEGPAPWGFR 95.00% 2.9 0.552 1.96 664.3638 1,326.71 1,327.72 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VVLEGPAPWGFR 95.00% 3.24 0.605 3.62 664.3638 1,326.71 1,327.72 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% VVLEGPAPWGFR 95.00% 2.12 0.344 1.31 664.3647 1,326.71 1,327.72 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% GAIFcPPcYDVR 95.00% 2.69 0.415 3.15 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8318 1,453.65 1,454.66 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% GAIFcPPcYDVR 95.00% 2.92 0.416 1.96 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8325 1,453.65 1,454.66 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% GAIFcPPcYDVR 95.00% 2.56 0.343 2.77 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.834 1,453.65 1,454.66 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% GAIFcPPcYDVR 95.00% 2.89 0.421 2.74 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8343 1,453.65 1,454.66 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% GAIFcPPcYDVR 95.00% 2.46 0.323 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8344 1,453.65 1,454.66 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% GAIFcPPcYDVR 95.00% 2.97 0.355 2.24 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8347 1,453.65 1,454.66 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% GAIFcPPcYDVR 95.00% 2.69 0.411 2.29 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8349 1,453.65 1,454.66 2
 SAMPLE 4 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 5 5 31 12.50% GAIFcPPcYDVR 95.00% 2.81 0.442 2.24 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8354 1,453.66 1,454.66 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% YAPDKTSTVLTR 95.00% 1.61 0.336 0 451.2501 1,350.73 1,351.72 3
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% YAPDKTSTVLTR 95.00% 1.73 0.332 0 451.2506 1,350.73 1,351.72 3
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% DFNVPLSISR 95.00% 2.66 0.213 1.66 574.3076 1,146.60 1,147.61 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% DFNVPLSISR 95.00% 2.52 0.195 1.38 574.3097 1,146.60 1,147.61 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% DFNVPLSISR 95.00% 2.71 0.217 1.43 574.3107 1,146.61 1,147.61 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% DFNVPLSISR 95.00% 2.71 0.305 1.43 574.3111 1,146.61 1,147.61 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 2.1 0.176 1.72 642.3088 1,282.60 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 2.19 0.345 1.4 642.312 1,282.61 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 3.52 0.462 4.44 642.3122 1,282.61 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 3.8 0.407 4.27 642.3127 1,282.61 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 3.95 0.502 3.54 642.3131 1,282.61 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 2.79 0.46 3.17 642.3132 1,282.61 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 3.72 0.42 3.66 642.3132 1,282.61 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 4.05 0.472 3 642.3133 1,282.61 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 2.21 0.282 1.43 642.3134 1,282.61 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 3.11 0.378 3.72 642.3135 1,282.61 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 4.09 0.486 3.92 642.3139 1,282.61 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 3.19 0.436 4 642.3141 1,282.61 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VLEEGGFFEEK 95.00% 3.07 0.477 4.82 642.3143 1,282.61 1,283.62 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VVLEGPAPWGFR 95.00% 3.24 0.609 3.32 664.3628 1,326.71 1,327.72 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VVLEGPAPWGFR 95.00% 2.65 0.586 1.92 664.3634 1,326.71 1,327.72 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% VVLEGPAPWGFR 95.00% 2.52 0.463 2.3 664.3647 1,326.71 1,327.72 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% GAIFcPPcYDVR 95.00% 2.91 0.368 2.85 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8335 1,453.65 1,454.66 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% GAIFcPPcYDVR 95.00% 2.82 0.42 1.64 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8337 1,453.65 1,454.66 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% GAIFcPPcYDVR 95.00% 2.59 0.341 1.68 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8338 1,453.65 1,454.66 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% GAIFcPPcYDVR 95.00% 2.4 0.266 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.834 1,453.65 1,454.66 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% GAIFcPPcYDVR 95.00% 2.7 0.473 1.54 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8343 1,453.65 1,454.66 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% GAIFcPPcYDVR 95.00% 2.82 0.37 1.51 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8344 1,453.65 1,454.66 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% GAIFcPPcYDVR 95.00% 2.61 0.39 2.09 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8351 1,453.65 1,454.66 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% GAIFcPPcYDVR 95.00% 2.78 0.386 2.55 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 728.3364 1,454.66 1,454.66 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% GAIFcPPcYDVR 95.00% 2.93 0.348 2.51 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 728.3371 1,454.66 1,454.66 2
 SAMPLE 4R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 6 6 32 16.80% TSIVQAAAGGVPGGGSNNGK 95.00% 2.95 0.238 6.42 871.9367 1,741.86 1,741.88 2 HS90A_HUMAN,QOR_HUMAN
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% LQGGKDFNVPLSISR 95.00% 2.94 0.322 2.27 544.3011 1,629.88 1,630.89 3
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% LQGGKDFNVPLSISR 95.00% 2.9 0.209 0 544.6349 1,630.88 1,630.89 3
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% DFNVPLSISR 95.00% 2.7 0.351 1.64 574.3069 1,146.60 1,147.61 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% DFNVPLSISR 95.00% 2.64 0.236 1.96 574.307 1,146.60 1,147.61 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% DFNVPLSISR 95.00% 2.99 0.412 1.28 574.3075 1,146.60 1,147.61 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% DFNVPLSISR 95.00% 2.38 0.205 0 574.3076 1,146.60 1,147.61 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% DFNVPLSISR 95.00% 2.56 0.335 1.39 574.3078 1,146.60 1,147.61 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% DFNVPLSISR 95.00% 2.73 0.341 1.54 574.3078 1,146.60 1,147.61 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% DFNVPLSISR 95.00% 2.91 0.38 1.68 574.308 1,146.60 1,147.61 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% DFNVPLSISR 95.00% 2.12 0.262 1.74 574.3082 1,146.60 1,147.61 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% DFNVPLSISR 95.00% 2.46 0.249 2.23 574.3083 1,146.60 1,147.61 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% DFNVPLSISR 95.00% 3.04 0.346 1.64 574.3188 1,146.62 1,147.61 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VLEEGGFFEEK 95.00% 3.87 0.482 3.92 642.3084 1,282.60 1,283.62 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VLEEGGFFEEK 95.00% 3.52 0.459 4.7 642.3087 1,282.60 1,283.62 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VLEEGGFFEEK 95.00% 2.62 0.43 3.68 642.3103 1,282.61 1,283.62 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VLEEGGFFEEK 95.00% 4.1 0.469 3.15 642.3108 1,282.61 1,283.62 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VLEEGGFFEEK 95.00% 3.91 0.465 3.14 642.311 1,282.61 1,283.62 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VLEEGGFFEEK 95.00% 3.92 0.46 3.74 642.311 1,282.61 1,283.62 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VLEEGGFFEEK 95.00% 3.69 0.407 4.04 642.3111 1,282.61 1,283.62 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VLEEGGFFEEK 95.00% 3.49 0.432 4.7 642.3114 1,282.61 1,283.62 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VLEEGGFFEEK 95.00% 2.2 0.224 3.32 642.3123 1,282.61 1,283.62 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 1.94 0.349 0 664.2859 1,326.56 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 3.61 0.629 3.85 664.3587 1,326.70 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 2.55 0.49 0 664.36 1,326.70 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 3.08 0.606 3.55 664.3604 1,326.71 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 3.2 0.556 1.77 664.3607 1,326.71 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 3.5 0.61 2.82 664.3609 1,326.71 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 2.62 0.451 1.29 664.361 1,326.71 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 3.48 0.626 3.43 664.3612 1,326.71 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 2.35 0.407 1.43 664.3614 1,326.71 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 2.91 0.445 1.72 664.3666 1,326.72 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 3.39 0.539 2.19 664.3675 1,326.72 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 2.6 0.477 1.17 664.368 1,326.72 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 3.32 0.561 2.17 664.3723 1,326.73 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 3 0.374 0 664.3726 1,326.73 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 2.86 0.547 2.28 664.373 1,326.73 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% VVLEGPAPWGFR 95.00% 2.69 0.463 2.08 664.3734 1,326.73 1,327.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% YAPDKTSTVLTR 95.00% 2.2 0.253 0 676.3638 1,350.71 1,351.72 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% GAIFcPPcYDVR 95.00% 2.35 0.353 1.68 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8282 1,453.64 1,454.66 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% GAIFcPPcYDVR 95.00% 2.53 0.391 2.28 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.829 1,453.64 1,454.66 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% GAIFcPPcYDVR 95.00% 2.09 0.325 1.14 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8291 1,453.64 1,454.66 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% GAIFcPPcYDVR 95.00% 2.39 0.398 1.82 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8309 1,453.65 1,454.66 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% GAIFcPPcYDVR 95.00% 2.22 0.387 2.38 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8311 1,453.65 1,454.66 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% GAIFcPPcYDVR 95.00% 2.7 0.394 2.52 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8313 1,453.65 1,454.66 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% GAIFcPPcYDVR 95.00% 2.78 0.393 2.7 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8348 1,453.65 1,454.66 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% GAIFcPPcYDVR 95.00% 3.1 0.43 2.08 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8368 1,453.66 1,454.66 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% LQGGKDFNVPLSISR 95.00% 4.06 0.536 4.12 815.9481 1,629.88 1,630.89 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% LQGGKDFNVPLSISR 95.00% 4.33 0.533 7.74 815.9485 1,629.88 1,630.89 2
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% YLVALGHAYHPEEFVcSQcGK 95.00% 4.83 0.407 2.66 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 822.7155 2,465.12 2,465.14 3
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% YLVALGHAYHPEEFVcSQcGK 95.00% 4.48 0.346 2.6 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 822.7156 2,465.12 2,465.14 3
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% TSIVQAAAGGVPGGGSNNGK 95.00% 2.72 0.533 4.6 871.9378 1,741.86 1,741.88 2 HS90A_HUMAN,QOR_HUMAN
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% TSIVQAAAGGVPGGGSNNGK 95.00% 2.79 0.166 5.34 871.938 1,741.86 1,741.88 2 HS90A_HUMAN,QOR_HUMAN
 SAMPLE 1 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 9 53 22.50% TSIVQAAAGGVPGGGSNNGK 95.00% 0 0 4.08 872.4413 1,742.87 1,741.88 2 HS90A_HUMAN,QOR_HUMAN
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% YAPDKTSTVLTR 95.00% 1.65 0.283 0 451.2472 1,350.72 1,351.72 3
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% LQGGKDFNVPLSISR 95.00% 2.65 0.255 0 544.2994 1,629.87 1,630.89 3
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% LQGGKDFNVPLSISR 95.00% 2.63 0.291 1.21 544.3 1,629.88 1,630.89 3
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% LQGGKDFNVPLSISR 95.00% 2.66 0.284 0 544.3019 1,629.88 1,630.89 3
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% LQGGKDFNVPLSISR 95.00% 2.99 0.316 2.18 544.3022 1,629.88 1,630.89 3
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% DFNVPLSISR 95.00% 2.88 0.356 1.62 574.3073 1,146.60 1,147.61 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% DFNVPLSISR 95.00% 2.86 0.349 2.13 574.3079 1,146.60 1,147.61 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% DFNVPLSISR 95.00% 2.37 0.29 1.39 574.308 1,146.60 1,147.61 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% DFNVPLSISR 95.00% 2.87 0.326 1.8 574.3108 1,146.61 1,147.61 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% DFNVPLSISR 94.60% 2.22 0.207 0 574.3114 1,146.61 1,147.61 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% DFNVPLSISR 95.00% 2.91 0.347 0 574.3187 1,146.62 1,147.61 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VLEEGGFFEEK 95.00% 3.64 0.407 2.66 642.3091 1,282.60 1,283.62 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VLEEGGFFEEK 95.00% 3.87 0.423 4.15 642.3091 1,282.60 1,283.62 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VLEEGGFFEEK 95.00% 3.18 0.369 3.51 642.3093 1,282.60 1,283.62 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VLEEGGFFEEK 95.00% 2 0.346 0 642.3101 1,282.60 1,283.62 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VLEEGGFFEEK 95.00% 2.38 0.315 2.04 642.3103 1,282.61 1,283.62 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VLEEGGFFEEK 95.00% 1.98 0.226 1.82 642.3105 1,282.61 1,283.62 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VLEEGGFFEEK 95.00% 3.05 0.349 3.25 642.3112 1,282.61 1,283.62 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VLEEGGFFEEK 95.00% 2.19 0.292 3.28 642.3118 1,282.61 1,283.62 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VLEEGGFFEEK 95.00% 3.1 0.407 4.43 642.3133 1,282.61 1,283.62 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 2.16 0.448 0 664.2846 1,326.55 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 2.22 0.428 0 664.2849 1,326.55 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 2.11 0.388 0 664.2851 1,326.55 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 1.94 0.306 0 664.2857 1,326.56 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 2.9 0.561 2.59 664.3595 1,326.70 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 3.62 0.614 3.38 664.3598 1,326.70 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 3.08 0.518 3.32 664.3599 1,326.70 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 3.13 0.615 3.31 664.3603 1,326.70 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 2.1 0.221 1.74 664.3603 1,326.71 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 2.58 0.519 0 664.3606 1,326.71 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 1.9 0.211 1.48 664.3606 1,326.71 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 2.35 0.407 1.82 664.3614 1,326.71 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 3.39 0.539 2 664.3675 1,326.72 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 2.6 0.477 1.15 664.368 1,326.72 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 3.28 0.602 2.19 664.3733 1,326.73 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 3.22 0.585 2 664.3734 1,326.73 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 3.08 0.557 3.85 664.3736 1,326.73 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% VVLEGPAPWGFR 95.00% 2.41 0.467 1.3 664.8614 1,327.71 1,327.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% YAPDKTSTVLTR 95.00% 2.37 0.303 0 676.363 1,350.71 1,351.72 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% GAIFcPPcYDVR 95.00% 2.14 0.324 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.83 1,453.64 1,454.66 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% GAIFcPPcYDVR 95.00% 2.57 0.427 2.07 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.83 1,453.64 1,454.66 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% GAIFcPPcYDVR 95.00% 2.78 0.381 1.82 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8316 1,453.65 1,454.66 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% GAIFcPPcYDVR 95.00% 2.05 0.359 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8322 1,453.65 1,454.66 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% GAIFcPPcYDVR 95.00% 2.78 0.393 2.47 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8348 1,453.65 1,454.66 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% GAIFcPPcYDVR 95.00% 3.1 0.43 2.27 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8368 1,453.66 1,454.66 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% LQGGKDFNVPLSISR 95.00% 4.19 0.542 5.6 815.9486 1,629.88 1,630.89 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% LQGGKDFNVPLSISR 95.00% 3.85 0.557 5.12 815.951 1,629.89 1,630.89 2
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% YLVALGHAYHPEEFVcSQcGK 95.00% 5.01 0.396 2.4 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 822.7162 2,465.13 2,465.14 3
 SAMPLE 1R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 8 10 49 22.50% TSIVQAAAGGVPGGGSNNGK 95.00% 3.29 0.548 5.2 871.9363 1,741.86 1,741.88 2 HS90A_HUMAN,QOR_HUMAN
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% YAPDKTSTVLTR 95.00% 1.72 0.252 0 451.2489 1,350.72 1,351.72 3
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% LQGGKDFNVPLSISR 95.00% 2.5 0.244 0 544.3003 1,629.88 1,630.89 3
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% LQGGKDFNVPLSISR 95.00% 2.99 0.365 0 544.3003 1,629.88 1,630.89 3
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% ITGEIMHALK 95.00% 3.04 0.46 2.32 556.8088 1,111.60 1,112.61 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% ITGEIMHALK 95.00% 3.37 0.394 0 556.8091 1,111.60 1,112.61 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% DFNVPLSISR 95.00% 2.94 0.39 1.27 574.3061 1,146.60 1,147.61 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% DFNVPLSISR 95.00% 2.63 0.269 2.11 574.307 1,146.60 1,147.61 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% DFNVPLSISR 95.00% 2.08 0.323 2.02 574.3078 1,146.60 1,147.61 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% DFNVPLSISR 95.00% 3.11 0.369 1.64 574.3083 1,146.60 1,147.61 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% DFNVPLSISR 95.00% 2.74 0.303 1.15 574.3091 1,146.60 1,147.61 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% DFNVPLSISR 95.00% 2.85 0.338 1.82 574.3091 1,146.60 1,147.61 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% DFNVPLSISR 95.00% 2.78 0.3 0 574.3093 1,146.60 1,147.61 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 3.97 0.48 3.72 642.3099 1,282.60 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 3.58 0.417 4.55 642.3099 1,282.60 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 3.68 0.471 4.82 642.31 1,282.60 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 4.17 0.484 3.25 642.3103 1,282.60 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 2.93 0.346 3.74 642.3105 1,282.61 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 3.92 0.397 3.85 642.3108 1,282.61 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 4.01 0.462 3.43 642.3108 1,282.61 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 3.85 0.413 4.27 642.3109 1,282.61 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 3.19 0.451 4.48 642.3109 1,282.61 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 3.78 0.432 5.54 642.3109 1,282.61 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 2.84 0.405 4.14 642.3112 1,282.61 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 3.85 0.442 3.7 642.3115 1,282.61 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VLEEGGFFEEK 95.00% 2.83 0.358 2.89 642.8115 1,283.61 1,283.62 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VVLEGPAPWGFR 95.00% 1.97 0.399 0 664.2851 1,326.55 1,327.72 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VVLEGPAPWGFR 95.00% 2.34 0.439 1.34 664.3598 1,326.70 1,327.72 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VVLEGPAPWGFR 95.00% 3.4 0.581 2.24 664.3601 1,326.70 1,327.72 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VVLEGPAPWGFR 95.00% 3.28 0.601 2.36 664.3603 1,326.71 1,327.72 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VVLEGPAPWGFR 95.00% 2.82 0.453 1.51 664.3603 1,326.71 1,327.72 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VVLEGPAPWGFR 95.00% 3.18 0.526 3.12 664.3604 1,326.71 1,327.72 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VVLEGPAPWGFR 95.00% 3.46 0.61 1.82 664.3606 1,326.71 1,327.72 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VVLEGPAPWGFR 95.00% 3.14 0.578 2 664.3607 1,326.71 1,327.72 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% VVLEGPAPWGFR 95.00% 3.36 0.529 0 664.8625 1,327.71 1,327.72 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% YAPDKTSTVLTR 95.00% 2.14 0.402 0 676.3645 1,350.71 1,351.72 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% YAPDKTSTVLTR 95.00% 2.37 0.378 0 676.3655 1,350.72 1,351.72 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% HSQPATPTPLQSR 95.00% 2.86 0.57 1.82 710.372 1,418.73 1,419.73 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% ASAPAADPPRYTFAPSVSLNK 95.00% 2.7 0.297 0 721.0406 2,160.10 2,160.11 3
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% GAIFcPPcYDVR 95.00% 2.84 0.363 1.82 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8297 1,453.64 1,454.66 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% GAIFcPPcYDVR 95.00% 2.73 0.492 1.43 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8312 1,453.65 1,454.66 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% GAIFcPPcYDVR 95.00% 2.02 0.326 1.51 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8315 1,453.65 1,454.66 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% GAIFcPPcYDVR 95.00% 2.38 0.361 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8323 1,453.65 1,454.66 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% LQGGKDFNVPLSISR 95.00% 4.45 0.549 5.11 815.9487 1,629.88 1,630.89 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% LQGGKDFNVPLSISR 95.00% 5.33 0.498 3.96 816.4517 1,630.89 1,630.89 2
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% YLVALGHAYHPEEFVcSQcGK 95.00% 5.36 0.475 2.44 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 822.7167 2,465.13 2,465.14 3
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% YLVALGHAYHPEEFVcSQcGK 95.00% 5.06 0.422 1.8 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 822.7169 2,465.13 2,465.14 3
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% TSIVQAAAGGVPGGGSNNGK 95.00% 3.21 0.365 3.24 871.9381 1,741.86 1,741.88 2 HS90A_HUMAN,QOR_HUMAN
 SAMPLE 2 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 47 36.10% LMENTEDWRPRPGTGQSR 95.00% 2.61 0.394 0 1,065.51 2,129.01 2,130.02 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% LQGGKDFNVPLSISR 95.00% 2.91 0.346 0 544.3009 1,629.88 1,630.89 3
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% LQGGKDFNVPLSISR 95.00% 2.68 0.352 2.15 544.3016 1,629.88 1,630.89 3
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% DFNVPLSISR 95.00% 2.61 0.214 1.19 574.3067 1,146.60 1,147.61 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% DFNVPLSISR 95.00% 2.53 0.236 1.14 574.3077 1,146.60 1,147.61 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% DFNVPLSISR 95.00% 2.53 0.332 1.59 574.3077 1,146.60 1,147.61 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% DFNVPLSISR 95.00% 2.98 0.35 1.72 574.3086 1,146.60 1,147.61 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% DFNVPLSISR 95.00% 2.76 0.358 0 574.3093 1,146.60 1,147.61 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% DFNVPLSISR 95.00% 3.11 0.362 1.19 574.3095 1,146.60 1,147.61 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 2.23 0.227 2.04 642.3087 1,282.60 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 3.37 0.393 3.54 642.3097 1,282.60 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 3.25 0.453 3.49 642.3105 1,282.61 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 3.71 0.382 2.52 642.3106 1,282.61 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 3.58 0.324 4.27 642.3108 1,282.61 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 3.54 0.407 3.96 642.3109 1,282.61 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 3.88 0.427 3.96 642.311 1,282.61 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 3.45 0.262 4.15 642.3112 1,282.61 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 3.38 0.416 3.2 642.3112 1,282.61 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 2.11 0.207 2.28 642.3114 1,282.61 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 3.07 0.489 2.55 642.3121 1,282.61 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 2.63 0.415 4.01 642.7724 1,283.53 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VLEEGGFFEEK 95.00% 2.93 0.362 3.89 642.8136 1,283.61 1,283.62 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VVLEGPAPWGFR 95.00% 2.21 0.392 1.55 664.2859 1,326.56 1,327.72 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VVLEGPAPWGFR 95.00% 2.39 0.447 0 664.3591 1,326.70 1,327.72 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VVLEGPAPWGFR 95.00% 2.96 0.526 3.21 664.3601 1,326.70 1,327.72 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VVLEGPAPWGFR 95.00% 3.02 0.55 3.03 664.3603 1,326.70 1,327.72 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VVLEGPAPWGFR 95.00% 3.44 0.575 2.96 664.3603 1,326.70 1,327.72 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VVLEGPAPWGFR 95.00% 2.73 0.492 1.55 664.3603 1,326.70 1,327.72 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VVLEGPAPWGFR 95.00% 2.92 0.534 1.6 664.3608 1,326.71 1,327.72 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VVLEGPAPWGFR 95.00% 3.04 0.547 2.06 664.3608 1,326.71 1,327.72 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VVLEGPAPWGFR 95.00% 2.89 0.543 1.89 664.3618 1,326.71 1,327.72 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% VVLEGPAPWGFR 95.00% 2.85 0.44 1.17 664.8616 1,327.71 1,327.72 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% YAPDKTSTVLTR 95.00% 2.26 0.329 0 676.3661 1,350.72 1,351.72 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% YAPDKTSTVLTR 95.00% 2.32 0.323 2.24 676.367 1,350.72 1,351.72 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% HSQPATPTPLQSR 95.00% 2.92 0.568 0 710.3786 1,418.74 1,419.73 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% GAIFcPPcYDVR 95.00% 2.55 0.429 1.32 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8309 1,453.65 1,454.66 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% LQGGKDFNVPLSISR 95.00% 4.52 0.55 5.54 815.9482 1,629.88 1,630.89 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% LQGGKDFNVPLSISR 95.00% 4.41 0.507 6.22 815.9498 1,629.88 1,630.89 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% YLVALGHAYHPEEFVcSQcGK 95.00% 4.29 0.425 2.31 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 822.716 2,465.12 2,465.14 3
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% YLVALGHAYHPEEFVcSQcGK 95.00% 4.89 0.437 3.14 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 822.717 2,465.13 2,465.14 3
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% AFYMEEGVPYcER 95.00% 3.04 0.467 1.96 c11: Carbamidomethyl (+57.02) 825.8525 1,649.69 1,650.69 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% AFYMEEGVPYcER 95.00% 4.01 0.52 3.3 c11: Carbamidomethyl (+57.02) 826.3547 1,650.69 1,650.69 2
 SAMPLE 2R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 10 11 42 28.20% TSIVQAAAGGVPGGGSNNGK 95.00% 0 0 4.68 872.4378 1,742.86 1,741.88 2 HS90A_HUMAN,QOR_HUMAN
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% YAPDKTSTVLTR 95.00% 1.87 0.338 3.17 451.2454 1,350.71 1,351.72 3
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% YAPDKTSTVLTR 95.00% 1.78 0.269 2.52 451.2462 1,350.72 1,351.72 3
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% YAPDKTSTVLTR 95.00% 1.57 0.31 1.49 451.2463 1,350.72 1,351.72 3
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% YAPDKTSTVLTR 95.00% 1.54 0.336 0 451.2481 1,350.72 1,351.72 3
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% LQGGKDFNVPLSISR 95.00% 3.31 0.345 1.07 544.3022 1,629.88 1,630.89 3
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% LQGGKDFNVPLSISR 95.00% 2.99 0.299 1.57 544.6365 1,630.89 1,630.89 3
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% ITGEIMHALK 95.00% 3.36 0.427 1.7 556.8084 1,111.60 1,112.61 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% ITGEIMHALK 95.00% 3.04 0.425 1.62 556.8099 1,111.60 1,112.61 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% ITGEImHALK 95.00% 2.29 0.357 0 m6: Oxidation (+15.99) 564.8067 1,127.60 1,128.61 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% DFNVPLSISR 95.00% 2.29 0.228 1.12 574.3068 1,146.60 1,147.61 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% DFNVPLSISR 95.00% 2.67 0.284 2.06 574.3076 1,146.60 1,147.61 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% DFNVPLSISR 95.00% 3.03 0.359 1.89 574.3077 1,146.60 1,147.61 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% DFNVPLSISR 95.00% 2.12 0.305 1.52 574.3086 1,146.60 1,147.61 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% DFNVPLSISR 95.00% 2.47 0.329 1.12 574.3087 1,146.60 1,147.61 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 2.21 0.351 2.59 642.3096 1,282.60 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 3.76 0.487 3.66 642.3096 1,282.60 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 3.23 0.463 2.34 642.3098 1,282.60 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 3.73 0.437 4.06 642.3098 1,282.60 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 3.23 0.449 3.43 642.3098 1,282.60 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 2.49 0.334 2.28 642.3098 1,282.60 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 3.24 0.433 2.37 642.3103 1,282.61 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 3.85 0.426 4.21 642.3104 1,282.61 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 4 0.474 4.89 642.3106 1,282.61 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 3.85 0.41 4.62 642.3108 1,282.61 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 2.53 0.325 3 642.3112 1,282.61 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 3.34 0.391 4.2 642.3118 1,282.61 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 2.64 0.248 2.6 642.3122 1,282.61 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 3.47 0.432 4.24 642.81 1,283.60 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 2.65 0.155 2.52 642.8423 1,283.67 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VLEEGGFFEEK 95.00% 3.12 0.17 3.42 642.8425 1,283.67 1,283.62 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VVLEGPAPWGFR 95.00% 2.18 0.409 1.1 664.2851 1,326.55 1,327.72 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VVLEGPAPWGFR 95.00% 2.6 0.371 1.31 664.3601 1,326.70 1,327.72 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VVLEGPAPWGFR 95.00% 2.59 0.531 1.77 664.3603 1,326.71 1,327.72 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VVLEGPAPWGFR 95.00% 3.68 0.608 3.26 664.3607 1,326.71 1,327.72 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VVLEGPAPWGFR 95.00% 2.48 0.492 1.38 664.3607 1,326.71 1,327.72 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VVLEGPAPWGFR 95.00% 3.49 0.577 1.59 664.3609 1,326.71 1,327.72 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VVLEGPAPWGFR 95.00% 2.03 0.262 1.57 664.3609 1,326.71 1,327.72 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VVLEGPAPWGFR 95.00% 2.48 0.418 0 664.3611 1,326.71 1,327.72 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% VVLEGPAPWGFR 95.00% 2.43 0.438 0 664.3612 1,326.71 1,327.72 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% YAPDKTSTVLTR 95.00% 2.31 0.394 2.01 676.3636 1,350.71 1,351.72 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% YAPDKTSTVLTR 95.00% 2.13 0.398 0 676.3651 1,350.71 1,351.72 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% YAPDKTSTVLTR 95.00% 2.09 0.403 0 676.3658 1,350.72 1,351.72 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% HSQPATPTPLQSR 95.00% 3.12 0.658 2.7 710.3706 1,418.73 1,419.73 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% HSQPATPTPLQSR 95.00% 3.09 0.625 2.48 710.3722 1,418.73 1,419.73 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% GAIFcPPcYDVR 95.00% 2.81 0.447 2.34 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8296 1,453.64 1,454.66 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% GAIFcPPcYDVR 95.00% 2.74 0.318 1.25 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.83 1,453.64 1,454.66 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% GAIFcPPcYDVR 95.00% 2.34 0.298 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8307 1,453.65 1,454.66 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% GAIFcPPcYDVR 95.00% 2.65 0.447 2.1 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8309 1,453.65 1,454.66 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% GAIFcPPcYDVR 95.00% 2.39 0.404 1.48 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.832 1,453.65 1,454.66 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% LQGGKDFNVPLSISR 95.00% 4.56 0.535 4.32 815.9484 1,629.88 1,630.89 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% LQGGKDFNVPLSISR 95.00% 4.95 0.498 5.85 815.9498 1,629.88 1,630.89 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% YLVALGHAYHPEEFVcSQcGK 95.00% 5.56 0.491 3.7 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 822.7169 2,465.13 2,465.14 3
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% YLVALGHAYHPEEFVcSQcGK 95.00% 5.2 0.425 3.07 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 822.7192 2,465.13 2,465.14 3
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% AFYMEEGVPYcER 95.00% 3.79 0.546 5.05 c11: Carbamidomethyl (+57.02) 825.8477 1,649.68 1,650.69 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% AFYMEEGVPYcER 95.00% 4.09 0.569 4.82 c11: Carbamidomethyl (+57.02) 826.3537 1,650.69 1,650.69 2
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% TSIVQAAAGGVPGGGSNNGK 95.00% 2.86 0.415 7.34 871.9353 1,741.85 1,741.88 2 HS90A_HUMAN,QOR_HUMAN
 SAMPLE 3 PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 11 13 57 30.40% TSIVQAAAGGVPGGGSNNGK 95.00% 0 0 6.37 872.4392 1,742.86 1,741.88 2 HS90A_HUMAN,QOR_HUMAN
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% YAPDKTSTVLTR 95.00% 1.99 0.306 0 451.2478 1,350.72 1,351.72 3
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% YAPDKTSTVLTR 95.00% 1.79 0.254 3.37 451.2478 1,350.72 1,351.72 3
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% LQGGKDFNVPLSISR 95.00% 2.87 0.397 1.17 544.303 1,629.89 1,630.89 3
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% LQGGKDFNVPLSISR 95.00% 2.51 0.257 0 544.635 1,630.88 1,630.89 3
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% ITGEImHALK 95.00% 2.4 0.355 0 m6: Oxidation (+15.99) 564.8061 1,127.60 1,128.61 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% ITGEImHALK 95.00% 2.74 0.326 1.4 m6: Oxidation (+15.99) 565.3062 1,128.60 1,128.61 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% DFNVPLSISR 95.00% 1.98 0.238 1.64 574.3071 1,146.60 1,147.61 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% DFNVPLSISR 95.00% 2.65 0.322 0 574.3072 1,146.60 1,147.61 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% DFNVPLSISR 95.00% 2.88 0.332 1.21 574.3073 1,146.60 1,147.61 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% DFNVPLSISR 95.00% 2.13 0.256 1.89 574.3075 1,146.60 1,147.61 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% DFNVPLSISR 95.00% 2.16 0.175 1.37 574.3076 1,146.60 1,147.61 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% DFNVPLSISR 95.00% 2.73 0.32 1.19 574.3076 1,146.60 1,147.61 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% DFNVPLSISR 95.00% 2.59 0.336 0 574.308 1,146.60 1,147.61 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% DFNVPLSISR 95.00% 3.04 0.415 1.41 574.3081 1,146.60 1,147.61 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% DFNVPLSISR 95.00% 2.72 0.36 1.62 574.3083 1,146.60 1,147.61 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 3.49 0.414 4.96 642.3095 1,282.60 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 2.77 0.29 0 642.3097 1,282.60 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 3.29 0.386 2.12 642.3097 1,282.60 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 3.49 0.419 3.09 642.31 1,282.60 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 3.05 0.409 2.72 642.3104 1,282.61 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 3.98 0.459 4.19 642.3105 1,282.61 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 2.98 0.38 2.74 642.3106 1,282.61 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 2.42 0.154 2.16 642.3112 1,282.61 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 2.82 0.279 2.82 642.3119 1,282.61 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 2.86 0.44 3 642.3119 1,282.61 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 2.49 0.29 2.14 642.3123 1,282.61 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 1.79 0.178 1.66 642.3133 1,282.61 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VLEEGGFFEEK 95.00% 2.64 0 3.22 642.843 1,283.67 1,283.62 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VVLEGPAPWGFR 95.00% 2.57 0.443 2.12 664.3596 1,326.70 1,327.72 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VVLEGPAPWGFR 95.00% 3.27 0.616 2.72 664.3598 1,326.70 1,327.72 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VVLEGPAPWGFR 95.00% 2.08 0.416 1.36 664.3602 1,326.70 1,327.72 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VVLEGPAPWGFR 95.00% 2.83 0.48 2.51 664.3611 1,326.71 1,327.72 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VVLEGPAPWGFR 95.00% 2.77 0.446 1.28 664.3613 1,326.71 1,327.72 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VVLEGPAPWGFR 95.00% 2.37 0.308 0 664.3614 1,326.71 1,327.72 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VVLEGPAPWGFR 95.00% 2.78 0.555 1.82 664.3622 1,326.71 1,327.72 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VVLEGPAPWGFR 95.00% 2.45 0.316 0 664.8616 1,327.71 1,327.72 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VVLEGPAPWGFR 95.00% 2.23 0.385 0 664.8628 1,327.71 1,327.72 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% VVLEGPAPWGFR 95.00% 2.61 0.473 0 664.8631 1,327.71 1,327.72 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% YAPDKTSTVLTR 95.00% 2.41 0.387 0 676.3632 1,350.71 1,351.72 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% YAPDKTSTVLTR 95.00% 2.34 0.413 0 676.3641 1,350.71 1,351.72 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% HSQPATPTPLQSR 95.00% 3.03 0.618 1.92 710.3722 1,418.73 1,419.73 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% HSQPATPTPLQSR 95.00% 2.86 0.525 3.02 710.3741 1,418.73 1,419.73 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% GAIFcPPcYDVR 95.00% 2.25 0.374 1.46 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8306 1,453.65 1,454.66 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% GAIFcPPcYDVR 95.00% 2.51 0.415 2.21 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 727.8329 1,453.65 1,454.66 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% GAIFcPPcYDVR 95.00% 2.27 0.291 0 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 728.33 1,454.64 1,454.66 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% GAIFcPPcYDVR 95.00% 2.24 0.419 1.26 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 728.3303 1,454.64 1,454.66 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% GAIFcPPcYDVR 95.00% 2.91 0.392 2.15 c5: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 728.3307 1,454.65 1,454.66 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% LQGGKDFNVPLSISR 95.00% 4.31 0.539 6.05 815.9468 1,629.88 1,630.89 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% LQGGKDFNVPLSISR 95.00% 4.59 0.482 5.25 816.4498 1,630.88 1,630.89 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% YLVALGHAYHPEEFVcSQcGK 95.00% 5.35 0.421 3.1 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 822.7159 2,465.12 2,465.14 3
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% YLVALGHAYHPEEFVcSQcGK 95.00% 5.34 0.44 3.15 c16: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 822.7192 2,465.13 2,465.14 3
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% AFYMEEGVPYcER 95.00% 3.73 0.558 2.7 c11: Carbamidomethyl (+57.02) 825.8493 1,649.68 1,650.69 2
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% TSIVQAAAGGVPGGGSNNGK 95.00% 2.59 0.371 7.29 871.938 1,741.86 1,741.88 2 HS90A_HUMAN,QOR_HUMAN
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% AAQAGVAVGDWVLSIDGENAGSLTHIEAQNK 95.00% 4.39 0.495 3.92 1,041.52 3,121.54 3,121.56 3
 SAMPLE 3R PDZ and LIM domain protein 7  PDLIM7  PDLI7_HUMAN 49,826.40 100.00% 12 14 55 37.20% AAQAGVAVGDWVLSIDGENAGSLTHIEAQNK 95.00% 4.34 0.562 3.6 1,041.52 3,121.55 3,121.56 3
 SAMPLE 4R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 99.80% 2 3 6 12.70% VSFELFADKVPK 95.00% 2.56 0.411 1.12 460.5927 1,378.75 1,379.76 3
 SAMPLE 4R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 99.80% 2 3 6 12.70% VSFELFADKVPK 95.00% 3.13 0.453 0 460.5934 1,378.76 1,379.76 3
 SAMPLE 4R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 99.80% 2 3 6 12.70% FEDENFILK 95.00% 2.54 0.182 1.77 577.7932 1,153.57 1,154.57 2
 SAMPLE 4R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 99.80% 2 3 6 12.70% FEDENFILK 95.00% 2.46 0.133 2.24 577.7939 1,153.57 1,154.57 2
 SAMPLE 4R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 99.80% 2 3 6 12.70% VSFELFADKVPK 95.00% 3.09 0.504 2.85 690.3838 1,378.75 1,379.76 2
 SAMPLE 4R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 99.80% 2 3 6 12.70% VSFELFADKVPK 95.00% 3.58 0.473 2.38 690.385 1,378.75 1,379.76 2
 SAMPLE 1 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 99.80% 2 2 3 13.90% KITIADcGQLE 95.00% 3.45 0.532 1.59 c7: Carbamidomethyl (+57.02) 624.318 1,246.62 1,247.63 2
 SAMPLE 1 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 99.80% 2 2 3 13.90% VSFELFADKVPK 95.00% 2.75 0.371 3.77 690.3888 1,378.76 1,379.76 2
 SAMPLE 1 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 99.80% 2 2 3 13.90% VSFELFADKVPK 95.00% 2.13 0.304 2.39 690.3935 1,378.77 1,379.76 2
 SAMPLE 1R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 4 4 6 23.00% FEDENFILK 95.00% 2.74 0.0931 2.28 577.8008 1,153.59 1,154.57 2
 SAMPLE 1R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 4 4 6 23.00% KITIADcGQLE 95.00% 3.45 0.532 2.04 c7: Carbamidomethyl (+57.02) 624.318 1,246.62 1,247.63 2
 SAMPLE 1R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 4 4 6 23.00% VSFELFADKVPK 95.00% 2.75 0.371 3.89 690.3888 1,378.76 1,379.76 2
 SAMPLE 1R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 4 4 6 23.00% VSFELFADKVPK 95.00% 2.47 0.301 0 690.3934 1,378.77 1,379.76 2
 SAMPLE 1R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 4 4 6 23.00% VSFELFADKVPK 95.00% 3.4 0.428 2.74 690.3949 1,378.77 1,379.76 2
 SAMPLE 1R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 4 4 6 23.00% SIYGEKFEDENFILK 95.00% 4.49 0.423 5.7 916.9785 1,831.94 1,831.91 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% VSFELFADKVPK 95.00% 2.53 0.419 0 460.5904 1,378.75 1,379.76 3
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% VSFELFADKVPK 95.00% 3.41 0.522 0 460.5914 1,378.75 1,379.76 3
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% TEWLDGKHVVFGK 95.00% 3.68 0.431 1.09 505.9357 1,514.78 1,515.80 3
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% TEWLDGKHVVFGK 95.00% 2.92 0.41 1.29 505.9361 1,514.78 1,515.80 3
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% ITIADcGQLE 95.00% 2.65 0.391 0 c6: Carbamidomethyl (+57.02) 560.2676 1,118.52 1,119.54 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% ITIADcGQLE 95.00% 2.69 0.408 0 c6: Carbamidomethyl (+57.02) 560.2703 1,118.52 1,119.54 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% FEDENFILK 95.00% 3.12 0.0838 1.43 577.7876 1,153.56 1,154.57 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% FEDENFILK 95.00% 3.04 0.0608 1.4 577.7888 1,153.56 1,154.57 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% FEDENFILK 95.00% 2.8 0.0815 1.49 577.7889 1,153.56 1,154.57 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% KITIADcGQLE 95.00% 3.6 0.534 1.92 c7: Carbamidomethyl (+57.02) 624.3175 1,246.62 1,247.63 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% KITIADcGQLE 95.00% 3.63 0.531 1.82 c7: Carbamidomethyl (+57.02) 624.318 1,246.62 1,247.63 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% VSFELFADKVPK 95.00% 2.87 0 2.44 689.7677 1,377.52 1,379.76 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% VSFELFADKVPK 95.00% 3.84 0.419 2.16 690.3807 1,378.75 1,379.76 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% VSFELFADKVPK 95.00% 3.58 0.492 2.15 690.3822 1,378.75 1,379.76 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% VSFELFADKVPK 95.00% 3.47 0.453 2.7 690.3828 1,378.75 1,379.76 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% VSFELFADKVPK 95.00% 3.43 0.396 1.51 690.8834 1,379.75 1,379.76 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% TEWLDGKHVVFGK 95.00% 3.89 0.469 3.68 758.9015 1,515.79 1,515.80 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% IIPGFMcQGGDFTR 95.00% 2.52 0.365 0 c7: Carbamidomethyl (+57.02) 800.3792 1,598.74 1,598.75 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% IIPGFmcQGGDFTR 95.00% 2.11 0.384 4.85 m6: Oxidation (+15.99), c7: Carbamidomethyl (+57.02) 807.8728 1,613.73 1,614.74 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 6 8 20 35.80% IIPGFmcQGGDFTR 95.00% 1.59 0.31 4.21 m6: Oxidation (+15.99), c7: Carbamidomethyl (+57.02) 808.3746 1,614.73 1,614.74 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% VSFELFADKVPK 95.00% 2.25 0.346 0 460.592 1,378.75 1,379.76 3
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% VSFELFADKVPK 95.00% 3.23 0.521 1.1 460.5933 1,378.76 1,379.76 3
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% VSFELFADKVPK 95.00% 2.4 0.309 0 460.9258 1,379.75 1,379.76 3
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% TEWLDGKHVVFGK 95.00% 3.52 0.454 0 505.9359 1,514.78 1,515.80 3
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% TEWLDGKHVVFGK 95.00% 3.13 0.42 1.49 506.2708 1,515.79 1,515.80 3
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% VSFELFADK 95.00% 2.39 0.305 2.49 528.273 1,054.53 1,055.54 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% VSFELFADK 95.00% 2.41 0.358 2.96 528.2746 1,054.53 1,055.54 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% VSFELFADK 95.00% 2.27 0.328 1.96 528.307 1,054.60 1,055.54 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% ITIADcGQLE 95.00% 2.56 0.421 0 c6: Carbamidomethyl (+57.02) 560.2692 1,118.52 1,119.54 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% ITIADcGQLE 95.00% 2.43 0.349 0 c6: Carbamidomethyl (+57.02) 560.2693 1,118.52 1,119.54 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% FEDENFILK 95.00% 3.11 0.0707 1.66 577.7896 1,153.56 1,154.57 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% KITIADcGQLE 95.00% 3.18 0.442 0 c7: Carbamidomethyl (+57.02) 624.3169 1,246.62 1,247.63 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% KITIADcGQLE 95.00% 2.71 0.387 0 c7: Carbamidomethyl (+57.02) 624.3174 1,246.62 1,247.63 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% KITIADcGQLE 95.00% 3.44 0.446 0 c7: Carbamidomethyl (+57.02) 624.3178 1,246.62 1,247.63 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% KITIADcGQLE 95.00% 3.27 0.449 1.43 c7: Carbamidomethyl (+57.02) 624.3182 1,246.62 1,247.63 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% VSFELFADKVPK 95.00% 3.64 0.476 2.57 690.3809 1,378.75 1,379.76 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% VSFELFADKVPK 95.00% 3.73 0.484 2.22 690.3824 1,378.75 1,379.76 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% TEWLDGKHVVFGK 95.00% 3.53 0.567 4.44 758.4021 1,514.79 1,515.80 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% TEWLDGKHVVFGK 95.00% 3.31 0.542 3.92 758.404 1,514.79 1,515.80 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% IIPGFMcQGGDFTR 95.00% 3.23 0.512 0 c7: Carbamidomethyl (+57.02) 799.877 1,597.74 1,598.75 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% IIPGFmcQGGDFTR 95.00% 1.32 0.31 4.21 m6: Oxidation (+15.99), c7: Carbamidomethyl (+57.02) 807.8722 1,613.73 1,614.74 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 7 9 22 35.80% IIPGFmcQGGDFTR 95.00% 1.65 0.368 5.06 m6: Oxidation (+15.99), c7: Carbamidomethyl (+57.02) 807.8754 1,613.74 1,614.74 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% VSFELFADKVPK 95.00% 2.86 0.516 1.04 460.5908 1,378.75 1,379.76 3
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% VSFELFADKVPK 95.00% 2.25 0.329 0 460.5919 1,378.75 1,379.76 3
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% VKEGMNIVEAMER 95.00% 2.62 0.317 0 502.585 1,504.73 1,505.75 3
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% VKEGMNIVEAMER 95.00% 3.41 0.317 0 502.5876 1,504.74 1,505.75 3
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% VKEGmNIVEAmER 95.00% 2.45 0.256 0 m5: Oxidation (+15.99), m11: Oxidation (+15.99) 513.2484 1,536.72 1,537.74 3
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% VSFELFADK 95.00% 3.41 0.454 1.27 528.2732 1,054.53 1,055.54 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% VSFELFADK 95.00% 2.37 0.358 2.06 528.3089 1,054.60 1,055.54 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% FEDENFILK 94.70% 2.8 0.102 0 577.7904 1,153.57 1,154.57 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% FEDENFILK 95.00% 3.35 0.073 1.55 577.7904 1,153.57 1,154.57 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% KITIADcGQLE 95.00% 3.77 0.501 1.47 c7: Carbamidomethyl (+57.02) 624.3178 1,246.62 1,247.63 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% KITIADcGQLE 95.00% 3.64 0.516 0 c7: Carbamidomethyl (+57.02) 624.3181 1,246.62 1,247.63 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% KITIADcGQLE 95.00% 3.34 0.532 1.49 c7: Carbamidomethyl (+57.02) 624.3181 1,246.62 1,247.63 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% KITIADcGQLE 95.00% 3.3 0.421 0 c7: Carbamidomethyl (+57.02) 624.3184 1,246.62 1,247.63 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% ALSTGEKGFGYK 95.00% 2.56 0.477 1.08 629.3285 1,256.64 1,257.65 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% TEWLDGKHVVFGK 95.00% 4.03 0.512 5.77 758.4008 1,514.79 1,515.80 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% TEWLDGKHVVFGK 95.00% 4.04 0.496 5.49 758.4015 1,514.79 1,515.80 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% IIPGFMcQGGDFTR 95.00% 2.62 0.602 4.59 c7: Carbamidomethyl (+57.02) 799.8749 1,597.73 1,598.75 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% IIPGFMcQGGDFTR 95.00% 2.85 0.669 4.68 c7: Carbamidomethyl (+57.02) 799.8766 1,597.74 1,598.75 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% IIPGFMcQGGDFTR 95.00% 2.36 0.533 3.31 c7: Carbamidomethyl (+57.02) 799.8767 1,597.74 1,598.75 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% IIPGFMcQGGDFTR 95.00% 2.76 0.496 0 c7: Carbamidomethyl (+57.02) 799.877 1,597.74 1,598.75 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% IIPGFmcQGGDFTR 95.00% 1.68 0.555 4.33 m6: Oxidation (+15.99), c7: Carbamidomethyl (+57.02) 807.8723 1,613.73 1,614.74 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 22 50.90% IIPGFmcQGGDFTR 95.00% 1.86 0.56 4.52 m6: Oxidation (+15.99), c7: Carbamidomethyl (+57.02) 807.8728 1,613.73 1,614.74 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% VSFELFADKVPK 95.00% 2.27 0.458 0 460.5916 1,378.75 1,379.76 3
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% VSFELFADKVPK 95.00% 3 0.432 0 460.5929 1,378.76 1,379.76 3
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% VKEGmNIVEAmER 95.00% 2.86 0.204 0 m5: Oxidation (+15.99), m11: Oxidation (+15.99) 513.2494 1,536.72 1,537.74 3
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% ITIADcGQLE 95.00% 2.31 0.198 0 c6: Carbamidomethyl (+57.02) 560.2677 1,118.52 1,119.54 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% FEDENFILK 95.00% 3.17 0.0742 0 577.7872 1,153.56 1,154.57 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% FEDENFILK 95.00% 2.61 0.056 1.27 577.7893 1,153.56 1,154.57 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% FEDENFILK 95.00% 2.51 0.0841 1.48 577.79 1,153.56 1,154.57 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% FEDENFILK 95.00% 2.83 0.087 1.14 577.7902 1,153.56 1,154.57 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% KITIADcGQLE 95.00% 2.66 0.41 0 c7: Carbamidomethyl (+57.02) 624.3172 1,246.62 1,247.63 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% KITIADcGQLE 95.00% 3.58 0.478 2.77 c7: Carbamidomethyl (+57.02) 624.3178 1,246.62 1,247.63 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% KITIADcGQLE 95.00% 3.46 0.481 2.15 c7: Carbamidomethyl (+57.02) 624.3189 1,246.62 1,247.63 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% ALSTGEKGFGYK 95.00% 2.2 0.297 2.1 629.3275 1,256.64 1,257.65 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% TEWLDGKHVVFGK 95.00% 3.9 0.494 4.57 758.4 1,514.78 1,515.80 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% TEWLDGKHVVFGK 95.00% 3.94 0.438 3.19 758.9044 1,515.79 1,515.80 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% IIPGFMcQGGDFTR 95.00% 2.9 0.625 3.72 c7: Carbamidomethyl (+57.02) 799.8742 1,597.73 1,598.75 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% IIPGFMcQGGDFTR 95.00% 2.55 0.686 4.11 c7: Carbamidomethyl (+57.02) 799.8759 1,597.74 1,598.75 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% IIPGFMcQGGDFTR 95.00% 2.65 0.638 3.92 c7: Carbamidomethyl (+57.02) 799.8776 1,597.74 1,598.75 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% IIPGFMcQGGDFTR 95.00% 2.38 0.538 3.57 c7: Carbamidomethyl (+57.02) 799.879 1,597.74 1,598.75 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% IIPGFmcQGGDFTR 95.00% 1.91 0.35 4.05 m6: Oxidation (+15.99), c7: Carbamidomethyl (+57.02) 807.8726 1,613.73 1,614.74 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase A  PPIA  PPIA_HUMAN 17,994.90 100.00% 8 8 20 50.90% IIPGFmcQGGDFTR 95.00% 1.39 0.474 3.8 m6: Oxidation (+15.99), c7: Carbamidomethyl (+57.02) 807.8737 1,613.73 1,614.74 2
 SAMPLE 1 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 99.80% 2 2 5 12.00% TVDNFVALATGEK 95.00% 3.32 0.508 6.13 682.8556 1,363.70 1,364.71 2
 SAMPLE 1 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 99.80% 2 2 5 12.00% TVDNFVALATGEK 95.00% 4.5 0.524 3.82 682.856 1,363.70 1,364.71 2
 SAMPLE 1 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 99.80% 2 2 5 12.00% TVDNFVALATGEK 95.00% 2.27 0.415 0 682.8565 1,363.70 1,364.71 2
 SAMPLE 1 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 99.80% 2 2 5 12.00% TVDNFVALATGEK 95.00% 3.34 0.433 1.8 682.8643 1,363.71 1,364.71 2
 SAMPLE 1 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 99.80% 2 2 5 12.00% DTNGSQFFITTVK 95.00% 3.87 0.506 5.16 729.3755 1,456.74 1,457.73 2
 SAMPLE 1R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 99.80% 2 2 6 12.00% TVDNFVALATGEK 95.00% 3.35 0.496 3.34 682.8551 1,363.69 1,364.71 2
 SAMPLE 1R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 99.80% 2 2 6 12.00% TVDNFVALATGEK 95.00% 3.32 0.508 4.03 682.8556 1,363.70 1,364.71 2
 SAMPLE 1R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 99.80% 2 2 6 12.00% TVDNFVALATGEK 95.00% 3.28 0.56 2.22 682.8685 1,363.72 1,364.71 2
 SAMPLE 1R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 99.80% 2 2 6 12.00% TVDNFVALATGEK 95.00% 3.76 0.586 3.04 682.8694 1,363.72 1,364.71 2
 SAMPLE 1R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 99.80% 2 2 6 12.00% TVDNFVALATGEK 95.00% 3.06 0.534 2.37 682.8701 1,363.72 1,364.71 2
 SAMPLE 1R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 99.80% 2 2 6 12.00% DTNGSQFFITTVK 95.00% 3.87 0.506 4.74 729.3755 1,456.74 1,457.73 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 6 6 12 33.80% TAWLDGKHVVFGK 95.00% 2.95 0.302 0 486.6018 1,456.78 1,457.79 3
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 6 6 12 33.80% VLEGMEVVR 95.00% 3.25 0.402 1.51 516.2805 1,030.55 1,031.56 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 6 6 12 33.80% VLEGMEVVR 95.00% 2.82 0.424 1.8 516.2806 1,030.55 1,031.56 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 6 6 12 33.80% IEVEKPFAIAK 95.00% 3.08 0.331 0 622.8654 1,243.72 1,244.73 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 6 6 12 33.80% IEVEKPFAIAK 95.00% 3.15 0.226 0 622.8661 1,243.72 1,244.73 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 6 6 12 33.80% TVDNFVALATGEK 95.00% 4.24 0.558 3.8 682.8557 1,363.70 1,364.71 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 6 6 12 33.80% TVDNFVALATGEK 95.00% 4.43 0.538 2.89 682.8562 1,363.70 1,364.71 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 6 6 12 33.80% TVDNFVALATGEK 95.00% 2.91 0.502 2.72 682.8563 1,363.70 1,364.71 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 6 6 12 33.80% TVDNFVALATGEK 95.00% 3.07 0.273 1.89 682.8602 1,363.70 1,364.71 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 6 6 12 33.80% DTNGSQFFITTVK 95.00% 2.93 0.474 0 729.3671 1,456.72 1,457.73 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 6 6 12 33.80% DTNGSQFFITTVK 95.00% 3.26 0.403 1.64 729.8598 1,457.70 1,457.73 2
 SAMPLE 2 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 6 6 12 33.80% DKPLKDVIIADcGK 95.00% 3.69 0.526 4.28 c12: Carbamidomethyl (+57.02) 786.4265 1,570.84 1,571.85 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 4 4 9 22.70% VLEGMEVVR 95.00% 2.86 0.411 2.1 516.2804 1,030.55 1,031.56 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 4 4 9 22.70% VLEGMEVVR 95.00% 2.37 0.331 1.64 516.2806 1,030.55 1,031.56 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 4 4 9 22.70% TVDNFVALATGEK 95.00% 2.86 0.513 3.15 682.8534 1,363.69 1,364.71 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 4 4 9 22.70% TVDNFVALATGEK 95.00% 4.27 0.575 3.68 682.8552 1,363.69 1,364.71 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 4 4 9 22.70% TVDNFVALATGEK 95.00% 3.14 0.523 3.41 682.8563 1,363.70 1,364.71 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 4 4 9 22.70% TVDNFVALATGEK 95.00% 3.15 0.417 1.96 682.8573 1,363.70 1,364.71 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 4 4 9 22.70% DTNGSQFFITTVK 95.00% 3.29 0.364 2.16 729.8605 1,457.71 1,457.73 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 4 4 9 22.70% DTNGSQFFITTVK 95.00% 3.62 0.422 1.89 729.8615 1,457.71 1,457.73 2
 SAMPLE 2R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 4 4 9 22.70% DKPLKDVIIADcGK 95.00% 3.67 0.464 4.18 c12: Carbamidomethyl (+57.02) 786.426 1,570.84 1,571.85 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% VLEGMEVVR 95.00% 3.34 0.405 0 516.2801 1,030.54 1,031.56 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% VLEGMEVVR 95.00% 3.25 0.449 0 516.2804 1,030.55 1,031.56 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% VIKDFMIQGGDFTR 95.00% 3.25 0.294 1.25 542.9482 1,625.82 1,626.83 3
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% VIKDFMIQGGDFTR 95.00% 3.12 0.24 1.49 542.9485 1,625.82 1,626.83 3
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% VIKDFmIQGGDFTR 95.00% 3.19 0.272 0 m6: Oxidation (+15.99) 548.6125 1,642.81 1,642.83 3
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% VIKDFmIQGGDFTR 95.00% 3.46 0.296 0 m6: Oxidation (+15.99) 548.6143 1,642.82 1,642.83 3
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% IEVEKPFAIAK 95.00% 3.23 0.254 1.38 622.8642 1,243.71 1,244.73 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% IEVEKPFAIAK 95.00% 3.49 0.314 0 622.8648 1,243.71 1,244.73 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% TVDNFVALATGEK 95.00% 4.25 0.534 3.41 682.8546 1,363.69 1,364.71 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% TVDNFVALATGEK 95.00% 4.32 0.541 3.59 682.8559 1,363.70 1,364.71 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% TVDNFVALATGEK 95.00% 3.67 0.457 2.55 682.8561 1,363.70 1,364.71 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% TVDNFVALATGEK 95.00% 3.01 0.469 2.46 682.8568 1,363.70 1,364.71 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% DTNGSQFFITTVK 95.00% 4.41 0.587 4.28 729.3661 1,456.72 1,457.73 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% DTNGSQFFITTVK 95.00% 4.12 0.529 2.82 729.3686 1,456.72 1,457.73 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% DKPLKDVIIADcGK 95.00% 3.88 0.577 4.72 c12: Carbamidomethyl (+57.02) 786.4283 1,570.84 1,571.85 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% DKPLKDVIIADcGK 95.00% 4.29 0.554 3.37 c12: Carbamidomethyl (+57.02) 786.9318 1,571.85 1,571.85 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% SIYGERFPDENFK 95.00% 3.8 0.415 2.96 801.3831 1,600.75 1,601.76 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% SIYGERFPDENFK 95.00% 3.15 0.294 2.27 801.8807 1,601.75 1,601.76 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% VIKDFMIQGGDFTR 95.00% 4.35 0.545 5.04 813.9194 1,625.82 1,626.83 2
 SAMPLE 3 Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 8 20 40.30% VIKDFMIQGGDFTR 95.00% 4.43 0.548 4.74 814.4191 1,626.82 1,626.83 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% TVDNFVALATGEK 95.00% 3.92 0.351 1.92 455.5735 1,363.70 1,364.71 3
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% TVDNFVALATGEK 95.00% 3.8 0.42 0 455.5754 1,363.70 1,364.71 3
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% VLEGMEVVR 95.00% 3.31 0.48 1.48 516.2801 1,030.54 1,031.56 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% VLEGMEVVR 95.00% 3.19 0.465 1.47 516.2803 1,030.55 1,031.56 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% VIKDFMIQGGDFTR 95.00% 2.6 0.156 1.02 542.9486 1,625.82 1,626.83 3
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% VIKDFMIQGGDFTR 95.00% 2.65 0.237 1.17 542.949 1,625.82 1,626.83 3
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% IEVEKPFAIAK 95.00% 3.17 0.239 1.1 622.8654 1,243.72 1,244.73 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% TVDNFVALATGEK 95.00% 4.22 0.573 2.59 682.8556 1,363.70 1,364.71 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% TVDNFVALATGEK 95.00% 2.25 0.311 0 682.8559 1,363.70 1,364.71 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% TVDNFVALATGEK 95.00% 3.02 0.425 1.92 682.856 1,363.70 1,364.71 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% TVDNFVALATGEK 95.00% 3.64 0.511 2.89 682.8562 1,363.70 1,364.71 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% DTNGSQFFITTVK 95.00% 3.2 0.473 0 729.3674 1,456.72 1,457.73 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% DTNGSQFFITTVK 95.00% 4.41 0.573 1.7 729.3683 1,456.72 1,457.73 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% DTNGSQFFITTVK 95.00% 3.76 0.55 2.29 729.3685 1,456.72 1,457.73 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% DTNGSQFFITTVK 95.00% 2.76 0.381 1.47 729.369 1,456.72 1,457.73 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% DKPLKDVIIADcGK 95.00% 4.34 0.604 3.74 c12: Carbamidomethyl (+57.02) 786.4264 1,570.84 1,571.85 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% DKPLKDVIIADcGK 95.00% 4.1 0.501 3.96 c12: Carbamidomethyl (+57.02) 786.4284 1,570.84 1,571.85 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% SIYGERFPDENFK 95.00% 3.47 0.393 3.8 801.3784 1,600.74 1,601.76 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% SIYGERFPDENFK 95.00% 3.3 0.32 3.03 801.8835 1,601.75 1,601.76 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% SIYGERFPDENFK 95.00% 3.6 0.401 2.24 801.8843 1,601.75 1,601.76 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% VIKDFMIQGGDFTR 95.00% 4.36 0.512 6.3 813.9189 1,625.82 1,626.83 2
 SAMPLE 3R Peptidyl-prolyl cis-trans isomerase B  PPIB  PPIB_HUMAN 23,725.20 100.00% 7 9 22 40.30% VIKDFMIQGGDFTR 95.00% 4.32 0.483 6.06 814.4185 1,626.82 1,626.83 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% AAAITSDILEALGR 95.00% 3.88 0.434 1.55 467.5991 1,399.77 1,400.78 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GMTSEEKEILIR 95.00% 3.37 0.245 0 469.2494 1,404.72 1,405.74 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GMTSEEKEILIR 95.00% 3.16 0.245 0 469.2498 1,404.73 1,405.74 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GMTSEEKEILIR 95.00% 2.24 0.284 0 469.2498 1,404.73 1,405.74 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GMTSEEKEILIR 95.00% 3.48 0.261 0 469.2501 1,404.73 1,405.74 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% LLKLILQNHILK 95.00% 3.99 0.335 0 482.6554 1,444.94 1,445.96 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% LLKLILQNHILK 95.00% 2.73 0.277 0 482.6569 1,444.95 1,445.96 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% LILQNHILK 95.00% 2.94 0.189 0 546.3495 1,090.68 1,091.69 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% LILQNHILK 95.00% 2.83 0.213 0 546.3498 1,090.68 1,091.69 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIDGVPVEITEKETR 95.00% 2.21 0.385 0 566.9799 1,697.92 1,698.93 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIDGVPVEITEKETR 95.00% 2.47 0.348 0 566.9813 1,697.92 1,698.93 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DQGPNVcALQQILGTK 95.00% 4.28 0.364 2.08 c7: Carbamidomethyl (+57.02) 581.3007 1,740.88 1,741.89 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DQGPNVcALQQILGTK 95.00% 4.96 0.379 1.34 c7: Carbamidomethyl (+57.02) 581.6356 1,741.88 1,741.89 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% ESDIMTTNGVIHVVDK 95.00% 2.25 0.344 0 586.9631 1,757.87 1,757.87 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% ESDIMTTNGVIHVVDK 95.00% 2.29 0.302 0 586.9638 1,757.87 1,757.87 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GFEPGVTNILK 95.00% 2.72 0.348 0 587.8252 1,173.63 1,174.65 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GFEPGVTNILK 95.00% 2.54 0.305 1.33 587.8258 1,173.64 1,174.65 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GFEPGVTNILK 95.00% 2.05 0.241 1.66 587.8271 1,173.64 1,174.65 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VIEGSLQPIIK 95.00% 2.84 0.371 1.35 598.8648 1,195.71 1,196.73 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VIEGSLQPIIK 95.00% 2.84 0.396 0 598.8649 1,195.71 1,196.73 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VKIEGEPEFR 95.00% 2.93 0.428 1.33 602.3222 1,202.63 1,203.64 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VKIEGEPEFR 95.00% 2.71 0.383 1.55 602.3224 1,202.63 1,203.64 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VKIEGEPEFR 95.00% 2.63 0.37 0 602.3225 1,202.63 1,203.64 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DGHFTLFAPTNEAFEK 95.00% 2.72 0.213 0 608.6234 1,822.85 1,823.86 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DGHFTLFAPTNEAFEK 95.00% 2.76 0.287 0 608.6241 1,822.85 1,823.86 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DGHFTLFAPTNEAFEK 95.00% 3.06 0.351 0 608.6242 1,822.85 1,823.86 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DGHFTLFAPTNEAFEK 95.00% 3.06 0.304 1.49 608.6243 1,822.85 1,823.86 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DGHFTLFAPTNEAFEK 95.00% 3.49 0.36 1.57 608.9574 1,823.85 1,823.86 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DGHFTLFAPTNEAFEK 95.00% 2.95 0.32 1.32 608.9579 1,823.85 1,823.86 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DGHFTLFAPTNEAFEK 95.00% 2.63 0.268 0 608.959 1,823.85 1,823.86 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VGLNELYNGQILETIGGK 95.00% 4.66 0.373 1.92 640.014 1,917.02 1,918.03 3 CSRP1_HUMAN
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VGLNELYNGQILETIGGK 95.00% 4.93 0.372 2.55 640.3473 1,918.02 1,918.03 3 CSRP1_HUMAN
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GRDQGPNVcALQQILGTK 95.00% 2.8 0.242 1.34 c9: Carbamidomethyl (+57.02) 652.6762 1,955.01 1,955.01 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIHGNQIATNGVVHVIDR 95.00% 5.58 0.65 4.55 652.6971 1,955.07 1,956.08 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIHGNQIATNGVVHVIDR 95.00% 3 0.219 0 653.0298 1,956.07 1,956.08 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIHGNQIATNGVVHVIDR 95.00% 5.51 0.638 5.96 653.0308 1,956.07 1,956.08 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIHGNQIATNGVVHVIDR 95.00% 5.97 0.659 4.96 653.0309 1,956.07 1,956.08 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIHGNQIATNGVVHVIDR 95.00% 2.96 0.425 0 653.0312 1,956.07 1,956.08 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIHGNQIATNGVVHVIDR 95.00% 6.25 0.679 6.05 653.0313 1,956.07 1,956.08 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIDGVPVEITEK 95.00% 2.87 0.374 0 656.8709 1,311.73 1,312.74 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIDGVPVEITEK 95.00% 2.9 0.352 1.25 656.8715 1,311.73 1,312.74 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% AAAITSDILEALGR 95.00% 4.56 0.595 4.36 700.8891 1,399.76 1,400.78 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% AAAITSDILEALGR 95.00% 4.74 0.603 3.85 700.8893 1,399.76 1,400.78 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% AAAITSDILEALGR 95.00% 4.11 0.574 5.22 700.8896 1,399.76 1,400.78 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% AAAITSDILEALGR 95.00% 4.71 0.586 4 700.8897 1,399.76 1,400.78 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% AAAITSDILEALGR 95.00% 3.87 0.501 4.01 701.3873 1,400.76 1,400.78 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GMTSEEKEILIR 95.00% 2.81 0.304 2.36 703.3708 1,404.73 1,405.74 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GMTSEEKEILIR 95.00% 3.41 0.395 2.89 703.3711 1,404.73 1,405.74 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GMTSEEKEILIR 95.00% 3.4 0.378 2.8 703.3712 1,404.73 1,405.74 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GMTSEEKEILIR 95.00% 3.53 0.377 3.17 703.3713 1,404.73 1,405.74 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% TAVcIENScMEK 95.00% 3.73 0.516 5.18 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3072 1,440.60 1,441.61 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% TAVcIENScMEK 95.00% 3.7 0.544 3.04 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3072 1,440.60 1,441.61 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% TAVcIENScMEK 95.00% 3.61 0.516 2.34 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3072 1,440.60 1,441.61 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% TAVcIENScMEK 95.00% 3.78 0.502 3.32 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3092 1,440.60 1,441.61 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% TAVcIENScMEK 95.00% 2.83 0.254 0 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.9051 1,441.79 1,441.61 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% TTVLYEccPGYMR 95.00% 4.34 0.558 3.74 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3594 1,648.70 1,649.71 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% TTVLYEccPGYMR 95.00% 4.07 0.561 4.32 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3595 1,648.70 1,649.71 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% TTVLYEccPGYMR 95.00% 4.11 0.524 3.85 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3602 1,648.70 1,649.71 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% TTVLYEccPGYMR 95.00% 4.15 0.534 5.07 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3603 1,648.70 1,649.71 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% TTVLYEccPGYmR 95.00% 3.94 0.44 4.13 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 833.8571 1,665.70 1,665.71 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIDGVPVEITEKETR 95.00% 2.75 0.421 2.38 849.9663 1,697.92 1,698.93 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIDGVPVEITEKETR 95.00% 2.91 0.423 1.52 849.9678 1,697.92 1,698.93 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.19 0.244 1.77 c2: Carbamidomethyl (+57.02) 866.4533 2,596.34 2,596.36 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.27 0.235 2.66 c2: Carbamidomethyl (+57.02) 866.4551 2,596.34 2,596.36 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.37 0.288 3.8 c2: Carbamidomethyl (+57.02) 866.4556 2,596.34 2,596.36 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.38 0.162 3.09 c2: Carbamidomethyl (+57.02) 866.4561 2,596.34 2,596.36 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.81 0.313 3.44 c2: Carbamidomethyl (+57.02) 866.4565 2,596.35 2,596.36 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.7 0.443 2.41 c2: Carbamidomethyl (+57.02) 866.4576 2,596.35 2,596.36 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 2.54 0.255 1.7 c2: Carbamidomethyl (+57.02) 866.4687 2,596.38 2,596.36 3
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DQGPNVcALQQILGTK 95.00% 5.06 0.598 4.96 c7: Carbamidomethyl (+57.02) 871.447 1,740.88 1,741.89 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DQGPNVcALQQILGTK 95.00% 5.16 0.598 5.3 c7: Carbamidomethyl (+57.02) 871.447 1,740.88 1,741.89 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DQGPNVcALQQILGTK 95.00% 4.33 0.517 3.85 c7: Carbamidomethyl (+57.02) 871.4663 1,740.92 1,741.89 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DQGPNVcALQQILGTK 95.00% 4.86 0.599 4.44 c7: Carbamidomethyl (+57.02) 871.4669 1,740.92 1,741.89 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% ESDIMTTNGVIHVVDK 95.00% 3.31 0.188 0 879.4432 1,756.87 1,757.87 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% ESDIMTTNGVIHVVDK 95.00% 3.09 0.218 0 879.4463 1,756.88 1,757.87 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% EGETITEVIHGEPIIK 95.00% 4.22 0.588 4.05 882.9705 1,763.93 1,764.94 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% EGETITEVIHGEPIIK 95.00% 4.49 0.564 3.42 883.4739 1,764.93 1,764.94 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DGHFTLFAPTNEAFEK 95.00% 5.39 0.64 5.21 912.9322 1,823.85 1,823.86 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DGHFTLFAPTNEAFEK 95.00% 4.94 0.635 5.03 912.9326 1,823.85 1,823.86 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DGHFTLFAPTNEAFEK 95.00% 5.29 0.661 5.29 912.9331 1,823.85 1,823.86 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% DGHFTLFAPTNEAFEK 95.00% 4.84 0.627 4.55 912.9335 1,823.85 1,823.86 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VGLNELYNGQILETIGGK 95.00% 4.84 0.6 4.37 959.5156 1,917.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VGLNELYNGQILETIGGK 95.00% 5.02 0.573 4.42 959.5157 1,917.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VGLNELYNGQILETIGGK 95.00% 4.9 0.609 4.08 959.5168 1,917.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VGLNELYNGQILETIGGK 95.00% 5.23 0.623 4.82 959.5171 1,917.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VGLNELYNGQILETIGGK 95.00% 5.21 0.552 3.33 960.0157 1,918.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VGLNELYNGQILETIGGK 95.00% 4.89 0.569 3.19 960.0178 1,918.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% GRDQGPNVcALQQILGTK 95.00% 5.56 0.529 4.04 c9: Carbamidomethyl (+57.02) 978.5097 1,955.00 1,955.01 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% IIHGNQIATNGVVHVIDR 95.00% 5.57 0.562 8 979.0425 1,956.07 1,956.08 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% VKVGLNELYNGQILETIGGK 95.00% 5.49 0.539 8.74 1,073.60 2,145.18 2,145.19 2
 SAMPLE 1 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 21 30 91 28.60% LILQNHILKVKVGLNELYNGQILETIGGK 95.00% 2.99 0.238 0 1,073.60 3,217.77 3,217.87 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% AAAITSDILEALGR 95.00% 4.07 0.422 1.85 467.5973 1,399.77 1,400.78 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GMTSEEKEILIR 95.00% 3.19 0.165 0 469.2499 1,404.73 1,405.74 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GMTSEEKEILIR 95.00% 3.11 0.174 0 469.5837 1,405.73 1,405.74 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% IKVIEGSLQPIIK 95.00% 3.13 0.218 0 479.971 1,436.89 1,437.90 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% LLKLILQNHILK 95.00% 2.95 0.211 0 482.6563 1,444.95 1,445.96 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% LILQNHILK 95.00% 2.32 0.195 0 546.3492 1,090.68 1,091.69 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% LILQNHILK 95.00% 2.62 0.164 0 546.3495 1,090.68 1,091.69 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% EIPVTVYTTK 95.00% 1.88 0.357 0 575.8189 1,149.62 1,150.64 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% EIPVTVYTTK 95.00% 1.88 0.35 0 575.8203 1,149.63 1,150.64 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DQGPNVcALQQILGTK 95.00% 3.75 0.43 1.3 c7: Carbamidomethyl (+57.02) 581.2997 1,740.88 1,741.89 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% ESDIMTTNGVIHVVDK 95.00% 1.43 0.282 0 586.6284 1,756.86 1,757.87 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% ESDIMTTNGVIHVVDK 95.00% 1.72 0.302 0 586.6293 1,756.86 1,757.87 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% ESDIMTTNGVIHVVDK 95.00% 2.3 0.319 0 586.6294 1,756.86 1,757.87 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GFEPGVTNILK 95.00% 2.5 0.323 1.44 587.8258 1,173.64 1,174.65 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GFEPGVTNILK 95.00% 2.53 0.368 0 587.826 1,173.64 1,174.65 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GFEPGVTNILK 95.00% 2.27 0.251 0 587.8264 1,173.64 1,174.65 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VIEGSLQPIIK 95.00% 3.04 0.299 1.68 598.8647 1,195.71 1,196.73 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VIEGSLQPIIK 95.00% 2.73 0.333 1.64 598.8647 1,195.71 1,196.73 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VIEGSLQPIIK 95.00% 2.88 0.281 1.37 598.8656 1,195.72 1,196.73 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VIEGSLQPIIK 95.00% 2.66 0.352 0 598.8657 1,195.72 1,196.73 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VKIEGEPEFR 95.00% 2.83 0.425 1.2 602.3228 1,202.63 1,203.64 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VKIEGEPEFR 95.00% 2.97 0.416 1.14 602.323 1,202.63 1,203.64 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DGHFTLFAPTNEAFEK 95.00% 2.65 0.326 0 608.6235 1,822.85 1,823.86 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DGHFTLFAPTNEAFEK 95.00% 3.25 0.289 1.72 608.6238 1,822.85 1,823.86 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DGHFTLFAPTNEAFEK 95.00% 3.62 0.378 1.64 608.6242 1,822.85 1,823.86 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DGHFTLFAPTNEAFEK 95.00% 3.04 0.352 1.54 608.6246 1,822.85 1,823.86 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VGLNELYNGQILETIGGK 95.00% 5.07 0.439 2.05 640.0139 1,917.02 1,918.03 3 CSRP1_HUMAN
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VGLNELYNGQILETIGGK 95.00% 5.15 0.332 2 640.3481 1,918.02 1,918.03 3 CSRP1_HUMAN
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GRDQGPNVcALQQILGTK 95.00% 2.53 0.326 0 c9: Carbamidomethyl (+57.02) 652.3406 1,954.00 1,955.01 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GRDQGPNVcALQQILGTK 95.00% 2.62 0.135 1.31 c9: Carbamidomethyl (+57.02) 652.6766 1,955.01 1,955.01 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% IIHGNQIATNGVVHVIDR 95.00% 6.15 0.639 3.72 653.0296 1,956.07 1,956.08 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% IIHGNQIATNGVVHVIDR 95.00% 5.58 0.639 4.14 653.0303 1,956.07 1,956.08 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% IIHGNQIATNGVVHVIDR 95.00% 6.14 0.643 5.09 653.0308 1,956.07 1,956.08 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% IIHGNQIATNGVVHVIDR 95.00% 2.65 0.279 0 653.0317 1,956.07 1,956.08 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% IIHGNQIATNGVVHVIDR 95.00% 5.4 0.673 3.74 653.0317 1,956.07 1,956.08 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% IIDGVPVEITEK 95.00% 2.03 0.364 0 656.8707 1,311.73 1,312.74 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% IIDGVPVEITEK 95.00% 2.25 0.28 1.25 656.8708 1,311.73 1,312.74 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% AAAITSDILEALGR 95.00% 4.86 0.538 3.7 700.8885 1,399.76 1,400.78 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% AAAITSDILEALGR 95.00% 3.39 0.541 3.85 700.8889 1,399.76 1,400.78 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% AAAITSDILEALGR 95.00% 4.02 0.601 4.04 700.8895 1,399.76 1,400.78 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% AAAITSDILEALGR 95.00% 3.73 0.55 3.39 700.8896 1,399.76 1,400.78 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% AAAITSDILEALGR 95.00% 4.18 0.548 3.82 700.8897 1,399.76 1,400.78 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% AAAITSDILEALGR 95.00% 2.57 0.335 2.44 700.8903 1,399.76 1,400.78 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% AAAITSDILEALGR 95.00% 3.04 0.455 2.64 700.8915 1,399.77 1,400.78 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% AAAITSDILEALGR 95.00% 2.87 0.485 4.42 701.3597 1,400.70 1,400.78 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% AAAITSDILEALGR 95.00% 3.16 0.537 3.7 701.3601 1,400.70 1,400.78 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% AAAITSDILEALGR 95.00% 0 0 3.41 701.6952 1,401.37 1,400.78 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% AAAITSDILEALGR 95.00% 0 0 4.89 701.696 1,401.38 1,400.78 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GMTSEEKEILIR 95.00% 3.53 0.338 3.54 703.3697 1,404.72 1,405.74 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GMTSEEKEILIR 95.00% 3.5 0.367 2.54 703.372 1,404.73 1,405.74 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GMTSEEKEILIR 95.00% 3.41 0.369 3.66 703.3722 1,404.73 1,405.74 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GMTSEEKEILIR 95.00% 3.22 0.391 2.68 703.3723 1,404.73 1,405.74 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VKVGLNELYNGQILETIGGK 95.00% 4.55 0.479 1.28 716.0682 2,145.18 2,145.19 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VKVGLNELYNGQILETIGGK 95.00% 4.97 0.462 1.3 716.0686 2,145.18 2,145.19 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% TAVcIENScMEK 95.00% 3.49 0.488 3.19 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3067 1,440.60 1,441.61 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% TAVcIENScMEK 95.00% 3.69 0.533 2.52 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3081 1,440.60 1,441.61 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% TAVcIENScMEK 95.00% 3.18 0.483 0 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3083 1,440.60 1,441.61 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% TAVcIENScMEK 95.00% 3.54 0.515 2.6 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.309 1,440.60 1,441.61 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% ISTGGGETEETLKK 95.00% 2.61 0.388 0 725.3749 1,448.73 1,449.74 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% LLYPADTPVGNDQLLEILNK 95.00% 3.79 0.43 0 743.0743 2,226.20 2,226.20 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DIVTNNGVIHLIDQVLIPDSAK 95.00% 3.12 0.27 0 792.4371 2,374.29 2,374.30 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DIVTNNGVIHLIDQVLIPDSAK 95.00% 3.76 0.399 0 792.4381 2,374.29 2,374.30 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DIVTNNGVIHLIDQVLIPDSAK 95.00% 4.51 0.318 1.07 792.4396 2,374.30 2,374.30 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DIVTNNGVIHLIDQVLIPDSAK 95.00% 4.53 0.368 1.21 792.4397 2,374.30 2,374.30 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DIVTNNGVIHLIDQVLIPDSAK 95.00% 2.95 0.328 0 792.4398 2,374.30 2,374.30 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% TTVLYEccPGYMR 95.00% 4.28 0.551 4.51 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3578 1,648.70 1,649.71 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% TTVLYEccPGYMR 95.00% 3.98 0.5 4.48 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3585 1,648.70 1,649.71 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% TTVLYEccPGYMR 95.00% 4.09 0.527 3.77 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3597 1,648.70 1,649.71 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% TTVLYEccPGYMR 95.00% 4.09 0.429 2.36 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.861 1,649.71 1,649.71 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% TTVLYEccPGYmR 95.00% 3.65 0.485 3.14 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 833.3545 1,664.69 1,665.71 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% IIDGVPVEITEKETR 95.00% 3.48 0.54 1.36 850.469 1,698.92 1,698.93 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% IIDGVPVEITEKETR 95.00% 2.81 0.345 1.54 850.4691 1,698.92 1,698.93 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% IIDGVPVEITEKETR 95.00% 3.18 0.489 3.24 850.4699 1,698.92 1,698.93 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.66 0.407 2.44 c2: Carbamidomethyl (+57.02) 866.4537 2,596.34 2,596.36 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.89 0.265 2.18 c2: Carbamidomethyl (+57.02) 866.4545 2,596.34 2,596.36 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 4 0.417 3.21 c2: Carbamidomethyl (+57.02) 866.4553 2,596.34 2,596.36 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.8 0.384 3.32 c2: Carbamidomethyl (+57.02) 866.4558 2,596.34 2,596.36 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.29 0.246 2.59 c2: Carbamidomethyl (+57.02) 866.4564 2,596.35 2,596.36 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.63 0.297 2.06 c2: Carbamidomethyl (+57.02) 866.4571 2,596.35 2,596.36 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 2.76 0.267 1.05 c2: Carbamidomethyl (+57.02) 866.4589 2,596.35 2,596.36 3
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DQGPNVcALQQILGTK 95.00% 4.02 0.567 3.41 c7: Carbamidomethyl (+57.02) 871.4463 1,740.88 1,741.89 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DQGPNVcALQQILGTK 95.00% 4.85 0.543 5.12 c7: Carbamidomethyl (+57.02) 871.4469 1,740.88 1,741.89 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DQGPNVcALQQILGTK 95.00% 4.54 0.601 4.28 c7: Carbamidomethyl (+57.02) 871.4666 1,740.92 1,741.89 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DQGPNVcALQQILGTK 95.00% 5.03 0.619 5.49 c7: Carbamidomethyl (+57.02) 871.4671 1,740.92 1,741.89 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% ESDIMTTNGVIHVVDK 95.00% 3.08 0.279 0 879.4419 1,756.87 1,757.87 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% ESDIMTTNGVIHVVDK 95.00% 3.05 0.187 0 879.443 1,756.87 1,757.87 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% EGETITEVIHGEPIIK 95.00% 3.88 0.543 3.42 882.9694 1,763.92 1,764.94 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% EGETITEVIHGEPIIK 95.00% 3.58 0.517 2.74 882.9734 1,763.93 1,764.94 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DGHFTLFAPTNEAFEK 95.00% 4.96 0.672 5.07 912.4312 1,822.85 1,823.86 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DGHFTLFAPTNEAFEK 95.00% 4.94 0.641 6.8 912.9312 1,823.85 1,823.86 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DGHFTLFAPTNEAFEK 95.00% 5 0.637 5.03 912.9334 1,823.85 1,823.86 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% DGHFTLFAPTNEAFEK 95.00% 5.06 0.636 5.33 912.9345 1,823.85 1,823.86 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VGLNELYNGQILETIGGK 95.00% 4.25 0.668 3.07 959.5141 1,917.01 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VGLNELYNGQILETIGGK 95.00% 4.82 0.599 3.64 959.515 1,917.01 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VGLNELYNGQILETIGGK 95.00% 4.99 0.573 4.25 959.5162 1,917.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VGLNELYNGQILETIGGK 95.00% 4.66 0.585 1.42 959.5194 1,917.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VGLNELYNGQILETIGGK 95.00% 5.1 0.578 3.85 960.0169 1,918.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VGLNELYNGQILETIGGK 95.00% 4.89 0.527 2.92 960.0175 1,918.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% VGLNELYNGQILETIGGK 95.00% 4.77 0.552 2.54 960.0183 1,918.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% GRDQGPNVcALQQILGTK 95.00% 4.82 0.59 2.54 c9: Carbamidomethyl (+57.02) 978.5103 1,955.01 1,955.01 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% IIHGNQIATNGVVHVIDR 95.00% 6.4 0.671 10.2 979.0454 1,956.08 1,956.08 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% LLYPADTPVGNDQLLEILNK 95.00% 5.34 0.451 6.31 1,114.10 2,226.19 2,226.20 2
 SAMPLE 1R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 25 34 103 36.70% LLYPADTPVGNDQLLEILNK 95.00% 5.43 0.546 7.4 1,114.11 2,226.20 2,226.20 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% NGAIHIFR 95.00% 2.96 0.325 0 464.2613 926.5069 927.5165 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% NGAIHIFR 95.00% 3.07 0.277 0 464.2617 926.5077 927.5165 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IMGDKVASEALMK 95.00% 2.06 0.291 0 464.9118 1,391.71 1,392.72 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GMTSEEKEILIR 95.00% 3.74 0.196 0 469.2492 1,404.72 1,405.74 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GMTSEEKEILIR 95.00% 3.73 0.286 0 469.2494 1,404.72 1,405.74 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GMTSEEKEILIR 95.00% 3.42 0.306 0 469.2496 1,404.73 1,405.74 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GMTSEEKEILIR 95.00% 3.75 0.306 0.959 469.25 1,404.73 1,405.74 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IKVIEGSLQPIIK 95.00% 4.02 0.237 1.02 479.9715 1,436.89 1,437.90 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IKVIEGSLQPIIK 95.00% 3.85 0.297 1.51 479.9726 1,436.89 1,437.90 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% LLKLILQNHILK 95.00% 4.83 0.396 1.05 482.6567 1,444.95 1,445.96 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% LLKLILQNHILK 95.00% 4.66 0.375 0 482.99 1,445.95 1,445.96 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% LILQNHILK 95.00% 2.55 0.197 0 546.3499 1,090.68 1,091.69 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIDGVPVEITEKETR 95.00% 2.35 0.399 0 566.9799 1,697.92 1,698.93 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIDGVPVEITEKETR 95.00% 2.3 0.453 0 566.9802 1,697.92 1,698.93 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% EIPVTVYTTK 94.70% 1.73 0.351 0 575.8213 1,149.63 1,150.64 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% EIPVTVYTTK 95.00% 1.92 0.356 0 575.8214 1,149.63 1,150.64 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% ESDIMTTNGVIHVVDK 95.00% 2.22 0.363 1.36 586.9631 1,757.87 1,757.87 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GFEPGVTNILK 95.00% 2.65 0.327 2.18 587.8241 1,173.63 1,174.65 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GFEPGVTNILK 95.00% 2.46 0.306 2.28 587.8253 1,173.63 1,174.65 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GFEPGVTNILK 95.00% 1.92 0.255 1.42 587.8262 1,173.64 1,174.65 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GFEPGVTNILK 95.00% 2.25 0.366 2.1 587.8262 1,173.64 1,174.65 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GFEPGVTNILK 95.00% 2.17 0.266 0 587.8272 1,173.64 1,174.65 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GFEPGVTNILK 95.00% 2.1 0.259 1.49 588.3279 1,174.64 1,174.65 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VIEGSLQPIIK 95.00% 3 0.348 1.32 598.8653 1,195.71 1,196.73 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VIEGSLQPIIK 95.00% 2.9 0.354 1.21 598.8654 1,195.72 1,196.73 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VKIEGEPEFR 95.00% 2.82 0.422 1.7 602.3216 1,202.63 1,203.64 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VKIEGEPEFR 95.00% 2.83 0.426 1.66 602.3218 1,202.63 1,203.64 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DGHFTLFAPTNEAFEK 95.00% 2.74 0.305 0.921 608.6228 1,822.84 1,823.86 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DGHFTLFAPTNEAFEK 95.00% 2.86 0.253 1.28 608.6232 1,822.85 1,823.86 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DGHFTLFAPTNEAFEK 95.00% 2.29 0.253 1.62 608.6234 1,822.85 1,823.86 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DGHFTLFAPTNEAFEK 95.00% 3.14 0.436 1.02 608.6242 1,822.85 1,823.86 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DGHFTLFAPTNEAFEK 95.00% 3.51 0.363 0.959 608.6244 1,822.85 1,823.86 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DGHFTLFAPTNEAFEK 95.00% 3.61 0.459 2.42 608.6245 1,822.85 1,823.86 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DGHFTLFAPTNEAFEK 95.00% 3.16 0.247 1.39 608.9588 1,823.85 1,823.86 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% EGETITEVIHGEPIIKK 95.00% 2.03 0.252 0 632.0161 1,893.02 1,893.03 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GRDQGPNVcALQQILGTK 95.00% 3.72 0.296 1.92 c9: Carbamidomethyl (+57.02) 652.3426 1,954.00 1,955.01 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GRDQGPNVcALQQILGTK 95.00% 3.84 0.25 1.41 c9: Carbamidomethyl (+57.02) 652.6765 1,955.01 1,955.01 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIHGNQIATNGVVHVIDR 95.00% 4.56 0.47 1.55 653.029 1,956.06 1,956.08 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIHGNQIATNGVVHVIDR 95.00% 5.57 0.655 2.64 653.0302 1,956.07 1,956.08 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIHGNQIATNGVVHVIDR 95.00% 4.65 0.569 1.4 653.0304 1,956.07 1,956.08 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIHGNQIATNGVVHVIDR 95.00% 6.01 0.659 3.52 653.0312 1,956.07 1,956.08 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIHGNQIATNGVVHVIDR 95.00% 5.33 0.684 3.47 653.0314 1,956.07 1,956.08 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIHGNQIATNGVVHVIDR 95.00% 4.73 0.605 1.23 653.0316 1,956.07 1,956.08 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIDGVPVEITEK 95.00% 3.14 0.411 3.15 656.8705 1,311.73 1,312.74 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIDGVPVEITEK 95.00% 3.02 0.403 2.28 656.8713 1,311.73 1,312.74 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IMGDKVASEALMK 95.00% 4.16 0.568 4.96 696.8623 1,391.71 1,392.72 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IMGDKVASEALMK 95.00% 4.17 0.58 2.77 696.8633 1,391.71 1,392.72 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IMGDKVASEALMK 95.00% 2.36 0.32 0 696.864 1,391.71 1,392.72 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% AAAITSDILEALGR 95.00% 4.98 0.599 4.38 700.8899 1,399.76 1,400.78 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% AAAITSDILEALGR 95.00% 4.83 0.577 5 700.89 1,399.76 1,400.78 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% AAAITSDILEALGR 95.00% 4.34 0.515 6.04 700.8906 1,399.77 1,400.78 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% AAAITSDILEALGR 95.00% 4.52 0.496 3.85 700.891 1,399.77 1,400.78 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GMTSEEKEILIR 95.00% 3.68 0.411 2.92 703.3703 1,404.73 1,405.74 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GMTSEEKEILIR 95.00% 3.55 0.418 2.52 703.3704 1,404.73 1,405.74 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GMTSEEKEILIR 95.00% 3.68 0.397 2.68 703.3706 1,404.73 1,405.74 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GMTSEEKEILIR 95.00% 3.76 0.404 3.82 703.3712 1,404.73 1,405.74 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% LIKEGETITEVIHGEPIIK 95.00% 5.54 0.548 3.3 707.4038 2,119.19 2,119.20 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% LIKEGETITEVIHGEPIIK 95.00% 5.09 0.506 1.92 707.4054 2,119.19 2,119.20 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VKVGLNELYNGQILETIGGK 95.00% 5.44 0.483 1.8 716.0672 2,145.18 2,145.19 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VKVGLNELYNGQILETIGGK 95.00% 5.11 0.416 3.15 716.0688 2,145.18 2,145.19 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% TAVcIENScMEK 95.00% 3.43 0.518 4.09 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3088 1,440.60 1,441.61 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% TAVcIENScMEK 95.00% 3.8 0.569 3.72 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.309 1,440.60 1,441.61 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% TAVcIENScMEK 95.00% 3.36 0.468 3.64 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3091 1,440.60 1,441.61 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% ISTGGGETEETLKK 95.00% 2.39 0.394 0 725.3787 1,448.74 1,449.74 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GLESNVNVELLNALHSHMINK 95.00% 2.41 0.247 0 778.4086 2,332.20 2,332.21 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GLESNVNVELLNALHSHMINK 95.00% 3.63 0.44 1.13 778.4097 2,332.21 2,332.21 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% TTVLYEccPGYMR 95.00% 3.86 0.482 2.89 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3568 1,648.70 1,649.71 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% TTVLYEccPGYMR 95.00% 3.92 0.372 3.62 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3568 1,648.70 1,649.71 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% TTVLYEccPGYMR 95.00% 3.39 0.451 1.82 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3573 1,648.70 1,649.71 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% TTVLYEccPGYMR 95.00% 4.18 0.567 3.51 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3584 1,648.70 1,649.71 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% TTVLYEccPGYMR 95.00% 4.31 0.579 4.77 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.359 1,648.70 1,649.71 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% TTVLYEccPGYMR 95.00% 3.9 0.524 3.85 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3619 1,648.71 1,649.71 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% TTVLYEccPGYMR 95.00% 4 0.521 4.62 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.8595 1,649.70 1,649.71 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GLESNVNVELLNALHSHMINKR 95.00% 2.43 0.237 0 830.4499 2,488.33 2,488.31 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIDGVPVEITEKETR 95.00% 3.32 0.483 4.66 849.9669 1,697.92 1,698.93 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIDGVPVEITEKETR 95.00% 3.58 0.549 3.68 850.468 1,698.92 1,698.93 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.8 0.331 3.06 c2: Carbamidomethyl (+57.02) 866.4548 2,596.34 2,596.36 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.28 0.314 2.96 c2: Carbamidomethyl (+57.02) 866.4557 2,596.34 2,596.36 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.22 0.306 2.92 c2: Carbamidomethyl (+57.02) 866.4567 2,596.35 2,596.36 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DQGPNVcALQQILGTK 95.00% 4.64 0.603 4.21 c7: Carbamidomethyl (+57.02) 871.4467 1,740.88 1,741.89 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DQGPNVcALQQILGTK 95.00% 4.62 0.575 6.46 c7: Carbamidomethyl (+57.02) 871.4474 1,740.88 1,741.89 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DQGPNVcALQQILGTK 95.00% 4.48 0.528 4.44 c7: Carbamidomethyl (+57.02) 871.4475 1,740.88 1,741.89 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DQGPNVcALQQILGTK 95.00% 4.76 0.617 4.62 c7: Carbamidomethyl (+57.02) 871.4486 1,740.88 1,741.89 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DQGPNVcALQQILGTK 95.00% 4.68 0.597 5.89 c7: Carbamidomethyl (+57.02) 871.4495 1,740.88 1,741.89 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DQGPNVcALQQILGTK 95.00% 3.14 0.235 2.24 c7: Carbamidomethyl (+57.02) 871.4668 1,740.92 1,741.89 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DQGPNVcALQQILGTK 95.00% 4.75 0.601 4.74 c7: Carbamidomethyl (+57.02) 871.95 1,741.88 1,741.89 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% DQGPNVcALQQILGTK 95.00% 4.91 0.6 4.92 c7: Carbamidomethyl (+57.02) 871.9508 1,741.89 1,741.89 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% ESDIMTTNGVIHVVDK 95.00% 4.62 0.444 4.68 879.4384 1,756.86 1,757.87 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% ESDIMTTNGVIHVVDK 95.00% 4.65 0.432 4.26 879.4405 1,756.87 1,757.87 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% EGETITEVIHGEPIIK 95.00% 4.5 0.574 3.26 882.97 1,763.92 1,764.94 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% EGETITEVIHGEPIIK 95.00% 4.33 0.507 4.04 883.4715 1,764.93 1,764.94 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% EGETITEVIHGEPIIKK 95.00% 4.39 0.584 2.89 947.5184 1,893.02 1,893.03 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VGLNELYNGQILETIGGK 95.00% 3.66 0.581 2.16 959.5122 1,917.01 1,918.03 2 CSRP1_HUMAN
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VGLNELYNGQILETIGGK 95.00% 5.04 0.57 3.13 959.5144 1,917.01 1,918.03 2 CSRP1_HUMAN
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VGLNELYNGQILETIGGK 95.00% 4.86 0.52 4.06 960.0162 1,918.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VGLNELYNGQILETIGGK 95.00% 4.9 0.506 2.33 960.0172 1,918.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VGLNELYNGQILETIGGK 95.00% 4.97 0.547 2.15 960.0177 1,918.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VGLNELYNGQILETIGGK 95.00% 5.19 0.538 3.54 960.0179 1,918.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GRDQGPNVcALQQILGTK 95.00% 5.07 0.616 4.6 c9: Carbamidomethyl (+57.02) 978.0091 1,954.00 1,955.01 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% GRDQGPNVcALQQILGTK 95.00% 4.69 0.569 3.85 c9: Carbamidomethyl (+57.02) 978.0096 1,954.00 1,955.01 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIHGNQIATNGVVHVIDR 95.00% 6.34 0.668 10.3 979.0426 1,956.07 1,956.08 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% IIHGNQIATNGVVHVIDR 95.00% 6.16 0.621 10.8 979.0431 1,956.07 1,956.08 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VKVGLNELYNGQILETIGGK 95.00% 6.58 0.55 9.6 1,073.60 2,145.18 2,145.19 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% LILQNHILKVKVGLNELYNGQILETIGGK 95.00% 3.2 0.286 2.8 1,073.60 3,217.77 3,217.87 3
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% VKVGLNELYNGQILETIGGK 95.00% 6.9 0.6 6.57 1,073.60 2,145.18 2,145.19 2
 SAMPLE 2 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 30 38 106 37.30% LILQNHILKVKVGLNELYNGQILETIGGK 95.00% 3.41 0.272 2 1,073.60 3,217.77 3,217.87 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% NGAIHIFR 95.00% 2.97 0.33 0 464.2617 926.5077 927.5165 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% NGAIHIFR 95.00% 2.98 0.319 0 464.2625 926.5094 927.5165 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 2.5 0.164 1.36 467.5965 1,399.77 1,400.78 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 4.22 0.438 2.06 467.597 1,399.77 1,400.78 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GMTSEEKEILIR 95.00% 3.55 0.218 1.03 469.2498 1,404.73 1,405.74 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GMTSEEKEILIR 95.00% 3.33 0.3 0 469.2499 1,404.73 1,405.74 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GMTSEEKEILIR 95.00% 3.39 0.343 0 469.2508 1,404.73 1,405.74 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GMTSEEKEILIR 95.00% 3.5 0.254 0 469.2509 1,404.73 1,405.74 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GmTSEEKEILIR 95.00% 2.71 0.218 0 m2: Oxidation (+15.99) 474.5818 1,420.72 1,421.73 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IKVIEGSLQPIIK 95.00% 4.22 0.277 1.03 479.9729 1,436.90 1,437.90 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IKVIEGSLQPIIK 95.00% 4.15 0.251 1.28 479.973 1,436.90 1,437.90 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% LLKLILQNHILK 95.00% 4.35 0.369 0 482.6557 1,444.94 1,445.96 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% LLKLILQNHILK 95.00% 4.85 0.415 1.51 482.6561 1,444.94 1,445.96 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% EIPVTVYTTK 95.00% 2.15 0.388 1.28 575.8203 1,149.62 1,150.64 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% EIPVTVYTTK 95.00% 2.07 0.386 1.68 575.8214 1,149.63 1,150.64 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% ESDIMTTNGVIHVVDK 95.00% 1.88 0.388 1.26 586.6288 1,756.86 1,757.87 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GFEPGVTNILK 95.00% 2.02 0.267 1.24 587.8258 1,173.64 1,174.65 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GFEPGVTNILK 95.00% 2.04 0.291 1.92 587.826 1,173.64 1,174.65 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GFEPGVTNILK 95.00% 2 0.333 0 587.826 1,173.64 1,174.65 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GFEPGVTNILK 95.00% 2.18 0.289 0 587.8269 1,173.64 1,174.65 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GFEPGVTNILK 95.00% 2.15 0.296 1.92 587.8271 1,173.64 1,174.65 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% VIEGSLQPIIK 95.00% 2.92 0.328 2.26 598.8648 1,195.71 1,196.73 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% VIEGSLQPIIK 95.00% 2.97 0.308 0 599.3656 1,196.72 1,196.73 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DGHFTLFAPTNEAFEK 95.00% 3.02 0.302 1.06 608.6233 1,822.85 1,823.86 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DGHFTLFAPTNEAFEK 95.00% 2.57 0.217 1.21 608.6234 1,822.85 1,823.86 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DGHFTLFAPTNEAFEK 95.00% 3.5 0.312 1.85 608.624 1,822.85 1,823.86 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DGHFTLFAPTNEAFEK 95.00% 2.79 0.269 1.15 608.9584 1,823.85 1,823.86 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DGHFTLFAPTNEAFEK 95.00% 2.64 0.2 1.7 608.9591 1,823.85 1,823.86 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% VGLNELYNGQILETIGGK 95.00% 4.99 0.347 1.49 640.0135 1,917.02 1,918.03 3 CSRP1_HUMAN
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% VGLNELYNGQILETIGGK 95.00% 5.22 0.31 1.92 640.3478 1,918.02 1,918.03 3 CSRP1_HUMAN
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GRDQGPNVcALQQILGTK 95.00% 3.62 0.122 2.33 c9: Carbamidomethyl (+57.02) 652.6747 1,955.00 1,955.01 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GRDQGPNVcALQQILGTK 95.00% 2.68 0.111 1.03 c9: Carbamidomethyl (+57.02) 652.6753 1,955.00 1,955.01 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIHGNQIATNGVVHVIDR 95.00% 5.21 0.615 3.8 652.698 1,955.07 1,956.08 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIHGNQIATNGVVHVIDR 95.00% 4.77 0.584 1.51 652.6985 1,955.07 1,956.08 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIHGNQIATNGVVHVIDR 95.00% 3.45 0.43 0 652.6987 1,955.07 1,956.08 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIHGNQIATNGVVHVIDR 95.00% 5.32 0.639 2.77 653.0303 1,956.07 1,956.08 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIHGNQIATNGVVHVIDR 95.00% 4.26 0.566 2.47 653.0305 1,956.07 1,956.08 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIHGNQIATNGVVHVIDR 95.00% 5.73 0.653 4.85 653.0308 1,956.07 1,956.08 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIHGNQIATNGVVHVIDR 95.00% 5.52 0.668 4.92 653.031 1,956.07 1,956.08 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIDGVPVEITEK 95.00% 2.8 0.505 2.36 656.8713 1,311.73 1,312.74 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIDGVPVEITEK 95.00% 2.42 0.428 1.46 656.8714 1,311.73 1,312.74 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IMGDKVASEALMK 95.00% 4.19 0.521 2.1 696.8624 1,391.71 1,392.72 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IMGDKVASEALMK 95.00% 4 0.553 2.72 696.8648 1,391.71 1,392.72 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 4.3 0.538 4.57 700.8863 1,399.76 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 3.94 0.513 3.41 700.8893 1,399.76 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 4.61 0.55 3.96 700.8893 1,399.76 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 3.08 0.438 3.6 700.8893 1,399.76 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 4.73 0.596 3.11 700.8896 1,399.76 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 4.56 0.566 3.49 700.8897 1,399.76 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 3.53 0.529 2.96 700.8899 1,399.76 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 2.45 0.368 2.85 700.8899 1,399.76 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 4.66 0.562 3.92 700.8905 1,399.77 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 2.44 0.341 1.35 700.8911 1,399.77 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 3.02 0.456 2.64 700.8911 1,399.77 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 4.12 0.583 3.62 700.8912 1,399.77 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 4.05 0.532 4.29 701.3851 1,400.75 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% AAAITSDILEALGR 95.00% 3.7 0.513 3.09 701.3915 1,400.77 1,400.78 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GMTSEEKEILIR 95.00% 3.79 0.379 3.07 703.3694 1,404.72 1,405.74 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GMTSEEKEILIR 95.00% 3.38 0.367 3.12 703.3702 1,404.72 1,405.74 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GMTSEEKEILIR 95.00% 3.61 0.408 2.51 703.3705 1,404.73 1,405.74 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GMTSEEKEILIR 95.00% 3.14 0.281 3.28 703.3706 1,404.73 1,405.74 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% LIKEGETITEVIHGEPIIK 95.00% 3.85 0.433 1.57 707.4042 2,119.19 2,119.20 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% LIKEGETITEVIHGEPIIK 95.00% 3.86 0.396 1.15 707.4078 2,119.20 2,119.20 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% VKVGLNELYNGQILETIGGK 95.00% 5.16 0.454 1.55 716.0679 2,145.18 2,145.19 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% VKVGLNELYNGQILETIGGK 95.00% 5.34 0.429 1.72 716.069 2,145.18 2,145.19 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% TAVcIENScMEK 95.00% 3.92 0.554 3.54 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3086 1,440.60 1,441.61 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% TAVcIENScMEK 95.00% 3.35 0.48 2.23 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.309 1,440.60 1,441.61 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% TAVcIENScMEK 95.00% 3.29 0.499 2.68 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3107 1,440.61 1,441.61 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% TAVcIENScMEK 95.00% 3.98 0.511 2.62 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.81 1,441.60 1,441.61 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% ISTGGGETEETLKK 95.00% 2.77 0.396 2.55 725.3774 1,448.74 1,449.74 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% LLYPADTPVGNDQLLEILNK 95.00% 5.91 0.387 2.74 743.0717 2,226.19 2,226.20 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% LLYPADTPVGNDQLLEILNK 95.00% 5.95 0.459 2.92 743.0728 2,226.19 2,226.20 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% FSTFLSLLEAADLK 95.00% 5.01 0.472 4.57 777.9242 1,553.83 1,554.84 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GLESNVNVELLNALHSHMINK 95.00% 2.88 0.329 1.14 778.4074 2,332.20 2,332.21 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GLESNVNVELLNALHSHMINK 95.00% 3.17 0.344 0 778.4075 2,332.20 2,332.21 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DKNALQNIILYHLTPGVFIGK 95.00% 5.85 0.579 3.82 785.7792 2,354.31 2,354.32 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DKNALQNIILYHLTPGVFIGK 95.00% 5.94 0.565 2.62 785.7805 2,354.32 2,354.32 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DIVTNNGVIHLIDQVLIPDSAK 95.00% 4.63 0.22 1.89 792.4367 2,374.29 2,374.30 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DIVTNNGVIHLIDQVLIPDSAK 95.00% 3.54 0.346 0 792.4367 2,374.29 2,374.30 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DIVTNNGVIHLIDQVLIPDSAK 95.00% 4.63 0.353 0 792.4369 2,374.29 2,374.30 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DIVTNNGVIHLIDQVLIPDSAK 95.00% 3.68 0.203 0 792.4407 2,374.30 2,374.30 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% TTVLYEccPGYMR 95.00% 3.66 0.536 2.92 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.356 1,648.70 1,649.71 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% TTVLYEccPGYMR 95.00% 3.75 0.519 3.24 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3575 1,648.70 1,649.71 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% TTVLYEccPGYMR 95.00% 4.19 0.564 4.31 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3581 1,648.70 1,649.71 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% TTVLYEccPGYMR 95.00% 3.9 0.524 2.74 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3607 1,648.71 1,649.71 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% TTVLYEccPGYMR 95.00% 4.36 0.526 3.92 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.8595 1,649.70 1,649.71 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GLESNVNVELLNALHSHMINKR 95.00% 2.83 0.402 0 830.4477 2,488.32 2,488.31 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% TTVLYEccPGYmR 95.00% 3.82 0.414 3.38 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 833.3516 1,664.69 1,665.71 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% TTVLYEccPGYmR 95.00% 3.95 0.453 4.06 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 833.3551 1,664.69 1,665.71 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIDGVPVEITEKETR 95.00% 3.04 0.512 4.85 849.9653 1,697.92 1,698.93 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIDGVPVEITEKETR 95.00% 3.55 0.52 5.38 849.9671 1,697.92 1,698.93 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.71 0.282 2.77 c2: Carbamidomethyl (+57.02) 866.4553 2,596.34 2,596.36 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.67 0.447 2.82 c2: Carbamidomethyl (+57.02) 866.4556 2,596.34 2,596.36 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 4.05 0.381 1.8 c2: Carbamidomethyl (+57.02) 866.4566 2,596.35 2,596.36 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.94 0.375 1.68 c2: Carbamidomethyl (+57.02) 866.4578 2,596.35 2,596.36 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DQGPNVcALQQILGTK 95.00% 4.38 0.522 4.74 c7: Carbamidomethyl (+57.02) 871.4489 1,740.88 1,741.89 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DQGPNVcALQQILGTK 95.00% 4.85 0.565 5.49 c7: Carbamidomethyl (+57.02) 871.4489 1,740.88 1,741.89 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DQGPNVcALQQILGTK 95.00% 4.8 0.601 3.64 c7: Carbamidomethyl (+57.02) 871.449 1,740.88 1,741.89 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DQGPNVcALQQILGTK 95.00% 4.78 0.564 5.23 c7: Carbamidomethyl (+57.02) 871.45 1,740.88 1,741.89 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DQGPNVcALQQILGTK 95.00% 4.69 0.604 5.33 c7: Carbamidomethyl (+57.02) 871.946 1,741.88 1,741.89 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DQGPNVcALQQILGTK 95.00% 4.6 0.588 4.41 c7: Carbamidomethyl (+57.02) 871.9496 1,741.88 1,741.89 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% ESDIMTTNGVIHVVDK 95.00% 4.6 0.424 4.64 879.4392 1,756.86 1,757.87 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% ESDIMTTNGVIHVVDK 95.00% 4.7 0.431 3.66 879.9403 1,757.86 1,757.87 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% EGETITEVIHGEPIIK 95.00% 4.28 0.587 4.92 882.9716 1,763.93 1,764.94 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% EGETITEVIHGEPIIK 95.00% 4.26 0.505 3.08 882.9726 1,763.93 1,764.94 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DGHFTLFAPTNEAFEK 95.00% 4.9 0.655 4.82 912.431 1,822.85 1,823.86 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DGHFTLFAPTNEAFEK 95.00% 5.06 0.635 5.74 912.9325 1,823.85 1,823.86 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% VGLNELYNGQILETIGGK 95.00% 4.25 0.618 4.85 959.516 1,917.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% VGLNELYNGQILETIGGK 95.00% 4.84 0.54 3.07 960.0159 1,918.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% VGLNELYNGQILETIGGK 95.00% 3.17 0.311 0 960.0191 1,918.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GRDQGPNVcALQQILGTK 95.00% 4.78 0.581 5.8 c9: Carbamidomethyl (+57.02) 978.006 1,954.00 1,955.01 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% GRDQGPNVcALQQILGTK 95.00% 4.9 0.615 5.16 c9: Carbamidomethyl (+57.02) 978.008 1,954.00 1,955.01 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIHGNQIATNGVVHVIDR 95.00% 6.23 0.637 9.8 979.0407 1,956.07 1,956.08 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% IIHGNQIATNGVVHVIDR 95.00% 6.28 0.66 7 979.0417 1,956.07 1,956.08 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% VKVGLNELYNGQILETIGGK 95.00% 6.54 0.575 8.24 1,073.60 2,145.18 2,145.19 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% LILQNHILKVKVGLNELYNGQILETIGGK 95.00% 3.54 0.372 2.52 1,073.60 3,217.77 3,217.87 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% VKVGLNELYNGQILETIGGK 95.00% 6.64 0.571 6.37 1,073.60 2,145.18 2,145.19 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% LILQNHILKVKVGLNELYNGQILETIGGK 95.00% 3.84 0.477 2.24 1,073.60 3,217.78 3,217.87 3
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% LLYPADTPVGNDQLLEILNK 95.00% 5.42 0.516 6.11 1,114.10 2,226.19 2,226.20 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% LLYPADTPVGNDQLLEILNK 95.00% 5.43 0.493 7.07 1,114.10 2,226.19 2,226.20 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DIVTNNGVIHLIDQVLIPDSAK 95.00% 5.2 0.496 3.38 1,188.15 2,374.28 2,374.30 2
 SAMPLE 2R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 31 41 122 45.20% DIVTNNGVIHLIDQVLIPDSAK 95.00% 4.96 0.486 3.8 1,188.15 2,374.29 2,374.30 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% NGAIHIFR 95.00% 2.64 0.361 0 464.2609 926.5061 927.5165 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% NGAIHIFR 95.00% 2.73 0.361 0 464.2618 926.508 927.5165 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IMGDKVASEALMK 95.00% 2.26 0.245 0 464.913 1,391.72 1,392.72 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% GMTSEEKEILIR 95.00% 3.81 0.275 1.27 469.2502 1,404.73 1,405.74 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% GMTSEEKEILIR 95.00% 3.22 0.301 0 469.2509 1,404.73 1,405.74 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% LLKLILQNHILK 95.00% 3.85 0.422 0 482.6573 1,444.95 1,445.96 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% LILQNHILK 95.00% 2.94 0.196 0 546.3494 1,090.68 1,091.69 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% LILQNHILK 95.00% 2.41 0.276 0 546.3501 1,090.68 1,091.69 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IIDGVPVEITEKETR 95.00% 2.19 0.299 0 566.9801 1,697.92 1,698.93 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% DQGPNVcALQQILGTK 95.00% 4.16 0.422 1.52 c7: Carbamidomethyl (+57.02) 581.3004 1,740.88 1,741.89 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% ESDIMTTNGVIHVVDK 95.00% 2.28 0.402 0 586.6299 1,756.87 1,757.87 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% ESDIMTTNGVIHVVDK 95.00% 2.33 0.434 1.77 586.9634 1,757.87 1,757.87 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% VIEGSLQPIIK 95.00% 2.52 0.26 1.92 598.8647 1,195.71 1,196.73 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% VIEGSLQPIIK 95.00% 2.47 0.302 1.24 598.8663 1,195.72 1,196.73 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% DGHFTLFAPTNEAFEK 95.00% 2.91 0.355 0 608.6246 1,822.85 1,823.86 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% DGHFTLFAPTNEAFEK 95.00% 3.87 0.414 0 608.9587 1,823.85 1,823.86 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IIHGNQIATNGVVHVIDR 95.00% 3.91 0.443 0 653.0302 1,956.07 1,956.08 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IIHGNQIATNGVVHVIDR 95.00% 5.51 0.657 3.74 653.0307 1,956.07 1,956.08 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IIHGNQIATNGVVHVIDR 95.00% 5.53 0.654 3.31 653.0314 1,956.07 1,956.08 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IIDGVPVEITEK 95.00% 2.55 0.268 0 656.8713 1,311.73 1,312.74 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IIDGVPVEITEK 95.00% 2.89 0.362 1.08 656.8719 1,311.73 1,312.74 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IMGDKVASEALMK 95.00% 3.55 0.511 3.25 696.8638 1,391.71 1,392.72 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IMGDKVASEALMK 95.00% 3.55 0.579 2.19 696.8639 1,391.71 1,392.72 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% GMTSEEKEILIR 95.00% 3.65 0.391 3.22 703.3709 1,404.73 1,405.74 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% GMTSEEKEILIR 95.00% 3.49 0.387 2.74 703.3715 1,404.73 1,405.74 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% LIKEGETITEVIHGEPIIK 95.00% 5.09 0.524 2.85 707.4044 2,119.19 2,119.20 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% LIKEGETITEVIHGEPIIK 95.00% 5.01 0.504 2.7 707.406 2,119.19 2,119.20 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% VKVGLNELYNGQILETIGGK 95.00% 4.91 0.439 1.85 716.0693 2,145.18 2,145.19 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% TAVcIENScMEK 95.00% 2.72 0.405 1.85 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3053 1,440.60 1,441.61 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% TAVcIENScMEK 95.00% 3.27 0.5 2.82 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.309 1,440.60 1,441.61 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% TAVcIENScMEK 95.00% 3.85 0.55 3.96 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3092 1,440.60 1,441.61 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% TAVcIENScMEK 95.00% 3.8 0.549 5.14 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3098 1,440.60 1,441.61 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% TTVLYEccPGYMR 95.00% 4.56 0.495 2.47 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3576 1,648.70 1,649.71 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% TTVLYEccPGYMR 95.00% 3.92 0.44 3.01 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3595 1,648.70 1,649.71 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IIDGVPVEITEKETR 95.00% 2.62 0.38 0 849.9666 1,697.92 1,698.93 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IIDGVPVEITEKETR 95.00% 3.7 0.59 5.77 849.9671 1,697.92 1,698.93 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IIDGVPVEITEKETR 95.00% 3.79 0.556 4.68 849.9682 1,697.92 1,698.93 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.2 0.222 2.1 c2: Carbamidomethyl (+57.02) 866.4563 2,596.35 2,596.36 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.35 0.208 2.82 c2: Carbamidomethyl (+57.02) 866.457 2,596.35 2,596.36 3
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% DQGPNVcALQQILGTK 95.00% 4.53 0.563 4.8 c7: Carbamidomethyl (+57.02) 871.4471 1,740.88 1,741.89 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% DQGPNVcALQQILGTK 95.00% 3.89 0.525 4.96 c7: Carbamidomethyl (+57.02) 871.9471 1,741.88 1,741.89 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% DQGPNVcALQQILGTK 95.00% 4.33 0.55 3.44 c7: Carbamidomethyl (+57.02) 871.948 1,741.88 1,741.89 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% DQGPNVcALQQILGTK 95.00% 4.6 0.527 5.42 c7: Carbamidomethyl (+57.02) 871.9528 1,741.89 1,741.89 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% ESDIMTTNGVIHVVDK 95.00% 4.65 0.445 4.8 879.4407 1,756.87 1,757.87 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% ESDIMTTNGVIHVVDK 95.00% 4.69 0.464 2.26 879.4408 1,756.87 1,757.87 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% EGETITEVIHGEPIIK 95.00% 3.99 0.559 3.29 882.9704 1,763.93 1,764.94 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% EGETITEVIHGEPIIK 95.00% 3.94 0.555 3.55 883.4745 1,764.93 1,764.94 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% DGHFTLFAPTNEAFEK 95.00% 4.9 0.661 5.55 912.4318 1,822.85 1,823.86 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% DGHFTLFAPTNEAFEK 95.00% 4.99 0.624 4.35 912.9338 1,823.85 1,823.86 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IIHGNQIATNGVVHVIDR 95.00% 6.19 0.616 9.96 979.0409 1,956.07 1,956.08 2
 SAMPLE 3 Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 18 25 51 27.00% IIHGNQIATNGVVHVIDR 95.00% 6.03 0.649 10.2 979.0419 1,956.07 1,956.08 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% NGAIHIFR 95.00% 2.39 0.315 0 464.2622 926.5088 927.5165 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% NGAIHIFR 95.00% 2.72 0.33 0 464.2625 926.5094 927.5165 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% AAAITSDILEALGR 95.00% 4.77 0.438 2.17 467.5967 1,399.77 1,400.78 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% AAAITSDILEALGR 95.00% 4.5 0.404 2.17 467.5968 1,399.77 1,400.78 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% GMTSEEKEILIR 95.00% 3.36 0.279 0 469.25 1,404.73 1,405.74 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% GMTSEEKEILIR 95.00% 2.94 0.289 0 469.2507 1,404.73 1,405.74 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% LILQNHILK 95.00% 2.44 0.201 0 546.3498 1,090.68 1,091.69 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% LILQNHILK 95.00% 2.47 0.195 0 546.3498 1,090.68 1,091.69 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% IIDGVPVEITEKETR 95.00% 2.49 0.287 0 566.9803 1,697.92 1,698.93 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% IIDGVPVEITEKETR 95.00% 1.85 0.23 0 566.9804 1,697.92 1,698.93 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DQGPNVcALQQILGTK 95.00% 4.28 0.451 1.74 c7: Carbamidomethyl (+57.02) 581.3005 1,740.88 1,741.89 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DQGPNVcALQQILGTK 95.00% 3.78 0.408 1.92 c7: Carbamidomethyl (+57.02) 581.6348 1,741.88 1,741.89 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% ESDIMTTNGVIHVVDK 95.00% 2.59 0.383 1.03 586.6293 1,756.86 1,757.87 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% VIEGSLQPIIK 95.00% 2.59 0.256 0 598.8652 1,195.71 1,196.73 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% VIEGSLQPIIK 95.00% 2.41 0.273 0 598.8653 1,195.71 1,196.73 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DGHFTLFAPTNEAFEK 95.00% 2.84 0.25 1.26 608.6244 1,822.85 1,823.86 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DGHFTLFAPTNEAFEK 95.00% 3.25 0.364 0 608.9593 1,823.85 1,823.86 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% VGLNELYNGQILETIGGK 95.00% 4.7 0.357 0 640.3484 1,918.02 1,918.03 3 CSRP1_HUMAN
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% VGLNELYNGQILETIGGK 95.00% 4.88 0.375 0 640.3485 1,918.02 1,918.03 3 CSRP1_HUMAN
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% IIHGNQIATNGVVHVIDR 95.00% 5.42 0.639 4.89 652.6971 1,955.07 1,956.08 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% IIHGNQIATNGVVHVIDR 95.00% 5.49 0.596 4.24 653.0314 1,956.07 1,956.08 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% IIDGVPVEITEK 95.00% 2.98 0.398 0 656.8711 1,311.73 1,312.74 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% IIDGVPVEITEK 95.00% 2.42 0.348 0 656.8716 1,311.73 1,312.74 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% IMGDKVASEALMK 95.00% 3.53 0.591 2.14 696.8653 1,391.72 1,392.72 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% IMGDKVASEALMK 95.00% 2.61 0.332 0 696.8661 1,391.72 1,392.72 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% AAAITSDILEALGR 95.00% 4.18 0.526 3.17 700.8865 1,399.76 1,400.78 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% AAAITSDILEALGR 95.00% 4.47 0.592 3.31 700.8867 1,399.76 1,400.78 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% AAAITSDILEALGR 95.00% 1.89 0.189 1.77 700.8889 1,399.76 1,400.78 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% AAAITSDILEALGR 95.00% 2.8 0.387 1.72 700.8896 1,399.76 1,400.78 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% AAAITSDILEALGR 95.00% 4.85 0.558 3.96 700.8896 1,399.76 1,400.78 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% AAAITSDILEALGR 95.00% 4.34 0.559 3.55 700.8905 1,399.77 1,400.78 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% GMTSEEKEILIR 95.00% 3.66 0.464 2.28 703.3701 1,404.72 1,405.74 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% GMTSEEKEILIR 95.00% 3.32 0.394 3 703.3707 1,404.73 1,405.74 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% GMTSEEKEILIR 95.00% 2.79 0.264 1.22 703.3707 1,404.73 1,405.74 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% LIKEGETITEVIHGEPIIK 95.00% 4.52 0.426 2.44 707.4068 2,119.20 2,119.20 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% VKVGLNELYNGQILETIGGK 95.00% 4.91 0.477 1.92 716.0693 2,145.18 2,145.19 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% TAVcIENScMEK 95.00% 3.39 0.464 3.39 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3084 1,440.60 1,441.61 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% TAVcIENScMEK 95.00% 3.84 0.556 3.41 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3086 1,440.60 1,441.61 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% TAVcIENScMEK 95.00% 3.73 0.559 2.62 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 721.3101 1,440.60 1,441.61 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% ISTGGGETEETLKK 95.00% 2.75 0.468 2.08 725.8759 1,449.74 1,449.74 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DIVTNNGVIHLIDQVLIPDSAK 95.00% 5.6 0.395 1.48 792.4389 2,374.29 2,374.30 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% TTVLYEccPGYMR 95.00% 4.19 0.427 2.72 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3579 1,648.70 1,649.71 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% TTVLYEccPGYMR 95.00% 4.27 0.493 2.74 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.3582 1,648.70 1,649.71 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% TTVLYEccPGYMR 95.00% 3.87 0.0458 1.54 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.944 1,649.87 1,649.71 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% TTVLYEccPGYMR 95.00% 3.99 0.299 2.22 c7: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 825.945 1,649.87 1,649.71 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% IIDGVPVEITEKETR 95.00% 3.34 0.488 4.27 849.9667 1,697.92 1,698.93 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% IIDGVPVEITEKETR 95.00% 3.45 0.453 3.66 850.4669 1,698.92 1,698.93 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.33 0.357 2.7 c2: Carbamidomethyl (+57.02) 866.4564 2,596.35 2,596.36 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% GcPAVLPIDHVYGTLGIVGATTTQR 95.00% 3.28 0.239 3.11 c2: Carbamidomethyl (+57.02) 866.4568 2,596.35 2,596.36 3
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DQGPNVcALQQILGTK 95.00% 4.66 0.553 6.21 c7: Carbamidomethyl (+57.02) 871.4468 1,740.88 1,741.89 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DQGPNVcALQQILGTK 95.00% 4.3 0.537 3.89 c7: Carbamidomethyl (+57.02) 871.4478 1,740.88 1,741.89 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DQGPNVcALQQILGTK 95.00% 3.81 0.506 5.32 c7: Carbamidomethyl (+57.02) 871.4485 1,740.88 1,741.89 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DQGPNVcALQQILGTK 95.00% 4.37 0.525 4.64 c7: Carbamidomethyl (+57.02) 871.4492 1,740.88 1,741.89 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DQGPNVcALQQILGTK 95.00% 4.23 0.54 4.89 c7: Carbamidomethyl (+57.02) 871.4497 1,740.88 1,741.89 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DQGPNVcALQQILGTK 95.00% 3.72 0.369 4.41 c7: Carbamidomethyl (+57.02) 871.4592 1,740.90 1,741.89 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% ESDIMTTNGVIHVVDK 95.00% 4.7 0.431 3.19 879.4403 1,756.86 1,757.87 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% ESDIMTTNGVIHVVDK 95.00% 4.5 0.428 2.07 879.9405 1,757.87 1,757.87 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% EGETITEVIHGEPIIK 95.00% 4 0.505 4.8 883.4718 1,764.93 1,764.94 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% EGETITEVIHGEPIIK 95.00% 4.03 0.521 5.42 883.4748 1,764.93 1,764.94 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DGHFTLFAPTNEAFEK 95.00% 5.09 0.66 4.66 912.4327 1,822.85 1,823.86 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DGHFTLFAPTNEAFEK 95.00% 5.23 0.675 5.31 912.4331 1,822.85 1,823.86 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% VGLNELYNGQILETIGGK 95.00% 4.29 0.543 1.72 959.5178 1,917.02 1,918.03 2 CSRP1_HUMAN
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% VGLNELYNGQILETIGGK 95.00% 4.45 0.568 2.14 960.015 1,918.01 1,918.03 2 CSRP1_HUMAN
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% GRDQGPNVcALQQILGTK 95.00% 4.63 0.524 4.6 c9: Carbamidomethyl (+57.02) 978.5103 1,955.00 1,955.01 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% GRDQGPNVcALQQILGTK 95.00% 4.86 0.565 4.21 c9: Carbamidomethyl (+57.02) 978.5107 1,955.01 1,955.01 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% LLYPADTPVGNDQLLEILNK 95.00% 5.24 0.507 4.7 1,114.11 2,226.20 2,226.20 2
 SAMPLE 3R Periostin  POSTN  POSTN_HUMAN 93,300.00 100.00% 23 31 67 35.30% DIVTNNGVIHLIDQVLIPDSAK 95.00% 4.76 0.501 4.42 1,187.65 2,373.28 2,374.30 2
 SAMPLE 4 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 2 3 16.60% GLFIIDDKGILR 95.00% 2.64 0.341 0 453.9423 1,358.80 1,359.80 3
 SAMPLE 4 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 2 3 16.60% LVQAFQFTDK 95.00% 3.26 0.501 3.07 598.821 1,195.63 1,196.63 2
 SAMPLE 4 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 2 3 16.60% LVQAFQFTDK 95.00% 3.21 0.511 2.16 598.8213 1,195.63 1,196.63 2
 SAMPLE 4 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 2 3 16.60% QITVNDLPVGR 95.00% 2.93 0.48 0 606.3404 1,210.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 4 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 2 3 16.60% QITVNDLPVGR 95.00% 2.86 0.446 0 606.3413 1,210.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 4 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 2 3 16.60% QITVNDLPVGR 95.00% 3.05 0.5 1.7 606.3425 1,210.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 4 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 2 3 16.60% QITVNDLPVGR 95.00% 2.99 0.512 1.89 606.3426 1,210.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 4R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 6 16.60% GLFIIDDKGILR 95.00% 2.31 0.366 1.8 453.9427 1,358.80 1,359.80 3
 SAMPLE 4R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 6 16.60% GLFIIDDK 95.00% 2.29 0.297 0 460.7597 919.5038 920.5096 2
 SAMPLE 4R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 6 16.60% GLFIIDDK 95.00% 2.23 0.33 0 460.7621 919.5086 920.5096 2
 SAMPLE 4R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 6 16.60% LVQAFQFTDK 95.00% 3.15 0.515 2.6 598.8204 1,195.63 1,196.63 2
 SAMPLE 4R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 6 16.60% LVQAFQFTDK 95.00% 3.14 0.469 2.49 598.8219 1,195.63 1,196.63 2
 SAMPLE 4R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 6 16.60% QITVNDLPVGR 95.00% 3.04 0.48 0 606.3425 1,210.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 4R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 6 16.60% QITVNDLPVGR 95.00% 3.05 0.494 0 606.3426 1,210.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 4R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 6 16.60% QITVNDLPVGR 95.00% 2.41 0.371 0 606.3432 1,210.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 4R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 6 16.60% GLFIIDDKGILR 95.00% 2.54 0.419 2.49 680.4038 1,358.79 1,359.80 2
 SAMPLE 1R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 3 7 11.10% GLFIIDDKGILR 95.00% 2.49 0.333 2.11 453.9416 1,358.80 1,359.80 3
 SAMPLE 1R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 3 7 11.10% GLFIIDDKGILR 95.00% 2.48 0.381 0 453.9459 1,358.81 1,359.80 3
 SAMPLE 1R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 3 7 11.10% LVQAFQFTDK 95.00% 4.04 0.489 1.92 598.8292 1,195.64 1,196.63 2
 SAMPLE 1R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 3 7 11.10% GLFIIDDKGILR 95.00% 3.68 0.505 2.1 680.4018 1,358.79 1,359.80 2
 SAMPLE 1R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 3 7 11.10% GLFIIDDKGILR 95.00% 2.98 0.406 1.51 680.4038 1,358.79 1,359.80 2
 SAMPLE 1R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 3 7 11.10% GLFIIDDKGILR 95.00% 3.21 0.456 0 680.4107 1,358.81 1,359.80 2
 SAMPLE 1R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 99.80% 2 3 7 11.10% GLFIIDDKGILR 95.00% 3.53 0.442 1.82 680.4151 1,358.81 1,359.80 2
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% GLFIIDDKGILR 95.00% 2.91 0.43 2.48 453.9385 1,358.79 1,359.80 3
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% GLFIIDDKGILR 95.00% 2.8 0.45 3.72 453.9409 1,358.80 1,359.80 3
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% TIAQDYGVLK 95.00% 2.51 0.316 1.62 554.3061 1,106.60 1,107.61 2
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% TIAQDYGVLK 95.00% 2.13 0.315 0 554.3067 1,106.60 1,107.61 2
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% LVQAFQFTDK 95.00% 2.49 0.439 1.33 598.8171 1,195.62 1,196.63 2
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% LVQAFQFTDK 95.00% 3.58 0.521 2.23 598.8183 1,195.62 1,196.63 2
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% LVQAFQFTDK 95.00% 3.45 0.529 2.19 598.8189 1,195.62 1,196.63 2
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% LVQAFQFTDK 95.00% 2.87 0.492 1.64 598.8189 1,195.62 1,196.63 2
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% QITVNDLPVGR 95.00% 2.94 0.44 0 606.3388 1,210.66 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% QITVNDLPVGR 95.00% 2.87 0.433 1.43 606.339 1,210.66 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% QITVNDLPVGR 95.00% 2.95 0.412 1.85 606.3394 1,210.66 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% QITVNDLPVGR 95.00% 2.96 0.458 2.19 606.341 1,210.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% GLFIIDDKGILR 95.00% 3.71 0.505 2.07 680.4019 1,358.79 1,359.80 2
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% GLFIIDDKGILR 95.00% 3.7 0.489 2 680.4025 1,358.79 1,359.80 2
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% HGEVcPAGWKPGSDTIKPDVQK 95.00% 5.87 0.39 2.89 c5: Carbamidomethyl (+57.02) 803.0662 2,406.18 2,406.19 3
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% QGGLGPMNIPLVSDPK 95.00% 3.69 0.444 4.05 811.9311 1,621.85 1,622.86 2
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% QGGLGPMNIPLVSDPK 95.00% 3.98 0.427 4.28 811.9319 1,621.85 1,622.86 2
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% QGGLGPmNIPLVSDPK 95.00% 4.1 0.522 4.37 m7: Oxidation (+15.99) 819.929 1,637.84 1,638.85 2
 SAMPLE 2 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 5 6 15 40.70% QGGLGPmNIPLVSDPK 95.00% 4.4 0.448 2.85 m7: Oxidation (+15.99) 820.4293 1,638.84 1,638.85 2
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% GLFIIDDKGILR 95.00% 2.09 0.284 2.38 453.9392 1,358.79 1,359.80 3
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% GLFIIDDKGILR 95.00% 2.32 0.336 2.7 453.9397 1,358.80 1,359.80 3
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% TIAQDYGVLK 95.00% 3.02 0.514 1.68 554.3053 1,106.60 1,107.61 2
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% TIAQDYGVLK 95.00% 2.68 0.365 2.14 554.3061 1,106.60 1,107.61 2
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% KQGGLGPMNIPLVSDPK 95.00% 2.56 0.139 1.05 584.324 1,749.95 1,750.95 3 REV1_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% KQGGLGPMNIPLVSDPK 95.00% 2.56 0.249 1.57 584.655 1,750.94 1,750.95 3 REV1_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% LVQAFQFTDK 95.00% 3.49 0.514 2 598.8177 1,195.62 1,196.63 2
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% LVQAFQFTDK 95.00% 3.22 0.516 2.62 598.818 1,195.62 1,196.63 2
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% LVQAFQFTDK 95.00% 2.48 0.454 2.32 598.8187 1,195.62 1,196.63 2
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% LVQAFQFTDK 95.00% 2.58 0.463 3.17 598.8192 1,195.62 1,196.63 2
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% QITVNDLPVGR 95.00% 2.93 0.365 0 606.3398 1,210.66 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% QITVNDLPVGR 95.00% 3.07 0.538 2.7 606.3399 1,210.66 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% QITVNDLPVGR 95.00% 3.15 0.487 2.05 606.34 1,210.66 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% QITVNDLPVGR 95.00% 2.72 0.377 0 606.3405 1,210.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% GLFIIDDKGILR 95.00% 3.68 0.487 2.33 680.4018 1,358.79 1,359.80 2
 SAMPLE 2R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 3 4 10 30.20% GLFIIDDKGILR 95.00% 3.67 0.53 2.04 680.4027 1,358.79 1,359.80 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% TIAQDYGVLK 95.00% 3 0.463 2.4 554.3051 1,106.59 1,107.61 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% TIAQDYGVLK 95.00% 2.96 0.468 2.52 554.3051 1,106.59 1,107.61 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% DISLSDYKGK 95.00% 2.03 0.334 0 563.2931 1,124.57 1,125.58 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% ATAVMPDGQFK 95.00% 2.92 0.463 1.3 582.7887 1,163.56 1,164.57 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% ATAVMPDGQFK 95.00% 2.86 0.434 1.72 582.7887 1,163.56 1,164.57 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% KQGGLGPMNIPLVSDPK 95.00% 3.01 0.366 2.8 584.3213 1,749.94 1,750.95 3 REV1_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% KQGGLGPMNIPLVSDPK 95.00% 3.11 0.336 3.7 584.6555 1,750.94 1,750.95 3 REV1_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% ATAVmPDGQFK 95.00% 1.78 0.261 1.17 m5: Oxidation (+15.99) 590.7859 1,179.56 1,180.57 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% LVQAFQFTDK 95.00% 3.35 0.5 2.66 598.8177 1,195.62 1,196.63 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% LVQAFQFTDK 95.00% 3.64 0.542 2.14 598.8181 1,195.62 1,196.63 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% LVQAFQFTDK 95.00% 3.19 0.48 2.6 598.8181 1,195.62 1,196.63 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% LVQAFQFTDK 95.00% 3.69 0.533 2.68 598.8185 1,195.62 1,196.63 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% QITVNDLPVGR 95.00% 2.93 0.353 0 606.339 1,210.66 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% QITVNDLPVGR 95.00% 3.19 0.488 2.6 606.339 1,210.66 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% QITVNDLPVGR 95.00% 3.24 0.436 2 606.3393 1,210.66 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% QITVNDLPVGR 95.00% 2.85 0.384 0 606.3405 1,210.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% QITVNDLPVGR 95.00% 2.82 0.427 0 606.3429 1,210.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% QITVNDLPVGR 95.00% 2.45 0.246 0 606.8442 1,211.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% GLFIIDDKGILR 95.00% 3.71 0.459 1.77 680.4023 1,358.79 1,359.80 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% GLFIIDDKGILR 95.00% 3.88 0.515 1.96 680.4026 1,358.79 1,359.80 2
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% HGEVcPAGWKPGSDTIKPDVQK 95.00% 5.37 0.408 3.51 c5: Carbamidomethyl (+57.02) 803.0676 2,406.18 2,406.19 3
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% HGEVcPAGWKPGSDTIKPDVQK 95.00% 6.02 0.42 2.85 c5: Carbamidomethyl (+57.02) 803.0677 2,406.18 2,406.19 3
 SAMPLE 3 Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 7 7 15 51.80% QGGLGPMNIPLVSDPK 95.00% 2.53 0 2.23 812.4273 1,622.84 1,622.86 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% GLFIIDDKGILR 95.00% 3.01 0.428 1.52 453.9398 1,358.80 1,359.80 3
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% GLFIIDDKGILR 95.00% 3.26 0.348 0 453.9408 1,358.80 1,359.80 3
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% GLFIIDDK 95.00% 2.77 0.356 0 460.7578 919.4999 920.5096 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% GLFIIDDK 95.00% 2.77 0.343 0 460.7591 919.5025 920.5096 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% IGHPAPNFK 95.00% 1.9 0.254 0 490.7696 979.5235 980.5319 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% TIAQDYGVLK 95.00% 3.18 0.484 2.41 554.3051 1,106.59 1,107.61 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% TIAQDYGVLK 95.00% 2.7 0.42 2.28 554.3053 1,106.60 1,107.61 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% DISLSDYKGK 95.00% 2.09 0.325 0 563.2914 1,124.57 1,125.58 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% ATAVMPDGQFK 95.00% 2.48 0.469 1.66 582.7887 1,163.56 1,164.57 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% ATAVMPDGQFK 95.00% 2.47 0.481 1.31 582.789 1,163.56 1,164.57 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% KQGGLGPMNIPLVSDPK 95.00% 2.85 0.271 3.09 584.3215 1,749.94 1,750.95 3 REV1_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% KQGGLGPMNIPLVSDPK 95.00% 2.81 0.299 2 584.6556 1,750.94 1,750.95 3 REV1_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% LVQAFQFTDK 95.00% 2.18 0.409 1.26 598.8181 1,195.62 1,196.63 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% LVQAFQFTDK 95.00% 3.62 0.526 2.34 598.8192 1,195.62 1,196.63 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% LVQAFQFTDK 95.00% 2.31 0.418 2.6 598.8201 1,195.62 1,196.63 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% LVQAFQFTDK 95.00% 3.38 0.524 2.85 599.3181 1,196.62 1,196.63 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% QITVNDLPVGR 95.00% 2.95 0.319 0 606.3389 1,210.66 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% QITVNDLPVGR 95.00% 3.24 0.367 1.96 606.3395 1,210.66 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% QITVNDLPVGR 95.00% 2.96 0.448 2 606.3401 1,210.66 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% QITVNDLPVGR 95.00% 2.95 0.452 2.1 606.3405 1,210.67 1,211.68 2 MYH9_HUMAN,MAP1B_HUMAN,PRDX2_HUMAN
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% GLFIIDDKGILR 95.00% 3.6 0.489 2.19 680.4026 1,358.79 1,359.80 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% GLFIIDDKGILR 95.00% 3.67 0.489 2.16 680.4027 1,358.79 1,359.80 2
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% HGEVcPAGWKPGSDTIKPDVQK 95.00% 5.74 0.41 2.92 c5: Carbamidomethyl (+57.02) 803.0683 2,406.18 2,406.19 3
 SAMPLE 3R Peroxiredoxin-1  PRDX1  PRDX1_HUMAN 22,092.90 100.00% 8 9 17 56.30% KQGGLGPMNIPLVSDPK 95.00% 4.52 0.585 2.85 875.9773 1,749.94 1,750.95 2 REV1_HUMAN,TITIN_HUMAN,FLNA_HUMAN
 SAMPLE 1R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 3 4 9.09% KEGGLGPLNIPLLADVTR 95.00% 3.33 0.404 3.7 621.707 1,862.10 1,863.07 3
 SAMPLE 1R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 3 4 9.09% EGGLGPLNIPLLADVTR 95.00% 4.6 0.593 5.66 868.0088 1,734.00 1,734.98 2
 SAMPLE 1R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 3 4 9.09% EGGLGPLNIPLLADVTR 95.00% 4.76 0.604 4.01 868.4919 1,734.97 1,734.98 2
 SAMPLE 1R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 3 4 9.09% KEGGLGPLNIPLLADVTR 95.00% 5.76 0.623 5.96 932.5596 1,863.10 1,863.07 2
 SAMPLE 2 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 14.10% LSEDYGVLK 95.00% 2.18 0.31 1.77 512.2704 1,022.53 1,023.54 2
 SAMPLE 2 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 14.10% LSEDYGVLK 95.00% 1.92 0.251 1.77 512.2707 1,022.53 1,023.54 2
 SAMPLE 2 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 14.10% QITVNDLPVGR 95.00% 2.94 0.44 0 606.3388 1,210.66 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 2 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 14.10% QITVNDLPVGR 95.00% 2.87 0.433 1.43 606.339 1,210.66 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 2 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 14.10% QITVNDLPVGR 95.00% 2.95 0.412 1.85 606.3394 1,210.66 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 2 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 14.10% QITVNDLPVGR 95.00% 2.96 0.458 2.19 606.341 1,210.67 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 2 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 14.10% LSEDYGVLKTDEGIAYR 95.00% 2.44 0.441 1.29 643.9919 1,928.95 1,928.96 3
 SAMPLE 2R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.90% 2 2 2 15.20% ATAVVDGAFK 95.00% 2.55 0.422 1.44 489.7665 977.5173 978.5261 2
 SAMPLE 2R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.90% 2 2 2 15.20% LSEDYGVLK 95.00% 2.54 0.28 2.01 512.2698 1,022.52 1,023.54 2
 SAMPLE 2R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.90% 2 2 2 15.20% QITVNDLPVGR 95.00% 2.93 0.365 0 606.3398 1,210.66 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 2R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.90% 2 2 2 15.20% QITVNDLPVGR 95.00% 3.07 0.538 2.7 606.3399 1,210.66 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 2R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.90% 2 2 2 15.20% QITVNDLPVGR 95.00% 3.15 0.487 2.05 606.34 1,210.66 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 2R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.90% 2 2 2 15.20% QITVNDLPVGR 95.00% 2.72 0.377 0 606.3405 1,210.67 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 3 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 15.20% ATAVVDGAFK 95.00% 2.64 0.479 3.77 489.7656 977.5155 978.5261 2
 SAMPLE 3 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 15.20% ATAVVDGAFK 95.00% 2.87 0.505 2.41 489.7664 977.5172 978.5261 2
 SAMPLE 3 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 15.20% LSEDYGVLK 95.00% 2.47 0.235 0 512.2691 1,022.52 1,023.54 2
 SAMPLE 3 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 15.20% QITVNDLPVGR 95.00% 2.93 0.353 0 606.339 1,210.66 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 3 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 15.20% QITVNDLPVGR 95.00% 3.19 0.488 2.6 606.339 1,210.66 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 3 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 15.20% QITVNDLPVGR 95.00% 3.24 0.436 2 606.3393 1,210.66 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 3 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 15.20% QITVNDLPVGR 95.00% 2.85 0.384 0 606.3405 1,210.67 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 3 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 15.20% QITVNDLPVGR 95.00% 2.82 0.427 0 606.3429 1,210.67 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 3 Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 99.80% 2 2 3 15.20% QITVNDLPVGR 95.00% 2.45 0.246 0 606.8442 1,211.67 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 3R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 100.00% 3 3 5 19.70% ATAVVDGAFK 95.00% 2.94 0.463 2.34 489.7661 977.5165 978.5261 2
 SAMPLE 3R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 100.00% 3 3 5 19.70% ATAVVDGAFK 95.00% 2.89 0.465 1.49 489.7662 977.5168 978.5261 2
 SAMPLE 3R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 100.00% 3 3 5 19.70% QITVNDLPVGR 95.00% 2.95 0.319 0 606.3389 1,210.66 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 3R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 100.00% 3 3 5 19.70% QITVNDLPVGR 95.00% 3.24 0.367 1.96 606.3395 1,210.66 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 3R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 100.00% 3 3 5 19.70% QITVNDLPVGR 95.00% 2.96 0.448 2 606.3401 1,210.66 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 3R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 100.00% 3 3 5 19.70% QITVNDLPVGR 95.00% 2.95 0.452 2.1 606.3405 1,210.67 1,211.68 2 PRDX1_HUMAN,MYH9_HUMAN,MAP1B_HUMAN
 SAMPLE 3R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 100.00% 3 3 5 19.70% KEGGLGPLNIPLLADVTR 95.00% 2.97 0.347 3.55 621.6947 1,862.06 1,863.07 3
 SAMPLE 3R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 100.00% 3 3 5 19.70% KEGGLGPLNIPLLADVTR 95.00% 3.15 0.339 3.62 622.0284 1,863.06 1,863.07 3
 SAMPLE 3R Peroxiredoxin-2  PRDX2  PRDX2_HUMAN 21,874.40 100.00% 3 3 5 19.70% EGGLGPLNIPLLADVTR 95.00% 4.25 0.593 3.51 867.9917 1,733.97 1,734.98 2
 SAMPLE 2 Phosphate carrier protein, mitochondrial  SLC25A3  MPCP_HUMAN 40,077.90 99.80% 2 2 2 6.35% GIFNGFSVTLK 95.00% 1.74 0.382 0 591.8306 1,181.65 1,182.65 2
 SAMPLE 2 Phosphate carrier protein, mitochondrial  SLC25A3  MPCP_HUMAN 40,077.90 99.80% 2 2 2 6.35% IQTQPGYANTLR 95.00% 2.4 0.336 1.36 681.3622 1,360.71 1,361.72 2
 SAMPLE 2R Phosphate carrier protein, mitochondrial  SLC25A3  MPCP_HUMAN 40,077.90 99.80% 2 2 2 6.35% GIFNGFSVTLK 95.00% 2.32 0.338 1.7 591.8291 1,181.64 1,182.65 2
 SAMPLE 2R Phosphate carrier protein, mitochondrial  SLC25A3  MPCP_HUMAN 40,077.90 99.80% 2 2 2 6.35% IQTQPGYANTLR 95.00% 2.52 0.417 2.59 681.3623 1,360.71 1,361.72 2
 SAMPLE 2 Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 9 10.40% FDYEGLDPK 95.00% 2.57 0.226 0 542.253 1,082.49 1,083.50 2
 SAMPLE 2 Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 9 10.40% FDYEGLDPK 95.00% 2.48 0.285 2.28 542.2532 1,082.49 1,083.50 2
 SAMPLE 2 Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 9 10.40% TIFDFHAIK 95.00% 2.36 0.203 0 546.2955 1,090.58 1,091.59 2
 SAMPLE 2 Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 9 10.40% TIFDFHAIK 95.00% 2.33 0.202 0 546.2973 1,090.58 1,091.59 2
 SAMPLE 2 Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 9 10.40% VPVYETPAGWR 95.00% 3.64 0.404 3.34 637.8299 1,273.64 1,274.65 2
 SAMPLE 2 Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 9 10.40% VPVYETPAGWR 95.00% 3.46 0.408 3.19 637.8302 1,273.64 1,274.65 2
 SAMPLE 2 Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 9 10.40% TIEEYAIcPDLR 95.00% 3.91 0.477 3.33 c8: Carbamidomethyl (+57.02) 740.3602 1,478.70 1,479.72 2
 SAMPLE 2 Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 9 10.40% TIEEYAIcPDLR 95.00% 3.87 0.459 3.11 c8: Carbamidomethyl (+57.02) 740.3612 1,478.71 1,479.72 2
 SAMPLE 2 Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 9 10.40% SFIGQQFAVGSHVYSVAK 95.00% 5.1 0.562 6.8 963.5061 1,925.00 1,924.99 2
 SAMPLE 2R Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 6 12.90% FDYEGLDPK 95.00% 2.4 0.26 1.27 542.253 1,082.49 1,083.50 2
 SAMPLE 2R Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 6 12.90% FDYEGLDPK 95.00% 2.08 0.193 1.54 542.253 1,082.49 1,083.50 2
 SAMPLE 2R Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 6 12.90% VPVYETPAGWR 95.00% 3.37 0.425 2.28 637.8298 1,273.64 1,274.65 2
 SAMPLE 2R Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 6 12.90% TIEEYAIcPDLR 95.00% 3.78 0.44 3.43 c8: Carbamidomethyl (+57.02) 740.3596 1,478.70 1,479.72 2
 SAMPLE 2R Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 6 12.90% FNVANGGPAPDVVSDKIYQISK 95.00% 3.11 0.467 0 774.073 2,319.20 2,319.20 3
 SAMPLE 2R Phosphoglucomutase-like protein 5  PGM5  PGM5_HUMAN 62,209.10 100.00% 5 5 6 12.90% LIIGQNGILSTPAVScIIR 95.00% 4.07 0.556 1.89 c16: Carbamidomethyl (+57.02) 1,013.58 2,025.15 2,025.15 2
 SAMPLE 1 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 100.00% 4 4 7 17.00% LGDVYVNDAFGTAHR 95.00% 3.89 0.42 3.1 545.6 1,633.78 1,634.79 3
 SAMPLE 1 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 100.00% 4 4 7 17.00% LGDVYVNDAFGTAHR 95.00% 4.02 0.461 3.52 545.601 1,633.78 1,634.79 3
 SAMPLE 1 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 100.00% 4 4 7 17.00% VLPGVDALSNI 94.60% 1.65 0.283 1.37 549.3112 1,096.61 1,097.62 2 PABP1_HUMAN
 SAMPLE 1 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 100.00% 4 4 7 17.00% VLPGVDALSNI 95.00% 1.82 0.209 1.59 549.3142 1,096.61 1,097.62 2 PABP1_HUMAN
 SAMPLE 1 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 100.00% 4 4 7 17.00% VLPGVDALSNI 95.00% 2.02 0.351 1.54 549.3174 1,096.62 1,097.62 2 PABP1_HUMAN
 SAMPLE 1 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 100.00% 4 4 7 17.00% ALESPERPFLAILGGAK 95.00% 4.52 0.525 4.52 590.3356 1,767.98 1,769.00 3
 SAMPLE 1 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 100.00% 4 4 7 17.00% ALESPERPFLAILGGAK 95.00% 4.15 0.471 3.32 590.6703 1,768.99 1,769.00 3
 SAMPLE 1 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 100.00% 4 4 7 17.00% YSLEPVAVELK 95.00% 2.02 0.318 1.24 624.3476 1,246.68 1,247.69 2
 SAMPLE 1 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 100.00% 4 4 7 17.00% AcANPAAGSVILLENLR 95.00% 5.5 0.565 6.8 c2: Carbamidomethyl (+57.02) 884.9701 1,767.92 1,768.94 2
 SAMPLE 1 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 100.00% 4 4 7 17.00% AcANPAAGSVILLENLR 95.00% 5.13 0.486 3.7 c2: Carbamidomethyl (+57.02) 885.4715 1,768.93 1,768.94 2
 SAMPLE 1R Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 99.80% 2 2 4 10.30% LGDVYVNDAFGTAHR 95.00% 3.74 0.476 3.1 545.6 1,633.78 1,634.79 3
 SAMPLE 1R Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 99.80% 2 2 4 10.30% LGDVYVNDAFGTAHR 95.00% 3.68 0.464 2.26 545.6014 1,633.78 1,634.79 3
 SAMPLE 1R Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 99.80% 2 2 4 10.30% VLPGVDALSNI 95.00% 1.82 0.209 1.89 549.3142 1,096.61 1,097.62 2 PABP1_HUMAN
 SAMPLE 1R Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 99.80% 2 2 4 10.30% VLPGVDALSNI 95.00% 2.02 0.351 1.52 549.3174 1,096.62 1,097.62 2 PABP1_HUMAN
 SAMPLE 1R Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 99.80% 2 2 4 10.30% ALESPERPFLAILGGAK 95.00% 4.67 0.509 3.07 590.3343 1,767.98 1,769.00 3
 SAMPLE 1R Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 99.80% 2 2 4 10.30% ALESPERPFLAILGGAK 95.00% 4.44 0.514 3.92 590.3354 1,767.98 1,769.00 3
 SAMPLE 2 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 99.80% 2 2 3 7.67% LGDVYVNDAFGTAHR 95.00% 3.75 0.459 2.82 545.601 1,633.78 1,634.79 3
 SAMPLE 2 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 99.80% 2 2 3 7.67% ALESPERPFLAILGGAK 95.00% 4.76 0.536 3.17 590.6695 1,768.99 1,769.00 3
 SAMPLE 2 Phosphoglycerate kinase 1  PGK1  PGK1_HUMAN 44,597.30 99.80% 2 2 3 7.67% ALESPERPFLAILGGAK 95.00% 4.32 0.467 3.1 590.6702 1,768.99 1,769.00 3
 SAMPLE 2 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 7 23.60% SQLcEcDKAAATcFAR 95.00% 4.67 0.552 1.17 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 629.9417 1,886.80 1,887.82 3
 SAMPLE 2 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 7 23.60% SQLcEcDKAAATcFAR 95.00% 4.65 0.484 2.51 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 630.2771 1,887.81 1,887.82 3
 SAMPLE 2 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 7 23.60% EAALSYGFYGcHcGVGGR 95.00% 2.44 0.289 0 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 654.6192 1,960.83 1,960.84 3
 SAMPLE 2 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 7 23.60% SQLcEcDKAAATcFAR 95.00% 5.43 0.567 7.42 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 944.4095 1,886.80 1,887.82 2
 SAMPLE 2 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 7 23.60% SQLcEcDKAAATcFAR 95.00% 5.44 0.63 5.48 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 944.4099 1,886.80 1,887.82 2
 SAMPLE 2 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 7 23.60% EAALSYGFYGcHcGVGGR 95.00% 4.4 0.619 2.59 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4237 1,960.83 1,960.84 2
 SAMPLE 2 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 7 23.60% EAALSYGFYGcHcGVGGR 95.00% 4.9 0.581 2.8 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.425 1,960.83 1,960.84 2
 SAMPLE 2R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 100.00% 2 4 7 23.60% SQLcEcDKAAATcFAR 95.00% 3.98 0.529 1.11 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 629.9433 1,886.81 1,887.82 3
 SAMPLE 2R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 100.00% 2 4 7 23.60% SQLcEcDKAAATcFAR 95.00% 4.87 0.552 2.09 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 630.2762 1,887.81 1,887.82 3
 SAMPLE 2R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 100.00% 2 4 7 23.60% EAALSYGFYGcHcGVGGR 95.00% 3.16 0.422 1.47 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 654.6198 1,960.84 1,960.84 3
 SAMPLE 2R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 100.00% 2 4 7 23.60% SQLcEcDKAAATcFAR 95.00% 5.06 0.575 6 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 944.407 1,886.80 1,887.82 2
 SAMPLE 2R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 100.00% 2 4 7 23.60% SQLcEcDKAAATcFAR 95.00% 5.66 0.63 7.62 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 944.9078 1,887.80 1,887.82 2
 SAMPLE 2R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 100.00% 2 4 7 23.60% EAALSYGFYGcHcGVGGR 95.00% 4.59 0.623 3.17 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 980.9228 1,959.83 1,960.84 2
 SAMPLE 2R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 100.00% 2 4 7 23.60% EAALSYGFYGcHcGVGGR 95.00% 4.5 0.606 2.8 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4276 1,960.84 1,960.84 2
 SAMPLE 3 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 8 23.60% SQLcEcDKAAATcFAR 95.00% 4.68 0.595 2.28 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 629.9421 1,886.80 1,887.82 3
 SAMPLE 3 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 8 23.60% SQLcEcDKAAATcFAR 95.00% 4.67 0.584 1.08 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 630.2759 1,887.80 1,887.82 3
 SAMPLE 3 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 8 23.60% EAALSYGFYGcHcGVGGR 95.00% 2.73 0.332 0 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 654.6203 1,960.84 1,960.84 3
 SAMPLE 3 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 8 23.60% EAALSYGFYGcHcGVGGR 95.00% 2.85 0.49 2.02 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 654.6204 1,960.84 1,960.84 3
 SAMPLE 3 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 8 23.60% SQLcEcDKAAATcFAR 95.00% 5.74 0.655 7.96 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 944.4081 1,886.80 1,887.82 2
 SAMPLE 3 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 8 23.60% SQLcEcDKAAATcFAR 95.00% 5.1 0.6 7.6 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 944.4104 1,886.81 1,887.82 2
 SAMPLE 3 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 8 23.60% EAALSYGFYGcHcGVGGR 95.00% 4.5 0.594 3.19 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4251 1,960.83 1,960.84 2
 SAMPLE 3 Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.80% 2 4 8 23.60% EAALSYGFYGcHcGVGGR 95.00% 5.15 0.584 3.07 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.427 1,960.84 1,960.84 2
 SAMPLE 3R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.90% 2 4 8 23.60% SQLcEcDKAAATcFAR 95.00% 4.74 0.527 1.48 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 629.9431 1,886.81 1,887.82 3
 SAMPLE 3R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.90% 2 4 8 23.60% SQLcEcDKAAATcFAR 95.00% 4.36 0.504 0 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 629.9432 1,886.81 1,887.82 3
 SAMPLE 3R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.90% 2 4 8 23.60% EAALSYGFYGcHcGVGGR 95.00% 2.93 0.478 0 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 654.2854 1,959.83 1,960.84 3
 SAMPLE 3R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.90% 2 4 8 23.60% EAALSYGFYGcHcGVGGR 95.00% 2.15 0.253 0 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 654.6206 1,960.84 1,960.84 3
 SAMPLE 3R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.90% 2 4 8 23.60% SQLcEcDKAAATcFAR 95.00% 5.14 0.605 6.7 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 944.4099 1,886.80 1,887.82 2
 SAMPLE 3R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.90% 2 4 8 23.60% SQLcEcDKAAATcFAR 95.00% 5.56 0.6 6.06 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 944.9103 1,887.81 1,887.82 2
 SAMPLE 3R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.90% 2 4 8 23.60% EAALSYGFYGcHcGVGGR 95.00% 4.8 0.578 2.64 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4253 1,960.83 1,960.84 2
 SAMPLE 3R Phospholipase A2, membrane associated  PLA2G2A  PA2GA_HUMAN 16,065.00 99.90% 2 4 8 23.60% EAALSYGFYGcHcGVGGR 95.00% 4.79 0.616 3 c11: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 981.4254 1,960.84 1,960.84 2
 SAMPLE 1 Pigment epithelium-derived factor  SERPINF1  PEDF_HUMAN 46,326.40 100.00% 4 4 6 11.00% TVQAVLTVPK 95.00% 1.92 0.224 1.36 528.3245 1,054.63 1,055.65 2
 SAMPLE 1 Pigment epithelium-derived factor  SERPINF1  PEDF_HUMAN 46,326.40 100.00% 4 4 6 11.00% TVQAVLTVPK 95.00% 2.11 0.282 1.7 528.3253 1,054.63 1,055.65 2
 SAMPLE 1 Pigment epithelium-derived factor  SERPINF1  PEDF_HUMAN 46,326.40 100.00% 4 4 6 11.00% YGLDSDLScK 95.00% 3.12 0.547 4.13 c9: Carbamidomethyl (+57.02) 579.2588 1,156.50 1,157.52 2
 SAMPLE 1 Pigment epithelium-derived factor  SERPINF1  PEDF_HUMAN 46,326.40 100.00% 4 4 6 11.00% YGLDSDLScK 95.00% 3.13 0.577 3.4 c9: Carbamidomethyl (+57.02) 579.2622 1,156.51 1,157.52 2
 SAMPLE 1 Pigment epithelium-derived factor  SERPINF1  PEDF_HUMAN 46,326.40 100.00% 4 4 6 11.00% LQSLFDSPDFSK 95.00% 3.09 0.471 0 692.3421 1,382.67 1,383.68 2
 SAMPLE 1 Pigment epithelium-derived factor  SERPINF1  PEDF_HUMAN 46,326.40 100.00% 4 4 6 11.00% LAAAVSNFGYDLYR 95.00% 3.82 0.57 7.27 780.3958 1,558.78 1,559.79 2
 SAMPLE 1R Pigment epithelium-derived factor  SERPINF1  PEDF_HUMAN 46,326.40 100.00% 3 3 5 8.61% YGLDSDLScK 95.00% 2.71 0.526 3.44 c9: Carbamidomethyl (+57.02) 579.2579 1,156.50 1,157.52 2
 SAMPLE 1R Pigment epithelium-derived factor  SERPINF1  PEDF_HUMAN 46,326.40 100.00% 3 3 5 8.61% YGLDSDLScK 95.00% 2.99 0.57 3.92 c9: Carbamidomethyl (+57.02) 579.2594 1,156.50 1,157.52 2
 SAMPLE 1R Pigment epithelium-derived factor  SERPINF1  PEDF_HUMAN 46,326.40 100.00% 3 3 5 8.61% DTDTGALLFIGK 95.00% 2.54 0.368 3.74 626.3562 1,250.70 1,250.66 2
 SAMPLE 1R Pigment epithelium-derived factor  SERPINF1  PEDF_HUMAN 46,326.40 100.00% 3 3 5 8.61% LAAAVSNFGYDLYR 95.00% 3.81 0.593 5.62 780.3946 1,558.77 1,559.79 2
 SAMPLE 1R Pigment epithelium-derived factor  SERPINF1  PEDF_HUMAN 46,326.40 100.00% 3 3 5 8.61% LAAAVSNFGYDLYR 95.00% 3.66 0.586 6.48 780.3953 1,558.77 1,559.79 2
 SAMPLE 4R Plasminogen  PLG  PLMN_HUMAN 90,549.40 99.80% 2 2 3 4.69% WELcDIPR 95.00% 2.32 0.319 0 c4: Carbamidomethyl (+57.02) 544.7649 1,087.51 1,088.52 2
 SAMPLE 4R Plasminogen  PLG  PLMN_HUMAN 90,549.40 99.80% 2 2 3 4.69% SPRPSSYKVILGAHQEVNLEPHVQEIEVSR 95.00% 2.44 0.251 0 1,133.57 3,397.68 3,398.78 3
 SAMPLE 4R Plasminogen  PLG  PLMN_HUMAN 90,549.40 99.80% 2 2 3 4.69% SPRPSSYKVILGAHQEVNLEPHVQEIEVSR 95.00% 2.37 0.256 0 1,133.57 3,397.68 3,398.78 3
 SAMPLE 1 Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 4 4.20% WELcDIPR 95.00% 2.99 0.389 0 c4: Carbamidomethyl (+57.02) 544.7617 1,087.51 1,088.52 2
 SAMPLE 1 Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 4 4.20% EAQLPVIENK 95.00% 2.49 0.273 1.66 570.816 1,139.62 1,140.63 2
 SAMPLE 1 Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 4 4.20% EAQLPVIENK 95.00% 2.27 0.264 0 571.3159 1,140.62 1,140.63 2
 SAMPLE 1 Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 4 4.20% VIPAcLPSPNYVVADR 95.00% 2.84 0.543 3.23 c5: Carbamidomethyl (+57.02) 886.4652 1,770.91 1,770.92 2
 SAMPLE 1R Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 4 3.46% WELcDIPR 95.00% 2.67 0.264 0 c4: Carbamidomethyl (+57.02) 544.7628 1,087.51 1,088.52 2
 SAMPLE 1R Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 4 3.46% EAQLPVIENK 95.00% 2.5 0.231 0 570.8172 1,139.62 1,140.63 2
 SAMPLE 1R Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 4 3.46% FVTWIEGVMR 95.00% 2.78 0.336 1.59 619.3211 1,236.63 1,237.64 2
 SAMPLE 1R Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 4 3.46% FVTWIEGVMR 95.00% 2.73 0.307 2.57 619.8247 1,237.63 1,237.64 2
 SAMPLE 3 Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 4 3.58% WELcDIPR 95.00% 2.6 0.149 0 c4: Carbamidomethyl (+57.02) 544.7615 1,087.51 1,088.52 2
 SAMPLE 3 Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 4 3.58% WELcDIPR 95.00% 2.77 0.269 0 c4: Carbamidomethyl (+57.02) 544.7621 1,087.51 1,088.52 2
 SAMPLE 3 Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 4 3.58% EAQLPVIENK 95.00% 2.03 0.215 1.51 570.8159 1,139.62 1,140.63 2
 SAMPLE 3 Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 4 3.58% HSIFTPETNPR 95.00% 2.87 0.456 1.17 649.8268 1,297.64 1,298.65 2
 SAMPLE 3R Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 8 3.58% WELcDIPR 95.00% 2.66 0.22 0 c4: Carbamidomethyl (+57.02) 544.761 1,087.51 1,088.52 2
 SAMPLE 3R Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 8 3.58% WELcDIPR 95.00% 2.6 0.219 0 c4: Carbamidomethyl (+57.02) 544.7613 1,087.51 1,088.52 2
 SAMPLE 3R Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 8 3.58% WELcDIPR 95.00% 2.5 0.231 0 c4: Carbamidomethyl (+57.02) 544.7618 1,087.51 1,088.52 2
 SAMPLE 3R Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 8 3.58% WELcDIPR 95.00% 2.42 0.254 0 c4: Carbamidomethyl (+57.02) 544.7638 1,087.51 1,088.52 2
 SAMPLE 3R Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 8 3.58% FVTWIEGVMR 95.00% 2.7 0.349 1.33 619.3221 1,236.63 1,237.64 2
 SAMPLE 3R Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 8 3.58% FVTWIEGVMR 95.00% 2.57 0.272 1.43 619.3238 1,236.63 1,237.64 2
 SAMPLE 3R Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 8 3.58% HSIFTPETNPR 95.00% 2.92 0.515 1.36 649.8269 1,297.64 1,298.65 2
 SAMPLE 3R Plasminogen  PLG  PLMN_HUMAN 90,549.40 100.00% 3 3 8 3.58% HSIFTPETNPR 95.00% 2.53 0.44 0 649.8275 1,297.64 1,298.65 2
 SAMPLE 4 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 3 3 7 0.62% AELELELGR 95.00% 2.57 0.266 1.15 515.2824 1,028.55 1,029.56 2
 SAMPLE 4 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 3 3 7 0.62% ALQALEELR 95.00% 2.68 0.182 0 521.7989 1,041.58 1,042.59 2
 SAMPLE 4 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 3 3 7 0.62% ALQALEELR 95.00% 2.79 0.154 0 521.8003 1,041.58 1,042.59 2
 SAMPLE 4 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 3 3 7 0.62% SQVEEELFSVR 95.00% 2.07 0.337 2.51 661.8324 1,321.65 1,322.66 2
 SAMPLE 4 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 3 3 7 0.62% SQVEEELFSVR 95.00% 2.19 0.279 1.54 661.8347 1,321.65 1,322.66 2
 SAMPLE 4 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 3 3 7 0.62% SQVEEELFSVR 95.00% 2.27 0.363 2.55 661.8348 1,321.65 1,322.66 2
 SAMPLE 4 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 3 3 7 0.62% SQVEEELFSVR 95.00% 2.79 0.402 2.17 661.835 1,321.65 1,322.66 2
 SAMPLE 1 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 99.80% 2 2 2 0.43% ALQALEELR 95.00% 2.75 0.22 0 521.7967 1,041.58 1,042.59 2
 SAMPLE 1 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 99.80% 2 2 2 0.43% SQVEEELFSVR 95.00% 2.3 0.304 1.21 661.8315 1,321.65 1,322.66 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% LAQGHTTVDELAR 95.00% 4.14 0.477 3 471.2513 1,410.73 1,410.73 3
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% VIDRELYQQLQR 95.00% 3.82 0.375 0 520.9548 1,559.84 1,560.85 3
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% ALQALEELR 95.00% 3.08 0.245 1.54 521.7975 1,041.58 1,042.59 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% ALQALEELR 95.00% 2.53 0.284 1.38 521.7979 1,041.58 1,042.59 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% GGAEGELQALR 95.00% 2.67 0.288 0 550.7881 1,099.56 1,100.57 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% AALAHSEEVTASQVAATK 95.00% 3.76 0.471 0 595.3104 1,782.91 1,783.92 3
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% AALAHSEEVTASQVAATK 95.00% 3.1 0.37 1.26 595.6462 1,783.92 1,783.92 3
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% LLFNDVQTLK 95.00% 2.63 0.336 0 595.8429 1,189.67 1,190.68 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% SIQEELQQLR 95.00% 2.2 0.217 1.77 622.3354 1,242.66 1,243.66 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% WQAVLAQTDVR 95.00% 2.34 0.288 1.64 643.8457 1,285.68 1,286.69 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% AQVEQELTTLR 95.00% 2.8 0.415 3.02 644.3481 1,286.68 1,287.69 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% AQVEQELTTLR 95.00% 2.79 0.382 3.49 644.3484 1,286.68 1,287.69 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% SQVEEELFSVR 95.00% 3.04 0.484 2 661.8313 1,321.65 1,322.66 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% SQVEEELFSVR 95.00% 2.74 0.479 2.72 661.8318 1,321.65 1,322.66 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% IISLETYNLLR 95.00% 2.91 0.462 1.44 667.8867 1,333.76 1,334.77 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% ESADPLGAWLQDAR 95.00% 4.09 0.508 3.46 765.3737 1,528.73 1,528.74 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% LQEAGILSAEELQR 95.00% 2.76 0.331 4.13 778.9171 1,555.82 1,556.83 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% APVPASELLASGVLSR 95.00% 4.77 0.653 6.38 783.9472 1,565.88 1,566.89 2
 SAMPLE 2 Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 14 14 19 3.65% APVPASELLASGVLSR 95.00% 4.14 0.64 7.08 783.9472 1,565.88 1,566.89 2
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% LAQGHTTVDELAR 95.00% 4.22 0.509 1.23 470.9164 1,409.73 1,410.73 3
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% SWSLATFR 95.00% 2.38 0.359 0 484.2533 966.4909 967.5001 2
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% LSVYAALQR 95.00% 2.22 0.316 0 511.2979 1,020.58 1,020.58 2
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% LGFHLPLEVAYQR 95.00% 3.58 0.325 1.74 515.287 1,542.84 1,542.84 3
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% LGFHLPLEVAYQR 95.00% 2.48 0.25 0 515.2913 1,542.85 1,542.84 3
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% ALQALEELR 95.00% 2.77 0.271 1.17 521.7965 1,041.58 1,042.59 2
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% APVPASELLASGVLSR 95.00% 3.78 0.361 1.49 522.9653 1,565.87 1,566.89 3
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% RKQEELQQLEQQR 95.00% 3.91 0.309 0 571.6392 1,711.89 1,712.90 3
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% LTAEDLFEAR 95.00% 2.93 0.499 2.25 582.7974 1,163.58 1,164.59 2
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% LTAEDLFEAR 95.00% 2.75 0.464 1.68 582.7985 1,163.58 1,164.59 2
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% AALAHSEEVTASQVAATK 95.00% 3.68 0.516 0 595.3115 1,782.91 1,783.92 3
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% AALAHSEEVTASQVAATK 95.00% 4.07 0.464 1.41 595.6448 1,783.91 1,783.92 3
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% AQVEQELTTLR 95.00% 2.01 0.3 0 644.3489 1,286.68 1,287.69 2
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% IISLETYNLLR 95.00% 2.04 0.3 0 667.8856 1,333.76 1,334.77 2
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% LQNVQIALDYLR 95.00% 2.25 0.319 0 723.4099 1,444.80 1,445.81 2
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% ESADPLGAWLQDAR 95.00% 2.51 0.399 0 764.874 1,527.73 1,528.74 2
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% APVPASELLASGVLSR 95.00% 4.02 0.639 6.1 783.9469 1,565.88 1,566.89 2
 SAMPLE 2R Plectin-1  PLEC1  PLEC1_HUMAN 531,765.90 100.00% 13 14 18 3.35% APVPASELLASGVLSR 95.00% 4.29 0.663 5.82 783.9474 1,565.88 1,566.89 2
 SAMPLE 1R Polyadenylate-binding protein 1  PABPC1  PABP1_HUMAN 70,653.30 99.80% 2 2 3 3.14% GFGFVSFER 95.00% 2.25 0.242 0 523.2542 1,044.49 1,045.51 2
 SAMPLE 1R Polyadenylate-binding protein 1  PABPC1  PABP1_HUMAN 70,653.30 99.80% 2 2 3 3.14% FSPAGPILSIR 95.00% 2.13 0.423 1.13 579.338 1,156.66 1,157.67 2
 SAMPLE 1R Polyadenylate-binding protein 1  PABPC1  PABP1_HUMAN 70,653.30 99.80% 2 2 3 3.14% FSPAGPILSIR 95.00% 2.26 0.373 2.07 579.8362 1,157.66 1,157.67 2
 SAMPLE 3R Polyadenylate-binding protein 1  PABPC1  PABP1_HUMAN 70,653.30 99.80% 2 2 2 3.46% FSPAGPILSIR 95.00% 2.36 0.367 1.32 579.3385 1,156.66 1,157.67 2
 SAMPLE 3R Polyadenylate-binding protein 1  PABPC1  PABP1_HUMAN 70,653.30 99.80% 2 2 2 3.46% ALDTMNFDVIK 95.00% 2.37 0.326 0 633.8215 1,265.63 1,266.64 2
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% KSFTPDHVVYAR 95.00% 2.96 0.473 1.11 474.251 1,419.73 1,419.74 3
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% KSFTPDHVVYAR 95.00% 3.49 0.399 1.47 474.2532 1,419.74 1,419.74 3
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% SFTPDHVVYAR 95.00% 2.65 0.458 3 646.3237 1,290.63 1,291.64 2
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% SFTPDHVVYAR 95.00% 2.77 0.49 3.05 646.3247 1,290.63 1,291.64 2
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% SFTPDHVVYAR 95.00% 3.04 0.389 3.85 646.325 1,290.63 1,291.64 2
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% SFTPDHVVYAR 95.00% 2.79 0.37 4.17 646.3263 1,290.64 1,291.64 2
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% KLEVNEAELLR 95.00% 3.72 0.408 2.29 657.3732 1,312.73 1,313.74 2
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% KLEVNEAELLR 95.00% 3.32 0.362 2.34 657.3745 1,312.73 1,313.74 2
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% IIGAVDQIQLTQAQLEER 95.00% 5 0.572 0 676.0368 2,025.09 2,025.10 3
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% IIGAVDQIQLTQAQLEER 95.00% 5.24 0.622 1.46 676.0375 2,025.09 2,025.10 3
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% QAEMEGAVQSIQGELSK 95.00% 4.32 0.561 4.7 902.9401 1,803.86 1,804.88 2
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% QAEMEGAVQSIQGELSK 95.00% 5.45 0.559 4.64 902.9408 1,803.87 1,804.88 2
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% QAEMEGAVQSIQGELSK 95.00% 4.49 0.493 3.35 903.4384 1,804.86 1,804.88 2
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% QAEMEGAVQSIQGELSK 95.00% 5.69 0.491 4.05 903.4416 1,804.87 1,804.88 2
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% IIGAVDQIQLTQAQLEER 95.00% 6.55 0.644 6.8 1,013.55 2,025.08 2,025.10 2
 SAMPLE 1 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 5 6 16 14.90% IIGAVDQIQLTQAQLEER 95.00% 5.93 0.685 5.42 1,013.55 2,025.09 2,025.10 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% KSFTPDHVVYAR 95.00% 2.94 0.562 0 473.9173 1,418.73 1,419.74 3
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% KSFTPDHVVYAR 95.00% 2.77 0.359 0 473.9175 1,418.73 1,419.74 3
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% KSFTPDHVVYAR 95.00% 2.44 0.345 0 473.9202 1,418.74 1,419.74 3
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% KSFTPDHVVYAR 95.00% 3.07 0.448 0 473.921 1,418.74 1,419.74 3
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% SFTPDHVVYAR 95.00% 3.02 0.54 4.05 646.3224 1,290.63 1,291.64 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% SFTPDHVVYAR 95.00% 3.12 0.529 4.38 646.3239 1,290.63 1,291.64 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% SFTPDHVVYAR 95.00% 3.06 0.469 2.74 646.3248 1,290.63 1,291.64 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% SFTPDHVVYAR 95.00% 3.08 0.521 2.29 646.3249 1,290.63 1,291.64 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% KLEVNEAELLR 95.00% 3.34 0.329 2.2 657.3736 1,312.73 1,313.74 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% KLEVNEAELLR 95.00% 3.34 0.356 2.08 657.3741 1,312.73 1,313.74 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% IIGAVDQIQLTQAQLEER 95.00% 3.53 0.403 0 675.7033 2,024.09 2,025.10 3
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% IIGAVDQIQLTQAQLEER 95.00% 5.45 0.611 2.17 676.0345 2,025.08 2,025.10 3
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% IIGAVDQIQLTQAQLEER 95.00% 5 0.572 1.29 676.0374 2,025.09 2,025.10 3
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% IIGAVDQIQLTQAQLEER 95.00% 4 0.545 0.959 676.0511 2,025.13 2,025.10 3
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% SDQVNGVLVLSLLDK 95.00% 3.45 0.511 1.33 800.4485 1,598.88 1,599.90 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% SDQVNGVLVLSLLDK 95.00% 3.87 0.444 2.85 800.4492 1,598.88 1,599.90 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% SDQVNGVLVLSLLDK 95.00% 3.66 0.374 2.96 800.4513 1,598.89 1,599.90 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% SDQVNGVLVLSLLDK 95.00% 3.97 0.444 3.01 800.4525 1,598.89 1,599.90 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% SDQVNGVLVLSLLDK 95.00% 4.74 0.579 3.47 800.4527 1,598.89 1,599.90 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% SDQVNGVLVLSLLDK 95.00% 2.56 0.364 1.12 800.4621 1,598.91 1,599.90 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% SDQVNGVLVLSLLDK 95.00% 4.41 0.57 3.48 800.9553 1,599.89 1,599.90 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% QAEMEGAVQSIQGELSK 95.00% 4.91 0.539 3.64 902.941 1,803.87 1,804.88 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% QAEMEGAVQSIQGELSK 95.00% 5.44 0.484 3.23 903.4414 1,804.87 1,804.88 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% QAEMEGAVQSIQGELSK 95.00% 5.44 0.496 3.62 903.4422 1,804.87 1,804.88 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% IIGAVDQIQLTQAQLEER 95.00% 6.04 0.679 6.04 1,013.05 2,024.09 2,025.10 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% IIGAVDQIQLTQAQLEER 95.00% 6.38 0.653 5.72 1,013.55 2,025.08 2,025.10 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% IIGAVDQIQLTQAQLEER 95.00% 6.31 0.667 6.7 1,013.55 2,025.09 2,025.10 2
 SAMPLE 1R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 6 7 28 18.70% IIGAVDQIQLTQAQLEER 95.00% 6.41 0.639 4.34 1,013.57 2,025.13 2,025.10 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% KSFTPDHVVYAR 95.00% 2.81 0.469 0 473.9175 1,418.73 1,419.74 3
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% KSFTPDHVVYAR 95.00% 3.04 0.486 0 473.9177 1,418.73 1,419.74 3
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% KSFTPDHVVYAR 95.00% 3.03 0.308 0 474.2519 1,419.73 1,419.74 3
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% KLEVNEAELLRR 95.00% 2.2 0.318 0 490.9527 1,469.83 1,469.84 3
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% VPPFTFHVK 95.00% 1.99 0.311 0 536.3012 1,070.59 1,071.60 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% VPPFTFHVK 95.00% 2.08 0.33 1.29 536.3023 1,070.59 1,071.60 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% IREGQVEVLK 95.00% 2.59 0.197 0 585.8441 1,169.67 1,170.68 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% QAEMEGAVQSIQGELSK 95.00% 4.57 0.393 2.3 602.2947 1,803.86 1,804.88 3
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% QAEMEGAVQSIQGELSK 95.00% 4.45 0.459 1.34 602.2958 1,803.86 1,804.88 3
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% QAEMEGAVQSIQGELSK 95.00% 4.85 0.356 2.89 602.6291 1,804.86 1,804.88 3
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% QAEMEGAVQSIQGELSK 95.00% 4.86 0.379 1.85 602.6296 1,804.87 1,804.88 3
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% SFTPDHVVYAR 95.00% 2.83 0.494 2.82 646.3225 1,290.63 1,291.64 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% SFTPDHVVYAR 95.00% 3.01 0.465 2.32 646.3245 1,290.63 1,291.64 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% SFTPDHVVYAR 95.00% 3.23 0.542 3.51 646.3247 1,290.63 1,291.64 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% SFTPDHVVYAR 95.00% 3 0.525 4.34 646.3247 1,290.63 1,291.64 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% SFTPDHVVYAR 95.00% 2.61 0.506 2.54 646.326 1,290.64 1,291.64 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% SFTPDHVVYAR 95.00% 2.23 0.412 0 646.3264 1,290.64 1,291.64 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% IIGAVDQIQLTQAQLEER 95.00% 4.49 0.491 0 675.7042 2,024.09 2,025.10 3
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% IIGAVDQIQLTQAQLEER 95.00% 5.93 0.647 2.64 676.0369 2,025.09 2,025.10 3
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% IIGAVDQIQLTQAQLEER 95.00% 4.7 0.566 0 676.0374 2,025.09 2,025.10 3
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% KSFTPDHVVYAR 95.00% 3 0.523 5.13 710.3711 1,418.73 1,419.74 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% KSFTPDHVVYAR 95.00% 3.21 0.504 4.08 710.3736 1,418.73 1,419.74 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% KSFTPDHVVYAR 95.00% 2.63 0.323 0 710.3742 1,418.73 1,419.74 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% VMIYQDEVKLPAK 95.00% 3.15 0.519 2.4 767.4209 1,532.83 1,533.84 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% QAEMEGAVQSIQGELSK 95.00% 5.88 0.552 4.74 902.939 1,803.86 1,804.88 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% QAEMEGAVQSIQGELSK 95.00% 5.58 0.543 4.46 902.9397 1,803.86 1,804.88 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% QAEMEGAVQSIQGELSK 95.00% 5.75 0.559 3.7 902.94 1,803.86 1,804.88 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% QAEMEGAVQSIQGELSK 95.00% 5.72 0.529 3.68 903.4413 1,804.87 1,804.88 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% IIGAVDQIQLTQAQLEER 95.00% 6.26 0.648 6.07 1,013.05 2,024.09 2,025.10 2
 SAMPLE 2 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 8 11 30 23.30% IIGAVDQIQLTQAQLEER 95.00% 6.52 0.626 5.34 1,013.55 2,025.09 2,025.10 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% KSFTPDHVVYAR 95.00% 2.88 0.453 0 473.9169 1,418.73 1,419.74 3
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% KSFTPDHVVYAR 95.00% 3.17 0.434 0 473.9174 1,418.73 1,419.74 3
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% KSFTPDHVVYAR 95.00% 3.27 0.483 0 474.2526 1,419.73 1,419.74 3
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% KSFTPDHVVYAR 95.00% 3.1 0.474 1.24 474.2527 1,419.73 1,419.74 3
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% VPPFTFHVK 95.00% 2.31 0.436 1.62 536.3018 1,070.59 1,071.60 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% VPPFTFHVK 95.00% 2.19 0.37 0 536.3021 1,070.59 1,071.60 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% QAEMEGAVQSIQGELSK 95.00% 3.65 0.367 1.89 602.2953 1,803.86 1,804.88 3
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% QAEMEGAVQSIQGELSK 95.00% 5.07 0.374 4.08 602.6288 1,804.86 1,804.88 3
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SFTPDHVVYAR 95.00% 2.48 0.406 2.06 646.3237 1,290.63 1,291.64 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SFTPDHVVYAR 95.00% 3.07 0.577 3.62 646.3242 1,290.63 1,291.64 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SFTPDHVVYAR 95.00% 2.77 0.519 2.59 646.3244 1,290.63 1,291.64 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SFTPDHVVYAR 95.00% 2.6 0.446 1.41 646.3244 1,290.63 1,291.64 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SFTPDHVVYAR 95.00% 2.77 0.485 3.85 646.3249 1,290.63 1,291.64 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SFTPDHVVYAR 95.00% 2.69 0.455 2 646.3254 1,290.64 1,291.64 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SFTPDHVVYAR 95.00% 2.44 0.233 3.14 646.3261 1,290.64 1,291.64 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SFTPDHVVYAR 95.00% 2.12 0.33 1.41 646.3268 1,290.64 1,291.64 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SFTPDHVVYAR 95.00% 2.23 0.394 0 646.8239 1,291.63 1,291.64 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% IIGAVDQIQLTQAQLEER 95.00% 5.22 0.624 1.89 676.0363 2,025.09 2,025.10 3
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% IIGAVDQIQLTQAQLEER 95.00% 5.54 0.599 2.3 676.0386 2,025.09 2,025.10 3
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% KSFTPDHVVYAR 95.00% 3.26 0.494 4.74 710.3705 1,418.73 1,419.74 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% KSFTPDHVVYAR 95.00% 3.21 0.497 3.51 710.3725 1,418.73 1,419.74 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% VMIYQDEVKLPAK 95.00% 3.1 0.472 2.34 767.4208 1,532.83 1,533.84 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% VMIYQDEVKLPAK 95.00% 3.03 0.437 2.59 767.4223 1,532.83 1,533.84 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SDQVNGVLVLSLLDK 95.00% 3.44 0.489 2.62 800.4503 1,598.89 1,599.90 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SDQVNGVLVLSLLDK 95.00% 2.36 0.225 2.25 800.9447 1,599.87 1,599.90 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SDQVNGVLVLSLLDK 95.00% 3.65 0.469 2.55 800.9449 1,599.87 1,599.90 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% SDQVNGVLVLSLLDK 95.00% 3.63 0.493 1.89 800.9456 1,599.88 1,599.90 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% ATEMVEVGADDDEGGAERGEAGDLR 95.00% 3.93 0.534 3.77 850.7081 2,549.10 2,549.11 3
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% QAEMEGAVQSIQGELSK 95.00% 5.36 0.536 4.28 902.94 1,803.86 1,804.88 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% QAEMEGAVQSIQGELSK 95.00% 5.44 0.548 4.82 902.9412 1,803.87 1,804.88 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% QAEMEGAVQSIQGELSK 95.00% 5.5 0.548 4.43 902.9414 1,803.87 1,804.88 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% QAEMEGAVQSIQGELSK 95.00% 5.6 0.51 3.23 903.4377 1,804.86 1,804.88 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% ATEMVEVGADDDEGGAER 95.00% 5.08 0.468 6.19 925.8886 1,849.76 1,850.77 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% IIGAVDQIQLTQAQLEER 95.00% 6.24 0.681 5.77 1,013.05 2,024.08 2,025.10 2
 SAMPLE 2R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 9 12 35 27.90% IIGAVDQIQLTQAQLEER 95.00% 6.58 0.647 5.85 1,013.55 2,025.09 2,025.10 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% KSFTPDHVVYAR 95.00% 3.32 0.513 0 473.9168 1,418.73 1,419.74 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% KSFTPDHVVYAR 95.00% 3.22 0.364 1.27 473.917 1,418.73 1,419.74 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% KSFTPDHVVYAR 95.00% 3.81 0.517 0 473.9173 1,418.73 1,419.74 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% KSFTPDHVVYAR 95.00% 3.41 0.494 0 473.9173 1,418.73 1,419.74 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% KSFTPDHVVYAR 95.00% 3.1 0.522 0 474.2515 1,419.73 1,419.74 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% KSFTPDHVVYAR 95.00% 3.23 0.482 0 474.2517 1,419.73 1,419.74 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% KLEVNEAELLRR 95.00% 2.05 0.265 0 490.9534 1,469.84 1,469.84 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% VMIYQDEVKLPAK 95.00% 1.65 0.319 0 511.9489 1,532.82 1,533.84 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% VMIYQDEVKLPAK 95.00% 1.53 0.375 0 511.9494 1,532.82 1,533.84 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% VPPFTFHVK 95.00% 2.08 0.283 1.28 536.302 1,070.59 1,071.60 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% VPPFTFHVK 95.00% 2.32 0.315 1.42 536.302 1,070.59 1,071.60 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% VMIYQDEVK 95.00% 2.81 0.316 1.57 562.7853 1,123.56 1,124.57 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% LEVNEAELLR 95.00% 2.84 0.25 1.8 593.3245 1,184.63 1,185.65 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% LEVNEAELLR 95.00% 2.96 0.305 0 593.3258 1,184.64 1,185.65 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% LEVNEAELLR 95.00% 3.25 0.266 0 593.3265 1,184.64 1,185.65 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% QAEMEGAVQSIQGELSK 95.00% 5.21 0.447 1.44 602.2951 1,803.86 1,804.88 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% QAEMEGAVQSIQGELSK 95.00% 4.95 0.427 2.57 602.629 1,804.86 1,804.88 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% SFTPDHVVYAR 95.00% 2.09 0.402 1.96 646.3237 1,290.63 1,291.64 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% SFTPDHVVYAR 95.00% 3.1 0.562 4.52 646.3242 1,290.63 1,291.64 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% SFTPDHVVYAR 95.00% 2.46 0.439 2.06 646.3246 1,290.63 1,291.64 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% SFTPDHVVYAR 95.00% 2.93 0.536 3.16 646.3253 1,290.63 1,291.64 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% SFTPDHVVYAR 95.00% 2.86 0.519 2.51 646.3259 1,290.64 1,291.64 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% IIGAVDQIQLTQAQLEER 95.00% 4.36 0.479 1 676.0358 2,025.08 2,025.10 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% IIGAVDQIQLTQAQLEER 95.00% 6.35 0.637 3.7 676.0377 2,025.09 2,025.10 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% KSFTPDHVVYAR 95.00% 2.36 0.271 2.62 710.3687 1,418.72 1,419.74 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% KSFTPDHVVYAR 95.00% 2.78 0.465 3.26 710.3726 1,418.73 1,419.74 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% ATEMVEVGADDDEGGAERGEAGDLR 95.00% 3.75 0.427 2.32 850.7052 2,549.09 2,549.11 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% ATEMVEVGADDDEGGAERGEAGDLR 95.00% 0 0 3.82 851.0391 2,550.09 2,549.11 3
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% QAEMEGAVQSIQGELSK 95.00% 5.68 0.554 4.29 902.9393 1,803.86 1,804.88 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% QAEMEGAVQSIQGELSK 95.00% 5.77 0.553 1.85 902.9399 1,803.86 1,804.88 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% ATEMVEVGADDDEGGAER 95.00% 5.46 0.538 4.35 926.3882 1,850.76 1,850.77 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% ATEMVEVGADDDEGGAER 95.00% 4.86 0.471 4.36 926.3911 1,850.77 1,850.77 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% IIGAVDQIQLTQAQLEER 95.00% 6.67 0.663 6.08 1,013.55 2,025.09 2,025.10 2
 SAMPLE 3 Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 11 14 34 27.20% IIGAVDQIQLTQAQLEER 95.00% 6.64 0.663 4.89 1,013.55 2,025.09 2,025.10 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% KSFTPDHVVYAR 95.00% 3.72 0.496 1.27 473.9163 1,418.73 1,419.74 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% KSFTPDHVVYAR 95.00% 3.17 0.437 0 473.9169 1,418.73 1,419.74 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% KSFTPDHVVYAR 95.00% 3.35 0.484 0 473.9172 1,418.73 1,419.74 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% KSFTPDHVVYAR 95.00% 3.32 0.414 0 473.9178 1,418.73 1,419.74 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% KSFTPDHVVYAR 95.00% 3.38 0.512 0 473.9182 1,418.73 1,419.74 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% KSFTPDHVVYAR 95.00% 3.14 0.326 0 474.2516 1,419.73 1,419.74 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% VMIYQDEVKLPAK 95.00% 1.78 0.256 0 511.9481 1,532.82 1,533.84 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% VMIYQDEVKLPAK 95.00% 1.96 0.262 0 512.2824 1,533.82 1,533.84 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% VPPFTFHVK 95.00% 2.28 0.36 1.38 536.3017 1,070.59 1,071.60 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% VPPFTFHVK 94.80% 2.02 0.279 0 536.3022 1,070.59 1,071.60 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% LEVNEAELLR 95.00% 3.15 0.241 1.24 593.3261 1,184.64 1,185.65 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% QAEMEGAVQSIQGELSK 95.00% 5.02 0.427 2.57 602.2952 1,803.86 1,804.88 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% QAEMEGAVQSIQGELSK 95.00% 5.31 0.378 2.92 602.6295 1,804.87 1,804.88 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% SFTPDHVVYAR 95.00% 2.66 0.453 2.7 646.3239 1,290.63 1,291.64 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% SFTPDHVVYAR 95.00% 3.18 0.513 4.21 646.3241 1,290.63 1,291.64 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% SFTPDHVVYAR 95.00% 3.17 0.555 4.05 646.3244 1,290.63 1,291.64 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% SFTPDHVVYAR 95.00% 2.67 0.493 2.57 646.3245 1,290.63 1,291.64 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% SFTPDHVVYAR 95.00% 2.89 0.539 3.6 646.3255 1,290.64 1,291.64 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% SFTPDHVVYAR 95.00% 3.17 0.578 3.15 646.3257 1,290.64 1,291.64 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% SFTPDHVVYAR 95.00% 2.43 0.419 0 646.828 1,291.64 1,291.64 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% KLEVNEAELLR 95.00% 3.2 0.391 2.11 657.3736 1,312.73 1,313.74 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% KLEVNEAELLR 95.00% 3.5 0.377 2.08 657.8748 1,313.73 1,313.74 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% IIGAVDQIQLTQAQLEER 95.00% 4.47 0.571 0 675.7028 2,024.08 2,025.10 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% IIGAVDQIQLTQAQLEER 95.00% 4.19 0.505 1.03 676.0351 2,025.08 2,025.10 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% IIGAVDQIQLTQAQLEER 95.00% 5.51 0.585 1.6 676.038 2,025.09 2,025.10 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% KSFTPDHVVYAR 95.00% 2.64 0.414 3.29 710.37 1,418.72 1,419.74 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% KSFTPDHVVYAR 95.00% 3.29 0.471 3.8 710.8725 1,419.73 1,419.74 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% ATEMVEVGADDDEGGAERGEAGDLR 95.00% 4.25 0.488 4.92 850.7074 2,549.10 2,549.11 3
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% QAEMEGAVQSIQGELSK 95.00% 5.96 0.562 4.29 902.9389 1,803.86 1,804.88 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% QAEMEGAVQSIQGELSK 95.00% 6.19 0.534 1.13 903.4424 1,804.87 1,804.88 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% QAEMEGAVQSIQGELSK 95.00% 4.32 0.395 2.14 903.4494 1,804.88 1,804.88 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% QAEMEGAVQSIQGELSK 95.00% 2.99 0.219 0 903.453 1,804.89 1,804.88 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% ATEMVEVGADDDEGGAER 95.00% 4.13 0.532 4.18 925.8891 1,849.76 1,850.77 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% ATEMVEVGADDDEGGAER 95.00% 4.27 0.472 4.6 926.3883 1,850.76 1,850.77 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% IIGAVDQIQLTQAQLEER 95.00% 6.18 0.628 5.11 1,013.55 2,025.08 2,025.10 2
 SAMPLE 3R Polymerase I and transcript release factor  PTRF  PTRF_HUMAN 43,458.50 100.00% 10 13 36 26.90% IIGAVDQIQLTQAQLEER 95.00% 6.16 0.674 5.82 1,013.55 2,025.09 2,025.10 2
 SAMPLE 1R Procollagen C-endopeptidase enhancer 1  PCOLCE  PCOC1_HUMAN 47,954.50 99.90% 2 2 4 6.68% GFLLWYSGR 95.00% 2.66 0.295 2.23 549.7888 1,097.56 1,098.57 2
 SAMPLE 1R Procollagen C-endopeptidase enhancer 1  PCOLCE  PCOC1_HUMAN 47,954.50 99.90% 2 2 4 6.68% GFLLWYSGR 95.00% 2.95 0.486 2.21 549.7893 1,097.56 1,098.57 2
 SAMPLE 1R Procollagen C-endopeptidase enhancer 1  PCOLCE  PCOC1_HUMAN 47,954.50 99.90% 2 2 4 6.68% SQPPEKTEESPSAPDAPTcPK 95.00% 2.53 0.433 2.64 c19: Carbamidomethyl (+57.02) 751.6838 2,252.03 2,253.03 3
 SAMPLE 1R Procollagen C-endopeptidase enhancer 1  PCOLCE  PCOC1_HUMAN 47,954.50 99.90% 2 2 4 6.68% SQPPEKTEESPSAPDAPTcPK 95.00% 2.23 0.313 2.82 c19: Carbamidomethyl (+57.02) 752.0186 2,253.03 2,253.03 3
 SAMPLE 1R Procollagen C-endopeptidase enhancer 1  PCOLCE  PCOC1_HUMAN 47,954.50 99.90% 2 2 4 6.68% TEESPSAPDAPTcPK 95.00% 2.36 0.313 0 c13: Carbamidomethyl (+57.02) 793.8521 1,585.69 1,586.70 2
 SAMPLE 1R Procollagen C-endopeptidase enhancer 1  PCOLCE  PCOC1_HUMAN 47,954.50 99.90% 2 2 4 6.68% TEESPSAPDAPTcPK 95.00% 2.66 0.39 0 c13: Carbamidomethyl (+57.02) 794.355 1,586.69 1,586.70 2
 SAMPLE 2 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 32.90% TFVNITPAEVGVLVGKDR 95.00% 3.14 0.361 0 639.0256 1,914.05 1,915.07 3
 SAMPLE 2 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 32.90% STGGAPTFNVTVTK 95.00% 3.52 0.408 2.06 690.3593 1,378.70 1,379.72 2
 SAMPLE 2 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 32.90% SSFYVNGLTLGGQK 95.00% 4.01 0.48 3.82 735.8811 1,469.75 1,470.76 2
 SAMPLE 2 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 32.90% SSFYVNGLTLGGQK 95.00% 5.05 0.532 5 735.8814 1,469.75 1,470.76 2
 SAMPLE 2 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 32.90% SSFYVNGLTLGGQK 95.00% 4.87 0.542 4.52 735.8819 1,469.75 1,470.76 2
 SAMPLE 2 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 32.90% SSFYVNGLTLGGQK 95.00% 4.15 0.468 2.89 735.8831 1,469.75 1,470.76 2
 SAMPLE 2 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 32.90% TFVNITPAEVGVLVGK 95.00% 3.56 0.356 1.74 822.9743 1,643.93 1,643.94 2 MDHM_HUMAN,PEDF_HUMAN
 SAMPLE 2 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 32.90% TFVNITPAEVGVLVGK 95.00% 4.69 0.473 4.14 822.9752 1,643.93 1,643.94 2 MDHM_HUMAN,PEDF_HUMAN
 SAMPLE 2R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 41.40% STGGAPTFNVTVTK 95.00% 3.33 0.26 1.6 690.3592 1,378.70 1,379.72 2
 SAMPLE 2R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 41.40% STGGAPTFNVTVTK 95.00% 2.96 0.131 1.85 690.3598 1,378.70 1,379.72 2
 SAMPLE 2R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 41.40% STGGAPTFNVTVTK 95.00% 3.06 0.198 2.64 690.36 1,378.70 1,379.72 2
 SAMPLE 2R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 41.40% SSFYVNGLTLGGQK 95.00% 5.26 0.548 4.8 735.8815 1,469.75 1,470.76 2
 SAMPLE 2R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 41.40% SSFYVNGLTLGGQK 95.00% 4.92 0.563 4.96 735.8822 1,469.75 1,470.76 2
 SAMPLE 2R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 41.40% DSLLQDGEFSmDLR 95.00% 4.29 0.512 5.07 m11: Oxidation (+15.99) 821.3772 1,640.74 1,641.74 2
 SAMPLE 2R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 41.40% TFVNITPAEVGVLVGK 95.00% 4.67 0.484 4.64 822.4723 1,642.93 1,643.94 2 MDHM_HUMAN,PEDF_HUMAN
 SAMPLE 2R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 41.40% TFVNITPAEVGVLVGK 95.00% 4.77 0.488 3.25 822.9746 1,643.93 1,643.94 2 MDHM_HUMAN,PEDF_HUMAN
 SAMPLE 3 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 39.30% TDKTLVLLMGK 95.00% 3.03 0.403 3.35 609.8593 1,217.70 1,218.71 2
 SAMPLE 3 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 39.30% TDKTLVLLMGK 95.00% 2.83 0.457 4.68 609.8596 1,217.70 1,218.71 2
 SAMPLE 3 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 39.30% TDKTLVLLmGK 95.00% 2.58 0.346 1.7 m9: Oxidation (+15.99) 618.3587 1,234.70 1,234.71 2
 SAMPLE 3 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 39.30% STGGAPTFNVTVTK 95.00% 3.73 0.525 2.48 690.36 1,378.70 1,379.72 2
 SAMPLE 3 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 39.30% SSFYVNGLTLGGQK 95.00% 4.87 0.567 6.14 735.8816 1,469.75 1,470.76 2
 SAMPLE 3 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 39.30% SSFYVNGLTLGGQK 95.00% 4.98 0.544 5.85 735.8823 1,469.75 1,470.76 2
 SAMPLE 3 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 39.30% TFVNITPAEVGVLVGK 95.00% 4.6 0.42 2.15 822.4723 1,642.93 1,643.94 2 MDHM_HUMAN,PEDF_HUMAN
 SAMPLE 3 Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 3 3 6 39.30% TFVNITPAEVGVLVGK 95.00% 5.06 0.483 3.82 822.9746 1,643.93 1,643.94 2 MDHM_HUMAN,PEDF_HUMAN
 SAMPLE 3R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 4 4 7 47.90% DSPSVWAAVPGK 95.00% 2.06 0.272 1.52 607.3128 1,212.61 1,213.62 2
 SAMPLE 3R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 4 4 7 47.90% TDKTLVLLMGK 95.00% 3.12 0.396 2.23 609.86 1,217.70 1,218.71 2
 SAMPLE 3R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 4 4 7 47.90% TDKTLVLLMGK 95.00% 2.6 0.316 1.8 609.862 1,217.71 1,218.71 2
 SAMPLE 3R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 4 4 7 47.90% STGGAPTFNVTVTK 95.00% 3.99 0.546 4.55 690.3607 1,378.71 1,379.72 2
 SAMPLE 3R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 4 4 7 47.90% STGGAPTFNVTVTK 95.00% 3.83 0.527 4.17 690.3611 1,378.71 1,379.72 2
 SAMPLE 3R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 4 4 7 47.90% SSFYVNGLTLGGQK 95.00% 4.84 0.533 5.05 735.8817 1,469.75 1,470.76 2
 SAMPLE 3R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 4 4 7 47.90% SSFYVNGLTLGGQK 95.00% 5.26 0.528 6.57 735.8824 1,469.75 1,470.76 2
 SAMPLE 3R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 4 4 7 47.90% TFVNITPAEVGVLVGK 95.00% 4.75 0.452 3.68 822.4721 1,642.93 1,643.94 2 MDHM_HUMAN,PEDF_HUMAN
 SAMPLE 3R Profilin-1  PFN1  PROF1_HUMAN 15,036.30 100.00% 4 4 7 47.90% TFVNITPAEVGVLVGK 95.00% 4.46 0.455 5.06 822.4721 1,642.93 1,643.94 2 MDHM_HUMAN,PEDF_HUMAN
 SAMPLE 2 Profilin-2  PFN2  PROF2_HUMAN 15,028.20 99.80% 2 2 4 10.70% DREGFFTNGLTLGAK 95.00% 4.44 0.424 2.19 542.6133 1,624.82 1,625.83 3
 SAMPLE 2 Profilin-2  PFN2  PROF2_HUMAN 15,028.20 99.80% 2 2 4 10.70% DREGFFTNGLTLGAK 95.00% 3.29 0.4 1.7 542.6144 1,624.82 1,625.83 3
 SAMPLE 2 Profilin-2  PFN2  PROF2_HUMAN 15,028.20 99.80% 2 2 4 10.70% EGFFTNGLTLGAK 95.00% 3.47 0.527 0 677.8521 1,353.69 1,354.70 2
 SAMPLE 2 Profilin-2  PFN2  PROF2_HUMAN 15,028.20 99.80% 2 2 4 10.70% EGFFTNGLTLGAK 95.00% 3.37 0.515 0 677.8531 1,353.69 1,354.70 2
 SAMPLE 2R Profilin-2  PFN2  PROF2_HUMAN 15,028.20 99.80% 2 3 5 10.70% DREGFFTNGLTLGAK 95.00% 3.82 0.328 1.59 542.614 1,624.82 1,625.83 3
 SAMPLE 2R Profilin-2  PFN2  PROF2_HUMAN 15,028.20 99.80% 2 3 5 10.70% DREGFFTNGLTLGAK 95.00% 4.38 0.341 1.38 542.9479 1,625.82 1,625.83 3
 SAMPLE 2R Profilin-2  PFN2  PROF2_HUMAN 15,028.20 99.80% 2 3 5 10.70% EGFFTNGLTLGAK 95.00% 3.24 0.5 0 677.8524 1,353.69 1,354.70 2
 SAMPLE 2R Profilin-2  PFN2  PROF2_HUMAN 15,028.20 99.80% 2 3 5 10.70% EGFFTNGLTLGAK 95.00% 3.28 0.531 0 678.3547 1,354.69 1,354.70 2
 SAMPLE 2R Profilin-2  PFN2  PROF2_HUMAN 15,028.20 99.80% 2 3 5 10.70% DREGFFTNGLTLGAK 95.00% 4.8 0.412 3.48 813.9224 1,625.83 1,625.83 2
 SAMPLE 3 Profilin-2  PFN2  PROF2_HUMAN 15,028.20 99.80% 2 2 3 20.70% DREGFFTNGLTLGAK 95.00% 4.76 0.497 4.74 813.4158 1,624.82 1,625.83 2
 SAMPLE 3 Profilin-2  PFN2  PROF2_HUMAN 15,028.20 99.80% 2 2 3 20.70% DSLYVDGDcTMDIR 95.00% 4.36 0.488 6.37 c9: Carbamidomethyl (+57.02) 830.3519 1,658.69 1,659.70 2
 SAMPLE 3 Profilin-2  PFN2  PROF2_HUMAN 15,028.20 99.80% 2 2 3 20.70% DSLYVDGDcTMDIR 95.00% 4.27 0.475 7.85 c9: Carbamidomethyl (+57.02) 830.8543 1,659.69 1,659.70 2
 SAMPLE 3R Profilin-2  PFN2  PROF2_HUMAN 15,028.20 100.00% 3 4 7 20.70% DREGFFTNGLTLGAK 95.00% 4.15 0.356 2.15 542.6138 1,624.82 1,625.83 3
 SAMPLE 3R Profilin-2  PFN2  PROF2_HUMAN 15,028.20 100.00% 3 4 7 20.70% DREGFFTNGLTLGAK 95.00% 3.47 0.29 1.28 542.6146 1,624.82 1,625.83 3
 SAMPLE 3R Profilin-2  PFN2  PROF2_HUMAN 15,028.20 100.00% 3 4 7 20.70% EGFFTNGLTLGAK 95.00% 2.65 0.418 0 677.8504 1,353.69 1,354.70 2
 SAMPLE 3R Profilin-2  PFN2  PROF2_HUMAN 15,028.20 100.00% 3 4 7 20.70% EGFFTNGLTLGAK 95.00% 3.59 0.476 0 678.3452 1,354.67 1,354.70 2
 SAMPLE 3R Profilin-2  PFN2  PROF2_HUMAN 15,028.20 100.00% 3 4 7 20.70% SQGGEPTYNVAVGR 95.00% 3.39 0.408 4.19 717.852 1,433.69 1,434.70 2
 SAMPLE 3R Profilin-2  PFN2  PROF2_HUMAN 15,028.20 100.00% 3 4 7 20.70% SQGGEPTYNVAVGR 95.00% 3.25 0.395 3.7 717.8528 1,433.69 1,434.70 2
 SAMPLE 3R Profilin-2  PFN2  PROF2_HUMAN 15,028.20 100.00% 3 4 7 20.70% DREGFFTNGLTLGAK 95.00% 4.77 0.451 4.96 813.4205 1,624.83 1,625.83 2
 SAMPLE 3R Programmed cell death 6-interacting protein  PDCD6IP  PDC6I_HUMAN 96,007.40 99.80% 2 2 2 3.11% FYNELTEILVR 95.00% 2.61 0.284 1.96 698.8788 1,395.74 1,396.75 2
 SAMPLE 3R Programmed cell death 6-interacting protein  PDCD6IP  PDC6I_HUMAN 96,007.40 99.80% 2 2 2 3.11% SVIEQGGIQTVDQLIK 95.00% 4.95 0.493 5.7 864.4808 1,726.95 1,727.95 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% NLMQLNLAHNILR 95.00% 2.54 0.515 1.07 517.2926 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% NLMQLNLAHNILR 95.00% 2.54 0.477 0 517.2929 1,548.86 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% WINLDNNR 95.00% 2.55 0.166 0 522.7661 1,043.52 1,044.52 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LEHLYLNNNSIEK 95.00% 3.13 0.201 0 529.6105 1,585.81 1,586.82 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LEHLYLNNNSIEK 95.00% 3.38 0.212 0 529.6118 1,585.81 1,586.82 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LEHLYLNNNSIEK 95.00% 3 0.139 0 529.6118 1,585.81 1,586.82 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LEHLYLNNNSIEK 95.00% 2.86 0.243 0 529.6121 1,585.81 1,586.82 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LEHLYLNNNSIEK 95.00% 3.44 0.348 0 529.6126 1,585.81 1,586.82 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LEHLYLNNNSIEK 95.00% 3.58 0.236 0 529.6127 1,585.81 1,586.82 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LEHLYLNNNSIEK 95.00% 3.35 0.303 0 529.9459 1,586.81 1,586.82 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LEHLYLNNNSIEK 95.00% 3.44 0.242 0 529.946 1,586.81 1,586.82 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LEHLYLNNNSIEK 95.00% 3.04 0.31 0 529.9472 1,586.82 1,586.82 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LENLLLLDLQHNR 95.00% 3.75 0.455 1.2 530.9705 1,589.89 1,590.90 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LENLLLLDLQHNR 95.00% 3.98 0.485 1.04 530.9714 1,589.89 1,590.90 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LENLLLLDLQHNR 95.00% 3.9 0.458 2.24 530.9714 1,589.89 1,590.90 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LENLLLLDLQHNR 95.00% 4.14 0.494 2.17 530.9717 1,589.89 1,590.90 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LENLLLLDLQHNR 95.00% 4.73 0.48 2.82 530.9718 1,589.89 1,590.90 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LENLLLLDLQHNR 95.00% 3.91 0.47 1.47 530.9722 1,589.89 1,590.90 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% SFPNLAFIR 95.00% 2.5 0.288 0 532.7986 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% SFPNLAFIR 95.00% 2.55 0.207 1.49 532.799 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% SFPNLAFIR 95.00% 2.2 0.269 0 532.7992 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% SFPNLAFIR 95.00% 2.61 0.257 1.89 532.7992 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% SFPNLAFIR 95.00% 2.61 0.267 1.59 532.7995 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% SFPNLAFIR 95.00% 2.64 0.186 0 532.7995 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% SFPNLAFIR 95.00% 2.59 0.225 1.57 532.7995 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% SFPNLAFIR 95.00% 2.63 0.198 2.02 532.7997 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% SFPNLAFIR 95.00% 2.5 0.166 1.19 532.7998 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% SFPNLAFIR 95.00% 2.63 0.281 1.25 532.7999 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% SFPNLAFIR 95.00% 1.93 0.25 1.16 532.8 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 4.3 0.602 1.85 533.6233 1,597.85 1,598.85 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 2.74 0.482 0 533.6238 1,597.85 1,598.85 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 3.87 0.536 2.03 533.624 1,597.85 1,598.85 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 4.08 0.619 1.74 533.6242 1,597.85 1,598.85 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 4.48 0.568 2.03 533.6248 1,597.85 1,598.85 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 3.38 0.604 1.09 533.625 1,597.85 1,598.85 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 2.94 0.445 0.959 533.9591 1,598.85 1,598.85 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% ISSVPAINNR 95.00% 2.39 0.241 1.92 535.8023 1,069.59 1,070.60 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% ISSVPAINNR 95.00% 2.42 0.192 1.24 535.8023 1,069.59 1,070.60 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% ISSVPAINNR 95.00% 2.44 0.258 1.7 535.8024 1,069.59 1,070.60 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% ISSVPAINNR 95.00% 2.6 0.336 1.52 535.8026 1,069.59 1,070.60 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% ISSVPAINNR 95.00% 2.3 0.234 1.15 535.8026 1,069.59 1,070.60 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% ISSVPAINNR 95.00% 2.27 0.301 1.37 535.8026 1,069.59 1,070.60 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% ISSVPAINNR 95.00% 2.42 0.321 1.7 535.8027 1,069.59 1,070.60 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% ISSVPAINNR 95.00% 2.02 0.131 1.49 535.8027 1,069.59 1,070.60 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% ISSVPAINNR 95.00% 2.37 0.247 1.37 535.8027 1,069.59 1,070.60 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% ISSVPAINNR 95.00% 2.44 0.275 1.8 535.8033 1,069.59 1,070.60 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LSDGVFKPDTFHGLK 95.00% 2.9 0.341 0 554.2947 1,659.86 1,660.87 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LSDGVFKPDTFHGLK 95.00% 3.27 0.471 1.08 554.2957 1,659.86 1,660.87 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LSDGVFKPDTFHGLK 95.00% 3.41 0.542 2.62 554.2961 1,659.87 1,660.87 3
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% IETIPNGYFK 95.00% 2.36 0.248 0 591.3148 1,180.61 1,181.62 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% IETIPNGYFK 95.00% 2.29 0.225 0 591.3154 1,180.62 1,181.62 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% IETIPNGYFK 95.00% 2.26 0.271 0 591.3167 1,180.62 1,181.62 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LPGLVFLYmEK 95.00% 3.05 0.556 2.77 m9: Oxidation (+15.99) 663.364 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LPGLVFLYmEK 95.00% 1.9 0.421 0 m9: Oxidation (+15.99) 663.3648 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LPGLVFLYmEK 95.00% 3.61 0.5 2.24 m9: Oxidation (+15.99) 663.365 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LPGLVFLYmEK 95.00% 2.62 0.327 1.68 m9: Oxidation (+15.99) 663.366 1,324.72 1,325.72 2 SEP11_HUMAN
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% NQLEEVPSALPR 95.00% 4.31 0.506 3.68 676.8637 1,351.71 1,352.72 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% NQLEEVPSALPR 95.00% 4.14 0.462 2.4 676.8638 1,351.71 1,352.72 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% NQLEEVPSALPR 95.00% 4 0.47 2.39 676.8638 1,351.71 1,352.72 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% NQLEEVPSALPR 95.00% 4.16 0.447 2.8 676.8639 1,351.71 1,352.72 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% NQLEEVPSALPR 95.00% 4.11 0.45 2.85 676.8641 1,351.71 1,352.72 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% NQLEEVPSALPR 95.00% 4.18 0.485 2.96 676.8642 1,351.71 1,352.72 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% NQLEEVPSALPR 95.00% 4.34 0.47 3.23 676.8642 1,351.71 1,352.72 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% NQLEEVPSALPR 95.00% 4.07 0.46 3.68 676.8642 1,351.71 1,352.72 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% NQLEEVPSALPR 95.00% 4.57 0.453 3.39 676.8642 1,351.71 1,352.72 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% NQLEEVPSALPR 95.00% 2.45 0.33 0 676.8648 1,351.71 1,352.72 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LENLLLLDLQHNR 95.00% 4.28 0.539 3.21 795.9533 1,589.89 1,590.90 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LENLLLLDLQHNR 95.00% 4.52 0.494 2.96 795.9539 1,589.89 1,590.90 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LENLLLLDLQHNR 95.00% 4.7 0.491 3.82 795.9547 1,589.89 1,590.90 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LENLLLLDLQHNR 95.00% 4.49 0.482 2.74 795.9555 1,589.90 1,590.90 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LENLLLLDLQHNR 95.00% 4.67 0.492 2.34 796.4566 1,590.90 1,590.90 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LENLLLLDLQHNR 95.00% 4.23 0.493 2.57 796.4593 1,590.90 1,590.90 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 4.75 0.547 4.66 799.933 1,597.85 1,598.85 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 5.24 0.583 6.38 799.9339 1,597.85 1,598.85 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 5.15 0.575 4.8 799.934 1,597.85 1,598.85 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 5.19 0.585 4.74 799.9341 1,597.85 1,598.85 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 5.1 0.572 6.09 799.9341 1,597.85 1,598.85 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% VPTAIHQLYLDSNK 95.00% 4.92 0.545 5.57 800.437 1,598.86 1,598.85 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LSDGVFKPDTFHGLK 95.00% 3.44 0.449 1.85 830.9372 1,659.86 1,660.87 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LSDGVFKPDTFHGLK 95.00% 3.12 0.477 1.21 830.9395 1,659.86 1,660.87 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LSDGVFKPDTFHGLK 95.00% 4 0.509 3 830.9419 1,659.87 1,660.87 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LSDGVFKPDTFHGLK 95.00% 3.7 0.498 2.48 830.9419 1,659.87 1,660.87 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LSDGVFKPDTFHGLK 95.00% 4.26 0.49 2.42 831.443 1,660.87 1,660.87 2
 SAMPLE 4 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 8 11 61 33.50% LSDGVFKPDTFHGLK 95.00% 4.22 0.447 2.62 831.444 1,660.87 1,660.87 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% NLMQLNLAHNILR 95.00% 2.27 0.274 1.15 517.2927 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% NLMQLNLAHNILR 95.00% 2.44 0.464 1.38 517.2935 1,548.86 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% WINLDNNR 95.00% 2.5 0.17 0 522.7653 1,043.51 1,044.52 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% WINLDNNR 95.00% 2.51 0.168 0 522.7658 1,043.52 1,044.52 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% WINLDNNR 95.00% 2.57 0.186 0 522.7663 1,043.52 1,044.52 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% WINLDNNR 95.00% 2.51 0.185 0 522.7666 1,043.52 1,044.52 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LEHLYLNNNSIEK 95.00% 2.79 0.28 0 529.6124 1,585.81 1,586.82 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LEHLYLNNNSIEK 95.00% 2.69 0.299 0 529.613 1,585.82 1,586.82 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LEHLYLNNNSIEK 95.00% 3.25 0.209 1.13 529.9458 1,586.81 1,586.82 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LENLLLLDLQHNR 95.00% 3.68 0.419 2.08 530.9709 1,589.89 1,590.90 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LENLLLLDLQHNR 95.00% 3.79 0.467 2.19 530.9719 1,589.89 1,590.90 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LENLLLLDLQHNR 95.00% 3.91 0.504 3.96 530.9719 1,589.89 1,590.90 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LENLLLLDLQHNR 95.00% 4 0.485 2.54 530.9723 1,589.89 1,590.90 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LENLLLLDLQHNR 95.00% 3.62 0.397 2.36 531.3056 1,590.89 1,590.90 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% SFPNLAFIR 95.00% 2.19 0.222 0 532.7984 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% SFPNLAFIR 95.00% 2.51 0.18 1.59 532.7991 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% SFPNLAFIR 95.00% 2 0.14 1.77 532.7992 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% SFPNLAFIR 95.00% 2.6 0.183 1.35 532.7993 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% SFPNLAFIR 95.00% 2.64 0.233 1.62 532.7997 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% SFPNLAFIR 95.00% 2.46 0.201 1.18 532.7998 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% SFPNLAFIR 95.00% 2.61 0.205 1.38 532.7998 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% SFPNLAFIR 95.00% 2.33 0.082 1.46 532.7998 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% SFPNLAFIR 95.00% 1.98 0.202 1.8 532.8009 1,063.59 1,064.59 2 TENX_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% SFPNLAFIR 95.00% 2.2 0.238 1.38 533.2995 1,064.58 1,064.59 2 TENX_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% SFPNLAFIR 95.00% 2.35 0.195 1.28 533.3033 1,064.59 1,064.59 2 TENX_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VPTAIHQLYLDSNK 95.00% 3.39 0.594 2.46 533.6235 1,597.85 1,598.85 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VPTAIHQLYLDSNK 95.00% 3.3 0.69 1.92 533.6238 1,597.85 1,598.85 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VPTAIHQLYLDSNK 95.00% 2.62 0.464 1.09 533.6248 1,597.85 1,598.85 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VPTAIHQLYLDSNK 95.00% 3.42 0.559 0 533.6251 1,597.85 1,598.85 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VPTAIHQLYLDSNK 95.00% 2.7 0.464 1.04 533.6257 1,597.85 1,598.85 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VPTAIHQLYLDSNK 95.00% 2.67 0.521 1.48 533.9584 1,598.85 1,598.85 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% ISSVPAINNR 95.00% 2.28 0.252 0 535.8024 1,069.59 1,070.60 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% ISSVPAINNR 95.00% 2 0.201 1.35 535.8028 1,069.59 1,070.60 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% ISSVPAINNR 95.00% 2.51 0.241 1.7 535.8029 1,069.59 1,070.60 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% ISSVPAINNR 95.00% 2.53 0.307 1.85 535.803 1,069.59 1,070.60 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% ISSVPAINNR 95.00% 2.45 0.301 2.47 535.8033 1,069.59 1,070.60 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LSDGVFKPDTFHGLK 95.00% 3.17 0.492 0 554.2956 1,659.86 1,660.87 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LSDGVFKPDTFHGLK 95.00% 3.11 0.498 1.19 554.6303 1,660.87 1,660.87 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% IETIPNGYFK 95.00% 2.41 0.243 1.47 591.3142 1,180.61 1,181.62 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% IETIPNGYFK 95.00% 2.31 0.231 1.28 591.3158 1,180.62 1,181.62 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VLEKLPGLVFLYMEK 95.00% 2.92 0.378 1.89 593.6779 1,778.01 1,779.01 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VLEKLPGLVFLYMEK 95.00% 3.45 0.426 1.17 594.0129 1,779.02 1,779.01 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VLEKLPGLVFLYmEK 95.00% 2.63 0.383 0 m13: Oxidation (+15.99) 599.342 1,795.00 1,795.01 3
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LPGLVFLYMEK 95.00% 3.73 0.491 4.28 655.3653 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LPGLVFLYMEK 95.00% 3.7 0.467 4.03 655.3673 1,308.72 1,309.72 2 SEP11_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LPGLVFLYMEK 95.00% 3.32 0.451 3.92 655.3675 1,308.72 1,309.72 2 SEP11_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LPGLVFLYMEK 95.00% 2.94 0.469 3.62 655.369 1,308.72 1,309.72 2 SEP11_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LPGLVFLYmEK 95.00% 2.8 0.414 2.41 m9: Oxidation (+15.99) 663.364 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LPGLVFLYmEK 95.00% 3.04 0.471 1.59 m9: Oxidation (+15.99) 663.3654 1,324.72 1,325.72 2 SEP11_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LPGLVFLYmEK 95.00% 3.05 0.408 2.7 m9: Oxidation (+15.99) 663.8661 1,325.72 1,325.72 2 SEP11_HUMAN
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% NQLEEVPSALPR 95.00% 4.12 0.461 2.92 676.8636 1,351.71 1,352.72 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% NQLEEVPSALPR 95.00% 3.97 0.45 2.96 676.8636 1,351.71 1,352.72 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% NQLEEVPSALPR 95.00% 4.15 0.454 2.62 676.8639 1,351.71 1,352.72 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% NQLEEVPSALPR 95.00% 4.08 0.462 2.68 676.8639 1,351.71 1,352.72 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% NQLEEVPSALPR 95.00% 4.19 0.459 2.19 676.864 1,351.71 1,352.72 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% NQLEEVPSALPR 95.00% 4.08 0.446 2.62 676.864 1,351.71 1,352.72 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% NQLEEVPSALPR 95.00% 4.15 0.449 3.02 676.8642 1,351.71 1,352.72 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LENLLLLDLQHNR 95.00% 4.41 0.51 3.22 795.9538 1,589.89 1,590.90 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LENLLLLDLQHNR 95.00% 4.64 0.482 2.74 795.9552 1,589.89 1,590.90 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LENLLLLDLQHNR 95.00% 4.45 0.509 2.2 795.9556 1,589.90 1,590.90 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LENLLLLDLQHNR 95.00% 4.42 0.504 3.8 795.9558 1,589.90 1,590.90 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LENLLLLDLQHNR 95.00% 4.07 0.512 2.8 795.957 1,589.90 1,590.90 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LENLLLLDLQHNR 95.00% 4.19 0.499 2.21 796.4574 1,590.90 1,590.90 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VPTAIHQLYLDSNK 95.00% 4.69 0.382 7.85 799.9322 1,597.85 1,598.85 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VPTAIHQLYLDSNK 95.00% 5.29 0.541 5 799.9335 1,597.85 1,598.85 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VPTAIHQLYLDSNK 95.00% 5.05 0.536 5.82 799.934 1,597.85 1,598.85 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VPTAIHQLYLDSNK 95.00% 4.81 0.557 4.92 800.4364 1,598.86 1,598.85 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% VPTAIHQLYLDSNK 95.00% 5.09 0.561 4.41 800.437 1,598.86 1,598.85 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LSDGVFKPDTFHGLK 95.00% 3.53 0.461 1.7 830.9441 1,659.87 1,660.87 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LSDGVFKPDTFHGLK 95.00% 3.97 0.456 3.41 831.4412 1,660.87 1,660.87 2
 SAMPLE 4R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 12 53 34.60% LSDGVFKPDTFHGLK 95.00% 4.06 0.474 3.8 831.4448 1,660.87 1,660.87 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LSQNHISR 95.00% 2.3 0.262 0 477.761 953.5063 954.5121 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LNYNKLTDRGLPK 95.00% 3.44 0.331 0 511.2901 1,530.85 1,531.86 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NLMQLNLAHNILR 95.00% 2.6 0.452 1.68 517.2914 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NLMQLNLAHNILR 95.00% 3.04 0.425 1.03 517.2917 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NLMQLNLAHNILR 95.00% 2.22 0.413 1.39 517.2919 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NLMQLNLAHNILR 95.00% 2.96 0.474 1.6 517.2921 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LEHLYLNNNSIEK 95.00% 4.1 0.296 0 529.61 1,585.81 1,586.82 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LEHLYLNNNSIEK 95.00% 3.97 0.33 1.54 529.6102 1,585.81 1,586.82 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LENLLLLDLQHNR 95.00% 3.87 0.481 2.28 530.9693 1,589.88 1,590.90 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LENLLLLDLQHNR 95.00% 4.46 0.486 3.1 530.9695 1,589.89 1,590.90 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.67 0.236 1.74 532.7958 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.7 0.284 0 532.7959 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.49 0.225 1.15 532.7966 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.51 0.28 0 532.7968 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.63 0.241 0 532.7968 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2 0.25 1.26 532.7969 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.73 0.208 1.52 532.797 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.6 0.227 0 532.7974 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.43 0.269 1.7 532.7974 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.77 0.265 1.85 532.7975 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.71 0.234 0 532.7976 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.73 0.274 2.3 532.7981 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.03 0.22 1.62 532.7983 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.38 0.187 1.42 532.7992 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.39 0.282 1.48 532.7997 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.25 0.222 1.15 532.8023 1,063.59 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.44 0.24 1.28 532.8034 1,063.59 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% SFPNLAFIR 95.00% 2.22 0.16 2.72 533.2964 1,064.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 3.41 0.547 1.77 533.6204 1,597.84 1,598.85 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 4.22 0.543 1.7 533.6214 1,597.84 1,598.85 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 3.12 0.551 1.49 533.6215 1,597.84 1,598.85 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 3.53 0.617 2.64 533.6218 1,597.84 1,598.85 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 2.48 0.413 1.25 533.9554 1,598.84 1,598.85 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 3.52 0.567 1.92 533.9558 1,598.84 1,598.85 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 3.65 0.595 2.14 533.9567 1,598.85 1,598.85 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 3.19 0.426 1.59 533.9568 1,598.85 1,598.85 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% ISSVPAINNR 95.00% 2.63 0.326 1.32 535.8003 1,069.59 1,070.60 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LSDGVFKPDTFHGLK 95.00% 3.1 0.235 0 553.9495 1,658.83 1,660.87 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LSDGVFKPDTFHGLK 95.00% 3.49 0.497 2.04 554.2939 1,659.86 1,660.87 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LSDGVFKPDTFHGLK 95.00% 3.69 0.487 1.89 554.2943 1,659.86 1,660.87 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NLEQLRLSQNHISR 95.00% 2.46 0.358 0 569.979 1,706.91 1,707.93 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NLEQLRLSQNHISR 95.00% 3.2 0.416 0 569.9794 1,706.91 1,707.93 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% IETIPNGYFK 95.00% 2.54 0.321 1.33 591.3123 1,180.61 1,181.62 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% IETIPNGYFK 95.00% 2.67 0.287 2.16 591.313 1,180.61 1,181.62 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% IETIPNGYFK 95.00% 2.45 0.264 0 591.3131 1,180.61 1,181.62 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% IETIPNGYFK 95.00% 2.2 0.251 0 591.3133 1,180.61 1,181.62 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VLEKLPGLVFLYmEK 95.00% 3.19 0.407 2.29 m13: Oxidation (+15.99) 599.007 1,794.00 1,795.01 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LPGLVFLYMEK 95.00% 3 0.472 2.4 655.3687 1,308.72 1,309.72 2 SEP11_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LPGLVFLYmEK 95.00% 3.48 0.592 3.24 m9: Oxidation (+15.99) 663.3599 1,324.70 1,325.72 2 SEP11_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LPGLVFLYmEK 95.00% 3.88 0.541 4.74 m9: Oxidation (+15.99) 663.3605 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LPGLVFLYmEK 95.00% 3.63 0.578 2.62 m9: Oxidation (+15.99) 663.361 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LPGLVFLYmEK 95.00% 3.95 0.577 3.52 m9: Oxidation (+15.99) 663.362 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 2.48 0.471 2.37 676.8594 1,351.70 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 2.27 0.344 1.29 676.8605 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 4.23 0.484 3.07 676.8607 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 4.15 0.443 2.4 676.8608 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 2.45 0.302 1.7 676.8609 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 3.91 0.478 3.48 676.8609 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 4.29 0.471 3.47 676.8609 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 3.67 0.473 3.14 676.8609 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 2.48 0.248 2.15 676.8612 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 3.49 0.457 2.43 676.8612 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 3.97 0.479 3.34 676.8614 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 3.56 0.449 3.26 676.8617 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 4.08 0.478 3.47 676.862 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 3.87 0.487 2.59 676.8627 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 3.66 0.415 2.43 676.8644 1,351.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 3.74 0.484 2.52 676.8669 1,351.72 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NQLEEVPSALPR 95.00% 3.25 0.451 3.28 677.3618 1,352.71 1,352.72 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% EcYcPPDFPSALYcDSR 95.00% 2.54 0.272 0 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 713.2852 2,136.83 2,136.85 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NLMQLNLAHNILR 95.00% 4.67 0.452 4.02 775.4343 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% NLMQLNLAHNILR 95.00% 4.65 0.451 4.74 775.4351 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LEHLYLNNNSIEK 95.00% 4.16 0.462 4.02 793.9119 1,585.81 1,586.82 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LEHLYLNNNSIEK 95.00% 4.21 0.438 3.74 793.9122 1,585.81 1,586.82 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LEHLYLNNNSIEK 95.00% 4.06 0.445 3.96 793.9139 1,585.81 1,586.82 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LEHLYLNNNSIEK 95.00% 4.08 0.466 3.64 793.9151 1,585.81 1,586.82 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LENLLLLDLQHNR 95.00% 4.88 0.499 2.39 795.9498 1,589.88 1,590.90 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LENLLLLDLQHNR 95.00% 4.46 0.515 2.62 795.95 1,589.88 1,590.90 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LENLLLLDLQHNR 95.00% 4.36 0.527 2.82 795.95 1,589.88 1,590.90 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LENLLLLDLQHNR 95.00% 4.09 0.49 1.55 795.9502 1,589.88 1,590.90 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LENLLLLDLQHNR 95.00% 3.73 0.559 0 795.9582 1,589.90 1,590.90 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LENLLLLDLQHNR 95.00% 4.14 0.483 2.3 796.4502 1,590.88 1,590.90 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LENLLLLDLQHNR 95.00% 4.73 0.493 3.85 796.453 1,590.89 1,590.90 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 4.36 0.519 5.03 799.9281 1,597.84 1,598.85 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 5.09 0.556 4.64 799.9289 1,597.84 1,598.85 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 4.86 0.544 7.52 799.929 1,597.84 1,598.85 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 4.94 0.557 6.77 799.929 1,597.84 1,598.85 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 4.96 0.549 8.12 799.9303 1,597.84 1,598.85 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 4.61 0.452 4.64 799.9304 1,597.85 1,598.85 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 4.65 0.461 4.2 799.9306 1,597.85 1,598.85 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNK 95.00% 4.35 0.52 6.14 799.9341 1,597.85 1,598.85 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LSDGVFKPDTFHGLK 95.00% 4.19 0.501 2.31 830.9357 1,659.86 1,660.87 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LSDGVFKPDTFHGLK 95.00% 4.38 0.476 2.96 830.9368 1,659.86 1,660.87 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LSDGVFKPDTFHGLK 95.00% 4.52 0.47 2.52 830.9372 1,659.86 1,660.87 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% LSDGVFKPDTFHGLK 95.00% 4.49 0.474 2.27 830.9374 1,659.86 1,660.87 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNKIETIPNGYFK 95.00% 6.31 0.642 3.17 921.4888 2,761.44 2,761.46 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% VPTAIHQLYLDSNKIETIPNGYFK 95.00% 6.42 0.628 4.48 921.4904 2,761.45 2,761.46 3
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% EcYcPPDFPSALYcDSR 95.00% 4.66 0.603 5 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.42 2,136.83 2,136.85 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% EcYcPPDFPSALYcDSR 95.00% 4.64 0.621 4.29 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.84 2,136.85 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% EcYcPPDFPSALYcDSR 95.00% 4.52 0.626 4.72 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.84 2,136.85 2
 SAMPLE 1 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 18 76 44.00% EcYcPPDFPSALYcDSR 95.00% 4.45 0.61 4.42 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.84 2,136.85 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LNYNKLTDRGLPK 95.00% 2.71 0.216 0 511.2891 1,530.84 1,531.86 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LNYNKLTDRGLPK 95.00% 3.67 0.404 0 511.29 1,530.85 1,531.86 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLMQLNLAHNILR 95.00% 2.92 0.451 1.49 517.2912 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLMQLNLAHNILR 95.00% 2.87 0.493 1.92 517.2914 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLMQLNLAHNILR 95.00% 2.38 0.498 0 517.2919 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLMQLNLAHNILR 95.00% 2.63 0.338 0 517.2922 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLMQLNLAHNILR 95.00% 2.74 0.422 1.66 517.2923 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLmQLNLAHNILR 95.00% 2.88 0.4 0 m3: Oxidation (+15.99) 522.6213 1,564.84 1,565.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLmQLNLAHNILR 95.00% 2.95 0.318 0 m3: Oxidation (+15.99) 522.6229 1,564.85 1,565.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLmQLNLAHNILR 95.00% 2.77 0.39 0 m3: Oxidation (+15.99) 522.6229 1,564.85 1,565.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLmQLNLAHNILR 95.00% 2.84 0.35 0 m3: Oxidation (+15.99) 522.623 1,564.85 1,565.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLmQLNLAHNILR 95.00% 2.42 0.322 0 m3: Oxidation (+15.99) 522.6232 1,564.85 1,565.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% WINLDNNR 95.00% 2.47 0.18 0 522.763 1,043.51 1,044.52 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% WINLDNNR 95.00% 2.5 0.155 0 522.7633 1,043.51 1,044.52 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LEHLYLNNNSIEK 95.00% 4.08 0.311 0 529.6094 1,585.80 1,586.82 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LEHLYLNNNSIEK 95.00% 3.82 0.275 0 529.6095 1,585.81 1,586.82 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LENLLLLDLQHNR 95.00% 4.05 0.423 1.57 530.9686 1,589.88 1,590.90 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LENLLLLDLQHNR 95.00% 4.4 0.485 3.12 530.9691 1,589.88 1,590.90 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LENLLLLDLQHNR 95.00% 4.12 0.476 1.82 530.9692 1,589.88 1,590.90 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LENLLLLDLQHNR 95.00% 3.92 0.493 2.26 530.9696 1,589.89 1,590.90 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LENLLLLDLQHNR 95.00% 3.82 0.509 1.62 530.9698 1,589.89 1,590.90 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LENLLLLDLQHNR 95.00% 4.09 0.462 1.62 531.3037 1,590.89 1,590.90 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.6 0.208 1.68 532.7956 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.56 0.183 0 532.7957 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.65 0.196 1.77 532.7961 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.59 0.218 1.92 532.7965 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.36 0.173 1.27 532.7965 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.41 0.226 1.14 532.7965 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.09 0.214 1.17 532.7969 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.11 0.209 1.62 532.797 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.6 0.246 1.33 532.7971 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.39 0.256 1.77 532.7972 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.43 0.22 1.42 532.7972 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.62 0.181 1.57 532.7973 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.68 0.234 1.59 532.7973 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.24 0.148 1.68 532.7974 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.13 0.18 1.89 532.7979 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.47 0.163 1.72 532.7986 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.25 0.222 1.52 532.8023 1,063.59 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% SFPNLAFIR 95.00% 2.44 0.24 1.21 532.8034 1,063.59 1,064.59 2 TENX_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 2.91 0.552 1.77 533.6204 1,597.84 1,598.85 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 3.86 0.563 1.16 533.6212 1,597.84 1,598.85 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 3.19 0.539 3.39 533.6215 1,597.84 1,598.85 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 4.35 0.591 1.46 533.6216 1,597.84 1,598.85 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 3.33 0.573 2.43 533.6217 1,597.84 1,598.85 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 4.06 0.518 1.66 533.6217 1,597.84 1,598.85 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 3.82 0.576 1.34 533.6219 1,597.84 1,598.85 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 3.32 0.491 2.29 533.9559 1,598.84 1,598.85 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 3.34 0.41 2.37 533.9568 1,598.85 1,598.85 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% ISSVPAINNR 95.00% 2.64 0.283 2.29 535.8001 1,069.58 1,070.60 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LSDGVFKPDTFHGLK 95.00% 2.96 0.367 0 553.9496 1,658.83 1,660.87 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LSDGVFKPDTFHGLK 95.00% 3.4 0.396 0 553.9499 1,658.83 1,660.87 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LSDGVFKPDTFHGLK 95.00% 2.82 0.42 1.82 554.2935 1,659.86 1,660.87 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LSDGVFKPDTFHGLK 95.00% 3.67 0.507 1.66 554.2938 1,659.86 1,660.87 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% IETIPNGYFK 95.00% 2.6 0.265 0 591.3122 1,180.61 1,181.62 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% IETIPNGYFK 95.00% 2.77 0.317 0 591.3125 1,180.61 1,181.62 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% IETIPNGYFK 95.00% 2.77 0.283 2.64 591.3125 1,180.61 1,181.62 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% IETIPNGYFK 95.00% 2.82 0.274 1.8 591.3127 1,180.61 1,181.62 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VLEKLPGLVFLYMEK 95.00% 3.5 0.438 0 593.6718 1,777.99 1,779.01 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VLEKLPGLVFLYMEK 95.00% 3.11 0.415 0 593.6734 1,778.00 1,779.01 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VLEKLPGLVFLYMEK 95.00% 3.91 0.489 1.29 593.6736 1,778.00 1,779.01 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VLEKLPGLVFLYMEK 95.00% 4.24 0.487 1.12 593.6754 1,778.00 1,779.01 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VLEKLPGLVFLYMEK 95.00% 4.29 0.469 1.42 593.6757 1,778.00 1,779.01 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VLEKLPGLVFLYMEK 95.00% 3.35 0.241 1.6 594.0092 1,779.00 1,779.01 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYMEK 95.00% 3.01 0.404 2.21 655.3633 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYMEK 95.00% 3.88 0.489 3.37 655.3633 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYMEK 95.00% 3.72 0.493 2.92 655.3645 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYMEK 95.00% 3.79 0.458 4.34 655.3646 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYMEK 95.00% 3.39 0.471 2.77 655.3647 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYMEK 95.00% 3.45 0.456 2.74 655.3647 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYMEK 95.00% 3.6 0.479 3.55 655.3648 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYMEK 95.00% 3.43 0.422 2.85 655.3648 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYMEK 95.00% 3.15 0.45 3.68 655.3653 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYMEK 95.00% 2.84 0.476 3.92 655.3662 1,308.72 1,309.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYmEK 95.00% 3.18 0.534 2.85 m9: Oxidation (+15.99) 663.3611 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYmEK 95.00% 3.93 0.539 3.62 m9: Oxidation (+15.99) 663.3612 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYmEK 95.00% 3.56 0.591 3.72 m9: Oxidation (+15.99) 663.3618 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LPGLVFLYmEK 95.00% 3.49 0.541 3.13 m9: Oxidation (+15.99) 663.3626 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 3.27 0.436 1.77 676.8596 1,351.70 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 4.33 0.481 2.92 676.8602 1,351.70 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 4.11 0.449 2.89 676.8605 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 3.96 0.473 3.07 676.8607 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 4.39 0.489 2.77 676.8612 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 3.13 0.394 2.82 676.8612 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 2.55 0.329 2 676.8613 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 2.68 0.397 1.72 676.8613 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 3.44 0.471 3.04 676.8613 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 4.13 0.48 2.82 676.8616 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 2.45 0.43 1.92 676.8617 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 2.12 0.228 1.41 676.862 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 2.54 0.291 1.51 676.8623 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 3.61 0.468 3 676.863 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 3.66 0.415 3.18 676.8644 1,351.71 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NQLEEVPSALPR 95.00% 3.74 0.484 2.55 676.8669 1,351.72 1,352.72 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLMQLNLAHNILR 95.00% 4.54 0.451 3.66 775.4363 1,548.86 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLMQLNLAHNILR 95.00% 4.46 0.455 4.14 775.437 1,548.86 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLmQLNLAHNILR 95.00% 3.45 0.326 2.12 m3: Oxidation (+15.99) 783.4317 1,564.85 1,565.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% NLmQLNLAHNILR 95.00% 3.46 0.351 1.38 m3: Oxidation (+15.99) 783.4337 1,564.85 1,565.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LEHLYLNNNSIEK 95.00% 4.1 0.475 4.34 793.9111 1,585.81 1,586.82 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LEHLYLNNNSIEK 95.00% 4.35 0.449 4.42 793.9112 1,585.81 1,586.82 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LENLLLLDLQHNR 95.00% 3.88 0.506 3.38 795.9492 1,589.88 1,590.90 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LENLLLLDLQHNR 95.00% 4.3 0.47 3.32 795.9502 1,589.88 1,590.90 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LENLLLLDLQHNR 95.00% 4.88 0.513 3.47 795.9502 1,589.88 1,590.90 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LENLLLLDLQHNR 95.00% 3.72 0.455 3 795.956 1,589.90 1,590.90 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LENLLLLDLQHNR 95.00% 4.33 0.521 4.27 796.4525 1,590.89 1,590.90 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LENLLLLDLQHNR 95.00% 3.89 0.481 2.52 796.4527 1,590.89 1,590.90 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 5.34 0.557 5.55 799.9287 1,597.84 1,598.85 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 5.17 0.563 8.92 799.9292 1,597.84 1,598.85 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 4.85 0.518 5.62 799.9296 1,597.84 1,598.85 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 4.39 0.52 5.55 799.93 1,597.84 1,598.85 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 4.67 0.496 4.68 799.9304 1,597.85 1,598.85 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNK 95.00% 4.8 0.49 5.33 800.4297 1,598.84 1,598.85 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LSDGVFKPDTFHGLK 95.00% 4.04 0.445 2.48 830.9357 1,659.86 1,660.87 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LSDGVFKPDTFHGLK 95.00% 4.43 0.506 2.38 830.9373 1,659.86 1,660.87 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LSDGVFKPDTFHGLK 95.00% 4.39 0.539 1.96 830.9386 1,659.86 1,660.87 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% LSDGVFKPDTFHGLK 95.00% 4.01 0.446 1.89 830.9392 1,659.86 1,660.87 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VLEKLPGLVFLYMEK 95.00% 3.64 0.476 2.59 890.0075 1,778.00 1,779.01 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VLEKLPGLVFLYMEK 95.00% 4.54 0.549 4.92 890.5102 1,779.00 1,779.01 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VLEKLPGLVFLYMEK 95.00% 4.53 0.466 4.52 890.5109 1,779.01 1,779.01 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VLEKLPGLVFLYMEK 95.00% 4.68 0.54 5.06 890.511 1,779.01 1,779.01 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% VPTAIHQLYLDSNKIETIPNGYFK 95.00% 6.15 0.618 3.11 921.4897 2,761.45 2,761.46 3
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% EcYcPPDFPSALYcDSR 95.00% 4.65 0.651 6.14 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,068.92 2,135.83 2,136.85 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% EcYcPPDFPSALYcDSR 95.00% 4.44 0.61 6.62 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,068.93 2,135.83 2,136.85 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% EcYcPPDFPSALYcDSR 95.00% 4.39 0.556 4.66 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.83 2,136.85 2
 SAMPLE 1R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 17 92 42.40% EcYcPPDFPSALYcDSR 95.00% 4.65 0.631 4.24 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.84 2,136.85 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% KVPVIPPR 95.00% 2.05 0.247 0 453.3017 904.5878 905.5938 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NLMQLNLAHNILR 95.00% 2.61 0.446 0 517.2917 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NLMQLNLAHNILR 95.00% 2.19 0.254 0 517.2919 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NLMQLNLAHNILR 95.00% 2.41 0.447 0 517.292 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NLMQLNLAHNILR 95.00% 2.3 0.151 1.24 517.6268 1,549.86 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NLmQLNLAHNILR 95.00% 2.43 0.327 0 m3: Oxidation (+15.99) 522.6233 1,564.85 1,565.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% WINLDNNR 95.00% 2.69 0.182 0 522.7641 1,043.51 1,044.52 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% WINLDNNR 95.00% 2.48 0.156 0 522.7644 1,043.51 1,044.52 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LENLLLLDLQHNR 95.00% 4.2 0.51 2.05 530.9691 1,589.88 1,590.90 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LENLLLLDLQHNR 95.00% 3.95 0.456 1.57 530.9694 1,589.88 1,590.90 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LENLLLLDLQHNR 95.00% 3.67 0.502 2.19 530.9695 1,589.89 1,590.90 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LENLLLLDLQHNR 95.00% 3.67 0.463 1.46 530.9698 1,589.89 1,590.90 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LENLLLLDLQHNR 95.00% 4.15 0.479 2.44 530.9698 1,589.89 1,590.90 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LENLLLLDLQHNR 95.00% 4.29 0.512 2.8 530.9703 1,589.89 1,590.90 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% SFPNLAFIR 95.00% 2.52 0.204 2.05 532.7956 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% SFPNLAFIR 95.00% 2.23 0.249 1.33 532.7962 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% SFPNLAFIR 95.00% 2.8 0.229 1.77 532.7969 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% SFPNLAFIR 95.00% 2.71 0.264 0 532.797 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% SFPNLAFIR 95.00% 2.53 0.296 1.14 532.7971 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% SFPNLAFIR 95.00% 2.23 0.244 0 532.7973 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% SFPNLAFIR 95.00% 2.71 0.252 1.43 532.7975 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% SFPNLAFIR 95.00% 2.51 0.254 1.2 532.7977 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% SFPNLAFIR 95.00% 2.76 0.211 1.89 532.7979 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% SFPNLAFIR 95.00% 2.68 0.256 2 532.7979 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% SFPNLAFIR 95.00% 2.6 0.211 1.8 532.7981 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% VPTAIHQLYLDSNK 95.00% 3.49 0.624 2.38 533.6211 1,597.84 1,598.85 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% VPTAIHQLYLDSNK 95.00% 4.26 0.602 1.6 533.6216 1,597.84 1,598.85 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% VPTAIHQLYLDSNK 95.00% 4.37 0.596 2.89 533.6218 1,597.84 1,598.85 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% VPTAIHQLYLDSNK 95.00% 4.29 0.52 2.36 533.6222 1,597.84 1,598.85 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% VPTAIHQLYLDSNK 95.00% 4.32 0.583 1.44 533.6223 1,597.84 1,598.85 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% VPTAIHQLYLDSNK 95.00% 3.68 0.536 1.77 533.9552 1,598.84 1,598.85 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% ISSVPAINNR 95.00% 2.46 0.271 1.6 535.8009 1,069.59 1,070.60 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LSDGVFKPDTFHGLK 95.00% 3.29 0.41 1.38 554.2938 1,659.86 1,660.87 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LSDGVFKPDTFHGLK 95.00% 3.46 0.529 2.33 554.294 1,659.86 1,660.87 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LSDGVFKPDTFHGLK 95.00% 3.62 0.529 1.46 554.2942 1,659.86 1,660.87 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LSDGVFKPDTFHGLK 95.00% 2.41 0.306 1.06 554.6276 1,660.86 1,660.87 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LNYNKLTDR 95.00% 2.45 0.255 0 568.8065 1,135.60 1,136.61 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% IETIPNGYFK 95.00% 2.47 0.27 2.09 591.311 1,180.61 1,181.62 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% IETIPNGYFK 95.00% 1.93 0.23 1.62 591.3117 1,180.61 1,181.62 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% IETIPNGYFK 95.00% 2.71 0.262 1.54 591.3126 1,180.61 1,181.62 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% IETIPNGYFK 95.00% 2.27 0.334 2.12 591.3127 1,180.61 1,181.62 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LPGLVFLYmEK 95.00% 3.59 0.525 3.08 m9: Oxidation (+15.99) 663.3619 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LPGLVFLYmEK 95.00% 3.44 0.503 2.72 m9: Oxidation (+15.99) 663.3619 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LPGLVFLYmEK 95.00% 3.06 0.518 3.64 m9: Oxidation (+15.99) 663.3627 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NQLEEVPSALPR 95.00% 3.88 0.444 3.29 676.8597 1,351.70 1,352.72 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NQLEEVPSALPR 95.00% 4.05 0.457 3.09 676.8609 1,351.71 1,352.72 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NQLEEVPSALPR 95.00% 4.25 0.493 3.19 676.8609 1,351.71 1,352.72 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NQLEEVPSALPR 95.00% 4.52 0.44 2.89 676.8614 1,351.71 1,352.72 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NQLEEVPSALPR 95.00% 4.48 0.48 3.21 676.8615 1,351.71 1,352.72 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NQLEEVPSALPR 95.00% 3.58 0.48 1.92 676.8615 1,351.71 1,352.72 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NQLEEVPSALPR 95.00% 3.38 0.484 2.96 676.8616 1,351.71 1,352.72 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NQLEEVPSALPR 95.00% 4.01 0.485 3.36 676.862 1,351.71 1,352.72 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NQLEEVPSALPR 95.00% 2.41 0.266 0 677.3533 1,352.69 1,352.72 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NLMQLNLAHNILR 95.00% 4.39 0.429 3.96 775.4348 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% NLMQLNLAHNILR 95.00% 4.5 0.447 3.33 775.4353 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LEHLYLNNNSIEK 95.00% 4.1 0.415 2.51 793.913 1,585.81 1,586.82 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LENLLLLDLQHNR 95.00% 4.57 0.518 4.66 795.9503 1,589.88 1,590.90 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LENLLLLDLQHNR 95.00% 4.81 0.527 2.46 795.9505 1,589.89 1,590.90 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LENLLLLDLQHNR 95.00% 4.64 0.515 2.89 795.9509 1,589.89 1,590.90 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LENLLLLDLQHNR 95.00% 4.62 0.525 2.66 795.9511 1,589.89 1,590.90 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% VPTAIHQLYLDSNK 95.00% 5.16 0.582 6.51 799.9295 1,597.84 1,598.85 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% VPTAIHQLYLDSNK 95.00% 5.06 0.563 5.14 799.9301 1,597.84 1,598.85 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% VPTAIHQLYLDSNK 95.00% 5.35 0.554 7.54 799.9303 1,597.85 1,598.85 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% VPTAIHQLYLDSNK 95.00% 5.15 0.554 5.24 800.432 1,598.85 1,598.85 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LSDGVFKPDTFHGLK 95.00% 4.14 0.465 2.49 830.937 1,659.86 1,660.87 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LSDGVFKPDTFHGLK 95.00% 3.98 0.429 2.68 830.9384 1,659.86 1,660.87 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LSDGVFKPDTFHGLK 95.00% 4.42 0.494 2.2 831.4394 1,660.86 1,660.87 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% LSDGVFKPDTFHGLK 95.00% 4.35 0.501 2.28 831.4398 1,660.86 1,660.87 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% ISSVPAINNRLEHLYLNNNSIEK 95.00% 2.83 0.521 1.4 880.4712 2,638.39 2,638.40 3
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% EcYcPPDFPSALYcDSR 95.00% 4.7 0.649 5.47 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,068.92 2,135.83 2,136.85 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% EcYcPPDFPSALYcDSR 95.00% 4.69 0.568 5.77 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.84 2,136.85 2
 SAMPLE 2 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 12 15 53 42.40% EcYcPPDFPSALYcDSR 95.00% 4.6 0.581 5.32 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.84 2,136.85 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NLMQLNLAHNILR 95.00% 2.47 0.251 0 517.291 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NLMQLNLAHNILR 95.00% 2.6 0.257 0 517.2914 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NLmQLNLAHNILR 95.00% 2.14 0.255 0 m3: Oxidation (+15.99) 522.6224 1,564.84 1,565.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NLmQLNLAHNILR 95.00% 2.43 0.214 0 m3: Oxidation (+15.99) 522.9583 1,565.85 1,565.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LEHLYLNNNSIEK 95.00% 3.78 0.219 0 529.6103 1,585.81 1,586.82 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LEHLYLNNNSIEK 95.00% 3.25 0.255 0 529.6105 1,585.81 1,586.82 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LENLLLLDLQHNR 95.00% 4.17 0.515 2.28 530.9677 1,589.88 1,590.90 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LENLLLLDLQHNR 95.00% 3.9 0.459 1.19 530.9691 1,589.88 1,590.90 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LENLLLLDLQHNR 95.00% 3.78 0.489 1.4 530.9692 1,589.88 1,590.90 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LENLLLLDLQHNR 95.00% 4.35 0.506 2.08 530.9695 1,589.89 1,590.90 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LENLLLLDLQHNR 95.00% 4.07 0.493 1.12 530.9698 1,589.89 1,590.90 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LENLLLLDLQHNR 95.00% 3.98 0.409 1.05 530.9703 1,589.89 1,590.90 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LENLLLLDLQHNR 95.00% 3.83 0.419 1.41 531.3032 1,590.89 1,590.90 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% SFPNLAFIR 95.00% 2.09 0.251 1.49 532.7968 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% SFPNLAFIR 95.00% 2.51 0.175 1.77 532.7969 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% SFPNLAFIR 95.00% 2.21 0.199 1.17 532.797 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% SFPNLAFIR 95.00% 2.59 0.137 1.42 532.7972 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% SFPNLAFIR 95.00% 2.67 0.181 1.57 532.7973 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% SFPNLAFIR 95.00% 2.36 0.237 0 532.7975 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% SFPNLAFIR 95.00% 2.19 0.246 0 532.7975 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% SFPNLAFIR 95.00% 1.91 0.291 1.96 532.7976 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% SFPNLAFIR 95.00% 2.58 0.216 0 532.7976 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% SFPNLAFIR 95.00% 2.13 0.21 1.48 532.7978 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% SFPNLAFIR 95.00% 2.6 0.209 1.2 532.7979 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 3.06 0.508 1.17 533.6194 1,597.83 1,598.85 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 3.49 0.577 1.57 533.6219 1,597.84 1,598.85 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 2.82 0.45 1.82 533.6221 1,597.84 1,598.85 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 3.79 0.573 1.17 533.6223 1,597.84 1,598.85 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 2.92 0.508 1.64 533.6225 1,597.84 1,598.85 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 2.69 0.551 1.02 533.6229 1,597.85 1,598.85 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 4.07 0.489 1.17 533.9554 1,598.84 1,598.85 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 2.53 0.473 1.6 533.9556 1,598.84 1,598.85 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 3.2 0.336 1 533.957 1,598.85 1,598.85 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LSDGVFKPDTFHGLK 95.00% 3.15 0.287 0 553.9498 1,658.83 1,660.87 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LSDGVFKPDTFHGLK 95.00% 3.29 0.413 0 553.9499 1,658.83 1,660.87 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LSDGVFKPDTFHGLK 95.00% 3.63 0.527 2.38 554.2939 1,659.86 1,660.87 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LSDGVFKPDTFHGLK 95.00% 3.66 0.45 1.31 554.2946 1,659.86 1,660.87 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LSDGVFKPDTFHGLK 95.00% 3.03 0.515 1.55 554.6282 1,660.86 1,660.87 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% IETIPNGYFK 95.00% 2.38 0.142 1.32 591.313 1,180.61 1,181.62 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% IETIPNGYFK 95.00% 2.28 0.245 1.31 591.3134 1,180.61 1,181.62 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% IETIPNGYFK 95.00% 2.38 0.263 1.22 591.3134 1,180.61 1,181.62 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VLEKLPGLVFLYMEK 95.00% 3.57 0.487 1.15 593.6749 1,778.00 1,779.01 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VLEKLPGLVFLYMEK 95.00% 3.91 0.432 0 594.0085 1,779.00 1,779.01 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VLEKLPGLVFLYMEK 95.00% 2.4 0.249 0 594.0093 1,779.00 1,779.01 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VLEKLPGLVFLYMEK 95.00% 4.36 0.472 0 594.0098 1,779.01 1,779.01 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VLEKLPGLVFLYMEK 95.00% 3.06 0.358 0 594.0103 1,779.01 1,779.01 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LPGLVFLYMEK 95.00% 3.9 0.509 3.49 655.364 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LPGLVFLYMEK 95.00% 3.77 0.464 3.21 655.3646 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LPGLVFLYMEK 95.00% 3.52 0.492 3.48 655.3647 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LPGLVFLYMEK 95.00% 3.59 0.437 4 655.3647 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LPGLVFLYMEK 95.00% 4.01 0.504 3.05 655.3647 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LPGLVFLYMEK 95.00% 3.68 0.456 3.12 655.3667 1,308.72 1,309.72 2 SEP11_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LPGLVFLYmEK 95.00% 3 0.553 3.82 m9: Oxidation (+15.99) 663.3612 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LPGLVFLYmEK 95.00% 2.96 0.425 3.13 m9: Oxidation (+15.99) 663.3626 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NQLEEVPSALPR 95.00% 3.16 0.345 2.96 676.8507 1,351.69 1,352.72 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NQLEEVPSALPR 95.00% 2.69 0.289 1.7 676.8596 1,351.70 1,352.72 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NQLEEVPSALPR 95.00% 4.53 0.453 3 676.8611 1,351.71 1,352.72 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NQLEEVPSALPR 95.00% 4.45 0.514 3.13 676.8612 1,351.71 1,352.72 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NQLEEVPSALPR 95.00% 4.71 0.436 3.64 676.8613 1,351.71 1,352.72 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NQLEEVPSALPR 95.00% 3.13 0.489 3 676.8614 1,351.71 1,352.72 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NQLEEVPSALPR 95.00% 4.42 0.509 3.31 676.8618 1,351.71 1,352.72 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NQLEEVPSALPR 95.00% 3.89 0.492 3.37 676.8626 1,351.71 1,352.72 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NLMQLNLAHNILR 95.00% 4.62 0.498 4.41 775.4339 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% NLMQLNLAHNILR 95.00% 4.47 0.478 4.02 775.4342 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LEHLYLNNNSIEK 95.00% 4.15 0.478 3.05 793.9131 1,585.81 1,586.82 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LEHLYLNNNSIEK 95.00% 4.05 0.411 2.8 793.9132 1,585.81 1,586.82 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LEHLYLNNNSIEK 95.00% 3.84 0.418 3.11 793.9148 1,585.81 1,586.82 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LEHLYLNNNSIEK 95.00% 4.12 0.438 2.72 793.9179 1,585.82 1,586.82 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LENLLLLDLQHNR 95.00% 4.57 0.513 2.68 795.9495 1,589.88 1,590.90 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LENLLLLDLQHNR 95.00% 4.84 0.515 2.64 795.951 1,589.89 1,590.90 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LENLLLLDLQHNR 95.00% 4.38 0.51 2.48 795.9512 1,589.89 1,590.90 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LENLLLLDLQHNR 95.00% 4.58 0.48 2.96 795.9512 1,589.89 1,590.90 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LENLLLLDLQHNR 95.00% 4.05 0.513 2.42 796.452 1,590.89 1,590.90 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 5.52 0.578 6.85 799.9297 1,597.84 1,598.85 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 5.15 0.545 5.23 799.9301 1,597.84 1,598.85 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 5.1 0.556 5.38 800.4337 1,598.85 1,598.85 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VPTAIHQLYLDSNK 95.00% 5.07 0.529 5.16 800.4338 1,598.85 1,598.85 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LSDGVFKPDTFHGLK 95.00% 4.64 0.488 2.82 830.9362 1,659.86 1,660.87 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LSDGVFKPDTFHGLK 95.00% 4.21 0.483 2.89 830.9362 1,659.86 1,660.87 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LSDGVFKPDTFHGLK 95.00% 4.36 0.492 4.46 831.4379 1,660.86 1,660.87 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% LSDGVFKPDTFHGLK 95.00% 4.54 0.509 2.7 831.4395 1,660.86 1,660.87 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% ISSVPAINNRLEHLYLNNNSIEK 95.00% 3.07 0.487 1.74 880.4717 2,638.39 2,638.40 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% ISSVPAINNRLEHLYLNNNSIEK 95.00% 3.17 0.362 1.08 880.4726 2,638.39 2,638.40 3
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VLEKLPGLVFLYMEK 95.00% 4.23 0.548 4.92 890.0083 1,778.00 1,779.01 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% VLEKLPGLVFLYMEK 95.00% 4.79 0.573 5.31 890.5089 1,779.00 1,779.01 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% EcYcPPDFPSALYcDSR 95.00% 4.47 0.65 5.64 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.42 2,136.83 2,136.85 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% EcYcPPDFPSALYcDSR 95.00% 4.71 0.651 5.35 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.83 2,136.85 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% EcYcPPDFPSALYcDSR 95.00% 4.54 0.607 4.57 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.84 2,136.85 2
 SAMPLE 2R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 10 15 72 36.90% EcYcPPDFPSALYcDSR 95.00% 4.4 0.499 4.77 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.84 2,136.85 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 2.02 0.195 0 451.5786 1,351.71 1,352.72 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NLMQLNLAHNILR 95.00% 2.13 0.203 0 517.2911 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NLMQLNLAHNILR 95.00% 2.04 0.25 0 517.2912 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NLMQLNLAHNILR 95.00% 2.26 0.186 0 517.2914 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NLMQLNLAHNILR 95.00% 2.82 0.469 0 517.2919 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NLMQLNLAHNILR 95.00% 2.91 0.436 1.41 517.292 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% WINLDNNR 95.00% 2.6 0.193 0 522.7638 1,043.51 1,044.52 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% WINLDNNR 95.00% 2.51 0.176 0 522.7639 1,043.51 1,044.52 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NLmQLNLAHNILR 95.00% 3.21 0.444 0 m3: Oxidation (+15.99) 522.9562 1,565.85 1,565.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LENLLLLDLQHNR 95.00% 4.17 0.465 2.09 530.9686 1,589.88 1,590.90 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LENLLLLDLQHNR 95.00% 3.89 0.456 2.02 530.9691 1,589.88 1,590.90 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LENLLLLDLQHNR 95.00% 4 0.469 2.28 530.9694 1,589.88 1,590.90 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LENLLLLDLQHNR 95.00% 3.58 0.444 1.43 530.9695 1,589.89 1,590.90 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LENLLLLDLQHNR 95.00% 3.95 0.469 1.74 530.9698 1,589.89 1,590.90 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LENLLLLDLQHNR 95.00% 3.58 0.492 1.89 530.9698 1,589.89 1,590.90 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LENLLLLDLQHNR 95.00% 3.42 0.356 0 530.9699 1,589.89 1,590.90 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LENLLLLDLQHNR 95.00% 3.41 0.531 0 530.9702 1,589.89 1,590.90 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% SFPNLAFIR 95.00% 2 0.15 1.15 532.7957 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% SFPNLAFIR 95.00% 2.47 0.253 1.25 532.7966 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% SFPNLAFIR 95.00% 2.7 0.227 1.33 532.7975 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% SFPNLAFIR 95.00% 2.15 0.261 1.17 532.7975 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% SFPNLAFIR 95.00% 2.63 0.24 1.3 532.7976 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% SFPNLAFIR 95.00% 2.62 0.156 2.28 532.7978 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% SFPNLAFIR 95.00% 2.69 0.202 1.64 532.7978 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% SFPNLAFIR 95.00% 2.41 0.238 2.11 532.7978 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% SFPNLAFIR 95.00% 2.52 0.205 1.85 532.7979 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% VPTAIHQLYLDSNK 95.00% 3.99 0.559 0 533.6206 1,597.84 1,598.85 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% VPTAIHQLYLDSNK 95.00% 3.95 0.578 1.01 533.6218 1,597.84 1,598.85 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% VPTAIHQLYLDSNK 95.00% 3.24 0.609 2.26 533.6223 1,597.84 1,598.85 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% VPTAIHQLYLDSNK 95.00% 3.38 0.553 2 533.9563 1,598.85 1,598.85 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% ISSVPAINNR 95.00% 2.69 0.344 2.54 535.7995 1,069.58 1,070.60 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% ISSVPAINNR 95.00% 2.48 0.311 2 535.8003 1,069.58 1,070.60 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LSDGVFKPDTFHGLK 95.00% 2.68 0.308 0 554.2935 1,659.86 1,660.87 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LSDGVFKPDTFHGLK 95.00% 3 0.303 0 554.2939 1,659.86 1,660.87 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LSDGVFKPDTFHGLK 95.00% 3.53 0.473 1.7 554.2944 1,659.86 1,660.87 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LSDGVFKPDTFHGLK 95.00% 3.8 0.526 1.7 554.2946 1,659.86 1,660.87 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% IETIPNGYFK 95.00% 2.74 0.298 2.66 591.3128 1,180.61 1,181.62 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% IETIPNGYFK 95.00% 2.68 0.328 1.48 591.313 1,180.61 1,181.62 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% IETIPNGYFK 95.00% 2.69 0.281 1.17 591.3133 1,180.61 1,181.62 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% IETIPNGYFK 95.00% 2.45 0.292 0 591.3135 1,180.61 1,181.62 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 2.45 0.284 1.4 676.8602 1,351.70 1,352.72 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 3.54 0.464 2.28 676.8609 1,351.71 1,352.72 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 3.35 0.481 2.2 676.8611 1,351.71 1,352.72 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 2.38 0.344 0 676.8612 1,351.71 1,352.72 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 4.12 0.471 2.6 676.8614 1,351.71 1,352.72 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 4.23 0.472 2.6 676.8615 1,351.71 1,352.72 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 4 0.486 2.48 676.8617 1,351.71 1,352.72 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 4.1 0.457 2.96 676.8617 1,351.71 1,352.72 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 2.32 0.256 1.89 676.8618 1,351.71 1,352.72 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 2.37 0.277 2.89 676.862 1,351.71 1,352.72 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 2.17 0.276 0 676.8628 1,351.71 1,352.72 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NQLEEVPSALPR 95.00% 0 0 3.48 677.9865 1,353.96 1,352.72 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NLMQLNLAHNILR 95.00% 4.19 0.45 4.22 775.4344 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NLMQLNLAHNILR 95.00% 4.64 0.464 3.21 775.4344 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NLMQLNLAHNILR 95.00% 4.7 0.48 3.8 775.4351 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% NLMQLNLAHNILR 95.00% 4.54 0.45 4.2 775.9361 1,549.86 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LENLLLLDLQHNR 95.00% 4.73 0.488 3.11 795.9499 1,589.88 1,590.90 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LENLLLLDLQHNR 95.00% 4.46 0.528 2.8 795.9503 1,589.89 1,590.90 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LENLLLLDLQHNR 95.00% 4.32 0.57 2 795.9511 1,589.89 1,590.90 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LENLLLLDLQHNR 95.00% 4.57 0.51 2.39 796.453 1,590.89 1,590.90 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% VPTAIHQLYLDSNK 95.00% 4.21 0.548 7.2 799.93 1,597.84 1,598.85 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% VPTAIHQLYLDSNK 95.00% 5.34 0.56 5.85 799.93 1,597.84 1,598.85 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% VPTAIHQLYLDSNK 95.00% 5.38 0.548 5.21 799.9302 1,597.84 1,598.85 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% VPTAIHQLYLDSNK 95.00% 4.44 0.469 4.74 800.4308 1,598.85 1,598.85 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% VPTAIHQLYLDSNK 95.00% 5.31 0.551 5.37 800.4319 1,598.85 1,598.85 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% VPTAIHQLYLDSNK 95.00% 4.66 0.464 5.85 800.4333 1,598.85 1,598.85 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LSDGVFKPDTFHGLK 95.00% 4.01 0.515 2.04 830.9362 1,659.86 1,660.87 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LSDGVFKPDTFHGLK 95.00% 4.59 0.526 2.89 830.9373 1,659.86 1,660.87 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% LSDGVFKPDTFHGLK 95.00% 4.48 0.484 3.31 830.9386 1,659.86 1,660.87 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% ISSVPAINNRLEHLYLNNNSIEK 95.00% 3.17 0.481 1.89 880.4691 2,638.38 2,638.40 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% VPTAIHQLYLDSNKIETIPNGYFK 95.00% 6.49 0.622 4.54 921.4894 2,761.44 2,761.46 3
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% EcYcPPDFPSALYcDSR 95.00% 4.66 0.612 5.1 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.84 2,136.85 2
 SAMPLE 3 Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 9 13 52 35.10% EcYcPPDFPSALYcDSR 95.00% 4.57 0.582 4.16 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.84 2,136.85 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NLMQLNLAHNILR 95.00% 2.21 0.195 0 517.291 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NLMQLNLAHNILR 95.00% 2.06 0.212 0 517.2912 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NLMQLNLAHNILR 95.00% 2.89 0.448 0 517.2917 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NLMQLNLAHNILR 95.00% 2.82 0.409 0.959 517.2922 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NLMQLNLAHNILR 95.00% 2.24 0.33 0 517.2924 1,548.85 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NLMQLNLAHNILR 95.00% 2.18 0.364 0 517.2929 1,548.86 1,549.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NLmQLNLAHNILR 95.00% 2.24 0.22 0 m3: Oxidation (+15.99) 522.6242 1,564.85 1,565.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NLmQLNLAHNILR 95.00% 2.09 0.199 0 m3: Oxidation (+15.99) 522.7628 1,565.27 1,565.86 3 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% WINLDNNR 95.00% 2.52 0.18 0 522.7641 1,043.51 1,044.52 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LEHLYLNNNSIEK 95.00% 4.05 0.342 0 529.6099 1,585.81 1,586.82 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LEHLYLNNNSIEK 95.00% 4.46 0.37 1.59 529.6103 1,585.81 1,586.82 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LENLLLLDLQHNR 95.00% 3.29 0.496 0 530.9689 1,589.88 1,590.90 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LENLLLLDLQHNR 95.00% 3.89 0.432 1.74 530.9689 1,589.88 1,590.90 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LENLLLLDLQHNR 95.00% 4.45 0.443 1.7 530.9693 1,589.88 1,590.90 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LENLLLLDLQHNR 95.00% 3.83 0.453 2.21 530.9694 1,589.88 1,590.90 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LENLLLLDLQHNR 95.00% 4.27 0.477 1.96 530.9697 1,589.89 1,590.90 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LENLLLLDLQHNR 95.00% 4.16 0.435 1.59 530.9698 1,589.89 1,590.90 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LENLLLLDLQHNR 95.00% 3.94 0.463 1.34 531.3023 1,590.88 1,590.90 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LENLLLLDLQHNR 95.00% 3.44 0.428 0 531.3043 1,590.89 1,590.90 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% SFPNLAFIR 95.00% 2.17 0.227 1.4 532.7959 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% SFPNLAFIR 95.00% 1.99 0.254 1.59 532.7967 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% SFPNLAFIR 95.00% 1.98 0.271 1.64 532.7971 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% SFPNLAFIR 95.00% 2.59 0.151 0 532.7972 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% SFPNLAFIR 95.00% 2.49 0.203 1.89 532.7973 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% SFPNLAFIR 95.00% 2.42 0.274 0 532.7976 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% SFPNLAFIR 95.00% 2.72 0.136 1.66 532.7977 1,063.58 1,064.59 2 TENX_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VPTAIHQLYLDSNK 95.00% 4.05 0.605 1.74 533.6208 1,597.84 1,598.85 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VPTAIHQLYLDSNK 95.00% 2.91 0.432 1 533.6215 1,597.84 1,598.85 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VPTAIHQLYLDSNK 95.00% 3.22 0.412 0.959 533.6217 1,597.84 1,598.85 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VPTAIHQLYLDSNK 95.00% 3.45 0.537 1.59 533.6217 1,597.84 1,598.85 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VPTAIHQLYLDSNK 95.00% 3.6 0.569 2.21 533.6221 1,597.84 1,598.85 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% ISSVPAINNR 95.00% 2.6 0.319 1.43 535.7998 1,069.58 1,070.60 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% ISSVPAINNR 95.00% 2.35 0.261 1.13 535.8001 1,069.58 1,070.60 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LSDGVFKPDTFHGLK 95.00% 3.85 0.371 0 553.9495 1,658.83 1,660.87 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LSDGVFKPDTFHGLK 95.00% 3.65 0.256 0 553.9501 1,658.83 1,660.87 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LSDGVFKPDTFHGLK 95.00% 3.27 0.473 1.41 554.2944 1,659.86 1,660.87 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LSDGVFKPDTFHGLK 95.00% 2.54 0.401 0 554.6271 1,660.86 1,660.87 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LSDGVFKPDTFHGLK 95.00% 3.91 0.514 1.26 554.6285 1,660.86 1,660.87 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LSDGVFKPDTFHGLK 95.00% 2.58 0.178 0 554.6291 1,660.86 1,660.87 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% IETIPNGYFK 95.00% 1.94 0.304 0 591.3106 1,180.61 1,181.62 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% IETIPNGYFK 95.00% 2.02 0.276 0 591.3114 1,180.61 1,181.62 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% IETIPNGYFK 95.00% 2.71 0.333 2.55 591.3119 1,180.61 1,181.62 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% IETIPNGYFK 95.00% 2.6 0.248 1.16 591.3125 1,180.61 1,181.62 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% IETIPNGYFK 95.00% 2.69 0.36 1.19 591.313 1,180.61 1,181.62 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% IETIPNGYFK 95.00% 2.69 0.358 1.96 591.3134 1,180.61 1,181.62 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VLEKLPGLVFLYMEK 95.00% 2.07 0.314 0 593.3348 1,776.98 1,779.01 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VLEKLPGLVFLYMEK 95.00% 3.19 0.392 1.17 593.6743 1,778.00 1,779.01 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VLEKLPGLVFLYMEK 95.00% 4.36 0.513 1.96 593.6751 1,778.00 1,779.01 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VLEKLPGLVFLYMEK 95.00% 2.54 0.288 0 593.6754 1,778.00 1,779.01 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VLEKLPGLVFLYMEK 95.00% 3.2 0.365 1.55 594.0089 1,779.00 1,779.01 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VLEKLPGLVFLYMEK 95.00% 4.99 0.473 1.89 594.0096 1,779.01 1,779.01 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LPGLVFLYMEK 95.00% 2.11 0.32 2.25 655.3627 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LPGLVFLYMEK 95.00% 2.86 0.365 4.15 655.3634 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LPGLVFLYMEK 95.00% 4.14 0.509 2.48 655.3637 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LPGLVFLYMEK 95.00% 3.89 0.473 2.13 655.3643 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LPGLVFLYMEK 95.00% 2.45 0.431 2.89 655.3644 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LPGLVFLYMEK 95.00% 4.12 0.514 3.06 655.3645 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LPGLVFLYMEK 95.00% 3.81 0.487 3.29 655.3649 1,308.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LPGLVFLYMEK 95.00% 3.19 0.493 2.89 655.8637 1,309.71 1,309.72 2 SEP11_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LPGLVFLYmEK 95.00% 2.4 0.439 2.42 m9: Oxidation (+15.99) 663.3611 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LPGLVFLYmEK 95.00% 2.52 0.438 1.4 m9: Oxidation (+15.99) 663.3615 1,324.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LPGLVFLYmEK 95.00% 3.35 0.534 3.41 m9: Oxidation (+15.99) 663.8633 1,325.71 1,325.72 2 SEP11_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NQLEEVPSALPR 95.00% 2.64 0.39 1.64 676.8596 1,351.70 1,352.72 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NQLEEVPSALPR 95.00% 2.69 0.445 1.85 676.8603 1,351.70 1,352.72 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NQLEEVPSALPR 95.00% 2.86 0.382 2.06 676.8606 1,351.71 1,352.72 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NQLEEVPSALPR 95.00% 2.91 0.386 1.72 676.8612 1,351.71 1,352.72 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NQLEEVPSALPR 95.00% 4.12 0.461 3.51 676.8614 1,351.71 1,352.72 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NQLEEVPSALPR 95.00% 4.09 0.475 3 676.8615 1,351.71 1,352.72 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NQLEEVPSALPR 95.00% 4.43 0.489 3.2 676.8616 1,351.71 1,352.72 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NQLEEVPSALPR 95.00% 3.95 0.477 2.74 676.8616 1,351.71 1,352.72 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NQLEEVPSALPR 95.00% 3.26 0.485 2.41 676.8621 1,351.71 1,352.72 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NQLEEVPSALPR 95.00% 3.33 0.476 1.66 676.8622 1,351.71 1,352.72 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NQLEEVPSALPR 95.00% 2.39 0.379 2.2 676.8625 1,351.71 1,352.72 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% MPPRVPTAIHQLYLDSNK 95.00% 4.2 0.519 3.77 694.3727 2,080.09 2,080.10 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NLMQLNLAHNILR 95.00% 4.45 0.447 5.02 775.4336 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NLMQLNLAHNILR 95.00% 4.64 0.478 4.85 775.4342 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NLMQLNLAHNILR 95.00% 4.28 0.41 3.14 775.4342 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% NLMQLNLAHNILR 95.00% 4.63 0.451 4.07 775.4347 1,548.85 1,549.86 2 MYH9_HUMAN,SPON1_HUMAN,TAGL_HUMAN,MYH10_HUMAN
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LENLLLLDLQHNR 95.00% 4.31 0.506 2.72 795.9489 1,589.88 1,590.90 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LENLLLLDLQHNR 95.00% 4.57 0.493 2.72 795.9515 1,589.89 1,590.90 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LENLLLLDLQHNR 95.00% 4.35 0.509 2.09 795.9518 1,589.89 1,590.90 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LENLLLLDLQHNR 95.00% 4.6 0.518 2.4 796.451 1,590.89 1,590.90 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VPTAIHQLYLDSNK 95.00% 4.98 0.573 7.54 799.9298 1,597.84 1,598.85 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VPTAIHQLYLDSNK 95.00% 5.38 0.582 6.17 799.9312 1,597.85 1,598.85 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VPTAIHQLYLDSNK 95.00% 4.98 0.565 5.17 799.9312 1,597.85 1,598.85 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LSDGVFKPDTFHGLK 95.00% 4.59 0.474 2.77 830.9378 1,659.86 1,660.87 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LSDGVFKPDTFHGLK 95.00% 4.61 0.518 2.77 830.9388 1,659.86 1,660.87 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% LSDGVFKPDTFHGLK 95.00% 3.79 0.484 1.7 830.9419 1,659.87 1,660.87 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% ISSVPAINNRLEHLYLNNNSIEK 95.00% 3.35 0.498 0 880.4698 2,638.39 2,638.40 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VLEKLPGLVFLYMEK 95.00% 4.55 0.498 5.48 890.0079 1,778.00 1,779.01 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VLEKLPGLVFLYMEK 95.00% 3.75 0.153 2.12 890.0116 1,778.01 1,779.01 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VLEKLPGLVFLYMEK 95.00% 4.64 0.563 6.85 890.5102 1,779.00 1,779.01 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% VPTAIHQLYLDSNKIETIPNGYFK 95.00% 6.52 0.641 3.22 921.4897 2,761.45 2,761.46 3
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% EcYcPPDFPSALYcDSR 95.00% 4.59 0.566 5.54 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.84 2,136.85 2
 SAMPLE 3R Prolargin  PRELP  PRELP_HUMAN 43,794.40 100.00% 13 17 74 40.10% EcYcPPDFPSALYcDSR 95.00% 4.75 0.62 4.47 c2: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 1,069.43 2,136.84 2,136.85 2
 SAMPLE 1 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.52% LDGLcIPLR 95.00% 2.95 0.345 0 c5: Carbamidomethyl (+57.02) 528.7962 1,055.58 1,056.59 2
 SAMPLE 1 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.52% LDGLcIPLR 95.00% 3.01 0.354 0 c5: Carbamidomethyl (+57.02) 528.7962 1,055.58 1,056.59 2
 SAMPLE 1 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.52% GDYSVLVPGLR 95.00% 2.44 0.222 0 588.325 1,174.63 1,175.64 2
 SAMPLE 1 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.52% NVIALAFDYR 95.00% 2.84 0.479 2.21 591.318 1,180.62 1,181.63 2
 SAMPLE 1 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.52% NVIALAFDYR 95.00% 2.5 0.463 1.39 591.847 1,181.68 1,181.63 2
 SAMPLE 1 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.52% GPVGLAIDFPESK 95.00% 3.42 0.534 4.01 665.3546 1,328.69 1,329.71 2
 SAMPLE 1 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.52% GPVGLAIDFPESK 95.00% 3.86 0.551 5.23 665.3557 1,328.70 1,329.71 2
 SAMPLE 1 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.52% cPLNYFAcPSGR 95.00% 1.98 0.263 1.64 c1: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 721.3222 1,440.63 1,441.64 2
 SAMPLE 1 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.52% AVTDEEPFLIFANR 95.00% 4.17 0.533 3 811.4138 1,620.81 1,621.82 2
 SAMPLE 1R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 9 1.32% IVFPHGITLDLVSR 95.00% 2.4 0.332 0 522.9707 1,565.89 1,566.90 3
 SAMPLE 1R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 9 1.32% LDGLcIPLR 95.00% 1.9 0.315 0 c5: Carbamidomethyl (+57.02) 528.794 1,055.57 1,056.59 2
 SAMPLE 1R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 9 1.32% LDGLcIPLR 95.00% 2.85 0.342 1.55 c5: Carbamidomethyl (+57.02) 528.7949 1,055.57 1,056.59 2
 SAMPLE 1R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 9 1.32% LDGLcIPLR 95.00% 2.93 0.319 0 c5: Carbamidomethyl (+57.02) 528.7962 1,055.58 1,056.59 2
 SAMPLE 1R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 9 1.32% NVIALAFDYR 95.00% 2.87 0.563 2.54 591.3189 1,180.62 1,181.63 2
 SAMPLE 1R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 9 1.32% NVIALAFDYR 95.00% 2.9 0.513 2.32 591.32 1,180.62 1,181.63 2
 SAMPLE 1R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 9 1.32% GPVGLAIDFPESK 95.00% 3.34 0.516 5.15 665.3552 1,328.69 1,329.71 2
 SAMPLE 1R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 9 1.32% GPVGLAIDFPESK 95.00% 3.14 0.323 0 665.3553 1,328.70 1,329.71 2
 SAMPLE 1R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 9 1.32% AVTDEEPFLIFANR 95.00% 2.79 0.347 1.32 811.4131 1,620.81 1,621.82 2
 SAMPLE 2 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 6 1.43% IVFPHGITLDLVSR 95.00% 4.21 0.512 1.09 522.971 1,565.89 1,566.90 3
 SAMPLE 2 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 6 1.43% LDGLcIPLR 95.00% 3.25 0.325 0 c5: Carbamidomethyl (+57.02) 528.7967 1,055.58 1,056.59 2
 SAMPLE 2 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 6 1.43% LDGLcIPLR 95.00% 3.17 0.342 1.23 c5: Carbamidomethyl (+57.02) 528.7968 1,055.58 1,056.59 2
 SAMPLE 2 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 6 1.43% ITIVENVGSVEGLAYHR 95.00% 2.92 0.415 1.06 620 1,856.98 1,856.99 3
 SAMPLE 2 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 6 1.43% GPVGLAIDFPESK 95.00% 3.18 0.52 3.82 665.356 1,328.70 1,329.71 2
 SAMPLE 2 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 5 5 6 1.43% cPLNYFAcPSGR 95.00% 2.41 0.359 2.28 c1: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 721.3201 1,440.62 1,441.64 2
 SAMPLE 2R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.69% IVFPHGITLDLVSR 95.00% 3.03 0.34 0 522.97 1,565.89 1,566.90 3
 SAMPLE 2R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.69% LDGLcIPLR 95.00% 2.91 0.305 0 c5: Carbamidomethyl (+57.02) 528.7953 1,055.57 1,056.59 2
 SAMPLE 2R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.69% LDGLcIPLR 95.00% 3.13 0.334 1.22 c5: Carbamidomethyl (+57.02) 528.7957 1,055.58 1,056.59 2
 SAMPLE 2R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.69% NVIALAFDYR 95.00% 2.82 0.545 2.77 591.3185 1,180.62 1,181.63 2
 SAMPLE 2R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.69% NVIALAFDYR 95.00% 2.46 0.504 1.92 591.3195 1,180.62 1,181.63 2
 SAMPLE 2R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.69% AALSGANVLTLIEKDIR 95.00% 2.25 0.28 0 595.3495 1,783.03 1,784.03
 SAMPLE 2R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.69% GPVGLAIDFPESK 95.00% 3.36 0.556 2.47 665.3551 1,328.69 1,329.71 2
 SAMPLE 2R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.69% AVTDEEPFLIFANR 95.00% 2.79 0.197 0 811.4165 1,620.82 1,621.82 2
 SAMPLE 2R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 6 6 9 1.69% AVTDEEPFLIFANR 95.00% 4.42 0.59 4.55 811.9149 1,621.81 1,621.82 2
 SAMPLE 3 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 99.80% 2 2 3 0.57% LDGLcIPLR 95.00% 2.94 0.35 0 c5: Carbamidomethyl (+57.02) 528.7964 1,055.58 1,056.59 2
 SAMPLE 3 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 99.80% 2 2 3 0.57% LDGLcIPLR 95.00% 2.74 0.333 1.55 c5: Carbamidomethyl (+57.02) 528.7968 1,055.58 1,056.59 2
 SAMPLE 3 Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 99.80% 2 2 3 0.57% ITIVENVGSVEGLAYHR 95.00% 2.67 0.193 0 620.0018 1,856.98 1,856.99 3
 SAMPLE 3R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 4 4 7 1.03% LDGLcIPLR 95.00% 2.85 0.29 0 c5: Carbamidomethyl (+57.02) 528.7946 1,055.57 1,056.59 2
 SAMPLE 3R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 4 4 7 1.03% LDGLcIPLR 95.00% 2.72 0.247 0 c5: Carbamidomethyl (+57.02) 528.7954 1,055.58 1,056.59 2
 SAMPLE 3R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 4 4 7 1.03% GDYSVLVPGLR 95.00% 2.36 0.322 0 588.8241 1,175.63 1,175.64 2
 SAMPLE 3R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 4 4 7 1.03% GPVGLAIDFPESK 95.00% 2.24 0.358 0 665.3549 1,328.69 1,329.71 2
 SAMPLE 3R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 4 4 7 1.03% GPVGLAIDFPESK 95.00% 2.79 0.52 2.46 665.3559 1,328.70 1,329.71 2
 SAMPLE 3R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 4 4 7 1.03% AVTDEEPFLIFANR 95.00% 2.66 0.331 1.38 811.4145 1,620.81 1,621.82 2
 SAMPLE 3R Prolow-density lipoprotein receptor-related protein 1  LRP1  LRP1_HUMAN 504,542.80 100.00% 4 4 7 1.03% AVTDEEPFLIFANR 95.00% 3 0.313 0 811.4164 1,620.82 1,621.82 2
 SAMPLE 3 Properdin  CFP  PROP_HUMAN 51,256.10 100.00% 3 4 5 9.38% HcYSIQHcPLK 95.00% 4.31 0.455 0.959 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 481.5597 1,441.66 1,442.67 3
 SAMPLE 3 Properdin  CFP  PROP_HUMAN 51,256.10 100.00% 3 4 5 9.38% HcYSIQHcPLK 95.00% 3.68 0.337 0 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 481.5603 1,441.66 1,442.67 3
 SAMPLE 3 Properdin  CFP  PROP_HUMAN 51,256.10 100.00% 3 4 5 9.38% HcYSIQHcPLK 95.00% 2.86 0.543 2.85 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02) 721.8334 1,441.65 1,442.67 2
 SAMPLE 3 Properdin  CFP  PROP_HUMAN 51,256.10 100.00% 3 4 5 9.38% TcNHPVPQHGGPFcAGDATR 95.00% 4.24 0.442 3.68 c2: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 727.3234 2,178.95 2,178.96 3
 SAMPLE 3 Properdin  CFP  PROP_HUMAN 51,256.10 100.00% 3 4 5 9.38% SIScQEIPGQQSR 95.00% 2.98 0.377 1.21 c4: Carbamidomethyl (+57.02) 745.3574 1,488.70 1,489.71 2
 SAMPLE 3R Properdin  CFP  PROP_HUMAN 51,256.10 99.80% 2 2 3 7.04% TcNHPVPQHGGPFcAGDATR 95.00% 4.17 0.452 4.48 c2: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 727.3243 2,178.95 2,178.96 3
 SAMPLE 3R Properdin  CFP  PROP_HUMAN 51,256.10 99.80% 2 2 3 7.04% TcNHPVPQHGGPFcAGDATR 95.00% 5.4 0.505 3.06 c2: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 727.3251 2,178.95 2,178.96 3
 SAMPLE 3R Properdin  CFP  PROP_HUMAN 51,256.10 99.80% 2 2 3 7.04% SIScQEIPGQQSR 95.00% 3.35 0.381 1.55 c4: Carbamidomethyl (+57.02) 745.3546 1,488.69 1,489.71 2
 SAMPLE 3R Proteasome subunit alpha type-2  PSMA2  PSA2_HUMAN 25,880.90 99.80% 2 2 3 12.00% GYSFSLTTFSPSGK 95.00% 3.31 0.342 0 739.862 1,477.71 1,478.72 2
 SAMPLE 3R Proteasome subunit alpha type-2  PSMA2  PSA2_HUMAN 25,880.90 99.80% 2 2 3 12.00% GYSFSLTTFSPSGK 95.00% 4.15 0.503 3.11 740.3634 1,478.71 1,478.72 2
 SAMPLE 3R Proteasome subunit alpha type-2  PSMA2  PSA2_HUMAN 25,880.90 99.80% 2 2 3 12.00% LTPTEVKDYLAAIA 95.00% 1.87 0.337 0 753.4176 1,504.82 1,504.83 2
 SAMPLE 2R Proteasome subunit alpha type-7-like  PSMA8  PSA7L_HUMAN,PSA7_HUMAN 28,512.20 99.80% 2 2 4 9.77% ALLEVVQSGGK 95.00% 3.08 0.427 1.64 550.8177 1,099.62 1,100.63 2
 SAMPLE 2R Proteasome subunit alpha type-7-like  PSMA8  PSA7L_HUMAN,PSA7_HUMAN 28,512.20 99.80% 2 2 4 9.77% ALLEVVQSGGK 95.00% 3.36 0.446 2.31 550.8184 1,099.62 1,100.63 2
 SAMPLE 2R Proteasome subunit alpha type-7-like  PSMA8  PSA7L_HUMAN,PSA7_HUMAN 28,512.20 99.80% 2 2 4 9.77% LTVEDPVTVEYITR 95.00% 2.85 0.488 7.2 817.9336 1,633.85 1,634.86 2
 SAMPLE 2R Proteasome subunit alpha type-7-like  PSMA8  PSA7L_HUMAN,PSA7_HUMAN 28,512.20 99.80% 2 2 4 9.77% LTVEDPVTVEYITR 95.00% 3.46 0.512 7.24 817.9363 1,633.86 1,634.86 2
 SAMPLE 3 Proteasome subunit beta type-5  PSMB5  PSB5_HUMAN 28,463.00 100.00% 2 3 5 10.30% DAYSGGAVNLYHVR 95.00% 1.94 0.262 0 507.9187 1,520.73 1,521.75 3
 SAMPLE 3 Proteasome subunit beta type-5  PSMB5  PSB5_HUMAN 28,463.00 100.00% 2 3 5 10.30% ATAGAYIASQTVK 95.00% 3.85 0.47 2.57 640.8448 1,279.67 1,280.69 2
 SAMPLE 3 Proteasome subunit beta type-5  PSMB5  PSB5_HUMAN 28,463.00 100.00% 2 3 5 10.30% ATAGAYIASQTVK 95.00% 3.26 0.485 3.82 640.8464 1,279.68 1,280.69 2
 SAMPLE 3 Proteasome subunit beta type-5  PSMB5  PSB5_HUMAN 28,463.00 100.00% 2 3 5 10.30% DAYSGGAVNLYHVR 95.00% 3.59 0.417 5.82 761.3745 1,520.73 1,521.75 2
 SAMPLE 3 Proteasome subunit beta type-5  PSMB5  PSB5_HUMAN 28,463.00 100.00% 2 3 5 10.30% DAYSGGAVNLYHVR 95.00% 3.86 0.456 6.28 761.3751 1,520.73 1,521.75 2
 SAMPLE 3R Proteasome subunit beta type-5  PSMB5  PSB5_HUMAN 28,463.00 99.80% 2 2 3 10.30% ATAGAYIASQTVK 95.00% 3.47 0.481 2.12 640.8435 1,279.67 1,280.69 2
 SAMPLE 3R Proteasome subunit beta type-5  PSMB5  PSB5_HUMAN 28,463.00 99.80% 2 2 3 10.30% ATAGAYIASQTVK 95.00% 3.62 0.54 3.23 640.8452 1,279.67 1,280.69 2
 SAMPLE 3R Proteasome subunit beta type-5  PSMB5  PSB5_HUMAN 28,463.00 99.80% 2 2 3 10.30% DAYSGGAVNLYHVR 95.00% 3.54 0.439 4.07 761.377 1,520.74 1,521.75 2
 SAMPLE 2 Proteasome subunit beta type-6  PSMB6  PSB6_HUMAN 25,339.90 99.80% 2 2 3 8.79% QVLLGDQIPK 95.00% 2.3 0.237 1.57 555.8286 1,109.64 1,110.65 2
 SAMPLE 2 Proteasome subunit beta type-6  PSMB6  PSB6_HUMAN 25,339.90 99.80% 2 2 3 8.79% LAAIAESGVER 95.00% 3.71 0.456 2.96 558.3052 1,114.59 1,115.61 2
 SAMPLE 2 Proteasome subunit beta type-6  PSMB6  PSB6_HUMAN 25,339.90 99.80% 2 2 3 8.79% LAAIAESGVER 95.00% 3.61 0.444 4.12 558.3055 1,114.60 1,115.61 2
 SAMPLE 2R Proteasome subunit beta type-6  PSMB6  PSB6_HUMAN 25,339.90 99.80% 2 2 3 8.79% QVLLGDQIPK 95.00% 2.11 0.327 0 555.8296 1,109.64 1,110.65 2
 SAMPLE 2R Proteasome subunit beta type-6  PSMB6  PSB6_HUMAN 25,339.90 99.80% 2 2 3 8.79% LAAIAESGVER 95.00% 3.06 0.417 2.64 558.3051 1,114.59 1,115.61 2
 SAMPLE 2R Proteasome subunit beta type-6  PSMB6  PSB6_HUMAN 25,339.90 99.80% 2 2 3 8.79% LAAIAESGVER 95.00% 3.53 0.437 3.43 558.3054 1,114.60 1,115.61 2
 SAMPLE 2R Protein AMBP  AMBP  AMBP_HUMAN 38,981.50 99.80% 2 2 2 10.20% ETLLQDFR 95.00% 2.5 0.158 0 511.2686 1,020.52 1,021.53 2
 SAMPLE 2R Protein AMBP  AMBP  AMBP_HUMAN 38,981.50 99.80% 2 2 2 10.20% ETLLQDFR 95.00% 2.15 0.139 1.27 511.2688 1,020.52 1,021.53 2
 SAMPLE 2R Protein AMBP  AMBP  AMBP_HUMAN 38,981.50 99.80% 2 2 2 10.20% TVAAcNLPIVR 95.00% 3.08 0.21 0 c5: Carbamidomethyl (+57.02) 607.8436 1,213.67 1,213.67 2
 SAMPLE 2R Protein AMBP  AMBP  AMBP_HUMAN 38,981.50 99.80% 2 2 2 10.20% GEcVPGEQEPEPILIPR 95.00% 4.02 0.506 4 c3: Carbamidomethyl (+57.02) 960.9812 1,919.95 1,919.95 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% FLQDYFDGNLKR 95.00% 2.39 0.271 0 505.9235 1,514.75 1,515.76 3
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% FLQDYFDGNLKR 95.00% 2.67 0.365 0 505.9238 1,514.75 1,515.76 3
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% YGVSGYPTLK 95.00% 3.33 0.466 3.36 542.7863 1,083.56 1,084.57 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% YGVSGYPTLK 95.00% 3.3 0.502 3.26 542.7868 1,083.56 1,084.57 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% IFRDGEEAGAYDGPR 95.00% 4.37 0.443 3.44 551.592 1,651.75 1,652.77 3
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% IFRDGEEAGAYDGPR 95.00% 4.37 0.487 2.82 551.5928 1,651.75 1,652.77 3
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% FVMQEEFSR 95.00% 2.14 0.355 0 587.2774 1,172.54 1,172.54 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% LAPEYEAAATR 95.00% 3.1 0.359 1.92 596.3029 1,190.59 1,191.60 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% LAPEYEAAATR 95.00% 3.04 0.373 2.46 596.3032 1,190.59 1,191.60 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% GFPTIYFSPANK 95.00% 2.97 0.45 1.28 671.3436 1,340.67 1,341.68 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% GFPTIYFSPANK 95.00% 2.34 0.394 0 671.3451 1,340.67 1,341.68 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% SEPIPESNDGPVK 95.00% 2.5 0.476 1.82 684.8343 1,367.65 1,368.66 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% SEPIPESNDGPVK 95.00% 2.85 0.545 3 684.8347 1,367.65 1,368.66 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% ELSDFISYLQR 95.00% 4.02 0.444 1.35 685.8493 1,369.68 1,370.70 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% ELSDFISYLQR 95.00% 3.87 0.4 1.59 685.8501 1,369.68 1,370.70 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% FLQDYFDGNLKR 95.00% 4.21 0.397 2.92 758.3829 1,514.75 1,515.76 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% FLQDYFDGNLKR 95.00% 4.11 0.288 2.27 758.8841 1,515.75 1,515.76 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% EATNPPVIQEEKPK 95.00% 3.64 0.399 3.72 790.4181 1,578.82 1,579.83 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% EATNPPVIQEEKPK 95.00% 3.48 0.427 2.57 790.4188 1,578.82 1,579.83 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% IFRDGEEAGAYDGPR 95.00% 3.86 0.479 2.14 826.8917 1,651.77 1,652.77 2
 SAMPLE 1 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 10 12 21 24.20% MDATANDVPSPYEVR 95.00% 3.88 0.411 3.2 832.8818 1,663.75 1,664.76 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% YGVSGYPTLK 95.00% 3.23 0.529 2.62 542.7863 1,083.56 1,084.57 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% YGVSGYPTLK 95.00% 3.28 0.521 1.96 542.7868 1,083.56 1,084.57 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% IFRDGEEAGAYDGPR 95.00% 4.53 0.495 3.6 551.5925 1,651.75 1,652.77 3
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% IFRDGEEAGAYDGPR 95.00% 4.46 0.451 2.89 551.5951 1,651.76 1,652.77 3
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% LAPEYEAAATR 95.00% 3.12 0.345 1.48 596.3028 1,190.59 1,191.60 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% LAPEYEAAATR 95.00% 2.89 0.331 2.08 596.3048 1,190.59 1,191.60 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% GFPTIYFSPANK 95.00% 3.36 0.369 0 671.3437 1,340.67 1,341.68 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% SEPIPESNDGPVK 95.00% 2.28 0.414 2.02 684.834 1,367.65 1,368.66 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% SEPIPESNDGPVK 95.00% 2.57 0.441 1.82 684.8344 1,367.65 1,368.66 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% ELSDFISYLQR 95.00% 3.79 0.394 2.09 685.8498 1,369.68 1,370.70 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% ELSDFISYLQR 95.00% 4.02 0.42 1.89 685.8499 1,369.68 1,370.70 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% FLQDYFDGNLKR 95.00% 3.91 0.367 2.52 758.3808 1,514.75 1,515.76 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% FLQDYFDGNLKR 95.00% 3.01 0.442 1.59 758.383 1,514.75 1,515.76 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% EATNPPVIQEEKPK 95.00% 3.11 0.429 1.66 790.9243 1,579.83 1,579.83 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% DLLIAYYDVDYEK 95.00% 4.04 0.572 4.89 810.3947 1,618.77 1,619.78 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% DLLIAYYDVDYEK 95.00% 4.19 0.517 3.57 810.3956 1,618.78 1,619.78 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% MDATANDVPSPYEVR 95.00% 4.42 0.467 1.6 832.882 1,663.75 1,664.76 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% MDATANDVPSPYEVR 95.00% 4.43 0.448 3.07 833.3839 1,664.75 1,664.76 2
 SAMPLE 1R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 11 19 28.10% VVVAENFDEIVNNENK 95.00% 5.22 0.559 3.34 916.9555 1,831.90 1,832.90 2
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% FLQDYFDGNLKR 95.00% 2.49 0.316 0 505.9239 1,514.75 1,515.76 3
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% FLQDYFDGNLKR 95.00% 2.51 0.347 0 506.2567 1,515.75 1,515.76 3
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% IFRDGEEAGAYDGPR 95.00% 4.46 0.424 2.44 551.5947 1,651.76 1,652.77 3
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% IFRDGEEAGAYDGPR 95.00% 4.04 0.335 1.48 551.5955 1,651.76 1,652.77 3
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% FVMQEEFSR 95.00% 1.96 0.318 0 586.7731 1,171.53 1,172.54 2
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% FVMQEEFSR 95.00% 2.21 0.31 0 586.7732 1,171.53 1,172.54 2
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% LAPEYEAAATR 95.00% 2.17 0.394 1.19 596.3019 1,190.59 1,191.60 2
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% LAPEYEAAATR 95.00% 2.93 0.213 2.14 596.3031 1,190.59 1,191.60 2
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% LAPEYEAAATR 95.00% 3.02 0.28 2.08 596.3034 1,190.59 1,191.60 2
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% LAPEYEAAATR 95.00% 2.66 0.24 0 596.3036 1,190.59 1,191.60 2
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% LAPEYEAAATR 95.00% 2.59 0.262 0 596.304 1,190.59 1,191.60 2
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% LAPEYEAAATR 95.00% 2.59 0.388 0 596.3043 1,190.59 1,191.60 2
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% EATNPPVIQEEKPK 95.00% 3.43 0.418 1.74 790.4231 1,578.83 1,579.83 2
 SAMPLE 2 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 14 12.10% EATNPPVIQEEKPK 95.00% 3.57 0.422 2.11 790.9231 1,579.83 1,579.83 2
 SAMPLE 2R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 10 12.70% IFRDGEEAGAYDGPR 95.00% 3.52 0.426 1.89 551.5916 1,651.75 1,652.77 3
 SAMPLE 2R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 10 12.70% IFRDGEEAGAYDGPR 95.00% 3.33 0.297 1 551.5934 1,651.76 1,652.77 3
 SAMPLE 2R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 10 12.70% LAPEYEAAATR 95.00% 2.73 0.237 1.62 596.3026 1,190.59 1,191.60 2
 SAMPLE 2R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 10 12.70% LAPEYEAAATR 95.00% 2.76 0.158 1.41 596.3026 1,190.59 1,191.60 2
 SAMPLE 2R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 10 12.70% LAPEYEAAATR 95.00% 2.9 0.311 0 596.303 1,190.59 1,191.60 2
 SAMPLE 2R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 10 12.70% SEPIPESNDGPVK 95.00% 2.12 0.344 0 684.835 1,367.65 1,368.66 2
 SAMPLE 2R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 10 12.70% ELSDFISYLQR 95.00% 3.4 0.317 1.48 685.8491 1,369.68 1,370.70 2
 SAMPLE 2R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 10 12.70% ELSDFISYLQR 95.00% 3.37 0.331 0 685.8495 1,369.68 1,370.70 2
 SAMPLE 2R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 10 12.70% EATNPPVIQEEKPK 95.00% 3.23 0.389 2.43 790.9227 1,579.83 1,579.83 2
 SAMPLE 2R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 5 5 10 12.70% EATNPPVIQEEKPK 95.00% 3.52 0.461 1.13 790.9228 1,579.83 1,579.83 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% FLQDYFDGNLKR 95.00% 3.14 0.348 0 505.9239 1,514.75 1,515.76 3
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% FLQDYFDGNLKR 95.00% 3.56 0.44 0 505.9243 1,514.75 1,515.76 3
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% YGVSGYPTLK 95.00% 3.09 0.489 2.74 542.7858 1,083.56 1,084.57 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% YGVSGYPTLK 95.00% 3.2 0.444 3.46 542.7863 1,083.56 1,084.57 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% YGVSGYPTLK 95.00% 2.76 0.434 2.92 542.7867 1,083.56 1,084.57 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% YGVSGYPTLK 95.00% 2.9 0.349 3.25 542.7869 1,083.56 1,084.57 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% FVMQEEFSR 95.00% 2.73 0.365 2.41 586.7737 1,171.53 1,172.54 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% FVMQEEFSR 95.00% 2.53 0.377 2.09 586.7749 1,171.53 1,172.54 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% LAPEYEAAATR 95.00% 3.07 0.311 2.29 596.3023 1,190.59 1,191.60 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% LAPEYEAAATR 95.00% 3.01 0.273 2 596.3027 1,190.59 1,191.60 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% LAPEYEAAATR 95.00% 3.16 0.314 2.27 596.3031 1,190.59 1,191.60 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% LAPEYEAAATR 95.00% 3 0.276 1.6 596.3034 1,190.59 1,191.60 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% LAPEYEAAATR 95.00% 3.2 0.325 1.96 596.3036 1,190.59 1,191.60 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% LAPEYEAAATR 95.00% 2.96 0.271 1.89 596.3039 1,190.59 1,191.60 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% LSKDPNIVIAK 95.00% 2.79 0.22 1.57 599.3628 1,196.71 1,197.72 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% LSKDPNIVIAK 95.00% 2.65 0.219 1.6 599.3629 1,196.71 1,197.72 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% QAGPASVPLRTEEEFKK 95.00% 2.3 0.301 0 630.0039 1,886.99 1,887.00 3
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% QAGPASVPLRTEEEFKK 95.00% 2.44 0.341 0 630.0054 1,886.99 1,887.00 3
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% GFPTIYFSPANK 95.00% 2.63 0.414 0 671.3462 1,340.68 1,341.68 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% SEPIPESNDGPVK 95.00% 2.6 0.495 1.6 684.835 1,367.65 1,368.66 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% SEPIPESNDGPVK 95.00% 2.43 0.45 0 684.8353 1,367.65 1,368.66 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% FLQDYFDGNLKR 95.00% 3.5 0.373 1.68 758.3829 1,514.75 1,515.76 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% FLQDYFDGNLKR 95.00% 3.38 0.409 1.12 758.3844 1,514.75 1,515.76 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% EATNPPVIQEEKPK 95.00% 3.2 0.367 5.06 790.4178 1,578.82 1,579.83 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% EATNPPVIQEEKPK 95.00% 3.58 0.397 3.64 790.4187 1,578.82 1,579.83 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% IFRDGEEAGAYDGPR 95.00% 4.2 0.497 3.44 826.8861 1,651.76 1,652.77 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% IFRDGEEAGAYDGPR 95.00% 3.88 0.468 2.26 827.3889 1,652.76 1,652.77 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% MDATANDVPSPYEVR 95.00% 4.68 0.488 3.96 832.881 1,663.75 1,664.76 2
 SAMPLE 3 Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 29 27.50% MDATANDVPSPYEVR 95.00% 4.85 0.478 5.44 832.8814 1,663.75 1,664.76 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% FLQDYFDGNLKR 95.00% 2.31 0.271 0 505.9236 1,514.75 1,515.76 3
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% YGVSGYPTLK 95.00% 3.09 0.51 3.31 542.7867 1,083.56 1,084.57 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% YGVSGYPTLK 95.00% 3.18 0.465 3.35 542.7868 1,083.56 1,084.57 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% YGVSGYPTLK 95.00% 2.72 0.381 2.09 542.787 1,083.56 1,084.57 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% YGVSGYPTLK 95.00% 2.43 0.329 1.24 542.7874 1,083.56 1,084.57 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% FVMQEEFSR 95.00% 2.59 0.435 1.74 586.7727 1,171.53 1,172.54 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% FVMQEEFSR 95.00% 2.81 0.467 2.09 586.773 1,171.53 1,172.54 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% LAPEYEAAATR 95.00% 2.84 0.246 2.21 596.3023 1,190.59 1,191.60 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% LAPEYEAAATR 95.00% 2.52 0.28 0 596.3024 1,190.59 1,191.60 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% LAPEYEAAATR 95.00% 3.04 0.259 0 596.3028 1,190.59 1,191.60 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% LAPEYEAAATR 95.00% 2.66 0.217 1.6 596.3028 1,190.59 1,191.60 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% LAPEYEAAATR 95.00% 3.06 0.26 2.68 596.3029 1,190.59 1,191.60 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% LAPEYEAAATR 95.00% 2.67 0.253 1.62 596.3033 1,190.59 1,191.60 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% LSKDPNIVIAK 95.00% 2.75 0.202 1.54 599.3629 1,196.71 1,197.72 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% GFPTIYFSPANK 95.00% 2.55 0.379 0 671.346 1,340.68 1,341.68 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% GFPTIYFSPANK 95.00% 2.44 0.326 0 671.347 1,340.68 1,341.68 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% SEPIPESNDGPVK 95.00% 2.22 0.434 1.17 684.8343 1,367.65 1,368.66 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% SEPIPESNDGPVK 95.00% 2.71 0.462 1.8 684.8343 1,367.65 1,368.66 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% ELSDFISYLQR 95.00% 2.51 0.334 0 685.8515 1,369.69 1,370.70 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% ELSDFISYLQR 95.00% 2.8 0.432 2.59 686.3515 1,370.69 1,370.70 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% FLQDYFDGNLKR 95.00% 3.39 0.414 2.59 758.383 1,514.75 1,515.76 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% FLQDYFDGNLKR 95.00% 3.88 0.343 1.47 758.8838 1,515.75 1,515.76 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% EATNPPVIQEEKPK 95.00% 3.51 0.428 2.89 790.419 1,578.82 1,579.83 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% EATNPPVIQEEKPK 95.00% 3.46 0.34 3.77 790.9216 1,579.83 1,579.83 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% IFRDGEEAGAYDGPR 95.00% 3.26 0.451 1.15 826.3941 1,650.77 1,652.77 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% IFRDGEEAGAYDGPR 95.00% 3.95 0.527 2.54 826.8855 1,651.76 1,652.77 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% MDATANDVPSPYEVR 95.00% 4.69 0.419 4.42 832.8812 1,663.75 1,664.76 2
 SAMPLE 3R Protein disulfide-isomerase A3  PDIA3  PDIA3_HUMAN 56,766.60 100.00% 11 12 28 26.30% MDATANDVPSPYEVR 95.00% 4.65 0.438 3.8 832.8816 1,663.75 1,664.76 2
 SAMPLE 1 Protein disulfide-isomerase A6  PDIA6  PDIA6_HUMAN 48,104.30 99.80% 2 2 2 6.82% IFQKGESPVDYDGGR 95.00% 3.4 0.259 0 556.9396 1,667.80 1,667.80 3
 SAMPLE 1 Protein disulfide-isomerase A6  PDIA6  PDIA6_HUMAN 48,104.30 99.80% 2 2 2 6.82% LAAVDATVNQVLASR 95.00% 3.98 0.503 4.26 764.4279 1,526.84 1,527.85 2
 SAMPLE 1R Protein disulfide-isomerase A6  PDIA6  PDIA6_HUMAN 48,104.30 99.80% 2 2 5 6.59% TGEAIVDAALSALR 95.00% 2.23 0.0145 3.82 693.8795 1,385.74 1,386.76 2
 SAMPLE 1R Protein disulfide-isomerase A6  PDIA6  PDIA6_HUMAN 48,104.30 99.80% 2 2 5 6.59% TGEAIVDAALSALR 95.00% 3.47 0.483 3.08 693.882 1,385.75 1,386.76 2
 SAMPLE 1R Protein disulfide-isomerase A6  PDIA6  PDIA6_HUMAN 48,104.30 99.80% 2 2 5 6.59% TGEAIVDAALSALR 95.00% 3.47 0.385 4.49 693.8829 1,385.75 1,386.76 2
 SAMPLE 1R Protein disulfide-isomerase A6  PDIA6  PDIA6_HUMAN 48,104.30 99.80% 2 2 5 6.59% LAAVDATVNQVLASR 95.00% 4.03 0.518 5.52 764.4277 1,526.84 1,527.85 2
 SAMPLE 1R Protein disulfide-isomerase A6  PDIA6  PDIA6_HUMAN 48,104.30 99.80% 2 2 5 6.59% LAAVDATVNQVLASR 95.00% 4.31 0.523 4.28 764.429 1,526.84 1,527.85 2
 SAMPLE 1 Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 3 4 6 6.89% ILEFFGLK 95.00% 2.79 0.293 0 483.7849 965.5542 966.5666 2
 SAMPLE 1 Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 3 4 6 6.89% ILEFFGLK 95.00% 2.62 0.186 0 483.7863 965.557 966.5666 2
 SAMPLE 1 Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 3 4 6 6.89% SNFAEALAAHK 95.00% 2.64 0.535 4.1 579.7972 1,157.58 1,158.59 2
 SAMPLE 1 Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 3 4 6 6.89% VDATEESDLAQQYGVR 95.00% 3.42 0.45 0 594.2817 1,779.82 1,780.84 3
 SAMPLE 1 Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 3 4 6 6.89% VDATEESDLAQQYGVR 95.00% 5.01 0.63 5.18 890.9206 1,779.83 1,780.84 2
 SAMPLE 1 Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 3 4 6 6.89% VDATEESDLAQQYGVR 95.00% 4.81 0.636 4.52 890.9212 1,779.83 1,780.84 2
 SAMPLE 1R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 6 6 10 14.60% ILEFFGLK 95.00% 2.73 0.246 0 483.7863 965.5569 966.5666 2
 SAMPLE 1R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 6 6 10 14.60% ILEFFGLK 95.00% 2.49 0.25 0 483.7863 965.557 966.5666 2
 SAMPLE 1R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 6 6 10 14.60% SNFAEALAAHK 95.00% 2.63 0.484 2.89 579.7967 1,157.58 1,158.59 2
 SAMPLE 1R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 6 6 10 14.60% SNFAEALAAHK 95.00% 2.53 0.547 4.28 579.7977 1,157.58 1,158.59 2
 SAMPLE 1R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 6 6 10 14.60% EADDIVNWLK 95.00% 2.83 0.357 1.46 601.8047 1,201.59 1,202.61 2
 SAMPLE 1R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 6 6 10 14.60% EADDIVNWLK 95.00% 2.74 0.38 0 601.8048 1,201.59 1,202.61 2
 SAMPLE 1R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 6 6 10 14.60% MDSTANEVEAVK 95.00% 2.18 0.121 1.85 647.34 1,292.66 1,293.60 2
 SAMPLE 1R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 6 6 10 14.60% NNFEGEVTKENLLDFIK 95.00% 2.71 0.362 0 670.6749 2,009.00 2,010.02 3
 SAMPLE 1R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 6 6 10 14.60% NNFEGEVTKENLLDFIK 95.00% 3.12 0.449 0 671.0099 2,010.01 2,010.02 3
 SAMPLE 1R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 6 6 10 14.60% VDATEESDLAQQYGVR 95.00% 4.88 0.62 5.47 891.4217 1,780.83 1,780.84 2
 SAMPLE 3 Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 3 3 6 7.28% SNFAEALAAHK 95.00% 2.96 0.506 4.48 579.7975 1,157.58 1,158.59 2
 SAMPLE 3 Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 3 3 6 7.28% SNFAEALAAHK 95.00% 3.15 0.5 5.24 579.799 1,157.58 1,158.59 2
 SAMPLE 3 Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 3 3 6 7.28% EADDIVNWLK 95.00% 2.71 0.19 0 601.805 1,201.59 1,202.61 2
 SAMPLE 3 Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 3 3 6 7.28% EADDIVNWLK 95.00% 2.85 0.306 0 601.8052 1,201.59 1,202.61 2
 SAMPLE 3 Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 3 3 6 7.28% VDATEESDLAQQYGVR 95.00% 4.58 0.636 5.31 890.9196 1,779.82 1,780.84 2
 SAMPLE 3 Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 3 3 6 7.28% VDATEESDLAQQYGVR 95.00% 4.79 0.624 5.32 891.4236 1,780.83 1,780.84 2
 SAMPLE 3R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 5 5 6 12.40% YQLDKDGVVLFK 95.00% 2.56 0.24 0 475.5954 1,423.76 1,424.78 3
 SAMPLE 3R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 5 5 6 12.40% ILEFFGLK 95.00% 2.47 0.214 0 483.7864 965.5571 966.5666 2
 SAMPLE 3R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 5 5 6 12.40% ILFIFIDSDHTDNQR 95.00% 2.37 0.193 0 611.975 1,832.90 1,833.91 3
 SAMPLE 3R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 5 5 6 12.40% MDSTANEVEAVK 95.00% 2.47 0.26 2.77 647.3378 1,292.66 1,293.60 2
 SAMPLE 3R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 5 5 6 12.40% VDATEESDLAQQYGVR 95.00% 4.08 0.607 6.31 890.9223 1,779.83 1,780.84 2
 SAMPLE 3R Protein disulfide-isomerase  P4HB  PDIA1_HUMAN 57,100.10 100.00% 5 5 6 12.40% VDATEESDLAQQYGVR 95.00% 4.55 0.605 5.3 890.9229 1,779.83 1,780.84 2
 SAMPLE 1R Protein NOV homolog  NOV  NOV_HUMAN 39,142.70 100.00% 4 4 5 16.00% NNEAFLQELELK 95.00% 3.84 0.442 3.11 724.3732 1,446.73 1,447.74 2
 SAMPLE 1R Protein NOV homolog  NOV  NOV_HUMAN 39,142.70 100.00% 4 4 5 16.00% NNEAFLQELELK 95.00% 2.53 0.319 0 724.3742 1,446.73 1,447.74 2
 SAMPLE 1R Protein NOV homolog  NOV  NOV_HUMAN 39,142.70 100.00% 4 4 5 16.00% AVLDGcSccLVcAR 95.00% 4.04 0.555 4.25c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02)821.3 3 1,640.70 1,640.70 2
 SAMPLE 1R Protein NOV homolog  NOV  NOV_HUMAN 39,142.70 100.00% 4 4 5 16.00% TIQAEFQcSPGQIVK 95.00% 5.01 0.567 5.96 c8: Carbamidomethyl (+57.02) 853.4325 1,704.85 1,705.86 2
 SAMPLE 1R Protein NOV homolog  NOV  NOV_HUMAN 39,142.70 100.00% 4 4 5 16.00% cQLDVLLPEPNcPAPR 95.00% 2.92 0.417 0 c1: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 939.912 1,877.81 1,878.92 2
 SAMPLE 2 Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 100.00% 2 2 3 2.14% LESGGSNPTTSDSYGDRASAR 95.00% 2.4 0.292 1.57 710.3246 2,127.95 2,127.95 3
 SAMPLE 2 Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 100.00% 2 2 3 2.14% LESGGSNPTTSDSYGDR 95.00% 4.85 0.599 7.51 872.3797 1,742.74 1,742.75 2
 SAMPLE 2 Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 100.00% 2 2 3 2.14% LESGGSNPTTSDSYGDR 95.00% 5.15 0.616 5 872.3819 1,742.75 1,742.75 2
 SAMPLE 2R Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 99.80% 2 2 4 2.14% LESGGSNPTTSDSYGDRASAR 95.00% 3.09 0.384 0 710.3245 2,127.95 2,127.95 3
 SAMPLE 2R Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 99.80% 2 2 4 2.14% LESGGSNPTTSDSYGDRASAR 95.00% 2.75 0.291 2.11 710.3249 2,127.95 2,127.95 3
 SAMPLE 2R Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 99.80% 2 2 4 2.14% LESGGSNPTTSDSYGDR 95.00% 3.73 0.526 4.55 871.8774 1,741.74 1,742.75 2
 SAMPLE 2R Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 99.80% 2 2 4 2.14% LESGGSNPTTSDSYGDR 95.00% 4.6 0.509 4.7 872.378 1,742.74 1,742.75 2
 SAMPLE 3 Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 99.80% 2 2 4 3.16% TKLQEAQLELADIK 95.00% 4.05 0.398 2.68 533.9688 1,598.88 1,599.90 3
 SAMPLE 3 Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 99.80% 2 2 4 3.16% TKLQEAQLELADIK 95.00% 3.42 0.256 2.6 533.9695 1,598.89 1,599.90 3
 SAMPLE 3 Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 99.80% 2 2 4 3.16% LESGGSNPTTSDSYGDR 95.00% 5.03 0.619 7 872.3783 1,742.74 1,742.75 2
 SAMPLE 3 Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 99.80% 2 2 4 3.16% LESGGSNPTTSDSYGDR 95.00% 5.23 0.622 6.96 872.3808 1,742.75 1,742.75 2
 SAMPLE 3R Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 99.80% 2 2 2 3.16% TKLQEAQLELADIK 95.00% 3.46 0.395 2.31 533.9694 1,598.88 1,599.90 3
 SAMPLE 3R Protein phosphatase 1 regulatory subunit 12B  PPP1R12B  MYPT2_HUMAN 110,387.70 99.80% 2 2 2 3.16% LESGGSNPTTSDSYGDR 95.00% 4.87 0.605 6.96 871.8783 1,741.74 1,742.75 2
 SAMPLE 2 Protein unc-13 homolog B  UNC13B  UN13B_HUMAN 180,661.80 99.80% 2 2 2 2.77% mKVQELQSPPRASQVVK 95.00% 3.5 0.285 0 m1: Oxidation (+15.99) 647.9406 1,940.80 1,941.06 3
 SAMPLE 2 Protein unc-13 homolog B  UNC13B  UN13B_HUMAN 180,661.80 99.80% 2 2 2 2.77% LLDQLHNSLRIDLSTYRNNFPAGSPER 95.00% 2.85 0.271 0 1,042.49 3,124.43 3,126.61 3
 SAMPLE 1 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 7 7 12 13.80% DLYLENPEIK 95.00% 2.74 0.326 0 617.3205 1,232.63 1,233.64 2
 SAMPLE 1 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 7 7 12 13.80% DLYLENPEIK 95.00% 3.08 0.38 0 617.321 1,232.63 1,233.64 2
 SAMPLE 1 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 7 7 12 13.80% DLYLENPEIK 95.00% 2.97 0.354 1.17 617.3213 1,232.63 1,233.64 2
 SAMPLE 1 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 7 7 12 13.80% LVVNFESDKLK 95.00% 2.25 0.289 0 646.36 1,290.70 1,291.73 2
 SAMPLE 1 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 7 7 12 13.80% SEGTYccGPVPVR 95.00% 3.55 0.572 3 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3283 1,480.64 1,481.65 2
 SAMPLE 1 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 7 7 12 13.80% SEGTYccGPVPVR 95.00% 3.55 0.52 3.11 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3288 1,480.64 1,481.65 2
 SAMPLE 1 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 7 7 12 13.80% YLLNLNLEPFSEK 95.00% 3.55 0.296 0 790.4208 1,578.83 1,579.84 2
 SAMPLE 1 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 7 7 12 13.80% TVSYNGILGPEcGTK 95.00% 3.43 0.561 2.22 c12: Carbamidomethyl (+57.02) 798.3879 1,594.76 1,595.77 2
 SAMPLE 1 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 7 7 12 13.80% TVSYNGILGPEcGTK 95.00% 4.08 0.542 5.2 c12: Carbamidomethyl (+57.02) 798.8879 1,595.76 1,595.77 2
 SAMPLE 1 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 7 7 12 13.80% TVEIPDPVEAGEEVK 95.00% 2.88 0.526 4.46 806.4101 1,610.80 1,611.81 2
 SAMPLE 1 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 7 7 12 13.80% TVEIPDPVEAGEEVK 95.00% 3.33 0.467 4.68 806.9085 1,611.80 1,611.81 2
 SAMPLE 1 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 7 7 12 13.80% VVSGMVNcNDDQGVLLGR 95.00% 4.24 0.546 4.4 c8: Carbamidomethyl (+57.02) 966.9653 1,931.92 1,932.93 2
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% ALLVEPVINSYLLAER 95.00% 4.4 0.566 1.85 600.6792 1,799.01 1,800.03 3
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% ALLVEPVINSYLLAER 95.00% 2.63 0.296 0 600.6795 1,799.02 1,800.03 3
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% ALLVEPVINSYLLAER 95.00% 4.78 0.458 3.49 600.6797 1,799.02 1,800.03 3
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% ALLVEPVINSYLLAER 95.00% 4.2 0.364 1.55 601.015 1,800.02 1,800.03 3
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% DLYLENPEIK 95.00% 2.46 0.337 0 617.3206 1,232.63 1,233.64 2
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% DLYLENPEIK 95.00% 2.97 0.396 1.59 617.3212 1,232.63 1,233.64 2
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% DLYLENPEIK 95.00% 2.63 0.249 0 617.826 1,233.64 1,233.64 2
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% SEGTYccGPVPVR 95.00% 3.46 0.566 3.23 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3281 1,480.64 1,481.65 2
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% SEGTYccGPVPVR 95.00% 3.24 0.563 2.8 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3298 1,480.64 1,481.65 2
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% TVSYNGILGPEcGTK 95.00% 4.15 0.506 4.05 c12: Carbamidomethyl (+57.02) 798.8884 1,595.76 1,595.77 2
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% TVEIPDPVEAGEEVK 95.00% 2.32 0.195 2.7 806.4131 1,610.81 1,611.81 2
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% ALLVEPVINSYLLAER 95.00% 4.96 0.578 6.39 901.0164 1,800.02 1,800.03 2
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% ALLVEPVINSYLLAER 95.00% 4.08 0.491 3.92 901.0179 1,800.02 1,800.03 2
 SAMPLE 1R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 6 7 14 12.70% VVSGMVNcNDDQGVLLGR 95.00% 4.42 0.536 5.37 c8: Carbamidomethyl (+57.02) 967.4652 1,932.91 1,932.93 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% LAEKEETGMAMR 95.00% 3.85 0.639 3.4 455.889 1,364.64 1,365.65 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% LAEKEETGMAMR 95.00% 3.78 0.654 3.02 455.8911 1,364.65 1,365.65 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% MDLLPLHMGLHK 95.00% 2.54 0.292 0 468.921 1,403.74 1,404.75 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% MDLLPLHMGLHK 95.00% 2.71 0.36 0 468.9214 1,403.74 1,404.75 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% YRDcLTESNLIK 95.00% 2.95 0.26 0 c4: Carbamidomethyl (+57.02) 504.5878 1,510.74 1,511.75 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% YRDcLTESNLIK 95.00% 3.68 0.384 0 c4: Carbamidomethyl (+57.02) 504.5884 1,510.74 1,511.75 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% YRDcLTESNLIK 95.00% 3.26 0.255 0 c4: Carbamidomethyl (+57.02) 504.9224 1,511.74 1,511.75 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% LVVNFESDK 95.00% 2.33 0.363 1.39 525.7757 1,049.54 1,050.55 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% LVVNFESDK 95.00% 2.29 0.301 1.64 525.7771 1,049.54 1,050.55 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% GQPFWLTLHFEGR 95.00% 1.55 0.397 0 529.9396 1,586.80 1,587.81 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 2.89 0.349 0 617.3199 1,232.62 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 3.01 0.347 0 617.3204 1,232.63 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 2.96 0.375 0 617.3209 1,232.63 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 3.39 0.4 0 617.3209 1,232.63 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 3.13 0.375 0 617.3211 1,232.63 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 3.29 0.37 1.35 617.3214 1,232.63 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 3.06 0.307 0 617.3218 1,232.63 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 3.1 0.356 1.32 617.3219 1,232.63 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 2.85 0.333 1.47 617.3224 1,232.63 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 2.82 0.324 0 617.3226 1,232.63 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 3.35 0.335 1.49 617.3227 1,232.63 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 2.66 0.279 1.19 617.3236 1,232.63 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% DLYLENPEIK 95.00% 3.1 0.369 1.28 617.8247 1,233.63 1,233.64 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% VVSGMVNcNDDQGVLLGR 95.00% 5.13 0.639 0 c8: Carbamidomethyl (+57.02) 645.314 1,932.92 1,932.93 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% VVSGMVNcNDDQGVLLGR 95.00% 3.73 0.436 0 c8: Carbamidomethyl (+57.02) 645.3152 1,932.92 1,932.93 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% LVVNFESDKLK 95.00% 3.34 0.496 1.8 646.3653 1,290.71 1,291.73 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% LVVNFESDKLK 95.00% 3.5 0.529 2.96 646.3658 1,290.72 1,291.73 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% QEYVLTQQGFIYQGSAK 95.00% 3.95 0.444 2.35 653.9988 1,958.97 1,959.98 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% LAEKEETGMAMR 95.00% 3.8 0.516 5.51 683.3277 1,364.64 1,365.65 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% LAEKEETGMAMR 95.00% 3.67 0.498 4.27 683.3287 1,364.64 1,365.65 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% SEGTYccGPVPVR 95.00% 3.11 0.511 5.09 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3283 1,480.64 1,481.65 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% SEGTYccGPVPVR 95.00% 3.84 0.58 4.42 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3284 1,480.64 1,481.65 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% SEGTYccGPVPVR 95.00% 3.86 0.569 3.96 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3298 1,480.64 1,481.65 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% SEGTYccGPVPVR 95.00% 2.96 0.53 2.49 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3299 1,480.64 1,481.65 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% SEGTYccGPVPVR 95.00% 2.31 0.427 3.89 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3306 1,480.65 1,481.65 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% SEGTYccGPVPVR 95.00% 2.28 0.32 2.59 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.831 1,481.65 1,481.65 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% SEGTYccGPVPVR 95.00% 3.38 0.475 2.92 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.8315 1,481.65 1,481.65 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% YRDcLTESNLIK 95.00% 3.93 0.475 3.82 c4: Carbamidomethyl (+57.02) 756.3792 1,510.74 1,511.75 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% YRDcLTESNLIK 95.00% 3.42 0.42 2.85 c4: Carbamidomethyl (+57.02) 756.3799 1,510.74 1,511.75 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% cDLELETNGRDHHTADLcR 95.00% 3.98 0.395 1.77 c1: Carbamidomethyl (+57.02), c18: Carbamidomethyl (+57.02) 771.6752 2,312.00 2,312.02 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% GQPFWLTLHFEGR 95.00% 3.71 0.502 3.49 794.9081 1,587.80 1,587.81 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% TVSYNGILGPEcGTK 95.00% 4.56 0.541 4.51 c12: Carbamidomethyl (+57.02) 798.3896 1,594.76 1,595.77 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% TVSYNGILGPEcGTK 95.00% 4.59 0.519 4.04 c12: Carbamidomethyl (+57.02) 798.3897 1,594.76 1,595.77 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% TVSYNGILGPEcGTK 95.00% 4.1 0.449 3.11 c12: Carbamidomethyl (+57.02) 798.8909 1,595.77 1,595.77 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% TVEIPDPVEAGEEVK 95.00% 3.19 0.532 5.49 806.4096 1,610.80 1,611.81 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% TVEIPDPVEAGEEVK 95.00% 3.06 0.515 4.46 806.9107 1,611.81 1,611.81 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% YPEGSSEEREAFTR 95.00% 3.17 0.433 0 829.3755 1,656.74 1,657.75 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% VVTNYNSAHDQNSNLLIEYFR 95.00% 6.05 0.568 3.85 833.4075 2,497.20 2,497.21 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% VVTNYNSAHDQNSNLLIEYFR 94.70% 0 0 3.09 833.7447 2,498.21 2,497.21 3
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% TVEIPDPVEAGEEVKVR 95.00% 4.26 0.606 5.12 933.9935 1,865.97 1,866.98 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% TVEIPDPVEAGEEVKVR 95.00% 4.25 0.559 5.82 934.4972 1,866.98 1,866.98 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% VVSGMVNcNDDQGVLLGR 95.00% 5.31 0.562 4.66 c8: Carbamidomethyl (+57.02) 966.9632 1,931.91 1,932.93 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% VVSGMVNcNDDQGVLLGR 95.00% 3.95 0.501 3.42 c8: Carbamidomethyl (+57.02) 966.964 1,931.91 1,932.93 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% VVSGMVNcNDDQGVLLGR 95.00% 4.78 0.535 6.34 c8: Carbamidomethyl (+57.02) 966.9664 1,931.92 1,932.93 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% VVSGMVNcNDDQGVLLGR 95.00% 4.64 0.538 4.47 c8: Carbamidomethyl (+57.02) 967.469 1,932.92 1,932.93 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% VVSGMVNcNDDQGVLLGR 95.00% 3.72 0.482 4.36 c8: Carbamidomethyl (+57.02) 967.4698 1,932.92 1,932.93 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% VVSGMVNcNDDQGVLLGR 95.00% 4.2 0.542 3.82 c8: Carbamidomethyl (+57.02) 967.4699 1,932.92 1,932.93 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% VVSGMVNcNDDQGVLLGR 95.00% 4.39 0.455 4.89 c8: Carbamidomethyl (+57.02) 967.4718 1,932.93 1,932.93 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% QEYVLTQQGFIYQGSAK 95.00% 4.98 0.576 6.1 980.492 1,958.97 1,959.98 2
 SAMPLE 2 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 16 22 60 29.70% VVTNYNSAHDQNSNLLIEYFR 95.00% 5.57 0.505 6 1,249.61 2,497.20 2,497.21 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% LAEKEETGMAMR 95.00% 3.49 0.562 1.12 455.8889 1,364.64 1,365.65 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% MDLLPLHMGLHK 95.00% 2.65 0.359 0 468.9208 1,403.74 1,404.75 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% MDLLPLHMGLHK 95.00% 2.6 0.282 0 468.9221 1,403.74 1,404.75 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% YRDcLTESNLIK 95.00% 3.42 0.289 0 c4: Carbamidomethyl (+57.02) 504.5879 1,510.74 1,511.75 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% YRDcLTESNLIK 95.00% 3.66 0.327 0 c4: Carbamidomethyl (+57.02) 504.5883 1,510.74 1,511.75 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% LVVNFESDK 95.00% 2.22 0.312 1.4 525.7758 1,049.54 1,050.55 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% LVVNFESDK 95.00% 2.34 0.319 1.89 525.7763 1,049.54 1,050.55 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% GQPFWLTLHFEGR 95.00% 1.18 0.306 0.959 529.9399 1,586.80 1,587.81 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DcLTESNLIK 95.00% 2.6 0.178 0 c2: Carbamidomethyl (+57.02) 596.7975 1,191.58 1,192.59 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 3.1 0.371 0 600.6793 1,799.01 1,800.03 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 5.44 0.583 5.28 600.6798 1,799.02 1,800.03 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 5.55 0.55 5.27 600.6801 1,799.02 1,800.03 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 4.76 0.54 3.46 601.0142 1,800.02 1,800.03 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 4.96 0.531 3.09 601.0146 1,800.02 1,800.03 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% SVGRDEREDITHTYK 95.00% 2.17 0.243 0 602.6304 1,804.87 1,805.88 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 2.47 0.386 0 617.3188 1,232.62 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 2.27 0.222 1.27 617.3191 1,232.62 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 3.23 0.402 0 617.3203 1,232.62 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 2.42 0.326 0 617.3207 1,232.63 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 3.28 0.402 0 617.3211 1,232.63 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 2.72 0.378 1.26 617.3217 1,232.63 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 2.79 0.356 0 617.3219 1,232.63 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 2.62 0.313 1.4 617.3224 1,232.63 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 2.49 0.306 1.82 617.3225 1,232.63 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 2.85 0.376 0 617.3225 1,232.63 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 2.73 0.335 0 617.3235 1,232.63 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 2.75 0.345 0 617.3235 1,232.63 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% DLYLENPEIK 95.00% 3.18 0.375 0 617.823 1,233.63 1,233.64 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% VVSGMVNcNDDQGVLLGR 95.00% 3.19 0.487 0 c8: Carbamidomethyl (+57.02) 644.9802 1,931.92 1,932.93 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% VVSGMVNcNDDQGVLLGR 95.00% 4.44 0.516 1.92 c8: Carbamidomethyl (+57.02) 645.3143 1,932.92 1,932.93 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% LVVNFESDKLK 95.00% 3.18 0.505 1.27 646.3653 1,290.72 1,291.73 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% LVVNFESDKLK 95.00% 3.3 0.463 1.85 646.3655 1,290.72 1,291.73 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% QEYVLTQQGFIYQGSAK 95.00% 4.24 0.403 1.49 653.9984 1,958.97 1,959.98 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% QEYVLTQQGFIYQGSAK 95.00% 4.75 0.428 3.85 654.333 1,959.98 1,959.98 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% LAEKEETGMAMR 95.00% 3.71 0.522 5.2 683.3273 1,364.64 1,365.65 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% LAEKEETGMAMR 95.00% 3.76 0.549 5.49 683.3294 1,364.64 1,365.65 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% SEGTYccGPVPVR 95.00% 3.28 0.55 2.7 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3262 1,480.64 1,481.65 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% SEGTYccGPVPVR 95.00% 2.93 0.528 2.96 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3282 1,480.64 1,481.65 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% SEGTYccGPVPVR 95.00% 3.73 0.585 2.32 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3286 1,480.64 1,481.65 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% SEGTYccGPVPVR 95.00% 2.7 0.519 2.66 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3286 1,480.64 1,481.65 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% SEGTYccGPVPVR 95.00% 3.63 0.541 3 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3287 1,480.64 1,481.65 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% SEGTYccGPVPVR 95.00% 2.94 0.501 3.16 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3289 1,480.64 1,481.65 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% YRDcLTESNLIK 95.00% 3.76 0.45 3.05 c4: Carbamidomethyl (+57.02) 756.3804 1,510.75 1,511.75 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% YRDcLTESNLIK 95.00% 3.57 0.444 3.27 c4: Carbamidomethyl (+57.02) 756.3806 1,510.75 1,511.75 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% YLLNLNLEPFSEK 95.00% 4.76 0.434 4.12 790.42 1,578.82 1,579.84 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% YLLNLNLEPFSEK 95.00% 4.54 0.431 4.03 790.4213 1,578.83 1,579.84 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% YLLNLNLEPFSEK 95.00% 4.15 0.44 3.38 790.4236 1,578.83 1,579.84 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% YLLNLNLEPFSEK 95.00% 2.68 0.261 0 790.4274 1,578.84 1,579.84 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% YLLNLNLEPFSEK 95.00% 4.55 0.451 2.37 790.9238 1,579.83 1,579.84 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% YLLNLNLEPFSEK 95.00% 3.9 0.446 2.46 790.9244 1,579.83 1,579.84 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% GQPFWLTLHFEGR 95.00% 3.68 0.54 2.46 794.4071 1,586.80 1,587.81 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% TVSYNGILGPEcGTK 95.00% 4.52 0.558 3.6 c12: Carbamidomethyl (+57.02) 798.3899 1,594.76 1,595.77 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% TVSYNGILGPEcGTK 95.00% 4.66 0.591 4.46 c12: Carbamidomethyl (+57.02) 798.3903 1,594.77 1,595.77 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% TVSYNGILGPEcGTK 95.00% 3.81 0.394 1.72 c12: Carbamidomethyl (+57.02) 798.8893 1,595.76 1,595.77 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% TVSYNGILGPEcGTK 95.00% 3.82 0.546 3.43 c12: Carbamidomethyl (+57.02) 798.8925 1,595.77 1,595.77 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% TVSYNGILGPEcGTK 95.00% 3.72 0.464 2.33 c12: Carbamidomethyl (+57.02) 798.8937 1,595.77 1,595.77 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% TVEIPDPVEAGEEVK 95.00% 3.3 0.524 4.66 806.4084 1,610.80 1,611.81 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% TVEIPDPVEAGEEVK 95.00% 3.74 0.543 3.85 806.4096 1,610.80 1,611.81 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% TVEIPDPVEAGEEVK 95.00% 2.8 0.533 4.34 806.4121 1,610.81 1,611.81 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% VVTNYNSAHDQNSNLLIEYFR 95.00% 4.52 0.517 1.92 833.4075 2,497.20 2,497.21 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% VVTNYNSAHDQNSNLLIEYFR 95.00% 5.28 0.552 3.92 833.4076 2,497.20 2,497.21 3
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 3.66 0.371 4.7 900.5115 1,799.01 1,800.03 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 4.82 0.575 7.54 900.5125 1,799.01 1,800.03 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 5.11 0.591 4.85 900.5141 1,799.01 1,800.03 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 4.06 0.498 3.28 900.5155 1,799.02 1,800.03 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 5.24 0.574 5.51 901.0161 1,800.02 1,800.03 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 4.35 0.469 4.51 901.0162 1,800.02 1,800.03 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 4.51 0.434 4.09 901.0163 1,800.02 1,800.03 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 4.2 0.426 4.68 901.019 1,800.02 1,800.03 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% ALLVEPVINSYLLAER 95.00% 3.34 0.513 4.24 901.0196 1,800.02 1,800.03 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% TVEIPDPVEAGEEVKVR 95.00% 4.35 0.555 7.57 934.4947 1,866.97 1,866.98 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% TVEIPDPVEAGEEVKVR 95.00% 4.07 0.523 5.85 934.4948 1,866.97 1,866.98 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% VVSGMVNcNDDQGVLLGR 95.00% 4.85 0.572 3.8 c8: Carbamidomethyl (+57.02) 966.966 1,931.92 1,932.93 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% VVSGMVNcNDDQGVLLGR 95.00% 3.63 0.452 2.77 c8: Carbamidomethyl (+57.02) 966.9691 1,931.92 1,932.93 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% VVSGMVNcNDDQGVLLGR 95.00% 4.81 0.565 4.85 c8: Carbamidomethyl (+57.02) 967.4657 1,932.92 1,932.93 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% VVSGmVNcNDDQGVLLGR 95.00% 4.02 0.562 5.49 m5: Oxidation (+15.99), c8: Carbamidomethyl (+57.02) 975.4628 1,948.91 1,948.92 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% QEYVLTQQGFIYQGSAK 95.00% 5.42 0.592 7.07 980.4919 1,958.97 1,959.98 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% QEYVLTQQGFIYQGSAK 95.00% 6.15 0.597 4.92 980.9955 1,959.98 1,959.98 2
 SAMPLE 2R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 18 25 79 31.30% VVTNYNSAHDQNSNLLIEYFR 95.00% 5.3 0.542 8.28 1,249.61 2,497.21 2,497.21 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% LAEKEETGMAMR 95.00% 3.44 0.626 1.07 455.8896 1,364.65 1,365.65 3
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% LAEKEETGMAMR 95.00% 3.39 0.614 1.72 455.8906 1,364.65 1,365.65 3
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% GQPFWLTLHFEGR 95.00% 1.8 0.402 1.35 529.9407 1,586.80 1,587.81 3
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% cDLELETNGR 95.00% 2.26 0.35 0 c1: Carbamidomethyl (+57.02) 604.3112 1,206.61 1,206.54 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% DLYLENPEIK 95.00% 3.33 0.383 0 617.3204 1,232.63 1,233.64 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% DLYLENPEIK 95.00% 3.15 0.371 0 617.3208 1,232.63 1,233.64 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% DLYLENPEIK 95.00% 2.97 0.35 0 617.3214 1,232.63 1,233.64 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% SEGTYccGPVPVR 95.00% 3.87 0.609 4.7 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3281 1,480.64 1,481.65 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% SEGTYccGPVPVR 95.00% 3.73 0.585 4.3 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3292 1,480.64 1,481.65 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% TVSYNGILGPEcGTK 95.00% 4.3 0.572 4.89 c12: Carbamidomethyl (+57.02) 798.3891 1,594.76 1,595.77 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% TVSYNGILGPEcGTK 95.00% 4.37 0.518 4.51 c12: Carbamidomethyl (+57.02) 798.3896 1,594.76 1,595.77 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% TVEIPDPVEAGEEVK 95.00% 3.31 0.529 5.89 806.4095 1,610.80 1,611.81 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% TVEIPDPVEAGEEVK 95.00% 3.49 0.558 4.57 806.4107 1,610.81 1,611.81 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% TVEIPDPVEAGEEVK 95.00% 3.07 0.534 3.12 806.4109 1,610.81 1,611.81 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% TVEIPDPVEAGEEVK 95.00% 3.28 0.481 5.1 806.9085 1,611.80 1,611.81 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% VVTNYNSAHDQNSNLLIEYFR 95.00% 3.33 0.353 0 833.4094 2,497.20 2,497.21 3
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% VVSGMVNcNDDQGVLLGR 95.00% 5.04 0.527 6.25 c8: Carbamidomethyl (+57.02) 967.4669 1,932.92 1,932.93 2
 SAMPLE 3 Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 9 9 18 18.50% VVSGMVNcNDDQGVLLGR 95.00% 5.15 0.552 6.07 c8: Carbamidomethyl (+57.02) 967.4671 1,932.92 1,932.93 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% LAEKEETGMAMR 95.00% 3.26 0.608 2.3 455.8901 1,364.65 1,365.65 3
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% LAEKEETGMAMR 95.00% 3.62 0.547 1.96 455.8904 1,364.65 1,365.65 3
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% GQPFWLTLHFEGR 95.00% 2.03 0.336 0 529.9389 1,586.79 1,587.81 3
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% GQPFWLTLHFEGR 95.00% 1.75 0.313 0 529.9406 1,586.80 1,587.81 3
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% NEFGEIQGDK 95.00% 1.97 0.172 1.57 568.7605 1,135.51 1,136.52 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% DLYLENPEIK 95.00% 2.84 0.375 0 617.3208 1,232.63 1,233.64 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% DLYLENPEIK 95.00% 2.66 0.369 0 617.3211 1,232.63 1,233.64 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% DLYLENPEIK 95.00% 3.06 0.405 0 617.3211 1,232.63 1,233.64 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% DLYLENPEIK 95.00% 2.33 0.251 0 617.3218 1,232.63 1,233.64 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% TVEIPDPVEAGEEVKVR 95.00% 1.99 0.338 0 622.9987 1,865.97 1,866.98 3
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% QEYVLTQQGFIYQGSAK 95.00% 2.99 0.159 0 654.3024 1,959.88 1,959.98 3
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% SEGTYccGPVPVR 95.00% 3.84 0.591 4.41 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.3282 1,480.64 1,481.65 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% SEGTYccGPVPVR 95.00% 3.74 0.591 3.24 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 741.33 1,480.64 1,481.65 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% YLLNLNLEPFSEK 95.00% 4.26 0.447 2.57 790.9218 1,579.83 1,579.84 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% YLLNLNLEPFSEK 95.00% 4.35 0.43 3.74 790.9228 1,579.83 1,579.84 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% TVSYNGILGPEcGTK 95.00% 4.23 0.552 3.92 c12: Carbamidomethyl (+57.02) 798.3902 1,594.76 1,595.77 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% TVSYNGILGPEcGTK 95.00% 4.01 0.572 3.43 c12: Carbamidomethyl (+57.02) 798.3914 1,594.77 1,595.77 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% TVEIPDPVEAGEEVK 95.00% 2.72 0.426 4.2 806.4095 1,610.80 1,611.81 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% TVEIPDPVEAGEEVK 95.00% 3.68 0.576 4.28 806.4095 1,610.80 1,611.81 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% VVTNYNSAHDQNSNLLIEYFR 95.00% 4.26 0.406 2.24 833.4093 2,497.20 2,497.21 3
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% ALLVEPVINSYLLAER 95.00% 5.14 0.54 4.43 901.0152 1,800.01 1,800.03 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% ALLVEPVINSYLLAER 95.00% 5.17 0.564 5.92 901.0177 1,800.02 1,800.03 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% VVSGMVNcNDDQGVLLGR 95.00% 4.98 0.498 4.48 c8: Carbamidomethyl (+57.02) 967.468 1,932.92 1,932.93 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% VVSGMVNcNDDQGVLLGR 95.00% 4.92 0.544 5.25 c8: Carbamidomethyl (+57.02) 967.4685 1,932.92 1,932.93 2
 SAMPLE 3R Protein-glutamine gamma-glutamyltransferase 2  TGM2  TGM2_HUMAN 77,311.10 100.00% 13 14 25 25.50% QEYVLTQQGFIYQGSAK 95.00% 4.4 0.511 3.47 980.9997 1,959.98 1,959.98 2
 SAMPLE 3R Protein-L-isoaspartate(D-aspartate) O-methyltransferase  PCMT1  PIMT_HUMAN 24,632.90 99.80% 2 2 2 11.50% VQLVVGDGR 95.00% 2.6 0.364 1.11 471.7722 941.5288 942.5374 2
 SAMPLE 3R Protein-L-isoaspartate(D-aspartate) O-methyltransferase  PCMT1  PIMT_HUMAN 24,632.90 99.80% 2 2 2 11.50% ALDVGSGSGILTAcFAR 95.00% 5.17 0.664 6.09 c14: Carbamidomethyl (+57.02) 847.9319 1,693.85 1,694.85 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% GIFPVLcK 95.00% 2.01 0.261 1.51 c7: Carbamidomethyl (+57.02) 467.2652 932.5147 933.5234 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% GDLGIEIPAEK 95.00% 2.24 0.315 0 571.6613 1,141.31 1,141.61 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% SVETLKEMIK 95.00% 2.75 0.439 1.47 589.3274 1,176.64 1,177.65 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% ITLDNAYMEK 95.00% 2.89 0.361 2 599.2927 1,196.57 1,197.58 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% ITLDNAYMEK 95.00% 2.56 0.322 1.2 599.2943 1,196.57 1,197.58 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% LDIDSPPITAR 95.00% 2.78 0.289 0 599.3251 1,196.63 1,197.65 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% ccSGAIIVLTK 95.00% 3.39 0.584 4.47 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 611.3192 1,220.62 1,221.63 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% ccSGAIIVLTK 95.00% 3.07 0.568 4.7 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 611.3203 1,220.63 1,221.63 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% LNFSHGTHEYHAETIK 95.00% 4.27 0.4 2.51 628.6378 1,882.89 1,883.90 3
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% LNFSHGTHEYHAETIK 95.00% 4.4 0.397 1.74 628.9728 1,883.89 1,883.90 3
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% GADFLVTEVENGGSLGSKK 95.00% 3.6 0.527 1.77 636.9954 1,907.96 1,907.97 3
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% GADFLVTEVENGGSLGSKK 95.00% 3 0.391 1.72 636.9957 1,907.96 1,907.97 3
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% QKGADFLVTEVENGGSLGSK 95.00% 3.51 0.374 1.28 679.6822 2,036.02 2,036.03 3
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% NTGIIcTIGPASR 95.00% 4.3 0.554 3.29 c6: Carbamidomethyl (+57.02) 680.3546 1,358.69 1,359.71 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% NTGIIcTIGPASR 95.00% 4.2 0.565 3.96 c6: Carbamidomethyl (+57.02) 680.3554 1,358.70 1,359.71 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% NTGIIcTIGPASR 95.00% 3.39 0.498 1.23 c6: Carbamidomethyl (+57.02) 680.3564 1,358.70 1,359.71 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% NTGIIcTIGPASR 95.00% 2.43 0.341 0 c6: Carbamidomethyl (+57.02) 680.7466 1,359.48 1,359.71 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% LAPITSDPTEATAVGAVEASFK 95.00% 4 0.523 1.96 726.0447 2,175.11 2,175.12 3
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% IYVDDGLISLQVK 95.00% 3.75 0.523 3.51 731.91 1,461.80 1,462.82 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% IYVDDGLISLQVK 95.00% 4.75 0.553 3.66 731.9109 1,461.81 1,462.82 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% GVNLPGAAVDLPAVSEKDIQDLK 95.00% 2.44 0.433 1.85 784.0944 2,349.26 2,349.27 3
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% GVNLPGAAVDLPAVSEKDIQDLK 95.00% 2.58 0.473 2.7 784.095 2,349.26 2,349.27 3
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% GVNLPGAAVDLPAVSEK 95.00% 5.16 0.586 4.7 818.9474 1,635.88 1,636.89 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% GVNLPGAAVDLPAVSEK 95.00% 5 0.577 5.07 819.4497 1,636.88 1,636.89 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% TATESFASDPILYRPVAVALDTK 95.00% 4 0.564 4.08 822.7681 2,465.28 2,465.29 3
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% TATESFASDPILYRPVAVALDTK 95.00% 4.38 0.571 4.32 822.7687 2,465.28 2,465.29 3
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% KGVNLPGAAVDLPAVSEK 95.00% 4.69 0.617 9.64 882.9951 1,763.97 1,764.99 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% KGVNLPGAAVDLPAVSEK 95.00% 4.93 0.625 4.72 883.4963 1,764.98 1,764.99 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% GADFLVTEVENGGSLGSK 95.00% 6.21 0.636 6.02 890.4403 1,778.86 1,779.88 2 ALBU_HUMAN
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% GADFLVTEVENGGSLGSK 95.00% 6.5 0.596 5.82 890.9413 1,779.87 1,779.88 2 ALBU_HUMAN
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% LNFSHGTHEYHAETIK 95.00% 5.3 0.57 5.44 942.9562 1,883.90 1,883.90 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% LNFSHGTHEYHAETIK 95.00% 5.09 0.558 5.57 942.9574 1,883.90 1,883.90 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% LAPITSDPTEATAVGAVEASFK 95.00% 6.52 0.545 9.28 1,088.56 2,175.11 2,175.12 2
 SAMPLE 1 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 16 18 32 36.20% LAPITSDPTEATAVGAVEASFK 95.00% 6.19 0.576 7.21 1,088.56 2,175.11 2,175.12 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% IISKIENHEGVR 95.00% 2.49 0.195 0 465.5973 1,393.77 1,394.78 3
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% GDYPLEAVR 95.00% 2.59 0.451 2.09 510.2573 1,018.50 1,019.52 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% GDYPLEAVR 95.00% 2.26 0.369 1.85 510.2594 1,018.50 1,019.52 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% SVETLKEMIK 95.00% 2.51 0.426 1.36 589.328 1,176.64 1,177.65 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% SVETLKEMIK 95.00% 2.29 0.297 0 589.3283 1,176.64 1,177.65 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% ITLDNAYMEK 95.00% 2.69 0.334 2.32 599.2928 1,196.57 1,197.58 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% ITLDNAYMEK 95.00% 2.79 0.354 2.57 599.2933 1,196.57 1,197.58 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% ccSGAIIVLTK 95.00% 3.05 0.536 3.85 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 611.3193 1,220.62 1,221.63 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% ccSGAIIVLTK 95.00% 2.98 0.535 4.49 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 611.3201 1,220.62 1,221.63 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% LNFSHGTHEYHAETIK 95.00% 4.06 0.406 0 628.6383 1,882.89 1,883.90 3
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% LNFSHGTHEYHAETIK 95.00% 3.98 0.412 2.04 628.971 1,883.89 1,883.90 3
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% GADFLVTEVENGGSLGSKK 95.00% 3.39 0.446 0 636.6597 1,906.96 1,907.97 3
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% GADFLVTEVENGGSLGSKK 95.00% 3.46 0.405 0 636.9962 1,907.97 1,907.97 3
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% QKGADFLVTEVENGGSLGSK 95.00% 3.81 0.501 2 679.6818 2,036.02 2,036.03 3
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% NTGIIcTIGPASR 95.00% 4.34 0.545 2.82 c6: Carbamidomethyl (+57.02) 680.3543 1,358.69 1,359.71 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% NTGIIcTIGPASR 95.00% 4.29 0.547 3.31 c6: Carbamidomethyl (+57.02) 680.3546 1,358.69 1,359.71 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% IISKIENHEGVR 95.00% 3.09 0.448 3.89 697.8907 1,393.77 1,394.78 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% IISKIENHEGVR 95.00% 3.1 0.434 1.96 697.8921 1,393.77 1,394.78 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% LAPITSDPTEATAVGAVEASFK 95.00% 4.77 0.55 5.32 726.0444 2,175.11 2,175.12 3
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% LAPITSDPTEATAVGAVEASFK 95.00% 2.87 0.392 2.02 726.0454 2,175.11 2,175.12 3
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% IYVDDGLISLQVK 95.00% 4.34 0.567 4.32 731.9115 1,461.81 1,462.82 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% IYVDDGLISLQVK 95.00% 4.68 0.523 3.43 732.4099 1,462.80 1,462.82 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% cDENILWLDYK 95.00% 4.21 0.524 1.35 c1: Carbamidomethyl (+57.02) 734.841 1,467.67 1,468.68 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% cDENILWLDYK 95.00% 4.09 0.536 0 c1: Carbamidomethyl (+57.02) 734.8435 1,467.67 1,468.68 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% GVNLPGAAVDLPAVSEK 95.00% 4.88 0.577 6.23 818.948 1,635.88 1,636.89 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% GVNLPGAAVDLPAVSEK 95.00% 4.79 0.555 5.22 818.9483 1,635.88 1,636.89 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% DPVQEAWAEDVDLR 95.00% 3.87 0.49 2.96 821.8868 1,641.76 1,642.77 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% DPVQEAWAEDVDLR 95.00% 3.67 0.465 4.04 821.8871 1,641.76 1,642.77 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% GADFLVTEVENGGSLGSK 95.00% 6.16 0.616 7.89 890.4391 1,778.86 1,779.88 2 ALBU_HUMAN
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% GADFLVTEVENGGSLGSK 95.00% 6.11 0.599 6.89 890.9391 1,779.86 1,779.88 2 ALBU_HUMAN
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% LAPITSDPTEATAVGAVEASFK 95.00% 6.4 0.557 7.89 1,088.56 2,175.11 2,175.12 2
 SAMPLE 1R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 16 30 33.70% LAPITSDPTEATAVGAVEASFK 95.00% 6.34 0.589 9.07 1,088.56 2,175.11 2,175.12 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% IISKIENHEGVR 95.00% 3.08 0.323 0 465.5973 1,393.77 1,394.78 3
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% IISKIENHEGVR 95.00% 2.9 0.36 0 465.5984 1,393.77 1,394.78 3
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% LDIDSPPITAR 95.00% 2.95 0.462 1.49 599.3256 1,196.64 1,197.65 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% LDIDSPPITAR 95.00% 3.5 0.477 2.02 599.3258 1,196.64 1,197.65 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% LDIDSPPITAR 95.00% 3.28 0.398 1.68 599.3268 1,196.64 1,197.65 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% GADFLVTEVENGGSLGSKK 95.00% 3.1 0.376 0 636.9958 1,907.96 1,907.97 3
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% NTGIIcTIGPASR 95.00% 4.43 0.598 2.77 c6: Carbamidomethyl (+57.02) 680.3559 1,358.70 1,359.71 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% NTGIIcTIGPASR 95.00% 4.44 0.577 4.42 c6: Carbamidomethyl (+57.02) 680.3561 1,358.70 1,359.71 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% IISKIENHEGVR 95.00% 3.25 0.471 2.16 697.8899 1,393.76 1,394.78 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% IISKIENHEGVR 95.00% 3.25 0.48 1.85 697.89 1,393.76 1,394.78 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% IYVDDGLISLQVK 95.00% 4.56 0.545 4.23 731.909 1,461.80 1,462.82 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% IYVDDGLISLQVK 95.00% 3.59 0.338 1.62 731.9118 1,461.81 1,462.82 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% TATESFASDPILYR 95.00% 2.06 0.332 0 786.3921 1,570.77 1,570.78 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% GVNLPGAAVDLPAVSEK 95.00% 3.77 0.608 5.2 818.9475 1,635.88 1,636.89 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% GVNLPGAAVDLPAVSEK 95.00% 5.22 0.624 6.74 818.9477 1,635.88 1,636.89 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% NTGIIcTIGPASRSVETLKEmIK 95.00% 2.01 0.319 0 c6: Carbamidomethyl (+57.02), m21: Oxidation (+15.99) 845.3988 2,533.17 2,534.33 3
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% KGVNLPGAAVDLPAVSEK 95.00% 4.19 0.582 5.89 882.9937 1,763.97 1,764.99 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% GADFLVTEVENGGSLGSK 95.00% 5.97 0.624 6.36 890.4395 1,778.86 1,779.88 2 ALBU_HUMAN
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% GADFLVTEVENGGSLGSK 95.00% 6.01 0.624 7.64 890.4411 1,778.87 1,779.88 2 ALBU_HUMAN
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% LNFSHGTHEYHAETIK 95.00% 4.73 0.614 4.6 942.4543 1,882.89 1,883.90 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% LNFSHGTHEYHAETIK 95.00% 4.85 0.589 4.92 942.9542 1,883.89 1,883.90 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% LAPITSDPTEATAVGAVEASFK 95.00% 6.3 0.533 8.92 1,088.56 2,175.11 2,175.12 2
 SAMPLE 2 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 11 12 21 27.70% LAPITSDPTEATAVGAVEASFK 95.00% 6.06 0.57 7.54 1,088.56 2,175.11 2,175.12 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% IISKIENHEGVR 95.00% 2.32 0.211 0 465.5978 1,393.77 1,394.78 3
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% LDIDSPPITAR 95.00% 3.23 0.443 1.43 599.3263 1,196.64 1,197.65 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% LDIDSPPITAR 95.00% 3.27 0.417 1.68 599.3268 1,196.64 1,197.65 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% ccSGAIIVLTK 95.00% 2.78 0.454 4.66 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 611.3194 1,220.62 1,221.63 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% ccSGAIIVLTK 95.00% 2.94 0.448 5.15 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 611.3204 1,220.63 1,221.63 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% NTGIIcTIGPASR 95.00% 4.31 0.511 4.66 c6: Carbamidomethyl (+57.02) 680.3551 1,358.69 1,359.71 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% NTGIIcTIGPASR 95.00% 4.2 0.577 3.11 c6: Carbamidomethyl (+57.02) 680.3563 1,358.70 1,359.71 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% IISKIENHEGVR 95.00% 2.68 0.396 2.08 697.893 1,393.77 1,394.78 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% IISKIENHEGVR 95.00% 3.03 0.38 1.8 697.8933 1,393.77 1,394.78 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% LAPITSDPTEATAVGAVEASFK 95.00% 3.63 0.527 2.82 726.0441 2,175.11 2,175.12 3
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% IYVDDGLISLQVK 95.00% 4.1 0.571 3.66 731.9104 1,461.81 1,462.82 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% IYVDDGLISLQVK 95.00% 3.22 0.42 4.3 731.9137 1,461.81 1,462.82 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% cDENILWLDYK 95.00% 2.02 0.341 0 c1: Carbamidomethyl (+57.02) 734.8435 1,467.67 1,468.68 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% cDENILWLDYK 95.00% 3.63 0.52 2.28 c1: Carbamidomethyl (+57.02) 735.3443 1,468.67 1,468.68 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% GVNLPGAAVDLPAVSEK 95.00% 4.26 0.612 4.89 818.9485 1,635.88 1,636.89 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% GVNLPGAAVDLPAVSEK 95.00% 5.35 0.622 8.35 819.4483 1,636.88 1,636.89 2
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% GADFLVTEVENGGSLGSK 95.00% 6.06 0.623 6.54 890.4398 1,778.86 1,779.88 2 ALBU_HUMAN
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% GADFLVTEVENGGSLGSK 95.00% 6.51 0.604 7.48 890.9408 1,779.87 1,779.88 2 ALBU_HUMAN
 SAMPLE 2R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 8 10 17 24.10% LAPITSDPTEATAVGAVEASFK 95.00% 6.48 0.569 10.3 1,088.56 2,175.11 2,175.12 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% IISKIENHEGVR 95.00% 3.13 0.334 1.7 465.5967 1,393.77 1,394.78 3
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% IISKIENHEGVR 95.00% 3.16 0.422 0 465.5973 1,393.77 1,394.78 3
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% GIFPVLcK 95.00% 2.1 0.208 1.31 c7: Carbamidomethyl (+57.02) 467.2644 932.5132 933.5234 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% GIFPVLcK 95.00% 2.17 0.239 1.35 c7: Carbamidomethyl (+57.02) 467.2649 932.5142 933.5234 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% ITLDNAYMEK 95.00% 3.14 0.474 1.72 599.2935 1,196.57 1,197.58 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% ITLDNAYMEK 95.00% 3.3 0.479 2.07 599.2935 1,196.57 1,197.58 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% KGATLKITLDNAYMEK 95.00% 2.51 0.391 0 599.2936 1,794.86 1,795.96 3
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% KGATLKITLDNAYMEK 95.00% 2.63 0.327 0 599.2936 1,794.86 1,795.96 3
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% RFDEILEASDGIMVAR 95.00% 3.62 0.389 0 608.3094 1,821.90 1,821.92 3
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% RFDEILEASDGIMVAR 95.00% 3.43 0.257 0 608.3107 1,821.91 1,821.92 3
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% ccSGAIIVLTK 95.00% 3.12 0.575 4.64 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 611.3198 1,220.62 1,221.63 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% ccSGAIIVLTK 95.00% 3.26 0.481 4.4 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 611.32 1,220.62 1,221.63 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% GADFLVTEVENGGSLGSKK 95.00% 3.48 0.348 0 636.6614 1,906.96 1,907.97 3
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% GADFLVTEVENGGSLGSKK 95.00% 3.62 0.442 0 636.9951 1,907.96 1,907.97 3
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% NTGIIcTIGPASR 95.00% 2.91 0.355 1.2 c6: Carbamidomethyl (+57.02) 680.3525 1,358.69 1,359.71 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% NTGIIcTIGPASR 95.00% 4.41 0.584 4.52 c6: Carbamidomethyl (+57.02) 680.3554 1,358.70 1,359.71 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% NTGIIcTIGPASR 95.00% 4.23 0.554 2.66 c6: Carbamidomethyl (+57.02) 680.356 1,358.70 1,359.71 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% IISKIENHEGVR 95.00% 3.66 0.487 2.15 697.8904 1,393.77 1,394.78 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% IISKIENHEGVR 95.00% 3.71 0.525 2.43 697.8909 1,393.77 1,394.78 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% IYVDDGLISLQVK 95.00% 4.48 0.572 4.15 731.9107 1,461.81 1,462.82 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% IYVDDGLISLQVK 95.00% 3.08 0.329 0 731.9123 1,461.81 1,462.82 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% GVNLPGAAVDLPAVSEK 95.00% 5.19 0.603 6.4 818.9483 1,635.88 1,636.89 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% GVNLPGAAVDLPAVSEK 95.00% 5.07 0.582 5.03 818.9494 1,635.88 1,636.89 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% TATESFASDPILYRPVAVALDTK 95.00% 3.76 0.574 2.96 822.7689 2,465.28 2,465.29 3
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% TATESFASDPILYRPVAVALDTK 95.00% 3.75 0.535 2.62 822.7698 2,465.29 2,465.29 3
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% KGVNLPGAAVDLPAVSEK 95.00% 4.66 0.609 7.66 882.9939 1,763.97 1,764.99 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% GADFLVTEVENGGSLGSK 95.00% 5.94 0.614 7.47 890.4398 1,778.86 1,779.88 2 ALBU_HUMAN
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% GADFLVTEVENGGSLGSK 95.00% 5.64 0.628 8.09 890.4408 1,778.87 1,779.88 2 ALBU_HUMAN
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% LNFSHGTHEYHAETIK 95.00% 4.49 0.458 5.3 942.9558 1,883.90 1,883.90 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% LAPITSDPTEATAVGAVEASFK 95.00% 6.34 0.525 10.6 1,088.56 2,175.11 2,175.12 2
 SAMPLE 3 Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 14 15 29 35.00% LAPITSDPTEATAVGAVEASFK 95.00% 6.28 0.579 9.19 1,088.56 2,175.11 2,175.12 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% IISKIENHEGVR 95.00% 3.38 0.381 1.1 465.5967 1,393.77 1,394.78 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% IISKIENHEGVR 95.00% 3.21 0.391 0 465.5973 1,393.77 1,394.78 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% GIFPVLcK 95.00% 1.95 0.186 1.51 c7: Carbamidomethyl (+57.02) 467.2656 932.5156 933.5234 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% VNFAMNVGK 95.00% 2.24 0.314 0 490.2534 978.4911 979.5035 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% VNFAMNVGK 95.00% 2.32 0.349 0 490.2539 978.4921 979.5035 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% ITLDNAYMEK 95.00% 2.93 0.414 1.92 599.2938 1,196.57 1,197.58 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% ITLDNAYMEK 95.00% 2.76 0.426 2.21 599.2953 1,196.58 1,197.58 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% LDIDSPPITAR 95.00% 3.19 0.435 1.7 599.3271 1,196.64 1,197.65 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% LDIDSPPITAR 95.00% 3.3 0.421 1.85 599.3275 1,196.64 1,197.65 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% RFDEILEASDGIMVAR 95.00% 3.43 0.313 0 608.309 1,821.90 1,821.92 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% RFDEILEASDGIMVAR 95.00% 2.63 0.244 0 608.311 1,821.91 1,821.92 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% GDLGIEIPAEKVFLAQK 95.00% 2.67 0.255 0 610.3453 1,828.01 1,828.02 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% ccSGAIIVLTK 95.00% 3.18 0.502 5.72 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 611.3181 1,220.62 1,221.63 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% ccSGAIIVLTK 95.00% 2.96 0.517 2.68 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 611.3201 1,220.62 1,221.63 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% GADFLVTEVENGGSLGSKK 95.00% 2.77 0.288 0 636.658 1,906.95 1,907.97 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% GADFLVTEVENGGSLGSKK 95.00% 2.81 0.344 0 636.9918 1,907.95 1,907.97 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% QKGADFLVTEVENGGSLGSK 95.00% 3.69 0.377 1.37 679.6811 2,036.02 2,036.03 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% QKGADFLVTEVENGGSLGSK 95.00% 3.97 0.383 1.85 679.6821 2,036.02 2,036.03 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% NTGIIcTIGPASR 95.00% 2.37 0.208 1.12 c6: Carbamidomethyl (+57.02) 680.3505 1,358.69 1,359.71 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% NTGIIcTIGPASR 95.00% 2.7 0.166 1.29 c6: Carbamidomethyl (+57.02) 680.3554 1,358.70 1,359.71 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% NTGIIcTIGPASR 95.00% 4.32 0.565 4.57 c6: Carbamidomethyl (+57.02) 680.3555 1,358.70 1,359.71 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% NTGIIcTIGPASR 95.00% 4.28 0.572 3.62 c6: Carbamidomethyl (+57.02) 680.3556 1,358.70 1,359.71 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% EAEAAIYHLQLFEELRR 95.00% 2.95 0.417 0 697.0327 2,088.07 2,088.09 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% IISKIENHEGVR 95.00% 3.64 0.541 2.77 697.8905 1,393.77 1,394.78 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% IISKIENHEGVR 95.00% 3.05 0.486 2.24 697.8906 1,393.77 1,394.78 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% LAPITSDPTEATAVGAVEASFK 95.00% 4.82 0.626 3.44 726.0449 2,175.11 2,175.12 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% IYVDDGLISLQVK 95.00% 4.45 0.521 3.32 732.4115 1,462.81 1,462.82 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% IYVDDGLISLQVK 95.00% 4.5 0.563 3.62 732.412 1,462.81 1,462.82 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% GVNLPGAAVDLPAVSEK 95.00% 4.73 0.621 5.14 818.9467 1,635.88 1,636.89 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% GVNLPGAAVDLPAVSEK 95.00% 4.82 0.612 5.43 819.4461 1,636.88 1,636.89 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% TATESFASDPILYRPVAVALDTK 95.00% 3.85 0.502 2.38 822.7706 2,465.29 2,465.29 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% AEGSDVANAVLDGADcIMLSGETAK 95.00% 4.86 0.561 3.44 c16: Carbamidomethyl (+57.02) 832.3843 2,494.13 2,494.14 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% AEGSDVANAVLDGADcIMLSGETAK 95.00% 3.67 0.437 2 c16: Carbamidomethyl (+57.02) 832.3851 2,494.13 2,494.14 3
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% GADFLVTEVENGGSLGSK 95.00% 5.07 0.648 5.72 890.4381 1,778.86 1,779.88 2 ALBU_HUMAN
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% GADFLVTEVENGGSLGSK 95.00% 6.67 0.611 7.23 890.9407 1,779.87 1,779.88 2 ALBU_HUMAN
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% RFDEILEASDGIMVAR 95.00% 4.58 0.429 3.18 911.4569 1,820.90 1,821.92 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% AGKPVIcATQMLESMIK 95.00% 3.29 0.468 5.57 c7: Carbamidomethyl (+57.02) 939.4919 1,876.97 1,876.97 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% LNFSHGTHEYHAETIK 95.00% 4.82 0.557 5.08 942.9546 1,883.89 1,883.90 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% LNFSHGTHEYHAETIK 95.00% 4.48 0.531 5.92 942.9558 1,883.90 1,883.90 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% QKGADFLVTEVENGGSLGSK 95.00% 2.28 0.433 3.4 1,019.02 2,036.02 2,036.03 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% LAPITSDPTEATAVGAVEASFK 95.00% 6.34 0.537 9.54 1,088.56 2,175.11 2,175.12 2
 SAMPLE 3R Pyruvate kinase isozymes M1/M2  PKM2  KPYM_HUMAN 57,919.50 100.00% 19 23 40 52.40% LAPITSDPTEATAVGAVEASFK 95.00% 6.37 0.55 9.59 1,088.56 2,175.11 2,175.12 2
 SAMPLE 2R Quinone oxidoreductase  CRYZ  QOR_HUMAN 35,189.30 99.80% 2 2 2 10.30% VFEFGGPEVLK 95.00% 1.87 0.227 1.23 611.3315 1,220.65 1,221.65 2
 SAMPLE 2R Quinone oxidoreductase  CRYZ  QOR_HUMAN 35,189.30 99.80% 2 2 2 10.30% AGESVLVHGASGGVGLAAcQIAR 95.00% 2.67 0.496 0 c19: Carbamidomethyl (+57.02) 1,090.83 2,179.65 2,180.12 2
 SAMPLE 3R Quinone oxidoreductase  CRYZ  QOR_HUMAN 35,189.30 99.80% 2 2 3 7.60% IVLQNGAHEVFNHR 95.00% 2.39 0.256 0 545.6238 1,633.85 1,633.86 3
 SAMPLE 3R Quinone oxidoreductase  CRYZ  QOR_HUMAN 35,189.30 99.80% 2 2 3 7.60% VFEFGGPEVLK 95.00% 2.78 0.441 2.05 611.3302 1,220.64 1,221.65 2
 SAMPLE 3R Quinone oxidoreductase  CRYZ  QOR_HUMAN 35,189.30 99.80% 2 2 3 7.60% VFEFGGPEVLK 95.00% 3.07 0.381 1.64 611.8274 1,221.64 1,221.65 2
 SAMPLE 1 Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 5 5 8 3.74% LGNFFSPK 95.00% 2.52 0.38 0 455.2456 908.4755 909.4835 2
 SAMPLE 1 Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 5 5 8 3.74% LGNFFSPK 95.00% 2.44 0.377 0 455.2459 908.4762 909.4835 2
 SAMPLE 1 Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 5 5 8 3.74% TLQALQIPAAK 95.00% 2.74 0.304 1.3 577.3511 1,152.69 1,153.69 2
 SAMPLE 1 Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 5 5 8 3.74% ALESGDVNTVWK 95.00% 2.02 0.291 0 659.8332 1,317.65 1,318.66 2
 SAMPLE 1 Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 5 5 8 3.74% ALESGDVNTVWK 95.00% 2.1 0.33 1.38 660.3371 1,318.66 1,318.66 2
 SAMPLE 1 Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 5 5 8 3.74% LEGVLAEVAQHYQDTLIR 95.00% 3.23 0.474 1.42 686.0338 2,055.08 2,055.09 3
 SAMPLE 1 Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 5 5 8 3.74% LEGVLAEVAQHYQDTLIR 95.00% 3.88 0.624 2.82 686.0342 2,055.08 2,055.09 3
 SAMPLE 1 Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 5 5 8 3.74% EQLWLANEGLITR 95.00% 3.12 0.451 3.51 771.9153 1,541.81 1,542.83 2
 SAMPLE 1R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 5 11 3.44% LGNFFSPK 95.00% 2.31 0.319 0 455.2452 908.4748 909.4835 2
 SAMPLE 1R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 5 11 3.44% ILAIGLINEALDEGDAQK 95.00% 5.06 0.514 4.37 628.3422 1,882.00 1,883.01 3
 SAMPLE 1R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 5 11 3.44% ILAIGLINEALDEGDAQK 95.00% 2.74 0.243 0 628.6748 1,883.00 1,883.01 3
 SAMPLE 1R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 5 11 3.44% ILAIGLINEALDEGDAQK 95.00% 4.64 0.428 3.85 628.6766 1,883.01 1,883.01 3
 SAMPLE 1R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 5 11 3.44% LEGVLAEVAQHYQDTLIR 95.00% 4.06 0.478 2.52 686.0331 2,055.08 2,055.09 3
 SAMPLE 1R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 5 11 3.44% LEGVLAEVAQHYQDTLIR 95.00% 2.71 0.315 0 686.0339 2,055.08 2,055.09 3
 SAMPLE 1R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 5 11 3.44% LGLAPQIQDLYGK 95.00% 2.35 0.341 0 708.3995 1,414.78 1,415.79 2
 SAMPLE 1R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 5 11 3.44% ILAIGLINEALDEGDAQK 95.00% 5.64 0.617 4.54 942.0077 1,882.00 1,883.01 2
 SAMPLE 1R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 5 11 3.44% ILAIGLINEALDEGDAQK 95.00% 6.14 0.569 4.36 942.5093 1,883.00 1,883.01 2
 SAMPLE 1R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 5 11 3.44% ILAIGLINEALDEGDAQK 95.00% 4.64 0.529 3.77 942.5094 1,883.00 1,883.01 2
 SAMPLE 1R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 5 11 3.44% ILAIGLINEALDEGDAQK 95.00% 5.41 0.503 5.09 942.5101 1,883.00 1,883.01 2
 SAMPLE 2 Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 99.80% 2 2 3 1.57% LGNFFSPK 95.00% 2.24 0.308 0 455.2463 908.477 909.4835 2
 SAMPLE 2 Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 99.80% 2 2 3 1.57% LGNFFSPK 95.00% 2.26 0.278 0 455.2489 908.4822 909.4835 2
 SAMPLE 2 Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 99.80% 2 2 3 1.57% LEGVLAEVAQHYQDTLIR 95.00% 2.57 0.278 0 685.701 2,054.08 2,055.09 3
 SAMPLE 2R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 3 3 5 2.17% LIFQMPQNK 95.00% 2.32 0.294 0 559.8051 1,117.59 1,118.60 2
 SAMPLE 2R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 3 3 5 2.17% LIFQMPQNK 94.90% 2.07 0.236 0 559.808 1,117.60 1,118.60 2
 SAMPLE 2R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 3 3 5 2.17% IIGNLLYYR 95.00% 2.93 0.313 0 562.8249 1,123.63 1,124.65 2
 SAMPLE 2R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 3 3 5 2.17% IIGNLLYYR 95.00% 2.85 0.306 0 562.8268 1,123.64 1,124.65 2
 SAMPLE 2R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 3 3 5 2.17% ILAIGLINEALDEGDAQK 95.00% 4.06 0.381 0 628.343 1,882.01 1,883.01 3
 SAMPLE 3R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 4 5 3.32% IIGNLLYYR 95.00% 2.47 0.28 0 562.8265 1,123.64 1,124.65 2
 SAMPLE 3R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 4 5 3.32% IIGNLLYYR 95.00% 2.41 0.222 0 562.828 1,123.64 1,124.65 2
 SAMPLE 3R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 4 5 3.32% YGIQMPAFSK 95.00% 2.73 0.502 3.68 571.2893 1,140.56 1,141.57 2
 SAMPLE 3R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 4 5 3.32% LEGVLAEVAQHYQDTLIR 95.00% 2.26 0.326 1.64 686.0347 2,055.08 2,055.09 3
 SAMPLE 3R Ras GTPase-activating-like protein IQGAP1  IQGAP1  IQGA1_HUMAN 189,240.60 100.00% 4 4 5 3.32% ILAIGLINEALDEGDAQK 95.00% 5.13 0.577 5.38 942.51 1,883.00 1,883.01 2
 SAMPLE 1 Ras suppressor protein 1  RSU1  RSU1_HUMAN 31,524.20 99.80% 2 2 6 11.90% LQILSLRDNDLISLPK 95.00% 2.71 0.275 0 613.7043 1,838.09 1,838.08 3
 SAMPLE 1 Ras suppressor protein 1  RSU1  RSU1_HUMAN 31,524.20 99.80% 2 2 6 11.90% LTVLPPELGNLDLTGQK 95.00% 3.57 0.498 5.36 904.5081 1,807.00 1,808.02 2
 SAMPLE 1 Ras suppressor protein 1  RSU1  RSU1_HUMAN 31,524.20 99.80% 2 2 6 11.90% LTVLPPELGNLDLTGQK 95.00% 3.49 0.497 2.46 904.5179 1,807.02 1,808.02 2
 SAMPLE 1 Ras suppressor protein 1  RSU1  RSU1_HUMAN 31,524.20 99.80% 2 2 6 11.90% LTVLPPELGNLDLTGQK 95.00% 3.08 0.34 3.05 904.5182 1,807.02 1,808.02 2
 SAMPLE 1 Ras suppressor protein 1  RSU1  RSU1_HUMAN 31,524.20 99.80% 2 2 6 11.90% LTVLPPELGNLDLTGQK 95.00% 4.19 0.553 5.02 905.0112 1,808.01 1,808.02 2
 SAMPLE 1 Ras suppressor protein 1  RSU1  RSU1_HUMAN 31,524.20 99.80% 2 2 6 11.90% LTVLPPELGNLDLTGQK 95.00% 3.63 0.23 4.62 905.031 1,808.05 1,808.02 2
 SAMPLE 1R Ras suppressor protein 1  RSU1  RSU1_HUMAN 31,524.20 99.80% 2 2 6 11.90% LQILSLRDNDLISLPK 95.00% 2.71 0.275 0 613.7043 1,838.09 1,838.08 3
 SAMPLE 1R Ras suppressor protein 1  RSU1  RSU1_HUMAN 31,524.20 99.80% 2 2 6 11.90% LQILSLRDNDLISLPK 95.00% 3.03 0.378 0 613.709 1,838.10 1,838.08 3
 SAMPLE 1R Ras suppressor protein 1  RSU1  RSU1_HUMAN 31,524.20 99.80% 2 2 6 11.90% LTVLPPELGNLDLTGQK 95.00% 3.49 0.497 2.57 904.5179 1,807.02 1,808.02 2
 SAMPLE 1R Ras suppressor protein 1  RSU1  RSU1_HUMAN 31,524.20 99.80% 2 2 6 11.90% LTVLPPELGNLDLTGQK 95.00% 3.08 0.34 3.04 904.5182 1,807.02 1,808.02 2
 SAMPLE 1R Ras suppressor protein 1  RSU1  RSU1_HUMAN 31,524.20 99.80% 2 2 6 11.90% LTVLPPELGNLDLTGQK 95.00% 2.16 0.392 0 904.5294 1,807.04 1,808.02 2
 SAMPLE 1R Ras suppressor protein 1  RSU1  RSU1_HUMAN 31,524.20 99.80% 2 2 6 11.90% LTVLPPELGNLDLTGQK 95.00% 3.7 0.308 5.42 904.5296 1,807.04 1,808.02 2
 SAMPLE 2 Ras-related C3 botulinum toxin substrate 1  RAC1  RAC1_HUMAN,RAC2_HUMAN 21,432.60 99.80% 2 2 4 11.50% LDLRDDKDTIEK 95.00% 2.46 0.208 0 487.591 1,459.75 1,460.76 3
 SAMPLE 2 Ras-related C3 botulinum toxin substrate 1  RAC1  RAC1_HUMAN,RAC2_HUMAN 21,432.60 99.80% 2 2 4 11.50% YLEcSALTQR 95.00% 3.28 0.44 0 c4: Carbamidomethyl (+57.02) 620.8012 1,239.59 1,240.60 2
 SAMPLE 2 Ras-related C3 botulinum toxin substrate 1  RAC1  RAC1_HUMAN,RAC2_HUMAN 21,432.60 99.80% 2 2 4 11.50% YLEcSALTQR 95.00% 3.12 0.447 1.64 c4: Carbamidomethyl (+57.02) 620.8026 1,239.59 1,240.60 2
 SAMPLE 2 Ras-related C3 botulinum toxin substrate 1  RAC1  RAC1_HUMAN,RAC2_HUMAN 21,432.60 99.80% 2 2 4 11.50% YLEcSALTQR 95.00% 2.65 0.327 1.17 c4: Carbamidomethyl (+57.02) 620.8044 1,239.59 1,240.60 2
 SAMPLE 2R Ras-related C3 botulinum toxin substrate 1  RAC1  RAC1_HUMAN,RAC2_HUMAN 21,432.60 99.80% 2 2 3 11.50% LDLRDDKDTIEK 95.00% 2.64 0.296 0 487.9255 1,460.75 1,460.76 3
 SAMPLE 2R Ras-related C3 botulinum toxin substrate 1  RAC1  RAC1_HUMAN,RAC2_HUMAN 21,432.60 99.80% 2 2 3 11.50% YLEcSALTQR 95.00% 2.35 0.305 3.43 c4: Carbamidomethyl (+57.02) 620.8023 1,239.59 1,240.60 2
 SAMPLE 2R Ras-related C3 botulinum toxin substrate 1  RAC1  RAC1_HUMAN,RAC2_HUMAN 21,432.60 99.80% 2 2 3 11.50% YLEcSALTQR 95.00% 2.13 0.314 1.11 c4: Carbamidomethyl (+57.02) 620.8065 1,239.60 1,240.60 2
 SAMPLE 2 Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 100.00% 3 3 4 17.00% IcSVDGIPAR 95.00% 2.44 0.242 0 c2: Carbamidomethyl (+57.02) 544.2788 1,086.54 1,087.56 2
 SAMPLE 2 Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 100.00% 3 3 4 17.00% VKDRDDFPVVLVGNK 95.00% 4.61 0.339 2.14 567.6477 1,699.92 1,700.93 3
 SAMPLE 2 Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 100.00% 3 3 4 17.00% VKDRDDFPVVLVGNK 95.00% 4.36 0.345 1.72 567.9828 1,700.92 1,700.93 3
 SAMPLE 2 Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 100.00% 3 3 4 17.00% LNVDEAFEQLVR 95.00% 3.84 0.522 3.89 716.8749 1,431.73 1,432.74 2
 SAMPLE 2R Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 99.80% 2 3 5 12.40% VKDRDDFPVVLVGNK 95.00% 3.93 0.435 1.6 567.6484 1,699.92 1,700.93 3
 SAMPLE 2R Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 99.80% 2 3 5 12.40% VKDRDDFPVVLVGNK 95.00% 3.93 0.308 2.01 567.9832 1,700.93 1,700.93 3
 SAMPLE 2R Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 99.80% 2 3 5 12.40% LNVDEAFEQLVR 95.00% 2.9 0.472 3.43 716.8767 1,431.74 1,432.74 2
 SAMPLE 2R Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 99.80% 2 3 5 12.40% LNVDEAFEQLVR 95.00% 4.13 0.507 4.7 717.3761 1,432.74 1,432.74 2
 SAMPLE 2R Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 99.80% 2 3 5 12.40% VKDRDDFPVVLVGNK 95.00% 0 0 3.49 852.3071 1,702.60 1,700.93 2
 SAMPLE 3 Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 99.80% 2 2 2 16.10% VKDRDDFPVVLVGNK 95.00% 4.7 0.419 1.92 567.6474 1,699.92 1,700.93 3
 SAMPLE 3 Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 99.80% 2 2 2 16.10% SEASAFGASHHVAYFEASAK 95.00% 2.48 0.298 0 689.9894 2,066.94 2,066.96 3
 SAMPLE 3R Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 99.80% 2 2 3 12.40% VKDRDDFPVVLVGNK 95.00% 4.88 0.388 2.74 567.9832 1,700.93 1,700.93 3
 SAMPLE 3R Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 99.80% 2 2 3 12.40% VKDRDDFPVVLVGNK 95.00% 4.36 0.323 1.24 567.9839 1,700.93 1,700.93 3
 SAMPLE 3R Ras-related protein R-Ras  RRAS  RRAS_HUMAN 23,462.50 99.80% 2 2 3 12.40% LNVDEAFEQLVR 95.00% 3.84 0.524 2.96 716.8732 1,431.73 1,432.74 2
 SAMPLE 1R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 2 13.60% LVVLGSGGVGK 95.00% 2.73 0.431 3 493.3115 984.6073 985.6048 2 NEXN_HUMAN,VINC_HUMAN,F10A1_HUMAN
 SAMPLE 1R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 2 13.60% SKINVNEIFYDLVR 95.00% 3.2 0.384 0 570.9809 1,709.92 1,709.92 3
 SAMPLE 1R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 2 13.60% INVNEIFYDLVR 95.00% 3.9 0.489 2.32 747.9123 1,493.81 1,494.80 2
 SAMPLE 2 Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 100.00% 4 4 7 27.20% LVVLGSGGVGK 95.00% 3.12 0.386 2.44 493.3047 984.5937 985.6048 2 NEXN_HUMAN,VINC_HUMAN,F10A1_HUMAN
 SAMPLE 2 Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 100.00% 4 4 7 27.20% LVVLGSGGVGK 95.00% 3.04 0.407 2.27 493.3048 984.594 985.6048 2 NEXN_HUMAN,VINC_HUMAN,F10A1_HUMAN
 SAMPLE 2 Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 100.00% 4 4 7 27.20% VKDTEDVPMILVGNK 95.00% 1.95 0.293 0 553.2985 1,656.87 1,657.88 3
 SAMPLE 2 Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 100.00% 4 4 7 27.20% YDPTIEDSYR 95.00% 2.63 0.354 0 629.7818 1,257.55 1,258.56 2
 SAMPLE 2 Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 100.00% 4 4 7 27.20% YDPTIEDSYR 95.00% 2.39 0.459 1.2 629.7824 1,257.55 1,258.56 2
 SAMPLE 2 Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 100.00% 4 4 7 27.20% YDPTIEDSYRK 95.00% 2.45 0.391 1.82 693.8291 1,385.64 1,386.65 2
 SAMPLE 2 Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 100.00% 4 4 7 27.20% YDPTIEDSYRK 95.00% 2.43 0.243 0 693.8315 1,385.65 1,386.65 2
 SAMPLE 2 Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 100.00% 4 4 7 27.20% QWcNcAFLESSAK 95.00% 3.68 0.562 4.08 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 800.8476 1,599.68 1,600.69 2
 SAMPLE 2 Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 100.00% 4 4 7 27.20% QWcNcAFLESSAK 95.00% 3.43 0.508 2.11 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 800.8482 1,599.68 1,600.69 2
 SAMPLE 2R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 4 18.50% LVVLGSGGVGK 95.00% 2.99 0.43 2.49 493.3048 984.5939 985.6048 2 NEXN_HUMAN,VINC_HUMAN,F10A1_HUMAN
 SAMPLE 2R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 4 18.50% LVVLGSGGVGK 95.00% 2.93 0.412 2.92 493.3049 984.5941 985.6048 2 NEXN_HUMAN,VINC_HUMAN,F10A1_HUMAN
 SAMPLE 2R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 4 18.50% YDPTIEDSYR 95.00% 2.34 0.362 0 629.7815 1,257.55 1,258.56 2
 SAMPLE 2R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 4 18.50% YDPTIEDSYR 95.00% 2.38 0.308 0 629.783 1,257.55 1,258.56 2
 SAMPLE 2R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 4 18.50% QWcNcAFLESSAK 95.00% 3.42 0.474 1.24 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 800.8456 1,599.68 1,600.69 2
 SAMPLE 2R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 4 18.50% QWcNcAFLESSAK 95.00% 3.68 0.516 1.6 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 800.8468 1,599.68 1,600.69 2
 SAMPLE 3R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 3 20.70% LVVLGSGGVGK 95.00% 2.89 0.426 3.22 493.3051 984.5946 985.6048 2 NEXN_HUMAN,VINC_HUMAN,F10A1_HUMAN
 SAMPLE 3R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 3 20.70% LVVLGSGGVGK 95.00% 2.89 0.404 2.89 493.3056 984.5955 985.6048 2 NEXN_HUMAN,VINC_HUMAN,F10A1_HUMAN
 SAMPLE 3R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 3 20.70% LVVLGSGGVGK 95.00% 2.63 0.389 2.42 493.3058 984.596 985.6048 2 NEXN_HUMAN,VINC_HUMAN,F10A1_HUMAN
 SAMPLE 3R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 3 20.70% LVVLGSGGVGK 95.00% 2.54 0.422 2.06 493.8059 985.5962 985.6048 2 NEXN_HUMAN,VINC_HUMAN,F10A1_HUMAN
 SAMPLE 3R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 3 20.70% SKINVNEIFYDLVR 95.00% 3.58 0.463 1.46 570.6454 1,708.91 1,709.92 3
 SAMPLE 3R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 3 20.70% SKINVNEIFYDLVR 95.00% 4.07 0.357 0 570.9797 1,709.92 1,709.92 3
 SAMPLE 3R Ras-related protein Rap-1A  RAP1A  RAP1A_HUMAN 20,969.30 99.80% 2 2 3 20.70% QWcNcAFLESSAK 95.00% 3.5 0.351 0 c3: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 800.849 1,599.68 1,600.69 2
 SAMPLE 2R Retinitis pigmentosa 1-like 1 protein  RP1L1  RP1L1_HUMAN 261,078.50 99.80% 2 2 3 1.49% TPEDGVDSASPSAQIGAER 95.00% 2.12 0.278 0 629.3019 1,884.88 1,886.87 3
 SAMPLE 2R Retinitis pigmentosa 1-like 1 protein  RP1L1  RP1L1_HUMAN 261,078.50 99.80% 2 2 3 1.49% DKDPKLGEAEGDAmAQER 95.00% 2.11 0.279 0 m14: Oxidation (+15.99) 658.8817 1,973.62 1,975.90 3
 SAMPLE 2R Retinitis pigmentosa 1-like 1 protein  RP1L1  RP1L1_HUMAN 261,078.50 99.80% 2 2 3 1.49% DKDPKLGEAEGDAmAQER 95.00% 2.62 0.332 0 m14: Oxidation (+15.99) 659.3835 1,975.13 1,975.90 3
 SAMPLE 1 Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 99.80% 2 2 7 15.20% SIQEIQELDKDDESLR 95.00% 2.36 0.284 1.19 640.3179 1,917.93 1,917.94 3
 SAMPLE 1 Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 99.80% 2 2 7 15.20% SIQEIQELDKDDESLR 95.00% 2.64 0.384 1.54 640.318 1,917.93 1,917.94 3
 SAMPLE 1 Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 99.80% 2 2 7 15.20% AEEYEFLTPVEEAPK 95.00% 4.14 0.552 4.15 876.4209 1,750.83 1,751.84 2
 SAMPLE 1 Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 99.80% 2 2 7 15.20% AEEYEFLTPVEEAPK 95.00% 4.44 0.575 3.49 876.421 1,750.83 1,751.84 2
 SAMPLE 1 Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 99.80% 2 2 7 15.20% AEEYEFLTPVEEAPK 95.00% 3.82 0.468 3.57 876.4219 1,750.83 1,751.84 2
 SAMPLE 1 Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 99.80% 2 2 7 15.20% AEEYEFLTPVEEAPK 95.00% 4.07 0.566 4.03 876.9247 1,751.83 1,751.84 2
 SAMPLE 1 Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 99.80% 2 2 7 15.20% AEEYEFLTPVEEAPK 95.00% 4.48 0.505 3.35 876.9348 1,751.85 1,751.84 2
 SAMPLE 2 Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 100.00% 3 3 5 15.70% SIQEIQELDKDDESLR 95.00% 2.38 0.319 0 640.3188 1,917.93 1,917.94 3
 SAMPLE 2 Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 100.00% 3 3 5 15.70% SIQEIQELDKDDESLRK 95.00% 3.78 0.477 0 683.015 2,046.02 2,046.04 3
 SAMPLE 2 Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 100.00% 3 3 5 15.70% SIQEIQELDKDDESLRK 95.00% 3.7 0.456 1.49 683.0163 2,046.03 2,046.04 3
 SAMPLE 2 Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 100.00% 3 3 5 15.70% AEEYEFLTPVEEAPK 95.00% 3.54 0.534 4.66 876.4209 1,750.83 1,751.84 2
 SAMPLE 2 Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 100.00% 3 3 5 15.70% AEEYEFLTPVEEAPK 95.00% 4.33 0.511 4.55 876.9205 1,751.83 1,751.84 2
 SAMPLE 2R Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 99.80% 2 2 3 15.70% SIQEIQELDKDDESLRK 95.00% 3.41 0.511 0 683.017 2,046.03 2,046.04 3
 SAMPLE 2R Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 99.80% 2 2 3 15.70% AEEYEFLTPVEEAPK 95.00% 4.09 0.558 5.28 876.4212 1,750.83 1,751.84 2
 SAMPLE 2R Rho GDP-dissociation inhibitor 1  ARHGDIA  GDIR1_HUMAN 23,189.50 99.80% 2 2 3 15.70% AEEYEFLTPVEEAPK 95.00% 4.05 0.497 3.96 876.4217 1,750.83 1,751.84 2
 SAMPLE 3 Rho-related GTP-binding protein RhoC  RHOC  RHOC_HUMAN 21,988.70 99.80% 2 2 2 13.00% LVIVGDGAcGK 95.00% 1.95 0.339 2 c9: Carbamidomethyl (+57.02) 544.7915 1,087.57 1,088.58 2
 SAMPLE 3 Rho-related GTP-binding protein RhoC  RHOC  RHOC_HUMAN 21,988.70 99.80% 2 2 2 13.00% HFcPNVPIILVGNK 95.00% 3.55 0.562 5.55 c3: Carbamidomethyl (+57.02) 804.4407 1,606.87 1,607.87 2
 SAMPLE 4 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 3 3 6 15.90% FTGDccFDYDR 95.00% 3.42 0.582 3.1 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 728.272 1,454.53 1,455.53 2
 SAMPLE 4 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 3 3 6 15.90% VYGTcFcDQAcR 95.00% 3.19 0.305 0 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8093 1,535.60 1,536.60 2
 SAMPLE 4 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 3 3 6 15.90% VYGTcFcDQAcR 95.00% 3.91 0.418 3.48 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8121 1,535.61 1,536.60 2
 SAMPLE 4 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 3 3 6 15.90% VYGTcFcDQAcR 95.00% 3.69 0.393 2.01 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.814 1,535.61 1,536.60 2
 SAMPLE 4 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 3 3 6 15.90% SVQQEPQNGGAPcPPLEER 95.00% 4.51 0.526 4.66 c13: Carbamidomethyl (+57.02) 1,047.49 2,092.97 2,092.97 2
 SAMPLE 4 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 3 3 6 15.90% SVQQEPQNGGAPcPPLEER 95.00% 5.04 0.582 6.36 c13: Carbamidomethyl (+57.02) 1,047.49 2,092.97 2,092.97 2
 SAMPLE 4R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 99.80% 2 2 5 8.71% FTGDccFDYDR 95.00% 3.1 0.385 3.52 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 728.2716 1,454.53 1,455.53 2
 SAMPLE 4R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 99.80% 2 2 5 8.71% FTGDccFDYDR 95.00% 3.45 0.516 3.08 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 728.2721 1,454.53 1,455.53 2
 SAMPLE 4R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 99.80% 2 2 5 8.71% VYGTcFcDQAcR 95.00% 3.81 0.419 3.66 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8132 1,535.61 1,536.60 2
 SAMPLE 4R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 99.80% 2 2 5 8.71% VYGTcFcDQAcR 95.00% 3.73 0.391 2.92 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8147 1,535.61 1,536.60 2
 SAMPLE 4R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 99.80% 2 2 5 8.71% VYGTcFcDQAcR 95.00% 3.67 0.375 1.36 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8175 1,535.62 1,536.60 2
 SAMPLE 2 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 7 22.30% TESLTPHcALENWPLTR 95.00% 4.74 0.576 1.6 c8: Carbamidomethyl (+57.02) 676.0004 2,024.98 2,024.99 3
 SAMPLE 2 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 7 22.30% TESLTPHcALENWPLTR 95.00% 3.29 0.563 1.02 c8: Carbamidomethyl (+57.02) 676.0005 2,024.98 2,024.99 3
 SAMPLE 2 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 7 22.30% FTGDccFDYDR 95.00% 3.52 0.555 2.92 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 728.2677 1,454.52 1,455.53 2
 SAMPLE 2 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 7 22.30% VYGTcFcDQAcR 95.00% 4.01 0.546 3.82 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8047 1,535.59 1,536.60 2
 SAMPLE 2 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 7 22.30% VYGTcFcDQAcR 95.00% 3.83 0.503 3.89 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8062 1,535.60 1,536.60 2
 SAMPLE 2 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 7 22.30% SVQQEPQNGGAPcPPLEER 95.00% 5.09 0.597 6.82 c13: Carbamidomethyl (+57.02) 1,046.99 2,091.96 2,092.97 2
 SAMPLE 2 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 7 22.30% SVQQEPQNGGAPcPPLEER 95.00% 5.1 0.583 5.11 c13: Carbamidomethyl (+57.02) 1,047.49 2,092.96 2,092.97 2
 SAMPLE 2R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 8 22.30% TESLTPHcALENWPLTR 95.00% 4.26 0.512 0 c8: Carbamidomethyl (+57.02) 676.0002 2,024.98 2,024.99 3
 SAMPLE 2R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 8 22.30% TESLTPHcALENWPLTR 95.00% 4.22 0.572 0 c8: Carbamidomethyl (+57.02) 676.0015 2,024.98 2,024.99 3
 SAMPLE 2R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 8 22.30% FTGDccFDYDR 95.00% 3.54 0.599 3.09 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 728.268 1,454.52 1,455.53 2
 SAMPLE 2R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 8 22.30% FTGDccFDYDR 95.00% 3.34 0.54 2.66 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 728.2682 1,454.52 1,455.53 2
 SAMPLE 2R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 8 22.30% VYGTcFcDQAcR 95.00% 3.79 0.492 3.96 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8056 1,535.60 1,536.60 2
 SAMPLE 2R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 8 22.30% VYGTcFcDQAcR 95.00% 3.92 0.431 3.47 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 769.3064 1,536.60 1,536.60 2
 SAMPLE 2R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 8 22.30% SVQQEPQNGGAPcPPLEER 95.00% 4.84 0.577 4.52 c13: Carbamidomethyl (+57.02) 1,047.49 2,092.96 2,092.97 2
 SAMPLE 2R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 4 4 8 22.30% SVQQEPQNGGAPcPPLEER 95.00% 5.09 0.561 5.19 c13: Carbamidomethyl (+57.02) 1,047.49 2,092.96 2,092.97 2
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% RVDQcScPAVHSFIFI 95.00% 3.12 0.439 1.38 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 645.9781 1,934.91 1,935.92 3
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% RVDQcScPAVHSFIFI 95.00% 3.28 0.496 0 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 646.3118 1,935.91 1,935.92 3
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% FTGDccFDYDR 95.00% 3.38 0.577 2.85 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 728.2682 1,454.52 1,455.53 2
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% FTGDccFDYDR 95.00% 3.13 0.555 3.26 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 728.2686 1,454.52 1,455.53 2
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% ccPGRDPAcFAR 95.00% 1.97 0.327 1.85 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 733.8053 1,465.59 1,466.61 2
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% RSVQQEPQNGGAPcPPLEER 95.00% 3.13 0.216 1 c14: Carbamidomethyl (+57.02) 750.695 2,249.06 2,249.07 3
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% RSVQQEPQNGGAPcPPLEER 95.00% 3.71 0.189 1.47 c14: Carbamidomethyl (+57.02) 750.6973 2,249.07 2,249.07 3
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% VYGTcFcDQAcR 95.00% 2.33 0.265 2 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.802 1,535.59 1,536.60 2
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% VYGTcFcDQAcR 95.00% 3.97 0.546 4.49 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8026 1,535.59 1,536.60 2
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% VYGTcFcDQAcR 95.00% 2.88 0.391 2.74 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8039 1,535.59 1,536.60 2
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% VYGTcFcDQAcR 95.00% 4.04 0.504 4.03 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8048 1,535.59 1,536.60 2
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% VYGTcFcDQAcR 95.00% 3.09 0.517 4.05 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8065 1,535.60 1,536.60 2
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% SVQQEPQNGGAPcPPLEER 95.00% 5.15 0.606 5.23 c13: Carbamidomethyl (+57.02) 1,046.99 2,091.96 2,092.97 2
 SAMPLE 3 RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 6 6 14 26.90% SVQQEPQNGGAPcPPLEER 95.00% 5.24 0.587 5.7 c13: Carbamidomethyl (+57.02) 1,047.49 2,092.96 2,092.97 2
 SAMPLE 3R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 5 6 12 22.00% RVDQcScPAVHSFIFI 95.00% 2.41 0.401 0 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 646.3108 1,935.91 1,935.92 3
 SAMPLE 3R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 5 6 12 22.00% RVDQcScPAVHSFIFI 95.00% 2.78 0.424 0 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 646.3118 1,935.91 1,935.92 3
 SAMPLE 3R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 5 6 12 22.00% FTGDccFDYDR 95.00% 3.14 0.545 2.52 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 728.2674 1,454.52 1,455.53 2
 SAMPLE 3R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 5 6 12 22.00% FTGDccFDYDR 95.00% 3.29 0.609 3 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 728.7672 1,455.52 1,455.53 2
 SAMPLE 3R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 5 6 12 22.00% VYGTcFcDQAcR 95.00% 3.98 0.489 3.7 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8035 1,535.59 1,536.60 2
 SAMPLE 3R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 5 6 12 22.00% VYGTcFcDQAcR 95.00% 2.28 0.32 1.7 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 768.8076 1,535.60 1,536.60 2
 SAMPLE 3R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 5 6 12 22.00% VYGTcFcDQAcR 95.00% 3.88 0.507 4.39 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c11: Carbamidomethyl (+57.02) 769.3056 1,536.60 1,536.60 2
 SAMPLE 3R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 5 6 12 22.00% VDQcScPAVHSFIFI 95.00% 2.79 0.372 2.09 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 890.9152 1,779.81 1,779.82 2
 SAMPLE 3R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 5 6 12 22.00% RVDQcScPAVHSFIFI 95.00% 3.31 0.488 1.23 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 968.4635 1,934.91 1,935.92 2
 SAMPLE 3R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 5 6 12 22.00% RVDQcScPAVHSFIFI 95.00% 3.52 0.52 1.6 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 968.9591 1,935.90 1,935.92 2
 SAMPLE 3R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 5 6 12 22.00% SVQQEPQNGGAPcPPLEER 95.00% 4.89 0.61 4.64 c13: Carbamidomethyl (+57.02) 1,046.99 2,091.96 2,092.97 2
 SAMPLE 3R RPE-spondin  RPESP  RPESP_HUMAN 29,591.40 100.00% 5 6 12 22.00% SVQQEPQNGGAPcPPLEER 95.00% 5.25 0.57 5.89 c13: Carbamidomethyl (+57.02) 1,047.49 2,092.96 2,092.97 2
 SAMPLE 3 Sclerostin  SOST  SOST_HUMAN 24,012.50 99.80% 2 2 3 14.10% SAKPVTELVcSGQcGPAR 95.00% 3.08 0.35 1.42 c10: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 639.9825 1,916.92 1,916.93 3
 SAMPLE 3 Sclerostin  SOST  SOST_HUMAN 24,012.50 99.80% 2 2 3 14.10% VQLLcPGGEAPR 95.00% 3.3 0.398 2.21 c5: Carbamidomethyl (+57.02) 648.839 1,295.66 1,296.67 2
 SAMPLE 3 Sclerostin  SOST  SOST_HUMAN 24,012.50 99.80% 2 2 3 14.10% VQLLcPGGEAPR 95.00% 3.01 0.36 1.74 c5: Carbamidomethyl (+57.02) 648.8398 1,295.66 1,296.67 2
 SAMPLE 1 Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 100.00% 3 3 8 14.00% SEAIIEHLcASEFALR 95.00% 4.64 0.514 1.77 c9: Carbamidomethyl (+57.02) 615.9754 1,844.90 1,845.92 3
 SAMPLE 1 Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 100.00% 3 3 8 14.00% FYTKPPQcVDIPADLR 95.00% 3.45 0.431 0 c8: Carbamidomethyl (+57.02) 640.6638 1,918.97 1,919.97 3
 SAMPLE 1 Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 100.00% 3 3 8 14.00% FYTKPPQcVDIPADLR 95.00% 3.7 0.455 0 c8: Carbamidomethyl (+57.02) 641.0009 1,919.98 1,919.97 3
 SAMPLE 1 Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 100.00% 3 3 8 14.00% QQASSWVPLLNK 95.00% 2.53 0.327 0 685.7054 1,369.40 1,370.74 2
 SAMPLE 1 Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 100.00% 3 3 8 14.00% QQASSWVPLLNK 95.00% 2.34 0.354 0 685.8726 1,369.73 1,370.74 2
 SAMPLE 1 Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 100.00% 3 3 8 14.00% QQASSWVPLLNK 95.00% 2.91 0.4 1.19 685.8726 1,369.73 1,370.74 2
 SAMPLE 1 Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 100.00% 3 3 8 14.00% QQASSWVPLLNK 95.00% 3.24 0.389 1.39 685.8741 1,369.73 1,370.74 2
 SAMPLE 1 Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 100.00% 3 3 8 14.00% QQASSWVPLLNK 95.00% 3.16 0.362 0 685.8749 1,369.73 1,370.74 2
 SAMPLE 1R Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 99.80% 2 2 5 8.92% FYTKPPQcVDIPADLR 95.00% 3.45 0.431 0 c8: Carbamidomethyl (+57.02) 640.6638 1,918.97 1,919.97 3
 SAMPLE 1R Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 99.80% 2 2 5 8.92% FYTKPPQcVDIPADLR 95.00% 3.7 0.455 0 c8: Carbamidomethyl (+57.02) 641.0009 1,919.98 1,919.97 3
 SAMPLE 1R Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 99.80% 2 2 5 8.92% QQASSWVPLLNK 95.00% 2.62 0.247 0 685.7048 1,369.39 1,370.74 2
 SAMPLE 1R Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 99.80% 2 2 5 8.92% QQASSWVPLLNK 95.00% 2.91 0.4 1.66 685.8726 1,369.73 1,370.74 2
 SAMPLE 1R Secreted frizzled-related protein 1  SFRP1  SFRP1_HUMAN 35,368.30 99.80% 2 2 5 8.92% QQASSWVPLLNK 95.00% 3.16 0.362 0 685.8749 1,369.73 1,370.74 2
 SAMPLE 3 Septin-11  SEPT11  SEP11_HUMAN 49,381.10 99.80% 2 3 3 11.70% SLDLVTMK 95.00% 1.86 0.406 0 453.7519 905.4881 906.4972 2
 SAMPLE 3 Septin-11  SEPT11  SEP11_HUMAN 49,381.10 99.80% 2 3 3 11.70% VNIIPIIAK 95.00% 2.07 0.229 0 490.8277 979.6397 980.651 2 SEPT7_HUMAN
 SAMPLE 3 Septin-11  SEPT11  SEP11_HUMAN 49,381.10 99.80% 2 3 3 11.70% VNIIPIIAK 95.00% 2.59 0.335 0 490.8282 979.6408 980.651 2 SEPT7_HUMAN
 SAMPLE 3 Septin-11  SEPT11  SEP11_HUMAN 49,381.10 99.80% 2 3 3 11.70% VNIIPIIAK 95.00% 2.18 0.287 2.11 490.8283 979.6409 980.651 2 SEPT7_HUMAN
 SAMPLE 3 Septin-11  SEPT11  SEP11_HUMAN 49,381.10 99.80% 2 3 3 11.70% FESDPATHNEPGVR 95.00% 2.2 0.449 0 519.2421 1,554.70 1,555.71 3 VIME_HUMAN
 SAMPLE 3 Septin-11  SEPT11  SEP11_HUMAN 49,381.10 99.80% 2 3 3 11.70% AAAQLLQSQAQQSGAQQTK 95.00% 5.01 0.573 3.77 653.0076 1,956.00 1,957.01 3
 SAMPLE 3 Septin-11  SEPT11  SEP11_HUMAN 49,381.10 99.80% 2 3 3 11.70% AAAQLLQSQAQQSGAQQTK 95.00% 5.8 0.601 7.85 979.5102 1,957.00 1,957.01 2
 SAMPLE 3R Septin-11  SEPT11  SEP11_HUMAN 49,381.10 99.80% 2 2 2 11.70% SLDLVTMK 95.00% 2.43 0.358 0 453.7531 905.4905 906.4972 2
 SAMPLE 3R Septin-11  SEPT11  SEP11_HUMAN 49,381.10 99.80% 2 2 2 11.70% VNIIPIIAK 95.00% 2.56 0.3 0 490.8272 979.6387 980.651 2 SEPT7_HUMAN
 SAMPLE 3R Septin-11  SEPT11  SEP11_HUMAN 49,381.10 99.80% 2 2 2 11.70% VNIIPIIAK 95.00% 2.64 0.298 0 490.8281 979.6405 980.651 2 SEPT7_HUMAN
 SAMPLE 3R Septin-11  SEPT11  SEP11_HUMAN 49,381.10 99.80% 2 2 2 11.70% FESDPATHNEPGVR 95.00% 1.72 0.285 0 519.2422 1,554.70 1,555.71 3 VIME_HUMAN
 SAMPLE 3R Septin-11  SEPT11  SEP11_HUMAN 49,381.10 99.80% 2 2 2 11.70% AAAQLLQSQAQQSGAQQTK 95.00% 5.85 0.596 6.16 979.5091 1,957.00 1,957.01 2
 SAMPLE 1 Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 99.80% 2 2 2 11.10% ILDEIEEHNIK 95.00% 3.83 0.351 1.62 676.8585 1,351.70 1,352.71 2
 SAMPLE 1 Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 99.80% 2 2 2 11.10% TIISYIDEQFER 95.00% 3.23 0.521 5.33 757.3782 1,512.74 1,513.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,ACTB_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 99.80% 2 2 2 11.10% TIISYIDEQFER 95.00% 4.18 0.566 4.11 757.3796 1,512.74 1,513.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,ACTB_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 99.80% 2 2 2 11.10% TIISYIDEQFER 95.00% 3.71 0.62 4.96 757.38 1,512.74 1,513.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,ACTB_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 99.80% 2 2 2 11.10% TIISYIDEQFER 95.00% 4.05 0.553 4.14 757.3865 1,512.76 1,513.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,ACTB_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 99.80% 2 2 2 11.10% TIISYIDEQFER 95.00% 2.72 0.336 4.62 757.395 1,512.77 1,513.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,ACTB_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1 Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 99.80% 2 2 2 11.10% ASIPFSVVGSNQLIEAK 95.00% 4.46 0.456 3.85 880.9804 1,759.95 1,759.96 2
 SAMPLE 1R Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 100.00% 3 3 5 15.50% ILDEIEEHNIK 95.00% 3.34 0.448 1.62 676.8558 1,351.70 1,352.71 2
 SAMPLE 1R Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 100.00% 3 3 5 15.50% ILDEIEEHNIK 95.00% 3.12 0.407 0 676.8566 1,351.70 1,352.71 2
 SAMPLE 1R Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 100.00% 3 3 5 15.50% TIISYIDEQFER 95.00% 3.44 0.557 3.43 757.3766 1,512.74 1,513.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,ACTB_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 100.00% 3 3 5 15.50% TIISYIDEQFER 95.00% 4.18 0.566 4.26 757.3796 1,512.74 1,513.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,ACTB_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 100.00% 3 3 5 15.50% TIISYIDEQFER 95.00% 4.05 0.553 4.23 757.3865 1,512.76 1,513.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,ACTB_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 100.00% 3 3 5 15.50% TIISYIDEQFER 95.00% 3.52 0.543 2.64 757.3958 1,512.78 1,513.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,ACTB_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 100.00% 3 3 5 15.50% TIISYIDEQFER 95.00% 3.86 0.564 3.85 757.8799 1,513.74 1,513.75 2 LRP1_HUMAN,SPON1_HUMAN,ACTC_HUMAN,ACTB_HUMAN,DHSB_HUMAN,TITIN_HUMAN,ACTG_HUMAN
 SAMPLE 1R Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 100.00% 3 3 5 15.50% ASIPFSVVGSNQLIEAK 95.00% 3.48 0.485 5.07 880.4814 1,758.95 1,759.96 2
 SAMPLE 1R Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 100.00% 3 3 5 15.50% ASIPFSVVGSNQLIEAK 95.00% 4.02 0.437 3.19 880.9818 1,759.95 1,759.96 2
 SAMPLE 1R Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 100.00% 3 3 5 15.50% STLINSLFLTDLYPER 95.00% 3.13 0.431 1.51 942.0016 1,881.99 1,882.00 2
 SAMPLE 3 Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 99.80% 2 2 2 5.54% VNIVPVIAK 95.00% 1.89 0.254 1.09 476.813 951.6104 952.6196 2
 SAMPLE 3 Septin-2  SEPT2  SEPT2_HUMAN 41,470.10 99.80% 2 2 2 5.54% ILDEIEEHNIK 95.00% 2.56 0.404 1.25 676.8546 1,351.69 1,352.71 2
 SAMPLE 1 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 3 3 5 8.24% VNIIPLIAK 95.00% 2.41 0.29 1.42 490.8278 979.64 980.651 2 SEP11_HUMAN
 SAMPLE 1 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 3 3 5 8.24% VNIIPLIAK 95.00% 2.3 0.274 1.26 490.8286 979.6416 980.651 2 SEP11_HUMAN
 SAMPLE 1 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 3 3 5 8.24% FEDYLNAESR 95.00% 2.81 0.345 2.57 622.2822 1,242.55 1,243.56 2
 SAMPLE 1 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 3 3 5 8.24% FEDYLNAESR 95.00% 2.98 0.356 2.64 622.2823 1,242.55 1,243.56 2
 SAMPLE 1 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 3 3 5 8.24% NLEGYVGFANLPNQVYR 95.00% 4.25 0.623 4.42 977.4843 1,952.95 1,953.98 2
 SAMPLE 1R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 7 11.40% VNIIPLIAK 95.00% 2.63 0.291 1.68 490.8285 979.6413 980.651 2 SEP11_HUMAN
 SAMPLE 1R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 7 11.40% VNIIPLIAK 95.00% 2.07 0.319 0 491.3284 980.6411 980.651 2 SEP11_HUMAN
 SAMPLE 1R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 7 11.40% FEDYLNAESR 95.00% 2.54 0.227 2.14 622.2821 1,242.55 1,243.56 2
 SAMPLE 1R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 7 11.40% ADTLTPEEcQQFK 95.00% 2.29 0.381 0 c9: Carbamidomethyl (+57.02) 783.8597 1,565.70 1,566.71 2
 SAMPLE 1R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 7 11.40% ADTLTPEEcQQFKK 95.00% 2.64 0.246 0 c9: Carbamidomethyl (+57.02) 847.9062 1,693.80 1,694.81 2
 SAMPLE 1R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 7 11.40% ADTLTPEEcQQFKK 95.00% 2.67 0.245 0 c9: Carbamidomethyl (+57.02) 848.4091 1,694.80 1,694.81 2
 SAMPLE 1R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 7 11.40% NLEGYVGFANLPNQVYR 95.00% 5.21 0.608 6.52 977.993 1,953.97 1,953.98 2
 SAMPLE 2 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 99.80% 2 2 4 6.41% QFEDEKANWEAQQR 95.00% 3.05 0.259 0 593.6074 1,777.80 1,778.81 3
 SAMPLE 2 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 99.80% 2 2 4 6.41% QFEDEKANWEAQQR 95.00% 3.41 0.308 0 593.6074 1,777.80 1,778.81 3
 SAMPLE 2 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 99.80% 2 2 4 6.41% ADTLTPEEcQQFKK 95.00% 3.35 0.403 0 c9: Carbamidomethyl (+57.02) 847.9068 1,693.80 1,694.81 2
 SAMPLE 2 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 99.80% 2 2 4 6.41% ADTLTPEEcQQFKK 95.00% 3.37 0.342 0 c9: Carbamidomethyl (+57.02) 848.4071 1,694.80 1,694.81 2
 SAMPLE 2R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 99.80% 2 2 3 5.26% VNIIPLIAK 95.00% 2.31 0.307 0 490.8279 979.6402 980.651 2 SEP11_HUMAN
 SAMPLE 2R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 99.80% 2 2 3 5.26% VNIIPLIAK 95.00% 2.47 0.317 0 490.8279 979.6402 980.651 2 SEP11_HUMAN
 SAMPLE 2R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 99.80% 2 2 3 5.26% ADTLTPEEcQQFKK 95.00% 2.9 0.308 0 c9: Carbamidomethyl (+57.02) 847.9093 1,693.80 1,694.81 2
 SAMPLE 3 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 9 13.50% VNIIPLIAK 95.00% 2.07 0.229 0 490.8277 979.6397 980.651 2 SEP11_HUMAN
 SAMPLE 3 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 9 13.50% VNIIPLIAK 95.00% 2.59 0.335 0 490.8282 979.6408 980.651 2 SEP11_HUMAN
 SAMPLE 3 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 9 13.50% VNIIPLIAK 95.00% 2.18 0.287 2.11 490.8283 979.6409 980.651 2 SEP11_HUMAN
 SAMPLE 3 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 9 13.50% QFEDEKANWEAQQR 95.00% 2.9 0.231 0 593.6072 1,777.80 1,778.81 3
 SAMPLE 3 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 9 13.50% FEDYLNAESR 95.00% 2.79 0.351 2.92 622.2809 1,242.55 1,243.56 2
 SAMPLE 3 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 9 13.50% FEDYLNAESR 95.00% 2.54 0.291 2.64 622.2835 1,242.55 1,243.56 2
 SAMPLE 3 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 9 13.50% DVTNNVHYENYR 95.00% 2.8 0.525 0 762.3477 1,522.68 1,523.69 2
 SAMPLE 3 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 9 13.50% ADTLTPEEcQQFKK 95.00% 2.93 0.347 0 c9: Carbamidomethyl (+57.02) 847.9078 1,693.80 1,694.81 2
 SAMPLE 3 Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 5 5 9 13.50% ADTLTPEEcQQFKK 95.00% 3.26 0.299 0 c9: Carbamidomethyl (+57.02) 848.4058 1,694.80 1,694.81 2
 SAMPLE 3R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 4 4 7 10.80% VNIIPLIAK 95.00% 2.56 0.3 0 490.8272 979.6387 980.651 2 SEP11_HUMAN
 SAMPLE 3R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 4 4 7 10.80% VNIIPLIAK 95.00% 2.64 0.298 0 490.8281 979.6405 980.651 2 SEP11_HUMAN
 SAMPLE 3R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 4 4 7 10.80% QFEDEKANWEAQQR 95.00% 2.87 0.175 0 593.9407 1,778.80 1,778.81 3
 SAMPLE 3R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 4 4 7 10.80% FEDYLNAESR 95.00% 2.27 0.259 1.85 622.2802 1,242.54 1,243.56 2
 SAMPLE 3R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 4 4 7 10.80% FEDYLNAESR 95.00% 2.93 0.367 2.43 622.7848 1,243.55 1,243.56 2
 SAMPLE 3R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 4 4 7 10.80% ADTLTPEEcQQFKK 95.00% 3.02 0.347 0 c9: Carbamidomethyl (+57.02) 848.4075 1,694.80 1,694.81 2
 SAMPLE 3R Septin-7  SEPT7  SEPT7_HUMAN 50,662.20 100.00% 4 4 7 10.80% ADTLTPEEcQQFKK 95.00% 3.25 0.339 0 c9: Carbamidomethyl (+57.02) 848.4083 1,694.80 1,694.81 2
 SAMPLE 1 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 99.80% 2 2 6 4.27% VVNIVPVIAK 95.00% 1.72 0.341 1.8 526.3462 1,050.68 1,051.69 2
 SAMPLE 1 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 99.80% 2 2 6 4.27% VVNIVPVIAK 95.00% 1.86 0.391 1.39 526.3468 1,050.68 1,051.69 2
 SAMPLE 1 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 99.80% 2 2 6 4.27% LEPKPQPPVAEATPR 95.00% 3.23 0.355 1.7 543.9684 1,628.88 1,629.90 3
 SAMPLE 1 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 99.80% 2 2 6 4.27% LEPKPQPPVAEATPR 95.00% 2.71 0.393 1.04 543.9686 1,628.88 1,629.90 3
 SAMPLE 1 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 99.80% 2 2 6 4.27% LEPKPQPPVAEATPR 95.00% 3.04 0.253 1 543.9692 1,628.88 1,629.90 3
 SAMPLE 1 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 99.80% 2 2 6 4.27% LEPKPQPPVAEATPR 95.00% 3.28 0.305 1.49 544.3044 1,629.89 1,629.90 3
 SAMPLE 2 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 4 9 5.80% STLINTLFK 95.00% 2.19 0.287 0 518.8053 1,035.60 1,036.60 2
 SAMPLE 2 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 4 9 5.80% VVNIVPVIAK 95.00% 2.2 0.414 0 526.3464 1,050.68 1,051.69 2
 SAMPLE 2 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 4 9 5.80% VVNIVPVIAK 95.00% 2.43 0.366 1.51 526.3466 1,050.68 1,051.69 2
 SAMPLE 2 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 4 9 5.80% LEPKPQPPVAEATPR 95.00% 3.28 0.275 0 543.9692 1,628.88 1,629.90 3
 SAMPLE 2 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 4 9 5.80% LEPKPQPPVAEATPR 95.00% 2.61 0.394 0 543.9707 1,628.89 1,629.90 3
 SAMPLE 2 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 4 9 5.80% LEPKPQPPVAEATPR 95.00% 3.59 0.531 1.68 544.303 1,629.89 1,629.90 3
 SAMPLE 2 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 4 9 5.80% LEPKPQPPVAEATPR 95.00% 3.5 0.419 0 544.3036 1,629.89 1,629.90 3
 SAMPLE 2 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 4 9 5.80% LEPKPQPPVAEATPR 95.00% 2.19 0.344 2.72 815.4495 1,628.88 1,629.90 2
 SAMPLE 2 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 4 9 5.80% LEPKPQPPVAEATPR 95.00% 2.8 0.5 3.8 815.4498 1,628.88 1,629.90 2
 SAMPLE 2R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.66% FQDLGVKNSEPSAR 95.00% 2.13 0.204 1.77 516.9268 1,547.76 1,547.78 3
 SAMPLE 2R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.66% VVNIVPVIAK 95.00% 2.15 0.411 0 526.3469 1,050.68 1,051.69 2
 SAMPLE 2R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.66% VVNIVPVIAK 95.00% 2.02 0.4 2.26 526.3475 1,050.68 1,051.69 2
 SAMPLE 2R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.66% LEPKPQPPVAEATPR 95.00% 2.84 0.367 0.959 543.9682 1,628.88 1,629.90 3
 SAMPLE 2R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.66% LEPKPQPPVAEATPR 95.00% 3.96 0.513 3.64 543.9689 1,628.88 1,629.90 3
 SAMPLE 2R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.66% LEPKPQPPVAEATPR 95.00% 3.74 0.537 2.72 543.9693 1,628.88 1,629.90 3
 SAMPLE 2R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.66% LEPKPQPPVAEATPR 95.00% 3.56 0.386 0 544.3048 1,629.89 1,629.90 3
 SAMPLE 3 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.83% VVNIVPVIAK 95.00% 2.07 0.434 1.44 526.3468 1,050.68 1,051.69 2
 SAMPLE 3 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.83% VVNIVPVIAK 95.00% 2.17 0.411 1.64 526.3471 1,050.68 1,051.69 2
 SAMPLE 3 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.83% LEPKPQPPVAEATPR 95.00% 4.03 0.466 2.19 543.9694 1,628.88 1,629.90 3
 SAMPLE 3 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.83% LEPKPQPPVAEATPR 95.00% 3.29 0.44 2.33 543.9698 1,628.89 1,629.90 3
 SAMPLE 3 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.83% LEPKPQPPVAEATPR 95.00% 3.33 0.465 2.66 543.9699 1,628.89 1,629.90 3
 SAMPLE 3 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.83% LEPKPQPPVAEATPR 95.00% 2.93 0.394 0 544.3022 1,629.88 1,629.90 3
 SAMPLE 3 Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 100.00% 3 3 7 6.83% VPEVPTAPATDAAPK 95.00% 2.69 0.392 3.1 732.8911 1,463.77 1,463.77 2
 SAMPLE 3R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 99.80% 2 2 6 4.27% VVNIVPVIAK 95.00% 2 0.361 0 526.3465 1,050.68 1,051.69 2
 SAMPLE 3R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 99.80% 2 2 6 4.27% VVNIVPVIAK 95.00% 2.08 0.344 0 526.3474 1,050.68 1,051.69 2
 SAMPLE 3R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 99.80% 2 2 6 4.27% LEPKPQPPVAEATPR 95.00% 3.65 0.451 2.33 543.9682 1,628.88 1,629.90 3
 SAMPLE 3R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 99.80% 2 2 6 4.27% LEPKPQPPVAEATPR 95.00% 3.76 0.471 2.54 543.9686 1,628.88 1,629.90 3
 SAMPLE 3R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 99.80% 2 2 6 4.27% LEPKPQPPVAEATPR 95.00% 3.29 0.473 1.96 543.969 1,628.88 1,629.90 3
 SAMPLE 3R Septin-9  SEPT9  SEPT9_HUMAN 65,384.30 99.80% 2 2 6 4.27% LEPKPQPPVAEATPR 95.00% 3.35 0.48 2.74 543.9697 1,628.89 1,629.90 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IAPAVVHIELFR 95.00% 1.53 0.298 0 455.6063 1,363.80 1,364.81 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IAPAVVHIELFR 95.00% 1.32 0.335 1.08 455.6073 1,363.80 1,364.81 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IAPAVVHIELFR 95.00% 1.71 0.475 0 455.6081 1,363.80 1,364.81 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IAPAVVHIELFR 95.00% 1.41 0.322 1 455.6105 1,363.81 1,364.81 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IAPAVVHIELFR 95.00% 1.66 0.454 1.47 455.6109 1,363.81 1,364.81 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IAPAVVHIELFR 95.00% 1.33 0.412 0 455.9441 1,364.81 1,364.81 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IDHQGKLPVLLLGR 95.00% 4.72 0.495 1.43 520.3185 1,557.93 1,558.94 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IDHQGKLPVLLLGR 95.00% 3.73 0.349 2.02 520.3187 1,557.93 1,558.94 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IDHQGKLPVLLLGR 95.00% 2.45 0.335 0 520.3215 1,557.94 1,558.94 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IDHQGKLPVLLLGR 95.00% 3.59 0.398 1.52 520.3229 1,557.95 1,558.94 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IDHQGKLPVLLLGR 95.00% 4.77 0.514 1.62 520.653 1,558.94 1,558.94 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IDHQGKLPVLLLGR 95.00% 3.42 0.317 0 520.6535 1,558.94 1,558.94 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IKDVDEKADIALIK 95.00% 4.28 0.318 0 524.3054 1,569.89 1,570.91 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IKDVDEKADIALIK 95.00% 2.88 0.311 0 524.308 1,569.90 1,570.91 3
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% YNFIADVVEK 95.00% 3.26 0.432 2.59 599.3094 1,196.60 1,197.62 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% YNFIADVVEK 95.00% 2.81 0.395 0 599.3097 1,196.60 1,197.62 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% YNFIADVVEK 95.00% 3.24 0.414 1.89 599.31 1,196.60 1,197.62 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% YNFIADVVEK 95.00% 3.03 0.417 1.82 599.3104 1,196.61 1,197.62 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% YNFIADVVEK 95.00% 2.41 0.416 2.85 599.3107 1,196.61 1,197.62 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% YNFIADVVEK 95.00% 2.86 0.422 1.74 599.3107 1,196.61 1,197.62 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% YNFIADVVEK 95.00% 2.54 0.434 0 599.3107 1,196.61 1,197.62 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% YNFIADVVEK 95.00% 2.57 0.399 1.17 599.3108 1,196.61 1,197.62 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% YNFIADVVEK 95.00% 2.6 0.393 1.15 599.3149 1,196.61 1,197.62 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% YNFIADVVEK 95.00% 2.95 0.466 1.89 599.3213 1,196.63 1,197.62 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% VTAGISFAIPSDK 95.00% 4.07 0.581 5 653.3545 1,304.69 1,305.71 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% VTAGISFAIPSDK 95.00% 4.4 0.602 3.96 653.3553 1,304.70 1,305.71 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% VTAGISFAIPSDK 95.00% 4.22 0.582 3.23 653.356 1,304.70 1,305.71 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% VTAGISFAIPSDK 95.00% 2.96 0.374 2.36 653.3582 1,304.70 1,305.71 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% VTAGISFAIPSDK 95.00% 4.22 0.598 4.4 653.3607 1,304.71 1,305.71 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IAPAVVHIELFR 95.00% 1.91 0.39 1.85 682.9036 1,363.79 1,364.81 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IAPAVVHIELFR 95.00% 2.06 0.406 2.04 682.9055 1,363.80 1,364.81 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IAPAVVHIELFR 95.00% 3.01 0.258 3.17 682.9148 1,363.81 1,364.81 2
 SAMPLE 1 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 5 7 33 13.10% IKDVDEKADIALIK 95.00% 4.98 0.273 4.42 786.4581 1,570.90 1,570.91 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% IAPAVVHIELFR 95.00% 1.56 0.449 0 455.6075 1,363.80 1,364.81 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% IAPAVVHIELFR 95.00% 1.41 0.322 0 455.6105 1,363.81 1,364.81 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% IAPAVVHIELFR 95.00% 1.66 0.454 1.32 455.6109 1,363.81 1,364.81 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% IAPAVVHIELFR 95.00% 1.55 0.535 1.51 455.9421 1,364.80 1,364.81 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% VKVELKNGATYEAK 95.00% 2.09 0.239 0 517.6185 1,549.83 1,549.86 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% VKVELKNGATYEAK 95.00% 2.4 0.285 0 517.6187 1,549.83 1,549.86 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% IDHQGKLPVLLLGR 95.00% 4.06 0.394 1.74 520.3149 1,557.92 1,558.94 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% IDHQGKLPVLLLGR 95.00% 3.96 0.447 1.12 520.3166 1,557.93 1,558.94 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% IDHQGKLPVLLLGR 95.00% 2.89 0.345 1.74 520.3183 1,557.93 1,558.94 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% IDHQGKLPVLLLGR 95.00% 2.45 0.335 0 520.3215 1,557.94 1,558.94 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% IDHQGKLPVLLLGR 95.00% 3.59 0.398 1.92 520.3229 1,557.95 1,558.94 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% IDHQGKLPVLLLGR 95.00% 3.35 0.338 2.14 520.6532 1,558.94 1,558.94 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% IKDVDEKADIALIK 95.00% 4.1 0.384 0 524.3062 1,569.90 1,570.91 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% IKDVDEKADIALIK 95.00% 3.21 0.303 0 524.3069 1,569.90 1,570.91 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% YNFIADVVEK 95.00% 2.68 0.426 1.8 599.3087 1,196.60 1,197.62 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% YNFIADVVEK 95.00% 2.87 0.384 1.25 599.309 1,196.60 1,197.62 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% YNFIADVVEK 95.00% 2.8 0.42 1.2 599.3094 1,196.60 1,197.62 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% YNFIADVVEK 95.00% 2.85 0.408 2.34 599.3096 1,196.60 1,197.62 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% YNFIADVVEK 95.00% 3.17 0.395 0 599.3101 1,196.60 1,197.62 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% YNFIADVVEK 95.00% 2.22 0.396 0 599.3104 1,196.61 1,197.62 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% YNFIADVVEK 95.00% 3.22 0.423 1.62 599.3108 1,196.61 1,197.62 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% YNFIADVVEK 95.00% 2.49 0.425 0 599.3115 1,196.61 1,197.62 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% YNFIADVVEK 95.00% 2.6 0.393 0 599.3149 1,196.61 1,197.62 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% YNFIADVVEK 95.00% 2.91 0.413 1.59 599.3216 1,196.63 1,197.62 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% VTAGISFAIPSDK 95.00% 2.91 0.494 1.3 653.3541 1,304.69 1,305.71 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% VTAGISFAIPSDK 95.00% 3.06 0.514 2.27 653.3549 1,304.69 1,305.71 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% VTAGISFAIPSDK 95.00% 3.61 0.539 1.47 653.3554 1,304.70 1,305.71 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% VTAGISFAIPSDK 95.00% 3.86 0.605 1.6 653.3554 1,304.70 1,305.71 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% VTAGISFAIPSDK 95.00% 4.22 0.582 3 653.356 1,304.70 1,305.71 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% VTAGISFAIPSDK 95.00% 3.33 0.448 1.64 653.3562 1,304.70 1,305.71 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% VTAGISFAIPSDK 95.00% 2.5 0.227 0 653.3565 1,304.70 1,305.71 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% VTAGISFAIPSDK 95.00% 4.22 0.598 3.21 653.3607 1,304.71 1,305.71 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% VTAGISFAIPSDK 95.00% 2.16 0.266 0 653.367 1,304.72 1,305.71 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% EVPVASGSGFIVSEDGLIVTNAHVVTNK 95.00% 2.23 0.216 0.959 947.5076 2,839.50 2,839.48 3
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% RGNEDIMITVIPEEIDP 95.00% 2.32 0.333 0 970.9836 1,939.95 1,940.96 2
 SAMPLE 1R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 9 9 36 31.50% AQAGLcVcASSEPVcGSDANTYANLcQLR 95.00% 2.85 0.246 0c6: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02), c26: Carbamidomethyl (+57.02)1,058. 6 3,172.66 3,172.39 3
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% IAPAVVHIELFR 95.00% 1.35 0.288 1.38 455.6068 1,363.80 1,364.81 3
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% IAPAVVHIELFR 95.00% 1.36 0.393 1.59 455.6071 1,363.80 1,364.81 3
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% IAPAVVHIELFR 95.00% 1.38 0.298 0 455.6071 1,363.80 1,364.81 3
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% IAPAVVHIELFR 95.00% 1.6 0.309 0.959 455.6087 1,363.80 1,364.81 3
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% IAPAVVHIELFR 95.00% 1.61 0.394 0 455.9417 1,364.80 1,364.81 3
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% VKVELKNGATYEAK 95.00% 1.94 0.25 1.26 517.6194 1,549.83 1,549.86 3
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% IDHQGKLPVLLLGR 95.00% 2.4 0.293 1.21 520.3173 1,557.93 1,558.94 3
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% IDHQGKLPVLLLGR 95.00% 3.39 0.411 1.36 520.3179 1,557.93 1,558.94 3
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% YNFIADVVEK 95.00% 3.07 0.41 1.82 599.3085 1,196.60 1,197.62 2
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% YNFIADVVEK 95.00% 3.01 0.383 1.89 599.3094 1,196.60 1,197.62 2
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% YNFIADVVEK 95.00% 2.98 0.375 1.49 599.31 1,196.60 1,197.62 2
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% YNFIADVVEK 95.00% 3.1 0.352 1.4 599.3101 1,196.60 1,197.62 2
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% YNFIADVVEK 95.00% 3.07 0.428 1.46 599.3102 1,196.60 1,197.62 2
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% VTAGISFAIPSDK 95.00% 3.89 0.554 2.72 653.3543 1,304.69 1,305.71 2
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% VTAGISFAIPSDK 95.00% 3.88 0.57 2.26 653.3547 1,304.69 1,305.71 2
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% VTAGISFAIPSDK 95.00% 4.36 0.562 2.27 653.3548 1,304.69 1,305.71 2
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% VTAGISFAIPSDK 95.00% 3.5 0.504 1.89 653.3552 1,304.69 1,305.71 2
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% IAPAVVHIELFR 95.00% 2.99 0.514 3.21 682.9034 1,363.79 1,364.81 2
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% IAPAVVHIELFR 95.00% 3 0.523 2.42 683.4056 1,364.80 1,364.81 2
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% SAPLAAGcPDRcEPAR 95.00% 2.98 0.429 0 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 864.4026 1,726.79 1,727.80 2
 SAMPLE 2 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 7 21 16.50% SAPLAAGcPDRcEPAR 95.00% 2.93 0.399 0 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 864.9008 1,727.79 1,727.80 2
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% IAPAVVHIELFR 95.00% 1.33 0.369 1.01 455.6082 1,363.80 1,364.81 3
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% IDHQGKLPVLLLGR 95.00% 3.06 0.329 2.14 520.3173 1,557.93 1,558.94 3
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% IDHQGKLPVLLLGR 95.00% 3.04 0.401 1.74 520.3184 1,557.93 1,558.94 3
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% IKDVDEKADIALIK 95.00% 2.7 0.194 0 524.3081 1,569.90 1,570.91 3
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% YNFIADVVEK 95.00% 2.83 0.433 1.64 599.3102 1,196.60 1,197.62 2
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% YNFIADVVEK 95.00% 3 0.392 1.33 599.3105 1,196.61 1,197.62 2
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% YNFIADVVEK 95.00% 2.93 0.423 1.72 599.3111 1,196.61 1,197.62 2
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% YNFIADVVEK 95.00% 2.84 0.384 2.14 599.8121 1,197.61 1,197.62 2
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% VTAGISFAIPSDK 95.00% 2.68 0.512 0 653.3554 1,304.70 1,305.71 2
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% VTAGISFAIPSDK 95.00% 4.02 0.553 2.05 653.3557 1,304.70 1,305.71 2
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% VTAGISFAIPSDK 95.00% 3.68 0.523 2.28 653.3559 1,304.70 1,305.71 2
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% VTAGISFAIPSDK 95.00% 2.95 0.546 1.46 653.3563 1,304.70 1,305.71 2
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% SAPLAAGcPDRcEPAR 95.00% 2.56 0.32 0 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 864.4019 1,726.79 1,727.80 2
 SAMPLE 2R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 6 6 14 16.50% SAPLAAGcPDRcEPAR 95.00% 2.62 0.356 0 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 864.4026 1,726.79 1,727.80 2
 SAMPLE 3 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 3 4 7 8.12% SAPLAAGcPDRcEPAR 95.00% 1.55 0.378 0 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 576.6018 1,726.78 1,727.80 3
 SAMPLE 3 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 3 4 7 8.12% YNFIADVVEK 95.00% 3.04 0.441 0 599.3094 1,196.60 1,197.62 2
 SAMPLE 3 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 3 4 7 8.12% VTAGISFAIPSDK 95.00% 3.63 0.56 2.82 653.3549 1,304.69 1,305.71 2
 SAMPLE 3 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 3 4 7 8.12% VTAGISFAIPSDK 95.00% 3.41 0.507 1.66 653.3551 1,304.69 1,305.71 2
 SAMPLE 3 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 3 4 7 8.12% VTAGISFAIPSDK 95.00% 2.68 0.377 0 653.3567 1,304.70 1,305.71 2
 SAMPLE 3 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 3 4 7 8.12% SAPLAAGcPDRcEPAR 95.00% 2.58 0.321 0 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 864.4046 1,726.79 1,727.80 2
 SAMPLE 3 Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 3 4 7 8.12% SAPLAAGcPDRcEPAR 95.00% 2.81 0.353 0 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 864.9024 1,727.79 1,727.80 2
 SAMPLE 3R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 3 3 5 8.54% IAPAVVHIELFR 95.00% 1.38 0.395 0 455.6061 1,363.79 1,364.81 3
 SAMPLE 3R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 3 3 5 8.54% VTAGISFAIPSDK 95.00% 3.15 0.543 3.52 653.3557 1,304.70 1,305.71 2
 SAMPLE 3R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 3 3 5 8.54% VTAGISFAIPSDK 95.00% 3.07 0.502 0 653.3568 1,304.70 1,305.71 2
 SAMPLE 3R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 3 3 5 8.54% VTAGISFAIPSDK 95.00% 2.8 0.534 1.21 653.357 1,304.70 1,305.71 2
 SAMPLE 3R Serine protease HTRA1  HTRA1  HTRA1_HUMAN 51,269.30 100.00% 3 3 5 8.54% SAPLAAGcPDRcEPAR 95.00% 2.85 0.35 0 c8: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 864.4015 1,726.79 1,727.80 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% cLKDGAGDVAFVK 95.00% 3.95 0.499 4 c1: Carbamidomethyl (+57.02) 460.5708 1,378.69 1,379.70 3
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% cLKDGAGDVAFVK 95.00% 4.09 0.539 2.23 c1: Carbamidomethyl (+57.02) 460.5723 1,378.69 1,379.70 3
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% DGAGDVAFVK 95.00% 3.33 0.435 2 489.7469 977.4781 978.4898 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% DGAGDVAFVK 95.00% 3.23 0.468 1.92 489.7479 977.4801 978.4898 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% ASYLDcIR 95.00% 2.07 0.24 0 c6: Carbamidomethyl (+57.02) 499.2407 996.4658 997.4778 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% ASYLDcIR 95.00% 2.03 0.34 1.33 c6: Carbamidomethyl (+57.02) 499.2414 996.4671 997.4778 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% ASYLDcIR 95.00% 2.34 0.32 0 c6: Carbamidomethyl (+57.02) 499.2419 996.4681 997.4778 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% YLGEEYVK 95.00% 2.46 0.366 1.59 500.7518 999.488 1,000.50 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% YLGEEYVK 95.00% 2.38 0.352 1.85 500.7521 999.4886 1,000.50 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% KPVEEYANcHLAR 95.00% 3.36 0.473 0 c9: Carbamidomethyl (+57.02) 529.5962 1,585.77 1,586.78 3
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% DSGFQMNQLR 95.00% 2.42 0.226 0 598.2774 1,194.54 1,195.55 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% HSTIFENLANK 95.00% 3.88 0.551 3.05 637.3289 1,272.64 1,273.65 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% HSTIFENLANK 95.00% 3.71 0.51 2.49 637.3293 1,272.64 1,273.65 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% EFQLFSSPHGK 95.00% 3.35 0.395 1.51 638.8168 1,275.62 1,276.63 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% EFQLFSSPHGK 95.00% 3.13 0.41 1.19 638.8194 1,275.62 1,276.63 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% EGYYGYTGAFR 95.00% 2.87 0.466 2.66 642.2872 1,282.56 1,283.57 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% EGYYGYTGAFR 95.00% 3.08 0.527 3.41 642.2878 1,282.56 1,283.57 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% cLVEKGDVAFVK 95.00% 3.44 0.354 1.85 c1: Carbamidomethyl (+57.02) 682.8639 1,363.71 1,364.73 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% SVIPSDGPSVAcVK 95.00% 3.1 0.505 3.4 c12: Carbamidomethyl (+57.02) 708.3623 1,414.71 1,415.72 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% SVIPSDGPSVAcVK 95.00% 2.95 0.522 3.38 c12: Carbamidomethyl (+57.02) 708.8657 1,415.72 1,415.72 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% NLREGTcPEAPTDEcKPVK 95.00% 4.52 0.486 0 c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 734.6818 2,201.02 2,201.03 3
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% MYLGYEYVTAIR 95.00% 4.65 0.666 4.24 740.3722 1,478.73 1,478.74 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% MYLGYEYVTAIR 95.00% 4.71 0.644 3.77 740.3727 1,478.73 1,478.74 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% LKcDEWSVNSVGK 95.00% 3.12 0.42 0 c3: Carbamidomethyl (+57.02) 761.372 1,520.73 1,521.74 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% cSTSSLLEAcTFR 95.00% 4.54 0.423 4.59 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 766.3523 1,530.69 1,531.69 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% cSTSSLLEAcTFR 95.00% 4.57 0.569 4.34 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 766.8493 1,531.68 1,531.69 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% FDEFFSEGcAPGSK 95.00% 5.09 0.628 5.37 c9: Carbamidomethyl (+57.02) 789.3307 1,576.65 1,577.66 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% FDEFFSEGcAPGSK 95.00% 4.77 0.613 4.26 c9: Carbamidomethyl (+57.02) 789.3325 1,576.65 1,577.66 2
 SAMPLE 1 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 17 17 29 28.10% EDPQTFYYAVAVVK 95.00% 4.13 0.571 3.92 815.91 1,629.80 1,629.82 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% cLVEKGDVAFVK 95.00% 3.84 0.537 1.06 c1: Carbamidomethyl (+57.02) 455.58 1,363.72 1,364.73 3
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% cLVEKGDVAFVK 95.00% 3.71 0.451 0 c1: Carbamidomethyl (+57.02) 455.5805 1,363.72 1,364.73 3
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% cLKDGAGDVAFVK 95.00% 4.56 0.539 2.28 c1: Carbamidomethyl (+57.02) 460.9048 1,379.69 1,379.70 3
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% DGAGDVAFVK 95.00% 3.14 0.464 1.66 489.7475 977.4794 978.4898 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% DGAGDVAFVK 95.00% 3.14 0.435 1.85 489.7477 977.4797 978.4898 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% DGAGDVAFVK 95.00% 2.07 0.232 2.55 490.2478 978.4799 978.4898 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% LKcDEWSVNSVGK 95.00% 2.79 0.226 0 c3: Carbamidomethyl (+57.02) 507.9153 1,520.72 1,521.74 3
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% DSGFQMNQLR 95.00% 3.08 0.343 1.36 598.278 1,194.54 1,195.55 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% DSGFQMNQLR 95.00% 3.16 0.392 0 598.2782 1,194.54 1,195.55 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% HSTIFENLANK 95.00% 4 0.567 3.15 637.3295 1,272.64 1,273.65 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% HSTIFENLANK 95.00% 3.85 0.516 2.36 637.3298 1,272.64 1,273.65 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% EFQLFSSPHGK 95.00% 2.23 0.3 1.33 638.8199 1,275.62 1,276.63 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% EFQLFSSPHGK 95.00% 2.52 0.367 3.59 638.8214 1,275.63 1,276.63 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% EGYYGYTGAFR 95.00% 3.33 0.478 2.8 642.2874 1,282.56 1,283.57 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% EGYYGYTGAFR 95.00% 2.83 0.4 1.85 642.2878 1,282.56 1,283.57 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% HQTVPQNTGGKNPDPWAK 95.00% 2.48 0.369 0 658.9959 1,973.96 1,974.98 3
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% cLKDGAGDVAFVK 95.00% 2.49 0.308 2.68 c1: Carbamidomethyl (+57.02) 690.3531 1,378.69 1,379.70 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% SVIPSDGPSVAcVK 95.00% 3.06 0.503 3.21 c12: Carbamidomethyl (+57.02) 708.3629 1,414.71 1,415.72 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% SVIPSDGPSVAcVK 95.00% 2.4 0.498 2.43 c12: Carbamidomethyl (+57.02) 708.3643 1,414.71 1,415.72 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% MYLGYEYVTAIR 95.00% 4.46 0.651 4.4 739.8692 1,477.72 1,478.74 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% MYLGYEYVTAIR 95.00% 4.41 0.65 5.52 739.871 1,477.73 1,478.74 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% LKcDEWSVNSVGK 95.00% 3.44 0.517 1.31 c3: Carbamidomethyl (+57.02) 761.3723 1,520.73 1,521.74 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% LKcDEWSVNSVGK 95.00% 3.44 0.444 0 c3: Carbamidomethyl (+57.02) 761.3739 1,520.73 1,521.74 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% cSTSSLLEAcTFR 95.00% 4.72 0.608 3.52 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 766.3477 1,530.68 1,531.69 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% cSTSSLLEAcTFR 95.00% 4.49 0.555 3.72 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 766.3492 1,530.68 1,531.69 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% FDEFFSEGcAPGSK 95.00% 4.95 0.624 6.39 c9: Carbamidomethyl (+57.02) 789.3314 1,576.65 1,577.66 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% TAGWNIPMGLLYNK 95.00% 3.85 0.429 2.39 789.4087 1,576.80 1,577.82 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% TAGWNIPMGLLYNK 95.00% 4.02 0.413 2.82 789.9109 1,577.81 1,577.82 2
 SAMPLE 1R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 15 17 29 25.80% EDPQTFYYAVAVVK 95.00% 3.28 0.456 3.62 815.409 1,628.80 1,629.82 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% cLVEKGDVAFVK 95.00% 3.96 0.515 1.52 c1: Carbamidomethyl (+57.02) 455.5806 1,363.72 1,364.73 3
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% cLVEKGDVAFVK 95.00% 2.88 0.481 0 c1: Carbamidomethyl (+57.02) 455.581 1,363.72 1,364.73 3
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% cLKDGAGDVAFVK 95.00% 3.83 0.334 2.29 c1: Carbamidomethyl (+57.02) 460.5725 1,378.69 1,379.70 3
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% DGAGDVAFVK 95.00% 3.24 0.487 2.82 489.7479 977.4801 978.4898 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% DGAGDVAFVK 95.00% 3.36 0.498 2.36 489.7481 977.4806 978.4898 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% SKEFQLFSSPHGK 95.00% 3.68 0.309 1.07 497.9236 1,490.75 1,491.76 3
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% SKEFQLFSSPHGK 95.00% 3.54 0.349 0 498.2589 1,491.75 1,491.76 3
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% ASYLDcIR 95.00% 2.3 0.252 1.68 c6: Carbamidomethyl (+57.02) 499.2417 996.4677 997.4778 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% ASYLDcIR 95.00% 2.44 0.281 0 c6: Carbamidomethyl (+57.02) 499.2426 996.4695 997.4778 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% YLGEEYVK 95.00% 2.1 0.287 0 500.7514 999.4872 1,000.50 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% YLGEEYVK 95.00% 2.54 0.341 0 500.7519 999.4881 1,000.50 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% KPVEEYANcHLAR 95.00% 4.56 0.551 2.77 c9: Carbamidomethyl (+57.02) 529.5945 1,585.76 1,586.78 3
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% KPVEEYANcHLAR 95.00% 4.49 0.578 3.52 c9: Carbamidomethyl (+57.02) 529.5955 1,585.76 1,586.78 3
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% KPVEEYANcHLAR 95.00% 3.29 0.313 0 c9: Carbamidomethyl (+57.02) 529.5968 1,585.77 1,586.78 3
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% KASYLDcIR 95.00% 2.61 0.244 0 c7: Carbamidomethyl (+57.02) 563.2884 1,124.56 1,125.57 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% KASYLDcIR 95.00% 2.52 0.276 0 c7: Carbamidomethyl (+57.02) 563.289 1,124.56 1,125.57 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% DSGFQMNQLR 95.00% 2.68 0.248 0 598.2768 1,194.54 1,195.55 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% DSGFQMNQLR 95.00% 2.65 0.262 2 598.2787 1,194.54 1,195.55 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% SASDLTWDNLK 95.00% 3.05 0.331 0 625.3053 1,248.60 1,249.61 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% SASDLTWDNLK 95.00% 3.77 0.405 0 625.3069 1,248.60 1,249.61 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% HSTIFENLANK 95.00% 3.83 0.531 1.7 637.3293 1,272.64 1,273.65 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% HSTIFENLANK 95.00% 3.5 0.514 1.77 637.3302 1,272.64 1,273.65 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% EFQLFSSPHGK 95.00% 2.67 0.328 0 638.8189 1,275.62 1,276.63 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% EGYYGYTGAFR 95.00% 3.19 0.519 2.68 642.2874 1,282.56 1,283.57 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% EGYYGYTGAFR 95.00% 3.04 0.541 2.39 642.2876 1,282.56 1,283.57 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% MYLGYEYVTAIR 95.00% 4.06 0.595 5.15 739.8711 1,477.73 1,478.74 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% MYLGYEYVTAIR 95.00% 4.48 0.627 4.21 739.8717 1,477.73 1,478.74 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% cSTSSLLEAcTFR 95.00% 4.57 0.625 4.89 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 766.3479 1,530.68 1,531.69 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% cSTSSLLEAcTFR 95.00% 4.83 0.658 4.4 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 766.3486 1,530.68 1,531.69 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% FDEFFSEGcAPGSK 95.00% 5.28 0.623 4.64 c9: Carbamidomethyl (+57.02) 789.332 1,576.65 1,577.66 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% FDEFFSEGcAPGSK 95.00% 5.03 0.602 5.96 c9: Carbamidomethyl (+57.02) 789.3336 1,576.65 1,577.66 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% EDPQTFYYAVAVVK 95.00% 3.6 0.563 3.96 815.4112 1,628.81 1,629.82 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% IEcVSAETTEDcIAK 95.00% 4.91 0.651 5.14 c3: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 863.3846 1,724.75 1,725.77 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% EGTcPEAPTDEcKPVK 95.00% 3.16 0.488 2.8 c4: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 909.4083 1,816.80 1,817.81 2
 SAMPLE 2 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 18 18 33 27.90% EGTcPEAPTDEcKPVK 95.00% 3.86 0.445 2.33 c4: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 909.4087 1,816.80 1,817.81 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% cLVEKGDVAFVK 95.00% 3.72 0.567 0 c1: Carbamidomethyl (+57.02) 455.579 1,363.71 1,364.73 3
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% DGAGDVAFVK 95.00% 3.22 0.466 2.92 489.7472 977.4788 978.4898 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% DGAGDVAFVK 95.00% 3.32 0.469 3.05 489.7473 977.479 978.4898 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% SKEFQLFSSPHGK 95.00% 3.8 0.326 0 498.2597 1,491.76 1,491.76 3
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% ASYLDcIR 95.00% 2.26 0.325 0 c6: Carbamidomethyl (+57.02) 499.2412 996.4667 997.4778 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% ASYLDcIR 95.00% 2.1 0.339 0 c6: Carbamidomethyl (+57.02) 499.2413 996.4669 997.4778 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% KPVEEYANcHLAR 95.00% 4.82 0.626 3.7 c9: Carbamidomethyl (+57.02) 529.5942 1,585.76 1,586.78 3
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% KPVEEYANcHLAR 95.00% 4.64 0.598 3.02 c9: Carbamidomethyl (+57.02) 529.5952 1,585.76 1,586.78 3
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% SASDLTWDNLK 95.00% 3.37 0.408 1.14 625.3059 1,248.60 1,249.61 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% SASDLTWDNLK 95.00% 2.74 0.247 0 625.3062 1,248.60 1,249.61 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% HSTIFENLANK 95.00% 3.34 0.525 2.19 637.3288 1,272.64 1,273.65 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% HSTIFENLANK 95.00% 3.31 0.547 2.72 637.3306 1,272.65 1,273.65 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% EFQLFSSPHGK 95.00% 3.07 0.395 2.59 638.8197 1,275.62 1,276.63 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% EGYYGYTGAFR 95.00% 2.55 0.445 3.02 642.2867 1,282.56 1,283.57 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% cLKDGAGDVAFVK 95.00% 3.63 0.429 2.89 c1: Carbamidomethyl (+57.02) 690.8565 1,379.70 1,379.70 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% MYLGYEYVTAIR 95.00% 4.3 0.61 4.31 739.87 1,477.72 1,478.74 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% MYLGYEYVTAIR 95.00% 3.86 0.649 5.41 739.8709 1,477.73 1,478.74 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% cSTSSLLEAcTFR 95.00% 4.25 0.54 4.44 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 766.3487 1,530.68 1,531.69 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% cSTSSLLEAcTFR 95.00% 4.71 0.605 3.85 c1: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 766.3496 1,530.68 1,531.69 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% FDEFFSEGcAPGSK 95.00% 4.83 0.64 5.38 c9: Carbamidomethyl (+57.02) 789.3311 1,576.65 1,577.66 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% FDEFFSEGcAPGSK 95.00% 4.91 0.563 5.66 c9: Carbamidomethyl (+57.02) 789.333 1,576.65 1,577.66 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% EDPQTFYYAVAVVK 95.00% 2.31 0.292 0 815.4131 1,628.81 1,629.82 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% EDPQTFYYAVAVVK 95.00% 4.04 0.615 5.09 815.9113 1,629.81 1,629.82 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% IEcVSAETTEDcIAK 95.00% 5.24 0.614 7.96 c3: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 863.3866 1,724.76 1,725.77 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% IEcVSAETTEDcIAK 95.00% 4.8 0.664 5.72 c3: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 863.3868 1,724.76 1,725.77 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% EGTcPEAPTDEcKPVK 95.00% 2.75 0.396 0 c4: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 909.4054 1,816.80 1,817.81 2
 SAMPLE 2R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 16 16 27 25.20% EGTcPEAPTDEcKPVK 95.00% 2.83 0.452 0 c4: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 909.4102 1,816.80 1,817.81 2
 SAMPLE 3 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 5 5 6 8.74% KPVEEYANcHLAR 95.00% 3.95 0.439 1.04 c9: Carbamidomethyl (+57.02) 529.9298 1,586.77 1,586.78 3
 SAMPLE 3 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 5 5 6 8.74% DSGFQMNQLR 95.00% 2.9 0.367 0 598.2785 1,194.54 1,195.55 2
 SAMPLE 3 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 5 5 6 8.74% SASDLTWDNLK 95.00% 3.29 0.306 0 625.3087 1,248.60 1,249.61 2
 SAMPLE 3 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 5 5 6 8.74% EGYYGYTGAFR 95.00% 2.53 0.528 1.96 642.288 1,282.56 1,283.57 2
 SAMPLE 3 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 5 5 6 8.74% EGYYGYTGAFR 95.00% 2.39 0.412 2.23 642.2881 1,282.56 1,283.57 2
 SAMPLE 3 Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 5 5 6 8.74% EGTcPEAPTDEcKPVK 95.00% 2.71 0.378 0 c4: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 909.9049 1,817.79 1,817.81 2
 SAMPLE 3R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 3 3 3 5.30% DGAGDVAFVK 95.00% 2.22 0.309 1.68 490.2531 978.4906 978.4898 2
 SAMPLE 3R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 3 3 3 5.30% EGYYGYTGAFR 95.00% 2.43 0.417 1.33 642.2862 1,282.56 1,283.57 2
 SAMPLE 3R Serotransferrin  TF  TRFE_HUMAN 77,032.20 100.00% 3 3 3 5.30% EGTcPEAPTDEcKPVK 95.00% 2.51 0.378 0 c4: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 909.4027 1,816.79 1,817.81 2
 SAMPLE 1 Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 3 3 4 9.57% LFYADHPFIFLVR 95.00% 2.27 0.261 0 546.6324 1,636.87 1,637.88 3
 SAMPLE 1 Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 3 3 4 9.57% DTQSGSLLFIGR 95.00% 2.71 0.348 1.85 647.3428 1,292.67 1,293.68 2
 SAMPLE 1 Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 3 3 4 9.57% LYGPSSVSFADDFVR 95.00% 4.72 0.626 6.11 830.4027 1,658.79 1,659.80 2
 SAMPLE 1 Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 3 3 4 9.57% LYGPSSVSFADDFVR 95.00% 4.57 0.589 6.17 830.9005 1,659.79 1,659.80 2
 SAMPLE 1R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 5 5 6 20.80% HLAGLGLTEAIDKNK 95.00% 2.84 0.411 2.14 527.2964 1,578.87 1,579.88 3
 SAMPLE 1R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 5 5 6 20.80% HLAGLGLTEAIDKNK 95.00% 3.91 0.509 2.24 527.2969 1,578.87 1,579.88 3
 SAMPLE 1R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 5 5 6 20.80% DTQSGSLLFIGR 95.00% 2.47 0.405 2.55 647.3439 1,292.67 1,293.68 2
 SAMPLE 1R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 5 5 6 20.80% AVLSAEQLRDEEVHAGLGELLR 95.00% 3.76 0.518 4.39 802.7635 2,405.27 2,405.28 3
 SAMPLE 1R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 5 5 6 20.80% SALQSINEWAAQTTDGKLPEVTK 95.00% 3.75 0.491 1.4 830.0927 2,487.25 2,487.27 3
 SAMPLE 1R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 5 5 6 20.80% LYGPSSVSFADDFVR 95.00% 4.37 0.605 4.82 830.4026 1,658.79 1,659.80 2
 SAMPLE 2R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 99.80% 2 2 4 6.94% SAGLAFSLYQAMAK 95.00% 2.65 0.471 0 729.3748 1,456.73 1,457.75 2
 SAMPLE 2R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 99.80% 2 2 4 6.94% SAGLAFSLYQAMAK 95.00% 2.97 0.39 1.34 729.8766 1,457.74 1,457.75 2
 SAMPLE 2R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 99.80% 2 2 4 6.94% LYGPSSVSFADDFVR 95.00% 4.18 0.542 5.07 830.4038 1,658.79 1,659.80 2
 SAMPLE 2R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 99.80% 2 2 4 6.94% LYGPSSVSFADDFVR 95.00% 3.46 0.501 6.29 830.4038 1,658.79 1,659.80 2
 SAMPLE 3 Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 99.80% 2 2 3 6.46% DTQSGSLLFIGR 95.00% 1.96 0.204 2.4 647.3417 1,292.67 1,293.68 2
 SAMPLE 3 Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 99.80% 2 2 3 6.46% LYGPSSVSFADDFVR 95.00% 3.85 0.531 4.62 830.4021 1,658.79 1,659.80 2
 SAMPLE 3 Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 99.80% 2 2 3 6.46% LYGPSSVSFADDFVR 95.00% 3.41 0.474 5.59 830.4038 1,658.79 1,659.80 2
 SAMPLE 3R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 4 4 7 12.90% LFYADHPFIFLVR 95.00% 3.02 0.309 0 546.9659 1,637.87 1,637.88 3
 SAMPLE 3R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 4 4 7 12.90% DTQSGSLLFIGR 95.00% 2.14 0.403 3.34 647.3436 1,292.67 1,293.68 2
 SAMPLE 3R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 4 4 7 12.90% DTQSGSLLFIGR 95.00% 1.81 0.177 1.89 647.3454 1,292.68 1,293.68 2
 SAMPLE 3R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 4 4 7 12.90% SAGLAFSLYQAMAK 95.00% 3.08 0.513 2.07 729.3769 1,456.74 1,457.75 2
 SAMPLE 3R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 4 4 7 12.90% SAGLAFSLYQAMAK 95.00% 3.4 0.563 1.16 729.3777 1,456.74 1,457.75 2
 SAMPLE 3R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 4 4 7 12.90% LYGPSSVSFADDFVR 95.00% 3.34 0.429 5.28 830.9034 1,659.79 1,659.80 2
 SAMPLE 3R Serpin H1  SERPINH1  SERPH_HUMAN 46,424.00 100.00% 4 4 7 12.90% LYGPSSVSFADDFVR 95.00% 3.77 0.413 4.4 830.9073 1,659.80 1,659.80 2
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% LcTVATLR 95.00% 2.05 0.283 0 c2: Carbamidomethyl (+57.02) 467.265 932.5144 933.5193 2
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% FQNALLVR 95.00% 2.65 0.145 0 480.7865 959.5573 960.5631 2 VINC_HUMAN
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% FQNALLVR 95.00% 2.56 0.143 0 480.7867 959.5578 960.5631 2 VINC_HUMAN
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% LVAASQAALGL 95.00% 3 0.593 3.13 507.3035 1,012.59 1,013.60 2
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% LVAASQAALGL 95.00% 1.75 0.249 1.66 507.3037 1,012.59 1,013.60 2
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% LVAASQAALGL 95.00% 2.85 0.57 3.17 507.3041 1,012.59 1,013.60 2
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% KVPQVSTPTLVEVSR 95.00% 4.04 0.516 0 547.3184 1,638.93 1,639.94 3
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% KVPQVSTPTLVEVSR 95.00% 3.5 0.376 0 547.3189 1,638.93 1,639.94 3
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% KVPQVSTPTLVEVSR 95.00% 3.62 0.391 0 547.3197 1,638.94 1,639.94 3
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% KVPQVSTPTLVEVSR 95.00% 3.83 0.484 0 547.3201 1,638.94 1,639.94 3
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% KVPQVSTPTLVEVSR 95.00% 3.87 0.424 0 547.6527 1,639.93 1,639.94 3
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% KVPQVSTPTLVEVSR 95.00% 3.81 0.317 1.42 547.6533 1,639.94 1,639.94 3
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% FKDLGEENFK 95.00% 2.51 0.297 1.42 613.8041 1,225.59 1,226.61 2
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% FKDLGEENFK 95.00% 2.68 0.287 2.48 613.8061 1,225.60 1,226.61 2
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% RPcFSALEVDETYVPK 95.00% 3.21 0.421 1.68 c3: Carbamidomethyl (+57.02) 637.9853 1,910.93 1,910.93 3
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% RPcFSALEVDETYVPK 95.00% 3.09 0.4 1.02 c3: Carbamidomethyl (+57.02) 637.9857 1,910.93 1,910.93 3
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% VHTEccHGDLLEcADDR 95.00% 2.66 0.233 0 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 696.2852 2,085.83 2,086.84 3
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% VPQVSTPTLVEVSR 95.00% 3.18 0.485 4.57 756.4292 1,510.84 1,511.84 2
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% VPQVSTPTLVEVSR 95.00% 3.67 0.502 6.96 756.4294 1,510.84 1,511.84 2
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% KVPQVSTPTLVEVSR 95.00% 3.38 0.429 1.47 820.977 1,639.94 1,639.94 2
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% QNcELFEQLGEYK 95.00% 4.34 0.574 3.92 c3: Carbamidomethyl (+57.02) 829.3822 1,656.75 1,657.75 2
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% RPcFSALEVDETYVPK 95.00% 3.86 0.383 3.92 c3: Carbamidomethyl (+57.02) 955.9714 1,909.93 1,910.93 2
 SAMPLE 4 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 8 10 21 16.10% RPcFSALEVDETYVPK 95.00% 3.53 0.319 2.32 c3: Carbamidomethyl (+57.02) 956.4735 1,910.93 1,910.93 2
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% LcTVATLR 95.00% 1.99 0.322 0 c2: Carbamidomethyl (+57.02) 467.2644 932.5132 933.5193 2
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% FQNALLVR 95.00% 2.62 0.148 0 480.7867 959.5578 960.5631 2 VINC_HUMAN
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% LVAASQAALGL 95.00% 2.41 0.473 2.8 507.3043 1,012.59 1,013.60 2
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% KVPQVSTPTLVEVSR 95.00% 3.36 0.391 0 547.3185 1,638.93 1,639.94 3
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% KVPQVSTPTLVEVSR 95.00% 3.67 0.43 1.41 547.3187 1,638.93 1,639.94 3
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% KVPQVSTPTLVEVSR 95.00% 3.75 0.417 0 547.3201 1,638.94 1,639.94 3
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% KVPQVSTPTLVEVSR 95.00% 3.12 0.38 0 547.3201 1,638.94 1,639.94 3
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% KVPQVSTPTLVEVSR 95.00% 2.9 0.346 0 547.3206 1,638.94 1,639.94 3
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% KVPQVSTPTLVEVSR 95.00% 3.77 0.393 0 547.6543 1,639.94 1,639.94 3
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% KVPQVSTPTLVEVSR 95.00% 3.49 0.41 0 547.6545 1,639.94 1,639.94 3
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% FKDLGEENFK 95.00% 2.61 0.253 2.68 613.8036 1,225.59 1,226.61 2
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% FKDLGEENFK 95.00% 2.61 0.224 3.54 613.8064 1,225.60 1,226.61 2
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% RPcFSALEVDETYVPK 95.00% 3.07 0.423 0 c3: Carbamidomethyl (+57.02) 637.6511 1,909.93 1,910.93 3
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% RPcFSALEVDETYVPK 95.00% 3.83 0.458 1.4 c3: Carbamidomethyl (+57.02) 637.986 1,910.93 1,910.93 3
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% VPQVSTPTLVEVSR 95.00% 3.26 0.449 4.96 756.4279 1,510.84 1,511.84 2
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% VPQVSTPTLVEVSR 95.00% 3.69 0.531 5.44 756.9287 1,511.84 1,511.84 2
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% RPcFSALEVDETYVPK 95.00% 3.84 0.456 3.4 c3: Carbamidomethyl (+57.02) 955.9705 1,909.93 1,910.93 2
 SAMPLE 4R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 6 7 17 11.20% RPcFSALEVDETYVPK 95.00% 3.52 0.278 2.34 c3: Carbamidomethyl (+57.02) 956.4729 1,910.93 1,910.93 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% YLYEIAR 95.00% 2.19 0.151 1.62 464.25 926.4843 927.494 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% YLYEIAR 95.00% 2.38 0.204 0 464.25 926.4843 927.494 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FQNALLVR 95.00% 2.71 0.234 0 480.7837 959.5517 960.5631 2 VINC_HUMAN
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FQNALLVR 95.00% 2.47 0.177 0 480.7839 959.5522 960.5631 2 VINC_HUMAN
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FQNALLVR 95.00% 2.71 0.186 0 480.784 959.5523 960.5631 2 VINC_HUMAN
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FQNALLVR 95.00% 2.46 0.22 0 480.784 959.5523 960.5631 2 VINC_HUMAN
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FQNALLVR 95.00% 2.75 0.158 0 480.7841 959.5525 960.5631 2 VINC_HUMAN
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FQNALLVR 95.00% 2.61 0.207 0 480.7841 959.5525 960.5631 2 VINC_HUMAN
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FQNALLVR 95.00% 2.42 0.187 0 480.7851 959.5546 960.5631 2 VINC_HUMAN
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FQNALLVR 95.00% 2.61 0.212 0 480.7855 959.5554 960.5631 2 VINC_HUMAN
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% RHPDYSVVLLLR 95.00% 2.08 0.219 0 489.7346 1,466.18 1,467.84 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 3.2 0.514 3.74 507.3007 1,012.59 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 2.69 0.615 3.04 507.3017 1,012.59 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 3.44 0.597 4.04 507.3019 1,012.59 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 2.88 0.58 2.2 507.3021 1,012.59 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 2.66 0.439 3.21 507.3022 1,012.59 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 3.17 0.59 3.54 507.3025 1,012.59 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 2.36 0.45 2.92 507.3026 1,012.59 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 2.48 0.523 3.1 507.3026 1,012.59 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 2.49 0.532 3.14 507.3027 1,012.59 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 2.31 0.432 0 507.3028 1,012.59 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 1.85 0.41 1.89 507.3034 1,012.59 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 1.86 0.451 0 507.3051 1,012.59 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 2.63 0.509 4.96 507.7867 1,013.56 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVAASQAALGL 95.00% 2.42 0.353 1.41 507.8082 1,013.60 1,013.60 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% SLHTLFGDK 95.00% 2.13 0.301 0 509.2707 1,016.53 1,017.54 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% KYLYEIAR 95.00% 2.38 0.333 0 528.2943 1,054.57 1,055.59 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% KVPQVSTPTLVEVSR 95.00% 4.41 0.491 2.77 547.3156 1,638.92 1,639.94 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% KVPQVSTPTLVEVSR 95.00% 4 0.481 1 547.3161 1,638.92 1,639.94 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% KVPQVSTPTLVEVSR 95.00% 4.06 0.508 1.8 547.3163 1,638.93 1,639.94 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% KVPQVSTPTLVEVSR 95.00% 4.77 0.538 3.36 547.3165 1,638.93 1,639.94 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% KVPQVSTPTLVEVSR 95.00% 3.73 0.43 1.85 547.3168 1,638.93 1,639.94 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% KVPQVSTPTLVEVSR 95.00% 3.5 0.374 0 547.3171 1,638.93 1,639.94 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% KVPQVSTPTLVEVSR 95.00% 3.16 0.282 0 547.3205 1,638.94 1,639.94 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% KVPQVSTPTLVEVSR 95.00% 4.19 0.453 0 547.6512 1,639.93 1,639.94 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% KVPQVSTPTLVEVSR 95.00% 3.54 0.359 0 547.6522 1,639.93 1,639.94 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% YKAAFTEccQAADK 95.00% 3.36 0.48 2 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 554.9131 1,661.72 1,662.73 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% YKAAFTEccQAADK 95.00% 3.59 0.477 3.06 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 555.2464 1,662.72 1,662.73 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 3.07 0.401 1.59 575.3092 1,148.60 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 2.41 0.241 0 575.3102 1,148.60 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 2.83 0.294 2.66 575.3103 1,148.60 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 3.09 0.408 2.21 575.3103 1,148.60 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 3 0.362 2 575.3105 1,148.61 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 3.03 0.367 2.38 575.3105 1,148.61 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 2.77 0.336 2.39 575.3106 1,148.61 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 3.25 0.436 3.02 575.3106 1,148.61 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 2.9 0.352 2.08 575.3107 1,148.61 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 3.41 0.512 3.28 575.3108 1,148.61 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 2.82 0.381 2.47 575.3109 1,148.61 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 2.5 0.339 1.82 575.3109 1,148.61 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 2.34 0.274 0 575.3111 1,148.61 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 2.79 0.352 2.82 575.3111 1,148.61 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 2.71 0.32 1.55 575.3128 1,148.61 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% LVNEVTEFAK 95.00% 2.69 0.395 1.85 575.314 1,148.61 1,149.62 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FKDLGEENFK 95.00% 2.19 0.214 1.72 613.8045 1,225.59 1,226.61 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FKDLGEENFK 95.00% 2.28 0.259 2.57 613.8046 1,225.59 1,226.61 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FKDLGEENFK 95.00% 2.05 0.198 2.2 613.8048 1,225.59 1,226.61 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FKDLGEENFK 95.00% 2.92 0.325 2.1 613.8052 1,225.59 1,226.61 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% FKDLGEENFK 95.00% 3.14 0.326 1.8 613.8056 1,225.60 1,226.61 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% RPcFSALEVDETYVPK 95.00% 2.53 0.273 1.72 c3: Carbamidomethyl (+57.02) 637.9809 1,910.92 1,910.93 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% RPcFSALEVDETYVPK 95.00% 3.1 0.369 1.62 c3: Carbamidomethyl (+57.02) 637.9816 1,910.92 1,910.93 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% RPcFSALEVDETYVPK 95.00% 3.34 0.423 1.49 c3: Carbamidomethyl (+57.02) 637.9816 1,910.92 1,910.93 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% RPcFSALEVDETYVPK 95.00% 3.28 0.347 1.09 c3: Carbamidomethyl (+57.02) 637.9821 1,910.92 1,910.93 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% RPcFSALEVDETYVPK 95.00% 2.87 0.378 1.66 c3: Carbamidomethyl (+57.02) 637.9832 1,910.93 1,910.93 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% NEcFLQHKDDNPNLPR 95.00% 3.7 0.438 0 c3: Carbamidomethyl (+57.02) 666.6494 1,996.92 1,996.93 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% AVMDDFAAFVEK 95.00% 2.7 0.505 2.57 671.8178 1,341.62 1,342.64 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% AVMDDFAAFVEK 95.00% 2.65 0.532 1.72 671.8192 1,341.62 1,342.64 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% AVMDDFAAFVEK 95.00% 2.69 0.414 2.44 671.8204 1,341.63 1,342.64 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% AVMDDFAAFVEK 95.00% 3.89 0.597 2.77 671.8205 1,341.63 1,342.64 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% AVMDDFAAFVEK 95.00% 4.03 0.522 3.23 671.8208 1,341.63 1,342.64 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% AVMDDFAAFVEK 95.00% 2.36 0.334 1.7 671.8214 1,341.63 1,342.64 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% AVMDDFAAFVEK 95.00% 2.75 0.359 1.14 671.8222 1,341.63 1,342.64 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% AVMDDFAAFVEK 95.00% 3.21 0.456 0 671.8234 1,341.63 1,342.64 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% VFDEFKPLVEEPQNLIK 95.00% 4.62 0.517 4.16 682.7023 2,045.08 2,045.10 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% VFDEFKPLVEEPQNLIK 95.00% 4.83 0.459 2.31 682.7027 2,045.08 2,045.10 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% VFDEFKPLVEEPQNLIK 95.00% 5.21 0.518 4.77 682.7032 2,045.09 2,045.10 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% VFDEFKPLVEEPQNLIK 95.00% 4.88 0.442 3.82 682.7033 2,045.09 2,045.10 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% VHTEccHGDLLEcADDR 95.00% 5.16 0.573 2.89 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 696.2825 2,085.82 2,086.84 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% VHTEccHGDLLEcADDR 95.00% 5.51 0.6 2.42 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 696.6166 2,086.83 2,086.84 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% AAFTEccQAADKAAcLLPK 95.00% 3.71 0.421 2.31 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 708.9995 2,123.97 2,124.99 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% ETYGEMADccAK 95.00% 2.5 0.523 0 c9: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 718.2691 1,434.52 1,434.53 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% VPQVSTPTLVEVSR 95.00% 3.7 0.554 5.17 756.4242 1,510.83 1,511.84 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% KVPQVSTPTLVEVSR 95.00% 3.73 0.584 3.33 820.9721 1,639.93 1,639.94 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% KVPQVSTPTLVEVSR 95.00% 3.67 0.479 3.44 820.9729 1,639.93 1,639.94 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% QNcELFEQLGEYK 95.00% 4.57 0.634 3.4 c3: Carbamidomethyl (+57.02) 829.378 1,656.74 1,657.75 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% QNcELFEQLGEYK 95.00% 4.2 0.533 3.52 c3: Carbamidomethyl (+57.02) 829.3784 1,656.74 1,657.75 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% QNcELFEQLGEYK 95.00% 4.44 0.587 3.72 c3: Carbamidomethyl (+57.02) 829.8798 1,657.74 1,657.75 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% QNcELFEQLGEYK 95.00% 4.65 0.562 3.66 c3: Carbamidomethyl (+57.02) 829.8827 1,657.75 1,657.75 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% YKAAFTEccQAADK 95.00% 4.17 0.535 3.54 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 831.8637 1,661.71 1,662.73 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% VHTEccHGDLLEcADDRADLAK 95.00% 4.57 0.305 2.05 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 862.7114 2,585.11 2,585.12 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% VHTEccHGDLLEcADDRADLAK 95.00% 4.92 0.388 2.14 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 862.7119 2,585.11 2,585.12 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% QEPERNEcFLQHKDDNPNLPR 95.00% 3.96 0.423 0 c8: Carbamidomethyl (+57.02) 879.7454 2,636.21 2,636.23 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% QEPERNEcFLQHKDDNPNLPR 95.00% 3.93 0.492 0 c8: Carbamidomethyl (+57.02) 879.7462 2,636.22 2,636.23 3
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% RPcFSALEVDETYVPK 95.00% 2.49 0.409 0 c3: Carbamidomethyl (+57.02) 955.9658 1,909.92 1,910.93 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% RPcFSALEVDETYVPK 95.00% 4.28 0.38 3.54 c3: Carbamidomethyl (+57.02) 955.9674 1,909.92 1,910.93 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% RPcFSALEVDETYVPK 95.00% 3.55 0.352 2.2 c3: Carbamidomethyl (+57.02) 956.4672 1,910.92 1,910.93 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% RPcFSALEVDETYVPK 95.00% 3.29 0.29 0 c3: Carbamidomethyl (+57.02) 956.4693 1,910.92 1,910.93 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% RPcFSALEVDETYVPK 95.00% 4.21 0.381 2.66 c3: Carbamidomethyl (+57.02) 956.4697 1,910.92 1,910.93 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% SLHTLFGDKLcTVATLR 95.00% 4.81 0.512 5.59 c11: Carbamidomethyl (+57.02) 967.024 1,932.03 1,932.04 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% SLHTLFGDKLcTVATLR 95.00% 4.99 0.528 5.1 c11: Carbamidomethyl (+57.02) 967.0271 1,932.04 1,932.04 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% VFDEFKPLVEEPQNLIK 95.00% 5.6 0.544 4.04 1,023.55 2,045.08 2,045.10 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% VFDEFKPLVEEPQNLIK 95.00% 5.19 0.554 3.52 1,023.55 2,045.09 2,045.10 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% VHTEccHGDLLEcADDR 95.00% 6.08 0.629 6.27 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,044.42 2,086.82 2,086.84 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% AAFTEccQAADKAAcLLPK 95.00% 4.21 0.517 2.96 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,063.49 2,124.97 2,124.99 2
 SAMPLE 1 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 21 27 97 36.90% AAFTEccQAADKAAcLLPK 95.00% 4.8 0.566 3.74 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,063.50 2,124.98 2,124.99 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% YLYEIAR 95.00% 2.31 0.164 0 464.2494 926.4831 927.494 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% YLYEIAR 95.00% 2.2 0.192 1.14 464.2511 926.4865 927.494 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% FQNALLVR 95.00% 2.45 0.228 0 480.784 959.5523 960.5631 2 VINC_HUMAN
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% FQNALLVR 95.00% 2.84 0.243 0 480.7841 959.5525 960.5631 2 VINC_HUMAN
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% FQNALLVR 95.00% 2.66 0.199 0 480.7841 959.5526 960.5631 2 VINC_HUMAN
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% FQNALLVR 95.00% 2.38 0.267 0 480.7842 959.5527 960.5631 2 VINC_HUMAN
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% FQNALLVR 95.00% 2.4 0.156 0 480.7844 959.5531 960.5631 2 VINC_HUMAN
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% FQNALLVR 95.00% 2.63 0.211 0 480.7845 959.5533 960.5631 2 VINC_HUMAN
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% FQNALLVR 95.00% 2.38 0.182 0 480.7854 959.5551 960.5631 2 VINC_HUMAN
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% QTALVELVK 95.00% 2.01 0.282 0 500.8043 999.5929 1,000.60 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVAASQAALGL 95.00% 2.05 0.529 2 507.3015 1,012.59 1,013.60 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVAASQAALGL 95.00% 2.08 0.509 1.8 507.3015 1,012.59 1,013.60 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVAASQAALGL 95.00% 2.19 0.426 3.2 507.3021 1,012.59 1,013.60 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVAASQAALGL 95.00% 2.41 0.375 2.43 507.3022 1,012.59 1,013.60 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVAASQAALGL 95.00% 1.76 0.34 1.92 507.3022 1,012.59 1,013.60 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVAASQAALGL 95.00% 2.3 0.338 1.21 507.3023 1,012.59 1,013.60 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVAASQAALGL 95.00% 3.1 0.587 3.41 507.3024 1,012.59 1,013.60 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVAASQAALGL 95.00% 2.17 0.428 2.25 507.3026 1,012.59 1,013.60 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVAASQAALGL 95.00% 2.63 0.386 3.18 507.3027 1,012.59 1,013.60 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVAASQAALGL 95.00% 2.96 0.518 4.47 507.3028 1,012.59 1,013.60 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVAASQAALGL 95.00% 1.59 0.216 3.92 507.3029 1,012.59 1,013.60 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 3.65 0.373 1.09 547.3156 1,638.92 1,639.94 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 2.59 0.289 0 547.316 1,638.92 1,639.94 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 4.15 0.532 2.13 547.3162 1,638.93 1,639.94 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 4.32 0.47 2.44 547.3166 1,638.93 1,639.94 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 2.59 0.223 0 547.3166 1,638.93 1,639.94 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 4.29 0.503 3.34 547.3168 1,638.93 1,639.94 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 3.94 0.407 1.05 547.3169 1,638.93 1,639.94 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 4.04 0.519 0 547.3171 1,638.93 1,639.94 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 3.83 0.414 0 547.3172 1,638.93 1,639.94 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 3.62 0.403 0 547.3173 1,638.93 1,639.94 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 4.31 0.445 0 547.6502 1,639.93 1,639.94 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 3.18 0.375 0 547.6525 1,639.93 1,639.94 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% AEFAEVSKLVTDLTK 95.00% 3.85 0.478 1.77 550.9687 1,649.88 1,650.90 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% AEFAEVSKLVTDLTK 95.00% 3.67 0.448 2.26 550.9689 1,649.88 1,650.90 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% YKAAFTEccQAADK 95.00% 3.77 0.393 2.82 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 554.9123 1,661.71 1,662.73 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% YKAAFTEccQAADK 95.00% 3.54 0.43 2.92 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 554.9129 1,661.72 1,662.73 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVNEVTEFAK 95.00% 1.97 0.29 0 575.3062 1,148.60 1,149.62 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVNEVTEFAK 95.00% 2.76 0.347 1.25 575.3098 1,148.60 1,149.62 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVNEVTEFAK 95.00% 2.87 0.321 2.24 575.3099 1,148.60 1,149.62 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVNEVTEFAK 95.00% 3.13 0.382 2.03 575.3103 1,148.61 1,149.62 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVNEVTEFAK 95.00% 2.98 0.382 2 575.3105 1,148.61 1,149.62 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVNEVTEFAK 95.00% 3.14 0.42 2.7 575.3105 1,148.61 1,149.62 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVNEVTEFAK 95.00% 2.5 0.231 0 575.3106 1,148.61 1,149.62 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVNEVTEFAK 95.00% 3.32 0.438 2.37 575.3106 1,148.61 1,149.62 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVNEVTEFAK 95.00% 3.21 0.434 2.82 575.3106 1,148.61 1,149.62 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVNEVTEFAK 95.00% 3.09 0.408 2.22 575.3108 1,148.61 1,149.62 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVNEVTEFAK 95.00% 3.2 0.406 2.66 575.3111 1,148.61 1,149.62 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% LVNEVTEFAK 95.00% 2.69 0.395 1.57 575.314 1,148.61 1,149.62 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% FKDLGEENFK 95.00% 2.89 0.217 1.68 613.8045 1,225.59 1,226.61 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% FKDLGEENFK 95.00% 3.29 0.306 1.7 613.8053 1,225.59 1,226.61 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% FKDLGEENFK 95.00% 2.2 0.163 1.85 613.8053 1,225.60 1,226.61 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% RPcFSALEVDETYVPK 95.00% 2.26 0.26 1.19 c3: Carbamidomethyl (+57.02) 637.6489 1,909.92 1,910.93 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% RPcFSALEVDETYVPK 95.00% 2.66 0.401 1.09 c3: Carbamidomethyl (+57.02) 637.9817 1,910.92 1,910.93 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% RPcFSALEVDETYVPK 95.00% 2.9 0.315 0 c3: Carbamidomethyl (+57.02) 637.9821 1,910.92 1,910.93 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% RPcFSALEVDETYVPK 95.00% 3.31 0.401 2.06 c3: Carbamidomethyl (+57.02) 637.9824 1,910.92 1,910.93 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% RPcFSALEVDETYVPK 95.00% 2.32 0.304 1.19 c3: Carbamidomethyl (+57.02) 637.9825 1,910.92 1,910.93 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% AVMDDFAAFVEK 95.00% 2.57 0.282 0 671.8196 1,341.62 1,342.64 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% AVMDDFAAFVEK 95.00% 2.53 0.428 2.64 671.8202 1,341.62 1,342.64 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% AVMDDFAAFVEK 95.00% 2.03 0.191 1.66 671.8208 1,341.63 1,342.64 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% AVmDDFAAFVEK 95.00% 2.76 0.488 2 m3: Oxidation (+15.99) 679.8169 1,357.62 1,358.63 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% AVmDDFAAFVEK 95.00% 1.87 0.205 1.21 m3: Oxidation (+15.99) 679.8172 1,357.62 1,358.63 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VFDEFKPLVEEPQNLIK 95.00% 3.1 0.301 0 682.3602 2,044.06 2,045.10 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VFDEFKPLVEEPQNLIK 95.00% 3.85 0.351 2.51 682.3699 2,044.09 2,045.10 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VFDEFKPLVEEPQNLIK 95.00% 4.19 0.391 2.18 682.3701 2,044.09 2,045.10 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VFDEFKPLVEEPQNLIK 95.00% 4.62 0.445 4.96 682.703 2,045.09 2,045.10 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VFDEFKPLVEEPQNLIK 95.00% 4.89 0.516 2.62 682.7031 2,045.09 2,045.10 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VFDEFKPLVEEPQNLIK 95.00% 4.52 0.496 3.85 682.7043 2,045.09 2,045.10 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VFDEFKPLVEEPQNLIK 95.00% 4.34 0.473 3.33 682.7044 2,045.09 2,045.10 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VFDEFKPLVEEPQNLIK 95.00% 4.37 0.521 3.24 682.7044 2,045.09 2,045.10 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VHTEccHGDLLEcADDR 95.00% 4.4 0.561 2.18 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 696.6171 2,086.83 2,086.84 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VHTEccHGDLLEcADDR 95.00% 4.64 0.594 2.19 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 696.6171 2,086.83 2,086.84 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VPQVSTPTLVEVSR 95.00% 3.62 0.466 5.82 756.4228 1,510.83 1,511.84 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VPQVSTPTLVEVSR 95.00% 3.65 0.495 4.74 756.4249 1,510.83 1,511.84 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VPQVSTPTLVEVSR 95.00% 2.52 0.19 3.03 756.9085 1,511.80 1,511.84 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 4.08 0.578 3.46 820.471 1,638.93 1,639.94 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% KVPQVSTPTLVEVSR 95.00% 3.46 0.496 3.96 820.4714 1,638.93 1,639.94 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% AEFAEVSKLVTDLTK 95.00% 4.53 0.449 5.15 825.9497 1,649.88 1,650.90 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% AEFAEVSKLVTDLTK 95.00% 3.98 0.469 4.13 825.9498 1,649.88 1,650.90 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% QNcELFEQLGEYK 95.00% 4.22 0.475 4 c3: Carbamidomethyl (+57.02) 829.3788 1,656.74 1,657.75 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% QNcELFEQLGEYK 95.00% 4.29 0.489 5.08 c3: Carbamidomethyl (+57.02) 829.3801 1,656.74 1,657.75 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% YKAAFTEccQAADK 95.00% 4.52 0.499 5.54 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 831.8643 1,661.71 1,662.73 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VHTEccHGDLLEcADDRADLAK 95.00% 5.09 0.378 2.39 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 862.71 2,585.11 2,585.12 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VHTEccHGDLLEcADDRADLAK 95.00% 5.05 0.436 3.04 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 862.7132 2,585.12 2,585.12 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% QEPERNEcFLQHKDDNPNLPR 95.00% 3.89 0.504 2.62 c8: Carbamidomethyl (+57.02) 879.7466 2,636.22 2,636.23 3
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% RPcFSALEVDETYVPK 95.00% 2.48 0.305 0 c3: Carbamidomethyl (+57.02) 955.9682 1,909.92 1,910.93 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% RPcFSALEVDETYVPK 95.00% 3.89 0.333 2.28 c3: Carbamidomethyl (+57.02) 956.4694 1,910.92 1,910.93 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% RPcFSALEVDETYVPK 95.00% 3.65 0.336 2.54 c3: Carbamidomethyl (+57.02) 956.4695 1,910.92 1,910.93 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% SLHTLFGDKLcTVATLR 95.00% 5.23 0.501 4.55 c11: Carbamidomethyl (+57.02) 967.0227 1,932.03 1,932.04 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% SLHTLFGDKLcTVATLR 95.00% 4.78 0.472 5.74 c11: Carbamidomethyl (+57.02) 967.0259 1,932.04 1,932.04 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% NEcFLQHKDDNPNLPR 95.00% 3.8 0.471 2.2 c3: Carbamidomethyl (+57.02) 998.9743 1,995.93 1,996.93 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VFDEFKPLVEEPQNLIK 95.00% 5.13 0.568 3.68 1,023.05 2,044.08 2,045.10 2
 SAMPLE 1R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 18 23 86 35.60% VFDEFKPLVEEPQNLIK 95.00% 5.47 0.559 4.82 1,023.55 2,045.09 2,045.10 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LcTVATLR 95.00% 2.15 0.239 0 c2: Carbamidomethyl (+57.02) 467.2625 932.5093 933.5193 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% FQNALLVR 95.00% 2.76 0.226 0 480.7838 959.552 960.5631 2 VINC_HUMAN
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% FQNALLVR 95.00% 2.93 0.248 0 480.784 959.5524 960.5631 2 VINC_HUMAN
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% FQNALLVR 95.00% 2.59 0.214 0 480.7846 959.5536 960.5631 2 VINC_HUMAN
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% FQNALLVR 95.00% 2.56 0.22 0 480.7846 959.5536 960.5631 2 VINC_HUMAN
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% FQNALLVR 95.00% 2.41 0.178 0 480.7846 959.5536 960.5631 2 VINC_HUMAN
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% RHPDYSVVLLLR 95.00% 3.75 0.478 1.11 489.9521 1,466.83 1,467.84 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% RHPDYSVVLLLR 95.00% 3.56 0.352 1.89 490.2869 1,467.84 1,467.84 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% QTALVELVK 95.00% 1.99 0.319 0 500.804 999.5924 1,000.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% QTALVELVK 95.00% 1.82 0.342 0 500.8044 999.5932 1,000.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% QTALVELVK 95.00% 2.2 0.293 0 500.805 999.5943 1,000.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVAASQAALGL 95.00% 2.7 0.555 2.25 507.3011 1,012.59 1,013.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVAASQAALGL 95.00% 2.76 0.504 1.96 507.3015 1,012.59 1,013.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVAASQAALGL 95.00% 2.15 0.33 3.35 507.302 1,012.59 1,013.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVAASQAALGL 95.00% 2.36 0.521 2.46 507.3024 1,012.59 1,013.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVAASQAALGL 95.00% 1.94 0.342 3.74 507.3024 1,012.59 1,013.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVAASQAALGL 95.00% 2.62 0.496 1.72 507.3026 1,012.59 1,013.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVAASQAALGL 95.00% 2.24 0.478 2.14 507.3027 1,012.59 1,013.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVAASQAALGL 95.00% 2.23 0.353 1.85 507.3027 1,012.59 1,013.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVAASQAALGL 95.00% 2.38 0.494 2.92 507.3028 1,012.59 1,013.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVAASQAALGL 95.00% 3.33 0.6 3.57 507.3031 1,012.59 1,013.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVAASQAALGL 95.00% 3.21 0.583 4 507.3032 1,012.59 1,013.60 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% SLHTLFGDK 95.00% 2.05 0.377 0 509.2716 1,016.53 1,017.54 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KYLYEIAR 95.00% 1.93 0.362 0 528.2654 1,054.52 1,055.59 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KYLYEIAR 95.00% 2.16 0.303 0 528.5976 1,055.18 1,055.59 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 4.1 0.445 2.77 547.3164 1,638.93 1,639.94 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 4.53 0.484 4.8 547.3166 1,638.93 1,639.94 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 3.6 0.441 0 547.3169 1,638.93 1,639.94 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 4.15 0.504 0 547.317 1,638.93 1,639.94 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 3.64 0.39 0 547.317 1,638.93 1,639.94 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 3.01 0.312 0 547.3178 1,638.93 1,639.94 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 4.13 0.431 0 547.3181 1,638.93 1,639.94 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 3.75 0.436 0 547.3186 1,638.93 1,639.94 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 4.42 0.529 2.55 547.6503 1,639.93 1,639.94 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 3.98 0.401 1.39 547.6517 1,639.93 1,639.94 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 4.68 0.478 1.17 547.6518 1,639.93 1,639.94 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 3.7 0.419 0 547.6526 1,639.93 1,639.94 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AEFAEVSKLVTDLTK 95.00% 3.86 0.492 1.77 550.9693 1,649.88 1,650.90 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AEFAEVSKLVTDLTK 95.00% 3.84 0.466 2.15 550.9698 1,649.89 1,650.90 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% QNcELFEQLGEYK 95.00% 3.76 0.517 1.1 c3: Carbamidomethyl (+57.02) 553.5891 1,657.74 1,657.75 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% YKAAFTEccQAADK 95.00% 4.14 0.496 3.66 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 554.9127 1,661.71 1,662.73 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% YKAAFTEccQAADK 95.00% 4.68 0.555 4.01 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 554.913 1,661.72 1,662.73 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% ccTESLVNR 95.00% 2.82 0.416 0 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 569.7511 1,137.49 1,138.50 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% ccTESLVNR 95.00% 2.74 0.406 0 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 569.7539 1,137.49 1,138.50 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 3.13 0.353 1.68 575.3089 1,148.60 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 3.14 0.401 1.68 575.3097 1,148.60 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 3.52 0.513 2.19 575.3101 1,148.60 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.56 0.306 0 575.3102 1,148.60 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.46 0.348 0 575.3103 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.45 0.313 1.82 575.3105 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.76 0.34 1.48 575.3105 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.9 0.405 0 575.3105 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.63 0.355 0 575.3106 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.28 0.276 2.7 575.3107 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.66 0.383 1.27 575.3107 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.44 0.332 1.92 575.3108 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.72 0.425 0 575.3108 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.59 0.359 1.72 575.3112 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.73 0.361 2.17 575.3112 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.53 0.296 0 575.3119 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LVNEVTEFAK 95.00% 2.33 0.343 1.49 575.3119 1,148.61 1,149.62 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% FKDLGEENFK 95.00% 2.24 0.232 1.41 613.8027 1,225.59 1,226.61 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% FKDLGEENFK 95.00% 2.85 0.298 0 613.8048 1,225.59 1,226.61 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% FKDLGEENFK 95.00% 2.61 0.24 3.59 613.8052 1,225.59 1,226.61 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% FKDLGEENFK 95.00% 3.44 0.294 1.19 613.8058 1,225.60 1,226.61 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% FKDLGEENFK 95.00% 2.64 0.271 1.41 613.8059 1,225.60 1,226.61 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% FKDLGEENFK 95.00% 2.02 0.177 1.19 613.8081 1,225.60 1,226.61 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% RPcFSALEVDETYVPK 95.00% 3.2 0.434 1.36 c3: Carbamidomethyl (+57.02) 637.6487 1,909.92 1,910.93 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% RPcFSALEVDETYVPK 95.00% 1.82 0.19 1.55 c3: Carbamidomethyl (+57.02) 637.9813 1,910.92 1,910.93 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% RPcFSALEVDETYVPK 95.00% 3.51 0.415 1.52 c3: Carbamidomethyl (+57.02) 637.9818 1,910.92 1,910.93 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% RPcFSALEVDETYVPK 95.00% 3.47 0.433 1.96 c3: Carbamidomethyl (+57.02) 637.9822 1,910.92 1,910.93 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% PLVEEPQNLIK 95.00% 2.56 0.371 0 640.3364 1,278.66 1,279.73 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% SLHTLFGDKLcTVATLR 95.00% 2.94 0.517 0 c11: Carbamidomethyl (+57.02) 644.6841 1,931.03 1,932.04 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% NEcFLQHKDDNPNLPR 95.00% 4.25 0.453 1.48 c3: Carbamidomethyl (+57.02) 666.3146 1,995.92 1,996.93 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% NEcFLQHKDDNPNLPR 95.00% 4.64 0.428 2.21 c3: Carbamidomethyl (+57.02) 666.649 1,996.92 1,996.93 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AVMDDFAAFVEK 95.00% 2.76 0.349 2.26 671.8197 1,341.62 1,342.64 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AVMDDFAAFVEK 95.00% 2.6 0.479 1.85 671.8199 1,341.62 1,342.64 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AVMDDFAAFVEK 95.00% 2.95 0.508 2.96 671.8203 1,341.62 1,342.64 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AVMDDFAAFVEK 95.00% 3.96 0.533 3.46 671.8203 1,341.63 1,342.64 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AVMDDFAAFVEK 95.00% 2.83 0.546 2.52 671.8205 1,341.63 1,342.64 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AVMDDFAAFVEK 95.00% 3.93 0.593 3.6 671.8208 1,341.63 1,342.64 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AVMDDFAAFVEK 95.00% 2.85 0.444 1.85 671.821 1,341.63 1,342.64 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AVmDDFAAFVEK 95.00% 2.79 0.41 2.42 m3: Oxidation (+15.99) 679.818 1,357.62 1,358.63 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VFDEFKPLVEEPQNLIK 95.00% 4.05 0.496 3.7 682.7034 2,045.09 2,045.10 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VFDEFKPLVEEPQNLIK 95.00% 4.72 0.523 3.47 682.7038 2,045.09 2,045.10 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VFDEFKPLVEEPQNLIK 95.00% 4.63 0.482 3.11 682.7038 2,045.09 2,045.10 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VHTEccHGDLLEcADDR 95.00% 4.4 0.566 2.26 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 696.6178 2,086.83 2,086.84 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VHTEccHGDLLEcADDR 95.00% 4.45 0.572 2.47 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 696.6181 2,086.83 2,086.84 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AAFTEccQAADKAAcLLPK 95.00% 3.45 0.402 1.37 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 709.3326 2,124.97 2,124.99 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AAFTEccQAADKAAcLLPK 95.00% 4.25 0.434 1.89 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 709.3353 2,124.98 2,124.99 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% ETYGEMADccAK 95.00% 3.74 0.629 2.26 c9: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 717.7697 1,433.52 1,434.53 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% ETYGEMADccAK 95.00% 3.5 0.594 2.66 c9: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 717.771 1,433.53 1,434.53 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% YIcENQDSISSK 95.00% 4.12 0.521 4.6 c3: Carbamidomethyl (+57.02) 722.321 1,442.63 1,443.64 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% YIcENQDSISSK 95.00% 4.13 0.528 4.4 c3: Carbamidomethyl (+57.02) 722.3236 1,442.63 1,443.64 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VPQVSTPTLVEVSR 95.00% 3.49 0.574 5.7 756.4218 1,510.83 1,511.84 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VPQVSTPTLVEVSR 95.00% 3.57 0.505 4.55 756.4244 1,510.83 1,511.84 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VPQVSTPTLVEVSR 95.00% 3.56 0.452 5.18 756.4254 1,510.84 1,511.84 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VPQVSTPTLVEVSR 95.00% 3.65 0.513 4.77 756.9251 1,511.83 1,511.84 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LKEccEKPLLEK 95.00% 3.59 0.286 1.28 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 773.9038 1,545.79 1,546.80 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% LKEccEKPLLEK 95.00% 3.91 0.289 2.43 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 774.404 1,546.79 1,546.80 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 3.88 0.58 5.37 820.4702 1,638.92 1,639.94 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 3.34 0.499 1.6 820.4703 1,638.93 1,639.94 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 4.12 0.593 4 820.4713 1,638.93 1,639.94 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 3.25 0.526 2.42 820.4726 1,638.93 1,639.94 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 2.72 0.484 3.77 820.4729 1,638.93 1,639.94 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 2.68 0.337 1.82 820.4763 1,638.94 1,639.94 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 3.9 0.514 3.52 820.9724 1,639.93 1,639.94 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% KVPQVSTPTLVEVSR 95.00% 4.02 0.588 3.15 820.9758 1,639.94 1,639.94 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AEFAEVSKLVTDLTK 95.00% 4.55 0.484 5.64 825.9497 1,649.88 1,650.90 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AEFAEVSKLVTDLTK 95.00% 5.06 0.43 6.11 825.95 1,649.88 1,650.90 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% YKAAFTEccQAADK 95.00% 5.06 0.546 6.46 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 831.8642 1,661.71 1,662.73 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% YKAAFTEccQAADK 95.00% 4.98 0.536 5.41 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 831.8664 1,661.72 1,662.73 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VHTEccHGDLLEcADDRADLAK 95.00% 5.03 0.347 1.4 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 862.7108 2,585.11 2,585.12 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VHTEccHGDLLEcADDRADLAK 95.00% 5.61 0.347 1.89 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 862.7122 2,585.11 2,585.12 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% QEPERNEcFLQHKDDNPNLPR 95.00% 4.07 0.516 2.17 c8: Carbamidomethyl (+57.02) 879.7468 2,636.22 2,636.23 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% QEPERNEcFLQHKDDNPNLPR 95.00% 4.15 0.531 0 c8: Carbamidomethyl (+57.02) 879.7476 2,636.22 2,636.23 3
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% RPcFSALEVDETYVPK 95.00% 3.62 0.531 2.51 c3: Carbamidomethyl (+57.02) 955.9677 1,909.92 1,910.93 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% RPcFSALEVDETYVPK 95.00% 2.92 0.28 1.7 c3: Carbamidomethyl (+57.02) 955.9682 1,909.92 1,910.93 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% RPcFSALEVDETYVPK 95.00% 4.16 0.402 3.1 c3: Carbamidomethyl (+57.02) 956.4691 1,910.92 1,910.93 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% SLHTLFGDKLcTVATLR 95.00% 5.07 0.455 5.37 c11: Carbamidomethyl (+57.02) 967.0229 1,932.03 1,932.04 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% NEcFLQHKDDNPNLPR 95.00% 4.72 0.534 2.77 c3: Carbamidomethyl (+57.02) 998.9682 1,995.92 1,996.93 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VFDEFKPLVEEPQNLIK 95.00% 5.3 0.522 3.85 1,023.55 2,045.09 2,045.10 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% VFDEFKPLVEEPQNLIK 95.00% 5.38 0.548 2.72 1,023.55 2,045.09 2,045.10 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AAFTEccQAADKAAcLLPK 95.00% 5.11 0.58 4.82 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,063.50 2,124.98 2,124.99 2
 SAMPLE 2 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 27 35 120 46.30% AAFTEccQAADKAAcLLPK 95.00% 4.94 0.526 4.74 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,063.50 2,124.99 2,124.99 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LcTVATLR 95.00% 2.2 0.308 0 c2: Carbamidomethyl (+57.02) 467.2632 932.5108 933.5193 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% FQNALLVR 95.00% 2.49 0.228 0 480.7841 959.5525 960.5631 2 VINC_HUMAN
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% FQNALLVR 95.00% 2.27 0.213 0 480.7841 959.5525 960.5631 2 VINC_HUMAN
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% FQNALLVR 95.00% 2.55 0.182 0 480.7845 959.5533 960.5631 2 VINC_HUMAN
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% FQNALLVR 95.00% 2.55 0.186 0 480.7849 959.5542 960.5631 2 VINC_HUMAN
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% FQNALLVR 95.00% 2.66 0.205 0 480.7851 959.5546 960.5631 2 VINC_HUMAN
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% RHPDYSVVLLLR 95.00% 3.02 0.439 1.62 489.9521 1,466.83 1,467.84 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% RHPDYSVVLLLR 95.00% 3.03 0.398 1.08 489.9528 1,466.84 1,467.84 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% QTALVELVK 95.00% 1.83 0.362 0 500.8052 999.5948 1,000.60 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVAASQAALGL 95.00% 2.65 0.596 2.25 507.3013 1,012.59 1,013.60 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVAASQAALGL 95.00% 1.73 0.353 1.62 507.3016 1,012.59 1,013.60 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVAASQAALGL 95.00% 2.41 0.417 2.07 507.3017 1,012.59 1,013.60 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVAASQAALGL 95.00% 3.06 0.584 3.68 507.3017 1,012.59 1,013.60 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVAASQAALGL 95.00% 3.46 0.614 2.55 507.3019 1,012.59 1,013.60 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVAASQAALGL 95.00% 2.53 0.512 1.85 507.3022 1,012.59 1,013.60 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVAASQAALGL 95.00% 2.58 0.5 2.77 507.3022 1,012.59 1,013.60 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVAASQAALGL 95.00% 2.31 0.371 0 507.3024 1,012.59 1,013.60 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVAASQAALGL 95.00% 2.05 0.399 1.62 507.3042 1,012.59 1,013.60 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% SLHTLFGDK 95.00% 2.12 0.379 0 509.271 1,016.53 1,017.54 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% SLHTLFGDK 95.00% 2.12 0.378 1.96 509.2713 1,016.53 1,017.54 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 2.4 0.193 0 547.3162 1,638.93 1,639.94 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 4.5 0.491 1.59 547.3165 1,638.93 1,639.94 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 3.61 0.497 0 547.3168 1,638.93 1,639.94 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 4.35 0.434 1.68 547.3168 1,638.93 1,639.94 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 4.84 0.527 3.24 547.3172 1,638.93 1,639.94 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 3.81 0.44 0 547.3177 1,638.93 1,639.94 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 2.81 0.224 0 547.3185 1,638.93 1,639.94 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 3.98 0.438 1.23 547.6514 1,639.93 1,639.94 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 4.07 0.417 1.01 547.6517 1,639.93 1,639.94 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 2.98 0.291 1.14 547.6523 1,639.93 1,639.94 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% YKAAFTEccQAADK 95.00% 4.59 0.539 3.8 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 554.9116 1,661.71 1,662.73 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% YKAAFTEccQAADK 95.00% 4.43 0.528 3.47 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 554.9121 1,661.71 1,662.73 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% ccTESLVNR 95.00% 2.51 0.375 0 c1: Carbamidomethyl (+57.02), c2: Carbamidomethyl (+57.02) 569.7522 1,137.49 1,138.50 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 3.05 0.403 2.39 575.3096 1,148.60 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.38 0.367 0 575.31 1,148.60 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.59 0.373 2.17 575.31 1,148.60 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.33 0.254 1.3 575.3101 1,148.60 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 3.44 0.465 1.55 575.3101 1,148.60 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.84 0.353 2.19 575.3103 1,148.60 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.25 0.294 0 575.3104 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.28 0.398 0 575.3104 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.39 0.271 0 575.3106 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.07 0.287 1.47 575.3108 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 3.15 0.455 2.17 575.3109 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.7 0.372 2.16 575.311 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.88 0.411 2.41 575.3111 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.47 0.284 0 575.3112 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.36 0.248 1.19 575.3112 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.36 0.248 0 575.3113 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.93 0.331 1.62 575.3113 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 2.33 0.331 0 575.3114 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LVNEVTEFAK 95.00% 3.15 0.43 2.19 575.3122 1,148.61 1,149.62 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% FKDLGEENFK 95.00% 2.34 0.272 1.12 613.8056 1,225.60 1,226.61 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% FKDLGEENFK 95.00% 3.12 0.31 1.51 613.8059 1,225.60 1,226.61 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% FKDLGEENFK 95.00% 3.39 0.362 1.74 613.8059 1,225.60 1,226.61 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% FKDLGEENFK 95.00% 1.93 0.169 1.49 613.806 1,225.60 1,226.61 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% RPcFSALEVDETYVPK 95.00% 3.05 0.349 1.4 c3: Carbamidomethyl (+57.02) 637.6487 1,909.92 1,910.93 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% RPcFSALEVDETYVPK 95.00% 3.68 0.466 1.72 c3: Carbamidomethyl (+57.02) 637.9828 1,910.93 1,910.93 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% SLHTLFGDKLcTVATLR 95.00% 3.6 0.576 2.8 c11: Carbamidomethyl (+57.02) 644.6837 1,931.03 1,932.04 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% SLHTLFGDKLcTVATLR 95.00% 4.02 0.553 2.38 c11: Carbamidomethyl (+57.02) 645.0182 1,932.03 1,932.04 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% NEcFLQHKDDNPNLPR 95.00% 4.37 0.515 1.14 c3: Carbamidomethyl (+57.02) 666.3147 1,995.92 1,996.93 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% NEcFLQHKDDNPNLPR 95.00% 3.86 0.408 0 c3: Carbamidomethyl (+57.02) 666.3149 1,995.92 1,996.93 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% AVMDDFAAFVEK 95.00% 2.35 0.209 2.43 671.8195 1,341.62 1,342.64 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% AVMDDFAAFVEK 95.00% 3.61 0.566 2.3 671.8195 1,341.62 1,342.64 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% AVMDDFAAFVEK 95.00% 2.63 0.37 1.8 671.8202 1,341.62 1,342.64 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% AVMDDFAAFVEK 95.00% 2.6 0.433 2 671.8208 1,341.63 1,342.64 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% AVMDDFAAFVEK 95.00% 1.95 0.214 1.51 671.821 1,341.63 1,342.64 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% VFDEFKPLVEEPQNLIK 95.00% 4.94 0.511 4.6 682.7032 2,045.09 2,045.10 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% VFDEFKPLVEEPQNLIK 95.00% 4.41 0.518 3.01 682.7043 2,045.09 2,045.10 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% VHTEccHGDLLEcADDR 95.00% 4.92 0.584 1.89 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 696.6171 2,086.83 2,086.84 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% VHTEccHGDLLEcADDR 95.00% 4.84 0.584 1.14 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 696.618 2,086.83 2,086.84 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% AAFTEccQAADKAAcLLPK 95.00% 3.54 0.371 1.85 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 709.3343 2,124.98 2,124.99 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% AAFTEccQAADKAAcLLPK 95.00% 3.08 0.326 2.38 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 709.3347 2,124.98 2,124.99 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% ETYGEMADccAK 95.00% 3.33 0.538 2.01 c9: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 717.7697 1,433.52 1,434.53 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% ETYGEMADccAK 95.00% 3.59 0.58 2.54 c9: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 717.7707 1,433.53 1,434.53 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% YIcENQDSISSK 95.00% 4.05 0.529 5.89 c3: Carbamidomethyl (+57.02) 722.3229 1,442.63 1,443.64 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% VPQVSTPTLVEVSR 95.00% 3.54 0.599 5.39 756.4259 1,510.84 1,511.84 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% VPQVSTPTLVEVSR 95.00% 3.35 0.459 4.41 756.9256 1,511.84 1,511.84 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% VPQVSTPTLVEVSR 95.00% 0 0 4.3 757.8234 1,513.63 1,511.84 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LKEccEKPLLEK 95.00% 3.8 0.291 2.2 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 773.9005 1,545.79 1,546.80 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% LKEccEKPLLEK 95.00% 3.81 0.286 2 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 773.9037 1,545.79 1,546.80 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 4.07 0.579 4.74 820.472 1,638.93 1,639.94 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 3.75 0.502 5 820.4726 1,638.93 1,639.94 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% KVPQVSTPTLVEVSR 95.00% 3.27 0.484 2 820.4735 1,638.93 1,639.94 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% AEFAEVSKLVTDLTK 95.00% 4.87 0.471 5.49 825.9502 1,649.88 1,650.90 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% AEFAEVSKLVTDLTK 95.00% 4.67 0.468 4.62 825.951 1,649.89 1,650.90 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% QNcELFEQLGEYK 95.00% 4.14 0.41 2.92 c3: Carbamidomethyl (+57.02) 829.3789 1,656.74 1,657.75 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% QNcELFEQLGEYK 95.00% 4.37 0.589 3.57 c3: Carbamidomethyl (+57.02) 829.3794 1,656.74 1,657.75 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% YKAAFTEccQAADK 95.00% 4.83 0.53 6.62 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 831.8659 1,661.72 1,662.73 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% YKAAFTEccQAADK 95.00% 4.87 0.493 5.22 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 832.3684 1,662.72 1,662.73 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% VHTEccHGDLLEcADDRADLAK 95.00% 4.8 0.372 2.26 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 862.7109 2,585.11 2,585.12 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% VHTEccHGDLLEcADDRADLAK 95.00% 4.92 0.331 1.48 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 862.7115 2,585.11 2,585.12 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% QEPERNEcFLQHKDDNPNLPR 95.00% 3.9 0.381 0 c8: Carbamidomethyl (+57.02) 879.747 2,636.22 2,636.23 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% QEPERNEcFLQHKDDNPNLPR 95.00% 3.98 0.405 1.13 c8: Carbamidomethyl (+57.02) 879.747 2,636.22 2,636.23 3
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% RPcFSALEVDETYVPK 95.00% 3.48 0.482 3.46 c3: Carbamidomethyl (+57.02) 955.9671 1,909.92 1,910.93 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% RPcFSALEVDETYVPK 95.00% 2.96 0.36 2.33 c3: Carbamidomethyl (+57.02) 956.4659 1,910.92 1,910.93 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% RPcFSALEVDETYVPK 95.00% 3.23 0.304 2 c3: Carbamidomethyl (+57.02) 956.4747 1,910.93 1,910.93 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% SLHTLFGDKLcTVATLR 95.00% 4.83 0.519 6.7 c11: Carbamidomethyl (+57.02) 966.5306 1,931.05 1,932.04 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% SLHTLFGDKLcTVATLR 95.00% 4.87 0.466 5.62 c11: Carbamidomethyl (+57.02) 967.0295 1,932.04 1,932.04 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% VFDEFKPLVEEPQNLIK 95.00% 5.3 0.484 5.66 1,023.05 2,044.08 2,045.10 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% VFDEFKPLVEEPQNLIK 95.00% 5.38 0.528 4.74 1,023.55 2,045.08 2,045.10 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% VHTEccHGDLLEcADDR 95.00% 6.2 0.659 4.72 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 1,044.42 2,086.83 2,086.84 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% AAFTEccQAADKAAcLLPK 95.00% 5.2 0.579 5.02 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,063.00 2,123.98 2,124.99 2
 SAMPLE 2R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 25 32 99 45.00% AAFTEccQAADKAAcLLPK 95.00% 5.32 0.581 3.92 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 1,063.50 2,124.98 2,124.99 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% FQNALLVR 95.00% 2.83 0.168 0 480.7845 959.5534 960.5631 2 VINC_HUMAN
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% KVPQVSTPTLVEVSR 95.00% 3.6 0.317 0 547.3159 1,638.92 1,639.94 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% KVPQVSTPTLVEVSR 95.00% 3.08 0.389 0 547.3162 1,638.93 1,639.94 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% KVPQVSTPTLVEVSR 95.00% 4.16 0.401 1.06 547.3166 1,638.93 1,639.94 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% KVPQVSTPTLVEVSR 95.00% 2.66 0.256 0 547.317 1,638.93 1,639.94 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% KVPQVSTPTLVEVSR 95.00% 2.76 0.264 0 547.3171 1,638.93 1,639.94 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% KVPQVSTPTLVEVSR 95.00% 3.48 0.292 0 547.3181 1,638.93 1,639.94 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% KVPQVSTPTLVEVSR 95.00% 3.29 0.283 1.27 547.319 1,638.93 1,639.94 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% KVPQVSTPTLVEVSR 95.00% 4.23 0.451 0 547.6517 1,639.93 1,639.94 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% YKAAFTEccQAADK 95.00% 3.44 0.458 1.62 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 554.9112 1,661.71 1,662.73 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% YKAAFTEccQAADK 95.00% 3.88 0.44 2.04 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 555.2488 1,662.72 1,662.73 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% LVNEVTEFAK 95.00% 2.83 0.38 2 575.309 1,148.60 1,149.62 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% LVNEVTEFAK 95.00% 3.21 0.432 1.82 575.3098 1,148.60 1,149.62 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% LVNEVTEFAK 95.00% 2.18 0.292 0 575.3106 1,148.61 1,149.62 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% LVNEVTEFAK 95.00% 2.19 0.357 0 575.3112 1,148.61 1,149.62 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% LVNEVTEFAK 95.00% 2.43 0.239 1.21 575.3114 1,148.61 1,149.62 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% LVNEVTEFAK 95.00% 2.5 0.29 1.39 575.8122 1,149.61 1,149.62 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% FKDLGEENFK 95.00% 3.09 0.338 1.38 613.8054 1,225.60 1,226.61 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% FKDLGEENFK 95.00% 2.81 0.242 1.74 613.8058 1,225.60 1,226.61 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% RPcFSALEVDETYVPK 95.00% 2.49 0.318 0 c3: Carbamidomethyl (+57.02) 637.6477 1,909.92 1,910.93 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% NEcFLQHKDDNPNLPR 95.00% 2.95 0.487 0 c3: Carbamidomethyl (+57.02) 666.6489 1,996.92 1,996.93 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% NEcFLQHKDDNPNLPR 95.00% 2.56 0.361 0 c3: Carbamidomethyl (+57.02) 666.6502 1,996.93 1,996.93 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% AVMDDFAAFVEK 95.00% 3.44 0.544 2.74 671.819 1,341.62 1,342.64 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% AVMDDFAAFVEK 95.00% 3.62 0.522 2.89 671.8201 1,341.62 1,342.64 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% AVMDDFAAFVEK 95.00% 2.39 0.445 2.64 671.8211 1,341.63 1,342.64 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% AVMDDFAAFVEK 95.00% 2.46 0.267 1.34 672.326 1,342.64 1,342.64 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% VFDEFKPLVEEPQNLIK 95.00% 4.84 0.541 5.37 682.7037 2,045.09 2,045.10 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% VFDEFKPLVEEPQNLIK 95.00% 4.7 0.526 4.85 682.704 2,045.09 2,045.10 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% AAFTEccQAADKAAcLLPK 95.00% 2.46 0.24 0 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 709.0021 2,123.98 2,124.99 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% AAFTEccQAADKAAcLLPK 95.00% 2.59 0.255 0 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 709.335 2,124.98 2,124.99 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% YIcENQDSISSK 95.00% 2.93 0.466 2.29 c3: Carbamidomethyl (+57.02) 722.3217 1,442.63 1,443.64 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% YIcENQDSISSK 95.00% 3.74 0.528 5.92 c3: Carbamidomethyl (+57.02) 722.3248 1,442.63 1,443.64 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% VPQVSTPTLVEVSR 95.00% 2.96 0.502 4.14 756.425 1,510.83 1,511.84 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% KVPQVSTPTLVEVSR 95.00% 4.1 0.516 3.48 820.4721 1,638.93 1,639.94 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% KVPQVSTPTLVEVSR 95.00% 4.01 0.522 3.08 820.4723 1,638.93 1,639.94 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% QNcELFEQLGEYK 95.00% 4.2 0.517 3.25 c3: Carbamidomethyl (+57.02) 829.3819 1,656.75 1,657.75 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% QEPERNEcFLQHKDDNPNLPR 95.00% 3.6 0.444 1 c8: Carbamidomethyl (+57.02) 879.7491 2,636.22 2,636.23 3
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% RPcFSALEVDETYVPK 95.00% 4 0.415 2.48 c3: Carbamidomethyl (+57.02) 955.9677 1,909.92 1,910.93 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% RPcFSALEVDETYVPK 95.00% 3.78 0.348 2.57 c3: Carbamidomethyl (+57.02) 956.4704 1,910.93 1,910.93 2
 SAMPLE 3 Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 16 39 25.50% VFDEFKPLVEEPQNLIK 95.00% 5.4 0.492 3.59 1,023.55 2,045.09 2,045.10 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% FQNALLVR 95.00% 2.78 0.191 0 480.7837 959.5518 960.5631 2 VINC_HUMAN
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% FQNALLVR 95.00% 2.59 0.178 0 480.7842 959.5528 960.5631 2 VINC_HUMAN
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% LVAASQAALGL 95.00% 1.71 0.259 2 507.3021 1,012.59 1,013.60 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% LVAASQAALGL 95.00% 2.6 0.494 2.77 507.3024 1,012.59 1,013.60 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% LVAASQAALGL 95.00% 2.82 0.43 4.37 507.3025 1,012.59 1,013.60 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% LVAASQAALGL 95.00% 1.75 0.256 1.08 507.3033 1,012.59 1,013.60 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% KVPQVSTPTLVEVSR 95.00% 3.82 0.451 0 547.3166 1,638.93 1,639.94 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% KVPQVSTPTLVEVSR 95.00% 4.17 0.442 0 547.3168 1,638.93 1,639.94 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% KVPQVSTPTLVEVSR 95.00% 2.53 0.306 0 547.3183 1,638.93 1,639.94 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% KVPQVSTPTLVEVSR 95.00% 3.99 0.447 0 547.6508 1,639.93 1,639.94 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% YKAAFTEccQAADK 95.00% 3.83 0.454 2.34 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 555.2476 1,662.72 1,662.73 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% YKAAFTEccQAADK 95.00% 3.16 0.409 1.82 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 555.2479 1,662.72 1,662.73 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% LVNEVTEFAK 95.00% 2.35 0.288 0 575.3072 1,148.60 1,149.62 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% LVNEVTEFAK 95.00% 2.37 0.296 1.57 575.3105 1,148.61 1,149.62 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% LVNEVTEFAK 95.00% 3.43 0.496 1.85 575.311 1,148.61 1,149.62 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% LVNEVTEFAK 95.00% 3.1 0.431 1.41 575.3111 1,148.61 1,149.62 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% LVNEVTEFAK 95.00% 2.09 0.255 1.28 575.3115 1,148.61 1,149.62 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% LVNEVTEFAK 95.00% 2.16 0.226 0 575.3123 1,148.61 1,149.62 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% LVNEVTEFAK 95.00% 2.28 0.355 0 575.3123 1,148.61 1,149.62 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% FKDLGEENFK 95.00% 2.81 0.268 3.12 613.8037 1,225.59 1,226.61 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% FKDLGEENFK 95.00% 2.92 0.326 2.4 613.8061 1,225.60 1,226.61 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% RPcFSALEVDETYVPK 95.00% 2.74 0.359 1.6 c3: Carbamidomethyl (+57.02) 637.6486 1,909.92 1,910.93 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% RPcFSALEVDETYVPK 95.00% 2.66 0.274 1.14 c3: Carbamidomethyl (+57.02) 637.9829 1,910.93 1,910.93 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% NEcFLQHKDDNPNLPR 95.00% 3.23 0.452 0 c3: Carbamidomethyl (+57.02) 666.6486 1,996.92 1,996.93 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% VFDEFKPLVEEPQNLIK 95.00% 4.37 0.484 4.05 682.7036 2,045.09 2,045.10 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% VFDEFKPLVEEPQNLIK 95.00% 4.44 0.426 4 682.7036 2,045.09 2,045.10 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% VHTEccHGDLLEcADDR 95.00% 3.68 0.564 0 c5: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02) 696.616 2,086.82 2,086.84 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% AAFTEccQAADKAAcLLPK 95.00% 2.55 0.31 0 c6: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02), c15: Carbamidomethyl (+57.02) 709.3339 2,124.98 2,124.99 3
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% YIcENQDSISSK 95.00% 3.61 0.577 5.37 c3: Carbamidomethyl (+57.02) 722.3233 1,442.63 1,443.64 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% YIcENQDSISSK 95.00% 3.32 0.509 4.07 c3: Carbamidomethyl (+57.02) 722.3264 1,442.64 1,443.64 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% VPQVSTPTLVEVSR 95.00% 2.87 0.451 4.55 756.4243 1,510.83 1,511.84 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% VPQVSTPTLVEVSR 95.00% 2.75 0.479 2.85 756.4256 1,510.84 1,511.84 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% KVPQVSTPTLVEVSR 95.00% 3.54 0.519 4.96 820.4716 1,638.93 1,639.94 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% KVPQVSTPTLVEVSR 95.00% 3.7 0.506 5.77 820.4731 1,638.93 1,639.94 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% QNcELFEQLGEYK 95.00% 4.33 0.45 4.02 c3: Carbamidomethyl (+57.02) 829.3827 1,656.75 1,657.75 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% RPcFSALEVDETYVPK 95.00% 3.49 0.498 1.13 c3: Carbamidomethyl (+57.02) 956.4704 1,910.93 1,910.93 2
 SAMPLE 3R Serum albumin  ALB  ALBU_HUMAN 69,348.90 100.00% 13 15 35 27.30% RPcFSALEVDETYVPK 95.00% 2.58 0.267 0 c3: Carbamidomethyl (+57.02) 956.4729 1,910.93 1,910.93 2
 SAMPLE 4 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 3 3 9 16.10% VGEYSLYIGR 95.00% 3.25 0.397 3.02 578.8048 1,155.59 1,156.60 2
 SAMPLE 4 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 3 3 9 16.10% VGEYSLYIGR 95.00% 3.35 0.467 3.38 578.8051 1,155.59 1,156.60 2
 SAMPLE 4 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 3 3 9 16.10% VGEYSLYIGR 95.00% 3.32 0.474 3.37 578.8053 1,155.60 1,156.60 2
 SAMPLE 4 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 3 3 9 16.10% VGEYSLYIGR 95.00% 3.91 0.454 3.01 578.8056 1,155.60 1,156.60 2
 SAMPLE 4 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 3 3 9 16.10% VGEYSLYIGR 95.00% 3 0.392 3 579.303 1,156.59 1,156.60 2
 SAMPLE 4 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 3 3 9 16.10% VGEYSLYIGR 95.00% 3.89 0.439 3.41 579.307 1,156.60 1,156.60 2
 SAMPLE 4 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 3 3 9 16.10% QGYFVEAQPK 95.00% 2.91 0.447 1.29 583.7976 1,165.58 1,166.58 2
 SAMPLE 4 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 3 3 9 16.10% QGYFVEAQPK 95.00% 2.82 0.434 0 583.7983 1,165.58 1,166.58 2
 SAMPLE 4 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 3 3 9 16.10% IVLGQEQDSYGGK 95.00% 2.25 0.348 0 697.3535 1,392.69 1,393.70 2
 SAMPLE 4 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 3 3 9 16.10% IVLGQEQDSYGGKFDR 95.00% 4.46 0.588 3.89 906.4528 1,810.89 1,811.89 2 PGCA_HUMAN
 SAMPLE 4 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 3 3 9 16.10% IVLGQEQDSYGGKFDR 95.00% 4.35 0.61 3.89 906.4543 1,810.89 1,811.89 2 PGCA_HUMAN
 SAMPLE 4R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 99.80% 2 2 8 8.97% VGEYSLYIGR 95.00% 2.54 0.26 3.06 578.8039 1,155.59 1,156.60 2
 SAMPLE 4R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 99.80% 2 2 8 8.97% VGEYSLYIGR 95.00% 2.78 0.341 3.05 578.8045 1,155.59 1,156.60 2
 SAMPLE 4R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 99.80% 2 2 8 8.97% VGEYSLYIGR 95.00% 3.13 0.425 3.08 578.8047 1,155.59 1,156.60 2
 SAMPLE 4R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 99.80% 2 2 8 8.97% VGEYSLYIGR 95.00% 3.17 0.387 3.89 578.805 1,155.59 1,156.60 2
 SAMPLE 4R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 99.80% 2 2 8 8.97% VGEYSLYIGR 95.00% 2.93 0.288 2.21 578.8053 1,155.59 1,156.60 2
 SAMPLE 4R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 99.80% 2 2 8 8.97% VGEYSLYIGR 95.00% 3.64 0.424 3.28 578.8062 1,155.60 1,156.60 2
 SAMPLE 4R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 99.80% 2 2 8 8.97% QGYFVEAQPK 95.00% 2.66 0.345 0 583.799 1,165.58 1,166.58 2
 SAMPLE 4R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 99.80% 2 2 8 8.97% QGYFVEAQPK 95.00% 2.38 0.28 0 583.8005 1,165.59 1,166.58 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% DNELLVYK 95.00% 2.7 0.371 1.15 497.2695 992.5233 993.5258 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% DNELLVYK 95.00% 3.1 0.332 0 497.2722 992.5288 993.5258 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 3.69 0.473 3.1 578.8017 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 3.47 0.491 4.15 578.8018 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 2.92 0.475 1.96 578.8018 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 3.82 0.5 3.68 578.8021 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 3.39 0.431 3.85 578.8022 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 4.06 0.496 3.23 578.8022 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 3.62 0.456 3.7 578.8023 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 3.35 0.455 1.35 578.8025 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 3.37 0.473 1.32 578.8027 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 3.06 0.442 0 578.8029 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 3.35 0.488 1.96 578.803 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 3.55 0.489 2.52 578.8034 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 3.41 0.498 2.66 578.8042 1,155.59 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 3.93 0.492 2.57 578.8099 1,155.60 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% VGEYSLYIGR 95.00% 2.05 0.333 0 578.8152 1,155.61 1,156.60 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% QGYFVEAQPK 95.00% 2.91 0.517 1.52 583.7943 1,165.57 1,166.58 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% QGYFVEAQPK 95.00% 2.86 0.378 0 583.7955 1,165.58 1,166.58 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% IVLGQEQDSYGGKFDR 95.00% 1.94 0.271 0 604.6335 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% IVLGQEQDSYGGKFDR 95.00% 1.65 0.202 2.51 604.6387 1,810.89 1,811.89 3 PGCA_HUMAN
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% IVLGQEQDSYGGKFDR 95.00% 2.12 0.317 0 604.9734 1,811.90 1,811.89 3 PGCA_HUMAN
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% DNELLVYKER 95.00% 3.62 0.424 1.72 639.8362 1,277.66 1,278.67 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% DNELLVYKER 95.00% 3.63 0.381 1.19 639.8367 1,277.66 1,278.67 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% GYVIIKPLVWV 95.00% 2.77 0.407 1.6 643.9054 1,285.80 1,286.79 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% IVLGQEQDSYGGK 95.00% 3.43 0.55 5.92 697.3504 1,392.69 1,393.70 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% IVLGQEQDSYGGK 95.00% 3.75 0.544 5.46 697.3506 1,392.69 1,393.70 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% IVLGQEQDSYGGK 95.00% 3.91 0.536 4.52 697.3506 1,392.69 1,393.70 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% IVLGQEQDSYGGK 95.00% 3.77 0.558 4.59 697.3558 1,392.70 1,393.70 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% AYSLFSYNTQGR 95.00% 2.32 0.429 0 703.8342 1,405.65 1,406.67 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% AYSLFSYNTQGR 95.00% 4.4 0.535 3.57 703.8363 1,405.66 1,406.67 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% AYSLFSYNTQGR 95.00% 3.57 0.551 2.74 703.8368 1,405.66 1,406.67 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% AYSLFSYNTQGR 95.00% 2.45 0.253 0 703.837 1,405.66 1,406.67 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% AYSLFSYNTQGR 95.00% 3.58 0.583 2.54 703.8373 1,405.66 1,406.67 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% AYSLFSYNTQGR 95.00% 4.64 0.533 4.18 703.8375 1,405.66 1,406.67 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% AYSLFSYNTQGR 95.00% 2.34 0.355 1.92 703.8381 1,405.66 1,406.67 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% AYSLFSYNTQGR 95.00% 4.34 0.563 3.62 703.8391 1,405.66 1,406.67 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% AYSLFSYNTQGR 95.00% 4.39 0.577 4.28 703.8445 1,405.67 1,406.67 2
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% IVLGQEQDSYGGKFDR 95.00% 4.69 0.628 5.29 906.4516 1,810.89 1,811.89 2 PGCA_HUMAN
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% IVLGQEQDSYGGKFDR 95.00% 4.87 0.646 2.96 906.453 1,810.89 1,811.89 2 PGCA_HUMAN
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% IVLGQEQDSYGGKFDR 95.00% 4.66 0.612 4 906.4537 1,810.89 1,811.89 2 PGCA_HUMAN
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% IVLGQEQDSYGGKFDR 95.00% 4.91 0.545 3.19 906.9541 1,811.89 1,811.89 2 PGCA_HUMAN
 SAMPLE 1 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 8 8 36 43.90% FPAPVHIcVSWESSSGIAEFWINGTPLVK 95.00% 0 0 5.66 c8: Carbamidomethyl (+57.02) 1,077.56 3,229.64 3,228.62 3
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% DNELLVYK 95.00% 2.7 0.371 0 497.2695 992.5233 993.5258 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% DNELLVYK 95.00% 3.1 0.332 0 497.2722 992.5288 993.5258 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 2.92 0.475 2.2 578.8018 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.5 0.46 2.66 578.8022 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.67 0.495 3.19 578.8024 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.31 0.442 1.89 578.8025 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.54 0.483 2.77 578.8025 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.55 0.474 2.31 578.8027 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.02 0.456 2.89 578.8031 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.03 0.456 2.22 578.8031 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.16 0.473 3 578.8032 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.24 0.399 2.35 578.8033 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.63 0.462 3.6 578.8034 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 2.9 0.344 3.17 578.8037 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.22 0.418 2.55 578.8039 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.2 0.426 1.8 578.804 1,155.59 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 3.93 0.492 2.42 578.8099 1,155.60 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 2.47 0.293 1.36 578.8103 1,155.61 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 2.45 0.366 0 578.8108 1,155.61 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 2.72 0.428 1.23 578.8125 1,155.61 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 2.29 0.368 0 578.8128 1,155.61 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% VGEYSLYIGR 95.00% 2.05 0.333 0 578.8152 1,155.61 1,156.60 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% QGYFVEAQPK 95.00% 2.6 0.284 0 583.8039 1,165.59 1,166.58 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% IVLGQEQDSYGGKFDR 95.00% 1.95 0.294 0 604.9683 1,811.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% IVLGQEQDSYGGKFDR 95.00% 2.12 0.317 0 604.9734 1,811.90 1,811.89 3 PGCA_HUMAN
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% GYVIIKPLVWV 95.00% 2 0.28 0 643.8968 1,285.78 1,286.79 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% GYVIIKPLVWV 95.00% 2.56 0.318 0 643.9018 1,285.79 1,286.79 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% GYVIIKPLVWV 95.00% 2.5 0.369 0 643.9034 1,285.79 1,286.79 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% GYVIIKPLVWV 95.00% 2.77 0.407 1.82 643.9054 1,285.80 1,286.79 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% IVLGQEQDSYGGK 95.00% 3.91 0.536 4.36 697.3506 1,392.69 1,393.70 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% IVLGQEQDSYGGK 95.00% 3.77 0.558 4.26 697.3558 1,392.70 1,393.70 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% AYSLFSYNTQGR 95.00% 2.32 0.429 0 703.8342 1,405.65 1,406.67 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% AYSLFSYNTQGR 95.00% 2.5 0.437 2.29 703.8368 1,405.66 1,406.67 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% AYSLFSYNTQGR 95.00% 3.55 0.572 3.54 703.8375 1,405.66 1,406.67 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% AYSLFSYNTQGR 95.00% 3.18 0.545 2.77 703.8377 1,405.66 1,406.67 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% AYSLFSYNTQGR 95.00% 2.68 0.433 2.68 703.8378 1,405.66 1,406.67 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% AYSLFSYNTQGR 95.00% 2.78 0.387 1.44 703.8382 1,405.66 1,406.67 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% AYSLFSYNTQGR 95.00% 2.33 0.339 1.33 703.8387 1,405.66 1,406.67 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% AYSLFSYNTQGR 95.00% 4.34 0.563 4.22 703.8391 1,405.66 1,406.67 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% AYSLFSYNTQGR 95.00% 4.39 0.577 4.27 703.8445 1,405.67 1,406.67 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% AYSLFSYNTQGR 95.00% 4.24 0.576 4.44 703.8509 1,405.69 1,406.67 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% AYSLFSYNTQGR 95.00% 3.73 0.554 3.8 703.8515 1,405.69 1,406.67 2
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% IVLGQEQDSYGGKFDR 95.00% 4.87 0.646 2.96 906.453 1,810.89 1,811.89 2 PGCA_HUMAN
 SAMPLE 1R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 6 6 40 30.00% IVLGQEQDSYGGKFDR 95.00% 4.66 0.612 4.43 906.4537 1,810.89 1,811.89 2 PGCA_HUMAN
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 2.24 0.437 1.92 469.8966 1,406.67 1,406.67 3
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% ERVGEYSLYIGR 95.00% 2.6 0.309 0 481.2524 1,440.73 1,441.74 3
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% ERVGEYSLYIGR 95.00% 2.97 0.251 0 481.253 1,440.74 1,441.74 3
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% DNELLVYK 95.00% 3.14 0.294 1.31 497.2649 992.5141 993.5258 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% DNELLVYK 95.00% 3.06 0.307 0 497.2651 992.5146 993.5258 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% DNELLVYK 95.00% 2.2 0.292 0 497.2651 992.5146 993.5258 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% DNELLVYK 95.00% 2.56 0.341 0 497.2652 992.5147 993.5258 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% DNELLVYK 95.00% 2.26 0.305 0 497.2653 992.515 993.5258 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% DNELLVYK 95.00% 2.29 0.266 0 497.2656 992.5155 993.5258 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% DNELLVYK 95.00% 2.66 0.284 0 497.2657 992.5157 993.5258 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% DNELLVYK 95.00% 2.57 0.339 0 497.2659 992.5161 993.5258 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% GLRQGYFVEAQPK 95.00% 3.8 0.274 0 498.6023 1,492.78 1,492.79 3
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 2.81 0.36 2.4 578.8014 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.8 0.471 2.96 578.8016 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.63 0.472 2.92 578.8018 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.54 0.491 2.96 578.802 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.67 0.506 1.62 578.802 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.67 0.481 2.7 578.802 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.09 0.346 1.85 578.8022 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.88 0.515 3.16 578.8023 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.9 0.5 2.74 578.8023 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.26 0.383 2.89 578.8025 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.57 0.458 3 578.8026 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.62 0.44 1.89 578.8027 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.56 0.495 3.04 578.8028 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.58 0.418 3.11 578.8029 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.44 0.392 3.29 578.8029 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.86 0.484 1.85 578.8029 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.55 0.45 2.77 578.8031 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 3.85 0.496 2.64 578.8033 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 2.36 0.333 0 578.8036 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% VGEYSLYIGR 95.00% 2.57 0.38 0 578.8047 1,155.59 1,156.60 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% QGYFVEAQPK 95.00% 3.29 0.532 2.07 583.7947 1,165.57 1,166.58 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% QGYFVEAQPK 95.00% 2.59 0.436 0 583.7948 1,165.57 1,166.58 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% QGYFVEAQPK 95.00% 2.95 0.516 1.89 583.7948 1,165.57 1,166.58 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% QGYFVEAQPK 95.00% 3.11 0.481 1.59 583.7948 1,165.57 1,166.58 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% QGYFVEAQPK 95.00% 2.79 0.462 1.48 583.7948 1,165.57 1,166.58 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% QGYFVEAQPK 95.00% 2.46 0.256 2.51 584.2843 1,166.55 1,166.58 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% QGYFVEAQPK 95.00% 2.32 0.319 1.89 584.2852 1,166.55 1,166.58 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGKFDR 95.00% 1.69 0.269 0 604.635 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGKFDR 95.00% 1.77 0.29 0 604.6357 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGKFDR 95.00% 2.57 0.445 0 604.6357 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGKFDR 95.00% 2.31 0.386 1.32 604.636 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGKFDR 95.00% 2.35 0.26 0 604.9682 1,811.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% DNELLVYKER 95.00% 2.58 0.304 0 639.8368 1,277.66 1,278.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGK 95.00% 4 0.472 4.55 697.3498 1,392.68 1,393.70 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGK 95.00% 4 0.495 5.02 697.3501 1,392.68 1,393.70 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGK 95.00% 2.92 0.487 5.04 697.3502 1,392.68 1,393.70 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGK 95.00% 4 0.478 3.62 697.3505 1,392.69 1,393.70 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGK 95.00% 4.34 0.528 4 697.3507 1,392.69 1,393.70 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGK 95.00% 2.9 0.488 4.24 697.3518 1,392.69 1,393.70 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 3.69 0.532 3.03 703.8361 1,405.66 1,406.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 3.5 0.368 2.96 703.8361 1,405.66 1,406.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 4.45 0.531 4.09 703.8367 1,405.66 1,406.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 3.79 0.509 2.92 703.8367 1,405.66 1,406.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 3.08 0.583 2.96 703.837 1,405.66 1,406.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 4.56 0.56 3.8 703.8371 1,405.66 1,406.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 3.75 0.567 2.24 703.8377 1,405.66 1,406.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 3.75 0.535 2.54 703.8381 1,405.66 1,406.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 3.18 0.582 3.85 703.8388 1,405.66 1,406.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 4.11 0.549 3.31 703.8394 1,405.66 1,406.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 2.9 0.525 1.49 703.8401 1,405.66 1,406.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% AYSLFSYNTQGR 95.00% 3.65 0.521 4.64 704.3333 1,406.65 1,406.67 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% GLRQGYFVEAQPK 95.00% 3.32 0.29 2.27 746.8975 1,491.78 1,492.79 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% GLRQGYFVEAQPK 95.00% 2.99 0.222 1.66 747.4004 1,492.79 1,492.79 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% ESVTDHVNLITPLEK 95.00% 4.01 0.488 0 847.9482 1,693.88 1,694.90 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% ESVTDHVNLITPLEK 95.00% 4.17 0.51 0 847.9501 1,693.88 1,694.90 2
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGKFDR 95.00% 4.66 0.62 5.47 906.4485 1,810.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGKFDR 95.00% 4.52 0.633 4.03 906.4486 1,810.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGKFDR 95.00% 4.57 0.648 4.24 906.4521 1,810.89 1,811.89 2 PGCA_HUMAN
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGKFDR 95.00% 4.45 0.593 5.02 906.9495 1,811.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGKFDR 95.00% 4.88 0.623 3.96 906.9496 1,811.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGKFDR 95.00% 4.36 0.574 2.92 906.9496 1,811.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 2 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 11 62 34.10% IVLGQEQDSYGGKFDR 95.00% 4.52 0.596 4.21 906.9497 1,811.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% AYSLFSYNTQGR 95.00% 2.22 0.519 2.01 469.561 1,405.66 1,406.67 3
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% ERVGEYSLYIGR 95.00% 3 0.367 0 481.2513 1,440.73 1,441.74 3
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% DNELLVYK 95.00% 2.47 0.27 0 497.2647 992.5137 993.5258 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% DNELLVYK 95.00% 2.26 0.267 0 497.2648 992.514 993.5258 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% DNELLVYK 95.00% 2.81 0.286 0 497.2654 992.5151 993.5258 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% DNELLVYK 95.00% 2.27 0.28 0 497.2655 992.5154 993.5258 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% DNELLVYK 95.00% 3.06 0.297 0 497.2659 992.5162 993.5258 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.19 0.506 2.77 578.7996 1,155.58 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.57 0.444 3.28 578.802 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.76 0.478 2.6 578.8022 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.93 0.488 2.42 578.8023 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.37 0.481 2.16 578.8024 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.4 0.463 1.42 578.8025 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.41 0.467 2.85 578.8026 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 2.76 0.266 0 578.8026 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.04 0.348 1.23 578.8027 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.81 0.492 2.7 578.8028 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.89 0.483 2.96 578.8028 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.28 0.449 2.48 578.8031 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.93 0.49 2.55 578.8033 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 2.26 0.443 2 578.8034 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.29 0.381 2.41 578.8037 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 2.81 0.439 2.32 578.8037 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.04 0.466 2.48 578.8037 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.35 0.479 1.48 578.8049 1,155.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 3.37 0.394 1.21 579.2831 1,156.55 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 2.97 0.218 1.57 579.2838 1,156.55 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% VGEYSLYIGR 95.00% 2.53 0.291 1.2 579.3019 1,156.59 1,156.60 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% QGYFVEAQPK 95.00% 2.78 0.385 0 583.7951 1,165.57 1,166.58 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% QGYFVEAQPK 95.00% 2.78 0.375 1.82 583.7952 1,165.57 1,166.58 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% QGYFVEAQPK 95.00% 2.24 0.277 0 583.7952 1,165.57 1,166.58 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% QGYFVEAQPK 95.00% 2.21 0.224 0 583.7953 1,165.58 1,166.58 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% QGYFVEAQPK 95.00% 2.76 0.451 0 583.7954 1,165.58 1,166.58 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGKFDR 95.00% 2.22 0.258 0 604.6349 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGKFDR 95.00% 1.82 0.357 0 604.6353 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGKFDR 95.00% 2.29 0.484 0 604.9678 1,811.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGKFDR 95.00% 2.32 0.395 2.11 604.9692 1,811.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% DNELLVYKER 95.00% 2.9 0.283 1.46 639.8349 1,277.65 1,278.67 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% DNELLVYKER 95.00% 2.99 0.349 0 639.8357 1,277.66 1,278.67 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGK 95.00% 3.6 0.507 3.85 697.3486 1,392.68 1,393.70 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGK 95.00% 3.62 0.539 3.89 697.3487 1,392.68 1,393.70 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGK 95.00% 3.58 0.528 5.09 697.3501 1,392.68 1,393.70 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGK 95.00% 3.68 0.487 4.59 697.3501 1,392.68 1,393.70 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGK 95.00% 3.77 0.515 4.2 697.3509 1,392.69 1,393.70 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGK 95.00% 4.22 0.476 4.41 697.3512 1,392.69 1,393.70 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% AYSLFSYNTQGR 95.00% 4.46 0.544 4.33 703.8374 1,405.66 1,406.67 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% AYSLFSYNTQGR 95.00% 4.73 0.539 4.52 703.8376 1,405.66 1,406.67 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% AYSLFSYNTQGR 95.00% 2.96 0.524 2.92 703.8376 1,405.66 1,406.67 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% AYSLFSYNTQGR 95.00% 4.48 0.579 3.54 703.8377 1,405.66 1,406.67 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% AYSLFSYNTQGR 95.00% 4.25 0.53 4.15 703.8379 1,405.66 1,406.67 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% AYSLFSYNTQGR 95.00% 2.96 0.452 2.41 703.838 1,405.66 1,406.67 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% AYSLFSYNTQGR 95.00% 4.34 0.488 4.15 703.8396 1,405.66 1,406.67 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% AYSLFSYNTQGR 95.00% 2.4 0.209 2.62 703.8405 1,405.67 1,406.67 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% GLRQGYFVEAQPK 95.00% 3.08 0.217 2.23 746.8997 1,491.78 1,492.79 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% GLRQGYFVEAQPK 95.00% 2.83 0.275 1.12 746.9007 1,491.79 1,492.79 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% ESVTDHVNLITPLEK 95.00% 4.07 0.504 0 847.9516 1,693.89 1,694.90 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% ESVTDHVNLITPLEK 95.00% 4.52 0.507 0 848.4521 1,694.89 1,694.90 2
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGKFDR 95.00% 4.62 0.621 3.96 906.4485 1,810.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGKFDR 95.00% 4.43 0.637 4.72 906.4506 1,810.89 1,811.89 2 PGCA_HUMAN
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGKFDR 95.00% 4.46 0.592 3.8 906.9479 1,811.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGKFDR 95.00% 4.73 0.586 4.17 906.9485 1,811.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGKFDR 95.00% 4.82 0.567 3.4 906.95 1,811.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 2R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 9 10 53 34.10% IVLGQEQDSYGGKFDR 95.00% 4.61 0.61 3.68 906.951 1,811.89 1,811.89 2 PGCA_HUMAN
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% DNELLVYK 95.00% 2.83 0.264 0 497.2662 992.5168 993.5258 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% DNELLVYK 95.00% 2.56 0.261 0 497.2668 992.5179 993.5258 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% VGEYSLYIGR 95.00% 3.8 0.466 2 578.8023 1,155.59 1,156.60 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% VGEYSLYIGR 95.00% 3.78 0.477 2.43 578.8023 1,155.59 1,156.60 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% VGEYSLYIGR 95.00% 3.75 0.479 3.18 578.8025 1,155.59 1,156.60 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% VGEYSLYIGR 95.00% 3.8 0.502 3.12 578.8028 1,155.59 1,156.60 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% VGEYSLYIGR 95.00% 2.69 0.33 1.57 578.803 1,155.59 1,156.60 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% VGEYSLYIGR 95.00% 3.38 0.384 3.32 578.803 1,155.59 1,156.60 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% VGEYSLYIGR 95.00% 4.02 0.491 3.28 578.8033 1,155.59 1,156.60 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% VGEYSLYIGR 95.00% 3.58 0.339 2.74 578.8043 1,155.59 1,156.60 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% VGEYSLYIGR 95.00% 3.31 0.429 2.51 578.806 1,155.60 1,156.60 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% QGYFVEAQPK 95.00% 2.73 0.325 0 583.7934 1,165.57 1,166.58 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% QGYFVEAQPK 95.00% 2.5 0.339 0 583.794 1,165.57 1,166.58 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% QGYFVEAQPK 95.00% 2.69 0.395 0 583.7953 1,165.58 1,166.58 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% QGYFVEAQPK 95.00% 2.63 0.422 0 583.7954 1,165.58 1,166.58 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% IVLGQEQDSYGGKFDR 95.00% 1.85 0.37 0 604.6341 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% IVLGQEQDSYGGKFDR 95.00% 1.91 0.37 0 604.6356 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% IVLGQEQDSYGGKFDR 95.00% 1.59 0.167 1.46 604.6357 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% IVLGQEQDSYGGKFDR 95.00% 2.24 0.41 0 604.9692 1,811.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% IVLGQEQDSYGGKFDR 95.00% 2.48 0.479 1.49 604.9694 1,811.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% IVLGQEQDSYGGK 95.00% 3.89 0.499 3.8 697.3501 1,392.68 1,393.70 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% IVLGQEQDSYGGK 95.00% 3.91 0.491 3.96 697.3501 1,392.68 1,393.70 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% AYSLFSYNTQGR 95.00% 4.3 0.548 4.7 703.8365 1,405.66 1,406.67 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% AYSLFSYNTQGR 95.00% 4.26 0.534 4.25 703.8368 1,405.66 1,406.67 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% AYSLFSYNTQGR 95.00% 4.27 0.578 4 703.8369 1,405.66 1,406.67 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% AYSLFSYNTQGR 95.00% 3.94 0.56 3.52 703.8371 1,405.66 1,406.67 2
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% IVLGQEQDSYGGKFDR 95.00% 4.55 0.639 3.59 906.4493 1,810.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% IVLGQEQDSYGGKFDR 95.00% 4.81 0.612 3.96 906.95 1,811.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% IVLGQEQDSYGGKFDR 95.00% 4.84 0.625 3.62 906.9502 1,811.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 3 Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 21 25.10% IVLGQEQDSYGGKFDR 95.00% 4.59 0.608 3.46 906.9503 1,811.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% VGEYSLYIGR 95.00% 2.42 0.226 0 578.7999 1,155.58 1,156.60 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% VGEYSLYIGR 95.00% 3.04 0.277 3.24 578.8017 1,155.59 1,156.60 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% VGEYSLYIGR 95.00% 3.61 0.439 2.66 578.8021 1,155.59 1,156.60 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% VGEYSLYIGR 95.00% 3.75 0.464 3.2 578.8023 1,155.59 1,156.60 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% VGEYSLYIGR 95.00% 3.71 0.423 2.57 578.8024 1,155.59 1,156.60 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% VGEYSLYIGR 95.00% 3.57 0.476 2.46 578.8029 1,155.59 1,156.60 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% VGEYSLYIGR 95.00% 3.83 0.53 2.55 578.8029 1,155.59 1,156.60 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% VGEYSLYIGR 95.00% 2.87 0.342 2.46 578.8033 1,155.59 1,156.60 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% VGEYSLYIGR 95.00% 3.72 0.484 1.16 578.8033 1,155.59 1,156.60 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% VGEYSLYIGR 95.00% 2.77 0.332 1.96 578.8034 1,155.59 1,156.60 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% VGEYSLYIGR 95.00% 2.87 0.354 1.24 578.8037 1,155.59 1,156.60 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% QGYFVEAQPK 95.00% 2.85 0.26 0 583.7906 1,165.57 1,166.58 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% QGYFVEAQPK 95.00% 2.96 0.333 0 583.7945 1,165.57 1,166.58 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% QGYFVEAQPK 95.00% 3.12 0.444 2.33 583.7947 1,165.57 1,166.58 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% QGYFVEAQPK 95.00% 2.81 0.412 1.89 583.7955 1,165.58 1,166.58 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% IVLGQEQDSYGGKFDR 95.00% 1.95 0.364 0 604.6348 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% IVLGQEQDSYGGKFDR 95.00% 1.88 0.365 0 604.6351 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% IVLGQEQDSYGGKFDR 95.00% 2.64 0.502 0 604.6353 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% IVLGQEQDSYGGKFDR 95.00% 1.87 0.256 0 604.6357 1,810.88 1,811.89 3 PGCA_HUMAN
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% IVLGQEQDSYGGKFDR 95.00% 2.33 0.302 0 604.9699 1,811.89 1,811.89 3 PGCA_HUMAN
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% GYVIIKPLVWV 95.00% 2.38 0.333 0 643.8969 1,285.78 1,286.79 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% GYVIIKPLVWV 95.00% 3.07 0.505 1.6 643.8974 1,285.78 1,286.79 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% IVLGQEQDSYGGK 95.00% 3.64 0.518 4.8 697.3493 1,392.68 1,393.70 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% IVLGQEQDSYGGK 95.00% 3.58 0.558 4.66 697.3506 1,392.69 1,393.70 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% AYSLFSYNTQGR 95.00% 4.38 0.585 4.09 703.8363 1,405.66 1,406.67 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% AYSLFSYNTQGR 95.00% 4.14 0.607 4.19 703.8372 1,405.66 1,406.67 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% AYSLFSYNTQGR 95.00% 3.88 0.481 3.82 703.8385 1,405.66 1,406.67 2
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% IVLGQEQDSYGGKFDR 95.00% 4.4 0.617 3.72 906.4475 1,810.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% IVLGQEQDSYGGKFDR 95.00% 4.76 0.64 4.85 906.4499 1,810.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% IVLGQEQDSYGGKFDR 95.00% 4.81 0.603 3.82 906.9494 1,811.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 3R Serum amyloid P-component  APCS  SAMP_HUMAN 25,369.70 100.00% 5 5 22 26.50% IVLGQEQDSYGGKFDR 95.00% 4.74 0.6 4.89 906.9494 1,811.88 1,811.89 2 PGCA_HUMAN
 SAMPLE 2R SH3 domain-binding glutamic acid-rich-like protein  SH3BGRL  SH3L1_HUMAN 12,756.50 99.80% 2 2 3 21.90% VYIASSSGSTAIK 95.00% 3.68 0.431 3.92 642.3457 1,282.68 1,283.68 2
 SAMPLE 2R SH3 domain-binding glutamic acid-rich-like protein  SH3BGRL  SH3L1_HUMAN 12,756.50 99.80% 2 2 3 21.90% VYIASSSGSTAIK 95.00% 3.64 0.45 4 642.3461 1,282.68 1,283.68 2
 SAMPLE 2R SH3 domain-binding glutamic acid-rich-like protein  SH3BGRL  SH3L1_HUMAN 12,756.50 99.80% 2 2 3 21.90% QQDVLGFLEANK 95.00% 2.89 0.259 0 681.8593 1,361.70 1,361.71 2
 SAMPLE 3R SH3 domain-binding glutamic acid-rich-like protein  SH3BGRL  SH3L1_HUMAN 12,756.50 99.80% 2 2 2 20.20% GDYDAFFEAR 95.00% 2.56 0.174 1.16 595.7592 1,189.50 1,190.51 2
 SAMPLE 3R SH3 domain-binding glutamic acid-rich-like protein  SH3BGRL  SH3L1_HUMAN 12,756.50 99.80% 2 2 2 20.20% VYIASSSGSTAIK 95.00% 3.33 0.39 4.8 642.3451 1,282.67 1,283.68 2
 SAMPLE 4 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.90% 2 2 11 3.05% TTTVESSFVR 95.00% 2.66 0.0816 2.12 563.7877 1,125.56 1,126.57 2
 SAMPLE 4 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.90% 2 2 11 3.05% TTTVESSFVR 95.00% 2.96 0.316 2.01 563.7898 1,125.56 1,126.57 2
 SAMPLE 4 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.90% 2 2 11 3.05% TTTVESSFVR 95.00% 2.89 0.435 1.92 563.7908 1,125.57 1,126.57 2
 SAMPLE 4 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.90% 2 2 11 3.05% TTTVESSFVR 95.00% 2.8 0.253 0 563.7909 1,125.57 1,126.57 2
 SAMPLE 4 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.90% 2 2 11 3.05% TTTVESSFVR 95.00% 2.99 0.494 2.02 563.7918 1,125.57 1,126.57 2
 SAMPLE 4 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.90% 2 2 11 3.05% TTTVESSFVR 95.00% 3.07 0.452 2.06 563.7924 1,125.57 1,126.57 2
 SAMPLE 4 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.90% 2 2 11 3.05% TTTVESSFVR 95.00% 3.03 0.487 2.14 563.7924 1,125.57 1,126.57 2
 SAMPLE 4 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.90% 2 2 11 3.05% LGSVTHVTSFSHAPPSSR 95.00% 4.4 0.557 3.54 622.9891 1,865.94 1,866.95 3
 SAMPLE 4 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.90% 2 2 11 3.05% LGSVTHVTSFSHAPPSSR 95.00% 3.68 0.4 0 622.9894 1,865.94 1,866.95 3
 SAMPLE 4 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.90% 2 2 11 3.05% LGSVTHVTSFSHAPPSSR 95.00% 4.34 0.528 3.92 622.9894 1,865.94 1,866.95 3
 SAMPLE 4 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.90% 2 2 11 3.05% LGSVTHVTSFSHAPPSSR 95.00% 4.15 0.537 2.92 623.3258 1,866.95 1,866.95 3
 SAMPLE 4R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.80% 2 2 8 3.05% TTTVESSFVR 95.00% 2.76 0.109 1.89 563.7861 1,125.56 1,126.57 2
 SAMPLE 4R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.80% 2 2 8 3.05% TTTVESSFVR 95.00% 2.65 0.215 1.19 563.788 1,125.56 1,126.57 2
 SAMPLE 4R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.80% 2 2 8 3.05% TTTVESSFVR 95.00% 2.73 0.0848 1.68 563.7881 1,125.56 1,126.57 2
 SAMPLE 4R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.80% 2 2 8 3.05% TTTVESSFVR 95.00% 2.38 0.399 0 563.7918 1,125.57 1,126.57 2
 SAMPLE 4R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.80% 2 2 8 3.05% TTTVESSFVR 95.00% 2.66 0.442 1.74 563.7921 1,125.57 1,126.57 2
 SAMPLE 4R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.80% 2 2 8 3.05% LGSVTHVTSFSHAPPSSR 95.00% 3.43 0.494 2.49 622.9886 1,865.94 1,866.95 3
 SAMPLE 4R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.80% 2 2 8 3.05% LGSVTHVTSFSHAPPSSR 95.00% 3.63 0.389 1.85 623.3233 1,866.95 1,866.95 3
 SAMPLE 4R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.80% 2 2 8 3.05% LGSVTHVTSFSHAPPSSR 95.00% 3.66 0.44 1.59 623.3239 1,866.95 1,866.95 3
 SAMPLE 1R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.80% 2 2 2 2.51% GVAQPLAQLR 95.00% 2.34 0.198 0 526.8131 1,051.61 1,052.62 2
 SAMPLE 1R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 99.80% 2 2 2 2.51% APPTLLSTSSGGK 95.00% 2.53 0.494 2.6 608.3335 1,214.65 1,215.66 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% GVAQPLAQLR 95.00% 2.21 0.149 1.24 526.813 1,051.61 1,052.62 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% GVAQPLAQLR 95.00% 2.82 0.274 2.27 526.8134 1,051.61 1,052.62 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% GVAQPLAQLR 95.00% 2.68 0.401 2.04 526.8134 1,051.61 1,052.62 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% GVAQPLAQLR 95.00% 2.9 0.318 2.39 526.8137 1,051.61 1,052.62 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% GVAQPLAQLR 95.00% 2.85 0.357 1.96 526.8138 1,051.61 1,052.62 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% GQASTGRVLLPTGNQR 95.00% 1.75 0.324 0 551.9937 1,652.96 1,654.90 3
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% TTTVESSFVR 95.00% 2.69 0 2 563.7829 1,125.55 1,126.57 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% TTTVESSFVR 95.00% 3.05 0.179 1.7 563.7857 1,125.56 1,126.57 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% TTTVESSFVR 95.00% 2.96 0.0919 2.32 563.786 1,125.56 1,126.57 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% APPTLLSTSSGGK 95.00% 2.78 0.582 3.59 608.3303 1,214.64 1,215.66 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% AQEIEAATLAGR 95.00% 2.64 0.378 3.64 615.3282 1,228.64 1,229.65 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% STSFGVPNANSIK 95.00% 2.22 0.36 0 661.3372 1,320.66 1,321.68 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% STSFGVPNANSIK 95.00% 2.54 0.447 1.28 661.3381 1,320.66 1,321.68 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% MLDQSTDFEER 95.00% 2.5 0.46 1.85 685.7973 1,369.58 1,370.59 2
 SAMPLE 2 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 8 8 15 10.80% ESTPLASGPSSFQR 95.00% 2.21 0.304 1.4 732.3597 1,462.70 1,463.71 2
 SAMPLE 2R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 3 3 7 3.38% GVAQPLAQLR 95.00% 2.82 0.306 2.34 526.8138 1,051.61 1,052.62 2
 SAMPLE 2R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 3 3 7 3.38% GVAQPLAQLR 95.00% 2.95 0.279 2.28 526.8143 1,051.61 1,052.62 2
 SAMPLE 2R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 3 3 7 3.38% TTTVESSFVR 95.00% 2.71 0.0262 2.89 563.7849 1,125.55 1,126.57 2
 SAMPLE 2R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 3 3 7 3.38% TTTVESSFVR 95.00% 2.92 0.127 2.77 563.7883 1,125.56 1,126.57 2
 SAMPLE 2R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 3 3 7 3.38% TTTVESSFVR 95.00% 3.1 0.204 2.72 563.789 1,125.56 1,126.57 2
 SAMPLE 2R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 3 3 7 3.38% LLEVTADLAER 95.00% 2.91 0.174 1.34 615.3385 1,228.66 1,229.67 2
 SAMPLE 2R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 3 3 7 3.38% LLEVTADLAER 95.00% 2.75 0.184 0 615.341 1,228.67 1,229.67 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% GVAQPLAQLR 95.00% 2.99 0.41 1.6 526.8132 1,051.61 1,052.62 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% GVAQPLAQLR 95.00% 3.28 0.426 3.19 526.8133 1,051.61 1,052.62 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% GVAQPLAQLR 95.00% 2.5 0.352 1.96 526.8133 1,051.61 1,052.62 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% GVAQPLAQLR 95.00% 2.31 0.298 2.2 526.8133 1,051.61 1,052.62 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% GVAQPLAQLR 95.00% 3.12 0.401 1.33 526.8135 1,051.61 1,052.62 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% GVAQPLAQLR 95.00% 2.94 0.378 1.82 526.8136 1,051.61 1,052.62 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% QMLLDWcR 95.00% 2.09 0.302 0 c7: Carbamidomethyl (+57.02) 561.2641 1,120.51 1,121.52 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% QMLLDWcR 95.00% 1.99 0.32 0 c7: Carbamidomethyl (+57.02) 561.2656 1,120.52 1,121.52 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% QELEREEEALASKR 95.00% 3.54 0.362 1.24 563.2891 1,686.84 1,687.86 3
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% QELEREEEALASKR 95.00% 2.87 0.254 0 563.6253 1,687.85 1,687.86 3
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% TTTVESSFVR 95.00% 2.9 0.0627 1.96 563.7858 1,125.56 1,126.57 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% TTTVESSFVR 95.00% 2.95 0.379 2.17 563.7904 1,125.57 1,126.57 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% APPTLLSTSSGGK 95.00% 2.87 0.55 4.51 608.3317 1,214.65 1,215.66 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% APPTLLSTSSGGK 95.00% 3.46 0.688 4.6 608.332 1,214.65 1,215.66 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% APPTLLSTSSGGK 95.00% 3.09 0.611 4.7 608.3325 1,214.65 1,215.66 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% APPTLLSTSSGGK 95.00% 3.24 0.569 5.23 608.3328 1,214.65 1,215.66 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% LLEVTADLAER 95.00% 3.19 0.399 0 615.3371 1,228.66 1,229.67 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% LGSVTHVTSFSHAPPSSR 95.00% 4.15 0.523 2.08 623.3198 1,866.94 1,866.95 3
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% LGSVTHVTSFSHAPPSSR 95.00% 3.9 0.404 2.52 623.321 1,866.94 1,866.95 3
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% LGSVTHVTSFSHAPPSSR 95.00% 3.92 0.512 1.02 623.3217 1,866.94 1,866.95 3
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% STSFGVPNANSIK 95.00% 2.16 0.349 0 661.3389 1,320.66 1,321.68 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% STSFGVPNANSIK 95.00% 2.1 0.331 0 661.3401 1,320.66 1,321.68 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% MLDQSTDFEER 95.00% 2.47 0.462 0 685.7961 1,369.58 1,370.59 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% MLDQSTDFEER 95.00% 2.58 0.44 2.04 685.7976 1,369.58 1,370.59 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% ESTPLASGPSSFQR 95.00% 2.48 0.522 1.28 732.3606 1,462.71 1,463.71 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% ESTPLASGPSSFQR 95.00% 2.8 0.532 2.35 732.3607 1,462.71 1,463.71 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% ESTPLASGPSSFQR 95.00% 2.37 0.39 1.14 732.3612 1,462.71 1,463.71 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% ESTPLASGPSSFQR 95.00% 2.85 0.489 2.08 732.8604 1,463.71 1,463.71 2
 SAMPLE 3 Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 11 11 29 15.40% SPLSAEELMTIEDEGVLDK 95.00% 5.24 0.685 5.77 1,038.50 2,074.99 2,076.01 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% GVAQPLAQLR 95.00% 3.17 0.419 1.72 526.8131 1,051.61 1,052.62 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% GVAQPLAQLR 95.00% 2.79 0.41 2.72 526.8133 1,051.61 1,052.62 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% GVAQPLAQLR 95.00% 2.35 0.261 2.27 526.8134 1,051.61 1,052.62 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% GVAQPLAQLR 95.00% 2.8 0.396 1.59 526.8135 1,051.61 1,052.62 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% GVAQPLAQLR 95.00% 2.13 0.349 0 526.8137 1,051.61 1,052.62 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% QELEREEEALASKR 95.00% 3.02 0.217 0 563.2919 1,686.85 1,687.86 3
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% QELEREEEALASKR 95.00% 3.47 0.366 0 563.627 1,687.86 1,687.86 3
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% TTTVESSFVR 95.00% 2.98 0.0934 2.2 563.7867 1,125.56 1,126.57 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% cVFTYVQSLYNHLR 95.00% 3.85 0.517 1.41 c1: Carbamidomethyl (+57.02) 600.6338 1,798.88 1,799.89 3
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% cVFTYVQSLYNHLR 95.00% 3.28 0.514 1.28 c1: Carbamidomethyl (+57.02) 600.9691 1,799.88 1,799.89 3
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% APPTLLSTSSGGK 95.00% 2.87 0.535 5.26 608.3315 1,214.65 1,215.66 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% APPTLLSTSSGGK 95.00% 3.35 0.649 4.52 608.3318 1,214.65 1,215.66 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% APPTLLSTSSGGK 95.00% 3.28 0.652 3.64 608.3321 1,214.65 1,215.66 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% APPTLLSTSSGGK 95.00% 3.14 0.55 3.36 608.3326 1,214.65 1,215.66 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% AQEIEAATLAGR 95.00% 3.53 0.444 2.28 615.3274 1,228.64 1,229.65 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% AQEIEAATLAGR 95.00% 3.25 0.444 3.11 615.3285 1,228.64 1,229.65 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% LLEVTADLAER 95.00% 3.15 0.286 0 615.3393 1,228.66 1,229.67 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% LLEVTADLAER 95.00% 3.08 0.27 0 615.3395 1,228.66 1,229.67 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% LGSVTHVTSFSHAPPSSR 95.00% 2.55 0.388 0 622.9869 1,865.94 1,866.95 3
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% ESTPLASGPSSFQR 95.00% 2.03 0.413 0 732.3596 1,462.70 1,463.71 2
 SAMPLE 3R Smoothelin  SMTN  SMTN_HUMAN 99,503.40 100.00% 9 9 21 12.60% ESTPLASGPSSFQR 95.00% 3.02 0.476 1.66 732.8596 1,463.70 1,463.71 2
 SAMPLE 4R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 3 3 5 2.79% TYIELLPPAEK 95.00% 2.16 0.184 2.01 637.3578 1,272.70 1,273.70 2
 SAMPLE 4R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 3 3 5 2.79% TYIELLPPAEK 95.00% 2.71 0.422 1.49 637.3595 1,272.70 1,273.70 2
 SAMPLE 4R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 3 3 5 2.79% FGDLLNIDDTAK 95.00% 2.25 0.165 2.22 661.337 1,320.66 1,321.66 2
 SAMPLE 4R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 3 3 5 2.79% FGDLLNIDDTAK 95.00% 2.53 0.22 2.11 661.3387 1,320.66 1,321.66 2
 SAMPLE 4R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 3 3 5 2.79% QGIFPITYVDVIK 95.00% 2.24 0.312 0 746.9277 1,491.84 1,492.84 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% SIYEYQPGK 95.00% 1.89 0.35 0 542.7701 1,083.52 1,084.53 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% YSFSEDTKSPLSVPR 95.00% 3.75 0.582 1.46 571.6205 1,711.84 1,712.85 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% YSFSEDTKSPLSVPR 95.00% 3.49 0.536 1.47 571.6205 1,711.84 1,712.85 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% YSFSEDTKSPLSVPR 95.00% 2.89 0.471 0 571.7548 1,712.24 1,712.85 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% YSFSEDTKSPLSVPR 95.00% 3.66 0.495 2.55 571.9547 1,712.84 1,712.85 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% KLTPVQVLEYGEAIAK 95.00% 3.98 0.293 3.77 587.3374 1,758.99 1,759.00 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% KLTPVQVLEYGEAIAK 95.00% 4.07 0.297 3.15 587.3377 1,758.99 1,759.00 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% KLTPVQVLEYGEAIAK 95.00% 3.7 0.224 2.52 587.338 1,758.99 1,759.00 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% KLTPVQVLEYGEAIAK 95.00% 3.88 0.305 1.17 587.338 1,758.99 1,759.00 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% KLTPVQVLEYGEAIAK 95.00% 3.96 0.37 1.82 587.3381 1,758.99 1,759.00 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% KLTPVQVLEYGEAIAK 95.00% 4.29 0.451 4.85 587.3381 1,758.99 1,759.00 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% KLTPVQVLEYGEAIAK 95.00% 3.95 0.467 3.11 587.3385 1,758.99 1,759.00 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% TYIELLPPAEK 95.00% 2.13 0.251 0 637.355 1,272.69 1,273.70 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% TYIELLPPAEK 95.00% 2.29 0.507 4.01 637.3553 1,272.69 1,273.70 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% TYIELLPPAEK 95.00% 2.22 0.292 2.25 637.3559 1,272.70 1,273.70 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% FGDLLNIDDTAK 95.00% 3.28 0.42 3.4 661.3332 1,320.65 1,321.66 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% FGDLLNIDDTAK 95.00% 3.89 0.419 4.43 661.3336 1,320.65 1,321.66 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% FGDLLNIDDTAK 95.00% 3.68 0.432 2.62 661.3339 1,320.65 1,321.66 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% FGDLLNIDDTAK 95.00% 2.97 0.267 3.46 661.3339 1,320.65 1,321.66 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% FGDLLNIDDTAK 95.00% 2.27 0.206 2.36 661.3341 1,320.65 1,321.66 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% FGDLLNIDDTAK 95.00% 3.76 0.399 2.74 661.3344 1,320.65 1,321.66 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% FGDLLNIDDTAK 95.00% 3.99 0.431 2.89 661.3344 1,320.65 1,321.66 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% FGDLLNIDDTAK 95.00% 2.74 0.277 3.6 661.3361 1,320.66 1,321.66 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% FGDLLNIDDTAK 95.00% 3.63 0.422 2.44 661.3401 1,320.66 1,321.66 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% QGIFPITYVDVIK 95.00% 2.43 0.302 0 746.9267 1,491.84 1,492.84 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% SVLEGGDIPLQGLSGLK 95.00% 5.22 0.452 2.72 841.9682 1,681.92 1,682.93 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% SVLEGGDIPLQGLSGLK 95.00% 5.2 0.484 7.55 841.9687 1,681.92 1,682.93 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% SVLEGGDIPLQGLSGLK 95.00% 5.15 0.523 5.16 841.9691 1,681.92 1,682.93 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% SVLEGGDIPLQGLSGLK 95.00% 4.99 0.564 7.68 841.9696 1,681.92 1,682.93 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% SVLEGGDIPLQGLSGLK 95.00% 5.06 0.549 5.74 841.9696 1,681.92 1,682.93 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% SVLEGGDIPLQGLSGLK 95.00% 4.99 0.534 4.29 841.9696 1,681.92 1,682.93 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% KLTPVQVLEYGEAIAK 95.00% 4.52 0.503 3.72 880.5039 1,758.99 1,759.00 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 8 9 33 8.59% STQDLSDVSMDEVGIPLR 95.00% 4.09 0.577 4 981.979 1,961.94 1,961.95 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% LTPVQVLEYGEAIAK 95.00% 3.46 0.393 0 544.3068 1,629.90 1,630.91 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% YSFSEDTKSPLSVPR 95.00% 3.72 0.535 2.17 571.6199 1,711.84 1,712.85 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% YSFSEDTKSPLSVPR 95.00% 3.22 0.482 1.27 571.6202 1,711.84 1,712.85 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% YSFSEDTKSPLSVPR 95.00% 3.13 0.438 1.11 571.6202 1,711.84 1,712.85 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% YSFSEDTKSPLSVPR 95.00% 3.68 0.591 1.54 571.6204 1,711.84 1,712.85 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% KLTPVQVLEYGEAIAK 95.00% 3.19 0.374 2.72 587.3375 1,758.99 1,759.00 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% KLTPVQVLEYGEAIAK 95.00% 4.53 0.467 2.89 587.338 1,758.99 1,759.00 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% KLTPVQVLEYGEAIAK 95.00% 4.18 0.395 4.72 587.3381 1,758.99 1,759.00 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% KLTPVQVLEYGEAIAK 95.00% 3.78 0.445 2.77 587.3384 1,758.99 1,759.00 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% FGDLLNIDDTAK 95.00% 3.73 0.44 2.74 661.3329 1,320.65 1,321.66 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% FGDLLNIDDTAK 94.90% 1.89 0.151 3.29 661.3334 1,320.65 1,321.66 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% FGDLLNIDDTAK 95.00% 3.22 0.318 2.07 661.3338 1,320.65 1,321.66 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% FGDLLNIDDTAK 95.00% 2.72 0.302 1.68 661.334 1,320.65 1,321.66 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% FGDLLNIDDTAK 95.00% 3.1 0.264 2.59 661.3347 1,320.65 1,321.66 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% FGDLLNIDDTAK 95.00% 2.94 0.141 3.41 661.3349 1,320.65 1,321.66 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% FGDLLNIDDTAK 95.00% 2.83 0.353 2.89 661.3349 1,320.65 1,321.66 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% FGDLLNIDDTAK 95.00% 2.75 0.34 3.24 661.3354 1,320.66 1,321.66 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% FGDLLNIDDTAK 95.00% 3.63 0.422 2.82 661.3401 1,320.66 1,321.66 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% QGIFPITYVDVIK 95.00% 3.09 0.448 2.74 746.9225 1,491.83 1,492.84 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% QGIFPITYVDVIK 95.00% 3.17 0.345 2.46 746.9232 1,491.83 1,492.84 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% QGIFPITYVDVIK 95.00% 3.13 0.379 3.47 746.9232 1,491.83 1,492.84 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% QGIFPITYVDVIK 95.00% 3.53 0.434 3.74 746.9239 1,491.83 1,492.84 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% QGIFPITYVDVIK 95.00% 3.18 0.416 2.47 746.9243 1,491.83 1,492.84 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% QGIFPITYVDVIK 95.00% 3.09 0.357 4.32 746.9245 1,491.83 1,492.84 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% QGIFPITYVDVIK 95.00% 2.12 0.286 0 746.9246 1,491.83 1,492.84 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% QGIFPITYVDVIK 95.00% 2.29 0.299 0 746.9249 1,491.83 1,492.84 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% QGIFPITYVDVIK 95.00% 3.39 0.434 3.44 747.4259 1,492.84 1,492.84 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% LTPVQVLEYGEAIAK 95.00% 3.25 0.308 4.89 815.9554 1,629.90 1,630.91 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% LTPVQVLEYGEAIAK 95.00% 3.56 0.417 5.74 815.9578 1,629.90 1,630.91 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% SVLEGGDIPLQGLSGLK 95.00% 5.01 0.481 7.77 841.9673 1,681.92 1,682.93 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% SVLEGGDIPLQGLSGLK 95.00% 5.58 0.519 8.02 841.9673 1,681.92 1,682.93 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% SVLEGGDIPLQGLSGLK 95.00% 4.63 0.499 3.7 841.968 1,681.92 1,682.93 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% SVLEGGDIPLQGLSGLK 95.00% 5.36 0.516 7.92 841.9688 1,681.92 1,682.93 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% SVLEGGDIPLQGLSGLK 95.00% 4.86 0.46 3.96 841.9691 1,681.92 1,682.93 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% SVLEGGDIPLQGLSGLK 95.00% 5.3 0.545 5.92 841.9695 1,681.92 1,682.93 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% SVLEGGDIPLQGLSGLK 95.00% 5.33 0.508 7.38 842.4701 1,682.92 1,682.93 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% SVLEGGDIPLQGLSGLK 95.00% 5.31 0.493 6.77 842.4705 1,682.93 1,682.93 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% SVLEGGDIPLQGLSGLK 95.00% 5.39 0.484 5.89 842.4706 1,682.93 1,682.93 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% FNFNGDTQVEMSFR 95.00% 2.36 0.345 0 846.4562 1,690.90 1,691.75 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% KLTPVQVLEYGEAIAK 95.00% 4.44 0.497 3.38 880.0017 1,757.99 1,759.00 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% KLTPVQVLEYGEAIAK 95.00% 4.52 0.529 3.77 880.0021 1,757.99 1,759.00 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 7 9 42 6.73% KLTPVQVLEYGEAIAK 95.00% 4.38 0.479 4.85 880.5026 1,758.99 1,759.00 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SATLPLPAR 95.00% 2.17 0.387 0 463.2778 924.54 925.5472 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SIYEYQPGK 95.00% 2.61 0.446 1.6 542.7681 1,083.52 1,084.53 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SIYEYQPGK 95.00% 2.52 0.476 0 542.7681 1,083.52 1,084.53 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SIYEYQPGK 95.00% 2.48 0.44 1.18 542.7683 1,083.52 1,084.53 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SIYEYQPGK 95.00% 2.43 0.48 1.21 542.7689 1,083.52 1,084.53 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% YSFSEDTKSPLSVPR 95.00% 3.61 0.581 1.55 571.6204 1,711.84 1,712.85 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% YSFSEDTKSPLSVPR 95.00% 3.81 0.473 2.74 571.6209 1,711.84 1,712.85 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% YSFSEDTKSPLSVPR 95.00% 3.93 0.607 2.43 571.9543 1,712.84 1,712.85 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% YSFSEDTKSPLSVPR 95.00% 3.78 0.562 2.77 571.9545 1,712.84 1,712.85 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% KLTPVQVLEYGEAIAK 95.00% 4.2 0.474 3.51 587.0048 1,757.99 1,759.00 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% KLTPVQVLEYGEAIAK 95.00% 4.54 0.465 2.92 587.005 1,757.99 1,759.00 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% KLTPVQVLEYGEAIAK 95.00% 4.75 0.49 3.59 587.0052 1,757.99 1,759.00 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% KLTPVQVLEYGEAIAK 95.00% 4.12 0.437 3.7 587.3366 1,758.99 1,759.00 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% KLTPVQVLEYGEAIAK 95.00% 4.03 0.32 3.96 587.3387 1,758.99 1,759.00 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% QIDQNWYEGEHHGR 95.00% 2.64 0.301 0 590.5974 1,768.77 1,768.78 3 SRBS2_HUMAN
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% LSSLSDPVSER 95.00% 3.12 0.38 0 595.3054 1,188.60 1,189.61 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% LSSLSDPVSER 95.00% 2.44 0.272 0 595.3055 1,188.60 1,189.61 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% LSSLSDPVSER 95.00% 3 0.373 0 595.3056 1,188.60 1,189.61 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% LSSLSDPVSER 95.00% 3.22 0.425 0 595.3056 1,188.60 1,189.61 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% LSSLSDPVSER 95.00% 3.09 0.366 0 595.3085 1,188.60 1,189.61 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% TYIELLPPAEK 95.00% 2.54 0.475 1.82 637.3533 1,272.69 1,273.70 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% TYIELLPPAEK 95.00% 2.92 0.459 3.4 637.3546 1,272.69 1,273.70 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% cDDGWFVGTSR 95.00% 3.31 0.409 2.34 c1: Carbamidomethyl (+57.02) 650.2747 1,298.53 1,299.54 2 SRBS2_HUMAN
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% cDDGWFVGTSR 95.00% 3.21 0.437 2.48 c1: Carbamidomethyl (+57.02) 650.2749 1,298.53 1,299.54 2 SRBS2_HUMAN
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% cDDGWFVGTSR 95.00% 3.21 0.436 2.32 c1: Carbamidomethyl (+57.02) 650.2749 1,298.53 1,299.54 2 SRBS2_HUMAN
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% cDDGWFVGTSR 95.00% 2.98 0.348 2.33 c1: Carbamidomethyl (+57.02) 650.2758 1,298.54 1,299.54 2 SRBS2_HUMAN
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% FGDLLNIDDTAK 95.00% 4.03 0.403 4.37 661.3351 1,320.65 1,321.66 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% FGDLLNIDDTAK 95.00% 4 0.435 3.4 661.3352 1,320.65 1,321.66 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SVLEGGDIPLQGLSGLK 95.00% 5.03 0.536 6.05 841.968 1,681.92 1,682.93 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SVLEGGDIPLQGLSGLK 95.00% 5.47 0.508 5.72 841.9684 1,681.92 1,682.93 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SVLEGGDIPLQGLSGLK 95.00% 5.21 0.512 8.11 841.9685 1,681.92 1,682.93 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SVLEGGDIPLQGLSGLK 95.00% 5.36 0.495 5.92 841.9685 1,681.92 1,682.93 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SVLEGGDIPLQGLSGLK 95.00% 5.21 0.566 6.82 841.9686 1,681.92 1,682.93 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SVLEGGDIPLQGLSGLK 95.00% 4.96 0.532 5.03 841.9705 1,681.93 1,682.93 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SVLEGGDIPLQGLSGLK 95.00% 4.96 0.498 3.54 842.4709 1,682.93 1,682.93 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% SVLEGGDIPLQGLSGLK 95.00% 5.24 0.494 7.06 842.4714 1,682.93 1,682.93 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 11 11 37 11.10% STQDLSDVSMDEVGIPLR 95.00% 4.87 0.617 6.03 981.9767 1,961.94 1,961.95 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% SATLPLPAR 95.00% 1.91 0.328 0 463.2773 924.5389 925.5472 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% SATLPLPAR 95.00% 2.04 0.391 0 463.2774 924.5391 925.5472 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% SATLPLPAR 95.00% 2.06 0.298 0 463.2777 924.5398 925.5472 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% LTPVQVLEYGEAIAK 95.00% 2.86 0.409 0 544.3065 1,629.90 1,630.91 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% LTPVQVLEYGEAIAK 95.00% 3.85 0.484 1.04 544.6395 1,630.89 1,630.91 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% LTPVQVLEYGEAIAK 95.00% 3.01 0.308 0 544.6406 1,630.90 1,630.91 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% ELPLQKGDIVYIYK 95.00% 2.42 0.488 0 560.6523 1,678.93 1,678.94 3 MYH11_HUMAN
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% YSFSEDTKSPLSVPR 95.00% 3.98 0.548 2.64 571.6203 1,711.84 1,712.85 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% YSFSEDTKSPLSVPR 95.00% 3.86 0.523 2.19 571.6204 1,711.84 1,712.85 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% YSFSEDTKSPLSVPR 95.00% 3.8 0.508 2.43 571.6208 1,711.84 1,712.85 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% YSFSEDTKSPLSVPR 95.00% 3.55 0.484 1.51 571.6213 1,711.84 1,712.85 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% KLTPVQVLEYGEAIAK 95.00% 3.81 0.386 2.39 587.0047 1,757.99 1,759.00 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% KLTPVQVLEYGEAIAK 95.00% 3.85 0.41 3.07 587.0059 1,757.99 1,759.00 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% KLTPVQVLEYGEAIAK 95.00% 4.89 0.483 3.57 587.3387 1,758.99 1,759.00 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% KLTPVQVLEYGEAIAK 95.00% 4.36 0.456 2.52 587.3394 1,758.99 1,759.00 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% LSSLSDPVSER 95.00% 3.16 0.315 1.96 595.3046 1,188.59 1,189.61 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% TYIELLPPAEK 95.00% 2.81 0.513 1.85 637.355 1,272.69 1,273.70 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% FGDLLNIDDTAK 95.00% 3.36 0.336 2.28 661.334 1,320.65 1,321.66 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% FGDLLNIDDTAK 95.00% 3.7 0.358 3.49 661.3346 1,320.65 1,321.66 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% SKSEMSYIDGEK 95.00% 1.91 0.373 0 687.0938 1,372.17 1,373.63 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% QGIFPITYVDVIK 95.00% 2.48 0.36 1.89 746.9218 1,491.83 1,492.84 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% QGIFPITYVDVIK 95.00% 3.16 0.402 4.6 746.9226 1,491.83 1,492.84 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% QGIFPITYVDVIK 95.00% 2.66 0.328 1.19 746.9228 1,491.83 1,492.84 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% QGIFPITYVDVIK 95.00% 2.92 0.415 2.68 746.9235 1,491.83 1,492.84 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% QGIFPITYVDVIK 95.00% 2.63 0.365 3.15 746.9236 1,491.83 1,492.84 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% QGIFPITYVDVIK 95.00% 3.24 0.415 3.4 746.9245 1,491.83 1,492.84 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% QGIFPITYVDVIK 95.00% 3.15 0.414 3.92 747.425 1,492.83 1,492.84 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% QGIFPITYVDVIK 95.00% 3.41 0.384 4.92 747.4259 1,492.84 1,492.84 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% LTPVQVLEYGEAIAK 95.00% 4.64 0.521 8.42 815.9552 1,629.89 1,630.91 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% LTPVQVLEYGEAIAK 95.00% 3.66 0.462 5.89 815.9556 1,629.90 1,630.91 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% LTPVQVLEYGEAIAK 95.00% 3.31 0.444 5.49 815.956 1,629.90 1,630.91 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% LTPVQVLEYGEAIAK 95.00% 4.45 0.554 7.6 815.9564 1,629.90 1,630.91 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% LTPVQVLEYGEAIAK 95.00% 2.83 0.375 2.8 815.9586 1,629.90 1,630.91 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% LTPVQVLEYGEAIAK 95.00% 4.86 0.48 6.92 816.4568 1,630.90 1,630.91 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% LTPVQVLEYGEAIAK 95.00% 4.66 0.49 6.6 816.4575 1,630.90 1,630.91 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% SVLEGGDIPLQGLSGLK 95.00% 5.13 0.526 6.02 841.9672 1,681.92 1,682.93 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% SVLEGGDIPLQGLSGLK 95.00% 5.33 0.523 5.33 841.9682 1,681.92 1,682.93 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% SVLEGGDIPLQGLSGLK 95.00% 4.89 0.539 5.85 841.9684 1,681.92 1,682.93 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% SVLEGGDIPLQGLSGLK 95.00% 4.96 0.528 4.51 841.9695 1,681.92 1,682.93 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% SVLEGGDIPLQGLSGLK 95.00% 5.19 0.458 5.36 842.4699 1,682.92 1,682.93 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% SVLEGGDIPLQGLSGLK 95.00% 5.34 0.45 3.96 842.4706 1,682.93 1,682.93 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% SVLEGGDIPLQGLSGLK 95.00% 5.36 0.493 5.28 842.4712 1,682.93 1,682.93 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% SVLEGGDIPLQGLSGLK 95.00% 5.42 0.503 5.77 842.4713 1,682.93 1,682.93 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% ESDGAPGDLTSLENER 95.00% 3.39 0.365 1.74 845.3842 1,688.75 1,689.76 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% YSFSEDTKSPLSVPR 95.00% 4.3 0.45 2.59 857.4304 1,712.85 1,712.85 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% NPVDYMDLPFSSSPSR 95.00% 5.72 0.513 5.16 906.9169 1,811.82 1,811.83 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% NPVDYMDLPFSSSPSR 95.00% 5.49 0.527 7.14 906.9175 1,811.82 1,811.83 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% NPVDYMDLPFSSSPSR 95.00% 5.37 0.478 6.32 906.918 1,811.82 1,811.83 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% NPVDYMDLPFSSSPSR 95.00% 5.3 0.495 5.77 906.918 1,811.82 1,811.83 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% STQDLSDVSMDEVGIPLR 95.00% 3.9 0.54 6.72 981.4748 1,960.93 1,961.95 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% STQDLSDVSMDEVGIPLR 95.00% 3.83 0.537 7.14 981.4762 1,960.94 1,961.95 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 13 15 51 13.90% STQDLSDVSMDEVGIPLR 95.00% 4.27 0.605 6.03 981.979 1,961.94 1,961.95 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% SATLPLPAR 95.00% 2.33 0.28 0 463.2762 924.5368 925.5472 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% SATLPLPAR 95.00% 2 0.326 0 463.2763 924.537 925.5472 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% FGDLLNIDDTAKR 95.00% 2.91 0.438 0 493.2586 1,476.75 1,477.77 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% FGDLLNIDDTAKR 95.00% 3.29 0.449 1.09 493.2592 1,476.75 1,477.77 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% SIYEYQPGK 95.00% 2.38 0.468 0 542.7683 1,083.52 1,084.53 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% SIYEYQPGK 95.00% 2.26 0.435 0 542.7688 1,083.52 1,084.53 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% SIYEYQPGK 95.00% 1.87 0.276 0 542.7695 1,083.52 1,084.53 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% YSFSEDTKSPLSVPR 95.00% 3.54 0.523 1.89 571.6206 1,711.84 1,712.85 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% YSFSEDTKSPLSVPR 95.00% 3.63 0.537 1.41 571.6207 1,711.84 1,712.85 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% YSFSEDTKSPLSVPR 95.00% 3.61 0.47 2.66 571.6207 1,711.84 1,712.85 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% YSFSEDTKSPLSVPR 95.00% 3.6 0.502 0 571.621 1,711.84 1,712.85 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% YSFSEDTKSPLSVPR 95.00% 3.24 0.584 1.24 571.9548 1,712.84 1,712.85 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% KLTPVQVLEYGEAIAK 95.00% 3.73 0.318 2.82 587.0041 1,757.99 1,759.00 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% KLTPVQVLEYGEAIAK 95.00% 2.63 0.375 1.46 587.335 1,758.98 1,759.00 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% KLTPVQVLEYGEAIAK 95.00% 3.81 0.429 2.85 587.3381 1,758.99 1,759.00 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% QIDQNWYEGEHHGR 95.00% 2.66 0.213 0 590.2629 1,767.77 1,768.78 3 SRBS2_HUMAN
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% QIDQNWYEGEHHGR 95.00% 2.96 0.278 0 590.5969 1,768.77 1,768.78 3 SRBS2_HUMAN
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% QIDQNWYEGEHHGR 94.90% 2.23 0.235 0 590.5983 1,768.77 1,768.78 3 SRBS2_HUMAN
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% LSSLSDPVSER 95.00% 3.29 0.434 1.09 595.3034 1,188.59 1,189.61 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% LSSLSDPVSER 95.00% 3.26 0.398 0 595.3061 1,188.60 1,189.61 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% TYIELLPPAEK 95.00% 3.22 0.492 2.38 637.3548 1,272.69 1,273.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% TYIELLPPAEK 95.00% 1.84 0.345 1.17 637.355 1,272.69 1,273.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% TYIELLPPAEK 95.00% 3.01 0.508 1.26 637.3553 1,272.69 1,273.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% TYIELLPPAEK 95.00% 2.91 0.596 0 637.3553 1,272.70 1,273.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% TYIELLPPAEK 95.00% 3.17 0.514 1.1 637.3553 1,272.70 1,273.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% TYIELLPPAEK 95.00% 2.26 0.383 1.49 637.8573 1,273.70 1,273.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% cDDGWFVGTSR 95.00% 3.67 0.402 0 c1: Carbamidomethyl (+57.02) 650.2735 1,298.53 1,299.54 2 SRBS2_HUMAN
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% cDDGWFVGTSR 95.00% 3.63 0.352 0 c1: Carbamidomethyl (+57.02) 650.274 1,298.53 1,299.54 2 SRBS2_HUMAN
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% cDDGWFVGTSR 95.00% 1.81 0.358 0 c1: Carbamidomethyl (+57.02) 650.6565 1,299.30 1,299.54 2 SRBS2_HUMAN
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% FGDLLNIDDTAK 95.00% 3.95 0.405 3.66 661.334 1,320.65 1,321.66 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% FGDLLNIDDTAK 95.00% 3.52 0.355 3.15 661.3343 1,320.65 1,321.66 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% FGDLLNIDDTAK 95.00% 3.9 0.421 3.42 661.3344 1,320.65 1,321.66 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% FGDLLNIDDTAK 95.00% 3.93 0.468 4.19 661.3346 1,320.65 1,321.66 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% FGDLLNIDDTAK 95.00% 3.42 0.468 1.96 661.8357 1,321.66 1,321.66 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% SVLEGGDIPLQGLSGLK 95.00% 5.41 0.507 6.72 841.9679 1,681.92 1,682.93 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% SVLEGGDIPLQGLSGLK 95.00% 5.01 0.528 8.42 841.9691 1,681.92 1,682.93 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% SVLEGGDIPLQGLSGLK 95.00% 5.36 0.523 4.34 841.9691 1,681.92 1,682.93 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% SVLEGGDIPLQGLSGLK 95.00% 5.15 0.516 8.19 841.9693 1,681.92 1,682.93 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% SVLEGGDIPLQGLSGLK 95.00% 5.35 0.514 7.26 842.4684 1,682.92 1,682.93 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% ESDGAPGDLTSLENER 95.00% 3.99 0.481 3.28 845.3817 1,688.75 1,689.76 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% ESDGAPGDLTSLENER 95.00% 4.17 0.486 1.6 845.883 1,689.75 1,689.76 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% LSSSADANGNAQPSSLAAK 95.00% 2.5 0.33 1.2 895.4348 1,788.85 1,788.87 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% NPVDYMDLPFSSSPSR 95.00% 4.94 0.535 5.74 906.4146 1,810.81 1,811.83 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% NPVDYMDLPFSSSPSR 95.00% 3.54 0.415 2.6 906.4147 1,810.81 1,811.83 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 15 15 45 15.10% STQDLSDVSMDEVGIPLR 95.00% 4.34 0.631 4.66 981.4793 1,960.94 1,961.95 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SATLPLPAR 95.00% 2.11 0.313 0 463.2773 924.5389 925.5472 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SATLPLPAR 95.00% 1.88 0.338 0 463.2777 924.5398 925.5472 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% GDIVYIYK 95.00% 2.01 0.38 0 485.7663 969.5169 970.5251 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% FGDLLNIDDTAKR 95.00% 2.89 0.424 0 493.2576 1,476.75 1,477.77 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% FGDLLNIDDTAKR 95.00% 2.56 0.343 0 493.2585 1,476.75 1,477.77 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SIYEYQPGK 95.00% 2.13 0.378 2 542.7684 1,083.52 1,084.53 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SIYEYQPGK 95.00% 2.4 0.384 1.23 542.7688 1,083.52 1,084.53 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SIYEYQPGK 95.00% 2.11 0.337 0 543.2646 1,084.51 1,084.53 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% LTPVQVLEYGEAIAK 95.00% 2.29 0.308 0 544.304 1,629.89 1,630.91 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% YSFSEDTKSPLSVPR 95.00% 3.66 0.588 3.34 571.6207 1,711.84 1,712.85 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% YSFSEDTKSPLSVPR 95.00% 3.74 0.506 2.28 571.6208 1,711.84 1,712.85 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% YSFSEDTKSPLSVPR 95.00% 3.82 0.523 2.14 571.9546 1,712.84 1,712.85 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% YSFSEDTKSPLSVPR 95.00% 3.38 0.543 1.21 571.9551 1,712.84 1,712.85 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% KLTPVQVLEYGEAIAK 95.00% 2.59 0.229 0 587.0045 1,757.99 1,759.00 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% KLTPVQVLEYGEAIAK 95.00% 2.56 0.298 1.89 587.3368 1,758.99 1,759.00 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% KLTPVQVLEYGEAIAK 95.00% 2.78 0.275 1.09 587.3376 1,758.99 1,759.00 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% KLTPVQVLEYGEAIAK 95.00% 2.78 0.279 1.31 587.3378 1,758.99 1,759.00 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% KLTPVQVLEYGEAIAK 95.00% 3.58 0.325 2.51 587.3381 1,758.99 1,759.00 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% KLTPVQVLEYGEAIAK 95.00% 4.01 0.371 2.24 587.3385 1,758.99 1,759.00 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% QIDQNWYEGEHHGR 95.00% 3.03 0.248 0 590.2651 1,767.77 1,768.78 3 SRBS2_HUMAN
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% LSSLSDPVSER 95.00% 2.57 0.199 0 595.3069 1,188.60 1,189.61 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% TYIELLPPAEK 95.00% 2.84 0.507 2.8 637.3547 1,272.69 1,273.70 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% TYIELLPPAEK 95.00% 2.88 0.524 2.74 637.3549 1,272.69 1,273.70 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% TYIELLPPAEK 95.00% 3.28 0.504 1.08 637.3552 1,272.69 1,273.70 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% TYIELLPPAEK 95.00% 2.04 0.272 0 637.3552 1,272.69 1,273.70 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% TYIELLPPAEK 95.00% 1.82 0.336 1.08 637.3558 1,272.70 1,273.70 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% FGDLLNIDDTAK 95.00% 3.19 0.389 2.6 661.3341 1,320.65 1,321.66 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% FGDLLNIDDTAK 95.00% 3.42 0.403 3.49 661.3346 1,320.65 1,321.66 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% FGDLLNIDDTAK 95.00% 3.7 0.319 2.77 661.3346 1,320.65 1,321.66 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% FGDLLNIDDTAK 95.00% 3.57 0.402 2.52 661.3352 1,320.65 1,321.66 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% FGDLLNIDDTAK 95.00% 2.3 0.221 2.08 661.3388 1,320.66 1,321.66 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% QGIFPITYVDVIK 95.00% 2.16 0.247 0 746.922 1,491.83 1,492.84 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% QGIFPITYVDVIK 95.00% 2.34 0.295 0 746.9238 1,491.83 1,492.84 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% QGIFPITYVDVIK 95.00% 2.36 0.303 0 746.9239 1,491.83 1,492.84 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% LTPVQVLEYGEAIAK 95.00% 4.37 0.527 6.1 815.9549 1,629.89 1,630.91 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% LTPVQVLEYGEAIAK 95.00% 4.3 0.543 6.59 815.9558 1,629.90 1,630.91 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% LTPVQVLEYGEAIAK 95.00% 3.53 0.506 4.6 815.9566 1,629.90 1,630.91 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SVLEGGDIPLQGLSGLK 95.00% 5.26 0.518 6.44 841.9666 1,681.92 1,682.93 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SVLEGGDIPLQGLSGLK 95.00% 5.31 0.519 4.7 841.9682 1,681.92 1,682.93 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SVLEGGDIPLQGLSGLK 95.00% 5.33 0.484 7.64 841.9691 1,681.92 1,682.93 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SVLEGGDIPLQGLSGLK 95.00% 4.97 0.519 4.24 841.9693 1,681.92 1,682.93 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SVLEGGDIPLQGLSGLK 95.00% 5.31 0.479 5.47 841.97 1,681.92 1,682.93 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SVLEGGDIPLQGLSGLK 95.00% 4.81 0.479 5.41 841.9715 1,681.93 1,682.93 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SVLEGGDIPLQGLSGLK 95.00% 5.56 0.485 5.89 842.4696 1,682.92 1,682.93 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% SVLEGGDIPLQGLSGLK 95.00% 5.27 0.505 6.28 842.471 1,682.93 1,682.93 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% ESDGAPGDLTSLENER 95.00% 3.61 0.485 2.14 845.3799 1,688.74 1,689.76 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% ESDGAPGDLTSLENER 95.00% 3.92 0.488 1.77 845.3847 1,688.75 1,689.76 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% ESDGAPGDLTSLENER 95.00% 3.96 0.443 2.6 845.8849 1,689.75 1,689.76 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% YSFSEDTKSPLSVPR 95.00% 4.42 0.479 2.6 857.4284 1,712.84 1,712.85 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% KLTPVQVLEYGEAIAK 95.00% 4.99 0.586 5.68 880.0022 1,757.99 1,759.00 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% KLTPVQVLEYGEAIAK 95.00% 4.66 0.53 4.41 880.0024 1,757.99 1,759.00 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% KLTPVQVLEYGEAIAK 95.00% 4.37 0.539 3.74 880.5021 1,758.99 1,759.00 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% KLTPVQVLEYGEAIAK 95.00% 4.72 0.539 4.74 880.506 1,759.00 1,759.00 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% LSSSADANGNAQPSSLAAK 95.00% 3.96 0.472 5.31 895.4316 1,788.85 1,788.87 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% LSSSADANGNAQPSSLAAK 95.00% 4.13 0.523 3.08 895.4322 1,788.85 1,788.87 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% LSSSADANGNAQPSSLAAK 95.00% 3.21 0.447 3.35 895.4326 1,788.85 1,788.87 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% LSSSADANGNAQPSSLAAK 95.00% 2.91 0.438 2.26 895.4336 1,788.85 1,788.87 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% NPVDYMDLPFSSSPSR 95.00% 4.1 0.515 5.28 906.4111 1,810.81 1,811.83 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% NPVDYMDLPFSSSPSR 95.00% 4.57 0.545 5.39 906.4136 1,810.81 1,811.83 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% NPVDYMDLPFSSSPSR 95.00% 3.49 0.417 4.05 906.4197 1,810.82 1,811.83 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% NPVDYMDLPFSSSPSR 95.00% 4.81 0.425 6.43 906.9187 1,811.82 1,811.83 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 1  SORBS1  SRBS1_HUMAN 142,482.80 100.00% 17 20 62 15.90% STQDLSDVSMDEVGIPLR 95.00% 4.74 0.613 4.12 981.9781 1,961.94 1,961.95 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% QGIFPVSYVEVVKK 95.00% 2.48 0.367 0 531.9713 1,592.89 1,592.91 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% QGIFPVSYVEVVKK 95.00% 2.45 0.451 0 531.9727 1,592.89 1,592.91 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% SIFEYEPGK 95.00% 2.26 0.342 0 535.2622 1,068.51 1,069.52 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% SIFEYEPGK 95.00% 2.27 0.343 0 535.2626 1,068.51 1,069.52 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% SIFEYEPGK 95.00% 1.95 0.32 0 535.2628 1,068.51 1,069.52 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% SIFEYEPGK 95.00% 1.76 0.278 1.37 535.263 1,068.51 1,069.52 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% TSPGRVDLPGSSTTLTK 95.00% 2.06 0.321 1.12 573.309 1,716.90 1,716.91 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% SYSSTLTDMGR 95.00% 2.06 0.0082 5.42 609.831 1,217.65 1,217.55 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% VDLPGSSTTLTK 95.00% 2.05 0.361 0 609.8329 1,217.65 1,218.66 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% VGIFPISYVEK 95.00% 2.34 0.321 2.66 626.351 1,250.69 1,251.70 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% VGIFPISYVEK 95.00% 2.61 0.394 2.43 626.3514 1,250.69 1,251.70 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% VGIFPISYVEK 95.00% 3.37 0.406 2.37 626.3524 1,250.69 1,251.70 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% VGIFPISYVEK 95.00% 2.82 0.358 2.21 626.353 1,250.69 1,251.70 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% VGIFPISYVEK 95.00% 2.97 0.436 1.64 626.3659 1,250.72 1,251.70 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% VGIFPISYVEK 95.00% 2.75 0.322 0 626.3671 1,250.72 1,251.70 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% FFGTFPGNYVK 95.00% 2.74 0.417 1.25 638.8213 1,275.63 1,276.64 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% FFGTFPGNYVK 95.00% 3.23 0.459 0 639.3225 1,276.63 1,276.64 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% APHYPGIGPVDESGIPTAIR 95.00% 3.25 0.373 2.03 683.024 2,046.05 2,047.06 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% APHYPGIGPVDESGIPTAIR 95.00% 5.33 0.5 2.96 683.3602 2,047.06 2,047.06 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% AQPARPPPPAQPGEIGEAIAK 95.00% 2.82 0.431 2.77 699.382 2,095.12 2,095.13 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% AQPARPPPPAQPGEIGEAIAK 95.00% 2.92 0.405 2.47 699.3828 2,095.12 2,095.13 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% AQPARPPPPAQPGEIGEAIAK 95.00% 2.15 0.15 2 699.3828 2,095.13 2,095.13 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% AQPARPPPPAQPGEIGEAIAK 95.00% 2.04 0.248 1.04 699.3867 2,095.14 2,095.13 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% AQPARPPPPAQPGEIGEAIAK 95.00% 3.2 0.296 1.34 699.387 2,095.14 2,095.13 3
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% QGIFPVSYVEVVK 95.00% 2.89 0.457 3.41 732.9067 1,463.80 1,464.81 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% QGIFPVSYVEVVK 95.00% 2.83 0.476 3.62 732.9078 1,463.80 1,464.81 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% QGIFPVSYVEVVK 95.00% 2.36 0.306 0 732.9173 1,463.82 1,464.81 2
 SAMPLE 1 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 11 11 28 11.60% YNFNADTNVELSLR 95.00% 3.93 0.482 3.64 828.403 1,654.79 1,655.80 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% VDLPGSSTTLTK 95.00% 2.03 0.262 0 609.8315 1,217.65 1,218.66 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% VDLPGSSTTLTK 95.00% 2.33 0.266 2.37 609.8317 1,217.65 1,218.66 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% VGIFPISYVEK 95.00% 2.56 0.281 1.68 626.3532 1,250.69 1,251.70 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% VGIFPISYVEK 95.00% 2.67 0.308 0 626.3647 1,250.71 1,251.70 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% FFGTFPGNYVK 95.00% 2.68 0.419 0 638.8202 1,275.62 1,276.64 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% FFGTFPGNYVK 95.00% 2.63 0.383 0 638.8211 1,275.63 1,276.64 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% APHYPGIGPVDESGIPTAIR 95.00% 2.93 0.386 1.24 683.0247 2,046.05 2,047.06 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% AQPARPPPPAQPGEIGEAIAK 95.00% 2.72 0.321 0 699.0495 2,094.13 2,095.13 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% AQPARPPPPAQPGEIGEAIAK 95.00% 2.59 0.44 4.34 699.3798 2,095.12 2,095.13 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% AQPARPPPPAQPGEIGEAIAK 95.00% 2.5 0.485 3.17 699.382 2,095.12 2,095.13 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% AQPARPPPPAQPGEIGEAIAK 95.00% 2.33 0.211 2.43 699.3821 2,095.12 2,095.13 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% AQPARPPPPAQPGEIGEAIAK 95.00% 2.37 0.355 3.68 699.3831 2,095.13 2,095.13 3
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% QGIFPVSYVEVVK 95.00% 2.79 0.494 2.52 732.907 1,463.80 1,464.81 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% QGIFPVSYVEVVK 95.00% 2.81 0.421 2 732.9079 1,463.80 1,464.81 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% QGIFPVSYVEVVK 95.00% 2.36 0.306 0 732.9173 1,463.82 1,464.81 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% YNFNADTNVELSLR 95.00% 3.45 0.478 3.19 828.4044 1,654.79 1,655.80 2
 SAMPLE 1R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 17 9.27% YNFNADTNVELSLR 95.00% 3.74 0.464 5.35 828.4049 1,654.79 1,655.80 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% SIFEYEPGK 95.00% 2.31 0.314 0 535.2629 1,068.51 1,069.52 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% SIFEYEPGK 95.00% 2.33 0.306 0 535.263 1,068.51 1,069.52 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% SIFEYEPGK 95.00% 2.28 0.408 0 535.2632 1,068.51 1,069.52 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% SIFEYEPGK 95.00% 2.18 0.326 0 535.2632 1,068.51 1,069.52 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% VDQNWYEGK 95.00% 2.22 0.269 0 569.7585 1,137.50 1,138.52 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% VDQNWYEGK 95.00% 2.27 0.244 2.82 569.7602 1,137.50 1,138.52 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% TSPGRVDLPGSSTTLTK 95.00% 2.22 0.225 0 572.9756 1,715.90 1,716.91 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% ESDVIDVMEK 95.00% 2 0.331 0 582.7733 1,163.53 1,164.55 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% ESDVIDVMEK 95.00% 2.04 0.34 1.24 582.7758 1,163.54 1,164.55 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% SYSSTLTDMGR 95.00% 2.35 0.342 2.96 609.2755 1,216.54 1,217.55 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% SYSSTLTDMGR 95.00% 3.03 0.447 4.72 609.2772 1,216.54 1,217.55 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% SYSSTLTDMGR 95.00% 3.06 0.225 4.31 609.8309 1,217.65 1,217.55 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% VGIFPISYVEK 95.00% 3.36 0.43 1.64 626.3513 1,250.69 1,251.70 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% VGIFPISYVEK 95.00% 2.94 0.475 2.09 626.3525 1,250.69 1,251.70 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% VGIFPISYVEK 95.00% 3.39 0.477 1.15 626.3529 1,250.69 1,251.70 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% VGIFPISYVEK 95.00% 3.31 0.415 1.46 626.3529 1,250.69 1,251.70 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% VGIFPISYVEK 95.00% 2.94 0.333 1.48 626.3548 1,250.69 1,251.70 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% FFGTFPGNYVK 95.00% 3.06 0.445 1.22 638.8206 1,275.63 1,276.64 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% FFGTFPGNYVK 95.00% 2.96 0.399 2.19 638.8217 1,275.63 1,276.64 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% FFGTFPGNYVK 95.00% 2.98 0.476 0 638.8218 1,275.63 1,276.64 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% FFGTFPGNYVK 95.00% 3.04 0.386 2.05 638.8219 1,275.63 1,276.64 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% SLERPmSSASmASDFRK 95.00% 3.03 0.309 0 m6: Oxidation (+15.99), m11: Oxidation (+15.99) 644.8547 1,931.54 1,931.90 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% cDDGWFVGTSR 95.00% 3.31 0.409 2.34 c1: Carbamidomethyl (+57.02) 650.2747 1,298.53 1,299.54 2 SRBS1_HUMAN
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% cDDGWFVGTSR 95.00% 3.21 0.437 2.48 c1: Carbamidomethyl (+57.02) 650.2749 1,298.53 1,299.54 2 SRBS1_HUMAN
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% cDDGWFVGTSR 95.00% 3.21 0.436 2.32 c1: Carbamidomethyl (+57.02) 650.2749 1,298.53 1,299.54 2 SRBS1_HUMAN
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% cDDGWFVGTSR 95.00% 2.98 0.348 2.33 c1: Carbamidomethyl (+57.02) 650.2758 1,298.54 1,299.54 2 SRBS1_HUMAN
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% APHYPGIGPVDESGIPTAIR 95.00% 3.23 0.449 2.23 683.0241 2,046.05 2,047.06 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% APHYPGIGPVDESGIPTAIR 95.00% 4.76 0.536 3.46 683.358 2,047.05 2,047.06 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% APHYPGIGPVDESGIPTAIR 95.00% 4.56 0.51 3.96 683.3593 2,047.05 2,047.06 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% AQPARPPPPAQPGEIGEAIAK 95.00% 2.85 0.422 3.57 699.3817 2,095.12 2,095.13 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% AQPARPPPPAQPGEIGEAIAK 95.00% 2.9 0.495 2.77 699.3818 2,095.12 2,095.13 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% AQPARPPPPAQPGEIGEAIAK 95.00% 2.51 0.258 1.55 699.3819 2,095.12 2,095.13 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% AQPARPPPPAQPGEIGEAIAK 95.00% 3.04 0.476 3 699.3822 2,095.12 2,095.13 3
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% YNFNADTNVELSLR 95.00% 4.09 0.51 5.07 828.4044 1,654.79 1,655.80 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% TSPGRVDLPGSSTTLTK 95.00% 4.74 0.52 1.39 859.4558 1,716.90 1,716.91 2
 SAMPLE 2 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 12 13 32 16.30% GAEDYPDPPIPHSYSSDR 95.00% 3.42 0.477 0 1,002.45 2,002.88 2,002.88 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% KGDTVYILR 95.00% 2.69 0.173 0 532.8084 1,063.60 1,064.61 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% KGDTVYILR 95.00% 2.76 0.248 1.6 532.8085 1,063.60 1,064.61 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% KGDTVYILR 95.00% 2.51 0.237 1.49 532.809 1,063.60 1,064.61 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% SIFEYEPGK 95.00% 2.21 0.336 0 535.263 1,068.51 1,069.52 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% SIFEYEPGK 95.00% 1.93 0.298 0 535.2631 1,068.51 1,069.52 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% SIFEYEPGK 95.00% 2.19 0.344 0 535.2633 1,068.51 1,069.52 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% TSPGRVDLPGSSTTLTK 95.00% 2.02 0.294 0 573.3096 1,716.91 1,716.91 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% SYSSTLTDMGR 95.00% 2.88 0.529 3.96 609.2755 1,216.54 1,217.55 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% SYSSTLTDMGR 95.00% 2.14 0.31 2.8 609.2776 1,216.54 1,217.55 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% VGIFPISYVEK 95.00% 3.24 0.424 2.37 626.3523 1,250.69 1,251.70 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% VGIFPISYVEK 95.00% 3.11 0.309 2.33 626.3526 1,250.69 1,251.70 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% FFGTFPGNYVK 95.00% 2.96 0.473 2.29 638.8209 1,275.63 1,276.64 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% FFGTFPGNYVK 95.00% 2.81 0.414 0 638.8211 1,275.63 1,276.64 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% APHYPGIGPVDESGIPTAIR 95.00% 4.67 0.544 3.21 683.3585 2,047.05 2,047.06 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% APHYPGIGPVDESGIPTAIR 95.00% 4.02 0.515 3.59 683.3591 2,047.05 2,047.06 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% APHYPGIGPVDESGIPTAIR 95.00% 3.9 0.429 3.28 683.3602 2,047.06 2,047.06 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% APHYPGIGPVDESGIPTAIR 95.00% 3.7 0.44 2.55 683.3612 2,047.06 2,047.06 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% AQPARPPPPAQPGEIGEAIAK 95.00% 2.53 0.427 2.66 699.382 2,095.12 2,095.13 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% AQPARPPPPAQPGEIGEAIAK 95.00% 2.76 0.427 2.09 699.383 2,095.13 2,095.13 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% AQPARPPPPAQPGEIGEAIAK 95.00% 2.89 0.509 2.59 699.3841 2,095.13 2,095.13 3
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% QGIFPVSYVEVVK 95.00% 2.31 0.403 2.92 732.907 1,463.80 1,464.81 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% YNFNADTNVELSLR 95.00% 4.02 0.503 4.72 828.4056 1,654.80 1,655.80 2
 SAMPLE 2R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 10 11 23 12.40% AQPARPPPPAQPGEIGEAIAK 95.00% 4.94 0.587 3.25 1,048.57 2,095.12 2,095.13 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% SIFEYEPGK 95.00% 1.88 0.196 1.35 535.2625 1,068.51 1,069.52 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% SIFEYEPGK 95.00% 1.94 0.324 1.57 535.2633 1,068.51 1,069.52 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% VDQNWYEGKIPGTNR 95.00% 2.61 0.223 0 592.9565 1,775.85 1,776.87 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% VGIFPISYVEK 95.00% 2.77 0.375 1.96 626.3515 1,250.69 1,251.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% VGIFPISYVEK 95.00% 3.14 0.427 1.4 626.3517 1,250.69 1,251.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% VGIFPISYVEK 95.00% 3 0.29 1.38 626.352 1,250.69 1,251.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% VGIFPISYVEK 95.00% 2.76 0.317 1.77 626.352 1,250.69 1,251.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% VGIFPISYVEK 95.00% 3.35 0.443 1.28 626.3527 1,250.69 1,251.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% VGIFPISYVEK 95.00% 3.02 0.413 1.38 626.3531 1,250.69 1,251.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% VGIFPISYVEK 95.00% 3.13 0.431 1.59 626.3549 1,250.69 1,251.70 2
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% cDDGWFVGTSR 95.00% 3.67 0.402 0 c1: Carbamidomethyl (+57.02) 650.2735 1,298.53 1,299.54 2 SRBS1_HUMAN
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% cDDGWFVGTSR 95.00% 3.63 0.352 0 c1: Carbamidomethyl (+57.02) 650.274 1,298.53 1,299.54 2 SRBS1_HUMAN
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% cDDGWFVGTSR 95.00% 1.81 0.358 0 c1: Carbamidomethyl (+57.02) 650.6565 1,299.30 1,299.54 2 SRBS1_HUMAN
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% APHYPGIGPVDESGIPTAIR 95.00% 4.08 0.457 2.72 683.3597 2,047.06 2,047.06 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% SSILQHERPASLYQSSIDR 95.00% 4.16 0.527 2.8 729.71 2,186.11 2,187.12 3
 SAMPLE 3 Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 6 6 13 8.91% QGIFPVSYVEVVK 95.00% 1.77 0.335 0 732.9081 1,463.80 1,464.81 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% KGDTVYILR 95.00% 2.62 0.192 1.14 532.8086 1,063.60 1,064.61 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% SYSSTLTDMGR 95.00% 2.42 0.323 1.77 609.2744 1,216.53 1,217.55 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% VGIFPISYVEK 95.00% 2.82 0.334 1.92 626.3528 1,250.69 1,251.70 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% VGIFPISYVEK 95.00% 3 0.301 1.49 626.3529 1,250.69 1,251.70 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% VGIFPISYVEK 95.00% 2.46 0.34 1.96 626.3529 1,250.69 1,251.70 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% VGIFPISYVEK 95.00% 3.2 0.314 2.15 626.3532 1,250.69 1,251.70 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% VGIFPISYVEK 95.00% 3.22 0.393 2.32 626.3535 1,250.69 1,251.70 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% FFGTFPGNYVK 95.00% 2.81 0.461 1.57 638.8208 1,275.63 1,276.64 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% FFGTFPGNYVK 95.00% 2.64 0.403 0 638.8211 1,275.63 1,276.64 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% APHYPGIGPVDESGIPTAIR 95.00% 3.16 0.315 0 683.3607 2,047.06 2,047.06 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% AQPARPPPPAQPGEIGEAIAK 95.00% 2.54 0.426 1.17 699.3802 2,095.12 2,095.13 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% AQPARPPPPAQPGEIGEAIAK 95.00% 2.74 0.44 1.74 699.3818 2,095.12 2,095.13 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% AQPARPPPPAQPGEIGEAIAK 95.00% 2.44 0.307 2.52 699.3821 2,095.12 2,095.13 3
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% TSPGRVDLPGSSTTLTK 95.00% 3.7 0.452 0 859.4594 1,716.90 1,716.91 2
 SAMPLE 3R Sorbin and SH3 domain-containing protein 2  SORBS2  SRBS2_HUMAN 124,092.10 100.00% 7 7 15 9.09% TSPGRVDLPGSSTTLTK 95.00% 4.18 0.433 2.85 859.4599 1,716.90 1,716.91 2
 SAMPLE 3 SPARC-like protein 1  SPARCL1  SPRL1_HUMAN 75,197.50 100.00% 3 3 4 9.79% LLAGDHPIDLLLR 95.00% 1.93 0.336 0 482.619 1,444.83 1,445.85 3
 SAMPLE 3 SPARC-like protein 1  SPARCL1  SPRL1_HUMAN 75,197.50 100.00% 3 3 4 9.79% LLAGDHPIDLLLR 95.00% 1.65 0.257 0 482.62 1,444.84 1,445.85 3
 SAMPLE 3 SPARC-like protein 1  SPARCL1  SPRL1_HUMAN 75,197.50 100.00% 3 3 4 9.79% VLTHSELAPLR 95.00% 1.99 0.293 0 618.3603 1,234.71 1,235.71 2
 SAMPLE 3 SPARC-like protein 1  SPARCL1  SPRL1_HUMAN 75,197.50 100.00% 3 3 4 9.79% EKVHENENIGTTEPGEHQEAKK 95.00% 2.18 0.221 0 835.4109 2,503.21 2,504.20 3
 SAMPLE 3 SPARC-like protein 1  SPARCL1  SPRL1_HUMAN 75,197.50 100.00% 3 3 4 9.79% TVSEALLmEPTDDGNTTPR 95.00% 2.71 0.179 0 m8: Oxidation (+15.99) 1,031.94 2,061.87 2,062.96 2
 SAMPLE 1R SPARC-related modular calcium-binding protein 2  SMOC2  SMOC2_HUMAN 49,655.80 99.80% 2 2 3 4.71% FSALTFLR 95.00% 2.45 0.237 1.55 477.773 953.5303 954.5413 2
 SAMPLE 1R SPARC-related modular calcium-binding protein 2  SMOC2  SMOC2_HUMAN 49,655.80 99.80% 2 2 3 4.71% FSALTFLR 95.00% 2.17 0.251 0 477.7762 953.5367 954.5413 2
 SAMPLE 1R SPARC-related modular calcium-binding protein 2  SMOC2  SMOC2_HUMAN 49,655.80 99.80% 2 2 3 4.71% LSEPDPSHTLEER 95.00% 2.39 0.27 0 503.9106 1,508.71 1,509.72 3
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LFGAAEVQR 95.00% 3.33 0.267 1.41 495.7706 989.5256 990.5373 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LFGAAEVQR 95.00% 3.14 0.276 1.29 495.7717 989.5277 990.5373 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% HQALQAEIAGHEPR 95.00% 3.42 0.439 3.66 519.9368 1,556.79 1,556.79 3
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% HQALQAEIAGHEPR 95.00% 4.01 0.52 1.54 519.937 1,556.79 1,556.79 3
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% HQAFEAELHANADR 95.00% 3.09 0.328 3.03 536.9222 1,607.74 1,608.75 3
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% HQAFEAELHANADR 95.00% 3.38 0.357 1.89 537.2551 1,608.74 1,608.75 3
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LLVGSEDYGR 95.00% 2.2 0.261 0 554.7844 1,107.55 1,108.56 2 PLEC1_HUMAN,F10A1_HUMAN
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LIDVNHYAKDEVAAR 95.00% 2.32 0.224 0 572.3016 1,713.88 1,713.89 3
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LIQSHPESAEDLQEK 95.00% 3.5 0.207 1.8 575.2866 1,722.84 1,723.85 3
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LIQSHPESAEDLQEK 95.00% 3.48 0.101 2.16 575.6219 1,723.84 1,723.85 3
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% TATDEAYKDPSNLQGK 95.00% 2.36 0.311 1.31 580.2823 1,737.82 1,737.83 3
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% TATDEAYKDPSNLQGK 95.00% 2.4 0.279 0 580.2827 1,737.82 1,737.83 3
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LSDDNTIGKEEIQQR 95.00% 3.13 0.342 1 582.96 1,745.86 1,745.87 3
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% DVTGAEALLER 95.00% 3.36 0.427 1.66 587.3077 1,172.60 1,173.61 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% DLSSVQTLLTK 95.00% 2.96 0.435 0 602.8417 1,203.67 1,204.68 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% WSQLLANSAAR 95.00% 2.73 0.35 0 608.824 1,215.63 1,216.64 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% DVEDEETWIR 95.00% 2.29 0.359 2 646.2931 1,290.57 1,291.58 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% VLETAEDIQER 95.00% 2.94 0.496 2.28 651.8311 1,301.65 1,302.65 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% KVEDLFLTFAK 95.00% 3.31 0.505 2.74 655.8707 1,309.73 1,310.74 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LGESQTLQQFSR 95.00% 2.94 0.453 2.59 697.356 1,392.70 1,393.71 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LGESQTLQQFSR 95.00% 3.11 0.476 2.55 697.3575 1,392.70 1,393.71 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LGESQTLQQFSR 95.00% 3.22 0.432 3.7 698.0132 1,394.01 1,393.71 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LGESQTLQQFSR 95.00% 3.09 0.407 2.54 698.0141 1,394.01 1,393.71 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% DVDEIEAWISEK 95.00% 3.3 0.353 3.72 717.3412 1,432.67 1,433.68 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% GLVSSDELAKDVTGAEALLER 95.00% 3.56 0.398 2.05 725.3845 2,173.13 2,173.14 3
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% DAEELEKWIQEK 95.00% 3.52 0.349 2.12 759.8765 1,517.74 1,517.75 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LAALADQWQFLVQK 95.00% 4.13 0.487 2.41 815.9482 1,629.88 1,630.90 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LAALADQWQFLVQK 95.00% 4.15 0.49 2.12 815.9494 1,629.88 1,630.90 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LAALADQWQFLVQK 95.00% 4.51 0.532 2.68 815.9503 1,629.89 1,630.90 2
 SAMPLE 1 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 9.43% LAALADQWQFLVQK 95.00% 4.92 0.519 3.52 816.452 1,630.89 1,630.90 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% AALLELWELRR 95.00% 2 0.262 0 457.2711 1,368.79 1,369.80 3
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% LFGAAEVQR 95.00% 3.05 0.243 2.08 495.7709 989.5261 990.5373 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% LFGAAEVQR 95.00% 2.72 0.249 1.15 495.7713 989.527 990.5373 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% LFGAAEVQR 95.00% 3.17 0.207 1.92 495.7717 989.5278 990.5373 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% HQALQAEIAGHEPR 95.00% 3.95 0.45 3.12 519.9357 1,556.78 1,556.79 3
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% HQAFEAELHANADR 95.00% 3.55 0.358 3.06 537.2546 1,608.74 1,608.75 3
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% AQLADSFHLQQFFR 95.00% 1.88 0.334 0 570.292 1,707.85 1,707.86 3
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% LIQSHPESAEDLQEK 95.00% 3.1 0.133 1.41 575.2872 1,722.84 1,723.85 3
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% LIQSHPESAEDLQEK 95.00% 3.73 0.155 0.959 575.2878 1,722.84 1,723.85 3
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% TATDEAYKDPSNLQGK 95.00% 2.45 0.332 1.14 579.9481 1,736.82 1,737.83 3
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% TATDEAYKDPSNLQGK 95.00% 2.63 0.306 0 580.2839 1,737.83 1,737.83 3
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% LSDDNTIGKEEIQQR 95.00% 4.25 0.432 1.06 582.6262 1,744.86 1,745.87 3
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% LSDDNTIGKEEIQQR 95.00% 3.94 0.36 0 582.6268 1,744.86 1,745.87 3
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% DVTGAEALLER 95.00% 3.16 0.412 2.4 587.308 1,172.60 1,173.61 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% DVTGAEALLER 95.00% 3.31 0.398 1.51 587.309 1,172.60 1,173.61 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% DLMSWINGIR 95.00% 2.92 0.345 0 602.8083 1,203.60 1,204.62 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% DLMSWINGIR 95.00% 2.87 0.343 0 602.8084 1,203.60 1,204.62 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% DLSSVQTLLTK 95.00% 2.98 0.24 2.8 602.8466 1,203.68 1,204.68 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% WSQLLANSAAR 95.00% 3.81 0.358 0 608.8253 1,215.63 1,216.64 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% KVEDLFLTFAK 95.00% 3.07 0.417 3.06 655.8713 1,309.73 1,310.74 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% LGESQTLQQFSR 95.00% 2.4 0.314 2.8 698.0132 1,394.01 1,393.71 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% DVDEIEAWISEK 95.00% 3.6 0.389 2.28 717.846 1,433.68 1,433.68 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% ELPTAFDYVEFTR 95.00% 2.41 0.246 0 794.3869 1,586.76 1,587.77 2 MYH11_HUMAN
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% LAALADQWQFLVQK 95.00% 4.38 0.541 3.36 815.9505 1,629.89 1,630.90 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% LAALADQWQFLVQK 95.00% 4.1 0.495 3 815.9511 1,629.89 1,630.90 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% LAALADQWQFLVQK 95.00% 4.47 0.519 3.59 815.9518 1,629.89 1,630.90 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% LAALADQWQFLVQK 95.00% 3.97 0.437 2.72 816.4533 1,630.89 1,630.90 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% DLAALGDKVNSLGETAER 95.00% 4.94 0.667 5.89 929.9742 1,857.93 1,858.95 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% SSLSSAQADFNQLAELDR 95.00% 4.58 0.551 4.72 976.4686 1,950.92 1,951.94 2
 SAMPLE 1R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 18 18 29 10.10% SSLSSAQADFNQLAELDR 95.00% 4.93 0.635 5.06 976.9721 1,951.93 1,951.94 2
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% HQALQAEIAGHEPR 95.00% 4.09 0.525 3.39 519.6016 1,555.78 1,556.79 3
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% HQALQAEIAGHEPR 95.00% 4.01 0.482 3.54 519.9357 1,556.78 1,556.79 3
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% LIQSHPESAEDLQEK 95.00% 3.53 0.218 2.54 575.2874 1,722.84 1,723.85 3
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% LIQSHPESAEDLQEK 95.00% 2.53 0.358 0 575.2874 1,722.84 1,723.85 3
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% LIQSHPESAEDLQEK 95.00% 3.35 0.185 1.74 575.2878 1,722.84 1,723.85 3
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% LSDDNTIGKEEIQQR 95.00% 3.66 0.325 0.921 582.6259 1,744.85 1,745.87 3
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% WSQLLANSAAR 95.00% 2.66 0.174 0 608.8182 1,215.62 1,216.64 2
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% WSQLLANSAAR 95.00% 2.92 0.241 0 609.3249 1,216.63 1,216.64 2
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% DLAALGDKVNSLGETAER 95.00% 4.06 0.573 1 620.3225 1,857.94 1,858.95 3
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% VLETAEDIQER 95.00% 2.86 0.439 1.16 652.3315 1,302.65 1,302.65 2
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% LAALADQWQFLVQK 95.00% 2.63 0.348 2.05 815.9489 1,629.88 1,630.90 2
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% LAALADQWQFLVQK 95.00% 4.37 0.545 2.89 815.9494 1,629.88 1,630.90 2
 SAMPLE 2 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 7 7 13 3.96% LAALADQWQFLVQK 95.00% 4.79 0.52 4.55 816.4539 1,630.89 1,630.90 2
 SAMPLE 2R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 9 9 12 5.26% HQALQAEIAGHEPR 95.00% 2.81 0.42 0.959 519.601 1,555.78 1,556.79 3
 SAMPLE 2R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 9 9 12 5.26% HQAFEAELHANADR 95.00% 3.56 0.386 2.28 536.9201 1,607.74 1,608.75 3
 SAMPLE 2R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 9 9 12 5.26% HQAFEAELHANADR 95.00% 2.97 0.26 3.52 536.921 1,607.74 1,608.75 3
 SAMPLE 2R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 9 9 12 5.26% LIDVNHYAKDEVAAR 95.00% 2.81 0.47 0 572.3039 1,713.89 1,713.89 3
 SAMPLE 2R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 9 9 12 5.26% LIQSHPESAEDLQEK 95.00% 2.94 0.186 0 575.2861 1,722.83 1,723.85 3
 SAMPLE 2R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 9 9 12 5.26% LIQSHPESAEDLQEK 95.00% 2.99 0.153 1.36 575.2883 1,722.84 1,723.85 3
 SAMPLE 2R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 9 9 12 5.26% TATDEAYKDPSNLQGK 95.00% 2.68 0.292 0 579.9506 1,736.83 1,737.83 3
 SAMPLE 2R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 9 9 12 5.26% LSDDNTIGKEEIQQR 95.00% 4.05 0.297 1.15 582.6256 1,744.85 1,745.87 3
 SAMPLE 2R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 9 9 12 5.26% VLETAEDIQER 95.00% 2.11 0.317 0 651.8303 1,301.64 1,302.65 2
 SAMPLE 2R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 9 9 12 5.26% KVEDLFLTFAK 95.00% 2.6 0.408 1.8 655.8684 1,309.72 1,310.74 2
 SAMPLE 2R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 9 9 12 5.26% IAALQAFADQLIAAGHYAK 95.00% 5.1 0.602 3.49 658.3606 1,972.06 1,972.07 3
 SAMPLE 2R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 9 9 12 5.26% IAALQAFADQLIAAGHYAK 95.00% 5.02 0.541 2.05 658.3619 1,972.06 1,972.07 3
 SAMPLE 3 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 3 3 4 1.62% DLAALEDKVK 95.00% 1.96 0.235 1.62 551.3112 1,100.61 1,101.62 2
 SAMPLE 3 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 3 3 4 1.62% LIQSHPESAEDLQEK 95.00% 2.59 0.259 0 575.2879 1,722.84 1,723.85 3
 SAMPLE 3 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 3 3 4 1.62% LIQSHPESAEDLQEK 95.00% 3.37 0.234 0 575.6212 1,723.84 1,723.85 3
 SAMPLE 3 Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 3 3 4 1.62% LSDDNTIGKEEIQQR 95.00% 3.53 0.351 1.68 582.6277 1,744.86 1,745.87 3
 SAMPLE 3R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 4 4 6 2.22% LIQSHPESAEDLQEK 95.00% 3.57 0.454 0 575.2883 1,722.84 1,723.85 3
 SAMPLE 3R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 4 4 6 2.22% LIQSHPESAEDLQEK 95.00% 3.08 0.189 0 575.2887 1,722.84 1,723.85 3
 SAMPLE 3R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 4 4 6 2.22% LSDDNTIGKEEIQQR 95.00% 3.46 0.328 0 582.6272 1,744.86 1,745.87 3
 SAMPLE 3R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 4 4 6 2.22% WSQLLANSAAR 95.00% 2.85 0.307 0 608.9868 1,215.96 1,216.64 2
 SAMPLE 3R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 4 4 6 2.22% LAALADQWQFLVQK 95.00% 3.9 0.453 2.3 815.9513 1,629.89 1,630.90 2
 SAMPLE 3R Spectrin alpha chain, brain  SPTAN1  SPTA2_HUMAN 284,524.70 100.00% 4 4 6 2.22% LAALADQWQFLVQK 95.00% 4.07 0.494 2.42 815.9513 1,629.89 1,630.90 2
 SAMPLE 1 Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 5 5 7 9.62% FATHAAALSVR 95.00% 2.92 0.427 2.64 572.3162 1,142.62 1,143.63 2
 SAMPLE 1 Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 5 5 7 9.62% FAQHGTFEYEYSQR 95.00% 3.76 0.387 1.37 588.2631 1,761.77 1,762.78 3
 SAMPLE 1 Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 5 5 7 9.62% YGEPGEVFINK 95.00% 3.15 0.275 2.77 626.8121 1,251.61 1,252.62 2
 SAMPLE 1 Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 5 5 7 9.62% YGEPGEVFINK 95.00% 2.93 0.172 1.2 626.8122 1,251.61 1,252.62 2
 SAMPLE 1 Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 5 5 7 9.62% LFVGNLPADITEDEFKR 95.00% 2.73 0.421 1.89 655.6753 1,964.00 1,964.01 3
 SAMPLE 1 Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 5 5 7 9.62% FGQGGAGPVGGQGPR 95.00% 3.43 0.571 6.4 671.3356 1,340.66 1,341.67 2
 SAMPLE 1 Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 5 5 7 9.62% FGQGGAGPVGGQGPR 95.00% 3.75 0.636 7.19 671.3364 1,340.66 1,341.67 2
 SAMPLE 1R Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 4 4 6 7.64% FATHAAALSVR 95.00% 2.74 0.466 1.89 572.316 1,142.62 1,143.63 2
 SAMPLE 1R Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 4 4 6 7.64% YGEPGEVFINK 95.00% 2.76 0.196 1.29 626.8126 1,251.61 1,252.62 2
 SAMPLE 1R Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 4 4 6 7.64% LFVGNLPADITEDEFKR 95.00% 3.38 0.291 0 655.3409 1,963.00 1,964.01 3
 SAMPLE 1R Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 4 4 6 7.64% LFVGNLPADITEDEFKR 95.00% 3.18 0.428 0.959 655.6764 1,964.01 1,964.01 3
 SAMPLE 1R Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 4 4 6 7.64% FGQGGAGPVGGQGPR 95.00% 3.57 0.508 3.34 671.3358 1,340.66 1,341.67 2
 SAMPLE 1R Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 100.00% 4 4 6 7.64% FGQGGAGPVGGQGPR 95.00% 3.29 0.49 5.14 671.3363 1,340.66 1,341.67 2
 SAMPLE 2R Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 99.80% 2 2 2 4.53% LFVGNLPADITEDEFKR 95.00% 2.52 0.263 0 655.6762 1,964.01 1,964.01 3
 SAMPLE 2R Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 99.80% 2 2 2 4.53% FGQGGAGPVGGQGPR 95.00% 2.63 0.439 0 671.3358 1,340.66 1,341.67 2
 SAMPLE 3 Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 99.80% 2 2 4 3.68% YGEPGEVFINK 95.00% 2.84 0.46 2.09 626.8132 1,251.61 1,252.62 2
 SAMPLE 3 Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 99.80% 2 2 4 3.68% YGEPGEVFINK 95.00% 2.78 0.448 4.17 626.8134 1,251.61 1,252.62 2
 SAMPLE 3 Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 99.80% 2 2 4 3.68% FGQGGAGPVGGQGPR 95.00% 3.84 0.608 5.77 671.3358 1,340.66 1,341.67 2
 SAMPLE 3 Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 99.80% 2 2 4 3.68% FGQGGAGPVGGQGPR 95.00% 3.07 0.517 4.48 671.3358 1,340.66 1,341.67 2
 SAMPLE 3R Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 99.80% 2 2 3 3.68% YGEPGEVFINK 95.00% 2.73 0.481 1.47 626.8131 1,251.61 1,252.62 2
 SAMPLE 3R Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 99.80% 2 2 3 3.68% FGQGGAGPVGGQGPR 95.00% 3.85 0.601 6.14 671.3349 1,340.65 1,341.67 2
 SAMPLE 3R Splicing factor, proline- and glutamine-rich  SFPQ  SFPQ_HUMAN 76,131.50 99.80% 2 2 3 3.68% FGQGGAGPVGGQGPR 95.00% 3.64 0.599 4 671.336 1,340.66 1,341.67 2
 SAMPLE 1 Spondin-1  SPON1  SPON1_HUMAN 90,955.60 99.80% 2 2 4 2.97% IIYFQDEGSLTK 95.00% 3.07 0.443 2.12 707.3651 1,412.71 1,413.73 2
 SAMPLE 1 Spondin-1  SPON1  SPON1_HUMAN 90,955.60 99.80% 2 2 4 2.97% IIYFQDEGSLTK 95.00% 3.11 0.459 1.72 707.3666 1,412.72 1,413.73 2
 SAMPLE 1 Spondin-1  SPON1  SPON1_HUMAN 90,955.60 99.80% 2 2 4 2.97% AQWPAWQPLNVR 95.00% 3.4 0.461 3.08 733.3869 1,464.76 1,465.77 2
 SAMPLE 1 Spondin-1  SPON1  SPON1_HUMAN 90,955.60 99.80% 2 2 4 2.97% AQWPAWQPLNVR 95.00% 3.36 0.442 2.33 733.3881 1,464.76 1,465.77 2
 SAMPLE 1 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 6 5.45% VQQTVQDLFGR 95.00% 3.37 0.597 3.25 645.8418 1,289.67 1,290.68 2
 SAMPLE 1 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 6 5.45% VQQTVQDLFGR 95.00% 3.12 0.552 2.46 645.842 1,289.67 1,290.68 2
 SAMPLE 1 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 6 5.45% AQFEGIVTDLIR 95.00% 3.86 0.5 3.28 681.3718 1,360.73 1,361.74 2
 SAMPLE 1 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 6 5.45% AQFEGIVTDLIR 95.00% 3.15 0.4 2.51 681.3743 1,360.73 1,361.74 2
 SAMPLE 1 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 6 5.45% QAVTNPNNTFYATK 95.00% 2.93 0.479 2.77 784.8856 1,567.76 1,568.77 2
 SAMPLE 1 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 6 5.45% QAVTNPNNTFYATK 95.00% 3.47 0.44 3.05 785.3889 1,568.76 1,568.77 2
 SAMPLE 1R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 5 5.74% VQQTVQDLFGR 95.00% 3.2 0.592 3.35 645.8417 1,289.67 1,290.68 2
 SAMPLE 1R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 5 5.74% VQQTVQDLFGR 95.00% 3.03 0.524 2.48 645.8418 1,289.67 1,290.68 2
 SAMPLE 1R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 5 5.74% LYSPSQIGAFVLMK 95.00% 2.72 0.36 3.96 777.9246 1,553.83 1,553.84 2
 SAMPLE 1R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 5 5.74% QAVTNPNNTFYATK 95.00% 2.71 0.464 1.48 784.8868 1,567.76 1,568.77 2
 SAMPLE 1R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 5 5.74% QAVTNPNNTFYATK 95.00% 3.26 0.447 3.38 785.3894 1,568.76 1,568.77 2
 SAMPLE 2 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 99.80% 2 2 3 3.83% AQFEGIVTDLIR 95.00% 3.64 0.449 3.25 681.3753 1,360.73 1,361.74 2
 SAMPLE 2 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 99.80% 2 2 3 3.83% QAVTNPNNTFYATK 95.00% 3.11 0.58 2.31 784.8895 1,567.76 1,568.77 2
 SAMPLE 2 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 99.80% 2 2 3 3.83% QAVTNPNNTFYATK 95.00% 3.73 0.516 3.68 785.3907 1,568.77 1,568.77 2
 SAMPLE 2R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 3 5.89% AQFEGIVTDLIR 95.00% 2.43 0.367 0 681.374 1,360.73 1,361.74 2
 SAMPLE 2R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 3 5.89% LYSPSQIGAFVLMK 95.00% 2.51 0.264 2.54 777.4242 1,552.83 1,553.84 2
 SAMPLE 2R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 3 5.89% QAVTNPNNTFYATK 95.00% 3.02 0.49 1.82 784.8893 1,567.76 1,568.77 2
 SAMPLE 3 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 6 5.74% VQQTVQDLFGR 95.00% 1.93 0.38 1.85 645.8426 1,289.67 1,290.68 2
 SAMPLE 3 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 6 5.74% VQQTVQDLFGR 95.00% 3 0.52 4.41 645.8435 1,289.67 1,290.68 2
 SAMPLE 3 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 6 5.74% VQQTVQDLFGR 95.00% 2.89 0.551 3.64 645.8437 1,289.67 1,290.68 2
 SAMPLE 3 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 6 5.74% TTPSVVAFTADGER 95.00% 2.94 0.568 3.35 726.3632 1,450.71 1,450.72 2
 SAMPLE 3 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 6 5.74% QAVTNPNNTFYATK 95.00% 3.09 0.489 2.68 784.8876 1,567.76 1,568.77 2
 SAMPLE 3 Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 3 3 6 5.74% QAVTNPNNTFYATK 95.00% 2.9 0.443 3.66 784.889 1,567.76 1,568.77 2
 SAMPLE 3R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 4 4 7 7.51% MKETAENYLGHTAK 95.00% 3.03 0.427 0 531.5966 1,591.77 1,592.77 3
 SAMPLE 3R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 4 4 7 7.51% VQQTVQDLFGR 95.00% 1.95 0.418 1.18 645.842 1,289.67 1,290.68 2
 SAMPLE 3R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 4 4 7 7.51% VQQTVQDLFGR 95.00% 3.1 0.57 3.48 645.8423 1,289.67 1,290.68 2
 SAMPLE 3R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 4 4 7 7.51% VQQTVQDLFGR 95.00% 2.41 0.507 0 645.8432 1,289.67 1,290.68 2
 SAMPLE 3R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 4 4 7 7.51% AQFEGIVTDLIR 95.00% 2.5 0.383 0 681.3731 1,360.73 1,361.74 2
 SAMPLE 3R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 4 4 7 7.51% LYSPSQIGAFVLMK 95.00% 2.84 0.341 1.72 777.4233 1,552.83 1,553.84 2
 SAMPLE 3R Stress-70 protein, mitochondrial  HSPA9  GRP75_HUMAN 73,663.30 100.00% 4 4 7 7.51% LYSPSQIGAFVLMK 95.00% 2.91 0.433 3.55 777.4242 1,552.83 1,553.84 2
 SAMPLE 1R Stress-induced-phosphoprotein 1  STIP1  STIP1_HUMAN 62,624.10 99.80% 2 2 3 4.79% LMDVGLIAIR 95.00% 2.56 0.242 0 550.8263 1,099.64 1,100.65 2
 SAMPLE 1R Stress-induced-phosphoprotein 1  STIP1  STIP1_HUMAN 62,624.10 99.80% 2 2 3 4.79% TYEEGLKHEANNPQLK 95.00% 2.84 0.521 1.08 624.3145 1,869.92 1,870.93 3
 SAMPLE 1R Stress-induced-phosphoprotein 1  STIP1  STIP1_HUMAN 62,624.10 99.80% 2 2 3 4.79% TYEEGLKHEANNPQLK 95.00% 2.77 0.575 1.13 624.6475 1,870.92 1,870.93 3
 SAMPLE 2 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial  SDHA  DHSA_HUMAN 72,673.70 99.80% 2 2 2 4.22% KHTLSYVDVGTGK 95.00% 3.07 0.409 0 468.9212 1,403.74 1,404.75 3
 SAMPLE 2 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial  SDHA  DHSA_HUMAN 72,673.70 99.80% 2 2 2 4.22% IDEYDYSKPIQGQQK 95.00% 2.86 0.336 1.33 604.63 1,810.87 1,811.88 3
 SAMPLE 2R Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial  SDHA  DHSA_HUMAN 72,673.70 100.00% 3 3 4 6.78% KHTLSYVDVGTGK 95.00% 2.55 0.215 0 468.9212 1,403.74 1,404.75 3
 SAMPLE 2R Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial  SDHA  DHSA_HUMAN 72,673.70 100.00% 3 3 4 6.78% KHTLSYVDVGTGK 95.00% 3.46 0.481 0 469.2545 1,404.74 1,404.75 3
 SAMPLE 2R Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial  SDHA  DHSA_HUMAN 72,673.70 100.00% 3 3 4 6.78% IDEYDYSKPIQGQQK 95.00% 2.58 0.356 1.62 604.6305 1,810.87 1,811.88 3
 SAMPLE 2R Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial  SDHA  DHSA_HUMAN 72,673.70 100.00% 3 3 4 6.78% AAFGLSEAGFNTAcVTK 95.00% 4.84 0.613 8.16 c14: Carbamidomethyl (+57.02) 872.4217 1,742.83 1,743.84 2
 SAMPLE 3 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial  SDHA  DHSA_HUMAN 72,673.70 99.80% 2 2 3 4.22% KHTLSYVDVGTGK 95.00% 3.23 0.442 0 468.9205 1,403.74 1,404.75 3
 SAMPLE 3 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial  SDHA  DHSA_HUMAN 72,673.70 99.80% 2 2 3 4.22% IDEYDYSKPIQGQQK 95.00% 2.91 0.399 1.44 604.9638 1,811.87 1,811.88 3
 SAMPLE 3 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial  SDHA  DHSA_HUMAN 72,673.70 99.80% 2 2 3 4.22% IDEYDYSKPIQGQQK 95.00% 2.54 0.338 0 604.9656 1,811.87 1,811.88 3
 SAMPLE 3R Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial  SDHB  DHSB_HUMAN 31,613.00 100.00% 3 3 4 11.40% LQDPFSLYR 95.00% 2.25 0.12 1.37 569.7967 1,137.58 1,138.59 2
 SAMPLE 3R Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial  SDHB  DHSB_HUMAN 31,613.00 100.00% 3 3 4 11.40% LQDPFSLYR 95.00% 2.21 0.142 1.34 569.7968 1,137.58 1,138.59 2
 SAMPLE 3R Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial  SDHB  DHSB_HUMAN 31,613.00 100.00% 3 3 4 11.40% cGPMVLDALIK 95.00% 2.48 0.217 0 c1: Carbamidomethyl (+57.02) 608.8222 1,215.63 1,216.64 2
 SAMPLE 3R Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial  SDHB  DHSB_HUMAN 31,613.00 100.00% 3 3 4 11.40% YLGPAVLMQAYR 95.00% 1.76 0.303 0 691.3684 1,380.72 1,381.73 2
 SAMPLE 2R Superoxide dismutase [Cu-Zn]  SOD1  SODC_HUMAN 15,917.30 99.80% 2 2 4 22.70% TLVVHEKADDLGKGGNEESTK 95.00% 4.15 0.493 3.82 743.0477 2,226.12 2,227.12 3
 SAMPLE 2R Superoxide dismutase [Cu-Zn]  SOD1  SODC_HUMAN 15,917.30 99.80% 2 2 4 22.70% TLVVHEKADDLGKGGNEESTK 95.00% 4.75 0.555 4.57 743.382 2,227.12 2,227.12 3
 SAMPLE 2R Superoxide dismutase [Cu-Zn]  SOD1  SODC_HUMAN 15,917.30 99.80% 2 2 4 22.70% GDGPVQGIINFEQK 95.00% 4.01 0.467 2.34 751.3865 1,500.76 1,501.77 2
 SAMPLE 2R Superoxide dismutase [Cu-Zn]  SOD1  SODC_HUMAN 15,917.30 99.80% 2 2 4 22.70% GDGPVQGIINFEQK 95.00% 4.17 0.408 2.77 751.8846 1,501.75 1,501.77 2
 SAMPLE 1 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 2 2 4 3.44% SPPSYSVLYPSSDPK 95.00% 2.57 0.402 0 812.3976 1,622.78 1,623.79 2
 SAMPLE 1 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 2 2 4 3.44% VTPNPDLLDLVQTADEK 95.00% 4.55 0.689 5.15 934.4838 1,866.95 1,867.97 2
 SAMPLE 1 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 2 2 4 3.44% VTPNPDLLDLVQTADEK 95.00% 5.1 0.637 6.35 934.9857 1,867.96 1,867.97 2
 SAMPLE 1 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 2 2 4 3.44% VTPNPDLLDLVQTADEK 95.00% 5.19 0.638 4.26 934.986 1,867.96 1,867.97 2
 SAMPLE 1R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 9 5.38% AASPAKPSSLDLVPNLPK 95.00% 2.96 0.213 0 602.3397 1,804.00 1,805.02 3
 SAMPLE 1R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 9 5.38% VASEEEEVPLVVYLK 95.00% 4.43 0.536 3.68 852.4572 1,702.90 1,703.91 2
 SAMPLE 1R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 9 5.38% VASEEEEVPLVVYLK 95.00% 4.96 0.568 3.8 852.4574 1,702.90 1,703.91 2
 SAMPLE 1R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 9 5.38% VTPNPDLLDLVQTADEK 95.00% 3.6 0.571 3.8 934.4799 1,866.94 1,867.97 2
 SAMPLE 1R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 9 5.38% VTPNPDLLDLVQTADEK 95.00% 4.52 0.67 6.04 934.4843 1,866.95 1,867.97 2
 SAMPLE 1R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 9 5.38% VTPNPDLLDLVQTADEK 95.00% 2.36 0.405 0 934.4845 1,866.95 1,867.97 2
 SAMPLE 1R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 9 5.38% VTPNPDLLDLVQTADEK 95.00% 4.15 0.7 5.64 934.4848 1,866.95 1,867.97 2
 SAMPLE 1R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 9 5.38% VTPNPDLLDLVQTADEK 95.00% 4.42 0.69 5.6 934.4867 1,866.96 1,867.97 2
 SAMPLE 1R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 9 5.38% VTPNPDLLDLVQTADEK 95.00% 4.4 0.64 4.6 934.9874 1,867.96 1,867.97 2
 SAMPLE 2 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 5 5.06% SPPSYSVLYPSSDPK 95.00% 2.96 0.435 2.92 812.3955 1,622.78 1,623.79 2
 SAMPLE 2 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 5 5.06% SPPSYSVLYPSSDPK 95.00% 3.65 0.52 3.7 812.9015 1,623.79 1,623.79 2
 SAMPLE 2 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 5 5.06% VASEEEEVPLVVYLK 95.00% 4.91 0.506 3.74 852.4595 1,702.90 1,703.91 2
 SAMPLE 2 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 5 5.06% VTPNPDLLDLVQTADEK 95.00% 4.92 0.653 4.77 934.4853 1,866.96 1,867.97 2
 SAMPLE 2 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 3 3 5 5.06% VTPNPDLLDLVQTADEK 95.00% 4.57 0.671 2.24 934.9862 1,867.96 1,867.97 2
 SAMPLE 2R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 4 4 9 6.46% TGILEESMAR 95.00% 2.13 0.227 1.66 553.7791 1,105.54 1,106.55 2
 SAMPLE 2R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 4 4 9 6.46% TGILEESMAR 95.00% 2.26 0.27 1.41 553.7792 1,105.54 1,106.55 2
 SAMPLE 2R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 4 4 9 6.46% AASPAKPSSLDLVPNLPK 95.00% 2.39 0.271 0 602.3416 1,804.00 1,805.02 3
 SAMPLE 2R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 4 4 9 6.46% AASPAKPSSLDLVPNLPK 95.00% 2.32 0.293 0 602.3426 1,804.00 1,805.02 3
 SAMPLE 2R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 4 4 9 6.46% SPPSYSVLYPSSDPK 95.00% 2.5 0.414 0 812.3987 1,622.78 1,623.79 2
 SAMPLE 2R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 4 4 9 6.46% SPPSYSVLYPSSDPK 95.00% 3.42 0.531 2.72 812.8983 1,623.78 1,623.79 2
 SAMPLE 2R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 4 4 9 6.46% VTPNPDLLDLVQTADEK 95.00% 3.15 0.513 1.46 934.485 1,866.95 1,867.97 2
 SAMPLE 2R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 4 4 9 6.46% VTPNPDLLDLVQTADEK 95.00% 4.93 0.635 4.85 934.9854 1,867.96 1,867.97 2
 SAMPLE 2R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 4 4 9 6.46% VTPNPDLLDLVQTADEK 95.00% 4.85 0.622 4.96 934.9862 1,867.96 1,867.97 2
 SAMPLE 3 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 99.80% 2 2 4 3.44% SPPSYSVLYPSSDPK 95.00% 3.03 0.444 2.05 812.3972 1,622.78 1,623.79 2
 SAMPLE 3 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 99.80% 2 2 4 3.44% SPPSYSVLYPSSDPK 95.00% 3.41 0.529 4.11 812.8957 1,623.78 1,623.79 2
 SAMPLE 3 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 99.80% 2 2 4 3.44% VTPNPDLLDLVQTADEK 95.00% 2.39 0.274 0 934.9848 1,867.95 1,867.97 2
 SAMPLE 3 Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 99.80% 2 2 4 3.44% VTPNPDLLDLVQTADEK 95.00% 4.78 0.678 5 934.9856 1,867.96 1,867.97 2
 SAMPLE 3R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 2 2 3 3.12% APAPQPPSLPDR 95.00% 1.93 0.381 0 623.3329 1,244.65 1,245.66 2
 SAMPLE 3R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 2 2 3 3.12% VTPNPDLLDLVQTADEK 95.00% 4.12 0.613 4.44 934.984 1,867.95 1,867.97 2
 SAMPLE 3R Synaptopodin  SYNPO  SYNPO_HUMAN 99,445.70 100.00% 2 2 3 3.12% VTPNPDLLDLVQTADEK 95.00% 4.47 0.694 5.59 934.985 1,867.95 1,867.97 2
 SAMPLE 4 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 3 3 5 5.95% VAEELILR 95.00% 2.4 0.213 1.15 471.7856 941.5555 942.5625 2 SH3L1_HUMAN,TITIN_HUMAN
 SAMPLE 4 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 3 3 5 5.95% GASGPLVALPGAEK 95.00% 2.14 0.308 0 633.8581 1,265.70 1,266.71 2 HS90A_HUMAN,TITIN_HUMAN
 SAMPLE 4 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 3 3 5 5.95% GPQAAVASQNYTPK 95.00% 3.29 0.582 0 716.3678 1,430.72 1,431.72 2
 SAMPLE 4 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 3 3 5 5.95% GPQAAVASQNYTPK 95.00% 3.49 0.598 0 716.3697 1,430.72 1,431.72 2
 SAMPLE 4 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 3 3 5 5.95% YVVDSDTVQAHAAR 95.00% 4.15 0.625 4.96 766.3822 1,530.75 1,531.75 2
 SAMPLE 4 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 3 3 5 5.95% YVVDSDTVQAHAAR 95.00% 4.52 0.612 4.48 766.3846 1,530.75 1,531.75 2
 SAMPLE 4 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 3 3 5 5.95% SIALLLTDAPNPNSK 95.00% 2.95 0.372 1.43 777.9329 1,553.85 1,553.85 2
 SAMPLE 4R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 99.80% 2 2 2 4.57% VAEELILR 95.00% 2.12 0.245 1.55 471.7868 941.5579 942.5625 2 SH3L1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 99.80% 2 2 2 4.57% VAEELILR 94.70% 2.01 0.15 1.23 471.787 941.5584 942.5625 2 SH3L1_HUMAN,TITIN_HUMAN
 SAMPLE 4R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 99.80% 2 2 2 4.57% GASGPLVALPGAEK 95.00% 2.57 0.291 0 633.8608 1,265.71 1,266.71 2 HS90A_HUMAN,TITIN_HUMAN
 SAMPLE 4R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 99.80% 2 2 2 4.57% GPQAAVASQNYTPK 95.00% 3.7 0.593 0 716.869 1,431.72 1,431.72 2
 SAMPLE 4R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 99.80% 2 2 2 4.57% VIQESEAGDAGLPR 95.00% 2.99 0.476 6.09 721.3711 1,440.73 1,441.73 2
 SAMPLE 1R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 99.80% 2 2 2 3.20% YVVDSDTVQAHAAR 95.00% 3.96 0.592 4.82 766.3795 1,530.74 1,531.75 2
 SAMPLE 1R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 99.80% 2 2 2 3.20% EPKVSPNPELLSLLQNSEGKR 95.00% 2.36 0.259 0 778.9418 2,333.80 2,335.26 3
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% VAEELILR 95.00% 2.66 0.16 0 471.7838 941.552 942.5625 2 SH3L1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% VAEELILR 95.00% 2.64 0.23 1.12 471.7838 941.552 942.5625 2 SH3L1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% VAEELILR 95.00% 2.65 0.166 0 471.7841 941.5526 942.5625 2 SH3L1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% VAEELILR 95.00% 2.48 0.19 0 471.7851 941.5546 942.5625 2 SH3L1_HUMAN,TITIN_HUMAN
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% GPQAAVASQNYTPK 95.00% 2.54 0.452 0 716.3661 1,430.72 1,431.72 2
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% APPPVAYNPIHSPSYPLAALK 95.00% 2.42 0.617 2.89 735.4023 2,203.18 2,203.19 3
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% APPPVAYNPIHSPSYPLAALK 95.00% 2.37 0.492 1.54 735.4035 2,203.19 2,203.19 3
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% APPPVAYNPIHSPSYPLAALK 95.00% 2.77 0.533 2.19 735.4056 2,203.19 2,203.19 3
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% YVVDSDTVQAHAAR 95.00% 3.42 0.53 5.09 766.3755 1,530.74 1,531.75 2
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% YVVDSDTVQAHAAR 95.00% 4.24 0.612 7.29 766.3785 1,530.74 1,531.75 2
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% YVVDSDTVQAHAAR 95.00% 4.82 0.641 7.33 766.3791 1,530.74 1,531.75 2
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% SIALLLTDAPNPNSK 95.00% 4.53 0.606 2.66 777.4306 1,552.85 1,553.85 2
 SAMPLE 2 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 8.51% EPKVSPNPELLSLLQNSEGKR 95.00% 2.16 0.238 0 778.9436 2,333.81 2,335.26 3
 SAMPLE 2R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 7.32% VAEELILR 95.00% 2.7 0.146 0 471.7836 941.5516 942.5625 2 SH3L1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 7.32% VAEELILR 95.00% 2.62 0.16 0 471.7848 941.554 942.5625 2 SH3L1_HUMAN,TITIN_HUMAN
 SAMPLE 2R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 7.32% VEVILDcSDR 95.00% 2.6 0.35 0 c7: Carbamidomethyl (+57.02) 603.2932 1,204.57 1,205.58 2
 SAMPLE 2R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 7.32% TQcTEFFLAPVK 95.00% 2.54 0.296 2.05 c3: Carbamidomethyl (+57.02) 720.8629 1,439.71 1,440.72 2
 SAMPLE 2R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 7.32% APPPVAYNPIHSPSYPLAALK 95.00% 2.73 0.566 3.06 735.4013 2,203.18 2,203.19 3
 SAMPLE 2R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 7.32% APPPVAYNPIHSPSYPLAALK 95.00% 2.68 0.511 3.64 735.4029 2,203.19 2,203.19 3
 SAMPLE 2R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 7.32% APPPVAYNPIHSPSYPLAALK 95.00% 2.18 0.259 0 735.4056 2,203.19 2,203.19 3
 SAMPLE 2R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 7.32% YVVDSDTVQAHAAR 95.00% 4.86 0.622 5.59 766.3792 1,530.74 1,531.75 2
 SAMPLE 2R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 7.32% YVVDSDTVQAHAAR 95.00% 4.27 0.641 5.4 766.3798 1,530.74 1,531.75 2
 SAMPLE 2R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 7.32% SIALLLTDAPNPNSK 95.00% 4.58 0.59 2.54 777.4298 1,552.84 1,553.85 2
 SAMPLE 2R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 5 9 7.32% SIALLLTDAPNPNSK 95.00% 4.25 0.582 1.92 777.43 1,552.84 1,553.85 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% VAEELILR 95.00% 2.35 0.161 0 471.7842 941.5528 942.5625 2 SH3L1_HUMAN,TITIN_HUMAN
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% YVVDSDTVQAHAAR 95.00% 1.84 0.283 0 511.2534 1,530.74 1,531.75 3
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% QESASSSYFVAPRPK 95.00% 1.94 0.29 0 552.3253 1,653.95 1,653.82 3
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% MDQITAQKEEDKVGGTPSR 95.00% 3.13 0.344 0 697.6765 2,090.01 2,090.02 3
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% MDQITAQKEEDKVGGTPSR 95.00% 4.37 0.264 1.77 697.679 2,090.01 2,090.02 3
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% GPQAAVASQNYTPK 95.00% 3.12 0.607 0 716.3638 1,430.71 1,431.72 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% GPQAAVASQNYTPK 95.00% 1.95 0.385 0 716.3643 1,430.71 1,431.72 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% GPQAAVASQNYTPK 95.00% 2.4 0.434 0 716.3663 1,430.72 1,431.72 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% VIQESEAGDAGLPR 95.00% 3.51 0.455 2.33 721.3665 1,440.72 1,441.73 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% VIQESEAGDAGLPR 95.00% 3.63 0.53 4.31 721.3673 1,440.72 1,441.73 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% VIQESEAGDAGLPR 95.00% 3.27 0.496 3.24 721.3679 1,440.72 1,441.73 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% APPPVAYNPIHSPSYPLAALK 95.00% 2.74 0.556 3.2 735.4015 2,203.18 2,203.19 3
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% APPPVAYNPIHSPSYPLAALK 95.00% 2.33 0.496 3.72 735.4018 2,203.18 2,203.19 3
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% APPPVAYNPIHSPSYPLAALK 95.00% 2.23 0.507 2.07 735.4028 2,203.18 2,203.19 3
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% APPPVAYNPIHSPSYPLAALK 95.00% 1.76 0.178 1.36 735.4042 2,203.19 2,203.19 3
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% YVVDSDTVQAHAAR 95.00% 4.27 0.622 5.96 766.378 1,530.74 1,531.75 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% YVVDSDTVQAHAAR 95.00% 4.28 0.62 6.46 766.3784 1,530.74 1,531.75 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% YVVDSDTVQAHAAR 95.00% 4.02 0.642 5.89 766.3784 1,530.74 1,531.75 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% YVVDSDTVQAHAAR 95.00% 4.79 0.615 5.55 766.3795 1,530.74 1,531.75 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% YVVDSDTVQAHAAR 95.00% 4.14 0.639 5.57 766.3802 1,530.74 1,531.75 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% YVVDSDTVQAHAAR 95.00% 4.66 0.6 5 766.8788 1,531.74 1,531.75 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% SIALLLTDAPNPNSK 95.00% 3.83 0.579 4 777.4286 1,552.84 1,553.85 2
 SAMPLE 3 Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 7 8 22 11.00% SIALLLTDAPNPNSK 95.00% 5.15 0.586 3.85 777.4292 1,552.84 1,553.85 2
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% YVVDSDTVQAHAAR 95.00% 1.89 0.429 0 511.5893 1,531.74 1,531.75 3
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% GPQAAVASQNYTPK 95.00% 1.97 0.274 0 716.3647 1,430.71 1,431.72 2
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% VIQESEAGDAGLPR 95.00% 3.99 0.524 4.74 721.8687 1,441.72 1,441.73 2
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% APPPVAYNPIHSPSYPLAALK 95.00% 2.99 0.457 3.47 735.0708 2,202.19 2,203.19 3
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% APPPVAYNPIHSPSYPLAALK 95.00% 2.28 0.37 1.89 735.4049 2,203.19 2,203.19 3
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% YVVDSDTVQAHAAR 95.00% 4.62 0.632 6.55 766.3775 1,530.74 1,531.75 2
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% YVVDSDTVQAHAAR 95.00% 4.47 0.618 5.72 766.3783 1,530.74 1,531.75 2
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% YVVDSDTVQAHAAR 95.00% 4.67 0.615 6.49 766.379 1,530.74 1,531.75 2
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% YVVDSDTVQAHAAR 95.00% 4.63 0.623 7.28 766.3808 1,530.75 1,531.75 2
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% YVVDSDTVQAHAAR 95.00% 3.82 0.552 6.19 766.8788 1,531.74 1,531.75 2
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% YVVDSDTVQAHAAR 95.00% 4.14 0.595 6.47 766.8806 1,531.75 1,531.75 2
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% SIALLLTDAPNPNSK 95.00% 4.72 0.62 3.92 777.4304 1,552.85 1,553.85 2
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% SIALLLTDAPNPNSK 95.00% 4.65 0.598 3.8 777.4312 1,552.85 1,553.85 2
 SAMPLE 3R Synaptopodin-2  SYNPO2  SYNP2_HUMAN 117,495.80 100.00% 5 6 14 7.14% SIALLLTDAPNPNSK 95.00% 3.49 0.475 0 777.4321 1,552.85 1,553.85 2
 SAMPLE 2 T-complex protein 1 subunit gamma  CCT3  TCPG_HUMAN 60,517.40 99.80% 2 2 3 4.40% AVAQALEVIPR 95.00% 3.06 0.308 0 583.8474 1,165.68 1,166.69 2
 SAMPLE 2 T-complex protein 1 subunit gamma  CCT3  TCPG_HUMAN 60,517.40 99.80% 2 2 3 4.40% AVAQALEVIPR 95.00% 3.05 0.232 1.66 583.8481 1,165.68 1,166.69 2
 SAMPLE 2 T-complex protein 1 subunit gamma  CCT3  TCPG_HUMAN 60,517.40 99.80% 2 2 3 4.40% IPGGIIEDScVLR 95.00% 2.8 0.43 1.42 c10: Carbamidomethyl (+57.02) 714.8782 1,427.74 1,428.75 2
 SAMPLE 2R T-complex protein 1 subunit gamma  CCT3  TCPG_HUMAN 60,517.40 99.80% 2 2 4 4.04% AVAQALEVIPR 95.00% 3.19 0.279 1.23 583.8463 1,165.68 1,166.69 2
 SAMPLE 2R T-complex protein 1 subunit gamma  CCT3  TCPG_HUMAN 60,517.40 99.80% 2 2 4 4.04% AVAQALEVIPR 95.00% 3.02 0.261 1.23 583.8478 1,165.68 1,166.69 2
 SAMPLE 2R T-complex protein 1 subunit gamma  CCT3  TCPG_HUMAN 60,517.40 99.80% 2 2 4 4.04% TAVETAVLLLR 95.00% 3.31 0.343 2.82 593.3618 1,184.71 1,185.72 2
 SAMPLE 2R T-complex protein 1 subunit gamma  CCT3  TCPG_HUMAN 60,517.40 99.80% 2 2 4 4.04% TAVETAVLLLR 95.00% 3.28 0.278 2.82 593.3645 1,184.71 1,185.72 2
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% TSTPEDFIR 94.80% 1.96 0.262 0 533.2658 1,064.52 1,065.52 2
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% EGTETFADHREGILK 95.00% 2.04 0.293 0 568.2863 1,701.84 1,702.84 3
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% TYGVSFFLVK 95.00% 2.32 0.336 1.44 580.8241 1,159.63 1,160.64 2 MVP_HUMAN
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% MATNAAAQNAIK 95.00% 2.28 0.271 0 602.2769 1,202.54 1,203.62 2
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% QAAASATQTIAAAQHAASTPK 95.00% 2.63 0.131 1.41 666.0179 1,995.03 1,995.03 3
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% LAQAAQSSVATITR 95.00% 3.68 0.606 4.7 708.8952 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% LAQAAQSSVATITR 95.00% 3.48 0.564 6.14 708.8957 1,415.78 1,416.78 2 LAMA5_HUMAN
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% LAQAAQSSVATITR 95.00% 2.95 0.535 6.59 708.8958 1,415.78 1,416.78 2 LAMA5_HUMAN
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% LAQAAQSSVATITR 95.00% 1.97 0.372 0 709.0347 1,416.05 1,416.78 2 LAMA5_HUMAN
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% LAQAAQSSVATITR 95.00% 3.91 0.595 7.7 709.3976 1,416.78 1,416.78 2 LAMA5_HUMAN
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% ILAQATSDLVNAIK 95.00% 4.19 0.564 4.42 728.9243 1,455.83 1,456.84 2
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% AVAEQIPLLVQGVR 95.00% 3.42 0.508 3.15 746.9466 1,491.88 1,492.89 2
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% AVAEQIPLLVQGVR 95.00% 2.85 0.457 1.7 746.9476 1,491.88 1,492.89 2
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% AVAEQIPLLVQGVR 95.00% 3.35 0.436 2.21 746.9489 1,491.88 1,492.89 2
 SAMPLE 4 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 9 9 15 4.96% EADESLNFEEQILEAAK 95.00% 5.08 0.37 4.24 968.4618 1,934.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% AGFLDLKDFLPK 95.00% 2.59 0.284 0 455.2617 1,362.76 1,363.76 3
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% AVASAAAALVLK 95.00% 2.58 0.284 3.12 542.8401 1,083.66 1,084.67 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% GLAGAVSELLR 95.00% 2.37 0.291 2.57 542.9324 1,083.85 1,085.63 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% GLAGAVSELLR 95.00% 2.54 0.282 1.48 543.2663 1,084.52 1,085.63 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% TYGVSFFLVK 95.00% 1.98 0.285 0 580.823 1,159.63 1,160.64 2 MVP_HUMAN
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% TYGVSFFLVK 95.00% 2.27 0.333 0 580.8235 1,159.63 1,160.64 2 MVP_HUMAN
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% TYGVSFFLVK 95.00% 2.28 0.257 1.77 581.322 1,160.63 1,160.64 2 MVP_HUMAN
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% LLAALLEDEGGSGRPLLQAAK 95.00% 3.45 0.525 0 708.4041 2,122.19 2,122.19 3
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% LAQAAQSSVATITR 95.00% 2.95 0.54 4.02 708.895 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% LAQAAQSSVATITR 95.00% 2.66 0.547 5.1 708.8966 1,415.78 1,416.78 2 LAMA5_HUMAN
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% LAQAAQSSVATITR 95.00% 4.12 0.595 5.77 709.3975 1,416.78 1,416.78 2 LAMA5_HUMAN
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% ILAQATSDLVNAIK 95.00% 3.77 0.619 6.28 728.9253 1,455.84 1,456.84 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% ILAQATSDLVNAIK 95.00% 3.02 0.529 4.51 728.9259 1,455.84 1,456.84 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% ILAQATSDLVNAIK 95.00% 4.23 0.596 4.7 729.4259 1,456.84 1,456.84 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% AVAEQIPLLVQGVR 95.00% 3.19 0.505 3.28 746.9483 1,491.88 1,492.89 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% AVAEQIPLLVQGVR 95.00% 3.16 0.427 3.54 746.9488 1,491.88 1,492.89 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% AVAEQIPLLVQGVR 95.00% 3.71 0.489 4.47 746.949 1,491.88 1,492.89 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% AVAEQIPLLVQGVR 95.00% 2.09 0.179 4.38 746.9491 1,491.88 1,492.89 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% AVAEQIPLLVQGVR 95.00% 3.71 0.472 4.68 746.9492 1,491.88 1,492.89 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% AVAEQIPLLVQGVR 95.00% 3.78 0.543 4.54 746.9507 1,491.89 1,492.89 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% AVAEQIPLLVQGVR 95.00% 2.57 0.18 3.05 747.4485 1,492.88 1,492.89 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% AVAEQIPLLVQGVR 95.00% 4.02 0.454 3.66 747.4486 1,492.88 1,492.89 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% TLAESALQLLYTAK 95.00% 3.37 0.575 3.72 761.4344 1,520.85 1,521.85 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% TLAESALQLLYTAK 95.00% 3.2 0.579 5.19 761.4348 1,520.85 1,521.85 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% TLAESALQLLYTAK 95.00% 3.49 0.605 6.66 761.4348 1,520.85 1,521.85 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% TLAESALQLLYTAK 95.00% 3.27 0.485 4.34 761.9319 1,521.85 1,521.85 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% DPVQLNLLYVQAR 95.00% 4.01 0.437 2.51 764.9296 1,527.84 1,528.85 2
 SAMPLE 4R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 11 11 28 6.10% LNEAAAGLNQAATELVQASR 95.00% 5.68 0.597 8.82 1,014.53 2,027.05 2,027.05 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DPPSWSVLAGHSR 95.00% 3.93 0.557 2.05 470.2372 1,407.69 1,408.70 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DPPSWSVLAGHSR 95.00% 2.91 0.458 2.25 470.2372 1,407.69 1,408.70 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DPPSWSVLAGHSR 95.00% 3.95 0.545 2.11 470.2377 1,407.69 1,408.70 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DPPSWSVLAGHSR 95.00% 3.16 0.461 1.31 470.2379 1,407.69 1,408.70 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DPPSWSVLAGHSR 95.00% 2.84 0.454 2.19 470.2379 1,407.69 1,408.70 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DPPSWSVLAGHSR 95.00% 3.81 0.521 1.89 470.2383 1,407.69 1,408.70 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% EAAYHPEVAPDVR 95.00% 1.83 0.304 0 485.2401 1,452.70 1,453.71 3 DDX1_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% EAAYHPEVAPDVR 95.00% 2.03 0.323 0 485.2406 1,452.70 1,453.71 3 DDX1_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ALGDLISATK 95.00% 3.53 0.37 2.92 494.7853 987.5549 988.5681 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ALGDLISATK 95.00% 3.49 0.363 1.64 494.7857 987.5558 988.5681 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ALGDLISATK 95.00% 3.18 0.413 1.59 494.7862 987.5567 988.5681 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ALGDLISATK 95.00% 2.53 0.289 0 494.7864 987.5571 988.5681 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ALGDLISATK 95.00% 2.84 0.355 2.11 494.7866 987.5575 988.5681 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ALGDLISATK 95.00% 3.35 0.346 2.62 494.7866 987.5575 988.5681 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VQELGHGcAALVTK 95.00% 2.51 0.393 0 c8: Carbamidomethyl (+57.02) 494.9258 1,481.75 1,482.77 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VQELGHGcAALVTK 95.00% 2.34 0.409 0 c8: Carbamidomethyl (+57.02) 494.9288 1,481.76 1,482.77 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VQELGHGcAALVTK 95.00% 2.41 0.312 0 c8: Carbamidomethyl (+57.02) 494.9294 1,481.76 1,482.77 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VQELGHGcAALVTK 95.00% 2.52 0.428 0 c8: Carbamidomethyl (+57.02) 495.2612 1,482.76 1,482.77 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VQELGHGcAALVTK 95.00% 2.18 0.388 1.15 c8: Carbamidomethyl (+57.02) 495.2628 1,482.77 1,482.77 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VQELGHGcAALVTK 95.00% 2.34 0.266 0 c8: Carbamidomethyl (+57.02) 495.2638 1,482.77 1,482.77 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 4.6 0.375 2.46 498.2984 1,491.87 1,492.89 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 4.94 0.457 4.24 498.2991 1,491.87 1,492.89 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 4.15 0.357 1.46 498.2993 1,491.87 1,492.89 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 4.07 0.411 1.3 498.6333 1,492.88 1,492.89 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% IGITNHDEYSLVR 95.00% 2.78 0.301 0 506.2615 1,515.76 1,516.78 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% IGITNHDEYSLVR 95.00% 3.37 0.499 0 506.2621 1,515.76 1,516.78 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ALDYYMLR 95.00% 2.55 0.363 1.11 522.7619 1,043.51 1,044.52 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ALDYYMLR 95.00% 2.64 0.32 0 522.762 1,043.51 1,044.52 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ALDYYMLR 95.00% 2.08 0.372 0 522.763 1,043.51 1,044.52 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NLGTALAELR 95.00% 2.69 0.399 2.47 529.3 1,056.58 1,057.60 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NLGTALAELR 95.00% 2.31 0.337 2 529.3008 1,056.59 1,057.60 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NLGTALAELR 95.00% 2.36 0.323 0 529.3012 1,056.59 1,057.60 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NLGTALAELR 95.00% 2.48 0.365 2.12 529.3016 1,056.59 1,057.60 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NLGTALAELR 95.00% 2.68 0.44 2.82 529.3016 1,056.59 1,057.60 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NLGTALAELR 95.00% 2.51 0.252 2.29 529.3017 1,056.59 1,057.60 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NLGTALAELR 95.00% 3.01 0.435 2.42 529.3021 1,056.59 1,057.60 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NLGTALAELR 95.00% 2.74 0.264 2.96 529.3026 1,056.59 1,057.60 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NLGTALAELR 95.00% 2.97 0.425 1.85 529.3032 1,056.59 1,057.60 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NLGTALAELR 95.00% 2.88 0.45 1.96 529.3033 1,056.59 1,057.60 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NLGTALAELR 95.00% 2.08 0.287 2.08 529.3033 1,056.59 1,057.60 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NLGTALAELR 95.00% 3.15 0.456 2.54 529.3034 1,056.59 1,057.60 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% TSTPEDFIR 95.00% 2.46 0.213 0 533.2631 1,064.51 1,065.52 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% TSTPEDFIR 95.00% 2.49 0.23 0 533.2636 1,064.51 1,065.52 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% TSTPEDFIR 95.00% 2.19 0.335 0 533.2643 1,064.51 1,065.52 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% TSTPEDFIR 95.00% 2.19 0.369 0 533.2658 1,064.52 1,065.52 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVASAAAALVLK 95.00% 2.97 0.357 4.72 542.837 1,083.66 1,084.67 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVASAAAALVLK 95.00% 3.72 0.375 3.06 542.8387 1,083.66 1,084.67 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVASAAAALVLK 95.00% 3.35 0.378 4.52 542.839 1,083.66 1,084.67 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVASAAAALVLK 95.00% 3.95 0.418 2.74 542.8391 1,083.66 1,084.67 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVASAAAALVLK 95.00% 3.89 0.451 3.6 542.8397 1,083.66 1,084.67 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AAMEPIVISAK 95.00% 2.64 0.33 0 565.3164 1,128.62 1,129.63 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AAMEPIVISAK 95.00% 2.66 0.408 2.06 565.317 1,128.62 1,129.63 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% EGTETFADHREGILK 95.00% 2.03 0.27 0 568.2839 1,701.83 1,702.84 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% TLSHPQQMALLDQTK 95.00% 4.44 0.347 1.85 570.9648 1,709.87 1,710.89 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% TLSHPQQMALLDQTK 95.00% 3.94 0.283 1.31 570.9655 1,709.87 1,710.89 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% TYGVSFFLVK 95.00% 2.71 0.421 2.8 580.82 1,159.62 1,160.64 2 MVP_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% RVAGSVTELIQAAEAMK 95.00% 2.58 0.329 0 592.3234 1,773.95 1,773.95 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DLDQASLAAVSQQLAPR 95.00% 2.88 0.415 0 594.9827 1,781.92 1,782.94 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DLDQASLAAVSQQLAPR 95.00% 4.06 0.541 3.24 594.9828 1,781.93 1,782.94 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DLDQASLAAVSQQLAPR 95.00% 4.13 0.463 1.96 595.317 1,782.93 1,782.94 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ALDGAFTEENR 95.00% 3.21 0.493 1.74 611.7874 1,221.56 1,222.57 2 BMP4_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ALDGAFTEENR 95.00% 3.1 0.372 1.6 611.7885 1,221.56 1,222.57 2 BMP4_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VGDDPAVWQLK 95.00% 3.62 0.454 3.92 614.3202 1,226.62 1,227.64 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VGDDPAVWQLK 95.00% 2.91 0.342 4.38 614.321 1,226.63 1,227.64 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VGDDPAVWQLK 95.00% 3.16 0.4 3.28 614.3215 1,226.63 1,227.64 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VGDDPAVWQLK 95.00% 3.51 0.413 3.36 614.3217 1,226.63 1,227.64 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VGDDPAVWQLK 95.00% 2.93 0.386 3 614.3218 1,226.63 1,227.64 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% FLPSELRDEH 95.00% 2.15 0.472 2.11 621.8078 1,241.60 1,242.61 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% FLPSELRDEH 95.00% 2.14 0.397 1.46 621.8091 1,241.60 1,242.61 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AIAVTVQEMVTK 95.00% 3.89 0.65 4.54 645.3625 1,288.71 1,289.71 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AIAVTVQEMVTK 95.00% 3.86 0.641 6.07 645.3628 1,288.71 1,289.71 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% QEDVIATANLSR 95.00% 2.54 0.196 0 658.8416 1,315.67 1,316.68 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% QEDVIATANLSR 95.00% 3.07 0.269 0 658.8432 1,315.67 1,316.68 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% QEDVIATANLSR 95.00% 3.45 0.366 2.28 658.8434 1,315.67 1,316.68 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% QAAASATQTIAAAQHAASTPK 95.00% 2.88 0.419 1.15 665.6794 1,994.01 1,995.03 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% QAAASATQTIAAAQHAASTPK 95.00% 4.1 0.47 2.51 665.6794 1,994.01 1,995.03 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% QAAASATQTIAAAQHAASTPK 95.00% 3.7 0.564 2.52 665.6801 1,994.02 1,995.03 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% QAAASATQTIAAAQHAASTPK 95.00% 3.45 0.462 0 666.0129 1,995.02 1,995.03 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% QAAASATQTIAAAQHAASTPK 95.00% 3.88 0.502 1.55 666.0134 1,995.02 1,995.03 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% QAAASATQTIAAAQHAASTPK 95.00% 4.05 0.517 1.48 666.0136 1,995.02 1,995.03 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VSHVLAALQAGNR 95.00% 3.59 0.509 3.11 668.3768 1,334.74 1,335.75 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VSHVLAALQAGNR 95.00% 4.05 0.52 3.4 668.3773 1,334.74 1,335.75 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LNEAAAGLNQAATELVQASR 95.00% 2.57 0.315 0 676.348 2,026.02 2,027.05 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LNEAAAGLNQAATELVQASR 95.00% 5.06 0.597 2.82 676.3547 2,026.04 2,027.05 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LNEAAAGLNQAATELVQASR 95.00% 5.14 0.505 2.04 676.6872 2,027.04 2,027.05 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DPPSWSVLAGHSR 95.00% 3.1 0.549 3.11 704.8501 1,407.68 1,408.70 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DPPSWSVLAGHSR 95.00% 2.63 0.42 2.59 704.8507 1,407.69 1,408.70 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LLAALLEDEGGSGRPLLQAAK 95.00% 4.64 0.531 4.4 708.0665 2,121.18 2,122.19 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LLAALLEDEGGSGRPLLQAAK 95.00% 4.72 0.577 3.7 708.3999 2,122.18 2,122.19 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LLAALLEDEGGSGRPLLQAAK 95.00% 5.14 0.502 3.89 708.4003 2,122.18 2,122.19 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LLAALLEDEGGSGRPLLQAAK 95.00% 5.54 0.577 6.11 708.4003 2,122.18 2,122.19 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LLAALLEDEGGSGRPLLQAAK 95.00% 4.87 0.574 4.07 708.4004 2,122.18 2,122.19 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LLAALLEDEGGSGRPLLQAAK 95.00% 4.06 0.483 4.96 708.4005 2,122.18 2,122.19 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LLAALLEDEGGSGRPLLQAAK 95.00% 5.06 0.577 4.72 708.4009 2,122.18 2,122.19 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LAQAAQSSVATITR 95.00% 3.81 0.592 5.28 708.893 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LAQAAQSSVATITR 95.00% 3.98 0.587 5.27 708.8932 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LAQAAQSSVATITR 95.00% 4.04 0.601 7.38 708.8933 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LAQAAQSSVATITR 95.00% 3.52 0.575 5.96 708.8946 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VLGEAMTGISQNAK 95.00% 3.9 0.556 2.08 709.8691 1,417.72 1,418.73 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VLGEAMTGISQNAK 95.00% 3.05 0.49 1.62 709.87 1,417.72 1,418.73 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VVAPTISSPVcQEQLVEAGR 95.00% 4.27 0.566 1.44 c11: Carbamidomethyl (+57.02) 714.3742 2,140.10 2,140.11 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VVAPTISSPVcQEQLVEAGR 95.00% 3.67 0.483 1.96 c11: Carbamidomethyl (+57.02) 714.3743 2,140.10 2,140.11 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% EAAYHPEVAPDVR 95.00% 2.61 0.333 2.36 727.356 1,452.70 1,453.71 2 DDX1_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% EAAYHPEVAPDVR 95.00% 2.82 0.462 2.18 727.3579 1,452.70 1,453.71 2 DDX1_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ASAGPQPLLVQScK 95.00% 3.53 0.52 5.36 c13: Carbamidomethyl (+57.02) 728.3861 1,454.76 1,455.76 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ASAGPQPLLVQScK 95.00% 3.07 0.532 0 c13: Carbamidomethyl (+57.02) 728.3867 1,454.76 1,455.76 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ASAGPQPLLVQScK 95.00% 3.46 0.527 3.23 c13: Carbamidomethyl (+57.02) 728.3871 1,454.76 1,455.76 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ILAQATSDLVNAIK 95.00% 2.28 0.153 2.49 728.92 1,455.82 1,456.84 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ILAQATSDLVNAIK 95.00% 4.86 0.574 5.42 728.9204 1,455.83 1,456.84 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ILAQATSDLVNAIK 95.00% 4.84 0.567 4.25 728.9211 1,455.83 1,456.84 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ILAQATSDLVNAIK 95.00% 4.77 0.59 4.89 728.9211 1,455.83 1,456.84 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ILAQATSDLVNAIK 95.00% 5.01 0.562 4.92 728.9213 1,455.83 1,456.84 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ILAQATSDLVNAIK 95.00% 4.95 0.58 4.7 728.9221 1,455.83 1,456.84 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ILAQATSDLVNAIK 95.00% 3.85 0.184 3.21 728.9234 1,455.83 1,456.84 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% ILAQATSDLVNAIK 95.00% 3.38 0 1.54 729.3493 1,456.68 1,456.84 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VQELGHGcAALVTK 95.00% 4.14 0.482 4.96 c8: Carbamidomethyl (+57.02) 741.8881 1,481.76 1,482.77 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VQELGHGcAALVTK 95.00% 3.91 0.459 5.41 c8: Carbamidomethyl (+57.02) 741.8901 1,481.76 1,482.77 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LASEAKPAAVAAENEEIGSHIK 95.00% 6.84 0.553 4 746.0593 2,235.15 2,235.16 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LASEAKPAAVAAENEEIGSHIK 95.00% 6.87 0.57 3.62 746.0596 2,235.16 2,235.16 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 3.94 0.365 4.54 746.9437 1,491.87 1,492.89 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 3.66 0.301 5.33 746.9449 1,491.87 1,492.89 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 4.59 0.515 5.89 746.9457 1,491.88 1,492.89 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 4.41 0.526 5.74 746.946 1,491.88 1,492.89 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 4.28 0.487 5.43 746.9464 1,491.88 1,492.89 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 4.14 0.509 6.48 746.9466 1,491.88 1,492.89 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 4.21 0.475 5.33 746.9466 1,491.88 1,492.89 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 3.69 0.448 5.49 746.9468 1,491.88 1,492.89 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVAEQIPLLVQGVR 95.00% 3.36 0.407 3.47 746.9474 1,491.88 1,492.89 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% AVTDSINQLITMcTQQAPGQK 95.00% 2.68 0.398 0 c13: Carbamidomethyl (+57.02) 769.0492 2,304.12 2,304.13 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DKAPGQLEcETAIAALNScLR 95.00% 3.91 0.391 0 c9: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 773.3807 2,317.12 2,317.13 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DKAPGQLEcETAIAALNScLR 95.00% 3.83 0.362 0 c9: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 773.3813 2,317.12 2,317.13 3
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% QELAVFcSPEPPAK 95.00% 3.2 0.472 3.43 c7: Carbamidomethyl (+57.02) 786.887 1,571.76 1,572.77 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% QELAVFcSPEPPAK 95.00% 3.25 0.522 2.89 c7: Carbamidomethyl (+57.02) 786.891 1,571.77 1,572.77 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% QELAVFcSPEPPAK 95.00% 2.7 0.34 3.04 c7: Carbamidomethyl (+57.02) 787.3908 1,572.77 1,572.77 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VAGSVTELIQAAEAMK 95.00% 4.93 0.562 4.31 809.4302 1,616.84 1,617.85 2 IF4G3_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VAGSVTELIQAAEAMK 95.00% 3.85 0.244 2.1 809.4303 1,616.85 1,617.85 2 IF4G3_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VAGSVTELIQAAEAMK 95.00% 5.25 0.537 5.89 809.9294 1,617.84 1,617.85 2 IF4G3_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NGNLPEFGDAISTASK 95.00% 4.07 0.517 3.66 810.8954 1,619.78 1,620.79 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NGNLPEFGDAISTASK 95.00% 4.3 0.593 5.03 810.8968 1,619.78 1,620.79 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% NGNLPEFGDAISTASK 95.00% 3.03 0.39 1.4 810.8993 1,619.78 1,620.79 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DLDQASLAAVSQQLAPR 95.00% 2.62 0.218 2.85 891.9702 1,781.92 1,782.94 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DLDQASLAAVSQQLAPR 95.00% 2.61 0.229 4.3 891.9712 1,781.93 1,782.94 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% DLDQASLAAVSQQLAPR 95.00% 4.42 0.567 3.54 892.4702 1,782.92 1,782.94 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% EADESLNFEEQILEAAK 95.00% 6.08 0.492 7.13 968.4605 1,934.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% EADESLNFEEQILEAAK 95.00% 5.9 0.47 6.03 968.9608 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% EADESLNFEEQILEAAK 95.00% 6.04 0.501 6.52 968.9608 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% EADESLNFEEQILEAAK 95.00% 5.63 0.472 5.06 968.961 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% EADESLNFEEQILEAAK 95.00% 5.95 0.462 6.38 968.9618 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LNEAAAGLNQAATELVQASR 95.00% 5.82 0.647 8.77 1,014.03 2,026.04 2,027.05 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LNEAAAGLNQAATELVQASR 95.00% 6.41 0.616 10.9 1,014.53 2,027.03 2,027.05 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LNEAAAGLNQAATELVQASR 95.00% 5.21 0.512 7.38 1,014.53 2,027.04 2,027.05 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LNEAAAGLNQAATELVQASR 95.00% 6.59 0.599 9.52 1,014.53 2,027.04 2,027.05 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LLSDSLPPSTGTFQEAQSR 95.00% 3.49 0.573 2 1,017.51 2,033.00 2,034.01 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LLSDSLPPSTGTFQEAQSR 95.00% 4.81 0.613 2.48 1,018.01 2,034.01 2,034.01 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VVAPTISSPVcQEQLVEAGR 95.00% 5.6 0.625 9.09 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VVAPTISSPVcQEQLVEAGR 95.00% 5.67 0.608 6.85 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% LGAASLGAEDPETQVVLINAVK 95.00% 5.38 0.614 5.12 1,098.60 2,195.18 2,195.19 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VGAIPANALDDGQWSQGLISAAR 95.00% 5.56 0.666 5.37 1,156.09 2,310.17 2,310.18 2
 SAMPLE 1 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 40 47 159 22.90% VGAIPANALDDGQWSQGLISAAR 95.00% 6.08 0.687 7.48 1,156.09 2,310.17 2,310.18 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AGFLDLKDFLPK 95.00% 2.58 0.147 1.22 455.2592 1,362.75 1,363.76 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AGFLDLKDFLPK 95.00% 2.55 0.0963 1.27 455.2601 1,362.76 1,363.76 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AGFLDLKDFLPK 95.00% 3.1 0.169 1.17 455.2602 1,362.76 1,363.76 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AGFLDLKDFLPK 94.90% 2.19 0.175 0 455.2633 1,362.77 1,363.76 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DPPSWSVLAGHSR 95.00% 2.3 0.319 0 470.2364 1,407.69 1,408.70 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DPPSWSVLAGHSR 95.00% 2.66 0.348 0 470.2367 1,407.69 1,408.70 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DPPSWSVLAGHSR 95.00% 3.01 0.389 0 470.2378 1,407.69 1,408.70 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DPPSWSVLAGHSR 95.00% 3.77 0.496 1.1 470.2378 1,407.69 1,408.70 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DPPSWSVLAGHSR 95.00% 2.5 0.501 0 470.2381 1,407.69 1,408.70 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DPPSWSVLAGHSR 95.00% 4.08 0.555 0 470.239 1,407.69 1,408.70 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TMLESAGGLIQTAR 95.00% 3.18 0.335 1.8 483.2577 1,446.75 1,447.76 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% EAAYHPEVAPDVR 95.00% 1.77 0.272 0 485.2394 1,452.69 1,453.71 3 DDX1_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ALGDLISATK 95.00% 2.64 0.307 0 494.7862 987.5567 988.5681 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ALGDLISATK 95.00% 2.82 0.356 2.39 494.7864 987.5571 988.5681 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ALGDLISATK 95.00% 3.45 0.382 2.04 494.7866 987.5575 988.5681 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ALGDLISATK 95.00% 2.42 0.35 0 494.7867 987.5577 988.5681 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ALGDLISATK 95.00% 2.87 0.397 2.21 494.7869 987.5581 988.5681 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VQELGHGcAALVTK 95.00% 2.29 0.404 0 c8: Carbamidomethyl (+57.02) 494.9285 1,481.76 1,482.77 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VQELGHGcAALVTK 95.00% 2.08 0.364 0 c8: Carbamidomethyl (+57.02) 494.9293 1,481.76 1,482.77 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 4.3 0.406 2.66 498.2986 1,491.87 1,492.89 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 3.63 0.366 2.34 498.2986 1,491.87 1,492.89 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 4.03 0.412 2.24 498.2987 1,491.87 1,492.89 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 4.27 0.464 3.04 498.2989 1,491.87 1,492.89 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 3.75 0.408 2.08 498.2993 1,491.87 1,492.89 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 4.04 0.404 1.52 498.2999 1,491.88 1,492.89 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% IGITNHDEYSLVR 95.00% 2.68 0.443 0 506.5968 1,516.77 1,516.78 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% IGITNHDEYSLVR 95.00% 2.96 0.368 0 506.5984 1,516.77 1,516.78 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TLAESALQLLYTAK 95.00% 4.14 0.427 1.49 507.9527 1,520.83 1,521.85 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TLAESALQLLYTAK 95.00% 3.17 0.246 0 507.9546 1,520.84 1,521.85 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TLAESALQLLYTAK 95.00% 4.43 0.441 2.35 507.9549 1,520.84 1,521.85 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TLAESALQLLYTAK 95.00% 4.05 0.406 2.07 507.955 1,520.84 1,521.85 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TLAESALQLLYTAK 95.00% 3.75 0.381 1.4 507.9551 1,520.84 1,521.85 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TLAESALQLLYTAK 95.00% 4.72 0.464 3.82 507.9556 1,520.84 1,521.85 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ALDYYMLR 95.00% 2.3 0.335 0 522.7597 1,043.50 1,044.52 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ALDYYMLR 95.00% 2.3 0.388 0 522.7622 1,043.51 1,044.52 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ALDYYMLR 95.00% 2.3 0.275 0 522.7642 1,043.51 1,044.52 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ALDYYMLR 95.00% 2.23 0.341 0 523.2669 1,044.52 1,044.52 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% NLGTALAELR 95.00% 2.62 0.308 1.92 529.3003 1,056.59 1,057.60 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% NLGTALAELR 95.00% 2.34 0.231 1.7 529.3008 1,056.59 1,057.60 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% NLGTALAELR 95.00% 2.19 0.271 1.77 529.3017 1,056.59 1,057.60 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% NLGTALAELR 95.00% 2.41 0.396 2.08 529.3021 1,056.59 1,057.60 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% NLGTALAELR 95.00% 2.67 0.295 1.89 529.3026 1,056.59 1,057.60 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% NLGTALAELR 95.00% 2.89 0.447 2.11 529.3027 1,056.59 1,057.60 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% NLGTALAELR 95.00% 2.34 0.301 1.66 529.3028 1,056.59 1,057.60 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% NLGTALAELR 95.00% 2.89 0.428 1.68 529.3033 1,056.59 1,057.60 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TSTPEDFIR 95.00% 2.16 0.314 0 533.2626 1,064.51 1,065.52 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TSTPEDFIR 95.00% 2.12 0.244 0 533.2647 1,064.51 1,065.52 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VAGSVTELIQAAEAMK 95.00% 3.6 0.41 1.37 539.9551 1,616.84 1,617.85 3 IF4G3_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVASAAAALVLK 95.00% 3.5 0.41 3.39 542.8371 1,083.66 1,084.67 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVASAAAALVLK 95.00% 3.53 0.398 5.3 542.8388 1,083.66 1,084.67 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVASAAAALVLK 95.00% 3.45 0.376 4.26 542.8389 1,083.66 1,084.67 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVASAAAALVLK 95.00% 3.68 0.305 3.39 542.8393 1,083.66 1,084.67 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% GLAGAVSELLR 95.00% 3.15 0.269 1.12 543.3162 1,084.62 1,085.63 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% GLAGAVSELLR 95.00% 2.87 0.301 1.7 543.3172 1,084.62 1,085.63 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% GLAGAVSELLR 95.00% 3.59 0.365 2.04 543.3175 1,084.62 1,085.63 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% GLAGAVSELLR 95.00% 3.69 0.37 2.05 543.3181 1,084.62 1,085.63 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% EGTETFADHREGILK 95.00% 1.56 0.305 0 568.2828 1,701.82 1,702.84 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TLSHPQQMALLDQTK 95.00% 3.92 0.353 1.01 570.9652 1,709.87 1,710.89 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TLSHPQQMALLDQTK 95.00% 3.82 0.228 0 571.3005 1,710.88 1,710.89 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TYGVSFFLVK 95.00% 2.71 0.403 4.62 580.8194 1,159.62 1,160.64 2 MVP_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% TYGVSFFLVK 95.00% 2.73 0.393 2.48 580.8212 1,159.63 1,160.64 2 MVP_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% RVAGSVTELIQAAEAMK 95.00% 2.8 0.246 0 592.3233 1,773.95 1,773.95 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DLDQASLAAVSQQLAPR 95.00% 3.81 0.523 3.51 594.9807 1,781.92 1,782.94 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DLDQASLAAVSQQLAPR 95.00% 4.68 0.377 3.12 595.3166 1,782.93 1,782.94 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DLDQASLAAVSQQLAPR 95.00% 3.19 0.298 0 595.3184 1,782.93 1,782.94 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% MATNAAAQNAIK 95.00% 3.29 0.461 2.31 602.309 1,202.60 1,203.62 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% MATNAAAQNAIK 95.00% 3.44 0.481 2.46 602.8131 1,203.61 1,203.62 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VMVTNVTSLLK 95.00% 3.04 0.461 1.12 602.8495 1,203.68 1,204.70 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% MVGGIAQIIAAQEEMLR 95.00% 4.46 0.415 3.32 610.6575 1,828.95 1,829.96 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VGDDPAVWQLK 95.00% 3.54 0.462 3.7 614.3222 1,226.63 1,227.64 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VGDDPAVWQLK 95.00% 3.57 0.387 3.43 614.3225 1,226.63 1,227.64 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% FLPSELRDEH 95.00% 2.16 0.4 2.82 621.8089 1,241.60 1,242.61 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% FLPSELRDEH 95.00% 1.97 0.319 1.27 621.8091 1,241.60 1,242.61 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% QEDVIATANLSR 95.00% 3.29 0.325 1.74 658.8432 1,315.67 1,316.68 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% QEDVIATANLSR 95.00% 2.94 0.276 2 658.8434 1,315.67 1,316.68 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% QAAASATQTIAAAQHAASTPK 95.00% 4.29 0.567 3.03 665.679 1,994.01 1,995.03 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% QAAASATQTIAAAQHAASTPK 95.00% 3.42 0.503 1.7 666.014 1,995.02 1,995.03 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% QAAASATQTIAAAQHAASTPK 95.00% 2.68 0.36 1.05 666.0141 1,995.02 1,995.03 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% QAAASATQTIAAAQHAASTPK 95.00% 4.04 0.485 1.7 666.0145 1,995.02 1,995.03 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VSHVLAALQAGNR 95.00% 3.64 0.479 4.47 668.3773 1,334.74 1,335.75 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LNEAAAGLNQAATELVQASR 95.00% 5.02 0.503 3.04 676.6885 2,027.04 2,027.05 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LNEAAAGLNQAATELVQASR 95.00% 4.6 0.495 2.24 676.6891 2,027.04 2,027.05 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LNEAAAGLNQAATELVQASR 95.00% 5.21 0.496 3.85 676.6895 2,027.04 2,027.05 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DPPSWSVLAGHSR 95.00% 3.06 0.552 3 704.852 1,407.69 1,408.70 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LLAALLEDEGGSGRPLLQAAK 95.00% 4.14 0.563 5.37 708.0661 2,121.17 2,122.19 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LLAALLEDEGGSGRPLLQAAK 95.00% 4.99 0.568 4.39 708.3993 2,122.17 2,122.19 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LLAALLEDEGGSGRPLLQAAK 95.00% 4.69 0.489 3.66 708.3994 2,122.17 2,122.19 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LLAALLEDEGGSGRPLLQAAK 95.00% 5.25 0.531 3.31 708.4005 2,122.18 2,122.19 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LLAALLEDEGGSGRPLLQAAK 95.00% 5.14 0.568 4.72 708.4011 2,122.18 2,122.19 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LLAALLEDEGGSGRPLLQAAK 95.00% 5.2 0.557 4.6 708.402 2,122.18 2,122.19 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LAQAAQSSVATITR 95.00% 3.48 0.589 5.74 708.8924 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LAQAAQSSVATITR 95.00% 3.44 0.618 6.31 708.8932 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LAQAAQSSVATITR 95.00% 2.62 0.399 4.68 708.8965 1,415.78 1,416.78 2 LAMA5_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VLGEAMTGISQNAK 95.00% 3.41 0.475 2.05 709.8678 1,417.72 1,418.73 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VLGEAMTGISQNAK 95.00% 3.28 0.496 1.92 709.8695 1,417.72 1,418.73 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VVAPTISSPVcQEQLVEAGR 95.00% 3.94 0.509 3.28 c11: Carbamidomethyl (+57.02) 714.3741 2,140.10 2,140.11 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VVAPTISSPVcQEQLVEAGR 95.00% 3.65 0.548 1.92 c11: Carbamidomethyl (+57.02) 714.3752 2,140.10 2,140.11 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% EAAYHPEVAPDVR 95.00% 2.58 0.416 0 727.3559 1,452.70 1,453.71 2 DDX1_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% EAAYHPEVAPDVR 95.00% 2.26 0.306 1.32 727.3561 1,452.70 1,453.71 2 DDX1_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VSQMAQYFEPLTLAAVGAASK 95.00% 4.22 0.482 1.92 728.3788 2,182.11 2,182.12 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VSQMAQYFEPLTLAAVGAASK 95.00% 4.21 0.427 2.8 728.3795 2,182.11 2,182.12 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ASAGPQPLLVQScK 95.00% 3.23 0.55 3.38 c13: Carbamidomethyl (+57.02) 728.3834 1,454.75 1,455.76 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ASAGPQPLLVQScK 95.00% 3.04 0.562 2.74 c13: Carbamidomethyl (+57.02) 728.3841 1,454.75 1,455.76 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ILAQATSDLVNAIK 95.00% 4.44 0.569 4.2 728.9201 1,455.82 1,456.84 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ILAQATSDLVNAIK 95.00% 4.61 0.594 5.57 728.921 1,455.83 1,456.84 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ILAQATSDLVNAIK 95.00% 4.53 0.572 4.6 728.9212 1,455.83 1,456.84 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ILAQATSDLVNAIK 95.00% 4.92 0.577 4.72 728.9217 1,455.83 1,456.84 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ILAQATSDLVNAIK 95.00% 4.04 0.587 4.21 728.9219 1,455.83 1,456.84 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ILAQATSDLVNAIK 95.00% 4.39 0.604 6.36 728.9223 1,455.83 1,456.84 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ILAQATSDLVNAIK 95.00% 3.77 0.0589 2.85 729.3477 1,456.68 1,456.84 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ILAQATSDLVNAIK 95.00% 3.65 0.0361 2.7 729.3485 1,456.68 1,456.84 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% QVAASTAQLLVAcK 95.00% 2.53 0.387 3.92 c13: Carbamidomethyl (+57.02) 730.4029 1,458.79 1,459.79 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% QVAASTAQLLVAcK 95.00% 2.78 0.428 3.89 c13: Carbamidomethyl (+57.02) 730.403 1,458.79 1,459.79 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LGAASLGAEDPETQVVLINAVK 95.00% 3.82 0.384 1.52 732.4026 2,194.18 2,195.19 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LGAASLGAEDPETQVVLINAVK 95.00% 5.4 0.583 0 732.7357 2,195.18 2,195.19 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VQELGHGcAALVTK 95.00% 4.26 0.497 5.6 c8: Carbamidomethyl (+57.02) 741.8875 1,481.76 1,482.77 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LASEAKPAAVAAENEEIGSHIK 95.00% 4.21 0.456 1.44 746.0585 2,235.15 2,235.16 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LASEAKPAAVAAENEEIGSHIK 95.00% 6.49 0.567 3.32 746.0587 2,235.15 2,235.16 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 4.55 0.527 5.57 746.9459 1,491.88 1,492.89 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 4 0.466 3.82 746.9461 1,491.88 1,492.89 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 4.19 0.49 4.41 746.9461 1,491.88 1,492.89 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 4.43 0.507 6.19 746.9463 1,491.88 1,492.89 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 4.01 0.457 3.77 746.9466 1,491.88 1,492.89 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 2.86 0.219 2.96 746.9473 1,491.88 1,492.89 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 3.31 0.358 3.07 746.9474 1,491.88 1,492.89 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 4.11 0.446 5.6 747.4473 1,492.88 1,492.89 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% AVAEQIPLLVQGVR 95.00% 3.7 0.39 4.62 747.4491 1,492.88 1,492.89 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VGAIPANALDDGQWSQGLISAAR 95.00% 4.81 0.525 2.48 771.0663 2,310.18 2,310.18 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VGAIPANALDDGQWSQGLISAAR 95.00% 4.81 0.515 1.34 771.067 2,310.18 2,310.18 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DKAPGQLEcETAIAALNScLR 95.00% 4.2 0.418 0 c9: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 773.382 2,317.12 2,317.13 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% QELAVFcSPEPPAK 95.00% 2.82 0.37 1.92 c7: Carbamidomethyl (+57.02) 786.8874 1,571.76 1,572.77 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% QELAVFcSPEPPAK 95.00% 2.83 0.392 2.85 c7: Carbamidomethyl (+57.02) 786.8896 1,571.76 1,572.77 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VAGSVTELIQAAEAMK 95.00% 4.95 0.537 5.41 809.4279 1,616.84 1,617.85 2 IF4G3_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VAGSVTELIQAAEAMK 95.00% 5.41 0.546 5.1 809.4297 1,616.84 1,617.85 2 IF4G3_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VAGSVTELIQAAEAMK 95.00% 3.8 0.465 3.07 809.4304 1,616.85 1,617.85 2 IF4G3_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% NGNLPEFGDAISTASK 95.00% 4 0.593 2.21 810.8963 1,619.78 1,620.79 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% NGNLPEFGDAISTASK 95.00% 3.59 0.549 2.05 810.8967 1,619.78 1,620.79 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% MVAAATNNLcEAANAAVQGHASQEK 95.00% 4.3 0.481 1.85 c10: Carbamidomethyl (+57.02) 853.0689 2,556.18 2,556.19 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LGAASLGAEDPETQVVLINAVKDVAK 95.00% 3.06 0.499 0 870.4782 2,608.41 2,608.42 3
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DLDQASLAAVSQQLAPR 95.00% 2.56 0.236 1.36 891.9695 1,781.92 1,782.94 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% DLDQASLAAVSQQLAPR 95.00% 3.65 0.451 3.38 892.4706 1,782.93 1,782.94 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% EADESLNFEEQILEAAK 95.00% 5.81 0.477 4.96 968.4604 1,934.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% EADESLNFEEQILEAAK 95.00% 5.86 0.513 6.08 968.4622 1,934.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% EADESLNFEEQILEAAK 95.00% 5.39 0.444 5.05 968.9641 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LNEAAAGLNQAATELVQASR 95.00% 5.78 0.658 9.32 1,014.03 2,026.04 2,027.05 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LNEAAAGLNQAATELVQASR 95.00% 5.47 0.556 7.52 1,014.53 2,027.04 2,027.05 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LNEAAAGLNQAATELVQASR 95.00% 6.27 0.576 9.21 1,014.53 2,027.04 2,027.05 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LNEAAAGLNQAATELVQASR 95.00% 6.29 0.611 8.64 1,014.53 2,027.04 2,027.05 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LNEAAAGLNQAATELVQASR 95.00% 6.48 0.598 8.6 1,014.53 2,027.04 2,027.05 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LNEAAAGLNQAATELVQASR 95.00% 5.42 0.599 9.32 1,014.53 2,027.05 2,027.05 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% GVGAAATAVTQALNELLQHVK 95.00% 5.05 0.65 6.15 1,046.58 2,091.14 2,091.16 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% GVGAAATAVTQALNELLQHVK 95.00% 5.61 0.702 6.14 1,046.58 2,091.15 2,091.16 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% ASVPTIQDQASAMQLSQcAK 95.00% 5.2 0.585 5.68 c18: Carbamidomethyl (+57.02) 1,068.02 2,134.02 2,134.03 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VVAPTISSPVcQEQLVEAGR 95.00% 5.53 0.614 9.34 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.09 2,140.11 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VVAPTISSPVcQEQLVEAGR 95.00% 5 0.583 4.92 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VVAPTISSPVcQEQLVEAGR 95.00% 5.82 0.633 7.22 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% LGAASLGAEDPETQVVLINAVK 95.00% 5.61 0.601 5.8 1,098.60 2,195.18 2,195.19 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% SNTSPEELGPLANQLTSDYGR 95.00% 4.77 0.621 6.15 1,125.54 2,249.06 2,249.07 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% SNTSPEELGPLANQLTSDYGR 95.00% 4.54 0.576 4.7 1,125.54 2,249.06 2,249.07 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VGAIPANALDDGQWSQGLISAAR 95.00% 5.3 0.682 6.66 1,156.10 2,310.17 2,310.18 2
 SAMPLE 1R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 59 161 28.60% VGAIPANALDDGQWSQGLISAAR 95.00% 5.76 0.716 6.43 1,156.10 2,310.18 2,310.18 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% DPPSWSVLAGHSR 95.00% 2.04 0.309 1.14 470.2367 1,407.69 1,408.70 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% DPPSWSVLAGHSR 95.00% 3.46 0.559 1.77 470.2374 1,407.69 1,408.70 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% DPPSWSVLAGHSR 95.00% 3 0.506 0 470.2384 1,407.69 1,408.70 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% DPPSWSVLAGHSR 95.00% 3.02 0.425 0.921 470.5711 1,408.69 1,408.70 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% TMLESAGGLIQTAR 95.00% 3.06 0.339 1 483.591 1,447.75 1,447.76 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% EAAYHPEVAPDVR 95.00% 1.91 0.27 0 485.2399 1,452.70 1,453.71 3 DDX1_HUMAN
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% EAAYHPEVAPDVR 95.00% 1.95 0.259 0 485.5751 1,453.70 1,453.71 3 DDX1_HUMAN
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% QVAASTAQLLVAcK 95.00% 2.96 0.344 0 c13: Carbamidomethyl (+57.02) 487.2694 1,458.78 1,459.79 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ALGDLISATK 95.00% 2.25 0.373 0 494.786 987.5564 988.5681 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ALGDLISATK 95.00% 2.84 0.41 1.85 494.7862 987.5568 988.5681 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ALGDLISATK 95.00% 3.34 0.378 1.96 494.7863 987.557 988.5681 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ALGDLISATK 95.00% 2.74 0.372 2.09 494.7863 987.557 988.5681 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ALGDLISATK 95.00% 3.4 0.389 1.92 494.7865 987.5574 988.5681 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ALGDLISATK 95.00% 3.2 0.391 1.82 494.787 987.5584 988.5681 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VQELGHGcAALVTK 95.00% 2.1 0.256 0 c8: Carbamidomethyl (+57.02) 494.9279 1,481.76 1,482.77 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VQELGHGcAALVTK 95.00% 2.37 0.402 0 c8: Carbamidomethyl (+57.02) 494.9281 1,481.76 1,482.77 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VQELGHGcAALVTK 95.00% 2.12 0.307 0 c8: Carbamidomethyl (+57.02) 494.9285 1,481.76 1,482.77 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VQELGHGcAALVTK 95.00% 1.95 0.346 0 c8: Carbamidomethyl (+57.02) 494.9288 1,481.76 1,482.77 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VQELGHGcAALVTK 95.00% 2.2 0.23 0 c8: Carbamidomethyl (+57.02) 495.2622 1,482.76 1,482.77 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVAEQIPLLVQGVR 95.00% 4.38 0.389 2.24 498.2992 1,491.87 1,492.89 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVAEQIPLLVQGVR 95.00% 4.07 0.53 2.32 498.2995 1,491.88 1,492.89 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVAEQIPLLVQGVR 95.00% 4.12 0.431 0 498.3 1,491.88 1,492.89 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVAEQIPLLVQGVR 95.00% 4.4 0.354 1.96 498.6326 1,492.87 1,492.89 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% IGITNHDEYSLVR 95.00% 3.58 0.509 1.96 506.2621 1,515.76 1,516.78 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% IGITNHDEYSLVR 95.00% 3.91 0.474 1.18 506.2626 1,515.76 1,516.78 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% IGITNHDEYSLVR 95.00% 2.88 0.383 0 506.5974 1,516.77 1,516.78 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ALDYYMLR 95.00% 2.71 0.349 0 522.7623 1,043.51 1,044.52 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ALDYYMLR 95.00% 1.78 0.294 0 522.7625 1,043.51 1,044.52 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% NLGTALAELR 95.00% 2.06 0.238 1.49 529.3013 1,056.59 1,057.60 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% NLGTALAELR 95.00% 2.81 0.41 1.96 529.3029 1,056.59 1,057.60 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% NLGTALAELR 95.00% 2.64 0.429 3.24 529.3029 1,056.59 1,057.60 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% NLGTALAELR 95.00% 1.75 0.312 0 529.303 1,056.59 1,057.60 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% NLGTALAELR 95.00% 2.2 0.376 1.44 529.3032 1,056.59 1,057.60 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% NLGTALAELR 95.00% 2.39 0.387 1.3 529.3033 1,056.59 1,057.60 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% NLGTALAELR 95.00% 2.6 0.426 1.41 529.3034 1,056.59 1,057.60 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% NLGTALAELR 95.00% 2.99 0.431 2.46 529.3037 1,056.59 1,057.60 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% NLGTALAELR 95.00% 2.54 0.262 0 529.3054 1,056.60 1,057.60 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% TSTPEDFIR 95.00% 2 0.409 0 533.263 1,064.51 1,065.52 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% TSTPEDFIR 95.00% 1.98 0.353 0 533.2632 1,064.51 1,065.52 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVASAAAALVLK 95.00% 3.59 0.437 2.19 542.8387 1,083.66 1,084.67 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVASAAAALVLK 95.00% 3.3 0.461 2.8 542.8388 1,083.66 1,084.67 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVASAAAALVLK 95.00% 3.6 0.411 3.08 542.8388 1,083.66 1,084.67 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVASAAAALVLK 95.00% 2.95 0.347 3.08 542.8389 1,083.66 1,084.67 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVASAAAALVLK 95.00% 3.64 0.425 2.82 542.839 1,083.66 1,084.67 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVASAAAALVLK 95.00% 3.1 0.363 2.89 542.8391 1,083.66 1,084.67 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVASAAAALVLK 95.00% 3.54 0.41 2.51 542.8393 1,083.66 1,084.67 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVASAAAALVLK 95.00% 3.7 0.455 3.34 542.8396 1,083.66 1,084.67 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVASAAAALVLK 95.00% 2.67 0.348 2.96 542.8402 1,083.66 1,084.67 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% EVIQEWNLTNIKR 95.00% 2.01 0.319 0 548.3019 1,641.88 1,642.89 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LHTDDELNWLDHGR 95.00% 3.12 0.149 0 574.2704 1,719.79 1,720.80 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% MATNAAAQNAIK 95.00% 2.34 0.37 0 602.3098 1,202.60 1,203.62 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VGDDPAVWQLK 95.00% 2.64 0.0816 3.42 613.8302 1,225.64 1,227.64 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VGDDPAVWQLK 95.00% 3.15 0.362 3.55 614.3208 1,226.63 1,227.64 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VGDDPAVWQLK 95.00% 2.93 0.384 2.66 614.3212 1,226.63 1,227.64 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VGDDPAVWQLK 95.00% 3.37 0.344 4.26 614.322 1,226.63 1,227.64 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VGDDPAVWQLK 95.00% 2.91 0.318 3 614.3224 1,226.63 1,227.64 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% FLPSELRDEH 95.00% 2.23 0.411 1.92 621.8086 1,241.60 1,242.61 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% FLPSELRDEH 95.00% 2.09 0.415 1.92 621.8097 1,241.60 1,242.61 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AIAVTVQEMVTK 95.00% 0 0 4.05 646.3308 1,290.65 1,289.71 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% QEDVIATANLSR 95.00% 3.01 0.308 1.25 658.8428 1,315.67 1,316.68 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% QEDVIATANLSR 95.00% 3.45 0.399 2.19 658.8437 1,315.67 1,316.68 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% QAAASATQTIAAAQHAASTPK 95.00% 2.8 0.393 0 665.679 1,994.01 1,995.03 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% QAAASATQTIAAAQHAASTPK 95.00% 3.87 0.462 1.33 666.0137 1,995.02 1,995.03 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VSHVLAALQAGNR 95.00% 3.83 0.51 3.41 668.3766 1,334.74 1,335.75 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LNEAAAGLNQAATELVQASR 95.00% 2.7 0.332 0 676.3551 2,026.04 2,027.05 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LNEAAAGLNQAATELVQASR 95.00% 4.1 0.477 3.96 676.3551 2,026.04 2,027.05 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LNEAAAGLNQAATELVQASR 95.00% 2.97 0.259 0 676.6884 2,027.04 2,027.05 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% DPPSWSVLAGHSR 95.00% 3.49 0.607 3.46 704.8504 1,407.69 1,408.70 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% DPPSWSVLAGHSR 95.00% 3.71 0.608 3.74 704.8521 1,407.69 1,408.70 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LLAALLEDEGGSGRPLLQAAK 95.00% 5.36 0.567 4.54 708.4006 2,122.18 2,122.19 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LLAALLEDEGGSGRPLLQAAK 95.00% 5.03 0.564 4.82 708.4017 2,122.18 2,122.19 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LLAALLEDEGGSGRPLLQAAK 95.00% 5.26 0.546 4.2 708.4029 2,122.19 2,122.19 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LAQAAQSSVATITR 95.00% 4.21 0.633 5.19 708.8919 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LAQAAQSSVATITR 95.00% 4.71 0.637 5.48 708.8932 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LAQAAQSSVATITR 95.00% 2.85 0.526 7.03 708.8935 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LAQAAQSSVATITR 95.00% 4.04 0.619 5.12 708.8935 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LAQAAQSSVATITR 95.00% 4.64 0.659 5.38 708.8935 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LAQAAQSSVATITR 95.00% 3.05 0.54 5.68 708.8943 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LAQAAQSSVATITR 95.00% 4 0.588 6.35 709.3941 1,416.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VLGEAMTGISQNAK 95.00% 3.99 0.557 3 709.8693 1,417.72 1,418.73 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VLGEAMTGISQNAK 95.00% 3.96 0.611 2.37 709.8694 1,417.72 1,418.73 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VVAPTISSPVcQEQLVEAGR 95.00% 3.18 0.351 1.59 c11: Carbamidomethyl (+57.02) 714.0413 2,139.10 2,140.11 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VVAPTISSPVcQEQLVEAGR 95.00% 4.93 0.572 2.43 c11: Carbamidomethyl (+57.02) 714.3734 2,140.10 2,140.11 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ASAGPQPLLVQScK 95.00% 3.6 0.491 4.09 c13: Carbamidomethyl (+57.02) 728.3846 1,454.75 1,455.76 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ASAGPQPLLVQScK 95.00% 3.68 0.496 4.72 c13: Carbamidomethyl (+57.02) 728.3855 1,454.76 1,455.76 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ASAGPQPLLVQScK 95.00% 3.09 0.53 3.85 c13: Carbamidomethyl (+57.02) 728.3857 1,454.76 1,455.76 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ASAGPQPLLVQScK 95.00% 3.38 0.567 3.8 c13: Carbamidomethyl (+57.02) 728.8859 1,455.76 1,455.76 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ILAQATSDLVNAIK 95.00% 4.73 0.554 5.92 728.9201 1,455.82 1,456.84 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ILAQATSDLVNAIK 95.00% 4.74 0.576 5.42 728.9218 1,455.83 1,456.84 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ILAQATSDLVNAIK 95.00% 4.7 0.588 5.8 728.9228 1,455.83 1,456.84 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ILAQATSDLVNAIK 95.00% 4.5 0.558 4.17 728.9234 1,455.83 1,456.84 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ILAQATSDLVNAIK 95.00% 5.01 0.592 5.72 728.9237 1,455.83 1,456.84 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% QVAASTAQLLVAcK 95.00% 3.27 0.587 3.57 c13: Carbamidomethyl (+57.02) 730.4006 1,458.79 1,459.79 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% QVAASTAQLLVAcK 95.00% 3.01 0.551 3.14 c13: Carbamidomethyl (+57.02) 730.4024 1,458.79 1,459.79 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% QVAASTAQLLVAcK 95.00% 2.98 0.398 2.31 c13: Carbamidomethyl (+57.02) 730.899 1,459.78 1,459.79 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VQELGHGcAALVTK 95.00% 4.63 0.488 6.96 c8: Carbamidomethyl (+57.02) 741.8896 1,481.76 1,482.77 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VQELGHGcAALVTK 95.00% 2.72 0.404 1.39 c8: Carbamidomethyl (+57.02) 741.89 1,481.76 1,482.77 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VQELGHGcAALVTK 95.00% 4.24 0.446 4.77 c8: Carbamidomethyl (+57.02) 742.3903 1,482.77 1,482.77 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LASEAKPAAVAAENEEIGSHIK 95.00% 6.74 0.585 3.21 745.7253 2,234.15 2,235.16 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LASEAKPAAVAAENEEIGSHIK 95.00% 7.18 0.595 4.05 746.0589 2,235.15 2,235.16 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LASEAKPAAVAAENEEIGSHIK 95.00% 6.06 0.599 2.92 746.06 2,235.16 2,235.16 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVAEQIPLLVQGVR 95.00% 4.28 0.53 6.77 746.9455 1,491.88 1,492.89 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVAEQIPLLVQGVR 95.00% 4.25 0.505 7.74 746.9457 1,491.88 1,492.89 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVAEQIPLLVQGVR 95.00% 3.14 0.425 2.42 746.946 1,491.88 1,492.89 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVAEQIPLLVQGVR 95.00% 4.72 0.528 6.77 746.947 1,491.88 1,492.89 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% AVAEQIPLLVQGVR 95.00% 4.25 0.483 5.47 746.9477 1,491.88 1,492.89 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% QELAVFcSPEPPAK 95.00% 3.89 0.402 2.72 c7: Carbamidomethyl (+57.02) 787.3912 1,572.77 1,572.77 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% NGNLPEFGDAISTASK 95.00% 4.56 0.575 2.74 810.8975 1,619.78 1,620.79 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% NGNLPEFGDAISTASK 95.00% 4.43 0.517 1.68 811.399 1,620.78 1,620.79 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% MVAAATNNLcEAANAAVQGHASQEK 95.00% 3.99 0.485 3.28 c10: Carbamidomethyl (+57.02) 853.069 2,556.18 2,556.19 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% MVAAATNNLcEAANAAVQGHASQEK 95.00% 4.71 0.536 2.85 c10: Carbamidomethyl (+57.02) 853.0698 2,556.19 2,556.19 3
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% EADESLNFEEQILEAAK 95.00% 5.43 0.528 5.74 968.4615 1,934.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% EADESLNFEEQILEAAK 95.00% 5.4 0.448 5.28 968.9634 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% EADESLNFEEQILEAAK 95.00% 5.08 0.411 3.6 968.9645 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LNEAAAGLNQAATELVQASR 95.00% 6.51 0.62 10 1,014.03 2,026.04 2,027.05 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LNEAAAGLNQAATELVQASR 95.00% 6.41 0.59 9.85 1,014.53 2,027.04 2,027.05 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LLSDSLPPSTGTFQEAQSR 95.00% 3.72 0.609 3.68 1,017.51 2,033.01 2,034.01 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% LLSDSLPPSTGTFQEAQSR 95.00% 4.42 0.609 5.37 1,018.01 2,034.01 2,034.01 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ASVPTIQDQASAMQLSQcAK 95.00% 6.39 0.659 6.52 c18: Carbamidomethyl (+57.02) 1,068.01 2,134.01 2,134.03 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% ASVPTIQDQASAMQLSQcAK 95.00% 6.1 0.649 7.6 c18: Carbamidomethyl (+57.02) 1,068.02 2,134.01 2,134.03 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VVAPTISSPVcQEQLVEAGR 95.00% 5.42 0.61 6.82 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 2 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 35 41 122 20.10% VVAPTISSPVcQEQLVEAGR 95.00% 5.6 0.61 6.62 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AGFLDLKDFLPK 95.00% 2.82 0.218 1.11 455.2598 1,362.76 1,363.76 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AGFLDLKDFLPK 95.00% 2.81 0.288 1.19 455.2609 1,362.76 1,363.76 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AGFLDLKDFLPK 95.00% 2.82 0.184 0 455.5932 1,363.76 1,363.76 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% DPPSWSVLAGHSR 95.00% 3.14 0.547 1.64 470.237 1,407.69 1,408.70 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% DPPSWSVLAGHSR 95.00% 3.27 0.458 2.21 470.2372 1,407.69 1,408.70 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% DPPSWSVLAGHSR 95.00% 3.04 0.501 1.77 470.2374 1,407.69 1,408.70 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% DPPSWSVLAGHSR 95.00% 1.84 0.374 0 470.2379 1,407.69 1,408.70 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% DPPSWSVLAGHSR 95.00% 2.11 0.323 0 470.2385 1,407.69 1,408.70 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% DPPSWSVLAGHSR 95.00% 2.82 0.36 0 470.5709 1,408.69 1,408.70 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% TMLESAGGLIQTAR 95.00% 3.1 0.284 1.89 483.5909 1,447.75 1,447.76 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% EAAYHPEVAPDVR 95.00% 1.85 0.298 0 485.2425 1,452.70 1,453.71 3 DDX1_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ALGDLISATK 95.00% 3.36 0.366 1.82 494.7863 987.5569 988.5681 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ALGDLISATK 95.00% 3.48 0.371 2.32 494.7866 987.5575 988.5681 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VQELGHGcAALVTK 95.00% 1.99 0.31 0 c8: Carbamidomethyl (+57.02) 494.9281 1,481.76 1,482.77 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VQELGHGcAALVTK 95.00% 2.1 0.324 0 c8: Carbamidomethyl (+57.02) 494.9287 1,481.76 1,482.77 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VQELGHGcAALVTK 95.00% 2.1 0.257 0 c8: Carbamidomethyl (+57.02) 495.2632 1,482.77 1,482.77 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVAEQIPLLVQGVR 95.00% 4.13 0.458 1.82 498.2991 1,491.87 1,492.89 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVAEQIPLLVQGVR 95.00% 3.56 0.434 0 498.2992 1,491.87 1,492.89 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVAEQIPLLVQGVR 95.00% 3.41 0.311 0 498.2994 1,491.87 1,492.89 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVAEQIPLLVQGVR 95.00% 4.25 0.429 2.29 498.2996 1,491.88 1,492.89 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVAEQIPLLVQGVR 95.00% 2.78 0.208 0 498.6335 1,492.88 1,492.89 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% IGITNHDEYSLVR 95.00% 3.01 0.404 0 506.261 1,515.76 1,516.78 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% IGITNHDEYSLVR 95.00% 3.29 0.385 0 506.262 1,515.76 1,516.78 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% IGITNHDEYSLVR 95.00% 4.18 0.493 0 506.2623 1,515.76 1,516.78 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% TLAESALQLLYTAK 95.00% 2.97 0.3 0 507.9548 1,520.84 1,521.85 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% TLAESALQLLYTAK 95.00% 3.38 0.474 2.54 508.2892 1,521.84 1,521.85 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ALDYYMLR 95.00% 2.51 0.295 0 522.7618 1,043.51 1,044.52 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ALDYYMLR 95.00% 2.92 0.421 0 522.7621 1,043.51 1,044.52 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% NLGTALAELR 95.00% 2.08 0.351 1.92 529.3023 1,056.59 1,057.60 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% NLGTALAELR 95.00% 3.02 0.428 1.92 529.3029 1,056.59 1,057.60 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% NLGTALAELR 95.00% 2.62 0.334 1.92 529.3032 1,056.59 1,057.60 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% NLGTALAELR 95.00% 2.28 0.336 2 529.3033 1,056.59 1,057.60 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% NLGTALAELR 95.00% 2.65 0.39 2.07 529.3033 1,056.59 1,057.60 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% NLGTALAELR 95.00% 3.07 0.427 1.62 529.3036 1,056.59 1,057.60 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% NLGTALAELR 95.00% 2.24 0.289 1.82 529.3044 1,056.59 1,057.60 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VAGSVTELIQAAEAMK 95.00% 4.04 0.265 2.11 540.2889 1,617.84 1,617.85 3 IF4G3_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVASAAAALVLK 95.00% 2.62 0.383 3.01 542.8379 1,083.66 1,084.67 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVASAAAALVLK 95.00% 3.39 0.383 3.96 542.8387 1,083.66 1,084.67 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVASAAAALVLK 95.00% 3.8 0.448 3.34 542.8387 1,083.66 1,084.67 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVASAAAALVLK 95.00% 2.89 0.356 3.72 542.8389 1,083.66 1,084.67 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVASAAAALVLK 95.00% 3.65 0.404 3.08 542.839 1,083.66 1,084.67 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVASAAAALVLK 95.00% 3.47 0.407 3.96 542.839 1,083.66 1,084.67 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVASAAAALVLK 95.00% 1.91 0.208 2.4 542.8393 1,083.66 1,084.67 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVASAAAALVLK 95.00% 3.3 0.373 3.8 542.8393 1,083.66 1,084.67 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVASAAAALVLK 95.00% 3.77 0.46 4.4 542.8404 1,083.67 1,084.67 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVASAAAALVLK 95.00% 2.89 0.402 2.89 542.8409 1,083.67 1,084.67 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% GLAGAVSELLR 95.00% 3.73 0.376 1.72 543.3191 1,084.62 1,085.63 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% GLAGAVSELLR 95.00% 3.74 0.362 1.64 543.3192 1,084.62 1,085.63 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% EGTETFADHREGILK 95.00% 1.99 0.217 0 568.285 1,701.83 1,702.84 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% EGTETFADHREGILK 95.00% 1.73 0.305 0 568.6181 1,702.83 1,702.84 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LHTDDELNWLDHGR 95.00% 2.55 0.274 0 574.6043 1,720.79 1,720.80 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% DLDQASLAAVSQQLAPR 95.00% 3.45 0.402 1.96 594.9827 1,781.92 1,782.94 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% DLDQASLAAVSQQLAPR 95.00% 2.77 0.318 0 594.9843 1,781.93 1,782.94 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ALSTDPAAPNLK 95.00% 2.95 0.411 3.72 599.3269 1,196.64 1,197.65 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ALSTDPAAPNLK 95.00% 2.87 0.444 3.37 599.3278 1,196.64 1,197.65 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% FLPSELRDEH 95.00% 2.03 0.454 2.44 621.8091 1,241.60 1,242.61 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VLVQNAAGSQEK 95.00% 2.49 0.515 0 622.3333 1,242.65 1,243.66 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% QEDVIATANLSR 95.00% 2.73 0.183 0 658.8427 1,315.67 1,316.68 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% QEDVIATANLSR 95.00% 3.09 0.111 1.74 658.8435 1,315.67 1,316.68 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% QAAASATQTIAAAQHAASTPK 95.00% 2.97 0.405 1.25 665.6794 1,994.01 1,995.03 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% QAAASATQTIAAAQHAASTPK 95.00% 3.19 0.498 1.51 665.6797 1,994.02 1,995.03 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VSHVLAALQAGNR 95.00% 4.07 0.498 3.32 668.3765 1,334.74 1,335.75 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VSHVLAALQAGNR 95.00% 4.06 0.541 3.89 668.3776 1,334.74 1,335.75 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LNEAAAGLNQAATELVQASR 95.00% 2.8 0.271 0 676.3551 2,026.04 2,027.05 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LNEAAAGLNQAATELVQASR 95.00% 3.57 0.311 0 676.3558 2,026.04 2,027.05 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LNEAAAGLNQAATELVQASR 95.00% 2.99 0.29 0 676.6895 2,027.04 2,027.05 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% GVGAAATAVTQALNELLQHVK 95.00% 4.95 0.586 4.02 697.7227 2,090.14 2,091.16 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% GVGAAATAVTQALNELLQHVK 95.00% 4.69 0.604 3.64 698.0574 2,091.15 2,091.16 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LLAALLEDEGGSGRPLLQAAK 95.00% 3.3 0.366 0 708.0677 2,121.18 2,122.19 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LLAALLEDEGGSGRPLLQAAK 95.00% 4.89 0.532 3.96 708.0687 2,121.18 2,122.19 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LLAALLEDEGGSGRPLLQAAK 95.00% 4.46 0.461 3.72 708.3983 2,122.17 2,122.19 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LLAALLEDEGGSGRPLLQAAK 95.00% 3.58 0.326 3.15 708.3994 2,122.17 2,122.19 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LLAALLEDEGGSGRPLLQAAK 95.00% 5.19 0.548 4.16 708.4008 2,122.18 2,122.19 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LLAALLEDEGGSGRPLLQAAK 95.00% 4.71 0.53 3.47 708.4009 2,122.18 2,122.19 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LLAALLEDEGGSGRPLLQAAK 95.00% 4.74 0.59 3.82 708.4011 2,122.18 2,122.19 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LAQAAQSSVATITR 95.00% 2.6 0.533 5.17 708.8923 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LAQAAQSSVATITR 95.00% 4.37 0.627 5.85 708.8931 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LAQAAQSSVATITR 95.00% 2.59 0.435 5.4 708.8931 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LAQAAQSSVATITR 95.00% 3.53 0.55 5.07 708.8935 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LAQAAQSSVATITR 95.00% 4.69 0.657 5.41 708.8936 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LAQAAQSSVATITR 95.00% 3.08 0.535 6.21 708.8939 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VLGEAMTGISQNAK 95.00% 3.68 0.572 3.52 709.8692 1,417.72 1,418.73 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VLGEAMTGISQNAK 95.00% 4.32 0.535 3.34 709.8693 1,417.72 1,418.73 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VVAPTISSPVcQEQLVEAGR 95.00% 3.13 0.457 0 c11: Carbamidomethyl (+57.02) 714.04 2,139.10 2,140.11 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VVAPTISSPVcQEQLVEAGR 95.00% 3.88 0.495 0 c11: Carbamidomethyl (+57.02) 714.3765 2,140.11 2,140.11 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% EAAYHPEVAPDVR 95.00% 2.58 0.391 2.52 727.3574 1,452.70 1,453.71 2 DDX1_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% EAAYHPEVAPDVR 95.00% 2.8 0.406 2.32 727.8581 1,453.70 1,453.71 2 DDX1_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ASAGPQPLLVQScK 95.00% 3.49 0.569 4.64 c13: Carbamidomethyl (+57.02) 728.3838 1,454.75 1,455.76 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ASAGPQPLLVQScK 95.00% 2.49 0.537 0 c13: Carbamidomethyl (+57.02) 728.3854 1,454.76 1,455.76 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ASAGPQPLLVQScK 95.00% 3.61 0.498 5.54 c13: Carbamidomethyl (+57.02) 728.3861 1,454.76 1,455.76 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ASAGPQPLLVQScK 95.00% 3.05 0.548 1.92 c13: Carbamidomethyl (+57.02) 728.3867 1,454.76 1,455.76 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ILAQATSDLVNAIK 95.00% 4.55 0.594 5.07 728.9212 1,455.83 1,456.84 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ILAQATSDLVNAIK 95.00% 2.94 0.405 3.26 728.9214 1,455.83 1,456.84 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ILAQATSDLVNAIK 95.00% 3.81 0.549 3.28 728.922 1,455.83 1,456.84 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ILAQATSDLVNAIK 95.00% 4.96 0.583 4.8 728.9226 1,455.83 1,456.84 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ILAQATSDLVNAIK 95.00% 4.73 0.556 5.17 728.9226 1,455.83 1,456.84 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ILAQATSDLVNAIK 95.00% 4.96 0.593 4.33 728.9238 1,455.83 1,456.84 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% QVAASTAQLLVAcK 95.00% 4.17 0.618 4.8 c13: Carbamidomethyl (+57.02) 730.3997 1,458.78 1,459.79 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% QVAASTAQLLVAcK 95.00% 2.25 0.318 0 c13: Carbamidomethyl (+57.02) 730.4 1,458.78 1,459.79 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% QVAASTAQLLVAcK 95.00% 3.96 0.626 4.82 c13: Carbamidomethyl (+57.02) 730.4002 1,458.78 1,459.79 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VQELGHGcAALVTK 95.00% 4.38 0.441 5.15 c8: Carbamidomethyl (+57.02) 741.8899 1,481.76 1,482.77 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VQELGHGcAALVTK 95.00% 4.4 0.453 6.43 c8: Carbamidomethyl (+57.02) 741.8901 1,481.76 1,482.77 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VQELGHGcAALVTK 95.00% 3.1 0.527 6.28 c8: Carbamidomethyl (+57.02) 741.8902 1,481.76 1,482.77 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LASEAKPAAVAAENEEIGSHIK 95.00% 5.75 0.525 3.16 746.0588 2,235.15 2,235.16 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LASEAKPAAVAAENEEIGSHIK 95.00% 6.76 0.586 3.82 746.0591 2,235.15 2,235.16 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVAEQIPLLVQGVR 95.00% 3.92 0.527 4.51 746.9441 1,491.87 1,492.89 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVAEQIPLLVQGVR 95.00% 3.51 0.476 2.31 746.9447 1,491.87 1,492.89 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVAEQIPLLVQGVR 95.00% 2.93 0.456 2.7 746.9457 1,491.88 1,492.89 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVAEQIPLLVQGVR 95.00% 4.13 0.514 2 746.9458 1,491.88 1,492.89 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVAEQIPLLVQGVR 95.00% 4.57 0.524 7.19 746.9461 1,491.88 1,492.89 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% AVAEQIPLLVQGVR 95.00% 4.46 0.529 5.52 746.9463 1,491.88 1,492.89 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% TLAESALQLLYTAK 95.00% 4.5 0.594 8.46 761.4297 1,520.84 1,521.85 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% TLAESALQLLYTAK 95.00% 4.44 0.597 5.37 761.4306 1,520.85 1,521.85 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% TLAESALQLLYTAK 95.00% 2.72 0 2.17 761.899 1,521.78 1,521.85 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% QELAVFcSPEPPAK 95.00% 3.33 0.379 2.89 c7: Carbamidomethyl (+57.02) 786.8897 1,571.76 1,572.77 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% QELAVFcSPEPPAK 95.00% 2.48 0.258 0 c7: Carbamidomethyl (+57.02) 787.0431 1,572.07 1,572.77 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% QELAVFcSPEPPAK 95.00% 3.22 0.336 0 c7: Carbamidomethyl (+57.02) 787.3897 1,572.76 1,572.77 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VAGSVTELIQAAEAMK 95.00% 4.57 0.564 5 809.4283 1,616.84 1,617.85 2 IF4G3_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VAGSVTELIQAAEAMK 95.00% 2.5 0.263 0 809.4294 1,616.84 1,617.85 2 IF4G3_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VAGSVTELIQAAEAMK 95.00% 4.58 0.567 3.41 809.431 1,616.85 1,617.85 2 IF4G3_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VAGSVTELIQAAEAMK 95.00% 5.05 0.513 4.85 809.9326 1,617.85 1,617.85 2 IF4G3_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% NGNLPEFGDAISTASK 95.00% 4.52 0.541 2.96 811.3994 1,620.78 1,620.79 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% NGNLPEFGDAISTASK 95.00% 4.48 0.503 1.72 811.3997 1,620.78 1,620.79 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% DLDQASLAAVSQQLAPR 95.00% 2.57 0.254 3 892.4726 1,782.93 1,782.94 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% GSQAQPDSPSAQLALIAASQSFLQPGGK 95.00% 4.34 0.513 2.19 919.1388 2,754.39 2,754.41 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ILAQATSDLVNAIKADAEGESDLENSR 95.00% 5.49 0.655 4.03 944.4733 2,830.40 2,830.41 3
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% EADESLNFEEQILEAAK 95.00% 5.27 0.536 5.85 968.4631 1,934.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% EADESLNFEEQILEAAK 95.00% 4.45 0.384 4.89 968.4635 1,934.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% EADESLNFEEQILEAAK 95.00% 5.54 0.413 4.72 968.9624 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% EADESLNFEEQILEAAK 95.00% 4.69 0.473 4.46 968.9652 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LNEAAAGLNQAATELVQASR 95.00% 6.23 0.655 7.51 1,014.03 2,026.04 2,027.05 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LNEAAAGLNQAATELVQASR 95.00% 6.44 0.624 7.64 1,014.03 2,026.04 2,027.05 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LNEAAAGLNQAATELVQASR 95.00% 6.11 0.608 11 1,014.53 2,027.04 2,027.05 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LLSDSLPPSTGTFQEAQSR 95.00% 4.69 0.6 5.66 1,018.01 2,034.00 2,034.01 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LLSDSLPPSTGTFQEAQSR 95.00% 4.54 0.617 6.21 1,018.01 2,034.01 2,034.01 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% GVGAAATAVTQALNELLQHVK 95.00% 5.56 0.686 5.59 1,046.58 2,091.15 2,091.16 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ASVPTIQDQASAMQLSQcAK 95.00% 6.39 0.671 4.74 c18: Carbamidomethyl (+57.02) 1,068.02 2,134.02 2,134.03 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% ASVPTIQDQASAMQLSQcAK 95.00% 6.42 0.641 6 c18: Carbamidomethyl (+57.02) 1,068.02 2,134.02 2,134.03 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VVAPTISSPVcQEQLVEAGR 95.00% 5.14 0.591 5.57 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VSQMAQYFEPLTLAAVGAASK 95.00% 5.96 0.582 6.17 1,092.06 2,182.11 2,182.12 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VSQMAQYFEPLTLAAVGAASK 95.00% 6.25 0.59 7.16 1,092.06 2,182.11 2,182.12 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LGAASLGAEDPETQVVLINAVK 95.00% 4.86 0.663 3.62 1,098.60 2,195.19 2,195.19 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% LGAASLGAEDPETQVVLINAVK 95.00% 5.1 0.664 3.6 1,098.60 2,195.19 2,195.19 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VGAIPANALDDGQWSQGLISAAR 95.00% 4.98 0.651 7.55 1,156.09 2,310.16 2,310.18 2
 SAMPLE 2R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 43 52 145 26.20% VGAIPANALDDGQWSQGLISAAR 95.00% 5.58 0.705 7.74 1,156.09 2,310.17 2,310.18 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VEHGSVALPAIMR 95.00% 2.42 0.189 0 460.5881 1,378.74 1,379.75 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% DPPSWSVLAGHSR 95.00% 3.75 0.499 2.42 470.237 1,407.69 1,408.70 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% DPPSWSVLAGHSR 95.00% 3.3 0.456 2.28 470.2371 1,407.69 1,408.70 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% DPPSWSVLAGHSR 95.00% 3.61 0.507 3.07 470.2373 1,407.69 1,408.70 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% DPPSWSVLAGHSR 95.00% 3.18 0.493 1.74 470.5717 1,408.69 1,408.70 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TMLESAGGLIQTAR 95.00% 3.67 0.392 2.59 483.2572 1,446.75 1,447.76 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EAAYHPEVAPDVR 95.00% 1.84 0.185 1.46 485.2396 1,452.70 1,453.71 3 DDX1_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EAAYHPEVAPDVR 95.00% 2.32 0.264 1.07 485.2411 1,452.70 1,453.71 3 DDX1_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EAAYHPEVAPDVR 95.00% 2.03 0.208 1 485.2412 1,452.70 1,453.71 3 DDX1_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EAAYHPEVAPDVR 95.00% 2.45 0.368 1.19 485.5736 1,453.70 1,453.71 3 DDX1_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALGDLISATK 95.00% 3.02 0.342 1.8 494.7865 987.5573 988.5681 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALGDLISATK 95.00% 2.65 0.353 1.64 494.787 987.5584 988.5681 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALGDLISATK 95.00% 2.97 0.32 1.77 494.7871 987.5585 988.5681 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALGDLISATK 95.00% 3.36 0.373 1.89 494.7871 987.5586 988.5681 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALGDLISATK 95.00% 2.59 0.342 1.46 494.7872 987.5588 988.5681 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALGDLISATK 95.00% 2.96 0.34 2.04 494.7877 987.5597 988.5681 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VQELGHGcAALVTK 95.00% 2.2 0.31 0 c8: Carbamidomethyl (+57.02) 494.9278 1,481.76 1,482.77 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VQELGHGcAALVTK 95.00% 2.48 0.43 0 c8: Carbamidomethyl (+57.02) 494.9288 1,481.76 1,482.77 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VQELGHGcAALVTK 95.00% 2.48 0.444 0 c8: Carbamidomethyl (+57.02) 494.9289 1,481.76 1,482.77 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VQELGHGcAALVTK 95.00% 2.28 0.39 0 c8: Carbamidomethyl (+57.02) 495.2625 1,482.76 1,482.77 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VQELGHGcAALVTK 95.00% 2.08 0.239 0 c8: Carbamidomethyl (+57.02) 495.2635 1,482.77 1,482.77 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVAEQIPLLVQGVR 95.00% 4.4 0.413 3.68 498.2989 1,491.87 1,492.89 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVAEQIPLLVQGVR 95.00% 4.33 0.47 1.4 498.299 1,491.87 1,492.89 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVAEQIPLLVQGVR 95.00% 4.84 0.44 4.24 498.2991 1,491.87 1,492.89 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVAEQIPLLVQGVR 95.00% 4.59 0.487 1.21 498.2993 1,491.87 1,492.89 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% KFFYSDQNVDSR 95.00% 2.68 0.189 0 502.5706 1,504.69 1,505.70 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% IGITNHDEYSLVR 95.00% 2.61 0.374 0 506.2619 1,515.76 1,516.78 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% IGITNHDEYSLVR 95.00% 2.94 0.377 1.04 506.2626 1,515.76 1,516.78 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% IGITNHDEYSLVR 95.00% 4.2 0.468 2.13 506.263 1,515.77 1,516.78 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALDYYMLR 95.00% 2.78 0.464 1.34 522.7615 1,043.51 1,044.52 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALDYYMLR 95.00% 2.26 0.315 0 522.7616 1,043.51 1,044.52 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALDYYMLR 95.00% 2.14 0.336 0 522.762 1,043.51 1,044.52 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALDYYMLR 95.00% 2.19 0.299 0 522.7627 1,043.51 1,044.52 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALDYYMLR 95.00% 2.63 0.444 0 522.7627 1,043.51 1,044.52 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALDYYMLR 95.00% 2.58 0.367 1.11 522.7628 1,043.51 1,044.52 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALDYYMLR 95.00% 2.27 0.316 0 522.7628 1,043.51 1,044.52 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALDYYMLR 95.00% 2.54 0.417 1.31 522.7646 1,043.51 1,044.52 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% NLGTALAELR 95.00% 2.6 0.43 1.43 529.3013 1,056.59 1,057.60 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% NLGTALAELR 95.00% 2.51 0.412 2.37 529.3018 1,056.59 1,057.60 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% NLGTALAELR 95.00% 3.11 0.433 2.19 529.302 1,056.59 1,057.60 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% NLGTALAELR 95.00% 2.8 0.47 2.42 529.3023 1,056.59 1,057.60 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% NLGTALAELR 95.00% 2.88 0.353 1.89 529.3029 1,056.59 1,057.60 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% NLGTALAELR 95.00% 3.04 0.444 1.85 529.3029 1,056.59 1,057.60 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% NLGTALAELR 95.00% 2.69 0.39 2.62 529.3034 1,056.59 1,057.60 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% NLGTALAELR 95.00% 3 0.452 1.89 529.3036 1,056.59 1,057.60 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% NLGTALAELR 95.00% 2.66 0.367 2.72 529.3039 1,056.59 1,057.60 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TSTPEDFIR 95.00% 2.18 0.342 0 533.2636 1,064.51 1,065.52 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TSTPEDFIR 95.00% 2.2 0.357 0 533.2639 1,064.51 1,065.52 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVASAAAALVLK 95.00% 3.15 0.401 3.38 542.8385 1,083.66 1,084.67 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVASAAAALVLK 95.00% 3.84 0.435 3.2 542.8385 1,083.66 1,084.67 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVASAAAALVLK 95.00% 3.25 0.436 3.89 542.8387 1,083.66 1,084.67 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVASAAAALVLK 95.00% 3.8 0.435 3.01 542.8388 1,083.66 1,084.67 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVASAAAALVLK 95.00% 3.83 0.452 3.36 542.839 1,083.66 1,084.67 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVASAAAALVLK 95.00% 3.34 0.453 2.8 542.839 1,083.66 1,084.67 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVASAAAALVLK 95.00% 3.42 0.456 2.62 542.8391 1,083.66 1,084.67 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVASAAAALVLK 95.00% 4.07 0.493 2.59 542.8392 1,083.66 1,084.67 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVASAAAALVLK 95.00% 4.02 0.359 2.92 542.8392 1,083.66 1,084.67 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVASAAAALVLK 95.00% 3.23 0.456 3.32 542.8394 1,083.66 1,084.67 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% GLAGAVSELLR 95.00% 3.38 0.371 1.68 543.3175 1,084.62 1,085.63 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% GLAGAVSELLR 95.00% 3.14 0.361 1.42 543.3183 1,084.62 1,085.63 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AAMEPIVISAK 95.00% 2.73 0.389 2.05 565.3174 1,128.62 1,129.63 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AAMEPIVISAK 95.00% 2.9 0.425 1.48 565.3178 1,128.62 1,129.63 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EGTETFADHREGILK 95.00% 1.81 0.335 0 568.285 1,701.83 1,702.84 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TLSHPQQMALLDQTK 95.00% 4.76 0.433 3.48 570.9658 1,709.87 1,710.89 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TLSHPQQMALLDQTK 95.00% 5.17 0.424 1.62 571.2999 1,710.88 1,710.89 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LHTDDELNWLDHGR 95.00% 3.35 0.188 0 574.2723 1,719.79 1,720.80 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TYGVSFFLVK 95.00% 2.84 0.381 3.09 580.8198 1,159.62 1,160.64 2 MVP_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TYGVSFFLVK 95.00% 2.95 0.411 2.72 580.821 1,159.63 1,160.64 2 MVP_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TYGVSFFLVK 95.00% 2.6 0.291 2.17 580.8222 1,159.63 1,160.64 2 MVP_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TYGVSFFLVK 95.00% 2.15 0.279 1.8 580.8227 1,159.63 1,160.64 2 MVP_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% RVAGSVTELIQAAEAMK 95.00% 3.58 0.366 0 591.9886 1,772.94 1,773.95 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% RVAGSVTELIQAAEAMK 95.00% 3.44 0.412 1.57 591.9887 1,772.94 1,773.95 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% DLDQASLAAVSQQLAPR 95.00% 4.02 0.497 2.66 594.9822 1,781.92 1,782.94 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% DLDQASLAAVSQQLAPR 95.00% 3.2 0.42 2.04 594.9822 1,781.92 1,782.94 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VMVTNVTSLLK 95.00% 3.58 0.491 2.64 602.8505 1,203.69 1,204.70 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VMVTNVTSLLK 95.00% 3.97 0.495 1.82 602.851 1,203.69 1,204.70 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VMVTNVTSLLK 95.00% 3.83 0.458 2.57 602.8521 1,203.69 1,204.70 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% mATNAAAQNAIK 95.00% 2.5 0.436 2.49 m1: Oxidation (+15.99) 610.3076 1,218.60 1,219.61 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALDGAFTEENR 95.00% 3.53 0.553 3.21 611.7883 1,221.56 1,222.57 2 BMP4_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ALDGAFTEENR 95.00% 3.41 0.527 2.33 611.7884 1,221.56 1,222.57 2 BMP4_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VGDDPAVWQLK 95.00% 3.37 0.433 3.43 614.3208 1,226.63 1,227.64 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VGDDPAVWQLK 95.00% 3.35 0.426 3.48 614.3216 1,226.63 1,227.64 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VGDDPAVWQLK 95.00% 3.61 0.422 2.6 614.3217 1,226.63 1,227.64 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VGDDPAVWQLK 95.00% 3.28 0.324 3.46 614.3217 1,226.63 1,227.64 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VGDDPAVWQLK 95.00% 3.81 0.348 3.35 614.3219 1,226.63 1,227.64 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VGDDPAVWQLK 95.00% 3.17 0.327 5.64 614.3225 1,226.63 1,227.64 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% FLPSELRDEH 95.00% 2.12 0.405 1.85 621.8091 1,241.60 1,242.61 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% FLPSELRDEH 95.00% 2.22 0.419 1.54 621.8097 1,241.60 1,242.61 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AIAVTVQEMVTK 95.00% 3.73 0.605 4.74 645.3593 1,288.70 1,289.71 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AIAVTVQEMVTK 95.00% 2.6 0.518 4.2 645.36 1,288.70 1,289.71 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AIAVTVQEMVTK 95.00% 4.15 0.634 3.89 645.3625 1,288.71 1,289.71 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AIAVTVQEMVTK 95.00% 4.3 0.634 3.66 645.3628 1,288.71 1,289.71 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EADESLNFEEQILEAAK 95.00% 2.64 0.167 0 645.9782 1,934.91 1,935.92 3 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EADESLNFEEQILEAAK 95.00% 2.81 0.202 0 646.3113 1,935.91 1,935.92 3 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QEDVIATANLSR 95.00% 3.14 0.231 0 658.8435 1,315.67 1,316.68 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QEDVIATANLSR 95.00% 3.15 0.281 0 658.8435 1,315.67 1,316.68 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QAAASATQTIAAAQHAASTPK 95.00% 2.97 0.361 1.28 665.6788 1,994.01 1,995.03 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QAAASATQTIAAAQHAASTPK 95.00% 3.1 0.296 0 666.0135 1,995.02 1,995.03 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QAAASATQTIAAAQHAASTPK 95.00% 3.02 0.538 1.24 666.014 1,995.02 1,995.03 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QAAASATQTIAAAQHAASTPK 95.00% 3.31 0.467 0 666.014 1,995.02 1,995.03 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QAAASATQTIAAAQHAASTPK 95.00% 3.57 0.467 1.01 666.0145 1,995.02 1,995.03 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QAAASATQTIAAAQHAASTPK 95.00% 2.94 0.408 1.44 666.0146 1,995.02 1,995.03 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VSHVLAALQAGNR 95.00% 3.83 0.426 3.72 668.3763 1,334.74 1,335.75 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VSHVLAALQAGNR 95.00% 3.83 0.459 5.89 668.378 1,334.74 1,335.75 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% DPPSWSVLAGHSR 95.00% 3.08 0.641 3.38 704.8501 1,407.68 1,408.70 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% DPPSWSVLAGHSR 95.00% 3.35 0.624 4.34 704.8506 1,407.69 1,408.70 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% DPPSWSVLAGHSR 95.00% 2.17 0.305 1.92 704.8517 1,407.69 1,408.70 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LLAALLEDEGGSGRPLLQAAK 95.00% 4.99 0.564 5.12 708.4002 2,122.18 2,122.19 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LLAALLEDEGGSGRPLLQAAK 95.00% 5.41 0.54 4.01 708.4014 2,122.18 2,122.19 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LAQAAQSSVATITR 95.00% 3.93 0.635 5.6 708.8925 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LAQAAQSSVATITR 95.00% 3.34 0.617 5.72 708.8933 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LAQAAQSSVATITR 95.00% 4.61 0.663 6.44 708.894 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LAQAAQSSVATITR 95.00% 4.77 0.65 5.62 709.3943 1,416.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VLGEAMTGISQNAK 95.00% 4.4 0.575 3.44 709.8689 1,417.72 1,418.73 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VLGEAMTGISQNAK 95.00% 4.43 0.58 5.42 709.8692 1,417.72 1,418.73 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VVAPTISSPVcQEQLVEAGR 95.00% 4.61 0.552 3.25 c11: Carbamidomethyl (+57.02) 714.3751 2,140.10 2,140.11 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VVAPTISSPVcQEQLVEAGR 95.00% 5.26 0.571 2.92 c11: Carbamidomethyl (+57.02) 714.3752 2,140.10 2,140.11 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TMLESAGGLIQTAR 95.00% 4.37 0.405 5.23 724.383 1,446.75 1,447.76 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TMLESAGGLIQTAR 95.00% 2.97 0.306 4.21 724.3836 1,446.75 1,447.76 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TMLESAGGLIQTAR 95.00% 4.5 0.411 5.02 724.3839 1,446.75 1,447.76 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% TMLESAGGLIQTAR 95.00% 3.78 0.423 4.89 724.3839 1,446.75 1,447.76 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EAAYHPEVAPDVR 95.00% 1.9 0.264 1.59 727.3576 1,452.70 1,453.71 2 DDX1_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EAAYHPEVAPDVR 95.00% 2.77 0.409 2.44 727.3579 1,452.70 1,453.71 2 DDX1_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EAAYHPEVAPDVR 95.00% 2.74 0.35 2.25 727.3579 1,452.70 1,453.71 2 DDX1_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ASAGPQPLLVQScK 95.00% 3.79 0.477 3.22 c13: Carbamidomethyl (+57.02) 728.3842 1,454.75 1,455.76 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ASAGPQPLLVQScK 95.00% 3.45 0.505 3.57 c13: Carbamidomethyl (+57.02) 728.3845 1,454.75 1,455.76 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ASAGPQPLLVQScK 95.00% 2.17 0.306 0 c13: Carbamidomethyl (+57.02) 728.3858 1,454.76 1,455.76 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ASAGPQPLLVQScK 95.00% 2.56 0.462 0 c13: Carbamidomethyl (+57.02) 728.3867 1,454.76 1,455.76 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ILAQATSDLVNAIK 95.00% 4.51 0.594 5.47 728.9225 1,455.83 1,456.84 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LASEAKPAAVAAENEEIGSHIK 95.00% 7.07 0.602 3.82 746.0584 2,235.15 2,235.16 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LASEAKPAAVAAENEEIGSHIK 95.00% 6.81 0.536 3.07 746.0591 2,235.15 2,235.16 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVAEQIPLLVQGVR 95.00% 4.3 0.508 4.32 746.9449 1,491.87 1,492.89 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVAEQIPLLVQGVR 95.00% 4.93 0.553 4.02 746.9452 1,491.87 1,492.89 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVAEQIPLLVQGVR 95.00% 4.47 0.505 4.85 746.946 1,491.88 1,492.89 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVAEQIPLLVQGVR 95.00% 4.48 0.522 5.2 746.9461 1,491.88 1,492.89 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVAEQIPLLVQGVR 95.00% 4.28 0.525 3.62 746.9469 1,491.88 1,492.89 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AVAEQIPLLVQGVR 95.00% 2.89 0.448 2.64 746.9474 1,491.88 1,492.89 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% IGITNHDEYSLVR 95.00% 2.68 0.25 0 758.8915 1,515.77 1,516.78 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% IGITNHDEYSLVR 95.00% 2.83 0.34 0 759 1,515.98 1,516.78 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% DKAPGQLEcETAIAALNScLR 95.00% 4.33 0.429 0 c9: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 773.3812 2,317.12 2,317.13 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QELAVFcSPEPPAK 95.00% 3.61 0.507 4.11 c7: Carbamidomethyl (+57.02) 786.8867 1,571.76 1,572.77 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QELAVFcSPEPPAK 95.00% 2.4 0.296 0 c7: Carbamidomethyl (+57.02) 787.0465 1,572.08 1,572.77 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QELAVFcSPEPPAK 95.00% 3.1 0.366 2.59 c7: Carbamidomethyl (+57.02) 787.3894 1,572.76 1,572.77 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QELAVFcSPEPPAK 95.00% 3.78 0.416 3.38 c7: Carbamidomethyl (+57.02) 787.3924 1,572.77 1,572.77 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% NGNLPEFGDAISTASK 95.00% 4.53 0.543 4.68 810.8962 1,619.78 1,620.79 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% NGNLPEFGDAISTASK 95.00% 1.96 0.303 0 810.8965 1,619.78 1,620.79 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% NGNLPEFGDAISTASK 95.00% 4.34 0.511 4.19 810.8972 1,619.78 1,620.79 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% AAAFEEQENETVVVK 95.00% 4.22 0.498 3.17 832.9119 1,663.81 1,663.82 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% GAAAHPDSEEQQQRLREAAEGLR 95.00% 2.67 0.186 0 840.431 2,518.27 2,519.24 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% MVAAATNNLcEAANAAVQGHASQEK 95.00% 4.44 0.545 2.05 c10: Carbamidomethyl (+57.02) 853.0688 2,556.18 2,556.19 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% MVAAATNNLcEAANAAVQGHASQEK 95.00% 4.81 0.517 2.07 c10: Carbamidomethyl (+57.02) 853.0692 2,556.18 2,556.19 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% MVAAATNNLcEAANAAVQGHASQEK 95.00% 3.98 0.407 1.66 c10: Carbamidomethyl (+57.02) 853.0697 2,556.19 2,556.19 3
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% DLDQASLAAVSQQLAPR 95.00% 2.72 0.404 2.55 891.9687 1,781.92 1,782.94 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% DLDQASLAAVSQQLAPR 95.00% 4.44 0.61 3.62 892.4722 1,782.93 1,782.94 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EADESLNFEEQILEAAK 95.00% 5.99 0.52 6.21 968.4605 1,934.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EADESLNFEEQILEAAK 95.00% 5.97 0.493 5.01 968.9612 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EADESLNFEEQILEAAK 95.00% 6.11 0.494 6.05 968.9631 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EADESLNFEEQILEAAK 95.00% 5.96 0.496 6.19 968.9633 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EADESLNFEEQILEAAK 95.00% 6.48 0.49 5.59 968.9633 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% EADESLNFEEQILEAAK 95.00% 5.97 0.505 5.92 968.9643 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% QAAASATQTIAAAQHAASTPK 95.00% 5.28 0.634 2.8 998.519 1,995.02 1,995.03 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LNEAAAGLNQAATELVQASR 95.00% 6.29 0.652 8.47 1,014.03 2,026.04 2,027.05 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LNEAAAGLNQAATELVQASR 95.00% 6.42 0.641 8.33 1,014.03 2,026.04 2,027.05 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LLSDSLPPSTGTFQEAQSR 95.00% 3.81 0.58 4.4 1,017.51 2,033.00 2,034.01 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LLSDSLPPSTGTFQEAQSR 95.00% 3.9 0.507 4.64 1,017.51 2,033.01 2,034.01 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ASVPTIQDQASAMQLSQcAK 95.00% 5.78 0.711 4.35 c18: Carbamidomethyl (+57.02) 1,067.51 2,133.01 2,134.03 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% ASVPTIQDQASAMQLSQcAK 95.00% 6.54 0.662 7.27 c18: Carbamidomethyl (+57.02) 1,068.02 2,134.02 2,134.03 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VVAPTISSPVcQEQLVEAGR 95.00% 5.35 0.625 7.34 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VVAPTISSPVcQEQLVEAGR 95.00% 5.88 0.643 7.68 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VVAPTISSPVcQEQLVEAGR 95.00% 5.66 0.613 9.24 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LGAASLGAEDPETQVVLINAVK 95.00% 5.61 0.574 9.04 1,098.10 2,194.18 2,195.19 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% LGAASLGAEDPETQVVLINAVK 95.00% 5.43 0.626 5.72 1,098.60 2,195.18 2,195.19 2
 SAMPLE 3 Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 49 58 173 28.80% VGAIPANALDDGQWSQGLISAAR 95.00% 5.5 0.694 6.68 1,156.09 2,310.17 2,310.18 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AGFLDLKDFLPK 95.00% 3.39 0.238 0 455.2585 1,362.75 1,363.76 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AGFLDLKDFLPK 95.00% 2.94 0.247 0 455.2589 1,362.75 1,363.76 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AGFLDLKDFLPK 95.00% 3.29 0.293 1.17 455.2602 1,362.76 1,363.76 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AGFLDLKDFLPK 95.00% 3.12 0.221 1.25 455.2603 1,362.76 1,363.76 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AGFLDLKDFLPK 95.00% 3.05 0.219 1.47 455.2614 1,362.76 1,363.76 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VEHGSVALPAIMR 95.00% 2.35 0.279 0 460.586 1,378.73 1,379.75 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VEHGSVALPAIMR 95.00% 2.09 0.114 1.72 460.5885 1,378.74 1,379.75 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DPPSWSVLAGHSR 95.00% 2.92 0.469 0 470.2357 1,407.68 1,408.70 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DPPSWSVLAGHSR 95.00% 4.04 0.505 1.72 470.2371 1,407.69 1,408.70 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DPPSWSVLAGHSR 95.00% 1.98 0.34 0 470.2372 1,407.69 1,408.70 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DPPSWSVLAGHSR 95.00% 3.08 0.485 1.92 470.2377 1,407.69 1,408.70 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DPPSWSVLAGHSR 95.00% 3.32 0.466 2.29 470.2377 1,407.69 1,408.70 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DPPSWSVLAGHSR 95.00% 3.2 0.514 2.92 470.5713 1,408.69 1,408.70 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TMLESAGGLIQTAR 95.00% 3.85 0.45 2.05 483.2556 1,446.74 1,447.76 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TMLESAGGLIQTAR 95.00% 2.53 0.208 0 483.2568 1,446.75 1,447.76 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% EAAYHPEVAPDVR 95.00% 1.96 0.297 0 485.2398 1,452.70 1,453.71 3 DDX1_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% EAAYHPEVAPDVR 95.00% 2.17 0.202 0 485.2401 1,452.70 1,453.71 3 DDX1_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% EAAYHPEVAPDVR 95.00% 1.91 0.317 0 485.2402 1,452.70 1,453.71 3 DDX1_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALGDLISATK 95.00% 3.17 0.362 2.8 494.7859 987.5561 988.5681 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALGDLISATK 95.00% 2.6 0.345 2.37 494.7863 987.557 988.5681 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALGDLISATK 95.00% 2.12 0.338 0 494.7864 987.5571 988.5681 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALGDLISATK 95.00% 2.96 0.376 1.23 494.7864 987.5572 988.5681 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALGDLISATK 95.00% 3.41 0.402 1.85 494.7864 987.5572 988.5681 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALGDLISATK 95.00% 2.68 0.345 1.55 494.7866 987.5575 988.5681 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALGDLISATK 95.00% 2.43 0.333 1.62 494.7868 987.5579 988.5681 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALGDLISATK 95.00% 3.08 0.335 1.92 494.7869 987.5581 988.5681 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALGDLISATK 95.00% 2.65 0.372 1.1 494.7871 987.5586 988.5681 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VQELGHGcAALVTK 95.00% 1.99 0.296 0 c8: Carbamidomethyl (+57.02) 494.9275 1,481.76 1,482.77 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VQELGHGcAALVTK 95.00% 2.32 0.27 0 c8: Carbamidomethyl (+57.02) 494.9279 1,481.76 1,482.77 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VQELGHGcAALVTK 95.00% 2.21 0.296 0 c8: Carbamidomethyl (+57.02) 494.9282 1,481.76 1,482.77 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VQELGHGcAALVTK 95.00% 2.61 0.406 0 c8: Carbamidomethyl (+57.02) 494.9282 1,481.76 1,482.77 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VQELGHGcAALVTK 95.00% 2.34 0.306 0 c8: Carbamidomethyl (+57.02) 494.9285 1,481.76 1,482.77 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VQELGHGcAALVTK 95.00% 1.91 0.23 0 c8: Carbamidomethyl (+57.02) 494.929 1,481.76 1,482.77 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 3.94 0.429 0 498.2971 1,491.87 1,492.89 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 4.3 0.411 2.68 498.2994 1,491.87 1,492.89 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 4.29 0.399 3.35 498.3003 1,491.88 1,492.89 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 3.59 0.358 3.15 498.3003 1,491.88 1,492.89 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% IGITNHDEYSLVR 95.00% 2.58 0.295 0 506.2622 1,515.76 1,516.78 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% IGITNHDEYSLVR 95.00% 3.88 0.438 2.29 506.2628 1,515.76 1,516.78 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% IGITNHDEYSLVR 95.00% 3.68 0.537 1.12 506.2628 1,515.76 1,516.78 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TLAESALQLLYTAK 95.00% 4.15 0.348 0 507.9556 1,520.84 1,521.85 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALDYYMLR 95.00% 2.56 0.39 1.16 522.7619 1,043.51 1,044.52 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALDYYMLR 95.00% 2.27 0.362 0 522.7621 1,043.51 1,044.52 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALDYYMLR 95.00% 2.03 0.276 0 522.7624 1,043.51 1,044.52 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALDYYMLR 95.00% 2.06 0.262 0 522.7625 1,043.51 1,044.52 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALDYYMLR 95.00% 2.28 0.331 0 522.7625 1,043.51 1,044.52 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% NLGTALAELR 95.00% 2.36 0.337 1.82 529.302 1,056.59 1,057.60 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% NLGTALAELR 95.00% 2.45 0.384 2.08 529.3025 1,056.59 1,057.60 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% NLGTALAELR 95.00% 2.93 0.448 2.17 529.3027 1,056.59 1,057.60 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% NLGTALAELR 95.00% 2.98 0.429 2.09 529.3028 1,056.59 1,057.60 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% NLGTALAELR 95.00% 2.74 0.432 1.82 529.3031 1,056.59 1,057.60 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% NLGTALAELR 95.00% 2.36 0.293 1.14 529.3039 1,056.59 1,057.60 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% NLGTALAELR 95.00% 2.88 0.432 2.42 529.3042 1,056.59 1,057.60 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TSTPEDFIR 95.00% 2.02 0.289 0 533.2645 1,064.51 1,065.52 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TSTPEDFIR 95.00% 2.26 0.335 0 533.2647 1,064.51 1,065.52 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VAGSVTELIQAAEAMK 95.00% 3.63 0.467 1.39 539.955 1,616.84 1,617.85 3 IF4G3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VAGSVTELIQAAEAMK 95.00% 3.18 0.438 0 540.2888 1,617.84 1,617.85 3 IF4G3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VAGSVTELIQAAEAMK 95.00% 4.06 0.426 0.959 540.2894 1,617.84 1,617.85 3 IF4G3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VAGSVTELIQAAEAMK 95.00% 4.22 0.49 2.3 540.2904 1,617.85 1,617.85 3 IF4G3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVASAAAALVLK 95.00% 3.36 0.453 2.24 542.8387 1,083.66 1,084.67 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVASAAAALVLK 95.00% 3.51 0.428 3.15 542.8388 1,083.66 1,084.67 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVASAAAALVLK 95.00% 3.93 0.441 2.38 542.8391 1,083.66 1,084.67 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVASAAAALVLK 95.00% 3.27 0.431 3.12 542.8393 1,083.66 1,084.67 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVASAAAALVLK 95.00% 3.67 0.385 2.64 542.8394 1,083.66 1,084.67 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVASAAAALVLK 95.00% 3.21 0.441 2.74 542.8394 1,083.66 1,084.67 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVASAAAALVLK 95.00% 3.21 0.428 3.23 542.8397 1,083.66 1,084.67 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% GLAGAVSELLR 95.00% 2.17 0.275 0 543.3169 1,084.62 1,085.63 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVASAAAALVLK 95.00% 3.44 0.45 3.57 543.3416 1,084.67 1,084.67 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AAMEPIVISAK 95.00% 2.61 0.41 1.36 565.3178 1,128.62 1,129.63 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AAMEPIVISAK 95.00% 2.82 0.409 1.16 565.3179 1,128.62 1,129.63 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TLSHPQQMALLDQTK 95.00% 4.07 0.406 1.82 570.9672 1,709.88 1,710.89 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TLSHPQQMALLDQTK 95.00% 4.42 0.346 1.85 571.3008 1,710.88 1,710.89 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TYGVSFFLVK 95.00% 2.84 0.33 2.82 580.8195 1,159.62 1,160.64 2 MVP_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TYGVSFFLVK 95.00% 2.8 0.394 2.42 580.8199 1,159.62 1,160.64 2 MVP_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% RVAGSVTELIQAAEAMK 95.00% 3.58 0.338 0 592.3234 1,773.95 1,773.95 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% RVAGSVTELIQAAEAMK 95.00% 3.45 0.45 0 592.3244 1,773.95 1,773.95 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DLDQASLAAVSQQLAPR 95.00% 3.23 0.411 1.64 595.3165 1,782.93 1,782.94 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DLDQASLAAVSQQLAPR 95.00% 4.42 0.468 3.19 595.3166 1,782.93 1,782.94 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DLDQASLAAVSQQLAPR 95.00% 4.73 0.5 2.37 595.3166 1,782.93 1,782.94 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% MATNAAAQNAIK 95.00% 3.79 0.377 2.62 602.3093 1,202.60 1,203.62 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% MATNAAAQNAIK 95.00% 3.79 0.408 2.22 602.3099 1,202.60 1,203.62 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VMVTNVTSLLK 95.00% 3.02 0.436 1.17 602.8509 1,203.69 1,204.70 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VMVTNVTSLLK 95.00% 2.46 0.303 0 602.8512 1,203.69 1,204.70 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VMVTNVTSLLK 95.00% 1.96 0.315 0 602.8516 1,203.69 1,204.70 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VMVTNVTSLLK 95.00% 2.82 0.372 0 602.8528 1,203.69 1,204.70 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% MVGGIAQIIAAQEEMLR 95.00% 4.5 0.44 2.34 610.993 1,829.96 1,829.96 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ALDGAFTEENR 95.00% 2.85 0.476 3.11 611.7849 1,221.55 1,222.57 2 BMP4_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VGDDPAVWQLK 95.00% 2.72 0.265 2.49 614.3221 1,226.63 1,227.64 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VGDDPAVWQLK 95.00% 2.95 0.254 3.54 614.3232 1,226.63 1,227.64 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% FLPSELRDEH 95.00% 2.17 0.404 1.72 621.8092 1,241.60 1,242.61 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% FLPSELRDEH 95.00% 1.98 0.287 2.19 621.8103 1,241.61 1,242.61 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AIAVTVQEMVTK 95.00% 3.68 0.633 3.92 645.36 1,288.70 1,289.71 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AIAVTVQEMVTK 95.00% 3.68 0.621 2.74 645.8592 1,289.70 1,289.71 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AIAVTVQEMVTK 95.00% 0 0 3.19 646.3293 1,290.64 1,289.71 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% MVGGIAQIIAAQEEMLRK 95.00% 2.63 0.243 0 653.6885 1,958.04 1,958.06 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% QEDVIATANLSR 95.00% 3.11 0.3 0 658.8432 1,315.67 1,316.68 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% QAAASATQTIAAAQHAASTPK 95.00% 2.53 0.319 0 665.6807 1,994.02 1,995.03 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LNEAAAGLNQAATELVQASR 95.00% 3.73 0.531 0 676.3528 2,026.04 2,027.05 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LNEAAAGLNQAATELVQASR 95.00% 4.2 0.557 1.72 676.3539 2,026.04 2,027.05 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DPPSWSVLAGHSR 95.00% 3.14 0.552 2.55 704.8517 1,407.69 1,408.70 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TVTDMLMTIcAR 95.00% 2.44 0.402 1.68 c10: Carbamidomethyl (+57.02) 706.3401 1,410.66 1,411.68 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TVTDMLMTIcAR 95.00% 2.66 0.438 2.66 c10: Carbamidomethyl (+57.02) 706.3407 1,410.67 1,411.68 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LLAALLEDEGGSGRPLLQAAK 95.00% 4.2 0.491 1.39 708.0652 2,121.17 2,122.19 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LLAALLEDEGGSGRPLLQAAK 95.00% 4.89 0.561 4.3 708.4011 2,122.18 2,122.19 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LLAALLEDEGGSGRPLLQAAK 95.00% 5.29 0.601 4.66 708.4022 2,122.18 2,122.19 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LAQAAQSSVATITR 95.00% 3.98 0.618 6.08 708.893 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LAQAAQSSVATITR 95.00% 3.03 0.508 3.52 708.8933 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LAQAAQSSVATITR 95.00% 4.16 0.644 6.39 708.8941 1,415.77 1,416.78 2 LAMA5_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LAQAAQSSVATITR 95.00% 2.28 0.254 0 708.8955 1,415.78 1,416.78 2 LAMA5_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VLGEAMTGISQNAK 95.00% 4.3 0.595 2.6 709.8693 1,417.72 1,418.73 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VLGEAMTGISQNAK 95.00% 3.87 0.531 3.24 709.8697 1,417.72 1,418.73 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VVAPTISSPVcQEQLVEAGR 95.00% 3.49 0.511 1.92 c11: Carbamidomethyl (+57.02) 714.3744 2,140.10 2,140.11 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VVAPTISSPVcQEQLVEAGR 95.00% 5.03 0.647 3.28 c11: Carbamidomethyl (+57.02) 714.3746 2,140.10 2,140.11 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TMLESAGGLIQTAR 95.00% 4.35 0.421 6.47 724.382 1,446.75 1,447.76 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TMLESAGGLIQTAR 95.00% 3.23 0.254 3.36 724.3829 1,446.75 1,447.76 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TMLESAGGLIQTAR 95.00% 4.3 0.4 4.72 724.3838 1,446.75 1,447.76 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TMLESAGGLIQTAR 95.00% 3.26 0.382 4.66 724.3853 1,446.76 1,447.76 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% EAAYHPEVAPDVR 95.00% 2.69 0.43 1.8 727.3566 1,452.70 1,453.71 2 DDX1_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% EAAYHPEVAPDVR 95.00% 2.34 0.356 1.18 727.3579 1,452.70 1,453.71 2 DDX1_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VSQMAQYFEPLTLAAVGAASK 95.00% 4.19 0.388 0 728.3766 2,182.11 2,182.12 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ASAGPQPLLVQScK 95.00% 2.89 0.587 1.48 c13: Carbamidomethyl (+57.02) 728.3829 1,454.75 1,455.76 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ASAGPQPLLVQScK 95.00% 2.44 0.45 0 c13: Carbamidomethyl (+57.02) 728.3849 1,454.75 1,455.76 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ILAQATSDLVNAIK 95.00% 4.71 0.575 5.48 728.9217 1,455.83 1,456.84 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ILAQATSDLVNAIK 95.00% 4.87 0.558 5.05 728.922 1,455.83 1,456.84 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ILAQATSDLVNAIK 95.00% 2.42 0.344 3.3 728.9225 1,455.83 1,456.84 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ILAQATSDLVNAIK 95.00% 4.57 0.571 3.64 728.9242 1,455.83 1,456.84 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ILAQATSDLVNAIK 95.00% 4.56 0.565 4.66 729.4242 1,456.83 1,456.84 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VQELGHGcAALVTK 95.00% 2.86 0.356 0 c8: Carbamidomethyl (+57.02) 741.8905 1,481.77 1,482.77 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LASEAKPAAVAAENEEIGSHIK 95.00% 6.49 0.547 3.54 746.0583 2,235.15 2,235.16 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LASEAKPAAVAAENEEIGSHIK 95.00% 6.61 0.55 2.41 746.0599 2,235.16 2,235.16 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 3.55 0.326 3.15 746.9433 1,491.87 1,492.89 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 3.89 0.504 3.55 746.945 1,491.87 1,492.89 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 2.66 0.281 3.23 746.9457 1,491.88 1,492.89 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 2.72 0.365 1.74 746.946 1,491.88 1,492.89 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 4.21 0.533 3.92 746.9466 1,491.88 1,492.89 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 3.77 0.461 4.35 746.9467 1,491.88 1,492.89 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 4.37 0.51 5.04 746.9469 1,491.88 1,492.89 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 3.34 0.451 3.68 746.9469 1,491.88 1,492.89 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AVAEQIPLLVQGVR 95.00% 3.98 0.512 3.48 746.9472 1,491.88 1,492.89 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TLAESALQLLYTAK 95.00% 4.62 0.638 5.48 761.4277 1,520.84 1,521.85 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TLAESALQLLYTAK 95.00% 4.69 0.592 5.36 761.4284 1,520.84 1,521.85 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TLAESALQLLYTAK 95.00% 4.36 0.643 5.48 761.4291 1,520.84 1,521.85 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TLAESALQLLYTAK 95.00% 4.15 0.579 3.6 761.4292 1,520.84 1,521.85 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TLAESALQLLYTAK 95.00% 3.95 0.553 4.23 761.4298 1,520.84 1,521.85 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% TLAESALQLLYTAK 95.00% 2.7 0 4.03 761.9033 1,521.79 1,521.85 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DKAPGQLEcETAIAALNScLR 95.00% 4.03 0.466 0 c9: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 773.378 2,317.11 2,317.13 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DKAPGQLEcETAIAALNScLR 95.00% 4.55 0.378 0 c9: Carbamidomethyl (+57.02), c19: Carbamidomethyl (+57.02) 773.3825 2,317.12 2,317.13 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% QELAVFcSPEPPAK 95.00% 3.4 0.492 3.35 c7: Carbamidomethyl (+57.02) 786.8894 1,571.76 1,572.77 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% QELAVFcSPEPPAK 95.00% 3.46 0.286 1.82 c7: Carbamidomethyl (+57.02) 787.388 1,572.76 1,572.77 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VAGSVTELIQAAEAMK 95.00% 3.91 0.55 4.47 809.4283 1,616.84 1,617.85 2 IF4G3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VAGSVTELIQAAEAMK 95.00% 5.26 0.547 5.39 809.4294 1,616.84 1,617.85 2 IF4G3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VAGSVTELIQAAEAMK 95.00% 5.68 0.568 4.8 809.4295 1,616.84 1,617.85 2 IF4G3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VAGSVTELIQAAEAMK 95.00% 2.95 0.512 3.7 809.4312 1,616.85 1,617.85 2 IF4G3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VAGSVTELIQAAEAMK 95.00% 4.94 0.536 6.01 809.9322 1,617.85 1,617.85 2 IF4G3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% NGNLPEFGDAISTASK 95.00% 4.02 0.531 4.68 810.8969 1,619.78 1,620.79 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% NGNLPEFGDAISTASK 95.00% 4.36 0.48 3.04 811.3983 1,620.78 1,620.79 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% AAAFEEQENETVVVK 95.00% 3.84 0.495 2.62 832.9136 1,663.81 1,663.82 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LGAASLGAEDPETQVVLINAVKDVAK 95.00% 2.99 0.485 0 870.4792 2,608.41 2,608.42 3
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DLDQASLAAVSQQLAPR 95.00% 2.67 0.273 4.85 891.972 1,781.93 1,782.94 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% DLDQASLAAVSQQLAPR 95.00% 3.84 0.536 4.24 892.4698 1,782.92 1,782.94 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% EADESLNFEEQILEAAK 95.00% 5.13 0.429 4.96 968.4602 1,934.90 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% EADESLNFEEQILEAAK 95.00% 5.14 0.47 4.72 968.461 1,934.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% EADESLNFEEQILEAAK 95.00% 5.88 0.512 5.48 968.4615 1,934.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% EADESLNFEEQILEAAK 95.00% 4.79 0.456 5.09 968.9596 1,935.90 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% EADESLNFEEQILEAAK 95.00% 5.66 0.482 5.48 968.963 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% EADESLNFEEQILEAAK 95.00% 5.26 0.39 4.46 968.9641 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% EADESLNFEEQILEAAK 95.00% 6.28 0.486 5.44 968.9644 1,935.91 1,935.92 2 ANK3_HUMAN,PDLI3_HUMAN
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% QAAASATQTIAAAQHAASTPK 95.00% 4.59 0.565 0 998.0166 1,994.02 1,995.03 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LNEAAAGLNQAATELVQASR 95.00% 4.83 0.605 7.17 1,014.03 2,026.04 2,027.05 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LNEAAAGLNQAATELVQASR 95.00% 6.3 0.654 8.55 1,014.03 2,026.04 2,027.05 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LNEAAAGLNQAATELVQASR 95.00% 5.81 0.595 7.96 1,014.53 2,027.04 2,027.05 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LNEAAAGLNQAATELVQASR 95.00% 6.7 0.629 8.92 1,014.53 2,027.04 2,027.05 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LLSDSLPPSTGTFQEAQSR 95.00% 3.41 0.541 2.89 1,018.01 2,034.00 2,034.01 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LLSDSLPPSTGTFQEAQSR 95.00% 4.12 0.592 3.57 1,018.01 2,034.01 2,034.01 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LLAALLEDEGGSGRPLLQAAK 95.00% 5.6 0.557 5.52 1,062.10 2,122.18 2,122.19 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ASVPTIQDQASAMQLSQcAK 95.00% 6.22 0.657 5.85 c18: Carbamidomethyl (+57.02) 1,068.02 2,134.02 2,134.03 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% ASVPTIQDQASAMQLSQcAK 95.00% 6.64 0.67 5.47 c18: Carbamidomethyl (+57.02) 1,068.02 2,134.02 2,134.03 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VVAPTISSPVcQEQLVEAGR 95.00% 4.83 0.634 6.82 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VVAPTISSPVcQEQLVEAGR 95.00% 5.38 0.617 6.47 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VVAPTISSPVcQEQLVEAGR 95.00% 5.66 0.586 9.92 c11: Carbamidomethyl (+57.02) 1,071.06 2,140.10 2,140.11 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% VSQMAQYFEPLTLAAVGAASK 95.00% 6.2 0.66 6.37 1,092.06 2,182.11 2,182.12 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LGAASLGAEDPETQVVLINAVK 95.00% 5.86 0.622 5.96 1,098.60 2,195.18 2,195.19 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% LGAASLGAEDPETQVVLINAVK 95.00% 5.85 0.618 5.82 1,098.60 2,195.19 2,195.19 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% SNTSPEELGPLANQLTSDYGR 95.00% 5.09 0.602 5.4 1,125.54 2,249.06 2,249.07 2
 SAMPLE 3R Talin-1  TLN1  TLN1_HUMAN 269,747.10 100.00% 51 64 185 27.90% SNTSPEELGPLANQLTSDYGR 95.00% 4.91 0.602 6.17 1,125.54 2,249.06 2,249.07 2
 SAMPLE 4 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 5 11 5.49% FYNIGDQR 95.00% 2.52 0.325 0 506.747 1,011.48 1,012.49 2
 SAMPLE 4 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 5 11 5.49% FYNIGDQR 95.00% 2.36 0.274 1.24 506.7471 1,011.48 1,012.49 2
 SAMPLE 4 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 5 11 5.49% IYLSDSLTGK 95.00% 2.66 0.417 0 548.8003 1,095.58 1,096.59 2
 SAMPLE 4 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 5 11 5.49% IYLSDSLTGK 95.00% 2.56 0.392 0 548.8006 1,095.59 1,096.59 2
 SAMPLE 4 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 5 11 5.49% FTEAIVDAEPK 95.00% 2.98 0.465 3.52 610.3134 1,218.61 1,219.62 2
 SAMPLE 4 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 5 11 5.49% FTEAIVDAEPK 95.00% 3.51 0.515 1.89 610.3156 1,218.62 1,219.62 2
 SAMPLE 4 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 5 11 5.49% FTEAIVDAEPK 95.00% 3.01 0.417 2.46 610.3164 1,218.62 1,219.62 2
 SAMPLE 4 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 5 11 5.49% TGQQLTSDQLPIKEGYFR 95.00% 3 0.449 0.959 694.6956 2,081.06 2,081.07 3
 SAMPLE 4 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 5 11 5.49% TGQQLTSDQLPIKEGYFR 95.00% 2.87 0.441 0 694.6974 2,081.07 2,081.07 3
 SAMPLE 4 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 5 11 5.49% KFVGVQLcNSLR 95.00% 2.7 0.0734 4.68 c8: Carbamidomethyl (+57.02) 711.3604 1,420.71 1,420.77 2
 SAMPLE 4 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 5 11 5.49% KFVGVQLcNSLR 95.00% 2.59 0.147 2.64 c8: Carbamidomethyl (+57.02) 711.3616 1,420.71 1,420.77 2
 SAMPLE 4R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 3 3 8 3.63% IYLSDSLTGK 95.00% 2.55 0.426 0 548.7998 1,095.58 1,096.59 2
 SAMPLE 4R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 3 3 8 3.63% IYLSDSLTGK 95.00% 2.8 0.407 1.23 548.8006 1,095.59 1,096.59 2
 SAMPLE 4R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 3 3 8 3.63% FTEAIVDAEPK 95.00% 2.6 0.474 2.36 609.819 1,217.62 1,219.62 2
 SAMPLE 4R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 3 3 8 3.63% FTEAIVDAEPK 95.00% 3.12 0.471 3.36 610.3122 1,218.61 1,219.62 2
 SAMPLE 4R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 3 3 8 3.63% FTEAIVDAEPK 95.00% 3.02 0.433 2.77 610.3147 1,218.61 1,219.62 2
 SAMPLE 4R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 3 3 8 3.63% FTEAIVDAEPK 95.00% 2.95 0.476 2.35 610.3153 1,218.61 1,219.62 2
 SAMPLE 4R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 3 3 8 3.63% TGQQLTSDQLPIKEGYFR 95.00% 3.03 0.308 0 694.6964 2,081.07 2,081.07 3
 SAMPLE 4R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 3 3 8 3.63% TGQQLTSDQLPIKEGYFR 95.00% 3.57 0.494 1.09 694.6969 2,081.07 2,081.07 3
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% FYNIGDQR 95.00% 2.42 0.282 0 506.7429 1,011.47 1,012.49 2
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% FYNIGDQR 95.00% 2.52 0.288 0 506.7442 1,011.47 1,012.49 2
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% YLIVVRPAPPPSQK 95.00% 2.03 0.29 1.52 522.3119 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% YLIVVRPAPPPSQK 95.00% 2.48 0.265 1.51 522.6458 1,564.91 1,564.92 3 RL17_HUMAN
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% IYLSDSLTGK 95.00% 2.75 0.427 1.64 548.7964 1,095.58 1,096.59 2
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% IYLSDSLTGK 95.00% 3.03 0.454 2.01 548.7968 1,095.58 1,096.59 2
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% YIQKPDNSPcSITDSVK 95.00% 2.91 0.407 0 c10: Carbamidomethyl (+57.02) 651.3165 1,950.93 1,951.94 3
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% YIQKPDNSPcSITDSVK 95.00% 3.46 0.504 0 c10: Carbamidomethyl (+57.02) 651.6523 1,951.93 1,951.94 3
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% YIQKPDNSPcSITDSVK 95.00% 3.27 0.463 1.77 c10: Carbamidomethyl (+57.02) 651.6529 1,951.94 1,951.94 3
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% YIQKPDNSPcSITDSVK 95.00% 3.42 0.457 1.03 c10: Carbamidomethyl (+57.02) 651.654 1,951.94 1,951.94 3
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% IQSTYDQDHTVPAYVPR 95.00% 2.5 0.33 1.2 663.9945 1,988.96 1,989.97 3
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% IQSTYDQDHTVPAYVPR 95.00% 2.62 0.333 0.959 664.3266 1,989.96 1,989.97 3
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% IQSTYDQDHTVPAYVPR 95.00% 2.23 0.302 1.34 664.3273 1,989.96 1,989.97 3
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% TGQQLTSDQLPIKEGYFR 95.00% 4.84 0.582 0 694.6948 2,081.06 2,081.07 3
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% TGQQLTSDQLPIKEGYFR 95.00% 4.14 0.506 1.57 694.695 2,081.06 2,081.07 3
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% IQSTYDQDHTVPAYVPR 95.00% 3.91 0.523 3.89 995.985 1,989.95 1,989.97 2
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% IQSTYDQDHTVPAYVPR 95.00% 4.58 0.611 4.68 995.9876 1,989.96 1,989.97 2
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% IQSTYDQDHTVPAYVPR 95.00% 5.24 0.606 5.41 995.9891 1,989.96 1,989.97 2
 SAMPLE 1 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 7 8 19 9.86% NPLGEGPVSNTVAFSTESADPR 95.00% 6.64 0.586 8.82 1,123.54 2,245.06 2,245.07 2
 SAMPLE 1R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 6 12 6.88% YLIVVRPAPPPSQK 95.00% 2.6 0.354 1.37 522.3104 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 1R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 6 12 6.88% YLIVVRPAPPPSQK 95.00% 1.92 0.255 1.16 522.3121 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 1R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 6 12 6.88% FTEAIVDAEPK 95.00% 3.33 0.304 2.64 610.312 1,218.61 1,219.62 2
 SAMPLE 1R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 6 12 6.88% FTEAIVDAEPK 95.00% 3.36 0.361 1.82 610.3127 1,218.61 1,219.62 2
 SAMPLE 1R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 6 12 6.88% YIQKPDNSPcSITDSVK 95.00% 3.28 0.463 2.11 c10: Carbamidomethyl (+57.02) 651.3193 1,950.93 1,951.94 3
 SAMPLE 1R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 6 12 6.88% TGQQLTSDQLPIKEGYFR 95.00% 3.66 0.476 1.07 694.6933 2,081.06 2,081.07 3
 SAMPLE 1R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 6 12 6.88% TGQQLTSDQLPIKEGYFR 95.00% 3.91 0.484 1.31 694.6934 2,081.06 2,081.07 3
 SAMPLE 1R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 6 12 6.88% LPASLMFEISDALK 95.00% 4.82 0.608 4.12 767.9121 1,533.81 1,534.82 2
 SAMPLE 1R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 6 12 6.88% LPASLMFEISDALK 95.00% 4.58 0.556 4.39 767.9122 1,533.81 1,534.82 2
 SAMPLE 1R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 6 12 6.88% LPASLMFEISDALK 95.00% 3.9 0.567 3.42 767.9136 1,533.81 1,534.82 2
 SAMPLE 1R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 6 12 6.88% LPASLMFEISDALK 95.00% 4.43 0.595 3.92 768.4162 1,534.82 1,534.82 2
 SAMPLE 1R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 5 6 12 6.88% YLIVVRPAPPPSQK 95.00% 4.54 0.448 3.26 783.4616 1,564.91 1,564.92 2 RL17_HUMAN
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% KFVGVQLcNSLR 95.00% 3.8 0.264 0 c8: Carbamidomethyl (+57.02) 474.2622 1,419.76 1,420.77 3
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% KFVGVQLcNSLR 95.00% 3.19 0.122 0 c8: Carbamidomethyl (+57.02) 474.2627 1,419.76 1,420.77 3
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FYNIGDQR 95.00% 2.71 0.36 0 506.7451 1,011.47 1,012.49 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FYNIGDQR 95.00% 2.36 0.315 0 506.7451 1,011.47 1,012.49 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FYNIGDQR 95.00% 2.27 0.283 0 506.7454 1,011.48 1,012.49 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FYNIGDQR 95.00% 2.27 0.278 0 506.7456 1,011.48 1,012.49 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% YLIVVRPAPPPSQK 95.00% 2.26 0.345 2.02 522.3105 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% YLIVVRPAPPPSQK 95.00% 2.03 0.244 1 522.3112 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% YLIVVRPAPPPSQK 95.00% 2.25 0.27 1.54 522.3118 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% YLIVVRPAPPPSQK 95.00% 2.36 0.358 2.77 522.312 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% YLIVVRPAPPPSQK 95.00% 2.43 0.431 1.89 522.3121 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FTEAIVDAEPK 95.00% 3.64 0.496 3.25 610.3119 1,218.61 1,219.62 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FTEAIVDAEPK 95.00% 3.62 0.474 2.6 610.3123 1,218.61 1,219.62 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FTEAIVDAEPK 95.00% 3.19 0.503 1.51 610.313 1,218.61 1,219.62 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FTEAIVDAEPK 95.00% 3.47 0.496 2.4 610.3133 1,218.61 1,219.62 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FTEAIVDAEPK 95.00% 2.97 0.474 1.66 610.3133 1,218.61 1,219.62 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FTEAIVDAEPK 95.00% 4.1 0.514 2.42 610.3134 1,218.61 1,219.62 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FTEAIVDAEPK 95.00% 4 0.536 1.52 610.3139 1,218.61 1,219.62 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FTEAIVDAEPK 95.00% 3.11 0.506 2.64 610.3139 1,218.61 1,219.62 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% FTEAIVDAEPK 95.00% 3.74 0.44 3.35 610.315 1,218.61 1,219.62 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% YIQKPDNSPcSITDSVK 95.00% 3.18 0.455 2.57 c10: Carbamidomethyl (+57.02) 651.319 1,950.93 1,951.94 3
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% IQSTYDQDHTVPAYVPR 95.00% 2.25 0.353 0 663.9935 1,988.96 1,989.97 3
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% TGQQLTSDQLPIKEGYFR 95.00% 4.39 0.497 1.29 694.3585 2,080.05 2,081.07 3
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% YKIYLSDSLTGK 95.00% 3.15 0.498 2.26 694.377 1,386.74 1,387.75 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% TGQQLTSDQLPIKEGYFR 95.00% 4.89 0.563 1.64 694.6934 2,081.06 2,081.07 3
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% TGQQLTSDQLPIKEGYFR 95.00% 4.1 0.529 2.09 694.6949 2,081.06 2,081.07 3
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% TGQQLTSDQLPIKEGYFR 95.00% 4.09 0.543 1.89 694.695 2,081.06 2,081.07 3
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% TGQQLTSDQLPIKEGYFR 95.00% 3.36 0.365 0 694.6957 2,081.06 2,081.07 3
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% KFVGVQLcNSLR 95.00% 2.72 0.273 4 c8: Carbamidomethyl (+57.02) 710.8898 1,419.76 1,420.77 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% KFVGVQLcNSLR 95.00% 3.37 0.331 3.39 c8: Carbamidomethyl (+57.02) 711.3914 1,420.77 1,420.77 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% YIQKPDNSPcSITDSVK 95.00% 4.34 0.573 4.6 c10: Carbamidomethyl (+57.02) 976.4723 1,950.93 1,951.94 2
 SAMPLE 2 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 9 11 32 12.20% NPLGEGPVSNTVAFSTESADPR 95.00% 6.6 0.565 10.1 1,123.54 2,245.06 2,245.07 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% KFVGVQLcNSLR 95.00% 2.54 0.259 0 c8: Carbamidomethyl (+57.02) 474.2639 1,419.77 1,420.77 3
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% YLIVVRPAPPPSQK 95.00% 1.94 0.333 0 522.6451 1,564.91 1,564.92 3 RL17_HUMAN
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% IYLSDSLTGK 95.00% 2.32 0.378 0 548.7973 1,095.58 1,096.59 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% IYLSDSLTGK 95.00% 2.53 0.404 1.11 548.7977 1,095.58 1,096.59 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FTEAIVDAEPK 95.00% 3.15 0.476 2.66 610.3113 1,218.61 1,219.62 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FTEAIVDAEPK 95.00% 3.19 0.486 2.47 610.3115 1,218.61 1,219.62 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FTEAIVDAEPK 95.00% 3 0.498 2.35 610.3127 1,218.61 1,219.62 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FTEAIVDAEPK 95.00% 3.86 0.438 2.6 610.3138 1,218.61 1,219.62 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FTEAIVDAEPK 95.00% 3.41 0.472 1.96 610.314 1,218.61 1,219.62 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FTEAIVDAEPK 95.00% 3.26 0.399 2.47 610.3142 1,218.61 1,219.62 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FTEAIVDAEPK 95.00% 3.84 0.466 2.57 610.3145 1,218.61 1,219.62 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FTEAIVDAEPK 95.00% 3.27 0.472 2.14 610.3148 1,218.61 1,219.62 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FTEAIVDAEPK 95.00% 3.86 0.504 2.07 610.3148 1,218.61 1,219.62 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FTEAIVDAEPK 95.00% 3.56 0.546 3.04 610.3149 1,218.61 1,219.62 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FTEAIVDAEPK 95.00% 3.46 0.466 2.72 610.316 1,218.62 1,219.62 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FVGVQLcNSLR 95.00% 2.59 0.383 0 c7: Carbamidomethyl (+57.02) 646.8414 1,291.67 1,292.68 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% FVGVQLcNSLR 95.00% 2.42 0.261 0 c7: Carbamidomethyl (+57.02) 647.336 1,292.66 1,292.68 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% YIQKPDNSPcSITDSVK 95.00% 3.64 0.513 2.37 c10: Carbamidomethyl (+57.02) 651.6541 1,951.94 1,951.94 3
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% YKIYLSDSLTGK 95.00% 2.34 0.329 3.05 694.3758 1,386.74 1,387.75 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% TGQQLTSDQLPIKEGYFR 95.00% 3.28 0.378 0 694.6934 2,081.06 2,081.07 3
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% KFVGVQLcNSLR 95.00% 3.07 0.346 4.17 c8: Carbamidomethyl (+57.02) 710.8928 1,419.77 1,420.77 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% LPASLMFEISDALK 95.00% 3.73 0.516 2.24 767.9135 1,533.81 1,534.82 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% LPASLMFEISDALK 95.00% 4.88 0.561 3.92 767.9138 1,533.81 1,534.82 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% LPASLMFEISDALK 95.00% 4.42 0.51 3 767.9139 1,533.81 1,534.82 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% LPASLMFEISDALK 95.00% 4.27 0.553 3.49 767.9145 1,533.81 1,534.82 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% IQSTYDQDHTVPAYVPR 95.00% 4.51 0.626 5.48 995.9871 1,989.96 1,989.97 2
 SAMPLE 2R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 27 10.70% IQSTYDQDHTVPAYVPR 95.00% 4.22 0.584 6.19 995.9897 1,989.96 1,989.97 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% YKIYLSDSLTGK 95.00% 2.64 0.374 0 463.2547 1,386.74 1,387.75 3
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% KFVGVQLcNSLR 95.00% 4.19 0.247 0 c8: Carbamidomethyl (+57.02) 474.2626 1,419.76 1,420.77 3
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% KFVGVQLcNSLR 95.00% 3.74 0.245 0 c8: Carbamidomethyl (+57.02) 474.2639 1,419.77 1,420.77 3
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% KLIPITIIK 95.00% 2.26 0.212 1.52 519.8672 1,037.72 1,038.73 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% KLIPITIIK 95.00% 2.08 0.158 1.25 519.8673 1,037.72 1,038.73 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% YLIVVRPAPPPSQK 95.00% 2.29 0.0522 4.54 522.3111 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% YLIVVRPAPPPSQK 95.00% 2.24 0.218 0 522.3113 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% YLIVVRPAPPPSQK 95.00% 2.4 0.337 2.34 522.6457 1,564.91 1,564.92 3 RL17_HUMAN
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% YLIVVRPAPPPSQK 95.00% 2.61 0.342 1.66 522.6458 1,564.91 1,564.92 3 RL17_HUMAN
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% YLIVVRPAPPPSQK 95.00% 2.39 0.277 2.05 522.6459 1,564.91 1,564.92 3 RL17_HUMAN
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% IYLSDSLTGK 95.00% 2.34 0.341 0 548.7977 1,095.58 1,096.59 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% DNVEGGIWSK 95.00% 2.53 0.3 1.7 552.7688 1,103.52 1,104.53 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 3.45 0.454 2.33 610.3119 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 3.65 0.492 1.85 610.312 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 3.93 0.523 2.57 610.3123 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 4.04 0.52 2.92 610.3125 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 3.39 0.479 2.6 610.3128 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 3.8 0.475 2.96 610.313 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 3.56 0.514 2.15 610.3133 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 4.02 0.548 2.89 610.314 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 3.46 0.48 2.23 610.3142 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 4.14 0.536 2.57 610.3142 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 3.97 0.541 2.39 610.3143 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 3.57 0.518 2.36 610.3145 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 3.75 0.514 2.42 610.3149 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% FTEAIVDAEPK 95.00% 3.55 0.517 2.66 610.315 1,218.61 1,219.62 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% YIQKPDNSPcSITDSVK 95.00% 4.1 0.504 1.4 c10: Carbamidomethyl (+57.02) 651.6546 1,951.94 1,951.94 3
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% YKIYLSDSLTGK 95.00% 3.21 0.449 3 694.3783 1,386.74 1,387.75 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% YKIYLSDSLTGK 95.00% 2.4 0.353 2.59 694.8795 1,387.74 1,387.75 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% KFVGVQLcNSLR 95.00% 2.76 0.317 1.96 c8: Carbamidomethyl (+57.02) 710.8872 1,419.76 1,420.77 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% IQSTYDQDHTVPAYVPR 95.00% 4.17 0.615 4.6 995.9849 1,989.95 1,989.97 2
 SAMPLE 3 Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 12 32 11.50% NPLGEGPVSNTVAFSTESADPR 95.00% 5.99 0.644 6.92 1,123.54 2,245.06 2,245.07 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% YKIYLSDSLTGK 95.00% 3.08 0.352 0 463.2551 1,386.74 1,387.75 3
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% KFVGVQLcNSLR 95.00% 2.97 0.3 0 c8: Carbamidomethyl (+57.02) 474.2626 1,419.76 1,420.77 3
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% YLIVVRPAPPPSQK 95.00% 2.54 0.361 1.4 522.3106 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% YLIVVRPAPPPSQK 95.00% 2.12 0.307 1.59 522.3109 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% YLIVVRPAPPPSQK 95.00% 2.6 0.404 1.32 522.3114 1,563.91 1,564.92 3 RL17_HUMAN
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% YLIVVRPAPPPSQK 95.00% 2.18 0.249 1.54 522.6452 1,564.91 1,564.92 3 RL17_HUMAN
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% IPLSPEVTHTKPAPK 95.00% 1.9 0.292 0 539.3114 1,614.91 1,614.92 3
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% IYLSDSLTGK 95.00% 2.76 0.428 1.09 548.7969 1,095.58 1,096.59 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% IYLSDSLTGK 95.00% 2.18 0.347 0 548.7971 1,095.58 1,096.59 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% IYLSDSLTGK 95.00% 3.06 0.408 1.4 548.7975 1,095.58 1,096.59 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% IYLSDSLTGK 95.00% 2.62 0.43 0 548.7976 1,095.58 1,096.59 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% IYLSDSLTGK 95.00% 2.44 0.35 0 548.8006 1,095.59 1,096.59 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 3.21 0.487 2.28 610.3117 1,218.61 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 3.39 0.539 2.96 610.312 1,218.61 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 2.74 0.387 3.13 610.3127 1,218.61 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 4.3 0.532 2.66 610.3128 1,218.61 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 3.26 0.469 1.92 610.3133 1,218.61 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 3.38 0.507 3.19 610.3139 1,218.61 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 3.18 0.44 2.92 610.3141 1,218.61 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 2.59 0.426 2.34 610.3141 1,218.61 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 3.14 0.501 1.82 610.3144 1,218.61 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 3.02 0.406 2.68 610.3146 1,218.61 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 4.31 0.527 1.89 610.315 1,218.61 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 2.69 0.404 2.2 610.3153 1,218.61 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 2.64 0.404 1.82 610.3155 1,218.62 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FTEAIVDAEPK 95.00% 2.69 0.44 1.46 610.316 1,218.62 1,219.62 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FVGVQLcNSLR 95.00% 2.26 0.261 0 c7: Carbamidomethyl (+57.02) 646.8407 1,291.67 1,292.68 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% FVGVQLcNSLR 95.00% 2.46 0.277 0 c7: Carbamidomethyl (+57.02) 647.3398 1,292.66 1,292.68 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% TGQQLTSDQLPIKEGYFR 95.00% 3.45 0.269 0 694.3577 2,080.05 2,081.07 3
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% TGQQLTSDQLPIKEGYFR 95.00% 3.37 0.504 2.19 694.3586 2,080.05 2,081.07 3
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% TGQQLTSDQLPIKEGYFR 95.00% 4.09 0.495 1.64 694.6952 2,081.06 2,081.07 3
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% KFVGVQLcNSLR 95.00% 2.91 0.299 3.29 c8: Carbamidomethyl (+57.02) 710.8899 1,419.76 1,420.77 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% KFVGVQLcNSLR 95.00% 3.04 0.344 3.27 c8: Carbamidomethyl (+57.02) 710.8915 1,419.77 1,420.77 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% TGQQLTSDQLPIK 95.00% 2.61 0.303 2.12 714.8908 1,427.77 1,428.77 2
 SAMPLE 3R Target of Nesh-SH3  ABI3BP  TARSH_HUMAN 118,626.20 100.00% 10 11 35 8.93% LPASLMFEISDALK 95.00% 3.72 0.486 1.96 767.9126 1,533.81 1,534.82 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 2.38 0.294 1.21 491.296 980.5763 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 2.68 0.369 1.22 491.2962 980.5767 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 2.36 0.3 1.59 491.2964 980.5772 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 2.65 0.279 2.02 491.2965 980.5773 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 2.72 0.311 0 491.2966 980.5775 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 2.95 0.345 0 491.2967 980.5778 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 2.86 0.3 0 491.2967 980.5778 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 2.93 0.3 1.85 491.2968 980.5779 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 3.16 0.267 1.64 491.2969 980.5781 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 3.02 0.305 1.59 491.2971 980.5786 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 3.03 0.317 1.24 491.2972 980.5788 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 2.76 0.357 0 491.2974 980.5791 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 2.84 0.367 1.89 491.2983 980.5809 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% IQALNGPLR 95.00% 2.16 0.269 0 491.2985 980.5814 981.5847 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% FTTDLDSPR 95.00% 2.81 0.426 2.03 526.2567 1,050.50 1,051.51 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% FTTDLDSPR 95.00% 2.64 0.528 1.82 526.257 1,050.50 1,051.51 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% FTTDLDSPR 95.00% 2.09 0.313 0 526.2572 1,050.50 1,051.51 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% FTTDLDSPR 95.00% 2.17 0.439 1.57 526.2575 1,050.50 1,051.51 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% FTTDLDSPR 95.00% 2.81 0.511 1.74 526.2576 1,050.50 1,051.51 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% FTTDLDSPR 95.00% 2.69 0.487 2.42 526.2577 1,050.50 1,051.51 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% FTTDLDSPR 95.00% 2.78 0.456 2.19 526.2577 1,050.50 1,051.51 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% FTTDLDSPR 95.00% 2.36 0.386 1.68 526.258 1,050.50 1,051.51 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% FTTDLDSPR 95.00% 2.42 0.452 1.43 526.2581 1,050.50 1,051.51 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% FTTDLDSPR 95.00% 2.71 0.452 2.02 526.2581 1,050.50 1,051.51 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% FTTDLDSPR 95.00% 2 0.413 2.62 526.2594 1,050.50 1,051.51 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% FTTDLDSPR 95.00% 2.17 0.492 1.8 526.2605 1,050.51 1,051.51 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ITAQGQYELR 95.00% 2.87 0.401 0 589.8093 1,177.60 1,178.62 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ITAQGQYELR 95.00% 3.19 0.426 0 589.8133 1,177.61 1,178.62 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ITAQGQYELR 95.00% 2.38 0.294 0 589.8134 1,177.61 1,178.62 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ITAQGQYELR 95.00% 3.34 0.424 0 589.8136 1,177.61 1,178.62 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ETFTTGLDAPR 95.00% 2.9 0.417 1.44 604.3008 1,206.59 1,207.60 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ETFTTGLDAPR 95.00% 3.17 0.498 3.33 604.3012 1,206.59 1,207.60 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ETFTTGLDAPR 95.00% 2.99 0.529 1.52 604.3014 1,206.59 1,207.60 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ETFTTGLDAPR 95.00% 3.31 0.494 2.62 604.3023 1,206.59 1,207.60 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ETFTTGLDAPR 95.00% 3.07 0.519 1.66 604.3023 1,206.59 1,207.60 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ETFTTGLDAPR 95.00% 3.08 0.454 2.17 604.3029 1,206.59 1,207.60 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ETFTTGLDAPR 95.00% 3.27 0.532 2.41 604.3035 1,206.59 1,207.60 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ETFTTGLDAPR 95.00% 3.25 0.531 1.96 604.3036 1,206.59 1,207.60 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% ETFTTGLDAPR 95.00% 3.29 0.496 1.92 604.3048 1,206.59 1,207.60 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% VATYLPAPEGLK 95.00% 2.69 0.311 0 629.8562 1,257.70 1,258.70 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% VATYLPAPEGLK 95.00% 2.62 0.355 1.19 629.8578 1,257.70 1,258.70 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% VATYLPAPEGLK 95.00% 2.63 0.335 0 630.3585 1,258.70 1,258.70 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% LEELENLVSSLR 95.00% 4.55 0.43 4.23 701.385 1,400.75 1,401.76 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% EEFWLGLDNLNK 95.00% 2.88 0.294 0 739.3718 1,476.73 1,477.73 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% EEFWLGLDNLNK 95.00% 3.49 0.452 1.55 739.3721 1,476.73 1,477.73 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% EEFWLGLDNLNK 95.00% 2.95 0.389 0 739.374 1,476.73 1,477.73 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% EEFWLGLDNLNK 95.00% 3.45 0.343 1.15 739.8739 1,477.73 1,477.73 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% VSQTDNSITLEWR 95.00% 3.48 0.384 3.31 774.887 1,547.76 1,548.77 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% VSQTDNSITLEWR 95.00% 3.14 0.395 3.68 774.8874 1,547.76 1,548.77 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% VSQTDNSITLEWR 95.00% 2.82 0.371 2.85 774.8878 1,547.76 1,548.77 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% VSQTDNSITLEWR 95.00% 3.17 0.332 4.49 774.8882 1,547.76 1,548.77 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% VSQTDNSITLEWR 95.00% 3.39 0.365 3.62 774.8894 1,547.76 1,548.77 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% VSQTDNSITLEWR 95.00% 3.67 0.433 4.96 774.8898 1,547.76 1,548.77 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% VSQTDNSITLEWR 95.00% 2.48 0.402 2.59 774.8899 1,547.76 1,548.77 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% GLEPGQEYNVLLTAEK 95.00% 4.38 0.616 3.51 880.9571 1,759.90 1,760.91 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% GLEPGQEYNVLLTAEK 95.00% 3.9 0.531 4.07 880.958 1,759.90 1,760.91 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% GLEPGQEYNVLLTAEK 95.00% 3.54 0.533 4.15 880.9588 1,759.90 1,760.91 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% GLEPGQEYNVLLTAEK 95.00% 3.78 0.55 3.96 880.959 1,759.90 1,760.91 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% GLEPGQEYNVLLTAEK 95.00% 3.99 0.559 4.32 880.959 1,759.90 1,760.91 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% GLEPGQEYNVLLTAEK 95.00% 4.01 0.572 4.15 880.9602 1,759.90 1,760.91 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% GLEPGQEYNVLLTAEK 95.00% 4.16 0.533 3.82 880.9608 1,759.91 1,760.91 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% GLEPGQEYNVLLTAEK 95.00% 4.12 0.588 3.7 881.4599 1,760.90 1,760.91 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% GLEPGQEYNVLLTAEK 95.00% 3.7 0.515 4.34 881.4608 1,760.91 1,760.91 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% GLEPGQEYNVLLTAEK 95.00% 4.06 0.554 3.02 881.4613 1,760.91 1,760.91 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% GLEPGQEYNVLLTAEK 95.00% 3.6 0.543 4.64 881.4614 1,760.91 1,760.91 2
 SAMPLE 4 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 10 10 66 5.63% TTLTGLRPGTEYGIGVSAVK 95.00% 4.16 0.487 5.85 1,010.55 2,019.09 2,020.11 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 2.51 0.225 0 491.2959 980.5762 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 2.96 0.256 1.33 491.2961 980.5765 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 2.45 0.307 0 491.2962 980.5767 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 2.19 0.282 0 491.2964 980.5771 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 2.85 0.297 0 491.2965 980.5774 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 2.88 0.373 1.6 491.2966 980.5776 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 2.89 0.325 0 491.2966 980.5776 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 2.39 0.317 1.6 491.2968 980.5779 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 2.77 0.297 0 491.297 980.5783 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 2.54 0.282 2.44 491.297 980.5783 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 2.45 0.26 0 491.2973 980.579 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 2.36 0.338 2.37 491.2978 980.5799 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% IQALNGPLR 95.00% 1.79 0.272 1.49 491.299 980.5824 981.5847 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% FTTDLDSPR 95.00% 2.66 0.466 1.92 526.2563 1,050.50 1,051.51 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% FTTDLDSPR 95.00% 2.13 0.444 1.68 526.257 1,050.50 1,051.51 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% FTTDLDSPR 95.00% 2.5 0.469 0 526.2574 1,050.50 1,051.51 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% FTTDLDSPR 95.00% 2.92 0.471 2.02 526.2574 1,050.50 1,051.51 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% FTTDLDSPR 95.00% 2.64 0.463 1.74 526.2578 1,050.50 1,051.51 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% FTTDLDSPR 95.00% 2.49 0.448 1.85 526.2578 1,050.50 1,051.51 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% FTTDLDSPR 95.00% 2.11 0.328 1.96 526.258 1,050.50 1,051.51 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% FTTDLDSPR 95.00% 2.51 0.459 2.02 526.258 1,050.50 1,051.51 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% FTTDLDSPR 95.00% 2.41 0.437 2.08 526.258 1,050.50 1,051.51 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% FTTDLDSPR 95.00% 2.67 0.473 2.52 526.2586 1,050.50 1,051.51 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% FTTDLDSPR 95.00% 2.3 0.463 1.89 526.2603 1,050.51 1,051.51 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ITAQGQYELR 95.00% 3.02 0.436 0 589.811 1,177.61 1,178.62 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ITAQGQYELR 95.00% 2.87 0.389 0 589.8114 1,177.61 1,178.62 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ITAQGQYELR 95.00% 3.16 0.349 0 589.8119 1,177.61 1,178.62 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ITAQGQYELR 95.00% 2.66 0.351 0 589.8125 1,177.61 1,178.62 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ITAQGQYELR 95.00% 3.17 0.365 1.24 589.8126 1,177.61 1,178.62 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ITAQGQYELR 95.00% 3.21 0.446 0 589.8127 1,177.61 1,178.62 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ITAQGQYELR 95.00% 2.74 0.392 0 589.8135 1,177.61 1,178.62 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ITAQGQYELR 95.00% 3.26 0.433 0 589.8142 1,177.61 1,178.62 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ETFTTGLDAPR 95.00% 3.13 0.469 1.92 604.3025 1,206.59 1,207.60 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ETFTTGLDAPR 95.00% 3.17 0.499 2.12 604.3025 1,206.59 1,207.60 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ETFTTGLDAPR 95.00% 3.21 0.466 1.96 604.3027 1,206.59 1,207.60 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ETFTTGLDAPR 95.00% 2.71 0.403 1.85 604.3027 1,206.59 1,207.60 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ETFTTGLDAPR 95.00% 2.78 0.428 0 604.3027 1,206.59 1,207.60 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ETFTTGLDAPR 95.00% 3.05 0.511 2.13 604.3035 1,206.59 1,207.60 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ETFTTGLDAPR 95.00% 2.16 0.354 0 604.3042 1,206.59 1,207.60 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% ETFTTGLDAPR 95.00% 3.14 0.464 2.44 604.3043 1,206.59 1,207.60 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% TTLTGLRPGTEYGIGVSAVK 95.00% 2.37 0.285 0 674.3769 2,020.11 2,020.11 3
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% TTLTGLRPGTEYGIGVSAVK 95.00% 1.84 0.195 1.51 674.3779 2,020.11 2,020.11 3
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% VSQTDNSITLEWR 95.00% 2.88 0.3 2.77 774.8893 1,547.76 1,548.77 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% VSQTDNSITLEWR 95.00% 3.17 0.419 3.89 774.8894 1,547.76 1,548.77 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% VSQTDNSITLEWR 95.00% 3.37 0.411 3.92 774.891 1,547.77 1,548.77 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% VSQTDNSITLEWR 95.00% 3.5 0.28 2.62 775.3893 1,548.76 1,548.77 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% VSQTDNSITLEWR 95.00% 3.54 0.415 3.51 775.3898 1,548.76 1,548.77 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% VSQTDNSITLEWR 95.00% 3.19 0.258 3.08 775.3921 1,548.77 1,548.77 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% VSQTDNSITLEWR 95.00% 3.6 0.34 3.06 775.3943 1,548.77 1,548.77 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 3.67 0.562 4.85 880.9564 1,759.90 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 3.6 0.512 4.08 880.9575 1,759.90 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 3.83 0.588 3.8 880.958 1,759.90 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 3.79 0.547 3.55 880.9585 1,759.90 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 3.32 0.515 3.89 880.9592 1,759.90 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 4.11 0.537 4.7 880.9597 1,759.90 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 3.14 0.527 3.42 880.9602 1,759.90 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 3.92 0.558 4.2 880.9604 1,759.91 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 4.13 0.569 5.05 880.9607 1,759.91 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 4.25 0.552 4 881.4602 1,760.90 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 4.15 0.51 4.92 881.4603 1,760.90 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 4.47 0.563 4.44 881.4609 1,760.91 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 4.05 0.57 4.96 881.4614 1,760.91 1,760.91 2
 SAMPLE 4R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 63 4.00% GLEPGQEYNVLLTAEK 95.00% 4.1 0.552 3.64 881.4615 1,760.91 1,760.91 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% IQALNGPLR 95.00% 1.91 0.275 1.44 491.2953 980.575 981.5847 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% FTTDLDSPR 95.00% 2.5 0.438 1.66 526.2545 1,050.49 1,051.51 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% FTTDLDSPR 95.00% 2.61 0.42 1.64 526.2556 1,050.50 1,051.51 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% FTTDLDSPR 95.00% 2.57 0.464 1.52 526.2566 1,050.50 1,051.51 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% APTAQVESFR 95.00% 2.34 0.328 0 553.2844 1,104.55 1,105.56 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% APTAQVESFR 95.00% 1.97 0.301 0 553.2852 1,104.55 1,105.56 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% ITAQGQYELR 95.00% 2.55 0.228 0 589.9649 1,177.91 1,178.62 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% ETFTTGLDAPR 95.00% 3.04 0.48 1.96 604.3 1,206.58 1,207.60 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% GLEPGQEYNVLLTAEK 95.00% 3.8 0.576 3.37 880.955 1,759.89 1,760.91 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% GLEPGQEYNVLLTAEK 95.00% 3.75 0.54 4.41 880.9551 1,759.89 1,760.91 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% GLEPGQEYNVLLTAEK 95.00% 4.31 0.577 4.03 880.9554 1,759.90 1,760.91 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% GLEPGQEYNVLLTAEK 95.00% 3.73 0.556 4.19 880.9558 1,759.90 1,760.91 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% GLEPGQEYNVLLTAEK 95.00% 4.17 0.512 2.82 880.9574 1,759.90 1,760.91 2
 SAMPLE 1 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 14 2.95% GLEPGQEYNVLLTAEK 95.00% 4.12 0.55 2.85 881.458 1,760.90 1,760.91 2
 SAMPLE 1R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 7 1.59% FTTDLDSPR 95.00% 2.09 0.338 1.62 526.2558 1,050.50 1,051.51 2
 SAMPLE 1R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 7 1.59% FTTDLDSPR 95.00% 2.24 0.344 1.37 526.2569 1,050.50 1,051.51 2
 SAMPLE 1R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 7 1.59% FTTDLDSPR 95.00% 2.35 0.415 0 526.257 1,050.50 1,051.51 2
 SAMPLE 1R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 7 1.59% ITAQGQYELR 95.00% 2.91 0.394 0 589.8111 1,177.61 1,178.62 2
 SAMPLE 1R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 7 1.59% ITAQGQYELR 95.00% 2.84 0.39 0 589.8115 1,177.61 1,178.62 2
 SAMPLE 1R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 7 1.59% GLEPGQEYNVLLTAEK 95.00% 3.91 0.527 2.64 880.9551 1,759.89 1,760.91 2
 SAMPLE 1R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 7 1.59% GLEPGQEYNVLLTAEK 95.00% 4.1 0.528 4.2 881.4581 1,760.90 1,760.91 2
 SAMPLE 2 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 11 3.09% IQALNGPLR 95.00% 2.31 0.292 0 491.2944 980.5732 981.5847 2
 SAMPLE 2 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 11 3.09% IQALNGPLR 95.00% 3.03 0.352 0 491.2946 980.5735 981.5847 2
 SAMPLE 2 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 11 3.09% IQALNGPLR 95.00% 2.76 0.351 0 491.2951 980.5746 981.5847 2
 SAMPLE 2 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 11 3.09% APTAQVESFR 95.00% 2.7 0.485 0 553.285 1,104.55 1,105.56 2
 SAMPLE 2 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 11 3.09% APTAQVESFR 95.00% 2.98 0.438 1.72 553.2864 1,104.56 1,105.56 2
 SAMPLE 2 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 11 3.09% ITAQGQYELR 95.00% 3.27 0.448 1.24 589.8104 1,177.61 1,178.62 2
 SAMPLE 2 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 11 3.09% ITAQGQYELR 95.00% 2.97 0.437 0 589.8108 1,177.61 1,178.62 2
 SAMPLE 2 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 11 3.09% ITAQGQYELR 95.00% 2.97 0.355 1.19 589.8109 1,177.61 1,178.62 2
 SAMPLE 2 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 11 3.09% ETFTTGLDAPR 95.00% 2.74 0.427 2.24 604.3013 1,206.59 1,207.60 2
 SAMPLE 2 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 11 3.09% VATYLPAPEGLK 95.00% 2.26 0.386 0 629.8555 1,257.70 1,258.70 2
 SAMPLE 2 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 6 6 11 3.09% GLEPGQEYNVLLTAEK 95.00% 4.27 0.558 3.52 880.9553 1,759.89 1,760.91 2
 SAMPLE 2R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 11 1.68% ITAQGQYELR 95.00% 2.56 0.271 0 589.8098 1,177.60 1,178.62 2
 SAMPLE 2R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 11 1.68% ITAQGQYELR 95.00% 2.65 0.426 0 589.8098 1,177.60 1,178.62 2
 SAMPLE 2R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 11 1.68% ITAQGQYELR 95.00% 2.81 0.147 0 589.8101 1,177.60 1,178.62 2
 SAMPLE 2R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 11 1.68% ITAQGQYELR 95.00% 3.24 0.462 0 589.8106 1,177.61 1,178.62 2
 SAMPLE 2R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 11 1.68% ITAQGQYELR 95.00% 3.14 0.45 0 589.8113 1,177.61 1,178.62 2
 SAMPLE 2R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 11 1.68% ITAQGQYELR 95.00% 2.81 0.448 0 589.8128 1,177.61 1,178.62 2
 SAMPLE 2R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 11 1.68% ETFTTGLDAPR 95.00% 2.72 0.423 1.89 604.2992 1,206.58 1,207.60 2
 SAMPLE 2R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 11 1.68% ETFTTGLDAPR 95.00% 2.88 0.457 2.03 604.3001 1,206.58 1,207.60 2
 SAMPLE 2R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 11 1.68% GLEPGQEYNVLLTAEK 95.00% 3.91 0.542 2 880.9566 1,759.90 1,760.91 2
 SAMPLE 2R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 11 1.68% GLEPGQEYNVLLTAEK 95.00% 3.55 0.511 3.47 880.9568 1,759.90 1,760.91 2
 SAMPLE 2R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 3 3 11 1.68% GLEPGQEYNVLLTAEK 95.00% 4.23 0.561 3.77 881.4556 1,760.90 1,760.91 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% IQALNGPLR 95.00% 2.79 0.366 0 491.2947 980.5737 981.5847 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% IQALNGPLR 95.00% 1.77 0.327 0 491.295 980.5743 981.5847 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% FTTDLDSPR 95.00% 2.82 0.491 1.46 526.2554 1,050.50 1,051.51 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% FTTDLDSPR 95.00% 2.52 0.442 1.44 526.2555 1,050.50 1,051.51 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% FTTDLDSPR 95.00% 2.43 0.468 0 526.256 1,050.50 1,051.51 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% FTTDLDSPR 95.00% 2.69 0.466 2 526.2561 1,050.50 1,051.51 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% APTAQVESFR 95.00% 3.17 0.421 2.18 553.2842 1,104.55 1,105.56 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% APTAQVESFR 95.00% 2.86 0.374 2.23 553.2848 1,104.55 1,105.56 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% ITAQGQYELR 95.00% 2.8 0.431 0 589.8117 1,177.61 1,178.62 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% ITAQGQYELR 95.00% 2.72 0.407 0 589.8118 1,177.61 1,178.62 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% ETFTTGLDAPR 95.00% 2.84 0.439 1.12 604.3003 1,206.59 1,207.60 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% ETFTTGLDAPR 95.00% 3 0.445 2.15 604.3018 1,206.59 1,207.60 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% ETFTTGLDAPR 94.60% 2.16 0.286 0 605.0403 1,208.07 1,207.60 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% VATYLPAPEGLK 95.00% 2.09 0.348 0 629.8549 1,257.69 1,258.70 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% VATYLPAPEGLK 95.00% 2.51 0.474 0 629.8554 1,257.70 1,258.70 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% VSQTDNSITLEWR 95.00% 1.85 0.213 1.14 774.8854 1,547.76 1,548.77 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% GLEPGQEYNVLLTAEK 95.00% 3.65 0.523 3.42 880.9572 1,759.90 1,760.91 2
 SAMPLE 3 Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 8 8 18 4.09% GLEPGQEYNVLLTAEK 95.00% 3.82 0.515 1.77 881.4561 1,760.90 1,760.91 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% IQALNGPLR 95.00% 1.96 0.246 0 491.2945 980.5734 981.5847 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% FTTDLDSPR 95.00% 2.28 0.392 0 526.2552 1,050.49 1,051.51 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% FTTDLDSPR 95.00% 2.52 0.406 1.8 526.2555 1,050.50 1,051.51 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% APTAQVESFR 95.00% 2.29 0.263 0 553.2655 1,104.52 1,105.56 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% APTAQVESFR 95.00% 3.09 0.374 2.48 553.2812 1,104.55 1,105.56 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% APTAQVESFR 95.00% 2.91 0.442 2.31 553.2846 1,104.55 1,105.56 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% APTAQVESFR 95.00% 2.13 0.237 0 553.286 1,104.56 1,105.56 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% ITAQGQYELR 95.00% 2.99 0.414 0 589.8096 1,177.60 1,178.62 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% ITAQGQYELR 95.00% 2.87 0.412 0 589.8097 1,177.60 1,178.62 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% ITAQGQYELR 95.00% 2.5 0.332 0 590.2823 1,178.55 1,178.62 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% ETFTTGLDAPR 95.00% 2.46 0.376 1.29 604.3 1,206.58 1,207.60 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% ETFTTGLDAPR 95.00% 3.03 0.398 1.62 604.3012 1,206.59 1,207.60 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% ETFTTGLDAPR 95.00% 2.77 0.395 1.51 604.3014 1,206.59 1,207.60 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% VSQTDNSITLEWR 95.00% 3.02 0.388 3.4 775.3904 1,548.77 1,548.77 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% GLEPGQEYNVLLTAEK 95.00% 4.3 0.585 3.72 880.9552 1,759.89 1,760.91 2
 SAMPLE 3R Tenascin  TNC  TENA_HUMAN 240,845.20 100.00% 7 7 16 3.54% GLEPGQEYNVLLTAEK 95.00% 4.07 0.558 2.49 880.9557 1,759.90 1,760.91 2
 SAMPLE 4 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 12 1.33% FLLYGLSGR 95.00% 1.88 0.36 1.46 513.2946 1,024.57 1,025.58 2
 SAMPLE 4 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 12 1.33% FDSFTVQYK 95.00% 1.77 0.335 1.36 567.7754 1,133.54 1,134.55 2
 SAMPLE 4 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 12 1.33% FDSFTVQYK 95.00% 2.14 0.373 3.17 567.7769 1,133.54 1,134.55 2
 SAMPLE 4 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 12 1.33% FDSFTVQYK 95.00% 2.52 0.423 3.23 567.7769 1,133.54 1,134.55 2
 SAMPLE 4 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 12 1.33% FDSFTVQYK 95.00% 2.32 0.381 3.19 567.7785 1,133.54 1,134.55 2
 SAMPLE 4 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 12 1.33% FDSFTVQYK 95.00% 1.89 0.405 3.39 567.7804 1,133.55 1,134.55 2
 SAMPLE 4 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 12 1.33% FLLFGIQDGK 95.00% 2.39 0.297 1.21 569.32 1,136.62 1,137.63 2
 SAMPLE 4 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 12 1.33% FLLFGIQDGK 95.00% 3 0.432 0 569.3203 1,136.63 1,137.63 2
 SAMPLE 4 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 12 1.33% FLLFGIQDGK 95.00% 3.42 0.432 0 569.3205 1,136.63 1,137.63 2
 SAMPLE 4 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 12 1.33% FLLFGIQDGK 95.00% 2.54 0.273 1.59 569.3216 1,136.63 1,137.63 2
 SAMPLE 4 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 12 1.33% VRGEESEVTVGGLEPGRK 95.00% 1.82 0.262 0 633.3102 1,896.91 1,898.99 3 IQGA1_HUMAN,STIP1_HUMAN
 SAMPLE 4 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 12 1.33% AGQcVcVEGFR 95.00% 2.78 0.482 0 c4: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 642.2865 1,282.56 1,282.57 2
 SAMPLE 4R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 8 1.33% FLLYGLSGR 95.00% 2.58 0.274 2 513.2933 1,024.57 1,025.58 2
 SAMPLE 4R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 8 1.33% FLLYGLSGR 95.00% 2.57 0.334 0 513.2944 1,024.57 1,025.58 2
 SAMPLE 4R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 8 1.33% FDSFTVQYK 95.00% 2.48 0.5 3.31 567.7771 1,133.54 1,134.55 2
 SAMPLE 4R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 8 1.33% FDSFTVQYK 95.00% 1.6 0.345 3.59 567.7781 1,133.54 1,134.55 2
 SAMPLE 4R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 8 1.33% FDSFTVQYK 95.00% 2.1 0.37 2.68 568.2784 1,134.54 1,134.55 2
 SAMPLE 4R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 8 1.33% FLLFGIQDGK 95.00% 2.49 0.248 0 568.8278 1,135.64 1,137.63 2
 SAMPLE 4R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 8 1.33% FLLFGIQDGK 95.00% 3.1 0.416 1.38 569.3195 1,136.62 1,137.63 2
 SAMPLE 4R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 5 5 8 1.33% PSDPIIYQGImDKDEEKPGK 95.00% 2.51 0.226 0 m11: Oxidation (+15.99) 758.9252 2,273.75 2,276.11 3
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% TSDSLLLR 95.00% 2.47 0.298 1.34 452.7613 903.507 904.5105 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% FTLFGIANK 95.00% 2.49 0.3 1.7 505.7868 1,009.56 1,010.57 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% FTLFGIANK 95.00% 2.54 0.344 1.72 505.7868 1,009.56 1,010.57 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% FVLYGFVGK 95.00% 2.52 0.329 1.21 515.2907 1,028.57 1,029.58 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% TLSPVLESPR 94.70% 2.3 0.0941 3.35 550.2867 1,098.56 1,098.62 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% SVTVTPLDAGR 95.00% 2.73 0.427 1.89 558.3059 1,114.60 1,115.61 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% SVTVTPLDAGR 95.00% 2.66 0.43 1.92 558.3062 1,114.60 1,115.61 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% FDSFTVQYK 95.00% 2.04 0.167 3.24 567.7748 1,133.53 1,134.55 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% FDSFTVQYK 95.00% 2.65 0.462 3.06 567.776 1,133.54 1,134.55 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% FDSFTVQYK 95.00% 1.79 0.192 1.8 567.7762 1,133.54 1,134.55 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% FDSFTVQYK 95.00% 1.93 0.239 3.35 567.7762 1,133.54 1,134.55 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% FDSFTVQYK 95.00% 2.4 0.427 4 567.7765 1,133.54 1,134.55 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% FLLFGIQDGK 95.00% 3.66 0.383 1.15 568.8258 1,135.64 1,137.63 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% FLLFGIQDGK 95.00% 3.5 0.435 2 568.8264 1,135.64 1,137.63 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% FLLFGIQDGK 95.00% 2.78 0.382 1.14 569.3174 1,136.62 1,137.63 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% FLLFGIQDGK 95.00% 2.76 0.381 0 569.3181 1,136.62 1,137.63 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% LQVVPVAANQR 95.00% 3.12 0.444 2.27 597.8499 1,193.68 1,194.70 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% LQVVPVAANQR 95.00% 2.94 0.45 3.19 597.8505 1,193.69 1,194.70 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% VRGEESEVTVGGLEPGRK 95.00% 4.63 0.418 2.4 633.6677 1,897.98 1,898.99 3 IQGA1_HUMAN,STIP1_HUMAN
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% IGGDRNDITLSGLESDHR 95.00% 4.35 0.472 2.82 652.6621 1,954.96 1,954.96 3
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% TVTVEDLEPGKK 95.00% 2.41 0.358 0 658.3552 1,314.69 1,315.71 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% EVTVYNLEPER 95.00% 2.57 0.433 0 675.3395 1,348.66 1,348.67 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% YLVTLYGFSDGK 95.00% 2.14 0.353 0 681.8512 1,361.69 1,362.69 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% ILISGLEPSTPYR 95.00% 3.28 0.474 2.51 723.4034 1,444.79 1,445.80 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% ILISGLEPSTPYR 95.00% 3.47 0.5 2.62 723.4041 1,444.79 1,445.80 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% LGPISADSTTAPLEK 95.00% 4.53 0.449 6.7 750.4008 1,498.79 1,499.80 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% LGPISADSTTAPLEK 95.00% 4.58 0.446 6.82 750.4025 1,498.79 1,499.80 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% LSQLSVTDVTTSSLR 95.00% 4.85 0.571 7.31 803.9353 1,605.86 1,606.87 2 MYH9_HUMAN
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% LSQLSVTDVTTSSLR 95.00% 4.44 0.581 7.32 803.9383 1,605.86 1,606.87 2 MYH9_HUMAN
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% LGPLSAEGTTGLAPAGQTSEESRPR 95.00% 3.36 0.4 2.29 828.4236 2,482.25 2,482.25 3
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% LGPLSAEGTTGLAPAGQTSEESRPR 95.00% 3.16 0.417 2.8 828.4239 2,482.25 2,482.25 3
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% LGELWVTDPTPDSLR 95.00% 4.78 0.565 3.25 849.9361 1,697.86 1,698.87 2
 SAMPLE 1 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 18 18 31 5.39% LGELWVTDPTPDSLR 95.00% 4.9 0.583 3.36 849.9369 1,697.86 1,698.87 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% LGELTVTDR 95.00% 2.6 0.445 0 502.2731 1,002.53 1,003.54 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% LGELTVTDR 95.00% 3.16 0.371 1.52 502.2731 1,002.53 1,003.54 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FTLFGIANK 95.00% 2.27 0.37 0 505.7864 1,009.56 1,010.57 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FLLYGLLGK 95.00% 1.94 0.188 1.54 512.3136 1,022.61 1,023.62 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FLLYGLLGK 95.00% 2.19 0.221 1.42 512.3147 1,022.61 1,023.62 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FLLYGLLGK 95.00% 2.6 0.158 1.51 512.3148 1,022.61 1,023.62 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FLLYGLSGR 95.00% 3.45 0.419 1.57 513.2918 1,024.57 1,025.58 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FLLYGLSGR 95.00% 2.87 0.367 0 513.2919 1,024.57 1,025.58 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% YEVTVVSVR 95.00% 2.19 0.416 2.52 526.6866 1,051.36 1,051.58 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% YEVTVVSVR 95.00% 2.09 0.371 1.55 526.6872 1,051.36 1,051.58 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% YEVTVVSVR 95.00% 1.67 0.356 1.38 526.6882 1,051.36 1,051.58 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% SVTVTPLDAGR 95.00% 2.59 0.406 0 558.3054 1,114.60 1,115.61 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% SVTVTPLDAGR 95.00% 2.65 0.409 0 558.3074 1,114.60 1,115.61 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FDSFTVQYK 95.00% 2.26 0.465 4.03 567.7762 1,133.54 1,134.55 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FDSFTVQYK 95.00% 2.35 0.425 3 567.7763 1,133.54 1,134.55 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FLLFGIQDGK 95.00% 3.54 0.413 1.35 568.8253 1,135.64 1,137.63 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FLLFGIQDGK 95.00% 3.61 0.409 1.12 568.8255 1,135.64 1,137.63 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FLLFGIQDGK 95.00% 2.71 0.269 0 569.3171 1,136.62 1,137.63 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FLLFGIQDGK 95.00% 2.81 0.387 0 569.3189 1,136.62 1,137.63 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% FLLFGIQDGK 95.00% 2.7 0.385 0 569.8176 1,137.62 1,137.63 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% LQVVPVAANQR 95.00% 2.78 0.394 2.06 597.851 1,193.69 1,194.70 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% LQVVPVAANQR 95.00% 3.16 0.326 2.03 598.3513 1,194.69 1,194.70 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% MNLYGFHGGQR 95.00% 2.79 0.321 1.96 640.302 1,278.59 1,279.60 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% MNLYGFHGGQR 95.00% 3 0.417 1.85 640.3022 1,278.59 1,279.60 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% TVTVEDLEPGKK 95.00% 2.16 0.278 0 658.3531 1,314.69 1,315.71 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% EVTVYNLEPER 95.00% 1.95 0.344 1.2 675.3434 1,348.67 1,348.67 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% YLVTLYGFSDGK 95.00% 2.04 0.364 0 681.8501 1,361.68 1,362.69 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% YLVTLYGFSDGK 95.00% 3.43 0.481 4.09 682.3504 1,362.69 1,362.69 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% SGTLYSLTLYGLR 95.00% 3.72 0.161 0 722.3956 1,442.78 1,443.78 2 LAMC1_HUMAN
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% ILISGLEPSTPYR 95.00% 2.27 0.482 1.49 723.4062 1,444.80 1,445.80 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% ILISGLEPSTPYR 95.00% 3.3 0.457 2.82 723.9046 1,445.79 1,445.80 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% LGPISADSTTAPLEK 95.00% 4.11 0.456 3.92 750.3996 1,498.78 1,499.80 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% LGPISADSTTAPLEK 95.00% 4.25 0.5 3.8 750.4024 1,498.79 1,499.80 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% LSQLSVTDVTTSSLR 95.00% 4.35 0.578 7.92 803.9352 1,605.85 1,606.87 2 MYH9_HUMAN
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% LSQLSVTDVTTSSLR 95.00% 4.47 0.565 7.24 803.9365 1,605.86 1,606.87 2 MYH9_HUMAN
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% DAQGQPQAVPVSGDLR 95.00% 3.29 0.477 1.57 819.4165 1,636.82 1,637.83 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% DAQGQPQAVPVSGDLR 95.00% 3.59 0.501 2.82 819.417 1,636.82 1,637.83 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% LGPLSAEGTTGLAPAGQTSEESRPR 95.00% 3.18 0.371 2.57 828.4243 2,482.25 2,482.25 3
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% LGELWVTDPTPDSLR 95.00% 1.75 0.457 1.26 849.1935 1,696.37 1,698.87 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% LGELWVTDPTPDSLR 95.00% 4.66 0.577 4.22 849.9356 1,697.86 1,698.87 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% LGELWVTDPTPDSLR 95.00% 4.64 0.549 3.29 849.9382 1,697.86 1,698.87 2
 SAMPLE 1R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 21 21 40 6.11% VGGEESEVTVGGLEPGRK 95.00% 3.52 0.441 2.16 900.9616 1,799.91 1,799.91 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% TSDSLLLR 95.00% 2.62 0.29 0 452.76 903.5044 904.5105 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% TSDSLLLR 95.00% 2.44 0.324 0 452.7607 903.5057 904.5105 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% FTLFGIANK 95.00% 2.74 0.315 1.96 505.7855 1,009.56 1,010.57 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% FTLFGIANK 95.00% 2.63 0.332 0 505.7867 1,009.56 1,010.57 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% FLLYGLSGR 95.00% 3.36 0.421 0 513.2919 1,024.57 1,025.58 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% FLLYGLSGR 95.00% 3.16 0.413 1.52 513.2922 1,024.57 1,025.58 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% FVLYGFVGK 95.00% 2.48 0.305 0 515.2917 1,028.57 1,029.58 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% SFVVSSLDPDHKYR 95.00% 2.06 0.246 0 550.6139 1,648.82 1,649.83 3
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% SVTVTPLDAGR 95.00% 2.78 0.429 1.28 558.3061 1,114.60 1,115.61 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% SVTVTPLDAGR 95.00% 2.57 0.43 0 558.3071 1,114.60 1,115.61 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% FDSFTVQYK 95.00% 2.04 0.264 2.41 567.774 1,133.53 1,134.55 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% FDSFTVQYK 95.00% 2.23 0.41 3.57 567.7754 1,133.54 1,134.55 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% FDSFTVQYK 95.00% 2.64 0.449 2.49 567.7763 1,133.54 1,134.55 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% FLLFGIQDGK 95.00% 3.49 0.394 0 568.824 1,135.63 1,137.63 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% FLLFGIQDGK 95.00% 2.82 0.375 0 569.3174 1,136.62 1,137.63 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% FLLFGIQDGK 95.00% 3.77 0.439 0 569.3182 1,136.62 1,137.63 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% FLLFGIQDGK 95.00% 3.29 0.396 0 569.3186 1,136.62 1,137.63 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% DKDGQPQVVPVAADQR 95.00% 2.81 0.245 1.62 575.2973 1,722.87 1,722.88 3
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% DKDGQPQVVPVAADQR 95.00% 2.66 0.355 0 575.2981 1,722.87 1,722.88 3
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% DRDGQPQVVPVEGSLR 95.00% 2.69 0.184 1.24 584.6391 1,750.89 1,751.90 3
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% DRDGQPQVVPVEGPQR 95.00% 2.58 0.23 1.59 592.9708 1,775.89 1,776.90 3
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% DRDGQPQVVPVEGPQR 95.00% 2.67 0.166 1.24 593.3063 1,776.90 1,776.90 3
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% LQVVPVAANQR 95.00% 2.82 0.404 2.14 597.8504 1,193.69 1,194.70 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% LQVVPVAANQR 95.00% 2.97 0.447 3.09 597.851 1,193.69 1,194.70 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% DRDPNSLLIScAVSYR 95.00% 3.12 0.374 1.72 c11: Carbamidomethyl (+57.02) 622.9773 1,865.91 1,865.92 3
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% EVTVYNLEPER 95.00% 2.1 0.356 0 675.3435 1,348.67 1,348.67 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% SGTLYSLTLYGLR 95.00% 3.91 0.167 1.96 722.3947 1,442.77 1,443.78 2 LAMC1_HUMAN
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% ELPPHLGELTVAEETSSSLR 95.00% 3.28 0.459 0 722.7083 2,165.10 2,165.11 3
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% ILISGLEPSTPYR 95.00% 3.04 0.449 0 723.4061 1,444.80 1,445.80 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% YGPLTADGTTAPER 95.00% 2.8 0.398 2.54 724.8536 1,447.69 1,448.70 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% YGPLTADGTTAPER 95.00% 2.27 0.29 2.54 724.8545 1,447.69 1,448.70 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% LGPISADSTTAPLEK 95.00% 4.45 0.405 4.26 750.4016 1,498.79 1,499.80 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% LGPISADSTTAPLEK 95.00% 4.34 0.424 4.62 750.4041 1,498.79 1,499.80 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% PSDPIIYQGImDKDEEKPGK 94.60% 2.63 0.195 0 m11: Oxidation (+15.99) 758.9222 2,273.74 2,276.11 3
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% LSQLSVTDVTTSSLR 95.00% 4.24 0.574 6.54 803.9355 1,605.86 1,606.87 2 MYH9_HUMAN
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% LSQLSVTDVTTSSLR 95.00% 4.48 0.577 6.4 803.9356 1,605.86 1,606.87 2 MYH9_HUMAN
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% DAQGQPQAVPVSGDLR 95.00% 4.25 0.528 3.96 819.4149 1,636.81 1,637.83 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% DAQGQPQAVPVSGDLR 95.00% 4.42 0.551 3.8 819.4154 1,636.82 1,637.83 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% LGPLSAEGTTGLAPAGQTSEESRPR 95.00% 3.08 0.364 2 828.4218 2,482.24 2,482.25 3
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% LGPLSAEGTTGLAPAGQTSEESRPR 95.00% 3.85 0.452 2.6 828.4246 2,482.25 2,482.25 3
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% LGELWVTDPTPDSLR 95.00% 4.31 0.527 3.2 849.9374 1,697.86 1,698.87 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% LGELWVTDPTPDSLR 95.00% 4.39 0.55 3.74 850.4388 1,698.86 1,698.87 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% VGGEESEVTVGGLEPGRK 95.00% 4.47 0.47 3.31 900.9595 1,799.90 1,799.91 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% VGGEESEVTVGGLEPGRK 95.00% 4.41 0.463 2.4 900.96 1,799.90 1,799.91 2
 SAMPLE 2 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 26 26 43 8.67% VGPVSAVGVTAPEEESPDAPLAK 95.00% 5.89 0.6 10.3 1,111.08 2,220.14 2,220.14 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% TSDSLLLR 95.00% 2.25 0.254 0 452.7599 903.5042 904.5105 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% TSDSLLLR 95.00% 2.41 0.217 1.52 452.7613 903.5069 904.5105 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FTLFGIANK 95.00% 2.36 0.272 1.18 505.7863 1,009.56 1,010.57 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FTLFGIANK 95.00% 2.58 0.35 1.47 505.7863 1,009.56 1,010.57 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FLLYGLLGK 95.00% 2.16 0.267 0 512.3139 1,022.61 1,023.62 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FLLYGLLGK 95.00% 2.22 0.264 0 512.3149 1,022.61 1,023.62 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FVLYGFVGK 95.00% 2.11 0.241 1.15 515.2912 1,028.57 1,029.58 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% YEVTVVSVR 95.00% 1.66 0.358 0 526.6877 1,051.36 1,051.58 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% YEVTVVSVR 95.00% 2.23 0.393 1.96 526.6884 1,051.36 1,051.58 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% SVTVTPLDAGR 95.00% 2.68 0.475 0 558.3073 1,114.60 1,115.61 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% SVTVTPLDAGR 95.00% 2.62 0.43 1.72 558.3076 1,114.60 1,115.61 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FDSFTVQYK 95.00% 2.27 0.394 3.02 567.7769 1,133.54 1,134.55 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FDSFTVQYK 95.00% 2.02 0.288 3.21 567.7773 1,133.54 1,134.55 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FDSFTVQYK 95.00% 1.95 0.221 3.25 567.7777 1,133.54 1,134.55 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FDSFTVQYK 95.00% 2.46 0.466 3.55 568.2784 1,134.54 1,134.55 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FLLFGIQDGK 95.00% 3.42 0.405 0 568.8255 1,135.64 1,137.63 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FLLFGIQDGK 95.00% 3.29 0.422 1.59 568.8257 1,135.64 1,137.63 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FLLFGIQDGK 95.00% 3.29 0.422 1.59 568.8257 1,135.64 1,137.63 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% EEESPPRPSLSQPPR 95.00% 1.91 0.416 0 569.2869 1,704.84 1,705.85 3
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FLLFGIQDGK 95.00% 2.92 0.391 0 569.3183 1,136.62 1,137.63 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% FLLFGIQDGK 95.00% 2.68 0.405 1.96 569.3186 1,136.62 1,137.63 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% DKDGQPQVVPVAADQR 95.00% 2.42 0.286 1.42 574.9623 1,721.86 1,722.88 3
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% LQVVPVAANQR 95.00% 2.83 0.438 2.43 597.8506 1,193.69 1,194.70 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% LQVVPVAANQR 95.00% 2.64 0.405 1.96 597.8509 1,193.69 1,194.70 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% VGPISAVAITAGR 95.00% 3.54 0.511 3.42 606.3571 1,210.70 1,211.71 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% VGPISAVAITAGR 95.00% 3.59 0.553 3.3 606.3578 1,210.70 1,211.71 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% YLVTLYGFSDGK 95.00% 3.35 0.547 3.43 682.3517 1,362.69 1,362.69 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% YLVTLYGFSDGK 95.00% 3.18 0.525 5.32 682.3523 1,362.69 1,362.69 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% ILISGLEPSTPYR 95.00% 3.08 0.478 1.48 723.4041 1,444.79 1,445.80 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% ILISGLEPSTPYR 95.00% 2.77 0.451 2.01 723.4042 1,444.79 1,445.80 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% YGPLTADGTTAPER 95.00% 2.5 0.287 0 724.8537 1,447.69 1,448.70 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% LGPISADSTTAPLEK 95.00% 4.45 0.414 5.19 750.4 1,498.78 1,499.80 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% LGPISADSTTAPLEK 95.00% 4.21 0.452 5.24 750.4017 1,498.79 1,499.80 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% LSQLSVTDVTTSSLR 95.00% 4.53 0.596 5.33 804.4367 1,606.86 1,606.87 2 MYH9_HUMAN
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% LSQLSVTDVTTSSLR 95.00% 4.75 0.537 6.1 804.4372 1,606.86 1,606.87 2 MYH9_HUMAN
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% DAQGQPQAVPVSGDLR 95.00% 3.54 0.526 3.68 819.4179 1,636.82 1,637.83 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% LGPLSAEGTTGLAPAGQTSEESRPR 95.00% 3.78 0.465 3.03 828.4229 2,482.25 2,482.25 3
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% LGPLSAEGTTGLAPAGQTSEESRPR 95.00% 3.47 0.438 2.72 828.4242 2,482.25 2,482.25 3
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% DKDGQPQVVPVAADQR 95.00% 3.37 0.495 3.03 861.9381 1,721.86 1,722.88 2
 SAMPLE 2R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 20 21 38 5.99% VGGEESEVTVGGLEPGRK 95.00% 3.88 0.48 2.89 900.9614 1,799.91 1,799.91 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% TSDSLLLR 95.00% 2.46 0.223 0 452.7586 903.5016 904.5105 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% TSDSLLLR 95.00% 2.69 0.265 0 452.7604 903.5052 904.5105 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% LGELTVTDR 95.00% 2.7 0.447 0 502.2735 1,002.53 1,003.54 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% LGELTVTDR 95.00% 2 0.286 0 502.2747 1,002.53 1,003.54 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% FTLFGIANK 95.00% 2.75 0.311 1.21 505.786 1,009.56 1,010.57 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% FTLFGIANK 95.00% 2.68 0.326 1.29 505.7867 1,009.56 1,010.57 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% FLLYGLSGR 95.00% 3.4 0.435 1.39 513.2918 1,024.57 1,025.58 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% FLLYGLSGR 95.00% 3.3 0.41 1.89 513.292 1,024.57 1,025.58 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% YEVTVVSVR 95.00% 3.08 0.525 2.72 526.2922 1,050.57 1,051.58 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% YEVTVVSVR 95.00% 3.06 0.485 2.48 526.2926 1,050.57 1,051.58 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% SVTVTPLDAGR 95.00% 2.81 0.457 1.44 558.3059 1,114.60 1,115.61 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% SVTVTPLDAGR 95.00% 2.49 0.444 1.3 558.3067 1,114.60 1,115.61 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% FDSFTVQYK 95.00% 2.41 0.363 2.48 567.7763 1,133.54 1,134.55 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% FDSFTVQYK 95.00% 2.58 0.385 2.82 567.7768 1,133.54 1,134.55 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% FLLFGIQDGK 95.00% 3.57 0.419 0 568.8257 1,135.64 1,137.63 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% FLLFGIQDGK 95.00% 3.64 0.38 0 568.8263 1,135.64 1,137.63 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% FLLFGIQDGK 95.00% 2.92 0.406 0 569.3214 1,136.63 1,137.63 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% LQVVPVAANQR 95.00% 3.18 0.431 3.08 597.8504 1,193.69 1,194.70 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% LQVVPVAANQR 95.00% 2.94 0.391 2.23 597.8518 1,193.69 1,194.70 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% VGPISAVAITAGR 95.00% 4.06 0.58 3.54 606.3576 1,210.70 1,211.71 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% VGPISAVAITAGR 95.00% 3.84 0.559 3.55 606.3587 1,210.70 1,211.71 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% EVTVQGLEPSR 95.00% 2.85 0.305 1.43 607.8231 1,213.63 1,214.64 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% EVSVPGLDPAHR 95.00% 1.95 0.382 1.32 638.8385 1,275.66 1,276.67 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% TVTVEDLEPGKK 95.00% 2.31 0.313 0 658.3582 1,314.70 1,315.71 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% GFEFSVPFTEMK 95.00% 3.08 0.489 1.8 710.3376 1,418.66 1,418.67 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% ILISGLEPSTPYR 95.00% 3.33 0.487 1.42 723.4035 1,444.79 1,445.80 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% ILISGLEPSTPYR 95.00% 2.94 0.448 1.92 723.4059 1,444.80 1,445.80 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% YGPLTADGTTAPER 95.00% 2.81 0.392 2 725.3549 1,448.69 1,448.70 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% WRPQPPAEGPGGELTVPGTTR 95.00% 2.59 0.382 0 735.0193 2,202.03 2,203.13 3
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% VGPVSAVGVTAPEEESPDAPLAK 95.00% 2.98 0.457 0 741.0532 2,220.14 2,220.14 3
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% LGPISADSTTAPLEK 95.00% 4.55 0.425 5.14 750.4015 1,498.79 1,499.80 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% LGVLTVTDTTPDSMR 95.00% 3.51 0.593 3.05 803.4106 1,604.81 1,605.82 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% LSQLSVTDVTTSSLR 95.00% 4.36 0.604 6.77 803.9369 1,605.86 1,606.87 2 MYH9_HUMAN
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% LSQLSVTDVTTSSLR 95.00% 4.66 0.579 6.17 804.4355 1,606.86 1,606.87 2 MYH9_HUMAN
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% DAQGQPQAVPVSGDLR 95.00% 4.42 0.52 4.48 819.4147 1,636.81 1,637.83 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% DAQGQPQAVPVSGDLR 95.00% 4.12 0.547 3.11 819.4148 1,636.81 1,637.83 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% LGPLSAEGTTGLAPAGQTSEESRPR 95.00% 3.14 0.441 1.66 828.4233 2,482.25 2,482.25 3
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% LGPLSAEGTTGLAPAGQTSEESRPR 95.00% 3.67 0.517 2.85 828.4245 2,482.25 2,482.25 3
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% LGELWVTDPTPDSLR 95.00% 4.43 0.528 2.68 849.9369 1,697.86 1,698.87 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% LGELWVTDPTPDSLR 95.00% 4.78 0.543 2.54 849.9378 1,697.86 1,698.87 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% cVcDPGYTGEDcGTR 95.00% 1.66 0.381 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 873.3731 1,744.73 1,746.65 2
 SAMPLE 3 Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 25 26 40 7.74% VGPVSAVGVTAPEEESPDAPLAK 95.00% 5.82 0.622 7.96 1,111.07 2,220.13 2,220.14 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% TSDSLLLR 95.00% 2.3 0.328 0 452.7594 903.5031 904.5105 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% TSDSLLLR 95.00% 2.46 0.302 1.08 452.761 903.5063 904.5105 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LGELTVTDR 95.00% 2.38 0.362 0 502.2744 1,002.53 1,003.54 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LGELTVTDR 95.00% 2.42 0.503 1.33 502.2745 1,002.53 1,003.54 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FTLFGIANK 95.00% 2.1 0.316 2.23 505.7853 1,009.56 1,010.57 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FTLFGIANK 95.00% 2.48 0.348 0 505.7867 1,009.56 1,010.57 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FLLYGLSGR 95.00% 3.38 0.393 1.6 513.2917 1,024.57 1,025.58 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FLLYGLSGR 95.00% 3.36 0.404 1.33 513.2918 1,024.57 1,025.58 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% SFVVSSLDPDHKYR 95.00% 2.15 0.293 0 550.6138 1,648.82 1,649.83 3
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% SVTVTPLDAGR 95.00% 2.51 0.395 1.1 558.3093 1,114.60 1,115.61 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FDSFTVQYK 95.00% 2.06 0.322 2.08 567.7764 1,133.54 1,134.55 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FDSFTVQYK 95.00% 2.08 0.245 2.64 567.7771 1,133.54 1,134.55 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FDSFTVQYK 95.00% 2.33 0.387 3.72 568.2776 1,134.54 1,134.55 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FLLFGIQDGK 95.00% 3.53 0.425 0 568.8253 1,135.63 1,137.63 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FLLFGIQDGK 95.00% 3.4 0.418 0 568.8261 1,135.64 1,137.63 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FLLFGIQDGK 95.00% 3.16 0.398 0 569.3181 1,136.62 1,137.63 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FLLFGIQDGK 95.00% 3.01 0.412 0 569.3188 1,136.62 1,137.63 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FLLFGIQDGK 95.00% 2.82 0.366 0 569.3192 1,136.62 1,137.63 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% FLLFGIQDGK 95.00% 3.34 0.422 0 569.32 1,136.62 1,137.63 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LQVVPVAANQR 95.00% 2.85 0.402 2.42 597.8497 1,193.68 1,194.70 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LQVVPVAANQR 95.00% 2.58 0.396 2.41 597.8502 1,193.68 1,194.70 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% VGPISAVAITAGR 95.00% 3.76 0.599 3.14 606.3589 1,210.70 1,211.71 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% VGPISAVAITAGR 95.00% 4.03 0.596 3.7 606.3592 1,210.70 1,211.71 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% IGGDRNDITLSGLESDHR 95.00% 3.46 0.428 0 652.6584 1,954.95 1,954.96 3
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% GFEFSVPFTEMK 95.00% 3.22 0.364 2.24 710.3365 1,418.66 1,418.67 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% ILISGLEPSTPYR 95.00% 3.06 0.489 1.74 723.4044 1,444.79 1,445.80 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% ILISGLEPSTPYR 95.00% 2.78 0.434 1.17 723.4046 1,444.79 1,445.80 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% VGPVSAVGVTAPEEESPDAPLAK 95.00% 2.68 0.318 0 741.0527 2,220.13 2,220.14 3
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LGPISADSTTAPLEK 95.00% 3.95 0.408 5.23 750.4009 1,498.79 1,499.80 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LGPISADSTTAPLEK 95.00% 3.97 0.448 5.92 750.401 1,498.79 1,499.80 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LGVLTVTDTTPDSMR 95.00% 3.78 0.492 2.85 803.4126 1,604.81 1,605.82 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LSQLSVTDVTTSSLR 95.00% 4.41 0.59 6.06 803.9362 1,605.86 1,606.87 2 MYH9_HUMAN
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LSQLSVTDVTTSSLR 95.00% 4.42 0.55 5.66 803.9373 1,605.86 1,606.87 2 MYH9_HUMAN
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% DAQGQPQAVPVSGDLR 95.00% 3.38 0.504 1.57 819.4153 1,636.81 1,637.83 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LGPLSAEGTTGLAPAGQTSEESRPR 95.00% 2.82 0.269 2.03 828.4229 2,482.25 2,482.25 3
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LGPLSAEGTTGLAPAGQTSEESRPR 95.00% 3.99 0.435 2.17 828.4243 2,482.25 2,482.25 3
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LGELWVTDPTPDSLR 95.00% 4.08 0.562 3.35 849.938 1,697.86 1,698.87 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% LGELWVTDPTPDSLR 95.00% 4.46 0.569 3.66 849.9384 1,697.86 1,698.87 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% cVcDPGYTGEDcGTR 95.00% 2.17 0.462 0 c1: Carbamidomethyl (+57.02), c3: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 873.8681 1,745.72 1,746.65 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% VGGEESEVTVGGLEPGRK 95.00% 3.84 0.396 2.48 900.9615 1,799.91 1,799.91 2
 SAMPLE 3R Tenascin-X  TNXB  TENX_HUMAN 464,420.20 100.00% 22 23 39 7.06% VGPVSAVGVTAPEEESPDAPLAK 95.00% 5 0.657 7.72 1,111.08 2,220.13 2,220.14 2
 SAMPLE 1 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 5 5 11 4.27% LLSGFGLER 95.00% 2.83 0.36 0 496.2809 990.5462 991.5578 2
 SAMPLE 1 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 5 5 11 4.27% LLSGFGLER 95.00% 2.36 0.378 0 496.281 990.5464 991.5578 2
 SAMPLE 1 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 5 5 11 4.27% LLSGFGLER 95.00% 2.73 0.388 0 496.2812 990.5467 991.5578 2
 SAMPLE 1 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 5 5 11 4.27% VLEFGWPDLHTPALEK 95.00% 3.08 0.34 1.11 617.9926 1,850.95 1,851.96 3
 SAMPLE 1 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 5 5 11 4.27% ATSETLAADPTPAATIVHFK 95.00% 2.39 0.259 0 681.3586 2,041.05 2,041.06 3
 SAMPLE 1 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 5 5 11 4.27% VSAQGITLTDNQR 95.00% 3.38 0.413 2.35 701.8697 1,401.72 1,402.73 2
 SAMPLE 1 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 5 5 11 4.27% IIAVSFPSTANEENFR 95.00% 3.62 0.505 0 897.9557 1,793.90 1,794.90 2
 SAMPLE 1 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 5 5 11 4.27% IIAVSFPSTANEENFR 95.00% 4.68 0.631 3.82 898.4546 1,794.89 1,794.90 2
 SAMPLE 1 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 5 5 11 4.27% IIAVSFPSTANEENFR 95.00% 4.27 0.57 2.21 898.4563 1,794.90 1,794.90 2
 SAMPLE 1 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 5 5 11 4.27% IIAVSFPSTANEENFR 95.00% 4.56 0.598 4.2 898.4569 1,794.90 1,794.90 2
 SAMPLE 1 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 5 5 11 4.27% IIAVSFPSTANEENFR 95.00% 4.34 0.601 4.08 898.4593 1,794.90 1,794.90 2
 SAMPLE 1R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 6 6 9 5.13% LLSGFGLER 95.00% 2.38 0.347 0 496.2805 990.5453 991.5578 2
 SAMPLE 1R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 6 6 9 5.13% LLSGFGLER 95.00% 2.33 0.334 0 496.281 990.5464 991.5578 2
 SAMPLE 1R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 6 6 9 5.13% YVHYFSGLLSGSIK 95.00% 2.56 0.328 0 524.2817 1,569.82 1,570.83 3
 SAMPLE 1R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 6 6 9 5.13% TPEEEPLNLEGLVAHR 95.00% 2.58 0.476 0 602.3228 1,803.94 1,803.92 3
 SAMPLE 1R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 6 6 9 5.13% VLEFGWPDLHTPALEK 95.00% 3 0.362 0 617.9893 1,850.94 1,851.96 3
 SAMPLE 1R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 6 6 9 5.13% EQAIALLKDQEPGAFIIR 95.00% 3.26 0.481 0 671.7109 2,012.11 2,012.12 3
 SAMPLE 1R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 6 6 9 5.13% IIAVSFPSTANEENFR 95.00% 3.42 0.59 2.77 897.951 1,793.89 1,794.90 2
 SAMPLE 1R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 6 6 9 5.13% IIAVSFPSTANEENFR 95.00% 2.59 0.472 0 897.9554 1,793.90 1,794.90 2
 SAMPLE 1R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 6 6 9 5.13% IIAVSFPSTANEENFR 95.00% 2.49 0.357 0 898.4585 1,794.90 1,794.90 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% LLSGFGLER 95.00% 2.38 0.287 1.25 496.2782 990.5407 991.5578 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% LLSGFGLER 95.00% 2.31 0.281 0 496.2794 990.5431 991.5578 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% LLSGFGLER 95.00% 2.76 0.223 0 496.2811 990.5465 991.5578 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% LLSGFGLER 95.00% 2.5 0.216 0 496.2812 990.5467 991.5578 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% LLSGFGLER 95.00% 2.78 0.335 1.49 496.2813 990.5469 991.5578 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% LLSGFGLER 95.00% 2.39 0.275 0 496.2813 990.5469 991.5578 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% LLSGFGLER 95.00% 2.33 0.239 0 496.2813 990.547 991.5578 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% LLSGFGLER 95.00% 2.62 0.282 0 496.2813 990.547 991.5578 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% LLSGFGLER 95.00% 2.51 0.29 0 496.2816 990.5475 991.5578 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% LLSGFGLER 95.00% 2.39 0.307 0 496.2818 990.5479 991.5578 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% LLSGFGLER 95.00% 3.12 0.345 0 496.282 990.5483 991.5578 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% LLSGFGLER 95.00% 2.36 0.274 0 496.2822 990.5488 991.5578 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% HGGNYLLFNLSER 95.00% 2.64 0.165 0 507.2598 1,518.76 1,519.77 3
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% HFLIETGPR 95.00% 2.22 0.304 0 535.2916 1,068.57 1,069.58 2 TITIN_HUMAN
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% HFLIETGPR 95.00% 2.28 0.304 0 535.2921 1,068.57 1,069.58 2 TITIN_HUMAN
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% VATTPGSPSLGR 95.00% 2.29 0.404 0 571.81 1,141.60 1,142.62 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% VATTPGSPSLGR 95.00% 2.15 0.316 0 571.81 1,141.60 1,142.62 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% VATTPGSPSLGR 95.00% 2.26 0.4 0 571.8105 1,141.61 1,142.62 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% VATTPGSPSLGR 95.00% 2.37 0.447 0 571.8108 1,141.61 1,142.62 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% VATTPGSPSLGR 95.00% 2.33 0.458 1.68 571.811 1,141.61 1,142.62 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% VATTPGSPSLGR 95.00% 2.05 0.469 0 571.8111 1,141.61 1,142.62 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% VATTPGSPSLGR 95.00% 1.98 0.36 0 571.8112 1,141.61 1,142.62 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% VATTPGSPSLGR 95.00% 2.31 0.423 0 571.8112 1,141.61 1,142.62 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% TPEEEPLNLEGLVAHR 95.00% 4.93 0.505 1.26 601.9783 1,802.91 1,803.92 3
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% TPEEEPLNLEGLVAHR 95.00% 5.02 0.526 2.52 602.3147 1,803.92 1,803.92 3
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% VLEFGWPDLHTPALEK 95.00% 2.98 0.345 0.921 618.3278 1,851.96 1,851.96 3
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% VLEFGWPDLHTPALEK 95.00% 2.9 0.347 1.17 618.3279 1,851.96 1,851.96 3
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% YSMPDNSPETR 95.00% 2.47 0.486 2.82 648.7788 1,295.54 1,296.55 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% TPTQPLLESGFR 95.00% 1.97 0.42 1.34 673.3584 1,344.70 1,345.71 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% TPTQPLLESGFR 95.00% 2.64 0.44 2.04 673.3587 1,344.70 1,345.71 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% TPTQPLLESGFR 95.00% 2.89 0.537 2.27 673.3591 1,344.70 1,345.71 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% TPTQPLLESGFR 95.00% 3 0.508 2.04 673.3593 1,344.70 1,345.71 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% VSAQGITLTDNQR 95.00% 2.77 0.302 2.7 701.8675 1,401.72 1,402.73 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% VSAQGITLTDNQR 95.00% 3.05 0.398 2.06 701.8692 1,401.72 1,402.73 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% HVAYGGYSTPEDR 95.00% 3.72 0.657 5.57 726.33 1,450.64 1,451.66 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% HVAYGGYSTPEDR 95.00% 2.46 0.555 3.4 726.3311 1,450.65 1,451.66 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% HVAYGGYSTPEDR 95.00% 3.83 0.637 5.22 726.3318 1,450.65 1,451.66 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% IIAVSFPSTANEENFR 95.00% 4.77 0.657 4.34 897.9533 1,793.89 1,794.90 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% IIAVSFPSTANEENFR 95.00% 3.89 0.617 3.33 897.9538 1,793.89 1,794.90 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% IIAVSFPSTANEENFR 95.00% 4.8 0.609 3.29 898.4543 1,794.89 1,794.90 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% IIAVSFPSTANEENFR 95.00% 4.28 0.627 4.41 898.4554 1,794.90 1,794.90 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% IIAVSFPSTANEENFR 95.00% 5.13 0.64 5.2 898.4558 1,794.90 1,794.90 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% SQSFSEAEPQLPPAPVR 95.00% 2.61 0.49 2.59 920.4613 1,838.91 1,839.92 2
 SAMPLE 2 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 11 11 42 9.05% SQSFSEAEPQLPPAPVR 95.00% 3.69 0.601 3.8 920.9659 1,839.92 1,839.92 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% LLSGFGLER 95.00% 2.61 0.29 0 496.2806 990.5456 991.5578 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% LLSGFGLER 95.00% 2.66 0.365 1.26 496.2811 990.5466 991.5578 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% LLSGFGLER 95.00% 2.67 0.41 0 496.2812 990.5467 991.5578 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% LLSGFGLER 95.00% 2.4 0.354 0 496.2818 990.548 991.5578 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% LLSGFGLER 95.00% 2.41 0.322 0 496.2821 990.5486 991.5578 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VATTPGSPSLGR 95.00% 2.32 0.312 0 571.809 1,141.60 1,142.62 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VATTPGSPSLGR 95.00% 2.34 0.366 0 571.81 1,141.60 1,142.62 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VATTPGSPSLGR 95.00% 2.23 0.353 0 571.8101 1,141.60 1,142.62 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VATTPGSPSLGR 95.00% 1.95 0.355 0 571.8102 1,141.60 1,142.62 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VATTPGSPSLGR 95.00% 2.21 0.384 0 571.8103 1,141.61 1,142.62 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VATTPGSPSLGR 95.00% 2.06 0.391 0 571.8106 1,141.61 1,142.62 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VATTPGSPSLGR 95.00% 1.8 0.391 0 571.8113 1,141.61 1,142.62 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VATTPGSPSLGR 95.00% 2.18 0.337 0 571.8113 1,141.61 1,142.62 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VATTPGSPSLGR 95.00% 2.2 0.368 1.89 571.8113 1,141.61 1,142.62 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% TPEEEPLNLEGLVAHR 95.00% 4.77 0.541 0 602.315 1,803.92 1,803.92 3
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% SGYIPSGHSLGTPEPAPR 95.00% 2.16 0.286 0 608.6419 1,822.90 1,822.91 3
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VLEFGWPDLHTPALEK 95.00% 3.11 0.233 1.68 618.3257 1,851.95 1,851.96 3
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VLEFGWPDLHTPALEK 95.00% 3.4 0.52 1.16 618.3269 1,851.96 1,851.96 3
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VLEFGWPDLHTPALEK 95.00% 2.97 0.416 0 618.3271 1,851.96 1,851.96 3
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% TPTQPLLESGFR 95.00% 2.16 0.366 1.66 673.3581 1,344.70 1,345.71 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VSAQGITLTDNQR 95.00% 3.19 0.415 1.35 701.8694 1,401.72 1,402.73 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VSAQGITLTDNQR 95.00% 2.03 0.206 2.25 701.8699 1,401.72 1,402.73 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% VSAQGITLTDNQR 95.00% 3.32 0.384 3.35 701.871 1,401.73 1,402.73 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% IIAVSFPSTANEENFR 95.00% 4.21 0.63 2.8 897.9488 1,793.88 1,794.90 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% IIAVSFPSTANEENFR 95.00% 3.7 0.561 1.3 897.9534 1,793.89 1,794.90 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% IIAVSFPSTANEENFR 95.00% 3.76 0.563 4.16 897.9536 1,793.89 1,794.90 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% IIAVSFPSTANEENFR 95.00% 4.68 0.658 6.3 897.9555 1,793.90 1,794.90 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% IIAVSFPSTANEENFR 95.00% 3.46 0.467 0 898.4549 1,794.89 1,794.90 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% IIAVSFPSTANEENFR 95.00% 4.85 0.615 4.89 898.455 1,794.89 1,794.90 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% IIAVSFPSTANEENFR 95.00% 5.28 0.623 5.28 898.4554 1,794.90 1,794.90 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% IIAVSFPSTANEENFR 95.00% 4.71 0.632 5.34 898.4555 1,794.90 1,794.90 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% SQSFSEAEPQLPPAPVR 95.00% 3.19 0.487 3.42 920.4666 1,838.92 1,839.92 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% SQSFSEAEPQLPPAPVR 95.00% 3.7 0.421 1.59 920.9654 1,839.92 1,839.92 2
 SAMPLE 2R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 10 10 34 8.82% SQSVPGAWPGASPLSSQPLSGSSR 95.00% 4.66 0.601 6.64 1,171.08 2,340.15 2,340.16 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% LLSGFGLER 95.00% 2.34 0.35 1.24 496.2801 990.5445 991.5578 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% LLSGFGLER 95.00% 2.15 0.286 0 496.2805 990.5454 991.5578 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% LLSGFGLER 95.00% 2.93 0.39 1.22 496.2806 990.5455 991.5578 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% LLSGFGLER 95.00% 2.32 0.276 0 496.2808 990.546 991.5578 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% LLSGFGLER 95.00% 2.59 0.331 0 496.2809 990.5462 991.5578 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% LLSGFGLER 95.00% 2.76 0.399 1.33 496.2811 990.5466 991.5578 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% LLSGFGLER 95.00% 2.7 0.356 0 496.2818 990.5479 991.5578 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% LLSGFGLER 95.00% 2.97 0.358 0 496.2823 990.549 991.5578 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VATTPGSPSLGR 95.00% 2.32 0.307 0 571.8099 1,141.60 1,142.62 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VATTPGSPSLGR 95.00% 2.02 0.383 0 571.81 1,141.60 1,142.62 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VATTPGSPSLGR 95.00% 2.32 0.366 0 571.8105 1,141.61 1,142.62 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VATTPGSPSLGR 95.00% 2.35 0.448 1.19 571.8105 1,141.61 1,142.62 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VATTPGSPSLGR 95.00% 2.35 0.422 0 571.8105 1,141.61 1,142.62 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VATTPGSPSLGR 95.00% 2.48 0.325 0 571.8106 1,141.61 1,142.62 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VATTPGSPSLGR 95.00% 2.5 0.363 1.66 571.8109 1,141.61 1,142.62 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VATTPGSPSLGR 95.00% 2.36 0.368 0 571.8111 1,141.61 1,142.62 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VATTPGSPSLGR 95.00% 2.55 0.372 1.2 571.8111 1,141.61 1,142.62 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VATTPGSPSLGR 95.00% 2.48 0.328 2.96 571.8112 1,141.61 1,142.62 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VATTPGSPSLGR 95.00% 2.36 0.429 1.64 571.8112 1,141.61 1,142.62 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VATTPGSPSLGR 95.00% 2 0.396 0 571.8121 1,141.61 1,142.62 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% AQFSVAGVHTVPGSPQAR 95.00% 2.05 0.257 0 603.6503 1,807.93 1,808.94 3
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% AQFSVAGVHTVPGSPQAR 95.00% 2.42 0.272 2.11 603.6512 1,807.93 1,808.94 3
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% AQFSVAGVHTVPGSPQAR 95.00% 2.47 0.383 1.59 603.6517 1,807.93 1,808.94 3
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% SGYIPSGHSLGTPEPAPR 95.00% 2.23 0.379 0 608.3044 1,821.89 1,822.91 3
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% SGYIPSGHSLGTPEPAPR 95.00% 2.37 0.465 0 608.3057 1,821.89 1,822.91 3
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VLEFGWPDLHTPALEK 95.00% 2.89 0.285 0 618.3275 1,851.96 1,851.96 3
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% SGSLGQPSPSAQR 95.00% 2.22 0.415 0 636.3215 1,270.63 1,271.63 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% YSMPDNSPETR 95.00% 2.24 0.369 1.19 648.7784 1,295.54 1,296.55 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% YSMPDNSPETR 95.00% 2.02 0.276 0 648.7786 1,295.54 1,296.55 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% TPTQPLLESGFR 95.00% 3.01 0.495 1.68 673.3581 1,344.70 1,345.71 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% TPTQPLLESGFR 95.00% 2.13 0.198 1.74 673.3587 1,344.70 1,345.71 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% TPTQPLLESGFR 95.00% 2.69 0.547 1.68 673.3595 1,344.70 1,345.71 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% TPTQPLLESGFR 95.00% 1.9 0.427 0 673.3612 1,344.71 1,345.71 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% ATSETLAADPTPAATIVHFK 95.00% 2.26 0.185 1.03 681.3572 2,041.05 2,041.06 3
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VSAQGITLTDNQR 95.00% 2.64 0.378 1.54 701.8672 1,401.72 1,402.73 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VSAQGITLTDNQR 95.00% 2.54 0.369 0 701.8703 1,401.72 1,402.73 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% VSSPPPTIMQQNK 95.00% 2.21 0.434 0 713.8709 1,425.73 1,426.74 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% HVAYGGYSTPEDR 95.00% 3.98 0.617 4.82 726.326 1,450.64 1,451.66 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% HVAYGGYSTPEDR 95.00% 4.29 0.646 6.72 726.3299 1,450.64 1,451.66 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% HVAYGGYSTPEDR 95.00% 4.01 0.648 5.72 726.3318 1,450.65 1,451.66 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% HVAYGGYSTPEDR 95.00% 4.09 0.592 5.82 726.8276 1,451.64 1,451.66 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% YVHYFSGLLSGSIK 95.00% 2.41 0.326 0 786.4174 1,570.82 1,570.83 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% TVGTNTPPSPGFGWR 95.00% 2.98 0.382 0 787.3878 1,572.76 1,573.78 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% TVGTNTPPSPGFGWR 95.00% 3.27 0.516 0 787.3898 1,572.76 1,573.78 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% TDKTDEPVPGASSATAALSPQEKR 95.00% 2.99 0.365 0 819.0391 2,454.09 2,456.23 3
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% IIAVSFPSTANEENFR 95.00% 3.18 0.549 0 897.9541 1,793.89 1,794.90 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% IIAVSFPSTANEENFR 95.00% 4.92 0.558 5.1 898.4558 1,794.90 1,794.90 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% IIAVSFPSTANEENFR 95.00% 4.55 0.506 0 898.456 1,794.90 1,794.90 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% SQSFSEAEPQLPPAPVR 95.00% 2 0.36 1.66 920.464 1,838.91 1,839.92 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% SQSFSEAEPQLPPAPVR 95.00% 2.28 0.307 1.15 920.4652 1,838.91 1,839.92 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% SQSFSEAEPQLPPAPVR 95.00% 3.22 0.438 3.47 920.966 1,839.92 1,839.92 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% AASDGQYENQSPEATSPR 95.00% 4.14 0.564 3.4 954.4012 1,906.79 1,907.84 2
 SAMPLE 3 Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 18 18 53 15.70% AASDGQYENQSPEATSPR 95.00% 4.72 0.627 4.34 954.419 1,906.82 1,907.84 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% LLSGFGLER 95.00% 2.83 0.315 0 496.2805 990.5454 991.5578 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% LLSGFGLER 95.00% 2.31 0.305 0 496.2809 990.5461 991.5578 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% LLSGFGLER 95.00% 2.73 0.364 2.43 496.2812 990.5467 991.5578 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% LLSGFGLER 95.00% 2.55 0.338 1.12 496.2817 990.5477 991.5578 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% LLSGFGLER 95.00% 2.52 0.305 0 496.282 990.5484 991.5578 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VATTPGSPSLGR 95.00% 2.78 0.342 0 571.808 1,141.60 1,142.62 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VATTPGSPSLGR 95.00% 2.14 0.343 0 571.8082 1,141.60 1,142.62 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VATTPGSPSLGR 95.00% 2.44 0.379 0 571.8098 1,141.60 1,142.62 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VATTPGSPSLGR 95.00% 1.99 0.403 0 571.8101 1,141.60 1,142.62 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VATTPGSPSLGR 95.00% 2.42 0.327 1.38 571.8101 1,141.60 1,142.62 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VATTPGSPSLGR 95.00% 2.68 0.369 1.12 571.8106 1,141.61 1,142.62 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VATTPGSPSLGR 95.00% 2.52 0.333 0 571.8107 1,141.61 1,142.62 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VATTPGSPSLGR 95.00% 2.18 0.29 0 571.8116 1,141.61 1,142.62 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VATTPGSPSLGR 95.00% 2.13 0.355 0 571.8116 1,141.61 1,142.62 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VATTPGSPSLGR 95.00% 2.58 0.349 0 571.8119 1,141.61 1,142.62 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VATTPGSPSLGR 95.00% 2.16 0.374 0 571.8122 1,141.61 1,142.62 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VATTPGSPSLGR 95.00% 2.19 0.404 0 571.8122 1,141.61 1,142.62 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% AQFSVAGVHTVPGSPQAR 95.00% 1.99 0.253 2.39 603.6497 1,807.93 1,808.94 3
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% AQFSVAGVHTVPGSPQAR 95.00% 1.94 0.247 1.19 603.6506 1,807.93 1,808.94 3
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% AQFSVAGVHTVPGSPQAR 95.00% 2.62 0.348 0 603.9869 1,808.94 1,808.94 3
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% SGYIPSGHSLGTPEPAPR 95.00% 2.06 0.432 0 608.3056 1,821.89 1,822.91 3
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% SGYIPSGHSLGTPEPAPR 95.00% 2.38 0.25 0 608.6414 1,822.90 1,822.91 3
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VLEFGWPDLHTPALEK 95.00% 2.89 0.215 0 618.3265 1,851.96 1,851.96 3
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% TPTQPLLESGFR 95.00% 2.87 0.413 1.66 673.3584 1,344.70 1,345.71 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% TPTQPLLESGFR 95.00% 2.83 0.442 2.24 673.3588 1,344.70 1,345.71 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% TPTQPLLESGFR 95.00% 2.72 0.551 1.82 673.3604 1,344.71 1,345.71 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% TPTQPLLESGFR 95.00% 2.03 0.365 0 673.3614 1,344.71 1,345.71 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% TPTQPLLESGFR 95.00% 1.85 0.327 1.82 673.362 1,344.71 1,345.71 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VSAQGITLTDNQR 95.00% 2.57 0.38 2.44 701.8662 1,401.72 1,402.73 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VSSPPPTIMQQNK 95.00% 2.34 0.346 0 713.8708 1,425.73 1,426.74 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% VSSPPPTIMQQNK 95.00% 2.61 0.39 0 714.3707 1,426.73 1,426.74 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% HVAYGGYSTPEDR 95.00% 4.25 0.639 6.21 726.3239 1,450.63 1,451.66 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% HVAYGGYSTPEDR 95.00% 3.74 0.676 6.25 726.3275 1,450.64 1,451.66 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% HVAYGGYSTPEDR 95.00% 3.05 0.627 5.92 726.3299 1,450.64 1,451.66 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% HVAYGGYSTPEDR 95.00% 3.6 0.647 5.6 726.3321 1,450.65 1,451.66 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% HVAYGGYSTPEDR 95.00% 3.49 0.321 4.44 726.3574 1,450.70 1,451.66 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% YVHYFSGLLSGSIK 95.00% 2.49 0.287 0 786.4208 1,570.83 1,570.83 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% TVGTNTPPSPGFGWR 95.00% 2.09 0.261 0 787.3902 1,572.76 1,573.78 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% IIAVSFPSTANEENFR 95.00% 4.05 0.56 3.49 897.9541 1,793.89 1,794.90 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% IIAVSFPSTANEENFR 95.00% 3.8 0.539 1.85 897.9545 1,793.89 1,794.90 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% IIAVSFPSTANEENFR 95.00% 3.74 0.56 1.7 897.9552 1,793.89 1,794.90 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% IIAVSFPSTANEENFR 95.00% 2.39 0.498 0 897.9605 1,793.91 1,794.90 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% IIAVSFPSTANEENFR 95.00% 4.29 0.582 4.07 898.4543 1,794.89 1,794.90 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% IIAVSFPSTANEENFR 95.00% 3.94 0.515 2.8 898.4583 1,794.90 1,794.90 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% SQSFSEAEPQLPPAPVR 95.00% 2.26 0.426 1.11 920.4675 1,838.92 1,839.92 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% SQSFSEAEPQLPPAPVR 95.00% 2.71 0.42 0 920.4677 1,838.92 1,839.92 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% SQSFSEAEPQLPPAPVR 95.00% 2.35 0.362 2.16 920.9649 1,839.91 1,839.92 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% AASDGQYENQSPEATSPR 95.00% 4.49 0.53 3.48 954.9198 1,907.82 1,907.84 2
 SAMPLE 3R Tensin-1  TNS1  TENS1_HUMAN 185,683.40 100.00% 14 14 49 11.80% AASDGQYENQSPEATSPR 95.00% 4.95 0.543 3.3 954.9229 1,907.83 1,907.84 2
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% cEGFELHFWR 95.00% 3.31 0.489 1.36 c1: Carbamidomethyl (+57.02) 460.8754 1,379.60 1,380.62 3
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% EGDPAIYAER 95.00% 2.63 0.284 0 560.7661 1,119.52 1,120.53 2
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% EGDPAIYAER 95.00% 2.85 0.367 0 560.7665 1,119.52 1,120.53 2
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% YKSEALGVGDVK 95.00% 2.51 0.518 3.62 633.3425 1,264.67 1,265.67 2
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% YKSEALGVGDVK 95.00% 2.72 0.512 4.26 633.8443 1,265.67 1,265.67 2
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% QLPAHDQDPSKcHELSPR 95.00% 2.77 0.41 2.59 c12: Carbamidomethyl (+57.02) 706.0062 2,115.00 2,115.00 3
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% QLPAHDQDPSKcHELSPR 95.00% 2.66 0.467 3.29 c12: Carbamidomethyl (+57.02) 706.0068 2,115.00 2,115.00 3
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% NHAVVcQGcHNAIDPEVQR 95.00% 2.85 0.388 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.3412 2,203.00 2,204.01 3
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% NHAVVcQGcHNAIDPEVQR 95.00% 3.32 0.481 2.96 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.674 2,204.00 2,204.01 3
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% NHAVVcQGcHNAIDPEVQR 95.00% 3.44 0.529 2.66 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.675 2,204.00 2,204.01 3
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% LFEDTKYTTLIAK 95.00% 4.42 0.448 3.68 771.9239 1,541.83 1,542.84 2
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% LFEDTKYTTLIAK 95.00% 4.42 0.478 2.72 771.9246 1,541.83 1,542.84 2
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% KNVSINTVTYEWAPPVQNQALAR 95.00% 3.83 0.342 1.31 867.4582 2,599.35 2,599.36 3
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% cGQEEHDVLLSNEEDR 95.00% 0 0 3.48 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 956.9058 1,911.80 1,912.80 2
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% QLPAHDQDPSKcHELSPR 95.00% 2.5 0.425 1.6 c12: Carbamidomethyl (+57.02) 1,058.51 2,115.00 2,115.00 2
 SAMPLE 2 Testin  TES  TES_HUMAN 47,977.60 100.00% 8 9 16 28.70% QLPAHDQDPSKcHELSPR 95.00% 2.71 0.385 1.68 c12: Carbamidomethyl (+57.02) 1,058.51 2,115.01 2,115.00 2
 SAMPLE 2R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 6 10 19.70% cEGFELHFWR 95.00% 3.08 0.445 1.12 c1: Carbamidomethyl (+57.02) 460.8772 1,379.61 1,380.62 3
 SAMPLE 2R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 6 10 19.70% QLPAHDQDPSKcHELSPR 95.00% 2.67 0.491 2.22 c12: Carbamidomethyl (+57.02) 706.0054 2,114.99 2,115.00 3
 SAMPLE 2R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 6 10 19.70% QLPAHDQDPSKcHELSPR 95.00% 3.04 0.449 1.89 c12: Carbamidomethyl (+57.02) 706.0073 2,115.00 2,115.00 3
 SAMPLE 2R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 6 10 19.70% NHAVVcQGcHNAIDPEVQR 95.00% 3.44 0.513 2.92 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.6741 2,204.00 2,204.01 3
 SAMPLE 2R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 6 10 19.70% NHAVVcQGcHNAIDPEVQR 95.00% 3.84 0.55 3.31 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.6748 2,204.00 2,204.01 3
 SAMPLE 2R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 6 10 19.70% LFEDTKYTTLIAK 95.00% 3.73 0.453 3.85 771.9234 1,541.83 1,542.84 2
 SAMPLE 2R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 6 10 19.70% LFEDTKYTTLIAK 95.00% 4.39 0.522 3.82 771.9253 1,541.84 1,542.84 2
 SAMPLE 2R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 6 10 19.70% KNVSINTVTYEWAPPVQNQALAR 95.00% 3.33 0.243 2.55 867.4623 2,599.36 2,599.36 3
 SAMPLE 2R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 6 10 19.70% NHAVVcQGcHNAIDPEVQR 95.00% 5.43 0.614 5.85 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,103.01 2,204.00 2,204.01 2
 SAMPLE 2R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 6 10 19.70% NHAVVcQGcHNAIDPEVQR 95.00% 5.03 0.583 5.02 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,103.01 2,204.01 2,204.01 2
 SAMPLE 3 Testin  TES  TES_HUMAN 47,977.60 100.00% 4 4 9 14.50% LPcEMDAQGPK 95.00% 2.74 0.407 1.12 c3: Carbamidomethyl (+57.02) 623.2839 1,244.55 1,245.56 2
 SAMPLE 3 Testin  TES  TES_HUMAN 47,977.60 100.00% 4 4 9 14.50% LPcEMDAQGPK 95.00% 3.18 0.458 1.48 c3: Carbamidomethyl (+57.02) 623.2864 1,244.56 1,245.56 2
 SAMPLE 3 Testin  TES  TES_HUMAN 47,977.60 100.00% 4 4 9 14.50% QLPAHDQDPSKcHELSPR 95.00% 3.19 0.467 3.33 c12: Carbamidomethyl (+57.02) 705.6726 2,113.99 2,115.00 3
 SAMPLE 3 Testin  TES  TES_HUMAN 47,977.60 100.00% 4 4 9 14.50% QLPAHDQDPSKcHELSPR 95.00% 2.72 0.487 1.82 c12: Carbamidomethyl (+57.02) 706.007 2,115.00 2,115.00 3
 SAMPLE 3 Testin  TES  TES_HUMAN 47,977.60 100.00% 4 4 9 14.50% NHAVVcQGcHNAIDPEVQR 95.00% 2.95 0.314 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.6736 2,204.00 2,204.01 3
 SAMPLE 3 Testin  TES  TES_HUMAN 47,977.60 100.00% 4 4 9 14.50% NHAVVcQGcHNAIDPEVQR 95.00% 3.07 0.47 2.28 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.6743 2,204.00 2,204.01 3
 SAMPLE 3 Testin  TES  TES_HUMAN 47,977.60 100.00% 4 4 9 14.50% NHAVVcQGcHNAIDPEVQR 95.00% 3.2 0.44 2.17 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.6744 2,204.00 2,204.01 3
 SAMPLE 3 Testin  TES  TES_HUMAN 47,977.60 100.00% 4 4 9 14.50% LFEDTKYTTLIAK 95.00% 3.43 0.423 2.21 771.9265 1,541.84 1,542.84 2
 SAMPLE 3 Testin  TES  TES_HUMAN 47,977.60 100.00% 4 4 9 14.50% LFEDTKYTTLIAK 95.00% 2.7 0.447 0 771.9267 1,541.84 1,542.84 2
 SAMPLE 3R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 5 8 19.70% LPcEMDAQGPK 95.00% 2.71 0.431 2.2 c3: Carbamidomethyl (+57.02) 623.2844 1,244.55 1,245.56 2
 SAMPLE 3R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 5 8 19.70% LPcEMDAQGPK 95.00% 2.94 0.451 1.35 c3: Carbamidomethyl (+57.02) 623.2851 1,244.55 1,245.56 2
 SAMPLE 3R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 5 8 19.70% YKSEALGVGDVK 95.00% 1.77 0.319 2.05 633.3389 1,264.66 1,265.67 2
 SAMPLE 3R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 5 8 19.70% QLPAHDQDPSKcHELSPR 95.00% 2.87 0.467 1.57 c12: Carbamidomethyl (+57.02) 705.6729 2,114.00 2,115.00 3
 SAMPLE 3R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 5 8 19.70% QLPAHDQDPSKcHELSPR 95.00% 3.18 0.442 1.89 c12: Carbamidomethyl (+57.02) 706.006 2,114.99 2,115.00 3
 SAMPLE 3R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 5 8 19.70% NHAVVcQGcHNAIDPEVQR 95.00% 3.51 0.552 2 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.3409 2,203.00 2,204.01 3
 SAMPLE 3R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 5 8 19.70% NHAVVcQGcHNAIDPEVQR 95.00% 3.51 0.535 3.24 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.6729 2,204.00 2,204.01 3
 SAMPLE 3R Testin  TES  TES_HUMAN 47,977.60 100.00% 5 5 8 19.70% KNVSINTVTYEWAPPVQNQALAR 95.00% 3.74 0.239 0 867.4598 2,599.36 2,599.36 3
 SAMPLE 1R Thioredoxin domain-containing protein 5  TXNDC5  TXND5_HUMAN 47,611.10 100.00% 3 3 6 8.10% FVLSQAKDEL 95.00% 2.11 0.326 0 575.3088 1,148.60 1,149.62 2
 SAMPLE 1R Thioredoxin domain-containing protein 5  TXNDC5  TXND5_HUMAN 47,611.10 100.00% 3 3 6 8.10% FVLSQAKDEL 95.00% 2.1 0.347 0 575.3095 1,148.60 1,149.62 2
 SAMPLE 1R Thioredoxin domain-containing protein 5  TXNDC5  TXND5_HUMAN 47,611.10 100.00% 3 3 6 8.10% GYPTLLWFR 95.00% 2.64 0.536 2.28 576.8111 1,151.61 1,152.62 2
 SAMPLE 1R Thioredoxin domain-containing protein 5  TXNDC5  TXND5_HUMAN 47,611.10 100.00% 3 3 6 8.10% GYPTLLWFR 95.00% 2.67 0.492 2.08 576.8114 1,151.61 1,152.62 2
 SAMPLE 1R Thioredoxin domain-containing protein 5  TXNDC5  TXND5_HUMAN 47,611.10 100.00% 3 3 6 8.10% VDcTQHYELcSGNQVR 95.00% 3.27 0.19 0 c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 656.2888 1,965.84 1,965.85 3
 SAMPLE 1R Thioredoxin domain-containing protein 5  TXNDC5  TXND5_HUMAN 47,611.10 100.00% 3 3 6 8.10% VDcTQHYELcSGNQVR 95.00% 3.62 0.174 0 c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 656.2896 1,965.85 1,965.85 3
 SAMPLE 3R Thioredoxin domain-containing protein 5  TXNDC5  TXND5_HUMAN 47,611.10 100.00% 3 3 3 8.10% GYPTLLLFR 95.00% 1.56 0.417 0 540.3306 1,078.65 1,079.63 2
 SAMPLE 3R Thioredoxin domain-containing protein 5  TXNDC5  TXND5_HUMAN 47,611.10 100.00% 3 3 3 8.10% FVLSQAKDEL 95.00% 2.3 0.31 0 575.3122 1,148.61 1,149.62 2
 SAMPLE 3R Thioredoxin domain-containing protein 5  TXNDC5  TXND5_HUMAN 47,611.10 100.00% 3 3 3 8.10% VDcTAHSDVcSAQGVR 95.00% 2.74 0.293 1.1 c3: Carbamidomethyl (+57.02), c10: Carbamidomethyl (+57.02) 587.764 1,760.27 1,761.76 3
 SAMPLE 2R Thioredoxin  TXN  THIO_HUMAN 11,719.30 99.80% 2 2 4 22.90% EKLEATINELV 95.00% 2.93 0.39 1.42 629.8459 1,257.68 1,258.69 2
 SAMPLE 2R Thioredoxin  TXN  THIO_HUMAN 11,719.30 99.80% 2 2 4 22.90% EKLEATINELV 95.00% 2.69 0.42 0 629.8485 1,257.68 1,258.69 2
 SAMPLE 2R Thioredoxin  TXN  THIO_HUMAN 11,719.30 99.80% 2 2 4 22.90% TAFQEALDAAGDK 95.00% 3.83 0.387 3.36 668.8203 1,335.62 1,336.64 2
 SAMPLE 2R Thioredoxin  TXN  THIO_HUMAN 11,719.30 99.80% 2 2 4 22.90% TAFQEALDAAGDK 95.00% 3.51 0.372 4.43 668.8214 1,335.63 1,336.64 2
 SAMPLE 3R Thioredoxin  TXN  THIO_HUMAN 11,719.30 99.80% 2 2 4 22.90% EKLEATINELV 95.00% 3.08 0.405 1.31 629.8472 1,257.68 1,258.69 2
 SAMPLE 3R Thioredoxin  TXN  THIO_HUMAN 11,719.30 99.80% 2 2 4 22.90% EKLEATINELV 95.00% 3.29 0.415 1.38 629.848 1,257.68 1,258.69 2
 SAMPLE 3R Thioredoxin  TXN  THIO_HUMAN 11,719.30 99.80% 2 2 4 22.90% TAFQEALDAAGDK 95.00% 3.37 0.375 3.66 668.8199 1,335.62 1,336.64 2
 SAMPLE 3R Thioredoxin  TXN  THIO_HUMAN 11,719.30 99.80% 2 2 4 22.90% TAFQEALDAAGDK 95.00% 3.5 0.368 3.44 668.8227 1,335.63 1,336.64 2
 SAMPLE 1 Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 100.00% 3 3 9 2.74% GFLLLASLR 95.00% 3.65 0.246 0 495.3098 988.604 989.6149 2
 SAMPLE 1 Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 100.00% 3 3 9 2.74% GFLLLASLR 95.00% 3.23 0.311 1.12 495.3106 988.6056 989.6149 2
 SAMPLE 1 Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 100.00% 3 3 9 2.74% GFLLLASLR 95.00% 3.24 0.231 1.96 495.316 988.6164 989.6149 2
 SAMPLE 1 Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 100.00% 3 3 9 2.74% GFLLLASLR 95.00% 3.51 0.284 0 495.3163 988.6169 989.6149 2
 SAMPLE 1 Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 100.00% 3 3 9 2.74% TIVTTLQDSIR 95.00% 2.29 0.307 1.23 623.8536 1,245.69 1,246.70 2
 SAMPLE 1 Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 100.00% 3 3 9 2.74% FVFGTTPEDILR 95.00% 3.38 0.517 3.54 697.8673 1,393.72 1,394.73 2
 SAMPLE 1 Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 100.00% 3 3 9 2.74% FVFGTTPEDILR 95.00% 3.13 0.482 6.02 697.8684 1,393.72 1,394.73 2
 SAMPLE 1 Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 100.00% 3 3 9 2.74% FVFGTTPEDILR 95.00% 3.22 0.422 2.35 697.8791 1,393.74 1,394.73 2
 SAMPLE 1 Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 100.00% 3 3 9 2.74% FVFGTTPEDILR 95.00% 2.82 0.539 3.01 697.8845 1,393.75 1,394.73 2
 SAMPLE 1R Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 99.80% 2 2 4 1.79% GFLLLASLR 95.00% 3.24 0.231 2.01 495.316 988.6164 989.6149 2
 SAMPLE 1R Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 99.80% 2 2 4 1.79% GFLLLASLR 95.00% 3.51 0.284 0 495.3163 988.6169 989.6149 2
 SAMPLE 1R Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 99.80% 2 2 4 1.79% FVFGTTPEDILR 95.00% 3.22 0.422 1.96 697.8791 1,393.74 1,394.73 2
 SAMPLE 1R Thrombospondin-1  THBS1  TSP1_HUMAN 129,363.70 99.80% 2 2 4 1.79% FVFGTTPEDILR 95.00% 3.11 0.421 3.77 697.8837 1,393.75 1,394.73 2
 SAMPLE 4 Titin  TTN  TITIN_HUMAN 3,815,832.20 99.90% 2 2 5 0.11% PEVYHVSANAMSIR 95.00% 2.09 0.198 0 525.2769 1,572.81 1,573.78 3 ,SFPQ_HUMAN,PGM5_HUMAN,BMP4_HUMAN,MUC16_HUMAN,LAMB2_HUMAN,HCD2_HUMAN
 SAMPLE 4 Titin  TTN  TITIN_HUMAN 3,815,832.20 99.90% 2 2 5 0.11% PEVYHVSANAMSIR 95.00% 2.04 0.252 0 525.2791 1,572.81 1,573.78 3 ,SFPQ_HUMAN,PGM5_HUMAN,BMP4_HUMAN,MUC16_HUMAN,LAMB2_HUMAN,HCD2_HUMAN
 SAMPLE 4 Titin  TTN  TITIN_HUMAN 3,815,832.20 99.90% 2 2 5 0.11% WEPPLKDGGSPILGYIIERcEEGK 95.00% 1.85 0.196 1.42 c20: Carbamidomethyl (+57.02) 914.9492 2,741.82 2,743.38 3 TERA_HUMAN
 SAMPLE 4 Titin  TTN  TITIN_HUMAN 3,815,832.20 99.90% 2 2 5 0.11% WEPPLKDGGSPILGYIIERcEEGK 95.00% 2.19 0.319 0 c20: Carbamidomethyl (+57.02) 915.4508 2,743.33 2,743.38 3 TERA_HUMAN
 SAMPLE 4 Titin  TTN  TITIN_HUMAN 3,815,832.20 99.90% 2 2 5 0.11% WEPPLKDGGSPILGYIIERcEEGK 95.00% 1.93 0.294 0 c20: Carbamidomethyl (+57.02) 915.4509 2,743.33 2,743.38 3 TERA_HUMAN
 SAMPLE 4R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 2 2 4 0.13% ALQAAVASEQPGLFSEWLR 95.00% 1.64 0.382 0 691.7047 2,072.09 2,073.08 3 RP1L1_HUMAN
 SAMPLE 4R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 2 2 4 0.13% WEPPLKDGGSPILGYIIERcEEGK 94.60% 1.76 0.178 1.22 c20: Carbamidomethyl (+57.02) 914.9508 2,741.83 2,743.38 3 TERA_HUMAN
 SAMPLE 4R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 2 2 4 0.13% WEPPLKDGGSPILGYIIERcEEGK 95.00% 2.13 0.257 0 c20: Carbamidomethyl (+57.02) 914.9513 2,741.83 2,743.38 3 TERA_HUMAN
 SAMPLE 4R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 2 2 4 0.13% WEPPLKDGGSPILGYIIERcEEGK 95.00% 1.97 0.249 0 c20: Carbamidomethyl (+57.02) 915.4485 2,743.32 2,743.38 3 TERA_HUMAN
 SAMPLE 1 Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 2 2 6 0.11% DWLVKPIRDQHVK 95.00% 2.92 0.229 0 544.9724 1,631.89 1,633.92 3
 SAMPLE 1 Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 2 2 6 0.11% DWLVKPIRDQHVK 95.00% 2.77 0.179 0 544.9731 1,631.90 1,633.92 3
 SAMPLE 1 Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 2 2 6 0.11% WEPPLKDGGSPILGYIIERcEEGK 95.00% 2.09 0.265 0 c20: Carbamidomethyl (+57.02) 914.9434 2,741.81 2,743.38 3 TERA_HUMAN
 SAMPLE 1 Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 2 2 6 0.11% WEPPLKDGGSPILGYIIERcEEGK 95.00% 1.99 0.224 1.11 c20: Carbamidomethyl (+57.02) 914.9448 2,741.81 2,743.38 3 TERA_HUMAN
 SAMPLE 1 Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 2 2 6 0.11% WEPPLKDGGSPILGYIIERcEEGK 95.00% 2.07 0.262 0 c20: Carbamidomethyl (+57.02) 915.4456 2,743.31 2,743.38 3 TERA_HUMAN
 SAMPLE 1 Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 2 2 6 0.11% WEPPLKDGGSPILGYIIERcEEGK 95.00% 1.84 0.267 0 c20: Carbamidomethyl (+57.02) 915.4495 2,743.32 2,743.38 3 TERA_HUMAN
 SAMPLE 1R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 3 3 4 0.17% DWLVKPIRDQHVK 95.00% 2.85 0.245 0 544.9725 1,631.89 1,633.92 3
 SAMPLE 1R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 3 3 4 0.17% LHTTRSVSmQDEGKTHSITFK 95.00% 2.43 0.218 0 m9: Oxidation (+15.99) 807.47 2,419.39 2,419.20 3 ITAV_HUMAN
 SAMPLE 1R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 3 3 4 0.17% WEPPLKDGGSPILGYIIERcEEGK 95.00% 2.01 0.234 1.24 c20: Carbamidomethyl (+57.02) 914.9442 2,741.81 2,743.38 3 TERA_HUMAN
 SAMPLE 1R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 3 3 4 0.17% WEPPLKDGGSPILGYIIERcEEGK 95.00% 2.28 0.315 0 c20: Carbamidomethyl (+57.02) 914.9453 2,741.81 2,743.38 3 TERA_HUMAN
 SAMPLE 3 Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 2 2 2 0.11% VAGTPELSVEWYK 95.00% 2.12 0.278 0 493.256 1,476.74 1,478.75 3
 SAMPLE 3 Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 2 2 2 0.11% NESGVERcYAFLLVQEPAQIVEK 95.00% 2.54 0.232 0 c8: Carbamidomethyl (+57.02) 893.9457 2,678.81 2,679.35 3
 SAMPLE 3R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 4 4 6 0.24% VAGTPELSVEWYK 95.00% 2.14 0.278 0 493.2556 1,476.74 1,478.75 3
 SAMPLE 3R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 4 4 6 0.24% VLDTPSPPVNLK 95.00% 1.69 0.322 0 640.3074 1,278.60 1,279.73 2
 SAMPLE 3R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 4 4 6 0.24% WEPPLKDGGSPILGYIIERcEEGK 95.00% 1.97 0.328 0 c20: Carbamidomethyl (+57.02) 914.945 2,741.81 2,743.38 3 TERA_HUMAN
 SAMPLE 3R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 4 4 6 0.24% WEPPLKDGGSPILGYIIERcEEGK 95.00% 2.05 0.258 0 c20: Carbamidomethyl (+57.02) 914.9452 2,741.81 2,743.38 3 TERA_HUMAN
 SAMPLE 3R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 4 4 6 0.24% WEPPLKDGGSPILGYIIERcEEGK 95.00% 1.83 0.189 1.35 c20: Carbamidomethyl (+57.02) 914.9458 2,741.81 2,743.38 3 TERA_HUMAN
 SAMPLE 3R Titin  TTN  TITIN_HUMAN 3,815,832.20 100.00% 4 4 6 0.24% MTLVENTATLTVLKVGKGDAGQYTcYASNIAGK 95.00% 2.15 0.293 0 c25: Carbamidomethyl (+57.02) 1,159.03 3,474.06 3,474.76 3
 SAMPLE 4R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 99.80% 2 2 4 2.17% DFLQLFAPR 95.00% 2.46 0.283 0 553.8055 1,105.60 1,106.60 2
 SAMPLE 4R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 99.80% 2 2 4 2.17% DFLQLFAPR 95.00% 2.32 0.211 1.32 553.8064 1,105.60 1,106.60 2
 SAMPLE 4R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 99.80% 2 2 4 2.17% DFLQLFAPR 95.00% 2.74 0.331 0 553.8074 1,105.60 1,106.60 2
 SAMPLE 4R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 99.80% 2 2 4 2.17% RDFLQLFAPR 95.00% 2.26 0.239 2.66 631.8589 1,261.70 1,262.70 2
 SAMPLE 1 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 4 4 8 17.80% ASATSATLELDR 95.00% 3.44 0.465 3.89 617.8166 1,233.62 1,234.63 2
 SAMPLE 1 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 4 4 8 17.80% ASATSATLELDR 95.00% 3.86 0.483 3.96 617.8166 1,233.62 1,234.63 2
 SAMPLE 1 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 4 4 8 17.80% GLcGScNKPIAGQVVTALGR 95.00% 4.08 0.548 1.85 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 686.6901 2,057.05 2,058.06 3
 SAMPLE 1 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 4 4 8 17.80% GLcGScNKPIAGQVVTALGR 95.00% 3.69 0.471 2.28 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 686.6904 2,057.05 2,058.06 3
 SAMPLE 1 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 4 4 8 17.80% GLcGScNKPIAGQVVTALGR 95.00% 4.36 0.584 2.44 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 687.0241 2,058.05 2,058.06 3
 SAMPLE 1 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 4 4 8 17.80% GLcGScNKPIAGQVVTALGR 95.00% 3.61 0.429 1.02 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 687.0253 2,058.05 2,058.06 3
 SAMPLE 1 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 4 4 8 17.80% AGKPYcQPcFLK 95.00% 3.26 0.324 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 734.8619 1,467.71 1,468.71 2 CNN3_HUMAN
 SAMPLE 1 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 4 4 8 17.80% DGAPFcPEcYFER 95.00% 3.11 0.329 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 824.3316 1,646.65 1,647.66 2 RS9_HUMAN
 SAMPLE 1 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 4 4 8 17.80% PAAPAAPPFSSSSGVLGTGLcELDR 95.00% 4.15 0.644 0 c21: Carbamidomethyl (+57.02) 1,229.61 2,457.20 2,457.21 2
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% DFLQLFAPR 95.00% 2.89 0.291 0 553.8015 1,105.59 1,106.60 2
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% DFLQLFAPR 95.00% 2.82 0.314 0 553.8019 1,105.59 1,106.60 2
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% DFLQLFAPR 95.00% 2.85 0.362 0 553.8038 1,105.59 1,106.60 2
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% DFLQLFAPR 95.00% 3.13 0.339 0 554.3059 1,106.60 1,106.60 2
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% ASATSATLELDR 95.00% 3.93 0.483 2.52 617.8161 1,233.62 1,234.63 2
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% ASATSATLELDR 95.00% 3.78 0.416 3.24 617.8164 1,233.62 1,234.63 2
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% GLcGScNKPIAGQVVTALGR 95.00% 2.47 0.294 1.64 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 686.6901 2,057.05 2,058.06 3
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% GLcGScNKPIAGQVVTALGR 95.00% 4.21 0.537 3.28 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 687.0208 2,058.04 2,058.06 3
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% GLcGScNKPIAGQVVTALGR 95.00% 3.91 0.477 3.06 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 687.0258 2,058.05 2,058.06 3
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% GLcGScNKPIAGQVVTALGR 95.00% 3.98 0.504 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 687.0267 2,058.06 2,058.06 3
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% GSLcATcGLPVTGR 95.00% 2.83 0.363 2.21 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 724.8523 1,447.69 1,448.70 2
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% DGAPFcPEcYFER 95.00% 3.34 0.473 1.68 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 824.3284 1,646.64 1,647.66 2 RS9_HUMAN
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% DGAPFcPEcYFER 95.00% 2.93 0.267 1.46 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 824.3305 1,646.65 1,647.66 2 RS9_HUMAN
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% DGAPFcPEcYFER 95.00% 3.41 0.408 1.25 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 824.8317 1,647.65 1,647.66 2 RS9_HUMAN
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% DGAPFcPEcYFER 95.00% 3.09 0.424 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 824.8322 1,647.65 1,647.66 2 RS9_HUMAN
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% GSLDTMLGLLQSDLSR 95.00% 5.12 0.554 3.8 853.4406 1,704.87 1,705.88 2
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% GSLDTMLGLLQSDLSR 95.00% 5.87 0.519 5.55 853.9443 1,705.87 1,705.88 2
 SAMPLE 1R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 14 18.20% GSLDTMLGLLQSDLSR 95.00% 4.98 0.5 6.46 853.9469 1,705.88 1,705.88 2
 SAMPLE 2 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 7 14.50% cGFcNQPIR 95.00% 2.55 0.277 2.17 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 576.2612 1,150.51 1,151.51 2
 SAMPLE 2 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 7 14.50% ASATSATLELDR 95.00% 3.43 0.487 2 617.8164 1,233.62 1,234.63 2
 SAMPLE 2 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 7 14.50% GLcGScNKPIAGQVVTALGR 95.00% 3.94 0.343 2.64 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 686.6906 2,057.05 2,058.06 3
 SAMPLE 2 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 7 14.50% GLcGScNKPIAGQVVTALGR 95.00% 4.43 0.529 3.64 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 687.0249 2,058.05 2,058.06 3
 SAMPLE 2 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 7 14.50% GSLcATcGLPVTGR 95.00% 3.09 0.537 3.48 c4: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 724.8523 1,447.69 1,448.70 2
 SAMPLE 2 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 7 14.50% AGKPYcQPcFLK 95.00% 3.41 0.417 1.39 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 734.8575 1,467.70 1,468.71 2 CNN3_HUMAN
 SAMPLE 2 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 5 7 14.50% AGKPYcQPcFLK 95.00% 3.86 0.461 2.07 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 734.8576 1,467.70 1,468.71 2 CNN3_HUMAN
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% AGKPYcQPcFLK 95.00% 2.81 0.159 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 490.2406 1,467.70 1,468.71 3 CNN3_HUMAN
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% DFLQLFAPR 95.00% 2.21 0.242 0 553.8022 1,105.59 1,106.60 2
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% DFLQLFAPR 95.00% 2.63 0.32 0 553.8035 1,105.59 1,106.60 2
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% DFLQLFAPR 95.00% 2.66 0.36 0 553.8039 1,105.59 1,106.60 2
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% DFLQLFAPR 95.00% 2.63 0.35 0 553.8039 1,105.59 1,106.60 2
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% DFLQLFAPR 95.00% 2.45 0.358 0 553.8043 1,105.59 1,106.60 2
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% DFLQLFAPR 95.00% 2.44 0.327 0 553.8044 1,105.59 1,106.60 2
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% DFLQLFAPR 95.00% 2.74 0.338 1.64 554.3064 1,106.60 1,106.60 2
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% cGFcNQPIR 95.00% 1.85 0.251 1.38 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 576.2575 1,150.50 1,151.51 2
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% GLcGScNKPIAGQVVTALGR 95.00% 3.57 0.498 0 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 686.6895 2,057.04 2,058.06 3
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% GLcGScNKPIAGQVVTALGR 95.00% 2.85 0.39 1.42 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 686.6898 2,057.05 2,058.06 3
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% AGKPYcQPcFLK 95.00% 3.47 0.471 2.66 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 734.8567 1,467.70 1,468.71 2 CNN3_HUMAN
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% AGKPYcQPcFLK 95.00% 3.67 0.404 1.8 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 734.8577 1,467.70 1,468.71 2 CNN3_HUMAN
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% DGAPFcPEcYFER 95.00% 2.92 0.42 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 824.3332 1,646.65 1,647.66 2 RS9_HUMAN
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% DGAPFcPEcYFER 95.00% 2.84 0.371 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 824.3335 1,646.65 1,647.66 2 RS9_HUMAN
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% GSLDTMLGLLQSDLSR 95.00% 5.59 0.537 5.38 853.442 1,704.87 1,705.88 2
 SAMPLE 2R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 15 17.10% GSLDTMLGLLQSDLSR 95.00% 5.79 0.538 3.28 853.9456 1,705.88 1,705.88 2
 SAMPLE 3 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 10 16.90% LMASLSDFR 95.00% 2.71 0.447 0 520.2648 1,038.51 1,039.52 2
 SAMPLE 3 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 10 16.90% LMASLSDFR 95.00% 2.57 0.424 1.85 520.265 1,038.51 1,039.52 2
 SAMPLE 3 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 10 16.90% cGFcNQPIR 95.00% 2.94 0.333 2.43 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 576.257 1,150.50 1,151.51 2
 SAMPLE 3 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 10 16.90% cGFcNQPIR 95.00% 2.84 0.323 2 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 576.258 1,150.50 1,151.51 2
 SAMPLE 3 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 10 16.90% GLcGScNKPIAGQVVTALGR 95.00% 4.38 0.485 3.27 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 687.0228 2,058.05 2,058.06 3
 SAMPLE 3 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 10 16.90% GLcGScNKPIAGQVVTALGR 95.00% 4.83 0.539 2.31 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 687.0243 2,058.05 2,058.06 3
 SAMPLE 3 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 10 16.90% AGKPYcQPcFLK 95.00% 3.86 0.405 2.96 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 734.8575 1,467.70 1,468.71 2 CNN3_HUMAN
 SAMPLE 3 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 10 16.90% AGKPYcQPcFLK 95.00% 4 0.397 2.47 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.3586 1,468.70 1,468.71 2 CNN3_HUMAN
 SAMPLE 3 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 10 16.90% KRPSLPSSPSPGLPK 95.00% 2.5 0.34 0 774.8897 1,547.76 1,547.89 2
 SAMPLE 3 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 10 16.90% DGAPFcPEcYFER 95.00% 2.95 0.443 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 824.3313 1,646.65 1,647.66 2 RS9_HUMAN
 SAMPLE 3 Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 5 6 10 16.90% GLcGScNKPIAGQVVTALGR 95.00% 6.29 0.636 6.08 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 1,030.03 2,058.05 2,058.06 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% LMASLSDFR 95.00% 2.02 0.333 0 520.2639 1,038.51 1,039.52 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% LMASLSDFR 95.00% 2.22 0.356 0 520.2639 1,038.51 1,039.52 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% DFLQLFAPR 95.00% 2.73 0.223 0 553.8014 1,105.59 1,106.60 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% DFLQLFAPR 95.00% 2.47 0.349 0 553.802 1,105.59 1,106.60 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% DFLQLFAPR 95.00% 2.42 0.209 0 553.8022 1,105.59 1,106.60 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% DFLQLFAPR 95.00% 2.35 0.251 1.36 553.8028 1,105.59 1,106.60 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% DFLQLFAPR 95.00% 2.85 0.305 0 553.8028 1,105.59 1,106.60 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% DFLQLFAPR 95.00% 2.78 0.33 0 553.8031 1,105.59 1,106.60 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% DFLQLFAPR 95.00% 2.81 0.329 0 553.8037 1,105.59 1,106.60 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% DFLQLFAPR 95.00% 2.77 0.294 0 554.303 1,106.59 1,106.60 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% cGFcNQPIR 95.00% 2.5 0.384 2.47 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 576.2587 1,150.50 1,151.51 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% RDFLQLFAPR 95.00% 2.87 0.242 2.64 631.8526 1,261.69 1,262.70 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% RDFLQLFAPR 95.00% 2.9 0.28 2.13 631.8532 1,261.69 1,262.70 2
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% GLcGScNKPIAGQVVTALGR 95.00% 4.29 0.53 2.08 c3: Carbamidomethyl (+57.02), c6: Carbamidomethyl (+57.02) 687.0244 2,058.05 2,058.06 3
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% AGKPYcQPcFLK 95.00% 3.73 0.334 2.06 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.3565 1,468.70 1,468.71 2 CNN3_HUMAN
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% AGKPYcQPcFLK 95.00% 3.76 0.411 1.7 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.3583 1,468.70 1,468.71 2 CNN3_HUMAN
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% DGAPFcPEcYFER 95.00% 2.94 0.396 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 824.3298 1,646.64 1,647.66 2 RS9_HUMAN
 SAMPLE 3R Transforming growth factor beta-1-induced transcript 1 protein  TGFB1I1  TGFI1_HUMAN 49,796.20 100.00% 6 6 16 15.80% DGAPFcPEcYFER 95.00% 3.16 0.463 3.8 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 824.3302 1,646.64 1,647.66 2 RS9_HUMAN
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% YLYHGQTLETLGGK 95.00% 2.27 0.28 0 527.2765 1,578.81 1,579.81 3
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% YLYHGQTLETLGGK 95.00% 3.71 0.271 1.43 527.2772 1,578.81 1,579.81 3
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% YLYHGQTLETLGGK 95.00% 3.56 0.298 1.13 527.6104 1,579.81 1,579.81 3
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% DLLNNHILK 95.00% 2.43 0.181 0 540.3157 1,078.62 1,079.62 2
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% ADHHATNGVVHLIDK 95.00% 3.39 0.418 0 542.952 1,625.83 1,626.84 3
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% NSLcIENScIAAHDKR 95.00% 2.27 0.298 0 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 629.9663 1,886.88 1,887.88 3 HNRH2_HUMAN,SEPT2_HUMAN
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% NSLcIENScIAAHDKR 95.00% 2.3 0.311 0 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 629.9671 1,886.88 1,887.88 3 HNRH2_HUMAN,SEPT2_HUMAN
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% NSLcIENScIAAHDKR 95.00% 2.07 0.224 0 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 629.9677 1,886.88 1,887.88 3 HNRH2_HUMAN,SEPT2_HUMAN
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% SLQGDKLEVSLK 95.00% 2.94 0.216 1.82 658.8766 1,315.74 1,316.74 2
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% SPYQLVLQHSR 95.00% 3.39 0.353 0 664.3606 1,326.71 1,327.71 2
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% SPYQLVLQHSR 95.00% 3.58 0.423 2.62 664.3609 1,326.71 1,327.71 2
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% GDELADSALEIFK 95.00% 3.8 0.268 3.14 704.3543 1,406.69 1,407.70 2
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% GDELADSALEIFK 95.00% 3.39 0.253 2.24 704.3548 1,406.69 1,407.70 2
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% VLTPPMGTVMDVLK 95.00% 2.69 0.438 3.96 750.9139 1,499.81 1,500.82 2 TITIN_HUMAN
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% VLTPPMGTVMDVLK 95.00% 2.35 0.305 5.77 750.9156 1,499.82 1,500.82 2 TITIN_HUMAN
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% VLTPPmGTVMDVLK 95.00% 2.23 0.328 2.03 m6: Oxidation (+15.99) 758.912 1,515.81 1,516.81 2 TITIN_HUMAN
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% VLTPPmGTVMDVLK 95.00% 2.4 0.429 3.96 m6: Oxidation (+15.99) 758.9126 1,515.81 1,516.81 2 TITIN_HUMAN
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% YLYHGQTLETLGGK 95.00% 4.49 0.509 4.29 790.4121 1,578.81 1,579.81 2
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% YLYHGQTLETLGGK 95.00% 4.55 0.53 4.72 790.4129 1,578.81 1,579.81 2
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% YLYHGQTLETLGGK 95.00% 4.24 0.499 4.82 790.4138 1,578.81 1,579.81 2
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% EGVYTVFAPTNEAFR 95.00% 4.29 0.557 3.14 850.9194 1,699.82 1,700.83 2
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% EGVYTVFAPTNEAFR 95.00% 3.97 0.583 3.44 850.9198 1,699.82 1,700.83 2
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% NSLcIENScIAAHDK 95.00% 4.36 0.544 3.46 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 866.3962 1,730.78 1,731.78 2
 SAMPLE 4 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 11 20 17.40% NSLcIENScIAAHDKR 95.00% 4.17 0.443 2.6 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 944.4435 1,886.87 1,887.88 2 HNRH2_HUMAN,SEPT2_HUMAN
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% YLYHGQTLETLGGK 95.00% 3.2 0.237 0 527.2769 1,578.81 1,579.81 3
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% YLYHGQTLETLGGK 95.00% 2.64 0.258 0 527.2773 1,578.81 1,579.81 3
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% YLYHGQTLETLGGK 95.00% 4.09 0.405 1 527.6117 1,579.81 1,579.81 3
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% YLYHGQTLETLGGK 95.00% 2.55 0.202 0 527.6118 1,579.81 1,579.81 3
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% NSLcIENScIAAHDKR 95.00% 2.24 0.305 0 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 629.9663 1,886.88 1,887.88 3 HNRH2_HUMAN,SEPT2_HUMAN
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% NHIIKDQLASK 95.00% 2.71 0.458 3.85 633.8678 1,265.72 1,266.72 2
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% LTLLAPLNSVFK 95.00% 2.4 0.23 2.41 658.4048 1,314.79 1,315.80 2 MAP1B_HUMAN
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% LTLLAPLNSVFK 95.00% 3.02 0.322 2.85 658.4049 1,314.79 1,315.80 2 MAP1B_HUMAN
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% LTLLAPLNSVFK 95.00% 3.19 0.357 4.02 658.4054 1,314.80 1,315.80 2 MAP1B_HUMAN
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% LTLLAPLNSVFK 95.00% 2.3 0.262 1.52 658.406 1,314.80 1,315.80 2 MAP1B_HUMAN
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% LTLLAPLNSVFK 95.00% 2.87 0.315 2.51 658.406 1,314.80 1,315.80 2 MAP1B_HUMAN
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% LTLLAPLNSVFK 95.00% 2.43 0.247 0 658.4062 1,314.80 1,315.80 2 MAP1B_HUMAN
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% SPYQLVLQHSR 95.00% 3.37 0.34 0 664.3606 1,326.71 1,327.71 2
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% GDELADSALEIFK 95.00% 2.91 0.203 3.25 704.3531 1,406.69 1,407.70 2
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% VLTPPMGTVMDVLK 95.00% 2.65 0.444 5.85 750.915 1,499.81 1,500.82 2 TITIN_HUMAN
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% VLTPPMGTVMDVLK 95.00% 3.12 0.483 4.96 750.9152 1,499.81 1,500.82 2 TITIN_HUMAN
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% VLTPPmGTVMDVLK 95.00% 3.16 0.502 2.27 m6: Oxidation (+15.99) 758.9129 1,515.81 1,516.81 2 TITIN_HUMAN
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% VLTPPmGTVMDVLK 95.00% 3.07 0.451 2.46 m6: Oxidation (+15.99) 759.4132 1,516.81 1,516.81 2 TITIN_HUMAN
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% YLYHGQTLETLGGK 95.00% 4.67 0.521 3.6 790.4127 1,578.81 1,579.81 2
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% YLYHGQTLETLGGK 95.00% 4.56 0.486 3.77 790.4129 1,578.81 1,579.81 2
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% YLYHGQTLETLGGK 95.00% 4.24 0.528 4.3 790.4159 1,578.82 1,579.81 2
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% YLYHGQTLETLGGK 95.00% 4.25 0.522 3.96 790.9145 1,579.81 1,579.81 2
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% EGVYTVFAPTNEAFR 95.00% 3.21 0.585 0 850.9192 1,699.82 1,700.83 2
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% EGVYTVFAPTNEAFR 95.00% 3.3 0.483 0 850.9193 1,699.82 1,700.83 2
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% EGVYTVFAPTNEAFR 95.00% 3.89 0.567 2.51 850.9212 1,699.83 1,700.83 2
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% NSLcIENScIAAHDK 95.00% 4.28 0.516 2.59 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 866.8966 1,731.78 1,731.78 2
 SAMPLE 4R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 8 9 23 15.50% NSLcIENScIAAHDK 95.00% 4.3 0.493 2.59 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 866.898 1,731.78 1,731.78 2
 SAMPLE 2 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 6 6 10 14.30% NHIIKDQLASK 95.00% 2.7 0.366 2.35 633.8618 1,265.71 1,266.72 2
 SAMPLE 2 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 6 6 10 14.30% SLQGDKLEVSLK 95.00% 3.3 0.35 1.74 658.874 1,315.73 1,316.74 2
 SAMPLE 2 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 6 6 10 14.30% SLQGDKLEVSLK 95.00% 3.45 0.37 1.26 658.8748 1,315.73 1,316.74 2
 SAMPLE 2 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 6 6 10 14.30% GDELADSALEIFK 95.00% 4.31 0.572 3.6 704.3531 1,406.69 1,407.70 2
 SAMPLE 2 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 6 6 10 14.30% GDELADSALEIFK 95.00% 2.77 0.39 3.55 704.3536 1,406.69 1,407.70 2
 SAMPLE 2 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 6 6 10 14.30% STVISYEccPGYEKVPGEK 95.00% 2.5 0.336 1.44 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.3384 2,202.99 2,203.01 3
 SAMPLE 2 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 6 6 10 14.30% STVISYEccPGYEKVPGEK 95.00% 3.55 0.395 0 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.3408 2,203.00 2,203.01 3
 SAMPLE 2 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 6 6 10 14.30% VLTPPMGTVMDVLK 95.00% 2.49 0.375 4.85 750.9118 1,499.81 1,500.82 2 TITIN_HUMAN
 SAMPLE 2 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 6 6 10 14.30% VLTPPMGTVMDVLK 95.00% 2.61 0.362 4.03 750.9121 1,499.81 1,500.82 2 TITIN_HUMAN
 SAMPLE 2 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 6 6 10 14.30% YLYHGQTLETLGGK 95.00% 4.58 0.532 3.85 790.4093 1,578.80 1,579.81 2
 SAMPLE 2 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 6 6 10 14.30% YLYHGQTLETLGGK 95.00% 4.63 0.518 4.14 790.4096 1,578.80 1,579.81 2
 SAMPLE 2 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 6 6 10 14.30% NSLcIENScIAAHDK 95.00% 4.12 0.529 4.04 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 866.3918 1,730.77 1,731.78 2
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% YGTLFTMDR 95.00% 2.38 0.445 1.82 552.2621 1,102.51 1,103.52 2
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% YGTLFTMDR 95.00% 2.88 0.442 2.85 552.263 1,102.51 1,103.52 2
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% YLYHGQTLETLGGKK 95.00% 3.74 0.376 1.2 570.3077 1,707.90 1,707.91 3
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% NSLcIENScIAAHDKR 95.00% 2.59 0.292 0 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 629.9646 1,886.87 1,887.88 3 HNRH2_HUMAN,SEPT2_HUMAN
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% NHIIKDQLASK 95.00% 2.67 0.335 0 633.8601 1,265.70 1,266.72 2
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% NHIIKDQLASK 95.00% 2.68 0.286 3.07 634.3658 1,266.72 1,266.72 2
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% SLQGDKLEVSLK 95.00% 3.37 0.379 2.37 658.8741 1,315.73 1,316.74 2
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% FSMLVAAIQSAGLTETLNR 95.00% 4.38 0.498 3.59 675.0283 2,022.06 2,022.07 3
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% GDELADSALEIFK 95.00% 3.76 0.534 4.11 704.3516 1,406.69 1,407.70 2
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% GDELADSALEIFK 95.00% 3.15 0.449 3.77 704.3527 1,406.69 1,407.70 2
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% STVISYEccPGYEKVPGEK 95.00% 3.55 0.381 0 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.3395 2,203.00 2,203.01 3
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% STVISYEccPGYEKVPGEK 95.00% 3.69 0.466 0 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.3401 2,203.00 2,203.01 3
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% VLTPPMGTVMDVLK 95.00% 2.69 0.566 5.11 750.9122 1,499.81 1,500.82 2 TITIN_HUMAN
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% VLTPPMGTVMDVLK 95.00% 2.36 0.448 3.42 750.9132 1,499.81 1,500.82 2 TITIN_HUMAN
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% YLYHGQTLETLGGK 95.00% 4.3 0.474 4.42 790.4077 1,578.80 1,579.81 2
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% YLYHGQTLETLGGK 95.00% 4.36 0.505 3.96 790.9132 1,579.81 1,579.81 2
 SAMPLE 2R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 10 15 21.40% YHIGDEILVSGGIGALVR 95.00% 2.48 0.246 0 935.021 1,868.03 1,869.02 2
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% YGTLFTMDR 95.00% 2.6 0.378 1.96 552.2622 1,102.51 1,103.52 2
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% YGTLFTMDR 95.00% 2.74 0.371 2.96 552.2624 1,102.51 1,103.52 2
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% YLYHGQTLETLGGKK 95.00% 4.91 0.483 1.2 569.9733 1,706.90 1,707.91 3
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% YLYHGQTLETLGGKK 95.00% 4.78 0.41 1.32 570.3071 1,707.90 1,707.91 3
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% YHIGDEILVSGGIGALVR 95.00% 3.53 0.394 2.96 624.0143 1,869.02 1,869.02 3
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% NSLcIENScIAAHDKR 95.00% 2.45 0.226 0 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 629.9637 1,886.87 1,887.88 3 HNRH2_HUMAN,SEPT2_HUMAN
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% SLQGDKLEVSLK 95.00% 3.2 0.322 1.09 658.8734 1,315.73 1,316.74 2
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% SLQGDKLEVSLK 95.00% 2.84 0.22 0 658.8737 1,315.73 1,316.74 2
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% SPYQLVLQHSR 95.00% 2.52 0.0659 2.03 664.3584 1,326.70 1,327.71 2
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% STVISYEccPGYEKVPGEK 95.00% 2.22 0.307 0 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.0045 2,201.99 2,203.01 3
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% YLYHGQTLETLGGK 95.00% 4.22 0.461 4.47 790.4093 1,578.80 1,579.81 2
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% YLYHGQTLETLGGK 95.00% 4.43 0.471 3.72 790.4097 1,578.80 1,579.81 2
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% NSLcIENScIAAHDK 95.00% 4.36 0.532 4.28 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 866.3916 1,730.77 1,731.78 2
 SAMPLE 3 Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 9 10 14 14.60% NSLcIENScIAAHDKR 95.00% 3.9 0.387 3.23 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 944.4398 1,886.86 1,887.88 2 HNRH2_HUMAN,SEPT2_HUMAN
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% YLYHGQTLETLGGKK 95.00% 4.24 0.421 1.19 569.9727 1,706.89 1,707.91 3
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% YLYHGQTLETLGGKK 95.00% 4.37 0.35 0 569.9729 1,706.90 1,707.91 3
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% YHIGDEILVSGGIGALVR 95.00% 3.14 0.405 2.07 624.0132 1,869.02 1,869.02 3
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% YHIGDEILVSGGIGALVR 95.00% 2.82 0.392 2.28 624.0143 1,869.02 1,869.02 3
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% NHIIKDQLASK 95.00% 2.34 0.393 0 633.8582 1,265.70 1,266.72 2
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% SLQGDKLEVSLK 95.00% 3.44 0.296 2.14 658.8736 1,315.73 1,316.74 2
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% SLQGDKLEVSLK 95.00% 3.38 0.308 2.43 658.8744 1,315.73 1,316.74 2
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% FSMLVAAIQSAGLTETLNR 95.00% 5.53 0.558 2.89 675.0282 2,022.06 2,022.07 3
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% FSMLVAAIQSAGLTETLNR 95.00% 5.06 0.506 3.96 675.0283 2,022.06 2,022.07 3
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% GDELADSALEIFK 95.00% 2.78 0.263 3.44 704.3526 1,406.69 1,407.70 2
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% GDELADSALEIFK 95.00% 3.47 0.506 3.77 704.3532 1,406.69 1,407.70 2
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% STVISYEccPGYEKVPGEK 95.00% 3.33 0.464 0 c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 735.3379 2,202.99 2,203.01 3
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% VLTPPMGTVMDVLK 95.00% 2.49 0.495 0 750.9101 1,499.80 1,500.82 2 TITIN_HUMAN
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% VLTPPMGTVMDVLK 95.00% 1.79 0.211 2.1 750.9117 1,499.81 1,500.82 2 TITIN_HUMAN
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% VLTPPMGTVMDVLK 95.00% 1.94 0.331 1.3 750.9123 1,499.81 1,500.82 2 TITIN_HUMAN
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% VLTPPmGTVMDVLK 95.00% 2.6 0.37 1.49 m6: Oxidation (+15.99) 758.909 1,515.80 1,516.81 2 TITIN_HUMAN
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% YLYHGQTLETLGGK 95.00% 4.32 0.501 3.25 790.4077 1,578.80 1,579.81 2
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% YLYHGQTLETLGGK 95.00% 4.2 0.524 3.55 790.4097 1,578.80 1,579.81 2
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% EGVYTVFAPTNEAFR 95.00% 4.01 0.558 5.66 850.9156 1,699.82 1,700.83 2
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% EGVYTVFAPTNEAFR 95.00% 3.99 0.597 5.14 850.9165 1,699.82 1,700.83 2
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% YHIGDEILVSGGIGALVR 95.00% 4.19 0.469 2.46 935.5204 1,869.03 1,869.02 2
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% YHIGDEILVSGGIGALVR 95.00% 4.08 0.447 3.4 935.5207 1,869.03 1,869.02 2
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% NSLcIENScIAAHDKR 95.00% 4.13 0.464 2.7 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 944.9435 1,887.87 1,887.88 2 HNRH2_HUMAN,SEPT2_HUMAN
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% NSLcIENScIAAHDKR 95.00% 4.41 0.491 3.2 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 944.9435 1,887.87 1,887.88 2 HNRH2_HUMAN,SEPT2_HUMAN
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% FSMLVAAIQSAGLTETLNR 95.00% 5.57 0.522 6.12 1,012.04 2,022.06 2,022.07 2
 SAMPLE 3R Transforming growth factor-beta-induced protein ig-h3  TGFBI  BGH3_HUMAN 74,664.90 100.00% 10 12 22 22.30% FSMLVAAIQSAGLTETLNR 95.00% 5.61 0.54 7.34 1,012.04 2,022.06 2,022.07 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LGFQVWLK 95.00% 2.53 0.231 0 495.7928 989.57 990.5778 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LGFQVWLK 95.00% 2.27 0.08 1.32 495.793 989.5704 990.5778 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LGFQVWLK 95.00% 3 0.275 0 495.7932 989.5707 990.5778 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LGFQVWLK 95.00% 3 0.293 0 495.7933 989.5709 990.5778 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LGFQVWLK 95.00% 3.16 0.261 0 495.7934 989.5711 990.5778 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LGFQVWLK 95.00% 2.75 0.296 0 495.7941 989.5726 990.5778 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LGFQVWLK 95.00% 2.96 0.189 0 495.7944 989.5732 990.5778 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LVNSLYPDGSKPVK 95.00% 2.08 0.246 0 506.2833 1,515.83 1,516.84 3
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LVNSLYPDGSKPVK 95.00% 2.59 0.393 0 506.2847 1,515.83 1,516.84 3
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LVNSLYPDGSK 95.00% 2.62 0.444 0 596.8144 1,191.61 1,192.62 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LVNSLYPDGSK 95.00% 3.16 0.385 0 596.8165 1,191.62 1,192.62 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% TLMALGSLAVTK 95.00% 0 0 3.59 603.8349 1,205.65 1,204.70 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% TLMALGSLAVTK 95.00% 0 0 3.15 603.8349 1,205.65 1,204.70 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% HVIGLQmGSNR 95.00% 2.17 0.444 2.48 m7: Oxidation (+15.99) 614.3183 1,226.62 1,227.63 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% HVIGLQmGSNR 95.00% 1.89 0.242 1.38 m7: Oxidation (+15.99) 614.3216 1,226.63 1,227.63 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% VPENPPSMVFK 95.00% 2.28 0.376 1.43 622.8233 1,243.63 1,244.64 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% VPENPPSMVFK 95.00% 2.39 0.417 1.52 622.8235 1,243.63 1,244.64 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% VPENPPSmVFK 95.00% 1.92 0.306 0 m8: Oxidation (+15.99) 630.8194 1,259.62 1,260.63 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% VPENPPSmVFK 95.00% 2.1 0.294 0 m8: Oxidation (+15.99) 630.8194 1,259.62 1,260.63 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% VPENPPSmVFK 95.00% 2.03 0.351 0 m8: Oxidation (+15.99) 630.8211 1,259.63 1,260.63 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LVNSLYPDGSKPVK 95.00% 3.7 0.416 3.02 758.9245 1,515.83 1,516.84 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LVNSLYPDGSKPVK 95.00% 3.24 0.398 3.16 758.9246 1,515.83 1,516.84 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LVNSLYPDGSKPVK 95.00% 3.24 0.403 2.05 758.9253 1,515.83 1,516.84 2
 SAMPLE 4 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 6 7 24 27.90% LVNSLYPDGSKPVK 95.00% 3.79 0.495 2.74 758.9254 1,515.84 1,516.84 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LGFQVWLK 95.00% 2.94 0.283 0 495.7933 989.571 990.5778 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LGFQVWLK 95.00% 2.75 0.217 0 495.7934 989.5711 990.5778 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LGFQVWLK 95.00% 3.08 0.253 0 495.7935 989.5713 990.5778 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LGFQVWLK 95.00% 2.87 0.274 0 495.7935 989.5713 990.5778 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LGFQVWLK 95.00% 3 0.26 0 495.7936 989.5716 990.5778 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LGFQVWLK 95.00% 2.36 0.198 0 495.7939 989.5721 990.5778 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LGFQVWLK 95.00% 2.61 0.25 0 495.794 989.5723 990.5778 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LGFQVWLK 95.00% 2.51 0.209 0 495.7943 989.573 990.5778 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LVNSLYPDGSKPVK 95.00% 2.04 0.246 0 506.2846 1,515.83 1,516.84 3
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LVNSLYPDGSKPVK 95.00% 2.36 0.321 0 506.6182 1,516.83 1,516.84 3
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LVNSLYPDGSK 95.00% 3.04 0.428 0 596.8163 1,191.62 1,192.62 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LVNSLYPDGSK 95.00% 2.84 0.496 0 596.8167 1,191.62 1,192.62 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% TLMALGSLAVTK 95.00% 0 0 3.48 603.8366 1,205.66 1,204.70 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% VPENPPSMVFK 95.00% 2.45 0.415 1.52 622.821 1,243.63 1,244.64 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% VPENPPSMVFK 95.00% 2.19 0.354 0 622.8239 1,243.63 1,244.64 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% VPENPPSmVFK 95.00% 2.17 0.334 0 m8: Oxidation (+15.99) 630.8209 1,259.63 1,260.63 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% VPENPPSmVFK 95.00% 2.04 0.308 0 m8: Oxidation (+15.99) 630.8215 1,259.63 1,260.63 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LVNSLYPDGSKPVK 95.00% 3.06 0.439 3.54 758.9231 1,515.83 1,516.84 2
 SAMPLE 4R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 5 6 19 22.40% LVNSLYPDGSKPVK 95.00% 3.45 0.467 3.14 758.9251 1,515.83 1,516.84 2
 SAMPLE 1 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 3 3 10 16.40% LGFQVWLK 95.00% 2.89 0.296 0 495.7936 989.5716 990.5778 2
 SAMPLE 1 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 3 3 10 16.40% LGFQVWLK 95.00% 2.57 0.221 0 495.7955 989.5754 990.5778 2
 SAMPLE 1 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 3 3 10 16.40% LGFQVWLK 95.00% 2.83 0.233 1.68 495.7984 989.5812 990.5778 2
 SAMPLE 1 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 3 3 10 16.40% LGFQVWLK 95.00% 3.09 0.258 0 495.8 989.5844 990.5778 2
 SAMPLE 1 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 3 3 10 16.40% LGFQVWLK 95.00% 2.87 0.308 0 495.8011 989.5866 990.5778 2
 SAMPLE 1 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 3 3 10 16.40% TLMALGSLAVTK 95.00% 3.42 0.419 4.96 602.8543 1,203.69 1,204.70 2
 SAMPLE 1 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 3 3 10 16.40% TLMALGSLAVTK 95.00% 4.46 0.491 3.46 602.8623 1,203.71 1,204.70 2
 SAMPLE 1 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 3 3 10 16.40% TLMALGSLAVTK 95.00% 3.89 0.403 3.77 602.8626 1,203.71 1,204.70 2
 SAMPLE 1 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 3 3 10 16.40% TDMFQTVDLFEGK 95.00% 4.68 0.489 4.08 765.8748 1,529.73 1,530.72 2
 SAMPLE 1 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 3 3 10 16.40% TDMFQTVDLFEGK 95.00% 4.66 0.564 3.64 765.8752 1,529.73 1,530.72 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% LGFQVWLK 95.00% 2.1 0.218 0 495.7913 989.567 990.5778 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% LGFQVWLK 95.00% 2.19 0.217 0 495.7916 989.5675 990.5778 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% LGFQVWLK 95.00% 2.14 0.211 0 495.7922 989.5688 990.5778 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% LGFQVWLK 95.00% 2.57 0.221 0 495.7955 989.5754 990.5778 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% LGFQVWLK 95.00% 3.17 0.27 0 495.7967 989.5777 990.5778 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% LGFQVWLK 95.00% 2.93 0.179 0 495.8 989.5843 990.5778 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% TLMALGSLAVTK 95.00% 2.11 0.214 2.21 602.8169 1,203.62 1,204.70 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% TLMALGSLAVTK 95.00% 3.46 0.387 4.57 602.8624 1,203.71 1,204.70 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% TLMALGSLAVTK 95.00% 4.13 0.417 3.26 602.8626 1,203.71 1,204.70 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% TLMALGSLAVTK 95.00% 4.05 0.448 3.85 602.8627 1,203.71 1,204.70 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% TLMALGSLAVTK 95.00% 3.34 0.466 5.07 602.8634 1,203.71 1,204.70 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% TLMALGSLAVTK 94.60% 0 0 3.25 603.8318 1,205.65 1,204.70 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% TDMFQTVDLFEGK 95.00% 4.02 0.505 3.85 765.8607 1,529.71 1,530.72 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% TDMFQTVDLFEGK 95.00% 4.61 0.509 4.04 765.8752 1,529.73 1,530.72 2
 SAMPLE 1R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 4 4 15 25.40% LVEWIIVQcGPDVGRPDR 95.00% 3.52 0.266 1.7 c9: Carbamidomethyl (+57.02) 1,055.57 2,109.12 2,109.09 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% AAEDYGVIK 95.00% 2.91 0.436 1.68 483.2504 964.4851 965.4945 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% AAEDYGVIK 95.00% 2.95 0.43 1.82 483.2504 964.4851 965.4945 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LGFQVWLK 95.00% 3.13 0.27 0 495.7915 989.5674 990.5778 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LGFQVWLK 95.00% 2.68 0.21 0 495.7921 989.5685 990.5778 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LGFQVWLK 95.00% 3 0.286 0 495.7922 989.5687 990.5778 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LGFQVWLK 95.00% 2.89 0.2 0 495.7932 989.5708 990.5778 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LVNSLYPDGSKPVK 95.00% 2.22 0.244 0 506.2837 1,515.83 1,516.84 3
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% IEKKYDEELEER 95.00% 4.31 0.345 0 527.5989 1,579.77 1,580.78 3
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% IEKKYDEELEER 95.00% 4.07 0.336 0 527.9338 1,580.78 1,580.78 3
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LVNSLYPDGSK 95.00% 2.58 0.226 0 596.812 1,191.61 1,192.62 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LVNSLYPDGSK 95.00% 3.68 0.516 0 596.8134 1,191.61 1,192.62 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LVNSLYPDGSK 95.00% 2.66 0.278 0 596.8134 1,191.61 1,192.62 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LVNSLYPDGSK 95.00% 3.46 0.437 0 596.8141 1,191.61 1,192.62 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% TLMALGSLAVTK 95.00% 3.92 0.438 4.46 602.8512 1,203.69 1,204.70 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% TLMALGSLAVTK 95.00% 4.26 0.458 5.05 602.8513 1,203.69 1,204.70 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% TLMALGSLAVTK 95.00% 3.71 0.398 5 602.8517 1,203.69 1,204.70 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% KYDEELEER 95.00% 2.63 0.32 0 605.7841 1,209.55 1,210.56 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% KYDEELEER 95.00% 2.11 0.306 0 605.7845 1,209.55 1,210.56 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% HVIGLQMGSNR 95.00% 2.88 0.545 6.46 606.3181 1,210.62 1,211.63 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% HVIGLQMGSNR 95.00% 2.74 0.565 3.15 606.3191 1,210.62 1,211.63 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% TLmALGSLAVTK 95.00% 2.97 0.456 1.27 m3: Oxidation (+15.99) 610.8479 1,219.68 1,220.69 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% TLmALGSLAVTK 95.00% 3.34 0.455 2.47 m3: Oxidation (+15.99) 610.8485 1,219.68 1,220.69 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% HVIGLQmGSNR 95.00% 2.12 0.526 2.04 m7: Oxidation (+15.99) 614.318 1,226.62 1,227.63 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% HVIGLQmGSNR 95.00% 2.36 0.547 3.04 m7: Oxidation (+15.99) 614.3182 1,226.62 1,227.63 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% VPENPPSMVFK 95.00% 2.62 0.256 1.6 622.8174 1,243.62 1,244.64 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% VPENPPSMVFK 95.00% 2.25 0.304 1.28 622.8202 1,243.62 1,244.64 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% VPENPPSmVFK 95.00% 2.49 0.32 1.28 m8: Oxidation (+15.99) 630.8179 1,259.62 1,260.63 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% VPENPPSmVFK 95.00% 2.47 0.392 1.18 m8: Oxidation (+15.99) 630.818 1,259.62 1,260.63 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% EFTESQLQEGK 95.00% 2.94 0.5 1.8 648.3075 1,294.60 1,295.61 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LVNSLYPDGSKPVK 95.00% 3.48 0.4 2.66 758.9193 1,515.82 1,516.84 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LVNSLYPDGSKPVK 95.00% 3.89 0.497 3.36 758.9217 1,515.83 1,516.84 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LVNSLYPDGSKPVK 95.00% 3.28 0.418 2.82 758.9218 1,515.83 1,516.84 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% LVNSLYPDGSKPVK 95.00% 3.98 0.501 4.85 758.9221 1,515.83 1,516.84 2
 SAMPLE 2 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 11 12 34 50.20% TDmFQTVDLFEGK 95.00% 3.48 0.381 3.66 m3: Oxidation (+15.99) 773.8571 1,545.70 1,546.71 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% AAEDYGVIK 95.00% 2.54 0.376 1.72 483.2501 964.4845 965.4945 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% AAEDYGVIK 95.00% 2.83 0.379 2.05 483.2509 964.4861 965.4945 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% LGFQVWLK 95.00% 2.62 0.157 0 495.7915 989.5674 990.5778 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% LGFQVWLK 95.00% 2.95 0.258 0 495.7918 989.568 990.5778 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% LGFQVWLK 95.00% 2.17 0.237 0 495.7921 989.5685 990.5778 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% LGFQVWLK 95.00% 2.79 0.249 0 495.7925 989.5694 990.5778 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% IEKKYDEELEER 95.00% 4.09 0.363 1.2 527.5986 1,579.77 1,580.78 3
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% IEKKYDEELEER 95.00% 4.42 0.498 0 527.9333 1,580.78 1,580.78 3
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% LVNSLYPDGSK 95.00% 2.31 0.25 0 596.8138 1,191.61 1,192.62 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% LVNSLYPDGSK 95.00% 2.59 0.278 0 597.3136 1,192.61 1,192.62 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% TLMALGSLAVTK 95.00% 2.81 0.402 3.89 602.8037 1,203.59 1,204.70 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% TLMALGSLAVTK 95.00% 2.86 0.325 6 602.8045 1,203.59 1,204.70 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% TLMALGSLAVTK 95.00% 3 0.306 5.42 602.8501 1,203.68 1,204.70 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% TLMALGSLAVTK 95.00% 3.95 0.424 4.24 602.8507 1,203.69 1,204.70 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% TLMALGSLAVTK 95.00% 3.7 0.425 5 602.8509 1,203.69 1,204.70 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% TLMALGSLAVTK 95.00% 4.09 0.454 4.06 602.851 1,203.69 1,204.70 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% HVIGLQMGSNR 95.00% 2.8 0.57 3.13 606.3189 1,210.62 1,211.63 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% HVIGLQMGSNR 95.00% 2.68 0.558 5.1 606.3195 1,210.62 1,211.63 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% TLmALGSLAVTK 95.00% 2.57 0.403 1.28 m3: Oxidation (+15.99) 610.8473 1,219.68 1,220.69 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% TLmALGSLAVTK 95.00% 3.15 0.473 2.05 m3: Oxidation (+15.99) 610.848 1,219.68 1,220.69 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% HVIGLQmGSNR 95.00% 1.98 0.231 1.22 m7: Oxidation (+15.99) 614.3187 1,226.62 1,227.63 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% VPENPPSMVFK 95.00% 2.89 0.438 3.35 622.8192 1,243.62 1,244.64 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% VPENPPSMVFK 95.00% 2.98 0.427 3.17 622.8195 1,243.62 1,244.64 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% VPENPPSmVFK 95.00% 1.9 0.29 0 m8: Oxidation (+15.99) 630.8183 1,259.62 1,260.63 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% EFTESQLQEGK 95.00% 2.61 0.444 1.41 648.3061 1,294.60 1,295.61 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% EFTESQLQEGK 95.00% 2.53 0.43 2.08 648.8073 1,295.60 1,295.61 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% LVNSLYPDGSKPVK 95.00% 4.03 0.458 3.24 758.9215 1,515.83 1,516.84 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% LVNSLYPDGSKPVK 95.00% 3.85 0.454 3.41 759.4225 1,516.83 1,516.84 2
 SAMPLE 2R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 10 29 50.20% TDMFQTVDLFEGK 95.00% 0 0 3.38 767.3871 1,532.76 1,530.72 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% GASQAGMTGYGRPR 95.00% 1.94 0.231 0 470.2309 1,407.67 1,408.68 3
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% AAEDYGVIK 95.00% 2.76 0.443 1.85 483.2495 964.4834 965.4945 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% AAEDYGVIK 95.00% 2.65 0.449 1.89 483.2502 964.4848 965.4945 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% LGFQVWLK 95.00% 2.74 0.249 1.1 495.7909 989.5662 990.5778 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% LGFQVWLK 95.00% 2.9 0.241 0 495.791 989.5663 990.5778 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% GDPNWFMK 95.00% 2.4 0.658 0 497.725 993.4343 994.4458 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% GDPNWFMK 95.00% 2.48 0.614 1.54 497.7263 993.4369 994.4458 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% LVNSLYPDGSKPVK 95.00% 2.19 0.402 0 506.2831 1,515.83 1,516.84 3
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% LVNSLYPDGSK 95.00% 3.37 0.528 0 596.8127 1,191.61 1,192.62 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% LVNSLYPDGSK 95.00% 3.72 0.517 0 596.8131 1,191.61 1,192.62 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% LVNSLYPDGSK 95.00% 2.49 0.255 0 596.8136 1,191.61 1,192.62 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% TLMALGSLAVTK 95.00% 4.01 0.441 4.26 602.8504 1,203.69 1,204.70 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% TLMALGSLAVTK 95.00% 4.35 0.418 4.19 602.8507 1,203.69 1,204.70 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% TLMALGSLAVTK 95.00% 3.72 0.439 4.92 602.8509 1,203.69 1,204.70 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% TLMALGSLAVTK 95.00% 3.15 0.317 2.47 602.8518 1,203.69 1,204.70 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% KYDEELEER 95.00% 2.63 0.271 1.43 605.7838 1,209.55 1,210.56 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% HVIGLQMGSNR 95.00% 1.69 0.516 1.36 605.9919 1,209.97 1,211.63 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% HVIGLQMGSNR 95.00% 2.69 0.539 4.92 606.3183 1,210.62 1,211.63 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% TLmALGSLAVTK 95.00% 3.11 0.426 2.16 m3: Oxidation (+15.99) 610.8466 1,219.68 1,220.69 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% TLmALGSLAVTK 95.00% 3.15 0.409 2.42 m3: Oxidation (+15.99) 610.8479 1,219.68 1,220.69 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% QMEQVAQFLK 95.00% 2.29 0.206 0 611.3178 1,220.62 1,221.63 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% HVIGLQmGSNR 95.00% 1.63 0.346 2.11 m7: Oxidation (+15.99) 614.8202 1,227.62 1,227.63 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% VPENPPSMVFK 95.00% 2.08 0.341 0 622.8187 1,243.62 1,244.64 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% VPENPPSMVFK 95.00% 2.22 0.389 0 622.8194 1,243.62 1,244.64 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% EFTESQLQEGK 95.00% 2.25 0.408 1.68 648.3112 1,294.61 1,295.61 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% EFTESQLQEGK 95.00% 2.65 0.397 1.8 648.8114 1,295.61 1,295.61 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% LVEWIIVQcGPDVGRPDR 95.00% 3.5 0.554 2.74 c9: Carbamidomethyl (+57.02) 704.0345 2,109.08 2,109.09 3
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% LVEWIIVQcGPDVGRPDR 95.00% 4.36 0.558 2.35 c9: Carbamidomethyl (+57.02) 704.0352 2,109.08 2,109.09 3
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% LVNSLYPDGSKPVK 95.00% 3.61 0.436 2.48 758.921 1,515.83 1,516.84 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% LVNSLYPDGSKPVK 95.00% 3.49 0.445 2.8 758.9213 1,515.83 1,516.84 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% LVNSLYPDGSKPVK 95.00% 3.62 0.462 1.72 758.9219 1,515.83 1,516.84 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% LVNSLYPDGSKPVK 95.00% 3.16 0.388 2.28 758.9223 1,515.83 1,516.84 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% TDMFQTVDLFEGK 95.00% 4.28 0.549 4.12 765.8596 1,529.70 1,530.72 2
 SAMPLE 3 Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 14 15 34 73.60% TDMFQTVDLFEGK 95.00% 4.5 0.499 3.8 765.8627 1,529.71 1,530.72 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% LGFQVWLK 95.00% 2.98 0.234 0 495.7909 989.5661 990.5778 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% LGFQVWLK 95.00% 2.95 0.216 0 495.7917 989.5677 990.5778 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% LGFQVWLK 95.00% 2.78 0.254 0 495.7919 989.5681 990.5778 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% LGFQVWLK 95.00% 2.92 0.221 0 495.7919 989.5682 990.5778 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% GDPNWFMK 95.00% 2.08 0.338 0 497.7247 993.4338 994.4458 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% GDPNWFMK 95.00% 2.3 0.305 0 497.7259 993.4361 994.4458 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% LVNSLYPDGSKPVK 95.00% 2.83 0.427 0 506.2829 1,515.83 1,516.84 3
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% LVNSLYPDGSKPVK 95.00% 2.72 0.491 0 506.2834 1,515.83 1,516.84 3
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% LVNSLYPDGSK 95.00% 3.53 0.488 0 596.8133 1,191.61 1,192.62 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% LVNSLYPDGSK 95.00% 3.73 0.517 0 596.8138 1,191.61 1,192.62 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% TLMALGSLAVTK 95.00% 3.68 0.363 2.85 602.8507 1,203.69 1,204.70 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% TLMALGSLAVTK 95.00% 3.41 0.297 3.49 602.8509 1,203.69 1,204.70 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% TLMALGSLAVTK 95.00% 3.72 0.349 3.37 602.8512 1,203.69 1,204.70 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% TLMALGSLAVTK 95.00% 3.13 0.396 4.96 602.8528 1,203.69 1,204.70 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% TLMALGSLAVTK 95.00% 3.33 0.274 3.54 602.8532 1,203.69 1,204.70 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% TLMALGSLAVTK 95.00% 3.12 0.4 3.62 603.353 1,204.69 1,204.70 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% HVIGLQMGSNR 95.00% 2.1 0.521 4.37 606.3206 1,210.63 1,211.63 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% TLmALGSLAVTK 95.00% 2.82 0.399 1.7 m3: Oxidation (+15.99) 610.8479 1,219.68 1,220.69 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% TLmALGSLAVTK 95.00% 3.09 0.476 1.51 m3: Oxidation (+15.99) 610.8492 1,219.68 1,220.69 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% HVIGLQmGSNR 95.00% 1.88 0.337 1.74 m7: Oxidation (+15.99) 614.3167 1,226.62 1,227.63 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% VPENPPSMVFK 95.00% 3.22 0.427 3.14 622.8197 1,243.62 1,244.64 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% VPENPPSMVFK 95.00% 2.99 0.4 1.82 622.8201 1,243.62 1,244.64 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% VPENPPSMVFK 95.00% 2.14 0.314 0 622.8233 1,243.63 1,244.64 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% VPENPPSMVFK 95.00% 2.5 0.383 0 623.3208 1,244.63 1,244.64 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% EFTESQLQEGK 95.00% 3.51 0.489 2.85 648.3087 1,294.60 1,295.61 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% EFTESQLQEGK 95.00% 3.67 0.453 3.64 648.3091 1,294.60 1,295.61 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% EFTESQLQEGK 95.00% 2.59 0.45 0 648.3106 1,294.61 1,295.61 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% EFTESQLQEGK 95.00% 2.86 0.455 1.89 648.3114 1,294.61 1,295.61 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% LVEWIIVQcGPDVGRPDR 95.00% 4.04 0.584 2.48 c9: Carbamidomethyl (+57.02) 704.0364 2,109.09 2,109.09 3
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% LVNSLYPDGSKPVK 95.00% 3.64 0.455 2.43 758.9225 1,515.83 1,516.84 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% LVNSLYPDGSKPVK 95.00% 3.89 0.466 3.21 758.9231 1,515.83 1,516.84 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% TDMFQTVDLFEGK 95.00% 4.9 0.567 4.08 765.86 1,529.70 1,530.72 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% TDMFQTVDLFEGK 95.00% 4.75 0.543 3.54 765.8628 1,529.71 1,530.72 2
 SAMPLE 3R Transgelin  TAGLN  TAGL_HUMAN 22,592.90 100.00% 10 11 34 52.70% TDMFQTVDLFEGK 95.00% 0 0 3.28 767.4109 1,532.81 1,530.72 2
 SAMPLE 1 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 99.90% 2 2 3 13.60% TLMNLGGLAVAR 95.00% 4.01 0.409 2.74 608.3572 1,214.70 1,215.69 2
 SAMPLE 1 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 99.90% 2 2 3 13.60% TLMNLGGLAVAR 95.00% 3.96 0.407 2.51 608.3576 1,214.70 1,215.69 2
 SAMPLE 1 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 99.90% 2 2 3 13.60% DDGLFSGDPNWFPKK 95.00% 4.5 0.507 3.62 861.9232 1,721.83 1,722.81 2
 SAMPLE 1R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 5 11 31.70% TLMNLGGLAVAR 95.00% 4.11 0.431 3.25 608.3574 1,214.70 1,215.69 2
 SAMPLE 1R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 5 11 31.70% TLMNLGGLAVAR 95.00% 3.97 0.405 3.22 608.3576 1,214.70 1,215.69 2
 SAMPLE 1R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 5 11 31.70% DDGLFSGDPNWFPK 95.00% 3.76 0.513 2.77 797.8687 1,593.72 1,594.72 2
 SAMPLE 1R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 5 11 31.70% DDGLFSGDPNWFPK 95.00% 2.61 0.418 1.82 797.8754 1,593.74 1,594.72 2
 SAMPLE 1R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 5 11 31.70% DGTVLcELINALYPEGQAPVKK 95.00% 4.1 0.504 2.15 c6: Carbamidomethyl (+57.02) 806.1035 2,415.29 2,415.26 3
 SAMPLE 1R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 5 11 31.70% DGTVLcELINALYPEGQAPVKK 95.00% 3.37 0.498 1.72 c6: Carbamidomethyl (+57.02) 806.1045 2,415.29 2,415.26 3
 SAMPLE 1R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 5 11 31.70% QMEQISQFLQAAER 95.00% 4.65 0.508 4.48 839.931 1,677.85 1,678.82 2
 SAMPLE 1R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 5 11 31.70% QMEQISQFLQAAER 95.00% 4.61 0.505 3.44 839.9311 1,677.85 1,678.82 2
 SAMPLE 1R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 5 11 31.70% QmEQISQFLQAAER 95.00% 3.19 0.403 2 m2: Oxidation (+15.99) 847.929 1,693.84 1,694.82 2
 SAMPLE 1R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 5 11 31.70% DDGLFSGDPNWFPKK 95.00% 4.41 0.497 2.74 862.425 1,722.83 1,722.81 2
 SAMPLE 1R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 5 11 31.70% DDGLFSGDPNWFPKK 95.00% 4.3 0.469 2.08 862.4275 1,722.84 1,722.81 2
 SAMPLE 2 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 12 24.10% QMEQISQFLQAAER 95.00% 2.7 0.384 0 560.7734 1,679.30 1,678.82 3
 SAMPLE 2 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 12 24.10% NVIGLQMGTNR 95.00% 2.93 0.526 3.77 601.818 1,201.62 1,202.63 2
 SAMPLE 2 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 12 24.10% NVIGLQMGTNR 95.00% 2.93 0.526 3.25 601.8184 1,201.62 1,202.63 2
 SAMPLE 2 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 12 24.10% TLMNLGGLAVAR 95.00% 3.24 0.363 1.85 608.3452 1,214.67 1,215.69 2
 SAMPLE 2 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 12 24.10% TLMNLGGLAVAR 95.00% 4.17 0.412 2.33 608.3462 1,214.68 1,215.69 2
 SAMPLE 2 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 12 24.10% TLMNLGGLAVAR 95.00% 4.18 0.436 2.59 608.347 1,214.68 1,215.69 2
 SAMPLE 2 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 12 24.10% NVIGLQmGTNR 95.00% 2.82 0.499 3.72 m7: Oxidation (+15.99) 609.8142 1,217.61 1,218.63 2
 SAMPLE 2 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 12 24.10% NVIGLQmGTNR 95.00% 3.14 0.512 2.04 m7: Oxidation (+15.99) 609.8152 1,217.61 1,218.63 2
 SAMPLE 2 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 12 24.10% TLmNLGGLAVAR 95.00% 3.47 0.369 1.62 m3: Oxidation (+15.99) 616.3438 1,230.67 1,231.68 2
 SAMPLE 2 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 12 24.10% TLmNLGGLAVAR 95.00% 3.47 0.388 2.27 m3: Oxidation (+15.99) 616.3439 1,230.67 1,231.68 2
 SAMPLE 2 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 12 24.10% NFSDNQLQEGK 95.00% 2.19 0.329 0 640.2981 1,278.58 1,279.59 2
 SAMPLE 2 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 12 24.10% NFSDNQLQEGK 95.00% 2.28 0.419 0 640.299 1,278.58 1,279.59 2
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% QMEQISQFLQAAER 95.00% 2.98 0.312 0 560.7745 1,679.30 1,678.82 3
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% NVIGLQMGTNR 95.00% 3.03 0.554 4.55 601.8181 1,201.62 1,202.63 2
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% NVIGLQMGTNR 95.00% 3.03 0.571 3.74 601.8187 1,201.62 1,202.63 2
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% TLMNLGGLAVAR 95.00% 3.85 0.398 3.37 608.3459 1,214.68 1,215.69 2
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% TLMNLGGLAVAR 95.00% 4.22 0.432 3.07 608.3467 1,214.68 1,215.69 2
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% NVIGLQmGTNR 95.00% 2.98 0.48 3.7 m7: Oxidation (+15.99) 609.8154 1,217.62 1,218.63 2
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% NVIGLQmGTNR 95.00% 2.5 0.474 2.41 m7: Oxidation (+15.99) 609.8158 1,217.62 1,218.63 2
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% TLmNLGGLAVAR 95.00% 3.28 0.307 2.36 m3: Oxidation (+15.99) 616.3443 1,230.67 1,231.68 2
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% TLmNLGGLAVAR 95.00% 3.54 0.372 1.43 m3: Oxidation (+15.99) 616.3444 1,230.67 1,231.68 2
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% NFSDNQLQEGK 95.00% 2.23 0.25 2.19 640.7904 1,279.57 1,279.59 2
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% GASQAGMTGYGMPR 95.00% 2.28 0.369 0 692.3104 1,382.61 1,383.62 2
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% GASQAGmTGYGmPR 95.00% 2.88 0.46 1.26 m7: Oxidation (+15.99), m12: Oxidation (+15.99) 708.808 1,415.60 1,415.60 2
 SAMPLE 2R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 5 6 13 31.20% QmEQISQFLQAAER 95.00% 3.71 0.469 2.02 m2: Oxidation (+15.99) 847.9129 1,693.81 1,694.82 2
 SAMPLE 3 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 7 25.60% TLMNLGGLAVAR 95.00% 4.05 0.43 2.41 608.3475 1,214.68 1,215.69 2
 SAMPLE 3 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 7 25.60% TLMNLGGLAVAR 95.00% 4.07 0.404 2.3 608.3479 1,214.68 1,215.69 2
 SAMPLE 3 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 7 25.60% NVIGLQmGTNR 95.00% 2.41 0.368 0 m7: Oxidation (+15.99) 609.8152 1,217.61 1,218.63 2
 SAMPLE 3 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 7 25.60% TLmNLGGLAVAR 95.00% 2.8 0.269 2.41 m3: Oxidation (+15.99) 616.3427 1,230.67 1,231.68 2
 SAMPLE 3 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 7 25.60% TLmNLGGLAVAR 95.00% 2.86 0.318 2.02 m3: Oxidation (+15.99) 616.3434 1,230.67 1,231.68 2
 SAMPLE 3 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 7 25.60% GASQAGMTGYGMPR 95.00% 2.78 0.546 4.02 692.3091 1,382.60 1,383.62 2
 SAMPLE 3 Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 7 25.60% QMEQISQFLQAAER 95.00% 4.62 0.543 3.62 839.9133 1,677.81 1,678.82 2
 SAMPLE 3R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 8 25.60% TLMNLGGLAVAR 95.00% 4.06 0.434 2.51 608.3474 1,214.68 1,215.69 2
 SAMPLE 3R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 8 25.60% TLMNLGGLAVAR 95.00% 3.85 0.433 2.6 608.3484 1,214.68 1,215.69 2
 SAMPLE 3R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 8 25.60% NVIGLQmGTNR 95.00% 2.28 0.388 1.59 m7: Oxidation (+15.99) 609.8151 1,217.61 1,218.63 2
 SAMPLE 3R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 8 25.60% NVIGLQmGTNR 95.00% 2.43 0.392 2.49 m7: Oxidation (+15.99) 609.8163 1,217.62 1,218.63 2
 SAMPLE 3R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 8 25.60% TLmNLGGLAVAR 95.00% 2.45 0.277 1.77 m3: Oxidation (+15.99) 616.3435 1,230.67 1,231.68 2
 SAMPLE 3R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 8 25.60% TLmNLGGLAVAR 95.00% 2.89 0.374 1.44 m3: Oxidation (+15.99) 616.3438 1,230.67 1,231.68 2
 SAMPLE 3R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 8 25.60% GASQAGMTGYGMPR 95.00% 2.55 0.501 1.82 692.3108 1,382.61 1,383.62 2
 SAMPLE 3R Transgelin-2  TAGLN2  TAGL2_HUMAN 22,373.90 100.00% 4 4 8 25.60% QMEQISQFLQAAER 95.00% 4.62 0.535 3.39 839.9138 1,677.81 1,678.82 2
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% DVDLEFLAK 95.00% 2.75 0.407 1.7 525.2774 1,048.54 1,049.55 2
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% DVDLEFLAK 95.00% 2.87 0.413 0 525.2792 1,048.54 1,049.55 2
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% GILLYGPPGTGK 95.00% 3.67 0.498 3.27 586.8358 1,171.66 1,172.67 2
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% GILLYGPPGTGK 95.00% 3.65 0.5 1.6 586.8365 1,171.66 1,172.67 2
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% WALSQSNPSALR 95.00% 3.56 0.459 3.19 665.3484 1,328.68 1,329.69 2
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% WALSQSNPSALR 95.00% 3.43 0.462 3.34 665.3485 1,328.68 1,329.69 2
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% LIVDEAINEDNSVVSLSQPK 95.00% 4.68 0.516 3.62 724.3779 2,170.11 2,170.12 3
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% LIVDEAINEDNSVVSLSQPK 95.00% 4.42 0.488 1.64 724.3795 2,170.12 2,170.12 3
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% LDQLIYIPLPDEK 95.00% 4.4 0.406 2.29 778.9311 1,555.85 1,556.86 2
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% LDQLIYIPLPDEK 95.00% 4.23 0.402 4.3 778.9314 1,555.85 1,556.86 2
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% AIANEcQANFISIK 95.00% 4.13 0.535 3.7 c6: Carbamidomethyl (+57.02) 789.9013 1,577.79 1,578.80 2
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% VINQILTEMDGMSTK 95.00% 4.35 0.508 5.35 840.4185 1,678.82 1,679.84 2
 SAMPLE 1 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 8 13 11.80% LIVDEAINEDNSVVSLSQPK 95.00% 5.7 0.636 6.22 1,086.06 2,170.11 2,170.12 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% IVSQLLTLMDGLK 95.00% 2.95 0.295 0 477.6141 1,429.82 1,430.83 3
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% IVSQLLTLMDGLK 95.00% 3.17 0.535 2.57 477.6158 1,429.82 1,430.83 3
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% DVDLEFLAK 95.00% 2.26 0.358 1.64 525.5929 1,049.17 1,049.55 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% DVDLEFLAK 95.00% 1.69 0.276 1.82 525.9274 1,049.84 1,049.55 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% WALSQSNPSALR 95.00% 3.19 0.31 2.55 665.3509 1,328.69 1,329.69 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% IVSQLLTLMDGLK 95.00% 4.95 0.644 3.74 715.9159 1,429.82 1,430.83 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% IVSQLLTLMDGLK 95.00% 4.48 0.609 3.7 715.9174 1,429.82 1,430.83 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% LIVDEAINEDNSVVSLSQPK 95.00% 3.72 0.305 0 724.0452 2,169.11 2,170.12 3
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% LIVDEAINEDNSVVSLSQPK 95.00% 3.72 0.407 0 724.3793 2,170.11 2,170.12 3
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% LGDVISIQPcPDVK 95.00% 4 0.479 1.38 c10: Carbamidomethyl (+57.02) 770.9068 1,539.80 1,540.80 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% LDQLIYIPLPDEK 95.00% 4.26 0.44 1.48 778.9316 1,555.85 1,556.86 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% LDQLIYIPLPDEK 95.00% 4.29 0.445 3.59 778.9323 1,555.85 1,556.86 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% AIANEcQANFISIK 95.00% 3.94 0.559 4.08 c6: Carbamidomethyl (+57.02) 789.8984 1,577.78 1,578.80 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% AIANEcQANFISIK 95.00% 3.57 0.515 3.85 c6: Carbamidomethyl (+57.02) 789.9023 1,577.79 1,578.80 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% VINQILTEMDGMSTK 95.00% 4.26 0.457 6.8 840.4233 1,678.83 1,679.84 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% VINQILTEMDGMSTK 95.00% 4.17 0.533 5.15 840.9207 1,679.83 1,679.84 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% LIVDEAINEDNSVVSLSQPK 95.00% 5.66 0.632 7.74 1,086.06 2,170.11 2,170.12 2
 SAMPLE 1R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 10 18 13.60% LIVDEAINEDNSVVSLSQPK 95.00% 5.97 0.648 6.48 1,086.06 2,170.11 2,170.12 2
 SAMPLE 2 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 3 3 4 5.09% LGDVISIQPcPDVK 95.00% 3.23 0.429 0 c10: Carbamidomethyl (+57.02) 771.0915 1,540.17 1,540.80 2
 SAMPLE 2 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 3 3 4 5.09% LDQLIYIPLPDEK 95.00% 4.46 0.464 1.64 778.9323 1,555.85 1,556.86 2
 SAMPLE 2 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 3 3 4 5.09% LDQLIYIPLPDEK 95.00% 3.72 0.37 0 779.4325 1,556.85 1,556.86 2
 SAMPLE 2 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 3 3 4 5.09% AIANEcQANFISIK 95.00% 3.79 0.522 3.74 c6: Carbamidomethyl (+57.02) 789.8993 1,577.78 1,578.80 2
 SAMPLE 2R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 6 6 8 10.50% IVSQLLTLMDGLK 95.00% 3.38 0.496 2.2 715.9178 1,429.82 1,430.83 2
 SAMPLE 2R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 6 6 8 10.50% IVSQLLTLMDGLK 95.00% 4.65 0.644 3.16 715.9185 1,429.82 1,430.83 2
 SAMPLE 2R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 6 6 8 10.50% LGDVISIQPcPDVK 95.00% 2.91 0.318 0 c10: Carbamidomethyl (+57.02) 771.0916 1,540.17 1,540.80 2
 SAMPLE 2R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 6 6 8 10.50% LDQLIYIPLPDEK 95.00% 3.85 0.484 2.34 778.9303 1,555.84 1,556.86 2
 SAMPLE 2R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 6 6 8 10.50% LDQLIYIPLPDEK 95.00% 4.08 0.459 2.02 778.9312 1,555.85 1,556.86 2
 SAMPLE 2R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 6 6 8 10.50% AIANEcQANFISIK 95.00% 4.04 0.491 4.32 c6: Carbamidomethyl (+57.02) 790.3997 1,578.78 1,578.80 2
 SAMPLE 2R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 6 6 8 10.50% VINQILTEMDGMSTK 95.00% 3.78 0.439 5.11 840.9239 1,679.83 1,679.84 2
 SAMPLE 2R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 6 6 8 10.50% MTNGFSGADLTEIcQR 95.00% 2.7 0.493 2.15 c14: Carbamidomethyl (+57.02) 899.9776 1,797.94 1,799.81 2
 SAMPLE 3 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 7 10 12.30% GILLYGPPGTGK 95.00% 2.26 0.384 0 586.6082 1,171.20 1,172.67 2
 SAMPLE 3 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 7 10 12.30% EVDIGIPDATGR 95.00% 2.47 0.37 0 621.8184 1,241.62 1,242.63 2
 SAMPLE 3 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 7 10 12.30% WALSQSNPSALR 95.00% 3.49 0.48 1.48 665.3483 1,328.68 1,329.69 2
 SAMPLE 3 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 7 10 12.30% WALSQSNPSALR 95.00% 3.83 0.517 1.89 665.3485 1,328.68 1,329.69 2
 SAMPLE 3 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 7 10 12.30% LIVDEAINEDNSVVSLSQPK 95.00% 3.52 0.377 0 724.3798 2,170.12 2,170.12 3
 SAMPLE 3 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 7 10 12.30% LGDVISIQPcPDVK 95.00% 4.23 0.491 3.09 c10: Carbamidomethyl (+57.02) 770.9048 1,539.79 1,540.80 2
 SAMPLE 3 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 7 10 12.30% LGDVISIQPcPDVK 95.00% 4.26 0.487 3.01 c10: Carbamidomethyl (+57.02) 771.4069 1,540.80 1,540.80 2
 SAMPLE 3 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 7 10 12.30% AIANEcQANFISIK 95.00% 4.19 0.536 2.62 c6: Carbamidomethyl (+57.02) 789.9014 1,577.79 1,578.80 2
 SAMPLE 3 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 7 10 12.30% AIANEcQANFISIK 95.00% 3.97 0.523 4.47 c6: Carbamidomethyl (+57.02) 789.9024 1,577.79 1,578.80 2
 SAMPLE 3 Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 7 7 10 12.30% VINQILTEMDGMSTK 95.00% 4.86 0.56 5.4 840.9215 1,679.83 1,679.84 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% GILLYGPPGTGK 95.00% 2.31 0.277 0 586.6082 1,171.20 1,172.67 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% WALSQSNPSALR 95.00% 3.66 0.455 1.74 665.3501 1,328.68 1,329.69 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% IVSQLLTLMDGLK 95.00% 4.48 0.622 2.64 715.9173 1,429.82 1,430.83 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% IVSQLLTLMDGLK 95.00% 4.42 0.606 3.66 715.9184 1,429.82 1,430.83 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% IVSQLLTLMDGLK 95.00% 3.62 0.469 4.54 716.4191 1,430.82 1,430.83 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% LGDVISIQPcPDVK 95.00% 4.2 0.512 1.77 c10: Carbamidomethyl (+57.02) 770.907 1,539.80 1,540.80 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% LGDVISIQPcPDVK 95.00% 4.17 0.472 0 c10: Carbamidomethyl (+57.02) 771.4067 1,540.80 1,540.80 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% LDQLIYIPLPDEK 95.00% 4.5 0.434 2.59 778.9319 1,555.85 1,556.86 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% LDQLIYIPLPDEK 95.00% 4.22 0.459 2.11 778.932 1,555.85 1,556.86 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% AIANEcQANFISIK 95.00% 3.87 0.472 2.64 c6: Carbamidomethyl (+57.02) 789.9003 1,577.78 1,578.80 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% VINQILTEMDGMSTK 95.00% 4.77 0.576 5.13 840.415 1,678.81 1,679.84 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% VINQILTEMDGMSTK 95.00% 4.63 0.514 7.14 840.922 1,679.83 1,679.84 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% MTNGFSGADLTEIcQR 95.00% 2.73 0.427 0 c14: Carbamidomethyl (+57.02) 899.9785 1,797.94 1,799.81 2
 SAMPLE 3R Transitional endoplasmic reticulum ATPase  VCP  TERA_HUMAN 89,306.80 100.00% 8 8 14 13.50% MTNGFSGADLTEIcQR 95.00% 4.58 0.609 3.82 c14: Carbamidomethyl (+57.02) 900.4041 1,798.79 1,799.81 2
 SAMPLE 3 Transketolase  TKT  TKT_HUMAN 67,861.40 99.80% 2 2 2 4.82% ISSDLDGHPVPK 95.00% 2.42 0.223 0 632.8277 1,263.64 1,264.65 2
 SAMPLE 3 Transketolase  TKT  TKT_HUMAN 67,861.40 99.80% 2 2 2 4.82% SVPTSTVFYPSDGVATEK 95.00% 3.42 0.522 1.72 942.9657 1,883.92 1,884.92 2
 SAMPLE 3R Transketolase  TKT  TKT_HUMAN 67,861.40 100.00% 3 3 4 7.87% ISSDLDGHPVPK 95.00% 2.5 0.41 1.72 632.8289 1,263.64 1,264.65 2
 SAMPLE 3R Transketolase  TKT  TKT_HUMAN 67,861.40 100.00% 3 3 4 7.87% SVPTSTVFYPSDGVATEK 95.00% 4.05 0.529 0 942.9699 1,883.92 1,884.92 2
 SAMPLE 3R Transketolase  TKT  TKT_HUMAN 67,861.40 100.00% 3 3 4 7.87% ILATPPQEDAPSVDIANIR 95.00% 4.03 0.553 4.06 1,011.04 2,020.06 2,020.07 2
 SAMPLE 3R Transketolase  TKT  TKT_HUMAN 67,861.40 100.00% 3 3 4 7.87% ILATPPQEDAPSVDIANIR 95.00% 3.77 0.566 5.12 1,011.04 2,020.07 2,020.07 2
 SAMPLE 2 Transthyretin  TTR  TTHY_HUMAN 15,868.90 100.00% 3 4 8 18.40% GSPAINVAVHVFR 95.00% 2.67 0.375 0 456.2575 1,365.75 1,366.76 3
 SAMPLE 2 Transthyretin  TTR  TTHY_HUMAN 15,868.90 100.00% 3 4 8 18.40% GSPAINVAVHVFR 95.00% 3.51 0.584 2.14 683.882 1,365.75 1,366.76 2
 SAMPLE 2 Transthyretin  TTR  TTHY_HUMAN 15,868.90 100.00% 3 4 8 18.40% GSPAINVAVHVFR 95.00% 3.61 0.585 2.96 683.8821 1,365.75 1,366.76 2
 SAMPLE 2 Transthyretin  TTR  TTHY_HUMAN 15,868.90 100.00% 3 4 8 18.40% AADDTWEPFASGK 95.00% 4.27 0.642 2.4 697.8114 1,393.61 1,394.62 2
 SAMPLE 2 Transthyretin  TTR  TTHY_HUMAN 15,868.90 100.00% 3 4 8 18.40% AADDTWEPFASGK 95.00% 4.37 0.639 3.51 697.813 1,393.61 1,394.62 2
 SAMPLE 2 Transthyretin  TTR  TTHY_HUMAN 15,868.90 100.00% 3 4 8 18.40% AADDTWEPFASGK 95.00% 4.21 0.631 3.77 697.8136 1,393.61 1,394.62 2
 SAMPLE 2 Transthyretin  TTR  TTHY_HUMAN 15,868.90 100.00% 3 4 8 18.40% AADDTWEPFASGK 95.00% 4.2 0.613 0 697.8144 1,393.61 1,394.62 2
 SAMPLE 2 Transthyretin  TTR  TTHY_HUMAN 15,868.90 100.00% 3 4 8 18.40% KAADDTWEPFASGK 95.00% 4.05 0.542 3.55 762.3653 1,522.72 1,522.72 2
 SAMPLE 2R Transthyretin  TTR  TTHY_HUMAN 15,868.90 99.80% 2 2 5 17.70% GSPAINVAVHVFR 95.00% 4.2 0.506 2.85 683.8822 1,365.75 1,366.76 2
 SAMPLE 2R Transthyretin  TTR  TTHY_HUMAN 15,868.90 99.80% 2 2 5 17.70% GSPAINVAVHVFR 95.00% 3.89 0.517 2.34 683.8829 1,365.75 1,366.76 2
 SAMPLE 2R Transthyretin  TTR  TTHY_HUMAN 15,868.90 99.80% 2 2 5 17.70% AADDTWEPFASGK 95.00% 4.15 0.631 0 697.8112 1,393.61 1,394.62 2
 SAMPLE 2R Transthyretin  TTR  TTHY_HUMAN 15,868.90 99.80% 2 2 5 17.70% AADDTWEPFASGK 95.00% 3.18 0.441 0 697.813 1,393.61 1,394.62 2
 SAMPLE 2R Transthyretin  TTR  TTHY_HUMAN 15,868.90 99.80% 2 2 5 17.70% AADDTWEPFASGK 95.00% 3.95 0.618 2.8 698.3155 1,394.62 1,394.62 2
 SAMPLE 3 Transthyretin  TTR  TTHY_HUMAN 15,868.90 99.80% 2 2 2 18.40% GSPAINVAVHVFR 95.00% 3.56 0.512 2.77 683.8828 1,365.75 1,366.76 2
 SAMPLE 3 Transthyretin  TTR  TTHY_HUMAN 15,868.90 99.80% 2 2 2 18.40% KAADDTWEPFASGK 95.00% 4.3 0.583 5.18 761.8616 1,521.71 1,522.72 2
 SAMPLE 1 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 3 4 6 6.03% GFYIYQEGVK 95.00% 2.99 0.473 1.85 602.3035 1,202.59 1,203.61 2
 SAMPLE 1 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 3 4 6 6.03% GFYIYQEGVK 95.00% 2.88 0.37 2.39 602.3036 1,202.59 1,203.61 2
 SAMPLE 1 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 3 4 6 6.03% TVLGTPEVLLGALPGAGGTQR 95.00% 3.37 0.392 2.43 670.0464 2,007.12 2,007.12 3
 SAMPLE 1 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 3 4 6 6.03% TVLGTPEVLLGALPGAGGTQR 95.00% 3.52 0.448 0 670.0466 2,007.12 2,007.12 3
 SAMPLE 1 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 3 4 6 6.03% FGGGNPELLTQMVSK 95.00% 4.44 0.515 5.64 789.4028 1,576.79 1,577.80 2
 SAMPLE 1 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 3 4 6 6.03% TVLGTPEVLLGALPGAGGTQR 95.00% 4.78 0.539 2.12 1,004.56 2,007.11 2,007.12 2
 SAMPLE 1R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 4 4 5 7.73% GFYIYQEGVK 95.00% 2.67 0.401 0 602.3034 1,202.59 1,203.61 2
 SAMPLE 1R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 4 4 5 7.73% GFYIYQEGVK 95.00% 2.86 0.474 0 602.8032 1,203.59 1,203.61 2
 SAMPLE 1R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 4 4 5 7.73% TVLGTPEVLLGALPGAGGTQR 95.00% 2.95 0.335 0 669.7122 2,006.11 2,007.12 3
 SAMPLE 1R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 4 4 5 7.73% TIEYLEEVAITFAK 95.00% 2.88 0.351 6.8 814.436 1,626.86 1,626.86 2
 SAMPLE 1R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 4 4 5 7.73% TLQEVTQLSQEAQR 95.00% 3.55 0.12 1.51 815.924 1,629.83 1,630.84 2
 SAMPLE 2 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 7 8 12 12.60% GFYIYQEGVK 95.00% 3.47 0.493 2.85 602.305 1,202.59 1,203.61 2
 SAMPLE 2 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 7 8 12 12.60% GFYIYQEGVK 95.00% 3.28 0.513 1.8 602.3051 1,202.59 1,203.61 2
 SAMPLE 2 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 7 8 12 12.60% MQLLEIITTEK 95.00% 3.5 0.398 1.68 659.8667 1,317.72 1,318.73 2
 SAMPLE 2 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 7 8 12 12.60% MQLLEIITTEK 95.00% 3.2 0.392 0 659.8678 1,317.72 1,318.73 2
 SAMPLE 2 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 7 8 12 12.60% TVLGTPEVLLGALPGAGGTQR 95.00% 2.81 0.301 1.14 670.0469 2,007.12 2,007.12 3
 SAMPLE 2 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 7 8 12 12.60% TVLGTPEVLLGALPGAGGTQR 95.00% 3.48 0.394 2.05 670.047 2,007.12 2,007.12 3
 SAMPLE 2 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 7 8 12 12.60% FGGGNPELLTQMVSK 95.00% 4.59 0.472 4.26 789.4028 1,576.79 1,577.80 2
 SAMPLE 2 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 7 8 12 12.60% TLQEVTQLSQEAQR 95.00% 4.44 0.423 2.35 816.4251 1,630.83 1,630.84 2
 SAMPLE 2 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 7 8 12 12.60% TGIEQGSDAGYLcESQK 95.00% 4.93 0.594 7.12 c13: Carbamidomethyl (+57.02) 921.9122 1,841.81 1,842.82 2
 SAMPLE 2 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 7 8 12 12.60% TGIEQGSDAGYLcESQKFGELVmTK 95.00% 2.08 0.251 1.24 c13: Carbamidomethyl (+57.02), m23: Oxidation (+15.99) 921.9123 2,762.71 2,764.28 3
 SAMPLE 2 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 7 8 12 12.60% TVLGTPEVLLGALPGAGGTQR 95.00% 3.8 0.501 2.2 1,004.56 2,007.11 2,007.12 2
 SAMPLE 2 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 7 8 12 12.60% TVLGTPEVLLGALPGAGGTQR 95.00% 3.64 0.457 1.68 1,004.57 2,007.12 2,007.12 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% GFYIYQEGVK 95.00% 3.17 0.483 2.17 602.3058 1,202.60 1,203.61 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% GFYIYQEGVK 95.00% 3.13 0.482 1.6 602.3059 1,202.60 1,203.61 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% LPPKSEVSSDEDIQFR 95.00% 1.99 0.171 1 616.3065 1,845.90 1,846.92 3
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% MQLLEIITTEK 95.00% 2.47 0.339 0 659.8675 1,317.72 1,318.73 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% MQLLEIITTEK 95.00% 2.71 0.331 1.42 659.8678 1,317.72 1,318.73 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% TVLGTPEVLLGALPGAGGTQR 95.00% 2.57 0.36 2.44 669.7118 2,006.11 2,007.12 3
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% TVLGTPEVLLGALPGAGGTQR 95.00% 3.54 0.398 2.02 670.0475 2,007.12 2,007.12 3
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% DLNSDMDSILASLK 95.00% 3.5 0.516 3.31 761.3736 1,520.73 1,521.75 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% DLNSDMDSILASLK 95.00% 3.88 0.556 4.74 761.3759 1,520.74 1,521.75 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% MVGVPAALDMMLTGR 95.00% 3.65 0.601 7.52 781.3966 1,560.78 1,561.79 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% MVGVPAALDMMLTGR 95.00% 3.71 0.599 6.92 781.8991 1,561.78 1,561.79 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% FGGGNPELLTQMVSK 95.00% 4.64 0.444 3.64 789.4029 1,576.79 1,577.80 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% FGGGNPELLTQMVSK 95.00% 4.69 0.444 4.42 789.9042 1,577.79 1,577.80 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% TLQEVTQLSQEAQR 95.00% 4.2 0.494 2.46 815.922 1,629.83 1,630.84 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% TLQEVTQLSQEAQR 95.00% 4.24 0.452 3.47 816.423 1,630.83 1,630.84 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% TGIEQGSDAGYLcESQK 95.00% 4.64 0.599 7.19 c13: Carbamidomethyl (+57.02) 921.9102 1,841.80 1,842.82 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% TVLGTPEVLLGALPGAGGTQR 95.00% 3.89 0.527 2.92 1,004.06 2,006.11 2,007.12 2
 SAMPLE 2R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 9 10 18 17.40% TVLGTPEVLLGALPGAGGTQR 95.00% 4.13 0.508 3.37 1,004.56 2,007.11 2,007.12 2
 SAMPLE 3 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 6 6 10 9.83% FGELVMTK 95.00% 2.68 0.427 2.09 462.7479 923.4801 924.4866 2
 SAMPLE 3 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 6 6 10 9.83% GFYIYQEGVK 95.00% 3.17 0.486 2.37 602.3047 1,202.59 1,203.61 2
 SAMPLE 3 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 6 6 10 9.83% GFYIYQEGVK 95.00% 3.3 0.546 2.1 602.3054 1,202.60 1,203.61 2
 SAMPLE 3 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 6 6 10 9.83% MQLLEIITTEK 95.00% 3.61 0.424 2.03 659.867 1,317.72 1,318.73 2
 SAMPLE 3 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 6 6 10 9.83% MQLLEIITTEK 95.00% 3.42 0.409 1.54 659.8672 1,317.72 1,318.73 2
 SAMPLE 3 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 6 6 10 9.83% FGGGNPELLTQMVSK 95.00% 4.77 0.447 5.17 789.4037 1,576.79 1,577.80 2
 SAMPLE 3 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 6 6 10 9.83% FGGGNPELLTQMVSK 95.00% 4.36 0.531 4.6 789.4041 1,576.79 1,577.80 2
 SAMPLE 3 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 6 6 10 9.83% TLQEVTQLSQEAQR 95.00% 4.57 0.511 2.92 815.9235 1,629.83 1,630.84 2
 SAMPLE 3 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 6 6 10 9.83% TLQEVTQLSQEAQR 95.00% 4.55 0.524 3.49 815.926 1,629.84 1,630.84 2
 SAMPLE 3 Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 6 6 10 9.83% TGIEQGSDAGYLcESQK 95.00% 5.38 0.601 4.47 c13: Carbamidomethyl (+57.02) 922.4141 1,842.81 1,842.82 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% GFYIYQEGVK 95.00% 3.14 0.524 1.35 602.3043 1,202.59 1,203.61 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% GFYIYQEGVK 95.00% 3.14 0.487 1.85 602.3044 1,202.59 1,203.61 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% MQLLEIITTEK 95.00% 2.85 0.42 1.62 659.8676 1,317.72 1,318.73 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% MQLLEIITTEK 95.00% 3.01 0.389 1.2 659.8678 1,317.72 1,318.73 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% SEVSSDEDIQFR 95.00% 2.84 0.386 2.96 706.3184 1,410.62 1,411.63 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% SEVSSDEDIQFR 95.00% 2.8 0.376 1.92 706.3198 1,410.62 1,411.63 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% DLNSDMDSILASLK 95.00% 3.99 0.505 4.68 761.3772 1,520.74 1,521.75 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% MVGVPAALDMMLTGR 95.00% 3.39 0.541 7.19 781.3997 1,560.78 1,561.79 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% MVGVPAALDMMLTGR 95.00% 3.81 0.604 6.41 781.8979 1,561.78 1,561.79 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% TIEYLEEVAITFAK 95.00% 2.43 0.264 4.57 813.9355 1,625.86 1,626.86 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% TIEYLEEVAITFAK 95.00% 2.62 0.433 2.89 813.9369 1,625.86 1,626.86 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% TLQEVTQLSQEAQR 95.00% 4.59 0.519 2.82 815.9248 1,629.83 1,630.84 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% TLQEVTQLSQEAQR 95.00% 4.55 0.47 2.66 816.4252 1,630.83 1,630.84 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% TVLGTPEVLLGALPGAGGTQR 95.00% 3 0.277 0 1,004.56 2,007.11 2,007.12 2
 SAMPLE 3R Trifunctional enzyme subunit alpha, mitochondrial  HADHA  ECHA_HUMAN 82,983.90 100.00% 8 8 15 14.50% TVLGTPEVLLGALPGAGGTQR 95.00% 4.73 0.495 3.36 1,004.57 2,007.12 2,007.12 2
 SAMPLE 1 Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 99.80% 2 2 3 3.80% LAAAFAVSR 95.00% 3.24 0.411 1.92 453.2659 904.5161 905.5208 2
 SAMPLE 1 Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 99.80% 2 2 3 3.80% AALTGLLHR 95.00% 2.75 0.45 2.59 476.291 950.5663 951.5741 2
 SAMPLE 1 Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 99.80% 2 2 3 3.80% AALTGLLHR 95.00% 2.95 0.397 1.8 476.291 950.5664 951.5741 2
 SAMPLE 1R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 99.80% 2 2 4 3.80% LAAAFAVSR 95.00% 2.42 0.297 1.3 453.2651 904.5145 905.5208 2
 SAMPLE 1R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 99.80% 2 2 4 3.80% LAAAFAVSR 95.00% 2.43 0.336 1.27 453.2651 904.5146 905.5208 2
 SAMPLE 1R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 99.80% 2 2 4 3.80% AALTGLLHR 95.00% 2.6 0.395 2.64 476.289 950.5624 951.5741 2
 SAMPLE 1R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 99.80% 2 2 4 3.80% AALTGLLHR 95.00% 2.6 0.415 2.29 476.2907 950.5657 951.5741 2
 SAMPLE 2 Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 6 5.70% LAAAFAVSR 95.00% 2.69 0.357 1.96 453.2645 904.5133 905.5208 2
 SAMPLE 2 Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 6 5.70% LAAAFAVSR 95.00% 2.47 0.335 1.85 453.2652 904.5147 905.5208 2
 SAMPLE 2 Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 6 5.70% AALTGLLHR 95.00% 2.91 0.34 2.29 476.2892 950.5628 951.5741 2
 SAMPLE 2 Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 6 5.70% AALTGLLHR 95.00% 3.06 0.349 2.89 476.2901 950.5646 951.5741 2
 SAMPLE 2 Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 6 5.70% NVVVVDGVR 95.00% 2.4 0.312 0 478.7798 955.5439 956.5529 2
 SAMPLE 2 Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 6 5.70% NVVVVDGVR 95.00% 2.34 0.319 0 478.7804 955.5451 956.5529 2
 SAMPLE 2R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 5 5.70% LAAAFAVSR 95.00% 2.75 0.34 1.72 453.2646 904.5135 905.5208 2
 SAMPLE 2R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 5 5.70% LAAAFAVSR 95.00% 2.88 0.33 1.49 453.2673 904.519 905.5208 2
 SAMPLE 2R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 5 5.70% AALTGLLHR 95.00% 2.72 0.298 2.48 476.2891 950.5625 951.5741 2
 SAMPLE 2R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 5 5.70% NVVVVDGVR 95.00% 2.15 0.273 0 478.7802 955.5447 956.5529 2
 SAMPLE 2R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 5 5.70% NVVVVDGVR 95.00% 2.34 0.292 0 478.7802 955.5448 956.5529 2
 SAMPLE 3R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 5 5.70% LAAAFAVSR 95.00% 2.47 0.322 1.72 453.2641 904.5125 905.5208 2
 SAMPLE 3R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 5 5.70% LAAAFAVSR 95.00% 2.47 0.395 1.57 453.2658 904.516 905.5208 2
 SAMPLE 3R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 5 5.70% AALTGLLHR 95.00% 3.09 0.152 3.42 476.2845 950.5534 951.5741 2
 SAMPLE 3R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 5 5.70% AALTGLLHR 95.00% 3 0.202 2.4 476.2869 950.5581 951.5741 2
 SAMPLE 3R Trifunctional enzyme subunit beta, mitochondrial  HADHB  ECHB_HUMAN 51,278.00 100.00% 3 3 5 5.70% LEQDEYALR 95.00% 2.52 0.331 0 568.7811 1,135.55 1,136.56 2
 SAMPLE 1 Triosephosphate isomerase  TPI1  TPIS_HUMAN 26,651.10 99.80% 2 2 4 11.20% IIYGGSVTGATcK 95.00% 3.45 0.433 2.85 c12: Carbamidomethyl (+57.02) 663.8438 1,325.67 1,326.67 2
 SAMPLE 1 Triosephosphate isomerase  TPI1  TPIS_HUMAN 26,651.10 99.80% 2 2 4 11.20% IIYGGSVTGATcK 95.00% 3.46 0.479 3.72 c12: Carbamidomethyl (+57.02) 663.8441 1,325.67 1,326.67 2
 SAMPLE 1 Triosephosphate isomerase  TPI1  TPIS_HUMAN 26,651.10 99.80% 2 2 4 11.20% VVLAYEPVWAIGTGK 95.00% 2.55 0.226 2.74 801.9466 1,601.88 1,602.89 2
 SAMPLE 1 Triosephosphate isomerase  TPI1  TPIS_HUMAN 26,651.10 99.80% 2 2 4 11.20% VVLAYEPVWAIGTGK 95.00% 4.13 0.522 3.66 802.4479 1,602.88 1,602.89 2
 SAMPLE 1R Triosephosphate isomerase  TPI1  TPIS_HUMAN 26,651.10 99.80% 2 2 3 11.20% IIYGGSVTGATcK 95.00% 3.45 0.433 2.96 c12: Carbamidomethyl (+57.02) 663.8438 1,325.67 1,326.67 2
 SAMPLE 1R Triosephosphate isomerase  TPI1  TPIS_HUMAN 26,651.10 99.80% 2 2 3 11.20% IIYGGSVTGATcK 95.00% 3.46 0.479 3.74 c12: Carbamidomethyl (+57.02) 663.8441 1,325.67 1,326.67 2
 SAMPLE 1R Triosephosphate isomerase  TPI1  TPIS_HUMAN 26,651.10 99.80% 2 2 3 11.20% VVLAYEPVWAIGTGK 95.00% 2.93 0.421 3.1 801.9631 1,601.91 1,602.89 2
 SAMPLE 2R Triosephosphate isomerase  TPI1  TPIS_HUMAN 26,651.10 99.80% 2 2 2 9.64% VIADNVKDWSK 95.00% 1.88 0.303 1.12 637.8433 1,273.67 1,274.67 2
 SAMPLE 2R Triosephosphate isomerase  TPI1  TPIS_HUMAN 26,651.10 99.80% 2 2 2 9.64% IIYGGSVTGATcK 95.00% 2.31 0.2 2.4 c12: Carbamidomethyl (+57.02) 663.8416 1,325.67 1,326.67 2
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDR 95.00% 4.5 0.438 0 467.2581 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDR 95.00% 4.58 0.409 0 467.2589 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDR 95.00% 3.99 0.469 1.19 467.2591 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDR 95.00% 4.22 0.401 1.02 467.2602 1,398.76 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDR 95.00% 2.13 0.32 0 467.2605 1,398.76 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LATALQKLEEAEK 95.00% 2.68 0.517 0 481.9415 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LATALQKLEEAEK 95.00% 3.25 0.458 0 481.9422 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LATALQKLEEAEK 95.00% 2.4 0.424 0 481.9425 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LATALQKLEEAEK 95.00% 2.33 0.336 0 481.9426 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KATDAEADVASLNR 95.00% 3.47 0.28 0 487.5853 1,459.73 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KATDAEADVASLNR 95.00% 3.52 0.315 0 487.5865 1,459.74 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KATDAEADVASLNR 95.00% 3.06 0.333 0 487.9221 1,460.74 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% ATDAEADVASLNRR 95.00% 1.73 0.188 1.09 496.9197 1,487.74 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KATDAEADVASLNRR 95.00% 2.26 0.192 0 539.6169 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KATDAEADVASLNRR 95.00% 2.22 0.319 0 539.618 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KATDAEADVASLNRR 95.00% 2.43 0.273 0 539.6183 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KATDAEADVASLNRR 95.00% 2.97 0.35 0 539.619 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KATDAEADVASLNRR 95.00% 3 0.226 0 539.9527 1,616.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% YSQKEDRYEEEIK 95.00% 2.12 0.21 0 572.9444 1,715.81 1,716.81 3
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% mEIQEIQLK 95.00% 2.37 0.285 0 m1: Oxidation (+15.99) 574.3081 1,146.60 1,147.60 2
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% IQLVEEELDRAQER 95.00% 1.9 0.267 0 576.6375 1,726.89 1,727.89 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LVIIESDLER 95.00% 3.55 0.392 1.62 593.8393 1,185.66 1,186.67 2
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LVIIESDLER 95.00% 3.52 0.406 1.77 593.8393 1,185.66 1,186.67 2
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 1.91 0.42 0 601.2994 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 2.19 0.555 1.57 601.3013 1,800.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 2.09 0.247 0 601.3019 1,800.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 2.3 0.304 1.17 601.3023 1,800.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 2.03 0.381 0 601.3024 1,800.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 1.89 0.273 0 601.3024 1,800.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 2.09 0.48 1.19 601.6356 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 2.39 0.561 2.8 601.6357 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 2.4 0.583 1.37 601.6366 1,801.89 1,801.88 3 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% IQLVEEELDR 95.00% 3.01 0.319 1.64 622.3319 1,242.65 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% IQLVEEELDR 95.00% 3.13 0.33 2.42 622.3322 1,242.65 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% IQLVEEELDR 95.00% 3.34 0.367 1.89 622.3322 1,242.65 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% IQLVEEELDR 95.00% 3.26 0.361 1.96 622.3322 1,242.65 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDRAQER 95.00% 3.66 0.293 0 628.671 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDRAQER 95.00% 3.49 0.374 0 628.6712 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDRAQER 95.00% 3.64 0.442 1 628.6717 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDRAQER 95.00% 3.85 0.403 1.12 628.6719 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDRAQER 95.00% 3.85 0.428 0 628.6719 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDRAQER 95.00% 3.18 0.28 0 629.0048 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDRAQER 95.00% 3.93 0.418 0 629.0054 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDRAQER 95.00% 3.99 0.29 1.82 629.0056 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDRAQER 95.00% 3.12 0.227 0 629.0062 1,884.00 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDRAQER 95.00% 4.05 0.314 1.1 629.0067 1,884.00 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% cAELEEELKTVTNNLK 95.00% 4.46 0.54 0 c1: Carbamidomethyl (+57.02) 630.9888 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% cAELEEELKTVTNNLK 95.00% 2.56 0.176 0 c1: Carbamidomethyl (+57.02) 630.9899 1,889.95 1,890.95 3 CO9_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% cAELEEELKTVTNNLK 95.00% 4.12 0.514 1.27 c1: Carbamidomethyl (+57.02) 631.3239 1,890.95 1,890.95 3 CO9_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% cAELEEELKTVTNNLK 95.00% 3.89 0.44 2.59 c1: Carbamidomethyl (+57.02) 631.3243 1,890.95 1,890.95 3 CO9_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% AQKDEEKMEIQEIQLK 95.00% 4.29 0.268 1.6 654.0086 1,959.00 1,960.01 3
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% AQKDEEKMEIQEIQLK 95.00% 3.71 0.295 0 654.3436 1,960.01 1,960.01 3
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% AQKDEEKMEIQEIQLK 95.00% 4.32 0.268 1.42 654.3438 1,960.01 1,960.01 3
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KLVIIESDLER 95.00% 2.86 0.294 0 657.2972 1,312.58 1,314.76 2
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KLVIIESDLER 95.00% 2.85 0.215 3 657.2985 1,312.58 1,314.76 2
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KLVIIESDLER 95.00% 3.17 0.396 2.54 657.8866 1,313.76 1,314.76 2
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KLVIIESDLER 95.00% 3.13 0.36 2.02 657.8886 1,313.76 1,314.76 2
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% AQKDEEKmEIQEIQLK 95.00% 4.2 0.19 0 m8: Oxidation (+15.99) 659.6751 1,976.00 1,976.00 3
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% AQKDEEKmEIQEIQLK 95.00% 4.74 0.319 1.02 m8: Oxidation (+15.99) 659.6755 1,976.00 1,976.00 3
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% AQKDEEKmEIQEIQLK 95.00% 4.26 0.236 1.3 m8: Oxidation (+15.99) 659.6758 1,976.00 1,976.00 3
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% AQKDEEKmEIQEIQLK 95.00% 4.19 0.24 2 m8: Oxidation (+15.99) 659.676 1,976.00 1,976.00 3
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% ATDAEADVASLNR 95.00% 1.79 0.261 1.21 666.8238 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% ATDAEADVASLNR 95.00% 3.92 0.464 3.1 666.8257 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% ATDAEADVASLNR 95.00% 3.37 0.455 2.7 666.826 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% ATDAEADVASLNR 95.00% 4.13 0.479 3.51 666.8264 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% ATDAEADVASLNR 95.00% 3.86 0.487 4.49 666.8266 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LATALQKLEEAEK 95.00% 4.08 0.375 3.02 722.4081 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LATALQKLEEAEK 95.00% 3.94 0.413 4.52 722.4091 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LATALQKLEEAEK 95.00% 4.11 0.487 2.82 722.4094 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LATALQKLEEAEK 95.00% 4.16 0.465 2.04 722.4101 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LATALQKLEEAEK 95.00% 3.46 0.282 1.77 722.4118 1,442.81 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LATALQKLEEAEK 95.00% 3.69 0.35 1.43 722.4137 1,442.81 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KATDAEADVASLNR 95.00% 2.84 0.28 2.38 730.3524 1,458.69 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KATDAEADVASLNR 95.00% 4.21 0.562 3.01 730.8737 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LATALQKLEEAEKAADESER 95.00% 4.61 0.58 5.7 735.0493 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LATALQKLEEAEKAADESER 95.00% 4.09 0.56 3.7 735.0499 2,202.13 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% ATDAEADVASLNRR 95.00% 2.55 0.268 1.21 744.8758 1,487.74 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KATDAEADVASLNRR 95.00% 2.51 0.253 0 808.9243 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% KATDAEADVASLNRR 95.00% 2.52 0.219 0 808.9243 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% IQLVEEELDRAQER 95.00% 3.95 0.295 0 864.4526 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% IQLVEEELDRAQER 95.00% 3.68 0.268 0 864.9528 1,727.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% IQLVEEELDRAQER 95.00% 3.63 0.199 0 864.9543 1,727.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% IQLVEEELDRAQER 95.00% 3.61 0.274 1.59 864.9543 1,727.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% IQLVEEELDRAQER 95.00% 4.1 0.236 0 864.9566 1,727.90 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 3.42 0.437 1.42 901.4507 1,800.89 1,801.88 2 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 3.82 0.519 1.36 901.4512 1,800.89 1,801.88 2 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 3.43 0.483 2.24 901.4525 1,800.89 1,801.88 2 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 3.97 0.531 2.85 901.9494 1,801.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 4 0.521 2.92 901.9499 1,801.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% HIAEDADRKYEEVAR 95.00% 3.22 0.422 2.21 901.9516 1,801.89 1,801.88 2 HSP71_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDRAQER 95.00% 2.57 0.268 1.74 943.0053 1,883.99 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% RIQLVEEELDRAQER 95.00% 3.06 0.254 1.72 943.0057 1,884.00 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% cAELEEELKTVTNNLK 95.00% 4.36 0.513 4.4 c1: Carbamidomethyl (+57.02) 946.4806 1,890.95 1,890.95 2 CO9_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% AQKDEEKMEIQEIQLK 95.00% 5.87 0.463 3.92 980.5104 1,959.01 1,960.01 2
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% AQKDEEKMEIQEIQLK 95.00% 6.18 0.329 5.16 981.0093 1,960.00 1,960.01 2
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LDKENALDRAEQAEADKK 95.00% 0 0 3.66 1,022.52 2,043.03 2,044.03 2 TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 7 10 37 48.60% LDKENALDRAEQAEADKK 95.00% 0 0 3.59 1,023.02 2,044.03 2,044.03 2 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDR 95.00% 3.39 0.385 1.41 467.258 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDR 95.00% 4.05 0.422 0 467.2582 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDR 95.00% 3.37 0.368 0 467.2591 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDR 95.00% 4.24 0.439 1.96 467.2591 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDR 95.00% 3.94 0.442 0 467.26 1,398.76 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDR 95.00% 4.23 0.387 1.11 467.2609 1,398.76 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LATALQKLEEAEK 95.00% 2.64 0.462 0 481.9422 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LATALQKLEEAEK 95.00% 2.54 0.4 0 481.9423 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LATALQKLEEAEK 95.00% 2.5 0.453 0 481.9424 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LATALQKLEEAEK 95.00% 2.13 0.274 0 482.2763 1,443.81 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LATALQKLEEAEK 95.00% 2.49 0.339 0 482.2775 1,443.81 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% KATDAEADVASLNR 95.00% 3.64 0.368 0 487.5847 1,459.73 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% ATDAEADVASLNRR 95.00% 2.08 0.205 0 496.9197 1,487.74 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% ATDAEADVASLNRR 95.00% 2.12 0.196 0 496.92 1,487.74 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% KATDAEADVASLNRR 95.00% 2.1 0.36 0 539.6176 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% KATDAEADVASLNRR 95.00% 2.41 0.249 0 539.6183 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% KATDAEADVASLNRR 95.00% 2.17 0.331 1.02 539.6188 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% KATDAEADVASLNRR 95.00% 2.68 0.225 0 539.6193 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% KATDAEADVASLNRR 95.00% 2.42 0.211 0 539.6195 1,615.84 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% ENALDRAEQAEADKK 95.00% 3.33 0.325 0 563.282 1,686.82 1,687.83 3 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% ENALDRAEQAEADKK 95.00% 4.05 0.336 0 563.6144 1,687.82 1,687.83 3 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% MEIQEIQLK 95.00% 2.82 0.209 0 566.3078 1,130.60 1,131.61 2
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% MEIQEIQLK 95.00% 3.03 0.251 0 566.3081 1,130.60 1,131.61 2
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDRAQER 95.00% 1.81 0.26 1.07 576.6376 1,726.89 1,727.89 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDRAQER 95.00% 1.83 0.283 0 576.9722 1,727.89 1,727.89 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% HIAEDADRKYEEVAR 95.00% 2.32 0.5 1.27 601.3004 1,800.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% HIAEDADRKYEEVAR 95.00% 1.93 0.412 0 601.3011 1,800.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% HIAEDADRKYEEVAR 95.00% 1.91 0.342 0 601.3024 1,800.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% HIAEDADRKYEEVAR 95.00% 2.21 0.598 1.96 601.6356 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% HIAEDADRKYEEVAR 95.00% 2.31 0.326 0 601.6371 1,801.89 1,801.88 3 HSP71_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% HIAEDADRKYEEVAR 95.00% 2.21 0.432 1.7 601.638 1,801.89 1,801.88 3 HSP71_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDR 95.00% 2.98 0.382 2.25 622.3294 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDR 95.00% 3.24 0.338 1.54 622.3318 1,242.65 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDR 95.00% 3.03 0.371 1.92 622.3333 1,242.65 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDRAQER 95.00% 3.79 0.374 0 628.6716 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDRAQER 95.00% 3.43 0.437 0 628.6716 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDRAQER 95.00% 3.78 0.321 0 628.6719 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDRAQER 95.00% 3.36 0.393 0 628.6721 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDRAQER 95.00% 3.43 0.319 0 628.6729 1,883.00 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDRAQER 95.00% 3.15 0.383 0 629.0051 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDRAQER 95.00% 3.26 0.266 1.01 629.0057 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDRAQER 95.00% 2.61 0.341 0 629.0095 1,884.01 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% cAELEEELKTVTNNLK 95.00% 4.37 0.556 2.55 c1: Carbamidomethyl (+57.02) 630.9895 1,889.95 1,890.95 3 CO9_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% cAELEEELKTVTNNLK 95.00% 2.94 0.473 1.03 c1: Carbamidomethyl (+57.02) 630.9896 1,889.95 1,890.95 3 CO9_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% cAELEEELKTVTNNLK 95.00% 4.3 0.475 1.68 c1: Carbamidomethyl (+57.02) 631.3228 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% cAELEEELKTVTNNLK 95.00% 5.16 0.503 1.23 c1: Carbamidomethyl (+57.02) 631.3235 1,890.95 1,890.95 3 CO9_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% cAELEEELKTVTNNLK 95.00% 2.52 0.295 0 c1: Carbamidomethyl (+57.02) 631.3239 1,890.95 1,890.95 3 CO9_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% cAELEEELKTVTNNLK 95.00% 3.91 0.436 1.8 c1: Carbamidomethyl (+57.02) 631.3246 1,890.95 1,890.95 3 CO9_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% AQKDEEKMEIQEIQLK 95.00% 4.72 0.356 1.1 654.3425 1,960.00 1,960.01 3
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% AQKDEEKMEIQEIQLK 95.00% 4.22 0.199 0 654.3444 1,960.01 1,960.01 3
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% AQKDEEKmEIQEIQLK 95.00% 3.57 0.129 2.06 m8: Oxidation (+15.99) 659.3415 1,975.00 1,976.00 3
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% AQKDEEKmEIQEIQLK 95.00% 3.5 0.188 1.32 m8: Oxidation (+15.99) 659.6747 1,976.00 1,976.00 3
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% AQKDEEKmEIQEIQLK 95.00% 4.43 0.239 1.38 m8: Oxidation (+15.99) 659.6748 1,976.00 1,976.00 3
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% ATDAEADVASLNR 95.00% 3.57 0.465 2.96 666.8254 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% ATDAEADVASLNR 95.00% 3.81 0.483 2.96 666.8256 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% ATDAEADVASLNR 95.00% 3.96 0.468 2.85 666.8257 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LATALQKLEEAEK 95.00% 4.21 0.416 2.8 722.4098 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LATALQKLEEAEK 95.00% 4.21 0.446 3.15 722.4103 1,442.81 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LATALQKLEEAEK 95.00% 4.04 0.466 1.85 722.4117 1,442.81 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LATALQKLEEAEK 95.00% 3.45 0.346 1.62 722.4117 1,442.81 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LATALQKLEEAEK 95.00% 3.55 0.359 1.37 722.9103 1,443.81 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LATALQKLEEAEK 95.00% 3.87 0.377 2.22 722.9113 1,443.81 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% KATDAEADVASLNR 95.00% 2.36 0.197 2.82 730.3531 1,458.69 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% KATDAEADVASLNR 95.00% 4.55 0.592 4.06 730.8725 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% KATDAEADVASLNR 95.00% 4.07 0.564 5.47 730.8745 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% KATDAEADVASLNR 95.00% 3.91 0.53 4.33 730.8747 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% KATDAEADVASLNR 95.00% 4.35 0.563 4.46 730.8763 1,459.74 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% ATDAEADVASLNRR 95.00% 2.39 0.299 1.22 744.8753 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% ATDAEADVASLNRR 95.00% 2.52 0.228 1.42 744.8753 1,487.74 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% ATDAEADVASLNRR 95.00% 2.21 0.253 2.14 744.8759 1,487.74 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% KATDAEADVASLNRR 95.00% 2.34 0.269 0 808.9239 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDRAQER 95.00% 3.54 0.138 0 864.4518 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDRAQER 95.00% 2.95 0.179 0 864.4522 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDRAQER 95.00% 3.77 0.274 1.54 864.4522 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDRAQER 95.00% 3.89 0.337 0 864.4524 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDRAQER 95.00% 3.98 0.298 1.74 864.4528 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDRAQER 95.00% 3.84 0.26 1.6 864.4531 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDRAQER 95.00% 3.88 0.245 0 864.4549 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% IQLVEEELDRAQER 95.00% 2.92 0.216 0 864.455 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% HIAEDADRKYEEVAR 95.00% 3.9 0.493 2.27 901.4474 1,800.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% HIAEDADRKYEEVAR 95.00% 3.91 0.513 2.59 901.4487 1,800.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% HIAEDADRKYEEVAR 95.00% 3.37 0.528 1.72 901.4499 1,800.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% HIAEDADRKYEEVAR 95.00% 3.48 0.456 3.46 901.4518 1,800.89 1,801.88 2 HSP71_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% HIAEDADRKYEEVAR 95.00% 3.14 0.431 1.44 901.9548 1,801.89 1,801.88 2 HSP71_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% cAELEEELKTVTNNLK 94.70% 0 0 3.21 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 937.466 1,872.92 1,873.92 2 CO9_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% RIQLVEEELDRAQER 95.00% 2.78 0.304 1.7 943.0033 1,883.99 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% cAELEEELKTVTNNLK 95.00% 5.15 0.449 4.04 c1: Carbamidomethyl (+57.02) 945.9781 1,889.94 1,890.95 2 CO9_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% cAELEEELKTVTNNLK 95.00% 5.36 0.41 2.96 c1: Carbamidomethyl (+57.02) 946.4818 1,890.95 1,890.95 2 CO9_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% cAELEEELKTVTNNLK 95.00% 0 0 4.08 c1: Carbamidomethyl (+57.02) 946.9243 1,891.83 1,890.95 2 CO9_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% cAELEEELKTVTNNLK 95.00% 0 0 3.32 c1: Carbamidomethyl (+57.02) 947.4189 1,892.82 1,890.95 2 CO9_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% AQKDEEKMEIQEIQLK 95.00% 5.79 0.292 5 981.0085 1,960.00 1,960.01 2
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LDKENALDRAEQAEADKK 95.00% 0 0 3.37 1,023.02 2,044.03 2,044.03 2 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 4 7 30 37.70% LDKENALDRAEQAEADKK 95.00% 0 0 3.8 1,023.02 2,044.03 2,044.03 2 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% RIQLVEEELDR 95.00% 4.3 0.395 1.05 467.2589 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% LATALQKLEEAEK 94.70% 2.31 0.252 0 481.9409 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% SKQLEDELVSLQK 95.00% 3.54 0.211 1.82 506.2781 1,515.81 1,516.82 3
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% SKQLEDELVSLQK 95.00% 4.81 0.251 2.17 506.2819 1,515.82 1,516.82 3
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% SKQLEDELVSLQK 95.00% 4.91 0.32 1.34 506.2833 1,515.83 1,516.82 3
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% KATDAEADVASLNRR 95.00% 2.14 0.253 1.17 539.6144 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% KATDAEADVASLNRR 95.00% 2.1 0.287 0 539.6156 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% SKQLEDELVSLQKK 95.00% 4.68 0.493 2.46 548.9766 1,643.91 1,644.92 3
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% SKQLEDELVSLQKK 95.00% 4.66 0.524 1.72 548.9796 1,643.92 1,644.92 3
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% SKQLEDELVSLQKK 95.00% 4.7 0.471 2.43 548.98 1,643.92 1,644.92 3
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% SKQLEDELVSLQKK 95.00% 4.17 0.41 2.51 548.9827 1,643.92 1,644.92 3
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% MEIQEIQLK 95.00% 3.15 0.259 0 566.3131 1,130.61 1,131.61 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% MEIQEIQLK 95.00% 3.41 0.225 0 566.3131 1,130.61 1,131.61 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% EDRYEEEIKVLSDK 95.00% 2.67 0.182 0 584.9568 1,751.85 1,752.87 3
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% LVIIESDLER 95.00% 3.57 0.426 2.29 593.8423 1,185.67 1,186.67 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% HIAEDADRKYEEVAR 95.00% 1.97 0.4 0 601.2972 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% HIAEDADRKYEEVAR 95.00% 2.31 0.478 1.01 601.2975 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% HIAEDADRKYEEVAR 95.00% 2.49 0.448 0 601.2976 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% HIAEDADRKYEEVAR 95.00% 2.07 0.493 0 601.2983 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% HIAEDADRKYEEVAR 95.00% 1.91 0.452 0 601.6323 1,801.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% HIAEDADRKYEEVAR 95.00% 2.17 0.29 0 601.6324 1,801.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% HIAEDADRKYEEVAR 95.00% 1.87 0.269 0 601.633 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% IQLVEEELDR 95.00% 2.31 0.295 1.35 622.3275 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% IQLVEEELDR 95.00% 2.6 0.301 0 622.3277 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% IQLVEEELDR 95.00% 2.67 0.252 2.55 622.3281 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% IQLVEEELDR 95.00% 2.77 0.355 1.29 622.3286 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% IQLVEEELDR 95.00% 3.06 0.327 2.04 622.3288 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% IQLVEEELDR 95.00% 2.46 0.158 1.92 622.9897 1,243.96 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% RIQLVEEELDRAQER 95.00% 3.58 0.261 0 628.6689 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% RIQLVEEELDRAQER 95.00% 3.56 0.358 0 628.6691 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% RIQLVEEELDRAQER 95.00% 3.92 0.37 0.959 628.672 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% RIQLVEEELDRAQER 95.00% 3.92 0.354 0 629.0012 1,883.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% RIQLVEEELDRAQER 95.00% 3.82 0.372 2.03 629.0013 1,883.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% RIQLVEEELDRAQER 95.00% 4.05 0.392 0 629.0026 1,883.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% cAELEEELKTVTNNLK 95.00% 4.25 0.493 2.46 c1: Carbamidomethyl (+57.02) 630.986 1,889.93 1,890.95 3 CO9_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% cAELEEELKTVTNNLK 95.00% 4.11 0.443 2.36 c1: Carbamidomethyl (+57.02) 630.9861 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% cAELEEELKTVTNNLK 95.00% 4.66 0.513 2.55 c1: Carbamidomethyl (+57.02) 630.9872 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% cAELEEELKTVTNNLK 95.00% 2.86 0.259 0 c1: Carbamidomethyl (+57.02) 630.9888 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% cAELEEELKTVTNNLK 95.00% 4.41 0.511 2.28 c1: Carbamidomethyl (+57.02) 630.9949 1,889.96 1,890.95 3 CO9_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% cAELEEELKTVTNNLK 95.00% 4.68 0.506 1.55 c1: Carbamidomethyl (+57.02) 631.3209 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% cAELEEELKTVTNNLK 95.00% 4.49 0.503 2.05 c1: Carbamidomethyl (+57.02) 631.3281 1,890.96 1,890.95 3 CO9_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% QLEDELVSLQK 95.00% 2.84 0.267 0 651.3478 1,300.68 1,301.70 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% AQKDEEKMEIQEIQLK 95.00% 2.67 0.228 0 654.3414 1,960.00 1,960.01 3
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% KLVIIESDLER 95.00% 3.39 0.256 2.02 657.8819 1,313.75 1,314.76 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% KLVIIESDLER 95.00% 3.63 0.329 1.55 657.8839 1,313.75 1,314.76 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% KLVIIESDLER 95.00% 3.86 0.354 3 657.8842 1,313.75 1,314.76 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% KLVIIESDLER 95.00% 3.29 0.369 3.32 657.8896 1,313.76 1,314.76 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% AQKDEEKmEIQEIQLK 95.00% 3.15 0.152 0 m8: Oxidation (+15.99) 659.6763 1,976.01 1,976.00 3
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% ATDAEADVASLNR 95.00% 4.07 0.414 2.82 666.8231 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% ATDAEADVASLNR 95.00% 4.5 0.439 3.7 666.8233 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% ATDAEADVASLNR 95.00% 3.45 0.504 2.55 666.8252 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% ATDAEADVASLNR 95.00% 3.68 0.394 2.89 666.8257 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% ATDAEADVASLNR 95.00% 4.22 0.504 3.37 666.8271 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% ATDAEADVASLNR 95.00% 4.32 0.461 3.7 666.8279 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% RIQLVEEELDR 95.00% 3.81 0.415 3.11 700.3786 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% RIQLVEEELDR 95.00% 3.27 0.359 1.96 700.3824 1,398.75 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% RIQLVEEELDR 95.00% 2.82 0.426 3.37 700.3833 1,398.75 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% LATALQKLEEAEK 95.00% 4.17 0.486 2.21 722.4055 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% LATALQKLEEAEK 95.00% 4.01 0.431 0 722.4107 1,442.81 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% LATALQKLEEAEK 95.00% 3.51 0.383 1.8 722.9082 1,443.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% KATDAEADVASLNR 95.00% 2.94 0.192 1.31 730.8697 1,459.72 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% LATALQKLEEAEKAADESER 95.00% 4.89 0.631 4.72 734.7192 2,201.13 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% LATALQKLEEAEKAADESER 95.00% 4.95 0.621 5.54 735.0455 2,202.11 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% LATALQKLEEAEKAADESER 95.00% 4.38 0.571 4.39 735.0457 2,202.11 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% LATALQKLEEAEKAADESER 95.00% 4.46 0.45 5.07 735.0531 2,202.14 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% SKQLEDELVSLQK 95.00% 4.85 0.316 2.46 758.9148 1,515.81 1,516.82 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% SKQLEDELVSLQK 95.00% 4.7 0.355 2.22 758.9206 1,515.83 1,516.82 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% SKQLEDELVSLQK 95.00% 4.59 0.324 1.89 759.4146 1,516.81 1,516.82 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% KATDAEADVASLNRR 95.00% 2.61 0.282 0 808.9199 1,615.82 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% KATDAEADVASLNRR 95.00% 2.57 0.319 0 808.9235 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% LVIIESDLERAEER 95.00% 3.02 0.317 0 836.4478 1,670.88 1,671.89 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% LVIIESDLERAEER 95.00% 2.98 0.293 0 836.4491 1,670.88 1,671.89 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% IQLVEEELDRAQER 95.00% 3.96 0.348 0 864.4477 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% IQLVEEELDRAQER 95.00% 4.3 0.335 2.46 864.4486 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% IQLVEEELDRAQER 95.00% 3.28 0.141 0 864.45 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% IQLVEEELDRAQER 95.00% 3.23 0.13 0 864.4565 1,726.90 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% IQLVEEELDRAQER 95.00% 3.71 0.189 0 864.9496 1,727.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% HIAEDADRKYEEVAR 95.00% 2.85 0.297 0 901.9476 1,801.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% RIQLVEEELDRAQER 95.00% 2.78 0.331 1.64 942.4986 1,882.98 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% cAELEEELKTVTNNLK 95.00% 5.11 0.476 3.24 c1: Carbamidomethyl (+57.02) 945.9856 1,889.96 1,890.95 2 CO9_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% cAELEEELKTVTNNLK 95.00% 5.3 0.423 6.89 c1: Carbamidomethyl (+57.02) 945.9865 1,889.96 1,890.95 2 CO9_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% cAELEEELKTVTNNLK 95.00% 5.38 0.408 4.42 c1: Carbamidomethyl (+57.02) 946.4754 1,890.94 1,890.95 2 CO9_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% cAELEEELKTVTNNLK 95.00% 5.67 0.416 3.96 c1: Carbamidomethyl (+57.02) 946.4763 1,890.94 1,890.95 2 CO9_HUMAN
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% AQKDEEKMEIQEIQLK 95.00% 5.45 0.48 3.13 980.5047 1,958.99 1,960.01 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% AQKDEEKMEIQEIQLK 95.00% 5.41 0.459 1.89 980.51 1,959.00 1,960.01 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% AQKDEEKMEIQEIQLK 95.00% 5.3 0.252 4.04 981.0051 1,959.99 1,960.01 2
 SAMPLE 1 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 11 15 46 48.90% AQKDEEKMEIQEIQLK 95.00% 2.99 0.329 0 981.0185 1,960.02 1,960.01 2
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% RIQLVEEELDR 95.00% 4.3 0.395 1.52 467.2589 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% KATDAEADVASLNR 95.00% 3.06 0.267 0 487.5826 1,459.72 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% SKQLEDELVSLQK 95.00% 4.81 0.251 1.15 506.2819 1,515.82 1,516.82 3
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% SKQLEDELVSLQK 95.00% 4.91 0.32 1.21 506.2833 1,515.83 1,516.82 3
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% KATDAEADVASLNRR 95.00% 2.07 0.229 0 539.6149 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% KATDAEADVASLNRR 95.00% 2.02 0.209 0 539.615 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% KATDAEADVASLNRR 95.00% 2.1 0.225 0 539.6158 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% SKQLEDELVSLQKK 95.00% 4.66 0.524 2.02 548.9796 1,643.92 1,644.92 3
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% SKQLEDELVSLQKK 95.00% 4.17 0.41 2.52 548.9827 1,643.92 1,644.92 3
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% MEIQEIQLK 95.00% 3.15 0.259 0 566.3131 1,130.61 1,131.61 2
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% MEIQEIQLK 95.00% 3.41 0.225 0 566.3131 1,130.61 1,131.61 2
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% MEIQEIQLK 95.00% 2.8 0.275 0 566.317 1,130.62 1,131.61 2
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% LVIIESDLER 95.00% 3.57 0.426 1.82 593.8423 1,185.67 1,186.67 2
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% HIAEDADRKYEEVAR 95.00% 1.95 0.286 0 601.2966 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% HIAEDADRKYEEVAR 95.00% 2.21 0.406 0 601.2975 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% HIAEDADRKYEEVAR 95.00% 2.49 0.448 0 601.2976 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% HIAEDADRKYEEVAR 95.00% 2.51 0.558 0 601.2983 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% IQLVEEELDR 95.00% 2.33 0.219 0 622.3271 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% IQLVEEELDR 95.00% 2.63 0.273 0 622.3291 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% IQLVEEELDR 95.00% 2.39 0.295 0 622.3346 1,242.65 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% RIQLVEEELDRAQER 95.00% 4 0.252 0 629.0031 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% cAELEEELKTVTNNLK 95.00% 2.86 0.259 0 c1: Carbamidomethyl (+57.02) 630.9888 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% cAELEEELKTVTNNLK 95.00% 4.41 0.511 2.07 c1: Carbamidomethyl (+57.02) 630.9949 1,889.96 1,890.95 3 CO9_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% cAELEEELKTVTNNLK 95.00% 4.05 0.437 1.44 c1: Carbamidomethyl (+57.02) 631.321 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% cAELEEELKTVTNNLK 95.00% 2.59 0.4 0 c1: Carbamidomethyl (+57.02) 631.3226 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% cAELEEELKTVTNNLK 95.00% 4.49 0.503 0.959 c1: Carbamidomethyl (+57.02) 631.3281 1,890.96 1,890.95 3 CO9_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% cAELEEELKTVTNNLK 95.00% 3.24 0.341 0 c1: Carbamidomethyl (+57.02) 631.3328 1,890.97 1,890.95 3 CO9_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% KLVIIESDLER 95.00% 3.39 0.256 2.02 657.8819 1,313.75 1,314.76 2
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% KLVIIESDLER 95.00% 3.29 0.369 3.25 657.8896 1,313.76 1,314.76 2
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% AQKDEEKmEIQEIQLK 95.00% 3.15 0.152 0 m8: Oxidation (+15.99) 659.6763 1,976.01 1,976.00 3
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% ATDAEADVASLNR 95.00% 2.86 0.49 2.35 666.8213 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% ATDAEADVASLNR 95.00% 2.83 0.405 2.96 666.8215 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% ATDAEADVASLNR 95.00% 4.22 0.504 3.11 666.8271 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% ATDAEADVASLNR 95.00% 4.32 0.461 2.82 666.8279 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% RIQLVEEELDR 95.00% 2.82 0.426 3.08 700.3833 1,398.75 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% LATALQKLEEAEK 95.00% 3.54 0.385 1.77 722.4043 1,442.79 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% LATALQKLEEAEK 95.00% 3.44 0.424 1.82 722.4093 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% LATALQKLEEAEK 95.00% 4.01 0.431 2.18 722.4107 1,442.81 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% KATDAEADVASLNR 95.00% 2.94 0.192 1.28 730.8697 1,459.72 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% LATALQKLEEAEKAADESER 95.00% 4.89 0.631 4.04 734.7192 2,201.13 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% LATALQKLEEAEKAADESER 95.00% 3.73 0.503 3.31 734.7269 2,201.16 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% LATALQKLEEAEKAADESER 95.00% 4.46 0.45 4.64 735.0531 2,202.14 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% SKQLEDELVSLQK 95.00% 4.7 0.355 2.31 758.9206 1,515.83 1,516.82 2
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% SKQLEDELVSLQK 95.00% 4.46 0.332 2.52 758.9262 1,515.84 1,516.82 2
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% KATDAEADVASLNRR 95.00% 2.61 0.282 0 808.9199 1,615.82 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% KATDAEADVASLNRR 95.00% 2.57 0.319 0 808.9235 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% IQLVEEELDRAQER 95.00% 4.3 0.335 1.49 864.4486 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% IQLVEEELDRAQER 95.00% 3.23 0.13 1.17 864.4565 1,726.90 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% IQLVEEELDRAQER 95.00% 4.05 0.326 0 864.4629 1,726.91 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% IQLVEEELDRAQER 95.00% 3.64 0.265 0 864.9503 1,727.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% KLVIIESDLERAEER 95.00% 2.12 0.285 0 900.4972 1,798.98 1,799.99 2
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% HIAEDADRKYEEVAR 95.00% 2.85 0.297 0 901.9476 1,801.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% cAELEEELKTVTNNLK 95.00% 3.69 0.432 1.92 c1: Carbamidomethyl (+57.02) 945.9762 1,889.94 1,890.95 2 CO9_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% cAELEEELKTVTNNLK 95.00% 5.11 0.476 3.11 c1: Carbamidomethyl (+57.02) 945.9856 1,889.96 1,890.95 2 CO9_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% cAELEEELKTVTNNLK 95.00% 5.3 0.423 5.21 c1: Carbamidomethyl (+57.02) 945.9865 1,889.96 1,890.95 2 CO9_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% cAELEEELKTVTNNLK 95.00% 5.07 0.392 3.92 c1: Carbamidomethyl (+57.02) 946.4959 1,890.98 1,890.95 2 CO9_HUMAN
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% AQKDEEKMEIQEIQLK 95.00% 5.41 0.459 2.17 980.51 1,959.00 1,960.01 2
 SAMPLE 1R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 9 13 31 44.00% AQKDEEKMEIQEIQLK 95.00% 2.99 0.329 0 981.0185 1,960.02 1,960.01 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 3.62 0.301 0 467.2557 1,398.74 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 4.07 0.411 0 467.2564 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 4.44 0.417 0 467.2564 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 3.68 0.396 0 467.2571 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 4.4 0.342 0 467.5913 1,399.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEK 95.00% 2.1 0.374 0 481.9393 1,442.79 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEK 95.00% 2.64 0.421 0 481.9395 1,442.79 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEK 95.00% 2.66 0.34 0 481.9396 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEK 95.00% 2.51 0.359 0 481.9405 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNR 95.00% 2.62 0.158 0 487.5811 1,459.72 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNR 95.00% 3.28 0.295 0 487.5812 1,459.72 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNR 95.00% 3.59 0.275 0 487.5821 1,459.72 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNR 95.00% 3.85 0.326 0 487.5821 1,459.72 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNR 95.00% 3.07 0.179 0 487.5824 1,459.72 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNRR 95.00% 1.93 0.292 0 496.9173 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% YEEEIKVLSDKLK 95.00% 3.12 0.409 0.959 531.9618 1,592.86 1,593.87 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% YEEEIKVLSDKLK 95.00% 3.92 0.475 1.7 531.9619 1,592.86 1,593.87 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNRR 95.00% 2.28 0.303 0 539.6151 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNRR 95.00% 2.04 0.283 0 539.6154 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNRR 95.00% 2.42 0.44 0 539.6161 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNRR 95.00% 2.2 0.376 0 539.6179 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% SKQLEDELVSLQKK 95.00% 2.91 0.331 0 548.9765 1,643.91 1,644.92 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% SKQLEDELVSLQKK 95.00% 4.63 0.504 2.51 548.9769 1,643.91 1,644.92 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% SKQLEDELVSLQKK 95.00% 4.68 0.503 2.7 549.3112 1,644.91 1,644.92 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% MEIQEIQLK 95.00% 2.47 0.269 0 566.3053 1,130.60 1,131.61 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% MEIQEIQLK 95.00% 2.6 0.275 0 566.307 1,130.60 1,131.61 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% MEIQEIQLK 95.00% 2.41 0.228 0 566.3073 1,130.60 1,131.61 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% YSQKEDRYEEEIK 95.00% 2.75 0.162 0 572.9401 1,715.80 1,716.81 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LVIIESDLER 95.00% 3.34 0.464 1.77 593.8366 1,185.66 1,186.67 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LVIIESDLER 95.00% 3.62 0.423 1.62 593.8368 1,185.66 1,186.67 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% SLEAQAEKYSQKEDR 95.00% 3.4 0.375 0 594.9612 1,781.86 1,781.87 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KLVIIESDLERAEER 95.00% 2.67 0.0918 1.68 600.6652 1,798.97 1,799.99 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KLVIIESDLERAEER 95.00% 2.38 0.124 1.4 600.6666 1,798.98 1,799.99 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 2.5 0.564 2.14 601.2971 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 2.25 0.526 1.96 601.2978 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 2.42 0.513 2.28 601.2985 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 2.38 0.494 1.08 601.2996 1,800.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 2.39 0.365 0 601.3004 1,800.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 2.36 0.58 2.04 601.6317 1,801.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 2.28 0.501 1 601.632 1,801.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 2.45 0.551 0.959 601.6323 1,801.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 2.35 0.539 2.19 601.6324 1,801.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 2.22 0.57 1.49 601.6326 1,801.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 2.16 0.533 1.55 601.6335 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 1.96 0.342 0 601.6349 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDR 95.00% 2.91 0.32 1.14 622.3278 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDR 95.00% 3.36 0.389 1.74 622.3282 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDR 95.00% 2.94 0.374 1.17 622.3286 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDR 95.00% 3.29 0.365 1.3 622.3291 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDR 95.00% 3.28 0.365 1.92 622.3291 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDR 95.00% 3.35 0.363 1.19 622.3293 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDR 95.00% 3.34 0.381 2 622.3293 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDR 95.00% 2.84 0.352 0 622.3307 1,242.65 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDR 95.00% 2.51 0.244 0 622.3308 1,242.65 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDRAQER 95.00% 3.72 0.436 0.921 628.6689 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDRAQER 95.00% 3.79 0.302 1.42 628.6689 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDRAQER 95.00% 3.39 0.347 2.12 628.669 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDRAQER 95.00% 4.03 0.419 1.96 628.6694 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDRAQER 95.00% 4.33 0.47 0 628.67 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDRAQER 95.00% 3.41 0.216 0 629.0023 1,883.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDRAQER 95.00% 4.01 0.4 0 629.0032 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDRAQER 95.00% 3.82 0.365 0 629.0032 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDRAQER 95.00% 3.55 0.309 1.31 629.0037 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% cAELEEELKTVTNNLK 95.00% 3.46 0.404 0.959 c1: Carbamidomethyl (+57.02) 630.9869 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% cAELEEELKTVTNNLK 95.00% 3.89 0.466 1.26 c1: Carbamidomethyl (+57.02) 630.9871 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% cAELEEELKTVTNNLK 95.00% 4.28 0.557 1.62 c1: Carbamidomethyl (+57.02) 630.9874 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% cAELEEELKTVTNNLK 95.00% 3.82 0.465 2.06 c1: Carbamidomethyl (+57.02) 631.3213 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% cAELEEELKTVTNNLK 95.00% 4.36 0.445 1.57 c1: Carbamidomethyl (+57.02) 631.3214 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% cAELEEELKTVTNNLK 95.00% 2.83 0.223 0 c1: Carbamidomethyl (+57.02) 631.3227 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% cAELEEELKTVTNNLK 95.00% 3.1 0.338 0 c1: Carbamidomethyl (+57.02) 631.324 1,890.95 1,890.95 3 CO9_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LDKENALDRAEQAEADK 95.00% 3.47 0.396 0 639.6506 1,915.93 1,915.94 3 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% AQKDEEKMEIQEIQLK 95.00% 3.84 0.347 2.08 654.006 1,958.99 1,960.01 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% AQKDEEKMEIQEIQLK 95.00% 3.81 0.303 0 654.3404 1,960.00 1,960.01 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% AQKDEEKMEIQEIQLK 95.00% 2.81 0.273 0 654.3405 1,960.00 1,960.01 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% AQKDEEKMEIQEIQLK 95.00% 4.62 0.261 1.96 654.3407 1,960.00 1,960.01 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% AQKDEEKMEIQEIQLK 95.00% 4.98 0.3 1.24 654.3407 1,960.00 1,960.01 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% AQKDEEKmEIQEIQLK 95.00% 4.29 0.251 0 m8: Oxidation (+15.99) 659.6727 1,975.99 1,976.00 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% AQKDEEKmEIQEIQLK 95.00% 4.47 0.27 0.921 m8: Oxidation (+15.99) 659.6739 1,976.00 1,976.00 3
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNR 95.00% 3.03 0.408 2.68 666.8213 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNR 95.00% 3.56 0.45 3.68 666.8221 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNR 95.00% 3.56 0.474 2.92 666.8222 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNR 95.00% 4.21 0.498 3.31 666.8222 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNR 95.00% 4.34 0.505 2.92 666.8224 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNR 95.00% 3.88 0.47 3.52 666.8226 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNR 95.00% 3.43 0.452 2.77 666.8227 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNR 95.00% 4.37 0.51 2.89 666.8227 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNR 95.00% 3.75 0.479 3.38 666.8229 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 3.17 0.383 1.82 700.3788 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 3.24 0.336 1.89 700.3788 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 3.38 0.384 2.14 700.3792 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 3.21 0.378 1.42 700.3795 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 3.49 0.373 2.41 700.3799 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 3.48 0.322 2.66 700.3802 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 3.24 0.3 2.64 700.3805 1,398.75 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDR 95.00% 3.86 0.404 1.92 700.3806 1,398.75 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEK 95.00% 4.01 0.421 3 722.4052 1,442.79 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEK 95.00% 3.94 0.437 2.19 722.4059 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEK 95.00% 4.24 0.483 3.31 722.4063 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEK 95.00% 4.12 0.402 2.21 722.4063 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEK 95.00% 2.79 0.169 0 722.4085 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEK 95.00% 3.43 0.294 0 722.4132 1,442.81 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNR 95.00% 4.52 0.573 4.15 730.8703 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNR 95.00% 4.56 0.569 2.49 730.8708 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNR 95.00% 3.87 0.527 3.19 730.8733 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNR 95.00% 4.51 0.507 3.51 731.3699 1,460.72 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNR 95.00% 4.08 0.506 3 731.3735 1,460.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNR 95.00% 4.5 0.519 3.96 731.3739 1,460.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEKAADESER 95.00% 4.22 0.554 4.74 734.7108 2,201.11 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEKAADESER 95.00% 4.47 0.623 6.14 735.0448 2,202.11 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEKAADESER 95.00% 4.44 0.548 5.04 735.0464 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEKAADESER 95.00% 4.9 0.592 3.54 735.0472 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEKAADESER 95.00% 4.53 0.598 6.52 735.0483 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LEEAEKAADESER 95.00% 3.67 0.509 4.35 738.8471 1,475.68 1,476.68 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNRR 95.00% 2.28 0.289 0 744.872 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNRR 94.80% 2.13 0.26 0 744.873 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNRR 95.00% 2.36 0.302 0 744.8745 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% ATDAEADVASLNRR 95.00% 2.37 0.186 1.17 744.8745 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% SKQLEDELVSLQK 95.00% 4.5 0.347 3.19 758.9132 1,515.81 1,516.82 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% SKQLEDELVSLQK 95.00% 4.15 0.377 2.14 759.4173 1,516.82 1,516.82 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LKEAETRAEFAER 95.00% 3.41 0.307 0 775.4012 1,548.79 1,549.80 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LKEAETRAEFAER 95.00% 3.45 0.301 0 775.4019 1,548.79 1,549.80 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNRR 95.00% 2.71 0.32 0 808.9207 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNRR 95.00% 2.49 0.243 0 808.9214 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% KATDAEADVASLNRR 95.00% 2.73 0.324 0 809.4236 1,616.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LVIIESDLERAEER 95.00% 3.29 0.368 0 836.4491 1,670.88 1,671.89 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LVIIESDLERAEER 95.00% 3.25 0.357 0 836.4502 1,670.88 1,671.89 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% YSQKEDRYEEEIK 95.00% 3.73 0.265 2.18 858.9113 1,715.81 1,716.81 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% YSQKEDRYEEEIK 95.00% 3.93 0.235 1.96 859.4068 1,716.80 1,716.81 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDRAQER 95.00% 3.47 0.212 1.12 864.4477 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDRAQER 95.00% 3.84 0.338 0 864.4483 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDRAQER 95.00% 3.88 0.303 0 864.4493 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDRAQER 95.00% 3.44 0.186 0 864.4494 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDRAQER 95.00% 3.59 0.311 1.21 864.4496 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDRAQER 95.00% 3.39 0.163 0 864.4502 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDRAQER 95.00% 4.18 0.295 0 864.4502 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDRAQER 95.00% 3.01 0.194 0 864.4516 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDRAQER 95.00% 3.4 0.192 0 864.9478 1,727.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDRAQER 95.00% 3.7 0.305 0 864.949 1,727.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDRAQER 95.00% 3.07 0.243 0 864.9494 1,727.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% IQLVEEELDRAQER 95.00% 3.78 0.186 0 864.9532 1,727.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 3.83 0.524 2.01 901.4436 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 3.87 0.562 2.05 901.444 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 3.93 0.52 2.38 901.4444 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 3.9 0.534 2.59 901.4447 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 3.94 0.521 2.34 901.445 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 3.92 0.515 2.6 901.9453 1,801.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 3.96 0.498 2.43 901.9471 1,801.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% HIAEDADRKYEEVAR 95.00% 3.74 0.432 2.74 901.9472 1,801.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDRAQER 95.00% 2.79 0.386 0 942.4984 1,882.98 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDRAQER 95.00% 3.07 0.363 0 942.4992 1,882.98 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% RIQLVEEELDRAQER 95.00% 3.09 0.34 0 943 1,883.98 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% cAELEEELKTVTNNLK 95.00% 5.25 0.445 3.59 c1: Carbamidomethyl (+57.02) 945.9756 1,889.94 1,890.95 2 CO9_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% AQKDEEKMEIQEIQLK 95.00% 3.78 0.523 2.64 980.0179 1,958.02 1,960.01 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% AQKDEEKMEIQEIQLK 95.00% 4.08 0.383 2.92 980.02 1,958.02 1,960.01 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% AQKDEEKMEIQEIQLK 95.00% 5.95 0.447 3.38 980.5051 1,958.99 1,960.01 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% AQKDEEKMEIQEIQLK 95.00% 5.98 0.29 3.4 981.0063 1,960.00 1,960.01 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% AQKDEEKmEIQEIQLK 95.00% 5.4 0.282 3.01 m8: Oxidation (+15.99) 989.0021 1,975.99 1,976.00 2
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LDKENALDRAEQAEADKK 95.00% 0 0 4.11 1,022.52 2,043.02 2,044.03 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LDKENALDRAEQAEADKK 95.00% 0 0 3.44 1,022.52 2,043.02 2,044.03 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LDKENALDRAEQAEADKK 95.00% 0 0 4 1,023.02 2,044.02 2,044.03 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 60 64.10% LATALQKLEEAEKAADESER 95.00% 5.29 0.665 7.7 1,102.07 2,202.13 2,202.13 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDR 95.00% 3.26 0.321 0 467.256 1,398.74 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDR 95.00% 3.35 0.372 0 467.2568 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDR 95.00% 3.96 0.402 1.36 467.2571 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDR 95.00% 4.02 0.35 0 467.2573 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDR 95.00% 4.17 0.298 0 467.5921 1,399.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEK 95.00% 2.84 0.228 0 481.9392 1,442.79 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEK 95.00% 2.36 0.291 0 481.9394 1,442.79 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEK 95.00% 2.12 0.294 0 482.2729 1,443.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNR 95.00% 3.69 0.24 0 487.582 1,459.72 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNR 95.00% 3.68 0.292 0 487.5822 1,459.72 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNR 95.00% 3.08 0.286 0 487.5827 1,459.72 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNR 95.00% 3.31 0.149 0 487.5836 1,459.73 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNRR 95.00% 1.98 0.216 0 496.9172 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNRR 95.00% 2.3 0.255 1.48 496.9179 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNRR 95.00% 2.13 0.213 0 496.918 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNRR 95.00% 2.21 0.226 0 496.9182 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% YEEEIKVLSDKLK 95.00% 3.6 0.51 0 531.9615 1,592.86 1,593.87 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% YEEEIKVLSDKLK 95.00% 2.91 0.405 1.25 532.2956 1,593.86 1,593.87 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNRR 95.00% 2.39 0.244 0 539.6149 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNRR 95.00% 2.04 0.304 0 539.6155 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNRR 95.00% 2.26 0.283 0 539.6155 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNRR 95.00% 2.26 0.37 0 539.616 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% SKQLEDELVSLQKK 95.00% 4.58 0.41 2.07 548.9759 1,643.90 1,644.92 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% SKQLEDELVSLQKK 95.00% 4.12 0.456 3.62 548.9774 1,643.91 1,644.92 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ENALDRAEQAEADKK 95.00% 4.24 0.439 0 563.2785 1,686.81 1,687.83 3 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ENALDRAEQAEADKK 95.00% 4.13 0.42 0 563.6128 1,687.81 1,687.83 3 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% MEIQEIQLK 95.00% 3.21 0.318 0 566.3054 1,130.60 1,131.61 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% MEIQEIQLK 95.00% 2.85 0.256 0 566.3057 1,130.60 1,131.61 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% MEIQEIQLK 95.00% 2.65 0.235 0 566.3062 1,130.60 1,131.61 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% MEIQEIQLK 95.00% 2.38 0.2 1.82 566.3077 1,130.60 1,131.61 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% YSQKEDRYEEEIK 95.00% 2.75 0.267 0 572.9418 1,715.80 1,716.81 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LVIIESDLER 95.00% 3.65 0.445 1.26 593.8361 1,185.66 1,186.67 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LVIIESDLER 95.00% 3.48 0.404 1.39 593.8366 1,185.66 1,186.67 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LVIIESDLER 95.00% 2.26 0.319 0 593.8372 1,185.66 1,186.67 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LVIIESDLER 95.00% 2.39 0.379 2.06 593.8374 1,185.66 1,186.67 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KLVIIESDLERAEER 95.00% 2.63 0.168 0 600.6665 1,798.98 1,799.99 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.34 0.383 0 601.2974 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.54 0.5 1.82 601.2976 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.09 0.514 1.49 601.2977 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.24 0.486 1.39 601.298 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.24 0.334 1.27 601.2981 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.37 0.563 2.08 601.2987 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.11 0.502 1.66 601.2989 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.34 0.456 0 601.2998 1,800.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.33 0.457 1.09 601.6321 1,801.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.51 0.559 1.96 601.6328 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.77 0.577 0 601.6328 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.05 0.374 0 601.6337 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 2.35 0.342 0 601.6357 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDR 95.00% 2.85 0.339 1.64 622.3279 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDR 95.00% 2.52 0.229 0 622.3288 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDR 95.00% 3.18 0.378 2.17 622.3289 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDR 95.00% 2.95 0.342 1.6 622.329 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDR 95.00% 2.78 0.312 1.35 622.3292 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDR 95.00% 3.26 0.368 1.4 622.3301 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDR 95.00% 3.27 0.365 2.12 622.3303 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDR 95.00% 3.08 0.321 1.74 622.331 1,242.65 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDR 95.00% 2.18 0.219 1.8 622.3318 1,242.65 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDRAQER 95.00% 3.78 0.331 0 628.6682 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDRAQER 95.00% 4.09 0.357 0.959 628.6684 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDRAQER 95.00% 3.71 0.336 1.01 628.669 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDRAQER 95.00% 3.53 0.382 1.64 628.6691 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDRAQER 95.00% 3.65 0.371 0 628.6692 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDRAQER 95.00% 4.23 0.36 1.62 628.6693 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDRAQER 95.00% 2.98 0.129 1.49 629.003 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDRAQER 95.00% 3.63 0.419 0 629.0034 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDRAQER 95.00% 3.26 0.344 0 629.0034 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 4.21 0.503 1.57 c1: Carbamidomethyl (+57.02) 630.9865 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 3.84 0.461 2.47 c1: Carbamidomethyl (+57.02) 630.9866 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 3.66 0.505 0 c1: Carbamidomethyl (+57.02) 630.9869 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 3.8 0.52 1.28 c1: Carbamidomethyl (+57.02) 630.9869 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 2.49 0.362 0 c1: Carbamidomethyl (+57.02) 631.32 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 3.84 0.469 0 c1: Carbamidomethyl (+57.02) 631.3207 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 3.68 0.47 0 c1: Carbamidomethyl (+57.02) 631.3208 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 4.98 0.397 2.28 c1: Carbamidomethyl (+57.02) 631.3212 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 3.72 0.505 2.32 c1: Carbamidomethyl (+57.02) 631.3217 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 4.07 0.481 1.06 c1: Carbamidomethyl (+57.02) 631.322 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LDKENALDRAEQAEADK 95.00% 3.56 0.37 0 639.65 1,915.93 1,915.94 3 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LDKENALDRAEQAEADK 95.00% 3.93 0.327 0 639.6509 1,915.93 1,915.94 3 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% AQKDEEKMEIQEIQLK 95.00% 3.06 0.373 1 653.8329 1,958.48 1,960.01 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% AQKDEEKMEIQEIQLK 95.00% 2.69 0.206 1.21 654.0045 1,958.99 1,960.01 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% AQKDEEKMEIQEIQLK 95.00% 3.1 0.258 0 654.3399 1,960.00 1,960.01 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% AQKDEEKMEIQEIQLK 95.00% 5.13 0.28 1.24 654.3406 1,960.00 1,960.01 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% AQKDEEKMEIQEIQLK 95.00% 4.65 0.242 1.59 654.3417 1,960.00 1,960.01 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% AQKDEEKmEIQEIQLK 95.00% 4.49 0.286 1.6 m8: Oxidation (+15.99) 659.3384 1,974.99 1,976.00 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% AQKDEEKmEIQEIQLK 95.00% 4.46 0.221 1.44 m8: Oxidation (+15.99) 659.6741 1,976.00 1,976.00 3
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNR 95.00% 3.88 0.507 2.8 666.8212 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNR 95.00% 2.78 0.388 2.17 666.8225 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNR 95.00% 3.79 0.5 2.92 666.8224 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNR 95.00% 3.36 0.443 3.44 666.8227 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNR 95.00% 2.24 0.319 2.31 666.8229 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNR 95.00% 3.14 0.464 3.06 666.823 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% YEEEIKVLSDK 95.00% 2.34 0.34 2.25 676.8485 1,351.68 1,352.70 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDR 95.00% 3.47 0.366 2.66 700.3785 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDR 95.00% 3.11 0.354 3.77 700.3797 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDR 95.00% 3.11 0.319 2.72 700.3799 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDR 95.00% 3.57 0.338 2.72 700.3802 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDR 95.00% 2.93 0.329 0 700.3803 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDR 95.00% 3.9 0.444 2.72 700.3805 1,398.75 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEK 95.00% 4.28 0.461 2.14 722.4053 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEK 95.00% 4.05 0.447 2.7 722.4058 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEK 95.00% 4.11 0.495 1.85 722.4066 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEK 95.00% 3.13 0.323 1.82 722.4079 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEK 95.00% 3.38 0.321 2.48 722.91 1,443.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNR 95.00% 4.43 0.546 4.13 730.8681 1,459.72 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNR 95.00% 4.43 0.576 4.6 730.8708 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNR 95.00% 4.22 0.572 4.82 730.8709 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNR 95.00% 2.89 0.191 0 730.8726 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNR 95.00% 3.29 0.473 3.92 730.8734 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNR 95.00% 3.62 0.484 1.85 730.8739 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNR 95.00% 2.63 0.277 1.6 730.8828 1,459.75 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEKAADESER 95.00% 4.37 0.534 3.44 735.0464 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEKAADESER 95.00% 4.7 0.582 3.39 735.0466 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEKAADESER 95.00% 4.24 0.603 4.29 735.0472 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEKAADESER 95.00% 4.52 0.565 4.03 735.0478 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEKAADESER 95.00% 4.34 0.605 4.68 735.0482 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEKAADESER 95.00% 4.13 0.45 3.64 735.0491 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LEEAEKAADESER 95.00% 4.04 0.568 4.2 738.8451 1,475.67 1,476.68 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LEEAEKAADESER 95.00% 3.8 0.481 3.8 738.8477 1,475.68 1,476.68 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNRR 95.00% 2.53 0.296 0 744.8729 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNRR 95.00% 2.29 0.275 0 744.8731 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNRR 95.00% 2.22 0.218 1.51 744.8734 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% ATDAEADVASLNRR 95.00% 2.44 0.289 1.33 744.8741 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% SKQLEDELVSLQK 95.00% 4.17 0.331 2.8 758.9118 1,515.81 1,516.82 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% SKQLEDELVSLQK 95.00% 4.31 0.35 2.7 758.9124 1,515.81 1,516.82 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LKEAETRAEFAER 95.00% 3.1 0.307 0 775.399 1,548.78 1,549.80 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LKEAETRAEFAER 95.00% 3.06 0.365 0 775.4015 1,548.79 1,549.80 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LKEAETRAEFAER 95.00% 3.13 0.301 0 775.9033 1,549.79 1,549.80 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNRR 95.00% 2.87 0.33 0 808.9209 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNRR 95.00% 2.29 0.31 0 808.9218 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNRR 95.00% 2.72 0.31 0 808.9218 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNRR 95.00% 2.74 0.316 0 808.9229 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% KATDAEADVASLNRR 95.00% 2.64 0.28 0 809.4219 1,616.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LVIIESDLERAEER 95.00% 3.39 0.387 1.19 836.4483 1,670.88 1,671.89 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LVIIESDLERAEER 95.00% 3.18 0.359 0 836.9485 1,671.88 1,671.89 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% YSQKEDRYEEEIK 95.00% 4.17 0.211 3.02 859.4109 1,716.81 1,716.81 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDRAQER 95.00% 3.46 0.17 0 864.4464 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDRAQER 95.00% 3.51 0.216 1.31 864.4475 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDRAQER 95.00% 3.81 0.26 0 864.4483 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDRAQER 95.00% 3.59 0.256 0 864.4488 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDRAQER 95.00% 3.7 0.249 1.24 864.4497 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDRAQER 95.00% 3.62 0.321 0 864.4506 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDRAQER 95.00% 3.58 0.234 1.32 864.4511 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDRAQER 95.00% 3.65 0.24 0 864.4512 1,726.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% IQLVEEELDRAQER 95.00% 4.19 0.339 0 864.951 1,727.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 3.96 0.523 2.24 901.4427 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 3.97 0.537 1.82 901.4436 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 3.88 0.552 3.14 901.4446 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 4.09 0.517 3.03 901.4453 1,800.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 3.77 0.505 4.39 901.4454 1,800.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 3.83 0.537 2.36 901.4475 1,800.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 4.23 0.529 3.05 901.943 1,801.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% HIAEDADRKYEEVAR 95.00% 3.69 0.404 1.38 901.9456 1,801.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 94.70% 0 0 3.26 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 937.4591 1,872.90 1,873.92 2 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 0 0 3.77 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 937.4642 1,872.91 1,873.92 2 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 0 0 3.74 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 937.964 1,873.91 1,873.92 2 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 0 0 3.59 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 937.9643 1,873.91 1,873.92 2 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDRAQER 95.00% 2.71 0.375 1.25 942.4998 1,882.98 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDRAQER 95.00% 2.87 0.43 0 942.5014 1,882.99 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% RIQLVEEELDRAQER 95.00% 2.64 0.318 0 943.0025 1,883.99 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 4.88 0.479 2.39 c1: Carbamidomethyl (+57.02) 945.9723 1,889.93 1,890.95 2 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% cAELEEELKTVTNNLK 95.00% 5.48 0.427 3.31 c1: Carbamidomethyl (+57.02) 946.4785 1,890.94 1,890.95 2 CO9_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% AQKDEEKMEIQEIQLK 95.00% 6.15 0.434 3.43 980.5042 1,958.99 1,960.01 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% AQKDEEKMEIQEIQLK 95.00% 6.06 0.285 3.54 981.0072 1,960.00 1,960.01 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% AQKDEEKmEIQEIQLK 95.00% 5.07 0.472 3.44 m8: Oxidation (+15.99) 988.5069 1,975.00 1,976.00 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% AQKDEEKmEIQEIQLK 95.00% 5.27 0.333 3.82 m8: Oxidation (+15.99) 989.0042 1,975.99 1,976.00 2
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LDKENALDRAEQAEADKK 95.00% 0 0 3.89 1,022.52 2,043.03 2,044.03 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LDKENALDRAEQAEADKK 95.00% 0 0 3.64 1,023.02 2,044.02 2,044.03 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LDKENALDRAEQAEADKK 95.00% 0 0 3.49 1,023.02 2,044.03 2,044.03 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEKAADESER 95.00% 5.07 0.642 7.1 1,102.07 2,202.11 2,202.13 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 12 16 68 61.30% LATALQKLEEAEKAADESER 95.00% 5.22 0.621 7.06 1,102.07 2,202.11 2,202.13 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% VLSDKLKEAETR 95.00% 2.32 0.247 0 463.5963 1,387.77 1,388.78 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% VLSDKLKEAETR 95.00% 2.62 0.439 1.43 463.5964 1,387.77 1,388.78 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDR 95.00% 3.62 0.374 0 467.2549 1,398.74 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDR 95.00% 3.27 0.4 0 467.2563 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDR 95.00% 4.03 0.368 0 467.2564 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDR 95.00% 2.96 0.199 0 467.5912 1,399.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEK 95.00% 2.01 0.329 0 481.9394 1,442.79 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEK 95.00% 2.48 0.311 0 482.2734 1,443.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNR 95.00% 3.3 0.257 0 487.5823 1,459.72 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNR 95.00% 3.57 0.293 0 487.5826 1,459.72 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LEEAEKAADESER 95.00% 2.29 0.248 0 492.899 1,475.67 1,476.68 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LEEAEKAADESER 95.00% 2.32 0.231 0 492.9008 1,475.68 1,476.68 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AEQAEADKK 95.00% 2.59 0.259 0 495.2493 988.4829 989.4905 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNRR 95.00% 2.08 0.208 2.08 496.9174 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNRR 95.00% 1.64 0.279 0 496.9177 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNRR 95.00% 1.99 0.268 0 496.9181 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% SKQLEDELVSLQK 95.00% 2.85 0.194 0 506.2789 1,515.81 1,516.82 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% YEEEIKVLSDKLK 95.00% 3.1 0.403 0 531.9609 1,592.86 1,593.87 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNRR 95.00% 2.61 0.364 1.02 539.615 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNRR 95.00% 2.57 0.326 0 539.6153 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNRR 95.00% 2.55 0.312 0 539.6157 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNRR 95.00% 2.67 0.286 0 539.6157 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNRR 95.00% 1.89 0.282 0 539.6162 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNRR 95.00% 2.74 0.294 0 539.6163 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNRR 95.00% 2.02 0.292 0 539.9502 1,616.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% SKQLEDELVSLQKK 95.00% 4.27 0.349 1.48 548.9747 1,643.90 1,644.92 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% SKQLEDELVSLQKK 95.00% 4.2 0.462 1.33 548.976 1,643.90 1,644.92 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% SKQLEDELVSLQKK 95.00% 4.39 0.391 2.27 548.9761 1,643.90 1,644.92 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% SKQLEDELVSLQKK 95.00% 4.52 0.52 2.28 549.3113 1,644.91 1,644.92 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ENALDRAEQAEADKK 95.00% 3.89 0.427 0 563.2781 1,686.81 1,687.83 3 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ENALDRAEQAEADKK 95.00% 4.49 0.406 1.11 563.2789 1,686.81 1,687.83 3 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% MEIQEIQLK 95.00% 2.74 0.249 0 566.3057 1,130.60 1,131.61 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% MEIQEIQLK 95.00% 3.04 0.254 0 566.3069 1,130.60 1,131.61 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% MQMLKLDKENALDR 95.00% 3.25 0.426 0 569.2998 1,704.88 1,704.88 3 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% YSQKEDRYEEEIK 95.00% 2.9 0.295 0 572.9403 1,715.80 1,716.81 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LVIIESDLER 95.00% 3.45 0.428 1.28 593.836 1,185.66 1,186.67 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LVIIESDLER 95.00% 3.52 0.44 1.74 593.8362 1,185.66 1,186.67 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LVIIESDLER 95.00% 3.65 0.437 1.92 593.8365 1,185.66 1,186.67 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LVIIESDLER 95.00% 3.53 0.46 1.85 593.8369 1,185.66 1,186.67 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LEEAEKAADESERGMK 95.00% 3.51 0.393 0 598.2825 1,791.82 1,792.84 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LEEAEKAADESERGMK 95.00% 3.46 0.437 0 598.283 1,791.83 1,792.84 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LEEAEKAADESERGMK 95.00% 3.67 0.392 0 598.2837 1,791.83 1,792.84 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LEEAEKAADESERGMK 95.00% 3.4 0.315 0 598.6157 1,792.82 1,792.84 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 1.98 0.407 1.06 601.297 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 2.26 0.452 1.4 601.2979 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 1.93 0.433 0 601.2982 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 2.09 0.394 0 601.2985 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 2.25 0.437 1.28 601.2986 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 2.42 0.567 1.8 601.632 1,801.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 2.3 0.506 1.04 601.6328 1,801.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 2.38 0.401 1.49 601.6329 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 1.98 0.283 0 601.6331 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 2.11 0.437 1.68 601.6331 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LEEAEKAADESERGmK 95.00% 3.05 0.368 0 m15: Oxidation (+15.99) 603.9519 1,808.83 1,808.83 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDR 95.00% 2.33 0.204 0 622.3283 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDR 95.00% 3.45 0.384 1.51 622.3286 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDR 95.00% 2.89 0.328 1.62 622.3288 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDR 95.00% 3.23 0.278 1.66 622.3294 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDR 95.00% 3.14 0.403 1.77 622.3299 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDR 95.00% 3.25 0.376 1.68 622.3303 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDR 95.00% 3.36 0.396 1.64 622.3303 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDR 95.00% 2.87 0.313 1.28 622.3325 1,242.65 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.6 0.383 1.17 628.6674 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.51 0.246 1.19 628.6678 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.31 0.299 0 628.6689 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 2.92 0.387 0 628.6712 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.7 0.359 0.959 629.0019 1,883.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.53 0.422 1.08 629.0021 1,883.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.34 0.418 0 629.0023 1,883.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.4 0.239 0 629.0025 1,883.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.68 0.429 0 629.0027 1,883.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.7 0.448 1.44 629.0031 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.35 0.303 0 629.0031 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.99 0.459 1.18 629.0034 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.41 0.149 0 629.0037 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.23 0.334 0 629.0055 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.78 0.374 0 629.0062 1,884.00 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% cAELEEELKTVTNNLK 95.00% 4.14 0.496 0 c1: Carbamidomethyl (+57.02) 630.9866 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% cAELEEELKTVTNNLK 95.00% 4.14 0.449 1.48 c1: Carbamidomethyl (+57.02) 631.3205 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% cAELEEELKTVTNNLK 95.00% 3.46 0.492 0 c1: Carbamidomethyl (+57.02) 631.3206 1,890.94 1,890.95 3 CO9_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% cAELEEELKTVTNNLK 95.00% 2.38 0.379 0 c1: Carbamidomethyl (+57.02) 631.3244 1,890.95 1,890.95 3 CO9_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LDKENALDRAEQAEADK 95.00% 3.19 0.344 0 639.6498 1,915.93 1,915.94 3 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LDKENALDRAEQAEADK 95.00% 3.54 0.437 1.14 639.6512 1,915.93 1,915.94 3 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AQKDEEKMEIQEIQLK 95.00% 4.69 0.48 1.25 654.0063 1,959.00 1,960.01 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AQKDEEKMEIQEIQLK 95.00% 4.91 0.133 0 654.3404 1,960.00 1,960.01 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AQKDEEKMEIQEIQLK 95.00% 3.64 0.422 0 654.3405 1,960.00 1,960.01 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AQKDEEKMEIQEIQLK 95.00% 3.75 0.285 0 654.3414 1,960.00 1,960.01 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AQKDEEKMEIQEIQLK 95.00% 4.07 0.172 0 654.3424 1,960.00 1,960.01 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% EAETRAEFAER 95.00% 2.05 0.345 0 654.8122 1,307.61 1,308.62 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KLVIIESDLER 95.00% 2.62 0.309 0 657.8446 1,313.67 1,314.76 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KLVIIESDLER 95.00% 2.86 0.343 2.82 657.8798 1,313.74 1,314.76 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KLVIIESDLER 95.00% 3.08 0.299 3.06 657.8822 1,313.75 1,314.76 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KLVIIESDLER 95.00% 3.26 0.328 2.77 657.8833 1,313.75 1,314.76 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KLVIIESDLER 95.00% 3.8 0.374 2.7 657.8845 1,313.75 1,314.76 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KLVIIESDLER 95.00% 3.93 0.374 2.59 657.8847 1,313.75 1,314.76 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KLVIIESDLER 95.00% 2.22 0.166 1.8 658.3296 1,314.64 1,314.76 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AQKDEEKmEIQEIQLK 95.00% 4.39 0.32 1.55 m8: Oxidation (+15.99) 659.3385 1,974.99 1,976.00 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AQKDEEKmEIQEIQLK 95.00% 4.47 0.284 1.35 m8: Oxidation (+15.99) 659.6712 1,975.99 1,976.00 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNR 95.00% 3.85 0.459 3.13 666.8219 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNR 95.00% 3.45 0.467 2.77 666.822 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNR 95.00% 4.03 0.45 2.68 666.8222 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNR 95.00% 3.61 0.438 3.42 666.8225 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNR 95.00% 4.46 0.458 3.7 666.8228 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNR 95.00% 3.31 0.437 3.82 666.8228 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNR 95.00% 4.41 0.487 3.8 666.8231 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNR 95.00% 2.95 0.44 2.17 666.8233 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% SLEAQAEKYSQK 95.00% 3.75 0.416 5.77 691.3505 1,380.69 1,381.70 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDR 95.00% 2.92 0.346 2.57 700.3797 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDR 95.00% 3.32 0.395 1.96 700.38 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDR 95.00% 3.23 0.336 2.85 700.3806 1,398.75 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDR 95.00% 3.13 0.369 2.02 700.3811 1,398.75 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDR 95.00% 2.96 0.359 2.77 700.8807 1,399.75 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEK 95.00% 4.16 0.502 2.57 722.4057 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEK 95.00% 4.2 0.476 2.47 722.4062 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEK 95.00% 2.27 0.155 1.1 722.4071 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEK 95.00% 3.63 0.393 2.18 722.4074 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEK 95.00% 3.52 0.411 2.68 722.408 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNR 95.00% 3.09 0.505 4.13 730.8676 1,459.72 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNR 95.00% 4.4 0.582 4.62 730.8679 1,459.72 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNR 95.00% 4.41 0.548 3.62 730.8699 1,459.72 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNR 95.00% 4.56 0.517 4.42 730.8705 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNR 95.00% 4.01 0.553 3.6 730.8706 1,459.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEKAADESER 95.00% 4.56 0.559 3.7 735.0465 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEKAADESER 95.00% 4.92 0.581 4.7 735.0469 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEKAADESER 95.00% 4.81 0.582 4.59 735.0471 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEKAADESER 95.00% 4.67 0.577 4.07 735.0472 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LEEAEKAADESER 95.00% 4.04 0.496 4.27 738.8461 1,475.68 1,476.68 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNRR 95.00% 2.4 0.23 1.34 744.8726 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNRR 95.00% 2.49 0.284 0 744.8749 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ATDAEADVASLNRR 95.00% 2.25 0.269 0 744.875 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% SKQLEDELVSLQK 95.00% 3.88 0.331 2 758.9142 1,515.81 1,516.82 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% SKQLEDELVSLQK 95.00% 4.42 0.338 2.22 759.4135 1,516.81 1,516.82 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LKEAETRAEFAER 95.00% 3.38 0.283 1.24 775.4004 1,548.79 1,549.80 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LKEAETRAEFAER 95.00% 3.37 0.317 0 775.901 1,549.79 1,549.80 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNRR 95.00% 2.94 0.392 0 808.9194 1,615.82 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KATDAEADVASLNRR 95.00% 2.68 0.281 0 809.422 1,616.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LVIIESDLERAEER 95.00% 2.84 0.293 0 836.9508 1,671.89 1,671.89 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ENALDRAEQAEADKK 95.00% 4.04 0.473 1.62 844.4151 1,686.81 1,687.83 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% ENALDRAEQAEADKK 95.00% 4.04 0.458 1.96 844.4153 1,686.82 1,687.83 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% YSQKEDRYEEEIK 95.00% 4.37 0.279 2.66 858.9061 1,715.80 1,716.81 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% YSQKEDRYEEEIK 95.00% 4.63 0.311 3.09 858.9065 1,715.80 1,716.81 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDRAQER 95.00% 3.53 0.215 0 864.4478 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDRAQER 95.00% 4.48 0.345 1.37 864.4483 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDRAQER 95.00% 3.59 0.258 0 864.4488 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDRAQER 95.00% 3.74 0.33 0 864.4488 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDRAQER 95.00% 3.74 0.326 0 864.4497 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDRAQER 95.00% 3.66 0.226 1.09 864.9501 1,727.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDRAQER 95.00% 3.62 0.206 0 864.9506 1,727.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDRAQER 95.00% 3.7 0.242 0 864.9524 1,727.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% IQLVEEELDRAQER 95.00% 3.28 0.312 0 864.9552 1,727.89 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AELSEGKcAELEEELKTVTNNLK 95.00% 5.83 0.554 2.82 c8: Carbamidomethyl (+57.02) 869.4388 2,605.29 2,605.30 3
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KLVIIESDLERAEER 95.00% 3.74 0.0999 0 900.4955 1,798.98 1,799.99 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% KLVIIESDLERAEER 95.00% 3.85 0.14 0 900.9976 1,799.98 1,799.99 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 2.98 0.403 2 901.4425 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 3.65 0.481 2.49 901.4435 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 2.91 0.473 2.07 901.4436 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 3.76 0.505 2.77 901.4447 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% HIAEDADRKYEEVAR 95.00% 3.69 0.486 2.34 901.946 1,801.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 2.52 0.251 0 942.4976 1,882.98 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 2.87 0.364 0 942.9986 1,883.98 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% RIQLVEEELDRAQER 95.00% 3.33 0.415 1.11 943.0002 1,883.98 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% cAELEEELKTVTNNLK 95.00% 5.12 0.448 2.77 c1: Carbamidomethyl (+57.02) 945.9749 1,889.93 1,890.95 2 CO9_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% cAELEEELKTVTNNLK 95.00% 5.84 0.44 2.82 c1: Carbamidomethyl (+57.02) 945.9762 1,889.94 1,890.95 2 CO9_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% cAELEEELKTVTNNLK 95.00% 5.63 0.389 3.51 c1: Carbamidomethyl (+57.02) 946.477 1,890.94 1,890.95 2 CO9_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LDKENALDRAEQAEADK 95.00% 5.13 0.518 5.89 958.4729 1,914.93 1,915.94 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LDKENALDRAEQAEADK 95.00% 5.03 0.485 6.36 958.9707 1,915.93 1,915.94 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AQKDEEKMEIQEIQLK 95.00% 5.96 0.447 3.49 980.5047 1,958.99 1,960.01 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AQKDEEKMEIQEIQLK 95.00% 5.46 0.284 2.44 981.0044 1,959.99 1,960.01 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AQKDEEKmEIQEIQLK 95.00% 5.48 0.537 3.25 m8: Oxidation (+15.99) 988.4997 1,974.98 1,976.00 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% AQKDEEKmEIQEIQLK 95.00% 5.4 0.466 3.4 m8: Oxidation (+15.99) 988.5018 1,974.99 1,976.00 2
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LDKENALDRAEQAEADKK 95.00% 0 0 3.39 1,022.52 2,043.02 2,044.03 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LDKENALDRAEQAEADKK 95.00% 0 0 3.43 1,023.02 2,044.02 2,044.03 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LDKENALDRAEQAEADKK 95.00% 0 0 3.48 1,023.02 2,044.02 2,044.03 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEKAADESER 95.00% 5.32 0.672 7.57 1,102.06 2,202.11 2,202.13 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 15 20 64 69.40% LATALQKLEEAEKAADESER 95.00% 5.19 0.644 6.85 1,102.07 2,202.12 2,202.13 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 4.4 0.42 0 467.2555 1,398.74 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 3.18 0.379 0 467.2561 1,398.74 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 4.69 0.395 0 467.2562 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 3.33 0.301 0 467.2569 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 3.41 0.371 0 467.2572 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 3.42 0.447 0 467.2576 1,398.75 1,399.75 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEK 95.00% 2.9 0.466 0 481.9397 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEK 95.00% 2.26 0.352 0 481.9397 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEK 95.00% 1.89 0.22 0 481.9399 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEK 95.00% 2.33 0.194 0 481.9412 1,442.80 1,443.81 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNR 95.00% 3.26 0.208 0 487.5817 1,459.72 1,460.73 3 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LEEAEKAADESER 95.00% 1.87 0.26 0 492.9 1,475.68 1,476.68 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LEEAEKAADESER 95.00% 2.03 0.229 0 492.9008 1,475.68 1,476.68 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNRR 95.00% 2.45 0.239 1.13 496.9168 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNRR 95.00% 2.02 0.144 1 496.9175 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNRR 95.00% 1.9 0.248 1.19 496.9175 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNRR 95.00% 1.89 0.291 0 496.9176 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNRR 95.00% 1.64 0.262 0 496.9177 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNRR 95.00% 1.87 0.283 0 496.9183 1,487.73 1,488.74 3 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% SKQLEDELVSLQK 95.00% 4.49 0.343 0 506.2784 1,515.81 1,516.82 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% YEEEIKVLSDKLK 95.00% 3.24 0.471 0 532.2962 1,593.87 1,593.87 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNRR 95.00% 2.38 0.237 0 539.6148 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNRR 95.00% 2.21 0.194 0 539.6151 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNRR 94.70% 2.15 0.187 0 539.6154 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNRR 95.00% 2.07 0.212 0 539.6156 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNRR 95.00% 2.3 0.259 0 539.6159 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNRR 95.00% 2.55 0.207 0 539.6163 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNRR 95.00% 1.64 0.192 1.11 539.6164 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNRR 95.00% 2.31 0.234 0 539.6167 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% SKQLEDELVSLQKK 95.00% 4.47 0.434 3.57 548.9757 1,643.90 1,644.92 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% SKQLEDELVSLQKK 95.00% 4.33 0.493 1.49 548.9763 1,643.91 1,644.92 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% SKQLEDELVSLQKK 95.00% 4.63 0.462 1.54 548.9773 1,643.91 1,644.92 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ENALDRAEQAEADKK 95.00% 3.93 0.42 0 563.2787 1,686.81 1,687.83 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ENALDRAEQAEADKK 95.00% 4.4 0.457 0 563.6122 1,687.81 1,687.83 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% MEIQEIQLK 95.00% 2.69 0.236 0 566.305 1,130.59 1,131.61 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% MEIQEIQLK 95.00% 3.26 0.284 0 566.3066 1,130.60 1,131.61 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% MEIQEIQLK 95.00% 3.23 0.295 0 566.307 1,130.60 1,131.61 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% MEIQEIQLK 95.00% 2.55 0.189 0 566.3074 1,130.60 1,131.61 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% MQMLKLDKENALDR 95.00% 2.92 0.333 0 568.9644 1,703.87 1,704.88 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% YSQKEDRYEEEIK 95.00% 2.93 0.321 0 572.9399 1,715.80 1,716.81 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% YSQKEDRYEEEIK 95.00% 3.39 0.312 0 572.9404 1,715.80 1,716.81 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LVIIESDLER 95.00% 3.41 0.415 2.24 593.8363 1,185.66 1,186.67 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LVIIESDLER 95.00% 3.68 0.437 1.89 593.8368 1,185.66 1,186.67 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LVIIESDLER 95.00% 3.67 0.431 1.74 593.8369 1,185.66 1,186.67 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LVIIESDLER 95.00% 3.36 0.45 1.77 593.8372 1,185.66 1,186.67 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% SLEAQAEKYSQKEDR 95.00% 3.3 0.36 0 594.6261 1,780.85 1,781.87 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LEEAEKAADESERGMK 95.00% 3.68 0.322 1.4 598.2838 1,791.83 1,792.84 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LEEAEKAADESERGMK 95.00% 3.39 0.322 2.92 598.2842 1,791.83 1,792.84 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KLVIIESDLERAEER 95.00% 2.71 0.106 1.36 600.6663 1,798.98 1,799.99 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KLVIIESDLERAEER 95.00% 3.07 0.116 1.54 600.6666 1,798.98 1,799.99 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 2.05 0.407 0 601.2957 1,800.86 1,801.88 3 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 2.16 0.379 0 601.2977 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 2.22 0.505 0 601.2983 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 1.91 0.389 0 601.2988 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 1.66 0.254 0 601.2991 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 2.5 0.544 1.32 601.2991 1,800.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 2.24 0.538 1.43 601.632 1,801.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 2.12 0.383 0 601.6326 1,801.87 1,801.88 3 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 1.92 0.469 1.62 601.6328 1,801.88 1,801.88 3 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LEEAEKAADESERGmK 95.00% 2.48 0.365 0 m15: Oxidation (+15.99) 603.618 1,807.83 1,808.83 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% IQLVEEELDR 95.00% 2.69 0.249 1.48 622.3284 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% IQLVEEELDR 95.00% 3.33 0.402 1.48 622.3293 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% IQLVEEELDR 95.00% 3.37 0.382 1.54 622.3294 1,242.64 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% IQLVEEELDR 95.00% 2.67 0.183 0 622.7936 1,243.57 1,243.65 2 TPM2_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 3.62 0.429 1.41 628.6683 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 3.88 0.401 1.36 628.6685 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 3.78 0.445 1.15 628.6689 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 4.07 0.411 0.959 628.669 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 3.77 0.46 0.959 628.669 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 3.46 0.292 0 628.6694 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 3.45 0.285 0 628.6694 1,882.98 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 3.86 0.479 0 628.6697 1,882.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 2.61 0.23 0 628.8526 1,883.53 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 3.33 0.371 0 629.0029 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 3.3 0.46 0 629.0033 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 3.02 0.235 0 629.0036 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 3.49 0.397 1.54 629.0045 1,883.99 1,883.99 3 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% cAELEEELKTVTNNLK 95.00% 2.1 0.296 0 c1: Carbamidomethyl (+57.02) 630.9855 1,889.93 1,890.95 3 CO9_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% cAELEEELKTVTNNLK 95.00% 4.18 0.386 2.52 c1: Carbamidomethyl (+57.02) 630.9869 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% cAELEEELKTVTNNLK 95.00% 3.86 0.529 1.04 c1: Carbamidomethyl (+57.02) 630.9873 1,889.94 1,890.95 3 CO9_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LDKENALDRAEQAEADK 95.00% 3.22 0.414 1.55 639.3169 1,914.93 1,915.94 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LDKENALDRAEQAEADK 95.00% 3.44 0.363 0 639.651 1,915.93 1,915.94 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKMEIQEIQLK 95.00% 4.68 0.31 1.92 654.0058 1,958.99 1,960.01 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKMEIQEIQLK 95.00% 4.72 0.358 1.66 654.0062 1,959.00 1,960.01 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKMEIQEIQLK 95.00% 2.49 0.226 0 654.3308 1,959.97 1,960.01 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKMEIQEIQLK 95.00% 3.93 0.457 0 654.3397 1,960.00 1,960.01 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKMEIQEIQLK 95.00% 2.87 0.236 0 654.3399 1,960.00 1,960.01 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKMEIQEIQLK 95.00% 4.77 0.268 0 654.34 1,960.00 1,960.01 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKMEIQEIQLK 95.00% 4.87 0.32 0 654.3415 1,960.00 1,960.01 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% EAETRAEFAER 95.00% 2.18 0.313 0 654.8123 1,307.61 1,308.62 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KLVIIESDLER 95.00% 3.43 0.357 3.1 657.8825 1,313.75 1,314.76 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KLVIIESDLER 95.00% 3.57 0.382 3.29 657.8838 1,313.75 1,314.76 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KLVIIESDLER 95.00% 3.45 0.36 3.39 657.8853 1,313.75 1,314.76 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KLVIIESDLER 95.00% 3.65 0.334 2.21 657.8855 1,313.76 1,314.76 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KLVIIESDLER 95.00% 3.35 0.332 2 657.8864 1,313.76 1,314.76 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKmEIQEIQLK 95.00% 4.44 0.278 1.26 m8: Oxidation (+15.99) 659.6725 1,975.99 1,976.00 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKmEIQEIQLK 95.00% 4.06 0.28 0 m8: Oxidation (+15.99) 659.6727 1,975.99 1,976.00 3
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNR 95.00% 3.3 0.46 4.23 666.8211 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNR 95.00% 3.28 0.435 2.07 666.8227 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNR 95.00% 3.31 0.428 2.52 666.8228 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNR 95.00% 3.52 0.448 2.33 666.823 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNR 95.00% 3.14 0.44 4.59 666.8231 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNR 95.00% 2.1 0.317 2.49 666.8233 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 3.35 0.417 2.3 700.3783 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 2.87 0.298 2.14 700.3784 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 2.98 0.361 3.11 700.3792 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 3.14 0.365 2.92 700.3796 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 3.27 0.366 2.51 700.3796 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 3.11 0.352 2.66 700.3799 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 2.61 0.234 0 700.3802 1,398.74 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDR 95.00% 3.13 0.313 1.62 700.3806 1,398.75 1,399.75 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEK 95.00% 2.98 0.326 2.82 722.4058 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEK 95.00% 3.86 0.454 3.38 722.4062 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEK 95.00% 4.11 0.505 2.35 722.4063 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEK 95.00% 3.28 0.42 3.14 722.407 1,442.80 1,443.81 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNR 95.00% 4.31 0.554 3.43 730.8667 1,459.72 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNR 95.00% 4.07 0.57 3.21 730.8692 1,459.72 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNR 95.00% 4.61 0.548 3.13 730.8698 1,459.72 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNR 95.00% 4.29 0.489 3.28 731.3744 1,460.73 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNR 95.00% 2.53 0.439 3.42 731.3768 1,460.74 1,460.73 2 CSPG2_HUMAN,DYHC1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEKAADESER 95.00% 2.15 0.417 0 734.3678 2,200.08 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEKAADESER 95.00% 2.07 0.394 0 734.3701 2,200.09 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEKAADESER 95.00% 4.23 0.536 5.6 735.0469 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEKAADESER 95.00% 5.37 0.586 5.89 735.0474 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEKAADESER 95.00% 4.51 0.558 4.85 735.048 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEKAADESER 95.00% 4.25 0.585 5.77 735.0487 2,202.12 2,202.13 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LEEAEKAADESER 95.00% 4.08 0.529 4 738.8451 1,475.67 1,476.68 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LEEAEKAADESER 95.00% 4.1 0.493 3.92 738.8466 1,475.68 1,476.68 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNRR 95.00% 2.24 0.256 1.44 744.8725 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNRR 95.00% 2.31 0.222 1.25 744.8731 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNRR 95.00% 2.66 0.242 1.28 744.8735 1,487.73 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ATDAEADVASLNRR 95.00% 2.24 0.311 0 744.8757 1,487.74 1,488.74 2 TPM2_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% SKQLEDELVSLQK 95.00% 3.94 0.344 2.59 758.9146 1,515.81 1,516.82 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LKEAETRAEFAER 95.00% 3.53 0.357 0 775.4013 1,548.79 1,549.80 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LKEAETRAEFAER 95.00% 3.75 0.332 0 775.4023 1,548.79 1,549.80 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNRR 95.00% 2.63 0.239 0 808.9193 1,615.82 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNRR 95.00% 3.03 0.376 0 808.9199 1,615.82 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNRR 95.00% 3.01 0.395 0 808.92 1,615.82 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KATDAEADVASLNRR 95.00% 2.86 0.233 0 808.9209 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LVIIESDLERAEER 95.00% 2.9 0.243 0 836.9477 1,671.88 1,671.89 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEKAADESERGMK 95.00% 0 0 3.8 840.4336 2,518.28 2,518.28 3 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ENALDRAEQAEADKK 95.00% 4.06 0.461 3.54 844.4165 1,686.82 1,687.83 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% ENALDRAEQAEADKK 95.00% 4.12 0.431 2.64 844.4166 1,686.82 1,687.83 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% YSQKEDRYEEEIK 95.00% 3.71 0.254 2.1 858.9057 1,715.80 1,716.81 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% YSQKEDRYEEEIK 95.00% 4.4 0.237 2.46 859.4079 1,716.80 1,716.81 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% IQLVEEELDRAQER 95.00% 3.26 0.247 0 864.4474 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% IQLVEEELDRAQER 95.00% 3.61 0.266 0 864.4484 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% IQLVEEELDRAQER 95.00% 2.85 0.243 0 864.4491 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% IQLVEEELDRAQER 95.00% 3.93 0.32 0 864.4492 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% IQLVEEELDRAQER 95.00% 4.03 0.364 1.33 864.4495 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% IQLVEEELDRAQER 95.00% 3.83 0.247 2.11 864.4497 1,726.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% IQLVEEELDRAQER 95.00% 3.5 0.217 0 864.9496 1,727.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% IQLVEEELDRAQER 95.00% 3.99 0.355 0 864.9497 1,727.88 1,727.89 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LEEAEKAADESERGMK 95.00% 5.18 0.567 3.82 896.9219 1,791.83 1,792.84 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LEEAEKAADESERGMK 95.00% 4.77 0.521 3.7 896.9232 1,791.83 1,792.84 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% KLVIIESDLERAEER 95.00% 3.78 0.301 1.39 900.4964 1,798.98 1,799.99 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 4.04 0.553 2.66 901.4437 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 4.09 0.562 3.33 901.4438 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 3.74 0.495 2.85 901.4438 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 4.24 0.565 2.8 901.4442 1,800.87 1,801.88 2 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 2.98 0.402 1.96 901.446 1,800.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 3.66 0.507 2.2 901.4464 1,800.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% HIAEDADRKYEEVAR 95.00% 3.74 0.487 2.2 901.9467 1,801.88 1,801.88 2 HSP71_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% cAELEEELKTVTNNLK 94.80% 0 0 3.14 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 937.4624 1,872.91 1,873.92 2 CO9_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 2.28 0.217 1.41 942.505 1,882.99 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% RIQLVEEELDRAQER 95.00% 3.17 0.382 0 942.9998 1,883.98 1,883.99 2 PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% cAELEEELKTVTNNLK 95.00% 5.87 0.39 4.15 c1: Carbamidomethyl (+57.02) 946.4776 1,890.94 1,890.95 2 CO9_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% cAELEEELKTVTNNLK 95.00% 5.47 0.398 2.36 c1: Carbamidomethyl (+57.02) 946.4776 1,890.94 1,890.95 2 CO9_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LDKENALDRAEQAEADK 95.00% 5.35 0.529 4.7 958.9694 1,915.92 1,915.94 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LDKENALDRAEQAEADK 95.00% 4.98 0.492 4.77 958.9708 1,915.93 1,915.94 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKMEIQEIQLK 95.00% 6.37 0.47 2.22 980.5038 1,958.99 1,960.01 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKMEIQEIQLK 95.00% 6.06 0.416 3.4 980.5046 1,958.99 1,960.01 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKmEIQEIQLK 95.00% 5.09 0.411 3.17 m8: Oxidation (+15.99) 988.5035 1,974.99 1,976.00 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% AQKDEEKmEIQEIQLK 95.00% 5.21 0.29 3.34 m8: Oxidation (+15.99) 989.0056 1,976.00 1,976.00 2
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LDKENALDRAEQAEADKK 95.00% 0 0 3.92 1,022.52 2,043.02 2,044.03 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LDKENALDRAEQAEADKK 94.70% 0 0 3.13 1,022.52 2,043.02 2,044.03 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LDKENALDRAEQAEADKK 95.00% 0 0 4.15 1,023.02 2,044.02 2,044.03 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEKAADESER 95.00% 4.95 0.634 6.64 1,102.06 2,202.11 2,202.13 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin alpha-1 chain  TPM1  TPM1_HUMAN 32,692.00 100.00% 13 19 63 66.90% LATALQKLEEAEKAADESER 95.00% 5.37 0.661 5.96 1,102.07 2,202.12 2,202.13 2 TPM2_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDR 95.00% 4.5 0.438 0 467.2581 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDR 95.00% 4.58 0.409 0 467.2589 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDR 95.00% 3.99 0.469 1.19 467.2591 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDR 95.00% 4.22 0.401 1.02 467.2602 1,398.76 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDR 95.00% 2.13 0.32 0 467.2605 1,398.76 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% LATALQKLEEAEK 95.00% 2.68 0.517 0 481.9415 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% LATALQKLEEAEK 95.00% 3.25 0.458 0 481.9422 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% LATALQKLEEAEK 95.00% 2.4 0.424 0 481.9425 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% LATALQKLEEAEK 95.00% 2.33 0.336 0 481.9426 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% IQLVEEELDRAQER 95.00% 1.9 0.267 0 576.6375 1,726.89 1,727.89 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% KIQALQQQADEAEDR 95.00% 4.77 0.513 2.55 581.628 1,741.86 1,742.87 3
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% KIQALQQQADEAEDR 95.00% 5.07 0.585 2.8 581.962 1,742.86 1,742.87 3
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% MEIQEmQLK 95.00% 2.46 0.216 0 m6: Oxidation (+15.99) 583.2835 1,164.55 1,165.56 2 TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% MEIQEmQLK 95.00% 2.3 0.211 0 m6: Oxidation (+15.99) 583.2843 1,164.55 1,165.56 2 TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% HIAEEADRKYEEVAR 95.00% 1.88 0.23 0 605.9731 1,814.90 1,815.90 3
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% HIAEEADRKYEEVAR 95.00% 1.96 0.133 1.66 605.9749 1,814.90 1,815.90 3
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% HIAEEADRKYEEVAR 95.00% 1.56 0.245 1 606.3082 1,815.90 1,815.90 3
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% HIAEEADRKYEEVAR 95.00% 2.1 0.197 0.959 606.3086 1,815.90 1,815.90 3
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% IQLVEEELDR 95.00% 3.01 0.319 1.64 622.3319 1,242.65 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% IQLVEEELDR 95.00% 3.13 0.33 2.42 622.3322 1,242.65 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% IQLVEEELDR 95.00% 3.34 0.367 1.89 622.3322 1,242.65 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% IQLVEEELDR 95.00% 3.26 0.361 1.96 622.3322 1,242.65 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDRAQER 95.00% 3.66 0.293 0 628.671 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDRAQER 95.00% 3.49 0.374 0 628.6712 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDRAQER 95.00% 3.64 0.442 1 628.6717 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDRAQER 95.00% 3.85 0.403 1.12 628.6719 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDRAQER 95.00% 3.85 0.428 0 628.6719 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDRAQER 95.00% 3.18 0.28 0 629.0048 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDRAQER 95.00% 3.93 0.418 0 629.0054 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDRAQER 95.00% 3.99 0.29 1.82 629.0056 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDRAQER 95.00% 3.12 0.227 0 629.0062 1,884.00 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDRAQER 95.00% 4.05 0.314 1.1 629.0067 1,884.00 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% AmKDEEKmEIQEmQLK 95.00% 2.46 0.236 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 676.9864 2,027.94 2,028.93 3 TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% AmKDEEKmEIQEmQLK 95.00% 2.8 0.359 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 676.9866 2,027.94 2,028.93 3 TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% AmKDEEKmEIQEmQLK 95.00% 3.05 0.466 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3188 2,028.93 2,028.93 3 TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% AmKDEEKmEIQEmQLK 95.00% 2.77 0.379 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3199 2,028.94 2,028.93 3 TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% AmKDEEKmEIQEmQLK 95.00% 3.18 0.315 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3212 2,028.94 2,028.93 3 TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% LATALQKLEEAEK 95.00% 4.08 0.375 3.02 722.4081 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% LATALQKLEEAEK 95.00% 3.94 0.413 4.52 722.4091 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% LATALQKLEEAEK 95.00% 4.11 0.487 2.82 722.4094 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% LATALQKLEEAEK 95.00% 4.16 0.465 2.04 722.4101 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% LATALQKLEEAEK 95.00% 3.46 0.282 1.77 722.4118 1,442.81 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% LATALQKLEEAEK 95.00% 3.69 0.35 1.43 722.4137 1,442.81 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% LATALQKLEEAEKAADESER 95.00% 4.61 0.58 5.7 735.0493 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% LATALQKLEEAEKAADESER 95.00% 4.09 0.56 3.7 735.0499 2,202.13 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% IQLVEEELDRAQER 95.00% 3.95 0.295 0 864.4526 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% IQLVEEELDRAQER 95.00% 3.68 0.268 0 864.9528 1,727.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% IQLVEEELDRAQER 95.00% 3.63 0.199 0 864.9543 1,727.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% IQLVEEELDRAQER 95.00% 3.61 0.274 1.59 864.9543 1,727.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% IQLVEEELDRAQER 95.00% 4.1 0.236 0 864.9566 1,727.90 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDRAQER 95.00% 2.57 0.268 1.74 943.0053 1,883.99 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% RIQLVEEELDRAQER 95.00% 3.06 0.254 1.72 943.0057 1,884.00 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% AmKDEEKmEIQEmQLK 95.00% 3.71 0.45 2.6 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 1,015.47 2,028.92 2,028.93 2 TPM2_HUMAN
 SAMPLE 4 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 6 32.70% AmKDEEKmEIQEmQLK 95.00% 2.75 0.329 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 1,015.48 2,028.94 2,028.93 2 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDR 95.00% 3.39 0.385 1.41 467.258 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDR 95.00% 4.05 0.422 0 467.2582 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDR 95.00% 3.37 0.368 0 467.2591 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDR 95.00% 4.24 0.439 1.96 467.2591 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDR 95.00% 3.94 0.442 0 467.26 1,398.76 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDR 95.00% 4.23 0.387 1.11 467.2609 1,398.76 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% LATALQKLEEAEK 95.00% 2.64 0.462 0 481.9422 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% LATALQKLEEAEK 95.00% 2.54 0.4 0 481.9423 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% LATALQKLEEAEK 95.00% 2.5 0.453 0 481.9424 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% LATALQKLEEAEK 95.00% 2.13 0.274 0 482.2763 1,443.81 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% LATALQKLEEAEK 95.00% 2.49 0.339 0 482.2775 1,443.81 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDRAQER 95.00% 1.81 0.26 1.07 576.6376 1,726.89 1,727.89 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDRAQER 95.00% 1.83 0.283 0 576.9722 1,727.89 1,727.89 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% KIQALQQQADEAEDR 95.00% 4.64 0.541 3.26 581.6302 1,741.87 1,742.87 3
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% KIQALQQQADEAEDR 95.00% 5.16 0.556 3.85 581.9631 1,742.87 1,742.87 3
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% MEIQEmQLK 95.00% 2.29 0.197 0 m6: Oxidation (+15.99) 583.2837 1,164.55 1,165.56 2 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% HIAEEADRKYEEVAR 95.00% 1.94 0.405 0 605.9724 1,814.89 1,815.90 3
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% HIAEEADRKYEEVAR 95.00% 2.22 0.3 0 605.9731 1,814.90 1,815.90 3
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% HIAEEADRKYEEVAR 95.00% 2.28 0.112 1.34 606.308 1,815.90 1,815.90 3
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDR 95.00% 2.98 0.382 2.25 622.3294 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDR 95.00% 3.24 0.338 1.54 622.3318 1,242.65 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDR 95.00% 3.03 0.371 1.92 622.3333 1,242.65 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDRAQER 95.00% 3.79 0.374 0 628.6716 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDRAQER 95.00% 3.43 0.437 0 628.6716 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDRAQER 95.00% 3.78 0.321 0 628.6719 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDRAQER 95.00% 3.36 0.393 0 628.6721 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDRAQER 95.00% 3.43 0.319 0 628.6729 1,883.00 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDRAQER 95.00% 3.15 0.383 0 629.0051 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDRAQER 95.00% 3.26 0.266 1.01 629.0057 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDRAQER 95.00% 2.61 0.341 0 629.0095 1,884.01 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% KLVILEGELER 95.00% 2.39 0.357 0 649.8902 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% KLVILEGELER 95.00% 3.43 0.394 4.57 649.8902 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% KLVILEGELER 95.00% 3.16 0.449 3.4 649.8907 1,297.77 1,298.77 2 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% KLVILEGELER 95.00% 2.83 0.398 1.35 649.8911 1,297.77 1,298.77 2 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% AmKDEEKmEIQEmQLK 95.00% 3.04 0.391 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 676.9861 2,027.93 2,028.93 3 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% AmKDEEKmEIQEmQLK 95.00% 2.64 0.335 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3202 2,028.94 2,028.93 3 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% AmKDEEKmEIQEmQLK 95.00% 2.64 0.384 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3207 2,028.94 2,028.93 3 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% AmKDEEKmEIQEmQLK 95.00% 3.01 0.28 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3209 2,028.94 2,028.93 3 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% LATALQKLEEAEK 95.00% 4.21 0.416 2.8 722.4098 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% LATALQKLEEAEK 95.00% 4.21 0.446 3.15 722.4103 1,442.81 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% LATALQKLEEAEK 95.00% 4.04 0.466 1.85 722.4117 1,442.81 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% LATALQKLEEAEK 95.00% 3.45 0.346 1.62 722.4117 1,442.81 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% LATALQKLEEAEK 95.00% 3.55 0.359 1.37 722.9103 1,443.81 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% LATALQKLEEAEK 95.00% 3.87 0.377 2.22 722.9113 1,443.81 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDRAQER 95.00% 3.54 0.138 0 864.4518 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDRAQER 95.00% 2.95 0.179 0 864.4522 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDRAQER 95.00% 3.77 0.274 1.54 864.4522 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDRAQER 95.00% 3.89 0.337 0 864.4524 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDRAQER 95.00% 3.98 0.298 1.74 864.4528 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDRAQER 95.00% 3.84 0.26 1.6 864.4531 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDRAQER 95.00% 3.88 0.245 0 864.4549 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% IQLVEEELDRAQER 95.00% 2.92 0.216 0 864.455 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% RIQLVEEELDRAQER 95.00% 2.78 0.304 1.7 943.0033 1,883.99 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% AmKDEEKmEIQEmQLK 95.00% 3.42 0.518 3 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 1,015.47 2,028.93 2,028.93 2 TPM2_HUMAN
 SAMPLE 4R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 99.80% 2 2 5 34.30% AmKDEEKmEIQEmQLK 95.00% 3.63 0.457 1.89 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 1,015.47 2,028.93 2,028.93 2 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% RIQLVEEELDR 95.00% 4.3 0.395 1.05 467.2589 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% LATALQKLEEAEK 94.70% 2.31 0.252 0 481.9409 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% KIQALQQQADEAEDR 95.00% 4.97 0.568 2.21 581.6287 1,741.86 1,742.87 3
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% KIQALQQQADEAEDR 95.00% 1.7 0.361 0 581.9626 1,742.86 1,742.87 3
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% LVILEGELER 95.00% 2.5 0.319 0 586.056 1,170.10 1,170.67 2 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% LVILEGELER 95.00% 1.87 0.417 0 586.0614 1,170.11 1,170.67 2 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% LVILEGELER 95.00% 2.9 0.349 0 586.0625 1,170.11 1,170.67 2 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% HIAEEADRKYEEVAR 95.00% 2 0.418 1 605.9692 1,814.88 1,815.90 3
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% HIAEEADRKYEEVAR 95.00% 2.77 0.572 1.2 605.9702 1,814.89 1,815.90 3
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQLVEEELDR 95.00% 2.31 0.295 1.35 622.3275 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQLVEEELDR 95.00% 2.6 0.301 0 622.3277 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQLVEEELDR 95.00% 2.67 0.252 2.55 622.3281 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQLVEEELDR 95.00% 2.77 0.355 1.29 622.3286 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQLVEEELDR 95.00% 3.06 0.327 2.04 622.3288 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQLVEEELDR 95.00% 2.46 0.158 1.92 622.9897 1,243.96 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% cGDLEEELKNVTNNLK 95.00% 5.56 0.173 0 c1: Carbamidomethyl (+57.02) 625.974 1,874.90 1,875.91 3 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% cGDLEEELKNVTNNLK 95.00% 4.5 0.158 0 c1: Carbamidomethyl (+57.02) 625.9856 1,874.93 1,875.91 3 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% cGDLEEELKNVTNNLK 95.00% 5.5 0.203 0 c1: Carbamidomethyl (+57.02) 625.9873 1,874.94 1,875.91 3 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% cGDLEEELKNVTNNLK 95.00% 5.11 0.46 3.08 c1: Carbamidomethyl (+57.02) 626.308 1,875.90 1,875.91 3 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% cGDLEEELKNVTNNLK 95.00% 4.74 0.541 0 c1: Carbamidomethyl (+57.02) 626.3141 1,875.92 1,875.91 3 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% RIQLVEEELDRAQER 95.00% 3.58 0.261 0 628.6689 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% RIQLVEEELDRAQER 95.00% 3.56 0.358 0 628.6691 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% RIQLVEEELDRAQER 95.00% 3.92 0.37 0.959 628.672 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% RIQLVEEELDRAQER 95.00% 3.92 0.354 0 629.0012 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% RIQLVEEELDRAQER 95.00% 3.82 0.372 2.03 629.0013 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% RIQLVEEELDRAQER 95.00% 4.05 0.392 0 629.0026 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% KLVILEGELER 95.00% 3.83 0.451 3.06 649.8864 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% KLVILEGELER 95.00% 3.97 0.453 3.74 649.8866 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% KLVILEGELER 95.00% 3.15 0.399 1.96 649.8879 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% KLVILEGELER 95.00% 3.86 0.448 3.24 649.8945 1,297.77 1,298.77 2 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% KLVILEGELER 95.00% 3.85 0.455 3.59 649.8954 1,297.78 1,298.77 2 TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% RIQLVEEELDR 95.00% 3.81 0.415 3.11 700.3786 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% RIQLVEEELDR 95.00% 3.27 0.359 1.96 700.3824 1,398.75 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% RIQLVEEELDR 95.00% 2.82 0.426 3.37 700.3833 1,398.75 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% LATALQKLEEAEK 95.00% 4.17 0.486 2.21 722.4055 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% LATALQKLEEAEK 95.00% 4.01 0.431 0 722.4107 1,442.81 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% LATALQKLEEAEK 95.00% 3.51 0.383 1.8 722.9082 1,443.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% LATALQKLEEAEKAADESER 95.00% 4.89 0.631 4.72 734.7192 2,201.13 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% LATALQKLEEAEKAADESER 95.00% 4.95 0.621 5.54 735.0455 2,202.11 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% LATALQKLEEAEKAADESER 95.00% 4.38 0.571 4.39 735.0457 2,202.11 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% LATALQKLEEAEKAADESER 95.00% 4.46 0.45 5.07 735.0531 2,202.14 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQALQQQADEAEDRAQGLQR 95.00% 3.2 0.281 2.44 757.0533 2,268.14 2,268.13 3
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQALQQQADEAEDR 95.00% 4.72 0.566 3.82 807.8916 1,613.77 1,614.77 2
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% LVILEGELERAEER 94.70% 2.46 0.218 0 828.4495 1,654.88 1,655.90 2
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQLVEEELDRAQER 95.00% 3.96 0.348 0 864.4477 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQLVEEELDRAQER 95.00% 4.3 0.335 2.46 864.4486 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQLVEEELDRAQER 95.00% 3.28 0.141 0 864.45 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQLVEEELDRAQER 95.00% 3.23 0.13 0 864.4565 1,726.90 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% IQLVEEELDRAQER 95.00% 3.71 0.189 0 864.9496 1,727.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% HIAEEADRKYEEVAR 95.00% 2.82 0.387 1.11 908.9554 1,815.90 1,815.90 2
 SAMPLE 1 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 6 8 41.10% RIQLVEEELDRAQER 95.00% 2.78 0.331 1.64 942.4986 1,882.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% RIQLVEEELDR 95.00% 4.3 0.395 1.52 467.2589 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% KIQALQQQADEAEDR 95.00% 4.97 0.568 2.14 581.6287 1,741.86 1,742.87 3
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% KIQALQQQADEAEDR 95.00% 1.7 0.361 0 581.9626 1,742.86 1,742.87 3
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% LVILEGELER 95.00% 3.23 0.382 1.15 585.8492 1,169.68 1,170.67 2 TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% LVILEGELER 95.00% 1.5 0.309 1.42 586.0559 1,170.10 1,170.67 2 TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% LVILEGELER 95.00% 2.71 0.185 2.19 586.057 1,170.10 1,170.67 2 TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% LVILEGELER 95.00% 2.9 0.349 0 586.0625 1,170.11 1,170.67 2 TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% HIAEEADRKYEEVAR 95.00% 2 0.418 0 605.9692 1,814.88 1,815.90 3
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% HIAEEADRKYEEVAR 95.00% 2.77 0.572 0 605.9702 1,814.89 1,815.90 3
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% IQLVEEELDR 95.00% 2.33 0.219 0 622.3271 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% IQLVEEELDR 95.00% 2.63 0.273 0 622.3291 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% IQLVEEELDR 95.00% 2.39 0.295 0 622.3346 1,242.65 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% cGDLEEELKNVTNNLK 95.00% 4.23 0.076 0 c1: Carbamidomethyl (+57.02) 625.9868 1,874.94 1,875.91 3 TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% cGDLEEELKNVTNNLK 95.00% 4.74 0.541 0 c1: Carbamidomethyl (+57.02) 626.3141 1,875.92 1,875.91 3 TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% RIQLVEEELDRAQER 95.00% 4 0.252 0 629.0031 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% KLVILEGELER 95.00% 3.16 0.443 3.89 649.8878 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% KLVILEGELER 95.00% 3.86 0.448 2.15 649.8945 1,297.77 1,298.77 2 TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% KLVILEGELER 95.00% 3.85 0.455 3.44 649.8954 1,297.78 1,298.77 2 TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% KLVILEGELER 95.00% 2.1 0.366 1.13 649.8954 1,297.78 1,298.77 2 TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% KLVILEGELER 95.00% 3.93 0.415 3.35 649.8994 1,297.78 1,298.77 2 TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% RIQLVEEELDR 95.00% 2.82 0.426 3.08 700.3833 1,398.75 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% LATALQKLEEAEK 95.00% 3.54 0.385 1.77 722.4043 1,442.79 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% LATALQKLEEAEK 95.00% 3.44 0.424 1.82 722.4093 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% LATALQKLEEAEK 95.00% 4.01 0.431 2.18 722.4107 1,442.81 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% LATALQKLEEAEKAADESER 95.00% 4.89 0.631 4.04 734.7192 2,201.13 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% LATALQKLEEAEKAADESER 95.00% 3.73 0.503 3.31 734.7269 2,201.16 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% LATALQKLEEAEKAADESER 95.00% 4.46 0.45 4.64 735.0531 2,202.14 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% IQALQQQADEAEDR 95.00% 4.72 0.566 5.49 807.8916 1,613.77 1,614.77 2
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% IQLVEEELDRAQER 95.00% 4.3 0.335 1.49 864.4486 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% IQLVEEELDRAQER 95.00% 3.23 0.13 1.17 864.4565 1,726.90 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% IQLVEEELDRAQER 95.00% 4.05 0.326 0 864.4629 1,726.91 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% IQLVEEELDRAQER 95.00% 3.64 0.265 0 864.9503 1,727.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 1R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 3 4 6 37.10% HIAEEADRKYEEVAR 95.00% 2.82 0.387 1.34 908.9554 1,815.90 1,815.90 2
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 3.62 0.301 0 467.2557 1,398.74 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 4.07 0.411 0 467.2564 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 4.44 0.417 0 467.2564 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 3.68 0.396 0 467.2571 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 4.4 0.342 0 467.5913 1,399.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEK 95.00% 2.1 0.374 0 481.9393 1,442.79 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEK 95.00% 2.64 0.421 0 481.9395 1,442.79 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEK 95.00% 2.66 0.34 0 481.9396 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEK 95.00% 2.51 0.359 0 481.9405 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% MEIQEMQLK 95.00% 2.58 0.222 0 575.2848 1,148.55 1,149.57 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% MEIQEMQLK 95.00% 3.04 0.261 0 575.2852 1,148.55 1,149.57 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% KIQALQQQADEAEDR 95.00% 5.38 0.588 3.05 581.6248 1,741.85 1,742.87 3
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% KIQALQQQADEAEDR 95.00% 6.64 0.53 2.55 581.9606 1,742.86 1,742.87 3
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LVILEGELER 95.00% 3.33 0.382 1.72 585.8056 1,169.60 1,170.67 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LVILEGELER 95.00% 3.75 0.483 0 585.8393 1,169.66 1,170.67 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LVILEGELER 95.00% 3.42 0.428 0 585.8398 1,169.66 1,170.67 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LVILEGELER 95.00% 3.16 0.387 1.77 586.0563 1,170.10 1,170.67 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% KLVILEGELERAEER 95.00% 2.57 0.265 0 595.6682 1,783.98 1,783.99 3
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% HIAEEADRKYEEVAR 95.00% 2.25 0.449 1.36 605.9701 1,814.89 1,815.90 3
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% HIAEEADRKYEEVAR 95.00% 2.38 0.381 1.12 605.9703 1,814.89 1,815.90 3
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% HIAEEADRKYEEVAR 95.00% 2.11 0.349 2.15 605.9705 1,814.89 1,815.90 3
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% HIAEEADRKYEEVAR 95.00% 1.92 0.243 1.24 605.9711 1,814.89 1,815.90 3
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDR 95.00% 2.91 0.32 1.14 622.3278 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDR 95.00% 3.36 0.389 1.74 622.3282 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDR 95.00% 2.94 0.374 1.17 622.3286 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDR 95.00% 3.29 0.365 1.3 622.3291 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDR 95.00% 3.28 0.365 1.92 622.3291 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDR 95.00% 3.35 0.363 1.19 622.3293 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDR 95.00% 3.34 0.381 2 622.3293 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDR 95.00% 2.84 0.352 0 622.3307 1,242.65 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDR 95.00% 2.51 0.244 0 622.3308 1,242.65 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% cGDLEEELKNVTNNLK 95.00% 5.01 0.129 0 c1: Carbamidomethyl (+57.02) 625.9744 1,874.90 1,875.91 3 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% cGDLEEELKNVTNNLK 95.00% 3.36 0.397 0 c1: Carbamidomethyl (+57.02) 626.3094 1,875.90 1,875.91 3 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% cGDLEEELKNVTNNLK 95.00% 3.95 0.438 0 c1: Carbamidomethyl (+57.02) 626.3096 1,875.91 1,875.91 3 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDRAQER 95.00% 3.72 0.436 0.921 628.6689 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDRAQER 95.00% 3.79 0.302 1.42 628.6689 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDRAQER 95.00% 3.39 0.347 2.12 628.669 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDRAQER 95.00% 4.03 0.419 1.96 628.6694 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDRAQER 95.00% 4.33 0.47 0 628.67 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDRAQER 95.00% 3.41 0.216 0 629.0023 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDRAQER 95.00% 4.01 0.4 0 629.0032 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDRAQER 95.00% 3.82 0.365 0 629.0032 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDRAQER 95.00% 3.55 0.309 1.31 629.0037 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% KLVILEGELER 95.00% 3.35 0.397 2.89 649.8869 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% KLVILEGELER 95.00% 3.61 0.425 3.14 649.8871 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% KLVILEGELER 95.00% 2.87 0.292 2.44 649.8875 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% KLVILEGELER 95.00% 3.27 0.351 2.92 649.888 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% AMKDEEKMEIQEMQLK 95.00% 3.35 0.325 1.1 660.9856 1,979.93 1,980.94 3 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% AMKDEEKMEIQEMQLK 95.00% 4.19 0.29 1.59 661.3182 1,980.93 1,980.94 3 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% AMKDEEKMEIQEMQLK 95.00% 4.88 0.39 1.17 661.3187 1,980.93 1,980.94 3 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 3.17 0.383 1.82 700.3788 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 3.24 0.336 1.89 700.3788 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 3.38 0.384 2.14 700.3792 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 3.21 0.378 1.42 700.3795 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 3.49 0.373 2.41 700.3799 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 3.48 0.322 2.66 700.3802 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 3.24 0.3 2.64 700.3805 1,398.75 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDR 95.00% 3.86 0.404 1.92 700.3806 1,398.75 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEK 95.00% 4.01 0.421 3 722.4052 1,442.79 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEK 95.00% 3.94 0.437 2.19 722.4059 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEK 95.00% 4.24 0.483 3.31 722.4063 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEK 95.00% 4.12 0.402 2.21 722.4063 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEK 95.00% 2.79 0.169 0 722.4085 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEK 95.00% 3.43 0.294 0 722.4132 1,442.81 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEKAADESER 95.00% 4.22 0.554 4.74 734.7108 2,201.11 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEKAADESER 95.00% 4.47 0.623 6.14 735.0448 2,202.11 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEKAADESER 95.00% 4.44 0.548 5.04 735.0464 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEKAADESER 95.00% 4.9 0.592 3.54 735.0472 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEKAADESER 95.00% 4.53 0.598 6.52 735.0483 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LEEAEKAADESER 95.00% 3.67 0.509 4.35 738.8471 1,475.68 1,476.68 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQALQQQADEAEDRAQGLQR 95.00% 2.87 0.302 2.44 756.7164 2,267.13 2,268.13 3
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQALQQQADEAEDRAQGLQR 95.00% 3.15 0.329 3.27 757.0499 2,268.13 2,268.13 3
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LKEAETRAEFAER 95.00% 3.41 0.307 0 775.4012 1,548.79 1,549.80 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LKEAETRAEFAER 95.00% 3.45 0.301 0 775.4019 1,548.79 1,549.80 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQALQQQADEAEDR 95.00% 4.61 0.529 5.39 807.8916 1,613.77 1,614.77 2
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQALQQQADEAEDR 95.00% 4.55 0.443 5.14 808.3907 1,614.77 1,614.77 2
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDRAQER 95.00% 3.47 0.212 1.12 864.4477 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDRAQER 95.00% 3.84 0.338 0 864.4483 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDRAQER 95.00% 3.88 0.303 0 864.4493 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDRAQER 95.00% 3.44 0.186 0 864.4494 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDRAQER 95.00% 3.59 0.311 1.21 864.4496 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDRAQER 95.00% 3.39 0.163 0 864.4502 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDRAQER 95.00% 4.18 0.295 0 864.4502 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDRAQER 95.00% 3.01 0.194 0 864.4516 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDRAQER 95.00% 3.4 0.192 0 864.9478 1,727.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDRAQER 95.00% 3.7 0.305 0 864.949 1,727.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDRAQER 95.00% 3.07 0.243 0 864.9494 1,727.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% IQLVEEELDRAQER 95.00% 3.78 0.186 0 864.9532 1,727.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% KIQALQQQADEAEDR 95.00% 5.15 0.624 6.52 871.9368 1,741.86 1,742.87 2
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% KIQALQQQADEAEDR 95.00% 5.5 0.631 6.92 871.9369 1,741.86 1,742.87 2
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% HIAEEADRKYEEVAR 95.00% 3.34 0.487 2.55 908.4492 1,814.88 1,815.90 2
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% HIAEEADRKYEEVAR 95.00% 3.74 0.471 3.36 908.4513 1,814.89 1,815.90 2
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% HIAEEADRKYEEVAR 95.00% 3.62 0.362 2.96 908.9537 1,815.89 1,815.90 2
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% HIAEEADRKYEEVAR 95.00% 3.66 0.273 2.29 908.9547 1,815.89 1,815.90 2
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% HIAEEADRKYEEVAR 95.00% 3.81 0.35 2.46 908.9552 1,815.89 1,815.90 2
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% HIAEEADRKYEEVAR 95.00% 2.93 0.324 0 908.9562 1,815.90 1,815.90 2
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% cGDLEEELKNVTNNLK 95.00% 4.48 0.525 2.32 c1: Carbamidomethyl (+57.02) 938.9512 1,875.89 1,875.91 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDRAQER 95.00% 2.79 0.386 0 942.4984 1,882.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDRAQER 95.00% 3.07 0.363 0 942.4992 1,882.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% RIQLVEEELDRAQER 95.00% 3.09 0.34 0 943 1,883.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% AMKDEEKMEIQEMQLK 95.00% 6.42 0.449 4.35 991.4743 1,980.93 1,980.94 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% AMKDEEKMEIQEMQLK 95.00% 6 0.492 3.38 991.4744 1,980.93 1,980.94 2 TPM2_HUMAN
 SAMPLE 2 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 7 19 52.80% LATALQKLEEAEKAADESER 95.00% 5.29 0.665 7.7 1,102.07 2,202.13 2,202.13 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDR 95.00% 3.26 0.321 0 467.256 1,398.74 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDR 95.00% 3.35 0.372 0 467.2568 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDR 95.00% 3.96 0.402 1.36 467.2571 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDR 95.00% 4.02 0.35 0 467.2573 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDR 95.00% 4.17 0.298 0 467.5921 1,399.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEK 95.00% 2.84 0.228 0 481.9392 1,442.79 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEK 95.00% 2.36 0.291 0 481.9394 1,442.79 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEK 95.00% 2.12 0.294 0 482.2729 1,443.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% YSEKEDKYEEEIK 95.00% 3.17 0.188 1.19 563.934 1,688.78 1,689.79 3
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% YSEKEDKYEEEIK 95.00% 4.45 0.189 0 564.2678 1,689.78 1,689.79 3
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% KIQALQQQADEAEDR 95.00% 5.95 0.589 4.2 581.627 1,741.86 1,742.87 3
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% KIQALQQQADEAEDR 95.00% 5.11 0.587 3.05 581.9606 1,742.86 1,742.87 3
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LVILEGELER 95.00% 3.63 0.469 2.05 585.8377 1,169.66 1,170.67 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LVILEGELER 95.00% 3.25 0.422 1.62 585.8385 1,169.66 1,170.67 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LVILEGELER 95.00% 3.55 0.461 0 585.8388 1,169.66 1,170.67 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LVILEGELER 95.00% 3.5 0.463 1.26 585.8394 1,169.66 1,170.67 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LVILEGELER 95.00% 3.08 0.275 2.29 586.0563 1,170.10 1,170.67 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LVILEGELER 95.00% 2.77 0.357 2.85 586.0577 1,170.10 1,170.67 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% HIAEEADRKYEEVAR 95.00% 2.24 0.299 2.82 605.9698 1,814.89 1,815.90 3
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% HIAEEADRKYEEVAR 95.00% 2.08 0.314 1.68 605.97 1,814.89 1,815.90 3
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% HIAEEADRKYEEVAR 95.00% 2.61 0.332 2.43 605.9705 1,814.89 1,815.90 3
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDR 95.00% 2.85 0.339 1.64 622.3279 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDR 95.00% 2.52 0.229 0 622.3288 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDR 95.00% 3.18 0.378 2.17 622.3289 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDR 95.00% 2.95 0.342 1.6 622.329 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDR 95.00% 2.78 0.312 1.35 622.3292 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDR 95.00% 3.26 0.368 1.4 622.3301 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDR 95.00% 3.27 0.365 2.12 622.3303 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDR 95.00% 3.08 0.321 1.74 622.331 1,242.65 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDR 95.00% 2.18 0.219 1.8 622.3318 1,242.65 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% cGDLEEELKNVTNNLK 95.00% 3.61 0.143 0 c1: Carbamidomethyl (+57.02) 625.9763 1,874.91 1,875.91 3 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% cGDLEEELKNVTNNLK 95.00% 6 0.534 1.57 c1: Carbamidomethyl (+57.02) 626.3083 1,875.90 1,875.91 3 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% cGDLEEELKNVTNNLK 95.00% 4.68 0.506 0 c1: Carbamidomethyl (+57.02) 626.3086 1,875.90 1,875.91 3 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% cGDLEEELKNVTNNLK 95.00% 3.12 0.238 0 c1: Carbamidomethyl (+57.02) 626.3099 1,875.91 1,875.91 3 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDRAQER 95.00% 3.78 0.331 0 628.6682 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDRAQER 95.00% 4.09 0.357 0.959 628.6684 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDRAQER 95.00% 3.71 0.336 1.01 628.669 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDRAQER 95.00% 3.53 0.382 1.64 628.6691 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDRAQER 95.00% 3.65 0.371 0 628.6692 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDRAQER 95.00% 4.23 0.36 1.62 628.6693 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDRAQER 95.00% 2.98 0.129 1.49 629.003 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDRAQER 95.00% 3.63 0.419 0 629.0034 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDRAQER 95.00% 3.26 0.344 0 629.0034 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% KLVILEGELER 95.00% 2.65 0.34 1.44 649.8857 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% KLVILEGELER 95.00% 3.17 0.414 2.8 649.8866 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% KLVILEGELER 95.00% 2.52 0.373 1.39 649.8869 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% KLVILEGELER 95.00% 3.23 0.348 3.8 649.8869 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% KLVILEGELER 95.00% 3.22 0.379 3.49 649.8871 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% AMKDEEKMEIQEMQLK 95.00% 4.98 0.314 1.62 661.3191 1,980.93 1,980.94 3 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% AMKDEEKMEIQEMQLK 95.00% 4.63 0.305 1.46 661.3232 1,980.95 1,980.94 3 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDR 95.00% 3.47 0.366 2.66 700.3785 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDR 95.00% 3.11 0.354 3.77 700.3797 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDR 95.00% 3.11 0.319 2.72 700.3799 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDR 95.00% 3.57 0.338 2.72 700.3802 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDR 95.00% 2.93 0.329 0 700.3803 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDR 95.00% 3.9 0.444 2.72 700.3805 1,398.75 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEK 95.00% 4.28 0.461 2.14 722.4053 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEK 95.00% 4.05 0.447 2.7 722.4058 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEK 95.00% 4.11 0.495 1.85 722.4066 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEK 95.00% 3.13 0.323 1.82 722.4079 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEK 95.00% 3.38 0.321 2.48 722.91 1,443.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEKAADESER 95.00% 4.37 0.534 3.44 735.0464 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEKAADESER 95.00% 4.7 0.582 3.39 735.0466 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEKAADESER 95.00% 4.24 0.603 4.29 735.0472 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEKAADESER 95.00% 4.52 0.565 4.03 735.0478 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEKAADESER 95.00% 4.34 0.605 4.68 735.0482 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEKAADESER 95.00% 4.13 0.45 3.64 735.0491 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LEEAEKAADESER 95.00% 4.04 0.568 4.2 738.8451 1,475.67 1,476.68 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LEEAEKAADESER 95.00% 3.8 0.481 3.8 738.8477 1,475.68 1,476.68 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQALQQQADEAEDRAQGLQR 95.00% 3.36 0.391 2.4 757.0508 2,268.13 2,268.13 3
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LKEAETRAEFAER 95.00% 3.1 0.307 0 775.399 1,548.78 1,549.80 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LKEAETRAEFAER 95.00% 3.06 0.365 0 775.4015 1,548.79 1,549.80 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LKEAETRAEFAER 95.00% 3.13 0.301 0 775.9033 1,549.79 1,549.80 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% EENVGLHQTLDQTLNELNcI 95.00% 2.5 0.225 1.07 c19: Carbamidomethyl (+57.02) 781.0422 2,340.10 2,340.11 3
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQALQQQADEAEDR 95.00% 4.05 0.474 6.05 807.8889 1,613.76 1,614.77 2
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQALQQQADEAEDR 95.00% 4.39 0.538 3.74 807.8891 1,613.76 1,614.77 2
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDRAQER 95.00% 3.46 0.17 0 864.4464 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDRAQER 95.00% 3.51 0.216 1.31 864.4475 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDRAQER 95.00% 3.81 0.26 0 864.4483 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDRAQER 95.00% 3.59 0.256 0 864.4488 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDRAQER 95.00% 3.7 0.249 1.24 864.4497 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDRAQER 95.00% 3.62 0.321 0 864.4506 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDRAQER 95.00% 3.58 0.234 1.32 864.4511 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDRAQER 95.00% 3.65 0.24 0 864.4512 1,726.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% IQLVEEELDRAQER 95.00% 4.19 0.339 0 864.951 1,727.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% KIQALQQQADEAEDR 95.00% 5.34 0.631 7.28 871.9366 1,741.86 1,742.87 2
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% KIQALQQQADEAEDR 95.00% 5.27 0.589 8.4 872.438 1,742.86 1,742.87 2
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% HIAEEADRKYEEVAR 95.00% 3.65 0.475 3.85 908.4518 1,814.89 1,815.90 2
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% HIAEEADRKYEEVAR 95.00% 3.31 0.445 2.24 908.4532 1,814.89 1,815.90 2
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% HIAEEADRKYEEVAR 95.00% 3.69 0.499 0 908.4536 1,814.89 1,815.90 2
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% HIAEEADRKYEEVAR 95.00% 2.91 0.29 0 908.4584 1,814.90 1,815.90 2
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% HIAEEADRKYEEVAR 95.00% 3.51 0.294 2.7 908.9539 1,815.89 1,815.90 2
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% HIAEEADRKYEEVAR 95.00% 3.75 0.355 0 908.9558 1,815.90 1,815.90 2
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDRAQER 95.00% 2.71 0.375 1.25 942.4998 1,882.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDRAQER 95.00% 2.87 0.43 0 942.5014 1,882.99 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% RIQLVEEELDRAQER 95.00% 2.64 0.318 0 943.0025 1,883.99 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LAQAKEENVGLHQTLDQTLNELNcI 95.00% 3.16 0.363 0 c24: Carbamidomethyl (+57.02) 951.4788 2,851.41 2,851.43 3
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% AMKDEEKMEIQEMQLK 95.00% 6.07 0.524 6.09 990.9714 1,979.93 1,980.94 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% AMKDEEKMEIQEMQLK 95.00% 6.18 0.511 4.55 990.9715 1,979.93 1,980.94 2 TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEKAADESER 95.00% 5.07 0.642 7.1 1,102.07 2,202.11 2,202.13 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% LATALQKLEEAEKAADESER 95.00% 5.22 0.621 7.06 1,102.07 2,202.11 2,202.13 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% EENVGLHQTLDQTLNELNcI 95.00% 5.41 0.487 4.14 c19: Carbamidomethyl (+57.02) 1,170.56 2,339.11 2,340.11 2
 SAMPLE 2R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 7 10 22 66.50% EENVGLHQTLDQTLNELNcI 95.00% 5.62 0.502 4.01 c19: Carbamidomethyl (+57.02) 1,171.06 2,340.11 2,340.11 2
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDR 95.00% 3.62 0.374 0 467.2549 1,398.74 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDR 95.00% 3.27 0.4 0 467.2563 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDR 95.00% 4.03 0.368 0 467.2564 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDR 95.00% 2.96 0.199 0 467.5912 1,399.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEK 95.00% 2.01 0.329 0 481.9394 1,442.79 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEK 95.00% 2.48 0.311 0 482.2734 1,443.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LEEAEKAADESER 95.00% 2.29 0.248 0 492.899 1,475.67 1,476.68 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LEEAEKAADESER 95.00% 2.32 0.231 0 492.9008 1,475.68 1,476.68 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% YSEKEDKYEEEIK 95.00% 3.87 0.169 1.09 563.9324 1,688.77 1,689.79 3
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% YSEKEDKYEEEIK 95.00% 3.89 0.252 1.85 563.9326 1,688.77 1,689.79 3
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% YSEKEDKYEEEIK 95.00% 2.78 0.223 0 563.9331 1,688.78 1,689.79 3
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% YSEKEDKYEEEIK 95.00% 3.71 0.157 0 563.9331 1,688.78 1,689.79 3
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% MEIQEMQLK 95.00% 3.13 0.234 0 575.2849 1,148.55 1,149.57 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% KIQALQQQADEAEDR 95.00% 5.27 0.505 3.66 581.9603 1,742.86 1,742.87 3
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LVILEGELER 95.00% 3.86 0.469 1.28 585.8393 1,169.66 1,170.67 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LVILEGELER 95.00% 3.72 0.478 0 585.8397 1,169.66 1,170.67 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LVILEGELER 95.00% 2.92 0.388 0 585.841 1,169.67 1,170.67 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LVILEGELER 95.00% 3.02 0.32 1.39 586.0563 1,170.10 1,170.67 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LEEAEKAADESERGMK 95.00% 3.51 0.393 0 598.2825 1,791.82 1,792.84 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LEEAEKAADESERGMK 95.00% 3.46 0.437 0 598.283 1,791.83 1,792.84 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LEEAEKAADESERGMK 95.00% 3.67 0.392 0 598.2837 1,791.83 1,792.84 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LEEAEKAADESERGMK 95.00% 3.4 0.315 0 598.6157 1,792.82 1,792.84 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LEEAEKAADESERGmK 95.00% 3.05 0.368 0 m15: Oxidation (+15.99) 603.9519 1,808.83 1,808.83 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% HIAEEADRKYEEVAR 95.00% 2.26 0.268 2.52 605.9697 1,814.89 1,815.90 3
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% HIAEEADRKYEEVAR 95.00% 2.74 0.42 1.1 605.9697 1,814.89 1,815.90 3
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% HIAEEADRKYEEVAR 95.00% 2.5 0.378 1.41 605.9709 1,814.89 1,815.90 3
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% HIAEEADRKYEEVAR 95.00% 2.6 0.085 2.08 606.3035 1,815.89 1,815.90 3
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDR 95.00% 2.33 0.204 0 622.3283 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDR 95.00% 3.45 0.384 1.51 622.3286 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDR 95.00% 2.89 0.328 1.62 622.3288 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDR 95.00% 3.23 0.278 1.66 622.3294 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDR 95.00% 3.14 0.403 1.77 622.3299 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDR 95.00% 3.25 0.376 1.68 622.3303 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDR 95.00% 3.36 0.396 1.64 622.3303 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDR 95.00% 2.87 0.313 1.28 622.3325 1,242.65 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% cGDLEEELKNVTNNLK 95.00% 5.16 0.488 0 c1: Carbamidomethyl (+57.02) 626.3071 1,875.90 1,875.91 3 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.6 0.383 1.17 628.6674 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.51 0.246 1.19 628.6678 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.31 0.299 0 628.6689 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 2.92 0.387 0 628.6712 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.7 0.359 0.959 629.0019 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.53 0.422 1.08 629.0021 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.34 0.418 0 629.0023 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.4 0.239 0 629.0025 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.68 0.429 0 629.0027 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.7 0.448 1.44 629.0031 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.35 0.303 0 629.0031 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.99 0.459 1.18 629.0034 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.41 0.149 0 629.0037 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.23 0.334 0 629.0055 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.78 0.374 0 629.0062 1,884.00 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% KLVILEGELER 95.00% 3.27 0.45 2.92 649.8855 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% KLVILEGELER 95.00% 3.91 0.45 3.96 649.8871 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% KLVILEGELER 95.00% 3.72 0.456 3.37 649.8874 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% KLVILEGELER 95.00% 3.78 0.42 4.01 649.8874 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% KLVILEGELER 95.00% 3.6 0.481 2.72 649.8881 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% EAETRAEFAER 95.00% 2.05 0.345 0 654.8122 1,307.61 1,308.62 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% AMKDEEKMEIQEMQLK 95.00% 3.06 0.3 1.32 660.9814 1,979.92 1,980.94 3 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% AMKDEEKMEIQEMQLK 95.00% 4.99 0.323 1.4 660.9853 1,979.93 1,980.94 3 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% AMKDEEKMEIQEMQLK 95.00% 3.99 0.262 4.01 661.319 1,980.93 1,980.94 3 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% AMKDEEKMEIQEMQLK 95.00% 3.69 0.311 0 661.3198 1,980.94 1,980.94 3 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% AMKDEEKMEIQEMQLK 95.00% 4.21 0.388 0 661.3215 1,980.94 1,980.94 3 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% AmKDEEKmEIQEmQLK 95.00% 3.15 0.371 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3141 2,028.92 2,028.93 3 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDR 95.00% 2.92 0.346 2.57 700.3797 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDR 95.00% 3.32 0.395 1.96 700.38 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDR 95.00% 3.23 0.336 2.85 700.3806 1,398.75 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDR 95.00% 3.13 0.369 2.02 700.3811 1,398.75 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDR 95.00% 2.96 0.359 2.77 700.8807 1,399.75 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEK 95.00% 4.16 0.502 2.57 722.4057 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEK 95.00% 4.2 0.476 2.47 722.4062 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEK 95.00% 2.27 0.155 1.1 722.4071 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEK 95.00% 3.63 0.393 2.18 722.4074 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEK 95.00% 3.52 0.411 2.68 722.408 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEKAADESER 95.00% 4.56 0.559 3.7 735.0465 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEKAADESER 95.00% 4.92 0.581 4.7 735.0469 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEKAADESER 95.00% 4.81 0.582 4.59 735.0471 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEKAADESER 95.00% 4.67 0.577 4.07 735.0472 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LEEAEKAADESER 95.00% 4.04 0.496 4.27 738.8461 1,475.68 1,476.68 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LKEAETRAEFAER 95.00% 3.38 0.283 1.24 775.4004 1,548.79 1,549.80 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LKEAETRAEFAER 95.00% 3.37 0.317 0 775.901 1,549.79 1,549.80 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQALQQQADEAEDR 95.00% 4.47 0.551 3.74 808.3916 1,614.77 1,614.77 2
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% YSEKEDKYEEEIK 95.00% 4.6 0.317 2.4 845.3953 1,688.77 1,689.79 2
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% YSEKEDKYEEEIK 95.00% 4.76 0.324 2.28 845.396 1,688.78 1,689.79 2
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDRAQER 95.00% 3.53 0.215 0 864.4478 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDRAQER 95.00% 4.48 0.345 1.37 864.4483 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDRAQER 95.00% 3.59 0.258 0 864.4488 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDRAQER 95.00% 3.74 0.33 0 864.4488 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDRAQER 95.00% 3.74 0.326 0 864.4497 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDRAQER 95.00% 3.66 0.226 1.09 864.9501 1,727.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDRAQER 95.00% 3.62 0.206 0 864.9506 1,727.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDRAQER 95.00% 3.7 0.242 0 864.9524 1,727.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% IQLVEEELDRAQER 95.00% 3.28 0.312 0 864.9552 1,727.89 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% KIQALQQQADEAEDR 95.00% 5.32 0.629 8.96 871.9356 1,741.86 1,742.87 2
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% KIQALQQQADEAEDR 95.00% 5.25 0.661 7.89 871.9364 1,741.86 1,742.87 2
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% KLVILEGELERAEER 95.00% 3.01 0.342 0 892.4117 1,782.81 1,783.99 2
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% KLVILEGELERAEER 95.00% 3.92 0.437 1.1 892.9127 1,783.81 1,783.99 2
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% HIAEEADRKYEEVAR 95.00% 4.07 0.536 2.49 908.4497 1,814.88 1,815.90 2
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% HIAEEADRKYEEVAR 95.00% 3.79 0.516 2.43 908.4522 1,814.89 1,815.90 2
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% HIAEEADRKYEEVAR 95.00% 3.59 0.449 2.34 908.4531 1,814.89 1,815.90 2
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% HIAEEADRKYEEVAR 95.00% 3.74 0.34 2.27 908.9568 1,815.90 1,815.90 2
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 2.52 0.251 0 942.4976 1,882.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 2.87 0.364 0 942.9986 1,883.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% RIQLVEEELDRAQER 95.00% 3.33 0.415 1.11 943.0002 1,883.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% AMKDEEKMEIQEMQLK 95.00% 6.47 0.465 5.42 990.9746 1,979.93 1,980.94 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% AMKDEEKMEIQEMQLK 95.00% 5.98 0.514 5.39 991.4744 1,980.93 1,980.94 2 TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEKAADESER 95.00% 5.32 0.672 7.57 1,102.06 2,202.11 2,202.13 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3 Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 5 8 20 56.90% LATALQKLEEAEKAADESER 95.00% 5.19 0.644 6.85 1,102.07 2,202.12 2,202.13 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 4.4 0.42 0 467.2555 1,398.74 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 3.18 0.379 0 467.2561 1,398.74 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 4.69 0.395 0 467.2562 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 3.33 0.301 0 467.2569 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 3.41 0.371 0 467.2572 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 3.42 0.447 0 467.2576 1,398.75 1,399.75 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEK 95.00% 2.9 0.466 0 481.9397 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEK 95.00% 2.26 0.352 0 481.9397 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEK 95.00% 1.89 0.22 0 481.9399 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEK 95.00% 2.33 0.194 0 481.9412 1,442.80 1,443.81 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LEEAEKAADESER 95.00% 1.87 0.26 0 492.9 1,475.68 1,476.68 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LEEAEKAADESER 95.00% 2.03 0.229 0 492.9008 1,475.68 1,476.68 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% YSEKEDKYEEEIK 95.00% 4.43 0.237 1.54 563.9326 1,688.77 1,689.79 3
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% YSEKEDKYEEEIK 95.00% 3.8 0.171 1.05 563.9332 1,688.78 1,689.79 3
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% MEIQEMQLK 95.00% 2.95 0.214 0 575.2861 1,148.56 1,149.57 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% MEIQEMQLK 95.00% 2.84 0.228 0 575.287 1,148.56 1,149.57 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% KIQALQQQADEAEDR 95.00% 4.98 0.568 3.96 581.6251 1,741.85 1,742.87 3
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% KIQALQQQADEAEDR 95.00% 5.37 0.524 3.7 581.627 1,741.86 1,742.87 3
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LVILEGELER 95.00% 3.36 0.392 1.33 585.8379 1,169.66 1,170.67 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LVILEGELER 95.00% 3.76 0.473 0 585.8387 1,169.66 1,170.67 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LVILEGELER 95.00% 3.51 0.431 1.4 585.8388 1,169.66 1,170.67 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LVILEGELER 95.00% 3.42 0.394 0 585.8407 1,169.67 1,170.67 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LVILEGELER 95.00% 2.76 0.262 0 586.0552 1,170.09 1,170.67 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LVILEGELER 95.00% 3.1 0.423 0 586.0553 1,170.10 1,170.67 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LVILEGELER 95.00% 2.78 0.288 1.72 586.0559 1,170.10 1,170.67 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LVILEGELER 95.00% 2.2 0.298 0 586.0565 1,170.10 1,170.67 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LVILEGELER 95.00% 2.89 0.277 1.68 586.0569 1,170.10 1,170.67 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LEEAEKAADESERGMK 95.00% 3.68 0.322 1.4 598.2838 1,791.83 1,792.84 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LEEAEKAADESERGMK 95.00% 3.39 0.322 2.92 598.2842 1,791.83 1,792.84 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LEEAEKAADESERGmK 95.00% 2.48 0.365 0 m15: Oxidation (+15.99) 603.618 1,807.83 1,808.83 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% HIAEEADRKYEEVAR 95.00% 1.75 0.284 0 605.9695 1,814.89 1,815.90 3
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% HIAEEADRKYEEVAR 95.00% 1.91 0.356 2.52 605.97 1,814.89 1,815.90 3
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% HIAEEADRKYEEVAR 95.00% 2.18 0.468 2.1 605.9704 1,814.89 1,815.90 3
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQLVEEELDR 95.00% 2.69 0.249 1.48 622.3284 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQLVEEELDR 95.00% 3.33 0.402 1.48 622.3293 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQLVEEELDR 95.00% 3.37 0.382 1.54 622.3294 1,242.64 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQLVEEELDR 95.00% 2.67 0.183 0 622.7936 1,243.57 1,243.65 2 TPM1_HUMAN,TPM2_HUMAN,LMNA_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% cGDLEEELKNVTNNLK 95.00% 5.12 0.488 1.77 c1: Carbamidomethyl (+57.02) 626.3086 1,875.90 1,875.91 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% cGDLEEELKNVTNNLK 95.00% 4.8 0.447 0 c1: Carbamidomethyl (+57.02) 626.3109 1,875.91 1,875.91 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 3.62 0.429 1.41 628.6683 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 3.88 0.401 1.36 628.6685 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 3.78 0.445 1.15 628.6689 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 4.07 0.411 0.959 628.669 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 3.77 0.46 0.959 628.669 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 3.46 0.292 0 628.6694 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 3.45 0.285 0 628.6694 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 3.86 0.479 0 628.6697 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 2.61 0.23 0 628.8526 1,883.53 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 3.33 0.371 0 629.0029 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 3.3 0.46 0 629.0033 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 3.02 0.235 0 629.0036 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 3.49 0.397 1.54 629.0045 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% KLVILEGELER 95.00% 3.26 0.45 3.82 649.8851 1,297.75 1,298.77 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% KLVILEGELER 95.00% 3.94 0.446 3.92 649.8864 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% KLVILEGELER 95.00% 3.26 0.445 2.31 649.8872 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% KLVILEGELER 95.00% 3.89 0.458 2.85 649.8872 1,297.76 1,298.77 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% EAETRAEFAER 95.00% 2.18 0.313 0 654.8123 1,307.61 1,308.62 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% AMKDEEKMEIQEMQLK 95.00% 4.26 0.434 0 660.9826 1,979.92 1,980.94 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% AMKDEEKMEIQEMQLK 95.00% 4.1 0.252 1.26 660.985 1,979.93 1,980.94 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% AMKDEEKMEIQEMQLK 95.00% 2.78 0.314 0 660.9852 1,979.93 1,980.94 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% AMKDEEKMEIQEMQLK 95.00% 4.43 0.287 1 660.986 1,979.93 1,980.94 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% AMKDEEKMEIQEMQLK 95.00% 3.17 0.281 1.68 661.319 1,980.93 1,980.94 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% AMKDEEKMEIQEMQLK 95.00% 4.71 0.299 2.01 661.3195 1,980.93 1,980.94 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% AMKDEEKMEIQEMQLK 95.00% 3.07 0.211 1.47 661.3203 1,980.94 1,980.94 3 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 3.35 0.417 2.3 700.3783 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 2.87 0.298 2.14 700.3784 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 2.98 0.361 3.11 700.3792 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 3.14 0.365 2.92 700.3796 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 3.27 0.366 2.51 700.3796 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 3.11 0.352 2.66 700.3799 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 2.61 0.234 0 700.3802 1,398.74 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDR 95.00% 3.13 0.313 1.62 700.3806 1,398.75 1,399.75 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEK 95.00% 2.98 0.326 2.82 722.4058 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEK 95.00% 3.86 0.454 3.38 722.4062 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEK 95.00% 4.11 0.505 2.35 722.4063 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEK 95.00% 3.28 0.42 3.14 722.407 1,442.80 1,443.81 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEKAADESER 95.00% 2.15 0.417 0 734.3678 2,200.08 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEKAADESER 95.00% 2.07 0.394 0 734.3701 2,200.09 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEKAADESER 95.00% 4.23 0.536 5.6 735.0469 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEKAADESER 95.00% 5.37 0.586 5.89 735.0474 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEKAADESER 95.00% 4.51 0.558 4.85 735.048 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEKAADESER 95.00% 4.25 0.585 5.77 735.0487 2,202.12 2,202.13 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LEEAEKAADESER 95.00% 4.08 0.529 4 738.8451 1,475.67 1,476.68 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LEEAEKAADESER 95.00% 4.1 0.493 3.92 738.8466 1,475.68 1,476.68 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LKEAETRAEFAER 95.00% 3.53 0.357 0 775.4013 1,548.79 1,549.80 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LKEAETRAEFAER 95.00% 3.75 0.332 0 775.4023 1,548.79 1,549.80 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQALQQQADEAEDR 95.00% 4.1 0.522 8.57 807.8921 1,613.77 1,614.77 2
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEKAADESERGMK 95.00% 0 0 3.8 840.4336 2,518.28 2,518.28 3 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% YSEKEDKYEEEIK 95.00% 4.68 0.343 2.17 845.3943 1,688.77 1,689.79 2
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% YSEKEDKYEEEIK 95.00% 4.92 0.322 2.51 845.3958 1,688.78 1,689.79 2
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQLVEEELDRAQER 95.00% 3.26 0.247 0 864.4474 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQLVEEELDRAQER 95.00% 3.61 0.266 0 864.4484 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQLVEEELDRAQER 95.00% 2.85 0.243 0 864.4491 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQLVEEELDRAQER 95.00% 3.93 0.32 0 864.4492 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQLVEEELDRAQER 95.00% 4.03 0.364 1.33 864.4495 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQLVEEELDRAQER 95.00% 3.83 0.247 2.11 864.4497 1,726.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQLVEEELDRAQER 95.00% 3.5 0.217 0 864.9496 1,727.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% IQLVEEELDRAQER 95.00% 3.99 0.355 0 864.9497 1,727.88 1,727.89 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% KIQALQQQADEAEDR 95.00% 5.34 0.625 8.02 871.9356 1,741.86 1,742.87 2
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% KIQALQQQADEAEDR 95.00% 5.32 0.631 5.96 872.4405 1,742.87 1,742.87 2
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% KLVILEGELERAEER 95.00% 3.2 0.329 0 892.4138 1,782.81 1,783.99 2
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LEEAEKAADESERGMK 95.00% 5.18 0.567 3.82 896.9219 1,791.83 1,792.84 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LEEAEKAADESERGMK 95.00% 4.77 0.521 3.7 896.9232 1,791.83 1,792.84 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% HIAEEADRKYEEVAR 95.00% 3.45 0.48 3.62 908.4503 1,814.89 1,815.90 2
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% HIAEEADRKYEEVAR 95.00% 3.83 0.506 1.92 908.4517 1,814.89 1,815.90 2
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% HIAEEADRKYEEVAR 95.00% 3.65 0.33 2.38 908.9541 1,815.89 1,815.90 2
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% HIAEEADRKYEEVAR 95.00% 3.68 0.337 1.47 908.956 1,815.90 1,815.90 2
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 2.28 0.217 1.41 942.505 1,882.99 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% RIQLVEEELDRAQER 95.00% 3.17 0.382 0 942.9998 1,883.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LAQAKEENVGLHQTLDQTLNELNcI 95.00% 4.09 0.471 2.25 c24: Carbamidomethyl (+57.02) 951.4827 2,851.42 2,851.43 3
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% AMKDEEKMEIQEMQLK 95.00% 5.97 0.49 4.96 990.9742 1,979.93 1,980.94 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% AMKDEEKMEIQEMQLK 95.00% 5.97 0.5 5.01 990.9743 1,979.93 1,980.94 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% AMKDEEKMEIQEMQLK 95.00% 5.28 0.454 5.54 990.9768 1,979.94 1,980.94 2 TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEKAADESER 95.00% 4.95 0.634 6.64 1,102.06 2,202.11 2,202.13 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% LATALQKLEEAEKAADESER 95.00% 5.37 0.661 5.96 1,102.07 2,202.12 2,202.13 2 TPM1_HUMAN,TPM2_HUMAN
 SAMPLE 3R Tropomyosin alpha-4 chain  TPM4  TPM4_HUMAN 28,504.40 100.00% 6 9 18 66.90% KLVILEGELER 95.00% 0.757 0.315 1.18 1,297.60 1,296.59 1,298.77 1 TPM2_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDR 95.00% 4.5 0.438 0 467.2581 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDR 95.00% 4.58 0.409 0 467.2589 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDR 95.00% 3.99 0.469 1.19 467.2591 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDR 95.00% 4.22 0.401 1.02 467.2602 1,398.76 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDR 95.00% 2.13 0.32 0 467.2605 1,398.76 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LATALQKLEEAEK 95.00% 2.68 0.517 0 481.9415 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LATALQKLEEAEK 95.00% 3.25 0.458 0 481.9422 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LATALQKLEEAEK 95.00% 2.4 0.424 0 481.9425 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LATALQKLEEAEK 95.00% 2.33 0.336 0 481.9426 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KATDAEADVASLNR 95.00% 3.47 0.28 0 487.5853 1,459.73 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KATDAEADVASLNR 95.00% 3.52 0.315 0 487.5865 1,459.74 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KATDAEADVASLNR 95.00% 3.06 0.333 0 487.9221 1,460.74 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% ATDAEADVASLNRR 95.00% 1.73 0.188 1.09 496.9197 1,487.74 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% GTEDEVEKYSESVK 95.00% 2.33 0.349 0 533.9192 1,598.73 1,599.74 3
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% GTEDEVEKYSESVK 95.00% 2.14 0.274 0 533.9196 1,598.74 1,599.74 3
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KATDAEADVASLNRR 95.00% 2.26 0.192 0 539.6169 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KATDAEADVASLNRR 95.00% 2.22 0.319 0 539.618 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KATDAEADVASLNRR 95.00% 2.43 0.273 0 539.6183 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KATDAEADVASLNRR 95.00% 2.97 0.35 0 539.619 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KATDAEADVASLNRR 95.00% 3 0.226 0 539.9527 1,616.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% cKQLEEEQQALQK 95.00% 4.27 0.283 0 c1: Carbamidomethyl (+57.02) 544.6088 1,630.80 1,631.81 3
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% cKQLEEEQQALQK 95.00% 4.65 0.314 0 c1: Carbamidomethyl (+57.02) 544.6091 1,630.80 1,631.81 3
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% IQLVEEELDRAQER 95.00% 1.9 0.267 0 576.6375 1,726.89 1,727.89 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% MELQEmQLK 95.00% 2.46 0.216 0 m6: Oxidation (+15.99) 583.2835 1,164.55 1,165.56 2 TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% MELQEmQLK 95.00% 2.3 0.211 0 m6: Oxidation (+15.99) 583.2843 1,164.55 1,165.56 2 TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% EDKYEEEIKLLEEK 95.00% 4.11 0.274 0 598.9737 1,793.90 1,794.90 3
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% EDKYEEEIKLLEEK 95.00% 3.94 0.276 0 598.9741 1,793.90 1,794.90 3
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LKGTEDEVEKYSESVK 95.00% 3.85 0.555 1.8 614.3126 1,839.91 1,840.92 3
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LKGTEDEVEKYSESVK 95.00% 3.22 0.264 1.92 614.6475 1,840.92 1,840.92 3
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% IQLVEEELDR 95.00% 3.01 0.319 1.64 622.3319 1,242.65 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% IQLVEEELDR 95.00% 3.13 0.33 2.42 622.3322 1,242.65 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% IQLVEEELDR 95.00% 3.34 0.367 1.89 622.3322 1,242.65 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% IQLVEEELDR 95.00% 3.26 0.361 1.96 622.3322 1,242.65 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDRAQER 95.00% 3.66 0.293 0 628.671 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDRAQER 95.00% 3.49 0.374 0 628.6712 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDRAQER 95.00% 3.64 0.442 1 628.6717 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDRAQER 95.00% 3.85 0.403 1.12 628.6719 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDRAQER 95.00% 3.85 0.428 0 628.6719 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDRAQER 95.00% 3.18 0.28 0 629.0048 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDRAQER 95.00% 3.93 0.418 0 629.0054 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDRAQER 95.00% 3.99 0.29 1.82 629.0056 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDRAQER 95.00% 3.12 0.227 0 629.0062 1,884.00 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDRAQER 95.00% 4.05 0.314 1.1 629.0067 1,884.00 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% YSESVKEAQEKLEQAEK 95.00% 4.01 0.386 2.72 666.0006 1,994.98 1,995.99 3
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% YSESVKEAQEKLEQAEK 95.00% 4.35 0.474 1.24 666.0023 1,994.98 1,995.99 3
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% ATDAEADVASLNR 95.00% 1.79 0.261 1.21 666.8238 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% ATDAEADVASLNR 95.00% 3.92 0.464 3.1 666.8257 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% ATDAEADVASLNR 95.00% 3.37 0.455 2.7 666.826 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% ATDAEADVASLNR 95.00% 4.13 0.479 3.51 666.8264 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% ATDAEADVASLNR 95.00% 3.86 0.487 4.49 666.8266 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% AmKDEEKmELQEmQLK 95.00% 2.46 0.236 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 676.9864 2,027.94 2,028.93 3 TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% AmKDEEKmELQEmQLK 95.00% 2.8 0.359 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 676.9866 2,027.94 2,028.93 3 TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% AmKDEEKmELQEmQLK 95.00% 3.05 0.466 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3188 2,028.93 2,028.93 3 TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% AmKDEEKmELQEmQLK 95.00% 2.77 0.379 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3199 2,028.94 2,028.93 3 TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% AmKDEEKmELQEmQLK 95.00% 3.18 0.315 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3212 2,028.94 2,028.93 3 TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LATALQKLEEAEK 95.00% 4.08 0.375 3.02 722.4081 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LATALQKLEEAEK 95.00% 3.94 0.413 4.52 722.4091 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LATALQKLEEAEK 95.00% 4.11 0.487 2.82 722.4094 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LATALQKLEEAEK 95.00% 4.16 0.465 2.04 722.4101 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LATALQKLEEAEK 95.00% 3.46 0.282 1.77 722.4118 1,442.81 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LATALQKLEEAEK 95.00% 3.69 0.35 1.43 722.4137 1,442.81 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% GTEDEVEKYSESVKEAQEK 95.00% 4.5 0.504 1.92 729.0113 2,184.01 2,185.02 3
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% GTEDEVEKYSESVKEAQEK 95.00% 4.33 0.442 1.72 729.3462 2,185.02 2,185.02 3
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KATDAEADVASLNR 95.00% 2.84 0.28 2.38 730.3524 1,458.69 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KATDAEADVASLNR 95.00% 4.21 0.562 3.01 730.8737 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LATALQKLEEAEKAADESER 95.00% 4.61 0.58 5.7 735.0493 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LATALQKLEEAEKAADESER 95.00% 4.09 0.56 3.7 735.0499 2,202.13 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% ATDAEADVASLNRR 95.00% 2.55 0.268 1.21 744.8758 1,487.74 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% GTEDEVEKYSESVK 95.00% 4.98 0.557 2.26 800.3755 1,598.74 1,599.74 2
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% GTEDEVEKYSESVK 95.00% 5.03 0.582 2.48 800.3773 1,598.74 1,599.74 2
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% cKQLEEEQQALQK 95.00% 0 0 4.44 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 807.8961 1,613.78 1,614.78 2
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KATDAEADVASLNRR 95.00% 2.51 0.253 0 808.9243 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KATDAEADVASLNRR 95.00% 2.52 0.219 0 808.9243 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% cKQLEEEQQALQK 95.00% 4.74 0.507 3.59 c1: Carbamidomethyl (+57.02) 816.4112 1,630.81 1,631.81 2
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% IQLVEEELDRAQER 95.00% 3.95 0.295 0 864.4526 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% IQLVEEELDRAQER 95.00% 3.68 0.268 0 864.9528 1,727.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% IQLVEEELDRAQER 95.00% 3.63 0.199 0 864.9543 1,727.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% IQLVEEELDRAQER 95.00% 3.61 0.274 1.59 864.9543 1,727.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% IQLVEEELDRAQER 95.00% 4.1 0.236 0 864.9566 1,727.90 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% cKQLEEEQQALQKK 95.00% 0 0 5.23 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 872.4442 1,742.87 1,742.88 2
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KLVILEGELERSEER 95.00% 4.24 0.387 3.36 900.4978 1,798.98 1,799.99 2
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% KLVILEGELERSEER 95.00% 4.01 0.398 2.8 900.9996 1,799.98 1,799.99 2
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LKGTEDEVEKYSESVK 95.00% 5.59 0.522 7.48 921.468 1,840.92 1,840.92 2
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDRAQER 95.00% 2.57 0.268 1.74 943.0053 1,883.99 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% RIQLVEEELDRAQER 95.00% 3.06 0.254 1.72 943.0057 1,884.00 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% AmKDEEKmELQEmQLK 95.00% 3.71 0.45 2.6 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 1,015.47 2,028.92 2,028.93 2 TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% AmKDEEKmELQEmQLK 95.00% 2.75 0.329 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 1,015.48 2,028.94 2,028.93 2 TPM4_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LDKENAIDRAEQAEADKK 95.00% 0 0 3.66 1,022.52 2,043.03 2,044.03 2 TPM1_HUMAN
 SAMPLE 4 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 19 28 73 53.90% LDKENAIDRAEQAEADKK 95.00% 0 0 3.59 1,023.02 2,044.03 2,044.03 2 TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDR 95.00% 3.39 0.385 1.41 467.258 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDR 95.00% 4.05 0.422 0 467.2582 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDR 95.00% 3.37 0.368 0 467.2591 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDR 95.00% 4.24 0.439 1.96 467.2591 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDR 95.00% 3.94 0.442 0 467.26 1,398.76 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDR 95.00% 4.23 0.387 1.11 467.2609 1,398.76 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LATALQKLEEAEK 95.00% 2.64 0.462 0 481.9422 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LATALQKLEEAEK 95.00% 2.54 0.4 0 481.9423 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LATALQKLEEAEK 95.00% 2.5 0.453 0 481.9424 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LATALQKLEEAEK 95.00% 2.13 0.274 0 482.2763 1,443.81 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LATALQKLEEAEK 95.00% 2.49 0.339 0 482.2775 1,443.81 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KATDAEADVASLNR 95.00% 3.64 0.368 0 487.5847 1,459.73 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% ATDAEADVASLNRR 95.00% 2.08 0.205 0 496.9197 1,487.74 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% ATDAEADVASLNRR 95.00% 2.12 0.196 0 496.92 1,487.74 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% GTEDEVEKYSESVK 95.00% 2.49 0.358 0 533.919 1,598.73 1,599.74 3
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% GTEDEVEKYSESVK 95.00% 2.38 0.433 0 533.9191 1,598.73 1,599.74 3
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KATDAEADVASLNRR 95.00% 2.1 0.36 0 539.6176 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KATDAEADVASLNRR 95.00% 2.41 0.249 0 539.6183 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KATDAEADVASLNRR 95.00% 2.17 0.331 1.02 539.6188 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KATDAEADVASLNRR 95.00% 2.68 0.225 0 539.6193 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KATDAEADVASLNRR 95.00% 2.42 0.211 0 539.6195 1,615.84 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% cKQLEEEQQALQK 95.00% 4.22 0.283 0 c1: Carbamidomethyl (+57.02) 544.9427 1,631.80 1,631.81 3
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% cKQLEEEQQALQK 95.00% 4.01 0.281 0 c1: Carbamidomethyl (+57.02) 544.944 1,631.81 1,631.81 3
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% ENAIDRAEQAEADKK 95.00% 3.33 0.325 0 563.282 1,686.82 1,687.83 3 TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% ENAIDRAEQAEADKK 95.00% 4.05 0.336 0 563.6144 1,687.82 1,687.83 3 TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDRAQER 95.00% 1.81 0.26 1.07 576.6376 1,726.89 1,727.89 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDRAQER 95.00% 1.83 0.283 0 576.9722 1,727.89 1,727.89 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% MELQEmQLK 95.00% 2.29 0.197 0 m6: Oxidation (+15.99) 583.2837 1,164.55 1,165.56 2 TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% EDKYEEEIKLLEEK 95.00% 3.8 0.223 0 598.9733 1,793.90 1,794.90 3
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% EDKYEEEIKLLEEK 95.00% 3.68 0.275 0 599.3085 1,794.90 1,794.90 3
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LKGTEDEVEKYSESVK 95.00% 3.4 0.51 1 614.3126 1,839.91 1,840.92 3
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LKGTEDEVEKYSESVK 95.00% 3.1 0.368 1.24 614.3129 1,839.92 1,840.92 3
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDR 95.00% 2.98 0.382 2.25 622.3294 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDR 95.00% 3.24 0.338 1.54 622.3318 1,242.65 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDR 95.00% 3.03 0.371 1.92 622.3333 1,242.65 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDRAQER 95.00% 3.79 0.374 0 628.6716 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDRAQER 95.00% 3.43 0.437 0 628.6716 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDRAQER 95.00% 3.78 0.321 0 628.6719 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDRAQER 95.00% 3.36 0.393 0 628.6721 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDRAQER 95.00% 3.43 0.319 0 628.6729 1,883.00 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDRAQER 95.00% 3.15 0.383 0 629.0051 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDRAQER 95.00% 3.26 0.266 1.01 629.0057 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDRAQER 95.00% 2.61 0.341 0 629.0095 1,884.01 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KLVILEGELER 95.00% 2.39 0.357 0 649.8902 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KLVILEGELER 95.00% 3.43 0.394 4.57 649.8902 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KLVILEGELER 95.00% 3.16 0.449 3.4 649.8907 1,297.77 1,298.77 2 TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KLVILEGELER 95.00% 2.83 0.398 1.35 649.8911 1,297.77 1,298.77 2 TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% YSESVKEAQEKLEQAEK 95.00% 4.38 0.518 1.57 666.3367 1,995.99 1,995.99 3
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% ATDAEADVASLNR 95.00% 3.57 0.465 2.96 666.8254 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% ATDAEADVASLNR 95.00% 3.81 0.483 2.96 666.8256 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% ATDAEADVASLNR 95.00% 3.96 0.468 2.85 666.8257 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% AmKDEEKmELQEmQLK 95.00% 3.04 0.391 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 676.9861 2,027.93 2,028.93 3 TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% AmKDEEKmELQEmQLK 95.00% 2.64 0.335 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3202 2,028.94 2,028.93 3 TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% AmKDEEKmELQEmQLK 95.00% 2.64 0.384 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3207 2,028.94 2,028.93 3 TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% AmKDEEKmELQEmQLK 95.00% 3.01 0.28 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3209 2,028.94 2,028.93 3 TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LATALQKLEEAEK 95.00% 4.21 0.416 2.8 722.4098 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LATALQKLEEAEK 95.00% 4.21 0.446 3.15 722.4103 1,442.81 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LATALQKLEEAEK 95.00% 4.04 0.466 1.85 722.4117 1,442.81 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LATALQKLEEAEK 95.00% 3.45 0.346 1.62 722.4117 1,442.81 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LATALQKLEEAEK 95.00% 3.55 0.359 1.37 722.9103 1,443.81 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LATALQKLEEAEK 95.00% 3.87 0.377 2.22 722.9113 1,443.81 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% GTEDEVEKYSESVKEAQEK 95.00% 3.89 0.414 1.51 729.3459 2,185.01 2,185.02 3
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KATDAEADVASLNR 95.00% 2.36 0.197 2.82 730.3531 1,458.69 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KATDAEADVASLNR 95.00% 4.55 0.592 4.06 730.8725 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KATDAEADVASLNR 95.00% 4.07 0.564 5.47 730.8745 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KATDAEADVASLNR 95.00% 3.91 0.53 4.33 730.8747 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KATDAEADVASLNR 95.00% 4.35 0.563 4.46 730.8763 1,459.74 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% ATDAEADVASLNRR 95.00% 2.39 0.299 1.22 744.8753 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% ATDAEADVASLNRR 95.00% 2.52 0.228 1.42 744.8753 1,487.74 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% ATDAEADVASLNRR 95.00% 2.21 0.253 2.14 744.8759 1,487.74 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% GTEDEVEKYSESVK 95.00% 4.53 0.569 3.54 800.3747 1,598.73 1,599.74 2
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% GTEDEVEKYSESVK 95.00% 4.93 0.548 3.96 800.3761 1,598.74 1,599.74 2
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KATDAEADVASLNRR 95.00% 2.34 0.269 0 808.9239 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% cKQLEEEQQALQK 95.00% 4.83 0.468 4.82 c1: Carbamidomethyl (+57.02) 816.4098 1,630.80 1,631.81 2
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% cKQLEEEQQALQK 95.00% 4.89 0.462 3.44 c1: Carbamidomethyl (+57.02) 816.411 1,630.81 1,631.81 2
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDRAQER 95.00% 3.54 0.138 0 864.4518 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDRAQER 95.00% 2.95 0.179 0 864.4522 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDRAQER 95.00% 3.77 0.274 1.54 864.4522 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDRAQER 95.00% 3.89 0.337 0 864.4524 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDRAQER 95.00% 3.98 0.298 1.74 864.4528 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDRAQER 95.00% 3.84 0.26 1.6 864.4531 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDRAQER 95.00% 3.88 0.245 0 864.4549 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% IQLVEEELDRAQER 95.00% 2.92 0.216 0 864.455 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% cKQLEEEQQALQKK 94.50% 0 0 3.19 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 871.9431 1,741.87 1,742.88 2
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KLVILEGELERSEER 95.00% 3.71 0.426 0 900.4974 1,798.98 1,799.99 2
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% KLVILEGELERSEER 95.00% 3.63 0.324 0 900.5006 1,798.99 1,799.99 2
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LKGTEDEVEKYSESVK 95.00% 4.92 0.585 4.85 920.9638 1,839.91 1,840.92 2
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LKGTEDEVEKYSESVK 95.00% 5.06 0.58 7.39 920.9657 1,839.92 1,840.92 2
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% RIQLVEEELDRAQER 95.00% 2.78 0.304 1.7 943.0033 1,883.99 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% AmKDEEKmELQEmQLK 95.00% 3.42 0.518 3 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 1,015.47 2,028.93 2,028.93 2 TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% AmKDEEKmELQEmQLK 95.00% 3.63 0.457 1.89 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 1,015.47 2,028.93 2,028.93 2 TPM4_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LDKENAIDRAEQAEADKK 95.00% 0 0 3.37 1,023.02 2,044.03 2,044.03 2 TPM1_HUMAN
 SAMPLE 4R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 20 29 81 51.40% LDKENAIDRAEQAEADKK 95.00% 0 0 3.8 1,023.02 2,044.03 2,044.03 2 TPM1_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% RIQLVEEELDR 95.00% 4.3 0.395 1.05 467.2589 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LATALQKLEEAEK 94.70% 2.31 0.252 0 481.9409 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KATDAEADVASLNRR 95.00% 2.14 0.253 1.17 539.6144 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KATDAEADVASLNRR 95.00% 2.1 0.287 0 539.6156 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LVILEGELER 95.00% 2.5 0.319 0 586.056 1,170.10 1,170.67 2 TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LVILEGELER 95.00% 1.87 0.417 0 586.0614 1,170.11 1,170.67 2 TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LVILEGELER 95.00% 2.9 0.349 0 586.0625 1,170.11 1,170.67 2 TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% EDKYEEEIKLLEEK 95.00% 3.98 0.243 0 598.9708 1,793.89 1,794.90 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% EDKYEEEIKLLEEK 95.00% 4.04 0.235 0 598.9715 1,793.89 1,794.90 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% EDKYEEEIKLLEEK 95.00% 3.91 0.266 0 598.9788 1,793.91 1,794.90 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% EDKYEEEIKLLEEK 95.00% 3.85 0.24 0 599.312 1,794.91 1,794.90 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LKGTEDEVEKYSESVK 95.00% 2.17 0.249 0 614.3094 1,839.90 1,840.92 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LKGTEDEVEKYSESVK 95.00% 1.82 0.375 0 614.31 1,839.91 1,840.92 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% IQLVEEELDR 95.00% 2.31 0.295 1.35 622.3275 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% IQLVEEELDR 95.00% 2.6 0.301 0 622.3277 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% IQLVEEELDR 95.00% 2.67 0.252 2.55 622.3281 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% IQLVEEELDR 95.00% 2.77 0.355 1.29 622.3286 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% IQLVEEELDR 95.00% 3.06 0.327 2.04 622.3288 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% IQLVEEELDR 95.00% 2.46 0.158 1.92 622.9897 1,243.96 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% RIQLVEEELDRAQER 95.00% 3.58 0.261 0 628.6689 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% RIQLVEEELDRAQER 95.00% 3.56 0.358 0 628.6691 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% RIQLVEEELDRAQER 95.00% 3.92 0.37 0.959 628.672 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% RIQLVEEELDRAQER 95.00% 3.92 0.354 0 629.0012 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% RIQLVEEELDRAQER 95.00% 3.82 0.372 2.03 629.0013 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% RIQLVEEELDRAQER 95.00% 4.05 0.392 0 629.0026 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KLVILEGELER 95.00% 3.83 0.451 3.06 649.8864 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KLVILEGELER 95.00% 3.97 0.453 3.74 649.8866 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KLVILEGELER 95.00% 3.15 0.399 1.96 649.8879 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KLVILEGELER 95.00% 3.86 0.448 3.24 649.8945 1,297.77 1,298.77 2 TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KLVILEGELER 95.00% 3.85 0.455 3.59 649.8954 1,297.78 1,298.77 2 TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% YSESVKEAQEKLEQAEK 95.00% 4.66 0.57 0 666.3343 1,995.98 1,995.99 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% YSESVKEAQEKLEQAEK 95.00% 4.46 0.481 1 666.3345 1,995.98 1,995.99 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% YSESVKEAQEKLEQAEK 95.00% 4.04 0.46 1.6 666.337 1,995.99 1,995.99 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% YSESVKEAQEKLEQAEK 95.00% 4.75 0.513 1.89 666.3381 1,995.99 1,995.99 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% ATDAEADVASLNR 95.00% 4.07 0.414 2.82 666.8231 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% ATDAEADVASLNR 95.00% 4.5 0.439 3.7 666.8233 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% ATDAEADVASLNR 95.00% 3.45 0.504 2.55 666.8252 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% ATDAEADVASLNR 95.00% 3.68 0.394 2.89 666.8257 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% ATDAEADVASLNR 95.00% 4.22 0.504 3.37 666.8271 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% ATDAEADVASLNR 95.00% 4.32 0.461 3.7 666.8279 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% RIQLVEEELDR 95.00% 3.81 0.415 3.11 700.3786 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% RIQLVEEELDR 95.00% 3.27 0.359 1.96 700.3824 1,398.75 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% RIQLVEEELDR 95.00% 2.82 0.426 3.37 700.3833 1,398.75 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LATALQKLEEAEK 95.00% 4.17 0.486 2.21 722.4055 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LATALQKLEEAEK 95.00% 4.01 0.431 0 722.4107 1,442.81 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LATALQKLEEAEK 95.00% 3.51 0.383 1.8 722.9082 1,443.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% GTEDEVEKYSESVKEAQEK 95.00% 4.13 0.453 1.21 729.3435 2,185.01 2,185.02 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% GTEDEVEKYSESVKEAQEK 95.00% 3.77 0.409 0 729.3437 2,185.01 2,185.02 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% GTEDEVEKYSESVKEAQEK 95.00% 4.83 0.472 2.6 729.3466 2,185.02 2,185.02 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% GTEDEVEKYSESVKEAQEK 95.00% 4.46 0.501 1.89 729.3491 2,185.02 2,185.02 3
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KATDAEADVASLNR 95.00% 2.94 0.192 1.31 730.8697 1,459.72 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LATALQKLEEAEKAADESER 95.00% 4.89 0.631 4.72 734.7192 2,201.13 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LATALQKLEEAEKAADESER 95.00% 4.95 0.621 5.54 735.0455 2,202.11 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LATALQKLEEAEKAADESER 95.00% 4.38 0.571 4.39 735.0457 2,202.11 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LATALQKLEEAEKAADESER 95.00% 4.46 0.45 5.07 735.0531 2,202.14 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% TIDDLEDEVYAQK 95.00% 3.49 0.417 3.38 769.8653 1,537.72 1,538.72 2
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% GTEDEVEKYSESVK 95.00% 4.63 0.597 4 800.3716 1,598.73 1,599.74 2
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% GTEDEVEKYSESVK 95.00% 4.61 0.605 2.85 800.3748 1,598.73 1,599.74 2
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% GTEDEVEKYSESVK 95.00% 4.42 0.594 3.3 800.376 1,598.74 1,599.74 2
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% GTEDEVEKYSESVK 95.00% 4.35 0.579 2.96 800.3778 1,598.74 1,599.74 2
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KATDAEADVASLNRR 95.00% 2.61 0.282 0 808.9199 1,615.82 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KATDAEADVASLNRR 95.00% 2.57 0.319 0 808.9235 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% cKQLEEEQQALQK 95.00% 4.84 0.484 2.62 c1: Carbamidomethyl (+57.02) 816.4072 1,630.80 1,631.81 2
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% IQLVEEELDRAQER 95.00% 3.96 0.348 0 864.4477 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% IQLVEEELDRAQER 95.00% 4.3 0.335 2.46 864.4486 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% IQLVEEELDRAQER 95.00% 3.28 0.141 0 864.45 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% IQLVEEELDRAQER 95.00% 3.23 0.13 0 864.4565 1,726.90 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% IQLVEEELDRAQER 95.00% 3.71 0.189 0 864.9496 1,727.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% EDKYEEEIKLLEEK 95.00% 3.88 0.19 2.43 898.4655 1,794.92 1,794.90 2
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KLVILEGELERSEER 95.00% 2.78 0.319 0 900.5028 1,798.99 1,799.99 2
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KLVILEGELERSEER 95.00% 4.06 0.426 0 900.9956 1,799.98 1,799.99 2
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% KLVILEGELERSEER 95.00% 3.74 0.402 0 900.9985 1,799.98 1,799.99 2
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% LKGTEDEVEKYSESVK 95.00% 4.47 0.561 3.3 920.964 1,839.91 1,840.92 2
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% RIQLVEEELDRAQER 95.00% 2.78 0.331 1.64 942.4986 1,882.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 1 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 17 23 62 46.10% YSESVKEAQEKLEQAEK 95.00% 3.94 0.493 3.03 998.9941 1,995.97 1,995.99 2
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% RIQLVEEELDR 95.00% 4.3 0.395 1.52 467.2589 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KATDAEADVASLNR 95.00% 3.06 0.267 0 487.5826 1,459.72 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KATDAEADVASLNRR 95.00% 2.07 0.229 0 539.6149 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KATDAEADVASLNRR 95.00% 2.02 0.209 0 539.615 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KATDAEADVASLNRR 95.00% 2.1 0.225 0 539.6158 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% LVILEGELER 95.00% 3.23 0.382 1.15 585.8492 1,169.68 1,170.67 2 TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% LVILEGELER 95.00% 1.5 0.309 1.42 586.0559 1,170.10 1,170.67 2 TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% LVILEGELER 95.00% 2.71 0.185 2.19 586.057 1,170.10 1,170.67 2 TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% LVILEGELER 95.00% 2.9 0.349 0 586.0625 1,170.11 1,170.67 2 TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% EDKYEEEIKLLEEK 95.00% 3.91 0.266 0 598.9788 1,793.91 1,794.90 3
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% EDKYEEEIKLLEEK 95.00% 3.85 0.24 0 599.312 1,794.91 1,794.90 3
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% IQLVEEELDR 95.00% 2.33 0.219 0 622.3271 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% IQLVEEELDR 95.00% 2.63 0.273 0 622.3291 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% IQLVEEELDR 95.00% 2.39 0.295 0 622.3346 1,242.65 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% RIQLVEEELDRAQER 95.00% 4 0.252 0 629.0031 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KLVILEGELER 95.00% 3.16 0.443 3.89 649.8878 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KLVILEGELER 95.00% 3.86 0.448 2.15 649.8945 1,297.77 1,298.77 2 TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KLVILEGELER 95.00% 3.85 0.455 3.44 649.8954 1,297.78 1,298.77 2 TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KLVILEGELER 95.00% 2.1 0.366 1.13 649.8954 1,297.78 1,298.77 2 TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KLVILEGELER 95.00% 3.93 0.415 3.35 649.8994 1,297.78 1,298.77 2 TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% YSESVKEAQEKLEQAEK 95.00% 4.04 0.46 1.35 666.337 1,995.99 1,995.99 3
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% YSESVKEAQEKLEQAEK 95.00% 4.75 0.513 2.31 666.3381 1,995.99 1,995.99 3
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% ATDAEADVASLNR 95.00% 2.86 0.49 2.35 666.8213 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% ATDAEADVASLNR 95.00% 2.83 0.405 2.96 666.8215 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% ATDAEADVASLNR 95.00% 4.22 0.504 3.11 666.8271 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% ATDAEADVASLNR 95.00% 4.32 0.461 2.82 666.8279 1,331.64 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% RIQLVEEELDR 95.00% 2.82 0.426 3.08 700.3833 1,398.75 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% LATALQKLEEAEK 95.00% 3.54 0.385 1.77 722.4043 1,442.79 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% LATALQKLEEAEK 95.00% 3.44 0.424 1.82 722.4093 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% LATALQKLEEAEK 95.00% 4.01 0.431 2.18 722.4107 1,442.81 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% GTEDEVEKYSESVKEAQEK 95.00% 4.83 0.472 1.96 729.3466 2,185.02 2,185.02 3
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% GTEDEVEKYSESVKEAQEK 95.00% 4.46 0.501 1.72 729.3491 2,185.02 2,185.02 3
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KATDAEADVASLNR 95.00% 2.94 0.192 1.28 730.8697 1,459.72 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% LATALQKLEEAEKAADESER 95.00% 4.89 0.631 4.04 734.7192 2,201.13 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% LATALQKLEEAEKAADESER 95.00% 3.73 0.503 3.31 734.7269 2,201.16 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% LATALQKLEEAEKAADESER 95.00% 4.46 0.45 4.64 735.0531 2,202.14 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% GTEDEVEKYSESVK 95.00% 4.42 0.594 3.24 800.376 1,598.74 1,599.74 2
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% GTEDEVEKYSESVK 95.00% 4.35 0.579 2.44 800.3778 1,598.74 1,599.74 2
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KATDAEADVASLNRR 95.00% 2.61 0.282 0 808.9199 1,615.82 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KATDAEADVASLNRR 95.00% 2.57 0.319 0 808.9235 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% cKQLEEEQQALQK 95.00% 4.84 0.484 3.1 c1: Carbamidomethyl (+57.02) 816.4072 1,630.80 1,631.81 2
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% IQLVEEELDRAQER 95.00% 4.3 0.335 1.49 864.4486 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% IQLVEEELDRAQER 95.00% 3.23 0.13 1.17 864.4565 1,726.90 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% IQLVEEELDRAQER 95.00% 4.05 0.326 0 864.4629 1,726.91 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% IQLVEEELDRAQER 95.00% 3.64 0.265 0 864.9503 1,727.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% EDKYEEEIKLLEEK 95.00% 3.88 0.19 1.23 898.4655 1,794.92 1,794.90 2
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% KLVILEGELERSEER 95.00% 2.78 0.319 0 900.5028 1,798.99 1,799.99 2
 SAMPLE 1R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 16 20 44 41.50% LKGTEDEVEKYSESVK 95.00% 4.47 0.561 3.35 920.964 1,839.91 1,840.92 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 3.62 0.301 0 467.2557 1,398.74 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 4.07 0.411 0 467.2564 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 4.44 0.417 0 467.2564 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 3.68 0.396 0 467.2571 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 4.4 0.342 0 467.5913 1,399.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% EAQEKLEQAEKK 95.00% 2.48 0.295 0 477.5895 1,429.75 1,430.75 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEK 95.00% 2.1 0.374 0 481.9393 1,442.79 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEK 95.00% 2.64 0.421 0 481.9395 1,442.79 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEK 95.00% 2.66 0.34 0 481.9396 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEK 95.00% 2.51 0.359 0 481.9405 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNR 95.00% 2.62 0.158 0 487.5811 1,459.72 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNR 95.00% 3.28 0.295 0 487.5812 1,459.72 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNR 95.00% 3.59 0.275 0 487.5821 1,459.72 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNR 95.00% 3.85 0.326 0 487.5821 1,459.72 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNR 95.00% 3.07 0.179 0 487.5824 1,459.72 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNRR 95.00% 1.93 0.292 0 496.9173 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% GTEDEVEKYSESVK 95.00% 2.47 0.496 0 533.9172 1,598.73 1,599.74 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% GTEDEVEKYSESVK 95.00% 2.26 0.463 0 533.9175 1,598.73 1,599.74 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNRR 95.00% 2.28 0.303 0 539.6151 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNRR 95.00% 2.04 0.283 0 539.6154 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNRR 95.00% 2.42 0.44 0 539.6161 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNRR 95.00% 2.2 0.376 0 539.6179 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQK 95.00% 4.35 0.329 0 c1: Carbamidomethyl (+57.02) 544.6066 1,630.80 1,631.81 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQK 95.00% 4.19 0.266 0 c1: Carbamidomethyl (+57.02) 544.6067 1,630.80 1,631.81 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQK 95.00% 3.96 0.283 0 c1: Carbamidomethyl (+57.02) 544.6069 1,630.80 1,631.81 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% MELQEMQLK 95.00% 2.58 0.222 0 575.2848 1,148.55 1,149.57 2 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% MELQEMQLK 95.00% 3.04 0.261 0 575.2852 1,148.55 1,149.57 2 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LVILEGELER 95.00% 3.33 0.382 1.72 585.8056 1,169.60 1,170.67 2 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LVILEGELER 95.00% 3.75 0.483 0 585.8393 1,169.66 1,170.67 2 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LVILEGELER 95.00% 3.42 0.428 0 585.8398 1,169.66 1,170.67 2 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LVILEGELER 95.00% 3.16 0.387 1.77 586.0563 1,170.10 1,170.67 2 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQKK 95.00% 4.7 0.395 0 c1: Carbamidomethyl (+57.02) 587.3052 1,758.89 1,759.90 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% EDKYEEEIKLLEEK 95.00% 2.57 0.258 0 598.9697 1,793.89 1,794.90 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% EDKYEEEIKLLEEK 95.00% 3.44 0.207 0 598.9718 1,793.89 1,794.90 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% EDKYEEEIKLLEEK 95.00% 3.28 0.205 0 598.9723 1,793.89 1,794.90 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% EDKYEEEIKLLEEK 95.00% 3.44 0.206 0 599.3065 1,794.90 1,794.90 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDR 95.00% 2.91 0.32 1.14 622.3278 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDR 95.00% 3.36 0.389 1.74 622.3282 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDR 95.00% 2.94 0.374 1.17 622.3286 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDR 95.00% 3.29 0.365 1.3 622.3291 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDR 95.00% 3.28 0.365 1.92 622.3291 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDR 95.00% 3.35 0.363 1.19 622.3293 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDR 95.00% 3.34 0.381 2 622.3293 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDR 95.00% 2.84 0.352 0 622.3307 1,242.65 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDR 95.00% 2.51 0.244 0 622.3308 1,242.65 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDRAQER 95.00% 3.72 0.436 0.921 628.6689 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDRAQER 95.00% 3.79 0.302 1.42 628.6689 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDRAQER 95.00% 3.39 0.347 2.12 628.669 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDRAQER 95.00% 4.03 0.419 1.96 628.6694 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDRAQER 95.00% 4.33 0.47 0 628.67 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDRAQER 95.00% 3.41 0.216 0 629.0023 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDRAQER 95.00% 4.01 0.4 0 629.0032 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDRAQER 95.00% 3.82 0.365 0 629.0032 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDRAQER 95.00% 3.55 0.309 1.31 629.0037 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LDKENAIDRAEQAEADK 95.00% 3.47 0.396 0 639.6506 1,915.93 1,915.94 3 TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KLVILEGELER 95.00% 3.35 0.397 2.89 649.8869 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KLVILEGELER 95.00% 3.61 0.425 3.14 649.8871 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KLVILEGELER 95.00% 2.87 0.292 2.44 649.8875 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KLVILEGELER 95.00% 3.27 0.351 2.92 649.888 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% AMKDEEKMELQEMQLK 95.00% 3.35 0.325 1.1 660.9856 1,979.93 1,980.94 3 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% AMKDEEKMELQEMQLK 95.00% 4.19 0.29 1.59 661.3182 1,980.93 1,980.94 3 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% AMKDEEKMELQEMQLK 95.00% 4.88 0.39 1.17 661.3187 1,980.93 1,980.94 3 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% YSESVKEAQEKLEQAEK 95.00% 4.85 0.465 2.64 666.0008 1,994.98 1,995.99 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% YSESVKEAQEKLEQAEK 95.00% 5 0.504 1.59 666.334 1,995.98 1,995.99 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% YSESVKEAQEKLEQAEK 95.00% 3.36 0.299 0 666.3343 1,995.98 1,995.99 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% YSESVKEAQEKLEQAEK 95.00% 3.77 0.533 0 666.3353 1,995.98 1,995.99 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNR 95.00% 3.03 0.408 2.68 666.8213 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNR 95.00% 3.56 0.45 3.68 666.8221 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNR 95.00% 3.56 0.474 2.92 666.8222 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNR 95.00% 4.21 0.498 3.31 666.8222 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNR 95.00% 4.34 0.505 2.92 666.8224 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNR 95.00% 3.88 0.47 3.52 666.8226 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNR 95.00% 3.43 0.452 2.77 666.8227 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNR 95.00% 4.37 0.51 2.89 666.8227 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNR 95.00% 3.75 0.479 3.38 666.8229 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% QLEEEQQALQK 95.00% 3.65 0.263 1.24 672.3432 1,342.67 1,343.68 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% QLEEEQQALQK 95.00% 3.87 0.284 0 672.3438 1,342.67 1,343.68 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 3.17 0.383 1.82 700.3788 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 3.24 0.336 1.89 700.3788 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 3.38 0.384 2.14 700.3792 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 3.21 0.378 1.42 700.3795 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 3.49 0.373 2.41 700.3799 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 3.48 0.322 2.66 700.3802 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 3.24 0.3 2.64 700.3805 1,398.75 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDR 95.00% 3.86 0.404 1.92 700.3806 1,398.75 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEK 95.00% 4.01 0.421 3 722.4052 1,442.79 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEK 95.00% 3.94 0.437 2.19 722.4059 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEK 95.00% 4.24 0.483 3.31 722.4063 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEK 95.00% 4.12 0.402 2.21 722.4063 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEK 95.00% 2.79 0.169 0 722.4085 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEK 95.00% 3.43 0.294 0 722.4132 1,442.81 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% GTEDEVEKYSESVKEAQEK 95.00% 3.92 0.447 0 729.3441 2,185.01 2,185.02 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% GTEDEVEKYSESVKEAQEK 95.00% 4.16 0.457 1.89 729.3444 2,185.01 2,185.02 3
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNR 95.00% 4.52 0.573 4.15 730.8703 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNR 95.00% 4.56 0.569 2.49 730.8708 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNR 95.00% 3.87 0.527 3.19 730.8733 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNR 95.00% 4.51 0.507 3.51 731.3699 1,460.72 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNR 95.00% 4.08 0.506 3 731.3735 1,460.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNR 95.00% 4.5 0.519 3.96 731.3739 1,460.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEKAADESER 95.00% 4.22 0.554 4.74 734.7108 2,201.11 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEKAADESER 95.00% 4.47 0.623 6.14 735.0448 2,202.11 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEKAADESER 95.00% 4.44 0.548 5.04 735.0464 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEKAADESER 95.00% 4.9 0.592 3.54 735.0472 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEKAADESER 95.00% 4.53 0.598 6.52 735.0483 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LEEAEKAADESER 95.00% 3.67 0.509 4.35 738.8471 1,475.68 1,476.68 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNRR 95.00% 2.28 0.289 0 744.872 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNRR 94.80% 2.13 0.26 0 744.873 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNRR 95.00% 2.36 0.302 0 744.8745 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% ATDAEADVASLNRR 95.00% 2.37 0.186 1.17 744.8745 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LKEAETRAEFAER 95.00% 3.41 0.307 0 775.4012 1,548.79 1,549.80 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LKEAETRAEFAER 95.00% 3.45 0.301 0 775.4019 1,548.79 1,549.80 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% GTEDEVEKYSESVK 95.00% 4.73 0.594 4.32 800.372 1,598.73 1,599.74 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% GTEDEVEKYSESVK 95.00% 4.58 0.575 6.54 800.373 1,598.73 1,599.74 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% GTEDEVEKYSESVK 95.00% 4.73 0.549 3.7 800.8734 1,599.73 1,599.74 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% GTEDEVEKYSESVK 95.00% 4.71 0.583 3.46 800.8755 1,599.74 1,599.74 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQK 95.00% 0 0 4.33 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 807.8927 1,613.77 1,614.78 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQK 95.00% 0 0 4.64 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 807.8929 1,613.77 1,614.78 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQK 95.00% 0 0 4.11 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 807.894 1,613.77 1,614.78 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNRR 95.00% 2.71 0.32 0 808.9207 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNRR 95.00% 2.49 0.243 0 808.9214 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KATDAEADVASLNRR 95.00% 2.73 0.324 0 809.4236 1,616.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQK 95.00% 5.2 0.528 2.74 c1: Carbamidomethyl (+57.02) 816.4047 1,630.79 1,631.81 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQK 95.00% 5.14 0.534 2.89 c1: Carbamidomethyl (+57.02) 816.4062 1,630.80 1,631.81 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQK 95.00% 4.99 0.517 3.06 c1: Carbamidomethyl (+57.02) 816.4068 1,630.80 1,631.81 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQK 95.00% 5.49 0.491 2 c1: Carbamidomethyl (+57.02) 816.9085 1,631.80 1,631.81 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDRAQER 95.00% 3.47 0.212 1.12 864.4477 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDRAQER 95.00% 3.84 0.338 0 864.4483 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDRAQER 95.00% 3.88 0.303 0 864.4493 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDRAQER 95.00% 3.44 0.186 0 864.4494 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDRAQER 95.00% 3.59 0.311 1.21 864.4496 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDRAQER 95.00% 3.39 0.163 0 864.4502 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDRAQER 95.00% 4.18 0.295 0 864.4502 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDRAQER 95.00% 3.01 0.194 0 864.4516 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDRAQER 95.00% 3.4 0.192 0 864.9478 1,727.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDRAQER 95.00% 3.7 0.305 0 864.949 1,727.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDRAQER 95.00% 3.07 0.243 0 864.9494 1,727.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% IQLVEEELDRAQER 95.00% 3.78 0.186 0 864.9532 1,727.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQKK 95.00% 0 0 3.8 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 872.439 1,742.86 1,742.88 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQKK 95.00% 0 0 3.34 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 872.4403 1,742.87 1,742.88 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% cKQLEEEQQALQKK 95.00% 0 0 4.07 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 872.4414 1,742.87 1,742.88 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KLVILEGELERSEER 95.00% 4.09 0.423 0 900.997 1,799.98 1,799.99 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KLVILEGELERSEER 95.00% 3.93 0.295 1.82 900.9974 1,799.98 1,799.99 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% KLVILEGELERSEER 95.00% 4.22 0.405 0 900.9976 1,799.98 1,799.99 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% HIAEDSDRKYEEVAR 95.00% 3.57 0.427 0 909.4425 1,816.87 1,817.88 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% HIAEDSDRKYEEVAR 95.00% 3.8 0.509 2.24 909.9542 1,817.89 1,817.88 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LKGTEDEVEKYSESVK 95.00% 4.91 0.619 4.96 920.9607 1,839.91 1,840.92 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LKGTEDEVEKYSESVK 95.00% 5.06 0.556 3.82 921.4633 1,840.91 1,840.92 2
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDRAQER 95.00% 2.79 0.386 0 942.4984 1,882.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDRAQER 95.00% 3.07 0.363 0 942.4992 1,882.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% RIQLVEEELDRAQER 95.00% 3.09 0.34 0 943 1,883.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% AMKDEEKMELQEMQLK 95.00% 6.42 0.449 4.35 991.4743 1,980.93 1,980.94 2 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% AMKDEEKMELQEMQLK 95.00% 6 0.492 3.38 991.4744 1,980.93 1,980.94 2 TPM4_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LDKENAIDRAEQAEADKK 95.00% 0 0 4.11 1,022.52 2,043.02 2,044.03 2 TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LDKENAIDRAEQAEADKK 95.00% 0 0 3.44 1,022.52 2,043.02 2,044.03 2 TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LDKENAIDRAEQAEADKK 95.00% 0 0 4 1,023.02 2,044.02 2,044.03 2 TPM1_HUMAN
 SAMPLE 2 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 27 37 135 63.70% LATALQKLEEAEKAADESER 95.00% 5.29 0.665 7.7 1,102.07 2,202.13 2,202.13 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDR 95.00% 3.26 0.321 0 467.256 1,398.74 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDR 95.00% 3.35 0.372 0 467.2568 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDR 95.00% 3.96 0.402 1.36 467.2571 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDR 95.00% 4.02 0.35 0 467.2573 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDR 95.00% 4.17 0.298 0 467.5921 1,399.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEK 95.00% 2.84 0.228 0 481.9392 1,442.79 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEK 95.00% 2.36 0.291 0 481.9394 1,442.79 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEK 95.00% 2.12 0.294 0 482.2729 1,443.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNR 95.00% 3.69 0.24 0 487.582 1,459.72 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNR 95.00% 3.68 0.292 0 487.5822 1,459.72 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNR 95.00% 3.08 0.286 0 487.5827 1,459.72 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNR 95.00% 3.31 0.149 0 487.5836 1,459.73 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% QLEEEQQALQKK 95.00% 2.24 0.22 0 491.2625 1,470.76 1,471.78 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% QLEEEQQALQKK 95.00% 2.32 0.262 0 491.2637 1,470.77 1,471.78 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNRR 95.00% 1.98 0.216 0 496.9172 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNRR 95.00% 2.3 0.255 1.48 496.9179 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNRR 95.00% 2.13 0.213 0 496.918 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNRR 95.00% 2.21 0.226 0 496.9182 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% GTEDEVEKYSESVK 95.00% 2.64 0.449 0 533.9167 1,598.73 1,599.74 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% GTEDEVEKYSESVK 95.00% 2.36 0.419 0 533.9172 1,598.73 1,599.74 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNRR 95.00% 2.39 0.244 0 539.6149 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNRR 95.00% 2.04 0.304 0 539.6155 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNRR 95.00% 2.26 0.283 0 539.6155 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNRR 95.00% 2.26 0.37 0 539.616 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% cKQLEEEQQALQK 95.00% 3.94 0.248 0 c1: Carbamidomethyl (+57.02) 544.9391 1,631.79 1,631.81 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ENAIDRAEQAEADKK 95.00% 4.24 0.439 0 563.2785 1,686.81 1,687.83 3 TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ENAIDRAEQAEADKK 95.00% 4.13 0.42 0 563.6128 1,687.81 1,687.83 3 TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LVILEGELER 95.00% 3.63 0.469 2.05 585.8377 1,169.66 1,170.67 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LVILEGELER 95.00% 3.25 0.422 1.62 585.8385 1,169.66 1,170.67 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LVILEGELER 95.00% 3.55 0.461 0 585.8388 1,169.66 1,170.67 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LVILEGELER 95.00% 3.5 0.463 1.26 585.8394 1,169.66 1,170.67 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LVILEGELER 95.00% 3.08 0.275 2.29 586.0563 1,170.10 1,170.67 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LVILEGELER 95.00% 2.77 0.357 2.85 586.0577 1,170.10 1,170.67 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% cKQLEEEQQALQKK 95.00% 3.84 0.479 0 c1: Carbamidomethyl (+57.02) 587.3059 1,758.89 1,759.90 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% cKQLEEEQQALQKK 95.00% 4.06 0.47 0 c1: Carbamidomethyl (+57.02) 587.6395 1,759.90 1,759.90 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% EDKYEEEIKLLEEK 95.00% 2.95 0.288 0 598.9704 1,793.89 1,794.90 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% EDKYEEEIKLLEEK 95.00% 3.98 0.289 0 598.9718 1,793.89 1,794.90 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% EDKYEEEIKLLEEK 95.00% 3.5 0.253 0 599.3052 1,794.89 1,794.90 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% EDKYEEEIKLLEEK 95.00% 2.68 0.257 0 599.3059 1,794.89 1,794.90 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDR 95.00% 2.85 0.339 1.64 622.3279 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDR 95.00% 2.52 0.229 0 622.3288 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDR 95.00% 3.18 0.378 2.17 622.3289 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDR 95.00% 2.95 0.342 1.6 622.329 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDR 95.00% 2.78 0.312 1.35 622.3292 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDR 95.00% 3.26 0.368 1.4 622.3301 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDR 95.00% 3.27 0.365 2.12 622.3303 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDR 95.00% 3.08 0.321 1.74 622.331 1,242.65 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDR 95.00% 2.18 0.219 1.8 622.3318 1,242.65 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDRAQER 95.00% 3.78 0.331 0 628.6682 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDRAQER 95.00% 4.09 0.357 0.959 628.6684 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDRAQER 95.00% 3.71 0.336 1.01 628.669 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDRAQER 95.00% 3.53 0.382 1.64 628.6691 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDRAQER 95.00% 3.65 0.371 0 628.6692 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDRAQER 95.00% 4.23 0.36 1.62 628.6693 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDRAQER 95.00% 2.98 0.129 1.49 629.003 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDRAQER 95.00% 3.63 0.419 0 629.0034 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDRAQER 95.00% 3.26 0.344 0 629.0034 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LDKENAIDRAEQAEADK 95.00% 3.56 0.37 0 639.65 1,915.93 1,915.94 3 TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LDKENAIDRAEQAEADK 95.00% 3.93 0.327 0 639.6509 1,915.93 1,915.94 3 TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KLVILEGELER 95.00% 2.65 0.34 1.44 649.8857 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KLVILEGELER 95.00% 3.17 0.414 2.8 649.8866 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KLVILEGELER 95.00% 2.52 0.373 1.39 649.8869 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KLVILEGELER 95.00% 3.23 0.348 3.8 649.8869 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KLVILEGELER 95.00% 3.22 0.379 3.49 649.8871 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% AMKDEEKMELQEMQLK 95.00% 4.98 0.314 1.62 661.3191 1,980.93 1,980.94 3 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% AMKDEEKMELQEMQLK 95.00% 4.63 0.305 1.46 661.3232 1,980.95 1,980.94 3 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% YSESVKEAQEKLEQAEK 95.00% 5.08 0.519 1.64 666.0004 1,994.98 1,995.99 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% YSESVKEAQEKLEQAEK 95.00% 3.45 0.373 0 666.0004 1,994.98 1,995.99 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% YSESVKEAQEKLEQAEK 95.00% 2.79 0.433 0 666.0005 1,994.98 1,995.99 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% YSESVKEAQEKLEQAEK 95.00% 4.59 0.489 0 666.3348 1,995.98 1,995.99 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNR 95.00% 3.88 0.507 2.8 666.8212 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNR 95.00% 2.78 0.388 2.17 666.8225 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNR 95.00% 3.79 0.5 2.92 666.8224 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNR 95.00% 3.36 0.443 3.44 666.8227 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNR 95.00% 2.24 0.319 2.31 666.8229 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNR 95.00% 3.14 0.464 3.06 666.823 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% QLEEEQQALQK 95.00% 3.75 0.271 0 672.3436 1,342.67 1,343.68 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% QLEEEQQALQK 95.00% 3.8 0.272 0 672.344 1,342.67 1,343.68 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% QLEEEQQALQK 95.00% 3.26 0.293 0 672.3454 1,342.68 1,343.68 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDR 95.00% 3.47 0.366 2.66 700.3785 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDR 95.00% 3.11 0.354 3.77 700.3797 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDR 95.00% 3.11 0.319 2.72 700.3799 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDR 95.00% 3.57 0.338 2.72 700.3802 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDR 95.00% 2.93 0.329 0 700.3803 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDR 95.00% 3.9 0.444 2.72 700.3805 1,398.75 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEK 95.00% 4.28 0.461 2.14 722.4053 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEK 95.00% 4.05 0.447 2.7 722.4058 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEK 95.00% 4.11 0.495 1.85 722.4066 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEK 95.00% 3.13 0.323 1.82 722.4079 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEK 95.00% 3.38 0.321 2.48 722.91 1,443.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% GTEDEVEKYSESVKEAQEK 95.00% 4.1 0.412 0 729.3443 2,185.01 2,185.02 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNR 95.00% 4.43 0.546 4.13 730.8681 1,459.72 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNR 95.00% 4.43 0.576 4.6 730.8708 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNR 95.00% 4.22 0.572 4.82 730.8709 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNR 95.00% 2.89 0.191 0 730.8726 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNR 95.00% 3.29 0.473 3.92 730.8734 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNR 95.00% 3.62 0.484 1.85 730.8739 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNR 95.00% 2.63 0.277 1.6 730.8828 1,459.75 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEKAADESER 95.00% 4.37 0.534 3.44 735.0464 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEKAADESER 95.00% 4.7 0.582 3.39 735.0466 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEKAADESER 95.00% 4.24 0.603 4.29 735.0472 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEKAADESER 95.00% 4.52 0.565 4.03 735.0478 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEKAADESER 95.00% 4.34 0.605 4.68 735.0482 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEKAADESER 95.00% 4.13 0.45 3.64 735.0491 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LEEAEKAADESER 95.00% 4.04 0.568 4.2 738.8451 1,475.67 1,476.68 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LEEAEKAADESER 95.00% 3.8 0.481 3.8 738.8477 1,475.68 1,476.68 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNRR 95.00% 2.53 0.296 0 744.8729 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNRR 95.00% 2.29 0.275 0 744.8731 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNRR 95.00% 2.22 0.218 1.51 744.8734 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% ATDAEADVASLNRR 95.00% 2.44 0.289 1.33 744.8741 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LKEAETRAEFAER 95.00% 3.1 0.307 0 775.399 1,548.78 1,549.80 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LKEAETRAEFAER 95.00% 3.06 0.365 0 775.4015 1,548.79 1,549.80 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LKEAETRAEFAER 95.00% 3.13 0.301 0 775.9033 1,549.79 1,549.80 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% GTEDEVEKYSESVK 95.00% 4.93 0.576 5.23 800.3722 1,598.73 1,599.74 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% GTEDEVEKYSESVK 95.00% 4.75 0.577 3.57 800.3725 1,598.73 1,599.74 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% GTEDEVEKYSESVK 95.00% 4.3 0.56 3.59 800.3761 1,598.74 1,599.74 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% GTEDEVEKYSESVK 95.00% 4.45 0.532 4.72 800.8746 1,599.73 1,599.74 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNRR 95.00% 2.87 0.33 0 808.9209 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNRR 95.00% 2.29 0.31 0 808.9218 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNRR 95.00% 2.72 0.31 0 808.9218 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNRR 95.00% 2.74 0.316 0 808.9229 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KATDAEADVASLNRR 95.00% 2.64 0.28 0 809.4219 1,616.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LKGTEDEVEKYSESVKEAQEK 94.80% 0 0 3.19 809.7387 2,426.19 2,426.19 3
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% cKQLEEEQQALQK 95.00% 5.42 0.541 3.28 c1: Carbamidomethyl (+57.02) 816.4056 1,630.80 1,631.81 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% cKQLEEEQQALQK 95.00% 5.27 0.515 3.11 c1: Carbamidomethyl (+57.02) 816.4059 1,630.80 1,631.81 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% cKQLEEEQQALQK 95.00% 5.03 0.525 2.7 c1: Carbamidomethyl (+57.02) 816.4061 1,630.80 1,631.81 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% cKQLEEEQQALQK 95.00% 5.07 0.514 2.96 c1: Carbamidomethyl (+57.02) 816.4063 1,630.80 1,631.81 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDRAQER 95.00% 3.46 0.17 0 864.4464 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDRAQER 95.00% 3.51 0.216 1.31 864.4475 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDRAQER 95.00% 3.81 0.26 0 864.4483 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDRAQER 95.00% 3.59 0.256 0 864.4488 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDRAQER 95.00% 3.7 0.249 1.24 864.4497 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDRAQER 95.00% 3.62 0.321 0 864.4506 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDRAQER 95.00% 3.58 0.234 1.32 864.4511 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDRAQER 95.00% 3.65 0.24 0 864.4512 1,726.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% IQLVEEELDRAQER 95.00% 4.19 0.339 0 864.951 1,727.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% cKQLEEEQQALQKK 95.00% 0 0 3.38 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 872.4405 1,742.87 1,742.88 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% cKQLEEEQQALQKK 95.00% 0 0 3.89 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 872.4406 1,742.87 1,742.88 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KLVILEGELERSEER 95.00% 3.7 0.345 1.7 900.4966 1,798.98 1,799.99 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% KLVILEGELERSEER 95.00% 4.18 0.446 2.04 900.498 1,798.98 1,799.99 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% HIAEDSDRKYEEVAR 95.00% 3.78 0.411 2.29 909.4415 1,816.87 1,817.88 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% HIAEDSDRKYEEVAR 95.00% 3.86 0.492 1.48 909.445 1,816.87 1,817.88 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% HIAEDSDRKYEEVAR 95.00% 3.47 0.488 1.74 909.9433 1,817.87 1,817.88 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% HIAEDSDRKYEEVAR 95.00% 3.62 0.456 1.96 909.9441 1,817.87 1,817.88 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LKGTEDEVEKYSESVK 95.00% 5.55 0.569 5.77 920.9615 1,839.91 1,840.92 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LKGTEDEVEKYSESVK 95.00% 4.98 0.562 6.22 920.9627 1,839.91 1,840.92 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDRAQER 95.00% 2.71 0.375 1.25 942.4998 1,882.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDRAQER 95.00% 2.87 0.43 0 942.5014 1,882.99 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% RIQLVEEELDRAQER 95.00% 2.64 0.318 0 943.0025 1,883.99 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% AMKDEEKMELQEMQLK 95.00% 6.07 0.524 6.09 990.9714 1,979.93 1,980.94 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% AMKDEEKMELQEMQLK 95.00% 6.18 0.511 4.55 990.9715 1,979.93 1,980.94 2 TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% YSESVKEAQEKLEQAEK 95.00% 2.53 0.295 0 997.859 1,993.70 1,995.99 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% YSESVKEAQEKLEQAEK 95.00% 2.46 0.374 1.32 997.8602 1,993.70 1,995.99 2
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LDKENAIDRAEQAEADKK 95.00% 0 0 3.89 1,022.52 2,043.03 2,044.03 2 TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LDKENAIDRAEQAEADKK 95.00% 0 0 3.64 1,023.02 2,044.02 2,044.03 2 TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LDKENAIDRAEQAEADKK 95.00% 0 0 3.49 1,023.02 2,044.03 2,044.03 2 TPM1_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEKAADESER 95.00% 5.07 0.642 7.1 1,102.07 2,202.11 2,202.13 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 2R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 28 39 137 63.70% LATALQKLEEAEKAADESER 95.00% 5.22 0.621 7.06 1,102.07 2,202.11 2,202.13 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDR 95.00% 3.62 0.374 0 467.2549 1,398.74 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDR 95.00% 3.27 0.4 0 467.2563 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDR 95.00% 4.03 0.368 0 467.2564 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDR 95.00% 2.96 0.199 0 467.5912 1,399.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% HIAEDSDR 95.00% 2.35 0.359 1.74 471.7179 941.4202 942.4282 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEK 95.00% 2.01 0.329 0 481.9394 1,442.79 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEK 95.00% 2.48 0.311 0 482.2734 1,443.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNR 95.00% 3.3 0.257 0 487.5823 1,459.72 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNR 95.00% 3.57 0.293 0 487.5826 1,459.72 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LEEAEKAADESER 95.00% 2.29 0.248 0 492.899 1,475.67 1,476.68 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LEEAEKAADESER 95.00% 2.32 0.231 0 492.9008 1,475.68 1,476.68 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% AEQAEADKK 95.00% 2.59 0.259 0 495.2493 988.4829 989.4905 2 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNRR 95.00% 2.08 0.208 2.08 496.9174 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNRR 95.00% 1.64 0.279 0 496.9177 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNRR 95.00% 1.99 0.268 0 496.9181 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% GTEDEVEKYSESVK 95.00% 1.93 0.402 0 533.9173 1,598.73 1,599.74 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% GTEDEVEKYSESVK 95.00% 1.84 0.24 0 533.9177 1,598.73 1,599.74 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNRR 95.00% 2.61 0.364 1.02 539.615 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNRR 95.00% 2.57 0.326 0 539.6153 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNRR 95.00% 2.55 0.312 0 539.6157 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNRR 95.00% 2.67 0.286 0 539.6157 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNRR 95.00% 1.89 0.282 0 539.6162 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNRR 95.00% 2.74 0.294 0 539.6163 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNRR 95.00% 2.02 0.292 0 539.9502 1,616.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQK 95.00% 3.52 0.265 0 c1: Carbamidomethyl (+57.02) 544.6052 1,630.79 1,631.81 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQK 95.00% 3.91 0.282 0 c1: Carbamidomethyl (+57.02) 544.6068 1,630.80 1,631.81 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ENAIDRAEQAEADKK 95.00% 3.89 0.427 0 563.2781 1,686.81 1,687.83 3 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ENAIDRAEQAEADKK 95.00% 4.49 0.406 1.11 563.2789 1,686.81 1,687.83 3 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% MQMLKLDKENAIDR 95.00% 3.25 0.426 0 569.2998 1,704.88 1,704.88 3 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% MELQEMQLK 95.00% 3.13 0.234 0 575.2849 1,148.55 1,149.57 2 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LVILEGELER 95.00% 3.86 0.469 1.28 585.8393 1,169.66 1,170.67 2 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LVILEGELER 95.00% 3.72 0.478 0 585.8397 1,169.66 1,170.67 2 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LVILEGELER 95.00% 2.92 0.388 0 585.841 1,169.67 1,170.67 2 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LVILEGELER 95.00% 3.02 0.32 1.39 586.0563 1,170.10 1,170.67 2 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQKK 95.00% 5.33 0.468 0 c1: Carbamidomethyl (+57.02) 587.305 1,758.89 1,759.90 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQKK 95.00% 4.17 0.478 0 c1: Carbamidomethyl (+57.02) 587.3075 1,758.90 1,759.90 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQKK 95.00% 3.57 0.416 0 c1: Carbamidomethyl (+57.02) 587.639 1,759.89 1,759.90 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQKK 95.00% 5.11 0.507 0.959 c1: Carbamidomethyl (+57.02) 587.6393 1,759.89 1,759.90 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LEEAEKAADESERGMK 95.00% 3.51 0.393 0 598.2825 1,791.82 1,792.84 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LEEAEKAADESERGMK 95.00% 3.46 0.437 0 598.283 1,791.83 1,792.84 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LEEAEKAADESERGMK 95.00% 3.67 0.392 0 598.2837 1,791.83 1,792.84 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LEEAEKAADESERGMK 95.00% 3.4 0.315 0 598.6157 1,792.82 1,792.84 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% EDKYEEEIKLLEEK 95.00% 2.98 0.167 0 598.9703 1,793.89 1,794.90 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% EDKYEEEIKLLEEK 95.00% 2.98 0.304 0 598.9709 1,793.89 1,794.90 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% EDKYEEEIKLLEEK 95.00% 3.47 0.174 0 599.3055 1,794.89 1,794.90 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% EDKYEEEIKLLEEK 95.00% 3.4 0.25 0 599.3062 1,794.90 1,794.90 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LEEAEKAADESERGmK 95.00% 3.05 0.368 0 m15: Oxidation (+15.99) 603.9519 1,808.83 1,808.83 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDR 95.00% 2.33 0.204 0 622.3283 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDR 95.00% 3.45 0.384 1.51 622.3286 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDR 95.00% 2.89 0.328 1.62 622.3288 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDR 95.00% 3.23 0.278 1.66 622.3294 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDR 95.00% 3.14 0.403 1.77 622.3299 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDR 95.00% 3.25 0.376 1.68 622.3303 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDR 95.00% 3.36 0.396 1.64 622.3303 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDR 95.00% 2.87 0.313 1.28 622.3325 1,242.65 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.6 0.383 1.17 628.6674 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.51 0.246 1.19 628.6678 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.31 0.299 0 628.6689 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 2.92 0.387 0 628.6712 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.7 0.359 0.959 629.0019 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.53 0.422 1.08 629.0021 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.34 0.418 0 629.0023 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.4 0.239 0 629.0025 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.68 0.429 0 629.0027 1,883.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.7 0.448 1.44 629.0031 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.35 0.303 0 629.0031 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.99 0.459 1.18 629.0034 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.41 0.149 0 629.0037 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.23 0.334 0 629.0055 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.78 0.374 0 629.0062 1,884.00 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LDKENAIDRAEQAEADK 95.00% 3.19 0.344 0 639.6498 1,915.93 1,915.94 3 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LDKENAIDRAEQAEADK 95.00% 3.54 0.437 1.14 639.6512 1,915.93 1,915.94 3 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KLVILEGELER 95.00% 3.27 0.45 2.92 649.8855 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KLVILEGELER 95.00% 3.91 0.45 3.96 649.8871 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KLVILEGELER 95.00% 3.72 0.456 3.37 649.8874 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KLVILEGELER 95.00% 3.78 0.42 4.01 649.8874 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KLVILEGELER 95.00% 3.6 0.481 2.72 649.8881 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% EAETRAEFAER 95.00% 2.05 0.345 0 654.8122 1,307.61 1,308.62 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% AMKDEEKMELQEMQLK 95.00% 3.06 0.3 1.32 660.9814 1,979.92 1,980.94 3 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% AMKDEEKMELQEMQLK 95.00% 4.99 0.323 1.4 660.9853 1,979.93 1,980.94 3 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% AMKDEEKMELQEMQLK 95.00% 3.99 0.262 4.01 661.319 1,980.93 1,980.94 3 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% AMKDEEKMELQEMQLK 95.00% 3.69 0.311 0 661.3198 1,980.94 1,980.94 3 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% AMKDEEKMELQEMQLK 95.00% 4.21 0.388 0 661.3215 1,980.94 1,980.94 3 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% YSESVKEAQEKLEQAEK 95.00% 4.3 0.322 2.21 666.0004 1,994.98 1,995.99 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% YSESVKEAQEKLEQAEK 95.00% 4.32 0.49 0 666.3343 1,995.98 1,995.99 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNR 95.00% 3.85 0.459 3.13 666.8219 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNR 95.00% 3.45 0.467 2.77 666.822 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNR 95.00% 4.03 0.45 2.68 666.8222 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNR 95.00% 3.61 0.438 3.42 666.8225 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNR 95.00% 4.46 0.458 3.7 666.8228 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNR 95.00% 3.31 0.437 3.82 666.8228 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNR 95.00% 4.41 0.487 3.8 666.8231 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNR 95.00% 2.95 0.44 2.17 666.8233 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% QLEEEQQALQK 95.00% 3.72 0.255 0 672.3425 1,342.67 1,343.68 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% QLEEEQQALQK 95.00% 3.53 0.28 0 672.343 1,342.67 1,343.68 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% QLEEEQQALQK 95.00% 3.56 0.324 1.68 672.3441 1,342.67 1,343.68 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% QLEEEQQALQK 95.00% 3.4 0.286 0 672.3443 1,342.67 1,343.68 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% AmKDEEKmELQEmQLK 95.00% 3.15 0.371 0 m2: Oxidation (+15.99), m8: Oxidation (+15.99), m13: Oxidation (+15.99) 677.3141 2,028.92 2,028.93 3 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDR 95.00% 2.92 0.346 2.57 700.3797 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDR 95.00% 3.32 0.395 1.96 700.38 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDR 95.00% 3.23 0.336 2.85 700.3806 1,398.75 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDR 95.00% 3.13 0.369 2.02 700.3811 1,398.75 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDR 95.00% 2.96 0.359 2.77 700.8807 1,399.75 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEK 95.00% 4.16 0.502 2.57 722.4057 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEK 95.00% 4.2 0.476 2.47 722.4062 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEK 95.00% 2.27 0.155 1.1 722.4071 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEK 95.00% 3.63 0.393 2.18 722.4074 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEK 95.00% 3.52 0.411 2.68 722.408 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% GTEDEVEKYSESVKEAQEK 95.00% 5.35 0.616 1.74 729.0092 2,184.00 2,185.02 3
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNR 95.00% 3.09 0.505 4.13 730.8676 1,459.72 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNR 95.00% 4.4 0.582 4.62 730.8679 1,459.72 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNR 95.00% 4.41 0.548 3.62 730.8699 1,459.72 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNR 95.00% 4.56 0.517 4.42 730.8705 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNR 95.00% 4.01 0.553 3.6 730.8706 1,459.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEKAADESER 95.00% 4.56 0.559 3.7 735.0465 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEKAADESER 95.00% 4.92 0.581 4.7 735.0469 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEKAADESER 95.00% 4.81 0.582 4.59 735.0471 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEKAADESER 95.00% 4.67 0.577 4.07 735.0472 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LEEAEKAADESER 95.00% 4.04 0.496 4.27 738.8461 1,475.68 1,476.68 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNRR 95.00% 2.4 0.23 1.34 744.8726 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNRR 95.00% 2.49 0.284 0 744.8749 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ATDAEADVASLNRR 95.00% 2.25 0.269 0 744.875 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% TIDDLEDEVYAQK 95.00% 3.87 0.473 4.89 769.8632 1,537.71 1,538.72 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% TIDDLEDEVYAQK 95.00% 3.99 0.429 5.4 770.3683 1,538.72 1,538.72 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LKEAETRAEFAER 95.00% 3.38 0.283 1.24 775.4004 1,548.79 1,549.80 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LKEAETRAEFAER 95.00% 3.37 0.317 0 775.901 1,549.79 1,549.80 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% GTEDEVEKYSESVK 95.00% 4.43 0.594 3.43 800.3725 1,598.73 1,599.74 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% GTEDEVEKYSESVK 95.00% 4.68 0.569 5.54 800.373 1,598.73 1,599.74 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNRR 95.00% 2.94 0.392 0 808.9194 1,615.82 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KATDAEADVASLNRR 95.00% 2.68 0.281 0 809.422 1,616.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQK 95.00% 4.47 0.478 3.37 c1: Carbamidomethyl (+57.02) 816.4043 1,630.79 1,631.81 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQK 95.00% 5 0.491 2.96 c1: Carbamidomethyl (+57.02) 816.4051 1,630.79 1,631.81 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQK 95.00% 5.23 0.51 3.19 c1: Carbamidomethyl (+57.02) 816.4051 1,630.79 1,631.81 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQK 95.00% 5.09 0.51 3.36 c1: Carbamidomethyl (+57.02) 816.4062 1,630.80 1,631.81 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQK 95.00% 4.82 0.516 4.49 c1: Carbamidomethyl (+57.02) 816.4063 1,630.80 1,631.81 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQK 95.00% 4.76 0.504 3.12 c1: Carbamidomethyl (+57.02) 816.4078 1,630.80 1,631.81 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQK 95.00% 4.68 0.436 2.96 c1: Carbamidomethyl (+57.02) 816.9083 1,631.80 1,631.81 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQK 95.00% 5.04 0.499 3.08 c1: Carbamidomethyl (+57.02) 816.9091 1,631.80 1,631.81 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ENAIDRAEQAEADKK 95.00% 4.04 0.473 1.62 844.4151 1,686.81 1,687.83 2 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% ENAIDRAEQAEADKK 95.00% 4.04 0.458 1.96 844.4153 1,686.82 1,687.83 2 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDRAQER 95.00% 3.53 0.215 0 864.4478 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDRAQER 95.00% 4.48 0.345 1.37 864.4483 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDRAQER 95.00% 3.59 0.258 0 864.4488 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDRAQER 95.00% 3.74 0.33 0 864.4488 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDRAQER 95.00% 3.74 0.326 0 864.4497 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDRAQER 95.00% 3.66 0.226 1.09 864.9501 1,727.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDRAQER 95.00% 3.62 0.206 0 864.9506 1,727.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDRAQER 95.00% 3.7 0.242 0 864.9524 1,727.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% IQLVEEELDRAQER 95.00% 3.28 0.312 0 864.9552 1,727.89 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQKK 95.00% 0 0 4.74 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 871.9403 1,741.87 1,742.88 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQKK 95.00% 0 0 3.89 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 871.9404 1,741.87 1,742.88 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQKK 95.00% 5.76 0.505 3.42 c1: Carbamidomethyl (+57.02) 880.453 1,758.89 1,759.90 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% cKQLEEEQQALQKK 95.00% 5.78 0.482 3.06 c1: Carbamidomethyl (+57.02) 880.4539 1,758.89 1,759.90 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% EDKYEEEIKLLEEK 95.00% 3.36 0.343 1.21 897.9514 1,793.89 1,794.90 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% EDKYEEEIKLLEEK 95.00% 4.53 0.429 2.92 898.4535 1,794.89 1,794.90 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KLVILEGELERSEER 95.00% 4.06 0.377 2.22 900.494 1,798.97 1,799.99 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% KLVILEGELERSEER 95.00% 3.96 0.366 2 901.001 1,799.99 1,799.99 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% HIAEDSDRKYEEVAR 95.00% 3.82 0.468 2.66 909.4403 1,816.86 1,817.88 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% HIAEDSDRKYEEVAR 95.00% 4.15 0.507 2.42 909.9438 1,817.87 1,817.88 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LKGTEDEVEKYSESVK 95.00% 5.16 0.572 6.23 920.9601 1,839.90 1,840.92 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LKGTEDEVEKYSESVK 95.00% 5.14 0.569 5.36 920.9614 1,839.91 1,840.92 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 2.52 0.251 0 942.4976 1,882.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 2.87 0.364 0 942.9986 1,883.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% RIQLVEEELDRAQER 95.00% 3.33 0.415 1.11 943.0002 1,883.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LDKENAIDRAEQAEADK 95.00% 5.13 0.518 5.89 958.4729 1,914.93 1,915.94 2 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LDKENAIDRAEQAEADK 95.00% 5.03 0.485 6.36 958.9707 1,915.93 1,915.94 2 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% AMKDEEKMELQEMQLK 95.00% 6.47 0.465 5.42 990.9746 1,979.93 1,980.94 2 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% AMKDEEKMELQEMQLK 95.00% 5.98 0.514 5.39 991.4744 1,980.93 1,980.94 2 TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% YSESVKEAQEKLEQAEK 95.00% 5.12 0.558 4.03 998.4961 1,994.98 1,995.99 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% YSESVKEAQEKLEQAEK 95.00% 5.02 0.517 3.66 998.4972 1,994.98 1,995.99 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LDKENAIDRAEQAEADKK 95.00% 0 0 3.39 1,022.52 2,043.02 2,044.03 2 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LDKENAIDRAEQAEADKK 95.00% 0 0 3.43 1,023.02 2,044.02 2,044.03 2 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LDKENAIDRAEQAEADKK 95.00% 0 0 3.48 1,023.02 2,044.02 2,044.03 2 TPM1_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% GTEDEVEKYSESVKEAQEK 95.00% 5.55 0.497 5.6 1,093.51 2,185.00 2,185.02 2
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEKAADESER 95.00% 5.32 0.672 7.57 1,102.06 2,202.11 2,202.13 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3 Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 33 49 150 71.10% LATALQKLEEAEKAADESER 95.00% 5.19 0.644 6.85 1,102.07 2,202.12 2,202.13 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 4.4 0.42 0 467.2555 1,398.74 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 3.18 0.379 0 467.2561 1,398.74 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 4.69 0.395 0 467.2562 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 3.33 0.301 0 467.2569 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 3.41 0.371 0 467.2572 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 3.42 0.447 0 467.2576 1,398.75 1,399.75 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% HIAEDSDR 95.00% 2.28 0.303 0 471.7205 941.4253 942.4282 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEK 95.00% 2.9 0.466 0 481.9397 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEK 95.00% 2.26 0.352 0 481.9397 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEK 95.00% 1.89 0.22 0 481.9399 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEK 95.00% 2.33 0.194 0 481.9412 1,442.80 1,443.81 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNR 95.00% 3.26 0.208 0 487.5817 1,459.72 1,460.73 3 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LEEAEKAADESER 95.00% 1.87 0.26 0 492.9 1,475.68 1,476.68 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LEEAEKAADESER 95.00% 2.03 0.229 0 492.9008 1,475.68 1,476.68 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNRR 95.00% 2.45 0.239 1.13 496.9168 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNRR 95.00% 2.02 0.144 1 496.9175 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNRR 95.00% 1.9 0.248 1.19 496.9175 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNRR 95.00% 1.89 0.291 0 496.9176 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNRR 95.00% 1.64 0.262 0 496.9177 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNRR 95.00% 1.87 0.283 0 496.9183 1,487.73 1,488.74 3 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% GTEDEVEKYSESVK 95.00% 2.15 0.268 0 533.9171 1,598.73 1,599.74 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% GTEDEVEKYSESVK 95.00% 2.27 0.224 0 533.9177 1,598.73 1,599.74 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNRR 95.00% 2.38 0.237 0 539.6148 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNRR 95.00% 2.21 0.194 0 539.6151 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNRR 94.70% 2.15 0.187 0 539.6154 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNRR 95.00% 2.07 0.212 0 539.6156 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNRR 95.00% 2.3 0.259 0 539.6159 1,615.82 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNRR 95.00% 2.55 0.207 0 539.6163 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNRR 95.00% 1.64 0.192 1.11 539.6164 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNRR 95.00% 2.31 0.234 0 539.6167 1,615.83 1,616.84 3 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQK 95.00% 4.05 0.313 0 c1: Carbamidomethyl (+57.02) 544.6057 1,630.79 1,631.81 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQK 95.00% 3.99 0.253 0 c1: Carbamidomethyl (+57.02) 544.6059 1,630.79 1,631.81 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQK 95.00% 3.69 0.197 0 c1: Carbamidomethyl (+57.02) 544.939 1,631.79 1,631.81 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ENAIDRAEQAEADKK 95.00% 3.93 0.42 0 563.2787 1,686.81 1,687.83 3 TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ENAIDRAEQAEADKK 95.00% 4.4 0.457 0 563.6122 1,687.81 1,687.83 3 TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% MQMLKLDKENAIDR 95.00% 2.92 0.333 0 568.9644 1,703.87 1,704.88 3 TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% MELQEMQLK 95.00% 2.95 0.214 0 575.2861 1,148.56 1,149.57 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% MELQEMQLK 95.00% 2.84 0.228 0 575.287 1,148.56 1,149.57 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LVILEGELER 95.00% 3.36 0.392 1.33 585.8379 1,169.66 1,170.67 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LVILEGELER 95.00% 3.76 0.473 0 585.8387 1,169.66 1,170.67 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LVILEGELER 95.00% 3.51 0.431 1.4 585.8388 1,169.66 1,170.67 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LVILEGELER 95.00% 3.42 0.394 0 585.8407 1,169.67 1,170.67 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LVILEGELER 95.00% 2.76 0.262 0 586.0552 1,170.09 1,170.67 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LVILEGELER 95.00% 3.1 0.423 0 586.0553 1,170.10 1,170.67 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LVILEGELER 95.00% 2.78 0.288 1.72 586.0559 1,170.10 1,170.67 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LVILEGELER 95.00% 2.2 0.298 0 586.0565 1,170.10 1,170.67 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LVILEGELER 95.00% 2.89 0.277 1.68 586.0569 1,170.10 1,170.67 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQKK 95.00% 5.53 0.492 0 c1: Carbamidomethyl (+57.02) 587.3043 1,758.89 1,759.90 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQKK 95.00% 5.34 0.493 0 c1: Carbamidomethyl (+57.02) 587.6381 1,759.89 1,759.90 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQKK 95.00% 3.18 0.327 0 c1: Carbamidomethyl (+57.02) 587.6387 1,759.89 1,759.90 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LEEAEKAADESERGMK 95.00% 3.68 0.322 1.4 598.2838 1,791.83 1,792.84 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LEEAEKAADESERGMK 95.00% 3.39 0.322 2.92 598.2842 1,791.83 1,792.84 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% EDKYEEEIKLLEEK 95.00% 3.21 0.242 0 598.9695 1,793.89 1,794.90 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% EDKYEEEIKLLEEK 95.00% 3.44 0.169 0 598.9706 1,793.89 1,794.90 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% EDKYEEEIKLLEEK 95.00% 3.17 0.156 0 599.305 1,794.89 1,794.90 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% EDKYEEEIKLLEEK 95.00% 3.64 0.185 0 599.3059 1,794.89 1,794.90 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LEEAEKAADESERGmK 95.00% 2.48 0.365 0 m15: Oxidation (+15.99) 603.618 1,807.83 1,808.83 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% IQLVEEELDR 95.00% 2.69 0.249 1.48 622.3284 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% IQLVEEELDR 95.00% 3.33 0.402 1.48 622.3293 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% IQLVEEELDR 95.00% 3.37 0.382 1.54 622.3294 1,242.64 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% IQLVEEELDR 95.00% 2.67 0.183 0 622.7936 1,243.57 1,243.65 2 TPM1_HUMAN,TPM4_HUMAN,LMNA_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 3.62 0.429 1.41 628.6683 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 3.88 0.401 1.36 628.6685 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 3.78 0.445 1.15 628.6689 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 4.07 0.411 0.959 628.669 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 3.77 0.46 0.959 628.669 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 3.46 0.292 0 628.6694 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 3.45 0.285 0 628.6694 1,882.98 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 3.86 0.479 0 628.6697 1,882.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 2.61 0.23 0 628.8526 1,883.53 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 3.33 0.371 0 629.0029 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 3.3 0.46 0 629.0033 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 3.02 0.235 0 629.0036 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 3.49 0.397 1.54 629.0045 1,883.99 1,883.99 3 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LDKENAIDRAEQAEADK 95.00% 3.22 0.414 1.55 639.3169 1,914.93 1,915.94 3 TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LDKENAIDRAEQAEADK 95.00% 3.44 0.363 0 639.651 1,915.93 1,915.94 3 TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KLVILEGELER 95.00% 3.26 0.45 3.82 649.8851 1,297.75 1,298.77 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KLVILEGELER 95.00% 3.94 0.446 3.92 649.8864 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KLVILEGELER 95.00% 3.26 0.445 2.31 649.8872 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KLVILEGELER 95.00% 3.89 0.458 2.85 649.8872 1,297.76 1,298.77 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% EAETRAEFAER 95.00% 2.18 0.313 0 654.8123 1,307.61 1,308.62 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% AMKDEEKMELQEMQLK 95.00% 4.26 0.434 0 660.9826 1,979.92 1,980.94 3 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% AMKDEEKMELQEMQLK 95.00% 4.1 0.252 1.26 660.985 1,979.93 1,980.94 3 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% AMKDEEKMELQEMQLK 95.00% 2.78 0.314 0 660.9852 1,979.93 1,980.94 3 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% AMKDEEKMELQEMQLK 95.00% 4.43 0.287 1 660.986 1,979.93 1,980.94 3 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% AMKDEEKMELQEMQLK 95.00% 3.17 0.281 1.68 661.319 1,980.93 1,980.94 3 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% AMKDEEKMELQEMQLK 95.00% 4.71 0.299 2.01 661.3195 1,980.93 1,980.94 3 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% AMKDEEKMELQEMQLK 95.00% 3.07 0.211 1.47 661.3203 1,980.94 1,980.94 3 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% YSESVKEAQEKLEQAEK 95.00% 5.2 0.479 0 666.3342 1,995.98 1,995.99 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% YSESVKEAQEKLEQAEK 95.00% 4.81 0.509 1.19 666.3344 1,995.98 1,995.99 3
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNR 95.00% 3.3 0.46 4.23 666.8211 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNR 95.00% 3.28 0.435 2.07 666.8227 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNR 95.00% 3.31 0.428 2.52 666.8228 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNR 95.00% 3.52 0.448 2.33 666.823 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNR 95.00% 3.14 0.44 4.59 666.8231 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNR 95.00% 2.1 0.317 2.49 666.8233 1,331.63 1,332.64 2 ALDOA_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% QLEEEQQALQK 95.00% 3.33 0.319 1.37 672.3429 1,342.67 1,343.68 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% QLEEEQQALQK 95.00% 3.17 0.288 0 672.3441 1,342.67 1,343.68 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% QLEEEQQALQK 95.00% 3.37 0.286 1.31 672.3448 1,342.67 1,343.68 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% QLEEEQQALQK 95.00% 2.98 0.283 0 672.3453 1,342.68 1,343.68 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 3.35 0.417 2.3 700.3783 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 2.87 0.298 2.14 700.3784 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 2.98 0.361 3.11 700.3792 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 3.14 0.365 2.92 700.3796 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 3.27 0.366 2.51 700.3796 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 3.11 0.352 2.66 700.3799 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 2.61 0.234 0 700.3802 1,398.74 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDR 95.00% 3.13 0.313 1.62 700.3806 1,398.75 1,399.75 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEK 95.00% 2.98 0.326 2.82 722.4058 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEK 95.00% 3.86 0.454 3.38 722.4062 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEK 95.00% 4.11 0.505 2.35 722.4063 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEK 95.00% 3.28 0.42 3.14 722.407 1,442.80 1,443.81 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNR 95.00% 4.31 0.554 3.43 730.8667 1,459.72 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNR 95.00% 4.07 0.57 3.21 730.8692 1,459.72 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNR 95.00% 4.61 0.548 3.13 730.8698 1,459.72 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNR 95.00% 4.29 0.489 3.28 731.3744 1,460.73 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNR 95.00% 2.53 0.439 3.42 731.3768 1,460.74 1,460.73 2 CSPG2_HUMAN,TPM1_HUMAN,DYHC1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEKAADESER 95.00% 2.15 0.417 0 734.3678 2,200.08 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEKAADESER 95.00% 2.07 0.394 0 734.3701 2,200.09 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEKAADESER 95.00% 4.23 0.536 5.6 735.0469 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEKAADESER 95.00% 5.37 0.586 5.89 735.0474 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEKAADESER 95.00% 4.51 0.558 4.85 735.048 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEKAADESER 95.00% 4.25 0.585 5.77 735.0487 2,202.12 2,202.13 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LEEAEKAADESER 95.00% 4.08 0.529 4 738.8451 1,475.67 1,476.68 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LEEAEKAADESER 95.00% 4.1 0.493 3.92 738.8466 1,475.68 1,476.68 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNRR 95.00% 2.24 0.256 1.44 744.8725 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNRR 95.00% 2.31 0.222 1.25 744.8731 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNRR 95.00% 2.66 0.242 1.28 744.8735 1,487.73 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ATDAEADVASLNRR 95.00% 2.24 0.311 0 744.8757 1,487.74 1,488.74 2 TPM1_HUMAN,HTRA1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% TIDDLEDEVYAQK 95.00% 3.05 0.334 2.48 769.864 1,537.71 1,538.72 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% TIDDLEDEVYAQK 95.00% 4.05 0.434 4.89 770.3666 1,538.72 1,538.72 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LKEAETRAEFAER 95.00% 3.53 0.357 0 775.4013 1,548.79 1,549.80 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LKEAETRAEFAER 95.00% 3.75 0.332 0 775.4023 1,548.79 1,549.80 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% GTEDEVEKYSESVK 95.00% 4.37 0.557 2.42 800.3726 1,598.73 1,599.74 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% GTEDEVEKYSESVK 95.00% 4.31 0.524 0 800.3735 1,598.73 1,599.74 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNRR 95.00% 2.63 0.239 0 808.9193 1,615.82 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNRR 95.00% 3.03 0.376 0 808.9199 1,615.82 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNRR 95.00% 3.01 0.395 0 808.92 1,615.82 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KATDAEADVASLNRR 95.00% 2.86 0.233 0 808.9209 1,615.83 1,616.84 2 CO5A2_HUMAN,TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQK 95.00% 4.6 0.504 2.74 c1: Carbamidomethyl (+57.02) 816.4032 1,630.79 1,631.81 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQK 95.00% 4.94 0.537 3.43 c1: Carbamidomethyl (+57.02) 816.406 1,630.80 1,631.81 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQK 95.00% 4.74 0.48 3.41 c1: Carbamidomethyl (+57.02) 816.4073 1,630.80 1,631.81 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQK 95.00% 4.79 0.527 2.68 c1: Carbamidomethyl (+57.02) 816.4083 1,630.80 1,631.81 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQK 95.00% 5.03 0.482 3.02 c1: Carbamidomethyl (+57.02) 816.905 1,631.79 1,631.81 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEKAADESERGMK 95.00% 0 0 3.8 840.4336 2,518.28 2,518.28 3 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ENAIDRAEQAEADKK 95.00% 4.06 0.461 3.54 844.4165 1,686.82 1,687.83 2 TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% ENAIDRAEQAEADKK 95.00% 4.12 0.431 2.64 844.4166 1,686.82 1,687.83 2 TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% IQLVEEELDRAQER 95.00% 3.26 0.247 0 864.4474 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% IQLVEEELDRAQER 95.00% 3.61 0.266 0 864.4484 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% IQLVEEELDRAQER 95.00% 2.85 0.243 0 864.4491 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% IQLVEEELDRAQER 95.00% 3.93 0.32 0 864.4492 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% IQLVEEELDRAQER 95.00% 4.03 0.364 1.33 864.4495 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% IQLVEEELDRAQER 95.00% 3.83 0.247 2.11 864.4497 1,726.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% IQLVEEELDRAQER 95.00% 3.5 0.217 0 864.9496 1,727.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% IQLVEEELDRAQER 95.00% 3.99 0.355 0 864.9497 1,727.88 1,727.89 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQKK 95.00% 0 0 4.48 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 871.9395 1,741.86 1,742.88 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQKK 95.00% 0 0 4.14 c1: Carbamidomethyl (+57.02), c1: Pyro-cmC (-17.03) 872.4425 1,742.87 1,742.88 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQKK 95.00% 5.79 0.484 3.7 c1: Carbamidomethyl (+57.02) 880.4526 1,758.89 1,759.90 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% cKQLEEEQQALQKK 95.00% 5.49 0.504 4.16 c1: Carbamidomethyl (+57.02) 880.4535 1,758.89 1,759.90 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LEEAEKAADESERGMK 95.00% 5.18 0.567 3.82 896.9219 1,791.83 1,792.84 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LEEAEKAADESERGMK 95.00% 4.77 0.521 3.7 896.9232 1,791.83 1,792.84 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% EDKYEEEIKLLEEK 95.00% 4.05 0.37 2.44 898.4566 1,794.90 1,794.90 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% EDKYEEEIKLLEEK 95.00% 4.78 0.431 2.52 898.4566 1,794.90 1,794.90 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KLVILEGELERSEER 95.00% 4.1 0.387 1.43 900.4988 1,798.98 1,799.99 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KLVILEGELERSEER 95.00% 3.78 0.361 0 900.9971 1,799.98 1,799.99 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KLVILEGELERSEER 95.00% 4.01 0.362 1.6 900.999 1,799.98 1,799.99 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% HIAEDSDRKYEEVAR 95.00% 3.71 0.441 0 909.4424 1,816.87 1,817.88 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% HIAEDSDRKYEEVAR 95.00% 2.84 0.343 1.27 909.4435 1,816.87 1,817.88 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% HIAEDSDRKYEEVAR 95.00% 3.78 0.444 3.74 909.9446 1,817.87 1,817.88 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LKGTEDEVEKYSESVK 95.00% 5.08 0.576 5.28 920.9617 1,839.91 1,840.92 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LKGTEDEVEKYSESVK 95.00% 4.85 0.598 4.4 921.4626 1,840.91 1,840.92 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 2.28 0.217 1.41 942.505 1,882.99 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% RIQLVEEELDRAQER 95.00% 3.17 0.382 0 942.9998 1,883.98 1,883.99 2 TPM1_HUMAN,PLEC1_HUMAN,AHNK_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LDKENAIDRAEQAEADK 95.00% 5.35 0.529 4.7 958.9694 1,915.92 1,915.94 2 TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LDKENAIDRAEQAEADK 95.00% 4.98 0.492 4.77 958.9708 1,915.93 1,915.94 2 TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% AMKDEEKMELQEMQLK 95.00% 5.97 0.49 4.96 990.9742 1,979.93 1,980.94 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% AMKDEEKMELQEMQLK 95.00% 5.97 0.5 5.01 990.9743 1,979.93 1,980.94 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% AMKDEEKMELQEMQLK 95.00% 5.28 0.454 5.54 990.9768 1,979.94 1,980.94 2 TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% YSESVKEAQEKLEQAEK 95.00% 4.83 0.537 3.85 998.4956 1,994.98 1,995.99 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% YSESVKEAQEKLEQAEK 95.00% 5.06 0.517 3.47 998.4962 1,994.98 1,995.99 2
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LDKENAIDRAEQAEADKK 95.00% 0 0 3.92 1,022.52 2,043.02 2,044.03 2 TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LDKENAIDRAEQAEADKK 94.70% 0 0 3.13 1,022.52 2,043.02 2,044.03 2 TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LDKENAIDRAEQAEADKK 95.00% 0 0 4.15 1,023.02 2,044.02 2,044.03 2 TPM1_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEKAADESER 95.00% 4.95 0.634 6.64 1,102.06 2,202.11 2,202.13 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% LATALQKLEEAEKAADESER 95.00% 5.37 0.661 5.96 1,102.07 2,202.12 2,202.13 2 TPM1_HUMAN,TPM4_HUMAN
 SAMPLE 3R Tropomyosin beta chain  TPM2  TPM2_HUMAN 32,833.70 100.00% 32 49 167 71.10% KLVILEGELER 95.00% 0.757 0.315 1.18 1,297.60 1,296.59 1,298.77 1 TPM4_HUMAN
 SAMPLE 4 Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 99.80% 2 2 2 9.82% VPImENHIcDAK 95.00% 2.16 0.272 0 m4: Oxidation (+15.99), c9: Carbamidomethyl (+57.02) 481.5657 1,441.67 1,442.68 3
 SAMPLE 4 Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 99.80% 2 2 2 9.82% EQHLYYQDQLLPVSR 95.00% 4.82 0.545 4.39 945.4884 1,888.96 1,888.96 2
 SAMPLE 1 Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 3 3 3 12.70% LPPPFPLK 95.00% 2.14 0.207 1.64 454.7885 907.5613 908.5612 2
 SAMPLE 1 Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 3 3 3 12.70% YHLGAYTGDDVR 95.00% 2.63 0.239 0 456.221 1,365.64 1,366.64 3
 SAMPLE 1 Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 3 3 3 12.70% EQHLYYQDQLLPVSR 95.00% 3.34 0.232 1.01 630.3215 1,887.94 1,888.96 3
 SAMPLE 1R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 99.80% 2 2 2 7.27% LPPPFPLK 95.00% 2.14 0.207 1.27 454.7885 907.5613 908.5612 2
 SAMPLE 1R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 99.80% 2 2 2 7.27% YHLGAYTGDDVR 95.00% 2.63 0.239 0 456.221 1,365.64 1,366.64 3
 SAMPLE 2R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 3 3 5 14.20% VPIMENHIcDAK 95.00% 2.02 0.259 0 c9: Carbamidomethyl (+57.02) 476.2329 1,425.68 1,426.68 3
 SAMPLE 2R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 3 3 5 14.20% EQHLYYQDQLLPVSR 95.00% 4.26 0.303 1.6 630.3229 1,887.95 1,888.96 3
 SAMPLE 2R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 3 3 5 14.20% EQHLYYQDQLLPVSR 95.00% 4.43 0.389 1.54 630.3229 1,887.95 1,888.96 3
 SAMPLE 2R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 3 3 5 14.20% YHLGAYTGDDVR 95.00% 2.86 0.517 1.77 683.8183 1,365.62 1,366.64 2
 SAMPLE 2R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 3 3 5 14.20% YHLGAYTGDDVR 95.00% 3.03 0.413 1.49 683.8215 1,365.63 1,366.64 2
 SAMPLE 3 Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 5 7 17.10% LPPPFPLK 95.00% 1.71 0.342 1.59 454.7852 907.5547 908.5612 2
 SAMPLE 3 Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 5 7 17.10% VPIMENHIcDAK 95.00% 2.48 0.357 0 c9: Carbamidomethyl (+57.02) 476.2324 1,425.67 1,426.68 3
 SAMPLE 3 Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 5 7 17.10% EQHLYYQDQLLPVSR 95.00% 4.33 0.288 0 630.3218 1,887.94 1,888.96 3
 SAMPLE 3 Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 5 7 17.10% EQHLYYQDQLLPVSR 95.00% 3.78 0.231 1.1 630.3229 1,887.95 1,888.96 3
 SAMPLE 3 Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 5 7 17.10% YHLGAYTGDDVR 95.00% 2.9 0.435 2.22 683.8224 1,365.63 1,366.64 2
 SAMPLE 3 Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 5 7 17.10% YHLGAYTGDDVR 95.00% 2.88 0.458 1.96 684.3223 1,366.63 1,366.64 2
 SAMPLE 3 Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 5 7 17.10% EQHLYYQDQLLPVSR 95.00% 4.62 0.568 3.96 944.9803 1,887.95 1,888.96 2
 SAMPLE 3R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 4 6 17.10% LPPPFPLK 95.00% 1.68 0.205 1.32 454.7863 907.557 908.5612 2
 SAMPLE 3R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 4 6 17.10% VPIMENHIcDAK 95.00% 2.55 0.407 0 c9: Carbamidomethyl (+57.02) 476.2314 1,425.67 1,426.68 3
 SAMPLE 3R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 4 6 17.10% VPIMENHIcDAK 95.00% 2.32 0.237 0 c9: Carbamidomethyl (+57.02) 476.2318 1,425.67 1,426.68 3
 SAMPLE 3R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 4 6 17.10% EQHLYYQDQLLPVSR 95.00% 3.71 0.226 0 630.6574 1,888.95 1,888.96 3
 SAMPLE 3R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 4 6 17.10% YHLGAYTGDDVR 95.00% 2.56 0.439 1.8 683.8195 1,365.62 1,366.64 2
 SAMPLE 3R Tryptase beta-1  TPSAB1  TRYB1_HUMAN,TRYB2_HUMAN 30,496.40 100.00% 4 4 6 17.10% YHLGAYTGDDVR 95.00% 2.73 0.452 2.14 683.823 1,365.63 1,366.64 2
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% QLFHPEQLITGK 95.00% 2.75 0.253 1.42 470.9296 1,409.77 1,410.77 3 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% QLFHPEQLITGK 95.00% 2.29 0.304 0 470.9299 1,409.77 1,410.77 3 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% QLFHPEQLITGK 95.00% 2.91 0.256 0 470.9301 1,409.77 1,410.77 3 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% LIGQIVSSITASLR 95.00% 2.87 0.386 2.68 486.6263 1,456.86 1,457.87 3
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% DVNAAIATIK 95.00% 3.27 0.377 1.37 508.2915 1,014.57 1,015.58 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% DVNAAIATIK 95.00% 2.51 0.309 1.85 508.292 1,014.57 1,015.58 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% DVNAAIATIK 95.00% 3.05 0.38 2.21 508.2921 1,014.57 1,015.58 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% DVNAAIATIK 95.00% 2.31 0.251 1.82 508.2934 1,014.57 1,015.58 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% EIIDLVLDR 95.00% 2.46 0.452 0 543.3132 1,084.61 1,085.62 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% EIIDLVLDR 95.00% 2.86 0.401 1.11 543.3138 1,084.61 1,085.62 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 4.8 0.605 3.01 567.9733 1,700.90 1,701.91 3 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 4.33 0.6 2.57 567.9734 1,700.90 1,701.91 3 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 3.23 0.331 0 568.31 1,701.91 1,701.91 3 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% NLDIERPTYTNLNR 95.00% 2.16 0.2 0 573.6317 1,717.87 1,718.88 3 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% IHFPLATYAPVISAEK 95.00% 2.92 0.369 1.89 586.3251 1,755.95 1,756.96 3 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% IHFPLATYAPVISAEK 95.00% 2.88 0.282 1.48 586.6583 1,756.95 1,756.96 3 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVcMLSNTTAIAEAWAR 95.00% 3.66 0.301 0 c3: Carbamidomethyl (+57.02) 622.3064 1,863.90 1,864.91 3 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVcMLSNTTAIAEAWAR 95.00% 4.31 0.427 0 c3: Carbamidomethyl (+57.02) 622.3065 1,863.90 1,864.91 3 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% YMAccLLYR 95.00% 2.23 0.431 3.14 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 625.2793 1,248.54 1,249.55 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% YMAccLLYR 95.00% 2.07 0.446 1.15 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 625.2796 1,248.54 1,249.55 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% LDHKFDLMYAK 95.00% 2.18 0.351 0 690.8532 1,379.69 1,380.70 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% QLFHPEQLITGK 95.00% 2.39 0.28 0 705.89 1,409.76 1,410.77 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% QLFHPEQLITGK 95.00% 2.32 0.353 0 706.391 1,410.77 1,410.77 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% LIGQIVSSITASLR 95.00% 3.46 0.512 2.47 729.4384 1,456.86 1,457.87 2
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% TIQFVDWcPTGFK 95.00% 3.39 0.529 2.21 c8: Carbamidomethyl (+57.02) 799.886 1,597.76 1,598.77 2
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% TIQFVDWcPTGFK 95.00% 4.2 0.499 3.8 c8: Carbamidomethyl (+57.02) 800.3874 1,598.76 1,598.77 2
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% QLFHPEQLITGKEDAANNYAR 95.00% 3.78 0.464 3.85 806.0742 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% QLFHPEQLITGKEDAANNYAR 95.00% 4.2 0.435 3.09 806.0756 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 2.66 0.388 0 851.452 1,700.89 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 5.05 0.51 2.54 851.4538 1,700.89 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 5.07 0.5 2.05 851.4541 1,700.89 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 5.26 0.475 1.96 851.455 1,700.89 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 4.54 0.365 1.68 851.455 1,700.89 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 4.99 0.476 1.82 851.4552 1,700.89 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 4.85 0.469 2.49 851.4554 1,700.90 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 4.73 0.501 2.36 851.4554 1,700.90 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 4.38 0.474 1.41 851.4568 1,700.90 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 4.65 0.479 3.32 851.4583 1,700.90 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 4.43 0.491 2.44 851.4584 1,700.90 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 3.91 0.358 2.12 851.9558 1,701.90 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVFVDLEPTVIDEVR 95.00% 4.94 0.381 1.4 851.9594 1,701.90 1,701.91 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% NLDIERPTYTNLNR 95.00% 3.35 0.328 0 859.9428 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% NLDIERPTYTNLNR 95.00% 3.36 0.369 0 859.9439 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% IHFPLATYAPVISAEK 95.00% 3.7 0.537 4.19 878.9837 1,755.95 1,756.96 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% IHFPLATYAPVISAEK 95.00% 3.84 0.563 4.7 879.486 1,756.96 1,756.96 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% VGINYQPPTVVPGGDLAK 95.00% 4.4 0.483 3.16 912.9945 1,823.97 1,824.99 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% VGINYQPPTVVPGGDLAK 95.00% 2.2 0.14 1.54 912.997 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% VGINYQPPTVVPGGDLAK 95.00% 4.06 0.551 1.82 913.4929 1,824.97 1,824.99 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% VGINYQPPTVVPGGDLAK 95.00% 3.46 0.403 2.11 913.4938 1,824.97 1,824.99 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% VGINYQPPTVVPGGDLAK 95.00% 4.14 0.589 2.13 913.4955 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% VGINYQPPTVVPGGDLAK 95.00% 5.06 0.512 3.11 913.4983 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% VGINYQPPTVVPGGDLAK 95.00% 5.05 0.518 2.34 913.4986 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVcMLSNTTAIAEAWAR 95.00% 4.17 0.496 2.72 c3: Carbamidomethyl (+57.02) 932.9548 1,863.89 1,864.91 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVcMLSNTTAIAEAWAR 95.00% 5.37 0.624 4.72 c3: Carbamidomethyl (+57.02) 933.4564 1,864.90 1,864.91 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% AVcMLSNTTAIAEAWAR 95.00% 2.72 0.323 2.74 c3: Carbamidomethyl (+57.02) 933.4573 1,864.90 1,864.91 2 TBA4A_HUMAN,TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% TIGGGDDSFNTFFSETGAGK 95.00% 6.12 0.661 5.03 1,004.95 2,007.88 2,007.89 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-1A chain  TUBA1A  TBA1A_HUMAN 50,117.70 99.80% 2 3 4 41.50% TIGGGDDSFNTFFSETGAGK 95.00% 6.34 0.635 6.17 1,004.95 2,007.88 2,007.89 2 TBA1B_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 3.05 0.374 1.92 508.2934 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 2.74 0.385 2.7 508.294 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 2.65 0.349 2.11 508.2942 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 1.77 0.146 3.64 508.2944 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 2.8 0.365 2.38 508.2946 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 3.14 0.357 1.8 508.7435 1,015.47 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 2.56 0.278 2.82 508.744 1,015.47 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 2.69 0.285 2.05 508.9945 1,015.97 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% AVFVDLEPTVIDEVR 95.00% 3.89 0.461 0 567.9736 1,700.90 1,701.91 3 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% AVFVDLEPTVIDEVR 95.00% 3.01 0.37 0 567.9758 1,700.90 1,701.91 3 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% NLDIERPTYTNLNR 95.00% 2.12 0.333 0 573.6336 1,717.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% NLDIERPTYTNLNR 95.00% 2.72 0.346 0 573.6338 1,717.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% NLDIERPTYTNLNR 95.00% 2.19 0.27 0 573.6339 1,717.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% NLDIERPTYTNLNR 95.00% 2.06 0.281 0 573.634 1,717.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% NLDIERPTYTNLNR 95.00% 2.23 0.219 0 573.6341 1,717.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% NLDIERPTYTNLNR 95.00% 2.38 0.277 0 573.968 1,718.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% NLDIERPTYTNLNR 95.00% 2.78 0.31 0 573.9689 1,718.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% IHFPLATYAPVISAEK 95.00% 2.99 0.386 1.64 586.327 1,755.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% IHFPLATYAPVISAEK 95.00% 3.17 0.393 3.47 586.3303 1,755.97 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% IHFPLATYAPVISAEK 95.00% 2.36 0.168 1.23 586.662 1,756.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% IHFPLATYAPVISAEK 95.00% 3.54 0.443 3.35 586.6627 1,756.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% SIQFVDWcPTGFK 95.00% 2.91 0.226 2.21 c8: Carbamidomethyl (+57.02) 792.8833 1,583.75 1,584.75 2 TBA4A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% AVFVDLEPTVIDEVR 95.00% 4.92 0.473 3.77 851.4581 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% AVFVDLEPTVIDEVR 95.00% 5.19 0.469 2.12 851.4616 1,700.91 1,701.91 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% AVFVDLEPTVIDEVR 95.00% 5.14 0.463 2.54 851.9601 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% AVFVDLEPTVIDEVR 95.00% 5.06 0.461 3.25 851.9611 1,701.91 1,701.91 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% AVFVDLEPTVIDEVR 95.00% 5.13 0.475 2.28 851.9612 1,701.91 1,701.91 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% AVFVDLEPTVIDEVR 95.00% 5.4 0.469 2.02 851.9615 1,701.91 1,701.91 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% AVFVDLEPTVIDEVR 95.00% 5.16 0.421 1.96 851.9631 1,701.91 1,701.91 2 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% NLDIERPTYTNLNR 95.00% 2.99 0.271 0 859.9502 1,717.88 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% IHFPLATYAPVISAEK 95.00% 3.86 0.656 7.24 878.9893 1,755.96 1,756.96 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 3.4 0.443 2.77 912.9974 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 4.06 0.547 2.21 912.9979 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 4.29 0.549 3.14 912.9981 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 3.82 0.493 1.8 912.9984 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 4.2 0.504 2.44 912.9985 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 4.15 0.531 2.48 912.9991 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 4.13 0.505 3.19 912.9998 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 4.28 0.445 2.92 912.9998 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 4.05 0.351 2.19 913.4969 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 4.59 0.513 2.82 913.4983 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 3.24 0.402 0 913.4995 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 4.5 0.469 2.85 913.4995 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% VGINYQPPTVVPGGDLAK 95.00% 4.15 0.439 1.39 913.5016 1,824.99 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 1.39 0.268 0 1,016.48 1,015.47 1,015.58 1 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 1.46 0.215 1.59 1,016.48 1,015.47 1,015.58 1 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 1.34 0.217 1.41 1,016.48 1,015.47 1,015.58 1 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 1.55 0.236 1.46 1,016.48 1,015.47 1,015.58 1 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 1.49 0.185 1.29 1,016.98 1,015.97 1,015.58 1 TBA1A_HUMAN
 SAMPLE 4 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 6 10 50 19.10% DVNAAIATIK 95.00% 1.48 0.155 0 1,016.98 1,015.98 1,015.58 1 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 2.99 0.311 1.27 496.6324 1,486.87 1,487.88 3 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 3.42 0.389 2 496.6326 1,486.87 1,487.88 3 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 2.44 0.263 1.32 496.6328 1,486.87 1,487.88 3 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 2.72 0.271 2.37 496.9666 1,487.88 1,487.88 3 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 3.92 0.492 1.16 496.9695 1,487.88 1,487.88 3 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% DVNAAIATIK 95.00% 2.69 0.361 2.47 508.293 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% DVNAAIATIK 95.00% 2.75 0.312 1.8 508.2937 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% DVNAAIATIK 95.00% 2.31 0.289 2.82 508.2941 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% DVNAAIATIK 95.00% 2.19 0.238 1.62 508.2941 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% DVNAAIATIK 95.00% 3.01 0.356 1.96 508.2942 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% DVNAAIATIK 95.00% 2.42 0.109 2.17 508.2943 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% DVNAAIATIK 95.00% 2.56 0.292 2.06 508.2943 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% DVNAAIATIK 95.00% 2.2 0.107 2.49 508.2946 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% DVNAAIATIK 95.00% 3.12 0.333 1.96 508.744 1,015.47 1,015.58 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% EIIDLVLDR 95.00% 2.43 0.261 0 543.3156 1,084.62 1,085.62 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% EIIDLVLDR 95.00% 2.58 0.306 1.72 543.3157 1,084.62 1,085.62 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% NLDIERPTYTNLNR 95.00% 2.29 0.302 0 573.6336 1,717.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% NLDIERPTYTNLNR 95.00% 2.68 0.211 0 573.6338 1,717.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% NLDIERPTYTNLNR 95.00% 2.28 0.33 0 573.6338 1,717.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% NLDIERPTYTNLNR 95.00% 2.33 0.307 0 573.634 1,717.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% NLDIERPTYTNLNR 95.00% 2.32 0.215 0 573.6345 1,717.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% IHFPLATYAPVISAEK 95.00% 3.02 0.303 3.03 586.3278 1,755.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% IHFPLATYAPVISAEK 95.00% 3.07 0.336 1.92 586.3307 1,755.97 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% IHFPLATYAPVISAEK 95.00% 2.96 0.284 2.96 586.6617 1,756.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% IHFPLATYAPVISAEK 95.00% 3.79 0.461 2.13 586.6622 1,756.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% IHFPLATYAPVISAEK 95.00% 3.51 0.396 2.12 586.6624 1,756.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% IHFPLATYAPVISAEK 95.00% 3.71 0.33 2.07 586.6625 1,756.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% IHFPLATYAPVISAEK 95.00% 3.55 0.388 2 586.663 1,756.97 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 3.83 0.507 2.85 744.4451 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 3.31 0.535 2.85 744.4451 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 3.44 0.48 3.43 744.4453 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 3.29 0.534 2.8 744.4461 1,486.88 1,487.88 2 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 4.09 0.538 4.96 744.4464 1,486.88 1,487.88 2 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 4.38 0.565 3.29 744.4465 1,486.88 1,487.88 2 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 3.76 0.517 3.33 744.4472 1,486.88 1,487.88 2 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 4.31 0.561 4.8 744.4473 1,486.88 1,487.88 2 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 3.4 0.477 3.34 744.448 1,486.88 1,487.88 2 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% LISQIVSSITASLR 95.00% 4.43 0.561 4.4 744.9485 1,487.88 1,487.88 2 TBA4A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% AVFVDLEPTVIDEVR 95.00% 4.87 0.419 2.24 851.4582 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% AVFVDLEPTVIDEVR 95.00% 5.05 0.497 3.14 851.4596 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% AVFVDLEPTVIDEVR 95.00% 4.8 0.459 2 851.4612 1,700.91 1,701.91 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% AVFVDLEPTVIDEVR 95.00% 4.91 0.487 2.4 851.4633 1,700.91 1,701.91 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% AVFVDLEPTVIDEVR 95.00% 5.35 0.376 3.02 851.9608 1,701.91 1,701.91 2 TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% NLDIERPTYTNLNR 95.00% 2.83 0.264 0 859.9484 1,717.88 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% IHFPLATYAPVISAEK 95.00% 3.89 0.61 6.18 878.9909 1,755.97 1,756.96 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% VGINYQPPTVVPGGDLAK 95.00% 3.85 0.504 3.72 912.9978 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% VGINYQPPTVVPGGDLAK 95.00% 3.68 0.537 3.82 912.9983 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% VGINYQPPTVVPGGDLAK 95.00% 3.76 0.477 3.47 913.0005 1,823.99 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% VGINYQPPTVVPGGDLAK 95.00% 2.92 0.509 2.4 913.0033 1,823.99 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% VGINYQPPTVVPGGDLAK 95.00% 3.98 0.474 4.19 913.4983 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% VGINYQPPTVVPGGDLAK 95.00% 4.57 0.476 2.74 913.4992 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% VGINYQPPTVVPGGDLAK 95.00% 4.36 0.468 3.49 913.4996 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% VGINYQPPTVVPGGDLAK 95.00% 4.16 0.431 1.59 913.5005 1,824.99 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% VGINYQPPTVVPGGDLAK 95.00% 4.4 0.425 3.72 913.5009 1,824.99 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% VGINYQPPTVVPGGDLAK 95.00% 4.12 0.374 2.06 913.5019 1,824.99 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% VGINYQPPTVVPGGDLAK 95.00% 3.17 0.411 1.92 913.5019 1,824.99 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 4R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 10 57 21.30% VGINYQPPTVVPGGDLAK 95.00% 4.33 0.476 3.46 913.5037 1,824.99 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% DVNAAIATIK 95.00% 2.13 0.16 1.62 508.2918 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% DVNAAIATIK 95.00% 2.76 0.283 1.31 508.2928 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% DVNAAIATIK 95.00% 2.01 0.345 1.89 508.9919 1,015.97 1,015.58 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% EIIDLVLDR 95.00% 2.46 0.368 0 543.3125 1,084.61 1,085.62 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% EIIDLVLDR 95.00% 2.61 0.367 1.41 543.3127 1,084.61 1,085.62 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% EIIDLVLDR 95.00% 2.39 0.392 1.24 543.3127 1,084.61 1,085.62 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% EIIDLVLDR 95.00% 2.44 0.379 0 543.3133 1,084.61 1,085.62 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% AVFVDLEPTVIDEVR 95.00% 2.27 0.301 0 568.3062 1,701.90 1,701.91 3 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% NLDIERPTYTNLNR 95.00% 2.37 0.235 0 573.6313 1,717.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% NLDIERPTYTNLNR 95.00% 2.05 0.254 0 573.6318 1,717.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% IHFPLATYAPVISAEK 95.00% 3.15 0.385 2.15 586.6595 1,756.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% LISQIVSSITASLR 95.00% 3.96 0.54 4.89 744.4484 1,486.88 1,487.88 2 TBA4A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% LISQIVSSITASLR 95.00% 3.78 0.552 2.62 744.4516 1,486.89 1,487.88 2 TBA4A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% QLFHPEQLITGKEDAANNYAR 95.00% 4.29 0.533 3.27 806.0735 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% QLFHPEQLITGKEDAANNYAR 95.00% 4.11 0.573 4.92 806.0754 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% AVFVDLEPTVIDEVR 95.00% 5.43 0.484 3 851.4533 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% AVFVDLEPTVIDEVR 95.00% 4.93 0.473 1.92 851.4538 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% AVFVDLEPTVIDEVR 95.00% 5.22 0.526 2.74 851.4549 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% AVFVDLEPTVIDEVR 95.00% 5.04 0.479 1.72 851.4554 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% AVFVDLEPTVIDEVR 95.00% 5.12 0.451 2.96 851.4557 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% AVFVDLEPTVIDEVR 95.00% 4.81 0.497 1.64 851.4561 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% AVFVDLEPTVIDEVR 95.00% 4 0.463 0 851.9627 1,701.91 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% NLDIERPTYTNLNR 95.00% 3.06 0.363 0 860.4455 1,718.88 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% NLDIERPTYTNLNR 95.00% 3.23 0.305 0 860.4461 1,718.88 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% VGINYQPPTVVPGGDLAK 95.00% 4.49 0.54 2.07 912.9947 1,823.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% VGINYQPPTVVPGGDLAK 95.00% 3.7 0.325 1.49 913.4944 1,824.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% VGINYQPPTVVPGGDLAK 95.00% 4.95 0.473 1.52 913.4947 1,824.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% VGINYQPPTVVPGGDLAK 95.00% 4.68 0.523 1.96 913.4964 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% VGINYQPPTVVPGGDLAK 95.00% 4.05 0.524 2.28 913.4966 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% VGINYQPPTVVPGGDLAK 95.00% 4 0.509 2.42 913.5005 1,824.99 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% VGINYQPPTVVPGGDLAK 95.00% 4.05 0.468 2.7 913.5025 1,824.99 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% TIGGGDDSFNTFFSETGAGK 95.00% 4.98 0.663 3.74 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 1 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 9 11 33 30.40% TIGGGDDSFNTFFSETGAGK 95.00% 6.02 0.604 5.06 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% LISQIVSSITASLR 95.00% 3.26 0.326 1.96 496.9657 1,487.87 1,487.88 3 TBA4A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% EIIDLVLDR 95.00% 2.19 0.283 0 543.3136 1,084.61 1,085.62 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% EIIDLVLDR 95.00% 2.4 0.383 1.74 543.3235 1,084.63 1,085.62 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% NLDIERPTYTNLNR 95.00% 2.3 0.256 0 573.9651 1,718.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% NLDIERPTYTNLNR 95.00% 2.54 0.331 0 573.9653 1,718.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% NLDIERPTYTNLNR 95.00% 2.52 0.332 0 573.9668 1,718.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% LISQIVSSITASLR 95.00% 3.09 0.412 2.07 744.4426 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% LISQIVSSITASLR 95.00% 2.95 0.372 0 744.4427 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% LISQIVSSITASLR 95.00% 3.22 0.526 1.77 744.443 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% LISQIVSSITASLR 95.00% 3.72 0.546 2.03 744.4453 1,486.88 1,487.88 2 TBA4A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% LISQIVSSITASLR 95.00% 3.96 0.54 5.21 744.4484 1,486.88 1,487.88 2 TBA4A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% LISQIVSSITASLR 95.00% 3.78 0.552 2.72 744.4516 1,486.89 1,487.88 2 TBA4A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% LISQIVSSITASLR 95.00% 3.57 0.448 0 744.9447 1,487.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% QLFHPEQLITGKEDAANNYAR 95.00% 4.08 0.517 4.24 806.0733 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% AVFVDLEPTVIDEVR 95.00% 5 0.501 1.89 851.4533 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% AVFVDLEPTVIDEVR 95.00% 5.02 0.487 3.28 851.4546 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% AVFVDLEPTVIDEVR 95.00% 5.11 0.479 2.85 851.4547 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% AVFVDLEPTVIDEVR 95.00% 5.11 0.491 0 851.4559 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% AVFVDLEPTVIDEVR 95.00% 4.89 0.475 3.18 851.4585 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% AVFVDLEPTVIDEVR 95.00% 5.19 0.469 2.89 851.9571 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% AVFVDLEPTVIDEVR 95.00% 4.78 0.451 2.85 851.9579 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% NLDIERPTYTNLNR 95.00% 3.33 0.346 0 860.4458 1,718.88 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% NLDIERPTYTNLNR 95.00% 3.46 0.35 0 860.4467 1,718.88 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% VGINYQPPTVVPGGDLAK 95.00% 4 0.53 3.96 912.9964 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% VGINYQPPTVVPGGDLAK 95.00% 4.78 0.485 3.21 913.4953 1,824.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% VGINYQPPTVVPGGDLAK 95.00% 4.58 0.469 3.11 913.4959 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% VGINYQPPTVVPGGDLAK 95.00% 4.58 0.566 2.33 913.4997 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% VGINYQPPTVVPGGDLAK 95.00% 3.76 0.518 3.2 913.5152 1,825.01 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% TIGGGDDSFNTFFSETGAGK 95.00% 5.97 0.705 5.82 1,004.45 2,006.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% TIGGGDDSFNTFFSETGAGK 95.00% 5.78 0.658 5.96 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% TIGGGDDSFNTFFSETGAGK 95.00% 5.78 0.695 5.4 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 1R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 7 9 32 24.60% TIGGGDDSFNTFFSETGAGK 95.00% 6.04 0.65 5.85 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% QLFHPEQLITGK 95.00% 2.21 0.216 0 470.9296 1,409.77 1,410.77 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% DVNAAIATIK 95.00% 2.49 0.361 1.66 508.2898 1,014.56 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% DVNAAIATIK 95.00% 2.2 0.193 1.51 508.29 1,014.56 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% DVNAAIATIK 95.00% 2.82 0.243 2.77 508.291 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% DVNAAIATIK 95.00% 2.78 0.401 2.32 508.2913 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% DVNAAIATIK 95.00% 2.63 0.335 1.22 508.2913 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% DVNAAIATIK 95.00% 2.74 0.374 1.6 508.2921 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% DVNAAIATIK 95.00% 2.56 0.364 0 508.2922 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% DVNAAIATIK 95.00% 2.21 0.234 1.82 508.2923 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% DVNAAIATIK 95.00% 2.07 0.152 2.24 508.2924 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% EIIDLVLDR 95.00% 2.29 0.292 0 543.3121 1,084.61 1,085.62 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% EIIDLVLDR 95.00% 2.42 0.189 0 543.3136 1,084.61 1,085.62 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% NLDIERPTYTNLNR 95.00% 2.69 0.363 0 573.6306 1,717.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% NLDIERPTYTNLNR 95.00% 2.47 0.388 0 573.6313 1,717.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% NLDIERPTYTNLNR 95.00% 3.06 0.294 0 573.6319 1,717.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% NLDIERPTYTNLNR 95.00% 2.63 0.298 0 573.9659 1,718.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% NLDIERPTYTNLNR 95.00% 2.56 0.293 0 573.9659 1,718.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% IHFPLATYAPVISAEK 95.00% 3.74 0.456 2.17 586.325 1,755.95 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% IHFPLATYAPVISAEK 95.00% 2.87 0.244 1.62 586.3265 1,755.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% IHFPLATYAPVISAEK 95.00% 2.99 0.295 1.85 586.3273 1,755.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 2.78 0.157 0 609.0004 1,823.98 1,824.99 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 3.33 0.256 0 609.3366 1,824.99 1,824.99 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% YMAccLLYR 95.00% 1.85 0.436 0 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 625.279 1,248.54 1,249.55 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% LDHKFDLMYAK 95.00% 3.09 0.433 2.74 690.8543 1,379.69 1,380.70 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% QLFHPEQLITGKEDAANNYAR 95.00% 4.32 0.525 5 806.0706 2,415.19 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% QLFHPEQLITGKEDAANNYAR 95.00% 4.15 0.458 4.68 806.0742 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% QLFHPEQLITGKEDAANNYAR 95.00% 4.23 0.502 4.12 806.0743 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% QLFHPEQLITGKEDAANNYAR 95.00% 4.57 0.526 3.92 806.075 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 5.32 0.503 2.96 851.4525 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 4.64 0.474 1.72 851.4527 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 5.07 0.511 3.12 851.4538 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 5.05 0.522 2.8 851.4541 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 4.98 0.504 3.25 851.4543 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 5.09 0.499 3.13 851.4555 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 4.99 0.485 2.35 851.4557 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 4.93 0.499 2.4 851.4566 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 5.09 0.485 2.77 851.4582 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 4.78 0.394 2.92 851.9556 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 5.13 0.496 2.14 851.9569 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 5.45 0.399 3.19 851.958 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVFVDLEPTVIDEVR 95.00% 4.72 0.39 1.2 851.9582 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% NLDIERPTYTNLNR 95.00% 3.16 0.307 0 859.9433 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% NLDIERPTYTNLNR 95.00% 3.22 0.183 0 859.9435 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% NLDIERPTYTNLNR 95.00% 3.45 0.355 0 859.9436 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% NLDIERPTYTNLNR 95.00% 3.11 0.238 0 859.9438 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% NLDIERPTYTNLNR 95.00% 3.52 0.312 0 859.9439 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% NLDIERPTYTNLNR 95.00% 3.18 0.353 0 860.4444 1,718.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% IHFPLATYAPVISAEK 95.00% 4.17 0.632 6.8 879.4856 1,756.96 1,756.96 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 3.21 0.346 2.28 912.9926 1,823.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 4.17 0.386 1.89 912.9939 1,823.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 4.41 0.504 1.96 912.9939 1,823.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 4.54 0.494 2.96 912.9944 1,823.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 4.12 0.438 3.13 912.9944 1,823.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 3.83 0.562 3.16 912.9947 1,823.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 4.06 0.5 3.26 912.9962 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 3.78 0.57 1.6 912.9969 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 4.04 0.494 2 912.9973 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 4.19 0.46 0 913.4956 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 4 0.386 2.46 913.4969 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 3.84 0.341 1.6 913.4969 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 4.57 0.529 2.92 913.4971 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 3.59 0.494 2.74 913.4977 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 4.47 0.462 1.32 913.498 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% VGINYQPPTVVPGGDLAK 95.00% 4.32 0.507 3.08 913.498 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% AVcMLSNTTAIAEAWAR 95.00% 4.38 0.603 7.12 c3: Carbamidomethyl (+57.02) 932.9537 1,863.89 1,864.91 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% TIGGGDDSFNTFFSETGAGK 95.00% 5.99 0.682 5.66 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% TIGGGDDSFNTFFSETGAGK 95.00% 6.14 0.619 5.55 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% TIGGGDDSFNTFFSETGAGK 95.00% 6.12 0.652 5.33 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% TIGGGDDSFNTFFSETGAGK 95.00% 4.7 0.6 2.08 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% DVNAAIATIK 95.00% 1.27 0.2 1.77 1,016.48 1,015.47 1,015.58 1 TBA1A_HUMAN
 SAMPLE 2 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 12 16 71 35.50% DVNAAIATIK 95.00% 1.21 0.242 0.824 1,016.48 1,015.47 1,015.58 1 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LDHKFDLMYAK 95.00% 4.03 0.418 1.24 460.9044 1,379.69 1,380.70 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LDHKFDLMYAK 95.00% 4.17 0.381 0 461.2383 1,380.69 1,380.70 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LISQIVSSITASLR 95.00% 4.29 0.452 3.07 496.6307 1,486.87 1,487.88 3 TBA4A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LISQIVSSITASLR 95.00% 2.61 0.407 1.68 496.6309 1,486.87 1,487.88 3 TBA4A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LISQIVSSITASLR 95.00% 2.59 0.341 0 496.6315 1,486.87 1,487.88 3 TBA4A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LISQIVSSITASLR 95.00% 4.26 0.473 2.24 496.9642 1,487.87 1,487.88 3 TBA4A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% DVNAAIATIK 95.00% 2.6 0.25 0 508.2904 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% DVNAAIATIK 95.00% 2.49 0.423 1.35 508.2913 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% DVNAAIATIK 95.00% 2.43 0.407 2.08 508.2914 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% DVNAAIATIK 95.00% 2.78 0.322 1.51 508.2914 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% DVNAAIATIK 95.00% 2.95 0.413 2.06 508.2916 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% DVNAAIATIK 95.00% 2.35 0.251 1.37 508.2918 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% DVNAAIATIK 95.00% 2.38 0.283 2.96 508.2918 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% DVNAAIATIK 95.00% 2.32 0.316 2.82 508.2921 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% DVNAAIATIK 95.00% 2.6 0.414 2.21 508.2923 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 5 0.606 2.49 567.9725 1,700.89 1,701.91 3 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 4.75 0.52 3.09 568.3076 1,701.90 1,701.91 3 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% NLDIERPTYTNLNR 95.00% 2.5 0.275 0 573.6317 1,717.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% NLDIERPTYTNLNR 95.00% 2.27 0.288 0 573.6317 1,717.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% NLDIERPTYTNLNR 95.00% 2.35 0.234 0 573.6331 1,717.88 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% NLDIERPTYTNLNR 95.00% 2.3 0.228 0 573.9659 1,718.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% NLDIERPTYTNLNR 95.00% 2.67 0.387 1.08 573.9661 1,718.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% IHFPLATYAPVISAEK 95.00% 3.01 0.438 1.89 586.3254 1,755.95 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% IHFPLATYAPVISAEK 95.00% 2.9 0.298 2.66 586.3263 1,755.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% IHFPLATYAPVISAEK 95.00% 3.36 0.33 2.8 586.6583 1,756.95 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% IHFPLATYAPVISAEK 95.00% 4.02 0.494 3.16 586.6589 1,756.95 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% IHFPLATYAPVISAEK 95.00% 2.82 0.299 1.7 586.6591 1,756.95 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% IHFPLATYAPVISAEK 95.00% 2.93 0.336 2.57 586.6591 1,756.95 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% IHFPLATYAPVISAEK 95.00% 2.95 0.23 0 586.6606 1,756.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% IHFPLATYAPVISAEK 95.00% 3.33 0.444 1.54 586.6608 1,756.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 2.91 0.232 0 609.3322 1,824.97 1,824.99 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVcMLSNTTAIAEAWAR 95.00% 3.75 0.4 0 c3: Carbamidomethyl (+57.02) 622.3066 1,863.90 1,864.91 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVcMLSNTTAIAEAWAR 95.00% 4.34 0.43 1.43 c3: Carbamidomethyl (+57.02) 622.6396 1,864.90 1,864.91 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LISQIVSSITASLR 95.00% 3.96 0.543 4.44 744.4415 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LISQIVSSITASLR 95.00% 4.41 0.563 4.62 744.4424 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LISQIVSSITASLR 95.00% 3.71 0.583 4.48 744.4426 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LISQIVSSITASLR 95.00% 4.15 0.575 4.23 744.4427 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LISQIVSSITASLR 95.00% 4.06 0.51 4.43 744.4436 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LISQIVSSITASLR 95.00% 3.86 0.52 3.66 744.9437 1,487.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% LISQIVSSITASLR 95.00% 4.68 0.522 3.55 744.9461 1,487.88 1,487.88 2 TBA4A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% qLFHPEQLITGKEDAANNYAR 95.00% 0 0 3.89 n-term: Pyro-cmC (-17.03) 800.3984 2,398.17 2,398.18 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% QLFHPEQLITGKEDAANNYAR 95.00% 4.72 0.482 3.01 806.0721 2,415.19 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% QLFHPEQLITGKEDAANNYAR 95.00% 4.85 0.447 3.11 806.074 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 5.03 0.478 3.01 851.454 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 4.82 0.503 3 851.454 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 4.95 0.425 2.74 851.4543 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 4.96 0.521 3.44 851.4548 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 4.71 0.417 1.92 851.4554 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 5.27 0.443 4.24 851.4556 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 4.51 0.378 1.34 851.9565 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 5.35 0.442 3.08 851.957 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 5.13 0.438 2.4 851.9572 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 4.83 0.454 2.16 851.9573 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 4.52 0.406 1.35 851.9577 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 5.22 0.489 3.38 851.9577 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVFVDLEPTVIDEVR 95.00% 5.34 0.469 2.82 851.959 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% NLDIERPTYTNLNR 95.00% 3.28 0.329 0 859.9428 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% NLDIERPTYTNLNR 95.00% 3.61 0.37 1.55 859.9439 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% NLDIERPTYTNLNR 95.00% 3.24 0.304 0 859.9444 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% NLDIERPTYTNLNR 95.00% 2.79 0.283 0 860.4455 1,718.88 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% NLDIERPTYTNLNR 95.00% 3.09 0.333 0 860.4458 1,718.88 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% NLDIERPTYTNLNR 95.00% 3.18 0.226 0 860.4484 1,718.88 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% IHFPLATYAPVISAEK 95.00% 3.52 0.412 3.62 878.9842 1,755.95 1,756.96 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% IHFPLATYAPVISAEK 95.00% 3.97 0.51 5.41 879.487 1,756.96 1,756.96 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% IHFPLATYAPVISAEK 95.00% 4.19 0.548 7.15 879.4872 1,756.96 1,756.96 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% IHFPLATYAPVISAEK 95.00% 4.17 0.561 6.57 879.4876 1,756.96 1,756.96 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 4.01 0.524 3.74 912.9939 1,823.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 3.44 0.557 2.64 912.9942 1,823.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 3.43 0.371 0 912.9953 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 3.85 0.501 2.82 912.9957 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 3.15 0.384 1.15 912.9958 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 4.36 0.561 1.64 912.9976 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 4 0.364 0 913.4928 1,824.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 3.9 0.289 0 913.4945 1,824.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 4.47 0.534 2.92 913.4953 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 4.24 0.421 1.43 913.4964 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 4.81 0.526 2.96 913.4965 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 4.34 0.475 2.54 913.4967 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% VGINYQPPTVVPGGDLAK 95.00% 4.06 0.4 1.49 913.4994 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVcMLSNTTAIAEAWAR 95.00% 3.78 0.44 3.21 c3: Carbamidomethyl (+57.02) 932.9532 1,863.89 1,864.91 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% AVcMLSNTTAIAEAWAR 95.00% 4.45 0.624 5.37 c3: Carbamidomethyl (+57.02) 932.9553 1,863.89 1,864.91 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% TIGGGDDSFNTFFSETGAGK 95.00% 5.78 0.671 6.66 1,004.45 2,006.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% TIGGGDDSFNTFFSETGAGK 95.00% 3.92 0.616 3.49 1,004.45 2,006.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% TIGGGDDSFNTFFSETGAGK 95.00% 4.5 0.547 2.96 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% TIGGGDDSFNTFFSETGAGK 95.00% 5.03 0.64 4.89 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% TIGGGDDSFNTFFSETGAGK 95.00% 6.03 0.629 4.42 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% TIGGGDDSFNTFFSETGAGK 95.00% 5.37 0.676 5.32 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% TIGGGDDSFNTFFSETGAGK 95.00% 5.81 0.623 4.41 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% TIGGGDDSFNTFFSETGAGK 95.00% 2.51 0.335 0 1,004.95 2,007.89 2,007.89 2 TBA1A_HUMAN
 SAMPLE 2R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 10 17 90 34.60% DVNAAIATIK 95.00% 1.51 0.249 2.82 1,016.98 1,015.97 1,015.58 1 TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% QLFHPEQLITGK 95.00% 2.24 0.312 0 470.9286 1,409.76 1,410.77 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% QLFHPEQLITGK 95.00% 1.98 0.331 0 470.9288 1,409.76 1,410.77 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% QLFHPEQLITGK 95.00% 3.04 0.214 0 470.9302 1,409.77 1,410.77 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% QLFHPEQLITGK 95.00% 2.9 0.264 0 470.9307 1,409.77 1,410.77 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% DVNAAIATIK 95.00% 2.5 0.29 1.36 508.291 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% DVNAAIATIK 95.00% 2.22 0.314 2.11 508.2914 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% DVNAAIATIK 95.00% 2.99 0.39 2.6 508.2915 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% DVNAAIATIK 95.00% 3.38 0.387 2.04 508.2916 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% DVNAAIATIK 95.00% 2.64 0.321 1.23 508.2917 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% EIIDLVLDR 95.00% 2.4 0.483 1.57 543.3133 1,084.61 1,085.62 2 TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% EIIDLVLDR 95.00% 2.35 0.466 0 543.3135 1,084.61 1,085.62 2 TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% NLDIERPTYTNLNR 95.00% 2.33 0.337 0 573.6313 1,717.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% NLDIERPTYTNLNR 95.00% 2.38 0.244 0 573.9657 1,718.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% IHFPLATYAPVISAEK 95.00% 3.79 0.42 2.02 586.6602 1,756.96 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% VGINYQPPTVVPGGDLAK 95.00% 2.87 0.321 0 609.3339 1,824.98 1,824.99 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% VGINYQPPTVVPGGDLAK 95.00% 3.06 0.255 0 609.3342 1,824.98 1,824.99 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% AVcMLSNTTAIAEAWAR 95.00% 3.99 0.411 0 c3: Carbamidomethyl (+57.02) 622.3044 1,863.89 1,864.91 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% AVcMLSNTTAIAEAWAR 95.00% 3.85 0.402 1.8 c3: Carbamidomethyl (+57.02) 622.6397 1,864.90 1,864.91 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% YMAccLLYR 95.00% 1.76 0.344 0 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 625.2786 1,248.54 1,249.55 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% YMAccLLYR 95.00% 2.04 0.471 0 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 625.279 1,248.54 1,249.55 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% QLFHPEQLITGK 95.00% 3.15 0.397 1.32 705.8888 1,409.76 1,410.77 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% QLFHPEQLITGK 95.00% 2.17 0.358 1.47 705.8896 1,409.76 1,410.77 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% QLFHPEQLITGKEDAANNYAR 95.00% 4.14 0.426 3.32 806.0737 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% QLFHPEQLITGKEDAANNYAR 95.00% 3.99 0.466 3.31 806.075 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% AVFVDLEPTVIDEVR 95.00% 4.88 0.472 2.92 851.4546 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% AVFVDLEPTVIDEVR 95.00% 5.08 0.47 2.51 851.4563 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% NLDIERPTYTNLNR 95.00% 3.09 0.227 1.52 859.9431 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% NLDIERPTYTNLNR 95.00% 3.29 0.322 0 859.9433 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% NLDIERPTYTNLNR 95.00% 3.32 0.299 0 860.4459 1,718.88 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% IHFPLATYAPVISAEK 95.00% 4.1 0.597 5.31 879.4866 1,756.96 1,756.96 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% IHFPLATYAPVISAEK 95.00% 4.14 0.635 5.48 879.4868 1,756.96 1,756.96 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% VGINYQPPTVVPGGDLAK 95.00% 4.3 0.513 3.62 912.9951 1,823.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% VGINYQPPTVVPGGDLAK 95.00% 4.49 0.518 3.06 912.9973 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% VGINYQPPTVVPGGDLAK 95.00% 3.97 0.533 2.8 912.9988 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% VGINYQPPTVVPGGDLAK 95.00% 3.8 0.575 1.47 913.4956 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% VGINYQPPTVVPGGDLAK 95.00% 4.72 0.569 3.19 913.4958 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% VGINYQPPTVVPGGDLAK 95.00% 4.29 0.556 1.74 913.4964 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% AVcMLSNTTAIAEAWAR 95.00% 5 0.657 5.68 c3: Carbamidomethyl (+57.02) 932.9541 1,863.89 1,864.91 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% AVcMLSNTTAIAEAWAR 95.00% 5.37 0.623 6.28 c3: Carbamidomethyl (+57.02) 932.9548 1,863.89 1,864.91 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% TIGGGDDSFNTFFSETGAGK 95.00% 5.71 0.706 6.77 1,004.45 2,006.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 11 16 41 33.00% TIGGGDDSFNTFFSETGAGK 95.00% 6.09 0.647 4.77 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% QLFHPEQLITGK 95.00% 2.75 0.253 1.42 470.9296 1,409.77 1,410.77 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% QLFHPEQLITGK 95.00% 2.29 0.304 0 470.9299 1,409.77 1,410.77 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% QLFHPEQLITGK 95.00% 2.91 0.256 0 470.9301 1,409.77 1,410.77 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% LISQIVSSITASLR 95.00% 2.58 0.268 1.32 496.9647 1,487.87 1,487.88 3 TBA4A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% DVNAAIATIK 95.00% 3.27 0.377 1.37 508.2915 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% DVNAAIATIK 95.00% 2.51 0.309 1.85 508.292 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% DVNAAIATIK 95.00% 3.05 0.38 2.21 508.2921 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% DVNAAIATIK 95.00% 2.31 0.251 1.82 508.2934 1,014.57 1,015.58 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% EIIDLVLDR 95.00% 2.46 0.452 0 543.3132 1,084.61 1,085.62 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% EIIDLVLDR 95.00% 2.86 0.401 1.11 543.3138 1,084.61 1,085.62 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 4.8 0.605 3.01 567.9733 1,700.90 1,701.91 3 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 4.33 0.6 2.57 567.9734 1,700.90 1,701.91 3 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 3.23 0.331 0 568.31 1,701.91 1,701.91 3 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% NLDIERPTYTNLNR 95.00% 2.16 0.2 0 573.6317 1,717.87 1,718.88 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% IHFPLATYAPVISAEK 95.00% 2.92 0.369 1.89 586.3251 1,755.95 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% IHFPLATYAPVISAEK 95.00% 2.88 0.282 1.48 586.6583 1,756.95 1,756.96 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVcMLSNTTAIAEAWAR 95.00% 3.66 0.301 0 c3: Carbamidomethyl (+57.02) 622.3064 1,863.90 1,864.91 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVcMLSNTTAIAEAWAR 95.00% 4.31 0.427 0 c3: Carbamidomethyl (+57.02) 622.3065 1,863.90 1,864.91 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% YMAccLLYR 95.00% 2.23 0.431 3.14 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 625.2793 1,248.54 1,249.55 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% YMAccLLYR 95.00% 2.07 0.446 1.15 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 625.2796 1,248.54 1,249.55 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% LDHKFDLMYAK 95.00% 2.18 0.351 0 690.8532 1,379.69 1,380.70 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% QLFHPEQLITGK 95.00% 2.39 0.28 0 705.89 1,409.76 1,410.77 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% QLFHPEQLITGK 95.00% 2.32 0.353 0 706.391 1,410.77 1,410.77 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% LISQIVSSITASLR 95.00% 3.69 0.53 4.22 744.4418 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% LISQIVSSITASLR 95.00% 3.52 0.569 4.37 744.4425 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% LISQIVSSITASLR 95.00% 2.8 0.388 2.64 744.4431 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% LISQIVSSITASLR 95.00% 4.29 0.579 4.68 744.4431 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% LISQIVSSITASLR 95.00% 2.4 0.313 0 744.4437 1,486.87 1,487.88 2 TBA4A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% QLFHPEQLITGKEDAANNYAR 95.00% 3.78 0.464 3.85 806.0742 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% QLFHPEQLITGKEDAANNYAR 95.00% 4.2 0.435 3.09 806.0756 2,415.20 2,415.21 3 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 2.66 0.388 0 851.452 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 5.05 0.51 2.54 851.4538 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 5.07 0.5 2.05 851.4541 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 5.26 0.475 1.96 851.455 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 4.54 0.365 1.68 851.455 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 4.99 0.476 1.82 851.4552 1,700.89 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 4.85 0.469 2.49 851.4554 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 4.73 0.501 2.36 851.4554 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 4.38 0.474 1.41 851.4568 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 4.65 0.479 3.32 851.4583 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 4.43 0.491 2.44 851.4584 1,700.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 3.91 0.358 2.12 851.9558 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVFVDLEPTVIDEVR 95.00% 4.94 0.381 1.4 851.9594 1,701.90 1,701.91 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% NLDIERPTYTNLNR 95.00% 3.35 0.328 0 859.9428 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% NLDIERPTYTNLNR 95.00% 3.36 0.369 0 859.9439 1,717.87 1,718.88 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% IHFPLATYAPVISAEK 95.00% 3.7 0.537 4.19 878.9837 1,755.95 1,756.96 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% IHFPLATYAPVISAEK 95.00% 3.84 0.563 4.7 879.486 1,756.96 1,756.96 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% VGINYQPPTVVPGGDLAK 95.00% 4.4 0.483 3.16 912.9945 1,823.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% VGINYQPPTVVPGGDLAK 95.00% 2.2 0.14 1.54 912.997 1,823.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% VGINYQPPTVVPGGDLAK 95.00% 4.06 0.551 1.82 913.4929 1,824.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% VGINYQPPTVVPGGDLAK 95.00% 3.46 0.403 2.11 913.4938 1,824.97 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% VGINYQPPTVVPGGDLAK 95.00% 4.14 0.589 2.13 913.4955 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% VGINYQPPTVVPGGDLAK 95.00% 5.06 0.512 3.11 913.4983 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% VGINYQPPTVVPGGDLAK 95.00% 5.05 0.518 2.34 913.4986 1,824.98 1,824.99 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVcMLSNTTAIAEAWAR 95.00% 4.17 0.496 2.72 c3: Carbamidomethyl (+57.02) 932.9548 1,863.89 1,864.91 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVcMLSNTTAIAEAWAR 95.00% 5.37 0.624 4.72 c3: Carbamidomethyl (+57.02) 933.4564 1,864.90 1,864.91 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% AVcMLSNTTAIAEAWAR 95.00% 2.72 0.323 2.74 c3: Carbamidomethyl (+57.02) 933.4573 1,864.90 1,864.91 2 TBA4A_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% TIGGGDDSFNTFFSETGAGK 95.00% 6.12 0.661 5.03 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-1B chain  TUBA1B  TBA1B_HUMAN 50,133.70 100.00% 13 19 59 38.60% TIGGGDDSFNTFFSETGAGK 95.00% 6.34 0.635 6.17 1,004.95 2,007.88 2,007.89 2 TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% QLFHPEQLITGK 95.00% 2.24 0.312 0 470.9286 1,409.76 1,410.77 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% QLFHPEQLITGK 95.00% 1.98 0.331 0 470.9288 1,409.76 1,410.77 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% QLFHPEQLITGK 95.00% 3.04 0.214 0 470.9302 1,409.77 1,410.77 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% QLFHPEQLITGK 95.00% 2.9 0.264 0 470.9307 1,409.77 1,410.77 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% DVNAAIAAIK 95.00% 2.98 0.507 2.62 493.2875 984.5594 985.5683 2
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% EIIDPVLDR 95.00% 2.18 0.383 0 535.2976 1,068.58 1,069.59 2
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% EIIDPVLDR 95.00% 2.17 0.386 0 535.2977 1,068.58 1,069.59 2
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% NLDIERPTYTNLNR 95.00% 2.33 0.337 0 573.6313 1,717.87 1,718.88 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% NLDIERPTYTNLNR 95.00% 2.38 0.244 0 573.9657 1,718.87 1,718.88 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% IHFPLATYAPVISAEK 95.00% 3.79 0.42 2.02 586.6602 1,756.96 1,756.96 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% VGINYQPPTVVPGGDLAK 95.00% 2.87 0.321 0 609.3339 1,824.98 1,824.99 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% VGINYQPPTVVPGGDLAK 95.00% 3.06 0.255 0 609.3342 1,824.98 1,824.99 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% AVcMLSNTTAIAEAWAR 95.00% 3.99 0.411 0 c3: Carbamidomethyl (+57.02) 622.3044 1,863.89 1,864.91 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% AVcMLSNTTAIAEAWAR 95.00% 3.85 0.402 1.8 c3: Carbamidomethyl (+57.02) 622.6397 1,864.90 1,864.91 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% YMAccLLYR 95.00% 1.76 0.344 0 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 625.2786 1,248.54 1,249.55 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% YMAccLLYR 95.00% 2.04 0.471 0 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 625.279 1,248.54 1,249.55 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% QLFHPEQLITGK 95.00% 3.15 0.397 1.32 705.8888 1,409.76 1,410.77 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% QLFHPEQLITGK 95.00% 2.17 0.358 1.47 705.8896 1,409.76 1,410.77 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% QLFHPEQLITGKEDAANNYAR 95.00% 4.14 0.426 3.32 806.0737 2,415.20 2,415.21 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% QLFHPEQLITGKEDAANNYAR 95.00% 3.99 0.466 3.31 806.075 2,415.20 2,415.21 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% NLDIERPTYTNLNR 95.00% 3.09 0.227 1.52 859.9431 1,717.87 1,718.88 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% NLDIERPTYTNLNR 95.00% 3.29 0.322 0 859.9433 1,717.87 1,718.88 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% NLDIERPTYTNLNR 95.00% 3.32 0.299 0 860.4459 1,718.88 1,718.88 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% IHFPLATYAPVISAEK 95.00% 4.1 0.597 5.31 879.4866 1,756.96 1,756.96 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% IHFPLATYAPVISAEK 95.00% 4.14 0.635 5.48 879.4868 1,756.96 1,756.96 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% VGINYQPPTVVPGGDLAK 95.00% 4.3 0.513 3.62 912.9951 1,823.97 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% VGINYQPPTVVPGGDLAK 95.00% 4.49 0.518 3.06 912.9973 1,823.98 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% VGINYQPPTVVPGGDLAK 95.00% 3.97 0.533 2.8 912.9988 1,823.98 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% VGINYQPPTVVPGGDLAK 95.00% 3.8 0.575 1.47 913.4956 1,824.98 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% VGINYQPPTVVPGGDLAK 95.00% 4.72 0.569 3.19 913.4958 1,824.98 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% VGINYQPPTVVPGGDLAK 95.00% 4.29 0.556 1.74 913.4964 1,824.98 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% AVcMLSNTTAIAEAWAR 95.00% 5 0.657 5.68 c3: Carbamidomethyl (+57.02) 932.9541 1,863.89 1,864.91 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3 Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 3 25.40% AVcMLSNTTAIAEAWAR 95.00% 5.37 0.623 6.28 c3: Carbamidomethyl (+57.02) 932.9548 1,863.89 1,864.91 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% QLFHPEQLITGK 95.00% 2.75 0.253 1.42 470.9296 1,409.77 1,410.77 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% QLFHPEQLITGK 95.00% 2.29 0.304 0 470.9299 1,409.77 1,410.77 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% QLFHPEQLITGK 95.00% 2.91 0.256 0 470.9301 1,409.77 1,410.77 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% DVNAAIAAIK 95.00% 3.02 0.478 2.32 493.2864 984.5572 985.5683 2
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% DVNAAIAAIK 95.00% 3.03 0.456 2.12 493.2879 984.5602 985.5683 2
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% LISQIVSSITASLR 95.00% 2.58 0.268 1.32 496.9647 1,487.87 1,487.88 3 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% EIIDPVLDR 95.00% 2.06 0.324 0 535.2975 1,068.58 1,069.59 2
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% EIIDPVLDR 95.00% 2.03 0.356 0 535.2979 1,068.58 1,069.59 2
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% NLDIERPTYTNLNR 95.00% 2.16 0.2 0 573.6317 1,717.87 1,718.88 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% IHFPLATYAPVISAEK 95.00% 2.92 0.369 1.89 586.3251 1,755.95 1,756.96 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% IHFPLATYAPVISAEK 95.00% 2.88 0.282 1.48 586.6583 1,756.95 1,756.96 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% AVcMLSNTTAIAEAWAR 95.00% 3.66 0.301 0 c3: Carbamidomethyl (+57.02) 622.3064 1,863.90 1,864.91 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% AVcMLSNTTAIAEAWAR 95.00% 4.31 0.427 0 c3: Carbamidomethyl (+57.02) 622.3065 1,863.90 1,864.91 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% YMAccLLYR 95.00% 2.23 0.431 3.14 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 625.2793 1,248.54 1,249.55 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% YMAccLLYR 95.00% 2.07 0.446 1.15 c4: Carbamidomethyl (+57.02), c5: Carbamidomethyl (+57.02) 625.2796 1,248.54 1,249.55 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% LDHKFDLMYAK 95.00% 2.18 0.351 0 690.8532 1,379.69 1,380.70 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% QLFHPEQLITGK 95.00% 2.39 0.28 0 705.89 1,409.76 1,410.77 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% QLFHPEQLITGK 95.00% 2.32 0.353 0 706.391 1,410.77 1,410.77 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% LISQIVSSITASLR 95.00% 3.69 0.53 4.22 744.4418 1,486.87 1,487.88 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% LISQIVSSITASLR 95.00% 3.52 0.569 4.37 744.4425 1,486.87 1,487.88 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% LISQIVSSITASLR 95.00% 2.8 0.388 2.64 744.4431 1,486.87 1,487.88 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% LISQIVSSITASLR 95.00% 4.29 0.579 4.68 744.4431 1,486.87 1,487.88 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% LISQIVSSITASLR 95.00% 2.4 0.313 0 744.4437 1,486.87 1,487.88 2 TBA1B_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% QLFHPEQLITGKEDAANNYAR 95.00% 3.78 0.464 3.85 806.0742 2,415.20 2,415.21 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% QLFHPEQLITGKEDAANNYAR 95.00% 4.2 0.435 3.09 806.0756 2,415.20 2,415.21 3 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% NLDIERPTYTNLNR 95.00% 3.35 0.328 0 859.9428 1,717.87 1,718.88 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% NLDIERPTYTNLNR 95.00% 3.36 0.369 0 859.9439 1,717.87 1,718.88 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% IHFPLATYAPVISAEK 95.00% 3.7 0.537 4.19 878.9837 1,755.95 1,756.96 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% IHFPLATYAPVISAEK 95.00% 3.84 0.563 4.7 879.486 1,756.96 1,756.96 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% VGINYQPPTVVPGGDLAK 95.00% 4.4 0.483 3.16 912.9945 1,823.97 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% VGINYQPPTVVPGGDLAK 95.00% 2.2 0.14 1.54 912.997 1,823.98 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% VGINYQPPTVVPGGDLAK 95.00% 4.06 0.551 1.82 913.4929 1,824.97 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% VGINYQPPTVVPGGDLAK 95.00% 3.46 0.403 2.11 913.4938 1,824.97 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% VGINYQPPTVVPGGDLAK 95.00% 4.14 0.589 2.13 913.4955 1,824.98 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% VGINYQPPTVVPGGDLAK 95.00% 5.06 0.512 3.11 913.4983 1,824.98 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% VGINYQPPTVVPGGDLAK 95.00% 5.05 0.518 2.34 913.4986 1,824.98 1,824.99 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% AVcMLSNTTAIAEAWAR 95.00% 4.17 0.496 2.72 c3: Carbamidomethyl (+57.02) 932.9548 1,863.89 1,864.91 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% AVcMLSNTTAIAEAWAR 95.00% 5.37 0.624 4.72 c3: Carbamidomethyl (+57.02) 933.4564 1,864.90 1,864.91 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 3R Tubulin alpha-4A chain  TUBA4A  TBA4A_HUMAN 49,906.60 99.80% 2 2 4 31.00% AVcMLSNTTAIAEAWAR 95.00% 2.72 0.323 2.74 c3: Carbamidomethyl (+57.02) 933.4573 1,864.90 1,864.91 2 TBA1B_HUMAN,TBA1A_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% TAVcDIPPR 95.00% 2.28 0.382 2.16 c4: Carbamidomethyl (+57.02) 514.7647 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% TAVcDIPPR 95.00% 2.35 0.344 3.06 c4: Carbamidomethyl (+57.02) 514.7653 1,027.52 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% TAVcDIPPR 95.00% 2.61 0.486 2.25 c4: Carbamidomethyl (+57.02) 514.7658 1,027.52 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% TAVcDIPPR 95.00% 2.38 0.368 3.01 c4: Carbamidomethyl (+57.02) 514.7661 1,027.52 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% TAVcDIPPR 95.00% 2.56 0.442 1.44 c4: Carbamidomethyl (+57.02) 514.7663 1,027.52 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% TAVcDIPPR 95.00% 2.56 0.468 1.92 c4: Carbamidomethyl (+57.02) 514.7664 1,027.52 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% TAVcDIPPR 95.00% 2.27 0.334 2.19 c4: Carbamidomethyl (+57.02) 514.7665 1,027.52 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% TAVcDIPPR 95.00% 1.82 0.27 2.14 c4: Carbamidomethyl (+57.02) 514.7668 1,027.52 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% TAVcDIPPR 95.00% 2.32 0.345 2.27 c4: Carbamidomethyl (+57.02) 514.7671 1,027.52 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% YLTVAAVFR 95.00% 2.95 0.387 3.28 520.3015 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% YLTVAAVFR 95.00% 2.92 0.376 2.62 520.3015 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% YLTVAAVFR 95.00% 2.91 0.385 2.05 520.3021 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% YLTVAAVFR 95.00% 2.66 0.418 2.09 520.3021 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% YLTVAAVFR 95.00% 2.99 0.425 2.6 520.3022 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% YLTVAAVFR 95.00% 2.82 0.391 2.43 520.3025 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% YLTVAAVFR 95.00% 2.86 0.387 2.96 520.3025 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% YLTVAAVFR 95.00% 3.08 0.367 2.28 520.3025 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% YLTVAAVFR 95.00% 2.81 0.376 2.92 520.3028 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% YLTVAAVFR 95.00% 2.84 0.397 2.66 520.3036 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 3.41 0.524 0 553.9707 1,658.89 1,659.90 3
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 2.89 0.495 0 553.9713 1,658.89 1,659.90 3
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 4.09 0.578 2.92 553.9727 1,658.89 1,659.90 3
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 3.78 0.432 1.82 554.3063 1,659.90 1,659.90 3
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 4.09 0.395 2.09 554.3065 1,659.90 1,659.90 3
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 4.69 0.509 2.02 554.3068 1,659.90 1,659.90 3
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 3.2 0.471 0 554.3068 1,659.90 1,659.90 3
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 3.9 0.418 1.38 554.3069 1,659.90 1,659.90 3
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% LAVNMVPFPR 95.00% 3.48 0.517 2.03 572.3208 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% LAVNMVPFPR 95.00% 3.67 0.484 1.8 572.3211 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% LAVNMVPFPR 95.00% 3.3 0.47 2.33 572.3219 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% LAVNMVPFPR 95.00% 3.69 0.513 1.82 572.3226 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% LAVNMVPFPR 95.00% 3.52 0.494 2.06 572.3227 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% LAVNMVPFPR 95.00% 3.84 0.547 2 572.3227 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% LAVNmVPFPR 95.00% 2.67 0.395 0 m5: Oxidation (+15.99) 580.3197 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% LAVNmVPFPR 95.00% 3.16 0.384 1.49 m5: Oxidation (+15.99) 580.3203 1,158.63 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% LAVNmVPFPR 95.00% 3.06 0.445 2.68 m5: Oxidation (+15.99) 580.3206 1,158.63 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% LAVNmVPFPR 95.00% 3.31 0.456 2.52 m5: Oxidation (+15.99) 580.3211 1,158.63 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% LAVNmVPFPR 95.00% 2.92 0.371 1.24 m5: Oxidation (+15.99) 580.3211 1,158.63 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% EIVHIQAGQcGNQIGAK 95.00% 2.37 0.301 0 c10: Carbamidomethyl (+57.02) 608.3142 1,821.92 1,822.92 3 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% EIVHIQAGQcGNQIGAK 95.00% 2.24 0.218 1.03 c10: Carbamidomethyl (+57.02) 608.6492 1,822.92 1,822.92 3 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% EIVHIQAGQcGNQIGAK 95.00% 3.03 0.307 2.05 c10: Carbamidomethyl (+57.02) 608.6498 1,822.93 1,822.92 3 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ISVYYNEATGGK 95.00% 3.52 0.476 2.64 651.3244 1,300.63 1,301.64 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ISVYYNEATGGK 95.00% 3.4 0.464 3.7 651.3246 1,300.63 1,301.64 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ISVYYNEATGGK 95.00% 3.67 0.508 3.49 651.3249 1,300.63 1,301.64 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ISVYYNEATGGK 95.00% 3.26 0.467 3.6 651.3253 1,300.64 1,301.64 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% GHYTEGAELVDSVLDVVR 95.00% 3.12 0.359 0 654.0021 1,958.98 1,958.98 3 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% GHYTEGAELVDSVLDVVR 95.00% 3.82 0.386 1.48 654.0023 1,958.98 1,958.98 3 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% GHYTEGAELVDSVLDVVR 95.00% 3.52 0.4 0 654.004 1,958.99 1,958.98 3 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% mSmKEVDEQmLNVQNK 95.00% 3.79 0.23 0 m1: Oxidation (+15.99), m3: Oxidation (+15.99), m10: Oxidation (+15.99) 658.3031 1,971.89 1,971.88 3 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% MREIVHIQAGQcGNQIGAK 95.00% 4.3 0.425 3.38 c12: Carbamidomethyl (+57.02) 704.3177 2,109.93 2,110.07 3 TBB2C_HUMAN
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% AILVDLEPGTmDSVR 95.00% 3.64 0.119 2.8 m11: Oxidation (+15.99) 816.4234 1,630.83 1,631.83 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% AILVDLEPGTmDSVR 95.00% 4.28 0.459 3.74 m11: Oxidation (+15.99) 816.9244 1,631.83 1,631.83 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 3.97 0.433 7.09 830.4538 1,658.89 1,659.90 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 4.37 0.547 6.02 830.4539 1,658.89 1,659.90 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 4.16 0.512 6.92 830.4539 1,658.89 1,659.90 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 4.09 0.536 4.96 830.4539 1,658.89 1,659.90 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 4.19 0.527 7.12 830.4541 1,658.89 1,659.90 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 3.5 0.534 5.06 830.4543 1,658.89 1,659.90 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 4.13 0.546 7.72 830.4546 1,658.89 1,659.90 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 4.29 0.528 8.96 830.4547 1,658.89 1,659.90 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 4.24 0.508 5.55 830.4557 1,658.90 1,659.90 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 4.33 0.498 6.82 830.9563 1,659.90 1,659.90 2
 SAMPLE 4 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 8 9 43 27.70% ALTVPELTQQVFDAK 95.00% 4.56 0.559 3.92 830.9564 1,659.90 1,659.90 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% TAVcDIPPR 95.00% 2.52 0.381 1.89 c4: Carbamidomethyl (+57.02) 514.765 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% TAVcDIPPR 95.00% 2.41 0.256 2.66 c4: Carbamidomethyl (+57.02) 514.7655 1,027.52 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% TAVcDIPPR 95.00% 2.61 0.432 3.32 c4: Carbamidomethyl (+57.02) 514.7669 1,027.52 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% TAVcDIPPR 95.00% 2.27 0.347 3.12 c4: Carbamidomethyl (+57.02) 514.7674 1,027.52 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% TAVcDIPPR 95.00% 2.41 0.309 0 c4: Carbamidomethyl (+57.02) 514.7685 1,027.52 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% TAVcDIPPR 95.00% 2.22 0.262 0 c4: Carbamidomethyl (+57.02) 515.2641 1,028.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% YLTVAAVFR 95.00% 3.2 0.407 3.7 520.3011 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% YLTVAAVFR 95.00% 3.12 0.379 3.44 520.3014 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% YLTVAAVFR 95.00% 2.89 0.385 1.85 520.302 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% YLTVAAVFR 95.00% 2.88 0.394 2.26 520.3021 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% YLTVAAVFR 95.00% 2.9 0.375 2.8 520.3022 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% YLTVAAVFR 95.00% 2.59 0.411 1.66 520.3022 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% YLTVAAVFR 95.00% 2.97 0.424 1.49 520.3023 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% YLTVAAVFR 95.00% 2.66 0.359 1.72 520.3028 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% YLTVAAVFR 95.00% 2.79 0.41 2.06 520.3033 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% YLTVAAVFR 95.00% 2.02 0.263 3 520.3037 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% FPGQLNADLR 95.00% 2.56 0.224 0 565.8017 1,129.59 1,130.60 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% FPGQLNADLR 95.00% 2.58 0.326 0 565.8028 1,129.59 1,130.60 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNMVPFPR 95.00% 3.79 0.5 1.77 572.3214 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNMVPFPR 95.00% 3.53 0.51 4.01 572.3214 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNMVPFPR 95.00% 3.58 0.457 3 572.3217 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNMVPFPR 95.00% 3.56 0.499 2.46 572.322 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNMVPFPR 95.00% 3.13 0.452 3.51 572.3225 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNMVPFPR 95.00% 2.65 0.353 1.29 572.3226 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNMVPFPR 95.00% 3.03 0.324 1.3 572.3226 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNMVPFPR 95.00% 3.51 0.4 2 572.3227 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNMVPFPR 95.00% 3.84 0.526 3.41 572.323 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNMVPFPR 95.00% 3.3 0.475 2.11 572.323 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNMVPFPR 95.00% 2.93 0.369 2.54 572.3249 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNmVPFPR 95.00% 2.52 0.357 1.74 m5: Oxidation (+15.99) 580.3194 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNmVPFPR 95.00% 2.81 0.449 1.57 m5: Oxidation (+15.99) 580.3201 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNmVPFPR 95.00% 3.21 0.398 1.36 m5: Oxidation (+15.99) 580.3203 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% LAVNmVPFPR 95.00% 3 0.442 1.57 m5: Oxidation (+15.99) 580.3207 1,158.63 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ISVYYNEATGGKYVPR 95.00% 2.6 0.189 0 606.6484 1,816.92 1,816.92 3
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ISEQFTAMFR 95.00% 2.53 0.412 0 615.3046 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ISVYYNEATGGK 95.00% 3.46 0.424 3.85 651.3255 1,300.64 1,301.64 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ISVYYNEATGGK 95.00% 3.44 0.502 4.35 651.3268 1,300.64 1,301.64 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ISVYYNEATGGK 95.00% 3.22 0.422 2.74 651.3272 1,300.64 1,301.64 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ISVYYNEATGGK 95.00% 2.97 0.445 3.92 651.8288 1,301.64 1,301.64 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% GHYTEGAELVDSVLDVVR 95.00% 2.53 0.145 1.85 653.6687 1,957.98 1,958.98 3 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% GHYTEGAELVDSVLDVVR 95.00% 2.76 0.359 0 654.001 1,958.98 1,958.98 3 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% GHYTEGAELVDSVLDVVRK 95.00% 2.71 0.351 1.08 696.6979 2,087.07 2,087.08 3 TBB2C_HUMAN,PGS1_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% MREIVHIQAGQcGNQIGAK 95.00% 3.71 0.447 4.19 c12: Carbamidomethyl (+57.02) 704.3189 2,109.93 2,110.07 3 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% MREIVHIQAGQcGNQIGAK 95.00% 2.62 0.227 1.16 c12: Carbamidomethyl (+57.02) 704.3207 2,109.94 2,110.07 3 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% AILVDLEPGTmDSVR 95.00% 3.06 0.118 3.42 m11: Oxidation (+15.99) 816.4207 1,630.83 1,631.83 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% AILVDLEPGTmDSVR 95.00% 3.08 0.273 1.8 m11: Oxidation (+15.99) 816.4236 1,630.83 1,631.83 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ALTVPELTQQVFDAK 95.00% 4.23 0.537 6.08 830.4528 1,658.89 1,659.90 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ALTVPELTQQVFDAK 95.00% 4.22 0.513 5.66 830.4536 1,658.89 1,659.90 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ALTVPELTQQVFDAK 95.00% 3.22 0.441 2.09 830.4543 1,658.89 1,659.90 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ALTVPELTQQVFDAK 95.00% 4.09 0.494 6.19 830.4543 1,658.89 1,659.90 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ALTVPELTQQVFDAK 95.00% 4.11 0.508 5.47 830.4544 1,658.89 1,659.90 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ALTVPELTQQVFDAK 95.00% 3.95 0.514 5.74 830.4547 1,658.89 1,659.90 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ALTVPELTQQVFDAK 95.00% 4.16 0.513 5.21 830.4561 1,658.90 1,659.90 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ALTVPELTQQVFDAK 95.00% 3.89 0.53 5.44 830.4565 1,658.90 1,659.90 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ALTVPELTQQVFDAK 95.00% 4.33 0.499 4.96 830.9557 1,659.90 1,659.90 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ALTVPELTQQVFDAK 95.00% 4.39 0.551 4.51 830.9574 1,659.90 1,659.90 2
 SAMPLE 4R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 9 9 34 29.70% ALTVPELTQQVFDAK 95.00% 4.09 0.451 3.7 830.9577 1,659.90 1,659.90 2
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% TAVcDIPPR 95.00% 2.23 0.396 2.54 c4: Carbamidomethyl (+57.02) 514.7618 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% TAVcDIPPR 95.00% 2.23 0.265 1.7 c4: Carbamidomethyl (+57.02) 514.7629 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% TAVcDIPPR 95.00% 2.17 0.196 1.17 c4: Carbamidomethyl (+57.02) 515.2608 1,028.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% YLTVAAVFR 95.00% 2.84 0.388 2.89 520.2988 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% YLTVAAVFR 95.00% 2.71 0.377 1.17 520.2989 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% YLTVAAVFR 95.00% 2.3 0.404 2.54 520.2995 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% YLTVAAVFR 95.00% 3.04 0.388 3.18 520.3 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% FPGQLNADLR 95.00% 2.66 0.303 1.28 565.7996 1,129.58 1,130.60 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% FPGQLNADLR 95.00% 2.87 0.338 1.33 565.8008 1,129.59 1,130.60 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% LAVNMVPFPR 95.00% 2.91 0.416 2.14 572.317 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% LAVNMVPFPR 95.00% 3.69 0.492 1.59 572.3197 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% LAVNMVPFPR 95.00% 4 0.534 2.8 572.3198 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% LAVNMVPFPR 95.00% 3.82 0.536 2.17 572.32 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% LAVNMVPFPR 95.00% 3.79 0.554 3 572.3201 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% LAVNMVPFPR 95.00% 3.5 0.499 2.82 572.3204 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% LAVNMVPFPR 95.00% 3.32 0.39 2.28 572.3205 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% LAVNMVPFPR 95.00% 3.42 0.456 0 572.3217 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% LAVNMVPFPR 95.00% 3.48 0.458 2.14 572.3254 1,142.64 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% LAVNmVPFPR 95.00% 2.84 0.39 2 m5: Oxidation (+15.99) 580.3164 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% LAVNmVPFPR 95.00% 2.9 0.384 1.39 m5: Oxidation (+15.99) 580.3194 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% EIVHIQAGQcGNQIGAK 95.00% 4.31 0.414 1.82 c10: Carbamidomethyl (+57.02) 608.3149 1,821.92 1,822.92 3 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% EIVHIQAGQcGNQIGAK 95.00% 3.64 0.332 2.54 c10: Carbamidomethyl (+57.02) 608.6473 1,822.92 1,822.92 3 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% ISEQFTAMFR 95.00% 3.77 0.552 1.72 615.2993 1,228.58 1,229.60 2 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% ISEQFTAMFR 95.00% 3.68 0.561 2.11 615.3009 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% ISEQFTAMFR 95.00% 3.78 0.519 2.08 615.3011 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% ISEQFTAMFR 95.00% 3.63 0.523 0 615.3018 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% ISEQFTAMFR 95.00% 3.21 0.355 0 615.8029 1,229.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% ISVYYNEATGGK 95.00% 3.54 0.547 3 651.3209 1,300.63 1,301.64 2
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% ISVYYNEATGGK 95.00% 3.65 0.479 2.85 651.3224 1,300.63 1,301.64 2
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% GHYTEGAELVDSVLDVVR 95.00% 4.6 0.428 1.29 653.9988 1,958.97 1,958.98 3 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% GHYTEGAELVDSVLDVVR 95.00% 3.95 0.462 1.26 653.9989 1,958.97 1,958.98 3 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% IMNTFSVVPSPK 95.00% 2.86 0.476 2.28 660.354 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% IMNTFSVVPSPK 95.00% 3.26 0.437 3.64 660.354 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% GHYTEGAELVDSVLDVVRK 95.00% 4.58 0.462 2.82 696.3635 2,086.07 2,087.08 3 TBB2C_HUMAN,PGS1_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% GHYTEGAELVDSVLDVVRK 95.00% 4.11 0.403 3.49 696.6972 2,087.07 2,087.08 3 TBB2C_HUMAN,PGS1_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% GHYTEGAELVDSVLDVVRK 95.00% 3.81 0.213 0 696.7245 2,087.15 2,087.08 3 TBB2C_HUMAN,PGS1_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% MREIVHIQAGQcGNQIGAK 95.00% 4.28 0.373 3.11 c12: Carbamidomethyl (+57.02) 704.3633 2,110.07 2,110.07 3 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% MREIVHIQAGQcGNQIGAK 95.00% 4.01 0.482 2.55 c12: Carbamidomethyl (+57.02) 704.3636 2,110.07 2,110.07 3 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% EVDEQMLNVQNK 95.00% 3.8 0.273 0 723.8446 1,445.67 1,446.69 2 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% EVDEQMLNVQNK 95.00% 4.18 0.244 1.72 723.8456 1,445.68 1,446.69 2 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% EVDEQMLNVQNK 95.00% 4.08 0.246 1.54 723.8531 1,445.69 1,446.69 2 TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% ALTVPELTQQVFDAK 95.00% 3.55 0.493 3.96 830.4503 1,658.89 1,659.90 2
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% ALTVPELTQQVFDAK 95.00% 3.56 0.417 5.07 830.4514 1,658.89 1,659.90 2
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% ALTVPELTQQVFDAK 95.00% 3.17 0.534 3.2 830.4557 1,658.90 1,659.90 2
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% ALTVPELTQQVFDAK 95.00% 2.68 0.347 2.37 830.4695 1,658.92 1,659.90 2
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% ALTVPELTQQVFDAK 95.00% 4.21 0.492 6.39 830.9693 1,659.92 1,659.90 2
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% NSSYFVEWIPNNVK 95.00% 4.58 0.48 2.44 848.9184 1,695.82 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% NSSYFVEWIPNNVK 95.00% 4.49 0.422 0 848.9194 1,695.82 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% NSSYFVEWIPNNVK 95.00% 2.36 0.344 0 848.929 1,695.84 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% NSSYFVEWIPNNVK 95.00% 4.55 0.432 2.19 849.4221 1,696.83 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 11 33 34.00% EIVHIQAGQcGNQIGAK 95.00% 4.59 0.469 4.25 c10: Carbamidomethyl (+57.02) 912.4642 1,822.91 1,822.92 2 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% TAVcDIPPR 95.00% 2.32 0.345 2.85 c4: Carbamidomethyl (+57.02) 514.7627 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% TAVcDIPPR 95.00% 2.34 0.377 1.82 c4: Carbamidomethyl (+57.02) 514.7633 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% TAVcDIPPR 95.00% 2.45 0.318 2.08 c4: Carbamidomethyl (+57.02) 514.7633 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% YLTVAAVFR 95.00% 1.83 0.223 1.96 520.2976 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% YLTVAAVFR 95.00% 2.47 0.387 1.96 520.2983 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% YLTVAAVFR 95.00% 2.96 0.382 2.3 520.2986 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% YLTVAAVFR 95.00% 2.23 0.233 3.03 520.299 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% FPGQLNADLR 95.00% 2.85 0.35 1.14 565.7998 1,129.58 1,130.60 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% FPGQLNADLR 95.00% 3.18 0.374 1.64 565.8004 1,129.59 1,130.60 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNMVPFPR 95.00% 2.91 0.424 2.77 572.3188 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNMVPFPR 95.00% 3.93 0.539 3.18 572.3195 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNMVPFPR 95.00% 3.86 0.467 3.27 572.3195 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNMVPFPR 95.00% 3.84 0.522 2.54 572.32 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNMVPFPR 95.00% 3.83 0.512 2.82 572.3205 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNMVPFPR 95.00% 3.45 0.52 3.55 572.3206 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNMVPFPR 95.00% 3.12 0.472 1.92 572.3209 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNMVPFPR 95.00% 2.87 0.338 2.15 572.3217 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNMVPFPR 95.00% 3.42 0.456 0 572.3217 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNMVPFPR 95.00% 3.48 0.458 2.33 572.3254 1,142.64 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNMVPFPR 95.00% 3.33 0.412 1.59 572.3311 1,142.65 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNMVPFPR 95.00% 3.34 0.406 2.14 572.3321 1,142.65 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNmVPFPR 95.00% 2.82 0.357 1.92 m5: Oxidation (+15.99) 580.317 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% LAVNmVPFPR 95.00% 2.86 0.407 1.96 m5: Oxidation (+15.99) 580.3184 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ISEQFTAMFR 95.00% 3.43 0.545 2.77 615.3003 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ISEQFTAMFR 95.00% 3.4 0.551 1.89 615.3008 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ISEQFTAMFR 95.00% 3.44 0.539 1.66 615.3017 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ISEQFTAMFR 95.00% 3.21 0.355 0 615.8029 1,229.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ISVYYNEATGGK 95.00% 3.78 0.543 2.12 651.3212 1,300.63 1,301.64 2
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ISVYYNEATGGK 95.00% 3.31 0.471 5.41 651.3222 1,300.63 1,301.64 2
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% GHYTEGAELVDSVLDVVRK 95.00% 4.33 0.371 2.27 696.3617 2,086.06 2,087.08 3 TBB2C_HUMAN,PGS1_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% GHYTEGAELVDSVLDVVRK 95.00% 3.62 0.292 0 696.6989 2,087.07 2,087.08 3 TBB2C_HUMAN,PGS1_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% GHYTEGAELVDSVLDVVRK 95.00% 3.81 0.213 0 696.7245 2,087.15 2,087.08 3 TBB2C_HUMAN,PGS1_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% MREIVHIQAGQcGNQIGAK 95.00% 5.44 0.526 4.1 c12: Carbamidomethyl (+57.02) 704.3611 2,110.06 2,110.07 3 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% MREIVHIQAGQcGNQIGAK 95.00% 5.07 0.465 3.51 c12: Carbamidomethyl (+57.02) 704.3616 2,110.06 2,110.07 3 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% EVDEQMLNVQNK 95.00% 3.94 0.262 1.35 723.8459 1,445.68 1,446.69 2 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% EVDEQMLNVQNK 95.00% 3.52 0.274 0 723.85 1,445.68 1,446.69 2 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% AILVDLEPGTMDSVR 95.00% 4.08 0.575 3.05 808.9217 1,615.83 1,615.84 2
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% AILVDLEPGTMDSVR 95.00% 3.97 0.551 3.02 808.9278 1,615.84 1,615.84 2
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ALTVPELTQQVFDAK 95.00% 2.07 0.33 1.92 830.4494 1,658.88 1,659.90 2
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ALTVPELTQQVFDAK 95.00% 2.8 0.387 2.64 830.4501 1,658.88 1,659.90 2
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ALTVPELTQQVFDAK 95.00% 3.97 0.516 6.19 830.4503 1,658.89 1,659.90 2
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ALTVPELTQQVFDAK 95.00% 3.89 0.496 5.06 830.4507 1,658.89 1,659.90 2
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ALTVPELTQQVFDAK 95.00% 3.88 0.423 6.14 830.4508 1,658.89 1,659.90 2
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ALTVPELTQQVFDAK 95.00% 3.76 0.503 4.64 830.451 1,658.89 1,659.90 2
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ALTVPELTQQVFDAK 95.00% 2.96 0.337 4.85 830.4543 1,658.89 1,659.90 2
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% ALTVPELTQQVFDAK 95.00% 4.07 0.495 4.46 830.9518 1,659.89 1,659.90 2
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% NSSYFVEWIPNNVK 95.00% 4.43 0.449 3.08 848.9185 1,695.82 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% NSSYFVEWIPNNVK 95.00% 4.4 0.439 3.13 848.9195 1,695.82 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% EIVHIQAGQcGNQIGAK 95.00% 4.82 0.501 3.59 c10: Carbamidomethyl (+57.02) 911.9616 1,821.91 1,822.92 2 TBB2C_HUMAN
 SAMPLE 1R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 10 10 31 34.70% EIVHIQAGQcGNQIGAK 95.00% 4.55 0.486 5.24 c10: Carbamidomethyl (+57.02) 911.9665 1,821.92 1,822.92 2 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% TAVcDIPPR 95.00% 2.62 0.455 1.49 c4: Carbamidomethyl (+57.02) 514.7626 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% TAVcDIPPR 95.00% 2.22 0.283 1.29 c4: Carbamidomethyl (+57.02) 514.7627 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% TAVcDIPPR 95.00% 2.79 0.444 1.82 c4: Carbamidomethyl (+57.02) 514.7627 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% TAVcDIPPR 95.00% 2.39 0.363 1.23 c4: Carbamidomethyl (+57.02) 514.763 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% TAVcDIPPR 95.00% 2.45 0.399 1.25 c4: Carbamidomethyl (+57.02) 514.7636 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% YLTVAAVFR 95.00% 2.65 0.344 1.96 520.2994 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% YLTVAAVFR 95.00% 2.67 0.383 1.85 520.2998 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% NMMAAcDPR 95.00% 2.24 0.431 1.49 c6: Carbamidomethyl (+57.02) 533.2146 1,064.41 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% NMMAAcDPR 95.00% 2.1 0.446 1.92 c6: Carbamidomethyl (+57.02) 533.2159 1,064.42 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% NMMAAcDPR 95.00% 2.35 0.422 1.96 c6: Carbamidomethyl (+57.02) 533.2169 1,064.42 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% NMMAAcDPR 95.00% 2.39 0.437 1.92 c6: Carbamidomethyl (+57.02) 533.2173 1,064.42 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LHFFMPGFAPLTSR 95.00% 3.32 0.31 2.24 540.9494 1,619.82 1,620.84 3 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LHFFMPGFAPLTSR 95.00% 2.79 0.112 1.52 540.9499 1,619.83 1,620.84 3 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ALTVPELTQQVFDAK 95.00% 3.58 0.553 1 553.9686 1,658.88 1,659.90 3
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ALTVPELTQQVFDAK 95.00% 4.59 0.598 1.77 553.97 1,658.89 1,659.90 3
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ALTVPELTQQVFDAK 95.00% 4.41 0.623 3.38 553.97 1,658.89 1,659.90 3
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ALTVPELTQQVFDAK 95.00% 4.23 0.474 1.11 554.3041 1,659.89 1,659.90 3
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% FPGQLNADLR 95.00% 2.44 0.207 0 565.8 1,129.58 1,130.60 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% FPGQLNADLR 95.00% 2.86 0.303 0 565.8001 1,129.58 1,130.60 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNMVPFPR 95.00% 3.72 0.472 1.96 572.3042 1,142.59 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNMVPFPR 95.00% 3.9 0.544 2.82 572.319 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNMVPFPR 95.00% 2.98 0.396 1.8 572.3194 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNMVPFPR 95.00% 3.4 0.464 2.6 572.3204 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNMVPFPR 95.00% 3.65 0.512 3.08 572.3204 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNMVPFPR 95.00% 3.91 0.549 2.59 572.3207 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNMVPFPR 95.00% 4.14 0.547 2.28 572.3207 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNMVPFPR 95.00% 3.67 0.51 2.15 572.3214 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNMVPFPR 95.00% 3.46 0.481 3.12 572.3214 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNMVPFPR 95.00% 3.71 0.53 2.8 572.3217 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNMVPFPR 95.00% 2.8 0.358 1.54 572.8076 1,143.60 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNmVPFPR 95.00% 3.3 0.395 2.59 m5: Oxidation (+15.99) 580.318 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LAVNmVPFPR 95.00% 3.19 0.401 2.54 m5: Oxidation (+15.99) 580.3181 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISVYYNEATGGKYVPR 95.00% 3.68 0.426 0 606.312 1,815.91 1,816.92 3
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISVYYNEATGGKYVPR 95.00% 2.12 0.451 0 606.6455 1,816.91 1,816.92 3
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% EIVHIQAGQcGNQIGAK 95.00% 3.27 0.248 1.77 c10: Carbamidomethyl (+57.02) 608.3118 1,821.91 1,822.92 3 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% EIVHIQAGQcGNQIGAK 95.00% 3.87 0.465 2.17 c10: Carbamidomethyl (+57.02) 608.3121 1,821.91 1,822.92 3 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% EIVHIQAGQcGNQIGAK 95.00% 2.51 0.344 1.74 c10: Carbamidomethyl (+57.02) 608.3125 1,821.91 1,822.92 3 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% EIVHIQAGQcGNQIGAK 95.00% 3.24 0.42 2.11 c10: Carbamidomethyl (+57.02) 608.3129 1,821.92 1,822.92 3 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% EIVHIQAGQcGNQIGAK 95.00% 3.58 0.466 1.46 c10: Carbamidomethyl (+57.02) 608.6472 1,822.92 1,822.92 3 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISEQFTAMFR 95.00% 3.83 0.543 2.3 615.3006 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISEQFTAMFR 95.00% 2.72 0.443 1.92 615.3204 1,228.63 1,229.60 2 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISEQFTAmFR 95.00% 2.36 0.374 1.34 m8: Oxidation (+15.99) 623.3 1,244.58 1,245.59 2 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% FPGQLNADLRK 95.00% 3 0.271 1.11 629.8479 1,257.68 1,258.69 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% FPGQLNADLRK 95.00% 2.83 0.277 1.38 629.8486 1,257.68 1,258.69 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISVYYNEATGGK 95.00% 3.11 0.553 3.51 651.321 1,300.63 1,301.64 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISVYYNEATGGK 95.00% 3.64 0.478 3.46 651.3211 1,300.63 1,301.64 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISVYYNEATGGK 95.00% 3.91 0.53 2.43 651.3216 1,300.63 1,301.64 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISVYYNEATGGK 95.00% 3.64 0.497 1.66 651.3219 1,300.63 1,301.64 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISVYYNEATGGK 95.00% 3.46 0.521 4.19 651.322 1,300.63 1,301.64 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISVYYNEATGGK 95.00% 2.71 0.512 1.74 651.3222 1,300.63 1,301.64 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISVYYNEATGGK 95.00% 3.47 0.511 2.05 651.3224 1,300.63 1,301.64 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ISVYYNEATGGK 95.00% 3.99 0.512 4.34 651.8224 1,301.63 1,301.64 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% IMNTFSVVPSPK 95.00% 2.91 0.361 2.89 660.3531 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% IMNTFSVVPSPK 95.00% 4.18 0.509 3.11 660.3541 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% IMNTFSVVPSPK 95.00% 3.98 0.538 3.29 660.3543 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% MREIVHIQAGQcGNQIGAK 95.00% 5.32 0.555 3.89 c12: Carbamidomethyl (+57.02) 704.0262 2,109.06 2,110.07 3 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% MREIVHIQAGQcGNQIGAK 95.00% 5.59 0.485 4.44 c12: Carbamidomethyl (+57.02) 704.0271 2,109.06 2,110.07 3 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% EVDEQMLNVQNK 95.00% 4.34 0.271 1.36 723.8473 1,445.68 1,446.69 2 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% EVDEQMLNVQNK 95.00% 4.02 0.271 1.59 723.8482 1,445.68 1,446.69 2 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% AILVDLEPGTMDSVR 95.00% 4.38 0.593 4.77 808.4201 1,614.82 1,615.84 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% AILVDLEPGTMDSVR 95.00% 4.35 0.582 6.16 808.4208 1,614.83 1,615.84 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% AILVDLEPGTMDSVR 95.00% 4.01 0.598 5.92 808.4217 1,614.83 1,615.84 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% AILVDLEPGTMDSVR 95.00% 3.28 0.347 2.07 808.4221 1,614.83 1,615.84 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% AILVDLEPGTMDSVR 95.00% 3.83 0.515 4.1 808.4223 1,614.83 1,615.84 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% AILVDLEPGTMDSVR 95.00% 4.27 0.516 3.96 808.9236 1,615.83 1,615.84 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LHFFMPGFAPLTSR 95.00% 3.69 0.497 3.77 810.922 1,619.83 1,620.84 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% LHFFMPGFAPLTSR 95.00% 3.59 0.451 2.37 811.4234 1,620.83 1,620.84 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% AILVDLEPGTmDSVR 95.00% 4.21 0.564 3.54 m11: Oxidation (+15.99) 816.4202 1,630.82 1,631.83 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% AILVDLEPGTmDSVR 95.00% 4.26 0.559 4.77 m11: Oxidation (+15.99) 816.4206 1,630.83 1,631.83 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% AILVDLEPGTmDSVR 95.00% 4.16 0.472 5.23 m11: Oxidation (+15.99) 816.9184 1,631.82 1,631.83 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% AILVDLEPGTmDSVR 95.00% 4.36 0.516 3.66 m11: Oxidation (+15.99) 816.9218 1,631.83 1,631.83 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ALTVPELTQQVFDAK 95.00% 3.75 0.469 6.8 830.45 1,658.88 1,659.90 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ALTVPELTQQVFDAK 95.00% 4.17 0.482 5.57 830.45 1,658.88 1,659.90 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ALTVPELTQQVFDAK 95.00% 4.26 0.532 5.42 830.45 1,658.88 1,659.90 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ALTVPELTQQVFDAK 95.00% 4.17 0.47 5.14 830.9519 1,659.89 1,659.90 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ALTVPELTQQVFDAK 95.00% 4.39 0.553 5.23 830.9522 1,659.89 1,659.90 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% ALTVPELTQQVFDAK 95.00% 4.39 0.528 5.09 830.9539 1,659.89 1,659.90 2
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% NSSYFVEWIPNNVK 95.00% 4.61 0.464 2.82 848.9192 1,695.82 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% NSSYFVEWIPNNVK 95.00% 3.85 0.44 3.16 848.9196 1,695.82 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% EIVHIQAGQcGNQIGAK 95.00% 5.24 0.515 4.49 c10: Carbamidomethyl (+57.02) 911.9647 1,821.91 1,822.92 2 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% EIVHIQAGQcGNQIGAK 95.00% 5.08 0.425 2.37 c10: Carbamidomethyl (+57.02) 912.4666 1,822.92 1,822.92 2 TBB2C_HUMAN
 SAMPLE 2 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 16 57 39.40% MREIVHIQAGQcGNQIGAK 95.00% 5.89 0.508 6.2 c12: Carbamidomethyl (+57.02) 1,056.04 2,110.06 2,110.07 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% TAVcDIPPR 95.00% 2.32 0.253 0 c4: Carbamidomethyl (+57.02) 514.7613 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% TAVcDIPPR 95.00% 1.99 0.256 0 c4: Carbamidomethyl (+57.02) 514.7619 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% TAVcDIPPR 95.00% 2.14 0.304 2.04 c4: Carbamidomethyl (+57.02) 514.7621 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% TAVcDIPPR 95.00% 2.2 0.322 2.22 c4: Carbamidomethyl (+57.02) 514.7625 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% TAVcDIPPR 95.00% 2.33 0.444 1.47 c4: Carbamidomethyl (+57.02) 514.7625 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% TAVcDIPPR 95.00% 2.46 0.336 2.54 c4: Carbamidomethyl (+57.02) 514.7627 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% TAVcDIPPR 95.00% 2.41 0.362 2.2 c4: Carbamidomethyl (+57.02) 514.7627 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% TAVcDIPPR 95.00% 2.34 0.414 1.7 c4: Carbamidomethyl (+57.02) 514.763 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% TAVcDIPPR 95.00% 2.24 0.254 0 c4: Carbamidomethyl (+57.02) 514.7639 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% YLTVAAVFR 95.00% 1.87 0.165 1.74 520.2979 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% YLTVAAVFR 95.00% 2.35 0.287 2.49 520.2984 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% YLTVAAVFR 95.00% 2.32 0.458 1.66 520.2987 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% YLTVAAVFR 95.00% 2.12 0.248 2 520.2989 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% YLTVAAVFR 95.00% 2.36 0.466 2.43 520.2991 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% YLTVAAVFR 95.00% 1.98 0.265 0 520.2992 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% YLTVAAVFR 95.00% 1.96 0.305 2.89 520.2997 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% YLTVAAVFR 95.00% 1.62 0.286 1.96 520.3003 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% NMMAAcDPR 95.00% 2.41 0.391 2.03 c6: Carbamidomethyl (+57.02) 533.2153 1,064.42 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ALTVPELTQQVFDAK 95.00% 4.11 0.609 1.06 553.9698 1,658.89 1,659.90 3
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ALTVPELTQQVFDAK 95.00% 2.82 0.466 1.1 553.97 1,658.89 1,659.90 3
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ALTVPELTQQVFDAK 95.00% 4.3 0.515 2.4 554.3033 1,659.89 1,659.90 3
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ALTVPELTQQVFDAK 95.00% 3.84 0.477 2.28 554.3046 1,659.89 1,659.90 3
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% FPGQLNADLR 95.00% 2.88 0.312 1.8 565.8011 1,129.59 1,130.60 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% FPGQLNADLR 95.00% 2.62 0.269 0 565.802 1,129.59 1,130.60 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNMVPFPR 95.00% 3.06 0.486 0 572.3053 1,142.59 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNMVPFPR 95.00% 3.86 0.528 2.43 572.3188 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNMVPFPR 95.00% 3.68 0.489 2.62 572.3194 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNMVPFPR 95.00% 3.08 0.447 1.64 572.3195 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNMVPFPR 95.00% 4 0.539 2.28 572.32 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNMVPFPR 95.00% 3.84 0.518 2.38 572.3202 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNMVPFPR 95.00% 3.5 0.479 2.11 572.3202 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNMVPFPR 95.00% 3.18 0.42 2.62 572.3203 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNMVPFPR 95.00% 3.07 0.438 2.02 572.3205 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNMVPFPR 95.00% 3.17 0.369 2.41 572.3207 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNMVPFPR 95.00% 3.53 0.485 2.28 572.3235 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNmVPFPR 95.00% 3.31 0.442 1.82 m5: Oxidation (+15.99) 580.318 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LAVNmVPFPR 95.00% 2.97 0.398 1.44 m5: Oxidation (+15.99) 580.3216 1,158.63 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISVYYNEATGGKYVPR 95.00% 3.44 0.434 0 606.312 1,815.91 1,816.92 3
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISVYYNEATGGKYVPR 95.00% 4 0.45 0 606.647 1,816.92 1,816.92 3
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% EIVHIQAGQcGNQIGAK 95.00% 3.07 0.367 1.77 c10: Carbamidomethyl (+57.02) 608.3124 1,821.91 1,822.92 3 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% EIVHIQAGQcGNQIGAK 95.00% 2.87 0.332 2.1 c10: Carbamidomethyl (+57.02) 608.3128 1,821.91 1,822.92 3 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% EIVHIQAGQcGNQIGAK 95.00% 3.16 0.439 2.06 c10: Carbamidomethyl (+57.02) 608.3149 1,821.92 1,822.92 3 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% EIVHIQAGQcGNQIGAK 95.00% 3.54 0.344 1.47 c10: Carbamidomethyl (+57.02) 608.6463 1,822.92 1,822.92 3 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISEQFTAMFR 95.00% 2.92 0.457 0 615.2971 1,228.58 1,229.60 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISEQFTAMFR 95.00% 2.69 0.204 1.52 615.2989 1,228.58 1,229.60 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISEQFTAMFR 95.00% 3.64 0.562 2.47 615.3002 1,228.58 1,229.60 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISEQFTAMFR 95.00% 3.61 0.568 2.04 615.3008 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISEQFTAMFR 95.00% 3.14 0.363 1.35 615.3022 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISEQFTAMFR 95.00% 2.53 0.37 0 615.3036 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISEQFTAMFR 95.00% 2.76 0.284 0 615.8012 1,229.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% FPGQLNADLRK 95.00% 2.84 0.288 2.15 629.8482 1,257.68 1,258.69 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% FPGQLNADLRK 95.00% 2.76 0.238 2.4 629.8486 1,257.68 1,258.69 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISVYYNEATGGK 95.00% 3.55 0.491 2.7 651.3214 1,300.63 1,301.64 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISVYYNEATGGK 95.00% 3.69 0.511 3.82 651.3217 1,300.63 1,301.64 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISVYYNEATGGK 95.00% 3.54 0.495 3.96 651.3227 1,300.63 1,301.64 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ISVYYNEATGGK 95.00% 2.5 0.475 0 651.3236 1,300.63 1,301.64 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% GHYTEGAELVDSVLDVVR 95.00% 3.8 0.295 1.8 653.6643 1,957.97 1,958.98 3 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% GHYTEGAELVDSVLDVVR 95.00% 3.67 0.315 0 653.9984 1,958.97 1,958.98 3 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% GHYTEGAELVDSVLDVVR 95.00% 3.62 0.473 1.57 653.9988 1,958.97 1,958.98 3 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% GHYTEGAELVDSVLDVVR 95.00% 3.83 0.355 1.12 654.0009 1,958.98 1,958.98 3 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% IMNTFSVVPSPK 95.00% 3.13 0.483 2.68 660.3539 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% IMNTFSVVPSPK 95.00% 2.62 0.356 1.7 660.3544 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% IMNTFSVVPSPK 95.00% 2.6 0.355 1.6 660.3553 1,318.70 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% IMNTFSVVPSPK 95.00% 2 0.505 0 660.6049 1,319.19 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% IMNTFSVVPSPK 95.00% 0 0 3.46 661.5095 1,321.00 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% GHYTEGAELVDSVLDVVRK 95.00% 4.17 0.435 2.8 696.6994 2,087.07 2,087.08 3 TBB2C_HUMAN,PGS1_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% MREIVHIQAGQcGNQIGAK 95.00% 5.29 0.535 6.02 c12: Carbamidomethyl (+57.02) 704.3588 2,110.05 2,110.07 3 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% MREIVHIQAGQcGNQIGAK 95.00% 5.28 0.51 4.43 c12: Carbamidomethyl (+57.02) 704.3596 2,110.06 2,110.07 3 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% EVDEQMLNVQNK 95.00% 3.86 0.296 0 723.8471 1,445.68 1,446.69 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% EVDEQMLNVQNK 95.00% 3.98 0.286 1.46 723.8485 1,445.68 1,446.69 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% AILVDLEPGTMDSVR 95.00% 4.01 0.585 3.96 808.4201 1,614.82 1,615.84 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% AILVDLEPGTMDSVR 95.00% 3.93 0.565 3.36 808.4209 1,614.83 1,615.84 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% AILVDLEPGTMDSVR 95.00% 4.08 0.571 3.89 808.4212 1,614.83 1,615.84 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% AILVDLEPGTMDSVR 95.00% 3.83 0.588 3.06 808.4218 1,614.83 1,615.84 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% AILVDLEPGTMDSVR 95.00% 4.01 0.603 3.96 808.422 1,614.83 1,615.84 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% AILVDLEPGTMDSVR 95.00% 4.36 0.631 4.29 808.4223 1,614.83 1,615.84 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% AILVDLEPGTMDSVR 95.00% 4.15 0.581 4.26 808.4234 1,614.83 1,615.84 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LHFFMPGFAPLTSR 95.00% 3.3 0.408 2.68 810.9202 1,619.82 1,620.84 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% LHFFMPGFAPLTSR 95.00% 3.46 0.418 2.42 810.9221 1,619.83 1,620.84 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% AILVDLEPGTmDSVR 95.00% 4.16 0.52 3.34 m11: Oxidation (+15.99) 816.4179 1,630.82 1,631.83 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% AILVDLEPGTmDSVR 95.00% 4.34 0.538 3.05 m11: Oxidation (+15.99) 816.9202 1,631.82 1,631.83 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ALTVPELTQQVFDAK 95.00% 4.16 0.522 5.51 830.4497 1,658.88 1,659.90 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ALTVPELTQQVFDAK 95.00% 4.21 0.546 6.34 830.4501 1,658.88 1,659.90 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ALTVPELTQQVFDAK 95.00% 3.7 0.467 4.77 830.4516 1,658.89 1,659.90 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ALTVPELTQQVFDAK 95.00% 3.69 0.435 5.68 830.452 1,658.89 1,659.90 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ALTVPELTQQVFDAK 95.00% 3.88 0.5 5.42 830.4532 1,658.89 1,659.90 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ALTVPELTQQVFDAK 95.00% 4.09 0.449 5.2 830.9525 1,659.89 1,659.90 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ALTVPELTQQVFDAK 95.00% 4.02 0.507 4.54 830.9541 1,659.89 1,659.90 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% ALTVPELTQQVFDAK 95.00% 3.76 0.515 5.8 830.9552 1,659.89 1,659.90 2
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% NSSYFVEWIPNNVK 95.00% 2.87 0.372 0 848.9167 1,695.82 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% NSSYFVEWIPNNVK 95.00% 4.34 0.436 3.01 848.92 1,695.82 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% NSSYFVEWIPNNVK 95.00% 3.97 0.363 3 849.4198 1,696.82 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% EIVHIQAGQcGNQIGAK 95.00% 4.77 0.505 5.68 c10: Carbamidomethyl (+57.02) 911.964 1,821.91 1,822.92 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% EIVHIQAGQcGNQIGAK 95.00% 4.87 0.505 4.17 c10: Carbamidomethyl (+57.02) 911.9673 1,821.92 1,822.92 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% GHYTEGAELVDSVLDVVR 95.00% 6.87 0.566 7.43 980.4943 1,958.97 1,958.98 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% GHYTEGAELVDSVLDVVR 95.00% 7.24 0.545 10.3 980.4948 1,958.97 1,958.98 2 TBB2C_HUMAN
 SAMPLE 2R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 14 18 66 43.70% MREIVHIQAGQcGNQIGAK 95.00% 5.82 0.561 6.48 c12: Carbamidomethyl (+57.02) 1,056.04 2,110.06 2,110.07 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% TAVcDIPPR 95.00% 2.28 0.274 0 c4: Carbamidomethyl (+57.02) 514.7617 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% TAVcDIPPR 95.00% 2.29 0.326 0 c4: Carbamidomethyl (+57.02) 514.7617 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% TAVcDIPPR 95.00% 2.54 0.364 1.66 c4: Carbamidomethyl (+57.02) 514.7621 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% TAVcDIPPR 95.00% 1.8 0.224 1.1 c4: Carbamidomethyl (+57.02) 514.7623 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% TAVcDIPPR 95.00% 2.69 0.451 1.72 c4: Carbamidomethyl (+57.02) 514.7628 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% TAVcDIPPR 95.00% 2.08 0.404 3.17 c4: Carbamidomethyl (+57.02) 514.7628 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% TAVcDIPPR 95.00% 2.38 0.292 2.09 c4: Carbamidomethyl (+57.02) 514.763 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% TAVcDIPPR 95.00% 2.4 0.345 1.77 c4: Carbamidomethyl (+57.02) 514.7635 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% YLTVAAVFR 95.00% 2.5 0.34 2.44 520.2989 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% YLTVAAVFR 95.00% 3.09 0.387 2.55 520.2991 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% YLTVAAVFR 95.00% 2.79 0.387 2.64 520.2996 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% NMMAAcDPR 95.00% 2.18 0.36 0 c6: Carbamidomethyl (+57.02) 533.2162 1,064.42 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% NMMAAcDPR 95.00% 2.57 0.419 1.37 c6: Carbamidomethyl (+57.02) 533.2169 1,064.42 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% NMMAAcDPR 95.00% 2.79 0.45 1.19 c6: Carbamidomethyl (+57.02) 533.2176 1,064.42 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% NMMAAcDPR 95.00% 2.46 0.45 1.15 c6: Carbamidomethyl (+57.02) 533.2177 1,064.42 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ALTVPELTQQVFDAK 95.00% 3.99 0.567 0 553.9696 1,658.89 1,659.90 3
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ALTVPELTQQVFDAK 95.00% 4.03 0.498 0 554.3032 1,659.89 1,659.90 3
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ALTVPELTQQVFDAK 95.00% 4.83 0.547 2.12 554.3048 1,659.89 1,659.90 3
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% LAVNMVPFPR 95.00% 3.06 0.454 2.24 572.3067 1,142.60 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% LAVNMVPFPR 95.00% 3.44 0.538 2.57 572.3186 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% LAVNMVPFPR 95.00% 2.82 0.329 1.21 572.3191 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% LAVNMVPFPR 95.00% 3.65 0.505 2.09 572.3197 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% LAVNMVPFPR 95.00% 3.62 0.523 2.03 572.3198 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% LAVNMVPFPR 95.00% 3.14 0.391 1.48 572.3198 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% LAVNMVPFPR 95.00% 2.89 0.394 1.59 572.32 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% LAVNMVPFPR 95.00% 3.57 0.443 2.54 572.3202 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% LAVNMVPFPR 95.00% 2.42 0.302 1.15 572.3203 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% LAVNMVPFPR 95.00% 2.59 0.162 0 572.3216 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% LAVNmVPFPR 95.00% 3.5 0.433 2.12 m5: Oxidation (+15.99) 580.3174 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% LAVNmVPFPR 95.00% 3.03 0.381 1.59 m5: Oxidation (+15.99) 580.3188 1,158.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISVYYNEATGGKYVPR 95.00% 3.1 0.342 0 606.6475 1,816.92 1,816.92 3
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% EIVHIQAGQcGNQIGAK 95.00% 3.67 0.447 3.55 c10: Carbamidomethyl (+57.02) 608.3124 1,821.91 1,822.92 3 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% EIVHIQAGQcGNQIGAK 95.00% 3.58 0.405 2.29 c10: Carbamidomethyl (+57.02) 608.6464 1,822.92 1,822.92 3 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISEQFTAMFR 95.00% 3.4 0.552 1.62 615.3016 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISEQFTAMFR 95.00% 3.92 0.563 1.68 615.3023 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISEQFTAMFR 95.00% 4.05 0.549 1.74 615.3025 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISEQFTAMFR 95.00% 3.12 0.546 1.49 615.3257 1,228.64 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISEQFTAMFR 95.00% 3.87 0.482 1.48 615.8039 1,229.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISEQFTAmFR 95.00% 2.66 0.347 2.21 m8: Oxidation (+15.99) 623.2972 1,244.58 1,245.59 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISVYYNEATGGK 95.00% 2.59 0.473 3 651.3212 1,300.63 1,301.64 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISVYYNEATGGK 95.00% 3.71 0.52 4.13 651.3215 1,300.63 1,301.64 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISVYYNEATGGK 95.00% 2.27 0.396 0 651.3215 1,300.63 1,301.64 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISVYYNEATGGK 95.00% 3.54 0.522 3.92 651.3218 1,300.63 1,301.64 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISVYYNEATGGK 95.00% 3.53 0.47 2.96 651.3222 1,300.63 1,301.64 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISVYYNEATGGK 95.00% 3.18 0.522 3.59 651.3222 1,300.63 1,301.64 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISVYYNEATGGK 95.00% 3.28 0.465 3.6 651.3231 1,300.63 1,301.64 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ISVYYNEATGGK 95.00% 2.64 0.345 1.6 651.8229 1,301.63 1,301.64 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% IMNTFSVVPSPK 95.00% 2.64 0.328 2.74 660.3535 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% IMNTFSVVPSPK 95.00% 3.77 0.502 4.7 660.3548 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% IMNTFSVVPSPK 95.00% 3.88 0.557 4.02 660.3549 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% MREIVHIQAGQcGNQIGAK 95.00% 4.42 0.472 4.39 c12: Carbamidomethyl (+57.02) 704.3604 2,110.06 2,110.07 3 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% MREIVHIQAGQcGNQIGAK 95.00% 4.39 0.467 3.89 c12: Carbamidomethyl (+57.02) 704.3605 2,110.06 2,110.07 3 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% mREIVHIQAGQcGNQIGAK 95.00% 4.27 0.464 4.48 m1: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 709.688 2,126.04 2,126.06 3 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% EVDEQMLNVQNK 95.00% 4.43 0.299 1.52 723.8471 1,445.68 1,446.69 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% EVDEQMLNVQNK 95.00% 3.02 0.254 0 723.8477 1,445.68 1,446.69 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% EVDEQMLNVQNK 95.00% 4.41 0.301 1.48 723.8481 1,445.68 1,446.69 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% AILVDLEPGTMDSVR 95.00% 4.43 0.6 5.4 808.4206 1,614.83 1,615.84 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% AILVDLEPGTMDSVR 95.00% 4.15 0.569 3.85 808.4207 1,614.83 1,615.84 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% AILVDLEPGTMDSVR 95.00% 4.32 0.571 4.48 808.4212 1,614.83 1,615.84 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% AILVDLEPGTMDSVR 95.00% 3.36 0.541 2.52 808.422 1,614.83 1,615.84 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% AILVDLEPGTMDSVR 95.00% 4.18 0.617 4.03 808.423 1,614.83 1,615.84 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% AILVDLEPGTMDSVR 95.00% 4.33 0.539 3.34 808.9218 1,615.83 1,615.84 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% AILVDLEPGTmDSVR 95.00% 3.86 0.557 3 m11: Oxidation (+15.99) 816.418 1,630.82 1,631.83 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% AILVDLEPGTmDSVR 95.00% 2.61 0.434 1.19 m11: Oxidation (+15.99) 816.4181 1,630.82 1,631.83 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% AILVDLEPGTmDSVR 95.00% 3.59 0.484 2.14 m11: Oxidation (+15.99) 816.4206 1,630.83 1,631.83 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ALTVPELTQQVFDAK 95.00% 3.13 0.471 2.05 830.4495 1,658.88 1,659.90 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ALTVPELTQQVFDAK 95.00% 4.05 0.554 4.48 830.4505 1,658.89 1,659.90 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ALTVPELTQQVFDAK 95.00% 3.86 0.486 4.92 830.4506 1,658.89 1,659.90 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ALTVPELTQQVFDAK 95.00% 3.65 0.436 5.37 830.4507 1,658.89 1,659.90 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ALTVPELTQQVFDAK 95.00% 4.14 0.446 4.7 830.4522 1,658.89 1,659.90 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ALTVPELTQQVFDAK 95.00% 3.91 0.525 3.4 830.9513 1,659.89 1,659.90 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% ALTVPELTQQVFDAK 95.00% 4.22 0.549 4.72 830.9513 1,659.89 1,659.90 2
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% NSSYFVEWIPNNVK 95.00% 4.42 0.443 3.25 848.9193 1,695.82 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% NSSYFVEWIPNNVK 95.00% 3.81 0.373 0 849.4198 1,696.82 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% EIVHIQAGQcGNQIGAK 95.00% 5.19 0.505 5.77 c10: Carbamidomethyl (+57.02) 911.9644 1,821.91 1,822.92 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% EIVHIQAGQcGNQIGAK 95.00% 5.06 0.492 5.96 c10: Carbamidomethyl (+57.02) 912.4644 1,822.91 1,822.92 2 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% EAEScDcLQGFQLTHSLGGGTGSGMGTLLISK 95.00% 0 0 4.89 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 1,105.18 3,312.53 3,311.54 3 TBB2C_HUMAN
 SAMPLE 3 Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 12 14 54 43.50% FPGQLNADLRK 95.00% 1.94 0.109 0 1,258.64 1,257.63 1,258.69 1 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% TAVcDIPPR 95.00% 2.27 0.263 0 c4: Carbamidomethyl (+57.02) 514.7613 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% TAVcDIPPR 95.00% 2.48 0.347 1.26 c4: Carbamidomethyl (+57.02) 514.7622 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% TAVcDIPPR 95.00% 2.28 0.324 1.37 c4: Carbamidomethyl (+57.02) 514.7622 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% TAVcDIPPR 95.00% 2.5 0.373 1.55 c4: Carbamidomethyl (+57.02) 514.7625 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% TAVcDIPPR 95.00% 2.48 0.355 2.04 c4: Carbamidomethyl (+57.02) 514.7627 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% TAVcDIPPR 95.00% 2.64 0.435 1.49 c4: Carbamidomethyl (+57.02) 514.7632 1,027.51 1,028.52 2 VINC_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% YLTVAAVFR 95.00% 2.21 0.331 3.07 520.2989 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% YLTVAAVFR 95.00% 2.97 0.421 2.38 520.299 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% YLTVAAVFR 95.00% 2.96 0.439 3.11 520.2995 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% YLTVAAVFR 95.00% 2.22 0.243 1.55 520.3003 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% YLTVAAVFR 95.00% 2.2 0.264 0 520.3003 1,038.58 1,039.59 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% YLTVAAVFR 95.00% 2.13 0.269 2.77 520.3013 1,038.59 1,039.59 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% NMMAAcDPR 95.00% 2.41 0.423 1.74 c6: Carbamidomethyl (+57.02) 533.2143 1,064.41 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% NMMAAcDPR 95.00% 2.36 0.405 0 c6: Carbamidomethyl (+57.02) 533.2162 1,064.42 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% NMMAAcDPR 95.00% 2.52 0.402 0 c6: Carbamidomethyl (+57.02) 533.2167 1,064.42 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% NMMAAcDPR 95.00% 2.46 0.434 1.25 c6: Carbamidomethyl (+57.02) 533.217 1,064.42 1,065.43 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% AILVDLEPGTMDSVR 95.00% 2.67 0.235 0 539.617 1,615.83 1,615.84 3
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LHFFMPGFAPLTSR 95.00% 3.03 0.27 1.42 540.9496 1,619.83 1,620.84 3 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LHFFMPGFAPLTSR 95.00% 2.42 0.107 1.31 540.9506 1,619.83 1,620.84 3 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ALTVPELTQQVFDAK 95.00% 4.04 0.536 2 553.9689 1,658.88 1,659.90 3
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ALTVPELTQQVFDAK 95.00% 3.97 0.455 1.62 554.3032 1,659.89 1,659.90 3
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNMVPFPR 95.00% 2.42 0.4 1.8 572.306 1,142.60 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNMVPFPR 95.00% 2.88 0.369 0 572.318 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNMVPFPR 95.00% 3.71 0.553 2.01 572.3188 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNMVPFPR 95.00% 3.43 0.468 1.77 572.319 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNMVPFPR 95.00% 3.32 0.458 1.55 572.3191 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNMVPFPR 95.00% 3.13 0.392 2.7 572.3192 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNMVPFPR 95.00% 3.29 0.446 1.43 572.3196 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNMVPFPR 95.00% 3.97 0.538 2.77 572.3199 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNMVPFPR 95.00% 2.18 0.288 0 572.3202 1,142.62 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNMVPFPR 95.00% 3.42 0.435 2.1 572.3203 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNMVPFPR 95.00% 3.78 0.519 2.52 572.3204 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNMVPFPR 95.00% 3.43 0.499 2.46 572.321 1,142.63 1,143.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LAVNmVPFPR 95.00% 2.5 0.357 1.77 m5: Oxidation (+15.99) 580.8198 1,159.62 1,159.63 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% EIVHIQAGQcGNQIGAK 95.00% 3.07 0.435 1.49 c10: Carbamidomethyl (+57.02) 608.3109 1,821.91 1,822.92 3 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% EIVHIQAGQcGNQIGAK 95.00% 3.93 0.447 2.23 c10: Carbamidomethyl (+57.02) 608.3121 1,821.91 1,822.92 3 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% EIVHIQAGQcGNQIGAK 95.00% 4.18 0.426 2.09 c10: Carbamidomethyl (+57.02) 608.646 1,822.91 1,822.92 3 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISEQFTAMFR 95.00% 3.58 0.545 2.57 615.2987 1,228.58 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISEQFTAMFR 95.00% 3.11 0.5 2.11 615.2993 1,228.58 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISEQFTAMFR 95.00% 3.68 0.538 2.33 615.2993 1,228.58 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISEQFTAMFR 95.00% 3.73 0.529 2.57 615.3003 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISEQFTAMFR 95.00% 3.22 0.516 0 615.3022 1,228.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISEQFTAMFR 95.00% 2.28 0.444 0 615.6549 1,229.29 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISEQFTAMFR 95.00% 2.49 0.474 0 615.6551 1,229.29 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISEQFTAMFR 95.00% 3.27 0.488 1.66 615.8021 1,229.59 1,229.60 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% MAVTFIGNSTAIQELFK 95.00% 2.75 0.308 0 623.9964 1,868.97 1,869.98 3
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% MAVTFIGNSTAIQELFK 95.00% 3.23 0.396 1.44 623.9972 1,868.97 1,869.98 3
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% FPGQLNADLRK 95.00% 2.79 0.278 1.21 629.8476 1,257.68 1,258.69 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% FPGQLNADLRK 95.00% 2.94 0.202 0 629.8484 1,257.68 1,258.69 2 ,TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISVYYNEATGGK 95.00% 2.75 0.546 2.77 651.3207 1,300.63 1,301.64 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISVYYNEATGGK 95.00% 3.91 0.547 4.62 651.3211 1,300.63 1,301.64 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISVYYNEATGGK 95.00% 2.03 0.293 0 651.3217 1,300.63 1,301.64 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISVYYNEATGGK 95.00% 3.6 0.493 2.57 651.3222 1,300.63 1,301.64 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISVYYNEATGGK 95.00% 3.5 0.519 3.42 651.3231 1,300.63 1,301.64 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISVYYNEATGGK 95.00% 2.9 0.569 2.11 651.3236 1,300.63 1,301.64 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISVYYNEATGGK 95.00% 3.07 0.497 3.62 651.3237 1,300.63 1,301.64 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ISVYYNEATGGK 95.00% 3.74 0.465 2.92 651.8233 1,301.63 1,301.64 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% IMNTFSVVPSPK 95.00% 4.39 0.501 4.02 660.3546 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,H4_HUMAN,TITIN_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% GHYTEGAELVDSVLDVVRK 95.00% 4.92 0.475 0 696.6957 2,087.06 2,087.08 3 TBB2C_HUMAN,PGS1_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% MREIVHIQAGQcGNQIGAK 95.00% 4.45 0.468 2.72 c12: Carbamidomethyl (+57.02) 704.3615 2,110.06 2,110.07 3 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% EVDEQMLNVQNK 95.00% 4.41 0.275 1.77 723.8474 1,445.68 1,446.69 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% EVDEQmLNVQNK 95.00% 3.63 0.372 1.21 m6: Oxidation (+15.99) 731.845 1,461.67 1,462.68 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% AILVDLEPGTMDSVR 95.00% 4.14 0.558 3.43 808.4216 1,614.83 1,615.84 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% AILVDLEPGTMDSVR 95.00% 3.13 0.472 3.49 808.4227 1,614.83 1,615.84 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% AILVDLEPGTMDSVR 95.00% 4.05 0.611 4.07 808.4235 1,614.83 1,615.84 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% AILVDLEPGTMDSVR 95.00% 4.47 0.536 4.18 808.9198 1,615.82 1,615.84 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% AILVDLEPGTMDSVR 95.00% 3.95 0.59 4.72 808.9213 1,615.83 1,615.84 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% AILVDLEPGTMDSVR 95.00% 4.52 0.499 3.64 808.9232 1,615.83 1,615.84 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% AILVDLEPGTMDSVR 95.00% 4.49 0.548 3.51 808.924 1,615.83 1,615.84 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% LHFFMPGFAPLTSR 95.00% 3.87 0.431 2.7 811.4229 1,620.83 1,620.84 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% AILVDLEPGTmDSVR 95.00% 3.92 0.48 3.82 m11: Oxidation (+15.99) 816.4203 1,630.82 1,631.83 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% AILVDLEPGTmDSVR 95.00% 3.82 0.602 4.66 m11: Oxidation (+15.99) 816.4215 1,630.83 1,631.83 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ALTVPELTQQVFDAK 95.00% 3.74 0.483 4.42 830.4501 1,658.88 1,659.90 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ALTVPELTQQVFDAK 95.00% 3.95 0.505 5.46 830.4503 1,658.89 1,659.90 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ALTVPELTQQVFDAK 95.00% 3.27 0.433 5.54 830.4505 1,658.89 1,659.90 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ALTVPELTQQVFDAK 95.00% 4.29 0.531 7.66 830.4514 1,658.89 1,659.90 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ALTVPELTQQVFDAK 95.00% 2.69 0.238 2.33 830.4519 1,658.89 1,659.90 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ALTVPELTQQVFDAK 95.00% 4.16 0.529 4.82 830.9527 1,659.89 1,659.90 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ALTVPELTQQVFDAK 95.00% 4.15 0.483 5 830.953 1,659.89 1,659.90 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ALTVPELTQQVFDAK 95.00% 3.57 0.47 4.72 830.9533 1,659.89 1,659.90 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% ALTVPELTQQVFDAK 95.00% 3.97 0.535 5.59 830.9536 1,659.89 1,659.90 2
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% NSSYFVEWIPNNVK 95.00% 4.7 0.446 2.82 848.9188 1,695.82 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% NSSYFVEWIPNNVK 95.00% 4.38 0.411 2.8 849.4214 1,696.83 1,696.83 2 TBB6_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% EIVHIQAGQcGNQIGAK 95.00% 4.63 0.556 4.96 c10: Carbamidomethyl (+57.02) 911.9626 1,821.91 1,822.92 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% EIVHIQAGQcGNQIGAK 95.00% 4.61 0.517 4.55 c10: Carbamidomethyl (+57.02) 911.9645 1,821.91 1,822.92 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% EIVHIQAGQcGNQIGAK 95.00% 4.55 0.427 3.37 c10: Carbamidomethyl (+57.02) 912.4627 1,822.91 1,822.92 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% GHYTEGAELVDSVLDVVR 95.00% 7.41 0.574 4.62 980.4937 1,958.97 1,958.98 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% GHYTEGAELVDSVLDVVR 95.00% 7.37 0.578 4.37 980.4943 1,958.97 1,958.98 2 TBB2C_HUMAN
 SAMPLE 3R Tubulin beta chain  TUBB  TBB5_HUMAN 49,652.60 100.00% 15 19 67 53.80% EAEScDcLQGFQLTHSLGGGTGSGMGTLLISK 95.00% 0 0 4.21 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 1,105.18 3,312.52 3,311.54 3 TBB2C_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% TAVcDIPPR 95.00% 2.52 0.381 1.89 c4: Carbamidomethyl (+57.02) 514.765 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% TAVcDIPPR 95.00% 2.41 0.256 2.66 c4: Carbamidomethyl (+57.02) 514.7655 1,027.52 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% TAVcDIPPR 95.00% 2.61 0.432 3.32 c4: Carbamidomethyl (+57.02) 514.7669 1,027.52 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% TAVcDIPPR 95.00% 2.27 0.347 3.12 c4: Carbamidomethyl (+57.02) 514.7674 1,027.52 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% TAVcDIPPR 95.00% 2.41 0.309 0 c4: Carbamidomethyl (+57.02) 514.7685 1,027.52 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% TAVcDIPPR 95.00% 2.22 0.262 0 c4: Carbamidomethyl (+57.02) 515.2641 1,028.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% YLTVAAVFR 95.00% 3.2 0.407 3.7 520.3011 1,038.59 1,039.59 2 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% YLTVAAVFR 95.00% 3.12 0.379 3.44 520.3014 1,038.59 1,039.59 2 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% YLTVAAVFR 95.00% 2.89 0.385 1.85 520.302 1,038.59 1,039.59 2 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% YLTVAAVFR 95.00% 2.88 0.394 2.26 520.3021 1,038.59 1,039.59 2 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% YLTVAAVFR 95.00% 2.9 0.375 2.8 520.3022 1,038.59 1,039.59 2 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% YLTVAAVFR 95.00% 2.59 0.411 1.66 520.3022 1,038.59 1,039.59 2 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% YLTVAAVFR 95.00% 2.97 0.424 1.49 520.3023 1,038.59 1,039.59 2 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% YLTVAAVFR 95.00% 2.66 0.359 1.72 520.3028 1,038.59 1,039.59 2 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% YLTVAAVFR 95.00% 2.79 0.41 2.06 520.3033 1,038.59 1,039.59 2 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% YLTVAAVFR 95.00% 2.02 0.263 3 520.3037 1,038.59 1,039.59 2 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% FPGQLNADLR 95.00% 2.56 0.224 0 565.8017 1,129.59 1,130.60 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% FPGQLNADLR 95.00% 2.58 0.326 0 565.8028 1,129.59 1,130.60 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNMVPFPR 95.00% 3.79 0.5 1.77 572.3214 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNMVPFPR 95.00% 3.53 0.51 4.01 572.3214 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNMVPFPR 95.00% 3.58 0.457 3 572.3217 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNMVPFPR 95.00% 3.56 0.499 2.46 572.322 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNMVPFPR 95.00% 3.13 0.452 3.51 572.3225 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNMVPFPR 95.00% 2.65 0.353 1.29 572.3226 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNMVPFPR 95.00% 3.03 0.324 1.3 572.3226 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNMVPFPR 95.00% 3.51 0.4 2 572.3227 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNMVPFPR 95.00% 3.84 0.526 3.41 572.323 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNMVPFPR 95.00% 3.3 0.475 2.11 572.323 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNMVPFPR 95.00% 2.93 0.369 2.54 572.3249 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNmVPFPR 95.00% 2.52 0.357 1.74 m5: Oxidation (+15.99) 580.3194 1,158.62 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNmVPFPR 95.00% 2.81 0.449 1.57 m5: Oxidation (+15.99) 580.3201 1,158.62 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNmVPFPR 95.00% 3.21 0.398 1.36 m5: Oxidation (+15.99) 580.3203 1,158.62 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% LAVNmVPFPR 95.00% 3 0.442 1.57 m5: Oxidation (+15.99) 580.3207 1,158.63 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% ISEQFTAMFR 95.00% 2.53 0.412 0 615.3046 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% GHYTEGAELVDSVLDVVR 95.00% 2.53 0.145 1.85 653.6687 1,957.98 1,958.98 3 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% GHYTEGAELVDSVLDVVR 95.00% 2.76 0.359 0 654.001 1,958.98 1,958.98 3 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% INVYYNEATGGK 95.00% 3.47 0.437 3.05 664.8294 1,327.64 1,328.65 2
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% INVYYNEATGGK 95.00% 3.3 0.41 2.54 664.8298 1,327.64 1,328.65 2
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% INVYYNEATGGK 95.00% 3.11 0.412 2.8 664.83 1,327.64 1,328.65 2
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% INVYYNEATGGK 95.00% 3.6 0.497 2.24 664.8302 1,327.64 1,328.65 2
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% GHYTEGAELVDSVLDVVRK 95.00% 2.71 0.351 1.08 696.6979 2,087.07 2,087.08 3 TBB5_HUMAN,PGS1_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% MREIVHLQAGQcGNQIGAK 95.00% 3.71 0.447 4.19 c12: Carbamidomethyl (+57.02) 704.3189 2,109.93 2,110.07 3 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% MREIVHLQAGQcGNQIGAK 95.00% 2.62 0.227 1.16 c12: Carbamidomethyl (+57.02) 704.3207 2,109.94 2,110.07 3 TBB5_HUMAN
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% ALTVPELTQQMFDAK 95.00% 3.32 0.427 3.7 846.4394 1,690.86 1,691.87 2
 SAMPLE 4R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 6 25.40% ALTVPELTQQMFDAK 95.00% 3.5 0.535 4.37 846.4408 1,690.87 1,691.87 2
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% TAVcDIPPR 95.00% 2.32 0.345 2.85 c4: Carbamidomethyl (+57.02) 514.7627 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% TAVcDIPPR 95.00% 2.34 0.377 1.82 c4: Carbamidomethyl (+57.02) 514.7633 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% TAVcDIPPR 95.00% 2.45 0.318 2.08 c4: Carbamidomethyl (+57.02) 514.7633 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% YLTVAAVFR 95.00% 1.83 0.223 1.96 520.2976 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% YLTVAAVFR 95.00% 2.47 0.387 1.96 520.2983 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% YLTVAAVFR 95.00% 2.96 0.382 2.3 520.2986 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% YLTVAAVFR 95.00% 2.23 0.233 3.03 520.299 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% FPGQLNADLR 95.00% 2.85 0.35 1.14 565.7998 1,129.58 1,130.60 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% FPGQLNADLR 95.00% 3.18 0.374 1.64 565.8004 1,129.59 1,130.60 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNMVPFPR 95.00% 2.91 0.424 2.77 572.3188 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNMVPFPR 95.00% 3.93 0.539 3.18 572.3195 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNMVPFPR 95.00% 3.86 0.467 3.27 572.3195 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNMVPFPR 95.00% 3.84 0.522 2.54 572.32 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNMVPFPR 95.00% 3.83 0.512 2.82 572.3205 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNMVPFPR 95.00% 3.45 0.52 3.55 572.3206 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNMVPFPR 95.00% 3.12 0.472 1.92 572.3209 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNMVPFPR 95.00% 2.87 0.338 2.15 572.3217 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNMVPFPR 95.00% 3.42 0.456 0 572.3217 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNMVPFPR 95.00% 3.48 0.458 2.33 572.3254 1,142.64 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNMVPFPR 95.00% 3.33 0.412 1.59 572.3311 1,142.65 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNMVPFPR 95.00% 3.34 0.406 2.14 572.3321 1,142.65 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNmVPFPR 95.00% 2.82 0.357 1.92 m5: Oxidation (+15.99) 580.317 1,158.62 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% LAVNmVPFPR 95.00% 2.86 0.407 1.96 m5: Oxidation (+15.99) 580.3184 1,158.62 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% ISEQFTAMFR 95.00% 3.43 0.545 2.77 615.3003 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% ISEQFTAMFR 95.00% 3.4 0.551 1.89 615.3008 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% ISEQFTAMFR 95.00% 3.44 0.539 1.66 615.3017 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% ISEQFTAMFR 95.00% 3.21 0.355 0 615.8029 1,229.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% GHYTEGAELVDSVLDVVRK 95.00% 4.33 0.371 2.27 696.3617 2,086.06 2,087.08 3 TBB5_HUMAN,PGS1_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% GHYTEGAELVDSVLDVVRK 95.00% 3.62 0.292 0 696.6989 2,087.07 2,087.08 3 TBB5_HUMAN,PGS1_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% GHYTEGAELVDSVLDVVRK 95.00% 3.81 0.213 0 696.7245 2,087.15 2,087.08 3 TBB5_HUMAN,PGS1_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% MREIVHLQAGQcGNQIGAK 95.00% 5.44 0.526 4.1 c12: Carbamidomethyl (+57.02) 704.3611 2,110.06 2,110.07 3 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% MREIVHLQAGQcGNQIGAK 95.00% 5.07 0.465 3.51 c12: Carbamidomethyl (+57.02) 704.3616 2,110.06 2,110.07 3 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% EVDEQMLNVQNK 95.00% 3.94 0.262 1.35 723.8459 1,445.68 1,446.69 2 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% EVDEQMLNVQNK 95.00% 3.52 0.274 0 723.85 1,445.68 1,446.69 2 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% AVLVDLEPGTMDSVR 95.00% 2.99 0.314 0 801.4121 1,600.81 1,601.82 2
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% AVLVDLEPGTMDSVR 95.00% 2.92 0.351 0 801.4139 1,600.81 1,601.82 2
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% ALTVPELTQQMFDAK 95.00% 3.95 0.57 5.23 846.4345 1,690.85 1,691.87 2
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% ALTVPELTQQMFDAK 95.00% 3.89 0.533 5.82 846.4366 1,690.86 1,691.87 2
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% ALTVPELTQQMFDAK 95.00% 3.43 0.553 4.92 846.9385 1,691.86 1,691.87 2
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% NSSYFVEWIPNNVK 95.00% 4.43 0.449 3.08 848.9185 1,695.82 1,696.83 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% NSSYFVEWIPNNVK 95.00% 4.4 0.439 3.13 848.9195 1,695.82 1,696.83 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% EIVHLQAGQcGNQIGAK 95.00% 4.82 0.501 3.59 c10: Carbamidomethyl (+57.02) 911.9616 1,821.91 1,822.92 2 TBB5_HUMAN
 SAMPLE 1R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 31.90% EIVHLQAGQcGNQIGAK 95.00% 4.55 0.486 5.24 c10: Carbamidomethyl (+57.02) 911.9665 1,821.92 1,822.92 2 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% TAVcDIPPR 95.00% 2.62 0.455 1.49 c4: Carbamidomethyl (+57.02) 514.7626 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% TAVcDIPPR 95.00% 2.22 0.283 1.29 c4: Carbamidomethyl (+57.02) 514.7627 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% TAVcDIPPR 95.00% 2.79 0.444 1.82 c4: Carbamidomethyl (+57.02) 514.7627 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% TAVcDIPPR 95.00% 2.39 0.363 1.23 c4: Carbamidomethyl (+57.02) 514.763 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% TAVcDIPPR 95.00% 2.45 0.399 1.25 c4: Carbamidomethyl (+57.02) 514.7636 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% YLTVAAVFR 95.00% 2.65 0.344 1.96 520.2994 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% YLTVAAVFR 95.00% 2.67 0.383 1.85 520.2998 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% NMMAAcDPR 95.00% 2.24 0.431 1.49 c6: Carbamidomethyl (+57.02) 533.2146 1,064.41 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% NMMAAcDPR 95.00% 2.1 0.446 1.92 c6: Carbamidomethyl (+57.02) 533.2159 1,064.42 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% NMMAAcDPR 95.00% 2.35 0.422 1.96 c6: Carbamidomethyl (+57.02) 533.2169 1,064.42 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% NMMAAcDPR 95.00% 2.39 0.437 1.92 c6: Carbamidomethyl (+57.02) 533.2173 1,064.42 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LHFFMPGFAPLTSR 95.00% 3.32 0.31 2.24 540.9494 1,619.82 1,620.84 3 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LHFFMPGFAPLTSR 95.00% 2.79 0.112 1.52 540.9499 1,619.83 1,620.84 3 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% FPGQLNADLR 95.00% 2.44 0.207 0 565.8 1,129.58 1,130.60 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% FPGQLNADLR 95.00% 2.86 0.303 0 565.8001 1,129.58 1,130.60 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNMVPFPR 95.00% 3.72 0.472 1.96 572.3042 1,142.59 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNMVPFPR 95.00% 3.9 0.544 2.82 572.319 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNMVPFPR 95.00% 2.98 0.396 1.8 572.3194 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNMVPFPR 95.00% 3.4 0.464 2.6 572.3204 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNMVPFPR 95.00% 3.65 0.512 3.08 572.3204 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNMVPFPR 95.00% 3.91 0.549 2.59 572.3207 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNMVPFPR 95.00% 4.14 0.547 2.28 572.3207 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNMVPFPR 95.00% 3.67 0.51 2.15 572.3214 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNMVPFPR 95.00% 3.46 0.481 3.12 572.3214 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNMVPFPR 95.00% 3.71 0.53 2.8 572.3217 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNMVPFPR 95.00% 2.8 0.358 1.54 572.8076 1,143.60 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNmVPFPR 95.00% 3.3 0.395 2.59 m5: Oxidation (+15.99) 580.318 1,158.62 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LAVNmVPFPR 95.00% 3.19 0.401 2.54 m5: Oxidation (+15.99) 580.3181 1,158.62 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% EIVHLQAGQcGNQIGAK 95.00% 3.27 0.248 1.77 c10: Carbamidomethyl (+57.02) 608.3118 1,821.91 1,822.92 3 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% EIVHLQAGQcGNQIGAK 95.00% 3.87 0.465 2.17 c10: Carbamidomethyl (+57.02) 608.3121 1,821.91 1,822.92 3 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% EIVHLQAGQcGNQIGAK 95.00% 2.51 0.344 1.74 c10: Carbamidomethyl (+57.02) 608.3125 1,821.91 1,822.92 3 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% EIVHLQAGQcGNQIGAK 95.00% 3.24 0.42 2.11 c10: Carbamidomethyl (+57.02) 608.3129 1,821.92 1,822.92 3 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% EIVHLQAGQcGNQIGAK 95.00% 3.58 0.466 1.46 c10: Carbamidomethyl (+57.02) 608.6472 1,822.92 1,822.92 3 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% ISEQFTAMFR 95.00% 3.83 0.543 2.3 615.3006 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% INVYYNEATGGKYVPR 95.00% 2.92 0.366 0 615.3145 1,842.92 1,843.93 3
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% INVYYNEATGGKYVPR 95.00% 2.85 0.412 0 615.3145 1,842.92 1,843.93 3
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% ISEQFTAMFR 95.00% 2.72 0.443 1.92 615.3204 1,228.63 1,229.60 2 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% ISEQFTAmFR 95.00% 2.36 0.374 1.34 m8: Oxidation (+15.99) 623.3 1,244.58 1,245.59 2 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% FPGQLNADLRK 95.00% 3 0.271 1.11 629.8479 1,257.68 1,258.69 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% FPGQLNADLRK 95.00% 2.83 0.277 1.38 629.8486 1,257.68 1,258.69 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% IMNTFSVVPSPK 95.00% 2.91 0.361 2.89 660.3531 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,TBB5_HUMAN,H4_HUMAN,TITIN_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% IMNTFSVVPSPK 95.00% 4.18 0.509 3.11 660.3541 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,TBB5_HUMAN,H4_HUMAN,TITIN_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% IMNTFSVVPSPK 95.00% 3.98 0.538 3.29 660.3543 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,TBB5_HUMAN,H4_HUMAN,TITIN_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% MREIVHLQAGQcGNQIGAK 95.00% 5.32 0.555 3.89 c12: Carbamidomethyl (+57.02) 704.0262 2,109.06 2,110.07 3 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% MREIVHLQAGQcGNQIGAK 95.00% 5.59 0.485 4.44 c12: Carbamidomethyl (+57.02) 704.0271 2,109.06 2,110.07 3 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% EVDEQMLNVQNK 95.00% 4.34 0.271 1.36 723.8473 1,445.68 1,446.69 2 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% EVDEQMLNVQNK 95.00% 4.02 0.271 1.59 723.8482 1,445.68 1,446.69 2 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LHFFMPGFAPLTSR 95.00% 3.69 0.497 3.77 810.922 1,619.83 1,620.84 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% LHFFMPGFAPLTSR 95.00% 3.59 0.451 2.37 811.4234 1,620.83 1,620.84 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% ALTVPELTQQMFDAK 95.00% 3.97 0.58 6.18 846.4344 1,690.85 1,691.87 2
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% ALTVPELTQQMFDAK 95.00% 3.96 0.574 3.96 846.9363 1,691.86 1,691.87 2
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% ALTVPELTQQMFDAK 95.00% 4.09 0.53 3.36 846.9364 1,691.86 1,691.87 2
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% NSSYFVEWIPNNVK 95.00% 4.61 0.464 2.82 848.9192 1,695.82 1,696.83 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% NSSYFVEWIPNNVK 95.00% 3.85 0.44 3.16 848.9196 1,695.82 1,696.83 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% EIVHLQAGQcGNQIGAK 95.00% 5.24 0.515 4.49 c10: Carbamidomethyl (+57.02) 911.9647 1,821.91 1,822.92 2 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% EIVHLQAGQcGNQIGAK 95.00% 5.08 0.425 2.37 c10: Carbamidomethyl (+57.02) 912.4666 1,822.92 1,822.92 2 TBB5_HUMAN
 SAMPLE 2 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 5 36.00% MREIVHLQAGQcGNQIGAK 95.00% 5.89 0.508 6.2 c12: Carbamidomethyl (+57.02) 1,056.04 2,110.06 2,110.07 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% TAVcDIPPR 95.00% 2.32 0.253 0 c4: Carbamidomethyl (+57.02) 514.7613 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% TAVcDIPPR 95.00% 1.99 0.256 0 c4: Carbamidomethyl (+57.02) 514.7619 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% TAVcDIPPR 95.00% 2.14 0.304 2.04 c4: Carbamidomethyl (+57.02) 514.7621 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% TAVcDIPPR 95.00% 2.2 0.322 2.22 c4: Carbamidomethyl (+57.02) 514.7625 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% TAVcDIPPR 95.00% 2.33 0.444 1.47 c4: Carbamidomethyl (+57.02) 514.7625 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% TAVcDIPPR 95.00% 2.46 0.336 2.54 c4: Carbamidomethyl (+57.02) 514.7627 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% TAVcDIPPR 95.00% 2.41 0.362 2.2 c4: Carbamidomethyl (+57.02) 514.7627 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% TAVcDIPPR 95.00% 2.34 0.414 1.7 c4: Carbamidomethyl (+57.02) 514.763 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% TAVcDIPPR 95.00% 2.24 0.254 0 c4: Carbamidomethyl (+57.02) 514.7639 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% YLTVAAVFR 95.00% 1.87 0.165 1.74 520.2979 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% YLTVAAVFR 95.00% 2.35 0.287 2.49 520.2984 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% YLTVAAVFR 95.00% 2.32 0.458 1.66 520.2987 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% YLTVAAVFR 95.00% 2.12 0.248 2 520.2989 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% YLTVAAVFR 95.00% 2.36 0.466 2.43 520.2991 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% YLTVAAVFR 95.00% 1.98 0.265 0 520.2992 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% YLTVAAVFR 95.00% 1.96 0.305 2.89 520.2997 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% YLTVAAVFR 95.00% 1.62 0.286 1.96 520.3003 1,038.59 1,039.59 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% NMMAAcDPR 95.00% 2.41 0.391 2.03 c6: Carbamidomethyl (+57.02) 533.2153 1,064.42 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% ALTVPELTQQMFDAK 95.00% 2.97 0.411 0 564.6282 1,690.86 1,691.87 3
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% FPGQLNADLR 95.00% 2.88 0.312 1.8 565.8011 1,129.59 1,130.60 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% FPGQLNADLR 95.00% 2.62 0.269 0 565.802 1,129.59 1,130.60 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNMVPFPR 95.00% 3.06 0.486 0 572.3053 1,142.59 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNMVPFPR 95.00% 3.86 0.528 2.43 572.3188 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNMVPFPR 95.00% 3.68 0.489 2.62 572.3194 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNMVPFPR 95.00% 3.08 0.447 1.64 572.3195 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNMVPFPR 95.00% 4 0.539 2.28 572.32 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNMVPFPR 95.00% 3.84 0.518 2.38 572.3202 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNMVPFPR 95.00% 3.5 0.479 2.11 572.3202 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNMVPFPR 95.00% 3.18 0.42 2.62 572.3203 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNMVPFPR 95.00% 3.07 0.438 2.02 572.3205 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNMVPFPR 95.00% 3.17 0.369 2.41 572.3207 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNMVPFPR 95.00% 3.53 0.485 2.28 572.3235 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNmVPFPR 95.00% 3.31 0.442 1.82 m5: Oxidation (+15.99) 580.318 1,158.62 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LAVNmVPFPR 95.00% 2.97 0.398 1.44 m5: Oxidation (+15.99) 580.3216 1,158.63 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% EIVHLQAGQcGNQIGAK 95.00% 3.07 0.367 1.77 c10: Carbamidomethyl (+57.02) 608.3124 1,821.91 1,822.92 3 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% EIVHLQAGQcGNQIGAK 95.00% 2.87 0.332 2.1 c10: Carbamidomethyl (+57.02) 608.3128 1,821.91 1,822.92 3 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% EIVHLQAGQcGNQIGAK 95.00% 3.16 0.439 2.06 c10: Carbamidomethyl (+57.02) 608.3149 1,821.92 1,822.92 3 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% EIVHLQAGQcGNQIGAK 95.00% 3.54 0.344 1.47 c10: Carbamidomethyl (+57.02) 608.6463 1,822.92 1,822.92 3 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% ISEQFTAMFR 95.00% 2.92 0.457 0 615.2971 1,228.58 1,229.60 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% ISEQFTAMFR 95.00% 2.69 0.204 1.52 615.2989 1,228.58 1,229.60 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% ISEQFTAMFR 95.00% 3.64 0.562 2.47 615.3002 1,228.58 1,229.60 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% ISEQFTAMFR 95.00% 3.61 0.568 2.04 615.3008 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% ISEQFTAMFR 95.00% 3.14 0.363 1.35 615.3022 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% ISEQFTAMFR 95.00% 2.53 0.37 0 615.3036 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% INVYYNEATGGKYVPR 95.00% 2.33 0.327 0 615.6502 1,843.93 1,843.93 3
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% ISEQFTAMFR 95.00% 2.76 0.284 0 615.8012 1,229.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% FPGQLNADLRK 95.00% 2.84 0.288 2.15 629.8482 1,257.68 1,258.69 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% FPGQLNADLRK 95.00% 2.76 0.238 2.4 629.8486 1,257.68 1,258.69 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% GHYTEGAELVDSVLDVVR 95.00% 3.8 0.295 1.8 653.6643 1,957.97 1,958.98 3 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% GHYTEGAELVDSVLDVVR 95.00% 3.67 0.315 0 653.9984 1,958.97 1,958.98 3 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% GHYTEGAELVDSVLDVVR 95.00% 3.62 0.473 1.57 653.9988 1,958.97 1,958.98 3 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% GHYTEGAELVDSVLDVVR 95.00% 3.83 0.355 1.12 654.0009 1,958.98 1,958.98 3 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% IMNTFSVVPSPK 95.00% 3.13 0.483 2.68 660.3539 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,TBB5_HUMAN,H4_HUMAN,TITIN_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% IMNTFSVVPSPK 95.00% 2.62 0.356 1.7 660.3544 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,TBB5_HUMAN,H4_HUMAN,TITIN_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% IMNTFSVVPSPK 95.00% 2.6 0.355 1.6 660.3553 1,318.70 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,TBB5_HUMAN,H4_HUMAN,TITIN_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% IMNTFSVVPSPK 95.00% 2 0.505 0 660.6049 1,319.19 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,TBB5_HUMAN,H4_HUMAN,TITIN_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% IMNTFSVVPSPK 95.00% 0 0 3.46 661.5095 1,321.00 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,TBB5_HUMAN,H4_HUMAN,TITIN_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% GHYTEGAELVDSVLDVVRK 95.00% 4.17 0.435 2.8 696.6994 2,087.07 2,087.08 3 TBB5_HUMAN,PGS1_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% MREIVHLQAGQcGNQIGAK 95.00% 5.29 0.535 6.02 c12: Carbamidomethyl (+57.02) 704.3588 2,110.05 2,110.07 3 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% MREIVHLQAGQcGNQIGAK 95.00% 5.28 0.51 4.43 c12: Carbamidomethyl (+57.02) 704.3596 2,110.06 2,110.07 3 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% EVDEQMLNVQNK 95.00% 3.86 0.296 0 723.8471 1,445.68 1,446.69 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% EVDEQMLNVQNK 95.00% 3.98 0.286 1.46 723.8485 1,445.68 1,446.69 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% AVLVDLEPGTMDSVR 95.00% 4.12 0.396 3.7 801.4127 1,600.81 1,601.82 2
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% AVLVDLEPGTMDSVR 95.00% 3.37 0.392 3.51 801.4137 1,600.81 1,601.82 2
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% AVLVDLEPGTMDSVR 95.00% 3.42 0.377 2.96 801.9162 1,601.82 1,601.82 2
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LHFFMPGFAPLTSR 95.00% 3.3 0.408 2.68 810.9202 1,619.82 1,620.84 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% LHFFMPGFAPLTSR 95.00% 3.46 0.418 2.42 810.9221 1,619.83 1,620.84 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% ALTVPELTQQMFDAK 95.00% 4.09 0.549 4.89 846.4335 1,690.85 1,691.87 2
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% ALTVPELTQQMFDAK 95.00% 4.08 0.559 5.55 846.4353 1,690.86 1,691.87 2
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% ALTVPELTQQMFDAK 95.00% 4.1 0.54 3.89 846.4357 1,690.86 1,691.87 2
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% ALTVPELTQQMFDAK 95.00% 3.88 0.484 5.96 846.9354 1,691.86 1,691.87 2
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% NSSYFVEWIPNNVK 95.00% 2.87 0.372 0 848.9167 1,695.82 1,696.83 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% NSSYFVEWIPNNVK 95.00% 4.34 0.436 3.01 848.92 1,695.82 1,696.83 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% NSSYFVEWIPNNVK 95.00% 3.97 0.363 3 849.4198 1,696.82 1,696.83 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% EIVHLQAGQcGNQIGAK 95.00% 4.77 0.505 5.68 c10: Carbamidomethyl (+57.02) 911.964 1,821.91 1,822.92 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% EIVHLQAGQcGNQIGAK 95.00% 4.87 0.505 4.17 c10: Carbamidomethyl (+57.02) 911.9673 1,821.92 1,822.92 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% GHYTEGAELVDSVLDVVR 95.00% 6.87 0.566 7.43 980.4943 1,958.97 1,958.98 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% GHYTEGAELVDSVLDVVR 95.00% 7.24 0.545 10.3 980.4948 1,958.97 1,958.98 2 TBB5_HUMAN
 SAMPLE 2R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 100.00% 3 4 9 43.60% MREIVHLQAGQcGNQIGAK 95.00% 5.82 0.561 6.48 c12: Carbamidomethyl (+57.02) 1,056.04 2,110.06 2,110.07 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% TAVcDIPPR 95.00% 2.28 0.274 0 c4: Carbamidomethyl (+57.02) 514.7617 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% TAVcDIPPR 95.00% 2.29 0.326 0 c4: Carbamidomethyl (+57.02) 514.7617 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% TAVcDIPPR 95.00% 2.54 0.364 1.66 c4: Carbamidomethyl (+57.02) 514.7621 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% TAVcDIPPR 95.00% 1.8 0.224 1.1 c4: Carbamidomethyl (+57.02) 514.7623 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% TAVcDIPPR 95.00% 2.69 0.451 1.72 c4: Carbamidomethyl (+57.02) 514.7628 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% TAVcDIPPR 95.00% 2.08 0.404 3.17 c4: Carbamidomethyl (+57.02) 514.7628 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% TAVcDIPPR 95.00% 2.38 0.292 2.09 c4: Carbamidomethyl (+57.02) 514.763 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% TAVcDIPPR 95.00% 2.4 0.345 1.77 c4: Carbamidomethyl (+57.02) 514.7635 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% YLTVAAVFR 95.00% 2.5 0.34 2.44 520.2989 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% YLTVAAVFR 95.00% 3.09 0.387 2.55 520.2991 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% YLTVAAVFR 95.00% 2.79 0.387 2.64 520.2996 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% NMMAAcDPR 95.00% 2.18 0.36 0 c6: Carbamidomethyl (+57.02) 533.2162 1,064.42 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% NMMAAcDPR 95.00% 2.57 0.419 1.37 c6: Carbamidomethyl (+57.02) 533.2169 1,064.42 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% NMMAAcDPR 95.00% 2.79 0.45 1.19 c6: Carbamidomethyl (+57.02) 533.2176 1,064.42 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% NMMAAcDPR 95.00% 2.46 0.45 1.15 c6: Carbamidomethyl (+57.02) 533.2177 1,064.42 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% LAVNMVPFPR 95.00% 3.06 0.454 2.24 572.3067 1,142.60 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% LAVNMVPFPR 95.00% 3.44 0.538 2.57 572.3186 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% LAVNMVPFPR 95.00% 2.82 0.329 1.21 572.3191 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% LAVNMVPFPR 95.00% 3.65 0.505 2.09 572.3197 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% LAVNMVPFPR 95.00% 3.62 0.523 2.03 572.3198 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% LAVNMVPFPR 95.00% 3.14 0.391 1.48 572.3198 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% LAVNMVPFPR 95.00% 2.89 0.394 1.59 572.32 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% LAVNMVPFPR 95.00% 3.57 0.443 2.54 572.3202 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% LAVNMVPFPR 95.00% 2.42 0.302 1.15 572.3203 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% LAVNMVPFPR 95.00% 2.59 0.162 0 572.3216 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% LAVNmVPFPR 95.00% 3.5 0.433 2.12 m5: Oxidation (+15.99) 580.3174 1,158.62 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% LAVNmVPFPR 95.00% 3.03 0.381 1.59 m5: Oxidation (+15.99) 580.3188 1,158.62 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% EIVHLQAGQcGNQIGAK 95.00% 3.67 0.447 3.55 c10: Carbamidomethyl (+57.02) 608.3124 1,821.91 1,822.92 3 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% EIVHLQAGQcGNQIGAK 95.00% 3.58 0.405 2.29 c10: Carbamidomethyl (+57.02) 608.6464 1,822.92 1,822.92 3 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% ISEQFTAMFR 95.00% 3.4 0.552 1.62 615.3016 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% ISEQFTAMFR 95.00% 3.92 0.563 1.68 615.3023 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% ISEQFTAMFR 95.00% 4.05 0.549 1.74 615.3025 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% ISEQFTAMFR 95.00% 3.12 0.546 1.49 615.3257 1,228.64 1,229.60 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% ISEQFTAMFR 95.00% 3.87 0.482 1.48 615.8039 1,229.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% ISEQFTAmFR 95.00% 2.66 0.347 2.21 m8: Oxidation (+15.99) 623.2972 1,244.58 1,245.59 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% IMNTFSVVPSPK 95.00% 2.64 0.328 2.74 660.3535 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,TBB5_HUMAN,H4_HUMAN,TITIN_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% IMNTFSVVPSPK 95.00% 3.77 0.502 4.7 660.3548 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,TBB5_HUMAN,H4_HUMAN,TITIN_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% IMNTFSVVPSPK 95.00% 3.88 0.557 4.02 660.3549 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,TBB5_HUMAN,H4_HUMAN,TITIN_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% MREIVHLQAGQcGNQIGAK 95.00% 4.42 0.472 4.39 c12: Carbamidomethyl (+57.02) 704.3604 2,110.06 2,110.07 3 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% MREIVHLQAGQcGNQIGAK 95.00% 4.39 0.467 3.89 c12: Carbamidomethyl (+57.02) 704.3605 2,110.06 2,110.07 3 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% mREIVHLQAGQcGNQIGAK 95.00% 4.27 0.464 4.48 m1: Oxidation (+15.99), c12: Carbamidomethyl (+57.02) 709.688 2,126.04 2,126.06 3 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% EVDEQMLNVQNK 95.00% 4.43 0.299 1.52 723.8471 1,445.68 1,446.69 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% EVDEQMLNVQNK 95.00% 3.02 0.254 0 723.8477 1,445.68 1,446.69 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% EVDEQMLNVQNK 95.00% 4.41 0.301 1.48 723.8481 1,445.68 1,446.69 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% AVLVDLEPGTMDSVR 95.00% 4.31 0.42 4.49 801.4124 1,600.81 1,601.82 2
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% AVLVDLEPGTMDSVR 95.00% 4.29 0.434 4.89 801.4142 1,600.81 1,601.82 2
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% ALTVPELTQQMFDAK 95.00% 4.14 0.568 4 846.4347 1,690.85 1,691.87 2
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% ALTVPELTQQMFDAK 95.00% 4.1 0.555 4.39 846.9374 1,691.86 1,691.87 2
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% NSSYFVEWIPNNVK 95.00% 4.42 0.443 3.25 848.9193 1,695.82 1,696.83 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% NSSYFVEWIPNNVK 95.00% 3.81 0.373 0 849.4198 1,696.82 1,696.83 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% EIVHLQAGQcGNQIGAK 95.00% 5.19 0.505 5.77 c10: Carbamidomethyl (+57.02) 911.9644 1,821.91 1,822.92 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% EIVHLQAGQcGNQIGAK 95.00% 5.06 0.492 5.96 c10: Carbamidomethyl (+57.02) 912.4644 1,822.91 1,822.92 2 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% EAEScDcLQGFQLTHSLGGGTGSGMGTLLISK 95.00% 0 0 4.89 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 1,105.18 3,312.53 3,311.54 3 TBB5_HUMAN
 SAMPLE 3 Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 39.80% FPGQLNADLRK 95.00% 1.94 0.109 0 1,258.64 1,257.63 1,258.69 1 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% TAVcDIPPR 95.00% 2.27 0.263 0 c4: Carbamidomethyl (+57.02) 514.7613 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% TAVcDIPPR 95.00% 2.48 0.347 1.26 c4: Carbamidomethyl (+57.02) 514.7622 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% TAVcDIPPR 95.00% 2.28 0.324 1.37 c4: Carbamidomethyl (+57.02) 514.7622 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% TAVcDIPPR 95.00% 2.5 0.373 1.55 c4: Carbamidomethyl (+57.02) 514.7625 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% TAVcDIPPR 95.00% 2.48 0.355 2.04 c4: Carbamidomethyl (+57.02) 514.7627 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% TAVcDIPPR 95.00% 2.64 0.435 1.49 c4: Carbamidomethyl (+57.02) 514.7632 1,027.51 1,028.52 2 TBB5_HUMAN,VINC_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% YLTVAAVFR 95.00% 2.21 0.331 3.07 520.2989 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% YLTVAAVFR 95.00% 2.97 0.421 2.38 520.299 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% YLTVAAVFR 95.00% 2.96 0.439 3.11 520.2995 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% YLTVAAVFR 95.00% 2.22 0.243 1.55 520.3003 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% YLTVAAVFR 95.00% 2.2 0.264 0 520.3003 1,038.58 1,039.59 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% YLTVAAVFR 95.00% 2.13 0.269 2.77 520.3013 1,038.59 1,039.59 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% NMMAAcDPR 95.00% 2.41 0.423 1.74 c6: Carbamidomethyl (+57.02) 533.2143 1,064.41 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% NMMAAcDPR 95.00% 2.36 0.405 0 c6: Carbamidomethyl (+57.02) 533.2162 1,064.42 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% NMMAAcDPR 95.00% 2.52 0.402 0 c6: Carbamidomethyl (+57.02) 533.2167 1,064.42 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% NMMAAcDPR 95.00% 2.46 0.434 1.25 c6: Carbamidomethyl (+57.02) 533.217 1,064.42 1,065.43 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LHFFMPGFAPLTSR 95.00% 3.03 0.27 1.42 540.9496 1,619.83 1,620.84 3 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LHFFMPGFAPLTSR 95.00% 2.42 0.107 1.31 540.9506 1,619.83 1,620.84 3 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNMVPFPR 95.00% 2.42 0.4 1.8 572.306 1,142.60 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNMVPFPR 95.00% 2.88 0.369 0 572.318 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNMVPFPR 95.00% 3.71 0.553 2.01 572.3188 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNMVPFPR 95.00% 3.43 0.468 1.77 572.319 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNMVPFPR 95.00% 3.32 0.458 1.55 572.3191 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNMVPFPR 95.00% 3.13 0.392 2.7 572.3192 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNMVPFPR 95.00% 3.29 0.446 1.43 572.3196 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNMVPFPR 95.00% 3.97 0.538 2.77 572.3199 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNMVPFPR 95.00% 2.18 0.288 0 572.3202 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNMVPFPR 95.00% 3.42 0.435 2.1 572.3203 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNMVPFPR 95.00% 3.78 0.519 2.52 572.3204 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNMVPFPR 95.00% 3.43 0.499 2.46 572.321 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LAVNmVPFPR 95.00% 2.5 0.357 1.77 m5: Oxidation (+15.99) 580.8198 1,159.62 1,159.63 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% EIVHLQAGQcGNQIGAK 95.00% 3.07 0.435 1.49 c10: Carbamidomethyl (+57.02) 608.3109 1,821.91 1,822.92 3 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% EIVHLQAGQcGNQIGAK 95.00% 3.93 0.447 2.23 c10: Carbamidomethyl (+57.02) 608.3121 1,821.91 1,822.92 3 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% EIVHLQAGQcGNQIGAK 95.00% 4.18 0.426 2.09 c10: Carbamidomethyl (+57.02) 608.646 1,822.91 1,822.92 3 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% ISEQFTAMFR 95.00% 3.58 0.545 2.57 615.2987 1,228.58 1,229.60 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% ISEQFTAMFR 95.00% 3.11 0.5 2.11 615.2993 1,228.58 1,229.60 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% ISEQFTAMFR 95.00% 3.68 0.538 2.33 615.2993 1,228.58 1,229.60 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% ISEQFTAMFR 95.00% 3.73 0.529 2.57 615.3003 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% ISEQFTAMFR 95.00% 3.22 0.516 0 615.3022 1,228.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% ISEQFTAMFR 95.00% 2.28 0.444 0 615.6549 1,229.29 1,229.60 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% ISEQFTAMFR 95.00% 2.49 0.474 0 615.6551 1,229.29 1,229.60 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% ISEQFTAMFR 95.00% 3.27 0.488 1.66 615.8021 1,229.59 1,229.60 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% FPGQLNADLRK 95.00% 2.79 0.278 1.21 629.8476 1,257.68 1,258.69 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% FPGQLNADLRK 95.00% 2.94 0.202 0 629.8484 1,257.68 1,258.69 2 ,TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% IMNTFSVVPSPK 95.00% 4.39 0.501 4.02 660.3546 1,318.69 1,319.70 2 FBN1_HUMAN,ITA7_HUMAN,TBB5_HUMAN,H4_HUMAN,TITIN_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% GHYTEGAELVDSVLDVVRK 95.00% 4.92 0.475 0 696.6957 2,087.06 2,087.08 3 TBB5_HUMAN,PGS1_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% MREIVHLQAGQcGNQIGAK 95.00% 4.45 0.468 2.72 c12: Carbamidomethyl (+57.02) 704.3615 2,110.06 2,110.07 3 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% EVDEQMLNVQNK 95.00% 4.41 0.275 1.77 723.8474 1,445.68 1,446.69 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% EVDEQmLNVQNK 95.00% 3.63 0.372 1.21 m6: Oxidation (+15.99) 731.845 1,461.67 1,462.68 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% AVLVDLEPGTMDSVR 95.00% 4.36 0.423 5.62 801.4135 1,600.81 1,601.82 2
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% AVLVDLEPGTMDSVR 95.00% 4.52 0.462 7 801.4146 1,600.81 1,601.82 2
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% LHFFMPGFAPLTSR 95.00% 3.87 0.431 2.7 811.4229 1,620.83 1,620.84 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% ALTVPELTQQMFDAK 95.00% 3.91 0.58 5.43 846.4351 1,690.85 1,691.87 2
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% ALTVPELTQQMFDAK 95.00% 4.15 0.527 6.96 846.4353 1,690.86 1,691.87 2
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% NSSYFVEWIPNNVK 95.00% 4.7 0.446 2.82 848.9188 1,695.82 1,696.83 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% NSSYFVEWIPNNVK 95.00% 4.38 0.411 2.8 849.4214 1,696.83 1,696.83 2 TBB5_HUMAN,TBB6_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% EIVHLQAGQcGNQIGAK 95.00% 4.63 0.556 4.96 c10: Carbamidomethyl (+57.02) 911.9626 1,821.91 1,822.92 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% EIVHLQAGQcGNQIGAK 95.00% 4.61 0.517 4.55 c10: Carbamidomethyl (+57.02) 911.9645 1,821.91 1,822.92 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% EIVHLQAGQcGNQIGAK 95.00% 4.55 0.427 3.37 c10: Carbamidomethyl (+57.02) 912.4627 1,822.91 1,822.92 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% GHYTEGAELVDSVLDVVR 95.00% 7.41 0.574 4.62 980.4937 1,958.97 1,958.98 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% GHYTEGAELVDSVLDVVR 95.00% 7.37 0.578 4.37 980.4943 1,958.97 1,958.98 2 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-2C chain  TUBB2C  TBB2C_HUMAN 49,812.70 99.80% 2 2 4 47.20% EAEScDcLQGFQLTHSLGGGTGSGMGTLLISK 95.00% 0 0 4.21 c5: Carbamidomethyl (+57.02), c7: Carbamidomethyl (+57.02) 1,105.18 3,312.52 3,311.54 3 TBB5_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% NMMAAcDPR 95.00% 2.41 0.423 1.74 c6: Carbamidomethyl (+57.02) 533.2143 1,064.41 1,065.43 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% NMMAAcDPR 95.00% 2.36 0.405 0 c6: Carbamidomethyl (+57.02) 533.2162 1,064.42 1,065.43 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% NMMAAcDPR 95.00% 2.52 0.402 0 c6: Carbamidomethyl (+57.02) 533.2167 1,064.42 1,065.43 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% NMMAAcDPR 95.00% 2.46 0.434 1.25 c6: Carbamidomethyl (+57.02) 533.217 1,064.42 1,065.43 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LHFFMPGFAPLTSR 95.00% 3.03 0.27 1.42 540.9496 1,619.83 1,620.84 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LHFFMPGFAPLTSR 95.00% 2.42 0.107 1.31 540.9506 1,619.83 1,620.84 3 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNMVPFPR 95.00% 2.42 0.4 1.8 572.306 1,142.60 1,143.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNMVPFPR 95.00% 2.88 0.369 0 572.318 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNMVPFPR 95.00% 3.71 0.553 2.01 572.3188 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNMVPFPR 95.00% 3.43 0.468 1.77 572.319 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNMVPFPR 95.00% 3.32 0.458 1.55 572.3191 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNMVPFPR 95.00% 3.13 0.392 2.7 572.3192 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNMVPFPR 95.00% 3.29 0.446 1.43 572.3196 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNMVPFPR 95.00% 3.97 0.538 2.77 572.3199 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNMVPFPR 95.00% 2.18 0.288 0 572.3202 1,142.62 1,143.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNMVPFPR 95.00% 3.42 0.435 2.1 572.3203 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNMVPFPR 95.00% 3.78 0.519 2.52 572.3204 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNMVPFPR 95.00% 3.43 0.499 2.46 572.321 1,142.63 1,143.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LAVNmVPFPR 95.00% 2.5 0.357 1.77 m5: Oxidation (+15.99) 580.8198 1,159.62 1,159.63 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% EIVHIQAGQcGNQIGTK 95.00% 3.82 0.425 2.72 c10: Carbamidomethyl (+57.02) 618.6494 1,852.92 1,852.93 3
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% FPGQLNADLRK 95.00% 2.79 0.278 1.21 629.8476 1,257.68 1,258.69 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% FPGQLNADLRK 95.00% 2.94 0.202 0 629.8484 1,257.68 1,258.69 2 ,TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% LHFFMPGFAPLTSR 95.00% 3.87 0.431 2.7 811.4229 1,620.83 1,620.84 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% NSSYFVEWIPNNVK 95.00% 4.7 0.446 2.82 848.9188 1,695.82 1,696.83 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% NSSYFVEWIPNNVK 95.00% 4.38 0.411 2.8 849.4214 1,696.83 1,696.83 2 TBB5_HUMAN,TBB2C_HUMAN
 SAMPLE 3R Tubulin beta-6 chain  TUBB6  TBB6_HUMAN 49,839.10 99.80% 2 2 2 20.20% ALTVPELTQQMFDAR 95.00% 3.99 0.532 4.66 860.9431 1,719.87 1,719.87 2
 SAMPLE 4 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 99.80% 2 2 4 9.21% GGIYSHTPVSLGRPER 95.00% 1.94 0.271 0 575.6075 1,723.80 1,725.90 3
 SAMPLE 4 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 99.80% 2 2 4 9.21% GGIYSHTPVSLGRPER 95.00% 2.78 0.305 0 575.973 1,724.90 1,725.90 3
 SAMPLE 4 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 99.80% 2 2 4 9.21% GGIYSHTPVSLGRPER 95.00% 3.21 0.399 0 576.3088 1,725.90 1,725.90 3
 SAMPLE 4 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 99.80% 2 2 4 9.21% ITGWGEETLPDGR 95.00% 4.28 0.534 3.08 715.8511 1,429.69 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 4 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 99.80% 2 2 4 9.21% ITGWGEETLPDGR 95.00% 4.19 0.547 2.33 715.8512 1,429.69 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 4 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 99.80% 2 2 4 9.21% ITGWGEETLPDGR 95.00% 4.37 0.522 2.85 715.8513 1,429.69 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 4 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 99.80% 2 2 4 9.21% ITGWGEETLPDGR 95.00% 4.15 0.537 2.05 715.852 1,429.69 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 4 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 99.80% 2 2 4 9.21% IYPVLGTYWDNcNR 95.00% 3.67 0.338 1.48 c12: Carbamidomethyl (+57.02) 886.4224 1,770.83 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% GVVSDHcYPFSGR 95.00% 2.49 0.231 2.15 c7: Carbamidomethyl (+57.02) 494.2251 1,479.65 1,480.66 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% GVVSDHcYPFSGR 95.00% 2.39 0.286 2.17 c7: Carbamidomethyl (+57.02) 494.2252 1,479.65 1,480.66 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% GVVSDHcYPFSGR 95.00% 2.43 0.217 2.92 c7: Carbamidomethyl (+57.02) 494.2263 1,479.66 1,480.66 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% GVVSDHcYPFSGR 95.00% 2.84 0.332 2.19 c7: Carbamidomethyl (+57.02) 494.228 1,479.66 1,480.66 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% GVVSDHcYPFSGR 95.00% 2.46 0.217 1.25 c7: Carbamidomethyl (+57.02) 494.2292 1,479.66 1,480.66 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% RGVVSDHcYPFSGR 95.00% 2.06 0.239 0 c8: Carbamidomethyl (+57.02) 546.2592 1,635.75 1,636.77 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% GGIYSHTPVSLGRPER 95.00% 2.23 0.429 0 575.9692 1,724.88 1,725.90 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% GGIYSHTPVSLGRPER 95.00% 2.69 0.445 0 575.9713 1,724.89 1,725.90 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 4.29 0.592 2.46 c12: Carbamidomethyl (+57.02) 590.9462 1,769.82 1,770.83 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 4.94 0.584 1.55 c12: Carbamidomethyl (+57.02) 591.2801 1,770.82 1,770.83 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% ITGWGEETLPDGR 95.00% 4.43 0.49 1.42 715.8468 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% ITGWGEETLPDGR 95.00% 2.52 0.391 1.6 715.8474 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% ITGWGEETLPDGR 95.00% 3.34 0.452 2.15 715.8474 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% ITGWGEETLPDGR 95.00% 4.38 0.537 1.96 715.8476 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% ITGWGEETLPDGR 95.00% 3.65 0.555 2.66 715.8479 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% ITGWGEETLPDGR 95.00% 4.05 0.513 2.64 715.8479 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% ITGWGEETLPDGR 95.00% 3.19 0.458 2.51 715.8479 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% ITGWGEETLPDGR 95.00% 3.49 0.486 1.8 715.8542 1,429.69 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% ITGWGEETLPDGR 95.00% 4.3 0.476 2.18 715.857 1,429.70 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% ITGWGEETLPDGR 95.00% 4 0.487 2.55 715.8588 1,429.70 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% GVVSDHcYPFSGR 95.00% 2.58 0.523 0 c7: Carbamidomethyl (+57.02) 740.8372 1,479.66 1,480.66 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% GVVSDHcYPFSGR 95.00% 3.3 0.556 1.39 c7: Carbamidomethyl (+57.02) 741.3344 1,480.65 1,480.66 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% GVVSDHcYPFSGR 95.00% 2.72 0.483 1.66 c7: Carbamidomethyl (+57.02) 741.336 1,480.66 1,480.66 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% GGIYSHTPVSLGRPER 95.00% 2.94 0.28 3.35 863.4548 1,724.89 1,725.90 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% GGIYSHTPVSLGRPER 95.00% 3.51 0.391 2.54 863.4576 1,724.90 1,725.90 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% YWTAANSWGPAWGER 95.00% 4.95 0.656 5.33 876.3959 1,750.78 1,751.79 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% YWTAANSWGPAWGER 95.00% 5.23 0.594 4.89 876.8994 1,751.78 1,751.79 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 5.2 0.642 5.25 c12: Carbamidomethyl (+57.02) 885.9134 1,769.81 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 4.55 0.578 4.05 c12: Carbamidomethyl (+57.02) 885.9142 1,769.81 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 5.25 0.568 4.21 c12: Carbamidomethyl (+57.02) 885.9145 1,769.81 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 4.93 0.609 4 c12: Carbamidomethyl (+57.02) 885.9146 1,769.81 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 4.66 0.612 4.37 c12: Carbamidomethyl (+57.02) 885.9154 1,769.82 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 4.87 0.57 5.74 c12: Carbamidomethyl (+57.02) 885.9159 1,769.82 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 4.8 0.579 5.19 c12: Carbamidomethyl (+57.02) 885.9163 1,769.82 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 2.15 0.357 0 c12: Carbamidomethyl (+57.02) 885.9187 1,769.82 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 3.89 0.569 1.64 c12: Carbamidomethyl (+57.02) 885.9217 1,769.83 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 4.28 0.508 2.12 c12: Carbamidomethyl (+57.02) 885.9236 1,769.83 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 4.33 0.586 4.68 c12: Carbamidomethyl (+57.02) 885.9331 1,769.85 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 4.84 0.589 4.39 c12: Carbamidomethyl (+57.02) 885.9336 1,769.85 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 4.68 0.435 3.64 c12: Carbamidomethyl (+57.02) 886.4156 1,770.82 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 4.43 0.506 1.96 c12: Carbamidomethyl (+57.02) 886.416 1,770.82 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% IYPVLGTYWDNcNR 95.00% 5.36 0.601 4.28 c12: Carbamidomethyl (+57.02) 886.4165 1,770.82 1,770.83 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 5.72 0.595 3.33 c6: Carbamidomethyl (+57.02) 942.4418 2,824.30 2,824.31 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 6.39 0.602 1.66 c6: Carbamidomethyl (+57.02) 942.4418 2,824.30 2,824.31 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 5.63 0.571 2.74 c6: Carbamidomethyl (+57.02) 942.4426 2,824.30 2,824.31 3
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% QWQcDQEPcLVDPDMIK 95.00% 4.82 0.435 4.14 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,081.97 2,161.93 2,161.94 2
 SAMPLE 1 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 7 10 37 24.20% QWQcDQEPcLVDPDMIK 95.00% 4.86 0.443 3.82 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,081.97 2,161.93 2,161.94 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GVVSDHcYPFSGR 95.00% 2.67 0.377 1.74 c7: Carbamidomethyl (+57.02) 494.225 1,479.65 1,480.66 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GVVSDHcYPFSGR 95.00% 2.22 0.17 1.32 c7: Carbamidomethyl (+57.02) 494.2254 1,479.65 1,480.66 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GVVSDHcYPFSGR 95.00% 2.53 0.293 2.8 c7: Carbamidomethyl (+57.02) 494.2255 1,479.65 1,480.66 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GVVSDHcYPFSGR 95.00% 2.46 0.217 0 c7: Carbamidomethyl (+57.02) 494.2292 1,479.66 1,480.66 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GVVSDHcYPFSGR 95.00% 2.27 0.152 1.28 c7: Carbamidomethyl (+57.02) 494.5598 1,480.66 1,480.66 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% RGVVSDHcYPFSGR 95.00% 2.95 0.229 0 c8: Carbamidomethyl (+57.02) 546.2563 1,635.75 1,636.77 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% RGVVSDHcYPFSGR 95.00% 3.08 0.437 0 c8: Carbamidomethyl (+57.02) 546.2588 1,635.75 1,636.77 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% RGVVSDHcYPFSGR 95.00% 4.12 0.498 0 c8: Carbamidomethyl (+57.02) 546.5919 1,636.75 1,636.77 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GGIYSHTPVSLGRPER 95.00% 3.61 0.467 1.17 576.305 1,725.89 1,725.90 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% LDGAWWFLR 95.00% 3.86 0.435 1.8 582.3015 1,162.59 1,163.60 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% LDGAWWFLR 95.00% 3.78 0.45 1.74 582.3016 1,162.59 1,163.60 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% LDGAWWFLR 95.00% 3.39 0.437 1.6 582.3018 1,162.59 1,163.60 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% LDGAWWFLR 95.00% 3.9 0.433 1.6 582.3026 1,162.59 1,163.60 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 4.28 0.6 2.07 c12: Carbamidomethyl (+57.02) 591.2798 1,770.82 1,770.83 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 3.86 0.498 2.21 c12: Carbamidomethyl (+57.02) 591.2806 1,770.82 1,770.83 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% DAGGRYcQEQDLccR 95.00% 3.52 0.355 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 629.9234 1,886.75 1,887.75 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% DAGGRYcQEQDLccR 95.00% 3.14 0.346 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 630.2558 1,887.74 1,887.75 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% ITGWGEETLPDGR 95.00% 3.47 0.542 3.39 715.8459 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% ITGWGEETLPDGR 95.00% 3.16 0.373 2.42 715.8467 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% ITGWGEETLPDGR 95.00% 3.5 0.53 3.7 715.847 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% ITGWGEETLPDGR 95.00% 4.44 0.519 2.51 715.8479 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% ITGWGEETLPDGR 95.00% 4.39 0.549 2.24 715.849 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% ITGWGEETLPDGR 95.00% 4.3 0.476 2.3 715.857 1,429.70 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% ITGWGEETLPDGR 95.00% 4 0.487 2.43 715.8588 1,429.70 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% ITGWGEETLPDGR 95.00% 2.96 0.424 1.89 715.8611 1,429.71 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GVVSDHcYPFSGR 95.00% 3.78 0.54 5.11 c7: Carbamidomethyl (+57.02) 740.8334 1,479.65 1,480.66 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GVVSDHcYPFSGR 95.00% 4.01 0.529 3.66 c7: Carbamidomethyl (+57.02) 740.8344 1,479.65 1,480.66 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GVVSDHcYPFSGR 95.00% 3.59 0.559 3.74 c7: Carbamidomethyl (+57.02) 740.8347 1,479.65 1,480.66 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GVVSDHcYPFSGR 95.00% 2.58 0.523 0 c7: Carbamidomethyl (+57.02) 740.8372 1,479.66 1,480.66 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% RGVVSDHcYPFSGR 95.00% 3.49 0.525 0 c8: Carbamidomethyl (+57.02) 818.8869 1,635.76 1,636.77 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GGIYSHTPVSLGRPER 95.00% 3.38 0.365 1.13 863.9541 1,725.89 1,725.90 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GGIYSHTPVSLGRPER 95.00% 2.88 0.29 0 863.9557 1,725.90 1,725.90 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% YWTAANSWGPAWGER 95.00% 4.74 0.627 5.77 876.395 1,750.77 1,751.79 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% YWTAANSWGPAWGER 95.00% 5.21 0.663 6.14 876.3992 1,750.78 1,751.79 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% YWTAANSWGPAWGER 95.00% 5.3 0.577 5.17 876.8987 1,751.78 1,751.79 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% YWTAANSWGPAWGER 95.00% 4.64 0.61 4.44 876.9002 1,751.78 1,751.79 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 4.58 0.588 4.33 c12: Carbamidomethyl (+57.02) 885.9137 1,769.81 1,770.83 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 4.77 0.577 4.85 c12: Carbamidomethyl (+57.02) 885.9138 1,769.81 1,770.83 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 3.07 0.292 2.25 c12: Carbamidomethyl (+57.02) 885.9176 1,769.82 1,770.83 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 3.89 0.569 2.6 c12: Carbamidomethyl (+57.02) 885.9217 1,769.83 1,770.83 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 4.77 0.623 5.38 c12: Carbamidomethyl (+57.02) 885.9331 1,769.85 1,770.83 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 3.18 0.461 1.74 c12: Carbamidomethyl (+57.02) 885.9335 1,769.85 1,770.83 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 4.46 0.608 5.22 c12: Carbamidomethyl (+57.02) 885.9339 1,769.85 1,770.83 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 4.68 0.435 3.49 c12: Carbamidomethyl (+57.02) 886.4156 1,770.82 1,770.83 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 5.36 0.601 4.32 c12: Carbamidomethyl (+57.02) 886.4165 1,770.82 1,770.83 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 5.09 0.532 5.33 c12: Carbamidomethyl (+57.02) 886.4168 1,770.82 1,770.83 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% IYPVLGTYWDNcNR 95.00% 4.88 0.541 3.31 c12: Carbamidomethyl (+57.02) 886.4179 1,770.82 1,770.83 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 6.25 0.611 2.44 c6: Carbamidomethyl (+57.02) 942.4392 2,824.29 2,824.31 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 6.07 0.63 2.37 c6: Carbamidomethyl (+57.02) 942.4398 2,824.30 2,824.31 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 6.68 0.602 2.37 c6: Carbamidomethyl (+57.02) 942.4406 2,824.30 2,824.31 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 6.16 0.583 2.82 c6: Carbamidomethyl (+57.02) 942.4412 2,824.30 2,824.31 3
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% GVNEcDIESFVLGVWGR 95.00% 4.19 0.485 5.24 c5: Carbamidomethyl (+57.02) 969.4661 1,936.92 1,936.92 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% QWQcDQEPcLVDPDMIK 95.00% 4.76 0.45 2.3 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,081.97 2,161.92 2,161.94 2
 SAMPLE 1R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 10 14 46 33.00% QWQcDQEPcLVDPDMIK 95.00% 4.93 0.431 3.11 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,081.97 2,161.93 2,161.94 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GGRLDGAWWFLR 95.00% 2.71 0.29 0 478.586 1,432.73 1,433.74 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GVVSDHcYPFSGR 95.00% 2.34 0.316 1.39 c7: Carbamidomethyl (+57.02) 494.2251 1,479.65 1,480.66 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GVVSDHcYPFSGR 95.00% 2.27 0.3 3 c7: Carbamidomethyl (+57.02) 494.2252 1,479.65 1,480.66 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GVVSDHcYPFSGR 95.00% 2.17 0.124 1.06 c7: Carbamidomethyl (+57.02) 494.226 1,479.65 1,480.66 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GVVSDHcYPFSGR 95.00% 2.42 0.35 0 c7: Carbamidomethyl (+57.02) 494.226 1,479.65 1,480.66 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GVVSDHcYPFSGR 95.00% 2.08 0.285 1.42 c7: Carbamidomethyl (+57.02) 494.2261 1,479.65 1,480.66 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GVVSDHcYPFSGR 95.00% 2.29 0.301 1.33 c7: Carbamidomethyl (+57.02) 494.2266 1,479.66 1,480.66 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% RGVVSDHcYPFSGR 95.00% 3.45 0.428 0 c8: Carbamidomethyl (+57.02) 546.2585 1,635.75 1,636.77 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% RGVVSDHcYPFSGR 95.00% 3.11 0.386 0 c8: Carbamidomethyl (+57.02) 546.2602 1,635.76 1,636.77 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% RGVVSDHcYPFSGR 95.00% 3.11 0.4 0 c8: Carbamidomethyl (+57.02) 546.2621 1,635.76 1,636.77 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GGIYSHTPVSLGRPER 95.00% 2.6 0.168 0 575.9702 1,724.89 1,725.90 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GGIYSHTPVSLGRPER 95.00% 2.41 0.23 0 575.972 1,724.89 1,725.90 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GGIYSHTPVSLGRPER 95.00% 3.65 0.409 0 576.3052 1,725.89 1,725.90 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GGIYSHTPVSLGRPER 95.00% 2.69 0.28 0 576.3061 1,725.89 1,725.90 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% IYPVLGTYWDNcNR 95.00% 4.08 0.535 2.6 c12: Carbamidomethyl (+57.02) 590.9464 1,769.82 1,770.83 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% IYPVLGTYWDNcNR 95.00% 4.07 0.535 1.23 c12: Carbamidomethyl (+57.02) 590.9474 1,769.82 1,770.83 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% IYPVLGTYWDNcNR 95.00% 3.62 0.566 0 c12: Carbamidomethyl (+57.02) 591.2836 1,770.83 1,770.83 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ERDEAGPAPPcMMHSR 95.00% 3.06 0.337 1.07 c11: Carbamidomethyl (+57.02) 614.2676 1,839.78 1,840.79 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DAGGRYcQEQDLccR 95.00% 5.59 0.542 2.09 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 629.9216 1,886.74 1,887.75 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DAGGRYcQEQDLccR 95.00% 5.33 0.537 1.31 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 629.9216 1,886.74 1,887.75 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DAGGRYcQEQDLccR 95.00% 3.96 0.284 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 629.9225 1,886.74 1,887.75 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DAGGRYcQEQDLccR 95.00% 4.37 0.471 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 629.9233 1,886.75 1,887.75 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DAGGRYcQEQDLccR 95.00% 5.43 0.491 1.85 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 629.9233 1,886.75 1,887.75 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DAGGRYcQEQDLccR 95.00% 4.89 0.51 1.38 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 630.2574 1,887.75 1,887.75 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GGIYSHTPVSLGR 95.00% 3.63 0.624 0 672.3566 1,342.70 1,343.71 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GGIYSHTPVSLGR 95.00% 3.13 0.535 0 672.3573 1,342.70 1,343.71 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ITGWGEETLPDGR 95.00% 4.2 0.536 3.07 715.8479 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ITGWGEETLPDGR 95.00% 4.48 0.53 4.08 715.8479 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ITGWGEETLPDGR 95.00% 4.53 0.508 4.15 715.8479 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ITGWGEETLPDGR 95.00% 5.1 0.553 3.08 715.8479 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ITGWGEETLPDGR 95.00% 4.36 0.53 3.16 715.848 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ITGWGEETLPDGR 95.00% 4.2 0.51 2.59 715.8481 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ITGWGEETLPDGR 95.00% 4.68 0.542 2.24 715.8484 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ITGWGEETLPDGR 95.00% 4.28 0.535 2.6 715.8485 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ITGWGEETLPDGR 95.00% 4.32 0.495 2.55 715.8486 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ITGWGEETLPDGR 95.00% 4.53 0.518 2.74 715.8486 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ITGWGEETLPDGR 95.00% 3.51 0.491 2.7 715.8487 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ITGWGEETLPDGR 95.00% 2.82 0.384 1.66 715.849 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% YcQEQDLccR 95.00% 2.62 0.288 1.48 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 716.2753 1,430.53 1,431.55 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% YcQEQDLccR 95.00% 2.46 0.386 1.72 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 716.276 1,430.54 1,431.55 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% YcQEQDLccR 95.00% 2.91 0.145 1.34 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 716.2766 1,430.54 1,431.55 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GVVSDHcYPFSGR 95.00% 3.25 0.609 3 c7: Carbamidomethyl (+57.02) 740.833 1,479.65 1,480.66 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GVVSDHcYPFSGR 95.00% 3.51 0.545 3.27 c7: Carbamidomethyl (+57.02) 740.8346 1,479.65 1,480.66 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GVVSDHcYPFSGR 95.00% 3.47 0.575 3.09 c7: Carbamidomethyl (+57.02) 740.8351 1,479.65 1,480.66 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GVVSDHcYPFSGR 95.00% 3.42 0.561 2.8 c7: Carbamidomethyl (+57.02) 740.8355 1,479.66 1,480.66 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DEAGPAPPcMMHSR 95.00% 3.22 0.413 3.57 c9: Carbamidomethyl (+57.02) 778.3226 1,554.63 1,555.65 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DEAGPAPPcMMHSR 95.00% 2.89 0.342 3.62 c9: Carbamidomethyl (+57.02) 778.3255 1,554.64 1,555.65 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DEAGPAPPcmMHSR 95.00% 2.78 0.445 0 c9: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 786.3235 1,570.63 1,571.64 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DEAGPAPPcmMHSR 95.00% 3.16 0.43 0 c9: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 786.3271 1,570.64 1,571.64 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% RGVVSDHcYPFSGR 95.00% 4.17 0.517 2.49 c8: Carbamidomethyl (+57.02) 818.8883 1,635.76 1,636.77 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GGIYSHTPVSLGRPER 95.00% 3.06 0.352 3.68 863.4546 1,724.89 1,725.90 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GGIYSHTPVSLGRPER 95.00% 3.27 0.387 1.66 863.4577 1,724.90 1,725.90 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GGIYSHTPVSLGRPER 94.80% 2.71 0.227 0 863.9546 1,725.89 1,725.90 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% GGIYSHTPVSLGRPER 95.00% 3.02 0.329 1.48 863.9549 1,725.89 1,725.90 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% YWTAANSWGPAWGER 95.00% 5.05 0.639 5.85 876.3983 1,750.78 1,751.79 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% YWTAANSWGPAWGER 95.00% 5.32 0.628 4.39 876.8997 1,751.78 1,751.79 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% IYPVLGTYWDNcNR 95.00% 3.43 0.392 1.12 c12: Carbamidomethyl (+57.02) 885.9146 1,769.81 1,770.83 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% IYPVLGTYWDNcNR 95.00% 4.82 0.586 7.72 c12: Carbamidomethyl (+57.02) 885.9146 1,769.81 1,770.83 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% IYPVLGTYWDNcNR 95.00% 4.83 0.612 4.43 c12: Carbamidomethyl (+57.02) 885.9157 1,769.82 1,770.83 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% IYPVLGTYWDNcNR 95.00% 4.89 0.586 4.85 c12: Carbamidomethyl (+57.02) 885.9161 1,769.82 1,770.83 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% IYPVLGTYWDNcNR 95.00% 4.77 0.603 4.29 c12: Carbamidomethyl (+57.02) 885.9167 1,769.82 1,770.83 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% IYPVLGTYWDNcNR 95.00% 5.03 0.54 4.72 c12: Carbamidomethyl (+57.02) 886.4165 1,770.82 1,770.83 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% IYPVLGTYWDNcNR 95.00% 4.72 0.489 3.26 c12: Carbamidomethyl (+57.02) 886.4177 1,770.82 1,770.83 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% ERDEAGPAPPcMMHSR 95.00% 4.89 0.469 3.22 c11: Carbamidomethyl (+57.02) 920.8989 1,839.78 1,840.79 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% qATAHcPNSYVNNNDIYQVTPVYR 95.00% 0 0 3.32 c6: Carbamidomethyl (+57.02), n-term: Pyro-cmC (-17.03) 936.7667 2,807.28 2,807.28 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 6.15 0.589 1.82 c6: Carbamidomethyl (+57.02) 942.44 2,824.30 2,824.31 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 6.03 0.564 2.55 c6: Carbamidomethyl (+57.02) 942.4416 2,824.30 2,824.31 3
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DAGGRYcQEQDLccR 95.00% 3.29 0.581 3.66 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 944.3808 1,886.75 1,887.75 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DAGGRYcQEQDLccR 95.00% 3.24 0.512 3.36 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 944.3817 1,886.75 1,887.75 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% DAGGRYcQEQDLccR 95.00% 3.37 0.549 3.52 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 944.8773 1,887.74 1,887.75 2
 SAMPLE 2 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 59 33.40% QWQcDQEPcLVDPDMIK 95.00% 5.07 0.444 4.26 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,081.97 2,161.92 2,161.94 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGRLDGAWWFLR 95.00% 3.24 0.352 0 478.9211 1,433.74 1,433.74 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GVVSDHcYPFSGR 95.00% 2.23 0.208 0 c7: Carbamidomethyl (+57.02) 494.2251 1,479.65 1,480.66 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GVVSDHcYPFSGR 95.00% 1.99 0.287 0 c7: Carbamidomethyl (+57.02) 494.2253 1,479.65 1,480.66 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GVVSDHcYPFSGR 95.00% 2.68 0.405 1.68 c7: Carbamidomethyl (+57.02) 494.2255 1,479.65 1,480.66 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GVVSDHcYPFSGR 95.00% 2.16 0.232 1.23 c7: Carbamidomethyl (+57.02) 494.2258 1,479.65 1,480.66 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GVVSDHcYPFSGR 95.00% 2.62 0.352 2.57 c7: Carbamidomethyl (+57.02) 494.226 1,479.65 1,480.66 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% RGVVSDHcYPFSGR 95.00% 3.25 0.458 0 c8: Carbamidomethyl (+57.02) 546.2601 1,635.76 1,636.77 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 2.45 0.282 0 575.9701 1,724.89 1,725.90 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 3.54 0.398 0 575.9702 1,724.89 1,725.90 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 2.33 0.223 0 575.9714 1,724.89 1,725.90 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 2.72 0.379 0 575.9725 1,724.89 1,725.90 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 2.78 0.257 0 576.3041 1,725.89 1,725.90 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 3.42 0.428 0 576.3047 1,725.89 1,725.90 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 3.23 0.288 0 576.3048 1,725.89 1,725.90 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% LDGAWWFLR 95.00% 2.8 0.345 0 582.3 1,162.58 1,163.60 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% LDGAWWFLR 95.00% 3.06 0.432 1.8 582.3004 1,162.59 1,163.60 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% LDGAWWFLR 95.00% 3.45 0.412 1.57 582.3007 1,162.59 1,163.60 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% LDGAWWFLR 95.00% 3.59 0.457 1.6 582.3018 1,162.59 1,163.60 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% LDGAWWFLR 95.00% 3 0.394 1.54 582.302 1,162.59 1,163.60 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% LDGAWWFLR 95.00% 3.66 0.469 1.52 582.3026 1,162.59 1,163.60 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% LDGAWWFLR 95.00% 3.44 0.443 1.74 582.3026 1,162.59 1,163.60 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% IYPVLGTYWDNcNR 95.00% 4.25 0.589 2.7 c12: Carbamidomethyl (+57.02) 591.2809 1,770.82 1,770.83 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% IYPVLGTYWDNcNR 95.00% 4.15 0.532 2.37 c12: Carbamidomethyl (+57.02) 591.2811 1,770.82 1,770.83 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ERDEAGPAPPcMMHSR 95.00% 3.65 0.376 0 c11: Carbamidomethyl (+57.02) 614.267 1,839.78 1,840.79 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ERDEAGPAPPcMMHSR 95.00% 3.11 0.271 0 c11: Carbamidomethyl (+57.02) 614.5989 1,840.77 1,840.79 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% DAGGRYcQEQDLccR 95.00% 5.04 0.511 2.77 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 629.9232 1,886.75 1,887.75 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% DAGGRYcQEQDLccR 95.00% 3.43 0.339 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 629.9244 1,886.75 1,887.75 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% DAGGRYcQEQDLccR 95.00% 4.93 0.491 1.28 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 629.9244 1,886.75 1,887.75 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% DAGGRYcQEQDLccR 95.00% 4.6 0.448 1.14 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 630.2567 1,887.75 1,887.75 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% DAGGRYcQEQDLccR 95.00% 4.54 0.445 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 630.2573 1,887.75 1,887.75 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGR 95.00% 3.09 0.556 0 672.3569 1,342.70 1,343.71 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGR 95.00% 2.86 0.348 0 672.357 1,342.70 1,343.71 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ITGWGEETLPDGR 95.00% 4.14 0.555 2.43 715.8468 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ITGWGEETLPDGR 95.00% 4.33 0.514 1.38 715.8481 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ITGWGEETLPDGR 95.00% 4.48 0.554 3.06 715.8482 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ITGWGEETLPDGR 95.00% 4.44 0.549 2.52 715.8483 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ITGWGEETLPDGR 95.00% 4.27 0.496 2.66 715.8484 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ITGWGEETLPDGR 95.00% 4.42 0.542 3.72 715.8484 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ITGWGEETLPDGR 95.00% 2.96 0.321 1.38 715.8487 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ITGWGEETLPDGR 95.00% 4.44 0.54 1.85 715.8487 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ITGWGEETLPDGR 95.00% 3.65 0.448 2.21 715.8487 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ITGWGEETLPDGR 95.00% 3.41 0.477 3.17 715.849 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ITGWGEETLPDGR 95.00% 4.42 0.542 3 715.8496 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% YcQEQDLccR 95.00% 2.97 0.244 1.51 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 716.2801 1,430.54 1,431.55 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% YcQEQDLccR 95.00% 2.97 0.133 1.82 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 716.7792 1,431.54 1,431.55 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GVVSDHcYPFSGR 95.00% 3.58 0.572 4.34 c7: Carbamidomethyl (+57.02) 740.8341 1,479.65 1,480.66 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GVVSDHcYPFSGR 95.00% 3.37 0.622 3.7 c7: Carbamidomethyl (+57.02) 740.8346 1,479.65 1,480.66 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GVVSDHcYPFSGR 95.00% 3.93 0.567 4.1 c7: Carbamidomethyl (+57.02) 740.8352 1,479.65 1,480.66 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GVVSDHcYPFSGR 95.00% 3.87 0.528 3.48 c7: Carbamidomethyl (+57.02) 740.8355 1,479.66 1,480.66 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GVVSDHcYPFSGR 95.00% 3.62 0.518 4.43 c7: Carbamidomethyl (+57.02) 740.8366 1,479.66 1,480.66 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GVVSDHcYPFSGR 95.00% 2.9 0.532 1.96 c7: Carbamidomethyl (+57.02) 740.8382 1,479.66 1,480.66 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% DEAGPAPPcMMHSR 95.00% 2.99 0.421 4.12 c9: Carbamidomethyl (+57.02) 778.3278 1,554.64 1,555.65 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% DEAGPAPPcmMHSR 95.00% 2.31 0.319 0 c9: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 786.3219 1,570.63 1,571.64 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% RGVVSDHcYPFSGR 95.00% 4.41 0.584 3.13 c8: Carbamidomethyl (+57.02) 818.8868 1,635.76 1,636.77 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% RGVVSDHcYPFSGR 95.00% 4.09 0.576 2.7 c8: Carbamidomethyl (+57.02) 818.888 1,635.76 1,636.77 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 2.71 0.209 1.46 863.4532 1,724.89 1,725.90 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 3.45 0.422 2.34 863.4544 1,724.89 1,725.90 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 3.07 0.422 1.85 863.4547 1,724.89 1,725.90 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 2.33 0.245 2.22 863.4566 1,724.90 1,725.90 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 2.89 0.197 1.3 863.9561 1,725.90 1,725.90 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% GGIYSHTPVSLGRPER 95.00% 3.74 0.407 1.64 863.9563 1,725.90 1,725.90 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% YWTAANSWGPAWGER 95.00% 5.3 0.627 6.39 876.3982 1,750.78 1,751.79 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% YWTAANSWGPAWGER 95.00% 5.02 0.542 5.68 876.8999 1,751.78 1,751.79 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% IYPVLGTYWDNcNR 95.00% 4.58 0.622 2.89 c12: Carbamidomethyl (+57.02) 885.9135 1,769.81 1,770.83 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% IYPVLGTYWDNcNR 95.00% 2.88 0.439 2.14 c12: Carbamidomethyl (+57.02) 885.9138 1,769.81 1,770.83 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% IYPVLGTYWDNcNR 95.00% 4.67 0.594 4.54 c12: Carbamidomethyl (+57.02) 885.9149 1,769.81 1,770.83 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% IYPVLGTYWDNcNR 95.00% 5.09 0.609 4.41 c12: Carbamidomethyl (+57.02) 885.9154 1,769.82 1,770.83 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% IYPVLGTYWDNcNR 95.00% 4.65 0.595 4.14 c12: Carbamidomethyl (+57.02) 885.9158 1,769.82 1,770.83 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% IYPVLGTYWDNcNR 95.00% 3 0.411 0 c12: Carbamidomethyl (+57.02) 885.9159 1,769.82 1,770.83 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% IYPVLGTYWDNcNR 95.00% 4.7 0.624 4.7 c12: Carbamidomethyl (+57.02) 886.4145 1,770.81 1,770.83 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% IYPVLGTYWDNcNR 95.00% 4.82 0.557 5.42 c12: Carbamidomethyl (+57.02) 886.4151 1,770.81 1,770.83 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% IYPVLGTYWDNcNR 95.00% 4.53 0.592 4.03 c12: Carbamidomethyl (+57.02) 886.417 1,770.82 1,770.83 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% IYPVLGTYWDNcNR 95.00% 4.99 0.565 3.46 c12: Carbamidomethyl (+57.02) 886.418 1,770.82 1,770.83 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% ERDEAGPAPPcMMHSR 95.00% 4.7 0.452 3.05 c11: Carbamidomethyl (+57.02) 920.8987 1,839.78 1,840.79 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 5.94 0.564 2.03 c6: Carbamidomethyl (+57.02) 942.4401 2,824.30 2,824.31 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 5.48 0.588 1.92 c6: Carbamidomethyl (+57.02) 942.4431 2,824.31 2,824.31 3
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% DAGGRYcQEQDLccR 95.00% 3.61 0.531 2.72 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 944.3788 1,886.74 1,887.75 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% DAGGRYcQEQDLccR 95.00% 2.9 0.433 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 944.3814 1,886.75 1,887.75 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% DAGGRYcQEQDLccR 95.00% 3.55 0.501 4.32 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 944.8808 1,887.75 1,887.75 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% DAGGRYcQEQDLccR 95.00% 3.47 0.54 1.96 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 944.8814 1,887.75 1,887.75 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% QWQcDQEPcLVDPDMIK 95.00% 4.79 0.433 3.57 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,081.97 2,161.92 2,161.94 2
 SAMPLE 2R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 71 33.40% QWQcDQEPcLVDPDMIK 95.00% 5.02 0.454 2.96 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,081.97 2,161.93 2,161.94 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GVVSDHcYPFSGR 95.00% 2.55 0.338 1.49 c7: Carbamidomethyl (+57.02) 494.2257 1,479.65 1,480.66 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GVVSDHcYPFSGR 95.00% 2.46 0.237 0 c7: Carbamidomethyl (+57.02) 494.2261 1,479.65 1,480.66 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GVVSDHcYPFSGR 95.00% 2.35 0.217 2.72 c7: Carbamidomethyl (+57.02) 494.2261 1,479.65 1,480.66 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GVVSDHcYPFSGR 95.00% 2.64 0.317 0 c7: Carbamidomethyl (+57.02) 494.2262 1,479.66 1,480.66 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% VGMEDMGHH 95.00% 2 0.266 0 506.7035 1,011.39 1,012.40 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% DEAGPAPPcMMHSR 95.00% 2.13 0.423 0 c9: Carbamidomethyl (+57.02) 519.2192 1,554.63 1,555.65 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% DEAGPAPPcMMHSR 95.00% 1.76 0.324 0 c9: Carbamidomethyl (+57.02) 519.2205 1,554.64 1,555.65 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% RGVVSDHcYPFSGR 95.00% 3.54 0.474 1.24 c8: Carbamidomethyl (+57.02) 546.2597 1,635.76 1,636.77 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% RGVVSDHcYPFSGR 95.00% 3.79 0.499 0 c8: Carbamidomethyl (+57.02) 546.5934 1,636.76 1,636.77 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% LGSNDKEIMK 95.00% 2.51 0.241 0 567.7974 1,133.58 1,134.58 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% LGSNDKEIMK 95.00% 2.64 0.18 0 567.7975 1,133.58 1,134.58 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGRPER 95.00% 2.65 0.275 0 575.9712 1,724.89 1,725.90 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGRPER 95.00% 2.9 0.358 0 575.9713 1,724.89 1,725.90 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGRPER 95.00% 2.8 0.27 0 575.9713 1,724.89 1,725.90 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGRPER 95.00% 2.75 0.3 0 575.9721 1,724.89 1,725.90 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGRPER 95.00% 2.96 0.415 0 576.3047 1,725.89 1,725.90 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGRPER 95.00% 3.57 0.509 0 576.3058 1,725.89 1,725.90 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGRPER 95.00% 2.6 0.36 0 576.3073 1,725.90 1,725.90 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% IYPVLGTYWDNcNR 95.00% 4.16 0.474 2.21 c12: Carbamidomethyl (+57.02) 591.2806 1,770.82 1,770.83 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% IYPVLGTYWDNcNR 95.00% 4.24 0.643 1.85 c12: Carbamidomethyl (+57.02) 591.2812 1,770.82 1,770.83 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ERDEAGPAPPcMMHSR 95.00% 3.25 0.426 0 c11: Carbamidomethyl (+57.02) 614.2671 1,839.78 1,840.79 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ERDEAGPAPPcMMHSR 95.00% 2.55 0.399 2.4 c11: Carbamidomethyl (+57.02) 614.6015 1,840.78 1,840.79 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ERDEAGPAPPcMmHSR 95.00% 3.59 0.343 2.17 c11: Carbamidomethyl (+57.02), m13: Oxidation (+15.99) 619.6005 1,855.78 1,856.78 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ERDEAGPAPPcmMHSR 95.00% 2.58 0.216 1.27 c11: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 619.9349 1,856.78 1,856.78 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ERDEAGPAPPcmMHSR 95.00% 2.38 0.296 0 c11: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 619.9352 1,856.78 1,856.78 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ERDEAGPAPPcmMHSR 95.00% 2.77 0.208 1.64 c11: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 619.937 1,856.79 1,856.78 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% DAGGRYcQEQDLccR 95.00% 4.42 0.444 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 630.2556 1,887.74 1,887.75 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% DAGGRYcQEQDLccR 95.00% 3.62 0.425 2.17 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 630.2557 1,887.74 1,887.75 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% DAGGRYcQEQDLccR 95.00% 5.32 0.491 1.44 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 630.2562 1,887.75 1,887.75 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% DAGGRYcQEQDLccR 95.00% 5.17 0.53 1.96 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 630.2569 1,887.75 1,887.75 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGR 95.00% 3.8 0.661 0 672.3555 1,342.70 1,343.71 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGR 95.00% 3.81 0.656 0 672.3558 1,342.70 1,343.71 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ITGWGEETLPDGR 95.00% 3.44 0.352 3.04 715.8455 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ITGWGEETLPDGR 95.00% 4.17 0.533 2.74 715.8471 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ITGWGEETLPDGR 95.00% 4.39 0.495 2.59 715.8479 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ITGWGEETLPDGR 95.00% 2.62 0.337 1.57 715.8481 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ITGWGEETLPDGR 95.00% 3.28 0.448 2.06 715.8482 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ITGWGEETLPDGR 95.00% 4.28 0.508 2.24 715.8482 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ITGWGEETLPDGR 95.00% 3.2 0.48 3.74 715.8487 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ITGWGEETLPDGR 95.00% 2.03 0.209 1.89 715.8497 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% YcQEQDLccR 95.00% 2.65 0.336 2.85 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 716.2757 1,430.54 1,431.55 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% YcQEQDLccR 95.00% 3.05 0.297 2.54 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 716.2783 1,430.54 1,431.55 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ITGWGEETLPDGR 95.00% 4.59 0.54 2.89 716.3469 1,430.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GVVSDHcYPFSGR 95.00% 3.69 0.489 2.85 c7: Carbamidomethyl (+57.02) 740.8336 1,479.65 1,480.66 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GVVSDHcYPFSGR 95.00% 4.06 0.579 3.12 c7: Carbamidomethyl (+57.02) 740.8348 1,479.65 1,480.66 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GVVSDHcYPFSGR 95.00% 3.61 0.61 3.42 c7: Carbamidomethyl (+57.02) 740.8354 1,479.66 1,480.66 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% DEAGPAPPcMMHSR 95.00% 3.28 0.472 4.03 c9: Carbamidomethyl (+57.02) 778.3235 1,554.63 1,555.65 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% DEAGPAPPcMMHSR 95.00% 3.38 0.461 2.8 c9: Carbamidomethyl (+57.02) 778.3244 1,554.63 1,555.65 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% DEAGPAPPcmMHSR 95.00% 2.6 0.477 0 c9: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 786.323 1,570.63 1,571.64 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% DEAGPAPPcmMHSR 95.00% 2.85 0.482 0 c9: Carbamidomethyl (+57.02), m10: Oxidation (+15.99) 786.8242 1,571.63 1,571.64 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGRPER 95.00% 2.82 0.347 2.57 863.4533 1,724.89 1,725.90 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGRPER 95.00% 2.94 0.421 3.11 863.4547 1,724.89 1,725.90 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGRPER 95.00% 2.64 0.309 2.77 863.4549 1,724.89 1,725.90 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% GGIYSHTPVSLGRPER 95.00% 2.79 0.293 1.72 863.9561 1,725.90 1,725.90 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% YWTAANSWGPAWGER 95.00% 5.06 0.629 4.82 876.3983 1,750.78 1,751.79 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% YWTAANSWGPAWGER 95.00% 5.15 0.616 5.66 876.8999 1,751.78 1,751.79 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% IYPVLGTYWDNcNR 95.00% 4.96 0.592 4.96 c12: Carbamidomethyl (+57.02) 885.9116 1,769.81 1,770.83 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% IYPVLGTYWDNcNR 95.00% 4.77 0.606 3.85 c12: Carbamidomethyl (+57.02) 885.9119 1,769.81 1,770.83 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% IYPVLGTYWDNcNR 95.00% 4.55 0.578 4.1 c12: Carbamidomethyl (+57.02) 885.9138 1,769.81 1,770.83 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% IYPVLGTYWDNcNR 95.00% 5.01 0.616 4.7 c12: Carbamidomethyl (+57.02) 885.914 1,769.81 1,770.83 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% IYPVLGTYWDNcNR 95.00% 4.95 0.601 5.46 c12: Carbamidomethyl (+57.02) 885.9152 1,769.81 1,770.83 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% IYPVLGTYWDNcNR 95.00% 4.85 0.616 4.68 c12: Carbamidomethyl (+57.02) 885.9153 1,769.81 1,770.83 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% IYPVLGTYWDNcNR 95.00% 5.11 0.578 5.54 c12: Carbamidomethyl (+57.02) 886.4185 1,770.82 1,770.83 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ERDEAGPAPPcMMHSR 95.00% 4.75 0.431 3.96 c11: Carbamidomethyl (+57.02) 920.8979 1,839.78 1,840.79 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ERDEAGPAPPcMMHSR 95.00% 4.26 0.387 3.09 c11: Carbamidomethyl (+57.02) 921.3974 1,840.78 1,840.79 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ERDEAGPAPPcmMHSR 95.00% 2.55 0.275 1.39 c11: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 929.3951 1,856.77 1,856.78 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% ERDEAGPAPPcmMHSR 95.00% 2.92 0.433 1.15 c11: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 929.3989 1,856.78 1,856.78 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 6.22 0.607 1.7 c6: Carbamidomethyl (+57.02) 942.4403 2,824.30 2,824.31 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 6.13 0.588 2.77 c6: Carbamidomethyl (+57.02) 942.4411 2,824.30 2,824.31 3
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% DAGGRYcQEQDLccR 95.00% 4.06 0.637 3.96 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 944.3796 1,886.74 1,887.75 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% QWQcDQEPcLVDPDMIK 95.00% 4.94 0.48 3.85 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,081.97 2,161.92 2,161.94 2
 SAMPLE 3 Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 14 20 63 34.90% QWQcDQEPcLVDPDMIK 95.00% 5.12 0.444 2.8 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,081.97 2,161.93 2,161.94 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GVVSDHcYPFSGR 95.00% 2.31 0.259 0 c7: Carbamidomethyl (+57.02) 494.226 1,479.65 1,480.66 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GVVSDHcYPFSGR 95.00% 2.21 0.259 1.92 c7: Carbamidomethyl (+57.02) 494.2263 1,479.66 1,480.66 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GVVSDHcYPFSGR 95.00% 2.63 0.328 0 c7: Carbamidomethyl (+57.02) 494.227 1,479.66 1,480.66 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% DEAGPAPPcMMHSR 95.00% 2.33 0.45 0 c9: Carbamidomethyl (+57.02) 519.2189 1,554.63 1,555.65 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% DEAGPAPPcMMHSR 95.00% 2.39 0.429 0 c9: Carbamidomethyl (+57.02) 519.2194 1,554.63 1,555.65 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% RGVVSDHcYPFSGR 95.00% 3.23 0.373 0 c8: Carbamidomethyl (+57.02) 546.2578 1,635.75 1,636.77 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% RGVVSDHcYPFSGR 95.00% 3.47 0.424 0 c8: Carbamidomethyl (+57.02) 546.2595 1,635.75 1,636.77 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% RGVVSDHcYPFSGR 95.00% 3 0.447 0 c8: Carbamidomethyl (+57.02) 546.5927 1,636.75 1,636.77 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GGIYSHTPVSLGRPER 95.00% 3.38 0.404 0 576.3065 1,725.90 1,725.90 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GGIYSHTPVSLGRPER 95.00% 2.72 0.378 0 576.3065 1,725.90 1,725.90 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GGIYSHTPVSLGRPER 95.00% 3.74 0.414 0 576.3074 1,725.90 1,725.90 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% LDGAWWFLR 95.00% 3.57 0.489 1.68 582.3018 1,162.59 1,163.60 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% LDGAWWFLR 95.00% 3.19 0.289 1.28 582.302 1,162.59 1,163.60 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% LDGAWWFLR 95.00% 3.31 0.399 2.03 582.3026 1,162.59 1,163.60 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% LDGAWWFLR 95.00% 3.49 0.437 1.96 582.3026 1,162.59 1,163.60 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% LDGAWWFLR 95.00% 3.59 0.493 2.07 582.3028 1,162.59 1,163.60 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% LDGAWWFLR 95.00% 3.65 0.372 1.07 582.3028 1,162.59 1,163.60 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% IYPVLGTYWDNcNR 95.00% 3.74 0.557 1.32 c12: Carbamidomethyl (+57.02) 590.9464 1,769.82 1,770.83 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% IYPVLGTYWDNcNR 95.00% 4.05 0.566 0 c12: Carbamidomethyl (+57.02) 591.2803 1,770.82 1,770.83 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ERDEAGPAPPcMMHSR 95.00% 3.66 0.486 0 c11: Carbamidomethyl (+57.02) 614.2669 1,839.78 1,840.79 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ERDEAGPAPPcMMHSR 95.00% 3.34 0.416 1.01 c11: Carbamidomethyl (+57.02) 614.2672 1,839.78 1,840.79 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ERDEAGPAPPcMMHSR 95.00% 2.93 0.297 0 c11: Carbamidomethyl (+57.02) 614.6002 1,840.78 1,840.79 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ERDEAGPAPPcmMHSR 95.00% 2.69 0.254 0 c11: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 619.5974 1,855.77 1,856.78 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ERDEAGPAPPcmMHSR 95.00% 2.29 0.139 1.18 c11: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 619.6008 1,855.78 1,856.78 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ERDEAGPAPPcMmHSR 95.00% 3.09 0.284 0 c11: Carbamidomethyl (+57.02), m13: Oxidation (+15.99) 619.9331 1,856.78 1,856.78 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ERDEAGPAPPcmMHSR 95.00% 2.65 0.228 0 c11: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 619.9349 1,856.78 1,856.78 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% DAGGRYcQEQDLccR 95.00% 4.01 0.491 1.28 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 630.2543 1,887.74 1,887.75 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% DAGGRYcQEQDLccR 95.00% 3.96 0.411 1.44 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 630.2548 1,887.74 1,887.75 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% DAGGRYcQEQDLccR 95.00% 3.83 0.437 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 630.2567 1,887.75 1,887.75 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% DAGGRYcQEQDLccR 95.00% 4.11 0.545 1.89 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 630.2574 1,887.75 1,887.75 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GGIYSHTPVSLGR 95.00% 3.44 0.617 0 672.3557 1,342.70 1,343.71 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GGIYSHTPVSLGR 95.00% 3.48 0.619 0 672.3565 1,342.70 1,343.71 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ITGWGEETLPDGR 95.00% 2.92 0.397 2.1 715.8457 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ITGWGEETLPDGR 95.00% 2.41 0.414 1.26 715.8463 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ITGWGEETLPDGR 95.00% 4.4 0.483 2.42 715.8477 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ITGWGEETLPDGR 95.00% 4.16 0.511 2.89 715.8479 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ITGWGEETLPDGR 95.00% 3.95 0.532 2.16 715.8483 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ITGWGEETLPDGR 95.00% 2.67 0.381 0 715.8483 1,429.68 1,430.69 2 ,AHNK_HUMAN
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% YcQEQDLccR 95.00% 2.54 0.311 2 c2: Carbamidomethyl (+57.02), c8: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 716.2749 1,430.53 1,431.55 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GVVSDHcYPFSGR 95.00% 2.94 0.543 0 c7: Carbamidomethyl (+57.02) 740.8331 1,479.65 1,480.66 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GVVSDHcYPFSGR 95.00% 3.99 0.571 3.92 c7: Carbamidomethyl (+57.02) 740.8347 1,479.65 1,480.66 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GVVSDHcYPFSGR 95.00% 3.99 0.578 4.1 c7: Carbamidomethyl (+57.02) 740.8354 1,479.66 1,480.66 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GVVSDHcYPFSGR 95.00% 3.21 0.602 3.89 c7: Carbamidomethyl (+57.02) 740.8377 1,479.66 1,480.66 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% DEAGPAPPcMMHSR 95.00% 3.12 0.484 4.04 c9: Carbamidomethyl (+57.02) 778.3249 1,554.63 1,555.65 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% DEAGPAPPcMMHSR 95.00% 3.42 0.427 4.51 c9: Carbamidomethyl (+57.02) 778.8274 1,555.64 1,555.65 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GGIYSHTPVSLGRPER 95.00% 3.19 0.347 1.51 863.4543 1,724.89 1,725.90 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GGIYSHTPVSLGRPER 95.00% 3.64 0.49 0 863.455 1,724.89 1,725.90 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GGIYSHTPVSLGRPER 95.00% 3.19 0.373 2.25 863.4552 1,724.89 1,725.90 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% GGIYSHTPVSLGRPER 95.00% 3.03 0.344 1.38 863.4565 1,724.90 1,725.90 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% YWTAANSWGPAWGER 95.00% 5.04 0.663 5.4 876.3986 1,750.78 1,751.79 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% YWTAANSWGPAWGER 95.00% 5.23 0.59 6.1 876.8997 1,751.78 1,751.79 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% IYPVLGTYWDNcNR 95.00% 4.6 0.634 4.6 c12: Carbamidomethyl (+57.02) 885.9127 1,769.81 1,770.83 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% IYPVLGTYWDNcNR 95.00% 4.85 0.592 4.66 c12: Carbamidomethyl (+57.02) 885.9148 1,769.81 1,770.83 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% IYPVLGTYWDNcNR 95.00% 4.87 0.599 4.4 c12: Carbamidomethyl (+57.02) 885.9155 1,769.82 1,770.83 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% IYPVLGTYWDNcNR 95.00% 4.15 0.615 5.34 c12: Carbamidomethyl (+57.02) 885.9162 1,769.82 1,770.83 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% IYPVLGTYWDNcNR 95.00% 4.84 0.602 3.6 c12: Carbamidomethyl (+57.02) 885.9165 1,769.82 1,770.83 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% IYPVLGTYWDNcNR 95.00% 4.6 0.621 3.09 c12: Carbamidomethyl (+57.02) 885.9179 1,769.82 1,770.83 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% IYPVLGTYWDNcNR 95.00% 4.36 0.58 3.82 c12: Carbamidomethyl (+57.02) 886.4168 1,770.82 1,770.83 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% IYPVLGTYWDNcNR 95.00% 5.21 0.562 5.85 c12: Carbamidomethyl (+57.02) 886.418 1,770.82 1,770.83 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% IYPVLGTYWDNcNR 95.00% 5.16 0.552 5.47 c12: Carbamidomethyl (+57.02) 886.4184 1,770.82 1,770.83 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% IYPVLGTYWDNcNR 95.00% 5.12 0.625 3.59 c12: Carbamidomethyl (+57.02) 886.4197 1,770.82 1,770.83 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ERDEAGPAPPcMMHSR 95.00% 4.75 0.459 3.39 c11: Carbamidomethyl (+57.02) 920.896 1,839.78 1,840.79 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ERDEAGPAPPcMMHSR 95.00% 4.65 0.424 4.25 c11: Carbamidomethyl (+57.02) 921.399 1,840.78 1,840.79 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% ERDEAGPAPPcmMHSR 95.00% 2.35 0.278 1.66 c11: Carbamidomethyl (+57.02), m12: Oxidation (+15.99) 929.3967 1,856.78 1,856.78 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 6.15 0.55 3 c6: Carbamidomethyl (+57.02) 942.4393 2,824.29 2,824.31 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% QATAHcPNSYVNNNDIYQVTPVYR 95.00% 6.38 0.594 1.49 c6: Carbamidomethyl (+57.02) 942.4416 2,824.30 2,824.31 3
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% DAGGRYcQEQDLccR 95.00% 3.78 0.573 3.35 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 944.3774 1,886.74 1,887.75 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% DAGGRYcQEQDLccR 95.00% 3.15 0.49 0 c7: Carbamidomethyl (+57.02), c13: Carbamidomethyl (+57.02), c14: Carbamidomethyl (+57.02) 944.8813 1,887.75 1,887.75 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% QWQcDQEPcLVDPDMIK 95.00% 4.68 0.479 4.05 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,081.97 2,161.92 2,161.94 2
 SAMPLE 3R Tubulointerstitial nephritis antigen-like  TINAGL1  TINAL_HUMAN 52,369.00 100.00% 13 19 64 32.80% QWQcDQEPcLVDPDMIK 95.00% 4.52 0.478 4.6 c4: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02) 1,081.97 2,161.93 2,161.94 2
 SAMPLE 2 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.90% 2 2 5 44.70% ESTLHLVLR 95.00% 2.77 0.26 0 534.3112 1,066.61 1,067.62 2
 SAMPLE 2 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.90% 2 2 5 44.70% ESTLHLVLR 95.00% 2.68 0.23 0 534.3132 1,066.61 1,067.62 2
 SAMPLE 2 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.90% 2 2 5 44.70% TLSDYNIQK 95.00% 2.54 0.392 1.39 541.2788 1,080.54 1,081.55 2
 SAMPLE 2 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.90% 2 2 5 44.70% TLSDYNIQK 95.00% 2.34 0.418 1.82 541.2796 1,080.54 1,081.55 2
 SAMPLE 2 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.90% 2 2 5 44.70% TITLEVEPSDTIENVK 95.00% 2.8 0.357 0 894.4629 1,786.91 1,787.93 2
 SAMPLE 2 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.90% 2 2 5 44.70% TITLEVEPSDTIENVK 95.00% 4.36 0.607 4.59 894.4667 1,786.92 1,787.93 2
 SAMPLE 2 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.90% 2 2 5 44.70% TITLEVEPSDTIENVK 95.00% 4.71 0.624 3.92 894.4677 1,786.92 1,787.93 2
 SAMPLE 2R Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 100.00% 3 3 5 61.80% ESTLHLVLR 95.00% 2.74 0.195 0 534.3129 1,066.61 1,067.62 2
 SAMPLE 2R Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 100.00% 3 3 5 61.80% TLSDYNIQK 95.00% 2.27 0.356 1.4 541.2784 1,080.54 1,081.55 2
 SAMPLE 2R Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 100.00% 3 3 5 61.80% IQDKEGIPPDQQR 95.00% 2.39 0.399 0 762.3964 1,522.78 1,523.78 2
 SAMPLE 2R Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 100.00% 3 3 5 61.80% IQDKEGIPPDQQR 95.00% 2.4 0.389 0 762.3991 1,522.78 1,523.78 2
 SAMPLE 2R Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 100.00% 3 3 5 61.80% TITLEVEPSDTIENVK 95.00% 4.22 0.582 3.89 894.9667 1,787.92 1,787.93 2
 SAMPLE 2R Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 100.00% 3 3 5 61.80% TITLEVEPSDTIENVK 95.00% 4.29 0.575 4.21 894.9691 1,787.92 1,787.93 2
 SAMPLE 3 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.80% 2 2 7 38.20% IQDKEGIPPDQQR 95.00% 2.99 0.424 2.21 762.3954 1,522.78 1,523.78 2
 SAMPLE 3 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.80% 2 2 7 38.20% IQDKEGIPPDQQR 95.00% 2.99 0.441 0 762.3977 1,522.78 1,523.78 2
 SAMPLE 3 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.80% 2 2 7 38.20% IQDKEGIPPDQQR 95.00% 3.18 0.395 1.92 762.399 1,522.78 1,523.78 2
 SAMPLE 3 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.80% 2 2 7 38.20% IQDKEGIPPDQQR 95.00% 2.86 0.495 1.59 762.3997 1,522.78 1,523.78 2
 SAMPLE 3 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.80% 2 2 7 38.20% IQDKEGIPPDQQR 95.00% 2.53 0.25 0 762.8973 1,523.78 1,523.78 2
 SAMPLE 3 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.80% 2 2 7 38.20% TITLEVEPSDTIENVK 95.00% 4.16 0.554 3.77 894.9677 1,787.92 1,787.93 2
 SAMPLE 3 Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 99.80% 2 2 7 38.20% TITLEVEPSDTIENVK 95.00% 4.34 0.575 4 894.9698 1,787.92 1,787.93 2
 SAMPLE 3R Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 100.00% 3 3 6 50.00% TLSDYNIQK 94.70% 2.09 0.232 0 541.2791 1,080.54 1,081.55 2
 SAMPLE 3R Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 100.00% 3 3 6 50.00% IQDKEGIPPDQQR 95.00% 2.82 0.28 2.01 762.3944 1,522.77 1,523.78 2
 SAMPLE 3R Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 100.00% 3 3 6 50.00% IQDKEGIPPDQQR 95.00% 3.22 0.432 1.55 762.3958 1,522.78 1,523.78 2
 SAMPLE 3R Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 100.00% 3 3 6 50.00% IQDKEGIPPDQQR 95.00% 2.83 0.426 2.17 762.397 1,522.78 1,523.78 2
 SAMPLE 3R Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 100.00% 3 3 6 50.00% IQDKEGIPPDQQR 95.00% 3.16 0.427 1.08 762.397 1,522.78 1,523.78 2
 SAMPLE 3R Ubiquitin  RPS27A  UBIQ_HUMAN 8,547.20 100.00% 3 3 6 50.00% TITLEVEPSDTIENVK 95.00% 3.17 0.49 0 894.4665 1,786.92 1,787.93 2
 SAMPLE 2R Uncharacterized protein KIAA1602  KIAA1602  K1602_HUMAN 138,998.10 99.80% 2 2 5 2.11% AYLSSRARPR 95.00% 2.06 0.309 0 588.8212 1,175.63 1,176.66 2
 SAMPLE 2R Uncharacterized protein KIAA1602  KIAA1602  K1602_HUMAN 138,998.10 99.80% 2 2 5 2.11% AYLSSRARPR 95.00% 2.09 0.269 0 588.8212 1,175.63 1,176.66 2
 SAMPLE 2R Uncharacterized protein KIAA1602  KIAA1602  K1602_HUMAN 138,998.10 99.80% 2 2 5 2.11% AYLSSRARPR 95.00% 2.3 0.209 0 588.8213 1,175.63 1,176.66 2
 SAMPLE 2R Uncharacterized protein KIAA1602  KIAA1602  K1602_HUMAN 138,998.10 99.80% 2 2 5 2.11% AYLSSRARPR 95.00% 2.23 0.231 0 588.8229 1,175.63 1,176.66 2
 SAMPLE 2R Uncharacterized protein KIAA1602  KIAA1602  K1602_HUMAN 138,998.10 99.80% 2 2 5 2.11% VELAKSRLAGALcPQVPR 95.00% 1.83 0.248 1.35 c13: Carbamidomethyl (+57.02) 655.8061 1,964.39 1,965.11 3
 SAMPLE 1R UTP--glucose-1-phosphate uridylyltransferase  UGP2  UGPA_HUMAN 56,924.00 100.00% 3 3 5 8.07% LVEIAQVPK 95.00% 2 0.321 1.47 499.2657 996.5157 996.6095 2
 SAMPLE 1R UTP--glucose-1-phosphate uridylyltransferase  UGP2  UGPA_HUMAN 56,924.00 100.00% 3 3 5 8.07% LVEIAQVPK 95.00% 1.44 0.327 2.66 499.2657 996.5158 996.6095 2
 SAMPLE 1R UTP--glucose-1-phosphate uridylyltransferase  UGP2  UGPA_HUMAN 56,924.00 100.00% 3 3 5 8.07% GLPDNISSVLNK 95.00% 2.51 0.299 1.46 628.8443 1,255.67 1,256.69 2
 SAMPLE 1R UTP--glucose-1-phosphate uridylyltransferase  UGP2  UGPA_HUMAN 56,924.00 100.00% 3 3 5 8.07% GLPDNISSVLNK 95.00% 2.91 0.343 2.23 628.8444 1,255.67 1,256.69 2
 SAMPLE 1R UTP--glucose-1-phosphate uridylyltransferase  UGP2  UGPA_HUMAN 56,924.00 100.00% 3 3 5 8.07% TLDGGLNVIQLETAVGAAIK 95.00% 5.88 0.592 6.3 992.5614 1,983.11 1,983.11 2
 SAMPLE 1R Vasodilator-stimulated phosphoprotein  VASP  VASP_HUMAN 39,811.10 99.80% 2 2 3 10.30% VQIYHNPTANSFR 95.00% 2.28 0.267 0 516.2618 1,545.76 1,546.78 3
 SAMPLE 1R Vasodilator-stimulated phosphoprotein  VASP  VASP_HUMAN 39,811.10 99.80% 2 2 3 10.30% VQIYHNPTANSFR 95.00% 3 0.45 0 516.2642 1,545.77 1,546.78 3
 SAMPLE 1R Vasodilator-stimulated phosphoprotein  VASP  VASP_HUMAN 39,811.10 99.80% 2 2 3 10.30% VKEEIIEAFVQELR 95.00% 3.39 0.266 0 568.3172 1,701.93 1,702.94 3
 SAMPLE 1R Vasodilator-stimulated phosphoprotein  VASP  VASP_HUMAN 39,811.10 99.80% 2 2 3 10.30% YNQATPNFHQWR 95.00% 3.13 0.265 1.38 781.3617 1,560.71 1,561.73 2
 SAMPLE 3 Vasodilator-stimulated phosphoprotein  VASP  VASP_HUMAN 39,811.10 99.90% 2 2 3 6.32% VKQELLEEVKK 95.00% 3.66 0.425 1.32 671.8996 1,341.78 1,342.79 2
 SAMPLE 3 Vasodilator-stimulated phosphoprotein  VASP  VASP_HUMAN 39,811.10 99.90% 2 2 3 6.32% VKQELLEEVKK 95.00% 2.73 0.341 0 672.4011 1,342.79 1,342.79 2
 SAMPLE 3 Vasodilator-stimulated phosphoprotein  VASP  VASP_HUMAN 39,811.10 99.90% 2 2 3 6.32% VQIYHNPTANSFR 95.00% 3.77 0.546 4.14 773.8917 1,545.77 1,546.78 2
 SAMPLE 3R Vasodilator-stimulated phosphoprotein  VASP  VASP_HUMAN 39,811.10 99.80% 2 2 4 6.32% VKQELLEEVKK 95.00% 3.63 0.433 2.96 671.8991 1,341.78 1,342.79 2
 SAMPLE 3R Vasodilator-stimulated phosphoprotein  VASP  VASP_HUMAN 39,811.10 99.80% 2 2 4 6.32% VKQELLEEVKK 95.00% 3.41 0.362 1.43 671.9011 1,341.79 1,342.79 2
 SAMPLE 3R Vasodilator-stimulated phosphoprotein  VASP  VASP_HUMAN 39,811.10 99.80% 2 2 4 6.32% VQIYHNPTANSFR 95.00% 3.36 0.549 5.42 773.89 1,545.76 1,546.78 2
 SAMPLE 3R Vasodilator-stimulated phosphoprotein  VASP  VASP_HUMAN 39,811.10 99.80% 2 2 4 6.32% VQIYHNPTANSFR 95.00% 3.22 0.479 2.34 773.8909 1,545.77 1,546.78 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% FDAYcFK 95.00% 2.62 0.29 0 c5: Carbamidomethyl (+57.02) 475.7091 949.4025 950.4083 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% FDAYcFK 95.00% 2.57 0.238 0 c5: Carbamidomethyl (+57.02) 475.71 949.4043 950.4083 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LLASDAGLYR 95.00% 2.91 0.404 1.92 539.7989 1,077.58 1,078.59 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LLASDAGLYR 95.00% 2.66 0.434 2.8 539.8 1,077.58 1,078.59 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LLASDAGLYR 95.00% 3 0.418 2.48 539.8003 1,077.58 1,078.59 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LLASDAGLYR 95.00% 2.79 0.406 2.62 539.8003 1,077.58 1,078.59 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LLASDAGLYR 95.00% 2.31 0.319 1.92 539.8004 1,077.59 1,078.59 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LLASDAGLYR 95.00% 3.25 0.462 2.32 539.8008 1,077.59 1,078.59 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LLASDAGLYR 95.00% 2.41 0.508 0 539.8034 1,077.59 1,078.59 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% AQcGGGLLGVR 95.00% 3.06 0.318 0 c3: Carbamidomethyl (+57.02) 544.77 1,087.52 1,087.57 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% AQcGGGLLGVR 95.00% 2.97 0.311 1.15 c3: Carbamidomethyl (+57.02) 544.7705 1,087.53 1,087.57 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% AATSRYTLNFEAAQK 95.00% 2.69 0.366 0 557.6219 1,669.84 1,670.85 3
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% AATSRYTLNFEAAQK 95.00% 2.73 0.267 0 557.6229 1,669.85 1,670.85 3
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% AATSRYTLNFEAAQK 95.00% 2.77 0.298 0 557.9575 1,670.85 1,670.85 3
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% YTLNFEAAQK 95.00% 2.05 0.349 2.02 592.802 1,183.59 1,184.60 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% VSVPTHPEAVGDASLTVVK 95.00% 2.34 0.399 0 636.3497 1,906.03 1,906.03 3
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% VSVPTHPEAVGDASLTVVK 95.00% 3.02 0.45 0.959 636.3506 1,906.03 1,906.03 3
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% VSVPTHPEAVGDASLTVVK 95.00% 3.49 0.399 2.8 636.3508 1,906.03 1,906.03 3
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% VSVPTHPEAVGDASLTVVK 95.00% 2.82 0.457 0 636.3511 1,906.03 1,906.03 3
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% VSVPTHPEAVGDASLTVVK 95.00% 3.11 0.539 1.33 636.3514 1,906.03 1,906.03 3
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% VSVPTHPEAVGDASLTVVK 95.00% 2.33 0.409 0 636.3516 1,906.03 1,906.03 3
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% VSVPTHPEAVGDASLTVVK 95.00% 3.11 0.52 0 636.3516 1,906.03 1,906.03 3
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% VSVPTHPEAVGDASLTVVK 95.00% 2.38 0.306 0 636.352 1,906.03 1,906.03 3
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.17 0.483 3.51 657.8633 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.58 0.55 3.4 657.8638 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.85 0.474 3.8 657.8639 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.66 0.531 2.85 657.8639 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.68 0.536 2.68 657.864 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.27 0.483 3.06 657.864 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.75 0.559 2.68 657.864 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.54 0.489 3.72 657.864 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 2.18 0.322 1.8 657.864 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.77 0.511 3.28 657.8643 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.94 0.462 2.74 657.8644 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 2.8 0.433 2.77 657.8644 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.32 0.417 2.06 657.8645 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.01 0.478 2.52 657.8646 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.91 0.513 2.85 657.8647 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.19 0.419 3.06 657.8648 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 2.59 0.34 2.18 657.8649 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 2.21 0.38 0 657.8656 1,313.72 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.42 0.523 4.21 657.866 1,313.72 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% LATVGELQAAWR 95.00% 3.15 0.408 3.09 657.8662 1,313.72 1,314.72 2 RS2_HUMAN
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% ETTVLVAQNGNIK 95.00% 2.2 0 2 694.3753 1,386.74 1,386.76 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% AATSRYTLNFEAAQK 95.00% 3.73 0.34 2.64 836.4322 1,670.85 1,670.85 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% AATSRYTLNFEAAQK 95.00% 3.92 0.418 3.39 836.4342 1,670.85 1,670.85 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% VSVPTHPEAVGDASLTVVK 95.00% 4.81 0.598 4.08 953.5197 1,905.02 1,906.03 2
 SAMPLE 4 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 8 10 48 2.56% VSVPTHPEAVGDASLTVVK 95.00% 4.56 0.593 4.16 954.0148 1,906.01 1,906.03 2
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LLASDAGLYR 95.00% 2.34 0.342 2.54 539.8012 1,077.59 1,078.59 2
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% AQcGGGLLGVR 95.00% 3.72 0.41 2.4 c3: Carbamidomethyl (+57.02) 544.2896 1,086.56 1,087.57 2
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% AQcGGGLLGVR 95.00% 3.8 0.332 1.82 c3: Carbamidomethyl (+57.02) 544.2898 1,086.56 1,087.57 2
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% AATSRYTLNFEAAQK 95.00% 2.2 0.267 0 557.6226 1,669.84 1,670.85 3
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% AATSRYTLNFEAAQK 95.00% 2.48 0.39 0 557.623 1,669.85 1,670.85 3
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% YTLNFEAAQK 95.00% 2.36 0.337 1.19 592.8017 1,183.59 1,184.60 2
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% YTLNFEAAQK 95.00% 1.97 0.375 1.52 592.8036 1,183.59 1,184.60 2
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% VSVPTHPEAVGDASLTVVK 95.00% 3.1 0.505 0 636.0159 1,905.02 1,906.03 3
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% VSVPTHPEAVGDASLTVVK 95.00% 2.21 0.318 0 636.351 1,906.03 1,906.03 3
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% VSVPTHPEAVGDASLTVVK 95.00% 3.39 0.335 0 636.3519 1,906.03 1,906.03 3
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 3.73 0.517 4.19 657.863 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 1.98 0.254 1.38 657.8633 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 2.52 0.384 1.52 657.8633 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 3.35 0.521 3.6 657.8635 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 2.42 0.468 2.21 657.8638 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 3.32 0.526 4.48 657.864 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 2.58 0.369 1.96 657.8641 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 3.32 0.486 2.38 657.8643 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 3.39 0.469 3.47 657.8644 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 3.59 0.456 3.82 657.8644 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 3.85 0.518 3.18 657.8652 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 2.31 0.281 1.42 657.8656 1,313.72 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 2.43 0.308 2.28 657.8659 1,313.72 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 2.57 0.349 2.3 658.3656 1,314.72 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% LATVGELQAAWR 95.00% 2.45 0.257 1.96 658.3689 1,314.72 1,314.72 2 RS2_HUMAN
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% AATSRYTLNFEAAQK 95.00% 3.57 0.376 3 835.9304 1,669.85 1,670.85 2
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% AATSRYTLNFEAAQK 95.00% 3.7 0.381 3.43 835.9341 1,669.85 1,670.85 2
 SAMPLE 4R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 6 8 28 1.97% VSVPTHPEAVGDASLTVVK 95.00% 4.78 0.601 4.51 954.0229 1,906.03 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ITEEFLGK 95.00% 2.04 0.292 0 468.7551 935.4945 936.5044 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ITEEFLGK 95.00% 2.11 0.235 0 468.7561 935.4966 936.5044 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ITEEFLGK 95.00% 2.07 0.241 0 468.7564 935.4971 936.5044 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ITEEFLGK 95.00% 2 0.257 0 468.7566 935.4975 936.5044 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAK 95.00% 1.59 0.235 1.4 471.7309 941.4461 942.4573 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAK 95.00% 2 0.271 2.14 471.731 941.4463 942.4573 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAK 95.00% 1.77 0.317 1.96 471.7325 941.4493 942.4573 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFK 95.00% 2.4 0.296 0 c5: Carbamidomethyl (+57.02) 475.7063 949.397 950.4083 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFK 95.00% 2.5 0.178 0 c5: Carbamidomethyl (+57.02) 475.7065 949.3973 950.4083 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFK 95.00% 2.27 0.178 0 c5: Carbamidomethyl (+57.02) 475.7067 949.3978 950.4083 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFK 95.00% 2.36 0.207 0 c5: Carbamidomethyl (+57.02) 475.7069 949.3981 950.4083 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFK 95.00% 2.5 0.205 0 c5: Carbamidomethyl (+57.02) 475.707 949.3983 950.4083 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFK 95.00% 2.45 0.174 0 c5: Carbamidomethyl (+57.02) 475.707 949.3984 950.4083 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFK 95.00% 2.53 0.25 0 c5: Carbamidomethyl (+57.02) 475.7073 949.3989 950.4083 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFK 95.00% 2.4 0.244 0 c5: Carbamidomethyl (+57.02) 475.7073 949.399 950.4083 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFK 95.00% 2.25 0.229 0 c5: Carbamidomethyl (+57.02) 475.7076 949.3996 950.4083 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% MFEHDFR 95.00% 2.17 0.277 0 491.2159 980.4162 981.4253 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YEINSLIR 95.00% 2.6 0.297 1.64 504.2782 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YEINSLIR 95.00% 2.74 0.303 1.18 504.2785 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YEINSLIR 95.00% 2.86 0.346 1.72 504.2786 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YEINSLIR 95.00% 2.83 0.337 1.44 504.2793 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YEINSLIR 95.00% 2.5 0.256 0 504.2795 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YEINSLIR 95.00% 2.59 0.335 0 504.2798 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YEINSLIR 95.00% 2.56 0.331 1.35 504.2799 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YEINSLIR 95.00% 2.78 0.31 0 504.2809 1,006.55 1,007.55 2 TITIN_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YEINSLIR 95.00% 2.18 0.195 1.19 504.7705 1,007.53 1,007.55 2 TITIN_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YEINSLIR 95.00% 2.03 0.156 1.46 504.7707 1,007.53 1,007.55 2 TITIN_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YEINSLIR 95.00% 2.36 0.255 0 504.7708 1,007.53 1,007.55 2 TITIN_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 2.61 0.347 2.17 539.7945 1,077.57 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 2.65 0.352 2.43 539.7946 1,077.57 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 2.37 0.326 2.19 539.7971 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 2.88 0.466 2.46 539.7971 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 3.17 0.556 3.68 539.7971 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 2.25 0.203 2.7 539.7973 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 3.29 0.476 2.74 539.7973 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 3.36 0.595 2.43 539.7973 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 3.44 0.578 2.72 539.7973 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 3.45 0.582 3.33 539.7975 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 3.14 0.496 3.64 539.7976 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 3.37 0.485 2.18 539.7978 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 3.39 0.552 3.42 539.7979 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 2.51 0.424 4.05 539.7986 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 3.48 0.521 3.24 539.7998 1,077.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 3.34 0.575 3.64 539.8003 1,077.59 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 94.70% 1.89 0 1.38 539.8007 1,077.59 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 1.89 0.536 0 539.8053 1,077.60 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 2.45 0.364 2.51 540.2969 1,078.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 2.31 0.331 1.48 540.2974 1,078.58 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LLASDAGLYR 95.00% 2.12 0.423 2.42 540.3065 1,078.60 1,078.59 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 3.89 0.384 1.32 c3: Carbamidomethyl (+57.02) 544.286 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 3.47 0.348 1.15 c3: Carbamidomethyl (+57.02) 544.2861 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 3.97 0.404 1.34 c3: Carbamidomethyl (+57.02) 544.2861 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 3.87 0.398 1.41 c3: Carbamidomethyl (+57.02) 544.2863 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 3.89 0.384 1.74 c3: Carbamidomethyl (+57.02) 544.2865 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 3.85 0.409 1.68 c3: Carbamidomethyl (+57.02) 544.2866 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 4.02 0.387 1.82 c3: Carbamidomethyl (+57.02) 544.2867 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 3.95 0.387 1.54 c3: Carbamidomethyl (+57.02) 544.2869 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 3.85 0.39 1.41 c3: Carbamidomethyl (+57.02) 544.2871 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 3.52 0.36 1.42 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 3.52 0.354 1.7 c3: Carbamidomethyl (+57.02) 544.2875 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 2.28 0.4 1.89 c3: Carbamidomethyl (+57.02) 544.2878 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 3.34 0.383 1.34 c3: Carbamidomethyl (+57.02) 544.2887 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 3.43 0.382 1.68 c3: Carbamidomethyl (+57.02) 544.2893 1,086.56 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AQcGGGLLGVR 95.00% 2.3 0.333 0 c3: Carbamidomethyl (+57.02) 544.293 1,086.57 1,087.57 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.4 0.421 0 557.6185 1,669.83 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.18 0.315 1.02 557.6201 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.4 0.405 1.68 557.6202 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 2.78 0.372 0 557.6204 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.61 0.401 1.29 557.6205 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.1 0.396 0 557.6205 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.09 0.356 1.2 557.6205 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.17 0.403 0 557.6207 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.13 0.423 1.13 557.6208 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.28 0.354 1.96 557.6208 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.42 0.397 1.38 557.6208 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.02 0.347 1.15 557.6212 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.4 0.355 1.13 557.6212 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.3 0.281 1.44 557.6215 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.07 0.411 1.52 557.6216 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.4 0.207 0 557.6222 1,669.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.27 0.364 0 557.6235 1,669.85 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 2.75 0.304 0 557.624 1,669.85 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.03 0.358 0 557.625 1,669.85 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.5 0.283 1.1 557.9542 1,670.84 1,670.85 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% DLKETTVLVAQNGNIK 95.00% 2.93 0.158 0.959 581.9871 1,742.94 1,742.97 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% DLKETTVLVAQNGNIK 95.00% 3.13 0.205 2.29 581.9873 1,742.94 1,742.97 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% DLKETTVLVAQNGNIK 95.00% 4.41 0.374 1.31 581.9888 1,742.94 1,742.97 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% DLKETTVLVAQNGNIK 95.00% 4.17 0.34 1.77 581.9892 1,742.94 1,742.97 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFKPK 95.00% 2.99 0.446 1.77 c5: Carbamidomethyl (+57.02) 588.2797 1,174.54 1,175.56 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFKPK 95.00% 2.95 0.434 0 c5: Carbamidomethyl (+57.02) 588.2801 1,174.54 1,175.56 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFKPK 95.00% 3.05 0.408 1.55 c5: Carbamidomethyl (+57.02) 588.2801 1,174.54 1,175.56 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFKPK 95.00% 2.98 0.346 1.38 c5: Carbamidomethyl (+57.02) 588.2803 1,174.55 1,175.56 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFKPK 95.00% 2.83 0.369 1.62 c5: Carbamidomethyl (+57.02) 588.2805 1,174.55 1,175.56 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFKPK 95.00% 2.77 0.344 1.74 c5: Carbamidomethyl (+57.02) 588.2807 1,174.55 1,175.56 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFKPK 95.00% 2.99 0.441 1.48 c5: Carbamidomethyl (+57.02) 588.2807 1,174.55 1,175.56 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFKPK 95.00% 2.68 0.417 1.28 c5: Carbamidomethyl (+57.02) 588.2809 1,174.55 1,175.56 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FDAYcFKPK 95.00% 2.72 0.364 1.41 c5: Carbamidomethyl (+57.02) 588.2809 1,174.55 1,175.56 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YTLNFEAAQK 95.00% 3.15 0.491 3.04 592.7994 1,183.58 1,184.60 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YTLNFEAAQK 95.00% 2.83 0.411 1.89 592.8001 1,183.58 1,184.60 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YTLNFEAAQK 95.00% 3.12 0.495 2.28 592.8002 1,183.58 1,184.60 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YTLNFEAAQK 95.00% 2.69 0.497 1.4 592.8003 1,183.59 1,184.60 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% YTLNFEAAQK 95.00% 3.06 0.53 2.09 592.8008 1,183.59 1,184.60 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LGEPNYGAEIR 95.00% 2.61 0.182 1.68 609.8083 1,217.60 1,218.61 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LGEPNYGAEIR 95.00% 3.09 0.228 1.34 609.8084 1,217.60 1,218.61 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LGEPNYGAEIR 95.00% 2.92 0.264 1.54 609.809 1,217.60 1,218.61 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LGEPNYGAEIR 95.00% 2.6 0.145 1.46 610.3112 1,218.61 1,218.61 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 3.92 0.551 2.51 636.0132 1,905.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 3.87 0.478 2.72 636.0132 1,905.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.72 0.515 3.34 636.0132 1,905.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.85 0.523 2.32 636.0133 1,905.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 3.46 0.518 2.77 636.0135 1,905.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.53 0.524 3.11 636.0142 1,905.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.39 0.515 1.96 636.0142 1,905.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 2.42 0.393 0 636.0261 1,905.05 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 3.6 0.539 2.62 636.3475 1,906.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 3.22 0.521 1.52 636.348 1,906.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 3.87 0.492 2.54 636.3481 1,906.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 2.84 0.396 1.54 636.3482 1,906.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.73 0.537 1.96 636.3484 1,906.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.12 0.581 1.68 636.3486 1,906.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.07 0.534 2.12 636.3486 1,906.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 3.82 0.523 2.68 636.3492 1,906.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.62 0.591 2 636.3493 1,906.02 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 3.51 0.472 1.47 636.3497 1,906.03 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 2.28 0.406 0 636.3528 1,906.04 1,906.03 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 2.78 0.348 1.14 c10: Carbamidomethyl (+57.02) 648.9497 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.07 0.51 3.59 c10: Carbamidomethyl (+57.02) 648.95 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.04 0.497 3.72 c10: Carbamidomethyl (+57.02) 648.9509 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 3.37 0.44 2.28 c10: Carbamidomethyl (+57.02) 648.951 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.06 0.503 2.77 c10: Carbamidomethyl (+57.02) 648.9515 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.18 0.503 1.23 c10: Carbamidomethyl (+57.02) 648.9521 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 1.62 0.311 0 c10: Carbamidomethyl (+57.02) 648.9525 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 3.11 0.443 1.82 c10: Carbamidomethyl (+57.02) 648.9535 1,943.84 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 3.03 0.389 1.6 c10: Carbamidomethyl (+57.02) 648.954 1,943.84 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.33 0.483 3.42 c10: Carbamidomethyl (+57.02) 649.2844 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.07 0.444 3.21 c10: Carbamidomethyl (+57.02) 649.2852 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.06 0.451 4 c10: Carbamidomethyl (+57.02) 649.2853 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.9 0.486 3.19 c10: Carbamidomethyl (+57.02) 649.2863 1,944.84 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.28 0.471 2.74 c10: Carbamidomethyl (+57.02) 649.2871 1,944.84 1,944.84 3 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 2.42 0.439 0 657.8584 1,313.70 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.19 0.488 1.62 657.8593 1,313.70 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.99 0.565 4.17 657.8601 1,313.70 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 2.56 0.401 2.6 657.8603 1,313.70 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.65 0.533 3.68 657.8603 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 2.38 0.278 0 657.8604 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.54 0.484 3.37 657.8604 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 4.15 0.597 3.28 657.8609 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.81 0.572 3.02 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 4.24 0.576 3.28 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.63 0.533 2.85 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.81 0.591 3.66 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.89 0.577 4.08 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.99 0.577 3.96 657.8612 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 4.05 0.542 3.36 657.8612 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 4.17 0.554 3.74 657.8613 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 4.16 0.586 3.24 657.8613 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.68 0.496 3.85 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 2.7 0.352 4.05 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 2.04 0.304 1.7 657.8618 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.79 0.577 3.13 657.8618 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 2.45 0.328 2.19 657.8619 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 2.39 0.464 1.66 657.8624 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 2.46 0.22 0 657.8626 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 2.46 0.418 2.42 657.8628 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.47 0.444 3.92 657.8631 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 2.73 0.433 0 657.8648 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 2.39 0.407 0 657.8652 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 2.28 0.271 0 657.8678 1,313.72 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 4.01 0.588 3.43 657.8697 1,313.72 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 3.72 0.554 4.11 657.8745 1,313.73 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% LATVGELQAAWR 95.00% 0 0 3.92 658.8833 1,315.75 1,314.72 2 RS2_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 3.69 0.329 3.27 c6: Carbamidomethyl (+57.02) 663.9507 1,988.83 1,989.84 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 3.56 0.268 6.48 c6: Carbamidomethyl (+57.02) 664.2859 1,989.83 1,989.84 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 2.58 0.15 1.96 c6: Carbamidomethyl (+57.02) 664.36 1,990.06 1,989.84 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ITcMNPSAYQR 95.00% 2.2 0.25 2 c3: Carbamidomethyl (+57.02) 670.8062 1,339.60 1,340.61 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ITcMNPSAYQR 95.00% 2.68 0.396 2.35 c3: Carbamidomethyl (+57.02) 670.807 1,339.60 1,340.61 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ITcMNPSAYQR 95.00% 2.17 0.343 2.09 c3: Carbamidomethyl (+57.02) 670.807 1,339.60 1,340.61 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ITcMNPSAYQR 95.00% 2.88 0.505 2.96 c3: Carbamidomethyl (+57.02) 670.8072 1,339.60 1,340.61 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ITcMNPSAYQR 95.00% 2.95 0.355 2.12 c3: Carbamidomethyl (+57.02) 670.8076 1,339.60 1,340.61 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 3.28 0.494 3 693.8811 1,385.75 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 3.85 0.466 2.85 693.8831 1,385.75 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.65 0.204 2.47 694.373 1,386.73 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.67 0.25 2.64 694.3734 1,386.73 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.69 0.253 2.12 694.3737 1,386.73 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.5 0.163 2.33 694.3739 1,386.73 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.59 0.155 1.8 694.3739 1,386.73 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.77 0.218 1.96 694.3739 1,386.73 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.54 0.234 1.49 694.3741 1,386.73 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.72 0.215 2.48 694.3741 1,386.73 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.53 0.153 1.92 694.3741 1,386.73 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.69 0.138 1.59 694.3743 1,386.73 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.52 0.23 2 694.3745 1,386.73 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.71 0.167 2.27 694.3753 1,386.74 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.7 0.227 2.24 694.3754 1,386.74 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% ETTVLVAQNGNIK 95.00% 2.53 0.146 1.41 694.3773 1,386.74 1,386.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% GTVAcGQPPVVENAK 95.00% 4.29 0.5 1.46 c5: Carbamidomethyl (+57.02) 763.8819 1,525.75 1,526.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% GTVAcGQPPVVENAK 95.00% 3.86 0.449 0 c5: Carbamidomethyl (+57.02) 763.8835 1,525.75 1,526.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% GTVAcGQPPVVENAK 95.00% 4.27 0.471 1.57 c5: Carbamidomethyl (+57.02) 763.8837 1,525.75 1,526.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% GTVAcGQPPVVENAK 95.00% 4.35 0.496 2.66 c5: Carbamidomethyl (+57.02) 763.8849 1,525.75 1,526.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% GTVAcGQPPVVENAK 95.00% 4.5 0.495 2.72 c5: Carbamidomethyl (+57.02) 763.885 1,525.75 1,526.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% GTVAcGQPPVVENAK 95.00% 4.4 0.481 1.92 c5: Carbamidomethyl (+57.02) 763.885 1,525.75 1,526.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% GTVAcGQPPVVENAK 95.00% 4.19 0.491 2 c5: Carbamidomethyl (+57.02) 763.8851 1,525.75 1,526.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% GTVAcGQPPVVENAK 95.00% 4.38 0.482 2.34 c5: Carbamidomethyl (+57.02) 763.8852 1,525.75 1,526.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% GTVAcGQPPVVENAK 95.00% 4.03 0.474 2.17 c5: Carbamidomethyl (+57.02) 763.8853 1,525.76 1,526.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% GTVAcGQPPVVENAK 95.00% 4.35 0.473 2.44 c5: Carbamidomethyl (+57.02) 763.8855 1,525.76 1,526.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% GTVAcGQPPVVENAK 95.00% 4.39 0.504 2.92 c5: Carbamidomethyl (+57.02) 763.8856 1,525.76 1,526.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% GTVAcGQPPVVENAK 95.00% 4.37 0.485 2.17 c5: Carbamidomethyl (+57.02) 763.8864 1,525.76 1,526.76 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.31 0.29 3.44 835.4089 1,668.80 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.49 0.305 3.41 835.4099 1,668.80 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 2.94 0.223 2.49 835.4113 1,668.81 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 4.13 0.355 4.51 835.9237 1,669.83 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 4.17 0.376 3.89 835.9263 1,669.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.95 0.379 4.24 835.9264 1,669.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 4.18 0.434 4.89 835.9267 1,669.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.94 0.381 3.8 835.9272 1,669.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 4.27 0.402 4.2 835.9272 1,669.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.86 0.4 4.42 835.9273 1,669.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 4.33 0.407 3.92 835.9275 1,669.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 4.08 0.39 4.59 835.9281 1,669.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.94 0.368 3.66 835.9281 1,669.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 4 0.373 4.48 835.929 1,669.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 4.02 0.377 4 835.929 1,669.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.82 0.34 3.47 835.935 1,669.85 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.4 0.313 2.27 835.9351 1,669.85 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 4.08 0.36 5.42 836.4281 1,670.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.89 0.385 4.24 836.429 1,670.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 3.94 0.391 3.57 836.4295 1,670.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% AATSRYTLNFEAAQK 95.00% 4.18 0.36 5.36 836.4301 1,670.84 1,670.85 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% DLKETTVLVAQNGNIK 95.00% 3.22 0.127 3.8 872.4762 1,742.94 1,742.97 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% DLKETTVLVAQNGNIK 95.00% 3.24 0.0758 5.36 872.4778 1,742.94 1,742.97 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% DLKETTVLVAQNGNIK 95.00% 3.64 0.162 4.17 872.4779 1,742.94 1,742.97 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% DLKETTVLVAQNGNIK 95.00% 3.24 0.127 4.2 872.4795 1,742.94 1,742.97 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% DLKETTVLVAQNGNIK 95.00% 0 0 3.8 872.9781 1,743.94 1,742.97 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% DLKETTVLVAQNGNIK 95.00% 0 0 3.92 872.9782 1,743.94 1,742.97 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% DLKETTVLVAQNGNIK 95.00% 0 0 4.28 872.9785 1,743.94 1,742.97 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% DLKETTVLVAQNGNIK 95.00% 0 0 4.28 873.7393 1,745.46 1,742.97 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVRHPVTVAR 95.00% 4.86 0.567 3.19 c6: Carbamidomethyl (+57.02) 917.7621 2,750.26 2,750.27 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVRHPVTVAR 95.00% 3.93 0.404 1.36 c6: Carbamidomethyl (+57.02) 917.7625 2,750.26 2,750.27 3
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 2.53 0.549 2 953.4562 1,904.90 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 5.04 0.6 3.23 953.5143 1,905.01 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 5.16 0.623 4.8 953.5156 1,905.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.81 0.57 3.13 953.5157 1,905.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.66 0.572 3.72 953.5158 1,905.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 5.17 0.617 4.8 953.516 1,905.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 5.06 0.631 5.72 953.5164 1,905.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 5.16 0.622 3.13 953.5166 1,905.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.55 0.583 3 953.5185 1,905.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 3.31 0.472 3.7 953.527 1,905.04 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.24 0.548 4.12 953.5293 1,905.04 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.66 0.57 3.57 954.0168 1,906.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.98 0.565 5.2 954.0172 1,906.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.99 0.602 3.82 954.0172 1,906.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.93 0.563 4.4 954.0174 1,906.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.96 0.584 4.03 954.0175 1,906.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.95 0.539 3.89 954.0178 1,906.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.83 0.541 5.08 954.0182 1,906.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.84 0.552 4.55 954.0188 1,906.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.83 0.571 4.28 954.0188 1,906.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% VSVPTHPEAVGDASLTVVK 95.00% 4.72 0.538 3.77 954.019 1,906.02 1,906.03 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.77 0.592 5.28 c10: Carbamidomethyl (+57.02) 972.9205 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.77 0.599 4.96 c10: Carbamidomethyl (+57.02) 972.9215 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.89 0.581 4.3 c10: Carbamidomethyl (+57.02) 972.9216 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.56 0.614 3.28 c10: Carbamidomethyl (+57.02) 972.9218 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.74 0.611 4.66 c10: Carbamidomethyl (+57.02) 972.9236 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.49 0.552 3.27 c10: Carbamidomethyl (+57.02) 972.9239 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.97 0.644 5.07 c10: Carbamidomethyl (+57.02) 972.9245 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 5.09 0.598 3.48 c10: Carbamidomethyl (+57.02) 973.4218 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.8 0.606 4.6 c10: Carbamidomethyl (+57.02) 973.4223 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.94 0.624 3.68 c10: Carbamidomethyl (+57.02) 973.4226 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.95 0.538 3.7 c10: Carbamidomethyl (+57.02) 973.4228 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.6 0.519 3.55 c10: Carbamidomethyl (+57.02) 973.4229 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.68 0.608 2.8 c10: Carbamidomethyl (+57.02) 973.423 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.93 0.617 2.96 c10: Carbamidomethyl (+57.02) 973.4232 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.93 0.579 5.17 c10: Carbamidomethyl (+57.02) 973.4239 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% FTFEEAAKEcENQDAR 95.00% 4.74 0.597 4.16 c10: Carbamidomethyl (+57.02) 973.4247 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 5.63 0.52 4.96 c6: Carbamidomethyl (+57.02) 995.4178 1,988.82 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 5.83 0.514 4.43 c6: Carbamidomethyl (+57.02) 995.4185 1,988.82 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 5.58 0.537 4.77 c6: Carbamidomethyl (+57.02) 995.4199 1,988.82 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 5.96 0.518 5.85 c6: Carbamidomethyl (+57.02) 995.4205 1,988.83 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 5.79 0.535 4.4 c6: Carbamidomethyl (+57.02) 995.4218 1,988.83 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 5.51 0.525 4.74 c6: Carbamidomethyl (+57.02) 995.4221 1,988.83 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 5.67 0.539 3.96 c6: Carbamidomethyl (+57.02) 995.4226 1,988.83 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 5.88 0.517 5.64 c6: Carbamidomethyl (+57.02) 995.9222 1,989.83 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 5.85 0.529 4.39 c6: Carbamidomethyl (+57.02) 995.923 1,989.83 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 5.96 0.533 5.62 c6: Carbamidomethyl (+57.02) 995.9232 1,989.83 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 6.3 0.531 3.85 c6: Carbamidomethyl (+57.02) 995.9238 1,989.83 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 5.99 0.542 5.06 c6: Carbamidomethyl (+57.02) 995.924 1,989.83 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 4.77 0.493 4.72 c6: Carbamidomethyl (+57.02) 995.9283 1,989.84 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% NGFDQcDYGWLSDASVR 95.00% 4.98 0.504 4.85 c6: Carbamidomethyl (+57.02) 995.9305 1,989.85 1,989.84 2
 SAMPLE 1 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 19 23 249 6.15% QEIESETTSEEQIQEEK 95.00% 5.65 0.488 4.85 1,019.46 2,036.91 2,036.92 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ITEEFLGK 95.00% 1.96 0.261 0 468.7545 935.4933 936.5044 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ITEEFLGK 95.00% 2.03 0.229 0 468.7551 935.4945 936.5044 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ITEEFLGK 95.00% 2.08 0.283 0 468.7557 935.4958 936.5044 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ITEEFLGK 95.00% 2.08 0.299 0 468.7557 935.4958 936.5044 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ITEEFLGK 95.00% 1.85 0.317 0 468.7568 935.4979 936.5044 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAK 95.00% 1.9 0.327 1.47 471.7314 941.4471 942.4573 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAK 95.00% 1.88 0.336 2.54 471.7318 941.448 942.4573 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAK 95.00% 1.96 0.304 2.29 471.732 941.4483 942.4573 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAK 95.00% 1.81 0.279 0 471.7322 941.4488 942.4573 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAK 95.00% 2.06 0.364 2.08 471.7323 941.4489 942.4573 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAK 95.00% 1.74 0.284 2.1 471.7324 941.4491 942.4573 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAK 95.00% 1.78 0.293 2 471.7327 941.4497 942.4573 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAK 95.00% 1.66 0.205 1.57 471.7327 941.4498 942.4573 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFK 95.00% 2.36 0.246 0 c5: Carbamidomethyl (+57.02) 475.7065 949.3974 950.4083 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFK 95.00% 2.4 0.299 0 c5: Carbamidomethyl (+57.02) 475.7066 949.3975 950.4083 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFK 95.00% 2.51 0.254 0 c5: Carbamidomethyl (+57.02) 475.7067 949.3977 950.4083 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFK 95.00% 2.46 0.215 0 c5: Carbamidomethyl (+57.02) 475.7067 949.3977 950.4083 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFK 95.00% 2.52 0.227 0 c5: Carbamidomethyl (+57.02) 475.7068 949.3979 950.4083 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFK 95.00% 2.56 0.228 0 c5: Carbamidomethyl (+57.02) 475.707 949.3983 950.4083 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFK 95.00% 2.22 0.233 0 c5: Carbamidomethyl (+57.02) 475.7072 949.3987 950.4083 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFK 95.00% 2.31 0.304 0 c5: Carbamidomethyl (+57.02) 475.7072 949.3988 950.4083 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFK 95.00% 2.55 0.171 0 c5: Carbamidomethyl (+57.02) 475.7074 949.3991 950.4083 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFK 95.00% 2.24 0.28 0 c5: Carbamidomethyl (+57.02) 475.7075 949.3994 950.4083 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFK 95.00% 2.53 0.265 0 c5: Carbamidomethyl (+57.02) 475.708 949.4004 950.4083 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% MFEHDFR 95.00% 2.09 0.256 0 491.2152 980.4148 981.4253 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% MFEHDFR 95.00% 2.4 0.397 0 491.2156 980.4156 981.4253 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% MFEHDFR 95.00% 2.43 0.433 0 491.2159 980.4162 981.4253 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YEINSLIR 95.00% 2.01 0.267 0 504.2785 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YEINSLIR 95.00% 2.25 0.227 0 504.2787 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YEINSLIR 95.00% 2.39 0.323 1.54 504.2797 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YEINSLIR 95.00% 2.31 0.208 0 504.2797 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YEINSLIR 95.00% 2.81 0.279 0 504.2798 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YEINSLIR 95.00% 2.64 0.295 1.18 504.2802 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YEINSLIR 95.00% 2.46 0.255 0 504.7702 1,007.52 1,007.55 2 TITIN_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YEINSLIR 95.00% 2.01 0.241 1.55 504.7705 1,007.53 1,007.55 2 TITIN_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VGHDYQWIGLNDK 95.00% 2.25 0.242 0 515.5872 1,543.74 1,544.75 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 1.92 0.331 2.17 539.2807 1,076.55 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 1.91 0.23 3.52 539.2815 1,076.55 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.37 0.228 3.16 539.282 1,076.55 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.19 0.383 2.25 539.2825 1,076.55 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.2 0.346 3.85 539.2826 1,076.55 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.73 0.485 2.15 539.7958 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.45 0.539 2.29 539.7968 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.57 0.526 2.39 539.7969 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.14 0.276 0 539.7969 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.94 0.474 3.19 539.797 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.45 0.507 2.62 539.797 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.48 0.597 2.55 539.797 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.26 0.519 2.26 539.7972 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.94 0.457 2.37 539.7973 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.54 0.507 2.46 539.7973 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.21 0.497 1.96 539.7973 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.89 0.447 2.74 539.7975 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.09 0.498 3.08 539.7977 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.51 0.452 3.55 539.7977 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.22 0.512 3.14 539.7977 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.09 0.528 1.96 539.7978 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.44 0.502 2.46 539.7978 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.95 0.512 3.11 539.798 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 1.98 0.361 1.7 539.7987 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.16 0.432 0 539.7989 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.8 0.449 1.82 539.7991 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.55 0.435 2.21 539.7997 1,077.58 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.34 0.575 2.62 539.8003 1,077.59 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 1.89 0.536 0 539.8053 1,077.60 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 2.49 0.348 3.14 539.9859 1,077.96 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LLASDAGLYR 95.00% 3.07 0.462 2.92 540.3047 1,078.59 1,078.59 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 2.3 0.263 0 c3: Carbamidomethyl (+57.02) 544.2841 1,086.55 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.92 0.351 1.85 c3: Carbamidomethyl (+57.02) 544.2859 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.26 0.425 1.7 c3: Carbamidomethyl (+57.02) 544.2859 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.79 0.389 1.55 c3: Carbamidomethyl (+57.02) 544.2862 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.92 0.373 1.47 c3: Carbamidomethyl (+57.02) 544.2863 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.77 0.398 1.55 c3: Carbamidomethyl (+57.02) 544.2865 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.53 0.402 1.54 c3: Carbamidomethyl (+57.02) 544.2865 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.92 0.316 1.6 c3: Carbamidomethyl (+57.02) 544.2866 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.93 0.393 1.74 c3: Carbamidomethyl (+57.02) 544.2866 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.82 0.405 1.68 c3: Carbamidomethyl (+57.02) 544.2867 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.74 0.426 1.33 c3: Carbamidomethyl (+57.02) 544.2867 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.94 0.391 1.59 c3: Carbamidomethyl (+57.02) 544.2868 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.69 0.41 1.68 c3: Carbamidomethyl (+57.02) 544.2868 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.94 0.368 2.4 c3: Carbamidomethyl (+57.02) 544.287 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 3.54 0.401 2.07 c3: Carbamidomethyl (+57.02) 544.2876 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 2.8 0.367 0 c3: Carbamidomethyl (+57.02) 544.2879 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AQcGGGLLGVR 95.00% 2.91 0.374 1.36 c3: Carbamidomethyl (+57.02) 544.2889 1,086.56 1,087.57 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% KGTVAcGQPPVVENAK 95.00% 2.71 0.355 0 c6: Carbamidomethyl (+57.02) 552.2896 1,653.85 1,654.86 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.1 0.409 0 557.6188 1,669.83 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 2.84 0.324 0 557.6201 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.6 0.434 1.39 557.6201 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 2.97 0.323 1.34 557.6204 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 2.78 0.372 0 557.6204 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.01 0.326 1.54 557.6205 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.08 0.324 1.39 557.6205 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 2.94 0.363 1.62 557.6205 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.21 0.358 0 557.6205 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.4 0.309 0.959 557.6206 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 2.69 0.376 1.11 557.6206 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.07 0.386 2.1 557.6207 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.43 0.288 1.05 557.6207 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.02 0.279 0 557.6208 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.32 0.378 0 557.6209 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.23 0.328 0 557.621 1,669.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.03 0.358 0 557.625 1,669.85 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.54 0.445 1.85 557.9546 1,670.84 1,670.85 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% DLKETTVLVAQNGNIK 95.00% 4.29 0.328 1.28 581.988 1,742.94 1,742.97 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% DLKETTVLVAQNGNIK 95.00% 3.16 0.155 1.25 581.9887 1,742.94 1,742.97 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% DLKETTVLVAQNGNIK 95.00% 3.58 0.19 1.8 581.9888 1,742.94 1,742.97 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% DLKETTVLVAQNGNIK 95.00% 3.67 0.375 2 581.989 1,742.94 1,742.97 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% DLKETTVLVAQNGNIK 95.00% 3.3 0.157 0 581.9902 1,742.95 1,742.97 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFKPK 95.00% 2.92 0.344 1.57 c5: Carbamidomethyl (+57.02) 588.28 1,174.54 1,175.56 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFKPK 95.00% 2.93 0.412 1.82 c5: Carbamidomethyl (+57.02) 588.2801 1,174.54 1,175.56 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFKPK 95.00% 2.56 0.322 1.43 c5: Carbamidomethyl (+57.02) 588.2801 1,174.54 1,175.56 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFKPK 95.00% 2.44 0.437 0 c5: Carbamidomethyl (+57.02) 588.2803 1,174.55 1,175.56 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFKPK 95.00% 3.05 0.388 1.57 c5: Carbamidomethyl (+57.02) 588.2804 1,174.55 1,175.56 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFKPK 95.00% 2.72 0.419 1.27 c5: Carbamidomethyl (+57.02) 588.2805 1,174.55 1,175.56 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFKPK 95.00% 2.77 0.388 0 c5: Carbamidomethyl (+57.02) 588.2807 1,174.55 1,175.56 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFKPK 95.00% 2.97 0.377 1.21 c5: Carbamidomethyl (+57.02) 588.2807 1,174.55 1,175.56 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FDAYcFKPK 95.00% 2.64 0.313 1.31 c5: Carbamidomethyl (+57.02) 588.2809 1,174.55 1,175.56 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YTLNFEAAQK 95.00% 2.7 0.462 1.46 592.7986 1,183.58 1,184.60 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YTLNFEAAQK 95.00% 2.95 0.558 3.03 592.7995 1,183.58 1,184.60 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YTLNFEAAQK 95.00% 2.57 0.418 1.59 592.7995 1,183.58 1,184.60 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YTLNFEAAQK 95.00% 2.77 0.407 1.28 592.7997 1,183.58 1,184.60 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YTLNFEAAQK 95.00% 3.12 0.525 2.59 592.7998 1,183.58 1,184.60 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YTLNFEAAQK 95.00% 3.07 0.522 2.68 592.7998 1,183.58 1,184.60 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YTLNFEAAQK 95.00% 2.73 0.461 1.74 592.8 1,183.58 1,184.60 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YTLNFEAAQK 95.00% 3.2 0.545 2.6 592.8003 1,183.59 1,184.60 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YTLNFEAAQK 95.00% 2.94 0.473 2.55 592.8003 1,183.59 1,184.60 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% YTLNFEAAQK 95.00% 2.93 0.515 1.62 593.3019 1,184.59 1,184.60 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LGEPNYGAEIR 95.00% 2.99 0.294 1.7 609.808 1,217.60 1,218.61 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LGEPNYGAEIR 95.00% 3.01 0.292 1.17 609.809 1,217.60 1,218.61 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 3.57 0.329 1.51 636.0115 1,905.01 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.37 0.538 2.82 636.0131 1,905.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 2.57 0.348 1.12 636.0132 1,905.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.22 0.502 2.1 636.0139 1,905.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 3.41 0.546 1.46 636.0139 1,905.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 3.96 0.599 2.33 636.014 1,905.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 2.76 0.414 0 636.0145 1,905.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 2.74 0.474 0 636.0146 1,905.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 2.42 0.393 0 636.0261 1,905.05 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 2.47 0.346 0 636.347 1,906.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 3.21 0.535 3.49 636.3471 1,906.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.55 0.527 2.66 636.348 1,906.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.52 0.579 2.41 636.3481 1,906.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.43 0.529 3.1 636.3484 1,906.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.29 0.542 3.96 636.3484 1,906.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.27 0.541 1.7 636.3485 1,906.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 3.96 0.528 1.92 636.3486 1,906.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 3.67 0.522 2.27 636.3486 1,906.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 3.17 0.548 2.62 636.3488 1,906.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 2.95 0.337 0 636.3491 1,906.02 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 2.28 0.406 0 636.3528 1,906.04 1,906.03 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.29 0.493 2.14 c10: Carbamidomethyl (+57.02) 648.9496 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 3.81 0.474 2.62 c10: Carbamidomethyl (+57.02) 648.9507 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 3.92 0.472 2.01 c10: Carbamidomethyl (+57.02) 648.9507 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.2 0.503 3.17 c10: Carbamidomethyl (+57.02) 648.951 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 3.83 0.454 0 c10: Carbamidomethyl (+57.02) 648.9512 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 3.43 0.52 2 c10: Carbamidomethyl (+57.02) 648.9521 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 1.62 0.311 0 c10: Carbamidomethyl (+57.02) 648.9525 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 3.77 0.453 1.02 c10: Carbamidomethyl (+57.02) 648.9527 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 3.03 0.389 1.32 c10: Carbamidomethyl (+57.02) 648.954 1,943.84 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.04 0.503 2.6 c10: Carbamidomethyl (+57.02) 649.2848 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 2.07 0.271 0 c10: Carbamidomethyl (+57.02) 649.2851 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 3.19 0.269 1 c10: Carbamidomethyl (+57.02) 649.2858 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.23 0.469 2.2 c10: Carbamidomethyl (+57.02) 649.2864 1,944.84 1,944.84 3 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.19 0.488 1.72 657.8593 1,313.70 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 2.35 0.189 1.46 657.8604 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.78 0.593 3.44 657.8606 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.7 0.519 4.23 657.8606 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.53 0.496 3.3 657.8607 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 2.69 0.473 2.44 657.8609 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.27 0.48 3.19 657.861 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.63 0.533 2.89 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.81 0.508 4.21 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.89 0.577 3.43 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 2.33 0.373 1.96 657.8613 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.74 0.57 3.74 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 2.75 0.349 3.48 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.41 0.454 3.27 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.61 0.587 4.08 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.42 0.455 4.16 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 2.89 0.464 2.77 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.77 0.516 3.64 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.72 0.595 3.28 657.8616 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 4.01 0.563 4.32 657.8617 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.78 0.568 4.77 657.8617 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.25 0.391 3.51 657.8621 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 2.39 0.464 1.64 657.8624 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 2.92 0.559 3.39 657.864 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 4.01 0.588 3.47 657.8697 1,313.72 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 4 0.512 3.38 657.8735 1,313.73 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.65 0.559 3.92 657.8736 1,313.73 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.35 0.522 3.48 657.8742 1,313.73 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 3.42 0.474 4.38 657.8748 1,313.73 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% LATVGELQAAWR 95.00% 0 0 3.55 658.9796 1,315.94 1,314.72 2 RS2_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 3.9 0.242 1.38 c6: Carbamidomethyl (+57.02) 664.2847 1,989.83 1,989.84 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 2.94 0.284 1.74 c6: Carbamidomethyl (+57.02) 664.285 1,989.83 1,989.84 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 3.32 0.329 1.41 c6: Carbamidomethyl (+57.02) 664.2852 1,989.83 1,989.84 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 3.67 0.286 0 c6: Carbamidomethyl (+57.02) 664.2858 1,989.83 1,989.84 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ITcMNPSAYQR 95.00% 2.73 0.425 2.19 c3: Carbamidomethyl (+57.02) 670.8069 1,339.60 1,340.61 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ITcMNPSAYQR 95.00% 3.34 0.437 2.89 c3: Carbamidomethyl (+57.02) 670.8078 1,339.60 1,340.61 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ITcMNPSAYQR 95.00% 2.5 0.207 3.07 c3: Carbamidomethyl (+57.02) 670.8089 1,339.60 1,340.61 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ITcMNPSAYQR 95.00% 3.54 0.531 1.7 c3: Carbamidomethyl (+57.02) 671.3089 1,340.60 1,340.61 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 3.14 0.395 2.21 693.882 1,385.75 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 2.28 0.376 0 693.8824 1,385.75 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 2.67 0.131 1.8 694.373 1,386.73 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 2.7 0.181 2.02 694.3736 1,386.73 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 2.58 0.116 2.07 694.3737 1,386.73 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 2.63 0.22 2.51 694.3741 1,386.73 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 2.65 0.193 3.04 694.3742 1,386.73 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 2.62 0.162 1.85 694.3742 1,386.73 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 2.54 0.246 2.85 694.3744 1,386.73 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 2.69 0.258 2.4 694.3744 1,386.73 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 2.6 0.217 2.11 694.3745 1,386.73 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 2.68 0.252 2 694.3763 1,386.74 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% ETTVLVAQNGNIK 95.00% 2.53 0.146 1.28 694.3773 1,386.74 1,386.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% GTVAcGQPPVVENAK 95.00% 3.87 0.461 3.11 c5: Carbamidomethyl (+57.02) 763.8822 1,525.75 1,526.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% GTVAcGQPPVVENAK 95.00% 4.1 0.493 2.96 c5: Carbamidomethyl (+57.02) 763.8825 1,525.75 1,526.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% GTVAcGQPPVVENAK 95.00% 2.64 0.345 0 c5: Carbamidomethyl (+57.02) 763.8825 1,525.75 1,526.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% GTVAcGQPPVVENAK 95.00% 4.15 0.489 3.64 c5: Carbamidomethyl (+57.02) 763.8843 1,525.75 1,526.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% GTVAcGQPPVVENAK 95.00% 3.95 0.442 4.47 c5: Carbamidomethyl (+57.02) 763.8847 1,525.75 1,526.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% GTVAcGQPPVVENAK 95.00% 3.68 0.397 1.89 c5: Carbamidomethyl (+57.02) 763.8847 1,525.75 1,526.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% GTVAcGQPPVVENAK 95.00% 4.44 0.472 2.7 c5: Carbamidomethyl (+57.02) 763.885 1,525.75 1,526.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% GTVAcGQPPVVENAK 95.00% 4.45 0.506 3.06 c5: Carbamidomethyl (+57.02) 763.8852 1,525.75 1,526.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% GTVAcGQPPVVENAK 95.00% 4.23 0.502 3.14 c5: Carbamidomethyl (+57.02) 763.8852 1,525.75 1,526.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% GTVAcGQPPVVENAK 95.00% 4.31 0.523 3.17 c5: Carbamidomethyl (+57.02) 763.8859 1,525.76 1,526.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% GTVAcGQPPVVENAK 95.00% 4.07 0.457 2.22 c5: Carbamidomethyl (+57.02) 763.8863 1,525.76 1,526.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% GTVAcGQPPVVENAK 95.00% 4.11 0.447 3.55 c5: Carbamidomethyl (+57.02) 763.8865 1,525.76 1,526.76 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.96 0.386 3.66 835.9265 1,669.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 4.23 0.361 3.64 835.9268 1,669.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.8 0.368 3.85 835.927 1,669.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 4.22 0.393 3.74 835.927 1,669.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.95 0.394 3.1 835.9273 1,669.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.76 0.292 3.68 835.9275 1,669.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.99 0.351 4 835.9275 1,669.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.86 0.349 3.8 835.9281 1,669.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 4.21 0.384 3.59 835.9281 1,669.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 4.11 0.36 4.44 835.9291 1,669.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.82 0.34 2.96 835.935 1,669.85 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.4 0.313 2.31 835.9351 1,669.85 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 4.04 0.371 5 836.4281 1,670.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 4.13 0.394 3.92 836.4285 1,670.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 4.13 0.346 4.74 836.4289 1,670.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.89 0.324 3.92 836.43 1,670.84 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% AATSRYTLNFEAAQK 95.00% 3.89 0.39 3.6 836.4312 1,670.85 1,670.85 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% DLKETTVLVAQNGNIK 95.00% 3.11 0.152 4.31 872.4768 1,742.94 1,742.97 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% DLKETTVLVAQNGNIK 95.00% 3.57 0.186 4.48 872.4776 1,742.94 1,742.97 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% DLKETTVLVAQNGNIK 95.00% 3.81 0.212 4.92 872.4777 1,742.94 1,742.97 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% DLKETTVLVAQNGNIK 95.00% 4.07 0.223 4.23 872.4788 1,742.94 1,742.97 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% DLKETTVLVAQNGNIK 95.00% 0 0 3.82 872.9782 1,743.94 1,742.97 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVRHPVTVAR 95.00% 2.85 0.301 0 c6: Carbamidomethyl (+57.02) 917.7631 2,750.27 2,750.27 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVRHPVTVAR 95.00% 3.86 0.49 1.26 c6: Carbamidomethyl (+57.02) 917.7633 2,750.27 2,750.27 3
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 3.75 0.458 3.21 953.5127 1,905.01 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.71 0.559 4.26 953.5147 1,905.01 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 5.09 0.626 4.32 953.5151 1,905.01 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.94 0.592 4.89 953.5154 1,905.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.75 0.53 5.92 953.5155 1,905.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.83 0.618 2.35 953.5161 1,905.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.74 0.626 4.17 953.5166 1,905.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.89 0.563 5.59 953.5171 1,905.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.69 0.625 4.15 953.5171 1,905.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 3.31 0.472 4.62 953.527 1,905.04 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.24 0.548 4.36 953.5293 1,905.04 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 5.12 0.567 6.74 954.0165 1,906.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.56 0.577 4.57 954.0167 1,906.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 5.11 0.603 5.38 954.0175 1,906.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.67 0.575 4.96 954.0175 1,906.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 5.05 0.606 5.19 954.0176 1,906.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.81 0.587 6.01 954.0177 1,906.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 5.09 0.625 4.49 954.0179 1,906.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% VSVPTHPEAVGDASLTVVK 95.00% 4.61 0.605 3.72 954.0182 1,906.02 1,906.03 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.89 0.603 3.92 c10: Carbamidomethyl (+57.02) 972.9201 1,943.82 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.81 0.6 5.92 c10: Carbamidomethyl (+57.02) 972.9209 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.83 0.613 4.8 c10: Carbamidomethyl (+57.02) 972.9211 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.92 0.586 5.2 c10: Carbamidomethyl (+57.02) 972.9212 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.65 0.593 5.55 c10: Carbamidomethyl (+57.02) 972.9213 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.94 0.616 4.64 c10: Carbamidomethyl (+57.02) 972.9214 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.46 0.593 3.82 c10: Carbamidomethyl (+57.02) 972.9224 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.98 0.649 4.24 c10: Carbamidomethyl (+57.02) 972.9229 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.69 0.611 5.62 c10: Carbamidomethyl (+57.02) 972.9233 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.93 0.589 3.96 c10: Carbamidomethyl (+57.02) 973.4217 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.82 0.606 3.39 c10: Carbamidomethyl (+57.02) 973.4218 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.82 0.587 3.85 c10: Carbamidomethyl (+57.02) 973.4225 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.67 0.628 4.74 c10: Carbamidomethyl (+57.02) 973.4236 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.64 0.612 2.92 c10: Carbamidomethyl (+57.02) 973.4237 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.58 0.529 3.85 c10: Carbamidomethyl (+57.02) 973.4244 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% FTFEEAAKEcENQDAR 95.00% 4.87 0.622 3 c10: Carbamidomethyl (+57.02) 973.4264 1,944.84 1,944.84 2 DESM_HUMAN
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 5.75 0.514 5.11 c6: Carbamidomethyl (+57.02) 995.419 1,988.82 1,989.84 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 5.82 0.508 5.47 c6: Carbamidomethyl (+57.02) 995.4193 1,988.82 1,989.84 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 5.57 0.516 5.15 c6: Carbamidomethyl (+57.02) 995.4195 1,988.82 1,989.84 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 5.89 0.527 5.17 c6: Carbamidomethyl (+57.02) 995.4226 1,988.83 1,989.84 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 5.51 0.528 4.6 c6: Carbamidomethyl (+57.02) 995.9218 1,989.83 1,989.84 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 5.82 0.55 3.64 c6: Carbamidomethyl (+57.02) 995.9223 1,989.83 1,989.84 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 5.74 0.532 3.46 c6: Carbamidomethyl (+57.02) 995.9229 1,989.83 1,989.84 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 5.96 0.535 4.77 c6: Carbamidomethyl (+57.02) 995.9232 1,989.83 1,989.84 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 5.63 0.534 4.82 c6: Carbamidomethyl (+57.02) 995.9236 1,989.83 1,989.84 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 6.25 0.538 5.52 c6: Carbamidomethyl (+57.02) 995.9237 1,989.83 1,989.84 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 5.73 0.498 3.29 c6: Carbamidomethyl (+57.02) 995.9241 1,989.83 1,989.84 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% NGFDQcDYGWLSDASVR 95.00% 5.81 0.503 4.17 c6: Carbamidomethyl (+57.02) 995.9242 1,989.83 1,989.84 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% QEIESETTSEEQIQEEK 95.00% 5.59 0.51 4 1,019.46 2,036.91 2,036.92 2
 SAMPLE 1R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 21 25 262 6.57% QEIESETTSEEQIQEEK 95.00% 5.85 0.502 6.49 1,019.46 2,036.91 2,036.92 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ITEEFLGK 95.00% 2.34 0.309 0 468.7551 935.4945 936.5044 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ITEEFLGK 95.00% 2.01 0.345 0 468.7555 935.4954 936.5044 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAK 95.00% 2.1 0.289 1.77 471.7314 941.4472 942.4573 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAK 95.00% 1.92 0.313 0 471.7318 941.4479 942.4573 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAK 95.00% 1.94 0.256 1.3 471.7318 941.4479 942.4573 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAK 95.00% 1.91 0.323 1.28 471.7318 941.4479 942.4573 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAK 95.00% 1.95 0.299 1.4 471.7321 941.4485 942.4573 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAK 95.00% 1.77 0.275 1.72 471.7321 941.4486 942.4573 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAK 95.00% 1.84 0.3 0 471.7322 941.4488 942.4573 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAK 95.00% 1.85 0.22 2.52 471.7327 941.4498 942.4573 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.51 0.251 0 c5: Carbamidomethyl (+57.02) 475.7065 949.3974 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.27 0.183 0 c5: Carbamidomethyl (+57.02) 475.7065 949.3974 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.64 0.292 0 c5: Carbamidomethyl (+57.02) 475.7066 949.3976 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.63 0.24 0 c5: Carbamidomethyl (+57.02) 475.7067 949.3978 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.46 0.29 0 c5: Carbamidomethyl (+57.02) 475.7068 949.398 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.56 0.291 0 c5: Carbamidomethyl (+57.02) 475.7069 949.3981 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.48 0.279 0 c5: Carbamidomethyl (+57.02) 475.7071 949.3985 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.35 0.218 0 c5: Carbamidomethyl (+57.02) 475.7071 949.3986 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.48 0.166 0 c5: Carbamidomethyl (+57.02) 475.7072 949.3987 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.43 0.198 0 c5: Carbamidomethyl (+57.02) 475.7072 949.3988 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.51 0.264 0 c5: Carbamidomethyl (+57.02) 475.7072 949.3988 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.49 0.279 0 c5: Carbamidomethyl (+57.02) 475.7073 949.3989 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFK 95.00% 2.45 0.288 0 c5: Carbamidomethyl (+57.02) 475.7073 949.399 950.4083 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YEINSLIR 95.00% 2.85 0.283 0 504.2787 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YEINSLIR 95.00% 2.05 0.273 0 504.2788 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YEINSLIR 95.00% 2.49 0.298 0 504.2788 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YEINSLIR 95.00% 2.72 0.301 0 504.2791 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YEINSLIR 95.00% 3.03 0.28 0 504.2792 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YEINSLIR 95.00% 2.27 0.313 0 504.2793 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YEINSLIR 95.00% 2.34 0.296 1.36 504.2795 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YEINSLIR 95.00% 2.18 0.26 0 504.2797 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YEINSLIR 95.00% 2.22 0.262 0 504.619 1,007.22 1,007.55 2 TITIN_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VGHDYQWIGLNDK 95.00% 2.22 0.221 0 515.5859 1,543.73 1,544.75 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VGHDYQWIGLNDK 95.00% 2.86 0.31 0 515.586 1,543.73 1,544.75 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 2.91 0.478 1.6 539.7975 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.37 0.504 2.1 539.7975 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.15 0.485 2.62 539.7975 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.46 0.583 1.82 539.7977 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.12 0.497 1.82 539.7977 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.64 0.547 2.77 539.7978 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.41 0.491 1.64 539.7978 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 2.87 0.448 2.28 539.7978 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.7 0.517 2.2 539.7979 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.93 0.518 2.28 539.798 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 2.35 0.378 2.17 539.7981 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.46 0.59 2.09 539.7982 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.6 0.532 2.52 539.7982 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.61 0.536 1.92 539.7982 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.28 0.528 1.12 539.7987 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 3.02 0.475 1.82 539.7992 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 1.81 0.248 1.28 539.7998 1,077.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LLASDAGLYR 95.00% 2.73 0.466 2.19 540.2998 1,078.58 1,078.59 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 2.26 0.255 0 c3: Carbamidomethyl (+57.02) 544.2841 1,086.55 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 1.92 0.287 0 c3: Carbamidomethyl (+57.02) 544.2848 1,086.55 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 3.64 0.436 1.66 c3: Carbamidomethyl (+57.02) 544.2865 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 3.86 0.338 1.51 c3: Carbamidomethyl (+57.02) 544.2865 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 2.57 0.358 0 c3: Carbamidomethyl (+57.02) 544.2868 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 3.94 0.38 1.55 c3: Carbamidomethyl (+57.02) 544.2868 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 3.75 0.347 0 c3: Carbamidomethyl (+57.02) 544.287 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 3.61 0.402 1.77 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 3.9 0.385 1.7 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 3.95 0.39 0 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 3.93 0.326 1.66 c3: Carbamidomethyl (+57.02) 544.2874 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 3.21 0.394 0 c3: Carbamidomethyl (+57.02) 544.2877 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 2.31 0.292 0 c3: Carbamidomethyl (+57.02) 544.2882 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 2.83 0.248 1.66 c3: Carbamidomethyl (+57.02) 544.2883 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 2.3 0.242 1.15 c3: Carbamidomethyl (+57.02) 544.2892 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 2.31 0.308 0 c3: Carbamidomethyl (+57.02) 544.2895 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 2.4 0.428 0 c3: Carbamidomethyl (+57.02) 544.2896 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 2.76 0.355 0 c3: Carbamidomethyl (+57.02) 544.2896 1,086.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 2.58 0.231 0 c3: Carbamidomethyl (+57.02) 544.2912 1,086.57 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 2.56 0.245 0 c3: Carbamidomethyl (+57.02) 544.2917 1,086.57 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 2.14 0.26 0 c3: Carbamidomethyl (+57.02) 544.2918 1,086.57 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AQcGGGLLGVR 95.00% 2.64 0.227 0 c3: Carbamidomethyl (+57.02) 544.7868 1,087.56 1,087.57 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% KGTVAcGQPPVVENAK 95.00% 2.65 0.378 2.32 c6: Carbamidomethyl (+57.02) 552.291 1,653.85 1,654.86 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.1 0.341 0 557.6202 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.54 0.378 0 557.6204 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 2.99 0.338 0 557.6205 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.1 0.347 0 557.6206 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.24 0.403 0 557.6207 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.46 0.324 0 557.6207 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.33 0.361 1.48 557.6209 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.34 0.339 0 557.6209 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.5 0.309 0 557.621 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.3 0.383 1.15 557.6211 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.11 0.386 2.08 557.6211 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.45 0.313 1.3 557.6212 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.08 0.38 0 557.6212 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.45 0.362 1.64 557.6212 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 2.97 0.296 1.41 557.6214 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.83 0.425 1.48 557.6214 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 2.35 0.281 0 557.622 1,669.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.1 0.338 0 557.9545 1,670.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 2.7 0.233 0 557.9545 1,670.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.23 0.348 0 557.9553 1,670.84 1,670.85 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 2.8 0.184 0.921 581.9871 1,742.94 1,742.97 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 3.59 0.253 0 581.9875 1,742.94 1,742.97 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 3.43 0.236 1.31 581.9879 1,742.94 1,742.97 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 2.86 0.195 0 581.9879 1,742.94 1,742.97 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 3.01 0.26 0 581.9886 1,742.94 1,742.97 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFKPK 95.00% 2.99 0.423 1.15 c5: Carbamidomethyl (+57.02) 588.2807 1,174.55 1,175.56 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFKPK 95.00% 2.83 0.459 0 c5: Carbamidomethyl (+57.02) 588.281 1,174.55 1,175.56 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FDAYcFKPK 95.00% 1.97 0.237 1.42 c5: Carbamidomethyl (+57.02) 588.8079 1,175.60 1,175.56 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YTLNFEAAQK 95.00% 2.75 0.482 2.4 592.8 1,183.58 1,184.60 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YTLNFEAAQK 95.00% 2.93 0.457 1.96 592.8 1,183.58 1,184.60 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YTLNFEAAQK 95.00% 2.79 0.446 1.89 592.8 1,183.58 1,184.60 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YTLNFEAAQK 95.00% 3.13 0.506 1.72 592.8001 1,183.58 1,184.60 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YTLNFEAAQK 95.00% 2.78 0.386 1.74 592.8003 1,183.58 1,184.60 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YTLNFEAAQK 95.00% 3.15 0.552 3.32 592.8003 1,183.59 1,184.60 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YTLNFEAAQK 95.00% 3.08 0.515 2.22 592.8004 1,183.59 1,184.60 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% YTLNFEAAQK 95.00% 2.92 0.517 2.1 592.8007 1,183.59 1,184.60 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LGEPNYGAEIR 95.00% 2.84 0.255 2.23 610.3004 1,218.59 1,218.61 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LGEPNYGAEIR 95.00% 2.95 0.202 4.21 610.3012 1,218.59 1,218.61 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 3.4 0.492 2.28 636.0128 1,905.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.05 0.535 2.48 636.0134 1,905.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 3.79 0.52 2 636.0135 1,905.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.46 0.556 0 636.0137 1,905.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.32 0.537 2.72 636.0137 1,905.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.08 0.535 2.8 636.014 1,905.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 2.53 0.441 0 636.0141 1,905.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.83 0.588 2.8 636.0142 1,905.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 3.73 0.533 2.23 636.0143 1,905.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 3.28 0.475 1.72 636.3474 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 3.31 0.448 3.01 636.3475 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.07 0.475 2.32 636.3476 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 3.87 0.462 0 636.3477 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.26 0.503 0.959 636.3481 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 3.89 0.498 1.96 636.3481 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.12 0.525 1.68 636.3481 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 3.29 0.497 3.96 636.3482 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 3.69 0.524 2.8 636.3486 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 3.55 0.486 3.55 636.3486 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.2 0.544 1.68 636.349 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.16 0.502 1.85 636.349 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 3.28 0.46 1.89 636.3491 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.57 0.508 3.36 636.3491 1,906.02 1,906.03 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 3.88 0.479 3.1 c10: Carbamidomethyl (+57.02) 648.95 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.05 0.503 3.2 c10: Carbamidomethyl (+57.02) 648.951 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 3.49 0.465 3.89 c10: Carbamidomethyl (+57.02) 648.9512 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.45 0.539 3.77 c10: Carbamidomethyl (+57.02) 648.9515 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 3.72 0.46 2.46 c10: Carbamidomethyl (+57.02) 648.9517 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.12 0.501 2.72 c10: Carbamidomethyl (+57.02) 648.9518 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.78 0.484 3.15 c10: Carbamidomethyl (+57.02) 649.284 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 3.49 0.523 2.36 c10: Carbamidomethyl (+57.02) 649.2852 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.2 0.463 3.6 c10: Carbamidomethyl (+57.02) 649.2854 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 3.4 0.445 3.02 c10: Carbamidomethyl (+57.02) 649.2855 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 3.28 0.33 2.8 c10: Carbamidomethyl (+57.02) 649.2857 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 3.05 0.493 1.55 c10: Carbamidomethyl (+57.02) 649.2864 1,944.84 1,944.84 3 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 3.12 0.458 2.64 657.8596 1,313.70 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.69 0.449 2.96 657.8605 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 3.77 0.595 3.68 657.8608 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 3.8 0.568 2.72 657.8608 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 4.11 0.566 3.37 657.8609 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.54 0.288 1.85 657.8608 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 4.11 0.554 3.4 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 3.99 0.578 3.66 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 4.03 0.563 3.7 657.8612 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.66 0.379 0 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 4.14 0.564 3.54 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 3.71 0.567 2.8 657.8618 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 4.14 0.572 2.89 657.8619 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 4.05 0.57 3.82 657.8619 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 3.85 0.592 3.51 657.862 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 4.2 0.53 3.36 657.862 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 3.99 0.518 3.57 657.862 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 3.8 0.508 2.74 657.8621 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 4.18 0.541 3 657.8622 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 4.07 0.507 3.77 657.8623 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.23 0.235 0 657.8629 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.36 0.326 0 657.8633 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.29 0.249 2.51 657.8637 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 3.76 0.57 3.08 657.8651 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.88 0.367 0 657.8652 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.6 0.347 2.19 657.8653 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 3.03 0.503 2.22 657.8659 1,313.72 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.32 0.397 0 657.8684 1,313.72 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 3.48 0.498 2.82 658.34 1,314.66 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.3 0.392 0 658.3596 1,314.70 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.06 0.485 0 658.3603 1,314.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.73 0.39 2.48 658.3629 1,314.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% LATVGELQAAWR 95.00% 2.22 0.528 0 658.3665 1,314.72 1,314.72 2 RS2_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 4.27 0.43 2.85 c6: Carbamidomethyl (+57.02) 664.2841 1,989.83 1,989.84 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 4.49 0.354 5.14 c6: Carbamidomethyl (+57.02) 664.2849 1,989.83 1,989.84 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 3.34 0.355 1.64 c6: Carbamidomethyl (+57.02) 664.2854 1,989.83 1,989.84 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 3.41 0.479 2.52 693.8833 1,385.75 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 3.51 0.428 3.06 693.8836 1,385.75 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.49 0.215 2.54 694.3737 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.69 0.186 1.74 694.3738 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.59 0.174 2.54 694.3739 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.53 0.138 2.37 694.3741 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.82 0.216 2.27 694.3742 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.71 0.214 2.72 694.3742 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.44 0.187 2.49 694.3742 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.69 0.179 2.68 694.3745 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.67 0.158 2.49 694.3745 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.6 0.169 1.89 694.3746 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.7 0.183 2.29 694.3748 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.66 0.164 2.43 694.3748 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.67 0.203 2.46 694.3751 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.63 0.162 3.36 694.3752 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.73 0.194 2.7 694.3752 1,386.73 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.68 0.208 2.27 694.3756 1,386.74 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% ETTVLVAQNGNIK 95.00% 2.32 0.184 2.7 694.3761 1,386.74 1,386.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% GTVAcGQPPVVENAK 95.00% 4.46 0.461 3.96 c5: Carbamidomethyl (+57.02) 763.885 1,525.75 1,526.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% GTVAcGQPPVVENAK 95.00% 3.68 0.481 3.57 c5: Carbamidomethyl (+57.02) 763.8853 1,525.76 1,526.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% GTVAcGQPPVVENAK 95.00% 4.55 0.488 3.14 c5: Carbamidomethyl (+57.02) 763.886 1,525.76 1,526.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% GTVAcGQPPVVENAK 95.00% 3.97 0.453 3.77 c5: Carbamidomethyl (+57.02) 763.886 1,525.76 1,526.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% GTVAcGQPPVVENAK 95.00% 4.16 0.454 2.38 c5: Carbamidomethyl (+57.02) 763.8861 1,525.76 1,526.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% GTVAcGQPPVVENAK 95.00% 4.04 0.448 3.37 c5: Carbamidomethyl (+57.02) 763.8862 1,525.76 1,526.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% GTVAcGQPPVVENAK 95.00% 4.25 0.476 3.34 c5: Carbamidomethyl (+57.02) 763.888 1,525.76 1,526.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% GTVAcGQPPVVENAK 95.00% 4.88 0.53 3.17 c5: Carbamidomethyl (+57.02) 764.3846 1,526.75 1,526.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% GTVAcGQPPVVENAK 95.00% 4.33 0.486 2.17 c5: Carbamidomethyl (+57.02) 764.3858 1,526.76 1,526.76 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.06 0.284 2.28 835.4082 1,668.80 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.49 0.344 4.11 835.4115 1,668.81 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.79 0.456 3.02 835.9125 1,669.81 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.98 0.408 3.55 835.9253 1,669.83 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.97 0.387 3.57 835.9256 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 4.11 0.371 4.06 835.9267 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 4.03 0.363 3.49 835.9267 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 4.13 0.412 2.72 835.9268 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 4.02 0.402 4 835.9271 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.71 0.385 3.85 835.9272 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 4.02 0.382 3.62 835.9272 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.85 0.327 3.55 835.9272 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.76 0.411 3.1 835.9273 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 4.1 0.378 3.22 835.9275 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.9 0.398 2.92 835.9277 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 4.11 0.338 3.49 835.9279 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.94 0.365 3.82 835.9281 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 4.13 0.4 3.15 835.9281 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.99 0.403 3.39 835.9287 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 4.09 0.409 3.47 835.9288 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.95 0.379 3.19 835.929 1,669.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 2.67 0.26 1.38 836.418 1,670.82 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.74 0.364 3.19 836.4279 1,670.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 4.15 0.398 3.55 836.4288 1,670.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% AATSRYTLNFEAAQK 95.00% 3.95 0.349 3.82 836.429 1,670.84 1,670.85 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 3.16 0.126 4.28 872.4756 1,742.94 1,742.97 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 3.32 0.0991 3.46 872.4759 1,742.94 1,742.97 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 3.35 0.12 4.14 872.4765 1,742.94 1,742.97 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 3.32 0.0717 4.1 872.4779 1,742.94 1,742.97 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 3.48 0.172 2.85 872.4783 1,742.94 1,742.97 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 3.48 0.173 4.48 872.4801 1,742.94 1,742.97 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 0 0 3.57 872.9793 1,743.94 1,742.97 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% DLKETTVLVAQNGNIK 95.00% 0 0 3.77 872.9795 1,743.94 1,742.97 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVRHPVTVAR 95.00% 4.98 0.52 3.2 c6: Carbamidomethyl (+57.02) 917.7615 2,750.26 2,750.27 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVRHPVTVAR 95.00% 5.32 0.58 2.66 c6: Carbamidomethyl (+57.02) 917.7634 2,750.27 2,750.27 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVRHPVTVAR 95.00% 5.01 0.602 3.07 c6: Carbamidomethyl (+57.02) 917.7643 2,750.27 2,750.27 3
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.75 0.634 4.74 953.5138 1,905.01 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.98 0.578 4.33 953.5152 1,905.01 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.79 0.61 6.11 953.5154 1,905.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.8 0.587 4.74 953.5156 1,905.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 5.22 0.605 5.77 953.5159 1,905.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.78 0.572 4.35 953.516 1,905.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.77 0.61 4.82 953.5163 1,905.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.94 0.581 4.52 953.5165 1,905.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.85 0.595 4.92 953.5166 1,905.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 5 0.62 4.09 953.5168 1,905.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 5.28 0.584 3.77 953.5172 1,905.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 5.36 0.629 5.26 953.5178 1,905.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.99 0.55 3.8 954.0158 1,906.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.89 0.527 5.66 954.0169 1,906.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.95 0.578 5.41 954.0169 1,906.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.86 0.586 6.89 954.0171 1,906.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.94 0.585 4.43 954.0172 1,906.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 5.14 0.606 3.96 954.0174 1,906.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.6 0.533 3.82 954.0177 1,906.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 5.06 0.54 5.26 954.0177 1,906.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.95 0.55 6.38 954.0177 1,906.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 5.01 0.596 3.74 954.018 1,906.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 4.82 0.556 3.55 954.0185 1,906.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% VSVPTHPEAVGDASLTVVK 95.00% 5.22 0.612 4.62 954.0187 1,906.02 1,906.03 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.89 0.584 5.1 c10: Carbamidomethyl (+57.02) 972.921 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 5.04 0.631 5.22 c10: Carbamidomethyl (+57.02) 972.9218 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 5.14 0.646 4.54 c10: Carbamidomethyl (+57.02) 972.9221 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 5.1 0.644 4.72 c10: Carbamidomethyl (+57.02) 972.9223 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.95 0.593 4.89 c10: Carbamidomethyl (+57.02) 972.9234 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.79 0.592 4.89 c10: Carbamidomethyl (+57.02) 973.4212 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.72 0.591 3.89 c10: Carbamidomethyl (+57.02) 973.4214 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 5.03 0.59 4.72 c10: Carbamidomethyl (+57.02) 973.4228 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.74 0.596 5.57 c10: Carbamidomethyl (+57.02) 973.4229 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.94 0.58 3.41 c10: Carbamidomethyl (+57.02) 973.4232 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.89 0.605 4.03 c10: Carbamidomethyl (+57.02) 973.4234 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.74 0.548 4.68 c10: Carbamidomethyl (+57.02) 973.4235 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.59 0.563 3.8 c10: Carbamidomethyl (+57.02) 973.4235 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.93 0.616 4.44 c10: Carbamidomethyl (+57.02) 973.4239 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.87 0.56 4.09 c10: Carbamidomethyl (+57.02) 973.424 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% FTFEEAAKEcENQDAR 95.00% 4.81 0.62 4.02 c10: Carbamidomethyl (+57.02) 973.4252 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.29 0.504 3.85 c6: Carbamidomethyl (+57.02) 995.4187 1,988.82 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 6.02 0.541 6.09 c6: Carbamidomethyl (+57.02) 995.4198 1,988.82 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.66 0.523 4.96 c6: Carbamidomethyl (+57.02) 995.422 1,988.83 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.5 0.503 5.28 c6: Carbamidomethyl (+57.02) 995.4229 1,988.83 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.97 0.523 4.82 c6: Carbamidomethyl (+57.02) 995.9223 1,989.83 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.91 0.526 4.27 c6: Carbamidomethyl (+57.02) 995.9223 1,989.83 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 6.06 0.526 6.2 c6: Carbamidomethyl (+57.02) 995.9224 1,989.83 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.92 0.528 5.01 c6: Carbamidomethyl (+57.02) 995.9226 1,989.83 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.79 0.553 5.96 c6: Carbamidomethyl (+57.02) 995.9226 1,989.83 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.72 0.544 4.89 c6: Carbamidomethyl (+57.02) 995.9229 1,989.83 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.77 0.524 4.52 c6: Carbamidomethyl (+57.02) 995.9234 1,989.83 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.98 0.54 4.72 c6: Carbamidomethyl (+57.02) 995.9237 1,989.83 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.75 0.504 6.07 c6: Carbamidomethyl (+57.02) 995.9238 1,989.83 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.93 0.507 5.24 c6: Carbamidomethyl (+57.02) 995.9238 1,989.83 1,989.84 2
 SAMPLE 2 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 18 22 266 5.54% NGFDQcDYGWLSDASVR 95.00% 5.95 0.513 5.06 c6: Carbamidomethyl (+57.02) 995.9258 1,989.84 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ITEEFLGK 95.00% 2.09 0.268 0 468.7546 935.4935 936.5044 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ITEEFLGK 95.00% 1.91 0.289 0 468.7554 935.4952 936.5044 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ITEEFLGK 95.00% 1.88 0.297 0 468.756 935.4963 936.5044 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAK 95.00% 1.95 0.293 1.57 471.7319 941.4482 942.4573 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAK 95.00% 1.73 0.28 1.82 471.7321 941.4485 942.4573 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAK 95.00% 1.76 0.31 0 471.7321 941.4485 942.4573 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAK 95.00% 1.91 0.324 2.24 471.7322 941.4488 942.4573 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAK 95.00% 1.76 0.267 1.66 471.7325 941.4493 942.4573 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAK 95.00% 1.93 0.261 1.92 471.7326 941.4496 942.4573 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.34 0.241 0 c5: Carbamidomethyl (+57.02) 475.706 949.3963 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.66 0.22 0 c5: Carbamidomethyl (+57.02) 475.7064 949.3971 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.56 0.214 0 c5: Carbamidomethyl (+57.02) 475.707 949.3983 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.44 0.211 0 c5: Carbamidomethyl (+57.02) 475.707 949.3984 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.45 0.275 0 c5: Carbamidomethyl (+57.02) 475.7072 949.3987 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.43 0.237 0 c5: Carbamidomethyl (+57.02) 475.7072 949.3988 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.18 0.194 0 c5: Carbamidomethyl (+57.02) 475.7073 949.3989 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.58 0.27 0 c5: Carbamidomethyl (+57.02) 475.7074 949.3991 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.27 0.245 0 c5: Carbamidomethyl (+57.02) 475.7075 949.3993 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.56 0.174 0 c5: Carbamidomethyl (+57.02) 475.7075 949.3994 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.5 0.225 0 c5: Carbamidomethyl (+57.02) 475.7075 949.3994 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.12 0.208 0 c5: Carbamidomethyl (+57.02) 475.7076 949.3995 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFK 95.00% 2.51 0.271 0 c5: Carbamidomethyl (+57.02) 475.708 949.4003 950.4083 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YEINSLIR 95.00% 2.39 0.214 0 504.2784 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YEINSLIR 95.00% 2.68 0.296 1.77 504.2785 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YEINSLIR 95.00% 2.29 0.269 1.4 504.2788 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YEINSLIR 95.00% 2.6 0.33 1.49 504.2789 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YEINSLIR 95.00% 3 0.331 0 504.2795 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 2.17 0.243 2.09 539.7954 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 2.48 0.482 1.41 539.797 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.57 0.53 1.96 539.7974 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.27 0.475 2.44 539.7974 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 2.41 0.503 1.8 539.7975 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.54 0.568 1.92 539.7975 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 2.61 0.439 0 539.7976 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.19 0.442 2.43 539.7977 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 2.92 0.461 1.92 539.7977 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.52 0.542 1.8 539.7978 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.29 0.547 3.59 539.7978 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.04 0.48 1.24 539.7978 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.43 0.598 2.13 539.7979 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.24 0.47 2.38 539.7979 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.57 0.506 1.62 539.7979 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.21 0.459 3.03 539.798 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.47 0.495 2.4 539.798 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.1 0.489 1.68 539.7981 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 2.73 0.484 2.24 539.7982 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 3.43 0.594 2.26 539.7982 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 2.81 0.434 2.21 539.7984 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 2.1 0.344 0 539.7987 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 2.41 0.382 1.89 539.7992 1,077.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 2.2 0.329 0 539.9896 1,077.96 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LLASDAGLYR 95.00% 2.62 0.413 2.59 540.2991 1,078.58 1,078.59 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.52 0.397 1.96 c3: Carbamidomethyl (+57.02) 544.286 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.33 0.425 2.77 c3: Carbamidomethyl (+57.02) 544.2861 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.41 0.376 1.92 c3: Carbamidomethyl (+57.02) 544.2863 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.59 0.375 2.7 c3: Carbamidomethyl (+57.02) 544.2864 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.84 0.358 2.74 c3: Carbamidomethyl (+57.02) 544.2864 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.84 0.398 1.74 c3: Carbamidomethyl (+57.02) 544.2865 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 4.04 0.388 1.64 c3: Carbamidomethyl (+57.02) 544.2866 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.81 0.328 1.6 c3: Carbamidomethyl (+57.02) 544.2867 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.86 0.39 2.49 c3: Carbamidomethyl (+57.02) 544.2868 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 4.02 0.378 2.19 c3: Carbamidomethyl (+57.02) 544.2868 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.96 0.377 1.59 c3: Carbamidomethyl (+57.02) 544.2869 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.5 0.42 2.09 c3: Carbamidomethyl (+57.02) 544.287 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.99 0.381 1.17 c3: Carbamidomethyl (+57.02) 544.287 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.41 0.384 1.42 c3: Carbamidomethyl (+57.02) 544.2871 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.27 0.442 2.74 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.87 0.352 1.39 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.69 0.343 1.74 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.73 0.389 2.1 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.83 0.352 1.72 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 3.82 0.387 2.14 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 4.02 0.379 1.82 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 2.54 0.299 1.57 c3: Carbamidomethyl (+57.02) 544.2881 1,086.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 2.73 0.35 1.77 c3: Carbamidomethyl (+57.02) 544.7867 1,087.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AQcGGGLLGVR 95.00% 2.92 0.237 0 c3: Carbamidomethyl (+57.02) 544.7868 1,087.56 1,087.57 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% KGTVAcGQPPVVENAK 95.00% 2.33 0.323 0 c6: Carbamidomethyl (+57.02) 552.2892 1,653.84 1,654.86 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% KGTVAcGQPPVVENAK 95.00% 2.32 0.399 0 c6: Carbamidomethyl (+57.02) 552.2913 1,653.85 1,654.86 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 2.86 0.28 0 557.6203 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.18 0.38 1.47 557.6205 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.61 0.411 0 557.6208 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 2.83 0.327 0 557.6208 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.68 0.371 0.959 557.621 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.49 0.384 2.02 557.621 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.65 0.342 0 557.6211 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.72 0.366 0 557.6211 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.57 0.348 1.27 557.6211 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.35 0.322 0 557.6212 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.35 0.356 0 557.6212 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.33 0.417 1.66 557.6213 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.25 0.388 1.11 557.6213 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.2 0.369 1.54 557.6213 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 2.84 0.36 0 557.6214 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.13 0.352 0 557.6217 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 2.36 0.189 0 557.6217 1,669.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.45 0.398 1.05 557.9548 1,670.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.14 0.383 0 557.9552 1,670.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.2 0.363 0 557.9553 1,670.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.28 0.299 0 557.9553 1,670.84 1,670.85 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% DLKETTVLVAQNGNIK 95.00% 2.86 0.144 2.09 581.9882 1,742.94 1,742.97 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFKPK 95.00% 2.67 0.436 1.62 c5: Carbamidomethyl (+57.02) 588.2802 1,174.54 1,175.56 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FDAYcFKPK 95.00% 2.51 0.361 1.77 c5: Carbamidomethyl (+57.02) 588.2816 1,174.55 1,175.56 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YTLNFEAAQK 95.00% 2 0.433 0 592.7959 1,183.58 1,184.60 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YTLNFEAAQK 95.00% 2.81 0.5 2.6 592.7993 1,183.58 1,184.60 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YTLNFEAAQK 95.00% 2.74 0.52 1.39 592.7998 1,183.58 1,184.60 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YTLNFEAAQK 95.00% 2.87 0.511 1.66 592.8002 1,183.58 1,184.60 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YTLNFEAAQK 95.00% 2.98 0.542 2.77 592.8004 1,183.59 1,184.60 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YTLNFEAAQK 95.00% 2.83 0.512 1.19 592.8004 1,183.59 1,184.60 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YTLNFEAAQK 95.00% 3.13 0.484 2.85 592.8006 1,183.59 1,184.60 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% YTLNFEAAQK 95.00% 2.08 0.378 1.46 592.8008 1,183.59 1,184.60 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.13 0.404 1.05 636.0131 1,905.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.24 0.537 4.36 636.0134 1,905.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.59 0.467 1.85 636.0139 1,905.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.59 0.571 1.36 636.014 1,905.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.58 0.552 1.74 636.0142 1,905.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.74 0.47 1.85 636.0144 1,905.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 2.87 0.452 0 636.0146 1,905.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 2.16 0.252 0 636.3455 1,906.01 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.24 0.454 0 636.3469 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.51 0.552 2.39 636.3472 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.1 0.502 1.51 636.3474 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 2.6 0.307 0 636.3477 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.79 0.53 3.68 636.3477 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.5 0.484 1.37 636.3477 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.28 0.514 3.12 636.3477 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 2.91 0.259 0 636.3479 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.7 0.445 2.48 636.348 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 2.93 0.313 0 636.3481 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.87 0.562 2.52 636.3482 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.8 0.57 2.7 636.3483 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.01 0.516 2.59 636.3483 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.01 0.459 2.72 636.3484 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.99 0.534 2.02 636.3484 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.05 0.569 3.28 636.3485 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 2.19 0.285 0 636.3486 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.35 0.567 2.51 636.3486 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.58 0.517 1.92 636.3487 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 2.2 0.411 0 636.3493 1,906.02 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 3.94 0.565 1.8 636.3499 1,906.03 1,906.03 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 2.43 0.312 1.38 c10: Carbamidomethyl (+57.02) 648.95 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.17 0.393 2.41 c10: Carbamidomethyl (+57.02) 648.9509 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.14 0.505 3.72 c10: Carbamidomethyl (+57.02) 648.9509 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 3.4 0.446 2.92 c10: Carbamidomethyl (+57.02) 648.9512 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 3.13 0.355 1.43 c10: Carbamidomethyl (+57.02) 648.9512 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 3.45 0.506 3.32 c10: Carbamidomethyl (+57.02) 648.9515 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.24 0.541 2.59 c10: Carbamidomethyl (+57.02) 648.9518 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.12 0.463 1.82 c10: Carbamidomethyl (+57.02) 648.9519 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 3.69 0.44 2.43 c10: Carbamidomethyl (+57.02) 648.9532 1,943.84 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 3.41 0.448 1.82 c10: Carbamidomethyl (+57.02) 649.2835 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 3.95 0.484 1.96 c10: Carbamidomethyl (+57.02) 649.2839 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.56 0.534 3.28 c10: Carbamidomethyl (+57.02) 649.2841 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 3.94 0.46 2.77 c10: Carbamidomethyl (+57.02) 649.2845 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.27 0.457 2.11 c10: Carbamidomethyl (+57.02) 649.2848 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.22 0.527 1.89 c10: Carbamidomethyl (+57.02) 649.2852 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.42 0.49 1.66 c10: Carbamidomethyl (+57.02) 649.2853 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.37 0.498 2.04 c10: Carbamidomethyl (+57.02) 649.2853 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 3.46 0.399 1.66 c10: Carbamidomethyl (+57.02) 649.2855 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 3.79 0.521 2.18 c10: Carbamidomethyl (+57.02) 649.2861 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.03 0.487 1.89 c10: Carbamidomethyl (+57.02) 649.2867 1,944.84 1,944.84 3 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 3.68 0.492 3.13 657.8603 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 3.72 0.532 2.92 657.8605 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 3.6 0.507 3.57 657.8606 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 4.2 0.574 3.82 657.8607 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 3.61 0.546 3.7 657.8608 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 3.79 0.589 3.82 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 3.51 0.419 2.85 657.8612 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 3.98 0.526 4.01 657.8612 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 4.15 0.564 3.77 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 3.88 0.49 3.72 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 3.24 0.516 3.25 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 3.86 0.488 3.47 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 4.07 0.536 3.57 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 4.22 0.528 3.3 657.8617 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 4.07 0.515 4.23 657.8617 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 3.67 0.53 3.11 657.8617 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 4.28 0.563 2.89 657.8618 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 3.97 0.557 3.2 657.8622 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 2.78 0.365 2.62 658.3434 1,314.67 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% LATVGELQAAWR 95.00% 2.41 0.377 1.21 658.4026 1,314.79 1,314.72 2 RS2_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 2.39 0.145 1.34 c6: Carbamidomethyl (+57.02) 664.3609 1,990.06 1,989.84 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 3.23 0.405 1.49 693.8825 1,385.75 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 3.37 0.374 2.33 693.8834 1,385.75 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.57 0.143 2.37 694.3736 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.49 0.15 2.96 694.3738 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.43 0.206 3 694.3739 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.71 0.176 1.82 694.3741 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.66 0.222 2.18 694.3742 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.64 0.193 3.24 694.3745 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 3.07 0.223 2.43 694.3745 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.61 0.175 2.1 694.3746 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.66 0.203 3.26 694.3748 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.53 0.167 2.74 694.3748 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.28 0.175 2.27 694.3749 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.71 0.225 2.7 694.375 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.68 0.215 1.8 694.3751 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.74 0.163 1.96 694.3753 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.69 0.221 2.44 694.3752 1,386.73 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% ETTVLVAQNGNIK 95.00% 2.48 0.187 2.25 694.3759 1,386.74 1,386.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% GTVAcGQPPVVENAK 95.00% 4.2 0.472 2.47 c5: Carbamidomethyl (+57.02) 763.8841 1,525.75 1,526.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% GTVAcGQPPVVENAK 95.00% 4.45 0.465 2.19 c5: Carbamidomethyl (+57.02) 763.8845 1,525.75 1,526.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% GTVAcGQPPVVENAK 95.00% 4.64 0.489 3.54 c5: Carbamidomethyl (+57.02) 763.8851 1,525.75 1,526.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% GTVAcGQPPVVENAK 95.00% 4.5 0.504 1.96 c5: Carbamidomethyl (+57.02) 763.886 1,525.76 1,526.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% GTVAcGQPPVVENAK 95.00% 3.93 0.467 2.64 c5: Carbamidomethyl (+57.02) 763.8864 1,525.76 1,526.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% GTVAcGQPPVVENAK 95.00% 3.89 0.428 2.32 c5: Carbamidomethyl (+57.02) 763.887 1,525.76 1,526.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% GTVAcGQPPVVENAK 95.00% 4.14 0.505 1.89 c5: Carbamidomethyl (+57.02) 763.8872 1,525.76 1,526.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% GTVAcGQPPVVENAK 95.00% 3.71 0.411 2.33 c5: Carbamidomethyl (+57.02) 763.8881 1,525.76 1,526.76 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.5 0.388 3.8 835.41 1,668.80 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.77 0.396 3.47 835.9259 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 4.07 0.431 3.01 835.9261 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.82 0.379 3.09 835.9272 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 4.09 0.419 3.4 835.9272 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.92 0.373 3.8 835.9273 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.99 0.41 3.46 835.9275 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.91 0.38 5.1 835.9276 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.97 0.378 2.85 835.9277 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.98 0.379 4.17 835.9278 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.85 0.364 2.8 835.9279 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.95 0.389 3.62 835.9281 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 4.21 0.392 3.38 835.9284 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.95 0.39 3.01 835.9286 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.81 0.361 3.2 835.9287 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 4.12 0.407 3.13 835.9288 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.93 0.42 3.46 835.9289 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 4 0.368 3.23 835.929 1,669.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.97 0.337 3.21 836.4289 1,670.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.91 0.353 2.72 836.4291 1,670.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% AATSRYTLNFEAAQK 95.00% 3.98 0.371 2.92 836.43 1,670.84 1,670.85 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% DLKETTVLVAQNGNIK 95.00% 3.11 0.176 3.77 872.4761 1,742.94 1,742.97 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% DLKETTVLVAQNGNIK 95.00% 3.23 0.154 4.31 872.4762 1,742.94 1,742.97 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% DLKETTVLVAQNGNIK 95.00% 2.94 0.0429 4.4 872.4785 1,742.94 1,742.97 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% DLKETTVLVAQNGNIK 95.00% 3.18 0.0897 2.48 872.4787 1,742.94 1,742.97 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% DLKETTVLVAQNGNIK 95.00% 3.69 0.244 4.48 872.479 1,742.94 1,742.97 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% DLKETTVLVAQNGNIK 95.00% 0 0 4.23 872.9749 1,743.93 1,742.97 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% DLKETTVLVAQNGNIK 95.00% 0 0 4.47 872.9792 1,743.94 1,742.97 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% DLKETTVLVAQNGNIK 95.00% 0 0 4.64 872.9793 1,743.94 1,742.97 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVRHPVTVAR 95.00% 4.72 0.56 2.43 c6: Carbamidomethyl (+57.02) 917.7637 2,750.27 2,750.27 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVRHPVTVAR 95.00% 4.5 0.56 2.17 c6: Carbamidomethyl (+57.02) 917.7639 2,750.27 2,750.27 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVRHPVTVAR 95.00% 5.02 0.599 2.59 c6: Carbamidomethyl (+57.02) 917.7668 2,750.28 2,750.27 3
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.89 0.625 4.77 953.5141 1,905.01 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.71 0.638 5.01 953.5148 1,905.01 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.89 0.615 7.48 953.5149 1,905.01 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.9 0.591 5.92 953.5151 1,905.01 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 5.04 0.609 4.4 953.5152 1,905.01 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 5.26 0.566 5.04 953.5159 1,905.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.88 0.619 4.23 953.516 1,905.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.97 0.616 4.92 953.5172 1,905.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 5.13 0.596 4.96 953.5176 1,905.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.99 0.598 4.43 954.0157 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.98 0.562 4.49 954.0163 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 5.01 0.568 4.57 954.0165 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.45 0.521 5.11 954.0166 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.75 0.581 6.07 954.0167 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.57 0.577 4.7 954.0171 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 5.05 0.59 4.77 954.0172 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.87 0.598 3.82 954.0174 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.86 0.546 7.72 954.0174 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 5.07 0.592 5.49 954.0177 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.98 0.578 6.52 954.0178 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 5.06 0.573 6.32 954.018 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.8 0.576 5.07 954.018 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.72 0.58 7.23 954.0185 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% VSVPTHPEAVGDASLTVVK 95.00% 4.91 0.557 6.21 954.0201 1,906.02 1,906.03 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.68 0.589 4.66 c10: Carbamidomethyl (+57.02) 972.9209 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.68 0.595 5.03 c10: Carbamidomethyl (+57.02) 972.9221 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.84 0.625 4.72 c10: Carbamidomethyl (+57.02) 972.9224 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.9 0.61 3.96 c10: Carbamidomethyl (+57.02) 972.9231 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.89 0.603 4.74 c10: Carbamidomethyl (+57.02) 972.9237 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.57 0.62 4.82 c10: Carbamidomethyl (+57.02) 972.9245 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.79 0.629 5.59 c10: Carbamidomethyl (+57.02) 973.4208 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.92 0.545 3.68 c10: Carbamidomethyl (+57.02) 973.422 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.88 0.567 4.44 c10: Carbamidomethyl (+57.02) 973.4227 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.77 0.615 4.29 c10: Carbamidomethyl (+57.02) 973.423 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.75 0.56 3.51 c10: Carbamidomethyl (+57.02) 973.4235 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.63 0.539 3.85 c10: Carbamidomethyl (+57.02) 973.4238 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.82 0.636 3.64 c10: Carbamidomethyl (+57.02) 973.4244 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.64 0.544 3.96 c10: Carbamidomethyl (+57.02) 973.4248 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% FTFEEAAKEcENQDAR 95.00% 4.54 0.593 3.62 c10: Carbamidomethyl (+57.02) 973.4256 1,944.84 1,944.84 2 DESM_HUMAN
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.39 0.519 4.22 c6: Carbamidomethyl (+57.02) 995.4187 1,988.82 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 4.15 0.434 2.96 c6: Carbamidomethyl (+57.02) 995.4213 1,988.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.62 0.502 4.21 c6: Carbamidomethyl (+57.02) 995.4221 1,988.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.81 0.52 4.72 c6: Carbamidomethyl (+57.02) 995.921 1,989.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.4 0.551 5.07 c6: Carbamidomethyl (+57.02) 995.922 1,989.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.86 0.521 4.8 c6: Carbamidomethyl (+57.02) 995.9222 1,989.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 6.03 0.525 6.33 c6: Carbamidomethyl (+57.02) 995.9223 1,989.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.75 0.539 5.4 c6: Carbamidomethyl (+57.02) 995.9223 1,989.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.87 0.545 5.92 c6: Carbamidomethyl (+57.02) 995.9227 1,989.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.85 0.546 3 c6: Carbamidomethyl (+57.02) 995.9228 1,989.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 6.14 0.557 4.15 c6: Carbamidomethyl (+57.02) 995.9231 1,989.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.9 0.534 4.29 c6: Carbamidomethyl (+57.02) 995.9236 1,989.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.89 0.525 3.14 c6: Carbamidomethyl (+57.02) 995.9236 1,989.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.96 0.516 6.19 c6: Carbamidomethyl (+57.02) 995.9236 1,989.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.93 0.53 4.37 c6: Carbamidomethyl (+57.02) 995.924 1,989.83 1,989.84 2
 SAMPLE 2R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 16 20 253 4.83% NGFDQcDYGWLSDASVR 95.00% 5.72 0.519 4.27 c6: Carbamidomethyl (+57.02) 995.9243 1,989.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAK 95.00% 1.9 0.237 1.08 471.7312 941.4467 942.4573 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAK 95.00% 1.92 0.338 1.72 471.7316 941.4475 942.4573 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAK 95.00% 2.13 0.383 2.06 471.7316 941.4476 942.4573 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAK 95.00% 1.94 0.247 0 471.7319 941.4482 942.4573 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAK 95.00% 1.81 0.278 1.85 471.7321 941.4486 942.4573 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAK 95.00% 1.88 0.304 0 471.7321 941.4486 942.4573 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAK 95.00% 1.9 0.221 1.48 471.7321 941.4486 942.4573 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAK 95.00% 1.8 0.327 1.52 471.7322 941.4487 942.4573 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAK 95.00% 1.63 0.251 1.57 471.7322 941.4488 942.4573 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAK 95.00% 1.83 0.303 2.89 471.7324 941.4491 942.4573 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAK 95.00% 1.94 0.255 1.28 471.7326 941.4496 942.4573 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAK 95.00% 1.75 0.313 1.39 471.7328 941.45 942.4573 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFK 95.00% 2.33 0.21 0 c5: Carbamidomethyl (+57.02) 475.7066 949.3976 950.4083 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFK 95.00% 2.4 0.203 0 c5: Carbamidomethyl (+57.02) 475.7067 949.3977 950.4083 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFK 95.00% 2.39 0.3 0 c5: Carbamidomethyl (+57.02) 475.7067 949.3978 950.4083 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFK 95.00% 2.43 0.243 0 c5: Carbamidomethyl (+57.02) 475.7068 949.398 950.4083 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFK 95.00% 2.38 0.216 0 c5: Carbamidomethyl (+57.02) 475.707 949.3983 950.4083 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFK 95.00% 2.22 0.232 0 c5: Carbamidomethyl (+57.02) 475.7072 949.3988 950.4083 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFK 95.00% 2.46 0.275 0 c5: Carbamidomethyl (+57.02) 475.7074 949.3991 950.4083 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFK 95.00% 2.4 0.288 0 c5: Carbamidomethyl (+57.02) 475.7075 949.3994 950.4083 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFK 95.00% 2.35 0.225 0 c5: Carbamidomethyl (+57.02) 475.7076 949.3995 950.4083 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFK 95.00% 2.47 0.152 0 c5: Carbamidomethyl (+57.02) 475.7081 949.4006 950.4083 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFK 95.00% 2.38 0.27 0 c5: Carbamidomethyl (+57.02) 475.7083 949.4009 950.4083 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% YEINSLIR 95.00% 2.8 0.337 1.24 504.2786 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% YEINSLIR 95.00% 2.86 0.313 1.14 504.2786 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% YEINSLIR 95.00% 2.77 0.285 1.39 504.2792 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% YEINSLIR 95.00% 2.1 0.264 0 504.2793 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% YEINSLIR 95.00% 2.62 0.322 0 504.2794 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.46 0.532 2.18 539.7962 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.34 0.585 1.92 539.7965 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.16 0.456 2.27 539.7971 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.33 0.443 1.85 539.7974 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.33 0.508 3.55 539.7975 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.38 0.512 2.28 539.7975 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.25 0.399 1.96 539.7975 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.45 0.588 2.46 539.7976 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.04 0.409 2.32 539.7976 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.41 0.531 2.85 539.7976 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 2.88 0.463 2.89 539.7977 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.28 0.591 2.28 539.7977 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.5 0.555 2.15 539.7978 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.39 0.57 2.27 539.7979 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.64 0.538 2.72 539.7979 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.35 0.467 2.64 539.798 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.45 0.581 3.23 539.7981 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 3.47 0.538 3 539.7982 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 1.7 0.275 1.21 539.7989 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 1.57 0.29 1.48 539.7995 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 1.69 0.343 0 539.7997 1,077.58 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 1.65 0.261 1.39 539.8024 1,077.59 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LLASDAGLYR 95.00% 2.6 0.396 0 540.3011 1,078.59 1,078.59 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 4.09 0.383 1.82 c3: Carbamidomethyl (+57.02) 544.2863 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 3.53 0.4 2.34 c3: Carbamidomethyl (+57.02) 544.2865 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 3.86 0.387 1.82 c3: Carbamidomethyl (+57.02) 544.2865 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 3.56 0.41 1.42 c3: Carbamidomethyl (+57.02) 544.2866 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 4.01 0.372 1.92 c3: Carbamidomethyl (+57.02) 544.2867 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 2.14 0.293 0 c3: Carbamidomethyl (+57.02) 544.2867 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 3.55 0.354 2.06 c3: Carbamidomethyl (+57.02) 544.2869 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 2.61 0.274 1.38 c3: Carbamidomethyl (+57.02) 544.287 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 2.38 0.281 1.38 c3: Carbamidomethyl (+57.02) 544.287 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 4.04 0.389 1.42 c3: Carbamidomethyl (+57.02) 544.2871 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 4 0.393 3 c3: Carbamidomethyl (+57.02) 544.2871 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 3.91 0.402 1.8 c3: Carbamidomethyl (+57.02) 544.2871 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 3.39 0.398 1.89 c3: Carbamidomethyl (+57.02) 544.2872 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 4.01 0.336 2.2 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 3.93 0.394 1.92 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 3.7 0.323 1.89 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 3.55 0.381 2.01 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 2.46 0.313 1.48 c3: Carbamidomethyl (+57.02) 544.2874 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 4.04 0.334 1.66 c3: Carbamidomethyl (+57.02) 544.2874 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 3.9 0.4 1.74 c3: Carbamidomethyl (+57.02) 544.2874 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 3.53 0.352 1.55 c3: Carbamidomethyl (+57.02) 544.2876 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 2.96 0.355 1.85 c3: Carbamidomethyl (+57.02) 544.2876 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 4.08 0.39 2.19 c3: Carbamidomethyl (+57.02) 544.2876 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 2.53 0.355 1.28 c3: Carbamidomethyl (+57.02) 544.289 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 2.31 0.285 0 c3: Carbamidomethyl (+57.02) 544.2891 1,086.56 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AQcGGGLLGVR 95.00% 2.34 0.33 0 c3: Carbamidomethyl (+57.02) 544.2911 1,086.57 1,087.57 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 2.19 0.188 0 557.6182 1,669.83 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.25 0.359 0 557.6207 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 2.4 0.335 0 557.6207 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.5 0.396 0 557.6208 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 2.94 0.381 0 557.6208 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.33 0.472 0 557.621 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.19 0.336 2.01 557.621 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.3 0.386 1.51 557.6212 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.57 0.376 1.6 557.6213 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.06 0.348 0 557.6214 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.21 0.349 1.34 557.6215 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.43 0.363 0 557.6215 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.18 0.353 0 557.6216 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 2.76 0.363 0 557.6221 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.44 0.397 0 557.6222 1,669.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.27 0.36 0 557.9545 1,670.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.15 0.373 0 557.9547 1,670.84 1,670.85 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFKPK 95.00% 2.95 0.448 1.1 c5: Carbamidomethyl (+57.02) 588.2799 1,174.54 1,175.56 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFKPK 95.00% 2.99 0.427 1.37 c5: Carbamidomethyl (+57.02) 588.2801 1,174.54 1,175.56 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFKPK 95.00% 2.89 0.413 1.17 c5: Carbamidomethyl (+57.02) 588.2807 1,174.55 1,175.56 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FDAYcFKPK 95.00% 2.92 0.376 1.22 c5: Carbamidomethyl (+57.02) 588.2808 1,174.55 1,175.56 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% YTLNFEAAQK 95.00% 2.77 0.524 1.96 592.7987 1,183.58 1,184.60 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% YTLNFEAAQK 95.00% 2.49 0.398 1.6 592.799 1,183.58 1,184.60 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% YTLNFEAAQK 95.00% 2.73 0.464 1.92 592.7998 1,183.58 1,184.60 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% YTLNFEAAQK 95.00% 3.16 0.514 2.57 592.7998 1,183.58 1,184.60 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% YTLNFEAAQK 95.00% 2.82 0.459 1.89 592.8004 1,183.59 1,184.60 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% YTLNFEAAQK 95.00% 2.81 0.4 2.47 592.8008 1,183.59 1,184.60 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% YTLNFEAAQK 95.00% 2.82 0.546 1.89 592.8017 1,183.59 1,184.60 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LGEPNYGAEIR 95.00% 2.76 0.309 0 609.8072 1,217.60 1,218.61 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 3.81 0.547 3.11 636.013 1,905.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 3.27 0.497 2.07 636.0131 1,905.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.06 0.542 3.23 636.0131 1,905.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 3.66 0.456 1.09 636.0132 1,905.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.36 0.52 2.11 636.0136 1,905.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 3.99 0.503 2.4 636.0136 1,905.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.62 0.532 3.28 636.0138 1,905.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 3.76 0.538 2.42 636.0141 1,905.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.17 0.597 2.47 636.0142 1,905.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.67 0.548 2.74 636.0143 1,905.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 3 0.44 1.46 636.015 1,905.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 3.58 0.439 1.89 636.3465 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 2.66 0.545 0 636.3466 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 2.46 0.353 0 636.3468 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.06 0.481 2.3 636.3471 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 3.59 0.548 2.7 636.3472 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.9 0.594 2.51 636.3477 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 3.82 0.48 2.22 636.3477 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 2.88 0.467 0 636.348 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 2.68 0.393 2.42 636.348 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 2.48 0.332 0 636.3481 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 3.92 0.524 3.24 636.3482 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.33 0.563 2 636.3491 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 3.48 0.509 2.92 636.3492 1,906.02 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 3.69 0.531 1.82 636.3503 1,906.03 1,906.03 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 3.81 0.532 2.68 c10: Carbamidomethyl (+57.02) 648.9509 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.21 0.487 3.25 c10: Carbamidomethyl (+57.02) 648.951 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 3.89 0.466 2.68 c10: Carbamidomethyl (+57.02) 648.9514 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.05 0.541 3.01 c10: Carbamidomethyl (+57.02) 648.9514 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 3.57 0.344 2.1 c10: Carbamidomethyl (+57.02) 648.9526 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 3.99 0.51 3.89 c10: Carbamidomethyl (+57.02) 649.2849 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 3.81 0.545 3.14 c10: Carbamidomethyl (+57.02) 649.2851 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 3.12 0.488 0 c10: Carbamidomethyl (+57.02) 649.2852 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 3.66 0.516 1.51 c10: Carbamidomethyl (+57.02) 649.2864 1,944.84 1,944.84 3 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.46 0.564 2.39 c10: Carbamidomethyl (+57.02) 649.2872 1,944.84 1,944.84 3 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 4.06 0.563 2.92 657.8607 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.77 0.589 3.36 657.8608 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 4.17 0.548 2.62 657.8609 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.94 0.566 3.21 657.861 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.76 0.524 2.96 657.8612 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.74 0.534 2.74 657.8612 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 4 0.562 2.82 657.8612 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 4.09 0.563 2.8 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 4.26 0.548 3 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.86 0.548 2.85 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 4.08 0.573 3.05 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 4.18 0.554 2.92 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 1.96 0.341 1.62 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.74 0.546 3 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 4.12 0.604 3.24 657.8616 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.81 0.581 3.32 657.8616 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.82 0.521 2.15 657.8617 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.51 0.571 2.96 657.8617 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.9 0.563 3.41 657.8617 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.73 0.501 3.06 657.8627 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 4.05 0.545 2.47 657.8628 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 2.6 0.436 0 657.8633 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.52 0.476 2.21 657.864 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 2.97 0.428 3.4 657.8642 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 2.55 0.216 0 657.8648 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 3.1 0.493 2.13 657.865 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% LATVGELQAAWR 95.00% 2.35 0.207 0 657.865 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 3.27 0.167 1.06 c6: Carbamidomethyl (+57.02) 663.9515 1,988.83 1,989.84 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 3.59 0.206 2.47 c6: Carbamidomethyl (+57.02) 664.2846 1,989.83 1,989.84 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.19 0.211 2.1 694.3722 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.44 0.146 3.64 694.3723 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.7 0.211 3.74 694.3736 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.5 0.172 2.77 694.3738 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.46 0.203 3.15 694.3738 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.7 0.249 3.35 694.3739 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.64 0.172 3.85 694.3739 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.66 0.233 2.16 694.374 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.56 0.22 2.52 694.3741 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.56 0.188 2.19 694.3741 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.19 0.19 3.17 694.3742 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.59 0.208 2.72 694.3742 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.48 0.162 2.66 694.3742 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.71 0.205 3.06 694.3744 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.77 0.209 2.72 694.3746 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.64 0.187 3.48 694.3746 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.59 0.186 2.64 694.3748 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.58 0.171 2.48 694.3751 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.53 0.195 2.8 694.3752 1,386.73 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.85 0.316 2.85 694.3756 1,386.74 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% ETTVLVAQNGNIK 95.00% 2.8 0.274 2.92 694.3756 1,386.74 1,386.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% GTVAcGQPPVVENAK 95.00% 4.05 0.457 0 c5: Carbamidomethyl (+57.02) 763.8833 1,525.75 1,526.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% GTVAcGQPPVVENAK 95.00% 4.08 0.487 2.82 c5: Carbamidomethyl (+57.02) 763.8838 1,525.75 1,526.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% GTVAcGQPPVVENAK 95.00% 4.26 0.49 1.66 c5: Carbamidomethyl (+57.02) 763.8847 1,525.75 1,526.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% GTVAcGQPPVVENAK 95.00% 4.21 0.477 3.21 c5: Carbamidomethyl (+57.02) 763.8848 1,525.75 1,526.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% GTVAcGQPPVVENAK 95.00% 4.24 0.461 1.66 c5: Carbamidomethyl (+57.02) 763.8866 1,525.76 1,526.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% GTVAcGQPPVVENAK 95.00% 2.32 0.368 0 c5: Carbamidomethyl (+57.02) 763.8876 1,525.76 1,526.76 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.12 0.301 2.1 835.4108 1,668.81 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 2.81 0.224 2.42 835.4181 1,668.82 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.05 0.335 1.6 835.9141 1,669.81 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 4.15 0.365 3.07 835.9267 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 4.12 0.407 2.62 835.9267 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 4.12 0.341 3.24 835.9272 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.67 0.403 2.82 835.9273 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.83 0.408 2.64 835.9276 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 4 0.415 2.8 835.9278 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.89 0.377 2.77 835.9278 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 4 0.395 2.85 835.9279 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.8 0.407 3.42 835.928 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.83 0.345 2.68 835.9281 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.93 0.384 2.74 835.9282 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 4.21 0.408 2.44 835.9283 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 4.12 0.418 3.28 835.9283 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.94 0.377 3.28 835.9284 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 4.02 0.401 2.74 835.9285 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 4.29 0.409 3.21 835.9288 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.91 0.349 2.82 835.9297 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.84 0.37 2.68 835.9297 1,669.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.61 0.362 2.48 836.4288 1,670.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% AATSRYTLNFEAAQK 95.00% 3.83 0.393 3.03 836.4293 1,670.84 1,670.85 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% DLKETTVLVAQNGNIK 95.00% 3.12 0.0487 3.49 872.4767 1,742.94 1,742.97 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% DLKETTVLVAQNGNIK 95.00% 3.31 0.157 4.35 872.4776 1,742.94 1,742.97 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% DLKETTVLVAQNGNIK 95.00% 3.44 0.0905 4.36 872.4782 1,742.94 1,742.97 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% DLKETTVLVAQNGNIK 95.00% 0 0 3.74 872.9774 1,743.94 1,742.97 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% DLKETTVLVAQNGNIK 95.00% 0 0 3.44 872.9778 1,743.94 1,742.97 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% DLKETTVLVAQNGNIK 94.60% 0 0 3.13 872.9811 1,743.95 1,742.97 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVRHPVTVAR 95.00% 4.72 0.587 3.42 c6: Carbamidomethyl (+57.02) 917.7605 2,750.26 2,750.27 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVRHPVTVAR 95.00% 5.21 0.547 3.6 c6: Carbamidomethyl (+57.02) 917.7609 2,750.26 2,750.27 3
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 5.17 0.609 6.38 953.515 1,905.01 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.39 0.557 4.8 953.5155 1,905.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 5.02 0.623 5.19 953.5156 1,905.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.76 0.607 3.8 953.5158 1,905.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 5.03 0.611 4.68 953.516 1,905.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.23 0.554 4.29 953.516 1,905.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.97 0.621 2.92 953.5162 1,905.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.77 0.574 4.1 953.5163 1,905.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.92 0.608 5.6 953.5164 1,905.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.92 0.568 5.26 953.5167 1,905.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.6 0.57 4.28 953.5171 1,905.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.44 0.518 5.96 954.0161 1,906.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.92 0.563 6.16 954.0164 1,906.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.91 0.579 4.74 954.0172 1,906.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.85 0.607 6.19 954.0173 1,906.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 5.03 0.575 5.7 954.0173 1,906.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.36 0.53 4.01 954.0175 1,906.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.38 0.573 5.4 954.0175 1,906.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.65 0.543 5.07 954.0177 1,906.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.91 0.564 6.24 954.018 1,906.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 5 0.613 4.92 954.0183 1,906.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% VSVPTHPEAVGDASLTVVK 95.00% 4.98 0.584 6.03 954.0198 1,906.02 1,906.03 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.98 0.645 5.85 c10: Carbamidomethyl (+57.02) 972.9214 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.87 0.644 2.92 c10: Carbamidomethyl (+57.02) 972.9214 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 5.2 0.623 4.55 c10: Carbamidomethyl (+57.02) 972.9219 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.58 0.624 5.03 c10: Carbamidomethyl (+57.02) 972.9222 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.95 0.643 4.51 c10: Carbamidomethyl (+57.02) 972.9226 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.66 0.619 3.8 c10: Carbamidomethyl (+57.02) 972.9229 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.48 0.577 3.08 c10: Carbamidomethyl (+57.02) 972.9233 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.42 0.601 3.23 c10: Carbamidomethyl (+57.02) 972.9248 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.51 0.555 3.37 c10: Carbamidomethyl (+57.02) 973.4194 1,944.82 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.84 0.607 3.92 c10: Carbamidomethyl (+57.02) 973.4221 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.75 0.568 3.17 c10: Carbamidomethyl (+57.02) 973.4225 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.64 0.634 4.62 c10: Carbamidomethyl (+57.02) 973.4226 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.78 0.594 4.01 c10: Carbamidomethyl (+57.02) 973.4237 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.96 0.605 4.96 c10: Carbamidomethyl (+57.02) 973.4252 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% FTFEEAAKEcENQDAR 95.00% 4.91 0.636 4.57 c10: Carbamidomethyl (+57.02) 973.4261 1,944.84 1,944.84 2 DESM_HUMAN
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 5.68 0.533 6.68 c6: Carbamidomethyl (+57.02) 995.4205 1,988.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 5.5 0.531 4.44 c6: Carbamidomethyl (+57.02) 995.4215 1,988.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 5.42 0.541 5.38 c6: Carbamidomethyl (+57.02) 995.4221 1,988.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 5.19 0.531 6.72 c6: Carbamidomethyl (+57.02) 995.4221 1,988.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 5.48 0.507 5.16 c6: Carbamidomethyl (+57.02) 995.4221 1,988.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 5.93 0.508 5.55 c6: Carbamidomethyl (+57.02) 995.922 1,989.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 6.11 0.543 5.06 c6: Carbamidomethyl (+57.02) 995.9227 1,989.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 5.67 0.523 6.47 c6: Carbamidomethyl (+57.02) 995.9229 1,989.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 6.02 0.523 4.96 c6: Carbamidomethyl (+57.02) 995.9229 1,989.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 5.79 0.528 6.43 c6: Carbamidomethyl (+57.02) 995.923 1,989.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 5.6 0.533 4.7 c6: Carbamidomethyl (+57.02) 995.9233 1,989.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 5.83 0.522 5.48 c6: Carbamidomethyl (+57.02) 995.9236 1,989.83 1,989.84 2
 SAMPLE 3 Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 18 248 4.89% NGFDQcDYGWLSDASVR 95.00% 5.31 0.508 4.52 c6: Carbamidomethyl (+57.02) 995.9244 1,989.83 1,989.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ITEEFLGK 95.00% 2.13 0.26 0 468.7552 935.4948 936.5044 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ITEEFLGK 95.00% 1.92 0.253 0 468.7566 935.4976 936.5044 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAK 95.00% 1.75 0.311 1.92 471.731 941.4463 942.4573 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAK 95.00% 1.89 0.289 1.55 471.7318 941.448 942.4573 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAK 95.00% 2.01 0.305 2.14 471.732 941.4484 942.4573 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAK 95.00% 1.93 0.309 0 471.7322 941.4487 942.4573 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAK 95.00% 1.74 0.295 0 471.7323 941.4489 942.4573 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAK 95.00% 1.84 0.328 1.54 471.7323 941.4489 942.4573 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAK 95.00% 1.79 0.289 1.62 471.7327 941.4497 942.4573 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAK 95.00% 1.84 0.203 1.96 471.7331 941.4505 942.4573 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAK 95.00% 2.06 0.338 1.47 471.7336 941.4515 942.4573 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFK 95.00% 2.3 0.174 0 c5: Carbamidomethyl (+57.02) 475.7063 949.3969 950.4083 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFK 95.00% 2.47 0.257 0 c5: Carbamidomethyl (+57.02) 475.7067 949.3977 950.4083 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFK 95.00% 2.48 0.21 0 c5: Carbamidomethyl (+57.02) 475.7071 949.3985 950.4083 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFK 95.00% 2.52 0.266 0 c5: Carbamidomethyl (+57.02) 475.7072 949.3987 950.4083 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFK 95.00% 2.44 0.261 0 c5: Carbamidomethyl (+57.02) 475.7072 949.3988 950.4083 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFK 95.00% 2.07 0.264 0 c5: Carbamidomethyl (+57.02) 475.7073 949.399 950.4083 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFK 95.00% 2.2 0.223 0 c5: Carbamidomethyl (+57.02) 475.7075 949.3994 950.4083 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFK 95.00% 2.41 0.241 0 c5: Carbamidomethyl (+57.02) 475.7076 949.3996 950.4083 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFK 95.00% 2.31 0.199 0 c5: Carbamidomethyl (+57.02) 475.7082 949.4008 950.4083 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFK 95.00% 2.17 0.192 0 c5: Carbamidomethyl (+57.02) 475.709 949.4024 950.4083 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% YEINSLIR 95.00% 2.17 0.204 0 504.2784 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% YEINSLIR 95.00% 2.38 0.265 1.52 504.2791 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% YEINSLIR 95.00% 2.32 0.195 0 504.2794 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% YEINSLIR 95.00% 1.71 0.242 2.17 504.2794 1,006.54 1,007.55 2 TITIN_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 2.2 0.139 2.14 539.7796 1,077.54 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.33 0.512 3.54 539.7967 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.14 0.553 2.3 539.797 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.02 0.456 2.74 539.7973 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.44 0.507 2.8 539.7973 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 2.76 0.375 2.96 539.7974 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 2.55 0.411 2.92 539.7975 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.02 0.456 2.35 539.7975 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.45 0.545 2.36 539.7976 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.39 0.522 2.62 539.7977 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.59 0.53 2.11 539.7977 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.42 0.58 2.59 539.7978 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.37 0.589 2.32 539.7978 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 2.91 0.431 3.26 539.7979 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.38 0.483 2.22 539.7979 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.59 0.555 2.54 539.798 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.07 0.454 3.7 539.798 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.48 0.537 3.8 539.7981 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 2.72 0.378 2.22 539.7981 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.4 0.606 2.15 539.7981 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 2.86 0.425 2.72 539.7981 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.49 0.542 3.34 539.7982 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 1.85 0.269 1.74 539.7982 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.54 0.547 2.82 539.7984 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 1.75 0.297 2.54 539.7984 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 2.86 0.386 2.59 539.7985 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.14 0.519 2.57 539.7986 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 3.14 0.501 2.85 539.7986 1,077.58 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 2.01 0.305 1.6 539.9873 1,077.96 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LLASDAGLYR 95.00% 2.11 0.274 1.62 540.3224 1,078.63 1,078.59 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 1.94 0.284 0 c3: Carbamidomethyl (+57.02) 544.2845 1,086.55 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.77 0.387 1.6 c3: Carbamidomethyl (+57.02) 544.2861 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.28 0.368 0 c3: Carbamidomethyl (+57.02) 544.2861 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 2.8 0.401 1.32 c3: Carbamidomethyl (+57.02) 544.2862 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.89 0.343 1.26 c3: Carbamidomethyl (+57.02) 544.2864 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.49 0.376 1.68 c3: Carbamidomethyl (+57.02) 544.2868 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.47 0.425 1.4 c3: Carbamidomethyl (+57.02) 544.2868 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.42 0.379 2.12 c3: Carbamidomethyl (+57.02) 544.2868 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.74 0.35 2.57 c3: Carbamidomethyl (+57.02) 544.2869 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.83 0.38 2.01 c3: Carbamidomethyl (+57.02) 544.287 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 4.08 0.343 1.49 c3: Carbamidomethyl (+57.02) 544.2871 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.97 0.39 1.21 c3: Carbamidomethyl (+57.02) 544.2871 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.29 0.403 1.21 c3: Carbamidomethyl (+57.02) 544.2871 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.38 0.436 2.14 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.96 0.362 1.46 c3: Carbamidomethyl (+57.02) 544.2873 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 4 0.411 1.96 c3: Carbamidomethyl (+57.02) 544.2876 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 3.77 0.365 1.29 c3: Carbamidomethyl (+57.02) 544.2879 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 2.4 0.35 1.11 c3: Carbamidomethyl (+57.02) 544.2879 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AQcGGGLLGVR 95.00% 2.59 0.369 0 c3: Carbamidomethyl (+57.02) 544.2881 1,086.56 1,087.57 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.25 0.346 0 557.6203 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 2.78 0.389 0 557.6203 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.41 0.412 1.28 557.6205 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.3 0.392 1.22 557.6207 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.27 0.409 1.12 557.621 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.22 0.338 0 557.621 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.1 0.314 0 557.621 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.32 0.345 0 557.6212 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.55 0.373 0 557.6213 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 2.75 0.303 0 557.6213 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.36 0.384 0 557.6214 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 2.4 0.301 0 557.6215 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 2.84 0.402 0 557.6218 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.36 0.35 1.72 557.6218 1,669.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.03 0.36 0 557.9534 1,670.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.29 0.337 0 557.955 1,670.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.17 0.361 0 557.9551 1,670.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.36 0.338 0 557.9552 1,670.84 1,670.85 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% DLKETTVLVAQNGNIK 95.00% 3.07 0.219 2.08 581.9882 1,742.94 1,742.97 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFKPK 95.00% 2.91 0.431 1.39 c5: Carbamidomethyl (+57.02) 588.2805 1,174.55 1,175.56 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFKPK 95.00% 2.8 0.388 1.66 c5: Carbamidomethyl (+57.02) 588.2809 1,174.55 1,175.56 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFKPK 95.00% 2.94 0.427 1.72 c5: Carbamidomethyl (+57.02) 588.2809 1,174.55 1,175.56 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FDAYcFKPK 95.00% 2.88 0.37 1.22 c5: Carbamidomethyl (+57.02) 588.2813 1,174.55 1,175.56 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% YTLNFEAAQK 95.00% 2.42 0.291 0 592.7985 1,183.58 1,184.60 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% YTLNFEAAQK 95.00% 2.57 0.464 2.14 592.7989 1,183.58 1,184.60 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% YTLNFEAAQK 95.00% 2.71 0.424 1.82 592.8004 1,183.59 1,184.60 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% YTLNFEAAQK 95.00% 2.5 0.344 0 592.8004 1,183.59 1,184.60 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LGEPNYGAEIR 95.00% 2.4 0.21 0 609.8083 1,217.60 1,218.61 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LGEPNYGAEIR 95.00% 2.7 0.231 0 609.8085 1,217.60 1,218.61 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.5 0.549 3.49 636.0132 1,905.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.73 0.561 3.23 636.0132 1,905.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.63 0.389 0 636.0132 1,905.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.62 0.523 4.36 636.0135 1,905.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.13 0.511 2.7 636.0136 1,905.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.77 0.564 2.57 636.0138 1,905.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.63 0.502 2.92 636.0139 1,905.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.8 0.461 1.77 636.0141 1,905.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.33 0.547 2.34 636.0145 1,905.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.9 0.476 1.92 636.0145 1,905.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.2 0.437 0 636.345 1,906.01 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.46 0.539 0 636.3458 1,906.01 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.29 0.499 2.48 636.3475 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 2.61 0.289 0 636.3479 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.87 0.508 2.08 636.348 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.16 0.497 2.55 636.348 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.34 0.502 1.06 636.3481 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.77 0.539 1.68 636.3481 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.75 0.523 2.03 636.3482 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.56 0.582 2.8 636.3483 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.15 0.557 0 636.3484 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.33 0.433 1.72 636.3484 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.85 0.55 3.4 636.3488 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.67 0.402 1.39 636.3488 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.96 0.477 3 636.3489 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.32 0.518 2.96 636.349 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.69 0.469 2.33 636.349 1,906.02 1,906.03 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 3.98 0.485 2.74 c10: Carbamidomethyl (+57.02) 648.9508 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 2.77 0.291 0 c10: Carbamidomethyl (+57.02) 648.951 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.22 0.559 2.77 c10: Carbamidomethyl (+57.02) 648.9521 1,943.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.21 0.531 3.09 c10: Carbamidomethyl (+57.02) 649.2826 1,944.82 1,944.84 3 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.16 0.448 2.74 c10: Carbamidomethyl (+57.02) 649.2846 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.37 0.533 1.85 c10: Carbamidomethyl (+57.02) 649.285 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 2.36 0.281 0 c10: Carbamidomethyl (+57.02) 649.2851 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.57 0.444 2.35 c10: Carbamidomethyl (+57.02) 649.2852 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.35 0.461 2.96 c10: Carbamidomethyl (+57.02) 649.2853 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 3.52 0.436 0 c10: Carbamidomethyl (+57.02) 649.2856 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 3.7 0.52 1.07 c10: Carbamidomethyl (+57.02) 649.2859 1,944.83 1,944.84 3 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 3.93 0.473 2.28 c10: Carbamidomethyl (+57.02) 649.2862 1,944.84 1,944.84 3 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 2.1 0.315 0 657.8602 1,313.70 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.45 0.517 3.72 657.8604 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.42 0.524 3.62 657.8607 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 4.17 0.5 3.37 657.8608 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.61 0.53 3.55 657.861 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.95 0.513 4.11 657.861 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.78 0.508 3.57 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.43 0.504 3.28 657.8611 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.71 0.546 4 657.8612 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 4.12 0.571 3.85 657.8612 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.83 0.571 3.39 657.8612 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.52 0.541 4.38 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.77 0.446 4 657.8614 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.82 0.549 3.72 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 4 0.565 3.72 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 1.79 0.288 2.31 657.8615 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 4.04 0.566 4.72 657.8616 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.84 0.539 3.31 657.8617 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.33 0.561 3.02 657.8618 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.95 0.566 3.59 657.8618 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 4.03 0.501 4.39 657.8618 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.72 0.48 4.89 657.862 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 4.23 0.527 3.28 657.8623 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 3.78 0.536 3.41 657.8623 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% LATVGELQAAWR 95.00% 2.6 0.436 0 657.8633 1,313.71 1,314.72 2 RS2_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 3.15 0.223 0 c6: Carbamidomethyl (+57.02) 663.9517 1,988.83 1,989.84 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 3.83 0.419 4.21 c6: Carbamidomethyl (+57.02) 664.2847 1,989.83 1,989.84 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 2.64 0.213 2.7 c6: Carbamidomethyl (+57.02) 664.2849 1,989.83 1,989.84 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 4.18 0.372 0 c6: Carbamidomethyl (+57.02) 664.2851 1,989.83 1,989.84 3
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.4 0.169 3.16 694.3733 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.96 0.272 2.85 694.3735 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.51 0.117 2.68 694.3738 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.63 0.291 2.2 694.3739 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.31 0.193 2.46 694.3741 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.77 0.205 2 694.3741 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.69 0.274 3.16 694.3741 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.78 0.225 3.28 694.3741 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.72 0.158 2.42 694.3742 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.18 0.175 1.37 694.3743 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.74 0.2 2 694.3744 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.84 0.192 2.7 694.3744 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.52 0.141 2.41 694.3747 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.43 0.163 1.38 694.3749 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.27 0.171 2.37 694.375 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.47 0.197 2.3 694.3752 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.67 0.194 2.28 694.3752 1,386.73 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.58 0.152 3.37 694.3754 1,386.74 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.23 0.181 2.96 694.3755 1,386.74 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.87 0.193 2.72 694.3761 1,386.74 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% ETTVLVAQNGNIK 95.00% 2.46 0.315 2.4 694.3764 1,386.74 1,386.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% GTVAcGQPPVVENAK 95.00% 4.24 0.51 2.82 c5: Carbamidomethyl (+57.02) 763.8835 1,525.75 1,526.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% GTVAcGQPPVVENAK 95.00% 4.27 0.482 2.74 c5: Carbamidomethyl (+57.02) 763.8852 1,525.75 1,526.76 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.83 0.393 3.74 835.9247 1,669.83 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 4.16 0.359 2.33 835.9259 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 4.36 0.368 3.14 835.9265 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 4.08 0.386 3.62 835.9268 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.93 0.459 3.49 835.9269 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.94 0.4 3.8 835.9269 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.89 0.373 3.41 835.9273 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.6 0.345 3.02 835.9275 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.96 0.412 3.74 835.9276 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 4.14 0.401 3.8 835.9278 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.81 0.334 3.7 835.9281 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.72 0.374 2.82 835.9283 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.75 0.422 2.89 835.9285 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.72 0.38 4 835.9286 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.95 0.428 3.77 835.9287 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.8 0.382 3.14 835.9303 1,669.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 4.11 0.372 3.02 836.4294 1,670.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 4.01 0.393 3.08 836.4298 1,670.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% AATSRYTLNFEAAQK 95.00% 3.82 0.402 3.02 836.4302 1,670.84 1,670.85 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% DLKETTVLVAQNGNIK 95.00% 3.19 0.11 3.74 872.4765 1,742.94 1,742.97 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% DLKETTVLVAQNGNIK 95.00% 0 0 3.48 872.9798 1,743.94 1,742.97 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 2.96 0.398 0 953.5144 1,905.01 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 5.15 0.58 4.57 953.5148 1,905.01 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.77 0.568 5.17 953.5149 1,905.01 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.7 0.607 5.89 953.516 1,905.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.97 0.579 4.77 953.5164 1,905.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.93 0.611 3.66 953.5167 1,905.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.94 0.626 4.06 953.5175 1,905.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 3.59 0.625 4.68 953.5177 1,905.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.88 0.554 4.12 954.0168 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 5.15 0.613 4.6 954.0171 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.84 0.535 5.49 954.0171 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.81 0.508 6.89 954.0177 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.97 0.586 5 954.0178 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.38 0.567 3.85 954.0179 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.86 0.542 4.8 954.0182 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.42 0.5 3.74 954.0183 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.72 0.606 3.57 954.0189 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.48 0.531 4.92 954.0191 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.35 0.559 5.17 954.0193 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.52 0.583 4.25 954.0199 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.75 0.614 5.24 954.02 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% VSVPTHPEAVGDASLTVVK 95.00% 4.51 0.552 6.05 954.0202 1,906.02 1,906.03 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.82 0.622 4.62 c10: Carbamidomethyl (+57.02) 972.9206 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.91 0.559 3.24 c10: Carbamidomethyl (+57.02) 972.9228 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.42 0.605 4.08 c10: Carbamidomethyl (+57.02) 972.9228 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.53 0.601 3.96 c10: Carbamidomethyl (+57.02) 972.9231 1,943.83 1,944.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.58 0.565 4.04 c10: Carbamidomethyl (+57.02) 972.9231 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.35 0.578 2.89 c10: Carbamidomethyl (+57.02) 972.9231 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.59 0.623 3.29 c10: Carbamidomethyl (+57.02) 972.9234 1,943.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.85 0.577 4.06 c10: Carbamidomethyl (+57.02) 973.4192 1,944.82 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.81 0.585 2.55 c10: Carbamidomethyl (+57.02) 973.4212 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.19 0.492 2.92 c10: Carbamidomethyl (+57.02) 973.4213 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 5.05 0.618 4.19 c10: Carbamidomethyl (+57.02) 973.423 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.92 0.603 2.64 c10: Carbamidomethyl (+57.02) 973.4233 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.95 0.532 3.06 c10: Carbamidomethyl (+57.02) 973.4237 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.75 0.576 3.15 c10: Carbamidomethyl (+57.02) 973.4242 1,944.83 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% FTFEEAAKEcENQDAR 95.00% 4.67 0.527 4.33 c10: Carbamidomethyl (+57.02) 973.426 1,944.84 1,944.84 2 DESM_HUMAN
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 5.57 0.504 4.11 c6: Carbamidomethyl (+57.02) 995.4176 1,988.82 1,989.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 5.5 0.524 4.82 c6: Carbamidomethyl (+57.02) 995.4212 1,988.83 1,989.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 5.97 0.504 4.59 c6: Carbamidomethyl (+57.02) 995.4214 1,988.83 1,989.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 5.39 0.549 6.06 c6: Carbamidomethyl (+57.02) 995.4229 1,988.83 1,989.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 5.42 0.509 4.72 c6: Carbamidomethyl (+57.02) 995.423 1,988.83 1,989.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 5.64 0.515 5.38 c6: Carbamidomethyl (+57.02) 995.4231 1,988.83 1,989.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 5.64 0.506 6.25 c6: Carbamidomethyl (+57.02) 995.9207 1,989.83 1,989.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 5.9 0.49 4.24 c6: Carbamidomethyl (+57.02) 995.9223 1,989.83 1,989.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 4.75 0.515 4.92 c6: Carbamidomethyl (+57.02) 995.9237 1,989.83 1,989.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 5.72 0.525 5.36 c6: Carbamidomethyl (+57.02) 995.9239 1,989.83 1,989.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 5.95 0.532 4.42 c6: Carbamidomethyl (+57.02) 995.9242 1,989.83 1,989.84 2
 SAMPLE 3R Versican core protein  VCAN  CSPG2_HUMAN 372,794.60 100.00% 15 19 233 4.92% NGFDQcDYGWLSDASVR 95.00% 5.56 0.535 5.74 c6: Carbamidomethyl (+57.02) 995.9244 1,989.83 1,989.84 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% mFGGPGTASR 95.00% 2.44 0.29 0 m1: Oxidation (+15.99) 498.7359 995.4562 996.4574 2 ATPG_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% mFGGPGTASR 95.00% 2.12 0.27 0 m1: Oxidation (+15.99) 498.7361 995.4566 996.4574 2 ATPG_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% HLREYQDLLNVK 95.00% 4.52 0.401 1.11 509.9485 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% HLREYQDLLNVK 95.00% 5.09 0.357 0 509.9492 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% HLREYQDLLNVK 95.00% 3.57 0.267 0 509.9493 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% HLREYQDLLNVK 95.00% 4.21 0.352 0 510.2816 1,527.82 1,527.83 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% HLREYQDLLNVK 95.00% 4.88 0.382 0 510.282 1,527.82 1,527.83 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% ILLAELEQLKGQGK 95.00% 1.71 0.367 0 513.9758 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% ILLAELEQLKGQGK 95.00% 1.91 0.407 0 513.9766 1,538.91 1,539.91 3 SEP11_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% ILLAELEQLKGQGK 95.00% 1.82 0.418 0 513.9767 1,538.91 1,539.91 3 SEP11_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 3.9 0.314 0 529.9384 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 4.16 0.339 1.46 529.9384 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 3.67 0.38 0 529.9385 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 2.54 0.214 0 529.9385 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 4.07 0.29 1.02 529.9387 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 4.03 0.344 1.25 529.939 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 2.82 0.235 0 529.939 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 4.05 0.333 1.28 529.9391 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 3.59 0.329 0 529.9395 1,586.80 1,587.80 3 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% FADLSEAANR 95.00% 3.67 0.472 1.59 547.2688 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% FADLSEAANR 95.00% 3.25 0.48 2.74 547.2693 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% KVESLQEEIAFLKK 95.00% 5.2 0.254 0 554.655 1,660.94 1,661.95 3
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% KVESLQEEIAFLKK 95.00% 3.25 0.153 0 554.6553 1,660.94 1,661.95 3
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% KVESLQEEIAFLKK 95.00% 4.8 0.241 1.43 554.6559 1,660.94 1,661.95 3
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% KVESLQEEIAFLKK 95.00% 4.75 0.261 0 554.6564 1,660.95 1,661.95 3
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% KVESLQEEIAFLKK 95.00% 4.23 0.262 0 554.9896 1,661.95 1,661.95 3
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% KVESLQEEIAFLKK 95.00% 4.04 0.154 1.52 554.9897 1,661.95 1,661.95 3
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% VELQELNDR 95.00% 2.84 0.362 1.37 558.2888 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% VELQELNDR 95.00% 2.64 0.272 1.6 558.2891 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% VELQELNDR 95.00% 2.51 0.324 1.55 558.2893 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% VELQELNDR 95.00% 3.25 0.355 0 558.2896 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% VELQELNDR 95.00% 3.08 0.316 0 558.2898 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% VELQELNDR 95.00% 2.87 0.328 1.24 558.29 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% VELQELNDR 95.00% 2.63 0.312 1.19 558.2901 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% VELQELNDR 95.00% 2.88 0.361 1.68 558.2902 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.21 0.364 0 561.2964 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.14 0.315 0 561.2966 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.18 0.304 0 561.2967 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.04 0.36 0 561.2968 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.22 0.387 1.42 561.2969 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.2 0.34 0 561.2969 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.11 0.39 0 561.2972 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.08 0.412 0 561.2972 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.14 0.32 0 561.2973 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.07 0.306 0 561.2973 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2 0.258 0 561.2975 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.23 0.369 0 561.2975 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.31 0.393 0 561.2975 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.16 0.353 0 561.2977 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% EYQDLLNVK 95.00% 2.15 0.39 0 561.298 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% ILLAELEQLK 95.00% 3.76 0.249 1.74 585.3621 1,168.71 1,169.71 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% ILLAELEQLK 95.00% 3.86 0.233 2.66 585.3623 1,168.71 1,169.71 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% ILLAELEQLK 95.00% 3.44 0.245 1.4 585.3623 1,168.71 1,169.71 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% ILLAELEQLK 95.00% 3.38 0.234 2.23 585.3624 1,168.71 1,169.71 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% FADLSEAANRNNDALR 95.00% 2.19 0.21 1.66 592.9626 1,775.86 1,776.86 3
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% FADLSEAANRNNDALR 95.00% 3.18 0.48 2.21 593.2946 1,776.86 1,776.86 3
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% FADLSEAANRNNDALR 95.00% 3.1 0.402 2.55 593.295 1,776.86 1,776.86 3
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% FADLSEAANRNNDALR 95.00% 3.04 0.41 1.68 593.2955 1,776.86 1,776.86 3
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% NLQEAEEWYK 95.00% 2.52 0.302 1.26 655.3075 1,308.60 1,309.61 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% NLQEAEEWYK 95.00% 2.89 0.369 1.55 655.309 1,308.60 1,309.61 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% NLQEAEEWYK 95.00% 2.92 0.32 2.21 655.8096 1,309.60 1,309.61 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% NLQEAEEWYK 95.00% 2.73 0.256 2.19 655.812 1,309.61 1,309.61 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% SLYASSPGGVYATR 95.00% 4.44 0.594 7.3 714.8613 1,427.71 1,428.71 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% SLYASSPGGVYATR 95.00% 2.52 0.387 4.8 714.8638 1,427.71 1,428.71 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% SLYASSPGGVYATR 95.00% 4.05 0.547 4.77 715.3633 1,428.71 1,428.71 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% SLYASSPGGVYATR 95.00% 4.57 0.514 5.43 715.3636 1,428.71 1,428.71 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% SLYASSPGGVYATR 95.00% 3.27 0.225 3.24 715.364 1,428.71 1,428.71 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% SLYASSPGGVYATR 95.00% 4.01 0.535 5.14 715.365 1,428.71 1,428.71 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% HLREYQDLLNVK 95.00% 3.65 0.238 0 764.4214 1,526.83 1,527.83 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% HLREYQDLLNVK 95.00% 3.52 0.173 1.51 764.9203 1,527.82 1,527.83 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% HLREYQDLLNVK 95.00% 3.67 0.23 0 764.9208 1,527.83 1,527.83 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% KVESLQEEIAFLK 95.00% 4.84 0.381 3.57 767.4315 1,532.85 1,533.85 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% KVESLQEEIAFLK 95.00% 4.86 0.321 3.96 767.4324 1,532.85 1,533.85 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% KVESLQEEIAFLK 95.00% 4.47 0.279 4 767.4328 1,532.85 1,533.85 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% KVESLQEEIAFLK 95.00% 4.15 0.261 4.21 767.4345 1,532.85 1,533.85 2
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 4.56 0.477 2.89 794.4044 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 4.29 0.459 2.29 794.4051 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 4.48 0.484 2.12 794.4054 1,586.80 1,587.80 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 4.5 0.469 3.38 794.4059 1,586.80 1,587.80 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 4.44 0.474 3.14 794.4064 1,586.80 1,587.80 2 DESM_HUMAN
 SAMPLE 4 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 13 15 81 22.10% TNEKVELQELNDR 95.00% 4.47 0.462 3 794.4074 1,586.80 1,587.80 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% mFGGPGTASR 95.00% 2.59 0.239 0 m1: Oxidation (+15.99) 498.7374 995.4592 996.4574 2 ATPG_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% HLREYQDLLNVK 95.00% 3.37 0.245 0 509.9478 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% HLREYQDLLNVK 95.00% 3.08 0.326 0 509.948 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% HLREYQDLLNVK 95.00% 4.54 0.359 0 509.9496 1,526.83 1,527.83 3 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% HLREYQDLLNVK 95.00% 4.27 0.35 0 509.95 1,526.83 1,527.83 3 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLKGQGK 95.00% 2.02 0.345 0 513.9761 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLKGQGK 95.00% 1.87 0.393 0 513.9763 1,538.91 1,539.91 3 SEP11_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLKGQGK 95.00% 1.92 0.409 0 513.9764 1,538.91 1,539.91 3 SEP11_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLKGQGK 95.00% 2.06 0.402 0 513.9766 1,538.91 1,539.91 3 SEP11_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLKGQGK 95.00% 1.93 0.275 0 513.9771 1,538.91 1,539.91 3 SEP11_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLKGQGK 95.00% 1.82 0.407 0 514.3107 1,539.91 1,539.91 3 SEP11_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 4.06 0.338 1.03 529.9381 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 4.01 0.322 0 529.9382 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 4.04 0.261 0 529.9384 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 4.84 0.395 0 529.9387 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 2.74 0.266 0 529.9389 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 3.98 0.308 0.959 529.939 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 3.14 0.307 0 529.9391 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 4.25 0.317 0 529.9397 1,586.80 1,587.80 3 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% KLLEGEESR 95.00% 2.1 0.243 0 530.7877 1,059.56 1,060.56 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% KLLEGEESR 95.00% 2.37 0.186 0 530.7914 1,059.57 1,060.56 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% FADLSEAANR 95.00% 2.35 0.437 1.77 547.2684 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% FADLSEAANR 95.00% 3.9 0.435 1.32 547.2686 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% FADLSEAANR 95.00% 3.89 0.451 0 547.2696 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% KVESLQEEIAFLKK 95.00% 4.35 0.22 0 554.6553 1,660.94 1,661.95 3
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% KVESLQEEIAFLKK 95.00% 4.22 0.166 0 554.6558 1,660.94 1,661.95 3
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% KVESLQEEIAFLKK 95.00% 4.74 0.192 0 554.9898 1,661.95 1,661.95 3
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% KVESLQEEIAFLKK 95.00% 4.57 0.253 1.19 554.9901 1,661.95 1,661.95 3
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% KVESLQEEIAFLKK 95.00% 3.37 0.154 0 554.9918 1,661.95 1,661.95 3
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% VELQELNDR 95.00% 2.8 0.304 0 558.2892 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% VELQELNDR 95.00% 2.56 0.292 1.4 558.2895 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% VELQELNDR 95.00% 2.97 0.309 0 558.2896 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% VELQELNDR 95.00% 2.88 0.311 0 558.2896 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% VELQELNDR 95.00% 2.61 0.323 0 558.2899 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% VELQELNDR 95.00% 3.19 0.361 0 558.2901 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 2.05 0.266 0 561.2964 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 1.98 0.328 0 561.2965 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 2.2 0.382 0 561.2966 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 2.13 0.385 0 561.2969 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 2.13 0.309 0 561.2969 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 2.09 0.339 0 561.2971 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 2.11 0.34 0 561.2971 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 2.13 0.371 0 561.2972 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 2.33 0.375 0 561.2972 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 2.02 0.268 0 561.2972 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 2.25 0.408 0 561.2975 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 1.95 0.37 0 561.298 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% EYQDLLNVK 95.00% 1.91 0.307 0 561.2985 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% FANYIDKVR 95.00% 2.88 0.401 0 563.3073 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLK 95.00% 3.57 0.312 1.72 585.3621 1,168.71 1,169.71 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLK 95.00% 3.7 0.249 2.19 585.3621 1,168.71 1,169.71 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLK 95.00% 3.43 0.225 1.46 585.3623 1,168.71 1,169.71 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLK 95.00% 3.85 0.296 1.74 585.3625 1,168.71 1,169.71 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% FADLSEAANRNNDALR 95.00% 3 0.41 1.44 592.9605 1,775.86 1,776.86 3
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% FADLSEAANRNNDALR 95.00% 3.02 0.404 2.44 592.9613 1,775.86 1,776.86 3
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% FADLSEAANRNNDALR 95.00% 2.73 0.432 1.54 592.9615 1,775.86 1,776.86 3
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% FADLSEAANRNNDALR 95.00% 2.85 0.381 2.03 593.2957 1,776.86 1,776.86 3
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% NLQEAEEWYK 95.00% 2.87 0.348 1.23 655.3077 1,308.60 1,309.61 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% NLQEAEEWYK 95.00% 2.87 0.292 2.09 655.3087 1,308.60 1,309.61 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% SLYASSPGGVYATR 95.00% 4.27 0.572 5.51 714.8607 1,427.71 1,428.71 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% SLYASSPGGVYATR 95.00% 4.32 0.585 5.43 714.8619 1,427.71 1,428.71 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% SLYASSPGGVYATR 95.00% 4.38 0.404 4.12 715.3661 1,428.72 1,428.71 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% SLYASSPGGVYATR 95.00% 3.76 0.526 5.64 715.3669 1,428.72 1,428.71 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% HLREYQDLLNVK 95.00% 3.95 0.258 1.35 764.42 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% HLREYQDLLNVK 95.00% 3.66 0.301 2.25 764.4205 1,526.83 1,527.83 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% HLREYQDLLNVK 95.00% 3.63 0.219 0 764.4207 1,526.83 1,527.83 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% KVESLQEEIAFLK 95.00% 4.26 0.334 5.46 767.4334 1,532.85 1,533.85 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% KVESLQEEIAFLK 95.00% 3.97 0.276 4.77 767.4358 1,532.86 1,533.85 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% KVESLQEEIAFLK 95.00% 4.77 0.304 4.31 767.9323 1,533.85 1,533.85 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLKGQGK 95.00% 3.39 0.301 2.89 770.4601 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLKGQGK 95.00% 3.67 0.408 2.85 770.4624 1,538.91 1,539.91 2 SEP11_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ILLAELEQLKGQGK 95.00% 3.97 0.345 1.74 770.9664 1,539.92 1,539.91 2 SEP11_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ISLPLPNFSSLNLR 95.00% 2.98 0.4 2.96 785.9524 1,569.89 1,570.90 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ISLPLPNFSSLNLR 95.00% 2.98 0.482 2.31 785.954 1,569.89 1,570.90 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% ISLPLPNFSSLNLR 95.00% 2.89 0.539 5.04 785.9558 1,569.90 1,570.90 2
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 4.22 0.491 3.77 794.4043 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 4.49 0.473 3.66 794.4048 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 4.39 0.473 3.44 794.405 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 4.22 0.476 3.28 794.4059 1,586.80 1,587.80 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 4.31 0.467 3.42 794.406 1,586.80 1,587.80 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 4.12 0.498 2.62 794.4065 1,586.80 1,587.80 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% TNEKVELQELNDR 95.00% 3.31 0.424 1.43 794.4076 1,586.80 1,587.80 2 DESM_HUMAN
 SAMPLE 4R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 16 20 83 29.00% KVESLQEEIAFLKK 95.00% 4.4 0.436 4.34 832.0534 1,662.09 1,661.95 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SYVTTSTR 95.00% 2.19 0.264 1.15 457.7347 913.4538 914.4583 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DVRQQYESVAAK 95.00% 2.72 0.408 1.09 465.2411 1,392.70 1,393.71 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DVRQQYESVAAK 95.00% 3.42 0.438 1.29 465.5746 1,393.70 1,393.71 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% MALDIEIATYRK 95.00% 2.71 0.228 0 475.2596 1,422.76 1,423.76 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% MALDIEIATYRK 95.00% 2.84 0.188 0 475.5928 1,423.75 1,423.76 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 3.87 0.518 4.33 476.9086 1,427.70 1,428.71 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% mALDIEIATYRK 95.00% 2.58 0.269 0 m1: Oxidation (+15.99) 480.5899 1,438.75 1,439.76 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% mALDIEIATYRK 95.00% 2.68 0.381 0 m1: Oxidation (+15.99) 480.5914 1,438.75 1,439.76 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALR 95.00% 3.04 0.392 0 484.2631 966.5105 967.5213 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALR 95.00% 2.86 0.399 0 484.2631 966.5106 967.5213 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALK 95.00% 3.69 0.293 2.54 c7: Carbamidomethyl (+57.02) 497.5874 1,489.74 1,490.75 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% mFGGPGTASR 95.00% 2.7 0.269 0 m1: Oxidation (+15.99) 498.7328 995.4499 996.4574 2 ATPG_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% mFGGPGTASR 95.00% 2.69 0.267 0 m1: Oxidation (+15.99) 498.7333 995.451 996.4574 2 ATPG_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALRPSTSR 95.00% 2.22 0.282 1.1 499.2657 1,494.77 1,495.79 3 SPTA2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALRPSTSR 95.00% 2.05 0.398 0 499.266 1,494.77 1,495.79 3 SPTA2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALRPSTSR 95.00% 2.07 0.463 1.77 499.2667 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SRLGDLYEEEMR 95.00% 3.54 0.228 0 499.9039 1,496.69 1,497.70 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SRLGDLYEEEMR 95.00% 3.31 0.234 0 499.9048 1,496.69 1,497.70 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% mFGGPGTASRPSSSR 95.00% 1.73 0.224 1.24 m1: Oxidation (+15.99) 504.2407 1,509.70 1,510.71 3 TPM4_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% mFGGPGTASRPSSSR 95.00% 1.75 0.269 1.28 m1: Oxidation (+15.99) 504.5759 1,510.70 1,510.71 3 TPM4_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% HLREYQDLLNVK 95.00% 4.41 0.313 0 509.9453 1,526.81 1,527.83 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% HLREYQDLLNVK 95.00% 5.06 0.342 0 509.9464 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% HLREYQDLLNVK 95.00% 4.97 0.418 0 509.9466 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% HLREYQDLLNVK 95.00% 2.73 0.219 0 510.2791 1,527.81 1,527.83 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 4.67 0.344 1.7 511.9543 1,532.84 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 5.74 0.354 1.62 511.9543 1,532.84 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 3.49 0.42 0 511.9544 1,532.84 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 5.55 0.374 2.24 511.9544 1,532.84 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 5.72 0.29 1.85 511.9547 1,532.84 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 4.05 0.421 2.92 511.9547 1,532.84 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 5.8 0.316 1.68 511.9547 1,532.84 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 4.72 0.307 1.21 511.9548 1,532.84 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 5.71 0.349 1.35 511.9549 1,532.84 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 2.64 0.273 0 511.9549 1,532.84 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 5.15 0.361 1.37 511.955 1,532.84 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 2.87 0.261 0 511.9557 1,532.84 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 3.6 0.365 0 511.9605 1,532.86 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 4.81 0.354 1.34 511.9608 1,532.86 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 4.23 0.306 0 511.9616 1,532.86 1,533.85 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 1.95 0.404 0 513.9732 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 2.07 0.359 1.03 513.9733 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 1.7 0.296 0 513.9733 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 1.85 0.279 0 513.9735 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 1.81 0.431 0 513.9738 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 1.78 0.454 1 513.9739 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 2.11 0.438 0 513.9739 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 2.17 0.437 0 513.974 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 1.87 0.411 0 513.9743 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 1.89 0.374 0 513.978 1,538.91 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 2.08 0.306 0 513.9788 1,538.91 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 1.79 0.38 0 513.9796 1,538.92 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 2.09 0.372 0 514.3091 1,539.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQR 95.00% 2.67 0.245 0 523.7674 1,045.52 1,046.53 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQR 95.00% 2.76 0.244 0 523.7687 1,045.52 1,046.53 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQR 95.00% 2.8 0.295 0 523.769 1,045.52 1,046.53 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 3.49 0.266 0.959 529.9357 1,586.78 1,587.80 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 3.21 0.33 1.25 529.9359 1,586.78 1,587.80 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.01 0.324 1.38 529.9359 1,586.78 1,587.80 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 3.25 0.306 1.92 529.9359 1,586.78 1,587.80 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 3.16 0.261 0 529.936 1,586.78 1,587.80 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.08 0.363 1.72 529.9362 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.43 0.326 1.28 529.9365 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.03 0.315 0 529.938 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 3.9 0.329 0 529.9389 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.32 0.366 1.11 529.9402 1,586.80 1,587.80 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 3.84 0.353 1.24 530.2705 1,587.79 1,587.80 3 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KLLEGEESR 95.00% 2.64 0.178 0 530.7879 1,059.56 1,060.56 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEmLQR 95.00% 2.34 0.197 0 m5: Oxidation (+15.99) 531.765 1,061.51 1,062.53 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DNLAEDIMR 95.00% 2.52 0.146 1.21 538.754 1,075.49 1,076.50 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DNLAEDIMR 95.00% 2.58 0.192 0 538.7544 1,075.49 1,076.50 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DNLAEDIMR 95.00% 2.73 0.27 0 538.7544 1,075.49 1,076.50 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DNLAEDIMR 95.00% 2.81 0.258 0 538.7546 1,075.49 1,076.50 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DNLAEDIMR 95.00% 3.16 0.253 0 538.7549 1,075.49 1,076.50 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DNLAEDIMR 95.00% 2.81 0.254 0 538.7551 1,075.49 1,076.50 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DNLAEDIMR 95.00% 2.62 0.164 0 538.7613 1,075.51 1,076.50 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DNLAEDIMR 95.00% 2.73 0.251 0 538.7621 1,075.51 1,076.50 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QDVDNASLAR 95.00% 2.49 0.425 1.23 544.7696 1,087.52 1,088.53 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 3.18 0.409 2.2 547.2632 1,092.51 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 3.3 0.398 1.36 547.2644 1,092.51 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 4.09 0.438 0 547.266 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 2.18 0.252 0 547.2663 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 4.27 0.439 1.54 547.2663 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 3.56 0.482 1.12 547.2663 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 3.01 0.371 0 547.2663 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 3.61 0.463 0 547.2664 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 4.32 0.452 0 547.2664 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 3.92 0.497 0 547.2666 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 3.89 0.463 1.23 547.2667 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 3.91 0.419 0 547.2668 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 4.35 0.413 1.15 547.2674 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 3.07 0.385 1.66 547.2681 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 2.33 0.334 0 547.2683 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 3.79 0.504 0 547.2684 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 3.11 0.324 1.72 547.2691 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 2.6 0.3 0 547.2711 1,092.53 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANR 95.00% 2.34 0.308 0 547.2738 1,092.53 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 4.52 0.265 1.09 554.6522 1,660.93 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.29 0.224 1 554.6523 1,660.93 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 4.27 0.207 0 554.6526 1,660.93 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.62 0.283 2.11 554.653 1,660.94 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.53 0.292 0 554.653 1,660.94 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.38 0.269 1.54 554.6533 1,660.94 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.38 0.231 2.31 554.6534 1,660.94 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.09 0.192 1.57 554.6536 1,660.94 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 3.46 0.131 0 554.6539 1,660.94 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.4 0.258 1.23 554.6596 1,660.96 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.02 0.276 1.08 554.6598 1,660.96 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.35 0.27 1.62 554.9869 1,661.94 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 3.96 0.151 0 554.9883 1,661.94 1,661.95 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSK 95.00% 1.6 0.286 0 556.9516 1,667.83 1,668.84 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSK 95.00% 1.8 0.283 0 556.9518 1,667.83 1,668.84 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VELQELNDR 95.00% 2.22 0.221 0 558.2864 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VELQELNDR 95.00% 2.42 0.29 0 558.2867 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VELQELNDR 95.00% 2.11 0.241 0 558.2877 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VELQELNDR 95.00% 2.48 0.183 0 558.2884 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNMK 95.00% 2.67 0.288 0 559.7782 1,117.54 1,118.55 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNMK 95.00% 2.42 0.229 0 559.7788 1,117.54 1,118.55 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.33 0.386 0 561.2931 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.02 0.278 0 561.2939 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 1.87 0.387 0 561.2939 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.08 0.394 0 561.2943 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.16 0.355 0 561.2943 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.06 0.307 0 561.2945 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.21 0.372 0 561.2945 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.17 0.339 0 561.2946 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.06 0.286 0 561.2946 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.3 0.371 0 561.2946 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.13 0.337 0 561.2948 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.01 0.274 0 561.2954 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.24 0.408 0 561.3018 1,120.59 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.14 0.357 0 561.3041 1,120.59 1,121.58 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FANYIDKVR 95.00% 3.52 0.385 1.31 563.3048 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FANYIDKVR 95.00% 3.21 0.386 1.18 563.305 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FANYIDKVR 95.00% 3.31 0.371 0 563.3051 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FANYIDKVR 95.00% 3.26 0.421 1.74 563.3051 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FANYIDKVR 95.00% 2.18 0.277 0 563.3062 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FANYIDKVR 95.00% 3.15 0.407 1.51 563.3069 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FANYIDKVR 95.00% 2.84 0.397 0 563.3091 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 2.96 0.447 0 563.6119 1,687.81 1,688.83 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 2.95 0.299 0 563.6126 1,687.81 1,688.83 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 2.89 0.189 1.1 563.6127 1,687.81 1,688.83 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 2.98 0.34 1.46 563.6128 1,687.81 1,688.83 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 3.23 0.348 1.82 563.6128 1,687.81 1,688.83 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 3.05 0.334 1.64 563.613 1,687.82 1,688.83 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 3.29 0.342 1.8 563.6132 1,687.82 1,688.83 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 2.68 0.329 0 563.6134 1,687.82 1,688.83 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 2.65 0.352 1.19 563.6148 1,687.82 1,688.83 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 3.16 0.292 2.7 563.6187 1,687.83 1,688.83 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 3.15 0.335 1.59 563.9472 1,688.82 1,688.83 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDImR 95.00% 3.46 0.448 2.74 m13: Oxidation (+15.99) 568.9449 1,703.81 1,704.82 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDImR 95.00% 3.8 0.451 3.4 m13: Oxidation (+15.99) 568.9458 1,703.81 1,704.82 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDImR 95.00% 2.92 0.446 0 m13: Oxidation (+15.99) 568.946 1,703.81 1,704.82 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDImR 95.00% 3.33 0.372 1.07 m13: Oxidation (+15.99) 568.9468 1,703.82 1,704.82 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDImR 95.00% 3.4 0.343 1.51 m13: Oxidation (+15.99) 569.2773 1,704.81 1,704.82 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNMKEEMAR 95.00% 2.24 0.239 0 578.9401 1,733.80 1,734.82 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNMKEEMAR 95.00% 2.44 0.307 0 578.9419 1,733.80 1,734.82 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNMKEEMAR 95.00% 2.66 0.367 0 578.9466 1,733.82 1,734.82 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNMKEEMAR 95.00% 2.29 0.235 0 579.2761 1,734.80 1,734.82 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNMKEEMAR 95.00% 2.88 0.293 1.11 579.2762 1,734.81 1,734.82 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 3.22 0.335 2.36 585.3589 1,168.70 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 4 0.249 2.07 585.3589 1,168.70 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 4.02 0.306 2.06 585.3592 1,168.70 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 3.9 0.273 2.19 585.3592 1,168.70 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 3.93 0.263 1.21 585.3594 1,168.70 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 3.89 0.246 1.31 585.3595 1,168.70 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 3.43 0.321 1.85 585.3598 1,168.70 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 3.36 0.288 2 585.3605 1,168.71 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 3.92 0.248 1.72 585.3608 1,168.71 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 2.78 0.175 2.06 585.3621 1,168.71 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 3.27 0.257 1.37 585.3622 1,168.71 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 4.23 0.289 1.51 585.3639 1,168.71 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 3.84 0.323 2.51 585.3665 1,168.72 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 3.51 0.275 2 585.3705 1,168.73 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 4.02 0.304 1.28 585.3708 1,168.73 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 3.85 0.246 1.48 585.3723 1,168.73 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLK 95.00% 3.84 0.304 1.52 585.8613 1,169.71 1,169.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.9 0.442 1.89 592.9574 1,775.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.73 0.413 1.28 592.9578 1,775.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.49 0.244 1.7 592.9579 1,775.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.96 0.379 1.85 592.9579 1,775.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.96 0.378 2.13 592.958 1,775.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 3.13 0.433 1.46 592.9581 1,775.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.51 0.444 1.44 592.9583 1,775.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.37 0.344 1.55 592.9585 1,775.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.89 0.404 3.07 592.9586 1,775.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 3.04 0.423 1.57 592.9611 1,775.86 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.67 0.441 2.89 593.289 1,776.84 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.51 0.27 0 593.2897 1,776.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.77 0.411 1.22 593.2911 1,776.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.6 0.116 1.41 593.2919 1,776.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.85 0.446 2 593.2922 1,776.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.32 0.258 1.49 593.2927 1,776.85 1,776.86 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMRELRR 95.00% 3.3 0.242 1.52 603.636 1,807.88 1,808.90 3 COF1_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMRELRR 95.00% 3.4 0.273 1.03 603.6363 1,807.89 1,808.90 3 COF1_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMRELRR 95.00% 3.21 0.172 0.959 603.969 1,808.88 1,808.90 3 COF1_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSKR 95.00% 2.19 0.202 0 608.9858 1,823.93 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSKR 95.00% 2.39 0.277 0 608.9866 1,823.94 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSKR 95.00% 2.02 0.276 0 608.9874 1,823.94 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% GQGKSRLGDLYEEEMR 95.00% 2.25 0.283 0 623.3573 1,867.05 1,867.90 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMR 95.00% 3.84 0.494 2.05 627.7859 1,253.56 1,254.57 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMR 95.00% 3.65 0.509 2.01 627.7861 1,253.56 1,254.57 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMR 95.00% 3.83 0.531 1.92 627.7862 1,253.56 1,254.57 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMR 95.00% 3.7 0.51 2.4 627.7862 1,253.56 1,254.57 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMR 95.00% 2.52 0.52 2.28 627.7865 1,253.56 1,254.57 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMR 95.00% 3.76 0.537 1.51 627.7866 1,253.56 1,254.57 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMR 95.00% 3.02 0.541 0 627.7867 1,253.56 1,254.57 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMR 95.00% 3.65 0.545 1.35 627.7873 1,253.56 1,254.57 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMR 95.00% 3.62 0.447 2.42 627.7928 1,253.57 1,254.57 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMR 95.00% 3.63 0.48 1.64 627.7937 1,253.57 1,254.57 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SRLGDLYEEEMRELR 95.00% 2.64 0.204 1.04 632.6501 1,894.93 1,895.93 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SRLGDLYEEEMRELR 95.00% 2.98 0.394 0 632.9791 1,895.91 1,895.93 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEmR 95.00% 3.35 0.534 2.74 m9: Oxidation (+15.99) 635.7845 1,269.55 1,270.56 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEmR 95.00% 3.46 0.471 2.64 m9: Oxidation (+15.99) 635.785 1,269.55 1,270.56 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEmR 95.00% 3.27 0.456 3.02 m9: Oxidation (+15.99) 635.7885 1,269.56 1,270.56 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEmR 95.00% 3.13 0.442 2.22 m9: Oxidation (+15.99) 635.7896 1,269.56 1,270.56 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ARVEVERDNLAEDIMR 95.00% 2.98 0.375 0 639.3249 1,914.95 1,915.97 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ARVEVERDNLAEDIMR 95.00% 2.74 0.419 1.37 639.6628 1,915.96 1,915.97 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% MALDIEIATYR 95.00% 4.1 0.379 3.28 648.3355 1,294.66 1,295.67 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% MALDIEIATYR 95.00% 4.12 0.361 3.28 648.336 1,294.66 1,295.67 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% MALDIEIATYR 95.00% 4.18 0.356 3.96 648.3362 1,294.66 1,295.67 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% MALDIEIATYR 95.00% 4.56 0.386 4.1 648.3367 1,294.66 1,295.67 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% MALDIEIATYR 95.00% 3.44 0.268 4 648.3452 1,294.67 1,295.67 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% MALDIEIATYR 95.00% 4.16 0.392 3.31 648.3456 1,294.68 1,295.67 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EKLQEEMLQR 95.00% 3.23 0.372 0 652.3365 1,302.66 1,303.67 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EKLQEEMLQR 95.00% 3 0.369 1.82 652.3377 1,302.66 1,303.67 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SKFADLSEAANR 95.00% 3.34 0.496 1.82 654.8302 1,307.64 1,308.65 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SKFADLSEAANR 95.00% 2.74 0.263 0 654.831 1,307.65 1,308.65 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 2.31 0.254 2 655.3043 1,308.59 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 3.37 0.419 1.49 655.3054 1,308.60 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 2.56 0.306 2.32 655.3055 1,308.60 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 2.31 0.429 2.21 655.3057 1,308.60 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 3.68 0.451 2.29 655.3058 1,308.60 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 2.17 0.214 1.64 655.3058 1,308.60 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 2.18 0.296 2.85 655.3061 1,308.60 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 3.21 0.323 2.27 655.3064 1,308.60 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 2.37 0.316 0 655.3066 1,308.60 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 2.05 0.33 2.21 655.3069 1,308.60 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 2.45 0.251 0 655.307 1,308.60 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 2.39 0.349 1.55 655.3078 1,308.60 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 1.97 0.179 1.96 655.3116 1,308.61 1,309.61 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% mALDIEIATYR 95.00% 3.55 0.514 3.6 m1: Oxidation (+15.99) 656.3341 1,310.65 1,311.66 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% mALDIEIATYR 95.00% 3.39 0.504 3.35 m1: Oxidation (+15.99) 656.3363 1,310.66 1,311.66 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EKLQEEmLQR 95.00% 2.69 0.231 1.72 m7: Oxidation (+15.99) 660.3349 1,318.65 1,319.66 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EKLQEEmLQR 95.00% 2.62 0.277 1.26 m7: Oxidation (+15.99) 660.3364 1,318.66 1,319.66 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFR 95.00% 3.36 0.44 2.44 662.3116 1,322.61 1,323.62 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFR 95.00% 2.35 0.438 0 662.3118 1,322.61 1,323.62 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFR 95.00% 2.32 0.467 0 662.3118 1,322.61 1,323.62 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFR 95.00% 3.46 0.449 2.55 662.3133 1,322.61 1,323.62 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SKFADLSEAANRNNDALR 95.00% 2.34 0.18 0 664.6667 1,990.98 1,991.99 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SKFADLSEAANRNNDALR 95.00% 2.32 0.287 2.17 665.0014 1,991.98 1,991.99 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALRQAK 95.00% 3.68 0.495 2.17 702.3544 2,104.04 2,104.05 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VESLQEEIAFLK 95.00% 3.33 0.215 2.52 703.3807 1,404.75 1,405.76 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VESLQEEIAFLK 95.00% 3.61 0.276 2.42 703.3811 1,404.75 1,405.76 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VESLQEEIAFLK 95.00% 3.06 0.201 0 703.3822 1,404.75 1,405.76 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VESLQEEIAFLK 95.00% 4.15 0.291 2.34 703.3824 1,404.75 1,405.76 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VESLQEEIAFLK 95.00% 3.45 0.28 2.54 703.383 1,404.75 1,405.76 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VESLQEEIAFLK 95.00% 3.86 0.184 2.68 703.3914 1,404.77 1,405.76 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VESLQEEIAFLK 95.00% 3.28 0.243 1.68 703.3932 1,404.77 1,405.76 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VESLQEEIAFLK 95.00% 4.35 0.28 2.74 703.8806 1,405.75 1,405.76 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 3.8 0.541 5.26 714.8571 1,427.70 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 4.47 0.565 5.14 714.8582 1,427.70 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 4.48 0.592 5.68 714.8584 1,427.70 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 4.19 0.569 5.38 714.8586 1,427.70 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 3.98 0.608 5.47 714.8586 1,427.70 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 4.08 0.593 5.43 714.8591 1,427.70 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 3.48 0.515 3.85 714.8604 1,427.71 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 2.99 0.403 4.49 714.8607 1,427.71 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 4 0.536 5.39 714.8609 1,427.71 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 4.32 0.556 5.49 714.8623 1,427.71 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 3.12 0.524 4 714.8625 1,427.71 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 4.32 0.538 4.59 714.8627 1,427.71 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 4.46 0.6 5.47 714.8629 1,427.71 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 4.38 0.57 5.42 714.8631 1,427.71 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 4.34 0.562 5.07 715.3591 1,428.70 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 2.68 0.4 1.89 715.3602 1,428.70 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 3.86 0.567 4.82 715.3602 1,428.70 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SLYASSPGGVYATR 95.00% 1.82 0.365 2.89 715.3693 1,428.72 1,428.71 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% mALDIEIATYRK 95.00% 2.87 0.353 0 m1: Oxidation (+15.99) 720.3827 1,438.75 1,439.76 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EMEENFAVEAANYQDTIGR 95.00% 6.02 0.569 3.49 729.9939 2,186.96 2,186.97 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EMEENFAVEAANYQDTIGR 95.00% 6.04 0.524 4.6 729.9944 2,186.96 2,186.97 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VELQELNDRFANYIDKVR 95.00% 2.49 0.259 0 741.142 2,220.40 2,222.16 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VELQELNDRFANYIDKVR 95.00% 4.94 0.546 3.04 741.7238 2,222.15 2,222.16 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALK 95.00% 3.92 0.502 4.2 c7: Carbamidomethyl (+57.02) 745.8774 1,489.74 1,490.75 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALK 95.00% 4.18 0.549 4.3 c7: Carbamidomethyl (+57.02) 745.8781 1,489.74 1,490.75 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALK 95.00% 3.28 0.48 1.26 c7: Carbamidomethyl (+57.02) 745.8785 1,489.74 1,490.75 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALK 95.00% 4.12 0.5 4.17 c7: Carbamidomethyl (+57.02) 745.8789 1,489.74 1,490.75 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALK 95.00% 3.13 0.364 1.82 c7: Carbamidomethyl (+57.02) 745.8796 1,489.74 1,490.75 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALK 95.00% 3.8 0.513 3.28 c7: Carbamidomethyl (+57.02) 745.8806 1,489.75 1,490.75 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALK 95.00% 3.53 0.481 3.06 c7: Carbamidomethyl (+57.02) 745.8812 1,489.75 1,490.75 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALK 95.00% 3.79 0.42 2.21 c7: Carbamidomethyl (+57.02) 745.8866 1,489.76 1,490.75 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALK 95.00% 4.12 0.453 3.3 c7: Carbamidomethyl (+57.02) 746.3792 1,490.74 1,490.75 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALK 95.00% 2.84 0.394 0 c7: Carbamidomethyl (+57.02) 746.3793 1,490.74 1,490.75 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% MFGGPGTASRPSSSR 95.00% 2.97 0.492 0 747.8598 1,493.70 1,494.71 2 TPM4_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% MFGGPGTASRPSSSR 95.00% 2.49 0.305 0 747.8611 1,493.71 1,494.71 2 TPM4_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALRPSTSR 95.00% 2.65 0.438 0 748.3943 1,494.77 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALRPSTSR 95.00% 2.34 0.3 0 748.3949 1,494.77 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALRPSTSR 95.00% 2.33 0.342 0 748.3952 1,494.77 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALRPSTSR 95.00% 2.61 0.416 0 748.3966 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALRPSTSR 95.00% 2.24 0.331 0 748.3976 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALRPSTSR 95.00% 2.21 0.312 0 748.3979 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALRPSTSR 95.00% 2.27 0.354 0 748.3993 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TYSLGSALRPSTSR 95.00% 2.27 0.361 0 748.4024 1,494.79 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SRLGDLYEEEMR 95.00% 3.68 0.488 2.47 749.354 1,496.69 1,497.70 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SRLGDLYEEEMR 95.00% 3.57 0.452 2.8 749.8545 1,497.69 1,497.70 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYKSK 95.00% 3.92 0.399 4.01 762.869 1,523.72 1,524.73 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYKSK 95.00% 4.14 0.436 2.39 762.8697 1,523.72 1,524.73 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYKSK 95.00% 3.61 0.478 3.01 762.8711 1,523.73 1,524.73 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% HLREYQDLLNVK 95.00% 3.43 0.177 0 764.4159 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% HLREYQDLLNVK 95.00% 3.26 0.142 0 764.416 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% HLREYQDLLNVK 95.00% 3.93 0.221 0 764.9181 1,527.82 1,527.83 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% HLREYQDLLNVK 95.00% 3.69 0.218 1.55 764.9185 1,527.82 1,527.83 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 3.93 0.28 3.8 767.4278 1,532.84 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 4.94 0.335 4.06 767.4282 1,532.84 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 4.63 0.307 4.54 767.4289 1,532.84 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VESLQEEIAFLKK 95.00% 4.26 0.276 3.7 767.4291 1,532.84 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 5.02 0.307 4.35 767.4292 1,532.84 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 5.02 0.313 3.89 767.4293 1,532.84 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VESLQEEIAFLKK 95.00% 2.75 0.298 1.74 767.4294 1,532.84 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 1.77 0.262 1.51 767.4297 1,532.84 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 4.63 0.29 3.7 767.4303 1,532.85 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 5.01 0.301 5.08 767.4303 1,532.85 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VESLQEEIAFLKK 95.00% 3.42 0.233 2.68 767.4308 1,532.85 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 4.79 0.277 4.74 767.4312 1,532.85 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 5.27 0.354 4.41 767.4372 1,532.86 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 4.05 0.381 2.68 767.4386 1,532.86 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VESLQEEIAFLKK 95.00% 4.47 0.239 3.17 767.9298 1,533.84 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLK 95.00% 5.05 0.361 3.55 767.939 1,533.86 1,533.85 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 4.55 0.407 3.05 770.4565 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 3.95 0.245 2.29 770.4571 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 4.42 0.411 2.55 770.4575 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 4.51 0.424 2.4 770.4577 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 4.46 0.37 3.55 770.4578 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 4.25 0.36 2.34 770.4578 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 4.29 0.367 2.44 770.4579 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 3.91 0.263 2.96 770.4582 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 4.34 0.357 2.96 770.4583 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 3.75 0.277 1.77 770.4585 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 3.55 0.356 1.43 770.4585 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 4.68 0.415 3 770.4638 1,538.91 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 4.32 0.403 2.82 770.4643 1,538.91 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 4.37 0.391 3.21 770.4659 1,538.92 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ILLAELEQLKGQGK 95.00% 3.99 0.327 2.54 770.9596 1,539.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQREEAENTLQSFR 95.00% 4.22 0.551 2.92 784.7126 2,351.11 2,351.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQREEAENTLQSFR 95.00% 3.61 0.388 0 784.7139 2,351.12 2,351.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQREEAENTLQSFR 95.00% 6.07 0.523 3.68 784.7144 2,351.12 2,351.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQREEAENTLQSFR 95.00% 5.73 0.579 3.77 784.7154 2,351.12 2,351.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQREEAENTLQSFR 95.00% 5.72 0.546 4.05 784.7156 2,351.12 2,351.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQREEAENTLQSFR 95.00% 6.06 0.586 4.85 784.7157 2,351.12 2,351.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQREEAENTLQSFR 95.00% 4.33 0.474 2.08 784.7244 2,351.15 2,351.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ISLPLPNFSSLNLR 95.00% 3.34 0.527 5.38 785.9494 1,569.88 1,570.90 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ISLPLPNFSSLNLR 95.00% 3.34 0.517 5.74 785.9505 1,569.89 1,570.90 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ISLPLPNFSSLNLR 95.00% 3.09 0.407 2.68 785.9508 1,569.89 1,570.90 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ISLPLPNFSSLNLR 95.00% 3.08 0.431 3.32 785.9512 1,569.89 1,570.90 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ISLPLPNFSSLNLR 95.00% 3.62 0.456 4.2 785.9534 1,569.89 1,570.90 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ISLPLPNFSSLNLR 95.00% 3.47 0.453 5.52 785.9537 1,569.89 1,570.90 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ISLPLPNFSSLNLR 95.00% 3.11 0.441 4.32 785.9598 1,569.90 1,570.90 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 3.47 0.48 1.7 c7: Carbamidomethyl (+57.02) 793.3921 2,377.15 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 3.25 0.47 1.07 c7: Carbamidomethyl (+57.02) 793.3922 2,377.15 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 3.34 0.434 1.7 c7: Carbamidomethyl (+57.02) 793.3926 2,377.15 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 3.26 0.507 2.55 c7: Carbamidomethyl (+57.02) 793.3928 2,377.15 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 3.08 0.341 0 c7: Carbamidomethyl (+57.02) 793.3931 2,377.16 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 3.32 0.478 0 c7: Carbamidomethyl (+57.02) 793.3933 2,377.16 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 3.67 0.545 0 c7: Carbamidomethyl (+57.02) 793.3939 2,377.16 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 3.59 0.47 0 c7: Carbamidomethyl (+57.02) 793.3939 2,377.16 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 3.09 0.404 1.04 c7: Carbamidomethyl (+57.02) 793.3942 2,377.16 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 4.04 0.584 0 c7: Carbamidomethyl (+57.02) 793.3947 2,377.16 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 3.44 0.504 1.02 c7: Carbamidomethyl (+57.02) 793.3947 2,377.16 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 2.94 0.382 1.46 c7: Carbamidomethyl (+57.02) 793.3998 2,377.18 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 2.67 0.426 0 c7: Carbamidomethyl (+57.02) 793.4 2,377.18 2,377.17 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.08 0.464 2.33 794.4007 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 2.78 0.447 2.62 794.4008 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.47 0.466 3.64 794.4017 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 3.71 0.473 1.64 794.402 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 3.23 0.468 0 794.4023 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.16 0.478 3.74 794.4041 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.37 0.467 2.39 794.4043 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.4 0.484 3.44 794.4043 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.31 0.453 2.13 794.4062 1,586.80 1,587.80 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.09 0.491 2.41 794.4066 1,586.80 1,587.80 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 4.45 0.486 3.1 794.9038 1,587.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDR 95.00% 3.92 0.429 2.27 794.9049 1,587.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 4.01 0.526 1.6 798.7148 2,393.12 2,393.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 4.4 0.516 2.8 798.715 2,393.12 2,393.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 4.17 0.5 1.82 798.7158 2,393.12 2,393.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 3.81 0.487 1.74 798.7159 2,393.12 2,393.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 4.54 0.59 1.72 798.716 2,393.12 2,393.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 4.26 0.512 1.68 798.7162 2,393.13 2,393.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 3.28 0.305 1.44 798.7166 2,393.13 2,393.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 3.52 0.459 1.51 798.7218 2,393.14 2,393.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 3.92 0.527 2.32 798.7269 2,393.16 2,393.13 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TVETRDGQVINETSQHHDDLE 95.00% 5.16 0.384 2.85 808.7063 2,423.10 2,423.11 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TVETRDGQVINETSQHHDDLE 95.00% 5.2 0.396 3.66 808.7064 2,423.10 2,423.11 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TVETRDGQVINETSQHHDDLE 95.00% 3.59 0.41 1 808.7081 2,423.10 2,423.11 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDRFANYIDK 95.00% 4.28 0.393 2.68 814.077 2,439.21 2,439.22 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TNEKVELQELNDRFANYIDK 95.00% 4.35 0.39 1.32 814.078 2,439.21 2,439.22 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% eTNLDSLPLVDTHSK 95.00% 0 0 4.55 e1: Pyro_glu (-18.01) 825.9181 1,649.82 1,650.83 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% eTNLDSLPLVDTHSK 95.00% 0 0 4 e1: Pyro_glu (-18.01) 825.9194 1,649.82 1,650.83 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.42 0.471 5.24 831.4763 1,660.94 1,661.95 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.38 0.493 5.44 831.477 1,660.94 1,661.95 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.39 0.461 4.77 831.4771 1,660.94 1,661.95 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% KVESLQEEIAFLKK 95.00% 5.67 0.452 3.96 831.9785 1,661.94 1,661.95 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LLQDSVDFSLADAINTEFKNTR 95.00% 3.69 0.51 3.57 833.4222 2,497.24 2,497.26 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LLQDSVDFSLADAINTEFKNTR 95.00% 4.2 0.569 3.04 833.4234 2,497.25 2,497.26 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LLQDSVDFSLADAINTEFKNTR 95.00% 3.82 0.556 3.22 833.4235 2,497.25 2,497.26 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LLQDSVDFSLADAINTEFKNTR 95.00% 3.01 0.347 2.48 833.4239 2,497.25 2,497.26 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LLQDSVDFSLADAINTEFKNTR 95.00% 3.69 0.528 3.08 833.4254 2,497.25 2,497.26 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LLQDSVDFSLADAINTEFKNTR 95.00% 3.54 0.443 2.07 833.4335 2,497.28 2,497.26 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LLQDSVDFSLADAINTEFKNTR 95.00% 2.99 0.413 2.4 833.4349 2,497.28 2,497.26 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSK 95.00% 4.25 0.545 2.35 834.9239 1,667.83 1,668.84 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSK 95.00% 4.46 0.552 4.03 834.925 1,667.83 1,668.84 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSK 95.00% 4.41 0.574 2.6 834.9251 1,667.83 1,668.84 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSK 95.00% 4.59 0.551 3.42 835.4258 1,668.84 1,668.84 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSK 95.00% 3.88 0.465 2.22 835.4267 1,668.84 1,668.84 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 3.25 0.291 0 844.915 1,687.81 1,688.83 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 3.3 0.244 0 844.9162 1,687.82 1,688.83 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 2.93 0.285 0 844.9237 1,687.83 1,688.83 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDIMR 95.00% 2.82 0.27 0 844.9259 1,687.84 1,688.83 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% RQVQSLTcEVDALKGTNESLER 95.00% 5.91 0.444 3.19 c8: Carbamidomethyl (+57.02) 845.4252 2,533.25 2,533.27 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% RQVQSLTcEVDALKGTNESLER 95.00% 5.88 0.507 3.35 c8: Carbamidomethyl (+57.02) 845.4268 2,533.26 2,533.27 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% RQVQSLTcEVDALKGTNESLER 95.00% 5.73 0.479 3.23 c8: Carbamidomethyl (+57.02) 845.4282 2,533.26 2,533.27 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% RQVQSLTcEVDALKGTNESLER 95.00% 6.02 0.484 4 c8: Carbamidomethyl (+57.02) 845.4282 2,533.26 2,533.27 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDImR 95.00% 2.71 0.423 2.57 m13: Oxidation (+15.99) 852.9128 1,703.81 1,704.82 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDImR 95.00% 2.44 0.34 1.54 m13: Oxidation (+15.99) 852.9151 1,703.81 1,704.82 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDImR 95.00% 2.67 0.38 2.35 m13: Oxidation (+15.99) 852.9152 1,703.81 1,704.82 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VEVERDNLAEDImR 95.00% 2.36 0.385 1.92 m13: Oxidation (+15.99) 852.9171 1,703.82 1,704.82 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNMKEEMAR 95.00% 4.61 0.439 7.8 867.9084 1,733.80 1,734.82 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNMKEEMAR 95.00% 4.89 0.377 6 867.9091 1,733.80 1,734.82 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNMKEEMAR 95.00% 4.63 0.353 5 867.9105 1,733.81 1,734.82 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNMKEEMAR 95.00% 4.94 0.408 4.39 867.9107 1,733.81 1,734.82 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EKLQEEMLQREEAENTLQSFR 95.00% 3.8 0.429 1.57 870.4262 2,608.26 2,608.27 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EKLQEEMLQREEAENTLQSFR 95.00% 4.59 0.416 1.8 870.4265 2,608.26 2,608.27 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EKLQEEMLQREEAENTLQSFR 95.00% 4.86 0.426 1.39 870.4277 2,608.26 2,608.27 3
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNmKEEMAR 95.00% 4.54 0.421 5.31 m8: Oxidation (+15.99) 875.907 1,749.80 1,750.81 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNmKEEMAR 95.00% 4.28 0.477 4.19 m8: Oxidation (+15.99) 876.4083 1,750.80 1,750.81 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNmKEEmAR 95.00% 3.75 0.567 0 m8: Oxidation (+15.99), m12: Oxidation (+15.99) 883.907 1,765.80 1,766.81 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQDEIQNmKEEmAR 95.00% 3.23 0.511 0 m8: Oxidation (+15.99), m12: Oxidation (+15.99) 884.4096 1,766.80 1,766.81 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.31 0.188 1.35 888.9331 1,775.85 1,776.86 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.54 0.236 1.47 889.4331 1,776.85 1,776.86 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% FADLSEAANRNNDALR 95.00% 2.58 0.154 1.85 889.4342 1,776.85 1,776.86 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LGDLYEEEMRELRR 95.00% 2.74 0.346 0 904.9531 1,807.89 1,808.90 2 COF1_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSKR 95.00% 3.84 0.465 2.8 912.9743 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSKR 95.00% 3.36 0.474 0 912.9748 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSKR 95.00% 3.33 0.458 1.96 912.9752 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSKR 95.00% 3.79 0.391 3.89 913.4753 1,824.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% ETNLDSLPLVDTHSKR 95.00% 4.33 0.464 1.21 913.479 1,824.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DGQVINETSQHHDDLE 95.00% 3.45 0.321 3.06 918.9005 1,835.79 1,836.80 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DGQVINETSQHHDDLE 95.00% 3.63 0.333 4.18 918.901 1,835.79 1,836.80 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DGQVINETSQHHDDLE 95.00% 4.02 0.494 2.92 918.9019 1,835.79 1,836.80 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DGQVINETSQHHDDLE 95.00% 3.48 0.377 2.92 919.4031 1,836.79 1,836.80 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% DGQVINETSQHHDDLE 95.00% 3.18 0.371 4.03 919.4054 1,836.80 1,836.80 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% VELQELNDRFANYIDK 95.00% 4.82 0.499 3.7 984.4888 1,966.96 1,966.99 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% SKFADLSEAANRNNDALR 94.80% 2.64 0.302 0 996.999 1,991.98 1,991.99 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LLQDSVDFSLADAINTEFK 95.00% 6.29 0.645 7.74 1,064.05 2,126.08 2,126.07 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LLQDSVDFSLADAINTEFK 95.00% 6.91 0.644 6.74 1,064.05 2,126.09 2,126.07 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EMEENFAVEAANYQDTIGR 95.00% 6.11 0.624 5.96 1,093.98 2,185.95 2,186.97 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EMEENFAVEAANYQDTIGR 95.00% 6.24 0.639 6.41 1,093.98 2,185.95 2,186.97 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EMEENFAVEAANYQDTIGR 95.00% 6.27 0.637 7.17 1,094.48 2,186.95 2,186.97 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EMEENFAVEAANYQDTIGR 95.00% 5.78 0.627 4.49 1,094.48 2,186.95 2,186.97 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EMEENFAVEAANYQDTIGR 95.00% 5 0.662 4.74 1,094.48 2,186.95 2,186.97 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EMEENFAVEAANYQDTIGR 95.00% 6.2 0.648 4.7 1,094.49 2,186.96 2,186.97 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EMEENFAVEAANYQDTIGR 95.00% 6.27 0.642 5.7 1,094.49 2,186.96 2,186.97 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EMEENFAVEAANYQDTIGR 95.00% 3.72 0.523 5.27 1,094.49 2,186.96 2,186.97 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EMEENFAVEAANYQDTIGR 95.00% 5.47 0.647 4.82 1,094.50 2,186.99 2,186.97 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EMEENFAVEAANYQDTIGR 95.00% 5.53 0.615 4.27 1,094.51 2,187.00 2,186.97 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EmEENFAVEAANYQDTIGR 95.00% 5.37 0.664 8.15 m2: Oxidation (+15.99) 1,102.48 2,202.95 2,202.96 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EmEENFAVEAANYQDTIGR 95.00% 5.26 0.615 7.17 m2: Oxidation (+15.99) 1,102.48 2,202.95 2,202.96 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EmEENFAVEAANYQDTIGR 95.00% 5.29 0.669 7.51 m2: Oxidation (+15.99) 1,102.48 2,202.95 2,202.96 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EmEENFAVEAANYQDTIGR 95.00% 5.29 0.651 7.92 m2: Oxidation (+15.99) 1,102.49 2,202.96 2,202.96 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.3 0.216 1.05 1,122.50 1,121.49 1,121.58 1 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.26 0.285 1.15 1,123.00 1,121.99 1,121.58 1 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.51 0.285 0 1,123.00 1,121.99 1,121.58 1 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EYQDLLNVK 95.00% 2.3 0.248 0.854 1,123.00 1,121.99 1,121.58 1 DESM_HUMAN
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQREEAENTLQSFR 95.00% 4.87 0.426 3.13 1,176.57 2,351.12 2,351.13 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQREEAENTLQSFR 95.00% 4.46 0.385 3.96 1,176.57 2,351.12 2,351.13 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQREEAENTLQSFR 95.00% 4.79 0.429 5.55 1,176.57 2,351.12 2,351.13 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% LQEEMLQREEAENTLQSFR 95.00% 4.8 0.397 3.8 1,176.57 2,351.13 2,351.13 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% qVQSLTcEVDALKGTNESLER 95.00% 0 0 6.7 c7: Carbamidomethyl (+57.02), n-term: Pyro-cmC (-17.03) 1,181.07 2,360.13 2,360.14 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 4.62 0.576 4.82 c7: Carbamidomethyl (+57.02) 1,189.58 2,377.15 2,377.17 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 4.56 0.582 5.04 c7: Carbamidomethyl (+57.02) 1,189.58 2,377.15 2,377.17 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 4.58 0.562 4.55 c7: Carbamidomethyl (+57.02) 1,189.58 2,377.15 2,377.17 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 4.37 0.571 3.89 c7: Carbamidomethyl (+57.02) 1,189.58 2,377.15 2,377.17 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 4.54 0.595 5.19 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 3.65 0.551 2.44 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% QVQSLTcEVDALKGTNESLER 95.00% 4.62 0.601 4 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 3.65 0.393 0 1,197.57 2,393.12 2,393.13 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 3.9 0.405 0 1,197.57 2,393.12 2,393.13 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 3.95 0.43 0 1,197.57 2,393.12 2,393.13 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 3.72 0.409 0 1,197.57 2,393.12 2,393.13 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 4.06 0.431 1.49 1,197.57 2,393.12 2,393.13 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% EEAENTLQSFRQDVDNASLAR 95.00% 4.14 0.457 1.34 1,197.57 2,393.13 2,393.13 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TVETRDGQVINETSQHHDDLE 95.00% 3.78 0.469 5.54 1,212.56 2,423.10 2,423.11 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% TVETRDGQVINETSQHHDDLE 95.00% 4.07 0.516 5.15 1,212.56 2,423.10 2,423.11 2
 SAMPLE 1 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 59 84 493 78.80% NLQEAEEWYK 95.00% 2.38 0.268 0.854 1,310.60 1,309.60 1,309.61 1
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SYVTTSTR 95.00% 2.06 0.226 1.27 457.7336 913.4515 914.4583 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DVRQQYESVAAK 95.00% 3.08 0.469 1.64 465.2415 1,392.70 1,393.71 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DVRQQYESVAAK 95.00% 3.13 0.427 1.17 465.5755 1,393.70 1,393.71 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% MALDIEIATYRK 95.00% 3.63 0.163 1.11 475.5926 1,423.75 1,423.76 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% MALDIEIATYRK 95.00% 3.14 0.236 0 475.5927 1,423.75 1,423.76 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% MALDIEIATYRK 95.00% 3.06 0.191 0 475.5927 1,423.75 1,423.76 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 3.76 0.474 2.1 476.9099 1,427.71 1,428.71 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% mALDIEIATYRK 95.00% 2.39 0.367 0 m1: Oxidation (+15.99) 480.5892 1,438.74 1,439.76 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% mALDIEIATYRK 95.00% 2.57 0.351 1.2 m1: Oxidation (+15.99) 480.59 1,438.75 1,439.76 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TYSLGSALR 95.00% 2.63 0.434 0 484.2625 966.5094 967.5213 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TYSLGSALR 95.00% 2.39 0.4 0 484.2636 966.5115 967.5213 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% MFGGPGTASR 95.00% 2.55 0.17 0 490.7378 979.4599 980.4625 2 ATPG_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% mFGGPGTASR 95.00% 2.77 0.27 0 m1: Oxidation (+15.99) 498.7323 995.449 996.4574 2 ATPG_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% mFGGPGTASR 95.00% 2.58 0.238 0 m1: Oxidation (+15.99) 498.7324 995.4492 996.4574 2 ATPG_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% mFGGPGTASR 95.00% 2.62 0.218 0 m1: Oxidation (+15.99) 498.7357 995.4557 996.4574 2 ATPG_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% MFGGPGTASRPSSSR 95.00% 1.44 0.341 0 498.9079 1,493.70 1,494.71 3 TPM4_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TYSLGSALRPSTSR 95.00% 2.01 0.319 1.1 499.2663 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TYSLGSALRPSTSR 95.00% 1.83 0.353 1.68 499.2676 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TYSLGSALRPSTSR 95.00% 1.83 0.165 1.26 499.5992 1,495.77 1,495.79 3 SPTA2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SRLGDLYEEEMR 95.00% 3.42 0.321 1.57 499.904 1,496.69 1,497.70 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SRLGDLYEEEMR 95.00% 3.06 0.286 1.09 499.9041 1,496.69 1,497.70 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% mFGGPGTASRPSSSR 95.00% 1.68 0.298 0.959 m1: Oxidation (+15.99) 504.2401 1,509.70 1,510.71 3 TPM4_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% mFGGPGTASRPSSSR 95.00% 1.67 0.294 0 m1: Oxidation (+15.99) 504.2404 1,509.70 1,510.71 3 TPM4_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% NLQEAEEWYKSK 95.00% 2.46 0.256 0 508.9143 1,523.72 1,524.73 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% NLQEAEEWYKSK 95.00% 2.04 0.255 0 508.9147 1,523.72 1,524.73 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 4.77 0.349 0 509.9463 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 4.64 0.315 0 509.9467 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 3.54 0.342 0 509.9467 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 4.99 0.4 0.959 509.9468 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 3.2 0.23 0 509.9469 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 3.33 0.223 0 510.2785 1,527.81 1,527.83 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 4.9 0.357 1.01 510.2809 1,527.82 1,527.83 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 4.85 0.35 0 511.9535 1,532.84 1,533.85 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 5.24 0.357 1.28 511.954 1,532.84 1,533.85 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 5.54 0.335 1.6 511.954 1,532.84 1,533.85 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 4.95 0.316 0 511.9541 1,532.84 1,533.85 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 5.66 0.302 1.96 511.9543 1,532.84 1,533.85 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 4.54 0.296 1.01 511.9551 1,532.84 1,533.85 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 3.6 0.365 0 511.9605 1,532.86 1,533.85 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 4.81 0.354 0 511.9608 1,532.86 1,533.85 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 1.86 0.409 0 513.9741 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 1.73 0.262 0 513.9743 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 1.97 0.256 0 513.9745 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 2.27 0.404 1.68 513.9748 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 2.17 0.462 0 513.9749 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 2.22 0.387 1.08 513.975 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 1.89 0.374 0 513.978 1,538.91 1,539.91 3 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 1.79 0.38 0 513.9796 1,538.92 1,539.91 3 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 1.82 0.351 0 513.9835 1,538.93 1,539.91 3 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 1.7 0.453 0 513.9836 1,538.93 1,539.91 3 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 1.86 0.289 0 513.9837 1,538.93 1,539.91 3 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 1.8 0.288 0 514.3083 1,539.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQEEMLQR 95.00% 2.62 0.238 0 523.7664 1,045.52 1,046.53 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQEEMLQR 95.00% 2.93 0.269 0 523.7678 1,045.52 1,046.53 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQEEMLQR 95.00% 2.94 0.307 0 523.7679 1,045.52 1,046.53 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQEEMLQR 95.00% 2.59 0.263 0 523.7681 1,045.52 1,046.53 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.96 0.459 1.62 524.3019 1,569.88 1,570.90 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.93 0.376 0 524.3026 1,569.88 1,570.90 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.88 0.472 1.29 524.3027 1,569.88 1,570.90 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 2.75 0.465 0 524.3028 1,569.88 1,570.90 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.58 0.424 0 524.3041 1,569.89 1,570.90 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.66 0.423 0 524.3137 1,569.92 1,570.90 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.7 0.368 0 524.6364 1,570.89 1,570.90 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 2.46 0.251 0 524.6366 1,570.89 1,570.90 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.95 0.494 2.06 524.6366 1,570.89 1,570.90 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 4.24 0.382 1.19 524.6372 1,570.89 1,570.90 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 3.99 0.292 1.02 529.9349 1,586.78 1,587.80 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 3.66 0.31 1.07 529.936 1,586.78 1,587.80 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 4.78 0.36 1.19 529.9364 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 3.96 0.313 1.11 529.9366 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 4.89 0.333 1.96 529.9371 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 3.95 0.378 0 529.9373 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 3.9 0.329 0.959 529.9389 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 4.32 0.366 0 529.9402 1,586.80 1,587.80 3 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DNLAEDIMR 95.00% 2.88 0.329 0 538.7536 1,075.49 1,076.50 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DNLAEDIMR 95.00% 2.48 0.26 0 538.7545 1,075.49 1,076.50 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DNLAEDIMR 95.00% 2.76 0.147 0 538.7547 1,075.49 1,076.50 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DNLAEDIMR 95.00% 2.87 0.254 0 538.7549 1,075.49 1,076.50 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DNLAEDIMR 95.00% 2.62 0.164 0 538.7613 1,075.51 1,076.50 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DNLAEDIMR 95.00% 2.73 0.251 0 538.7621 1,075.51 1,076.50 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QDVDNASLAR 95.00% 2.31 0.391 0 544.77 1,087.52 1,088.53 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.9 0.495 0 547.2657 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.58 0.378 0 547.2658 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.77 0.49 1.11 547.2663 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.76 0.442 0 547.2663 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 4.01 0.462 0 547.2664 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.35 0.434 1.32 547.2664 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.54 0.345 1.28 547.2665 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.93 0.509 0 547.2665 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.72 0.494 1.35 547.2667 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.72 0.481 0 547.2669 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.38 0.451 1.33 547.2671 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.49 0.362 2.6 547.2674 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.08 0.396 0 547.3159 1,092.62 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 3.18 0.438 1.42 547.3166 1,092.62 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANR 95.00% 2.88 0.405 0 547.8144 1,093.61 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 4.29 0.203 0 554.6494 1,660.92 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 5.53 0.301 0 554.6518 1,660.93 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 4.53 0.215 0 554.6523 1,660.93 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 5.12 0.26 0 554.6523 1,660.93 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 5.02 0.247 1.92 554.6524 1,660.93 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 4.45 0.272 1.05 554.6527 1,660.93 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 4.33 0.218 1.14 554.6528 1,660.94 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 4.1 0.0863 0 554.653 1,660.94 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 4.26 0.208 0 554.6532 1,660.94 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 5.35 0.253 1.39 554.6534 1,660.94 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 4.78 0.207 0 554.6538 1,660.94 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 5.4 0.258 1.62 554.6596 1,660.96 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 5.02 0.276 0 554.6598 1,660.96 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 4.81 0.201 1.29 554.986 1,661.93 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 4.69 0.256 0 554.9865 1,661.94 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 4.67 0.21 1.42 554.9868 1,661.94 1,661.95 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSK 95.00% 1.81 0.317 0 556.9519 1,667.83 1,668.84 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSK 95.00% 1.49 0.273 0 556.9526 1,667.83 1,668.84 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSK 95.00% 1.8 0.333 0 557.2864 1,668.84 1,668.84 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VELQELNDR 95.00% 3.07 0.331 0 558.2863 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VELQELNDR 95.00% 2.42 0.29 0 558.2867 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VELQELNDR 95.00% 3.05 0.317 0 558.2871 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 2.05 0.387 0 561.2932 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 2.15 0.379 0 561.2945 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 1.98 0.356 0 561.2946 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 2.12 0.333 0 561.2948 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 2.53 0.409 1.25 561.2949 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 2.65 0.322 0 561.295 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 2.12 0.365 0 561.2956 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 2.24 0.408 0 561.3018 1,120.59 1,121.58 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 2.14 0.357 0 561.3041 1,120.59 1,121.58 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FANYIDKVR 95.00% 3.2 0.399 1.7 563.3045 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FANYIDKVR 95.00% 3.17 0.423 1.82 563.3047 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FANYIDKVR 95.00% 3.28 0.372 1.89 563.3051 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FANYIDKVR 95.00% 3.15 0.426 1.57 563.3054 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FANYIDKVR 95.00% 2.84 0.397 0 563.3091 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDIMR 95.00% 3.22 0.448 1.21 563.6124 1,687.81 1,688.83 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDIMR 95.00% 3.29 0.281 0 563.6127 1,687.81 1,688.83 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDIMR 95.00% 2.46 0.312 0 563.6128 1,687.81 1,688.83 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDIMR 95.00% 2.62 0.171 0 563.613 1,687.82 1,688.83 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDIMR 95.00% 3.16 0.292 2.2 563.6187 1,687.83 1,688.83 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDIMR 95.00% 2.65 0.189 0 563.9476 1,688.82 1,688.83 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDImR 95.00% 4.04 0.49 1.57 m13: Oxidation (+15.99) 568.9446 1,703.81 1,704.82 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDImR 95.00% 3.32 0.386 2.31 m13: Oxidation (+15.99) 568.9448 1,703.81 1,704.82 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDImR 95.00% 4.16 0.483 2.89 m13: Oxidation (+15.99) 568.9448 1,703.81 1,704.82 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDImR 95.00% 3.76 0.445 1.59 m13: Oxidation (+15.99) 569.2786 1,704.81 1,704.82 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNMKEEMAR 95.00% 2.91 0.269 1.38 578.9421 1,733.80 1,734.82 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNMKEEMAR 95.00% 2.55 0.298 0 578.9424 1,733.80 1,734.82 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNMKEEMAR 95.00% 2.38 0.225 0 578.9424 1,733.80 1,734.82 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 2.54 0.27 2.68 585.3572 1,168.70 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 4.1 0.309 1.15 585.359 1,168.70 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 3.91 0.258 1.96 585.3591 1,168.70 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 4.13 0.299 1.15 585.3596 1,168.70 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 3.98 0.261 1.66 585.3596 1,168.70 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 2.57 0.167 1.66 585.3602 1,168.70 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 2.69 0.176 2.09 585.3603 1,168.70 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 2.98 0.188 1.52 585.3604 1,168.71 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 3.14 0.246 1.82 585.3604 1,168.71 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 3.36 0.288 1.7 585.3605 1,168.71 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 2.6 0.26 2.43 585.3607 1,168.71 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 2.65 0.231 1.48 585.3611 1,168.71 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 2.78 0.175 1.8 585.3621 1,168.71 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 3.27 0.257 0 585.3622 1,168.71 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 4.23 0.289 1.25 585.3639 1,168.71 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 3.84 0.323 1.8 585.3665 1,168.72 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 3.74 0.341 2.02 585.3708 1,168.73 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 3.9 0.319 1.89 585.3708 1,168.73 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 4.07 0.308 1.74 585.371 1,168.73 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLK 95.00% 4.09 0.309 1.46 585.3712 1,168.73 1,169.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.75 0.281 0 592.9562 1,775.85 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 3.31 0.446 1.47 592.9581 1,775.85 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.78 0.446 1.6 592.9582 1,775.85 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.76 0.349 1.25 592.9583 1,775.85 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 3 0.504 2.01 592.9584 1,775.85 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.57 0.302 1.74 592.9588 1,775.85 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 1.99 0.206 2 592.9588 1,775.85 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 3.04 0.423 1.57 592.9611 1,775.86 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.68 0.284 1.29 593.2874 1,776.84 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.36 0.186 1.38 593.2909 1,776.85 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.86 0.285 1.1 593.2914 1,776.85 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.83 0.4 1.96 593.2916 1,776.85 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.93 0.402 2.74 593.2917 1,776.85 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.77 0.473 3.31 593.2919 1,776.85 1,776.86 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEMRELRR 95.00% 3.18 0.183 0 603.636 1,807.88 1,808.90 3 COF1_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEMRELRR 95.00% 3.65 0.319 0 603.6362 1,807.89 1,808.90 3 COF1_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEMRELRR 95.00% 3.46 0.307 1.12 603.6364 1,807.89 1,808.90 3 COF1_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSKR 95.00% 2.08 0.233 0 609.3176 1,824.93 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSKR 95.00% 2.4 0.288 0 609.3192 1,824.93 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSKR 95.00% 2.13 0.26 0 609.3199 1,824.94 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSKR 95.00% 2.02 0.244 0 609.3209 1,824.94 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSKR 95.00% 2.4 0.421 0 609.3298 1,824.97 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% GQGKSRLGDLYEEEMR 95.00% 2.25 0.283 0 623.3573 1,867.05 1,867.90 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEMR 95.00% 3.79 0.539 2.72 627.7848 1,253.55 1,254.57 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEMR 95.00% 2.08 0.397 0 627.7856 1,253.56 1,254.57 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEMR 95.00% 3.63 0.519 2.49 627.7861 1,253.56 1,254.57 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEMR 95.00% 1.99 0.441 1.26 627.7863 1,253.56 1,254.57 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEMR 95.00% 3.79 0.491 2.27 627.7864 1,253.56 1,254.57 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEMR 95.00% 3.7 0.543 2.85 627.7866 1,253.56 1,254.57 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEMR 95.00% 3.62 0.447 1.77 627.7928 1,253.57 1,254.57 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEMR 95.00% 3.63 0.48 2.19 627.7937 1,253.57 1,254.57 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SRLGDLYEEEMRELR 95.00% 3.07 0.247 0 632.9807 1,895.92 1,895.93 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SRLGDLYEEEMRELR 95.00% 2.87 0.38 0 632.9811 1,895.92 1,895.93 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SRLGDLYEEEMRELR 95.00% 2.83 0.395 0 632.9832 1,895.93 1,895.93 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEmR 95.00% 2.91 0.305 2.42 m9: Oxidation (+15.99) 635.7842 1,269.55 1,270.56 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEmR 95.00% 3.36 0.52 2.26 m9: Oxidation (+15.99) 635.7871 1,269.56 1,270.56 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEmR 95.00% 3.23 0.456 2.28 m9: Oxidation (+15.99) 635.7875 1,269.56 1,270.56 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEmR 95.00% 2.83 0.362 1.66 m9: Oxidation (+15.99) 635.7931 1,269.57 1,270.56 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ARVEVERDNLAEDIMR 95.00% 2.36 0.3 0 639.3253 1,914.95 1,915.97 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ARVEVERDNLAEDIMR 95.00% 2.63 0.242 1.52 639.3255 1,914.95 1,915.97 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% MALDIEIATYR 95.00% 2.24 0.258 0 648.3382 1,294.66 1,295.67 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% MALDIEIATYR 95.00% 4.16 0.392 2.92 648.3456 1,294.68 1,295.67 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% MALDIEIATYR 95.00% 2.91 0.338 1.28 648.3487 1,294.68 1,295.67 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EKLQEEMLQR 95.00% 2.97 0.359 1.7 652.3358 1,302.66 1,303.67 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EKLQEEMLQR 95.00% 3.08 0.397 0 652.336 1,302.66 1,303.67 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EKLQEEMLQR 95.00% 2.87 0.388 0 652.3364 1,302.66 1,303.67 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EKLQEEMLQR 95.00% 3.06 0.316 1.17 652.3372 1,302.66 1,303.67 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SKFADLSEAANR 95.00% 3.71 0.524 2.72 654.8293 1,307.64 1,308.65 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SKFADLSEAANR 95.00% 3.21 0.569 3 654.8321 1,307.65 1,308.65 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% NLQEAEEWYK 95.00% 2.37 0.26 0 655.2744 1,308.53 1,309.61 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% NLQEAEEWYK 95.00% 3.04 0.443 2.11 655.3048 1,308.59 1,309.61 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% NLQEAEEWYK 95.00% 2.17 0.337 2.24 655.3054 1,308.60 1,309.61 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% NLQEAEEWYK 95.00% 3.26 0.362 2.37 655.3055 1,308.60 1,309.61 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% NLQEAEEWYK 95.00% 3.29 0.487 2.26 655.3056 1,308.60 1,309.61 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% NLQEAEEWYK 95.00% 3.14 0.379 2.47 655.3056 1,308.60 1,309.61 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% NLQEAEEWYK 95.00% 3.26 0.472 2.12 655.3061 1,308.60 1,309.61 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% NLQEAEEWYK 95.00% 2.37 0.316 0 655.3066 1,308.60 1,309.61 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% NLQEAEEWYK 95.00% 2.32 0.393 3.57 655.3086 1,308.60 1,309.61 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% NLQEAEEWYK 95.00% 1.97 0.179 1.92 655.3116 1,308.61 1,309.61 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EKLQEEmLQR 95.00% 2.62 0.347 0 m7: Oxidation (+15.99) 660.3343 1,318.65 1,319.66 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EKLQEEmLQR 95.00% 2.56 0.297 0 m7: Oxidation (+15.99) 660.3352 1,318.65 1,319.66 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFR 95.00% 2.81 0.309 0 662.311 1,322.61 1,323.62 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFR 95.00% 3.32 0.417 2.28 662.3111 1,322.61 1,323.62 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFR 95.00% 2.48 0.262 0 662.3112 1,322.61 1,323.62 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFR 95.00% 3.32 0.41 2.52 662.3113 1,322.61 1,323.62 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFR 95.00% 2.14 0.383 0 662.3114 1,322.61 1,323.62 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFR 95.00% 2.4 0.295 0 662.3122 1,322.61 1,323.62 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SKFADLSEAANRNNDALR 95.00% 2.41 0.189 1.2 664.6671 1,990.98 1,991.99 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALRQAK 95.00% 3.64 0.496 1.33 702.0212 2,103.04 2,104.05 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VESLQEEIAFLK 95.00% 2.73 0.241 0 703.3795 1,404.74 1,405.76 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VESLQEEIAFLK 95.00% 3.71 0.167 2.82 703.3807 1,404.75 1,405.76 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VESLQEEIAFLK 95.00% 3.22 0.338 1.72 703.3811 1,404.75 1,405.76 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VESLQEEIAFLK 95.00% 3.86 0.184 2.8 703.3914 1,404.77 1,405.76 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VESLQEEIAFLK 95.00% 3.28 0.243 1.62 703.3932 1,404.77 1,405.76 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VESLQEEIAFLK 95.00% 3.39 0.264 1.82 703.3981 1,404.78 1,405.76 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VESLQEEIAFLK 95.00% 4.24 0.247 3.12 703.883 1,405.75 1,405.76 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFK 95.00% 5.22 0.577 3.06 709.3584 2,125.05 2,126.07 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFK 95.00% 5.81 0.659 3.96 709.6928 2,126.06 2,126.07 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFK 95.00% 5.32 0.625 4.62 709.6943 2,126.06 2,126.07 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 2.03 0.256 2.22 714.8573 1,427.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 4.52 0.554 4.82 714.8575 1,427.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 4.25 0.585 4.35 714.8575 1,427.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 2.54 0.35 4.19 714.8575 1,427.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 3.2 0.484 3.05 714.8584 1,427.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 4.38 0.564 4.54 714.8586 1,427.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 2.65 0.307 3.44 714.8586 1,427.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 3.26 0.473 3.37 714.859 1,427.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 3.85 0.526 5.21 714.8592 1,427.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 3.53 0.505 4.49 714.8592 1,427.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 4.07 0.593 4.29 714.8593 1,427.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 2.97 0.444 2.34 714.8595 1,427.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 2.71 0.354 0 714.8607 1,427.71 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 4.14 0.6 5.28 714.8617 1,427.71 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 4.46 0.6 5.92 714.8629 1,427.71 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 4.38 0.57 5 714.8631 1,427.71 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SLYASSPGGVYATR 95.00% 4.65 0.578 6.11 715.3588 1,428.70 1,428.71 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% mALDIEIATYRK 95.00% 3.5 0.452 2.38 m1: Oxidation (+15.99) 720.383 1,438.75 1,439.76 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EMEENFAVEAANYQDTIGR 95.00% 5.77 0.564 4.18 729.9926 2,186.95 2,186.97 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EMEENFAVEAANYQDTIGR 95.00% 5.7 0.602 4.07 729.9946 2,186.96 2,186.97 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% qVQSLTcEVDALK 95.00% 0 0 3.54 c7: Carbamidomethyl (+57.02), n-term: Pyro-cmC (-17.03) 737.8493 1,473.68 1,473.73 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VELQELNDRFANYIDKVR 95.00% 5.23 0.53 2.74 741.7255 2,222.15 2,222.16 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALK 95.00% 3.3 0.489 2.11 c7: Carbamidomethyl (+57.02) 745.8772 1,489.74 1,490.75 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALK 95.00% 3.67 0.497 3.96 c7: Carbamidomethyl (+57.02) 745.8803 1,489.75 1,490.75 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALK 95.00% 3.75 0.433 3.85 c7: Carbamidomethyl (+57.02) 745.8809 1,489.75 1,490.75 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALK 95.00% 3.79 0.42 2 c7: Carbamidomethyl (+57.02) 745.8866 1,489.76 1,490.75 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALK 95.00% 4.23 0.426 2.92 c7: Carbamidomethyl (+57.02) 746.3797 1,490.74 1,490.75 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALK 95.00% 4.66 0.528 3.82 c7: Carbamidomethyl (+57.02) 746.3799 1,490.74 1,490.75 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% MFGGPGTASRPSSSR 95.00% 3.02 0.467 0 747.8585 1,493.70 1,494.71 2 TPM4_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% MFGGPGTASRPSSSR 95.00% 2.82 0.249 0 747.86 1,493.70 1,494.71 2 TPM4_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TYSLGSALRPSTSR 95.00% 2.56 0.447 0 748.3946 1,494.77 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TYSLGSALRPSTSR 95.00% 2.35 0.346 0 748.395 1,494.77 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TYSLGSALRPSTSR 95.00% 2.28 0.334 0 748.3952 1,494.77 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TYSLGSALRPSTSR 95.00% 2.42 0.339 0 748.396 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TYSLGSALRPSTSR 95.00% 2.53 0.402 0 748.3962 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TYSLGSALRPSTSR 95.00% 2.27 0.354 0 748.3993 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SRLGDLYEEEMR 95.00% 3.17 0.533 4.18 749.3521 1,496.69 1,497.70 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SRLGDLYEEEMR 95.00% 3.28 0.528 2.85 749.3543 1,496.69 1,497.70 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 2.54 0.215 0 764.416 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 3.57 0.292 0 764.4164 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 3.72 0.218 1.62 764.417 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 3.43 0.186 0 764.4174 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 3.44 0.341 0 764.9145 1,527.81 1,527.83 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% HLREYQDLLNVK 95.00% 3.73 0.205 0 764.917 1,527.82 1,527.83 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 2.88 0.28 2.4 767.3869 1,532.76 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 4.8 0.338 4.77 767.4273 1,532.84 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 5.46 0.333 3.92 767.4276 1,532.84 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 5.07 0.342 3.77 767.4281 1,532.84 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 5.21 0.351 4.28 767.4283 1,532.84 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 5.11 0.325 3.64 767.4295 1,532.84 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 1.77 0.262 1.36 767.4297 1,532.84 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 5.37 0.337 4.32 767.4298 1,532.84 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VESLQEEIAFLKK 95.00% 3.72 0.285 3.64 767.43 1,532.84 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 5.27 0.354 5.35 767.4372 1,532.86 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 5.13 0.374 3.74 767.4398 1,532.86 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 4.52 0.403 4.06 767.4432 1,532.87 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 4.63 0.321 4.54 767.9301 1,533.84 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 4.74 0.31 3.82 767.9312 1,533.85 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 4.68 0.325 4.07 767.9323 1,533.85 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLK 95.00% 5.05 0.361 4.96 767.939 1,533.86 1,533.85 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 4.26 0.336 2.54 770.4569 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 4.5 0.428 2.09 770.4572 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 4.51 0.433 2.1 770.4581 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 4.12 0.222 2.68 770.4584 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 4.44 0.321 3.35 770.4585 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 3.84 0.228 3.25 770.4586 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 2.55 0.314 0 770.46 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 2.76 0.376 0 770.4609 1,538.91 1,539.91 2 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 4.68 0.415 2.62 770.4638 1,538.91 1,539.91 2 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 4.32 0.403 2.85 770.4643 1,538.91 1,539.91 2 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ILLAELEQLKGQGK 95.00% 2.88 0.39 0 770.8958 1,539.78 1,539.91 2 SEP11_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQEEMLQREEAENTLQSFR 95.00% 5.93 0.607 4.26 784.7137 2,351.12 2,351.13 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQEEMLQREEAENTLQSFR 95.00% 6.38 0.58 4.74 784.7144 2,351.12 2,351.13 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQEEMLQREEAENTLQSFR 95.00% 5.64 0.58 3.4 784.7154 2,351.12 2,351.13 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQEEMLQREEAENTLQSFR 95.00% 5.91 0.556 4.38 784.7155 2,351.12 2,351.13 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQEEMLQREEAENTLQSFR 95.00% 4.33 0.474 2.04 784.7244 2,351.15 2,351.13 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.22 0.486 5.32 785.95 1,569.88 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.44 0.496 4.68 785.9503 1,569.89 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.32 0.502 4.6 785.9506 1,569.89 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 2.92 0.549 4.85 785.9508 1,569.89 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.02 0.491 2.74 785.951 1,569.89 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3 0.399 2.7 785.9511 1,569.89 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 2.79 0.382 4.82 785.9511 1,569.89 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.11 0.441 3.28 785.9598 1,569.90 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 2.57 0.429 2.8 785.9671 1,569.92 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 2.45 0.352 1.82 785.9676 1,569.92 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.35 0.504 5.01 786.4508 1,570.89 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.32 0.443 4.57 786.4515 1,570.89 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.44 0.472 6.02 786.4516 1,570.89 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 2.94 0.444 2.41 786.4518 1,570.89 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 2.36 0.448 3.2 786.4525 1,570.89 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ISLPLPNFSSLNLR 95.00% 3.13 0.486 4.15 786.4528 1,570.89 1,570.90 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 3.68 0.526 1.57 c7: Carbamidomethyl (+57.02) 793.3929 2,377.16 2,377.17 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 3.66 0.406 2.47 c7: Carbamidomethyl (+57.02) 793.3929 2,377.16 2,377.17 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 3.26 0.459 0 c7: Carbamidomethyl (+57.02) 793.3931 2,377.16 2,377.17 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 3.69 0.485 0.959 c7: Carbamidomethyl (+57.02) 793.3936 2,377.16 2,377.17 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 3.26 0.486 0 c7: Carbamidomethyl (+57.02) 793.3936 2,377.16 2,377.17 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 3.14 0.451 0 c7: Carbamidomethyl (+57.02) 793.3937 2,377.16 2,377.17 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 2.99 0.439 0 c7: Carbamidomethyl (+57.02) 793.3948 2,377.16 2,377.17 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 3.08 0.436 0 c7: Carbamidomethyl (+57.02) 793.3954 2,377.16 2,377.17 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 2.94 0.382 2.01 c7: Carbamidomethyl (+57.02) 793.3998 2,377.18 2,377.17 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 4.17 0.543 1.19 c7: Carbamidomethyl (+57.02) 793.4073 2,377.20 2,377.17 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 4.48 0.484 3.02 794.402 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 4.26 0.484 3.55 794.4027 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 4.44 0.481 3.7 794.4028 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 4.09 0.489 3.15 794.4034 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 4.45 0.468 3.55 794.4044 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 4.31 0.453 2.14 794.4062 1,586.80 1,587.80 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 4.09 0.491 2.55 794.4066 1,586.80 1,587.80 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 4.58 0.438 1.8 794.4108 1,586.81 1,587.80 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDR 95.00% 4.57 0.497 2.89 794.901 1,587.79 1,587.80 2 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SYVTTSTRTYSLGSALRPSTSR 95.00% 3.5 0.539 0 798.0797 2,391.22 2,391.23 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFRQDVDNASLAR 95.00% 4.22 0.57 1.82 798.7146 2,393.12 2,393.13 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFRQDVDNASLAR 95.00% 4.44 0.565 2.25 798.7146 2,393.12 2,393.13 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFRQDVDNASLAR 95.00% 4.37 0.542 1.36 798.7147 2,393.12 2,393.13 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFRQDVDNASLAR 95.00% 4.78 0.608 1.74 798.7156 2,393.12 2,393.13 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFRQDVDNASLAR 95.00% 3.52 0.459 1.49 798.7218 2,393.14 2,393.13 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFRQDVDNASLAR 95.00% 3.92 0.527 2.19 798.7269 2,393.16 2,393.13 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFRQDVDNASLAR 95.00% 3.83 0.506 1.55 798.7321 2,393.17 2,393.13 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TVETRDGQVINETSQHHDDLE 95.00% 5.06 0.41 2.82 808.7059 2,423.09 2,423.11 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TVETRDGQVINETSQHHDDLE 95.00% 5.46 0.431 5.41 808.706 2,423.09 2,423.11 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TVETRDGQVINETSQHHDDLE 95.00% 5.17 0.348 3.11 808.7064 2,423.10 2,423.11 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TVETRDGQVINETSQHHDDLE 95.00% 5.53 0.471 3.33 808.7075 2,423.10 2,423.11 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDRFANYIDK 95.00% 4.2 0.342 1.96 814.076 2,439.20 2,439.22 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TNEKVELQELNDRFANYIDK 95.00% 4.26 0.452 2.26 814.0781 2,439.21 2,439.22 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 5.48 0.483 4.04 831.4769 1,660.94 1,661.95 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 4.85 0.417 4.4 831.9773 1,661.94 1,661.95 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 4.41 0.412 4.09 831.9774 1,661.94 1,661.95 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% KVESLQEEIAFLKK 95.00% 5.3 0.478 4.11 831.9779 1,661.94 1,661.95 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFKNTR 95.00% 3.5 0.535 2.8 833.4237 2,497.25 2,497.26 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFKNTR 95.00% 3.59 0.522 2.74 833.4239 2,497.25 2,497.26 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFKNTR 95.00% 3.05 0.403 2.36 833.4244 2,497.25 2,497.26 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFKNTR 95.00% 3.54 0.443 1.92 833.4335 2,497.28 2,497.26 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFKNTR 95.00% 2.99 0.413 2.48 833.4349 2,497.28 2,497.26 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSK 95.00% 4 0.57 3.09 834.9244 1,667.83 1,668.84 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSK 95.00% 3.8 0.522 2.38 834.925 1,667.83 1,668.84 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSK 95.00% 3.86 0.529 2.85 834.925 1,667.83 1,668.84 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSK 95.00% 4.15 0.567 2.66 834.9254 1,667.84 1,668.84 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSK 95.00% 3.63 0.503 2.96 834.9255 1,667.84 1,668.84 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSK 95.00% 3.89 0.541 4.28 834.926 1,667.84 1,668.84 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDIMR 95.00% 3.11 0.157 0 844.9223 1,687.83 1,688.83 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDIMR 95.00% 2.93 0.285 0 844.9237 1,687.83 1,688.83 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDIMR 95.00% 2.82 0.27 0 844.9259 1,687.84 1,688.83 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% RQVQSLTcEVDALKGTNESLER 95.00% 5.71 0.483 2.8 c8: Carbamidomethyl (+57.02) 845.4268 2,533.26 2,533.27 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% RQVQSLTcEVDALKGTNESLER 95.00% 5.82 0.427 3.13 c8: Carbamidomethyl (+57.02) 845.4272 2,533.26 2,533.27 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% RQVQSLTcEVDALKGTNESLER 95.00% 5.45 0.429 3.44 c8: Carbamidomethyl (+57.02) 845.4277 2,533.26 2,533.27 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% RQVQSLTcEVDALKGTNESLER 95.00% 6.07 0.404 4.77 c8: Carbamidomethyl (+57.02) 845.4282 2,533.26 2,533.27 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDImR 95.00% 2.64 0.395 0 m13: Oxidation (+15.99) 852.911 1,703.81 1,704.82 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDImR 95.00% 2.62 0.407 2.14 m13: Oxidation (+15.99) 852.9129 1,703.81 1,704.82 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDImR 95.00% 2.38 0.364 1.51 m13: Oxidation (+15.99) 852.9141 1,703.81 1,704.82 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% VEVERDNLAEDImR 95.00% 2.72 0.403 1.85 m13: Oxidation (+15.99) 852.9141 1,703.81 1,704.82 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNMKEEMAR 95.00% 4.58 0.368 5.48 867.9091 1,733.80 1,734.82 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNMKEEMAR 95.00% 4.93 0.404 5.43 867.9093 1,733.80 1,734.82 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNMKEEMAR 95.00% 5.06 0.413 7.7 867.91 1,733.80 1,734.82 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNMKEEMAR 95.00% 4.61 0.374 5.43 868.4129 1,734.81 1,734.82 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EKLQEEMLQREEAENTLQSFR 95.00% 4.49 0.326 1.41 870.4282 2,608.26 2,608.27 3
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNmKEEMAR 95.00% 4.44 0.509 3.47 m8: Oxidation (+15.99) 875.9066 1,749.80 1,750.81 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNmKEEMAR 95.00% 3.7 0.495 2 m8: Oxidation (+15.99) 875.9077 1,749.80 1,750.81 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNmKEEMAR 95.00% 4.35 0.479 3.7 m8: Oxidation (+15.99) 876.4083 1,750.80 1,750.81 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNmKEEMAR 95.00% 3.54 0.476 3.47 m8: Oxidation (+15.99) 876.4124 1,750.81 1,750.81 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNmKEEmAR 95.00% 3.42 0.461 2.77 m8: Oxidation (+15.99), m12: Oxidation (+15.99) 883.9047 1,765.79 1,766.81 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQDEIQNmKEEmAR 95.00% 3.47 0.513 2.47 m8: Oxidation (+15.99), m12: Oxidation (+15.99) 884.4085 1,766.80 1,766.81 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.65 0.259 0 888.9328 1,775.85 1,776.86 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.41 0.17 1.16 888.9333 1,775.85 1,776.86 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% FADLSEAANRNNDALR 95.00% 2.46 0.264 1.85 888.9344 1,775.85 1,776.86 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LGDLYEEEMRELRR 95.00% 2.67 0.24 0 905.4507 1,808.89 1,808.90 2 COF1_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSKR 95.00% 4.05 0.465 3.18 912.9739 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSKR 95.00% 3.69 0.483 4.16 912.9745 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSKR 95.00% 3.97 0.417 3.89 913.4765 1,824.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% ETNLDSLPLVDTHSKR 95.00% 3.93 0.362 3.89 913.4774 1,824.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DGQVINETSQHHDDLE 95.00% 4.04 0.461 3.09 918.9014 1,835.79 1,836.80 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DGQVINETSQHHDDLE 95.00% 3.83 0.393 5.42 918.9021 1,835.79 1,836.80 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DGQVINETSQHHDDLE 95.00% 3.9 0.429 3.82 918.9023 1,835.79 1,836.80 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DGQVINETSQHHDDLE 95.00% 3.81 0.422 3.47 918.904 1,835.79 1,836.80 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% DGQVINETSQHHDDLE 95.00% 3.18 0.371 4.24 919.4054 1,836.80 1,836.80 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% SKFADLSEAANRNNDALR 95.00% 3.56 0.412 1.89 997.0006 1,991.99 1,991.99 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFK 95.00% 6.86 0.638 9.31 1,064.03 2,126.05 2,126.07 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFK 95.00% 6.53 0.611 10.6 1,064.04 2,126.05 2,126.07 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFK 95.00% 6.32 0.629 10.1 1,064.04 2,126.06 2,126.07 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFK 95.00% 6.59 0.631 10.7 1,064.04 2,126.06 2,126.07 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFK 95.00% 6.29 0.645 9.72 1,064.05 2,126.08 2,126.07 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFK 95.00% 6.91 0.644 10.9 1,064.05 2,126.09 2,126.07 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFK 95.00% 5.87 0.609 5.46 1,064.06 2,126.10 2,126.07 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFK 95.00% 6.1 0.657 9.74 1,064.06 2,126.10 2,126.07 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LLQDSVDFSLADAINTEFK 95.00% 5.59 0.606 11 1,064.06 2,126.10 2,126.07 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EMEENFAVEAANYQDTIGR 95.00% 5.88 0.654 6.54 1,093.98 2,185.95 2,186.97 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EMEENFAVEAANYQDTIGR 95.00% 4.57 0.639 5.51 1,094.01 2,186.00 2,186.97 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EMEENFAVEAANYQDTIGR 95.00% 5.5 0.664 5.08 1,094.48 2,186.95 2,186.97 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EMEENFAVEAANYQDTIGR 95.00% 6.16 0.634 5.66 1,094.48 2,186.95 2,186.97 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EMEENFAVEAANYQDTIGR 95.00% 6.02 0.608 6.21 1,094.49 2,186.96 2,186.97 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EMEENFAVEAANYQDTIGR 95.00% 6.2 0.617 5.41 1,094.49 2,186.96 2,186.97 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EMEENFAVEAANYQDTIGR 95.00% 3.72 0.523 5.35 1,094.49 2,186.96 2,186.97 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EMEENFAVEAANYQDTIGR 95.00% 5.47 0.647 5.09 1,094.50 2,186.99 2,186.97 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EMEENFAVEAANYQDTIGR 95.00% 5.57 0.615 6.57 1,094.51 2,187.00 2,186.97 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EmEENFAVEAANYQDTIGR 95.00% 1.84 0.346 0 m2: Oxidation (+15.99) 1,101.97 2,201.92 2,202.96 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EmEENFAVEAANYQDTIGR 95.00% 5.26 0.682 8.28 m2: Oxidation (+15.99) 1,102.48 2,202.95 2,202.96 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EmEENFAVEAANYQDTIGR 95.00% 5.17 0.645 7.23 m2: Oxidation (+15.99) 1,102.48 2,202.95 2,202.96 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EmEENFAVEAANYQDTIGR 95.00% 5.61 0.659 7.18 m2: Oxidation (+15.99) 1,102.48 2,202.95 2,202.96 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 2.56 0.184 1.09 1,122.99 1,121.99 1,121.58 1 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 2.35 0.213 0.854 1,123.00 1,121.99 1,121.58 1 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 2.18 0.304 1.47 1,123.00 1,121.99 1,121.58 1 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EYQDLLNVK 95.00% 2.19 0.413 1.62 1,123.00 1,121.99 1,121.58 1 DESM_HUMAN
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQEEMLQREEAENTLQSFR 95.00% 4.7 0.417 4.52 1,176.57 2,351.12 2,351.13 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% LQEEMLQREEAENTLQSFR 95.00% 4.5 0.397 4.11 1,176.57 2,351.12 2,351.13 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% qVQSLTcEVDALKGTNESLER 95.00% 0 0 7.59 c7: Carbamidomethyl (+57.02), n-term: Pyro-cmC (-17.03) 1,181.07 2,360.13 2,360.14 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% qVQSLTcEVDALKGTNESLER 95.00% 0 0 4.96 c7: Carbamidomethyl (+57.02), n-term: Pyro-cmC (-17.03) 1,181.07 2,360.13 2,360.14 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 4.63 0.595 4.47 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 4.46 0.583 4.82 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 4.6 0.574 4.4 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 4.08 0.547 3.85 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 3.65 0.551 2.51 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% QVQSLTcEVDALKGTNESLER 95.00% 4.66 0.568 4.92 c7: Carbamidomethyl (+57.02) 1,189.61 2,377.20 2,377.17 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFRQDVDNASLAR 95.00% 4.1 0.416 0 1,197.07 2,392.12 2,393.13 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFRQDVDNASLAR 95.00% 3.77 0.346 0 1,197.57 2,393.12 2,393.13 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFRQDVDNASLAR 95.00% 3.91 0.427 1.6 1,197.57 2,393.12 2,393.13 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% EEAENTLQSFRQDVDNASLAR 95.00% 4.16 0.443 1.64 1,197.57 2,393.13 2,393.13 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TVETRDGQVINETSQHHDDLE 95.00% 3.95 0.45 5.03 1,212.55 2,423.09 2,423.11 2
 SAMPLE 1R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 82 462 77.00% TVETRDGQVINETSQHHDDLE 95.00% 4.22 0.492 4.68 1,212.56 2,423.10 2,423.11 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DVRQQYESVAAK 95.00% 2.99 0.342 1.12 465.2393 1,392.69 1,393.71 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DVRQQYESVAAK 95.00% 2.91 0.431 1.92 465.2416 1,392.70 1,393.71 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LLEGEESR 95.00% 2.51 0.244 0 466.7379 931.4601 932.469 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LLEGEESR 95.00% 2.44 0.248 0 466.7391 931.4626 932.469 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% MALDIEIATYRK 95.00% 3.31 0.241 0 475.5928 1,423.76 1,423.76 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% MALDIEIATYRK 95.00% 2.93 0.324 1.66 475.5933 1,423.76 1,423.76 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 3.65 0.51 4.36 476.9088 1,427.70 1,428.71 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 2.98 0.447 1.17 476.9091 1,427.70 1,428.71 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% mALDIEIATYRK 95.00% 2.57 0.374 0 m1: Oxidation (+15.99) 480.5903 1,438.75 1,439.76 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% mALDIEIATYRK 95.00% 2.67 0.41 0 m1: Oxidation (+15.99) 480.5907 1,438.75 1,439.76 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALR 95.00% 2.02 0.362 0 484.263 966.5104 967.5213 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALR 95.00% 2.26 0.39 0 484.2636 966.5116 967.5213 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% mFGGPGTASR 95.00% 2.77 0.276 0 m1: Oxidation (+15.99) 498.7316 995.4475 996.4574 2 ATPG_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% mFGGPGTASR 95.00% 2.83 0.261 0 m1: Oxidation (+15.99) 498.7319 995.4482 996.4574 2 ATPG_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% mFGGPGTASR 95.00% 2.18 0.297 0 m1: Oxidation (+15.99) 498.7326 995.4496 996.4574 2 ATPG_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% mFGGPGTASR 95.00% 2.59 0.278 0 m1: Oxidation (+15.99) 498.7327 995.4498 996.4574 2 ATPG_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% mFGGPGTASR 95.00% 2.52 0.24 0 m1: Oxidation (+15.99) 498.7331 995.4506 996.4574 2 ATPG_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% mFGGPGTASR 95.00% 2.44 0.25 0 m1: Oxidation (+15.99) 498.7335 995.4513 996.4574 2 ATPG_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 1.74 0.32 0 499.2661 1,494.77 1,495.79 3 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 1.66 0.255 1.07 499.2662 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 1.72 0.313 1.8 499.2669 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 1.74 0.309 1.32 499.2673 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 1.92 0.295 1.06 499.6037 1,495.79 1,495.79 3 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SRLGDLYEEEMR 95.00% 2.77 0.363 0 499.904 1,496.69 1,497.70 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SRLGDLYEEEMR 95.00% 2.43 0.223 0 499.9042 1,496.69 1,497.70 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% mFGGPGTASRPSSSR 95.00% 1.68 0.167 1.3 m1: Oxidation (+15.99) 504.2418 1,509.70 1,510.71 3 TPM4_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% NLQEAEEWYKSK 95.00% 1.98 0.251 0 508.9147 1,523.72 1,524.73 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% NLQEAEEWYKSK 95.00% 2.6 0.331 0 508.9152 1,523.72 1,524.73 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% HLREYQDLLNVK 95.00% 4.76 0.406 0 509.9468 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% HLREYQDLLNVK 95.00% 4.85 0.37 1 509.9471 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLK 95.00% 3.29 0.365 0 511.9546 1,532.84 1,533.85 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLK 95.00% 3.59 0.264 0 511.9551 1,532.84 1,533.85 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLK 95.00% 3.54 0.239 1.51 511.9559 1,532.84 1,533.85 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLK 95.00% 3.34 0.233 1.08 512.2899 1,533.85 1,533.85 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 2 0.36 0 513.9723 1,538.89 1,539.91 3 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 2.03 0.351 0 513.9731 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 1.78 0.382 0 513.9737 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 1.99 0.423 0 513.9741 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 1.63 0.272 0 513.9742 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 1.94 0.398 0 513.9743 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 2.12 0.291 1.13 513.9744 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 1.95 0.366 0 513.9761 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 2.11 0.332 0 514.3082 1,539.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 2.13 0.334 0 514.3084 1,539.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQEEMLQR 95.00% 2.32 0.222 0 523.7662 1,045.52 1,046.53 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQEEMLQR 95.00% 2.59 0.258 0 523.7676 1,045.52 1,046.53 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQEEMLQR 95.00% 2.87 0.299 0 523.7676 1,045.52 1,046.53 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 2.97 0.23 0 529.8176 1,586.43 1,587.80 3 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 3.97 0.31 0 529.9355 1,586.78 1,587.80 3 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 3.57 0.328 0 529.9374 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 3.7 0.313 1.11 529.9376 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 4.01 0.322 1.02 529.9382 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 3.69 0.336 0 530.2711 1,587.79 1,587.80 3 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KLLEGEESR 95.00% 2.56 0.229 1.38 530.7854 1,059.56 1,060.56 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KLLEGEESR 95.00% 2.28 0.199 0 530.7872 1,059.56 1,060.56 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DNLAEDIMR 95.00% 2.57 0.164 0 538.7543 1,075.49 1,076.50 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DNLAEDIMR 95.00% 2.91 0.296 1.25 538.7548 1,075.49 1,076.50 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DNLAEDIMR 95.00% 2.54 0.214 0 538.7551 1,075.49 1,076.50 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QDVDNASLAR 95.00% 2.52 0.353 1.42 544.7682 1,087.52 1,088.53 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QDVDNASLAR 95.00% 2.32 0.255 0 544.7704 1,087.53 1,088.53 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QDVDNASLAR 95.00% 2.34 0.197 0 544.7721 1,087.53 1,088.53 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 3.77 0.503 0 547.2662 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 2.92 0.431 1.82 547.2663 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 3.7 0.509 0 547.2664 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 3.52 0.425 1.74 547.2666 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 3.65 0.496 1.21 547.2666 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 3.76 0.515 1.57 547.2668 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 3.31 0.438 0 547.2668 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 3.94 0.516 1.55 547.2669 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 3.79 0.505 1.32 547.2669 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 3.97 0.434 1.48 547.267 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 3.61 0.502 1.43 547.2672 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 3.06 0.399 1.4 547.2675 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 2.55 0.288 1.19 547.2687 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 3.33 0.415 1.77 547.2693 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 2.86 0.494 0 547.2704 1,092.53 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 1.95 0.275 1.85 547.2716 1,092.53 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 2.4 0.207 0 547.3185 1,092.62 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANR 95.00% 2.88 0.424 1.72 547.5954 1,093.18 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLKK 95.00% 5.51 0.301 1.8 554.6528 1,660.94 1,661.95 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLKK 95.00% 5.64 0.268 2.21 554.6532 1,660.94 1,661.95 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLKK 95.00% 4.15 0.12 0 554.9868 1,661.94 1,661.95 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLKK 95.00% 4.5 0.185 0 554.9872 1,661.94 1,661.95 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ETNLDSLPLVDTHSK 95.00% 1.48 0.285 0 556.9523 1,667.83 1,668.84 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ETNLDSLPLVDTHSK 95.00% 1.66 0.313 0 556.9524 1,667.83 1,668.84 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ETNLDSLPLVDTHSK 95.00% 2.04 0.3 0 557.2872 1,668.84 1,668.84 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VELQELNDR 95.00% 2.52 0.313 0 558.2866 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VELQELNDR 95.00% 3.24 0.353 0 558.2874 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VELQELNDR 95.00% 2.55 0.288 0 558.2874 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VELQELNDR 95.00% 3.04 0.279 0 558.2876 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VELQELNDR 95.00% 2.81 0.263 1.44 558.2878 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VELQELNDR 95.00% 2.5 0.227 0 558.2885 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNMK 95.00% 2.68 0.358 1.46 559.7788 1,117.54 1,118.55 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EYQDLLNVK 95.00% 2.01 0.338 0 561.2945 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EYQDLLNVK 95.00% 2.11 0.333 0 561.2946 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EYQDLLNVK 95.00% 2.29 0.365 1.35 561.2946 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EYQDLLNVK 95.00% 2.09 0.361 0 561.2948 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EYQDLLNVK 95.00% 2.03 0.424 0 561.2949 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EYQDLLNVK 95.00% 2.23 0.353 1.33 561.295 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EYQDLLNVK 95.00% 2.09 0.322 0 561.2951 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FANYIDKVR 95.00% 2.7 0.358 0 563.3049 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FANYIDKVR 95.00% 3.18 0.395 1.59 563.3054 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FANYIDKVR 95.00% 3.2 0.411 1.35 563.3058 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FANYIDKVR 95.00% 2.95 0.374 1.54 563.3059 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FANYIDKVR 95.00% 2.83 0.407 0 563.3059 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 2.92 0.34 0 563.612 1,687.81 1,688.83 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.27 0.394 1.44 563.6128 1,687.81 1,688.83 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.23 0.352 0 563.613 1,687.82 1,688.83 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.4 0.433 2.68 563.6131 1,687.82 1,688.83 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.5 0.386 1.03 563.6131 1,687.82 1,688.83 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.73 0.452 2.31 563.6132 1,687.82 1,688.83 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.15 0.322 1.55 563.6132 1,687.82 1,688.83 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.61 0.373 2.1 563.6133 1,687.82 1,688.83 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.58 0.481 1.18 563.6133 1,687.82 1,688.83 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 2.4 0.193 0 563.6133 1,687.82 1,688.83 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 4.14 0.452 2.59 563.6134 1,687.82 1,688.83 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 2.66 0.268 0 563.9462 1,688.82 1,688.83 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDImR 95.00% 3.54 0.466 2.16 m13: Oxidation (+15.99) 568.9446 1,703.81 1,704.82 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDImR 95.00% 4.4 0.384 3 m13: Oxidation (+15.99) 568.9449 1,703.81 1,704.82 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDImR 95.00% 3.56 0.394 1.22 m13: Oxidation (+15.99) 569.2756 1,704.80 1,704.82 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDImR 95.00% 2.89 0.375 0 m13: Oxidation (+15.99) 569.2775 1,704.81 1,704.82 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNMKEEMAR 95.00% 2.18 0.255 0 578.942 1,733.80 1,734.82 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNMKEEMAR 95.00% 2.22 0.264 0 578.9424 1,733.80 1,734.82 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNMKEEMAR 95.00% 2.4 0.372 0 578.9427 1,733.80 1,734.82 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNMKEEMAR 95.00% 2.43 0.406 0 578.9429 1,733.81 1,734.82 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNMKEEMAR 95.00% 2.66 0.338 0 578.9431 1,733.81 1,734.82 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNMKEEMAR 95.00% 2.21 0.387 0 578.9438 1,733.81 1,734.82 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLK 95.00% 2.75 0.254 1.44 585.3592 1,168.70 1,169.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLK 95.00% 4.09 0.308 1.48 585.3593 1,168.70 1,169.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLK 95.00% 3.72 0.26 1.43 585.3596 1,168.70 1,169.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLK 95.00% 3.81 0.242 1.21 585.3598 1,168.70 1,169.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLK 95.00% 3.92 0.253 1.24 585.3598 1,168.70 1,169.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLK 95.00% 3.95 0.259 1.38 585.3598 1,168.70 1,169.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLK 95.00% 3.97 0.307 0 585.3599 1,168.70 1,169.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLK 95.00% 2.27 0.31 0 585.36 1,168.70 1,169.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLK 95.00% 3.77 0.248 1.72 585.36 1,168.70 1,169.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLK 95.00% 3.92 0.248 1.43 585.3602 1,168.70 1,169.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLK 95.00% 3.58 0.254 1.8 585.3603 1,168.70 1,169.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLK 95.00% 3.72 0.324 1.47 585.3604 1,168.71 1,169.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TLLIKTVETR 95.00% 2.55 0.223 1.7 587.3629 1,172.71 1,173.72 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.72 0.407 2.03 592.9558 1,775.84 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.34 0.426 2.12 592.9573 1,775.85 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.46 0.333 1.68 592.9573 1,775.85 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.66 0.373 0.959 592.9578 1,775.85 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.51 0.385 1.59 592.9583 1,775.85 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.59 0.316 1.89 592.9584 1,775.85 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.91 0.506 1.89 592.9588 1,775.85 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.97 0.336 1.32 592.9589 1,775.85 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.23 0.285 1 592.9598 1,775.86 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.36 0.295 1.92 593.291 1,776.85 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.22 0.302 1.12 593.2913 1,776.85 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.94 0.288 1.74 593.2918 1,776.85 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.91 0.463 1.51 593.2928 1,776.86 1,776.86 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 2.25 0.331 0 613.2733 1,836.80 1,836.80 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMR 95.00% 3.71 0.505 2.06 627.7855 1,253.56 1,254.57 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMR 95.00% 3.47 0.532 2.59 627.7856 1,253.56 1,254.57 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMR 95.00% 3.48 0.519 2.17 627.7859 1,253.56 1,254.57 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMR 95.00% 3.41 0.519 1.96 627.786 1,253.56 1,254.57 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMR 95.00% 2.15 0.346 1.92 627.786 1,253.56 1,254.57 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMR 95.00% 2.55 0.511 2.31 627.7862 1,253.56 1,254.57 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMR 95.00% 3.88 0.525 1.85 627.7863 1,253.56 1,254.57 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMR 95.00% 2.84 0.487 1.96 627.7866 1,253.56 1,254.57 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMR 95.00% 2.94 0.25 2.92 627.7866 1,253.56 1,254.57 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMR 95.00% 3.81 0.535 2.8 627.7867 1,253.56 1,254.57 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMR 95.00% 2.6 0.446 3.11 627.7874 1,253.56 1,254.57 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEmR 95.00% 2.39 0.351 2.77 m9: Oxidation (+15.99) 635.7848 1,269.55 1,270.56 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ARVEVERDNLAEDIMR 95.00% 3.4 0.466 2.01 639.66 1,915.96 1,915.97 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% MALDIEIATYR 95.00% 4.37 0.383 3.49 648.3365 1,294.66 1,295.67 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% MALDIEIATYR 95.00% 4.43 0.379 3.18 648.3372 1,294.66 1,295.67 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% NLQEAEEWYK 95.00% 3.09 0.35 1.42 655.3047 1,308.59 1,309.61 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% NLQEAEEWYK 95.00% 3.35 0.374 1.52 655.3052 1,308.59 1,309.61 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% NLQEAEEWYK 95.00% 2.58 0.23 0 655.3054 1,308.60 1,309.61 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% NLQEAEEWYK 95.00% 3.29 0.37 1.62 655.3057 1,308.60 1,309.61 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% NLQEAEEWYK 95.00% 3.1 0.408 2.08 655.3061 1,308.60 1,309.61 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% NLQEAEEWYK 95.00% 2.35 0.255 0 655.3066 1,308.60 1,309.61 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% NLQEAEEWYK 95.00% 2.65 0.252 0 655.3094 1,308.60 1,309.61 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% mALDIEIATYR 95.00% 3.46 0.452 4.02 m1: Oxidation (+15.99) 656.3343 1,310.65 1,311.66 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EEAENTLQSFR 95.00% 2.58 0.441 1.19 662.3103 1,322.60 1,323.62 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EEAENTLQSFR 95.00% 2.41 0.251 0 662.3111 1,322.61 1,323.62 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EEAENTLQSFR 95.00% 3.34 0.428 2.2 662.312 1,322.61 1,323.62 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EEAENTLQSFR 95.00% 2.29 0.478 1.38 662.3122 1,322.61 1,323.62 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EEAENTLQSFR 95.00% 3.36 0.459 1.92 662.3123 1,322.61 1,323.62 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EEAENTLQSFR 95.00% 1.98 0.294 0 662.3123 1,322.61 1,323.62 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EEAENTLQSFR 95.00% 2.7 0.456 1.68 662.3136 1,322.61 1,323.62 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALRQAK 95.00% 3.82 0.472 2.34 702.3562 2,104.05 2,104.05 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALRQAK 95.00% 4.33 0.494 2.05 702.3579 2,104.05 2,104.05 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% MALDIEIATYRK 95.00% 3.43 0.339 1.15 712.3835 1,422.75 1,423.76 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% MALDIEIATYRK 95.00% 3.54 0.314 1.41 712.3844 1,422.75 1,423.76 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.16 0.607 6.59 714.857 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 3.08 0.403 3.66 714.8574 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.48 0.559 6.92 714.8575 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.37 0.572 6.92 714.8578 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.54 0.567 7.7 714.858 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 2.66 0.237 3 714.8582 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.31 0.58 6.41 714.8586 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 2.28 0.21 1.57 714.8586 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.51 0.585 5.8 714.8589 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.39 0.575 5.47 714.8589 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.45 0.583 6.33 714.8591 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.38 0.59 6.52 714.8594 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.27 0.61 6.55 714.8595 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.5 0.588 5.77 714.8596 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 2.98 0.459 4.59 714.8598 1,427.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 3.04 0.563 4.01 714.8609 1,427.71 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 3.15 0.493 3.7 714.8614 1,427.71 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 3.41 0.58 5.77 714.8615 1,427.71 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.31 0.595 4.08 714.8615 1,427.71 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 3.14 0.396 2.68 714.862 1,427.71 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 4.19 0.498 6.72 715.3593 1,428.70 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATR 95.00% 3.51 0.549 5.09 715.3607 1,428.71 1,428.71 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VELQELNDRFANYIDKVR 95.00% 5.01 0.561 2.12 741.3892 2,221.14 2,222.16 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALK 95.00% 3.57 0.42 3.66 c7: Carbamidomethyl (+57.02) 745.8784 1,489.74 1,490.75 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALK 95.00% 3.47 0.48 2.57 c7: Carbamidomethyl (+57.02) 745.8788 1,489.74 1,490.75 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALK 95.00% 4.18 0.54 4.26 c7: Carbamidomethyl (+57.02) 745.8788 1,489.74 1,490.75 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALK 95.00% 1.96 0.219 1.26 c7: Carbamidomethyl (+57.02) 745.8794 1,489.74 1,490.75 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALK 95.00% 4.21 0.514 4.21 c7: Carbamidomethyl (+57.02) 745.8811 1,489.75 1,490.75 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% MFGGPGTASRPSSSR 95.00% 3.13 0.414 0 747.8592 1,493.70 1,494.71 2 TPM4_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% MFGGPGTASRPSSSR 95.00% 3.32 0.49 0 747.8606 1,493.71 1,494.71 2 TPM4_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 2.43 0.351 0 748.3957 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 2.44 0.403 0 748.396 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 2.26 0.367 0 748.3961 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 2.51 0.394 0 748.3964 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 2.43 0.421 0 748.3968 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 2.48 0.411 0 748.3971 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 2.51 0.269 0 748.3977 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 2.47 0.373 0 748.3977 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TYSLGSALRPSTSR 95.00% 2.26 0.343 0 748.3979 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SRLGDLYEEEMR 95.00% 3.48 0.524 3.29 749.3524 1,496.69 1,497.70 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SRLGDLYEEEMR 95.00% 3.62 0.556 2.89 749.354 1,496.69 1,497.70 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% NLQEAEEWYKSK 95.00% 4.09 0.466 3.38 762.8694 1,523.72 1,524.73 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% NLQEAEEWYKSK 95.00% 3.99 0.413 3.19 762.8701 1,523.72 1,524.73 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% HLREYQDLLNVK 95.00% 4.06 0.265 0 764.4186 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% HLREYQDLLNVK 95.00% 3.83 0.296 2.64 764.9187 1,527.82 1,527.83 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VESLQEEIAFLKK 95.00% 3.89 0.23 2.59 767.4273 1,532.84 1,533.85 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VESLQEEIAFLKK 95.00% 4.06 0.262 3.74 767.4288 1,532.84 1,533.85 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLK 95.00% 5.19 0.338 4 767.4291 1,532.84 1,533.85 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLK 95.00% 5.28 0.35 2.7 767.4292 1,532.84 1,533.85 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLK 95.00% 5.15 0.336 2.41 767.4303 1,532.84 1,533.85 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLK 95.00% 5.26 0.329 3.89 767.4303 1,532.85 1,533.85 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLK 95.00% 4.85 0.353 1.96 767.4305 1,532.85 1,533.85 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLK 95.00% 5.09 0.342 3.72 767.9288 1,533.84 1,533.85 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 4.17 0.353 2.82 770.4571 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 4.6 0.416 3 770.4576 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 4.06 0.324 2 770.4576 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 3.18 0.268 2.85 770.4579 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 4.66 0.392 3.09 770.458 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 4.06 0.324 3.68 770.4583 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 4.46 0.391 2.68 770.459 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 4.55 0.384 2.68 770.4591 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 3.81 0.316 2.92 770.4592 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 4.41 0.378 2.29 770.4598 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ILLAELEQLKGQGK 95.00% 4.35 0.343 2 770.9597 1,539.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQEEMLQREEAENTLQSFR 95.00% 5.86 0.559 3.74 784.7154 2,351.12 2,351.13 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQEEMLQREEAENTLQSFR 95.00% 5.83 0.55 4.33 784.7156 2,351.12 2,351.13 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALKGTNESLER 95.00% 3.01 0.447 0 c7: Carbamidomethyl (+57.02) 793.3918 2,377.15 2,377.17 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALKGTNESLER 95.00% 2.85 0.447 0 c7: Carbamidomethyl (+57.02) 793.392 2,377.15 2,377.17 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALKGTNESLER 95.00% 3.04 0.456 1 c7: Carbamidomethyl (+57.02) 793.3929 2,377.16 2,377.17 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALKGTNESLER 95.00% 2.99 0.349 0 c7: Carbamidomethyl (+57.02) 793.3931 2,377.16 2,377.17 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALKGTNESLER 95.00% 2.68 0.313 0 c7: Carbamidomethyl (+57.02) 793.394 2,377.16 2,377.17 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALKGTNESLER 95.00% 3.06 0.388 0 c7: Carbamidomethyl (+57.02) 793.3945 2,377.16 2,377.17 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALKGTNESLER 95.00% 3.21 0.446 1.1 c7: Carbamidomethyl (+57.02) 793.3951 2,377.16 2,377.17 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 4.09 0.469 3.12 794.3995 1,586.78 1,587.80 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 4.2 0.455 2.85 794.4018 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 3.76 0.453 1.96 794.4019 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 4.06 0.445 1.17 794.4019 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 4.36 0.463 2.42 794.4022 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 4.22 0.444 2.57 794.4024 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 4.18 0.478 1.92 794.4033 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 4.08 0.45 2.92 794.4033 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 3.82 0.423 2.36 794.4044 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDR 95.00% 4.22 0.481 2.38 794.9043 1,587.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EEAENTLQSFRQDVDNASLAR 95.00% 4.49 0.536 0.959 798.7156 2,393.12 2,393.13 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TVETRDGQVINETSQHHDDLE 95.00% 4.8 0.375 2.55 808.7072 2,423.10 2,423.11 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TVETRDGQVINETSQHHDDLE 95.00% 5.29 0.404 1.85 808.7079 2,423.10 2,423.11 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TVETRDGQVINETSQHHDDLE 95.00% 5.98 0.535 2.85 808.7084 2,423.10 2,423.11 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDRFANYIDK 95.00% 4.65 0.484 2.51 814.0766 2,439.21 2,439.22 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TNEKVELQELNDRFANYIDK 95.00% 4.68 0.464 1.89 814.077 2,439.21 2,439.22 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMRELR 95.00% 2.91 0.0643 2.59 826.9023 1,651.79 1,652.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLKK 95.00% 5.4 0.498 5.28 831.477 1,660.94 1,661.95 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% KVESLQEEIAFLKK 95.00% 5.54 0.509 4.47 831.9767 1,661.94 1,661.95 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LLQDSVDFSLADAINTEFKNTR 95.00% 3.16 0.316 1.74 833.4253 2,497.25 2,497.26 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ETNLDSLPLVDTHSK 95.00% 4.16 0.568 2.41 834.9251 1,667.83 1,668.84 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ETNLDSLPLVDTHSK 95.00% 4.07 0.579 3.52 834.9252 1,667.83 1,668.84 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ETNLDSLPLVDTHSK 95.00% 4.28 0.537 3.66 834.9253 1,667.83 1,668.84 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ETNLDSLPLVDTHSK 95.00% 3.91 0.471 2.72 835.4256 1,668.84 1,668.84 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.38 0.401 0 844.9162 1,687.82 1,688.83 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.46 0.416 0 845.4178 1,688.82 1,688.83 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.41 0.41 0 845.4178 1,688.82 1,688.83 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.36 0.41 0 845.4185 1,688.82 1,688.83 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.46 0.422 0 845.419 1,688.82 1,688.83 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDIMR 95.00% 3.47 0.381 0 845.4193 1,688.82 1,688.83 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDImR 95.00% 2.56 0.342 0 m13: Oxidation (+15.99) 853.4145 1,704.81 1,704.82 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% VEVERDNLAEDImR 95.00% 2.48 0.309 1.13 m13: Oxidation (+15.99) 853.4154 1,704.82 1,704.82 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNMKEEMAR 95.00% 4.52 0.369 5.35 867.9112 1,733.81 1,734.82 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNMKEEMAR 95.00% 4.95 0.414 6.92 867.9126 1,733.81 1,734.82 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNMKEEMAR 95.00% 4.8 0.367 3.54 868.4124 1,734.81 1,734.82 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EKLQEEMLQREEAENTLQSFR 95.00% 3.42 0.455 2 870.427 2,608.26 2,608.27 3
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNmKEEMAR 95.00% 4.37 0.483 4.25 m8: Oxidation (+15.99) 875.9071 1,749.80 1,750.81 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNmKEEMAR 95.00% 4.38 0.486 4.39 m8: Oxidation (+15.99) 875.9076 1,749.80 1,750.81 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LQDEIQNmKEEmAR 95.00% 3.56 0.502 0 m8: Oxidation (+15.99), m12: Oxidation (+15.99) 883.909 1,765.80 1,766.81 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.54 0.325 0 888.9326 1,775.85 1,776.86 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.49 0.206 1.41 888.9335 1,775.85 1,776.86 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.55 0.258 1.51 888.9343 1,775.85 1,776.86 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% FADLSEAANRNNDALR 95.00% 2.73 0.29 2.24 889.4354 1,776.86 1,776.86 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMRELRR 95.00% 2.43 0.265 0 904.9497 1,807.88 1,808.90 2 COF1_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% LGDLYEEEMRELRR 95.00% 2.77 0.255 1.39 905.4538 1,808.89 1,808.90 2 COF1_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ETNLDSLPLVDTHSKR 95.00% 3.42 0.537 1.46 912.9723 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ETNLDSLPLVDTHSKR 95.00% 4.49 0.476 2.19 912.9734 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ETNLDSLPLVDTHSKR 95.00% 3.38 0.499 0 912.9773 1,823.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% ETNLDSLPLVDTHSKR 95.00% 3.32 0.373 1.48 913.4806 1,824.95 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 3.81 0.412 3.6 918.9011 1,835.79 1,836.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 3.92 0.464 3 918.9018 1,835.79 1,836.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 3.55 0.385 2.72 918.9021 1,835.79 1,836.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 3.63 0.43 3.23 918.9027 1,835.79 1,836.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 3.82 0.409 4.09 918.903 1,835.79 1,836.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 3.58 0.418 2.89 918.9032 1,835.79 1,836.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 3.61 0.38 3.57 918.9032 1,835.79 1,836.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 3.83 0.39 2.52 918.9039 1,835.79 1,836.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 3.45 0.374 3.13 918.9045 1,835.79 1,836.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 3.6 0.399 2.82 919.4023 1,836.79 1,836.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 3.65 0.345 4.12 919.4023 1,836.79 1,836.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% DGQVINETSQHHDDLE 95.00% 3.64 0.422 3.66 919.4027 1,836.79 1,836.80 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SLYASSPGGVYATRSSAVR 95.00% 3.04 0.499 0 964.9959 1,927.98 1,928.98 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% SKFADLSEAANRNNDALR 95.00% 3.51 0.405 0 997.0003 1,991.98 1,991.99 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EMEENFAVEAANYQDTIGR 95.00% 6.17 0.62 7.54 1,094.48 2,186.95 2,186.97 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EMEENFAVEAANYQDTIGR 95.00% 5.75 0.625 7.06 1,094.48 2,186.95 2,186.97 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EMEENFAVEAANYQDTIGR 95.00% 6.25 0.634 6.74 1,094.48 2,186.95 2,186.97 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EYQDLLNVK 95.00% 2.47 0.216 0.538 1,123.00 1,121.99 1,121.58 1 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EYQDLLNVK 95.00% 2.23 0.116 0.796 1,123.00 1,121.99 1,121.58 1 DESM_HUMAN
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% qVQSLTcEVDALKGTNESLER 95.00% 0 0 6.29 c7: Carbamidomethyl (+57.02), n-term: Pyro-cmC (-17.03) 1,181.07 2,360.13 2,360.14 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALKGTNESLER 95.00% 4.73 0.613 5.1 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALKGTNESLER 95.00% 4.78 0.612 4.82 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% QVQSLTcEVDALKGTNESLER 95.00% 4.48 0.58 4.37 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EEAENTLQSFRQDVDNASLAR 95.00% 3.99 0.406 0 1,197.57 2,393.12 2,393.13 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% EEAENTLQSFRQDVDNASLAR 95.00% 3.97 0.399 0 1,197.57 2,393.12 2,393.13 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TVETRDGQVINETSQHHDDLE 95.00% 4.18 0.513 4.85 1,212.55 2,423.09 2,423.11 2
 SAMPLE 2 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 53 73 337 76.00% TVETRDGQVINETSQHHDDLE 95.00% 4.04 0.546 4.42 1,212.56 2,423.10 2,423.11 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DVRQQYESVAAK 95.00% 3.46 0.459 1.19 465.2403 1,392.70 1,393.71 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DVRQQYESVAAK 95.00% 2.58 0.264 0 465.2422 1,392.70 1,393.71 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% MALDIEIATYRK 95.00% 3.17 0.233 0 475.5925 1,423.75 1,423.76 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% MALDIEIATYRK 95.00% 3.34 0.222 0 475.5933 1,423.76 1,423.76 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 2.72 0.267 0 476.9086 1,427.70 1,428.71 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 3.56 0.566 4.74 476.9091 1,427.70 1,428.71 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% mFGGPGTASR 95.00% 2.57 0.311 0 m1: Oxidation (+15.99) 498.7316 995.4475 996.4574 2 ATPG_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% mFGGPGTASR 95.00% 2.44 0.256 0 m1: Oxidation (+15.99) 498.7319 995.4481 996.4574 2 ATPG_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% mFGGPGTASR 95.00% 2.29 0.246 0 m1: Oxidation (+15.99) 498.7331 995.4506 996.4574 2 ATPG_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% mFGGPGTASR 95.00% 2.11 0.284 0 m1: Oxidation (+15.99) 498.7339 995.4521 996.4574 2 ATPG_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% MFGGPGTASRPSSSR 95.00% 1.55 0.213 1.07 498.9077 1,493.70 1,494.71 3 TPM4_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TYSLGSALRPSTSR 95.00% 1.9 0.245 1.24 499.2658 1,494.77 1,495.79 3 SPTA2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TYSLGSALRPSTSR 95.00% 1.6 0.281 0 499.2667 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TYSLGSALRPSTSR 95.00% 1.73 0.266 0 499.6004 1,495.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SRLGDLYEEEMR 95.00% 3.41 0.239 0 499.9046 1,496.69 1,497.70 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% mFGGPGTASRPSSSR 95.00% 1.78 0.24 1.04 m1: Oxidation (+15.99) 504.5756 1,510.70 1,510.71 3 TPM4_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% NLQEAEEWYKSK 95.00% 2.26 0.272 0 508.9147 1,523.72 1,524.73 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% HLREYQDLLNVK 95.00% 4.11 0.35 0 509.9456 1,526.81 1,527.83 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% HLREYQDLLNVK 95.00% 3.65 0.257 0 509.9467 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% HLREYQDLLNVK 95.00% 3.95 0.421 0 509.9469 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% HLREYQDLLNVK 95.00% 4.88 0.392 0.959 509.9471 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% HLREYQDLLNVK 95.00% 2.57 0.183 0 509.9487 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% HLREYQDLLNVK 95.00% 3.75 0.327 0 510.2818 1,527.82 1,527.83 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 5.25 0.309 3.19 511.9544 1,532.84 1,533.85 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 4.21 0.364 1.55 511.9545 1,532.84 1,533.85 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 3.82 0.323 1.77 511.9546 1,532.84 1,533.85 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 3.24 0.0698 1.07 511.9549 1,532.84 1,533.85 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 5.28 0.327 2.07 511.955 1,532.84 1,533.85 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 2.68 0.266 0 511.9554 1,532.84 1,533.85 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 2.15 0.358 0 513.9727 1,538.89 1,539.91 3 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 1.72 0.467 0 513.9741 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 1.76 0.353 0 513.9745 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 1.85 0.28 0 513.9747 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 1.64 0.4 0 513.9747 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 1.97 0.249 0 514.3078 1,539.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 1.72 0.288 0 514.3089 1,539.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQEEMLQR 95.00% 2.6 0.292 0 523.7679 1,045.52 1,046.53 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQEEMLQR 95.00% 2.66 0.275 0 523.7679 1,045.52 1,046.53 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 4.6 0.484 1.89 524.3022 1,569.88 1,570.90 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 3.57 0.441 0 524.3026 1,569.88 1,570.90 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 4.09 0.47 0.959 524.6366 1,570.89 1,570.90 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 3.84 0.488 1 524.6368 1,570.89 1,570.90 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 4.43 0.294 1.08 529.9366 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 3.47 0.32 0 529.9367 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 4.13 0.298 0 529.937 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 3.73 0.288 0 529.9371 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 4.46 0.286 0 529.9373 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 3.41 0.136 0 529.9373 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 3.9 0.325 1.07 530.27 1,587.79 1,587.80 3 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DNLAEDIMR 95.00% 2.77 0.23 1.25 538.755 1,075.49 1,076.50 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QDVDNASLAR 95.00% 2.35 0.367 1.28 544.7689 1,087.52 1,088.53 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANR 95.00% 4.01 0.45 0 547.2661 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANR 95.00% 3.83 0.474 1.82 547.2661 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANR 95.00% 2.73 0.376 1.85 547.2667 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANR 95.00% 3.68 0.45 1.16 547.2668 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANR 95.00% 3.94 0.426 0 547.2668 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANR 95.00% 3.88 0.51 1.31 547.2668 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANR 95.00% 3.22 0.442 2.68 547.2671 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANR 95.00% 4.09 0.438 1.15 547.2672 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANR 95.00% 3.57 0.484 1.7 547.2672 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANR 95.00% 3.75 0.458 1.64 547.2674 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANR 95.00% 2.86 0.428 2.32 547.2683 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANR 95.00% 2.92 0.407 2.82 547.7658 1,093.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLKK 95.00% 5.58 0.309 2.05 554.6531 1,660.94 1,661.95 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLKK 95.00% 4.74 0.135 1.52 554.6534 1,660.94 1,661.95 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLKK 95.00% 4.86 0.273 2.11 554.6535 1,660.94 1,661.95 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLKK 95.00% 4.42 0.17 0 554.6537 1,660.94 1,661.95 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ETNLDSLPLVDTHSK 95.00% 1.46 0.306 0 556.9525 1,667.83 1,668.84 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ETNLDSLPLVDTHSK 95.00% 1.59 0.319 0 556.9528 1,667.84 1,668.84 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ETNLDSLPLVDTHSK 95.00% 1.72 0.323 0 557.2871 1,668.84 1,668.84 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EYQDLLNVK 95.00% 1.83 0.321 0 561.2942 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EYQDLLNVK 95.00% 2.13 0.351 0 561.2949 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EYQDLLNVK 95.00% 2.09 0.341 0 561.295 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EYQDLLNVK 95.00% 2.09 0.36 0 561.2961 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FANYIDKVR 95.00% 3.01 0.434 0 563.3048 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FANYIDKVR 95.00% 3.37 0.384 0 563.3053 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FANYIDKVR 95.00% 2.84 0.366 1.12 563.3062 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 2.44 0.271 0 563.6118 1,687.81 1,688.83 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 3.63 0.435 0 563.6124 1,687.81 1,688.83 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 3.18 0.303 1.19 563.6126 1,687.81 1,688.83 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 3.36 0.465 1.31 563.613 1,687.82 1,688.83 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 2.37 0.361 0 563.6132 1,687.82 1,688.83 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 2.8 0.269 0 563.6133 1,687.82 1,688.83 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 2.62 0.415 0 563.6135 1,687.82 1,688.83 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 3.06 0.273 0 563.9467 1,688.82 1,688.83 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 2.87 0.218 0 563.9472 1,688.82 1,688.83 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 2.87 0.148 1.13 563.9473 1,688.82 1,688.83 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 3.46 0.444 0 563.9479 1,688.82 1,688.83 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDImR 95.00% 3.32 0.458 1.43 m13: Oxidation (+15.99) 568.9444 1,703.81 1,704.82 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDImR 95.00% 3.33 0.435 1.31 m13: Oxidation (+15.99) 569.2772 1,704.81 1,704.82 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDImR 95.00% 2.5 0.276 0 m13: Oxidation (+15.99) 569.2797 1,704.82 1,704.82 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDImR 95.00% 2.8 0.279 1.4 m13: Oxidation (+15.99) 569.281 1,704.82 1,704.82 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQDEIQNMKEEMAR 95.00% 2.28 0.245 0 578.9428 1,733.81 1,734.82 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQDEIQNMKEEMAR 95.00% 2.32 0.29 0 578.9433 1,733.81 1,734.82 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQDEIQNMKEEMAR 95.00% 2.07 0.29 0 578.9439 1,733.81 1,734.82 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLK 95.00% 3.76 0.314 1.34 585.3593 1,168.70 1,169.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLK 95.00% 3.78 0.333 1.3 585.3594 1,168.70 1,169.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLK 95.00% 4.17 0.297 0 585.3595 1,168.70 1,169.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLK 95.00% 3.82 0.261 1.51 585.3598 1,168.70 1,169.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLK 95.00% 3.95 0.315 1.17 585.3598 1,168.70 1,169.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLK 95.00% 3.66 0.257 2.89 585.3599 1,168.70 1,169.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLK 95.00% 3.1 0.298 2.04 585.36 1,168.70 1,169.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLK 95.00% 3.9 0.337 1.55 585.36 1,168.70 1,169.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLK 95.00% 4.13 0.294 1.85 585.3605 1,168.71 1,169.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLK 95.00% 3.18 0.279 1.72 585.3611 1,168.71 1,169.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TLLIKTVETR 95.00% 2.6 0.193 1.51 587.3628 1,172.71 1,173.72 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.42 0.359 0.959 592.9574 1,775.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 3.21 0.405 1.85 592.9581 1,775.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 3.01 0.313 2.49 592.9583 1,775.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.54 0.36 1.46 592.9583 1,775.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.21 0.281 1.92 592.9587 1,775.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.48 0.307 1.66 592.959 1,775.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.39 0.336 1.19 592.9591 1,775.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.15 0.361 1.24 593.2902 1,776.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.74 0.438 1.22 593.2916 1,776.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.4 0.239 1.72 593.292 1,776.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.76 0.374 2.01 593.292 1,776.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.86 0.232 1.85 593.2927 1,776.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.9 0.433 1.89 593.2928 1,776.85 1,776.86 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 2.43 0.298 0 612.9367 1,835.79 1,836.80 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 2.07 0.223 0 612.937 1,835.79 1,836.80 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 2.03 0.274 0 612.9374 1,835.79 1,836.80 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LGDLYEEEMR 95.00% 3.48 0.505 2.39 627.7862 1,253.56 1,254.57 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LGDLYEEEMR 95.00% 2.91 0.465 2 627.7864 1,253.56 1,254.57 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LGDLYEEEMR 95.00% 3.15 0.502 1.96 627.7867 1,253.56 1,254.57 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LGDLYEEEMR 95.00% 3.4 0.569 1.72 627.7868 1,253.56 1,254.57 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LGDLYEEEMR 95.00% 3.7 0.53 1.72 627.787 1,253.56 1,254.57 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LGDLYEEEmR 95.00% 2.28 0.315 3.2 m9: Oxidation (+15.99) 635.7849 1,269.55 1,270.56 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LGDLYEEEmR 95.00% 2.11 0.294 1.49 m9: Oxidation (+15.99) 635.7862 1,269.56 1,270.56 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATRSSAVR 95.00% 1.82 0.315 1.66 644.0011 1,928.98 1,928.98 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% NLQEAEEWYK 95.00% 3.29 0.371 2.14 655.3058 1,308.60 1,309.61 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% mALDIEIATYR 95.00% 1.99 0.345 3.25 m1: Oxidation (+15.99) 656.3355 1,310.66 1,311.66 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFR 95.00% 2.53 0.434 1.22 662.3112 1,322.61 1,323.62 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFR 95.00% 2.6 0.337 1.34 662.3113 1,322.61 1,323.62 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFR 95.00% 3.48 0.46 2.41 662.3114 1,322.61 1,323.62 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFR 95.00% 2.24 0.347 0 662.3116 1,322.61 1,323.62 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFR 95.00% 3.42 0.402 2.54 662.3117 1,322.61 1,323.62 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFR 95.00% 2.16 0.372 0 662.811 1,323.61 1,323.62 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALRQAK 95.00% 3.8 0.501 2.4 702.022 2,103.04 2,104.05 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALRQAK 95.00% 4.26 0.57 2.77 702.3561 2,104.04 2,104.05 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VESLQEEIAFLK 95.00% 3.18 0.239 2.37 703.3824 1,404.75 1,405.76 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFK 95.00% 6.17 0.634 5.46 709.6934 2,126.06 2,126.07 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFK 95.00% 5.86 0.609 4.33 709.6941 2,126.06 2,126.07 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% MALDIEIATYRK 95.00% 3.35 0.314 0 712.383 1,422.75 1,423.76 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% MALDIEIATYRK 95.00% 3.44 0.39 0 712.3835 1,422.75 1,423.76 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 4.19 0.58 5.89 714.8562 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 4.44 0.59 5.24 714.8575 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 4.34 0.567 6.24 714.8576 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 4.3 0.579 5.04 714.8578 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 4.31 0.581 5.68 714.8579 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 4.41 0.557 5.82 714.858 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 4.47 0.573 6.44 714.8589 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 2.67 0.362 2.15 714.8589 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 3.41 0.458 4.89 714.8592 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 3.99 0.596 5.18 714.8593 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 4.21 0.558 6.01 714.8596 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 2.47 0.437 4.28 714.8597 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 3.73 0.561 5.31 714.8598 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 3.3 0.52 4.89 714.8601 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 4.27 0.558 5.8 714.8603 1,427.70 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 3.59 0.554 5 714.8606 1,427.71 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 2.67 0.38 3.28 714.8607 1,427.71 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 2.94 0.449 3.62 714.8616 1,427.71 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SLYASSPGGVYATR 95.00% 4.71 0.566 7.24 715.3612 1,428.71 1,428.71 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VELQELNDRFANYIDKVR 95.00% 5.06 0.555 1.89 741.7237 2,222.15 2,222.16 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VELQELNDRFANYIDKVR 95.00% 4.78 0.606 2.11 741.7243 2,222.15 2,222.16 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALK 95.00% 4.13 0.508 3.38 c7: Carbamidomethyl (+57.02) 745.8796 1,489.74 1,490.75 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALK 95.00% 3.92 0.498 3.62 c7: Carbamidomethyl (+57.02) 745.8801 1,489.74 1,490.75 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALK 95.00% 2.94 0.405 0 c7: Carbamidomethyl (+57.02) 745.8808 1,489.75 1,490.75 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALK 95.00% 4.03 0.467 4.68 c7: Carbamidomethyl (+57.02) 746.3815 1,490.75 1,490.75 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% MFGGPGTASRPSSSR 95.00% 2.71 0.411 0 747.8578 1,493.70 1,494.71 2 TPM4_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% MFGGPGTASRPSSSR 95.00% 2.8 0.429 0 747.8601 1,493.70 1,494.71 2 TPM4_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TYSLGSALRPSTSR 95.00% 2.35 0.297 0 748.3961 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TYSLGSALRPSTSR 95.00% 2.54 0.408 0 748.3962 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TYSLGSALRPSTSR 95.00% 2.39 0.368 0 748.3968 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TYSLGSALRPSTSR 95.00% 2.48 0.293 0 748.3969 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TYSLGSALRPSTSR 95.00% 2.47 0.372 0 748.3974 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TYSLGSALRPSTSR 95.00% 2.49 0.341 0 748.3981 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TYSLGSALRPSTSR 95.00% 2.46 0.382 0 748.3985 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SRLGDLYEEEMR 95.00% 3.3 0.52 2.89 749.3534 1,496.69 1,497.70 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SRLGDLYEEEMR 95.00% 3.25 0.512 2.77 749.3557 1,496.70 1,497.70 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% NLQEAEEWYKSK 95.00% 4.24 0.44 3.29 762.8694 1,523.72 1,524.73 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% NLQEAEEWYKSK 95.00% 3.94 0.377 3 762.8704 1,523.73 1,524.73 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% HLREYQDLLNVK 95.00% 3.79 0.283 1.35 764.4164 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% HLREYQDLLNVK 95.00% 3.79 0.288 3.72 764.9202 1,527.82 1,527.83 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 5.17 0.331 4.66 767.4278 1,532.84 1,533.85 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VESLQEEIAFLKK 95.00% 3.94 0.324 2.55 767.4279 1,532.84 1,533.85 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 5.05 0.352 3.77 767.4289 1,532.84 1,533.85 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 4.64 0.375 3.57 767.4295 1,532.84 1,533.85 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 4.92 0.35 4.12 767.4298 1,532.84 1,533.85 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 5.27 0.369 3.55 767.43 1,532.84 1,533.85 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 4.67 0.343 4.55 767.4301 1,532.84 1,533.85 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 5.09 0.337 3.38 767.4301 1,532.84 1,533.85 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 4.35 0.363 4.29 767.4301 1,532.84 1,533.85 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 4.94 0.361 5.66 767.431 1,532.85 1,533.85 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VESLQEEIAFLKK 95.00% 3.74 0.248 3.59 767.4312 1,532.85 1,533.85 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLK 95.00% 4.55 0.371 4.7 767.4315 1,532.85 1,533.85 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 4.29 0.357 2.17 770.4558 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 4.47 0.382 4.89 770.4577 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 3.65 0.428 2.8 770.4577 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 3.73 0.382 1.74 770.4583 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 4.45 0.393 2.59 770.4585 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 4.43 0.374 2.57 770.4597 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 3.87 0.322 2.77 770.4608 1,538.91 1,539.91 2 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ILLAELEQLKGQGK 95.00% 3.9 0.399 2.51 770.9604 1,539.91 1,539.91 2 SEP11_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQEEMLQREEAENTLQSFR 95.00% 4.53 0.483 1.77 784.7142 2,351.12 2,351.13 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQEEMLQREEAENTLQSFR 95.00% 5.84 0.576 4.52 784.7159 2,351.12 2,351.13 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 2.26 0.265 0 785.9501 1,569.88 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 2.48 0.47 3.15 785.9501 1,569.88 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 2.33 0.443 1.47 785.9504 1,569.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 3.38 0.518 5.28 785.9505 1,569.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 3.44 0.504 4.42 785.9507 1,569.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 2.61 0.473 3.7 785.9508 1,569.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 2.55 0.329 2.89 785.951 1,569.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 2.97 0.495 3.77 785.9513 1,569.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 2.89 0.435 2.68 785.9514 1,569.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 2.57 0.432 1.14 785.9516 1,569.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 3.15 0.321 3.89 785.9521 1,569.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 3.04 0.501 3.96 785.953 1,569.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 3.12 0.535 1.96 785.9545 1,569.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 2.28 0.348 0 786.4508 1,570.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 3.28 0.474 3.11 786.4519 1,570.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ISLPLPNFSSLNLR 95.00% 3.45 0.498 3.3 786.4535 1,570.89 1,570.90 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 3.19 0.451 1.12 c7: Carbamidomethyl (+57.02) 793.3918 2,377.15 2,377.17 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 3.51 0.506 0 c7: Carbamidomethyl (+57.02) 793.3933 2,377.16 2,377.17 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 2.62 0.262 0 c7: Carbamidomethyl (+57.02) 793.3935 2,377.16 2,377.17 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 3.33 0.513 1.19 c7: Carbamidomethyl (+57.02) 793.3936 2,377.16 2,377.17 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 3.62 0.459 1 c7: Carbamidomethyl (+57.02) 793.3937 2,377.16 2,377.17 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 3.69 0.488 0 c7: Carbamidomethyl (+57.02) 793.394 2,377.16 2,377.17 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 3.19 0.448 1.21 c7: Carbamidomethyl (+57.02) 793.394 2,377.16 2,377.17 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 3.43 0.546 0 c7: Carbamidomethyl (+57.02) 793.3941 2,377.16 2,377.17 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 3.29 0.521 1.82 c7: Carbamidomethyl (+57.02) 793.3948 2,377.16 2,377.17 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 3.01 0.359 0 c7: Carbamidomethyl (+57.02) 793.3957 2,377.16 2,377.17 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 3.91 0.41 2.57 794.4023 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 4.41 0.486 2.96 794.4031 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 4.16 0.485 2.77 794.4033 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 3.5 0.461 2.22 794.4034 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 4.28 0.475 3.01 794.4034 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 4.01 0.498 2.15 794.4034 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 3.94 0.508 2.59 794.4036 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 4.43 0.471 3.08 794.4041 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TNEKVELQELNDR 95.00% 3.92 0.451 2.48 794.9028 1,587.79 1,587.80 2 DESM_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% SYVTTSTRTYSLGSALRPSTSR 95.00% 3.88 0.49 0 798.0798 2,391.22 2,391.23 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFRQDVDNASLAR 95.00% 2.96 0.268 0 798.7159 2,393.12 2,393.13 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFRQDVDNASLAR 95.00% 3.17 0.48 1.96 798.7159 2,393.12 2,393.13 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFRQDVDNASLAR 95.00% 3.3 0.33 0.959 798.716 2,393.12 2,393.13 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFRQDVDNASLAR 95.00% 4.05 0.573 2.19 798.7162 2,393.13 2,393.13 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFRQDVDNASLAR 95.00% 3.56 0.545 1.26 798.7162 2,393.13 2,393.13 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TVETRDGQVINETSQHHDDLE 95.00% 5.05 0.474 3.2 808.7063 2,423.10 2,423.11 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TVETRDGQVINETSQHHDDLE 95.00% 5.08 0.414 3.43 808.7072 2,423.10 2,423.11 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLKK 95.00% 5.06 0.453 4.57 831.4763 1,660.94 1,661.95 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLKK 95.00% 5.2 0.441 5.57 831.4771 1,660.94 1,661.95 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% KVESLQEEIAFLKK 95.00% 3.37 0.407 0 831.9059 1,661.80 1,661.95 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFKNTR 95.00% 3.52 0.381 2.17 833.423 2,497.25 2,497.26 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFKNTR 95.00% 2.7 0.188 2.19 833.4232 2,497.25 2,497.26 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFKNTR 95.00% 3.37 0.441 3 833.4235 2,497.25 2,497.26 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFKNTR 95.00% 2.94 0.356 2.38 833.4241 2,497.25 2,497.26 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFKNTR 95.00% 3.59 0.435 2 833.4243 2,497.25 2,497.26 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFKNTR 95.00% 3.41 0.505 1.7 833.4244 2,497.25 2,497.26 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFKNTR 95.00% 4.61 0.554 2.2 833.4247 2,497.25 2,497.26 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFKNTR 95.00% 3.16 0.386 2.48 833.4251 2,497.25 2,497.26 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFKNTR 95.00% 2.85 0.401 1.68 833.4255 2,497.25 2,497.26 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFKNTR 95.00% 3.75 0.416 1.22 833.4274 2,497.26 2,497.26 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ETNLDSLPLVDTHSK 95.00% 4.12 0.55 3.35 834.9242 1,667.83 1,668.84 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ETNLDSLPLVDTHSK 95.00% 4.08 0.549 3.48 834.9244 1,667.83 1,668.84 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 3.49 0.377 0 844.9157 1,687.82 1,688.83 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 3.38 0.416 1.68 844.916 1,687.82 1,688.83 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 3.65 0.451 0 844.9165 1,687.82 1,688.83 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 3.27 0.406 1.4 844.9167 1,687.82 1,688.83 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 3.25 0.365 1.57 844.9176 1,687.82 1,688.83 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDIMR 95.00% 3.2 0.347 1.51 844.9181 1,687.82 1,688.83 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDImR 95.00% 2.55 0.4 0 m13: Oxidation (+15.99) 852.9139 1,703.81 1,704.82 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% VEVERDNLAEDImR 95.00% 2.48 0.384 0 m13: Oxidation (+15.99) 852.9153 1,703.81 1,704.82 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQDEIQNMKEEMAR 95.00% 3.66 0.353 2.85 867.9021 1,733.79 1,734.82 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQDEIQNMKEEMAR 95.00% 4.97 0.374 5.19 867.9104 1,733.81 1,734.82 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQDEIQNMKEEMAR 95.00% 4.61 0.414 5.29 867.9132 1,733.81 1,734.82 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQDEIQNMKEEMAR 95.00% 4.51 0.371 5.19 868.4123 1,734.81 1,734.82 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EKLQEEMLQREEAENTLQSFR 95.00% 1.69 0.396 0 870.0688 2,607.18 2,608.27 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EKLQEEMLQREEAENTLQSFR 95.00% 2.38 0.383 0 870.0707 2,607.19 2,608.27 3
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQDEIQNmKEEMAR 95.00% 4.31 0.46 4.41 m8: Oxidation (+15.99) 875.9095 1,749.80 1,750.81 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQDEIQNmKEEMAR 95.00% 4.14 0.499 3.23 m8: Oxidation (+15.99) 875.9098 1,749.80 1,750.81 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LQDEIQNmKEEmAR 95.00% 3.95 0.581 0 m8: Oxidation (+15.99), m12: Oxidation (+15.99) 883.9055 1,765.80 1,766.81 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.43 0.196 1.8 888.9328 1,775.85 1,776.86 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.78 0.337 0 888.9337 1,775.85 1,776.86 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.95 0.326 0 889.4347 1,776.85 1,776.86 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% FADLSEAANRNNDALR 95.00% 2.73 0.328 0 889.4366 1,776.86 1,776.86 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LGDLYEEEMRELRR 95.00% 2.76 0.277 0 905.4516 1,808.89 1,808.90 2 COF1_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ETNLDSLPLVDTHSKR 95.00% 4.66 0.476 3.09 912.9745 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% ETNLDSLPLVDTHSKR 95.00% 4.54 0.38 2.54 913.4803 1,824.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.84 0.358 5.05 918.9013 1,835.79 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.63 0.437 3.08 918.9013 1,835.79 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.64 0.421 5.12 918.9015 1,835.79 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.5 0.405 4.96 918.9019 1,835.79 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.58 0.344 2.85 918.9021 1,835.79 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.68 0.355 3.92 918.9048 1,835.79 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.33 0.358 3.92 918.9051 1,835.79 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.05 0.281 1.41 919.3961 1,836.78 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.81 0.431 2.96 919.4013 1,836.79 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.55 0.294 4.3 919.4035 1,836.79 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.65 0.361 3.64 919.4035 1,836.79 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.73 0.396 4.09 919.404 1,836.79 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% DGQVINETSQHHDDLE 95.00% 3.66 0.333 3.08 919.4047 1,836.79 1,836.80 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% MFGGPGTASR 95.00% 1.65 0.324 0 981.4867 980.4789 980.4625 1 ATPG_HUMAN
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFK 95.00% 6.4 0.651 9.15 1,064.04 2,126.06 2,126.07 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFK 95.00% 6.39 0.641 9.7 1,064.04 2,126.06 2,126.07 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFK 95.00% 6.4 0.624 9.09 1,064.04 2,126.06 2,126.07 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EMEENFAVEAANYQDTIGR 95.00% 5.86 0.635 6.11 1,094.48 2,186.94 2,186.97 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EMEENFAVEAANYQDTIGR 95.00% 5.38 0.624 4.4 1,094.48 2,186.95 2,186.97 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EMEENFAVEAANYQDTIGR 95.00% 5.65 0.677 5.22 1,094.48 2,186.95 2,186.97 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EMEENFAVEAANYQDTIGR 95.00% 6.23 0.638 5.06 1,094.49 2,186.96 2,186.97 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EMEENFAVEAANYQDTIGR 95.00% 6.1 0.592 5.74 1,094.49 2,186.96 2,186.97 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% qVQSLTcEVDALKGTNESLER 95.00% 0 0 6.05 c7: Carbamidomethyl (+57.02), n-term: Pyro-cmC (-17.03) 1,181.07 2,360.13 2,360.14 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 4.44 0.587 5.1 c7: Carbamidomethyl (+57.02) 1,189.58 2,377.15 2,377.17 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 4.73 0.583 4.39 c7: Carbamidomethyl (+57.02) 1,189.58 2,377.15 2,377.17 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 4.64 0.595 3.74 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% QVQSLTcEVDALKGTNESLER 95.00% 4.42 0.534 3.85 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFRQDVDNASLAR 95.00% 4.04 0.441 1.28 1,197.57 2,393.12 2,393.13 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% EEAENTLQSFRQDVDNASLAR 95.00% 4.14 0.424 0 1,197.57 2,393.12 2,393.13 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TVETRDGQVINETSQHHDDLE 95.00% 4.32 0.454 3.72 1,212.56 2,423.10 2,423.11 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% TVETRDGQVINETSQHHDDLE 95.00% 3.85 0.477 4.96 1,212.56 2,423.10 2,423.11 2
 SAMPLE 2R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 48 71 321 78.50% LLQDSVDFSLADAINTEFKNTR 95.00% 5.19 0.653 7.64 1,249.63 2,497.25 2,497.26 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SYVTTSTR 95.00% 2.05 0.178 2.04 457.7341 913.4525 914.4583 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SYVTTSTR 94.70% 2.08 0.0595 3.14 457.7344 913.4531 914.4583 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DVRQQYESVAAK 95.00% 3.36 0.276 0 465.2404 1,392.70 1,393.71 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DVRQQYESVAAK 95.00% 3.05 0.45 1.74 465.2411 1,392.70 1,393.71 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LLEGEESR 95.00% 2.17 0.256 0 466.7375 931.4594 932.469 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LLEGEESR 95.00% 2.4 0.257 0 466.7378 931.4599 932.469 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LLEGEESR 95.00% 2.39 0.247 0 466.7381 931.4605 932.469 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MALDIEIATYRK 95.00% 3.43 0.305 1.96 475.2586 1,422.75 1,423.76 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MALDIEIATYRK 95.00% 2.87 0.287 0 475.2588 1,422.75 1,423.76 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 2.75 0.297 1.42 476.9091 1,427.70 1,428.71 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% mALDIEIATYRK 95.00% 2.45 0.315 0 m1: Oxidation (+15.99) 480.589 1,438.74 1,439.76 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALR 95.00% 3.11 0.402 0 484.2632 966.5108 967.5213 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALR 95.00% 3.47 0.44 0 484.2633 966.5109 967.5213 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MFGGPGTASR 95.00% 2.53 0.163 0 490.7332 979.4508 980.4625 2 ATPG_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MFGGPGTASR 95.00% 2.89 0.209 0 490.7333 979.451 980.4625 2 ATPG_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MFGGPGTASR 95.00% 2.86 0.279 0 490.7336 979.4516 980.4625 2 ATPG_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MFGGPGTASR 95.00% 2.61 0.156 0 490.734 979.4524 980.4625 2 ATPG_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% mFGGPGTASR 95.00% 2.9 0.265 0 m1: Oxidation (+15.99) 498.7312 995.4468 996.4574 2 ATPG_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% mFGGPGTASR 95.00% 3.1 0.27 0 m1: Oxidation (+15.99) 498.7315 995.4473 996.4574 2 ATPG_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% mFGGPGTASR 95.00% 2.15 0.277 0 m1: Oxidation (+15.99) 498.7323 995.449 996.4574 2 ATPG_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% mFGGPGTASR 95.00% 2.24 0.253 0 m1: Oxidation (+15.99) 498.7327 995.4497 996.4574 2 ATPG_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MFGGPGTASRPSSSR 95.00% 1.4 0.313 0 498.9076 1,493.70 1,494.71 3 TPM4_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MFGGPGTASRPSSSR 95.00% 1.5 0.414 0 498.9081 1,493.70 1,494.71 3 TPM4_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MFGGPGTASRPSSSR 95.00% 1.57 0.386 0 498.9087 1,493.70 1,494.71 3 TPM4_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2 0.437 1.51 499.2661 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.16 0.269 1.03 499.2664 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 1.8 0.177 1.89 499.2668 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.23 0.223 1.47 499.2671 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 1.7 0.272 1.7 499.2673 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.04 0.208 0 499.2675 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.24 0.186 0 499.2679 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.29 0.285 1.26 499.268 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SRLGDLYEEEMR 95.00% 3.63 0.293 0 499.9037 1,496.69 1,497.70 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SRLGDLYEEEMR 95.00% 3.86 0.333 0 499.9044 1,496.69 1,497.70 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SRLGDLYEEEMR 95.00% 3.61 0.219 0 499.9045 1,496.69 1,497.70 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% mFGGPGTASRPSSSR 95.00% 1.67 0.264 0 m1: Oxidation (+15.99) 504.2408 1,509.70 1,510.71 3 TPM4_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% mFGGPGTASRPSSSR 95.00% 1.69 0.169 1.28 m1: Oxidation (+15.99) 504.2415 1,509.70 1,510.71 3 TPM4_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% mFGGPGTASRPSSSR 95.00% 1.6 0.311 1.59 m1: Oxidation (+15.99) 504.5735 1,510.70 1,510.71 3 TPM4_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYKSK 95.00% 1.73 0.27 0 508.9145 1,523.72 1,524.73 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYKSK 95.00% 2.33 0.409 0 508.9148 1,523.72 1,524.73 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYKSK 95.00% 1.86 0.246 0 508.915 1,523.72 1,524.73 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYKSK 95.00% 2.22 0.224 0 508.915 1,523.72 1,524.73 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 5.29 0.364 0 509.9459 1,526.81 1,527.83 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 4.22 0.343 0 509.9466 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 4.36 0.372 0 509.9467 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 5.54 0.35 0 509.9467 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 3.66 0.328 0 509.9467 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 3.76 0.286 0 509.9467 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 4.29 0.349 0 509.9468 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 2.87 0.277 0 509.9469 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 4.5 0.372 0 509.9469 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 2.84 0.202 0 509.9473 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 4.46 0.367 0 510.2805 1,527.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 4.48 0.306 0 510.2805 1,527.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 4.57 0.315 1.32 511.9536 1,532.84 1,533.85 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.24 0.338 1.36 511.9547 1,532.84 1,533.85 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.32 0.382 1.57 511.9548 1,532.84 1,533.85 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.56 0.34 1.3 511.955 1,532.84 1,533.85 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.89 0.359 1.21 511.9551 1,532.84 1,533.85 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.82 0.341 1.51 511.9551 1,532.84 1,533.85 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.26 0.302 1 511.9552 1,532.84 1,533.85 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 4.89 0.365 0 511.9553 1,532.84 1,533.85 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.02 0.341 1.96 511.9554 1,532.84 1,533.85 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 2.43 0.205 0 512.0148 1,533.02 1,533.85 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 4.81 0.384 1.85 512.2888 1,533.84 1,533.85 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 1.88 0.33 0 513.9742 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 2.03 0.37 0 513.9743 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 2.12 0.411 0 513.9743 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 2 0.392 0 513.9745 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 1.75 0.368 0 513.9749 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 1.91 0.325 1.2 514.3081 1,539.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 1.87 0.255 0 514.3082 1,539.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 2.37 0.25 0 514.3088 1,539.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQEEMLQR 95.00% 3.03 0.26 0 523.768 1,045.52 1,046.53 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQEEMLQR 95.00% 3.09 0.293 0 523.7682 1,045.52 1,046.53 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQEEMLQR 95.00% 2.31 0.295 0 523.7684 1,045.52 1,046.53 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.77 0.367 1.19 529.9362 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.01 0.352 0.959 529.9363 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.21 0.351 1 529.9365 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.25 0.326 0 529.9368 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 3.87 0.35 1.51 529.9368 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.71 0.377 1.68 529.9369 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 3.66 0.27 0 529.9371 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.15 0.269 0 529.9376 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 3.5 0.343 0 529.9385 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 2.83 0.319 0 529.9391 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 3.62 0.315 0 529.9393 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 3.09 0.385 0 529.9401 1,586.80 1,587.80 3 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DNLAEDIMR 95.00% 2.79 0.133 0 538.7534 1,075.49 1,076.50 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DNLAEDIMR 95.00% 2.84 0.225 0 538.7539 1,075.49 1,076.50 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DNLAEDIMR 95.00% 2.78 0.167 0 538.7545 1,075.49 1,076.50 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DNLAEDIMR 95.00% 1.83 0.238 1.11 538.7546 1,075.49 1,076.50 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DNLAEDIMR 95.00% 2.67 0.321 0 538.7547 1,075.49 1,076.50 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DNLAEDIMR 95.00% 2.85 0.294 0 538.7548 1,075.49 1,076.50 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DNLAEDIMR 95.00% 2.61 0.194 0 538.7549 1,075.49 1,076.50 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DNLAEDIMR 95.00% 2.75 0.18 1.37 538.7551 1,075.49 1,076.50 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QDVDNASLAR 95.00% 2.34 0.384 0 544.7687 1,087.52 1,088.53 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QDVDNASLAR 95.00% 2.48 0.322 1.85 544.7693 1,087.52 1,088.53 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QDVDNASLAR 95.00% 2.65 0.342 1.11 544.7697 1,087.52 1,088.53 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QDVDNASLAR 95.00% 2.74 0.326 1.89 544.7697 1,087.52 1,088.53 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QDVDNASLAR 95.00% 2.03 0.173 1.89 544.7697 1,087.52 1,088.53 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QDVDNASLAR 95.00% 1.91 0.264 0 544.77 1,087.52 1,088.53 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 2.83 0.348 1.29 547.2646 1,092.51 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 2.77 0.284 1.59 547.2657 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 2.69 0.281 1.16 547.2657 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.67 0.453 1.16 547.2659 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 2.26 0.356 1.64 547.2661 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.39 0.472 1.72 547.2661 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.73 0.459 1.35 547.2662 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.67 0.461 0 547.2665 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.82 0.447 1.12 547.2665 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.71 0.418 1.49 547.2667 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.46 0.494 1.8 547.2668 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.67 0.46 1.11 547.2668 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.56 0.501 1.33 547.2668 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.69 0.451 1.66 547.2668 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.16 0.409 1.85 547.2668 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3 0.483 0 547.2671 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.62 0.447 1.54 547.2672 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 2.75 0.323 0 547.2674 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 4.22 0.45 1.16 547.2674 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.53 0.448 1.43 547.2676 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 4.05 0.437 2.37 547.2677 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.48 0.464 1.41 547.2677 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.79 0.477 2.01 547.2681 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 2.98 0.392 1.59 547.2697 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 3.49 0.387 2.23 547.2709 1,092.53 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 2.96 0.442 0 547.7686 1,093.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 2.76 0.348 1.09 547.7686 1,093.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANR 95.00% 2.57 0.343 1.47 547.7707 1,093.53 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 4.4 0.152 0 554.6525 1,660.93 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 5.15 0.207 1.37 554.6526 1,660.93 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 4.17 0.191 1.36 554.6528 1,660.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 5.26 0.218 2.48 554.6532 1,660.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 4.17 0.132 1.42 554.6534 1,660.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 5.5 0.265 1.85 554.6535 1,660.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 4.9 0.259 1.17 554.6536 1,660.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 2.99 0.232 0 554.6536 1,660.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 5.04 0.219 1.35 554.654 1,660.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 4.18 0.0883 0 554.6544 1,660.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 2.3 0.179 0 554.6558 1,660.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 3.79 0.162 0 554.6562 1,660.95 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 4 0.0963 0 554.9875 1,661.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 5.46 0.277 2.46 554.9878 1,661.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 4.97 0.276 1.77 554.9879 1,661.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 4.89 0.132 0 554.9879 1,661.94 1,661.95 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSK 94.80% 1.73 0.292 0 557.2866 1,668.84 1,668.84 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VELQELNDR 95.00% 2.92 0.329 1.64 558.287 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VELQELNDR 95.00% 2.96 0.339 0 558.2871 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VELQELNDR 95.00% 3.11 0.305 0 558.2879 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VELQELNDR 95.00% 3.2 0.347 0 558.2879 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VELQELNDR 95.00% 2.94 0.362 1.96 558.2879 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VELQELNDR 95.00% 3.21 0.317 0 558.2879 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VELQELNDR 95.00% 3.01 0.385 0 558.2882 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VELQELNDR 95.00% 2.62 0.355 1.31 558.2883 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EYQDLLNVK 95.00% 1.88 0.303 0 561.2943 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EYQDLLNVK 95.00% 2.52 0.319 0 561.2944 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EYQDLLNVK 95.00% 2.12 0.305 0 561.2944 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EYQDLLNVK 95.00% 2.02 0.313 0 561.2945 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EYQDLLNVK 95.00% 2.19 0.298 1.47 561.2945 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EYQDLLNVK 95.00% 1.95 0.343 0 561.2946 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EYQDLLNVK 95.00% 2.29 0.345 0 561.2946 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EYQDLLNVK 95.00% 2.11 0.354 0 561.2948 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EYQDLLNVK 95.00% 2.11 0.373 0 561.295 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EYQDLLNVK 95.00% 1.88 0.341 0 561.2957 1,120.58 1,121.58 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EYQDLLNVK 95.00% 2.16 0.336 0 561.7957 1,121.58 1,121.58 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FANYIDKVR 95.00% 2.81 0.369 1.24 563.3051 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FANYIDKVR 95.00% 3.19 0.367 1.23 563.3052 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FANYIDKVR 95.00% 3.19 0.389 1.43 563.3054 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FANYIDKVR 95.00% 3.24 0.399 1.21 563.3055 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FANYIDKVR 95.00% 3.21 0.376 0 563.3056 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FANYIDKVR 95.00% 3.14 0.396 1.32 563.3058 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FANYIDKVR 95.00% 2.97 0.399 0 563.3059 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FANYIDKVR 95.00% 3.09 0.393 1.08 563.3061 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.42 0.266 0 563.6122 1,687.81 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.05 0.325 1.33 563.6124 1,687.81 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.94 0.405 1.77 563.6127 1,687.81 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.82 0.372 2.41 563.6128 1,687.81 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.61 0.419 1.92 563.6129 1,687.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 2.99 0.339 1.59 563.613 1,687.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 2.94 0.299 1.6 563.613 1,687.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.76 0.378 1.8 563.6132 1,687.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.77 0.4 1.68 563.6133 1,687.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.35 0.416 1.89 563.6135 1,687.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.58 0.465 2.02 563.6135 1,687.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.13 0.385 2.38 563.6136 1,687.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 4.2 0.444 2.57 563.6138 1,687.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 2.83 0.268 0 563.6143 1,687.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 2.68 0.161 0 563.6144 1,687.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.33 0.32 0 563.6153 1,687.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.53 0.403 1.92 563.9468 1,688.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.43 0.315 1.57 563.9471 1,688.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.48 0.318 1.47 563.9471 1,688.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.17 0.358 2.02 563.9476 1,688.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 2.72 0.229 0 563.9484 1,688.82 1,688.83 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDImR 95.00% 3.35 0.438 1.6 m13: Oxidation (+15.99) 568.9445 1,703.81 1,704.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDImR 95.00% 3.85 0.428 0 m13: Oxidation (+15.99) 568.9449 1,703.81 1,704.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDImR 95.00% 3.62 0.419 2 m13: Oxidation (+15.99) 568.9451 1,703.81 1,704.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDImR 95.00% 3.36 0.391 2.89 m13: Oxidation (+15.99) 568.9452 1,703.81 1,704.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDImR 95.00% 2.82 0.352 1.37 m13: Oxidation (+15.99) 568.9452 1,703.81 1,704.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDImR 95.00% 3.69 0.455 3.05 m13: Oxidation (+15.99) 568.9456 1,703.81 1,704.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 1.88 0.177 1.29 578.9426 1,733.80 1,734.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 2.66 0.236 0 578.9428 1,733.81 1,734.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 2.51 0.341 0 578.9428 1,733.81 1,734.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 2.73 0.199 0 578.9429 1,733.81 1,734.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 2.16 0.199 0 578.9429 1,733.81 1,734.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 2.04 0.194 1.55 578.943 1,733.81 1,734.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 2.65 0.308 0 578.9431 1,733.81 1,734.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 2.44 0.231 1.92 578.9434 1,733.81 1,734.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 2.33 0.297 0 579.2751 1,734.80 1,734.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 2.81 0.288 0 579.2762 1,734.81 1,734.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 2.39 0.288 0 579.2776 1,734.81 1,734.82 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 2.17 0.247 1.64 585.3589 1,168.70 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 2.94 0.325 1.23 585.3592 1,168.70 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 3.71 0.262 0 585.3593 1,168.70 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 3.81 0.241 0 585.3594 1,168.70 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 3.91 0.308 1.49 585.3596 1,168.70 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 4.06 0.311 1.39 585.3597 1,168.70 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 3.91 0.316 1.16 585.3598 1,168.70 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 3.92 0.267 1.11 585.3598 1,168.70 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 4.13 0.31 1.18 585.3602 1,168.70 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 4.12 0.307 0 585.3604 1,168.71 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 3.94 0.255 0 585.3606 1,168.71 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 3.98 0.261 1.36 585.3607 1,168.71 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 3.21 0.332 0 585.3609 1,168.71 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 3.4 0.234 1.38 585.3617 1,168.71 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 3.14 0.295 1.85 585.3623 1,168.71 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLK 95.00% 3.19 0.252 2.04 585.3628 1,168.71 1,169.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.71 0.366 1.19 592.9579 1,775.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.91 0.358 2.41 592.9581 1,775.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.69 0.312 1.85 592.9582 1,775.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 3.04 0.407 2.48 592.9583 1,775.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.88 0.423 1.8 592.9585 1,775.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.81 0.386 1.66 592.9586 1,775.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.87 0.373 1.66 592.9587 1,775.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 3.03 0.444 2.24 592.959 1,775.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.85 0.248 0 592.959 1,775.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 3.11 0.487 2.04 592.959 1,775.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.41 0.338 0.959 592.9596 1,775.86 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.67 0.357 1.33 593.284 1,776.83 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.82 0.39 1.66 593.2909 1,776.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.88 0.36 2.38 593.2921 1,776.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.64 0.382 3.27 593.2924 1,776.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 3.13 0.405 2.14 593.2925 1,776.85 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 1.97 0.216 2.77 593.2928 1,776.86 1,776.86 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMRELRR 95.00% 3.71 0.328 1.07 603.6354 1,807.88 1,808.90 3 COF1_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMRELRR 95.00% 3.26 0.212 1 603.6356 1,807.88 1,808.90 3 COF1_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMRELRR 95.00% 3.65 0.379 1.74 603.6359 1,807.88 1,808.90 3 COF1_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMRELRR 95.00% 3.01 0.155 0 603.9697 1,808.89 1,808.90 3 COF1_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMRELRR 95.00% 3.21 0.228 0 603.97 1,808.89 1,808.90 3 COF1_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMRELRR 95.00% 3.76 0.323 1.23 603.9704 1,808.89 1,808.90 3 COF1_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMRELRR 95.00% 3.52 0.275 0 603.9706 1,808.89 1,808.90 3 COF1_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMRELRR 95.00% 3 0.258 1 603.9709 1,808.89 1,808.90 3 COF1_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSKR 95.00% 2.05 0.234 0 608.986 1,823.93 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSKR 95.00% 1.89 0.232 0 608.9861 1,823.93 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSKR 95.00% 2.27 0.259 2.17 608.9861 1,823.93 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSKR 95.00% 2.05 0.401 0 608.9871 1,823.94 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 2.5 0.272 0 612.9369 1,835.79 1,836.80 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 2.2 0.317 0 612.9373 1,835.79 1,836.80 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 2.32 0.342 0 612.9373 1,835.79 1,836.80 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 1.75 0.241 0 612.9382 1,835.79 1,836.80 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 2.67 0.34 1.82 627.7844 1,253.55 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 2.97 0.503 1.89 627.7859 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 3.69 0.492 3 627.7859 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 3.76 0.523 3.03 627.786 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 2.53 0.359 0 627.7861 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 3.74 0.537 2.37 627.7863 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 3.67 0.537 2.19 627.7865 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 3.76 0.511 2.77 627.7865 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 4.11 0.506 2 627.7868 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 3.78 0.524 1.66 627.787 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 3.71 0.503 2.92 627.7872 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 2.88 0.462 2.8 627.7874 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 3.88 0.545 3.29 627.7877 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 3 0.567 2.26 627.7882 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 3.15 0.389 2.96 627.7886 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 2.91 0.462 2.54 627.7888 1,253.56 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMR 95.00% 3.16 0.469 2.49 627.7906 1,253.57 1,254.57 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEmR 95.00% 3.09 0.494 3.21 m9: Oxidation (+15.99) 635.7863 1,269.56 1,270.56 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEmR 95.00% 2.25 0.246 0 m9: Oxidation (+15.99) 635.7877 1,269.56 1,270.56 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ARVEVERDNLAEDIMR 95.00% 2.74 0.265 0 639.3235 1,914.95 1,915.97 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ARVEVERDNLAEDIMR 95.00% 2.88 0.342 1.17 639.3239 1,914.95 1,915.97 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVDQLTNDKAR 95.00% 2.24 0.172 1.14 644.3396 1,286.66 1,287.67 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MALDIEIATYR 95.00% 2.75 0.38 1.74 648.3369 1,294.66 1,295.67 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MALDIEIATYR 95.00% 4.37 0.384 3.6 648.3374 1,294.66 1,295.67 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MALDIEIATYR 95.00% 3.78 0.382 3.42 648.3376 1,294.66 1,295.67 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MALDIEIATYR 95.00% 2.71 0.414 1.89 648.3396 1,294.66 1,295.67 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MALDIEIATYR 95.00% 3.48 0.425 2.15 648.3397 1,294.66 1,295.67 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EKLQEEMLQR 95.00% 2.73 0.337 0 652.3363 1,302.66 1,303.67 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EKLQEEMLQR 95.00% 3.24 0.356 1.59 652.3371 1,302.66 1,303.67 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EKLQEEMLQR 95.00% 2.93 0.357 0 652.3372 1,302.66 1,303.67 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EKLQEEMLQR 95.00% 3.04 0.364 1.29 652.3372 1,302.66 1,303.67 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EKLQEEMLQR 95.00% 2.89 0.379 0 652.3374 1,302.66 1,303.67 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EKLQEEMLQR 95.00% 2.9 0.376 0 652.338 1,302.66 1,303.67 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SKFADLSEAANR 95.00% 3.68 0.591 2.96 654.8296 1,307.64 1,308.65 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 2.17 0.341 0 655.3046 1,308.59 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 3.16 0.481 2.8 655.3048 1,308.59 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 2.86 0.331 0 655.3051 1,308.59 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 3.37 0.352 1.96 655.3054 1,308.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 3.25 0.397 1.85 655.3056 1,308.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 2.33 0.426 2.23 655.3057 1,308.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 3.79 0.438 2.7 655.3058 1,308.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 2.8 0.384 2.21 655.306 1,308.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 3.47 0.487 2.74 655.3062 1,308.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 2.86 0.331 1.57 655.3064 1,308.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 3.11 0.351 1.51 655.3068 1,308.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 3.27 0.426 2.64 655.3068 1,308.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 2.74 0.388 2.44 655.307 1,308.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 3.67 0.44 1.8 655.3072 1,308.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 3.17 0.443 1.8 655.3073 1,308.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 3.73 0.408 2.47 655.8061 1,309.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 2.33 0.301 0 655.8064 1,309.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 2.54 0.329 0 655.8081 1,309.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYK 95.00% 2.29 0.37 1.77 655.8084 1,309.60 1,309.61 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% mALDIEIATYR 95.00% 2.23 0.357 2.34 m1: Oxidation (+15.99) 656.3304 1,310.65 1,311.66 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% mALDIEIATYR 95.00% 2.27 0.39 0 m1: Oxidation (+15.99) 656.3328 1,310.65 1,311.66 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% mALDIEIATYR 95.00% 2.19 0.41 2.03 m1: Oxidation (+15.99) 656.3343 1,310.65 1,311.66 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% mALDIEIATYR 95.00% 3.55 0.505 2.52 m1: Oxidation (+15.99) 656.3353 1,310.65 1,311.66 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EKLQEEmLQR 95.00% 2.98 0.368 1.24 m7: Oxidation (+15.99) 660.3366 1,318.66 1,319.66 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EKLQEEmLQR 95.00% 2.88 0.254 1.27 m7: Oxidation (+15.99) 660.8353 1,319.65 1,319.66 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 2.04 0.281 0 662.3081 1,322.60 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 2.41 0.248 0 662.3097 1,322.60 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 2.09 0.286 0 662.3105 1,322.61 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 3.1 0.429 1.68 662.3109 1,322.61 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 3.18 0.436 1.38 662.3112 1,322.61 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 3.21 0.408 2.55 662.3119 1,322.61 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 1.81 0.328 0 662.312 1,322.61 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 2.75 0.452 0 662.312 1,322.61 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 3.26 0.43 1.72 662.3122 1,322.61 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 2.67 0.347 1.36 662.3125 1,322.61 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 2.71 0.426 0 662.3144 1,322.61 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 2.84 0.398 0 662.3165 1,322.62 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFR 95.00% 2.59 0.505 0 662.8119 1,323.61 1,323.62 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DVRQQYESVAAK 95.00% 2.87 0.408 1.57 697.3567 1,392.70 1,393.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MALDIEIATYRK 95.00% 3.05 0.354 0 712.3824 1,422.75 1,423.76 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MALDIEIATYRK 95.00% 3.47 0.351 2.2 712.3836 1,422.75 1,423.76 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.52 0.555 6.13 714.8576 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 3.56 0.471 6.82 714.8578 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.37 0.55 4.6 714.8581 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.47 0.585 4.92 714.8588 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.6 0.583 6.48 714.8589 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.47 0.583 6.43 714.8589 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.4 0.588 5.36 714.8589 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.57 0.58 6 714.8589 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 3.75 0.481 3.85 714.859 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.52 0.566 5.96 714.859 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.43 0.603 5.13 714.8592 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.32 0.585 6.37 714.8592 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.29 0.563 6.06 714.8592 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.64 0.563 5.85 714.8592 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.44 0.571 5.96 714.8593 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 3.91 0.568 6.18 714.8596 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.33 0.55 5.72 714.8596 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 3.18 0.421 4.82 714.8597 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 3.54 0.435 4.8 714.8597 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 3.03 0.39 2.44 714.8603 1,427.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 3.88 0.569 5 714.8604 1,427.71 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.06 0.501 3.92 714.8607 1,427.71 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 2.7 0.543 1.29 714.8612 1,427.71 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SLYASSPGGVYATR 95.00% 4.08 0.537 4.62 715.3602 1,428.70 1,428.71 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EMEENFAVEAANYQDTIGR 95.00% 3.48 0.444 2.13 729.6595 2,185.96 2,186.97 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EMEENFAVEAANYQDTIGR 95.00% 6.44 0.529 4.72 729.9937 2,186.96 2,186.97 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EMEENFAVEAANYQDTIGR 95.00% 4.86 0.642 3.57 729.9937 2,186.96 2,186.97 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EMEENFAVEAANYQDTIGR 95.00% 6.2 0.544 4.52 729.9949 2,186.96 2,186.97 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VELQELNDRFANYIDKVR 95.00% 4.73 0.555 3.66 741.7249 2,222.15 2,222.16 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALK 95.00% 3.8 0.524 3.82 c7: Carbamidomethyl (+57.02) 745.878 1,489.74 1,490.75 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALK 95.00% 2.02 0.351 0 c7: Carbamidomethyl (+57.02) 745.878 1,489.74 1,490.75 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALK 95.00% 4.48 0.535 3.85 c7: Carbamidomethyl (+57.02) 745.8782 1,489.74 1,490.75 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALK 95.00% 4.61 0.546 4.8 c7: Carbamidomethyl (+57.02) 745.8783 1,489.74 1,490.75 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALK 95.00% 3.39 0.497 2.89 c7: Carbamidomethyl (+57.02) 745.8789 1,489.74 1,490.75 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALK 95.00% 3.52 0.484 2.54 c7: Carbamidomethyl (+57.02) 745.8791 1,489.74 1,490.75 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALK 95.00% 3.71 0.471 3.74 c7: Carbamidomethyl (+57.02) 745.8797 1,489.74 1,490.75 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALK 95.00% 2.74 0.38 0 c7: Carbamidomethyl (+57.02) 745.8809 1,489.75 1,490.75 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALK 95.00% 3.71 0.497 2.77 c7: Carbamidomethyl (+57.02) 745.881 1,489.75 1,490.75 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALK 95.00% 3.46 0.445 2.28 c7: Carbamidomethyl (+57.02) 746.3797 1,490.74 1,490.75 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MFGGPGTASRPSSSR 95.00% 2.55 0.411 0 747.8581 1,493.70 1,494.71 2 TPM4_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MFGGPGTASRPSSSR 95.00% 2.91 0.368 0 747.8591 1,493.70 1,494.71 2 TPM4_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MFGGPGTASRPSSSR 95.00% 2.38 0.381 0 747.8597 1,493.70 1,494.71 2 TPM4_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% MFGGPGTASRPSSSR 95.00% 2.75 0.394 0 747.8603 1,493.70 1,494.71 2 TPM4_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.59 0.39 0 748.3917 1,494.77 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.52 0.343 0 748.3954 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.39 0.326 0 748.3956 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.46 0.333 0 748.3957 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.16 0.317 0 748.3958 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.53 0.429 0 748.3959 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.58 0.403 0 748.3963 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.5 0.396 0 748.3964 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.24 0.289 0 748.3965 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.51 0.295 0 748.3966 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.56 0.381 0 748.3968 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TYSLGSALRPSTSR 95.00% 2.56 0.416 0 748.3981 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SRLGDLYEEEMR 95.00% 3.02 0.357 3.17 749.3504 1,496.69 1,497.70 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SRLGDLYEEEMR 95.00% 3.1 0.447 3 749.354 1,496.69 1,497.70 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SRLGDLYEEEMR 95.00% 3.07 0.466 2.29 749.3561 1,496.70 1,497.70 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SRLGDLYEEEMR 95.00% 3.51 0.455 2.8 749.3562 1,496.70 1,497.70 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SRLGDLYEEEMR 95.00% 3.03 0.379 2.51 749.8551 1,497.69 1,497.70 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SRLGDLYEEEMR 95.00% 2.94 0.418 2.52 749.8562 1,497.70 1,497.70 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYKSK 95.00% 3.89 0.45 4.28 762.8687 1,523.72 1,524.73 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% NLQEAEEWYKSK 95.00% 4.13 0.435 3.17 762.8698 1,523.72 1,524.73 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 3.94 0.303 1.43 764.417 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 3.19 0.32 0 764.4175 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 3.62 0.267 0 764.4181 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 3.84 0.279 1.16 764.4192 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% HLREYQDLLNVK 95.00% 3.82 0.268 1.82 764.9189 1,527.82 1,527.83 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.72 0.365 3.55 767.4275 1,532.84 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.16 0.331 3.54 767.4285 1,532.84 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 4.98 0.365 4.27 767.4285 1,532.84 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.18 0.374 3.55 767.429 1,532.84 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 4.95 0.319 4.96 767.429 1,532.84 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VESLQEEIAFLKK 95.00% 4.16 0.24 3.24 767.429 1,532.84 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.39 0.358 4.09 767.4292 1,532.84 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.39 0.364 2.59 767.4294 1,532.84 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 5.23 0.308 3.55 767.43 1,532.84 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 4.86 0.307 4.28 767.4303 1,532.85 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 4.84 0.344 3.42 767.4304 1,532.85 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 4.71 0.245 4.1 767.4315 1,532.85 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 4.77 0.352 4.36 767.4317 1,532.85 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLK 95.00% 4.15 0.294 3.92 767.9359 1,533.86 1,533.85 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.19 0.375 1.96 770.4566 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.62 0.396 2.7 770.4568 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 3.33 0.516 0 770.4569 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.5 0.349 3.28 770.4575 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.6 0.36 2.07 770.4576 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 3.68 0.413 2.62 770.4577 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.58 0.407 1.82 770.4579 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.52 0.368 2.39 770.458 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.05 0.37 2.23 770.458 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.57 0.364 3 770.4582 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.37 0.374 2.06 770.4584 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 3.76 0.376 3.7 770.4586 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.42 0.35 1.82 770.4597 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 3.8 0.456 3.01 770.4602 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 3.61 0.422 1.82 770.4627 1,538.91 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.28 0.42 2.96 770.9573 1,539.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.58 0.333 1.55 770.9575 1,539.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 4.72 0.394 1.42 770.9602 1,539.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ILLAELEQLKGQGK 95.00% 3.82 0.351 2 770.9624 1,539.91 1,539.91 2 SEP11_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQEEMLQREEAENTLQSFR 95.00% 5.49 0.56 4.85 784.714 2,351.12 2,351.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQEEMLQREEAENTLQSFR 95.00% 5.84 0.573 3.85 784.7142 2,351.12 2,351.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQEEMLQREEAENTLQSFR 95.00% 4.07 0.51 2.29 784.715 2,351.12 2,351.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQEEMLQREEAENTLQSFR 95.00% 6.12 0.633 4.92 784.715 2,351.12 2,351.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQEEMLQREEAENTLQSFR 95.00% 5.84 0.596 3.39 784.7169 2,351.13 2,351.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ISLPLPNFSSLNLR 95.00% 3.11 0.336 2.66 786.4524 1,570.89 1,570.90 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ISLPLPNFSSLNLR 95.00% 2.24 0.334 0 786.4535 1,570.89 1,570.90 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ISLPLPNFSSLNLR 95.00% 2.86 0.409 2.8 786.4553 1,570.89 1,570.90 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.23 0.577 1.43 c7: Carbamidomethyl (+57.02) 793.0603 2,376.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.83 0.54 1.85 c7: Carbamidomethyl (+57.02) 793.3919 2,377.15 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.45 0.487 2.05 c7: Carbamidomethyl (+57.02) 793.393 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 2.92 0.358 0 c7: Carbamidomethyl (+57.02) 793.3932 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.48 0.405 0 c7: Carbamidomethyl (+57.02) 793.3933 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.16 0.486 2.39 c7: Carbamidomethyl (+57.02) 793.3934 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.36 0.424 0 c7: Carbamidomethyl (+57.02) 793.3935 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.41 0.494 2.41 c7: Carbamidomethyl (+57.02) 793.3937 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.44 0.524 2.23 c7: Carbamidomethyl (+57.02) 793.3937 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.08 0.485 0 c7: Carbamidomethyl (+57.02) 793.3937 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.27 0.518 0 c7: Carbamidomethyl (+57.02) 793.3939 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.27 0.502 1.38 c7: Carbamidomethyl (+57.02) 793.394 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.54 0.463 1.16 c7: Carbamidomethyl (+57.02) 793.394 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.48 0.507 1.7 c7: Carbamidomethyl (+57.02) 793.3941 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.28 0.517 2.02 c7: Carbamidomethyl (+57.02) 793.3941 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.2 0.446 0 c7: Carbamidomethyl (+57.02) 793.3943 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.27 0.402 1.54 c7: Carbamidomethyl (+57.02) 793.3943 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.36 0.432 1.32 c7: Carbamidomethyl (+57.02) 793.3943 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.18 0.488 1.02 c7: Carbamidomethyl (+57.02) 793.3947 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.32 0.407 1.21 c7: Carbamidomethyl (+57.02) 793.395 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.24 0.491 1.02 c7: Carbamidomethyl (+57.02) 793.3954 2,377.16 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 3.05 0.474 0 c7: Carbamidomethyl (+57.02) 793.3972 2,377.17 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 2.61 0.422 0 c7: Carbamidomethyl (+57.02) 793.3973 2,377.17 2,377.17 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.5 0.469 3.17 794.4007 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.53 0.461 3.49 794.4009 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.43 0.451 3.72 794.4012 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.25 0.461 2.96 794.4016 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 3.84 0.486 2.4 794.4016 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.3 0.463 2.54 794.4017 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.42 0.462 2.89 794.4019 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.49 0.479 3.68 794.4022 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 3.9 0.434 1.82 794.4024 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.17 0.461 3.62 794.4027 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.19 0.429 2.82 794.4027 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.07 0.45 3.03 794.4037 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 3.79 0.468 1.92 794.4039 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDR 95.00% 4.11 0.446 2.38 794.9044 1,587.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.26 0.584 1.82 798.7158 2,393.12 2,393.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.17 0.588 1.48 798.7161 2,393.12 2,393.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFRQDVDNASLAR 95.00% 3.29 0.24 1.43 798.7165 2,393.13 2,393.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.43 0.577 1.82 798.7165 2,393.13 2,393.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.59 0.565 0 798.7165 2,393.13 2,393.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.21 0.509 1.52 798.7167 2,393.13 2,393.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.42 0.538 1.41 798.7175 2,393.13 2,393.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.07 0.552 1.21 798.7186 2,393.13 2,393.13 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TVETRDGQVINETSQHHDDLE 95.00% 4.47 0.297 2.17 808.7044 2,423.09 2,423.11 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TVETRDGQVINETSQHHDDLE 95.00% 5.13 0.364 4.11 808.7075 2,423.10 2,423.11 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TVETRDGQVINETSQHHDDLE 95.00% 4.93 0.432 3.52 808.7078 2,423.10 2,423.11 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TVETRDGQVINETSQHHDDLE 95.00% 5.25 0.419 3.4 808.7085 2,423.10 2,423.11 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TVETRDGQVINETSQHHDDLE 95.00% 4.83 0.336 3.08 808.7087 2,423.10 2,423.11 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TVETRDGQVINETSQHHDDLE 95.00% 5.01 0.432 3.82 808.7089 2,423.10 2,423.11 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDRFANYIDK 95.00% 4.52 0.413 2.29 814.0763 2,439.21 2,439.22 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TNEKVELQELNDRFANYIDK 95.00% 4.26 0.46 1.85 814.0768 2,439.21 2,439.22 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 5.18 0.448 5.31 831.4749 1,660.93 1,661.95 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 4.79 0.508 5.96 831.4773 1,660.94 1,661.95 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 4.88 0.459 6.19 831.4786 1,660.94 1,661.95 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 4.5 0.507 4.06 831.7257 1,661.44 1,661.95 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 5.44 0.47 5.15 831.9773 1,661.94 1,661.95 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% KVESLQEEIAFLKK 95.00% 5.44 0.455 4.77 831.979 1,661.94 1,661.95 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSK 95.00% 3.92 0.536 2.89 834.9248 1,667.83 1,668.84 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSK 95.00% 4.48 0.573 3.51 834.9254 1,667.84 1,668.84 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSK 95.00% 4.17 0.538 2.13 834.9265 1,667.84 1,668.84 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSK 95.00% 3.09 0.379 2.13 834.9277 1,667.84 1,668.84 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSK 95.00% 3.94 0.545 0 834.9286 1,667.84 1,668.84 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSK 95.00% 3.76 0.453 2.24 835.4261 1,668.84 1,668.84 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSK 95.00% 3.81 0.429 1.31 835.4264 1,668.84 1,668.84 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSK 95.00% 3.96 0.503 2.47 835.4266 1,668.84 1,668.84 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSK 95.00% 4.4 0.552 2.04 835.427 1,668.84 1,668.84 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSK 95.00% 3.26 0.358 2.59 835.428 1,668.84 1,668.84 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSK 95.00% 4.17 0.491 2.77 835.4295 1,668.84 1,668.84 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.09 0.302 0 844.9132 1,687.81 1,688.83 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.39 0.418 0 844.9144 1,687.81 1,688.83 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.27 0.409 0 844.9144 1,687.81 1,688.83 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.36 0.4 0 844.915 1,687.81 1,688.83 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.51 0.358 0 844.9162 1,687.82 1,688.83 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.16 0.371 0 844.9164 1,687.82 1,688.83 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.39 0.419 1.89 844.9167 1,687.82 1,688.83 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.32 0.378 1.59 844.9173 1,687.82 1,688.83 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.53 0.427 0 844.9174 1,687.82 1,688.83 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.37 0.405 1.19 845.418 1,688.82 1,688.83 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDIMR 95.00% 3.26 0.399 0 845.4182 1,688.82 1,688.83 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% RQVQSLTcEVDALKGTNESLER 95.00% 6.71 0.542 3.96 c8: Carbamidomethyl (+57.02) 845.4288 2,533.26 2,533.27 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDImR 95.00% 2.57 0.39 0 m13: Oxidation (+15.99) 852.9148 1,703.81 1,704.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% VEVERDNLAEDImR 95.00% 2.5 0.366 2.39 m13: Oxidation (+15.99) 853.4148 1,704.81 1,704.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.56 0.389 4.52 867.9083 1,733.80 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.16 0.407 5.85 867.9089 1,733.80 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.42 0.444 4.62 867.9093 1,733.80 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.99 0.404 4.37 867.9095 1,733.80 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.82 0.432 5.57 867.9101 1,733.80 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.58 0.345 5.11 867.9113 1,733.81 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.59 0.39 6.13 867.9114 1,733.81 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.33 0.364 6.74 867.9115 1,733.81 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.41 0.399 3.12 868.408 1,734.80 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.42 0.37 4.85 868.41 1,734.80 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.33 0.36 3.8 868.4103 1,734.81 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.49 0.385 3.04 868.4107 1,734.81 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.18 0.433 3.27 868.4111 1,734.81 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNMKEEMAR 95.00% 4.57 0.382 3.7 868.4112 1,734.81 1,734.82 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EKLQEEMLQREEAENTLQSFR 95.00% 2.68 0.413 0 870.067 2,607.18 2,608.27 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EKLQEEMLQREEAENTLQSFR 95.00% 4.26 0.398 1.49 870.4279 2,608.26 2,608.27 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EKLQEEMLQREEAENTLQSFR 95.00% 4.04 0.418 2.06 870.4282 2,608.26 2,608.27 3
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNmKEEMAR 95.00% 4.18 0.531 4.62 m8: Oxidation (+15.99) 875.9072 1,749.80 1,750.81 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNmKEEMAR 95.00% 4.17 0.421 2.1 m8: Oxidation (+15.99) 876.4086 1,750.80 1,750.81 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNmKEEMAR 95.00% 4.06 0.497 1.22 m8: Oxidation (+15.99) 876.4092 1,750.80 1,750.81 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNmKEEMAR 95.00% 4.34 0.528 4.82 m8: Oxidation (+15.99) 876.4095 1,750.80 1,750.81 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNmKEEmAR 95.00% 4.15 0.528 2.46 m8: Oxidation (+15.99), m12: Oxidation (+15.99) 883.9044 1,765.79 1,766.81 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQDEIQNmKEEmAR 95.00% 3.84 0.543 2 m8: Oxidation (+15.99), m12: Oxidation (+15.99) 884.4048 1,766.79 1,766.81 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.8 0.27 0 888.9334 1,775.85 1,776.86 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.78 0.293 1.34 888.9345 1,775.85 1,776.86 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% FADLSEAANRNNDALR 95.00% 2.82 0.321 0 889.437 1,776.86 1,776.86 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMRELRR 95.00% 2.54 0.293 0 904.9495 1,807.88 1,808.90 2 COF1_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LGDLYEEEMRELRR 95.00% 2.61 0.294 0 904.9511 1,807.89 1,808.90 2 COF1_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSKR 95.00% 4.43 0.495 2.82 912.9749 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSKR 95.00% 4.03 0.487 2.77 912.9751 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSKR 95.00% 3.79 0.512 2.92 912.9752 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSKR 95.00% 3.47 0.469 0 912.9752 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSKR 95.00% 3.77 0.537 3.19 912.9759 1,823.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSKR 95.00% 3.99 0.425 3.38 913.4751 1,824.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSKR 95.00% 4.37 0.443 2.24 913.4752 1,824.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% ETNLDSLPLVDTHSKR 95.00% 3.74 0.332 3.32 913.4771 1,824.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.69 0.414 3.8 918.9004 1,835.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.73 0.4 3.74 918.9004 1,835.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.55 0.388 3.17 918.9013 1,835.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.58 0.356 4.42 918.9015 1,835.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.41 0.392 3.85 918.9018 1,835.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.79 0.414 4.66 918.9022 1,835.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.7 0.393 4.49 918.9031 1,835.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.82 0.421 3.59 919.4021 1,836.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.64 0.393 4.18 919.4029 1,836.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.88 0.346 3.6 919.403 1,836.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.81 0.39 5.14 919.4038 1,836.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 4.09 0.447 3.42 919.404 1,836.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.72 0.391 3.34 919.404 1,836.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% DGQVINETSQHHDDLE 95.00% 3.71 0.429 3.36 919.4049 1,836.79 1,836.80 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SKFADLSEAANRNNDALR 95.00% 3.21 0.356 1.24 997.0002 1,991.98 1,991.99 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% SKFADLSEAANRNNDALR 95.00% 2.98 0.337 2.1 997.0018 1,991.99 1,991.99 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EMEENFAVEAANYQDTIGR 95.00% 6.13 0.642 6.96 1,093.98 2,185.95 2,186.97 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EMEENFAVEAANYQDTIGR 95.00% 5.91 0.657 6.34 1,093.99 2,185.95 2,186.97 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EMEENFAVEAANYQDTIGR 95.00% 6.18 0.637 5.42 1,094.48 2,186.95 2,186.97 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EMEENFAVEAANYQDTIGR 95.00% 6.41 0.629 5.4 1,094.48 2,186.95 2,186.97 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EMEENFAVEAANYQDTIGR 95.00% 6.04 0.617 5.11 1,094.49 2,186.96 2,186.97 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EMEENFAVEAANYQDTIGR 95.00% 6.17 0.612 5.66 1,094.49 2,186.96 2,186.97 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EMEENFAVEAANYQDTIGR 95.00% 6.22 0.624 6.19 1,094.49 2,186.96 2,186.97 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EMEENFAVEAANYQDTIGR 95.00% 6.23 0.624 5.28 1,094.49 2,186.96 2,186.97 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EmEENFAVEAANYQDTIGR 95.00% 5.31 0.656 8.68 m2: Oxidation (+15.99) 1,102.48 2,202.95 2,202.96 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EmEENFAVEAANYQDTIGR 95.00% 5.19 0.659 8.64 m2: Oxidation (+15.99) 1,102.48 2,202.95 2,202.96 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EYQDLLNVK 95.00% 2.35 0.248 0.602 1,123.00 1,121.99 1,121.58 1 DESM_HUMAN
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQEEMLQREEAENTLQSFR 95.00% 4.63 0.543 3.41 1,176.06 2,350.11 2,351.13 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% LQEEMLQREEAENTLQSFR 95.00% 4.66 0.403 2.29 1,176.57 2,351.12 2,351.13 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% qVQSLTcEVDALKGTNESLER 95.00% 0 0 5.46 c7: Carbamidomethyl (+57.02), n-term: Pyro-cmC (-17.03) 1,181.07 2,360.13 2,360.14 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 4.76 0.574 4.47 c7: Carbamidomethyl (+57.02) 1,189.58 2,377.15 2,377.17 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 4.72 0.595 5.18 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 4.38 0.573 5.07 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 4.57 0.566 4.47 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 4.51 0.585 3.57 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 4.4 0.585 3.82 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% QVQSLTcEVDALKGTNESLER 95.00% 4.62 0.564 5.12 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.02 0.4 0 1,197.57 2,393.12 2,393.13 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.03 0.419 0 1,197.57 2,393.12 2,393.13 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TVETRDGQVINETSQHHDDLE 95.00% 4.15 0.491 4.07 1,212.56 2,423.10 2,423.11 2
 SAMPLE 3 Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 52 77 606 75.30% TVETRDGQVINETSQHHDDLE 95.00% 3.96 0.535 3.54 1,212.56 2,423.10 2,423.11 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DVRQQYESVAAK 95.00% 3.59 0.386 0 465.2402 1,392.70 1,393.71 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DVRQQYESVAAK 95.00% 2.61 0.378 0 465.2412 1,392.70 1,393.71 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLEGEESR 95.00% 2.47 0.185 0 466.7379 931.4601 932.469 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLEGEESR 95.00% 2.61 0.243 0 466.7384 931.4612 932.469 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MALDIEIATYRK 95.00% 3.72 0.315 1.07 475.2583 1,422.75 1,423.76 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MALDIEIATYRK 95.00% 3.13 0.411 1.96 475.2584 1,422.75 1,423.76 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mALDIEIATYRK 95.00% 2.27 0.277 0 m1: Oxidation (+15.99) 480.5896 1,438.75 1,439.76 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mALDIEIATYRK 95.00% 2.62 0.22 0 m1: Oxidation (+15.99) 480.5904 1,438.75 1,439.76 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALR 95.00% 2.28 0.428 0 484.2635 966.5113 967.5213 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALR 95.00% 2.31 0.454 0 484.264 966.5124 967.5213 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mFGGPGTASR 95.00% 2.48 0.218 0 m1: Oxidation (+15.99) 498.7312 995.4468 996.4574 2 ATPG_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mFGGPGTASR 95.00% 2.77 0.288 0 m1: Oxidation (+15.99) 498.7313 995.4469 996.4574 2 ATPG_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mFGGPGTASR 95.00% 2.82 0.281 0 m1: Oxidation (+15.99) 498.7315 995.4474 996.4574 2 ATPG_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mFGGPGTASR 95.00% 2.25 0.28 0 m1: Oxidation (+15.99) 498.7325 995.4493 996.4574 2 ATPG_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mFGGPGTASR 95.00% 2.44 0.321 0 m1: Oxidation (+15.99) 498.7328 995.4499 996.4574 2 ATPG_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mFGGPGTASR 95.00% 2.43 0.305 0 m1: Oxidation (+15.99) 498.7332 995.4507 996.4574 2 ATPG_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mFGGPGTASR 95.00% 2.77 0.259 0 m1: Oxidation (+15.99) 498.7336 995.4515 996.4574 2 ATPG_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mFGGPGTASR 95.00% 2.07 0.271 0 m1: Oxidation (+15.99) 498.7337 995.4518 996.4574 2 ATPG_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mFGGPGTASR 95.00% 2.35 0.319 0 m1: Oxidation (+15.99) 498.7341 995.4525 996.4574 2 ATPG_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MFGGPGTASRPSSSR 94.60% 1.25 0.304 0 498.9083 1,493.70 1,494.71 3 TPM4_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 1.62 0.241 1.8 499.2652 1,494.77 1,495.79 3 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 1.77 0.291 0 499.2658 1,494.77 1,495.79 3 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 1.61 0.271 0 499.267 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 1.7 0.259 2.17 499.2674 1,494.78 1,495.79 3 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SRLGDLYEEEMR 95.00% 3.43 0.199 0 499.9041 1,496.69 1,497.70 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SRLGDLYEEEMR 95.00% 3.9 0.237 0 499.9042 1,496.69 1,497.70 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SRLGDLYEEEMR 95.00% 2.94 0.268 0 499.9053 1,496.69 1,497.70 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SRLGDLYEEEMR 95.00% 2.97 0.384 0 499.9058 1,496.69 1,497.70 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SRLGDLYEEEMR 95.00% 3.42 0.247 0 499.906 1,496.69 1,497.70 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mFGGPGTASRPSSSR 95.00% 1.62 0.26 0 m1: Oxidation (+15.99) 504.2404 1,509.70 1,510.71 3 TPM4_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mFGGPGTASRPSSSR 95.00% 1.68 0.265 0.959 m1: Oxidation (+15.99) 504.5739 1,510.70 1,510.71 3 TPM4_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYKSK 95.00% 1.62 0.31 0 508.9144 1,523.72 1,524.73 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYKSK 95.00% 1.9 0.283 0 508.915 1,523.72 1,524.73 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYKSK 95.00% 1.98 0.346 0 508.9152 1,523.72 1,524.73 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 4.68 0.385 0.959 509.9446 1,526.81 1,527.83 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 4.7 0.339 0 509.946 1,526.81 1,527.83 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 2.96 0.161 0 509.9463 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 4.67 0.33 0 509.9468 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 3.14 0.188 0 509.9468 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 4.47 0.381 0 509.9472 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 4.67 0.361 0 509.9473 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 4.58 0.355 0 509.9475 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 4.28 0.324 0 509.9477 1,526.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 3.9 0.429 0 510.2803 1,527.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 3.88 0.24 0 510.2808 1,527.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 4.46 0.373 0 510.2814 1,527.82 1,527.83 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.87 0.363 2.12 511.9546 1,532.84 1,533.85 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.21 0.325 1.77 511.955 1,532.84 1,533.85 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.94 0.342 1.3 511.9551 1,532.84 1,533.85 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 5.58 0.339 1.8 511.9551 1,532.84 1,533.85 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 5.55 0.359 1.66 511.9552 1,532.84 1,533.85 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 3.25 0.179 0 511.9554 1,532.84 1,533.85 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.48 0.291 2.29 511.9557 1,532.84 1,533.85 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QQYESVAAK 95.00% 2.17 0.273 0 512.2627 1,022.51 1,023.51 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.47 0.287 2.44 512.2892 1,533.84 1,533.85 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 5.39 0.308 1.7 512.2896 1,533.85 1,533.85 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 1.68 0.385 0 513.9736 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 1.98 0.356 0 513.9738 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 1.9 0.318 0 513.9739 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 1.63 0.299 0 513.9739 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 1.63 0.346 0 513.9741 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 2.1 0.263 0 513.9741 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 2.16 0.4 0 513.9742 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 1.83 0.341 0 513.9743 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 1.95 0.403 0 513.9744 1,538.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 2.1 0.322 0 514.3079 1,539.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 1.92 0.26 0 514.3083 1,539.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 2.34 0.343 0 514.3085 1,539.90 1,539.91 3 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQEEMLQR 95.00% 3.2 0.307 0 523.7675 1,045.52 1,046.53 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQEEMLQR 95.00% 3.16 0.27 0 523.7677 1,045.52 1,046.53 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 3.24 0.435 0 524.3012 1,569.88 1,570.90 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 3.54 0.474 0 524.3022 1,569.88 1,570.90 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 4.23 0.505 2.8 524.3024 1,569.88 1,570.90 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 2.36 0.294 0 524.3024 1,569.88 1,570.90 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 2.74 0.315 0 524.5917 1,570.75 1,570.90 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 5 0.497 3.74 524.6369 1,570.89 1,570.90 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 3.54 0.312 0 529.9361 1,586.78 1,587.80 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.03 0.324 0 529.9362 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.07 0.354 1.42 529.9364 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.3 0.287 1.25 529.9365 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.3 0.357 0 529.9368 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 3.94 0.344 0 529.9371 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.11 0.295 0 529.9371 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.55 0.349 1.39 529.9371 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.19 0.311 0 529.9375 1,586.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.14 0.403 0 530.2709 1,587.79 1,587.80 3 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DNLAEDIMR 95.00% 2.31 0.101 1.18 538.7546 1,075.49 1,076.50 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DNLAEDIMR 95.00% 2.53 0.0911 1.29 538.7547 1,075.49 1,076.50 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DNLAEDIMR 95.00% 2.78 0.207 0 538.7549 1,075.49 1,076.50 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DNLAEDIMR 95.00% 2.54 0.163 0 538.7558 1,075.50 1,076.50 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QDVDNASLAR 95.00% 2.63 0.391 2.25 544.7691 1,087.52 1,088.53 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QDVDNASLAR 95.00% 2.41 0.269 1.12 544.7698 1,087.52 1,088.53 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QDVDNASLAR 95.00% 2.47 0.458 2.14 544.7701 1,087.52 1,088.53 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QDVDNASLAR 95.00% 2.22 0.278 0 544.7702 1,087.52 1,088.53 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QDVDNASLAR 95.00% 2.23 0.23 0 544.7711 1,087.53 1,088.53 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.39 0.429 1.11 547.2652 1,092.51 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.18 0.4 1.09 547.2657 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 4.16 0.459 0 547.2658 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.86 0.506 0 547.2658 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.5 0.398 1.14 547.2661 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.98 0.486 0 547.2664 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.2 0.452 1.72 547.2664 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.88 0.495 1.57 547.2664 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.55 0.475 1.55 547.2666 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.87 0.504 0 547.2666 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.23 0.42 1.7 547.2667 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.67 0.501 1.6 547.2667 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.83 0.502 1.17 547.2672 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 2.13 0.364 1.16 547.2675 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 4.16 0.435 1.22 547.2679 1,092.52 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANR 95.00% 3.14 0.456 0 547.2745 1,092.53 1,093.53 2 LRP1_HUMAN,K2C5_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELR 95.00% 3.14 0.253 0 551.6021 1,651.78 1,652.80 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELR 95.00% 3.05 0.167 0 551.6024 1,651.78 1,652.80 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 4.72 0.209 0 554.6528 1,660.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 4.35 0.113 0 554.6529 1,660.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 4.6 0.0855 0 554.6532 1,660.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 4.68 0.311 0 554.6533 1,660.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 4.92 0.201 1.08 554.6533 1,660.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 4.99 0.225 1.13 554.6534 1,660.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 4.62 0.19 1.8 554.6534 1,660.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 5.43 0.246 1.48 554.6539 1,660.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 4.25 0.188 0 554.9869 1,661.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 4.34 0.152 0 554.9874 1,661.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 3.76 0.176 0 554.9875 1,661.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 5.22 0.237 0 554.9878 1,661.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 5.59 0.264 1.92 554.988 1,661.94 1,661.95 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 1.88 0.243 0 556.9526 1,667.83 1,668.84 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VELQELNDR 95.00% 3.01 0.35 0 558.285 1,114.55 1,115.57 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VELQELNDR 95.00% 2.74 0.317 0 558.2862 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VELQELNDR 95.00% 3.06 0.329 0 558.2874 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VELQELNDR 95.00% 3.2 0.289 0 558.2876 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VELQELNDR 95.00% 3.15 0.318 0 558.2876 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VELQELNDR 95.00% 2.72 0.312 0 558.2881 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VELQELNDR 95.00% 2.89 0.363 0 558.289 1,114.56 1,115.57 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EYQDLLNVK 95.00% 2.08 0.334 0 561.2941 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EYQDLLNVK 95.00% 2.02 0.296 0 561.2942 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EYQDLLNVK 95.00% 2.27 0.35 0 561.2943 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EYQDLLNVK 95.00% 2.16 0.388 0 561.2947 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EYQDLLNVK 95.00% 1.9 0.355 0 561.2947 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EYQDLLNVK 95.00% 2.09 0.356 0 561.2949 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EYQDLLNVK 95.00% 1.78 0.323 0 561.2953 1,120.57 1,121.58 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FANYIDKVR 95.00% 3.36 0.387 1.27 563.3048 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FANYIDKVR 95.00% 2.95 0.406 1.21 563.3051 1,124.59 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FANYIDKVR 95.00% 2.95 0.397 0 563.3054 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FANYIDKVR 95.00% 2.99 0.389 1.34 563.3055 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FANYIDKVR 95.00% 3.11 0.343 1.43 563.3056 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FANYIDKVR 95.00% 3.06 0.399 1.35 563.3061 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FANYIDKVR 95.00% 2.37 0.319 0 563.3075 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FANYIDKVR 95.00% 2.19 0.304 0 563.3084 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FANYIDKVR 95.00% 2.48 0.32 0 563.3086 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FANYIDKVR 95.00% 2.22 0.373 0 563.309 1,124.60 1,125.61 2 MVP_HUMAN,LAMB2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.57 0.335 0 563.6125 1,687.81 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.23 0.419 2.02 563.6129 1,687.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.37 0.373 1.89 563.6129 1,687.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.2 0.401 3.54 563.6129 1,687.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.86 0.474 2.38 563.613 1,687.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.68 0.409 1.92 563.613 1,687.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.08 0.416 2.28 563.6132 1,687.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.64 0.443 2.96 563.6133 1,687.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.94 0.407 2.16 563.6133 1,687.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.35 0.402 2.24 563.6134 1,687.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.33 0.38 1.47 563.6134 1,687.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.36 0.335 2.38 563.6136 1,687.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 2.72 0.248 1.41 563.6137 1,687.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.65 0.466 2.7 563.947 1,688.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.27 0.362 1.85 563.9474 1,688.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.7 0.339 1.59 563.9474 1,688.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.2 0.267 1.57 563.9478 1,688.82 1,688.83 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDImR 95.00% 3.45 0.457 2.09 m13: Oxidation (+15.99) 568.9444 1,703.81 1,704.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDImR 95.00% 3.21 0.382 2.59 m13: Oxidation (+15.99) 568.9446 1,703.81 1,704.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDImR 95.00% 3.6 0.375 1.27 m13: Oxidation (+15.99) 568.9455 1,703.81 1,704.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDImR 95.00% 3.92 0.411 2.49 m13: Oxidation (+15.99) 568.9457 1,703.81 1,704.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDImR 95.00% 3.68 0.45 1.96 m13: Oxidation (+15.99) 568.946 1,703.81 1,704.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDImR 95.00% 3.41 0.386 1.64 m13: Oxidation (+15.99) 569.2794 1,704.81 1,704.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDImR 95.00% 3 0.41 0 m13: Oxidation (+15.99) 569.2794 1,704.81 1,704.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDImR 95.00% 2.83 0.24 0 m13: Oxidation (+15.99) 569.2814 1,704.82 1,704.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 3.21 0.413 0 578.9415 1,733.80 1,734.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 2.23 0.351 0 578.9418 1,733.80 1,734.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 2.71 0.236 0 578.9421 1,733.80 1,734.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 2.35 0.342 0 578.9424 1,733.80 1,734.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 2.73 0.169 0 578.9426 1,733.80 1,734.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 2.21 0.315 0 578.9427 1,733.80 1,734.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 1.89 0.243 0 578.9431 1,733.81 1,734.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 2.32 0.409 0 578.9434 1,733.81 1,734.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 2.5 0.386 0 578.9438 1,733.81 1,734.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 2.56 0.282 0 579.2758 1,734.80 1,734.82 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 3.88 0.235 0 585.3587 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 2.68 0.262 1.2 585.3588 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 3.75 0.251 2.54 585.3593 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 3.66 0.242 1.66 585.3594 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 3.93 0.258 2.07 585.3595 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 3.51 0.241 1.92 585.3595 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 3.99 0.273 0 585.3595 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 4.16 0.311 1.85 585.3596 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 3.81 0.262 2.05 585.3598 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 4.02 0.322 1.12 585.3598 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 3.45 0.264 2.05 585.3598 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 4.11 0.296 1.33 585.36 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 2.25 0.301 1.14 585.3601 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 4.06 0.302 1.51 585.3601 1,168.70 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLK 95.00% 2.85 0.232 1.44 585.3627 1,168.71 1,169.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 3.12 0.391 1.89 592.9576 1,775.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.77 0.435 1.57 592.9578 1,775.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.99 0.404 2.89 592.9583 1,775.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.84 0.377 1.28 592.9583 1,775.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.81 0.382 2.82 592.9586 1,775.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 3.14 0.446 1.85 592.9587 1,775.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 3.24 0.376 2 592.9587 1,775.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.51 0.293 1.57 592.9587 1,775.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.7 0.459 1.6 592.959 1,775.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.16 0.286 0 592.9596 1,775.86 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.99 0.38 2 593.2868 1,776.84 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.75 0.395 1.32 593.2869 1,776.84 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.95 0.42 1.92 593.2897 1,776.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 3.05 0.447 1.09 593.2897 1,776.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.67 0.322 2.19 593.2916 1,776.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.54 0.383 1.96 593.2916 1,776.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.43 0.319 2.02 593.2924 1,776.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.88 0.348 2.37 593.2926 1,776.85 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.57 0.378 1.7 593.2938 1,776.86 1,776.86 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELRR 95.00% 3.4 0.193 0 603.636 1,807.88 1,808.90 3 COF1_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELRR 95.00% 3.87 0.321 1.01 603.6367 1,807.89 1,808.90 3 COF1_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELRR 95.00% 2.94 0.138 0 603.6389 1,807.89 1,808.90 3 COF1_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELRR 95.00% 3.06 0.211 0 603.9694 1,808.88 1,808.90 3 COF1_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELRR 95.00% 3.17 0.183 0 603.9695 1,808.89 1,808.90 3 COF1_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELRR 95.00% 3.7 0.301 1.03 603.9697 1,808.89 1,808.90 3 COF1_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELRR 95.00% 3.2 0.293 0 603.97 1,808.89 1,808.90 3 COF1_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELRR 95.00% 3.11 0.17 0 603.9703 1,808.89 1,808.90 3 COF1_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELRR 95.00% 2.96 0.197 0 603.9704 1,808.89 1,808.90 3 COF1_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSKR 95.00% 1.74 0.31 0 608.9863 1,823.94 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSKR 95.00% 1.98 0.332 0 608.9866 1,823.94 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSKR 95.00% 1.96 0.26 0 608.988 1,823.94 1,824.95 3 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 2.13 0.28 0 612.937 1,835.79 1,836.80 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 2.69 0.328 0 612.9376 1,835.79 1,836.80 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 1.93 0.248 0 612.9381 1,835.79 1,836.80 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMR 95.00% 3.33 0.547 1.74 627.7856 1,253.56 1,254.57 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMR 95.00% 3.42 0.55 1.62 627.7863 1,253.56 1,254.57 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMR 95.00% 3.73 0.544 2.16 627.7865 1,253.56 1,254.57 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMR 95.00% 3.61 0.504 3 627.7865 1,253.56 1,254.57 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMR 95.00% 3.59 0.533 2.64 627.7867 1,253.56 1,254.57 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMR 95.00% 3.69 0.537 1.21 627.7871 1,253.56 1,254.57 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMR 95.00% 2.76 0.564 1.72 627.7871 1,253.56 1,254.57 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMR 95.00% 3.68 0.524 2.3 627.7871 1,253.56 1,254.57 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMR 95.00% 3.56 0.489 2.89 627.7873 1,253.56 1,254.57 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMR 95.00% 3.58 0.47 1.41 627.7873 1,253.56 1,254.57 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SRLGDLYEEEMRELR 95.00% 3.2 0.396 0 632.6457 1,894.91 1,895.93 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEmR 95.00% 3.17 0.407 2.14 m9: Oxidation (+15.99) 635.7854 1,269.56 1,270.56 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEmR 95.00% 3.31 0.438 2.64 m9: Oxidation (+15.99) 635.7854 1,269.56 1,270.56 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ARVEVERDNLAEDIMR 95.00% 3.34 0.46 2.48 639.6592 1,915.95 1,915.97 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVDQLTNDKAR 95.00% 3.05 0.265 0 644.3351 1,286.65 1,287.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVDQLTNDKAR 95.00% 2.41 0.367 0 644.3402 1,286.66 1,287.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MALDIEIATYR 95.00% 2.96 0.453 1.57 648.3355 1,294.66 1,295.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MALDIEIATYR 95.00% 2.8 0.311 2.66 648.336 1,294.66 1,295.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MALDIEIATYR 95.00% 2.52 0.386 1.49 648.3368 1,294.66 1,295.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MALDIEIATYR 95.00% 2.47 0.292 3.19 648.3374 1,294.66 1,295.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MALDIEIATYR 95.00% 3.38 0.45 2.43 648.3387 1,294.66 1,295.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MALDIEIATYR 95.00% 3.92 0.4 2.6 648.339 1,294.66 1,295.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EKLQEEMLQR 95.00% 3.06 0.407 1.36 652.336 1,302.66 1,303.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EKLQEEMLQR 95.00% 2.83 0.383 1.55 652.3365 1,302.66 1,303.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EKLQEEMLQR 95.00% 2.46 0.338 0 652.3366 1,302.66 1,303.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EKLQEEMLQR 95.00% 2.82 0.421 0 652.3369 1,302.66 1,303.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EKLQEEMLQR 95.00% 3.1 0.382 1.41 652.337 1,302.66 1,303.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EKLQEEMLQR 95.00% 3.16 0.376 1.17 652.3376 1,302.66 1,303.67 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SKFADLSEAANR 95.00% 3.43 0.507 2.57 654.8303 1,307.64 1,308.65 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SKFADLSEAANR 95.00% 3.28 0.556 2.77 654.8307 1,307.65 1,308.65 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYK 95.00% 2.26 0.327 0 655.3055 1,308.60 1,309.61 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYK 95.00% 3.16 0.451 1.51 655.3056 1,308.60 1,309.61 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYK 95.00% 3.09 0.492 1.38 655.3057 1,308.60 1,309.61 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYK 95.00% 2.85 0.418 2.48 655.3057 1,308.60 1,309.61 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYK 95.00% 3.19 0.443 2.52 655.3061 1,308.60 1,309.61 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYK 95.00% 3.2 0.456 2.21 655.3063 1,308.60 1,309.61 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYK 95.00% 3.51 0.468 2.64 655.3063 1,308.60 1,309.61 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYK 95.00% 3.34 0.502 2.51 655.3065 1,308.60 1,309.61 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYK 95.00% 2.49 0.357 2.92 655.3073 1,308.60 1,309.61 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYK 95.00% 2.94 0.451 2.28 655.3078 1,308.60 1,309.61 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mALDIEIATYR 95.00% 3.72 0.495 3.64 m1: Oxidation (+15.99) 656.3346 1,310.65 1,311.66 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% mALDIEIATYR 95.00% 3.94 0.458 3.15 m1: Oxidation (+15.99) 656.3352 1,310.65 1,311.66 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EKLQEEmLQR 95.00% 2.71 0.278 0 m7: Oxidation (+15.99) 660.3364 1,318.66 1,319.66 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFR 95.00% 2.38 0.448 0 662.3109 1,322.61 1,323.62 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFR 95.00% 2.96 0.427 1.8 662.3112 1,322.61 1,323.62 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFR 95.00% 2.5 0.44 1.19 662.3113 1,322.61 1,323.62 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFR 95.00% 3.2 0.382 2.2 662.3116 1,322.61 1,323.62 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFR 95.00% 3.42 0.459 2.02 662.3122 1,322.61 1,323.62 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFR 95.00% 3.3 0.471 1.85 662.3127 1,322.61 1,323.62 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFR 95.00% 2.6 0.433 0 662.3129 1,322.61 1,323.62 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFR 95.00% 2.45 0.335 1.42 662.3132 1,322.61 1,323.62 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DVRQQYESVAAK 95.00% 3.11 0.35 0 697.3548 1,392.69 1,393.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DVRQQYESVAAK 95.00% 2.81 0.32 0 697.358 1,392.70 1,393.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VESLQEEIAFLK 95.00% 3.41 0.214 3.54 703.3797 1,404.74 1,405.76 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VESLQEEIAFLK 95.00% 4.15 0.32 2.49 703.3812 1,404.75 1,405.76 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 6.84 0.641 5.02 709.6931 2,126.06 2,126.07 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 5.92 0.638 4.17 709.6934 2,126.06 2,126.07 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 3.1 0.431 0 709.6938 2,126.06 2,126.07 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 5.55 0.608 4.11 709.6938 2,126.06 2,126.07 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 5.34 0.647 2.46 709.6942 2,126.06 2,126.07 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 4.43 0.524 3 709.6944 2,126.06 2,126.07 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 6.36 0.624 5.03 709.6945 2,126.06 2,126.07 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MALDIEIATYRK 95.00% 3.31 0.394 1.21 712.3822 1,422.75 1,423.76 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MALDIEIATYRK 95.00% 3.26 0.394 1.2 712.3858 1,422.76 1,423.76 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4.23 0.57 6 714.8581 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4.38 0.568 5.34 714.8584 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4.43 0.558 6.38 714.8585 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4.41 0.595 6.07 714.8586 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 3.42 0.488 4.96 714.8586 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4.56 0.58 5.85 714.8588 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4.13 0.539 5.02 714.8589 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4.1 0.591 7.19 714.859 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 3.43 0.536 3.37 714.859 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4.33 0.605 5.52 714.859 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 3.54 0.484 4.72 714.8593 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4.51 0.565 6.2 714.8593 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4.52 0.584 5.28 714.8596 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 3.48 0.539 6.17 714.86 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4 0.532 6.19 714.8601 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4.31 0.558 5.8 714.8603 1,427.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 2.9 0.456 4.54 714.8631 1,427.71 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 4.8 0.564 7.1 715.3596 1,428.70 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 3.46 0.436 2.48 715.3608 1,428.71 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SLYASSPGGVYATR 95.00% 2.82 0.298 1.68 715.3623 1,428.71 1,428.71 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EMEENFAVEAANYQDTIGR 95.00% 3.76 0.497 1.14 729.6592 2,185.95 2,186.97 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EMEENFAVEAANYQDTIGR 95.00% 5.77 0.636 4.47 729.6597 2,185.96 2,186.97 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EMEENFAVEAANYQDTIGR 95.00% 4 0.459 2.12 729.9952 2,186.96 2,186.97 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EMEENFAVEAANYQDTIGR 95.00% 6.01 0.587 5 729.9955 2,186.96 2,186.97 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VELQELNDRFANYIDKVR 95.00% 4.85 0.557 3.62 741.7238 2,222.15 2,222.16 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VELQELNDRFANYIDKVR 95.00% 5.04 0.503 3.08 741.7251 2,222.15 2,222.16 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALK 95.00% 4.01 0.524 4.09 c7: Carbamidomethyl (+57.02) 745.8795 1,489.74 1,490.75 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALK 95.00% 3.68 0.503 2.19 c7: Carbamidomethyl (+57.02) 745.8797 1,489.74 1,490.75 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALK 95.00% 2.9 0.311 0 c7: Carbamidomethyl (+57.02) 745.8798 1,489.74 1,490.75 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALK 95.00% 2.93 0.306 0 c7: Carbamidomethyl (+57.02) 745.8801 1,489.74 1,490.75 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALK 95.00% 3.94 0.494 4.19 c7: Carbamidomethyl (+57.02) 745.8802 1,489.74 1,490.75 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALK 95.00% 2.53 0.278 0 c7: Carbamidomethyl (+57.02) 745.8803 1,489.74 1,490.75 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALK 95.00% 3.78 0.469 2.77 c7: Carbamidomethyl (+57.02) 745.8818 1,489.75 1,490.75 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALK 95.00% 3.66 0.431 1.89 c7: Carbamidomethyl (+57.02) 746.3789 1,490.74 1,490.75 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALK 95.00% 3.41 0.282 0 c7: Carbamidomethyl (+57.02) 746.3805 1,490.75 1,490.75 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALK 95.00% 3.88 0.437 2.51 c7: Carbamidomethyl (+57.02) 746.3835 1,490.75 1,490.75 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MFGGPGTASRPSSSR 95.00% 2.86 0.426 0 747.8592 1,493.70 1,494.71 2 TPM4_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% MFGGPGTASRPSSSR 95.00% 2.95 0.552 0 747.8606 1,493.71 1,494.71 2 TPM4_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 2.4 0.392 0 748.3952 1,494.77 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 2.74 0.307 0 748.3952 1,494.77 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 2.65 0.439 0 748.3963 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 2.42 0.422 0 748.3966 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 2.41 0.293 0 748.3971 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 2.34 0.356 0 748.3978 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 2.19 0.374 0 748.398 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 2.25 0.344 0 748.399 1,494.78 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TYSLGSALRPSTSR 95.00% 2.49 0.404 0 748.4009 1,494.79 1,495.79 2 SPTA2_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SRLGDLYEEEMR 95.00% 2.35 0.317 0 749.0016 1,495.99 1,497.70 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SRLGDLYEEEMR 95.00% 3.26 0.429 2.48 749.356 1,496.70 1,497.70 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SRLGDLYEEEMR 95.00% 2.7 0.385 3.49 749.3565 1,496.70 1,497.70 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYKSK 95.00% 3.87 0.386 3.55 762.8695 1,523.72 1,524.73 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% NLQEAEEWYKSK 95.00% 4.05 0.426 3.72 762.8698 1,523.72 1,524.73 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 3.78 0.262 0 764.4156 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 3.82 0.284 1.59 764.4176 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 3.41 0.296 0 764.4187 1,526.82 1,527.83 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% HLREYQDLLNVK 95.00% 3.58 0.279 1.25 764.9201 1,527.82 1,527.83 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 2.26 0.417 0 766.8485 1,531.68 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.56 0.394 4.96 767.4272 1,532.84 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.66 0.315 5.19 767.428 1,532.84 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 5.1 0.33 3.41 767.4283 1,532.84 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.95 0.332 4.43 767.4291 1,532.84 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VESLQEEIAFLKK 95.00% 4.26 0.296 3.52 767.4293 1,532.84 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.47 0.377 4.6 767.4294 1,532.84 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 5.18 0.358 2.82 767.4298 1,532.84 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.89 0.382 3.03 767.4298 1,532.84 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 5.08 0.34 4.15 767.43 1,532.84 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.99 0.333 4.07 767.43 1,532.84 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VESLQEEIAFLKK 95.00% 3.94 0.279 2.8 767.4304 1,532.85 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 5.12 0.351 4.68 767.4308 1,532.85 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.91 0.289 3.54 767.4317 1,532.85 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 5.15 0.317 3.52 767.9314 1,533.85 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.65 0.297 3.03 767.9315 1,533.85 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.14 0.207 2.21 767.932 1,533.85 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLK 95.00% 4.15 0.294 3.92 767.9359 1,533.86 1,533.85 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 4.56 0.322 1.8 770.458 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 4.62 0.369 2.85 770.4581 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 4.53 0.325 3 770.4584 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 4.24 0.349 2.04 770.4585 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 4.57 0.325 3.17 770.4585 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 4.43 0.386 1.92 770.4586 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 4.25 0.411 2.47 770.4586 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 3.86 0.339 2.59 770.459 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 4.68 0.378 2.6 770.459 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 4.17 0.328 2.34 770.4591 1,538.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 4.26 0.358 1.8 770.4604 1,538.91 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 3.65 0.276 2.08 770.4613 1,538.91 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 4.35 0.345 2.82 770.9599 1,539.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ILLAELEQLKGQGK 95.00% 4.31 0.357 2.57 770.9601 1,539.90 1,539.91 2 SEP11_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQEEMLQREEAENTLQSFR 95.00% 4.29 0.614 2.38 784.3812 2,350.12 2,351.13 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQEEMLQREEAENTLQSFR 95.00% 6.24 0.579 4.68 784.7153 2,351.12 2,351.13 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQEEMLQREEAENTLQSFR 95.00% 5.23 0.543 3.6 784.7157 2,351.12 2,351.13 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQEEMLQREEAENTLQSFR 95.00% 5.42 0.533 3.74 784.7175 2,351.13 2,351.13 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 3.55 0.445 5 785.9488 1,569.88 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 3.64 0.463 4.96 785.9499 1,569.88 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 2.17 0.338 3.17 785.9505 1,569.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 3.47 0.493 5 785.9506 1,569.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 3.39 0.408 3.89 785.9507 1,569.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 3.12 0.465 3.7 785.9508 1,569.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 2.81 0.426 2.8 785.9515 1,569.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 2.24 0.339 1.38 785.9516 1,569.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 3.3 0.489 4.55 785.9525 1,569.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 2.35 0.385 2.96 785.9528 1,569.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 1.81 0.385 1.41 785.9537 1,569.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 3.57 0.538 4.89 786.4518 1,570.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 3.41 0.467 5.3 786.4521 1,570.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 3.34 0.427 4.16 786.4525 1,570.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ISLPLPNFSSLNLR 95.00% 3.23 0.502 3.17 786.4528 1,570.89 1,570.90 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 4.09 0.553 2.57 c7: Carbamidomethyl (+57.02) 793.0582 2,376.15 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.17 0.454 0 c7: Carbamidomethyl (+57.02) 793.3929 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.43 0.507 0 c7: Carbamidomethyl (+57.02) 793.393 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.25 0.496 1.22 c7: Carbamidomethyl (+57.02) 793.3931 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.75 0.499 1.4 c7: Carbamidomethyl (+57.02) 793.3931 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.17 0.441 0 c7: Carbamidomethyl (+57.02) 793.3932 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.3 0.478 1.96 c7: Carbamidomethyl (+57.02) 793.3932 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.56 0.402 1.34 c7: Carbamidomethyl (+57.02) 793.3936 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.41 0.404 1.2 c7: Carbamidomethyl (+57.02) 793.394 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.28 0.404 2.77 c7: Carbamidomethyl (+57.02) 793.3943 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.04 0.533 1.22 c7: Carbamidomethyl (+57.02) 793.3945 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.4 0.536 0 c7: Carbamidomethyl (+57.02) 793.3947 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.22 0.474 1.24 c7: Carbamidomethyl (+57.02) 793.3947 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.46 0.426 1.68 c7: Carbamidomethyl (+57.02) 793.3948 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.59 0.47 0.959 c7: Carbamidomethyl (+57.02) 793.3951 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.45 0.52 1.89 c7: Carbamidomethyl (+57.02) 793.3952 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.26 0.469 0 c7: Carbamidomethyl (+57.02) 793.3953 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 3.15 0.459 2.02 c7: Carbamidomethyl (+57.02) 793.3958 2,377.16 2,377.17 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.34 0.464 3.7 794.3991 1,586.78 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.5 0.479 3.6 794.4014 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 3.8 0.466 3.82 794.4018 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.14 0.464 3.34 794.402 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.05 0.458 2.3 794.402 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.4 0.461 2.57 794.4022 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.23 0.5 2.3 794.4024 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 3.87 0.451 3.54 794.4025 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.26 0.476 3.34 794.4029 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.27 0.466 2.1 794.4029 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.4 0.466 3.42 794.4031 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 4.15 0.472 3.33 794.4033 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 3.8 0.437 2.77 794.4035 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 3.95 0.466 2.39 794.404 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDR 95.00% 3.74 0.437 2.68 794.4047 1,586.79 1,587.80 2 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.49 0.595 2.23 798.7153 2,393.12 2,393.13 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.46 0.562 1.89 798.7154 2,393.12 2,393.13 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.07 0.523 1.33 798.7159 2,393.12 2,393.13 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.13 0.548 2.02 798.7159 2,393.12 2,393.13 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFRQDVDNASLAR 95.00% 3.91 0.546 1.28 798.7161 2,393.12 2,393.13 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.58 0.549 1.21 798.7163 2,393.13 2,393.13 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFRQDVDNASLAR 95.00% 4.44 0.593 1.44 798.7172 2,393.13 2,393.13 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TVETRDGQVINETSQHHDDLE 95.00% 5.21 0.448 3.66 808.7053 2,423.09 2,423.11 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TVETRDGQVINETSQHHDDLE 95.00% 5.23 0.437 2.82 808.7061 2,423.09 2,423.11 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TVETRDGQVINETSQHHDDLE 95.00% 4.71 0.41 3.37 808.7075 2,423.10 2,423.11 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TVETRDGQVINETSQHHDDLE 95.00% 4.27 0.362 1.52 808.7096 2,423.11 2,423.11 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDRFANYIDK 95.00% 4.58 0.413 1.38 814.0765 2,439.21 2,439.22 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TNEKVELQELNDRFANYIDK 95.00% 4.36 0.401 2.42 814.0768 2,439.21 2,439.22 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 4.84 0.48 3.46 831.4765 1,660.94 1,661.95 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% KVESLQEEIAFLKK 95.00% 4.88 0.448 3.66 831.977 1,661.94 1,661.95 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFKNTR 95.00% 3.85 0.478 2.92 833.4222 2,497.24 2,497.26 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFKNTR 95.00% 3.96 0.511 1.82 833.4229 2,497.25 2,497.26 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFKNTR 95.00% 4.51 0.575 3.32 833.4235 2,497.25 2,497.26 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFKNTR 95.00% 3.73 0.511 2.77 833.4236 2,497.25 2,497.26 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFKNTR 95.00% 3.67 0.39 1.19 833.4239 2,497.25 2,497.26 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFKNTR 95.00% 3.28 0.408 2.51 833.4239 2,497.25 2,497.26 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFKNTR 95.00% 3.56 0.513 3.34 833.424 2,497.25 2,497.26 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFKNTR 95.00% 3.35 0.437 1.96 833.4245 2,497.25 2,497.26 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFKNTR 95.00% 3.55 0.505 2.64 833.4254 2,497.25 2,497.26 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFKNTR 95.00% 3.35 0.434 0 833.4259 2,497.25 2,497.26 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 4.2 0.578 2.35 834.9246 1,667.83 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 3.93 0.496 3.02 834.9255 1,667.84 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 4 0.561 2.43 834.9258 1,667.84 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 3.2 0.301 1.49 834.9279 1,667.84 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 3.23 0.466 0 834.9304 1,667.85 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 4.03 0.519 2.39 834.9305 1,667.85 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 2.93 0.389 0 834.9306 1,667.85 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 3.89 0.368 2.18 835.4243 1,668.83 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 3.6 0.389 2.08 835.4248 1,668.83 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 3.37 0.335 1.39 835.4275 1,668.84 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 4.32 0.486 2.51 835.4283 1,668.84 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 3.5 0.475 1.55 835.4296 1,668.84 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSK 95.00% 3.77 0.413 2.28 835.4308 1,668.85 1,668.84 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.24 0.413 0 844.916 1,687.82 1,688.83 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.28 0.385 1.08 844.917 1,687.82 1,688.83 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.57 0.404 1.41 844.9176 1,687.82 1,688.83 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.48 0.322 0 844.9178 1,687.82 1,688.83 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.21 0.413 0 844.9178 1,687.82 1,688.83 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.17 0.363 0 844.9189 1,687.82 1,688.83 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.14 0.336 0 845.4149 1,688.81 1,688.83 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.59 0.469 0 845.4167 1,688.82 1,688.83 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.34 0.41 0 845.4167 1,688.82 1,688.83 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.1 0.379 0 845.4192 1,688.82 1,688.83 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 3.38 0.443 0 845.4198 1,688.82 1,688.83 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDIMR 95.00% 2.72 0.25 0 845.4204 1,688.83 1,688.83 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% RQVQSLTcEVDALKGTNESLER 95.00% 6.1 0.493 3.52 c8: Carbamidomethyl (+57.02) 845.427 2,533.26 2,533.27 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% RQVQSLTcEVDALKGTNESLER 95.00% 6.18 0.49 2.54 c8: Carbamidomethyl (+57.02) 845.4272 2,533.26 2,533.27 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDImR 95.00% 2.48 0.3 1.08 m13: Oxidation (+15.99) 852.9154 1,703.82 1,704.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% VEVERDNLAEDImR 95.00% 2.64 0.295 1.28 m13: Oxidation (+15.99) 853.4157 1,704.82 1,704.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 4.26 0.399 5.7 867.909 1,733.80 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 4.32 0.373 6.11 867.9095 1,733.80 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 4.69 0.391 4.74 867.9102 1,733.80 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 5.1 0.4 7.29 867.9102 1,733.80 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 4.41 0.405 5.6 867.9107 1,733.81 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 4.6 0.387 5.59 867.9107 1,733.81 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 4.63 0.372 5.72 867.9108 1,733.81 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 4.59 0.369 5.11 867.9112 1,733.81 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 4.42 0.412 5.3 867.9126 1,733.81 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 4.66 0.394 6.51 868.4101 1,734.80 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 4.29 0.43 4.6 868.4107 1,734.81 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 4.46 0.359 4.46 868.4119 1,734.81 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNMKEEMAR 95.00% 4.15 0.379 5.35 868.4126 1,734.81 1,734.82 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EKLQEEMLQREEAENTLQSFR 95.00% 2 0.259 0 870.067 2,607.18 2,608.27 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EKLQEEMLQREEAENTLQSFR 95.00% 4.22 0.464 2.43 870.4274 2,608.26 2,608.27 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EKLQEEMLQREEAENTLQSFR 95.00% 4.5 0.337 2.51 870.4296 2,608.27 2,608.27 3
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNmKEEMAR 95.00% 4.12 0.453 3.32 m8: Oxidation (+15.99) 876.4049 1,750.79 1,750.81 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNmKEEMAR 95.00% 4.39 0.476 3.74 m8: Oxidation (+15.99) 876.4079 1,750.80 1,750.81 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNmKEEMAR 95.00% 4.22 0.484 3.92 m8: Oxidation (+15.99) 876.4082 1,750.80 1,750.81 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNmKEEmAR 95.00% 3.71 0.478 1.39 m8: Oxidation (+15.99), m12: Oxidation (+15.99) 883.9044 1,765.79 1,766.81 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNmKEEmAR 95.00% 4.41 0.573 4.92 m8: Oxidation (+15.99), m12: Oxidation (+15.99) 883.9063 1,765.80 1,766.81 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQDEIQNmKEEmAR 95.00% 3.19 0.45 0 m8: Oxidation (+15.99), m12: Oxidation (+15.99) 883.9079 1,765.80 1,766.81 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.46 0.219 1.44 888.9347 1,775.85 1,776.86 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.68 0.24 0 888.935 1,775.85 1,776.86 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.58 0.196 1.42 889.434 1,776.85 1,776.86 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% FADLSEAANRNNDALR 95.00% 2.73 0.355 0 889.4341 1,776.85 1,776.86 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELRR 95.00% 2.63 0.249 0 905.4496 1,808.88 1,808.90 2 COF1_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LGDLYEEEMRELRR 95.00% 2.73 0.27 0 905.4531 1,808.89 1,808.90 2 COF1_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSKR 95.00% 3.69 0.513 2.46 912.9751 1,823.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSKR 95.00% 3.76 0.427 3.57 912.9754 1,823.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSKR 95.00% 3.63 0.356 2.82 913.4748 1,824.93 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSKR 95.00% 3.37 0.451 2.92 913.4759 1,824.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSKR 95.00% 4.17 0.443 3.25 913.4759 1,824.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSKR 95.00% 4.67 0.429 3.4 913.4772 1,824.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% ETNLDSLPLVDTHSKR 95.00% 3.74 0.468 2.12 913.4786 1,824.94 1,824.95 2 TBA4A_HUMAN,MY18B_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.53 0.408 3.37 918.9021 1,835.79 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.64 0.39 4.77 918.9022 1,835.79 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.45 0.365 3.68 919.3975 1,836.78 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.39 0.307 3.74 919.3976 1,836.78 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.41 0.259 3.12 919.4011 1,836.79 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.74 0.383 3.22 919.4019 1,836.79 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.47 0.351 3.13 919.402 1,836.79 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.71 0.406 2.8 919.402 1,836.79 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.68 0.4 2.72 919.403 1,836.79 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.69 0.347 2.8 919.4032 1,836.79 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 4.02 0.439 1.7 919.4035 1,836.79 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.86 0.387 2.48 919.4047 1,836.79 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.89 0.399 3.07 919.4049 1,836.79 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% DGQVINETSQHHDDLE 95.00% 3.64 0.329 2.92 919.406 1,836.80 1,836.80 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% SKFADLSEAANRNNDALR 95.00% 3.19 0.439 2.24 997.0018 1,991.99 1,991.99 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 6.55 0.623 7.12 1,064.04 2,126.06 2,126.07 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 6.62 0.637 7.57 1,064.04 2,126.06 2,126.07 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 6.65 0.636 7.29 1,064.04 2,126.06 2,126.07 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 6.48 0.652 7.2 1,064.04 2,126.06 2,126.07 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 6.86 0.622 7.8 1,064.04 2,126.06 2,126.07 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LLQDSVDFSLADAINTEFK 95.00% 5.51 0.711 7.27 1,064.04 2,126.06 2,126.07 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EMEENFAVEAANYQDTIGR 95.00% 4.99 0.685 7.11 1,093.99 2,185.95 2,186.97 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EMEENFAVEAANYQDTIGR 95.00% 5.57 0.637 6.46 1,093.99 2,185.96 2,186.97 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EMEENFAVEAANYQDTIGR 95.00% 6.33 0.614 5.3 1,094.48 2,186.95 2,186.97 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EMEENFAVEAANYQDTIGR 95.00% 6.09 0.622 6.14 1,094.49 2,186.95 2,186.97 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EMEENFAVEAANYQDTIGR 95.00% 6.27 0.623 5.74 1,094.49 2,186.96 2,186.97 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EMEENFAVEAANYQDTIGR 95.00% 6.44 0.628 6.37 1,094.49 2,186.96 2,186.97 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EMEENFAVEAANYQDTIGR 95.00% 6.11 0.581 6.74 1,094.49 2,186.96 2,186.97 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EMEENFAVEAANYQDTIGR 95.00% 6.16 0.598 5.68 1,094.49 2,186.96 2,186.97 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EmEENFAVEAANYQDTIGR 95.00% 5.26 0.677 4.89 m2: Oxidation (+15.99) 1,102.48 2,202.95 2,202.96 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EmEENFAVEAANYQDTIGR 95.00% 5.18 0.674 5.8 m2: Oxidation (+15.99) 1,102.48 2,202.95 2,202.96 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EYQDLLNVK 95.00% 2.33 0.202 0.569 1,122.50 1,121.49 1,121.58 1 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EYQDLLNVK 95.00% 2.34 0.178 0.658 1,123.00 1,121.99 1,121.58 1 DESM_HUMAN
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQEEMLQREEAENTLQSFR 95.00% 4.76 0.437 4.14 1,176.57 2,351.12 2,351.13 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% LQEEMLQREEAENTLQSFR 95.00% 4.64 0.372 1.82 1,176.57 2,351.12 2,351.13 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% qVQSLTcEVDALKGTNESLER 95.00% 0 0 4.68 c7: Carbamidomethyl (+57.02), n-term: Pyro-cmC (-17.03) 1,181.07 2,360.13 2,360.14 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% qVQSLTcEVDALKGTNESLER 95.00% 0 0 6.14 c7: Carbamidomethyl (+57.02), n-term: Pyro-cmC (-17.03) 1,181.07 2,360.13 2,360.14 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% qVQSLTcEVDALKGTNESLER 95.00% 0 0 4.16 c7: Carbamidomethyl (+57.02), n-term: Pyro-cmC (-17.03) 1,181.07 2,360.13 2,360.14 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 4.62 0.613 4.64 c7: Carbamidomethyl (+57.02) 1,189.58 2,377.15 2,377.17 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 4.68 0.58 4.32 c7: Carbamidomethyl (+57.02) 1,189.58 2,377.15 2,377.17 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 4.68 0.589 5.89 c7: Carbamidomethyl (+57.02) 1,189.58 2,377.15 2,377.17 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 4.72 0.593 4.92 c7: Carbamidomethyl (+57.02) 1,189.58 2,377.15 2,377.17 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 4.61 0.572 5.43 c7: Carbamidomethyl (+57.02) 1,189.58 2,377.15 2,377.17 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% QVQSLTcEVDALKGTNESLER 95.00% 4.59 0.589 4 c7: Carbamidomethyl (+57.02) 1,189.59 2,377.16 2,377.17 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFRQDVDNASLAR 95.00% 3.83 0.428 0 1,197.57 2,393.13 2,393.13 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% EEAENTLQSFRQDVDNASLAR 95.00% 3.91 0.41 0 1,197.57 2,393.13 2,393.13 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TVETRDGQVINETSQHHDDLE 95.00% 3.98 0.497 5.82 1,212.56 2,423.10 2,423.11 2
 SAMPLE 3R Vimentin  VIM  VIME_HUMAN 53,634.60 100.00% 57 83 576 78.30% TVETRDGQVINETSQHHDDLE 95.00% 4.12 0.505 5.44 1,212.56 2,423.10 2,423.11 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% SLGEISALTSK 95.00% 3.58 0.508 2.92 553.3098 1,104.60 1,105.61 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% SLGEISALTSK 95.00% 3.43 0.462 4.1 553.3105 1,104.61 1,105.61 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% ELTPQVVSAAR 95.00% 2.64 0.343 2.06 585.8284 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% ELTPQVVSAAR 95.00% 2.37 0.41 0 585.8286 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% ELTPQVVSAAR 95.00% 2.34 0.328 1.89 585.8286 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% ELTPQVVSAAR 95.00% 2.6 0.374 0 585.8293 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% ELTPQVVSAAR 95.00% 2.55 0.458 1.64 585.8297 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% ELTPQVVSAAR 95.00% 2.5 0.346 0 585.8301 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% ALASQLQDSLK 95.00% 2.29 0.36 1.42 587.3285 1,172.64 1,173.65 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% ALASQLQDSLK 95.00% 2.64 0.351 2.82 587.3288 1,172.64 1,173.65 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% ALASQLQDSLK 95.00% 2.53 0.478 2.43 587.3289 1,172.64 1,173.65 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% ALASQLQDSLK 95.00% 2.52 0.494 2.29 587.3292 1,172.64 1,173.65 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% ALASQLQDSLK 95.00% 3.05 0.521 2.43 587.3294 1,172.64 1,173.65 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% ALASQLQDSLK 95.00% 2.11 0.328 1.29 587.3299 1,172.64 1,173.65 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% MSAEINEIIR 95.00% 2.65 0.156 0 588.3103 1,174.61 1,175.61 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% MSAEINEIIR 95.00% 2.92 0.138 1.22 588.3117 1,174.61 1,175.61 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% GWLRDPSASPGDAGEQAIR 95.00% 3.13 0.361 2.37 661.9975 1,982.97 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% AQQVSQGLDVLTAK 95.00% 4.47 0.596 4.24 729.4038 1,456.79 1,457.80 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% AQQVSQGLDVLTAK 95.00% 4.71 0.608 4.28 729.404 1,456.79 1,457.80 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% AQQVSQGLDVLTAK 95.00% 2.76 0.452 3.47 729.4043 1,456.79 1,457.80 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% AQQVSQGLDVLTAK 95.00% 3.01 0.448 4.19 729.4047 1,456.79 1,457.80 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% AQQVSQGLDVLTAK 95.00% 3.72 0.569 4.51 729.4049 1,456.79 1,457.80 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% AQQVSQGLDVLTAK 95.00% 3.79 0.577 5 729.4056 1,456.80 1,457.80 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% AQQVSQGLDVLTAK 95.00% 4.45 0.595 4.31 729.9058 1,457.80 1,457.80 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% DPSASPGDAGEQAIR 95.00% 3.28 0.514 0 735.8407 1,469.67 1,470.68 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% DPSASPGDAGEQAIR 95.00% 2.37 0.411 0 735.8431 1,469.67 1,470.68 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% DPSASPGDAGEQAIR 95.00% 2.56 0.364 1.82 735.8443 1,469.67 1,470.68 2
 SAMPLE 4 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 7 7 22 7.85% MLGQMTDQVADLR 95.00% 2.72 0.336 3.7 739.3675 1,476.72 1,477.71 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% SLGEISALTSK 95.00% 3.59 0.475 3.14 553.3094 1,104.60 1,105.61 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% SLGEISALTSK 95.00% 3.5 0.494 2.35 553.3096 1,104.60 1,105.61 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% SLGEISALTSK 95.00% 3.42 0.506 3.04 553.3097 1,104.60 1,105.61 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% SLGEISALTSK 95.00% 2.94 0.414 4.74 553.3099 1,104.60 1,105.61 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% STVEGIQASVK 95.00% 2.46 0.297 1.19 559.8076 1,117.60 1,118.61 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% STVEGIQASVK 95.00% 2.72 0.443 2.18 559.8079 1,117.60 1,118.61 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% ELTPQVVSAAR 95.00% 2.46 0.388 1.51 585.8289 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% ELTPQVVSAAR 95.00% 2.41 0.365 1.96 585.8296 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% ELTPQVVSAAR 95.00% 2.58 0.367 2.7 585.8297 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% ELTPQVVSAAR 95.00% 2.39 0.229 1.6 585.8301 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% ALASQLQDSLK 95.00% 3.02 0.48 2.85 587.3291 1,172.64 1,173.65 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% ALASQLQDSLK 95.00% 2.71 0.48 2.35 587.3294 1,172.64 1,173.65 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% ALASQLQDSLK 95.00% 2.76 0.443 1.96 587.3299 1,172.64 1,173.65 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% ALASQLQDSLK 95.00% 2.52 0.395 2.55 587.3302 1,172.64 1,173.65 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% MSAEINEIIR 95.00% 2.88 0.192 1.49 588.3061 1,174.60 1,175.61 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% MSAEINEIIR 95.00% 3.05 0.156 1.92 588.3078 1,174.60 1,175.61 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% MSAEINEIIR 95.00% 2.95 0.152 2.29 588.3089 1,174.60 1,175.61 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% MSAEINEIIR 95.00% 2.98 0.168 2.07 588.3097 1,174.60 1,175.61 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% MSAEINEIIR 95.00% 3.08 0.14 2.09 588.3101 1,174.60 1,175.61 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% GWLRDPSASPGDAGEQAIR 95.00% 2.98 0.328 0.959 661.9967 1,982.97 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% AQQVSQGLDVLTAK 95.00% 3.35 0.568 5.96 729.4044 1,456.79 1,457.80 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% AQQVSQGLDVLTAK 95.00% 3.12 0.47 4.14 729.4045 1,456.79 1,457.80 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% AQQVSQGLDVLTAK 95.00% 2.59 0.436 4.14 729.4047 1,456.79 1,457.80 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% AQQVSQGLDVLTAK 95.00% 4.11 0.542 4.15 729.4052 1,456.79 1,457.80 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% AQQVSQGLDVLTAK 95.00% 4.19 0.582 3.8 729.9067 1,457.80 1,457.80 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% AQQVSQGLDVLTAK 95.00% 4.71 0.577 4.31 729.907 1,457.80 1,457.80 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% AQQVSQGLDVLTAK 95.00% 0 0 3.49 730.4034 1,458.79 1,457.80 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% MLGQMTDQVADLR 95.00% 2.49 0.302 1.22 739.3675 1,476.72 1,477.71 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% VLQLTSWDEDAWASK 95.00% 3.54 0.474 3.26 875.4306 1,748.85 1,748.85 2
 SAMPLE 4R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 9 9 26 12.40% WIDNPTVDDRGVGQAAIRGLVAEGHR 95.00% 1.98 0.281 0 934.4457 2,800.31 2,802.44 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% DYLIDGSR 95.00% 2.09 0.323 0 469.7331 937.4505 938.4585 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% SFLDSGYR 95.00% 3.17 0.373 0 472.7274 943.4391 944.4478 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% SFLDSGYR 95.00% 2.79 0.316 0 472.7277 943.4398 944.4478 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VDQLTAQLADLAAR 95.00% 3.44 0.397 3.05 495.6065 1,483.80 1,484.81 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% IPTISTQLK 95.00% 1.75 0.346 0 500.8033 999.5909 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% IPTISTQLK 95.00% 2.03 0.269 0 500.8042 999.5927 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% IPTISTQLK 95.00% 2.17 0.287 0 500.8043 999.593 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% IPTISTQLK 95.00% 2.11 0.316 0 500.8051 999.5946 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLKDLK 95.00% 2.1 0.328 0 510.6204 1,528.84 1,529.85 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLKDLK 95.00% 2.19 0.342 0 510.6208 1,528.84 1,529.85 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% AAVHLEGKIEQAQR 95.00% 3.57 0.37 0 517.2847 1,548.83 1,549.85 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% AAVHLEGKIEQAQR 95.00% 2.9 0.403 0 517.6196 1,549.84 1,549.85 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% AAVHLEGKIEQAQR 95.00% 3.86 0.39 2.57 517.6203 1,549.84 1,549.85 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% SLGEISALTSK 95.00% 3.49 0.424 3.43 553.307 1,104.60 1,105.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% SLGEISALTSK 95.00% 3.56 0.472 2.7 553.3071 1,104.60 1,105.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% SLGEISALTSK 95.00% 3.41 0.461 2.6 553.3077 1,104.60 1,105.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% SLGEISALTSK 95.00% 3.6 0.504 2.24 553.3081 1,104.60 1,105.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% SLGEISALTSK 95.00% 3.28 0.496 2.37 553.3081 1,104.60 1,105.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% SLGEISALTSK 95.00% 3.63 0.461 3.57 553.3085 1,104.60 1,105.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% STVEGIQASVK 95.00% 2.94 0.465 2.52 559.8044 1,117.59 1,118.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% STVEGIQASVK 95.00% 3.28 0.458 3.82 559.8049 1,117.59 1,118.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% STVEGIQASVK 95.00% 3.21 0.467 2.51 559.8053 1,117.60 1,118.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% STVEGIQASVK 95.00% 3.38 0.483 2.82 559.8056 1,117.60 1,118.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% STVEGIQASVK 95.00% 3.5 0.503 2.46 559.8058 1,117.60 1,118.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% STVEGIQASVK 95.00% 2.97 0.449 2.48 559.8058 1,117.60 1,118.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% STVEGIQASVK 95.00% 3.08 0.495 3.1 559.8059 1,117.60 1,118.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% QILDEAGKVGELcAGK 95.00% 2.99 0.333 0 c13: Carbamidomethyl (+57.02) 563.293 1,686.86 1,687.87 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% QILDEAGKVGELcAGK 95.00% 2.66 0.3 1.29 c13: Carbamidomethyl (+57.02) 563.293 1,686.86 1,687.87 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% QILDEAGKVGELcAGK 95.00% 3.29 0.278 1.16 c13: Carbamidomethyl (+57.02) 563.2935 1,686.86 1,687.87 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% NPGNQAAYEHFETMK 95.00% 2.52 0.344 1.77 579.5937 1,735.76 1,736.77 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% NPGNQAAYEHFETMK 95.00% 2.53 0.343 1.82 579.5939 1,735.76 1,736.77 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% NPGNQAAYEHFETMK 95.00% 2.78 0.372 1.21 579.5943 1,735.76 1,736.77 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% NPGNQAAYEHFETMK 95.00% 2.8 0.427 1.42 579.9285 1,736.76 1,736.77 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ELTPQVVSAAR 95.00% 2.3 0.258 0 585.821 1,169.63 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ELTPQVVSAAR 95.00% 2.66 0.275 0 585.8249 1,169.63 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ELTPQVVSAAR 95.00% 2.69 0.309 0 585.8266 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLK 95.00% 2.53 0.489 1.42 587.3249 1,172.63 1,173.65 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLK 95.00% 2.28 0.407 2.24 587.3255 1,172.64 1,173.65 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLK 95.00% 3 0.49 1.85 587.3257 1,172.64 1,173.65 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLK 95.00% 2.31 0.473 2.24 587.3261 1,172.64 1,173.65 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLK 95.00% 2.88 0.448 1.85 587.3263 1,172.64 1,173.65 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLK 95.00% 2.47 0.501 2.25 587.3266 1,172.64 1,173.65 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLK 95.00% 2.52 0.487 1.43 587.3266 1,172.64 1,173.65 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLK 95.00% 2.61 0.489 1.82 587.3269 1,172.64 1,173.65 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLK 95.00% 2.59 0.399 1.24 587.3275 1,172.64 1,173.65 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLK 95.00% 2.38 0.438 1.52 587.3277 1,172.64 1,173.65 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MSAEINEIIR 95.00% 3.2 0.119 1.24 588.3074 1,174.60 1,175.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MSAEINEIIR 95.00% 3.63 0.141 1.16 588.3076 1,174.60 1,175.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MSAEINEIIR 95.00% 3.35 0.109 1.6 588.3077 1,174.60 1,175.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MSAEINEIIR 95.00% 3.41 0.138 1.44 588.3082 1,174.60 1,175.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MSAEINEIIR 95.00% 3.11 0.154 1.48 588.3085 1,174.60 1,175.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MSAEINEIIR 95.00% 3.33 0.147 1.49 588.3086 1,174.60 1,175.61 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% mSAEINEIIR 95.00% 2.53 0.31 1.89 m1: Oxidation (+15.99) 596.3015 1,190.59 1,191.60 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% mSAEINEIIR 95.00% 2.28 0.31 2.42 m1: Oxidation (+15.99) 596.6534 1,191.29 1,191.60 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VGKETVQTTEDQILKR 95.00% 4.95 0.451 4.15 615.6736 1,844.00 1,845.01 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% WIDNPTVDDR 95.00% 2.48 0.152 1.57 615.787 1,229.56 1,230.58 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% WIDNPTVDDR 95.00% 2.71 0.318 1.44 615.7879 1,229.56 1,230.58 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% WIDNPTVDDR 95.00% 3.33 0.393 1.47 615.7895 1,229.56 1,230.58 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% WIDNPTVDDR 95.00% 3.36 0.412 1.54 615.7895 1,229.56 1,230.58 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% WIDNPTVDDR 95.00% 3.11 0.353 1.38 615.7898 1,229.56 1,230.58 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% WIDNPTVDDR 95.00% 3.13 0.416 1.82 615.79 1,229.56 1,230.58 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VGKETVQTTEDQILKR 95.00% 5.16 0.446 3.03 616.0077 1,845.00 1,845.01 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VMLVNSMNTVK 95.00% 3.14 0.404 2.21 618.3266 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VMLVNSMNTVK 95.00% 2.87 0.335 2.36 618.3268 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VMLVNSMNTVK 95.00% 2.71 0.342 1.33 618.3293 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% cDRVDQLTAQLADLAAR 95.00% 3.75 0.413 1.85 c1: Carbamidomethyl (+57.02) 639.3256 1,914.95 1,915.97 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% cDRVDQLTAQLADLAAR 95.00% 3.93 0.434 2.18 c1: Carbamidomethyl (+57.02) 639.3256 1,914.95 1,915.97 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% cDRVDQLTAQLADLAAR 95.00% 3.73 0.422 0 c1: Carbamidomethyl (+57.02) 639.3261 1,914.95 1,915.97 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% cDRVDQLTAQLADLAAR 95.00% 3.05 0.342 1.37 c1: Carbamidomethyl (+57.02) 639.6594 1,915.95 1,915.97 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% cDRVDQLTAQLADLAAR 95.00% 3.64 0.474 1.64 c1: Carbamidomethyl (+57.02) 639.6601 1,915.96 1,915.97 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MTGLVDEAIDTK 95.00% 4.17 0.588 3.49 646.8236 1,291.63 1,292.64 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MTGLVDEAIDTK 95.00% 4.04 0.588 4.48 646.8237 1,291.63 1,292.64 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MTGLVDEAIDTK 95.00% 3.71 0.53 3.28 646.8241 1,291.63 1,292.64 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% IAELcDDPKERDDILR 95.00% 2.8 0.256 0 c5: Carbamidomethyl (+57.02) 653.6602 1,957.96 1,957.97 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% QVATALQNLQTK 95.00% 3.52 0.534 2.89 657.8709 1,313.73 1,314.74 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% QVATALQNLQTK 95.00% 3.68 0.544 3.26 657.8715 1,313.73 1,314.74 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% LVQAAQMLQSDPYSVPAR 95.00% 2.66 0.309 2.29 659.0083 1,974.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% GWLRDPSASPGDAGEQAIR 95.00% 3.16 0.407 4.25 661.6604 1,981.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% GWLRDPSASPGDAGEQAIR 95.00% 4.01 0.34 3.68 661.9941 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% GWLRDPSASPGDAGEQAIR 95.00% 4.35 0.451 4.06 661.9948 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASIDSKLNQAK 95.00% 3 0.493 1.23 679.8843 1,357.75 1,358.76 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% DPSASPGDAGEQAIR 95.00% 3.57 0.554 4.59 735.8428 1,469.67 1,470.68 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% DPSASPGDAGEQAIR 95.00% 2.64 0.33 1.57 735.8435 1,469.67 1,470.68 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% DPSASPGDAGEQAIR 95.00% 3.47 0.532 4.92 735.8435 1,469.67 1,470.68 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MLGQMTDQVADLR 95.00% 4.24 0.539 3.7 739.3593 1,476.70 1,477.71 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MLGQMTDQVADLR 95.00% 4.23 0.524 3.59 739.3603 1,476.70 1,477.71 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MLGQMTDQVADLR 95.00% 3.38 0.51 2.66 739.3611 1,476.71 1,477.71 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% MLGQMTDQVADLR 95.00% 4.17 0.552 3.38 739.8599 1,477.70 1,477.71 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VDQLTAQLADLAAR 95.00% 4.73 0.546 3.96 742.9071 1,483.80 1,484.81 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VDQLTAQLADLAAR 95.00% 4.28 0.515 3 742.9081 1,483.80 1,484.81 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLKDLK 95.00% 2.73 0.206 1.28 764.9148 1,527.81 1,529.85 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLKDLK 95.00% 4.13 0.268 2.64 765.4286 1,528.84 1,529.85 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLKDLK 95.00% 3.23 0.145 2.43 765.429 1,528.84 1,529.85 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLKDLK 95.00% 3.39 0.183 2.06 765.4304 1,528.85 1,529.85 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% ALASQLQDSLKDLK 95.00% 3.87 0.355 3.32 765.9308 1,529.85 1,529.85 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% AAVHLEGKIEQAQR 95.00% 3.89 0.396 5.15 775.4262 1,548.84 1,549.85 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% LLAVAATAPPDAPNREEVFDER 95.00% 2.49 0.42 2.74 794.7416 2,381.20 2,381.21 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% LLAVAATAPPDAPNREEVFDER 95.00% 2.92 0.45 3.08 794.7423 2,381.20 2,381.21 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% LLAVAATAPPDAPNREEVFDER 95.00% 2.87 0.45 4 794.7426 2,381.20 2,381.21 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% LLAVAATAPPDAPNREEVFDER 95.00% 2.17 0.317 2.66 794.7428 2,381.20 2,381.21 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% LLAVAATAPPDAPNREEVFDER 95.00% 2.57 0.376 3.44 794.7437 2,381.21 2,381.21 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% KIDAAQNWLADPNGGPEGEEQIR 95.00% 3.25 0.453 0 836.9169 2,507.73 2,508.21 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% KIDAAQNWLADPNGGPEGEEQIR 95.00% 6.18 0.461 5.09 837.0735 2,508.20 2,508.21 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% KIDAAQNWLADPNGGPEGEEQIR 95.00% 5.71 0.409 3.92 837.0753 2,508.20 2,508.21 3
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% QILDEAGKVGELcAGK 95.00% 3.77 0.447 3.24 c13: Carbamidomethyl (+57.02) 844.4388 1,686.86 1,687.87 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% QILDEAGKVGELcAGK 95.00% 3.59 0.437 2.42 c13: Carbamidomethyl (+57.02) 844.4392 1,686.86 1,687.87 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% QILDEAGKVGELcAGK 95.00% 3.88 0.455 3.43 c13: Carbamidomethyl (+57.02) 844.9392 1,687.86 1,687.87 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VLQLTSWDEDAWASK 95.00% 5.01 0.661 10.3 874.926 1,747.84 1,748.85 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VLQLTSWDEDAWASK 95.00% 4.86 0.696 9.15 874.9268 1,747.84 1,748.85 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VLQLTSWDEDAWASK 95.00% 3.93 0.573 4.1 875.4253 1,748.84 1,748.85 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VGKETVQTTEDQILKR 95.00% 5.25 0.483 4.22 923.0047 1,843.99 1,845.01 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VGKETVQTTEDQILKR 95.00% 5.29 0.472 5 923.5064 1,845.00 1,845.01 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% cDRVDQLTAQLADLAAR 95.00% 3.75 0.458 4.32 c1: Carbamidomethyl (+57.02) 958.9843 1,915.95 1,915.97 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% cDRVDQLTAQLADLAAR 95.00% 3.64 0.441 5.29 c1: Carbamidomethyl (+57.02) 958.987 1,915.96 1,915.97 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% LVQAAQMLQSDPYSVPAR 95.00% 5.24 0.399 5.37 988.0075 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% LVQAAQMLQSDPYSVPAR 95.00% 5.14 0.411 5.52 988.0081 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% GWLRDPSASPGDAGEQAIR 95.00% 5.09 0.486 3.03 991.9861 1,981.96 1,982.97 2 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% VAMANIQPQMLVAGATSIAR 95.00% 5.64 0.486 6.62 1,022.05 2,042.08 2,042.09 2
 SAMPLE 1 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 27 36 113 32.10% LLAVAATAPPDAPNREEVFDER 95.00% 4.01 0.498 3.82 1,191.61 2,381.20 2,381.21 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% DYLIDGSR 95.00% 2.62 0.378 0 469.7319 937.4482 938.4585 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% SFLDSGYR 95.00% 2.82 0.323 0 472.7265 943.4374 944.4478 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% SFLDSGYR 95.00% 2.85 0.34 0 472.7275 943.4394 944.4478 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% IPTISTQLK 95.00% 1.92 0.259 0 500.8041 999.5926 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% IPTISTQLK 95.00% 1.8 0.291 0 500.8044 999.5932 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% IPTISTQLK 95.00% 2.04 0.314 0 500.8051 999.5946 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% AAVHLEGKIEQAQR 95.00% 4.95 0.393 2.96 517.2855 1,548.83 1,549.85 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% AAVHLEGKIEQAQR 95.00% 4.77 0.35 1.62 517.2855 1,548.83 1,549.85 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% IPTISTQLKILSTVK 95.00% 2.11 0.374 0 548.0089 1,641.00 1,642.02 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% SLGEISALTSK 95.00% 3 0.469 3.28 553.3065 1,104.60 1,105.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% SLGEISALTSK 95.00% 3.33 0.443 3.28 553.3069 1,104.60 1,105.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% SLGEISALTSK 95.00% 3.28 0.411 3.7 553.307 1,104.60 1,105.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% SLGEISALTSK 95.00% 3.35 0.485 3.21 553.308 1,104.60 1,105.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% SLGEISALTSK 95.00% 3 0.416 3.08 553.3082 1,104.60 1,105.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% STVEGIQASVK 95.00% 3.5 0.513 4.01 559.8047 1,117.59 1,118.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% STVEGIQASVK 95.00% 3.35 0.485 2.82 559.8048 1,117.59 1,118.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% STVEGIQASVK 95.00% 3.37 0.467 4.02 559.8053 1,117.59 1,118.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% STVEGIQASVK 95.00% 3.28 0.478 2.96 559.8059 1,117.60 1,118.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% STVEGIQASVK 95.00% 3.18 0.463 2.51 559.8067 1,117.60 1,118.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% QILDEAGKVGELcAGK 95.00% 2.79 0.26 0 c13: Carbamidomethyl (+57.02) 563.2928 1,686.85 1,687.87 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% QILDEAGKVGELcAGK 95.00% 2.9 0.273 0 c13: Carbamidomethyl (+57.02) 563.2938 1,686.86 1,687.87 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% QILDEAGKVGELcAGK 95.00% 2.58 0.312 1.64 c13: Carbamidomethyl (+57.02) 563.2942 1,686.86 1,687.87 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% QILDEAGKVGELcAGK 95.00% 2.92 0.377 0 c13: Carbamidomethyl (+57.02) 563.6277 1,687.86 1,687.87 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% IRTDAGFTLR 95.00% 2.55 0.278 1.82 575.3185 1,148.62 1,149.64 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% IRTDAGFTLR 95.00% 2.6 0.327 2 575.3199 1,148.62 1,149.64 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% MALLMAEMSR 95.00% 2.73 0.334 2.29 576.7826 1,151.55 1,152.56 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% NPGNQAAYEHFETMK 95.00% 3.43 0.361 1.36 579.928 1,736.76 1,736.77 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% NPGNQAAYEHFETMK 95.00% 2.41 0.506 0 579.9284 1,736.76 1,736.77 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% NPGNQAAYEHFETMK 95.00% 2.61 0.476 0 579.929 1,736.76 1,736.77 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ELTPQVVSAAR 95.00% 2.62 0.333 1.29 585.8268 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ALASQLQDSLK 95.00% 2.51 0.473 1.8 587.3241 1,172.63 1,173.65 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ALASQLQDSLK 95.00% 2.96 0.526 1.7 587.326 1,172.64 1,173.65 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ALASQLQDSLK 95.00% 2.86 0.388 1.7 587.3271 1,172.64 1,173.65 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ALASQLQDSLK 95.00% 3.01 0.503 1.7 587.3271 1,172.64 1,173.65 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ALASQLQDSLK 95.00% 2.24 0.439 1.96 587.3275 1,172.64 1,173.65 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ALASQLQDSLK 95.00% 2.32 0.404 2.38 587.3277 1,172.64 1,173.65 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% MSAEINEIIR 95.00% 3.33 0.155 1.28 588.3072 1,174.60 1,175.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% MSAEINEIIR 95.00% 3.1 0.125 1.35 588.3076 1,174.60 1,175.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% MSAEINEIIR 95.00% 3.18 0.129 1.92 588.3087 1,174.60 1,175.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% MSAEINEIIR 95.00% 3.13 0.146 0 588.3092 1,174.60 1,175.61 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% mSAEINEIIR 95.00% 2.82 0.4 0 m1: Oxidation (+15.99) 596.3028 1,190.59 1,191.60 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ELLPVLISAMK 95.00% 2.59 0.352 0 607.3627 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ELLPVLISAMK 95.00% 2.4 0.395 2.12 607.3628 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ELLPVLISAMK 95.00% 2.7 0.383 1.21 607.3629 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ELLPVLISAMK 95.00% 2.76 0.413 1.85 607.363 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ELLPVLISAMK 95.00% 2.66 0.386 1.82 607.3636 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ELLPVLISAMK 95.00% 2.69 0.455 2.77 607.3639 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ELLPVLISAMK 95.00% 2.79 0.371 2.06 607.364 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ELLPVLISAMK 95.00% 2.37 0.409 1.48 607.3644 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ELLPVLISAMK 95.00% 2.36 0.414 2.27 607.3644 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ELLPVLISAMK 95.00% 2.89 0.395 0 607.365 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% VGKETVQTTEDQILKR 95.00% 4.87 0.495 4.82 615.6731 1,844.00 1,845.01 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% VGKETVQTTEDQILKR 95.00% 5 0.512 3.09 615.6743 1,844.00 1,845.01 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% WIDNPTVDDR 95.00% 3.14 0.372 2.05 615.7893 1,229.56 1,230.58 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% WIDNPTVDDR 95.00% 2.46 0.306 1.46 615.7896 1,229.56 1,230.58 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% WIDNPTVDDR 95.00% 3.09 0.434 1.51 615.7899 1,229.56 1,230.58 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% WIDNPTVDDR 95.00% 2.75 0.392 1.72 615.7901 1,229.56 1,230.58 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% WIDNPTVDDR 95.00% 3.07 0.363 1.89 616.2922 1,230.57 1,230.58 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% VMLVNSMNTVK 95.00% 2.87 0.361 2.15 618.3272 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% VMLVNSMNTVK 95.00% 2.6 0.414 1.92 618.328 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% cDRVDQLTAQLADLAAR 95.00% 3.39 0.368 1.4 c1: Carbamidomethyl (+57.02) 639.327 1,914.96 1,915.97 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% cDRVDQLTAQLADLAAR 95.00% 4.36 0.408 2.13 c1: Carbamidomethyl (+57.02) 639.6591 1,915.95 1,915.97 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% cDRVDQLTAQLADLAAR 95.00% 3.28 0.273 1.4 c1: Carbamidomethyl (+57.02) 639.6599 1,915.96 1,915.97 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% cDRVDQLTAQLADLAAR 95.00% 4.14 0.408 1.6 c1: Carbamidomethyl (+57.02) 639.6602 1,915.96 1,915.97 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% MTGLVDEAIDTK 95.00% 3.22 0.512 2.14 646.823 1,291.63 1,292.64 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% MTGLVDEAIDTK 95.00% 4.05 0.585 3.74 646.823 1,291.63 1,292.64 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% MTGLVDEAIDTK 95.00% 3.89 0.543 4.33 646.8238 1,291.63 1,292.64 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% LVQAAQMLQSDPYSVPAR 95.00% 2.93 0.304 1.19 658.6749 1,973.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% LVQAAQMLQSDPYSVPAR 95.00% 3.6 0.413 4.02 659.0087 1,974.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% LVQAAQMLQSDPYSVPAR 95.00% 2.53 0.231 0 659.0093 1,974.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% GWLRDPSASPGDAGEQAIR 95.00% 2.6 0.302 1.05 661.6599 1,981.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% GWLRDPSASPGDAGEQAIR 95.00% 3.91 0.399 2.96 661.9944 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% GWLRDPSASPGDAGEQAIR 95.00% 4.19 0.391 4.52 661.9948 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% GWLRDPSASPGDAGEQAIR 95.00% 3.81 0.393 2.68 661.9954 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% AQQVSQGLDVLTAK 95.00% 4.93 0.591 5.54 729.4046 1,456.79 1,457.80 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% DPSASPGDAGEQAIR 95.00% 2.11 0.31 1.42 735.8436 1,469.67 1,470.68 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% DPSASPGDAGEQAIR 94.70% 2.12 0.161 1.33 735.8437 1,469.67 1,470.68 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% DPSASPGDAGEQAIR 95.00% 3.72 0.539 3.82 735.8437 1,469.67 1,470.68 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% DPSASPGDAGEQAIR 95.00% 3.26 0.51 4.14 735.8456 1,469.68 1,470.68 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% MLGQMTDQVADLR 95.00% 3.39 0.572 3.15 739.3598 1,476.70 1,477.71 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% MLGQMTDQVADLR 95.00% 3.91 0.542 4.18 739.3601 1,476.70 1,477.71 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% MLGQMTDQVADLR 95.00% 4.25 0.553 4.46 739.361 1,476.71 1,477.71 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% MLGQMTDQVADLR 95.00% 3.31 0.474 3.21 739.361 1,476.71 1,477.71 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% VDQLTAQLADLAAR 95.00% 4.06 0.584 2.72 742.9068 1,483.80 1,484.81 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% VDQLTAQLADLAAR 95.00% 4.25 0.519 3.39 742.9074 1,483.80 1,484.81 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ALASQLQDSLKDLK 95.00% 3.25 0.193 1.96 765.4302 1,528.84 1,529.85 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ALASQLQDSLKDLK 95.00% 3.69 0.225 2.46 765.4304 1,528.85 1,529.85 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% ALASQLQDSLKDLK 95.00% 4.09 0.255 3.62 765.4305 1,528.85 1,529.85 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 2.22 0.207 1.24 794.7416 2,381.20 2,381.21 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 3 0.364 3.96 794.7426 2,381.20 2,381.21 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 2.56 0.467 2.82 794.7431 2,381.21 2,381.21 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 2.36 0.271 2.1 794.7432 2,381.21 2,381.21 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 2.77 0.346 2.96 794.7432 2,381.21 2,381.21 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 2.86 0.338 1.54 794.7434 2,381.21 2,381.21 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 2.72 0.409 3.72 794.7437 2,381.21 2,381.21 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% KIDAAQNWLADPNGGPEGEEQIR 95.00% 6.07 0.448 3.32 837.0736 2,508.20 2,508.21 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% KIDAAQNWLADPNGGPEGEEQIR 95.00% 6.55 0.45 3.25 837.075 2,508.20 2,508.21 3
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% QILDEAGKVGELcAGK 95.00% 3.99 0.497 2.89 c13: Carbamidomethyl (+57.02) 844.4364 1,686.86 1,687.87 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% QILDEAGKVGELcAGK 95.00% 3.57 0.382 2.92 c13: Carbamidomethyl (+57.02) 844.9392 1,687.86 1,687.87 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% VLQLTSWDEDAWASK 95.00% 5.02 0.694 8.37 874.9269 1,747.84 1,748.85 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% VLQLTSWDEDAWASK 95.00% 4.43 0.66 8.28 874.9271 1,747.84 1,748.85 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% VLQLTSWDEDAWASK 95.00% 4.85 0.678 7.13 874.9299 1,747.84 1,748.85 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% cDRVDQLTAQLADLAAR 95.00% 3.62 0.444 4.06 c1: Carbamidomethyl (+57.02) 958.4851 1,914.95 1,915.97 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% cDRVDQLTAQLADLAAR 95.00% 3.77 0.452 4.89 c1: Carbamidomethyl (+57.02) 958.9839 1,915.95 1,915.97 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% cDRVDQLTAQLADLAAR 95.00% 3.92 0.47 3.18 c1: Carbamidomethyl (+57.02) 958.9882 1,915.96 1,915.97 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% LVQAAQMLQSDPYSVPAR 95.00% 5.44 0.433 5.7 988.0081 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% LVQAAQMLQSDPYSVPAR 95.00% 4.78 0.355 4.4 988.0086 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% GWLRDPSASPGDAGEQAIR 95.00% 5.13 0.54 2.32 992.489 1,982.96 1,982.97 2 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% GWLRDPSASPGDAGEQAIR 95.00% 5.51 0.542 1.47 992.4897 1,982.96 1,982.97 2 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% GILSGTSDLLLTFDEAEVR 95.00% 4.9 0.597 4.96 1,018.53 2,035.04 2,036.06 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% GILSGTSDLLLTFDEAEVR 95.00% 5.52 0.557 6.14 1,018.53 2,035.04 2,036.06 2
 SAMPLE 1R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 34 109 34.70% AIPDLTAPVAAVQAAVSNLVR 95.00% 5.43 0.68 10.4 1,039.09 2,076.17 2,076.18 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% DYLIDGSR 95.00% 2.72 0.453 0 469.7316 937.4475 938.4585 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% DYLIDGSR 95.00% 2.68 0.421 0 469.7321 937.4485 938.4585 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% SFLDSGYR 95.00% 3.07 0.354 1.59 472.7267 943.4377 944.4478 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% SFLDSGYR 95.00% 2.9 0.323 1.42 472.727 943.4384 944.4478 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% SFLDSGYR 95.00% 3 0.34 0 472.7273 943.4389 944.4478 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% SFLDSGYR 95.00% 2.9 0.307 1.38 472.7275 943.4394 944.4478 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AQQVSQGLDVLTAK 95.00% 4.21 0.485 3.82 486.6027 1,456.78 1,457.80 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AQQVSQGLDVLTAK 95.00% 4.03 0.493 3.3 486.6028 1,456.79 1,457.80 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% IPTISTQLK 95.00% 2.18 0.294 0 500.803 999.5904 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% IPTISTQLK 95.00% 2.09 0.299 0 500.8043 999.593 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% IPTISTQLK 95.00% 2.26 0.314 1.21 500.8046 999.5935 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% IPTISTQLK 95.00% 2.17 0.305 0 500.8051 999.5945 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ALASQLQDSLKDLK 95.00% 2.22 0.189 0 510.621 1,528.84 1,529.85 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ALASQLQDSLKDLK 95.00% 2.35 0.306 0 510.6219 1,528.84 1,529.85 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AAVHLEGKIEQAQR 95.00% 3.86 0.437 1.47 517.2845 1,548.83 1,549.85 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AAVHLEGKIEQAQR 95.00% 4.57 0.365 2.7 517.2858 1,548.83 1,549.85 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AAVHLEGKIEQAQR 95.00% 3.08 0.366 0 517.2865 1,548.84 1,549.85 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AAVHLEGKIEQAQR 95.00% 2.89 0.403 0 517.2869 1,548.84 1,549.85 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% SLGEISALTSK 95.00% 3.61 0.471 2.66 553.3075 1,104.60 1,105.61 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% SLGEISALTSK 95.00% 3.58 0.476 3.09 553.3078 1,104.60 1,105.61 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% SLGEISALTSK 95.00% 3.8 0.486 2.77 553.3079 1,104.60 1,105.61 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% SLGEISALTSK 95.00% 3.8 0.505 4.11 553.308 1,104.60 1,105.61 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% SLGEISALTSK 95.00% 3.36 0.494 3.05 553.3088 1,104.60 1,105.61 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% STVEGIQASVK 95.00% 3.52 0.513 2.4 559.8052 1,117.59 1,118.61 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% STVEGIQASVK 95.00% 3.34 0.507 3.92 559.8052 1,117.59 1,118.61 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% STVEGIQASVK 95.00% 3.62 0.497 3.77 559.8056 1,117.60 1,118.61 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% STVEGIQASVK 95.00% 2.98 0.362 2.49 559.8056 1,117.60 1,118.61 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% STVEGIQASVK 95.00% 3.23 0.495 3.49 559.8058 1,117.60 1,118.61 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% QILDEAGKVGELcAGK 95.00% 3.27 0.44 1.24 c13: Carbamidomethyl (+57.02) 563.2939 1,686.86 1,687.87 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% QILDEAGKVGELcAGK 95.00% 3.01 0.408 1.46 c13: Carbamidomethyl (+57.02) 563.6284 1,687.86 1,687.87 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% NQWIDNVEK 95.00% 2.25 0.262 0 573.2813 1,144.55 1,145.56 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% NQWIDNVEK 95.00% 2.27 0.3 0 573.2814 1,144.55 1,145.56 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% IRTDAGFTLR 95.00% 2.54 0.358 0 575.3216 1,148.63 1,149.64 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% IRTDAGFTLR 95.00% 2.9 0.406 1.62 575.3224 1,148.63 1,149.64 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% IRTDAGFTLR 95.00% 2.24 0.2 1.13 575.3228 1,148.63 1,149.64 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% MALLMAEMSR 95.00% 3.7 0.269 3.62 576.7807 1,151.55 1,152.56 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% MALLMAEMSR 95.00% 4.15 0.314 4.55 576.7812 1,151.55 1,152.56 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% NPGNQAAYEHFETMK 95.00% 2.85 0.47 1.3 579.5941 1,735.76 1,736.77 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% NPGNQAAYEHFETMK 95.00% 2.89 0.51 0 579.5943 1,735.76 1,736.77 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% NPGNQAAYEHFETMK 95.00% 3.33 0.48 1.04 579.5948 1,735.76 1,736.77 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% NPGNQAAYEHFETMK 95.00% 3.28 0.506 1.66 579.928 1,736.76 1,736.77 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ELTPQVVSAAR 95.00% 2.76 0.377 1.51 585.8268 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ELTPQVVSAAR 95.00% 2.76 0.383 1.8 585.8268 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ELTPQVVSAAR 95.00% 2.73 0.452 1.8 585.8274 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ALASQLQDSLK 95.00% 2.99 0.433 2.11 587.3263 1,172.64 1,173.65 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ALASQLQDSLK 95.00% 3.26 0.49 2.23 587.3264 1,172.64 1,173.65 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ALASQLQDSLK 95.00% 3.01 0.516 1.7 587.3266 1,172.64 1,173.65 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ALASQLQDSLK 95.00% 2.81 0.481 2 587.3272 1,172.64 1,173.65 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% MSAEINEIIR 95.00% 3.6 0.134 1.17 588.3081 1,174.60 1,175.61 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% MSAEINEIIR 95.00% 3.02 0.174 1.43 588.3092 1,174.60 1,175.61 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% mSAEINEIIR 95.00% 2.91 0.405 1.34 m1: Oxidation (+15.99) 596.3044 1,190.59 1,191.60 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VGKETVQTTEDQILKR 95.00% 4.23 0.49 1.8 615.6734 1,844.00 1,845.01 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VGKETVQTTEDQILKR 95.00% 4.18 0.432 2.31 615.6736 1,844.00 1,845.01 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VGKETVQTTEDQILKR 95.00% 4.1 0.483 1.64 615.674 1,844.00 1,845.01 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VGKETVQTTEDQILKR 95.00% 4.68 0.544 1.85 615.6741 1,844.00 1,845.01 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% WIDNPTVDDR 95.00% 3.07 0.317 2 615.789 1,229.56 1,230.58 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% WIDNPTVDDR 95.00% 2.83 0.339 2.09 615.7899 1,229.56 1,230.58 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% WIDNPTVDDR 95.00% 3.07 0.307 2.89 615.7901 1,229.56 1,230.58 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VGKETVQTTEDQILKR 95.00% 3.31 0.34 1.08 616.0103 1,845.01 1,845.01 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VMLVNSMNTVK 95.00% 2.93 0.44 1.44 618.3247 1,234.63 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VMLVNSMNTVK 95.00% 3.41 0.441 3.24 618.3261 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VMLVNSMNTVK 95.00% 3.6 0.449 2.48 618.327 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VMLVNSMNTVK 95.00% 3.45 0.428 2.4 618.3274 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VMLVNSMNTVK 95.00% 3.37 0.393 2.34 618.3274 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% cDRVDQLTAQLADLAAR 95.00% 3.71 0.467 2.28 c1: Carbamidomethyl (+57.02) 639.3264 1,914.96 1,915.97 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% cDRVDQLTAQLADLAAR 95.00% 4.61 0.463 2.36 c1: Carbamidomethyl (+57.02) 639.3267 1,914.96 1,915.97 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% cDRVDQLTAQLADLAAR 95.00% 4.02 0.434 2.8 c1: Carbamidomethyl (+57.02) 639.327 1,914.96 1,915.97 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% cDRVDQLTAQLADLAAR 95.00% 3.57 0.418 2.77 c1: Carbamidomethyl (+57.02) 639.6616 1,915.96 1,915.97 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% IAELcDDPKERDDILR 95.00% 2.81 0.262 0 c5: Carbamidomethyl (+57.02) 653.3273 1,956.96 1,957.97 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% IAELcDDPKERDDILR 95.00% 2.73 0.314 0 c5: Carbamidomethyl (+57.02) 653.3278 1,956.96 1,957.97 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LVQAAQMLQSDPYSVPAR 95.00% 2.8 0.274 0 658.6776 1,973.01 1,974.01 3 A1BG_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LVQAAQMLQSDPYSVPAR 95.00% 3.13 0.442 1.66 659.0088 1,974.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LVQAAQMLQSDPYSVPAR 95.00% 3.69 0.467 2.89 659.009 1,974.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% GWLRDPSASPGDAGEQAIR 95.00% 4.05 0.404 3.32 661.6607 1,981.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% GWLRDPSASPGDAGEQAIR 95.00% 2.37 0.313 1.19 661.6611 1,981.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% GWLRDPSASPGDAGEQAIR 95.00% 4.41 0.384 4.64 661.9948 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VAMANIQPQMLVAGATSIAR 95.00% 3.9 0.489 1.07 681.7015 2,042.08 2,042.09 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AQQVSQGLDVLTAK 95.00% 4.95 0.571 5.42 729.4007 1,456.79 1,457.80 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AQQVSQGLDVLTAK 95.00% 2.46 0.418 3.42 729.4009 1,456.79 1,457.80 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AQQVSQGLDVLTAK 95.00% 4.99 0.625 4.6 729.401 1,456.79 1,457.80 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AQQVSQGLDVLTAK 95.00% 5.09 0.602 4.74 729.401 1,456.79 1,457.80 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AQQVSQGLDVLTAK 95.00% 3.4 0.506 4.46 729.4022 1,456.79 1,457.80 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AQQVSQGLDVLTAK 95.00% 4.6 0.614 3.85 729.403 1,456.79 1,457.80 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% DPSASPGDAGEQAIR 95.00% 3.96 0.543 4.14 735.8437 1,469.67 1,470.68 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% DPSASPGDAGEQAIR 95.00% 2.68 0.453 2.92 735.844 1,469.67 1,470.68 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% DPSASPGDAGEQAIR 95.00% 3.3 0.431 4.96 735.844 1,469.67 1,470.68 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% DPSASPGDAGEQAIR 95.00% 3.71 0.496 4.96 735.8449 1,469.67 1,470.68 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% MLGQMTDQVADLR 95.00% 4.3 0.51 5.3 739.3595 1,476.70 1,477.71 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% MLGQMTDQVADLR 95.00% 4.16 0.539 4 739.3599 1,476.70 1,477.71 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% MLGQMTDQVADLR 95.00% 4.22 0.515 3.44 739.3602 1,476.70 1,477.71 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% MLGQMTDQVADLR 95.00% 4.22 0.544 5.4 739.3602 1,476.70 1,477.71 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AGEVINQPMMMAAR 95.00% 3.86 0.531 3.32 759.8641 1,517.71 1,518.72 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AGEVINQPMMMAAR 95.00% 4.2 0.564 3.12 759.8641 1,517.71 1,518.72 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AGEVINQPMMMAAR 95.00% 4.39 0.503 3.68 759.8644 1,517.71 1,518.72 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AGEVINQPMMMAAR 95.00% 4.58 0.49 4.8 759.8656 1,517.72 1,518.72 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ALASQLQDSLKDLK 95.00% 3.88 0.3 3.31 765.4281 1,528.84 1,529.85 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ALASQLQDSLKDLK 95.00% 4.35 0.309 2.16 765.4297 1,528.84 1,529.85 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ALASQLQDSLKDLK 95.00% 4.11 0.293 3.48 765.4299 1,528.84 1,529.85 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ALASQLQDSLKDLK 95.00% 4.22 0.322 2.64 765.4302 1,528.84 1,529.85 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% ETVQTTEDQILKR 95.00% 3.61 0.384 1.44 780.9154 1,559.82 1,560.82 2 RS20_HUMAN,ANK3_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 2.75 0.41 3.44 794.7417 2,381.20 2,381.21 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 2.95 0.414 3.7 794.7421 2,381.20 2,381.21 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 3.17 0.486 3.55 794.7423 2,381.20 2,381.21 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 2.98 0.391 4.14 794.7426 2,381.20 2,381.21 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 3 0.448 2.96 794.7428 2,381.20 2,381.21 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 2.53 0.478 1.82 794.7443 2,381.21 2,381.21 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% qILDEAGKVGELcAGK 95.00% 0 0 3.66 c13: Carbamidomethyl (+57.02), n-term: Pyro-cmC (-17.03) 835.9247 1,669.83 1,670.84 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% KIDAAQNWLADPNGGPEGEEQIR 95.00% 6.09 0.448 5.13 837.075 2,508.20 2,508.21 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% KIDAAQNWLADPNGGPEGEEQIR 95.00% 6.31 0.492 5.12 837.075 2,508.20 2,508.21 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% KIDAAQNWLADPNGGPEGEEQIR 95.00% 6.1 0.496 5.28 837.0758 2,508.20 2,508.21 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% KIDAAQNWLADPNGGPEGEEQIR 95.00% 6.63 0.525 5.51 837.0761 2,508.20 2,508.21 3
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% QILDEAGKVGELcAGK 95.00% 4.03 0.477 3.57 c13: Carbamidomethyl (+57.02) 844.4371 1,686.86 1,687.87 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% QILDEAGKVGELcAGK 95.00% 3.72 0.47 2.92 c13: Carbamidomethyl (+57.02) 844.9405 1,687.87 1,687.87 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VLQLTSWDEDAWASK 95.00% 4.58 0.633 6.49 874.9264 1,747.84 1,748.85 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VLQLTSWDEDAWASK 95.00% 4.11 0.58 4.52 874.9265 1,747.84 1,748.85 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VLQLTSWDEDAWASK 95.00% 4.81 0.674 5.38 875.4275 1,748.84 1,748.85 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VLQLTSWDEDAWASK 95.00% 5.27 0.693 8.49 875.4286 1,748.84 1,748.85 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VGKETVQTTEDQILKR 95.00% 5.4 0.498 4.89 923.0095 1,844.00 1,845.01 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% AAAVGTANKSTVEGIQASVK 95.00% 4.59 0.645 4.28 952.0213 1,902.03 1,902.03 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% cDRVDQLTAQLADLAAR 95.00% 4.19 0.455 4.92 c1: Carbamidomethyl (+57.02) 958.4849 1,914.95 1,915.97 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% cDRVDQLTAQLADLAAR 95.00% 4.19 0.47 4.49 c1: Carbamidomethyl (+57.02) 958.4856 1,914.96 1,915.97 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% cDRVDQLTAQLADLAAR 95.00% 3.56 0.454 4.25 c1: Carbamidomethyl (+57.02) 958.9862 1,915.96 1,915.97 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LVQAAQMLQSDPYSVPAR 95.00% 4.72 0.389 5.14 987.5066 1,973.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LVQAAQMLQSDPYSVPAR 95.00% 4.78 0.38 5.21 987.5088 1,973.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LVQAAQMLQSDPYSVPAR 95.00% 4.98 0.365 5.06 988.0083 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LVQAAQMLQSDPYSVPAR 95.00% 5.24 0.407 4.72 988.0087 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% GWLRDPSASPGDAGEQAIR 95.00% 5.3 0.527 3.03 991.9875 1,981.96 1,982.97 2 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% GWLRDPSASPGDAGEQAIR 95.00% 5 0.512 2.42 992.4875 1,982.96 1,982.97 2 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% VAMANIQPQMLVAGATSIAR 95.00% 6.07 0.481 7.52 1,022.05 2,042.08 2,042.09 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 4.19 0.5 4.17 1,191.61 2,381.20 2,381.21 2
 SAMPLE 2 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 30 39 123 34.70% LLAVAATAPPDAPNREEVFDER 95.00% 4.11 0.509 3.72 1,191.61 2,381.20 2,381.21 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% DYLIDGSR 95.00% 2.84 0.455 1.89 469.732 937.4484 938.4585 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% DYLIDGSR 95.00% 2.46 0.392 1.6 469.7332 937.4507 938.4585 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% SFLDSGYR 95.00% 2.86 0.431 1.85 472.7268 943.4379 944.4478 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% SFLDSGYR 95.00% 2.69 0.362 1.7 472.7269 943.4381 944.4478 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% SFLDSGYR 95.00% 2.73 0.311 0 472.7271 943.4385 944.4478 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% AQQVSQGLDVLTAK 95.00% 3.57 0.366 2.03 486.6046 1,456.79 1,457.80 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% AQQVSQGLDVLTAK 95.00% 4.04 0.515 3.51 486.9371 1,457.79 1,457.80 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% AQQVSQGLDVLTAK 95.00% 4.19 0.465 2.92 486.9375 1,457.79 1,457.80 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VDQLTAQLADLAAR 95.00% 3.54 0.415 1.8 495.6064 1,483.80 1,484.81 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% IPTISTQLK 95.00% 2.2 0.351 1.19 500.8032 999.5907 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% IPTISTQLK 95.00% 2.17 0.303 0 500.8047 999.5937 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% AAVHLEGKIEQAQR 95.00% 4.34 0.397 1.85 517.2843 1,548.83 1,549.85 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% AAVHLEGKIEQAQR 95.00% 3.39 0.369 0 517.2856 1,548.83 1,549.85 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% AAVHLEGKIEQAQR 95.00% 3.87 0.401 0 517.2867 1,548.84 1,549.85 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% AAVHLEGKIEQAQR 95.00% 4.34 0.399 2.51 517.62 1,549.84 1,549.85 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% SLGEISALTSK 95.00% 3.69 0.498 3.33 553.3073 1,104.60 1,105.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% SLGEISALTSK 95.00% 3.35 0.501 3.13 553.3077 1,104.60 1,105.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% SLGEISALTSK 95.00% 3.7 0.483 3.46 553.3078 1,104.60 1,105.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% SLGEISALTSK 95.00% 3.01 0.45 2.74 553.308 1,104.60 1,105.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% SLGEISALTSK 95.00% 2.66 0.448 3.05 553.3081 1,104.60 1,105.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% SLGEISALTSK 95.00% 3.42 0.491 3.82 553.3082 1,104.60 1,105.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% SLGEISALTSK 95.00% 2 0.315 0 553.3097 1,104.60 1,105.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% SLGEISALTSK 95.00% 2.29 0.363 0 553.3108 1,104.61 1,105.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% STVEGIQASVK 95.00% 3.6 0.505 3.57 559.8053 1,117.60 1,118.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% STVEGIQASVK 95.00% 3.35 0.47 2.57 559.8053 1,117.60 1,118.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% STVEGIQASVK 95.00% 3.23 0.491 2.34 559.8054 1,117.60 1,118.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% STVEGIQASVK 95.00% 3.27 0.506 3.35 559.8056 1,117.60 1,118.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% STVEGIQASVK 95.00% 2.68 0.373 2.7 559.806 1,117.60 1,118.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% QILDEAGKVGELcAGK 95.00% 2.95 0.4 0 c13: Carbamidomethyl (+57.02) 563.2933 1,686.86 1,687.87 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% QILDEAGKVGELcAGK 95.00% 2.77 0.365 0 c13: Carbamidomethyl (+57.02) 563.2933 1,686.86 1,687.87 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% QILDEAGKVGELcAGK 95.00% 3.38 0.468 1.21 c13: Carbamidomethyl (+57.02) 563.2935 1,686.86 1,687.87 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% QILDEAGKVGELcAGK 95.00% 2.96 0.36 1.8 c13: Carbamidomethyl (+57.02) 563.6281 1,687.86 1,687.87 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VGKETVQTTEDQILK 95.00% 3.38 0.373 2.62 563.6387 1,687.89 1,688.91 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VGKETVQTTEDQILK 95.00% 3.03 0.389 0 563.9747 1,688.90 1,688.91 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% NQWIDNVEK 95.00% 2.29 0.297 0 573.2809 1,144.55 1,145.56 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% IRTDAGFTLR 95.00% 2.71 0.348 2.47 575.3214 1,148.63 1,149.64 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% IRTDAGFTLR 95.00% 2.39 0.289 1.44 575.326 1,148.64 1,149.64 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% NPGNQAAYEHFETMK 95.00% 2.66 0.4 1.37 579.5935 1,735.76 1,736.77 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% NPGNQAAYEHFETMK 95.00% 2.99 0.396 1.29 579.5937 1,735.76 1,736.77 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% NPGNQAAYEHFETMK 95.00% 2.96 0.47 0.959 579.5941 1,735.76 1,736.77 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ELTPQVVSAAR 95.00% 2.75 0.322 0 585.8272 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ELTPQVVSAAR 95.00% 2.42 0.322 0 585.8274 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ELTPQVVSAAR 95.00% 2.88 0.458 1.66 585.8278 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ALASQLQDSLK 95.00% 2.67 0.52 2.03 587.3266 1,172.64 1,173.65 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ALASQLQDSLK 95.00% 2.92 0.484 2.36 587.3269 1,172.64 1,173.65 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ALASQLQDSLK 95.00% 2.94 0.504 2 587.3271 1,172.64 1,173.65 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ALASQLQDSLK 95.00% 2.51 0.434 2.18 587.3275 1,172.64 1,173.65 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ALASQLQDSLK 95.00% 2.75 0.499 2.1 587.3276 1,172.64 1,173.65 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ALASQLQDSLK 95.00% 2.92 0.538 2 587.3277 1,172.64 1,173.65 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% MSAEINEIIR 95.00% 2.34 0.135 2.31 588.3054 1,174.60 1,175.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% MSAEINEIIR 95.00% 2.7 0.165 1.54 588.308 1,174.60 1,175.61 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% mSAEINEIIR 95.00% 2.32 0.368 0 m1: Oxidation (+15.99) 596.3035 1,190.59 1,191.60 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% mSAEINEIIR 95.00% 2.6 0.373 0 m1: Oxidation (+15.99) 596.3067 1,190.60 1,191.60 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ELLPVLISAMK 95.00% 2.23 0.326 0 607.3633 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ELLPVLISAMK 95.00% 1.83 0.319 0 607.3634 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ELLPVLISAMK 95.00% 2.33 0.348 0 607.3638 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ELLPVLISAMK 95.00% 2.56 0.343 0 607.364 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ELLPVLISAMK 95.00% 2.63 0.387 1.6 607.364 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ELLPVLISAMK 95.00% 2.7 0.387 1.77 607.3645 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ELLPVLISAMK 95.00% 2.89 0.405 2.09 607.3646 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ELLPVLISAMK 95.00% 2.29 0.371 1.92 607.3661 1,212.72 1,213.72 2 ANK3_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VGKETVQTTEDQILKR 95.00% 4.11 0.471 1.72 615.6732 1,844.00 1,845.01 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% WIDNPTVDDR 95.00% 2.54 0.319 0 615.7882 1,229.56 1,230.58 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% WIDNPTVDDR 95.00% 3.36 0.386 1.28 615.7899 1,229.56 1,230.58 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VGKETVQTTEDQILKR 95.00% 4.67 0.405 2.15 616.0087 1,845.00 1,845.01 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VMLVNSMNTVK 95.00% 2.98 0.386 2.3 618.3266 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VMLVNSMNTVK 95.00% 3.28 0.429 2.64 618.3269 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VMLVNSMNTVK 95.00% 3.37 0.433 3.08 618.327 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VMLVNSMNTVK 95.00% 3.39 0.371 2.12 618.3275 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VMLVNSMNTVK 95.00% 2.82 0.488 2 618.3303 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% cDRVDQLTAQLADLAAR 95.00% 3.6 0.49 0 c1: Carbamidomethyl (+57.02) 639.3254 1,914.95 1,915.97 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% cDRVDQLTAQLADLAAR 95.00% 4.31 0.419 2 c1: Carbamidomethyl (+57.02) 639.6611 1,915.96 1,915.97 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% cDRVDQLTAQLADLAAR 95.00% 4.68 0.366 2.24 c1: Carbamidomethyl (+57.02) 639.6611 1,915.96 1,915.97 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% cDRVDQLTAQLADLAAR 95.00% 3.45 0.4 1.34 c1: Carbamidomethyl (+57.02) 639.662 1,915.96 1,915.97 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% MTGLVDEAIDTK 95.00% 3.01 0.526 1.59 646.8239 1,291.63 1,292.64 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% MTGLVDEAIDTK 95.00% 2.46 0.349 0 646.8251 1,291.63 1,292.64 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% MTGLVDEAIDTK 95.00% 2.7 0.521 1.42 646.8261 1,291.64 1,292.64 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% IAELcDDPKERDDILR 95.00% 2.4 0.272 0 c5: Carbamidomethyl (+57.02) 653.3264 1,956.96 1,957.97 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% IAELcDDPKERDDILR 95.00% 3.2 0.325 0 c5: Carbamidomethyl (+57.02) 653.6609 1,957.96 1,957.97 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LVQAAQMLQSDPYSVPAR 95.00% 2.74 0.323 2.49 659.0085 1,974.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LVQAAQMLQSDPYSVPAR 95.00% 4.33 0.502 3.8 659.0086 1,974.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% GWLRDPSASPGDAGEQAIR 95.00% 4.8 0.502 3.25 661.9944 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% GWLRDPSASPGDAGEQAIR 95.00% 3.82 0.348 3.17 661.9952 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VAMANIQPQMLVAGATSIAR 95.00% 3.14 0.393 0 681.6997 2,042.08 2,042.09 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VAMANIQPQMLVAGATSIAR 95.00% 3.58 0.445 2.02 681.7014 2,042.08 2,042.09 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VAMANIQPQmLVAGATSIAR 95.00% 2.85 0.273 1.37 m10: Oxidation (+15.99) 687.0328 2,058.08 2,058.08 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% AQQVSQGLDVLTAK 95.00% 4.62 0.591 5.49 729.4021 1,456.79 1,457.80 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% AQQVSQGLDVLTAK 95.00% 5.04 0.573 5.8 729.4024 1,456.79 1,457.80 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% DPSASPGDAGEQAIR 95.00% 3.27 0.519 3.1 735.8432 1,469.67 1,470.68 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% DPSASPGDAGEQAIR 95.00% 3.89 0.56 3.52 735.8436 1,469.67 1,470.68 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% DPSASPGDAGEQAIR 95.00% 3.14 0.479 4.12 735.8445 1,469.67 1,470.68 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% DPSASPGDAGEQAIR 95.00% 3.16 0.484 2.49 735.8446 1,469.67 1,470.68 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% MLGQMTDQVADLR 95.00% 4.22 0.579 4.51 739.3589 1,476.70 1,477.71 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% MLGQMTDQVADLR 95.00% 4.04 0.558 4 739.36 1,476.70 1,477.71 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% MLGQMTDQVADLR 95.00% 3.79 0.552 5.59 739.3601 1,476.70 1,477.71 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% MLGQMTDQVADLR 95.00% 3.98 0.518 4.02 739.8618 1,477.71 1,477.71 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VDQLTAQLADLAAR 95.00% 4.65 0.515 3.92 742.9054 1,483.80 1,484.81 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VDQLTAQLADLAAR 95.00% 4.36 0.577 2.89 742.907 1,483.80 1,484.81 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VDQLTAQLADLAAR 95.00% 2.91 0.489 2.1 742.9073 1,483.80 1,484.81 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% AGEVINQPMMMAAR 95.00% 4.07 0.525 2.29 759.8653 1,517.72 1,518.72 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% AGEVINQPMMMAAR 95.00% 3.77 0.49 2.74 759.8659 1,517.72 1,518.72 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% AGEVINQPMMMAAR 95.00% 4.18 0.551 3.19 759.8661 1,517.72 1,518.72 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ALASQLQDSLKDLK 95.00% 4.03 0.277 3.01 765.4296 1,528.84 1,529.85 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ALASQLQDSLKDLK 95.00% 3.96 0.273 2.59 765.4314 1,528.85 1,529.85 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ALASQLQDSLKDLK 95.00% 3.96 0.334 3.01 765.4314 1,528.85 1,529.85 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% ALASQLQDSLKDLK 95.00% 3.84 0.267 2.22 765.4318 1,528.85 1,529.85 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LLAVAATAPPDAPNREEVFDER 95.00% 3.02 0.469 3.14 794.7415 2,381.20 2,381.21 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LLAVAATAPPDAPNREEVFDER 95.00% 3.02 0.331 3.96 794.7424 2,381.20 2,381.21 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LLAVAATAPPDAPNREEVFDER 95.00% 2.88 0.375 3.52 794.7425 2,381.20 2,381.21 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LLAVAATAPPDAPNREEVFDER 95.00% 2.9 0.451 2.48 794.7429 2,381.21 2,381.21 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LLAVAATAPPDAPNREEVFDER 95.00% 3.08 0.454 3.48 794.743 2,381.21 2,381.21 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LLAVAATAPPDAPNREEVFDER 95.00% 2.7 0.435 3.03 794.7435 2,381.21 2,381.21 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% KIDAAQNWLADPNGGPEGEEQIR 95.00% 5.17 0.439 2.57 837.0713 2,508.19 2,508.21 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% KIDAAQNWLADPNGGPEGEEQIR 95.00% 6.61 0.459 3.89 837.075 2,508.20 2,508.21 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% KIDAAQNWLADPNGGPEGEEQIR 95.00% 5.93 0.502 3.82 837.0754 2,508.20 2,508.21 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% KIDAAQNWLADPNGGPEGEEQIR 95.00% 6.4 0.373 4.06 837.0757 2,508.20 2,508.21 3
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% QILDEAGKVGELcAGK 95.00% 3.71 0.443 3.8 c13: Carbamidomethyl (+57.02) 844.4392 1,686.86 1,687.87 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% QILDEAGKVGELcAGK 95.00% 4.27 0.422 3.28 c13: Carbamidomethyl (+57.02) 844.9387 1,687.86 1,687.87 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VGKETVQTTEDQILK 95.00% 4.1 0.43 2.44 844.9575 1,687.90 1,688.91 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% NPGNQAAYEHFETMK 95.00% 5.29 0.605 6.96 868.8877 1,735.76 1,736.77 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% NPGNQAAYEHFETMK 95.00% 5.4 0.566 6.36 868.8888 1,735.76 1,736.77 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% NPGNQAAYEHFETMK 95.00% 5.28 0.575 5.59 869.3867 1,736.76 1,736.77 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% NPGNQAAYEHFETMK 95.00% 5.68 0.603 6.26 869.3883 1,736.76 1,736.77 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VLQLTSWDEDAWASK 95.00% 4.79 0.676 9.12 874.9269 1,747.84 1,748.85 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VLQLTSWDEDAWASK 95.00% 5.02 0.669 7.38 875.4283 1,748.84 1,748.85 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VLQLTSWDEDAWASK 95.00% 4.81 0.697 7.22 875.4295 1,748.84 1,748.85 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VGKETVQTTEDQILKR 95.00% 5.72 0.435 5.06 923.5102 1,845.00 1,845.01 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% cDRVDQLTAQLADLAAR 95.00% 3.86 0.413 5.41 c1: Carbamidomethyl (+57.02) 958.4842 1,914.95 1,915.97 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% cDRVDQLTAQLADLAAR 95.00% 3.56 0.428 3.39 c1: Carbamidomethyl (+57.02) 958.4857 1,914.96 1,915.97 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% cDRVDQLTAQLADLAAR 95.00% 4.09 0.436 3.85 c1: Carbamidomethyl (+57.02) 958.9851 1,915.95 1,915.97 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% cDRVDQLTAQLADLAAR 95.00% 3.87 0.433 4.41 c1: Carbamidomethyl (+57.02) 958.9864 1,915.96 1,915.97 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LVQAAQMLQSDPYSVPAR 95.00% 3.8 0.396 4.77 987.5056 1,973.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LVQAAQMLQSDPYSVPAR 95.00% 4.6 0.348 5.17 987.5097 1,973.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LVQAAQMLQSDPYSVPAR 95.00% 5.31 0.404 5.47 988.0069 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LVQAAQMLQSDPYSVPAR 95.00% 4.87 0.348 7.16 988.0099 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% GWLRDPSASPGDAGEQAIR 95.00% 5 0.515 1.22 992.487 1,982.96 1,982.97 2 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% GWLRDPSASPGDAGEQAIR 95.00% 5.06 0.464 2.31 992.4876 1,982.96 1,982.97 2 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VAMANIQPQMLVAGATSIAR 95.00% 5.76 0.537 5.14 1,021.54 2,041.07 2,042.09 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VAMANIQPQMLVAGATSIAR 95.00% 6.08 0.517 5.14 1,022.05 2,042.08 2,042.09 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VAMANIQPQMLVAGATSIAR 95.00% 6.07 0.45 5.49 1,022.05 2,042.08 2,042.09 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% VAMANIQPQMLVAGATSIAR 95.00% 5.9 0.481 5.4 1,022.05 2,042.08 2,042.09 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LLAVAATAPPDAPNREEVFDER 95.00% 4.37 0.544 2.06 1,191.61 2,381.20 2,381.21 2
 SAMPLE 2R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 31 42 135 35.00% LLAVAATAPPDAPNREEVFDER 95.00% 4.12 0.489 5.06 1,191.61 2,381.20 2,381.21 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% DYLIDGSR 95.00% 3.05 0.459 0 469.7324 937.4491 938.4585 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% DYLIDGSR 95.00% 2.49 0.366 1.18 469.7335 937.4513 938.4585 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SFLDSGYR 95.00% 2.78 0.362 0 472.7268 943.438 944.4478 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SFLDSGYR 95.00% 2.71 0.333 0 472.7271 943.4385 944.4478 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SFLDSGYR 95.00% 2.98 0.356 1.15 472.7272 943.4388 944.4478 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SFLDSGYR 95.00% 2.67 0.338 0 472.7275 943.4394 944.4478 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% IPTISTQLK 95.00% 2.24 0.317 0 500.8033 999.5909 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% IPTISTQLK 95.00% 1.99 0.282 0 500.8045 999.5934 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% IPTISTQLK 95.00% 1.96 0.337 0 500.8046 999.5935 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% IPTISTQLK 95.00% 2.17 0.324 0 500.8049 999.5942 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% IPTISTQLK 95.00% 2 0.379 0 500.8052 999.5948 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% IPTISTQLK 95.00% 2.03 0.248 0 500.8054 999.5951 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLKDLK 95.00% 2.03 0.277 0 510.6212 1,528.84 1,529.85 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLKDLK 95.00% 2.24 0.298 0 510.6214 1,528.84 1,529.85 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AAVHLEGKIEQAQR 95.00% 2.8 0.39 0 517.2841 1,548.83 1,549.85 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AAVHLEGKIEQAQR 95.00% 3.8 0.373 2.57 517.2853 1,548.83 1,549.85 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AAVHLEGKIEQAQR 95.00% 4.64 0.429 0 517.2855 1,548.83 1,549.85 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AAVHLEGKIEQAQR 95.00% 3.02 0.367 0 517.2858 1,548.83 1,549.85 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AAVHLEGKIEQAQR 95.00% 3.92 0.433 0 517.2859 1,548.83 1,549.85 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AAVHLEGKIEQAQR 95.00% 4.44 0.377 2 517.6201 1,549.84 1,549.85 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% GQGSSPVAMQK 95.00% 2.35 0.32 1.24 545.2732 1,088.53 1,089.54 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% GQGSSPVAMQK 95.00% 2.65 0.38 2.14 545.2736 1,088.53 1,089.54 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% TISPMVMDAK 95.00% 1.98 0.281 0 546.7741 1,091.53 1,092.54 2 TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLGEISALTSK 95.00% 3.18 0.496 4.92 553.3071 1,104.60 1,105.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLGEISALTSK 95.00% 3.6 0.437 3.51 553.3072 1,104.60 1,105.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLGEISALTSK 95.00% 2.96 0.462 3.12 553.3072 1,104.60 1,105.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLGEISALTSK 95.00% 3.54 0.501 2.66 553.3075 1,104.60 1,105.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLGEISALTSK 95.00% 2.98 0.473 2.64 553.3076 1,104.60 1,105.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLGEISALTSK 95.00% 3.78 0.499 3.1 553.3076 1,104.60 1,105.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLGEISALTSK 95.00% 3.89 0.49 2.77 553.3078 1,104.60 1,105.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLGEISALTSK 95.00% 3.25 0.433 3.19 553.3082 1,104.60 1,105.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLGEISALTSK 95.00% 3.44 0.428 3.47 553.3084 1,104.60 1,105.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% STVEGIQASVK 95.00% 1.99 0.265 0 559.804 1,117.59 1,118.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% STVEGIQASVK 95.00% 3.85 0.534 2.15 559.8051 1,117.59 1,118.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% STVEGIQASVK 95.00% 2.99 0.46 2.3 559.8054 1,117.60 1,118.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% STVEGIQASVK 95.00% 3.42 0.493 2.34 559.8057 1,117.60 1,118.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% QILDEAGKVGELcAGK 95.00% 2.48 0.24 0 c13: Carbamidomethyl (+57.02) 563.2928 1,686.86 1,687.87 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% QILDEAGKVGELcAGK 95.00% 2.67 0.436 0 c13: Carbamidomethyl (+57.02) 563.293 1,686.86 1,687.87 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% QILDEAGKVGELcAGK 95.00% 3.12 0.431 0.959 c13: Carbamidomethyl (+57.02) 563.2935 1,686.86 1,687.87 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% QILDEAGKVGELcAGK 95.00% 2.93 0.419 1.46 c13: Carbamidomethyl (+57.02) 563.6279 1,687.86 1,687.87 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% QILDEAGKVGELcAGK 95.00% 2.82 0.396 1.16 c13: Carbamidomethyl (+57.02) 563.6282 1,687.86 1,687.87 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% NQWIDNVEK 95.00% 2.43 0.356 0 573.282 1,144.55 1,145.56 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% NQWIDNVEK 95.00% 2.22 0.38 0 573.2821 1,144.55 1,145.56 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% IRTDAGFTLR 95.00% 3.21 0.361 2.12 575.3222 1,148.63 1,149.64 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% IRTDAGFTLR 95.00% 3.12 0.375 2.74 575.3224 1,148.63 1,149.64 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LANVMMGPYR 95.00% 2.37 0.338 2.27 576.2909 1,150.57 1,151.57 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MALLMAEMSR 95.00% 2.78 0.276 1.74 576.7813 1,151.55 1,152.56 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MALLMAEMSR 95.00% 3.42 0.265 3.68 576.7818 1,151.55 1,152.56 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% NPGNQAAYEHFETMK 95.00% 2.68 0.349 0 579.5937 1,735.76 1,736.77 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% NPGNQAAYEHFETMK 95.00% 2.39 0.321 0 579.5942 1,735.76 1,736.77 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% NPGNQAAYEHFETMK 95.00% 2.87 0.432 1.6 579.5944 1,735.76 1,736.77 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% NPGNQAAYEHFETMK 95.00% 2.8 0.407 1.52 579.9279 1,736.76 1,736.77 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% NPGNQAAYEHFETMK 95.00% 2.86 0.489 0 579.9283 1,736.76 1,736.77 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% NPGNQAAYEHFETMK 95.00% 2.83 0.43 1.21 579.9286 1,736.76 1,736.77 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VLQLTSWDEDAWASK 95.00% 4.94 0.551 3.14 583.9553 1,748.84 1,748.85 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VLQLTSWDEDAWASK 95.00% 4.84 0.548 3.77 583.9554 1,748.84 1,748.85 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ELTPQVVSAAR 95.00% 2.6 0.48 2.19 585.8268 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ELTPQVVSAAR 95.00% 2.08 0.312 0 585.8324 1,169.65 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLK 95.00% 2.76 0.516 1.64 587.3255 1,172.64 1,173.65 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLK 95.00% 2.35 0.481 2.6 587.3258 1,172.64 1,173.65 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLK 95.00% 2.91 0.478 1.62 587.3264 1,172.64 1,173.65 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLK 95.00% 2.74 0.466 1.49 587.3267 1,172.64 1,173.65 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLK 95.00% 2.93 0.533 1.7 587.3267 1,172.64 1,173.65 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLK 95.00% 2.82 0.49 1.82 587.3268 1,172.64 1,173.65 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLK 95.00% 3.12 0.507 1.8 587.3271 1,172.64 1,173.65 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLK 95.00% 2.69 0.481 1.54 587.3275 1,172.64 1,173.65 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLK 95.00% 2.27 0.388 1.72 587.3285 1,172.64 1,173.65 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLK 95.00% 2.03 0.32 0 587.9781 1,173.94 1,173.65 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MSAEINEIIR 95.00% 3.01 0.199 0 588.3072 1,174.60 1,175.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MSAEINEIIR 95.00% 3.03 0.113 1.16 588.3075 1,174.60 1,175.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MSAEINEIIR 95.00% 3.09 0.0527 1.18 588.3084 1,174.60 1,175.61 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLLDASEEAIK 95.00% 2.92 0.378 2.02 588.3101 1,174.60 1,175.62 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLLDASEEAIK 95.00% 3.12 0.321 2.42 588.3103 1,174.60 1,175.62 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% mSAEINEIIR 95.00% 2.11 0.275 1.39 m1: Oxidation (+15.99) 596.3221 1,190.63 1,191.60 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% mSAEINEIIR 95.00% 2.23 0.28 1.43 m1: Oxidation (+15.99) 596.6543 1,191.29 1,191.60 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LANVMMGPYRQDLLAK 95.00% 2.26 0.219 0 607.3229 1,818.95 1,819.96 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LANVMMGPYRQDLLAK 95.00% 2.18 0.305 0 607.3233 1,818.95 1,819.96 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VGKETVQTTEDQILKR 95.00% 4.92 0.508 1.82 615.6743 1,844.00 1,845.01 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VGKETVQTTEDQILKR 95.00% 3.94 0.48 1.54 615.6743 1,844.00 1,845.01 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VGKETVQTTEDQILKR 95.00% 4.17 0.409 2.44 615.6745 1,844.00 1,845.01 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% WIDNPTVDDR 95.00% 3.42 0.423 2.07 615.7896 1,229.56 1,230.58 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% WIDNPTVDDR 95.00% 3.2 0.401 1.68 615.7899 1,229.56 1,230.58 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% WIDNPTVDDR 95.00% 3.2 0.345 2.2 615.7901 1,229.56 1,230.58 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% WIDNPTVDDR 95.00% 2.84 0.293 1.33 615.7904 1,229.57 1,230.58 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% WIDNPTVDDR 95.00% 3.32 0.3 2.47 615.7904 1,229.57 1,230.58 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% WIDNPTVDDR 95.00% 3.08 0.374 1.44 615.7911 1,229.57 1,230.58 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% WIDNPTVDDR 95.00% 3.01 0.332 2.32 615.7913 1,229.57 1,230.58 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VGKETVQTTEDQILKR 95.00% 5.28 0.489 2.89 616.0076 1,845.00 1,845.01 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VGKETVQTTEDQILKR 95.00% 4.54 0.445 2.92 616.0079 1,845.00 1,845.01 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VGKETVQTTEDQILKR 95.00% 4.43 0.392 2.33 616.0093 1,845.00 1,845.01 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VMLVNSMNTVK 95.00% 2.94 0.389 1.68 618.3249 1,234.63 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VMLVNSMNTVK 95.00% 3.45 0.38 2.32 618.3266 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VMLVNSMNTVK 95.00% 3.26 0.438 3 618.3273 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VMLVNSMNTVK 95.00% 3.32 0.453 2.62 618.3275 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VMLVNSMNTVK 95.00% 3.3 0.362 2.19 618.3275 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VMLVNSMNTVK 95.00% 2.78 0.406 1.8 618.3277 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VMLVNSMNTVK 95.00% 2.91 0.381 2.37 618.3279 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VMLVNSMNTVK 95.00% 2.94 0.387 2.09 618.328 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VMLVNSMNTVK 95.00% 3.4 0.388 2.7 618.3283 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VMLVNSMNTVK 95.00% 2.99 0.393 2.1 618.329 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VMLVNSmNTVK 95.00% 2.31 0.32 0 m7: Oxidation (+15.99) 626.3245 1,250.63 1,251.64 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VMLVNSmNTVK 95.00% 2.64 0.436 0 m7: Oxidation (+15.99) 626.3252 1,250.63 1,251.64 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% cDRVDQLTAQLADLAAR 95.00% 3.97 0.446 2.74 c1: Carbamidomethyl (+57.02) 639.3259 1,914.95 1,915.97 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% cDRVDQLTAQLADLAAR 95.00% 2.81 0.302 0 c1: Carbamidomethyl (+57.02) 639.33 1,914.97 1,915.97 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% cDRVDQLTAQLADLAAR 95.00% 4.14 0.405 2.22 c1: Carbamidomethyl (+57.02) 639.6605 1,915.96 1,915.97 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% cDRVDQLTAQLADLAAR 95.00% 4.31 0.444 2.44 c1: Carbamidomethyl (+57.02) 639.6608 1,915.96 1,915.97 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% cDRVDQLTAQLADLAAR 95.00% 4.14 0.396 2.52 c1: Carbamidomethyl (+57.02) 639.6609 1,915.96 1,915.97 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MTGLVDEAIDTK 95.00% 3.98 0.619 3.77 646.823 1,291.63 1,292.64 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MTGLVDEAIDTK 95.00% 3.87 0.581 3.66 646.8239 1,291.63 1,292.64 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLLDASEEAIKK 95.00% 2.61 0.287 1.82 652.3606 1,302.71 1,303.71 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% SLLDASEEAIKK 95.00% 2.62 0.297 2.28 652.3625 1,302.71 1,303.71 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% IAELcDDPKERDDILR 95.00% 2.48 0.166 0 c5: Carbamidomethyl (+57.02) 653.3263 1,956.96 1,957.97 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% IAELcDDPKERDDILR 95.00% 2.81 0.185 0 c5: Carbamidomethyl (+57.02) 653.3263 1,956.96 1,957.97 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LVQAAQMLQSDPYSVPAR 95.00% 2.16 0.331 1.54 659.009 1,974.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LVQAAQMLQSDPYSVPAR 95.00% 4.87 0.495 5.6 659.0097 1,974.01 1,974.01 3 A1BG_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% GWLRDPSASPGDAGEQAIR 95.00% 2.63 0.312 2.55 661.6597 1,981.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% GWLRDPSASPGDAGEQAIR 95.00% 3.11 0.409 3.96 661.6611 1,981.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% GWLRDPSASPGDAGEQAIR 95.00% 4.22 0.416 3.96 661.6611 1,981.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% GWLRDPSASPGDAGEQAIR 95.00% 3.53 0.449 1.07 661.9938 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% GWLRDPSASPGDAGEQAIR 95.00% 4.37 0.38 3.8 661.9944 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% GWLRDPSASPGDAGEQAIR 95.00% 3.45 0.388 2.42 661.9953 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VAMANIQPQMLVAGATSIAR 95.00% 4.33 0.472 2.77 681.3672 2,041.08 2,042.09 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VAMANIQPQMLVAGATSIAR 95.00% 5.33 0.595 2.96 681.7012 2,042.08 2,042.09 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VAMANIQPQMLVAGATSIAR 95.00% 3.65 0.323 1.64 681.7017 2,042.08 2,042.09 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VAMANIQPQmLVAGATSIAR 95.00% 3.05 0.436 0 m10: Oxidation (+15.99) 687.0345 2,058.08 2,058.08 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AQQVSQGLDVLTAK 95.00% 4.11 0.581 4.54 729.4031 1,456.79 1,457.80 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AQQVSQGLDVLTAK 95.00% 3.79 0.577 5.37 729.4037 1,456.79 1,457.80 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% DPSASPGDAGEQAIR 95.00% 2.85 0.391 0 735.8434 1,469.67 1,470.68 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% DPSASPGDAGEQAIR 95.00% 3.89 0.537 4.74 735.8438 1,469.67 1,470.68 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% DPSASPGDAGEQAIR 95.00% 3.1 0.447 3.15 735.8445 1,469.67 1,470.68 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% DPSASPGDAGEQAIR 95.00% 3.88 0.538 4.72 735.8447 1,469.67 1,470.68 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% DPSASPGDAGEQAIR 95.00% 3.49 0.454 2.05 735.8447 1,469.67 1,470.68 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% DPSASPGDAGEQAIR 95.00% 3.34 0.424 2.39 735.8456 1,469.68 1,470.68 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MLGQMTDQVADLR 95.00% 3.86 0.53 4.06 739.3589 1,476.70 1,477.71 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MLGQMTDQVADLR 95.00% 4.45 0.57 4.08 739.359 1,476.70 1,477.71 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MLGQMTDQVADLR 95.00% 4.26 0.544 2.54 739.359 1,476.70 1,477.71 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MLGQMTDQVADLR 95.00% 3.65 0.483 2.39 739.3591 1,476.70 1,477.71 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MLGQMTDQVADLR 95.00% 4.37 0.524 4.8 739.3593 1,476.70 1,477.71 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MLGQMTDQVADLR 95.00% 3.71 0.549 3.64 739.3593 1,476.70 1,477.71 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MLGQMTDQVADLR 95.00% 3.75 0.52 4.62 739.3598 1,476.70 1,477.71 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MLGQMTDQVADLR 95.00% 4.56 0.573 3.77 739.3599 1,476.70 1,477.71 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MLGQMTDQVADLR 95.00% 3.92 0.553 2.18 739.3615 1,476.71 1,477.71 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VDQLTAQLADLAAR 95.00% 2.78 0.317 1.59 742.9062 1,483.80 1,484.81 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VDQLTAQLADLAAR 95.00% 4.09 0.533 3.85 742.9079 1,483.80 1,484.81 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AGEVINQPMMMAAR 95.00% 3.83 0.578 3.89 759.8643 1,517.71 1,518.72 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AGEVINQPMMMAAR 95.00% 3.28 0.525 1.42 759.8653 1,517.71 1,518.72 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AGEVINQPMMMAAR 95.00% 2.74 0.349 0 759.8653 1,517.72 1,518.72 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AGEVINQPMMMAAR 95.00% 4.46 0.512 4.03 759.8658 1,517.72 1,518.72 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AGEVINQPMMMAAR 95.00% 2.13 0.283 0 760.0163 1,518.02 1,518.72 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AGEVINQPMMMAAR 95.00% 3.64 0.512 2.34 760.366 1,518.72 1,518.72 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLKDLK 95.00% 4.15 0.286 2.62 765.4293 1,528.84 1,529.85 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLKDLK 95.00% 4.19 0.322 2.66 765.43 1,528.84 1,529.85 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLKDLK 95.00% 4.38 0.381 2.59 765.43 1,528.84 1,529.85 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLKDLK 95.00% 3.88 0.323 2.92 765.4309 1,528.85 1,529.85 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ALASQLQDSLKDLK 95.00% 3.37 0.299 2.01 765.4311 1,528.85 1,529.85 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AAVHLEGKIEQAQR 95.00% 3.71 0.387 4.24 775.4254 1,548.84 1,549.85 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AAVHLEGKIEQAQR 95.00% 4.07 0.366 6.46 775.4259 1,548.84 1,549.85 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AAVHLEGKIEQAQR 95.00% 4.46 0.391 4.25 775.4276 1,548.84 1,549.85 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ETVQTTEDQILKR 95.00% 3.6 0.407 0 780.9145 1,559.81 1,560.82 2 RS20_HUMAN,ANK3_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ETVQTTEDQILKR 95.00% 3.38 0.381 0 780.9145 1,559.81 1,560.82 2 RS20_HUMAN,ANK3_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% ETVQTTEDQILKR 95.00% 3.56 0.415 0 780.9149 1,559.81 1,560.82 2 RS20_HUMAN,ANK3_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LLAVAATAPPDAPNREEVFDER 95.00% 3.12 0.491 3.42 794.7418 2,381.20 2,381.21 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LLAVAATAPPDAPNREEVFDER 95.00% 2.94 0.457 2.85 794.7422 2,381.20 2,381.21 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LLAVAATAPPDAPNREEVFDER 95.00% 3.12 0.403 3.07 794.7423 2,381.20 2,381.21 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LLAVAATAPPDAPNREEVFDER 95.00% 2.82 0.392 2.59 794.7424 2,381.20 2,381.21 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LLAVAATAPPDAPNREEVFDER 95.00% 2.83 0.323 2.28 794.7426 2,381.20 2,381.21 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LLAVAATAPPDAPNREEVFDER 95.00% 2.94 0.451 2.07 794.7435 2,381.21 2,381.21 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LLAVAATAPPDAPNREEVFDER 95.00% 2.72 0.184 0 794.7435 2,381.21 2,381.21 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LLAVAATAPPDAPNREEVFDER 95.00% 2.89 0.433 2.32 794.7436 2,381.21 2,381.21 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% KIDAAQNWLADPNGGPEGEEQIR 95.00% 6.74 0.483 6.66 837.0746 2,508.20 2,508.21 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% KIDAAQNWLADPNGGPEGEEQIR 95.00% 5.38 0.428 4.6 837.0752 2,508.20 2,508.21 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% KIDAAQNWLADPNGGPEGEEQIR 95.00% 5.45 0.348 5.51 837.0761 2,508.20 2,508.21 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% KIDAAQNWLADPNGGPEGEEQIR 95.00% 5.56 0.389 3.46 837.0774 2,508.21 2,508.21 3
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% QILDEAGKVGELcAGK 95.00% 3.35 0.388 1.89 c13: Carbamidomethyl (+57.02) 844.4385 1,686.86 1,687.87 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% QILDEAGKVGELcAGK 95.00% 4.02 0.475 2.89 c13: Carbamidomethyl (+57.02) 844.9399 1,687.86 1,687.87 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% VGKETVQTTEDQILK 95.00% 4.34 0.42 1.89 845.4537 1,688.89 1,688.91 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% DMPPAFIKVENAcTK 95.00% 3.74 0.525 2.59 c13: Carbamidomethyl (+57.02) 860.9195 1,719.82 1,720.84 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% DMPPAFIKVENAcTK 95.00% 2.53 0.431 1.92 c13: Carbamidomethyl (+57.02) 860.927 1,719.84 1,720.84 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% NPGNQAAYEHFETMK 95.00% 5.31 0.606 8.2 868.8866 1,735.76 1,736.77 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% NPGNQAAYEHFETMK 95.00% 5.16 0.59 8.51 868.8873 1,735.76 1,736.77 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% NPGNQAAYEHFETMK 95.00% 5.11 0.585 9.89 868.8887 1,735.76 1,736.77 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% AAAVGTANKSTVEGIQASVK 95.00% 4.79 0.628 5.09 952.0176 1,902.02 1,902.03 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% cDRVDQLTAQLADLAAR 95.00% 3.65 0.485 5 c1: Carbamidomethyl (+57.02) 958.4842 1,914.95 1,915.97 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% cDRVDQLTAQLADLAAR 95.00% 4.07 0.378 3.82 c1: Carbamidomethyl (+57.02) 958.4854 1,914.96 1,915.97 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LVQAAQMLQSDPYSVPAR 95.00% 4.98 0.343 6.85 987.508 1,973.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LVQAAQMLQSDPYSVPAR 95.00% 5.09 0.409 4.06 988.0077 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LVQAAQMLQSDPYSVPAR 95.00% 5.13 0.39 6 988.0091 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LVQAAQMLQSDPYSVPAR 95.00% 5.04 0.376 3.96 988.0094 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% GWLRDPSASPGDAGEQAIR 95.00% 4.87 0.533 4.2 991.9857 1,981.96 1,982.97 2 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% GWLRDPSASPGDAGEQAIR 95.00% 5.08 0.454 0 992.4892 1,982.96 1,982.97 2 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% WIDNPTVDDRGVGQAAIR 95.00% 3.16 0.201 0 992.5017 1,982.99 1,983.01 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% WIDNPTVDDRGVGQAAIR 95.00% 3.21 0.0674 1.54 992.5023 1,982.99 1,983.01 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LVQAAQmLQSDPYSVPAR 95.00% 2.73 0.298 2.41 m7: Oxidation (+15.99) 995.5046 1,988.99 1,990.01 2 A1BG_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LVQAAQmLQSDPYSVPAR 95.00% 4.78 0.598 4.23 m7: Oxidation (+15.99) 996.0086 1,990.00 1,990.01 2 A1BG_HUMAN
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MQEAMTQEVSDVFSDTTTPIK 95.00% 6.75 0.696 10.9 1,180.04 2,358.07 2,358.08 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% MQEAMTQEVSDVFSDTTTPIK 95.00% 7.17 0.686 7.44 1,180.05 2,358.08 2,358.08 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LLAVAATAPPDAPNREEVFDER 95.00% 4.2 0.487 3.48 1,191.61 2,381.20 2,381.21 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% LLAVAATAPPDAPNREEVFDER 95.00% 4.14 0.504 3.6 1,191.61 2,381.21 2,381.21 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% KIDAAQNWLADPNGGPEGEEQIR 95.00% 5.83 0.659 6.1 1,255.11 2,508.20 2,508.21 2
 SAMPLE 3 Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 41 50 185 43.90% KIDAAQNWLADPNGGPEGEEQIR 95.00% 6.06 0.679 5.8 1,255.11 2,508.21 2,508.21 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% DYLIDGSR 95.00% 2.63 0.461 1.35 469.7322 937.4488 938.4585 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SFLDSGYR 95.00% 3.02 0.34 1.38 472.7273 943.4389 944.4478 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SFLDSGYR 95.00% 2.99 0.371 1.85 472.7273 943.439 944.4478 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SFLDSGYR 95.00% 2.22 0.259 1.62 472.7278 943.4399 944.4478 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SFLDSGYR 95.00% 3 0.376 1.55 472.7284 943.4411 944.4478 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VDQLTAQLADLAAR 95.00% 2.51 0.23 1.44 495.6065 1,483.80 1,484.81 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% IPTISTQLK 95.00% 2 0.327 0 500.8032 999.5908 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% IPTISTQLK 95.00% 2.05 0.327 0 500.8044 999.5931 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% IPTISTQLK 95.00% 2.14 0.348 0 500.8046 999.5935 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% IPTISTQLK 95.00% 1.88 0.309 0 500.8047 999.5937 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% IPTISTQLK 95.00% 1.67 0.336 0 500.8051 999.5945 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% IPTISTQLK 95.00% 1.88 0.341 0 500.8052 999.5947 1,000.60 2 GBB1_HUMAN,GBB2_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AGEVINQPMMMAAR 95.00% 3.1 0.411 0 506.9105 1,517.71 1,518.72 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AGEVINQPMMMAAR 95.00% 2.79 0.28 0 506.9122 1,517.71 1,518.72 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLKDLK 95.00% 2.05 0.26 0 510.9566 1,529.85 1,529.85 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AAVHLEGKIEQAQR 95.00% 1.95 0.279 0 517.285 1,548.83 1,549.85 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AAVHLEGKIEQAQR 95.00% 4.63 0.36 0 517.2852 1,548.83 1,549.85 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AAVHLEGKIEQAQR 95.00% 4.44 0.374 0 517.2852 1,548.83 1,549.85 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AAVHLEGKIEQAQR 95.00% 4.86 0.412 1.46 517.6196 1,549.84 1,549.85 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AAVHLEGKIEQAQR 95.00% 4.77 0.377 1.27 517.6197 1,549.84 1,549.85 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GQGSSPVAMQK 95.00% 2.31 0.292 1.52 545.2689 1,088.52 1,089.54 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GQGSSPVAMQK 95.00% 2.81 0.429 2.02 545.2704 1,088.53 1,089.54 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GQGSSPVAMQK 95.00% 2.71 0.415 1.92 545.2719 1,088.53 1,089.54 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% IPTISTQLKILSTVK 95.00% 1.82 0.299 0 548.3444 1,642.01 1,642.02 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLGEISALTSK 95.00% 3.27 0.494 3.72 553.3065 1,104.60 1,105.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLGEISALTSK 95.00% 3.5 0.436 3.06 553.3076 1,104.60 1,105.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLGEISALTSK 95.00% 2.15 0.301 2.26 553.3081 1,104.60 1,105.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLGEISALTSK 95.00% 3.03 0.43 3.05 553.3081 1,104.60 1,105.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLGEISALTSK 95.00% 3.79 0.502 3.41 553.3083 1,104.60 1,105.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLGEISALTSK 95.00% 3.68 0.479 3.44 553.3083 1,104.60 1,105.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLGEISALTSK 95.00% 3.27 0.421 2.89 553.3085 1,104.60 1,105.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLGEISALTSK 95.00% 2.57 0.445 3.39 553.3087 1,104.60 1,105.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% STVEGIQASVK 95.00% 2.99 0.398 3.37 559.8048 1,117.59 1,118.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% STVEGIQASVK 95.00% 3.39 0.522 2.77 559.805 1,117.59 1,118.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% STVEGIQASVK 95.00% 3.51 0.502 2.6 559.8051 1,117.59 1,118.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% STVEGIQASVK 95.00% 2.91 0.461 2.8 559.8056 1,117.60 1,118.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% STVEGIQASVK 95.00% 3.04 0.482 2.25 559.8057 1,117.60 1,118.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% STVEGIQASVK 95.00% 3.38 0.518 3.8 559.807 1,117.60 1,118.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% QILDEAGKVGELcAGK 95.00% 2.7 0.348 0 c13: Carbamidomethyl (+57.02) 563.6283 1,687.86 1,687.87 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% QILDEAGKVGELcAGK 95.00% 3.05 0.311 0 c13: Carbamidomethyl (+57.02) 563.6283 1,687.86 1,687.87 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% QILDEAGKVGELcAGK 95.00% 3.15 0.407 0 c13: Carbamidomethyl (+57.02) 563.6288 1,687.86 1,687.87 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% QILDEAGKVGELcAGK 95.00% 3.09 0.414 0 c13: Carbamidomethyl (+57.02) 563.6293 1,687.86 1,687.87 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VGKETVQTTEDQILK 95.00% 2.55 0.224 0 563.6397 1,687.90 1,688.91 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% NQWIDNVEK 95.00% 1.9 0.282 0 573.2825 1,144.55 1,145.56 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% IRTDAGFTLR 95.00% 3.03 0.393 1.8 575.3208 1,148.63 1,149.64 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% IRTDAGFTLR 95.00% 2.82 0.392 1.43 575.3226 1,148.63 1,149.64 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LANVMMGPYR 95.00% 2.07 0.305 0 576.6285 1,151.24 1,151.57 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MALLMAEMSR 95.00% 3.54 0.26 3.06 576.7781 1,151.54 1,152.56 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MALLMAEMSR 95.00% 2.89 0.269 0 576.7793 1,151.54 1,152.56 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MALLMAEMSR 95.00% 3.03 0.231 2.82 577.2838 1,152.55 1,152.56 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% NPGNQAAYEHFETMK 95.00% 3.32 0.442 1.4 579.5941 1,735.76 1,736.77 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% NPGNQAAYEHFETMK 95.00% 2.1 0.374 0 579.9274 1,736.76 1,736.77 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% NPGNQAAYEHFETMK 95.00% 2.92 0.54 0 579.928 1,736.76 1,736.77 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% NPGNQAAYEHFETMK 95.00% 3 0.469 0 579.9283 1,736.76 1,736.77 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% NPGNQAAYEHFETMK 95.00% 2.23 0.275 0 579.9285 1,736.76 1,736.77 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% NPGNQAAYEHFETMK 95.00% 2.45 0.262 0 579.9287 1,736.76 1,736.77 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VLQLTSWDEDAWASK 95.00% 5.16 0.599 3.19 583.6201 1,747.84 1,748.85 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VLQLTSWDEDAWASK 95.00% 3.29 0.364 0 583.6202 1,747.84 1,748.85 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ELTPQVVSAAR 95.00% 2.3 0.35 0 585.8263 1,169.64 1,170.65 2 SYNP2_HUMAN,NEXN_HUMAN,HNRPM_HUMAN,TITIN_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLK 95.00% 3.01 0.428 2.28 587.3257 1,172.64 1,173.65 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLK 95.00% 2.61 0.423 1.96 587.3261 1,172.64 1,173.65 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLK 95.00% 2.57 0.491 1.62 587.3263 1,172.64 1,173.65 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLK 95.00% 2.94 0.509 1.8 587.3267 1,172.64 1,173.65 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLK 95.00% 2.8 0.433 2.24 587.3268 1,172.64 1,173.65 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLK 95.00% 2.97 0.483 1.96 587.3268 1,172.64 1,173.65 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLK 95.00% 2.72 0.428 2.31 587.3271 1,172.64 1,173.65 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLK 95.00% 2.79 0.455 1.7 587.3275 1,172.64 1,173.65 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLK 95.00% 2.57 0.471 2.54 587.3288 1,172.64 1,173.65 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLK 95.00% 2.7 0.454 4.14 587.8286 1,173.64 1,173.65 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MSAEINEIIR 95.00% 2.97 0.142 0 588.3043 1,174.59 1,175.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MSAEINEIIR 95.00% 3.03 0.148 0 588.3083 1,174.60 1,175.61 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLLDASEEAIK 95.00% 2.65 0.17 1.85 588.3099 1,174.60 1,175.62 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLLDASEEAIK 95.00% 2.3 0.182 2.35 588.3101 1,174.60 1,175.62 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% mSAEINEIIR 95.00% 2.4 0.39 0 m1: Oxidation (+15.99) 596.304 1,190.59 1,191.60 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LANVMMGPYRQDLLAK 95.00% 2.26 0.196 0 607.3233 1,818.95 1,819.96 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ELLPVLISAMK 95.00% 2.3 0.339 0 607.3636 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ELLPVLISAMK 95.00% 2.56 0.336 1.28 607.3636 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ELLPVLISAMK 95.00% 2.73 0.369 1.85 607.3636 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ELLPVLISAMK 95.00% 2.03 0.278 1.21 607.3642 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ELLPVLISAMK 95.00% 2.81 0.356 4.62 607.3642 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ELLPVLISAMK 95.00% 2.43 0.356 2.1 607.3643 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ELLPVLISAMK 95.00% 2.94 0.395 3.6 607.3646 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ELLPVLISAMK 95.00% 2.47 0.425 2.49 607.365 1,212.71 1,213.72 2 ANK3_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LANVMMGPYRQDLLAK 95.00% 2.48 0.288 0 607.6574 1,819.95 1,819.96 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VGKETVQTTEDQILKR 95.00% 4.67 0.535 1.72 615.6725 1,843.99 1,845.01 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VGKETVQTTEDQILKR 95.00% 5.04 0.503 3.17 615.6733 1,844.00 1,845.01 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VGKETVQTTEDQILKR 95.00% 4.34 0.457 2.14 615.674 1,844.00 1,845.01 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% WIDNPTVDDR 95.00% 3.02 0.26 0 615.7888 1,229.56 1,230.58 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% WIDNPTVDDR 95.00% 3.15 0.335 1.32 615.7901 1,229.56 1,230.58 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% WIDNPTVDDR 95.00% 2.58 0.338 1.72 615.7902 1,229.56 1,230.58 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% WIDNPTVDDR 95.00% 2.9 0.33 2.34 615.7909 1,229.57 1,230.58 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% WIDNPTVDDR 95.00% 3.12 0.361 1.6 615.791 1,229.57 1,230.58 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% WIDNPTVDDR 95.00% 3.05 0.317 1.72 615.791 1,229.57 1,230.58 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% WIDNPTVDDR 95.00% 2.81 0.378 2.23 615.7918 1,229.57 1,230.58 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VGKETVQTTEDQILKR 95.00% 5.38 0.458 2.38 616.0076 1,845.00 1,845.01 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VGKETVQTTEDQILKR 95.00% 4.57 0.453 2.21 616.0078 1,845.00 1,845.01 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VGKETVQTTEDQILKR 95.00% 5.59 0.499 4.02 616.0083 1,845.00 1,845.01 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VMLVNSMNTVK 95.00% 2.94 0.365 1.54 618.3258 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VMLVNSMNTVK 95.00% 3.4 0.462 3 618.327 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VMLVNSMNTVK 95.00% 2.99 0.374 1.77 618.3271 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VMLVNSMNTVK 95.00% 3.15 0.357 1.85 618.3274 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VMLVNSMNTVK 95.00% 3.29 0.413 1.92 618.3278 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VMLVNSMNTVK 95.00% 2.93 0.426 2.49 618.3288 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VMLVNSMNTVK 95.00% 2.47 0.379 0 618.3298 1,234.64 1,235.65 2 IQGA1_HUMAN,AHNK_HUMAN,CO6A1_HUMAN,AGRIN_HUMAN,TCPG_HUMAN,TITIN_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% cDRVDQLTAQLADLAAR 95.00% 3.82 0.401 2.64 c1: Carbamidomethyl (+57.02) 639.3249 1,914.95 1,915.97 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% cDRVDQLTAQLADLAAR 95.00% 4.13 0.447 1.92 c1: Carbamidomethyl (+57.02) 639.3262 1,914.96 1,915.97 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% cDRVDQLTAQLADLAAR 95.00% 2.64 0.266 1.13 c1: Carbamidomethyl (+57.02) 639.3264 1,914.96 1,915.97 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% cDRVDQLTAQLADLAAR 95.00% 3.93 0.481 2.48 c1: Carbamidomethyl (+57.02) 639.3272 1,914.96 1,915.97 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% cDRVDQLTAQLADLAAR 95.00% 3.09 0.344 1.77 c1: Carbamidomethyl (+57.02) 639.6588 1,915.95 1,915.97 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% cDRVDQLTAQLADLAAR 95.00% 4.09 0.44 2.05 c1: Carbamidomethyl (+57.02) 639.6608 1,915.96 1,915.97 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MTGLVDEAIDTK 95.00% 3.88 0.563 4.74 646.8238 1,291.63 1,292.64 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MTGLVDEAIDTK 95.00% 3.8 0.605 3.62 646.8244 1,291.63 1,292.64 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLLDASEEAIKK 95.00% 3.47 0.384 4.55 652.359 1,302.70 1,303.71 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLLDASEEAIKK 95.00% 3.14 0.375 3.38 652.3603 1,302.71 1,303.71 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLLDASEEAIKK 95.00% 2.31 0.276 3.32 652.3615 1,302.71 1,303.71 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% SLLDASEEAIKK 95.00% 2.79 0.307 4.37 652.8596 1,303.70 1,303.71 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% IAELcDDPKERDDILR 95.00% 2.62 0.222 0 c5: Carbamidomethyl (+57.02) 653.3267 1,956.96 1,957.97 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% IAELcDDPKERDDILR 95.00% 3.41 0.406 0 c5: Carbamidomethyl (+57.02) 653.6611 1,957.96 1,957.97 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% QVATALQNLQTK 95.00% 2.98 0.413 2.38 657.8714 1,313.73 1,314.74 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% QVATALQNLQTK 95.00% 2.88 0.446 1.39 657.8731 1,313.73 1,314.74 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LVQAAQMLQSDPYSVPAR 95.00% 2.84 0.417 1.44 658.6752 1,973.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LVQAAQMLQSDPYSVPAR 95.00% 2.28 0.246 1.49 658.6758 1,973.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% QVATALQNLQTK 95.00% 0 0 3.64 658.8438 1,315.67 1,314.74 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LVQAAQMLQSDPYSVPAR 95.00% 2.73 0.339 2.27 659.0082 1,974.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LVQAAQMLQSDPYSVPAR 95.00% 2.8 0.309 2.68 659.0095 1,974.00 1,974.01 3 A1BG_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LVQAAQMLQSDPYSVPAR 95.00% 3.12 0.418 1.1 659.0095 1,974.01 1,974.01 3 A1BG_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GWLRDPSASPGDAGEQAIR 95.00% 4.07 0.419 3.33 661.6595 1,981.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GWLRDPSASPGDAGEQAIR 95.00% 3.5 0.332 3 661.6607 1,981.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GWLRDPSASPGDAGEQAIR 95.00% 4.54 0.505 3.64 661.6611 1,981.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GWLRDPSASPGDAGEQAIR 95.00% 4.14 0.41 3.59 661.9948 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GWLRDPSASPGDAGEQAIR 95.00% 4.02 0.36 3.17 661.9951 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GWLRDPSASPGDAGEQAIR 95.00% 3.77 0.444 2.96 661.9955 1,982.96 1,982.97 3 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VAMANIQPQMLVAGATSIAR 95.00% 5 0.553 2.17 681.7009 2,042.08 2,042.09 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VAMANIQPQMLVAGATSIAR 95.00% 5.03 0.58 2.03 681.7012 2,042.08 2,042.09 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VAMANIQPQmLVAGATSIAR 95.00% 3.49 0.331 1.27 m10: Oxidation (+15.99) 687.0341 2,058.08 2,058.08 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ETVQTTEDQILK 95.00% 2.5 0.297 0 703.3626 1,404.71 1,404.72 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% DPSASPGDAGEQAIR 95.00% 3.81 0.568 3.64 735.8443 1,469.67 1,470.68 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% DPSASPGDAGEQAIR 95.00% 2.61 0.394 1.92 735.8444 1,469.67 1,470.68 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% DPSASPGDAGEQAIR 95.00% 2.98 0.361 3.03 735.8448 1,469.67 1,470.68 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% DPSASPGDAGEQAIR 95.00% 3.8 0.568 4.68 735.8454 1,469.68 1,470.68 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% DPSASPGDAGEQAIR 95.00% 3.01 0.521 0 736.3473 1,470.68 1,470.68 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MLGQMTDQVADLR 95.00% 3.76 0.485 3.47 739.3572 1,476.70 1,477.71 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MLGQMTDQVADLR 95.00% 3.61 0.557 3.92 739.3586 1,476.70 1,477.71 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MLGQMTDQVADLR 95.00% 4.4 0.525 4.17 739.3599 1,476.70 1,477.71 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MLGQMTDQVADLR 95.00% 4.3 0.52 4.08 739.36 1,476.70 1,477.71 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MLGQMTDQVADLR 95.00% 3.45 0.497 4.57 739.36 1,476.70 1,477.71 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MLGQMTDQVADLR 95.00% 3.59 0.587 4.54 739.3601 1,476.70 1,477.71 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MLGQMTDQVADLR 95.00% 3.28 0.464 2.14 739.3604 1,476.71 1,477.71 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MLGQMTDQVADLR 95.00% 3.69 0.541 3.59 739.3608 1,476.71 1,477.71 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AGEVINQPMMMAAR 95.00% 2.39 0.275 0 759.8641 1,517.71 1,518.72 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AGEVINQPMMMAAR 95.00% 4.86 0.479 5.14 759.8646 1,517.71 1,518.72 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AGEVINQPMMMAAR 95.00% 3.99 0.548 4.14 759.8679 1,517.72 1,518.72 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AGEVINQPMMMAAR 95.00% 2.47 0.32 0 760.0166 1,518.02 1,518.72 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLKDLK 95.00% 3.72 0.282 2.74 765.4295 1,528.84 1,529.85 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLKDLK 95.00% 3.89 0.269 3.7 765.4295 1,528.84 1,529.85 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLKDLK 95.00% 3.24 0.324 2.6 765.4299 1,528.84 1,529.85 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLKDLK 95.00% 3.35 0.35 1.96 765.4308 1,528.85 1,529.85 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLKDLK 95.00% 4.17 0.299 2.59 765.4308 1,528.85 1,529.85 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLKDLK 95.00% 3.97 0.299 3.28 765.432 1,528.85 1,529.85 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ALASQLQDSLKDLK 95.00% 3.85 0.397 2.77 765.9358 1,529.86 1,529.85 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AAVHLEGKIEQAQR 95.00% 3.78 0.368 5.96 775.4255 1,548.84 1,549.85 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AAVHLEGKIEQAQR 95.00% 4.01 0.362 5.32 775.4256 1,548.84 1,549.85 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% ETVQTTEDQILKR 95.00% 3.31 0.379 1.22 780.916 1,559.82 1,560.82 2 RS20_HUMAN,ANK3_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LLAVAATAPPDAPNREEVFDER 95.00% 2.86 0.437 3.34 794.7407 2,381.20 2,381.21 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LLAVAATAPPDAPNREEVFDER 95.00% 2.81 0.421 2.54 794.7421 2,381.20 2,381.21 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LLAVAATAPPDAPNREEVFDER 95.00% 2.46 0.263 2.92 794.7421 2,381.20 2,381.21 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LLAVAATAPPDAPNREEVFDER 95.00% 2.77 0.38 3.09 794.7422 2,381.20 2,381.21 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LLAVAATAPPDAPNREEVFDER 95.00% 3 0.351 2.72 794.7429 2,381.21 2,381.21 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LLAVAATAPPDAPNREEVFDER 95.00% 2.7 0.412 3.04 794.743 2,381.21 2,381.21 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LLAVAATAPPDAPNREEVFDER 95.00% 2.74 0.436 2.66 794.7432 2,381.21 2,381.21 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LLAVAATAPPDAPNREEVFDER 95.00% 2.49 0.395 3.1 794.7438 2,381.21 2,381.21 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% KIDAAQNWLADPNGGPEGEEQIR 95.00% 5.97 0.535 6.26 837.0746 2,508.20 2,508.21 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% KIDAAQNWLADPNGGPEGEEQIR 95.00% 5.61 0.455 5 837.0751 2,508.20 2,508.21 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% KIDAAQNWLADPNGGPEGEEQIR 95.00% 5.35 0.41 4.47 837.0759 2,508.20 2,508.21 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% QILDEAGKVGELcAGK 95.00% 3.93 0.468 3.34 c13: Carbamidomethyl (+57.02) 844.4369 1,686.86 1,687.87 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% QILDEAGKVGELcAGK 95.00% 4.28 0.485 3.49 c13: Carbamidomethyl (+57.02) 844.4375 1,686.86 1,687.87 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% QILDEAGKVGELcAGK 95.00% 4.27 0.454 3.52 c13: Carbamidomethyl (+57.02) 844.9373 1,687.86 1,687.87 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% DMPPAFIKVENAcTK 95.00% 3.11 0.267 1.18 c13: Carbamidomethyl (+57.02) 860.9197 1,719.82 1,720.84 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% DMPPAFIKVENAcTK 95.00% 3.82 0.567 3.17 c13: Carbamidomethyl (+57.02) 860.9229 1,719.83 1,720.84 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% NPGNQAAYEHFETMK 95.00% 5.33 0.581 8 868.8887 1,735.76 1,736.77 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% NPGNQAAYEHFETMK 95.00% 5.42 0.617 7.82 869.3847 1,736.75 1,736.77 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% NPGNQAAYEHFETMK 95.00% 5.24 0.563 8.44 869.388 1,736.76 1,736.77 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% NPGNQAAYEHFETMK 95.00% 5.38 0.636 8.62 869.3898 1,736.76 1,736.77 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VLQLTSWDEDAWASK 95.00% 4.52 0.676 6.35 874.9265 1,747.84 1,748.85 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VLQLTSWDEDAWASK 95.00% 4.11 0.566 4.35 875.4283 1,748.84 1,748.85 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VGKETVQTTEDQILKR 95.00% 4.92 0.492 3.92 923.0065 1,844.00 1,845.01 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% cDRVDQLTAQLADLAAR 95.00% 3.73 0.497 4.27 c1: Carbamidomethyl (+57.02) 958.4841 1,914.95 1,915.97 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% cDRVDQLTAQLADLAAR 95.00% 3.78 0.493 4.7 c1: Carbamidomethyl (+57.02) 958.4847 1,914.95 1,915.97 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% cDRVDQLTAQLADLAAR 95.00% 3.76 0.458 5.6 c1: Carbamidomethyl (+57.02) 958.485 1,914.95 1,915.97 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% cDRVDQLTAQLADLAAR 95.00% 3.85 0.454 4.89 c1: Carbamidomethyl (+57.02) 958.9856 1,915.96 1,915.97 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LVQAAQMLQSDPYSVPAR 95.00% 3.76 0.34 3.8 988.0059 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LVQAAQMLQSDPYSVPAR 95.00% 4.98 0.388 4.51 988.0078 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LVQAAQMLQSDPYSVPAR 95.00% 4.52 0.349 4.59 988.0087 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LVQAAQMLQSDPYSVPAR 95.00% 4.65 0.377 7.46 988.0087 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LVQAAQMLQSDPYSVPAR 95.00% 5.13 0.356 6 988.0089 1,974.00 1,974.01 2 A1BG_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GWLRDPSASPGDAGEQAIR 95.00% 3.74 0.158 0 991.9953 1,981.97 1,982.97 2 RL18A_HUMAN,CO4A6_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LVQAAQmLQSDPYSVPAR 95.00% 3.71 0.36 3.21 m7: Oxidation (+15.99) 996.0056 1,990.00 1,990.01 2 A1BG_HUMAN
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% TNISDEESEQATEMLVHNAQNLMQSVK 95.00% 0 0 3.17 1,016.81 3,047.40 3,046.41 3
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GILSGTSDLLLTFDEAEVR 95.00% 7.21 0.564 6.7 1,019.03 2,036.04 2,036.06 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GILSGTSDLLLTFDEAEVR 95.00% 7.08 0.554 6.29 1,019.03 2,036.04 2,036.06 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GILSGTSDLLLTFDEAEVR 95.00% 6 0.561 4.19 1,019.03 2,036.05 2,036.06 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VAMANIQPQMLVAGATSIAR 95.00% 5 0.495 4.39 1,022.04 2,042.07 2,042.09 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VAMANIQPQMLVAGATSIAR 95.00% 6.26 0.494 5.49 1,022.05 2,042.08 2,042.09 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VAMANIQPQMLVAGATSIAR 95.00% 5.81 0.497 5.4 1,022.05 2,042.08 2,042.09 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VAMANIQPQMLVAGATSIAR 95.00% 5.83 0.513 7.06 1,022.05 2,042.08 2,042.09 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VAMANIQPQmLVAGATSIAR 95.00% 5.46 0.574 4.66 m10: Oxidation (+15.99) 1,030.04 2,058.07 2,058.08 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% VAMANIQPQmLVAGATSIAR 95.00% 3.9 0.415 4.23 m10: Oxidation (+15.99) 1,030.04 2,058.07 2,058.08 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% AQQVSQGLDVLTAKVENAAR 95.00% 3.57 0.498 1.32 1,050.05 2,098.09 2,098.13 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% GILSGTSDLLLTFDEAEVRK 95.00% 5.01 0.568 3.85 1,083.08 2,164.14 2,164.15 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MQEAMTQEVSDVFSDTTTPIK 95.00% 7.02 0.693 9.11 1,180.04 2,358.07 2,358.08 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% MQEAMTQEVSDVFSDTTTPIK 95.00% 6.87 0.689 11.5 1,180.05 2,358.07 2,358.08 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LLAVAATAPPDAPNREEVFDER 95.00% 3.98 0.504 5.64 1,191.61 2,381.20 2,381.21 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% LLAVAATAPPDAPNREEVFDER 95.00% 4.16 0.512 4.03 1,191.61 2,381.21 2,381.21 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% KIDAAQNWLADPNGGPEGEEQIR 95.00% 5.9 0.656 6.1 1,255.11 2,508.20 2,508.21 2
 SAMPLE 3R Vinculin  VCL  VINC_HUMAN 123,783.20 100.00% 46 59 207 48.80% KIDAAQNWLADPNGGPEGEEQIR 95.00% 6.46 0.691 6.03 1,255.11 2,508.20 2,508.21 2
 SAMPLE 1 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 5 5 11 10.40% ELAELSAELDKDLR 95.00% 2.33 0.42 0 534.9513 1,601.83 1,601.84 3
 SAMPLE 1 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 5 5 11 10.40% IPASQHTQNWSATWTK 95.00% 2.23 0.184 0 619.3065 1,854.90 1,855.91 3
 SAMPLE 1 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 5 5 11 10.40% IPASQHTQNWSATWTK 95.00% 3 0.389 0 619.6394 1,855.89 1,855.91 3
 SAMPLE 1 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 5 5 11 10.40% FGTFPGNYVAPV 95.00% 2.5 0.471 1.8 634.818 1,267.62 1,268.63 2
 SAMPLE 1 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 5 5 11 10.40% QGIFPASYVQVSR 95.00% 2.9 0.484 2.6 726.3832 1,450.75 1,451.76 2
 SAMPLE 1 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 5 5 11 10.40% QGIFPASYVQVSR 95.00% 3.29 0.491 5.89 726.3835 1,450.75 1,451.76 2
 SAMPLE 1 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 5 5 11 10.40% QGIFPASYVQVSR 95.00% 2.94 0.435 3.28 726.3848 1,450.75 1,451.76 2
 SAMPLE 1 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 5 5 11 10.40% QGIFPASYVQVSR 95.00% 2.9 0.43 4.28 726.3854 1,450.76 1,451.76 2
 SAMPLE 1 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 5 5 11 10.40% QGIFPASYVQVSR 95.00% 2.91 0.325 2.7 726.3934 1,450.77 1,451.76 2
 SAMPLE 1 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 5 5 11 10.40% QGIFPASYVQVSR 95.00% 2.72 0.442 2.57 726.3962 1,450.78 1,451.76 2
 SAMPLE 1 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 5 5 11 10.40% SPADPTDLGGQTSPR 95.00% 3.3 0.559 3.04 749.862 1,497.71 1,498.71 2
 SAMPLE 1R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 99.90% 2 2 5 4.32% IPASQHTQNWSATWTK 95.00% 3.17 0.355 0 619.6401 1,855.90 1,855.91 3
 SAMPLE 1R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 99.90% 2 2 5 4.32% QGIFPASYVQVSR 95.00% 2.91 0.521 2.82 726.3827 1,450.75 1,451.76 2
 SAMPLE 1R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 99.90% 2 2 5 4.32% QGIFPASYVQVSR 95.00% 2.77 0.414 2.51 726.3833 1,450.75 1,451.76 2
 SAMPLE 1R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 99.90% 2 2 5 4.32% QGIFPASYVQVSR 95.00% 2.91 0.325 2.11 726.3934 1,450.77 1,451.76 2
 SAMPLE 1R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 99.90% 2 2 5 4.32% QGIFPASYVQVSR 95.00% 2.72 0.442 2.96 726.3962 1,450.78 1,451.76 2
 SAMPLE 2 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 3 4 7 6.41% ELAELSAELDKDLR 95.00% 1.67 0.272 0 534.617 1,600.83 1,601.84 3
 SAMPLE 2 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 3 4 7 6.41% ELAELSAELDKDLR 95.00% 2.3 0.442 0 534.617 1,600.83 1,601.84 3
 SAMPLE 2 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 3 4 7 6.41% PQTQNLGTPGPALSHSR 95.00% 4.78 0.534 0 587.6393 1,759.89 1,760.90 3
 SAMPLE 2 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 3 4 7 6.41% PQTQNLGTPGPALSHSR 95.00% 4.12 0.529 0 587.9723 1,760.89 1,760.90 3
 SAMPLE 2 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 3 4 7 6.41% FGTFPGNYVAPV 95.00% 1.82 0.348 0 634.8186 1,267.62 1,268.63 2
 SAMPLE 2 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 3 4 7 6.41% FGTFPGNYVAPV 95.00% 1.73 0.378 1.82 634.82 1,267.62 1,268.63 2
 SAMPLE 2 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 3 4 7 6.41% ELAELSAELDKDLR 95.00% 3.13 0.42 1.85 801.4224 1,600.83 1,601.84 2
 SAMPLE 2R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 4 4 6 8.05% MADGGSPFLGR 95.00% 2.16 0.234 1.44 554.2639 1,106.51 1,107.53 2
 SAMPLE 2R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 4 4 6 8.05% IPASQHTQNWSATWTK 95.00% 3.06 0.369 0 619.6406 1,855.90 1,855.91 3
 SAMPLE 2R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 4 4 6 8.05% QGIFPASYVQVSR 95.00% 2.33 0.354 0 726.3843 1,450.75 1,451.76 2
 SAMPLE 2R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 4 4 6 8.05% QGIFPASYVQVSR 95.00% 3.03 0.501 6.51 726.3853 1,450.75 1,451.76 2
 SAMPLE 2R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 4 4 6 8.05% ELAELSAELDKDLR 95.00% 2.93 0.439 3 801.4213 1,600.83 1,601.84 2
 SAMPLE 2R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 4 4 6 8.05% ELAELSAELDKDLR 95.00% 2.69 0.415 4.33 801.4225 1,600.83 1,601.84 2
 SAMPLE 3 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 3 3 5 6.11% ELAELSAELDKDLR 95.00% 2.35 0.316 0 534.6177 1,600.83 1,601.84 3
 SAMPLE 3 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 3 3 5 6.11% MADGGSPFLGR 95.00% 2.63 0.436 3.49 554.264 1,106.51 1,107.53 2
 SAMPLE 3 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 3 3 5 6.11% MADGGSPFLGR 95.00% 2.77 0.489 2.37 554.2671 1,106.52 1,107.53 2
 SAMPLE 3 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 3 3 5 6.11% IPASQHTQNWSATWTK 95.00% 2.89 0.34 0 619.6411 1,855.90 1,855.91 3
 SAMPLE 3 Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 3 3 5 6.11% IPASQHTQNWSATWTK 95.00% 3.3 0.453 0 619.6418 1,855.90 1,855.91 3
 SAMPLE 3R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 4 5 5 8.05% ELAELSAELDKDLR 95.00% 1.78 0.261 0 534.6172 1,600.83 1,601.84 3
 SAMPLE 3R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 4 5 5 8.05% MADGGSPFLGR 95.00% 2.64 0.371 2.48 554.2653 1,106.51 1,107.53 2
 SAMPLE 3R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 4 5 5 8.05% IPASQHTQNWSATWTK 95.00% 2.59 0.383 0 619.6421 1,855.90 1,855.91 3
 SAMPLE 3R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 4 5 5 8.05% QGIFPASYVQVSR 95.00% 2.33 0.406 2.09 726.3842 1,450.75 1,451.76 2
 SAMPLE 3R Vinexin  SORBS3  VINEX_HUMAN 75,311.90 100.00% 4 5 5 8.05% ELAELSAELDKDLR 95.00% 2.61 0.44 0 801.4226 1,600.83 1,601.84 2
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% IYISGMAPR 95.00% 3.17 0.374 0 504.2697 1,006.52 1,007.53 2
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% IYISGMAPR 95.00% 2.99 0.335 0 504.2706 1,006.53 1,007.53 2
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% DWHGVPGQVDAAMAGR 95.00% 3.7 0.441 3.96 556.2628 1,665.76 1,666.78 3
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% DWHGVPGQVDAAMAGR 95.00% 3.33 0.463 3.74 556.2629 1,665.77 1,666.78 3
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% GQYcYELDEK 95.00% 3.63 0.445 1.47 c4: Carbamidomethyl (+57.02) 652.7744 1,303.53 1,304.55 2
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% GQYcYELDEK 95.00% 3.37 0.512 1.17 c4: Carbamidomethyl (+57.02) 652.775 1,303.53 1,304.55 2
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% GQYcYELDEK 95.00% 2.7 0.471 1.82 c4: Carbamidomethyl (+57.02) 652.7755 1,303.54 1,304.55 2
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% GQYcYELDEK 95.00% 3.09 0.488 1.66 c4: Carbamidomethyl (+57.02) 652.7757 1,303.54 1,304.55 2
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% GQYcYELDEK 95.00% 3.04 0.505 1.57 c4: Carbamidomethyl (+57.02) 652.7763 1,303.54 1,304.55 2
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% GQYcYELDEK 95.00% 3.11 0.371 1.77 c4: Carbamidomethyl (+57.02) 652.7774 1,303.54 1,304.55 2
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% GQYcYELDEK 95.00% 3.19 0.51 1.74 c4: Carbamidomethyl (+57.02) 652.7811 1,303.55 1,304.55 2
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% FEDGVLDPDYPR 95.00% 3.4 0.269 1.96 711.8252 1,421.63 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% FEDGVLDPDYPR 95.00% 3.52 0.304 2.62 711.8257 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% FEDGVLDPDYPR 95.00% 3.3 0.315 2.34 711.8284 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% FEDGVLDPDYPR 95.00% 3.47 0.399 2.36 711.8286 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% FEDGVLDPDYPR 95.00% 3.28 0.407 1.49 711.8289 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% FEDGVLDPDYPR 95.00% 3.93 0.418 3.37 711.8292 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% FEDGVLDPDYPR 95.00% 3.46 0.416 2.02 711.8296 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% FEDGVLDPDYPR 95.00% 4.38 0.395 2.89 711.8301 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% FEDGVLDPDYPR 95.00% 4.01 0.424 2.26 711.8318 1,421.65 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% FEDGVLDPDYPR 95.00% 3.7 0.309 1.92 712.3305 1,422.65 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% DVWGIEGPIDAAFTR 95.00% 4.5 0.579 6.66 823.9243 1,645.83 1,646.82 2
 SAMPLE 1 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 4 4 13 13.00% DVWGIEGPIDAAFTR 95.00% 4.37 0.577 6.3 823.9254 1,645.84 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% IYISGMAPR 95.00% 2.73 0.28 0 504.2703 1,006.52 1,007.53 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DWHGVPGQVDAAMAGR 95.00% 3.2 0.329 2.77 556.5964 1,666.77 1,666.78 3
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% GQYcYELDEK 95.00% 1.96 0.277 0 c4: Carbamidomethyl (+57.02) 652.7733 1,303.53 1,304.55 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% GQYcYELDEK 95.00% 2.19 0.31 1.22 c4: Carbamidomethyl (+57.02) 652.7754 1,303.54 1,304.55 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% GQYcYELDEK 95.00% 2.68 0.519 2.72 c4: Carbamidomethyl (+57.02) 652.7764 1,303.54 1,304.55 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% GQYcYELDEK 95.00% 2.62 0.422 0 c4: Carbamidomethyl (+57.02) 652.7764 1,303.54 1,304.55 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% GQYcYELDEK 95.00% 3.19 0.51 1.49 c4: Carbamidomethyl (+57.02) 652.7811 1,303.55 1,304.55 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% GQYcYELDEK 95.00% 2.85 0.475 1.54 c4: Carbamidomethyl (+57.02) 652.7856 1,303.56 1,304.55 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% FEDGVLDPDYPR 95.00% 2.86 0.344 2.74 711.8272 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% FEDGVLDPDYPR 95.00% 3.04 0.398 2.29 711.8274 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% FEDGVLDPDYPR 95.00% 3.11 0.292 1.35 711.8285 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% FEDGVLDPDYPR 95.00% 3.85 0.423 1.23 711.8288 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% FEDGVLDPDYPR 95.00% 4.38 0.395 2.8 711.8301 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% FEDGVLDPDYPR 95.00% 2.79 0.464 1.6 711.8302 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% FEDGVLDPDYPR 95.00% 4.01 0.424 1.7 711.8318 1,421.65 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% FEDGVLDPDYPR 95.00% 4.11 0.351 2.54 711.8419 1,421.67 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% FEDGVLDPDYPR 95.00% 3.46 0.498 1.77 712.3319 1,422.65 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 2.76 0.426 4.36 823.9087 1,645.80 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 4.48 0.591 5.66 823.9099 1,645.80 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 3.28 0.617 6.26 823.9119 1,645.81 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 3.79 0.548 5.1 823.9123 1,645.81 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 3.91 0.47 7.96 823.9125 1,645.81 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 4.46 0.574 6.8 823.9127 1,645.81 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 4 0.502 7.12 823.9128 1,645.81 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 3.38 0.545 7.14 823.9138 1,645.81 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 4.5 0.579 6.6 823.9243 1,645.83 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 3.66 0.573 6.64 823.9248 1,645.83 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 4.37 0.577 6.21 823.9254 1,645.84 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 3.65 0.562 5.68 823.9284 1,645.84 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% DVWGIEGPIDAAFTR 95.00% 3.85 0.586 6.92 824.4104 1,646.81 1,646.82 2
 SAMPLE 1R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 22 16.10% SIAQYWLGcPAPGHL 95.00% 3.52 0.366 4.21 c9: Carbamidomethyl (+57.02) 835.4069 1,668.80 1,669.82 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% IYISGMAPR 95.00% 2.94 0.283 0 504.2696 1,006.52 1,007.53 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% IYISGMAPR 95.00% 3.11 0.365 0 504.2699 1,006.52 1,007.53 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% IYISGMAPR 95.00% 2.24 0.236 0 504.2699 1,006.52 1,007.53 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% DWHGVPGQVDAAMAGR 95.00% 4.08 0.406 2.09 556.2625 1,665.76 1,666.78 3
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% DWHGVPGQVDAAMAGR 95.00% 3.67 0.382 1.6 556.2628 1,665.77 1,666.78 3
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% DWHGVPGQVDAAMAGR 95.00% 3.75 0.434 2.55 556.2628 1,665.77 1,666.78 3
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% DWHGVPGQVDAAmAGR 95.00% 2.65 0.212 2.49 m13: Oxidation (+15.99) 561.5947 1,681.76 1,682.77 3
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% DWHGVPGQVDAAmAGR 95.00% 3.31 0.352 2.64 m13: Oxidation (+15.99) 561.9278 1,682.76 1,682.77 3
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% VDTVDPPYPR 95.00% 3.3 0.51 2.11 579.7932 1,157.57 1,158.58 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% VDTVDPPYPR 95.00% 3.26 0.499 2.02 579.7935 1,157.57 1,158.58 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% GQYcYELDEK 95.00% 3.24 0.493 2.03 c4: Carbamidomethyl (+57.02) 652.7758 1,303.54 1,304.55 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% GQYcYELDEK 95.00% 2.92 0.451 1.96 c4: Carbamidomethyl (+57.02) 652.7762 1,303.54 1,304.55 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% GQYcYELDEK 95.00% 3.44 0.522 1.44 c4: Carbamidomethyl (+57.02) 652.7762 1,303.54 1,304.55 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% GQYcYELDEK 95.00% 3.36 0.491 1.6 c4: Carbamidomethyl (+57.02) 652.7763 1,303.54 1,304.55 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% GQYcYELDEK 95.00% 3.43 0.506 2.09 c4: Carbamidomethyl (+57.02) 652.7763 1,303.54 1,304.55 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% GQYcYELDEK 95.00% 3.36 0.475 2.01 c4: Carbamidomethyl (+57.02) 652.7765 1,303.54 1,304.55 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% GQYcYELDEK 95.00% 3.11 0.536 2.17 c4: Carbamidomethyl (+57.02) 652.7768 1,303.54 1,304.55 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% GQYcYELDEK 95.00% 3.44 0.512 2.36 c4: Carbamidomethyl (+57.02) 652.777 1,303.54 1,304.55 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% GQYcYELDEK 95.00% 3.36 0.531 2.17 c4: Carbamidomethyl (+57.02) 652.7771 1,303.54 1,304.55 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% FEDGVLDPDYPR 95.00% 3.42 0.212 1.6 711.8271 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% FEDGVLDPDYPR 95.00% 3.06 0.408 1.92 711.8286 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% FEDGVLDPDYPR 95.00% 3.09 0.53 1.85 711.8287 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% FEDGVLDPDYPR 95.00% 3.07 0.324 2.96 711.8289 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% FEDGVLDPDYPR 95.00% 2.97 0.341 1.21 711.8297 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% FEDGVLDPDYPR 95.00% 3.33 0.377 1.92 711.8302 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% FEDGVLDPDYPR 95.00% 3.45 0.302 2.15 712.3303 1,422.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% FEDGVLDPDYPR 95.00% 3.69 0.337 2.74 712.3319 1,422.65 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% DWHGVPGQVDAAMAGR 95.00% 4.22 0.548 8.34 833.8888 1,665.76 1,666.78 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% DWHGVPGQVDAAMAGR 95.00% 3.58 0.521 7.39 833.8899 1,665.76 1,666.78 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% DWHGVPGQVDAAMAGR 95.00% 3.95 0.534 6.41 833.8921 1,665.77 1,666.78 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% DWHGVPGQVDAAMAGR 95.00% 4.01 0.565 7.09 833.8927 1,665.77 1,666.78 2
 SAMPLE 2 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 24 15.10% SIAQYWLGcPAPGHL 95.00% 4.16 0.454 3.8 c9: Carbamidomethyl (+57.02) 835.9126 1,669.81 1,669.82 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% IYISGMAPR 95.00% 2.48 0.384 0 503.6078 1,005.20 1,007.53 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DWHGVPGQVDAAMAGR 95.00% 4.07 0.423 3.96 556.2626 1,665.76 1,666.78 3
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DWHGVPGQVDAAMAGR 95.00% 3.14 0.333 0.959 556.2629 1,665.77 1,666.78 3
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DWHGVPGQVDAAMAGR 95.00% 4.08 0.468 3.41 556.263 1,665.77 1,666.78 3
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% VDTVDPPYPR 95.00% 2.5 0.271 0 579.7915 1,157.57 1,158.58 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% GQYcYELDEK 95.00% 3.01 0.472 1.23 c4: Carbamidomethyl (+57.02) 652.7749 1,303.53 1,304.55 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% GQYcYELDEK 95.00% 3.39 0.459 1.8 c4: Carbamidomethyl (+57.02) 652.7758 1,303.54 1,304.55 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% GQYcYELDEK 95.00% 3.21 0.489 1.12 c4: Carbamidomethyl (+57.02) 652.7762 1,303.54 1,304.55 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% GQYcYELDEK 95.00% 3.4 0.513 1.42 c4: Carbamidomethyl (+57.02) 652.7764 1,303.54 1,304.55 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% GQYcYELDEK 95.00% 2.13 0.309 0 c4: Carbamidomethyl (+57.02) 652.7766 1,303.54 1,304.55 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% GQYcYELDEK 95.00% 3.32 0.482 1.39 c4: Carbamidomethyl (+57.02) 652.7766 1,303.54 1,304.55 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% GQYcYELDEK 95.00% 3.28 0.49 1.29 c4: Carbamidomethyl (+57.02) 652.7771 1,303.54 1,304.55 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% FEDGVLDPDYPR 95.00% 3.71 0.299 1.82 711.8271 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% FEDGVLDPDYPR 95.00% 2.98 0.32 1.64 711.8286 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% FEDGVLDPDYPR 95.00% 2.72 0.364 2.32 711.8288 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% FEDGVLDPDYPR 95.00% 3.12 0.37 1.82 711.8297 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% FEDGVLDPDYPR 95.00% 3.08 0.235 1.35 711.8302 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% FEDGVLDPDYPR 95.00% 3.08 0.33 1.96 711.8303 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% FEDGVLDPDYPR 95.00% 3.77 0.431 3.28 712.3292 1,422.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% FEDGVLDPDYPR 95.00% 3.49 0.509 2.82 712.3323 1,422.65 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DVWGIEGPIDAAFTR 95.00% 3.53 0.474 5.21 823.9099 1,645.80 1,646.82 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DVWGIEGPIDAAFTR 95.00% 4.23 0.59 6.23 823.9107 1,645.81 1,646.82 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DVWGIEGPIDAAFTR 95.00% 2.54 0.261 2.59 823.9125 1,645.81 1,646.82 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DVWGIEGPIDAAFTR 95.00% 3.57 0.428 5.6 823.9129 1,645.81 1,646.82 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DVWGIEGPIDAAFTR 95.00% 3.75 0.583 7.74 823.9135 1,645.81 1,646.82 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DVWGIEGPIDAAFTR 95.00% 3.84 0.557 6.82 824.4107 1,646.81 1,646.82 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DVWGIEGPIDAAFTR 95.00% 3.43 0.501 6.15 824.411 1,646.81 1,646.82 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DVWGIEGPIDAAFTR 95.00% 4.16 0.545 6.08 824.4132 1,646.81 1,646.82 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DVWGIEGPIDAAFTR 95.00% 4.72 0.567 6.68 824.4134 1,646.81 1,646.82 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% DWHGVPGQVDAAMAGR 95.00% 3.71 0.534 6.43 833.8907 1,665.77 1,666.78 2
 SAMPLE 2R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 6 7 23 18.20% SIAQYWLGcPAPGHL 95.00% 4.06 0.353 2.23 c9: Carbamidomethyl (+57.02) 835.4057 1,668.80 1,669.82 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% IYISGMAPR 95.00% 2.5 0.336 0 504.2703 1,006.53 1,007.53 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% IYISGMAPR 95.00% 2.75 0.349 0 504.2704 1,006.53 1,007.53 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% IYISGMAPR 95.00% 2.91 0.265 0 504.2704 1,006.53 1,007.53 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% IYISGMAPR 95.00% 2.18 0.226 0 504.2707 1,006.53 1,007.53 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% DWHGVPGQVDAAMAGR 95.00% 4.4 0.458 2.92 556.2628 1,665.77 1,666.78 3
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% DWHGVPGQVDAAMAGR 95.00% 4.1 0.438 3.77 556.2631 1,665.77 1,666.78 3
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% DWHGVPGQVDAAMAGR 95.00% 4.84 0.472 4.15 556.2631 1,665.77 1,666.78 3
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% DWHGVPGQVDAAMAGR 95.00% 4.43 0.446 4.1 556.2632 1,665.77 1,666.78 3
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% DWHGVPGQVDAAMAGR 95.00% 4.69 0.463 2.92 556.2632 1,665.77 1,666.78 3
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% DWHGVPGQVDAAMAGR 95.00% 4.05 0.467 4.09 556.2634 1,665.77 1,666.78 3
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% DWHGVPGQVDAAmAGR 95.00% 3.35 0.342 2.55 m13: Oxidation (+15.99) 561.5944 1,681.76 1,682.77 3
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% DWHGVPGQVDAAmAGR 95.00% 2.42 0.117 2.55 m13: Oxidation (+15.99) 561.5951 1,681.76 1,682.77 3
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% VDTVDPPYPR 95.00% 2.55 0.423 1.92 579.7917 1,157.57 1,158.58 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% VDTVDPPYPR 95.00% 3.23 0.517 2.66 579.7924 1,157.57 1,158.58 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% VDTVDPPYPR 95.00% 3.54 0.491 1.92 579.7929 1,157.57 1,158.58 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% GQYcYELDEK 95.00% 2.98 0.522 0 c4: Carbamidomethyl (+57.02) 652.7757 1,303.54 1,304.55 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% GQYcYELDEK 95.00% 3.05 0.472 1.66 c4: Carbamidomethyl (+57.02) 652.7763 1,303.54 1,304.55 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% GQYcYELDEK 95.00% 3.08 0.509 1.57 c4: Carbamidomethyl (+57.02) 652.7763 1,303.54 1,304.55 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% GQYcYELDEK 95.00% 2.54 0.341 1.77 c4: Carbamidomethyl (+57.02) 652.7765 1,303.54 1,304.55 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% GQYcYELDEK 95.00% 3.31 0.523 1.92 c4: Carbamidomethyl (+57.02) 652.7766 1,303.54 1,304.55 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 2.68 0.354 0 711.825 1,421.63 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 2.36 0.189 1.08 711.8275 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 2.27 0.269 1.36 711.8279 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 3.11 0.467 1.92 711.8281 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 2.59 0.261 1.24 711.8284 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 3.41 0.243 0 711.8289 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 3.54 0.343 1.32 711.8292 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 3.51 0.335 2.66 711.8296 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 2.2 0.336 0 711.8296 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 3.46 0.42 3.32 711.8302 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 2.65 0.208 0 711.8302 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 3.38 0.303 1.28 711.8303 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% FEDGVLDPDYPR 95.00% 4.36 0.432 1.52 711.8313 1,421.65 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% SIAQYWLGcPAPGHL 95.00% 4.14 0.556 3.07 c9: Carbamidomethyl (+57.02) 835.4091 1,668.80 1,669.82 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% SIAQYWLGcPAPGHL 95.00% 3.48 0.558 3.49 c9: Carbamidomethyl (+57.02) 835.411 1,668.81 1,669.82 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% SIAQYWLGcPAPGHL 95.00% 3.83 0.601 2.38 c9: Carbamidomethyl (+57.02) 835.4121 1,668.81 1,669.82 2
 SAMPLE 3 Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 5 24 15.10% SIAQYWLGcPAPGHL 95.00% 4.53 0.577 3.44 c9: Carbamidomethyl (+57.02) 835.9132 1,669.81 1,669.82 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% IYISGMAPR 95.00% 2.7 0.352 0 504.2694 1,006.52 1,007.53 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DVWGIEGPIDAAFTR 95.00% 3.53 0.515 0 549.9433 1,646.81 1,646.82 3
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DWHGVPGQVDAAMAGR 95.00% 4.35 0.44 3.72 556.2625 1,665.76 1,666.78 3
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DWHGVPGQVDAAMAGR 95.00% 4.33 0.402 3.68 556.2628 1,665.77 1,666.78 3
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DWHGVPGQVDAAMAGR 95.00% 4.09 0.419 2.92 556.2628 1,665.77 1,666.78 3
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DWHGVPGQVDAAMAGR 95.00% 3.93 0.429 4.2 556.2629 1,665.77 1,666.78 3
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DWHGVPGQVDAAMAGR 95.00% 4.27 0.441 3.89 556.263 1,665.77 1,666.78 3
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DWHGVPGQVDAAMAGR 95.00% 4.38 0.481 2.24 556.2634 1,665.77 1,666.78 3
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DWHGVPGQVDAAmAGR 95.00% 3.28 0.34 3.08 m13: Oxidation (+15.99) 561.5948 1,681.76 1,682.77 3
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% GQYcYELDEK 95.00% 3.08 0.49 0 c4: Carbamidomethyl (+57.02) 652.7756 1,303.54 1,304.55 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% GQYcYELDEK 95.00% 2.84 0.492 1.27 c4: Carbamidomethyl (+57.02) 652.7758 1,303.54 1,304.55 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% GQYcYELDEK 95.00% 2.09 0.438 0 c4: Carbamidomethyl (+57.02) 652.7758 1,303.54 1,304.55 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% GQYcYELDEK 95.00% 3.3 0.512 1.51 c4: Carbamidomethyl (+57.02) 652.7765 1,303.54 1,304.55 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% GQYcYELDEK 95.00% 3.17 0.494 1.1 c4: Carbamidomethyl (+57.02) 652.7766 1,303.54 1,304.55 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% GQYcYELDEK 95.00% 2.73 0.447 0 c4: Carbamidomethyl (+57.02) 652.7774 1,303.54 1,304.55 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% GQYcYELDEK 95.00% 3.01 0.443 1.59 c4: Carbamidomethyl (+57.02) 652.7776 1,303.54 1,304.55 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% FEDGVLDPDYPR 95.00% 2.18 0.328 0 711.7204 1,421.43 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% FEDGVLDPDYPR 95.00% 2.81 0.225 2.36 711.8266 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% FEDGVLDPDYPR 95.00% 2.73 0.315 0 711.8272 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% FEDGVLDPDYPR 95.00% 3.62 0.321 1.64 711.8287 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% FEDGVLDPDYPR 95.00% 2.58 0.458 0 711.8289 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% FEDGVLDPDYPR 95.00% 3.84 0.306 1.47 711.8301 1,421.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% FEDGVLDPDYPR 95.00% 2.55 0.263 2.03 711.8304 1,421.65 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% FEDGVLDPDYPR 95.00% 2.3 0.17 1.42 711.8319 1,421.65 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% FEDGVLDPDYPR 95.00% 3.95 0.33 1.92 712.33 1,422.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% FEDGVLDPDYPR 95.00% 3.09 0.481 1.34 712.3302 1,422.64 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% FEDGVLDPDYPR 95.00% 3.91 0.338 2.35 712.3309 1,422.65 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% FEDGVLDPDYPR 95.00% 4.2 0.367 2.29 712.3311 1,422.65 1,422.65 2 COR1C_HUMAN,MUC16_HUMAN
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DVWGIEGPIDAAFTR 95.00% 2.23 0.341 1.39 823.9098 1,645.80 1,646.82 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DVWGIEGPIDAAFTR 95.00% 4.39 0.598 5.85 823.911 1,645.81 1,646.82 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DVWGIEGPIDAAFTR 95.00% 3.91 0.57 6.42 823.9115 1,645.81 1,646.82 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DVWGIEGPIDAAFTR 95.00% 2.86 0.388 2.19 823.9129 1,645.81 1,646.82 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DVWGIEGPIDAAFTR 95.00% 3.22 0.513 6.92 823.9136 1,645.81 1,646.82 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DVWGIEGPIDAAFTR 95.00% 3.05 0.543 5.31 823.9138 1,645.81 1,646.82 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DVWGIEGPIDAAFTR 95.00% 3.61 0.503 4.77 824.4118 1,646.81 1,646.82 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DVWGIEGPIDAAFTR 95.00% 4.81 0.598 6.28 824.4124 1,646.81 1,646.82 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% DVWGIEGPIDAAFTR 95.00% 4.67 0.513 6.4 824.4131 1,646.81 1,646.82 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% SIAQYWLGcPAPGHL 95.00% 3.94 0.55 2.92 c9: Carbamidomethyl (+57.02) 835.9117 1,669.81 1,669.82 2
 SAMPLE 3R Vitronectin  VTN  VTNC_HUMAN 54,288.10 100.00% 5 6 27 16.10% SIAQYWLGcPAPGHL 95.00% 4.07 0.586 3.39 c9: Carbamidomethyl (+57.02) 835.9125 1,669.81 1,669.82 2
 SAMPLE 2 Voltage-dependent anion-selective channel protein 1  VDAC1  VDAC1_HUMAN 30,755.90 99.80% 2 2 3 7.42% LTLSALLDGK 95.00% 3.02 0.357 1.89 515.8106 1,029.61 1,030.62 2
 SAMPLE 2 Voltage-dependent anion-selective channel protein 1  VDAC1  VDAC1_HUMAN 30,755.90 99.80% 2 2 3 7.42% VTQSNFAVGYK 95.00% 2.46 0.282 2.74 607.3106 1,212.61 1,213.62 2
 SAMPLE 2 Voltage-dependent anion-selective channel protein 1  VDAC1  VDAC1_HUMAN 30,755.90 99.80% 2 2 3 7.42% VTQSNFAVGYK 95.00% 2.73 0.364 0 607.3148 1,212.61 1,213.62 2
 SAMPLE 3 Voltage-dependent anion-selective channel protein 1  VDAC1  VDAC1_HUMAN 30,755.90 99.80% 2 2 4 11.30% VNNSSLIGLGYTQTLKPGIK 95.00% 2.92 0 1.55 702.0566 2,103.15 2,103.18 3
 SAMPLE 3 Voltage-dependent anion-selective channel protein 1  VDAC1  VDAC1_HUMAN 30,755.90 99.80% 2 2 4 11.30% VNNSSLIGLGYTQTLKPGIK 95.00% 3.45 0 1.82 702.0647 2,103.17 2,103.18 3
 SAMPLE 3 Voltage-dependent anion-selective channel protein 1  VDAC1  VDAC1_HUMAN 30,755.90 99.80% 2 2 4 11.30% YQIDPDAcFSAK 95.00% 2.29 0.427 2.15 c8: Carbamidomethyl (+57.02) 707.8172 1,413.62 1,414.63 2
 SAMPLE 3 Voltage-dependent anion-selective channel protein 1  VDAC1  VDAC1_HUMAN 30,755.90 99.80% 2 2 4 11.30% YQIDPDAcFSAK 95.00% 2.46 0.42 2.16 c8: Carbamidomethyl (+57.02) 707.8175 1,413.62 1,414.63 2
 SAMPLE 1 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 99.80% 2 2 5 10.90% YQLDPTASISAK 95.00% 2.05 0.214 2.11 647.3374 1,292.66 1,293.67 2
 SAMPLE 1 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 99.80% 2 2 5 10.90% YQLDPTASISAK 95.00% 2.64 0.422 1.89 647.338 1,292.66 1,293.67 2
 SAMPLE 1 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 99.80% 2 2 5 10.90% YQLDPTASISAK 95.00% 3.02 0.383 2.04 647.3411 1,292.67 1,293.67 2
 SAMPLE 1 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 99.80% 2 2 5 10.90% YQLDPTASISAK 95.00% 2.53 0.366 0 647.3442 1,292.67 1,293.67 2
 SAMPLE 1 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 99.80% 2 2 5 10.90% VNNSSLIGVGYTQTLRPGVK 95.00% 2.5 0.22 0 702.0558 2,103.14 2,103.16 3
 SAMPLE 2 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 6 20.70% LTLSALVDGK 95.00% 1.87 0.294 0 508.8019 1,015.59 1,016.60 2
 SAMPLE 2 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 6 20.70% LTLSALVDGK 95.00% 2.73 0.324 0 508.8022 1,015.59 1,016.60 2
 SAMPLE 2 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 6 20.70% YQLDPTASISAK 95.00% 2.9 0.425 2.57 647.337 1,292.66 1,293.67 2
 SAMPLE 2 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 6 20.70% YQLDPTASISAK 95.00% 2.74 0.431 2.8 647.3372 1,292.66 1,293.67 2
 SAMPLE 2 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 6 20.70% VNNSSLIGVGYTQTLRPGVK 95.00% 3.77 0.21 0 702.0568 2,103.15 2,103.16 3
 SAMPLE 2 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 6 20.70% ScSGVEFSTSGSSNTDTGK 95.00% 5.2 0.599 6.92 c2: Carbamidomethyl (+57.02) 954.3999 1,906.78 1,907.79 2
 SAMPLE 2R Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 8 20.70% LTLSALVDGK 95.00% 2.65 0.422 1.23 508.8017 1,015.59 1,016.60 2
 SAMPLE 2R Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 8 20.70% LTLSALVDGK 95.00% 2.58 0.443 1.32 508.8025 1,015.59 1,016.60 2
 SAMPLE 2R Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 8 20.70% LTLSALVDGK 95.00% 2.72 0.429 0 508.8027 1,015.59 1,016.60 2
 SAMPLE 2R Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 8 20.70% YQLDPTASISAK 95.00% 2.67 0.463 1.89 647.3369 1,292.66 1,293.67 2
 SAMPLE 2R Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 8 20.70% YQLDPTASISAK 95.00% 2.71 0.449 2 647.3382 1,292.66 1,293.67 2
 SAMPLE 2R Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 8 20.70% ScSGVEFSTSGSSNTDTGK 95.00% 5.18 0.563 6.27 c2: Carbamidomethyl (+57.02) 954.3999 1,906.78 1,907.79 2
 SAMPLE 2R Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 8 20.70% VNNSSLIGVGYTQTLRPGVK 95.00% 4.37 0.397 3.54 1,052.58 2,103.15 2,103.16 2
 SAMPLE 2R Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 8 20.70% VNNSSLIGVGYTQTLRPGVK 95.00% 4.22 0.445 2.44 1,052.59 2,103.16 2,103.16 2
 SAMPLE 3 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 5 19.00% LTLSALVDGK 95.00% 2.67 0.458 1.29 508.8017 1,015.59 1,016.60 2
 SAMPLE 3 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 5 19.00% YQLDPTASISAK 95.00% 3.16 0.466 1.74 647.3369 1,292.66 1,293.67 2
 SAMPLE 3 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 5 19.00% YQLDPTASISAK 95.00% 2.97 0.442 2.6 647.3371 1,292.66 1,293.67 2
 SAMPLE 3 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 5 19.00% VNNSSLIGVGYTQTLRPGVK 95.00% 3.01 0.139 0 701.7212 2,102.14 2,103.16 3
 SAMPLE 3 Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 100.00% 4 4 5 19.00% LTFDTTFSPNTGKK 95.00% 2.33 0.253 0 778.8985 1,555.78 1,556.80 2
 SAMPLE 3R Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 99.80% 2 2 2 10.20% LTLSALVDGK 95.00% 2.55 0.359 0 508.8007 1,015.59 1,016.60 2
 SAMPLE 3R Voltage-dependent anion-selective channel protein 2  VDAC2  VDAC2_HUMAN 31,549.30 99.80% 2 2 2 10.20% VNNSSLIGVGYTQTLRPGVK 95.00% 4.46 0.514 2.59 1,052.58 2,103.15 2,103.16 2
 SAMPLE 4 von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 3 7 11.90% LLRPQILR 95.00% 2.33 0.196 0 504.8385 1,007.66 1,008.67 2 PLEC1_HUMAN
 SAMPLE 4 von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 3 7 11.90% DLGVTVFIVSTGR 95.00% 3.72 0.574 3.04 682.3852 1,362.75 1,363.76 2
 SAMPLE 4 von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 3 7 11.90% DLGVTVFIVSTGR 95.00% 3 0.395 1.36 682.3861 1,362.76 1,363.76 2
 SAMPLE 4 von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 3 7 11.90% DLGVTVFIVSTGR 95.00% 2.83 0.306 1.39 682.3896 1,362.76 1,363.76 2
 SAMPLE 4 von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 3 7 11.90% GNFLELSAAASAPAEK 95.00% 4.74 0.481 5.02 788.4076 1,574.80 1,575.80 2
 SAMPLE 4 von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 3 7 11.90% GNFLELSAAASAPAEK 95.00% 4.37 0.457 4.8 788.4077 1,574.80 1,575.80 2
 SAMPLE 4 von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 3 7 11.90% EQLFAEASGARPGVPK 95.00% 4.24 0.424 3.7 828.9415 1,655.87 1,656.87 2
 SAMPLE 4 von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 3 7 11.90% EQLFAEASGARPGVPK 95.00% 4.27 0.48 4.77 829.4444 1,656.87 1,656.87 2
 SAMPLE 4R von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 4 8 11.20% EQLFAEASGARPGVPK 95.00% 2.08 0.4 0 552.965 1,655.87 1,656.87 3
 SAMPLE 4R von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 4 8 11.20% EQLFAEASGARPGVPK 95.00% 2.35 0.411 0 553.2982 1,656.87 1,656.87 3
 SAMPLE 4R von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 4 8 11.20% GNFLELSAAASAPAEK 95.00% 4.42 0.467 3.28 788.4065 1,574.80 1,575.80 2
 SAMPLE 4R von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 4 8 11.20% GNFLELSAAASAPAEK 95.00% 4.19 0.482 3.3 788.4099 1,574.80 1,575.80 2
 SAMPLE 4R von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 4 8 11.20% EQLFAEASGARPGVPK 95.00% 4.37 0.52 4.27 828.9399 1,655.86 1,656.87 2
 SAMPLE 4R von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 4 8 11.20% EQLFAEASGARPGVPK 95.00% 4.33 0.503 2.54 828.9426 1,655.87 1,656.87 2
 SAMPLE 4R von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 4 8 11.20% EQLFAEASGARPGVPK 95.00% 4.01 0.513 3.96 828.9431 1,655.87 1,656.87 2
 SAMPLE 4R von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 100.00% 3 4 8 11.20% EFVGQLVAPLPLGTGALR 95.00% 4.85 0.584 2.12 919.5318 1,837.05 1,838.05 2
 SAMPLE 1R von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 99.80% 2 2 3 7.64% EQLFAEASGARPGVPK 95.00% 4.2 0.436 4.62 829.4416 1,656.87 1,656.87 2
 SAMPLE 1R von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 99.80% 2 2 3 7.64% EFVGQLVAPLPLGTGALR 95.00% 5.19 0.615 2.6 919.528 1,837.04 1,838.05 2
 SAMPLE 1R von Willebrand factor A domain-containing protein 1  VWA1  VWA1_HUMAN 46,786.20 99.80% 2 2 3 7.64% EFVGQLVAPLPLGTGALR 95.00% 4 0.529 1.82 920.0309 1,838.05 1,838.05 2
 SAMPLE 1 WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 100.00% 3 3 4 6.93% VFASLPQVER 95.00% 3.06 0.384 0 573.3189 1,144.62 1,145.63 2
 SAMPLE 1 WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 100.00% 3 3 4 6.93% VFASLPQVER 95.00% 2.79 0.304 0 573.8218 1,145.63 1,145.63 2
 SAMPLE 1 WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 100.00% 3 3 4 6.93% YAPSGFYIASGDVSGK 95.00% 3.63 0.515 2.51 809.8907 1,617.77 1,618.78 2
 SAMPLE 1 WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 100.00% 3 3 4 6.93% FATASADGQIYIYDGK 95.00% 4.28 0.598 5.72 860.9152 1,719.81 1,719.82 2
 SAMPLE 1R WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 99.80% 2 2 3 4.29% VFASLPQVER 95.00% 2.88 0.324 0 573.3189 1,144.62 1,145.63 2
 SAMPLE 1R WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 99.80% 2 2 3 4.29% VFASLPQVER 95.00% 3.07 0.385 0 573.319 1,144.62 1,145.63 2
 SAMPLE 1R WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 99.80% 2 2 3 4.29% YAPSGFYIASGDVSGK 95.00% 4.74 0.56 6.72 810.3927 1,618.77 1,618.78 2
 SAMPLE 3 WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 100.00% 3 3 7 6.60% VFASLPQVER 95.00% 2.82 0.358 0 573.3183 1,144.62 1,145.63 2
 SAMPLE 3 WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 100.00% 3 3 7 6.60% VFASLPQVER 95.00% 2.44 0.165 1.48 573.3198 1,144.62 1,145.63 2
 SAMPLE 3 WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 100.00% 3 3 7 6.60% VFASLPQVER 95.00% 2.84 0.345 0 573.321 1,144.63 1,145.63 2
 SAMPLE 3 WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 100.00% 3 3 7 6.60% LYSILGTTLKDEGK 95.00% 3.51 0.474 2.2 769.4282 1,536.84 1,537.85 2
 SAMPLE 3 WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 100.00% 3 3 7 6.60% LYSILGTTLKDEGK 95.00% 3.05 0.432 2.74 769.4311 1,536.85 1,537.85 2
 SAMPLE 3 WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 100.00% 3 3 7 6.60% YAPSGFYIASGDVSGK 95.00% 5.08 0.62 6 809.8893 1,617.76 1,618.78 2
 SAMPLE 3 WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 100.00% 3 3 7 6.60% YAPSGFYIASGDVSGK 95.00% 5.08 0.621 5.54 809.8897 1,617.76 1,618.78 2
 SAMPLE 3R WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 99.80% 2 2 4 4.29% VFASLPQVER 95.00% 2.57 0.344 0 573.3191 1,144.62 1,145.63 2
 SAMPLE 3R WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 99.80% 2 2 4 4.29% VFASLPQVER 95.00% 2.74 0.358 0 573.321 1,144.63 1,145.63 2
 SAMPLE 3R WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 99.80% 2 2 4 4.29% YAPSGFYIASGDVSGK 95.00% 5 0.592 6.59 809.8896 1,617.76 1,618.78 2
 SAMPLE 3R WD repeat-containing protein 1  WDR1  WDR1_HUMAN 66,175.20 99.80% 2 2 4 4.29% YAPSGFYIASGDVSGK 95.00% 4.88 0.585 5.85 809.8903 1,617.77 1,618.78 2
 SAMPLE 2 WNT1-inducible-signaling pathway protein 2  WISP2  WISP2_HUMAN 26,806.00 99.80% 2 2 2 8.80% LPSWDcPHPR 95.00% 1.91 0.409 0 c6: Carbamidomethyl (+57.02) 633.3064 1,264.60 1,264.59 2
 SAMPLE 2 WNT1-inducible-signaling pathway protein 2  WISP2  WISP2_HUMAN 26,806.00 99.80% 2 2 2 8.80% EGETFQPHcSIR 95.00% 3.7 0.335 1.57 c9: Carbamidomethyl (+57.02) 730.8324 1,459.65 1,460.66 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% FGPVVAPKPK 95.00% 2.2 0.434 0 520.3163 1,038.62 1,039.63 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% FGPVVAPKPK 95.00% 2.36 0.418 1.8 520.3174 1,038.62 1,039.63 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% AYHPHcFTcVVcAR 95.00% 3.42 0.538 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 593.2601 1,776.76 1,777.77 3
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% QNVAVNELcGR 95.00% 2.2 0.387 0 c9: Carbamidomethyl (+57.02) 629.6689 1,257.32 1,259.62 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% QNVAVNELcGR 95.00% 2.8 0.584 3.26 c9: Carbamidomethyl (+57.02) 630.3095 1,258.60 1,259.62 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% QNVAVNELcGR 95.00% 2.53 0.423 1.32 c9: Carbamidomethyl (+57.02) 630.3098 1,258.60 1,259.62 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% QNVAVNELcGR 95.00% 1.52 0.418 0 c9: Carbamidomethyl (+57.02) 630.3098 1,258.60 1,259.62 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% QNVAVNELcGR 95.00% 2.94 0.596 2.3 c9: Carbamidomethyl (+57.02) 630.3098 1,258.60 1,259.62 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% QNVAVNELcGR 95.00% 2.78 0.363 0 c9: Carbamidomethyl (+57.02) 630.3114 1,258.61 1,259.62 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% QNVAVNELcGR 95.00% 2.72 0.531 2.96 c9: Carbamidomethyl (+57.02) 630.3156 1,258.62 1,259.62 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% VNPFRPGDSEPPPAPGAQR 95.00% 3.55 0.514 1.8 663.6697 1,987.99 1,988.99 3
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% VNPFRPGDSEPPPAPGAQR 95.00% 3.18 0.458 3.85 664.005 1,988.99 1,988.99 3
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% PQVQLHVQSQTQPVSLANTQPR 95.00% 4.85 0.576 0 819.7725 2,456.29 2,456.30 3
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% PQVQLHVQSQTQPVSLANTQPR 95.00% 5.83 0.608 0 819.7731 2,456.30 2,456.30 3
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% SSTKPAAGGTAPLPPWK 95.00% 3.82 0.478 1.72 833.4497 1,664.88 1,665.90 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% VSSGYVPPPVATPFSSK 95.00% 2.86 0.46 2.8 860.4472 1,718.88 1,719.90 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% VSSGYVPPPVATPFSSK 95.00% 2.97 0.36 1.28 860.452 1,718.89 1,719.90 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% VSSGYVPPPVATPFSSK 95.00% 2.51 0.214 1.7 860.951 1,719.89 1,719.90 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% VSSGYVPPPVATPFSSK 95.00% 3.01 0.457 2.52 860.9518 1,719.89 1,719.90 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 4.55 0.427 4.07 866.7626 2,597.26 2,597.28 3
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% PSPAISVSVSAPAFYAPQK 95.00% 5.14 0.679 0 959.0069 1,916.00 1,917.01 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% PSPAISVSVSAPAFYAPQK 95.00% 5.35 0.665 0 959.5079 1,917.00 1,917.01 2
 SAMPLE 1 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 22 32.20% SPSSSQPLPQVPAPAQSQTQFHVQPQPQPK 95.00% 5.25 0.56 0 1,074.88 3,221.63 3,221.63 3
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% SPGAPGPLTLK 95.00% 2.64 0.437 3.28 519.3018 1,036.59 1,037.60 2
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% FGPVVAPKPK 95.00% 2.2 0.404 0 520.3165 1,038.62 1,039.63 2
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% AYHPHcFTcVVcAR 95.00% 3.72 0.499 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 593.2606 1,776.76 1,777.77 3
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% QNVAVNELcGR 95.00% 2.84 0.584 3.4 c9: Carbamidomethyl (+57.02) 630.309 1,258.60 1,259.62 2
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% QNVAVNELcGR 95.00% 2.74 0.537 2.36 c9: Carbamidomethyl (+57.02) 630.3094 1,258.60 1,259.62 2
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% QNVAVNELcGR 95.00% 2.51 0.442 1.11 c9: Carbamidomethyl (+57.02) 630.3112 1,258.61 1,259.62 2
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% QNVAVNELcGR 95.00% 3.25 0.552 2.44 c9: Carbamidomethyl (+57.02) 630.3113 1,258.61 1,259.62 2
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% QNVAVNELcGR 95.00% 2.72 0.531 3.55 c9: Carbamidomethyl (+57.02) 630.3156 1,258.62 1,259.62 2
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% VNPFRPGDSEPPPAPGAQR 95.00% 3.81 0.514 3.62 664.0046 1,988.99 1,988.99 3
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% VNPFRPGDSEPPPAPGAQR 95.00% 3.67 0.421 2.85 664.0057 1,988.99 1,988.99 3
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% VSSGYVPPPVATPFSSK 95.00% 2.63 0.254 1.85 860.451 1,718.89 1,719.90 2
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% VSSGYVPPPVATPFSSK 95.00% 2.93 0.458 2.74 860.952 1,719.89 1,719.90 2
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 4.17 0.358 2.77 866.7598 2,597.26 2,597.28 3
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 4.01 0.526 4.47 866.7628 2,597.26 2,597.28 3
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 4.21 0.492 2.74 866.7634 2,597.27 2,597.28 3
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 3.65 0.462 3 866.7642 2,597.27 2,597.28 3
 SAMPLE 1R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 8 8 17 22.00% PSPAISVSVSAPAFYAPQK 95.00% 5.28 0.676 0 959.5102 1,917.00 1,917.01 2
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% FGPVVAPKPK 95.00% 2.93 0.414 1.7 520.3174 1,038.62 1,039.63 2
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% FGPVVAPKPK 95.00% 3.04 0.428 1.6 520.3177 1,038.62 1,039.63 2
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% AYHPHcFTcVVcAR 95.00% 4.46 0.592 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 593.2609 1,776.76 1,777.77 3
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% QNVAVNELcGR 95.00% 2.89 0.601 3.47 c9: Carbamidomethyl (+57.02) 630.311 1,258.61 1,259.62 2
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% QNVAVNELcGR 95.00% 2.96 0.572 3.14 c9: Carbamidomethyl (+57.02) 630.3112 1,258.61 1,259.62 2
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% PAAGGTAPLPPWK 95.00% 2.08 0.427 0 632.016 1,262.02 1,262.69 2
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% PAAGGTAPLPPWK 95.00% 2.12 0.381 0 632.0168 1,262.02 1,262.69 2
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% VNPFRPGDSEPPPAPGAQR 95.00% 3.14 0.401 3.51 664.0045 1,988.99 1,988.99 3
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% cSVcSEPIMPEPGRDETVR 95.00% 2.6 0.366 2.1 c1: Carbamidomethyl (+57.02), c4: Carbamidomethyl (+57.02) 740.668 2,218.98 2,218.99 3
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% PQVQLHVQSQTQPVSLANTQPR 95.00% 5.77 0.615 0 819.7723 2,456.29 2,456.30 3
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% PQVQLHVQSQTQPVSLANTQPR 95.00% 6.25 0.618 0 819.773 2,456.30 2,456.30 3
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% SSTKPAAGGTAPLPPWK 95.00% 4.34 0.482 4 833.9533 1,665.89 1,665.90 2
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% qHPVPPPAQNQNQVR 95.00% 0 0 3.49 n-term: Pyro-cmC (-17.03) 847.4319 1,692.85 1,692.86 2
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% VSSGYVPPPVATPFSSK 95.00% 3.01 0.478 2.72 860.4508 1,718.89 1,719.90 2
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% VSSGYVPPPVATPFSSK 95.00% 2.36 0.374 2.52 860.4511 1,718.89 1,719.90 2
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% VSSGYVPPPVATPFSSK 95.00% 3.46 0.525 3.72 860.9516 1,719.89 1,719.90 2
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 5.26 0.556 5.68 866.7631 2,597.27 2,597.28 3
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 4.49 0.535 5.1 866.7634 2,597.27 2,597.28 3
 SAMPLE 2 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 11 18 32.90% PSPAISVSVSAPAFYAPQK 95.00% 5.72 0.613 0 959.5096 1,917.00 1,917.01 2
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% FGPVVAPKPK 95.00% 2.86 0.465 1.85 520.3176 1,038.62 1,039.63 2
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% AYHPHcFTcVVcAR 95.00% 3.91 0.559 0 c6: Carbamidomethyl (+57.02), c9: Carbamidomethyl (+57.02), c12: Carbamidomethyl (+57.02) 593.5979 1,777.77 1,777.77 3
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% QNVAVNELcGR 95.00% 2.95 0.606 3.7 c9: Carbamidomethyl (+57.02) 630.3112 1,258.61 1,259.62 2
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% QNVAVNELcGR 95.00% 3.06 0.545 3.62 c9: Carbamidomethyl (+57.02) 630.3113 1,258.61 1,259.62 2
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% PAAGGTAPLPPWK 95.00% 2.03 0.47 0 631.6812 1,261.35 1,262.69 2
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% PAAGGTAPLPPWK 95.00% 2.05 0.409 0 632.0168 1,262.02 1,262.69 2
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% VNPFRPGDSEPPPAPGAQR 95.00% 3.59 0.548 3.51 664.0065 1,989.00 1,988.99 3
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% PQVQLHVQSQTQPVSLANTQPR 95.00% 6.02 0.616 0 819.7722 2,456.29 2,456.30 3
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% PQVQLHVQSQTQPVSLANTQPR 95.00% 5.84 0.59 0 819.7736 2,456.30 2,456.30 3
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% qHPVPPPAQNQNQVR 95.00% 0 0 3.92 n-term: Pyro-cmC (-17.03) 847.4315 1,692.85 1,692.86 2
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% VSSGYVPPPVATPFSSK 95.00% 2.28 0.425 3.35 860.45 1,718.88 1,719.90 2
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% VSSGYVPPPVATPFSSK 95.00% 3.04 0.453 3.33 860.9521 1,719.89 1,719.90 2
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 4.26 0.519 3.85 866.7611 2,597.26 2,597.28 3
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 4.22 0.553 4.03 866.7628 2,597.26 2,597.28 3
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% PSPAISVSVSAPAFYAPQK 95.00% 5.4 0.627 0 959.5106 1,917.01 1,917.01 2
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% PSPAISVSVSAPAFYAPQK 95.00% 5.06 0.624 0 959.5114 1,917.01 1,917.01 2
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% VNPFRPGDSEPPPAPGAQR 95.00% 2.93 0.405 1.59 995.4807 1,988.95 1,988.99 2
 SAMPLE 2R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 11 12 18 34.10% SPSSSQPLPQVPAPAQSQTQFHVQPQPQPK 95.00% 4.88 0.593 0 1,074.88 3,221.62 3,221.63 3
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% SPGAPGPLTLK 95.00% 2.06 0.351 0 519.3023 1,036.59 1,037.60 2
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% SPGAPGPLTLK 95.00% 2.05 0.275 1.8 519.3025 1,036.59 1,037.60 2
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% FGPVVAPKPK 95.00% 2.45 0.419 1.64 520.317 1,038.62 1,039.63 2
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% FGPVVAPKPK 95.00% 2.71 0.442 1.09 520.3172 1,038.62 1,039.63 2
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% SSTKPAAGGTAPLPPWK 95.00% 1.84 0.179 1.48 555.9705 1,664.89 1,665.90 3
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% QNVAVNELcGR 95.00% 2.87 0.374 1.08 c9: Carbamidomethyl (+57.02) 630.3112 1,258.61 1,259.62 2
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% QNVAVNELcGR 95.00% 2.55 0.517 1.64 c9: Carbamidomethyl (+57.02) 630.3113 1,258.61 1,259.62 2
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% PAAGGTAPLPPWK 95.00% 2.34 0.532 0 631.6831 1,261.35 1,262.69 2
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% VNPFRPGDSEPPPAPGAQR 95.00% 3.61 0.364 2.92 664.0026 1,988.98 1,988.99 3
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% VNPFRPGDSEPPPAPGAQR 95.00% 3.67 0.353 3.33 664.0043 1,988.99 1,988.99 3
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% PQVQLHVQSQTQPVSLANTQPR 95.00% 5.39 0.601 0 819.7732 2,456.30 2,456.30 3
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% VSSGYVPPPVATPFSSK 95.00% 2.79 0.438 3.05 860.4503 1,718.89 1,719.90 2
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% VSSGYVPPPVATPFSSK 95.00% 2.22 0.2 2.59 860.4506 1,718.89 1,719.90 2
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% VSSGYVPPPVATPFSSK 95.00% 3.37 0.419 1.54 860.9534 1,719.89 1,719.90 2
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% VSSGYVPPPVATPFSSK 95.00% 2.78 0.351 2.14 860.9538 1,719.89 1,719.90 2
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 4.18 0.512 4.8 866.7624 2,597.26 2,597.28 3
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 4.49 0.532 5.12 866.7632 2,597.27 2,597.28 3
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 5.18 0.588 4 866.7633 2,597.27 2,597.28 3
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 4.22 0.516 5.62 866.7636 2,597.27 2,597.28 3
 SAMPLE 3 Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 9 9 19 28.30% SPSSSQPLPQVPAPAQSQTQFHVQPQPQPK 95.00% 4.64 0.624 0 1,074.88 3,221.62 3,221.63 3
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% SPGAPGPLTLK 95.00% 2.07 0.34 1.57 519.3023 1,036.59 1,037.60 2
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% SPGAPGPLTLK 95.00% 2.1 0.272 0 519.3036 1,036.59 1,037.60 2
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% SPGAPGPLTLK 95.00% 2.1 0.298 1.44 519.8042 1,037.59 1,037.60 2
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% FGPVVAPKPK 95.00% 2.7 0.408 1.92 520.3165 1,038.62 1,039.63 2
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% FGPVVAPKPK 95.00% 2.91 0.43 0 520.317 1,038.62 1,039.63 2
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% QNVAVNELcGR 95.00% 3.02 0.576 2.72 c9: Carbamidomethyl (+57.02) 630.3112 1,258.61 1,259.62 2
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% QNVAVNELcGR 95.00% 2.81 0.553 1.57 c9: Carbamidomethyl (+57.02) 630.3113 1,258.61 1,259.62 2
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% QNVAVNELcGR 95.00% 2.29 0.254 0 c9: Carbamidomethyl (+57.02) 630.3114 1,258.61 1,259.62 2
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% VNPFRPGDSEPPPAPGAQR 95.00% 3.52 0.404 3.68 663.6695 1,987.99 1,988.99 3
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% VNPFRPGDSEPPPAPGAQR 95.00% 2.18 0.274 0 663.6721 1,987.99 1,988.99 3
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% VNPFRPGDSEPPPAPGAQR 95.00% 3.02 0.423 3 664.0065 1,989.00 1,988.99 3
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% PQVQLHVQSQTQPVSLANTQPR 95.00% 5.6 0.638 0 819.7723 2,456.29 2,456.30 3
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% PQVQLHVQSQTQPVSLANTQPR 95.00% 5.62 0.631 0 819.7749 2,456.30 2,456.30 3
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% VSSGYVPPPVATPFSSK 95.00% 2.46 0.365 2.54 860.4528 1,718.89 1,719.90 2
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% VSSGYVPPPVATPFSSK 95.00% 2.66 0.338 2.72 860.4545 1,718.89 1,719.90 2
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% VSSGYVPPPVATPFSSK 95.00% 2.43 0.0985 3.23 860.9539 1,719.89 1,719.90 2
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% VSSGYVPPPVATPFSSK 95.00% 3.11 0.325 3.17 860.9541 1,719.89 1,719.90 2
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 4.8 0.529 3.96 866.7632 2,597.27 2,597.28 3
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 5.04 0.543 5.02 866.7634 2,597.27 2,597.28 3
 SAMPLE 3R Zyxin  ZYX  ZYX_HUMAN 61,258.00 100.00% 7 7 20 20.10% LGHPEALSAGTGSPQPPSFTYAQQR 95.00% 4.38 0.518 4 866.764 2,597.27 2,597.28 3
